1 hsa-let-7a-1 hsa03022 Basal transcription factors 2967_2961_2960_2963_6881_54457_2968_6879_6878_6877_6874_6872_2957_6873_2958_6884_2959_6880_6882_138474_6883 21 1.94E-35 1.26E-33 1.26E-33 2 hsa-let-7a-1 hsa05200 Pathways in cancer 5925_5594_6256_3326_4193_5970_7157_6688_3725_10401_4609_2353_2033_8554_7184 15 4.37E-11 2.84E-09 1.42E-09 3 hsa-let-7a-1 hsa05215 Prostate cancer 5925_5594_3326_4193_5970_7157_2033_7184 8 1.11E-08 7.24E-07 1.97E-07 4 hsa-let-7a-1 hsa05212 Pancreatic cancer 5925_5594_3326_4193_5970_7157_2033_7184 8 1.21E-08 7.87E-07 1.97E-07 5 hsa-let-7a-1 hsa05222 Small cell lung cancer 5925_6256_5970_7157_10401_4609_8554 7 1.92E-07 1.25E-05 2.50E-06 6 hsa-let-7a-1 hsa05220 Chronic myeloid leukemia 5925_5594_4193_5970_7157_4609 6 1.63E-06 0.000106142 1.77E-05 7 hsa-let-7a-1 hsa05219 Bladder cancer 5925_5594_4193_7157_4609 5 2.05E-06 0.000133441 1.91E-05 8 hsa-let-7a-1 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 3.76E-06 0.000244401 3.06E-05 9 hsa-let-7a-1 hsa05216 Thyroid cancer 5594_6256_7157_4609 4 1.34E-05 0.0008735 9.71E-05 10 hsa-let-7a-1 hsa04110 Cell cycle 5925_4193_7157_4171_4085_2033 6 2.01E-05 0.001309216 0.000130922 11 hsa-let-7a-1 hsa04010 MAPK signaling pathway 3727_5594_5970_3312_7157_3725_4609_2353 8 3.71E-05 0.002410564 0.000219142 12 hsa-let-7a-1 hsa05210 Colorectal cancer 5594_7157_3725_4609_2353 5 4.79E-05 0.003113308 0.000259442 13 hsa-let-7a-1 hsa04310 Wnt signaling pathway 1460_8607_7157_3725_4609_2033 6 7.49E-05 0.004865764 0.00037429 14 hsa-let-7a-1 hsa05223 Non-small cell lung cancer 5925_5594_6256_7157 4 0.000127933 0.008315673 0.000593977 15 hsa-let-7a-1 hsa05221 Acute myeloid leukemia 5594_5970_6688_4609 4 0.000176581 0.011477736 0.000765182 16 hsa-let-7a-1 hsa05016 Huntington's disease 6874_9001_5430_7157_3064_2033 6 0.000229523 0.014918981 0.000932436 17 hsa-let-7a-1 hsa05214 Glioma 5925_5594_4193_7157 4 0.000251091 0.01632092 0.000960054 18 hsa-let-7a-1 hsa05218 Melanoma 5925_5594_4193_7157 4 0.000345887 0.022482668 0.001249037 19 hsa-let-7a-1 hsa04662 B cell receptor signaling pathway 5594_5970_3725_2353 4 0.000421797 0.027416813 0.00144299 20 hsa-let-7a-1 hsa03420 Nucleotide excision repair 2967_2968_5887 3 0.001182634 0.07687119 0.00384356 21 hsa-let-7a-1 hsa04620 Toll-like receptor signaling pathway 5594_5970_3725_2353 4 0.001272446 0.08270899 0.003938523 22 hsa-let-7a-1 hsa04660 T cell receptor signaling pathway 5594_5970_3725_2353 4 0.001663531 0.1081295 0.004914977 23 hsa-let-7a-1 hsa05213 Endometrial cancer 5594_7157_4609 3 0.001864907 0.121218972 0.00527039 24 hsa-let-7a-1 hsa05211 Renal cell carcinoma 5594_3725_2033 3 0.004502222 0.292644441 0.012193518 25 hsa-let-7a-1 hsa04630 Jak-STAT signaling pathway 10401_4609_2033_8554 4 0.005490711 0.356896225 0.014275849 26 hsa-let-7a-1 hsa04520 Adherens junction 1460_5594_2033 3 0.005971651 0.388157339 0.014929128 27 hsa-let-7a-1 hsa04350 TGF-beta signaling pathway 5594_4609_2033 3 0.00746691 0.485349136 0.017333898 28 hsa-let-7a-1 hsa04012 ErbB signaling pathway 5594_3725_4609 3 0.00746691 0.485349136 0.017333898 29 hsa-let-7a-1 hsa04612 Antigen processing and presentation 3326_4801_3312 3 0.007931055 0.515518593 0.017776503 30 hsa-let-7a-1 hsa04330 Notch signaling pathway 2033_8850 2 0.019860078 1 0.043030168 31 hsa-let-7a-1 hsa04120 Ubiquitin mediated proteolysis 4193_10401_8554 3 0.025183516 1 0.052804147 32 hsa-let-7a-1 hsa05322 Systemic lupus erythematosus 8340_3014_3015 3 0.027522157 1 0.055904381 33 hsa-let-7a-1 hsa04920 Adipocytokine signaling pathway 6256_5970 2 0.037426761 1 0.073719378 34 hsa-let-7a-1 hsa04115 p53 signaling pathway 4193_7157 2 0.039420171 1 0.075362092 35 hsa-let-7a-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_3725 2 0.041453112 1 0.076984351 36 hsa-let-7a-1 hsa04720 Long-term potentiation 5594_2033 2 0.04563424 1 0.082395156 37 hsa-let-7a-2 hsa05200 Pathways in cancer 3320_5925_3326_1147_3551_1499_5595_5594_1387_6256_1487_367_8517_2932_6774_5970_6688_2113_4087_1869_862_6502_2353_4088_7175_3065_1488_2033_4791_4792 30 1.45E-23 1.07E-21 1.07E-21 38 hsa-let-7a-2 hsa05215 Prostate cancer 3320_5925_3326_1147_3551_1499_5595_5594_1387_367_8517_2932_5970_1869_2033_4792 16 2.22E-17 1.64E-15 6.42E-16 39 hsa-let-7a-2 hsa05212 Pancreatic cancer 3320_5925_3326_1147_3551_1499_5595_5594_1387_367_8517_2932_5970_1869_2033_4792 16 2.60E-17 1.93E-15 6.42E-16 40 hsa-let-7a-2 hsa04010 MAPK signaling pathway 1147_3551_5595_5594_6722_9261_1326_4208_3305_3303_5566_8517_7867_3312_5971_5970_3310_2353_1432_4791 20 2.03E-14 1.50E-12 3.76E-13 41 hsa-let-7a-2 hsa05220 Chronic myeloid leukemia 5925_1147_3551_5595_5594_1487_8517_5970_1869_4088_3065_1488_4792 13 4.09E-14 3.03E-12 6.05E-13 42 hsa-let-7a-2 hsa04660 T cell receptor signaling pathway 1147_3551_5595_5594_1326_8517_2932_5970_4794_2353_1432_4792_4793 13 3.39E-12 2.51E-10 4.18E-11 43 hsa-let-7a-2 hsa04310 Wnt signaling pathway 23291_1499_1387_8607_1487_5566_2932_8454_6500_4087_8945_4088_1488_2033 14 1.09E-11 8.07E-10 1.15E-10 44 hsa-let-7a-2 hsa04662 B cell receptor signaling pathway 1147_3551_5595_5594_8517_2932_5970_4794_2353_4792_4793 11 1.97E-11 1.46E-09 1.82E-10 45 hsa-let-7a-2 hsa04350 TGF-beta signaling pathway 5595_5594_1387_8454_3397_3398_6500_4087_3399_4088_2033 11 8.40E-11 6.22E-09 6.91E-10 46 hsa-let-7a-2 hsa04110 Cell cycle 5925_5591_1387_2932_8454_6500_4087_1869_6502_4088_3065_2033 12 1.28E-10 9.46E-09 9.46E-10 47 hsa-let-7a-2 hsa04330 Notch signaling pathway 388585_1387_4851_1487_9612_3065_1488_2033_8850 9 1.67E-10 1.24E-08 1.13E-09 48 hsa-let-7a-2 hsa05221 Acute myeloid leukemia 1147_3551_5595_5594_8517_6774_5970_6688_862 9 1.01E-09 7.51E-08 6.25E-09 49 hsa-let-7a-2 hsa04920 Adipocytokine signaling pathway 1147_3551_6256_8517_6774_5970_4794_4792_4793 9 2.80E-09 2.07E-07 1.59E-08 50 hsa-let-7a-2 hsa04620 Toll-like receptor signaling pathway 1147_3551_5595_5594_1326_8517_5970_2353_1432_4792 10 5.93E-09 4.39E-07 3.13E-08 51 hsa-let-7a-2 hsa04916 Melanogenesis 1499_5595_5594_1387_5566_2932_2033_808_801_805 10 7.04E-09 5.21E-07 3.47E-08 52 hsa-let-7a-2 hsa05222 Small cell lung cancer 5925_1147_3551_6256_8517_5970_1869_6502_4792 9 2.06E-08 1.52E-06 9.32E-08 53 hsa-let-7a-2 hsa04062 Chemokine signaling pathway 1147_3551_5595_5594_5566_8517_2932_6774_5970_653361_4792_4793 12 2.14E-08 1.58E-06 9.32E-08 54 hsa-let-7a-2 hsa04120 Ubiquitin mediated proteolysis 7329_23291_672_8454_6500_3093_8945_6502_10273_7323 10 9.17E-08 6.79E-06 3.77E-07 55 hsa-let-7a-2 hsa04720 Long-term potentiation 5595_5594_1387_5566_2033_808_801_805 8 1.12E-07 8.28E-06 4.36E-07 56 hsa-let-7a-2 hsa03020 RNA polymerase 25885_64425_5437_51082_84172_5441 6 1.36E-07 1.01E-05 5.04E-07 57 hsa-let-7a-2 hsa04520 Adherens junction 1499_5595_5594_1387_4087_4088_2033_71 8 1.77E-07 1.31E-05 6.24E-07 58 hsa-let-7a-2 hsa05131 Shigellosis 347733_1499_7278_10382_84617_203068_71 7 2.65E-07 1.96E-05 8.52E-07 59 hsa-let-7a-2 hsa05130 Pathogenic Escherichia coli infection 347733_1499_7278_10382_84617_203068_71 7 2.65E-07 1.96E-05 8.52E-07 60 hsa-let-7a-2 hsa04540 Gap junction 347733_5595_5594_5566_7278_10382_84617_203068 8 5.16E-07 3.82E-05 1.59E-06 61 hsa-let-7a-2 hsa05214 Glioma 5925_5595_5594_1869_808_801_805 7 6.69E-07 4.95E-05 1.98E-06 62 hsa-let-7a-2 hsa05210 Colorectal cancer 1499_5595_5594_2932_4087_2353_4088 7 3.29E-06 0.0002435 9.37E-06 63 hsa-let-7a-2 hsa05216 Thyroid cancer 1499_5595_5594_6256_7175 5 3.49E-06 0.00025816 9.56E-06 64 hsa-let-7a-2 hsa04612 Antigen processing and presentation 3320_3326_3309_3305_3303_3312_3310 7 4.71E-06 0.000348318 1.20E-05 65 hsa-let-7a-2 hsa04210 Apoptosis 1147_3551_5566_8517_5970_8837_4792 7 4.71E-06 0.000348318 1.20E-05 66 hsa-let-7a-2 hsa04910 Insulin signaling pathway 3551_5595_5594_5566_2932_808_801_805 8 8.25E-06 0.00061074 2.04E-05 67 hsa-let-7a-2 hsa04912 GnRH signaling pathway 5595_5594_5566_1432_808_801_805 7 1.55E-05 0.00114676 3.62E-05 68 hsa-let-7a-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_3551_8517_5970_1432_4792 6 1.56E-05 0.001158045 3.62E-05 69 hsa-let-7a-2 hsa04270 Vascular smooth muscle contraction 5595_5594_5566_4637_808_801_805 7 2.66E-05 0.001969591 5.97E-05 70 hsa-let-7a-2 hsa05223 Non-small cell lung cancer 5925_5595_5594_6256_1869 5 5.46E-05 0.004039508 0.000118809 71 hsa-let-7a-2 hsa05016 Huntington's disease 1387_292_293_5437_1213_3065_2033_5441 8 6.83E-05 0.005056508 0.000144472 72 hsa-let-7a-2 hsa05211 Renal cell carcinoma 5595_5594_1387_2113_2033 5 0.000194888 0.014421747 0.000400604 73 hsa-let-7a-2 hsa04370 VEGF signaling pathway 5595_5594_9261_7867_1432 5 0.000261762 0.0193704 0.000523524 74 hsa-let-7a-2 hsa05219 Bladder cancer 5925_5595_5594_1869 4 0.000284132 0.02102579 0.00055331 75 hsa-let-7a-2 hsa04930 Type II diabetes mellitus 3551_5595_5594_3651 4 0.000363016 0.026863175 0.000688799 76 hsa-let-7a-2 hsa05213 Endometrial cancer 1499_5595_5594_2932 4 0.000606101 0.044851509 0.001121288 77 hsa-let-7a-2 hsa04340 Hedgehog signaling pathway 23291_5566_2932_8945 4 0.000838403 0.062041836 0.001513216 78 hsa-let-7a-2 hsa04810 Regulation of actin cytoskeleton 5595_5594_4627_4628_10788_10627_71 7 0.001013975 0.075034139 0.001786527 79 hsa-let-7a-2 hsa05010 Alzheimer's disease 5595_5594_2932_808_801_805 6 0.001736325 0.128488064 0.002988095 80 hsa-let-7a-2 hsa05218 Melanoma 5925_5595_5594_1869 4 0.001811904 0.134080919 0.003047294 81 hsa-let-7a-2 hsa04670 Leukocyte transendothelial migration 1499_653361_10627_1432_71 5 0.001901067 0.140678975 0.003126199 82 hsa-let-7a-2 hsa04020 Calcium signaling pathway 292_5566_293_808_801_805 6 0.002097188 0.155191878 0.003373736 83 hsa-let-7a-2 hsa04530 Tight junction 1499_4627_4628_10627_71 5 0.003084737 0.228270512 0.004856819 84 hsa-let-7a-2 hsa04510 Focal adhesion 1499_5595_5594_2932_10627_71 6 0.003605476 0.266805236 0.005558442 85 hsa-let-7a-2 hsa04630 Jak-STAT signaling pathway 3559_1387_6778_6774_2033 5 0.00511597 0.378581777 0.007726159 86 hsa-let-7a-2 hsa03010 Ribosome 6156_6128_6207_6202 4 0.00627975 0.464701466 0.009294029 87 hsa-let-7a-2 hsa04950 Maturity onset diabetes of the young 168620_3651 2 0.013755984 1 0.019959663 88 hsa-let-7a-2 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.017348445 1 0.024688171 89 hsa-let-7a-2 hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432 3 0.019140709 1 0.026724763 90 hsa-let-7a-2 hsa04012 ErbB signaling pathway 5595_5594_2932 3 0.024402888 1 0.033440995 91 hsa-let-7a-2 hsa03410 Base excision repair 3146_142 2 0.028197096 1 0.037937911 92 hsa-let-7a-3 hsa04110 Cell cycle 1869_25_5925_545_995_1871_1026_5591_1870_983_4088_7534_1017_2932_4193_7027_902_1387_3066_7157_1031_9232_5347_1022_1029_4087_7532_3065_1111_2033_890_11200_8556_8555_472 35 7.96E-36 6.69E-34 6.69E-34 93 hsa-let-7a-3 hsa05200 Pathways in cancer 1147_3320_1869_5743_3326_5747_25_5925_675_998_1871_1026_5594_5595_5599_1870_596_5601_6789_1856_4088_613_1017_2932_4193_367_1387_5578_51588_8554_5371_3066_4436_7157_598_4609_1029_4087_5888_5728_3065_3091_2033_3910_4792_5602 46 5.71E-34 4.80E-32 2.40E-32 94 hsa-let-7a-3 hsa04115 p53 signaling pathway 50484_545_6241_1026_25898_983_1017_27113_4194_4193_900_7157_7161_1029_64326_5728_51246_1111_11200_472 20 7.73E-21 6.49E-19 2.16E-19 95 hsa-let-7a-3 hsa05215 Prostate cancer 1147_3320_1869_3326_5925_1871_1026_5594_5595_1385_1870_596_1017_2932_4193_367_1387_7157_5728_2033_4792 21 2.55E-20 2.14E-18 5.24E-19 96 hsa-let-7a-3 hsa05212 Pancreatic cancer 1147_3320_1869_3326_5925_1871_1026_5594_5595_1385_1870_596_1017_2932_4193_367_1387_7157_5728_2033_4792 21 3.12E-20 2.62E-18 5.24E-19 97 hsa-let-7a-3 hsa05220 Chronic myeloid leukemia 1147_1869_25_5925_1871_1026_5594_5595_1870_4088_613_4193_3066_7157_598_4609_1029_3065_4792 19 6.37E-19 5.35E-17 8.91E-18 98 hsa-let-7a-3 hsa05222 Small cell lung cancer 1147_1869_5743_5747_5925_1871_1870_596_1017_51588_8554_7157_598_4609_5728_3910_4792 17 1.67E-15 1.40E-13 2.00E-14 99 hsa-let-7a-3 hsa04310 Wnt signaling pathway 1460_5518_5515_5599_5601_1856_1457_4088_2932_1387_5578_7157_4609_1452_4087_5527_2033_5602 18 6.82E-13 5.73E-11 7.16E-12 100 hsa-let-7a-3 hsa05219 Bladder cancer 1869_5925_1871_1026_5594_5595_1870_4193_7157_4609_1029 11 1.24E-11 1.04E-09 1.15E-10 101 hsa-let-7a-3 hsa05214 Glioma 1869_5925_1871_1026_5594_5595_1870_4193_5578_7157_1029_5728 12 5.05E-11 4.24E-09 4.24E-10 102 hsa-let-7a-3 hsa05210 Colorectal cancer 5594_5595_5599_596_5601_1856_4088_2932_4436_7157_4609_4087_5602 13 5.63E-11 4.73E-09 4.30E-10 103 hsa-let-7a-3 hsa04010 MAPK signaling pathway 1147_998_5594_5595_5599_5601_3304_3305_3303_6789_3315_5578_3164_7157_4609_1386_1616_5923_5602 19 7.78E-10 6.53E-08 5.44E-09 104 hsa-let-7a-3 hsa05218 Melanoma 1869_5925_1871_1026_5594_5595_1870_4193_7157_1029_5728 11 1.71E-09 1.44E-07 1.06E-08 105 hsa-let-7a-3 hsa04120 Ubiquitin mediated proteolysis 10055_672_7319_25898_84447_4193_3093_51588_8554_5371_64326_7329_10075_7337 14 1.77E-09 1.49E-07 1.06E-08 106 hsa-let-7a-3 hsa05223 Non-small cell lung cancer 1869_5925_1871_5594_5595_1870_6789_5578_7157_1029 10 2.05E-09 1.72E-07 1.15E-08 107 hsa-let-7a-3 hsa04350 TGF-beta signaling pathway 5518_5515_5594_5595_6667_4088_7027_1387_4609_4087_2033 11 1.17E-08 9.82E-07 5.78E-08 108 hsa-let-7a-3 hsa04012 ErbB signaling pathway 5747_25_1026_5594_5595_5599_5601_2932_5578_4609_5602 11 1.17E-08 9.82E-07 5.78E-08 109 hsa-let-7a-3 hsa04330 Notch signaling pathway 1856_1387_3066_9612_3065_2033_8850_4851 8 1.54E-07 1.30E-05 7.20E-07 110 hsa-let-7a-3 hsa04510 Focal adhesion 5747_998_5594_5595_5599_596_5601_5499_2932_5578_5728_5923_3910_5602 14 1.79E-07 1.50E-05 7.91E-07 111 hsa-let-7a-3 hsa03022 Basal transcription factors 2965_2969_2957_6908_51616_2958_6880 7 4.98E-07 4.18E-05 2.09E-06 112 hsa-let-7a-3 hsa04520 Adherens junction 1460_998_5594_5595_1457_4088_1387_4087_2033 9 6.27E-07 5.26E-05 2.51E-06 113 hsa-let-7a-3 hsa03420 Nucleotide excision repair 2965_4331_2074_6117_2071_902_1022 7 1.41E-06 0.000118244 5.37E-06 114 hsa-let-7a-3 hsa05016 Huntington's disease 25942_3064_1385_6908_6667_27113_1387_3066_7157_3065_2033 11 1.43E-05 0.001199644 5.22E-05 115 hsa-let-7a-3 hsa04920 Adipocytokine signaling pathway 1147_5563_6794_5599_5601_4792_5602 7 1.76E-05 0.001480208 6.17E-05 116 hsa-let-7a-3 hsa04916 Melanogenesis 5594_5595_1385_1856_2932_1387_5578_2033 8 3.50E-05 0.002939104 0.000117564 117 hsa-let-7a-3 hsa04910 Insulin signaling pathway 5563_5594_5595_5599_5601_5499_6720_2932_5602 9 3.89E-05 0.003263685 0.000125526 118 hsa-let-7a-3 hsa04370 VEGF signaling pathway 5743_5747_998_5594_5595_3315_5578 7 4.04E-05 0.003391646 0.000125617 119 hsa-let-7a-3 hsa05213 Endometrial cancer 5594_5595_2932_7157_4609_5728 6 4.26E-05 0.003577475 0.000127767 120 hsa-let-7a-3 hsa04660 T cell receptor signaling pathway 1147_998_5594_5595_5601_2932_959_4792 8 5.08E-05 0.004271252 0.000147285 121 hsa-let-7a-3 hsa04612 Antigen processing and presentation 3320_3326_1385_3309_3304_3305_3303 7 9.49E-05 0.007975609 0.000257278 122 hsa-let-7a-3 hsa04210 Apoptosis 1147_823_596_7157_598_4792_472 7 9.49E-05 0.007975609 0.000257278 123 hsa-let-7a-3 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_998_5599_5601_4792_5602 6 0.000209418 0.017591088 0.000524517 124 hsa-let-7a-3 hsa04620 Toll-like receptor signaling pathway 1147_5594_5595_5599_5601_4792_5602 7 0.000210174 0.017654611 0.000524517 125 hsa-let-7a-3 hsa04530 Tight junction 1460_998_5518_5515_1457_5578_5728_5520 8 0.000214284 0.017999885 0.000524517 126 hsa-let-7a-3 hsa04930 Type II diabetes mellitus 5594_5595_5599_5601_5602 5 0.000221676 0.018620779 0.000524517 127 hsa-let-7a-3 hsa05211 Renal cell carcinoma 998_5594_5595_1387_3091_2033 6 0.000224793 0.018882604 0.000524517 128 hsa-let-7a-3 hsa04720 Long-term potentiation 5594_5595_5499_1387_5578_2033 6 0.000276309 0.02320994 0.000610788 129 hsa-let-7a-3 hsa04662 B cell receptor signaling pathway 1147_5594_5595_1380_2932_4792 6 0.000276309 0.02320994 0.000610788 130 hsa-let-7a-3 hsa04912 GnRH signaling pathway 998_5594_5595_5599_5601_5578_5602 7 0.000292196 0.024544437 0.000629345 131 hsa-let-7a-3 hsa04664 Fc epsilon RI signaling pathway 5594_5595_5599_5601_5578_5602 6 0.000358926 0.030149756 0.000753744 132 hsa-let-7a-3 hsa03440 Homologous recombination 675_6117_641_5888 4 0.000406941 0.034183052 0.000822811 133 hsa-let-7a-3 hsa04150 mTOR signaling pathway 5563_5594_6794_5595_3091 5 0.000411406 0.034558069 0.000822811 134 hsa-let-7a-3 hsa05216 Thyroid cancer 5594_5595_7157_4609 4 0.00045908 0.038562682 0.000896807 135 hsa-let-7a-3 hsa05131 Shigellosis 25_998_7534_5578_4691 5 0.000563955 0.047372238 0.001052716 136 hsa-let-7a-3 hsa05130 Pathogenic Escherichia coli infection 25_998_7534_5578_4691 5 0.000563955 0.047372238 0.001052716 137 hsa-let-7a-3 hsa05221 Acute myeloid leukemia 1147_5594_5595_5371_4609 5 0.00070362 0.059104072 0.001284871 138 hsa-let-7a-3 hsa04360 Axon guidance 5747_25_998_5594_5595_2932_1020 7 0.000872009 0.073248742 0.001558484 139 hsa-let-7a-3 hsa03410 Base excision repair 142_3146_328_4913 4 0.000965101 0.081068472 0.001688927 140 hsa-let-7a-3 hsa04730 Long-term depression 5518_5515_5594_5595_5578 5 0.001531602 0.128654553 0.002625603 141 hsa-let-7a-3 hsa04062 Chemokine signaling pathway 1147_5747_998_5594_5595_2932_6362_4792 8 0.001821434 0.153000495 0.00306001 142 hsa-let-7a-3 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_7157_598_1616 4 0.004335778 0.364205335 0.007141281 143 hsa-let-7a-3 hsa04540 Gap junction 5594_5595_983_1453_5578 5 0.004629628 0.388888738 0.00747863 144 hsa-let-7a-3 hsa03030 DNA replication 6117_5557_5422 3 0.009019878 0.757669732 0.01406608 145 hsa-let-7a-3 hsa04630 Jak-STAT signaling pathway 1387_51588_8554_598_4609_2033 6 0.00904248 0.759568339 0.01406608 146 hsa-let-7a-3 hsa03450 Non-homologous end-joining 5591_2547 2 0.013099625 1 0.0200067 147 hsa-let-7a-3 hsa05010 Alzheimer's disease 22926_5594_5595_823_2932_1020 6 0.016179838 1 0.024269757 148 hsa-let-7a-3 hsa05217 Basal cell carcinoma 1856_2932_7157 3 0.026152051 1 0.038539865 149 hsa-let-7a-3 hsa04340 Hedgehog signaling pathway 1453_2932_1452 3 0.028544853 1 0.041340822 150 hsa-let-7a-3 hsa03430 Mismatch repair 6117_4436 2 0.03069316 1 0.043698736 151 hsa-let-7a-3 hsa04270 Vascular smooth muscle contraction 5594_5595_5499_5578 4 0.046222328 1 0.06471126 152 hsa-let-7b hsa04110 Cell cycle 1869_25_5925_545_995_1871_1026_5591_1870_983_4088_7534_1017_2932_4193_7027_902_1387_3066_7157_1031_9232_5347_1022_1029_4087_7532_3065_1111_2033_890_11200_8556_8555_472 35 7.96E-36 6.69E-34 6.69E-34 153 hsa-let-7b hsa05200 Pathways in cancer 1147_3320_1869_5743_3326_5747_25_5925_675_998_1871_1026_5594_5595_5599_1870_596_5601_6789_1856_4088_613_1017_2932_4193_367_1387_5578_51588_8554_5371_3066_4436_7157_598_4609_1029_4087_5888_5728_3065_3091_2033_3910_4792_5602 46 5.71E-34 4.80E-32 2.40E-32 154 hsa-let-7b hsa04115 p53 signaling pathway 50484_545_6241_1026_25898_983_1017_27113_4194_4193_900_7157_7161_1029_64326_5728_51246_1111_11200_472 20 7.73E-21 6.49E-19 2.16E-19 155 hsa-let-7b hsa05215 Prostate cancer 1147_3320_1869_3326_5925_1871_1026_5594_5595_1385_1870_596_1017_2932_4193_367_1387_7157_5728_2033_4792 21 2.55E-20 2.14E-18 5.24E-19 156 hsa-let-7b hsa05212 Pancreatic cancer 1147_3320_1869_3326_5925_1871_1026_5594_5595_1385_1870_596_1017_2932_4193_367_1387_7157_5728_2033_4792 21 3.12E-20 2.62E-18 5.24E-19 157 hsa-let-7b hsa05220 Chronic myeloid leukemia 1147_1869_25_5925_1871_1026_5594_5595_1870_4088_613_4193_3066_7157_598_4609_1029_3065_4792 19 6.37E-19 5.35E-17 8.91E-18 158 hsa-let-7b hsa05222 Small cell lung cancer 1147_1869_5743_5747_5925_1871_1870_596_1017_51588_8554_7157_598_4609_5728_3910_4792 17 1.67E-15 1.40E-13 2.00E-14 159 hsa-let-7b hsa04310 Wnt signaling pathway 1460_5518_5515_5599_5601_1856_1457_4088_2932_1387_5578_7157_4609_1452_4087_5527_2033_5602 18 6.82E-13 5.73E-11 7.16E-12 160 hsa-let-7b hsa05219 Bladder cancer 1869_5925_1871_1026_5594_5595_1870_4193_7157_4609_1029 11 1.24E-11 1.04E-09 1.15E-10 161 hsa-let-7b hsa05214 Glioma 1869_5925_1871_1026_5594_5595_1870_4193_5578_7157_1029_5728 12 5.05E-11 4.24E-09 4.24E-10 162 hsa-let-7b hsa05210 Colorectal cancer 5594_5595_5599_596_5601_1856_4088_2932_4436_7157_4609_4087_5602 13 5.63E-11 4.73E-09 4.30E-10 163 hsa-let-7b hsa04010 MAPK signaling pathway 1147_998_5594_5595_5599_5601_3304_3305_3303_6789_3315_5578_3164_7157_4609_1386_1616_5923_5602 19 7.78E-10 6.53E-08 5.44E-09 164 hsa-let-7b hsa05218 Melanoma 1869_5925_1871_1026_5594_5595_1870_4193_7157_1029_5728 11 1.71E-09 1.44E-07 1.06E-08 165 hsa-let-7b hsa04120 Ubiquitin mediated proteolysis 10055_672_7319_25898_84447_4193_3093_51588_8554_5371_64326_7329_10075_7337 14 1.77E-09 1.49E-07 1.06E-08 166 hsa-let-7b hsa05223 Non-small cell lung cancer 1869_5925_1871_5594_5595_1870_6789_5578_7157_1029 10 2.05E-09 1.72E-07 1.15E-08 167 hsa-let-7b hsa04350 TGF-beta signaling pathway 5518_5515_5594_5595_6667_4088_7027_1387_4609_4087_2033 11 1.17E-08 9.82E-07 5.78E-08 168 hsa-let-7b hsa04012 ErbB signaling pathway 5747_25_1026_5594_5595_5599_5601_2932_5578_4609_5602 11 1.17E-08 9.82E-07 5.78E-08 169 hsa-let-7b hsa04330 Notch signaling pathway 1856_1387_3066_9612_3065_2033_8850_4851 8 1.54E-07 1.30E-05 7.20E-07 170 hsa-let-7b hsa04510 Focal adhesion 5747_998_5594_5595_5599_596_5601_5499_2932_5578_5728_5923_3910_5602 14 1.79E-07 1.50E-05 7.91E-07 171 hsa-let-7b hsa03022 Basal transcription factors 2965_2969_2957_6908_51616_2958_6880 7 4.98E-07 4.18E-05 2.09E-06 172 hsa-let-7b hsa04520 Adherens junction 1460_998_5594_5595_1457_4088_1387_4087_2033 9 6.27E-07 5.26E-05 2.51E-06 173 hsa-let-7b hsa03420 Nucleotide excision repair 2965_4331_2074_6117_2071_902_1022 7 1.41E-06 0.000118244 5.37E-06 174 hsa-let-7b hsa05016 Huntington's disease 25942_3064_1385_6908_6667_27113_1387_3066_7157_3065_2033 11 1.43E-05 0.001199644 5.22E-05 175 hsa-let-7b hsa04920 Adipocytokine signaling pathway 1147_5563_6794_5599_5601_4792_5602 7 1.76E-05 0.001480208 6.17E-05 176 hsa-let-7b hsa04916 Melanogenesis 5594_5595_1385_1856_2932_1387_5578_2033 8 3.50E-05 0.002939104 0.000117564 177 hsa-let-7b hsa04910 Insulin signaling pathway 5563_5594_5595_5599_5601_5499_6720_2932_5602 9 3.89E-05 0.003263685 0.000125526 178 hsa-let-7b hsa04370 VEGF signaling pathway 5743_5747_998_5594_5595_3315_5578 7 4.04E-05 0.003391646 0.000125617 179 hsa-let-7b hsa05213 Endometrial cancer 5594_5595_2932_7157_4609_5728 6 4.26E-05 0.003577475 0.000127767 180 hsa-let-7b hsa04660 T cell receptor signaling pathway 1147_998_5594_5595_5601_2932_959_4792 8 5.08E-05 0.004271252 0.000147285 181 hsa-let-7b hsa04612 Antigen processing and presentation 3320_3326_1385_3309_3304_3305_3303 7 9.49E-05 0.007975609 0.000257278 182 hsa-let-7b hsa04210 Apoptosis 1147_823_596_7157_598_4792_472 7 9.49E-05 0.007975609 0.000257278 183 hsa-let-7b hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_998_5599_5601_4792_5602 6 0.000209418 0.017591088 0.000524517 184 hsa-let-7b hsa04620 Toll-like receptor signaling pathway 1147_5594_5595_5599_5601_4792_5602 7 0.000210174 0.017654611 0.000524517 185 hsa-let-7b hsa04530 Tight junction 1460_998_5518_5515_1457_5578_5728_5520 8 0.000214284 0.017999885 0.000524517 186 hsa-let-7b hsa04930 Type II diabetes mellitus 5594_5595_5599_5601_5602 5 0.000221676 0.018620779 0.000524517 187 hsa-let-7b hsa05211 Renal cell carcinoma 998_5594_5595_1387_3091_2033 6 0.000224793 0.018882604 0.000524517 188 hsa-let-7b hsa04720 Long-term potentiation 5594_5595_5499_1387_5578_2033 6 0.000276309 0.02320994 0.000610788 189 hsa-let-7b hsa04662 B cell receptor signaling pathway 1147_5594_5595_1380_2932_4792 6 0.000276309 0.02320994 0.000610788 190 hsa-let-7b hsa04912 GnRH signaling pathway 998_5594_5595_5599_5601_5578_5602 7 0.000292196 0.024544437 0.000629345 191 hsa-let-7b hsa04664 Fc epsilon RI signaling pathway 5594_5595_5599_5601_5578_5602 6 0.000358926 0.030149756 0.000753744 192 hsa-let-7b hsa03440 Homologous recombination 675_6117_641_5888 4 0.000406941 0.034183052 0.000822811 193 hsa-let-7b hsa04150 mTOR signaling pathway 5563_5594_6794_5595_3091 5 0.000411406 0.034558069 0.000822811 194 hsa-let-7b hsa05216 Thyroid cancer 5594_5595_7157_4609 4 0.00045908 0.038562682 0.000896807 195 hsa-let-7b hsa05131 Shigellosis 25_998_7534_5578_4691 5 0.000563955 0.047372238 0.001052716 196 hsa-let-7b hsa05130 Pathogenic Escherichia coli infection 25_998_7534_5578_4691 5 0.000563955 0.047372238 0.001052716 197 hsa-let-7b hsa05221 Acute myeloid leukemia 1147_5594_5595_5371_4609 5 0.00070362 0.059104072 0.001284871 198 hsa-let-7b hsa04360 Axon guidance 5747_25_998_5594_5595_2932_1020 7 0.000872009 0.073248742 0.001558484 199 hsa-let-7b hsa03410 Base excision repair 142_3146_328_4913 4 0.000965101 0.081068472 0.001688927 200 hsa-let-7b hsa04730 Long-term depression 5518_5515_5594_5595_5578 5 0.001531602 0.128654553 0.002625603 201 hsa-let-7b hsa04062 Chemokine signaling pathway 1147_5747_998_5594_5595_2932_6362_4792 8 0.001821434 0.153000495 0.00306001 202 hsa-let-7b hsa05014 Amyotrophic lateral sclerosis (ALS) 596_7157_598_1616 4 0.004335778 0.364205335 0.007141281 203 hsa-let-7b hsa04540 Gap junction 5594_5595_983_1453_5578 5 0.004629628 0.388888738 0.00747863 204 hsa-let-7b hsa03030 DNA replication 6117_5557_5422 3 0.009019878 0.757669732 0.01406608 205 hsa-let-7b hsa04630 Jak-STAT signaling pathway 1387_51588_8554_598_4609_2033 6 0.00904248 0.759568339 0.01406608 206 hsa-let-7b hsa03450 Non-homologous end-joining 5591_2547 2 0.013099625 1 0.0200067 207 hsa-let-7b hsa05010 Alzheimer's disease 22926_5594_5595_823_2932_1020 6 0.016179838 1 0.024269757 208 hsa-let-7b hsa05217 Basal cell carcinoma 1856_2932_7157 3 0.026152051 1 0.038539865 209 hsa-let-7b hsa04340 Hedgehog signaling pathway 1453_2932_1452 3 0.028544853 1 0.041340822 210 hsa-let-7b hsa03430 Mismatch repair 6117_4436 2 0.03069316 1 0.043698736 211 hsa-let-7b hsa04270 Vascular smooth muscle contraction 5594_5595_5499_5578 4 0.046222328 1 0.06471126 212 hsa-let-7c hsa03022 Basal transcription factors 2967_2961_2960_2963_6881_54457_2968_6877_6874_6878_2957_6879_6908_6872_2958_6873_2959_6880_6882_138474_6884_6883 22 3.42E-30 2.49E-28 2.49E-28 213 hsa-let-7c hsa05200 Pathways in cancer 2249_367_1499_5595_5594_5914_1387_6256_10401_1487_1488_2932_4193_6776_6777_5970_7157_6688_4609_3725_2353_3065_4087_4088_4089_5925_2033_207_208_3326_8554_7184 32 4.46E-22 3.25E-20 1.63E-20 214 hsa-let-7c hsa05220 Chronic myeloid leukemia 5595_5594_1487_1488_4193_6776_6777_5970_7157_4609_3065_4088_4089_5925_207_208 16 1.96E-16 1.43E-14 4.78E-15 215 hsa-let-7c hsa05215 Prostate cancer 367_1499_5595_5594_1387_2932_4193_5970_7157_468_5925_2033_207_208_3326_7184 16 1.80E-15 1.31E-13 3.08E-14 216 hsa-let-7c hsa05212 Pancreatic cancer 367_1499_5595_5594_1387_2932_4193_5970_7157_468_5925_2033_207_208_3326_7184 16 2.11E-15 1.54E-13 3.08E-14 217 hsa-let-7c hsa04110 Cell cycle 993_1387_4171_983_7534_7533_7532_2932_4193_4085_7157_3065_4087_4088_4089_5925_2033 17 8.34E-15 6.09E-13 1.01E-13 218 hsa-let-7c hsa05210 Colorectal cancer 1499_5595_5594_2932_7157_4609_3725_2353_4087_4088_4089_207_208 13 5.10E-12 3.72E-10 5.32E-11 219 hsa-let-7c hsa04310 Wnt signaling pathway 1460_1499_1387_8607_1487_1488_2932_7157_4609_3725_4087_4088_4089_2033 14 4.30E-10 3.14E-08 3.93E-09 220 hsa-let-7c hsa05221 Acute myeloid leukemia 5595_5594_5914_6776_6777_5970_6688_4609_207_208 10 6.89E-10 5.03E-08 5.59E-09 221 hsa-let-7c hsa04012 ErbB signaling pathway 6714_5595_5594_2932_6776_6777_4609_3725_5058_207_208 11 1.58E-09 1.16E-07 1.16E-08 222 hsa-let-7c hsa04520 Adherens junction 1460_1499_6714_5595_5594_1387_4087_4088_4089_2033 10 9.80E-09 7.16E-07 6.51E-08 223 hsa-let-7c hsa04010 MAPK signaling pathway 6722_3727_2249_5595_5594_1649_3312_5970_7157_468_4609_3725_2353_5058_207_208 16 1.13E-08 8.22E-07 6.85E-08 224 hsa-let-7c hsa05213 Endometrial cancer 1499_5595_5594_2932_7157_4609_207_208 8 7.12E-08 5.20E-06 4.00E-07 225 hsa-let-7c hsa05222 Small cell lung cancer 6256_10401_5970_7157_4609_5925_207_208_8554 9 2.19E-07 1.60E-05 1.14E-06 226 hsa-let-7c hsa04350 TGF-beta signaling pathway 6667_5595_5594_1387_4609_4087_4088_4089_2033 9 2.40E-07 1.75E-05 1.17E-06 227 hsa-let-7c hsa05016 Huntington's disease 6667_6874_25942_1387_6908_9001_5430_7157_3065_3064_10476_2033 12 3.34E-07 2.44E-05 1.52E-06 228 hsa-let-7c hsa04330 Notch signaling pathway 1387_1487_1488_9612_3065_2033_8850 7 5.81E-07 4.24E-05 2.50E-06 229 hsa-let-7c hsa05218 Melanoma 2249_5595_5594_4193_7157_5925_207_208 8 6.25E-07 4.56E-05 2.53E-06 230 hsa-let-7c hsa05211 Renal cell carcinoma 5595_5594_1387_3725_5058_2033_207_208 8 6.89E-07 5.03E-05 2.53E-06 231 hsa-let-7c hsa05216 Thyroid cancer 1499_5595_5594_6256_7157_4609 6 6.92E-07 5.05E-05 2.53E-06 232 hsa-let-7c hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_3725_2353_207_208 8 9.16E-07 6.69E-05 3.19E-06 233 hsa-let-7c hsa05223 Non-small cell lung cancer 5595_5594_6256_7157_5925_207_208 7 1.36E-06 9.90E-05 4.50E-06 234 hsa-let-7c hsa04660 T cell receptor signaling pathway 5595_5594_2932_5970_3725_2353_5058_207_208 9 1.49E-06 0.000109123 4.74E-06 235 hsa-let-7c hsa04630 Jak-STAT signaling pathway 1387_10401_6776_6777_4609_2033_3977_207_208_8554 10 2.95E-06 0.00021507 8.96E-06 236 hsa-let-7c hsa05214 Glioma 5595_5594_4193_7157_5925_207_208 7 4.21E-06 0.000307121 1.23E-05 237 hsa-let-7c hsa05219 Bladder cancer 5595_5594_4193_7157_4609_5925 6 4.74E-06 0.00034593 1.33E-05 238 hsa-let-7c hsa04620 Toll-like receptor signaling pathway 5595_5594_5970_3725_2353_207_208 7 6.40E-05 0.004670189 0.00017297 239 hsa-let-7c hsa04950 Maturity onset diabetes of the young 3651_6927_3172_5080 4 0.000114844 0.00838363 0.000299415 240 hsa-let-7c hsa03050 Proteasome 5705_5701_5702_5719_5710 5 0.000119815 0.008746512 0.000301604 241 hsa-let-7c hsa04510 Focal adhesion 1499_6714_5595_5594_2932_3725_5058_207_208 9 0.000165803 0.012103594 0.000403453 242 hsa-let-7c hsa04530 Tight junction 1460_1499_6714_4628_60412_207_208 7 0.00036051 0.026317233 0.000848943 243 hsa-let-7c hsa04910 Insulin signaling pathway 5595_5594_2932_5211_207_208_2538 7 0.000375905 0.027441101 0.000857534 244 hsa-let-7c hsa04920 Adipocytokine signaling pathway 6256_5970_207_208_2538 5 0.000507773 0.037067394 0.001109063 245 hsa-let-7c hsa04916 Melanogenesis 1499_5595_5594_1387_2932_2033 6 0.000517339 0.037765725 0.001109063 246 hsa-let-7c hsa04062 Chemokine signaling pathway 5595_5594_2932_6777_5970_5058_207_208 8 0.000531743 0.038817215 0.001109063 247 hsa-let-7c hsa04720 Long-term potentiation 5595_5594_1387_468_2033 5 0.000822584 0.060048631 0.001668018 248 hsa-let-7c hsa04370 VEGF signaling pathway 6714_5595_5594_207_208 5 0.000920009 0.067160675 0.001815153 249 hsa-let-7c hsa03420 Nucleotide excision repair 2967_2968_4331_5887 4 0.000946548 0.069098018 0.001818369 250 hsa-let-7c hsa04150 mTOR signaling pathway 5595_5594_207_208 4 0.001688186 0.123237547 0.003093072 251 hsa-let-7c hsa04612 Antigen processing and presentation 4801_4800_1514_3312_3326 5 0.001694834 0.123722894 0.003093072 252 hsa-let-7c hsa04540 Gap junction 6714_5595_5594_983_10382 5 0.002036302 0.148650031 0.003625611 253 hsa-let-7c hsa04912 GnRH signaling pathway 6714_5595_5594_468_3725 5 0.003771824 0.275343176 0.00655579 254 hsa-let-7c hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5970_3725_5058 4 0.00488524 0.356622545 0.008293548 255 hsa-let-7c hsa04664 Fc epsilon RI signaling pathway 5595_5594_207_208 4 0.006981957 0.509682856 0.011583701 256 hsa-let-7c hsa04930 Type II diabetes mellitus 3651_5595_5594 3 0.009486581 0.692520444 0.015389343 257 hsa-let-7c hsa04210 Apoptosis 5970_7157_207_208 4 0.010342351 0.754991642 0.016412862 258 hsa-let-7c hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.015841104 1 0.024604268 259 hsa-let-7c hsa05131 Shigellosis 1499_7534_10382 3 0.016580022 1 0.02470085 260 hsa-let-7c hsa05130 Pathogenic Escherichia coli infection 1499_7534_10382 3 0.016580022 1 0.02470085 261 hsa-let-7c hsa04115 p53 signaling pathway 983_4193_7157 3 0.027926018 1 0.040771987 262 hsa-let-7c hsa04360 Axon guidance 5595_5594_2932_5058 4 0.035008199 1 0.050109775 263 hsa-let-7c hsa04120 Ubiquitin mediated proteolysis 672_10401_4193_8554 4 0.041816075 1 0.058703337 264 hsa-let-7c hsa03410 Base excision repair 3146_142 2 0.046648205 1 0.064251301 265 hsa-let-7e hsa05200 Pathways in cancer 3320_25_1499_1387_6256_836_1019_1017_5578_7157_2113_3725_841_861_6774_4088_4089_3065_5925_2033_324 21 4.08E-20 2.61E-18 2.61E-18 266 hsa-let-7e hsa04350 TGF-beta signaling pathway 3400_1387_6667_3397_3399_3398_4086_4088_4089_2033_4093_4092 12 1.22E-15 7.80E-14 3.90E-14 267 hsa-let-7e hsa04110 Cell cycle 25_1387_1019_1017_7157_1028_4088_4089_3065_5925_2033 11 1.12E-12 7.15E-11 2.38E-11 268 hsa-let-7e hsa05220 Chronic myeloid leukemia 25_1019_7157_861_4088_4089_3065_5925 8 5.31E-10 3.40E-08 8.49E-09 269 hsa-let-7e hsa05016 Huntington's disease 1387_836_6667_3092_7157_841_1213_3065_2033_6908 10 2.02E-09 1.29E-07 2.59E-08 270 hsa-let-7e hsa04310 Wnt signaling pathway 1499_1387_5578_7157_3725_4088_4089_2033_324 9 5.54E-09 3.54E-07 5.73E-08 271 hsa-let-7e hsa05214 Glioma 1019_5578_7157_5925_808_801_805 7 6.27E-09 4.01E-07 5.73E-08 272 hsa-let-7e hsa05210 Colorectal cancer 1499_836_7157_3725_4088_4089_324 7 3.26E-08 2.09E-06 2.61E-07 273 hsa-let-7e hsa05215 Prostate cancer 3320_1499_1387_1017_7157_5925_2033 7 4.40E-08 2.82E-06 3.03E-07 274 hsa-let-7e hsa05212 Pancreatic cancer 3320_1499_1387_1017_7157_5925_2033 7 4.74E-08 3.03E-06 3.03E-07 275 hsa-let-7e hsa04916 Melanogenesis 1499_1387_5578_2033_808_801_805 7 1.29E-07 8.28E-06 7.52E-07 276 hsa-let-7e hsa04720 Long-term potentiation 1387_5578_2033_808_801_805 6 4.09E-07 2.62E-05 2.18E-06 277 hsa-let-7e hsa04330 Notch signaling pathway 1387_9612_3065_2033_8850 5 1.07E-06 6.85E-05 5.27E-06 278 hsa-let-7e hsa05223 Non-small cell lung cancer 6256_1019_5578_7157_5925 5 2.02E-06 0.000129333 9.24E-06 279 hsa-let-7e hsa05014 Amyotrophic lateral sclerosis (ALS) 836_834_1432_7157_1616 5 2.39E-06 0.00015284 1.02E-05 280 hsa-let-7e hsa04912 GnRH signaling pathway 1432_5578_3725_808_801_805 6 3.06E-06 0.000196046 1.23E-05 281 hsa-let-7e hsa04115 p53 signaling pathway 836_1019_1017_7157_841 5 6.24E-06 0.000399249 2.35E-05 282 hsa-let-7e hsa04010 MAPK signaling pathway 6722_836_1432_5578_4342_7157_3725_1616 8 6.65E-06 0.000425603 2.36E-05 283 hsa-let-7e hsa04520 Adherens junction 1499_1387_4088_4089_2033 5 1.23E-05 0.000788648 4.15E-05 284 hsa-let-7e hsa05222 Small cell lung cancer 6256_1019_1017_7157_5925 5 1.72E-05 0.001099743 5.50E-05 285 hsa-let-7e hsa05211 Renal cell carcinoma 1387_2113_3725_2033 4 0.000147781 0.009458005 0.000450381 286 hsa-let-7e hsa04070 Phosphatidylinositol signaling system 5578_808_801_805 4 0.000180241 0.011535414 0.000524337 287 hsa-let-7e hsa05216 Thyroid cancer 1499_6256_7157 3 0.00018997 0.012158101 0.000528613 288 hsa-let-7e hsa04210 Apoptosis 836_839_7157_841 4 0.000321395 0.02056929 0.000857054 289 hsa-let-7e hsa05010 Alzheimer's disease 836_841_808_801_805 5 0.000452844 0.028982046 0.001159282 290 hsa-let-7e hsa05219 Bladder cancer 1019_7157_5925 3 0.000525888 0.033656837 0.001294494 291 hsa-let-7e hsa04270 Vascular smooth muscle contraction 5578_808_801_805 4 0.000894982 0.057278875 0.00212144 292 hsa-let-7e hsa05213 Endometrial cancer 1499_7157_324 3 0.000948017 0.060673081 0.002166896 293 hsa-let-7e hsa05217 Basal cell carcinoma 1499_7157_324 3 0.001106586 0.070821488 0.002400884 294 hsa-let-7e hsa05131 Shigellosis 25_1499_5578 3 0.001162928 0.0744274 0.002400884 295 hsa-let-7e hsa05130 Pathogenic Escherichia coli infection 25_1499_5578 3 0.001162928 0.0744274 0.002400884 296 hsa-let-7e hsa04530 Tight junction 1499_1019_5578_9223 4 0.001528464 0.097821708 0.003056928 297 hsa-let-7e hsa04120 Ubiquitin mediated proteolysis 11059_997_11060_7329 4 0.001609459 0.103005397 0.003121376 298 hsa-let-7e hsa05218 Melanoma 1019_7157_5925 3 0.002232864 0.142903277 0.004082951 299 hsa-let-7e hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_1432_3725 3 0.002232864 0.142903277 0.004082951 300 hsa-let-7e hsa04950 Maturity onset diabetes of the young 168620_4760 2 0.003707765 0.237296968 0.006591582 301 hsa-let-7e hsa04012 ErbB signaling pathway 25_5578_3725 3 0.003886997 0.248767803 0.006723454 302 hsa-let-7e hsa04020 Calcium signaling pathway 5578_808_801_805 4 0.004311545 0.275938909 0.00726155 303 hsa-let-7e hsa04620 Toll-like receptor signaling pathway 1432_3725_841 3 0.005973302 0.382291328 0.009802342 304 hsa-let-7e hsa04660 T cell receptor signaling pathway 1019_1432_3725 3 0.007312617 0.468007476 0.011700187 305 hsa-let-7e hsa04670 Leukocyte transendothelial migration 1499_1432_5578 3 0.009630727 0.616366552 0.015033331 306 hsa-let-7e hsa04910 Insulin signaling pathway 808_801_805 3 0.013318293 0.852370723 0.020294541 307 hsa-let-7e hsa04630 Jak-STAT signaling pathway 1387_6774_2033 3 0.018005215 1 0.02679846 308 hsa-let-7e hsa05221 Acute myeloid leukemia 861_6774 2 0.019290532 1 0.028058955 309 hsa-let-7e hsa04920 Adipocytokine signaling pathway 6256_6774 2 0.024289515 1 0.034545088 310 hsa-let-7e hsa04370 VEGF signaling pathway 1432_5578 2 0.031192771 1 0.043398638 311 hsa-let-7e hsa04664 Fc epsilon RI signaling pathway 1432_5578 2 0.032656137 1 0.044467931 312 hsa-let-7e hsa04510 Focal adhesion 1499_5578_3725 3 0.03690632 1 0.049208427 313 hsa-let-7e hsa04710 Circadian rhythm - mammal 79365 1 0.047747485 1 0.062364062 314 hsa-let-7f-1 hsa04010 MAPK signaling pathway 9261_6722_8986_6195_207_9252_5595_1432_5594_6196_6197 11 4.51E-12 2.57E-10 2.57E-10 315 hsa-let-7f-1 hsa04150 mTOR signaling pathway 6195_207_5595_5594_6196_6197 6 1.19E-09 6.80E-08 3.40E-08 316 hsa-let-7f-1 hsa05221 Acute myeloid leukemia 6688_207_5595_6774_7704_5594 6 2.41E-09 1.37E-07 4.58E-08 317 hsa-let-7f-1 hsa04720 Long-term potentiation 6195_5595_5594_6196_6197_1387 6 9.25E-09 5.27E-07 1.32E-07 318 hsa-let-7f-1 hsa05200 Pathways in cancer 2736_6688_207_2932_5595_6774_7704_5594_1387 9 1.33E-08 7.57E-07 1.51E-07 319 hsa-let-7f-1 hsa04370 VEGF signaling pathway 9261_207_5595_1432_5594 5 4.57E-07 2.61E-05 4.35E-06 320 hsa-let-7f-1 hsa05215 Prostate cancer 207_2932_5595_5594_1387 5 8.58E-07 4.89E-05 6.45E-06 321 hsa-let-7f-1 hsa05212 Pancreatic cancer 207_2932_5595_5594_1387 5 9.05E-07 5.16E-05 6.45E-06 322 hsa-let-7f-1 hsa04660 T cell receptor signaling pathway 207_2932_5595_1432_5594 5 2.46E-06 0.000139979 1.56E-05 323 hsa-let-7f-1 hsa05213 Endometrial cancer 207_2932_5595_5594 4 3.69E-06 0.000210478 2.10E-05 324 hsa-let-7f-1 hsa05211 Renal cell carcinoma 207_5595_5594_1387 4 1.25E-05 0.000715167 6.50E-05 325 hsa-let-7f-1 hsa04662 B cell receptor signaling pathway 207_2932_5595_5594 4 1.46E-05 0.000834072 6.95E-05 326 hsa-let-7f-1 hsa04664 Fc epsilon RI signaling pathway 207_5595_1432_5594 4 1.78E-05 0.00101448 7.80E-05 327 hsa-let-7f-1 hsa05210 Colorectal cancer 207_2932_5595_5594 4 2.24E-05 0.001278485 9.13E-05 328 hsa-let-7f-1 hsa04012 ErbB signaling pathway 207_2932_5595_5594 4 2.56E-05 0.001459261 9.73E-05 329 hsa-let-7f-1 hsa04062 Chemokine signaling pathway 207_2932_5595_6774_5594 5 3.43E-05 0.001955023 0.000122189 330 hsa-let-7f-1 hsa04620 Toll-like receptor signaling pathway 207_5595_1432_5594 4 4.66E-05 0.002656712 0.000156277 331 hsa-let-7f-1 hsa04916 Melanogenesis 2932_5595_5594_1387 4 5.01E-05 0.002858131 0.000158785 332 hsa-let-7f-1 hsa05219 Bladder cancer 9252_5595_5594 3 8.22E-05 0.004687491 0.00024671 333 hsa-let-7f-1 hsa04930 Type II diabetes mellitus 3651_5595_5594 3 9.98E-05 0.00569094 0.000284547 334 hsa-let-7f-1 hsa04910 Insulin signaling pathway 207_2932_5595_5594 4 0.000144937 0.00826139 0.0003934 335 hsa-let-7f-1 hsa05223 Non-small cell lung cancer 207_5595_5594 3 0.000166909 0.009513827 0.000432447 336 hsa-let-7f-1 hsa05214 Glioma 207_5595_5594 3 0.000281762 0.016060457 0.000698281 337 hsa-let-7f-1 hsa05218 Melanoma 207_5595_5594 3 0.000361583 0.020610244 0.00082441 338 hsa-let-7f-1 hsa04730 Long-term depression 5595_5592_5594 3 0.000361583 0.020610244 0.00082441 339 hsa-let-7f-1 hsa05220 Chronic myeloid leukemia 207_5595_5594 3 0.000422116 0.024060589 0.000925407 340 hsa-let-7f-1 hsa04520 Adherens junction 5595_5594_1387 3 0.000506465 0.028868501 0.001069204 341 hsa-let-7f-1 hsa04510 Focal adhesion 207_2932_5595_5594 4 0.000640095 0.036485403 0.001261136 342 hsa-let-7f-1 hsa04350 TGF-beta signaling pathway 5595_5594_1387 3 0.000641631 0.036572946 0.001261136 343 hsa-let-7f-1 hsa04540 Gap junction 5595_5592_5594 3 0.000774218 0.04413043 0.001471014 344 hsa-let-7f-1 hsa04912 GnRH signaling pathway 5595_1432_5594 3 0.001178462 0.067172317 0.002166849 345 hsa-let-7f-1 hsa04270 Vascular smooth muscle contraction 5595_5592_5594 3 0.001510011 0.086070619 0.002645135 346 hsa-let-7f-1 hsa05216 Thyroid cancer 5595_5594 2 0.001531394 0.087289459 0.002645135 347 hsa-let-7f-1 hsa04360 Axon guidance 2932_5595_5594 3 0.002021081 0.115201604 0.003388282 348 hsa-let-7f-1 hsa04630 Jak-STAT signaling pathway 207_6774_1387 3 0.003221557 0.183628721 0.005246535 349 hsa-let-7f-1 hsa05010 Alzheimer's disease 2932_5595_5594 3 0.00463895 0.264420178 0.007345005 350 hsa-let-7f-1 hsa05217 Basal cell carcinoma 2736_2932 2 0.005095701 0.290454984 0.007850135 351 hsa-let-7f-1 hsa04340 Hedgehog signaling pathway 2736_2932 2 0.005449885 0.310643454 0.008174828 352 hsa-let-7f-1 hsa04920 Adipocytokine signaling pathway 207_6774 2 0.007384152 0.420896636 0.010792221 353 hsa-let-7f-1 hsa04110 Cell cycle 2932_1387 2 0.021486265 1 0.030617928 354 hsa-let-7f-1 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594 2 0.028158506 1 0.039147191 355 hsa-let-7f-1 hsa04310 Wnt signaling pathway 2932_1387 2 0.033537225 1 0.045514806 356 hsa-let-7f-1 hsa04950 Maturity onset diabetes of the young 3651 1 0.045570794 1 0.060407797 357 hsa-let-7f-1 hsa05016 Huntington's disease 3064_1387 2 0.049000722 1 0.063478208 358 hsa-let-7i hsa04110 Cell cycle 4088_4089_3066_1870_1871_7157_2033_1017_890_4193_1869_1029_5934_5933 14 1.32E-20 4.50E-19 4.50E-19 359 hsa-let-7i hsa05220 Chronic myeloid leukemia 4088_4089_4609_3066_1870_1871_7157_4193_1869_1029 10 1.80E-15 6.13E-14 3.06E-14 360 hsa-let-7i hsa05200 Pathways in cancer 4088_4089_4609_3066_1870_1871_1050_4149_7157_2033_1017_4193_1869_1029 14 9.73E-15 3.31E-13 1.10E-13 361 hsa-let-7i hsa04350 TGF-beta signaling pathway 4088_4089_4609_1874_1875_6667_2033_5934_5933 9 4.15E-13 1.41E-11 3.53E-12 362 hsa-let-7i hsa05219 Bladder cancer 4609_1870_1871_7157_4193_1869_1029 7 8.98E-12 3.05E-10 6.10E-11 363 hsa-let-7i hsa05215 Prostate cancer 1870_1871_7157_2033_1017_4193_1869_1385 8 2.36E-11 8.01E-10 1.25E-10 364 hsa-let-7i hsa05212 Pancreatic cancer 1870_1871_7157_2033_1017_4193_1869_1385 8 2.56E-11 8.72E-10 1.25E-10 365 hsa-let-7i hsa05222 Small cell lung cancer 4609_1870_1871_4149_7157_1017_1869 7 9.23E-10 3.14E-08 3.92E-09 366 hsa-let-7i hsa05214 Glioma 1870_1871_7157_4193_1869_1029 6 7.75E-09 2.63E-07 2.93E-08 367 hsa-let-7i hsa05218 Melanoma 1870_1871_7157_4193_1869_1029 6 1.27E-08 4.32E-07 4.32E-08 368 hsa-let-7i hsa05223 Non-small cell lung cancer 1870_1871_7157_1869_1029 5 1.45E-07 4.94E-06 4.50E-07 369 hsa-let-7i hsa04310 Wnt signaling pathway 4088_4089_4609_7157_2033_8061 6 9.24E-07 3.14E-05 2.62E-06 370 hsa-let-7i hsa04115 p53 signaling pathway 7157_1017_4193_1029 4 1.60E-05 0.000545487 4.20E-05 371 hsa-let-7i hsa05210 Colorectal cancer 4088_4089_4609_7157 4 3.36E-05 0.001141975 8.16E-05 372 hsa-let-7i hsa05016 Huntington's disease 3066_7157_6667_2033_1385 5 4.98E-05 0.001693159 0.000112877 373 hsa-let-7i hsa04330 Notch signaling pathway 3066_2033_4851 3 0.000152791 0.005194898 0.000324681 374 hsa-let-7i hsa04010 MAPK signaling pathway 4609_6722_4149_7157_1386 5 0.000274473 0.009332096 0.000548947 375 hsa-let-7i hsa04520 Adherens junction 4088_4089_2033 3 0.00068242 0.023202278 0.001289015 376 hsa-let-7i hsa04612 Antigen processing and presentation 4802_4800_1385 3 0.0009205 0.031297007 0.001647211 377 hsa-let-7i hsa05216 Thyroid cancer 4609_7157 2 0.001872476 0.063664179 0.003183209 378 hsa-let-7i hsa05213 Endometrial cancer 4609_7157 2 0.005589569 0.190045355 0.009049779 379 hsa-let-7i hsa05221 Acute myeloid leukemia 4609_1050 2 0.00708229 0.240797861 0.010945357 380 hsa-let-7i hsa04916 Melanogenesis 2033_1385 2 0.020298733 0.690156938 0.030006823 381 hsa-let-7i hsa04120 Ubiquitin mediated proteolysis 4193_672 2 0.034390392 1 0.048719722 382 hsa-let-7i hsa04630 Jak-STAT signaling pathway 4609_2033 2 0.041788796 1 0.056832762 383 hsa-mir-100 hsa05200 Pathways in cancer 3320_5925_3326_1147_3551_1499_5595_5594_1387_6256_1487_367_8517_2932_6774_5970_6688_2113_4087_1869_862_6502_2353_4088_7175_3065_1488_2033_4791_4792 30 1.45E-23 1.07E-21 1.07E-21 384 hsa-mir-100 hsa05215 Prostate cancer 3320_5925_3326_1147_3551_1499_5595_5594_1387_367_8517_2932_5970_1869_2033_4792 16 2.22E-17 1.64E-15 6.42E-16 385 hsa-mir-100 hsa05212 Pancreatic cancer 3320_5925_3326_1147_3551_1499_5595_5594_1387_367_8517_2932_5970_1869_2033_4792 16 2.60E-17 1.93E-15 6.42E-16 386 hsa-mir-100 hsa04010 MAPK signaling pathway 1147_3551_5595_5594_6722_9261_1326_4208_3305_3303_5566_8517_7867_3312_5971_5970_3310_2353_1432_4791 20 2.03E-14 1.50E-12 3.76E-13 387 hsa-mir-100 hsa05220 Chronic myeloid leukemia 5925_1147_3551_5595_5594_1487_8517_5970_1869_4088_3065_1488_4792 13 4.09E-14 3.03E-12 6.05E-13 388 hsa-mir-100 hsa04660 T cell receptor signaling pathway 1147_3551_5595_5594_1326_8517_2932_5970_4794_2353_1432_4792_4793 13 3.39E-12 2.51E-10 4.18E-11 389 hsa-mir-100 hsa04310 Wnt signaling pathway 23291_1499_1387_8607_1487_5566_2932_8454_6500_4087_8945_4088_1488_2033 14 1.09E-11 8.07E-10 1.15E-10 390 hsa-mir-100 hsa04662 B cell receptor signaling pathway 1147_3551_5595_5594_8517_2932_5970_4794_2353_4792_4793 11 1.97E-11 1.46E-09 1.82E-10 391 hsa-mir-100 hsa04350 TGF-beta signaling pathway 5595_5594_1387_8454_3397_3398_6500_4087_3399_4088_2033 11 8.40E-11 6.22E-09 6.91E-10 392 hsa-mir-100 hsa04110 Cell cycle 5925_5591_1387_2932_8454_6500_4087_1869_6502_4088_3065_2033 12 1.28E-10 9.46E-09 9.46E-10 393 hsa-mir-100 hsa04330 Notch signaling pathway 388585_1387_4851_1487_9612_3065_1488_2033_8850 9 1.67E-10 1.24E-08 1.13E-09 394 hsa-mir-100 hsa05221 Acute myeloid leukemia 1147_3551_5595_5594_8517_6774_5970_6688_862 9 1.01E-09 7.51E-08 6.25E-09 395 hsa-mir-100 hsa04920 Adipocytokine signaling pathway 1147_3551_6256_8517_6774_5970_4794_4792_4793 9 2.80E-09 2.07E-07 1.59E-08 396 hsa-mir-100 hsa04620 Toll-like receptor signaling pathway 1147_3551_5595_5594_1326_8517_5970_2353_1432_4792 10 5.93E-09 4.39E-07 3.13E-08 397 hsa-mir-100 hsa04916 Melanogenesis 1499_5595_5594_1387_5566_2932_2033_808_801_805 10 7.04E-09 5.21E-07 3.47E-08 398 hsa-mir-100 hsa05222 Small cell lung cancer 5925_1147_3551_6256_8517_5970_1869_6502_4792 9 2.06E-08 1.52E-06 9.32E-08 399 hsa-mir-100 hsa04062 Chemokine signaling pathway 1147_3551_5595_5594_5566_8517_2932_6774_5970_653361_4792_4793 12 2.14E-08 1.58E-06 9.32E-08 400 hsa-mir-100 hsa04120 Ubiquitin mediated proteolysis 7329_23291_672_8454_6500_3093_8945_6502_10273_7323 10 9.17E-08 6.79E-06 3.77E-07 401 hsa-mir-100 hsa04720 Long-term potentiation 5595_5594_1387_5566_2033_808_801_805 8 1.12E-07 8.28E-06 4.36E-07 402 hsa-mir-100 hsa03020 RNA polymerase 25885_64425_5437_51082_84172_5441 6 1.36E-07 1.01E-05 5.04E-07 403 hsa-mir-100 hsa04520 Adherens junction 1499_5595_5594_1387_4087_4088_2033_71 8 1.77E-07 1.31E-05 6.24E-07 404 hsa-mir-100 hsa05131 Shigellosis 347733_1499_7278_10382_84617_203068_71 7 2.65E-07 1.96E-05 8.52E-07 405 hsa-mir-100 hsa05130 Pathogenic Escherichia coli infection 347733_1499_7278_10382_84617_203068_71 7 2.65E-07 1.96E-05 8.52E-07 406 hsa-mir-100 hsa04540 Gap junction 347733_5595_5594_5566_7278_10382_84617_203068 8 5.16E-07 3.82E-05 1.59E-06 407 hsa-mir-100 hsa05214 Glioma 5925_5595_5594_1869_808_801_805 7 6.69E-07 4.95E-05 1.98E-06 408 hsa-mir-100 hsa05210 Colorectal cancer 1499_5595_5594_2932_4087_2353_4088 7 3.29E-06 0.0002435 9.37E-06 409 hsa-mir-100 hsa05216 Thyroid cancer 1499_5595_5594_6256_7175 5 3.49E-06 0.00025816 9.56E-06 410 hsa-mir-100 hsa04612 Antigen processing and presentation 3320_3326_3309_3305_3303_3312_3310 7 4.71E-06 0.000348318 1.20E-05 411 hsa-mir-100 hsa04210 Apoptosis 1147_3551_5566_8517_5970_8837_4792 7 4.71E-06 0.000348318 1.20E-05 412 hsa-mir-100 hsa04910 Insulin signaling pathway 3551_5595_5594_5566_2932_808_801_805 8 8.25E-06 0.00061074 2.04E-05 413 hsa-mir-100 hsa04912 GnRH signaling pathway 5595_5594_5566_1432_808_801_805 7 1.55E-05 0.00114676 3.62E-05 414 hsa-mir-100 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_3551_8517_5970_1432_4792 6 1.56E-05 0.001158045 3.62E-05 415 hsa-mir-100 hsa04270 Vascular smooth muscle contraction 5595_5594_5566_4637_808_801_805 7 2.66E-05 0.001969591 5.97E-05 416 hsa-mir-100 hsa05223 Non-small cell lung cancer 5925_5595_5594_6256_1869 5 5.46E-05 0.004039508 0.000118809 417 hsa-mir-100 hsa05016 Huntington's disease 1387_292_293_5437_1213_3065_2033_5441 8 6.83E-05 0.005056508 0.000144472 418 hsa-mir-100 hsa05211 Renal cell carcinoma 5595_5594_1387_2113_2033 5 0.000194888 0.014421747 0.000400604 419 hsa-mir-100 hsa04370 VEGF signaling pathway 5595_5594_9261_7867_1432 5 0.000261762 0.0193704 0.000523524 420 hsa-mir-100 hsa05219 Bladder cancer 5925_5595_5594_1869 4 0.000284132 0.02102579 0.00055331 421 hsa-mir-100 hsa04930 Type II diabetes mellitus 3551_5595_5594_3651 4 0.000363016 0.026863175 0.000688799 422 hsa-mir-100 hsa05213 Endometrial cancer 1499_5595_5594_2932 4 0.000606101 0.044851509 0.001121288 423 hsa-mir-100 hsa04340 Hedgehog signaling pathway 23291_5566_2932_8945 4 0.000838403 0.062041836 0.001513216 424 hsa-mir-100 hsa04810 Regulation of actin cytoskeleton 5595_5594_4627_4628_10788_10627_71 7 0.001013975 0.075034139 0.001786527 425 hsa-mir-100 hsa05010 Alzheimer's disease 5595_5594_2932_808_801_805 6 0.001736325 0.128488064 0.002988095 426 hsa-mir-100 hsa05218 Melanoma 5925_5595_5594_1869 4 0.001811904 0.134080919 0.003047294 427 hsa-mir-100 hsa04670 Leukocyte transendothelial migration 1499_653361_10627_1432_71 5 0.001901067 0.140678975 0.003126199 428 hsa-mir-100 hsa04020 Calcium signaling pathway 292_5566_293_808_801_805 6 0.002097188 0.155191878 0.003373736 429 hsa-mir-100 hsa04530 Tight junction 1499_4627_4628_10627_71 5 0.003084737 0.228270512 0.004856819 430 hsa-mir-100 hsa04510 Focal adhesion 1499_5595_5594_2932_10627_71 6 0.003605476 0.266805236 0.005558442 431 hsa-mir-100 hsa04630 Jak-STAT signaling pathway 3559_1387_6778_6774_2033 5 0.00511597 0.378581777 0.007726159 432 hsa-mir-100 hsa03010 Ribosome 6156_6128_6207_6202 4 0.00627975 0.464701466 0.009294029 433 hsa-mir-100 hsa04950 Maturity onset diabetes of the young 168620_3651 2 0.013755984 1 0.019959663 434 hsa-mir-100 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.017348445 1 0.024688171 435 hsa-mir-100 hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432 3 0.019140709 1 0.026724763 436 hsa-mir-100 hsa04012 ErbB signaling pathway 5595_5594_2932 3 0.024402888 1 0.033440995 437 hsa-mir-100 hsa03410 Base excision repair 3146_142 2 0.028197096 1 0.037937911 438 hsa-mir-101-1 hsa03022 Basal transcription factors 2959_6908 2 0.000307874 0.004925982 0.004925982 439 hsa-mir-101-1 hsa05215 Prostate cancer 2033_367 2 0.001630478 0.026087648 0.008887749 440 hsa-mir-101-1 hsa05212 Pancreatic cancer 2033_367 2 0.001666453 0.026663248 0.008887749 441 hsa-mir-101-1 hsa05016 Huntington's disease 2033_6908 2 0.007024157 0.112386512 0.028096628 442 hsa-mir-101-1 hsa05200 Pathways in cancer 2033_367 2 0.020546316 0.328741053 0.063014757 443 hsa-mir-101-1 hsa03410 Base excision repair 3146 1 0.024371354 0.389941658 0.063014757 444 hsa-mir-101-1 hsa03420 Nucleotide excision repair 4331 1 0.029566123 0.473057967 0.063014757 445 hsa-mir-101-1 hsa04330 Notch signaling pathway 2033 1 0.031507378 0.504118054 0.063014757 446 hsa-mir-101-1 hsa05211 Renal cell carcinoma 2033 1 0.047541657 0.760666506 0.07605444 447 hsa-mir-101-1 hsa04720 Long-term potentiation 2033 1 0.049448734 0.791179745 0.07605444 448 hsa-mir-101-2 hsa05200 Pathways in cancer 3716_3326_3725_25_1956_1387_2064_5159_5747_5156_2261_3815_2932_3265_6774_6776_6777_5879_8772_4609_2353_4087_4088_4089_3065_5925_2033_207_8554_5970_7046_7186 32 4.64E-32 3.11E-30 3.11E-30 449 hsa-mir-101-2 hsa04630 Jak-STAT signaling pathway 3717_3716_3560_3561_1387_6774_6776_6777_6773_3459_58985_3455_5781_7297_4609_1439_2033_207_8554_10379 20 1.55E-22 1.04E-20 5.19E-21 450 hsa-mir-101-2 hsa04010 MAPK signaling pathway 3725_1956_5159_5156_7132_3303_2261_2264_9252_3265_1432_1845_5879_22800_4609_2353_207_5970_7046_7186 20 4.78E-18 3.21E-16 1.07E-16 451 hsa-mir-101-2 hsa04012 ErbB signaling pathway 3725_25_818_817_1956_6714_2064_5747_2932_3265_6776_6777_4609_207 14 2.69E-17 1.80E-15 4.51E-16 452 hsa-mir-101-2 hsa04060 Cytokine-cytokine receptor interaction 2321_1956_3560_3561_90_5159_5156_7133_7132_1234_1230_3815_3459_3791_7852_58985_3455_1439_7046 19 4.10E-17 2.75E-15 5.49E-16 453 hsa-mir-101-2 hsa05220 Chronic myeloid leukemia 25_3265_6776_6777_5781_4609_4088_4089_3065_5925_207_5970_7046 13 1.61E-16 1.08E-14 1.80E-15 454 hsa-mir-101-2 hsa05210 Colorectal cancer 3725_1956_5159_5156_2932_5879_4609_2353_4087_4088_4089_207_7046 13 6.05E-16 4.05E-14 5.79E-15 455 hsa-mir-101-2 hsa04350 TGF-beta signaling pathway 1387_90_6667_4609_4086_4087_4088_4089_2033_4093_7046_57154 12 2.88E-14 1.93E-12 2.41E-13 456 hsa-mir-101-2 hsa05215 Prostate cancer 3326_1956_1387_2064_5159_5156_2932_3265_5925_2033_207_5970 12 3.26E-14 2.18E-12 2.43E-13 457 hsa-mir-101-2 hsa05212 Pancreatic cancer 3326_1956_1387_2064_5159_5156_2932_3265_5925_2033_207_5970 12 3.69E-14 2.47E-12 2.47E-13 458 hsa-mir-101-2 hsa04520 Adherens junction 1956_6714_1387_2064_5879_4087_4088_4089_2033_7046_2534 11 3.65E-13 2.44E-11 2.22E-12 459 hsa-mir-101-2 hsa04062 Chemokine signaling pathway 3717_5580_5747_1234_1230_2932_3265_6774_6777_6773_5879_7852_207_5970 14 6.81E-13 4.56E-11 3.80E-12 460 hsa-mir-101-2 hsa04510 Focal adhesion 3725_2321_1956_6714_2064_5159_5747_5156_2932_3265_5879_3791_207_2534 14 1.56E-12 1.05E-10 8.05E-12 461 hsa-mir-101-2 hsa04110 Cell cycle 25_1387_2932_4174_4172_4087_4088_4089_3065_5925_2033 11 1.93E-11 1.29E-09 9.24E-11 462 hsa-mir-101-2 hsa04920 Adipocytokine signaling pathway 3717_8717_7133_7132_6774_5781_207_5970_7186 9 6.55E-11 4.39E-09 2.93E-10 463 hsa-mir-101-2 hsa04310 Wnt signaling pathway 3725_818_817_1387_2932_5879_4609_4087_4088_4089_2033 11 2.24E-10 1.50E-08 9.39E-10 464 hsa-mir-101-2 hsa05221 Acute myeloid leukemia 3815_3265_6774_6776_6777_4609_207_5970 8 7.29E-10 4.88E-08 2.87E-09 465 hsa-mir-101-2 hsa05214 Glioma 818_817_1956_5159_5156_3265_5925_207 8 1.47E-09 9.83E-08 5.46E-09 466 hsa-mir-101-2 hsa05219 Bladder cancer 1956_2064_2261_9252_3265_4609_5925 7 2.39E-09 1.60E-07 8.44E-09 467 hsa-mir-101-2 hsa04660 T cell receptor signaling pathway 3725_3932_2932_3265_1432_2353_207_5970_2534 9 3.78E-09 2.53E-07 1.27E-08 468 hsa-mir-101-2 hsa04662 B cell receptor signaling pathway 3725_2932_3265_5879_6850_2353_207_5970 8 4.15E-09 2.78E-07 1.32E-08 469 hsa-mir-101-2 hsa04620 Toll-like receptor signaling pathway 3725_1432_5879_3455_8772_2353_207_5970 8 3.89E-08 2.61E-06 1.18E-07 470 hsa-mir-101-2 hsa04912 GnRH signaling pathway 3725_5580_818_817_1956_6714_3265_1432 8 5.90E-08 3.95E-06 1.72E-07 471 hsa-mir-101-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1956_6714_1432_5879_5781_5970 7 6.60E-08 4.42E-06 1.84E-07 472 hsa-mir-101-2 hsa05211 Renal cell carcinoma 3725_1387_3265_5879_5781_2033_207 7 7.22E-08 4.83E-06 1.93E-07 473 hsa-mir-101-2 hsa04720 Long-term potentiation 818_817_1387_2902_2906_3265_2033 7 9.36E-08 6.27E-06 2.41E-07 474 hsa-mir-101-2 hsa04370 VEGF signaling pathway 6714_5747_3265_1432_5879_3791_207 7 1.11E-07 7.41E-06 2.75E-07 475 hsa-mir-101-2 hsa04664 Fc epsilon RI signaling pathway 5580_3265_1432_5879_6850_207_2534 7 1.30E-07 8.73E-06 3.12E-07 476 hsa-mir-101-2 hsa05222 Small cell lung cancer 5747_4609_5925_207_8554_5970_7186 7 2.24E-07 1.50E-05 5.17E-07 477 hsa-mir-101-2 hsa04020 Calcium signaling pathway 818_817_1956_2064_5159_2902_2906_5156_147 9 2.50E-07 1.67E-05 5.45E-07 478 hsa-mir-101-2 hsa05213 Endometrial cancer 1956_2064_2932_3265_4609_207 6 2.52E-07 1.69E-05 5.45E-07 479 hsa-mir-101-2 hsa04210 Apoptosis 8717_7132_8772_1439_207_5970_7186 7 2.78E-07 1.87E-05 5.83E-07 480 hsa-mir-101-2 hsa04650 Natural killer cell mediated cytotoxicity 3932_3265_5879_3459_6850_3455_5781_2534 8 3.49E-07 2.34E-05 7.09E-07 481 hsa-mir-101-2 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906_7133_7132_1432_5879 6 3.78E-07 2.53E-05 7.44E-07 482 hsa-mir-101-2 hsa04916 Melanogenesis 818_817_1387_3815_2932_3265_2033 7 7.50E-07 5.03E-05 1.44E-06 483 hsa-mir-101-2 hsa04810 Regulation of actin cytoskeleton 1956_5159_5747_5156_2261_2264_3265_5879_22800 9 1.01E-06 6.77E-05 1.88E-06 484 hsa-mir-101-2 hsa05218 Melanoma 1956_5159_5156_3265_5925_207 6 1.38E-06 9.23E-05 2.50E-06 485 hsa-mir-101-2 hsa04360 Axon guidance 25_5747_2932_3265_5879_7852_2534 7 3.23E-06 0.000216708 5.70E-06 486 hsa-mir-101-2 hsa05223 Non-small cell lung cancer 1956_2064_3265_5925_207 5 7.16E-06 0.00047948 1.23E-05 487 hsa-mir-101-2 hsa05010 Alzheimer's disease 22926_2902_2906_7132_2932_8772_351 7 2.12E-05 0.001421814 3.55E-05 488 hsa-mir-101-2 hsa04530 Tight junction 8573_5580_6714_3265_22800_207 6 4.87E-05 0.003260663 7.95E-05 489 hsa-mir-101-2 hsa04540 Gap junction 1956_6714_5159_5156_3265 5 8.43E-05 0.005650182 0.000134528 490 hsa-mir-101-2 hsa05016 Huntington's disease 1387_2902_6667_3065_2033_9519 6 0.000258777 0.017338039 0.00040321 491 hsa-mir-101-2 hsa04670 Leukocyte transendothelial migration 5747_1432_5879_7852_5781 5 0.000284419 0.019056056 0.000433092 492 hsa-mir-101-2 hsa04612 Antigen processing and presentation 3326_3303_4800_4801 4 0.000849088 0.056888919 0.001264198 493 hsa-mir-101-2 hsa04330 Notch signaling pathway 1387_3065_2033 3 0.001508851 0.101093038 0.002197675 494 hsa-mir-101-2 hsa04120 Ubiquitin mediated proteolysis 672_7329_8554_57154 4 0.00408537 0.273719802 0.005823826 495 hsa-mir-101-2 hsa05216 Thyroid cancer 3265_4609 2 0.00862898 0.578141663 0.012044618 496 hsa-mir-101-2 hsa05340 Primary immunodeficiency 3932_3561 2 0.012143112 0.813588491 0.016603847 497 hsa-mir-101-2 hsa03030 DNA replication 4174_4172 2 0.012780198 0.856273243 0.017125465 498 hsa-mir-101-2 hsa03022 Basal transcription factors 2969_9519 2 0.013431589 0.899916463 0.017645421 499 hsa-mir-101-2 hsa04910 Insulin signaling pathway 2932_3265_207 3 0.026183364 1 0.033736257 500 hsa-mir-101-2 hsa05131 Shigellosis 25_2534 2 0.028345339 1 0.035169217 501 hsa-mir-101-2 hsa05130 Pathogenic Escherichia coli infection 25_2534 2 0.028345339 1 0.035169217 502 hsa-mir-103-1 hsa05200 Pathways in cancer 3716_5371_675_1956_5595_5594_5599_1387_5159_5156_5601_9915_1399_1398_367_3815_2932_6774_6777_6772_3091_4436_7157_4609_3725_867_2353_4088_4089_1050_5925_2034_2033_5970 34 9.73E-26 6.81E-24 6.81E-24 503 hsa-mir-103-1 hsa04010 MAPK signaling pathway 1956_5595_5594_6722_5599_5159_5156_5601_5600_5603_1399_1398_1386_1432_1649_8550_7157_4773_4609_3725_3727_2353_5970_9252 24 4.84E-17 3.39E-15 1.69E-15 504 hsa-mir-103-1 hsa05210 Colorectal cancer 1956_5595_5594_5599_5159_5156_5601_2932_4436_7157_4609_3725_2353_4088_4089 15 3.66E-15 2.56E-13 8.53E-14 505 hsa-mir-103-1 hsa04012 ErbB signaling pathway 1956_6714_5595_5594_5599_2066_5601_1399_1398_2932_6777_4609_3725_867_6464 15 5.80E-15 4.06E-13 1.01E-13 506 hsa-mir-103-1 hsa05220 Chronic myeloid leukemia 5595_5594_1399_1398_6777_7157_5781_4609_867_4088_4089_5925_5970_6464 14 1.79E-14 1.26E-12 2.51E-13 507 hsa-mir-103-1 hsa04630 Jak-STAT signaling pathway 3717_3716_3718_85480_3560_3561_1387_3575_6774_6777_6772_2057_5781_4609_867_2690_2033 17 7.48E-14 5.23E-12 8.72E-13 508 hsa-mir-103-1 hsa04660 T cell receptor signaling pathway 3932_5595_5594_5601_5600_5603_919_2932_1432_4773_3725_867_2353_5970_1493 15 1.28E-13 8.93E-12 1.28E-12 509 hsa-mir-103-1 hsa05215 Prostate cancer 1956_5595_5594_1387_5159_5156_367_2932_7157_5925_2033_5970_9586 13 2.26E-12 1.58E-10 1.98E-11 510 hsa-mir-103-1 hsa05212 Pancreatic cancer 1956_5595_5594_1387_5159_5156_367_2932_7157_5925_2033_5970_9586 13 2.57E-12 1.80E-10 2.00E-11 511 hsa-mir-103-1 hsa04310 Wnt signaling pathway 5515_5599_1387_5601_2932_7157_8061_4773_4609_3725_1457_1459_4088_4089_2033 15 9.11E-12 6.38E-10 6.38E-11 512 hsa-mir-103-1 hsa04520 Adherens junction 1956_6714_3643_5595_5594_1387_5770_1457_1459_4088_4089_2033 12 1.37E-11 9.59E-10 8.72E-11 513 hsa-mir-103-1 hsa04350 TGF-beta signaling pathway 5515_5595_5594_1387_6667_7027_4609_3399_4088_4089_2033_4093 12 3.32E-11 2.32E-09 1.94E-10 514 hsa-mir-103-1 hsa05211 Renal cell carcinoma 5595_5594_1387_9915_1399_1398_3091_5781_3725_2034_2033 11 8.29E-11 5.80E-09 4.46E-10 515 hsa-mir-103-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_5599_5601_5600_5603_1432_5781_3725_5970 10 1.24E-09 8.69E-08 6.21E-09 516 hsa-mir-103-1 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5601_5600_5603_1432_6772_3725_2353_5970 11 2.41E-09 1.69E-07 1.12E-08 517 hsa-mir-103-1 hsa04910 Insulin signaling pathway 3643_5595_5594_5599_5601_1399_1398_2932_5770_23265_867_6464 12 4.29E-09 3.00E-07 1.86E-08 518 hsa-mir-103-1 hsa05221 Acute myeloid leukemia 5371_5595_5594_3815_6774_6777_4609_1050_5970 9 4.52E-09 3.17E-07 1.86E-08 519 hsa-mir-103-1 hsa04062 Chemokine signaling pathway 3717_3718_5595_5594_1399_1398_1234_2932_6774_6777_6772_5970_6464 13 1.71E-08 1.19E-06 6.63E-08 520 hsa-mir-103-1 hsa04662 B cell receptor signaling pathway 695_5595_5594_6850_2932_4773_3725_2353_5970 9 3.02E-08 2.11E-06 1.11E-07 521 hsa-mir-103-1 hsa04510 Focal adhesion 1956_6714_5595_5594_5599_5159_5156_5601_1399_1398_2932_3725_6464 13 3.52E-08 2.47E-06 1.23E-07 522 hsa-mir-103-1 hsa04664 Fc epsilon RI signaling pathway 695_5595_5594_5599_6850_5601_5600_5603_1432 9 4.55E-08 3.19E-06 1.52E-07 523 hsa-mir-103-1 hsa04912 GnRH signaling pathway 1956_6714_5595_5594_5599_5601_5600_5603_1432_3725 10 4.95E-08 3.47E-06 1.58E-07 524 hsa-mir-103-1 hsa04110 Cell cycle 1387_2932_7027_7157_4088_4089_5925_2033_891_8379 10 1.15E-07 8.08E-06 3.51E-07 525 hsa-mir-103-1 hsa05219 Bladder cancer 1956_5595_5594_7157_4609_5925_9252 7 1.43E-07 9.99E-06 4.16E-07 526 hsa-mir-103-1 hsa05214 Glioma 1956_5595_5594_5159_5156_7157_5925_6464 8 1.50E-07 1.05E-05 4.21E-07 527 hsa-mir-103-1 hsa05218 Melanoma 1956_5595_5594_5159_5156_7157_5925 7 3.59E-06 0.000251149 9.66E-06 528 hsa-mir-103-1 hsa04370 VEGF signaling pathway 6714_5595_5594_5600_5603_1432_4773 7 5.90E-06 0.000413057 1.53E-05 529 hsa-mir-103-1 hsa05213 Endometrial cancer 1956_5595_5594_2932_7157_4609 6 7.92E-06 0.000554235 1.98E-05 530 hsa-mir-103-1 hsa04060 Cytokine-cytokine receptor interaction 85480_1956_3560_3561_5159_5156_3575_1234_3815_2057_2690 11 1.69E-05 0.001184599 4.08E-05 531 hsa-mir-103-1 hsa05340 Primary immunodeficiency 3718_695_3932_3561_3575 5 1.82E-05 0.001271871 4.24E-05 532 hsa-mir-103-1 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6850_919_5781_4773_6464 8 2.82E-05 0.00197581 6.37E-05 533 hsa-mir-103-1 hsa04920 Adipocytokine signaling pathway 3717_5599_5601_6774_5781_5970 6 3.01E-05 0.002104784 6.58E-05 534 hsa-mir-103-1 hsa04930 Type II diabetes mellitus 3643_5595_5594_5599_5601 5 5.47E-05 0.003832045 0.000116123 535 hsa-mir-103-1 hsa05223 Non-small cell lung cancer 1956_5595_5594_7157_5925 5 0.000121855 0.008529833 0.000250877 536 hsa-mir-103-1 hsa05216 Thyroid cancer 5595_5594_7157_4609 4 0.000147415 0.010319074 0.000294831 537 hsa-mir-103-1 hsa04540 Gap junction 1956_6714_5595_5594_5159_5156 6 0.000165904 0.011613284 0.000322591 538 hsa-mir-103-1 hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_867_64326_7325_7329 7 0.000205913 0.014413941 0.000389566 539 hsa-mir-103-1 hsa05016 Huntington's disease 1387_6908_4724_6667_1537_7157_2033_9586 8 0.000221 0.015470027 0.000407106 540 hsa-mir-103-1 hsa04916 Melanogenesis 5595_5594_1387_3815_2932_2033 6 0.000294361 0.020605261 0.00052834 541 hsa-mir-103-1 hsa05014 Amyotrophic lateral sclerosis (ALS) 5600_5603_1432_7157 4 0.001478714 0.103510002 0.00258775 542 hsa-mir-103-1 hsa03010 Ribosome 6124_6129_6143_6222_6231 5 0.001884989 0.131949234 0.003218274 543 hsa-mir-103-1 hsa04810 Regulation of actin cytoskeleton 1956_5595_5594_5159_5156_1399_1398 7 0.00267116 0.186981215 0.004451934 544 hsa-mir-103-1 hsa05010 Alzheimer's disease 5595_5594_4724_2932_840_1537 6 0.004037956 0.282656885 0.006425756 545 hsa-mir-103-1 hsa04720 Long-term potentiation 5595_5594_1387_2033 4 0.004039047 0.282733269 0.006425756 546 hsa-mir-103-1 hsa03022 Basal transcription factors 2963_2969_6908 3 0.004253113 0.297717877 0.006615953 547 hsa-mir-103-1 hsa05222 Small cell lung cancer 7157_4609_5925_5970 4 0.006407962 0.448557318 0.009751246 548 hsa-mir-103-1 hsa04330 Notch signaling pathway 1387_9612_2033 3 0.007948363 0.556385381 0.011837987 549 hsa-mir-103-1 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.010327109 0.722897638 0.015060367 550 hsa-mir-103-1 hsa04670 Leukocyte transendothelial migration 5600_5603_1432_5781 4 0.020027796 1 0.028611138 551 hsa-mir-103-1 hsa04115 p53 signaling pathway 7157_64326_891 3 0.02122746 1 0.029718444 552 hsa-mir-103-1 hsa04730 Long-term depression 5515_5595_5594 3 0.02280193 1 0.031296767 553 hsa-mir-103-1 hsa03440 Homologous recombination 675_4683 2 0.024860664 1 0.033064526 554 hsa-mir-103-1 hsa04360 Axon guidance 5595_5594_2932_4773 4 0.02503457 1 0.033064526 555 hsa-mir-103-1 hsa04530 Tight junction 5515_6714_1457_1459 4 0.028755536 1 0.037275695 556 hsa-mir-103-1 hsa04640 Hematopoietic cell lineage 3575_3815_2057 3 0.037615297 1 0.047874014 557 hsa-mir-103-1 hsa04210 Apoptosis 840_7157_5970 3 0.039740838 1 0.049676047 558 hsa-mir-103-1-as hsa05200 Pathways in cancer 1387_3065_5925_2033_2249_8554_367_3725_6776_6777_2353_5914_5970_6256 14 1.98E-14 9.48E-13 9.48E-13 559 hsa-mir-103-1-as hsa04330 Notch signaling pathway 9612_1387_3065_2033_8850 5 9.70E-08 4.66E-06 2.33E-06 560 hsa-mir-103-1-as hsa04110 Cell cycle 1387_3065_993_5925_2033_983 6 3.09E-07 1.48E-05 4.95E-06 561 hsa-mir-103-1-as hsa05220 Chronic myeloid leukemia 3065_5925_6776_6777_5970 5 8.57E-07 4.11E-05 1.03E-05 562 hsa-mir-103-1-as hsa04630 Jak-STAT signaling pathway 1387_2033_3977_8554_6776_6777 6 1.37E-06 6.56E-05 1.31E-05 563 hsa-mir-103-1-as hsa05215 Prostate cancer 1387_5925_2033_367_5970 5 1.81E-06 8.70E-05 1.31E-05 564 hsa-mir-103-1-as hsa05212 Pancreatic cancer 1387_5925_2033_367_5970 5 1.91E-06 9.17E-05 1.31E-05 565 hsa-mir-103-1-as hsa05221 Acute myeloid leukemia 6776_6777_5914_5970 4 1.08E-05 0.000516809 6.46E-05 566 hsa-mir-103-1-as hsa05222 Small cell lung cancer 5925_8554_5970_6256 4 4.42E-05 0.002122055 0.000235784 567 hsa-mir-103-1-as hsa05016 Huntington's disease 1387_3065_6908_6667_2033 5 6.26E-05 0.003002623 0.000300262 568 hsa-mir-103-1-as hsa05211 Renal cell carcinoma 1387_2033_3725 3 0.000582757 0.027972319 0.002542938 569 hsa-mir-103-1-as hsa04662 B cell receptor signaling pathway 3725_2353_5970 3 0.000653529 0.031369401 0.002614117 570 hsa-mir-103-1-as hsa04350 TGF-beta signaling pathway 1387_6667_2033 3 0.000990752 0.047556088 0.003396863 571 hsa-mir-103-1-as hsa04012 ErbB signaling pathway 3725_6776_6777 3 0.000990752 0.047556088 0.003396863 572 hsa-mir-103-1-as hsa04620 Toll-like receptor signaling pathway 3725_2353_5970 3 0.001544899 0.074155155 0.004943677 573 hsa-mir-103-1-as hsa04660 T cell receptor signaling pathway 3725_2353_5970 3 0.001906015 0.091488729 0.005718046 574 hsa-mir-103-1-as hsa04010 MAPK signaling pathway 2249_3725_2353_5970 4 0.003072051 0.147458454 0.00820558 575 hsa-mir-103-1-as hsa03410 Base excision repair 142_3146 2 0.003077092 0.147700434 0.00820558 576 hsa-mir-103-1-as hsa04310 Wnt signaling pathway 1387_2033_3725 3 0.004646319 0.223023324 0.01173807 577 hsa-mir-103-1-as hsa05223 Non-small cell lung cancer 5925_6256 2 0.006574318 0.315567269 0.015778363 578 hsa-mir-103-1-as hsa04920 Adipocytokine signaling pathway 5970_6256 2 0.009836416 0.472147991 0.022483238 579 hsa-mir-103-1-as hsa05218 Melanoma 5925_2249 2 0.010957991 0.525983591 0.022868852 580 hsa-mir-103-1-as hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5970 2 0.010957991 0.525983591 0.022868852 581 hsa-mir-103-1-as hsa04720 Long-term potentiation 1387_2033 2 0.012133277 0.582397305 0.024266554 582 hsa-mir-103-1-as hsa04520 Adherens junction 1387_2033 2 0.013676424 0.656468329 0.026258733 583 hsa-mir-103-1-as hsa05210 Colorectal cancer 3725_2353 2 0.014968995 0.718511755 0.027635068 584 hsa-mir-103-1-as hsa04612 Antigen processing and presentation 4800_1514 2 0.016655715 0.799474325 0.02961016 585 hsa-mir-103-1-as hsa04916 Melanogenesis 1387_2033 2 0.022171809 1 0.038008816 586 hsa-mir-103-1-as hsa03450 Non-homologous end-joining 2547 1 0.031950844 1 0.052884155 587 hsa-mir-103-1-as hsa04120 Ubiquitin mediated proteolysis 672_8554 2 0.037479932 1 0.059967891 588 hsa-mir-103-2-as hsa05200 Pathways in cancer 3320_4149_5371_1499_5595_5599_1387_5604_2932_2353_6774_6502_5970_5894_1029_4087_4088_5881_4292_1050_5925_2033 22 2.30E-21 1.43E-19 1.43E-19 589 hsa-mir-103-2-as hsa04110 Cell cycle 990_993_1387_983_2932_8454_6502_6500_1029_4087_4088_5925_2033_5933 14 4.01E-17 2.48E-15 1.24E-15 590 hsa-mir-103-2-as hsa05210 Colorectal cancer 1499_5595_5599_5604_2932_2353_5894_4087_4088_5881_4292 11 3.69E-14 2.29E-12 7.64E-13 591 hsa-mir-103-2-as hsa04540 Gap junction 6714_5595_5598_983_5604_7277_7278_10376_5894_7846_51807 11 1.03E-13 6.38E-12 1.59E-12 592 hsa-mir-103-2-as hsa04310 Wnt signaling pathway 1499_5599_1387_2932_8454_6500_1457_1459_4087_4088_5881_2033 12 6.43E-13 3.98E-11 7.97E-12 593 hsa-mir-103-2-as hsa04520 Adherens junction 1499_6714_5595_1387_1457_1459_4087_4088_5881_2033 10 8.58E-13 5.32E-11 8.87E-12 594 hsa-mir-103-2-as hsa05215 Prostate cancer 3320_1499_5595_1387_5604_2932_5970_5894_5925_2033 10 2.05E-12 1.27E-10 1.76E-11 595 hsa-mir-103-2-as hsa05212 Pancreatic cancer 3320_1499_5595_1387_5604_2932_5970_5894_5925_2033 10 2.28E-12 1.41E-10 1.76E-11 596 hsa-mir-103-2-as hsa04350 TGF-beta signaling pathway 5595_1387_6667_8454_6500_4087_4088_2033_5933 9 5.91E-11 3.67E-09 4.07E-10 597 hsa-mir-103-2-as hsa05131 Shigellosis 1499_7277_7278_10376_7846_51807_4691 7 2.58E-09 1.60E-07 1.46E-08 598 hsa-mir-103-2-as hsa05130 Pathogenic Escherichia coli infection 1499_7277_7278_10376_7846_51807_4691 7 2.58E-09 1.60E-07 1.46E-08 599 hsa-mir-103-2-as hsa05221 Acute myeloid leukemia 5371_5595_5604_6774_5970_5894_1050 7 3.60E-09 2.23E-07 1.86E-08 600 hsa-mir-103-2-as hsa05220 Chronic myeloid leukemia 5595_5604_5970_5894_1029_4088_5925 7 1.68E-08 1.04E-06 7.44E-08 601 hsa-mir-103-2-as hsa04662 B cell receptor signaling pathway 5595_5604_2932_2353_5970_5894_5881 7 1.68E-08 1.04E-06 7.44E-08 602 hsa-mir-103-2-as hsa05213 Endometrial cancer 1499_5595_5604_2932_5894_4292 6 5.76E-08 3.57E-06 2.38E-07 603 hsa-mir-103-2-as hsa04010 MAPK signaling pathway 4149_5595_5599_5598_5604_2353_1386_5970_5894_5881 10 6.62E-08 4.10E-06 2.56E-07 604 hsa-mir-103-2-as hsa04916 Melanogenesis 1499_5595_1387_5604_2932_5894_2033 7 1.38E-07 8.56E-06 5.03E-07 605 hsa-mir-103-2-as hsa05219 Bladder cancer 5595_5604_5894_1029_5925 5 6.71E-07 4.16E-05 2.31E-06 606 hsa-mir-103-2-as hsa04510 Focal adhesion 1499_6714_5595_5599_5604_2932_5894_5881 8 9.49E-07 5.88E-05 3.04E-06 607 hsa-mir-103-2-as hsa04012 ErbB signaling pathway 6714_5595_5599_5604_2932_5894 6 9.82E-07 6.09E-05 3.04E-06 608 hsa-mir-103-2-as hsa05223 Non-small cell lung cancer 5595_5604_5894_1029_5925 5 2.12E-06 0.000131276 6.25E-06 609 hsa-mir-103-2-as hsa04912 GnRH signaling pathway 6714_5595_5599_5598_5604_5894 6 3.24E-06 0.00020066 9.12E-06 610 hsa-mir-103-2-as hsa04660 T cell receptor signaling pathway 5595_5604_2932_2353_5970_5894 6 3.58E-06 0.000221987 9.65E-06 611 hsa-mir-103-2-as hsa05214 Glioma 5595_5604_5894_1029_5925 5 4.96E-06 0.000307766 1.28E-05 612 hsa-mir-103-2-as hsa04062 Chemokine signaling pathway 5595_5604_2932_6774_5970_5894_7074 7 7.19E-06 0.000445584 1.78E-05 613 hsa-mir-103-2-as hsa05218 Melanoma 5595_5604_5894_1029_5925 5 7.45E-06 0.000461996 1.78E-05 614 hsa-mir-103-2-as hsa05211 Renal cell carcinoma 5595_1387_5604_5894_2033 5 7.95E-06 0.000492702 1.82E-05 615 hsa-mir-103-2-as hsa04720 Long-term potentiation 5595_1387_5604_5894_2033 5 9.59E-06 0.000594493 2.12E-05 616 hsa-mir-103-2-as hsa04370 VEGF signaling pathway 6714_5595_5604_5894_5881 5 1.08E-05 0.000670995 2.31E-05 617 hsa-mir-103-2-as hsa04664 Fc epsilon RI signaling pathway 5595_5599_5604_5894_5881 5 1.22E-05 0.000754975 2.52E-05 618 hsa-mir-103-2-as hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_8454_6502_6500 6 1.29E-05 0.000800905 2.58E-05 619 hsa-mir-103-2-as hsa04330 Notch signaling pathway 1387_2033_2648_8850 4 3.19E-05 0.001980166 6.19E-05 620 hsa-mir-103-2-as hsa04620 Toll-like receptor signaling pathway 5595_5599_5604_2353_5970 5 3.93E-05 0.002438392 7.39E-05 621 hsa-mir-103-2-as hsa04910 Insulin signaling pathway 5595_5599_5604_2932_5894 5 0.000155403 0.00963498 0.000283382 622 hsa-mir-103-2-as hsa05216 Thyroid cancer 1499_5595_5604 3 0.000195344 0.012111299 0.000346037 623 hsa-mir-103-2-as hsa05222 Small cell lung cancer 4149_6502_5970_5925 4 0.00029394 0.018224292 0.00050623 624 hsa-mir-103-2-as hsa04612 Antigen processing and presentation 3320_4801_4802_1514 4 0.000333173 0.020656737 0.00055829 625 hsa-mir-103-2-as hsa03022 Basal transcription factors 2962_2969_6908 3 0.000381232 0.0236364 0.000622011 626 hsa-mir-103-2-as hsa04810 Regulation of actin cytoskeleton 5595_5604_5894_5881_7074 5 0.00120141 0.074487395 0.001909933 627 hsa-mir-103-2-as hsa04530 Tight junction 1499_6714_1457_1459 4 0.001582506 0.0981154 0.002452885 628 hsa-mir-103-2-as hsa04650 Natural killer cell mediated cytotoxicity 5595_5604_5894_5881 4 0.001624017 0.100689065 0.002455831 629 hsa-mir-103-2-as hsa04920 Adipocytokine signaling pathway 5599_6774_5970 3 0.001956661 0.121313007 0.002888405 630 hsa-mir-103-2-as hsa04115 p53 signaling pathway 983_7161_1029 3 0.002120993 0.131501543 0.003058175 631 hsa-mir-103-2-as hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5599_5970 3 0.002293658 0.1422068 0.003160151 632 hsa-mir-103-2-as hsa04730 Long-term depression 5595_5604_5894 3 0.002293658 0.1422068 0.003160151 633 hsa-mir-103-2-as hsa04950 Maturity onset diabetes of the young 3172_6928 2 0.003776824 0.234163114 0.005090502 634 hsa-mir-103-2-as hsa05016 Huntington's disease 1387_6908_6667_2033 4 0.004802108 0.297730712 0.006334696 635 hsa-mir-103-2-as hsa04270 Vascular smooth muscle contraction 5595_5604_5894 3 0.009045883 0.560844735 0.011684265 636 hsa-mir-103-2-as hsa04360 Axon guidance 5595_2932_5881 3 0.011918876 0.738970318 0.014847468 637 hsa-mir-103-2-as hsa04930 Type II diabetes mellitus 5595_5599 2 0.011973764 0.742373396 0.014847468 638 hsa-mir-103-2-as hsa05217 Basal cell carcinoma 1499_2932 2 0.017280522 1 0.021007693 639 hsa-mir-103-2-as hsa04630 Jak-STAT signaling pathway 1387_6774_2033 3 0.018458267 1 0.022007933 640 hsa-mir-105-1 hsa05200 Pathways in cancer 4087_4088_4089_5881_1050_836_2033_367_1499_6774_2353_1387 12 1.25E-14 5.73E-13 5.73E-13 641 hsa-mir-105-1 hsa04520 Adherens junction 4087_4088_4089_5881_2033_1499_6714_1387 8 2.24E-13 1.03E-11 5.14E-12 642 hsa-mir-105-1 hsa05210 Colorectal cancer 4087_4088_4089_5881_836_1499_2353 7 2.63E-11 1.21E-09 4.03E-10 643 hsa-mir-105-1 hsa04310 Wnt signaling pathway 4087_4088_4089_5881_2033_1499_1387 7 1.36E-09 6.25E-08 1.56E-08 644 hsa-mir-105-1 hsa04350 TGF-beta signaling pathway 4087_4088_4089_2033_1387 5 1.28E-07 5.89E-06 1.18E-06 645 hsa-mir-105-1 hsa04110 Cell cycle 4087_4088_4089_2033_1387 5 5.69E-07 2.62E-05 4.36E-06 646 hsa-mir-105-1 hsa05215 Prostate cancer 2033_367_1499_1387 4 6.24E-06 0.00028713 3.75E-05 647 hsa-mir-105-1 hsa05212 Pancreatic cancer 2033_367_1499_1387 4 6.52E-06 0.000299755 3.75E-05 648 hsa-mir-105-1 hsa04010 MAPK signaling pathway 5881_836_1432_5598_2353 5 2.91E-05 0.001340653 0.000148961 649 hsa-mir-105-1 hsa04330 Notch signaling pathway 2033_8850_1387 3 3.80E-05 0.001748671 0.000174867 650 hsa-mir-105-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_6714_1432 3 0.000123048 0.005660212 0.000514565 651 hsa-mir-105-1 hsa04370 VEGF signaling pathway 5881_6714_1432 3 0.000155118 0.007135424 0.000594619 652 hsa-mir-105-1 hsa04916 Melanogenesis 2033_1499_1387 3 0.000365777 0.016825735 0.001294287 653 hsa-mir-105-1 hsa04912 GnRH signaling pathway 6714_1432_5598 3 0.000407308 0.018736162 0.001338297 654 hsa-mir-105-1 hsa04950 Maturity onset diabetes of the young 6928_3172 2 0.000523383 0.024075624 0.001605042 655 hsa-mir-105-1 hsa04630 Jak-STAT signaling pathway 2033_6774_1387 3 0.001135503 0.052233137 0.003264571 656 hsa-mir-105-1 hsa05010 Alzheimer's disease 836_1020_840 3 0.001650097 0.075904473 0.004464969 657 hsa-mir-105-1 hsa05016 Huntington's disease 836_2033_1387 3 0.001954087 0.089888003 0.004993778 658 hsa-mir-105-1 hsa04510 Focal adhesion 5881_1499_6714 3 0.002522862 0.116051634 0.005964239 659 hsa-mir-105-1 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432 2 0.002593147 0.119284774 0.005964239 660 hsa-mir-105-1 hsa05221 Acute myeloid leukemia 1050_6774 2 0.002863781 0.131733935 0.006273045 661 hsa-mir-105-1 hsa05211 Renal cell carcinoma 2033_1387 2 0.004182142 0.192378517 0.008315763 662 hsa-mir-105-1 hsa04720 Long-term potentiation 2033_1387 2 0.004519436 0.207894064 0.008315763 663 hsa-mir-105-1 hsa05220 Chronic myeloid leukemia 4088_4089 2 0.004519436 0.207894064 0.008315763 664 hsa-mir-105-1 hsa04662 B cell receptor signaling pathway 5881_2353 2 0.004519436 0.207894064 0.008315763 665 hsa-mir-105-1 hsa04664 Fc epsilon RI signaling pathway 5881_1432 2 0.004988114 0.229453251 0.008825125 666 hsa-mir-105-1 hsa04210 Apoptosis 836_840 2 0.006253179 0.28764624 0.010653564 667 hsa-mir-105-1 hsa04540 Gap junction 6714_5598 2 0.00679597 0.312614628 0.011164808 668 hsa-mir-105-1 hsa04620 Toll-like receptor signaling pathway 1432_2353 2 0.008092526 0.372256178 0.01283642 669 hsa-mir-105-1 hsa04660 T cell receptor signaling pathway 1432_2353 2 0.009330911 0.429221901 0.014307397 670 hsa-mir-105-1 hsa04670 Leukocyte transendothelial migration 1499_1432 2 0.011336202 0.521465301 0.016821461 671 hsa-mir-105-1 hsa04360 Axon guidance 5881_1020 2 0.012953508 0.595861377 0.018620668 672 hsa-mir-105-1 hsa04530 Tight junction 1499_6714 2 0.01408438 0.647881463 0.0193158 673 hsa-mir-105-1 hsa04650 Natural killer cell mediated cytotoxicity 5881_836 2 0.014276895 0.656737184 0.0193158 674 hsa-mir-105-1 hsa05216 Thyroid cancer 1499 1 0.038243049 1 0.050262293 675 hsa-mir-105-2 hsa05200 Pathways in cancer 4087_4088_4089_5881_1050_836_2033_367_1499_6774_2353_1387 12 1.25E-14 5.73E-13 5.73E-13 676 hsa-mir-105-2 hsa04520 Adherens junction 4087_4088_4089_5881_2033_1499_6714_1387 8 2.24E-13 1.03E-11 5.14E-12 677 hsa-mir-105-2 hsa05210 Colorectal cancer 4087_4088_4089_5881_836_1499_2353 7 2.63E-11 1.21E-09 4.03E-10 678 hsa-mir-105-2 hsa04310 Wnt signaling pathway 4087_4088_4089_5881_2033_1499_1387 7 1.36E-09 6.25E-08 1.56E-08 679 hsa-mir-105-2 hsa04350 TGF-beta signaling pathway 4087_4088_4089_2033_1387 5 1.28E-07 5.89E-06 1.18E-06 680 hsa-mir-105-2 hsa04110 Cell cycle 4087_4088_4089_2033_1387 5 5.69E-07 2.62E-05 4.36E-06 681 hsa-mir-105-2 hsa05215 Prostate cancer 2033_367_1499_1387 4 6.24E-06 0.00028713 3.75E-05 682 hsa-mir-105-2 hsa05212 Pancreatic cancer 2033_367_1499_1387 4 6.52E-06 0.000299755 3.75E-05 683 hsa-mir-105-2 hsa04010 MAPK signaling pathway 5881_836_1432_5598_2353 5 2.91E-05 0.001340653 0.000148961 684 hsa-mir-105-2 hsa04330 Notch signaling pathway 2033_8850_1387 3 3.80E-05 0.001748671 0.000174867 685 hsa-mir-105-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_6714_1432 3 0.000123048 0.005660212 0.000514565 686 hsa-mir-105-2 hsa04370 VEGF signaling pathway 5881_6714_1432 3 0.000155118 0.007135424 0.000594619 687 hsa-mir-105-2 hsa04916 Melanogenesis 2033_1499_1387 3 0.000365777 0.016825735 0.001294287 688 hsa-mir-105-2 hsa04912 GnRH signaling pathway 6714_1432_5598 3 0.000407308 0.018736162 0.001338297 689 hsa-mir-105-2 hsa04950 Maturity onset diabetes of the young 6928_3172 2 0.000523383 0.024075624 0.001605042 690 hsa-mir-105-2 hsa04630 Jak-STAT signaling pathway 2033_6774_1387 3 0.001135503 0.052233137 0.003264571 691 hsa-mir-105-2 hsa05010 Alzheimer's disease 836_1020_840 3 0.001650097 0.075904473 0.004464969 692 hsa-mir-105-2 hsa05016 Huntington's disease 836_2033_1387 3 0.001954087 0.089888003 0.004993778 693 hsa-mir-105-2 hsa04510 Focal adhesion 5881_1499_6714 3 0.002522862 0.116051634 0.005964239 694 hsa-mir-105-2 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432 2 0.002593147 0.119284774 0.005964239 695 hsa-mir-105-2 hsa05221 Acute myeloid leukemia 1050_6774 2 0.002863781 0.131733935 0.006273045 696 hsa-mir-105-2 hsa05211 Renal cell carcinoma 2033_1387 2 0.004182142 0.192378517 0.008315763 697 hsa-mir-105-2 hsa04720 Long-term potentiation 2033_1387 2 0.004519436 0.207894064 0.008315763 698 hsa-mir-105-2 hsa05220 Chronic myeloid leukemia 4088_4089 2 0.004519436 0.207894064 0.008315763 699 hsa-mir-105-2 hsa04662 B cell receptor signaling pathway 5881_2353 2 0.004519436 0.207894064 0.008315763 700 hsa-mir-105-2 hsa04664 Fc epsilon RI signaling pathway 5881_1432 2 0.004988114 0.229453251 0.008825125 701 hsa-mir-105-2 hsa04210 Apoptosis 836_840 2 0.006253179 0.28764624 0.010653564 702 hsa-mir-105-2 hsa04540 Gap junction 6714_5598 2 0.00679597 0.312614628 0.011164808 703 hsa-mir-105-2 hsa04620 Toll-like receptor signaling pathway 1432_2353 2 0.008092526 0.372256178 0.01283642 704 hsa-mir-105-2 hsa04660 T cell receptor signaling pathway 1432_2353 2 0.009330911 0.429221901 0.014307397 705 hsa-mir-105-2 hsa04670 Leukocyte transendothelial migration 1499_1432 2 0.011336202 0.521465301 0.016821461 706 hsa-mir-105-2 hsa04360 Axon guidance 5881_1020 2 0.012953508 0.595861377 0.018620668 707 hsa-mir-105-2 hsa04530 Tight junction 1499_6714 2 0.01408438 0.647881463 0.0193158 708 hsa-mir-105-2 hsa04650 Natural killer cell mediated cytotoxicity 5881_836 2 0.014276895 0.656737184 0.0193158 709 hsa-mir-105-2 hsa05216 Thyroid cancer 1499 1 0.038243049 1 0.050262293 710 hsa-mir-106a hsa05200 Pathways in cancer 3320_5371_1488_1017_5595_5594_5599_861_5914_1387_6256_595_6502_836_6258_367_2932_4193_4149_7704_842_6774_3091_5970_7428_1870_1871_7157_4824_4087_6688_5604_2113_4609_1869_3725_841_1029_1487_4088_4089_3066_3065_4292_1050_5925_2034_2033_4846_207_9915_5894 52 7.62E-41 5.11E-39 5.11E-39 711 hsa-mir-106a hsa05220 Chronic myeloid leukemia 1488_5595_5594_861_595_4193_5970_1870_1871_7157_5604_4609_1869_1029_1487_4088_4089_3066_3065_5925_207_6464_5894 23 2.78E-24 1.86E-22 9.32E-23 712 hsa-mir-106a hsa04110 Cell cycle 890_5591_1017_1387_595_983_6502_2932_4193_8454_6500_1870_1871_7157_4087_1869_1029_4088_4089_3066_3065_5925_2033_5933_5934_990 26 4.68E-24 3.13E-22 1.04E-22 713 hsa-mir-106a hsa05215 Prostate cancer 3320_1017_5595_5594_1387_595_367_2932_4193_1385_842_5970_1870_1871_7157_4824_5604_1869_5925_2033_207_5894 22 1.24E-21 8.27E-20 2.04E-20 714 hsa-mir-106a hsa05212 Pancreatic cancer 3320_1017_5595_5594_1387_595_367_2932_4193_1385_842_5970_1870_1871_7157_4824_5604_1869_5925_2033_207_5894 22 1.53E-21 1.02E-19 2.04E-20 715 hsa-mir-106a hsa04350 TGF-beta signaling pathway 3399_5595_5594_1387_6667_8454_3398_6500_1874_1875_4087_4609_4088_4089_2033_5933_4093_5934 18 1.14E-16 7.67E-15 1.28E-15 716 hsa-mir-106a hsa05223 Non-small cell lung cancer 5595_5594_6256_595_6258_842_1870_1871_7157_5604_1869_1029_5925_207_5894 15 9.82E-16 6.58E-14 9.40E-15 717 hsa-mir-106a hsa05210 Colorectal cancer 5595_5594_5599_595_836_2932_842_7157_4087_5604_4609_3725_4088_4089_4292_207_5894 17 1.13E-15 7.56E-14 9.45E-15 718 hsa-mir-106a hsa05221 Acute myeloid leukemia 5371_5595_5594_861_5914_595_7704_6774_5970_6688_5604_4609_1050_207_5894 15 3.01E-15 2.02E-13 2.24E-14 719 hsa-mir-106a hsa05214 Glioma 815_5595_5594_595_4193_1870_1871_7157_5604_1869_1029_5925_207_6464_5894 15 1.03E-14 6.91E-13 6.91E-14 720 hsa-mir-106a hsa05222 Small cell lung cancer 1017_6256_595_6502_6258_4149_842_5970_1870_1871_7157_4609_1869_5925_4846_207 16 2.51E-14 1.68E-12 1.43E-13 721 hsa-mir-106a hsa05219 Bladder cancer 5595_5594_595_4193_1870_1871_7157_5604_4609_1869_1029_5925_5894 13 2.55E-14 1.71E-12 1.43E-13 722 hsa-mir-106a hsa04310 Wnt signaling pathway 815_1488_5599_1387_595_2932_8454_6500_7157_4087_4609_3725_1457_1487_1459_4088_4089_2033 18 6.49E-13 4.35E-11 3.34E-12 723 hsa-mir-106a hsa04010 MAPK signaling pathway 5595_5594_5599_5598_4208_836_4149_3312_1386_5970_9261_7157_5604_4609_3725_6195_4763_1616_207_2002_2005_5894 22 2.25E-12 1.51E-10 1.08E-11 724 hsa-mir-106a hsa05213 Endometrial cancer 5595_5594_595_2932_842_7157_5604_4609_4292_207_2002_5894 12 4.95E-12 3.32E-10 2.21E-11 725 hsa-mir-106a hsa05218 Melanoma 5595_5594_595_4193_1870_1871_7157_5604_1869_1029_5925_207_5894 13 8.28E-12 5.55E-10 3.47E-11 726 hsa-mir-106a hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_5604_2113_3725_2034_2033_207_9915_5894 13 9.68E-12 6.48E-10 3.81E-11 727 hsa-mir-106a hsa04012 ErbB signaling pathway 815_6714_5595_5594_5599_2932_5604_4609_3725_207_6464_2002_5894 13 8.04E-11 5.38E-09 2.99E-10 728 hsa-mir-106a hsa04540 Gap junction 6714_5595_5594_5598_983_7277_7278_5604_7846_51807_10376_5894 12 1.97E-09 1.32E-07 6.95E-09 729 hsa-mir-106a hsa05216 Thyroid cancer 5595_5594_6256_595_6258_7157_5604_4609 8 5.68E-09 3.80E-07 1.90E-08 730 hsa-mir-106a hsa04330 Notch signaling pathway 1488_1387_2648_1487_9612_3066_3065_2033_4851 9 1.00E-08 6.71E-07 3.19E-08 731 hsa-mir-106a hsa04115 p53 signaling pathway 1017_595_983_836_4193_842_7157_841_7161_1029 10 1.64E-08 1.10E-06 4.99E-08 732 hsa-mir-106a hsa04520 Adherens junction 6714_5595_5594_1387_4087_1457_1459_4088_4089_2033 10 5.84E-08 3.92E-06 1.68E-07 733 hsa-mir-106a hsa05016 Huntington's disease 6874_1387_2902_6908_836_6667_1385_842_7157_841_3066_3065_3064_2033 14 6.00E-08 4.02E-06 1.68E-07 734 hsa-mir-106a hsa04720 Long-term potentiation 815_5595_5594_1387_2902_5604_6195_2033_5894 9 3.72E-07 2.49E-05 9.96E-07 735 hsa-mir-106a hsa04370 VEGF signaling pathway 6714_5595_5594_842_9261_5604_4846_207_5894 9 4.55E-07 3.05E-05 1.17E-06 736 hsa-mir-106a hsa04912 GnRH signaling pathway 815_6714_5595_5594_5599_5598_5604_3725_2002_5894 10 7.59E-07 5.09E-05 1.88E-06 737 hsa-mir-106a hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_5604_3725_207_5894 8 3.74E-06 0.000250732 8.95E-06 738 hsa-mir-106a hsa04916 Melanogenesis 815_5595_5594_1387_2932_1385_5604_2033_5894 9 4.56E-06 0.000305637 1.05E-05 739 hsa-mir-106a hsa04510 Focal adhesion 6714_5595_5594_5599_595_2932_5604_3725_207_6464_2002_5894 12 5.92E-06 0.000396333 1.28E-05 740 hsa-mir-106a hsa04910 Insulin signaling pathway 6720_5595_5594_5599_2932_5604_207_6464_2002_5894 10 5.94E-06 0.000397869 1.28E-05 741 hsa-mir-106a hsa04210 Apoptosis 836_839_842_840_5970_7157_841_207 8 1.20E-05 0.000804339 2.51E-05 742 hsa-mir-106a hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5970_5604_3725_841_207 8 3.01E-05 0.002015855 6.11E-05 743 hsa-mir-106a hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_6502_4193_8454_6500_7428_7329 9 4.00E-05 0.002682995 7.89E-05 744 hsa-mir-106a hsa05010 Alzheimer's disease 22926_5595_5594_2902_836_2932_842_840_841_4846 10 4.52E-05 0.003026732 8.65E-05 745 hsa-mir-106a hsa04660 T cell receptor signaling pathway 5595_5594_2932_5970_5604_3725_207_5894 8 4.98E-05 0.003336698 9.27E-05 746 hsa-mir-106a hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_842_7157_1616_4846 6 6.13E-05 0.004109065 0.000105361 747 hsa-mir-106a hsa05131 Shigellosis 7277_7278_7846_51807_4691_10376 6 6.13E-05 0.004109065 0.000105361 748 hsa-mir-106a hsa05130 Pathogenic Escherichia coli infection 7277_7278_7846_51807_4691_10376 6 6.13E-05 0.004109065 0.000105361 749 hsa-mir-106a hsa04062 Chemokine signaling pathway 5595_5594_7074_2932_6774_5970_5604_207_6464_5894 10 8.98E-05 0.006014739 0.000150368 750 hsa-mir-106a hsa03022 Basal transcription factors 2963_2962_6874_2969_6908 5 9.43E-05 0.006319284 0.000154129 751 hsa-mir-106a hsa04920 Adipocytokine signaling pathway 5599_6256_6258_6774_5970_207 6 0.000153509 0.010285107 0.000244883 752 hsa-mir-106a hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5604_207_5894 6 0.000353322 0.023672599 0.000550526 753 hsa-mir-106a hsa04150 mTOR signaling pathway 5595_5594_3091_6195_207 5 0.000405884 0.027194253 0.000618051 754 hsa-mir-106a hsa04612 Antigen processing and presentation 3320_4800_4801_4802_1385_3312 6 0.000640768 0.042931444 0.000954032 755 hsa-mir-106a hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5599_836_5970_3725 5 0.001511809 0.101291179 0.002155131 756 hsa-mir-106a hsa04730 Long-term depression 5595_5594_5604_4846_5894 5 0.001511809 0.101291179 0.002155131 757 hsa-mir-106a hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_5604_6464_5894 6 0.005263344 0.352644071 0.007346751 758 hsa-mir-106a hsa04630 Jak-STAT signaling pathway 1387_595_6774_4609_2033_207 6 0.008919457 0.597603604 0.012195992 759 hsa-mir-106a hsa04930 Type II diabetes mellitus 5595_5594_5599 3 0.015755146 1 0.021111895 760 hsa-mir-106a hsa04270 Vascular smooth muscle contraction 5595_5594_5604_5894 4 0.045810228 1 0.060182064 761 hsa-mir-106b hsa05200 Pathways in cancer 3320_5371_9063_5595_5594_5599_5914_1387_6256_595_1487_1488_836_367_1017_2932_2353_4149_7704_3091_5970_7428_1870_1871_2885_7157_2113_4609_1869_3725_5604_1029_5601_4087_4088_4089_3066_3065_4292_1050_5925_2034_2033_4846_6502_5894_7186 47 1.41E-42 9.43E-41 9.43E-41 762 hsa-mir-106b hsa04110 Cell cycle 990_5591_1387_595_983_1017_2932_8454_6500_1870_1871_7157_1869_1029_4087_4088_4089_3066_3065_5925_2033_5933_890_6502_5934 25 1.15E-26 7.69E-25 3.85E-25 763 hsa-mir-106b hsa05220 Chronic myeloid leukemia 5595_5594_595_1487_1488_5970_1870_1871_2885_7157_4609_1869_5604_1029_4088_4089_3066_3065_5925_6464_5894 21 7.91E-25 5.30E-23 1.77E-23 764 hsa-mir-106b hsa04010 MAPK signaling pathway 6722_5595_5594_5599_5598_4208_5600_3303_836_2353_4149_3312_1386_1432_5970_9344_2885_7157_4609_3725_5604_5606_5601_4763_2005_5894_7186 27 6.41E-21 4.29E-19 1.07E-19 765 hsa-mir-106b hsa05210 Colorectal cancer 5595_5594_5599_595_836_2932_2353_2885_7157_4609_3725_5604_5601_4087_4088_4089_4292_5894 18 1.21E-19 8.10E-18 1.62E-18 766 hsa-mir-106b hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_8454_3397_3399_3398_6500_1874_1875_4609_4087_4088_4089_2033_5933_5934 18 2.10E-19 1.40E-17 2.34E-18 767 hsa-mir-106b hsa05215 Prostate cancer 3320_5595_5594_1387_595_367_1017_2932_5970_1870_1871_2885_7157_1869_5604_5925_2033_5894 18 2.51E-19 1.68E-17 2.40E-18 768 hsa-mir-106b hsa05212 Pancreatic cancer 3320_5595_5594_1387_595_367_1017_2932_5970_1870_1871_2885_7157_1869_5604_5925_2033_5894 18 3.00E-19 2.01E-17 2.51E-18 769 hsa-mir-106b hsa04310 Wnt signaling pathway 5599_1387_595_1487_1488_1459_2932_8454_6500_7157_8061_4609_3725_1457_5601_4087_4088_4089_2033 19 9.34E-17 6.26E-15 6.95E-16 770 hsa-mir-106b hsa05222 Small cell lung cancer 9063_6256_595_1017_4149_5970_1870_1871_7157_4609_1869_5925_4846_6502_7186 15 2.11E-15 1.42E-13 1.42E-14 771 hsa-mir-106b hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_2885_7157_1869_5604_1029_5925_5894 13 4.24E-15 2.84E-13 2.58E-14 772 hsa-mir-106b hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5604_1029_5925_5894 12 8.51E-15 5.70E-13 4.75E-14 773 hsa-mir-106b hsa05214 Glioma 5595_5594_595_1870_1871_2885_7157_1869_5604_1029_5925_6464_5894 13 3.42E-14 2.29E-12 1.76E-13 774 hsa-mir-106b hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_5970_2885_4609_5604_1050_5894 12 2.83E-13 1.90E-11 1.36E-12 775 hsa-mir-106b hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2885_2113_3725_5604_2034_2033_5894 12 2.29E-12 1.53E-10 1.02E-11 776 hsa-mir-106b hsa04540 Gap junction 5595_5594_5598_983_7277_2885_7846_5604_7278_51807_10376_5894 12 3.43E-11 2.30E-09 1.44E-10 777 hsa-mir-106b hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5604_1029_5925_5894 11 3.89E-11 2.61E-09 1.53E-10 778 hsa-mir-106b hsa05213 Endometrial cancer 5595_5594_595_2932_2885_7157_4609_5604_4292_5894 10 4.61E-11 3.09E-09 1.72E-10 779 hsa-mir-106b hsa04912 GnRH signaling pathway 5595_5594_5599_5598_5600_1432_2885_3725_5604_5606_5601_5894 12 1.67E-10 1.12E-08 5.90E-10 780 hsa-mir-106b hsa04660 T cell receptor signaling pathway 5595_5594_5600_2932_2353_1432_5970_2885_3725_5604_5601_5894 12 2.03E-10 1.36E-08 6.81E-10 781 hsa-mir-106b hsa04012 ErbB signaling pathway 5595_5594_5599_2932_2885_4609_3725_5604_5601_6464_5894 11 2.80E-10 1.87E-08 8.92E-10 782 hsa-mir-106b hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5600_2353_1432_5970_3725_5604_5606_5601 11 1.31E-09 8.79E-08 3.99E-09 783 hsa-mir-106b hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5600_1432_2885_5604_5606_5601_5894 10 1.82E-09 1.22E-07 5.30E-09 784 hsa-mir-106b hsa04330 Notch signaling pathway 2648_1387_1487_1488_9612_3066_3065_2033 8 9.84E-09 6.59E-07 2.73E-08 785 hsa-mir-106b hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609_5604 7 1.02E-08 6.82E-07 2.73E-08 786 hsa-mir-106b hsa04662 B cell receptor signaling pathway 5595_5594_2932_2353_5970_2885_3725_5604_5894 9 1.83E-08 1.23E-06 4.72E-08 787 hsa-mir-106b hsa04520 Adherens junction 5595_5594_1387_1459_1457_4087_4088_4089_2033 9 3.06E-08 2.05E-06 7.59E-08 788 hsa-mir-106b hsa04910 Insulin signaling pathway 6720_5595_5594_5599_2932_2885_5604_5601_6464_5894 10 2.45E-07 1.64E-05 5.87E-07 789 hsa-mir-106b hsa05016 Huntington's disease 6874_1387_2902_6908_836_6667_7157_3066_3065_3064_2033 11 4.63E-07 3.10E-05 1.07E-06 790 hsa-mir-106b hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_5600_836_1432_7157_5606_4846 7 5.66E-07 3.79E-05 1.26E-06 791 hsa-mir-106b hsa04510 Focal adhesion 5595_5594_5599_595_2932_2885_3725_5604_5601_6464_5894 11 1.09E-06 7.30E-05 2.35E-06 792 hsa-mir-106b hsa04115 p53 signaling pathway 595_983_836_1017_7157_7161_1029 7 2.05E-06 0.000137564 4.30E-06 793 hsa-mir-106b hsa04120 Ubiquitin mediated proteolysis 55294_5371_9063_672_8454_6500_7428_7329_6502 9 2.38E-06 0.000159424 4.83E-06 794 hsa-mir-106b hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5600_836_1432_5970_3725_5601 7 2.45E-06 0.000164083 4.83E-06 795 hsa-mir-106b hsa04720 Long-term potentiation 5595_5594_1387_2902_5604_2033_5894 7 3.43E-06 0.000230036 6.57E-06 796 hsa-mir-106b hsa04370 VEGF signaling pathway 5595_5594_5600_1432_5604_4846_5894 7 4.04E-06 0.000270509 7.51E-06 797 hsa-mir-106b hsa05131 Shigellosis 7277_7846_7278_51807_4691_10376 6 8.42E-06 0.000564246 1.48E-05 798 hsa-mir-106b hsa05130 Pathogenic Escherichia coli infection 7277_7846_7278_51807_4691_10376 6 8.42E-06 0.000564246 1.48E-05 799 hsa-mir-106b hsa04916 Melanogenesis 5595_5594_1387_2932_5604_2033_5894 7 2.54E-05 0.001701205 4.36E-05 800 hsa-mir-106b hsa04062 Chemokine signaling pathway 5595_5594_2932_5970_2885_5604_7074_6464_5894 9 2.92E-05 0.001957872 4.89E-05 801 hsa-mir-106b hsa04612 Antigen processing and presentation 3320_3303_4800_4801_4802_3312 6 9.64E-05 0.006457281 0.000157495 802 hsa-mir-106b hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_2885_5604_6464_5894 7 0.00013836 0.009270124 0.000220717 803 hsa-mir-106b hsa04920 Adipocytokine signaling pathway 5599_6256_5970_5601_7186 5 0.000239392 0.016039244 0.000373006 804 hsa-mir-106b hsa03022 Basal transcription factors 2962_2969_6874_6908 4 0.000278325 0.018647788 0.000423813 805 hsa-mir-106b hsa04730 Long-term depression 5595_5594_5604_4846_5894 5 0.000308313 0.020656972 0.000459044 806 hsa-mir-106b hsa04930 Type II diabetes mellitus 5595_5594_5599_5601 4 0.000554925 0.037179954 0.00080826 807 hsa-mir-106b hsa05010 Alzheimer's disease 5595_5594_2902_836_2932_6622_4846 7 0.000587752 0.039379394 0.000837859 808 hsa-mir-106b hsa04630 Jak-STAT signaling pathway 9063_1387_595_2885_4609_2033 6 0.001603795 0.10745425 0.00223863 809 hsa-mir-106b hsa04210 Apoptosis 836_5970_7157_7186 4 0.005877447 0.393788966 0.00803651 810 hsa-mir-106b hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.008828926 0.591538067 0.011830761 811 hsa-mir-106b hsa04270 Vascular smooth muscle contraction 5595_5594_5604_5894 4 0.014889906 0.997623676 0.019561249 812 hsa-mir-106b hsa04810 Regulation of actin cytoskeleton 5595_5594_5604_7074_5894 5 0.030189739 1 0.038898317 813 hsa-mir-107 hsa05200 Pathways in cancer 7046_1499_5914_596_598_1017_4193_5578_3091_2249_2064_3065_5925_613_7184_5743_5747_25_1956_6789_4824_4436_5970_2885_6774_10401_207_208_3716_1147_998_2261_5595_5594_5599_6258_1387_6256_836_367_2932_6777_6772_5879_7157_6688_1869_3725_6776_4087_4088_4089_9063_5888_5728_2033_3910_4790_4792_3320_3326_5371_675_5159_5156_5604_5601_5602_1856_3815_842_841_51588_8772_4609_1026_2353_8554 78 8.46E-49 7.36E-47 7.36E-47 814 hsa-mir-107 hsa04010 MAPK signaling pathway 6722_7046_6195_2264_9252_5578_1845_7132_2249_4773_5923_1956_3304_3305_3303_6789_1432_5970_2885_1616_207_208_1147_998_2261_5595_5594_5599_836_3312_3315_5879_3164_7157_3725_3727_9344_5058_4790_5159_9261_5156_5604_5606_5601_5600_5602_9479_4609_2353_2002_2005 52 6.48E-29 5.64E-27 2.82E-27 815 hsa-mir-107 hsa03022 Basal transcription factors 54457_6879_51616_138474_6883_6881_2965_2967_2961_2960_2963_2962_2969_2968_6878_6877_6874_6873_6872_6908_6884_2958_2959_6880_2957_6882 26 1.39E-26 1.21E-24 3.13E-25 816 hsa-mir-107 hsa05215 Prostate cancer 1499_596_1017_4193_2064_5925_7184_1956_4824_5970_2885_207_208_1147_5595_5594_1385_1387_367_2932_7157_1869_5728_2033_4790_4792_3320_3326_5159_5156_5604_842_1026 33 1.44E-26 1.25E-24 3.13E-25 817 hsa-mir-107 hsa05212 Pancreatic cancer 1499_596_1017_4193_2064_5925_7184_1956_4824_5970_2885_207_208_1147_5595_5594_1385_1387_367_2932_7157_1869_5728_2033_4790_4792_3320_3326_5159_5156_5604_842_1026 33 1.93E-26 1.68E-24 3.37E-25 818 hsa-mir-107 hsa04110 Cell cycle 4171_1017_4193_902_4174_4172_3065_5925_25_9232_545_995_5347_7534_5591_1387_11200_7532_2932_7027_7157_1869_4085_4087_4088_4089_2033_890_1031_983_1026_1022_1111_8556_8555_472 36 3.38E-26 2.94E-24 4.91E-25 819 hsa-mir-107 hsa05210 Colorectal cancer 7046_1499_596_1956_4436_2885_207_208_5595_5594_5599_836_2932_5879_7157_3725_4087_4088_4089_5159_5156_5604_5601_5602_1856_842_4609_2353 28 1.32E-21 1.15E-19 1.65E-20 820 hsa-mir-107 hsa05220 Chronic myeloid leukemia 7046_598_4193_3065_5925_613_25_5970_2885_207_208_1147_5595_5594_6777_7157_1869_6776_4088_4089_4790_4792_5604_5781_4609_1026 26 1.65E-20 1.44E-18 1.80E-19 821 hsa-mir-107 hsa04012 ErbB signaling pathway 818_815_817_5578_2064_5747_25_1956_6714_2885_207_208_5595_5594_5599_2932_6777_3725_6776_5058_5604_5601_5602_4609_1026_2002 26 3.58E-19 3.11E-17 3.46E-18 822 hsa-mir-107 hsa05222 Small cell lung cancer 596_598_1017_5925_5743_5747_5970_10401_207_208_1147_6258_6256_7157_1869_9063_5728_3910_4790_4792_842_51588_4609_8554 24 3.13E-17 2.73E-15 2.73E-16 823 hsa-mir-107 hsa04115 p53 signaling pathway 1017_4194_4193_900_50484_6241_51246_545_7161_11200_836_7157_64326_5728_27113_25898_983_842_841_1026_1111_472 22 6.32E-17 5.50E-15 5.00E-16 824 hsa-mir-107 hsa04310 Wnt signaling pathway 818_815_817_1499_8607_5578_4773_6423_1460_5599_1387_2932_5879_7157_3725_1457_1452_4087_4088_4089_2033_5518_5515_5601_5602_1856_4609_5527 28 8.14E-16 7.08E-14 5.90E-15 825 hsa-mir-107 hsa04630 Jak-STAT signaling pathway 598_58985_3455_3459_3560_3561_1439_2885_6774_10401_3977_207_208_3717_3716_1387_6777_6772_6773_7297_6776_9063_2033_51588_10379_5781_4609_8554 28 1.26E-15 1.10E-13 8.44E-15 826 hsa-mir-107 hsa04510 Focal adhesion 1499_596_5578_2064_5923_2534_5747_3791_1956_6714_5499_2885_207_208_998_5595_5594_5599_2932_5879_3725_5058_5728_3910_2321_5159_5156_5604_5601_5602_2002 31 3.36E-15 2.93E-13 2.09E-14 827 hsa-mir-107 hsa04920 Adipocytokine signaling pathway 6794_7132_8717_2538_5970_6774_207_208_3717_1147_5599_6258_6256_4790_4792_5601_5602_5563_5781_7133 20 4.70E-15 4.09E-13 2.72E-14 828 hsa-mir-107 hsa05214 Glioma 818_815_817_4193_5578_5925_1956_2885_207_208_5595_5594_7157_1869_5728_5159_5156_5604_1026 19 3.12E-14 2.72E-12 1.70E-13 829 hsa-mir-107 hsa04620 Toll-like receptor signaling pathway 3455_1432_5970_207_208_1147_5595_5594_5599_6772_5879_3725_4790_4792_5604_5606_5601_5600_5602_841_8772_2353 22 6.26E-14 5.45E-12 3.20E-13 830 hsa-mir-107 hsa04660 T cell receptor signaling pathway 4773_2534_3932_1432_5970_2885_207_208_1147_998_5595_5594_2932_3725_5058_959_4790_4792_5604_5601_5600_2353 22 2.38E-13 2.07E-11 1.15E-12 831 hsa-mir-107 hsa04210 Apoptosis 596_598_7132_8717_823_1439_5970_207_208_1147_836_839_7157_4790_4792_842_841_840_8772_472 20 4.48E-13 3.90E-11 2.05E-12 832 hsa-mir-107 hsa05221 Acute myeloid leukemia 5914_5970_2885_6774_207_208_1147_5595_5594_6777_6688_6776_4790_5371_5604_3815_4609 17 8.58E-13 7.47E-11 3.73E-12 833 hsa-mir-107 hsa04350 TGF-beta signaling pathway 7046_90_3398_57154_6667_3397_3399_659_5595_5594_1387_7027_4087_4088_4089_2033_5518_5515_4609 19 2.67E-12 2.32E-10 1.10E-11 834 hsa-mir-107 hsa05223 Non-small cell lung cancer 5578_2064_5925_1956_6789_2885_207_208_5595_5594_6258_6256_7157_1869_5604_842 16 2.82E-12 2.46E-10 1.12E-11 835 hsa-mir-107 hsa04370 VEGF signaling pathway 5578_4773_5743_5747_3791_6714_1432_207_208_998_5595_5594_3315_5879_9261_5604_5600_842 18 3.75E-12 3.26E-10 1.42E-11 836 hsa-mir-107 hsa04912 GnRH signaling pathway 818_815_817_5578_5580_1956_6714_1432_2885_998_5595_5594_5599_3725_5604_5606_5601_5600_5602_2002 20 1.00E-11 8.72E-10 3.63E-11 837 hsa-mir-107 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_1432_5970_1147_998_5599_836_5879_3725_5058_4790_4792_5601_5600_5602_5781 17 1.07E-11 9.33E-10 3.73E-11 838 hsa-mir-107 hsa05213 Endometrial cancer 1499_2064_1956_2885_207_208_5595_5594_2932_7157_5728_5604_842_4609_2002 15 1.87E-11 1.63E-09 6.27E-11 839 hsa-mir-107 hsa04662 B cell receptor signaling pathway 4773_6850_5970_2885_207_208_1147_5595_5594_1380_2932_5879_3725_4790_4792_5604_2353 17 2.27E-11 1.97E-09 7.31E-11 840 hsa-mir-107 hsa04062 Chemokine signaling pathway 1234_1230_5747_5580_7852_5970_2885_6362_6774_207_208_3717_1147_998_5595_5594_2932_6777_6772_6773_5879_5058_4790_4792_5604 25 3.02E-11 2.63E-09 9.39E-11 841 hsa-mir-107 hsa04664 Fc epsilon RI signaling pathway 5578_2534_5580_6850_1432_2885_207_208_5595_5594_5599_5879_5604_5606_5601_5600_5602 17 4.61E-11 4.01E-09 1.38E-10 842 hsa-mir-107 hsa04520 Adherens junction 7046_1499_2064_2534_1956_6714_1460_998_5595_5594_1387_5879_1457_4087_4088_4089_2033 17 5.48E-11 4.76E-09 1.59E-10 843 hsa-mir-107 hsa05219 Bladder cancer 9252_4193_2064_5925_1956_2261_5595_5594_7157_1869_5604_4609_1026 13 2.01E-10 1.75E-08 5.64E-10 844 hsa-mir-107 hsa05218 Melanoma 4193_2249_5925_1956_207_208_5595_5594_7157_1869_5728_5159_5156_5604_1026 15 7.96E-10 6.93E-08 2.16E-09 845 hsa-mir-107 hsa05211 Renal cell carcinoma 3091_2885_207_208_998_5595_5594_1387_5879_3725_5058_2033_5604_5781 14 7.42E-09 6.46E-07 1.96E-08 846 hsa-mir-107 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_7132_1432_1616_836_5879_7157_5606_5600_842_7133 12 3.44E-08 3.00E-06 8.81E-08 847 hsa-mir-107 hsa04120 Ubiquitin mediated proteolysis 4193_3093_57154_7319_84447_10401_10055_9063_64326_7337_7329_5371_672_25898_51588_10075_8554 17 9.27E-08 8.07E-06 2.31E-07 848 hsa-mir-107 hsa04060 Cytokine-cytokine receptor interaction 7046_1234_1230_7132_58985_3455_3459_90_3791_1956_3560_3561_1439_7852_6362_659_3977_959_2321_5159_5156_3815_7133 23 1.53E-07 1.33E-05 3.69E-07 849 hsa-mir-107 hsa03420 Nucleotide excision repair 902_5887_2965_2967_2968_4331_2071_2074_1022_6117 10 2.99E-07 2.61E-05 7.04E-07 850 hsa-mir-107 hsa04916 Melanogenesis 818_815_817_1499_5578_5595_5594_1385_1387_2932_2033_5604_1856_3815 14 4.41E-07 3.84E-05 1.01E-06 851 hsa-mir-107 hsa05216 Thyroid cancer 1499_5595_5594_6258_6256_7157_5604_4609 8 1.35E-06 0.000117116 3.00E-06 852 hsa-mir-107 hsa04910 Insulin signaling pathway 2538_5499_2885_5211_207_208_5595_5594_5599_2932_5604_5601_5602_5563_2002 15 2.03E-06 0.000176466 4.30E-06 853 hsa-mir-107 hsa04650 Natural killer cell mediated cytotoxicity 5578_3455_3459_4773_2534_3932_6850_2885_5595_5594_836_5879_5058_5604_5781 15 2.03E-06 0.000176466 4.30E-06 854 hsa-mir-107 hsa04720 Long-term potentiation 818_815_817_6195_5578_5499_5595_5594_1387_2033_5604 11 3.59E-06 0.000311932 7.43E-06 855 hsa-mir-107 hsa04540 Gap junction 5578_10382_1956_6714_2885_5595_5594_1453_5159_983_5156_5604 12 4.34E-06 0.000377243 8.77E-06 856 hsa-mir-107 hsa05016 Huntington's disease 3065_3064_25942_6667_1385_1387_836_9001_5430_7157_2033_27113_6874_6908_842_841 16 1.67E-05 0.001448962 3.29E-05 857 hsa-mir-107 hsa04530 Tight junction 1499_5578_5580_6714_207_208_1460_998_1457_5728_5518_5515_5520 13 3.61E-05 0.003142554 6.98E-05 858 hsa-mir-107 hsa04150 mTOR signaling pathway 6794_6195_3091_207_208_5595_5594_5563 8 5.67E-05 0.004929761 0.000107169 859 hsa-mir-107 hsa04612 Antigen processing and presentation 3309_3304_3305_3303_1385_3312_3320_3326_4800_4801 10 7.89E-05 0.006861822 0.000145996 860 hsa-mir-107 hsa05131 Shigellosis 1499_5578_10382_2534_25_998_7534_4691 8 9.06E-05 0.007882981 0.000160877 861 hsa-mir-107 hsa05130 Pathogenic Escherichia coli infection 1499_5578_10382_2534_25_998_7534_4691 8 9.06E-05 0.007882981 0.000160877 862 hsa-mir-107 hsa04360 Axon guidance 4773_2534_5747_25_7852_998_5595_5594_2932_5879_5058_1020 12 9.75E-05 0.00848403 0.000169681 863 hsa-mir-107 hsa03050 Proteasome 5684_5705_5701_5702_5719_5717_5710 7 0.000222088 0.019321646 0.000378856 864 hsa-mir-107 hsa03030 DNA replication 4171_4174_4172_5557_6117_5422 6 0.000330272 0.028733654 0.00055257 865 hsa-mir-107 hsa05010 Alzheimer's disease 7132_823_6622_22926_5595_5594_836_2932_842_841_840_8772_1020 13 0.000388213 0.033774492 0.000637255 866 hsa-mir-107 hsa04810 Regulation of actin cytoskeleton 2264_2249_5747_1956_5499_998_2261_5595_5594_5879_5058_5159_5156_5604 14 0.000860474 0.074861205 0.001386319 867 hsa-mir-107 hsa04930 Type II diabetes mellitus 5580_5595_5594_5599_5601_5602 6 0.000956103 0.083180925 0.00151238 868 hsa-mir-107 hsa04330 Notch signaling pathway 9612_3065_1387_2033_8850_1856 6 0.001173579 0.102101332 0.001823238 869 hsa-mir-107 hsa04670 Leukocyte transendothelial migration 1499_5578_5747_1432_7852_998_5879_5600_5781 9 0.002872714 0.249926153 0.004384669 870 hsa-mir-107 hsa03440 Homologous recombination 641_5888_675_6117 4 0.005497832 0.478311409 0.008246748 871 hsa-mir-107 hsa04730 Long-term depression 5578_5595_5594_5518_5515_5604 6 0.007722247 0.671835475 0.011387042 872 hsa-mir-107 hsa03410 Base excision repair 3146_142_4913_328 4 0.012139758 1 0.017602649 873 hsa-mir-107 hsa04950 Maturity onset diabetes of the young 5080_6927_3172 3 0.022084115 1 0.031497016 874 hsa-mir-107 hsa04270 Vascular smooth muscle contraction 5578_147_5580_5499_5595_5594_5604 7 0.022943321 1 0.032194659 875 hsa-mir-107 hsa04020 Calcium signaling pathway 818_815_817_5578_2064_147_1956_5159_5156 9 0.043215361 1 0.059086788 876 hsa-mir-107 hsa05217 Basal cell carcinoma 1499_2932_7157_1856 4 0.043466143 1 0.059086788 877 hsa-mir-107 hsa04340 Hedgehog signaling pathway 53944_2932_1452_1453 4 0.048154021 1 0.064452305 878 hsa-mir-107 hsa03450 Non-homologous end-joining 2547_5591 2 0.049061585 1 0.06467209 879 hsa-mir-10a hsa05200 Pathways in cancer 3320_5371_3551_1499_5595_5594_5599_5914_1387_6257_6256_595_1487_1488_836_6258_367_1147_8517_2932_7704_3091_5970_7428_1870_1871_8031_7157_6688_2113_4609_1869_3725_862_5881_6774_6502_4087_4088_4089_7175_3066_3065_1050_5925_2034_2033_4846_207_3326_8554_4286_4791_4792_2353 55 2.63E-39 2.03E-37 2.03E-37 880 hsa-mir-10a hsa05220 Chronic myeloid leukemia 3551_5595_5594_595_1487_1488_1147_8517_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_207_4792_6464 22 6.19E-21 4.76E-19 2.38E-19 881 hsa-mir-10a hsa04110 Cell cycle 993_5591_1387_595_983_7532_2932_7534_1870_1871_7157_10912_1869_6502_6500_4087_4088_4089_3066_3065_5925_2033_4616_5933_8454 25 1.41E-20 1.08E-18 3.61E-19 882 hsa-mir-10a hsa04010 MAPK signaling pathway 6722_1326_5598_3551_5595_5594_5599_9261_4208_836_1147_8517_7867_1432_5971_5970_3312_7157_10912_4609_3725_5881_3310_4763_5058_4616_3303_207_4791_3305_2353_5566 32 3.84E-19 2.96E-17 7.39E-18 883 hsa-mir-10a hsa05215 Prostate cancer 3320_3551_1499_5595_5594_1387_595_367_1147_8517_2932_5970_1870_1871_7157_1869_5925_2033_207_3326_4792 21 1.81E-18 1.39E-16 2.78E-17 884 hsa-mir-10a hsa05212 Pancreatic cancer 3320_3551_1499_5595_5594_1387_595_367_1147_8517_2932_5970_1870_1871_7157_1869_5925_2033_207_3326_4792 21 2.21E-18 1.70E-16 2.83E-17 885 hsa-mir-10a hsa05222 Small cell lung cancer 3551_6257_6256_595_6258_1147_8517_5970_1870_1871_7157_4609_1869_6502_5925_4846_207_8554_4792 19 2.68E-16 2.06E-14 2.94E-15 886 hsa-mir-10a hsa04310 Wnt signaling pathway 23291_1499_5599_1387_595_1487_1488_2932_7157_8945_8607_4609_3725_5881_1457_6500_4087_4088_4089_2033_8454_5566 22 3.02E-15 2.32E-13 2.91E-14 887 hsa-mir-10a hsa05221 Acute myeloid leukemia 5371_3551_5595_5594_5914_595_1147_8517_7704_5970_6688_4609_862_6774_1050_207 16 3.97E-15 3.06E-13 3.40E-14 888 hsa-mir-10a hsa04920 Adipocytokine signaling pathway 10891_3551_5599_6257_6256_6258_1147_8517_5970_4794_6774_207_4792_4793_2538 15 3.22E-13 2.48E-11 2.48E-12 889 hsa-mir-10a hsa05210 Colorectal cancer 1499_5595_5594_5599_595_836_2932_7157_4609_3725_5881_4087_4088_4089_207_2353 16 4.60E-13 3.54E-11 3.22E-12 890 hsa-mir-10a hsa05216 Thyroid cancer 1499_5595_5594_6257_6256_595_6258_8031_7157_4609_7175 11 4.01E-12 3.09E-10 2.58E-11 891 hsa-mir-10a hsa04662 B cell receptor signaling pathway 3551_5595_5594_1147_8517_2932_5970_4794_3725_5881_207_4792_4793_2353 14 1.71E-11 1.32E-09 9.73E-11 892 hsa-mir-10a hsa04660 T cell receptor signaling pathway 1326_3551_5595_5594_1147_8517_2932_1432_5970_4794_3725_5058_207_4792_4793_2353 16 1.77E-11 1.36E-09 9.73E-11 893 hsa-mir-10a hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_207_6464_808_801_805 13 4.26E-11 3.28E-09 2.19E-10 894 hsa-mir-10a hsa05223 Non-small cell lung cancer 5595_5594_6257_6256_595_6258_1870_1871_7157_1869_5925_207 12 8.30E-11 6.39E-09 3.99E-10 895 hsa-mir-10a hsa04350 TGF-beta signaling pathway 5595_5594_1387_3397_3399_3398_4609_6500_4087_4088_4089_2033_5933_8454 14 9.92E-11 7.63E-09 4.49E-10 896 hsa-mir-10a hsa04520 Adherens junction 1499_6714_5595_5594_1387_71_5881_1457_4087_4088_4089_2033 12 4.45E-09 3.43E-07 1.85E-08 897 hsa-mir-10a hsa04330 Notch signaling pathway 388585_1387_1487_1488_9612_3066_3065_2033_4851_8850 10 4.57E-09 3.52E-07 1.85E-08 898 hsa-mir-10a hsa04620 Toll-like receptor signaling pathway 1326_3551_5595_5594_5599_1147_8517_1432_5970_3725_207_4792_2353 13 6.01E-09 4.63E-07 2.31E-08 899 hsa-mir-10a hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3551_6714_5599_836_1147_8517_1432_5970_3725_5058_4792 11 1.46E-08 1.12E-06 5.36E-08 900 hsa-mir-10a hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2113_3725_5058_2034_2033_207 11 1.66E-08 1.28E-06 5.82E-08 901 hsa-mir-10a hsa04910 Insulin signaling pathway 6720_10891_3551_5595_5594_5599_2932_207_6464_2538_808_801_5566_805 14 2.25E-08 1.73E-06 7.53E-08 902 hsa-mir-10a hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5925 9 2.59E-08 2.00E-06 8.32E-08 903 hsa-mir-10a hsa04210 Apoptosis 3551_836_1147_8517_840_5970_7157_8837_207_4792_5566 11 1.19E-07 9.15E-06 3.66E-07 904 hsa-mir-10a hsa05016 Huntington's disease 6874_10891_1387_2902_836_293_1213_5437_7157_5441_292_3066_3065_3064_2033 15 1.35E-07 1.04E-05 3.99E-07 905 hsa-mir-10a hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5925_207_4286 10 1.49E-07 1.15E-05 4.25E-07 906 hsa-mir-10a hsa04120 Ubiquitin mediated proteolysis 5371_23291_672_3093_7428_10273_8945_7329_6502_6500_7323_8554_8454 13 1.71E-07 1.32E-05 4.72E-07 907 hsa-mir-10a hsa04540 Gap junction 203068_5598_6714_5595_5594_10382_983_7278_347733_84617_5566 11 1.78E-07 1.37E-05 4.73E-07 908 hsa-mir-10a hsa04062 Chemokine signaling pathway 3551_5595_5594_1147_8517_2932_5970_653361_6774_5058_207_4792_4793_6464_5566 15 1.85E-07 1.42E-05 4.74E-07 909 hsa-mir-10a hsa04916 Melanogenesis 1499_5595_5594_1387_2932_2033_4286_808_801_5566_805 11 4.98E-07 3.83E-05 1.24E-06 910 hsa-mir-10a hsa04912 GnRH signaling pathway 5598_6714_5595_5594_5599_1432_3725_808_801_5566_805 11 7.03E-07 5.41E-05 1.69E-06 911 hsa-mir-10a hsa04012 ErbB signaling pathway 6714_5595_5594_5599_2932_4609_3725_5058_207_6464 10 8.23E-07 6.34E-05 1.92E-06 912 hsa-mir-10a hsa04612 Antigen processing and presentation 3320_4800_1514_3312_3310_3309_3303_4801_3326_3305 10 9.96E-07 7.67E-05 2.25E-06 913 hsa-mir-10a hsa05213 Endometrial cancer 1499_5595_5594_595_2932_7157_4609_207 8 1.47E-06 0.000112863 3.22E-06 914 hsa-mir-10a hsa04510 Focal adhesion 1499_6714_5595_5594_5599_10627_595_2932_71_3725_5881_5058_207_6464 14 2.11E-06 0.000162285 4.40E-06 915 hsa-mir-10a hsa04720 Long-term potentiation 5595_5594_1387_2902_2033_808_801_5566_805 9 2.12E-06 0.000162925 4.40E-06 916 hsa-mir-10a hsa05131 Shigellosis 203068_1499_10382_7534_7278_347733_71_84617 8 2.42E-06 0.000186242 4.78E-06 917 hsa-mir-10a hsa05130 Pathogenic Escherichia coli infection 203068_1499_10382_7534_7278_347733_71_84617 8 2.42E-06 0.000186242 4.78E-06 918 hsa-mir-10a hsa04370 VEGF signaling pathway 6714_5595_5594_9261_7867_1432_5881_4846_207 9 2.58E-06 0.000198726 4.97E-06 919 hsa-mir-10a hsa03020 RNA polymerase 64425_5437_25885_5441_51082_84172 6 6.94E-06 0.000534274 1.30E-05 920 hsa-mir-10a hsa05010 Alzheimer's disease 1020_5595_5594_2902_836_2932_840_4846_808_801_805 11 5.60E-05 0.0043104 0.000102629 921 hsa-mir-10a hsa04630 Jak-STAT signaling pathway 3559_1387_595_6778_4609_6774_2033_207_8554 9 0.00042119 0.032431595 0.000754223 922 hsa-mir-10a hsa04950 Maturity onset diabetes of the young 3651_6928_3172_168620 4 0.000525355 0.040452327 0.000919371 923 hsa-mir-10a hsa04115 p53 signaling pathway 595_983_836_7157_10912_4616 6 0.00054592 0.042035802 0.000934129 924 hsa-mir-10a hsa04930 Type II diabetes mellitus 3651_3551_5595_5594_5599 5 0.000571706 0.044021342 0.000956986 925 hsa-mir-10a hsa04530 Tight junction 1499_6714_10627_4628_71_4627_1457_207 8 0.000841734 0.064813495 0.001379011 926 hsa-mir-10a hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_1432_5881_207 6 0.001058912 0.081536257 0.001698672 927 hsa-mir-10a hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_1432_7157_4846 5 0.00142169 0.109470135 0.002234084 928 hsa-mir-10a hsa04340 Hedgehog signaling pathway 23291_53944_2932_8945_5566 5 0.001529456 0.117768127 0.002355363 929 hsa-mir-10a hsa04270 Vascular smooth muscle contraction 5595_5594_4637_808_801_5566_805 7 0.001614625 0.12432615 0.002437768 930 hsa-mir-10a hsa04810 Regulation of actin cytoskeleton 5595_5594_10627_4628_71_10788_4627_5881_5058 9 0.004108265 0.316336426 0.006083393 931 hsa-mir-10a hsa04020 Calcium signaling pathway 2902_293_292_4846_808_801_5566_805 8 0.004842227 0.372851509 0.007034934 932 hsa-mir-10a hsa04150 mTOR signaling pathway 5595_5594_3091_207 4 0.007001847 0.539142202 0.009984115 933 hsa-mir-10a hsa04360 Axon guidance 1020_5595_5594_2932_5881_5058 6 0.011105128 0.855094875 0.01554718 934 hsa-mir-10a hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_5881_5058_6464 6 0.013929846 1 0.019153538 935 hsa-mir-10a hsa03320 PPAR signaling pathway 6257_6256_6258_2168 4 0.018160509 1 0.024532618 936 hsa-mir-10a hsa04670 Leukocyte transendothelial migration 1499_10627_1432_71_653361 5 0.029617891 1 0.039320303 937 hsa-mir-10a hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.044063154 1 0.057506151 938 hsa-mir-10b hsa05200 Pathways in cancer 3716_1147_3320_3725_5371_405_3480_1956_5595_5594_5599_6654_6258_1387_6257_6256_8031_5601_10401_836_208_4193_367_7704_842_841_2064_6776_2885_6772_5970_8503_7157_4824_4087_595_5295_2736_3065_4088_4089_2033_5914_207_2308_3326_2932_8554_4790 49 1.60E-34 1.19E-32 1.19E-32 939 hsa-mir-10b hsa05215 Prostate cancer 1147_3320_3480_1956_5595_5594_6654_1385_1387_208_4193_367_842_2064_2885_5970_8503_7157_4824_595_5295_2033_207_2308_3326_2932_4790 27 1.02E-26 7.55E-25 3.24E-25 940 hsa-mir-10b hsa05212 Pancreatic cancer 1147_3320_3480_1956_5595_5594_6654_1385_1387_208_4193_367_842_2064_2885_5970_8503_7157_4824_595_5295_2033_207_2308_3326_2932_4790 27 1.31E-26 9.73E-25 3.24E-25 941 hsa-mir-10b hsa04010 MAPK signaling pathway 1147_6722_3727_8986_3725_994_1956_5595_5594_5599_6654_9261_5601_3303_836_6197_208_4214_9252_3312_2885_5970_627_7157_10912_5566_1432_6195_6196_5058_4616_2872_207_4790_2002_2005 36 4.67E-24 3.45E-22 8.64E-23 942 hsa-mir-10b hsa05210 Colorectal cancer 3725_3480_1956_5595_5594_5599_6654_5601_836_208_842_2885_8503_7157_4087_595_5295_4088_4089_207_2932 21 1.73E-19 1.28E-17 2.55E-18 943 hsa-mir-10b hsa04012 ErbB signaling pathway 3725_815_1956_5595_6714_5594_5599_6654_5601_208_2064_6776_2885_8503_5295_5058_56924_207_2932_6464_2002 21 3.21E-19 2.38E-17 3.96E-18 944 hsa-mir-10b hsa05220 Chronic myeloid leukemia 1147_5595_5594_6654_208_4193_6776_2885_5970_8503_7157_595_5295_3065_4088_4089_207_4790_6464 19 7.57E-18 5.60E-16 8.00E-17 945 hsa-mir-10b hsa04910 Insulin signaling pathway 7249_10891_6720_5595_5594_5599_6654_5601_208_2885_8503_5770_5566_5295_2872_207_2308_2932_801_6464_2002_808_805 23 8.74E-18 6.47E-16 8.09E-17 946 hsa-mir-10b hsa05214 Glioma 815_3480_1956_5595_5594_6654_208_4193_2885_8503_7157_595_5295_207_801_6464_808_805 18 1.47E-17 1.09E-15 1.21E-16 947 hsa-mir-10b hsa05223 Non-small cell lung cancer 1956_5595_5594_6654_6258_6257_6256_208_842_2064_2885_8503_7157_595_5295_2309_207 17 1.92E-17 1.42E-15 1.42E-16 948 hsa-mir-10b hsa05213 Endometrial cancer 1956_5595_5594_6654_208_842_2064_2885_8503_7157_595_5295_2309_207_2932_2002 16 2.31E-16 1.71E-14 1.56E-15 949 hsa-mir-10b hsa05221 Acute myeloid leukemia 1147_5371_5595_5594_6654_208_7704_6776_2885_5970_8503_595_5295_5914_207_4790 16 1.24E-15 9.19E-14 7.66E-15 950 hsa-mir-10b hsa04660 T cell receptor signaling pathway 1147_3725_3932_5595_5594_6654_5601_208_5777_2885_5970_8503_1432_5295_5058_56924_207_2932_4790 19 3.63E-15 2.68E-13 2.06E-14 951 hsa-mir-10b hsa04630 Jak-STAT signaling pathway 3717_3716_6654_1387_10401_208_5777_6778_6776_2885_6772_8503_3454_3455_7297_595_5295_2033_207_8554_10379 21 9.71E-15 7.19E-13 5.13E-14 952 hsa-mir-10b hsa04110 Cell cycle 994_5591_7531_1387_7534_7533_4193_7157_4087_10912_902_595_3065_4088_4089_1022_4616_2033_2932 19 1.30E-14 9.59E-13 6.39E-14 953 hsa-mir-10b hsa04510 Focal adhesion 3725_9564_3480_1956_5595_6714_5594_5599_6654_5601_208_2064_2885_8503_857_595_5295_5058_56924_207_2932_6464_2002 23 2.21E-14 1.63E-12 1.02E-13 954 hsa-mir-10b hsa04062 Chemokine signaling pathway 3717_1147_9564_5595_5594_6654_2770_208_2931_2885_6772_5970_8503_7852_5566_5295_5058_2309_207_2932_4790_6464 22 5.58E-14 4.13E-12 2.43E-13 955 hsa-mir-10b hsa04620 Toll-like receptor signaling pathway 1147_3725_5595_5594_5599_5601_208_841_6772_5970_8503_3454_3455_1432_5295_207_4790 17 1.75E-13 1.29E-11 7.18E-13 956 hsa-mir-10b hsa04912 GnRH signaling pathway 3725_815_1956_5595_6714_5594_5599_6654_5601_4214_2885_5566_1432_801_2002_808_805 17 4.00E-13 2.96E-11 1.56E-12 957 hsa-mir-10b hsa04520 Adherens junction 3480_1956_5595_6714_5594_1387_5777_2064_4087_5770_1460_1457_4088_4089_2033 15 1.05E-12 7.74E-11 3.87E-12 958 hsa-mir-10b hsa05222 Small cell lung cancer 1147_6258_6257_6256_10401_208_842_5970_8503_7157_595_5295_207_8554_4790 15 2.63E-12 1.95E-10 9.28E-12 959 hsa-mir-10b hsa05211 Renal cell carcinoma 3725_405_5595_5594_6654_1387_208_2885_8503_5295_5058_56924_2033_207 14 3.89E-12 2.88E-10 1.31E-11 960 hsa-mir-10b hsa04662 B cell receptor signaling pathway 1147_3725_5595_5594_6654_208_5777_2885_5970_8503_5295_207_2932_4790 14 6.33E-12 4.68E-10 2.04E-11 961 hsa-mir-10b hsa03022 Basal transcription factors 2965_2963_2962_6881_2969_6879_6908_6872_2958_2959_6880 11 1.60E-11 1.19E-09 4.94E-11 962 hsa-mir-10b hsa04210 Apoptosis 1147_836_839_208_842_841_840_5970_8503_7157_5566_5295_207_4790 14 4.87E-11 3.60E-09 1.44E-10 963 hsa-mir-10b hsa04920 Adipocytokine signaling pathway 3717_1147_10891_5599_6258_6257_6256_5601_208_5970_207_4790 12 3.16E-10 2.34E-08 8.98E-10 964 hsa-mir-10b hsa04720 Long-term potentiation 815_5595_5594_1387_6197_5566_6195_6196_2033_801_808_805 12 9.99E-10 7.39E-08 2.74E-09 965 hsa-mir-10b hsa04310 Wnt signaling pathway 3725_815_5599_1387_5601_7157_4087_595_5566_1460_1457_4088_4089_2033_2932 15 3.66E-09 2.71E-07 9.68E-09 966 hsa-mir-10b hsa04150 mTOR signaling pathway 7249_5595_5594_6197_208_8503_6195_6196_5295_207 10 5.28E-09 3.91E-07 1.35E-08 967 hsa-mir-10b hsa05218 Melanoma 3480_1956_5595_5594_208_4193_8503_7157_595_5295_207 11 6.78E-09 5.02E-07 1.62E-08 968 hsa-mir-10b hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_3725_1956_6714_5599_5601_836_5970_1432_5058_4790 11 6.78E-09 5.02E-07 1.62E-08 969 hsa-mir-10b hsa05216 Thyroid cancer 5595_5594_6258_6257_6256_8031_7157_595 8 1.63E-08 1.21E-06 3.77E-08 970 hsa-mir-10b hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_6654_5601_208_2885_8503_1432_5295_207 11 1.84E-08 1.36E-06 4.13E-08 971 hsa-mir-10b hsa04916 Melanogenesis 815_5595_5594_1385_1387_2770_5566_2033_2932_801_808_805 12 2.79E-08 2.07E-06 6.08E-08 972 hsa-mir-10b hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6654_836_5777_2885_8503_3454_3455_5295_5058_6464 13 6.72E-08 4.97E-06 1.42E-07 973 hsa-mir-10b hsa04370 VEGF signaling pathway 5595_6714_5594_9261_208_842_8503_1432_5295_207 10 1.49E-07 1.10E-05 3.06E-07 974 hsa-mir-10b hsa05219 Bladder cancer 1956_5595_5594_9252_4193_2064_7157_595 8 1.97E-07 1.45E-05 3.93E-07 975 hsa-mir-10b hsa04115 p53 signaling pathway 7249_836_4193_842_841_7157_10912_595_4616 9 6.07E-07 4.49E-05 1.18E-06 976 hsa-mir-10b hsa05016 Huntington's disease 10891_1385_1387_6908_836_6667_842_841_627_7157_3065_3064_2033 13 1.80E-06 0.000133388 3.42E-06 977 hsa-mir-10b hsa04930 Type II diabetes mellitus 5595_5594_5599_5601_3651_8503_5295 7 3.87E-06 0.000286083 7.15E-06 978 hsa-mir-10b hsa04540 Gap junction 1956_5595_6714_5592_5594_6654_2770_2885_5566 9 5.85E-06 0.000432926 1.06E-05 979 hsa-mir-10b hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_4087_4088_4089_2033 8 2.72E-05 0.002014631 4.80E-05 980 hsa-mir-10b hsa05010 Alzheimer's disease 22926_5595_5594_836_842_841_840_2932_801_808_805 11 2.85E-05 0.002111849 4.91E-05 981 hsa-mir-10b hsa04612 Antigen processing and presentation 3320_1385_3303_4800_3312_6890_3326 7 0.000214648 0.015883972 0.000360999 982 hsa-mir-10b hsa04360 Axon guidance 5595_5998_5594_2770_7852_5058_56924_2932 8 0.000391068 0.028939031 0.00064309 983 hsa-mir-10b hsa04120 Ubiquitin mediated proteolysis 5371_672_10401_4214_4193_10273_7329_8554 8 0.000567587 0.04200146 0.000913075 984 hsa-mir-10b hsa04270 Vascular smooth muscle contraction 5595_5592_5594_5566_801_808_805 7 0.001053617 0.077967645 0.001658886 985 hsa-mir-10b hsa03450 Non-homologous end-joining 5591_7520_2547 3 0.001176369 0.087051333 0.001813569 986 hsa-mir-10b hsa04530 Tight junction 6714_2770_208_8189_1460_1457_207 7 0.002371935 0.175523186 0.003582106 987 hsa-mir-10b hsa04810 Regulation of actin cytoskeleton 9564_1956_5595_5594_6654_8503_5295_5058_56924 9 0.0025175 0.186295015 0.0037259 988 hsa-mir-10b hsa04730 Long-term depression 3480_5595_5592_5594_2770 5 0.002724015 0.201577095 0.003952492 989 hsa-mir-10b hsa03420 Nucleotide excision repair 2965_902_1022_4331 4 0.003094772 0.229013142 0.004404099 990 hsa-mir-10b hsa04070 Phosphatidylinositol signaling system 8503_5295_801_808_805 5 0.003590455 0.265693646 0.005013088 991 hsa-mir-10b hsa04330 Notch signaling pathway 1387_9612_3065_2033 4 0.003859274 0.285586261 0.005288634 992 hsa-mir-10b hsa04950 Maturity onset diabetes of the young 3172_3651_4760 3 0.00461106 0.341218417 0.006203971 993 hsa-mir-10b hsa04670 Leukocyte transendothelial migration 9564_2770_8503_7852_1432_5295 6 0.005705288 0.422191339 0.007539131 994 hsa-mir-10b hsa05014 Amyotrophic lateral sclerosis (ALS) 836_842_7157_1432 4 0.006895476 0.510265212 0.008952021 995 hsa-mir-10b hsa04020 Calcium signaling pathway 815_1956_2064_5566_801_808_805 7 0.010823457 0.800935822 0.013809238 996 hsa-mir-10b hsa03320 PPAR signaling pathway 6258_6257_6256_2168 4 0.014196696 1 0.017806025 997 hsa-mir-10b hsa05217 Basal cell carcinoma 7157_2736_2932 3 0.036608421 1 0.045150385 998 hsa-mir-10b hsa04340 Hedgehog signaling pathway 5566_2736_2932 3 0.03987016 1 0.04836708 999 hsa-mir-1179 hsa05200 Pathways in cancer 8031_4089_25_6688_2033_207_8554_5970_7704_5595_5594_6774_5599_6258_1387_6257_6256 17 2.24E-18 1.21E-16 1.21E-16 1000 hsa-mir-1179 hsa04920 Adipocytokine signaling pathway 10891_207_5970_6774_5599_6258_6257_6256 8 6.69E-12 3.61E-10 1.81E-10 1001 hsa-mir-1179 hsa05221 Acute myeloid leukemia 6688_207_5970_7704_5595_5594_6774 7 1.54E-10 8.33E-09 2.22E-09 1002 hsa-mir-1179 hsa05216 Thyroid cancer 8031_5595_5594_6258_6257_6256 6 1.65E-10 8.88E-09 2.22E-09 1003 hsa-mir-1179 hsa04350 TGF-beta signaling pathway 4086_4089_2033_4093_5595_5594_1387 7 1.93E-09 1.04E-07 2.08E-08 1004 hsa-mir-1179 hsa05223 Non-small cell lung cancer 207_5595_5594_6258_6257_6256 6 4.86E-09 2.62E-07 4.37E-08 1005 hsa-mir-1179 hsa05220 Chronic myeloid leukemia 4089_25_207_5970_5595_5594 6 3.03E-08 1.64E-06 2.34E-07 1006 hsa-mir-1179 hsa05222 Small cell lung cancer 207_8554_5970_6258_6257_6256 6 6.53E-08 3.53E-06 4.28E-07 1007 hsa-mir-1179 hsa05215 Prostate cancer 2033_207_5970_5595_5594_1387 6 7.44E-08 4.02E-06 4.28E-07 1008 hsa-mir-1179 hsa05212 Pancreatic cancer 2033_207_5970_5595_5594_1387 6 7.92E-08 4.28E-06 4.28E-07 1009 hsa-mir-1179 hsa04110 Cell cycle 4089_25_2033_4616_10912_1387 6 4.05E-07 2.19E-05 1.99E-06 1010 hsa-mir-1179 hsa05211 Renal cell carcinoma 2033_207_5595_5594_1387 5 8.87E-07 4.79E-05 3.99E-06 1011 hsa-mir-1179 hsa04520 Adherens junction 4089_2033_5595_5594_1387 5 1.45E-06 7.84E-05 6.03E-06 1012 hsa-mir-1179 hsa05210 Colorectal cancer 4089_207_5595_5594_5599 5 1.83E-06 9.86E-05 7.04E-06 1013 hsa-mir-1179 hsa04012 ErbB signaling pathway 25_207_5595_5594_5599 5 2.15E-06 0.000116151 7.74E-06 1014 hsa-mir-1179 hsa04010 MAPK signaling pathway 4616_207_10912_5970_5595_5594_5599 7 3.36E-06 0.000181576 1.13E-05 1015 hsa-mir-1179 hsa04620 Toll-like receptor signaling pathway 207_5970_5595_5594_5599 5 4.53E-06 0.000244605 1.44E-05 1016 hsa-mir-1179 hsa04910 Insulin signaling pathway 10891_207_5595_5594_5599 5 1.86E-05 0.001003344 5.57E-05 1017 hsa-mir-1179 hsa03320 PPAR signaling pathway 2168_6258_6257_6256 4 2.44E-05 0.001319165 6.94E-05 1018 hsa-mir-1179 hsa04720 Long-term potentiation 2033_5595_5594_1387 4 3.16E-05 0.00170801 7.82E-05 1019 hsa-mir-1179 hsa04662 B cell receptor signaling pathway 207_5970_5595_5594 4 3.16E-05 0.00170801 7.82E-05 1020 hsa-mir-1179 hsa04630 Jak-STAT signaling pathway 2033_207_8554_6774_1387 5 3.19E-05 0.00172108 7.82E-05 1021 hsa-mir-1179 hsa04664 Fc epsilon RI signaling pathway 207_5595_5594_5599 4 3.84E-05 0.00207482 9.02E-05 1022 hsa-mir-1179 hsa04062 Chemokine signaling pathway 207_5970_5595_5594_6774 5 8.76E-05 0.004732594 0.000197191 1023 hsa-mir-1179 hsa04916 Melanogenesis 2033_5595_5594_1387 4 0.000107397 0.005799435 0.000231977 1024 hsa-mir-1179 hsa04660 T cell receptor signaling pathway 207_5970_5595_5594 4 0.000132371 0.007148044 0.000274925 1025 hsa-mir-1179 hsa04930 Type II diabetes mellitus 5595_5594_5599 3 0.000177888 0.009605932 0.000355775 1026 hsa-mir-1179 hsa04330 Notch signaling pathway 9612_2033_1387 3 0.000200933 0.010850398 0.000387514 1027 hsa-mir-1179 hsa05213 Endometrial cancer 207_5595_5594 3 0.000266789 0.014406588 0.00048022 1028 hsa-mir-1179 hsa04150 mTOR signaling pathway 207_5595_5594 3 0.000266789 0.014406588 0.00048022 1029 hsa-mir-1179 hsa04310 Wnt signaling pathway 4089_2033_5599_1387 4 0.000438564 0.023682435 0.00076395 1030 hsa-mir-1179 hsa05214 Glioma 207_5595_5594 3 0.000499051 0.02694875 0.000842148 1031 hsa-mir-1179 hsa05218 Melanoma 207_5595_5594 3 0.000639292 0.034521785 0.001046115 1032 hsa-mir-1179 hsa04370 VEGF signaling pathway 207_5595_5594 3 0.000802456 0.043332644 0.00127449 1033 hsa-mir-1179 hsa04510 Focal adhesion 207_5595_5594_5599 4 0.001327768 0.071699486 0.002048557 1034 hsa-mir-1179 hsa04912 GnRH signaling pathway 5595_5594_5599 3 0.002060977 0.111292735 0.003091465 1035 hsa-mir-1179 hsa04360 Axon guidance 25_5595_5594 3 0.003510873 0.189587145 0.005123977 1036 hsa-mir-1179 hsa05219 Bladder cancer 5595_5594 2 0.004483881 0.2421296 0.006371832 1037 hsa-mir-1179 hsa05016 Huntington's disease 10891_2033_1387 3 0.009343516 0.504549889 0.012937177 1038 hsa-mir-1179 hsa04115 p53 signaling pathway 4616_10912 2 0.011325777 0.611591983 0.0152898 1039 hsa-mir-1179 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_5599 2 0.011942882 0.644915646 0.015355134 1040 hsa-mir-1179 hsa04730 Long-term depression 5595_5594 2 0.011942882 0.644915646 0.015355134 1041 hsa-mir-1179 hsa04210 Apoptosis 207_5970 2 0.018131591 0.979105918 0.022769905 1042 hsa-mir-1179 hsa04540 Gap junction 5595_5594 2 0.019656065 1 0.024123352 1043 hsa-mir-1179 hsa04270 Vascular smooth muscle contraction 5595_5594 2 0.030320989 1 0.036385186 1044 hsa-mir-1179 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594 2 0.040151499 1 0.047134368 1045 hsa-mir-1181 hsa05200 Pathways in cancer 5371_5595_5594_5914_1387_6256_595_836_367_7704_842_841_3091_5970_7428_1870_1871_7157_4824_4087_2113_4609_1869_3725_3065_4088_4089_3066_5925_2034_2033_4846_6258 33 3.67E-32 2.31E-30 2.31E-30 1046 hsa-mir-1181 hsa05220 Chronic myeloid leukemia 5595_5594_595_5970_1870_1871_7157_4609_1869_3065_4088_4089_3066_5925_6464 15 3.75E-19 2.36E-17 1.18E-17 1047 hsa-mir-1181 hsa05215 Prostate cancer 5595_5594_1387_595_367_1385_842_5970_1870_1871_7157_4824_1869_5925_2033 15 3.16E-18 1.99E-16 5.80E-17 1048 hsa-mir-1181 hsa05212 Pancreatic cancer 5595_5594_1387_595_367_1385_842_5970_1870_1871_7157_4824_1869_5925_2033 15 3.68E-18 2.32E-16 5.80E-17 1049 hsa-mir-1181 hsa04110 Cell cycle 5591_1387_595_1870_1871_7157_4087_1869_3065_4088_4089_3066_5925_2033_5933 15 1.86E-16 1.17E-14 2.35E-15 1050 hsa-mir-1181 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_842_1870_1871_7157_1869_5925_6258 11 1.95E-14 1.23E-12 2.05E-13 1051 hsa-mir-1181 hsa05222 Small cell lung cancer 6256_595_842_5970_1870_1871_7157_4609_1869_5925_4846_6258 12 7.04E-14 4.44E-12 6.34E-13 1052 hsa-mir-1181 hsa05210 Colorectal cancer 5595_5594_595_836_842_7157_4087_4609_3725_4088_4089 11 1.50E-12 9.46E-11 1.18E-11 1053 hsa-mir-1181 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5925 9 3.31E-12 2.08E-10 2.31E-11 1054 hsa-mir-1181 hsa05214 Glioma 815_5595_5594_595_1870_1871_7157_1869_5925_6464 10 3.77E-12 2.38E-10 2.38E-11 1055 hsa-mir-1181 hsa04010 MAPK signaling pathway 5595_5594_9261_4208_836_5970_3312_7157_4609_3725_6195_4763_2002_2005 14 1.72E-10 1.08E-08 9.86E-10 1056 hsa-mir-1181 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2113_3725_2034_2033 9 2.50E-10 1.58E-08 1.31E-09 1057 hsa-mir-1181 hsa05016 Huntington's disease 6874_1387_2902_836_1385_842_841_7157_3065_3066_3064_2033 12 3.46E-10 2.18E-08 1.68E-09 1058 hsa-mir-1181 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609_6258 7 4.41E-10 2.78E-08 1.99E-09 1059 hsa-mir-1181 hsa04310 Wnt signaling pathway 815_1387_595_1457_7157_4087_4609_3725_4088_4089_2033 11 5.55E-10 3.49E-08 2.32E-09 1060 hsa-mir-1181 hsa04520 Adherens junction 6714_5595_5594_1387_1457_4087_4088_4089_2033 9 5.90E-10 3.71E-08 2.32E-09 1061 hsa-mir-1181 hsa04350 TGF-beta signaling pathway 5595_5594_1387_4087_4609_4088_4089_2033_5933 9 1.17E-09 7.36E-08 4.33E-09 1062 hsa-mir-1181 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_5970_4609 8 1.42E-09 8.97E-08 4.98E-09 1063 hsa-mir-1181 hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5925 8 5.42E-09 3.41E-07 1.80E-08 1064 hsa-mir-1181 hsa05213 Endometrial cancer 5595_5594_595_842_7157_4609_2002 7 1.64E-08 1.03E-06 5.17E-08 1065 hsa-mir-1181 hsa04012 ErbB signaling pathway 815_6714_5595_5594_4609_3725_6464_2002 8 2.36E-08 1.49E-06 7.09E-08 1066 hsa-mir-1181 hsa04720 Long-term potentiation 815_5595_5594_1387_2902_6195_2033 7 1.66E-07 1.05E-05 4.77E-07 1067 hsa-mir-1181 hsa05010 Alzheimer's disease 22926_5595_5594_2902_836_842_841_840_4846 9 3.74E-07 2.36E-05 1.02E-06 1068 hsa-mir-1181 hsa04210 Apoptosis 836_839_842_841_840_5970_7157 7 4.93E-07 3.11E-05 1.29E-06 1069 hsa-mir-1181 hsa04370 VEGF signaling pathway 6714_5595_5594_9261_842_4846 6 3.50E-06 0.000220216 8.81E-06 1070 hsa-mir-1181 hsa04330 Notch signaling pathway 1387_9612_3065_3066_2033 5 5.75E-06 0.000362209 1.39E-05 1071 hsa-mir-1181 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_842_7157_4846 5 1.27E-05 0.000800205 2.96E-05 1072 hsa-mir-1181 hsa04916 Melanogenesis 815_5595_5594_1387_1385_2033 6 1.78E-05 0.001120953 4.00E-05 1073 hsa-mir-1181 hsa04912 GnRH signaling pathway 815_6714_5595_5594_3725_2002 6 2.18E-05 0.001373486 4.74E-05 1074 hsa-mir-1181 hsa04115 p53 signaling pathway 595_836_842_841_7157 5 3.27E-05 0.002058577 6.86E-05 1075 hsa-mir-1181 hsa04510 Focal adhesion 6714_5595_5594_595_3725_6464_2002 7 9.17E-05 0.005776005 0.000186323 1076 hsa-mir-1181 hsa04150 mTOR signaling pathway 5595_5594_3091_6195 4 0.000167953 0.01058105 0.000330658 1077 hsa-mir-1181 hsa04620 Toll-like receptor signaling pathway 5595_5594_841_5970_3725 5 0.000189406 0.011932602 0.000361594 1078 hsa-mir-1181 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_836_5970_3725 4 0.000517113 0.032578113 0.00095818 1079 hsa-mir-1181 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725 4 0.000629619 0.039666012 0.001133315 1080 hsa-mir-1181 hsa04910 Insulin signaling pathway 6720_5595_5594_6464_2002 5 0.000718419 0.045260393 0.001257233 1081 hsa-mir-1181 hsa03022 Basal transcription factors 2962_2969_6874 3 0.001002559 0.063161216 0.00170706 1082 hsa-mir-1181 hsa04612 Antigen processing and presentation 4800_4801_1385_3312 4 0.001160351 0.073102092 0.001923739 1083 hsa-mir-1181 hsa04660 T cell receptor signaling pathway 5595_5594_5970_3725 4 0.002449754 0.154334479 0.003957294 1084 hsa-mir-1181 hsa04920 Adipocytokine signaling pathway 6256_5970_6258 3 0.00499007 0.314374423 0.007859361 1085 hsa-mir-1181 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_6464 4 0.005364192 0.337944094 0.008242539 1086 hsa-mir-1181 hsa04730 Long-term depression 5595_5594_4846 3 0.005825795 0.367025112 0.008738693 1087 hsa-mir-1181 hsa04630 Jak-STAT signaling pathway 1387_595_4609_2033 4 0.007947985 0.500723045 0.011644722 1088 hsa-mir-1181 hsa04540 Gap junction 6714_5595_5594 3 0.011876588 0.748225026 0.017005114 1089 hsa-mir-1181 hsa04062 Chemokine signaling pathway 5595_5594_5970_6464 4 0.0163738 1 0.02292332 1090 hsa-mir-1181 hsa04930 Type II diabetes mellitus 5595_5594 2 0.022399356 1 0.030677379 1091 hsa-mir-1181 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428 3 0.033029995 1 0.044274249 1092 hsa-mir-1181 hsa03320 PPAR signaling pathway 6256_6258 2 0.048937028 1 0.064229849 1093 hsa-mir-1182 hsa04110 Cell cycle 7533 1 0.003999867 0.003999867 0.003999867 1094 hsa-mir-1183 hsa05200 Pathways in cancer 5371_9063_7046_367_1499_5595_5594_5599_5914_1387_6256_595_5601_836_7704_6774_2885_6772_3091_5970_7428_1870_1871_7157_6688_2113_4609_1869_3725_5604_862_6502_2353_4087_4088_4089_3066_3065_1050_5925_2034_2033_4846_207_9915 45 9.42E-35 6.50E-33 6.50E-33 1095 hsa-mir-1183 hsa05220 Chronic myeloid leukemia 7046_5595_5594_595_2885_5970_1870_1871_7157_4609_1869_5604_4088_4089_3066_3065_5925_207_6464 19 1.04E-19 7.17E-18 3.58E-18 1096 hsa-mir-1183 hsa04010 MAPK signaling pathway 6722_7046_5595_5594_5599_4208_5601_5600_836_7867_3312_1432_2885_5970_9261_9344_7157_468_4609_3725_3727_5604_5606_2353_4763_207_2005 27 5.72E-18 3.95E-16 1.32E-16 1097 hsa-mir-1183 hsa05210 Colorectal cancer 7046_1499_5595_5594_5599_595_5601_836_2885_7157_4609_3725_5604_2353_4087_4088_4089_207 18 1.28E-17 8.83E-16 2.21E-16 1098 hsa-mir-1183 hsa05215 Prostate cancer 367_1499_5595_5594_1387_595_2885_5970_1870_1871_7157_468_1869_5604_5925_2033_207 17 4.73E-16 3.26E-14 6.42E-15 1099 hsa-mir-1183 hsa05212 Pancreatic cancer 367_1499_5595_5594_1387_595_2885_5970_1870_1871_7157_468_1869_5604_5925_2033_207 17 5.58E-16 3.85E-14 6.42E-15 1100 hsa-mir-1183 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_6774_2885_5970_6688_4609_5604_862_1050_207 15 7.58E-16 5.23E-14 7.47E-15 1101 hsa-mir-1183 hsa05214 Glioma 5595_5594_595_2885_1870_1871_7157_1869_5604_5925_207_6464_808_801_805 15 2.61E-15 1.80E-13 2.25E-14 1102 hsa-mir-1183 hsa04110 Cell cycle 5591_1387_595_1870_1871_7157_1869_6502_4087_4088_4089_3066_3065_5925_2033_5933 16 5.32E-13 3.67E-11 4.08E-12 1103 hsa-mir-1183 hsa04350 TGF-beta signaling pathway 7046_5595_5594_1387_3397_3398_4609_3399_4087_4088_4089_2033_4093_5933 14 1.74E-12 1.20E-10 1.20E-11 1104 hsa-mir-1183 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_2885_1870_1871_7157_1869_5604_5925_207 12 2.44E-12 1.69E-10 1.53E-11 1105 hsa-mir-1183 hsa05211 Renal cell carcinoma 5595_5594_1387_2885_3091_7428_2113_3725_5604_2034_2033_207_9915 13 3.00E-12 2.07E-10 1.72E-11 1106 hsa-mir-1183 hsa05222 Small cell lung cancer 9063_6256_595_5970_1870_1871_7157_4609_1869_6502_5925_4846_207 13 2.21E-11 1.53E-09 1.18E-10 1107 hsa-mir-1183 hsa04912 GnRH signaling pathway 5595_5594_5599_5601_5600_1432_2885_468_3725_5604_5606_808_801_805 14 2.40E-11 1.66E-09 1.19E-10 1108 hsa-mir-1183 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5604_5925 10 9.40E-11 6.49E-09 4.33E-10 1109 hsa-mir-1183 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5601_5600_1432_6772_5970_3725_5604_5606_2353_207 13 1.52E-10 1.05E-08 6.54E-10 1110 hsa-mir-1183 hsa04520 Adherens junction 4301_7046_1499_5595_5594_1387_1457_4087_4088_4089_2033 11 1.94E-09 1.34E-07 7.87E-09 1111 hsa-mir-1183 hsa05216 Thyroid cancer 1499_5595_5594_6256_595_7157_4609_5604 8 2.73E-09 1.89E-07 1.05E-08 1112 hsa-mir-1183 hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5604_5925_207 10 8.65E-09 5.97E-07 3.14E-08 1113 hsa-mir-1183 hsa05213 Endometrial cancer 1499_5595_5594_595_2885_7157_4609_5604_207 9 9.76E-09 6.73E-07 3.37E-08 1114 hsa-mir-1183 hsa04310 Wnt signaling pathway 1499_5599_1387_595_5601_7157_4609_3725_1457_4087_4088_4089_2033 13 1.32E-08 9.11E-07 4.34E-08 1115 hsa-mir-1183 hsa04720 Long-term potentiation 5595_5594_1387_2902_468_5604_2033_808_801_805 10 1.39E-08 9.60E-07 4.36E-08 1116 hsa-mir-1183 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5601_5600_1432_2885_5604_5606_207 10 2.18E-08 1.51E-06 6.55E-08 1117 hsa-mir-1183 hsa04660 T cell receptor signaling pathway 5595_5594_5601_5600_1432_2885_5970_3725_5604_2353_207 11 4.01E-08 2.77E-06 1.12E-07 1118 hsa-mir-1183 hsa04910 Insulin signaling pathway 6720_5595_5594_5599_5601_2885_5604_207_6464_808_801_805 12 4.06E-08 2.80E-06 1.12E-07 1119 hsa-mir-1183 hsa04012 ErbB signaling pathway 5595_5594_5599_5601_2885_4609_3725_5604_207_6464 10 5.03E-08 3.47E-06 1.33E-07 1120 hsa-mir-1183 hsa04370 VEGF signaling pathway 5595_5594_5600_7867_1432_9261_5604_4846_207 9 2.08E-07 1.43E-05 5.31E-07 1121 hsa-mir-1183 hsa05010 Alzheimer's disease 22926_5595_5594_823_2902_836_9451_6622_4846_808_801_805 12 5.06E-07 3.49E-05 1.25E-06 1122 hsa-mir-1183 hsa04330 Notch signaling pathway 1387_388585_9612_3066_3065_2033_8850 7 1.10E-06 7.62E-05 2.63E-06 1123 hsa-mir-1183 hsa04662 B cell receptor signaling pathway 5595_5594_2885_5970_3725_5604_2353_207 8 1.88E-06 0.000129459 4.32E-06 1124 hsa-mir-1183 hsa04916 Melanogenesis 1499_5595_5594_1387_5604_2033_808_801_805 9 2.13E-06 0.000147209 4.75E-06 1125 hsa-mir-1183 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_5600_836_1432_7157_5606_4846 7 3.19E-06 0.000220447 6.89E-06 1126 hsa-mir-1183 hsa05016 Huntington's disease 6874_1387_2902_6908_836_7157_23186_3066_3065_3064_2033 11 5.79E-06 0.000399312 1.21E-05 1127 hsa-mir-1183 hsa04510 Focal adhesion 1499_5595_5594_5599_595_5601_2885_3725_5604_207_6464 11 1.31E-05 0.000904618 2.65E-05 1128 hsa-mir-1183 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5601_5600_836_1432_5970_3725 7 1.34E-05 0.000926314 2.65E-05 1129 hsa-mir-1183 hsa04630 Jak-STAT signaling pathway 9063_1387_595_6774_2885_6772_4609_2033_207 9 4.34E-05 0.002993425 8.32E-05 1130 hsa-mir-1183 hsa04920 Adipocytokine signaling pathway 5599_6256_5601_6774_5970_207 6 9.23E-05 0.006367094 0.000172084 1131 hsa-mir-1183 hsa04930 Type II diabetes mellitus 3651_5595_5594_5599_5601 5 0.00014175 0.009780733 0.000257388 1132 hsa-mir-1183 hsa04062 Chemokine signaling pathway 5595_5594_6774_2885_6772_5970_5604_207_6464 9 0.000212532 0.014664688 0.000376018 1133 hsa-mir-1183 hsa03022 Basal transcription factors 2963_6874_6908_2959 4 0.000741509 0.051164113 0.001279103 1134 hsa-mir-1183 hsa04270 Vascular smooth muscle contraction 5595_5594_5604_808_801_805 6 0.001584292 0.109316117 0.002666247 1135 hsa-mir-1183 hsa04150 mTOR signaling pathway 5595_5594_3091_207 4 0.00239186 0.165038357 0.003929485 1136 hsa-mir-1183 hsa04210 Apoptosis 823_836_5970_7157_207 5 0.002570464 0.177362019 0.004124698 1137 hsa-mir-1183 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_2885_5604_6464 6 0.00335174 0.231270037 0.005256137 1138 hsa-mir-1183 hsa04120 Ubiquitin mediated proteolysis 5371_9063_672_7428_6502_7329 6 0.003467729 0.239273333 0.005317185 1139 hsa-mir-1183 hsa04730 Long-term depression 5595_5594_5604_4846 4 0.006828971 0.471199029 0.010243457 1140 hsa-mir-1183 hsa04540 Gap junction 5595_5594_2885_5604 4 0.016429125 1 0.024119353 1141 hsa-mir-1183 hsa04950 Maturity onset diabetes of the young 3651_168620 2 0.027654981 1 0.039754035 1142 hsa-mir-1183 hsa04115 p53 signaling pathway 595_836_7157 3 0.03560738 1 0.050141005 1143 hsa-mir-1183 hsa04670 Leukocyte transendothelial migration 4301_1499_5600_1432 4 0.038029944 1 0.052481323 1144 hsa-mir-1183 hsa04020 Calcium signaling pathway 2902_4846_808_801_805 5 0.041882342 1 0.056664345 1145 hsa-mir-1183 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.04489832 1 0.059576617 1146 hsa-mir-1185-1 hsa04630 Jak-STAT signaling pathway 3717_3716_3718_867_2057_3575_5781_2033_85480_8554_3560_3561_6774_6777_6772_2690 16 1.11E-21 6.99E-20 6.99E-20 1147 hsa-mir-1185-1 hsa05200 Pathways in cancer 5159_3716_867_1399_1398_2033_3815_675_1956_8554_5156_3320_5595_5594_6774_6777_6772 17 3.84E-18 2.42E-16 1.21E-16 1148 hsa-mir-1185-1 hsa04012 ErbB signaling pathway 867_1399_1398_1956_6714_5595_5594_6777_6464_2066 10 2.56E-14 1.61E-12 5.38E-13 1149 hsa-mir-1185-1 hsa04062 Chemokine signaling pathway 3717_3718_1399_1398_1234_5595_5594_6774_6777_6464_6772 11 1.63E-12 1.03E-10 2.57E-11 1150 hsa-mir-1185-1 hsa05220 Chronic myeloid leukemia 867_5781_1399_1398_5595_5594_6777_6464 8 1.96E-11 1.23E-09 2.47E-10 1151 hsa-mir-1185-1 hsa04520 Adherens junction 71_2033_1956_5770_6714_3643_5595_5594 8 3.16E-11 1.99E-09 3.32E-10 1152 hsa-mir-1185-1 hsa04060 Cytokine-cytokine receptor interaction 5159_2057_3575_1234_85480_3815_1956_5156_3560_3561_2690 11 3.80E-11 2.40E-09 3.42E-10 1153 hsa-mir-1185-1 hsa04510 Focal adhesion 5159_1399_1398_71_1956_6714_5156_5595_5594_6464 10 8.09E-11 5.09E-09 6.37E-10 1154 hsa-mir-1185-1 hsa04910 Insulin signaling pathway 867_1399_1398_5770_3643_5595_5594_6464 8 1.86E-09 1.17E-07 1.30E-08 1155 hsa-mir-1185-1 hsa05215 Prostate cancer 5159_2033_1956_5156_3320_5595_5594 7 2.56E-09 1.61E-07 1.58E-08 1156 hsa-mir-1185-1 hsa05212 Pancreatic cancer 5159_2033_1956_5156_3320_5595_5594 7 2.75E-09 1.73E-07 1.58E-08 1157 hsa-mir-1185-1 hsa05214 Glioma 5159_1956_5156_5595_5594_6464 6 1.63E-08 1.02E-06 8.53E-08 1158 hsa-mir-1185-1 hsa05211 Renal cell carcinoma 5781_1399_1398_2033_5595_5594 6 2.88E-08 1.81E-06 1.39E-07 1159 hsa-mir-1185-1 hsa05340 Primary immunodeficiency 3718_695_3575_3932_3561 5 3.65E-08 2.30E-06 1.64E-07 1160 hsa-mir-1185-1 hsa04650 Natural killer cell mediated cytotoxicity 6850_919_5781_3932_5595_5594_6464 7 4.87E-08 3.07E-06 2.05E-07 1161 hsa-mir-1185-1 hsa04810 Regulation of actin cytoskeleton 5159_1399_1398_71_1956_5156_5595_5594 8 5.88E-08 3.71E-06 2.32E-07 1162 hsa-mir-1185-1 hsa04540 Gap junction 5159_1956_6714_5156_5595_5594 6 1.21E-07 7.61E-06 4.48E-07 1163 hsa-mir-1185-1 hsa04660 T cell receptor signaling pathway 867_919_3932_5595_5594_1493 6 3.10E-07 1.95E-05 1.09E-06 1164 hsa-mir-1185-1 hsa05221 Acute myeloid leukemia 3815_5595_5594_6774_6777 5 4.05E-07 2.55E-05 1.34E-06 1165 hsa-mir-1185-1 hsa05218 Melanoma 5159_1956_5156_5595_5594 5 9.61E-07 6.05E-05 3.03E-06 1166 hsa-mir-1185-1 hsa05210 Colorectal cancer 5159_1956_5156_5595_5594 5 2.11E-06 0.000132831 6.33E-06 1167 hsa-mir-1185-1 hsa04010 MAPK signaling pathway 5159_1399_1398_1956_5156_5595_5594 7 4.09E-06 0.000257719 1.17E-05 1168 hsa-mir-1185-1 hsa04662 B cell receptor signaling pathway 6850_695_5595_5594 4 3.55E-05 0.002234016 9.71E-05 1169 hsa-mir-1185-1 hsa04664 Fc epsilon RI signaling pathway 6850_695_5595_5594 4 4.31E-05 0.002713219 0.000113051 1170 hsa-mir-1185-1 hsa04350 TGF-beta signaling pathway 2033_5595_5594_5515 4 6.18E-05 0.003891271 0.000155651 1171 hsa-mir-1185-1 hsa04916 Melanogenesis 2033_3815_5595_5594 4 0.00012022 0.00757389 0.000291303 1172 hsa-mir-1185-1 hsa04912 GnRH signaling pathway 1956_6714_5595_5594 4 0.000138356 0.008716426 0.000322831 1173 hsa-mir-1185-1 hsa05219 Bladder cancer 1956_5595_5594 3 0.000159818 0.010068521 0.00035959 1174 hsa-mir-1185-1 hsa04930 Type II diabetes mellitus 3643_5595_5594 3 0.000193828 0.012211183 0.000421075 1175 hsa-mir-1185-1 hsa05213 Endometrial cancer 1956_5595_5594 3 0.000290595 0.018307507 0.00061025 1176 hsa-mir-1185-1 hsa05223 Non-small cell lung cancer 1956_5595_5594 3 0.000323025 0.020350553 0.000656469 1177 hsa-mir-1185-1 hsa04920 Adipocytokine signaling pathway 3717_5781_6774 3 0.000591387 0.037257373 0.001164293 1178 hsa-mir-1185-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5781_1956_6714 3 0.000695688 0.043828323 0.001289068 1179 hsa-mir-1185-1 hsa04730 Long-term depression 5595_5594_5515 3 0.000695688 0.043828323 0.001289068 1180 hsa-mir-1185-1 hsa04720 Long-term potentiation 2033_5595_5594 3 0.000811033 0.051095107 0.00145986 1181 hsa-mir-1185-1 hsa04370 VEGF signaling pathway 6714_5595_5594 3 0.000872988 0.054998238 0.001527729 1182 hsa-mir-1185-1 hsa04020 Calcium signaling pathway 5159_1956_5156_2066 4 0.000983367 0.061952117 0.001674382 1183 hsa-mir-1185-1 hsa04640 Hematopoietic cell lineage 2057_3575_3815 3 0.001227719 0.077346324 0.00203543 1184 hsa-mir-1185-1 hsa03010 Ribosome 6143_6124_6129 3 0.001910896 0.120386474 0.003009662 1185 hsa-mir-1185-1 hsa04620 Toll-like receptor signaling pathway 5595_5594_6772 3 0.001910896 0.120386474 0.003009662 1186 hsa-mir-1185-1 hsa05216 Thyroid cancer 5595_5594 2 0.002377872 0.149805923 0.003653803 1187 hsa-mir-1185-1 hsa04530 Tight junction 71_6714_5515 3 0.004305678 0.271257715 0.006458517 1188 hsa-mir-1185-1 hsa04120 Ubiquitin mediated proteolysis 867_672_8554 3 0.004479402 0.282202309 0.006562844 1189 hsa-mir-1185-1 hsa04330 Notch signaling pathway 9612_2033 2 0.005853572 0.368775043 0.008381251 1190 hsa-mir-1185-1 hsa04150 mTOR signaling pathway 5595_5594 2 0.007069741 0.445393699 0.009897638 1191 hsa-mir-1185-1 hsa05010 Alzheimer's disease 4724_5595_5594 3 0.008608245 0.54231944 0.011789553 1192 hsa-mir-1185-1 hsa04612 Antigen processing and presentation 3308_3320 2 0.019145003 1 0.02566245 1193 hsa-mir-1185-1 hsa04270 Vascular smooth muscle contraction 5595_5594 2 0.031976091 1 0.041968619 1194 hsa-mir-1185-1 hsa04670 Leukocyte transendothelial migration 5781_71 2 0.03395124 1 0.043651594 1195 hsa-mir-1185-1 hsa04360 Axon guidance 5595_5594 2 0.038564023 1 0.048590668 1196 hsa-mir-1193 hsa04110 Cell cycle 4088_4089_1870_1871_7157_1017_890_1869_5934_5933 10 3.46E-16 1.21E-14 1.21E-14 1197 hsa-mir-1193 hsa05200 Pathways in cancer 4088_4089_1870_1871_1050_4149_7157_1017_8554_1869_3320 11 1.71E-13 5.98E-12 2.99E-12 1198 hsa-mir-1193 hsa05222 Small cell lung cancer 1870_1871_4149_7157_1017_8554_1869 7 1.68E-11 5.89E-10 1.96E-10 1199 hsa-mir-1193 hsa05220 Chronic myeloid leukemia 4088_4089_1870_1871_7157_1869 6 5.82E-10 2.04E-08 5.09E-09 1200 hsa-mir-1193 hsa04350 TGF-beta signaling pathway 4088_4089_1874_1875_5934_5933 6 1.35E-09 4.73E-08 7.69E-09 1201 hsa-mir-1193 hsa05215 Prostate cancer 1870_1871_7157_1017_1869_3320 6 1.44E-09 5.05E-08 7.69E-09 1202 hsa-mir-1193 hsa05212 Pancreatic cancer 1870_1871_7157_1017_1869_3320 6 1.54E-09 5.39E-08 7.69E-09 1203 hsa-mir-1193 hsa05219 Bladder cancer 1870_1871_7157_1869 4 2.74E-07 9.57E-06 1.20E-06 1204 hsa-mir-1193 hsa05223 Non-small cell lung cancer 1870_1871_7157_1869 4 7.04E-07 2.46E-05 2.74E-06 1205 hsa-mir-1193 hsa05214 Glioma 1870_1871_7157_1869 4 1.42E-06 4.97E-05 4.97E-06 1206 hsa-mir-1193 hsa05218 Melanoma 1870_1871_7157_1869 4 1.99E-06 6.96E-05 6.32E-06 1207 hsa-mir-1193 hsa04520 Adherens junction 4088_4089_71 3 0.000136013 0.004760462 0.000396705 1208 hsa-mir-1193 hsa05210 Colorectal cancer 4088_4089_7157 3 0.000156391 0.005473687 0.000421053 1209 hsa-mir-1193 hsa04310 Wnt signaling pathway 4088_4089_7157 3 0.00084929 0.029725142 0.002123224 1210 hsa-mir-1193 hsa04115 p53 signaling pathway 7157_1017 2 0.003295012 0.115325403 0.00768836 1211 hsa-mir-1193 hsa04612 Antigen processing and presentation 3308_3320 2 0.005348882 0.187210854 0.011700678 1212 hsa-mir-1193 hsa05216 Thyroid cancer 7157 1 0.035355663 1 0.07279107 1213 hsa-mir-1193 hsa04010 MAPK signaling pathway 4149_7157 2 0.042905558 1 0.083427474 1214 hsa-mir-1197 hsa05200 Pathways in cancer 1499_5914_6934_7704_6502_3091_3065_5925_7046_1956_4824_2113_861_862_867_207_3716_5595_5594_5599_6258_1387_6256_836_367_25_2932_6774_6776_6772_5970_7157_6688_2736_4087_4088_4089_2033_4790_4792_3320_5371_5159_5156_5601_5602_1399_1398_3815_3265_842_841_2353_3326_8554 55 7.00E-36 5.32E-34 5.32E-34 1215 hsa-mir-1197 hsa04010 MAPK signaling pathway 6722_6197_9252_7867_4773_7046_8986_1956_3303_1432_207_22800_5595_5594_5599_1386_836_3312_1649_5970_7157_468_3727_6195_6196_4790_5159_9261_5156_4208_5601_5600_5602_1399_1398_3265_2353_8550_2002_2005 40 1.58E-24 1.20E-22 5.99E-23 1216 hsa-mir-1197 hsa05215 Prostate cancer 1499_6934_5925_1956_4824_9586_207_5595_5594_1385_1387_367_2932_5970_7157_468_2033_4790_4792_3320_5159_5156_3265_842_3326 25 8.95E-22 6.80E-20 2.15E-20 1217 hsa-mir-1197 hsa05212 Pancreatic cancer 1499_6934_5925_1956_4824_9586_207_5595_5594_1385_1387_367_2932_5970_7157_468_2033_4790_4792_3320_5159_5156_3265_842_3326 25 1.13E-21 8.59E-20 2.15E-20 1218 hsa-mir-1197 hsa05220 Chronic myeloid leukemia 3065_5925_7046_861_867_207_5595_5594_25_6776_5970_7157_4088_4089_4790_4792_1399_1398_3265_5781_6464 21 2.17E-18 1.65E-16 3.30E-17 1219 hsa-mir-1197 hsa05210 Colorectal cancer 1499_6934_7046_1956_207_5595_5594_5599_836_2932_7157_4087_4088_4089_5159_5156_5601_5602_842_2353 20 2.07E-16 1.58E-14 2.63E-15 1220 hsa-mir-1197 hsa04012 ErbB signaling pathway 815_1956_6714_867_207_5595_5594_5599_2066_25_2932_6776_5601_5602_1399_1398_3265_6464_2002 19 4.61E-15 3.51E-13 5.01E-14 1221 hsa-mir-1197 hsa05221 Acute myeloid leukemia 5914_6934_7704_861_862_207_5595_5594_6774_6776_5970_6688_4790_5371_3815_3265 16 3.82E-14 2.91E-12 3.63E-13 1222 hsa-mir-1197 hsa04520 Adherens junction 1499_6934_5770_5777_7046_1956_6714_4301_5595_5594_1387_1457_4087_4088_4089_2033_3643 17 1.89E-13 1.44E-11 1.60E-12 1223 hsa-mir-1197 hsa04630 Jak-STAT signaling pathway 3717_3559_5777_3560_3566_2057_867_2690_207_3716_1387_3575_6774_6775_6776_6772_6773_2033_5781_8554 20 5.63E-12 4.28E-10 4.28E-11 1224 hsa-mir-1197 hsa04910 Insulin signaling pathway 5770_867_207_5590_5595_5594_5599_2932_808_801_805_3643_5601_5602_1399_1398_3265_6464_2002 19 6.90E-12 5.24E-10 4.77E-11 1225 hsa-mir-1197 hsa04720 Long-term potentiation 815_6197_2902_2906_5595_5594_1387_468_6195_6196_2033_808_801_805_3265 15 1.07E-11 8.15E-10 6.80E-11 1226 hsa-mir-1197 hsa04660 T cell receptor signaling pathway 1493_5777_4773_1432_867_207_5595_5594_2932_5970_4790_4792_5601_5600_919_3265_2353 17 1.73E-11 1.32E-09 1.01E-10 1227 hsa-mir-1197 hsa05214 Glioma 815_5925_1956_207_5595_5594_7157_808_801_805_5159_5156_3265_6464 14 2.21E-11 1.68E-09 1.20E-10 1228 hsa-mir-1197 hsa04110 Cell cycle 6502_3065_5925_993_7534_5591_1387_7531_7533_25_2932_7157_4087_4088_4089_2033_983 17 5.28E-11 4.01E-09 2.67E-10 1229 hsa-mir-1197 hsa04912 GnRH signaling pathway 815_1956_6714_1432_5595_5594_5599_468_808_801_805_5601_5600_5602_3265_2002 16 1.20E-10 9.14E-09 5.71E-10 1230 hsa-mir-1197 hsa04310 Wnt signaling pathway 815_1499_6934_4773_5599_1387_2932_7157_8061_1457_4087_4088_4089_2033_5515_5601_5602 17 1.63E-09 1.24E-07 7.28E-09 1231 hsa-mir-1197 hsa03022 Basal transcription factors 6879_2963_2962_2969_6872_6908_2958_2959_6880_9519 10 2.53E-09 1.92E-07 1.07E-08 1232 hsa-mir-1197 hsa05213 Endometrial cancer 1499_6934_1956_207_5595_5594_2932_7157_3265_842_2002 11 3.72E-09 2.83E-07 1.45E-08 1233 hsa-mir-1197 hsa04920 Adipocytokine signaling pathway 3717_207_5599_6258_6256_6774_5970_4790_4792_5601_5602_5781 12 3.82E-09 2.90E-07 1.45E-08 1234 hsa-mir-1197 hsa04620 Toll-like receptor signaling pathway 1432_207_5595_5594_5599_6772_5970_4790_4792_5601_5600_5602_841_2353 14 4.25E-09 3.23E-07 1.54E-08 1235 hsa-mir-1197 hsa04916 Melanogenesis 815_1499_6934_5595_5594_1385_1387_2932_2033_808_801_805_3815_3265 14 5.32E-09 4.04E-07 1.84E-08 1236 hsa-mir-1197 hsa04350 TGF-beta signaling pathway 6667_3397_7046_3399_3398_5595_5594_1387_4087_4088_4089_2033_5515 13 6.08E-09 4.62E-07 2.01E-08 1237 hsa-mir-1197 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_1432_5599_836_5970_4790_4792_5601_5600_5602_5781 12 6.83E-09 5.19E-07 2.16E-08 1238 hsa-mir-1197 hsa04062 Chemokine signaling pathway 3717_7852_207_5590_5595_5594_2932_2931_6774_6772_6773_5970_4790_4792_1399_1398_3265_6464 18 7.58E-09 5.76E-07 2.31E-08 1239 hsa-mir-1197 hsa05223 Non-small cell lung cancer 5925_1956_207_5595_5594_6258_6256_7157_3265_842 10 5.82E-08 4.43E-06 1.70E-07 1240 hsa-mir-1197 hsa05211 Renal cell carcinoma 3091_2113_207_5595_5594_1387_2033_1399_1398_3265_5781 11 7.36E-08 5.59E-06 2.07E-07 1241 hsa-mir-1197 hsa05216 Thyroid cancer 1499_6934_5595_5594_6258_6256_7157_3265 8 8.94E-08 6.80E-06 2.43E-07 1242 hsa-mir-1197 hsa04510 Focal adhesion 1499_1956_6714_207_5595_5594_5599_2932_5159_5156_5601_5602_1399_1398_3265_6464_2002 17 1.03E-07 7.82E-06 2.70E-07 1243 hsa-mir-1197 hsa04662 B cell receptor signaling pathway 5777_4773_207_5595_5594_2932_5970_4790_4792_3265_2353 11 1.07E-07 8.13E-06 2.71E-07 1244 hsa-mir-1197 hsa04370 VEGF signaling pathway 7867_4773_6714_1432_207_5595_5594_9261_5600_3265_842 11 1.36E-07 1.03E-05 3.34E-07 1245 hsa-mir-1197 hsa05222 Small cell lung cancer 6502_5925_207_6258_6256_5970_7157_4790_4792_842_8554 11 3.73E-07 2.83E-05 8.85E-07 1246 hsa-mir-1197 hsa04930 Type II diabetes mellitus 3651_5590_5595_5594_5599_3643_5601_5602 8 1.65E-06 0.00012527 3.80E-06 1247 hsa-mir-1197 hsa05010 Alzheimer's disease 2902_2906_22926_5595_5594_836_2932_808_351_801_805_842_841_840 14 2.19E-06 0.000166067 4.88E-06 1248 hsa-mir-1197 hsa04210 Apoptosis 207_836_839_5970_7157_4790_4792_842_841_840 10 3.67E-06 0.000279265 7.98E-06 1249 hsa-mir-1197 hsa05016 Huntington's disease 6667_3065_3064_2902_9586_1385_1387_836_7157_2033_6908_842_841_9519 14 4.21E-06 0.000319679 8.88E-06 1250 hsa-mir-1197 hsa05218 Melanoma 5925_1956_207_5595_5594_7157_5159_5156_3265 9 4.61E-06 0.000350232 9.47E-06 1251 hsa-mir-1197 hsa04664 Fc epsilon RI signaling pathway 1432_207_5595_5594_5599_5601_5600_5602_3265 9 1.02E-05 0.000772577 2.03E-05 1252 hsa-mir-1197 hsa05219 Bladder cancer 9252_5925_1956_5595_5594_7157_3265 7 1.09E-05 0.000825371 2.12E-05 1253 hsa-mir-1197 hsa04530 Tight junction 1499_6714_8573_8189_207_22800_4301_5590_1457_5515_3265 11 2.34E-05 0.001778785 4.45E-05 1254 hsa-mir-1197 hsa04540 Gap junction 1956_6714_5592_5595_5594_5159_983_5156_3265 9 3.36E-05 0.002553042 6.23E-05 1255 hsa-mir-1197 hsa04150 mTOR signaling pathway 6197_3091_207_5595_5594_6195_6196 7 3.77E-05 0.00286428 6.82E-05 1256 hsa-mir-1197 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906_1432_836_7157_5600_842 7 5.79E-05 0.004401612 0.000102363 1257 hsa-mir-1197 hsa04120 Ubiquitin mediated proteolysis 55294_6502_867_10273_7329_83737_64326_5371_672_8554 10 0.00012852 0.009767509 0.000221989 1258 hsa-mir-1197 hsa04330 Notch signaling pathway 3065_388585_1387_9612_2033_8850 6 0.000177398 0.013482211 0.000299605 1259 hsa-mir-1197 hsa04650 Natural killer cell mediated cytotoxicity 5777_4773_5595_5594_836_919_3265_5781_6464 9 0.000543872 0.041334292 0.000898572 1260 hsa-mir-1197 hsa04612 Antigen processing and presentation 3303_1385_3312_1514_3320_4800_3326 7 0.000801509 0.060914657 0.001296057 1261 hsa-mir-1197 hsa04020 Calcium signaling pathway 815_1956_2902_2906_2066_808_801_805_5159_5156 10 0.00103959 0.079008858 0.001646018 1262 hsa-mir-1197 hsa04115 p53 signaling pathway 836_7157_64326_983_842_841 6 0.001164975 0.088538104 0.0018069 1263 hsa-mir-1197 hsa04060 Cytokine-cytokine receptor interaction 3559_7046_1956_3560_3566_7852_2057_2690_3575_5159_5156_3815 12 0.001410902 0.107228585 0.002144572 1264 hsa-mir-1197 hsa03450 Non-homologous end-joining 2547_7520_5591 3 0.002213151 0.168199507 0.00329803 1265 hsa-mir-1197 hsa05217 Basal cell carcinoma 1499_6934_2932_7157_2736 5 0.00249834 0.189873837 0.00365142 1266 hsa-mir-1197 hsa04360 Axon guidance 4773_7852_5595_5594_25_2932_3265 7 0.006235997 0.473935786 0.008942185 1267 hsa-mir-1197 hsa04730 Long-term depression 5592_5595_5594_5515_3265 5 0.006896244 0.52411458 0.009705826 1268 hsa-mir-1197 hsa04950 Maturity onset diabetes of the young 3087_3651_168620 3 0.008478193 0.644342669 0.011715321 1269 hsa-mir-1197 hsa04810 Regulation of actin cytoskeleton 1956_22800_5595_5594_5159_5156_1399_1398_3265 9 0.01028338 0.781536875 0.013956016 1270 hsa-mir-1197 hsa04270 Vascular smooth muscle contraction 5592_5595_5594_808_801_805 6 0.013661069 1 0.018214758 1271 hsa-mir-1197 hsa04640 Hematopoietic cell lineage 3559_3566_2057_3575_3815 5 0.015000521 1 0.019655855 1272 hsa-mir-1197 hsa04670 Leukocyte transendothelial migration 1499_1432_7852_4301_5600_5781 6 0.015758836 1 0.020299517 1273 hsa-mir-1-2 hsa05200 Pathways in cancer 2353_6777_5925_1387_2249_367_3725_6776_5914_5970_6256 11 6.25E-11 3.00E-09 3.00E-09 1274 hsa-mir-1-2 hsa05221 Acute myeloid leukemia 6777_6776_5914_5970 4 7.31E-06 0.000350972 0.000175486 1275 hsa-mir-1-2 hsa05220 Chronic myeloid leukemia 6777_5925_6776_5970 4 1.80E-05 0.000864824 0.000288275 1276 hsa-mir-1-2 hsa05215 Prostate cancer 5925_1387_367_5970 4 3.29E-05 0.001578029 0.000329309 1277 hsa-mir-1-2 hsa05212 Pancreatic cancer 5925_1387_367_5970 4 3.43E-05 0.001646545 0.000329309 1278 hsa-mir-1-2 hsa04110 Cell cycle 5925_1387_993_983 4 0.000102092 0.004900397 0.000816733 1279 hsa-mir-1-2 hsa04330 Notch signaling pathway 9612_1387_8850 3 0.000131835 0.006328093 0.000904013 1280 hsa-mir-1-2 hsa04630 Jak-STAT signaling pathway 6777_1387_3977_6776 4 0.000273553 0.013130544 0.001641318 1281 hsa-mir-1-2 hsa04662 B cell receptor signaling pathway 2353_3725_5970 3 0.00049214 0.023622717 0.002624746 1282 hsa-mir-1-2 hsa05222 Small cell lung cancer 5925_5970_6256 3 0.000723499 0.03472794 0.003261414 1283 hsa-mir-1-2 hsa04012 ErbB signaling pathway 6777_3725_6776 3 0.000747407 0.035875549 0.003261414 1284 hsa-mir-1-2 hsa04620 Toll-like receptor signaling pathway 2353_3725_5970 3 0.001168022 0.056065076 0.00467209 1285 hsa-mir-1-2 hsa04660 T cell receptor signaling pathway 2353_3725_5970 3 0.001442738 0.069251446 0.005327034 1286 hsa-mir-1-2 hsa04010 MAPK signaling pathway 2353_2249_3725_5970 4 0.002157438 0.103557025 0.00739693 1287 hsa-mir-1-2 hsa03410 Base excision repair 3146_142 2 0.0025443 0.122126405 0.00814176 1288 hsa-mir-1-2 hsa05223 Non-small cell lung cancer 5925_6256 2 0.005448834 0.261544045 0.016346503 1289 hsa-mir-1-2 hsa05016 Huntington's disease 1387_6667_6908 3 0.006323217 0.303514414 0.017853789 1290 hsa-mir-1-2 hsa04920 Adipocytokine signaling pathway 5970_6256 2 0.008166321 0.391983398 0.021356179 1291 hsa-mir-1-2 hsa05218 Melanoma 5925_2249 2 0.009102203 0.436905745 0.021356179 1292 hsa-mir-1-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5970 2 0.009102203 0.436905745 0.021356179 1293 hsa-mir-1-2 hsa05211 Renal cell carcinoma 1387_3725 2 0.009343328 0.448479761 0.021356179 1294 hsa-mir-1-2 hsa05210 Colorectal cancer 2353_3725 2 0.012454915 0.597835905 0.027174359 1295 hsa-mir-1-2 hsa04350 TGF-beta signaling pathway 1387_6667 2 0.013294342 0.638128422 0.027734626 1296 hsa-mir-1-2 hsa04612 Antigen processing and presentation 4800_1514 2 0.013867313 0.66563102 0.027734626 1297 hsa-mir-1-2 hsa03450 Non-homologous end-joining 2547 1 0.029047666 1 0.055771519 1298 hsa-mir-1-2 hsa04310 Wnt signaling pathway 1387_3725 2 0.036887239 1 0.068099519 1299 hsa-mir-1-2 hsa04950 Maturity onset diabetes of the young 6927 1 0.047950283 1 0.085244947 1300 hsa-mir-1200 hsa05200 Pathways in cancer 3725_7046_1499_5914_595_3815_2261_4193_7704_6502_3066_3065_1050_5925_5747_25_1956_1487_4824_2113_10401_5894_862_207_3716_2249_4233_5595_5594_5599_6258_1387_2064_6256_836_367_6774_6776_6777_6772_5979_5970_7157_4087_4088_4089_2033_4790_4791_4792_5879_3320_3326_5371_3480_5159_5156_842_841_8772_4609_1026_2353_1488_1441_8554 66 2.82E-45 2.29E-43 2.29E-43 1301 hsa-mir-1200 hsa04630 Jak-STAT signaling pathway 3559_595_5777_58985_3454_3455_3459_3460_3560_3561_3566_1439_10401_2690_3977_207_3717_3716_3718_85480_1387_3575_3570_3572_6774_6776_6777_6772_6773_7297_2033_149233_3953_5781_4609_1441_8554_10379 38 2.96E-29 2.39E-27 1.20E-27 1302 hsa-mir-1200 hsa05215 Prostate cancer 1499_595_4193_5925_1956_4824_5894_207_5595_5594_1385_1387_2064_367_5970_7157_10488_2033_4790_4792_3320_3326_3480_5159_5156_842_1026 27 2.68E-23 2.17E-21 6.97E-22 1303 hsa-mir-1200 hsa05212 Pancreatic cancer 1499_595_4193_5925_1956_4824_5894_207_5595_5594_1385_1387_2064_367_5970_7157_10488_2033_4790_4792_3320_3326_3480_5159_5156_842_1026 27 3.44E-23 2.79E-21 6.97E-22 1304 hsa-mir-1200 hsa04010 MAPK signaling pathway 3925_6722_3725_7046_2261_2264_7867_1845_5536_1956_7132_3303_1432_5894_207_2249_5595_5594_5599_836_9252_5970_7157_6195_4790_4791_51701_5879_5159_9261_5156_4208_5566_6885_4609_2353_2002_2005 38 1.67E-21 1.36E-19 2.71E-20 1305 hsa-mir-1200 hsa05220 Chronic myeloid leukemia 7046_595_4193_3066_3065_5925_25_1487_5894_207_5595_5594_6776_6777_5970_7157_4088_4089_4790_4792_5781_4609_1026_1488 24 3.29E-21 2.66E-19 4.44E-20 1306 hsa-mir-1200 hsa04060 Cytokine-cytokine receptor interaction 3556_3559_7046_3815_1234_58985_3454_3455_3459_90_3460_3791_1956_3560_3561_3566_7133_7132_1439_7852_659_2690_3977_85480_4233_1230_3575_3570_3572_2321_149233_5159_5156_3953_1441 35 2.20E-19 1.79E-17 2.55E-18 1307 hsa-mir-1200 hsa05210 Colorectal cancer 3725_7046_1499_595_1956_5894_207_4233_5595_5594_5599_836_7157_4087_4088_4089_5879_3480_5159_5156_842_4609_2353 23 4.17E-19 3.38E-17 4.22E-18 1308 hsa-mir-1200 hsa04520 Adherens junction 7046_1499_5777_2534_1956_6714_2241_4233_5595_5594_1387_2064_1457_4087_4088_4089_2033_51701_5879_3480_6885 21 3.04E-17 2.46E-15 2.74E-16 1309 hsa-mir-1200 hsa05214 Glioma 818_815_817_595_4193_5925_1956_5894_207_5595_5594_7157_808_801_805_3480_5159_5156_1026 19 1.86E-16 1.51E-14 1.51E-15 1310 hsa-mir-1200 hsa05221 Acute myeloid leukemia 5914_595_3815_7704_1050_5894_862_207_5595_5594_6774_6776_6777_5970_4790_5371_4609 17 8.87E-15 7.18E-13 6.53E-14 1311 hsa-mir-1200 hsa04350 TGF-beta signaling pathway 6667_7046_90_3397_57154_3399_3398_659_3400_5595_5594_1387_4086_4087_4088_4089_2033_4609_4093 19 1.79E-14 1.45E-12 1.11E-13 1312 hsa-mir-1200 hsa04012 ErbB signaling pathway 3725_818_815_817_5747_25_1956_6714_5894_207_5595_5594_5599_2064_6776_6777_4609_1026_2002 19 1.79E-14 1.45E-12 1.11E-13 1313 hsa-mir-1200 hsa04620 Toll-like receptor signaling pathway 3725_3454_3455_1432_207_3654_5595_5594_5599_6772_5970_4790_4792_5879_841_8772_6885_2353 18 2.11E-12 1.71E-10 1.14E-11 1314 hsa-mir-1200 hsa04310 Wnt signaling pathway 3725_818_815_817_1499_595_1487_5599_1387_7157_1457_4087_4088_4089_2033_51701_5879_5566_6885_4609_1488 21 2.11E-12 1.71E-10 1.14E-11 1315 hsa-mir-1200 hsa04110 Cell cycle 595_4193_6502_4174_4172_3066_3065_5925_25_5591_1387_7533_7157_4087_4088_4089_2033_2810_1026 19 2.48E-12 2.01E-10 1.25E-11 1316 hsa-mir-1200 hsa04210 Apoptosis 3556_7132_1439_207_3654_8717_836_839_5970_7157_4790_4792_5566_842_841_840_8772 17 2.84E-12 2.30E-10 1.35E-11 1317 hsa-mir-1200 hsa04062 Chemokine signaling pathway 1234_5747_5580_7852_5894_207_3055_3717_3718_5590_5595_5594_1230_6774_6777_6772_6773_5970_4790_4792_5879_5566_2185 23 3.01E-12 2.43E-10 1.35E-11 1318 hsa-mir-1200 hsa04912 GnRH signaling pathway 3725_818_815_817_5580_1956_6714_1432_5894_5595_5594_5599_808_801_805_5566_2185_2002 18 4.95E-12 4.01E-10 2.11E-11 1319 hsa-mir-1200 hsa05219 Bladder cancer 595_2261_4193_5925_1956_5894_5595_5594_2064_9252_7157_4609_1026 13 6.04E-12 4.89E-10 2.45E-11 1320 hsa-mir-1200 hsa04920 Adipocytokine signaling pathway 10891_7133_7132_207_3717_8717_5599_6258_6256_6774_5970_4790_4792_3953_5781 15 7.61E-12 6.17E-10 2.94E-11 1321 hsa-mir-1200 hsa05218 Melanoma 595_4193_5925_1956_5894_207_2249_4233_5595_5594_7157_3480_5159_5156_1026 15 1.56E-11 1.27E-09 5.76E-11 1322 hsa-mir-1200 hsa05222 Small cell lung cancer 595_6502_5925_5747_10401_207_6258_6256_5970_7157_4790_4792_842_4609_8554 15 1.69E-10 1.37E-08 5.96E-10 1323 hsa-mir-1200 hsa04916 Melanogenesis 818_815_817_1499_3815_5894_5595_5594_1385_1387_10488_2033_808_801_805_5566 16 2.19E-10 1.77E-08 7.39E-10 1324 hsa-mir-1200 hsa04510 Focal adhesion 3725_1499_595_2534_5747_3791_1956_6714_5894_207_4233_5595_5594_5599_2064_5879_2321_3480_5159_5156_2002 21 3.73E-10 3.02E-08 1.21E-09 1325 hsa-mir-1200 hsa04660 T cell receptor signaling pathway 3725_5777_2534_3932_1432_5894_207_5595_5594_920_5970_4790_4792_915_6885_2353 16 4.59E-10 3.72E-08 1.43E-09 1326 hsa-mir-1200 hsa05213 Endometrial cancer 1499_595_1956_5894_207_5595_5594_2064_7157_842_4609_2002 12 7.12E-10 5.77E-08 2.14E-09 1327 hsa-mir-1200 hsa05223 Non-small cell lung cancer 595_5925_1956_5894_207_5595_5594_6258_2064_6256_7157_842 12 1.03E-09 8.38E-08 2.99E-09 1328 hsa-mir-1200 hsa04720 Long-term potentiation 818_815_817_5894_5595_5594_1387_6195_2033_808_801_805_5566 13 3.01E-09 2.44E-07 8.40E-09 1329 hsa-mir-1200 hsa05216 Thyroid cancer 1499_595_5595_5594_6258_6256_5979_7157_4609 9 1.11E-08 9.00E-07 3.00E-08 1330 hsa-mir-1200 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1956_6714_1432_4233_5599_836_5970_4790_4792_5879_5781 12 1.57E-08 1.27E-06 4.10E-08 1331 hsa-mir-1200 hsa04662 B cell receptor signaling pathway 3725_5777_6850_5894_207_5595_5594_5970_4790_4792_5879_2353 12 2.70E-08 2.19E-06 6.84E-08 1332 hsa-mir-1200 hsa04370 VEGF signaling pathway 7867_5747_3791_6714_1432_5894_207_5595_5594_5879_9261_842 12 3.51E-08 2.84E-06 8.61E-08 1333 hsa-mir-1200 hsa04330 Notch signaling pathway 3066_3065_1487_3280_1387_9612_2033_8850_388585_1488 10 3.71E-08 3.01E-06 8.84E-08 1334 hsa-mir-1200 hsa04650 Natural killer cell mediated cytotoxicity 5777_3454_3455_3459_3460_2534_3932_6850_5894_5595_5594_836_5879_5781_2185 15 5.65E-08 4.58E-06 1.31E-07 1335 hsa-mir-1200 hsa05016 Huntington's disease 6667_10891_291_3066_3065_3064_1385_1387_836_5481_7157_23186_10488_2033_6908_842_841 17 8.87E-08 7.19E-06 2.00E-07 1336 hsa-mir-1200 hsa05211 Renal cell carcinoma 3725_2113_5894_207_4233_5595_5594_1387_2033_5879_5781 11 1.57E-07 1.27E-05 3.43E-07 1337 hsa-mir-1200 hsa04020 Calcium signaling pathway 818_815_817_291_147_1956_2064_5481_808_801_805_5159_5156_5566_2185 15 1.70E-06 0.000137459 3.62E-06 1338 hsa-mir-1200 hsa04664 Fc epsilon RI signaling pathway 2534_5580_6850_1432_5894_207_5595_5594_5599_5879 10 2.70E-06 0.000218474 5.60E-06 1339 hsa-mir-1200 hsa05340 Primary immunodeficiency 3932_3561_3718_920_3575_100_915 7 6.13E-06 0.000496808 1.24E-05 1340 hsa-mir-1200 hsa04950 Maturity onset diabetes of the young 6927_3280_4760_3651_168620_3175 6 9.55E-06 0.000773484 1.89E-05 1341 hsa-mir-1200 hsa04910 Insulin signaling pathway 10891_5894_207_5590_5595_5594_5599_808_801_805_5566_2002 12 1.01E-05 0.000814572 1.94E-05 1342 hsa-mir-1200 hsa05010 Alzheimer's disease 22926_3416_7132_5595_5594_836_808_801_805_842_841_840_8772 13 2.33E-05 0.001889077 4.39E-05 1343 hsa-mir-1200 hsa04612 Antigen processing and presentation 811_3303_920_1385_3320_3326_4800_4801_2923 9 4.38E-05 0.003544287 8.06E-05 1344 hsa-mir-1200 hsa04115 p53 signaling pathway 595_4193_836_7157_842_841_2810_1026 8 4.79E-05 0.00388158 8.63E-05 1345 hsa-mir-1200 hsa05014 Amyotrophic lateral sclerosis (ALS) 7133_7132_1432_836_7157_5879_842 7 9.27E-05 0.007504714 0.000163146 1346 hsa-mir-1200 hsa04640 Hematopoietic cell lineage 3559_3815_3566_920_3575_3570_915_1441 8 0.000212443 0.017207906 0.000362056 1347 hsa-mir-1200 hsa04930 Type II diabetes mellitus 5580_3651_5590_5595_5594_5599 6 0.000214551 0.017378665 0.000362056 1348 hsa-mir-1200 hsa04270 Vascular smooth muscle contraction 147_5580_5894_5595_5594_808_801_805_5566 9 0.000320402 0.025952538 0.000524004 1349 hsa-mir-1200 hsa04540 Gap junction 1956_6714_5894_5595_5594_5159_5156_5566 8 0.000323459 0.02620019 0.000524004 1350 hsa-mir-1200 hsa04360 Axon guidance 2534_5747_25_7852_2242_4233_5595_5594_5879 9 0.000653214 0.052910364 0.001037458 1351 hsa-mir-1200 hsa04810 Regulation of actin cytoskeleton 2261_2264_5747_1956_5894_2249_5595_5594_5879_5159_5156 11 0.001981546 0.160505186 0.003086638 1352 hsa-mir-1200 hsa04120 Ubiquitin mediated proteolysis 4193_6502_57154_10401_7329_5371_672_8554 8 0.003645606 0.295294058 0.005571586 1353 hsa-mir-1200 hsa03022 Basal transcription factors 2962_2969_6908_2959 4 0.004989121 0.404118838 0.007483682 1354 hsa-mir-1200 hsa04670 Leukocyte transendothelial migration 1499_5747_1432_7852_5879_5781_2185 7 0.006472966 0.524310229 0.009532913 1355 hsa-mir-1200 hsa04150 mTOR signaling pathway 207_5595_5594_6195 4 0.014851263 1 0.021481291 1356 hsa-mir-1200 hsa05131 Shigellosis 1499_2534_25_4691 4 0.018711658 1 0.026131799 1357 hsa-mir-1200 hsa05130 Pathogenic Escherichia coli infection 1499_2534_25_4691 4 0.018711658 1 0.026131799 1358 hsa-mir-1200 hsa03030 DNA replication 4174_4172_6118 3 0.028013356 1 0.038459014 1359 hsa-mir-1200 hsa03450 Non-homologous end-joining 2547_5591 2 0.02927955 1 0.039527392 1360 hsa-mir-1200 hsa04530 Tight junction 1499_5580_6714_207_5590_1457 6 0.035056092 1 0.046549892 1361 hsa-mir-1200 hsa04730 Long-term depression 5894_5595_5594_3480 4 0.038373789 1 0.050133498 1362 hsa-mir-1202 hsa04110 Cell cycle 5925_2033_1019_4088_1017_7027_1026_5933_1387 9 3.41E-11 1.57E-09 1.31E-09 1363 hsa-mir-1202 hsa05200 Pathways in cancer 6688_5925_2033_1019_4088_1017_367_8554_4609_1499_1026_1387 12 5.67E-11 2.61E-09 1.31E-09 1364 hsa-mir-1202 hsa05215 Prostate cancer 5925_2033_1017_367_468_1499_1026_1387 8 1.13E-10 5.21E-09 1.42E-09 1365 hsa-mir-1202 hsa05212 Pancreatic cancer 5925_2033_1017_367_468_1499_1026_1387 8 1.23E-10 5.67E-09 1.42E-09 1366 hsa-mir-1202 hsa04350 TGF-beta signaling pathway 1874_2033_4088_7027_4609_5933_1387 7 3.88E-09 1.78E-07 3.57E-08 1367 hsa-mir-1202 hsa05220 Chronic myeloid leukemia 5925_1019_4088_4609_1026 5 1.75E-06 8.05E-05 1.34E-05 1368 hsa-mir-1202 hsa05222 Small cell lung cancer 5925_1019_1017_8554_4609 5 3.31E-06 0.000152453 2.18E-05 1369 hsa-mir-1202 hsa05219 Bladder cancer 5925_1019_4609_1026 4 5.38E-06 0.000247287 3.09E-05 1370 hsa-mir-1202 hsa04950 Maturity onset diabetes of the young 5080_6927_3651 3 4.17E-05 0.001919609 0.00021329 1371 hsa-mir-1202 hsa04310 Wnt signaling pathway 2033_4088_4609_1499_1387 5 4.68E-05 0.002150601 0.00021506 1372 hsa-mir-1202 hsa04520 Adherens junction 2033_4088_1499_1387 4 5.92E-05 0.002721843 0.00024744 1373 hsa-mir-1202 hsa04530 Tight junction 1019_4628_60412_1499 4 0.000434668 0.01999474 0.001666228 1374 hsa-mir-1202 hsa05214 Glioma 5925_1019_1026 3 0.00066441 0.030562856 0.002243686 1375 hsa-mir-1202 hsa04630 Jak-STAT signaling pathway 2033_8554_4609_1387 4 0.000682861 0.031411604 0.002243686 1376 hsa-mir-1202 hsa04115 p53 signaling pathway 1019_1017_1026 3 0.000785046 0.036112102 0.002407473 1377 hsa-mir-1202 hsa05218 Melanoma 5925_1019_1026 3 0.000850242 0.039111116 0.002444445 1378 hsa-mir-1202 hsa04720 Long-term potentiation 2033_468_1387 3 0.000990726 0.045573404 0.002680788 1379 hsa-mir-1202 hsa05210 Colorectal cancer 4088_4609_1499 3 0.001358374 0.062485227 0.003326334 1380 hsa-mir-1202 hsa05016 Huntington's disease 2033_6908_10476_1387 4 0.001373921 0.063200349 0.003326334 1381 hsa-mir-1202 hsa04916 Melanogenesis 2033_1499_1387 3 0.00245466 0.112914339 0.005645717 1382 hsa-mir-1202 hsa05216 Thyroid cancer 4609_1499 2 0.002722714 0.125244854 0.005964041 1383 hsa-mir-1202 hsa03022 Basal transcription factors 2959_6908 2 0.004283246 0.197029328 0.008955879 1384 hsa-mir-1202 hsa04010 MAPK signaling pathway 468_4609_1649_1386 4 0.005128521 0.235911974 0.010257042 1385 hsa-mir-1202 hsa04330 Notch signaling pathway 2033_1387 2 0.006689302 0.307707875 0.012821161 1386 hsa-mir-1202 hsa05213 Endometrial cancer 4609_1499 2 0.008074715 0.371436884 0.014857475 1387 hsa-mir-1202 hsa05223 Non-small cell lung cancer 5925_1019 2 0.008661933 0.39844892 0.015324958 1388 hsa-mir-1202 hsa05221 Acute myeloid leukemia 6688_4609 2 0.010210894 0.469701144 0.017396339 1389 hsa-mir-1202 hsa05211 Renal cell carcinoma 2033_1387 2 0.014760487 0.678982423 0.024249372 1390 hsa-mir-1202 hsa04012 ErbB signaling pathway 4609_1026 2 0.020893884 0.961118644 0.033142022 1391 hsa-mir-1204 hsa04010 MAPK signaling pathway 9261_6722_8986_5601_6195_468_207_9252_3725_3727_1386_1432_1649_6196_6197_2353 16 4.83E-19 2.56E-17 2.56E-17 1392 hsa-mir-1204 hsa04660 T cell receptor signaling pathway 5601_207_2932_3725_1432_2353 6 1.35E-07 7.17E-06 3.59E-06 1393 hsa-mir-1204 hsa05200 Pathways in cancer 2736_5601_1050_207_2932_3725_2353_1387 8 4.31E-07 2.29E-05 7.62E-06 1394 hsa-mir-1204 hsa04720 Long-term potentiation 6195_468_6196_6197_1387 5 6.22E-07 3.30E-05 8.25E-06 1395 hsa-mir-1204 hsa05210 Colorectal cancer 5601_207_2932_3725_2353 5 1.06E-06 5.62E-05 1.12E-05 1396 hsa-mir-1204 hsa04620 Toll-like receptor signaling pathway 5601_207_3725_1432_2353 5 2.64E-06 0.000139905 2.33E-05 1397 hsa-mir-1204 hsa04150 mTOR signaling pathway 6195_207_6196_6197 4 5.21E-06 0.000275971 3.94E-05 1398 hsa-mir-1204 hsa04310 Wnt signaling pathway 5601_2932_8061_3725_1387 5 1.71E-05 0.000907783 0.000113473 1399 hsa-mir-1204 hsa04662 B cell receptor signaling pathway 207_2932_3725_2353 4 2.06E-05 0.00109028 0.000121142 1400 hsa-mir-1204 hsa04012 ErbB signaling pathway 5601_207_2932_3725 4 3.59E-05 0.001904493 0.000172855 1401 hsa-mir-1204 hsa05215 Prostate cancer 468_207_2932_1387 4 3.75E-05 0.00198805 0.000172855 1402 hsa-mir-1204 hsa05212 Pancreatic cancer 468_207_2932_1387 4 3.91E-05 0.002074259 0.000172855 1403 hsa-mir-1204 hsa03022 Basal transcription factors 2963_6874_6883 3 7.45E-05 0.003945997 0.000303538 1404 hsa-mir-1204 hsa04912 GnRH signaling pathway 5601_468_3725_1432 4 8.09E-05 0.004287319 0.000306237 1405 hsa-mir-1204 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5601_3725_1432 3 0.000465111 0.02465087 0.001602564 1406 hsa-mir-1204 hsa05211 Renal cell carcinoma 207_3725_1387 3 0.000483793 0.025641017 0.001602564 1407 hsa-mir-1204 hsa04370 VEGF signaling pathway 9261_207_1432 3 0.000584423 0.030974401 0.001822024 1408 hsa-mir-1204 hsa04664 Fc epsilon RI signaling pathway 5601_207_1432 3 0.000628135 0.033291177 0.00184951 1409 hsa-mir-1204 hsa04510 Focal adhesion 5601_207_2932_3725 4 0.000884532 0.046880206 0.002467379 1410 hsa-mir-1204 hsa04910 Insulin signaling pathway 5601_207_2932 3 0.00297994 0.157936827 0.007896841 1411 hsa-mir-1204 hsa04930 Type II diabetes mellitus 5601_3651 2 0.004128604 0.218816029 0.010419811 1412 hsa-mir-1204 hsa05213 Endometrial cancer 207_2932 2 0.00541581 0.287037907 0.013047178 1413 hsa-mir-1204 hsa05217 Basal cell carcinoma 2736_2932 2 0.006016769 0.318888769 0.013864729 1414 hsa-mir-1204 hsa04340 Hedgehog signaling pathway 2736_2932 2 0.00643357 0.340979207 0.014135933 1415 hsa-mir-1204 hsa05221 Acute myeloid leukemia 1050_207 2 0.006863174 0.363748197 0.014135933 1416 hsa-mir-1204 hsa05016 Huntington's disease 3064_6874_1387 3 0.006934609 0.367534258 0.014135933 1417 hsa-mir-1204 hsa04920 Adipocytokine signaling pathway 5601_207 2 0.008707483 0.461496596 0.017092467 1418 hsa-mir-1204 hsa04916 Melanogenesis 2932_1387 2 0.019689849 1 0.037270072 1419 hsa-mir-1204 hsa04110 Cell cycle 2932_1387 2 0.025195246 1 0.046046485 1420 hsa-mir-1204 hsa04630 Jak-STAT signaling pathway 207_1387 2 0.040579263 1 0.071690031 1421 hsa-mir-1204 hsa04950 Maturity onset diabetes of the young 3651 1 0.04953318 1 0.08468576 1422 hsa-mir-1205 hsa04010 MAPK signaling pathway 9261_6722_8986_5601_6195_468_207_9252_3725_3727_1386_1432_1649_6196_6197_2353 16 4.83E-19 2.56E-17 2.56E-17 1423 hsa-mir-1205 hsa04660 T cell receptor signaling pathway 5601_207_2932_3725_1432_2353 6 1.35E-07 7.17E-06 3.59E-06 1424 hsa-mir-1205 hsa05200 Pathways in cancer 2736_5601_1050_207_2932_3725_2353_1387 8 4.31E-07 2.29E-05 7.62E-06 1425 hsa-mir-1205 hsa04720 Long-term potentiation 6195_468_6196_6197_1387 5 6.22E-07 3.30E-05 8.25E-06 1426 hsa-mir-1205 hsa05210 Colorectal cancer 5601_207_2932_3725_2353 5 1.06E-06 5.62E-05 1.12E-05 1427 hsa-mir-1205 hsa04620 Toll-like receptor signaling pathway 5601_207_3725_1432_2353 5 2.64E-06 0.000139905 2.33E-05 1428 hsa-mir-1205 hsa04150 mTOR signaling pathway 6195_207_6196_6197 4 5.21E-06 0.000275971 3.94E-05 1429 hsa-mir-1205 hsa04310 Wnt signaling pathway 5601_2932_8061_3725_1387 5 1.71E-05 0.000907783 0.000113473 1430 hsa-mir-1205 hsa04662 B cell receptor signaling pathway 207_2932_3725_2353 4 2.06E-05 0.00109028 0.000121142 1431 hsa-mir-1205 hsa04012 ErbB signaling pathway 5601_207_2932_3725 4 3.59E-05 0.001904493 0.000172855 1432 hsa-mir-1205 hsa05215 Prostate cancer 468_207_2932_1387 4 3.75E-05 0.00198805 0.000172855 1433 hsa-mir-1205 hsa05212 Pancreatic cancer 468_207_2932_1387 4 3.91E-05 0.002074259 0.000172855 1434 hsa-mir-1205 hsa03022 Basal transcription factors 2963_6874_6883 3 7.45E-05 0.003945997 0.000303538 1435 hsa-mir-1205 hsa04912 GnRH signaling pathway 5601_468_3725_1432 4 8.09E-05 0.004287319 0.000306237 1436 hsa-mir-1205 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5601_3725_1432 3 0.000465111 0.02465087 0.001602564 1437 hsa-mir-1205 hsa05211 Renal cell carcinoma 207_3725_1387 3 0.000483793 0.025641017 0.001602564 1438 hsa-mir-1205 hsa04370 VEGF signaling pathway 9261_207_1432 3 0.000584423 0.030974401 0.001822024 1439 hsa-mir-1205 hsa04664 Fc epsilon RI signaling pathway 5601_207_1432 3 0.000628135 0.033291177 0.00184951 1440 hsa-mir-1205 hsa04510 Focal adhesion 5601_207_2932_3725 4 0.000884532 0.046880206 0.002467379 1441 hsa-mir-1205 hsa04910 Insulin signaling pathway 5601_207_2932 3 0.00297994 0.157936827 0.007896841 1442 hsa-mir-1205 hsa04930 Type II diabetes mellitus 5601_3651 2 0.004128604 0.218816029 0.010419811 1443 hsa-mir-1205 hsa05213 Endometrial cancer 207_2932 2 0.00541581 0.287037907 0.013047178 1444 hsa-mir-1205 hsa05217 Basal cell carcinoma 2736_2932 2 0.006016769 0.318888769 0.013864729 1445 hsa-mir-1205 hsa04340 Hedgehog signaling pathway 2736_2932 2 0.00643357 0.340979207 0.014135933 1446 hsa-mir-1205 hsa05221 Acute myeloid leukemia 1050_207 2 0.006863174 0.363748197 0.014135933 1447 hsa-mir-1205 hsa05016 Huntington's disease 3064_6874_1387 3 0.006934609 0.367534258 0.014135933 1448 hsa-mir-1205 hsa04920 Adipocytokine signaling pathway 5601_207 2 0.008707483 0.461496596 0.017092467 1449 hsa-mir-1205 hsa04916 Melanogenesis 2932_1387 2 0.019689849 1 0.037270072 1450 hsa-mir-1205 hsa04110 Cell cycle 2932_1387 2 0.025195246 1 0.046046485 1451 hsa-mir-1205 hsa04630 Jak-STAT signaling pathway 207_1387 2 0.040579263 1 0.071690031 1452 hsa-mir-1205 hsa04950 Maturity onset diabetes of the young 3651 1 0.04953318 1 0.08468576 1453 hsa-mir-1206 hsa04010 MAPK signaling pathway 9261_6722_8986_5601_6195_468_207_9252_3725_3727_1386_1432_1649_6196_6197_2353 16 4.83E-19 2.56E-17 2.56E-17 1454 hsa-mir-1206 hsa04660 T cell receptor signaling pathway 5601_207_2932_3725_1432_2353 6 1.35E-07 7.17E-06 3.59E-06 1455 hsa-mir-1206 hsa05200 Pathways in cancer 2736_5601_1050_207_2932_3725_2353_1387 8 4.31E-07 2.29E-05 7.62E-06 1456 hsa-mir-1206 hsa04720 Long-term potentiation 6195_468_6196_6197_1387 5 6.22E-07 3.30E-05 8.25E-06 1457 hsa-mir-1206 hsa05210 Colorectal cancer 5601_207_2932_3725_2353 5 1.06E-06 5.62E-05 1.12E-05 1458 hsa-mir-1206 hsa04620 Toll-like receptor signaling pathway 5601_207_3725_1432_2353 5 2.64E-06 0.000139905 2.33E-05 1459 hsa-mir-1206 hsa04150 mTOR signaling pathway 6195_207_6196_6197 4 5.21E-06 0.000275971 3.94E-05 1460 hsa-mir-1206 hsa04310 Wnt signaling pathway 5601_2932_8061_3725_1387 5 1.71E-05 0.000907783 0.000113473 1461 hsa-mir-1206 hsa04662 B cell receptor signaling pathway 207_2932_3725_2353 4 2.06E-05 0.00109028 0.000121142 1462 hsa-mir-1206 hsa04012 ErbB signaling pathway 5601_207_2932_3725 4 3.59E-05 0.001904493 0.000172855 1463 hsa-mir-1206 hsa05215 Prostate cancer 468_207_2932_1387 4 3.75E-05 0.00198805 0.000172855 1464 hsa-mir-1206 hsa05212 Pancreatic cancer 468_207_2932_1387 4 3.91E-05 0.002074259 0.000172855 1465 hsa-mir-1206 hsa03022 Basal transcription factors 2963_6874_6883 3 7.45E-05 0.003945997 0.000303538 1466 hsa-mir-1206 hsa04912 GnRH signaling pathway 5601_468_3725_1432 4 8.09E-05 0.004287319 0.000306237 1467 hsa-mir-1206 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5601_3725_1432 3 0.000465111 0.02465087 0.001602564 1468 hsa-mir-1206 hsa05211 Renal cell carcinoma 207_3725_1387 3 0.000483793 0.025641017 0.001602564 1469 hsa-mir-1206 hsa04370 VEGF signaling pathway 9261_207_1432 3 0.000584423 0.030974401 0.001822024 1470 hsa-mir-1206 hsa04664 Fc epsilon RI signaling pathway 5601_207_1432 3 0.000628135 0.033291177 0.00184951 1471 hsa-mir-1206 hsa04510 Focal adhesion 5601_207_2932_3725 4 0.000884532 0.046880206 0.002467379 1472 hsa-mir-1206 hsa04910 Insulin signaling pathway 5601_207_2932 3 0.00297994 0.157936827 0.007896841 1473 hsa-mir-1206 hsa04930 Type II diabetes mellitus 5601_3651 2 0.004128604 0.218816029 0.010419811 1474 hsa-mir-1206 hsa05213 Endometrial cancer 207_2932 2 0.00541581 0.287037907 0.013047178 1475 hsa-mir-1206 hsa05217 Basal cell carcinoma 2736_2932 2 0.006016769 0.318888769 0.013864729 1476 hsa-mir-1206 hsa04340 Hedgehog signaling pathway 2736_2932 2 0.00643357 0.340979207 0.014135933 1477 hsa-mir-1206 hsa05221 Acute myeloid leukemia 1050_207 2 0.006863174 0.363748197 0.014135933 1478 hsa-mir-1206 hsa05016 Huntington's disease 3064_6874_1387 3 0.006934609 0.367534258 0.014135933 1479 hsa-mir-1206 hsa04920 Adipocytokine signaling pathway 5601_207 2 0.008707483 0.461496596 0.017092467 1480 hsa-mir-1206 hsa04916 Melanogenesis 2932_1387 2 0.019689849 1 0.037270072 1481 hsa-mir-1206 hsa04110 Cell cycle 2932_1387 2 0.025195246 1 0.046046485 1482 hsa-mir-1206 hsa04630 Jak-STAT signaling pathway 207_1387 2 0.040579263 1 0.071690031 1483 hsa-mir-1206 hsa04950 Maturity onset diabetes of the young 3651 1 0.04953318 1 0.08468576 1484 hsa-mir-1207 hsa04010 MAPK signaling pathway 9261_6722_8986_5601_6195_468_207_9252_3725_3727_1386_1432_1649_6196_6197_2353 16 4.83E-19 2.56E-17 2.56E-17 1485 hsa-mir-1207 hsa04660 T cell receptor signaling pathway 5601_207_2932_3725_1432_2353 6 1.35E-07 7.17E-06 3.59E-06 1486 hsa-mir-1207 hsa05200 Pathways in cancer 2736_5601_1050_207_2932_3725_2353_1387 8 4.31E-07 2.29E-05 7.62E-06 1487 hsa-mir-1207 hsa04720 Long-term potentiation 6195_468_6196_6197_1387 5 6.22E-07 3.30E-05 8.25E-06 1488 hsa-mir-1207 hsa05210 Colorectal cancer 5601_207_2932_3725_2353 5 1.06E-06 5.62E-05 1.12E-05 1489 hsa-mir-1207 hsa04620 Toll-like receptor signaling pathway 5601_207_3725_1432_2353 5 2.64E-06 0.000139905 2.33E-05 1490 hsa-mir-1207 hsa04150 mTOR signaling pathway 6195_207_6196_6197 4 5.21E-06 0.000275971 3.94E-05 1491 hsa-mir-1207 hsa04310 Wnt signaling pathway 5601_2932_8061_3725_1387 5 1.71E-05 0.000907783 0.000113473 1492 hsa-mir-1207 hsa04662 B cell receptor signaling pathway 207_2932_3725_2353 4 2.06E-05 0.00109028 0.000121142 1493 hsa-mir-1207 hsa04012 ErbB signaling pathway 5601_207_2932_3725 4 3.59E-05 0.001904493 0.000172855 1494 hsa-mir-1207 hsa05215 Prostate cancer 468_207_2932_1387 4 3.75E-05 0.00198805 0.000172855 1495 hsa-mir-1207 hsa05212 Pancreatic cancer 468_207_2932_1387 4 3.91E-05 0.002074259 0.000172855 1496 hsa-mir-1207 hsa03022 Basal transcription factors 2963_6874_6883 3 7.45E-05 0.003945997 0.000303538 1497 hsa-mir-1207 hsa04912 GnRH signaling pathway 5601_468_3725_1432 4 8.09E-05 0.004287319 0.000306237 1498 hsa-mir-1207 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5601_3725_1432 3 0.000465111 0.02465087 0.001602564 1499 hsa-mir-1207 hsa05211 Renal cell carcinoma 207_3725_1387 3 0.000483793 0.025641017 0.001602564 1500 hsa-mir-1207 hsa04370 VEGF signaling pathway 9261_207_1432 3 0.000584423 0.030974401 0.001822024 1501 hsa-mir-1207 hsa04664 Fc epsilon RI signaling pathway 5601_207_1432 3 0.000628135 0.033291177 0.00184951 1502 hsa-mir-1207 hsa04510 Focal adhesion 5601_207_2932_3725 4 0.000884532 0.046880206 0.002467379 1503 hsa-mir-1207 hsa04910 Insulin signaling pathway 5601_207_2932 3 0.00297994 0.157936827 0.007896841 1504 hsa-mir-1207 hsa04930 Type II diabetes mellitus 5601_3651 2 0.004128604 0.218816029 0.010419811 1505 hsa-mir-1207 hsa05213 Endometrial cancer 207_2932 2 0.00541581 0.287037907 0.013047178 1506 hsa-mir-1207 hsa05217 Basal cell carcinoma 2736_2932 2 0.006016769 0.318888769 0.013864729 1507 hsa-mir-1207 hsa04340 Hedgehog signaling pathway 2736_2932 2 0.00643357 0.340979207 0.014135933 1508 hsa-mir-1207 hsa05221 Acute myeloid leukemia 1050_207 2 0.006863174 0.363748197 0.014135933 1509 hsa-mir-1207 hsa05016 Huntington's disease 3064_6874_1387 3 0.006934609 0.367534258 0.014135933 1510 hsa-mir-1207 hsa04920 Adipocytokine signaling pathway 5601_207 2 0.008707483 0.461496596 0.017092467 1511 hsa-mir-1207 hsa04916 Melanogenesis 2932_1387 2 0.019689849 1 0.037270072 1512 hsa-mir-1207 hsa04110 Cell cycle 2932_1387 2 0.025195246 1 0.046046485 1513 hsa-mir-1207 hsa04630 Jak-STAT signaling pathway 207_1387 2 0.040579263 1 0.071690031 1514 hsa-mir-1207 hsa04950 Maturity onset diabetes of the young 3651 1 0.04953318 1 0.08468576 1515 hsa-mir-122 hsa04110 Cell cycle 1387_993_983_5925 4 6.13E-07 1.53E-05 1.53E-05 1516 hsa-mir-122 hsa04330 Notch signaling pathway 1387_8850 2 0.000349508 0.008737699 0.004368849 1517 hsa-mir-122 hsa05215 Prostate cancer 1387_5925 2 0.001174155 0.029353887 0.007500885 1518 hsa-mir-122 hsa05212 Pancreatic cancer 1387_5925 2 0.001200142 0.03000354 0.007500885 1519 hsa-mir-122 hsa05200 Pathways in cancer 1387_5925 2 0.015034947 0.37587367 0.064921185 1520 hsa-mir-122 hsa03410 Base excision repair 3146 1 0.020754901 0.518872528 0.064921185 1521 hsa-mir-122 hsa05219 Bladder cancer 5925 1 0.024082113 0.60205283 0.064921185 1522 hsa-mir-122 hsa05223 Non-small cell lung cancer 5925 1 0.030704643 0.767616075 0.064921185 1523 hsa-mir-122 hsa05214 Glioma 5925 1 0.036738118 0.918452946 0.064921185 1524 hsa-mir-122 hsa04115 p53 signaling pathway 983 1 0.038923332 0.97308329 0.064921185 1525 hsa-mir-122 hsa05218 Melanoma 5925 1 0.040014188 1 0.064921185 1526 hsa-mir-122 hsa05211 Renal cell carcinoma 1387 1 0.040559179 1 0.064921185 1527 hsa-mir-122 hsa04720 Long-term potentiation 1387 1 0.042192406 1 0.064921185 1528 hsa-mir-122 hsa05220 Chronic myeloid leukemia 5925 1 0.042192406 1 0.064921185 1529 hsa-mir-122 hsa04520 Adherens junction 1387 1 0.044908637 1 0.064921185 1530 hsa-mir-122 hsa04512 ECM-receptor interaction 9672 1 0.0470764 1 0.064921185 1531 hsa-mir-122 hsa05222 Small cell lung cancer 5925 1 0.048158544 1 0.064921185 1532 hsa-mir-122 hsa04350 TGF-beta signaling pathway 1387 1 0.048699183 1 0.064921185 1533 hsa-mir-122 hsa04612 Antigen processing and presentation 1514 1 0.049779592 1 0.064921185 1534 hsa-mir-1224 hsa05200 Pathways in cancer 3320_3725_7046_1499_5595_5594_1387_6256_1019_1017_5578_6772_5970_7157_4088_862_6774_6502_4087_4089_3065_5925_2033 23 2.48E-19 1.59E-17 1.59E-17 1535 hsa-mir-1224 hsa04350 TGF-beta signaling pathway 6667_3400_7046_5595_5594_1387_3397_3399_3398_4088_4087_4089_2033_4092 14 8.15E-17 5.21E-15 2.61E-15 1536 hsa-mir-1224 hsa04520 Adherens junction 4301_7046_1499_5595_5594_1387_4088_1457_4087_4089_2033 11 8.59E-13 5.50E-11 1.83E-11 1537 hsa-mir-1224 hsa04110 Cell cycle 1387_1019_1017_7157_4088_1028_6502_4087_4089_3065_5925_2033 12 2.21E-12 1.42E-10 3.54E-11 1538 hsa-mir-1224 hsa05220 Chronic myeloid leukemia 7046_5595_5594_1019_5970_7157_4088_4089_3065_5925 10 1.28E-11 8.17E-10 1.63E-10 1539 hsa-mir-1224 hsa05215 Prostate cancer 3320_1499_5595_5594_1387_1017_5970_7157_5925_2033 10 5.41E-11 3.47E-09 5.48E-10 1540 hsa-mir-1224 hsa05212 Pancreatic cancer 3320_1499_5595_5594_1387_1017_5970_7157_5925_2033 10 6.00E-11 3.84E-09 5.48E-10 1541 hsa-mir-1224 hsa05214 Glioma 5595_5594_1019_5578_7157_5925_808_801_805 9 1.03E-10 6.57E-09 8.22E-10 1542 hsa-mir-1224 hsa04010 MAPK signaling pathway 6722_3725_7046_5595_5594_4208_7867_1432_5578_5970_9261_4342_7157_4773 14 1.57E-10 1.01E-08 1.12E-09 1543 hsa-mir-1224 hsa04310 Wnt signaling pathway 3725_1499_1387_5578_7157_4773_4088_1457_4087_4089_2033 11 5.16E-10 3.30E-08 3.30E-09 1544 hsa-mir-1224 hsa05210 Colorectal cancer 3725_7046_1499_5595_5594_7157_4088_4087_4089 9 8.26E-10 5.29E-08 4.81E-09 1545 hsa-mir-1224 hsa04916 Melanogenesis 1499_5595_5594_1387_5578_2033_808_801_805 9 4.72E-09 3.02E-07 2.52E-08 1546 hsa-mir-1224 hsa04720 Long-term potentiation 5595_5594_1387_5578_2033_808_801_805 8 7.64E-09 4.89E-07 3.76E-08 1547 hsa-mir-1224 hsa05223 Non-small cell lung cancer 5595_5594_6256_1019_5578_7157_5925 7 1.99E-08 1.27E-06 9.08E-08 1548 hsa-mir-1224 hsa04912 GnRH signaling pathway 3725_5595_5594_1432_5578_808_801_805 8 1.07E-07 6.88E-06 4.59E-07 1549 hsa-mir-1224 hsa04370 VEGF signaling pathway 5595_5594_7867_1432_5578_9261_4773 7 1.88E-07 1.20E-05 7.52E-07 1550 hsa-mir-1224 hsa04330 Notch signaling pathway 388585_1387_9612_3065_2033_8850 6 2.31E-07 1.48E-05 8.68E-07 1551 hsa-mir-1224 hsa05222 Small cell lung cancer 6256_1019_1017_5970_7157_6502_5925 7 3.79E-07 2.42E-05 1.35E-06 1552 hsa-mir-1224 hsa05216 Thyroid cancer 1499_5595_5594_6256_7157 5 6.39E-07 4.09E-05 2.15E-06 1553 hsa-mir-1224 hsa04660 T cell receptor signaling pathway 3725_5595_5594_1019_1432_5970_4773 7 1.80E-06 0.000115157 5.76E-06 1554 hsa-mir-1224 hsa05219 Bladder cancer 5595_5594_1019_7157_5925 5 3.35E-06 0.000214301 1.02E-05 1555 hsa-mir-1224 hsa04620 Toll-like receptor signaling pathway 3725_5595_5594_1432_6772_5970 6 1.54E-05 0.000987038 4.33E-05 1556 hsa-mir-1224 hsa05221 Acute myeloid leukemia 5595_5594_5970_862_6774 5 1.56E-05 0.000996582 4.33E-05 1557 hsa-mir-1224 hsa04270 Vascular smooth muscle contraction 5595_5594_5578_808_801_805 6 3.38E-05 0.002160843 9.00E-05 1558 hsa-mir-1224 hsa05218 Melanoma 5595_5594_1019_7157_5925 5 3.60E-05 0.00230408 9.22E-05 1559 hsa-mir-1224 hsa05211 Renal cell carcinoma 3725_5595_5594_1387_2033 5 3.84E-05 0.002454472 9.44E-05 1560 hsa-mir-1224 hsa04662 B cell receptor signaling pathway 3725_5595_5594_5970_4773 5 4.61E-05 0.00295163 0.00010932 1561 hsa-mir-1224 hsa05213 Endometrial cancer 1499_5595_5594_7157 4 0.000163659 0.010474198 0.000374079 1562 hsa-mir-1224 hsa04950 Maturity onset diabetes of the young 3651_168620_4760 3 0.0003049 0.019513568 0.000672882 1563 hsa-mir-1224 hsa04070 Phosphatidylinositol signaling system 5578_808_801_805 4 0.000643772 0.04120143 0.001373381 1564 hsa-mir-1224 hsa04530 Tight junction 4301_1499_1019_5578_1457 5 0.000675127 0.043208135 0.001393752 1565 hsa-mir-1224 hsa04910 Insulin signaling pathway 5595_5594_808_801_805 5 0.000696876 0.044600075 0.001393752 1566 hsa-mir-1224 hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432_5578 4 0.000739597 0.047334196 0.00143437 1567 hsa-mir-1224 hsa04012 ErbB signaling pathway 3725_5595_5594_5578 4 0.001043815 0.066804161 0.001964828 1568 hsa-mir-1224 hsa04930 Type II diabetes mellitus 3651_5595_5594 3 0.001672954 0.107069048 0.003059116 1569 hsa-mir-1224 hsa05010 Alzheimer's disease 5595_5594_808_801_805 5 0.002031473 0.130014276 0.003611508 1570 hsa-mir-1224 hsa05016 Huntington's disease 6667_1387_7157_3065_2033 5 0.002619108 0.167622943 0.00453035 1571 hsa-mir-1224 hsa04062 Chemokine signaling pathway 5595_5594_6772_5970_6774 5 0.002923358 0.187094914 0.00492355 1572 hsa-mir-1224 hsa04670 Leukocyte transendothelial migration 4301_1499_1432_5578 4 0.003428574 0.219428719 0.005626377 1573 hsa-mir-1224 hsa04510 Focal adhesion 3725_1499_5595_5594_5578 5 0.003833119 0.245319629 0.006132991 1574 hsa-mir-1224 hsa04920 Adipocytokine signaling pathway 6256_5970_6774 3 0.004897428 0.313435366 0.007644765 1575 hsa-mir-1224 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_5578_4773 4 0.005238631 0.335272354 0.007885719 1576 hsa-mir-1224 hsa04115 p53 signaling pathway 1019_1017_7157 3 0.005298218 0.339085934 0.007885719 1577 hsa-mir-1224 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1432_5970 3 0.005718187 0.365963968 0.008132533 1578 hsa-mir-1224 hsa04730 Long-term depression 5595_5594_5578 3 0.005718187 0.365963968 0.008132533 1579 hsa-mir-1224 hsa04630 Jak-STAT signaling pathway 1387_6772_6774_2033 4 0.007765277 0.49697773 0.010803864 1580 hsa-mir-1224 hsa04540 Gap junction 5595_5594_5578 3 0.011663339 0.746453696 0.015881994 1581 hsa-mir-1224 hsa04020 Calcium signaling pathway 5578_808_801_805 4 0.013710138 0.877448848 0.018280184 1582 hsa-mir-1224 hsa03050 Proteasome 5684_5710 2 0.024830139 1 0.032431202 1583 hsa-mir-1224 hsa04360 Axon guidance 5595_5594_4773 3 0.028021394 1 0.035867384 1584 hsa-mir-1224 hsa04150 mTOR signaling pathway 5595_5594 2 0.028642405 1 0.03594341 1585 hsa-mir-1224 hsa05217 Basal cell carcinoma 1499_7157 2 0.031644889 1 0.037339647 1586 hsa-mir-1224 hsa04120 Ubiquitin mediated proteolysis 997_7329_6502 3 0.032471912 1 0.037339647 1587 hsa-mir-1224 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_7157 2 0.032672191 1 0.037339647 1588 hsa-mir-1224 hsa05131 Shigellosis 1499_5578 2 0.032672191 1 0.037339647 1589 hsa-mir-1224 hsa05130 Pathogenic Escherichia coli infection 1499_5578 2 0.032672191 1 0.037339647 1590 hsa-mir-1225 hsa05200 Pathways in cancer 5371_5595_5594_5914_6256_595_836_367_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_4088_4089_3066_3065_5925_2034_2033_4846 28 4.16E-32 2.58E-30 2.58E-30 1591 hsa-mir-1225 hsa05220 Chronic myeloid leukemia 5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464 15 1.54E-22 9.54E-21 4.77E-21 1592 hsa-mir-1225 hsa04110 Cell cycle 5591_595_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933 14 3.66E-18 2.27E-16 7.56E-17 1593 hsa-mir-1225 hsa05215 Prostate cancer 5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033 11 9.26E-15 5.74E-13 1.29E-13 1594 hsa-mir-1225 hsa05212 Pancreatic cancer 5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033 11 1.04E-14 6.44E-13 1.29E-13 1595 hsa-mir-1225 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5925 9 3.49E-14 2.16E-12 3.60E-13 1596 hsa-mir-1225 hsa05210 Colorectal cancer 5595_5594_595_836_7157_4087_4609_3725_4088_4089 10 2.52E-13 1.56E-11 2.04E-12 1597 hsa-mir-1225 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925 9 2.63E-13 1.63E-11 2.04E-12 1598 hsa-mir-1225 hsa05222 Small cell lung cancer 6256_595_5970_1870_1871_7157_4609_1869_5925_4846 10 3.13E-13 1.94E-11 2.16E-12 1599 hsa-mir-1225 hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_6464 9 1.20E-12 7.43E-11 7.43E-12 1600 hsa-mir-1225 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_5970_4609 8 2.63E-11 1.63E-09 1.48E-10 1601 hsa-mir-1225 hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5925 8 1.02E-10 6.34E-09 5.28E-10 1602 hsa-mir-1225 hsa05211 Renal cell carcinoma 5595_5594_3091_7428_2113_3725_2034_2033 8 1.13E-10 7.03E-09 5.40E-10 1603 hsa-mir-1225 hsa04350 TGF-beta signaling pathway 5595_5594_4087_4609_4088_4089_2033_5933 8 4.58E-10 2.84E-08 2.03E-09 1604 hsa-mir-1225 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 9.15E-10 5.67E-08 3.78E-09 1605 hsa-mir-1225 hsa04310 Wnt signaling pathway 595_7157_4087_4609_3725_1457_4088_4089_2033 9 1.40E-09 8.68E-08 5.42E-09 1606 hsa-mir-1225 hsa04520 Adherens junction 5595_5594_4087_1457_4088_4089_2033 7 8.13E-09 5.04E-07 2.96E-08 1607 hsa-mir-1225 hsa04010 MAPK signaling pathway 5595_5594_4208_836_3312_5970_7157_4609_3725_4763 10 1.36E-08 8.45E-07 4.69E-08 1608 hsa-mir-1225 hsa05016 Huntington's disease 6874_2902_836_7157_3066_3065_3064_2033 8 1.38E-07 8.55E-06 4.50E-07 1609 hsa-mir-1225 hsa05213 Endometrial cancer 5595_5594_595_7157_4609 5 7.92E-07 4.91E-05 2.46E-06 1610 hsa-mir-1225 hsa04012 ErbB signaling pathway 5595_5594_4609_3725_6464 5 8.57E-06 0.000531387 2.53E-05 1611 hsa-mir-1225 hsa04330 Notch signaling pathway 9612_3066_3065_2033 4 1.68E-05 0.001041198 4.73E-05 1612 hsa-mir-1225 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_7157_4846 4 3.21E-05 0.001990422 8.65E-05 1613 hsa-mir-1225 hsa04720 Long-term potentiation 5595_5594_2902_2033 4 9.47E-05 0.005872995 0.00023492 1614 hsa-mir-1225 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725 4 9.47E-05 0.005872995 0.00023492 1615 hsa-mir-1225 hsa05010 Alzheimer's disease 5595_5594_2902_836_4846 5 0.000222199 0.013776311 0.000529858 1616 hsa-mir-1225 hsa04620 Toll-like receptor signaling pathway 5595_5594_5970_3725 4 0.00029453 0.018260834 0.000676327 1617 hsa-mir-1225 hsa04660 T cell receptor signaling pathway 5595_5594_5970_3725 4 0.000388502 0.024087104 0.000860254 1618 hsa-mir-1225 hsa04510 Focal adhesion 5595_5594_595_3725_6464 5 0.000438211 0.027169068 0.000936864 1619 hsa-mir-1225 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.000606587 0.037608391 0.001253613 1620 hsa-mir-1225 hsa04910 Insulin signaling pathway 6720_5595_5594_6464 4 0.000887004 0.054994227 0.00171857 1621 hsa-mir-1225 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_6464 4 0.000887004 0.054994227 0.00171857 1622 hsa-mir-1225 hsa04115 p53 signaling pathway 595_836_7157 3 0.001329343 0.082419271 0.002497554 1623 hsa-mir-1225 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_5970_3725 3 0.001438684 0.089198411 0.002548526 1624 hsa-mir-1225 hsa04730 Long-term depression 5595_5594_4846 3 0.001438684 0.089198411 0.002548526 1625 hsa-mir-1225 hsa04370 VEGF signaling pathway 5595_5594_4846 3 0.001800045 0.11160278 0.003100077 1626 hsa-mir-1225 hsa04612 Antigen processing and presentation 4800_4801_3312 3 0.002681283 0.166239573 0.004374726 1627 hsa-mir-1225 hsa04210 Apoptosis 836_5970_7157 3 0.002681283 0.166239573 0.004374726 1628 hsa-mir-1225 hsa04062 Chemokine signaling pathway 5595_5594_5970_6464 4 0.002936341 0.182053166 0.00466803 1629 hsa-mir-1225 hsa04916 Melanogenesis 5595_5594_2033 3 0.004103678 0.25442802 0.0063607 1630 hsa-mir-1225 hsa04912 GnRH signaling pathway 5595_5594_3725 3 0.004546884 0.281906832 0.006875776 1631 hsa-mir-1225 hsa04930 Type II diabetes mellitus 5595_5594 2 0.008763359 0.543328272 0.012922499 1632 hsa-mir-1225 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428 3 0.008962379 0.555667472 0.012922499 1633 hsa-mir-1225 hsa04630 Jak-STAT signaling pathway 595_4609_2033 3 0.011958015 0.741396911 0.01684993 1634 hsa-mir-1225 hsa04920 Adipocytokine signaling pathway 6256_5970 2 0.018228702 1 0.025115101 1635 hsa-mir-1225 hsa04664 Fc epsilon RI signaling pathway 5595_5594 2 0.024601767 1 0.033158903 1636 hsa-mir-1225 hsa04540 Gap junction 5595_5594 2 0.033006835 1 0.043540931 1637 hsa-mir-1225 hsa04710 Circadian rhythm - mammal 8863 1 0.041078632 1 0.0530599 1638 hsa-mir-1225 hsa03450 Non-homologous end-joining 5591 1 0.043948127 1 0.055607834 1639 hsa-mir-1227 hsa05215 Prostate cancer 10488 1 0.005924236 0.023696946 0.009316535 1640 hsa-mir-1227 hsa05212 Pancreatic cancer 10488 1 0.005990701 0.023962804 0.009316535 1641 hsa-mir-1227 hsa04916 Melanogenesis 10488 1 0.006987401 0.027949605 0.009316535 1642 hsa-mir-1227 hsa05016 Huntington's disease 10488 1 0.012559684 0.050238736 0.012559684 1643 hsa-mir-1228 hsa05200 Pathways in cancer 3716_1147_5747_3725_3551_1956_367_1499_5594_5599_6258_2064_6256_5159_8031_5156_2261_3815_2932_1387_6774_6257_6776_6777_5879_8772_2353_4087_4088_4089_2033_207_8554_5970_7046 35 1.67E-30 1.12E-28 1.12E-28 1644 hsa-mir-1228 hsa04010 MAPK signaling pathway 1147_3725_3727_3551_1956_5594_5599_1386_5159_5156_7132_2261_2264_9252_1432_1649_1845_5879_10912_468_2353_5058_4616_207_5970_7046 26 8.75E-22 5.86E-20 2.93E-20 1645 hsa-mir-1228 hsa04920 Adipocytokine signaling pathway 3717_1147_3551_10891_8717_5599_6258_6256_7133_7132_6774_6257_5781_207_5970_2538 16 1.73E-19 1.16E-17 3.87E-18 1646 hsa-mir-1228 hsa04630 Jak-STAT signaling pathway 3717_3716_3560_3561_1387_6774_6776_6777_6773_58985_3455_3459_5781_7297_1439_2033_207_8554_10379 19 4.67E-18 3.13E-16 7.81E-17 1647 hsa-mir-1228 hsa05215 Prostate cancer 1147_3551_1956_367_1499_5594_2064_5159_5156_2932_1387_468_2033_207_5970_90993 16 7.92E-18 5.30E-16 1.04E-16 1648 hsa-mir-1228 hsa05212 Pancreatic cancer 1147_3551_1956_367_1499_5594_2064_5159_5156_2932_1387_468_2033_207_5970_90993 16 9.29E-18 6.22E-16 1.04E-16 1649 hsa-mir-1228 hsa05210 Colorectal cancer 3725_1956_1499_5594_5599_5159_5156_2932_5879_2353_4087_4088_4089_207_7046 15 1.10E-16 7.37E-15 1.05E-15 1650 hsa-mir-1228 hsa04012 ErbB signaling pathway 5747_3725_818_817_1956_6714_5594_5599_2064_2932_6776_6777_5058_207 14 4.30E-15 2.88E-13 3.60E-14 1651 hsa-mir-1228 hsa04060 Cytokine-cytokine receptor interaction 2321_3791_1956_3560_3561_90_5159_5156_7133_7132_1234_1230_3815_7852_58985_3455_3459_1439_7046 19 3.45E-14 2.31E-12 2.51E-13 1652 hsa-mir-1228 hsa04520 Adherens junction 1956_1499_6714_5594_2064_1387_5879_4087_4088_4089_2033_7046_2534 13 3.75E-14 2.51E-12 2.51E-13 1653 hsa-mir-1228 hsa04062 Chemokine signaling pathway 3717_1147_5747_3551_5594_1234_1230_2932_5580_6774_6777_6773_5879_7852_5058_207_5970 17 4.27E-14 2.86E-12 2.60E-13 1654 hsa-mir-1228 hsa04510 Focal adhesion 5747_3725_2321_3791_1956_1499_6714_5594_5599_2064_5159_5156_2932_5879_5058_207_2534 17 1.15E-13 7.69E-12 6.41E-13 1655 hsa-mir-1228 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_3725_3551_1956_6714_5599_1432_5879_5781_5058_5970 11 5.76E-12 3.86E-10 2.97E-11 1656 hsa-mir-1228 hsa05220 Chronic myeloid leukemia 1147_3551_5594_6776_6777_5781_4088_4089_207_5970_7046 11 9.84E-12 6.60E-10 4.71E-11 1657 hsa-mir-1228 hsa04620 Toll-like receptor signaling pathway 1147_3725_3551_5594_5599_1432_5879_3455_8772_2353_207_5970 12 1.16E-11 7.80E-10 5.20E-11 1658 hsa-mir-1228 hsa04660 T cell receptor signaling pathway 1147_3725_3551_3932_5594_2932_1432_2353_5058_207_5970_2534 12 2.61E-11 1.75E-09 1.09E-10 1659 hsa-mir-1228 hsa04110 Cell cycle 7532_7534_2932_1387_10912_4174_4172_4087_4088_4089_4616_2033 12 6.08E-11 4.07E-09 2.39E-10 1660 hsa-mir-1228 hsa04662 B cell receptor signaling pathway 1147_3725_3551_5594_6850_2932_5879_2353_207_5970 10 2.06E-10 1.38E-08 7.66E-10 1661 hsa-mir-1228 hsa05221 Acute myeloid leukemia 1147_3551_5594_3815_6774_6776_6777_207_5970 9 5.76E-10 3.86E-08 2.03E-09 1662 hsa-mir-1228 hsa04310 Wnt signaling pathway 3725_818_817_1499_5599_2932_1387_5879_4087_4088_4089_2033 12 8.33E-10 5.58E-08 2.79E-09 1663 hsa-mir-1228 hsa04912 GnRH signaling pathway 3725_818_817_1956_6714_5594_5599_1432_5580_468 10 5.33E-09 3.57E-07 1.70E-08 1664 hsa-mir-1228 hsa05222 Small cell lung cancer 1147_5747_3551_6258_6256_6257_207_8554_5970 9 1.18E-08 7.92E-07 3.60E-08 1665 hsa-mir-1228 hsa04350 TGF-beta signaling pathway 5594_90_1387_4087_4088_4089_2033_7046_57154 9 1.30E-08 8.69E-07 3.78E-08 1666 hsa-mir-1228 hsa05211 Renal cell carcinoma 3725_5594_1387_5879_5781_5058_2033_207 8 5.10E-08 3.42E-06 1.42E-07 1667 hsa-mir-1228 hsa04916 Melanogenesis 818_817_1499_5594_3815_2932_1387_2033_90993 9 5.44E-08 3.64E-06 1.46E-07 1668 hsa-mir-1228 hsa05216 Thyroid cancer 1499_5594_6258_6256_8031_6257 6 9.33E-08 6.25E-06 2.40E-07 1669 hsa-mir-1228 hsa04664 Fc epsilon RI signaling pathway 5594_5599_6850_1432_5580_5879_207_2534 8 9.90E-08 6.63E-06 2.46E-07 1670 hsa-mir-1228 hsa05223 Non-small cell lung cancer 1956_5594_6258_2064_6256_6257_207 7 1.37E-07 9.15E-06 3.27E-07 1671 hsa-mir-1228 hsa04210 Apoptosis 1147_3551_8717_7132_8772_1439_207_5970 8 2.32E-07 1.55E-05 5.35E-07 1672 hsa-mir-1228 hsa05214 Glioma 818_817_1956_5594_5159_5156_207 7 4.34E-07 2.91E-05 9.70E-07 1673 hsa-mir-1228 hsa04650 Natural killer cell mediated cytotoxicity 3932_5594_6850_5879_3455_3459_5781_5058_2534 9 5.19E-07 3.48E-05 1.12E-06 1674 hsa-mir-1228 hsa04370 VEGF signaling pathway 5747_3791_6714_5594_1432_5879_207 7 1.25E-06 8.39E-05 2.62E-06 1675 hsa-mir-1228 hsa05213 Endometrial cancer 1956_1499_5594_2064_2932_207 6 2.06E-06 0.000137755 4.17E-06 1676 hsa-mir-1228 hsa05219 Bladder cancer 1956_5594_2064_2261_9252 5 1.31E-05 0.000879855 2.59E-05 1677 hsa-mir-1228 hsa04720 Long-term potentiation 818_817_5594_1387_468_2033 6 1.46E-05 0.000976641 2.79E-05 1678 hsa-mir-1228 hsa04810 Regulation of actin cytoskeleton 5747_1956_5594_5159_5156_2261_2264_5879_5058 9 1.88E-05 0.001262328 3.51E-05 1679 hsa-mir-1228 hsa04360 Axon guidance 5747_5594_2932_5879_7852_5058_2534 7 3.34E-05 0.002237341 6.05E-05 1680 hsa-mir-1228 hsa04910 Insulin signaling pathway 3551_10891_5594_5599_2932_207_2538 7 4.58E-05 0.003068868 8.08E-05 1681 hsa-mir-1228 hsa03320 PPAR signaling pathway 10062_6258_6256_6257_2168 5 0.000127663 0.008553398 0.000219318 1682 hsa-mir-1228 hsa05218 Melanoma 1956_5594_5159_5156_207 5 0.000135943 0.009108164 0.000227704 1683 hsa-mir-1228 hsa04670 Leukocyte transendothelial migration 5747_1499_1432_5879_7852_5781 6 0.000189593 0.012702746 0.000309823 1684 hsa-mir-1228 hsa04020 Calcium signaling pathway 818_817_1956_2064_5159_5156_147 7 0.000254749 0.017068161 0.000406385 1685 hsa-mir-1228 hsa04930 Type II diabetes mellitus 3551_5594_5599_5580 4 0.00028469 0.019074245 0.000443587 1686 hsa-mir-1228 hsa04120 Ubiquitin mediated proteolysis 11059_672_4734_7329_8554_57154 6 0.000371241 0.024873116 0.000565298 1687 hsa-mir-1228 hsa04540 Gap junction 1956_6714_5594_5159_5156 5 0.000445663 0.029859404 0.000663542 1688 hsa-mir-1228 hsa05014 Amyotrophic lateral sclerosis (ALS) 7133_7132_1432_5879 4 0.00061998 0.041538692 0.000903015 1689 hsa-mir-1228 hsa04330 Notch signaling pathway 1387_9612_2033 3 0.00415885 0.278642937 0.005928573 1690 hsa-mir-1228 hsa05131 Shigellosis 1499_7534_2534 3 0.006611851 0.442993993 0.009040694 1691 hsa-mir-1228 hsa05130 Pathogenic Escherichia coli infection 1499_7534_2534 3 0.006611851 0.442993993 0.009040694 1692 hsa-mir-1228 hsa04950 Maturity onset diabetes of the young 3172_4760 2 0.012179098 0.815999567 0.016319991 1693 hsa-mir-1228 hsa04530 Tight junction 1499_6714_5580_207 4 0.013403539 0.89803714 0.017608571 1694 hsa-mir-1228 hsa05340 Primary immunodeficiency 3932_3561 2 0.023829295 1 0.03070313 1695 hsa-mir-1228 hsa03030 DNA replication 4174_4172 2 0.025047902 1 0.031664329 1696 hsa-mir-1228 hsa05010 Alzheimer's disease 5594_7132_2932_8772 4 0.030192558 1 0.037461136 1697 hsa-mir-1228 hsa05016 Huntington's disease 10891_1387_2033_90993 4 0.036300292 1 0.044220356 1698 hsa-mir-1228 hsa04270 Vascular smooth muscle contraction 5594_5580_147 3 0.043894636 1 0.052516797 1699 hsa-mir-1228 hsa04150 mTOR signaling pathway 5594_207 2 0.047693006 1 0.0560602 1700 hsa-mir-1229 hsa05200 Pathways in cancer 3716_1147_4609_3320_3326_5970_675_1956_5468_5595_5594_5599_1387_6256_5159_595_5156_5601_898_1019_1399_1398_367_8517_3815_3551_5578_6774_6777_6772_10401_5371_4791_3725_867_1017_2353_4088_4089_3066_3065_5925_2033_8554_4790_4792 46 1.13E-28 9.01E-27 9.01E-27 1701 hsa-mir-1229 hsa05220 Chronic myeloid leukemia 1147_4609_5970_5595_5594_595_1019_1399_1398_8517_3551_6777_5781_867_4088_4089_3066_3065_5925_4790_4792_6464 22 2.50E-20 2.00E-18 1.00E-18 1702 hsa-mir-1229 hsa04010 MAPK signaling pathway 1147_4609_5970_1956_5595_5594_6722_5599_1386_5159_5156_5601_3305_3303_5566_1399_1398_8517_9252_3312_1432_3551_5578_1649_5971_1326_4342_5608_4791_6885_3725_9020_2353_4790 34 3.94E-20 3.16E-18 1.05E-18 1703 hsa-mir-1229 hsa04660 T cell receptor signaling pathway 1147_5970_3932_4794_5595_5594_5601_919_1019_8517_1432_3551_1326_6885_3725_9020_867_2353_4790_4792_4793_1493 22 2.86E-17 2.29E-15 5.72E-16 1704 hsa-mir-1229 hsa05215 Prostate cancer 1147_3320_3326_5970_1956_5595_5594_1387_5159_595_5156_898_367_8517_3551_1017_5925_2033_4790_4792 20 9.43E-17 7.54E-15 1.51E-15 1705 hsa-mir-1229 hsa05212 Pancreatic cancer 1147_3320_3326_5970_1956_5595_5594_1387_5159_595_5156_898_367_8517_3551_1017_5925_2033_4790_4792 20 1.14E-16 9.11E-15 1.52E-15 1706 hsa-mir-1229 hsa04630 Jak-STAT signaling pathway 3717_3716_4609_3718_8651_85480_3560_3561_1387_595_3575_6774_6777_6772_10401_2690_2057_5781_867_6778_2033_894_896_8554 24 1.78E-16 1.43E-14 2.04E-15 1707 hsa-mir-1229 hsa04620 Toll-like receptor signaling pathway 1147_5970_29110_5595_5594_5599_5601_3661_8517_9641_1432_3551_6772_1326_5608_6885_3725_2353_4790_4792 20 1.13E-15 9.01E-14 1.06E-14 1708 hsa-mir-1229 hsa04310 Wnt signaling pathway 4609_5515_23291_5519_5599_1387_595_8607_5601_5566_1457_8454_5578_8945_8061_6885_3725_6500_4088_4089_2033_894_896 23 1.19E-15 9.55E-14 1.06E-14 1709 hsa-mir-1229 hsa04920 Adipocytokine signaling pathway 3717_1147_5970_4794_5599_6256_5601_8517_3551_6774_5781_8471_4790_4792_4793_5465 16 5.91E-14 4.73E-12 4.73E-13 1710 hsa-mir-1229 hsa04110 Cell cycle 1111_5591_1387_595_898_1019_8454_5111_1028_1017_6500_4088_4089_3066_3065_5925_2033_894_896 19 1.57E-13 1.26E-11 1.12E-12 1711 hsa-mir-1229 hsa04350 TGF-beta signaling pathway 4609_5515_5519_3400_5595_5594_1387_6667_8454_3397_3399_3398_6500_4088_4089_2033_4092 17 1.68E-13 1.34E-11 1.12E-12 1712 hsa-mir-1229 hsa04062 Chemokine signaling pathway 3717_1147_3718_5970_5590_5595_5594_5566_1399_1398_1234_8517_3551_6774_6777_6772_653361_4790_4792_4793_6464 21 6.81E-12 5.45E-10 4.19E-11 1713 hsa-mir-1229 hsa04910 Insulin signaling pathway 8651_3643_5590_5595_5594_5599_5601_5566_1399_1398_5770_3551_8471_867_808_6464_801_805 18 1.46E-11 1.17E-09 8.34E-11 1714 hsa-mir-1229 hsa05222 Small cell lung cancer 1147_4609_5970_6256_595_898_1019_8517_3551_10401_1017_5925_8554_4790_4792 15 1.90E-11 1.52E-09 1.01E-10 1715 hsa-mir-1229 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_5970_1956_6714_5599_5601_8517_1432_3551_5781_3725_9020_4790_4792 14 2.11E-11 1.69E-09 1.03E-10 1716 hsa-mir-1229 hsa04012 ErbB signaling pathway 4609_1956_6714_5595_5594_5599_2066_5601_1399_1398_5578_6777_3725_867_6464 15 2.20E-11 1.76E-09 1.03E-10 1717 hsa-mir-1229 hsa05221 Acute myeloid leukemia 1147_4609_5970_5595_5594_595_8517_3815_3551_6774_6777_5371_4790 13 3.30E-11 2.64E-09 1.47E-10 1718 hsa-mir-1229 hsa04662 B cell receptor signaling pathway 1147_695_5970_4794_5595_5594_6850_8517_3551_3725_2353_4790_4792_4793 14 4.03E-11 3.22E-09 1.70E-10 1719 hsa-mir-1229 hsa05214 Glioma 1956_5595_5594_5159_595_5156_1019_5578_5925_808_6464_801_805 13 9.49E-11 7.59E-09 3.79E-10 1720 hsa-mir-1229 hsa04520 Adherens junction 1956_6714_3643_5595_5594_1387_1457_5770_71_6885_4088_4089_2033 13 9.18E-10 7.34E-08 3.50E-09 1721 hsa-mir-1229 hsa05210 Colorectal cancer 4609_1956_5595_5594_5599_5159_595_5156_5601_3725_2353_4088_4089 13 1.56E-09 1.25E-07 5.69E-09 1722 hsa-mir-1229 hsa04912 GnRH signaling pathway 1956_6714_5595_5594_5599_5601_5566_1432_5578_5608_3725_808_801_805 14 2.93E-09 2.34E-07 1.02E-08 1723 hsa-mir-1229 hsa04540 Gap junction 1956_6714_5595_5594_5159_5156_5566_5578_10382_347733_7278_203068_7846 13 4.75E-09 3.80E-07 1.58E-08 1724 hsa-mir-1229 hsa04510 Focal adhesion 1956_6714_5595_5594_5599_5159_595_5156_5601_1399_1398_5578_71_3725_894_896_6464 17 3.19E-08 2.55E-06 1.02E-07 1725 hsa-mir-1229 hsa04120 Ubiquitin mediated proteolysis 55294_8651_23291_997_672_51366_8454_10401_5371_8945_867_6500_64326_8554 14 5.46E-08 4.37E-06 1.68E-07 1726 hsa-mir-1229 hsa04930 Type II diabetes mellitus 8651_3643_5590_5595_5594_5599_5601_3551_8471 9 7.59E-08 6.07E-06 2.25E-07 1727 hsa-mir-1229 hsa05016 Huntington's disease 498_25942_5468_1387_292_6908_6667_1213_293_5437_3066_3065_2033_5441_4724 15 3.08E-07 2.47E-05 8.81E-07 1728 hsa-mir-1229 hsa04720 Long-term potentiation 814_5595_5594_1387_5566_5578_808_2033_801_805 10 4.28E-07 3.43E-05 1.18E-06 1729 hsa-mir-1229 hsa05219 Bladder cancer 4609_1956_5595_5594_595_1019_9252_5925 8 5.64E-07 4.51E-05 1.50E-06 1730 hsa-mir-1229 hsa03010 Ribosome 6124_6141_6155_6156_9349_6143_6129_6128_6207_6217_6188 11 7.88E-07 6.30E-05 2.03E-06 1731 hsa-mir-1229 hsa05223 Non-small cell lung cancer 1956_5595_5594_6256_595_1019_5578_5925 8 3.05E-06 0.000244396 7.64E-06 1732 hsa-mir-1229 hsa05131 Shigellosis 5578_71_10382_347733_7278_4691_203068_7846 8 3.90E-06 0.000311974 9.18E-06 1733 hsa-mir-1229 hsa05130 Pathogenic Escherichia coli infection 5578_71_10382_347733_7278_4691_203068_7846 8 3.90E-06 0.000311974 9.18E-06 1734 hsa-mir-1229 hsa04664 Fc epsilon RI signaling pathway 695_5595_5594_5599_6850_5601_1432_5578_5608 9 5.29E-06 0.000423184 1.21E-05 1735 hsa-mir-1229 hsa04916 Melanogenesis 5595_5594_1387_5566_3815_5578_808_2033_801_805 10 6.42E-06 0.000513548 1.43E-05 1736 hsa-mir-1229 hsa03020 RNA polymerase 64425_25885_5437_51082_84172_5441 6 1.00E-05 0.000802536 2.11E-05 1737 hsa-mir-1229 hsa05216 Thyroid cancer 4609_5468_5595_5594_6256_595 6 1.00E-05 0.000802536 2.11E-05 1738 hsa-mir-1229 hsa04330 Notch signaling pathway 1387_4851_9612_3066_3065_2033_8850 7 1.24E-05 0.000991236 2.54E-05 1739 hsa-mir-1229 hsa04210 Apoptosis 1147_5970_5566_8517_3551_9131_9020_4790_4792 9 1.28E-05 0.001026481 2.57E-05 1740 hsa-mir-1229 hsa04115 p53 signaling pathway 1111_595_898_1019_1017_64326_894_896 8 1.57E-05 0.001259267 3.07E-05 1741 hsa-mir-1229 hsa05218 Melanoma 1956_5595_5594_5159_595_5156_1019_5925 8 1.90E-05 0.001522522 3.63E-05 1742 hsa-mir-1229 hsa05211 Renal cell carcinoma 5595_5594_1387_1399_1398_5781_3725_2033 8 2.09E-05 0.001670562 3.89E-05 1743 hsa-mir-1229 hsa05340 Primary immunodeficiency 3718_695_3932_3561_3575_8517 6 2.58E-05 0.002066154 4.70E-05 1744 hsa-mir-1229 hsa04020 Calcium signaling pathway 814_1956_292_2066_5159_5156_5566_5578_293_808_801_805 12 3.12E-05 0.00249513 5.54E-05 1745 hsa-mir-1229 hsa03022 Basal transcription factors 2969_6878_6908_6872_6882_2959 6 3.42E-05 0.002733918 5.94E-05 1746 hsa-mir-1229 hsa04530 Tight junction 5515_5519_6714_5590_1457_1019_5578_71_4628 9 0.000286849 0.022947923 0.000488254 1747 hsa-mir-1229 hsa04810 Regulation of actin cytoskeleton 1956_5595_5594_5159_5156_1399_1398_71_4628_4342_10788 11 0.000564352 0.045148147 0.000940586 1748 hsa-mir-1229 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6850_919_5578_5781_6464 8 0.001330112 0.106408978 0.002171612 1749 hsa-mir-1229 hsa05213 Endometrial cancer 4609_1956_5595_5594_595 5 0.001392824 0.111425903 0.002228518 1750 hsa-mir-1229 hsa04060 Cytokine-cytokine receptor interaction 85480_1956_3560_3561_5159_5156_3575_1234_3815_2690_2057 11 0.002234982 0.178798526 0.003505853 1751 hsa-mir-1229 hsa04270 Vascular smooth muscle contraction 5595_5594_5566_5578_808_801_805 7 0.002324812 0.185984937 0.003576633 1752 hsa-mir-1229 hsa04612 Antigen processing and presentation 3320_3326_3309_3305_3303_3312 6 0.00259614 0.207691209 0.003918702 1753 hsa-mir-1229 hsa04730 Long-term depression 5515_5519_5595_5594_5578 5 0.004917881 0.393430453 0.007285749 1754 hsa-mir-1229 hsa04370 VEGF signaling pathway 6714_5595_5594_1432_5578 5 0.006771911 0.541752912 0.009850053 1755 hsa-mir-1229 hsa05012 Parkinson's disease 498_7314_292_293_7345_4724 6 0.017446439 1 0.024923485 1756 hsa-mir-1229 hsa05010 Alzheimer's disease 498_5595_5594_808_4724_801_805 7 0.017979711 1 0.025234682 1757 hsa-mir-1229 hsa03410 Base excision repair 5111_142_3146 3 0.018658448 1 0.025735791 1758 hsa-mir-1229 hsa03320 PPAR signaling pathway 10062_5468_6256_5465 4 0.022418418 1 0.030397854 1759 hsa-mir-1229 hsa04070 Phosphatidylinositol signaling system 5578_808_801_805 4 0.02882885 1 0.038438467 1760 hsa-mir-1229 hsa04670 Leukocyte transendothelial migration 1432_5578_71_5781_653361 5 0.037523933 1 0.049211715 1761 hsa-mir-1231 hsa05200 Pathways in cancer 7046_595_596_598_1017_4193_5578_3091_3066_3065_5925_613_5743_5747_25_1956_6789_2064_4436_5970_6774_207_3716_1147_998_367_4233_2261_5595_5594_5599_1387_10401_2932_6777_6772_5979_5879_1869_3725_6776_4087_4088_4089_5888_5728_2033_675_3910_4790_4792_3320_3326_5371_3480_5159_5156_5601_5602_1856_3815_51588_8772_1026_2353_1441_8554 67 1.11E-48 9.43E-47 9.43E-47 1762 hsa-mir-1231 hsa04110 Cell cycle 595_1017_4193_902_4174_4172_3066_3065_5925_25_9232_545_995_5347_5591_1387_11200_7534_7532_2932_7027_1869_4087_4088_4089_2033_890_1031_983_1026_1022_1111_8556_8555_472 35 1.56E-30 1.33E-28 6.65E-29 1763 hsa-mir-1231 hsa04630 Jak-STAT signaling pathway 3559_595_598_58985_3454_3455_3459_3560_3561_1439_6774_2690_207_3717_3716_3718_85480_1387_3575_3570_3572_10401_6777_6772_6773_7297_6776_2033_149233_3953_51588_10379_5781_1441_8554 35 3.42E-27 2.91E-25 9.69E-26 1764 hsa-mir-1231 hsa05215 Prostate cancer 595_596_1017_4193_5925_1956_2064_5970_207_1147_367_5595_5594_1387_2932_1869_5728_2033_4790_4792_3320_3326_3480_5159_5156_1026 26 4.99E-23 4.24E-21 1.06E-21 1765 hsa-mir-1231 hsa05212 Pancreatic cancer 595_596_1017_4193_5925_1956_2064_5970_207_1147_367_5595_5594_1387_2932_1869_5728_2033_4790_4792_3320_3326_3480_5159_5156_1026 26 6.36E-23 5.40E-21 1.08E-21 1766 hsa-mir-1231 hsa05220 Chronic myeloid leukemia 7046_595_598_4193_3066_3065_5925_613_25_5970_207_1147_5595_5594_6777_1869_6776_4088_4089_4790_4792_5781_1026 23 7.99E-21 6.79E-19 1.13E-19 1767 hsa-mir-1231 hsa04010 MAPK signaling pathway 3925_7046_2264_9252_5578_1845_7132_5923_1956_3304_3305_3303_6789_1432_5970_1616_207_1147_998_2261_5595_5594_5599_3315_5879_3164_3725_4790_51701_5159_5156_5601_5602_6885_2353 35 5.34E-20 4.54E-18 6.48E-19 1768 hsa-mir-1231 hsa05210 Colorectal cancer 7046_595_596_1956_4436_207_4233_5595_5594_5599_2932_5879_3725_4087_4088_4089_3480_5159_5156_5601_5602_1856_2353 23 6.84E-20 5.81E-18 7.26E-19 1769 hsa-mir-1231 hsa04060 Cytokine-cytokine receptor interaction 3556_3559_7046_1234_1230_7132_58985_3454_3455_3459_90_3791_1956_3560_3561_1439_7852_6362_2690_85480_4233_3575_3570_3572_959_2321_149233_5159_5156_3815_3953_7133_1441 33 1.03E-18 8.76E-17 9.74E-18 1770 hsa-mir-1231 hsa04520 Adherens junction 7046_2241_2534_1956_6714_2064_1460_998_4233_5595_5594_1387_5879_1457_4087_4088_4089_2033_51701_3480_6885 21 5.88E-18 5.00E-16 5.00E-17 1771 hsa-mir-1231 hsa04510 Focal adhesion 595_596_5578_5923_2534_5747_3791_1956_6714_5499_2064_207_998_4233_5595_5594_5599_2932_5879_3725_5728_3910_2321_3480_5159_5156_5601_5602 28 7.83E-17 6.66E-15 6.05E-16 1772 hsa-mir-1231 hsa04115 p53 signaling pathway 595_1017_4194_4193_900_50484_6241_51246_545_7161_11200_64326_5728_27113_25898_983_1026_1111_472 19 1.06E-16 9.04E-15 7.54E-16 1773 hsa-mir-1231 hsa04310 Wnt signaling pathway 818_817_595_5578_1460_5599_1387_2932_5879_3725_1457_1452_4087_4088_4089_2033_51701_5518_5515_5601_5602_1856_6885_5527 24 6.51E-16 5.53E-14 4.26E-15 1774 hsa-mir-1231 hsa04012 ErbB signaling pathway 818_817_5578_5747_25_1956_6714_2064_207_5595_5594_5599_2932_6777_3725_6776_5601_5602_1026 19 4.13E-15 3.51E-13 2.50E-14 1775 hsa-mir-1231 hsa04620 Toll-like receptor signaling pathway 3454_3455_1432_5970_207_1147_3654_5595_5594_5599_6772_5879_3725_4790_4792_5601_5602_8772_6885_2353 20 4.70E-15 4.00E-13 2.66E-14 1776 hsa-mir-1231 hsa04062 Chemokine signaling pathway 2185_1234_1230_5747_5580_5590_7852_5970_6362_6774_207_3055_3717_1147_3718_998_5595_5594_2932_6777_6772_6773_5879_4790_4792 25 9.83E-15 8.36E-13 5.22E-14 1777 hsa-mir-1231 hsa04920 Adipocytokine signaling pathway 6794_7132_8717_5970_6774_207_3717_1147_5599_4790_4792_5601_5602_5563_3953_5781_7133 17 1.39E-14 1.18E-12 6.97E-14 1778 hsa-mir-1231 hsa05222 Small cell lung cancer 595_596_598_1017_5925_5743_5747_5970_207_1147_10401_1869_5728_3910_4790_4792_51588_8554 18 4.15E-14 3.52E-12 1.96E-13 1779 hsa-mir-1231 hsa05214 Glioma 818_817_595_4193_5578_5925_1956_207_5595_5594_1869_5728_3480_5159_5156_1026 16 1.25E-13 1.07E-11 5.61E-13 1780 hsa-mir-1231 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_1432_5970_1147_998_4233_5599_5879_3725_4790_4792_5601_5602_5781 15 4.95E-12 4.21E-10 2.10E-11 1781 hsa-mir-1231 hsa04660 T cell receptor signaling pathway 2534_3932_1432_5970_207_1147_998_5595_5594_2932_3725_959_4790_4792_5601_6885_2353 17 1.57E-11 1.34E-09 6.37E-11 1782 hsa-mir-1231 hsa05218 Melanoma 595_4193_5925_1956_207_4233_5595_5594_1869_5728_3480_5159_5156_1026 14 5.72E-11 4.86E-09 2.21E-10 1783 hsa-mir-1231 hsa04350 TGF-beta signaling pathway 7046_90_57154_6667_5595_5594_1387_7027_4086_4087_4088_4089_2033_5518_5515 15 6.31E-11 5.37E-09 2.33E-10 1784 hsa-mir-1231 hsa04210 Apoptosis 3556_596_598_7132_8717_823_1439_5970_207_1147_3654_4790_4792_8772_472 15 8.39E-11 7.13E-09 2.97E-10 1785 hsa-mir-1231 hsa05219 Bladder cancer 595_9252_4193_5925_1956_2064_2261_5595_5594_1869_1026 11 4.97E-10 4.22E-08 1.69E-09 1786 hsa-mir-1231 hsa04912 GnRH signaling pathway 818_817_2185_5578_5580_1956_6714_1432_998_5595_5594_5599_3725_5601_5602 15 9.42E-10 8.00E-08 3.08E-09 1787 hsa-mir-1231 hsa05221 Acute myeloid leukemia 595_5970_6774_207_1147_5595_5594_6777_6776_4790_5371_3815 12 9.98E-10 8.48E-08 3.14E-09 1788 hsa-mir-1231 hsa04662 B cell receptor signaling pathway 6850_5970_207_1147_5595_5594_1380_2932_5879_3725_4790_4792_2353 13 1.13E-09 9.61E-08 3.43E-09 1789 hsa-mir-1231 hsa04120 Ubiquitin mediated proteolysis 4193_3093_57154_7319_84447_7329_10055_10401_64326_7337_5371_672_25898_51588_10075_8554 16 3.09E-09 2.63E-07 9.07E-09 1790 hsa-mir-1231 hsa04370 VEGF signaling pathway 5578_5743_5747_3791_6714_1432_207_998_5595_5594_3315_5879 12 1.44E-08 1.22E-06 4.07E-08 1791 hsa-mir-1231 hsa04664 Fc epsilon RI signaling pathway 5578_2534_5580_6850_1432_207_5595_5594_5599_5879_5601_5602 12 1.86E-08 1.58E-06 5.09E-08 1792 hsa-mir-1231 hsa05223 Non-small cell lung cancer 595_5578_5925_1956_6789_2064_207_5595_5594_1869 10 5.50E-08 4.67E-06 1.46E-07 1793 hsa-mir-1231 hsa05211 Renal cell carcinoma 3091_207_998_4233_5595_5594_1387_5879_3725_2033_5781 11 6.92E-08 5.88E-06 1.78E-07 1794 hsa-mir-1231 hsa03420 Nucleotide excision repair 902_2965_4331_2071_2074_6118_1022_6117 8 1.35E-06 0.000115161 3.39E-06 1795 hsa-mir-1231 hsa04330 Notch signaling pathway 3066_3065_3280_1387_2033_8850_388585_1856 8 2.10E-06 0.000178863 5.11E-06 1796 hsa-mir-1231 hsa04360 Axon guidance 2534_5747_25_7852_2242_998_4233_5595_5594_2932_5879_1020 12 2.69E-06 0.000228868 6.36E-06 1797 hsa-mir-1231 hsa05213 Endometrial cancer 595_1956_2064_207_5595_5594_2932_5728 8 4.13E-06 0.000351131 9.25E-06 1798 hsa-mir-1231 hsa04530 Tight junction 5578_5580_5590_6714_207_1460_998_1457_5728_5518_5515_5520 12 4.13E-06 0.000351414 9.25E-06 1799 hsa-mir-1231 hsa04650 Natural killer cell mediated cytotoxicity 2185_5578_3454_3455_3459_2534_3932_6850_5595_5594_5879_5781 12 4.43E-06 0.000376662 9.66E-06 1800 hsa-mir-1231 hsa03022 Basal transcription factors 51616_2965_2969_6908_2958_6880_2957 7 4.98E-06 0.000423095 1.06E-05 1801 hsa-mir-1231 hsa04916 Melanogenesis 818_817_5578_5595_5594_1387_2932_2033_1856_3815 10 1.23E-05 0.001049673 2.56E-05 1802 hsa-mir-1231 hsa04930 Type II diabetes mellitus 5580_5590_5595_5594_5599_5601_5602 7 1.56E-05 0.001326717 3.16E-05 1803 hsa-mir-1231 hsa04540 Gap junction 5578_1956_6714_5595_5594_1453_5159_983_5156 9 3.20E-05 0.002721177 6.33E-05 1804 hsa-mir-1231 hsa03030 DNA replication 4174_4172_5557_6118_6117_5422 6 4.53E-05 0.003850065 8.75E-05 1805 hsa-mir-1231 hsa04720 Long-term potentiation 818_817_5578_5499_5595_5594_1387_2033 8 4.66E-05 0.003960633 8.80E-05 1806 hsa-mir-1231 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_7132_1432_1616_5879_7133 7 5.57E-05 0.004735006 0.000102935 1807 hsa-mir-1231 hsa04910 Insulin signaling pathway 5590_5499_207_5595_5594_5599_2932_5601_5602_5563 10 0.000115586 0.00982481 0.000209039 1808 hsa-mir-1231 hsa03440 Homologous recombination 641_5888_675_6118_6117 5 0.000149113 0.012674584 0.000264054 1809 hsa-mir-1231 hsa04150 mTOR signaling pathway 6794_3091_207_5595_5594_5563 6 0.000283279 0.024078753 0.000491403 1810 hsa-mir-1231 hsa05340 Primary immunodeficiency 3932_3561_3718_3575_959 5 0.000378001 0.032130082 0.000642602 1811 hsa-mir-1231 hsa05131 Shigellosis 5578_2534_25_998_7534_4691 6 0.000408303 0.034705742 0.000667418 1812 hsa-mir-1231 hsa05130 Pathogenic Escherichia coli infection 5578_2534_25_998_7534_4691 6 0.000408303 0.034705742 0.000667418 1813 hsa-mir-1231 hsa04612 Antigen processing and presentation 3309_3304_3305_3303_3320_3326_2923 7 0.00077304 0.065708394 0.001239781 1814 hsa-mir-1231 hsa04670 Leukocyte transendothelial migration 2185_5578_5747_1432_7852_998_5879_5781 8 0.001017521 0.086489278 0.001601653 1815 hsa-mir-1231 hsa04810 Regulation of actin cytoskeleton 2264_5747_1956_5499_998_2261_5595_5594_5879_5159_5156 11 0.001042218 0.088588503 0.0016107 1816 hsa-mir-1231 hsa04730 Long-term depression 5578_5595_5594_3480_5518_5515 6 0.001294756 0.11005429 0.001965255 1817 hsa-mir-1231 hsa05216 Thyroid cancer 595_5595_5594_5979 4 0.001666975 0.141692869 0.00248584 1818 hsa-mir-1231 hsa04640 Hematopoietic cell lineage 3559_1380_3575_3570_3815_1441 6 0.003381548 0.287431622 0.004867091 1819 hsa-mir-1231 hsa03410 Base excision repair 3146_142_4913_328 4 0.003417395 0.290478599 0.004867091 1820 hsa-mir-1231 hsa04020 Calcium signaling pathway 818_817_2185_5578_147_1956_2064_5159_5156 9 0.003435594 0.29202545 0.004867091 1821 hsa-mir-1231 hsa05016 Huntington's disease 3066_3065_3064_25942_6667_1387_2033_27113_6908 9 0.0039305 0.334092536 0.005476927 1822 hsa-mir-1231 hsa03430 Mismatch repair 4436_6118_6117 3 0.007495393 0.637108392 0.010275942 1823 hsa-mir-1231 hsa04950 Maturity onset diabetes of the young 6927_3280_3172 3 0.008336116 0.708569896 0.011247141 1824 hsa-mir-1231 hsa04270 Vascular smooth muscle contraction 5578_147_5580_5499_5595_5594 6 0.013286319 1 0.017645892 1825 hsa-mir-1231 hsa04710 Circadian rhythm - mammal 1453_8553 2 0.022259675 1 0.029108806 1826 hsa-mir-1231 hsa03450 Non-homologous end-joining 2547_5591 2 0.025180827 1 0.032429853 1827 hsa-mir-1231 hsa05010 Alzheimer's disease 7132_823_5595_5594_2932_8772_1020 7 0.025804444 1 0.032736982 1828 hsa-mir-1236 hsa04110 Cell cycle 4088_983_595_993_5925_2033_894_896_1387 9 5.06E-13 1.87E-11 1.87E-11 1829 hsa-mir-1236 hsa04310 Wnt signaling pathway 4088_595_2033_894_896_3725_1387 7 6.24E-09 2.31E-07 1.15E-07 1830 hsa-mir-1236 hsa05200 Pathways in cancer 4088_595_5925_2033_367_3725_1387_2353 8 6.30E-08 2.33E-06 7.77E-07 1831 hsa-mir-1236 hsa05215 Prostate cancer 595_5925_2033_367_1387 5 3.93E-07 1.45E-05 3.07E-06 1832 hsa-mir-1236 hsa05212 Pancreatic cancer 595_5925_2033_367_1387 5 4.14E-07 1.53E-05 3.07E-06 1833 hsa-mir-1236 hsa04330 Notch signaling pathway 8850_9612_2033_1387 4 1.36E-06 5.01E-05 8.36E-06 1834 hsa-mir-1236 hsa04630 Jak-STAT signaling pathway 595_2033_894_896_1387 5 5.72E-06 0.000211713 2.66E-05 1835 hsa-mir-1236 hsa04115 p53 signaling pathway 983_595_894_896 4 5.75E-06 0.00021283 2.66E-05 1836 hsa-mir-1236 hsa05210 Colorectal cancer 4088_595_3725_2353 4 1.21E-05 0.000448039 4.98E-05 1837 hsa-mir-1236 hsa05211 Renal cell carcinoma 2033_3725_1387 3 0.000238273 0.008816093 0.000881609 1838 hsa-mir-1236 hsa05220 Chronic myeloid leukemia 4088_595_5925 3 0.000267546 0.009899201 0.000899927 1839 hsa-mir-1236 hsa04520 Adherens junction 4088_2033_1387 3 0.000321325 0.011889041 0.000990753 1840 hsa-mir-1236 hsa04510 Focal adhesion 595_894_896_3725 4 0.000354554 0.013118513 0.001009116 1841 hsa-mir-1236 hsa04350 TGF-beta signaling pathway 4088_2033_1387 3 0.000407643 0.015082809 0.001077344 1842 hsa-mir-1236 hsa05219 Bladder cancer 595_5925 2 0.002264782 0.083796921 0.005586461 1843 hsa-mir-1236 hsa05016 Huntington's disease 2033_25942_1387 3 0.003543673 0.131115887 0.007927076 1844 hsa-mir-1236 hsa05223 Non-small cell lung cancer 595_5925 2 0.00364217 0.134760299 0.007927076 1845 hsa-mir-1236 hsa05214 Glioma 595_5925 2 0.005171062 0.191329308 0.010629406 1846 hsa-mir-1236 hsa05218 Melanoma 595_5925 2 0.006109057 0.226035094 0.011896584 1847 hsa-mir-1236 hsa04720 Long-term potentiation 2033_1387 2 0.006774271 0.250648017 0.01193562 1848 hsa-mir-1236 hsa04662 B cell receptor signaling pathway 3725_2353 2 0.006774271 0.250648017 0.01193562 1849 hsa-mir-1236 hsa05222 Small cell lung cancer 595_5925 2 0.008764406 0.32428302 0.014740137 1850 hsa-mir-1236 hsa04620 Toll-like receptor signaling pathway 3725_2353 2 0.012066038 0.446443408 0.019288672 1851 hsa-mir-1236 hsa04916 Melanogenesis 2033_1387 2 0.012511571 0.46292812 0.019288672 1852 hsa-mir-1236 hsa04660 T cell receptor signaling pathway 3725_2353 2 0.013890774 0.51395865 0.020558346 1853 hsa-mir-1236 hsa05216 Thyroid cancer 595 1 0.046851743 1 0.066673635 1854 hsa-mir-1237 hsa04010 MAPK signaling pathway 1432_9344_6722_5606_5601_5600_2885_1649_3725_5595_5594_5604_5599_2005_2353_1386 16 1.36E-15 7.48E-14 7.48E-14 1855 hsa-mir-1237 hsa05210 Colorectal cancer 4088_5601_2885_4089_3725_5595_5594_5604_5599_2353 10 5.43E-13 2.99E-11 1.49E-11 1856 hsa-mir-1237 hsa04620 Toll-like receptor signaling pathway 1432_5606_5601_5600_3725_5595_5594_5604_5599_2353 10 3.24E-12 1.78E-10 5.94E-11 1857 hsa-mir-1237 hsa04912 GnRH signaling pathway 1432_5606_5601_5600_2885_3725_5595_5594_5604_5599 10 5.50E-12 3.02E-10 7.05E-11 1858 hsa-mir-1237 hsa05200 Pathways in cancer 4088_5601_2885_5925_2033_4089_9063_3725_5595_5594_5604_5599_2353_1387 14 6.41E-12 3.53E-10 7.05E-11 1859 hsa-mir-1237 hsa04664 Fc epsilon RI signaling pathway 1432_5606_5601_5600_2885_5595_5594_5604_5599 9 1.19E-11 6.54E-10 1.09E-10 1860 hsa-mir-1237 hsa04350 TGF-beta signaling pathway 4088_2033_4089_5595_5594_3397_3399_3398_1387 9 2.64E-11 1.45E-09 2.08E-10 1861 hsa-mir-1237 hsa04660 T cell receptor signaling pathway 1432_5601_5600_2885_3725_5595_5594_5604_2353 9 1.85E-10 1.02E-08 1.28E-09 1862 hsa-mir-1237 hsa05211 Renal cell carcinoma 2885_2033_3725_5595_5594_5604_1387 7 6.95E-09 3.82E-07 4.25E-08 1863 hsa-mir-1237 hsa05220 Chronic myeloid leukemia 4088_2885_5925_4089_5595_5594_5604 7 9.05E-09 4.98E-07 4.98E-08 1864 hsa-mir-1237 hsa04012 ErbB signaling pathway 5601_2885_3725_5595_5594_5604_5599 7 2.36E-08 1.30E-06 1.16E-07 1865 hsa-mir-1237 hsa05215 Prostate cancer 2885_5925_2033_5595_5594_5604_1387 7 2.54E-08 1.40E-06 1.16E-07 1866 hsa-mir-1237 hsa05212 Pancreatic cancer 2885_5925_2033_5595_5594_5604_1387 7 2.73E-08 1.50E-06 1.16E-07 1867 hsa-mir-1237 hsa04310 Wnt signaling pathway 4088_5601_2033_4089_8061_3725_5599_1387 8 5.18E-08 2.85E-06 2.03E-07 1868 hsa-mir-1237 hsa04110 Cell cycle 4088_983_5925_2033_4089_993_1387 7 1.79E-07 9.85E-06 6.57E-07 1869 hsa-mir-1237 hsa04662 B cell receptor signaling pathway 2885_3725_5595_5594_5604_2353 6 2.56E-07 1.41E-05 8.80E-07 1870 hsa-mir-1237 hsa04520 Adherens junction 4088_2033_4089_5595_5594_1387 6 3.66E-07 2.01E-05 1.18E-06 1871 hsa-mir-1237 hsa05223 Non-small cell lung cancer 2885_5925_5595_5594_5604 5 1.37E-06 7.52E-05 4.18E-06 1872 hsa-mir-1237 hsa05214 Glioma 2885_5925_5595_5594_5604 5 3.21E-06 0.000176707 9.30E-06 1873 hsa-mir-1237 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_5601_5600_3725_5599 5 4.83E-06 0.000265653 1.33E-05 1874 hsa-mir-1237 hsa04510 Focal adhesion 5601_2885_3725_5595_5594_5604_5599 7 6.04E-06 0.000331939 1.56E-05 1875 hsa-mir-1237 hsa04720 Long-term potentiation 2033_5595_5594_5604_1387 5 6.22E-06 0.000342178 1.56E-05 1876 hsa-mir-1237 hsa04370 VEGF signaling pathway 1432_5600_5595_5594_5604 5 7.03E-06 0.000386402 1.68E-05 1877 hsa-mir-1237 hsa04910 Insulin signaling pathway 5601_2885_5595_5594_5604_5599 6 7.46E-06 0.000410535 1.71E-05 1878 hsa-mir-1237 hsa05219 Bladder cancer 5925_5595_5594_5604 4 1.49E-05 0.000820068 3.28E-05 1879 hsa-mir-1237 hsa04540 Gap junction 983_2885_5595_5594_5604 5 1.68E-05 0.000923406 3.55E-05 1880 hsa-mir-1237 hsa04930 Type II diabetes mellitus 5601_5595_5594_5599 4 1.92E-05 0.001056907 3.91E-05 1881 hsa-mir-1237 hsa04916 Melanogenesis 2033_5595_5594_5604_1387 5 2.81E-05 0.001544794 5.52E-05 1882 hsa-mir-1237 hsa05213 Endometrial cancer 2885_5595_5594_5604 4 3.27E-05 0.001800806 6.21E-05 1883 hsa-mir-1237 hsa05221 Acute myeloid leukemia 2885_5595_5594_5604 4 5.22E-05 0.002870559 9.57E-05 1884 hsa-mir-1237 hsa05218 Melanoma 5925_5595_5594_5604 4 0.000103396 0.005686771 0.000183444 1885 hsa-mir-1237 hsa05216 Thyroid cancer 5595_5594_5604 3 0.000150396 0.008271789 0.000258493 1886 hsa-mir-1237 hsa04330 Notch signaling pathway 2033_8850_1387 3 0.000569859 0.031342228 0.000949764 1887 hsa-mir-1237 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_5606_5600 3 0.00092557 0.050906362 0.001497246 1888 hsa-mir-1237 hsa04650 Natural killer cell mediated cytotoxicity 2885_5595_5594_5604 4 0.001171578 0.064436783 0.001836917 1889 hsa-mir-1237 hsa04120 Ubiquitin mediated proteolysis 7329_64326_9063_672 4 0.001202346 0.066129003 0.001836917 1890 hsa-mir-1237 hsa04630 Jak-STAT signaling pathway 2885_2033_9063_1387 4 0.001774757 0.097611634 0.002579705 1891 hsa-mir-1237 hsa04730 Long-term depression 5595_5594_5604 3 0.001782342 0.098028783 0.002579705 1892 hsa-mir-1237 hsa04062 Chemokine signaling pathway 2885_5595_5594_5604 4 0.003840135 0.211207414 0.005415575 1893 hsa-mir-1237 hsa04270 Vascular smooth muscle contraction 5595_5594_5604 3 0.00710151 0.390583035 0.009764576 1894 hsa-mir-1237 hsa04150 mTOR signaling pathway 5595_5594 2 0.013193739 0.725655657 0.017698918 1895 hsa-mir-1237 hsa05010 Alzheimer's disease 6622_5595_5594 3 0.02058267 1 0.026817828 1896 hsa-mir-1237 hsa04920 Adipocytokine signaling pathway 5601_5599 2 0.020966666 1 0.026817828 1897 hsa-mir-1237 hsa04115 p53 signaling pathway 983_64326 2 0.022117092 1 0.027646365 1898 hsa-mir-1237 hsa05016 Huntington's disease 2033_6908_1387 3 0.024004056 1 0.02933829 1899 hsa-mir-1237 hsa05222 Small cell lung cancer 5925_9063 2 0.03289369 1 0.039329412 1900 hsa-mir-1237 hsa04810 Regulation of actin cytoskeleton 5595_5594_5604 3 0.035198795 1 0.041190079 1901 hsa-mir-124-1 hsa05200 Pathways in cancer 3551_1499_596_598_1017_8517_4193_7704_5578_6502_3091_2736_7175_3065_5925_613_7186_5743_5747_25_1487_1488_6789_4436_2113_862_207_1147_998_367_5595_5594_5599_861_1387_6256_836_2932_6774_5970_7157_6688_1869_3725_4087_4088_4089_5888_5728_2033_3910_4791_4792_3320_3326_5371_675_5601_5602_1856_51588_1026_2353_8554 64 4.17E-36 3.71E-34 3.71E-34 1902 hsa-mir-124-1 hsa04110 Cell cycle 1017_4193_902_6502_6500_3065_5925_25_891_10971_9232_545_995_5347_5591_1387_11200_7534_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_1031_983_8454_1026_1022_1111_8556_8555_472 37 1.66E-27 1.48E-25 7.38E-26 1903 hsa-mir-124-1 hsa04010 MAPK signaling pathway 6722_3551_6195_6197_8517_9252_7867_5578_4773_5923_7186_3304_3303_6789_1432_3305_1616_207_1147_998_5595_5594_5599_5598_8986_836_3310_3312_3315_5971_5970_3164_7157_3725_6196_4791_9261_1326_4208_5601_5602_2353_5566 43 1.51E-21 1.34E-19 4.48E-20 1904 hsa-mir-124-1 hsa04310 Wnt signaling pathway 1499_5578_6500_8945_4773_23291_1487_1488_8607_1460_5599_1387_2932_7157_3725_1457_1452_4087_4088_4089_2033_5518_5515_5601_5602_1856_8454_5527_5566 29 6.98E-17 6.21E-15 1.55E-15 1905 hsa-mir-124-1 hsa05220 Chronic myeloid leukemia 3551_598_8517_4193_3065_5925_613_25_1487_1488_207_1147_5595_5594_861_5970_7157_1869_4088_4089_4792_1026 22 1.91E-16 1.70E-14 3.41E-15 1906 hsa-mir-124-1 hsa05215 Prostate cancer 3551_1499_596_1017_8517_4193_5925_207_1147_367_5595_5594_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_1026 23 3.33E-16 2.96E-14 4.94E-15 1907 hsa-mir-124-1 hsa05212 Pancreatic cancer 3551_1499_596_1017_8517_4193_5925_207_1147_367_5595_5594_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_1026 23 4.11E-16 3.65E-14 5.22E-15 1908 hsa-mir-124-1 hsa04115 p53 signaling pathway 1017_4194_4193_50484_6241_891_51246_545_7161_11200_836_7157_900_64326_5728_27113_25898_983_1026_1111_472 21 4.99E-16 4.44E-14 5.55E-15 1909 hsa-mir-124-1 hsa05222 Small cell lung cancer 3551_596_598_1017_8517_6502_5925_7186_5743_5747_207_1147_6256_5970_7157_1869_5728_3910_4792_51588_8554 21 2.05E-14 1.82E-12 2.03E-13 1910 hsa-mir-124-1 hsa04350 TGF-beta signaling pathway 6500_3398_3400_6667_3397_3399_5595_5594_1387_7027_4086_4087_4088_4089_2033_5518_5515_8454_4093 19 1.98E-12 1.76E-10 1.76E-11 1911 hsa-mir-124-1 hsa05210 Colorectal cancer 1499_596_4436_207_5595_5594_5599_836_2932_7157_3725_4087_4088_4089_5601_5602_1856_2353 18 9.95E-12 8.85E-10 7.72E-11 1912 hsa-mir-124-1 hsa04120 Ubiquitin mediated proteolysis 4193_6502_6500_3093_8945_23291_7319_84447_7325_7329_10055_10273_64326_7337_5371_672_25898_7323_8454_51588_10075_8554 22 1.04E-11 9.27E-10 7.72E-11 1913 hsa-mir-124-1 hsa04920 Adipocytokine signaling pathway 3551_6794_8517_7186_4794_207_1147_5599_6256_6774_5970_4792_4793_5601_5602_5563 16 3.49E-11 3.10E-09 2.39E-10 1914 hsa-mir-124-1 hsa04660 T cell receptor signaling pathway 3551_8517_4773_4794_1432_207_1147_998_5595_5594_2932_5970_3725_959_4792_4793_1326_5601_2353 19 7.10E-11 6.32E-09 4.52E-10 1915 hsa-mir-124-1 hsa04662 B cell receptor signaling pathway 3551_8517_4773_4794_207_1147_5595_5594_1380_2932_5970_3725_4792_4793_2353 15 1.22E-09 1.09E-07 7.24E-09 1916 hsa-mir-124-1 hsa04210 Apoptosis 3551_596_598_8517_8837_7186_823_207_1147_836_5970_7157_4792_840_472_5566 16 1.35E-09 1.20E-07 7.50E-09 1917 hsa-mir-124-1 hsa05131 Shigellosis 1499_5578_10382_25_10971_998_7534_203068_347733_7278_71_84617_4691 13 3.27E-09 2.91E-07 1.62E-08 1918 hsa-mir-124-1 hsa05130 Pathogenic Escherichia coli infection 1499_5578_10382_25_10971_998_7534_203068_347733_7278_71_84617_4691 13 3.27E-09 2.91E-07 1.62E-08 1919 hsa-mir-124-1 hsa05221 Acute myeloid leukemia 3551_8517_7704_862_207_1147_5595_5594_861_6774_5970_6688_5371 13 5.64E-09 5.02E-07 2.64E-08 1920 hsa-mir-124-1 hsa05214 Glioma 4193_5578_5925_207_5595_5594_7157_1869_5728_808_801_805_1026 13 1.55E-08 1.38E-06 6.91E-08 1921 hsa-mir-124-1 hsa04620 Toll-like receptor signaling pathway 3551_8517_1432_207_1147_5595_5594_5599_5970_3725_4792_1326_5601_5602_2353 15 4.86E-08 4.32E-06 2.06E-07 1922 hsa-mir-124-1 hsa04720 Long-term potentiation 6195_6197_5578_5499_5595_5594_1387_6196_2033_808_801_805_5566 13 6.91E-08 6.15E-06 2.80E-07 1923 hsa-mir-124-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3551_8517_1432_1147_998_5599_836_5970_3725_4792_5601_5602 12 2.81E-07 2.50E-05 1.09E-06 1924 hsa-mir-124-1 hsa04330 Notch signaling pathway 3065_1487_1488_1387_9612_2033_8850_1856_388585_4851 10 4.35E-07 3.87E-05 1.61E-06 1925 hsa-mir-124-1 hsa04912 GnRH signaling pathway 5578_1432_998_5595_5594_5599_5598_3725_808_801_805_5601_5602_5566 14 5.43E-07 4.83E-05 1.93E-06 1926 hsa-mir-124-1 hsa04370 VEGF signaling pathway 7867_5578_4773_5743_5747_1432_207_998_5595_5594_3315_9261 12 6.10E-07 5.43E-05 2.09E-06 1927 hsa-mir-124-1 hsa04540 Gap junction 5578_10382_5592_5595_5594_5598_1453_203068_347733_983_7278_84617_5566 13 6.37E-07 5.67E-05 2.10E-06 1928 hsa-mir-124-1 hsa04510 Focal adhesion 1499_596_5578_5923_5747_5499_10627_207_998_5595_5594_5599_2932_3725_5728_3910_5601_5602_71 19 7.13E-07 6.34E-05 2.27E-06 1929 hsa-mir-124-1 hsa04520 Adherens junction 1499_1460_998_5595_5594_1387_1457_4087_4088_4089_2033_71 12 8.78E-07 7.82E-05 2.70E-06 1930 hsa-mir-124-1 hsa04012 ErbB signaling pathway 5578_5747_25_207_5595_5594_5599_2932_3725_5601_5602_1026 12 1.94E-06 0.000173076 5.77E-06 1931 hsa-mir-124-1 hsa03022 Basal transcription factors 51616_2965_2963_2969_6908_2958_6880_2957 8 5.66E-06 0.000503718 1.62E-05 1932 hsa-mir-124-1 hsa04530 Tight junction 1499_5578_4627_4628_10627_207_1460_998_1457_5728_5518_5515_71_5520 14 6.98E-06 0.000621133 1.94E-05 1933 hsa-mir-124-1 hsa04150 mTOR signaling pathway 6794_6195_6197_3091_207_5595_5594_6196_5563 9 7.33E-06 0.000652809 1.97E-05 1934 hsa-mir-124-1 hsa04910 Insulin signaling pathway 3551_5499_207_5595_5594_5599_2932_808_801_805_5601_5602_5563_5566 14 7.53E-06 0.000670489 1.97E-05 1935 hsa-mir-124-1 hsa05223 Non-small cell lung cancer 5578_5925_6789_207_5595_5594_6256_7157_1869 9 9.63E-06 0.000856693 2.45E-05 1936 hsa-mir-124-1 hsa04916 Melanogenesis 1499_5578_5595_5594_1387_2932_2033_808_801_805_1856_5566 12 1.03E-05 0.000916464 2.55E-05 1937 hsa-mir-124-1 hsa05219 Bladder cancer 9252_4193_5925_5595_5594_7157_1869_1026 8 1.28E-05 0.00113863 3.08E-05 1938 hsa-mir-124-1 hsa05016 Huntington's disease 292_293_1537_3065_3064_25942_6667_5441_1387_836_5437_7157_2033_27113_6908_1213 16 1.35E-05 0.001201698 3.16E-05 1939 hsa-mir-124-1 hsa04062 Chemokine signaling pathway 3551_8517_653361_5747_6362_207_1147_998_5595_5594_2932_6774_5970_4792_4793_5566 16 1.82E-05 0.001623609 4.16E-05 1940 hsa-mir-124-1 hsa05218 Melanoma 4193_5925_207_5595_5594_7157_1869_5728_1026 9 6.76E-05 0.006019602 0.00015049 1941 hsa-mir-124-1 hsa05211 Renal cell carcinoma 3091_2113_207_998_5595_5594_1387_3725_2033 9 7.46E-05 0.006641147 0.000161979 1942 hsa-mir-124-1 hsa03020 RNA polymerase 64425_25885_51082_5441_5437_84172 6 0.000106281 0.009459004 0.000219977 1943 hsa-mir-124-1 hsa05216 Thyroid cancer 1499_7175_5595_5594_6256_7157 6 0.000106281 0.009459004 0.000219977 1944 hsa-mir-124-1 hsa03420 Nucleotide excision repair 902_2965_4331_2071_2074_1022_6117 7 0.00012314 0.010959455 0.000249079 1945 hsa-mir-124-1 hsa04930 Type II diabetes mellitus 3551_3651_5595_5594_5599_5601_5602 7 0.000139612 0.012425431 0.000276121 1946 hsa-mir-124-1 hsa05213 Endometrial cancer 1499_207_5595_5594_2932_7157_5728 7 0.000311646 0.027736459 0.000602967 1947 hsa-mir-124-1 hsa04950 Maturity onset diabetes of the young 3651_3172_168620_4760_5080 5 0.000394766 0.03513416 0.000747535 1948 hsa-mir-124-1 hsa04340 Hedgehog signaling pathway 2736_8945_23291_2932_1452_1453_5566 7 0.000516131 0.045935691 0.000956994 1949 hsa-mir-124-1 hsa04270 Vascular smooth muscle contraction 5578_5499_5592_5595_5594_4637_808_801_805_5566 10 0.000564073 0.050202514 0.001024541 1950 hsa-mir-124-1 hsa04664 Fc epsilon RI signaling pathway 5578_1432_207_5595_5594_5599_5601_5602 8 0.000682037 0.06070126 0.001214025 1951 hsa-mir-124-1 hsa04612 Antigen processing and presentation 3309_3304_3303_3305_3310_3312_3320_3326 8 0.001392727 0.123952684 0.002430445 1952 hsa-mir-124-1 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_1432_1616_836_7157 6 0.002435579 0.216766509 0.004168587 1953 hsa-mir-124-1 hsa05010 Alzheimer's disease 1537_823_5595_5594_836_2932_808_801_805_840_1020 11 0.00320074 0.284865858 0.005374828 1954 hsa-mir-124-1 hsa03440 Homologous recombination 5888_641_675_6117 4 0.005175932 0.460657973 0.008530703 1955 hsa-mir-124-1 hsa04730 Long-term depression 5578_5592_5595_5594_5518_5515 6 0.007125104 0.634134293 0.011529714 1956 hsa-mir-124-1 hsa04670 Leukocyte transendothelial migration 1499_5578_653361_5747_1432_10627_998_71 8 0.008353615 0.743471752 0.013276281 1957 hsa-mir-124-1 hsa05217 Basal cell carcinoma 1499_2736_2932_7157_1856 5 0.010381391 0.923943788 0.01620954 1958 hsa-mir-124-1 hsa03010 Ribosome 6207_6202_6156_6222_6128_6125_6231 7 0.010626036 0.945717184 0.016305469 1959 hsa-mir-124-1 hsa04630 Jak-STAT signaling pathway 3559_598_207_1387_6778_6774_2033_51588_8554 9 0.010890712 0.969273335 0.016428362 1960 hsa-mir-124-1 hsa03410 Base excision repair 3146_142_4913_328 4 0.01145601 1 0.016993081 1961 hsa-mir-124-1 hsa04360 Axon guidance 4773_5747_25_998_5595_5594_2932_1020 8 0.012215242 1 0.017822239 1962 hsa-mir-124-1 hsa03050 Proteasome 5705_5684_5717_5710 4 0.0276301 1 0.039662563 1963 hsa-mir-124-1 hsa04070 Phosphatidylinositol signaling system 5578_5728_808_801_805 5 0.033559911 1 0.047410033 1964 hsa-mir-124-1 hsa04810 Regulation of actin cytoskeleton 10788_5747_5499_4627_4628_10627_998_5595_5594_71 10 0.0375427 1 0.052207818 1965 hsa-mir-124-1 hsa03450 Non-homologous end-joining 2547_5591 2 0.047571084 1 0.065135792 1966 hsa-mir-124-2 hsa05200 Pathways in cancer 25_5371_2249_7046_1499_5595_5594_5599_5914_1387_862_595_5601_6502_1019_4088_367_1017_6776_6777_6772_5970_6256_4087_6688_4609_3725_1026_2353_4089_1050_5925_2033_8554 34 3.04E-21 2.28E-19 2.28E-19 1967 hsa-mir-124-2 hsa04350 TGF-beta signaling pathway 7046_5595_5594_1387_4088_7027_3397_3399_3398_1874_4087_4609_4086_4089_2033_4093_6667_5933 18 1.56E-16 1.17E-14 5.85E-15 1968 hsa-mir-124-2 hsa04110 Cell cycle 25_993_1387_595_983_6502_1019_4088_1017_7027_4087_1026_4089_5925_2033_894_896_5933 18 1.98E-14 1.49E-12 4.95E-13 1969 hsa-mir-124-2 hsa04010 MAPK signaling pathway 6722_2249_7046_5595_5594_5599_1386_9261_4208_5601_5600_9252_7867_1432_1649_5970_468_4609_3725_3727_2353_5603_8550 23 4.31E-13 3.23E-11 8.08E-12 1970 hsa-mir-124-2 hsa05220 Chronic myeloid leukemia 25_7046_5595_5594_595_1019_4088_6776_6777_5970_4609_1026_4089_5925 14 1.30E-12 9.74E-11 1.95E-11 1971 hsa-mir-124-2 hsa05215 Prostate cancer 1499_5595_5594_1387_595_367_1017_5970_468_9586_1026_10488_5925_2033 14 8.88E-12 6.66E-10 1.09E-10 1972 hsa-mir-124-2 hsa05212 Pancreatic cancer 1499_5595_5594_1387_595_367_1017_5970_468_9586_1026_10488_5925_2033 14 1.02E-11 7.63E-10 1.09E-10 1973 hsa-mir-124-2 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_862_595_6776_6777_5970_6688_4609_1050 12 2.21E-11 1.66E-09 2.07E-10 1974 hsa-mir-124-2 hsa05210 Colorectal cancer 7046_1499_5595_5594_5599_595_5601_4088_4087_4609_3725_2353_4089 13 6.75E-11 5.06E-09 5.63E-10 1975 hsa-mir-124-2 hsa04310 Wnt signaling pathway 1499_5599_1387_595_5601_4088_4087_8061_4609_3725_1457_1459_4089_2033_894_896 16 8.24E-11 6.18E-09 6.18E-10 1976 hsa-mir-124-2 hsa04520 Adherens junction 4301_7046_1499_5595_5594_1387_4088_4087_1457_1459_4089_2033 12 5.09E-10 3.81E-08 3.47E-09 1977 hsa-mir-124-2 hsa04912 GnRH signaling pathway 5595_5594_5599_5601_5600_1432_468_3725_5603_808_801_805 12 1.12E-08 8.38E-07 6.99E-08 1978 hsa-mir-124-2 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5601_5600_1432_6772_5970_3725_2353_5603 11 6.08E-08 4.56E-06 3.51E-07 1979 hsa-mir-124-2 hsa05219 Bladder cancer 5595_5594_595_1019_9252_4609_1026_5925 8 7.98E-08 5.99E-06 4.28E-07 1980 hsa-mir-124-2 hsa04012 ErbB signaling pathway 25_5595_5594_5599_5601_6776_6777_4609_3725_1026 10 1.41E-07 1.06E-05 6.68E-07 1981 hsa-mir-124-2 hsa05214 Glioma 5595_5594_595_1019_1026_5925_808_801_805 9 1.43E-07 1.07E-05 6.68E-07 1982 hsa-mir-124-2 hsa04660 T cell receptor signaling pathway 5595_5594_5601_5600_1019_1432_5970_3725_2353_5603 10 1.04E-06 7.80E-05 4.59E-06 1983 hsa-mir-124-2 hsa05222 Small cell lung cancer 595_6502_1019_1017_5970_6256_4609_5925_8554 9 1.23E-06 9.26E-05 5.14E-06 1984 hsa-mir-124-2 hsa05216 Thyroid cancer 1499_5595_5594_595_6256_4609 6 2.30E-06 0.000172473 9.08E-06 1985 hsa-mir-124-2 hsa04630 Jak-STAT signaling pathway 1387_595_6776_6777_6772_4609_2033_3977_894_896_8554 11 2.91E-06 0.000218522 1.09E-05 1986 hsa-mir-124-2 hsa04720 Long-term potentiation 5595_5594_1387_468_2033_808_801_805 8 4.26E-06 0.000319549 1.52E-05 1987 hsa-mir-124-2 hsa04916 Melanogenesis 1499_5595_5594_1387_10488_2033_808_801_805 9 5.26E-06 0.000394555 1.79E-05 1988 hsa-mir-124-2 hsa04115 p53 signaling pathway 595_983_1019_1017_1026_894_896 7 2.31E-05 0.001730883 7.53E-05 1989 hsa-mir-124-2 hsa05218 Melanoma 2249_5595_5594_595_1019_1026_5925 7 2.74E-05 0.002052183 8.21E-05 1990 hsa-mir-124-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5601_5600_1432_5970_3725_5603 7 2.74E-05 0.002052183 8.21E-05 1991 hsa-mir-124-2 hsa04370 VEGF signaling pathway 5595_5594_9261_5600_7867_1432_5603 7 4.43E-05 0.003322841 0.000127802 1992 hsa-mir-124-2 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5601_5600_1432_5603 7 5.16E-05 0.003867537 0.000143242 1993 hsa-mir-124-2 hsa05223 Non-small cell lung cancer 5595_5594_595_1019_6256_5925 6 5.61E-05 0.00420711 0.000150254 1994 hsa-mir-124-2 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601_3651 5 0.000237231 0.017792326 0.000613528 1995 hsa-mir-124-2 hsa04950 Maturity onset diabetes of the young 3651_168620_6927_4760 4 0.000253671 0.019025297 0.000634177 1996 hsa-mir-124-2 hsa04330 Notch signaling pathway 388585_1387_9612_2033_8850 5 0.000285742 0.021430625 0.00069131 1997 hsa-mir-124-2 hsa05213 Endometrial cancer 1499_5595_5594_595_4609 5 0.000439863 0.032989696 0.001030928 1998 hsa-mir-124-2 hsa04510 Focal adhesion 1499_5595_5594_5599_595_5601_3725_894_896 9 0.000747018 0.05602633 0.001697768 1999 hsa-mir-124-2 hsa03022 Basal transcription factors 2963_6908_6874_6883 4 0.001119342 0.083950633 0.002469136 2000 hsa-mir-124-2 hsa04910 Insulin signaling pathway 5595_5594_5599_5601_808_801_805 7 0.001266483 0.094986218 0.002713892 2001 hsa-mir-124-2 hsa05016 Huntington's disease 25942_1387_6908_6874_9586_10488_2033_6667 8 0.0017047 0.127852463 0.003509027 2002 hsa-mir-124-2 hsa05211 Renal cell carcinoma 5595_5594_1387_3725_2033 5 0.00173112 0.12983399 0.003509027 2003 hsa-mir-124-2 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725_2353 5 0.002049928 0.153744588 0.00404591 2004 hsa-mir-124-2 hsa05010 Alzheimer's disease 5595_5594_823_9451_808_801_805 7 0.004800188 0.360014115 0.009231131 2005 hsa-mir-124-2 hsa04920 Adipocytokine signaling pathway 5599_5601_5970_6256 4 0.008270761 0.62030706 0.015507677 2006 hsa-mir-124-2 hsa04270 Vascular smooth muscle contraction 5595_5594_808_801_805 5 0.012520669 0.939050171 0.022903663 2007 hsa-mir-124-2 hsa04670 Leukocyte transendothelial migration 4301_1499_5600_1432_5603 5 0.014215596 1 0.025384992 2008 hsa-mir-124-2 hsa04530 Tight junction 4301_1499_1019_1457_1459 5 0.02192572 1 0.038242534 2009 hsa-mir-124-2 hsa04120 Ubiquitin mediated proteolysis 5371_6502_7329_672_8554 5 0.023123627 1 0.039415274 2010 hsa-mir-124-2 hsa05014 Amyotrophic lateral sclerosis (ALS) 5600_1432_5603 3 0.028379765 1 0.047299608 2011 hsa-mir-1243 hsa05200 Pathways in cancer 3320_5371_1499_5594_5914_1387_6256_595_1019_367_1017_2932_7704_5578_6774_3091_6688_3725_2353_4088_4089_3065_1050_5925_2033_207 26 1.58E-25 1.01E-23 1.01E-23 2012 hsa-mir-1243 hsa04110 Cell cycle 7534_1387_595_896_1019_1017_7532_2932_1028_4088_4089_3065_5925_2033_894 15 6.63E-18 4.24E-16 2.12E-16 2013 hsa-mir-1243 hsa04350 TGF-beta signaling pathway 6667_3400_5594_1387_3397_3398_3399_4088_4089_2033_4092 11 1.92E-13 1.23E-11 3.08E-12 2014 hsa-mir-1243 hsa05215 Prostate cancer 3320_1499_5594_1387_595_367_1017_2932_5925_2033_207 11 2.15E-13 1.38E-11 3.08E-12 2015 hsa-mir-1243 hsa05212 Pancreatic cancer 3320_1499_5594_1387_595_367_1017_2932_5925_2033_207 11 2.41E-13 1.54E-11 3.08E-12 2016 hsa-mir-1243 hsa05221 Acute myeloid leukemia 5371_5594_5914_595_7704_6774_6688_1050_207 9 6.99E-12 4.47E-10 7.46E-11 2017 hsa-mir-1243 hsa05214 Glioma 5594_595_1019_5578_5925_207_808_801_805 9 1.54E-11 9.84E-10 1.41E-10 2018 hsa-mir-1243 hsa04310 Wnt signaling pathway 1499_1387_595_896_2932_5578_3725_4088_4089_2033_894 11 5.29E-11 3.38E-09 4.23E-10 2019 hsa-mir-1243 hsa05210 Colorectal cancer 1499_5594_595_2932_3725_2353_4088_4089_207 9 1.26E-10 8.04E-09 8.94E-10 2020 hsa-mir-1243 hsa04916 Melanogenesis 1499_5594_1387_2932_5578_2033_808_801_805 9 7.30E-10 4.67E-08 4.67E-09 2021 hsa-mir-1243 hsa04510 Focal adhesion 1499_6714_5594_595_896_2932_5578_3725_5058_894_207 11 1.12E-09 7.19E-08 6.54E-09 2022 hsa-mir-1243 hsa05220 Chronic myeloid leukemia 5594_595_1019_4088_4089_3065_5925_207 8 1.44E-09 9.22E-08 7.69E-09 2023 hsa-mir-1243 hsa05223 Non-small cell lung cancer 5594_6256_595_1019_5578_5925_207 7 4.60E-09 2.94E-07 2.26E-08 2024 hsa-mir-1243 hsa04912 GnRH signaling pathway 6714_5594_1432_5578_3725_808_801_805 8 2.08E-08 1.33E-06 9.52E-08 2025 hsa-mir-1243 hsa04660 T cell receptor signaling pathway 5594_1019_2932_1432_3725_2353_5058_207 8 2.38E-08 1.53E-06 1.02E-07 2026 hsa-mir-1243 hsa05211 Renal cell carcinoma 5594_1387_3091_3725_5058_2033_207 7 2.88E-08 1.84E-06 1.15E-07 2027 hsa-mir-1243 hsa04720 Long-term potentiation 5594_1387_5578_2033_808_801_805 7 3.74E-08 2.39E-06 1.41E-07 2028 hsa-mir-1243 hsa04520 Adherens junction 1499_6714_5594_1387_4088_4089_2033 7 5.66E-08 3.62E-06 2.01E-07 2029 hsa-mir-1243 hsa04012 ErbB signaling pathway 6714_5594_2932_5578_3725_5058_207 7 9.69E-08 6.20E-06 3.26E-07 2030 hsa-mir-1243 hsa05222 Small cell lung cancer 6256_595_1019_1017_5925_207 6 1.81E-06 0.000115887 5.52E-06 2031 hsa-mir-1243 hsa04910 Insulin signaling pathway 5594_2932_207_2538_808_801_805 7 1.85E-06 0.000118465 5.52E-06 2032 hsa-mir-1243 hsa04010 MAPK signaling pathway 6722_5594_1432_5578_4342_3725_2353_5058_207 9 1.92E-06 0.000122659 5.52E-06 2033 hsa-mir-1243 hsa04330 Notch signaling pathway 1387_9612_3065_2033_8850 5 1.98E-06 0.00012685 5.52E-06 2034 hsa-mir-1243 hsa05213 Endometrial cancer 1499_5594_595_2932_207 5 3.14E-06 0.000201171 8.38E-06 2035 hsa-mir-1243 hsa04630 Jak-STAT signaling pathway 1387_595_896_6774_2033_894_207 7 3.87E-06 0.000247419 9.90E-06 2036 hsa-mir-1243 hsa05216 Thyroid cancer 1499_5594_6256_595 4 8.67E-06 0.000555178 2.14E-05 2037 hsa-mir-1243 hsa04115 p53 signaling pathway 595_896_1019_1017_894 5 1.15E-05 0.000733628 2.72E-05 2038 hsa-mir-1243 hsa05218 Melanoma 5594_595_1019_5925_207 5 1.31E-05 0.000836107 2.99E-05 2039 hsa-mir-1243 hsa04662 B cell receptor signaling pathway 5594_2932_3725_2353_207 5 1.68E-05 0.001074367 3.70E-05 2040 hsa-mir-1243 hsa04370 VEGF signaling pathway 6714_5594_1432_5578_207 5 1.89E-05 0.001211759 4.04E-05 2041 hsa-mir-1243 hsa05219 Bladder cancer 5594_595_1019_5925 4 3.32E-05 0.002127966 6.86E-05 2042 hsa-mir-1243 hsa04620 Toll-like receptor signaling pathway 5594_1432_3725_2353_207 5 6.82E-05 0.004364643 0.000136395 2043 hsa-mir-1243 hsa04270 Vascular smooth muscle contraction 5594_5578_808_801_805 5 0.000131826 0.008436855 0.000255662 2044 hsa-mir-1243 hsa04920 Adipocytokine signaling pathway 6256_6774_207_2538 4 0.000183473 0.011742287 0.000345361 2045 hsa-mir-1243 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_1432_3725_5058 4 0.000226741 0.014511398 0.000414611 2046 hsa-mir-1243 hsa04530 Tight junction 1499_6714_1019_5578_207 5 0.000257573 0.016484644 0.000457907 2047 hsa-mir-1243 hsa04070 Phosphatidylinositol signaling system 5578_808_801_805 4 0.000290596 0.018598152 0.000502653 2048 hsa-mir-1243 hsa04664 Fc epsilon RI signaling pathway 5594_1432_5578_207 4 0.00033458 0.021413119 0.000563503 2049 hsa-mir-1243 hsa05010 Alzheimer's disease 5594_2932_808_801_805 5 0.000798653 0.051113777 0.00131061 2050 hsa-mir-1243 hsa05016 Huntington's disease 6667_25942_1387_3065_2033 5 0.001038159 0.066442159 0.001661054 2051 hsa-mir-1243 hsa04062 Chemokine signaling pathway 5594_2932_6774_5058_207 5 0.001163078 0.074437013 0.001815537 2052 hsa-mir-1243 hsa04150 mTOR signaling pathway 5594_3091_207 3 0.001358207 0.086925226 0.002069648 2053 hsa-mir-1243 hsa05131 Shigellosis 7534_1499_5578 3 0.001663829 0.106485043 0.002420115 2054 hsa-mir-1243 hsa05130 Pathogenic Escherichia coli infection 7534_1499_5578 3 0.001663829 0.106485043 0.002420115 2055 hsa-mir-1243 hsa04950 Maturity onset diabetes of the young 168620_3172 2 0.004728351 0.30261445 0.006724766 2056 hsa-mir-1243 hsa04540 Gap junction 6714_5594_5578 3 0.006579337 0.421077541 0.009104107 2057 hsa-mir-1243 hsa04020 Calcium signaling pathway 5578_808_801_805 4 0.006685829 0.427893034 0.009104107 2058 hsa-mir-1243 hsa04670 Leukocyte transendothelial migration 1499_1432_5578 3 0.013475401 0.862425636 0.017967201 2059 hsa-mir-1243 hsa04360 Axon guidance 5594_2932_5058 3 0.016209833 1 0.021172027 2060 hsa-mir-1243 hsa04650 Natural killer cell mediated cytotoxicity 5594_5578_5058 3 0.018536322 1 0.023726493 2061 hsa-mir-1243 hsa05217 Basal cell carcinoma 1499_2932 2 0.021446677 1 0.026913476 2062 hsa-mir-1243 hsa04340 Hedgehog signaling pathway 53944_2932 2 0.022875092 1 0.02815396 2063 hsa-mir-1243 hsa04730 Long-term depression 5594_5578 2 0.033906089 1 0.040943202 2064 hsa-mir-124-3 hsa05200 Pathways in cancer 4087_4149_5371_2249_1871_5595_5594_5914_1387_6256_9915_367_1017_2932_7704_6776_6777_3091_5970_1870_7157_6688_836_4089_2113_1869_3725_861_6774_2353_4088_1050_5925_2034_2033_207 36 1.92E-33 1.23E-31 1.23E-31 2065 hsa-mir-124-3 hsa04350 TGF-beta signaling pathway 4087_5595_5594_1387_6667_3399_3398_1874_1875_4089_4088_2033_4093_5934_5933 15 3.76E-17 2.41E-15 1.20E-15 2066 hsa-mir-124-3 hsa05220 Chronic myeloid leukemia 1871_5595_5594_6776_6777_5970_1870_7157_4089_1869_861_4088_5925_207 14 1.63E-16 1.04E-14 3.47E-15 2067 hsa-mir-124-3 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_7704_6776_6777_5970_6688_861_6774_1050_207 13 3.03E-16 1.94E-14 4.85E-15 2068 hsa-mir-124-3 hsa05215 Prostate cancer 1871_5595_5594_1387_367_1017_2932_5970_1870_7157_1869_5925_2033_207 14 1.19E-15 7.60E-14 1.46E-14 2069 hsa-mir-124-3 hsa05212 Pancreatic cancer 1871_5595_5594_1387_367_1017_2932_5970_1870_7157_1869_5925_2033_207 14 1.37E-15 8.75E-14 1.46E-14 2070 hsa-mir-124-3 hsa04110 Cell cycle 4087_1871_1387_890_1017_2932_1870_7157_4089_1869_4088_5925_2033_5934_5933 15 2.51E-15 1.61E-13 2.30E-14 2071 hsa-mir-124-3 hsa05210 Colorectal cancer 4087_5595_5594_2932_7157_836_4089_3725_2353_4088_207 11 9.91E-12 6.34E-10 7.92E-11 2072 hsa-mir-124-3 hsa05211 Renal cell carcinoma 5595_5594_1387_9915_3091_2113_3725_2034_2033_207 10 5.24E-11 3.36E-09 3.73E-10 2073 hsa-mir-124-3 hsa05223 Non-small cell lung cancer 1871_5595_5594_6256_1870_7157_1869_5925_207 9 1.15E-10 7.35E-09 7.35E-10 2074 hsa-mir-124-3 hsa05222 Small cell lung cancer 4149_1871_6256_1017_5970_1870_7157_1869_5925_207 10 2.58E-10 1.65E-08 1.50E-09 2075 hsa-mir-124-3 hsa05218 Melanoma 2249_1871_5595_5594_1870_7157_1869_5925_207 9 1.03E-09 6.61E-08 5.51E-09 2076 hsa-mir-124-3 hsa04010 MAPK signaling pathway 4149_2249_5595_5594_1432_5598_5970_7157_836_4773_3725_2353_207_1616 14 1.68E-09 1.08E-07 8.29E-09 2077 hsa-mir-124-3 hsa05214 Glioma 1871_5595_5594_1870_7157_1869_5925_207 8 1.11E-08 7.11E-07 5.08E-08 2078 hsa-mir-124-3 hsa05219 Bladder cancer 1871_5595_5594_1870_7157_1869_5925 7 1.42E-08 9.11E-07 6.07E-08 2079 hsa-mir-124-3 hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_4773_3725_2353_207 8 3.10E-08 1.99E-06 1.24E-07 2080 hsa-mir-124-3 hsa04660 T cell receptor signaling pathway 5595_5594_2932_1432_5970_4773_3725_2353_207 9 3.55E-08 2.27E-06 1.34E-07 2081 hsa-mir-124-3 hsa04310 Wnt signaling pathway 4087_1387_2932_7157_4089_4773_3725_1457_4088_2033 10 4.24E-08 2.72E-06 1.51E-07 2082 hsa-mir-124-3 hsa04520 Adherens junction 4087_5595_5594_1387_4089_1457_4088_2033 8 4.93E-08 3.16E-06 1.66E-07 2083 hsa-mir-124-3 hsa04012 ErbB signaling pathway 5595_5594_2932_6776_6777_3725_207 7 1.36E-06 8.71E-05 4.35E-06 2084 hsa-mir-124-3 hsa04620 Toll-like receptor signaling pathway 5595_5594_1432_5970_3725_2353_207 7 3.68E-06 0.000235528 1.12E-05 2085 hsa-mir-124-3 hsa05213 Endometrial cancer 5595_5594_2932_7157_207 5 2.09E-05 0.00133656 6.08E-05 2086 hsa-mir-124-3 hsa05216 Thyroid cancer 5595_5594_6256_7157 4 4.01E-05 0.002566054 0.000111568 2087 hsa-mir-124-3 hsa04630 Jak-STAT signaling pathway 1387_6776_6777_6774_2033_3977_207 7 4.86E-05 0.003109314 0.000129555 2088 hsa-mir-124-3 hsa04370 VEGF signaling pathway 5595_5594_1432_4773_207 5 0.000121002 0.007744106 0.000309764 2089 hsa-mir-124-3 hsa04062 Chemokine signaling pathway 5595_5594_2932_6777_5970_6774_207 7 0.000181029 0.011585876 0.000445611 2090 hsa-mir-124-3 hsa04210 Apoptosis 840_5970_7157_836_207 5 0.000230103 0.014726576 0.000545429 2091 hsa-mir-124-3 hsa04150 mTOR signaling pathway 5595_5594_3091_207 4 0.000324196 0.020748557 0.00074102 2092 hsa-mir-124-3 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_7157_836_1616 4 0.000422693 0.027052353 0.00093284 2093 hsa-mir-124-3 hsa04916 Melanogenesis 5595_5594_1387_2932_2033 5 0.000456528 0.029217765 0.000973925 2094 hsa-mir-124-3 hsa04912 GnRH signaling pathway 5595_5594_1432_5598_3725 5 0.000538335 0.034453416 0.001111401 2095 hsa-mir-124-3 hsa05010 Alzheimer's disease 5595_5594_2932_840_836_1020 6 0.000740872 0.04741583 0.001481745 2096 hsa-mir-124-3 hsa04920 Adipocytokine signaling pathway 6256_5970_6774_207 4 0.000801352 0.05128655 0.001554138 2097 hsa-mir-124-3 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_5970_836_3725 4 0.000984487 0.063007157 0.001833309 2098 hsa-mir-124-3 hsa05016 Huntington's disease 1387_6908_6667_7157_836_2033 6 0.001002591 0.064165826 0.001833309 2099 hsa-mir-124-3 hsa04720 Long-term potentiation 5595_5594_1387_2033 4 0.001195214 0.076493703 0.002124825 2100 hsa-mir-124-3 hsa04360 Axon guidance 5595_5594_2932_4773_1020 5 0.001239889 0.079352903 0.002144673 2101 hsa-mir-124-3 hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432_207 4 0.001435656 0.091882007 0.002417948 2102 hsa-mir-124-3 hsa04910 Insulin signaling pathway 5595_5594_2932_23265_207 5 0.001548106 0.099078763 0.002540481 2103 hsa-mir-124-3 hsa04330 Notch signaling pathway 1387_9612_2033 3 0.003126004 0.20006424 0.005001606 2104 hsa-mir-124-3 hsa04510 Focal adhesion 5595_5594_2932_3725_207 5 0.008083177 0.517323297 0.012617641 2105 hsa-mir-124-3 hsa04115 p53 signaling pathway 1017_7157_836 3 0.008664387 0.554520796 0.013202876 2106 hsa-mir-124-3 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_4773 4 0.00973493 0.623035544 0.014489199 2107 hsa-mir-124-3 hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_7329 4 0.009970522 0.638113437 0.014502578 2108 hsa-mir-124-3 hsa04540 Gap junction 5595_5594_5598 3 0.018760598 1 0.026681739 2109 hsa-mir-124-3 hsa03022 Basal transcription factors 2963_6908 2 0.021761179 1 0.030276424 2110 hsa-mir-124-3 hsa04930 Type II diabetes mellitus 5595_5594 2 0.030800692 1 0.041941367 2111 hsa-mir-124-3 hsa05217 Basal cell carcinoma 2932_7157 2 0.043795317 1 0.058393755 2112 hsa-mir-1244-1 hsa05200 Pathways in cancer 3725_4149_1499_596_598_1017_8517_4193_3551_5578_3091_3066_3065_1050_5925_613_5743_5747_25_6789_4436_1870_1871_2113_6774_10401_836_324_207_9915_3716_1147_998_367_5595_5594_5599_1387_6256_4286_2932_6772_5970_7157_1869_2736_4087_4088_4089_5888_5728_2034_2033_5468_3910_898_4790_4791_4792_3320_3326_5371_675_5601_5602_1856_51588_4609_1026_1029_2353_8554 72 8.08E-38 7.11E-36 7.11E-36 2113 hsa-mir-1244-1 hsa04110 Cell cycle 1017_4193_902_6500_5111_3066_3065_5925_25_1870_1871_9232_5934_5933_545_995_993_5347_5591_1387_11200_7534_7532_2932_7027_7157_1031_1869_4087_4088_4089_2033_890_898_983_8454_1026_1022_1029_1111_8556_8555_472 43 1.65E-30 1.45E-28 7.26E-29 2114 hsa-mir-1244-1 hsa04010 MAPK signaling pathway 6722_3725_4149_6195_6197_8517_9252_3551_5578_9020_5923_3304_3305_3303_6789_1432_836_207_1147_998_5595_5594_5599_8986_1386_3312_3315_5971_5970_3164_7157_6196_4790_4791_1616_9261_1326_5601_5602_5608_9479_6885_4609_2353_5566 45 7.77E-20 6.84E-18 2.28E-18 2115 hsa-mir-1244-1 hsa05215 Prostate cancer 1499_596_1017_8517_4193_3551_5925_1870_1871_207_1147_367_5595_5594_1385_1387_2932_5970_7157_1869_5728_2033_898_4790_4792_3320_3326_1026 28 4.11E-19 3.61E-17 9.03E-18 2116 hsa-mir-1244-1 hsa05212 Pancreatic cancer 1499_596_1017_8517_4193_3551_5925_1870_1871_207_1147_367_5595_5594_1385_1387_2932_5970_7157_1869_5728_2033_898_4790_4792_3320_3326_1026 28 5.26E-19 4.63E-17 9.26E-18 2117 hsa-mir-1244-1 hsa05220 Chronic myeloid leukemia 598_8517_4193_3551_3066_3065_5925_613_25_1870_1871_207_1147_5595_5594_5970_7157_1869_4088_4089_4790_4792_4609_1026_1029 25 1.31E-17 1.16E-15 1.93E-16 2118 hsa-mir-1244-1 hsa05222 Small cell lung cancer 4149_596_598_1017_8517_3551_5925_5743_5747_1870_1871_10401_207_1147_6256_5970_7157_1869_5728_3910_898_4790_4792_51588_4609_8554 26 2.16E-17 1.90E-15 2.71E-16 2119 hsa-mir-1244-1 hsa04310 Wnt signaling pathway 3725_1499_5578_6500_8945_23291_8607_324_1460_5599_1387_2932_7157_1457_1452_4087_4088_4089_2033_5519_5518_5515_5601_5602_1856_8454_6423_6885_4609_5527_5566 31 2.64E-16 2.32E-14 2.90E-15 2120 hsa-mir-1244-1 hsa04115 p53 signaling pathway 1017_4194_4193_900_50484_6241_836_51246_545_7161_11200_7157_64326_5728_898_27113_25898_983_1026_1029_1111_472 22 2.50E-15 2.20E-13 2.45E-14 2121 hsa-mir-1244-1 hsa04350 TGF-beta signaling pathway 6500_3398_1875_6667_3399_1874_5934_5933_5595_5594_1387_7027_4087_4088_4089_2033_5519_5518_5515_8454_4609_4093 22 1.38E-13 1.21E-11 1.21E-12 2122 hsa-mir-1244-1 hsa04660 T cell receptor signaling pathway 3725_8517_5777_3551_9020_4794_1432_207_1147_998_5595_5594_2932_5970_959_4790_4792_4793_1326_5601_1739_6885_2353 23 1.19E-12 1.05E-10 9.54E-12 2123 hsa-mir-1244-1 hsa04620 Toll-like receptor signaling pathway 3725_8517_3551_3661_1432_207_1147_29110_5595_5594_5599_6772_5970_4790_4792_1326_5601_5602_5608_9641_6885_2353 22 2.16E-12 1.90E-10 1.58E-11 2124 hsa-mir-1244-1 hsa05210 Colorectal cancer 3725_1499_596_4436_836_324_207_5595_5594_5599_2932_7157_4087_4088_4089_5601_5602_1856_4609_2353 20 4.56E-12 4.02E-10 3.09E-11 2125 hsa-mir-1244-1 hsa04920 Adipocytokine signaling pathway 5465_6794_8517_3551_4794_8471_6774_207_1147_5599_6256_5970_4790_4792_4793_5601_5602_5563 18 9.66E-12 8.50E-10 6.07E-11 2126 hsa-mir-1244-1 hsa04120 Ubiquitin mediated proteolysis 55294_4193_6500_3093_8945_23291_84447_10401_7329_51366_11059_8651_10055_11060_64326_7337_5371_672_7319_25898_8454_51588_10075_8554 24 1.38E-11 1.22E-09 8.12E-11 2127 hsa-mir-1244-1 hsa04662 B cell receptor signaling pathway 3725_8517_5777_3551_4794_207_1147_695_5595_5594_1380_2932_5970_4790_4792_4793_2353 17 3.53E-10 3.10E-08 1.94E-09 2128 hsa-mir-1244-1 hsa05214 Glioma 4193_5578_5925_1870_1871_207_5595_5594_7157_1869_5728_808_801_805_1026_1029 16 4.12E-10 3.63E-08 2.13E-09 2129 hsa-mir-1244-1 hsa04210 Apoptosis 596_598_8517_3551_9020_823_836_207_1147_839_5970_7157_9131_4790_4792_472_5566 17 3.44E-09 3.03E-07 1.68E-08 2130 hsa-mir-1244-1 hsa03022 Basal transcription factors 51616_6882_6872_2965_2963_2969_6878_6908_2958_2959_6880_2957 12 4.76E-09 4.19E-07 2.21E-08 2131 hsa-mir-1244-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_8517_3551_9020_6714_1432_836_1147_998_5599_5970_4790_4792_5601_5602 15 8.78E-09 7.73E-07 3.86E-08 2132 hsa-mir-1244-1 hsa05219 Bladder cancer 9252_4193_5925_1870_1871_5595_5594_7157_1869_4609_1026_1029 12 1.57E-08 1.38E-06 6.56E-08 2133 hsa-mir-1244-1 hsa04520 Adherens junction 1499_5777_6714_1460_998_5595_5594_1387_1457_4087_4088_4089_2033_71_6885 15 3.56E-08 3.13E-06 1.42E-07 2134 hsa-mir-1244-1 hsa04910 Insulin signaling pathway 6720_3551_5590_5499_8471_207_8651_5595_5594_5599_23265_2932_808_801_805_5601_5602_5563_5566 19 4.91E-08 4.32E-06 1.88E-07 2135 hsa-mir-1244-1 hsa04720 Long-term potentiation 814_6195_6197_5578_5499_5595_5594_1387_6196_2033_808_801_805_5566 14 1.06E-07 9.35E-06 3.90E-07 2136 hsa-mir-1244-1 hsa05223 Non-small cell lung cancer 5578_5925_6789_1870_1871_207_5595_5594_6256_7157_1869_1029 12 1.67E-07 1.47E-05 5.89E-07 2137 hsa-mir-1244-1 hsa05131 Shigellosis 1499_5578_10382_25_998_7534_347733_7846_7278_71_4691_203068 12 2.36E-07 2.07E-05 7.68E-07 2138 hsa-mir-1244-1 hsa05130 Pathogenic Escherichia coli infection 1499_5578_10382_25_998_7534_347733_7846_7278_71_4691_203068 12 2.36E-07 2.07E-05 7.68E-07 2139 hsa-mir-1244-1 hsa05016 Huntington's disease 292_293_3066_3065_3064_498_25942_6667_836_4716_1385_1387_5437_7157_1213_3092_2033_5468_27113_6908_5441 21 2.49E-07 2.19E-05 7.82E-07 2140 hsa-mir-1244-1 hsa05218 Melanoma 4193_5925_1870_1871_207_5595_5594_4286_7157_1869_5728_1026_1029 13 3.67E-07 3.23E-05 1.11E-06 2141 hsa-mir-1244-1 hsa05221 Acute myeloid leukemia 8517_3551_1050_6774_207_1147_5595_5594_5970_4790_5371_4609 12 3.85E-07 3.39E-05 1.13E-06 2142 hsa-mir-1244-1 hsa04012 ErbB signaling pathway 3725_5578_5747_25_6714_207_5595_5594_5599_2932_5601_5602_4609_1026 14 5.31E-07 4.67E-05 1.51E-06 2143 hsa-mir-1244-1 hsa04530 Tight junction 10207_1499_5578_9223_5590_6714_4628_207_1460_998_1457_5728_5519_5518_5515_71_5520 17 9.22E-07 8.11E-05 2.53E-06 2144 hsa-mir-1244-1 hsa04912 GnRH signaling pathway 3725_5578_6714_1432_998_5595_5594_5599_808_801_805_5601_5602_5608_5566 15 1.13E-06 9.92E-05 3.01E-06 2145 hsa-mir-1244-1 hsa04062 Chemokine signaling pathway 8517_3551_653361_5747_5590_6362_6774_207_1147_998_5595_5594_2932_6772_6773_5970_4790_4792_4793_5566 20 1.40E-06 0.000122947 3.62E-06 2146 hsa-mir-1244-1 hsa04930 Type II diabetes mellitus 3551_5590_8471_3651_8651_5595_5594_5599_5601_5602 10 1.79E-06 0.000157923 4.51E-06 2147 hsa-mir-1244-1 hsa04510 Focal adhesion 3725_1499_596_5578_5923_5747_6714_5499_207_998_5595_5594_5599_2932_1729_5728_3910_5601_5602_71 20 3.48E-06 0.00030662 8.44E-06 2148 hsa-mir-1244-1 hsa04916 Melanogenesis 1499_5578_5595_5594_1385_1387_4286_2932_2033_808_801_805_1856_5566 14 3.55E-06 0.000312302 8.44E-06 2149 hsa-mir-1244-1 hsa04540 Gap junction 5578_10382_6714_5592_5595_5594_347733_7846_1453_983_7278_203068_5566 13 5.44E-06 0.000478377 1.26E-05 2150 hsa-mir-1244-1 hsa03420 Nucleotide excision repair 5981_902_5111_2965_4331_2071_2074_1022_6117 9 1.06E-05 0.000933359 2.39E-05 2151 hsa-mir-1244-1 hsa05211 Renal cell carcinoma 3725_3091_2113_207_9915_998_5595_5594_1387_2034_2033 11 1.35E-05 0.001187252 2.97E-05 2152 hsa-mir-1244-1 hsa04630 Jak-STAT signaling pathway 598_5777_3566_6774_10401_207_3716_8651_1387_6778_6772_6773_2033_51588_4609_8554 16 1.62E-05 0.001424271 3.47E-05 2153 hsa-mir-1244-1 hsa04370 VEGF signaling pathway 5578_5743_5747_6714_1432_207_998_5595_5594_3315_9261 11 2.37E-05 0.002085131 4.96E-05 2154 hsa-mir-1244-1 hsa05213 Endometrial cancer 1499_324_207_5595_5594_2932_7157_5728_4609 9 3.43E-05 0.003016812 6.86E-05 2155 hsa-mir-1244-1 hsa04150 mTOR signaling pathway 6794_6195_6197_3091_207_5595_5594_6196_5563 9 3.43E-05 0.003016812 6.86E-05 2156 hsa-mir-1244-1 hsa05216 Thyroid cancer 1499_5595_5594_6256_7157_5468_4609 7 4.13E-05 0.003632171 8.07E-05 2157 hsa-mir-1244-1 hsa04612 Antigen processing and presentation 3309_3304_3305_3303_1385_3312_1514_3320_3326_4800_4801 11 7.84E-05 0.006899601 0.000149991 2158 hsa-mir-1244-1 hsa04330 Notch signaling pathway 3066_3065_1387_9612_2033_8850_1856_4851 8 0.000103538 0.009111385 0.000193859 2159 hsa-mir-1244-1 hsa04664 Fc epsilon RI signaling pathway 5578_1432_207_695_5595_5594_5599_5601_5602_5608 10 0.000137537 0.012103239 0.000252151 2160 hsa-mir-1244-1 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_1432_836_834_7157_1616_5608 8 0.000304561 0.026801354 0.000537912 2161 hsa-mir-1244-1 hsa03020 RNA polymerase 64425_25885_51082_5437_84172_5441 6 0.000305632 0.026895623 0.000537912 2162 hsa-mir-1244-1 hsa03010 Ribosome 6207_9349_6141_6217_6130_6155_6156_6128_6125_6188 10 0.000882968 0.077701164 0.001523552 2163 hsa-mir-1244-1 hsa04340 Hedgehog signaling pathway 8945_23291_2932_1452_1453_2736_5566 7 0.00160574 0.141305148 0.002717407 2164 hsa-mir-1244-1 hsa03030 DNA replication 5981_5111_5557_6117_5422 5 0.004625523 0.40704604 0.00753789 2165 hsa-mir-1244-1 hsa03410 Base excision repair 3146_5111_142_4913_328 5 0.004625523 0.40704604 0.00753789 2166 hsa-mir-1244-1 hsa04730 Long-term depression 5578_5592_5595_5594_5519_5518_5515 7 0.004952781 0.43584475 0.00792445 2167 hsa-mir-1244-1 hsa05010 Alzheimer's disease 498_823_836_4716_22926_5595_5594_2932_808_801_805_1020 12 0.005214076 0.458838646 0.008193547 2168 hsa-mir-1244-1 hsa03430 Mismatch repair 5981_5111_4436_6117 4 0.005520963 0.485844757 0.008523592 2169 hsa-mir-1244-1 hsa05217 Basal cell carcinoma 1499_324_2932_7157_2736_1856 6 0.005808605 0.511157238 0.008813056 2170 hsa-mir-1244-1 hsa04270 Vascular smooth muscle contraction 5578_5499_5592_5595_5594_808_801_805_5566 9 0.007364242 0.648053339 0.010983955 2171 hsa-mir-1244-1 hsa03440 Homologous recombination 641_5888_675_6117 4 0.010180744 0.895905434 0.014931757 2172 hsa-mir-1244-1 hsa04360 Axon guidance 5747_25_998_5595_5594_2932_5998_1020 8 0.034158129 1 0.0492773 2173 hsa-mir-1244-3 hsa05200 Pathways in cancer 3320_8031_7157_2033_8554_5970_5594_841_5599_6258_1387_6257_6256 13 5.81E-14 3.43E-12 3.43E-12 2174 hsa-mir-1244-3 hsa05216 Thyroid cancer 8031_7157_5594_6258_6257_6256 6 4.94E-11 2.92E-09 1.46E-09 2175 hsa-mir-1244-3 hsa04920 Adipocytokine signaling pathway 10891_5970_5599_6258_6257_6256 6 4.91E-09 2.90E-07 9.65E-08 2176 hsa-mir-1244-3 hsa05222 Small cell lung cancer 7157_8554_5970_6258_6257_6256 6 2.00E-08 1.18E-06 2.39E-07 2177 hsa-mir-1244-3 hsa05215 Prostate cancer 3320_7157_2033_5970_5594_1387 6 2.28E-08 1.34E-06 2.39E-07 2178 hsa-mir-1244-3 hsa05212 Pancreatic cancer 3320_7157_2033_5970_5594_1387 6 2.43E-08 1.43E-06 2.39E-07 2179 hsa-mir-1244-3 hsa05223 Non-small cell lung cancer 7157_5594_6258_6257_6256 5 8.67E-08 5.12E-06 7.31E-07 2180 hsa-mir-1244-3 hsa04110 Cell cycle 4616_7157_10912_2033_1387 5 3.56E-06 0.000209869 2.62E-05 2181 hsa-mir-1244-3 hsa04115 p53 signaling pathway 4616_7157_10912_841 4 1.07E-05 0.00063062 6.66E-05 2182 hsa-mir-1244-3 hsa03320 PPAR signaling pathway 6258_2168_6257_6256 4 1.13E-05 0.000665735 6.66E-05 2183 hsa-mir-1244-3 hsa04010 MAPK signaling pathway 4616_7157_10912_5970_5594_5599 6 1.33E-05 0.000786843 7.15E-05 2184 hsa-mir-1244-3 hsa04520 Adherens junction 71_2033_5594_1387 4 1.87E-05 0.001101057 9.18E-05 2185 hsa-mir-1244-3 hsa05016 Huntington's disease 7157_10891_2033_841_1387 5 3.04E-05 0.001790927 0.000137764 2186 hsa-mir-1244-3 hsa04620 Toll-like receptor signaling pathway 5970_5594_841_5599 4 4.66E-05 0.00274993 0.000196424 2187 hsa-mir-1244-3 hsa04330 Notch signaling pathway 9612_2033_1387 3 0.000112843 0.006657715 0.000443848 2188 hsa-mir-1244-3 hsa04310 Wnt signaling pathway 7157_2033_5599_1387 4 0.00020788 0.012264921 0.000766558 2189 hsa-mir-1244-3 hsa05211 Renal cell carcinoma 2033_5594_1387 3 0.000376153 0.022193041 0.001305473 2190 hsa-mir-1244-3 hsa04720 Long-term potentiation 2033_5594_1387 3 0.000422116 0.02490482 0.00131078 2191 hsa-mir-1244-3 hsa05220 Chronic myeloid leukemia 7157_5970_5594 3 0.000422116 0.02490482 0.00131078 2192 hsa-mir-1244-3 hsa05210 Colorectal cancer 7157_5594_5599 3 0.000581195 0.034290489 0.001714524 2193 hsa-mir-1244-3 hsa04350 TGF-beta signaling pathway 2033_5594_1387 3 0.000641631 0.037856207 0.001802677 2194 hsa-mir-1244-3 hsa04210 Apoptosis 7157_5970_841 3 0.000684067 0.040359929 0.001834542 2195 hsa-mir-1244-3 hsa04916 Melanogenesis 2033_5594_1387 3 0.001060074 0.062544346 0.002719319 2196 hsa-mir-1244-3 hsa04910 Insulin signaling pathway 10891_5594_5599 3 0.002335749 0.137809201 0.00574205 2197 hsa-mir-1244-3 hsa05219 Bladder cancer 7157_5594 2 0.003067525 0.180983964 0.007239359 2198 hsa-mir-1244-3 hsa04630 Jak-STAT signaling pathway 2033_8554_1387 3 0.003221557 0.190071834 0.007310455 2199 hsa-mir-1244-3 hsa04930 Type II diabetes mellitus 5594_5599 2 0.003492766 0.20607321 0.007632341 2200 hsa-mir-1244-3 hsa05213 Endometrial cancer 7157_5594 2 0.004585238 0.270529021 0.009661751 2201 hsa-mir-1244-3 hsa05221 Acute myeloid leukemia 5970_5594 2 0.00581507 0.34308913 0.01183066 2202 hsa-mir-1244-3 hsa05214 Glioma 7157_5594 2 0.006975796 0.411571943 0.013337756 2203 hsa-mir-1244-3 hsa04510 Focal adhesion 71_5594_5599 3 0.007007974 0.413470449 0.013337756 2204 hsa-mir-1244-3 hsa05218 Melanoma 7157_5594 2 0.008232541 0.485719942 0.014718786 2205 hsa-mir-1244-3 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_5599 2 0.008232541 0.485719942 0.014718786 2206 hsa-mir-1244-3 hsa04662 B cell receptor signaling pathway 5970_5594 2 0.009122627 0.538235004 0.015830441 2207 hsa-mir-1244-3 hsa04664 Fc epsilon RI signaling pathway 5594_5599 2 0.010053765 0.593172138 0.016947775 2208 hsa-mir-1244-3 hsa04012 ErbB signaling pathway 5594_5599 2 0.012036656 0.710162732 0.019726743 2209 hsa-mir-1244-3 hsa04612 Antigen processing and presentation 3320_3308 2 0.01255705 0.740865957 0.020023404 2210 hsa-mir-1244-3 hsa04912 GnRH signaling pathway 5594_5599 2 0.017974488 1 0.027907757 2211 hsa-mir-1244-3 hsa04660 T cell receptor signaling pathway 5970_5594 2 0.018593097 1 0.028128018 2212 hsa-mir-1244-3 hsa04120 Ubiquitin mediated proteolysis 7329_8554 2 0.028530056 1 0.042081833 2213 hsa-mir-1244-3 hsa05010 Alzheimer's disease 5594_841 2 0.044040346 1 0.063375132 2214 hsa-mir-1245 hsa03022 Basal transcription factors 2967_2961_2960_2963_2962_6881_2969_2968_6879_6878_6877_6874_6872_2957_54457_2958_6873_6884_2959_6880_6882_138474_6883 23 1.05E-32 7.46E-31 7.46E-31 2215 hsa-mir-1245 hsa05200 Pathways in cancer 5371_1499_5594_6258_1387_6256_836_1019_1017_4193_5914_7704_842_841_6774_3091_5970_4824_7157_6688_2113_4609_3725_1026_2353_10401_1050_5925_2033_207_3326_8554_7184 33 2.75E-24 1.95E-22 9.77E-23 2216 hsa-mir-1245 hsa05215 Prostate cancer 1499_5594_1385_1387_1017_4193_842_5970_4824_7157_468_1026_5925_2033_207_3326_7184 17 2.37E-17 1.68E-15 4.98E-16 2217 hsa-mir-1245 hsa05212 Pancreatic cancer 1499_5594_1385_1387_1017_4193_842_5970_4824_7157_468_1026_5925_2033_207_3326_7184 17 2.80E-17 1.99E-15 4.98E-16 2218 hsa-mir-1245 hsa05222 Small cell lung cancer 6258_6256_1019_1017_842_5970_7157_4609_10401_5925_207_8554 12 3.87E-11 2.75E-09 5.50E-10 2219 hsa-mir-1245 hsa04110 Cell cycle 4171_5591_1387_1019_1017_4193_7027_7157_1026_4085_5925_2033_5933 13 9.58E-11 6.80E-09 1.13E-09 2220 hsa-mir-1245 hsa05221 Acute myeloid leukemia 5371_5594_5914_7704_6774_5970_6688_4609_1050_207 10 3.09E-10 2.19E-08 3.13E-09 2221 hsa-mir-1245 hsa04010 MAPK signaling pathway 5594_1386_9261_836_3312_1649_5970_7157_468_4609_3725_3727_6195_2353_207_2002_2005 17 4.65E-10 3.30E-08 4.13E-09 2222 hsa-mir-1245 hsa05220 Chronic myeloid leukemia 5594_1019_4193_5970_7157_4609_1026_5925_207 9 3.70E-08 2.63E-06 2.92E-07 2223 hsa-mir-1245 hsa05223 Non-small cell lung cancer 5594_6258_6256_1019_842_7157_5925_207 8 4.90E-08 3.48E-06 3.48E-07 2224 hsa-mir-1245 hsa05210 Colorectal cancer 1499_5594_836_842_7157_4609_3725_2353_207 9 9.06E-08 6.43E-06 5.85E-07 2225 hsa-mir-1245 hsa05219 Bladder cancer 5594_1019_4193_7157_4609_1026_5925 7 1.68E-07 1.19E-05 9.84E-07 2226 hsa-mir-1245 hsa05214 Glioma 815_5594_1019_4193_7157_1026_5925_207 8 1.80E-07 1.28E-05 9.84E-07 2227 hsa-mir-1245 hsa04115 p53 signaling pathway 836_1019_1017_4193_842_841_7157_1026 8 2.74E-07 1.95E-05 1.39E-06 2228 hsa-mir-1245 hsa05216 Thyroid cancer 1499_5594_6258_6256_7157_4609 6 4.27E-07 3.03E-05 2.02E-06 2229 hsa-mir-1245 hsa05213 Endometrial cancer 1499_5594_842_7157_4609_207_2002 7 6.20E-07 4.40E-05 2.75E-06 2230 hsa-mir-1245 hsa05016 Huntington's disease 6874_3064_1385_1387_836_9001_842_841_5430_7157_2033 11 1.04E-06 7.35E-05 4.33E-06 2231 hsa-mir-1245 hsa04310 Wnt signaling pathway 815_1499_1387_8607_7157_4609_3725_1460_1457_2033 10 1.19E-06 8.45E-05 4.69E-06 2232 hsa-mir-1245 hsa04012 ErbB signaling pathway 815_6714_5594_4609_3725_1026_207_2002 8 1.39E-06 9.87E-05 5.20E-06 2233 hsa-mir-1245 hsa04210 Apoptosis 836_839_842_841_840_5970_7157_207 8 1.63E-06 0.0001157 5.79E-06 2234 hsa-mir-1245 hsa05218 Melanoma 5594_1019_4193_7157_1026_5925_207 7 4.20E-06 0.000297876 1.42E-05 2235 hsa-mir-1245 hsa05211 Renal cell carcinoma 5594_1387_3091_2113_3725_2033_207 7 4.57E-06 0.000324525 1.48E-05 2236 hsa-mir-1245 hsa04520 Adherens junction 1499_6714_5594_1387_1460_1457_2033 7 8.71E-06 0.000618096 2.69E-05 2237 hsa-mir-1245 hsa04350 TGF-beta signaling pathway 5594_1387_7027_1874_4609_2033_5933 7 1.45E-05 0.001030316 4.29E-05 2238 hsa-mir-1245 hsa04720 Long-term potentiation 815_5594_1387_468_6195_2033 6 6.19E-05 0.004397178 0.000175887 2239 hsa-mir-1245 hsa03050 Proteasome 5710_5705_5701_5702_5719 5 8.13E-05 0.005772881 0.000222034 2240 hsa-mir-1245 hsa04620 Toll-like receptor signaling pathway 5594_841_5970_3725_2353_207 6 0.000302727 0.021493651 0.000796061 2241 hsa-mir-1245 hsa04916 Melanogenesis 815_1499_5594_1385_1387_2033 6 0.00033418 0.023726782 0.000847385 2242 hsa-mir-1245 hsa04920 Adipocytokine signaling pathway 6258_6256_6774_5970_207 5 0.000348471 0.024741415 0.000853152 2243 hsa-mir-1245 hsa04912 GnRH signaling pathway 815_6714_5594_468_3725_2002 6 0.000404732 0.02873596 0.000957865 2244 hsa-mir-1245 hsa04660 T cell receptor signaling pathway 5594_1019_5970_3725_2353_207 6 0.000444109 0.031531716 0.000991508 2245 hsa-mir-1245 hsa04630 Jak-STAT signaling pathway 1387_6774_4609_10401_2033_207_8554 7 0.000446877 0.031728262 0.000991508 2246 hsa-mir-1245 hsa04662 B cell receptor signaling pathway 5594_5970_3725_2353_207 5 0.000567175 0.040269426 0.001220286 2247 hsa-mir-1245 hsa04370 VEGF signaling pathway 6714_5594_9261_842_207 5 0.000635094 0.045091651 0.001326225 2248 hsa-mir-1245 hsa03420 Nucleotide excision repair 2967_2968_5981_5887 4 0.00069612 0.049424507 0.001412129 2249 hsa-mir-1245 hsa04330 Notch signaling pathway 1387_9612_2033_8850 4 0.000876686 0.062244714 0.00172902 2250 hsa-mir-1245 hsa04612 Antigen processing and presentation 1385_4800_4801_3312_3326 5 0.001178189 0.083651441 0.00226085 2251 hsa-mir-1245 hsa04150 mTOR signaling pathway 5594_3091_6195_207 4 0.001247161 0.088548446 0.002330222 2252 hsa-mir-1245 hsa04530 Tight junction 1499_6714_1019_1460_1457_207 6 0.001326322 0.094168894 0.002414587 2253 hsa-mir-1245 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_836_5970_3725 4 0.003647584 0.25897844 0.006474461 2254 hsa-mir-1245 hsa05010 Alzheimer's disease 22926_5594_836_842_841_840 6 0.004530135 0.32163956 0.007844867 2255 hsa-mir-1245 hsa04510 Focal adhesion 1499_6714_5594_3725_207_2002 6 0.009084279 0.644983837 0.015356758 2256 hsa-mir-1245 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_842_7157 3 0.013316551 0.945475102 0.021987793 2257 hsa-mir-1245 hsa04950 Maturity onset diabetes of the young 5080_6927 2 0.019838911 1 0.032012789 2258 hsa-mir-1245 hsa04910 Insulin signaling pathway 5594_5211_207_2002 4 0.031689699 1 0.049999302 2259 hsa-mir-1245 hsa04120 Ubiquitin mediated proteolysis 5371_4193_10401_8554 4 0.032395215 1 0.050001311 2260 hsa-mir-1245 hsa03030 DNA replication 5981_4171 2 0.040203688 1 0.060733231 2261 hsa-mir-1245 hsa04540 Gap junction 6714_5594_10382 3 0.046828596 1 0.069267299 2262 hsa-mir-1247 hsa05200 Pathways in cancer 6654_9915_5914_595_598_1017_4193_5578_3091_3066_3065_5925_4149_1050_5743_5747_25_405_1956_2308_6789_613_1387_2064_8503_4436_1870_1871_2885_596_2113_10401_861_5879_6502_207_208_836_5894_3716_1147_4609_998_1026_4233_2261_5595_5594_5599_6256_4286_367_2932_6776_6777_6772_5979_5970_7157_7704_1869_3725_2736_4087_4088_4089_5295_5888_5728_2033_675_4846_3910_4790_4792_3320_3326_5371_3480_5159_5156_5604_5601_5602_1856_3265_841_4292_51588_7428_1029_2353_2034_1441_8554 95 8.62E-53 7.67E-51 7.67E-51 2263 hsa-mir-1247 hsa04010 MAPK signaling pathway 3925_6722_6654_2264_4214_9252_5578_4773_4616_5923_4149_1956_3304_3305_3303_6789_1432_627_2885_22800_4763_5879_1616_2872_207_208_836_5894_1147_4609_994_998_2261_5595_5594_5599_5598_8986_1386_3312_3315_1649_5970_3164_7157_10912_3725_3727_6195_6196_6197_5058_4790_51701_5159_9261_5156_5604_4208_5601_5602_5566_3265_6885_2353 65 2.67E-32 2.38E-30 1.19E-30 2264 hsa-mir-1247 hsa04110 Cell cycle 595_1017_4193_902_6500_995_3066_3065_4616_5925_25_1387_1870_1871_9232_6502_5934_5933_545_994_1026_7534_5591_11200_7533_7532_2932_7027_7157_10912_1869_4087_4088_4089_2033_890_1031_983_8454_5347_1022_1029_1111_8556_8555_472_990 47 1.23E-31 1.09E-29 3.63E-30 2265 hsa-mir-1247 hsa05220 Chronic myeloid leukemia 6654_595_598_4193_3066_3065_5925_25_613_8503_1870_1871_2885_861_207_208_5894_1147_4609_1026_5595_5594_6776_6777_5970_7157_1869_4088_4089_5295_4790_4792_5604_3265_5781_1029_6464 37 6.98E-28 6.21E-26 1.55E-26 2266 hsa-mir-1247 hsa05215 Prostate cancer 6654_595_1017_4193_5925_1956_2308_1387_2064_8503_1870_1871_2885_596_207_208_5894_1147_1026_5595_5594_367_2932_5970_7157_1869_5295_5728_2033_4790_4792_3320_3326_3480_5159_5156_5604_3265 38 6.05E-27 5.38E-25 1.08E-25 2267 hsa-mir-1247 hsa05212 Pancreatic cancer 6654_595_1017_4193_5925_1956_2308_1387_2064_8503_1870_1871_2885_596_207_208_5894_1147_1026_5595_5594_367_2932_5970_7157_1869_5295_5728_2033_4790_4792_3320_3326_3480_5159_5156_5604_3265 38 8.37E-27 7.45E-25 1.24E-25 2268 hsa-mir-1247 hsa05210 Colorectal cancer 6654_595_1956_8503_4436_2885_596_5879_207_208_836_5894_4609_4233_5595_5594_5599_2932_7157_3725_4087_4088_4089_5295_3480_5159_5156_5604_5601_5602_1856_4292_2353 33 1.52E-22 1.35E-20 1.93E-21 2269 hsa-mir-1247 hsa05214 Glioma 6654_595_4193_5578_5925_1956_8503_1870_1871_2885_207_208_5894_1026_5595_5594_7157_1869_5295_5728_808_801_805_3480_5159_5156_5604_3265_1029_6464 30 3.28E-22 2.92E-20 3.65E-21 2270 hsa-mir-1247 hsa04630 Jak-STAT signaling pathway 3559_6654_595_598_5777_3454_3455_3560_1387_1439_8503_2885_10401_2690_207_208_3717_3716_4609_3718_85480_3575_3570_3572_6778_6776_6777_6772_7297_5295_2033_149233_3953_51588_10379_5781_1441_8554 38 9.17E-20 8.16E-18 9.06E-19 2271 hsa-mir-1247 hsa05222 Small cell lung cancer 595_598_1017_5925_4149_5743_5747_8503_1870_1871_596_10401_6502_207_208_1147_4609_6256_5970_7157_1869_5295_5728_4846_3910_4790_4792_51588_8554 29 1.67E-18 1.48E-16 1.48E-17 2272 hsa-mir-1247 hsa04012 ErbB signaling pathway 6654_5578_5747_25_1956_6714_2064_8503_2885_207_208_5894_4609_1026_5595_5594_5599_56924_2932_6776_6777_3725_5295_5058_5604_5601_5602_3265_6464 29 2.16E-18 1.92E-16 1.75E-17 2273 hsa-mir-1247 hsa05223 Non-small cell lung cancer 6654_595_5578_5925_1956_2309_6789_2064_8503_1870_1871_2885_207_208_5894_5595_5594_6256_7157_1869_5295_5604_3265_1029 24 9.53E-18 8.48E-16 7.07E-17 2274 hsa-mir-1247 hsa04115 p53 signaling pathway 595_1017_4194_4193_900_4616_50484_6241_51246_836_545_1026_11200_7249_7157_10912_64326_5728_27113_25898_983_841_7161_1029_1111_472 26 1.07E-17 9.57E-16 7.36E-17 2275 hsa-mir-1247 hsa04510 Focal adhesion 6654_595_5578_857_5923_5747_9564_1956_6714_5499_2064_8503_2885_596_5879_207_208_5894_998_4233_5595_5594_5599_56924_2932_1729_3725_5295_5058_5728_3910_2321_3480_5159_5156_5604_5601_5602_3265_6464 40 1.24E-17 1.10E-15 7.85E-17 2276 hsa-mir-1247 hsa05211 Renal cell carcinoma 6654_9915_3091_405_1387_8503_2885_2113_5879_207_208_5894_998_4233_5595_5594_56924_3725_5295_5058_2033_5604_3265_7428_5781_2034 26 2.51E-17 2.23E-15 1.49E-16 2277 hsa-mir-1247 hsa04062 Chemokine signaling pathway 2185_6654_1234_1230_7074_5747_5580_9564_5590_2309_8503_2885_6362_5879_207_208_3055_5894_3717_1147_3718_998_5595_5594_2932_6777_6772_5970_5295_5058_4790_4792_2770_5604_5566_3265_7852_6464 38 5.39E-17 4.80E-15 3.00E-16 2278 hsa-mir-1247 hsa05218 Melanoma 595_4193_5925_1956_8503_1870_1871_207_208_5894_1026_4233_5595_5594_4286_7157_1869_5295_5728_3480_5159_5156_5604_3265_1029 25 1.67E-16 1.48E-14 8.73E-16 2279 hsa-mir-1247 hsa04660 T cell receptor signaling pathway 6654_5777_4773_3932_1432_8503_2885_207_208_5894_1147_998_5595_5594_56924_2932_5970_3725_5295_5058_4790_4792_5604_5601_3265_1739_6885_2353_959 29 4.09E-16 3.64E-14 2.02E-15 2280 hsa-mir-1247 hsa05221 Acute myeloid leukemia 6654_5914_595_1050_8503_2885_861_207_208_5894_1147_4609_5595_5594_6776_6777_5970_7704_5295_4790_5371_5604_3265 23 4.51E-16 4.01E-14 2.11E-15 2281 hsa-mir-1247 hsa05219 Bladder cancer 595_9252_4193_5925_1956_2064_1870_1871_5894_4609_1026_2261_5595_5594_7157_1869_5604_3265_1029 19 1.90E-14 1.69E-12 8.46E-14 2282 hsa-mir-1247 hsa04662 B cell receptor signaling pathway 6654_5777_4773_8503_2885_6850_5879_207_208_5894_1147_5595_5594_1380_2932_5970_3725_5295_4790_4792_5604_3265_2353 23 3.11E-14 2.76E-12 1.32E-13 2283 hsa-mir-1247 hsa05213 Endometrial cancer 6654_595_1956_2309_2064_8503_2885_207_208_5894_4609_5595_5594_2932_7157_5295_5728_5604_3265_4292 20 4.56E-14 4.05E-12 1.84E-13 2284 hsa-mir-1247 hsa04910 Insulin signaling pathway 6720_10891_6654_5770_5590_5499_2308_8503_2885_2872_207_208_5894_5595_5594_5599_7249_2932_5295_808_801_805_5604_5601_5602_5566_3265_5563_6464 29 6.37E-14 5.67E-12 2.47E-13 2285 hsa-mir-1247 hsa04310 Wnt signaling pathway 595_1457_5578_6500_4773_1387_5879_4609_1460_5599_1459_2932_7157_8061_3725_1452_4087_4088_4089_2033_51701_5518_5515_5601_5602_5566_1856_8454_6885_5527 30 9.87E-14 8.78E-12 3.66E-13 2286 hsa-mir-1247 hsa04520 Adherens junction 1457_5770_5777_2241_1956_6714_1387_2064_5879_1460_998_4233_5595_5594_1459_4087_4088_4089_2033_51701_3480_6885 22 7.13E-13 6.34E-11 2.54E-12 2287 hsa-mir-1247 hsa04620 Toll-like receptor signaling pathway 3454_3455_1432_8503_5879_207_208_1147_3654_5595_5594_5599_6772_5970_3725_5295_4790_4792_5604_5601_5602_841_6885_2353 24 1.15E-12 1.02E-10 3.94E-12 2288 hsa-mir-1247 hsa04540 Gap junction 5592_6654_5578_51807_1956_6714_2885_5894_5595_5594_5598_1453_7846_5159_2770_983_5156_5604_5566_3265_7277_7278_10376 23 1.40E-12 1.25E-10 4.63E-12 2289 hsa-mir-1247 hsa04350 TGF-beta signaling pathway 6500_3398_1875_6667_1387_3399_1874_5934_5933_4609_5595_5594_7027_4086_4087_4088_4089_2033_5518_5515_8454_4093 22 2.95E-12 2.63E-10 9.38E-12 2290 hsa-mir-1247 hsa04912 GnRH signaling pathway 2185_6654_4214_5578_5580_1956_6714_1432_2885_5894_998_5595_5594_5599_5598_3725_808_801_805_5604_5601_5602_5566_3265 24 3.29E-12 2.93E-10 1.01E-11 2291 hsa-mir-1247 hsa04370 VEGF signaling pathway 5578_4773_5743_5747_6714_1432_8503_5879_207_208_5894_998_5595_5594_3315_5295_4846_9261_5604_3265 20 1.90E-11 1.69E-09 5.63E-11 2292 hsa-mir-1247 hsa04210 Apoptosis 3556_598_823_1439_8503_596_207_208_836_1147_3654_5970_7157_5295_4790_4792_5566_841_840_472 20 1.76E-10 1.56E-08 5.04E-10 2293 hsa-mir-1247 hsa04664 Fc epsilon RI signaling pathway 6654_5578_5580_1432_8503_2885_6850_5879_207_208_5894_5595_5594_5599_5295_5604_5601_5602_3265 19 1.86E-10 1.65E-08 5.17E-10 2294 hsa-mir-1247 hsa04720 Long-term potentiation 5578_2902_2906_5499_1387_5894_5595_5594_6195_6196_6197_2033_808_801_805_5604_5566_3265 18 5.75E-10 5.11E-08 1.55E-09 2295 hsa-mir-1247 hsa04120 Ubiquitin mediated proteolysis 55294_4214_4193_6500_3093_7319_84447_10401_10273_7329_6502_11059_10055_64326_7337_5371_672_25898_8454_51588_7428_10075_8554 23 1.57E-09 1.39E-07 4.10E-09 2296 hsa-mir-1247 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_1432_5879_836_1147_998_4233_5599_5970_3725_5058_4790_4792_5601_5602_5781 17 1.78E-09 1.58E-07 4.52E-09 2297 hsa-mir-1247 hsa03022 Basal transcription factors 51616_2957_2965_2963_2962_2969_6874_6908_2958_2959_6880_6881_9519 13 3.13E-09 2.78E-07 7.73E-09 2298 hsa-mir-1247 hsa04920 Adipocytokine signaling pathway 10891_6794_207_208_3717_1147_5599_6256_5970_4790_4792_5601_5602_3953_5781_5563 16 5.50E-09 4.89E-07 1.32E-08 2299 hsa-mir-1247 hsa04650 Natural killer cell mediated cytotoxicity 2185_6654_5777_5578_3454_3455_4773_3932_8503_2885_6850_5879_836_5894_5595_5594_5295_5058_5604_3265_5781_6464 22 6.48E-09 5.77E-07 1.52E-08 2300 hsa-mir-1247 hsa04150 mTOR signaling pathway 6794_3091_8503_207_208_5595_5594_7249_6195_6196_6197_5295_5563 13 9.37E-08 8.34E-06 2.14E-07 2301 hsa-mir-1247 hsa04530 Tight junction 10207_1457_5578_5580_5590_6714_22800_8573_207_208_1460_998_1459_5728_5518_5515_2770_3265_5520 19 4.77E-07 4.24E-05 1.06E-06 2302 hsa-mir-1247 hsa04916 Melanogenesis 5578_1387_5894_5595_5594_4286_2932_2033_808_801_805_2770_5604_5566_1856_3265 16 1.12E-06 9.97E-05 2.43E-06 2303 hsa-mir-1247 hsa05216 Thyroid cancer 595_4609_5595_5594_6256_5979_7157_5604_3265 9 2.01E-06 0.000179047 4.26E-06 2304 hsa-mir-1247 hsa04810 Regulation of actin cytoskeleton 6654_2264_7074_5747_9564_1956_5499_8503_22800_5879_5894_998_2261_5595_5594_56924_1729_5295_5058_5159_5156_5604_3265 23 2.63E-06 0.000233665 5.43E-06 2305 hsa-mir-1247 hsa04360 Axon guidance 4773_5747_25_5879_2242_998_4233_5595_5594_56924_2932_5058_5998_2770_3265_7852_1020 17 4.25E-06 0.000377815 8.59E-06 2306 hsa-mir-1247 hsa04060 Cytokine-cytokine receptor interaction 3556_3559_1234_1230_3454_3455_8764_1956_3560_1439_6362_2690_85480_4233_3575_3570_3572_2321_149233_5159_5156_3953_7852_959_1441 25 4.71E-06 0.000419394 9.32E-06 2307 hsa-mir-1247 hsa04930 Type II diabetes mellitus 3651_5580_5590_8503_5595_5594_5599_5295_5601_5602 10 7.06E-06 0.000628403 1.37E-05 2308 hsa-mir-1247 hsa04330 Notch signaling pathway 3066_3065_1387_9612_2033_8850_2648_1856_3280_388585 10 9.85E-06 0.000876758 1.87E-05 2309 hsa-mir-1247 hsa04730 Long-term depression 5592_5578_5894_5595_5594_4846_3480_5518_5515_2770_5604_3265 12 1.04E-05 0.000929448 1.94E-05 2310 hsa-mir-1247 hsa05016 Huntington's disease 10891_3066_3065_3064_25942_2902_6667_1387_627_836_4716_7157_23186_2033_27113_6874_6908_841_9519 19 3.09E-05 0.002747411 5.61E-05 2311 hsa-mir-1247 hsa05014 Amyotrophic lateral sclerosis (ALS) 598_2902_2906_1432_596_5879_1616_836_7157_4846 10 3.73E-05 0.003322241 6.39E-05 2312 hsa-mir-1247 hsa05131 Shigellosis 5578_51807_25_998_7534_4691_7846_7277_7278_10376 10 3.73E-05 0.003322241 6.39E-05 2313 hsa-mir-1247 hsa05130 Pathogenic Escherichia coli infection 5578_51807_25_998_7534_4691_7846_7277_7278_10376 10 3.73E-05 0.003322241 6.39E-05 2314 hsa-mir-1247 hsa04612 Antigen processing and presentation 6890_3309_3304_3305_3303_3312_3320_3326_4800_4801_4802_2923 12 7.69E-05 0.006839911 0.000129055 2315 hsa-mir-1247 hsa03420 Nucleotide excision repair 902_6117_2965_4331_2071_2074_6118_1022 8 0.000199484 0.017754073 0.000328779 2316 hsa-mir-1247 hsa05010 Alzheimer's disease 823_2902_2906_836_4716_5595_5594_2932_4846_808_351_801_805_841_840_1020 16 0.000405801 0.03611631 0.00065666 2317 hsa-mir-1247 hsa04270 Vascular smooth muscle contraction 5592_5578_5580_5499_5894_5595_5594_808_801_805_5604_5566 12 0.000814897 0.072525801 0.001295104 2318 hsa-mir-1247 hsa04670 Leukocyte transendothelial migration 2185_5578_5747_9564_1432_8503_5879_998_5295_2770_7852_5781 12 0.001063795 0.094677725 0.001661013 2319 hsa-mir-1247 hsa03410 Base excision repair 4350_142_4913_3146_328_6996 6 0.001860922 0.165622101 0.002855553 2320 hsa-mir-1247 hsa04950 Maturity onset diabetes of the young 3651_6927_4760_3280_3172 5 0.001895135 0.168667047 0.002858764 2321 hsa-mir-1247 hsa03440 Homologous recombination 641_6117_5888_675_6118 5 0.003416411 0.304060572 0.005067676 2322 hsa-mir-1247 hsa05340 Primary immunodeficiency 6890_3932_3718_3575_959 5 0.007915007 0.704435664 0.011548126 2323 hsa-mir-1247 hsa03430 Mismatch repair 4436_6117_4292_6118 4 0.009453416 0.841353998 0.013570226 2324 hsa-mir-1247 hsa04020 Calcium signaling pathway 2185_5578_1956_2902_2906_2064_4846_808_801_805_5159_5156_5566 13 0.011350481 1 0.016034806 2325 hsa-mir-1247 hsa04710 Circadian rhythm - mammal 8863_1453_8553 3 0.012643927 1 0.017582962 2326 hsa-mir-1247 hsa04070 Phosphatidylinositol signaling system 5578_8503_5295_5728_808_801_805 7 0.015334927 1 0.020997054 2327 hsa-mir-1247 hsa04740 Olfactory transduction 5592_808_801_805_5566 5 0.028013147 1 0.037775305 2328 hsa-mir-1247 hsa03030 DNA replication 6117_5557_6118_5422 4 0.035829635 1 0.04759459 2329 hsa-mir-1247 hsa04340 Hedgehog signaling pathway 2932_1452_1453_2736_5566 5 0.044611603 1 0.058388716 2330 hsa-mir-1248 hsa03022 Basal transcription factors 2967_2961_2960_2963_6881_54457_2968_6879_6878_6877_6874_6872_2957_6873_2958_6884_2959_6880_6882_138474_6883 21 1.58E-33 1.03E-31 1.03E-31 2331 hsa-mir-1248 hsa05200 Pathways in cancer 1869_4149_5925_1870_5594_6256_3326_1487_1488_4193_5970_1871_7157_6688_3725_4089_10401_4087_4609_2353_4088_1050_2033_8554_1017_7184 26 6.70E-22 4.35E-20 2.18E-20 2332 hsa-mir-1248 hsa04110 Cell cycle 1869_5925_1870_4193_1871_7157_4089_4087_4171_4085_4088_2033_5933_890_5934_1017 16 3.00E-17 1.95E-15 6.50E-16 2333 hsa-mir-1248 hsa05220 Chronic myeloid leukemia 1869_5925_1870_5594_1487_1488_4193_5970_1871_7157_4089_4609_4088 13 1.61E-15 1.05E-13 2.62E-14 2334 hsa-mir-1248 hsa05222 Small cell lung cancer 1869_4149_5925_1870_6256_5970_1871_7157_10401_4609_8554_1017 12 2.08E-13 1.35E-11 2.70E-12 2335 hsa-mir-1248 hsa05215 Prostate cancer 1869_5925_1870_5594_3326_4193_5970_1871_7157_2033_1017_7184 12 2.67E-13 1.73E-11 2.80E-12 2336 hsa-mir-1248 hsa05212 Pancreatic cancer 1869_5925_1870_5594_3326_4193_5970_1871_7157_2033_1017_7184 12 3.01E-13 1.96E-11 2.80E-12 2337 hsa-mir-1248 hsa04350 TGF-beta signaling pathway 5594_1874_1875_4089_4087_4609_4088_2033_5933_5934 10 1.27E-10 8.26E-09 1.03E-09 2338 hsa-mir-1248 hsa05219 Bladder cancer 1869_5925_1870_5594_4193_1871_7157_4609 8 2.58E-10 1.68E-08 1.86E-09 2339 hsa-mir-1248 hsa04310 Wnt signaling pathway 1460_8607_1487_1488_7157_3725_4089_4087_4609_4088_2033 11 1.45E-09 9.40E-08 9.40E-09 2340 hsa-mir-1248 hsa05210 Colorectal cancer 5594_7157_3725_4089_4087_4609_2353_4088 8 3.70E-08 2.40E-06 2.10E-07 2341 hsa-mir-1248 hsa05223 Non-small cell lung cancer 1869_5925_1870_5594_6256_1871_7157 7 3.87E-08 2.52E-06 2.10E-07 2342 hsa-mir-1248 hsa05214 Glioma 1869_5925_1870_5594_4193_1871_7157 7 1.24E-07 8.09E-06 6.22E-07 2343 hsa-mir-1248 hsa05218 Melanoma 1869_5925_1870_5594_4193_1871_7157 7 2.17E-07 1.41E-05 1.01E-06 2344 hsa-mir-1248 hsa04520 Adherens junction 1460_5594_4089_4087_4088_2033 6 7.21E-06 0.000468846 3.13E-05 2345 hsa-mir-1248 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 9.79E-06 0.000636326 3.98E-05 2346 hsa-mir-1248 hsa04010 MAPK signaling pathway 3727_4149_5594_5970_3312_7157_3725_4609_2353 9 2.33E-05 0.001516837 8.92E-05 2347 hsa-mir-1248 hsa05221 Acute myeloid leukemia 5594_5970_6688_4609_1050 5 2.48E-05 0.001612116 8.96E-05 2348 hsa-mir-1248 hsa05216 Thyroid cancer 5594_6256_7157_4609 4 2.91E-05 0.001888712 9.94E-05 2349 hsa-mir-1248 hsa04330 Notch signaling pathway 1487_1488_2033_8850 4 0.000164602 0.010699162 0.000534958 2350 hsa-mir-1248 hsa05016 Huntington's disease 6874_9001_5430_7157_3064_2033 6 0.000653093 0.042451074 0.00202148 2351 hsa-mir-1248 hsa04662 B cell receptor signaling pathway 5594_5970_3725_2353 4 0.000880817 0.057253127 0.002602415 2352 hsa-mir-1248 hsa03420 Nucleotide excision repair 2967_2968_5887 3 0.002073613 0.134784847 0.005860211 2353 hsa-mir-1248 hsa04620 Toll-like receptor signaling pathway 5594_5970_3725_2353 4 0.002604071 0.16926459 0.007052691 2354 hsa-mir-1248 hsa05213 Endometrial cancer 5594_7157_4609 3 0.003251524 0.211349053 0.008453962 2355 hsa-mir-1248 hsa04660 T cell receptor signaling pathway 5594_5970_3725_2353 4 0.003384244 0.21997589 0.008460611 2356 hsa-mir-1248 hsa04115 p53 signaling pathway 4193_7157_1017 3 0.006917126 0.449613207 0.016652341 2357 hsa-mir-1248 hsa05211 Renal cell carcinoma 5594_3725_2033 3 0.007740702 0.503145646 0.017969487 2358 hsa-mir-1248 hsa04630 Jak-STAT signaling pathway 10401_4609_2033_8554 4 0.01080616 0.702400373 0.024220703 2359 hsa-mir-1248 hsa04012 ErbB signaling pathway 5594_3725_4609 3 0.012705107 0.825831951 0.027527732 2360 hsa-mir-1248 hsa04612 Antigen processing and presentation 3326_4801_3312 3 0.013476247 0.875956073 0.028256648 2361 hsa-mir-1248 hsa04120 Ubiquitin mediated proteolysis 4193_10401_8554 3 0.041360123 1 0.084012749 2362 hsa-mir-1248 hsa05322 Systemic lupus erythematosus 8340_3014_3015 3 0.045049889 1 0.08873463 2363 hsa-mir-1249 hsa05200 Pathways in cancer 5371_5595_5594_5914_1387_6256_595_836_367_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_4088_4089_3066_3065_5925_2034_2033_4846_4286 30 5.04E-30 3.23E-28 3.23E-28 2364 hsa-mir-1249 hsa04110 Cell cycle 993_5591_1387_595_983_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933 17 2.21E-20 1.41E-18 7.07E-19 2365 hsa-mir-1249 hsa05220 Chronic myeloid leukemia 5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464 15 4.50E-20 2.88E-18 9.60E-19 2366 hsa-mir-1249 hsa05215 Prostate cancer 5595_5594_1387_595_367_5970_1870_1871_7157_1869_5925_2033 12 1.72E-14 1.10E-12 2.49E-13 2367 hsa-mir-1249 hsa05212 Pancreatic cancer 5595_5594_1387_595_367_5970_1870_1871_7157_1869_5925_2033 12 1.94E-14 1.24E-12 2.49E-13 2368 hsa-mir-1249 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5925 9 9.52E-13 6.09E-11 1.02E-11 2369 hsa-mir-1249 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925 9 7.09E-12 4.54E-10 6.49E-11 2370 hsa-mir-1249 hsa05210 Colorectal cancer 5595_5594_595_836_7157_4087_4609_3725_4088_4089 10 9.69E-12 6.20E-10 7.75E-11 2371 hsa-mir-1249 hsa05222 Small cell lung cancer 6256_595_5970_1870_1871_7157_4609_1869_5925_4846 10 1.20E-11 7.68E-10 8.53E-11 2372 hsa-mir-1249 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_4087_4609_4088_4089_2033_5933 10 1.33E-11 8.53E-10 8.53E-11 2373 hsa-mir-1249 hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_6464 9 3.18E-11 2.04E-09 1.85E-10 2374 hsa-mir-1249 hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5925_4286 9 6.54E-11 4.19E-09 3.49E-10 2375 hsa-mir-1249 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2113_3725_2034_2033 9 7.33E-11 4.69E-09 3.61E-10 2376 hsa-mir-1249 hsa04310 Wnt signaling pathway 1387_595_7157_4087_4773_4609_3725_1457_4088_4089_2033 11 1.27E-10 8.12E-09 5.80E-10 2377 hsa-mir-1249 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_5970_4609 8 4.79E-10 3.06E-08 2.04E-09 2378 hsa-mir-1249 hsa04520 Adherens junction 5595_5594_1387_4087_1457_4088_4089_2033 8 4.37E-09 2.80E-07 1.75E-08 2379 hsa-mir-1249 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 8.03E-09 5.14E-07 3.02E-08 2380 hsa-mir-1249 hsa05016 Huntington's disease 6874_1387_2902_836_6667_7157_3066_3065_3064_2033 10 1.49E-08 9.56E-07 5.31E-08 2381 hsa-mir-1249 hsa04010 MAPK signaling pathway 5595_5594_4208_836_3312_5970_7157_4773_4609_3725_4763 11 4.28E-08 2.74E-06 1.44E-07 2382 hsa-mir-1249 hsa04330 Notch signaling pathway 1387_9612_3066_3065_2033_8850 6 1.07E-07 6.83E-06 3.41E-07 2383 hsa-mir-1249 hsa05213 Endometrial cancer 5595_5594_595_7157_4609 5 4.66E-06 0.000298359 1.42E-05 2384 hsa-mir-1249 hsa04720 Long-term potentiation 5595_5594_1387_2902_2033 5 2.47E-05 0.001583414 6.88E-05 2385 hsa-mir-1249 hsa04662 B cell receptor signaling pathway 5595_5594_5970_4773_3725 5 2.47E-05 0.001583414 6.88E-05 2386 hsa-mir-1249 hsa04012 ErbB signaling pathway 5595_5594_4609_3725_6464 5 4.86E-05 0.003109001 0.000129542 2387 hsa-mir-1249 hsa04916 Melanogenesis 5595_5594_1387_2033_4286 5 0.000108902 0.006969709 0.000278788 2388 hsa-mir-1249 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_7157_4846 4 0.000129898 0.008313473 0.000319749 2389 hsa-mir-1249 hsa04660 T cell receptor signaling pathway 5595_5594_5970_4773_3725 5 0.000140167 0.008970667 0.000332247 2390 hsa-mir-1249 hsa04115 p53 signaling pathway 595_983_836_7157 4 0.00027776 0.017776628 0.00063488 2391 hsa-mir-1249 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_4773_6464 5 0.000385489 0.024671306 0.000850735 2392 hsa-mir-1249 hsa04370 VEGF signaling pathway 5595_5594_4773_4846 4 0.000413522 0.026465422 0.000882181 2393 hsa-mir-1249 hsa04612 Antigen processing and presentation 4800_4801_3312_1514 4 0.000697581 0.044645164 0.001440167 2394 hsa-mir-1249 hsa04620 Toll-like receptor signaling pathway 5595_5594_5970_3725 4 0.001137212 0.072781585 0.002220687 2395 hsa-mir-1249 hsa05010 Alzheimer's disease 5595_5594_2902_836_4846 5 0.001145042 0.073282685 0.002220687 2396 hsa-mir-1249 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.001709856 0.109430804 0.003218553 2397 hsa-mir-1249 hsa04510 Focal adhesion 5595_5594_595_3725_6464 5 0.002190666 0.140202609 0.004005789 2398 hsa-mir-1249 hsa04910 Insulin signaling pathway 6720_5595_5594_6464 4 0.003302758 0.211376492 0.005871569 2399 hsa-mir-1249 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_5970_3725 3 0.0039828 0.254899168 0.006707873 2400 hsa-mir-1249 hsa04730 Long-term depression 5595_5594_4846 3 0.0039828 0.254899168 0.006707873 2401 hsa-mir-1249 hsa04630 Jak-STAT signaling pathway 1387_595_4609_2033 4 0.004933857 0.315766835 0.008096586 2402 hsa-mir-1249 hsa04210 Apoptosis 836_5970_7157 3 0.00729768 0.467051515 0.011676288 2403 hsa-mir-1249 hsa04540 Gap junction 5595_5594_983 3 0.008201107 0.524870865 0.012801728 2404 hsa-mir-1249 hsa04062 Chemokine signaling pathway 5595_5594_5970_6464 4 0.010350299 0.66241914 0.015771884 2405 hsa-mir-1249 hsa04912 GnRH signaling pathway 5595_5594_3725 3 0.012156781 0.778033978 0.018093813 2406 hsa-mir-1249 hsa04930 Type II diabetes mellitus 5595_5594 2 0.017340874 1 0.02522309 2407 hsa-mir-1249 hsa03050 Proteasome 5684_5705 2 0.019488163 1 0.027716498 2408 hsa-mir-1249 hsa04360 Axon guidance 5595_5594_4773 3 0.020023892 1 0.027859329 2409 hsa-mir-1249 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428 3 0.023282233 1 0.031703466 2410 hsa-mir-1249 hsa04920 Adipocytokine signaling pathway 6256_5970 2 0.035414679 1 0.047219572 2411 hsa-mir-1249 hsa04664 Fc epsilon RI signaling pathway 5595_5594 2 0.047325058 1 0.061812321 2412 hsa-mir-1250 hsa04110 Cell cycle 4088_4089_1870_1871_7157_4087_2033_1017_890_1869_5934_5933 12 1.43E-20 4.15E-19 4.15E-19 2413 hsa-mir-1250 hsa05200 Pathways in cancer 4088_4089_1487_1870_1871_1488_1050_4149_7157_4087_2033_1017_1869 13 3.61E-17 1.05E-15 5.24E-16 2414 hsa-mir-1250 hsa05220 Chronic myeloid leukemia 4088_4089_1487_1870_1871_1488_7157_1869 8 4.12E-14 1.19E-12 3.98E-13 2415 hsa-mir-1250 hsa04350 TGF-beta signaling pathway 4088_4089_1874_1875_4087_2033_5934_5933 8 1.26E-13 3.65E-12 9.12E-13 2416 hsa-mir-1250 hsa04310 Wnt signaling pathway 4088_4089_1487_1488_7157_4087_2033 7 4.87E-10 1.41E-08 2.82E-09 2417 hsa-mir-1250 hsa05222 Small cell lung cancer 1870_1871_4149_7157_1017_1869 6 8.79E-10 2.55E-08 3.87E-09 2418 hsa-mir-1250 hsa05215 Prostate cancer 1870_1871_7157_2033_1017_1869 6 1.00E-09 2.90E-08 3.87E-09 2419 hsa-mir-1250 hsa05212 Pancreatic cancer 1870_1871_7157_2033_1017_1869 6 1.07E-09 3.10E-08 3.87E-09 2420 hsa-mir-1250 hsa05219 Bladder cancer 1870_1871_7157_1869 4 2.16E-07 6.26E-06 6.96E-07 2421 hsa-mir-1250 hsa05223 Non-small cell lung cancer 1870_1871_7157_1869 4 5.56E-07 1.61E-05 1.61E-06 2422 hsa-mir-1250 hsa05214 Glioma 1870_1871_7157_1869 4 1.12E-06 3.26E-05 2.96E-06 2423 hsa-mir-1250 hsa05218 Melanoma 1870_1871_7157_1869 4 1.57E-06 4.56E-05 3.80E-06 2424 hsa-mir-1250 hsa04520 Adherens junction 4088_4089_4087_2033 4 2.48E-06 7.18E-05 5.52E-06 2425 hsa-mir-1250 hsa05210 Colorectal cancer 4088_4089_7157_4087 4 2.98E-06 8.65E-05 6.18E-06 2426 hsa-mir-1250 hsa04330 Notch signaling pathway 1487_1488_2033 3 2.50E-05 0.000726442 4.84E-05 2427 hsa-mir-1250 hsa04115 p53 signaling pathway 7157_1017 2 0.002943471 0.085360656 0.005335041 2428 hsa-mir-1250 hsa05016 Huntington's disease 7157_2033 2 0.019556962 0.567151887 0.033361876 2429 hsa-mir-1250 hsa05216 Thyroid cancer 7157 1 0.033425763 0.969347133 0.053852619 2430 hsa-mir-1250 hsa04010 MAPK signaling pathway 4149_7157 2 0.038666791 1 0.059017734 2431 hsa-mir-1251 hsa05200 Pathways in cancer 3320_25_5371_2249_367_1499_5594_5595_5599_5914_1387_6257_6256_8031_5601_6258_208_861_6934_6774_6776_6777_6772_3091_5970_4087_6688_2113_3725_2736_2353_4088_4089_5602_5925_2033_207_2932_8554 39 7.48E-29 5.31E-27 5.31E-27 2432 hsa-mir-1251 hsa04010 MAPK signaling pathway 6722_8986_2249_5594_5595_5599_1386_9261_5601_1649_208_9252_1432_6197_5970_10912_468_3725_3727_6195_6196_2353_5600_5602_4616_207_8550_4773 28 1.61E-19 1.14E-17 5.71E-18 2433 hsa-mir-1251 hsa05215 Prostate cancer 3320_367_1499_5594_5595_1387_208_6934_5970_468_9586_10488_5925_2033_207_2932 16 3.89E-15 2.76E-13 8.08E-14 2434 hsa-mir-1251 hsa05212 Pancreatic cancer 3320_367_1499_5594_5595_1387_208_6934_5970_468_9586_10488_5925_2033_207_2932 16 4.55E-15 3.23E-13 8.08E-14 2435 hsa-mir-1251 hsa05210 Colorectal cancer 1499_5594_5595_5599_5601_208_6934_4087_3725_2353_4088_4089_5602_207_2932 15 3.61E-14 2.56E-12 5.13E-13 2436 hsa-mir-1251 hsa05221 Acute myeloid leukemia 5371_5594_5595_5914_208_861_6934_6774_6776_6777_5970_6688_207 13 1.78E-13 1.26E-11 2.10E-12 2437 hsa-mir-1251 hsa05220 Chronic myeloid leukemia 25_5594_5595_208_861_6776_6777_5970_4088_4089_5925_207 12 4.25E-11 3.02E-09 4.31E-10 2438 hsa-mir-1251 hsa04310 Wnt signaling pathway 1499_5599_1387_5601_6934_4087_8061_3725_1457_4088_4089_5602_2033_2932_4773 15 8.24E-11 5.85E-09 6.71E-10 2439 hsa-mir-1251 hsa04620 Toll-like receptor signaling pathway 5594_5595_5599_5601_208_1432_6772_5970_3725_2353_5600_5602_207 13 8.51E-11 6.04E-09 6.71E-10 2440 hsa-mir-1251 hsa04012 ErbB signaling pathway 25_5594_5595_5599_5601_208_6776_6777_3725_5602_207_2932 12 2.00E-10 1.42E-08 1.41E-09 2441 hsa-mir-1251 hsa04920 Adipocytokine signaling pathway 10891_5599_6257_6256_5601_6258_208_6774_5970_5602_207 11 2.18E-10 1.55E-08 1.41E-09 2442 hsa-mir-1251 hsa04110 Cell cycle 25_5591_1387_7534_7533_4087_10912_4088_4089_5925_2033_4616_2932 13 4.86E-10 3.45E-08 2.87E-09 2443 hsa-mir-1251 hsa04520 Adherens junction 1499_5594_5595_1387_6934_71_4087_1457_4088_4089_2033 11 1.19E-09 8.43E-08 6.49E-09 2444 hsa-mir-1251 hsa05216 Thyroid cancer 1499_5594_5595_6257_6256_8031_6258_6934 8 1.89E-09 1.34E-07 9.60E-09 2445 hsa-mir-1251 hsa04660 T cell receptor signaling pathway 5594_5595_5601_208_1432_5970_3725_2353_5600_207_2932_4773 12 2.31E-09 1.64E-07 1.10E-08 2446 hsa-mir-1251 hsa05211 Renal cell carcinoma 5594_5595_1387_208_3091_2113_3725_2033_207 9 8.28E-08 5.88E-06 3.67E-07 2447 hsa-mir-1251 hsa04150 mTOR signaling pathway 5594_5595_208_3091_6197_6195_6196_207 8 1.04E-07 7.37E-06 4.33E-07 2448 hsa-mir-1251 hsa04662 B cell receptor signaling pathway 5594_5595_208_5970_3725_2353_207_2932_4773 9 1.14E-07 8.09E-06 4.50E-07 2449 hsa-mir-1251 hsa05223 Non-small cell lung cancer 5594_5595_6257_6256_6258_208_5925_207 8 1.35E-07 9.58E-06 5.04E-07 2450 hsa-mir-1251 hsa04664 Fc epsilon RI signaling pathway 5594_5595_5599_5601_208_1432_5600_5602_207 9 1.71E-07 1.21E-05 6.07E-07 2451 hsa-mir-1251 hsa04630 Jak-STAT signaling pathway 1387_208_6774_6775_6776_6777_6772_2033_3977_207_8554 11 6.29E-07 4.46E-05 2.13E-06 2452 hsa-mir-1251 hsa04720 Long-term potentiation 5594_5595_1387_6197_468_6195_6196_2033 8 1.32E-06 9.40E-05 4.27E-06 2453 hsa-mir-1251 hsa05213 Endometrial cancer 1499_5594_5595_208_6934_207_2932 7 1.49E-06 0.000106101 4.61E-06 2454 hsa-mir-1251 hsa04370 VEGF signaling pathway 5594_5595_9261_208_1432_5600_207_4773 8 1.59E-06 0.000112804 4.70E-06 2455 hsa-mir-1251 hsa04912 GnRH signaling pathway 5594_5595_5599_5601_1432_468_3725_5600_5602 9 1.94E-06 0.000137987 5.52E-06 2456 hsa-mir-1251 hsa05222 Small cell lung cancer 6257_6256_6258_208_5970_5925_207_8554 8 3.41E-06 0.000242298 9.32E-06 2457 hsa-mir-1251 hsa04350 TGF-beta signaling pathway 6667_5594_5595_1387_4087_4088_4089_2033 8 3.70E-06 0.000262412 9.72E-06 2458 hsa-mir-1251 hsa04510 Focal adhesion 1499_5594_5595_5599_5601_208_71_3725_5602_207_2932 11 8.46E-06 0.000600667 2.15E-05 2459 hsa-mir-1251 hsa04930 Type II diabetes mellitus 5594_5595_5599_5601_5602_3651 6 9.00E-06 0.000638688 2.20E-05 2460 hsa-mir-1251 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5601_1432_5970_3725_5600_5602 7 9.92E-06 0.000704083 2.35E-05 2461 hsa-mir-1251 hsa04916 Melanogenesis 1499_5594_5595_1387_6934_10488_2033_2932 8 1.26E-05 0.000892672 2.80E-05 2462 hsa-mir-1251 hsa04910 Insulin signaling pathway 10891_5594_5595_5599_5601_208_5602_207_2932 9 1.26E-05 0.00089638 2.80E-05 2463 hsa-mir-1251 hsa05218 Melanoma 2249_5594_5595_208_5925_207 6 9.63E-05 0.006833919 0.000207088 2464 hsa-mir-1251 hsa04062 Chemokine signaling pathway 5594_5595_208_6774_6777_6772_5970_207_2932 9 0.000149984 0.010648846 0.000313201 2465 hsa-mir-1251 hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_83737_7329_64326_8554 7 0.000525173 0.037287311 0.001065352 2466 hsa-mir-1251 hsa05214 Glioma 5594_5595_208_5925_207 5 0.00055716 0.039558339 0.001098843 2467 hsa-mir-1251 hsa05016 Huntington's disease 6667_10891_1387_6908_9586_3064_10488_2033 8 0.000621766 0.044145397 0.001163203 2468 hsa-mir-1251 hsa03022 Basal transcription factors 2963_6908_6872_2959 4 0.00062256 0.044201726 0.001163203 2469 hsa-mir-1251 hsa05219 Bladder cancer 5594_5595_9252_5925 4 0.000966413 0.068615337 0.001759368 2470 hsa-mir-1251 hsa04950 Maturity onset diabetes of the young 6927_3087_3651 3 0.002122226 0.150678041 0.003766951 2471 hsa-mir-1251 hsa05217 Basal cell carcinoma 1499_6934_2736_2932 4 0.002446638 0.17371128 0.00423686 2472 hsa-mir-1251 hsa05131 Shigellosis 25_1499_7534_71 4 0.002601992 0.184741453 0.004296313 2473 hsa-mir-1251 hsa05130 Pathogenic Escherichia coli infection 25_1499_7534_71 4 0.002601992 0.184741453 0.004296313 2474 hsa-mir-1251 hsa03320 PPAR signaling pathway 6257_6256_6258_2168 4 0.005534527 0.392951391 0.008930713 2475 hsa-mir-1251 hsa03450 Non-homologous end-joining 5591_2547 2 0.009967323 0.70767996 0.015406509 2476 hsa-mir-1251 hsa04360 Axon guidance 25_5594_5595_2932_4773 5 0.009981682 0.708699425 0.015406509 2477 hsa-mir-1251 hsa04530 Tight junction 1499_208_71_1457_207 5 0.011871342 0.842865252 0.017910092 2478 hsa-mir-1251 hsa04330 Notch signaling pathway 1387_9612_2033 3 0.012108231 0.859684412 0.017910092 2479 hsa-mir-1251 hsa04115 p53 signaling pathway 10912_64326_4616 3 0.031644886 1 0.045852793 2480 hsa-mir-1251 hsa04670 Leukocyte transendothelial migration 1499_1432_71_5600 4 0.032889514 1 0.04670311 2481 hsa-mir-1251 hsa04730 Long-term depression 5592_5594_5595 3 0.033926065 1 0.047230404 2482 hsa-mir-1252 hsa05200 Pathways in cancer 3716_5747_3725_1956_1499_5594_1387_2064_6256_5159_5156_836_1487_2261_3815_4193_1488_2353_6774_6776_6777_5879_5970_7157_6688_4087_8772_4609_10401_4088_4089_5881_5925_2033_207_2308_3326_1050_8554_7046_7184 41 4.18E-28 3.18E-26 1.76E-26 2483 hsa-mir-1252 hsa03022 Basal transcription factors 2961_2960_2963_6881_2969_2967_6877_6874_6872_2957_54457_6879_6878_6873_2958_2968_6884_2959_6880_6882_138474_6883 22 4.62E-28 3.51E-26 1.76E-26 2484 hsa-mir-1252 hsa04630 Jak-STAT signaling pathway 3717_3716_3560_3561_1387_6774_6776_6777_6773_58985_3455_3459_5781_7297_4609_10401_1439_2033_207_8554_10379 21 1.18E-15 8.95E-14 2.98E-14 2485 hsa-mir-1252 hsa05210 Colorectal cancer 3725_1956_1499_5594_5159_5156_836_2353_5879_7157_4087_4609_4088_4089_5881_207_7046 17 1.83E-15 1.39E-13 3.48E-14 2486 hsa-mir-1252 hsa05215 Prostate cancer 1956_1499_5594_1387_2064_5159_5156_4193_5970_7157_5925_2033_207_2308_3326_7184 16 5.41E-14 4.11E-12 8.01E-13 2487 hsa-mir-1252 hsa05212 Pancreatic cancer 1956_1499_5594_1387_2064_5159_5156_4193_5970_7157_5925_2033_207_2308_3326_7184 16 6.32E-14 4.80E-12 8.01E-13 2488 hsa-mir-1252 hsa05220 Chronic myeloid leukemia 5594_1487_4193_1488_6776_6777_5970_7157_5781_4609_4088_4089_5925_207_7046 15 9.87E-14 7.50E-12 1.07E-12 2489 hsa-mir-1252 hsa04520 Adherens junction 1460_1956_1499_6714_5594_1387_2064_5879_4087_4088_4089_5881_2033_7046_2534 15 2.26E-13 1.72E-11 2.15E-12 2490 hsa-mir-1252 hsa04010 MAPK signaling pathway 3725_1956_5594_5598_5159_5156_7132_836_2261_2264_9252_2353_3312_1432_1845_5879_5970_7157_4609_3727_5881_207_7046 23 5.49E-13 4.17E-11 4.63E-12 2491 hsa-mir-1252 hsa04310 Wnt signaling pathway 3725_818_1460_817_1499_1387_8607_1487_1488_5879_7157_4087_4609_4088_4089_5881_2033 17 1.05E-11 7.96E-10 7.96E-11 2492 hsa-mir-1252 hsa04110 Cell cycle 993_1387_983_4193_7157_4087_4174_4171_4172_4085_4088_4089_5925_2033 14 3.89E-10 2.96E-08 2.69E-09 2493 hsa-mir-1252 hsa04060 Cytokine-cytokine receptor interaction 2321_3791_1956_3560_3561_90_5159_5156_7133_7132_1234_1230_3815_7852_58985_3455_3459_1439_7046 19 6.34E-10 4.82E-08 4.02E-09 2494 hsa-mir-1252 hsa04920 Adipocytokine signaling pathway 3717_8717_6256_7133_7132_6774_10891_5970_5781_5563_207 11 1.30E-09 9.88E-08 7.48E-09 2495 hsa-mir-1252 hsa04012 ErbB signaling pathway 5747_3725_818_817_1956_6714_5594_2064_6776_6777_4609_207 12 1.38E-09 1.05E-07 7.48E-09 2496 hsa-mir-1252 hsa05219 Bladder cancer 1956_5594_2064_2261_9252_4193_7157_4609_5925 9 5.44E-09 4.13E-07 2.67E-08 2497 hsa-mir-1252 hsa05221 Acute myeloid leukemia 5594_3815_6774_6776_6777_5970_6688_4609_207_1050 10 5.63E-09 4.28E-07 2.67E-08 2498 hsa-mir-1252 hsa05214 Glioma 818_817_1956_5594_5159_5156_4193_7157_5925_207 10 1.29E-08 9.82E-07 5.78E-08 2499 hsa-mir-1252 hsa04350 TGF-beta signaling pathway 5594_1387_90_6667_4087_4609_4088_4089_2033_7046_57154 11 1.53E-08 1.16E-06 6.47E-08 2500 hsa-mir-1252 hsa04510 Focal adhesion 5747_3725_2321_3791_1956_1499_6714_5594_2064_5159_5156_5879_5881_207_2534 15 3.92E-08 2.98E-06 1.57E-07 2501 hsa-mir-1252 hsa04062 Chemokine signaling pathway 3717_5747_5580_5594_1234_1230_6774_6777_6773_5879_7852_5970_207 13 7.28E-07 5.54E-05 2.77E-06 2502 hsa-mir-1252 hsa05222 Small cell lung cancer 5747_6256_5970_7157_4609_10401_5925_207_8554 9 1.36E-06 0.00010322 4.92E-06 2503 hsa-mir-1252 hsa04210 Apoptosis 8717_7132_836_840_5970_7157_8772_1439_207 9 1.77E-06 0.0001342 6.10E-06 2504 hsa-mir-1252 hsa05218 Melanoma 1956_5594_5159_5156_4193_7157_5925_207 8 3.19E-06 0.000242506 1.01E-05 2505 hsa-mir-1252 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1956_6714_836_1432_5879_5970_5781 8 3.19E-06 0.000242506 1.01E-05 2506 hsa-mir-1252 hsa05213 Endometrial cancer 1956_1499_5594_2064_7157_4609_207 7 4.57E-06 0.000347339 1.36E-05 2507 hsa-mir-1252 hsa04662 B cell receptor signaling pathway 3725_5594_2353_5879_5970_6850_5881_207 8 4.64E-06 0.000352558 1.36E-05 2508 hsa-mir-1252 hsa04620 Toll-like receptor signaling pathway 3725_5594_2353_1432_5879_5970_3455_8772_207 9 4.99E-06 0.000378959 1.40E-05 2509 hsa-mir-1252 hsa04370 VEGF signaling pathway 5747_3791_6714_5594_1432_5879_5881_207 8 5.55E-06 0.000421816 1.50E-05 2510 hsa-mir-1252 hsa05223 Non-small cell lung cancer 1956_5594_2064_6256_7157_5925_207 7 5.73E-06 0.000435679 1.50E-05 2511 hsa-mir-1252 hsa04664 Fc epsilon RI signaling pathway 5580_5594_1432_5879_6850_5881_207_2534 8 6.61E-06 0.000502249 1.67E-05 2512 hsa-mir-1252 hsa04650 Natural killer cell mediated cytotoxicity 3932_5594_836_5879_6850_3455_3459_5781_5881_2534 10 7.67E-06 0.000582819 1.82E-05 2513 hsa-mir-1252 hsa04912 GnRH signaling pathway 3725_5580_818_817_1956_6714_5594_5598_1432 9 7.68E-06 0.000583753 1.82E-05 2514 hsa-mir-1252 hsa04540 Gap junction 1956_6714_5594_5598_5159_983_5156_10382 8 1.99E-05 0.001514849 4.59E-05 2515 hsa-mir-1252 hsa04330 Notch signaling pathway 1387_1487_1488_9612_2033_8850 6 2.93E-05 0.002227342 6.55E-05 2516 hsa-mir-1252 hsa05211 Renal cell carcinoma 3725_5594_1387_5879_5781_2033_207 7 3.20E-05 0.002432973 6.95E-05 2517 hsa-mir-1252 hsa05216 Thyroid cancer 1499_5594_6256_7157_4609 5 3.81E-05 0.002895932 8.04E-05 2518 hsa-mir-1252 hsa04660 T cell receptor signaling pathway 3725_3932_5594_2353_1432_5970_207_2534 8 6.11E-05 0.004645043 0.000125542 2519 hsa-mir-1252 hsa05014 Amyotrophic lateral sclerosis (ALS) 7133_7132_836_1432_5879_7157 6 7.21E-05 0.005476595 0.000144121 2520 hsa-mir-1252 hsa05016 Huntington's disease 6874_1387_836_6667_9001_10891_5430_7157_3064_2033 10 9.29E-05 0.007058957 0.000180999 2521 hsa-mir-1252 hsa04950 Maturity onset diabetes of the young 6928_3172_6927_5080 4 0.000265107 0.020148146 0.000503704 2522 hsa-mir-1252 hsa04916 Melanogenesis 818_817_1499_5594_1387_3815_2033 7 0.000275702 0.020953338 0.000511057 2523 hsa-mir-1252 hsa03050 Proteasome 5719_5705_5701_5702_5710 5 0.000329709 0.025057885 0.000596616 2524 hsa-mir-1252 hsa04360 Axon guidance 5747_1020_5594_5879_7852_5881_2534 7 0.001015623 0.077187368 0.001795055 2525 hsa-mir-1252 hsa03030 DNA replication 79621_4174_4171_4172 4 0.001063653 0.080837595 0.001837218 2526 hsa-mir-1252 hsa04810 Regulation of actin cytoskeleton 5747_1956_5594_5159_5156_2261_2264_5879_5881 9 0.001222982 0.092946636 0.002065481 2527 hsa-mir-1252 hsa04720 Long-term potentiation 818_817_5594_1387_2033 5 0.002155635 0.163828292 0.003561485 2528 hsa-mir-1252 hsa04670 Leukocyte transendothelial migration 5747_1499_1432_5879_7852_5781 6 0.003417414 0.259723449 0.005526031 2529 hsa-mir-1252 hsa04910 Insulin signaling pathway 5594_10891_5563_5211_207_2308 6 0.006048674 0.459699221 0.009502049 2530 hsa-mir-1252 hsa04020 Calcium signaling pathway 818_817_1956_2064_5159_5156_147 7 0.006234911 0.473853222 0.009502049 2531 hsa-mir-1252 hsa04120 Ubiquitin mediated proteolysis 672_4193_7329_10401_8554_57154 6 0.006251348 0.475102438 0.009502049 2532 hsa-mir-1252 hsa04115 p53 signaling pathway 983_836_4193_7157 4 0.009473203 0.719963453 0.01411693 2533 hsa-mir-1252 hsa03420 Nucleotide excision repair 2967_2968_5887 3 0.016088134 1 0.023513426 2534 hsa-mir-1252 hsa05010 Alzheimer's disease 1020_5594_7132_836_840_8772 6 0.018165363 1 0.026048445 2535 hsa-mir-1252 hsa04612 Antigen processing and presentation 4801_3312_1514_3326 4 0.021349207 1 0.030047033 2536 hsa-mir-1252 hsa04530 Tight junction 5580_1460_1499_6714_207 5 0.022909968 1 0.031657411 2537 hsa-mir-1252 hsa04150 mTOR signaling pathway 5594_5563_207 3 0.024374509 1 0.033079691 2538 hsa-mir-1252 hsa05131 Shigellosis 1499_10382_2534 3 0.029231025 1 0.038302723 2539 hsa-mir-1252 hsa05130 Pathogenic Escherichia coli infection 1499_10382_2534 3 0.029231025 1 0.038302723 2540 hsa-mir-1253 hsa05200 Pathways in cancer 1147_3551_7046_1499_5914_595_2261_8517_4193_7704_3091_7175_3066_3065_5925_4087_5747_1956_1387_1870_1871_2113_5894_207_3716_5595_5594_5599_2064_6256_836_367_2932_6774_6776_6777_5970_7157_6688_1869_3725_4088_4089_2034_2033_4846_4790_4791_4792_5879_3320_3326_5371_1050_5159_5156_3815_7428_8772_4609_2353_8554 62 1.53E-46 1.19E-44 1.19E-44 2541 hsa-mir-1253 hsa05215 Prostate cancer 1147_3551_1499_595_8517_4193_5925_1956_1387_1870_1871_5894_207_5595_5594_1385_2064_367_2932_5970_7157_1869_2033_4790_4792_3320_3326_5159_5156 29 3.50E-28 2.73E-26 1.19E-26 2542 hsa-mir-1253 hsa05212 Pancreatic cancer 1147_3551_1499_595_8517_4193_5925_1956_1387_1870_1871_5894_207_5595_5594_1385_2064_367_2932_5970_7157_1869_2033_4790_4792_3320_3326_5159_5156 29 4.58E-28 3.57E-26 1.19E-26 2543 hsa-mir-1253 hsa05220 Chronic myeloid leukemia 1147_3551_7046_595_8517_4193_3066_3065_5925_1870_1871_5894_207_5595_5594_6776_6777_5970_7157_1869_4088_4089_4790_4792_5781_4609_6464 27 3.62E-27 2.83E-25 7.06E-26 2544 hsa-mir-1253 hsa04010 MAPK signaling pathway 1147_3551_7046_2261_2264_8517_1845_5536_1956_3305_3303_1432_5894_4763_207_5595_5594_5599_836_9252_3310_3312_5971_5970_7157_3725_4790_4791_5879_5159_1326_5156_4208_5566_4609_2353_7132 37 1.21E-23 9.47E-22 1.89E-22 2545 hsa-mir-1253 hsa05221 Acute myeloid leukemia 1147_3551_5914_595_8517_7704_5894_207_5595_5594_6774_6776_6777_5970_6688_4790_5371_1050_3815_4609 20 5.07E-20 3.96E-18 6.60E-19 2546 hsa-mir-1253 hsa05214 Glioma 818_817_595_4193_5925_1956_1870_1871_5894_207_5595_5594_7157_1869_808_801_805_5159_5156_6464 20 2.49E-19 1.94E-17 2.78E-18 2547 hsa-mir-1253 hsa05210 Colorectal cancer 7046_1499_595_4087_1956_5894_207_5595_5594_5599_836_2932_7157_3725_4088_4089_5879_5159_5156_4609_2353 21 1.17E-18 9.15E-17 1.14E-17 2548 hsa-mir-1253 hsa04110 Cell cycle 4172_595_4193_6500_4174_3066_3065_5925_4087_1387_1870_1871_5933_5591_7533_2932_7157_1869_4088_4089_2033_8454_2810 23 3.80E-18 2.96E-16 3.29E-17 2549 hsa-mir-1253 hsa04630 Jak-STAT signaling pathway 3559_595_58985_3455_3459_3560_3561_1387_1439_207_3717_3716_6778_6774_6776_6777_6773_7297_2033_3460_5781_4609_8554_10379 24 6.34E-17 4.95E-15 4.95E-16 2550 hsa-mir-1253 hsa04920 Adipocytokine signaling pathway 1147_3551_10891_8517_7133_207_3717_8717_5599_6256_6774_5970_4794_4790_4792_4793_5781_7132 18 1.20E-16 9.34E-15 8.49E-16 2551 hsa-mir-1253 hsa04660 T cell receptor signaling pathway 1147_3551_8517_2534_3932_1432_5894_207_5595_5594_920_2932_5970_3725_4794_4790_4792_4793_1326_915_2353 21 1.38E-16 1.08E-14 8.98E-16 2552 hsa-mir-1253 hsa04310 Wnt signaling pathway 818_817_1499_595_8607_6500_4087_8945_23291_1387_5599_2932_7157_8061_3725_1457_4088_4089_2033_5879_5566_8454_4609 23 4.45E-16 3.47E-14 2.67E-15 2553 hsa-mir-1253 hsa04062 Chemokine signaling pathway 1147_3551_8517_1230_653361_5747_5580_7852_5894_207_3717_5595_5594_1234_2932_6774_6777_6773_5970_4790_4792_4793_5879_5566_6464 25 6.09E-16 4.75E-14 3.39E-15 2554 hsa-mir-1253 hsa05219 Bladder cancer 595_2261_4193_5925_1956_1870_1871_5894_5595_5594_2064_9252_7157_1869_4609 15 1.28E-15 9.99E-14 6.66E-15 2555 hsa-mir-1253 hsa05222 Small cell lung cancer 1147_3551_595_8517_5925_5747_1870_1871_207_6256_5970_7157_1869_4846_4790_4792_4609_8554 18 5.19E-15 4.04E-13 2.53E-14 2556 hsa-mir-1253 hsa04662 B cell receptor signaling pathway 1147_3551_8517_6850_5894_207_5595_5594_2932_5970_3725_4794_4790_4792_4793_5879_2353 17 9.55E-15 7.45E-13 4.38E-14 2557 hsa-mir-1253 hsa04012 ErbB signaling pathway 818_817_5747_1956_6714_5894_207_5595_5594_5599_2064_2932_6776_6777_3725_4609_6464 17 8.00E-14 6.24E-12 3.47E-13 2558 hsa-mir-1253 hsa04520 Adherens junction 7046_1499_4087_2534_1956_6714_1387_71_5595_5594_2064_1457_4088_4089_2033_5879 16 3.17E-13 2.48E-11 1.30E-12 2559 hsa-mir-1253 hsa04620 Toll-like receptor signaling pathway 1147_3551_8517_3455_1432_207_5595_5594_5599_5970_3725_4790_4792_5879_1326_8772_2353 17 7.86E-13 6.13E-11 3.07E-12 2560 hsa-mir-1253 hsa04510 Focal adhesion 1499_595_2534_5747_3791_1956_6714_10627_5894_207_71_5595_5594_5599_2064_2932_3725_5879_2321_5159_5156_6464 22 1.21E-12 9.45E-11 4.50E-12 2561 hsa-mir-1253 hsa05223 Non-small cell lung cancer 595_5925_1956_1870_1871_5894_207_5595_5594_2064_6256_7157_1869 13 7.11E-12 5.55E-10 2.52E-11 2562 hsa-mir-1253 hsa05218 Melanoma 595_4193_5925_1956_1870_1871_5894_207_5595_5594_7157_1869_5159_5156 14 1.15E-11 8.97E-10 3.74E-11 2563 hsa-mir-1253 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_3551_8517_1956_6714_1432_5599_836_5970_3725_4790_4792_5879_5781 14 1.15E-11 8.97E-10 3.74E-11 2564 hsa-mir-1253 hsa04210 Apoptosis 1147_3551_8517_8837_1439_207_8717_836_5970_7157_4790_4792_5566_8772_7132 15 1.54E-11 1.20E-09 4.79E-11 2565 hsa-mir-1253 hsa04060 Cytokine-cytokine receptor interaction 3559_7046_8600_1230_58985_3455_3459_90_3791_1956_3560_3561_7133_1439_7852_1234_2321_5159_5156_3815_3460_7132 22 9.27E-11 7.23E-09 2.78E-10 2566 hsa-mir-1253 hsa05016 Huntington's disease 10891_292_293_291_3066_3065_3064_2902_1387_1385_836_5481_5437_7157_1213_2033_6874_6908_5441 19 1.01E-10 7.87E-09 2.91E-10 2567 hsa-mir-1253 hsa04916 Melanogenesis 818_817_1499_1387_5894_5595_5594_1385_2932_2033_808_801_805_5566_3815 15 1.10E-10 8.61E-09 3.08E-10 2568 hsa-mir-1253 hsa04350 TGF-beta signaling pathway 7046_6500_90_4087_57154_1387_5933_5595_5594_4088_4089_2033_8454_4609 14 1.27E-10 9.92E-09 3.42E-10 2569 hsa-mir-1253 hsa05211 Renal cell carcinoma 3091_1387_2113_5894_207_5595_5594_3725_2034_2033_5879_7428_5781 13 1.65E-10 1.29E-08 4.30E-10 2570 hsa-mir-1253 hsa04912 GnRH signaling pathway 818_817_5580_1956_6714_1432_5894_5595_5594_5599_3725_808_801_805_5566 15 1.78E-10 1.39E-08 4.48E-10 2571 hsa-mir-1253 hsa05213 Endometrial cancer 1499_595_1956_5894_207_5595_5594_2064_2932_7157_4609 11 9.87E-10 7.70E-08 2.40E-09 2572 hsa-mir-1253 hsa04540 Gap junction 10382_203068_1956_6714_5894_5595_5594_347733_5159_5156_5566_7278_84617 13 2.74E-09 2.14E-07 6.48E-09 2573 hsa-mir-1253 hsa04720 Long-term potentiation 818_817_2902_1387_5894_5595_5594_2033_808_801_805_5566 12 2.86E-09 2.23E-07 6.57E-09 2574 hsa-mir-1253 hsa04020 Calcium signaling pathway 818_817_292_293_291_147_1956_2902_2064_5481_4846_808_801_805_5159_5156_5566 17 3.44E-09 2.68E-07 7.66E-09 2575 hsa-mir-1253 hsa04612 Antigen processing and presentation 811_3309_3305_3303_920_1385_3310_3312_3320_3326_4800_4801 12 1.62E-08 1.26E-06 3.50E-08 2576 hsa-mir-1253 hsa04910 Insulin signaling pathway 6720_3551_10891_5894_207_5595_5594_5599_2932_808_801_805_5566_6464 14 2.85E-08 2.22E-06 6.01E-08 2577 hsa-mir-1253 hsa04120 Ubiquitin mediated proteolysis 4193_6500_3093_8945_57154_23291_10273_7323_7329_5371_672_8454_7428_8554 14 3.10E-08 2.42E-06 6.36E-08 2578 hsa-mir-1253 hsa05216 Thyroid cancer 1499_595_7175_5595_5594_6256_7157_4609 8 3.36E-08 2.62E-06 6.72E-08 2579 hsa-mir-1253 hsa04650 Natural killer cell mediated cytotoxicity 3455_3459_2534_3932_6850_5894_5595_5594_836_5879_3460_5781_6464 13 1.97E-07 1.54E-05 3.85E-07 2580 hsa-mir-1253 hsa05131 Shigellosis 1499_10382_2534_203068_71_347733_7278_84617_4691 9 2.70E-07 2.11E-05 5.02E-07 2581 hsa-mir-1253 hsa05130 Pathogenic Escherichia coli infection 1499_10382_2534_203068_71_347733_7278_84617_4691 9 2.70E-07 2.11E-05 5.02E-07 2582 hsa-mir-1253 hsa04370 VEGF signaling pathway 5747_3791_6714_1432_5894_207_5595_5594_4846_5879 10 3.51E-07 2.74E-05 6.37E-07 2583 hsa-mir-1253 hsa04664 Fc epsilon RI signaling pathway 2534_5580_6850_1432_5894_207_5595_5594_5599_5879 10 4.36E-07 3.40E-05 7.72E-07 2584 hsa-mir-1253 hsa04810 Regulation of actin cytoskeleton 2261_2264_10788_5747_1956_4627_4628_10627_5894_71_5595_5594_5879_5159_5156 15 1.06E-06 8.24E-05 1.83E-06 2585 hsa-mir-1253 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_7133_1432_836_7157_4846_5879_7132 8 2.78E-06 0.00021703 4.72E-06 2586 hsa-mir-1253 hsa03020 RNA polymerase 25885_64425_51082_5437_84172_5441 6 7.73E-06 0.000602953 1.28E-05 2587 hsa-mir-1253 hsa04270 Vascular smooth muscle contraction 147_5580_5894_5595_5594_4637_808_801_805_5566 10 1.21E-05 0.000940821 1.96E-05 2588 hsa-mir-1253 hsa05010 Alzheimer's disease 3416_2902_5595_5594_836_2932_4846_808_801_805_8772_7132 12 1.39E-05 0.001081497 2.21E-05 2589 hsa-mir-1253 hsa05340 Primary immunodeficiency 8517_100_3932_3561_920_915 6 2.00E-05 0.001557483 3.11E-05 2590 hsa-mir-1253 hsa04330 Notch signaling pathway 3066_3065_1387_9612_2033_4851 6 8.87E-05 0.006916571 0.000134688 2591 hsa-mir-1253 hsa04670 Leukocyte transendothelial migration 1499_653361_5747_1432_7852_10627_71_5879_5781 9 8.98E-05 0.0070038 0.000134688 2592 hsa-mir-1253 hsa04530 Tight junction 1499_5580_6714_4627_4628_10627_207_71_1457 9 0.000204737 0.015969496 0.000301311 2593 hsa-mir-1253 hsa04930 Type II diabetes mellitus 3551_5580_5595_5594_5599 5 0.000622805 0.04857878 0.000899607 2594 hsa-mir-1253 hsa04360 Axon guidance 2534_5747_7852_5595_5594_2932_5879 7 0.003138134 0.244774427 0.004450444 2595 hsa-mir-1253 hsa04115 p53 signaling pathway 595_4193_836_7157_2810 5 0.003616861 0.282115184 0.005037771 2596 hsa-mir-1253 hsa04150 mTOR signaling pathway 3091_207_5595_5594 4 0.007475854 0.583116613 0.010230116 2597 hsa-mir-1253 hsa04640 Hematopoietic cell lineage 3559_920_915_914_3815 5 0.009035579 0.704775167 0.012151296 2598 hsa-mir-1253 hsa04340 Hedgehog signaling pathway 8945_23291_2932_5566 4 0.010067329 0.785251684 0.013309351 2599 hsa-mir-1253 hsa05012 Parkinson's disease 292_293_291_7314_836_5481 6 0.014237254 1 0.01850843 2600 hsa-mir-1253 hsa03022 Basal transcription factors 2969_6874_6908 3 0.01769889 1 0.022631368 2601 hsa-mir-1253 hsa04730 Long-term depression 5894_5595_5594_4846 4 0.02019386 1 0.025405179 2602 hsa-mir-1253 hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.046167544 1 0.057159816 2603 hsa-mir-1254 hsa05200 Pathways in cancer 3320_25_4149_5371_5595_5594_5599_1387_5604_2932_6502_5970_5894_1029_4087_4088_4089_4292_1050_5925_2033 21 2.66E-20 1.54E-18 1.54E-18 2604 hsa-mir-1254 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_8454_3399_6500_4086_4087_4088_4089_2033_4093_5933 14 4.84E-19 2.80E-17 1.35E-17 2605 hsa-mir-1254 hsa04110 Cell cycle 25_990_1387_983_2932_8454_6502_6500_1029_4087_4088_4089_5925_2033_5933 15 6.99E-19 4.05E-17 1.35E-17 2606 hsa-mir-1254 hsa04540 Gap junction 5595_5594_5598_983_5604_7277_7278_10376_5894_7846_51807 11 7.45E-14 4.32E-12 1.08E-12 2607 hsa-mir-1254 hsa05220 Chronic myeloid leukemia 25_5595_5594_5604_5970_5894_1029_4088_4089_5925 10 3.55E-13 2.06E-11 4.12E-12 2608 hsa-mir-1254 hsa05210 Colorectal cancer 5595_5594_5599_5604_2932_5894_4087_4088_4089_4292 10 1.00E-12 5.81E-11 9.68E-12 2609 hsa-mir-1254 hsa05215 Prostate cancer 3320_5595_5594_1387_5604_2932_5970_5894_5925_2033 10 1.53E-12 8.90E-11 1.23E-11 2610 hsa-mir-1254 hsa05212 Pancreatic cancer 3320_5595_5594_1387_5604_2932_5970_5894_5925_2033 10 1.70E-12 9.87E-11 1.23E-11 2611 hsa-mir-1254 hsa04310 Wnt signaling pathway 5599_1387_2932_8454_6500_1457_1459_4087_4088_4089_2033 11 1.08E-11 6.28E-10 6.98E-11 2612 hsa-mir-1254 hsa04520 Adherens junction 5595_5594_1387_1457_1459_4087_4088_4089_2033 9 2.28E-11 1.32E-09 1.32E-10 2613 hsa-mir-1254 hsa05131 Shigellosis 25_7277_7278_10376_7846_51807_4691 7 2.11E-09 1.22E-07 1.02E-08 2614 hsa-mir-1254 hsa05130 Pathogenic Escherichia coli infection 25_7277_7278_10376_7846_51807_4691 7 2.11E-09 1.22E-07 1.02E-08 2615 hsa-mir-1254 hsa05221 Acute myeloid leukemia 5371_5595_5594_5604_5970_5894_1050 7 2.95E-09 1.71E-07 1.31E-08 2616 hsa-mir-1254 hsa05219 Bladder cancer 5595_5594_5604_5894_1029_5925 6 1.51E-08 8.77E-07 6.27E-08 2617 hsa-mir-1254 hsa04012 ErbB signaling pathway 25_5595_5594_5599_5604_2932_5894 7 3.58E-08 2.08E-06 1.38E-07 2618 hsa-mir-1254 hsa05213 Endometrial cancer 5595_5594_5604_2932_5894_4292 6 4.85E-08 2.81E-06 1.76E-07 2619 hsa-mir-1254 hsa05223 Non-small cell lung cancer 5595_5594_5604_5894_1029_5925 6 5.97E-08 3.46E-06 2.04E-07 2620 hsa-mir-1254 hsa04916 Melanogenesis 5595_5594_1387_5604_2932_5894_2033 7 1.13E-07 6.57E-06 3.65E-07 2621 hsa-mir-1254 hsa05214 Glioma 5595_5594_5604_5894_1029_5925 6 1.66E-07 9.61E-06 5.06E-07 2622 hsa-mir-1254 hsa05218 Melanoma 5595_5594_5604_5894_1029_5925 6 2.70E-07 1.56E-05 7.82E-07 2623 hsa-mir-1254 hsa05211 Renal cell carcinoma 5595_5594_1387_5604_5894_2033 6 2.91E-07 1.69E-05 8.05E-07 2624 hsa-mir-1254 hsa04720 Long-term potentiation 5595_5594_1387_5604_5894_2033 6 3.65E-07 2.12E-05 9.21E-07 2625 hsa-mir-1254 hsa04662 B cell receptor signaling pathway 5595_5594_5604_2932_5970_5894 6 3.65E-07 2.12E-05 9.21E-07 2626 hsa-mir-1254 hsa04010 MAPK signaling pathway 4149_5595_5594_5599_5598_5604_1386_5970_5894 9 5.69E-07 3.30E-05 1.38E-06 2627 hsa-mir-1254 hsa04910 Insulin signaling pathway 5595_5594_5599_5604_23265_2932_5894 7 7.00E-07 4.06E-05 1.63E-06 2628 hsa-mir-1254 hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_8454_6502_6500_7329 7 7.34E-07 4.26E-05 1.64E-06 2629 hsa-mir-1254 hsa04912 GnRH signaling pathway 5595_5594_5599_5598_5604_5894 6 2.74E-06 0.000158882 5.88E-06 2630 hsa-mir-1254 hsa04660 T cell receptor signaling pathway 5595_5594_5604_2932_5970_5894 6 3.03E-06 0.000175799 6.28E-06 2631 hsa-mir-1254 hsa04062 Chemokine signaling pathway 5595_5594_5604_2932_5970_5894_7074 7 5.95E-06 0.000344853 1.19E-05 2632 hsa-mir-1254 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5604_5894 5 1.06E-05 0.000614394 2.05E-05 2633 hsa-mir-1254 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5604_5970 5 3.43E-05 0.001988092 6.41E-05 2634 hsa-mir-1254 hsa04510 Focal adhesion 5595_5594_5599_5604_2932_5894 6 9.21E-05 0.005340681 0.000166896 2635 hsa-mir-1254 hsa04730 Long-term depression 5595_5594_5604_5894 4 0.000130358 0.007560791 0.000229115 2636 hsa-mir-1254 hsa04370 VEGF signaling pathway 5595_5594_5604_5894 4 0.000175657 0.010188093 0.000297478 2637 hsa-mir-1254 hsa05216 Thyroid cancer 5595_5594_5604 3 0.000179513 0.010411746 0.000297478 2638 hsa-mir-1254 hsa05222 Small cell lung cancer 4149_6502_5970_5925 4 0.000263497 0.01528282 0.000424523 2639 hsa-mir-1254 hsa03022 Basal transcription factors 2962_2969_6908 3 0.000350544 0.020331574 0.000549502 2640 hsa-mir-1254 hsa04930 Type II diabetes mellitus 5595_5594_5599 3 0.000601608 0.034893287 0.000918244 2641 hsa-mir-1254 hsa04330 Notch signaling pathway 1387_2648_2033 3 0.000678377 0.039345891 0.001008869 2642 hsa-mir-1254 hsa04270 Vascular smooth muscle contraction 5595_5594_5604_5894 4 0.000833141 0.048322175 0.001208054 2643 hsa-mir-1254 hsa04810 Regulation of actin cytoskeleton 5595_5594_5604_5894_7074 5 0.001057083 0.061310829 0.001495386 2644 hsa-mir-1254 hsa04360 Axon guidance 25_5595_5594_2932 4 0.001213373 0.070375651 0.001675611 2645 hsa-mir-1254 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_5604_5894 4 0.001461722 0.08477985 0.001971624 2646 hsa-mir-1254 hsa04115 p53 signaling pathway 983_7161_1029 3 0.001954848 0.113381169 0.002576845 2647 hsa-mir-1254 hsa04612 Antigen processing and presentation 3320_4801_4802 3 0.003918069 0.227248026 0.005049956 2648 hsa-mir-1254 hsa05016 Huntington's disease 1387_6908_6667_2033 4 0.004338861 0.251653966 0.005470738 2649 hsa-mir-1254 hsa04150 mTOR signaling pathway 5595_5594 2 0.014778537 0.857155135 0.018237343 2650 hsa-mir-1254 hsa04920 Adipocytokine signaling pathway 5599_5970 2 0.023439873 1 0.028323179 2651 hsa-mir-1254 hsa05010 Alzheimer's disease 5595_5594_2932 3 0.024047427 1 0.028464301 2652 hsa-mir-1254 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5970 2 0.026027464 1 0.030191858 2653 hsa-mir-1255a hsa05200 Pathways in cancer 3716_5879_5747_5371_1956_1499_2261_5595_5594_5914_2064_6256_5159_595_5156_836_2932_3815_367_7704_1387_842_6774_6776_6777_3091_5970_4824_7428_6258_1870_1871_7157_2113_8772_4609_1869_3725_862_841_2353_3065_4087_4088_4089_3066_5925_2034_2033_4846_6502_207_208_8554_9915_7046 56 4.43E-42 3.24E-40 3.24E-40 2654 hsa-mir-1255a hsa05215 Prostate cancer 1956_1499_5595_5594_2064_5159_595_5156_2932_1385_367_1387_842_5970_4824_1870_1871_7157_1869_5925_2033_207_208 23 1.51E-21 1.10E-19 4.56E-20 2655 hsa-mir-1255a hsa05212 Pancreatic cancer 1956_1499_5595_5594_2064_5159_595_5156_2932_1385_367_1387_842_5970_4824_1870_1871_7157_1869_5925_2033_207_208 23 1.87E-21 1.37E-19 4.56E-20 2656 hsa-mir-1255a hsa04010 MAPK signaling pathway 5879_6722_1956_2261_5595_5594_2264_5159_9261_5156_4208_7132_836_6195_9252_7867_1386_1432_1845_5970_3312_7157_4773_4609_3725_2353_4763_5058_207_208_2002_7046_2005 33 5.23E-21 3.82E-19 9.55E-20 2657 hsa-mir-1255a hsa05220 Chronic myeloid leukemia 5595_5594_595_6776_6777_5970_1870_1871_7157_5781_4609_1869_3065_4088_4089_3066_5925_207_208_6464_7046 21 2.61E-20 1.90E-18 3.81E-19 2658 hsa-mir-1255a hsa05214 Glioma 818_815_817_1956_5595_5594_5159_595_5156_808_1870_1871_7157_1869_5925_207_208_6464_805_801 20 4.37E-20 3.19E-18 5.32E-19 2659 hsa-mir-1255a hsa05210 Colorectal cancer 5879_1956_1499_5595_5594_5159_595_5156_836_2932_842_7157_4609_3725_2353_4087_4088_4089_207_208_7046 21 1.92E-19 1.40E-17 2.00E-18 2660 hsa-mir-1255a hsa04012 ErbB signaling pathway 5747_818_815_817_1956_6714_5595_5594_2064_2932_6776_6777_4609_3725_5058_207_208_6464_2002 19 9.00E-17 6.57E-15 7.71E-16 2661 hsa-mir-1255a hsa04110 Cell cycle 5591_7532_595_7534_2932_1387_1870_1871_7157_4172_1869_4174_3065_4087_4088_4089_3066_5925_2033_6502_5933 21 9.50E-17 6.93E-15 7.71E-16 2662 hsa-mir-1255a hsa04630 Jak-STAT signaling pathway 3717_3716_3560_595_1387_6774_6776_6777_6773_3459_58985_3455_5781_7297_4609_3561_1439_2033_207_208_8554_10379 22 1.03E-15 7.56E-14 7.56E-15 2663 hsa-mir-1255a hsa05223 Non-small cell lung cancer 1956_5595_5594_2064_6256_595_842_6258_1870_1871_7157_1869_5925_207_208 15 7.79E-15 5.69E-13 5.17E-14 2664 hsa-mir-1255a hsa05222 Small cell lung cancer 5747_6256_595_842_5970_6258_1870_1871_7157_4609_1869_5925_4846_6502_207_208_8554 17 1.61E-14 1.17E-12 9.78E-14 2665 hsa-mir-1255a hsa04350 TGF-beta signaling pathway 3399_5595_5594_90_1387_3398_4609_4087_4088_4089_2033_4093_3397_6667_57154_7046_5933 17 1.90E-14 1.39E-12 1.07E-13 2666 hsa-mir-1255a hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_3815_7704_6774_6776_6777_5970_4609_862_207_208 15 2.37E-14 1.73E-12 1.23E-13 2667 hsa-mir-1255a hsa05219 Bladder cancer 1956_2261_5595_5594_2064_595_9252_1870_1871_7157_4609_1869_5925 13 1.54E-13 1.12E-11 7.50E-13 2668 hsa-mir-1255a hsa05211 Renal cell carcinoma 5879_5595_5594_1387_3091_7428_5781_2113_3725_5058_2034_2033_207_208_9915 15 2.94E-13 2.15E-11 1.34E-12 2669 hsa-mir-1255a hsa04520 Adherens junction 5879_1956_1499_6714_5595_5594_2064_1387_1457_4087_4088_4089_2033_7046_2534 15 1.13E-12 8.22E-11 4.84E-12 2670 hsa-mir-1255a hsa05213 Endometrial cancer 1956_1499_5595_5594_2064_595_2932_842_7157_4609_207_208_2002 13 1.56E-12 1.14E-10 6.31E-12 2671 hsa-mir-1255a hsa04510 Focal adhesion 5879_5747_2321_1956_1499_6714_5595_5594_2064_5159_595_5156_2932_3791_3725_5058_207_208_6464_2002_2534 21 1.67E-12 1.22E-10 6.42E-12 2672 hsa-mir-1255a hsa04370 VEGF signaling pathway 5879_5747_6714_5595_5594_9261_7867_1432_842_3791_4773_4846_207_208 14 9.27E-12 6.77E-10 3.39E-11 2673 hsa-mir-1255a hsa05218 Melanoma 1956_5595_5594_5159_595_5156_1870_1871_7157_1869_5925_207_208 13 4.77E-11 3.49E-09 1.66E-10 2674 hsa-mir-1255a hsa04310 Wnt signaling pathway 5879_818_815_817_1499_595_2932_1387_7157_4773_4609_3725_1457_4087_4088_4089_2033 17 6.01E-11 4.39E-09 1.99E-10 2675 hsa-mir-1255a hsa04062 Chemokine signaling pathway 3717_5879_5747_5580_5595_5594_1234_1230_2932_6774_6777_6773_5970_7852_5058_207_208_6464 18 2.52E-10 1.84E-08 8.00E-10 2676 hsa-mir-1255a hsa04916 Melanogenesis 818_815_817_1499_5595_5594_808_2932_3815_1385_1387_2033_805_801 14 3.33E-10 2.43E-08 9.77E-10 2677 hsa-mir-1255a hsa04920 Adipocytokine signaling pathway 3717_8717_6256_7133_7132_6774_5970_6258_5781_207_208_2538 12 3.35E-10 2.44E-08 9.77E-10 2678 hsa-mir-1255a hsa04912 GnRH signaling pathway 5580_818_815_817_1956_6714_5595_5594_808_1432_3725_2002_805_801 14 5.21E-10 3.81E-08 1.46E-09 2679 hsa-mir-1255a hsa04210 Apoptosis 839_8717_7132_836_842_840_5970_7157_8772_841_1439_207_208 13 5.81E-10 4.24E-08 1.57E-09 2680 hsa-mir-1255a hsa04720 Long-term potentiation 818_815_817_5595_5594_2902_6195_808_1387_2033_805_801 12 1.06E-09 7.73E-08 2.76E-09 2681 hsa-mir-1255a hsa04060 Cytokine-cytokine receptor interaction 2321_1956_3560_90_5159_5156_7133_7132_1234_1230_3815_3459_3791_7852_58985_3455_3561_1439_7046 19 3.99E-09 2.91E-07 1.00E-08 2682 hsa-mir-1255a hsa04660 T cell receptor signaling pathway 3932_5595_5594_2932_1432_5970_4773_3725_2353_5058_207_208_2534 13 6.01E-09 4.39E-07 1.46E-08 2683 hsa-mir-1255a hsa04662 B cell receptor signaling pathway 5879_5595_5594_6850_2932_5970_4773_3725_2353_207_208 11 1.19E-08 8.72E-07 2.81E-08 2684 hsa-mir-1255a hsa05216 Thyroid cancer 1499_5595_5594_6256_595_6258_7157_4609 8 1.70E-08 1.24E-06 3.87E-08 2685 hsa-mir-1255a hsa04620 Toll-like receptor signaling pathway 5879_5595_5594_1432_5970_3455_8772_3725_841_2353_207_208 12 2.43E-08 1.77E-06 5.37E-08 2686 hsa-mir-1255a hsa05010 Alzheimer's disease 22926_5595_5594_2902_7132_836_808_2932_842_840_8772_841_4846_805_801 15 2.61E-08 1.90E-06 5.60E-08 2687 hsa-mir-1255a hsa04650 Natural killer cell mediated cytotoxicity 5879_3932_5595_5594_6850_836_3459_3455_5781_4773_5058_6464_2534 13 7.13E-08 5.21E-06 1.49E-07 2688 hsa-mir-1255a hsa05014 Amyotrophic lateral sclerosis (ALS) 5879_2902_7133_7132_836_1432_842_7157_4846 9 1.28E-07 9.37E-06 2.60E-07 2689 hsa-mir-1255a hsa04910 Insulin signaling pathway 6720_5595_5594_808_2932_207_208_6464_2002_2538_805_801 12 5.05E-07 3.68E-05 9.95E-07 2690 hsa-mir-1255a hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5879_1956_6714_836_1432_5970_5781_3725_5058 9 7.88E-07 5.75E-05 1.51E-06 2691 hsa-mir-1255a hsa04020 Calcium signaling pathway 818_815_817_1956_2064_5159_2902_5156_808_4846_147_805_801 13 1.52E-06 0.000111294 2.85E-06 2692 hsa-mir-1255a hsa04664 Fc epsilon RI signaling pathway 5879_5580_5595_5594_6850_1432_207_208_2534 9 1.78E-06 0.000129685 3.24E-06 2693 hsa-mir-1255a hsa05016 Huntington's disease 6874_2902_836_1385_1387_842_7157_841_3065_3066_3064_2033_6667 13 1.91E-06 0.000139268 3.40E-06 2694 hsa-mir-1255a hsa04330 Notch signaling pathway 1387_388585_9612_3065_8850_3066_2033 7 5.18E-06 0.000378151 9.00E-06 2695 hsa-mir-1255a hsa04360 Axon guidance 5879_5747_5595_5594_2932_7852_4773_5058_2534 9 7.66E-05 0.005591988 0.000130046 2696 hsa-mir-1255a hsa04150 mTOR signaling pathway 5595_5594_6195_3091_207_208 6 9.11E-05 0.006651317 0.000151166 2697 hsa-mir-1255a hsa04810 Regulation of actin cytoskeleton 5879_5747_1956_2261_5595_5594_2264_5159_5156_5058 10 0.000718871 0.05247755 0.001166168 2698 hsa-mir-1255a hsa04270 Vascular smooth muscle contraction 5580_5595_5594_808_147_805_801 7 0.001085422 0.079235816 0.001722518 2699 hsa-mir-1255a hsa04540 Gap junction 1956_6714_5595_5594_5159_5156 6 0.001636235 0.119445167 0.002541387 2700 hsa-mir-1255a hsa03022 Basal transcription factors 2963_2962_6874_2969 4 0.001758268 0.128353562 0.002674033 2701 hsa-mir-1255a hsa04115 p53 signaling pathway 595_836_842_7157_841 5 0.002478481 0.18092909 0.00369243 2702 hsa-mir-1255a hsa04120 Ubiquitin mediated proteolysis 5371_672_7428_7329_6502_8554_57154 7 0.002637157 0.192512453 0.003850249 2703 hsa-mir-1255a hsa04930 Type II diabetes mellitus 3651_5580_5595_5594 4 0.003398852 0.248116194 0.004865023 2704 hsa-mir-1255a hsa04950 Maturity onset diabetes of the young 3651_3172_168620 3 0.004677685 0.341470978 0.00656675 2705 hsa-mir-1255a hsa04670 Leukocyte transendothelial migration 5879_5747_1499_1432_7852_5781 6 0.005846633 0.426804211 0.00805291 2706 hsa-mir-1255a hsa04530 Tight junction 5580_1499_6714_1457_207_208 6 0.009848599 0.718947752 0.013313847 2707 hsa-mir-1255a hsa03050 Proteasome 5684_5705_5710 3 0.026681604 1 0.035413765 2708 hsa-mir-1255a hsa04612 Antigen processing and presentation 4800_1385_3312_4801 4 0.03047246 1 0.039723028 2709 hsa-mir-1255a hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.037083692 1 0.047493149 2710 hsa-mir-1255a hsa05131 Shigellosis 1499_7534_2534 3 0.038715875 1 0.047902693 2711 hsa-mir-1255a hsa05130 Pathogenic Escherichia coli infection 1499_7534_2534 3 0.038715875 1 0.047902693 2712 hsa-mir-1255b-2 hsa05200 Pathways in cancer 3326_25_7046_1499_5595_5594_1387_862_1487_1488_1019_367_1017_2932_51588_3265_6688_4609_3725_1026_6502_4087_4088_4089_3065_5925_2033_8554_7189 29 3.26E-25 2.25E-23 2.25E-23 2713 hsa-mir-1255b-2 hsa04350 TGF-beta signaling pathway 7046_5595_5594_1387_6667_7027_3397_3399_3398_1874_658_4609_4086_4087_4088_4089_2033_4093_5933 19 1.36E-23 9.40E-22 4.70E-22 2714 hsa-mir-1255b-2 hsa05220 Chronic myeloid leukemia 25_7046_5595_5594_1487_1488_1019_3265_4609_1026_4088_4089_3065_5925 14 7.77E-17 5.36E-15 1.79E-15 2715 hsa-mir-1255b-2 hsa04110 Cell cycle 25_1387_1019_1017_2932_7027_1026_6502_4087_4088_4089_3065_5925_2033_5933 15 1.15E-15 7.92E-14 1.98E-14 2716 hsa-mir-1255b-2 hsa05215 Prostate cancer 3326_1499_5595_5594_1387_367_1017_2932_3265_468_1026_5925_2033 13 1.53E-14 1.06E-12 2.01E-13 2717 hsa-mir-1255b-2 hsa05212 Pancreatic cancer 3326_1499_5595_5594_1387_367_1017_2932_3265_468_1026_5925_2033 13 1.74E-14 1.20E-12 2.01E-13 2718 hsa-mir-1255b-2 hsa04720 Long-term potentiation 5595_5594_1387_3265_2902_2906_468_2033_808_801_805 11 1.83E-12 1.27E-10 1.81E-11 2719 hsa-mir-1255b-2 hsa04010 MAPK signaling pathway 6722_7046_5595_5594_1386_9261_4208_7867_1432_1649_3265_468_4609_3725_22800_7189 16 7.57E-12 5.23E-10 6.53E-11 2720 hsa-mir-1255b-2 hsa05210 Colorectal cancer 7046_1499_5595_5594_2932_4609_3725_4087_4088_4089 10 1.25E-10 8.62E-09 9.57E-10 2721 hsa-mir-1255b-2 hsa05214 Glioma 5595_5594_1019_3265_1026_5925_808_801_805 9 3.19E-10 2.20E-08 2.20E-09 2722 hsa-mir-1255b-2 hsa04620 Toll-like receptor signaling pathway 3654_5595_5594_353376_3661_148022_1432_3725_4615_7189 10 7.18E-10 4.95E-08 4.18E-09 2723 hsa-mir-1255b-2 hsa04330 Notch signaling pathway 388585_1387_2648_1487_1488_3065_2033_8850 8 7.27E-10 5.02E-08 4.18E-09 2724 hsa-mir-1255b-2 hsa04916 Melanogenesis 1499_5595_5594_1387_2932_3265_2033_808_801_805 10 8.55E-10 5.90E-08 4.54E-09 2725 hsa-mir-1255b-2 hsa04520 Adherens junction 7046_1499_5595_5594_1387_4087_4088_4089_2033 9 1.71E-09 1.18E-07 8.43E-09 2726 hsa-mir-1255b-2 hsa04310 Wnt signaling pathway 1499_1387_1487_1488_2932_4609_3725_4087_4088_4089_2033 11 1.99E-09 1.37E-07 9.16E-09 2727 hsa-mir-1255b-2 hsa05219 Bladder cancer 5595_5594_1019_3265_4609_1026_5925 7 9.92E-09 6.84E-07 4.28E-08 2728 hsa-mir-1255b-2 hsa04912 GnRH signaling pathway 5595_5594_1432_3265_468_3725_808_801_805 9 1.95E-08 1.34E-06 7.90E-08 2729 hsa-mir-1255b-2 hsa05222 Small cell lung cancer 1019_1017_51588_4609_6502_5925_8554_7189 8 5.54E-08 3.82E-06 2.12E-07 2730 hsa-mir-1255b-2 hsa04012 ErbB signaling pathway 25_5595_5594_2932_3265_4609_3725_1026 8 6.02E-08 4.15E-06 2.19E-07 2731 hsa-mir-1255b-2 hsa05010 Alzheimer's disease 5595_5594_2932_2902_2906_808_351_22926_801_805 10 1.00E-07 6.92E-06 3.46E-07 2732 hsa-mir-1255b-2 hsa05213 Endometrial cancer 1499_5595_5594_2932_3265_4609 6 8.39E-07 5.79E-05 2.76E-06 2733 hsa-mir-1255b-2 hsa05216 Thyroid cancer 1499_5595_5594_3265_4609 5 1.20E-06 8.25E-05 3.75E-06 2734 hsa-mir-1255b-2 hsa05221 Acute myeloid leukemia 5595_5594_862_3265_6688_4609 6 1.66E-06 0.000114401 4.97E-06 2735 hsa-mir-1255b-2 hsa04660 T cell receptor signaling pathway 5595_5594_1019_2932_1432_3265_3725 7 4.18E-06 0.000288299 1.20E-05 2736 hsa-mir-1255b-2 hsa05218 Melanoma 5595_5594_1019_3265_1026_5925 6 4.51E-06 0.000310873 1.24E-05 2737 hsa-mir-1255b-2 hsa05211 Renal cell carcinoma 5595_5594_1387_3265_3725_2033 6 4.86E-06 0.000335245 1.29E-05 2738 hsa-mir-1255b-2 hsa04370 VEGF signaling pathway 5595_5594_9261_7867_1432_3265 6 6.98E-06 0.000481538 1.78E-05 2739 hsa-mir-1255b-2 hsa04910 Insulin signaling pathway 5595_5594_2932_3265_808_801_805 7 1.71E-05 0.001178853 4.21E-05 2740 hsa-mir-1255b-2 hsa05223 Non-small cell lung cancer 5595_5594_1019_3265_5925 5 1.93E-05 0.001328252 4.58E-05 2741 hsa-mir-1255b-2 hsa04662 B cell receptor signaling pathway 5595_5594_2932_3265_3725 5 8.42E-05 0.00580835 0.000193612 2742 hsa-mir-1255b-2 hsa05016 Huntington's disease 25942_1387_6667_2902_3065_2033_9519 7 0.000112108 0.007735443 0.00024953 2743 hsa-mir-1255b-2 hsa04950 Maturity onset diabetes of the young 168620_6927_3651 3 0.000441992 0.030497423 0.000953044 2744 hsa-mir-1255b-2 hsa04270 Vascular smooth muscle contraction 5595_5594_808_801_805 5 0.000625106 0.04313232 0.00130704 2745 hsa-mir-1255b-2 hsa04360 Axon guidance 25_5595_5594_2932_3265 5 0.00098309 0.06783323 0.001995095 2746 hsa-mir-1255b-2 hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432_3265 4 0.001184784 0.081750089 0.002254393 2747 hsa-mir-1255b-2 hsa04530 Tight junction 8573_1499_1019_3265_22800 5 0.001191795 0.082233826 0.002254393 2748 hsa-mir-1255b-2 hsa04510 Focal adhesion 1499_5595_5594_2932_3265_3725 6 0.001208878 0.083412559 0.002254393 2749 hsa-mir-1255b-2 hsa04120 Ubiquitin mediated proteolysis 51588_7329_6502_8554_7189 5 0.001268144 0.087501914 0.002302682 2750 hsa-mir-1255b-2 hsa04630 Jak-STAT signaling pathway 1387_51588_4609_2033_8554 5 0.002015422 0.139064122 0.003565747 2751 hsa-mir-1255b-2 hsa04930 Type II diabetes mellitus 5595_5594_3651 3 0.002400421 0.165629053 0.004140726 2752 hsa-mir-1255b-2 hsa04020 Calcium signaling pathway 2902_2906_808_801_805 5 0.004119893 0.28427264 0.006933479 2753 hsa-mir-1255b-2 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_2902_2906 3 0.004315918 0.297798364 0.007090437 2754 hsa-mir-1255b-2 hsa04115 p53 signaling pathway 1019_1017_1026 3 0.007514565 0.518504964 0.012058255 2755 hsa-mir-1255b-2 hsa04730 Long-term depression 5595_5594_3265 3 0.008102448 0.559068907 0.012706112 2756 hsa-mir-1255b-2 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.00968803 0.668474051 0.014854979 2757 hsa-mir-1255b-2 hsa04612 Antigen processing and presentation 3326_4800_4801 3 0.014605442 1 0.021908163 2758 hsa-mir-1255b-2 hsa04540 Gap junction 5595_5594_3265 3 0.016354389 1 0.024009635 2759 hsa-mir-1255b-2 hsa04062 Chemokine signaling pathway 5595_5594_2932_3265 4 0.024216215 1 0.03481081 2760 hsa-mir-1255b-2 hsa04810 Regulation of actin cytoskeleton 5595_5594_3265_22800 4 0.035797332 1 0.049855799 2761 hsa-mir-1255b-2 hsa04150 mTOR signaling pathway 5595_5594 2 0.036127391 1 0.049855799 2762 hsa-mir-1255b-2 hsa05217 Basal cell carcinoma 1499_2932 2 0.039864093 1 0.053560818 2763 hsa-mir-1255b-2 hsa05131 Shigellosis 25_1499 2 0.041140918 1 0.053560818 2764 hsa-mir-1255b-2 hsa05130 Pathogenic Escherichia coli infection 25_1499 2 0.041140918 1 0.053560818 2765 hsa-mir-1255b-2 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_3265 3 0.043796375 1 0.055962035 2766 hsa-mir-1258 hsa05200 Pathways in cancer 1147_3551_5594_5599_6258_1387_6257_6256_8031_836_5970_7157_3725_2353_4087_4088_4089_1050_5925_2033_207_8554 22 5.79E-19 3.36E-17 3.36E-17 2767 hsa-mir-1258 hsa04010 MAPK signaling pathway 9479_1147_3551_5594_5599_5598_1386_836_1432_5970_7157_10912_468_3725_3727_2353_4616_207 18 1.21E-15 7.01E-14 3.50E-14 2768 hsa-mir-1258 hsa05215 Prostate cancer 1147_3551_5594_1387_5970_7157_468_10488_5925_2033_207 11 8.69E-13 5.04E-11 1.41E-11 2769 hsa-mir-1258 hsa05212 Pancreatic cancer 1147_3551_5594_1387_5970_7157_468_10488_5925_2033_207 11 9.73E-13 5.64E-11 1.41E-11 2770 hsa-mir-1258 hsa05210 Colorectal cancer 5594_5599_836_7157_3725_2353_4087_4088_4089_207 10 1.53E-11 8.85E-10 1.56E-10 2771 hsa-mir-1258 hsa04110 Cell cycle 1387_7534_7532_7157_10912_4087_4088_4089_4616_5925_2033 11 1.78E-11 1.03E-09 1.56E-10 2772 hsa-mir-1258 hsa05222 Small cell lung cancer 1147_3551_6258_6257_6256_5970_7157_5925_207_8554 10 1.89E-11 1.10E-09 1.56E-10 2773 hsa-mir-1258 hsa04920 Adipocytokine signaling pathway 1147_3551_10891_5599_6258_6257_6256_5970_207 9 6.13E-11 3.56E-09 4.45E-10 2774 hsa-mir-1258 hsa05220 Chronic myeloid leukemia 1147_3551_5594_5970_7157_4088_4089_5925_207 9 1.54E-10 8.92E-09 9.91E-10 2775 hsa-mir-1258 hsa04310 Wnt signaling pathway 5599_1387_6423_7157_8061_3725_1457_4087_4088_4089_2033 11 2.07E-10 1.20E-08 1.20E-09 2776 hsa-mir-1258 hsa04620 Toll-like receptor signaling pathway 1147_3551_5594_5599_1432_5970_3725_2353_207 9 1.91E-09 1.11E-07 1.00E-08 2777 hsa-mir-1258 hsa05216 Thyroid cancer 5594_6258_6257_6256_8031_7157 6 1.05E-08 6.11E-07 4.93E-08 2778 hsa-mir-1258 hsa05223 Non-small cell lung cancer 5594_6258_6257_6256_7157_5925_207 7 1.10E-08 6.40E-07 4.93E-08 2779 hsa-mir-1258 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_3551_5599_836_1432_5970_3725 7 6.28E-08 3.64E-06 2.46E-07 2780 hsa-mir-1258 hsa04660 T cell receptor signaling pathway 1147_3551_5594_1432_5970_3725_2353_207 8 6.36E-08 3.69E-06 2.46E-07 2781 hsa-mir-1258 hsa04662 B cell receptor signaling pathway 1147_3551_5594_5970_3725_2353_207 7 8.90E-08 5.16E-06 3.23E-07 2782 hsa-mir-1258 hsa04520 Adherens junction 5594_1387_1457_4087_4088_4089_2033 7 1.34E-07 7.79E-06 4.58E-07 2783 hsa-mir-1258 hsa04350 TGF-beta signaling pathway 5594_1387_3398_4087_4088_4089_2033 7 2.29E-07 1.33E-05 7.38E-07 2784 hsa-mir-1258 hsa04210 Apoptosis 1147_3551_836_5970_7157_840_207 7 2.65E-07 1.54E-05 8.08E-07 2785 hsa-mir-1258 hsa05221 Acute myeloid leukemia 1147_3551_5594_5970_1050_207 6 4.81E-07 2.79E-05 1.39E-06 2786 hsa-mir-1258 hsa04912 GnRH signaling pathway 5594_5599_5598_1432_468_3725 6 1.30E-05 0.000752174 3.58E-05 2787 hsa-mir-1258 hsa03320 PPAR signaling pathway 10062_6258_6257_6256_2168 5 2.25E-05 0.001303659 5.93E-05 2788 hsa-mir-1258 hsa05211 Renal cell carcinoma 5594_1387_3725_2033_207 5 2.55E-05 0.001481719 6.44E-05 2789 hsa-mir-1258 hsa05016 Huntington's disease 10891_1387_836_7157_10488_2033 6 0.000248718 0.014425656 0.000601069 2790 hsa-mir-1258 hsa05214 Glioma 5594_7157_5925_207 4 0.000265739 0.015412853 0.000616514 2791 hsa-mir-1258 hsa04115 p53 signaling pathway 836_7157_10912_4616 4 0.000329979 0.019138794 0.000736107 2792 hsa-mir-1258 hsa05218 Melanoma 5594_7157_5925_207 4 0.000365951 0.02122514 0.000786116 2793 hsa-mir-1258 hsa04720 Long-term potentiation 5594_1387_468_2033 4 0.000446171 0.02587792 0.000924211 2794 hsa-mir-1258 hsa04910 Insulin signaling pathway 3551_10891_5594_5599_207 5 0.000474261 0.027507149 0.000948522 2795 hsa-mir-1258 hsa04664 Fc epsilon RI signaling pathway 5594_5599_1432_207 4 0.000538204 0.031215804 0.001040527 2796 hsa-mir-1258 hsa04012 ErbB signaling pathway 5594_5599_3725_207 4 0.000761472 0.044165375 0.00142469 2797 hsa-mir-1258 hsa05219 Bladder cancer 5594_7157_5925 3 0.001087215 0.063058457 0.001970577 2798 hsa-mir-1258 hsa04930 Type II diabetes mellitus 3551_5594_5599 3 0.001312282 0.076112382 0.002306436 2799 hsa-mir-1258 hsa04916 Melanogenesis 5594_1387_10488_2033 4 0.001440056 0.083523269 0.002448302 2800 hsa-mir-1258 hsa04330 Notch signaling pathway 1387_9612_2033 3 0.001477423 0.085690553 0.002448302 2801 hsa-mir-1258 hsa05213 Endometrial cancer 5594_7157_207 3 0.001945598 0.112844682 0.003134574 2802 hsa-mir-1258 hsa04062 Chemokine signaling pathway 1147_3551_5594_5970_207 5 0.002024822 0.117439661 0.003174045 2803 hsa-mir-1258 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432_7157 3 0.002379685 0.138021705 0.00363215 2804 hsa-mir-1258 hsa04370 VEGF signaling pathway 5594_1432_207 3 0.005617691 0.325826078 0.008354515 2805 hsa-mir-1258 hsa04630 Jak-STAT signaling pathway 1387_2033_207_8554 4 0.005784195 0.335483298 0.008387082 2806 hsa-mir-1258 hsa05010 Alzheimer's disease 5594_836_1020_840 4 0.00905334 0.52509372 0.012807164 2807 hsa-mir-1258 hsa04510 Focal adhesion 5594_5599_3725_207 4 0.014934712 0.866213299 0.020624126 2808 hsa-mir-1258 hsa04150 mTOR signaling pathway 5594_207 2 0.024490216 1 0.033033314 2809 hsa-mir-125a hsa05200 Pathways in cancer 3320_1387_6256_1019_1017_2932_841_5578_6774_7157_3725_2736_4088_4089_3065_5925_2033_207 18 1.26E-16 8.32E-15 8.32E-15 2810 hsa-mir-125a hsa04110 Cell cycle 1387_1019_1017_2932_7157_1028_4088_4089_3065_5925_2033 11 6.48E-13 4.28E-11 2.14E-11 2811 hsa-mir-125a hsa04350 TGF-beta signaling pathway 3399_6667_3400_1387_3398_3397_4088_4089_2033_4092 10 1.02E-12 6.75E-11 2.25E-11 2812 hsa-mir-125a hsa04720 Long-term potentiation 1387_5578_6195_6196_6197_2033_808_801_805 9 1.02E-11 6.75E-10 1.69E-10 2813 hsa-mir-125a hsa04010 MAPK signaling pathway 6722_8986_9261_9252_1432_5578_4342_7157_3725_6195_6196_6197_207 13 1.33E-11 8.80E-10 1.76E-10 2814 hsa-mir-125a hsa05214 Glioma 1019_5578_7157_5925_207_808_801_805 8 1.26E-10 8.29E-09 1.38E-09 2815 hsa-mir-125a hsa05215 Prostate cancer 3320_1387_1017_2932_7157_5925_2033_207 8 1.16E-09 7.68E-08 1.04E-08 2816 hsa-mir-125a hsa05212 Pancreatic cancer 3320_1387_1017_2932_7157_5925_2033_207 8 1.26E-09 8.34E-08 1.04E-08 2817 hsa-mir-125a hsa05220 Chronic myeloid leukemia 1019_7157_4088_4089_3065_5925_207 7 1.12E-08 7.39E-07 8.21E-08 2818 hsa-mir-125a hsa05223 Non-small cell lung cancer 6256_1019_5578_7157_5925_207 6 5.00E-08 3.30E-06 3.30E-07 2819 hsa-mir-125a hsa04310 Wnt signaling pathway 1387_2932_5578_7157_3725_4088_4089_2033 8 6.57E-08 4.34E-06 3.94E-07 2820 hsa-mir-125a hsa04916 Melanogenesis 1387_2932_5578_2033_808_801_805 7 9.24E-08 6.10E-06 5.08E-07 2821 hsa-mir-125a hsa05210 Colorectal cancer 2932_7157_3725_4088_4089_207 6 5.74E-07 3.79E-05 2.91E-06 2822 hsa-mir-125a hsa05222 Small cell lung cancer 6256_1019_1017_7157_5925_207 6 6.54E-07 4.32E-05 3.08E-06 2823 hsa-mir-125a hsa04330 Notch signaling pathway 1387_9612_3065_2033_8850 5 8.40E-07 5.54E-05 3.70E-06 2824 hsa-mir-125a hsa04912 GnRH signaling pathway 1432_5578_3725_808_801_805 6 2.31E-06 0.00015221 9.51E-06 2825 hsa-mir-125a hsa05016 Huntington's disease 6667_1387_841_7157_3065_3064_2033 7 4.14E-06 0.000273137 1.61E-05 2826 hsa-mir-125a hsa05219 Bladder cancer 1019_9252_7157_5925 4 1.68E-05 0.001109554 6.16E-05 2827 hsa-mir-125a hsa04150 mTOR signaling pathway 6195_6196_6197_207 4 3.69E-05 0.002434569 0.000128135 2828 hsa-mir-125a hsa04660 T cell receptor signaling pathway 1019_2932_1432_3725_207 5 4.20E-05 0.002775247 0.000138762 2829 hsa-mir-125a hsa04270 Vascular smooth muscle contraction 5592_5578_808_801_805 5 5.80E-05 0.003826116 0.000182196 2830 hsa-mir-125a hsa04115 p53 signaling pathway 1019_1017_841_7157 4 0.000104688 0.006909413 0.000314064 2831 hsa-mir-125a hsa05218 Melanoma 1019_7157_5925_207 4 0.000116313 0.007676637 0.000323302 2832 hsa-mir-125a hsa04910 Insulin signaling pathway 2932_207_808_801_805 5 0.00011822 0.007802494 0.000323302 2833 hsa-mir-125a hsa05211 Renal cell carcinoma 1387_3725_2033_207 4 0.000122463 0.008082559 0.000323302 2834 hsa-mir-125a hsa04070 Phosphatidylinositol signaling system 5578_808_801_805 4 0.00014944 0.009863018 0.000379347 2835 hsa-mir-125a hsa04370 VEGF signaling pathway 9261_1432_5578_207 4 0.000156804 0.010349071 0.000383299 2836 hsa-mir-125a hsa04520 Adherens junction 1387_4088_4089_2033 4 0.000180472 0.011911136 0.000425398 2837 hsa-mir-125a hsa04012 ErbB signaling pathway 2932_5578_3725_207 4 0.000245581 0.016208347 0.000558909 2838 hsa-mir-125a hsa05010 Alzheimer's disease 2932_841_808_801_805 5 0.000362028 0.023893828 0.000796461 2839 hsa-mir-125a hsa04620 Toll-like receptor signaling pathway 1432_841_3725_207 4 0.000439428 0.029002264 0.000935557 2840 hsa-mir-125a hsa05213 Endometrial cancer 2932_7157_207 3 0.000823423 0.054345901 0.001698309 2841 hsa-mir-125a hsa05217 Basal cell carcinoma 2932_7157_2736 3 0.000961505 0.0634593 0.001923009 2842 hsa-mir-125a hsa04920 Adipocytokine signaling pathway 6256_6774_207 3 0.001657332 0.10938393 0.003217174 2843 hsa-mir-125a hsa04630 Jak-STAT signaling pathway 1387_6774_2033_207 4 0.00198344 0.130907057 0.003740202 2844 hsa-mir-125a hsa04662 B cell receptor signaling pathway 2932_3725_207 3 0.002259573 0.149131849 0.004142551 2845 hsa-mir-125a hsa04664 Fc epsilon RI signaling pathway 1432_5578_207 3 0.002605296 0.171949512 0.004647284 2846 hsa-mir-125a hsa04950 Maturity onset diabetes of the young 3651_168620 2 0.003371436 0.222514758 0.005855652 2847 hsa-mir-125a hsa04210 Apoptosis 841_7157_207 3 0.003607048 0.238065199 0.005981253 2848 hsa-mir-125a hsa04020 Calcium signaling pathway 5578_808_801_805 4 0.003625002 0.239250121 0.005981253 2849 hsa-mir-125a hsa05216 Thyroid cancer 6256_7157 2 0.004771955 0.314949028 0.007681684 2850 hsa-mir-125a hsa04510 Focal adhesion 2932_5578_3725_207 4 0.005358216 0.353642224 0.008420053 2851 hsa-mir-125a hsa04530 Tight junction 1019_5578_207 3 0.011467107 0.756829063 0.017600676 2852 hsa-mir-125a hsa04120 Ubiquitin mediated proteolysis 997_672_7329 3 0.0119126 0.786231574 0.017868899 2853 hsa-mir-125a hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_7157 2 0.016006753 1 0.02347657 2854 hsa-mir-125a hsa04340 Hedgehog signaling pathway 2932_2736 2 0.016532934 1 0.023721166 2855 hsa-mir-125a hsa05221 Acute myeloid leukemia 6774_207 2 0.017607221 1 0.024725034 2856 hsa-mir-125a hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_3725 2 0.024644741 1 0.033194958 2857 hsa-mir-125a hsa04730 Long-term depression 5592_5578 2 0.024644741 1 0.033194958 2858 hsa-mir-125a hsa04062 Chemokine signaling pathway 2932_6774_207 3 0.027737095 1 0.036612965 2859 hsa-mir-125a hsa04540 Gap junction 5592_5578 2 0.039956421 1 0.05170831 2860 hsa-mir-125a hsa04740 Olfactory transduction 5592_808_801_805 4 0.041283849 1 0.052398731 2861 hsa-mir-125a hsa04710 Circadian rhythm - mammal 79365 1 0.045530072 1 0.056697826 2862 hsa-mir-125b-1 hsa05200 Pathways in cancer 3320_5925_3326_1147_3551_1499_5595_5594_1387_6256_1487_367_8517_2932_6774_5970_6688_2113_4087_1869_862_6502_2353_4088_7175_3065_1488_2033_4791_4792 30 1.45E-23 1.07E-21 1.07E-21 2863 hsa-mir-125b-1 hsa05215 Prostate cancer 3320_5925_3326_1147_3551_1499_5595_5594_1387_367_8517_2932_5970_1869_2033_4792 16 2.22E-17 1.64E-15 6.42E-16 2864 hsa-mir-125b-1 hsa05212 Pancreatic cancer 3320_5925_3326_1147_3551_1499_5595_5594_1387_367_8517_2932_5970_1869_2033_4792 16 2.60E-17 1.93E-15 6.42E-16 2865 hsa-mir-125b-1 hsa04010 MAPK signaling pathway 1147_3551_5595_5594_6722_9261_1326_4208_3305_3303_5566_8517_7867_3312_5971_5970_3310_2353_1432_4791 20 2.03E-14 1.50E-12 3.76E-13 2866 hsa-mir-125b-1 hsa05220 Chronic myeloid leukemia 5925_1147_3551_5595_5594_1487_8517_5970_1869_4088_3065_1488_4792 13 4.09E-14 3.03E-12 6.05E-13 2867 hsa-mir-125b-1 hsa04660 T cell receptor signaling pathway 1147_3551_5595_5594_1326_8517_2932_5970_4794_2353_1432_4792_4793 13 3.39E-12 2.51E-10 4.18E-11 2868 hsa-mir-125b-1 hsa04310 Wnt signaling pathway 23291_1499_1387_8607_1487_5566_2932_8454_6500_4087_8945_4088_1488_2033 14 1.09E-11 8.07E-10 1.15E-10 2869 hsa-mir-125b-1 hsa04662 B cell receptor signaling pathway 1147_3551_5595_5594_8517_2932_5970_4794_2353_4792_4793 11 1.97E-11 1.46E-09 1.82E-10 2870 hsa-mir-125b-1 hsa04350 TGF-beta signaling pathway 5595_5594_1387_8454_3397_3398_6500_4087_3399_4088_2033 11 8.40E-11 6.22E-09 6.91E-10 2871 hsa-mir-125b-1 hsa04110 Cell cycle 5925_5591_1387_2932_8454_6500_4087_1869_6502_4088_3065_2033 12 1.28E-10 9.46E-09 9.46E-10 2872 hsa-mir-125b-1 hsa04330 Notch signaling pathway 388585_1387_4851_1487_9612_3065_1488_2033_8850 9 1.67E-10 1.24E-08 1.13E-09 2873 hsa-mir-125b-1 hsa05221 Acute myeloid leukemia 1147_3551_5595_5594_8517_6774_5970_6688_862 9 1.01E-09 7.51E-08 6.25E-09 2874 hsa-mir-125b-1 hsa04920 Adipocytokine signaling pathway 1147_3551_6256_8517_6774_5970_4794_4792_4793 9 2.80E-09 2.07E-07 1.59E-08 2875 hsa-mir-125b-1 hsa04620 Toll-like receptor signaling pathway 1147_3551_5595_5594_1326_8517_5970_2353_1432_4792 10 5.93E-09 4.39E-07 3.13E-08 2876 hsa-mir-125b-1 hsa04916 Melanogenesis 1499_5595_5594_1387_5566_2932_2033_808_801_805 10 7.04E-09 5.21E-07 3.47E-08 2877 hsa-mir-125b-1 hsa05222 Small cell lung cancer 5925_1147_3551_6256_8517_5970_1869_6502_4792 9 2.06E-08 1.52E-06 9.32E-08 2878 hsa-mir-125b-1 hsa04062 Chemokine signaling pathway 1147_3551_5595_5594_5566_8517_2932_6774_5970_653361_4792_4793 12 2.14E-08 1.58E-06 9.32E-08 2879 hsa-mir-125b-1 hsa04120 Ubiquitin mediated proteolysis 7329_23291_672_8454_6500_3093_8945_6502_10273_7323 10 9.17E-08 6.79E-06 3.77E-07 2880 hsa-mir-125b-1 hsa04720 Long-term potentiation 5595_5594_1387_5566_2033_808_801_805 8 1.12E-07 8.28E-06 4.36E-07 2881 hsa-mir-125b-1 hsa03020 RNA polymerase 25885_64425_5437_51082_84172_5441 6 1.36E-07 1.01E-05 5.04E-07 2882 hsa-mir-125b-1 hsa04520 Adherens junction 1499_5595_5594_1387_4087_4088_2033_71 8 1.77E-07 1.31E-05 6.24E-07 2883 hsa-mir-125b-1 hsa05131 Shigellosis 347733_1499_7278_10382_84617_203068_71 7 2.65E-07 1.96E-05 8.52E-07 2884 hsa-mir-125b-1 hsa05130 Pathogenic Escherichia coli infection 347733_1499_7278_10382_84617_203068_71 7 2.65E-07 1.96E-05 8.52E-07 2885 hsa-mir-125b-1 hsa04540 Gap junction 347733_5595_5594_5566_7278_10382_84617_203068 8 5.16E-07 3.82E-05 1.59E-06 2886 hsa-mir-125b-1 hsa05214 Glioma 5925_5595_5594_1869_808_801_805 7 6.69E-07 4.95E-05 1.98E-06 2887 hsa-mir-125b-1 hsa05210 Colorectal cancer 1499_5595_5594_2932_4087_2353_4088 7 3.29E-06 0.0002435 9.37E-06 2888 hsa-mir-125b-1 hsa05216 Thyroid cancer 1499_5595_5594_6256_7175 5 3.49E-06 0.00025816 9.56E-06 2889 hsa-mir-125b-1 hsa04612 Antigen processing and presentation 3320_3326_3309_3305_3303_3312_3310 7 4.71E-06 0.000348318 1.20E-05 2890 hsa-mir-125b-1 hsa04210 Apoptosis 1147_3551_5566_8517_5970_8837_4792 7 4.71E-06 0.000348318 1.20E-05 2891 hsa-mir-125b-1 hsa04910 Insulin signaling pathway 3551_5595_5594_5566_2932_808_801_805 8 8.25E-06 0.00061074 2.04E-05 2892 hsa-mir-125b-1 hsa04912 GnRH signaling pathway 5595_5594_5566_1432_808_801_805 7 1.55E-05 0.00114676 3.62E-05 2893 hsa-mir-125b-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_3551_8517_5970_1432_4792 6 1.56E-05 0.001158045 3.62E-05 2894 hsa-mir-125b-1 hsa04270 Vascular smooth muscle contraction 5595_5594_5566_4637_808_801_805 7 2.66E-05 0.001969591 5.97E-05 2895 hsa-mir-125b-1 hsa05223 Non-small cell lung cancer 5925_5595_5594_6256_1869 5 5.46E-05 0.004039508 0.000118809 2896 hsa-mir-125b-1 hsa05016 Huntington's disease 1387_292_293_5437_1213_3065_2033_5441 8 6.83E-05 0.005056508 0.000144472 2897 hsa-mir-125b-1 hsa05211 Renal cell carcinoma 5595_5594_1387_2113_2033 5 0.000194888 0.014421747 0.000400604 2898 hsa-mir-125b-1 hsa04370 VEGF signaling pathway 5595_5594_9261_7867_1432 5 0.000261762 0.0193704 0.000523524 2899 hsa-mir-125b-1 hsa05219 Bladder cancer 5925_5595_5594_1869 4 0.000284132 0.02102579 0.00055331 2900 hsa-mir-125b-1 hsa04930 Type II diabetes mellitus 3551_5595_5594_3651 4 0.000363016 0.026863175 0.000688799 2901 hsa-mir-125b-1 hsa05213 Endometrial cancer 1499_5595_5594_2932 4 0.000606101 0.044851509 0.001121288 2902 hsa-mir-125b-1 hsa04340 Hedgehog signaling pathway 23291_5566_2932_8945 4 0.000838403 0.062041836 0.001513216 2903 hsa-mir-125b-1 hsa04810 Regulation of actin cytoskeleton 5595_5594_4627_4628_10788_10627_71 7 0.001013975 0.075034139 0.001786527 2904 hsa-mir-125b-1 hsa05010 Alzheimer's disease 5595_5594_2932_808_801_805 6 0.001736325 0.128488064 0.002988095 2905 hsa-mir-125b-1 hsa05218 Melanoma 5925_5595_5594_1869 4 0.001811904 0.134080919 0.003047294 2906 hsa-mir-125b-1 hsa04670 Leukocyte transendothelial migration 1499_653361_10627_1432_71 5 0.001901067 0.140678975 0.003126199 2907 hsa-mir-125b-1 hsa04020 Calcium signaling pathway 292_5566_293_808_801_805 6 0.002097188 0.155191878 0.003373736 2908 hsa-mir-125b-1 hsa04530 Tight junction 1499_4627_4628_10627_71 5 0.003084737 0.228270512 0.004856819 2909 hsa-mir-125b-1 hsa04510 Focal adhesion 1499_5595_5594_2932_10627_71 6 0.003605476 0.266805236 0.005558442 2910 hsa-mir-125b-1 hsa04630 Jak-STAT signaling pathway 3559_1387_6778_6774_2033 5 0.00511597 0.378581777 0.007726159 2911 hsa-mir-125b-1 hsa03010 Ribosome 6156_6128_6207_6202 4 0.00627975 0.464701466 0.009294029 2912 hsa-mir-125b-1 hsa04950 Maturity onset diabetes of the young 168620_3651 2 0.013755984 1 0.019959663 2913 hsa-mir-125b-1 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.017348445 1 0.024688171 2914 hsa-mir-125b-1 hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432 3 0.019140709 1 0.026724763 2915 hsa-mir-125b-1 hsa04012 ErbB signaling pathway 5595_5594_2932 3 0.024402888 1 0.033440995 2916 hsa-mir-125b-1 hsa03410 Base excision repair 3146_142 2 0.028197096 1 0.037937911 2917 hsa-mir-125b-2 hsa03022 Basal transcription factors 2967_2961_2960_2963_6881_54457_2968_6877_6874_6878_2957_6879_6908_6872_2958_6873_2959_6880_6882_138474_6884_6883 22 3.42E-30 2.49E-28 2.49E-28 2918 hsa-mir-125b-2 hsa05200 Pathways in cancer 2249_367_1499_5595_5594_5914_1387_6256_10401_1487_1488_2932_4193_6776_6777_5970_7157_6688_4609_3725_2353_3065_4087_4088_4089_5925_2033_207_208_3326_8554_7184 32 4.46E-22 3.25E-20 1.63E-20 2919 hsa-mir-125b-2 hsa05220 Chronic myeloid leukemia 5595_5594_1487_1488_4193_6776_6777_5970_7157_4609_3065_4088_4089_5925_207_208 16 1.96E-16 1.43E-14 4.78E-15 2920 hsa-mir-125b-2 hsa05215 Prostate cancer 367_1499_5595_5594_1387_2932_4193_5970_7157_468_5925_2033_207_208_3326_7184 16 1.80E-15 1.31E-13 3.08E-14 2921 hsa-mir-125b-2 hsa05212 Pancreatic cancer 367_1499_5595_5594_1387_2932_4193_5970_7157_468_5925_2033_207_208_3326_7184 16 2.11E-15 1.54E-13 3.08E-14 2922 hsa-mir-125b-2 hsa04110 Cell cycle 993_1387_4171_983_7534_7533_7532_2932_4193_4085_7157_3065_4087_4088_4089_5925_2033 17 8.34E-15 6.09E-13 1.01E-13 2923 hsa-mir-125b-2 hsa05210 Colorectal cancer 1499_5595_5594_2932_7157_4609_3725_2353_4087_4088_4089_207_208 13 5.10E-12 3.72E-10 5.32E-11 2924 hsa-mir-125b-2 hsa04310 Wnt signaling pathway 1460_1499_1387_8607_1487_1488_2932_7157_4609_3725_4087_4088_4089_2033 14 4.30E-10 3.14E-08 3.93E-09 2925 hsa-mir-125b-2 hsa05221 Acute myeloid leukemia 5595_5594_5914_6776_6777_5970_6688_4609_207_208 10 6.89E-10 5.03E-08 5.59E-09 2926 hsa-mir-125b-2 hsa04012 ErbB signaling pathway 6714_5595_5594_2932_6776_6777_4609_3725_5058_207_208 11 1.58E-09 1.16E-07 1.16E-08 2927 hsa-mir-125b-2 hsa04520 Adherens junction 1460_1499_6714_5595_5594_1387_4087_4088_4089_2033 10 9.80E-09 7.16E-07 6.51E-08 2928 hsa-mir-125b-2 hsa04010 MAPK signaling pathway 6722_3727_2249_5595_5594_1649_3312_5970_7157_468_4609_3725_2353_5058_207_208 16 1.13E-08 8.22E-07 6.85E-08 2929 hsa-mir-125b-2 hsa05213 Endometrial cancer 1499_5595_5594_2932_7157_4609_207_208 8 7.12E-08 5.20E-06 4.00E-07 2930 hsa-mir-125b-2 hsa05222 Small cell lung cancer 6256_10401_5970_7157_4609_5925_207_208_8554 9 2.19E-07 1.60E-05 1.14E-06 2931 hsa-mir-125b-2 hsa04350 TGF-beta signaling pathway 6667_5595_5594_1387_4609_4087_4088_4089_2033 9 2.40E-07 1.75E-05 1.17E-06 2932 hsa-mir-125b-2 hsa05016 Huntington's disease 6667_6874_25942_1387_6908_9001_5430_7157_3065_3064_10476_2033 12 3.34E-07 2.44E-05 1.52E-06 2933 hsa-mir-125b-2 hsa04330 Notch signaling pathway 1387_1487_1488_9612_3065_2033_8850 7 5.81E-07 4.24E-05 2.50E-06 2934 hsa-mir-125b-2 hsa05218 Melanoma 2249_5595_5594_4193_7157_5925_207_208 8 6.25E-07 4.56E-05 2.53E-06 2935 hsa-mir-125b-2 hsa05211 Renal cell carcinoma 5595_5594_1387_3725_5058_2033_207_208 8 6.89E-07 5.03E-05 2.53E-06 2936 hsa-mir-125b-2 hsa05216 Thyroid cancer 1499_5595_5594_6256_7157_4609 6 6.92E-07 5.05E-05 2.53E-06 2937 hsa-mir-125b-2 hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_3725_2353_207_208 8 9.16E-07 6.69E-05 3.19E-06 2938 hsa-mir-125b-2 hsa05223 Non-small cell lung cancer 5595_5594_6256_7157_5925_207_208 7 1.36E-06 9.90E-05 4.50E-06 2939 hsa-mir-125b-2 hsa04660 T cell receptor signaling pathway 5595_5594_2932_5970_3725_2353_5058_207_208 9 1.49E-06 0.000109123 4.74E-06 2940 hsa-mir-125b-2 hsa04630 Jak-STAT signaling pathway 1387_10401_6776_6777_4609_2033_3977_207_208_8554 10 2.95E-06 0.00021507 8.96E-06 2941 hsa-mir-125b-2 hsa05214 Glioma 5595_5594_4193_7157_5925_207_208 7 4.21E-06 0.000307121 1.23E-05 2942 hsa-mir-125b-2 hsa05219 Bladder cancer 5595_5594_4193_7157_4609_5925 6 4.74E-06 0.00034593 1.33E-05 2943 hsa-mir-125b-2 hsa04620 Toll-like receptor signaling pathway 5595_5594_5970_3725_2353_207_208 7 6.40E-05 0.004670189 0.00017297 2944 hsa-mir-125b-2 hsa04950 Maturity onset diabetes of the young 3651_6927_3172_5080 4 0.000114844 0.00838363 0.000299415 2945 hsa-mir-125b-2 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 0.000119815 0.008746512 0.000301604 2946 hsa-mir-125b-2 hsa04510 Focal adhesion 1499_6714_5595_5594_2932_3725_5058_207_208 9 0.000165803 0.012103594 0.000403453 2947 hsa-mir-125b-2 hsa04530 Tight junction 1460_1499_6714_4628_60412_207_208 7 0.00036051 0.026317233 0.000848943 2948 hsa-mir-125b-2 hsa04910 Insulin signaling pathway 5595_5594_2932_5211_207_208_2538 7 0.000375905 0.027441101 0.000857534 2949 hsa-mir-125b-2 hsa04920 Adipocytokine signaling pathway 6256_5970_207_208_2538 5 0.000507773 0.037067394 0.001109063 2950 hsa-mir-125b-2 hsa04916 Melanogenesis 1499_5595_5594_1387_2932_2033 6 0.000517339 0.037765725 0.001109063 2951 hsa-mir-125b-2 hsa04062 Chemokine signaling pathway 5595_5594_2932_6777_5970_5058_207_208 8 0.000531743 0.038817215 0.001109063 2952 hsa-mir-125b-2 hsa04720 Long-term potentiation 5595_5594_1387_468_2033 5 0.000822584 0.060048631 0.001668018 2953 hsa-mir-125b-2 hsa04370 VEGF signaling pathway 6714_5595_5594_207_208 5 0.000920009 0.067160675 0.001815153 2954 hsa-mir-125b-2 hsa03420 Nucleotide excision repair 2967_2968_4331_5887 4 0.000946548 0.069098018 0.001818369 2955 hsa-mir-125b-2 hsa04150 mTOR signaling pathway 5595_5594_207_208 4 0.001688186 0.123237547 0.003093072 2956 hsa-mir-125b-2 hsa04612 Antigen processing and presentation 4801_4800_1514_3312_3326 5 0.001694834 0.123722894 0.003093072 2957 hsa-mir-125b-2 hsa04540 Gap junction 6714_5595_5594_983_10382 5 0.002036302 0.148650031 0.003625611 2958 hsa-mir-125b-2 hsa04912 GnRH signaling pathway 6714_5595_5594_468_3725 5 0.003771824 0.275343176 0.00655579 2959 hsa-mir-125b-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5970_3725_5058 4 0.00488524 0.356622545 0.008293548 2960 hsa-mir-125b-2 hsa04664 Fc epsilon RI signaling pathway 5595_5594_207_208 4 0.006981957 0.509682856 0.011583701 2961 hsa-mir-125b-2 hsa04930 Type II diabetes mellitus 3651_5595_5594 3 0.009486581 0.692520444 0.015389343 2962 hsa-mir-125b-2 hsa04210 Apoptosis 5970_7157_207_208 4 0.010342351 0.754991642 0.016412862 2963 hsa-mir-125b-2 hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.015841104 1 0.024604268 2964 hsa-mir-125b-2 hsa05131 Shigellosis 1499_7534_10382 3 0.016580022 1 0.02470085 2965 hsa-mir-125b-2 hsa05130 Pathogenic Escherichia coli infection 1499_7534_10382 3 0.016580022 1 0.02470085 2966 hsa-mir-125b-2 hsa04115 p53 signaling pathway 983_4193_7157 3 0.027926018 1 0.040771987 2967 hsa-mir-125b-2 hsa04360 Axon guidance 5595_5594_2932_5058 4 0.035008199 1 0.050109775 2968 hsa-mir-125b-2 hsa04120 Ubiquitin mediated proteolysis 672_10401_4193_8554 4 0.041816075 1 0.058703337 2969 hsa-mir-125b-2 hsa03410 Base excision repair 3146_142 2 0.046648205 1 0.064251301 2970 hsa-mir-126 hsa03022 Basal transcription factors 2967_2961_2960_2963_6881_54457_2968_6879_6878_6877_6874_6872_2957_6873_2958_2959_6880_6882_138474_6884_6883 21 1.38E-33 9.22E-32 9.22E-32 2971 hsa-mir-126 hsa05200 Pathways in cancer 5925_9063_5595_5594_5599_6256_3326_5601_4193_1387_5970_2885_7157_6688_3725_4609_5604_2353_10401_2033_8554_7184 22 2.82E-17 1.89E-15 9.46E-16 2972 hsa-mir-126 hsa04010 MAPK signaling pathway 6722_5595_5594_5599_5606_5601_5600_3312_1432_5970_2885_7157_3725_4609_3727_5604_2353_9344_2005 19 2.03E-15 1.36E-13 4.53E-14 2973 hsa-mir-126 hsa05215 Prostate cancer 5925_5595_5594_3326_4193_1387_5970_2885_7157_5604_2033_7184 12 2.48E-13 1.66E-11 3.75E-12 2974 hsa-mir-126 hsa05212 Pancreatic cancer 5925_5595_5594_3326_4193_1387_5970_2885_7157_5604_2033_7184 12 2.80E-13 1.87E-11 3.75E-12 2975 hsa-mir-126 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5606_5601_5600_1432_5970_3725_5604_2353 11 2.58E-11 1.73E-09 2.89E-10 2976 hsa-mir-126 hsa05210 Colorectal cancer 5595_5594_5599_5601_2885_7157_3725_4609_5604_2353 10 8.72E-11 5.84E-09 8.34E-10 2977 hsa-mir-126 hsa05220 Chronic myeloid leukemia 5925_5595_5594_4193_5970_2885_7157_4609_5604 9 7.35E-10 4.92E-08 6.15E-09 2978 hsa-mir-126 hsa04912 GnRH signaling pathway 5595_5594_5599_5606_5601_5600_1432_2885_3725_5604 10 8.42E-10 5.64E-08 6.27E-09 2979 hsa-mir-126 hsa04660 T cell receptor signaling pathway 5595_5594_5601_5600_1432_5970_2885_3725_5604_2353 10 9.94E-10 6.66E-08 6.66E-09 2980 hsa-mir-126 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5606_5601_5600_1432_2885_5604 9 1.12E-09 7.50E-08 6.82E-09 2981 hsa-mir-126 hsa05219 Bladder cancer 5925_5595_5594_4193_7157_4609_5604 7 7.71E-09 5.16E-07 4.30E-08 2982 hsa-mir-126 hsa05216 Thyroid cancer 5595_5594_6256_7157_4609_5604 6 3.01E-08 2.02E-06 1.55E-07 2983 hsa-mir-126 hsa05223 Non-small cell lung cancer 5925_5595_5594_6256_2885_7157_5604 7 3.71E-08 2.49E-06 1.78E-07 2984 hsa-mir-126 hsa05222 Small cell lung cancer 5925_9063_6256_5970_7157_4609_10401_8554 8 4.17E-08 2.80E-06 1.79E-07 2985 hsa-mir-126 hsa04350 TGF-beta signaling pathway 5595_5594_1387_3397_3398_4609_3399_2033 8 4.54E-08 3.04E-06 1.79E-07 2986 hsa-mir-126 hsa04012 ErbB signaling pathway 5595_5594_5599_5601_2885_3725_4609_5604 8 4.54E-08 3.04E-06 1.79E-07 2987 hsa-mir-126 hsa05221 Acute myeloid leukemia 5595_5594_5970_2885_6688_4609_5604 7 6.48E-08 4.34E-06 2.41E-07 2988 hsa-mir-126 hsa05214 Glioma 5925_5595_5594_4193_2885_7157_5604 7 1.19E-07 7.99E-06 4.21E-07 2989 hsa-mir-126 hsa04310 Wnt signaling pathway 1460_5599_8607_5601_1387_7157_3725_4609_2033 9 2.24E-07 1.50E-05 7.26E-07 2990 hsa-mir-126 hsa05211 Renal cell carcinoma 5595_5594_1387_2885_3725_5604_2033 7 2.27E-07 1.52E-05 7.26E-07 2991 hsa-mir-126 hsa04662 B cell receptor signaling pathway 5595_5594_5970_2885_3725_5604_2353 7 2.94E-07 1.97E-05 8.96E-07 2992 hsa-mir-126 hsa05213 Endometrial cancer 5595_5594_2885_7157_4609_5604 6 6.78E-07 4.54E-05 1.97E-06 2993 hsa-mir-126 hsa05218 Melanoma 5925_5595_5594_4193_7157_5604 6 3.65E-06 0.000244748 9.79E-06 2994 hsa-mir-126 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5601_5600_1432_5970_3725 6 3.65E-06 0.000244748 9.79E-06 2995 hsa-mir-126 hsa04110 Cell cycle 5925_4193_1387_7157_4171_4085_2033 7 5.37E-06 0.000359963 1.38E-05 2996 hsa-mir-126 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 9.50E-06 0.000636605 2.36E-05 2997 hsa-mir-126 hsa04910 Insulin signaling pathway 5595_5594_5599_5601_2885_5604_5211 7 1.35E-05 0.000904279 3.23E-05 2998 hsa-mir-126 hsa04630 Jak-STAT signaling pathway 9063_1387_2885_4609_10401_2033_8554 7 2.76E-05 0.001850479 6.38E-05 2999 hsa-mir-126 hsa04720 Long-term potentiation 5595_5594_1387_5604_2033 5 7.09E-05 0.004749181 0.000158306 3000 hsa-mir-126 hsa04370 VEGF signaling pathway 5595_5594_5600_1432_5604 5 7.98E-05 0.00534428 0.000172396 3001 hsa-mir-126 hsa05016 Huntington's disease 6874_9001_1387_5430_7157_3064_2033 7 8.93E-05 0.005984445 0.000187014 3002 hsa-mir-126 hsa04520 Adherens junction 1460_5595_5594_1387_2033 5 9.47E-05 0.006342626 0.000192201 3003 hsa-mir-126 hsa04120 Ubiquitin mediated proteolysis 9063_672_4193_10401_7329_8554 6 0.00013293 0.008906333 0.000261951 3004 hsa-mir-126 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601 4 0.000137432 0.009207959 0.000263085 3005 hsa-mir-126 hsa04510 Focal adhesion 5595_5594_5599_5601_2885_3725_5604 7 0.000154428 0.010346658 0.000287407 3006 hsa-mir-126 hsa04540 Gap junction 5595_5594_10382_2885_5604 5 0.000185379 0.012420379 0.000335686 3007 hsa-mir-126 hsa05014 Amyotrophic lateral sclerosis (ALS) 5606_5600_1432_7157 4 0.000302214 0.020248334 0.000522692 3008 hsa-mir-126 hsa04916 Melanogenesis 5595_5594_1387_5604_2033 5 0.000304254 0.020384988 0.000522692 3009 hsa-mir-126 hsa04920 Adipocytokine signaling pathway 5599_6256_5601_5970 4 0.0005754 0.038551817 0.000963795 3010 hsa-mir-126 hsa03420 Nucleotide excision repair 2967_2968_5887 3 0.002037616 0.136520278 0.003329763 3011 hsa-mir-126 hsa04330 Notch signaling pathway 1387_2033_8850 3 0.002434378 0.163103324 0.003883412 3012 hsa-mir-126 hsa04062 Chemokine signaling pathway 5595_5594_5970_2885_5604 5 0.004298795 0.28801927 0.006698123 3013 hsa-mir-126 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_2885_5604 4 0.007182412 0.481221632 0.010921477 3014 hsa-mir-126 hsa04730 Long-term depression 5595_5594_5604 3 0.00733532 0.49146645 0.010921477 3015 hsa-mir-126 hsa04612 Antigen processing and presentation 3326_4801_3312 3 0.013256597 0.888191967 0.019308521 3016 hsa-mir-126 hsa04270 Vascular smooth muscle contraction 5595_5594_5604 3 0.027199974 1 0.038774431 3017 hsa-mir-126 hsa04150 mTOR signaling pathway 5595_5594 2 0.033810535 1 0.047193872 3018 hsa-mir-126 hsa05322 Systemic lupus erythematosus 3014_3015_8340 3 0.044372336 1 0.060672378 3019 hsa-mir-1260 hsa04330 Notch signaling pathway 9612_2033_3065 3 9.47E-07 1.52E-05 1.52E-05 3020 hsa-mir-1260 hsa05200 Pathways in cancer 8554_2033_3065 3 0.000281397 0.00450235 0.002251175 3021 hsa-mir-1260 hsa04110 Cell cycle 2033_3065 2 0.001036227 0.016579635 0.005526545 3022 hsa-mir-1260 hsa04630 Jak-STAT signaling pathway 8554_2033 2 0.001733966 0.027743449 0.006935862 3023 hsa-mir-1260 hsa05016 Huntington's disease 2033_3065 2 0.002523767 0.040380264 0.008076053 3024 hsa-mir-1260 hsa05211 Renal cell carcinoma 2033 1 0.028806201 0.460899224 0.043574592 3025 hsa-mir-1260 hsa04720 Long-term potentiation 2033 1 0.02997358 0.479577273 0.043574592 3026 hsa-mir-1260 hsa05220 Chronic myeloid leukemia 3065 1 0.02997358 0.479577273 0.043574592 3027 hsa-mir-1260 hsa04520 Adherens junction 2033 1 0.031916352 0.510661626 0.043574592 3028 hsa-mir-1260 hsa05222 Small cell lung cancer 8554 1 0.03424297 0.547887517 0.043574592 3029 hsa-mir-1260 hsa04350 TGF-beta signaling pathway 2033 1 0.034630241 0.554083853 0.043574592 3030 hsa-mir-1260 hsa05215 Prostate cancer 2033 1 0.035017369 0.560277911 0.043574592 3031 hsa-mir-1260 hsa05212 Pancreatic cancer 2033 1 0.035404356 0.566469692 0.043574592 3032 hsa-mir-1260 hsa04916 Melanogenesis 2033 1 0.041192105 0.659073685 0.047076692 3033 hsa-mir-1260b hsa03022 Basal transcription factors 2967_2961_2960_2963_2962_6881_2969_2968_6877_6874_6878_54457_6879_6908_2958_2957_6873_6872_6884_2959_6880_6882_6883_138474 24 1.02E-29 7.77E-28 4.07E-28 3034 hsa-mir-1260b hsa05200 Pathways in cancer 3320_4149_5371_2249_1956_1499_5595_5594_5914_1387_6256_862_1487_1488_2308_367_2932_4193_5599_10401_841_6776_6777_5970_7157_6688_5894_4609_3725_5604_861_1029_2353_4087_4088_4089_4292_1050_5925_2033_6502_3326_8554_4790_7184 45 1.07E-29 8.13E-28 4.07E-28 3035 hsa-mir-1260b hsa05215 Prostate cancer 3320_1956_1499_5595_5594_1387_2308_367_2932_4193_1385_5970_7157_468_5894_5604_5925_2033_3326_4790_7184 21 7.74E-19 5.88E-17 1.48E-17 3036 hsa-mir-1260b hsa05212 Pancreatic cancer 3320_1956_1499_5595_5594_1387_2308_367_2932_4193_1385_5970_7157_468_5894_5604_5925_2033_3326_4790_7184 21 9.45E-19 7.18E-17 1.48E-17 3037 hsa-mir-1260b hsa04010 MAPK signaling pathway 9479_6722_3727_4149_2249_1956_5595_5594_5598_1386_9261_4208_1649_5566_9252_7867_5599_3312_5970_7157_468_5894_4609_3725_5604_6195_6196_2353_1432_4790_2002 31 9.71E-19 7.38E-17 1.48E-17 3038 hsa-mir-1260b hsa04310 Wnt signaling pathway 815_1499_1387_1487_1488_1459_5566_1457_2932_8454_5599_6423_6500_7157_8061_4609_3725_4087_4088_4089_2033_1460_8607 23 1.20E-16 9.10E-15 1.52E-15 3039 hsa-mir-1260b hsa05220 Chronic myeloid leukemia 5595_5594_1487_1488_4193_6776_6777_5970_7157_5894_4609_5604_861_1029_4088_4089_5925_4790 18 2.27E-16 1.73E-14 2.47E-15 3040 hsa-mir-1260b hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_862_6776_6777_5970_6688_5894_4609_5604_861_1050_4790 15 3.55E-14 2.70E-12 3.37E-13 3041 hsa-mir-1260b hsa05210 Colorectal cancer 1956_1499_5595_5594_2932_5599_7157_5894_4609_3725_5604_2353_4087_4088_4089_4292 16 2.44E-13 1.85E-11 1.98E-12 3042 hsa-mir-1260b hsa04110 Cell cycle 990_1387_4171_2932_4193_8454_6500_7157_983_1029_4085_4087_4088_4089_5925_2033_6502_5933 18 2.61E-13 1.98E-11 1.98E-12 3043 hsa-mir-1260b hsa04350 TGF-beta signaling pathway 5595_5594_1387_8454_3399_3398_6500_4609_3397_4087_4088_4089_2033_6667_5933 15 4.88E-12 3.71E-10 3.37E-11 3044 hsa-mir-1260b hsa04912 GnRH signaling pathway 815_1956_5595_5594_5598_5566_5599_468_5894_3725_5604_1432_2002_808_801_805 16 7.42E-12 5.64E-10 4.70E-11 3045 hsa-mir-1260b hsa04720 Long-term potentiation 815_5595_5594_1387_5566_468_5894_5604_6195_6196_2033_808_801_805 14 9.83E-12 7.47E-10 5.75E-11 3046 hsa-mir-1260b hsa05214 Glioma 815_1956_5595_5594_4193_7157_5894_5604_1029_5925_808_801_805 13 2.55E-11 1.94E-09 1.38E-10 3047 hsa-mir-1260b hsa05219 Bladder cancer 1956_5595_5594_9252_4193_7157_5894_4609_5604_1029_5925 11 7.27E-11 5.52E-09 3.68E-10 3048 hsa-mir-1260b hsa04540 Gap junction 1956_5595_5594_5598_5566_7277_10382_983_5894_7846_5604_7278_51807_10376 14 1.27E-10 9.64E-09 6.02E-10 3049 hsa-mir-1260b hsa04916 Melanogenesis 815_1499_5595_5594_1387_5566_2932_1385_5894_5604_2033_808_801_805 14 4.78E-10 3.63E-08 2.14E-09 3050 hsa-mir-1260b hsa05213 Endometrial cancer 1956_1499_5595_5594_2932_7157_5894_4609_5604_4292_2002 11 5.23E-10 3.97E-08 2.21E-09 3051 hsa-mir-1260b hsa04012 ErbB signaling pathway 815_1956_5595_5594_2932_5599_6776_6777_5894_4609_3725_5604_2002 13 6.35E-10 4.82E-08 2.54E-09 3052 hsa-mir-1260b hsa04520 Adherens junction 1956_1499_5595_5594_1387_1459_1457_4087_4088_4089_2033_1460 12 2.80E-09 2.13E-07 1.06E-08 3053 hsa-mir-1260b hsa04910 Insulin signaling pathway 5595_5594_23265_2308_5566_2932_5599_5894_5604_5211_2002_808_801_805 14 1.34E-08 1.02E-06 4.84E-08 3054 hsa-mir-1260b hsa05218 Melanoma 2249_1956_5595_5594_4193_7157_5894_5604_1029_5925 10 1.01E-07 7.71E-06 3.50E-07 3055 hsa-mir-1260b hsa05223 Non-small cell lung cancer 1956_5595_5594_6256_7157_5894_5604_1029_5925 9 1.23E-07 9.35E-06 4.06E-07 3056 hsa-mir-1260b hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_841_5970_3725_5604_2353_1432_6348_4790 11 2.76E-07 2.10E-05 8.75E-07 3057 hsa-mir-1260b hsa05216 Thyroid cancer 1499_5595_5594_6256_7157_4609_5604 7 3.58E-07 2.72E-05 1.09E-06 3058 hsa-mir-1260b hsa05222 Small cell lung cancer 4149_6256_10401_5970_7157_4609_5925_6502_8554_4790 10 5.12E-07 3.89E-05 1.50E-06 3059 hsa-mir-1260b hsa04330 Notch signaling pathway 388585_1387_1487_1488_9612_2033_2648_8850 8 5.41E-07 4.11E-05 1.52E-06 3060 hsa-mir-1260b hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_5894_3725_5604_2353_4790 9 1.51E-06 0.000114386 4.09E-06 3061 hsa-mir-1260b hsa05131 Shigellosis 1499_7277_10382_7846_7278_51807_4691_10376 8 1.78E-06 0.000135094 4.50E-06 3062 hsa-mir-1260b hsa05130 Pathogenic Escherichia coli infection 1499_7277_10382_7846_7278_51807_4691_10376 8 1.78E-06 0.000135094 4.50E-06 3063 hsa-mir-1260b hsa04660 T cell receptor signaling pathway 5595_5594_2932_5970_5894_3725_5604_2353_1432_4790 10 4.00E-06 0.000304084 9.81E-06 3064 hsa-mir-1260b hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_4193_8454_10401_6500_7329_6502_8554 10 2.70E-05 0.002050454 6.41E-05 3065 hsa-mir-1260b hsa05016 Huntington's disease 6874_1387_6908_9001_1385_841_5430_7157_3064_2033_6667 11 6.45E-05 0.004902308 0.000148555 3066 hsa-mir-1260b hsa05211 Renal cell carcinoma 5595_5594_1387_5894_3725_5604_2033 7 7.70E-05 0.005852725 0.000172139 3067 hsa-mir-1260b hsa04062 Chemokine signaling pathway 5595_5594_5566_7074_2932_6777_5970_5894_5604_6348_4790 11 8.06E-05 0.006123704 0.000174963 3068 hsa-mir-1260b hsa04370 VEGF signaling pathway 5595_5594_9261_7867_5894_5604_1432 7 0.000113834 0.008651397 0.000240317 3069 hsa-mir-1260b hsa04270 Vascular smooth muscle contraction 5595_5594_5566_5894_5604_808_801_805 8 0.000250946 0.019071858 0.000515456 3070 hsa-mir-1260b hsa04612 Antigen processing and presentation 3320_4800_4802_1385_3312_4801_3326 7 0.000262264 0.019932034 0.000524527 3071 hsa-mir-1260b hsa04630 Jak-STAT signaling pathway 1387_10401_6778_6776_6777_4609_2033_3977_8554 9 0.000311527 0.023676024 0.000607078 3072 hsa-mir-1260b hsa04115 p53 signaling pathway 7161_4193_841_7157_983_1029 6 0.000438732 0.033343612 0.00083288 3073 hsa-mir-1260b hsa04950 Maturity onset diabetes of the young 3651_168620_6927_5080 4 0.000449317 0.034148095 0.00083288 3074 hsa-mir-1260b hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_5599_5970_3725_1432_4790 6 0.000505489 0.038417179 0.000914695 3075 hsa-mir-1260b hsa04510 Focal adhesion 1956_1499_5595_5594_2932_5599_5894_3725_5604_2002 10 0.000567133 0.043102073 0.001002374 3076 hsa-mir-1260b hsa03050 Proteasome 5705_5701_5702_5719_5710 5 0.000621334 0.047221353 0.001073213 3077 hsa-mir-1260b hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5894_5604_1432 6 0.00085493 0.064974675 0.001443882 3078 hsa-mir-1260b hsa03420 Nucleotide excision repair 2967_2968_4331_5887 4 0.003482132 0.264642016 0.005753087 3079 hsa-mir-1260b hsa04930 Type II diabetes mellitus 5595_5594_3651_5599 4 0.003753365 0.285255703 0.00606927 3080 hsa-mir-1260b hsa04150 mTOR signaling pathway 5595_5594_6195_6196 4 0.006061071 0.460641371 0.009596695 3081 hsa-mir-1260b hsa04210 Apoptosis 5566_841_5970_7157_4790 5 0.007718835 0.586631485 0.011972071 3082 hsa-mir-1260b hsa05010 Alzheimer's disease 5595_5594_2932_841_808_801_805 7 0.010579008 0.804004629 0.016080093 3083 hsa-mir-1260b hsa04920 Adipocytokine signaling pathway 6256_5599_5970_4790 4 0.013784497 1 0.020541603 3084 hsa-mir-1260b hsa04730 Long-term depression 5595_5594_5894_5604 4 0.016565272 1 0.024210782 3085 hsa-mir-1260b hsa04810 Regulation of actin cytoskeleton 2249_1956_5595_5594_7074_5894_5604 7 0.028959828 1 0.0415273 3086 hsa-mir-1260b hsa04020 Calcium signaling pathway 815_1956_5566_808_801_805 6 0.038416344 1 0.054067447 3087 hsa-mir-1260b hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.03975342 1 0.054931999 3088 hsa-mir-1260b hsa05014 Amyotrophic lateral sclerosis (ALS) 834_7157_1432 3 0.041492733 1 0.056311567 3089 hsa-mir-1262 hsa05200 Pathways in cancer 7046_1499_595_596_598_1019_2261_4193_5578_3091_2064_3066_3065_5925_7189_5743_5747_25_1956_6789_613_4436_2113_10401_3716_1147_998_1026_367_4233_1017_5595_5594_5599_861_1387_2932_6776_6777_6772_5979_5879_6688_1869_3725_4087_4088_5888_5728_2033_675_3910_4790_4792_5970_3320_3326_5371_3480_5159_5156_5601_5602_1856_51588_4609_1441_8554 68 7.67E-50 6.45E-48 6.45E-48 3090 hsa-mir-1262 hsa04110 Cell cycle 595_1019_4193_902_3066_3065_5925_25_9232_5933_545_995_1026_5591_1017_1387_11200_7534_7532_2932_7027_1869_4087_4088_2033_890_1031_983_5347_1022_1111_8556_8555_472 34 2.28E-29 1.92E-27 9.59E-28 3091 hsa-mir-1262 hsa05215 Prostate cancer 1499_595_596_4193_2064_5925_1956_1147_1026_367_1017_5595_5594_1387_2932_1869_5728_2033_4790_4792_5970_3320_3326_3480_5159_5156_468 27 2.97E-24 2.50E-22 8.01E-23 3092 hsa-mir-1262 hsa05212 Pancreatic cancer 1499_595_596_4193_2064_5925_1956_1147_1026_367_1017_5595_5594_1387_2932_1869_5728_2033_4790_4792_5970_3320_3326_3480_5159_5156_468 27 3.82E-24 3.21E-22 8.01E-23 3093 hsa-mir-1262 hsa05220 Chronic myeloid leukemia 7046_595_598_1019_4193_3066_3065_5925_25_613_1147_1026_5595_5594_861_6776_6777_1869_4088_4790_4792_5970_5781_4609 24 4.66E-22 3.91E-20 7.83E-21 3094 hsa-mir-1262 hsa04010 MAPK signaling pathway 3925_7046_2261_2264_9252_5578_5923_7189_1956_3304_3305_3303_6789_1616_1147_998_5595_5594_5599_1386_3315_1649_5879_3164_3725_3727_4790_51701_5970_5159_5156_5601_5602_6885_4609_468 36 6.21E-21 5.22E-19 8.70E-20 3095 hsa-mir-1262 hsa04630 Jak-STAT signaling pathway 3559_595_598_3454_3455_3560_1439_2690_10401_3717_3716_3718_85480_1387_3575_3570_3572_6776_6777_6772_2033_149233_3953_51588_5781_4609_1441_8554 28 9.61E-20 8.07E-18 1.15E-18 3096 hsa-mir-1262 hsa05210 Colorectal cancer 7046_1499_595_596_1956_4436_4233_5595_5594_5599_2932_5879_3725_4087_4088_3480_5159_5156_5601_5602_1856_4609 22 9.45E-19 7.94E-17 9.92E-18 3097 hsa-mir-1262 hsa04115 p53 signaling pathway 595_1019_4194_4193_900_50484_6241_27113_51246_545_1026_1017_11200_64326_5728_25898_983_7161_1111_472 20 6.81E-18 5.72E-16 6.35E-17 3098 hsa-mir-1262 hsa04520 Adherens junction 7046_1499_1460_2064_1956_6714_2241_998_4233_5595_5594_1387_5879_1457_4087_4088_2033_51701_3480_6885 20 7.86E-17 6.60E-15 6.60E-16 3099 hsa-mir-1262 hsa05222 Small cell lung cancer 595_596_598_1019_5925_7189_5743_5747_10401_1147_1017_1869_5728_3910_4790_4792_5970_51588_4609_8554 20 2.62E-16 2.20E-14 2.00E-15 3100 hsa-mir-1262 hsa04620 Toll-like receptor signaling pathway 3454_3455_4615_7189_3661_1147_3654_5595_5594_5599_6772_5879_3725_4790_4792_5970_5601_5602_353376_148022_6885 21 3.95E-16 3.32E-14 2.76E-15 3101 hsa-mir-1262 hsa04510 Focal adhesion 1499_595_596_5578_2064_5923_5747_1956_6714_5499_998_4233_5595_5594_5599_2932_5879_3725_5728_3910_2321_3480_5159_5156_5601_5602 26 4.75E-15 3.99E-13 3.07E-14 3102 hsa-mir-1262 hsa04310 Wnt signaling pathway 1499_595_5578_1460_5599_1387_2932_5879_3725_1457_1452_4087_4088_2033_51701_5518_5515_5601_5602_1856_6885_4609_5527 23 5.72E-15 4.80E-13 3.43E-14 3103 hsa-mir-1262 hsa04350 TGF-beta signaling pathway 7046_3398_6667_3399_1874_658_5933_5595_5594_1387_7027_4086_4087_4088_2033_5518_5515_4609 18 4.76E-14 4.00E-12 2.67E-13 3104 hsa-mir-1262 hsa04012 ErbB signaling pathway 5578_2064_5747_25_1956_6714_1026_5595_5594_5599_2932_6776_6777_3725_5601_5602_4609 17 5.45E-13 4.58E-11 2.86E-12 3105 hsa-mir-1262 hsa04060 Cytokine-cytokine receptor interaction 3556_3559_7046_1234_1230_3454_3455_1956_3560_1439_7852_6362_658_2690_85480_4233_3575_3570_3572_2321_149233_5159_5156_3953_959_1441 26 7.89E-13 6.63E-11 3.90E-12 3106 hsa-mir-1262 hsa05219 Bladder cancer 595_1019_2261_9252_4193_2064_5925_1956_1026_5595_5594_1869_4609 13 2.12E-12 1.78E-10 9.91E-12 3107 hsa-mir-1262 hsa04062 Chemokine signaling pathway 1234_1230_5747_5580_5590_7852_6362_3055_3717_1147_3718_998_5595_5594_2932_6777_6772_5879_4790_4792_5970_2185 22 3.89E-12 3.27E-10 1.72E-11 3108 hsa-mir-1262 hsa05214 Glioma 595_1019_4193_5578_5925_1956_1026_5595_5594_1869_5728_3480_5159_5156 14 1.98E-11 1.67E-09 8.33E-11 3109 hsa-mir-1262 hsa05218 Melanoma 595_1019_4193_5925_1956_1026_4233_5595_5594_1869_5728_3480_5159_5156 14 5.57E-11 4.68E-09 2.13E-10 3110 hsa-mir-1262 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_1147_998_4233_5599_5879_3725_4790_4792_5970_5601_5602_5781 14 5.57E-11 4.68E-09 2.13E-10 3111 hsa-mir-1262 hsa05221 Acute myeloid leukemia 595_1147_5595_5594_861_6776_6777_6688_4790_5970_5371_4609 12 9.75E-10 8.19E-08 3.56E-09 3112 hsa-mir-1262 hsa04120 Ubiquitin mediated proteolysis 4193_3093_7189_7319_84447_10401_7329_10055_64326_7337_5371_672_25898_51588_10075_8554 16 3.00E-09 2.52E-07 1.05E-08 3113 hsa-mir-1262 hsa04920 Adipocytokine signaling pathway 5563_6794_3717_1147_5599_4790_4792_5970_5601_5602_3953_5781 12 3.48E-09 2.93E-07 1.17E-08 3114 hsa-mir-1262 hsa04660 T cell receptor signaling pathway 1019_3932_1147_998_5595_5594_2932_3725_4790_4792_5970_5601_6885_959 14 9.18E-09 7.71E-07 2.97E-08 3115 hsa-mir-1262 hsa05223 Non-small cell lung cancer 595_1019_5578_2064_5925_1956_6789_5595_5594_1869 10 5.39E-08 4.53E-06 1.68E-07 3116 hsa-mir-1262 hsa04912 GnRH signaling pathway 5578_5580_1956_6714_998_5595_5594_5599_3725_5601_5602_2185_468 13 5.66E-08 4.75E-06 1.70E-07 3117 hsa-mir-1262 hsa04210 Apoptosis 3556_596_598_4615_823_1439_1147_3654_4790_4792_5970_472 12 5.96E-08 5.00E-06 1.73E-07 3118 hsa-mir-1262 hsa05211 Renal cell carcinoma 3091_2113_998_4233_5595_5594_1387_5879_3725_2033_5781 11 6.77E-08 5.69E-06 1.90E-07 3119 hsa-mir-1262 hsa04662 B cell receptor signaling pathway 6850_1147_5595_5594_1380_2932_5879_3725_4790_4792_5970 11 9.84E-08 8.27E-06 2.67E-07 3120 hsa-mir-1262 hsa03420 Nucleotide excision repair 5981_902_6117_2965_4331_2071_2074_6118_1022 9 1.19E-07 1.00E-05 3.13E-07 3121 hsa-mir-1262 hsa04330 Notch signaling pathway 3066_3065_3280_1387_2033_8850_1856_388585_2648 9 1.96E-07 1.64E-05 4.98E-07 3122 hsa-mir-1262 hsa05213 Endometrial cancer 1499_595_2064_1956_5595_5594_2932_5728_4609 9 4.18E-07 3.51E-05 1.03E-06 3123 hsa-mir-1262 hsa04530 Tight junction 1499_1019_5578_1460_5580_5590_6714_998_1457_5728_5518_5515_5520 13 7.02E-07 5.90E-05 1.68E-06 3124 hsa-mir-1262 hsa03022 Basal transcription factors 6880_51616_2965_2969_6908_2958_2957 7 4.91E-06 0.000412484 1.15E-05 3125 hsa-mir-1262 hsa04370 VEGF signaling pathway 5578_5743_5747_6714_998_5595_5594_3315_5879 9 7.87E-06 0.000661328 1.79E-05 3126 hsa-mir-1262 hsa04664 Fc epsilon RI signaling pathway 5578_5580_6850_5595_5594_5599_5879_5601_5602 9 9.52E-06 0.000799463 2.10E-05 3127 hsa-mir-1262 hsa04360 Axon guidance 5747_25_7852_2242_998_4233_5595_5594_2932_5879_1020 11 1.47E-05 0.001235873 3.16E-05 3128 hsa-mir-1262 hsa05216 Thyroid cancer 1499_595_5595_5594_5979_4609 6 1.52E-05 0.001275943 3.16E-05 3129 hsa-mir-1262 hsa04930 Type II diabetes mellitus 5580_5590_5595_5594_5599_5601_5602 7 1.54E-05 0.001293736 3.16E-05 3130 hsa-mir-1262 hsa04540 Gap junction 5578_1956_6714_5595_5594_1453_5159_983_5156 9 3.15E-05 0.002646143 6.30E-05 3131 hsa-mir-1262 hsa04650 Natural killer cell mediated cytotoxicity 5578_3454_3455_3932_6850_5595_5594_5879_5781_2185 10 0.000113648 0.009546461 0.000222011 3132 hsa-mir-1262 hsa04612 Antigen processing and presentation 3309_3304_3305_3303_3320_3326_4800_2923 8 0.000139263 0.0116981 0.000265866 3133 hsa-mir-1262 hsa03440 Homologous recombination 641_6117_5888_675_6118 5 0.000147679 0.012405033 0.000275667 3134 hsa-mir-1262 hsa04720 Long-term potentiation 5578_5499_5595_5594_1387_2033_468 7 0.000293334 0.024640083 0.000535654 3135 hsa-mir-1262 hsa04916 Melanogenesis 1499_5578_5595_5594_1387_2932_2033_1856 8 0.000374353 0.031445639 0.000669056 3136 hsa-mir-1262 hsa05131 Shigellosis 1499_5578_25_998_7534_4691 6 0.000403849 0.033923315 0.000692313 3137 hsa-mir-1262 hsa05130 Pathogenic Escherichia coli infection 1499_5578_25_998_7534_4691 6 0.000403849 0.033923315 0.000692313 3138 hsa-mir-1262 hsa03030 DNA replication 5981_6117_5557_6118_5422 5 0.00042104 0.035367371 0.000707347 3139 hsa-mir-1262 hsa04910 Insulin signaling pathway 5563_5590_5499_5595_5594_5599_2932_5601_5602 9 0.000512635 0.043061309 0.000844339 3140 hsa-mir-1262 hsa03430 Mismatch repair 5981_4436_6117_6118 4 0.000763678 0.064148935 0.001233633 3141 hsa-mir-1262 hsa04670 Leukocyte transendothelial migration 1499_5578_5747_7852_998_5879_5781_2185 8 0.001004128 0.084346728 0.001591448 3142 hsa-mir-1262 hsa04810 Regulation of actin cytoskeleton 2261_2264_5747_1956_5499_998_5595_5594_5879_5159_5156 11 0.001025012 0.086101031 0.001594464 3143 hsa-mir-1262 hsa04730 Long-term depression 5578_5595_5594_3480_5518_5515 6 0.001281152 0.10761673 0.001956668 3144 hsa-mir-1262 hsa04150 mTOR signaling pathway 5563_6794_3091_5595_5594 5 0.001919781 0.161261631 0.002879672 3145 hsa-mir-1262 hsa05340 Primary immunodeficiency 3932_3718_3575_959 4 0.00309042 0.259595317 0.004554304 3146 hsa-mir-1262 hsa03410 Base excision repair 3146_142_4913_328 4 0.003392196 0.284944504 0.004912836 3147 hsa-mir-1262 hsa05016 Huntington's disease 3066_3065_3064_25942_6667_27113_1387_2033_6908 9 0.003877965 0.325749083 0.005521171 3148 hsa-mir-1262 hsa04950 Maturity onset diabetes of the young 6927_3280_3172 3 0.008289069 0.696281774 0.011604696 3149 hsa-mir-1262 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_1616_5879 4 0.0142046 1 0.019560432 3150 hsa-mir-1262 hsa04640 Hematopoietic cell lineage 3559_1380_3575_3570_1441 5 0.014522579 1 0.019675752 3151 hsa-mir-1262 hsa04710 Circadian rhythm - mammal 1453_8553 2 0.022173578 1 0.02956477 3152 hsa-mir-1262 hsa03450 Non-homologous end-joining 2547_5591 2 0.025083958 1 0.032922695 3153 hsa-mir-1262 hsa04270 Vascular smooth muscle contraction 5578_5580_5499_5595_5594 5 0.043468931 1 0.056175234 3154 hsa-mir-1266 hsa05210 Colorectal cancer 4087_4088_4609 3 1.95E-06 3.32E-05 1.84E-05 3155 hsa-mir-1266 hsa04350 TGF-beta signaling pathway 4087_4088_4609 3 2.16E-06 3.68E-05 1.84E-05 3156 hsa-mir-1266 hsa04310 Wnt signaling pathway 4087_4088_4609 3 1.11E-05 0.000188646 6.29E-05 3157 hsa-mir-1266 hsa05200 Pathways in cancer 4087_4088_4609 3 0.000110184 0.00187313 0.000468282 3158 hsa-mir-1266 hsa05220 Chronic myeloid leukemia 4088_4609 2 0.000231234 0.003930974 0.000743029 3159 hsa-mir-1266 hsa04520 Adherens junction 4087_4088 2 0.000262245 0.004458172 0.000743029 3160 hsa-mir-1266 hsa04612 Antigen processing and presentation 4800_4801 2 0.000322912 0.005489511 0.000784216 3161 hsa-mir-1266 hsa04110 Cell cycle 4087_4088 2 0.000569823 0.00968699 0.001210874 3162 hsa-mir-1266 hsa05216 Thyroid cancer 4609 1 0.008962596 0.152364134 0.016929348 3163 hsa-mir-1266 hsa05219 Bladder cancer 4609 1 0.012824162 0.218010751 0.021801075 3164 hsa-mir-1266 hsa05213 Endometrial cancer 4609 1 0.01578549 0.268353325 0.024395757 3165 hsa-mir-1266 hsa05221 Acute myeloid leukemia 4609 1 0.017853718 0.303513211 0.025292768 3166 hsa-mir-1266 hsa05222 Small cell lung cancer 4609 1 0.025795031 0.43851552 0.031678351 3167 hsa-mir-1266 hsa04012 ErbB signaling pathway 4609 1 0.026088054 0.443496917 0.031678351 3168 hsa-mir-1266 hsa04630 Jak-STAT signaling pathway 4609 1 0.0458308 0.779123593 0.051941573 3169 hsa-mir-1267 hsa04010 MAPK signaling pathway 9261_6722_8986_5970_6195_207_9252_4790_1432_6196_6197 11 6.78E-12 3.87E-10 3.87E-10 3170 hsa-mir-1267 hsa05215 Prostate cancer 5970_4792_2033_207_2932_4790_1387 7 6.63E-10 3.78E-08 1.36E-08 3171 hsa-mir-1267 hsa05212 Pancreatic cancer 5970_4792_2033_207_2932_4790_1387 7 7.14E-10 4.07E-08 1.36E-08 3172 hsa-mir-1267 hsa05200 Pathways in cancer 2736_3716_5970_4792_2033_2113_207_2932_4790_1387 10 1.03E-09 5.85E-08 1.46E-08 3173 hsa-mir-1267 hsa04660 T cell receptor signaling pathway 5970_4792_207_2932_4790_5777_1432 7 2.88E-09 1.64E-07 3.28E-08 3174 hsa-mir-1267 hsa04662 B cell receptor signaling pathway 5970_4792_207_2932_4790_5777 6 1.15E-08 6.54E-07 1.09E-07 3175 hsa-mir-1267 hsa04630 Jak-STAT signaling pathway 3716_2033_207_3566_5777_6773_1387 7 2.77E-08 1.58E-06 2.25E-07 3176 hsa-mir-1267 hsa04062 Chemokine signaling pathway 5590_5970_4792_207_2932_4790_6773 7 1.17E-07 6.68E-06 8.35E-07 3177 hsa-mir-1267 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_4792_6714_4790_1432 5 3.73E-07 2.13E-05 2.36E-06 3178 hsa-mir-1267 hsa04720 Long-term potentiation 6195_2033_6196_6197_1387 5 4.83E-07 2.75E-05 2.75E-06 3179 hsa-mir-1267 hsa04620 Toll-like receptor signaling pathway 5970_4792_207_4790_1432 5 2.05E-06 0.000116932 1.06E-05 3180 hsa-mir-1267 hsa04150 mTOR signaling pathway 6195_207_6196_6197 4 4.25E-06 0.000242396 2.02E-05 3181 hsa-mir-1267 hsa04920 Adipocytokine signaling pathway 5970_4792_207_4790 4 1.10E-05 0.000627578 4.83E-05 3182 hsa-mir-1267 hsa05211 Renal cell carcinoma 2033_2113_207_1387 4 1.44E-05 0.000822747 5.88E-05 3183 hsa-mir-1267 hsa05220 Chronic myeloid leukemia 5970_4792_207_4790 4 1.68E-05 0.000959386 6.40E-05 3184 hsa-mir-1267 hsa04370 VEGF signaling pathway 9261_207_6714_1432 4 1.86E-05 0.001059297 6.62E-05 3185 hsa-mir-1267 hsa04520 Adherens junction 2033_6714_5777_1387 4 2.15E-05 0.00122323 7.20E-05 3186 hsa-mir-1267 hsa05222 Small cell lung cancer 5970_4792_207_4790 4 2.82E-05 0.00160601 8.92E-05 3187 hsa-mir-1267 hsa04210 Apoptosis 5970_4792_207_4790 4 3.21E-05 0.001827258 9.62E-05 3188 hsa-mir-1267 hsa05221 Acute myeloid leukemia 5970_207_4790 3 0.000237821 0.013555817 0.000677791 3189 hsa-mir-1267 hsa04012 ErbB signaling pathway 207_2932_6714 3 0.000711005 0.040527274 0.00192987 3190 hsa-mir-1267 hsa04916 Melanogenesis 2033_2932_1387 3 0.00117371 0.066901456 0.003040975 3191 hsa-mir-1267 hsa04110 Cell cycle 2033_2932_1387 3 0.001710519 0.097499582 0.004239112 3192 hsa-mir-1267 hsa04530 Tight junction 5590_207_6714 3 0.002530343 0.144229531 0.005886583 3193 hsa-mir-1267 hsa04910 Insulin signaling pathway 5590_207_2932 3 0.002581835 0.147164575 0.005886583 3194 hsa-mir-1267 hsa04310 Wnt signaling pathway 2033_2932_1387 3 0.003371643 0.192183667 0.007391679 3195 hsa-mir-1267 hsa04930 Type II diabetes mellitus 5590_3651 2 0.00374113 0.213244403 0.007897941 3196 hsa-mir-1267 hsa04330 Notch signaling pathway 2033_1387 2 0.004059862 0.23141216 0.00826472 3197 hsa-mir-1267 hsa05213 Endometrial cancer 207_2932 2 0.004909781 0.279857544 0.00965026 3198 hsa-mir-1267 hsa05217 Basal cell carcinoma 2736_2932 2 0.005455661 0.310972693 0.010365756 3199 hsa-mir-1267 hsa04340 Hedgehog signaling pathway 2736_2932 2 0.005834355 0.33255825 0.010727685 3200 hsa-mir-1267 hsa05016 Huntington's disease 3064_2033_1387 3 0.006030071 0.343714047 0.010741064 3201 hsa-mir-1267 hsa04510 Focal adhesion 207_2932_6714 3 0.007720803 0.44008579 0.013335933 3202 hsa-mir-1267 hsa04664 Fc epsilon RI signaling pathway 207_1432 2 0.010752732 0.612905713 0.018026639 3203 hsa-mir-1267 hsa05210 Colorectal cancer 207_2932 2 0.012055669 0.687173116 0.019633518 3204 hsa-mir-1267 hsa04350 TGF-beta signaling pathway 2033_1387 2 0.012869022 0.733534271 0.020375952 3205 hsa-mir-1267 hsa04540 Gap junction 6714_5592 2 0.01456546 0.830231213 0.022438681 3206 hsa-mir-1267 hsa04912 GnRH signaling pathway 6714_1432 2 0.019200085 1 0.028800127 3207 hsa-mir-1267 hsa05322 Systemic lupus erythematosus 333932_126961 2 0.0324414 1 0.047414354 3208 hsa-mir-1267 hsa04950 Maturity onset diabetes of the young 3651 1 0.047157806 1 0.067199874 3209 hsa-mir-1269 hsa05200 Pathways in cancer 5371_2249_1956_1499_5595_5594_1387_6256_862_595_6502_2308_1019_367_1017_5914_841_6776_6777_5970_6688_4609_3725_4088_1026_861_2353_4089_1050_5925_2033_8554_4790 33 2.50E-25 1.80E-23 1.80E-23 3210 hsa-mir-1269 hsa05215 Prostate cancer 1956_1499_5595_5594_1385_1387_595_2308_367_1017_5970_468_1026_5925_2033_4790 16 1.53E-16 1.11E-14 3.24E-15 3211 hsa-mir-1269 hsa04010 MAPK signaling pathway 6722_2249_1956_5595_5594_1386_9261_4208_5566_9252_7867_1649_5970_468_4609_3725_6195_6196_2353_1432_4790_51701_2002 23 1.77E-16 1.27E-14 3.24E-15 3212 hsa-mir-1269 hsa05212 Pancreatic cancer 1956_1499_5595_5594_1385_1387_595_2308_367_1017_5970_468_1026_5925_2033_4790 16 1.80E-16 1.29E-14 3.24E-15 3213 hsa-mir-1269 hsa05221 Acute myeloid leukemia 5371_5595_5594_862_595_5914_6776_6777_5970_6688_4609_861_1050_4790 14 4.90E-16 3.53E-14 7.05E-15 3214 hsa-mir-1269 hsa05220 Chronic myeloid leukemia 5595_5594_595_1019_6776_6777_5970_4609_4088_1026_861_4089_5925_4790 14 9.06E-15 6.52E-13 1.09E-13 3215 hsa-mir-1269 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_7027_3399_3398_1874_4609_4088_3397_4089_2033_5933 14 5.61E-14 4.04E-12 5.77E-13 3216 hsa-mir-1269 hsa04110 Cell cycle 1387_595_6502_1019_1017_7027_4088_1026_4089_5925_2033_894_896_5933 14 2.69E-12 1.94E-10 2.42E-11 3217 hsa-mir-1269 hsa04720 Long-term potentiation 815_5595_5594_1387_5566_468_6195_6196_2033_808_801_805 12 3.89E-12 2.80E-10 3.11E-11 3218 hsa-mir-1269 hsa05214 Glioma 815_1956_5595_5594_595_1019_1026_5925_808_801_805 11 1.82E-11 1.31E-09 1.31E-10 3219 hsa-mir-1269 hsa04310 Wnt signaling pathway 815_1499_1387_595_5566_4609_3725_4088_1457_4089_2033_894_896_51701 14 5.52E-11 3.97E-09 3.61E-10 3220 hsa-mir-1269 hsa04912 GnRH signaling pathway 815_1956_5595_5594_5566_468_3725_1432_2002_808_801_805 12 1.85E-10 1.33E-08 1.11E-09 3221 hsa-mir-1269 hsa05219 Bladder cancer 1956_5595_5594_595_1019_9252_4609_1026_5925 9 2.03E-10 1.46E-08 1.13E-09 3222 hsa-mir-1269 hsa04916 Melanogenesis 815_1499_5595_5594_1385_1387_5566_2033_808_801_805 11 1.73E-09 1.25E-07 8.90E-09 3223 hsa-mir-1269 hsa04520 Adherens junction 1956_1499_5595_5594_1387_4088_1457_4089_2033_51701 10 2.21E-09 1.59E-07 1.06E-08 3224 hsa-mir-1269 hsa05210 Colorectal cancer 1956_1499_5595_5594_595_4609_3725_4088_2353_4089 10 3.39E-09 2.44E-07 1.53E-08 3225 hsa-mir-1269 hsa05222 Small cell lung cancer 6256_595_6502_1019_1017_5970_4609_5925_8554_4790 10 4.18E-09 3.01E-07 1.77E-08 3226 hsa-mir-1269 hsa04012 ErbB signaling pathway 815_1956_5595_5594_6776_6777_4609_3725_1026_2002 10 4.63E-09 3.33E-07 1.85E-08 3227 hsa-mir-1269 hsa04630 Jak-STAT signaling pathway 1387_595_6778_6776_6777_4609_2033_3977_894_896_8554 11 8.10E-08 5.83E-06 3.07E-07 3228 hsa-mir-1269 hsa05218 Melanoma 2249_1956_5595_5594_595_1019_1026_5925 8 1.92E-07 1.38E-05 6.91E-07 3229 hsa-mir-1269 hsa04620 Toll-like receptor signaling pathway 5595_5594_841_5970_3725_2353_1432_6348_4790 9 2.26E-07 1.62E-05 7.73E-07 3230 hsa-mir-1269 hsa05216 Thyroid cancer 1499_5595_5594_6256_595_4609 6 2.78E-07 2.00E-05 9.10E-07 3231 hsa-mir-1269 hsa05213 Endometrial cancer 1956_1499_5595_5594_595_4609_2002 7 3.79E-07 2.73E-05 1.19E-06 3232 hsa-mir-1269 hsa05223 Non-small cell lung cancer 1956_5595_5594_6256_595_1019_5925 7 4.78E-07 3.44E-05 1.44E-06 3233 hsa-mir-1269 hsa04115 p53 signaling pathway 595_1019_1017_841_1026_894_896 7 2.17E-06 0.000156373 6.25E-06 3234 hsa-mir-1269 hsa04660 T cell receptor signaling pathway 5595_5594_1019_5970_3725_2353_1432_4790 8 4.15E-06 0.000298652 1.15E-05 3235 hsa-mir-1269 hsa04910 Insulin signaling pathway 5595_5594_2308_5566_2002_808_801_805 8 1.98E-05 0.00142776 5.29E-05 3236 hsa-mir-1269 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725_2353_4790 6 4.13E-05 0.002971086 0.00010611 3237 hsa-mir-1269 hsa04510 Focal adhesion 1956_1499_5595_5594_595_3725_894_896_2002 9 5.07E-05 0.003653236 0.000125889 3238 hsa-mir-1269 hsa04330 Notch signaling pathway 388585_1387_9612_2033_8850 5 5.25E-05 0.003776676 0.000125889 3239 hsa-mir-1269 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_5970_3725_1432_4790 5 0.000320547 0.023079387 0.000744496 3240 hsa-mir-1269 hsa05211 Renal cell carcinoma 5595_5594_1387_3725_2033 5 0.000340659 0.024527444 0.000766483 3241 hsa-mir-1269 hsa04270 Vascular smooth muscle contraction 5595_5594_5566_808_801_805 6 0.000430419 0.030990183 0.000939096 3242 hsa-mir-1269 hsa04370 VEGF signaling pathway 5595_5594_9261_7867_1432 5 0.000455897 0.032824561 0.000965428 3243 hsa-mir-1269 hsa05016 Huntington's disease 25942_1385_1387_6908_6667_841_2033 7 0.000869386 0.062595762 0.00178845 3244 hsa-mir-1269 hsa04150 mTOR signaling pathway 5595_5594_6195_6196 4 0.000951791 0.068528941 0.001903582 3245 hsa-mir-1269 hsa04062 Chemokine signaling pathway 5595_5594_5566_6777_5970_6348_4790 7 0.001007496 0.072539721 0.001960533 3246 hsa-mir-1269 hsa04950 Maturity onset diabetes of the young 3651_168620_6927 3 0.00118132 0.085055076 0.002238291 3247 hsa-mir-1269 hsa05010 Alzheimer's disease 5595_5594_841_808_801_805 6 0.003173313 0.22847851 0.005858423 3248 hsa-mir-1269 hsa04020 Calcium signaling pathway 815_1956_5566_808_801_805 6 0.003813367 0.274562394 0.00686406 3249 hsa-mir-1269 hsa04120 Ubiquitin mediated proteolysis 5371_672_6502_7329_8554 5 0.005456858 0.392893783 0.009582775 3250 hsa-mir-1269 hsa04210 Apoptosis 5566_841_5970_4790 4 0.00605371 0.435867155 0.010376976 3251 hsa-mir-1269 hsa04930 Type II diabetes mellitus 5595_5594_3651 3 0.006197361 0.446209978 0.010376976 3252 hsa-mir-1269 hsa04540 Gap junction 1956_5595_5594_5566 4 0.007013701 0.504986483 0.011476966 3253 hsa-mir-1269 hsa04920 Adipocytokine signaling pathway 6256_5970_4790 3 0.017320729 1 0.027713167 3254 hsa-mir-1269 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.023788643 1 0.037234398 3255 hsa-mir-1269 hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432 3 0.026196698 1 0.040131112 3256 hsa-mir-1269 hsa03410 Base excision repair 3146_142 2 0.035203562 1 0.052805344 3257 hsa-mir-1269 hsa03022 Basal transcription factors 6908_6880 2 0.036920157 1 0.054250027 3258 hsa-mir-1269 hsa03420 Nucleotide excision repair 5981_4331 2 0.049787999 1 0.071694718 3259 hsa-mir-127 hsa05200 Pathways in cancer 1147_3320_3326_405_2249_3480_1956_5594_5595_6654_5599_5914_1387_2064_6256_595_1488_2308_1487_208_367_4193_7704_6774_6776_6777_2885_5970_8503_8554_6258_7157_4087_6688_6257_4089_2113_10401_3725_861_2736_2353_4088_5295_5925_8031_2033_207_5601_2932_4790 51 1.38E-34 1.11E-32 1.11E-32 3260 hsa-mir-127 hsa04010 MAPK signaling pathway 9479_1147_2249_994_1956_5594_5595_6722_6654_9252_5599_8986_1649_5566_208_4214_1616_1386_1432_2885_5970_627_7157_10912_9261_468_3725_3727_6195_6196_6197_2353_5058_4616_2872_207_5601_4790 38 1.37E-24 1.10E-22 5.48E-23 3261 hsa-mir-127 hsa05215 Prostate cancer 1147_3320_3326_3480_1956_5594_5595_6654_1387_2064_595_2308_208_367_4193_2885_5970_8503_7157_468_5295_5925_2033_207_2932_4790 26 2.41E-24 1.92E-22 6.14E-23 3262 hsa-mir-127 hsa05212 Pancreatic cancer 1147_3320_3326_3480_1956_5594_5595_6654_1387_2064_595_2308_208_367_4193_2885_5970_8503_7157_468_5295_5925_2033_207_2932_4790 26 3.07E-24 2.46E-22 6.14E-23 3263 hsa-mir-127 hsa05220 Chronic myeloid leukemia 1147_5594_5595_6654_595_1488_1487_208_4193_6776_6777_2885_5970_8503_7157_4089_861_4088_5295_5925_207_4790_6464 23 5.49E-22 4.39E-20 8.78E-21 3264 hsa-mir-127 hsa05221 Acute myeloid leukemia 1147_5594_5595_6654_5914_595_208_7704_6774_6776_6777_2885_5970_8503_6688_861_5295_207_4790 19 1.02E-18 8.14E-17 1.36E-17 3265 hsa-mir-127 hsa05210 Colorectal cancer 3480_1956_5594_5595_6654_5599_595_208_2885_8503_7157_4087_4089_3725_2353_4088_5295_207_5601_2932 20 1.87E-17 1.49E-15 2.13E-16 3266 hsa-mir-127 hsa04012 ErbB signaling pathway 1956_6714_5594_5595_6654_5599_2064_56924_208_6776_6777_2885_8503_3725_5295_5058_207_5601_2932_6464 20 3.36E-17 2.69E-15 3.36E-16 3267 hsa-mir-127 hsa05214 Glioma 3480_1956_5594_5595_6654_595_208_4193_2885_8503_7157_5295_5925_207_801_6464_808_805 18 7.92E-17 6.34E-15 7.04E-16 3268 hsa-mir-127 hsa05223 Non-small cell lung cancer 1956_5594_5595_6654_2064_6256_595_208_2885_8503_6258_7157_6257_5295_5925_2309_207 17 9.50E-17 7.60E-15 7.60E-16 3269 hsa-mir-127 hsa04910 Insulin signaling pathway 6720_10891_5594_5595_6654_5599_2308_5566_7249_208_5770_2885_8503_5295_2872_207_5601_2932_801_6464_808_805 22 7.77E-16 6.22E-14 5.65E-15 3270 hsa-mir-127 hsa04660 T cell receptor signaling pathway 1147_5594_5595_6654_56924_208_5777_1432_2885_5970_8503_3725_2353_5295_5058_207_5601_2932_3932_4790 20 1.76E-15 1.41E-13 1.17E-14 3271 hsa-mir-127 hsa04110 Cell cycle 994_993_891_1387_595_983_7533_4193_902_7157_4087_10912_4089_1022_4088_5925_2033_4616_2932 19 7.24E-14 5.79E-12 4.46E-13 3272 hsa-mir-127 hsa04510 Focal adhesion 9564_3480_1956_6714_5594_5595_6654_5599_2064_595_56924_208_2885_8503_857_3725_5295_5058_207_5601_2932_71_6464 23 1.66E-13 1.33E-11 9.49E-13 3273 hsa-mir-127 hsa05213 Endometrial cancer 1956_5594_5595_6654_2064_595_208_2885_8503_7157_5295_2309_207_2932 14 3.07E-13 2.46E-11 1.64E-12 3274 hsa-mir-127 hsa05211 Renal cell carcinoma 405_5594_5595_6654_1387_56924_208_2885_8503_2113_3725_5295_5058_2033_207 15 1.08E-12 8.68E-11 5.42E-12 3275 hsa-mir-127 hsa04662 B cell receptor signaling pathway 1147_5594_5595_6654_208_5777_2885_5970_8503_3725_2353_5295_207_2932_4790 15 1.82E-12 1.45E-10 8.55E-12 3276 hsa-mir-127 hsa04520 Adherens junction 1460_3480_1956_6714_5594_5595_1387_2064_5770_5777_4087_4089_4088_2033_71 15 4.11E-12 3.29E-10 1.83E-11 3277 hsa-mir-127 hsa05222 Small cell lung cancer 1147_6256_595_208_5970_8503_8554_6258_7157_6257_10401_5295_5925_207_4790 15 1.03E-11 8.22E-10 4.33E-11 3278 hsa-mir-127 hsa04912 GnRH signaling pathway 1956_6714_5594_5595_6654_5599_5566_4214_1432_2885_468_3725_5601_801_808_805 16 1.90E-11 1.52E-09 7.59E-11 3279 hsa-mir-127 hsa04062 Chemokine signaling pathway 1147_9564_5594_5595_6654_2770_5566_208_6774_6777_2885_5970_8503_5295_5058_2309_207_2932_4790_6464 20 2.23E-11 1.78E-09 8.49E-11 3280 hsa-mir-127 hsa04310 Wnt signaling pathway 1460_5518_5599_1387_595_1488_5566_1487_6423_8061_7157_4087_4089_3725_4088_2033_5601_2932 18 3.05E-11 2.44E-09 1.11E-10 3281 hsa-mir-127 hsa05218 Melanoma 2249_3480_1956_5594_5595_595_208_4193_8503_7157_5295_5925_207 13 1.46E-10 1.17E-08 5.08E-10 3282 hsa-mir-127 hsa04620 Toll-like receptor signaling pathway 1147_5594_5595_5599_208_1432_5970_8503_3725_2353_5295_207_5601_4790 14 8.57E-10 6.86E-08 2.86E-09 3283 hsa-mir-127 hsa04920 Adipocytokine signaling pathway 1147_10891_5599_6256_208_6774_5970_6258_6257_207_5601_4790 12 9.37E-10 7.50E-08 3.00E-09 3284 hsa-mir-127 hsa04630 Jak-STAT signaling pathway 6654_1387_595_208_5777_6774_6776_6777_2885_8503_8554_10401_5295_2033_3977_207 16 2.39E-09 1.91E-07 7.36E-09 3285 hsa-mir-127 hsa04720 Long-term potentiation 5594_5595_1387_5566_468_6195_6196_6197_2033_801_808_805 12 2.94E-09 2.35E-07 8.71E-09 3286 hsa-mir-127 hsa04150 mTOR signaling pathway 5594_5595_7249_208_8503_6195_6196_6197_5295_207 10 1.31E-08 1.05E-06 3.75E-08 3287 hsa-mir-127 hsa05219 Bladder cancer 1956_5594_5595_9252_2064_595_4193_7157_5925 9 3.11E-08 2.49E-06 8.58E-08 3288 hsa-mir-127 hsa05216 Thyroid cancer 5594_5595_6256_595_6258_7157_6257_8031 8 3.42E-08 2.74E-06 9.12E-08 3289 hsa-mir-127 hsa04664 Fc epsilon RI signaling pathway 5594_5595_6654_5599_208_1432_2885_8503_5295_207_5601 11 4.89E-08 3.91E-06 1.26E-07 3290 hsa-mir-127 hsa04350 TGF-beta signaling pathway 3399_6667_5518_5594_5595_1387_3398_4087_4089_4088_2033 11 1.19E-07 9.54E-06 2.98E-07 3291 hsa-mir-127 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_1956_6714_5599_1432_5970_3725_5058_5601_4790 10 1.81E-07 1.45E-05 4.40E-07 3292 hsa-mir-127 hsa04210 Apoptosis 1147_5566_208_5970_8503_823_7157_5295_207_4790 10 1.21E-06 9.65E-05 2.84E-06 3293 hsa-mir-127 hsa04115 p53 signaling pathway 891_595_983_7249_4193_7157_10912_64326_4616 9 1.34E-06 0.000107346 3.07E-06 3294 hsa-mir-127 hsa04540 Gap junction 1956_6714_5594_5592_5595_6654_2770_983_5566_2885 10 1.74E-06 0.000139102 3.86E-06 3295 hsa-mir-127 hsa04370 VEGF signaling pathway 6714_5594_5595_208_1432_8503_9261_5295_207 9 3.07E-06 0.000245567 6.64E-06 3296 hsa-mir-127 hsa04916 Melanogenesis 5594_5595_1387_2770_5566_2033_2932_801_808_805 10 4.38E-06 0.000350665 9.23E-06 3297 hsa-mir-127 hsa04930 Type II diabetes mellitus 3651_5594_5595_5599_8503_5295_5601 7 7.23E-06 0.00057874 1.48E-05 3298 hsa-mir-127 hsa04650 Natural killer cell mediated cytotoxicity 5594_5595_6654_5777_2885_8503_5295_5058_3932_6464 10 4.33E-05 0.003461493 8.65E-05 3299 hsa-mir-127 hsa04330 Notch signaling pathway 1387_1488_1487_9612_2033_8850 6 8.98E-05 0.007185666 0.00017526 3300 hsa-mir-127 hsa04120 Ubiquitin mediated proteolysis 7325_672_4214_4193_8554_10273_10401_64326_7329 9 0.000230634 0.018450687 0.000439302 3301 hsa-mir-127 hsa03022 Basal transcription factors 2965_2963_6908_2959_6881 5 0.000276651 0.022132095 0.0005147 3302 hsa-mir-127 hsa04810 Regulation of actin cytoskeleton 9564_2249_1956_5594_5595_6654_56924_8503_5295_5058_71 11 0.000393025 0.031442027 0.000714592 3303 hsa-mir-127 hsa04730 Long-term depression 3480_5518_5594_5592_5595_2770 6 0.000702184 0.056174734 0.001248327 3304 hsa-mir-127 hsa05010 Alzheimer's disease 5594_5595_1537_823_9451_2932_801_808_805 9 0.001201788 0.096143076 0.002090067 3305 hsa-mir-127 hsa05016 Huntington's disease 6667_10891_1387_6908_1537_627_7157_3064_2033 9 0.00178621 0.142896807 0.003035702 3306 hsa-mir-127 hsa04270 Vascular smooth muscle contraction 5594_5592_5595_5566_801_808_805 7 0.001821421 0.145713717 0.003035702 3307 hsa-mir-127 hsa04612 Antigen processing and presentation 3320_3326_1514_3308_4800_6890 6 0.002091308 0.167304659 0.003414381 3308 hsa-mir-127 hsa03410 Base excision repair 6996_4350_3146_142 4 0.002229209 0.178336704 0.003566734 3309 hsa-mir-127 hsa04360 Axon guidance 5998_5594_5595_2770_56924_5058_2932 7 0.003178803 0.254304204 0.004986357 3310 hsa-mir-127 hsa04530 Tight junction 1460_5518_6714_2770_208_207_71 7 0.004018612 0.321488929 0.006182479 3311 hsa-mir-127 hsa03420 Nucleotide excision repair 2965_4331_902_1022 4 0.00435242 0.34819359 0.00656969 3312 hsa-mir-127 hsa04070 Phosphatidylinositol signaling system 8503_5295_801_808_805 5 0.005372557 0.429804528 0.007959343 3313 hsa-mir-127 hsa04950 Maturity onset diabetes of the young 3172_3651_6927 3 0.006015355 0.481228395 0.008749607 3314 hsa-mir-127 hsa04670 Leukocyte transendothelial migration 9564_2770_1432_8503_5295_71 6 0.008943118 0.715449444 0.012775883 3315 hsa-mir-127 hsa03320 PPAR signaling pathway 6256_6258_6257_2168 4 0.019469445 1 0.027325537 3316 hsa-mir-127 hsa05217 Basal cell carcinoma 7157_2736_2932 3 0.046433992 1 0.064046886 3317 hsa-mir-127 hsa05014 Amyotrophic lateral sclerosis (ALS) 1616_1432_7157 3 0.048437115 1 0.065677443 3318 hsa-mir-127 hsa04020 Calcium signaling pathway 1956_2064_5566_801_808_805 6 0.049428923 1 0.06590523 3319 hsa-mir-1271 hsa04350 TGF-beta signaling pathway 6667_1387_5595_5594_3399 5 1.46E-09 6.55E-08 6.55E-08 3320 hsa-mir-1271 hsa05215 Prostate cancer 1387_5595_5594_2932 4 1.91E-07 8.58E-06 2.99E-06 3321 hsa-mir-1271 hsa05212 Pancreatic cancer 1387_5595_5594_2932 4 1.99E-07 8.97E-06 2.99E-06 3322 hsa-mir-1271 hsa04916 Melanogenesis 1387_5595_5594_2932 4 3.64E-07 1.64E-05 4.09E-06 3323 hsa-mir-1271 hsa04910 Insulin signaling pathway 5595_5594_2932_23265 4 1.09E-06 4.90E-05 9.80E-06 3324 hsa-mir-1271 hsa05213 Endometrial cancer 5595_5594_2932 3 3.89E-06 0.000174901 2.92E-05 3325 hsa-mir-1271 hsa05211 Renal cell carcinoma 1387_5595_5594 3 9.93E-06 0.00044703 5.59E-05 3326 hsa-mir-1271 hsa04720 Long-term potentiation 1387_5595_5594 3 1.12E-05 0.000503111 5.59E-05 3327 hsa-mir-1271 hsa04662 B cell receptor signaling pathway 5595_5594_2932 3 1.12E-05 0.000503111 5.59E-05 3328 hsa-mir-1271 hsa04520 Adherens junction 1387_5595_5594 3 1.35E-05 0.000606571 6.07E-05 3329 hsa-mir-1271 hsa05210 Colorectal cancer 5595_5594_2932 3 1.55E-05 0.000698769 6.35E-05 3330 hsa-mir-1271 hsa04012 ErbB signaling pathway 5595_5594_2932 3 1.72E-05 0.00077367 6.45E-05 3331 hsa-mir-1271 hsa05200 Pathways in cancer 1387_5595_5594_2932 4 3.27E-05 0.00147198 0.000109254 3332 hsa-mir-1271 hsa04660 T cell receptor signaling pathway 5595_5594_2932 3 3.40E-05 0.001529551 0.000109254 3333 hsa-mir-1271 hsa04360 Axon guidance 5595_5594_2932 3 5.65E-05 0.002542627 0.000169508 3334 hsa-mir-1271 hsa05010 Alzheimer's disease 5595_5594_2932 3 0.000135548 0.006099643 0.000368018 3335 hsa-mir-1271 hsa05216 Thyroid cancer 5595_5594 2 0.000139029 0.006256313 0.000368018 3336 hsa-mir-1271 hsa04062 Chemokine signaling pathway 5595_5594_2932 3 0.000174263 0.007841852 0.000435658 3337 hsa-mir-1271 hsa04510 Focal adhesion 5595_5594_2932 3 0.000210531 0.009473916 0.000498627 3338 hsa-mir-1271 hsa05219 Bladder cancer 5595_5594 2 0.00028162 0.012672913 0.000633646 3339 hsa-mir-1271 hsa04930 Type II diabetes mellitus 5595_5594 2 0.000321488 0.014466956 0.000688903 3340 hsa-mir-1271 hsa04150 mTOR signaling pathway 5595_5594 2 0.000424587 0.019106402 0.000868473 3341 hsa-mir-1271 hsa05223 Non-small cell lung cancer 5595_5594 2 0.000456624 0.02054806 0.000893394 3342 hsa-mir-1271 hsa05221 Acute myeloid leukemia 5595_5594 2 0.000541709 0.024376889 0.001015704 3343 hsa-mir-1271 hsa05214 Glioma 5595_5594 2 0.000653185 0.029393313 0.001175733 3344 hsa-mir-1271 hsa05218 Melanoma 5595_5594 2 0.000774828 0.034867262 0.00129138 3345 hsa-mir-1271 hsa04730 Long-term depression 5595_5594 2 0.000774828 0.034867262 0.00129138 3346 hsa-mir-1271 hsa05220 Chronic myeloid leukemia 5595_5594 2 0.000861541 0.038769362 0.00138462 3347 hsa-mir-1271 hsa04370 VEGF signaling pathway 5595_5594 2 0.000906576 0.040795942 0.001406757 3348 hsa-mir-1271 hsa04664 Fc epsilon RI signaling pathway 5595_5594 2 0.000952728 0.042872739 0.001429091 3349 hsa-mir-1271 hsa04540 Gap junction 5595_5594 2 0.001306839 0.058807753 0.001897024 3350 hsa-mir-1271 hsa04620 Toll-like receptor signaling pathway 5595_5594 2 0.001562935 0.070332068 0.002197877 3351 hsa-mir-1271 hsa04912 GnRH signaling pathway 5595_5594 2 0.001745914 0.07856611 0.002380791 3352 hsa-mir-1271 hsa04270 Vascular smooth muscle contraction 5595_5594 2 0.002072466 0.09326096 0.002708481 3353 hsa-mir-1271 hsa04110 Cell cycle 1387_2932 2 0.002106596 0.094796841 0.002708481 3354 hsa-mir-1271 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594 2 0.002805524 0.126248575 0.003460069 3355 hsa-mir-1271 hsa04120 Ubiquitin mediated proteolysis 55294_7329 2 0.002844945 0.128022535 0.003460069 3356 hsa-mir-1271 hsa04310 Wnt signaling pathway 1387_2932 2 0.003381133 0.152150991 0.004003973 3357 hsa-mir-1271 hsa05016 Huntington's disease 6667_1387 2 0.005091795 0.229130791 0.005875148 3358 hsa-mir-1271 hsa04810 Regulation of actin cytoskeleton 5595_5594 2 0.006823388 0.307052456 0.007676311 3359 hsa-mir-1271 hsa04010 MAPK signaling pathway 5595_5594 2 0.01038693 0.467411838 0.011400289 3360 hsa-mir-1271 hsa04330 Notch signaling pathway 1387 1 0.026846659 1 0.028764278 3361 hsa-mir-1271 hsa05217 Basal cell carcinoma 2932 1 0.031254607 1 0.03270831 3362 hsa-mir-1271 hsa04340 Hedgehog signaling pathway 2932 1 0.032353654 1 0.033088964 3363 hsa-mir-1272 hsa04720 Long-term potentiation 5595_5594_1387_6197_6195_6196_2033_808_801_805 10 1.54E-12 9.38E-11 9.38E-11 3364 hsa-mir-1272 hsa05200 Pathways in cancer 5371_1499_5595_5594_1387_9915_2932_3091_862_6502_2736_5925_2034_2033_207 15 8.68E-12 5.29E-10 2.65E-10 3365 hsa-mir-1272 hsa04010 MAPK signaling pathway 6722_8986_5595_5594_9261_4208_6197_9252_7867_1432_6195_6196_207 13 1.24E-10 7.55E-09 2.52E-09 3366 hsa-mir-1272 hsa04916 Melanogenesis 1499_5595_5594_1387_2932_2033_808_801_805 9 7.30E-10 4.45E-08 1.11E-08 3367 hsa-mir-1272 hsa05211 Renal cell carcinoma 5595_5594_1387_9915_3091_2034_2033_207 8 1.07E-09 6.53E-08 1.31E-08 3368 hsa-mir-1272 hsa04150 mTOR signaling pathway 5595_5594_6197_3091_6195_6196_207 7 3.62E-09 2.21E-07 3.42E-08 3369 hsa-mir-1272 hsa04350 TGF-beta signaling pathway 5595_5594_1387_3397_3399_3398_2033_4093 8 4.27E-09 2.60E-07 3.42E-08 3370 hsa-mir-1272 hsa05215 Prostate cancer 1499_5595_5594_1387_2932_5925_2033_207 8 4.64E-09 2.83E-07 3.42E-08 3371 hsa-mir-1272 hsa05212 Pancreatic cancer 1499_5595_5594_1387_2932_5925_2033_207 8 5.04E-09 3.08E-07 3.42E-08 3372 hsa-mir-1272 hsa05214 Glioma 5595_5594_5925_207_808_801_805 7 1.50E-08 9.14E-07 9.14E-08 3373 hsa-mir-1272 hsa04370 VEGF signaling pathway 5595_5594_9261_7867_1432_207 6 9.87E-07 6.02E-05 5.47E-06 3374 hsa-mir-1272 hsa04520 Adherens junction 1499_5595_5594_1387_1457_2033 6 1.22E-06 7.42E-05 6.19E-06 3375 hsa-mir-1272 hsa04910 Insulin signaling pathway 5595_5594_2932_207_808_801_805 7 1.85E-06 0.000112912 8.64E-06 3376 hsa-mir-1272 hsa04330 Notch signaling pathway 388585_1387_9612_2033_8850 5 1.98E-06 0.000120904 8.64E-06 3377 hsa-mir-1272 hsa05213 Endometrial cancer 1499_5595_5594_2932_207 5 3.14E-06 0.000191741 1.28E-05 3378 hsa-mir-1272 hsa05221 Acute myeloid leukemia 5371_5595_5594_862_207 5 5.60E-06 0.00034154 2.13E-05 3379 hsa-mir-1272 hsa04912 GnRH signaling pathway 5595_5594_1432_808_801_805 6 6.31E-06 0.000384951 2.26E-05 3380 hsa-mir-1272 hsa04270 Vascular smooth muscle contraction 5592_5595_5594_808_801_805 6 1.02E-05 0.000624217 3.47E-05 3381 hsa-mir-1272 hsa05210 Colorectal cancer 1499_5595_5594_2932_207 5 2.82E-05 0.001718736 9.05E-05 3382 hsa-mir-1272 hsa05219 Bladder cancer 5595_5594_9252_5925 4 3.32E-05 0.002028218 0.000101411 3383 hsa-mir-1272 hsa05223 Non-small cell lung cancer 5595_5594_5925_207 4 8.33E-05 0.00508404 0.000242097 3384 hsa-mir-1272 hsa05010 Alzheimer's disease 5595_5594_2932_808_801_805 6 9.11E-05 0.005557024 0.000252592 3385 hsa-mir-1272 hsa04660 T cell receptor signaling pathway 5595_5594_2932_1432_207 5 9.60E-05 0.005856923 0.000254649 3386 hsa-mir-1272 hsa04110 Cell cycle 1387_2932_6502_5925_2033 5 0.000136935 0.008353023 0.000348043 3387 hsa-mir-1272 hsa05218 Melanoma 5595_5594_5925_207 4 0.000226741 0.013831176 0.000553247 3388 hsa-mir-1272 hsa05216 Thyroid cancer 1499_5595_5594 3 0.000274327 0.016733917 0.000603259 3389 hsa-mir-1272 hsa05220 Chronic myeloid leukemia 5595_5594_5925_207 4 0.000276906 0.016891245 0.000603259 3390 hsa-mir-1272 hsa04662 B cell receptor signaling pathway 5595_5594_2932_207 4 0.000276906 0.016891245 0.000603259 3391 hsa-mir-1272 hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432_207 4 0.00033458 0.020409379 0.000703772 3392 hsa-mir-1272 hsa04310 Wnt signaling pathway 1499_1387_2932_1457_2033 5 0.000408841 0.024939279 0.000831309 3393 hsa-mir-1272 hsa04012 ErbB signaling pathway 5595_5594_2932_207 4 0.000474953 0.028972146 0.000934585 3394 hsa-mir-1272 hsa04620 Toll-like receptor signaling pathway 5595_5594_1432_207 4 0.000843577 0.051458215 0.001608069 3395 hsa-mir-1272 hsa04930 Type II diabetes mellitus 3651_5595_5594 3 0.000913595 0.055729265 0.001688766 3396 hsa-mir-1272 hsa04510 Focal adhesion 1499_5595_5594_2932_207 5 0.001539833 0.093929826 0.002760267 3397 hsa-mir-1272 hsa05217 Basal cell carcinoma 1499_2932_2736 3 0.00158376 0.096609336 0.002760267 3398 hsa-mir-1272 hsa04120 Ubiquitin mediated proteolysis 7329_5371_672_6502 4 0.002536256 0.154711646 0.004297546 3399 hsa-mir-1272 hsa04730 Long-term depression 5592_5595_5594 3 0.003178324 0.193877777 0.00523994 3400 hsa-mir-1272 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.003822262 0.233157968 0.006135736 3401 hsa-mir-1272 hsa04950 Maturity onset diabetes of the young 3651_168620 2 0.004728351 0.288429397 0.007395626 3402 hsa-mir-1272 hsa05222 Small cell lung cancer 6502_5925_207 3 0.005334706 0.32541709 0.008135427 3403 hsa-mir-1272 hsa04540 Gap junction 5592_5595_5594 3 0.006579337 0.401339531 0.009788769 3404 hsa-mir-1272 hsa04062 Chemokine signaling pathway 5595_5594_2932_207 4 0.007858104 0.479344372 0.011412961 3405 hsa-mir-1272 hsa04360 Axon guidance 5595_5594_2932 3 0.016209833 0.988799824 0.022995345 3406 hsa-mir-1272 hsa04530 Tight junction 1499_1457_207 3 0.018193217 1 0.025222414 3407 hsa-mir-1272 hsa04340 Hedgehog signaling pathway 2932_2736 2 0.022875092 1 0.031008458 3408 hsa-mir-1272 hsa04630 Jak-STAT signaling pathway 1387_2033_207 3 0.02491943 1 0.033045331 3409 hsa-mir-1272 hsa04020 Calcium signaling pathway 808_801_805 3 0.038199013 1 0.049577442 3410 hsa-mir-1272 hsa05016 Huntington's disease 1387_3064_2033 3 0.040264047 1 0.051168893 3411 hsa-mir-1273 hsa05215 Prostate cancer 2033_367 2 0.001630478 0.026087648 0.013331624 3412 hsa-mir-1273 hsa05212 Pancreatic cancer 2033_367 2 0.001666453 0.026663248 0.013331624 3413 hsa-mir-1273 hsa05200 Pathways in cancer 2033_367 2 0.020546316 0.328741053 0.073494042 3414 hsa-mir-1273 hsa03410 Base excision repair 3146 1 0.024371354 0.389941658 0.073494042 3415 hsa-mir-1273 hsa03420 Nucleotide excision repair 4331 1 0.029566123 0.473057967 0.073494042 3416 hsa-mir-1273 hsa04330 Notch signaling pathway 2033 1 0.031507378 0.504118054 0.073494042 3417 hsa-mir-1273 hsa03050 Proteasome 5705 1 0.032153643 0.514458293 0.073494042 3418 hsa-mir-1273 hsa05211 Renal cell carcinoma 2033 1 0.047541657 0.760666506 0.08296848 3419 hsa-mir-1273 hsa04720 Long-term potentiation 2033 1 0.049448734 0.791179745 0.08296848 3420 hsa-mir-1273c hsa04310 Wnt signaling pathway 595_2033_894_896_3725_1387 6 5.21E-09 1.67E-07 1.67E-07 3421 hsa-mir-1273c hsa04110 Cell cycle 595_2033_894_896_1387 5 8.31E-08 2.66E-06 1.33E-06 3422 hsa-mir-1273c hsa04630 Jak-STAT signaling pathway 595_2033_894_896_1387 5 2.96E-07 9.48E-06 3.16E-06 3423 hsa-mir-1273c hsa05200 Pathways in cancer 595_2033_367_3725_1387_2353 6 4.72E-07 1.51E-05 3.78E-06 3424 hsa-mir-1273c hsa05215 Prostate cancer 595_2033_367_1387 4 1.37E-06 4.39E-05 7.64E-06 3425 hsa-mir-1273c hsa05212 Pancreatic cancer 595_2033_367_1387 4 1.43E-06 4.58E-05 7.64E-06 3426 hsa-mir-1273c hsa04330 Notch signaling pathway 9612_2033_1387 3 1.24E-05 0.000395324 5.65E-05 3427 hsa-mir-1273c hsa04510 Focal adhesion 595_894_896_3725 4 3.60E-05 0.001150823 0.000131907 3428 hsa-mir-1273c hsa04115 p53 signaling pathway 595_894_896 3 3.71E-05 0.001187161 0.000131907 3429 hsa-mir-1273c hsa05211 Renal cell carcinoma 2033_3725_1387 3 4.19E-05 0.001341702 0.00013417 3430 hsa-mir-1273c hsa05210 Colorectal cancer 595_3725_2353 3 6.53E-05 0.002091004 0.000190091 3431 hsa-mir-1273c hsa05016 Huntington's disease 2033_25942_1387 3 0.000662189 0.021190052 0.001765838 3432 hsa-mir-1273c hsa04720 Long-term potentiation 2033_1387 2 0.002185478 0.069935297 0.004995378 3433 hsa-mir-1273c hsa04662 B cell receptor signaling pathway 3725_2353 2 0.002185478 0.069935297 0.004995378 3434 hsa-mir-1273c hsa04520 Adherens junction 2033_1387 2 0.002473657 0.079157024 0.005277135 3435 hsa-mir-1273c hsa04350 TGF-beta signaling pathway 2033_1387 2 0.002905572 0.092978298 0.005811144 3436 hsa-mir-1273c hsa04620 Toll-like receptor signaling pathway 3725_2353 2 0.003941193 0.126118187 0.007271931 3437 hsa-mir-1273c hsa04916 Melanogenesis 2033_1387 2 0.004090461 0.130894763 0.007271931 3438 hsa-mir-1273c hsa04660 T cell receptor signaling pathway 3725_2353 2 0.004553845 0.145723044 0.007669634 3439 hsa-mir-1273c hsa04010 MAPK signaling pathway 3725_2353 2 0.025232456 0.807438607 0.04037193 3440 hsa-mir-1273c hsa05216 Thyroid cancer 595 1 0.026639638 0.852468432 0.040593735 3441 hsa-mir-1273c hsa05219 Bladder cancer 595 1 0.037970041 1 0.055229151 3442 hsa-mir-1273c hsa05213 Endometrial cancer 595 1 0.046599202 1 0.064421422 3443 hsa-mir-1273c hsa05223 Non-small cell lung cancer 595 1 0.048316067 1 0.064421422 3444 hsa-mir-1273d hsa05200 Pathways in cancer 1869_5371_367_1499_5595_5594_5914_1387_6256_595_836_1019_1017_2932_4149_7704_3091_5970_7428_2735_1870_1871_7157_4087_6688_2113_4609_3725_1026_2736_2737_4088_4089_3066_3065_1050_5925_2034_2033_4846_207_8554 42 1.52E-38 1.08E-36 1.08E-36 3445 hsa-mir-1273d hsa04110 Cell cycle 1869_5591_1387_595_1019_1017_2932_7027_1870_1871_7157_4087_1026_4088_4089_3066_3065_5925_2033_890_5934_5933 22 1.05E-23 7.44E-22 3.72E-22 3446 hsa-mir-1273d hsa05220 Chronic myeloid leukemia 1869_5595_5594_595_1019_5970_1870_1871_7157_4609_1026_4088_4089_3066_3065_5925_207_6464 18 2.23E-21 1.58E-19 5.27E-20 3447 hsa-mir-1273d hsa05215 Prostate cancer 1869_367_1499_5595_5594_1387_595_1017_2932_5970_1870_1871_7157_468_1026_5925_2033_207 18 2.73E-20 1.94E-18 4.64E-19 3448 hsa-mir-1273d hsa05212 Pancreatic cancer 1869_367_1499_5595_5594_1387_595_1017_2932_5970_1870_1871_7157_468_1026_5925_2033_207 18 3.26E-20 2.32E-18 4.64E-19 3449 hsa-mir-1273d hsa04010 MAPK signaling pathway 5595_5594_6722_9261_4208_836_6195_6197_9252_4149_1386_1432_1649_5970_3312_7157_468_4609_3725_3727_6196_8986_4763_207 24 7.20E-19 5.11E-17 8.52E-18 3450 hsa-mir-1273d hsa05222 Small cell lung cancer 1869_6256_595_1019_1017_4149_5970_1870_1871_7157_4609_5925_4846_207_8554 15 3.41E-16 2.42E-14 3.46E-15 3451 hsa-mir-1273d hsa05219 Bladder cancer 1869_5595_5594_595_1019_9252_1870_1871_7157_4609_1026_5925 12 1.96E-15 1.39E-13 1.74E-14 3452 hsa-mir-1273d hsa05210 Colorectal cancer 1499_5595_5594_595_836_2932_7157_4087_4609_3725_4088_4089_207 13 1.33E-13 9.44E-12 1.05E-12 3453 hsa-mir-1273d hsa05214 Glioma 1869_5595_5594_595_1019_1870_1871_7157_1026_5925_207_6464 12 1.83E-13 1.30E-11 1.29E-12 3454 hsa-mir-1273d hsa04350 TGF-beta signaling pathway 5595_5594_1387_7027_1874_1875_4087_4609_4088_4089_2033_5934_5933 13 1.99E-13 1.41E-11 1.29E-12 3455 hsa-mir-1273d hsa05223 Non-small cell lung cancer 1869_5595_5594_6256_595_1019_1870_1871_7157_5925_207 11 7.36E-13 5.23E-11 4.36E-12 3456 hsa-mir-1273d hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_5970_6688_4609_1050_207 11 1.73E-12 1.23E-10 9.44E-12 3457 hsa-mir-1273d hsa05218 Melanoma 1869_5595_5594_595_1019_1870_1871_7157_1026_5925_207 11 1.04E-11 7.39E-10 5.28E-11 3458 hsa-mir-1273d hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2113_3725_2034_2033_207 10 2.44E-10 1.73E-08 1.15E-09 3459 hsa-mir-1273d hsa04310 Wnt signaling pathway 1499_1387_595_2932_7157_4087_4609_3725_1457_4088_4089_2033 12 1.55E-09 1.10E-07 6.88E-09 3460 hsa-mir-1273d hsa05216 Thyroid cancer 1499_5595_5594_6256_595_7157_4609 7 4.37E-09 3.10E-07 1.83E-08 3461 hsa-mir-1273d hsa04720 Long-term potentiation 5595_5594_1387_2902_6195_6197_468_6196_2033 9 6.34E-09 4.50E-07 2.50E-08 3462 hsa-mir-1273d hsa05213 Endometrial cancer 1499_5595_5594_595_2932_7157_4609_207 8 7.71E-09 5.47E-07 2.88E-08 3463 hsa-mir-1273d hsa04520 Adherens junction 1499_5595_5594_1387_4087_1457_4088_4089_2033 9 1.06E-08 7.54E-07 3.77E-08 3464 hsa-mir-1273d hsa04150 mTOR signaling pathway 5595_5594_6195_6197_3091_6196_207 7 1.57E-07 1.11E-05 5.29E-07 3465 hsa-mir-1273d hsa04012 ErbB signaling pathway 5595_5594_2932_4609_3725_1026_207_6464 8 2.99E-07 2.12E-05 9.64E-07 3466 hsa-mir-1273d hsa04660 T cell receptor signaling pathway 5595_5594_1019_2932_1432_5970_3725_207 8 1.57E-06 0.000111632 4.85E-06 3467 hsa-mir-1273d hsa05217 Basal cell carcinoma 1499_2932_2735_7157_2736_2737 6 3.80E-06 0.000269815 1.12E-05 3468 hsa-mir-1273d hsa05016 Huntington's disease 6874_1387_2902_836_7157_3066_3065_3064_2033 9 9.08E-06 0.000644753 2.58E-05 3469 hsa-mir-1273d hsa04115 p53 signaling pathway 595_836_1019_1017_7157_1026 6 1.27E-05 0.000903935 3.48E-05 3470 hsa-mir-1273d hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_3725_207 6 1.98E-05 0.001408319 5.22E-05 3471 hsa-mir-1273d hsa04370 VEGF signaling pathway 5595_5594_9261_1432_4846_207 6 2.28E-05 0.001619496 5.78E-05 3472 hsa-mir-1273d hsa04330 Notch signaling pathway 1387_9612_3066_3065_2033 5 2.81E-05 0.001998308 6.89E-05 3473 hsa-mir-1273d hsa05010 Alzheimer's disease 5595_5594_823_2902_836_2932_9451_4846 8 4.25E-05 0.003019254 0.000100642 3474 hsa-mir-1273d hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_1432_7157_4846 5 6.13E-05 0.004352417 0.000140401 3475 hsa-mir-1273d hsa04620 Toll-like receptor signaling pathway 5595_5594_1432_5970_3725_207 6 0.000100423 0.007130009 0.000222813 3476 hsa-mir-1273d hsa04916 Melanogenesis 1499_5595_5594_1387_2932_2033 6 0.000111144 0.007891212 0.000239128 3477 hsa-mir-1273d hsa04510 Focal adhesion 1499_5595_5594_595_2932_3725_207_6464 8 0.000117713 0.00835763 0.000245813 3478 hsa-mir-1273d hsa04210 Apoptosis 823_836_5970_7157_207 5 0.000471637 0.033486217 0.000941924 3479 hsa-mir-1273d hsa04910 Insulin signaling pathway 6720_5595_5594_2932_207_6464 6 0.000477596 0.033909281 0.000941924 3480 hsa-mir-1273d hsa04340 Hedgehog signaling pathway 2932_2735_2736_2737 4 0.00080901 0.057439712 0.001552425 3481 hsa-mir-1273d hsa04630 Jak-STAT signaling pathway 1387_595_4609_2033_207_8554 6 0.000857685 0.06089567 0.001602518 3482 hsa-mir-1273d hsa04912 GnRH signaling pathway 5595_5594_1432_468_3725 5 0.001086695 0.077155361 0.001978343 3483 hsa-mir-1273d hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_1432_5970_3725 4 0.00174964 0.124224426 0.003029864 3484 hsa-mir-1273d hsa04730 Long-term depression 5592_5595_5594_4846 4 0.00174964 0.124224426 0.003029864 3485 hsa-mir-1273d hsa04062 Chemokine signaling pathway 5595_5594_2932_5970_207_6464 6 0.002518376 0.178804686 0.004187029 3486 hsa-mir-1273d hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432_207 4 0.002535806 0.180042258 0.004187029 3487 hsa-mir-1273d hsa04930 Type II diabetes mellitus 3651_5595_5594 3 0.004314071 0.306299013 0.006961341 3488 hsa-mir-1273d hsa04920 Adipocytokine signaling pathway 6256_5970_207 3 0.01224135 0.869135858 0.01931413 3489 hsa-mir-1273d hsa04950 Maturity onset diabetes of the young 3651_6927 2 0.013507957 0.959064933 0.020849238 3490 hsa-mir-1273d hsa04530 Tight junction 1499_1019_1457_207 4 0.016063861 1 0.024266684 3491 hsa-mir-1273d hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_6464 4 0.016443665 1 0.024322921 3492 hsa-mir-1273d hsa04120 Ubiquitin mediated proteolysis 5371_672_7428_8554 4 0.016829059 1 0.024384963 3493 hsa-mir-1273d hsa04612 Antigen processing and presentation 4800_4801_3312 3 0.025199351 1 0.035783079 3494 hsa-mir-1273d hsa04540 Gap junction 5592_5595_5594 3 0.028114111 1 0.039139253 3495 hsa-mir-1273d hsa03022 Basal transcription factors 2963_6874 2 0.029071409 1 0.039693655 3496 hsa-mir-1277 hsa04310 Wnt signaling pathway 6423_5599 2 0.000717967 0.016513243 0.016513243 3497 hsa-mir-1277 hsa04010 MAPK signaling pathway 9479_5599 2 0.002259216 0.051961969 0.025365731 3498 hsa-mir-1277 hsa05200 Pathways in cancer 5599_5925 2 0.003308574 0.076097192 0.025365731 3499 hsa-mir-1277 hsa05219 Bladder cancer 5925 1 0.011407604 0.2623749 0.030342088 3500 hsa-mir-1277 hsa04930 Type II diabetes mellitus 5599 1 0.012199217 0.280581992 0.030342088 3501 hsa-mir-1277 hsa05223 Non-small cell lung cancer 5925 1 0.014570728 0.335126752 0.030342088 3502 hsa-mir-1277 hsa05214 Glioma 5925 1 0.017462476 0.401636937 0.030342088 3503 hsa-mir-1277 hsa04920 Adipocytokine signaling pathway 5599 1 0.017987449 0.413711332 0.030342088 3504 hsa-mir-1277 hsa05218 Melanoma 5925 1 0.01903666 0.437843189 0.030342088 3505 hsa-mir-1277 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599 1 0.01903666 0.437843189 0.030342088 3506 hsa-mir-1277 hsa05220 Chronic myeloid leukemia 5925 1 0.020084891 0.461952482 0.030342088 3507 hsa-mir-1277 hsa04664 Fc epsilon RI signaling pathway 5599 1 0.02113214 0.486039231 0.030342088 3508 hsa-mir-1277 hsa05210 Colorectal cancer 5599 1 0.022439826 0.516115989 0.030342088 3509 hsa-mir-1277 hsa05222 Small cell lung cancer 5925 1 0.022962472 0.528136845 0.030342088 3510 hsa-mir-1277 hsa04350 TGF-beta signaling pathway 3398 1 0.023223703 0.534145164 0.030342088 3511 hsa-mir-1277 hsa04012 ErbB signaling pathway 5599 1 0.023223703 0.534145164 0.030342088 3512 hsa-mir-1277 hsa05215 Prostate cancer 5925 1 0.023484873 0.540152077 0.030342088 3513 hsa-mir-1277 hsa05212 Pancreatic cancer 5925 1 0.023745982 0.546157584 0.030342088 3514 hsa-mir-1277 hsa04620 Toll-like receptor signaling pathway 5599 1 0.027134844 0.62410142 0.032847443 3515 hsa-mir-1277 hsa04912 GnRH signaling pathway 5599 1 0.02869546 0.659995577 0.032999779 3516 hsa-mir-1277 hsa04110 Cell cycle 5925 1 0.0315509 0.725670696 0.034555747 3517 hsa-mir-1277 hsa04910 Insulin signaling pathway 5599 1 0.036465726 0.838711693 0.038123259 3518 hsa-mir-1278 hsa05200 Pathways in cancer 3320_3326_1871_1387_6256_1487_1488_9915_1019_1017_2932_3265_4149_5578_3091_5371_1870_7157_4087_1869_3725_6774_4088_4089_3065_1050_5925_2034_2033 29 9.77E-29 6.55E-27 6.55E-27 3519 hsa-mir-1278 hsa04110 Cell cycle 890_1871_1387_1019_1017_2932_1870_7157_4087_1869_1028_4088_4089_3065_5925_2033_5934_5933 18 5.42E-22 3.63E-20 1.82E-20 3520 hsa-mir-1278 hsa04350 TGF-beta signaling pathway 3400_1387_6667_3397_3399_3398_1874_1875_4087_4088_4089_2033_4093_4092_5934_5933 16 7.04E-21 4.72E-19 1.57E-19 3521 hsa-mir-1278 hsa05220 Chronic myeloid leukemia 1871_1487_1488_1019_3265_1870_7157_1869_4088_4089_3065_5925 12 2.76E-15 1.85E-13 4.63E-14 3522 hsa-mir-1278 hsa05215 Prostate cancer 3320_3326_1871_1387_1017_2932_3265_1870_7157_1869_5925_2033 12 1.56E-14 1.05E-12 1.97E-13 3523 hsa-mir-1278 hsa05212 Pancreatic cancer 3320_3326_1871_1387_1017_2932_3265_1870_7157_1869_5925_2033 12 1.77E-14 1.18E-12 1.97E-13 3524 hsa-mir-1278 hsa05214 Glioma 1871_1019_3265_5578_1870_7157_1869_5925_808_801_805 11 2.38E-14 1.60E-12 2.28E-13 3525 hsa-mir-1278 hsa04310 Wnt signaling pathway 1387_1487_1488_2932_5578_7157_4087_3725_1457_4088_4089_2033 12 6.20E-12 4.15E-10 4.92E-11 3526 hsa-mir-1278 hsa05223 Non-small cell lung cancer 1871_6256_1019_3265_5578_1870_7157_1869_5925 9 6.61E-12 4.43E-10 4.92E-11 3527 hsa-mir-1278 hsa04720 Long-term potentiation 1387_2902_2906_3265_5578_2033_808_801_805 9 9.54E-11 6.39E-09 6.39E-10 3528 hsa-mir-1278 hsa05222 Small cell lung cancer 1871_6256_1019_1017_4149_1870_7157_1869_5925 9 2.93E-10 1.96E-08 1.78E-09 3529 hsa-mir-1278 hsa05219 Bladder cancer 1871_1019_3265_1870_7157_1869_5925 7 1.57E-09 1.05E-07 8.75E-09 3530 hsa-mir-1278 hsa04330 Notch signaling pathway 1387_1487_1488_9612_3065_2033_8850 7 3.18E-09 2.13E-07 1.64E-08 3531 hsa-mir-1278 hsa04916 Melanogenesis 1387_2932_3265_5578_2033_808_801_805 8 2.80E-08 1.87E-06 1.34E-07 3532 hsa-mir-1278 hsa05218 Melanoma 1871_1019_3265_1870_7157_1869_5925 7 4.35E-08 2.92E-06 1.95E-07 3533 hsa-mir-1278 hsa05211 Renal cell carcinoma 1387_9915_3265_3091_3725_2034_2033 7 4.76E-08 3.19E-06 1.99E-07 3534 hsa-mir-1278 hsa04912 GnRH signaling pathway 3265_1432_5578_3725_808_801_805 7 6.34E-07 4.25E-05 2.50E-06 3535 hsa-mir-1278 hsa04520 Adherens junction 1387_4087_1457_4088_4089_2033 6 1.86E-06 0.000124658 6.93E-06 3536 hsa-mir-1278 hsa05210 Colorectal cancer 2932_7157_4087_3725_4088_4089 6 2.43E-06 0.00016281 8.57E-06 3537 hsa-mir-1278 hsa04010 MAPK signaling pathway 6722_3265_4149_1432_5578_4342_7157_22800_3725 9 3.50E-06 0.000234638 1.17E-05 3538 hsa-mir-1278 hsa05010 Alzheimer's disease 2902_2906_2932_808_351_801_805 7 1.43E-05 0.000960988 4.58E-05 3539 hsa-mir-1278 hsa05016 Huntington's disease 1387_2902_6667_7157_3065_2033_9519 7 2.09E-05 0.001397554 6.35E-05 3540 hsa-mir-1278 hsa04530 Tight junction 1019_3265_5578_22800_8573_1457 6 3.47E-05 0.002324663 0.000101072 3541 hsa-mir-1278 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906_1432_7157 4 0.000126073 0.008446875 0.000351953 3542 hsa-mir-1278 hsa04660 T cell receptor signaling pathway 1019_2932_3265_1432_3725 5 0.000135163 0.009055899 0.000362236 3543 hsa-mir-1278 hsa05221 Acute myeloid leukemia 3265_5371_6774_1050 4 0.000152496 0.010217238 0.000392971 3544 hsa-mir-1278 hsa04020 Calcium signaling pathway 2902_2906_5578_808_801_805 6 0.00016668 0.011167554 0.000413613 3545 hsa-mir-1278 hsa05216 Thyroid cancer 6256_3265_7157 3 0.000339503 0.022746685 0.000812382 3546 hsa-mir-1278 hsa04910 Insulin signaling pathway 2932_3265_808_801_805 5 0.000372008 0.024924563 0.000855332 3547 hsa-mir-1278 hsa04070 Phosphatidylinositol signaling system 5578_808_801_805 4 0.000382984 0.025659961 0.000855332 3548 hsa-mir-1278 hsa04012 ErbB signaling pathway 2932_3265_5578_3725 4 0.000624345 0.041831087 0.00134939 3549 hsa-mir-1278 hsa05213 Endometrial cancer 2932_3265_7157 3 0.001672398 0.112050656 0.003501583 3550 hsa-mir-1278 hsa04270 Vascular smooth muscle contraction 5578_808_801_805 4 0.00185464 0.124260853 0.00376548 3551 hsa-mir-1278 hsa04115 p53 signaling pathway 1019_1017_7157 3 0.003607799 0.241722523 0.007109486 3552 hsa-mir-1278 hsa04662 B cell receptor signaling pathway 2932_3265_3725 3 0.004517931 0.30270138 0.008648611 3553 hsa-mir-1278 hsa04370 VEGF signaling pathway 3265_1432_5578 3 0.00484935 0.324906462 0.00902518 3554 hsa-mir-1278 hsa04664 Fc epsilon RI signaling pathway 3265_1432_5578 3 0.005195089 0.348070943 0.009407323 3555 hsa-mir-1278 hsa03022 Basal transcription factors 2963_9519 2 0.011975762 0.802376058 0.021115159 3556 hsa-mir-1278 hsa04510 Focal adhesion 2932_3265_5578_3725 4 0.012507406 0.837996204 0.021487082 3557 hsa-mir-1278 hsa04120 Ubiquitin mediated proteolysis 997_5371_7329 3 0.022819546 1 0.03822274 3558 hsa-mir-1278 hsa05217 Basal cell carcinoma 2932_7157 2 0.024548139 1 0.040115252 3559 hsa-mir-1278 hsa04630 Jak-STAT signaling pathway 1387_6774_2033 3 0.030013134 1 0.047878094 3560 hsa-mir-1278 hsa04920 Adipocytokine signaling pathway 6256_6774 2 0.034918408 1 0.054407752 3561 hsa-mir-1278 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_3725 2 0.038691172 1 0.057606856 3562 hsa-mir-1278 hsa04730 Long-term depression 3265_5578 2 0.038691172 1 0.057606856 3563 hsa-mir-1279 hsa05200 Pathways in cancer 5371_1499_5594_5599_6258_1387_6257_6256_8031_1487_1488_836_367_842_841_6774_5970_4824_6688_2113_3725_4087_4088_5881_1050_5925_2033_8554_2353_7186 30 1.04E-26 6.94E-25 6.94E-25 3564 hsa-mir-1279 hsa04010 MAPK signaling pathway 5594_5599_9261_3303_836_1649_5970_10912_468_3725_3727_6195_5881_4616_2353_2002_2005_7186 18 3.82E-14 2.56E-12 1.28E-12 3565 hsa-mir-1279 hsa05215 Prostate cancer 1499_5594_1385_1387_367_842_5970_4824_468_5925_2033 11 7.30E-12 4.89E-10 1.37E-10 3566 hsa-mir-1279 hsa05212 Pancreatic cancer 1499_5594_1385_1387_367_842_5970_4824_468_5925_2033 11 8.16E-12 5.47E-10 1.37E-10 3567 hsa-mir-1279 hsa05210 Colorectal cancer 1499_5594_5599_836_842_3725_4087_4088_5881_2353 10 1.05E-10 7.00E-09 1.27E-09 3568 hsa-mir-1279 hsa04310 Wnt signaling pathway 815_1499_5599_1387_1487_1488_3725_1457_4087_4088_5881_2033 12 1.14E-10 7.64E-09 1.27E-09 3569 hsa-mir-1279 hsa04520 Adherens junction 1499_6714_5594_1387_1457_4087_4088_5881_2033 9 1.46E-09 9.77E-08 1.40E-08 3570 hsa-mir-1279 hsa04110 Cell cycle 993_5591_1387_983_10912_4087_4088_4616_5925_2033 10 2.42E-09 1.62E-07 2.02E-08 3571 hsa-mir-1279 hsa04920 Adipocytokine signaling pathway 10891_5599_6258_6257_6256_6774_5970_7186 8 7.96E-09 5.34E-07 5.93E-08 3572 hsa-mir-1279 hsa05216 Thyroid cancer 1499_5594_6258_6257_6256_8031 6 3.36E-08 2.25E-06 2.25E-07 3573 hsa-mir-1279 hsa05222 Small cell lung cancer 6258_6257_6256_842_5970_5925_8554_7186 8 4.81E-08 3.23E-06 2.93E-07 3574 hsa-mir-1279 hsa04330 Notch signaling pathway 1387_1487_1488_9612_2033_8850 6 4.38E-07 2.93E-05 2.44E-06 3575 hsa-mir-1279 hsa05223 Non-small cell lung cancer 5594_6258_6257_6256_842_5925 6 9.25E-07 6.20E-05 4.69E-06 3576 hsa-mir-1279 hsa04210 Apoptosis 836_839_842_841_840_5970_7186 7 9.81E-07 6.57E-05 4.69E-06 3577 hsa-mir-1279 hsa05221 Acute myeloid leukemia 5371_5594_6774_5970_6688_1050 6 1.49E-06 0.000100028 6.67E-06 3578 hsa-mir-1279 hsa04912 GnRH signaling pathway 815_6714_5594_5599_468_3725_2002 7 3.31E-06 0.000221557 1.37E-05 3579 hsa-mir-1279 hsa04115 p53 signaling pathway 983_836_842_841_10912_4616 6 3.48E-06 0.000233161 1.37E-05 3580 hsa-mir-1279 hsa04720 Long-term potentiation 815_5594_1387_468_6195_2033 6 5.46E-06 0.000365832 1.93E-05 3581 hsa-mir-1279 hsa05220 Chronic myeloid leukemia 5594_1487_1488_5970_4088_5925 6 5.46E-06 0.000365832 1.93E-05 3582 hsa-mir-1279 hsa04350 TGF-beta signaling pathway 5594_1387_659_4087_4088_2033 6 1.22E-05 0.000814296 3.86E-05 3583 hsa-mir-1279 hsa04012 ErbB signaling pathway 815_6714_5594_5599_3725_2002 6 1.22E-05 0.000814296 3.86E-05 3584 hsa-mir-1279 hsa05016 Huntington's disease 10891_1385_1387_6908_836_842_841_2033 8 1.27E-05 0.000848174 3.86E-05 3585 hsa-mir-1279 hsa04620 Toll-like receptor signaling pathway 5594_5599_841_5970_3725_2353 6 2.85E-05 0.001911614 8.31E-05 3586 hsa-mir-1279 hsa04916 Melanogenesis 815_1499_5594_1385_1387_2033 6 3.17E-05 0.002120643 8.84E-05 3587 hsa-mir-1279 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5599_836_5970_3725 5 6.05E-05 0.004050966 0.000162039 3588 hsa-mir-1279 hsa05211 Renal cell carcinoma 5594_1387_2113_3725_2033 5 6.44E-05 0.004313388 0.0001659 3589 hsa-mir-1279 hsa03022 Basal transcription factors 2962_2969_6908_2959 4 7.29E-05 0.004885445 0.000180942 3590 hsa-mir-1279 hsa04662 B cell receptor signaling pathway 5594_5970_3725_5881_2353 5 7.73E-05 0.005179892 0.000184996 3591 hsa-mir-1279 hsa04370 VEGF signaling pathway 6714_5594_9261_842_5881 5 8.70E-05 0.005828012 0.000200966 3592 hsa-mir-1279 hsa04510 Focal adhesion 1499_6714_5594_5599_3725_5881_2002 7 0.000172955 0.011587994 0.000386266 3593 hsa-mir-1279 hsa05213 Endometrial cancer 1499_5594_842_2002 4 0.000248222 0.01663085 0.000536479 3594 hsa-mir-1279 hsa05010 Alzheimer's disease 22926_5594_836_842_841_840 6 0.000512584 0.034343138 0.001073223 3595 hsa-mir-1279 hsa03320 PPAR signaling pathway 6258_6257_6256_2168 4 0.000720827 0.048295398 0.001463497 3596 hsa-mir-1279 hsa04612 Antigen processing and presentation 1385_3303_4800_1514 4 0.001688818 0.113150828 0.003327966 3597 hsa-mir-1279 hsa04660 T cell receptor signaling pathway 5594_5970_3725_2353 4 0.003534898 0.236838193 0.006766806 3598 hsa-mir-1279 hsa05214 Glioma 815_5594_5925 3 0.006105966 0.409099709 0.011363881 3599 hsa-mir-1279 hsa04910 Insulin signaling pathway 10891_5594_5599_2002 4 0.00765279 0.512736919 0.013857755 3600 hsa-mir-1279 hsa04950 Maturity onset diabetes of the young 3172_6928 2 0.008764897 0.587248113 0.015453898 3601 hsa-mir-1279 hsa04664 Fc epsilon RI signaling pathway 5594_5599_5881 3 0.010210894 0.684129919 0.017541793 3602 hsa-mir-1279 hsa04630 Jak-STAT signaling pathway 1387_6774_2033_8554 4 0.011261611 0.754527962 0.018863199 3603 hsa-mir-1279 hsa04540 Gap junction 6714_5594_983 3 0.015593219 1 0.025481602 3604 hsa-mir-1279 hsa05219 Bladder cancer 5594_5925 2 0.023939006 1 0.038188415 3605 hsa-mir-1279 hsa04930 Type II diabetes mellitus 5594_5599 2 0.027067872 1 0.042175521 3606 hsa-mir-1279 hsa04150 mTOR signaling pathway 5594_6195 2 0.034961506 1 0.053236839 3607 hsa-mir-1279 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_842 2 0.039823266 1 0.059292418 3608 hsa-mir-1279 hsa04530 Tight junction 1499_6714_1457 3 0.041156755 1 0.05971427 3609 hsa-mir-1279 hsa04650 Natural killer cell mediated cytotoxicity 5594_836_5881 3 0.041889115 1 0.05971427 3610 hsa-mir-1280 hsa04010 MAPK signaling pathway 9344_6722_5606_5601_5600_2885_5595_1432_5594_5604_5599_2005_2353 13 7.65E-18 3.82E-16 3.82E-16 3611 hsa-mir-1280 hsa04664 Fc epsilon RI signaling pathway 5606_5601_5600_2885_5595_1432_5594_5604_5599 9 9.21E-16 4.61E-14 2.30E-14 3612 hsa-mir-1280 hsa04620 Toll-like receptor signaling pathway 5606_5601_5600_5595_1432_5594_5604_5599_2353 9 8.00E-15 4.00E-13 1.33E-13 3613 hsa-mir-1280 hsa04912 GnRH signaling pathway 5606_5601_5600_2885_5595_1432_5594_5604_5599 9 1.30E-14 6.50E-13 1.63E-13 3614 hsa-mir-1280 hsa04350 TGF-beta signaling pathway 2033_5518_5595_5594_3397_3399_3398_1387 8 2.08E-13 1.04E-11 2.08E-12 3615 hsa-mir-1280 hsa04660 T cell receptor signaling pathway 5601_5600_2885_5595_1432_5594_5604_2353 8 1.23E-12 6.15E-11 1.03E-11 3616 hsa-mir-1280 hsa05200 Pathways in cancer 5601_2885_2033_9063_5595_5594_5604_5599_2353_1387 10 6.28E-12 3.14E-10 4.49E-11 3617 hsa-mir-1280 hsa05210 Colorectal cancer 5601_2885_5595_5594_5604_5599_2353 7 1.44E-11 7.20E-10 8.99E-11 3618 hsa-mir-1280 hsa05211 Renal cell carcinoma 2885_2033_5595_5594_5604_1387 6 4.61E-10 2.31E-08 2.56E-09 3619 hsa-mir-1280 hsa04012 ErbB signaling pathway 5601_2885_5595_5594_5604_5599 6 1.35E-09 6.76E-08 6.41E-09 3620 hsa-mir-1280 hsa05215 Prostate cancer 2885_2033_5595_5594_5604_1387 6 1.44E-09 7.21E-08 6.41E-09 3621 hsa-mir-1280 hsa05212 Pancreatic cancer 2885_2033_5595_5594_5604_1387 6 1.54E-09 7.69E-08 6.41E-09 3622 hsa-mir-1280 hsa04910 Insulin signaling pathway 5601_2885_5595_5594_5604_5599 6 1.89E-08 9.46E-07 7.28E-08 3623 hsa-mir-1280 hsa04720 Long-term potentiation 2033_5595_5594_5604_1387 5 4.17E-08 2.09E-06 1.39E-07 3624 hsa-mir-1280 hsa04662 B cell receptor signaling pathway 2885_5595_5594_5604_2353 5 4.17E-08 2.09E-06 1.39E-07 3625 hsa-mir-1280 hsa04370 VEGF signaling pathway 5600_5595_1432_5594_5604 5 4.73E-08 2.36E-06 1.48E-07 3626 hsa-mir-1280 hsa04510 Focal adhesion 5601_2885_5595_5594_5604_5599 6 1.88E-07 9.40E-06 5.49E-07 3627 hsa-mir-1280 hsa04916 Melanogenesis 2033_5595_5594_5604_1387 5 1.98E-07 9.89E-06 5.49E-07 3628 hsa-mir-1280 hsa04930 Type II diabetes mellitus 5601_5595_5594_5599 4 3.54E-07 1.77E-05 9.32E-07 3629 hsa-mir-1280 hsa05213 Endometrial cancer 2885_5595_5594_5604 4 6.10E-07 3.05E-05 1.53E-06 3630 hsa-mir-1280 hsa05223 Non-small cell lung cancer 2885_5595_5594_5604 4 7.04E-07 3.52E-05 1.68E-06 3631 hsa-mir-1280 hsa05221 Acute myeloid leukemia 2885_5595_5594_5604 4 9.84E-07 4.92E-05 2.24E-06 3632 hsa-mir-1280 hsa04310 Wnt signaling pathway 5601_2033_5518_5599_1387 5 1.21E-06 6.05E-05 2.63E-06 3633 hsa-mir-1280 hsa05214 Glioma 2885_5595_5594_5604 4 1.42E-06 7.10E-05 2.96E-06 3634 hsa-mir-1280 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5601_5600_1432_5599 4 1.99E-06 9.94E-05 3.82E-06 3635 hsa-mir-1280 hsa04730 Long-term depression 5518_5595_5594_5604 4 1.99E-06 9.94E-05 3.82E-06 3636 hsa-mir-1280 hsa05220 Chronic myeloid leukemia 2885_5595_5594_5604 4 2.45E-06 0.000122433 4.53E-06 3637 hsa-mir-1280 hsa04520 Adherens junction 2033_5595_5594_1387 4 3.13E-06 0.000156559 5.59E-06 3638 hsa-mir-1280 hsa04540 Gap junction 2885_5595_5594_5604 4 5.56E-06 0.000278038 9.59E-06 3639 hsa-mir-1280 hsa05216 Thyroid cancer 5595_5594_5604 3 7.66E-06 0.000382859 1.28E-05 3640 hsa-mir-1280 hsa05219 Bladder cancer 5595_5594_5604 3 2.17E-05 0.001083652 3.50E-05 3641 hsa-mir-1280 hsa04650 Natural killer cell mediated cytotoxicity 2885_5595_5594_5604 4 2.51E-05 0.001253747 3.92E-05 3642 hsa-mir-1280 hsa04630 Jak-STAT signaling pathway 2885_2033_9063_1387 4 3.90E-05 0.001951416 5.91E-05 3643 hsa-mir-1280 hsa05014 Amyotrophic lateral sclerosis (ALS) 5606_5600_1432 3 4.91E-05 0.002454174 7.22E-05 3644 hsa-mir-1280 hsa04062 Chemokine signaling pathway 2885_5595_5594_5604 4 8.97E-05 0.004485156 0.000128147 3645 hsa-mir-1280 hsa05218 Melanoma 5595_5594_5604 3 9.67E-05 0.004833666 0.000134268 3646 hsa-mir-1280 hsa04270 Vascular smooth muscle contraction 5595_5594_5604 3 0.000413191 0.020659557 0.000558366 3647 hsa-mir-1280 hsa04120 Ubiquitin mediated proteolysis 7329_9063_672 3 0.000658843 0.032942171 0.000866899 3648 hsa-mir-1280 hsa05010 Alzheimer's disease 6622_5595_5594 3 0.001306622 0.065331101 0.001675156 3649 hsa-mir-1280 hsa04330 Notch signaling pathway 2033_1387 2 0.001585339 0.07926697 0.001981674 3650 hsa-mir-1280 hsa04150 mTOR signaling pathway 5595_5594 2 0.001921856 0.096092782 0.002343726 3651 hsa-mir-1280 hsa04810 Regulation of actin cytoskeleton 5595_5594_5604 3 0.002375874 0.118793691 0.002828421 3652 hsa-mir-1280 hsa04920 Adipocytokine signaling pathway 5601_5599 2 0.003115381 0.155769066 0.003622536 3653 hsa-mir-1280 hsa04110 Cell cycle 2033_1387 2 0.009272164 0.463608215 0.01053655 3654 hsa-mir-1280 hsa04670 Leukocyte transendothelial migration 5600_1432 2 0.009717756 0.485887824 0.010797507 3655 hsa-mir-1280 hsa04360 Axon guidance 5595_5594 2 0.011110669 0.555533448 0.012076814 3656 hsa-mir-1280 hsa05016 Huntington's disease 2033_1387 2 0.021779742 1 0.023169938 3657 hsa-mir-1281 hsa05200 Pathways in cancer 7046_5467_1499_595_1019_2261_8517_4193_6934_7704_3551_5578_3091_7175_3066_3065_1050_5925_7184_5747_25_405_1956_1487_4436_2113_861_10401_207_4286_3716_1147_4233_1017_5595_5594_5599_1387_2064_6256_9915_367_2932_6774_6776_6777_6772_5979_5879_7157_6688_7849_1869_3725_4088_4089_2034_2033_5468_4790_4791_4792_5970_3320_3326_51176_5371_3480_5159_5156_5604_5601_3815_3265_4087_8772_4609_2956_1026_2736_2353_1488_1441_8554 84 1.81E-42 1.54E-40 1.54E-40 3658 hsa-mir-1281 hsa04010 MAPK signaling pathway 3925_6722_3727_7046_6195_6197_2261_2264_8517_3551_5578_1845_4773_8986_1956_7132_3303_1432_4342_22800_3305_207_1147_5595_5594_5599_1386_9252_3310_3312_1649_5971_5879_3164_7157_468_3725_6196_4790_4791_51701_5970_1616_5159_9261_1326_5156_5604_4208_5601_5600_5603_3265_6885_4609_2353_8550_2002_5566 59 5.42E-27 4.61E-25 2.30E-25 3659 hsa-mir-1281 hsa05215 Prostate cancer 1499_595_8517_4193_6934_3551_5925_7184_1956_207_9586_1147_1017_5595_5594_1387_2064_367_2932_7157_468_1869_2033_4790_4792_5970_3320_3326_51176_3480_5159_5156_5604_3265_1026 35 1.20E-23 1.02E-21 3.39E-22 3660 hsa-mir-1281 hsa05212 Pancreatic cancer 1499_595_8517_4193_6934_3551_5925_7184_1956_207_9586_1147_1017_5595_5594_1387_2064_367_2932_7157_468_1869_2033_4790_4792_5970_3320_3326_51176_3480_5159_5156_5604_3265_1026 35 1.62E-23 1.38E-21 3.44E-22 3661 hsa-mir-1281 hsa05220 Chronic myeloid leukemia 7046_595_1019_8517_4193_3551_3066_3065_5925_25_1487_861_207_1147_5595_5594_6776_6777_7157_1869_4088_4089_4790_4792_5970_5604_3265_5781_4609_1026_1488 31 1.70E-21 1.45E-19 2.90E-20 3662 hsa-mir-1281 hsa03022 Basal transcription factors 6880_6881_54457_2958_6872_138474_6883_2960_2957_6879_2967_2961_2963_2969_2968_6878_6877_6874_6873_6908_6884_6882_2959_9519 24 2.01E-20 1.71E-18 2.85E-19 3663 hsa-mir-1281 hsa04310 Wnt signaling pathway 818_817_5467_1499_595_6934_5578_4772_4773_1460_8945_23291_1487_5599_1387_2932_5879_7157_8061_3725_1457_1459_4088_4089_2033_8607_51701_51176_5601_6500_8454_4087_6885_4609_5527_1488_5566 37 7.22E-19 6.14E-17 8.77E-18 3664 hsa-mir-1281 hsa04630 Jak-STAT signaling pathway 3559_595_58985_3454_3455_3459_3560_3561_1439_2690_10401_207_3717_3716_3718_85480_1387_3575_3570_3572_6778_6774_6776_6777_6772_6773_7297_2033_149233_3953_5781_4609_1441_8554_10379 35 4.77E-17 4.05E-15 5.07E-16 3665 hsa-mir-1281 hsa05221 Acute myeloid leukemia 5467_595_8517_6934_7704_3551_1050_861_207_1147_5595_5594_6774_6776_6777_6688_4790_5970_51176_5371_5604_3815_3265_4609 24 7.93E-17 6.74E-15 7.49E-16 3666 hsa-mir-1281 hsa05210 Colorectal cancer 7046_1499_595_6934_1956_4436_207_4233_5595_5594_5599_2932_5879_7157_3725_4088_4089_51176_3480_5159_5156_5604_5601_4087_4609_2956_2353 27 1.20E-16 1.02E-14 1.02E-15 3667 hsa-mir-1281 hsa04110 Cell cycle 595_1019_4193_4174_4171_4172_3066_3065_5925_25_8379_5934_5933_5591_1017_1387_2932_7027_7157_5111_1869_4088_4089_2033_6500_8454_4085_4087_1026_1028 30 6.55E-16 5.57E-14 5.06E-15 3668 hsa-mir-1281 hsa04350 TGF-beta signaling pathway 7046_4086_90_57154_1875_6667_3397_3399_3398_1874_5934_5933_3400_5595_5594_1387_7027_4088_4089_2033_4093_6500_8454_4087_4609_4092 26 1.88E-15 1.60E-13 1.33E-14 3669 hsa-mir-1281 hsa04520 Adherens junction 7046_1499_6934_1460_2534_1956_6714_71_2241_4233_5595_5594_1387_2064_5879_1457_1459_4088_4089_2033_51701_51176_3480_4087_6885 25 2.77E-15 2.36E-13 1.81E-14 3670 hsa-mir-1281 hsa04620 Toll-like receptor signaling pathway 8517_3551_3454_3455_3665_3661_1432_207_1147_3654_5595_5594_5599_6772_5879_3725_4790_4792_5970_1326_5604_5601_5600_5603_8772_6885_2353 27 6.73E-15 5.72E-13 4.09E-14 3671 hsa-mir-1281 hsa04660 T cell receptor signaling pathway 1019_8517_3551_4772_4773_2534_3932_1432_4794_207_1147_5595_5594_2932_3725_4790_4792_4793_5970_1326_5604_5601_5600_5603_3265_6885_2353 27 3.22E-14 2.74E-12 1.78E-13 3672 hsa-mir-1281 hsa05214 Glioma 818_817_595_1019_4193_5578_5925_1956_207_5595_5594_7157_1869_808_801_805_3480_5159_5156_5604_3265_1026 22 3.35E-14 2.84E-12 1.78E-13 3673 hsa-mir-1281 hsa04920 Adipocytokine signaling pathway 10891_5465_8517_3551_7133_7132_4794_207_3717_1147_8717_5599_6256_6774_4790_4792_4793_5970_5601_3953_5781 21 4.41E-13 3.74E-11 2.20E-12 3674 hsa-mir-1281 hsa05216 Thyroid cancer 1499_595_6934_7175_5595_5594_6256_5979_7157_7849_5468_51176_5604_3265_4609 15 3.34E-12 2.84E-10 1.58E-11 3675 hsa-mir-1281 hsa04012 ErbB signaling pathway 818_817_5578_5747_25_1956_6714_207_5595_5594_5599_2064_2932_6776_6777_3725_5604_5601_3265_4609_1026_2002 22 4.60E-12 3.91E-10 2.06E-11 3676 hsa-mir-1281 hsa04062 Chemokine signaling pathway 1234_8517_3551_653361_5747_5580_7852_2309_207_3055_3717_1147_3718_5590_5595_5594_1230_2932_6774_6777_6772_6773_5879_4790_4792_4793_5970_5604_3265_2185_5566 31 8.20E-12 6.97E-10 3.48E-11 3677 hsa-mir-1281 hsa04662 B cell receptor signaling pathway 8517_3551_4772_4773_6850_4794_207_1147_5595_5594_2932_5879_3725_4790_4792_4793_5970_5604_3265_2353 20 1.90E-11 1.61E-09 7.68E-11 3678 hsa-mir-1281 hsa05219 Bladder cancer 595_1019_2261_4193_5925_1956_5595_5594_2064_9252_7157_1869_5604_3265_4609_1026 16 2.48E-11 2.11E-09 9.57E-11 3679 hsa-mir-1281 hsa04912 GnRH signaling pathway 818_817_5578_5580_1956_6714_1432_5595_5594_5599_468_3725_808_801_805_5604_5601_5600_5603_3265_2185_2002_5566 23 3.08E-11 2.62E-09 1.14E-10 3680 hsa-mir-1281 hsa04720 Long-term potentiation 818_817_6195_6197_5578_2902_5595_5594_1387_468_6196_2033_808_801_805_5604_3265_2906_5566 19 1.28E-10 1.08E-08 4.52E-10 3681 hsa-mir-1281 hsa05213 Endometrial cancer 1499_595_6934_1956_2309_207_5595_5594_2064_2932_7157_51176_5604_3265_4609_2002 16 3.37E-10 2.87E-08 1.15E-09 3682 hsa-mir-1281 hsa05218 Melanoma 595_1019_4193_5925_1956_207_4286_4233_5595_5594_7157_1869_3480_5159_5156_5604_3265_1026 18 3.87E-10 3.29E-08 1.26E-09 3683 hsa-mir-1281 hsa04330 Notch signaling pathway 1840_3066_3065_22938_1487_3280_2648_388585_1387_9612_2033_8850_9794_1488_4851 15 7.90E-10 6.71E-08 2.49E-09 3684 hsa-mir-1281 hsa04060 Cytokine-cytokine receptor interaction 3556_3559_7046_8600_1234_58985_3454_3455_3459_90_3791_1956_7852_3560_3561_7133_7132_1439_2690_85480_4233_1230_3575_3570_3572_2321_149233_5159_5156_3815_3953_1441 32 2.00E-09 1.70E-07 6.06E-09 3685 hsa-mir-1281 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 8517_3551_1956_6714_1432_1147_4233_5599_5879_3725_4790_4792_5970_5601_5600_5603_5781 17 2.50E-09 2.12E-07 7.31E-09 3686 hsa-mir-1281 hsa05223 Non-small cell lung cancer 595_1019_5578_5925_1956_2309_207_5595_5594_2064_6256_7157_1869_5604_3265 15 3.90E-09 3.32E-07 1.11E-08 3687 hsa-mir-1281 hsa05222 Small cell lung cancer 595_1019_8517_3551_5925_5747_10401_207_1147_1017_6256_7157_1869_4790_4792_5970_4609_8554 18 5.39E-09 4.58E-07 1.48E-08 3688 hsa-mir-1281 hsa04510 Focal adhesion 1499_595_5578_2534_5747_3791_1956_6714_10627_207_71_4233_5595_5594_5599_2064_2932_5879_3725_2321_3480_5159_5156_5604_5601_3265_2002 27 9.47E-09 8.05E-07 2.52E-08 3689 hsa-mir-1281 hsa04916 Melanogenesis 818_817_1499_6934_5578_4286_5595_5594_1387_2932_2033_808_801_805_51176_5604_3815_3265_5566 19 1.43E-08 1.22E-06 3.69E-08 3690 hsa-mir-1281 hsa05211 Renal cell carcinoma 3091_405_2113_207_4233_5595_5594_1387_9915_5879_3725_2034_2033_5604_3265_5781 16 1.82E-08 1.55E-06 4.56E-08 3691 hsa-mir-1281 hsa04370 VEGF signaling pathway 5578_4772_4773_5747_3791_6714_1432_207_5595_5594_5879_9261_5604_5600_5603_3265 16 4.13E-08 3.51E-06 1.00E-07 3692 hsa-mir-1281 hsa04210 Apoptosis 3556_8517_3551_8837_7132_1439_207_1147_3654_8717_7157_4790_4792_5970_840_8772_5566 17 4.63E-08 3.93E-06 1.09E-07 3693 hsa-mir-1281 hsa04664 Fc epsilon RI signaling pathway 5578_2534_5580_6850_1432_207_5595_5594_5599_5879_5604_5601_5600_5603_3265 15 3.03E-07 2.58E-05 6.97E-07 3694 hsa-mir-1281 hsa05322 Systemic lupus erythematosus 3021_3020_9555_8349_8365_8368_8364_3015_3014_8294_8370_121504_8361_8360_8363_8362_8367_8366_8359_8340 20 3.36E-07 2.86E-05 7.52E-07 3695 hsa-mir-1281 hsa04540 Gap junction 5592_5578_10382_7278_203068_1956_6714_5595_5594_347733_5159_5156_5604_3265_84617_5566 16 4.01E-07 3.41E-05 8.75E-07 3696 hsa-mir-1281 hsa05016 Huntington's disease 10891_293_1213_292_3066_3065_3064_2902_6667_5441_9586_1387_9001_5430_5437_7157_23186_2033_5468_6874_6908_9519 22 1.24E-06 0.000105247 2.63E-06 3697 hsa-mir-1281 hsa04910 Insulin signaling pathway 10891_3551_5211_207_5590_5595_5594_5599_23265_2932_808_801_805_5604_5601_3265_2002_5566 18 2.87E-06 0.000244235 5.96E-06 3698 hsa-mir-1281 hsa04530 Tight junction 1499_1019_5578_1460_5580_6714_4627_4628_22800_8573_10627_207_71_5590_1457_1459_3265 17 9.77E-06 0.000830549 1.98E-05 3699 hsa-mir-1281 hsa04120 Ubiquitin mediated proteolysis 55294_4193_3093_8945_57154_23291_10401_7323_8925_997_10273_5371_672_6500_8454_7329_8554 17 1.16E-05 0.000986305 2.29E-05 3700 hsa-mir-1281 hsa04650 Natural killer cell mediated cytotoxicity 5578_3454_3455_3459_4772_4773_2534_3932_6850_5595_5594_5879_5604_3265_5781_2185 16 3.76E-05 0.003194428 7.26E-05 3701 hsa-mir-1281 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_7133_7132_1432_5879_7157_1616_5600_5603_2906 10 4.52E-05 0.003840173 8.17E-05 3702 hsa-mir-1281 hsa05131 Shigellosis 1499_5578_10382_7278_2534_25_203068_71_347733_84617 10 4.52E-05 0.003840173 8.17E-05 3703 hsa-mir-1281 hsa05130 Pathogenic Escherichia coli infection 1499_5578_10382_7278_2534_25_203068_71_347733_84617 10 4.52E-05 0.003840173 8.17E-05 3704 hsa-mir-1281 hsa03410 Base excision repair 4350_142_252969_3146_328_2237_5111_6996 8 6.87E-05 0.005837572 0.000121616 3705 hsa-mir-1281 hsa03020 RNA polymerase 25885_51082_5441_64425_5430_5437_84172 7 0.000125622 0.010677899 0.000217916 3706 hsa-mir-1281 hsa04930 Type II diabetes mellitus 3551_5580_3651_5590_5595_5594_5599_5601 8 0.000266384 0.022642641 0.000452853 3707 hsa-mir-1281 hsa04020 Calcium signaling pathway 818_817_293_5578_292_147_1956_2902_2064_808_801_805_5159_5156_2906_2185_5566 17 0.000278565 0.023678041 0.000464275 3708 hsa-mir-1281 hsa04270 Vascular smooth muscle contraction 5592_5578_147_5580_5595_5594_4637_808_801_805_59_5604_5566 13 0.000308695 0.026239048 0.000504597 3709 hsa-mir-1281 hsa04950 Maturity onset diabetes of the young 5080_6927_3280_3651_168620_4760 6 0.00032719 0.027811129 0.000524738 3710 hsa-mir-1281 hsa03030 DNA replication 5981_4174_4171_4172_2237_5111_6118 7 0.000399142 0.033927091 0.000628279 3711 hsa-mir-1281 hsa04670 Leukocyte transendothelial migration 1499_5578_653361_5747_7852_1432_10627_71_5879_5600_5603_5781_2185 13 0.000413778 0.035171144 0.000639475 3712 hsa-mir-1281 hsa04360 Axon guidance 4772_4773_2534_5747_25_7852_2242_4233_5595_5594_2932_5879_3265 13 0.000765252 0.06504639 0.001161543 3713 hsa-mir-1281 hsa04810 Regulation of actin cytoskeleton 2261_2264_5747_1956_4627_4628_4342_22800_10627_71_5595_5594_5879_5159_5156_5604_3265_10788 18 0.001114121 0.094700322 0.001661409 3714 hsa-mir-1281 hsa03420 Nucleotide excision repair 5981_5886_5111_5887_2967_2968_6118 7 0.001148979 0.097663236 0.001683849 3715 hsa-mir-1281 hsa04612 Antigen processing and presentation 3309_3303_3305_3310_3312_3320_3326_4800_4801_2923 10 0.001293573 0.109953734 0.001863623 3716 hsa-mir-1281 hsa03430 Mismatch repair 5981_4436_5111_2956_6118 5 0.001778349 0.151159641 0.002519327 3717 hsa-mir-1281 hsa03450 Non-homologous end-joining 10111_2237_5591_4361 4 0.002237679 0.190202721 0.003118077 3718 hsa-mir-1281 hsa04150 mTOR signaling pathway 6195_6197_3091_207_5595_5594_6196 7 0.002715303 0.230800783 0.003722593 3719 hsa-mir-1281 hsa04115 p53 signaling pathway 595_1019_4194_4193_1017_7157_1026_7161 8 0.003227627 0.274348266 0.004354734 3720 hsa-mir-1281 hsa05340 Primary immunodeficiency 8517_3932_3561_3718_3575 5 0.00868455 0.738186716 0.011534167 3721 hsa-mir-1281 hsa04730 Long-term depression 5592_5578_5595_5594_3480_5604_3265 7 0.012503366 1 0.016350556 3722 hsa-mir-1281 hsa05217 Basal cell carcinoma 1499_6934_2932_7157_51176_2736 6 0.013248698 1 0.017051694 3723 hsa-mir-1281 hsa04710 Circadian rhythm - mammal 4862_79365_8553 3 0.013440747 1 0.017051694 3724 hsa-mir-1281 hsa03440 Homologous recombination 10111_4683_6118_4361 4 0.018464249 1 0.023080311 3725 hsa-mir-1281 hsa05010 Alzheimer's disease 2902_7132_5595_5594_2932_808_351_801_805_840_2906_8772 12 0.02126003 1 0.026189893 3726 hsa-mir-1281 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 0.027017888 1 0.032807436 3727 hsa-mir-1281 hsa04340 Hedgehog signaling pathway 8945_23291_2932_2736_5566 5 0.048346463 1 0.057879568 3728 hsa-mir-128-1 hsa05200 Pathways in cancer 3320_25_4149_5371_9063_1499_5595_5594_5599_5914_1387_6256_595_5601_5602_836_367_2932_861_7704_6772_3091_5970_7428_6934_1870_1871_2885_7157_4087_6688_2113_5894_4609_1869_3725_5604_862_1029_6774_6502_2353_4088_4089_3066_3065_4292_1050_5925_2034_2033_4846_8554 53 3.21E-38 2.34E-36 2.34E-36 3729 hsa-mir-128-1 hsa04010 MAPK signaling pathway 6722_4149_3727_5595_5594_5599_5598_9261_4208_5601_5600_5602_836_7867_3312_1386_1432_5970_9344_2885_7157_468_5894_4773_4609_3725_5604_5606_2353_4763_1649_8550_2005 33 1.06E-20 7.77E-19 3.88E-19 3730 hsa-mir-128-1 hsa05220 Chronic myeloid leukemia 25_5595_5594_595_861_5970_1870_1871_2885_7157_5894_4609_1869_5604_1029_4088_4089_3066_3065_5925_6464 21 4.18E-20 3.05E-18 1.02E-18 3731 hsa-mir-128-1 hsa04110 Cell cycle 25_990_5591_7533_1387_595_983_2932_8454_6500_1870_1871_7157_4087_1869_1029_6502_4088_4089_3066_3065_5925_2033_5933 24 6.48E-20 4.73E-18 1.18E-18 3732 hsa-mir-128-1 hsa05210 Colorectal cancer 1499_5595_5594_5599_595_5601_5602_836_2932_6934_2885_7157_4087_5894_4609_3725_5604_2353_4088_4089_4292 21 3.07E-19 2.24E-17 4.48E-18 3733 hsa-mir-128-1 hsa05215 Prostate cancer 3320_1499_5595_5594_1387_595_367_2932_5970_6934_1870_1871_2885_7157_468_5894_1869_5604_5925_2033_9586 21 6.98E-19 5.10E-17 8.50E-18 3734 hsa-mir-128-1 hsa05212 Pancreatic cancer 3320_1499_5595_5594_1387_595_367_2932_5970_6934_1870_1871_2885_7157_468_5894_1869_5604_5925_2033_9586 21 8.53E-19 6.23E-17 8.90E-18 3735 hsa-mir-128-1 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_861_7704_5970_6934_2885_6688_5894_4609_5604_862_6774_1050 17 1.07E-16 7.79E-15 9.73E-16 3736 hsa-mir-128-1 hsa05214 Glioma 5595_5594_595_1870_1871_2885_7157_5894_1869_5604_1029_5925_6464_808_801_805 16 7.05E-15 5.14E-13 5.72E-14 3737 hsa-mir-128-1 hsa04310 Wnt signaling pathway 1499_5599_1387_595_5601_5602_1459_2932_8454_6500_6934_7157_4087_4773_4609_3725_1457_4088_4089_2033_8061 21 1.19E-14 8.68E-13 8.68E-14 3738 hsa-mir-128-1 hsa04350 TGF-beta signaling pathway 3400_5595_5594_1387_8454_3397_3399_3398_6500_4087_4609_4088_4089_2033_5933_6667 16 3.64E-13 2.66E-11 2.41E-12 3739 hsa-mir-128-1 hsa04912 GnRH signaling pathway 5595_5594_5599_5598_5601_5600_5602_1432_2885_468_5894_3725_5604_5606_808_801_805 17 6.27E-13 4.58E-11 3.81E-12 3740 hsa-mir-128-1 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_2885_7157_5894_1869_5604_1029_5925 13 3.13E-12 2.29E-10 1.76E-11 3741 hsa-mir-128-1 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_5894_4609_1869_5604_1029_5925 12 3.89E-12 2.84E-10 2.03E-11 3742 hsa-mir-128-1 hsa05213 Endometrial cancer 1499_5595_5594_595_2932_6934_2885_7157_5894_4609_5604_4292 12 3.31E-11 2.42E-09 1.61E-10 3743 hsa-mir-128-1 hsa05222 Small cell lung cancer 4149_9063_6256_595_5970_1870_1871_7157_4609_1869_6502_5925_4846_8554 14 4.68E-11 3.42E-09 2.14E-10 3744 hsa-mir-128-1 hsa04012 ErbB signaling pathway 25_5595_5594_5599_5601_5602_2932_2885_5894_4609_3725_5604_6464 13 5.97E-10 4.36E-08 2.56E-09 3745 hsa-mir-128-1 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2885_2113_5894_3725_5604_2034_2033 12 9.04E-10 6.60E-08 3.67E-09 3746 hsa-mir-128-1 hsa05216 Thyroid cancer 1499_5595_5594_6256_595_6934_7157_4609_5604 9 1.08E-09 7.88E-08 4.15E-09 3747 hsa-mir-128-1 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5601_5600_5602_1432_6772_5970_3725_5604_5606_2353 13 3.45E-09 2.52E-07 1.26E-08 3748 hsa-mir-128-1 hsa04660 T cell receptor signaling pathway 5595_5594_5601_5600_2932_1432_5970_2885_5894_4773_3725_5604_2353 13 7.89E-09 5.76E-07 2.74E-08 3749 hsa-mir-128-1 hsa05218 Melanoma 5595_5594_595_1870_1871_7157_5894_1869_5604_1029_5925 11 9.05E-09 6.61E-07 3.00E-08 3750 hsa-mir-128-1 hsa04540 Gap junction 5595_5594_5598_983_7277_2885_5894_7846_5604_7278_51807_10376 12 1.22E-08 8.93E-07 3.82E-08 3751 hsa-mir-128-1 hsa04910 Insulin signaling pathway 6720_5595_5594_5599_5601_5602_2932_2885_5894_5604_6464_808_801_805 14 1.26E-08 9.17E-07 3.82E-08 3752 hsa-mir-128-1 hsa04720 Long-term potentiation 5595_5594_1387_2902_468_5894_5604_2033_808_801_805 11 1.51E-08 1.10E-06 4.41E-08 3753 hsa-mir-128-1 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5601_5600_5602_1432_2885_5894_5604_5606 11 2.45E-08 1.79E-06 6.88E-08 3754 hsa-mir-128-1 hsa04520 Adherens junction 1499_5595_5594_1387_1459_6934_4087_1457_4088_4089_2033 11 2.76E-08 2.01E-06 7.45E-08 3755 hsa-mir-128-1 hsa04916 Melanogenesis 1499_5595_5594_1387_2932_6934_5894_5604_2033_808_801_805 12 3.80E-08 2.77E-06 9.90E-08 3756 hsa-mir-128-1 hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_2885_5894_4773_3725_5604_2353 10 1.54E-07 1.12E-05 3.88E-07 3757 hsa-mir-128-1 hsa04370 VEGF signaling pathway 5595_5594_9261_5600_7867_1432_5894_4773_5604_4846 10 1.93E-07 1.41E-05 4.68E-07 3758 hsa-mir-128-1 hsa04330 Notch signaling pathway 388585_1387_9612_3066_3065_2033_2648_8850 8 5.21E-07 3.81E-05 1.23E-06 3759 hsa-mir-128-1 hsa04120 Ubiquitin mediated proteolysis 55294_5371_83737_9063_672_8454_6500_7428_7329_6502_64326_8554 12 6.90E-07 5.03E-05 1.57E-06 3760 hsa-mir-128-1 hsa03022 Basal transcription factors 2963_2962_2959_6874_2969_6908_6872 7 1.45E-06 0.000106155 3.22E-06 3761 hsa-mir-128-1 hsa05131 Shigellosis 25_1499_7277_7846_7278_51807_4691_10376 8 1.71E-06 0.000125022 3.57E-06 3762 hsa-mir-128-1 hsa05130 Pathogenic Escherichia coli infection 25_1499_7277_7846_7278_51807_4691_10376 8 1.71E-06 0.000125022 3.57E-06 3763 hsa-mir-128-1 hsa04510 Focal adhesion 1499_5595_5594_5599_595_5601_5602_2932_2885_5894_3725_5604_6464 13 6.27E-06 0.000457999 1.27E-05 3764 hsa-mir-128-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5601_5600_5602_836_1432_5970_3725 8 8.53E-06 0.000622582 1.68E-05 3765 hsa-mir-128-1 hsa05016 Huntington's disease 6874_1387_2902_6908_836_7157_3066_3065_3064_2033_6667_9586 12 1.28E-05 0.000932001 2.45E-05 3766 hsa-mir-128-1 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_5600_836_1432_7157_5606_4846 7 1.70E-05 0.001241331 3.18E-05 3767 hsa-mir-128-1 hsa04930 Type II diabetes mellitus 3651_5595_5594_5599_5601_5602 6 4.96E-05 0.003618878 9.05E-05 3768 hsa-mir-128-1 hsa04115 p53 signaling pathway 7161_595_983_836_7157_1029_64326 7 5.82E-05 0.004247805 0.000103605 3769 hsa-mir-128-1 hsa04630 Jak-STAT signaling pathway 6775_9063_1387_595_6772_2885_4609_6774_2033_8554 10 6.16E-05 0.004497736 0.000107089 3770 hsa-mir-128-1 hsa04062 Chemokine signaling pathway 5595_5594_2932_6772_5970_2885_5894_5604_6774_7074_6464 11 7.71E-05 0.005626615 0.000130852 3771 hsa-mir-128-1 hsa05010 Alzheimer's disease 5595_5594_2902_836_2932_6622_4846_808_801_805 10 0.000173416 0.012659336 0.000287712 3772 hsa-mir-128-1 hsa04920 Adipocytokine signaling pathway 5599_6256_5601_5602_5970_6774 6 0.000369127 0.026946299 0.000598807 3773 hsa-mir-128-1 hsa04950 Maturity onset diabetes of the young 3651_3087_4760_168620 4 0.000440917 0.032186962 0.000699717 3774 hsa-mir-128-1 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_2885_5894_4773_5604_6464 8 0.000651371 0.04755011 0.001011704 3775 hsa-mir-128-1 hsa04270 Vascular smooth muscle contraction 5595_5594_5894_5604_808_801_805 7 0.001237953 0.090370567 0.00188272 3776 hsa-mir-128-1 hsa04730 Long-term depression 5595_5594_5894_5604_4846 5 0.003071229 0.224199701 0.004575504 3777 hsa-mir-128-1 hsa05217 Basal cell carcinoma 1499_2932_6934_7157 4 0.007161264 0.522772249 0.010455445 3778 hsa-mir-128-1 hsa04612 Antigen processing and presentation 3320_4800_4801_4802_3312 5 0.007562572 0.552067782 0.010824858 3779 hsa-mir-128-1 hsa04360 Axon guidance 25_5595_5594_2932_4773 5 0.032147783 1 0.045130541 3780 hsa-mir-128-1 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.034328984 1 0.047283317 3781 hsa-mir-1282 hsa05200 Pathways in cancer 25_5594_5599_6258_1387_6257_6256_8031_1487_1488_5970_7157_6688_2113_3725_4087_4088_4089_2033_8554 20 1.29E-19 7.35E-18 7.35E-18 3782 hsa-mir-1282 hsa04350 TGF-beta signaling pathway 5594_1387_659_4086_4087_4088_4089_2033_4093 9 2.40E-11 1.37E-09 6.85E-10 3783 hsa-mir-1282 hsa04310 Wnt signaling pathway 5599_1387_1487_1488_7157_3725_4087_4088_4089_2033 10 1.17E-10 6.67E-09 2.22E-09 3784 hsa-mir-1282 hsa05220 Chronic myeloid leukemia 25_5594_1487_1488_5970_7157_4088_4089 8 2.58E-10 1.47E-08 3.68E-09 3785 hsa-mir-1282 hsa04110 Cell cycle 25_1387_7157_10912_4087_4088_4089_4616_2033 9 3.25E-10 1.85E-08 3.71E-09 3786 hsa-mir-1282 hsa05216 Thyroid cancer 5594_6258_6257_6256_8031_7157 6 1.35E-09 7.72E-08 1.29E-08 3787 hsa-mir-1282 hsa05210 Colorectal cancer 5594_5599_7157_3725_4087_4088_4089 7 1.75E-08 9.98E-07 1.43E-07 3788 hsa-mir-1282 hsa04920 Adipocytokine signaling pathway 10891_5599_6258_6257_6256_5970 6 1.29E-07 7.34E-06 9.18E-07 3789 hsa-mir-1282 hsa04010 MAPK signaling pathway 3727_5594_5599_5970_7157_10912_468_3725_4616 9 3.12E-07 1.78E-05 1.96E-06 3790 hsa-mir-1282 hsa04520 Adherens junction 5594_1387_4087_4088_4089_2033 6 3.44E-07 1.96E-05 1.96E-06 3791 hsa-mir-1282 hsa05222 Small cell lung cancer 6258_6257_6256_5970_7157_8554 6 5.14E-07 2.93E-05 2.66E-06 3792 hsa-mir-1282 hsa05215 Prostate cancer 5594_1387_5970_7157_468_2033 6 5.84E-07 3.33E-05 2.73E-06 3793 hsa-mir-1282 hsa05212 Pancreatic cancer 5594_1387_5970_7157_468_2033 6 6.22E-07 3.54E-05 2.73E-06 3794 hsa-mir-1282 hsa04330 Notch signaling pathway 1387_1487_1488_9612_2033 5 6.86E-07 3.91E-05 2.79E-06 3795 hsa-mir-1282 hsa05223 Non-small cell lung cancer 5594_6258_6257_6256_7157 5 1.30E-06 7.40E-05 4.93E-06 3796 hsa-mir-1282 hsa05211 Renal cell carcinoma 5594_1387_2113_3725_2033 5 4.90E-06 0.000279146 1.74E-05 3797 hsa-mir-1282 hsa03320 PPAR signaling pathway 6258_6257_6256_2168 4 9.43E-05 0.005372986 0.000316058 3798 hsa-mir-1282 hsa04720 Long-term potentiation 5594_1387_468_2033 4 0.0001216 0.006931196 0.000385066 3799 hsa-mir-1282 hsa04012 ErbB signaling pathway 25_5594_5599_3725 4 0.000210078 0.011974461 0.000630235 3800 hsa-mir-1282 hsa04620 Toll-like receptor signaling pathway 5594_5599_5970_3725 4 0.000376491 0.021459965 0.001072998 3801 hsa-mir-1282 hsa04912 GnRH signaling pathway 5594_5599_468_3725 4 0.000463895 0.026442009 0.001259143 3802 hsa-mir-1282 hsa05221 Acute myeloid leukemia 5594_5970_6688 3 0.001037831 0.059156385 0.002688927 3803 hsa-mir-1282 hsa04115 p53 signaling pathway 7157_10912_4616 3 0.001599371 0.091164157 0.003963659 3804 hsa-mir-1282 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5970_3725 3 0.001730415 0.098633676 0.004109736 3805 hsa-mir-1282 hsa04662 B cell receptor signaling pathway 5594_5970_3725 3 0.002012193 0.114695008 0.0045878 3806 hsa-mir-1282 hsa04210 Apoptosis 823_5970_7157 3 0.003216517 0.183341471 0.007051595 3807 hsa-mir-1282 hsa05016 Huntington's disease 10891_1387_7157_2033 4 0.003376981 0.192487898 0.007129181 3808 hsa-mir-1282 hsa04916 Melanogenesis 5594_1387_2033 3 0.004912128 0.27999128 0.009999689 3809 hsa-mir-1282 hsa04660 T cell receptor signaling pathway 5594_5970_3725 3 0.005715439 0.325780011 0.011233793 3810 hsa-mir-1282 hsa05219 Bladder cancer 5594_7157 2 0.008730632 0.497646033 0.016588201 3811 hsa-mir-1282 hsa04930 Type II diabetes mellitus 5594_5599 2 0.00991499 0.565154406 0.018230787 3812 hsa-mir-1282 hsa04910 Insulin signaling pathway 10891_5594_5599 3 0.010472329 0.596922758 0.018653836 3813 hsa-mir-1282 hsa05213 Endometrial cancer 5594_7157 2 0.012937248 0.737423156 0.022346156 3814 hsa-mir-1282 hsa04630 Jak-STAT signaling pathway 1387_2033_8554 3 0.014209208 0.809924842 0.023821319 3815 hsa-mir-1282 hsa05214 Glioma 5594_7157 2 0.019461934 1 0.03169515 3816 hsa-mir-1282 hsa05010 Alzheimer's disease 5594_823_9451 3 0.020033854 1 0.031720269 3817 hsa-mir-1282 hsa05218 Melanoma 5594_7157 2 0.022849625 1 0.035200773 3818 hsa-mir-1282 hsa04664 Fc epsilon RI signaling pathway 5594_5599 2 0.027713186 1 0.041569779 3819 hsa-mir-1282 hsa04510 Focal adhesion 5594_5599_3725 3 0.029440396 1 0.04302827 3820 hsa-mir-128-2 hsa05200 Pathways in cancer 2249_367_3725_6776_6777_2353_5914_5970_6256 9 2.14E-09 8.14E-08 8.14E-08 3821 hsa-mir-128-2 hsa05221 Acute myeloid leukemia 6776_6777_5914_5970 4 2.68E-06 0.00010185 5.09E-05 3822 hsa-mir-128-2 hsa05220 Chronic myeloid leukemia 6776_6777_5970 3 0.000235738 0.008958042 0.002239511 3823 hsa-mir-128-2 hsa04662 B cell receptor signaling pathway 3725_2353_5970 3 0.000235738 0.008958042 0.002239511 3824 hsa-mir-128-2 hsa04012 ErbB signaling pathway 3725_6776_6777 3 0.000359393 0.013656919 0.002731384 3825 hsa-mir-128-2 hsa04620 Toll-like receptor signaling pathway 3725_2353_5970 3 0.000564349 0.021445249 0.003574208 3826 hsa-mir-128-2 hsa04660 T cell receptor signaling pathway 3725_2353_5970 3 0.000698866 0.026556897 0.003793842 3827 hsa-mir-128-2 hsa04010 MAPK signaling pathway 2249_3725_2353_5970 4 0.000850712 0.032327066 0.004040883 3828 hsa-mir-128-2 hsa03410 Base excision repair 3146_142 2 0.001556398 0.059143125 0.006571458 3829 hsa-mir-128-2 hsa04630 Jak-STAT signaling pathway 3977_6776_6777 3 0.001834826 0.069723391 0.006972339 3830 hsa-mir-128-2 hsa04920 Adipocytokine signaling pathway 5970_6256 2 0.00503974 0.191510122 0.017410011 3831 hsa-mir-128-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5970 2 0.005623673 0.213699557 0.017808296 3832 hsa-mir-128-2 hsa05210 Colorectal cancer 3725_2353 2 0.007723408 0.293489501 0.02045201 3833 hsa-mir-128-2 hsa05222 Small cell lung cancer 5970_6256 2 0.00807332 0.306786146 0.02045201 3834 hsa-mir-128-2 hsa05215 Prostate cancer 367_5970 2 0.008430271 0.320350298 0.02045201 3835 hsa-mir-128-2 hsa05212 Pancreatic cancer 367_5970 2 0.008611373 0.327232161 0.02045201 3836 hsa-mir-128-2 hsa03450 Non-homologous end-joining 2547 1 0.02272554 0.863570507 0.050798265 3837 hsa-mir-128-2 hsa05016 Huntington's disease 6908_6667 2 0.034322921 1 0.071429355 3838 hsa-mir-128-2 hsa04062 Chemokine signaling pathway 6777_5970 2 0.03598526 1 0.071429355 3839 hsa-mir-128-2 hsa04950 Maturity onset diabetes of the young 6927 1 0.037594397 1 0.071429355 3840 hsa-mir-128-2 hsa05216 Thyroid cancer 6256 1 0.044945606 1 0.081330144 3841 hsa-mir-1284 hsa05200 Pathways in cancer 3716_3320_3326_5371_2249_5747_3480_1956_1499_4233_1488_2261_5595_5594_5599_5914_1387_6256_5159_862_595_5156_1487_1019_367_1017_3815_6774_2064_6776_6777_6772_5879_6688_4088_836_4089_4087_8772_4609_3725_1026_2353_10401_3066_3065_5979_5925_2033_1441_6502_207_8554_4286_4790_5970_7046 57 3.32E-42 2.56E-40 2.56E-40 3842 hsa-mir-1284 hsa04630 Jak-STAT signaling pathway 3717_3716_3718_3559_3570_3977_85480_3560_149233_1387_595_3575_3572_3953_6778_6774_6776_6777_6772_1439_58985_3454_3455_3459_5781_4609_3561_2690_10401_6773_7297_2033_1441_207_8554_10379 36 6.60E-31 5.08E-29 2.54E-29 3843 hsa-mir-1284 hsa04010 MAPK signaling pathway 3925_6722_2249_1956_2261_5595_5594_5599_5598_1386_5159_9261_5156_4208_7132_2264_9252_7867_1432_1649_5879_836_468_6885_4609_3725_1845_2353_207_4790_51701_5970_7046 33 1.82E-20 1.40E-18 4.68E-19 3844 hsa-mir-1284 hsa04060 Cytokine-cytokine receptor interaction 3556_2321_3559_3570_3977_85480_1956_4233_3560_149233_90_5159_5156_7132_3575_3572_1234_1230_3815_3953_1439_3791_7852_58985_3454_3455_3459_3561_2690_7133_1441_7046 32 5.32E-20 4.10E-18 1.02E-18 3845 hsa-mir-1284 hsa05215 Prostate cancer 3320_3326_3480_1956_1499_5595_5594_1387_5159_595_5156_367_1017_2064_468_1026_5925_2033_207_4790_5970 21 9.97E-19 7.68E-17 1.34E-17 3846 hsa-mir-1284 hsa05220 Chronic myeloid leukemia 1488_5595_5594_595_1487_1019_6776_6777_4088_5781_4089_4609_1026_3066_3065_5925_207_4790_5970_7046 20 1.05E-18 8.06E-17 1.34E-17 3847 hsa-mir-1284 hsa05212 Pancreatic cancer 3320_3326_3480_1956_1499_5595_5594_1387_5159_595_5156_367_1017_2064_468_1026_5925_2033_207_4790_5970 21 1.22E-18 9.38E-17 1.34E-17 3848 hsa-mir-1284 hsa04520 Adherens junction 2241_3480_1956_1499_6714_4233_5595_5594_1387_2064_5879_4088_4089_4087_6885_1460_2033_51701_7046_2534 20 3.09E-18 2.38E-16 2.97E-17 3849 hsa-mir-1284 hsa05210 Colorectal cancer 3480_1956_1499_4233_5595_5594_5599_5159_595_5156_5879_4088_836_4089_4087_4609_3725_2353_207_7046 20 7.01E-18 5.40E-16 6.00E-17 3850 hsa-mir-1284 hsa04350 TGF-beta signaling pathway 5595_5594_1387_90_6667_7027_3397_1874_4088_4089_4087_4609_4086_3398_2033_3399_7046_5933_57154 19 1.89E-16 1.45E-14 1.45E-15 3851 hsa-mir-1284 hsa05214 Glioma 818_817_3480_1956_5595_5594_5159_595_5156_1019_1026_5925_808_207_805_801 16 9.23E-15 7.11E-13 6.46E-14 3852 hsa-mir-1284 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_862_595_3815_6774_6776_6777_6688_4609_207_4790_5970 15 4.25E-14 3.28E-12 2.73E-13 3853 hsa-mir-1284 hsa04110 Cell cycle 7533_1387_595_1019_1017_7027_4088_4089_4087_4174_1026_4172_3066_3065_5925_2033_6502_5933 18 3.22E-13 2.48E-11 1.90E-12 3854 hsa-mir-1284 hsa04620 Toll-like receptor signaling pathway 3654_5595_5594_5599_1432_6772_5879_3454_3455_8772_6885_3725_2353_207_4790_5970 16 4.11E-12 3.17E-10 2.26E-11 3855 hsa-mir-1284 hsa04012 ErbB signaling pathway 818_817_5747_1956_6714_5595_5594_5599_2064_6776_6777_4609_3725_1026_207 15 5.83E-12 4.49E-10 2.91E-11 3856 hsa-mir-1284 hsa05218 Melanoma 2249_3480_1956_4233_5595_5594_5159_595_5156_1019_1026_5925_207_4286 14 6.06E-12 4.66E-10 2.91E-11 3857 hsa-mir-1284 hsa04912 GnRH signaling pathway 5580_818_817_1956_6714_5595_5594_5599_5598_1432_468_2185_3725_808_805_801 16 8.93E-12 6.88E-10 3.85E-11 3858 hsa-mir-1284 hsa04062 Chemokine signaling pathway 3717_3718_5580_5747_5590_5595_5594_1234_1230_6774_6777_6772_5879_7852_2185_6773_207_3055_4790_5970 20 8.99E-12 6.92E-10 3.85E-11 3859 hsa-mir-1284 hsa04310 Wnt signaling pathway 818_817_1499_1488_5599_1387_595_1487_5879_4088_4089_4087_6885_4609_3725_1460_2033_51701 18 1.33E-11 1.03E-09 5.40E-11 3860 hsa-mir-1284 hsa04510 Focal adhesion 2321_5747_3480_1956_1499_6714_4233_5595_5594_5599_5159_595_5156_1729_2064_5879_3791_3725_207_2534 20 2.66E-11 2.05E-09 1.02E-10 3861 hsa-mir-1284 hsa05219 Bladder cancer 1956_2261_5595_5594_595_1019_9252_2064_4609_1026_5925 11 8.29E-11 6.38E-09 3.04E-10 3862 hsa-mir-1284 hsa04920 Adipocytokine signaling pathway 3717_8717_5599_6256_7132_3953_6774_5781_7133_207_4790_5970 12 5.29E-10 4.08E-08 1.85E-09 3863 hsa-mir-1284 hsa05222 Small cell lung cancer 5747_6256_595_1019_1017_4609_10401_5925_6502_207_8554_4790_5970 13 6.50E-10 5.00E-08 2.17E-09 3864 hsa-mir-1284 hsa04330 Notch signaling pathway 1488_1387_1487_388585_9612_8850_3280_3066_3065_2033 10 3.46E-09 2.67E-07 1.11E-08 3865 hsa-mir-1284 hsa04660 T cell receptor signaling pathway 3932_5595_5594_1019_1432_1739_6885_3725_2353_207_4790_5970_2534 13 9.70E-09 7.47E-07 2.99E-08 3866 hsa-mir-1284 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_4233_5599_1432_5879_836_5781_3725_4790_5970 11 1.08E-08 8.34E-07 3.21E-08 3867 hsa-mir-1284 hsa04916 Melanogenesis 818_817_1499_5595_5594_1387_3815_808_2033_4286_805_801 12 4.59E-08 3.54E-06 1.31E-07 3868 hsa-mir-1284 hsa04210 Apoptosis 3654_3556_8717_7132_1439_836_8772_840_207_4790_5970 11 8.86E-08 6.83E-06 2.44E-07 3869 hsa-mir-1284 hsa05223 Non-small cell lung cancer 1956_5595_5594_6256_595_1019_2064_5925_207 9 1.37E-07 1.05E-05 3.63E-07 3870 hsa-mir-1284 hsa04720 Long-term potentiation 818_817_5595_5594_1387_468_808_2033_805_801 10 1.81E-07 1.39E-05 4.64E-07 3871 hsa-mir-1284 hsa04370 VEGF signaling pathway 5747_6714_5595_5594_9261_7867_1432_5879_3791_207 10 2.26E-07 1.74E-05 5.61E-07 3872 hsa-mir-1284 hsa05216 Thyroid cancer 1499_5595_5594_6256_595_4609_5979 7 3.89E-07 3.00E-05 9.37E-07 3873 hsa-mir-1284 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_5879_6850_3454_3455_3459_836_5781_2185_2534 12 7.71E-07 5.94E-05 1.80E-06 3874 hsa-mir-1284 hsa05213 Endometrial cancer 1956_1499_5595_5594_595_2064_4609_207 8 1.18E-06 9.08E-05 2.67E-06 3875 hsa-mir-1284 hsa05211 Renal cell carcinoma 4233_5595_5594_1387_5879_5781_3725_2033_207 9 1.22E-06 9.41E-05 2.69E-06 3876 hsa-mir-1284 hsa04662 B cell receptor signaling pathway 5595_5594_5879_6850_3725_2353_207_4790_5970 9 1.67E-06 0.000128321 3.56E-06 3877 hsa-mir-1284 hsa04664 Fc epsilon RI signaling pathway 5580_5595_5594_5599_1432_5879_6850_207_2534 9 2.47E-06 0.000190156 5.14E-06 3878 hsa-mir-1284 hsa04360 Axon guidance 2242_5747_4233_5998_5595_5594_5879_7852_1020_2534 10 1.86E-05 0.001432321 3.77E-05 3879 hsa-mir-1284 hsa04950 Maturity onset diabetes of the young 168620_6927_3172_3280_3651 5 3.52E-05 0.002711479 6.95E-05 3880 hsa-mir-1284 hsa05010 Alzheimer's disease 5595_5594_7132_836_8772_1020_840_808_4716_805_801 11 4.31E-05 0.003317422 8.29E-05 3881 hsa-mir-1284 hsa04930 Type II diabetes mellitus 5580_5590_5595_5594_5599_3651 6 5.46E-05 0.004203656 0.000102528 3882 hsa-mir-1284 hsa04020 Calcium signaling pathway 818_817_1956_5159_5156_2064_2185_808_147_805_801 11 6.00E-05 0.004620954 0.000110023 3883 hsa-mir-1284 hsa04810 Regulation of actin cytoskeleton 2249_5747_1956_2261_5595_5594_5159_5156_2264_1729_5879 11 0.000256585 0.019757076 0.000459467 3884 hsa-mir-1284 hsa04540 Gap junction 1956_6714_5595_5594_5598_5159_5156 7 0.000363014 0.027952102 0.000635275 3885 hsa-mir-1284 hsa04530 Tight junction 5580_10207_1499_6714_5590_1019_1460_207 8 0.000697199 0.053684296 0.001192984 3886 hsa-mir-1284 hsa04910 Insulin signaling pathway 5590_5595_5594_5599_808_207_805_801 8 0.000729318 0.056157488 0.001220815 3887 hsa-mir-1284 hsa04120 Ubiquitin mediated proteolysis 11059_5371_672_7329_10401_6502_8554_57154 8 0.000762618 0.058721571 0.001249395 3888 hsa-mir-1284 hsa05014 Amyotrophic lateral sclerosis (ALS) 7132_1432_5879_836_7133 5 0.001250246 0.096268945 0.002005603 3889 hsa-mir-1284 hsa04270 Vascular smooth muscle contraction 5580_5595_5594_808_147_805_801 7 0.001367744 0.105316324 0.002149313 3890 hsa-mir-1284 hsa04670 Leukocyte transendothelial migration 5747_1499_1432_5879_7852_5781_2185 7 0.001639681 0.126255441 0.002525109 3891 hsa-mir-1284 hsa05340 Primary immunodeficiency 3718_3932_3575_3561 4 0.001687855 0.129964858 0.002548331 3892 hsa-mir-1284 hsa03030 DNA replication 5981_4174_6118_4172 4 0.001856143 0.142922973 0.002748519 3893 hsa-mir-1284 hsa04115 p53 signaling pathway 595_1019_1017_836_1026 5 0.002946503 0.226880707 0.004280768 3894 hsa-mir-1284 hsa05016 Huntington's disease 1387_6908_6667_836_3066_3065_2033_4716 8 0.004607406 0.35477028 0.00656982 3895 hsa-mir-1284 hsa04640 Hematopoietic cell lineage 3559_3570_3575_3815_1441 5 0.007429679 0.572085321 0.010401551 3896 hsa-mir-1284 hsa03022 Basal transcription factors 2969_6908_2959 3 0.015587664 1 0.021433037 3897 hsa-mir-1284 hsa03420 Nucleotide excision repair 5981_4331_6118 3 0.023922874 1 0.032316865 3898 hsa-mir-1284 hsa04612 Antigen processing and presentation 3320_3326_4800_2923 4 0.034562682 1 0.04588494 3899 hsa-mir-1284 hsa04150 mTOR signaling pathway 5595_5594_207 3 0.035864846 1 0.046806664 3900 hsa-mir-1284 hsa03430 Mismatch repair 5981_6118 2 0.042452649 1 0.054480899 3901 hsa-mir-1285-1 hsa04010 MAPK signaling pathway 6722_8986_5595_5594_5599_5604_5606_5601_5600_3303_6195_6197_9252_3312_1432_9261_2885_7157_6196_2353_9344_1616_207_2005 24 7.81E-22 4.92E-20 4.92E-20 3902 hsa-mir-1285-1 hsa05200 Pathways in cancer 3320_5371_5595_5594_5599_1387_5604_5601_9915_2932_6772_3091_2885_7157_2113_861_2353_2736_9063_5925_2034_2033_207 23 8.46E-19 5.33E-17 2.67E-17 3903 hsa-mir-1285-1 hsa05211 Renal cell carcinoma 5595_5594_1387_5604_9915_3091_2885_2113_2034_2033_207 11 5.43E-13 3.42E-11 1.14E-11 3904 hsa-mir-1285-1 hsa05215 Prostate cancer 3320_5595_5594_1387_5604_2932_2885_7157_5925_2033_207 11 3.95E-12 2.49E-10 5.57E-11 3905 hsa-mir-1285-1 hsa05212 Pancreatic cancer 3320_5595_5594_1387_5604_2932_2885_7157_5925_2033_207 11 4.42E-12 2.78E-10 5.57E-11 3906 hsa-mir-1285-1 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5604_5606_5601_5600_1432_6772_2353_207 11 1.71E-11 1.08E-09 1.80E-10 3907 hsa-mir-1285-1 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5604_5606_5601_5600_1432_2885_207 10 3.45E-11 2.17E-09 3.10E-10 3908 hsa-mir-1285-1 hsa05210 Colorectal cancer 5595_5594_5599_5604_5601_2932_2885_7157_2353_207 10 6.00E-11 3.78E-09 4.72E-10 3909 hsa-mir-1285-1 hsa04720 Long-term potentiation 815_5595_5594_1387_5604_6195_6197_6196_2033 9 5.25E-10 3.31E-08 3.67E-09 3910 hsa-mir-1285-1 hsa04912 GnRH signaling pathway 815_5595_5594_5599_5604_5606_5601_5600_1432_2885 10 5.82E-10 3.67E-08 3.67E-09 3911 hsa-mir-1285-1 hsa04660 T cell receptor signaling pathway 5595_5594_5604_5601_5600_2932_1432_2885_2353_207 10 6.87E-10 4.33E-08 3.94E-09 3912 hsa-mir-1285-1 hsa04350 TGF-beta signaling pathway 5518_5595_5594_1387_3397_3399_3398_2033_4093 9 1.76E-09 1.11E-07 8.51E-09 3913 hsa-mir-1285-1 hsa04012 ErbB signaling pathway 815_5595_5594_5599_5604_5601_2932_2885_207 9 1.76E-09 1.11E-07 8.51E-09 3914 hsa-mir-1285-1 hsa03022 Basal transcription factors 2963_6879_6908_6872_2958_2959_6880 7 2.70E-09 1.70E-07 1.22E-08 3915 hsa-mir-1285-1 hsa05214 Glioma 815_5595_5594_5604_2885_7157_5925_207 8 4.12E-09 2.59E-07 1.73E-08 3916 hsa-mir-1285-1 hsa05220 Chronic myeloid leukemia 5595_5594_5604_2885_7157_861_5925_207 8 1.16E-08 7.28E-07 4.55E-08 3917 hsa-mir-1285-1 hsa05213 Endometrial cancer 5595_5594_5604_2932_2885_7157_207 7 2.26E-08 1.42E-06 7.89E-08 3918 hsa-mir-1285-1 hsa04150 mTOR signaling pathway 5595_5594_6195_6197_3091_6196_207 7 2.26E-08 1.42E-06 7.89E-08 3919 hsa-mir-1285-1 hsa05223 Non-small cell lung cancer 5595_5594_5604_2885_7157_5925_207 7 2.86E-08 1.80E-06 9.48E-08 3920 hsa-mir-1285-1 hsa05221 Acute myeloid leukemia 5371_5595_5594_5604_2885_861_207 7 5.00E-08 3.15E-06 1.57E-07 3921 hsa-mir-1285-1 hsa04310 Wnt signaling pathway 815_5518_5599_1387_5601_2932_7157_1457_2033 9 1.63E-07 1.02E-05 4.88E-07 3922 hsa-mir-1285-1 hsa05219 Bladder cancer 5595_5594_5604_9252_7157_5925 6 1.72E-07 1.08E-05 4.92E-07 3923 hsa-mir-1285-1 hsa04662 B cell receptor signaling pathway 5595_5594_5604_2932_2885_2353_207 7 2.28E-07 1.43E-05 6.24E-07 3924 hsa-mir-1285-1 hsa04370 VEGF signaling pathway 5595_5594_5604_5600_1432_9261_207 7 2.69E-07 1.69E-05 7.06E-07 3925 hsa-mir-1285-1 hsa04110 Cell cycle 5591_1387_7534_7531_2932_7157_5925_2033 8 3.25E-07 2.05E-05 8.18E-07 3926 hsa-mir-1285-1 hsa04910 Insulin signaling pathway 5595_5594_5599_5604_5601_2932_2885_207 8 9.40E-07 5.92E-05 2.28E-06 3927 hsa-mir-1285-1 hsa04916 Melanogenesis 815_5595_5594_1387_5604_2932_2033 7 1.80E-06 0.000113179 4.19E-06 3928 hsa-mir-1285-1 hsa05218 Melanoma 5595_5594_5604_7157_5925_207 6 2.94E-06 0.000184996 6.61E-06 3929 hsa-mir-1285-1 hsa04930 Type II diabetes mellitus 3651_5595_5594_5599_5601 5 5.91E-06 0.000372482 1.28E-05 3930 hsa-mir-1285-1 hsa04062 Chemokine signaling pathway 5595_5594_5604_2932_2931_6772_2885_207 8 1.01E-05 0.000635965 2.12E-05 3931 hsa-mir-1285-1 hsa05014 Amyotrophic lateral sclerosis (ALS) 5606_5600_1432_7157_1616 5 1.59E-05 0.000999365 3.13E-05 3932 hsa-mir-1285-1 hsa04510 Focal adhesion 5595_5594_5599_5604_5601_2932_2885_207 8 1.59E-05 0.001001292 3.13E-05 3933 hsa-mir-1285-1 hsa05216 Thyroid cancer 5595_5594_5604_7157 4 2.45E-05 0.001541174 4.67E-05 3934 hsa-mir-1285-1 hsa04730 Long-term depression 5518_5592_5595_5594_5604 5 4.63E-05 0.002917068 8.58E-05 3935 hsa-mir-1285-1 hsa04520 Adherens junction 5595_5594_1387_1457_2033 5 7.92E-05 0.004990417 0.000142583 3936 hsa-mir-1285-1 hsa03450 Non-homologous end-joining 5591_7520_2547 3 8.59E-05 0.005412041 0.000150334 3937 hsa-mir-1285-1 hsa04540 Gap junction 5592_5595_5594_5604_2885 5 0.000155446 0.009793083 0.000264678 3938 hsa-mir-1285-1 hsa04630 Jak-STAT signaling pathway 1387_6772_2885_9063_2033_207 6 0.000191362 0.012055807 0.000317258 3939 hsa-mir-1285-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5601_5600_1432 4 0.000614625 0.038721354 0.000992855 3940 hsa-mir-1285-1 hsa04120 Ubiquitin mediated proteolysis 7329_5371_672_10273_9063 5 0.000911445 0.057421052 0.001435526 3941 hsa-mir-1285-1 hsa05222 Small cell lung cancer 7157_9063_5925_207 4 0.001217428 0.076697942 0.001870682 3942 hsa-mir-1285-1 hsa04330 Notch signaling pathway 1387_9612_2033 3 0.002187032 0.137782985 0.003280547 3943 hsa-mir-1285-1 hsa05016 Huntington's disease 1387_6908_7157_3064_2033 5 0.003285054 0.206958409 0.004784323 3944 hsa-mir-1285-1 hsa05217 Basal cell carcinoma 2932_7157_2736 3 0.003341432 0.210510201 0.004784323 3945 hsa-mir-1285-1 hsa04270 Vascular smooth muscle contraction 5592_5595_5594_5604 4 0.003687513 0.232313327 0.005162518 3946 hsa-mir-1285-1 hsa04920 Adipocytokine signaling pathway 5599_5601_207 3 0.005668084 0.357089279 0.00776281 3947 hsa-mir-1285-1 hsa04530 Tight junction 5518_8189_1457_207 4 0.006146253 0.387213959 0.008238595 3948 hsa-mir-1285-1 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_5604_2885 4 0.006299593 0.396874379 0.008268216 3949 hsa-mir-1285-1 hsa04612 Antigen processing and presentation 3320_3303_3312 3 0.011981818 0.754854513 0.015405194 3950 hsa-mir-1285-1 hsa05010 Alzheimer's disease 5595_5594_2932_6622 4 0.014405618 0.907553925 0.018151079 3951 hsa-mir-1285-1 hsa04360 Axon guidance 5595_5594_2932 3 0.032041025 1 0.03958009 3952 hsa-mir-1285-1 hsa04340 Hedgehog signaling pathway 2932_2736 2 0.037108299 1 0.044958132 3953 hsa-mir-1286 hsa04350 TGF-beta signaling pathway 4086_4089_4093_3398_3399_1387 6 5.52E-09 1.93E-07 1.93E-07 3954 hsa-mir-1286 hsa05220 Chronic myeloid leukemia 4089_25_7157_5925_861 5 1.33E-07 4.64E-06 2.32E-06 3955 hsa-mir-1286 hsa05200 Pathways in cancer 4089_25_7157_5925_2113_861_1387 7 6.87E-07 2.41E-05 8.02E-06 3956 hsa-mir-1286 hsa04110 Cell cycle 4089_25_7157_5925_1387 5 1.18E-06 4.14E-05 1.03E-05 3957 hsa-mir-1286 hsa05215 Prostate cancer 7157_5925_90993_1387 4 1.11E-05 0.000389926 6.78E-05 3958 hsa-mir-1286 hsa05212 Pancreatic cancer 7157_5925_90993_1387 4 1.16E-05 0.000407006 6.78E-05 3959 hsa-mir-1286 hsa05016 Huntington's disease 6908_7157_90993_1387 4 0.000196192 0.006866727 0.000980961 3960 hsa-mir-1286 hsa04120 Ubiquitin mediated proteolysis 11059_7329_4734 3 0.001268263 0.044389189 0.005548649 3961 hsa-mir-1286 hsa04310 Wnt signaling pathway 4089_7157_1387 3 0.001630172 0.057056009 0.006339557 3962 hsa-mir-1286 hsa05219 Bladder cancer 7157_5925 2 0.001993642 0.069777476 0.006977748 3963 hsa-mir-1286 hsa05223 Non-small cell lung cancer 7157_5925 2 0.003208663 0.112303221 0.010026243 3964 hsa-mir-1286 hsa05014 Amyotrophic lateral sclerosis (ALS) 7157_1616 2 0.003437569 0.120314914 0.010026243 3965 hsa-mir-1286 hsa05214 Glioma 7157_5925 2 0.004558871 0.159560495 0.012273884 3966 hsa-mir-1286 hsa05218 Melanoma 7157_5925 2 0.005387936 0.188577762 0.012908824 3967 hsa-mir-1286 hsa05211 Renal cell carcinoma 2113_1387 2 0.005532353 0.193632353 0.012908824 3968 hsa-mir-1286 hsa04520 Adherens junction 4089_1387 2 0.006750896 0.236281345 0.014767584 3969 hsa-mir-1286 hsa05210 Colorectal cancer 4089_7157 2 0.007401751 0.259061287 0.015044997 3970 hsa-mir-1286 hsa05222 Small cell lung cancer 7157_5925 2 0.007737427 0.270809939 0.015044997 3971 hsa-mir-1286 hsa04916 Melanogenesis 90993_1387 2 0.011058466 0.387046293 0.020370858 3972 hsa-mir-1286 hsa05216 Thyroid cancer 7157 1 0.043991061 1 0.076984356 3973 hsa-mir-1287 hsa04110 Cell cycle 10971_7534_1387 3 1.30E-06 3.25E-05 3.25E-05 3974 hsa-mir-1287 hsa05131 Shigellosis 10971_7534 2 5.48E-05 0.001370156 0.000456719 3975 hsa-mir-1287 hsa05130 Pathogenic Escherichia coli infection 10971_7534 2 5.48E-05 0.001370156 0.000456719 3976 hsa-mir-1287 hsa04310 Wnt signaling pathway 1452_1387 2 0.000387283 0.009682071 0.002420518 3977 hsa-mir-1287 hsa04330 Notch signaling pathway 1387 1 0.009560571 0.239014273 0.027491398 3978 hsa-mir-1287 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432 1 0.01134467 0.283616744 0.027491398 3979 hsa-mir-1287 hsa04340 Hedgehog signaling pathway 1452 1 0.011542738 0.288568439 0.027491398 3980 hsa-mir-1287 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432 1 0.014312216 0.357805407 0.027491398 3981 hsa-mir-1287 hsa05211 Renal cell carcinoma 1387 1 0.014509789 0.362744713 0.027491398 3982 hsa-mir-1287 hsa04720 Long-term potentiation 1387 1 0.015102307 0.377557679 0.027491398 3983 hsa-mir-1287 hsa04370 VEGF signaling pathway 1432 1 0.015497155 0.387428866 0.027491398 3984 hsa-mir-1287 hsa04664 Fc epsilon RI signaling pathway 1432 1 0.01589187 0.397296755 0.027491398 3985 hsa-mir-1287 hsa04520 Adherens junction 1387 1 0.016089179 0.402229463 0.027491398 3986 hsa-mir-1287 hsa04350 TGF-beta signaling pathway 1387 1 0.017469414 0.436735348 0.027491398 3987 hsa-mir-1287 hsa05215 Prostate cancer 1387 1 0.017666459 0.441661466 0.027491398 3988 hsa-mir-1287 hsa05212 Pancreatic cancer 1387 1 0.01786347 0.44658676 0.027491398 3989 hsa-mir-1287 hsa04620 Toll-like receptor signaling pathway 1432 1 0.020421629 0.510540716 0.027491398 3990 hsa-mir-1287 hsa04916 Melanogenesis 1387 1 0.020814698 0.520367454 0.027491398 3991 hsa-mir-1287 hsa04912 GnRH signaling pathway 1432 1 0.021600443 0.540011072 0.027491398 3992 hsa-mir-1287 hsa04660 T cell receptor signaling pathway 1432 1 0.021993118 0.549827954 0.027491398 3993 hsa-mir-1287 hsa04670 Leukocyte transendothelial migration 1432 1 0.024346413 0.608660324 0.028983825 3994 hsa-mir-1287 hsa04630 Jak-STAT signaling pathway 1387 1 0.030793655 0.769841385 0.03499279 3995 hsa-mir-1287 hsa05016 Huntington's disease 1387 1 0.037205355 0.930133879 0.040440603 3996 hsa-mir-1288 hsa05200 Pathways in cancer 3716_3066_1870_1871_7157_4790_6688_5925_2033_2113_207_4193_4609_5595_7704_1387_5594_861_6774_1029_5970_4792 22 5.00E-24 2.85E-22 2.85E-22 3997 hsa-mir-1288 hsa05220 Chronic myeloid leukemia 3066_1870_1871_7157_4790_5925_207_4193_4609_5595_5594_861_1029_5970_4792 15 3.42E-23 1.95E-21 9.76E-22 3998 hsa-mir-1288 hsa05215 Prostate cancer 1870_1871_7157_4790_5925_2033_207_4193_5595_1387_5594_5970_4792_1385 14 1.91E-20 1.09E-18 3.14E-19 3999 hsa-mir-1288 hsa05212 Pancreatic cancer 1870_1871_7157_4790_5925_2033_207_4193_5595_1387_5594_5970_4792_1385 14 2.21E-20 1.26E-18 3.14E-19 4000 hsa-mir-1288 hsa05221 Acute myeloid leukemia 4790_6688_207_4609_5595_7704_5594_861_6774_5970 10 3.83E-15 2.18E-13 4.37E-14 4001 hsa-mir-1288 hsa05219 Bladder cancer 1870_1871_7157_5925_4193_4609_5595_5594_1029 9 1.46E-14 8.35E-13 1.39E-13 4002 hsa-mir-1288 hsa05214 Glioma 1870_1871_7157_5925_207_4193_5595_5594_1029 9 5.06E-13 2.88E-11 4.12E-12 4003 hsa-mir-1288 hsa05218 Melanoma 1870_1871_7157_5925_207_4193_5595_5594_1029 9 1.05E-12 5.97E-11 7.47E-12 4004 hsa-mir-1288 hsa05222 Small cell lung cancer 1870_1871_7157_4790_5925_207_4609_5970_4792 9 5.14E-12 2.93E-10 3.25E-11 4005 hsa-mir-1288 hsa05223 Non-small cell lung cancer 1870_1871_7157_5925_207_5595_5594_1029 8 6.44E-12 3.67E-10 3.67E-11 4006 hsa-mir-1288 hsa04110 Cell cycle 3066_1870_1871_7157_5925_2033_4193_1387_1029 9 7.75E-11 4.42E-09 4.02E-10 4007 hsa-mir-1288 hsa04350 TGF-beta signaling pathway 6667_2033_4609_5595_1387_5594_3398_3399 8 2.15E-10 1.23E-08 1.02E-09 4008 hsa-mir-1288 hsa04630 Jak-STAT signaling pathway 3716_2033_207_5777_4609_1387_3566_6774_6773 9 7.11E-10 4.05E-08 3.12E-09 4009 hsa-mir-1288 hsa04662 B cell receptor signaling pathway 4790_207_5777_5595_5594_5970_4792 7 2.78E-09 1.58E-07 1.13E-08 4010 hsa-mir-1288 hsa04062 Chemokine signaling pathway 4790_207_5595_5590_5594_6774_5970_6773_4792 9 4.46E-09 2.54E-07 1.69E-08 4011 hsa-mir-1288 hsa04660 T cell receptor signaling pathway 4790_207_5777_5595_5594_5970_4792 7 3.35E-08 1.91E-06 1.20E-07 4012 hsa-mir-1288 hsa05211 Renal cell carcinoma 2033_2113_207_5595_1387_5594 6 7.48E-08 4.26E-06 2.51E-07 4013 hsa-mir-1288 hsa04010 MAPK signaling pathway 7157_4790_207_1616_4609_5595_1386_5594_5970 9 7.93E-08 4.52E-06 2.51E-07 4014 hsa-mir-1288 hsa04520 Adherens junction 2033_5777_5595_6714_1387_5594 6 1.35E-07 7.67E-06 4.04E-07 4015 hsa-mir-1288 hsa05213 Endometrial cancer 7157_207_4609_5595_5594 5 4.98E-07 2.84E-05 1.42E-06 4016 hsa-mir-1288 hsa04620 Toll-like receptor signaling pathway 4790_207_5595_5594_5970_4792 6 5.22E-07 2.98E-05 1.42E-06 4017 hsa-mir-1288 hsa05016 Huntington's disease 6667_3066_6908_7157_2033_1387_1385 7 1.09E-06 6.20E-05 2.82E-06 4018 hsa-mir-1288 hsa04920 Adipocytokine signaling pathway 4790_207_6774_5970_4792 5 1.61E-06 9.19E-05 4.00E-06 4019 hsa-mir-1288 hsa05216 Thyroid cancer 7157_4609_5595_5594 4 1.98E-06 0.000112604 4.69E-06 4020 hsa-mir-1288 hsa05210 Colorectal cancer 7157_207_4609_5595_5594 5 4.61E-06 0.000262979 1.05E-05 4021 hsa-mir-1288 hsa04012 ErbB signaling pathway 207_4609_5595_6714_5594 5 5.43E-06 0.000309586 1.19E-05 4022 hsa-mir-1288 hsa04210 Apoptosis 7157_4790_207_5970_4792 5 6.04E-06 0.000344089 1.27E-05 4023 hsa-mir-1288 hsa04330 Notch signaling pathway 3066_2033_1387_4851 4 1.16E-05 0.000662498 2.37E-05 4024 hsa-mir-1288 hsa04916 Melanogenesis 2033_5595_1387_5594_1385 5 1.24E-05 0.000709333 2.45E-05 4025 hsa-mir-1288 hsa04910 Insulin signaling pathway 6720_207_5595_5590_5594 5 4.60E-05 0.002622427 8.74E-05 4026 hsa-mir-1288 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 4790_6714_5970_4792 4 5.38E-05 0.003066096 9.89E-05 4027 hsa-mir-1288 hsa04720 Long-term potentiation 2033_5595_1387_5594 4 6.59E-05 0.003758994 0.000117469 4028 hsa-mir-1288 hsa04370 VEGF signaling pathway 207_5595_6714_5594 4 7.27E-05 0.004145212 0.000125612 4029 hsa-mir-1288 hsa04930 Type II diabetes mellitus 5595_5590_5594 3 0.000309039 0.01761522 0.000518095 4030 hsa-mir-1288 hsa04150 mTOR signaling pathway 207_5595_5594 3 0.000462365 0.026354813 0.000752995 4031 hsa-mir-1288 hsa04310 Wnt signaling pathway 7157_2033_4609_1387 4 0.000888949 0.050670085 0.001407502 4032 hsa-mir-1288 hsa04115 p53 signaling pathway 7157_4193_1029 3 0.001016665 0.057949908 0.001566214 4033 hsa-mir-1288 hsa04664 Fc epsilon RI signaling pathway 207_5595_5594 3 0.001480412 0.084383464 0.002220617 4034 hsa-mir-1288 hsa04540 Gap junction 5595_6714_5594 3 0.002324014 0.132468805 0.003396636 4035 hsa-mir-1288 hsa04510 Focal adhesion 207_5595_6714_5594 4 0.0026391 0.150428689 0.003760717 4036 hsa-mir-1288 hsa04912 GnRH signaling pathway 5595_6714_5594 3 0.003503912 0.199722956 0.004871292 4037 hsa-mir-1288 hsa03022 Basal transcription factors 2969_6908 2 0.005094526 0.290387961 0.006913999 4038 hsa-mir-1288 hsa04530 Tight junction 207_6714_5590 3 0.006682388 0.380896095 0.008800774 4039 hsa-mir-1288 hsa04650 Natural killer cell mediated cytotoxicity 5777_5595_5594 3 0.006814411 0.388421399 0.008800774 4040 hsa-mir-1288 hsa04120 Ubiquitin mediated proteolysis 7329_4193_672 3 0.00694798 0.396034839 0.008800774 4041 hsa-mir-1288 hsa05014 Amyotrophic lateral sclerosis (ALS) 7157_1616 2 0.010991309 0.626504597 0.013619665 4042 hsa-mir-1288 hsa05010 Alzheimer's disease 22926_5595_5594 3 0.013206783 0.752786615 0.016016736 4043 hsa-mir-1288 hsa04730 Long-term depression 5595_5594 2 0.017021088 0.97020199 0.020212541 4044 hsa-mir-1288 hsa04270 Vascular smooth muscle contraction 5595_5594 2 0.042611339 1 0.049568293 4045 hsa-mir-1289-2 hsa05200 Pathways in cancer 5371_5595_5594_5599_5914_1387_6256_595_5601_836_367_1017_4149_7704_3091_5970_7428_1870_1871_7157_4087_6688_2113_4609_1869_3725_2353_4088_4089_3066_3065_1050_5925_2034_2033_4846_4286 37 1.12E-34 6.96E-33 6.96E-33 4046 hsa-mir-1289-2 hsa04110 Cell cycle 5591_1387_595_1017_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933_890_5934 18 2.15E-19 1.33E-17 6.65E-18 4047 hsa-mir-1289-2 hsa05220 Chronic myeloid leukemia 5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464 15 5.72E-18 3.55E-16 1.18E-16 4048 hsa-mir-1289-2 hsa04350 TGF-beta signaling pathway 5518_5595_5594_1387_6667_1874_1875_4087_4609_4088_4089_2033_5933_5934 14 1.11E-15 6.91E-14 1.73E-14 4049 hsa-mir-1289-2 hsa05210 Colorectal cancer 5595_5594_5599_595_5601_836_7157_4087_4609_3725_2353_4088_4089 13 1.89E-14 1.17E-12 2.35E-13 4050 hsa-mir-1289-2 hsa05215 Prostate cancer 5595_5594_1387_595_367_1017_5970_1870_1871_7157_1869_5925_2033 13 3.24E-14 2.01E-12 3.28E-13 4051 hsa-mir-1289-2 hsa05212 Pancreatic cancer 5595_5594_1387_595_367_1017_5970_1870_1871_7157_1869_5925_2033 13 3.70E-14 2.29E-12 3.28E-13 4052 hsa-mir-1289-2 hsa04310 Wnt signaling pathway 5518_5599_1387_595_5601_7157_4087_4773_4609_3725_1457_4088_4089_2033_8061 15 7.42E-14 4.60E-12 5.75E-13 4053 hsa-mir-1289-2 hsa05222 Small cell lung cancer 6256_595_1017_4149_5970_1870_1871_7157_4609_1869_5925_4846 12 5.97E-13 3.70E-11 4.11E-12 4054 hsa-mir-1289-2 hsa04010 MAPK signaling pathway 5595_5594_5599_4208_5601_836_4149_3312_1649_5970_7157_4773_4609_3725_1386_2353_4763 17 1.67E-12 1.04E-10 1.04E-11 4055 hsa-mir-1289-2 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_5970_6688_4609_1050 10 9.41E-12 5.83E-10 5.30E-11 4056 hsa-mir-1289-2 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5925 9 1.65E-11 1.02E-09 8.52E-11 4057 hsa-mir-1289-2 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925 9 1.21E-10 7.49E-09 5.76E-10 4058 hsa-mir-1289-2 hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_6464 9 5.33E-10 3.31E-08 2.36E-09 4059 hsa-mir-1289-2 hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5925_4286 9 1.09E-09 6.73E-08 4.49E-09 4060 hsa-mir-1289-2 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2113_3725_2034_2033 9 1.22E-09 7.54E-08 4.71E-09 4061 hsa-mir-1289-2 hsa05016 Huntington's disease 6874_1387_2902_6908_836_6667_7157_3066_3065_3064_2033 11 2.92E-08 1.81E-06 1.07E-07 4062 hsa-mir-1289-2 hsa04520 Adherens junction 5595_5594_1387_4087_1457_4088_4089_2033 8 5.15E-08 3.19E-06 1.72E-07 4063 hsa-mir-1289-2 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 5.27E-08 3.27E-06 1.72E-07 4064 hsa-mir-1289-2 hsa04012 ErbB signaling pathway 5595_5594_5599_5601_4609_3725_6464 7 1.41E-06 8.76E-05 4.38E-06 4065 hsa-mir-1289-2 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5601_5970_3725_2353 7 3.82E-06 0.000236811 1.13E-05 4066 hsa-mir-1289-2 hsa04660 T cell receptor signaling pathway 5595_5594_5601_5970_4773_3725_2353 7 6.11E-06 0.00037896 1.72E-05 4067 hsa-mir-1289-2 hsa04662 B cell receptor signaling pathway 5595_5594_5970_4773_3725_2353 6 8.43E-06 0.000522744 2.27E-05 4068 hsa-mir-1289-2 hsa04330 Notch signaling pathway 1387_9612_3066_3065_2033 5 1.36E-05 0.000845518 3.52E-05 4069 hsa-mir-1289-2 hsa05213 Endometrial cancer 5595_5594_595_7157_4609 5 2.15E-05 0.001330313 5.32E-05 4070 hsa-mir-1289-2 hsa04115 p53 signaling pathway 595_836_1017_7157_64326 5 7.62E-05 0.00472262 0.000181639 4071 hsa-mir-1289-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5601_836_5970_3725 5 8.65E-05 0.005365349 0.000198717 4072 hsa-mir-1289-2 hsa04720 Long-term potentiation 5595_5594_1387_2902_2033 5 0.000110498 0.006850907 0.000244675 4073 hsa-mir-1289-2 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601 4 0.000197251 0.012229589 0.00042171 4074 hsa-mir-1289-2 hsa04910 Insulin signaling pathway 6720_5595_5594_5599_5601_6464 6 0.000213559 0.013240631 0.000441354 4075 hsa-mir-1289-2 hsa04510 Focal adhesion 5595_5594_5599_595_5601_3725_6464 7 0.000275094 0.017055848 0.000550189 4076 hsa-mir-1289-2 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_7157_4846 4 0.000431775 0.026770025 0.000836563 4077 hsa-mir-1289-2 hsa04916 Melanogenesis 5595_5594_1387_2033_4286 5 0.000468393 0.029040356 0.000880011 4078 hsa-mir-1289-2 hsa04912 GnRH signaling pathway 5595_5594_5599_5601_3725 5 0.000552267 0.034240544 0.001007075 4079 hsa-mir-1289-2 hsa04920 Adipocytokine signaling pathway 5599_6256_5601_5970 4 0.000818336 0.050736862 0.001449625 4080 hsa-mir-1289-2 hsa04730 Long-term depression 5518_5595_5594_4846 4 0.001005249 0.062325416 0.001731262 4081 hsa-mir-1289-2 hsa04370 VEGF signaling pathway 5595_5594_4773_4846 4 0.001339042 0.083020588 0.0022438 4082 hsa-mir-1289-2 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5601 4 0.001465631 0.090869131 0.002391293 4083 hsa-mir-1289-2 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_4773_6464 5 0.001586901 0.09838784 0.002522765 4084 hsa-mir-1289-2 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428_7329_64326 5 0.001636301 0.10145069 0.002536267 4085 hsa-mir-1289-2 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.004161105 0.257988484 0.006292402 4086 hsa-mir-1289-2 hsa05010 Alzheimer's disease 5595_5594_2902_836_4846 5 0.004484676 0.27804989 0.006620235 4087 hsa-mir-1289-2 hsa04630 Jak-STAT signaling pathway 1387_595_4609_2033 4 0.014522429 0.900390599 0.020939316 4088 hsa-mir-1289-2 hsa04612 Antigen processing and presentation 4800_4801_3312 3 0.017019271 1 0.023448773 4089 hsa-mir-1289-2 hsa04210 Apoptosis 836_5970_7157 3 0.017019271 1 0.023448773 4090 hsa-mir-1289-2 hsa03022 Basal transcription factors 6874_6908 2 0.021990781 1 0.029639749 4091 hsa-mir-1289-2 hsa04062 Chemokine signaling pathway 5595_5594_5970_6464 4 0.029111992 1 0.038403053 4092 hsa-mir-1289-2 hsa03050 Proteasome 5684_5705 2 0.034867246 1 0.045036859 4093 hsa-mir-1289-2 hsa04360 Axon guidance 5595_5594_4773 3 0.04454249 1 0.056359885 4094 hsa-mir-1290 hsa05200 Pathways in cancer 3320_9063_1499_5594_5599_367_2932_4193_7704_1387_6774_6776_6777_5970_7157_2113_5894_3725_2353_4088_4089_1050_207_4790_4791 25 1.46E-22 1.02E-20 1.02E-20 4095 hsa-mir-1290 hsa05215 Prostate cancer 3320_1499_5594_1385_367_2932_4193_1387_5970_7157_5894_207_4790 13 1.15E-15 8.04E-14 3.06E-14 4096 hsa-mir-1290 hsa05212 Pancreatic cancer 3320_1499_5594_1385_367_2932_4193_1387_5970_7157_5894_207_4790 13 1.31E-15 9.18E-14 3.06E-14 4097 hsa-mir-1290 hsa04660 T cell receptor signaling pathway 3932_5594_920_915_2932_1432_5970_5894_3725_2353_5058_207_4790 13 1.59E-14 1.11E-12 2.78E-13 4098 hsa-mir-1290 hsa05220 Chronic myeloid leukemia 5594_4193_6776_6777_5970_7157_5894_4088_4089_207_4790 11 2.08E-13 1.46E-11 2.92E-12 4099 hsa-mir-1290 hsa04010 MAPK signaling pathway 5594_5599_5608_5566_1432_5970_7157_5894_3725_2353_5058_3303_207_5536_4790_4791 16 3.53E-13 2.47E-11 4.12E-12 4100 hsa-mir-1290 hsa05210 Colorectal cancer 1499_5594_5599_2932_7157_5894_3725_2353_4088_4089_207 11 6.43E-13 4.50E-11 6.40E-12 4101 hsa-mir-1290 hsa05221 Acute myeloid leukemia 5594_7704_6774_6776_6777_5970_5894_1050_207_4790 10 7.31E-13 5.12E-11 6.40E-12 4102 hsa-mir-1290 hsa04912 GnRH signaling pathway 6714_5594_5599_5608_5566_1432_5894_3725_808_801_805 11 7.91E-12 5.54E-10 6.16E-11 4103 hsa-mir-1290 hsa04110 Cell cycle 7534_5591_7533_7532_2932_4193_1387_7157_2810_4088_4089 11 2.09E-11 1.46E-09 1.46E-10 4104 hsa-mir-1290 hsa04012 ErbB signaling pathway 6714_5594_5599_2932_6776_6777_5894_3725_5058_207 10 2.43E-11 1.70E-09 1.55E-10 4105 hsa-mir-1290 hsa04910 Insulin signaling pathway 10891_5594_5599_5566_2932_5894_207_2538_808_801_805 11 9.23E-11 6.46E-09 5.38E-10 4106 hsa-mir-1290 hsa04916 Melanogenesis 1499_5594_1385_5566_2932_1387_5894_808_801_805 10 1.23E-10 8.62E-09 6.63E-10 4107 hsa-mir-1290 hsa05214 Glioma 5594_4193_7157_5894_207_808_801_805 8 1.56E-09 1.09E-07 7.78E-09 4108 hsa-mir-1290 hsa04620 Toll-like receptor signaling pathway 5594_5599_5608_1432_5970_3725_2353_207_4790 9 2.17E-09 1.52E-07 1.01E-08 4109 hsa-mir-1290 hsa04310 Wnt signaling pathway 1499_5599_5566_2932_1387_7157_8061_3725_4088_4089 10 3.89E-09 2.72E-07 1.70E-08 4110 hsa-mir-1290 hsa04662 B cell receptor signaling pathway 5594_2932_5970_5894_3725_2353_207_4790 8 4.39E-09 3.08E-07 1.81E-08 4111 hsa-mir-1290 hsa04062 Chemokine signaling pathway 5594_5566_2932_6774_6777_5970_5894_5058_207_4790 10 3.36E-08 2.35E-06 1.31E-07 4112 hsa-mir-1290 hsa04920 Adipocytokine signaling pathway 10891_5599_6774_5970_207_4790_2538 7 4.80E-08 3.36E-06 1.77E-07 4113 hsa-mir-1290 hsa04630 Jak-STAT signaling pathway 9063_1387_3460_6774_6776_6777_3595_3594_207 9 6.63E-08 4.64E-06 2.31E-07 4114 hsa-mir-1290 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5599_1432_5970_3725_5058_4790 7 6.94E-08 4.86E-06 2.31E-07 4115 hsa-mir-1290 hsa05211 Renal cell carcinoma 5594_1387_2113_5894_3725_5058_207 7 7.59E-08 5.31E-06 2.41E-07 4116 hsa-mir-1290 hsa04720 Long-term potentiation 5594_5566_1387_5894_808_801_805 7 9.84E-08 6.89E-06 2.99E-07 4117 hsa-mir-1290 hsa05213 Endometrial cancer 1499_5594_2932_7157_5894_207 6 2.63E-07 1.84E-05 7.68E-07 4118 hsa-mir-1290 hsa04510 Focal adhesion 1499_6714_5594_5599_2932_5894_3725_5058_207 9 6.59E-07 4.61E-05 1.84E-06 4119 hsa-mir-1290 hsa04664 Fc epsilon RI signaling pathway 5594_5599_5608_1432_5894_207 6 2.57E-06 0.000180231 6.93E-06 4120 hsa-mir-1290 hsa04520 Adherens junction 1499_6714_5594_1387_4088_4089 6 2.76E-06 0.000193029 7.15E-06 4121 hsa-mir-1290 hsa04612 Antigen processing and presentation 3320_811_920_1385_4800_3303 6 4.93E-06 0.000345084 1.23E-05 4122 hsa-mir-1290 hsa04270 Vascular smooth muscle contraction 5594_5566_5894_808_801_805 6 2.27E-05 0.001592027 5.49E-05 4123 hsa-mir-1290 hsa05218 Melanoma 5594_4193_7157_5894_207 5 2.57E-05 0.001800571 6.00E-05 4124 hsa-mir-1290 hsa05340 Primary immunodeficiency 3932_920_915_100 4 2.97E-05 0.002079541 6.71E-05 4125 hsa-mir-1290 hsa05016 Huntington's disease 10891_1385_291_6908_5481_1387_7157 7 3.23E-05 0.002258167 7.06E-05 4126 hsa-mir-1290 hsa04370 VEGF signaling pathway 6714_5594_1432_5894_207 5 3.72E-05 0.002601865 7.88E-05 4127 hsa-mir-1290 hsa05219 Bladder cancer 5594_4193_7157_5894 4 5.75E-05 0.004025345 0.000118393 4128 hsa-mir-1290 hsa05222 Small cell lung cancer 9063_5970_7157_207_4790 5 6.13E-05 0.004291882 0.000122625 4129 hsa-mir-1290 hsa04210 Apoptosis 5566_5970_7157_207_4790 5 7.16E-05 0.005010981 0.000139194 4130 hsa-mir-1290 hsa05223 Non-small cell lung cancer 5594_7157_5894_207 4 0.000143331 0.010033181 0.000271167 4131 hsa-mir-1290 hsa05010 Alzheimer's disease 5594_3416_2932_808_801_805 6 0.000196558 0.013759085 0.000362081 4132 hsa-mir-1290 hsa04020 Calcium signaling pathway 291_5566_5481_808_801_805 6 0.000240662 0.016846309 0.000431957 4133 hsa-mir-1290 hsa05216 Thyroid cancer 1499_5594_7157 3 0.000413867 0.028970691 0.000724267 4134 hsa-mir-1290 hsa04650 Natural killer cell mediated cytotoxicity 3932_5594_3460_5894_5058 5 0.000507012 0.035490871 0.000865631 4135 hsa-mir-1290 hsa04350 TGF-beta signaling pathway 5594_1387_4088_4089 4 0.000804252 0.056297607 0.001340419 4136 hsa-mir-1290 hsa04540 Gap junction 6714_5594_5566_5894 4 0.001020978 0.071468485 0.001662058 4137 hsa-mir-1290 hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.002362172 0.165352068 0.003694376 4138 hsa-mir-1290 hsa05014 Amyotrophic lateral sclerosis (ALS) 5608_1432_7157 3 0.002480509 0.173635655 0.003694376 4139 hsa-mir-1290 hsa05131 Shigellosis 7534_1499_4691 3 0.002480509 0.173635655 0.003694376 4140 hsa-mir-1290 hsa05130 Pathogenic Escherichia coli infection 7534_1499_4691 3 0.002480509 0.173635655 0.003694376 4141 hsa-mir-1290 hsa04340 Hedgehog signaling pathway 5566_2932_53944 3 0.002602453 0.182171695 0.003795244 4142 hsa-mir-1290 hsa04115 p53 signaling pathway 4193_7157_2810 3 0.004359646 0.305175219 0.006228066 4143 hsa-mir-1290 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.005648953 0.395426685 0.007908534 4144 hsa-mir-1290 hsa04950 Maturity onset diabetes of the young 3172_3175 2 0.006207371 0.434516 0.008519922 4145 hsa-mir-1290 hsa03022 Basal transcription factors 2969_6908 2 0.013618682 0.953307757 0.018332841 4146 hsa-mir-1290 hsa04930 Type II diabetes mellitus 5594_5599 2 0.0194044 1 0.025628453 4147 hsa-mir-1290 hsa04330 Notch signaling pathway 1387_9612 2 0.020985821 1 0.027203842 4148 hsa-mir-1290 hsa04360 Axon guidance 5594_2932_5058 3 0.023398713 1 0.02978018 4149 hsa-mir-1290 hsa04150 mTOR signaling pathway 5594_207 2 0.025163832 1 0.031454789 4150 hsa-mir-1290 hsa05012 Parkinson's disease 7314_291_5481 3 0.025717236 1 0.03158257 4151 hsa-mir-1290 hsa04530 Tight junction 1499_6714_207 3 0.026195239 1 0.031614944 4152 hsa-mir-1290 hsa04120 Ubiquitin mediated proteolysis 9063_4193_7329 3 0.027165528 1 0.032230287 4153 hsa-mir-1290 hsa04730 Long-term depression 5594_5894 2 0.043714023 1 0.050999694 4154 hsa-mir-1291 hsa05210 Colorectal cancer 4087_4088_4609 3 3.82E-06 7.25E-05 4.02E-05 4155 hsa-mir-1291 hsa04350 TGF-beta signaling pathway 4087_4088_4609 3 4.23E-06 8.04E-05 4.02E-05 4156 hsa-mir-1291 hsa04310 Wnt signaling pathway 4087_4088_4609 3 2.16E-05 0.000410932 0.000136977 4157 hsa-mir-1291 hsa03022 Basal transcription factors 2959_6908 2 8.98E-05 0.001706887 0.000426722 4158 hsa-mir-1291 hsa05200 Pathways in cancer 4087_4088_4609 3 0.000212827 0.004043706 0.000808741 4159 hsa-mir-1291 hsa05220 Chronic myeloid leukemia 4088_4609 2 0.000352053 0.006688998 0.001083486 4160 hsa-mir-1291 hsa04520 Adherens junction 4087_4088 2 0.000399179 0.007584403 0.001083486 4161 hsa-mir-1291 hsa04612 Antigen processing and presentation 4800_4801 2 0.000491328 0.009335227 0.001166903 4162 hsa-mir-1291 hsa04110 Cell cycle 4087_4088 2 0.000865862 0.016451381 0.001827931 4163 hsa-mir-1291 hsa05216 Thyroid cancer 4609 1 0.010942987 0.207916755 0.020791676 4164 hsa-mir-1291 hsa05219 Bladder cancer 4609 1 0.015651049 0.297369932 0.02703363 4165 hsa-mir-1291 hsa05213 Endometrial cancer 4609 1 0.019258761 0.365916464 0.030493039 4166 hsa-mir-1291 hsa05221 Acute myeloid leukemia 4609 1 0.021777003 0.413763058 0.031827928 4167 hsa-mir-1291 hsa05222 Small cell lung cancer 4609 1 0.031435255 0.597269847 0.040268977 4168 hsa-mir-1291 hsa04012 ErbB signaling pathway 4609 1 0.031791298 0.604034653 0.040268977 4169 hsa-mir-129-2 hsa05200 Pathways in cancer 3716_3320_3326_675_1956_367_1499_5594_5595_1387_5159_5156_4286_1399_1398_1147_8517_3815_2932_7704_3551_6774_6777_6772_6256_5970_8554_6688_2113_4609_1869_862_867_6502_2353_4087_4088_7175_3065_5925_2033_207_4791_4792 44 9.32E-33 7.09E-31 7.09E-31 4170 hsa-mir-129-2 hsa05215 Prostate cancer 3320_3326_1956_367_1499_5594_5595_1387_5159_5156_1147_8517_2932_3551_5970_1869_5925_2033_207_4792 20 1.71E-19 1.30E-17 4.58E-18 4171 hsa-mir-129-2 hsa05212 Pancreatic cancer 3320_3326_1956_367_1499_5594_5595_1387_5159_5156_1147_8517_2932_3551_5970_1869_5925_2033_207_4792 20 2.08E-19 1.58E-17 4.58E-18 4172 hsa-mir-129-2 hsa05220 Chronic myeloid leukemia 5594_5595_1399_1398_1147_8517_3551_6777_5970_5781_4609_1869_867_4088_3065_5925_207_4792_6464 19 2.41E-19 1.83E-17 4.58E-18 4173 hsa-mir-129-2 hsa04010 MAPK signaling pathway 1956_5594_5595_6722_5159_1326_5156_4208_3305_3303_5566_1399_1398_1147_8517_7867_3312_1432_3551_5971_5970_9261_3310_4609_2353_207_4791 27 1.79E-17 1.36E-15 2.72E-16 4174 hsa-mir-129-2 hsa04630 Jak-STAT signaling pathway 3717_3716_3718_85480_3560_3561_1387_3575_6774_6777_6772_8554_3559_2057_5781_4609_867_2690_6778_2033_207 21 2.47E-16 1.88E-14 3.13E-15 4175 hsa-mir-129-2 hsa04660 T cell receptor signaling pathway 3932_5594_5595_1326_919_1147_8517_2932_4794_1432_3551_5970_867_2353_207_4792_4793_1493 18 1.85E-15 1.41E-13 2.01E-14 4176 hsa-mir-129-2 hsa04062 Chemokine signaling pathway 3717_3718_5594_5595_5566_1399_1398_1147_1234_8517_2932_3551_6774_6777_6772_5970_653361_207_4792_4793_6464 21 1.32E-14 1.00E-12 1.25E-13 4177 hsa-mir-129-2 hsa05221 Acute myeloid leukemia 5594_5595_1147_8517_3815_7704_3551_6774_6777_5970_6688_4609_862_207 14 2.98E-14 2.26E-12 2.51E-13 4178 hsa-mir-129-2 hsa04662 B cell receptor signaling pathway 5594_5595_6850_695_1147_8517_2932_4794_3551_5970_2353_207_4792_4793 14 5.29E-13 4.02E-11 4.02E-12 4179 hsa-mir-129-2 hsa05214 Glioma 1956_5594_5595_5159_5156_1869_5925_808_207_6464_801_805 12 2.78E-11 2.11E-09 1.92E-10 4180 hsa-mir-129-2 hsa04920 Adipocytokine signaling pathway 3717_1147_8517_4794_3551_6774_6256_5970_5781_207_4792_4793 12 3.80E-11 2.89E-09 2.39E-10 4181 hsa-mir-129-2 hsa04350 TGF-beta signaling pathway 5515_5594_5595_1387_6500_8454_3397_3398_4609_3399_4087_4088_2033 13 4.40E-11 3.34E-09 2.39E-10 4182 hsa-mir-129-2 hsa04012 ErbB signaling pathway 1956_6714_5594_5595_2066_1399_1398_2932_6777_4609_867_207_6464 13 4.40E-11 3.34E-09 2.39E-10 4183 hsa-mir-129-2 hsa04910 Insulin signaling pathway 3643_5594_5595_5566_1399_1398_2932_5770_3551_867_808_207_6464_801_805 15 8.50E-11 6.46E-09 4.31E-10 4184 hsa-mir-129-2 hsa04520 Adherens junction 1956_1499_6714_3643_5594_5595_1387_5770_4087_4088_2033_71 12 2.39E-10 1.81E-08 1.13E-09 4185 hsa-mir-129-2 hsa05210 Colorectal cancer 1956_1499_5594_5595_5159_5156_2932_4609_2353_4087_4088_207 12 3.96E-10 3.01E-08 1.77E-09 4186 hsa-mir-129-2 hsa05222 Small cell lung cancer 1147_8517_3551_6256_5970_8554_4609_1869_6502_5925_207_4792 12 5.05E-10 3.84E-08 2.13E-09 4187 hsa-mir-129-2 hsa04540 Gap junction 203068_1956_6714_5594_5595_5159_5156_5566_347733_10382_84617_7278 12 1.14E-09 8.64E-08 4.55E-09 4188 hsa-mir-129-2 hsa04310 Wnt signaling pathway 5515_23291_1499_1387_8607_6500_5566_2932_8454_8945_4609_4087_4088_2033 14 2.65E-09 2.02E-07 1.01E-08 4189 hsa-mir-129-2 hsa04620 Toll-like receptor signaling pathway 5594_5595_1326_1147_8517_1432_3551_6772_5970_2353_207_4792 12 2.96E-09 2.25E-07 1.07E-08 4190 hsa-mir-129-2 hsa04916 Melanogenesis 1499_5594_5595_1387_4286_5566_3815_2932_808_2033_801_805 12 3.62E-09 2.75E-07 1.25E-08 4191 hsa-mir-129-2 hsa04110 Cell cycle 5591_1387_6500_2932_8454_1869_6502_4087_4088_3065_5925_2033 12 1.45E-08 1.10E-06 4.80E-08 4192 hsa-mir-129-2 hsa04120 Ubiquitin mediated proteolysis 23291_672_6500_8454_3093_8554_10273_8945_7329_867_6502_7323 12 7.11E-08 5.41E-06 2.25E-07 4193 hsa-mir-129-2 hsa04612 Antigen processing and presentation 3320_3326_3308_3309_3305_3303_4800_4801_3312_3310 10 9.29E-08 7.06E-06 2.78E-07 4194 hsa-mir-129-2 hsa04510 Focal adhesion 1956_1499_6714_5594_5595_5159_5156_1399_1398_2932_10627_207_71_6464 14 9.52E-08 7.23E-06 2.78E-07 4195 hsa-mir-129-2 hsa05218 Melanoma 1956_5594_5595_5159_5156_4286_1869_5925_207 9 1.61E-07 1.23E-05 4.38E-07 4196 hsa-mir-129-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_1147_8517_1432_3551_5970_5781_4792 9 1.61E-07 1.23E-05 4.38E-07 4197 hsa-mir-129-2 hsa05211 Renal cell carcinoma 5594_5595_1387_1399_1398_5781_2113_2033_207 9 1.80E-07 1.37E-05 4.71E-07 4198 hsa-mir-129-2 hsa04330 Notch signaling pathway 388585_1387_4851_9612_3065_2033_8850 7 1.49E-06 0.000112975 3.72E-06 4199 hsa-mir-129-2 hsa03020 RNA polymerase 5437_64425_25885_51082_84172_5441 6 1.57E-06 0.000119111 3.72E-06 4200 hsa-mir-129-2 hsa05216 Thyroid cancer 1499_5594_5595_6256_4609_7175 6 1.57E-06 0.000119111 3.72E-06 4201 hsa-mir-129-2 hsa04720 Long-term potentiation 5594_5595_1387_5566_808_2033_801_805 8 2.61E-06 0.000198595 6.02E-06 4202 hsa-mir-129-2 hsa05213 Endometrial cancer 1956_1499_5594_5595_2932_4609_207 7 2.74E-06 0.000208115 6.12E-06 4203 hsa-mir-129-2 hsa05223 Non-small cell lung cancer 1956_5594_5595_6256_1869_5925_207 7 3.44E-06 0.000261431 7.47E-06 4204 hsa-mir-129-2 hsa04912 GnRH signaling pathway 1956_6714_5594_5595_5566_1432_808_801_805 9 4.10E-06 0.000311507 8.35E-06 4205 hsa-mir-129-2 hsa05340 Primary immunodeficiency 3718_3932_3561_3575_695_8517 6 4.12E-06 0.000313008 8.35E-06 4206 hsa-mir-129-2 hsa05131 Shigellosis 203068_1499_347733_10382_84617_7278_71 7 4.29E-06 0.000325673 8.35E-06 4207 hsa-mir-129-2 hsa05130 Pathogenic Escherichia coli infection 203068_1499_347733_10382_84617_7278_71 7 4.29E-06 0.000325673 8.35E-06 4208 hsa-mir-129-2 hsa04810 Regulation of actin cytoskeleton 1956_5594_5595_5159_5156_1399_1398_4628_10788_4627_10627_71 12 6.52E-06 0.00049521 1.24E-05 4209 hsa-mir-129-2 hsa04060 Cytokine-cytokine receptor interaction 85480_1956_3560_3561_5159_8600_5156_3575_1234_3815_3559_2057_2690 13 7.50E-06 0.000569865 1.39E-05 4210 hsa-mir-129-2 hsa04210 Apoptosis 5566_1147_8517_8837_3551_5970_207_4792 8 8.44E-06 0.000641198 1.53E-05 4211 hsa-mir-129-2 hsa05219 Bladder cancer 1956_5594_5595_4609_1869_5925 6 1.06E-05 0.000803345 1.87E-05 4212 hsa-mir-129-2 hsa04370 VEGF signaling pathway 6714_5594_5595_7867_1432_9261_207 7 2.91E-05 0.002210856 5.02E-05 4213 hsa-mir-129-2 hsa04020 Calcium signaling pathway 1956_292_293_2066_5159_5156_5566_808_801_805 10 4.10E-05 0.003112869 6.92E-05 4214 hsa-mir-129-2 hsa05016 Huntington's disease 1387_292_293_6908_1213_5437_3065_2033_5441_4724 10 4.87E-05 0.003698307 8.04E-05 4215 hsa-mir-129-2 hsa04530 Tight junction 5515_1499_6714_4628_4627_10627_207_71 8 0.000150871 0.011466171 0.000242629 4216 hsa-mir-129-2 hsa03010 Ribosome 6124_6156_6143_6129_6207_6202_6128 7 0.000153239 0.011646198 0.000242629 4217 hsa-mir-129-2 hsa04930 Type II diabetes mellitus 3651_3643_5594_5595_3551 5 0.000174506 0.013262437 0.000270662 4218 hsa-mir-129-2 hsa04664 Fc epsilon RI signaling pathway 5594_5595_6850_695_1432_207 6 0.000272586 0.020716502 0.00041433 4219 hsa-mir-129-2 hsa04270 Vascular smooth muscle contraction 5594_5595_4637_5566_808_801_805 7 0.000355874 0.027046396 0.000530321 4220 hsa-mir-129-2 hsa05010 Alzheimer's disease 22926_5594_5595_2932_808_4724_801_805 8 0.00077285 0.058736592 0.00112955 4221 hsa-mir-129-2 hsa04650 Natural killer cell mediated cytotoxicity 3932_5594_5595_6850_919_5781_6464 7 0.000863231 0.065605526 0.00123784 4222 hsa-mir-129-2 hsa04670 Leukocyte transendothelial migration 1499_1432_5781_653361_10627_71 6 0.002327412 0.176883296 0.003275617 4223 hsa-mir-129-2 hsa04950 Maturity onset diabetes of the young 3651_168620_5080 3 0.002750104 0.209007938 0.003800144 4224 hsa-mir-129-2 hsa04340 Hedgehog signaling pathway 23291_5566_2932_8945 4 0.003832291 0.291254088 0.005200966 4225 hsa-mir-129-2 hsa03022 Basal transcription factors 2969_6908_2959 3 0.008406682 0.638907819 0.011208909 4226 hsa-mir-129-2 hsa04640 Hematopoietic cell lineage 3575_3815_3559_2057 4 0.015397563 1 0.020176117 4227 hsa-mir-129-2 hsa04150 mTOR signaling pathway 5594_5595_207 3 0.019911427 1 0.025648618 4228 hsa-mir-129-2 hsa04730 Long-term depression 5515_5594_5595 3 0.042625757 1 0.053992625 4229 hsa-mir-1293 hsa04010 MAPK signaling pathway 468_1649_3725_3727 4 2.23E-06 5.12E-05 5.12E-05 4230 hsa-mir-1293 hsa05211 Renal cell carcinoma 1387_3725 2 0.000325176 0.007479044 0.002260107 4231 hsa-mir-1293 hsa04720 Long-term potentiation 1387_468 2 0.000352053 0.008097208 0.002260107 4232 hsa-mir-1293 hsa05215 Prostate cancer 1387_468 2 0.000480625 0.011054384 0.002260107 4233 hsa-mir-1293 hsa05212 Pancreatic cancer 1387_468 2 0.000491328 0.011300537 0.002260107 4234 hsa-mir-1293 hsa04912 GnRH signaling pathway 468_3725 2 0.000716567 0.016481032 0.002746839 4235 hsa-mir-1293 hsa04310 Wnt signaling pathway 1387_3725 2 0.001395817 0.0321038 0.004586257 4236 hsa-mir-1293 hsa04710 Circadian rhythm - mammal 406 1 0.005120351 0.117768066 0.014721008 4237 hsa-mir-1293 hsa05200 Pathways in cancer 1387_3725 2 0.006355899 0.146185677 0.016242853 4238 hsa-mir-1293 hsa04330 Notch signaling pathway 1387 1 0.01745641 0.401497441 0.040149744 4239 hsa-mir-1293 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725 1 0.026080317 0.599847284 0.04569999 4240 hsa-mir-1293 hsa04662 B cell receptor signaling pathway 3725 1 0.027510926 0.632751289 0.04569999 4241 hsa-mir-1293 hsa04520 Adherens junction 1387 1 0.0292965 0.673819503 0.04569999 4242 hsa-mir-1293 hsa05210 Colorectal cancer 3725 1 0.030722813 0.706624705 0.04569999 4243 hsa-mir-1293 hsa04350 TGF-beta signaling pathway 1387 1 0.031791298 0.731199843 0.04569999 4244 hsa-mir-1293 hsa04012 ErbB signaling pathway 3725 1 0.031791298 0.731199843 0.04569999 4245 hsa-mir-1293 hsa04620 Toll-like receptor signaling pathway 3725 1 0.037117675 0.853706523 0.048333021 4246 hsa-mir-1293 hsa04916 Melanogenesis 1387 1 0.037825842 0.869994372 0.048333021 4247 hsa-mir-1293 hsa04660 T cell receptor signaling pathway 3725 1 0.039947504 0.918792601 0.048357505 4248 hsa-mir-1293 hsa04110 Cell cycle 1387 1 0.043122024 0.991806549 0.049590327 4249 hsa-mir-1294 hsa04115 p53 signaling pathway 891_7157 2 0.000823484 0.024704509 0.01754219 4250 hsa-mir-1294 hsa05210 Colorectal cancer 7157_2353 2 0.00120477 0.03614309 0.01754219 4251 hsa-mir-1294 hsa03010 Ribosome 6222_6231 2 0.001754219 0.052626569 0.01754219 4252 hsa-mir-1294 hsa04110 Cell cycle 891_7157 2 0.002363532 0.070905954 0.017726488 4253 hsa-mir-1294 hsa04120 Ubiquitin mediated proteolysis 7325_7329 2 0.003190529 0.095715862 0.019143172 4254 hsa-mir-1294 hsa05016 Huntington's disease 7157_1537 2 0.005704163 0.171124897 0.028520816 4255 hsa-mir-1294 hsa04010 MAPK signaling pathway 7157_2353 2 0.011614496 0.348434866 0.049776409 4256 hsa-mir-1294 hsa05200 Pathways in cancer 7157_2353 2 0.016790244 0.503707326 0.059474038 4257 hsa-mir-1294 hsa05216 Thyroid cancer 7157 1 0.017842211 0.535266341 0.059474038 4258 hsa-mir-1294 hsa04130 SNARE interactions in vesicular transport 9342 1 0.023135969 0.694079072 0.06578568 4259 hsa-mir-1294 hsa05219 Bladder cancer 7157 1 0.02548009 0.764402702 0.06578568 4260 hsa-mir-1294 hsa05213 Endometrial cancer 7157 1 0.031317172 0.939515157 0.06578568 4261 hsa-mir-1294 hsa05223 Non-small cell lung cancer 7157 1 0.032480619 0.974418567 0.06578568 4262 hsa-mir-1294 hsa05217 Basal cell carcinoma 7157 1 0.033061847 0.991855421 0.06578568 4263 hsa-mir-1294 hsa05014 Amyotrophic lateral sclerosis (ALS) 7157 1 0.033642746 1 0.06578568 4264 hsa-mir-1294 hsa05214 Glioma 7157 1 0.038856023 1 0.06578568 4265 hsa-mir-1294 hsa05218 Melanoma 7157 1 0.042316772 1 0.06578568 4266 hsa-mir-1294 hsa05220 Chronic myeloid leukemia 7157 1 0.044617397 1 0.06578568 4267 hsa-mir-1294 hsa04662 B cell receptor signaling pathway 2353 1 0.044617397 1 0.06578568 4268 hsa-mir-1294 hsa04260 Cardiac muscle contraction 1537 1 0.049202995 1 0.06578568 4269 hsa-mir-1295 hsa04350 TGF-beta signaling pathway 5518_1387_2033 3 5.63E-06 9.00E-05 9.00E-05 4270 hsa-mir-1295 hsa04310 Wnt signaling pathway 5518_1387_2033 3 2.87E-05 0.000459602 0.000229801 4271 hsa-mir-1295 hsa04330 Notch signaling pathway 1387_2033 2 0.000170558 0.002728922 0.000909641 4272 hsa-mir-1295 hsa05211 Renal cell carcinoma 1387_2033 2 0.000389562 0.006232993 0.001176782 4273 hsa-mir-1295 hsa04720 Long-term potentiation 1387_2033 2 0.000421732 0.006747719 0.001176782 4274 hsa-mir-1295 hsa04520 Adherens junction 1387_2033 2 0.000478134 0.007650137 0.001176782 4275 hsa-mir-1295 hsa05215 Prostate cancer 1387_2033 2 0.000575587 0.009209395 0.001176782 4276 hsa-mir-1295 hsa05212 Pancreatic cancer 1387_2033 2 0.000588391 0.009414257 0.001176782 4277 hsa-mir-1295 hsa04916 Melanogenesis 1387_2033 2 0.000796949 0.01275118 0.001416798 4278 hsa-mir-1295 hsa04110 Cell cycle 1387_2033 2 0.001036227 0.016579635 0.001657964 4279 hsa-mir-1295 hsa04630 Jak-STAT signaling pathway 1387_2033 2 0.001733966 0.027743449 0.002522132 4280 hsa-mir-1295 hsa05016 Huntington's disease 1387_2033 2 0.002523767 0.040380264 0.003365022 4281 hsa-mir-1295 hsa05200 Pathways in cancer 1387_2033 2 0.007570799 0.121132791 0.009317907 4282 hsa-mir-1295 hsa04730 Long-term depression 5518 1 0.028416789 0.45466863 0.032476331 4283 hsa-mir-1296 hsa03022 Basal transcription factors 2967_2961_2960_2963_6881_54457_2968_6878_6877_6874_6872_2957_6879_6873_2958_6884_2959_6880_6882_138474_6883 21 5.13E-34 3.44E-32 3.44E-32 4284 hsa-mir-1296 hsa05200 Pathways in cancer 3326_5925_5594_6256_4193_2353_1387_5970_7157_6688_3725_10401_4609_2033_8554_7184 16 3.55E-11 2.38E-09 1.19E-09 4285 hsa-mir-1296 hsa05215 Prostate cancer 3326_5925_5594_4193_1387_5970_7157_2033_7184 9 1.82E-09 1.22E-07 3.34E-08 4286 hsa-mir-1296 hsa05212 Pancreatic cancer 3326_5925_5594_4193_1387_5970_7157_2033_7184 9 2.00E-09 1.34E-07 3.34E-08 4287 hsa-mir-1296 hsa04110 Cell cycle 5925_993_983_4193_1387_7157_4171_4085_2033 9 2.12E-08 1.42E-06 2.84E-07 4288 hsa-mir-1296 hsa05222 Small cell lung cancer 5925_6256_5970_7157_10401_4609_8554 7 5.18E-07 3.47E-05 5.79E-06 4289 hsa-mir-1296 hsa05220 Chronic myeloid leukemia 5925_5594_4193_5970_7157_4609 6 3.81E-06 0.000255132 3.52E-05 4290 hsa-mir-1296 hsa05219 Bladder cancer 5925_5594_4193_7157_4609 5 4.20E-06 0.000281378 3.52E-05 4291 hsa-mir-1296 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 7.67E-06 0.000513579 5.71E-05 4292 hsa-mir-1296 hsa04310 Wnt signaling pathway 1460_8607_1387_7157_3725_4609_2033 7 1.84E-05 0.001234135 0.000123414 4293 hsa-mir-1296 hsa05216 Thyroid cancer 5594_6256_7157_4609 4 2.39E-05 0.001598163 0.000145288 4294 hsa-mir-1296 hsa05016 Huntington's disease 6874_9001_1387_5430_7157_3064_2033 7 6.76E-05 0.004532442 0.000377703 4295 hsa-mir-1296 hsa05210 Colorectal cancer 5594_2353_7157_3725_4609 5 9.57E-05 0.006408762 0.000492982 4296 hsa-mir-1296 hsa04010 MAPK signaling pathway 3727_5594_2353_3312_5970_7157_3725_4609 8 0.000103866 0.006958999 0.000497071 4297 hsa-mir-1296 hsa05223 Non-small cell lung cancer 5925_5594_6256_7157 4 0.000223979 0.015006569 0.001000438 4298 hsa-mir-1296 hsa05221 Acute myeloid leukemia 5594_5970_6688_4609 4 0.000308302 0.020656225 0.001291014 4299 hsa-mir-1296 hsa05214 Glioma 5925_5594_4193_7157 4 0.000436958 0.029276196 0.001722129 4300 hsa-mir-1296 hsa05218 Melanoma 5925_5594_4193_7157 4 0.000599958 0.040197205 0.002224381 4301 hsa-mir-1296 hsa05211 Renal cell carcinoma 5594_1387_3725_2033 4 0.000630795 0.042263241 0.002224381 4302 hsa-mir-1296 hsa04662 B cell receptor signaling pathway 5594_2353_5970_3725 4 0.000730035 0.048912346 0.002445617 4303 hsa-mir-1296 hsa04520 Adherens junction 1460_5594_1387_2033 4 0.000919202 0.061586547 0.002932693 4304 hsa-mir-1296 hsa04350 TGF-beta signaling pathway 5594_1387_4609_2033 4 0.00123861 0.082986846 0.003772129 4305 hsa-mir-1296 hsa04612 Antigen processing and presentation 3326_4801_3312_1514 4 0.001342496 0.089947225 0.003910749 4306 hsa-mir-1296 hsa04630 Jak-STAT signaling pathway 1387_10401_4609_2033_8554 5 0.001415158 0.094815603 0.00395065 4307 hsa-mir-1296 hsa03420 Nucleotide excision repair 2967_2968_5887 3 0.001796489 0.120364739 0.00481459 4308 hsa-mir-1296 hsa04330 Notch signaling pathway 1387_2033_8850 3 0.002147393 0.143875324 0.005385597 4309 hsa-mir-1296 hsa04620 Toll-like receptor signaling pathway 5594_2353_5970_3725 4 0.002170315 0.145411124 0.005385597 4310 hsa-mir-1296 hsa05213 Endometrial cancer 5594_7157_4609 3 0.002821353 0.189030656 0.006527075 4311 hsa-mir-1296 hsa04660 T cell receptor signaling pathway 5594_2353_5970_3725 4 0.002825152 0.189285189 0.006527075 4312 hsa-mir-1296 hsa04115 p53 signaling pathway 983_4193_7157 3 0.006021686 0.403452968 0.013448432 4313 hsa-mir-1296 hsa04720 Long-term potentiation 5594_1387_2033 3 0.007512529 0.503339468 0.016236757 4314 hsa-mir-1296 hsa04012 ErbB signaling pathway 5594_3725_4609 3 0.01109843 0.743594836 0.023237339 4315 hsa-mir-1296 hsa04540 Gap junction 5594_983_10382 3 0.01320293 0.884596298 0.026805948 4316 hsa-mir-1296 hsa04916 Melanogenesis 5594_1387_2033 3 0.017614356 1 0.034710643 4317 hsa-mir-1296 hsa04120 Ubiquitin mediated proteolysis 4193_10401_8554 3 0.0364824 1 0.069837737 4318 hsa-mir-1296 hsa05322 Systemic lupus erythematosus 3014_3015_8340 3 0.039773496 1 0.074022895 4319 hsa-mir-1296 hsa04920 Adipocytokine signaling pathway 6256_5970 2 0.048665044 1 0.088123187 4320 hsa-mir-1297 hsa05200 Pathways in cancer 2249_367_3725_6776_6777_2353_5914_5970_6256 9 9.03E-10 3.43E-08 3.43E-08 4321 hsa-mir-1297 hsa05221 Acute myeloid leukemia 6776_6777_5914_5970 4 1.85E-06 7.03E-05 3.52E-05 4322 hsa-mir-1297 hsa05220 Chronic myeloid leukemia 6776_6777_5970 3 0.000179685 0.006828022 0.001707005 4323 hsa-mir-1297 hsa04662 B cell receptor signaling pathway 3725_2353_5970 3 0.000179685 0.006828022 0.001707005 4324 hsa-mir-1297 hsa04012 ErbB signaling pathway 3725_6776_6777 3 0.000274263 0.010421976 0.002084395 4325 hsa-mir-1297 hsa04620 Toll-like receptor signaling pathway 3725_2353_5970 3 0.000431309 0.016389732 0.002731622 4326 hsa-mir-1297 hsa04660 T cell receptor signaling pathway 3725_2353_5970 3 0.000534536 0.020312379 0.002854227 4327 hsa-mir-1297 hsa04010 MAPK signaling pathway 2249_3725_2353_5970 4 0.00060089 0.022833818 0.002854227 4328 hsa-mir-1297 hsa04630 Jak-STAT signaling pathway 3977_6776_6777 3 0.001409613 0.053565292 0.005951699 4329 hsa-mir-1297 hsa04920 Adipocytokine signaling pathway 5970_6256 2 0.004218425 0.160300136 0.016030014 4330 hsa-mir-1297 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5970 2 0.004708842 0.178935979 0.016266907 4331 hsa-mir-1297 hsa05210 Colorectal cancer 3725_2353 2 0.006474344 0.246025068 0.018295347 4332 hsa-mir-1297 hsa05222 Small cell lung cancer 5970_6256 2 0.006768846 0.257216139 0.018295347 4333 hsa-mir-1297 hsa05215 Prostate cancer 367_5970 2 0.007069353 0.268635406 0.018295347 4334 hsa-mir-1297 hsa05212 Pancreatic cancer 367_5970 2 0.007221848 0.274430206 0.018295347 4335 hsa-mir-1297 hsa03450 Non-homologous end-joining 2547 1 0.020771447 0.789314997 0.049332187 4336 hsa-mir-1297 hsa05016 Huntington's disease 6908_6667 2 0.029030978 1 0.064283255 4337 hsa-mir-1297 hsa04062 Chemokine signaling pathway 6777_5970 2 0.030449963 1 0.064283255 4338 hsa-mir-1297 hsa04950 Maturity onset diabetes of the young 6927 1 0.034384455 1 0.068768911 4339 hsa-mir-1297 hsa05216 Thyroid cancer 6256 1 0.041121505 1 0.07813086 4340 hsa-mir-1301 hsa05200 Pathways in cancer 3320_3326_3725_1147_4087_4149_5371_405_3480_1956_1499_5595_5594_10401_6258_1387_2064_6256_595_1487_6502_2308_836_208_367_1017_4193_5914_7704_842_841_6776_5970_6654_8503_1870_1871_2885_7157_4824_2113_5295_1869_861_862_4088_4089_1050_5925_2033_207_8554_4286_4790 54 1.79E-43 1.32E-41 1.32E-41 4341 hsa-mir-1301 hsa05215 Prostate cancer 3320_3326_1147_3480_1956_1499_5595_5594_1385_1387_2064_595_2308_208_367_1017_4193_842_5970_6654_8503_1870_1871_2885_7157_4824_5295_1869_5925_2033_207_4790_90993 33 6.16E-37 4.55E-35 2.06E-35 4342 hsa-mir-1301 hsa05212 Pancreatic cancer 3320_3326_1147_3480_1956_1499_5595_5594_1385_1387_2064_595_2308_208_367_1017_4193_842_5970_6654_8503_1870_1871_2885_7157_4824_5295_1869_5925_2033_207_4790_90993 33 8.36E-37 6.18E-35 2.06E-35 4343 hsa-mir-1301 hsa05220 Chronic myeloid leukemia 1147_5595_5594_595_1487_208_4193_6776_5970_6654_8503_1870_1871_2885_7157_5295_1869_861_4088_4089_5925_207_4790_6464 24 8.81E-26 6.52E-24 1.63E-24 4344 hsa-mir-1301 hsa05214 Glioma 815_3480_1956_5595_5594_595_208_4193_6654_8503_1870_1871_2885_7157_5295_1869_5925_808_207_6464_801_805 22 3.55E-24 2.63E-22 5.26E-23 4345 hsa-mir-1301 hsa04010 MAPK signaling pathway 6722_3725_1147_4149_994_1956_5595_5594_9261_4208_836_5566_208_4214_7867_1432_5970_6654_627_2885_7157_10912_3727_6195_5058_4616_1616_6197_2872_207_4790_2002_2005 33 4.29E-23 3.17E-21 5.29E-22 4346 hsa-mir-1301 hsa05223 Non-small cell lung cancer 1956_5595_5594_6258_2064_6256_595_208_842_6654_8503_1870_1871_2885_7157_5295_1869_5925_2309_207 20 9.88E-23 7.31E-21 1.04E-21 4347 hsa-mir-1301 hsa04110 Cell cycle 4087_994_5591_1387_595_6502_1017_7533_4193_1870_1871_7157_10912_902_1869_4088_4089_1022_4616_5925_2033_890_5934_5933 24 1.06E-21 7.81E-20 9.77E-21 4348 hsa-mir-1301 hsa05221 Acute myeloid leukemia 1147_5371_5595_5594_595_208_5914_7704_6776_5970_6654_8503_2885_5295_861_862_1050_207_4790 19 1.05E-20 7.76E-19 8.62E-20 4349 hsa-mir-1301 hsa05222 Small cell lung cancer 1147_4149_10401_6258_6256_595_6502_208_1017_842_5970_8503_1870_1871_7157_5295_1869_5925_207_8554_4790 21 1.24E-20 9.18E-19 9.18E-20 4350 hsa-mir-1301 hsa05210 Colorectal cancer 3725_4087_3480_1956_1499_5595_5594_595_836_208_842_6654_8503_2885_7157_5295_4088_4089_207 19 3.00E-18 2.22E-16 2.02E-17 4351 hsa-mir-1301 hsa05213 Endometrial cancer 1956_1499_5595_5594_2064_595_208_842_6654_8503_2885_7157_5295_2309_207_2002 16 2.25E-17 1.67E-15 1.39E-16 4352 hsa-mir-1301 hsa04012 ErbB signaling pathway 3725_815_1956_6714_5595_5594_2064_208_6776_6654_8503_2885_5295_5058_56924_207_6464_2002 18 9.28E-17 6.86E-15 5.28E-16 4353 hsa-mir-1301 hsa04910 Insulin signaling pathway 6720_7249_10891_5595_5594_2308_5566_208_5770_6654_8503_2885_5295_808_2872_207_6464_2002_801_805 20 8.13E-16 6.02E-14 4.30E-15 4354 hsa-mir-1301 hsa05218 Melanoma 3480_1956_5595_5594_595_208_4193_8503_1870_1871_7157_5295_1869_5925_207_4286 16 1.51E-15 1.12E-13 7.44E-15 4355 hsa-mir-1301 hsa04520 Adherens junction 4087_3480_1956_1499_6714_5595_5594_1387_2064_5770_5777_1457_4088_4089_2033_1460 16 7.73E-15 5.72E-13 3.57E-14 4356 hsa-mir-1301 hsa05211 Renal cell carcinoma 3725_405_5595_5594_1387_208_6654_8503_2885_2113_5295_5058_56924_2033_207 15 3.21E-14 2.37E-12 1.40E-13 4357 hsa-mir-1301 hsa04660 T cell receptor signaling pathway 3725_1147_3932_5595_5594_208_5777_1432_5970_6654_8503_2885_5295_5058_56924_207_4790 17 4.79E-14 3.55E-12 1.97E-13 4358 hsa-mir-1301 hsa04510 Focal adhesion 3725_9564_3480_1956_1499_6714_5595_5594_2064_595_208_6654_8503_2885_857_5295_5058_56924_207_6464_2002 21 8.76E-14 6.49E-12 3.41E-13 4359 hsa-mir-1301 hsa04350 TGF-beta signaling pathway 4087_5595_5594_1387_3399_3398_1874_1875_4088_4089_2033_3397_6667_5934_5933 15 3.67E-13 2.72E-11 1.36E-12 4360 hsa-mir-1301 hsa04912 GnRH signaling pathway 3725_815_1956_6714_5595_5594_5566_4214_1432_6654_2885_808_2002_801_805 15 6.02E-12 4.45E-10 2.12E-11 4361 hsa-mir-1301 hsa04210 Apoptosis 1147_836_5566_839_208_842_841_840_5970_8503_7157_5295_207_4790 14 6.85E-12 5.07E-10 2.30E-11 4362 hsa-mir-1301 hsa05219 Bladder cancer 1956_5595_5594_2064_595_4193_1870_1871_7157_1869_5925 11 1.05E-11 7.79E-10 3.39E-11 4363 hsa-mir-1301 hsa04662 B cell receptor signaling pathway 3725_1147_5595_5594_208_5777_5970_6654_8503_2885_5295_207_4790 13 1.32E-11 9.73E-10 4.06E-11 4364 hsa-mir-1301 hsa04916 Melanogenesis 815_1499_5595_5594_1385_1387_2770_5566_808_2033_4286_90993_801_805 14 4.49E-11 3.32E-09 1.33E-10 4365 hsa-mir-1301 hsa04062 Chemokine signaling pathway 1147_9564_5595_5594_2770_5566_208_5970_6654_8503_2885_5295_5058_2309_207_4790_6464 17 1.73E-10 1.28E-08 4.94E-10 4366 hsa-mir-1301 hsa04720 Long-term potentiation 815_5595_5594_1387_5566_6195_6197_808_2033_801_805 11 2.46E-09 1.82E-07 6.73E-09 4367 hsa-mir-1301 hsa04370 VEGF signaling pathway 6714_5595_5594_9261_208_7867_1432_842_8503_5295_207 11 3.15E-09 2.33E-07 8.33E-09 4368 hsa-mir-1301 hsa04310 Wnt signaling pathway 3725_4087_815_1499_1387_595_1487_5566_7157_1457_4088_4089_2033_1460 14 4.25E-09 3.14E-07 1.08E-08 4369 hsa-mir-1301 hsa04620 Toll-like receptor signaling pathway 3725_1147_5595_5594_208_1432_841_5970_8503_5295_207_4790 12 4.47E-09 3.31E-07 1.10E-08 4370 hsa-mir-1301 hsa04115 p53 signaling pathway 7249_595_836_1017_4193_842_841_7157_10912_4616 10 1.46E-08 1.08E-06 3.49E-08 4371 hsa-mir-1301 hsa04150 mTOR signaling pathway 7249_5595_5594_208_8503_5295_6195_6197_207 9 1.97E-08 1.46E-06 4.56E-08 4372 hsa-mir-1301 hsa04630 Jak-STAT signaling pathway 10401_1387_595_208_5777_6776_6654_8503_2885_5295_2033_207_8554 13 4.27E-08 3.16E-06 9.58E-08 4373 hsa-mir-1301 hsa05216 Thyroid cancer 1499_5595_5594_6258_6256_595_7157 7 1.06E-07 7.82E-06 2.30E-07 4374 hsa-mir-1301 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1147_1956_6714_836_1432_5970_5058_4790 9 2.20E-07 1.63E-05 4.65E-07 4375 hsa-mir-1301 hsa04664 Fc epsilon RI signaling pathway 5595_5594_208_1432_6654_8503_2885_5295_207 9 5.02E-07 3.72E-05 1.03E-06 4376 hsa-mir-1301 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_836_5777_6654_8503_2885_5295_5058_6464 11 7.56E-07 5.59E-05 1.51E-06 4377 hsa-mir-1301 hsa04120 Ubiquitin mediated proteolysis 11059_5371_672_4734_10401_6502_4214_4193_10273_7329_8554 11 8.08E-07 5.98E-05 1.57E-06 4378 hsa-mir-1301 hsa04920 Adipocytokine signaling pathway 1147_10891_6258_6256_208_5970_207_4790 8 1.58E-06 0.000116941 3.00E-06 4379 hsa-mir-1301 hsa05016 Huntington's disease 10891_1385_1387_6908_836_842_841_627_7157_2033_6667_90993 12 2.15E-06 0.000159404 3.99E-06 4380 hsa-mir-1301 hsa03022 Basal transcription factors 2965_2962_2969_6908_2959_6881 6 6.77E-06 0.000500838 1.22E-05 4381 hsa-mir-1301 hsa04540 Gap junction 1956_6714_5595_5594_2770_5566_6654_2885 8 1.48E-05 0.00109761 2.61E-05 4382 hsa-mir-1301 hsa04330 Notch signaling pathway 388585_1387_1487_9612_2033_8850 6 2.33E-05 0.001721842 4.00E-05 4383 hsa-mir-1301 hsa05010 Alzheimer's disease 22926_5595_5594_836_842_841_840_808_801_805 10 4.09E-05 0.003023961 6.87E-05 4384 hsa-mir-1301 hsa04930 Type II diabetes mellitus 3651_5595_5594_8503_5295 5 0.000206906 0.01531108 0.000340246 4385 hsa-mir-1301 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432_842_7157_1616 5 0.000527155 0.039009435 0.000848031 4386 hsa-mir-1301 hsa04810 Regulation of actin cytoskeleton 9564_1956_5595_5594_6654_8503_5295_5058_56924 9 0.000918212 0.06794768 0.001445695 4387 hsa-mir-1301 hsa04530 Tight junction 1499_6714_2770_208_1457_207_1460 7 0.001025959 0.075920988 0.001581687 4388 hsa-mir-1301 hsa03420 Nucleotide excision repair 2965_902_1022_4331 4 0.001816616 0.134429595 0.002743461 4389 hsa-mir-1301 hsa04070 Phosphatidylinositol signaling system 8503_5295_808_801_805 5 0.001903962 0.14089321 0.002817864 4390 hsa-mir-1301 hsa04270 Vascular smooth muscle contraction 5595_5594_5566_808_801_805 6 0.002382634 0.176314926 0.003457155 4391 hsa-mir-1301 hsa04670 Leukocyte transendothelial migration 9564_1499_2770_1432_8503_5295 6 0.002791898 0.206600479 0.003973086 4392 hsa-mir-1301 hsa04950 Maturity onset diabetes of the young 3651_3172_168620 3 0.003050327 0.225724184 0.004258947 4393 hsa-mir-1301 hsa04612 Antigen processing and presentation 3320_3326_1385_4800_6890 5 0.003639958 0.269356912 0.004988091 4394 hsa-mir-1301 hsa04360 Axon guidance 5998_5595_5594_2770_5058_56924 6 0.003903012 0.288822861 0.005251325 4395 hsa-mir-1301 hsa04020 Calcium signaling pathway 815_1956_2064_5566_808_801_805 7 0.005007853 0.370581112 0.00661752 4396 hsa-mir-1301 hsa04730 Long-term depression 3480_5595_5594_2770 4 0.009036028 0.66866608 0.011730984 4397 hsa-mir-1301 hsa03050 Proteasome 5698_5705_5710 3 0.017948863 1 0.022900274 4398 hsa-mir-1302-1 hsa05200 Pathways in cancer 3716_5747_3725_675_1956_1499_5595_5594_1387_5159_5156_836_1019_1399_1398_1017_3815_6774_2064_6777_6772_2261_5879_7046_5970_6688_4089_8772_4609_1026_867_6776_4087_5925_2033_207_8554_2353 38 9.83E-33 7.28E-31 7.28E-31 4399 hsa-mir-1302-1 hsa04630 Jak-STAT signaling pathway 3717_3716_3718_85480_3560_3561_1387_3575_6774_6777_6772_6773_58985_2057_3455_3459_5781_7297_4609_867_6776_2690_1439_2033_207_8554_10379 27 8.25E-28 6.10E-26 3.05E-26 4400 hsa-mir-1302-1 hsa04012 ErbB signaling pathway 5747_3725_818_817_1956_6714_5595_5594_2066_1399_1398_2064_6777_4609_1026_867_6776_207_6464 19 1.65E-21 1.22E-19 4.06E-20 4401 hsa-mir-1302-1 hsa05220 Chronic myeloid leukemia 5595_5594_1019_1399_1398_6777_7046_5970_5781_4089_4609_1026_867_6776_5925_207_6464 17 1.32E-19 9.75E-18 1.96E-18 4402 hsa-mir-1302-1 hsa04010 MAPK signaling pathway 3725_1956_5595_5594_5598_1386_5159_5156_7132_836_1399_1398_2264_9252_1432_1649_2261_5879_7046_5970_468_4609_1845_207_2353 25 1.33E-19 9.82E-18 1.96E-18 4403 hsa-mir-1302-1 hsa04060 Cytokine-cytokine receptor interaction 2321_3791_85480_1956_90_3560_3561_5159_5156_7133_7132_3575_1234_1230_3815_7046_7852_58985_2057_3455_3459_2690_1439 23 9.66E-18 7.15E-16 1.19E-16 4404 hsa-mir-1302-1 hsa04520 Adherens junction 1956_1499_6714_3643_5595_5594_1387_5770_2064_5879_7046_4089_4087_2033_2534 15 2.31E-16 1.71E-14 2.44E-15 4405 hsa-mir-1302-1 hsa05210 Colorectal cancer 3725_1956_1499_5595_5594_5159_5156_836_5879_7046_4089_4609_4087_207_2353 15 4.40E-16 3.26E-14 4.07E-15 4406 hsa-mir-1302-1 hsa05215 Prostate cancer 1956_1499_5595_5594_1387_5159_5156_1017_2064_5970_468_1026_5925_2033_207 15 8.14E-16 6.02E-14 6.69E-15 4407 hsa-mir-1302-1 hsa05212 Pancreatic cancer 1956_1499_5595_5594_1387_5159_5156_1017_2064_5970_468_1026_5925_2033_207 15 9.45E-16 6.99E-14 6.99E-15 4408 hsa-mir-1302-1 hsa04062 Chemokine signaling pathway 3717_3718_5747_5580_5595_5594_1399_1398_1234_1230_6774_6777_6772_6773_5879_7852_5970_207_6464 19 1.09E-15 8.05E-14 7.32E-15 4409 hsa-mir-1302-1 hsa04350 TGF-beta signaling pathway 5515_90_5595_5594_1387_7027_7046_1874_4089_4609_4087_2033_57154_5933 14 1.55E-14 1.15E-12 9.58E-14 4410 hsa-mir-1302-1 hsa04510 Focal adhesion 5747_3725_2321_3791_1956_1499_6714_5595_5594_5159_5156_1399_1398_2064_5879_207_6464_2534 18 4.24E-14 3.14E-12 2.41E-13 4411 hsa-mir-1302-1 hsa05214 Glioma 818_817_1956_5595_5594_5159_5156_1019_1026_5925_207_6464 12 2.87E-13 2.12E-11 1.52E-12 4412 hsa-mir-1302-1 hsa04110 Cell cycle 1387_983_1019_1017_7027_4089_4174_1026_4172_4087_993_5925_2033_5933 14 7.60E-13 5.62E-11 3.75E-12 4413 hsa-mir-1302-1 hsa05219 Bladder cancer 1956_5595_5594_1019_9252_2064_2261_4609_1026_5925 10 3.14E-12 2.32E-10 1.45E-11 4414 hsa-mir-1302-1 hsa04660 T cell receptor signaling pathway 3725_3932_5595_5594_919_1019_1432_5970_867_207_2353_1493_2534 13 4.85E-12 3.59E-10 2.11E-11 4415 hsa-mir-1302-1 hsa05221 Acute myeloid leukemia 5595_5594_3815_6774_6777_5970_6688_4609_6776_207 10 6.08E-11 4.50E-09 2.50E-10 4416 hsa-mir-1302-1 hsa05211 Renal cell carcinoma 3725_5595_5594_1387_1399_1398_5879_5781_2033_207 10 3.53E-10 2.61E-08 1.38E-09 4417 hsa-mir-1302-1 hsa04620 Toll-like receptor signaling pathway 3725_5595_5594_1432_6772_5879_5970_3455_8772_207_2353 11 5.38E-10 3.98E-08 1.99E-09 4418 hsa-mir-1302-1 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_836_919_5879_6850_3455_3459_5781_6464_2534 12 8.56E-10 6.34E-08 3.02E-09 4419 hsa-mir-1302-1 hsa04912 GnRH signaling pathway 3725_5580_818_817_1956_6714_5595_5594_5598_1432_468 11 9.39E-10 6.95E-08 3.16E-09 4420 hsa-mir-1302-1 hsa05218 Melanoma 1956_5595_5594_5159_5156_1019_1026_5925_207 9 5.69E-09 4.21E-07 1.83E-08 4421 hsa-mir-1302-1 hsa04662 B cell receptor signaling pathway 3725_695_5595_5594_5879_5970_6850_207_2353 9 8.81E-09 6.52E-07 2.72E-08 4422 hsa-mir-1302-1 hsa04664 Fc epsilon RI signaling pathway 5580_695_5595_5594_1432_5879_6850_207_2534 9 1.33E-08 9.87E-07 3.95E-08 4423 hsa-mir-1302-1 hsa04310 Wnt signaling pathway 3725_5515_818_817_1499_1387_5879_4089_4609_4087_2033 11 2.60E-08 1.92E-06 7.40E-08 4424 hsa-mir-1302-1 hsa04920 Adipocytokine signaling pathway 3717_8717_7133_7132_6774_5970_5781_207 8 6.24E-08 4.62E-06 1.71E-07 4425 hsa-mir-1302-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1956_6714_836_1432_5879_5970_5781 8 9.42E-08 6.97E-06 2.49E-07 4426 hsa-mir-1302-1 hsa04370 VEGF signaling pathway 5747_3791_6714_5595_5594_1432_5879_207 8 1.67E-07 1.24E-05 4.27E-07 4427 hsa-mir-1302-1 hsa05213 Endometrial cancer 1956_1499_5595_5594_2064_4609_207 7 2.02E-07 1.50E-05 4.99E-07 4428 hsa-mir-1302-1 hsa05223 Non-small cell lung cancer 1956_5595_5594_1019_2064_5925_207 7 2.56E-07 1.89E-05 6.10E-07 4429 hsa-mir-1302-1 hsa05222 Small cell lung cancer 5747_1019_1017_5970_4609_5925_207_8554 8 3.67E-07 2.71E-05 8.48E-07 4430 hsa-mir-1302-1 hsa04210 Apoptosis 8717_7132_836_840_5970_8772_1439_207 8 4.68E-07 3.46E-05 1.05E-06 4431 hsa-mir-1302-1 hsa04540 Gap junction 1956_6714_5595_5594_5598_5159_983_5156 8 6.38E-07 4.72E-05 1.39E-06 4432 hsa-mir-1302-1 hsa04810 Regulation of actin cytoskeleton 5747_1956_5595_5594_5159_5156_1399_1398_2264_2261_5879 11 8.42E-07 6.23E-05 1.78E-06 4433 hsa-mir-1302-1 hsa04910 Insulin signaling pathway 3643_5595_5594_1399_1398_5770_867_207_6464 9 1.12E-06 8.30E-05 2.30E-06 4434 hsa-mir-1302-1 hsa04916 Melanogenesis 818_817_1499_5595_5594_1387_3815_2033 8 1.41E-06 0.000103989 2.81E-06 4435 hsa-mir-1302-1 hsa04720 Long-term potentiation 818_817_5595_5594_1387_468_2033 7 1.96E-06 0.000145382 3.83E-06 4436 hsa-mir-1302-1 hsa05340 Primary immunodeficiency 3718_695_3932_3561_3575 5 9.15E-06 0.000676888 1.74E-05 4437 hsa-mir-1302-1 hsa05010 Alzheimer's disease 5595_5594_7132_836_840_8772_1020_4724 8 5.55E-05 0.004108809 0.00010272 4438 hsa-mir-1302-1 hsa04360 Axon guidance 5747_5595_5594_5879_7852_1020_2534 7 5.99E-05 0.00443526 0.000108177 4439 hsa-mir-1302-1 hsa04020 Calcium signaling pathway 818_817_1956_2066_5159_5156_2064_147 8 7.21E-05 0.005332256 0.000126147 4440 hsa-mir-1302-1 hsa05014 Amyotrophic lateral sclerosis (ALS) 7133_7132_836_1432_5879 5 7.33E-05 0.005424316 0.000126147 4441 hsa-mir-1302-1 hsa05216 Thyroid cancer 1499_5595_5594_4609 4 8.52E-05 0.006306714 0.000143334 4442 hsa-mir-1302-1 hsa04115 p53 signaling pathway 983_836_1019_1017_1026 5 0.000184234 0.01363328 0.000302962 4443 hsa-mir-1302-1 hsa04670 Leukocyte transendothelial migration 5747_1499_1432_5879_7852_5781 6 0.000311402 0.023043777 0.000500952 4444 hsa-mir-1302-1 hsa04930 Type II diabetes mellitus 5580_3643_5595_5594 4 0.000403893 0.029888117 0.000635917 4445 hsa-mir-1302-1 hsa04330 Notch signaling pathway 1387_9612_2033_8850 4 0.000471145 0.034864724 0.000726348 4446 hsa-mir-1302-1 hsa04530 Tight junction 5580_5515_1499_6714_1019_207 6 0.000561732 0.041568151 0.00084833 4447 hsa-mir-1302-1 hsa03030 DNA replication 5981_4174_4172 3 0.002653443 0.196354761 0.003927095 4448 hsa-mir-1302-1 hsa04120 Ubiquitin mediated proteolysis 672_7329_867_8554_57154 5 0.003693206 0.27329726 0.00535877 4449 hsa-mir-1302-1 hsa04150 mTOR signaling pathway 5595_5594_207 3 0.007011812 0.518874086 0.009978348 4450 hsa-mir-1302-1 hsa04270 Vascular smooth muscle contraction 5580_5595_5594_147 4 0.011225232 0.830667162 0.015672965 4451 hsa-mir-1302-1 hsa04730 Long-term depression 5515_5595_5594 3 0.015712497 1 0.021531941 4452 hsa-mir-1302-1 hsa04640 Hematopoietic cell lineage 3575_3815_2057 3 0.026239926 1 0.035304628 4453 hsa-mir-1302-1 hsa03010 Ribosome 6124_6129_6143 3 0.038798005 1 0.051268793 4454 hsa-mir-1302-1 hsa05016 Huntington's disease 1387_836_2033_4724 4 0.048118522 1 0.06246966 4455 hsa-mir-1302-4 hsa04950 Maturity onset diabetes of the young 3651_5080 2 0.001275693 0.030616621 0.030616621 4456 hsa-mir-1302-4 hsa03022 Basal transcription factors 6908_2959 2 0.002859692 0.068632608 0.034316304 4457 hsa-mir-1302-4 hsa05016 Huntington's disease 2033_6908_10476 3 0.006934609 0.166430607 0.055476869 4458 hsa-mir-1302-4 hsa05215 Prostate cancer 2033_367 2 0.014466222 0.347189324 0.070906519 4459 hsa-mir-1302-4 hsa05212 Pancreatic cancer 2033_367 2 0.014772191 0.354532596 0.070906519 4460 hsa-mir-1302-4 hsa04530 Tight junction 60412_4628 2 0.032523426 0.780562215 0.130093703 4461 hsa-mir-1302-5 hsa03022 Basal transcription factors 2967_2961_2960_2963_6881_54457_2968_6879_6878_6877_6874_2957_6908_6873_6872_2958_6884_2959_6880_6882_138474_6883 22 3.03E-35 2.00E-33 2.00E-33 4462 hsa-mir-1302-5 hsa05200 Pathways in cancer 5925_5595_5594_5599_6256_3326_5601_4193_5970_7157_6688_3725_4609_2353_10401_4088_4089_2033_8554_7184 20 7.64E-15 5.04E-13 2.52E-13 4463 hsa-mir-1302-5 hsa05210 Colorectal cancer 5595_5594_5599_5601_7157_3725_4609_2353_4088_4089 10 1.11E-10 7.32E-09 2.44E-09 4464 hsa-mir-1302-5 hsa05220 Chronic myeloid leukemia 5925_5595_5594_4193_5970_7157_4609_4088_4089 9 9.12E-10 6.02E-08 1.50E-08 4465 hsa-mir-1302-5 hsa04310 Wnt signaling pathway 1460_5599_8607_5601_7157_3725_8061_4609_4088_4089_2033 11 1.75E-09 1.16E-07 2.32E-08 4466 hsa-mir-1302-5 hsa05215 Prostate cancer 5925_5595_5594_3326_4193_5970_7157_2033_7184 9 3.33E-09 2.20E-07 3.44E-08 4467 hsa-mir-1302-5 hsa05212 Pancreatic cancer 5925_5595_5594_3326_4193_5970_7157_2033_7184 9 3.65E-09 2.41E-07 3.44E-08 4468 hsa-mir-1302-5 hsa04010 MAPK signaling pathway 3727_5595_5594_5599_1386_5601_3312_1649_5970_7157_3725_4609_2353 13 7.01E-09 4.63E-07 5.78E-08 4469 hsa-mir-1302-5 hsa05219 Bladder cancer 5925_5595_5594_4193_7157_4609 6 2.48E-07 1.64E-05 1.82E-06 4470 hsa-mir-1302-5 hsa04110 Cell cycle 5925_4193_7157_4171_4085_4088_4089_2033 8 5.22E-07 3.44E-05 3.44E-06 4471 hsa-mir-1302-5 hsa05222 Small cell lung cancer 5925_6256_5970_7157_4609_10401_8554 7 8.23E-07 5.43E-05 4.94E-06 4472 hsa-mir-1302-5 hsa05216 Thyroid cancer 5595_5594_6256_7157_4609 5 1.13E-06 7.44E-05 6.20E-06 4473 hsa-mir-1302-5 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5601_5970_3725_2353 7 2.41E-06 0.000158782 1.22E-05 4474 hsa-mir-1302-5 hsa04520 Adherens junction 1460_5595_5594_4088_4089_2033 6 8.01E-06 0.000528473 3.77E-05 4475 hsa-mir-1302-5 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 1.07E-05 0.000705859 4.71E-05 4476 hsa-mir-1302-5 hsa04350 TGF-beta signaling pathway 5595_5594_4609_4088_4089_2033 6 1.26E-05 0.000830208 4.88E-05 4477 hsa-mir-1302-5 hsa04012 ErbB signaling pathway 5595_5594_5599_5601_3725_4609 6 1.26E-05 0.000830208 4.88E-05 4478 hsa-mir-1302-5 hsa05223 Non-small cell lung cancer 5925_5595_5594_6256_7157 5 1.82E-05 0.001199285 6.66E-05 4479 hsa-mir-1302-5 hsa05221 Acute myeloid leukemia 5595_5594_5970_6688_4609 5 2.71E-05 0.001786669 9.40E-05 4480 hsa-mir-1302-5 hsa05214 Glioma 5925_5595_5594_4193_7157 5 4.19E-05 0.002762188 0.000138109 4481 hsa-mir-1302-5 hsa04660 T cell receptor signaling pathway 5595_5594_5601_5970_3725_2353 6 4.42E-05 0.002914144 0.000138769 4482 hsa-mir-1302-5 hsa05218 Melanoma 5925_5595_5594_4193_7157 5 6.22E-05 0.004106534 0.000186661 4483 hsa-mir-1302-5 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725_2353 5 7.96E-05 0.005250376 0.000228277 4484 hsa-mir-1302-5 hsa05016 Huntington's disease 6874_6908_9001_5430_7157_3064_2033 7 0.000104041 0.006866739 0.000286114 4485 hsa-mir-1302-5 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601 4 0.00015095 0.009962682 0.000398507 4486 hsa-mir-1302-5 hsa05213 Endometrial cancer 5595_5594_7157_4609 4 0.000254008 0.01676451 0.000644789 4487 hsa-mir-1302-5 hsa04912 GnRH signaling pathway 5595_5594_5599_5601_3725 5 0.000401861 0.026522801 0.000982326 4488 hsa-mir-1302-5 hsa04920 Adipocytokine signaling pathway 5599_6256_5601_5970 4 0.000630551 0.041616377 0.001486299 4489 hsa-mir-1302-5 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5601_5970_3725 4 0.000775533 0.051185183 0.001765006 4490 hsa-mir-1302-5 hsa05211 Renal cell carcinoma 5595_5594_3725_2033 4 0.000815162 0.053800663 0.001793355 4491 hsa-mir-1302-5 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5601 4 0.001133511 0.074811727 0.002404622 4492 hsa-mir-1302-5 hsa04910 Insulin signaling pathway 5595_5594_5599_5601_5211 5 0.001165877 0.076947904 0.002404622 4493 hsa-mir-1302-5 hsa04120 Ubiquitin mediated proteolysis 672_4193_10401_64326_8554 5 0.001202555 0.07936864 0.00240511 4494 hsa-mir-1302-5 hsa03420 Nucleotide excision repair 2967_2968_5887 3 0.002183961 0.144141451 0.004239454 4495 hsa-mir-1302-5 hsa04510 Focal adhesion 5595_5594_5599_5601_3725 5 0.006208428 0.409756215 0.01170732 4496 hsa-mir-1302-5 hsa04115 p53 signaling pathway 4193_7157_64326 3 0.007272072 0.479956739 0.013332132 4497 hsa-mir-1302-5 hsa04720 Long-term potentiation 5595_5594_2033 3 0.009058179 0.597839838 0.016157833 4498 hsa-mir-1302-5 hsa04630 Jak-STAT signaling pathway 4609_10401_2033_8554 4 0.01149388 0.758596063 0.019963054 4499 hsa-mir-1302-5 hsa04612 Antigen processing and presentation 3326_4801_3312 3 0.014147568 0.93373947 0.023942038 4500 hsa-mir-1302-5 hsa04540 Gap junction 5595_5594_10382 3 0.015844675 1 0.026143714 4501 hsa-mir-1302-5 hsa04916 Melanogenesis 5595_5594_2033 3 0.021078649 1 0.033931483 4502 hsa-mir-1302-5 hsa04330 Notch signaling pathway 2033_8850 2 0.029567046 1 0.046462501 4503 hsa-mir-1302-5 hsa04150 mTOR signaling pathway 5595_5594 2 0.035348487 1 0.054255817 4504 hsa-mir-1302-5 hsa05322 Systemic lupus erythematosus 3014_3015_8340 3 0.047113112 1 0.070669669 4505 hsa-mir-1305 hsa05200 Pathways in cancer 2249_367_3725_6776_6777_2353_5914_5970_6256 9 2.03E-10 7.70E-09 7.70E-09 4506 hsa-mir-1305 hsa05221 Acute myeloid leukemia 6776_6777_5914_5970 4 9.84E-07 3.74E-05 1.87E-05 4507 hsa-mir-1305 hsa05220 Chronic myeloid leukemia 6776_6777_5970 3 0.000113081 0.004297074 0.001074269 4508 hsa-mir-1305 hsa04662 B cell receptor signaling pathway 3725_2353_5970 3 0.000113081 0.004297074 0.001074269 4509 hsa-mir-1305 hsa04012 ErbB signaling pathway 3725_6776_6777 3 0.00017291 0.006570564 0.001314113 4510 hsa-mir-1305 hsa04620 Toll-like receptor signaling pathway 3725_2353_5970 3 0.000272526 0.010355982 0.001606221 4511 hsa-mir-1305 hsa04010 MAPK signaling pathway 2249_3725_2353_5970 4 0.000330487 0.012558499 0.001606221 4512 hsa-mir-1305 hsa04660 T cell receptor signaling pathway 3725_2353_5970 3 0.000338152 0.012849769 0.001606221 4513 hsa-mir-1305 hsa04630 Jak-STAT signaling pathway 3977_6776_6777 3 0.000897685 0.03411204 0.003790227 4514 hsa-mir-1305 hsa04920 Adipocytokine signaling pathway 5970_6256 2 0.003115381 0.11838449 0.011838449 4515 hsa-mir-1305 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5970 2 0.003479392 0.132216888 0.012019717 4516 hsa-mir-1305 hsa05210 Colorectal cancer 3725_2353 2 0.004792101 0.18209983 0.0135505 4517 hsa-mir-1305 hsa05222 Small cell lung cancer 5970_6256 2 0.005011395 0.190433006 0.0135505 4518 hsa-mir-1305 hsa05215 Prostate cancer 367_5970 2 0.00523525 0.198939509 0.0135505 4519 hsa-mir-1305 hsa05212 Pancreatic cancer 367_5970 2 0.005348882 0.203257498 0.0135505 4520 hsa-mir-1305 hsa03450 Non-homologous end-joining 2547 1 0.01783249 0.677634628 0.042352164 4521 hsa-mir-1305 hsa05016 Huntington's disease 6908_6667 2 0.021779742 0.827630199 0.048257818 4522 hsa-mir-1305 hsa04062 Chemokine signaling pathway 6777_5970 2 0.022858967 0.868640727 0.048257818 4523 hsa-mir-1305 hsa04950 Maturity onset diabetes of the young 6927 1 0.02954865 1 0.0590973 4524 hsa-mir-1305 hsa05216 Thyroid cancer 6256 1 0.035355663 1 0.067175759 4525 hsa-mir-1305 hsa04080 Neuroactive ligand-receptor interaction 2908_7067 2 0.038234048 1 0.06918542 4526 hsa-mir-1305 hsa03410 Base excision repair 142 1 0.043428758 1 0.073648431 4527 hsa-mir-1305 hsa03022 Basal transcription factors 6908 1 0.044576682 1 0.073648431 4528 hsa-mir-1306 hsa05200 Pathways in cancer 2113_7157_861_5925_1387 5 1.32E-06 3.95E-05 3.95E-05 4529 hsa-mir-1306 hsa05220 Chronic myeloid leukemia 7157_861_5925 3 1.34E-05 0.000401696 0.000131923 4530 hsa-mir-1306 hsa04350 TGF-beta signaling pathway 3398_3399_1387 3 2.06E-05 0.000617532 0.000131923 4531 hsa-mir-1306 hsa05215 Prostate cancer 7157_5925_1387 3 2.13E-05 0.000638345 0.000131923 4532 hsa-mir-1306 hsa05212 Pancreatic cancer 7157_5925_1387 3 2.20E-05 0.000659615 0.000131923 4533 hsa-mir-1306 hsa04110 Cell cycle 7157_5925_1387 3 5.11E-05 0.001533416 0.000255569 4534 hsa-mir-1306 hsa05016 Huntington's disease 7157_1387_6908 3 0.000192852 0.005785569 0.00082651 4535 hsa-mir-1306 hsa05219 Bladder cancer 7157_5925 2 0.000316507 0.009495202 0.0011869 4536 hsa-mir-1306 hsa05223 Non-small cell lung cancer 7157_5925 2 0.000513053 0.01539158 0.001650923 4537 hsa-mir-1306 hsa05014 Amyotrophic lateral sclerosis (ALS) 7157_1616 2 0.000550308 0.016509235 0.001650923 4538 hsa-mir-1306 hsa05214 Glioma 7157_5925 2 0.000733726 0.022011783 0.002001071 4539 hsa-mir-1306 hsa05218 Melanoma 7157_5925 2 0.000870253 0.026107597 0.00206333 4540 hsa-mir-1306 hsa05211 Renal cell carcinoma 2113_1387 2 0.00089411 0.026823286 0.00206333 4541 hsa-mir-1306 hsa05222 Small cell lung cancer 7157_5925 2 0.001260899 0.037826976 0.002701927 4542 hsa-mir-1306 hsa04310 Wnt signaling pathway 7157_1387 2 0.003790764 0.11372293 0.007581529 4543 hsa-mir-1306 hsa04010 MAPK signaling pathway 7157_1616 2 0.011614496 0.348434866 0.021777179 4544 hsa-mir-1306 hsa05216 Thyroid cancer 7157 1 0.017842211 0.535266341 0.031486255 4545 hsa-mir-1306 hsa03022 Basal transcription factors 6908 1 0.022549107 0.676473219 0.037581845 4546 hsa-mir-1306 hsa04330 Notch signaling pathway 1387 1 0.028402771 0.852083127 0.04484648 4547 hsa-mir-1306 hsa05213 Endometrial cancer 7157 1 0.031317172 0.939515157 0.046975758 4548 hsa-mir-1306 hsa05217 Basal cell carcinoma 7157 1 0.033061847 0.991855421 0.047231211 4549 hsa-mir-1306 hsa05221 Acute myeloid leukemia 861 1 0.035383465 1 0.04825018 4550 hsa-mir-1306 hsa04115 p53 signaling pathway 7157 1 0.041164499 1 0.053692825 4551 hsa-mir-1306 hsa04720 Long-term potentiation 1387 1 0.044617397 1 0.055771746 4552 hsa-mir-1306 hsa04520 Adherens junction 1387 1 0.047485837 1 0.056983005 4553 hsa-mir-1306 hsa05210 Colorectal cancer 7157 1 0.049774731 1 0.057432382 4554 hsa-mir-1307 hsa05200 Pathways in cancer 4088_9915_4087_5371_2034_2033_3091_4609 8 5.70E-09 1.60E-07 1.60E-07 4555 hsa-mir-1307 hsa04350 TGF-beta signaling pathway 4088_4087_2033_4093_4609 5 8.45E-08 2.37E-06 1.18E-06 4556 hsa-mir-1307 hsa04310 Wnt signaling pathway 4088_4087_2033_4609_1457 5 1.21E-06 3.39E-05 1.13E-05 4557 hsa-mir-1307 hsa05211 Renal cell carcinoma 9915_2034_2033_3091 4 2.10E-06 5.87E-05 1.47E-05 4558 hsa-mir-1307 hsa04520 Adherens junction 4088_4087_2033_1457 4 3.13E-06 8.77E-05 1.75E-05 4559 hsa-mir-1307 hsa05210 Colorectal cancer 4088_4087_4609 3 0.000156391 0.00437895 0.000729825 4560 hsa-mir-1307 hsa04110 Cell cycle 4088_4087_2033 3 0.00042326 0.011851275 0.001693039 4561 hsa-mir-1307 hsa04330 Notch signaling pathway 9612_2033 2 0.001585339 0.044389503 0.005548688 4562 hsa-mir-1307 hsa05221 Acute myeloid leukemia 5371_4609 2 0.002444814 0.068454799 0.007606089 4563 hsa-mir-1307 hsa05220 Chronic myeloid leukemia 4088_4609 2 0.003862313 0.108144758 0.010814476 4564 hsa-mir-1307 hsa04612 Antigen processing and presentation 4800_4801 2 0.005348882 0.149768683 0.013615335 4565 hsa-mir-1307 hsa04120 Ubiquitin mediated proteolysis 5371_7329 2 0.012418347 0.347713705 0.028976142 4566 hsa-mir-1307 hsa04630 Jak-STAT signaling pathway 2033_4609 2 0.015224725 0.426292297 0.032791715 4567 hsa-mir-1307 hsa05216 Thyroid cancer 4609 1 0.035355663 0.989958551 0.070711325 4568 hsa-mir-1307 hsa03022 Basal transcription factors 2963 1 0.044576682 1 0.083209806 4569 hsa-mir-130a hsa05200 Pathways in cancer 1499_595_598_1019_1017_4193_5578_3091_4087_3065_1050_5925_5747_25_1956_2308_6789_613_4436_596_861_1147_998_1026_367_5595_5594_5599_5743_1387_9915_2932_6776_5970_6688_1869_3725_4088_4089_5888_5728_2034_2033_3910_4790_4792_3320_3326_5371_675_5601_5602_1856_841_51588_4609_2353_8554 58 1.66E-39 1.43E-37 1.43E-37 4570 hsa-mir-130a hsa04110 Cell cycle 595_1019_1017_4193_902_4087_3065_5925_25_9232_5933_545_995_1026_5591_1387_11200_7534_7532_2932_7027_1031_1869_4088_4089_2033_890_894_896_983_5347_1022_472_1111_8556_8555 36 5.38E-32 4.63E-30 2.31E-30 4571 hsa-mir-130a hsa05215 Prostate cancer 1499_595_1017_4193_5925_1956_2308_596_1147_1026_367_5595_5594_1385_1387_2932_5970_1869_5728_2033_4790_4792_3320_3326_468 25 5.12E-22 4.41E-20 1.39E-20 4572 hsa-mir-130a hsa05212 Pancreatic cancer 1499_595_1017_4193_5925_1956_2308_596_1147_1026_367_5595_5594_1385_1387_2932_5970_1869_5728_2033_4790_4792_3320_3326_468 25 6.47E-22 5.56E-20 1.39E-20 4573 hsa-mir-130a hsa04115 p53 signaling pathway 595_1019_1017_4194_4193_900_50484_6241_51246_545_1026_11200_64326_5728_894_896_27113_25898_983_841_7161_472_1111 23 1.14E-21 9.82E-20 1.96E-20 4574 hsa-mir-130a hsa05220 Chronic myeloid leukemia 595_598_1019_4193_3065_5925_25_613_861_1147_1026_5595_5594_6776_5970_1869_4088_4089_4790_4792_4609 21 1.36E-18 1.17E-16 1.95E-17 4575 hsa-mir-130a hsa04310 Wnt signaling pathway 815_1499_595_5578_4087_1460_5599_1387_2932_3725_1457_1452_4088_4089_2033_894_896_5518_5515_5601_5602_5566_1856_4609_5527 25 4.62E-17 3.97E-15 5.68E-16 4576 hsa-mir-130a hsa04010 MAPK signaling pathway 6722_6195_9252_5578_5923_1956_3304_3305_3303_6789_1616_1147_998_5595_5594_5599_1386_3315_1649_5970_3164_3725_6196_4790_5601_5602_5566_4609_2353_468_2002 31 1.05E-16 9.01E-15 1.13E-15 4577 hsa-mir-130a hsa05210 Colorectal cancer 1499_595_4087_1956_4436_596_5595_5594_5599_2932_3725_4088_4089_5601_5602_1856_4609_2353 18 2.19E-14 1.88E-12 2.09E-13 4578 hsa-mir-130a hsa05222 Small cell lung cancer 595_598_1019_1017_5925_5747_596_1147_5743_5970_1869_5728_3910_4790_4792_51588_4609_8554 18 3.12E-14 2.68E-12 2.68E-13 4579 hsa-mir-130a hsa04012 ErbB signaling pathway 815_5578_5747_25_1956_1026_5595_5594_5599_2932_6776_3725_5601_5602_4609_2002 16 4.76E-12 4.10E-10 3.73E-11 4580 hsa-mir-130a hsa04350 TGF-beta signaling pathway 4087_6667_1874_5933_5595_5594_1387_7027_4088_4089_2033_5518_5515_4609_4093 15 5.00E-11 4.30E-09 3.58E-10 4581 hsa-mir-130a hsa04510 Focal adhesion 1499_595_5578_5923_5747_1956_5499_596_998_5595_5594_5599_2932_3725_5728_894_896_3910_5601_5602_2002 21 6.22E-11 5.35E-09 4.12E-10 4582 hsa-mir-130a hsa05219 Bladder cancer 595_1019_9252_4193_5925_1956_1026_5595_5594_1869_4609 11 4.17E-10 3.58E-08 2.56E-09 4583 hsa-mir-130a hsa05221 Acute myeloid leukemia 595_1050_861_1147_5595_5594_6776_5970_6688_4790_5371_4609 12 8.26E-10 7.10E-08 4.74E-09 4584 hsa-mir-130a hsa05214 Glioma 815_595_1019_4193_5578_5925_1956_1026_5595_5594_1869_5728 12 2.18E-09 1.88E-07 1.17E-08 4585 hsa-mir-130a hsa04520 Adherens junction 1499_4087_1956_1460_998_5595_5594_1387_1457_4088_4089_2033 12 1.75E-08 1.51E-06 8.86E-08 4586 hsa-mir-130a hsa04620 Toll-like receptor signaling pathway 1147_5595_5594_5599_5970_3725_4790_4792_5601_5602_841_2353_6348 13 2.58E-08 2.22E-06 1.23E-07 4587 hsa-mir-130a hsa04912 GnRH signaling pathway 815_5578_1956_998_5595_5594_5599_3725_5601_5602_5566_468_2002 13 4.77E-08 4.11E-06 2.16E-07 4588 hsa-mir-130a hsa04660 T cell receptor signaling pathway 1019_1147_998_5595_5594_2932_5970_3725_4790_4792_5601_2353_959 13 5.81E-08 5.00E-06 2.50E-07 4589 hsa-mir-130a hsa04720 Long-term potentiation 815_6195_5578_5499_5595_5594_1387_6196_2033_5566_468 11 8.50E-08 7.31E-06 3.48E-07 4590 hsa-mir-130a hsa04120 Ubiquitin mediated proteolysis 4193_3093_7319_84447_7329_10055_64326_7337_5371_672_25898_51588_10075_8554 14 1.12E-07 9.65E-06 4.38E-07 4591 hsa-mir-130a hsa05213 Endometrial cancer 1499_595_1956_5595_5594_2932_5728_4609_2002 9 3.70E-07 3.18E-05 1.38E-06 4592 hsa-mir-130a hsa05218 Melanoma 595_1019_4193_5925_1956_1026_5595_5594_1869_5728 10 4.62E-07 3.98E-05 1.59E-06 4593 hsa-mir-130a hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_1147_998_5599_5970_3725_4790_4792_5601_5602 10 4.62E-07 3.98E-05 1.59E-06 4594 hsa-mir-130a hsa05223 Non-small cell lung cancer 595_1019_5578_5925_1956_6789_5595_5594_1869 9 4.92E-07 4.23E-05 1.63E-06 4595 hsa-mir-130a hsa04662 B cell receptor signaling pathway 1380_1147_5595_5594_2932_5970_3725_4790_4792_2353 10 7.29E-07 6.27E-05 2.32E-06 4596 hsa-mir-130a hsa03420 Nucleotide excision repair 5981_902_6117_2965_4331_2071_2074_1022 8 1.20E-06 0.000102864 3.67E-06 4597 hsa-mir-130a hsa04916 Melanogenesis 815_1499_5578_5595_5594_1385_1387_2932_2033_5566_1856 11 1.66E-06 0.000142723 4.92E-06 4598 hsa-mir-130a hsa04920 Adipocytokine signaling pathway 6794_1147_5599_5970_4790_4792_5601_5602_5563 9 2.48E-06 0.000213535 7.12E-06 4599 hsa-mir-130a hsa04210 Apoptosis 598_823_596_1147_5970_4790_4792_5566_841_472 10 3.00E-06 0.000258064 8.32E-06 4600 hsa-mir-130a hsa05211 Renal cell carcinoma 3091_998_5595_5594_1387_9915_3725_2034_2033 9 4.25E-06 0.000365483 1.14E-05 4601 hsa-mir-130a hsa03022 Basal transcription factors 51616_2957_2965_2963_6908_2958_6880 7 4.46E-06 0.00038371 1.16E-05 4602 hsa-mir-130a hsa04910 Insulin signaling pathway 5499_2308_5595_5594_5599_2932_5601_5602_5566_5563_2002 11 2.02E-05 0.001737377 5.01E-05 4603 hsa-mir-130a hsa04612 Antigen processing and presentation 3309_3304_3305_3303_1385_3320_3326_4800_4801 9 2.04E-05 0.001752714 5.01E-05 4604 hsa-mir-130a hsa04150 mTOR signaling pathway 6794_6195_3091_5595_5594_6196_5563 7 3.26E-05 0.002802911 7.79E-05 4605 hsa-mir-130a hsa04630 Jak-STAT signaling pathway 595_598_1387_6778_6776_2033_894_896_51588_4609_8554 11 5.47E-05 0.004703583 0.000127124 4606 hsa-mir-130a hsa04062 Chemokine signaling pathway 5747_6362_1147_998_5595_5594_2932_5970_4790_4792_5566_6348 12 8.44E-05 0.007257638 0.00019099 4607 hsa-mir-130a hsa04530 Tight junction 1499_1019_5578_1460_998_1457_5728_5518_5515_5520 10 9.53E-05 0.008196186 0.000210159 4608 hsa-mir-130a hsa04330 Notch signaling pathway 3065_1387_9612_2033_8850_1856 6 0.000156718 0.013477766 0.000334963 4609 hsa-mir-130a hsa05216 Thyroid cancer 1499_595_5595_5594_4609 5 0.000159692 0.013733498 0.000334963 4610 hsa-mir-130a hsa04370 VEGF signaling pathway 5578_5747_998_5595_5594_5743_3315 7 0.000311635 0.026800638 0.00063811 4611 hsa-mir-130a hsa05131 Shigellosis 1499_5578_25_998_7534_4691 6 0.000373719 0.032139869 0.000730452 4612 hsa-mir-130a hsa05130 Pathogenic Escherichia coli infection 1499_5578_25_998_7534_4691 6 0.000373719 0.032139869 0.000730452 4613 hsa-mir-130a hsa04540 Gap junction 5578_1956_5595_5594_1453_983_5566 7 0.000893567 0.076846759 0.001707706 4614 hsa-mir-130a hsa04930 Type II diabetes mellitus 5595_5594_5599_5601_5602 5 0.000994702 0.085544373 0.00185966 4615 hsa-mir-130a hsa05016 Huntington's disease 3065_3064_25942_6667_1385_1387_2033_27113_6908_841 10 0.001021631 0.087860282 0.001869368 4616 hsa-mir-130a hsa03440 Homologous recombination 641_6117_5888_675 4 0.001394773 0.11995049 0.002498969 4617 hsa-mir-130a hsa04664 Fc epsilon RI signaling pathway 5578_5595_5594_5599_5601_5602 6 0.001979859 0.170267863 0.003474854 4618 hsa-mir-130a hsa03030 DNA replication 5981_6117_5557_5422 4 0.00321931 0.27686062 0.00542864 4619 hsa-mir-130a hsa03410 Base excision repair 3146_142_4913_328 4 0.00321931 0.27686062 0.00542864 4620 hsa-mir-130a hsa04360 Axon guidance 5747_25_998_5595_5594_2932_1020 7 0.005522672 0.474949821 0.00913365 4621 hsa-mir-130a hsa04730 Long-term depression 5578_5595_5594_5518_5515 5 0.00627512 0.539660309 0.01018227 4622 hsa-mir-130a hsa03430 Mismatch repair 5981_4436_6117 3 0.007159526 0.615719272 0.011402209 4623 hsa-mir-130a hsa05014 Amyotrophic lateral sclerosis (ALS) 598_596_1616_834 4 0.013527617 1 0.021152274 4624 hsa-mir-130a hsa04340 Hedgehog signaling pathway 2932_1452_1453_5566 4 0.01430608 1 0.021970052 4625 hsa-mir-130a hsa05010 Alzheimer's disease 823_22926_5595_5594_2932_841_1020 7 0.02384292 1 0.035973529 4626 hsa-mir-130a hsa03450 Non-homologous end-joining 2547_5591 2 0.0244101 1 0.036194286 4627 hsa-mir-130a hsa04270 Vascular smooth muscle contraction 5578_5499_5595_5594_5566 5 0.041260709 1 0.060142728 4628 hsa-mir-130b hsa05200 Pathways in cancer 1956_5595_5594_5599_6258_1387_6257_6256_8031_2308_836_841_6776_5970_6688_4609_4088_861_4087_4089_1050_5925_2033_8554_4790 25 7.02E-24 4.35E-22 4.35E-22 4629 hsa-mir-130b hsa04010 MAPK signaling pathway 6722_1956_5595_5594_5599_5598_1386_836_5566_9252_1432_1649_5970_10912_468_4609_6195_6196_4616_4790_2002 21 2.48E-20 1.54E-18 7.69E-19 4630 hsa-mir-130b hsa05215 Prostate cancer 1956_5595_5594_1385_1387_2308_5970_468_5925_2033_4790 11 2.83E-13 1.76E-11 4.92E-12 4631 hsa-mir-130b hsa05212 Pancreatic cancer 1956_5595_5594_1385_1387_2308_5970_468_5925_2033_4790 11 3.17E-13 1.97E-11 4.92E-12 4632 hsa-mir-130b hsa05220 Chronic myeloid leukemia 5595_5594_6776_5970_4609_4088_861_4089_5925_4790 10 1.98E-12 1.23E-10 2.45E-11 4633 hsa-mir-130b hsa05221 Acute myeloid leukemia 5595_5594_6776_5970_6688_4609_861_1050_4790 9 8.76E-12 5.43E-10 9.05E-11 4634 hsa-mir-130b hsa04912 GnRH signaling pathway 815_1956_5595_5594_5599_5598_5566_1432_468_2002 10 5.51E-11 3.41E-09 4.81E-10 4635 hsa-mir-130b hsa04720 Long-term potentiation 815_5595_5594_1387_5566_468_6195_6196_2033 9 6.20E-11 3.84E-09 4.81E-10 4636 hsa-mir-130b hsa05216 Thyroid cancer 5595_5594_6258_6257_6256_8031_4609 7 1.14E-10 7.05E-09 7.84E-10 4637 hsa-mir-130b hsa05210 Colorectal cancer 1956_5595_5594_5599_836_4609_4088_4087_4089 9 1.57E-10 9.74E-09 9.74E-10 4638 hsa-mir-130b hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_4609_4088_4087_4089_2033 9 2.10E-10 1.30E-08 1.18E-09 4639 hsa-mir-130b hsa04520 Adherens junction 1956_5595_5594_1387_4088_4087_4089_2033 8 2.81E-09 1.75E-07 1.45E-08 4640 hsa-mir-130b hsa05222 Small cell lung cancer 6258_6257_6256_5970_4609_5925_8554_4790 8 4.78E-09 2.96E-07 2.26E-08 4641 hsa-mir-130b hsa04012 ErbB signaling pathway 815_1956_5595_5594_5599_6776_4609_2002 8 5.20E-09 3.22E-07 2.26E-08 4642 hsa-mir-130b hsa05223 Non-small cell lung cancer 1956_5595_5594_6258_6257_6256_5925 7 5.47E-09 3.39E-07 2.26E-08 4643 hsa-mir-130b hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_1432_841_5970_6348_4790 8 1.67E-08 1.03E-06 6.46E-08 4644 hsa-mir-130b hsa04310 Wnt signaling pathway 815_5599_1387_5566_4609_4088_4087_4089_2033 9 2.07E-08 1.28E-06 7.44E-08 4645 hsa-mir-130b hsa04920 Adipocytokine signaling pathway 5599_6258_6257_6256_5970_10891_4790 7 2.16E-08 1.34E-06 7.44E-08 4646 hsa-mir-130b hsa05219 Bladder cancer 1956_5595_5594_9252_4609_5925 6 4.16E-08 2.58E-06 1.36E-07 4647 hsa-mir-130b hsa04110 Cell cycle 1387_10912_4088_4087_4089_4616_5925_2033 8 5.15E-08 3.19E-06 1.60E-07 4648 hsa-mir-130b hsa04916 Melanogenesis 815_5595_5594_1385_1387_5566_2033 7 3.60E-07 2.23E-05 1.06E-06 4649 hsa-mir-130b hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_5599_836_1432_5970_4790 6 7.31E-07 4.53E-05 2.06E-06 4650 hsa-mir-130b hsa04910 Insulin signaling pathway 5595_5594_5599_2308_5566_10891_2002 7 2.19E-06 0.000135504 5.89E-06 4651 hsa-mir-130b hsa04210 Apoptosis 836_5566_841_840_5970_4790 6 2.53E-06 0.000156578 6.52E-06 4652 hsa-mir-130b hsa05213 Endometrial cancer 1956_5595_5594_4609_2002 5 3.55E-06 0.00022013 8.81E-06 4653 hsa-mir-130b hsa05214 Glioma 815_1956_5595_5594_5925 5 9.84E-06 0.00061013 2.35E-05 4654 hsa-mir-130b hsa05010 Alzheimer's disease 22926_5595_5594_836_841_840_1020 7 1.05E-05 0.000650652 2.41E-05 4655 hsa-mir-130b hsa05016 Huntington's disease 1385_1387_836_6667_841_10891_2033 7 1.53E-05 0.000948022 3.39E-05 4656 hsa-mir-130b hsa04540 Gap junction 1956_5595_5594_5598_5566 5 5.04E-05 0.003127848 0.000106399 4657 hsa-mir-130b hsa04630 Jak-STAT signaling pathway 1387_6776_4609_6778_2033_8554 6 5.15E-05 0.003191972 0.000106399 4658 hsa-mir-130b hsa04150 mTOR signaling pathway 5595_5594_6195_6196 4 7.99E-05 0.004955882 0.000159867 4659 hsa-mir-130b hsa04660 T cell receptor signaling pathway 5595_5594_1432_5970_4790 5 0.000107939 0.006692245 0.000209133 4660 hsa-mir-130b hsa04062 Chemokine signaling pathway 5595_5594_5566_5970_6348_4790 6 0.000165032 0.010231965 0.00031006 4661 hsa-mir-130b hsa04115 p53 signaling pathway 836_841_10912_4616 4 0.000224642 0.013927832 0.000409642 4662 hsa-mir-130b hsa03320 PPAR signaling pathway 6258_6257_6256_2168 4 0.00023674 0.0146779 0.000419369 4663 hsa-mir-130b hsa05218 Melanoma 1956_5595_5594_5925 4 0.0002493 0.01545659 0.00042935 4664 hsa-mir-130b hsa05211 Renal cell carcinoma 5595_5594_1387_2033 4 0.000262331 0.016264541 0.000439582 4665 hsa-mir-130b hsa04662 B cell receptor signaling pathway 5595_5594_5970_4790 4 0.000304361 0.018870367 0.000496589 4666 hsa-mir-130b hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_1432 4 0.000367639 0.022793589 0.000584451 4667 hsa-mir-130b hsa04930 Type II diabetes mellitus 5595_5594_5599 3 0.000981496 0.060852771 0.001521319 4668 hsa-mir-130b hsa04330 Notch signaling pathway 1387_9612_2033 3 0.001105712 0.068554134 0.001672052 4669 hsa-mir-130b hsa04510 Focal adhesion 1956_5595_5594_5599_2002 5 0.001717708 0.106497878 0.002535664 4670 hsa-mir-130b hsa05014 Amyotrophic lateral sclerosis (ALS) 836_834_1432 3 0.001786052 0.110735198 0.002575237 4671 hsa-mir-130b hsa04370 VEGF signaling pathway 5595_5594_1432 3 0.004244255 0.263143829 0.005980542 4672 hsa-mir-130b hsa04612 Antigen processing and presentation 1385_4800_4801 3 0.006263585 0.388342294 0.008629829 4673 hsa-mir-130b hsa04270 Vascular smooth muscle contraction 5595_5594_5566 3 0.013200225 0.818413934 0.017791607 4674 hsa-mir-130b hsa04360 Axon guidance 5595_5594_1020 3 0.017306946 1 0.022830439 4675 hsa-mir-130b hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836 3 0.019781106 1 0.025550596 4676 hsa-mir-130b hsa04730 Long-term depression 5595_5594 2 0.035473897 1 0.044885339 4677 hsa-mir-130b hsa04020 Calcium signaling pathway 815_1956_5566 3 0.040633489 1 0.050385526 4678 hsa-mir-132 hsa05200 Pathways in cancer 595_2261_4193_6934_3091_3066_3065_1050_5925_7184_25_1956_1487_1488_1870_1871_2113_861_10401_207_3716_1026_4233_5595_5594_5599_1387_2064_6256_3326_367_2932_6774_6776_6777_6772_5979_5879_7157_6688_3725_2736_4087_4088_4089_2033_4790_5970_3320_5371_3480_5159_5156_5601_5602_4609_1029_2353_1441_8554 60 2.11E-36 1.66E-34 1.66E-34 4679 hsa-mir-132 hsa03022 Basal transcription factors 54457_6879_2958_138474_6883_6880_6881_2967_2961_2960_2963_2969_2968_6878_6877_6874_6873_6872_6908_6884_6882_2959_2957 23 1.68E-24 1.32E-22 6.62E-23 4680 hsa-mir-132 hsa05215 Prostate cancer 595_4193_6934_5925_7184_1956_1870_1871_9586_207_1026_5595_5594_1385_1387_2064_3326_367_2932_7157_468_2033_4790_5970_3320_3480_5159_5156 28 3.37E-23 2.66E-21 8.59E-22 4681 hsa-mir-132 hsa05212 Pancreatic cancer 595_4193_6934_5925_7184_1956_1870_1871_9586_207_1026_5595_5594_1385_1387_2064_3326_367_2932_7157_468_2033_4790_5970_3320_3480_5159_5156 28 4.35E-23 3.43E-21 8.59E-22 4682 hsa-mir-132 hsa04010 MAPK signaling pathway 3925_6722_6197_2261_2264_9252_4773_8986_1956_1432_1616_207_5595_5594_5599_1386_3312_1649_5879_7157_468_3725_3727_6195_6196_4790_51701_5970_5159_9261_5156_5601_5600_5603_5602_9479_6885_4609_2353_8550 40 1.37E-21 1.08E-19 2.16E-20 4683 hsa-mir-132 hsa05220 Chronic myeloid leukemia 595_4193_3066_3065_5925_25_1487_1488_1870_1871_861_207_1026_5595_5594_6776_6777_7157_4088_4089_4790_5970_5781_4609_1029 25 2.92E-21 2.31E-19 3.85E-20 4684 hsa-mir-132 hsa04630 Jak-STAT signaling pathway 3559_595_3454_3455_3560_1439_2690_10401_207_3717_3716_3718_85480_1387_3575_3570_3572_6774_6775_6776_6777_6772_2033_149233_3953_5781_4609_1441_8554 29 1.64E-18 1.30E-16 1.85E-17 4685 hsa-mir-132 hsa05210 Colorectal cancer 595_6934_1956_207_4233_5595_5594_5599_2932_5879_7157_3725_4087_4088_4089_3480_5159_5156_5601_5602_4609_2353 22 5.34E-17 4.22E-15 5.28E-16 4686 hsa-mir-132 hsa04310 Wnt signaling pathway 595_8607_6934_1459_4773_1460_1487_1488_5599_1387_2932_5879_7157_8061_3725_1457_4087_4088_4089_2033_51701_5601_5602_6423_6885_4609 26 6.66E-16 5.26E-14 5.85E-15 4687 hsa-mir-132 hsa04520 Adherens junction 6934_1459_1460_1956_6714_2241_4233_5595_5594_1387_2064_5879_1457_4087_4088_4089_2033_51701_3480_6885 20 3.02E-15 2.39E-13 2.39E-14 4688 hsa-mir-132 hsa05219 Bladder cancer 595_2261_9252_4193_5925_1956_1870_1871_1026_5595_5594_2064_7157_4609_1029 15 1.19E-13 9.38E-12 8.53E-13 4689 hsa-mir-132 hsa04110 Cell cycle 595_4193_4171_3066_3065_5925_25_1870_1871_1026_5591_1387_7533_2932_7157_4085_4087_4088_4089_2033_1029 21 2.45E-13 1.94E-11 1.61E-12 4690 hsa-mir-132 hsa04620 Toll-like receptor signaling pathway 3454_3455_1432_207_3654_5595_5594_5599_6772_5879_3725_4790_5970_5601_5600_5603_5602_6885_2353 19 1.46E-12 1.15E-10 8.88E-12 4691 hsa-mir-132 hsa05218 Melanoma 595_4193_5925_1956_1870_1871_207_1026_4233_5595_5594_7157_3480_5159_5156_1029 16 7.06E-12 5.58E-10 3.85E-11 4692 hsa-mir-132 hsa05221 Acute myeloid leukemia 595_6934_1050_861_207_5595_5594_6774_6776_6777_6688_4790_5970_5371_4609 15 7.31E-12 5.78E-10 3.85E-11 4693 hsa-mir-132 hsa05214 Glioma 595_4193_5925_1956_1870_1871_207_1026_5595_5594_7157_3480_5159_5156_1029 15 2.40E-11 1.89E-09 1.18E-10 4694 hsa-mir-132 hsa04012 ErbB signaling pathway 25_1956_6714_207_1026_5595_5594_5599_2064_2932_6776_6777_3725_5601_5602_4609 16 1.01E-10 8.01E-09 4.71E-10 4695 hsa-mir-132 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_1432_4233_5599_5879_3725_4790_5970_5601_5600_5603_5602_5781 14 6.75E-10 5.34E-08 2.96E-09 4696 hsa-mir-132 hsa05223 Non-small cell lung cancer 595_5925_1956_1870_1871_207_5595_5594_2064_6256_7157_1029 12 3.48E-09 2.75E-07 1.45E-08 4697 hsa-mir-132 hsa04330 Notch signaling pathway 3066_3065_1487_1488_3280_388585_1387_9612_2033_8850_4851 11 9.86E-09 7.79E-07 3.89E-08 4698 hsa-mir-132 hsa04660 T cell receptor signaling pathway 4773_3932_1432_207_5595_5594_2932_3725_4790_5970_5601_5600_5603_6885_2353 15 1.50E-08 1.19E-06 5.66E-08 4699 hsa-mir-132 hsa04062 Chemokine signaling pathway 1234_1230_5580_7852_207_3055_3717_3718_5590_5595_5594_2932_6774_6777_6772_5879_4790_5970_2185 19 2.46E-08 1.94E-06 8.83E-08 4700 hsa-mir-132 hsa04060 Cytokine-cytokine receptor interaction 3556_3559_1234_1230_3454_3455_1956_3560_1439_7852_2690_85480_4233_3575_3570_3572_2321_149233_5159_5156_3953_1441 22 2.81E-08 2.22E-06 9.65E-08 4701 hsa-mir-132 hsa04912 GnRH signaling pathway 5580_1956_6714_1432_5595_5594_5599_468_3725_5601_5600_5603_5602_2185 14 8.04E-08 6.35E-06 2.65E-07 4702 hsa-mir-132 hsa04664 Fc epsilon RI signaling pathway 5580_6850_1432_207_5595_5594_5599_5879_5601_5600_5603_5602 12 1.45E-07 1.15E-05 4.60E-07 4703 hsa-mir-132 hsa05213 Endometrial cancer 595_6934_1956_207_5595_5594_2064_2932_7157_4609 10 2.32E-07 1.84E-05 7.01E-07 4704 hsa-mir-132 hsa04920 Adipocytokine signaling pathway 207_3717_5599_6256_6774_4790_5970_5601_5602_3953_5781 11 2.40E-07 1.89E-05 7.01E-07 4705 hsa-mir-132 hsa04510 Focal adhesion 595_1956_6714_207_4233_5595_5594_5599_2064_2932_5879_3725_2321_3480_5159_5156_5601_5602 18 2.97E-07 2.35E-05 8.38E-07 4706 hsa-mir-132 hsa05222 Small cell lung cancer 595_5925_1870_1871_10401_207_6256_7157_4790_5970_4609_8554 12 3.32E-07 2.63E-05 9.05E-07 4707 hsa-mir-132 hsa05216 Thyroid cancer 595_6934_5595_5594_6256_5979_7157_4609 8 3.61E-07 2.85E-05 9.47E-07 4708 hsa-mir-132 hsa04350 TGF-beta signaling pathway 6667_3399_3398_5595_5594_1387_4086_4087_4088_4089_2033_4609 12 3.72E-07 2.94E-05 9.47E-07 4709 hsa-mir-132 hsa05211 Renal cell carcinoma 3091_2113_207_4233_5595_5594_1387_5879_3725_2033_5781 11 4.57E-07 3.61E-05 1.13E-06 4710 hsa-mir-132 hsa04662 B cell receptor signaling pathway 4773_6850_207_5595_5594_2932_5879_3725_4790_5970_2353 11 6.58E-07 5.20E-05 1.58E-06 4711 hsa-mir-132 hsa04370 VEGF signaling pathway 4773_6714_1432_207_5595_5594_5879_9261_5600_5603 10 5.68E-06 0.000448372 1.32E-05 4712 hsa-mir-132 hsa04930 Type II diabetes mellitus 5580_3651_5590_5595_5594_5599_5601_5602 8 6.35E-06 0.000501909 1.43E-05 4713 hsa-mir-132 hsa04150 mTOR signaling pathway 6197_3091_207_5595_5594_6195_6196 7 0.00011862 0.009371014 0.000260306 4714 hsa-mir-132 hsa05016 Huntington's disease 3066_3065_3064_6667_9586_1385_1387_9001_5430_7157_2033_6874_6908 13 0.000124015 0.009797202 0.000264789 4715 hsa-mir-132 hsa04720 Long-term potentiation 6197_5595_5594_1387_468_6195_6196_2033 8 0.000172576 0.013633506 0.000358776 4716 hsa-mir-132 hsa04950 Maturity onset diabetes of the young 6927_3087_3280_3651_5080 5 0.00019044 0.015044759 0.000385763 4717 hsa-mir-132 hsa04612 Antigen processing and presentation 4801_1385_3326_3312_3320_4800_4802_2923 8 0.000502796 0.039720847 0.00095651 4718 hsa-mir-132 hsa04210 Apoptosis 3556_823_1439_207_3654_7157_4790_5970 8 0.000502796 0.039720847 0.00095651 4719 hsa-mir-132 hsa04910 Insulin signaling pathway 6720_5211_207_5590_5595_5594_5599_2932_5601_5602 10 0.000520632 0.041129925 0.00095651 4720 hsa-mir-132 hsa04650 Natural killer cell mediated cytotoxicity 3454_3455_4773_3932_6850_5595_5594_5879_5781_2185 10 0.000520632 0.041129925 0.00095651 4721 hsa-mir-132 hsa04540 Gap junction 10382_1956_6714_5592_5595_5594_5159_5156 8 0.000658628 0.052031621 0.001182537 4722 hsa-mir-132 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_1616_5879_7157_5600_5603 6 0.001095378 0.086534844 0.001922997 4723 hsa-mir-132 hsa04360 Axon guidance 4773_25_7852_2242_4233_5595_5594_2932_5879 9 0.001388186 0.109666692 0.002384059 4724 hsa-mir-132 hsa04120 Ubiquitin mediated proteolysis 55294_4193_10401_7329_83737_64326_5371_672_8554 9 0.002036321 0.16086938 0.003422753 4725 hsa-mir-132 hsa04115 p53 signaling pathway 595_4193_1026_7157_64326_1029 6 0.002923062 0.23092193 0.004810874 4726 hsa-mir-132 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 0.003177395 0.251014203 0.005122739 4727 hsa-mir-132 hsa04916 Melanogenesis 6934_5595_5594_1385_1387_2932_2033 7 0.005118492 0.404360901 0.008087218 4728 hsa-mir-132 hsa04670 Leukocyte transendothelial migration 1432_7852_5879_5600_5603_5781_2185 7 0.011315077 0.893891121 0.017527277 4729 hsa-mir-132 hsa04740 Olfactory transduction 5592 1 0.012314715 0.972862523 0.018708895 4730 hsa-mir-132 hsa03420 Nucleotide excision repair 5887_2967_2968_6118 4 0.012606856 0.995941585 0.018791351 4731 hsa-mir-132 hsa04530 Tight junction 1459_1460_5580_6714_207_5590_1457 7 0.019622248 1 0.028706621 4732 hsa-mir-132 hsa05217 Basal cell carcinoma 6934_2932_7157_2736 4 0.025115276 1 0.036074669 4733 hsa-mir-132 hsa05340 Primary immunodeficiency 3932_3718_3575 3 0.034466037 1 0.048621731 4734 hsa-mir-1321 hsa05200 Pathways in cancer 2249_367_3725_6776_6777_2353_5914_5970_6256 9 2.03E-10 7.70E-09 7.70E-09 4735 hsa-mir-1321 hsa05221 Acute myeloid leukemia 6776_6777_5914_5970 4 9.84E-07 3.74E-05 1.87E-05 4736 hsa-mir-1321 hsa05220 Chronic myeloid leukemia 6776_6777_5970 3 0.000113081 0.004297074 0.001074269 4737 hsa-mir-1321 hsa04662 B cell receptor signaling pathway 3725_2353_5970 3 0.000113081 0.004297074 0.001074269 4738 hsa-mir-1321 hsa04012 ErbB signaling pathway 3725_6776_6777 3 0.00017291 0.006570564 0.001314113 4739 hsa-mir-1321 hsa04620 Toll-like receptor signaling pathway 3725_2353_5970 3 0.000272526 0.010355982 0.001606221 4740 hsa-mir-1321 hsa04010 MAPK signaling pathway 2249_3725_2353_5970 4 0.000330487 0.012558499 0.001606221 4741 hsa-mir-1321 hsa04660 T cell receptor signaling pathway 3725_2353_5970 3 0.000338152 0.012849769 0.001606221 4742 hsa-mir-1321 hsa04630 Jak-STAT signaling pathway 3977_6776_6777 3 0.000897685 0.03411204 0.003790227 4743 hsa-mir-1321 hsa04920 Adipocytokine signaling pathway 5970_6256 2 0.003115381 0.11838449 0.011838449 4744 hsa-mir-1321 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5970 2 0.003479392 0.132216888 0.012019717 4745 hsa-mir-1321 hsa05210 Colorectal cancer 3725_2353 2 0.004792101 0.18209983 0.0135505 4746 hsa-mir-1321 hsa05222 Small cell lung cancer 5970_6256 2 0.005011395 0.190433006 0.0135505 4747 hsa-mir-1321 hsa05215 Prostate cancer 367_5970 2 0.00523525 0.198939509 0.0135505 4748 hsa-mir-1321 hsa05212 Pancreatic cancer 367_5970 2 0.005348882 0.203257498 0.0135505 4749 hsa-mir-1321 hsa03450 Non-homologous end-joining 2547 1 0.01783249 0.677634628 0.042352164 4750 hsa-mir-1321 hsa05016 Huntington's disease 6908_6667 2 0.021779742 0.827630199 0.048257818 4751 hsa-mir-1321 hsa04062 Chemokine signaling pathway 6777_5970 2 0.022858967 0.868640727 0.048257818 4752 hsa-mir-1321 hsa04950 Maturity onset diabetes of the young 6927 1 0.02954865 1 0.0590973 4753 hsa-mir-1321 hsa05216 Thyroid cancer 6256 1 0.035355663 1 0.067175759 4754 hsa-mir-1321 hsa04080 Neuroactive ligand-receptor interaction 2908_7067 2 0.038234048 1 0.06918542 4755 hsa-mir-1321 hsa03410 Base excision repair 142 1 0.043428758 1 0.073648431 4756 hsa-mir-1321 hsa03022 Basal transcription factors 6908 1 0.044576682 1 0.073648431 4757 hsa-mir-1322 hsa05200 Pathways in cancer 25_5371_5595_5599_861_1387_5601_5602_367_6934_6774_6772_3091_5970_6688_2113_4609_3725_2353_4087_4088_4089_5925_2033_1050_8554 26 2.62E-19 1.70E-17 1.70E-17 4758 hsa-mir-1322 hsa04310 Wnt signaling pathway 5599_1387_5601_5602_6934_8061_4773_4609_3725_1457_1459_4087_4088_4089_2033 15 5.89E-13 3.83E-11 1.91E-11 4759 hsa-mir-1322 hsa04010 MAPK signaling pathway 5595_5599_1386_5601_5600_5603_5602_9252_1432_1649_5970_468_4773_4609_3725_3727_2353_8550 18 1.64E-12 1.06E-10 3.55E-11 4760 hsa-mir-1322 hsa05210 Colorectal cancer 5595_5599_5601_5602_6934_4609_3725_2353_4087_4088_4089 11 4.84E-11 3.15E-09 7.87E-10 4761 hsa-mir-1322 hsa04620 Toll-like receptor signaling pathway 5595_5599_5601_5600_5603_5602_1432_6772_5970_3725_2353 11 3.24E-10 2.11E-08 4.22E-09 4762 hsa-mir-1322 hsa05221 Acute myeloid leukemia 5371_5595_861_6934_6774_5970_6688_4609_1050 9 8.56E-10 5.56E-08 9.27E-09 4763 hsa-mir-1322 hsa04520 Adherens junction 5595_1387_6934_1457_1459_4087_4088_4089_2033 9 9.77E-09 6.35E-07 9.07E-08 4764 hsa-mir-1322 hsa05215 Prostate cancer 5595_1387_367_6934_5970_468_9586_5925_2033 9 2.10E-08 1.36E-06 1.66E-07 4765 hsa-mir-1322 hsa05212 Pancreatic cancer 5595_1387_367_6934_5970_468_9586_5925_2033 9 2.30E-08 1.49E-06 1.66E-07 4766 hsa-mir-1322 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5601_5600_5603_5602_1432_5970_3725 8 6.53E-08 4.24E-06 4.24E-07 4767 hsa-mir-1322 hsa05220 Chronic myeloid leukemia 25_5595_861_5970_4609_4088_4089_5925 8 9.65E-08 6.27E-06 5.70E-07 4768 hsa-mir-1322 hsa04912 GnRH signaling pathway 5595_5599_5601_5600_5603_5602_1432_468_3725 9 1.08E-07 7.01E-06 5.84E-07 4769 hsa-mir-1322 hsa04660 T cell receptor signaling pathway 5595_5601_5600_5603_1432_5970_4773_3725_2353 9 1.25E-07 8.12E-06 6.24E-07 4770 hsa-mir-1322 hsa04110 Cell cycle 25_5591_1387_7533_4087_4088_4089_5925_2033 9 2.34E-07 1.52E-05 1.08E-06 4771 hsa-mir-1322 hsa04350 TGF-beta signaling pathway 5595_1387_6667_4609_4087_4088_4089_2033 8 2.77E-07 1.80E-05 1.20E-06 4772 hsa-mir-1322 hsa03022 Basal transcription factors 2963_6874_6872_6908_6883_2959 6 4.37E-07 2.84E-05 1.77E-06 4773 hsa-mir-1322 hsa04664 Fc epsilon RI signaling pathway 5595_5599_5601_5600_5603_5602_1432 7 1.98E-06 0.000128619 7.57E-06 4774 hsa-mir-1322 hsa04012 ErbB signaling pathway 25_5595_5599_5601_5602_4609_3725 7 3.60E-06 0.000234107 1.30E-05 4775 hsa-mir-1322 hsa05211 Renal cell carcinoma 5595_1387_3091_2113_3725_2033 6 1.51E-05 0.000982492 5.17E-05 4776 hsa-mir-1322 hsa04120 Ubiquitin mediated proteolysis 5371_83737_672_55294_7329_64326_8554 7 6.35E-05 0.00412686 0.000206343 4777 hsa-mir-1322 hsa04630 Jak-STAT signaling pathway 1387_6774_6775_6772_4609_2033_8554 7 0.000121848 0.00792012 0.000377149 4778 hsa-mir-1322 hsa04920 Adipocytokine signaling pathway 5599_5601_5602_6774_5970 5 0.00012968 0.008429211 0.000383146 4779 hsa-mir-1322 hsa04662 B cell receptor signaling pathway 5595_5970_4773_3725_2353 5 0.000213302 0.013864653 0.000602811 4780 hsa-mir-1322 hsa04370 VEGF signaling pathway 5595_5600_5603_1432_4773 5 0.000239473 0.015565757 0.000648573 4781 hsa-mir-1322 hsa05219 Bladder cancer 5595_9252_4609_5925 4 0.000264048 0.017163099 0.000686524 4782 hsa-mir-1322 hsa04930 Type II diabetes mellitus 5595_5599_5601_5602 4 0.00033746 0.021934917 0.000843651 4783 hsa-mir-1322 hsa05216 Thyroid cancer 5595_6934_4609 3 0.00130335 0.084717731 0.003137694 4784 hsa-mir-1322 hsa04720 Long-term potentiation 5595_1387_468_2033 4 0.002044482 0.132891298 0.004737465 4785 hsa-mir-1322 hsa05016 Huntington's disease 6874_1387_6908_6667_9586_2033 6 0.002113638 0.137386495 0.004737465 4786 hsa-mir-1322 hsa05222 Small cell lung cancer 5970_4609_5925_8554 4 0.003282716 0.213376561 0.007112552 4787 hsa-mir-1322 hsa04330 Notch signaling pathway 1387_9612_2033 3 0.004711741 0.306263195 0.009879458 4788 hsa-mir-1322 hsa05213 Endometrial cancer 5595_6934_4609 3 0.006153327 0.399966271 0.012347897 4789 hsa-mir-1322 hsa04916 Melanogenesis 5595_1387_6934_2033 4 0.006268932 0.407480606 0.012347897 4790 hsa-mir-1322 hsa05014 Amyotrophic lateral sclerosis (ALS) 5600_5603_1432 3 0.007476327 0.485961279 0.014292979 4791 hsa-mir-1322 hsa04510 Focal adhesion 5595_5599_5601_5602_3725 5 0.014542964 0.945292663 0.027008362 4792 hsa-mir-1322 hsa04910 Insulin signaling pathway 5595_5599_5601_5602 4 0.015926157 1 0.028755561 4793 hsa-mir-1322 hsa04062 Chemokine signaling pathway 5595_6774_6772_5970 4 0.045053212 1 0.079147535 4794 hsa-mir-133a-1 hsa05200 Pathways in cancer 5371_7046_1499_5595_5594_6258_1387_6256_836_7704_842_841_6774_6772_5970_4824_6688_862_6502_4087_5925_2033_207 23 6.13E-18 3.98E-16 3.98E-16 4795 hsa-mir-133a-1 hsa05215 Prostate cancer 1499_5595_5594_1385_1387_842_5970_4824_5925_2033_207 11 1.01E-11 6.57E-10 2.45E-10 4796 hsa-mir-133a-1 hsa05212 Pancreatic cancer 1499_5595_5594_1385_1387_842_5970_4824_5925_2033_207 11 1.13E-11 7.35E-10 2.45E-10 4797 hsa-mir-133a-1 hsa04520 Adherens junction 4301_7046_1499_6714_5595_5594_1387_1457_4087_2033 10 9.05E-11 5.88E-09 1.47E-09 4798 hsa-mir-133a-1 hsa05221 Acute myeloid leukemia 5371_5595_5594_7704_6774_5970_6688_862_207 9 1.63E-10 1.06E-08 2.08E-09 4799 hsa-mir-133a-1 hsa04350 TGF-beta signaling pathway 3399_3400_7046_5595_5594_1387_3398_4087_2033_3397 10 1.92E-10 1.25E-08 2.08E-09 4800 hsa-mir-133a-1 hsa04916 Melanogenesis 815_1499_5595_5594_1385_1387_2033_808_801_805 10 9.60E-10 6.24E-08 8.06E-09 4801 hsa-mir-133a-1 hsa04010 MAPK signaling pathway 6722_7046_5595_5594_4208_836_7867_1432_5970_9261_6195_207_2002_2005 14 9.93E-10 6.45E-08 8.06E-09 4802 hsa-mir-133a-1 hsa04720 Long-term potentiation 815_5595_5594_1387_6195_2033_808_801_805 9 1.13E-09 7.32E-08 8.13E-09 4803 hsa-mir-133a-1 hsa05214 Glioma 815_5595_5594_5925_207_808_801_805 8 8.10E-09 5.26E-07 5.26E-08 4804 hsa-mir-133a-1 hsa04912 GnRH signaling pathway 815_6714_5595_5594_1432_2002_808_801_805 9 2.16E-08 1.40E-06 1.28E-07 4805 hsa-mir-133a-1 hsa04370 VEGF signaling pathway 6714_5595_5594_7867_1432_842_9261_207 8 2.74E-08 1.78E-06 1.48E-07 4806 hsa-mir-133a-1 hsa05210 Colorectal cancer 7046_1499_5595_5594_836_842_4087_207 8 5.12E-08 3.33E-06 2.40E-07 4807 hsa-mir-133a-1 hsa05223 Non-small cell lung cancer 5595_5594_6258_6256_842_5925_207 7 5.17E-08 3.36E-06 2.40E-07 4808 hsa-mir-133a-1 hsa05010 Alzheimer's disease 22926_5595_5594_836_842_841_840_808_801_805 10 1.12E-07 7.28E-06 4.86E-07 4809 hsa-mir-133a-1 hsa05213 Endometrial cancer 1499_5595_5594_842_207_2002 6 8.99E-07 5.84E-05 3.65E-06 4810 hsa-mir-133a-1 hsa05222 Small cell lung cancer 6258_6256_842_5970_6502_5925_207 7 9.66E-07 6.28E-05 3.69E-06 4811 hsa-mir-133a-1 hsa04210 Apoptosis 836_839_842_841_840_5970_207 7 1.20E-06 7.79E-05 4.33E-06 4812 hsa-mir-133a-1 hsa05216 Thyroid cancer 1499_5595_5594_6258_6256 5 1.27E-06 8.24E-05 4.34E-06 4813 hsa-mir-133a-1 hsa04620 Toll-like receptor signaling pathway 5595_5594_1432_841_6772_5970_207 7 2.82E-06 0.000183158 9.16E-06 4814 hsa-mir-133a-1 hsa05220 Chronic myeloid leukemia 7046_5595_5594_5970_5925_207 6 6.48E-06 0.000421261 2.01E-05 4815 hsa-mir-133a-1 hsa04330 Notch signaling pathway 388585_1387_9612_2033_8850 5 1.09E-05 0.000709719 3.23E-05 4816 hsa-mir-133a-1 hsa04012 ErbB signaling pathway 815_6714_5595_5594_207_2002 6 1.44E-05 0.000936101 4.07E-05 4817 hsa-mir-133a-1 hsa04910 Insulin signaling pathway 5595_5594_207_2002_808_801_805 7 1.84E-05 0.001198763 4.99E-05 4818 hsa-mir-133a-1 hsa04920 Adipocytokine signaling pathway 6258_6256_6774_5970_207 5 5.37E-05 0.003490961 0.000139638 4819 hsa-mir-133a-1 hsa05211 Renal cell carcinoma 5595_5594_1387_2033_207 5 7.42E-05 0.004819811 0.000184101 4820 hsa-mir-133a-1 hsa04110 Cell cycle 5591_1387_6502_4087_5925_2033 6 7.65E-05 0.004970738 0.000184101 4821 hsa-mir-133a-1 hsa03022 Basal transcription factors 2962_2969_6908_2959 4 8.19E-05 0.005320928 0.000190033 4822 hsa-mir-133a-1 hsa05016 Huntington's disease 1385_1387_6908_836_842_841_2033 7 0.000120674 0.007843826 0.000270477 4823 hsa-mir-133a-1 hsa04310 Wnt signaling pathway 815_1499_1387_1457_4087_2033 6 0.000274982 0.017873829 0.000583158 4824 hsa-mir-133a-1 hsa04150 mTOR signaling pathway 5595_5594_6195_207 4 0.000278121 0.018077895 0.000583158 4825 hsa-mir-133a-1 hsa04950 Maturity onset diabetes of the young 3651_168620_4760 3 0.000457527 0.029739287 0.000929353 4826 hsa-mir-133a-1 hsa04660 T cell receptor signaling pathway 5595_5594_1432_5970_207 5 0.000485524 0.031559036 0.000956334 4827 hsa-mir-133a-1 hsa04270 Vascular smooth muscle contraction 5595_5594_808_801_805 5 0.000659456 0.042864663 0.001260725 4828 hsa-mir-133a-1 hsa05218 Melanoma 5595_5594_5925_207 4 0.000847485 0.055086556 0.001530182 4829 hsa-mir-133a-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_836_1432_5970 4 0.000847485 0.055086556 0.001530182 4830 hsa-mir-133a-1 hsa04062 Chemokine signaling pathway 5595_5594_6774_6772_5970_207 6 0.00092807 0.060324577 0.001630394 4831 hsa-mir-133a-1 hsa04662 B cell receptor signaling pathway 5595_5594_5970_207 4 0.001029631 0.066926004 0.001761211 4832 hsa-mir-133a-1 hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432_207 4 0.001237654 0.080447516 0.002036328 4833 hsa-mir-133a-1 hsa04530 Tight junction 4301_1499_6714_1457_207 5 0.00125601 0.081640645 0.002036328 4834 hsa-mir-133a-1 hsa04510 Focal adhesion 1499_6714_5595_5594_207_2002 6 0.001284453 0.083489452 0.002036328 4835 hsa-mir-133a-1 hsa05219 Bladder cancer 5595_5594_5925 3 0.002061634 0.13400623 0.003190625 4836 hsa-mir-133a-1 hsa04630 Jak-STAT signaling pathway 1387_6774_6772_2033_207 5 0.002121986 0.137929088 0.003207653 4837 hsa-mir-133a-1 hsa04930 Type II diabetes mellitus 3651_5595_5594 3 0.002482253 0.161346423 0.003666964 4838 hsa-mir-133a-1 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432_842 3 0.004460679 0.289944164 0.006443204 4839 hsa-mir-133a-1 hsa04115 p53 signaling pathway 836_842_841 3 0.007761771 0.504515124 0.01096772 4840 hsa-mir-133a-1 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.010003398 0.650220845 0.013834486 4841 hsa-mir-133a-1 hsa04540 Gap junction 6714_5595_5594 3 0.016873183 1 0.022849102 4842 hsa-mir-133a-1 hsa04020 Calcium signaling pathway 815_808_801_805 4 0.02164118 1 0.028707688 4843 hsa-mir-133a-1 hsa04670 Leukocyte transendothelial migration 4301_1499_1432 3 0.033396856 1 0.043415913 4844 hsa-mir-133a-1 hsa05012 Parkinson's disease 7314_836_842 3 0.043531799 1 0.055481704 4845 hsa-mir-133a-1 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836 3 0.045091462 1 0.056269911 4846 hsa-mir-133a-1 hsa04120 Ubiquitin mediated proteolysis 7329_5371_6502 3 0.04588162 1 0.056269911 4847 hsa-mir-133b hsa05200 Pathways in cancer 4087_836_2033_2249_4089_367_3725_6776_6777_2353_5914_5970_6256 13 3.71E-13 1.96E-11 1.96E-11 4848 hsa-mir-133b hsa05210 Colorectal cancer 4087_836_4089_3725_2353 5 1.35E-06 7.15E-05 3.57E-05 4849 hsa-mir-133b hsa04010 MAPK signaling pathway 836_2249_3725_1432_2353_5598_5970 7 2.23E-06 0.000117981 3.93E-05 4850 hsa-mir-133b hsa05221 Acute myeloid leukemia 6776_6777_5914_5970 4 1.01E-05 0.000536436 0.000134109 4851 hsa-mir-133b hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_3725_1432_5970 4 2.03E-05 0.001073857 0.000214771 4852 hsa-mir-133b hsa05220 Chronic myeloid leukemia 4089_6776_6777_5970 4 2.49E-05 0.001319034 0.000219839 4853 hsa-mir-133b hsa04350 TGF-beta signaling pathway 4087_6667_2033_4089 4 4.34E-05 0.002301892 0.000328842 4854 hsa-mir-133b hsa04620 Toll-like receptor signaling pathway 3725_1432_2353_5970 4 7.88E-05 0.004177564 0.000522195 4855 hsa-mir-133b hsa04660 T cell receptor signaling pathway 3725_1432_2353_5970 4 0.000104539 0.005540553 0.000615617 4856 hsa-mir-133b hsa04310 Wnt signaling pathway 4087_2033_4089_3725 4 0.000347879 0.018437568 0.001801574 4857 hsa-mir-133b hsa04630 Jak-STAT signaling pathway 2033_3977_6776_6777 4 0.000373912 0.01981731 0.001801574 4858 hsa-mir-133b hsa04662 B cell receptor signaling pathway 3725_2353_5970 3 0.000624588 0.033103147 0.002758596 4859 hsa-mir-133b hsa04520 Adherens junction 4087_2033_4089 3 0.000748658 0.039678899 0.002875067 4860 hsa-mir-133b hsa05016 Huntington's disease 6908_836_6667_2033 4 0.000759452 0.040250942 0.002875067 4861 hsa-mir-133b hsa04012 ErbB signaling pathway 3725_6776_6777 3 0.000947156 0.050199248 0.002972126 4862 hsa-mir-133b hsa05215 Prostate cancer 2033_367_5970 3 0.000977964 0.051832112 0.002972126 4863 hsa-mir-133b hsa04210 Apoptosis 836_840_5970 3 0.001009401 0.053498273 0.002972126 4864 hsa-mir-133b hsa05212 Pancreatic cancer 2033_367_5970 3 0.001009401 0.053498273 0.002972126 4865 hsa-mir-133b hsa04912 GnRH signaling pathway 3725_1432_5598 3 0.001732455 0.091820096 0.004832637 4866 hsa-mir-133b hsa04110 Cell cycle 4087_2033_4089 3 0.002267953 0.120201494 0.006010075 4867 hsa-mir-133b hsa04330 Notch signaling pathway 9612_2033 2 0.004918812 0.26069705 0.012414145 4868 hsa-mir-133b hsa05010 Alzheimer's disease 836_1020_840 3 0.006728729 0.356622623 0.015737539 4869 hsa-mir-133b hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432 2 0.006829498 0.361963397 0.015737539 4870 hsa-mir-133b hsa04920 Adipocytokine signaling pathway 5970_6256 2 0.009548406 0.506065508 0.021086063 4871 hsa-mir-133b hsa05211 Renal cell carcinoma 2033_3725 2 0.010918691 0.578690629 0.023147625 4872 hsa-mir-133b hsa05222 Small cell lung cancer 5970_6256 2 0.015182762 0.804686404 0.030949477 4873 hsa-mir-133b hsa03450 Non-homologous end-joining 2547 1 0.031467625 1 0.061769782 4874 hsa-mir-134 hsa05200 Pathways in cancer 3716_675_1956_5595_5594_5599_5914_1387_6257_6256_5159_595_5156_1488_1487_6258_1399_1398_367_3815_6774_6777_6772_5970_4436_4087_2113_4609_3725_867_2353_6776_4088_4089_5925_8031_2033_8554 38 1.69E-32 1.14E-30 1.14E-30 4875 hsa-mir-134 hsa04630 Jak-STAT signaling pathway 3717_3716_3718_85480_3560_3561_1387_595_3575_5777_6774_6777_6772_3559_2057_5781_4609_867_6776_2690_2033_894_896_8554 24 1.38E-23 9.23E-22 4.62E-22 4876 hsa-mir-134 hsa05220 Chronic myeloid leukemia 5595_5594_595_1488_1487_1399_1398_6777_5970_5781_4609_867_6776_4088_4089_5925_6464 17 1.67E-19 1.12E-17 3.73E-18 4877 hsa-mir-134 hsa05210 Colorectal cancer 1956_5595_5594_5599_5159_595_5156_4436_4087_4609_3725_2353_4088_4089 14 1.22E-14 8.17E-13 2.04E-13 4878 hsa-mir-134 hsa04012 ErbB signaling pathway 1956_5595_6714_5594_5599_2066_1399_1398_6777_4609_3725_867_6776_6464 14 1.88E-14 1.26E-12 2.52E-13 4879 hsa-mir-134 hsa04110 Cell cycle 1387_595_983_7027_4087_10912_8379_4088_4089_4616_993_5925_2033_894_896 15 5.51E-14 3.69E-12 6.15E-13 4880 hsa-mir-134 hsa04310 Wnt signaling pathway 5515_5599_1387_595_1488_1487_4087_4609_3725_1457_4088_4089_2033_894_896_8061 16 1.01E-13 6.76E-12 9.66E-13 4881 hsa-mir-134 hsa04520 Adherens junction 1956_5595_6714_3643_5594_1387_5770_5777_4087_1457_4088_4089_2033 13 1.47E-13 9.87E-12 1.23E-12 4882 hsa-mir-134 hsa05221 Acute myeloid leukemia 5595_5594_5914_595_3815_6774_6777_5970_4609_6776 10 6.96E-11 4.67E-09 5.18E-10 4883 hsa-mir-134 hsa05215 Prostate cancer 1956_5595_5594_1387_5159_595_5156_367_5970_5925_2033 11 1.47E-10 9.87E-09 9.87E-10 4884 hsa-mir-134 hsa05212 Pancreatic cancer 1956_5595_5594_1387_5159_595_5156_367_5970_5925_2033 11 1.64E-10 1.10E-08 1.00E-09 4885 hsa-mir-134 hsa05216 Thyroid cancer 5595_5594_6257_6256_595_6258_4609_8031 8 2.01E-10 1.34E-08 1.12E-09 4886 hsa-mir-134 hsa04510 Focal adhesion 1956_5595_6714_5594_5599_5159_595_5156_1399_1398_3725_894_896_6464 14 8.11E-10 5.44E-08 4.18E-09 4887 hsa-mir-134 hsa04660 T cell receptor signaling pathway 3932_5595_5594_919_5777_1432_5970_3725_867_2353_1493 11 1.30E-09 8.71E-08 6.22E-09 4888 hsa-mir-134 hsa04350 TGF-beta signaling pathway 5515_5595_5594_1387_7027_4087_4609_4088_4089_2033 10 2.16E-09 1.45E-07 9.66E-09 4889 hsa-mir-134 hsa04010 MAPK signaling pathway 1956_5595_5594_5599_5159_5156_1399_1398_1432_5970_10912_4609_3725_2353_4616 15 3.14E-09 2.10E-07 1.31E-08 4890 hsa-mir-134 hsa04062 Chemokine signaling pathway 3717_3718_5595_7852_5594_1399_1398_1234_6774_6777_6772_5970_6464 13 3.66E-09 2.45E-07 1.44E-08 4891 hsa-mir-134 hsa04920 Adipocytokine signaling pathway 3717_10891_5599_6257_6256_6258_6774_5970_5781 9 4.04E-09 2.71E-07 1.50E-08 4892 hsa-mir-134 hsa05211 Renal cell carcinoma 5595_5594_1387_1399_1398_5781_2113_3725_2033 9 7.17E-09 4.81E-07 2.53E-08 4893 hsa-mir-134 hsa05223 Non-small cell lung cancer 1956_5595_5594_6257_6256_595_6258_5925 8 1.51E-08 1.01E-06 5.05E-08 4894 hsa-mir-134 hsa05214 Glioma 1956_5595_5594_5159_595_5156_5925_6464 8 5.60E-08 3.75E-06 1.79E-07 4895 hsa-mir-134 hsa04060 Cytokine-cytokine receptor interaction 85480_1956_7852_3560_3561_5159_5156_3575_1234_3815_3559_2057_2690 13 1.12E-07 7.50E-06 3.41E-07 4896 hsa-mir-134 hsa04910 Insulin signaling pathway 10891_5595_3643_5594_5599_1399_1398_5770_867_6464 10 1.27E-07 8.54E-06 3.71E-07 4897 hsa-mir-134 hsa04662 B cell receptor signaling pathway 695_5595_5594_6850_5777_5970_3725_2353 8 1.54E-07 1.03E-05 4.31E-07 4898 hsa-mir-134 hsa05222 Small cell lung cancer 6257_6256_595_6258_5970_4609_5925_8554 8 4.07E-07 2.73E-05 1.09E-06 4899 hsa-mir-134 hsa05219 Bladder cancer 1956_5595_5594_595_4609_5925 6 1.22E-06 8.18E-05 3.15E-06 4900 hsa-mir-134 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_1432_6772_5970_3725_2353 8 1.36E-06 9.11E-05 3.37E-06 4901 hsa-mir-134 hsa05218 Melanoma 1956_5595_5594_5159_595_5156_5925 7 1.53E-06 0.000102716 3.54E-06 4902 hsa-mir-134 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_5599_1432_5970_5781_3725 7 1.53E-06 0.000102716 3.54E-06 4903 hsa-mir-134 hsa04330 Notch signaling pathway 1387_1488_1487_9612_2033_8850 6 2.22E-06 0.000148561 4.95E-06 4904 hsa-mir-134 hsa04540 Gap junction 1956_5595_6714_5594_5159_983_5156 7 8.13E-06 0.00054463 1.76E-05 4905 hsa-mir-134 hsa05340 Primary immunodeficiency 3718_695_3932_3561_3575 5 9.78E-06 0.000655253 2.05E-05 4906 hsa-mir-134 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6850_919_5777_5781_6464 8 1.12E-05 0.000750936 2.28E-05 4907 hsa-mir-134 hsa04115 p53 signaling pathway 595_983_10912_4616_894_896 6 1.71E-05 0.001142664 3.36E-05 4908 hsa-mir-134 hsa04912 GnRH signaling pathway 1956_5595_6714_5594_5599_1432_3725 7 2.03E-05 0.001361246 3.89E-05 4909 hsa-mir-134 hsa04664 Fc epsilon RI signaling pathway 695_5595_5594_5599_6850_1432 6 3.49E-05 0.002338293 6.50E-05 4910 hsa-mir-134 hsa05213 Endometrial cancer 1956_5595_5594_595_4609 5 5.64E-05 0.003776261 0.000102061 4911 hsa-mir-134 hsa04930 Type II diabetes mellitus 5595_3643_5594_5599 4 0.000425514 0.028509425 0.000750248 4912 hsa-mir-134 hsa04916 Melanogenesis 5595_5594_1387_3815_2033 5 0.001163342 0.077943918 0.001998562 4913 hsa-mir-134 hsa04810 Regulation of actin cytoskeleton 1956_5595_5594_5159_5156_1399_1398 7 0.001292657 0.086608015 0.0021652 4914 hsa-mir-134 hsa03320 PPAR signaling pathway 6257_6256_6258_2168 4 0.002009661 0.134647319 0.003284081 4915 hsa-mir-134 hsa04720 Long-term potentiation 5595_5594_1387_2033 4 0.002552215 0.170998383 0.00407139 4916 hsa-mir-134 hsa04370 VEGF signaling pathway 5595_6714_5594_1432 4 0.002794843 0.187254467 0.004354755 4917 hsa-mir-134 hsa04640 Hematopoietic cell lineage 3575_3815_3559_2057 4 0.004247168 0.284560246 0.006467278 4918 hsa-mir-134 hsa05016 Huntington's disease 10891_25942_1387_2033_4724 5 0.013032833 0.873199814 0.01940444 4919 hsa-mir-134 hsa04730 Long-term depression 5515_5595_5594 3 0.01629685 1 0.023736716 4920 hsa-mir-134 hsa03010 Ribosome 6124_6143_6129 3 0.040154192 1 0.057241082 4921 hsa-mir-134 hsa05010 Alzheimer's disease 5595_5594_840_4724 4 0.041960172 1 0.058569407 4922 hsa-mir-134 hsa04020 Calcium signaling pathway 1956_2066_5159_5156 4 0.047080778 1 0.064375757 4923 hsa-mir-135a-2 hsa05200 Pathways in cancer 25_2249_5595_5594_5914_1387_6256_1487_1488_367_7704_6774_6776_6777_5970_6688_3725_2353_4087_4088_4089_5925_2033_207 24 8.50E-24 5.35E-22 5.35E-22 4924 hsa-mir-135a-2 hsa05220 Chronic myeloid leukemia 25_5595_5594_1487_1488_6776_6777_5970_4088_4089_5925_207 12 3.84E-16 2.42E-14 1.21E-14 4925 hsa-mir-135a-2 hsa05221 Acute myeloid leukemia 5595_5594_5914_7704_6774_6776_6777_5970_6688_207 10 7.21E-14 4.54E-12 1.51E-12 4926 hsa-mir-135a-2 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_4086_4087_4088_4089_2033_4093 10 2.45E-12 1.55E-10 3.86E-11 4927 hsa-mir-135a-2 hsa04110 Cell cycle 25_993_1387_983_4087_4088_4089_5925_2033 9 1.02E-09 6.41E-08 1.28E-08 4928 hsa-mir-135a-2 hsa05210 Colorectal cancer 5595_5594_3725_2353_4087_4088_4089_207 8 1.64E-09 1.04E-07 1.73E-08 4929 hsa-mir-135a-2 hsa05215 Prostate cancer 5595_5594_1387_367_5970_5925_2033_207 8 2.31E-09 1.46E-07 1.98E-08 4930 hsa-mir-135a-2 hsa05212 Pancreatic cancer 5595_5594_1387_367_5970_5925_2033_207 8 2.52E-09 1.58E-07 1.98E-08 4931 hsa-mir-135a-2 hsa04520 Adherens junction 5595_5594_1387_4087_4088_4089_2033 7 3.09E-08 1.95E-06 2.16E-07 4932 hsa-mir-135a-2 hsa04330 Notch signaling pathway 1387_1487_1488_9612_2033_8850 6 3.92E-08 2.47E-06 2.47E-07 4933 hsa-mir-135a-2 hsa04012 ErbB signaling pathway 25_5595_5594_6776_6777_3725_207 7 5.30E-08 3.34E-06 3.03E-07 4934 hsa-mir-135a-2 hsa04310 Wnt signaling pathway 1387_1487_1488_3725_4087_4088_4089_2033 8 1.29E-07 8.10E-06 6.75E-07 4935 hsa-mir-135a-2 hsa05211 Renal cell carcinoma 5595_5594_1387_3725_2033_207 6 4.07E-07 2.57E-05 1.97E-06 4936 hsa-mir-135a-2 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725_2353_207 6 5.10E-07 3.21E-05 2.29E-06 4937 hsa-mir-135a-2 hsa04630 Jak-STAT signaling pathway 1387_6774_6776_6777_2033_3977_207 7 2.16E-06 0.000135798 9.05E-06 4938 hsa-mir-135a-2 hsa05223 Non-small cell lung cancer 5595_5594_6256_5925_207 5 2.43E-06 0.000153018 9.56E-06 4939 hsa-mir-135a-2 hsa04620 Toll-like receptor signaling pathway 5595_5594_5970_3725_2353_207 6 2.78E-06 0.000175023 1.03E-05 4940 hsa-mir-135a-2 hsa04660 T cell receptor signaling pathway 5595_5594_5970_3725_2353_207 6 4.21E-06 0.000265116 1.47E-05 4941 hsa-mir-135a-2 hsa05218 Melanoma 2249_5595_5594_5925_207 5 8.54E-06 0.000537758 2.83E-05 4942 hsa-mir-135a-2 hsa04010 MAPK signaling pathway 2249_5595_5594_5970_3725_2353_207 7 7.41E-05 0.004668216 0.000233411 4943 hsa-mir-135a-2 hsa04062 Chemokine signaling pathway 5595_5594_6774_6777_5970_207 6 8.90E-05 0.005604394 0.000266876 4944 hsa-mir-135a-2 hsa05214 Glioma 5595_5594_5925_207 4 0.000117209 0.007384149 0.000335643 4945 hsa-mir-135a-2 hsa04920 Adipocytokine signaling pathway 6256_6774_5970_207 4 0.000131004 0.008253264 0.000358838 4946 hsa-mir-135a-2 hsa04720 Long-term potentiation 5595_5594_1387_2033 4 0.000198131 0.01248224 0.000520093 4947 hsa-mir-135a-2 hsa05216 Thyroid cancer 5595_5594_6256 3 0.00021205 0.013359157 0.000534366 4948 hsa-mir-135a-2 hsa05222 Small cell lung cancer 6256_5970_5925_207 4 0.000326822 0.020589768 0.000791914 4949 hsa-mir-135a-2 hsa05219 Bladder cancer 5595_5594_5925 3 0.00058626 0.036934386 0.00136794 4950 hsa-mir-135a-2 hsa04916 Melanogenesis 5595_5594_1387_2033 4 0.000652122 0.041083675 0.001467274 4951 hsa-mir-135a-2 hsa05213 Endometrial cancer 5595_5594_207 3 0.001055814 0.066516261 0.002217209 4952 hsa-mir-135a-2 hsa04150 mTOR signaling pathway 5595_5594_207 3 0.001055814 0.066516261 0.002217209 4953 hsa-mir-135a-2 hsa04370 VEGF signaling pathway 5595_5594_207 3 0.003097001 0.195111053 0.006293905 4954 hsa-mir-135a-2 hsa04664 Fc epsilon RI signaling pathway 5595_5594_207 3 0.003320851 0.209213617 0.006537926 4955 hsa-mir-135a-2 hsa04950 Maturity onset diabetes of the young 6927_5080 2 0.003987569 0.251216845 0.007612632 4956 hsa-mir-135a-2 hsa04540 Gap junction 5595_5594_983 3 0.005165593 0.325432351 0.009535274 4957 hsa-mir-135a-2 hsa05016 Huntington's disease 1387_6908_6667_2033 4 0.005297374 0.333734584 0.009535274 4958 hsa-mir-135a-2 hsa04510 Focal adhesion 5595_5594_3725_207 4 0.007235797 0.455855227 0.012662645 4959 hsa-mir-135a-2 hsa04912 GnRH signaling pathway 5595_5594_3725 3 0.007712301 0.485874933 0.013131755 4960 hsa-mir-135a-2 hsa03410 Base excision repair 3146_142 2 0.008385287 0.528273063 0.013901923 4961 hsa-mir-135a-2 hsa04930 Type II diabetes mellitus 5595_5594 2 0.012624631 0.795351726 0.020227226 4962 hsa-mir-135a-2 hsa04360 Axon guidance 25_5595_5594 3 0.012842683 0.809089041 0.020227226 4963 hsa-mir-135a-2 hsa04910 Insulin signaling pathway 5595_5594_207 3 0.01471024 0.926745151 0.02260354 4964 hsa-mir-135a-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_3725 2 0.028884178 1 0.04231868 4965 hsa-mir-135a-2 hsa04730 Long-term depression 5595_5594 2 0.028884178 1 0.04231868 4966 hsa-mir-135a-2 hsa04612 Antigen processing and presentation 4800_1514 2 0.043167439 1 0.060434414 4967 hsa-mir-135a-2 hsa04210 Apoptosis 5970_207 2 0.043167439 1 0.060434414 4968 hsa-mir-135a-2 hsa04810 Regulation of actin cytoskeleton 2249_5595_5594 3 0.046998685 1 0.064367765 4969 hsa-mir-135b hsa05200 Pathways in cancer 3066_1499_25_5371_405_2034_2249_9063_5467_5468_5595_5594_5599_5914_1387_6256_595_861_5601_1488_1487_6258_367_1017_2956_1871_51176_4193_6934_7704_842_6776_6772_2885_3065_5970_1870_7157_4824_4087_6688_5604_2113_10401_4089_7849_4609_3725_6774_4286_1029_841_2353_6777_4088_1050_5925_3091_2033_207_836 61 1.62E-47 1.16E-45 1.16E-45 4970 hsa-mir-135b hsa05220 Chronic myeloid leukemia 3066_25_5595_5594_595_861_1488_1487_1871_4193_6776_2885_3065_5970_1870_7157_5604_4089_4609_1029_6777_4088_5925_207 24 4.38E-24 3.15E-22 1.58E-22 4971 hsa-mir-135b hsa05221 Acute myeloid leukemia 5371_5467_5595_5594_5914_595_861_51176_6934_7704_6776_2885_5970_6688_5604_4609_6774_6777_1050_207 20 1.08E-20 7.80E-19 2.60E-19 4972 hsa-mir-135b hsa05215 Prostate cancer 1499_5595_5594_1387_595_367_1017_1871_51176_4193_6934_1385_842_2885_5970_1870_7157_4824_5604_5925_2033_207 22 3.26E-20 2.35E-18 5.79E-19 4973 hsa-mir-135b hsa05212 Pancreatic cancer 1499_5595_5594_1387_595_367_1017_1871_51176_4193_6934_1385_842_2885_5970_1870_7157_4824_5604_5925_2033_207 22 4.02E-20 2.89E-18 5.79E-19 4974 hsa-mir-135b hsa05210 Colorectal cancer 1499_5595_5594_5599_595_5601_2956_51176_6934_842_2885_7157_4087_5604_4089_4609_3725_2353_4088_207_836 21 2.37E-19 1.70E-17 2.84E-18 4975 hsa-mir-135b hsa04010 MAPK signaling pathway 6722_2249_5595_5594_5599_1386_9261_4208_5606_5601_5600_3164_6195_9252_1432_2885_5970_9344_7157_5604_4609_3725_2353_207_836_2002_2005_4773 28 3.37E-16 2.43E-14 3.47E-15 4976 hsa-mir-135b hsa04310 Wnt signaling pathway 1499_4772_815_5467_5599_1387_595_5601_1488_1487_51176_1457_6934_7157_4087_4089_4609_3725_4088_5527_2033_4773 22 8.87E-16 6.39E-14 7.99E-15 4977 hsa-mir-135b hsa05216 Thyroid cancer 1499_5468_5595_5594_6256_595_6258_51176_6934_7157_5604_7849_4609 13 3.58E-15 2.58E-13 2.87E-14 4978 hsa-mir-135b hsa05223 Non-small cell lung cancer 5595_5594_6256_595_6258_1871_842_2885_1870_7157_5604_1029_5925_2309_207 15 9.05E-15 6.51E-13 6.51E-14 4979 hsa-mir-135b hsa04110 Cell cycle 3066_25_5591_1387_595_5111_1017_1871_4193_3065_5934_1870_7157_4087_4089_1029_4088_5925_2033 19 1.71E-14 1.23E-12 1.12E-13 4980 hsa-mir-135b hsa05213 Endometrial cancer 1499_5595_5594_595_51176_6934_842_2885_7157_5604_4609_2309_207_2002 14 1.03E-13 7.40E-12 6.17E-13 4981 hsa-mir-135b hsa04350 TGF-beta signaling pathway 5595_5594_1387_4092_6667_3397_3399_3398_5934_4087_4089_4609_4088_4086_2033_1875 16 3.00E-13 2.16E-11 1.66E-12 4982 hsa-mir-135b hsa04330 Notch signaling pathway 3066_22938_1387_2648_1488_1487_9794_3065_9612_2033_1840_8850_4851 13 5.90E-13 4.25E-11 3.03E-12 4983 hsa-mir-135b hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5606_5601_5600_3665_3661_1432_6772_5970_5604_3725_841_2353_207 16 2.61E-12 1.88E-10 1.26E-11 4984 hsa-mir-135b hsa05219 Bladder cancer 5595_5594_595_1871_9252_4193_1870_7157_5604_4609_1029_5925 12 3.36E-12 2.42E-10 1.51E-11 4985 hsa-mir-135b hsa04012 ErbB signaling pathway 25_815_6714_5595_5594_5599_5601_6776_2885_5604_4609_3725_6777_207_2002 15 3.80E-12 2.74E-10 1.61E-11 4986 hsa-mir-135b hsa05214 Glioma 815_5595_5594_595_1871_4193_2885_1870_7157_5604_1029_5925_207 13 2.05E-11 1.47E-09 8.18E-11 4987 hsa-mir-135b hsa05222 Small cell lung cancer 9063_6256_595_6258_1017_1871_842_5970_1870_7157_10401_4609_5925_207 14 3.96E-11 2.85E-09 1.50E-10 4988 hsa-mir-135b hsa05218 Melanoma 2249_5595_5594_595_1871_4193_1870_7157_5604_4286_1029_5925_207 13 5.42E-11 3.90E-09 1.95E-10 4989 hsa-mir-135b hsa04912 GnRH signaling pathway 5580_815_6714_5595_5594_5599_5606_5601_5600_1432_2885_5604_3725_2002 14 5.95E-10 4.29E-08 2.04E-09 4990 hsa-mir-135b hsa05211 Renal cell carcinoma 405_2034_5595_5594_1387_2885_5604_2113_3725_3091_2033_207 12 7.84E-10 5.64E-08 2.56E-09 4991 hsa-mir-135b hsa05322 Systemic lupus erythematosus 3020_8363_8365_3021_8359_8362_8294_8368_8370_121504_8361_8360_8364_8367_8366 15 2.29E-09 1.65E-07 6.89E-09 4992 hsa-mir-135b hsa04520 Adherens junction 1499_6714_5595_5594_1387_51176_1457_6934_4087_4089_4088_2033 12 2.30E-09 1.65E-07 6.89E-09 4993 hsa-mir-135b hsa04660 T cell receptor signaling pathway 4772_5595_5594_5601_5600_1432_2885_5970_5604_3725_2353_207_4773 13 6.79E-09 4.89E-07 1.96E-08 4994 hsa-mir-135b hsa04370 VEGF signaling pathway 4772_6714_5595_5594_9261_5600_1432_842_5604_207_4773 11 1.70E-08 1.22E-06 4.70E-08 4995 hsa-mir-135b hsa04664 Fc epsilon RI signaling pathway 5580_5595_5594_5599_5606_5601_5600_1432_2885_5604_207 11 2.16E-08 1.55E-06 5.75E-08 4996 hsa-mir-135b hsa04630 Jak-STAT signaling pathway 9063_1387_595_6776_6772_2885_10401_4609_6774_6777_2033_3977_207_6778 14 4.14E-08 2.98E-06 1.06E-07 4997 hsa-mir-135b hsa04115 p53 signaling pathway 595_1017_4194_4193_842_7157_7161_1029_841_836 10 6.75E-08 4.86E-06 1.68E-07 4998 hsa-mir-135b hsa04662 B cell receptor signaling pathway 4772_5595_5594_2885_5970_5604_3725_2353_207_4773 10 1.37E-07 9.87E-06 3.29E-07 4999 hsa-mir-135b hsa04916 Melanogenesis 1499_815_5595_5594_1387_51176_6934_1385_5604_4286_2033 11 2.77E-07 2.00E-05 6.44E-07 5000 hsa-mir-135b hsa04920 Adipocytokine signaling pathway 10891_5599_6256_5601_6258_5970_6774_207_5465 9 5.51E-07 3.97E-05 1.24E-06 5001 hsa-mir-135b hsa03410 Base excision repair 6996_252969_5111_4350_328_142_2237 7 1.14E-06 8.19E-05 2.48E-06 5002 hsa-mir-135b hsa05016 Huntington's disease 3066_10891_5468_1387_6908_6667_1385_842_3065_7157_841_2033_836 13 2.13E-06 0.000153701 4.52E-06 5003 hsa-mir-135b hsa03450 Non-homologous end-joining 10111_5591_2547_4361_2237 5 3.32E-06 0.000238946 6.83E-06 5004 hsa-mir-135b hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5599_5601_5600_1432_5970_3725_836 8 7.78E-06 0.000560206 1.56E-05 5005 hsa-mir-135b hsa04910 Insulin signaling pathway 10891_5595_5594_6720_5599_5601_2885_5604_207_2002 10 2.19E-05 0.001577572 4.26E-05 5006 hsa-mir-135b hsa04510 Focal adhesion 1499_6714_5595_5594_5599_595_5601_2885_5604_3725_207_2002 12 2.65E-05 0.001911152 5.03E-05 5007 hsa-mir-135b hsa04210 Apoptosis 839_842_840_5970_7157_841_207_836 8 3.53E-05 0.002542578 6.52E-05 5008 hsa-mir-135b hsa04062 Chemokine signaling pathway 5580_5595_5594_6772_2885_5970_5604_6774_6777_2309_207 11 6.89E-05 0.004960346 0.000124009 5009 hsa-mir-135b hsa04720 Long-term potentiation 815_5595_5594_1387_6195_5604_2033 7 8.75E-05 0.006303456 0.000153743 5010 hsa-mir-135b hsa05014 Amyotrophic lateral sclerosis (ALS) 5606_5600_1432_842_7157_836 6 0.000140217 0.010095654 0.000240373 5011 hsa-mir-135b hsa04930 Type II diabetes mellitus 5580_5595_5594_5599_5601 5 0.000437073 0.031469282 0.000731844 5012 hsa-mir-135b hsa04150 mTOR signaling pathway 5595_5594_6195_3091_207 5 0.000803035 0.057818514 0.001314057 5013 hsa-mir-135b hsa03022 Basal transcription factors 2962_2969_6908_2959 4 0.001825017 0.131401189 0.002920026 5014 hsa-mir-135b hsa04650 Natural killer cell mediated cytotoxicity 4772_5595_5594_2885_5604_836_4773 7 0.002685729 0.193372485 0.004100724 5015 hsa-mir-135b hsa05010 Alzheimer's disease 22926_5595_5594_842_840_841_6622_836 8 0.002712753 0.195318238 0.004100724 5016 hsa-mir-135b hsa03320 PPAR signaling pathway 5467_5468_6256_6258_5465 5 0.002746509 0.197748679 0.004100724 5017 hsa-mir-135b hsa04120 Ubiquitin mediated proteolysis 5371_9063_672_4193_10401_7329_8925 7 0.00279077 0.200935453 0.004100724 5018 hsa-mir-135b hsa04950 Maturity onset diabetes of the young 5080_6927_4760 3 0.004812662 0.346511676 0.006930234 5019 hsa-mir-135b hsa05217 Basal cell carcinoma 1499_51176_6934_7157 4 0.006854992 0.493559426 0.009677636 5020 hsa-mir-135b hsa03440 Homologous recombination 10111_4361_4683 3 0.007123115 0.512864299 0.009862775 5021 hsa-mir-135b hsa04540 Gap junction 6714_5595_5594_2885_5604 5 0.008527514 0.61398103 0.011584548 5022 hsa-mir-135b hsa04270 Vascular smooth muscle contraction 5580_5595_5594_59_5604 5 0.021019116 1 0.028025488 5023 hsa-mir-135b hsa03420 Nucleotide excision repair 4331_5111_5886 3 0.022131914 1 0.028972688 5024 hsa-mir-135b hsa04360 Axon guidance 25_4772_5595_5594_4773 5 0.030690163 1 0.039458781 5025 hsa-mir-135b hsa04530 Tight junction 1499_5580_6714_1457_207 5 0.035958792 1 0.045421631 5026 hsa-mir-135b hsa03430 Mismatch repair 5111_2956 2 0.040207958 1 0.049913327 5027 hsa-mir-136 hsa05200 Pathways in cancer 4149_7046_596_598_1017_4193_7704_5578_6502_3091_3066_3065_1050_5925_613_5743_5747_25_6789_4436_1870_1871_2113_5894_207_1147_998_5595_5594_5599_1387_2932_6774_6772_5970_7157_6688_1869_3725_2736_4087_4088_4089_5888_5728_2033_3910_4792_3320_3326_5371_675_5604_5601_5602_1856_4292_51588_4609_1026_1029_2353_8554 63 2.30E-42 1.95E-40 1.95E-40 5028 hsa-mir-136 hsa04110 Cell cycle 1017_4193_902_6502_6500_3066_3065_990_5925_25_1870_1871_9232_5933_545_995_5347_5591_1387_11200_7534_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_1031_983_8454_1026_1022_1029_1111_8556_8555_472 41 1.35E-36 1.15E-34 5.73E-35 5029 hsa-mir-136 hsa05220 Chronic myeloid leukemia 7046_598_4193_3066_3065_5925_613_25_1870_1871_5894_207_1147_5595_5594_5970_7157_1869_4088_4089_4792_5604_4609_1026_1029 25 1.76E-22 1.50E-20 4.99E-21 5030 hsa-mir-136 hsa04010 MAPK signaling pathway 6722_4149_7046_6195_6197_9252_5578_5923_3304_3305_3303_6789_1432_5894_1616_207_1147_998_5595_5594_5599_5598_8986_1386_3315_1649_5970_3164_7157_3725_6196_9261_5604_5601_5602_4609_2353 37 9.99E-21 8.49E-19 2.12E-19 5031 hsa-mir-136 hsa05215 Prostate cancer 596_1017_4193_5925_1870_1871_5894_207_1147_5595_5594_1385_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_5604_1026 24 6.37E-20 5.41E-18 1.08E-18 5032 hsa-mir-136 hsa05212 Pancreatic cancer 596_1017_4193_5925_1870_1871_5894_207_1147_5595_5594_1385_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_5604_1026 24 7.96E-20 6.76E-18 1.13E-18 5033 hsa-mir-136 hsa04115 p53 signaling pathway 1017_4194_4193_50484_6241_51246_545_7161_11200_7157_900_64326_5728_27113_25898_983_1026_1029_1111_472 20 2.95E-17 2.51E-15 3.58E-16 5034 hsa-mir-136 hsa05210 Colorectal cancer 7046_596_4436_5894_207_5595_5594_5599_2932_7157_3725_4087_4088_4089_5604_5601_5602_1856_4292_4609_2353 21 6.07E-17 5.16E-15 6.45E-16 5035 hsa-mir-136 hsa05222 Small cell lung cancer 4149_596_598_1017_6502_5925_5743_5747_1870_1871_207_1147_5970_7157_1869_5728_3910_4792_51588_4609_8554 21 9.14E-17 7.77E-15 8.63E-16 5036 hsa-mir-136 hsa04310 Wnt signaling pathway 5578_6500_1460_5599_1387_2932_7157_3725_1457_1452_1459_4087_4088_4089_8061_2033_5518_5515_5601_5602_1856_8454_4609_5527 24 3.35E-15 2.85E-13 2.85E-14 5037 hsa-mir-136 hsa05219 Bladder cancer 9252_4193_5925_1870_1871_5894_5595_5594_7157_1869_5604_4609_1026_1029 14 3.59E-13 3.05E-11 2.77E-12 5038 hsa-mir-136 hsa05214 Glioma 4193_5578_5925_1870_1871_5894_207_5595_5594_7157_1869_5728_5604_1026_1029 15 4.69E-12 3.99E-10 3.32E-11 5039 hsa-mir-136 hsa04350 TGF-beta signaling pathway 7046_6500_6667_5933_5595_5594_1387_7027_4087_4088_4089_2033_5518_5515_8454_4609 16 1.84E-11 1.56E-09 1.20E-10 5040 hsa-mir-136 hsa05223 Non-small cell lung cancer 5578_5925_6789_1870_1871_5894_207_5595_5594_7157_1869_5604_1029 13 7.99E-11 6.79E-09 4.85E-10 5041 hsa-mir-136 hsa05218 Melanoma 4193_5925_1870_1871_5894_207_5595_5594_7157_1869_5728_5604_1026_1029 14 1.50E-10 1.28E-08 8.53E-10 5042 hsa-mir-136 hsa04012 ErbB signaling pathway 5578_5747_25_5894_207_5595_5594_5599_2932_3725_5604_5601_5602_4609_1026 15 1.76E-10 1.50E-08 9.20E-10 5043 hsa-mir-136 hsa04120 Ubiquitin mediated proteolysis 55294_4193_6502_6500_3093_7319_84447_7329_10055_64326_7337_5371_672_25898_8454_51588_10075_8554 18 1.84E-10 1.56E-08 9.20E-10 5044 hsa-mir-136 hsa05221 Acute myeloid leukemia 7704_1050_5894_207_1147_5595_5594_6774_5970_6688_5371_5604_4609 13 2.07E-10 1.76E-08 9.77E-10 5045 hsa-mir-136 hsa04520 Adherens junction 7046_4301_1460_998_5595_5594_1387_1457_1459_4087_4088_4089_2033_71 14 6.01E-10 5.11E-08 2.69E-09 5046 hsa-mir-136 hsa04660 T cell receptor signaling pathway 1432_5894_207_1147_998_5595_5594_2932_5970_3725_959_4792_5604_5601_2353 15 3.21E-09 2.73E-07 1.37E-08 5047 hsa-mir-136 hsa04540 Gap junction 5578_51807_5894_5592_5595_5594_5598_7846_1453_983_5604_7277_7278_10376 14 3.44E-09 2.92E-07 1.39E-08 5048 hsa-mir-136 hsa04620 Toll-like receptor signaling pathway 1432_207_1147_5595_5594_5599_6772_5970_3725_4792_5604_5601_5602_2353 14 9.98E-09 8.48E-07 3.79E-08 5049 hsa-mir-136 hsa04510 Focal adhesion 596_5578_5923_5747_5499_5894_207_998_5595_5594_5599_2932_3725_5728_3910_5604_5601_5602_71 19 1.02E-08 8.71E-07 3.79E-08 5050 hsa-mir-136 hsa05131 Shigellosis 5578_51807_25_998_7534_7846_7277_7278_71_4691_10376 11 1.47E-08 1.25E-06 5.00E-08 5051 hsa-mir-136 hsa05130 Pathogenic Escherichia coli infection 5578_51807_25_998_7534_7846_7277_7278_71_4691_10376 11 1.47E-08 1.25E-06 5.00E-08 5052 hsa-mir-136 hsa04662 B cell receptor signaling pathway 5894_207_1147_5595_5594_1380_2932_5970_3725_4792_5604_2353 12 2.49E-08 2.11E-06 8.13E-08 5053 hsa-mir-136 hsa04370 VEGF signaling pathway 5578_5743_5747_1432_5894_207_998_5595_5594_3315_9261_5604 12 3.23E-08 2.74E-06 1.02E-07 5054 hsa-mir-136 hsa03022 Basal transcription factors 51616_2965_2963_2962_2969_6908_2958_6880_2957 9 6.24E-08 5.31E-06 1.90E-07 5055 hsa-mir-136 hsa05213 Endometrial cancer 5894_207_5595_5594_2932_7157_5728_5604_4292_4609 10 7.98E-08 6.79E-06 2.34E-07 5056 hsa-mir-136 hsa05211 Renal cell carcinoma 3091_2113_5894_207_998_5595_5594_1387_3725_2033_5604 11 1.45E-07 1.23E-05 4.11E-07 5057 hsa-mir-136 hsa04720 Long-term potentiation 6195_6197_5578_5499_5894_5595_5594_1387_6196_2033_5604 11 2.10E-07 1.79E-05 5.76E-07 5058 hsa-mir-136 hsa04920 Adipocytokine signaling pathway 6794_207_1147_5599_6774_5970_4792_5601_5602_5563 10 6.51E-07 5.53E-05 1.73E-06 5059 hsa-mir-136 hsa04150 mTOR signaling pathway 6794_6195_6197_3091_207_5595_5594_6196_5563 9 7.86E-07 6.68E-05 2.03E-06 5060 hsa-mir-136 hsa04912 GnRH signaling pathway 5578_1432_5894_998_5595_5594_5599_5598_3725_5604_5601_5602 12 8.96E-07 7.62E-05 2.24E-06 5061 hsa-mir-136 hsa04664 Fc epsilon RI signaling pathway 5578_1432_5894_207_5595_5594_5599_5604_5601_5602 10 2.52E-06 0.000214215 6.12E-06 5062 hsa-mir-136 hsa04062 Chemokine signaling pathway 7074_5747_6362_5894_207_1147_998_5595_5594_2932_6774_6772_5970_4792_5604 15 2.68E-06 0.000227581 6.32E-06 5063 hsa-mir-136 hsa04330 Notch signaling pathway 3066_3065_1387_2033_8850_1856_2648_4851 8 3.63E-06 0.000308306 8.33E-06 5064 hsa-mir-136 hsa04612 Antigen processing and presentation 3308_3309_3304_3305_3303_1385_3320_3326_4801_4802 10 6.65E-06 0.000565245 1.49E-05 5065 hsa-mir-136 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_1147_998_5599_5970_3725_4792_5601_5602 9 7.93E-06 0.000674211 1.73E-05 5066 hsa-mir-136 hsa04530 Tight junction 5578_207_4301_1460_998_1457_1459_5728_5518_5515_71_5520 12 8.70E-06 0.000739681 1.85E-05 5067 hsa-mir-136 hsa04910 Insulin signaling pathway 6720_5499_5894_207_5595_5594_5599_2932_5604_5601_5602_5563 12 9.32E-06 0.00079196 1.93E-05 5068 hsa-mir-136 hsa03420 Nucleotide excision repair 902_2965_4331_2071_2074_1022_6117 7 2.20E-05 0.001868541 4.45E-05 5069 hsa-mir-136 hsa04916 Melanogenesis 5578_5894_5595_5594_1385_1387_2932_2033_5604_1856 10 2.32E-05 0.00197436 4.59E-05 5070 hsa-mir-136 hsa04210 Apoptosis 596_598_823_207_1147_5970_7157_4792_472 9 4.12E-05 0.003505977 7.97E-05 5071 hsa-mir-136 hsa04730 Long-term depression 5578_5894_5592_5595_5594_5518_5515_5604 8 5.47E-05 0.004648206 0.000103293 5072 hsa-mir-136 hsa04930 Type II diabetes mellitus 3651_5595_5594_5599_5601_5602 6 0.0002059 0.017501497 0.000380467 5073 hsa-mir-136 hsa05216 Thyroid cancer 5595_5594_7157_5604_4609 5 0.000242875 0.020644361 0.000439242 5074 hsa-mir-136 hsa05016 Huntington's disease 3066_3065_3064_25942_6667_1385_1387_7157_2033_27113_6908 11 0.000579082 0.049221958 0.001025457 5075 hsa-mir-136 hsa04630 Jak-STAT signaling pathway 598_207_1387_6774_6772_2033_51588_4609_8554 9 0.001881212 0.15990304 0.003263327 5076 hsa-mir-136 hsa03440 Homologous recombination 641_5888_675_6117 4 0.00194153 0.165030064 0.003300601 5077 hsa-mir-136 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_1432_1616_7157 5 0.003586098 0.30481832 0.00597683 5078 hsa-mir-136 hsa03410 Base excision repair 3146_142_4913_328 4 0.004440786 0.377466849 0.007258978 5079 hsa-mir-136 hsa04270 Vascular smooth muscle contraction 5578_5499_5894_5592_5595_5594_5604 7 0.005248979 0.446163202 0.008418174 5080 hsa-mir-136 hsa04360 Axon guidance 5747_25_998_5595_5594_2932_1020 7 0.008874196 0.754306646 0.013968642 5081 hsa-mir-136 hsa03430 Mismatch repair 4436_4292_6117 3 0.00916756 0.779242627 0.014168048 5082 hsa-mir-136 hsa04810 Regulation of actin cytoskeleton 7074_5747_5499_5894_998_5595_5594_5604_71 9 0.015379823 1 0.023344374 5083 hsa-mir-136 hsa05217 Basal cell carcinoma 2932_7157_2736_1856 4 0.017254881 1 0.025730963 5084 hsa-mir-136 hsa04340 Hedgehog signaling pathway 2932_1452_1453_2736 4 0.019277966 1 0.028252191 5085 hsa-mir-136 hsa04670 Leukocyte transendothelial migration 5578_5747_1432_4301_998_71 6 0.021187854 1 0.030524875 5086 hsa-mir-136 hsa04740 Olfactory transduction 5592 1 0.025061796 1 0.035504211 5087 hsa-mir-136 hsa03030 DNA replication 5557_6117_5422 3 0.027470092 1 0.038277996 5088 hsa-mir-136 hsa03450 Non-homologous end-joining 2547_5591 2 0.028868931 1 0.039578372 5089 hsa-mir-137 hsa05200 Pathways in cancer 3725_5371_7046_367_1499_5595_5594_5914_6256_595_1488_836_1487_2932_5599_1387_51588_3091_5970_7428_1870_1871_7157_4087_2113_7704_4609_1869_2353_3065_4088_4089_3066_1050_5925_2034_2033_4846_207_208_5601_7189_7186 43 1.36E-31 9.82E-30 9.82E-30 5090 hsa-mir-137 hsa05220 Chronic myeloid leukemia 7046_5595_5594_595_1488_1487_5970_1870_1871_7157_4609_1869_3065_4088_4089_3066_5925_207_208_6464 20 1.20E-20 8.64E-19 4.32E-19 5091 hsa-mir-137 hsa04010 MAPK signaling pathway 6722_3725_3727_7046_5595_5594_1386_4208_5600_3303_836_9252_5599_1432_1649_5970_3312_7157_468_4609_2353_4763_5058_207_208_5601_5603_8550_7189_7186 30 1.95E-20 1.40E-18 4.68E-19 5092 hsa-mir-137 hsa04110 Cell cycle 993_5591_595_983_896_894_7534_2932_1387_1870_1871_7157_4087_1869_3065_4088_4089_7532_3066_5925_2033_5933 22 1.36E-19 9.76E-18 2.44E-18 5093 hsa-mir-137 hsa05210 Colorectal cancer 3725_7046_1499_5595_5594_595_836_2932_5599_7157_4087_4609_2353_4088_4089_207_208_5601 18 2.98E-17 2.15E-15 4.30E-16 5094 hsa-mir-137 hsa05215 Prostate cancer 367_1499_5595_5594_595_2932_1387_5970_1870_1871_7157_468_9586_1869_5925_2033_207_208 18 6.12E-17 4.41E-15 7.34E-16 5095 hsa-mir-137 hsa05212 Pancreatic cancer 367_1499_5595_5594_595_2932_1387_5970_1870_1871_7157_468_9586_1869_5925_2033_207_208 18 7.29E-17 5.25E-15 7.50E-16 5096 hsa-mir-137 hsa04620 Toll-like receptor signaling pathway 3725_3654_5595_5594_5600_3661_353376_148022_5599_1432_5970_2353_4615_207_208_5601_5603_7189 18 6.04E-16 4.35E-14 5.43E-15 5097 hsa-mir-137 hsa04310 Wnt signaling pathway 3725_1499_595_1488_896_894_1487_2932_5599_1387_7157_4087_8061_4609_1459_4088_4089_2033_5601_1457 20 2.27E-15 1.63E-13 1.82E-14 5098 hsa-mir-137 hsa05222 Small cell lung cancer 6256_595_51588_5970_1870_1871_7157_4609_1869_5925_4846_207_208_7189_7186 15 1.94E-13 1.40E-11 1.40E-12 5099 hsa-mir-137 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925_207_208 11 7.69E-11 5.54E-09 4.98E-10 5100 hsa-mir-137 hsa05211 Renal cell carcinoma 3725_5595_5594_1387_3091_7428_2113_5058_2034_2033_207_208 12 8.30E-11 5.97E-09 4.98E-10 5101 hsa-mir-137 hsa05219 Bladder cancer 5595_5594_595_9252_1870_1871_7157_4609_1869_5925 10 1.50E-10 1.08E-08 8.30E-10 5102 hsa-mir-137 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_5970_7704_4609_1050_207_208 11 1.78E-10 1.28E-08 9.13E-10 5103 hsa-mir-137 hsa04520 Adherens junction 7046_1499_6714_5595_5594_1387_4087_1459_4088_4089_2033_1457 12 2.47E-10 1.78E-08 1.19E-09 5104 hsa-mir-137 hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_207_208_6464 11 4.44E-10 3.20E-08 2.00E-09 5105 hsa-mir-137 hsa04012 ErbB signaling pathway 3725_6714_5595_5594_2932_5599_4609_5058_207_208_5601_6464 12 5.90E-10 4.25E-08 2.50E-09 5106 hsa-mir-137 hsa04660 T cell receptor signaling pathway 3725_5595_5594_5600_2932_1432_5970_2353_5058_207_208_5601_5603 13 6.36E-10 4.58E-08 2.55E-09 5107 hsa-mir-137 hsa04330 Notch signaling pathway 1488_1487_1387_9612_3065_3066_2033_2648_8850 9 6.75E-09 4.86E-07 2.55E-08 5108 hsa-mir-137 hsa04350 TGF-beta signaling pathway 7046_5595_5594_1387_4087_658_4609_4088_4089_2033_5933 11 7.08E-09 5.10E-07 2.55E-08 5109 hsa-mir-137 hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5925_207_208 10 1.36E-08 9.80E-07 4.42E-08 5110 hsa-mir-137 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_6714_5600_836_5599_1432_5970_5058_5601_5603 10 1.36E-08 9.80E-07 4.42E-08 5111 hsa-mir-137 hsa04510 Focal adhesion 3725_1499_6714_5595_5594_595_896_894_2932_5599_5058_207_208_5601_6464 15 1.46E-08 1.05E-06 4.42E-08 5112 hsa-mir-137 hsa05213 Endometrial cancer 1499_5595_5594_595_2932_7157_4609_207_208 9 1.47E-08 1.06E-06 4.42E-08 5113 hsa-mir-137 hsa05216 Thyroid cancer 1499_5595_5594_6256_595_7157_4609 7 8.41E-08 6.05E-06 2.42E-07 5114 hsa-mir-137 hsa04370 VEGF signaling pathway 6714_5595_5594_5600_1432_4846_207_208_5603 9 3.11E-07 2.24E-05 8.61E-07 5115 hsa-mir-137 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5600_5599_1432_207_208_5601_5603 9 3.79E-07 2.73E-05 1.01E-06 5116 hsa-mir-137 hsa04912 GnRH signaling pathway 3725_6714_5595_5594_5600_5599_1432_468_5601_5603 10 5.02E-07 3.61E-05 1.29E-06 5117 hsa-mir-137 hsa04920 Adipocytokine signaling pathway 6256_5599_5970_207_208_5601_2538_7186 8 1.23E-06 8.85E-05 3.05E-06 5118 hsa-mir-137 hsa05016 Huntington's disease 6874_25942_2902_836_1387_7157_9586_3065_10476_3066_3064_2033 12 1.52E-06 0.000109459 3.65E-06 5119 hsa-mir-137 hsa04662 B cell receptor signaling pathway 3725_5595_5594_2932_5970_2353_207_208 8 2.67E-06 0.000192527 6.21E-06 5120 hsa-mir-137 hsa04910 Insulin signaling pathway 5595_5594_6720_2932_5599_207_208_5601_6464_2538 10 3.98E-06 0.000286295 8.95E-06 5121 hsa-mir-137 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_5600_836_1432_7157_4846_5603 7 4.37E-06 0.000314899 9.54E-06 5122 hsa-mir-137 hsa04210 Apoptosis 3654_836_5970_7157_4615_207_208_7186 8 8.63E-06 0.000621356 1.83E-05 5123 hsa-mir-137 hsa04630 Jak-STAT signaling pathway 595_896_894_1387_51588_4609_2033_207_208 9 6.27E-05 0.004513395 0.000128954 5124 hsa-mir-137 hsa04115 p53 signaling pathway 595_983_836_896_894_7157 6 0.000139277 0.010027943 0.000278554 5125 hsa-mir-137 hsa04530 Tight junction 1499_6714_4628_60412_1459_207_208_1457 8 0.000154113 0.011096147 0.000299896 5126 hsa-mir-137 hsa04930 Type II diabetes mellitus 3651_5595_5594_5599_5601 5 0.000177048 0.012747437 0.000335459 5127 hsa-mir-137 hsa04720 Long-term potentiation 5595_5594_2902_1387_468_2033 6 0.000212992 0.015335453 0.000393217 5128 hsa-mir-137 hsa04150 mTOR signaling pathway 5595_5594_3091_207_208 5 0.000329567 0.023728793 0.00059322 5129 hsa-mir-137 hsa04916 Melanogenesis 1499_5595_5594_2932_1387_2033 6 0.001091424 0.07858251 0.001916647 5130 hsa-mir-137 hsa04062 Chemokine signaling pathway 5595_5594_2932_5970_5058_207_208_6464 8 0.001343285 0.096716488 0.002302774 5131 hsa-mir-137 hsa04950 Maturity onset diabetes of the young 3651_5080_3172 3 0.002774397 0.199756619 0.004645503 5132 hsa-mir-137 hsa04612 Antigen processing and presentation 3303_4800_1514_3312_4801 5 0.003154831 0.227147852 0.005162451 5133 hsa-mir-137 hsa05010 Alzheimer's disease 5595_5594_2902_836_2932_10476_4846 7 0.003406939 0.245299624 0.005451103 5134 hsa-mir-137 hsa04120 Ubiquitin mediated proteolysis 5371_672_51588_7428_7329_7189 6 0.004373094 0.314862772 0.006844843 5135 hsa-mir-137 hsa04710 Circadian rhythm - mammal 8863_406 2 0.010522564 0.757624624 0.016119673 5136 hsa-mir-137 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_5058_6464 5 0.017682648 1 0.026523971 5137 hsa-mir-137 hsa04540 Gap junction 6714_5595_5594_983 4 0.019216217 1 0.028236075 5138 hsa-mir-137 hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.023077179 1 0.033231138 5139 hsa-mir-137 hsa04730 Long-term depression 5595_5594_4846 3 0.042955021 1 0.060642383 5140 hsa-mir-137 hsa04670 Leukocyte transendothelial migration 1499_5600_1432_5603 4 0.044015821 1 0.060944983 5141 hsa-mir-139 hsa05200 Pathways in cancer 3320_1869_4149_5371_4292_1499_5595_5594_5599_861_5914_1387_6256_595_2308_836_1019_367_1017_2932_7704_3091_5970_7428_1870_1871_7157_6688_2113_5894_4609_3725_1026_5604_1029_6502_2353_4087_4088_4089_3066_3065_1050_5925_2034_2033_4846_5601_8554_4286 50 1.80E-39 1.35E-37 1.35E-37 5142 hsa-mir-139 hsa04110 Cell cycle 1869_990_5591_1387_595_983_1019_1017_2932_8454_7027_6500_1870_1871_7157_1026_1029_6502_4087_4088_4089_3066_3065_5925_2033_891_5933 27 8.19E-26 6.14E-24 3.07E-24 5143 hsa-mir-139 hsa05215 Prostate cancer 3320_1869_1499_5595_5594_1387_595_2308_367_1017_2932_5970_1870_1871_7157_468_5894_1026_5604_5925_2033_90993 22 4.88E-22 3.66E-20 9.05E-21 5144 hsa-mir-139 hsa05220 Chronic myeloid leukemia 1869_5595_5594_861_595_1019_5970_1870_1871_7157_5894_4609_1026_5604_1029_4088_4089_3066_3065_5925_6464 21 5.76E-22 4.32E-20 9.05E-21 5145 hsa-mir-139 hsa05212 Pancreatic cancer 3320_1869_1499_5595_5594_1387_595_2308_367_1017_2932_5970_1870_1871_7157_468_5894_1026_5604_5925_2033_90993 22 6.03E-22 4.53E-20 9.05E-21 5146 hsa-mir-139 hsa05210 Colorectal cancer 4292_1499_5595_5594_5599_595_836_2932_7157_5894_4609_3725_5604_2353_4087_4088_4089_5601 18 3.15E-17 2.36E-15 3.94E-16 5147 hsa-mir-139 hsa05219 Bladder cancer 1869_5595_5594_595_1019_1870_1871_7157_5894_4609_1026_5604_1029_5925 14 5.98E-16 4.48E-14 6.40E-15 5148 hsa-mir-139 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_8454_7027_3399_3398_6500_1874_4609_4087_4088_4089_2033_5933 16 1.52E-14 1.14E-12 1.43E-13 5149 hsa-mir-139 hsa05214 Glioma 1869_5595_5594_595_1019_1870_1871_7157_5894_1026_5604_1029_5925_6464 14 1.03E-13 7.73E-12 8.59E-13 5150 hsa-mir-139 hsa04010 MAPK signaling pathway 3727_4149_5595_5594_5599_5598_4208_836_1386_1432_1649_5970_3312_7157_468_5894_4609_3725_5604_2353_4763_1616_5601 23 1.22E-13 9.17E-12 9.17E-13 5151 hsa-mir-139 hsa05222 Small cell lung cancer 1869_4149_6256_595_1019_1017_5970_1870_1871_7157_4609_6502_5925_4846_8554 15 2.03E-13 1.52E-11 1.39E-12 5152 hsa-mir-139 hsa05223 Non-small cell lung cancer 1869_5595_5594_6256_595_1019_1870_1871_7157_5894_5604_1029_5925 13 2.31E-13 1.73E-11 1.45E-12 5153 hsa-mir-139 hsa05218 Melanoma 1869_5595_5594_595_1019_1870_1871_7157_5894_1026_5604_1029_5925_4286 14 2.98E-13 2.23E-11 1.69E-12 5154 hsa-mir-139 hsa04310 Wnt signaling pathway 1499_5599_1387_595_2932_8454_6500_7157_8061_4609_3725_1457_1459_4087_4088_4089_2033_5601 18 3.16E-13 2.37E-11 1.69E-12 5155 hsa-mir-139 hsa05221 Acute myeloid leukemia 5371_5595_5594_861_5914_595_7704_5970_6688_5894_4609_5604_1050 13 6.17E-13 4.62E-11 3.08E-12 5156 hsa-mir-139 hsa04115 p53 signaling pathway 7161_595_983_836_1019_1017_7157_1026_1029_64326_891 11 8.09E-10 6.07E-08 3.79E-09 5157 hsa-mir-139 hsa05213 Endometrial cancer 4292_1499_5595_5594_595_2932_7157_5894_4609_5604 10 9.57E-10 7.18E-08 4.22E-09 5158 hsa-mir-139 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2113_5894_3725_5604_2034_2033 11 1.21E-09 9.09E-08 5.05E-09 5159 hsa-mir-139 hsa05216 Thyroid cancer 1499_5595_5594_6256_595_7157_4609_5604 8 4.07E-09 3.06E-07 1.61E-08 5160 hsa-mir-139 hsa04012 ErbB signaling pathway 5595_5594_5599_2932_5894_4609_3725_1026_5604_5601_6464 11 7.32E-09 5.49E-07 2.74E-08 5161 hsa-mir-139 hsa04540 Gap junction 5595_5594_5598_983_7277_7278_5894_7846_5604_51807_10376 11 1.38E-08 1.03E-06 4.92E-08 5162 hsa-mir-139 hsa05016 Huntington's disease 10891_1387_2902_6908_6874_836_6667_1537_7157_3066_3065_3064_2033_90993 14 3.54E-08 2.66E-06 1.21E-07 5163 hsa-mir-139 hsa04520 Adherens junction 1499_5595_5594_1387_1457_1459_4087_4088_4089_2033 10 3.93E-08 2.95E-06 1.28E-07 5164 hsa-mir-139 hsa04660 T cell receptor signaling pathway 5595_5594_1019_2932_1432_5970_5894_3725_5604_2353_5601 11 6.73E-08 5.05E-06 2.10E-07 5165 hsa-mir-139 hsa04910 Insulin signaling pathway 6720_10891_5595_5594_5599_2308_5563_2932_5894_5604_5601_6464 12 7.07E-08 5.30E-06 2.12E-07 5166 hsa-mir-139 hsa04120 Ubiquitin mediated proteolysis 7325_11059_5371_672_4734_8454_55294_6500_7428_6502_64326_8554 12 7.61E-08 5.71E-06 2.20E-07 5167 hsa-mir-139 hsa04916 Melanogenesis 1499_5595_5594_1387_2932_5894_5604_2033_4286_90993 10 3.74E-07 2.81E-05 1.04E-06 5168 hsa-mir-139 hsa04912 GnRH signaling pathway 5595_5594_5599_5598_1432_468_5894_3725_5604_5601 10 5.16E-07 3.87E-05 1.38E-06 5169 hsa-mir-139 hsa04720 Long-term potentiation 5595_5594_1387_2902_468_5894_5604_2033 8 2.74E-06 0.000205205 6.74E-06 5170 hsa-mir-139 hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_5894_3725_5604_2353 8 2.74E-06 0.000205205 6.74E-06 5171 hsa-mir-139 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_1432_5970_3725_5604_2353_5601 9 2.79E-06 0.000208999 6.74E-06 5172 hsa-mir-139 hsa05131 Shigellosis 1499_4691_7277_7278_7846_51807_10376 7 4.46E-06 0.000334765 1.01E-05 5173 hsa-mir-139 hsa05130 Pathogenic Escherichia coli infection 1499_4691_7277_7278_7846_51807_10376 7 4.46E-06 0.000334765 1.01E-05 5174 hsa-mir-139 hsa04330 Notch signaling pathway 1387_9612_3066_3065_2033_2648 6 1.96E-05 0.001470064 4.32E-05 5175 hsa-mir-139 hsa04510 Focal adhesion 1499_5595_5594_5599_595_2932_5894_3725_5604_5601_6464 11 2.10E-05 0.001575009 4.50E-05 5176 hsa-mir-139 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_1432_5894_5604_5601 7 3.53E-05 0.002644944 7.35E-05 5177 hsa-mir-139 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_1432_7157_1616_4846 6 4.85E-05 0.00363626 9.83E-05 5178 hsa-mir-139 hsa04920 Adipocytokine signaling pathway 10891_5599_6256_5563_5970_5601 6 0.000121872 0.009140372 0.000240536 5179 hsa-mir-139 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_836_1432_5970_3725_5601 6 0.000163878 0.012290879 0.000314019 5180 hsa-mir-139 hsa05010 Alzheimer's disease 5595_5594_823_2902_836_2932_1537_9451_4846 9 0.000167477 0.01256074 0.000314019 5181 hsa-mir-139 hsa04370 VEGF signaling pathway 5595_5594_1432_5894_5604_4846 6 0.000247504 0.018562835 0.000452752 5182 hsa-mir-139 hsa03022 Basal transcription factors 2969_2962_6908_6874 4 0.000896059 0.067204403 0.001600105 5183 hsa-mir-139 hsa04730 Long-term depression 5595_5594_5894_5604_4846 5 0.001253955 0.09404662 0.002187131 5184 hsa-mir-139 hsa04062 Chemokine signaling pathway 5595_5594_2932_5970_5894_5604_6464_7074 8 0.001369889 0.102741641 0.002335037 5185 hsa-mir-139 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601 4 0.001755218 0.131641313 0.002925363 5186 hsa-mir-139 hsa04150 mTOR signaling pathway 5595_5594_5563_3091 4 0.00287273 0.215454783 0.0046838 5187 hsa-mir-139 hsa04612 Antigen processing and presentation 3320_4800_4802_3312_4801 5 0.003196898 0.239767383 0.005101434 5188 hsa-mir-139 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_5894_5604_6464 6 0.004292412 0.321930915 0.006706894 5189 hsa-mir-139 hsa04210 Apoptosis 823_836_5970_7157 4 0.016895044 1 0.025859762 5190 hsa-mir-139 hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.023263292 1 0.034894939 5191 hsa-mir-139 hsa04630 Jak-STAT signaling pathway 1387_595_4609_2033_8554 5 0.027439175 1 0.040351728 5192 hsa-mir-139 hsa03430 Mismatch repair 5981_4292 2 0.028230269 1 0.040716734 5193 hsa-mir-139 hsa04270 Vascular smooth muscle contraction 5595_5594_5894_5604 4 0.040256411 1 0.05696662 5194 hsa-mir-140 hsa05200 Pathways in cancer 1147_3320_3326_405_3480_1956_5595_5594_5599_6654_5914_2064_6256_595_5601_1488_2308_1487_208_367_4193_7704_1387_5970_8503_2885_7157_4087_10401_3725_2353_6776_4088_4089_5295_2033_207_8554_4790 39 7.01E-33 5.26E-31 5.26E-31 5195 hsa-mir-140 hsa05215 Prostate cancer 1147_3320_3326_3480_1956_5595_5594_6654_2064_595_2308_208_367_4193_1387_5970_8503_2885_7157_468_5295_2033_207_4790 24 3.20E-28 2.40E-26 1.01E-26 5196 hsa-mir-140 hsa05212 Pancreatic cancer 1147_3320_3326_3480_1956_5595_5594_6654_2064_595_2308_208_367_4193_1387_5970_8503_2885_7157_468_5295_2033_207_4790 24 4.04E-28 3.03E-26 1.01E-26 5197 hsa-mir-140 hsa04010 MAPK signaling pathway 1147_994_1956_5595_5594_5599_6654_5601_5566_208_4214_1386_1432_1649_5970_627_2885_7157_10912_468_3725_3727_6195_6197_2353_5058_4616_2872_207_4790 30 1.21E-24 9.07E-23 2.27E-23 5198 hsa-mir-140 hsa05220 Chronic myeloid leukemia 1147_5595_5594_6654_595_1488_1487_208_4193_5970_8503_2885_7157_6776_4088_4089_5295_207_4790_6464 20 1.58E-23 1.19E-21 2.37E-22 5199 hsa-mir-140 hsa05210 Colorectal cancer 3480_1956_5595_5594_5599_6654_595_5601_208_8503_2885_7157_4087_3725_2353_4088_4089_5295_207 19 3.09E-21 2.32E-19 3.86E-20 5200 hsa-mir-140 hsa04910 Insulin signaling pathway 6720_10891_5595_5594_5599_6654_5601_2308_5566_7249_208_5770_8503_2885_5295_2872_207_801_6464_808_805 21 3.51E-20 2.63E-18 3.76E-19 5201 hsa-mir-140 hsa05214 Glioma 3480_1956_5595_5594_6654_595_208_4193_8503_2885_7157_5295_207_801_6464_808_805 17 4.75E-20 3.57E-18 4.46E-19 5202 hsa-mir-140 hsa04012 ErbB signaling pathway 1956_6714_5595_5594_5599_6654_56924_2064_5601_208_8503_2885_3725_6776_5295_5058_207_6464 18 1.42E-19 1.07E-17 1.18E-18 5203 hsa-mir-140 hsa04660 T cell receptor signaling pathway 1147_3932_5595_5594_6654_56924_5601_208_5777_1432_5970_8503_2885_3725_2353_5295_5058_207_4790 19 2.73E-19 2.05E-17 2.05E-18 5204 hsa-mir-140 hsa05221 Acute myeloid leukemia 1147_5595_5594_6654_5914_595_208_7704_5970_8503_2885_6776_5295_207_4790 15 1.12E-17 8.44E-16 7.67E-17 5205 hsa-mir-140 hsa04510 Focal adhesion 9564_3480_1956_6714_5595_5594_5599_6654_56924_2064_595_5601_208_8503_857_2885_3725_5295_5058_207_6464 21 6.08E-17 4.56E-15 3.80E-16 5206 hsa-mir-140 hsa05223 Non-small cell lung cancer 1956_5595_5594_6654_2064_6256_595_208_8503_2885_7157_5295_2309_207 14 1.11E-16 8.32E-15 6.40E-16 5207 hsa-mir-140 hsa04912 GnRH signaling pathway 1956_6714_5595_5594_5599_6654_5601_5566_4214_1432_2885_468_3725_801_808_805 16 1.71E-15 1.28E-13 9.15E-15 5208 hsa-mir-140 hsa05213 Endometrial cancer 1956_5595_5594_6654_2064_595_208_8503_2885_7157_5295_2309_207 13 2.11E-15 1.58E-13 1.05E-14 5209 hsa-mir-140 hsa05211 Renal cell carcinoma 405_5595_5594_6654_56924_208_1387_8503_2885_3725_5295_5058_2033_207 14 3.62E-15 2.72E-13 1.70E-14 5210 hsa-mir-140 hsa04662 B cell receptor signaling pathway 1147_5595_5594_6654_208_5777_5970_8503_2885_3725_2353_5295_207_4790 14 5.98E-15 4.48E-13 2.64E-14 5211 hsa-mir-140 hsa04520 Adherens junction 1460_3480_1956_6714_5595_5594_2064_5770_5777_1387_4087_4088_4089_2033 14 1.32E-14 9.90E-13 5.50E-14 5212 hsa-mir-140 hsa04110 Cell cycle 994_891_595_7533_4193_902_1387_7157_4087_10912_1022_4088_4089_4616_2033 15 1.13E-13 8.49E-12 4.47E-13 5213 hsa-mir-140 hsa04620 Toll-like receptor signaling pathway 1147_5595_5594_5599_5601_208_1432_5970_8503_3725_2353_5295_207_4790 14 2.65E-13 1.99E-11 9.94E-13 5214 hsa-mir-140 hsa04062 Chemokine signaling pathway 1147_9564_5595_5594_6654_2770_5566_208_5970_8503_2885_5295_5058_2309_207_4790_6464 17 5.46E-13 4.09E-11 1.95E-12 5215 hsa-mir-140 hsa04310 Wnt signaling pathway 1460_5599_595_5601_1488_5566_1487_1387_7157_4087_8061_3725_4088_4089_2033 15 2.92E-12 2.19E-10 9.95E-12 5216 hsa-mir-140 hsa05222 Small cell lung cancer 1147_6256_595_208_5970_8503_7157_10401_5295_207_8554_4790 12 1.16E-11 8.73E-10 3.80E-11 5217 hsa-mir-140 hsa05218 Melanoma 3480_1956_5595_5594_595_208_4193_8503_7157_5295_207 11 3.09E-11 2.32E-09 9.65E-11 5218 hsa-mir-140 hsa04720 Long-term potentiation 5595_5594_5566_1387_468_6195_6197_2033_801_808_805 11 5.26E-11 3.94E-09 1.58E-10 5219 hsa-mir-140 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_6654_5601_208_1432_8503_2885_5295_207 11 8.71E-11 6.53E-09 2.51E-10 5220 hsa-mir-140 hsa04630 Jak-STAT signaling pathway 6654_595_208_5777_1387_8503_2885_10401_6776_5295_2033_207_8554 13 5.49E-10 4.12E-08 1.52E-09 5221 hsa-mir-140 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_1956_6714_5599_5601_1432_5970_3725_5058_4790 10 5.76E-10 4.32E-08 1.54E-09 5222 hsa-mir-140 hsa04150 mTOR signaling pathway 5595_5594_7249_208_8503_6195_6197_5295_207 9 8.32E-10 6.24E-08 2.15E-09 5223 hsa-mir-140 hsa04210 Apoptosis 1147_5566_208_5970_8503_823_7157_5295_207_4790 10 4.24E-09 3.18E-07 1.06E-08 5224 hsa-mir-140 hsa04920 Adipocytokine signaling pathway 1147_10891_5599_6256_5601_208_5970_207_4790 9 6.20E-09 4.65E-07 1.50E-08 5225 hsa-mir-140 hsa05219 Bladder cancer 1956_5595_5594_2064_595_4193_7157 7 8.31E-08 6.23E-06 1.95E-07 5226 hsa-mir-140 hsa04115 p53 signaling pathway 891_595_7249_4193_7157_10912_64326_4616 8 1.25E-07 9.35E-06 2.83E-07 5227 hsa-mir-140 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6654_5777_8503_2885_5295_5058_6464 10 2.01E-07 1.51E-05 4.37E-07 5228 hsa-mir-140 hsa04916 Melanogenesis 5595_5594_2770_5566_1387_2033_801_808_805 9 2.04E-07 1.53E-05 4.37E-07 5229 hsa-mir-140 hsa04370 VEGF signaling pathway 6714_5595_5594_208_1432_8503_5295_207 8 2.71E-07 2.03E-05 5.64E-07 5230 hsa-mir-140 hsa04350 TGF-beta signaling pathway 5595_5594_6667_1387_4087_4088_4089_2033 8 6.41E-07 4.81E-05 1.30E-06 5231 hsa-mir-140 hsa04540 Gap junction 1956_6714_5595_5594_6654_2770_5566_2885 8 1.02E-06 7.69E-05 2.02E-06 5232 hsa-mir-140 hsa04120 Ubiquitin mediated proteolysis 672_4214_4193_10401_10273_64326_7329_7325_8554 9 1.99E-06 0.000149554 3.83E-06 5233 hsa-mir-140 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601_8503_5295 6 2.34E-06 0.000175378 4.38E-06 5234 hsa-mir-140 hsa05216 Thyroid cancer 5595_5594_6256_595_7157 5 5.44E-06 0.000407931 9.95E-06 5235 hsa-mir-140 hsa04330 Notch signaling pathway 1488_1487_1387_9612_2033 5 4.55E-05 0.003411964 8.12E-05 5236 hsa-mir-140 hsa04810 Regulation of actin cytoskeleton 9564_1956_5595_5594_6654_56924_8503_5295_5058 9 6.33E-05 0.004748459 0.000110429 5237 hsa-mir-140 hsa05010 Alzheimer's disease 5595_5594_1537_823_9451_801_808_805 8 8.62E-05 0.006463121 0.000146889 5238 hsa-mir-140 hsa05016 Huntington's disease 10891_6908_6667_1387_1537_627_7157_2033 8 0.000128581 0.009643557 0.000214301 5239 hsa-mir-140 hsa03022 Basal transcription factors 2965_6908_2959_6881 4 0.000256456 0.019234175 0.000418134 5240 hsa-mir-140 hsa04270 Vascular smooth muscle contraction 5595_5594_5566_801_808_805 6 0.000367146 0.027535916 0.000585871 5241 hsa-mir-140 hsa04070 Phosphatidylinositol signaling system 8503_5295_801_808_805 5 0.000375675 0.028175601 0.000586992 5242 hsa-mir-140 hsa03420 Nucleotide excision repair 2965_902_4331_1022 4 0.000472843 0.035463199 0.000723739 5243 hsa-mir-140 hsa04360 Axon guidance 5998_5595_5594_56924_2770_5058 6 0.000623173 0.04673799 0.00093476 5244 hsa-mir-140 hsa04730 Long-term depression 3480_5595_5594_2770 4 0.002520845 0.189063408 0.003707126 5245 hsa-mir-140 hsa04670 Leukocyte transendothelial migration 9564_2770_1432_8503_5295 5 0.002819548 0.211466065 0.004066655 5246 hsa-mir-140 hsa04020 Calcium signaling pathway 1956_2064_5566_801_808_805 6 0.00329379 0.247034269 0.004661024 5247 hsa-mir-140 hsa04530 Tight junction 1460_6714_2770_208_207 5 0.004539158 0.340436887 0.006304387 5248 hsa-mir-140 hsa05340 Primary immunodeficiency 3932_6890 2 0.031729325 1 0.043267261 5249 hsa-mir-140 hsa04612 Antigen processing and presentation 3320_3326_6890 3 0.032573473 1 0.043625188 5250 hsa-mir-140 hsa03410 Base excision repair 6996_4350 2 0.033328701 1 0.043853553 5251 hsa-mir-141 hsa05200 Pathways in cancer 5914_595_596_598_2261_4193_6934_7704_5578_3091_3066_3065_5925_613_5747_25_1956_1487_1488_6789_4824_4436_1870_1871_2885_2113_861_10401_207_836_3716_1147_2249_998_4233_5595_5594_5599_6258_1387_2064_6256_3326_4286_367_2932_6774_6776_6777_6772_5979_5879_7157_6688_1869_3725_2736_4087_4088_4089_9063_5888_5728_2034_2033_675_4846_3910_4790_4792_5970_1017_3320_5371_3480_5159_5156_5604_5601_5602_1856_842_841_51588_7428_4609_1026_2353_1441_5743_8554 91 6.86E-57 5.97E-55 5.97E-55 5252 hsa-mir-141 hsa04010 MAPK signaling pathway 3925_6722_6197_2261_2264_9252_5578_4773_5923_8986_1956_3304_3303_6789_1432_2885_3305_4763_207_836_1147_2249_998_5595_5594_5599_1386_3312_3315_1649_5879_3164_7157_468_3725_3727_6195_6196_9344_4790_51701_5970_1616_5159_9261_5156_5604_4208_5601_5600_5602_6885_4609_5606_2353_8550_2002_2005 58 2.48E-31 2.16E-29 1.08E-29 5253 hsa-mir-141 hsa05215 Prostate cancer 595_596_4193_6934_5925_1956_4824_1870_1871_2885_9586_207_1147_5595_5594_1385_1387_2064_3326_367_2932_7157_468_1869_5728_2033_4790_4792_5970_1017_3320_3480_5159_5156_5604_842_1026 37 4.64E-29 4.03E-27 1.34E-27 5254 hsa-mir-141 hsa05212 Pancreatic cancer 595_596_4193_6934_5925_1956_4824_1870_1871_2885_9586_207_1147_5595_5594_1385_1387_2064_3326_367_2932_7157_468_1869_5728_2033_4790_4792_5970_1017_3320_3480_5159_5156_5604_842_1026 37 6.41E-29 5.57E-27 1.39E-27 5255 hsa-mir-141 hsa04110 Cell cycle 595_4193_902_5347_1022_3066_3065_5925_25_1870_1871_5933_545_995_7534_5591_1387_11200_7533_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_1017_1031_983_9232_1026_472_1111_8556_8555 38 2.93E-26 2.55E-24 5.10E-25 5256 hsa-mir-141 hsa05220 Chronic myeloid leukemia 595_598_4193_3066_3065_5925_613_25_1487_1488_1870_1871_2885_861_207_1147_5595_5594_6776_6777_7157_1869_4088_4089_4790_4792_5970_5604_5781_4609_1026_6464 32 1.83E-25 1.59E-23 2.65E-24 5257 hsa-mir-141 hsa05210 Colorectal cancer 595_596_6934_1956_4436_2885_207_836_4233_5595_5594_5599_2932_5879_7157_3725_4087_4088_4089_3480_5159_5156_5604_5601_5602_1856_842_4609_2353 29 3.99E-21 3.48E-19 4.96E-20 5258 hsa-mir-141 hsa04630 Jak-STAT signaling pathway 3559_595_598_3454_3455_3560_1439_2885_2690_10401_3977_207_3717_3716_3718_85480_1387_3575_3570_3572_6774_6775_6776_6777_6772_9063_2033_149233_3953_51588_5781_4609_1441_8554 34 3.07E-19 2.67E-17 3.34E-18 5259 hsa-mir-141 hsa05222 Small cell lung cancer 595_596_598_5925_5747_1870_1871_10401_207_1147_6258_6256_7157_1869_9063_5728_4846_3910_4790_4792_5970_1017_842_51588_4609_5743_8554 27 6.94E-19 6.03E-17 6.71E-18 5260 hsa-mir-141 hsa04115 p53 signaling pathway 595_4194_4193_50484_27113_51246_836_545_11200_7157_900_6241_64326_5728_1017_25898_983_842_841_1026_7161_472_1111 23 9.23E-17 8.03E-15 8.03E-16 5261 hsa-mir-141 hsa04310 Wnt signaling pathway 815_595_6934_5578_4773_1460_1487_1488_5599_1387_2932_5879_7157_8061_3725_1457_1452_4087_4088_4089_2033_51701_5518_5515_5601_5602_1856_6885_4609_5527 30 4.77E-16 4.15E-14 3.77E-15 5262 hsa-mir-141 hsa05214 Glioma 815_595_4193_5578_5925_1956_1870_1871_2885_207_5595_5594_7157_1869_5728_3480_5159_5156_5604_1026_6464 21 3.36E-15 2.93E-13 2.44E-14 5263 hsa-mir-141 hsa04012 ErbB signaling pathway 815_5578_5747_25_1956_6714_2885_207_5595_5594_5599_2064_2932_6776_6777_3725_5604_5601_5602_4609_1026_6464_2002 23 6.20E-15 5.40E-13 4.15E-14 5264 hsa-mir-141 hsa05221 Acute myeloid leukemia 5914_595_6934_7704_2885_861_207_1147_5595_5594_6774_6776_6777_6688_4790_5970_5371_5604_4609 19 7.32E-14 6.37E-12 4.55E-13 5265 hsa-mir-141 hsa04620 Toll-like receptor signaling pathway 3454_3455_1432_207_1147_3654_5595_5594_5599_6772_5879_3725_4790_4792_5970_5604_5601_5600_5602_841_6885_5606_2353 23 1.12E-13 9.78E-12 6.52E-13 5266 hsa-mir-141 hsa05218 Melanoma 595_4193_5925_1956_1870_1871_207_2249_4233_5595_5594_4286_7157_1869_5728_3480_5159_5156_5604_1026 20 1.33E-13 1.16E-11 7.24E-13 5267 hsa-mir-141 hsa05223 Non-small cell lung cancer 595_5578_5925_1956_6789_1870_1871_2885_207_5595_5594_6258_2064_6256_7157_1869_5604_842 18 2.04E-13 1.78E-11 1.04E-12 5268 hsa-mir-141 hsa04510 Focal adhesion 595_596_5578_5923_5747_1956_6714_5499_2885_207_998_4233_5595_5594_5599_2064_2932_5879_3725_5728_3910_2321_3480_5159_5156_5604_5601_5602_6464_2002 30 5.77E-13 5.02E-11 2.79E-12 5269 hsa-mir-141 hsa05219 Bladder cancer 595_2261_9252_4193_5925_1956_1870_1871_5595_5594_2064_7157_1869_5604_4609_1026 16 8.41E-13 7.32E-11 3.83E-12 5270 hsa-mir-141 hsa04520 Adherens junction 6934_1460_1956_6714_2241_998_4233_5595_5594_1387_2064_5879_1457_4087_4088_4089_2033_51701_3480_6885 20 8.80E-13 7.65E-11 3.83E-12 5271 hsa-mir-141 hsa04062 Chemokine signaling pathway 1234_1230_5747_5580_7852_2885_6362_207_3055_3717_1147_3718_998_5590_5595_5594_2932_6774_6777_6772_5879_4790_4792_5970_5604_2185_6464 27 1.91E-11 1.66E-09 7.89E-11 5272 hsa-mir-141 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_1432_836_1147_998_4233_5599_5879_3725_4790_4792_5970_5601_5600_5602_5781 17 8.07E-11 7.02E-09 3.19E-10 5273 hsa-mir-141 hsa04912 GnRH signaling pathway 815_5578_5580_1956_6714_1432_2885_998_5595_5594_5599_468_3725_5604_5601_5600_5602_2185_5606_2002 20 1.00E-10 8.74E-09 3.80E-10 5274 hsa-mir-141 hsa05213 Endometrial cancer 595_6934_1956_2885_207_5595_5594_2064_2932_7157_5728_5604_842_4609_2002 15 1.15E-10 9.98E-09 4.16E-10 5275 hsa-mir-141 hsa04660 T cell receptor signaling pathway 4773_3932_1432_2885_207_1147_998_5595_5594_2932_3725_4790_4792_5970_5604_5601_5600_6885_2353_959 20 1.34E-10 1.16E-08 4.66E-10 5276 hsa-mir-141 hsa04370 VEGF signaling pathway 5578_4773_5747_6714_1432_207_998_5595_5594_3315_5879_4846_9261_5604_5600_842_5743 17 2.40E-10 2.09E-08 7.99E-10 5277 hsa-mir-141 hsa04210 Apoptosis 3556_596_598_823_1439_207_836_1147_3654_839_7157_4790_4792_5970_842_841_840_472 18 2.48E-10 2.16E-08 7.99E-10 5278 hsa-mir-141 hsa04920 Adipocytokine signaling pathway 5563_6794_207_3717_1147_5599_6258_6256_6774_4790_4792_5970_5601_5602_3953_5781 16 3.00E-10 2.61E-08 9.32E-10 5279 hsa-mir-141 hsa05211 Renal cell carcinoma 3091_2885_2113_207_998_4233_5595_5594_1387_5879_3725_2034_2033_5604_7428_5781 16 7.46E-10 6.49E-08 2.24E-09 5280 hsa-mir-141 hsa04350 TGF-beta signaling pathway 6667_3397_3399_3398_5933_5595_5594_1387_7027_4086_4087_4088_4089_2033_5518_5515_4609 17 1.24E-09 1.07E-07 3.51E-09 5281 hsa-mir-141 hsa04662 B cell receptor signaling pathway 4773_6850_2885_207_1147_5595_5594_2932_5879_3725_4790_4792_5970_5604_2353_1380 16 1.25E-09 1.09E-07 3.51E-09 5282 hsa-mir-141 hsa03022 Basal transcription factors 6880_51616_2957_2965_2963_2962_2969_6874_6872_6908_2958_2959 12 2.78E-09 2.42E-07 7.55E-09 5283 hsa-mir-141 hsa04664 Fc epsilon RI signaling pathway 5578_5580_6850_1432_2885_207_5595_5594_5599_5879_5604_5601_5600_5602_5606 15 1.63E-08 1.41E-06 4.29E-08 5284 hsa-mir-141 hsa04120 Ubiquitin mediated proteolysis 55294_4193_3093_7319_84447_10401_7329_83737_10055_9063_64326_7337_5371_672_25898_10075_51588_7428_8554 19 2.55E-08 2.22E-06 6.53E-08 5285 hsa-mir-141 hsa05216 Thyroid cancer 595_6934_5595_5594_6258_6256_5979_7157_5604_4609 10 3.66E-08 3.18E-06 9.09E-08 5286 hsa-mir-141 hsa04060 Cytokine-cytokine receptor interaction 3556_3559_1234_1230_3454_3455_1956_3560_1439_7852_6362_2690_3977_85480_4233_3575_3570_3572_2321_149233_5159_5156_3953_959_1441 25 1.19E-07 1.04E-05 2.89E-07 5287 hsa-mir-141 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_2902_1432_836_5879_7157_4846_1616_5600_842_5606 12 1.41E-07 1.22E-05 3.30E-07 5288 hsa-mir-141 hsa04330 Notch signaling pathway 9612_3066_3065_1487_1488_3280_1387_2033_8850_388585_1856 11 2.17E-07 1.88E-05 4.96E-07 5289 hsa-mir-141 hsa04720 Long-term potentiation 815_6197_5578_2902_5499_5595_5594_1387_468_6195_6196_2033_5604 13 3.71E-07 3.23E-05 8.28E-07 5290 hsa-mir-141 hsa04910 Insulin signaling pathway 6720_5563_5499_2885_207_5590_5595_5594_5599_23265_2932_5604_5601_5602_6464_2002 16 2.30E-06 0.000200301 5.01E-06 5291 hsa-mir-141 hsa04650 Natural killer cell mediated cytotoxicity 5578_3454_3455_4773_3932_6850_2885_836_5595_5594_5879_5604_5781_2185_6464 15 9.65E-06 0.000839245 2.05E-05 5292 hsa-mir-141 hsa04540 Gap junction 5578_1956_6714_2885_5592_5595_5594_1453_5159_983_5156_5604 12 1.59E-05 0.001384023 3.30E-05 5293 hsa-mir-141 hsa05016 Huntington's disease 6667_3066_3065_3064_25942_2902_27113_9586_836_1385_1387_7157_2033_6874_6908_842_841 17 2.32E-05 0.0020208 4.65E-05 5294 hsa-mir-141 hsa04150 mTOR signaling pathway 5563_6794_6197_3091_207_5595_5594_6195_6196 9 2.35E-05 0.002045971 4.65E-05 5295 hsa-mir-141 hsa04916 Melanogenesis 815_6934_5578_5595_5594_1385_1387_4286_2932_2033_5604_1856 12 4.34E-05 0.003778811 8.40E-05 5296 hsa-mir-141 hsa03420 Nucleotide excision repair 2074_902_1022_6117_2965_4331_2071_6118 8 4.90E-05 0.004261741 9.26E-05 5297 hsa-mir-141 hsa04612 Antigen processing and presentation 3309_3304_3303_3305_1385_3326_3312_3320_4800_4801_2923 11 5.10E-05 0.00443517 9.44E-05 5298 hsa-mir-141 hsa04930 Type II diabetes mellitus 5580_3651_5590_5595_5594_5599_5601_5602 8 5.64E-05 0.004907869 0.000102247 5299 hsa-mir-141 hsa04730 Long-term depression 5578_5592_5595_5594_4846_3480_5518_5515_5604 9 0.000204377 0.017780779 0.000362873 5300 hsa-mir-141 hsa04360 Axon guidance 4773_5747_25_7852_2242_998_4233_5595_5594_2932_5879_1020 12 0.000321239 0.027947768 0.000558955 5301 hsa-mir-141 hsa04530 Tight junction 5578_1460_5580_6714_207_998_5590_1457_5728_5518_5515_5520 12 0.000467165 0.040643393 0.000796929 5302 hsa-mir-141 hsa04950 Maturity onset diabetes of the young 6927_3087_3280_3651_3172 5 0.000768873 0.066891941 0.001286383 5303 hsa-mir-141 hsa05010 Alzheimer's disease 22926_823_2902_836_5595_5594_2932_6622_4846_842_841_840_1020 13 0.001277191 0.111115643 0.002096522 5304 hsa-mir-141 hsa03440 Homologous recombination 641_6117_5888_675_6118 5 0.001412516 0.122888867 0.00227572 5305 hsa-mir-141 hsa03410 Base excision repair 3146_4913_142_328_6996 5 0.00377137 0.328109159 0.005965621 5306 hsa-mir-141 hsa04740 Olfactory transduction 815_5592 2 0.005204647 0.452804325 0.008085792 5307 hsa-mir-141 hsa04670 Leukocyte transendothelial migration 5578_5747_1432_7852_998_5879_5600_5781_2185 9 0.006631239 0.576917801 0.010121365 5308 hsa-mir-141 hsa04710 Circadian rhythm - mammal 8863_1453_8553 3 0.007267165 0.632243314 0.010900747 5309 hsa-mir-141 hsa04810 Regulation of actin cytoskeleton 2261_2264_5747_1956_5499_2249_998_5595_5594_5879_5159_5156_5604 13 0.009454857 0.822572538 0.013941907 5310 hsa-mir-141 hsa05340 Primary immunodeficiency 3932_3718_3575_959 4 0.017162359 1 0.02488542 5311 hsa-mir-141 hsa05217 Basal cell carcinoma 6934_2932_7157_2736_1856 5 0.018526433 1 0.026231304 5312 hsa-mir-141 hsa03030 DNA replication 6117_6118_5422_5557 4 0.018693573 1 0.026231304 5313 hsa-mir-141 hsa05131 Shigellosis 5578_25_998_7534_4691 5 0.01976907 1 0.026873579 5314 hsa-mir-141 hsa05130 Pathogenic Escherichia coli infection 5578_25_998_7534_4691 5 0.01976907 1 0.026873579 5315 hsa-mir-141 hsa03430 Mismatch repair 4436_6117_6118 3 0.027947857 1 0.037407131 5316 hsa-mir-141 hsa04640 Hematopoietic cell lineage 3559_3575_3570_914_1380_1441 6 0.032118253 1 0.042337697 5317 hsa-mir-141 hsa04270 Vascular smooth muscle contraction 5578_5580_5499_5592_5595_5594_5604 7 0.041811249 1 0.054292219 5318 hsa-mir-142 hsa05200 Pathways in cancer 3320_4149_5371_9063_1871_5595_5594_5599_6258_1387_6257_6256_8031_1870_5604_1488_9915_1487_1017_2932_2353_6502_4292_3091_5970_2885_7157_5894_1869_1029_5601_4087_4088_4089_5925_2034_2033_1050_8554_4286 40 9.44E-35 5.67E-33 5.67E-33 5319 hsa-mir-142 hsa04110 Cell cycle 890_990_1871_1387_1870_983_1017_2932_8454_6502_6500_7157_10912_1869_1029_4087_4088_4089_5925_2033_4616_5934_5933 23 1.83E-24 1.10E-22 5.49E-23 5320 hsa-mir-142 hsa04350 TGF-beta signaling pathway 5595_5594_1387_4093_6667_8454_3399_6500_1874_1875_3397_3398_4087_4088_4089_2033_5934_5933 18 7.48E-20 4.49E-18 1.50E-18 5321 hsa-mir-142 hsa05220 Chronic myeloid leukemia 1871_5595_5594_1870_5604_1488_1487_5970_2885_7157_5894_1869_1029_4088_4089_5925 16 5.77E-18 3.46E-16 8.65E-17 5322 hsa-mir-142 hsa05215 Prostate cancer 3320_1871_5595_5594_1387_1870_5604_1017_2932_5970_2885_7157_5894_1869_5925_2033 16 5.41E-17 3.25E-15 5.78E-16 5323 hsa-mir-142 hsa05212 Pancreatic cancer 3320_1871_5595_5594_1387_1870_5604_1017_2932_5970_2885_7157_5894_1869_5925_2033 16 6.34E-17 3.81E-15 5.78E-16 5324 hsa-mir-142 hsa05223 Non-small cell lung cancer 1871_5595_5594_6258_6257_6256_1870_5604_2885_7157_5894_1869_1029_5925 14 6.74E-17 4.04E-15 5.78E-16 5325 hsa-mir-142 hsa04010 MAPK signaling pathway 6722_4149_5595_5594_5599_5598_1386_5604_5606_5600_2353_1432_5970_9344_2885_7157_10912_5894_5601_4616_2005 21 5.48E-15 3.29E-13 4.11E-14 5326 hsa-mir-142 hsa05210 Colorectal cancer 5595_5594_5599_5604_2932_2353_4292_2885_7157_5894_5601_4087_4088_4089 14 1.47E-14 8.84E-13 9.82E-14 5327 hsa-mir-142 hsa05222 Small cell lung cancer 4149_9063_1871_6258_6257_6256_1870_1017_6502_5970_7157_1869_5925_8554 14 1.97E-14 1.18E-12 1.18E-13 5328 hsa-mir-142 hsa04310 Wnt signaling pathway 5599_1387_1488_1487_2932_8454_6500_7157_8061_1457_5601_1459_4087_4088_4089_2033 16 1.25E-13 7.48E-12 6.80E-13 5329 hsa-mir-142 hsa05219 Bladder cancer 1871_5595_5594_1870_5604_7157_5894_1869_1029_5925 10 4.12E-12 2.47E-10 2.06E-11 5330 hsa-mir-142 hsa05214 Glioma 1871_5595_5594_1870_5604_2885_7157_5894_1869_1029_5925 11 8.96E-12 5.38E-10 4.14E-11 5331 hsa-mir-142 hsa04540 Gap junction 5595_5594_5598_983_5604_7277_7278_10376_2885_5894_7846_51807 12 1.77E-11 1.06E-09 7.57E-11 5332 hsa-mir-142 hsa05218 Melanoma 1871_5595_5594_1870_5604_7157_5894_1869_1029_5925_4286 11 2.11E-11 1.27E-09 8.43E-11 5333 hsa-mir-142 hsa05216 Thyroid cancer 5595_5594_6258_6257_6256_8031_5604_7157 8 2.24E-10 1.34E-08 8.38E-10 5334 hsa-mir-142 hsa05211 Renal cell carcinoma 5595_5594_1387_5604_9915_3091_2885_5894_2034_2033 10 4.61E-10 2.77E-08 1.63E-09 5335 hsa-mir-142 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5604_5606_5600_1432_2885_5894_5601 10 1.05E-09 6.29E-08 3.50E-09 5336 hsa-mir-142 hsa04912 GnRH signaling pathway 5595_5594_5599_5598_5604_5606_5600_1432_2885_5894_5601 11 1.26E-09 7.53E-08 3.96E-09 5337 hsa-mir-142 hsa04660 T cell receptor signaling pathway 5595_5594_5604_5600_2932_2353_1432_5970_2885_5894_5601 11 1.50E-09 9.00E-08 4.50E-09 5338 hsa-mir-142 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5604_5606_5600_2353_1432_5970_5601 10 1.01E-08 6.06E-07 2.88E-08 5339 hsa-mir-142 hsa05213 Endometrial cancer 5595_5594_5604_2932_4292_2885_7157_5894 8 1.28E-08 7.70E-07 3.50E-08 5340 hsa-mir-142 hsa04520 Adherens junction 5595_5594_1387_1457_1459_4087_4088_4089_2033 9 1.87E-08 1.12E-06 4.88E-08 5341 hsa-mir-142 hsa05221 Acute myeloid leukemia 5371_5595_5594_5604_5970_2885_5894_1050 8 3.13E-08 1.88E-06 7.83E-08 5342 hsa-mir-142 hsa04910 Insulin signaling pathway 10891_5595_5594_5599_5604_2932_2885_5894_23265_5601 10 1.45E-07 8.68E-06 3.47E-07 5343 hsa-mir-142 hsa04662 B cell receptor signaling pathway 5595_5594_5604_2932_2353_5970_2885_5894 8 1.71E-07 1.03E-05 3.96E-07 5344 hsa-mir-142 hsa04012 ErbB signaling pathway 5595_5594_5599_5604_2932_2885_5894_5601 8 4.90E-07 2.94E-05 1.09E-06 5345 hsa-mir-142 hsa04920 Adipocytokine signaling pathway 10891_5599_6258_6257_6256_5970_5601 7 1.17E-06 7.03E-05 2.51E-06 5346 hsa-mir-142 hsa04115 p53 signaling pathway 983_1017_7157_10912_7161_1029_4616 7 1.41E-06 8.44E-05 2.91E-06 5347 hsa-mir-142 hsa04120 Ubiquitin mediated proteolysis 55294_5371_9063_672_8454_6502_6500_7329_8554 9 1.49E-06 8.93E-05 2.98E-06 5348 hsa-mir-142 hsa04916 Melanogenesis 5595_5594_1387_5604_2932_5894_2033_4286 8 1.73E-06 0.000103505 3.34E-06 5349 hsa-mir-142 hsa04330 Notch signaling pathway 1387_1488_9612_1487_2033_2648 6 2.40E-06 0.000143943 4.50E-06 5350 hsa-mir-142 hsa05131 Shigellosis 7277_7278_10376_7846_51807_4691 6 6.08E-06 0.000364993 1.07E-05 5351 hsa-mir-142 hsa05130 Pathogenic Escherichia coli infection 7277_7278_10376_7846_51807_4691 6 6.08E-06 0.000364993 1.07E-05 5352 hsa-mir-142 hsa04720 Long-term potentiation 5595_5594_1387_5604_5894_2033 6 2.86E-05 0.001717711 4.91E-05 5353 hsa-mir-142 hsa04370 VEGF signaling pathway 5595_5594_5604_5600_1432_5894 6 3.29E-05 0.001973742 5.48E-05 5354 hsa-mir-142 hsa04062 Chemokine signaling pathway 5595_5594_5604_2932_5970_2885_5894_7074 8 0.000119843 0.007190578 0.00019434 5355 hsa-mir-142 hsa04510 Focal adhesion 5595_5594_5599_5604_2932_2885_5894_5601 8 0.000184165 0.011049875 0.000290786 5356 hsa-mir-142 hsa03022 Basal transcription factors 2963_2962_2969_6908 4 0.000224064 0.013443854 0.000344714 5357 hsa-mir-142 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5600_1432_5970_5601 5 0.000237165 0.014229915 0.000355748 5358 hsa-mir-142 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601 4 0.000447944 0.026876669 0.000655529 5359 hsa-mir-142 hsa05014 Amyotrophic lateral sclerosis (ALS) 5606_5600_1432_7157 4 0.000968593 0.058115579 0.001383704 5360 hsa-mir-142 hsa03320 PPAR signaling pathway 6258_6257_6256_2168 4 0.002111523 0.126691362 0.002946311 5361 hsa-mir-142 hsa04730 Long-term depression 5595_5594_5604_5894 4 0.002217926 0.133075541 0.003024444 5362 hsa-mir-142 hsa05016 Huntington's disease 10891_1387_6908_6667_7157_2033 6 0.003066125 0.183967476 0.004088166 5363 hsa-mir-142 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_5604_2885_5894 5 0.004027286 0.241637164 0.005252982 5364 hsa-mir-142 hsa04612 Antigen processing and presentation 3320_4800_4801_4802 4 0.004814205 0.288852297 0.006145794 5365 hsa-mir-142 hsa04630 Jak-STAT signaling pathway 9063_1387_2885_2033_8554 5 0.006446743 0.38680455 0.008058428 5366 hsa-mir-142 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.007559082 0.453544929 0.009256019 5367 hsa-mir-142 hsa04270 Vascular smooth muscle contraction 5595_5594_5604_5894 4 0.012311818 0.738709092 0.014774182 5368 hsa-mir-142 hsa04810 Regulation of actin cytoskeleton 5595_5594_5604_5894_7074 5 0.024414797 1 0.02872329 5369 hsa-mir-142 hsa05010 Alzheimer's disease 5595_5594_2932_6622 4 0.043737883 1 0.050466789 5370 hsa-mir-143 hsa05200 Pathways in cancer 3320_1147_4149_5371_2249_1499_5595_5594_5599_5914_1387_6256_3326_5604_367_8517_2932_7704_6774_6502_6776_6777_5970_6688_2113_5894_4609_1869_3725_1029_2353_4087_4088_7175_3065_4292_3551_5925_2033_1050_207_4791_4792 43 6.09E-32 4.57E-30 4.57E-30 5371 hsa-mir-143 hsa05221 Acute myeloid leukemia 1147_5371_5595_5594_5914_5604_8517_7704_6774_6776_6777_5970_6688_5894_4609_3551_1050_207 18 9.72E-20 7.29E-18 3.65E-18 5372 hsa-mir-143 hsa05215 Prostate cancer 3320_1147_1499_5595_5594_1387_3326_5604_367_8517_2932_5970_5894_1869_3551_5925_2033_207_4792 19 2.40E-18 1.80E-16 5.41E-17 5373 hsa-mir-143 hsa05212 Pancreatic cancer 3320_1147_1499_5595_5594_1387_3326_5604_367_8517_2932_5970_5894_1869_3551_5925_2033_207_4792 19 2.89E-18 2.16E-16 5.41E-17 5374 hsa-mir-143 hsa05220 Chronic myeloid leukemia 1147_5595_5594_5604_8517_6776_6777_5970_5894_4609_1869_1029_4088_3065_3551_5925_207_4792 18 3.73E-18 2.80E-16 5.60E-17 5375 hsa-mir-143 hsa04010 MAPK signaling pathway 6722_1147_4149_2249_5595_5594_5599_5598_1326_5604_3305_3303_5566_8517_3310_3312_1386_5971_5970_51701_5894_4609_3725_2353_3551_207_4791 27 1.20E-17 8.98E-16 1.50E-16 5376 hsa-mir-143 hsa04310 Wnt signaling pathway 23291_1499_5599_1387_8607_5566_2932_8454_1459_51701_8061_4609_3725_1457_6500_4087_4088_2033_8945 19 1.90E-14 1.43E-12 2.04E-13 5377 hsa-mir-143 hsa04662 B cell receptor signaling pathway 1147_5595_5594_5604_4794_8517_2932_5970_5894_3725_2353_3551_207_4792_4793 15 2.52E-14 1.89E-12 2.27E-13 5378 hsa-mir-143 hsa04540 Gap junction 5595_5594_5598_983_5604_5566_347733_7277_10382_84617_5894_7846_7278_51807_203068_10376 16 2.72E-14 2.04E-12 2.27E-13 5379 hsa-mir-143 hsa04660 T cell receptor signaling pathway 1147_5595_5594_1326_5604_4794_8517_2932_5970_5894_3725_2353_3551_207_4792_4793 16 2.79E-13 2.09E-11 2.09E-12 5380 hsa-mir-143 hsa04110 Cell cycle 990_5591_1387_983_2932_8454_6502_1869_1029_6500_4087_4088_3065_5925_2033_5933 16 8.28E-13 6.21E-11 5.65E-12 5381 hsa-mir-143 hsa05210 Colorectal cancer 1499_5595_5594_5599_5604_2932_5894_4609_3725_2353_4087_4088_4292_207 14 1.68E-12 1.26E-10 1.05E-11 5382 hsa-mir-143 hsa05131 Shigellosis 1499_347733_7277_10382_84617_7846_7278_51807_4691_203068_71_10376 12 4.98E-12 3.74E-10 2.67E-11 5383 hsa-mir-143 hsa05130 Pathogenic Escherichia coli infection 1499_347733_7277_10382_84617_7846_7278_51807_4691_203068_71_10376 12 4.98E-12 3.74E-10 2.67E-11 5384 hsa-mir-143 hsa04062 Chemokine signaling pathway 1147_5595_5594_5604_5566_8517_2932_6774_6777_5970_653361_5894_3551_207_4792_4793_7074 17 7.69E-11 5.76E-09 3.84E-10 5385 hsa-mir-143 hsa04620 Toll-like receptor signaling pathway 1147_5595_5594_5599_1326_5604_8517_5970_3725_2353_3551_207_4792 13 2.17E-10 1.62E-08 1.02E-09 5386 hsa-mir-143 hsa05214 Glioma 5595_5594_5604_5894_1869_1029_5925_207_808_801_805 11 3.64E-10 2.73E-08 1.61E-09 5387 hsa-mir-143 hsa05222 Small cell lung cancer 1147_4149_6256_8517_6502_5970_4609_1869_3551_5925_207_4792 12 4.22E-10 3.17E-08 1.76E-09 5388 hsa-mir-143 hsa04920 Adipocytokine signaling pathway 1147_5599_6256_4794_8517_6774_5970_3551_207_4792_4793 11 4.86E-10 3.64E-08 1.92E-09 5389 hsa-mir-143 hsa04520 Adherens junction 1499_5595_5594_1387_1459_51701_1457_4087_4088_2033_71 11 2.62E-09 1.97E-07 9.84E-09 5390 hsa-mir-143 hsa04916 Melanogenesis 1499_5595_5594_1387_5604_5566_2932_5894_2033_808_801_805 12 3.03E-09 2.27E-07 1.08E-08 5391 hsa-mir-143 hsa04350 TGF-beta signaling pathway 5595_5594_1387_8454_4609_6500_4087_4088_2033_6667_5933 11 5.83E-09 4.37E-07 1.90E-08 5392 hsa-mir-143 hsa04012 ErbB signaling pathway 5595_5594_5599_5604_2932_6776_6777_5894_4609_3725_207 11 5.83E-09 4.37E-07 1.90E-08 5393 hsa-mir-143 hsa05213 Endometrial cancer 1499_5595_5594_5604_2932_5894_4609_4292_207 9 1.25E-08 9.40E-07 3.92E-08 5394 hsa-mir-143 hsa05223 Non-small cell lung cancer 5595_5594_6256_5604_5894_1869_1029_5925_207 9 1.68E-08 1.26E-06 5.04E-08 5395 hsa-mir-143 hsa04720 Long-term potentiation 5595_5594_1387_5604_5566_5894_2033_808_801_805 10 1.83E-08 1.37E-06 5.28E-08 5396 hsa-mir-143 hsa05219 Bladder cancer 5595_5594_5604_5894_4609_1869_1029_5925 8 4.25E-08 3.19E-06 1.18E-07 5397 hsa-mir-143 hsa04912 GnRH signaling pathway 5595_5594_5599_5598_5604_5566_5894_3725_808_801_805 11 4.53E-08 3.40E-06 1.21E-07 5398 hsa-mir-143 hsa04910 Insulin signaling pathway 5595_5594_5599_5604_5566_2932_5894_3551_207_808_801_805 12 5.57E-08 4.18E-06 1.44E-07 5399 hsa-mir-143 hsa04120 Ubiquitin mediated proteolysis 55294_5371_23291_672_8454_6502_3093_10273_6500_7323_7329_8945 12 5.99E-08 4.50E-06 1.50E-07 5400 hsa-mir-143 hsa05216 Thyroid cancer 1499_5595_5594_6256_5604_4609_7175 7 7.40E-08 5.55E-06 1.79E-07 5401 hsa-mir-143 hsa04612 Antigen processing and presentation 3320_3326_3309_3305_3303_4800_4801_4802_3310_3312 10 8.02E-08 6.02E-06 1.88E-07 5402 hsa-mir-143 hsa05218 Melanoma 2249_5595_5594_5604_5894_1869_1029_5925_207 9 1.41E-07 1.06E-05 3.21E-07 5403 hsa-mir-143 hsa05211 Renal cell carcinoma 5595_5594_1387_5604_2113_5894_3725_2033_207 9 1.57E-07 1.18E-05 3.47E-07 5404 hsa-mir-143 hsa05016 Huntington's disease 1387_292_6908_5437_1213_23186_3065_3064_293_2033_6667_5441 12 1.25E-06 9.37E-05 2.68E-06 5405 hsa-mir-143 hsa03020 RNA polymerase 64425_5437_25885_51082_84172_5441 6 1.43E-06 0.00010731 2.98E-06 5406 hsa-mir-143 hsa04270 Vascular smooth muscle contraction 5595_5594_4637_5604_5566_5894_808_801_805 9 7.08E-06 0.000530831 1.43E-05 5407 hsa-mir-143 hsa04210 Apoptosis 1147_5566_8517_5970_8837_3551_207_4792 8 7.52E-06 0.000564364 1.49E-05 5408 hsa-mir-143 hsa04630 Jak-STAT signaling pathway 3559_1387_6778_6774_6776_6777_4609_2033_3977_207 10 8.85E-06 0.000663573 1.70E-05 5409 hsa-mir-143 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_5599_8517_5970_3725_3551_4792 7 1.62E-05 0.001213397 3.03E-05 5410 hsa-mir-143 hsa04510 Focal adhesion 1499_5595_5594_5599_5604_2932_5894_3725_10627_207_71 11 1.72E-05 0.001286367 3.09E-05 5411 hsa-mir-143 hsa04330 Notch signaling pathway 1387_9612_3065_2033_2648_4851 6 1.73E-05 0.001299151 3.09E-05 5412 hsa-mir-143 hsa04810 Regulation of actin cytoskeleton 2249_5595_5594_5604_4627_4628_10788_5894_10627_71_7074 11 2.93E-05 0.002200776 5.12E-05 5413 hsa-mir-143 hsa04530 Tight junction 1499_4627_4628_1459_1457_10627_207_71 8 0.000135487 0.010161536 0.000230944 5414 hsa-mir-143 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5604_5894_207 6 0.00025058 0.018793501 0.000417633 5415 hsa-mir-143 hsa04370 VEGF signaling pathway 5595_5594_5604_5894_207 5 0.001598644 0.119898314 0.00258532 5416 hsa-mir-143 hsa04930 Type II diabetes mellitus 5595_5594_5599_3551 4 0.001620134 0.121510042 0.00258532 5417 hsa-mir-143 hsa05010 Alzheimer's disease 22926_5595_5594_2932_808_801_805 7 0.00307215 0.230411252 0.004800234 5418 hsa-mir-143 hsa04340 Hedgehog signaling pathway 23291_5566_2932_8945 4 0.003624011 0.271800815 0.005546955 5419 hsa-mir-143 hsa04730 Long-term depression 5595_5594_5604_5894 4 0.007547507 0.566063051 0.011321261 5420 hsa-mir-143 hsa03022 Basal transcription factors 2962_2969_6908 3 0.00805387 0.604040262 0.011843927 5421 hsa-mir-143 hsa03450 Non-homologous end-joining 5591_2547 2 0.011521526 0.864114432 0.016617585 5422 hsa-mir-143 hsa04020 Calcium signaling pathway 292_5566_293_808_801_805 6 0.014175041 1 0.02005902 5423 hsa-mir-143 hsa04150 mTOR signaling pathway 5595_5594_207 3 0.019109446 1 0.026540897 5424 hsa-mir-143 hsa03010 Ribosome 6156_6128_6207_6202 4 0.02413081 1 0.032905651 5425 hsa-mir-143 hsa04115 p53 signaling pathway 983_7161_1029 3 0.038281996 1 0.051270531 5426 hsa-mir-143 hsa04670 Leukocyte transendothelial migration 1499_653361_10627_71 4 0.041562113 1 0.05468699 5427 hsa-mir-143 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.048201684 1 0.062329764 5428 hsa-mir-144 hsa05200 Pathways in cancer 5371_5595_5594_6256_595_4286_367_5914_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_4088_4089_3066_3065_5925_2034_2033_4846_836 29 4.64E-33 2.87E-31 2.87E-31 5429 hsa-mir-144 hsa05220 Chronic myeloid leukemia 5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464 15 3.09E-22 1.91E-20 9.57E-21 5430 hsa-mir-144 hsa04110 Cell cycle 5591_595_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933 14 6.94E-18 4.30E-16 1.43E-16 5431 hsa-mir-144 hsa05215 Prostate cancer 5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033 11 1.52E-14 9.42E-13 2.11E-13 5432 hsa-mir-144 hsa05212 Pancreatic cancer 5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033 11 1.70E-14 1.06E-12 2.11E-13 5433 hsa-mir-144 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5925 9 5.22E-14 3.24E-12 5.39E-13 5434 hsa-mir-144 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925 9 3.94E-13 2.44E-11 3.05E-12 5435 hsa-mir-144 hsa05210 Colorectal cancer 5595_5594_595_7157_4087_4609_3725_4088_4089_836 10 3.94E-13 2.44E-11 3.05E-12 5436 hsa-mir-144 hsa05222 Small cell lung cancer 6256_595_5970_1870_1871_7157_4609_1869_5925_4846 10 4.89E-13 3.03E-11 3.37E-12 5437 hsa-mir-144 hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_6464 9 1.79E-12 1.11E-10 1.11E-11 5438 hsa-mir-144 hsa05218 Melanoma 5595_5594_595_4286_1870_1871_7157_1869_5925 9 3.69E-12 2.29E-10 2.08E-11 5439 hsa-mir-144 hsa05221 Acute myeloid leukemia 5371_5595_5594_595_5914_7704_5970_4609 8 3.75E-11 2.32E-09 1.94E-10 5440 hsa-mir-144 hsa05211 Renal cell carcinoma 5595_5594_3091_7428_2113_3725_2034_2033 8 1.61E-10 9.99E-09 7.69E-10 5441 hsa-mir-144 hsa04350 TGF-beta signaling pathway 5595_5594_4087_4609_4088_4089_2033_5933 8 6.51E-10 4.03E-08 2.88E-09 5442 hsa-mir-144 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 1.19E-09 7.39E-08 4.93E-09 5443 hsa-mir-144 hsa04310 Wnt signaling pathway 595_7157_4087_4609_3725_1457_4088_4089_2033 9 2.07E-09 1.28E-07 8.01E-09 5444 hsa-mir-144 hsa04520 Adherens junction 5595_5594_4087_1457_4088_4089_2033 7 1.10E-08 6.83E-07 4.02E-08 5445 hsa-mir-144 hsa04010 MAPK signaling pathway 5595_5594_4208_3312_5970_7157_4609_3725_4763_836 10 2.08E-08 1.29E-06 7.17E-08 5446 hsa-mir-144 hsa05016 Huntington's disease 6874_2902_7157_3066_3065_3064_2033_836 8 1.93E-07 1.20E-05 6.31E-07 5447 hsa-mir-144 hsa05213 Endometrial cancer 5595_5594_595_7157_4609 5 9.83E-07 6.10E-05 3.05E-06 5448 hsa-mir-144 hsa04012 ErbB signaling pathway 5595_5594_4609_3725_6464 5 1.06E-05 0.000656913 3.13E-05 5449 hsa-mir-144 hsa04330 Notch signaling pathway 9612_3066_3065_2033 4 1.99E-05 0.001235796 5.62E-05 5450 hsa-mir-144 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_7157_4846_836 4 3.81E-05 0.00236019 0.000102617 5451 hsa-mir-144 hsa04720 Long-term potentiation 5595_5594_2902_2033 4 0.000112099 0.006950151 0.000278006 5452 hsa-mir-144 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725 4 0.000112099 0.006950151 0.000278006 5453 hsa-mir-144 hsa05010 Alzheimer's disease 5595_5594_2902_4846_836 5 0.000272005 0.016864338 0.000648628 5454 hsa-mir-144 hsa04620 Toll-like receptor signaling pathway 5595_5594_5970_3725 4 0.000347565 0.021549049 0.000798113 5455 hsa-mir-144 hsa04916 Melanogenesis 5595_5594_4286_2033 4 0.000373172 0.023136643 0.000826309 5456 hsa-mir-144 hsa04660 T cell receptor signaling pathway 5595_5594_5970_3725 4 0.000458077 0.028400745 0.000979336 5457 hsa-mir-144 hsa04510 Focal adhesion 5595_5594_595_3725_6464 5 0.000534758 0.033154988 0.001105166 5458 hsa-mir-144 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.000688286 0.042673748 0.001376573 5459 hsa-mir-144 hsa04910 Insulin signaling pathway 6720_5595_5594_6464 4 0.001042813 0.064654432 0.001959225 5460 hsa-mir-144 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_6464 4 0.001042813 0.064654432 0.001959225 5461 hsa-mir-144 hsa04115 p53 signaling pathway 595_7157_836 3 0.001505878 0.093364444 0.002746013 5462 hsa-mir-144 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_3725_836 3 0.001629421 0.101024104 0.002806225 5463 hsa-mir-144 hsa04730 Long-term depression 5595_5594_4846 3 0.001629421 0.101024104 0.002806225 5464 hsa-mir-144 hsa04370 VEGF signaling pathway 5595_5594_4846 3 0.002037497 0.126324804 0.003414184 5465 hsa-mir-144 hsa04612 Antigen processing and presentation 4800_4801_3312 3 0.003031441 0.18794936 0.004819214 5466 hsa-mir-144 hsa04210 Apoptosis 5970_7157_836 3 0.003031441 0.18794936 0.004819214 5467 hsa-mir-144 hsa04062 Chemokine signaling pathway 5595_5594_5970_6464 4 0.003432618 0.212822338 0.005320558 5468 hsa-mir-144 hsa04912 GnRH signaling pathway 5595_5594_3725 3 0.005131225 0.318135948 0.007759413 5469 hsa-mir-144 hsa04930 Type II diabetes mellitus 5595_5594 2 0.009524046 0.590490858 0.014059306 5470 hsa-mir-144 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428 3 0.010084082 0.625213079 0.014539839 5471 hsa-mir-144 hsa04630 Jak-STAT signaling pathway 595_4609_2033 3 0.01343412 0.832915445 0.018929896 5472 hsa-mir-144 hsa04920 Adipocytokine signaling pathway 6256_5970 2 0.019773498 1 0.027243487 5473 hsa-mir-144 hsa04664 Fc epsilon RI signaling pathway 5595_5594 2 0.026659315 1 0.035932121 5474 hsa-mir-144 hsa04540 Gap junction 5595_5594 2 0.035724885 1 0.047126445 5475 hsa-mir-144 hsa04710 Circadian rhythm - mammal 8863 1 0.042861871 1 0.055363251 5476 hsa-mir-144 hsa03450 Non-homologous end-joining 5591 1 0.045852928 1 0.058017991 5477 hsa-mir-145 hsa05200 Pathways in cancer 3320_1147_4149_5371_2249_1499_5595_5594_5599_5914_1387_6256_3326_5604_367_8517_2932_7704_6774_6502_6776_6777_5970_6688_2113_5894_4609_1869_3725_1029_2353_4087_4088_7175_3065_4292_3551_5925_2033_1050_207_4791_4792 43 6.09E-32 4.57E-30 4.57E-30 5478 hsa-mir-145 hsa05221 Acute myeloid leukemia 1147_5371_5595_5594_5914_5604_8517_7704_6774_6776_6777_5970_6688_5894_4609_3551_1050_207 18 9.72E-20 7.29E-18 3.65E-18 5479 hsa-mir-145 hsa05215 Prostate cancer 3320_1147_1499_5595_5594_1387_3326_5604_367_8517_2932_5970_5894_1869_3551_5925_2033_207_4792 19 2.40E-18 1.80E-16 5.41E-17 5480 hsa-mir-145 hsa05212 Pancreatic cancer 3320_1147_1499_5595_5594_1387_3326_5604_367_8517_2932_5970_5894_1869_3551_5925_2033_207_4792 19 2.89E-18 2.16E-16 5.41E-17 5481 hsa-mir-145 hsa05220 Chronic myeloid leukemia 1147_5595_5594_5604_8517_6776_6777_5970_5894_4609_1869_1029_4088_3065_3551_5925_207_4792 18 3.73E-18 2.80E-16 5.60E-17 5482 hsa-mir-145 hsa04010 MAPK signaling pathway 6722_1147_4149_2249_5595_5594_5599_5598_1326_5604_3305_3303_5566_8517_3310_3312_1386_5971_5970_51701_5894_4609_3725_2353_3551_207_4791 27 1.20E-17 8.98E-16 1.50E-16 5483 hsa-mir-145 hsa04310 Wnt signaling pathway 23291_1499_5599_1387_8607_5566_2932_8454_1459_51701_8061_4609_3725_1457_6500_4087_4088_2033_8945 19 1.90E-14 1.43E-12 2.04E-13 5484 hsa-mir-145 hsa04662 B cell receptor signaling pathway 1147_5595_5594_5604_4794_8517_2932_5970_5894_3725_2353_3551_207_4792_4793 15 2.52E-14 1.89E-12 2.27E-13 5485 hsa-mir-145 hsa04540 Gap junction 5595_5594_5598_983_5604_5566_347733_7277_10382_84617_5894_7846_7278_51807_203068_10376 16 2.72E-14 2.04E-12 2.27E-13 5486 hsa-mir-145 hsa04660 T cell receptor signaling pathway 1147_5595_5594_1326_5604_4794_8517_2932_5970_5894_3725_2353_3551_207_4792_4793 16 2.79E-13 2.09E-11 2.09E-12 5487 hsa-mir-145 hsa04110 Cell cycle 990_5591_1387_983_2932_8454_6502_1869_1029_6500_4087_4088_3065_5925_2033_5933 16 8.28E-13 6.21E-11 5.65E-12 5488 hsa-mir-145 hsa05210 Colorectal cancer 1499_5595_5594_5599_5604_2932_5894_4609_3725_2353_4087_4088_4292_207 14 1.68E-12 1.26E-10 1.05E-11 5489 hsa-mir-145 hsa05131 Shigellosis 1499_347733_7277_10382_84617_7846_7278_51807_4691_203068_71_10376 12 4.98E-12 3.74E-10 2.67E-11 5490 hsa-mir-145 hsa05130 Pathogenic Escherichia coli infection 1499_347733_7277_10382_84617_7846_7278_51807_4691_203068_71_10376 12 4.98E-12 3.74E-10 2.67E-11 5491 hsa-mir-145 hsa04062 Chemokine signaling pathway 1147_5595_5594_5604_5566_8517_2932_6774_6777_5970_653361_5894_3551_207_4792_4793_7074 17 7.69E-11 5.76E-09 3.84E-10 5492 hsa-mir-145 hsa04620 Toll-like receptor signaling pathway 1147_5595_5594_5599_1326_5604_8517_5970_3725_2353_3551_207_4792 13 2.17E-10 1.62E-08 1.02E-09 5493 hsa-mir-145 hsa05214 Glioma 5595_5594_5604_5894_1869_1029_5925_207_808_801_805 11 3.64E-10 2.73E-08 1.61E-09 5494 hsa-mir-145 hsa05222 Small cell lung cancer 1147_4149_6256_8517_6502_5970_4609_1869_3551_5925_207_4792 12 4.22E-10 3.17E-08 1.76E-09 5495 hsa-mir-145 hsa04920 Adipocytokine signaling pathway 1147_5599_6256_4794_8517_6774_5970_3551_207_4792_4793 11 4.86E-10 3.64E-08 1.92E-09 5496 hsa-mir-145 hsa04520 Adherens junction 1499_5595_5594_1387_1459_51701_1457_4087_4088_2033_71 11 2.62E-09 1.97E-07 9.84E-09 5497 hsa-mir-145 hsa04916 Melanogenesis 1499_5595_5594_1387_5604_5566_2932_5894_2033_808_801_805 12 3.03E-09 2.27E-07 1.08E-08 5498 hsa-mir-145 hsa04350 TGF-beta signaling pathway 5595_5594_1387_8454_4609_6500_4087_4088_2033_6667_5933 11 5.83E-09 4.37E-07 1.90E-08 5499 hsa-mir-145 hsa04012 ErbB signaling pathway 5595_5594_5599_5604_2932_6776_6777_5894_4609_3725_207 11 5.83E-09 4.37E-07 1.90E-08 5500 hsa-mir-145 hsa05213 Endometrial cancer 1499_5595_5594_5604_2932_5894_4609_4292_207 9 1.25E-08 9.40E-07 3.92E-08 5501 hsa-mir-145 hsa05223 Non-small cell lung cancer 5595_5594_6256_5604_5894_1869_1029_5925_207 9 1.68E-08 1.26E-06 5.04E-08 5502 hsa-mir-145 hsa04720 Long-term potentiation 5595_5594_1387_5604_5566_5894_2033_808_801_805 10 1.83E-08 1.37E-06 5.28E-08 5503 hsa-mir-145 hsa05219 Bladder cancer 5595_5594_5604_5894_4609_1869_1029_5925 8 4.25E-08 3.19E-06 1.18E-07 5504 hsa-mir-145 hsa04912 GnRH signaling pathway 5595_5594_5599_5598_5604_5566_5894_3725_808_801_805 11 4.53E-08 3.40E-06 1.21E-07 5505 hsa-mir-145 hsa04910 Insulin signaling pathway 5595_5594_5599_5604_5566_2932_5894_3551_207_808_801_805 12 5.57E-08 4.18E-06 1.44E-07 5506 hsa-mir-145 hsa04120 Ubiquitin mediated proteolysis 55294_5371_23291_672_8454_6502_3093_10273_6500_7323_7329_8945 12 5.99E-08 4.50E-06 1.50E-07 5507 hsa-mir-145 hsa05216 Thyroid cancer 1499_5595_5594_6256_5604_4609_7175 7 7.40E-08 5.55E-06 1.79E-07 5508 hsa-mir-145 hsa04612 Antigen processing and presentation 3320_3326_3309_3305_3303_4800_4801_4802_3310_3312 10 8.02E-08 6.02E-06 1.88E-07 5509 hsa-mir-145 hsa05218 Melanoma 2249_5595_5594_5604_5894_1869_1029_5925_207 9 1.41E-07 1.06E-05 3.21E-07 5510 hsa-mir-145 hsa05211 Renal cell carcinoma 5595_5594_1387_5604_2113_5894_3725_2033_207 9 1.57E-07 1.18E-05 3.47E-07 5511 hsa-mir-145 hsa05016 Huntington's disease 1387_292_6908_5437_1213_23186_3065_3064_293_2033_6667_5441 12 1.25E-06 9.37E-05 2.68E-06 5512 hsa-mir-145 hsa03020 RNA polymerase 64425_5437_25885_51082_84172_5441 6 1.43E-06 0.00010731 2.98E-06 5513 hsa-mir-145 hsa04270 Vascular smooth muscle contraction 5595_5594_4637_5604_5566_5894_808_801_805 9 7.08E-06 0.000530831 1.43E-05 5514 hsa-mir-145 hsa04210 Apoptosis 1147_5566_8517_5970_8837_3551_207_4792 8 7.52E-06 0.000564364 1.49E-05 5515 hsa-mir-145 hsa04630 Jak-STAT signaling pathway 3559_1387_6778_6774_6776_6777_4609_2033_3977_207 10 8.85E-06 0.000663573 1.70E-05 5516 hsa-mir-145 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_5599_8517_5970_3725_3551_4792 7 1.62E-05 0.001213397 3.03E-05 5517 hsa-mir-145 hsa04510 Focal adhesion 1499_5595_5594_5599_5604_2932_5894_3725_10627_207_71 11 1.72E-05 0.001286367 3.09E-05 5518 hsa-mir-145 hsa04330 Notch signaling pathway 1387_9612_3065_2033_2648_4851 6 1.73E-05 0.001299151 3.09E-05 5519 hsa-mir-145 hsa04810 Regulation of actin cytoskeleton 2249_5595_5594_5604_4627_4628_10788_5894_10627_71_7074 11 2.93E-05 0.002200776 5.12E-05 5520 hsa-mir-145 hsa04530 Tight junction 1499_4627_4628_1459_1457_10627_207_71 8 0.000135487 0.010161536 0.000230944 5521 hsa-mir-145 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5604_5894_207 6 0.00025058 0.018793501 0.000417633 5522 hsa-mir-145 hsa04370 VEGF signaling pathway 5595_5594_5604_5894_207 5 0.001598644 0.119898314 0.00258532 5523 hsa-mir-145 hsa04930 Type II diabetes mellitus 5595_5594_5599_3551 4 0.001620134 0.121510042 0.00258532 5524 hsa-mir-145 hsa05010 Alzheimer's disease 22926_5595_5594_2932_808_801_805 7 0.00307215 0.230411252 0.004800234 5525 hsa-mir-145 hsa04340 Hedgehog signaling pathway 23291_5566_2932_8945 4 0.003624011 0.271800815 0.005546955 5526 hsa-mir-145 hsa04730 Long-term depression 5595_5594_5604_5894 4 0.007547507 0.566063051 0.011321261 5527 hsa-mir-145 hsa03022 Basal transcription factors 2962_2969_6908 3 0.00805387 0.604040262 0.011843927 5528 hsa-mir-145 hsa03450 Non-homologous end-joining 5591_2547 2 0.011521526 0.864114432 0.016617585 5529 hsa-mir-145 hsa04020 Calcium signaling pathway 292_5566_293_808_801_805 6 0.014175041 1 0.02005902 5530 hsa-mir-145 hsa04150 mTOR signaling pathway 5595_5594_207 3 0.019109446 1 0.026540897 5531 hsa-mir-145 hsa03010 Ribosome 6156_6128_6207_6202 4 0.02413081 1 0.032905651 5532 hsa-mir-145 hsa04115 p53 signaling pathway 983_7161_1029 3 0.038281996 1 0.051270531 5533 hsa-mir-145 hsa04670 Leukocyte transendothelial migration 1499_653361_10627_71 4 0.041562113 1 0.05468699 5534 hsa-mir-145 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.048201684 1 0.062329764 5535 hsa-mir-1468 hsa05215 Prostate cancer 1147_3551_2033_207_208_2932_367_1499_1387 9 4.81E-14 2.45E-12 1.35E-12 5536 hsa-mir-1468 hsa05212 Pancreatic cancer 1147_3551_2033_207_208_2932_367_1499_1387 9 5.28E-14 2.70E-12 1.35E-12 5537 hsa-mir-1468 hsa05200 Pathways in cancer 1147_4087_4088_4089_3551_2033_207_208_2932_367_1499_1387 12 2.64E-13 1.35E-11 4.49E-12 5538 hsa-mir-1468 hsa04110 Cell cycle 4087_4088_4089_2033_7534_7532_2932_1387 8 3.18E-11 1.62E-09 4.05E-10 5539 hsa-mir-1468 hsa04520 Adherens junction 4087_4088_4089_2033_1499_6714_1387 7 1.04E-10 5.29E-09 1.06E-09 5540 hsa-mir-1468 hsa05210 Colorectal cancer 4087_4088_4089_207_208_2932_1499 7 1.43E-10 7.29E-09 1.22E-09 5541 hsa-mir-1468 hsa05220 Chronic myeloid leukemia 1147_4088_4089_3551_207_208 6 4.05E-09 2.07E-07 2.95E-08 5542 hsa-mir-1468 hsa04310 Wnt signaling pathway 4087_4088_4089_2033_2932_1499_1387 7 7.25E-09 3.70E-07 4.62E-08 5543 hsa-mir-1468 hsa04660 T cell receptor signaling pathway 1147_5058_3551_207_208_2932 6 3.55E-08 1.81E-06 2.01E-07 5544 hsa-mir-1468 hsa04920 Adipocytokine signaling pathway 1147_3551_207_208_2538 5 1.20E-07 6.14E-06 6.14E-07 5545 hsa-mir-1468 hsa05211 Renal cell carcinoma 5058_2033_207_208_1387 5 1.69E-07 8.62E-06 7.84E-07 5546 hsa-mir-1468 hsa04662 B cell receptor signaling pathway 1147_3551_207_208_2932 5 2.05E-07 1.05E-05 8.71E-07 5547 hsa-mir-1468 hsa04350 TGF-beta signaling pathway 4087_4088_4089_2033_1387 5 4.13E-07 2.11E-05 1.51E-06 5548 hsa-mir-1468 hsa04012 ErbB signaling pathway 5058_207_208_2932_6714 5 4.13E-07 2.11E-05 1.51E-06 5549 hsa-mir-1468 hsa04062 Chemokine signaling pathway 1147_5058_3551_207_208_2932 6 8.63E-07 4.40E-05 2.93E-06 5550 hsa-mir-1468 hsa04510 Focal adhesion 5058_207_208_2932_1499_6714 6 1.25E-06 6.36E-05 3.98E-06 5551 hsa-mir-1468 hsa05213 Endometrial cancer 207_208_2932_1499 4 2.15E-06 0.000109794 6.46E-06 5552 hsa-mir-1468 hsa05221 Acute myeloid leukemia 1147_3551_207_208 4 3.46E-06 0.000176576 9.81E-06 5553 hsa-mir-1468 hsa04910 Insulin signaling pathway 3551_207_208_2932_2538 5 3.67E-06 0.000186948 9.84E-06 5554 hsa-mir-1468 hsa04010 MAPK signaling pathway 1147_6722_5058_3551_207_208 6 6.07E-06 0.00030971 1.55E-05 5555 hsa-mir-1468 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_5058_3551_6714 4 6.96E-06 0.000355163 1.69E-05 5556 hsa-mir-1468 hsa05222 Small cell lung cancer 1147_3551_207_208 4 1.44E-05 0.00073336 3.33E-05 5557 hsa-mir-1468 hsa04210 Apoptosis 1147_3551_207_208 4 1.64E-05 0.000834985 3.63E-05 5558 hsa-mir-1468 hsa04620 Toll-like receptor signaling pathway 1147_3551_207_208 4 2.74E-05 0.001398736 5.83E-05 5559 hsa-mir-1468 hsa04916 Melanogenesis 2033_2932_1499_1387 4 2.95E-05 0.001505338 6.02E-05 5560 hsa-mir-1468 hsa04530 Tight junction 207_208_1499_6714 4 8.35E-05 0.004260277 0.000163857 5561 hsa-mir-1468 hsa04630 Jak-STAT signaling pathway 2033_207_208_1387 4 0.000132851 0.006775404 0.000250941 5562 hsa-mir-1468 hsa04370 VEGF signaling pathway 207_208_6714 3 0.000306481 0.015630512 0.000558233 5563 hsa-mir-1468 hsa04330 Notch signaling pathway 2033_1387 2 0.00291712 0.148773115 0.005130107 5564 hsa-mir-1468 hsa04150 mTOR signaling pathway 207_208 2 0.003531285 0.180095551 0.006003185 5565 hsa-mir-1468 hsa05223 Non-small cell lung cancer 207_208 2 0.003792388 0.19341177 0.006093336 5566 hsa-mir-1468 hsa05217 Basal cell carcinoma 2932_1499 2 0.003926218 0.200237103 0.006093336 5567 hsa-mir-1468 hsa05131 Shigellosis 7534_1499 2 0.004062224 0.20717343 0.006093336 5568 hsa-mir-1468 hsa05130 Pathogenic Escherichia coli infection 7534_1499 2 0.004062224 0.20717343 0.006093336 5569 hsa-mir-1468 hsa04340 Hedgehog signaling pathway 2932_53944 2 0.0042004 0.214220386 0.006120582 5570 hsa-mir-1468 hsa05214 Glioma 207_208 2 0.005383042 0.27453516 0.007625977 5571 hsa-mir-1468 hsa05218 Melanoma 207_208 2 0.006358656 0.324291439 0.008764633 5572 hsa-mir-1468 hsa04720 Long-term potentiation 2033_1387 2 0.007050434 0.359572129 0.009462424 5573 hsa-mir-1468 hsa04664 Fc epsilon RI signaling pathway 207_208 2 0.007774794 0.396514501 0.010167038 5574 hsa-mir-1468 hsa04360 Axon guidance 5058_2932 2 0.019963764 1 0.0254538 5575 hsa-mir-1468 hsa05016 Huntington's disease 2033_1387 2 0.038516907 1 0.047911274 5576 hsa-mir-1468 hsa04950 Maturity onset diabetes of the young 3172 1 0.03999457 1 0.048564835 5577 hsa-mir-1468 hsa05216 Thyroid cancer 1499 1 0.047803337 1 0.056696981 5578 hsa-mir-1469 hsa05200 Pathways in cancer 3320_4149_5371_9063_367_1499_5594_5595_5599_6258_6256_1488_4286_1487_2932_1387_842_6502_6772_5970_8554_4824_5604_5894_3725_1029_841_4087_4088_4089_5601_4292_1050_5925_2033_207_836 37 1.27E-25 8.99E-24 8.99E-24 5579 hsa-mir-1469 hsa04110 Cell cycle 993_5591_7532_983_7531_2932_8454_7534_1387_6502_6500_1029_4087_4088_4089_990_5925_2033_5933 19 2.84E-16 2.01E-14 1.01E-14 5580 hsa-mir-1469 hsa04010 MAPK signaling pathway 9479_6722_4149_5594_5595_5599_5598_9261_5608_6195_3312_1386_1432_5970_5604_5894_3725_5601_5058_3303_207_836_51701_2002_2005 25 8.30E-16 5.90E-14 1.97E-14 5581 hsa-mir-1469 hsa04310 Wnt signaling pathway 815_1499_5599_1488_1487_5518_2932_8454_1387_6500_6423_3725_1457_1459_4087_4088_4089_5601_2033_51701 20 1.32E-15 9.36E-14 2.34E-14 5582 hsa-mir-1469 hsa05210 Colorectal cancer 1499_5594_5595_5599_2932_842_5604_5894_3725_4087_4088_4089_5601_4292_207_836 16 5.75E-15 4.08E-13 8.17E-14 5583 hsa-mir-1469 hsa05215 Prostate cancer 3320_367_1499_5594_5595_1385_2932_1387_842_5970_4824_5604_5894_5925_2033_207 16 1.09E-14 7.76E-13 1.29E-13 5584 hsa-mir-1469 hsa05212 Pancreatic cancer 3320_367_1499_5594_5595_1385_2932_1387_842_5970_4824_5604_5894_5925_2033_207 16 1.28E-14 9.07E-13 1.30E-13 5585 hsa-mir-1469 hsa04520 Adherens junction 1499_6714_5594_5595_1387_1457_1459_4087_4088_4089_2033_71_51701 13 1.25E-11 8.87E-10 1.11E-10 5586 hsa-mir-1469 hsa04350 TGF-beta signaling pathway 5594_5595_6667_5518_8454_1387_6500_3398_4087_4088_4089_2033_5933 13 3.21E-11 2.28E-09 2.28E-10 5587 hsa-mir-1469 hsa04012 ErbB signaling pathway 815_6714_5594_5595_5599_2932_5604_5894_3725_5601_5058_207_2002 13 3.21E-11 2.28E-09 2.28E-10 5588 hsa-mir-1469 hsa05220 Chronic myeloid leukemia 5594_5595_1488_1487_5970_5604_5894_1029_4088_4089_5925_207 12 9.14E-11 6.49E-09 5.90E-10 5589 hsa-mir-1469 hsa04912 GnRH signaling pathway 815_6714_5594_5595_5599_5598_5608_1432_5604_5894_3725_5601_2002 13 3.66E-10 2.60E-08 2.17E-09 5590 hsa-mir-1469 hsa05213 Endometrial cancer 1499_5594_5595_2932_842_5604_5894_4292_207_2002 10 7.06E-10 5.01E-08 3.86E-09 5591 hsa-mir-1469 hsa04540 Gap junction 7846_7277_6714_5594_5595_5598_983_7278_5604_5894_51807_10376 12 8.54E-10 6.06E-08 4.33E-09 5592 hsa-mir-1469 hsa05223 Non-small cell lung cancer 5594_5595_6258_6256_842_5604_5894_1029_5925_207 10 9.77E-10 6.94E-08 4.62E-09 5593 hsa-mir-1469 hsa04620 Toll-like receptor signaling pathway 5594_5595_5599_5608_1432_6772_5970_5604_3725_841_5601_207 12 2.23E-09 1.58E-07 9.88E-09 5594 hsa-mir-1469 hsa03022 Basal transcription factors 2962_2969_6879_6908_6872_2959_6880_2958 8 1.66E-08 1.18E-06 6.92E-08 5595 hsa-mir-1469 hsa05131 Shigellosis 7846_7277_1499_7534_7278_51807_4691_71_10376 9 2.05E-08 1.46E-06 7.67E-08 5596 hsa-mir-1469 hsa05130 Pathogenic Escherichia coli infection 7846_7277_1499_7534_7278_51807_4691_71_10376 9 2.05E-08 1.46E-06 7.67E-08 5597 hsa-mir-1469 hsa04916 Melanogenesis 815_1499_5594_5595_1385_4286_2932_1387_5604_5894_2033 11 2.88E-08 2.04E-06 1.02E-07 5598 hsa-mir-1469 hsa04660 T cell receptor signaling pathway 5594_5595_2932_1432_5970_5604_5894_3725_5601_5058_207 11 4.89E-08 3.47E-06 1.65E-07 5599 hsa-mir-1469 hsa05222 Small cell lung cancer 4149_9063_6258_6256_842_6502_5970_8554_5925_207 10 5.46E-08 3.88E-06 1.76E-07 5600 hsa-mir-1469 hsa04510 Focal adhesion 1499_6714_5594_5595_5599_2932_5604_5894_3725_5601_5058_207_71_2002 14 6.97E-08 4.95E-06 2.15E-07 5601 hsa-mir-1469 hsa05211 Renal cell carcinoma 5594_5595_1387_5604_5894_3725_5058_2033_207 9 1.45E-07 1.03E-05 4.30E-07 5602 hsa-mir-1469 hsa04370 VEGF signaling pathway 6714_5594_5595_9261_1432_842_5604_5894_207 9 2.45E-07 1.74E-05 6.95E-07 5603 hsa-mir-1469 hsa04664 Fc epsilon RI signaling pathway 5594_5595_5599_5608_1432_5604_5894_5601_207 9 2.99E-07 2.12E-05 8.16E-07 5604 hsa-mir-1469 hsa05221 Acute myeloid leukemia 5371_5594_5595_5970_5604_5894_1050_207 8 4.13E-07 2.93E-05 1.08E-06 5605 hsa-mir-1469 hsa04612 Antigen processing and presentation 3320_1385_3308_4800_4802_3312_1514_3303_4801 9 7.53E-07 5.35E-05 1.91E-06 5606 hsa-mir-1469 hsa05214 Glioma 815_5594_5595_5604_5894_1029_5925_207 8 8.07E-07 5.73E-05 1.97E-06 5607 hsa-mir-1469 hsa04330 Notch signaling pathway 1488_1487_1387_9612_2033_2648_8850 7 1.26E-06 8.92E-05 2.97E-06 5608 hsa-mir-1469 hsa05216 Thyroid cancer 1499_5594_5595_6258_6256_5604 6 1.35E-06 9.61E-05 3.10E-06 5609 hsa-mir-1469 hsa05218 Melanoma 5594_5595_4286_5604_5894_1029_5925_207 8 1.48E-06 0.000105409 3.19E-06 5610 hsa-mir-1469 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5599_1432_5970_3725_5601_5058_836 8 1.48E-06 0.000105409 3.19E-06 5611 hsa-mir-1469 hsa04720 Long-term potentiation 815_5594_5595_6195_1387_5604_5894_2033 8 2.17E-06 0.000153847 4.40E-06 5612 hsa-mir-1469 hsa04662 B cell receptor signaling pathway 5594_5595_2932_5970_5604_5894_3725_207 8 2.17E-06 0.000153847 4.40E-06 5613 hsa-mir-1469 hsa04910 Insulin signaling pathway 5594_5595_5599_2932_5604_5894_5601_207_2002_2538 10 3.09E-06 0.000219547 6.10E-06 5614 hsa-mir-1469 hsa04120 Ubiquitin mediated proteolysis 55294_5371_9063_672_8454_6502_6500_8554_10273_7329 10 3.29E-06 0.000233246 6.30E-06 5615 hsa-mir-1469 hsa04062 Chemokine signaling pathway 5594_5595_2932_2931_6772_5970_5604_5894_5058_7074_207 11 8.79E-06 0.000624381 1.64E-05 5616 hsa-mir-1469 hsa05219 Bladder cancer 5594_5595_5604_5894_1029_5925 6 9.16E-06 0.000650104 1.67E-05 5617 hsa-mir-1469 hsa04920 Adipocytokine signaling pathway 5599_6258_6256_5970_5601_207_2538 7 1.07E-05 0.000761778 1.90E-05 5618 hsa-mir-1469 hsa04210 Apoptosis 839_842_840_5970_841_207_836 7 5.87E-05 0.004168674 0.000101675 5619 hsa-mir-1469 hsa04115 p53 signaling pathway 983_842_7161_1029_841_836 6 0.000119333 0.008472633 0.000201729 5620 hsa-mir-1469 hsa04530 Tight junction 1499_6714_5518_8189_1457_1459_207_71 8 0.000126894 0.009009449 0.000209522 5621 hsa-mir-1469 hsa05010 Alzheimer's disease 22926_5594_5595_2932_842_840_1020_841_836 9 0.000132305 0.009393683 0.000213493 5622 hsa-mir-1469 hsa04630 Jak-STAT signaling pathway 9063_1387_6772_8554_3595_3594_2033_207 8 0.000282621 0.020066091 0.000445913 5623 hsa-mir-1469 hsa03450 Non-homologous end-joining 5591_7520_2547 3 0.000641819 0.045569164 0.000990634 5624 hsa-mir-1469 hsa05016 Huntington's disease 1385_6908_6667_1387_842_841_2033_836 8 0.00095435 0.067758877 0.001441678 5625 hsa-mir-1469 hsa04730 Long-term depression 5594_5595_5518_5604_5894 5 0.001090708 0.077440264 0.001613339 5626 hsa-mir-1469 hsa04930 Type II diabetes mellitus 5594_5595_5599_5601 4 0.001564508 0.111080097 0.002266941 5627 hsa-mir-1469 hsa04150 mTOR signaling pathway 5594_5595_6195_207 4 0.002565164 0.182126671 0.003642533 5628 hsa-mir-1469 hsa05014 Amyotrophic lateral sclerosis (ALS) 5608_1432_842_836 4 0.00329917 0.234241076 0.004592962 5629 hsa-mir-1469 hsa04650 Natural killer cell mediated cytotoxicity 5594_5595_5604_5894_5058_836 6 0.00368447 0.261597392 0.005030719 5630 hsa-mir-1469 hsa04810 Regulation of actin cytoskeleton 5594_5595_5604_5894_5058_7074_71 7 0.008781047 0.623454322 0.011763289 5631 hsa-mir-1469 hsa04360 Axon guidance 5594_5595_2932_1020_5058 5 0.012996191 0.922729594 0.017087585 5632 hsa-mir-1469 hsa04270 Vascular smooth muscle contraction 5594_5595_5604_5894 4 0.036536277 1 0.047165012 5633 hsa-mir-146b hsa05200 Pathways in cancer 3716_3320_3326_5925_5371_3480_1956_4233_5595_5594_5599_1387_2064_6256_5159_595_5156_367_2261_4193_6776_6777_6772_5979_5879_7157_6688_2113_4609_3725_1026_2353_10401_3066_3065_2033_1441_8554_4790_4792_5970_7184 42 4.02E-33 2.98E-31 2.98E-31 5634 hsa-mir-146b hsa03022 Basal transcription factors 2961_2960_2963_6881_2969_6874_6878_2957_6879_6877_6873_2958_6872_2968_54457_6884_2959_6882_6880_138474_2967_6883 22 3.42E-30 2.53E-28 1.26E-28 5635 hsa-mir-146b hsa04630 Jak-STAT signaling pathway 3717_3716_3718_3559_85480_3566_3560_149233_1387_595_3575_3570_3572_3953_5777_6776_6777_6772_1439_3454_3455_5781_4609_2690_10401_6773_2033_1441_8554 29 2.09E-27 1.54E-25 5.15E-26 5636 hsa-mir-146b hsa05215 Prostate cancer 3320_3326_5925_3480_1956_5595_5594_1387_2064_5159_595_5156_367_4193_7157_468_1026_2033_4790_4792_5970_7184 22 1.93E-23 1.43E-21 3.53E-22 5637 hsa-mir-146b hsa05212 Pancreatic cancer 3320_3326_5925_3480_1956_5595_5594_1387_2064_5159_595_5156_367_4193_7157_468_1026_2033_4790_4792_5970_7184 22 2.38E-23 1.76E-21 3.53E-22 5638 hsa-mir-146b hsa05220 Chronic myeloid leukemia 5925_5595_5594_595_4193_6776_6777_7157_5781_4609_1026_3066_3065_4790_4792_5970 16 1.96E-16 1.45E-14 2.42E-15 5639 hsa-mir-146b hsa04060 Cytokine-cytokine receptor interaction 3556_2321_3559_85480_1956_3566_4233_3560_149233_5159_5156_3575_3570_3572_1234_1230_3953_1439_7852_3454_3455_2690_1441 23 2.35E-15 1.74E-13 2.49E-14 5640 hsa-mir-146b hsa04010 MAPK signaling pathway 3925_1956_5595_5594_5599_5159_5156_2261_2264_9252_3312_1649_5879_7157_468_6885_4609_3725_3727_2353_4790_51701_5970 23 5.32E-15 3.94E-13 4.92E-14 5641 hsa-mir-146b hsa04520 Adherens junction 2241_3480_1956_6714_4233_5595_5594_1387_2064_5777_5879_6885_1460_2033_51701 15 9.30E-15 6.88E-13 7.64E-14 5642 hsa-mir-146b hsa05219 Bladder cancer 5925_1956_5595_5594_2064_595_2261_9252_4193_7157_4609_1026 12 6.06E-14 4.49E-12 4.49E-13 5643 hsa-mir-146b hsa05210 Colorectal cancer 3480_1956_4233_5595_5594_5599_5159_595_5156_5879_7157_4609_3725_2353 14 3.09E-13 2.28E-11 2.08E-12 5644 hsa-mir-146b hsa04062 Chemokine signaling pathway 3717_3718_5580_5590_5595_5594_1234_1230_6777_6772_5879_7852_3055_2185_6773_4790_4792_5970 18 1.08E-12 7.98E-11 6.65E-12 5645 hsa-mir-146b hsa04620 Toll-like receptor signaling pathway 3654_5595_5594_5599_6772_5879_3454_3455_6885_3725_2353_4790_4792_5970 14 3.31E-12 2.45E-10 1.88E-11 5646 hsa-mir-146b hsa05218 Melanoma 5925_3480_1956_4233_5595_5594_5159_595_5156_4193_7157_1026 12 1.36E-11 1.00E-09 7.17E-11 5647 hsa-mir-146b hsa05214 Glioma 5925_3480_1956_5595_5594_5159_595_5156_4193_7157_1026 11 9.66E-11 7.15E-09 4.77E-10 5648 hsa-mir-146b hsa05221 Acute myeloid leukemia 5371_5595_5594_595_6776_6777_6688_4609_4790_5970 10 6.89E-10 5.10E-08 3.19E-09 5649 hsa-mir-146b hsa04012 ErbB signaling pathway 1956_6714_5595_5594_5599_2064_6776_6777_4609_3725_1026 11 1.58E-09 1.17E-07 6.90E-09 5650 hsa-mir-146b hsa04110 Cell cycle 5925_7533_1387_595_4193_7157_1026_4171_4085_3066_3065_2033 12 3.02E-09 2.23E-07 1.24E-08 5651 hsa-mir-146b hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_4233_5599_5879_5781_3725_4790_4792_5970 10 3.46E-09 2.56E-07 1.35E-08 5652 hsa-mir-146b hsa04662 B cell receptor signaling pathway 5595_5594_5777_5879_6850_3725_2353_4790_4792_5970 10 5.58E-09 4.13E-07 2.07E-08 5653 hsa-mir-146b hsa04510 Focal adhesion 2321_3480_1956_6714_4233_5595_5594_5599_2064_5159_595_5156_5879_3725 14 1.65E-08 1.22E-06 5.82E-08 5654 hsa-mir-146b hsa05222 Small cell lung cancer 5925_6256_595_7157_4609_10401_8554_4790_4792_5970 10 1.84E-08 1.36E-06 6.20E-08 5655 hsa-mir-146b hsa05216 Thyroid cancer 5595_5594_6256_595_5979_7157_4609 7 3.15E-08 2.33E-06 1.01E-07 5656 hsa-mir-146b hsa04330 Notch signaling pathway 1387_388585_3280_9612_3066_3065_2033_8850 8 3.52E-08 2.61E-06 1.09E-07 5657 hsa-mir-146b hsa04310 Wnt signaling pathway 5599_1387_595_8607_5879_7157_6885_4609_3725_1460_2033_51701 12 3.82E-08 2.83E-06 1.13E-07 5658 hsa-mir-146b hsa05211 Renal cell carcinoma 4233_5595_5594_1387_5879_5781_2113_3725_2033 9 5.44E-08 4.03E-06 1.55E-07 5659 hsa-mir-146b hsa05223 Non-small cell lung cancer 5925_1956_5595_5594_2064_6256_595_7157 8 9.26E-08 6.85E-06 2.54E-07 5660 hsa-mir-146b hsa04660 T cell receptor signaling pathway 3932_5595_5594_5777_6885_3725_2353_4790_4792_5970 10 1.57E-07 1.16E-05 4.14E-07 5661 hsa-mir-146b hsa04920 Adipocytokine signaling pathway 3717_5599_6256_3953_5781_4790_4792_5970 8 4.17E-07 3.09E-05 1.06E-06 5662 hsa-mir-146b hsa05213 Endometrial cancer 1956_5595_5594_2064_595_7157_4609 7 1.08E-06 7.97E-05 2.63E-06 5663 hsa-mir-146b hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_5777_5879_6850_3454_3455_5781_2185 10 1.10E-06 8.14E-05 2.63E-06 5664 hsa-mir-146b hsa04912 GnRH signaling pathway 5580_1956_6714_5595_5594_5599_468_2185_3725 9 1.30E-06 9.60E-05 3.00E-06 5665 hsa-mir-146b hsa04210 Apoptosis 3654_3556_1439_7157_4790_4792_5970 7 2.83E-05 0.002093138 6.34E-05 5666 hsa-mir-146b hsa04540 Gap junction 1956_6714_5595_5594_5159_5156_10382 7 3.68E-05 0.002725786 8.02E-05 5667 hsa-mir-146b hsa05016 Huntington's disease 6874_1387_9001_5430_7157_3064_3066_3065_2033 9 8.56E-05 0.006332271 0.000180922 5668 hsa-mir-146b hsa04930 Type II diabetes mellitus 5580_5590_5595_5594_5599 5 9.04E-05 0.006693064 0.000185918 5669 hsa-mir-146b hsa03050 Proteasome 5710_5705_5701_5702_5719 5 0.000119815 0.008866327 0.00023963 5670 hsa-mir-146b hsa04664 Fc epsilon RI signaling pathway 5580_5595_5594_5599_5879_6850 6 0.000127572 0.009440347 0.00024843 5671 hsa-mir-146b hsa04350 TGF-beta signaling pathway 5595_5594_1387_4609_4086_2033 6 0.000209297 0.015487985 0.000397128 5672 hsa-mir-146b hsa04720 Long-term potentiation 5595_5594_1387_468_2033 5 0.000822584 0.060871215 0.00152178 5673 hsa-mir-146b hsa03420 Nucleotide excision repair 2968_6118_5887_2967 4 0.000946548 0.070044567 0.001708404 5674 hsa-mir-146b hsa04810 Regulation of actin cytoskeleton 1956_5595_5594_5159_5156_2261_2264_5879 8 0.001169773 0.086563176 0.002061028 5675 hsa-mir-146b hsa04640 Hematopoietic cell lineage 3559_3566_3575_3570_1441 5 0.001540831 0.114021459 0.002651662 5676 hsa-mir-146b hsa04360 Axon guidance 2242_4233_5595_5594_5879_7852 6 0.001620525 0.119918872 0.002725429 5677 hsa-mir-146b hsa04612 Antigen processing and presentation 3320_3326_4801_3312_2923 5 0.001694834 0.125417729 0.002787061 5678 hsa-mir-146b hsa04950 Maturity onset diabetes of the young 6927_3280_5080 3 0.001845166 0.136542267 0.00296831 5679 hsa-mir-146b hsa04115 p53 signaling pathway 595_4193_7157_1026 4 0.00443676 0.328320227 0.006985537 5680 hsa-mir-146b hsa05340 Primary immunodeficiency 3718_3932_3575 3 0.00494486 0.365919623 0.007623325 5681 hsa-mir-146b hsa04370 VEGF signaling pathway 6714_5595_5594_5879 4 0.006410736 0.474394465 0.00968152 5682 hsa-mir-146b hsa04710 Circadian rhythm - mammal 406_8553 2 0.007984069 0.590821074 0.011816421 5683 hsa-mir-146b hsa04910 Insulin signaling pathway 5590_5595_5594_5599_5211 5 0.010031868 0.742358219 0.014556044 5684 hsa-mir-146b hsa04120 Ubiquitin mediated proteolysis 5371_672_4193_10401_8554 5 0.010317727 0.763511826 0.01468292 5685 hsa-mir-146b hsa05322 Systemic lupus erythematosus 333932_3014_3015_8340_126961 5 0.011830978 0.875492359 0.016518724 5686 hsa-mir-146b hsa04916 Melanogenesis 5595_5594_1387_2033 4 0.017095705 1 0.023427448 5687 hsa-mir-146b hsa04670 Leukocyte transendothelial migration 5879_7852_5781_2185 4 0.02817868 1 0.037913133 5688 hsa-mir-146b hsa04020 Calcium signaling pathway 1956_2064_5159_5156_2185 5 0.029557949 1 0.038893386 5689 hsa-mir-146b hsa04730 Long-term depression 3480_5595_5594 3 0.029958419 1 0.038893386 5690 hsa-mir-146b hsa04530 Tight junction 5580_6714_5590_1460 4 0.040048823 1 0.051096774 5691 hsa-mir-146b hsa03030 DNA replication 6118_4171 2 0.046648205 1 0.058507918 5692 hsa-mir-1470 hsa05200 Pathways in cancer 25_5371_2034_7046_5595_5594_5599_861_5914_1387_6256_595_3326_10401_5601_4286_367_2932_4193_6688_7704_6772_3091_5970_7428_1870_1871_8554_7157_2113_4609_1869_3725_4088_2353_2736_4087_4089_3066_3065_1050_5925_2033_4846_207_836_7184 47 3.68E-31 2.80E-29 2.80E-29 5693 hsa-mir-1470 hsa03022 Basal transcription factors 2961_2960_2963_6881_2967_6879_6878_6877_2957_54457_2968_6908_6874_2958_6873_6872_6884_2959_6882_138474_6880_6883 22 1.97E-26 1.50E-24 7.49E-25 5694 hsa-mir-1470 hsa05220 Chronic myeloid leukemia 25_7046_5595_5594_861_595_4193_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_207_6464 20 1.46E-18 1.11E-16 3.70E-17 5695 hsa-mir-1470 hsa04010 MAPK signaling pathway 6722_7046_5595_5594_5599_5598_9261_4208_5601_5600_6197_9252_1432_5970_3312_7157_4609_3725_3727_6195_6196_2353_5603_8986_4763_1616_207_1649_8550_836 30 1.85E-17 1.41E-15 3.52E-16 5696 hsa-mir-1470 hsa04110 Cell cycle 25_4171_5591_1387_595_2932_4193_4085_1870_1871_7157_1869_4088_4087_4089_3066_3065_5925_2033_5933 20 3.54E-15 2.69E-13 5.38E-14 5697 hsa-mir-1470 hsa05215 Prostate cancer 5595_5594_1387_595_3326_367_2932_4193_5970_1870_1871_7157_9586_1869_5925_2033_207_7184 18 4.31E-15 3.27E-13 5.46E-14 5698 hsa-mir-1470 hsa05212 Pancreatic cancer 5595_5594_1387_595_3326_367_2932_4193_5970_1870_1871_7157_9586_1869_5925_2033_207_7184 18 5.11E-15 3.89E-13 5.55E-14 5699 hsa-mir-1470 hsa05210 Colorectal cancer 7046_5595_5594_5599_595_5601_2932_7157_4609_3725_4088_2353_4087_4089_207_836 16 3.83E-13 2.91E-11 3.63E-12 5700 hsa-mir-1470 hsa04350 TGF-beta signaling pathway 7046_5595_5594_1387_3399_3398_4609_4088_4086_4087_4089_2033_4093_5933 14 8.47E-11 6.43E-09 7.15E-10 5701 hsa-mir-1470 hsa05219 Bladder cancer 5595_5594_595_9252_4193_1870_1871_7157_4609_1869_5925 11 9.95E-11 7.56E-09 7.56E-10 5702 hsa-mir-1470 hsa04310 Wnt signaling pathway 1460_5599_1387_595_8607_5601_1459_2932_7157_8061_4609_3725_4088_1457_4087_4089_2033 17 1.46E-10 1.11E-08 1.01E-09 5703 hsa-mir-1470 hsa05221 Acute myeloid leukemia 5371_5595_5594_861_5914_595_6688_7704_5970_4609_1050_207 12 1.77E-10 1.34E-08 1.12E-09 5704 hsa-mir-1470 hsa05222 Small cell lung cancer 6256_595_10401_5970_1870_1871_8554_7157_4609_1869_5925_4846_207 13 8.00E-10 6.08E-08 4.67E-09 5705 hsa-mir-1470 hsa04520 Adherens junction 4301_1460_7046_5595_5594_1387_1459_4088_1457_4087_4089_2033 12 3.89E-09 2.96E-07 2.11E-08 5706 hsa-mir-1470 hsa05214 Glioma 5595_5594_595_4193_1870_1871_7157_1869_5925_207_6464 11 5.67E-09 4.31E-07 2.87E-08 5707 hsa-mir-1470 hsa05218 Melanoma 5595_5594_595_4286_4193_1870_1871_7157_1869_5925_207 11 1.29E-08 9.81E-07 5.88E-08 5708 hsa-mir-1470 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925_207 10 1.32E-08 1.00E-06 5.88E-08 5709 hsa-mir-1470 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5601_5600_1432_6772_5970_3725_2353_5603_207 12 4.55E-08 3.46E-06 1.92E-07 5710 hsa-mir-1470 hsa04660 T cell receptor signaling pathway 5595_5594_5601_5600_2932_1432_5970_1739_3725_2353_5603_207 12 9.72E-08 7.38E-06 3.89E-07 5711 hsa-mir-1470 hsa05211 Renal cell carcinoma 2034_5595_5594_1387_3091_7428_2113_3725_2033_207 10 1.50E-07 1.14E-05 5.70E-07 5712 hsa-mir-1470 hsa05016 Huntington's disease 1387_2902_6908_6874_9001_5430_7157_9586_3066_3065_3064_2033_836_4716 14 6.63E-07 5.04E-05 2.40E-06 5713 hsa-mir-1470 hsa04012 ErbB signaling pathway 25_5595_5594_5599_5601_2932_4609_3725_207_6464 10 7.38E-07 5.61E-05 2.55E-06 5714 hsa-mir-1470 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_5600_1432_7157_5603_1616_4846_836 8 2.21E-06 0.000168153 7.31E-06 5715 hsa-mir-1470 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 6.48E-06 0.000492337 2.05E-05 5716 hsa-mir-1470 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5601_5600_1432_5970_3725_5603_836 8 1.10E-05 0.000832334 3.33E-05 5717 hsa-mir-1470 hsa05213 Endometrial cancer 5595_5594_595_2932_7157_4609_207 7 1.37E-05 0.001041002 3.86E-05 5718 hsa-mir-1470 hsa04150 mTOR signaling pathway 5595_5594_6197_3091_6195_6196_207 7 1.37E-05 0.001041002 3.86E-05 5719 hsa-mir-1470 hsa04720 Long-term potentiation 5595_5594_1387_2902_6197_6195_6196_2033 8 1.58E-05 0.001201217 4.29E-05 5720 hsa-mir-1470 hsa04370 VEGF signaling pathway 5595_5594_9261_5600_1432_5603_4846_207 8 1.88E-05 0.001431932 4.94E-05 5721 hsa-mir-1470 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5601_5600_1432_5603_207 8 2.24E-05 0.001698746 5.66E-05 5722 hsa-mir-1470 hsa04912 GnRH signaling pathway 5595_5594_5599_5598_5601_5600_1432_3725_5603 9 2.92E-05 0.002218913 7.16E-05 5723 hsa-mir-1470 hsa04330 Notch signaling pathway 1387_9612_3066_3065_2033_8850 6 7.48E-05 0.005684294 0.000177634 5724 hsa-mir-1470 hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_3725_2353_207 7 0.000117286 0.008913704 0.000270112 5725 hsa-mir-1470 hsa04910 Insulin signaling pathway 5595_5594_5599_5601_5211_6720_2932_207_6464 9 0.00017124 0.013014272 0.000382773 5726 hsa-mir-1470 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601_3651 5 0.000541401 0.041146467 0.001175613 5727 hsa-mir-1470 hsa03050 Proteasome 5719_5710_5705_5701_5702 5 0.000709644 0.05393296 0.00146101 5728 hsa-mir-1470 hsa04510 Focal adhesion 5595_5594_5599_595_5601_2932_1729_3725_207_6464 10 0.000711281 0.054057361 0.00146101 5729 hsa-mir-1470 hsa04120 Ubiquitin mediated proteolysis 11059_5371_672_10401_4193_7428_8554_7329 8 0.000851601 0.064721711 0.001703203 5730 hsa-mir-1470 hsa05010 Alzheimer's disease 5595_5594_2902_840_2932_1020_4846_836_4716 9 0.000953264 0.072448045 0.001857642 5731 hsa-mir-1470 hsa04630 Jak-STAT signaling pathway 1387_595_10401_6772_8554_4609_2033_207 8 0.001651022 0.125477646 0.003136941 5732 hsa-mir-1470 hsa04920 Adipocytokine signaling pathway 5599_6256_5601_5970_207 5 0.00281371 0.213841942 0.005215657 5733 hsa-mir-1470 hsa04916 Melanogenesis 5595_5594_1387_4286_2932_2033 6 0.003691247 0.280534774 0.006679399 5734 hsa-mir-1470 hsa04210 Apoptosis 840_5970_7157_207_836 5 0.008703518 0.661467377 0.015382962 5735 hsa-mir-1470 hsa04540 Gap junction 5592_5595_5594_5598_10382 5 0.010314669 0.783914816 0.017752831 5736 hsa-mir-1470 hsa04360 Axon guidance 25_5998_5595_5594_2932_1020 6 0.010511544 0.798877376 0.017752831 5737 hsa-mir-1470 hsa04530 Tight junction 4301_1460_10207_1459_1457_207 6 0.012787 0.971811983 0.021126347 5738 hsa-mir-1470 hsa04115 p53 signaling pathway 595_4193_7157_836 4 0.016685169 1 0.026980273 5739 hsa-mir-1470 hsa04730 Long-term depression 5592_5595_5594_4846 4 0.018251698 1 0.028840903 5740 hsa-mir-1470 hsa04062 Chemokine signaling pathway 5595_5594_2932_6772_5970_207_6464 7 0.018594792 1 0.028840903 5741 hsa-mir-1470 hsa03420 Nucleotide excision repair 2967_5887_2968 3 0.025002393 1 0.038003638 5742 hsa-mir-1470 hsa04612 Antigen processing and presentation 3326_4800_4801_3312 4 0.036446619 1 0.054312609 5743 hsa-mir-1470 hsa05217 Basal cell carcinoma 2932_7157_2736 3 0.042772595 1 0.062513793 5744 hsa-mir-1470 hsa04950 Maturity onset diabetes of the young 3651_5080 2 0.047021031 1 0.067426384 5745 hsa-mir-148b hsa04350 TGF-beta signaling pathway 4087_4088_6667_2033_4093_4609_5594_1387_5595_3399 10 7.93E-14 4.44E-12 4.44E-12 5746 hsa-mir-148b hsa05200 Pathways in cancer 4087_4088_9915_5371_2034_2033_2932_4609_367_5594_3091_1387_5595_2353 14 2.88E-13 1.61E-11 8.07E-12 5747 hsa-mir-148b hsa05211 Renal cell carcinoma 9915_2034_2033_5594_3091_1387_5595 7 1.49E-09 8.37E-08 2.79E-08 5748 hsa-mir-148b hsa04520 Adherens junction 4087_4088_2033_5594_1387_5595_1457 7 2.96E-09 1.66E-07 4.15E-08 5749 hsa-mir-148b hsa05210 Colorectal cancer 4087_4088_2932_4609_5594_5595_2353 7 4.07E-09 2.28E-07 4.56E-08 5750 hsa-mir-148b hsa04310 Wnt signaling pathway 4087_4088_2033_2932_8061_4609_1387_1457 8 9.19E-09 5.15E-07 8.58E-08 5751 hsa-mir-148b hsa05215 Prostate cancer 2033_2932_367_5594_1387_5595 6 1.70E-07 9.51E-06 1.27E-06 5752 hsa-mir-148b hsa05212 Pancreatic cancer 2033_2932_367_5594_1387_5595 6 1.81E-07 1.01E-05 1.27E-06 5753 hsa-mir-148b hsa04110 Cell cycle 4087_4088_2033_891_2932_1387 6 9.18E-07 5.14E-05 5.71E-06 5754 hsa-mir-148b hsa03022 Basal transcription factors 2963_2969_2959_6908 4 3.94E-06 0.000220592 2.21E-05 5755 hsa-mir-148b hsa04916 Melanogenesis 2033_2932_5594_1387_5595 5 9.75E-06 0.000545774 4.96E-05 5756 hsa-mir-148b hsa05213 Endometrial cancer 2932_4609_5594_5595 4 1.39E-05 0.000776806 6.47E-05 5757 hsa-mir-148b hsa05221 Acute myeloid leukemia 5371_4609_5594_5595 4 2.22E-05 0.001242606 9.56E-05 5758 hsa-mir-148b hsa04720 Long-term potentiation 2033_5594_1387_5595 4 5.42E-05 0.003037423 0.000189839 5759 hsa-mir-148b hsa05220 Chronic myeloid leukemia 4088_4609_5594_5595 4 5.42E-05 0.003037423 0.000189839 5760 hsa-mir-148b hsa04662 B cell receptor signaling pathway 2932_5594_5595_2353 4 5.42E-05 0.003037423 0.000189839 5761 hsa-mir-148b hsa05216 Thyroid cancer 4609_5594_5595 3 7.88E-05 0.004413873 0.00025964 5762 hsa-mir-148b hsa04012 ErbB signaling pathway 2932_4609_5594_5595 4 9.42E-05 0.005277322 0.000293185 5763 hsa-mir-148b hsa05010 Alzheimer's disease 2932_22926_5594_5595_1537 5 0.000113365 0.006348447 0.000334129 5764 hsa-mir-148b hsa05016 Huntington's disease 6667_2033_6908_1387_1537 5 0.000149168 0.008353389 0.000417669 5765 hsa-mir-148b hsa05219 Bladder cancer 4609_5594_5595 3 0.00022009 0.01232503 0.000572514 5766 hsa-mir-148b hsa04660 T cell receptor signaling pathway 2932_5594_5595_2353 4 0.000224916 0.012595305 0.000572514 5767 hsa-mir-148b hsa04330 Notch signaling pathway 9612_2033_1387 3 0.00030118 0.016866088 0.000733308 5768 hsa-mir-148b hsa04150 mTOR signaling pathway 5594_3091_5595 3 0.000399398 0.022366299 0.000931929 5769 hsa-mir-148b hsa04910 Insulin signaling pathway 23265_2932_5594_5595 4 0.000518031 0.029009726 0.001145625 5770 hsa-mir-148b hsa04120 Ubiquitin mediated proteolysis 7325_55294_5371_7329 4 0.000531897 0.029786257 0.001145625 5771 hsa-mir-148b hsa04620 Toll-like receptor signaling pathway 5594_5595_2353 3 0.002600737 0.145641247 0.00539412 5772 hsa-mir-148b hsa04360 Axon guidance 2932_5594_5595 3 0.005155477 0.288706713 0.010310954 5773 hsa-mir-148b hsa04010 MAPK signaling pathway 4609_5594_5595_2353 4 0.005889246 0.329797764 0.011372337 5774 hsa-mir-148b hsa04930 Type II diabetes mellitus 5594_5595 2 0.006654459 0.372649706 0.012421657 5775 hsa-mir-148b hsa04630 Jak-STAT signaling pathway 2033_4609_1387 3 0.008113236 0.454341226 0.014656169 5776 hsa-mir-148b hsa05223 Non-small cell lung cancer 5594_5595 2 0.009338529 0.522957644 0.016342426 5777 hsa-mir-148b hsa05214 Glioma 5594_5595 2 0.013163812 0.737173458 0.02233859 5778 hsa-mir-148b hsa04062 Chemokine signaling pathway 2932_5594_5595 3 0.0144967 0.811815173 0.023876917 5779 hsa-mir-148b hsa05218 Melanoma 5594_5595 2 0.015491055 0.867499069 0.024097196 5780 hsa-mir-148b hsa04730 Long-term depression 5594_5595 2 0.015491055 0.867499069 0.024097196 5781 hsa-mir-148b hsa04510 Focal adhesion 2932_5594_5595 3 0.017179419 0.96204748 0.026001283 5782 hsa-mir-148b hsa04370 VEGF signaling pathway 5594_5595 2 0.017981053 1 0.026498394 5783 hsa-mir-148b hsa04664 Fc epsilon RI signaling pathway 5594_5595 2 0.018846274 1 0.027061316 5784 hsa-mir-148b hsa04612 Antigen processing and presentation 4800_4801 2 0.023427622 1 0.032798671 5785 hsa-mir-148b hsa04540 Gap junction 5594_5595 2 0.025375656 1 0.034659432 5786 hsa-mir-148b hsa03010 Ribosome 6222_6231 2 0.029989424 1 0.039985899 5787 hsa-mir-148b hsa04912 GnRH signaling pathway 5594_5595 2 0.033236173 1 0.043284319 5788 hsa-mir-148b hsa04270 Vascular smooth muscle contraction 5594_5595 2 0.038936358 1 0.049555364 5789 hsa-mir-151 hsa05200 Pathways in cancer 4087_4088_4089_836_2033_367 6 1.25E-07 4.00E-06 4.00E-06 5790 hsa-mir-151 hsa04520 Adherens junction 4087_4088_4089_2033 4 4.01E-07 1.28E-05 4.43E-06 5791 hsa-mir-151 hsa05210 Colorectal cancer 4087_4088_4089_836 4 4.84E-07 1.55E-05 4.43E-06 5792 hsa-mir-151 hsa04350 TGF-beta signaling pathway 4087_4088_4089_2033 4 5.54E-07 1.77E-05 4.43E-06 5793 hsa-mir-151 hsa04110 Cell cycle 4087_4088_4089_2033 4 1.85E-06 5.93E-05 1.19E-05 5794 hsa-mir-151 hsa04310 Wnt signaling pathway 4087_4088_4089_2033 4 4.77E-06 0.00015264 2.54E-05 5795 hsa-mir-151 hsa05010 Alzheimer's disease 836_1020_840 3 0.00030013 0.009604155 0.001372022 5796 hsa-mir-151 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432 2 0.000826523 0.026448733 0.003306092 5797 hsa-mir-151 hsa04010 MAPK signaling pathway 836_1432_5598 3 0.001039885 0.033276327 0.00369737 5798 hsa-mir-151 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_1432 2 0.001305326 0.041770435 0.004177043 5799 hsa-mir-151 hsa05220 Chronic myeloid leukemia 4088_4089 2 0.001450768 0.046424576 0.004220416 5800 hsa-mir-151 hsa05215 Prostate cancer 2033_367 2 0.001974351 0.063179226 0.004612169 5801 hsa-mir-151 hsa04210 Apoptosis 836_840 2 0.002017824 0.064570371 0.004612169 5802 hsa-mir-151 hsa05212 Pancreatic cancer 2033_367 2 0.002017824 0.064570371 0.004612169 5803 hsa-mir-151 hsa04912 GnRH signaling pathway 1432_5598 2 0.002929301 0.093737632 0.006249175 5804 hsa-mir-151 hsa05016 Huntington's disease 836_2033 2 0.008468312 0.270985989 0.016936624 5805 hsa-mir-151 hsa04330 Notch signaling pathway 2033 1 0.034601859 1 0.065132912 5806 hsa-mir-152 hsa05200 Pathways in cancer 1488_5595_4087_1487_3065_367_3725_5594 8 3.06E-13 1.32E-11 1.32E-11 5807 hsa-mir-152 hsa05220 Chronic myeloid leukemia 1488_5595_1487_3065_5594 5 1.50E-10 6.45E-09 3.22E-09 5808 hsa-mir-152 hsa05210 Colorectal cancer 5595_4087_3725_5594 4 4.83E-08 2.08E-06 6.93E-07 5809 hsa-mir-152 hsa04310 Wnt signaling pathway 1488_4087_1487_3725 4 4.84E-07 2.08E-05 5.20E-06 5810 hsa-mir-152 hsa04330 Notch signaling pathway 1488_1487_3065 3 1.23E-06 5.29E-05 1.06E-05 5811 hsa-mir-152 hsa05211 Renal cell carcinoma 5595_3725_5594 3 4.21E-06 0.000181029 2.79E-05 5812 hsa-mir-152 hsa04662 B cell receptor signaling pathway 5595_3725_5594 3 4.74E-06 0.0002038 2.79E-05 5813 hsa-mir-152 hsa04520 Adherens junction 5595_4087_5594 3 5.72E-06 0.000245832 2.79E-05 5814 hsa-mir-152 hsa04350 TGF-beta signaling pathway 5595_4087_5594 3 7.30E-06 0.000313774 2.79E-05 5815 hsa-mir-152 hsa04012 ErbB signaling pathway 5595_3725_5594 3 7.30E-06 0.000313774 2.79E-05 5816 hsa-mir-152 hsa05215 Prostate cancer 5595_367_5594 3 7.54E-06 0.00032439 2.79E-05 5817 hsa-mir-152 hsa05212 Pancreatic cancer 5595_367_5594 3 7.80E-06 0.00033524 2.79E-05 5818 hsa-mir-152 hsa04620 Toll-like receptor signaling pathway 5595_3725_5594 3 1.16E-05 0.000498806 3.84E-05 5819 hsa-mir-152 hsa04912 GnRH signaling pathway 5595_3725_5594 3 1.37E-05 0.000589335 4.15E-05 5820 hsa-mir-152 hsa04660 T cell receptor signaling pathway 5595_3725_5594 3 1.45E-05 0.000621759 4.15E-05 5821 hsa-mir-152 hsa05216 Thyroid cancer 5595_5594 2 8.00E-05 0.00343846 0.000214904 5822 hsa-mir-152 hsa04510 Focal adhesion 5595_3725_5594 3 9.04E-05 0.003888172 0.000228716 5823 hsa-mir-152 hsa05219 Bladder cancer 5595_5594 2 0.000162164 0.006973049 0.000387392 5824 hsa-mir-152 hsa04930 Type II diabetes mellitus 5595_5594 2 0.00018517 0.007962307 0.000419069 5825 hsa-mir-152 hsa04010 MAPK signaling pathway 5595_3725_5594 3 0.000205494 0.008836249 0.000441812 5826 hsa-mir-152 hsa05213 Endometrial cancer 5595_5594 2 0.000244704 0.010522286 0.000478286 5827 hsa-mir-152 hsa04150 mTOR signaling pathway 5595_5594 2 0.000244704 0.010522286 0.000478286 5828 hsa-mir-152 hsa05223 Non-small cell lung cancer 5595_5594 2 0.000263215 0.011318243 0.000492098 5829 hsa-mir-152 hsa05221 Acute myeloid leukemia 5595_5594 2 0.0003124 0.013433181 0.000559716 5830 hsa-mir-152 hsa05214 Glioma 5595_5594 2 0.000376887 0.016206153 0.000648246 5831 hsa-mir-152 hsa05218 Melanoma 5595_5594 2 0.000447313 0.019234459 0.000712387 5832 hsa-mir-152 hsa04730 Long-term depression 5595_5594 2 0.000447313 0.019234459 0.000712387 5833 hsa-mir-152 hsa04720 Long-term potentiation 5595_5594 2 0.000497549 0.02139462 0.000764094 5834 hsa-mir-152 hsa04370 VEGF signaling pathway 5595_5594 2 0.00052365 0.022516961 0.000776447 5835 hsa-mir-152 hsa04664 Fc epsilon RI signaling pathway 5595_5594 2 0.000550405 0.02366742 0.000788914 5836 hsa-mir-152 hsa04540 Gap junction 5595_5594 2 0.000755916 0.032504404 0.001048529 5837 hsa-mir-152 hsa04916 Melanogenesis 5595_5594 2 0.000939616 0.040403509 0.00126261 5838 hsa-mir-152 hsa04270 Vascular smooth muscle contraction 5595_5594 2 0.001201431 0.05166152 0.001544616 5839 hsa-mir-152 hsa04110 Cell cycle 4087_3065 2 0.001221325 0.052516954 0.001544616 5840 hsa-mir-152 hsa04360 Axon guidance 5595_5594 2 0.001472371 0.063311964 0.001808913 5841 hsa-mir-152 hsa04910 Insulin signaling pathway 5595_5594 2 0.001629267 0.070058476 0.001893472 5842 hsa-mir-152 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594 2 0.001629267 0.070058476 0.001893472 5843 hsa-mir-152 hsa05010 Alzheimer's disease 5595_5594 2 0.00264233 0.113620169 0.002990004 5844 hsa-mir-152 hsa05016 Huntington's disease 3065_25942 2 0.002970046 0.127711962 0.003274666 5845 hsa-mir-152 hsa04062 Chemokine signaling pathway 5595_5594 2 0.003125028 0.134376225 0.003359406 5846 hsa-mir-152 hsa04810 Regulation of actin cytoskeleton 5595_5594 2 0.003990952 0.17161092 0.004185632 5847 hsa-mir-152 hsa03410 Base excision repair 3146 1 0.015911537 0.684196071 0.016290383 5848 hsa-mir-152 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725 1 0.030747579 1 0.030747579 5849 hsa-mir-153-1 hsa04630 Jak-STAT signaling pathway 3717_867_2057_3559_5781_2033_5777_3560_6774_6772_3575_6776_2690 13 2.95E-18 1.74E-16 1.74E-16 5850 hsa-mir-153-1 hsa05200 Pathways in cancer 5159_5156_867_7157_1399_1398_2033_2113_3815_5594_6774_6772_1956_5914_6776 15 3.68E-17 2.17E-15 1.08E-15 5851 hsa-mir-153-1 hsa04012 ErbB signaling pathway 867_1399_1398_6714_5594_6464_1956_6776_2066 9 1.11E-13 6.57E-12 2.19E-12 5852 hsa-mir-153-1 hsa05220 Chronic myeloid leukemia 867_7157_5781_1399_1398_5594_6464_6776 8 2.25E-12 1.33E-10 3.31E-11 5853 hsa-mir-153-1 hsa04060 Cytokine-cytokine receptor interaction 5159_5156_7852_2057_3559_3815_3560_3575_1956_2690 10 5.27E-11 3.11E-09 6.22E-10 5854 hsa-mir-153-1 hsa04520 Adherens junction 2033_5777_5770_6714_3643_5594_1956 7 2.11E-10 1.25E-08 2.08E-09 5855 hsa-mir-153-1 hsa04062 Chemokine signaling pathway 3717_7852_1399_1398_5594_6774_6464_6772 8 2.78E-09 1.64E-07 2.35E-08 5856 hsa-mir-153-1 hsa05214 Glioma 5159_5156_7157_5594_6464_1956 6 3.31E-09 1.95E-07 2.44E-08 5857 hsa-mir-153-1 hsa04510 Focal adhesion 5159_5156_1399_1398_6714_5594_6464_1956 8 4.55E-09 2.69E-07 2.98E-08 5858 hsa-mir-153-1 hsa05211 Renal cell carcinoma 5781_1399_1398_2033_2113_5594 6 5.88E-09 3.47E-07 3.47E-08 5859 hsa-mir-153-1 hsa04910 Insulin signaling pathway 867_1399_1398_5770_3643_5594_6464 7 7.71E-09 4.55E-07 4.13E-08 5860 hsa-mir-153-1 hsa05215 Prostate cancer 5159_5156_7157_2033_5594_1956 6 1.82E-08 1.08E-06 8.82E-08 5861 hsa-mir-153-1 hsa05212 Pancreatic cancer 5159_5156_7157_2033_5594_1956 6 1.94E-08 1.15E-06 8.82E-08 5862 hsa-mir-153-1 hsa05221 Acute myeloid leukemia 3815_5594_6774_5914_6776 5 1.09E-07 6.43E-06 4.59E-07 5863 hsa-mir-153-1 hsa05218 Melanoma 5159_5156_7157_5594_1956 5 2.60E-07 1.53E-05 1.02E-06 5864 hsa-mir-153-1 hsa05210 Colorectal cancer 5159_5156_7157_5594_1956 5 5.73E-07 3.38E-05 2.11E-06 5865 hsa-mir-153-1 hsa04010 MAPK signaling pathway 5159_5156_7157_1399_1398_5594_1956 7 6.89E-07 4.06E-05 2.39E-06 5866 hsa-mir-153-1 hsa04540 Gap junction 5159_5156_6714_5594_1956 5 9.27E-07 5.47E-05 3.04E-06 5867 hsa-mir-153-1 hsa04660 T cell receptor signaling pathway 867_919_5777_1493_5594 5 2.05E-06 0.00012073 6.35E-06 5868 hsa-mir-153-1 hsa04810 Regulation of actin cytoskeleton 5159_5156_1399_1398_5594_1956 6 3.15E-06 0.000185917 9.30E-06 5869 hsa-mir-153-1 hsa04650 Natural killer cell mediated cytotoxicity 919_5781_5777_5594_6464 5 5.96E-06 0.000351615 1.67E-05 5870 hsa-mir-153-1 hsa04640 Hematopoietic cell lineage 2057_3559_3815_3575 4 2.22E-05 0.001306929 5.94E-05 5871 hsa-mir-153-1 hsa05219 Bladder cancer 7157_5594_1956 3 7.38E-05 0.004351511 0.000189196 5872 hsa-mir-153-1 hsa05213 Endometrial cancer 7157_5594_1956 3 0.000134639 0.007943696 0.000330987 5873 hsa-mir-153-1 hsa05223 Non-small cell lung cancer 7157_5594_1956 3 0.000149782 0.008837167 0.000353487 5874 hsa-mir-153-1 hsa04920 Adipocytokine signaling pathway 3717_5781_6774 3 0.00027563 0.016262165 0.000625468 5875 hsa-mir-153-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5781_6714_1956 3 0.000324754 0.019160457 0.000709647 5876 hsa-mir-153-1 hsa04020 Calcium signaling pathway 5159_5156_1956_2066 4 0.000367314 0.021671528 0.000773983 5877 hsa-mir-153-1 hsa04350 TGF-beta signaling pathway 2033_5594_5515 3 0.000576731 0.034027125 0.001173349 5878 hsa-mir-153-1 hsa04916 Melanogenesis 2033_3815_5594 3 0.000953646 0.056265122 0.001875504 5879 hsa-mir-153-1 hsa04912 GnRH signaling pathway 6714_5594_1956 3 0.001060357 0.062561043 0.002018098 5880 hsa-mir-153-1 hsa05216 Thyroid cancer 7157_5594 2 0.001425017 0.084075991 0.002627375 5881 hsa-mir-153-1 hsa04310 Wnt signaling pathway 7157_2033_5515 3 0.002752369 0.162389757 0.004920902 5882 hsa-mir-153-1 hsa04930 Type II diabetes mellitus 3643_5594 2 0.003252427 0.191893215 0.005643918 5883 hsa-mir-153-1 hsa04330 Notch signaling pathway 9612_2033 2 0.003530142 0.208278385 0.005950811 5884 hsa-mir-153-1 hsa04730 Long-term depression 5594_5515 2 0.00767476 0.452810835 0.012578079 5885 hsa-mir-153-1 hsa04720 Long-term potentiation 2033_5594 2 0.008506018 0.501855059 0.013206712 5886 hsa-mir-153-1 hsa04662 B cell receptor signaling pathway 5777_5594 2 0.008506018 0.501855059 0.013206712 5887 hsa-mir-153-1 hsa04370 VEGF signaling pathway 6714_5594 2 0.008936147 0.52723268 0.013518787 5888 hsa-mir-153-1 hsa04620 Toll-like receptor signaling pathway 5594_6772 2 0.015097431 0.890748452 0.022268711 5889 hsa-mir-153-1 hsa04110 Cell cycle 7157_2033 2 0.020072063 1 0.028884188 5890 hsa-mir-153-1 hsa04670 Leukocyte transendothelial migration 7852_5781 2 0.021012148 1 0.029517065 5891 hsa-mir-153-1 hsa04360 Axon guidance 7852_5594 2 0.023940182 1 0.032848156 5892 hsa-mir-153-1 hsa04530 Tight junction 6714_5515 2 0.025979895 1 0.034836678 5893 hsa-mir-153-1 hsa04120 Ubiquitin mediated proteolysis 867_7329 2 0.026675038 1 0.034973939 5894 hsa-mir-153-1 hsa05016 Huntington's disease 7157_2033 2 0.045909789 1 0.058884295 5895 hsa-mir-153-2 hsa05218 Melanoma 4286 1 0.009564701 0.028694103 0.020888276 5896 hsa-mir-153-2 hsa04916 Melanogenesis 4286 1 0.013925517 0.041776551 0.020888276 5897 hsa-mir-153-2 hsa05200 Pathways in cancer 4286 1 0.043662618 0.130987853 0.043662618 5898 hsa-mir-1537 hsa05200 Pathways in cancer 5371_9063_5595_5594_5599_5914_1387_6256_595_1871_5601_1488_836_367_2353_7704_3091_5970_7428_1870_2885_7157_4087_2113_4609_1869_3725_5604_1487_4088_4089_3066_3065_5925_2034_2033_4846 37 9.15E-39 5.76E-37 5.76E-37 5899 hsa-mir-1537 hsa05220 Chronic myeloid leukemia 5595_5594_595_1871_1488_5970_1870_2885_7157_4609_1869_5604_1487_4088_4089_3066_3065_5925_6464 19 3.56E-26 2.24E-24 1.12E-24 5900 hsa-mir-1537 hsa04010 MAPK signaling pathway 6722_5595_5594_5599_4208_5606_5601_5600_836_2353_3312_1432_5970_2885_7157_4773_4609_3725_5604_9344_4763_2005 22 2.57E-20 1.62E-18 5.41E-19 5901 hsa-mir-1537 hsa05210 Colorectal cancer 5595_5594_5599_595_5601_836_2353_2885_7157_4087_4609_3725_5604_4088_4089 15 7.24E-19 4.56E-17 1.14E-17 5902 hsa-mir-1537 hsa05215 Prostate cancer 5595_5594_1387_595_1871_367_5970_1870_2885_7157_1869_5604_5925_2033 14 4.70E-17 2.96E-15 5.69E-16 5903 hsa-mir-1537 hsa05212 Pancreatic cancer 5595_5594_1387_595_1871_367_5970_1870_2885_7157_1869_5604_5925_2033 14 5.42E-17 3.41E-15 5.69E-16 5904 hsa-mir-1537 hsa04110 Cell cycle 5591_1387_595_1871_1870_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933 15 8.01E-17 5.05E-15 7.21E-16 5905 hsa-mir-1537 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_3397_3399_3398_4087_4609_4088_4089_2033_5933 13 1.34E-15 8.42E-14 1.05E-14 5906 hsa-mir-1537 hsa04310 Wnt signaling pathway 5599_1387_595_5601_1488_7157_4087_4773_4609_3725_1457_1487_4088_4089_2033 15 2.26E-15 1.42E-13 1.58E-14 5907 hsa-mir-1537 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1871_1870_2885_7157_1869_5604_5925 11 1.05E-14 6.63E-13 6.63E-14 5908 hsa-mir-1537 hsa05219 Bladder cancer 5595_5594_595_1871_1870_7157_4609_1869_5604_5925 10 4.52E-14 2.85E-12 2.59E-13 5909 hsa-mir-1537 hsa05214 Glioma 5595_5594_595_1871_1870_2885_7157_1869_5604_5925_6464 11 6.45E-14 4.06E-12 3.39E-13 5910 hsa-mir-1537 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2885_2113_3725_5604_2034_2033 11 1.77E-13 1.11E-11 8.57E-13 5911 hsa-mir-1537 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_5970_2885_4609_5604 10 9.09E-13 5.73E-11 4.09E-12 5912 hsa-mir-1537 hsa05222 Small cell lung cancer 9063_6256_595_1871_5970_1870_7157_4609_1869_5925_4846 11 1.03E-12 6.50E-11 4.33E-12 5913 hsa-mir-1537 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5606_5601_5600_2353_1432_5970_3725_5604 11 5.66E-12 3.57E-10 2.23E-11 5914 hsa-mir-1537 hsa04660 T cell receptor signaling pathway 5595_5594_5601_5600_2353_1432_5970_2885_4773_3725_5604 11 1.20E-11 7.59E-10 4.46E-11 5915 hsa-mir-1537 hsa05218 Melanoma 5595_5594_595_1871_1870_7157_1869_5604_5925 9 1.36E-10 8.57E-09 4.76E-10 5916 hsa-mir-1537 hsa04912 GnRH signaling pathway 5595_5594_5599_5606_5601_5600_1432_2885_3725_5604 10 2.15E-10 1.35E-08 7.12E-10 5917 hsa-mir-1537 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609_5604 7 2.99E-10 1.88E-08 9.42E-10 5918 hsa-mir-1537 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5606_5601_5600_1432_2885_5604 9 3.25E-10 2.05E-08 9.75E-10 5919 hsa-mir-1537 hsa04012 ErbB signaling pathway 5595_5594_5599_5601_2885_4609_3725_5604_6464 9 7.15E-10 4.50E-08 2.05E-09 5920 hsa-mir-1537 hsa04662 B cell receptor signaling pathway 5595_5594_2353_5970_2885_4773_3725_5604 8 5.21E-09 3.28E-07 1.43E-08 5921 hsa-mir-1537 hsa04330 Notch signaling pathway 1387_1488_9612_1487_3066_3065_2033 7 5.92E-09 3.73E-07 1.55E-08 5922 hsa-mir-1537 hsa04520 Adherens junction 5595_5594_1387_4087_1457_4088_4089_2033 8 8.33E-09 5.25E-07 2.10E-08 5923 hsa-mir-1537 hsa05213 Endometrial cancer 5595_5594_595_2885_7157_4609_5604 7 1.12E-08 7.05E-07 2.71E-08 5924 hsa-mir-1537 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_5606_5600_836_1432_7157_4846 7 1.79E-08 1.13E-06 4.17E-08 5925 hsa-mir-1537 hsa05016 Huntington's disease 6874_1387_2902_836_6667_7157_3066_3065_3064_2033 10 3.26E-08 2.05E-06 7.34E-08 5926 hsa-mir-1537 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5601_5600_836_1432_5970_3725 7 8.05E-08 5.07E-06 1.75E-07 5927 hsa-mir-1537 hsa04370 VEGF signaling pathway 5595_5594_5600_1432_4773_5604_4846 7 1.35E-07 8.49E-06 2.83E-07 5928 hsa-mir-1537 hsa04910 Insulin signaling pathway 6720_5595_5594_5599_5601_2885_5604_6464 8 4.35E-07 2.74E-05 8.85E-07 5929 hsa-mir-1537 hsa04510 Focal adhesion 5595_5594_5599_595_5601_2885_3725_5604_6464 9 7.90E-07 4.98E-05 1.55E-06 5930 hsa-mir-1537 hsa04720 Long-term potentiation 5595_5594_1387_2902_5604_2033 6 2.20E-06 0.000138495 4.20E-06 5931 hsa-mir-1537 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_2885_4773_5604_6464 7 5.43E-06 0.000342202 1.01E-05 5932 hsa-mir-1537 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601 4 8.03E-05 0.005060446 0.000144584 5933 hsa-mir-1537 hsa04630 Jak-STAT signaling pathway 9063_1387_595_2885_4609_2033 6 0.000110071 0.00693446 0.000192624 5934 hsa-mir-1537 hsa04916 Melanogenesis 5595_5594_1387_5604_2033 5 0.000159602 0.010054956 0.000271756 5935 hsa-mir-1537 hsa05010 Alzheimer's disease 5595_5594_2902_836_6622_4846 6 0.000220927 0.013918411 0.000366274 5936 hsa-mir-1537 hsa04920 Adipocytokine signaling pathway 5599_6256_5601_5970 4 0.000340375 0.021443596 0.000545261 5937 hsa-mir-1537 hsa04062 Chemokine signaling pathway 5595_5594_5970_2885_5604_6464 6 0.000346198 0.021810443 0.000545261 5938 hsa-mir-1537 hsa04730 Long-term depression 5595_5594_5604_4846 4 0.000419723 0.026442571 0.000644941 5939 hsa-mir-1537 hsa04120 Ubiquitin mediated proteolysis 5371_9063_672_7428_7329 5 0.000577265 0.036367678 0.000865897 5940 hsa-mir-1537 hsa04540 Gap junction 5595_5594_2885_5604 4 0.001105901 0.069671754 0.001620273 5941 hsa-mir-1537 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.002156713 0.135872941 0.003088021 5942 hsa-mir-1537 hsa04115 p53 signaling pathway 595_836_7157 3 0.004629656 0.291668324 0.006481518 5943 hsa-mir-1537 hsa04612 Antigen processing and presentation 4800_4801_3312 3 0.009114978 0.574243626 0.012217949 5944 hsa-mir-1537 hsa04210 Apoptosis 836_5970_7157 3 0.009114978 0.574243626 0.012217949 5945 hsa-mir-1537 hsa04270 Vascular smooth muscle contraction 5595_5594_5604 3 0.018972507 1 0.024901415 5946 hsa-mir-1537 hsa03050 Proteasome 5684_5705 2 0.022689099 1 0.029171699 5947 hsa-mir-1537 hsa04360 Axon guidance 5595_5594_4773 3 0.02473844 1 0.031170434 5948 hsa-mir-1538 hsa05200 Pathways in cancer 3551_5467_1499_595_1017_8517_4193_6934_7704_3091_4087_3065_1050_5925_7187_5468_25_405_9063_1487_1488_2885_4824_2113_10401_861_207_836_1147_3320_5595_5594_5599_6258_1387_6256_10342_4286_367_2932_6774_6776_6777_6772_5970_7157_7849_3725_4088_4089_2034_2033_4790_4792_3326_51176_5371_5604_5601_842_841_4609_2956_2736_2353 65 1.10E-38 8.72E-37 8.72E-37 5949 hsa-mir-1538 hsa05215 Prostate cancer 3551_1499_595_1017_8517_4193_6934_5925_2885_4824_207_1147_3320_5595_5594_1385_1387_367_2932_5970_7157_2033_4790_4792_3326_51176_5604_842 28 4.42E-22 3.49E-20 1.50E-20 5950 hsa-mir-1538 hsa05212 Pancreatic cancer 3551_1499_595_1017_8517_4193_6934_5925_2885_4824_207_1147_3320_5595_5594_1385_1387_367_2932_5970_7157_2033_4790_4792_3326_51176_5604_842 28 5.70E-22 4.50E-20 1.50E-20 5951 hsa-mir-1538 hsa04010 MAPK signaling pathway 6722_3551_6197_8517_9252_4773_9020_3303_9344_1432_2885_3305_1616_207_836_1147_5595_5594_5599_1386_3310_3312_5971_5970_3164_7157_3725_6195_6196_4790_9261_1326_5604_4208_5606_5601_5600_4609_2353_8986_2002_2005 42 9.36E-22 7.39E-20 1.85E-20 5952 hsa-mir-1538 hsa04310 Wnt signaling pathway 815_5467_1499_595_8607_6934_4087_4772_4773_23291_1487_1488_5599_1387_2932_7157_3725_1457_4088_4089_2033_894_896_51176_5519_5518_5601_6500_8454_8945_4609_5527 32 2.12E-20 1.68E-18 3.36E-19 5953 hsa-mir-1538 hsa05220 Chronic myeloid leukemia 3551_595_8517_4193_3065_5925_25_1487_1488_2885_861_207_1147_5595_5594_6776_6777_5970_7157_4088_4089_4790_4792_5604_4609 25 2.92E-20 2.30E-18 3.84E-19 5954 hsa-mir-1538 hsa05221 Acute myeloid leukemia 3551_5467_595_8517_6934_7704_1050_2885_861_207_1147_5595_5594_6774_6776_6777_5970_4790_51176_5371_5604_4609 22 7.63E-19 6.03E-17 8.61E-18 5955 hsa-mir-1538 hsa04620 Toll-like receptor signaling pathway 3551_8517_7187_3665_3661_1432_207_1147_5595_5594_5599_6772_5970_3725_4790_4792_1326_5604_5606_5601_5600_9641_841_2353 24 1.42E-16 1.12E-14 1.40E-15 5956 hsa-mir-1538 hsa05210 Colorectal cancer 1499_595_6934_4087_2885_207_836_5595_5594_5599_2932_7157_3725_4088_4089_51176_5604_5601_842_4609_2956_2353 22 3.90E-16 3.08E-14 3.42E-15 5957 hsa-mir-1538 hsa04660 T cell receptor signaling pathway 3551_8517_4772_4773_9020_1432_2885_4794_207_1147_5595_5594_2932_5970_3725_4790_4792_4793_1326_5604_5601_5600_2353 23 5.55E-15 4.38E-13 4.38E-14 5958 hsa-mir-1538 hsa03010 Ribosome 6204_6205_6207_6202_6156_6141_6217_6130_6137_6135_6210_6191_6193_6222_6223_6229_6129_6128_6181_6189_6188_6232 22 1.25E-14 9.84E-13 8.95E-14 5959 hsa-mir-1538 hsa04350 TGF-beta signaling pathway 4086_4087_6667_3397_3399_3398_1875_5934_5595_5594_1387_4088_4089_2033_5519_5518_6500_8454_4609_4092 20 7.11E-14 5.62E-12 4.68E-13 5960 hsa-mir-1538 hsa05216 Thyroid cancer 1499_595_6934_5468_5595_5594_6258_6256_10342_7157_7849_51176_5604_4609 14 1.06E-13 8.35E-12 6.42E-13 5961 hsa-mir-1538 hsa04662 B cell receptor signaling pathway 3551_8517_4772_4773_2885_4794_207_1147_5595_5594_2932_5970_3725_4790_4792_4793_5604_2353 18 6.75E-13 5.34E-11 3.81E-12 5962 hsa-mir-1538 hsa05222 Small cell lung cancer 3551_595_1017_8517_5925_7187_9063_10401_207_1147_6258_6256_5970_7157_4790_4792_842_4609 18 4.98E-12 3.94E-10 2.62E-11 5963 hsa-mir-1538 hsa05213 Endometrial cancer 1499_595_6934_2309_2885_207_5595_5594_2932_7157_51176_5604_842_4609_2002 15 6.08E-12 4.80E-10 3.00E-11 5964 hsa-mir-1538 hsa04110 Cell cycle 595_1017_4193_5111_4087_3065_5925_25_5934_5591_1387_2932_7157_4088_4089_2033_894_896_6500_8454 20 1.14E-11 8.98E-10 5.28E-11 5965 hsa-mir-1538 hsa04920 Adipocytokine signaling pathway 3551_10891_5465_8517_4794_207_1147_5599_6258_6256_6774_5970_4790_4792_4793_5601 16 1.38E-11 1.09E-09 6.05E-11 5966 hsa-mir-1538 hsa04012 ErbB signaling pathway 815_25_6714_2885_207_5595_5594_5599_2932_6776_6777_3725_5604_5601_4609_2002 16 4.08E-10 3.22E-08 1.70E-09 5967 hsa-mir-1538 hsa04912 GnRH signaling pathway 815_5580_6714_1432_2885_5595_5594_5599_3725_808_801_805_5604_5606_5601_5600_2002 17 9.77E-10 7.72E-08 3.86E-09 5968 hsa-mir-1538 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3551_8517_9020_6714_1432_836_1147_5599_5970_3725_4790_4792_5601_5600 14 2.30E-09 1.82E-07 8.66E-09 5969 hsa-mir-1538 hsa04330 Notch signaling pathway 1840_3065_22938_1487_1488_9612_1387_2033_8850_2648_4851_9794 12 2.61E-09 2.06E-07 9.38E-09 5970 hsa-mir-1538 hsa03050 Proteasome 5708_5705_5700_5693_5719_5684_5717_5713_5687_5709_5706_5707 12 3.20E-09 2.53E-07 1.10E-08 5971 hsa-mir-1538 hsa04210 Apoptosis 3551_8517_9020_207_836_1147_839_5970_7157_9131_4790_4792_842_841_840 15 4.14E-09 3.27E-07 1.36E-08 5972 hsa-mir-1538 hsa05214 Glioma 815_595_4193_5925_2885_207_5595_5594_7157_808_801_805_5604 13 7.41E-09 5.85E-07 2.34E-08 5973 hsa-mir-1538 hsa04520 Adherens junction 1499_6934_4087_6714_71_5595_5594_1387_1457_4088_4089_2033_51176_8826 14 8.90E-09 7.03E-07 2.70E-08 5974 hsa-mir-1538 hsa05223 Non-small cell lung cancer 595_5925_2309_2885_207_5595_5594_6258_6256_7157_5604_842 12 1.01E-08 7.95E-07 2.95E-08 5975 hsa-mir-1538 hsa04916 Melanogenesis 815_1499_6934_5595_5594_1385_1387_4286_2932_2033_808_801_805_51176_5604 15 2.70E-08 2.13E-06 7.61E-08 5976 hsa-mir-1538 hsa04910 Insulin signaling pathway 3551_10891_2885_5211_207_5595_5594_5599_2932_2194_808_801_805_5604_5601_2002 16 1.46E-07 1.16E-05 3.99E-07 5977 hsa-mir-1538 hsa05211 Renal cell carcinoma 3091_405_2885_2113_207_5595_5594_1387_3725_2034_2033_5604 12 1.65E-07 1.30E-05 4.33E-07 5978 hsa-mir-1538 hsa04720 Long-term potentiation 815_6197_5595_5594_1387_6195_6196_2033_808_801_805_5604 12 2.44E-07 1.93E-05 6.13E-07 5979 hsa-mir-1538 hsa05322 Systemic lupus erythematosus 3020_8368_3018_8294_8370_121504_8361_8360_8363_8362_8365_8364_8367_8366_8359_3021 16 2.48E-07 1.96E-05 6.13E-07 5980 hsa-mir-1538 hsa04062 Chemokine signaling pathway 3551_8517_5580_2309_2885_207_1147_5595_5594_2932_6774_6777_6772_5970_4790_4792_4793_5604 18 4.90E-07 3.87E-05 1.17E-06 5981 hsa-mir-1538 hsa04115 p53 signaling pathway 595_1017_4194_4193_836_7157_894_896_842_841_7161 11 7.99E-07 6.31E-05 1.86E-06 5982 hsa-mir-1538 hsa05219 Bladder cancer 595_9252_4193_5925_5595_5594_7157_5604_4609 9 9.34E-07 7.38E-05 2.11E-06 5983 hsa-mir-1538 hsa05131 Shigellosis 7846_1499_10382_25_203068_71_347733_7278_84617_4691 10 1.01E-06 8.01E-05 2.16E-06 5984 hsa-mir-1538 hsa05130 Pathogenic Escherichia coli infection 7846_1499_10382_25_203068_71_347733_7278_84617_4691 10 1.01E-06 8.01E-05 2.16E-06 5985 hsa-mir-1538 hsa05016 Huntington's disease 10891_3065_3064_5468_25942_6667_836_1385_1387_5437_7157_2033_6908_842_841_5441_1213 17 1.50E-06 0.00011854 3.12E-06 5986 hsa-mir-1538 hsa04540 Gap junction 7846_10382_203068_6714_2885_5592_5595_5594_347733_5604_7278_84617 12 1.92E-06 0.000151296 3.88E-06 5987 hsa-mir-1538 hsa04370 VEGF signaling pathway 4772_4773_6714_1432_207_5595_5594_9261_5604_5600_842 11 2.10E-06 0.000166007 4.15E-06 5988 hsa-mir-1538 hsa04664 Fc epsilon RI signaling pathway 5580_1432_2885_207_5595_5594_5599_5604_5606_5601_5600 11 2.63E-06 0.000207879 5.07E-06 5989 hsa-mir-1538 hsa04630 Jak-STAT signaling pathway 595_9063_2885_10401_207_1387_6778_6774_6776_6777_6772_2033_894_896_4609 15 2.86E-06 0.000226183 5.39E-06 5990 hsa-mir-1538 hsa04510 Focal adhesion 1499_595_6714_2885_207_71_5595_5594_5599_2932_3725_894_896_5604_5601_85366_2002 17 4.71E-06 0.00037204 8.65E-06 5991 hsa-mir-1538 hsa04612 Antigen processing and presentation 3309_3303_3305_3320_1385_3310_3312_3326_4800_4801_4802 11 7.43E-06 0.00058716 1.33E-05 5992 hsa-mir-1538 hsa03410 Base excision repair 4350_5111_142_252969_328_2237_6996 7 2.68E-05 0.002117855 4.71E-05 5993 hsa-mir-1538 hsa03450 Non-homologous end-joining 10111_7520_2237_5591_4361 5 3.44E-05 0.002719003 5.91E-05 5994 hsa-mir-1538 hsa05218 Melanoma 595_4193_5925_207_5595_5594_4286_7157_5604 9 4.18E-05 0.003301308 7.02E-05 5995 hsa-mir-1538 hsa03020 RNA polymerase 64425_25885_51082_5437_84172_5441 6 7.53E-05 0.005952592 0.000124012 5996 hsa-mir-1538 hsa04120 Ubiquitin mediated proteolysis 4193_55294_23291_9063_10401_7329_8925_5371_672_6500_8454_8945 12 7.76E-05 0.006134259 0.000125189 5997 hsa-mir-1538 hsa04930 Type II diabetes mellitus 3551_5580_3651_5595_5594_5599_5601 7 9.47E-05 0.007484453 0.000149689 5998 hsa-mir-1538 hsa04150 mTOR signaling pathway 6197_3091_207_5595_5594_6195_6196 7 0.000213203 0.016843024 0.000330255 5999 hsa-mir-1538 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_1616_836_7157_5606_5600_842 7 0.000321976 0.025436141 0.000489157 6000 hsa-mir-1538 hsa04270 Vascular smooth muscle contraction 5580_5592_5595_5594_808_801_805_59_5604_85366 10 0.000346399 0.02736551 0.00051633 6001 hsa-mir-1538 hsa05010 Alzheimer's disease 6622_836_22926_5595_5594_2932_808_801_805_842_841_840 12 0.000620246 0.04899941 0.000907396 6002 hsa-mir-1538 hsa05217 Basal cell carcinoma 1499_6934_2932_7157_51176_2736 6 0.001636105 0.129252286 0.002350042 6003 hsa-mir-1538 hsa03022 Basal transcription factors 2963_2962_2969_6908_2959 5 0.001700189 0.134314899 0.00239848 6004 hsa-mir-1538 hsa04950 Maturity onset diabetes of the young 6927_4760_3651_5080 4 0.00252118 0.199173199 0.003494267 6005 hsa-mir-1538 hsa04530 Tight junction 1499_5580_6714_4627_207_71_1457_5519_5518 9 0.003503142 0.276748249 0.004771522 6006 hsa-mir-1538 hsa04730 Long-term depression 5592_5595_5594_5519_5518_5604 6 0.005294816 0.418290429 0.007089668 6007 hsa-mir-1538 hsa03320 PPAR signaling pathway 5465_5467_5468_6258_6256 5 0.019810281 1 0.026083537 6008 hsa-mir-1538 hsa03440 Homologous recombination 10111_4683_4361 3 0.025909961 1 0.033555524 6009 hsa-mir-1538 hsa04650 Natural killer cell mediated cytotoxicity 4772_4773_2885_836_5595_5594_5604 7 0.031859092 1 0.040594649 6010 hsa-mir-1538 hsa04340 Hedgehog signaling pathway 23291_2932_8945_2736 4 0.037735241 1 0.047318794 6011 hsa-mir-154 hsa05200 Pathways in cancer 7046_5468_595_2261_8517_3551_4089_3066_3065_5925_7187_5747_10342_1956_207_3716_1147_4233_5595_5594_5599_1387_2064_6256_367_10401_2932_6774_6776_6777_6772_5979_5879_3725_2033_898_4790_4791_4792_5970_3320_3326_5371_3480_5159_5156_3815_3265_8772_4609_1026_2353_1441_8554 54 2.14E-28 1.80E-26 1.80E-26 6012 hsa-mir-154 hsa04630 Jak-STAT signaling pathway 3559_595_58985_3454_3455_3560_3561_1439_2690_207_3717_3716_3718_8651_85480_1387_3575_3570_3572_10401_6778_6774_6776_6777_6772_6773_7297_2033_149233_3953_3459_5781_4609_1441_8554_10379 36 8.14E-24 6.84E-22 3.42E-22 6013 hsa-mir-154 hsa04010 MAPK signaling pathway 3925_6722_7046_2261_2264_8517_3551_1845_9020_1956_7132_3303_1432_22800_207_1147_5595_5594_5599_9252_3310_3312_5971_5879_3725_4790_4791_51701_5970_5159_1326_5156_5608_5566_3265_6885_4609_2353_3305 39 4.73E-19 3.97E-17 1.32E-17 6014 hsa-mir-154 hsa05215 Prostate cancer 595_8517_3551_5925_1956_207_1147_5595_5594_1387_2064_367_2932_2033_898_4790_4792_5970_3320_3326_3480_5159_5156_3265_1026 25 1.04E-18 8.75E-17 2.19E-17 6015 hsa-mir-154 hsa05212 Pancreatic cancer 595_8517_3551_5925_1956_207_1147_5595_5594_1387_2064_367_2932_2033_898_4790_4792_5970_3320_3326_3480_5159_5156_3265_1026 25 1.31E-18 1.10E-16 2.20E-17 6016 hsa-mir-154 hsa04620 Toll-like receptor signaling pathway 8517_3551_3454_3455_7187_3661_1432_207_1147_3654_29110_5595_5594_5599_6772_5879_3725_4790_4792_5970_1326_5608_9641_8772_6885_2353 26 2.05E-18 1.73E-16 2.88E-17 6017 hsa-mir-154 hsa03010 Ribosome 6155_6156_6128_6193_6204_6205_6207_6202_6141_6217_6137_6135_6210_6191_9349_6222_6223_6229_6129_6181_6130_6189_6188_6232 24 2.00E-16 1.68E-14 2.40E-15 6018 hsa-mir-154 hsa05220 Chronic myeloid leukemia 7046_595_8517_3551_4089_3066_3065_5925_207_1147_5595_5594_6776_6777_4790_4792_5970_3265_5781_4609_1026 21 7.96E-16 6.69E-14 8.36E-15 6019 hsa-mir-154 hsa04920 Adipocytokine signaling pathway 5465_8517_3551_7133_7132_8471_207_3717_1147_8717_5599_6256_6774_4794_4790_4792_4793_5970_3953_5781 20 1.39E-15 1.17E-13 1.30E-14 6020 hsa-mir-154 hsa04062 Chemokine signaling pathway 8517_1230_3551_653361_5747_5580_7852_207_3055_3717_1147_3718_5590_5595_5594_1234_2932_6774_6777_6772_6773_5879_4790_4792_4793_5970_5566_3265_2185 29 5.26E-15 4.42E-13 4.42E-14 6021 hsa-mir-154 hsa04060 Cytokine-cytokine receptor interaction 3556_3559_7046_1230_58985_3454_3455_90_3791_1956_3560_3561_7133_7132_1439_7852_2690_85480_4233_1234_3575_3570_3572_2321_149233_5159_5156_3815_3953_3459_1441 31 2.07E-13 1.74E-11 1.58E-12 6022 hsa-mir-154 hsa04520 Adherens junction 7046_4089_2534_1956_6714_71_2241_4233_5595_5594_1387_2064_5879_1457_2033_51701_3480_8826_6885 19 2.38E-13 2.00E-11 1.67E-12 6023 hsa-mir-154 hsa04660 T cell receptor signaling pathway 8517_3551_9020_2534_3932_1432_207_1147_5595_5594_2932_3725_4794_4790_4792_4793_5970_1326_3265_6885_2353 21 5.35E-13 4.49E-11 3.46E-12 6024 hsa-mir-154 hsa04662 B cell receptor signaling pathway 8517_3551_6850_207_1147_695_5595_5594_2932_5879_3725_4794_4790_4792_4793_5970_3265_2353 18 8.73E-13 7.33E-11 5.24E-12 6025 hsa-mir-154 hsa04310 Wnt signaling pathway 818_817_595_8607_6500_4089_23291_8945_5599_1387_2932_5879_3725_1457_2033_51701_5519_5518_5515_5566_8454_6885_4609 23 3.08E-12 2.59E-10 1.72E-11 6026 hsa-mir-154 hsa05221 Acute myeloid leukemia 595_8517_3551_207_1147_5595_5594_6774_6776_6777_4790_5970_5371_3815_3265_4609 16 3.34E-12 2.81E-10 1.75E-11 6027 hsa-mir-154 hsa05214 Glioma 818_817_595_5925_1956_207_5595_5594_808_801_805_3480_5159_5156_3265_1026 16 1.17E-11 9.81E-10 5.77E-11 6028 hsa-mir-154 hsa05210 Colorectal cancer 7046_595_4089_1956_207_4233_5595_5594_5599_2932_5879_3725_3480_5159_5156_4609_2353 17 3.93E-11 3.30E-09 1.83E-10 6029 hsa-mir-154 hsa04012 ErbB signaling pathway 818_817_5747_1956_6714_207_5595_5594_5599_2064_2932_6776_6777_3725_3265_4609_1026 17 6.37E-11 5.35E-09 2.82E-10 6030 hsa-mir-154 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 8517_3551_9020_1956_6714_1432_1147_4233_5599_5879_3725_4790_4792_5970_5781 15 3.29E-10 2.76E-08 1.38E-09 6031 hsa-mir-154 hsa05222 Small cell lung cancer 595_8517_3551_5925_7187_5747_207_1147_6256_10401_898_4790_4792_5970_4609_8554 16 4.38E-10 3.68E-08 1.75E-09 6032 hsa-mir-154 hsa04350 TGF-beta signaling pathway 7046_6500_4089_90_57154_6667_5595_5594_1387_4086_2033_5519_5518_5515_8454_4609 16 5.09E-10 4.28E-08 1.94E-09 6033 hsa-mir-154 hsa04210 Apoptosis 3556_8517_3551_9020_7132_1439_207_1147_3654_8717_9131_4790_4792_5970_5566_8772 16 6.83E-10 5.73E-08 2.49E-09 6034 hsa-mir-154 hsa04912 GnRH signaling pathway 818_817_5580_1956_6714_1432_5595_5594_5599_3725_808_801_805_5608_5566_3265_2185 17 1.23E-09 1.03E-07 4.31E-09 6035 hsa-mir-154 hsa04510 Focal adhesion 595_2534_5747_3791_1956_6714_207_71_4233_5595_5594_5599_2064_2932_5879_3725_2321_3480_5159_5156_3265_85366 22 3.71E-09 3.12E-07 1.23E-08 6036 hsa-mir-154 hsa03050 Proteasome 5709_5705_5706_5700_5693_5719_5717_5713_5684_5707_5687_5708 12 3.80E-09 3.19E-07 1.23E-08 6037 hsa-mir-154 hsa04110 Cell cycle 595_6500_4089_4174_4172_3066_3065_5925_5591_1387_2932_5111_2033_898_8454_1026_1111 17 4.59E-09 3.85E-07 1.43E-08 6038 hsa-mir-154 hsa04720 Long-term potentiation 818_814_817_2902_5595_5594_1387_2033_808_801_805_5566_3265_2906 14 5.20E-09 4.37E-07 1.56E-08 6039 hsa-mir-154 hsa05219 Bladder cancer 595_2261_5925_1956_5595_5594_2064_9252_3265_4609_1026 11 1.13E-08 9.47E-07 3.27E-08 6040 hsa-mir-154 hsa04540 Gap junction 10382_1956_6714_5595_5594_7846_203068_347733_5159_5156_5566_3265_7278_84617 14 5.86E-08 4.92E-06 1.64E-07 6041 hsa-mir-154 hsa05216 Thyroid cancer 5468_595_10342_5595_5594_6256_5979_3265_4609 9 7.25E-08 6.09E-06 1.96E-07 6042 hsa-mir-154 hsa05218 Melanoma 595_5925_1956_207_4233_5595_5594_3480_5159_5156_3265_1026 12 1.69E-07 1.42E-05 4.45E-07 6043 hsa-mir-154 hsa04910 Insulin signaling pathway 3551_8471_5211_207_8651_5590_5595_5594_5599_2932_2194_808_801_805_5566_3265 16 1.80E-07 1.51E-05 4.58E-07 6044 hsa-mir-154 hsa04020 Calcium signaling pathway 818_814_817_292_293_147_1956_2902_2064_808_801_805_5159_5156_5566_2906_2185_85366 18 3.21E-07 2.70E-05 7.93E-07 6045 hsa-mir-154 hsa04664 Fc epsilon RI signaling pathway 2534_5580_6850_1432_207_695_5595_5594_5599_5879_5608_3265 12 4.73E-07 3.98E-05 1.14E-06 6046 hsa-mir-154 hsa04916 Melanogenesis 818_817_5595_5594_1387_2932_2033_808_801_805_5566_3815_3265 13 1.18E-06 9.90E-05 2.75E-06 6047 hsa-mir-154 hsa04330 Notch signaling pathway 9612_3066_3065_3280_1387_2033_8850_388585_4851 9 2.40E-06 0.000201946 5.46E-06 6048 hsa-mir-154 hsa04530 Tight junction 5580_6714_4627_4628_22800_8573_207_71_5590_1457_5519_5518_5515_3265 14 4.07E-06 0.000342177 9.00E-06 6049 hsa-mir-154 hsa05213 Endometrial cancer 595_1956_207_5595_5594_2064_2932_3265_4609 9 5.01E-06 0.000421011 1.08E-05 6050 hsa-mir-154 hsa05223 Non-small cell lung cancer 595_5925_1956_207_5595_5594_2064_6256_3265 9 6.59E-06 0.000553514 1.38E-05 6051 hsa-mir-154 hsa05131 Shigellosis 10382_2534_71_7846_203068_347733_7278_84617_4691 9 8.57E-06 0.000720195 1.70E-05 6052 hsa-mir-154 hsa05130 Pathogenic Escherichia coli infection 10382_2534_71_7846_203068_347733_7278_84617_4691 9 8.57E-06 0.000720195 1.70E-05 6053 hsa-mir-154 hsa05211 Renal cell carcinoma 207_4233_5595_5594_1387_5879_3725_2033_3265_5781 10 8.72E-06 0.00073266 1.70E-05 6054 hsa-mir-154 hsa04810 Regulation of actin cytoskeleton 2261_2264_5747_1956_4627_4628_22800_71_5595_5594_5879_5159_5156_3265_10788_8826_85366 17 1.21E-05 0.001020421 2.32E-05 6055 hsa-mir-154 hsa04930 Type II diabetes mellitus 3551_5580_8471_8651_5590_5595_5594_5599 8 1.42E-05 0.001191594 2.65E-05 6056 hsa-mir-154 hsa04120 Ubiquitin mediated proteolysis 55294_6500_57154_23291_8945_7329_8651_51366_10401_5371_672_8454_8554 13 2.13E-05 0.001792643 3.90E-05 6057 hsa-mir-154 hsa05016 Huntington's disease 5468_292_293_3066_3065_498_2902_6667_5441_1387_5437_2033_6908_1213_9519 15 2.90E-05 0.002439545 5.19E-05 6058 hsa-mir-154 hsa03022 Basal transcription factors 2969_6878_6872_6908_6882_2959_9519 7 3.45E-05 0.002898825 6.04E-05 6059 hsa-mir-154 hsa03020 RNA polymerase 64425_25885_51082_5441_5437_84172 6 8.20E-05 0.006885071 0.000138582 6060 hsa-mir-154 hsa04370 VEGF signaling pathway 5747_3791_6714_1432_207_5595_5594_5879_3265 9 8.34E-05 0.007005792 0.000138582 6061 hsa-mir-154 hsa04650 Natural killer cell mediated cytotoxicity 3454_3455_2534_3932_6850_5595_5594_5879_3265_3459_5781_2185 12 8.41E-05 0.007067678 0.000138582 6062 hsa-mir-154 hsa05340 Primary immunodeficiency 8517_3932_3561_3718_695_3575 6 0.000204025 0.01713812 0.000329579 6063 hsa-mir-154 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_7133_7132_1432_5879_5608_2906 7 0.000352978 0.029650165 0.000559437 6064 hsa-mir-154 hsa05010 Alzheimer's disease 498_2902_7132_5595_5594_2932_808_351_801_805_2906_8772 12 0.000708616 0.059523758 0.001102292 6065 hsa-mir-154 hsa04360 Axon guidance 2534_5747_7852_2242_4233_5595_5594_2932_5879_3265 10 0.000834214 0.070073944 0.001274072 6066 hsa-mir-154 hsa04612 Antigen processing and presentation 3309_3303_3310_3312_3320_3326_2923_3305 8 0.001031092 0.086611735 0.001546638 6067 hsa-mir-154 hsa04730 Long-term depression 5595_5594_3480_5519_5518_5515_3265 7 0.001285898 0.108015411 0.001895007 6068 hsa-mir-154 hsa04270 Vascular smooth muscle contraction 147_5580_5595_5594_808_801_805_5566_85366 9 0.001505277 0.126443302 0.002180057 6069 hsa-mir-154 hsa03030 DNA replication 5981_4174_4172_5111_6118 5 0.001629255 0.136857415 0.002319617 6070 hsa-mir-154 hsa04670 Leukocyte transendothelial migration 653361_5747_1432_7852_71_5879_5781_2185 8 0.00636397 0.534573475 0.008909558 6071 hsa-mir-154 hsa03430 Mismatch repair 5981_5111_6118 3 0.016836633 1 0.023184871 6072 hsa-mir-154 hsa04340 Hedgehog signaling pathway 23291_8945_2932_5566 4 0.039557697 1 0.0535943 6073 hsa-mir-154 hsa03450 Non-homologous end-joining 5591_7520 2 0.043677528 1 0.058236704 6074 hsa-mir-154 hsa04640 Hematopoietic cell lineage 3559_3575_3570_3815_1441 5 0.044983891 1 0.059041356 6075 hsa-mir-154 hsa03410 Base excision repair 142_3146_5111 3 0.048486075 1 0.062658928 6076 hsa-mir-15a hsa05200 Pathways in cancer 4149_1499_595_2261_8517_4193_3551_3091_3066_3065_1050_5925_7184_1956_4436_1487_1488_1870_1871_10401_207_208_836_3716_1147_4233_5595_5594_5599_1387_2064_6256_9915_367_2932_6776_6777_6772_5979_5879_7157_6688_1869_3725_4286_2736_4087_4088_4089_2034_2033_898_4790_4791_4792_5970_1017_3320_3326_5371_3480_5159_5156_3265_4609_1026_2353_1441_8554 69 1.20E-46 9.71E-45 9.71E-45 6077 hsa-mir-15a hsa05215 Prostate cancer 1499_595_8517_4193_3551_5925_7184_1956_1870_1871_207_208_1147_5595_5594_1387_2064_367_2932_7157_1869_2033_898_4790_4792_5970_1017_3320_3326_3480_5159_5156_3265_1026 34 6.83E-31 5.53E-29 2.51E-29 6078 hsa-mir-15a hsa05212 Pancreatic cancer 1499_595_8517_4193_3551_5925_7184_1956_1870_1871_207_208_1147_5595_5594_1387_2064_367_2932_7157_1869_2033_898_4790_4792_5970_1017_3320_3326_3480_5159_5156_3265_1026 34 9.28E-31 7.52E-29 2.51E-29 6079 hsa-mir-15a hsa05220 Chronic myeloid leukemia 595_8517_4193_3551_3066_3065_5925_1487_1488_1870_1871_207_208_1147_5595_5594_6776_6777_7157_1869_4088_4089_4790_4792_5970_3265_5781_4609_1026 29 1.56E-26 1.26E-24 3.15E-25 6080 hsa-mir-15a hsa03022 Basal transcription factors 6880_54457_2958_138474_6883_6881_2957_6879_2967_2961_2960_2963_2969_2968_6878_6877_6874_6873_6872_6908_6884_6882_2959_9519 24 2.50E-26 2.03E-24 4.06E-25 6081 hsa-mir-15a hsa04010 MAPK signaling pathway 3925_6722_4149_2261_2264_8517_9252_3551_9020_8986_1956_1432_22800_207_208_836_1147_5595_5594_5599_5598_3312_5971_5879_7157_3725_3727_6195_6196_6197_5058_4790_4791_51701_5970_5159_9261_1326_5156_3265_6885_4609_2353 43 4.86E-25 3.94E-23 6.57E-24 6082 hsa-mir-15a hsa04110 Cell cycle 4171_595_4193_6500_3066_3065_5925_1870_1871_8379_5934_5933_7534_1387_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_898_1017_8454_4085_1026 29 8.27E-22 6.70E-20 9.57E-21 6083 hsa-mir-15a hsa04630 Jak-STAT signaling pathway 3559_595_3454_3455_3560_1439_10401_2690_207_208_3717_3716_3718_85480_1387_3575_3570_3572_6778_6776_6777_6772_7297_2033_149233_3953_5781_4609_1441_8554_10379 31 4.96E-21 4.02E-19 5.02E-20 6084 hsa-mir-15a hsa05210 Colorectal cancer 1499_595_1956_4436_207_208_836_4233_5595_5594_5599_2932_5879_7157_3725_4087_4088_4089_3480_5159_5156_4609_2353 23 1.60E-18 1.30E-16 1.44E-17 6085 hsa-mir-15a hsa05214 Glioma 595_4193_5925_1956_1870_1871_207_208_5595_5594_7157_1869_808_801_805_3480_5159_5156_3265_1026 20 4.17E-17 3.38E-15 3.38E-16 6086 hsa-mir-15a hsa05222 Small cell lung cancer 4149_595_8517_3551_5925_1870_1871_10401_207_208_1147_6256_7157_1869_898_4790_4792_5970_1017_4609_8554 21 3.59E-16 2.91E-14 2.64E-15 6087 hsa-mir-15a hsa04620 Toll-like receptor signaling pathway 8517_3551_3454_3455_1432_207_208_1147_3654_5595_5594_5599_6772_5879_3725_4790_4792_5970_1326_9641_6885_2353 22 6.69E-16 5.42E-14 4.52E-15 6088 hsa-mir-15a hsa04520 Adherens junction 1499_1457_1460_1956_6714_71_2241_4233_5595_5594_1387_2064_5879_4087_4088_4089_2033_51701_3480_6885 20 1.24E-15 1.00E-13 7.72E-15 6089 hsa-mir-15a hsa05218 Melanoma 595_4193_5925_1956_1870_1871_207_208_4233_5595_5594_7157_1869_4286_3480_5159_5156_3265_1026 19 2.22E-15 1.80E-13 1.29E-14 6090 hsa-mir-15a hsa04660 T cell receptor signaling pathway 8517_3551_9020_3932_1432_207_208_1147_5595_5594_2932_3725_5058_4794_4790_4792_4793_5970_1326_3265_6885_2353 22 2.63E-15 2.13E-13 1.42E-14 6091 hsa-mir-15a hsa05219 Bladder cancer 595_2261_9252_4193_5925_1956_1870_1871_5595_5594_2064_7157_1869_3265_4609_1026 16 3.80E-15 3.08E-13 1.92E-14 6092 hsa-mir-15a hsa05221 Acute myeloid leukemia 595_8517_3551_1050_207_208_1147_5595_5594_6776_6777_6688_4790_5970_5371_3265_4609 17 2.39E-14 1.94E-12 1.14E-13 6093 hsa-mir-15a hsa04062 Chemokine signaling pathway 8517_1230_3551_7852_207_208_3055_3717_1147_3718_5590_5595_5594_1234_2932_5580_6777_6772_5879_5058_4790_4792_4793_5970_3265_2185 26 3.48E-14 2.82E-12 1.57E-13 6094 hsa-mir-15a hsa04662 B cell receptor signaling pathway 8517_3551_6850_207_208_1147_5595_5594_2932_5879_3725_4794_4790_4792_4793_5970_3265_2353 18 6.08E-14 4.92E-12 2.59E-13 6095 hsa-mir-15a hsa04310 Wnt signaling pathway 1499_595_8607_1457_6500_1460_23291_1487_1488_5599_1387_2932_5879_7157_3725_4087_4088_4089_2033_51701_8454_6885_4609 23 1.20E-13 9.68E-12 4.84E-13 6096 hsa-mir-15a hsa05120 Epithelial cell signaling in Helicobacter pylori infection 8517_3551_9020_1956_6714_1432_836_1147_4233_5599_5879_3725_5058_4790_4792_5970_5781 17 3.14E-13 2.55E-11 1.21E-12 6097 hsa-mir-15a hsa04350 TGF-beta signaling pathway 6500_6667_1874_1875_5934_5933_5595_5594_1387_7027_4086_4087_4088_4089_2033_8454_4609_4093 18 5.48E-13 4.44E-11 2.02E-12 6098 hsa-mir-15a hsa04920 Adipocytokine signaling pathway 8517_3551_2538_207_208_3717_1147_5599_6256_4794_4790_4792_4793_5970_3953_5781 16 1.63E-12 1.32E-10 5.73E-12 6099 hsa-mir-15a hsa05223 Non-small cell lung cancer 595_5925_1956_1870_1871_207_208_5595_5594_2064_6256_7157_1869_3265 14 1.58E-11 1.28E-09 5.32E-11 6100 hsa-mir-15a hsa05211 Renal cell carcinoma 3091_207_208_4233_5595_5594_1387_9915_5879_3725_5058_2034_2033_3265_5781 15 4.37E-11 3.54E-09 1.42E-10 6101 hsa-mir-15a hsa04012 ErbB signaling pathway 1956_6714_207_208_5595_5594_5599_2064_2932_6776_6777_3725_5058_3265_4609_1026 16 5.07E-11 4.11E-09 1.58E-10 6102 hsa-mir-15a hsa04210 Apoptosis 3556_8517_3551_9020_1439_207_208_836_1147_3654_7157_4790_4792_5970_840 15 5.98E-10 4.85E-08 1.80E-09 6103 hsa-mir-15a hsa04510 Focal adhesion 1499_595_1956_6714_207_208_71_4233_5595_5594_5599_2064_2932_5879_3725_5058_2321_3480_5159_5156_3265 21 1.11E-09 9.01E-08 3.22E-09 6104 hsa-mir-15a hsa05213 Endometrial cancer 1499_595_1956_207_208_5595_5594_2064_2932_7157_3265_4609 12 1.42E-09 1.15E-07 3.95E-09 6105 hsa-mir-15a hsa04330 Notch signaling pathway 3066_3065_1487_1488_3280_1387_9612_2033_8850_388585_4851 11 6.07E-09 4.91E-07 1.62E-08 6106 hsa-mir-15a hsa04720 Long-term potentiation 2902_5595_5594_1387_6195_6196_6197_2033_808_801_805_3265_2906 13 6.22E-09 5.04E-07 1.62E-08 6107 hsa-mir-15a hsa04060 Cytokine-cytokine receptor interaction 3556_3559_1230_3454_3455_1956_7852_3560_1439_2690_85480_4233_1234_3575_3570_3572_2321_149233_5159_5156_3953_1441 22 1.22E-08 9.85E-07 3.08E-08 6108 hsa-mir-15a hsa05216 Thyroid cancer 1499_595_5595_5594_6256_5979_7157_3265_4609 9 1.88E-08 1.52E-06 4.61E-08 6109 hsa-mir-15a hsa04912 GnRH signaling pathway 1956_6714_1432_5595_5594_5599_5598_5580_3725_808_801_805_3265_2185 14 4.50E-08 3.65E-06 1.07E-07 6110 hsa-mir-15a hsa04910 Insulin signaling pathway 3551_2538_5211_207_208_5590_5595_5594_5599_2932_808_801_805_3265 14 7.00E-07 5.67E-05 1.62E-06 6111 hsa-mir-15a hsa05016 Huntington's disease 3066_3065_3064_2902_6667_836_5441_1387_9001_5430_5437_7157_2033_6874_6908_9519 16 1.00E-06 8.14E-05 2.26E-06 6112 hsa-mir-15a hsa03020 RNA polymerase 64425_25885_51082_5441_5430_5437_84172 7 3.10E-06 0.000250745 6.78E-06 6113 hsa-mir-15a hsa04664 Fc epsilon RI signaling pathway 6850_1432_207_208_5595_5594_5599_5580_5879_3265 10 4.62E-06 0.000374035 9.84E-06 6114 hsa-mir-15a hsa04916 Melanogenesis 1499_5595_5594_1387_2932_4286_2033_808_801_805_3265 11 7.55E-06 0.000611263 1.57E-05 6115 hsa-mir-15a hsa04150 mTOR signaling pathway 3091_207_208_5595_5594_6195_6196_6197 8 1.16E-05 0.000942928 2.36E-05 6116 hsa-mir-15a hsa04540 Gap junction 10382_1956_6714_5592_5595_5594_5598_5159_5156_3265 10 1.71E-05 0.001386912 3.31E-05 6117 hsa-mir-15a hsa04530 Tight junction 1499_1457_1460_6714_22800_8573_207_208_71_5590_5580_3265 12 1.72E-05 0.001391949 3.31E-05 6118 hsa-mir-15a hsa04650 Natural killer cell mediated cytotoxicity 3454_3455_3932_6850_836_5595_5594_5879_5058_3265_5781_2185 12 1.84E-05 0.001488712 3.46E-05 6119 hsa-mir-15a hsa04370 VEGF signaling pathway 6714_1432_207_208_5595_5594_5879_9261_3265 9 2.47E-05 0.001998491 4.54E-05 6120 hsa-mir-15a hsa04930 Type II diabetes mellitus 3551_3651_5590_5595_5594_5599_5580 7 3.87E-05 0.00313521 6.97E-05 6121 hsa-mir-15a hsa04950 Maturity onset diabetes of the young 6927_3280_3651_5080_3172 5 0.000152977 0.012391103 0.000269372 6122 hsa-mir-15a hsa05010 Alzheimer's disease 2902_836_5595_5594_2932_808_351_801_805_840_2906_1020 12 0.00017248 0.013970854 0.000297252 6123 hsa-mir-15a hsa04360 Axon guidance 7852_2242_4233_5595_5594_2932_5879_5058_3265_1020 10 0.00024449 0.01980365 0.000412576 6124 hsa-mir-15a hsa04810 Regulation of actin cytoskeleton 2261_2264_1956_22800_71_5595_5594_5879_5058_5159_5156_3265_10788 13 0.000320354 0.025948701 0.000529565 6125 hsa-mir-15a hsa04120 Ubiquitin mediated proteolysis 55294_4193_6500_23291_10401_7329_5371_672_8454_8554 10 0.000380639 0.030831791 0.000616636 6126 hsa-mir-15a hsa04115 p53 signaling pathway 595_4193_836_7157_898_1017_1026 7 0.000436716 0.035374001 0.000693608 6127 hsa-mir-15a hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_1432_836_5879_7157_2906 6 0.000859454 0.069615793 0.001338765 6128 hsa-mir-15a hsa04612 Antigen processing and presentation 3308_3312_3320_3326_4802_2923_4801 7 0.001751982 0.141910549 0.002677558 6129 hsa-mir-15a hsa03050 Proteasome 5705_5701_5702_5719_5710 5 0.002596161 0.210289076 0.003894242 6130 hsa-mir-15a hsa04020 Calcium signaling pathway 1956_2902_2064_808_801_805_5159_5156_2906_2185 10 0.002813104 0.227861426 0.004142935 6131 hsa-mir-15a hsa05340 Primary immunodeficiency 8517_3932_3718_3575 4 0.005157931 0.417792427 0.007460579 6132 hsa-mir-15a hsa04270 Vascular smooth muscle contraction 5592_5595_5594_5580_808_801_805 7 0.007537347 0.610525123 0.010710967 6133 hsa-mir-15a hsa04670 Leukocyte transendothelial migration 1499_7852_1432_71_5879_5781_2185 7 0.008892269 0.720273797 0.012418514 6134 hsa-mir-15a hsa03420 Nucleotide excision repair 5887_2967_2968_6118 4 0.010754591 0.871121876 0.014764778 6135 hsa-mir-15a hsa04730 Long-term depression 5592_5595_5594_3480_3265 5 0.011957968 0.968595402 0.016143257 6136 hsa-mir-15a hsa05217 Basal cell carcinoma 1499_2932_7157_2736 4 0.021580514 1 0.028656093 6137 hsa-mir-15a hsa05131 Shigellosis 1499_10382_71_7534 4 0.022803379 1 0.029318631 6138 hsa-mir-15a hsa05130 Pathogenic Escherichia coli infection 1499_10382_71_7534 4 0.022803379 1 0.029318631 6139 hsa-mir-15a hsa04340 Hedgehog signaling pathway 23291_53944_2932_2736 4 0.024067596 1 0.030460552 6140 hsa-mir-15a hsa03010 Ribosome 6156_6128_6207_9349_6229 5 0.044099579 1 0.054954859 6141 hsa-mir-15b hsa05200 Pathways in cancer 4088_4089_5925_1870_1871_3725_1050_5599_4149_7157_2249_1017_367_1869_6776_6777_2353_5914_5970_6256 20 8.14E-22 4.15E-20 4.15E-20 6142 hsa-mir-15b hsa05220 Chronic myeloid leukemia 4088_4089_5925_1870_1871_7157_1869_6776_6777_5970 10 1.54E-14 7.87E-13 3.93E-13 6143 hsa-mir-15b hsa04110 Cell cycle 4088_4089_5925_1870_1871_7157_1017_890_1869_5934_5933 11 2.89E-14 1.47E-12 4.90E-13 6144 hsa-mir-15b hsa05222 Small cell lung cancer 5925_1870_1871_4149_7157_1017_1869_5970_6256 9 2.54E-12 1.30E-10 2.88E-11 6145 hsa-mir-15b hsa05215 Prostate cancer 5925_1870_1871_7157_1017_468_367_1869_5970 9 3.08E-12 1.57E-10 2.88E-11 6146 hsa-mir-15b hsa05212 Pancreatic cancer 5925_1870_1871_7157_1017_468_367_1869_5970 9 3.38E-12 1.73E-10 2.88E-11 6147 hsa-mir-15b hsa04350 TGF-beta signaling pathway 4088_4089_1874_1875_6667_5934_5933_3398 8 1.16E-10 5.91E-09 8.45E-10 6148 hsa-mir-15b hsa04010 MAPK signaling pathway 3725_5599_4149_7157_2249_9479_468_3727_2353_5970 10 2.56E-09 1.31E-07 1.63E-08 6149 hsa-mir-15b hsa05223 Non-small cell lung cancer 5925_1870_1871_7157_1869_6256 6 9.56E-09 4.88E-07 5.42E-08 6150 hsa-mir-15b hsa05218 Melanoma 5925_1870_1871_7157_2249_1869 6 4.38E-08 2.23E-06 2.23E-07 6151 hsa-mir-15b hsa05210 Colorectal cancer 4088_4089_3725_5599_7157_2353 6 1.12E-07 5.71E-06 5.19E-07 6152 hsa-mir-15b hsa05219 Bladder cancer 5925_1870_1871_7157_1869 5 1.27E-07 6.49E-06 5.41E-07 6153 hsa-mir-15b hsa05221 Acute myeloid leukemia 1050_6776_6777_5914_5970 5 6.12E-07 3.12E-05 2.40E-06 6154 hsa-mir-15b hsa05214 Glioma 5925_1870_1871_7157_1869 5 9.60E-07 4.89E-05 3.50E-06 6155 hsa-mir-15b hsa04310 Wnt signaling pathway 4088_4089_3725_5599_7157_6423 6 3.08E-06 0.000157277 1.05E-05 6156 hsa-mir-15b hsa04012 ErbB signaling pathway 3725_5599_6776_6777 4 8.52E-05 0.00434388 0.000271492 6157 hsa-mir-15b hsa04620 Toll-like receptor signaling pathway 3725_5599_2353_5970 4 0.000153848 0.00784623 0.000461543 6158 hsa-mir-15b hsa04920 Adipocytokine signaling pathway 5599_5970_6256 3 0.00075152 0.038327521 0.002129307 6159 hsa-mir-15b hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5599_5970 3 0.000883542 0.045060636 0.002371612 6160 hsa-mir-15b hsa04662 B cell receptor signaling pathway 3725_2353_5970 3 0.001029428 0.052500806 0.00262504 6161 hsa-mir-15b hsa04210 Apoptosis 7157_5970_823 3 0.001656828 0.084498231 0.004023725 6162 hsa-mir-15b hsa05216 Thyroid cancer 7157_6256 2 0.002794329 0.142510797 0.006270449 6163 hsa-mir-15b hsa04912 GnRH signaling pathway 3725_5599_468 3 0.00282785 0.144220333 0.006270449 6164 hsa-mir-15b hsa04660 T cell receptor signaling pathway 3725_2353_5970 3 0.002974183 0.151683358 0.00632014 6165 hsa-mir-15b hsa04630 Jak-STAT signaling pathway 3977_6776_6777 3 0.00755587 0.385349355 0.015413974 6166 hsa-mir-15b hsa05016 Huntington's disease 7157_6667_6908 3 0.012623667 0.643807022 0.024761809 6167 hsa-mir-15b hsa04115 p53 signaling pathway 7157_1017 2 0.013992134 0.713598848 0.026429587 6168 hsa-mir-15b hsa04520 Adherens junction 4088_4089 2 0.018369197 0.936829049 0.03345818 6169 hsa-mir-15b hsa03450 Non-homologous end-joining 2547 1 0.037249315 1 0.065507416 6170 hsa-mir-16-1 hsa05200 Pathways in cancer 4149_1499_595_2261_8517_4193_3551_3091_3066_3065_1050_5925_7184_1956_4436_1487_1488_1870_1871_10401_207_208_836_3716_1147_4233_5595_5594_5599_1387_2064_6256_9915_367_2932_6776_6777_6772_5979_5879_7157_6688_1869_3725_4286_2736_4087_4088_4089_2034_2033_898_4790_4791_4792_5970_1017_3320_3326_5371_3480_5159_5156_3265_4609_1026_2353_1441_8554 69 1.20E-46 9.71E-45 9.71E-45 6171 hsa-mir-16-1 hsa05215 Prostate cancer 1499_595_8517_4193_3551_5925_7184_1956_1870_1871_207_208_1147_5595_5594_1387_2064_367_2932_7157_1869_2033_898_4790_4792_5970_1017_3320_3326_3480_5159_5156_3265_1026 34 6.83E-31 5.53E-29 2.51E-29 6172 hsa-mir-16-1 hsa05212 Pancreatic cancer 1499_595_8517_4193_3551_5925_7184_1956_1870_1871_207_208_1147_5595_5594_1387_2064_367_2932_7157_1869_2033_898_4790_4792_5970_1017_3320_3326_3480_5159_5156_3265_1026 34 9.28E-31 7.52E-29 2.51E-29 6173 hsa-mir-16-1 hsa05220 Chronic myeloid leukemia 595_8517_4193_3551_3066_3065_5925_1487_1488_1870_1871_207_208_1147_5595_5594_6776_6777_7157_1869_4088_4089_4790_4792_5970_3265_5781_4609_1026 29 1.56E-26 1.26E-24 3.15E-25 6174 hsa-mir-16-1 hsa03022 Basal transcription factors 6880_54457_2958_138474_6883_6881_2957_6879_2967_2961_2960_2963_2969_2968_6878_6877_6874_6873_6872_6908_6884_6882_2959_9519 24 2.50E-26 2.03E-24 4.06E-25 6175 hsa-mir-16-1 hsa04010 MAPK signaling pathway 3925_6722_4149_2261_2264_8517_9252_3551_9020_8986_1956_1432_22800_207_208_836_1147_5595_5594_5599_5598_3312_5971_5879_7157_3725_3727_6195_6196_6197_5058_4790_4791_51701_5970_5159_9261_1326_5156_3265_6885_4609_2353 43 4.86E-25 3.94E-23 6.57E-24 6176 hsa-mir-16-1 hsa04110 Cell cycle 4171_595_4193_6500_3066_3065_5925_1870_1871_8379_5934_5933_7534_1387_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_898_1017_8454_4085_1026 29 8.27E-22 6.70E-20 9.57E-21 6177 hsa-mir-16-1 hsa04630 Jak-STAT signaling pathway 3559_595_3454_3455_3560_1439_10401_2690_207_208_3717_3716_3718_85480_1387_3575_3570_3572_6778_6776_6777_6772_7297_2033_149233_3953_5781_4609_1441_8554_10379 31 4.96E-21 4.02E-19 5.02E-20 6178 hsa-mir-16-1 hsa05210 Colorectal cancer 1499_595_1956_4436_207_208_836_4233_5595_5594_5599_2932_5879_7157_3725_4087_4088_4089_3480_5159_5156_4609_2353 23 1.60E-18 1.30E-16 1.44E-17 6179 hsa-mir-16-1 hsa05214 Glioma 595_4193_5925_1956_1870_1871_207_208_5595_5594_7157_1869_808_801_805_3480_5159_5156_3265_1026 20 4.17E-17 3.38E-15 3.38E-16 6180 hsa-mir-16-1 hsa05222 Small cell lung cancer 4149_595_8517_3551_5925_1870_1871_10401_207_208_1147_6256_7157_1869_898_4790_4792_5970_1017_4609_8554 21 3.59E-16 2.91E-14 2.64E-15 6181 hsa-mir-16-1 hsa04620 Toll-like receptor signaling pathway 8517_3551_3454_3455_1432_207_208_1147_3654_5595_5594_5599_6772_5879_3725_4790_4792_5970_1326_9641_6885_2353 22 6.69E-16 5.42E-14 4.52E-15 6182 hsa-mir-16-1 hsa04520 Adherens junction 1499_1457_1460_1956_6714_71_2241_4233_5595_5594_1387_2064_5879_4087_4088_4089_2033_51701_3480_6885 20 1.24E-15 1.00E-13 7.72E-15 6183 hsa-mir-16-1 hsa05218 Melanoma 595_4193_5925_1956_1870_1871_207_208_4233_5595_5594_7157_1869_4286_3480_5159_5156_3265_1026 19 2.22E-15 1.80E-13 1.29E-14 6184 hsa-mir-16-1 hsa04660 T cell receptor signaling pathway 8517_3551_9020_3932_1432_207_208_1147_5595_5594_2932_3725_5058_4794_4790_4792_4793_5970_1326_3265_6885_2353 22 2.63E-15 2.13E-13 1.42E-14 6185 hsa-mir-16-1 hsa05219 Bladder cancer 595_2261_9252_4193_5925_1956_1870_1871_5595_5594_2064_7157_1869_3265_4609_1026 16 3.80E-15 3.08E-13 1.92E-14 6186 hsa-mir-16-1 hsa05221 Acute myeloid leukemia 595_8517_3551_1050_207_208_1147_5595_5594_6776_6777_6688_4790_5970_5371_3265_4609 17 2.39E-14 1.94E-12 1.14E-13 6187 hsa-mir-16-1 hsa04062 Chemokine signaling pathway 8517_1230_3551_7852_207_208_3055_3717_1147_3718_5590_5595_5594_1234_2932_5580_6777_6772_5879_5058_4790_4792_4793_5970_3265_2185 26 3.48E-14 2.82E-12 1.57E-13 6188 hsa-mir-16-1 hsa04662 B cell receptor signaling pathway 8517_3551_6850_207_208_1147_5595_5594_2932_5879_3725_4794_4790_4792_4793_5970_3265_2353 18 6.08E-14 4.92E-12 2.59E-13 6189 hsa-mir-16-1 hsa04310 Wnt signaling pathway 1499_595_8607_1457_6500_1460_23291_1487_1488_5599_1387_2932_5879_7157_3725_4087_4088_4089_2033_51701_8454_6885_4609 23 1.20E-13 9.68E-12 4.84E-13 6190 hsa-mir-16-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 8517_3551_9020_1956_6714_1432_836_1147_4233_5599_5879_3725_5058_4790_4792_5970_5781 17 3.14E-13 2.55E-11 1.21E-12 6191 hsa-mir-16-1 hsa04350 TGF-beta signaling pathway 6500_6667_1874_1875_5934_5933_5595_5594_1387_7027_4086_4087_4088_4089_2033_8454_4609_4093 18 5.48E-13 4.44E-11 2.02E-12 6192 hsa-mir-16-1 hsa04920 Adipocytokine signaling pathway 8517_3551_2538_207_208_3717_1147_5599_6256_4794_4790_4792_4793_5970_3953_5781 16 1.63E-12 1.32E-10 5.73E-12 6193 hsa-mir-16-1 hsa05223 Non-small cell lung cancer 595_5925_1956_1870_1871_207_208_5595_5594_2064_6256_7157_1869_3265 14 1.58E-11 1.28E-09 5.32E-11 6194 hsa-mir-16-1 hsa05211 Renal cell carcinoma 3091_207_208_4233_5595_5594_1387_9915_5879_3725_5058_2034_2033_3265_5781 15 4.37E-11 3.54E-09 1.42E-10 6195 hsa-mir-16-1 hsa04012 ErbB signaling pathway 1956_6714_207_208_5595_5594_5599_2064_2932_6776_6777_3725_5058_3265_4609_1026 16 5.07E-11 4.11E-09 1.58E-10 6196 hsa-mir-16-1 hsa04210 Apoptosis 3556_8517_3551_9020_1439_207_208_836_1147_3654_7157_4790_4792_5970_840 15 5.98E-10 4.85E-08 1.80E-09 6197 hsa-mir-16-1 hsa04510 Focal adhesion 1499_595_1956_6714_207_208_71_4233_5595_5594_5599_2064_2932_5879_3725_5058_2321_3480_5159_5156_3265 21 1.11E-09 9.01E-08 3.22E-09 6198 hsa-mir-16-1 hsa05213 Endometrial cancer 1499_595_1956_207_208_5595_5594_2064_2932_7157_3265_4609 12 1.42E-09 1.15E-07 3.95E-09 6199 hsa-mir-16-1 hsa04330 Notch signaling pathway 3066_3065_1487_1488_3280_1387_9612_2033_8850_388585_4851 11 6.07E-09 4.91E-07 1.62E-08 6200 hsa-mir-16-1 hsa04720 Long-term potentiation 2902_5595_5594_1387_6195_6196_6197_2033_808_801_805_3265_2906 13 6.22E-09 5.04E-07 1.62E-08 6201 hsa-mir-16-1 hsa04060 Cytokine-cytokine receptor interaction 3556_3559_1230_3454_3455_1956_7852_3560_1439_2690_85480_4233_1234_3575_3570_3572_2321_149233_5159_5156_3953_1441 22 1.22E-08 9.85E-07 3.08E-08 6202 hsa-mir-16-1 hsa05216 Thyroid cancer 1499_595_5595_5594_6256_5979_7157_3265_4609 9 1.88E-08 1.52E-06 4.61E-08 6203 hsa-mir-16-1 hsa04912 GnRH signaling pathway 1956_6714_1432_5595_5594_5599_5598_5580_3725_808_801_805_3265_2185 14 4.50E-08 3.65E-06 1.07E-07 6204 hsa-mir-16-1 hsa04910 Insulin signaling pathway 3551_2538_5211_207_208_5590_5595_5594_5599_2932_808_801_805_3265 14 7.00E-07 5.67E-05 1.62E-06 6205 hsa-mir-16-1 hsa05016 Huntington's disease 3066_3065_3064_2902_6667_836_5441_1387_9001_5430_5437_7157_2033_6874_6908_9519 16 1.00E-06 8.14E-05 2.26E-06 6206 hsa-mir-16-1 hsa03020 RNA polymerase 64425_25885_51082_5441_5430_5437_84172 7 3.10E-06 0.000250745 6.78E-06 6207 hsa-mir-16-1 hsa04664 Fc epsilon RI signaling pathway 6850_1432_207_208_5595_5594_5599_5580_5879_3265 10 4.62E-06 0.000374035 9.84E-06 6208 hsa-mir-16-1 hsa04916 Melanogenesis 1499_5595_5594_1387_2932_4286_2033_808_801_805_3265 11 7.55E-06 0.000611263 1.57E-05 6209 hsa-mir-16-1 hsa04150 mTOR signaling pathway 3091_207_208_5595_5594_6195_6196_6197 8 1.16E-05 0.000942928 2.36E-05 6210 hsa-mir-16-1 hsa04540 Gap junction 10382_1956_6714_5592_5595_5594_5598_5159_5156_3265 10 1.71E-05 0.001386912 3.31E-05 6211 hsa-mir-16-1 hsa04530 Tight junction 1499_1457_1460_6714_22800_8573_207_208_71_5590_5580_3265 12 1.72E-05 0.001391949 3.31E-05 6212 hsa-mir-16-1 hsa04650 Natural killer cell mediated cytotoxicity 3454_3455_3932_6850_836_5595_5594_5879_5058_3265_5781_2185 12 1.84E-05 0.001488712 3.46E-05 6213 hsa-mir-16-1 hsa04370 VEGF signaling pathway 6714_1432_207_208_5595_5594_5879_9261_3265 9 2.47E-05 0.001998491 4.54E-05 6214 hsa-mir-16-1 hsa04930 Type II diabetes mellitus 3551_3651_5590_5595_5594_5599_5580 7 3.87E-05 0.00313521 6.97E-05 6215 hsa-mir-16-1 hsa04950 Maturity onset diabetes of the young 6927_3280_3651_5080_3172 5 0.000152977 0.012391103 0.000269372 6216 hsa-mir-16-1 hsa05010 Alzheimer's disease 2902_836_5595_5594_2932_808_351_801_805_840_2906_1020 12 0.00017248 0.013970854 0.000297252 6217 hsa-mir-16-1 hsa04360 Axon guidance 7852_2242_4233_5595_5594_2932_5879_5058_3265_1020 10 0.00024449 0.01980365 0.000412576 6218 hsa-mir-16-1 hsa04810 Regulation of actin cytoskeleton 2261_2264_1956_22800_71_5595_5594_5879_5058_5159_5156_3265_10788 13 0.000320354 0.025948701 0.000529565 6219 hsa-mir-16-1 hsa04120 Ubiquitin mediated proteolysis 55294_4193_6500_23291_10401_7329_5371_672_8454_8554 10 0.000380639 0.030831791 0.000616636 6220 hsa-mir-16-1 hsa04115 p53 signaling pathway 595_4193_836_7157_898_1017_1026 7 0.000436716 0.035374001 0.000693608 6221 hsa-mir-16-1 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_1432_836_5879_7157_2906 6 0.000859454 0.069615793 0.001338765 6222 hsa-mir-16-1 hsa04612 Antigen processing and presentation 3308_3312_3320_3326_4802_2923_4801 7 0.001751982 0.141910549 0.002677558 6223 hsa-mir-16-1 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 0.002596161 0.210289076 0.003894242 6224 hsa-mir-16-1 hsa04020 Calcium signaling pathway 1956_2902_2064_808_801_805_5159_5156_2906_2185 10 0.002813104 0.227861426 0.004142935 6225 hsa-mir-16-1 hsa05340 Primary immunodeficiency 8517_3932_3718_3575 4 0.005157931 0.417792427 0.007460579 6226 hsa-mir-16-1 hsa04270 Vascular smooth muscle contraction 5592_5595_5594_5580_808_801_805 7 0.007537347 0.610525123 0.010710967 6227 hsa-mir-16-1 hsa04670 Leukocyte transendothelial migration 1499_7852_1432_71_5879_5781_2185 7 0.008892269 0.720273797 0.012418514 6228 hsa-mir-16-1 hsa03420 Nucleotide excision repair 5887_2967_2968_6118 4 0.010754591 0.871121876 0.014764778 6229 hsa-mir-16-1 hsa04730 Long-term depression 5592_5595_5594_3480_3265 5 0.011957968 0.968595402 0.016143257 6230 hsa-mir-16-1 hsa05217 Basal cell carcinoma 1499_2932_7157_2736 4 0.021580514 1 0.028656093 6231 hsa-mir-16-1 hsa05131 Shigellosis 1499_10382_71_7534 4 0.022803379 1 0.029318631 6232 hsa-mir-16-1 hsa05130 Pathogenic Escherichia coli infection 1499_10382_71_7534 4 0.022803379 1 0.029318631 6233 hsa-mir-16-1 hsa04340 Hedgehog signaling pathway 23291_53944_2932_2736 4 0.024067596 1 0.030460552 6234 hsa-mir-16-1 hsa03010 Ribosome 6156_6128_6207_9349_6229 5 0.044099579 1 0.054954859 6235 hsa-mir-16-2 hsa05200 Pathways in cancer 4088_4089_5925_1870_1871_3725_1050_5599_4149_7157_2249_1017_367_1869_6776_6777_2353_5914_5970_6256 20 8.14E-22 4.15E-20 4.15E-20 6236 hsa-mir-16-2 hsa05220 Chronic myeloid leukemia 4088_4089_5925_1870_1871_7157_1869_6776_6777_5970 10 1.54E-14 7.87E-13 3.93E-13 6237 hsa-mir-16-2 hsa04110 Cell cycle 4088_4089_5925_1870_1871_7157_1017_890_1869_5934_5933 11 2.89E-14 1.47E-12 4.90E-13 6238 hsa-mir-16-2 hsa05222 Small cell lung cancer 5925_1870_1871_4149_7157_1017_1869_5970_6256 9 2.54E-12 1.30E-10 2.88E-11 6239 hsa-mir-16-2 hsa05215 Prostate cancer 5925_1870_1871_7157_1017_468_367_1869_5970 9 3.08E-12 1.57E-10 2.88E-11 6240 hsa-mir-16-2 hsa05212 Pancreatic cancer 5925_1870_1871_7157_1017_468_367_1869_5970 9 3.38E-12 1.73E-10 2.88E-11 6241 hsa-mir-16-2 hsa04350 TGF-beta signaling pathway 4088_4089_1874_1875_6667_5934_5933_3398 8 1.16E-10 5.91E-09 8.45E-10 6242 hsa-mir-16-2 hsa04010 MAPK signaling pathway 3725_5599_4149_7157_2249_9479_468_3727_2353_5970 10 2.56E-09 1.31E-07 1.63E-08 6243 hsa-mir-16-2 hsa05223 Non-small cell lung cancer 5925_1870_1871_7157_1869_6256 6 9.56E-09 4.88E-07 5.42E-08 6244 hsa-mir-16-2 hsa05218 Melanoma 5925_1870_1871_7157_2249_1869 6 4.38E-08 2.23E-06 2.23E-07 6245 hsa-mir-16-2 hsa05210 Colorectal cancer 4088_4089_3725_5599_7157_2353 6 1.12E-07 5.71E-06 5.19E-07 6246 hsa-mir-16-2 hsa05219 Bladder cancer 5925_1870_1871_7157_1869 5 1.27E-07 6.49E-06 5.41E-07 6247 hsa-mir-16-2 hsa05221 Acute myeloid leukemia 1050_6776_6777_5914_5970 5 6.12E-07 3.12E-05 2.40E-06 6248 hsa-mir-16-2 hsa05214 Glioma 5925_1870_1871_7157_1869 5 9.60E-07 4.89E-05 3.50E-06 6249 hsa-mir-16-2 hsa04310 Wnt signaling pathway 4088_4089_3725_5599_7157_6423 6 3.08E-06 0.000157277 1.05E-05 6250 hsa-mir-16-2 hsa04012 ErbB signaling pathway 3725_5599_6776_6777 4 8.52E-05 0.00434388 0.000271492 6251 hsa-mir-16-2 hsa04620 Toll-like receptor signaling pathway 3725_5599_2353_5970 4 0.000153848 0.00784623 0.000461543 6252 hsa-mir-16-2 hsa04920 Adipocytokine signaling pathway 5599_5970_6256 3 0.00075152 0.038327521 0.002129307 6253 hsa-mir-16-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5599_5970 3 0.000883542 0.045060636 0.002371612 6254 hsa-mir-16-2 hsa04662 B cell receptor signaling pathway 3725_2353_5970 3 0.001029428 0.052500806 0.00262504 6255 hsa-mir-16-2 hsa04210 Apoptosis 7157_5970_823 3 0.001656828 0.084498231 0.004023725 6256 hsa-mir-16-2 hsa05216 Thyroid cancer 7157_6256 2 0.002794329 0.142510797 0.006270449 6257 hsa-mir-16-2 hsa04912 GnRH signaling pathway 3725_5599_468 3 0.00282785 0.144220333 0.006270449 6258 hsa-mir-16-2 hsa04660 T cell receptor signaling pathway 3725_2353_5970 3 0.002974183 0.151683358 0.00632014 6259 hsa-mir-16-2 hsa04630 Jak-STAT signaling pathway 3977_6776_6777 3 0.00755587 0.385349355 0.015413974 6260 hsa-mir-16-2 hsa05016 Huntington's disease 7157_6667_6908 3 0.012623667 0.643807022 0.024761809 6261 hsa-mir-16-2 hsa04115 p53 signaling pathway 7157_1017 2 0.013992134 0.713598848 0.026429587 6262 hsa-mir-16-2 hsa04520 Adherens junction 4088_4089 2 0.018369197 0.936829049 0.03345818 6263 hsa-mir-16-2 hsa03450 Non-homologous end-joining 2547 1 0.037249315 1 0.065507416 6264 hsa-mir-17 hsa05200 Pathways in cancer 4149_3551_1398_1499_5914_595_596_598_3815_1017_8517_4193_6934_5578_3091_2735_2064_3066_3065_5925_1050_613_5743_5747_10342_25_405_9063_1956_1487_6789_7046_4436_1870_1871_2113_6774_867_10401_207_208_9915_7187_4286_3716_1147_5879_2249_998_1488_2261_5595_5594_5599_861_1387_6256_836_367_2932_6777_6772_5970_7157_7849_1869_3725_5467_6776_4087_4088_4089_5888_5728_2034_2033_5468_4846_3910_898_4790_4791_4792_3320_3326_51176_5371_675_5159_5156_5604_5601_5602_1856_1399_3265_51588_7428_8772_4609_2956_1026_2736_2353_7704_2737_8554 107 1.09E-45 9.69E-44 9.69E-44 6265 hsa-mir-17 hsa04010 MAPK signaling pathway 6722_4149_3551_1398_6195_6197_2264_8517_9252_5578_1845_7132_4773_9020_5923_1956_3304_3305_3303_6789_1432_7046_22800_4763_1616_207_208_1147_5879_2249_998_3727_2261_5595_5594_5599_5598_8986_1386_1649_836_3310_3312_3315_5971_5970_3164_7157_3725_6196_5058_4790_4791_5159_9261_1326_5156_5604_4208_5601_5600_5603_5602_5608_1399_3265_6885_4609_2353_2002_8550_5566 72 1.47E-26 1.31E-24 6.54E-25 6266 hsa-mir-17 hsa05220 Chronic myeloid leukemia 3551_1398_595_598_8517_4193_3066_3065_5925_613_25_1487_7046_1870_1871_867_207_208_1147_1488_5595_5594_861_6777_5970_7157_1869_6776_4088_4089_4790_4792_5604_1399_3265_5781_4609_1026_6464 39 2.88E-23 2.56E-21 8.53E-22 6267 hsa-mir-17 hsa04110 Cell cycle 4174_4172_595_1017_4193_902_6500_3066_3065_5925_25_1870_1871_5111_9232_5934_5933_545_995_5347_7534_5591_1387_11200_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_898_1031_983_8454_1026_1022_1111_8556_8555_472 44 2.18E-21 1.94E-19 4.85E-20 6268 hsa-mir-17 hsa05215 Prostate cancer 3551_1499_595_596_1017_8517_4193_6934_2064_5925_1956_1870_1871_207_208_9586_1147_5595_5594_1387_367_2932_5970_7157_1869_5728_2033_898_4790_4792_3320_3326_51176_5159_5156_5604_3265_1026 38 1.64E-20 1.46E-18 2.92E-19 6269 hsa-mir-17 hsa05212 Pancreatic cancer 3551_1499_595_596_1017_8517_4193_6934_2064_5925_1956_1870_1871_207_208_9586_1147_5595_5594_1387_367_2932_5970_7157_1869_5728_2033_898_4790_4792_3320_3326_51176_5159_5156_5604_3265_1026 38 2.24E-20 1.99E-18 3.32E-19 6270 hsa-mir-17 hsa04310 Wnt signaling pathway 818_817_1499_595_8607_6934_5578_6500_4772_4773_23291_1487_5879_1460_1488_5599_1387_1459_2932_7157_8061_3725_5467_1457_1452_4087_4088_4089_2033_51176_5519_5518_5515_5601_5602_1856_8454_8945_6885_4609_5527_5566 42 1.16E-16 1.03E-14 1.48E-15 6271 hsa-mir-17 hsa04660 T cell receptor signaling pathway 3551_1493_8517_5777_4772_4773_9020_2534_3932_4794_1432_867_207_208_1147_998_5595_5594_2932_5970_3725_5058_959_4790_4792_4793_1326_5604_5601_5600_5603_919_3265_6885_2353 35 1.17E-15 1.04E-13 1.30E-14 6272 hsa-mir-17 hsa05222 Small cell lung cancer 4149_3551_595_596_598_1017_8517_5925_5743_5747_9063_1870_1871_10401_207_208_7187_1147_6256_5970_7157_1869_5728_4846_3910_898_4790_4792_51588_4609_8554 31 3.05E-15 2.72E-13 3.02E-14 6273 hsa-mir-17 hsa05210 Colorectal cancer 1499_595_596_6934_1956_7046_4436_207_208_5879_5595_5594_5599_836_2932_7157_3725_4087_4088_4089_51176_5159_5156_5604_5601_5602_1856_4609_2956_2353 30 1.04E-14 9.26E-13 9.26E-14 6274 hsa-mir-17 hsa04012 ErbB signaling pathway 818_817_1398_5578_2064_5747_25_1956_6714_867_207_208_5595_5594_5599_2066_2932_6777_3725_6776_5058_5604_5601_5602_1399_3265_4609_1026_2002_6464 30 2.22E-14 1.98E-12 1.80E-13 6275 hsa-mir-17 hsa05221 Acute myeloid leukemia 3551_5914_595_3815_8517_6934_1050_6774_207_208_1147_5595_5594_861_6777_5970_5467_6776_4790_51176_5371_5604_3265_4609_7704 25 7.83E-14 6.97E-12 5.61E-13 6276 hsa-mir-17 hsa04630 Jak-STAT signaling pathway 3559_595_598_5777_3455_3594_9063_3560_3561_6773_1439_3595_2057_6774_867_2690_10401_3459_3977_207_208_3717_3716_8651_1387_6778_6777_6772_7297_6776_2033_51588_10379_5781_58985_4609_3575_8554 38 8.19E-14 7.29E-12 5.61E-13 6277 hsa-mir-17 hsa04920 Adipocytokine signaling pathway 3551_10891_5465_6794_8517_7132_8717_2538_4794_8471_6774_207_208_3717_1147_5599_6256_5970_4790_4792_4793_5601_5602_5563_5781_7133 26 1.29E-13 1.15E-11 8.15E-13 6278 hsa-mir-17 hsa04620 Toll-like receptor signaling pathway 3551_8517_3455_3665_3661_1432_207_208_7187_1147_5879_29110_5595_5594_5599_6772_5970_3725_4790_4792_1326_5604_5601_5600_5603_5602_5608_9641_8772_6885_2353 31 1.37E-13 1.22E-11 8.15E-13 6279 hsa-mir-17 hsa05214 Glioma 818_817_595_4193_5578_5925_1956_1870_1871_207_208_5595_5594_7157_1869_5728_808_801_805_5159_5156_5604_3265_1026_6464 25 4.48E-13 3.98E-11 2.49E-12 6280 hsa-mir-17 hsa04520 Adherens junction 1499_6934_5770_5777_2064_2534_1956_6714_7046_5879_1460_998_5595_5594_1387_1459_1457_4087_4088_4089_2033_51176_3643_71_8826_6885 26 3.59E-12 3.20E-10 1.88E-11 6281 hsa-mir-17 hsa04910 Insulin signaling pathway 3551_10891_1398_6720_5770_2538_5590_5499_8471_867_5211_207_208_8651_5595_5594_5599_2932_2194_808_801_805_3643_5604_5601_5602_5563_1399_3265_2002_6464_5566 32 2.57E-11 2.28E-09 1.27E-10 6282 hsa-mir-17 hsa04662 B cell receptor signaling pathway 3551_8517_5777_4772_4773_4794_207_208_1147_5879_695_5595_5594_1380_2932_6850_5970_3725_4790_4792_4793_5604_3265_2353 24 3.15E-11 2.80E-09 1.48E-10 6283 hsa-mir-17 hsa04350 TGF-beta signaling pathway 6500_90_4086_1875_6667_7046_1874_57154_5934_5933_5595_5594_1387_7027_4087_4088_4089_2033_5519_5518_5515_8454_4609_4093_4092 25 8.45E-11 7.52E-09 3.76E-10 6284 hsa-mir-17 hsa04115 p53 signaling pathway 595_1017_4194_4193_900_50484_51246_545_7161_11200_836_7157_6241_64326_5728_898_27113_25898_983_1026_1111_472 22 2.19E-10 1.95E-08 9.29E-10 6285 hsa-mir-17 hsa04510 Focal adhesion 1398_1499_595_596_5578_2064_5923_2534_5747_3791_1956_6714_5499_207_208_5879_998_5595_5594_5599_2932_3725_5058_5728_3910_2321_5159_5156_5604_5601_5602_1399_3265_71_2002_85366_6464 37 4.52E-10 4.03E-08 1.83E-09 6286 hsa-mir-17 hsa04062 Chemokine signaling pathway 3551_1398_8517_653361_5747_5580_5590_6773_2309_6362_6774_207_208_3717_1147_5879_998_5595_5594_1234_2932_6777_6772_5970_5058_4790_4792_4793_1230_5604_1399_3265_7852_6464_5566 35 1.06E-09 9.45E-08 4.11E-09 6287 hsa-mir-17 hsa05219 Bladder cancer 595_9252_4193_2064_5925_1956_1870_1871_2261_5595_5594_7157_1869_5604_3265_4609_1026 17 1.31E-09 1.16E-07 4.85E-09 6288 hsa-mir-17 hsa03010 Ribosome 6193_6204_6205_6207_6202_6141_9349_6217_6137_6135_6210_6155_6156_6191_6222_6223_6229_6129_6128_6125_6130_6181_6189_6188_6232 25 1.42E-09 1.26E-07 5.05E-09 6289 hsa-mir-17 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3551_8517_9020_1956_6714_1432_1147_5879_998_5599_836_5970_3725_5058_4790_4792_5601_5600_5603_5602_5781 21 1.74E-09 1.55E-07 5.96E-09 6290 hsa-mir-17 hsa05211 Renal cell carcinoma 1398_3091_405_2113_207_208_9915_5879_998_5595_5594_1387_3725_5058_2034_2033_5604_1399_3265_7428_5781 21 2.15E-09 1.91E-07 7.08E-09 6291 hsa-mir-17 hsa05213 Endometrial cancer 1499_595_6934_2064_1956_2309_207_208_5595_5594_2932_7157_5728_51176_5604_3265_4609_2002 18 3.26E-09 2.90E-07 1.04E-08 6292 hsa-mir-17 hsa04912 GnRH signaling pathway 818_817_5578_5580_1956_6714_1432_998_5595_5594_5599_5598_3725_808_801_805_5604_5601_5600_5603_5602_5608_3265_2002_5566 25 3.86E-09 3.43E-07 1.18E-08 6293 hsa-mir-17 hsa05223 Non-small cell lung cancer 595_5578_2064_5925_1956_2309_6789_1870_1871_207_208_5595_5594_6256_7157_1869_5604_3265 18 5.31E-09 4.73E-07 1.58E-08 6294 hsa-mir-17 hsa04370 VEGF signaling pathway 5578_4772_4773_5743_5747_3791_6714_1432_207_208_5879_998_5595_5594_3315_4846_9261_5604_5600_5603_3265 21 5.87E-09 5.23E-07 1.69E-08 6295 hsa-mir-17 hsa05216 Thyroid cancer 1499_595_6934_10342_5595_5594_6256_7157_7849_5468_51176_5604_3265_4609 14 6.40E-09 5.70E-07 1.78E-08 6296 hsa-mir-17 hsa05218 Melanoma 595_4193_5925_1956_1870_1871_207_208_4286_2249_5595_5594_7157_1869_5728_5159_5156_5604_3265_1026 20 8.48E-09 7.55E-07 2.29E-08 6297 hsa-mir-17 hsa04210 Apoptosis 3551_596_598_8517_7132_8717_9020_823_1439_207_208_1147_836_5970_7157_9131_4790_4792_840_8772_472_5566 22 1.19E-08 1.06E-06 3.10E-08 6298 hsa-mir-17 hsa04720 Long-term potentiation 818_814_817_6195_6197_5578_2902_2906_5499_5595_5594_1387_6196_2033_808_801_805_5604_3265_5566 20 1.85E-08 1.65E-06 4.71E-08 6299 hsa-mir-17 hsa04120 Ubiquitin mediated proteolysis 4193_55294_6500_3093_23291_9063_7319_84447_867_10401_7329_8925_57154_8651_10055_51366_64326_7337_5371_672_25898_8454_8945_51588_7428_10075_8554 27 2.40E-08 2.13E-06 5.93E-08 6300 hsa-mir-17 hsa03022 Basal transcription factors 51616_6872_2965_2963_2969_6878_6874_6908_2958_2959_6880_2957_6882_9519 14 7.37E-08 6.56E-06 1.77E-07 6301 hsa-mir-17 hsa04664 Fc epsilon RI signaling pathway 5578_2534_5580_1432_207_208_5879_695_5595_5594_5599_6850_5604_5601_5600_5603_5602_5608_3265 19 1.67E-07 1.49E-05 3.91E-07 6302 hsa-mir-17 hsa04540 Gap junction 5592_5578_10382_1956_6714_5595_5594_5598_7846_1453_347733_5159_983_5156_5604_3265_7278_84617_203068_5566 20 3.78E-07 3.36E-05 8.62E-07 6303 hsa-mir-17 hsa04330 Notch signaling pathway 3066_3065_1840_9794_1487_2648_1488_1387_22938_9612_2033_8850_1856_4851 14 8.20E-07 7.30E-05 1.83E-06 6304 hsa-mir-17 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_7132_2902_2906_1432_1616_5879_836_7157_4846_5600_5603_5608_7133 15 1.04E-06 9.28E-05 2.26E-06 6305 hsa-mir-17 hsa04916 Melanogenesis 818_817_1499_3815_6934_5578_4286_5595_5594_1387_2932_2033_808_801_805_51176_5604_1856_3265_5566 20 1.74E-06 0.000154611 3.68E-06 6306 hsa-mir-17 hsa05131 Shigellosis 1499_5578_10382_2534_25_998_7534_7846_347733_7278_71_84617_4691_203068 14 4.71E-06 0.00041917 9.53E-06 6307 hsa-mir-17 hsa05130 Pathogenic Escherichia coli infection 1499_5578_10382_2534_25_998_7534_7846_347733_7278_71_84617_4691_203068 14 4.71E-06 0.00041917 9.53E-06 6308 hsa-mir-17 hsa04530 Tight junction 1499_5578_5580_5590_6714_4627_4628_22800_8573_207_208_1460_998_1459_1457_5728_5519_5518_5515_3265_71_5520 22 7.30E-06 0.000649919 1.44E-05 6309 hsa-mir-17 hsa04930 Type II diabetes mellitus 3551_5580_5590_8471_3651_8651_5595_5594_5599_3643_5601_5602 12 1.29E-05 0.001144695 2.49E-05 6310 hsa-mir-17 hsa03050 Proteasome 5708_5709_5705_5706_5700_5684_5719_5717_5713_5687_5693_5707 12 2.23E-05 0.001983967 4.22E-05 6311 hsa-mir-17 hsa05322 Systemic lupus erythematosus 3021_3020_8366_9555_8349_8362_8365_8368_3018_8294_8370_6628_121504_8360_8363_8364_8367_959_8359_8361 20 0.000114962 0.010231574 0.000213158 6312 hsa-mir-17 hsa04650 Natural killer cell mediated cytotoxicity 5777_5578_3455_4772_4773_2534_3932_3459_5879_5595_5594_836_6850_5058_5604_919_3265_5781_6464 19 0.00018639 0.016588666 0.000338544 6313 hsa-mir-17 hsa03420 Nucleotide excision repair 5981_902_5111_5886_2965_4331_2071_2074_1022_6117 10 0.000208973 0.018598561 0.000371971 6314 hsa-mir-17 hsa03410 Base excision repair 4350_142_4913_252969_5111_3146_328_2237_6996 9 0.000234704 0.020888642 0.000404365 6315 hsa-mir-17 hsa05016 Huntington's disease 10891_293_292_3066_3065_3064_498_25942_2902_6667_9586_1387_836_5437_7157_1213_2033_5468_27113_6874_6908_5441_9519 23 0.000236258 0.021026969 0.000404365 6316 hsa-mir-17 hsa03450 Non-homologous end-joining 2547_10111_7520_2237_5591_4361 6 0.000254676 0.022666203 0.000427664 6317 hsa-mir-17 hsa04060 Cytokine-cytokine receptor interaction 3559_3815_7132_3455_90_3594_3791_1956_3560_3561_1439_7046_3595_2057_6362_2690_3459_3977_1234_959_2321_1230_5159_5156_7852_58985_3575_7133 28 0.000428557 0.038141597 0.000706326 6318 hsa-mir-17 hsa04150 mTOR signaling pathway 6794_6195_6197_3091_207_208_5595_5594_6196_5563 10 0.000664511 0.059141519 0.0010753 6319 hsa-mir-17 hsa04810 Regulation of actin cytoskeleton 10788_1398_2264_5747_1956_5499_4627_4628_22800_5879_2249_998_2261_5595_5594_5058_5159_5156_5604_1399_3265_71_8826_85366 24 0.000734187 0.065342612 0.001166832 6320 hsa-mir-17 hsa03030 DNA replication 5981_4174_4172_5111_2237_5557_6117_5422 8 0.001009998 0.089889789 0.001577014 6321 hsa-mir-17 hsa03440 Homologous recombination 641_10111_4361_4683_5888_675_6117 7 0.001154958 0.102791261 0.001772263 6322 hsa-mir-17 hsa04340 Hedgehog signaling pathway 2735_23291_53944_2932_1452_1453_8945_2736_2737_5566 10 0.001235803 0.10998646 0.001864177 6323 hsa-mir-17 hsa04020 Calcium signaling pathway 818_814_817_293_5578_292_2064_1956_2902_2906_147_2066_4846_808_801_805_5159_5156_85366_5566 20 0.002418527 0.215248871 0.003587481 6324 hsa-mir-17 hsa04740 Olfactory transduction 818_817_5592_808_801_805_5566 7 0.002690948 0.239494361 0.003926137 6325 hsa-mir-17 hsa05217 Basal cell carcinoma 1499_6934_2735_2932_7157_51176_1856_2736_2737 9 0.003243108 0.288636595 0.004655429 6326 hsa-mir-17 hsa04730 Long-term depression 5592_5578_5595_5594_4846_5519_5518_5515_5604_3265 10 0.005138341 0.457312374 0.007258927 6327 hsa-mir-17 hsa03020 RNA polymerase 64425_25885_51082_5437_84172_5441 6 0.005784676 0.514836197 0.008007755 6328 hsa-mir-17 hsa04270 Vascular smooth muscle contraction 5592_5578_5580_147_5499_59_5595_5594_808_801_805_5604_85366_5566 14 0.005848361 0.520504088 0.008007755 6329 hsa-mir-17 hsa03430 Mismatch repair 5981_4436_5111_2956_6117 5 0.00967112 0.860729705 0.013041359 6330 hsa-mir-17 hsa04360 Axon guidance 4772_4773_2534_5747_25_5879_998_5595_5594_2932_5058_3265_7852_1020 14 0.010520257 0.936302834 0.013974669 6331 hsa-mir-17 hsa04950 Maturity onset diabetes of the young 5080_6927_4760_3651_3172 5 0.011235995 1 0.014705934 6332 hsa-mir-17 hsa05340 Primary immunodeficiency 8517_3932_3561_695_959_3575 6 0.012581327 1 0.016228089 6333 hsa-mir-17 hsa05010 Alzheimer's disease 7132_498_823_2902_2906_5595_5594_836_2932_4846_808_351_801_805_840_8772_1020 17 0.016210182 1 0.020610088 6334 hsa-mir-17 hsa04612 Antigen processing and presentation 3309_3304_3305_3303_3310_3312_3320_3326_4800_4801 10 0.027680759 1 0.034698417 6335 hsa-mir-17 hsa04670 Leukocyte transendothelial migration 1499_5578_653361_5747_1432_5879_998_5600_5603_7852_71_5781 12 0.037827534 1 0.046535049 6336 hsa-mir-17 hsa04710 Circadian rhythm - mammal 8863_4862_1453 3 0.038169197 1 0.046535049 6337 hsa-mir-181a-1 hsa05200 Pathways in cancer 4087_5925_6688_2249_207_7046_367_3725_7704_5970_5595_5594_6774_6776_6777_6772_2353_5914_1387_6256 20 3.31E-21 1.95E-19 1.95E-19 6338 hsa-mir-181a-1 hsa05221 Acute myeloid leukemia 6688_207_7704_5970_5595_5594_6774_6776_6777_5914 10 3.37E-15 1.99E-13 9.94E-14 6339 hsa-mir-181a-1 hsa05220 Chronic myeloid leukemia 5925_207_7046_5970_5595_5594_6776_6777 8 6.49E-11 3.83E-09 1.28E-09 6340 hsa-mir-181a-1 hsa05210 Colorectal cancer 4087_207_7046_3725_5595_5594_2353 7 5.31E-09 3.14E-07 7.61E-08 6341 hsa-mir-181a-1 hsa05215 Prostate cancer 5925_207_367_5970_5595_5594_1387 7 7.19E-09 4.24E-07 7.61E-08 6342 hsa-mir-181a-1 hsa05212 Pancreatic cancer 5925_207_367_5970_5595_5594_1387 7 7.74E-09 4.57E-07 7.61E-08 6343 hsa-mir-181a-1 hsa04620 Toll-like receptor signaling pathway 207_3725_5970_5595_5594_6772_2353 7 1.88E-08 1.11E-06 1.59E-07 6344 hsa-mir-181a-1 hsa04662 B cell receptor signaling pathway 207_3725_5970_5595_5594_2353 6 8.72E-08 5.15E-06 6.43E-07 6345 hsa-mir-181a-1 hsa04520 Adherens junction 4087_4301_7046_5595_5594_1387 6 1.25E-07 7.38E-06 8.20E-07 6346 hsa-mir-181a-1 hsa04350 TGF-beta signaling pathway 4087_6667_7046_5595_5594_1387 6 2.00E-07 1.18E-05 1.07E-06 6347 hsa-mir-181a-1 hsa04012 ErbB signaling pathway 207_3725_5595_5594_6776_6777 6 2.00E-07 1.18E-05 1.07E-06 6348 hsa-mir-181a-1 hsa04630 Jak-STAT signaling pathway 3977_207_6774_6776_6777_6772_1387 7 2.87E-07 1.69E-05 1.41E-06 6349 hsa-mir-181a-1 hsa05223 Non-small cell lung cancer 5925_207_5595_5594_6256 5 5.58E-07 3.29E-05 2.53E-06 6350 hsa-mir-181a-1 hsa04660 T cell receptor signaling pathway 207_3725_5970_5595_5594_2353 6 7.40E-07 4.37E-05 3.12E-06 6351 hsa-mir-181a-1 hsa04010 MAPK signaling pathway 2249_207_7046_3725_5970_5595_5594_2353 8 9.36E-07 5.52E-05 3.68E-06 6352 hsa-mir-181a-1 hsa04062 Chemokine signaling pathway 207_5970_5595_5594_6774_6777_6772 7 1.19E-06 7.00E-05 4.37E-06 6353 hsa-mir-181a-1 hsa05218 Melanoma 5925_2249_207_5595_5594 5 1.99E-06 0.000117213 6.89E-06 6354 hsa-mir-181a-1 hsa05211 Renal cell carcinoma 207_3725_5595_5594_1387 5 2.12E-06 0.00012509 6.95E-06 6355 hsa-mir-181a-1 hsa05214 Glioma 5925_207_5595_5594 4 3.69E-05 0.002178041 0.000114634 6356 hsa-mir-181a-1 hsa04920 Adipocytokine signaling pathway 207_5970_6774_6256 4 4.13E-05 0.002437979 0.000121899 6357 hsa-mir-181a-1 hsa05216 Thyroid cancer 5595_5594_6256 3 8.82E-05 0.005202577 0.000247742 6358 hsa-mir-181a-1 hsa05222 Small cell lung cancer 5925_207_5970_6256 4 0.000104534 0.006167505 0.000280341 6359 hsa-mir-181a-1 hsa05219 Bladder cancer 5925_5595_5594 3 0.000245989 0.014513361 0.000631016 6360 hsa-mir-181a-1 hsa05213 Endometrial cancer 207_5595_5594 3 0.000446068 0.026318005 0.00105272 6361 hsa-mir-181a-1 hsa04150 mTOR signaling pathway 207_5595_5594 3 0.000446068 0.026318005 0.00105272 6362 hsa-mir-181a-1 hsa04720 Long-term potentiation 5595_5594_1387 3 0.00123723 0.072996587 0.002807561 6363 hsa-mir-181a-1 hsa04370 VEGF signaling pathway 207_5595_5594 3 0.001331024 0.07853041 0.002908534 6364 hsa-mir-181a-1 hsa04664 Fc epsilon RI signaling pathway 207_5595_5594 3 0.001429177 0.08432143 0.00301148 6365 hsa-mir-181a-1 hsa04510 Focal adhesion 207_3725_5595_5594 4 0.002524265 0.148931661 0.005135575 6366 hsa-mir-181a-1 hsa04916 Melanogenesis 5595_5594_1387 3 0.003052417 0.180092576 0.006003086 6367 hsa-mir-181a-1 hsa04912 GnRH signaling pathway 3725_5595_5594 3 0.003385036 0.199717116 0.006442488 6368 hsa-mir-181a-1 hsa04110 Cell cycle 4087_5925_1387 3 0.004411233 0.260262772 0.008133212 6369 hsa-mir-181a-1 hsa03410 Base excision repair 3146_142 2 0.004727752 0.278937394 0.008452648 6370 hsa-mir-181a-1 hsa04910 Insulin signaling pathway 207_5595_5594 3 0.006587995 0.388691678 0.011432108 6371 hsa-mir-181a-1 hsa04930 Type II diabetes mellitus 5595_5594 2 0.007156968 0.42226114 0.012064604 6372 hsa-mir-181a-1 hsa04330 Notch signaling pathway 9612_1387 2 0.007758936 0.45777723 0.012716034 6373 hsa-mir-181a-1 hsa04310 Wnt signaling pathway 4087_3725_1387 3 0.008536581 0.503658301 0.013612387 6374 hsa-mir-181a-1 hsa05016 Huntington's disease 6667_6908_1387 3 0.014966365 0.883015554 0.023237251 6375 hsa-mir-181a-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5970 2 0.016632786 0.981334366 0.024533359 6376 hsa-mir-181a-1 hsa04730 Long-term depression 5595_5594 2 0.016632786 0.981334366 0.024533359 6377 hsa-mir-181a-1 hsa04810 Regulation of actin cytoskeleton 2249_5595_5594 3 0.022203153 1 0.031950879 6378 hsa-mir-181a-1 hsa04210 Apoptosis 207_5970 2 0.02512523 1 0.035294966 6379 hsa-mir-181a-1 hsa04540 Gap junction 5595_5594 2 0.027207464 1 0.037331172 6380 hsa-mir-181a-1 hsa03450 Non-homologous end-joining 2547 1 0.039647477 1 0.053163663 6381 hsa-mir-181a-1 hsa04270 Vascular smooth muscle contraction 5595_5594 2 0.041680852 1 0.054648228 6382 hsa-mir-181b-1 hsa05200 Pathways in cancer 2249_7046_5595_5594_5914_1387_6256_367_7704_6774_6776_6777_6772_5970_6688_3725_2353_4087_5925_207 20 2.00E-19 1.24E-17 1.24E-17 6383 hsa-mir-181b-1 hsa05221 Acute myeloid leukemia 5595_5594_5914_7704_6774_6776_6777_5970_6688_207 10 2.42E-14 1.50E-12 7.52E-13 6384 hsa-mir-181b-1 hsa05220 Chronic myeloid leukemia 7046_5595_5594_6776_6777_5970_5925_207 8 3.05E-10 1.89E-08 6.30E-09 6385 hsa-mir-181b-1 hsa05210 Colorectal cancer 7046_5595_5594_3725_2353_4087_207 7 2.02E-08 1.25E-06 3.03E-07 6386 hsa-mir-181b-1 hsa05215 Prostate cancer 5595_5594_1387_367_5970_5925_207 7 2.73E-08 1.69E-06 3.03E-07 6387 hsa-mir-181b-1 hsa05212 Pancreatic cancer 5595_5594_1387_367_5970_5925_207 7 2.94E-08 1.82E-06 3.03E-07 6388 hsa-mir-181b-1 hsa04620 Toll-like receptor signaling pathway 5595_5594_6772_5970_3725_2353_207 7 7.09E-08 4.40E-06 6.28E-07 6389 hsa-mir-181b-1 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725_2353_207 6 2.72E-07 1.69E-05 2.11E-06 6390 hsa-mir-181b-1 hsa04520 Adherens junction 4301_7046_5595_5594_1387_4087 6 3.89E-07 2.41E-05 2.68E-06 6391 hsa-mir-181b-1 hsa04350 TGF-beta signaling pathway 7046_5595_5594_1387_6667_4087 6 6.19E-07 3.84E-05 3.49E-06 6392 hsa-mir-181b-1 hsa04012 ErbB signaling pathway 5595_5594_6776_6777_3725_207 6 6.19E-07 3.84E-05 3.49E-06 6393 hsa-mir-181b-1 hsa04630 Jak-STAT signaling pathway 1387_6774_6776_6777_6772_3977_207 7 1.05E-06 6.54E-05 5.45E-06 6394 hsa-mir-181b-1 hsa05223 Non-small cell lung cancer 5595_5594_6256_5925_207 5 1.44E-06 8.91E-05 6.86E-06 6395 hsa-mir-181b-1 hsa04660 T cell receptor signaling pathway 5595_5594_5970_3725_2353_207 6 2.27E-06 0.000140658 1.00E-05 6396 hsa-mir-181b-1 hsa04010 MAPK signaling pathway 2249_7046_5595_5594_5970_3725_2353_207 8 3.98E-06 0.000246587 1.64E-05 6397 hsa-mir-181b-1 hsa04062 Chemokine signaling pathway 5595_5594_6774_6777_6772_5970_207 7 4.27E-06 0.000264979 1.66E-05 6398 hsa-mir-181b-1 hsa05218 Melanoma 2249_5595_5594_5925_207 5 5.08E-06 0.000314895 1.85E-05 6399 hsa-mir-181b-1 hsa05211 Renal cell carcinoma 5595_5594_1387_3725_207 5 5.42E-06 0.000335898 1.87E-05 6400 hsa-mir-181b-1 hsa04110 Cell cycle 993_1387_983_4087_5925 5 5.47E-05 0.003392683 0.000178562 6401 hsa-mir-181b-1 hsa05214 Glioma 5595_5594_5925_207 4 7.77E-05 0.004815423 0.000240771 6402 hsa-mir-181b-1 hsa04920 Adipocytokine signaling pathway 6256_6774_5970_207 4 8.69E-05 0.005385303 0.000256443 6403 hsa-mir-181b-1 hsa05216 Thyroid cancer 5595_5594_6256 3 0.000155019 0.009611149 0.00043687 6404 hsa-mir-181b-1 hsa05222 Small cell lung cancer 6256_5970_5925_207 4 0.00021788 0.01350858 0.00058733 6405 hsa-mir-181b-1 hsa05219 Bladder cancer 5595_5594_5925 3 0.000430095 0.026665898 0.001111079 6406 hsa-mir-181b-1 hsa04330 Notch signaling pathway 1387_9612_8850 3 0.000587113 0.036400989 0.00145604 6407 hsa-mir-181b-1 hsa05213 Endometrial cancer 5595_5594_207 3 0.000776664 0.048153181 0.001783451 6408 hsa-mir-181b-1 hsa04150 mTOR signaling pathway 5595_5594_207 3 0.000776664 0.048153181 0.001783451 6409 hsa-mir-181b-1 hsa04720 Long-term potentiation 5595_5594_1387 3 0.002133658 0.132286808 0.004724529 6410 hsa-mir-181b-1 hsa04370 VEGF signaling pathway 5595_5594_207 3 0.002293506 0.142197368 0.004903358 6411 hsa-mir-181b-1 hsa04664 Fc epsilon RI signaling pathway 5595_5594_207 3 0.002460594 0.152556801 0.005085227 6412 hsa-mir-181b-1 hsa04540 Gap junction 5595_5594_983 3 0.003841756 0.23818886 0.007683512 6413 hsa-mir-181b-1 hsa04510 Focal adhesion 5595_5594_3725_207 4 0.004990594 0.309416807 0.009669275 6414 hsa-mir-181b-1 hsa04916 Melanogenesis 5595_5594_1387 3 0.005201329 0.322482393 0.009772194 6415 hsa-mir-181b-1 hsa04912 GnRH signaling pathway 5595_5594_3725 3 0.005758634 0.357035327 0.010501039 6416 hsa-mir-181b-1 hsa03410 Base excision repair 3146_142 2 0.0068352 0.423782387 0.012108068 6417 hsa-mir-181b-1 hsa04930 Type II diabetes mellitus 5595_5594 2 0.010312935 0.63940195 0.017761165 6418 hsa-mir-181b-1 hsa04910 Insulin signaling pathway 5595_5594_207 3 0.011070813 0.686390421 0.018551092 6419 hsa-mir-181b-1 hsa04310 Wnt signaling pathway 1387_3725_4087 3 0.014263946 0.884364642 0.023272754 6420 hsa-mir-181b-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_3725 2 0.023740186 1 0.036797289 6421 hsa-mir-181b-1 hsa04730 Long-term depression 5595_5594 2 0.023740186 1 0.036797289 6422 hsa-mir-181b-1 hsa05016 Huntington's disease 1387_6908_6667 3 0.02464728 1 0.037271496 6423 hsa-mir-181b-1 hsa04612 Antigen processing and presentation 4800_1514 2 0.035628577 1 0.050890603 6424 hsa-mir-181b-1 hsa04210 Apoptosis 5970_207 2 0.035628577 1 0.050890603 6425 hsa-mir-181b-1 hsa04810 Regulation of actin cytoskeleton 2249_5595_5594 3 0.036115911 1 0.050890603 6426 hsa-mir-181b-1 hsa03450 Non-homologous end-joining 2547 1 0.047753682 1 0.065793962 6427 hsa-mir-181b-2 hsa03022 Basal transcription factors 6879_6872_6908_2959_6880_2958 6 4.67E-11 2.47E-09 2.47E-09 6428 hsa-mir-181b-2 hsa05200 Pathways in cancer 4088_3320_5601_5595_367_5599_6772_1387 8 3.71E-08 1.97E-06 9.83E-07 6429 hsa-mir-181b-2 hsa04310 Wnt signaling pathway 4088_5601_815_5599_1457_1387 6 1.32E-07 7.01E-06 2.34E-06 6430 hsa-mir-181b-2 hsa04110 Cell cycle 4088_7534_7531_5591_1387 5 1.18E-06 6.26E-05 1.57E-05 6431 hsa-mir-181b-2 hsa03450 Non-homologous end-joining 2547_5591_7520 3 2.10E-06 0.000111498 2.23E-05 6432 hsa-mir-181b-2 hsa04010 MAPK signaling pathway 6722_5601_3303_5595_3312_5599 6 3.65E-06 0.000193538 3.23E-05 6433 hsa-mir-181b-2 hsa04520 Adherens junction 4088_5595_1457_1387 4 7.76E-06 0.000411314 5.60E-05 6434 hsa-mir-181b-2 hsa05210 Colorectal cancer 4088_5601_5595_5599 4 9.34E-06 0.000494928 5.60E-05 6435 hsa-mir-181b-2 hsa04012 ErbB signaling pathway 5601_815_5595_5599 4 1.07E-05 0.000565403 5.60E-05 6436 hsa-mir-181b-2 hsa05215 Prostate cancer 3320_5595_367_1387 4 1.11E-05 0.000590459 5.60E-05 6437 hsa-mir-181b-2 hsa05212 Pancreatic cancer 3320_5595_367_1387 4 1.16E-05 0.000616324 5.60E-05 6438 hsa-mir-181b-2 hsa04620 Toll-like receptor signaling pathway 5601_5595_5599_6772 4 1.95E-05 0.001033863 8.62E-05 6439 hsa-mir-181b-2 hsa04912 GnRH signaling pathway 5601_815_5595_5599 4 2.42E-05 0.001284152 9.88E-05 6440 hsa-mir-181b-2 hsa04930 Type II diabetes mellitus 5601_5595_5599 3 5.18E-05 0.002745359 0.000196097 6441 hsa-mir-181b-2 hsa04720 Long-term potentiation 815_5595_1387 3 0.000220797 0.011702232 0.000780149 6442 hsa-mir-181b-2 hsa04664 Fc epsilon RI signaling pathway 5601_5595_5599 3 0.000255957 0.013565706 0.000847857 6443 hsa-mir-181b-2 hsa04350 TGF-beta signaling pathway 4088_5595_1387 3 0.000336714 0.017845848 0.001049756 6444 hsa-mir-181b-2 hsa04612 Antigen processing and presentation 3320_3303_3312 3 0.000359178 0.019036453 0.001057581 6445 hsa-mir-181b-2 hsa04916 Melanogenesis 815_5595_1387 3 0.000558872 0.029620222 0.001558959 6446 hsa-mir-181b-2 hsa04910 Insulin signaling pathway 5601_5595_5599 3 0.001242763 0.065866451 0.003293323 6447 hsa-mir-181b-2 hsa04062 Chemokine signaling pathway 5595_2931_6772 3 0.003171378 0.168083027 0.008003954 6448 hsa-mir-181b-2 hsa04510 Focal adhesion 5601_5595_5599 3 0.003797227 0.201253046 0.009147866 6449 hsa-mir-181b-2 hsa05214 Glioma 815_5595 2 0.004558871 0.241620178 0.010505225 6450 hsa-mir-181b-2 hsa04920 Adipocytokine signaling pathway 5601_5599 2 0.004828059 0.255887143 0.010661964 6451 hsa-mir-181b-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5601_5599 2 0.005387936 0.285560611 0.011277489 6452 hsa-mir-181b-2 hsa05211 Renal cell carcinoma 5595_1387 2 0.005532353 0.293214706 0.011277489 6453 hsa-mir-181b-2 hsa05220 Chronic myeloid leukemia 4088_5595 2 0.005976192 0.316738161 0.011731043 6454 hsa-mir-181b-2 hsa04660 T cell receptor signaling pathway 5601_5595 2 0.01228227 0.650960333 0.023248583 6455 hsa-mir-181b-2 hsa04530 Tight junction 8189_1457 2 0.018474408 0.979143622 0.033763573 6456 hsa-mir-181b-2 hsa04630 Jak-STAT signaling pathway 6772_1387 2 0.023192285 1 0.040973037 6457 hsa-mir-181b-2 hsa05016 Huntington's disease 6908_1387 2 0.032967131 1 0.056363159 6458 hsa-mir-181b-2 hsa05216 Thyroid cancer 5595 1 0.043991061 1 0.072860194 6459 hsa-mir-181c hsa05200 Pathways in cancer 1147_4087_4088_4089_3551_2033_207_2932_367_1499_1387 11 1.20E-13 6.12E-12 3.28E-12 6460 hsa-mir-181c hsa05215 Prostate cancer 1147_3551_2033_207_2932_367_1499_1387 8 1.77E-13 9.04E-12 3.28E-12 6461 hsa-mir-181c hsa05212 Pancreatic cancer 1147_3551_2033_207_2932_367_1499_1387 8 1.93E-13 9.84E-12 3.28E-12 6462 hsa-mir-181c hsa04110 Cell cycle 4087_4088_4089_2033_7534_7532_2932_1387 8 1.75E-12 8.91E-11 2.23E-11 6463 hsa-mir-181c hsa04520 Adherens junction 4087_4088_4089_2033_1499_6714_1387 7 8.42E-12 4.29E-10 8.59E-11 6464 hsa-mir-181c hsa04310 Wnt signaling pathway 4087_4088_4089_2033_2932_1499_1387 7 6.06E-10 3.09E-08 5.15E-09 6465 hsa-mir-181c hsa05210 Colorectal cancer 4087_4088_4089_207_2932_1499 6 9.25E-10 4.72E-08 6.74E-09 6466 hsa-mir-181c hsa05220 Chronic myeloid leukemia 1147_4088_4089_3551_207 5 3.60E-08 1.84E-06 2.30E-07 6467 hsa-mir-181c hsa04350 TGF-beta signaling pathway 4087_4088_4089_2033_1387 5 7.29E-08 3.72E-06 4.13E-07 6468 hsa-mir-181c hsa04660 T cell receptor signaling pathway 1147_5058_3551_207_2932 5 2.23E-07 1.14E-05 1.14E-06 6469 hsa-mir-181c hsa04920 Adipocytokine signaling pathway 1147_3551_207_2538 4 1.42E-06 7.24E-05 6.58E-06 6470 hsa-mir-181c hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_5058_3551_6714 4 1.77E-06 9.03E-05 7.32E-06 6471 hsa-mir-181c hsa05211 Renal cell carcinoma 5058_2033_207_1387 4 1.87E-06 9.52E-05 7.32E-06 6472 hsa-mir-181c hsa04662 B cell receptor signaling pathway 1147_3551_207_2932 4 2.18E-06 0.000111242 7.95E-06 6473 hsa-mir-181c hsa04062 Chemokine signaling pathway 1147_5058_3551_207_2932 5 3.27E-06 0.000166861 1.11E-05 6474 hsa-mir-181c hsa04012 ErbB signaling pathway 5058_207_2932_6714 4 3.84E-06 0.000195928 1.22E-05 6475 hsa-mir-181c hsa04510 Focal adhesion 5058_207_2932_1499_6714 5 4.46E-06 0.000227565 1.34E-05 6476 hsa-mir-181c hsa04916 Melanogenesis 2033_2932_1499_1387 4 7.60E-06 0.000387389 2.15E-05 6477 hsa-mir-181c hsa04910 Insulin signaling pathway 3551_207_2932_2538 4 2.24E-05 0.001141056 6.01E-05 6478 hsa-mir-181c hsa05213 Endometrial cancer 207_2932_1499 3 3.65E-05 0.001860503 9.30E-05 6479 hsa-mir-181c hsa05221 Acute myeloid leukemia 1147_3551_207 3 5.23E-05 0.002667129 0.000127006 6480 hsa-mir-181c hsa05222 Small cell lung cancer 1147_3551_207 3 0.000153687 0.007838033 0.000356274 6481 hsa-mir-181c hsa04210 Apoptosis 1147_3551_207 3 0.000169542 0.008646648 0.000375941 6482 hsa-mir-181c hsa04620 Toll-like receptor signaling pathway 1147_3551_207 3 0.000250475 0.012774208 0.000532259 6483 hsa-mir-181c hsa04010 MAPK signaling pathway 1147_5058_3551_207 4 0.000295936 0.015092739 0.00060371 6484 hsa-mir-181c hsa04530 Tight junction 207_1499_6714 3 0.000581586 0.029660866 0.001140803 6485 hsa-mir-181c hsa04630 Jak-STAT signaling pathway 2033_207_1387 3 0.000826131 0.042132657 0.001560469 6486 hsa-mir-181c hsa04330 Notch signaling pathway 2033_1387 2 0.001498921 0.076444984 0.002730178 6487 hsa-mir-181c hsa05217 Basal cell carcinoma 2932_1499 2 0.0020224 0.103142396 0.003443487 6488 hsa-mir-181c hsa05131 Shigellosis 7534_1499 2 0.0020931 0.106748089 0.003443487 6489 hsa-mir-181c hsa05130 Pathogenic Escherichia coli infection 7534_1499 2 0.0020931 0.106748089 0.003443487 6490 hsa-mir-181c hsa04340 Hedgehog signaling pathway 2932_53944 2 0.002164961 0.110413002 0.003450406 6491 hsa-mir-181c hsa04720 Long-term potentiation 2033_1387 2 0.003654022 0.186355128 0.005647125 6492 hsa-mir-181c hsa04370 VEGF signaling pathway 207_6714 2 0.003841982 0.195941069 0.005762973 6493 hsa-mir-181c hsa04360 Axon guidance 5058_2932 2 0.010524331 0.536740874 0.015335454 6494 hsa-mir-181c hsa05016 Huntington's disease 2033_1387 2 0.020655789 1 0.029262368 6495 hsa-mir-181c hsa04950 Maturity onset diabetes of the young 3172 1 0.028740237 1 0.039614921 6496 hsa-mir-181c hsa05216 Thyroid cancer 1499 1 0.034391211 1 0.046156625 6497 hsa-mir-181d hsa05200 Pathways in cancer 1147_3320_1499_3551_2249_367_5595_5599_5914_1387_6256_5601_2932_6776_6777_6772_5970_3725_2353_4087_4088_4089_5925_2033_207 25 1.64E-23 1.10E-21 1.10E-21 6498 hsa-mir-181d hsa05215 Prostate cancer 1147_3320_1499_3551_367_5595_1387_2932_5970_5925_2033_207 12 1.29E-14 8.65E-13 2.45E-13 6499 hsa-mir-181d hsa04110 Cell cycle 993_5591_1387_983_7534_7531_7532_2932_4087_4088_4089_5925_2033 13 1.35E-14 9.02E-13 2.45E-13 6500 hsa-mir-181d hsa05212 Pancreatic cancer 1147_3320_1499_3551_367_5595_1387_2932_5970_5925_2033_207 12 1.46E-14 9.78E-13 2.45E-13 6501 hsa-mir-181d hsa05210 Colorectal cancer 1499_5595_5599_5601_2932_3725_2353_4087_4088_4089_207 11 2.55E-13 1.71E-11 3.41E-12 6502 hsa-mir-181d hsa04012 ErbB signaling pathway 815_6714_5595_5599_5601_2932_6776_6777_3725_5058_207 11 3.62E-13 2.42E-11 4.04E-12 6503 hsa-mir-181d hsa05220 Chronic myeloid leukemia 1147_3551_5595_6776_6777_5970_4088_4089_5925_207 10 2.73E-12 1.83E-10 2.62E-11 6504 hsa-mir-181d hsa04310 Wnt signaling pathway 1499_815_5599_1387_5601_2932_3725_1457_4087_4088_4089_2033 12 5.14E-12 3.44E-10 4.30E-11 6505 hsa-mir-181d hsa04620 Toll-like receptor signaling pathway 1147_3551_5595_5599_5601_6772_5970_3725_2353_207 10 4.50E-11 3.01E-09 3.35E-10 6506 hsa-mir-181d hsa04660 T cell receptor signaling pathway 1147_3551_5595_5601_2932_5970_3725_2353_5058_207 10 8.97E-11 6.01E-09 6.01E-10 6507 hsa-mir-181d hsa04520 Adherens junction 1499_6714_5595_1387_1457_4087_4088_4089_2033 9 1.41E-10 9.42E-09 8.56E-10 6508 hsa-mir-181d hsa04010 MAPK signaling pathway 1147_3551_2249_5595_5599_5601_3303_3312_5970_3725_2353_5058_207 13 2.54E-10 1.70E-08 1.42E-09 6509 hsa-mir-181d hsa05221 Acute myeloid leukemia 1147_3551_5595_5914_6776_6777_5970_207 8 3.97E-10 2.66E-08 2.04E-09 6510 hsa-mir-181d hsa04920 Adipocytokine signaling pathway 1147_3551_5599_6256_5601_5970_207_2538 8 9.98E-10 6.69E-08 4.78E-09 6511 hsa-mir-181d hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_3551_6714_5599_5601_5970_3725_5058 8 1.52E-09 1.02E-07 6.80E-09 6512 hsa-mir-181d hsa04662 B cell receptor signaling pathway 1147_3551_5595_2932_5970_3725_2353_207 8 2.27E-09 1.52E-07 9.50E-09 6513 hsa-mir-181d hsa04062 Chemokine signaling pathway 1147_3551_5595_2932_2931_6777_6772_5970_5058_207 10 1.51E-08 1.01E-06 5.95E-08 6514 hsa-mir-181d hsa03022 Basal transcription factors 6879_6872_6908_2958_2959_6880 6 2.55E-08 1.71E-06 9.49E-08 6515 hsa-mir-181d hsa04350 TGF-beta signaling pathway 6667_5595_1387_4087_4088_4089_2033 7 1.43E-07 9.60E-06 5.05E-07 6516 hsa-mir-181d hsa04510 Focal adhesion 1499_6714_5595_5599_5601_2932_3725_5058_207 9 3.25E-07 2.18E-05 1.09E-06 6517 hsa-mir-181d hsa05211 Renal cell carcinoma 5595_1387_3725_5058_2033_207 6 9.53E-07 6.39E-05 3.04E-06 6518 hsa-mir-181d hsa05222 Small cell lung cancer 1147_3551_6256_5970_5925_207 6 2.52E-06 0.000169045 7.68E-06 6519 hsa-mir-181d hsa04910 Insulin signaling pathway 3551_5595_5599_5601_2932_207_2538 7 2.71E-06 0.000181487 7.89E-06 6520 hsa-mir-181d hsa04630 Jak-STAT signaling pathway 1387_6776_6777_6772_2033_3977_207 7 5.64E-06 0.000377751 1.57E-05 6521 hsa-mir-181d hsa04916 Melanogenesis 1499_815_5595_1387_2932_2033 6 7.13E-06 0.000477565 1.91E-05 6522 hsa-mir-181d hsa04912 GnRH signaling pathway 815_6714_5595_5599_5601_3725 6 8.76E-06 0.000586598 2.26E-05 6523 hsa-mir-181d hsa03450 Non-homologous end-joining 5591_7520_2547 3 4.65E-05 0.003118013 0.000115242 6524 hsa-mir-181d hsa04612 Antigen processing and presentation 3320_3303_4800_1514_3312 5 4.82E-05 0.003226779 0.000115242 6525 hsa-mir-181d hsa04930 Type II diabetes mellitus 3551_5595_5599_5601 4 5.34E-05 0.00357941 0.000123428 6526 hsa-mir-181d hsa04330 Notch signaling pathway 1387_9612_2033_8850 4 6.26E-05 0.004194606 0.00013982 6527 hsa-mir-181d hsa05213 Endometrial cancer 1499_5595_2932_207 4 9.05E-05 0.006066314 0.000195688 6528 hsa-mir-181d hsa05223 Non-small cell lung cancer 5595_6256_5925_207 4 0.000103916 0.006962346 0.000217573 6529 hsa-mir-181d hsa05214 Glioma 815_5595_5925_207 4 0.000204363 0.013692301 0.000414918 6530 hsa-mir-181d hsa05218 Melanoma 2249_5595_5925_207 4 0.000281825 0.018882306 0.000555362 6531 hsa-mir-181d hsa05216 Thyroid cancer 1499_5595_6256 3 0.000324243 0.021724293 0.000620694 6532 hsa-mir-181d hsa04530 Tight junction 1499_6714_8189_1457_207 5 0.000335125 0.022453372 0.000622786 6533 hsa-mir-181d hsa04720 Long-term potentiation 815_5595_1387_2033 4 0.000343927 0.023043086 0.000622786 6534 hsa-mir-181d hsa04664 Fc epsilon RI signaling pathway 5595_5599_5601_207 4 0.000415257 0.027822242 0.000732164 6535 hsa-mir-181d hsa04210 Apoptosis 1147_3551_5970_207 4 0.000638915 0.042807296 0.001097623 6536 hsa-mir-181d hsa04370 VEGF signaling pathway 6714_5595_207 3 0.004642225 0.311029095 0.007775727 6537 hsa-mir-181d hsa04950 Maturity onset diabetes of the young 6927_3172 2 0.005281518 0.353861704 0.008630773 6538 hsa-mir-181d hsa04540 Gap junction 6714_5595_983 3 0.007692343 0.515386948 0.012271118 6539 hsa-mir-181d hsa05016 Huntington's disease 6667_1387_6908_2033 4 0.008752636 0.586426624 0.013637828 6540 hsa-mir-181d hsa03410 Base excision repair 3146_142 2 0.011057219 0.740833645 0.016837128 6541 hsa-mir-181d hsa05219 Bladder cancer 5595_5925 2 0.014638965 0.980810636 0.021795792 6542 hsa-mir-181d hsa04360 Axon guidance 5595_2932_5058 3 0.018832535 1 0.027429996 6543 hsa-mir-181d hsa04150 mTOR signaling pathway 5595_207 2 0.02155285 1 0.030724276 6544 hsa-mir-181d hsa05217 Basal cell carcinoma 1499_2932 2 0.023844016 1 0.0330029 6545 hsa-mir-181d hsa05131 Shigellosis 1499_7534 2 0.02462903 1 0.0330029 6546 hsa-mir-181d hsa05130 Pathogenic Escherichia coli infection 1499_7534 2 0.02462903 1 0.0330029 6547 hsa-mir-181d hsa04340 Hedgehog signaling pathway 53944_2932 2 0.025424522 1 0.033400843 6548 hsa-mir-181d hsa03320 PPAR signaling pathway 10062_6256 2 0.036674834 1 0.047254113 6549 hsa-mir-182 hsa05200 Pathways in cancer 1147_3320_3326_5371_405_3480_1956_5595_5594_6654_5914_2064_6256_595_2308_9915_208_367_4193_7704_1387_6776_3091_5970_8503_2885_7157_10401_4087_3725_4088_4089_5295_2034_2033_207_8554_4790 38 1.01E-33 7.10E-32 7.10E-32 6550 hsa-mir-182 hsa05215 Prostate cancer 1147_3320_3326_3480_1956_5595_5594_6654_2064_595_2308_208_367_4193_1387_5970_8503_2885_7157_5295_2033_207_4790 23 5.86E-28 4.10E-26 1.71E-26 6551 hsa-mir-182 hsa05212 Pancreatic cancer 1147_3320_3326_3480_1956_5595_5594_6654_2064_595_2308_208_367_4193_1387_5970_8503_2885_7157_5295_2033_207_4790 23 7.33E-28 5.13E-26 1.71E-26 6552 hsa-mir-182 hsa05220 Chronic myeloid leukemia 1147_5595_5594_6654_595_208_4193_6776_5970_8503_2885_7157_4088_4089_5295_207_4790_6464 18 1.56E-21 1.09E-19 2.73E-20 6553 hsa-mir-182 hsa05214 Glioma 3480_1956_5595_5594_6654_595_208_4193_8503_2885_7157_5295_207_801_6464_808_805 17 5.99E-21 4.19E-19 8.38E-20 6554 hsa-mir-182 hsa05211 Renal cell carcinoma 405_5595_5594_6654_56924_9915_208_1387_3091_8503_2885_3725_5295_5058_2034_2033_207 17 2.69E-20 1.88E-18 3.14E-19 6555 hsa-mir-182 hsa05221 Acute myeloid leukemia 1147_5371_5595_5594_6654_5914_595_208_7704_6776_5970_8503_2885_5295_207_4790 16 5.31E-20 3.71E-18 5.31E-19 6556 hsa-mir-182 hsa04010 MAPK signaling pathway 1147_994_1956_5595_5594_6654_5566_6197_208_4214_1432_5970_627_2885_7157_10912_3725_3727_6195_5058_4616_2872_207_4790 24 4.54E-19 3.18E-17 3.97E-18 6557 hsa-mir-182 hsa04910 Insulin signaling pathway 6720_10891_5595_5594_6654_2308_5566_7249_208_5770_8503_2885_5295_2872_207_801_6464_808_805 19 1.26E-18 8.85E-17 9.83E-18 6558 hsa-mir-182 hsa05210 Colorectal cancer 3480_1956_5595_5594_6654_595_208_8503_2885_7157_4087_3725_4088_4089_5295_207 16 7.22E-18 5.06E-16 5.06E-17 6559 hsa-mir-182 hsa04012 ErbB signaling pathway 1956_6714_5595_5594_6654_56924_2064_208_6776_8503_2885_3725_5295_5058_207_6464 16 1.18E-17 8.29E-16 7.54E-17 6560 hsa-mir-182 hsa04660 T cell receptor signaling pathway 1147_5595_5594_6654_56924_208_5777_1432_5970_8503_2885_3725_5295_5058_207_3932_4790 17 1.52E-17 1.06E-15 8.85E-17 6561 hsa-mir-182 hsa05223 Non-small cell lung cancer 1956_5595_5594_6654_2064_6256_595_2309_208_8503_2885_7157_5295_207 14 2.04E-17 1.43E-15 1.10E-16 6562 hsa-mir-182 hsa04520 Adherens junction 1460_3480_1956_6714_5595_5594_2064_5770_5777_1387_4087_1457_4088_4089_2033 15 9.78E-17 6.85E-15 4.89E-16 6563 hsa-mir-182 hsa05213 Endometrial cancer 1956_5595_5594_6654_2064_595_2309_208_8503_2885_7157_5295_207 13 4.39E-16 3.07E-14 2.05E-15 6564 hsa-mir-182 hsa04510 Focal adhesion 9564_3480_1956_6714_5595_5594_6654_56924_2064_595_208_8503_857_2885_3725_5295_5058_207_6464 19 1.13E-15 7.91E-14 4.95E-15 6565 hsa-mir-182 hsa04662 B cell receptor signaling pathway 1147_5595_5594_6654_208_5777_5970_8503_2885_3725_5295_207_4790 13 2.81E-14 1.97E-12 1.16E-13 6566 hsa-mir-182 hsa04062 Chemokine signaling pathway 1147_9564_5595_5594_6654_2770_2309_5566_208_5970_8503_2885_5295_5058_207_4790_6464 17 7.62E-14 5.34E-12 2.96E-13 6567 hsa-mir-182 hsa04110 Cell cycle 994_595_7533_4193_902_1387_7157_10912_4087_1022_4088_4089_2033_4616 14 3.47E-13 2.43E-11 1.28E-12 6568 hsa-mir-182 hsa04912 GnRH signaling pathway 1956_6714_5595_5594_6654_5566_4214_1432_2885_3725_801_808_805 13 1.89E-12 1.33E-10 6.63E-12 6569 hsa-mir-182 hsa05222 Small cell lung cancer 1147_6256_595_208_5970_8503_7157_10401_5295_207_8554_4790 12 2.83E-12 1.98E-10 9.44E-12 6570 hsa-mir-182 hsa05218 Melanoma 3480_1956_5595_5594_595_208_4193_8503_7157_5295_207 11 8.43E-12 5.90E-10 2.68E-11 6571 hsa-mir-182 hsa04150 mTOR signaling pathway 5595_5594_7249_6197_208_3091_8503_6195_5295_207 10 1.14E-11 7.97E-10 3.46E-11 6572 hsa-mir-182 hsa04630 Jak-STAT signaling pathway 6654_595_208_5777_1387_6776_8503_2885_10401_5295_2033_207_8554 13 1.24E-10 8.70E-09 3.62E-10 6573 hsa-mir-182 hsa04720 Long-term potentiation 5595_5594_5566_6197_1387_6195_2033_801_808_805 10 2.90E-10 2.03E-08 7.87E-10 6574 hsa-mir-182 hsa04620 Toll-like receptor signaling pathway 1147_5595_5594_208_1432_5970_8503_3725_5295_207_4790 11 2.92E-10 2.05E-08 7.87E-10 6575 hsa-mir-182 hsa04664 Fc epsilon RI signaling pathway 5595_5594_6654_208_1432_8503_2885_5295_207 9 8.11E-09 5.68E-07 2.10E-08 6576 hsa-mir-182 hsa04310 Wnt signaling pathway 1460_595_5566_1387_7157_4087_3725_1457_4088_4089_2033 11 1.44E-08 1.01E-06 3.60E-08 6577 hsa-mir-182 hsa04350 TGF-beta signaling pathway 5595_5594_6667_1387_4087_4088_4089_2033_4093 9 1.76E-08 1.23E-06 4.24E-08 6578 hsa-mir-182 hsa04210 Apoptosis 1147_5566_208_5970_8503_7157_5295_207_4790 9 2.11E-08 1.48E-06 4.92E-08 6579 hsa-mir-182 hsa05219 Bladder cancer 1956_5595_5594_2064_595_4193_7157 7 3.65E-08 2.56E-06 8.25E-08 6580 hsa-mir-182 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_1956_6714_1432_5970_3725_5058_4790 8 6.05E-08 4.24E-06 1.32E-07 6581 hsa-mir-182 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_6654_5777_8503_2885_5295_5058_3932_6464 10 6.55E-08 4.59E-06 1.39E-07 6582 hsa-mir-182 hsa04916 Melanogenesis 5595_5594_2770_5566_1387_2033_801_808_805 9 7.34E-08 5.14E-06 1.51E-07 6583 hsa-mir-182 hsa04370 VEGF signaling pathway 6714_5595_5594_208_1432_8503_5295_207 8 1.08E-07 7.55E-06 2.16E-07 6584 hsa-mir-182 hsa04540 Gap junction 1956_6714_5595_5594_6654_2770_5566_2885 8 4.14E-07 2.90E-05 8.04E-07 6585 hsa-mir-182 hsa04920 Adipocytokine signaling pathway 1147_10891_6256_208_5970_207_4790 7 6.64E-07 4.65E-05 1.26E-06 6586 hsa-mir-182 hsa05216 Thyroid cancer 5595_5594_6256_595_7157 5 3.03E-06 0.000211871 5.58E-06 6587 hsa-mir-182 hsa04120 Ubiquitin mediated proteolysis 5371_672_4214_4193_10273_10401_7329_8554 8 7.02E-06 0.000491195 1.26E-05 6588 hsa-mir-182 hsa03022 Basal transcription factors 2965_2963_6881_6908_2959 5 8.86E-06 0.000620194 1.55E-05 6589 hsa-mir-182 hsa04115 p53 signaling pathway 595_7249_4193_7157_10912_4616 6 1.14E-05 0.000797927 1.95E-05 6590 hsa-mir-182 hsa04810 Regulation of actin cytoskeleton 9564_1956_5595_5594_6654_56924_8503_5295_5058 9 2.48E-05 0.001739312 4.14E-05 6591 hsa-mir-182 hsa04270 Vascular smooth muscle contraction 5595_5594_5566_801_808_805 6 0.000192787 0.013495073 0.000313839 6592 hsa-mir-182 hsa04070 Phosphatidylinositol signaling system 8503_5295_801_808_805 5 0.00021609 0.015126318 0.00034378 6593 hsa-mir-182 hsa03420 Nucleotide excision repair 2965_4331_902_1022 4 0.000300192 0.021013452 0.000466966 6594 hsa-mir-182 hsa04930 Type II diabetes mellitus 5595_5594_8503_5295 4 0.000325176 0.02276234 0.000491903 6595 hsa-mir-182 hsa04360 Axon guidance 5998_5595_5594_56924_2770_5058 6 0.000330278 0.023119436 0.000491903 6596 hsa-mir-182 hsa05016 Huntington's disease 10891_6908_6667_1387_627_7157_2033 7 0.000356966 0.024987608 0.000520575 6597 hsa-mir-182 hsa04530 Tight junction 1460_6714_2770_208_1457_207 6 0.000415214 0.029064982 0.000593163 6598 hsa-mir-182 hsa04730 Long-term depression 3480_5595_5594_2770 4 0.001629577 0.114070377 0.002281408 6599 hsa-mir-182 hsa04670 Leukocyte transendothelial migration 9564_2770_1432_8503_5295 5 0.001674308 0.117201546 0.00229807 6600 hsa-mir-182 hsa04020 Calcium signaling pathway 1956_2064_5566_801_808_805 6 0.001812334 0.126863414 0.002439681 6601 hsa-mir-182 hsa03410 Base excision repair 6996_3146_4350 3 0.002256167 0.1579317 0.002979843 6602 hsa-mir-182 hsa04330 Notch signaling pathway 1387_9612_2033 3 0.004585264 0.320968483 0.005943861 6603 hsa-mir-182 hsa05010 Alzheimer's disease 5595_5594_801_808_805 5 0.007731947 0.541236316 0.00984066 6604 hsa-mir-182 hsa04612 Antigen processing and presentation 3320_3326_6890 3 0.023966593 1 0.029958242 6605 hsa-mir-182 hsa05340 Primary immunodeficiency 6890_3932 2 0.02542847 1 0.031227945 6606 hsa-mir-182 hsa03050 Proteasome 5698_5705 2 0.044213542 1 0.053361171 6607 hsa-mir-1825 hsa05200 Pathways in cancer 4149_7046_1499_5914_595_3815_1019_1017_4193_7704_5578_6502_3091_2736_4089_3066_3065_1050_5925_7184_3716_1956_2308_1870_1871_2113_10401_6774_861_862_867_207_208_9915_4609_3725_5595_5594_5599_1387_6256_3326_836_367_2932_6776_6777_6772_5970_7157_6688_1869_2735_2737_4088_2034_2033_4846_4790_3320_5371_675_5159_5156_5601_1399_1398_841_7428_4087_2353_8554 72 3.34E-42 2.77E-40 2.77E-40 6608 hsa-mir-1825 hsa05220 Chronic myeloid leukemia 7046_595_1019_4193_4089_3066_3065_5925_1870_1871_861_867_207_208_4609_5595_5594_6776_6777_5970_7157_1869_4088_4790_1399_1398_5781_6464 28 2.27E-22 1.89E-20 9.43E-21 6609 hsa-mir-1825 hsa03022 Basal transcription factors 54457_138474_6882_6883_2967_2961_2960_2963_2968_6879_6878_6877_6874_6873_6872_6884_2958_2959_6880_6881_2957_6908 22 2.88E-21 2.39E-19 7.97E-20 6610 hsa-mir-1825 hsa05215 Prostate cancer 1499_595_1017_4193_5925_7184_1956_2308_1870_1871_207_208_5595_5594_1385_1387_3326_367_2932_5970_7157_468_1869_2033_4790_3320_5159_5156 28 7.86E-21 6.52E-19 1.40E-19 6611 hsa-mir-1825 hsa04010 MAPK signaling pathway 6722_4149_7046_6197_9252_7867_5578_4773_1956_1432_4342_4763_207_208_9479_4609_3725_5595_5594_5599_5598_8986_1386_836_3312_1649_5970_7157_468_3727_6195_6196_4790_5159_9261_5156_4208_5601_5566_1399_1398_2353_2002 43 8.47E-21 7.03E-19 1.40E-19 6612 hsa-mir-1825 hsa05212 Pancreatic cancer 1499_595_1017_4193_5925_7184_1956_2308_1870_1871_207_208_5595_5594_1385_1387_3326_367_2932_5970_7157_468_1869_2033_4790_3320_5159_5156 28 1.01E-20 8.39E-19 1.40E-19 6613 hsa-mir-1825 hsa04110 Cell cycle 595_1019_1017_4193_6502_4089_4171_3066_3065_5925_1870_1871_5934_5933_7534_5591_1387_2932_7157_1869_4085_4088_2033_890_891_4087_1028_10971 28 6.80E-18 5.64E-16 8.06E-17 6614 hsa-mir-1825 hsa05214 Glioma 815_595_1019_4193_5578_5925_1956_1870_1871_207_208_5595_5594_7157_1869_808_801_805_5159_5156_6464 21 4.50E-16 3.74E-14 4.67E-15 6615 hsa-mir-1825 hsa05221 Acute myeloid leukemia 5914_595_3815_7704_1050_6774_861_862_207_208_4609_5595_5594_6776_6777_5970_6688_4790_5371 19 1.19E-14 9.87E-13 1.10E-13 6616 hsa-mir-1825 hsa05210 Colorectal cancer 7046_1499_595_4089_1956_207_208_4609_3725_5595_5594_5599_836_2932_7157_4088_5159_5156_5601_4087_2353 21 3.32E-14 2.75E-12 2.75E-13 6617 hsa-mir-1825 hsa04350 TGF-beta signaling pathway 7046_4089_6667_3397_3399_3398_1874_1875_5934_5933_4609_3400_5595_5594_1387_4088_2033_5515_4087_4093_4092 21 5.99E-14 4.97E-12 4.14E-13 6618 hsa-mir-1825 hsa04012 ErbB signaling pathway 815_5578_1956_6714_867_207_208_4609_3725_5595_5594_5599_2066_2932_6776_6777_5601_1399_1398_6464_2002 21 5.99E-14 4.97E-12 4.14E-13 6619 hsa-mir-1825 hsa04310 Wnt signaling pathway 815_1499_595_8607_5578_4089_4773_4609_3725_1460_5599_1387_2932_7157_8061_1457_1452_4088_2033_5515_5601_5566_6423_4087 24 3.24E-12 2.69E-10 2.07E-11 6620 hsa-mir-1825 hsa05222 Small cell lung cancer 4149_595_1019_1017_6502_5925_1870_1871_10401_207_208_4609_6256_5970_7157_1869_4846_4790_8554 19 3.63E-12 3.01E-10 2.15E-11 6621 hsa-mir-1825 hsa04630 Jak-STAT signaling pathway 3717_595_3716_3560_3561_2057_10401_6774_867_2690_207_208_3575_4609_3718_85480_1387_6778_6776_6777_6772_2033_5781_8554 24 4.69E-12 3.89E-10 2.60E-11 6622 hsa-mir-1825 hsa04910 Insulin signaling pathway 6720_5770_2308_867_5211_207_208_5595_5594_5599_2932_808_801_805_3643_5601_5566_1399_1398_6464_2002 21 1.35E-10 1.12E-08 7.00E-10 6623 hsa-mir-1825 hsa05219 Bladder cancer 595_1019_9252_4193_5925_1956_1870_1871_4609_5595_5594_7157_1869 13 2.83E-10 2.35E-08 1.38E-09 6624 hsa-mir-1825 hsa05223 Non-small cell lung cancer 595_1019_5578_5925_1956_1870_1871_207_208_5595_5594_6256_7157_1869 14 4.20E-10 3.49E-08 1.94E-09 6625 hsa-mir-1825 hsa04520 Adherens junction 7046_1499_5770_4089_1956_6714_4301_1460_5595_5594_1387_1457_4088_2033_3643_4087 16 6.58E-10 5.46E-08 2.87E-09 6626 hsa-mir-1825 hsa05218 Melanoma 595_1019_4193_5925_1956_1870_1871_207_208_5595_5594_7157_1869_5159_5156 15 1.16E-09 9.67E-08 4.83E-09 6627 hsa-mir-1825 hsa05211 Renal cell carcinoma 3091_2113_207_208_9915_3725_5595_5594_1387_2034_2033_1399_1398_7428_5781 15 1.38E-09 1.14E-07 5.45E-09 6628 hsa-mir-1825 hsa04720 Long-term potentiation 815_6197_5578_2902_5595_5594_1387_468_6195_6196_2033_808_801_805_5566 15 2.25E-09 1.87E-07 8.48E-09 6629 hsa-mir-1825 hsa04912 GnRH signaling pathway 815_5578_1956_6714_1432_3725_5595_5594_5599_5598_468_808_801_805_5601_5566_2002 17 4.90E-09 4.06E-07 1.77E-08 6630 hsa-mir-1825 hsa04660 T cell receptor signaling pathway 1019_4773_1493_3932_1432_867_207_208_3725_5595_5594_2932_5970_4790_5601_919_2353 17 6.26E-09 5.20E-07 2.16E-08 6631 hsa-mir-1825 hsa05213 Endometrial cancer 1499_595_1956_207_208_4609_5595_5594_2932_7157_2002 11 1.90E-07 1.58E-05 6.32E-07 6632 hsa-mir-1825 hsa04620 Toll-like receptor signaling pathway 1432_207_208_3725_5595_5594_5599_6772_5970_4790_5601_841_2353_6348 14 4.98E-07 4.13E-05 1.59E-06 6633 hsa-mir-1825 hsa04916 Melanogenesis 815_1499_3815_5578_5595_5594_1385_1387_2932_2033_808_801_805_5566 14 6.15E-07 5.11E-05 1.89E-06 6634 hsa-mir-1825 hsa04662 B cell receptor signaling pathway 4773_6850_207_208_3725_695_5595_5594_2932_5970_4790_2353 12 7.63E-07 6.33E-05 2.26E-06 6635 hsa-mir-1825 hsa04510 Focal adhesion 1499_595_5578_1956_6714_207_208_3725_5595_5594_5599_2932_5159_5156_5601_1399_1398_6464_2002 19 1.39E-06 0.000115308 3.98E-06 6636 hsa-mir-1825 hsa04062 Chemokine signaling pathway 3717_1234_6774_207_208_3718_5595_5594_2932_6777_6772_5970_4790_5566_1399_1398_6348_6464 18 2.26E-06 0.000187926 6.26E-06 6637 hsa-mir-1825 hsa04370 VEGF signaling pathway 7867_5578_4773_6714_1432_207_208_5595_5594_4846_9261 11 5.87E-06 0.000487057 1.57E-05 6638 hsa-mir-1825 hsa05016 Huntington's disease 1537_3066_3065_3064_2902_6667_1385_1387_836_9001_5430_7157_2033_6874_841_6908_4724 17 6.29E-06 0.000521825 1.63E-05 6639 hsa-mir-1825 hsa04920 Adipocytokine signaling pathway 3717_6774_207_208_5599_6256_5970_4790_5601_5781 10 1.10E-05 0.000913331 2.77E-05 6640 hsa-mir-1825 hsa05216 Thyroid cancer 1499_595_4609_5595_5594_6256_7157 7 1.58E-05 0.001313022 3.86E-05 6641 hsa-mir-1825 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_1432_3725_5599_836_5970_4790_5601_5781 10 1.73E-05 0.001439768 4.11E-05 6642 hsa-mir-1825 hsa04540 Gap junction 5578_10382_1956_6714_5592_5595_5594_5598_5159_5156_5566 11 2.93E-05 0.002432846 6.76E-05 6643 hsa-mir-1825 hsa04664 Fc epsilon RI signaling pathway 5578_6850_1432_207_208_695_5595_5594_5599_5601 10 3.98E-05 0.003304047 8.93E-05 6644 hsa-mir-1825 hsa05010 Alzheimer's disease 1537_840_2902_22926_5595_5594_836_2932_4846_808_801_805_841_1020_4724 15 4.36E-05 0.003620937 9.53E-05 6645 hsa-mir-1825 hsa04150 mTOR signaling pathway 6197_3091_207_208_5595_5594_6195_6196 8 6.89E-05 0.005717017 0.00014659 6646 hsa-mir-1825 hsa04115 p53 signaling pathway 595_1019_1017_4193_836_7157_64326_891_841 9 7.81E-05 0.006481966 0.000162049 6647 hsa-mir-1825 hsa04120 Ubiquitin mediated proteolysis 4193_6502_10401_867_7325_7329_997_64326_5371_672_7428_8554 12 0.00021135 0.017542016 0.000427854 6648 hsa-mir-1825 hsa04330 Notch signaling pathway 3066_3065_1387_9612_2033_8850_388585 7 0.000234297 0.01944665 0.000463015 6649 hsa-mir-1825 hsa04210 Apoptosis 840_207_208_836_5970_7157_4790_5566_841 9 0.000448254 0.037205069 0.000865234 6650 hsa-mir-1825 hsa04930 Type II diabetes mellitus 3651_5595_5594_5599_3643_5601 6 0.001103998 0.091631823 0.002082541 6651 hsa-mir-1825 hsa03050 Proteasome 5705_5701_5702_5684_5719_5710 6 0.001493591 0.123968058 0.002754846 6652 hsa-mir-1825 hsa04020 Calcium signaling pathway 815_5578_1956_2902_2066_4846_808_801_805_5159_5156_5566 12 0.002112984 0.175377702 0.003812559 6653 hsa-mir-1825 hsa05340 Primary immunodeficiency 3932_3561_3575_3718_695 5 0.002181121 0.181033062 0.003851767 6654 hsa-mir-1825 hsa04530 Tight junction 1499_1019_5578_6714_207_208_4301_1460_1457_5515 10 0.002262662 0.187800987 0.003912521 6655 hsa-mir-1825 hsa04650 Natural killer cell mediated cytotoxicity 5578_4773_3932_6850_5595_5594_836_919_5781_6464 10 0.002377701 0.197349151 0.004027534 6656 hsa-mir-1825 hsa05217 Basal cell carcinoma 1499_2736_2932_7157_2735_2737 6 0.002803675 0.232704997 0.0046541 6657 hsa-mir-1825 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_1432_836_834_7157_4846 6 0.003044605 0.252702232 0.004954946 6658 hsa-mir-1825 hsa04340 Hedgehog signaling pathway 2736_2932_1452_2735_2737_5566 6 0.003300659 0.273954664 0.005268359 6659 hsa-mir-1825 hsa04730 Long-term depression 5578_5592_5595_5594_4846_5515 6 0.008795641 0.730038233 0.013774306 6660 hsa-mir-1825 hsa04270 Vascular smooth muscle contraction 5578_5592_5595_5594_808_801_805_5566 8 0.009016334 0.74835572 0.013858439 6661 hsa-mir-1825 hsa05131 Shigellosis 1499_5578_10382_7534_10971 5 0.013292367 1 0.01943703 6662 hsa-mir-1825 hsa05130 Pathogenic Escherichia coli infection 1499_5578_10382_7534_10971 5 0.013292367 1 0.01943703 6663 hsa-mir-1825 hsa03010 Ribosome 6129_9349_6222_6229_6124_6143_6231 7 0.013348322 1 0.01943703 6664 hsa-mir-1825 hsa04060 Cytokine-cytokine receptor interaction 7046_3815_1234_1956_3560_3561_2057_2690_3575_85480_5159_5156_6348 13 0.013690574 1 0.019591683 6665 hsa-mir-1825 hsa04612 Antigen processing and presentation 1385_3326_3312_3320_4800_4801 6 0.022864931 1 0.03216592 6666 hsa-mir-1825 hsa04950 Maturity onset diabetes of the young 3651_168620_5080 3 0.023748852 1 0.032852578 6667 hsa-mir-1825 hsa04710 Circadian rhythm - mammal 8863_79365 2 0.0458192 1 0.062344158 6668 hsa-mir-183 hsa04010 MAPK signaling pathway 468_2353_3725_3727_1432_1386 6 6.85E-06 0.000232769 0.000232769 6669 hsa-mir-183 hsa04310 Wnt signaling pathway 4089_8061_3725_1457 4 0.000133635 0.004543574 0.002271787 6670 hsa-mir-183 hsa05200 Pathways in cancer 4089_25_1050_2353_3725 5 0.000241208 0.008201056 0.002733685 6671 hsa-mir-183 hsa05210 Colorectal cancer 4089_2353_3725 3 0.000416364 0.014156372 0.003127073 6672 hsa-mir-183 hsa04350 TGF-beta signaling pathway 4086_4089_4093 3 0.000459864 0.015635364 0.003127073 6673 hsa-mir-183 hsa04620 Toll-like receptor signaling pathway 2353_3725_1432 3 0.000721049 0.024515677 0.00379191 6674 hsa-mir-183 hsa04912 GnRH signaling pathway 468_3725_1432 3 0.000847238 0.028806098 0.00379191 6675 hsa-mir-183 hsa04660 T cell receptor signaling pathway 2353_3725_1432 3 0.000892214 0.030335281 0.00379191 6676 hsa-mir-183 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1432 2 0.006612827 0.224836126 0.022661367 6677 hsa-mir-183 hsa05220 Chronic myeloid leukemia 4089_25 2 0.007331619 0.249275037 0.022661367 6678 hsa-mir-183 hsa04662 B cell receptor signaling pathway 2353_3725 2 0.007331619 0.249275037 0.022661367 6679 hsa-mir-183 hsa04520 Adherens junction 4089_1457 2 0.00827752 0.28143569 0.022916416 6680 hsa-mir-183 hsa04012 ErbB signaling pathway 25_3725 2 0.009688675 0.329414955 0.022916416 6681 hsa-mir-183 hsa05215 Prostate cancer 10488_468 2 0.009898421 0.336546309 0.022916416 6682 hsa-mir-183 hsa05212 Pancreatic cancer 10488_468 2 0.010110183 0.343746237 0.022916416 6683 hsa-mir-183 hsa04110 Cell cycle 4089_25 2 0.017366729 0.590468783 0.036904299 6684 hsa-mir-184 hsa05200 Pathways in cancer 2249_1499_5914_1387_6256_1019_367_1017_4193_6776_6777_5970_1870_1871_7157_6688_4609_3725_1026_1029_2353_3066_5925_2033_8554 25 2.51E-26 1.41E-24 1.41E-24 6685 hsa-mir-184 hsa05215 Prostate cancer 1499_1387_367_1017_4193_1385_5970_1870_1871_7157_468_1026_5925_2033 14 3.13E-19 1.75E-17 6.74E-18 6686 hsa-mir-184 hsa05212 Pancreatic cancer 1499_1387_367_1017_4193_1385_5970_1870_1871_7157_468_1026_5925_2033 14 3.61E-19 2.02E-17 6.74E-18 6687 hsa-mir-184 hsa05220 Chronic myeloid leukemia 1019_4193_6776_6777_5970_1870_1871_7157_4609_1026_1029_3066_5925 13 2.28E-18 1.28E-16 3.20E-17 6688 hsa-mir-184 hsa04110 Cell cycle 1387_1019_1017_4193_7027_1870_1871_7157_1026_1029_3066_5925_2033_5933 14 1.48E-17 8.30E-16 1.66E-16 6689 hsa-mir-184 hsa05219 Bladder cancer 1019_4193_1870_1871_7157_4609_1026_1029_5925 9 8.43E-14 4.72E-12 7.86E-13 6690 hsa-mir-184 hsa05222 Small cell lung cancer 6256_1019_1017_5970_1870_1871_7157_4609_5925_8554 10 8.30E-13 4.65E-11 6.64E-12 6691 hsa-mir-184 hsa05218 Melanoma 2249_1019_4193_1870_1871_7157_1026_1029_5925 9 5.94E-12 3.33E-10 4.16E-11 6692 hsa-mir-184 hsa05214 Glioma 1019_4193_1870_1871_7157_1026_1029_5925 8 1.16E-10 6.48E-09 7.20E-10 6693 hsa-mir-184 hsa05223 Non-small cell lung cancer 6256_1019_1870_1871_7157_1029_5925 7 1.27E-09 7.09E-08 7.09E-09 6694 hsa-mir-184 hsa04350 TGF-beta signaling pathway 1387_7027_1874_4609_2033_6667_5933 7 2.72E-08 1.52E-06 1.38E-07 6695 hsa-mir-184 hsa05221 Acute myeloid leukemia 5914_6776_6777_5970_6688_4609 6 7.67E-08 4.29E-06 3.58E-07 6696 hsa-mir-184 hsa04115 p53 signaling pathway 1019_1017_4193_7157_1026_1029 6 1.82E-07 1.02E-05 7.84E-07 6697 hsa-mir-184 hsa04010 MAPK signaling pathway 2249_1386_1649_5970_7157_468_4609_3725_2353 9 4.06E-07 2.27E-05 1.62E-06 6698 hsa-mir-184 hsa04330 Notch signaling pathway 1387_3066_9612_2033_4851 5 7.99E-07 4.48E-05 2.98E-06 6699 hsa-mir-184 hsa04630 Jak-STAT signaling pathway 1387_6776_6777_4609_2033_3977_8554 7 1.13E-06 6.32E-05 3.95E-06 6700 hsa-mir-184 hsa05016 Huntington's disease 1387_6908_1385_7157_3066_2033_6667 7 3.87E-06 0.000216754 1.28E-05 6701 hsa-mir-184 hsa05216 Thyroid cancer 1499_6256_7157_4609 4 4.19E-06 0.000234474 1.30E-05 6702 hsa-mir-184 hsa05210 Colorectal cancer 1499_7157_4609_3725_2353 5 1.16E-05 0.000649283 3.42E-05 6703 hsa-mir-184 hsa04012 ErbB signaling pathway 6776_6777_4609_3725_1026 5 1.36E-05 0.000763286 3.80E-05 6704 hsa-mir-184 hsa04310 Wnt signaling pathway 1499_1387_7157_4609_3725_2033 6 1.43E-05 0.000798024 3.80E-05 6705 hsa-mir-184 hsa04916 Melanogenesis 1499_1387_1385_2033 4 0.000454089 0.025429007 0.001155864 6706 hsa-mir-184 hsa04660 T cell receptor signaling pathway 1019_5970_3725_2353 4 0.00055697 0.031190302 0.0013561 6707 hsa-mir-184 hsa05213 Endometrial cancer 1499_7157_4609 3 0.000799827 0.044790294 0.001866262 6708 hsa-mir-184 hsa05211 Renal cell carcinoma 1387_3725_2033 3 0.001963133 0.109935459 0.004397418 6709 hsa-mir-184 hsa04720 Long-term potentiation 1387_468_2033 3 0.002196056 0.122979143 0.004554783 6710 hsa-mir-184 hsa04662 B cell receptor signaling pathway 5970_3725_2353 3 0.002196056 0.122979143 0.004554783 6711 hsa-mir-184 hsa04520 Adherens junction 1499_1387_2033 3 0.002621051 0.146778833 0.005242101 6712 hsa-mir-184 hsa04620 Toll-like receptor signaling pathway 5970_3725_2353 3 0.005076444 0.284280855 0.009802788 6713 hsa-mir-184 hsa03022 Basal transcription factors 2969_6908 2 0.007331284 0.41055191 0.013685064 6714 hsa-mir-184 hsa03420 Nucleotide excision repair 5981_4331 2 0.010088532 0.564957777 0.018224444 6715 hsa-mir-184 hsa04120 Ubiquitin mediated proteolysis 672_4193_8554 3 0.011595583 0.649352661 0.020292271 6716 hsa-mir-184 hsa05217 Basal cell carcinoma 1499_7157 2 0.015197422 0.85105563 0.025789565 6717 hsa-mir-184 hsa04920 Adipocytokine signaling pathway 6256_5970 2 0.021778312 1 0.035870161 6718 hsa-mir-184 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_3725 2 0.024190725 1 0.038705159 6719 hsa-mir-184 hsa04612 Antigen processing and presentation 4800_1385 2 0.036290881 1 0.054926739 6720 hsa-mir-184 hsa04210 Apoptosis 5970_7157 2 0.036290881 1 0.054926739 6721 hsa-mir-184 hsa03450 Non-homologous end-joining 2547 1 0.048228239 1 0.071073195 6722 hsa-mir-185 hsa05200 Pathways in cancer 5371_5595_5594_5914_1387_6256_595_836_367_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_4088_4089_3066_3065_5925_2034_2033_4846 29 9.48E-32 5.88E-30 5.88E-30 6723 hsa-mir-185 hsa05220 Chronic myeloid leukemia 5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464 15 1.32E-21 8.19E-20 4.10E-20 6724 hsa-mir-185 hsa04110 Cell cycle 5591_1387_595_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933 15 6.99E-19 4.33E-17 1.44E-17 6725 hsa-mir-185 hsa05215 Prostate cancer 5595_5594_1387_595_367_5970_1870_1871_7157_1869_5925_2033 12 1.09E-15 6.75E-14 1.53E-14 6726 hsa-mir-185 hsa05212 Pancreatic cancer 5595_5594_1387_595_367_5970_1870_1871_7157_1869_5925_2033 12 1.23E-15 7.64E-14 1.53E-14 6727 hsa-mir-185 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5925 9 1.21E-13 7.53E-12 1.25E-12 6728 hsa-mir-185 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925 9 9.13E-13 5.66E-11 7.76E-12 6729 hsa-mir-185 hsa05210 Colorectal cancer 5595_5594_595_836_7157_4087_4609_3725_4088_4089 10 1.00E-12 6.21E-11 7.76E-12 6730 hsa-mir-185 hsa05222 Small cell lung cancer 6256_595_5970_1870_1871_7157_4609_1869_5925_4846 10 1.24E-12 7.70E-11 8.56E-12 6731 hsa-mir-185 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_4087_4609_4088_4089_2033_5933 10 1.38E-12 8.56E-11 8.56E-12 6732 hsa-mir-185 hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_6464 9 4.13E-12 2.56E-10 2.33E-11 6733 hsa-mir-185 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2113_3725_2034_2033 9 9.57E-12 5.93E-10 4.94E-11 6734 hsa-mir-185 hsa04310 Wnt signaling pathway 1387_595_7157_4087_4773_4609_3725_1457_4088_4089_2033 11 1.08E-11 6.72E-10 5.17E-11 6735 hsa-mir-185 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_5970_4609 8 7.86E-11 4.88E-09 3.48E-10 6736 hsa-mir-185 hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5925 8 3.04E-10 1.89E-08 1.26E-09 6737 hsa-mir-185 hsa04520 Adherens junction 5595_5594_1387_4087_1457_4088_4089_2033 8 7.31E-10 4.53E-08 2.83E-09 6738 hsa-mir-185 hsa05016 Huntington's disease 6874_1387_2902_836_6667_7157_3066_3065_3064_2033 10 1.67E-09 1.04E-07 6.11E-09 6739 hsa-mir-185 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 2.07E-09 1.29E-07 7.14E-09 6740 hsa-mir-185 hsa04010 MAPK signaling pathway 5595_5594_4208_836_3312_5970_7157_4773_4609_3725_4763 11 4.02E-09 2.49E-07 1.31E-08 6741 hsa-mir-185 hsa04330 Notch signaling pathway 1387_9612_3066_3065_2033 5 9.73E-07 6.03E-05 3.01E-06 6742 hsa-mir-185 hsa05213 Endometrial cancer 5595_5594_595_7157_4609 5 1.55E-06 9.58E-05 4.56E-06 6743 hsa-mir-185 hsa04720 Long-term potentiation 5595_5594_1387_2902_2033 5 8.34E-06 0.000516989 2.25E-05 6744 hsa-mir-185 hsa04662 B cell receptor signaling pathway 5595_5594_5970_4773_3725 5 8.34E-06 0.000516989 2.25E-05 6745 hsa-mir-185 hsa04012 ErbB signaling pathway 5595_5594_4609_3725_6464 5 1.65E-05 0.001023785 4.27E-05 6746 hsa-mir-185 hsa04660 T cell receptor signaling pathway 5595_5594_5970_4773_3725 5 4.84E-05 0.003002512 0.0001201 6747 hsa-mir-185 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_7157_4846 4 5.44E-05 0.003372571 0.000129714 6748 hsa-mir-185 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_4773_6464 5 0.000135841 0.008422164 0.000311932 6749 hsa-mir-185 hsa04370 VEGF signaling pathway 5595_5594_4773_4846 4 0.000175657 0.01089072 0.000388954 6750 hsa-mir-185 hsa05010 Alzheimer's disease 5595_5594_2902_836_4846 5 0.000414675 0.025709879 0.000886548 6751 hsa-mir-185 hsa04620 Toll-like receptor signaling pathway 5595_5594_5970_3725 4 0.000491299 0.030460516 0.001015351 6752 hsa-mir-185 hsa04916 Melanogenesis 5595_5594_1387_2033 4 0.000527247 0.032689323 0.001054494 6753 hsa-mir-185 hsa04510 Focal adhesion 5595_5594_595_3725_6464 5 0.000809526 0.050190623 0.001568457 6754 hsa-mir-185 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.000896844 0.055604329 0.00168498 6755 hsa-mir-185 hsa04910 Insulin signaling pathway 6720_5595_5594_6464 4 0.001461722 0.090626737 0.002665492 6756 hsa-mir-185 hsa04115 p53 signaling pathway 595_836_7157 3 0.001954848 0.12120056 0.003462873 6757 hsa-mir-185 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_5970_3725 3 0.002114296 0.131086374 0.003542875 6758 hsa-mir-185 hsa04730 Long-term depression 5595_5594_4846 3 0.002114296 0.131086374 0.003542875 6759 hsa-mir-185 hsa04630 Jak-STAT signaling pathway 1387_595_4609_2033 4 0.002208463 0.136924734 0.003603282 6760 hsa-mir-185 hsa04612 Antigen processing and presentation 4800_4801_3312 3 0.003918069 0.242920304 0.006073008 6761 hsa-mir-185 hsa04210 Apoptosis 836_5970_7157 3 0.003918069 0.242920304 0.006073008 6762 hsa-mir-185 hsa04062 Chemokine signaling pathway 5595_5594_5970_6464 4 0.004750734 0.294545482 0.007184036 6763 hsa-mir-185 hsa04912 GnRH signaling pathway 5595_5594_3725 3 0.006604658 0.409488823 0.009749734 6764 hsa-mir-185 hsa04360 Axon guidance 5595_5594_4773 3 0.011034538 0.684141361 0.015910264 6765 hsa-mir-185 hsa04930 Type II diabetes mellitus 5595_5594 2 0.011338112 0.702962923 0.01597643 6766 hsa-mir-185 hsa03050 Proteasome 5684_5705 2 0.012763454 0.791334124 0.017377911 6767 hsa-mir-185 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428 3 0.012893289 0.799383912 0.017377911 6768 hsa-mir-185 hsa04920 Adipocytokine signaling pathway 6256_5970 2 0.023439873 1 0.030920683 6769 hsa-mir-185 hsa04664 Fc epsilon RI signaling pathway 5595_5594 2 0.03152989 1 0.040726108 6770 hsa-mir-185 hsa04540 Gap junction 5595_5594 2 0.042139387 1 0.053319224 6771 hsa-mir-185 hsa04710 Circadian rhythm - mammal 8863 1 0.046861183 1 0.058107867 6772 hsa-mir-186 hsa05200 Pathways in cancer 4087_5601_3065_1488_3725_2885_1487_2033_367_9063_5595_5594_5604_5599_2353_1387 16 5.90E-21 2.95E-19 2.95E-19 6773 hsa-mir-186 hsa04010 MAPK signaling pathway 9344_6722_5606_5601_5600_3725_2885_5595_1432_5594_5604_5599_2005_2353 14 1.07E-18 5.37E-17 2.68E-17 6774 hsa-mir-186 hsa04620 Toll-like receptor signaling pathway 5606_5601_5600_3725_5595_1432_5594_5604_5599_2353 10 3.50E-16 1.75E-14 5.83E-15 6775 hsa-mir-186 hsa04912 GnRH signaling pathway 5606_5601_5600_3725_2885_5595_1432_5594_5604_5599 10 5.99E-16 3.00E-14 7.49E-15 6776 hsa-mir-186 hsa04664 Fc epsilon RI signaling pathway 5606_5601_5600_2885_5595_1432_5594_5604_5599 9 3.38E-15 1.69E-13 3.38E-14 6777 hsa-mir-186 hsa05210 Colorectal cancer 4087_5601_3725_2885_5595_5594_5604_5599_2353 9 5.67E-15 2.83E-13 4.72E-14 6778 hsa-mir-186 hsa04660 T cell receptor signaling pathway 5601_5600_3725_2885_5595_1432_5594_5604_2353 9 5.56E-14 2.78E-12 3.97E-13 6779 hsa-mir-186 hsa04350 TGF-beta signaling pathway 4087_2033_5595_5594_3397_3399_3398_1387 8 6.49E-13 3.24E-11 4.06E-12 6780 hsa-mir-186 hsa05211 Renal cell carcinoma 3725_2885_2033_5595_5594_5604_1387 7 1.39E-11 6.93E-10 7.70E-11 6781 hsa-mir-186 hsa05220 Chronic myeloid leukemia 3065_1488_2885_1487_5595_5594_5604 7 1.81E-11 9.06E-10 9.06E-11 6782 hsa-mir-186 hsa04310 Wnt signaling pathway 4087_5601_1488_3725_1487_2033_5599_1387 8 4.47E-11 2.23E-09 2.00E-10 6783 hsa-mir-186 hsa04012 ErbB signaling pathway 5601_3725_2885_5595_5594_5604_5599 7 4.82E-11 2.41E-09 2.00E-10 6784 hsa-mir-186 hsa05215 Prostate cancer 2885_2033_367_5595_5594_5604_1387 7 5.20E-11 2.60E-09 2.00E-10 6785 hsa-mir-186 hsa05212 Pancreatic cancer 2885_2033_367_5595_5594_5604_1387 7 5.60E-11 2.80E-09 2.00E-10 6786 hsa-mir-186 hsa04662 B cell receptor signaling pathway 3725_2885_5595_5594_5604_2353 6 1.33E-09 6.63E-08 4.42E-09 6787 hsa-mir-186 hsa04330 Notch signaling pathway 3065_1488_1487_2033_1387 5 9.12E-09 4.56E-07 2.85E-08 6788 hsa-mir-186 hsa04510 Focal adhesion 5601_3725_2885_5595_5594_5604_5599 7 1.50E-08 7.48E-07 4.40E-08 6789 hsa-mir-186 hsa04910 Insulin signaling pathway 5601_2885_5595_5594_5604_5599 6 4.28E-08 2.14E-06 1.19E-07 6790 hsa-mir-186 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5601_5600_3725_1432_5599 5 6.33E-08 3.16E-06 1.67E-07 6791 hsa-mir-186 hsa04720 Long-term potentiation 2033_5595_5594_5604_1387 5 8.20E-08 4.10E-06 2.05E-07 6792 hsa-mir-186 hsa04370 VEGF signaling pathway 5600_5595_1432_5594_5604 5 9.29E-08 4.64E-06 2.21E-07 6793 hsa-mir-186 hsa04520 Adherens junction 4087_2033_5595_5594_1387 5 1.11E-07 5.57E-06 2.53E-07 6794 hsa-mir-186 hsa04916 Melanogenesis 2033_5595_5594_5604_1387 5 3.87E-07 1.94E-05 8.42E-07 6795 hsa-mir-186 hsa04930 Type II diabetes mellitus 5601_5595_5594_5599 4 6.05E-07 3.02E-05 1.26E-06 6796 hsa-mir-186 hsa05213 Endometrial cancer 2885_5595_5594_5604 4 1.04E-06 5.21E-05 2.08E-06 6797 hsa-mir-186 hsa05223 Non-small cell lung cancer 2885_5595_5594_5604 4 1.20E-06 6.00E-05 2.31E-06 6798 hsa-mir-186 hsa05221 Acute myeloid leukemia 2885_5595_5594_5604 4 1.68E-06 8.39E-05 3.11E-06 6799 hsa-mir-186 hsa05214 Glioma 2885_5595_5594_5604 4 2.42E-06 0.000121014 4.32E-06 6800 hsa-mir-186 hsa04540 Gap junction 2885_5595_5594_5604 4 9.44E-06 0.000471822 1.63E-05 6801 hsa-mir-186 hsa05216 Thyroid cancer 5595_5594_5604 3 1.14E-05 0.000569261 1.90E-05 6802 hsa-mir-186 hsa04110 Cell cycle 4087_3065_2033_1387 4 2.41E-05 0.001205033 3.89E-05 6803 hsa-mir-186 hsa05219 Bladder cancer 5595_5594_5604 3 3.22E-05 0.001608643 5.03E-05 6804 hsa-mir-186 hsa04650 Natural killer cell mediated cytotoxicity 2885_5595_5594_5604 4 4.23E-05 0.002114935 6.41E-05 6805 hsa-mir-186 hsa04630 Jak-STAT signaling pathway 2885_2033_9063_1387 4 6.57E-05 0.003284439 9.66E-05 6806 hsa-mir-186 hsa05014 Amyotrophic lateral sclerosis (ALS) 5606_5600_1432 3 7.27E-05 0.003636802 0.000103909 6807 hsa-mir-186 hsa05016 Huntington's disease 3065_2033_25942_1387 4 0.000136103 0.006805149 0.000188148 6808 hsa-mir-186 hsa05218 Melanoma 5595_5594_5604 3 0.000142992 0.007149614 0.000188148 6809 hsa-mir-186 hsa04730 Long-term depression 5595_5594_5604 3 0.000142992 0.007149614 0.000188148 6810 hsa-mir-186 hsa04062 Chemokine signaling pathway 2885_5595_5594_5604 4 0.000150225 0.007511234 0.000192596 6811 hsa-mir-186 hsa04270 Vascular smooth muscle contraction 5595_5594_5604 3 0.00060762 0.030380982 0.000759525 6812 hsa-mir-186 hsa04120 Ubiquitin mediated proteolysis 7329_9063_672 3 0.000966359 0.048317952 0.001178487 6813 hsa-mir-186 hsa05010 Alzheimer's disease 6622_5595_5594 3 0.001907557 0.095377839 0.002270901 6814 hsa-mir-186 hsa04150 mTOR signaling pathway 5595_5594 2 0.002486313 0.124315631 0.002891061 6815 hsa-mir-186 hsa04810 Regulation of actin cytoskeleton 5595_5594_5604 3 0.003450783 0.172539164 0.003921345 6816 hsa-mir-186 hsa04920 Adipocytokine signaling pathway 5601_5599 2 0.004023752 0.201187601 0.004470836 6817 hsa-mir-186 hsa04670 Leukocyte transendothelial migration 5600_1432 2 0.012476175 0.62380875 0.01356106 6818 hsa-mir-186 hsa04360 Axon guidance 5595_5594 2 0.014250563 0.712528162 0.015160174 6819 hsa-mir-186 hsa03410 Base excision repair 3146 1 0.049305461 1 0.051359855 6820 hsa-mir-187 hsa04350 TGF-beta signaling pathway 659 1 0.002933236 0.005866471 0.005866471 6821 hsa-mir-187 hsa04060 Cytokine-cytokine receptor interaction 659 1 0.008766374 0.017532749 0.008766374 6822 hsa-mir-18a hsa05200 Pathways in cancer 4149_3551_1398_1499_5914_595_596_598_3815_1017_8517_4193_6934_5578_3091_2735_2064_3066_3065_5925_1050_613_5743_5747_10342_25_405_9063_1956_1487_6789_7046_4436_1870_1871_2113_6774_867_10401_207_208_9915_7187_4286_3716_1147_5879_2249_998_1488_2261_5595_5594_5599_861_1387_6256_836_367_2932_6777_6772_5970_7157_7849_1869_3725_5467_6776_4087_4088_4089_5888_5728_2034_2033_5468_4846_3910_898_4790_4791_4792_3320_3326_51176_5371_675_5159_5156_5604_5601_5602_1856_1399_3265_51588_7428_8772_4609_2956_1026_2736_2353_7704_2737_8554 107 1.09E-45 9.69E-44 9.69E-44 6823 hsa-mir-18a hsa04010 MAPK signaling pathway 6722_4149_3551_1398_6195_6197_2264_8517_9252_5578_1845_7132_4773_9020_5923_1956_3304_3305_3303_6789_1432_7046_22800_4763_1616_207_208_1147_5879_2249_998_3727_2261_5595_5594_5599_5598_8986_1386_1649_836_3310_3312_3315_5971_5970_3164_7157_3725_6196_5058_4790_4791_5159_9261_1326_5156_5604_4208_5601_5600_5603_5602_5608_1399_3265_6885_4609_2353_2002_8550_5566 72 1.47E-26 1.31E-24 6.54E-25 6824 hsa-mir-18a hsa05220 Chronic myeloid leukemia 3551_1398_595_598_8517_4193_3066_3065_5925_613_25_1487_7046_1870_1871_867_207_208_1147_1488_5595_5594_861_6777_5970_7157_1869_6776_4088_4089_4790_4792_5604_1399_3265_5781_4609_1026_6464 39 2.88E-23 2.56E-21 8.53E-22 6825 hsa-mir-18a hsa04110 Cell cycle 4174_4172_595_1017_4193_902_6500_3066_3065_5925_25_1870_1871_5111_9232_5934_5933_545_995_5347_7534_5591_1387_11200_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_898_1031_983_8454_1026_1022_1111_8556_8555_472 44 2.18E-21 1.94E-19 4.85E-20 6826 hsa-mir-18a hsa05215 Prostate cancer 3551_1499_595_596_1017_8517_4193_6934_2064_5925_1956_1870_1871_207_208_9586_1147_5595_5594_1387_367_2932_5970_7157_1869_5728_2033_898_4790_4792_3320_3326_51176_5159_5156_5604_3265_1026 38 1.64E-20 1.46E-18 2.92E-19 6827 hsa-mir-18a hsa05212 Pancreatic cancer 3551_1499_595_596_1017_8517_4193_6934_2064_5925_1956_1870_1871_207_208_9586_1147_5595_5594_1387_367_2932_5970_7157_1869_5728_2033_898_4790_4792_3320_3326_51176_5159_5156_5604_3265_1026 38 2.24E-20 1.99E-18 3.32E-19 6828 hsa-mir-18a hsa04310 Wnt signaling pathway 818_817_1499_595_8607_6934_5578_6500_4772_4773_23291_1487_5879_1460_1488_5599_1387_1459_2932_7157_8061_3725_5467_1457_1452_4087_4088_4089_2033_51176_5519_5518_5515_5601_5602_1856_8454_8945_6885_4609_5527_5566 42 1.16E-16 1.03E-14 1.48E-15 6829 hsa-mir-18a hsa04660 T cell receptor signaling pathway 3551_1493_8517_5777_4772_4773_9020_2534_3932_4794_1432_867_207_208_1147_998_5595_5594_2932_5970_3725_5058_959_4790_4792_4793_1326_5604_5601_5600_5603_919_3265_6885_2353 35 1.17E-15 1.04E-13 1.30E-14 6830 hsa-mir-18a hsa05222 Small cell lung cancer 4149_3551_595_596_598_1017_8517_5925_5743_5747_9063_1870_1871_10401_207_208_7187_1147_6256_5970_7157_1869_5728_4846_3910_898_4790_4792_51588_4609_8554 31 3.05E-15 2.72E-13 3.02E-14 6831 hsa-mir-18a hsa05210 Colorectal cancer 1499_595_596_6934_1956_7046_4436_207_208_5879_5595_5594_5599_836_2932_7157_3725_4087_4088_4089_51176_5159_5156_5604_5601_5602_1856_4609_2956_2353 30 1.04E-14 9.26E-13 9.26E-14 6832 hsa-mir-18a hsa04012 ErbB signaling pathway 818_817_1398_5578_2064_5747_25_1956_6714_867_207_208_5595_5594_5599_2066_2932_6777_3725_6776_5058_5604_5601_5602_1399_3265_4609_1026_2002_6464 30 2.22E-14 1.98E-12 1.80E-13 6833 hsa-mir-18a hsa05221 Acute myeloid leukemia 3551_5914_595_3815_8517_6934_1050_6774_207_208_1147_5595_5594_861_6777_5970_5467_6776_4790_51176_5371_5604_3265_4609_7704 25 7.83E-14 6.97E-12 5.61E-13 6834 hsa-mir-18a hsa04630 Jak-STAT signaling pathway 3559_595_598_5777_3455_3594_9063_3560_3561_6773_1439_3595_2057_6774_867_2690_10401_3459_3977_207_208_3717_3716_8651_1387_6778_6777_6772_7297_6776_2033_51588_10379_5781_58985_4609_3575_8554 38 8.19E-14 7.29E-12 5.61E-13 6835 hsa-mir-18a hsa04920 Adipocytokine signaling pathway 3551_10891_5465_6794_8517_7132_8717_2538_4794_8471_6774_207_208_3717_1147_5599_6256_5970_4790_4792_4793_5601_5602_5563_5781_7133 26 1.29E-13 1.15E-11 8.15E-13 6836 hsa-mir-18a hsa04620 Toll-like receptor signaling pathway 3551_8517_3455_3665_3661_1432_207_208_7187_1147_5879_29110_5595_5594_5599_6772_5970_3725_4790_4792_1326_5604_5601_5600_5603_5602_5608_9641_8772_6885_2353 31 1.37E-13 1.22E-11 8.15E-13 6837 hsa-mir-18a hsa05214 Glioma 818_817_595_4193_5578_5925_1956_1870_1871_207_208_5595_5594_7157_1869_5728_808_801_805_5159_5156_5604_3265_1026_6464 25 4.48E-13 3.98E-11 2.49E-12 6838 hsa-mir-18a hsa04520 Adherens junction 1499_6934_5770_5777_2064_2534_1956_6714_7046_5879_1460_998_5595_5594_1387_1459_1457_4087_4088_4089_2033_51176_3643_71_8826_6885 26 3.59E-12 3.20E-10 1.88E-11 6839 hsa-mir-18a hsa04910 Insulin signaling pathway 3551_10891_1398_6720_5770_2538_5590_5499_8471_867_5211_207_208_8651_5595_5594_5599_2932_2194_808_801_805_3643_5604_5601_5602_5563_1399_3265_2002_6464_5566 32 2.57E-11 2.28E-09 1.27E-10 6840 hsa-mir-18a hsa04662 B cell receptor signaling pathway 3551_8517_5777_4772_4773_4794_207_208_1147_5879_695_5595_5594_1380_2932_6850_5970_3725_4790_4792_4793_5604_3265_2353 24 3.15E-11 2.80E-09 1.48E-10 6841 hsa-mir-18a hsa04350 TGF-beta signaling pathway 6500_90_4086_1875_6667_7046_1874_57154_5934_5933_5595_5594_1387_7027_4087_4088_4089_2033_5519_5518_5515_8454_4609_4093_4092 25 8.45E-11 7.52E-09 3.76E-10 6842 hsa-mir-18a hsa04115 p53 signaling pathway 595_1017_4194_4193_900_50484_51246_545_7161_11200_836_7157_6241_64326_5728_898_27113_25898_983_1026_1111_472 22 2.19E-10 1.95E-08 9.29E-10 6843 hsa-mir-18a hsa04510 Focal adhesion 1398_1499_595_596_5578_2064_5923_2534_5747_3791_1956_6714_5499_207_208_5879_998_5595_5594_5599_2932_3725_5058_5728_3910_2321_5159_5156_5604_5601_5602_1399_3265_71_2002_85366_6464 37 4.52E-10 4.03E-08 1.83E-09 6844 hsa-mir-18a hsa04062 Chemokine signaling pathway 3551_1398_8517_653361_5747_5580_5590_6773_2309_6362_6774_207_208_3717_1147_5879_998_5595_5594_1234_2932_6777_6772_5970_5058_4790_4792_4793_1230_5604_1399_3265_7852_6464_5566 35 1.06E-09 9.45E-08 4.11E-09 6845 hsa-mir-18a hsa05219 Bladder cancer 595_9252_4193_2064_5925_1956_1870_1871_2261_5595_5594_7157_1869_5604_3265_4609_1026 17 1.31E-09 1.16E-07 4.85E-09 6846 hsa-mir-18a hsa03010 Ribosome 6193_6204_6205_6207_6202_6141_9349_6217_6137_6135_6210_6155_6156_6191_6222_6223_6229_6129_6128_6125_6130_6181_6189_6188_6232 25 1.42E-09 1.26E-07 5.05E-09 6847 hsa-mir-18a hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3551_8517_9020_1956_6714_1432_1147_5879_998_5599_836_5970_3725_5058_4790_4792_5601_5600_5603_5602_5781 21 1.74E-09 1.55E-07 5.96E-09 6848 hsa-mir-18a hsa05211 Renal cell carcinoma 1398_3091_405_2113_207_208_9915_5879_998_5595_5594_1387_3725_5058_2034_2033_5604_1399_3265_7428_5781 21 2.15E-09 1.91E-07 7.08E-09 6849 hsa-mir-18a hsa05213 Endometrial cancer 1499_595_6934_2064_1956_2309_207_208_5595_5594_2932_7157_5728_51176_5604_3265_4609_2002 18 3.26E-09 2.90E-07 1.04E-08 6850 hsa-mir-18a hsa04912 GnRH signaling pathway 818_817_5578_5580_1956_6714_1432_998_5595_5594_5599_5598_3725_808_801_805_5604_5601_5600_5603_5602_5608_3265_2002_5566 25 3.86E-09 3.43E-07 1.18E-08 6851 hsa-mir-18a hsa05223 Non-small cell lung cancer 595_5578_2064_5925_1956_2309_6789_1870_1871_207_208_5595_5594_6256_7157_1869_5604_3265 18 5.31E-09 4.73E-07 1.58E-08 6852 hsa-mir-18a hsa04370 VEGF signaling pathway 5578_4772_4773_5743_5747_3791_6714_1432_207_208_5879_998_5595_5594_3315_4846_9261_5604_5600_5603_3265 21 5.87E-09 5.23E-07 1.69E-08 6853 hsa-mir-18a hsa05216 Thyroid cancer 1499_595_6934_10342_5595_5594_6256_7157_7849_5468_51176_5604_3265_4609 14 6.40E-09 5.70E-07 1.78E-08 6854 hsa-mir-18a hsa05218 Melanoma 595_4193_5925_1956_1870_1871_207_208_4286_2249_5595_5594_7157_1869_5728_5159_5156_5604_3265_1026 20 8.48E-09 7.55E-07 2.29E-08 6855 hsa-mir-18a hsa04210 Apoptosis 3551_596_598_8517_7132_8717_9020_823_1439_207_208_1147_836_5970_7157_9131_4790_4792_840_8772_472_5566 22 1.19E-08 1.06E-06 3.10E-08 6856 hsa-mir-18a hsa04720 Long-term potentiation 818_814_817_6195_6197_5578_2902_2906_5499_5595_5594_1387_6196_2033_808_801_805_5604_3265_5566 20 1.85E-08 1.65E-06 4.71E-08 6857 hsa-mir-18a hsa04120 Ubiquitin mediated proteolysis 4193_55294_6500_3093_23291_9063_7319_84447_867_10401_7329_8925_57154_8651_10055_51366_64326_7337_5371_672_25898_8454_8945_51588_7428_10075_8554 27 2.40E-08 2.13E-06 5.93E-08 6858 hsa-mir-18a hsa03022 Basal transcription factors 51616_6872_2965_2963_2969_6878_6874_6908_2958_2959_6880_2957_6882_9519 14 7.37E-08 6.56E-06 1.77E-07 6859 hsa-mir-18a hsa04664 Fc epsilon RI signaling pathway 5578_2534_5580_1432_207_208_5879_695_5595_5594_5599_6850_5604_5601_5600_5603_5602_5608_3265 19 1.67E-07 1.49E-05 3.91E-07 6860 hsa-mir-18a hsa04540 Gap junction 5592_5578_10382_1956_6714_5595_5594_5598_7846_1453_347733_5159_983_5156_5604_3265_7278_84617_203068_5566 20 3.78E-07 3.36E-05 8.62E-07 6861 hsa-mir-18a hsa04330 Notch signaling pathway 3066_3065_1840_9794_1487_2648_1488_1387_22938_9612_2033_8850_1856_4851 14 8.20E-07 7.30E-05 1.83E-06 6862 hsa-mir-18a hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_7132_2902_2906_1432_1616_5879_836_7157_4846_5600_5603_5608_7133 15 1.04E-06 9.28E-05 2.26E-06 6863 hsa-mir-18a hsa04916 Melanogenesis 818_817_1499_3815_6934_5578_4286_5595_5594_1387_2932_2033_808_801_805_51176_5604_1856_3265_5566 20 1.74E-06 0.000154611 3.68E-06 6864 hsa-mir-18a hsa05131 Shigellosis 1499_5578_10382_2534_25_998_7534_7846_347733_7278_71_84617_4691_203068 14 4.71E-06 0.00041917 9.53E-06 6865 hsa-mir-18a hsa05130 Pathogenic Escherichia coli infection 1499_5578_10382_2534_25_998_7534_7846_347733_7278_71_84617_4691_203068 14 4.71E-06 0.00041917 9.53E-06 6866 hsa-mir-18a hsa04530 Tight junction 1499_5578_5580_5590_6714_4627_4628_22800_8573_207_208_1460_998_1459_1457_5728_5519_5518_5515_3265_71_5520 22 7.30E-06 0.000649919 1.44E-05 6867 hsa-mir-18a hsa04930 Type II diabetes mellitus 3551_5580_5590_8471_3651_8651_5595_5594_5599_3643_5601_5602 12 1.29E-05 0.001144695 2.49E-05 6868 hsa-mir-18a hsa03050 Proteasome 5708_5709_5705_5706_5700_5684_5719_5717_5713_5687_5693_5707 12 2.23E-05 0.001983967 4.22E-05 6869 hsa-mir-18a hsa05322 Systemic lupus erythematosus 3021_3020_8366_9555_8349_8362_8365_8368_3018_8294_8370_6628_121504_8360_8363_8364_8367_959_8359_8361 20 0.000114962 0.010231574 0.000213158 6870 hsa-mir-18a hsa04650 Natural killer cell mediated cytotoxicity 5777_5578_3455_4772_4773_2534_3932_3459_5879_5595_5594_836_6850_5058_5604_919_3265_5781_6464 19 0.00018639 0.016588666 0.000338544 6871 hsa-mir-18a hsa03420 Nucleotide excision repair 5981_902_5111_5886_2965_4331_2071_2074_1022_6117 10 0.000208973 0.018598561 0.000371971 6872 hsa-mir-18a hsa03410 Base excision repair 4350_142_4913_252969_5111_3146_328_2237_6996 9 0.000234704 0.020888642 0.000404365 6873 hsa-mir-18a hsa05016 Huntington's disease 10891_293_292_3066_3065_3064_498_25942_2902_6667_9586_1387_836_5437_7157_1213_2033_5468_27113_6874_6908_5441_9519 23 0.000236258 0.021026969 0.000404365 6874 hsa-mir-18a hsa03450 Non-homologous end-joining 2547_10111_7520_2237_5591_4361 6 0.000254676 0.022666203 0.000427664 6875 hsa-mir-18a hsa04060 Cytokine-cytokine receptor interaction 3559_3815_7132_3455_90_3594_3791_1956_3560_3561_1439_7046_3595_2057_6362_2690_3459_3977_1234_959_2321_1230_5159_5156_7852_58985_3575_7133 28 0.000428557 0.038141597 0.000706326 6876 hsa-mir-18a hsa04150 mTOR signaling pathway 6794_6195_6197_3091_207_208_5595_5594_6196_5563 10 0.000664511 0.059141519 0.0010753 6877 hsa-mir-18a hsa04810 Regulation of actin cytoskeleton 10788_1398_2264_5747_1956_5499_4627_4628_22800_5879_2249_998_2261_5595_5594_5058_5159_5156_5604_1399_3265_71_8826_85366 24 0.000734187 0.065342612 0.001166832 6878 hsa-mir-18a hsa03030 DNA replication 5981_4174_4172_5111_2237_5557_6117_5422 8 0.001009998 0.089889789 0.001577014 6879 hsa-mir-18a hsa03440 Homologous recombination 641_10111_4361_4683_5888_675_6117 7 0.001154958 0.102791261 0.001772263 6880 hsa-mir-18a hsa04340 Hedgehog signaling pathway 2735_23291_53944_2932_1452_1453_8945_2736_2737_5566 10 0.001235803 0.10998646 0.001864177 6881 hsa-mir-18a hsa04020 Calcium signaling pathway 818_814_817_293_5578_292_2064_1956_2902_2906_147_2066_4846_808_801_805_5159_5156_85366_5566 20 0.002418527 0.215248871 0.003587481 6882 hsa-mir-18a hsa04740 Olfactory transduction 818_817_5592_808_801_805_5566 7 0.002690948 0.239494361 0.003926137 6883 hsa-mir-18a hsa05217 Basal cell carcinoma 1499_6934_2735_2932_7157_51176_1856_2736_2737 9 0.003243108 0.288636595 0.004655429 6884 hsa-mir-18a hsa04730 Long-term depression 5592_5578_5595_5594_4846_5519_5518_5515_5604_3265 10 0.005138341 0.457312374 0.007258927 6885 hsa-mir-18a hsa03020 RNA polymerase 64425_25885_51082_5437_84172_5441 6 0.005784676 0.514836197 0.008007755 6886 hsa-mir-18a hsa04270 Vascular smooth muscle contraction 5592_5578_5580_147_5499_59_5595_5594_808_801_805_5604_85366_5566 14 0.005848361 0.520504088 0.008007755 6887 hsa-mir-18a hsa03430 Mismatch repair 5981_4436_5111_2956_6117 5 0.00967112 0.860729705 0.013041359 6888 hsa-mir-18a hsa04360 Axon guidance 4772_4773_2534_5747_25_5879_998_5595_5594_2932_5058_3265_7852_1020 14 0.010520257 0.936302834 0.013974669 6889 hsa-mir-18a hsa04950 Maturity onset diabetes of the young 5080_6927_4760_3651_3172 5 0.011235995 1 0.014705934 6890 hsa-mir-18a hsa05340 Primary immunodeficiency 8517_3932_3561_695_959_3575 6 0.012581327 1 0.016228089 6891 hsa-mir-18a hsa05010 Alzheimer's disease 7132_498_823_2902_2906_5595_5594_836_2932_4846_808_351_801_805_840_8772_1020 17 0.016210182 1 0.020610088 6892 hsa-mir-18a hsa04612 Antigen processing and presentation 3309_3304_3305_3303_3310_3312_3320_3326_4800_4801 10 0.027680759 1 0.034698417 6893 hsa-mir-18a hsa04670 Leukocyte transendothelial migration 1499_5578_653361_5747_1432_5879_998_5600_5603_7852_71_5781 12 0.037827534 1 0.046535049 6894 hsa-mir-18a hsa04710 Circadian rhythm - mammal 8863_4862_1453 3 0.038169197 1 0.046535049 6895 hsa-mir-18b hsa05200 Pathways in cancer 3320_5371_1488_1017_5595_5594_5599_861_5914_1387_6256_595_6502_836_6258_367_2932_4193_4149_7704_842_6774_3091_5970_7428_1870_1871_7157_4824_4087_6688_5604_2113_4609_1869_3725_841_1029_1487_4088_4089_3066_3065_4292_1050_5925_2034_2033_4846_207_9915_5894 52 7.62E-41 5.11E-39 5.11E-39 6896 hsa-mir-18b hsa05220 Chronic myeloid leukemia 1488_5595_5594_861_595_4193_5970_1870_1871_7157_5604_4609_1869_1029_1487_4088_4089_3066_3065_5925_207_6464_5894 23 2.78E-24 1.86E-22 9.32E-23 6897 hsa-mir-18b hsa04110 Cell cycle 890_5591_1017_1387_595_983_6502_2932_4193_8454_6500_1870_1871_7157_4087_1869_1029_4088_4089_3066_3065_5925_2033_5933_5934_990 26 4.68E-24 3.13E-22 1.04E-22 6898 hsa-mir-18b hsa05215 Prostate cancer 3320_1017_5595_5594_1387_595_367_2932_4193_1385_842_5970_1870_1871_7157_4824_5604_1869_5925_2033_207_5894 22 1.24E-21 8.27E-20 2.04E-20 6899 hsa-mir-18b hsa05212 Pancreatic cancer 3320_1017_5595_5594_1387_595_367_2932_4193_1385_842_5970_1870_1871_7157_4824_5604_1869_5925_2033_207_5894 22 1.53E-21 1.02E-19 2.04E-20 6900 hsa-mir-18b hsa04350 TGF-beta signaling pathway 3399_5595_5594_1387_6667_8454_3398_6500_1874_1875_4087_4609_4088_4089_2033_5933_4093_5934 18 1.14E-16 7.67E-15 1.28E-15 6901 hsa-mir-18b hsa05223 Non-small cell lung cancer 5595_5594_6256_595_6258_842_1870_1871_7157_5604_1869_1029_5925_207_5894 15 9.82E-16 6.58E-14 9.40E-15 6902 hsa-mir-18b hsa05210 Colorectal cancer 5595_5594_5599_595_836_2932_842_7157_4087_5604_4609_3725_4088_4089_4292_207_5894 17 1.13E-15 7.56E-14 9.45E-15 6903 hsa-mir-18b hsa05221 Acute myeloid leukemia 5371_5595_5594_861_5914_595_7704_6774_5970_6688_5604_4609_1050_207_5894 15 3.01E-15 2.02E-13 2.24E-14 6904 hsa-mir-18b hsa05214 Glioma 815_5595_5594_595_4193_1870_1871_7157_5604_1869_1029_5925_207_6464_5894 15 1.03E-14 6.91E-13 6.91E-14 6905 hsa-mir-18b hsa05222 Small cell lung cancer 1017_6256_595_6502_6258_4149_842_5970_1870_1871_7157_4609_1869_5925_4846_207 16 2.51E-14 1.68E-12 1.43E-13 6906 hsa-mir-18b hsa05219 Bladder cancer 5595_5594_595_4193_1870_1871_7157_5604_4609_1869_1029_5925_5894 13 2.55E-14 1.71E-12 1.43E-13 6907 hsa-mir-18b hsa04310 Wnt signaling pathway 815_1488_5599_1387_595_2932_8454_6500_7157_4087_4609_3725_1457_1487_1459_4088_4089_2033 18 6.49E-13 4.35E-11 3.34E-12 6908 hsa-mir-18b hsa04010 MAPK signaling pathway 5595_5594_5599_5598_4208_836_4149_3312_1386_5970_9261_7157_5604_4609_3725_6195_4763_1616_207_2002_2005_5894 22 2.25E-12 1.51E-10 1.08E-11 6909 hsa-mir-18b hsa05213 Endometrial cancer 5595_5594_595_2932_842_7157_5604_4609_4292_207_2002_5894 12 4.95E-12 3.32E-10 2.21E-11 6910 hsa-mir-18b hsa05218 Melanoma 5595_5594_595_4193_1870_1871_7157_5604_1869_1029_5925_207_5894 13 8.28E-12 5.55E-10 3.47E-11 6911 hsa-mir-18b hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_5604_2113_3725_2034_2033_207_9915_5894 13 9.68E-12 6.48E-10 3.81E-11 6912 hsa-mir-18b hsa04012 ErbB signaling pathway 815_6714_5595_5594_5599_2932_5604_4609_3725_207_6464_2002_5894 13 8.04E-11 5.38E-09 2.99E-10 6913 hsa-mir-18b hsa04540 Gap junction 6714_5595_5594_5598_983_7277_7278_5604_7846_51807_10376_5894 12 1.97E-09 1.32E-07 6.95E-09 6914 hsa-mir-18b hsa05216 Thyroid cancer 5595_5594_6256_595_6258_7157_5604_4609 8 5.68E-09 3.80E-07 1.90E-08 6915 hsa-mir-18b hsa04330 Notch signaling pathway 1488_1387_2648_1487_9612_3066_3065_2033_4851 9 1.00E-08 6.71E-07 3.19E-08 6916 hsa-mir-18b hsa04115 p53 signaling pathway 1017_595_983_836_4193_842_7157_841_7161_1029 10 1.64E-08 1.10E-06 4.99E-08 6917 hsa-mir-18b hsa04520 Adherens junction 6714_5595_5594_1387_4087_1457_1459_4088_4089_2033 10 5.84E-08 3.92E-06 1.68E-07 6918 hsa-mir-18b hsa05016 Huntington's disease 6874_1387_2902_6908_836_6667_1385_842_7157_841_3066_3065_3064_2033 14 6.00E-08 4.02E-06 1.68E-07 6919 hsa-mir-18b hsa04720 Long-term potentiation 815_5595_5594_1387_2902_5604_6195_2033_5894 9 3.72E-07 2.49E-05 9.96E-07 6920 hsa-mir-18b hsa04370 VEGF signaling pathway 6714_5595_5594_842_9261_5604_4846_207_5894 9 4.55E-07 3.05E-05 1.17E-06 6921 hsa-mir-18b hsa04912 GnRH signaling pathway 815_6714_5595_5594_5599_5598_5604_3725_2002_5894 10 7.59E-07 5.09E-05 1.88E-06 6922 hsa-mir-18b hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_5604_3725_207_5894 8 3.74E-06 0.000250732 8.95E-06 6923 hsa-mir-18b hsa04916 Melanogenesis 815_5595_5594_1387_2932_1385_5604_2033_5894 9 4.56E-06 0.000305637 1.05E-05 6924 hsa-mir-18b hsa04510 Focal adhesion 6714_5595_5594_5599_595_2932_5604_3725_207_6464_2002_5894 12 5.92E-06 0.000396333 1.28E-05 6925 hsa-mir-18b hsa04910 Insulin signaling pathway 6720_5595_5594_5599_2932_5604_207_6464_2002_5894 10 5.94E-06 0.000397869 1.28E-05 6926 hsa-mir-18b hsa04210 Apoptosis 836_839_842_840_5970_7157_841_207 8 1.20E-05 0.000804339 2.51E-05 6927 hsa-mir-18b hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5970_5604_3725_841_207 8 3.01E-05 0.002015855 6.11E-05 6928 hsa-mir-18b hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_6502_4193_8454_6500_7428_7329 9 4.00E-05 0.002682995 7.89E-05 6929 hsa-mir-18b hsa05010 Alzheimer's disease 22926_5595_5594_2902_836_2932_842_840_841_4846 10 4.52E-05 0.003026732 8.65E-05 6930 hsa-mir-18b hsa04660 T cell receptor signaling pathway 5595_5594_2932_5970_5604_3725_207_5894 8 4.98E-05 0.003336698 9.27E-05 6931 hsa-mir-18b hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_842_7157_1616_4846 6 6.13E-05 0.004109065 0.000105361 6932 hsa-mir-18b hsa05131 Shigellosis 7277_7278_7846_51807_4691_10376 6 6.13E-05 0.004109065 0.000105361 6933 hsa-mir-18b hsa05130 Pathogenic Escherichia coli infection 7277_7278_7846_51807_4691_10376 6 6.13E-05 0.004109065 0.000105361 6934 hsa-mir-18b hsa04062 Chemokine signaling pathway 5595_5594_7074_2932_6774_5970_5604_207_6464_5894 10 8.98E-05 0.006014739 0.000150368 6935 hsa-mir-18b hsa03022 Basal transcription factors 2963_2962_6874_2969_6908 5 9.43E-05 0.006319284 0.000154129 6936 hsa-mir-18b hsa04920 Adipocytokine signaling pathway 5599_6256_6258_6774_5970_207 6 0.000153509 0.010285107 0.000244883 6937 hsa-mir-18b hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5604_207_5894 6 0.000353322 0.023672599 0.000550526 6938 hsa-mir-18b hsa04150 mTOR signaling pathway 5595_5594_3091_6195_207 5 0.000405884 0.027194253 0.000618051 6939 hsa-mir-18b hsa04612 Antigen processing and presentation 3320_4800_4801_4802_1385_3312 6 0.000640768 0.042931444 0.000954032 6940 hsa-mir-18b hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5599_836_5970_3725 5 0.001511809 0.101291179 0.002155131 6941 hsa-mir-18b hsa04730 Long-term depression 5595_5594_5604_4846_5894 5 0.001511809 0.101291179 0.002155131 6942 hsa-mir-18b hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_5604_6464_5894 6 0.005263344 0.352644071 0.007346751 6943 hsa-mir-18b hsa04630 Jak-STAT signaling pathway 1387_595_6774_4609_2033_207 6 0.008919457 0.597603604 0.012195992 6944 hsa-mir-18b hsa04930 Type II diabetes mellitus 5595_5594_5599 3 0.015755146 1 0.021111895 6945 hsa-mir-18b hsa04270 Vascular smooth muscle contraction 5595_5594_5604_5894 4 0.045810228 1 0.060182064 6946 hsa-mir-1909 hsa05216 Thyroid cancer 7157 1 0.004989512 0.104779753 0.020872303 6947 hsa-mir-1909 hsa05219 Bladder cancer 7157 1 0.007145439 0.150054223 0.020872303 6948 hsa-mir-1909 hsa05213 Endometrial cancer 7157 1 0.0088013 0.184827307 0.020872303 6949 hsa-mir-1909 hsa05223 Non-small cell lung cancer 7157 1 0.009132207 0.191776353 0.020872303 6950 hsa-mir-1909 hsa05217 Basal cell carcinoma 7157 1 0.009297628 0.19525018 0.020872303 6951 hsa-mir-1909 hsa05014 Amyotrophic lateral sclerosis (ALS) 7157 1 0.009463026 0.198723543 0.020872303 6952 hsa-mir-1909 hsa05214 Glioma 7157 1 0.010950616 0.229962939 0.020872303 6953 hsa-mir-1909 hsa04115 p53 signaling pathway 7157 1 0.011611193 0.243835062 0.020872303 6954 hsa-mir-1909 hsa05218 Melanoma 7157 1 0.01194135 0.250768344 0.020872303 6955 hsa-mir-1909 hsa05220 Chronic myeloid leukemia 7157 1 0.012601398 0.264629348 0.020872303 6956 hsa-mir-1909 hsa05210 Colorectal cancer 7157 1 0.014085216 0.295789526 0.020872303 6957 hsa-mir-1909 hsa05222 Small cell lung cancer 7157 1 0.01441471 0.30270892 0.020872303 6958 hsa-mir-1909 hsa05215 Prostate cancer 7157 1 0.014744117 0.309626463 0.020872303 6959 hsa-mir-1909 hsa04210 Apoptosis 7157 1 0.014908788 0.313084542 0.020872303 6960 hsa-mir-1909 hsa05212 Pancreatic cancer 7157 1 0.014908788 0.313084542 0.020872303 6961 hsa-mir-1909 hsa04110 Cell cycle 7157 1 0.019838671 0.416612086 0.026038255 6962 hsa-mir-1909 hsa04120 Ubiquitin mediated proteolysis 7329 1 0.02311428 0.485399873 0.028552934 6963 hsa-mir-1909 hsa04310 Wnt signaling pathway 7157 1 0.025238725 0.530013226 0.029445179 6964 hsa-mir-1909 hsa05016 Huntington's disease 7157 1 0.031102522 0.653152954 0.034376471 6965 hsa-mir-1909 hsa04010 MAPK signaling pathway 7157 1 0.044835671 0.9415491 0.047077455 6966 hsa-mir-190b hsa05200 Pathways in cancer 3716_5601_3065_1050_5925_2033_3326_2932_3265_8554_3725_6772_2353_1387_6256 15 1.56E-13 9.03E-12 9.03E-12 6967 hsa-mir-190b hsa04630 Jak-STAT signaling pathway 3717_3716_3454_3455_7297_2033_8554_10379_6778_6772_1387 11 3.33E-12 1.93E-10 9.66E-11 6968 hsa-mir-190b hsa05215 Prostate cancer 5925_2033_3326_468_2932_3265_1387 7 1.63E-08 9.44E-07 2.54E-07 6969 hsa-mir-190b hsa05212 Pancreatic cancer 5925_2033_3326_468_2932_3265_1387 7 1.75E-08 1.02E-06 2.54E-07 6970 hsa-mir-190b hsa04720 Long-term potentiation 2902_2906_2033_468_3265_1387 6 1.75E-07 1.02E-05 1.90E-06 6971 hsa-mir-190b hsa04010 MAPK signaling pathway 5601_468_22800_3265_3725_3727_1649_2353_1386 9 1.97E-07 1.14E-05 1.90E-06 6972 hsa-mir-190b hsa04620 Toll-like receptor signaling pathway 5601_3454_3455_3725_6772_2353 6 9.67E-07 5.61E-05 8.01E-06 6973 hsa-mir-190b hsa05016 Huntington's disease 2902_3065_6874_2033_6667_1387_9519 7 2.20E-06 0.00012772 1.60E-05 6974 hsa-mir-190b hsa03022 Basal transcription factors 6874_6883_2959_9519 4 7.27E-06 0.000421927 4.69E-05 6975 hsa-mir-190b hsa04310 Wnt signaling pathway 5601_2033_2932_8061_3725_1387 6 8.79E-06 0.000509697 5.10E-05 6976 hsa-mir-190b hsa04330 Notch signaling pathway 9612_3065_2033_1387 4 1.75E-05 0.001017405 9.25E-05 6977 hsa-mir-190b hsa04660 T cell receptor signaling pathway 5601_2932_3265_3725_2353 5 2.67E-05 0.001550351 0.000129196 6978 hsa-mir-190b hsa04110 Cell cycle 3065_5925_2033_2932_1387 5 3.84E-05 0.002226302 0.000171254 6979 hsa-mir-190b hsa05211 Renal cell carcinoma 2033_3265_3725_1387 4 8.50E-05 0.004930663 0.00035219 6980 hsa-mir-190b hsa04662 B cell receptor signaling pathway 2932_3265_3725_2353 4 9.89E-05 0.005734561 0.000382304 6981 hsa-mir-190b hsa05210 Colorectal cancer 5601_2932_3725_2353 4 0.000150302 0.008717505 0.000544844 6982 hsa-mir-190b hsa04012 ErbB signaling pathway 5601_2932_3265_3725 4 0.000171081 0.009922712 0.000583689 6983 hsa-mir-190b hsa04916 Melanogenesis 2033_2932_3265_1387 4 0.000329888 0.019133502 0.001052615 6984 hsa-mir-190b hsa04062 Chemokine signaling pathway 3717_7852_2932_3265_6772 5 0.000344822 0.019999687 0.001052615 6985 hsa-mir-190b hsa04912 GnRH signaling pathway 5601_468_3265_3725 4 0.000378819 0.021971481 0.001098574 6986 hsa-mir-190b hsa05223 Non-small cell lung cancer 5925_3265_6256 3 0.000695581 0.040343719 0.001921129 6987 hsa-mir-190b hsa04920 Adipocytokine signaling pathway 3717_5601_6256 3 0.001264945 0.073366812 0.003334855 6988 hsa-mir-190b hsa05220 Chronic myeloid leukemia 3065_5925_3265 3 0.001727632 0.100202653 0.004356637 6989 hsa-mir-190b hsa05010 Alzheimer's disease 2902_2906_2932_351 4 0.002252256 0.130630871 0.005442953 6990 hsa-mir-190b hsa05222 Small cell lung cancer 5925_8554_6256 3 0.002518009 0.146044545 0.00579818 6991 hsa-mir-190b hsa04350 TGF-beta signaling pathway 2033_6667_1387 3 0.002599184 0.150752687 0.00579818 6992 hsa-mir-190b hsa04510 Focal adhesion 5601_2932_3265_3725 4 0.003837441 0.222571572 0.008229354 6993 hsa-mir-190b hsa05216 Thyroid cancer 3265_6256 2 0.003972791 0.230421903 0.008229354 6994 hsa-mir-190b hsa05219 Bladder cancer 5925_3265 2 0.007879113 0.45698856 0.015246337 6995 hsa-mir-190b hsa04360 Axon guidance 7852_2932_3265 3 0.007886036 0.457390109 0.015246337 6996 hsa-mir-190b hsa04530 Tight junction 8573_22800_3265 3 0.008886372 0.51540955 0.015923603 6997 hsa-mir-190b hsa04910 Insulin signaling pathway 5601_2932_3265 3 0.009059981 0.525478905 0.015923603 6998 hsa-mir-190b hsa04650 Natural killer cell mediated cytotoxicity 3454_3455_3265 3 0.009059981 0.525478905 0.015923603 6999 hsa-mir-190b hsa05213 Endometrial cancer 2932_3265 2 0.011688079 0.677908602 0.019938488 7000 hsa-mir-190b hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906 2 0.013396421 0.776992405 0.022199783 7001 hsa-mir-190b hsa05221 Acute myeloid leukemia 1050_3265 2 0.014744443 0.855177722 0.023754937 7002 hsa-mir-190b hsa05214 Glioma 5925_3265 2 0.017607354 1 0.027600717 7003 hsa-mir-190b hsa05218 Melanoma 5925_3265 2 0.020685492 1 0.03076304 7004 hsa-mir-190b hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5601_3725 2 0.020685492 1 0.03076304 7005 hsa-mir-190b hsa04664 Fc epsilon RI signaling pathway 5601_3265 2 0.025109813 1 0.03633872 7006 hsa-mir-190b hsa04520 Adherens junction 2033_1387 2 0.025687716 1 0.03633872 7007 hsa-mir-190b hsa04512 ECM-receptor interaction 6383_9672 2 0.02805295 1 0.038739788 7008 hsa-mir-190b hsa04080 Neuroactive ligand-receptor interaction 2902_2906_7067 3 0.044049387 1 0.059415453 7009 hsa-mir-190b hsa04060 Cytokine-cytokine receptor interaction 7852_3454_3455 3 0.046597825 1 0.061424406 7010 hsa-mir-191 hsa05200 Pathways in cancer 1869_3725_4149_7046_5468_5914_595_2261_8517_7704_3551_6502_3091_3066_3065_1050_5925_5747_1956_1487_1488_1870_1871_2885_2113_10401_5894_861_207_3716_1147_5595_5594_5599_1387_2064_6256_836_367_2932_6774_6776_6777_6772_5879_7157_2736_4088_4089_9063_2034_2033_4846_4790_4791_4792_5970_3320_3326_5371_5159_5156_5604_5601_3815_4292_7428_4087_8772_4609_1029_2353_8554 73 2.51E-48 2.01E-46 2.01E-46 7011 hsa-mir-191 hsa04010 MAPK signaling pathway 6722_3725_4149_7046_6195_6197_2261_2264_8517_3551_1845_4773_9020_8986_1956_3303_1432_2885_5894_3305_4763_1616_207_1147_5595_5594_5599_5598_1386_836_9252_3312_5971_5879_7157_6196_9344_4790_4791_5970_5159_9261_1326_5156_5604_4208_5601_5600_5608_5566_6885_4609_5606_2353_7132_2005 56 8.86E-36 7.09E-34 3.55E-34 7012 hsa-mir-191 hsa05220 Chronic myeloid leukemia 1869_7046_595_8517_3551_3066_3065_5925_1487_1488_1870_1871_2885_5894_861_207_1147_5595_5594_6776_6777_7157_4088_4089_4790_4792_5970_5604_5781_4609_1029_6464 32 3.90E-29 3.12E-27 1.04E-27 7013 hsa-mir-191 hsa05215 Prostate cancer 1869_595_8517_3551_90993_5925_1956_1870_1871_2885_5894_207_1147_5595_5594_1387_2064_367_2932_7157_2033_4790_4792_5970_3320_3326_5159_5156_5604 29 6.24E-24 4.99E-22 1.25E-22 7014 hsa-mir-191 hsa05212 Pancreatic cancer 1869_595_8517_3551_90993_5925_1956_1870_1871_2885_5894_207_1147_5595_5594_1387_2064_367_2932_7157_2033_4790_4792_5970_3320_3326_5159_5156_5604 29 8.12E-24 6.50E-22 1.30E-22 7015 hsa-mir-191 hsa04620 Toll-like receptor signaling pathway 3725_8517_3551_3455_3661_1432_207_1147_29110_5595_5594_5599_6772_5879_4790_4792_5970_1326_5604_5601_5600_5608_9641_8772_6885_5606_2353 27 2.74E-20 2.19E-18 3.66E-19 7016 hsa-mir-191 hsa05221 Acute myeloid leukemia 5914_595_8517_7704_3551_1050_2885_5894_861_207_1147_5595_5594_6774_6776_6777_4790_5970_5371_5604_3815_4609 22 2.04E-19 1.63E-17 2.33E-18 7017 hsa-mir-191 hsa04310 Wnt signaling pathway 3725_818_817_595_8607_6500_4773_23291_1487_1488_8945_5599_1387_2932_5879_7157_8061_1457_1459_4088_4089_2033_5519_5515_5601_5566_8454_4087_6885_4609 30 2.86E-19 2.29E-17 2.86E-18 7018 hsa-mir-191 hsa05210 Colorectal cancer 3725_7046_595_1956_2885_5894_207_5595_5594_5599_836_2932_5879_7157_4088_4089_5159_5156_5604_5601_4292_4087_4609_2353 24 7.90E-19 6.32E-17 7.03E-18 7019 hsa-mir-191 hsa05214 Glioma 1869_818_817_595_5925_1956_1870_1871_2885_5894_207_5595_5594_7157_808_801_805_5159_5156_5604_1029_6464 22 1.12E-18 8.95E-17 8.95E-18 7020 hsa-mir-191 hsa04660 T cell receptor signaling pathway 3725_8517_3551_4773_9020_2534_3932_1432_4794_2885_5894_207_1147_5595_5594_2932_4790_4792_4793_5970_1326_5604_5601_5600_6885_2353 26 1.53E-18 1.22E-16 1.11E-17 7021 hsa-mir-191 hsa04110 Cell cycle 1869_595_6502_6500_4174_4172_3066_3065_5925_1870_1871_5933_990_5591_1387_2932_7157_5111_4088_4089_2033_983_8454_4087_1029_1111 26 8.14E-18 6.51E-16 5.43E-17 7022 hsa-mir-191 hsa04062 Chemokine signaling pathway 1234_8517_1230_3551_653361_7074_5747_5580_7852_2885_5894_207_3717_1147_5590_5595_5594_2932_6774_6777_6772_6773_5879_4790_4792_4793_5970_5604_5566_6464 30 9.82E-17 7.86E-15 6.05E-16 7023 hsa-mir-191 hsa05222 Small cell lung cancer 1869_4149_595_8517_3551_6502_5925_5747_1870_1871_10401_207_1147_6256_7157_9063_4846_4790_4792_5970_4609_8554 22 1.64E-16 1.31E-14 9.12E-16 7024 hsa-mir-191 hsa04662 B cell receptor signaling pathway 3725_8517_3551_4773_6850_4794_2885_5894_207_1147_695_5595_5594_2932_5879_4790_4792_4793_5970_5604_2353 21 1.71E-16 1.37E-14 9.12E-16 7025 hsa-mir-191 hsa04630 Jak-STAT signaling pathway 595_58985_3455_3459_3560_3561_1439_2885_10401_207_3717_3716_8651_1387_6778_6774_6776_6777_6772_6773_7297_9063_2033_5781_4609_8554_10379 27 2.80E-16 2.24E-14 1.40E-15 7026 hsa-mir-191 hsa04920 Adipocytokine signaling pathway 5465_8517_3551_7133_4794_8471_207_3717_1147_8717_5599_6256_6774_4790_4792_4793_5970_5601_5781_7132 20 3.19E-16 2.55E-14 1.50E-15 7027 hsa-mir-191 hsa04540 Gap junction 10382_51807_1956_6714_2885_5894_5592_5595_5594_5598_7846_347733_5159_983_5156_5604_5566_7277_7278_203068_10376 21 6.79E-15 5.43E-13 3.02E-14 7028 hsa-mir-191 hsa04912 GnRH signaling pathway 3725_818_817_5580_1956_6714_1432_2885_5894_5595_5594_5599_5598_808_801_805_5604_5601_5600_5608_5566_5606 22 9.81E-15 7.85E-13 4.13E-14 7029 hsa-mir-191 hsa05219 Bladder cancer 1869_595_2261_5925_1956_1870_1871_5894_5595_5594_2064_9252_7157_5604_4609_1029 16 1.32E-14 1.06E-12 5.29E-14 7030 hsa-mir-191 hsa04350 TGF-beta signaling pathway 7046_6500_90_57154_6667_3397_3399_3398_5933_5595_5594_1387_4088_4089_2033_5519_5515_8454_4087_4609 20 2.24E-14 1.79E-12 8.13E-14 7031 hsa-mir-191 hsa04012 ErbB signaling pathway 3725_818_817_5747_1956_6714_2885_5894_207_5595_5594_5599_2064_2932_6776_6777_5604_5601_4609_6464 20 2.24E-14 1.79E-12 8.13E-14 7032 hsa-mir-191 hsa05223 Non-small cell lung cancer 1869_595_5925_1956_1870_1871_2885_5894_207_5595_5594_2064_6256_7157_5604_1029 16 3.31E-13 2.64E-11 1.15E-12 7033 hsa-mir-191 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_8517_3551_9020_1956_6714_1432_1147_5599_836_5879_4790_4792_5970_5601_5600_5781 17 1.14E-12 9.11E-11 3.80E-12 7034 hsa-mir-191 hsa04720 Long-term potentiation 818_814_817_6195_6197_2902_5894_5595_5594_1387_6196_2033_808_801_805_5604_5566 17 2.44E-12 1.95E-10 7.80E-12 7035 hsa-mir-191 hsa04664 Fc epsilon RI signaling pathway 2534_5580_6850_1432_2885_5894_207_695_5595_5594_5599_5879_5604_5601_5600_5608_5606 17 5.01E-12 4.01E-10 1.54E-11 7036 hsa-mir-191 hsa04520 Adherens junction 7046_2534_1956_6714_71_5595_5594_1387_2064_5879_1457_1459_4088_4089_2033_4087_6885 17 5.97E-12 4.78E-10 1.77E-11 7037 hsa-mir-191 hsa04210 Apoptosis 8517_3551_9020_1439_207_1147_8717_836_7157_9131_4790_4792_5970_5566_840_8772_7132 17 2.62E-11 2.10E-09 7.49E-11 7038 hsa-mir-191 hsa05218 Melanoma 1869_595_5925_1956_1870_1871_5894_207_5595_5594_7157_5159_5156_5604_1029 15 1.13E-10 9.04E-09 3.12E-10 7039 hsa-mir-191 hsa05211 Renal cell carcinoma 3725_3091_2885_2113_5894_207_5595_5594_1387_5879_2034_2033_5604_7428_5781 15 1.34E-10 1.07E-08 3.58E-10 7040 hsa-mir-191 hsa04510 Focal adhesion 3725_595_2534_5747_3791_1956_6714_2885_5894_207_71_5595_5594_5599_2064_2932_5879_2321_5159_5156_5604_5601_6464 23 1.67E-10 1.34E-08 4.32E-10 7041 hsa-mir-191 hsa04910 Insulin signaling pathway 6720_3551_2885_5894_8471_207_8651_5590_5595_5594_5599_2932_808_801_805_5604_5601_5566_6464 19 2.75E-10 2.20E-08 6.89E-10 7042 hsa-mir-191 hsa05213 Endometrial cancer 595_1956_2885_5894_207_5595_5594_2064_2932_7157_5604_4292_4609 13 3.32E-10 2.66E-08 8.05E-10 7043 hsa-mir-191 hsa04120 Ubiquitin mediated proteolysis 55294_4734_6502_6500_57154_23291_10401_8945_51366_11059_8651_9063_7329_5371_672_8454_7428_8554 18 1.96E-09 1.57E-07 4.62E-09 7044 hsa-mir-191 hsa04370 VEGF signaling pathway 4773_5747_3791_6714_1432_5894_207_5595_5594_5879_4846_9261_5604_5600 14 2.63E-09 2.10E-07 6.00E-09 7045 hsa-mir-191 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_7133_1432_1616_836_5879_7157_4846_5600_5608_5606_7132 12 7.22E-09 5.77E-07 1.60E-08 7046 hsa-mir-191 hsa04916 Melanogenesis 818_817_90993_5894_5595_5594_1387_2932_2033_808_801_805_5604_5566_3815 15 1.19E-08 9.51E-07 2.57E-08 7047 hsa-mir-191 hsa05016 Huntington's disease 5468_292_293_90993_3066_3065_3064_498_2902_6667_1387_836_5437_7157_1213_2033_6874_6908_5441 19 2.84E-08 2.27E-06 5.97E-08 7048 hsa-mir-191 hsa05131 Shigellosis 10382_51807_2534_71_7846_347733_7277_7278_4691_203068_10376 11 6.70E-08 5.36E-06 1.34E-07 7049 hsa-mir-191 hsa05130 Pathogenic Escherichia coli infection 10382_51807_2534_71_7846_347733_7277_7278_4691_203068_10376 11 6.70E-08 5.36E-06 1.34E-07 7050 hsa-mir-191 hsa04930 Type II diabetes mellitus 3551_5580_8471_3651_8651_5590_5595_5594_5599_5601 10 9.71E-08 7.77E-06 1.89E-07 7051 hsa-mir-191 hsa04330 Notch signaling pathway 9612_3066_3065_1487_1488_1387_2033_8850_2648_4851 10 1.38E-07 1.11E-05 2.64E-07 7052 hsa-mir-191 hsa03022 Basal transcription factors 6872_2963_2962_2969_6878_6874_6908_6882_2959 9 2.20E-07 1.76E-05 4.10E-07 7053 hsa-mir-191 hsa04650 Natural killer cell mediated cytotoxicity 3455_3459_4773_2534_3932_6850_2885_5894_5595_5594_836_5879_5604_5781_6464 15 3.47E-07 2.78E-05 6.31E-07 7054 hsa-mir-191 hsa05216 Thyroid cancer 5468_595_5595_5594_6256_7157_5604_4609 8 4.64E-07 3.71E-05 8.25E-07 7055 hsa-mir-191 hsa04020 Calcium signaling pathway 818_814_817_292_293_147_1956_2902_2064_4846_808_801_805_5159_5156_5566 16 2.19E-06 0.000175471 3.81E-06 7056 hsa-mir-191 hsa04060 Cytokine-cytokine receptor interaction 7046_1234_1230_58985_3455_3459_90_3791_1956_3560_3561_7133_1439_7852_2321_5159_5156_3815_7132 19 3.14E-06 0.000250895 5.34E-06 7057 hsa-mir-191 hsa05010 Alzheimer's disease 498_2902_6622_1020_5595_5594_836_2932_4846_808_801_805_840_8772_7132 15 6.05E-06 0.000484262 1.01E-05 7058 hsa-mir-191 hsa04270 Vascular smooth muscle contraction 147_5580_5894_5592_5595_5594_808_801_805_5604_5566 11 4.68E-05 0.003742459 7.64E-05 7059 hsa-mir-191 hsa03020 RNA polymerase 25885_51082_64425_5437_84172_5441 6 5.35E-05 0.004277804 8.56E-05 7060 hsa-mir-191 hsa04810 Regulation of actin cytoskeleton 2261_2264_10788_7074_5747_1956_4628_5894_71_5595_5594_5879_5159_5156_5604 15 6.18E-05 0.00494795 9.70E-05 7061 hsa-mir-191 hsa04612 Antigen processing and presentation 3309_3303_3305_3312_3320_3326_4800_4801_4802 9 0.000128451 0.010276077 0.000197617 7062 hsa-mir-191 hsa04150 mTOR signaling pathway 6195_6197_3091_207_5595_5594_6196 7 0.000145802 0.011664158 0.000220078 7063 hsa-mir-191 hsa04730 Long-term depression 5894_5592_5595_5594_4846_5519_5515_5604 8 0.000153246 0.012259708 0.000227032 7064 hsa-mir-191 hsa04530 Tight junction 5580_6714_4628_207_71_5590_1457_1459_5519_5515 10 0.000638828 0.051106208 0.000929204 7065 hsa-mir-191 hsa04115 p53 signaling pathway 595_836_7157_983_7161_1029_1111 7 0.000703236 0.056258856 0.001004622 7066 hsa-mir-191 hsa03010 Ribosome 6155_6156_6207_9349_6141_6217_6128_6188 8 0.0014248 0.113984024 0.00199972 7067 hsa-mir-191 hsa04360 Axon guidance 4773_2534_5747_7852_1020_5595_5594_2932_5879 9 0.001744441 0.139555271 0.002406125 7068 hsa-mir-191 hsa04670 Leukocyte transendothelial migration 653361_5747_1432_7852_71_5879_5600_5781 8 0.004036849 0.322947912 0.005473693 7069 hsa-mir-191 hsa05340 Primary immunodeficiency 8517_3932_3561_695 4 0.006833899 0.546711925 0.009111865 7070 hsa-mir-191 hsa04340 Hedgehog signaling pathway 23291_8945_2932_2736_5566 5 0.007165751 0.573260049 0.009397706 7071 hsa-mir-191 hsa03030 DNA replication 5981_4174_4172_5111 4 0.007478417 0.598273336 0.00964957 7072 hsa-mir-191 hsa03430 Mismatch repair 5981_5111_4292 3 0.013705098 1 0.017403299 7073 hsa-mir-191 hsa03410 Base excision repair 3146_142_5111 3 0.040045578 1 0.050056972 7074 hsa-mir-1910 hsa05220 Chronic myeloid leukemia 3066_1870_1871_7157_4193_4609_1029 7 4.03E-13 1.37E-11 1.37E-11 7075 hsa-mir-1910 hsa05219 Bladder cancer 1870_1871_7157_4193_4609_1029 6 2.09E-12 7.10E-11 3.55E-11 7076 hsa-mir-1910 hsa04110 Cell cycle 3066_1870_1871_7157_2033_4193_1029 7 8.74E-12 2.97E-10 9.91E-11 7077 hsa-mir-1910 hsa05215 Prostate cancer 1870_1871_7157_2033_4193_1385 6 1.35E-10 4.60E-09 9.81E-10 7078 hsa-mir-1910 hsa05212 Pancreatic cancer 1870_1871_7157_2033_4193_1385 6 1.44E-10 4.90E-09 9.81E-10 7079 hsa-mir-1910 hsa05200 Pathways in cancer 3066_1870_1871_7157_2033_4193_4609_1029 8 2.28E-10 7.74E-09 1.29E-09 7080 hsa-mir-1910 hsa05214 Glioma 1870_1871_7157_4193_1029 5 3.05E-09 1.04E-07 1.48E-08 7081 hsa-mir-1910 hsa05218 Melanoma 1870_1871_7157_4193_1029 5 4.64E-09 1.58E-07 1.97E-08 7082 hsa-mir-1910 hsa05223 Non-small cell lung cancer 1870_1871_7157_1029 4 1.54E-07 5.23E-06 5.81E-07 7083 hsa-mir-1910 hsa05016 Huntington's disease 3066_7157_6667_2033_1385 5 4.99E-07 1.70E-05 1.70E-06 7084 hsa-mir-1910 hsa05222 Small cell lung cancer 1870_1871_7157_4609 4 9.10E-07 3.09E-05 2.81E-06 7085 hsa-mir-1910 hsa04330 Notch signaling pathway 3066_2033_4851 3 9.74E-06 0.000331123 2.76E-05 7086 hsa-mir-1910 hsa04115 p53 signaling pathway 7157_4193_1029 3 2.93E-05 0.000995455 7.66E-05 7087 hsa-mir-1910 hsa04350 TGF-beta signaling pathway 6667_2033_4609 3 5.71E-05 0.001941574 0.000138684 7088 hsa-mir-1910 hsa04310 Wnt signaling pathway 7157_2033_4609 3 0.000285499 0.009706957 0.00064713 7089 hsa-mir-1910 hsa05216 Thyroid cancer 7157_4609 2 0.000304946 0.010368147 0.000648009 7090 hsa-mir-1910 hsa05213 Endometrial cancer 7157_4609 2 0.0009275 0.031535016 0.001855001 7091 hsa-mir-1910 hsa04010 MAPK signaling pathway 7157_4609_1386 3 0.001521354 0.051726038 0.002873669 7092 hsa-mir-1910 hsa05210 Colorectal cancer 7157_4609 2 0.002330672 0.079242863 0.004170677 7093 hsa-mir-1910 hsa04916 Melanogenesis 2033_1385 2 0.003512677 0.119431022 0.005971551 7094 hsa-mir-1910 hsa04120 Ubiquitin mediated proteolysis 4193_672 2 0.006120155 0.208085273 0.009908823 7095 hsa-mir-1910 hsa04630 Jak-STAT signaling pathway 2033_4609 2 0.007532003 0.256088112 0.011640369 7096 hsa-mir-1910 hsa03022 Basal transcription factors 2969 1 0.031176672 1 0.046087254 7097 hsa-mir-1910 hsa05217 Basal cell carcinoma 7157 1 0.045616816 1 0.063121623 7098 hsa-mir-1910 hsa05014 Amyotrophic lateral sclerosis (ALS) 7157 1 0.046412958 1 0.063121623 7099 hsa-mir-1910 hsa05221 Acute myeloid leukemia 4609 1 0.048797561 1 0.063812195 7100 hsa-mir-1915 hsa05200 Pathways in cancer 3551_1398_7046_1499_595_1019_1017_8517_6502_3091_2736_4087_1050_5925_7189_7186_25_1956_862_867_207_4286_3716_1147_5595_5594_5599_6258_1387_6257_6256_9915_367_2932_6774_6777_6772_5970_7157_6688_3725_4088_4089_5881_2034_2033_898_4790_4791_4792_5371_675_5159_5156_1399_3815_841_51588_8031_4609_1026_2353_8554 63 1.05E-41 8.47E-40 8.47E-40 7101 hsa-mir-1915 hsa04010 MAPK signaling pathway 6722_3551_1398_7046_6195_6197_8517_9252_7867_4773_9020_4616_7189_7186_1956_3303_1432_207_1147_5595_5594_5599_1386_3312_1649_5971_5970_7157_10912_468_3725_6196_5881_4790_4791_5159_9261_1326_5156_4208_1399_4609_2353_8986 44 9.62E-27 7.79E-25 3.90E-25 7102 hsa-mir-1915 hsa05220 Chronic myeloid leukemia 3551_1398_7046_595_1019_8517_5925_25_867_207_1147_5595_5594_6777_5970_7157_4088_4089_4790_4792_1399_5781_4609_1026_6464 25 3.21E-22 2.60E-20 8.67E-21 7103 hsa-mir-1915 hsa05215 Prostate cancer 3551_1499_595_1017_8517_5925_1956_207_1147_5595_5594_1387_367_2932_5970_7157_468_2033_898_4790_4792_5159_5156_1026 24 1.12E-19 9.11E-18 2.28E-18 7104 hsa-mir-1915 hsa05212 Pancreatic cancer 3551_1499_595_1017_8517_5925_1956_207_1147_5595_5594_1387_367_2932_5970_7157_468_2033_898_4790_4792_5159_5156_1026 24 1.41E-19 1.14E-17 2.28E-18 7105 hsa-mir-1915 hsa04110 Cell cycle 595_1019_1017_6502_6500_4087_4616_5925_25_5933_993_1387_2932_7027_7157_10912_4088_4089_2033_891_894_896_898_983_8454_1026 26 3.86E-19 3.13E-17 5.22E-18 7106 hsa-mir-1915 hsa04660 T cell receptor signaling pathway 3551_1019_8517_4773_9020_1493_3932_1432_867_207_1147_5595_5594_2932_5970_3725_4794_4790_4792_4793_1326_919_1739_2353 24 9.35E-18 7.57E-16 1.08E-16 7107 hsa-mir-1915 hsa05222 Small cell lung cancer 3551_595_1019_1017_8517_6502_5925_7189_7186_207_1147_6258_6257_6256_5970_7157_898_4790_4792_51588_4609_8554 22 1.21E-17 9.82E-16 1.23E-16 7108 hsa-mir-1915 hsa04350 TGF-beta signaling pathway 6667_7046_6500_4087_3397_3399_3398_1874_658_5933_5595_5594_1387_7027_4086_4088_4089_2033_5515_4093_8454_4609 22 1.50E-17 1.21E-15 1.35E-16 7109 hsa-mir-1915 hsa04620 Toll-like receptor signaling pathway 3551_8517_4615_7189_3661_1432_207_1147_3654_5595_5594_5599_6772_5970_3725_4790_4792_1326_353376_148022_9641_841_2353 23 2.41E-17 1.96E-15 1.96E-16 7110 hsa-mir-1915 hsa04920 Adipocytokine signaling pathway 3717_3551_10891_8517_7186_207_1147_5599_6258_6257_6256_6774_5970_4794_4790_4792_4793_5781 18 5.41E-15 4.38E-13 3.98E-14 7111 hsa-mir-1915 hsa05221 Acute myeloid leukemia 3551_595_8517_1050_862_207_1147_5595_5594_6774_6777_5970_6688_4790_5371_3815_4609 17 1.17E-14 9.48E-13 7.90E-14 7112 hsa-mir-1915 hsa05210 Colorectal cancer 7046_1499_595_4087_1956_207_5595_5594_5599_2932_7157_3725_4088_4089_5881_5159_5156_4609_2353 19 1.40E-14 1.13E-12 8.70E-14 7113 hsa-mir-1915 hsa04662 B cell receptor signaling pathway 3551_8517_4773_6850_207_1147_695_5595_5594_2932_5970_3725_5881_4794_4790_4792_4793_2353 18 2.88E-14 2.33E-12 1.66E-13 7114 hsa-mir-1915 hsa04630 Jak-STAT signaling pathway 3717_595_3560_3561_2057_867_2690_207_3716_3718_1387_3575_6774_6777_6772_2033_894_896_51588_5781_4609_85480_8554 23 6.91E-14 5.60E-12 3.73E-13 7115 hsa-mir-1915 hsa04310 Wnt signaling pathway 1499_595_6500_4087_4773_23291_1460_5599_1387_2932_7157_3725_1457_4088_4089_5881_2033_894_896_5515_8454_4609 22 3.81E-13 3.08E-11 1.93E-12 7116 hsa-mir-1915 hsa04520 Adherens junction 7046_1499_5770_4087_1956_6714_4301_1460_5595_5594_1387_1457_4088_4089_5881_2033_3643 17 8.30E-13 6.72E-11 3.95E-12 7117 hsa-mir-1915 hsa04012 ErbB signaling pathway 1398_25_1956_6714_867_207_5595_5594_5599_2066_2932_6777_3725_1399_4609_1026_6464 17 2.70E-12 2.19E-10 1.21E-11 7118 hsa-mir-1915 hsa05214 Glioma 595_1019_5925_1956_207_5595_5594_7157_808_801_805_5159_5156_1026_6464 15 6.65E-12 5.39E-10 2.84E-11 7119 hsa-mir-1915 hsa05216 Thyroid cancer 1499_595_5595_5594_6258_6257_6256_7157_8031_4609 10 8.45E-10 6.85E-08 3.42E-09 7120 hsa-mir-1915 hsa04062 Chemokine signaling pathway 3717_3551_1398_8517_207_1147_3718_5595_5594_1234_2932_6774_6777_6772_5970_4790_4792_4793_1399_6464 20 1.01E-09 8.18E-08 3.90E-09 7121 hsa-mir-1915 hsa04115 p53 signaling pathway 595_1019_1017_4616_7157_10912_891_894_896_898_983_841_1026 13 1.50E-09 1.22E-07 5.54E-09 7122 hsa-mir-1915 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3551_8517_9020_1956_6714_1432_1147_5599_5970_3725_4790_4792_5781 13 2.05E-09 1.66E-07 7.20E-09 7123 hsa-mir-1915 hsa04910 Insulin signaling pathway 3551_10891_1398_5770_867_207_5595_5594_5599_2932_808_801_805_3643_1399_6464 16 1.13E-08 9.13E-07 3.81E-08 7124 hsa-mir-1915 hsa05223 Non-small cell lung cancer 595_1019_5925_1956_207_5595_5594_6258_6257_6256_7157 11 1.36E-08 1.10E-06 4.40E-08 7125 hsa-mir-1915 hsa04510 Focal adhesion 1398_1499_595_1956_6714_207_5595_5594_5599_2932_1729_3725_5881_894_896_5159_5156_1399_6464 19 1.52E-08 1.23E-06 4.73E-08 7126 hsa-mir-1915 hsa05219 Bladder cancer 595_1019_9252_5925_1956_5595_5594_7157_4609_1026 10 1.72E-08 1.39E-06 5.17E-08 7127 hsa-mir-1915 hsa05218 Melanoma 595_1019_5925_1956_207_4286_5595_5594_7157_5159_5156_1026 12 1.89E-08 1.53E-06 5.47E-08 7128 hsa-mir-1915 hsa05211 Renal cell carcinoma 1398_3091_207_5595_5594_1387_9915_3725_2034_2033_1399_5781 12 2.17E-08 1.76E-06 6.07E-08 7129 hsa-mir-1915 hsa04210 Apoptosis 3551_8517_9020_4615_7186_207_1147_3654_5970_7157_4790_4792_841 13 2.31E-08 1.87E-06 6.23E-08 7130 hsa-mir-1915 hsa04720 Long-term potentiation 6195_6197_5595_5594_1387_468_6196_2033_808_801_805 11 2.68E-07 2.17E-05 7.01E-07 7131 hsa-mir-1915 hsa04120 Ubiquitin mediated proteolysis 55294_6502_6500_7189_23291_867_7325_7329_11059_5371_672_8454_51588_8554 14 4.50E-07 3.65E-05 1.14E-06 7132 hsa-mir-1915 hsa05213 Endometrial cancer 1499_595_1956_207_5595_5594_2932_7157_4609 9 9.64E-07 7.81E-05 2.37E-06 7133 hsa-mir-1915 hsa04916 Melanogenesis 1499_4286_5595_5594_1387_2932_2033_808_801_805_3815 11 4.99E-06 0.000404158 1.19E-05 7134 hsa-mir-1915 hsa04912 GnRH signaling pathway 1956_6714_1432_5595_5594_5599_468_3725_808_801_805 11 6.95E-06 0.000563061 1.61E-05 7135 hsa-mir-1915 hsa05016 Huntington's disease 6667_10891_1537_3064_25942_4716_5441_1387_5437_7157_2033_6908_841_4724 14 1.19E-05 0.000965821 2.68E-05 7136 hsa-mir-1915 hsa04370 VEGF signaling pathway 7867_4773_6714_1432_207_5595_5594_5881_9261 9 1.75E-05 0.001416014 3.83E-05 7137 hsa-mir-1915 hsa03020 RNA polymerase 64425_25885_51082_5441_5437_84172 6 2.67E-05 0.002164939 5.70E-05 7138 hsa-mir-1915 hsa04330 Notch signaling pathway 388585_1387_9612_2033_8850_2648_4851 7 3.76E-05 0.003049415 7.82E-05 7139 hsa-mir-1915 hsa04150 mTOR signaling pathway 6195_6197_3091_207_5595_5594_6196 7 6.73E-05 0.005455222 0.000134047 7140 hsa-mir-1915 hsa05340 Primary immunodeficiency 8517_3932_3561_3718_695_3575 6 6.79E-05 0.005495944 0.000134047 7141 hsa-mir-1915 hsa04950 Maturity onset diabetes of the young 6928_6927_3651_168620_3172 5 0.000124636 0.010095513 0.000240369 7142 hsa-mir-1915 hsa04664 Fc epsilon RI signaling pathway 6850_1432_207_695_5595_5594_5599_5881 8 0.000129064 0.010454159 0.000242217 7143 hsa-mir-1915 hsa03010 Ribosome 6156_6207_6143_6222_6124_6129_6128_6130_6231 9 0.000131575 0.010657556 0.000242217 7144 hsa-mir-1915 hsa04930 Type II diabetes mellitus 3551_3651_5595_5594_5599_3643 6 0.00023506 0.019039838 0.000423108 7145 hsa-mir-1915 hsa04540 Gap junction 1956_6714_5592_5595_5594_5159_983_5156 8 0.000362165 0.029335328 0.000637725 7146 hsa-mir-1915 hsa04530 Tight junction 1499_1019_10207_6714_207_4301_1460_1457_5515 9 0.000992989 0.080432113 0.001711322 7147 hsa-mir-1915 hsa04650 Natural killer cell mediated cytotoxicity 4773_3932_6850_5595_5594_5881_919_5781_6464 9 0.001041996 0.084401646 0.001724613 7148 hsa-mir-1915 hsa04060 Cytokine-cytokine receptor interaction 7046_1956_3560_3561_2057_658_2690_1234_3575_5159_5156_3815_85480 13 0.001043284 0.084506042 0.001724613 7149 hsa-mir-1915 hsa05010 Alzheimer's disease 1537_4716_5595_5594_2932_808_801_805_841_4724 10 0.001565386 0.126796306 0.002535926 7150 hsa-mir-1915 hsa03022 Basal transcription factors 2963_2969_6908_2959 4 0.005295905 0.428968268 0.008411143 7151 hsa-mir-1915 hsa04810 Regulation of actin cytoskeleton 1398_1956_5595_5594_1729_5881_5159_5156_1399_10788 10 0.006605582 0.535052146 0.010289464 7152 hsa-mir-1915 hsa04360 Axon guidance 4773_25_5998_5595_5594_2932_5881 7 0.0100713 0.81577532 0.015391987 7153 hsa-mir-1915 hsa05217 Basal cell carcinoma 1499_2736_2932_7157 4 0.018707275 1 0.028060913 7154 hsa-mir-1915 hsa04270 Vascular smooth muscle contraction 5592_5595_5594_808_801_805 6 0.020521057 1 0.03022192 7155 hsa-mir-1915 hsa04612 Antigen processing and presentation 3303_3312_1514_4800_4802 5 0.023251727 1 0.033631962 7156 hsa-mir-1915 hsa03320 PPAR signaling pathway 2168_6258_6257_6256 4 0.038781729 1 0.055110878 7157 hsa-mir-1915 hsa04730 Long-term depression 5592_5595_5594_5515 4 0.040431196 1 0.056464256 7158 hsa-mir-1915 hsa04020 Calcium signaling pathway 1956_2066_808_801_805_5159_5156 7 0.047895187 1 0.065754409 7159 hsa-mir-192 hsa05200 Pathways in cancer 3320_4149_5371_4292_7046_5595_5599_1387_5604_1487_2932_6502_6772_5970_4088_5894_1029_4087_1050_5925_2033 21 1.10E-20 6.50E-19 6.50E-19 7160 hsa-mir-192 hsa04110 Cell cycle 990_1387_983_2932_8454_6502_6500_4088_1029_4087_5925_2033_5933 13 5.45E-16 3.21E-14 1.61E-14 7161 hsa-mir-192 hsa04350 TGF-beta signaling pathway 7046_5595_1387_6667_8454_6500_4088_4087_2033_5933 10 9.23E-13 5.45E-11 1.82E-11 7162 hsa-mir-192 hsa04540 Gap junction 5595_5598_983_5604_7277_7278_10376_5894_7846_51807 10 1.70E-12 1.01E-10 2.51E-11 7163 hsa-mir-192 hsa04310 Wnt signaling pathway 5599_1387_1487_2932_8454_6500_4088_1457_1459_4087_2033 11 6.98E-12 4.12E-10 8.24E-11 7164 hsa-mir-192 hsa05220 Chronic myeloid leukemia 7046_5595_5604_1487_5970_4088_5894_1029_5925 9 9.33E-12 5.50E-10 9.17E-11 7165 hsa-mir-192 hsa04520 Adherens junction 4301_7046_5595_1387_4088_1457_1459_4087_2033 9 1.59E-11 9.38E-10 1.34E-10 7166 hsa-mir-192 hsa05210 Colorectal cancer 4292_7046_5595_5599_5604_2932_4088_5894_4087 9 2.38E-11 1.40E-09 1.75E-10 7167 hsa-mir-192 hsa05215 Prostate cancer 3320_5595_1387_5604_2932_5970_5894_5925_2033 9 3.50E-11 2.06E-09 2.27E-10 7168 hsa-mir-192 hsa05212 Pancreatic cancer 3320_5595_1387_5604_2932_5970_5894_5925_2033 9 3.84E-11 2.27E-09 2.27E-10 7169 hsa-mir-192 hsa05131 Shigellosis 7277_7278_10376_7846_51807_4691 6 5.75E-08 3.39E-06 2.83E-07 7170 hsa-mir-192 hsa05130 Pathogenic Escherichia coli infection 7277_7278_10376_7846_51807_4691 6 5.75E-08 3.39E-06 2.83E-07 7171 hsa-mir-192 hsa05221 Acute myeloid leukemia 5371_5595_5604_5970_5894_1050 6 7.67E-08 4.52E-06 3.48E-07 7172 hsa-mir-192 hsa04010 MAPK signaling pathway 4149_7046_5595_5599_5598_5604_1386_5970_5894 9 4.06E-07 2.39E-05 1.71E-06 7173 hsa-mir-192 hsa05219 Bladder cancer 5595_5604_5894_1029_5925 5 4.78E-07 2.82E-05 1.88E-06 7174 hsa-mir-192 hsa05213 Endometrial cancer 4292_5595_5604_2932_5894 5 1.27E-06 7.50E-05 4.69E-06 7175 hsa-mir-192 hsa05223 Non-small cell lung cancer 5595_5604_5894_1029_5925 5 1.51E-06 8.92E-05 5.25E-06 7176 hsa-mir-192 hsa04916 Melanogenesis 5595_1387_5604_2932_5894_2033 6 1.77E-06 0.000104152 5.79E-06 7177 hsa-mir-192 hsa05214 Glioma 5595_5604_5894_1029_5925 5 3.55E-06 0.000209553 1.10E-05 7178 hsa-mir-192 hsa04062 Chemokine signaling pathway 5595_5604_2932_6772_5970_5894_7074 7 4.57E-06 0.000269771 1.35E-05 7179 hsa-mir-192 hsa05218 Melanoma 5595_5604_5894_1029_5925 5 5.34E-06 0.000314928 1.50E-05 7180 hsa-mir-192 hsa05211 Renal cell carcinoma 5595_1387_5604_5894_2033 5 5.69E-06 0.000335924 1.53E-05 7181 hsa-mir-192 hsa04720 Long-term potentiation 5595_1387_5604_5894_2033 5 6.87E-06 0.000405558 1.69E-05 7182 hsa-mir-192 hsa04662 B cell receptor signaling pathway 5595_5604_2932_5970_5894 5 6.87E-06 0.000405558 1.69E-05 7183 hsa-mir-192 hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_8454_6502_6500 6 8.73E-06 0.000515311 2.06E-05 7184 hsa-mir-192 hsa04012 ErbB signaling pathway 5595_5599_5604_2932_5894 5 1.36E-05 0.000804176 3.09E-05 7185 hsa-mir-192 hsa04330 Notch signaling pathway 1387_1487_2033_2648 4 2.44E-05 0.001441726 5.34E-05 7186 hsa-mir-192 hsa04620 Toll-like receptor signaling pathway 5595_5599_5604_6772_5970 5 2.83E-05 0.001672071 5.97E-05 7187 hsa-mir-192 hsa04912 GnRH signaling pathway 5595_5599_5598_5604_5894 5 3.68E-05 0.002173636 7.50E-05 7188 hsa-mir-192 hsa04660 T cell receptor signaling pathway 5595_5604_2932_5970_5894 5 4.01E-05 0.002364386 7.88E-05 7189 hsa-mir-192 hsa04910 Insulin signaling pathway 5595_5599_5604_2932_5894 5 0.000112753 0.006652447 0.000214595 7190 hsa-mir-192 hsa04664 Fc epsilon RI signaling pathway 5595_5599_5604_5894 4 0.000165789 0.009781558 0.000305674 7191 hsa-mir-192 hsa05222 Small cell lung cancer 4149_6502_5970_5925 4 0.00022651 0.013364096 0.000404973 7192 hsa-mir-192 hsa03022 Basal transcription factors 2962_2969_6908 3 0.000312163 0.01841764 0.000541695 7193 hsa-mir-192 hsa04510 Focal adhesion 5595_5599_5604_2932_5894 5 0.000676894 0.039936728 0.001141049 7194 hsa-mir-192 hsa04115 p53 signaling pathway 983_7161_1029 3 0.001746279 0.103030439 0.002861957 7195 hsa-mir-192 hsa04730 Long-term depression 5595_5604_5894 3 0.001889083 0.111455911 0.003012322 7196 hsa-mir-192 hsa04370 VEGF signaling pathway 5595_5604_5894 3 0.002360464 0.139267358 0.00366493 7197 hsa-mir-192 hsa04612 Antigen processing and presentation 3320_4801_4802 3 0.003506845 0.206903841 0.005305227 7198 hsa-mir-192 hsa05016 Huntington's disease 1387_6908_6667_2033 4 0.003769328 0.22239036 0.005559759 7199 hsa-mir-192 hsa05216 Thyroid cancer 5595_5604 2 0.004679807 0.27610859 0.006734356 7200 hsa-mir-192 hsa04810 Regulation of actin cytoskeleton 5595_5604_5894_7074 4 0.006378731 0.376345121 0.008960598 7201 hsa-mir-192 hsa04270 Vascular smooth muscle contraction 5595_5604_5894 3 0.007509714 0.443073125 0.010304026 7202 hsa-mir-192 hsa04930 Type II diabetes mellitus 5595_5599 2 0.010514518 0.620356541 0.014099012 7203 hsa-mir-192 hsa04530 Tight junction 4301_1457_1459 3 0.011161414 0.658523447 0.014592619 7204 hsa-mir-192 hsa04650 Natural killer cell mediated cytotoxicity 5595_5604_5894 3 0.011377297 0.671260497 0.014592619 7205 hsa-mir-192 hsa04630 Jak-STAT signaling pathway 1387_6772_2033 3 0.015418392 0.909685121 0.019355003 7206 hsa-mir-192 hsa04920 Adipocytokine signaling pathway 5599_5970 2 0.021778312 1 0.026769175 7207 hsa-mir-192 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5970 2 0.024190725 1 0.029127607 7208 hsa-mir-193a hsa05200 Pathways in cancer 3320_3326_4149_5371_1499_5595_5594_5599_5914_1387_6257_6256_862_595_1870_5604_9915_6258_367_2932_861_7704_6502_4292_3091_3265_5970_7428_1871_7157_2113_5894_4609_1869_3725_4286_1029_4087_4088_4089_3066_3065_1050_5925_8031_2034_2033_4846_8554_836 50 2.09E-38 1.48E-36 1.48E-36 7209 hsa-mir-193a hsa04110 Cell cycle 990_5591_1387_595_1870_983_2932_8454_6502_6500_4616_1871_7157_10912_1869_1029_4087_4088_4089_3066_3065_5925_2033_5933 24 1.61E-21 1.14E-19 5.72E-20 7210 hsa-mir-193a hsa05220 Chronic myeloid leukemia 5595_5594_595_1870_5604_861_3265_5970_1871_7157_5894_4609_1869_1029_4088_4089_3066_3065_5925_6464 20 3.33E-20 2.37E-18 7.89E-19 7211 hsa-mir-193a hsa05215 Prostate cancer 3320_3326_1499_5595_5594_1387_595_1870_5604_367_2932_3265_5970_1871_7157_5894_1869_5925_2033 19 8.92E-18 6.33E-16 1.52E-16 7212 hsa-mir-193a hsa05212 Pancreatic cancer 3320_3326_1499_5595_5594_1387_595_1870_5604_367_2932_3265_5970_1871_7157_5894_1869_5925_2033 19 1.07E-17 7.61E-16 1.52E-16 7213 hsa-mir-193a hsa05214 Glioma 5595_5594_595_1870_5604_3265_808_1871_7157_5894_1869_1029_5925_6464_801_805 16 6.01E-16 4.27E-14 7.11E-15 7214 hsa-mir-193a hsa05223 Non-small cell lung cancer 5595_5594_6257_6256_595_1870_5604_6258_3265_1871_7157_5894_1869_1029_5925 15 1.07E-15 7.61E-14 1.09E-14 7215 hsa-mir-193a hsa04350 TGF-beta signaling pathway 5518_5595_5594_1387_4093_6667_8454_3399_6500_4609_3397_3398_4087_4088_4089_2033_5933 17 2.08E-15 1.47E-13 1.84E-14 7216 hsa-mir-193a hsa04010 MAPK signaling pathway 6722_4149_5595_5594_5599_5598_1386_5604_4208_7867_1432_4616_3265_5970_9261_3312_7157_10912_5894_4609_3725_4763_22800_836_1616 25 5.29E-15 3.76E-13 4.18E-14 7217 hsa-mir-193a hsa05216 Thyroid cancer 1499_5595_5594_6257_6256_595_5604_6258_3265_7157_4609_8031 12 1.60E-14 1.14E-12 1.14E-13 7218 hsa-mir-193a hsa05210 Colorectal cancer 1499_5595_5594_5599_595_5604_2932_4292_7157_5894_4609_3725_4087_4088_4089_836 16 1.99E-14 1.41E-12 1.29E-13 7219 hsa-mir-193a hsa05219 Bladder cancer 5595_5594_595_1870_5604_3265_1871_7157_5894_4609_1869_1029_5925 13 2.75E-14 1.96E-12 1.63E-13 7220 hsa-mir-193a hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_862_595_5604_861_7704_3265_5970_5894_4609_1050 14 6.29E-14 4.47E-12 3.44E-13 7221 hsa-mir-193a hsa05222 Small cell lung cancer 4149_6257_6256_595_1870_6258_6502_5970_1871_7157_4609_1869_5925_4846_8554 15 4.09E-13 2.91E-11 2.08E-12 7222 hsa-mir-193a hsa04310 Wnt signaling pathway 5518_1499_5599_1387_595_2932_8454_6500_7157_4609_3725_1457_1459_4087_4088_4089_2033 17 7.24E-12 5.14E-10 3.43E-11 7223 hsa-mir-193a hsa05218 Melanoma 5595_5594_595_1870_5604_3265_1871_7157_5894_1869_4286_1029_5925 13 8.92E-12 6.33E-10 3.96E-11 7224 hsa-mir-193a hsa05211 Renal cell carcinoma 5595_5594_1387_5604_9915_3091_3265_7428_2113_5894_3725_2034_2033 13 1.04E-11 7.40E-10 4.35E-11 7225 hsa-mir-193a hsa05213 Endometrial cancer 1499_5595_5594_595_5604_2932_4292_3265_7157_5894_4609 11 9.34E-11 6.63E-09 3.68E-10 7226 hsa-mir-193a hsa04720 Long-term potentiation 5595_5594_1387_5604_3265_808_2902_2906_5894_2033_801_805 12 2.29E-10 1.62E-08 8.54E-10 7227 hsa-mir-193a hsa04916 Melanogenesis 1499_5595_5594_1387_5604_2932_3265_808_5894_4286_2033_801_805 13 6.36E-10 4.52E-08 2.26E-09 7228 hsa-mir-193a hsa04540 Gap junction 5595_5594_5598_983_5604_7277_7278_3265_10376_5894_7846_51807 12 2.11E-09 1.50E-07 7.12E-09 7229 hsa-mir-193a hsa04912 GnRH signaling pathway 5595_5594_5599_5598_5604_1432_3265_808_5894_3725_801_805 12 9.81E-09 6.97E-07 3.17E-08 7230 hsa-mir-193a hsa04910 Insulin signaling pathway 6720_10891_5595_5594_5599_5604_2932_3265_808_5894_6464_801_805 13 1.47E-08 1.04E-06 4.54E-08 7231 hsa-mir-193a hsa04520 Adherens junction 1499_5595_5594_1387_1457_1459_4087_4088_4089_2033 10 6.18E-08 4.39E-06 1.83E-07 7232 hsa-mir-193a hsa04012 ErbB signaling pathway 5595_5594_5599_5604_2932_3265_5894_4609_3725_6464 10 1.27E-07 9.01E-06 3.60E-07 7233 hsa-mir-193a hsa04330 Notch signaling pathway 388585_1387_9612_8850_3066_3065_2033_2648 8 1.58E-07 1.12E-05 4.31E-07 7234 hsa-mir-193a hsa05016 Huntington's disease 6874_10891_1387_6908_6667_2902_7157_3066_3065_3064_2033_836_9519 13 4.24E-07 3.01E-05 1.11E-06 7235 hsa-mir-193a hsa04370 VEGF signaling pathway 5595_5594_5604_7867_1432_3265_9261_5894_4846 9 4.78E-07 3.40E-05 1.21E-06 7236 hsa-mir-193a hsa04115 p53 signaling pathway 595_983_4616_7157_10912_7161_1029_836 8 2.21E-06 0.000156795 5.41E-06 7237 hsa-mir-193a hsa04662 B cell receptor signaling pathway 5595_5594_5604_2932_3265_5970_5894_3725 8 3.91E-06 0.000277523 9.25E-06 7238 hsa-mir-193a hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_2902_2906_7157_4846_836_1616 7 6.13E-06 0.000434879 1.32E-05 7239 hsa-mir-193a hsa05131 Shigellosis 1499_7277_7278_10376_7846_51807_4691 7 6.13E-06 0.000434879 1.32E-05 7240 hsa-mir-193a hsa05130 Pathogenic Escherichia coli infection 1499_7277_7278_10376_7846_51807_4691 7 6.13E-06 0.000434879 1.32E-05 7241 hsa-mir-193a hsa04660 T cell receptor signaling pathway 5595_5594_5604_2932_1432_3265_5970_5894_3725 9 7.32E-06 0.000519518 1.52E-05 7242 hsa-mir-193a hsa03022 Basal transcription factors 2963_2962_2969_6874_6908_9519 6 7.49E-06 0.000532057 1.52E-05 7243 hsa-mir-193a hsa05010 Alzheimer's disease 5595_5594_2932_808_2902_2906_4846_351_836_801_805 11 8.60E-06 0.000610384 1.70E-05 7244 hsa-mir-193a hsa04730 Long-term depression 5518_5595_5594_5604_3265_5894_4846 7 2.54E-05 0.001802688 4.87E-05 7245 hsa-mir-193a hsa04510 Focal adhesion 1499_5595_5594_5599_595_5604_2932_3265_5894_3725_6464 11 3.27E-05 0.002321282 6.11E-05 7246 hsa-mir-193a hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_8454_6502_6500_7428_7329_8554 9 4.19E-05 0.002976487 7.63E-05 7247 hsa-mir-193a hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5604_1432_3265_5894 7 4.79E-05 0.003400402 8.50E-05 7248 hsa-mir-193a hsa04920 Adipocytokine signaling pathway 10891_5599_6257_6256_6258_5970 6 0.000158512 0.011254364 0.000274497 7249 hsa-mir-193a hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5604_1432_5970_3725 7 0.00021399 0.01519327 0.000361745 7250 hsa-mir-193a hsa04062 Chemokine signaling pathway 5595_5594_5604_2932_3265_5970_5894_7074_6464 9 0.000439159 0.031180275 0.000725123 7251 hsa-mir-193a hsa04270 Vascular smooth muscle contraction 5595_5594_5604_808_5894_801_805 7 0.000492989 0.03500219 0.000795504 7252 hsa-mir-193a hsa04612 Antigen processing and presentation 3320_3326_4800_4801_4802_3312 6 0.000660857 0.046920813 0.001042685 7253 hsa-mir-193a hsa04530 Tight junction 8573_5518_1499_3265_1457_1459_22800 7 0.001137381 0.080754048 0.001755523 7254 hsa-mir-193a hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_5604_3265_5894_836_6464 7 0.001183986 0.084062973 0.001788574 7255 hsa-mir-193a hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_1432_5970_3725_836 5 0.001551584 0.110162468 0.002295051 7256 hsa-mir-193a hsa04930 Type II diabetes mellitus 5595_5594_5599_3651 4 0.002092779 0.148587288 0.003032394 7257 hsa-mir-193a hsa03320 PPAR signaling pathway 6257_6256_6258_2168 4 0.009169364 0.651024828 0.013020497 7258 hsa-mir-193a hsa04810 Regulation of actin cytoskeleton 5595_5594_5604_3265_5894_22800_7074 7 0.013185906 0.936199315 0.018356849 7259 hsa-mir-193a hsa04020 Calcium signaling pathway 808_2902_2906_4846_801_805 6 0.019339666 1 0.026406083 7260 hsa-mir-193a hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.02294898 1 0.030742973 7261 hsa-mir-193a hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.026351096 1 0.034646811 7262 hsa-mir-193a hsa04630 Jak-STAT signaling pathway 1387_595_4609_2033_8554 5 0.032801447 1 0.042083198 7263 hsa-mir-193a hsa04950 Maturity onset diabetes of the young 3651_168620 2 0.033192381 1 0.042083198 7264 hsa-mir-194-1 hsa05200 Pathways in cancer 1499_5595_5594_1387_4286_1019_1017_7704_6774_6688_4088_4609_1026_4087_5925_2033_207_8554 18 3.12E-16 1.90E-14 1.90E-14 7265 hsa-mir-194-1 hsa04350 TGF-beta signaling pathway 5595_5594_1387_7027_1874_4088_4609_4087_2033_5933 10 1.68E-12 1.02E-10 3.15E-11 7266 hsa-mir-194-1 hsa05215 Prostate cancer 1499_5595_5594_1387_1017_468_1026_5925_2033_207 10 1.86E-12 1.14E-10 3.15E-11 7267 hsa-mir-194-1 hsa05212 Pancreatic cancer 1499_5595_5594_1387_1017_468_1026_5925_2033_207 10 2.07E-12 1.26E-10 3.15E-11 7268 hsa-mir-194-1 hsa04110 Cell cycle 1387_1019_1017_7027_4088_1026_4087_5925_2033_5933 10 2.99E-11 1.83E-09 3.65E-10 7269 hsa-mir-194-1 hsa05220 Chronic myeloid leukemia 5595_5594_1019_4088_4609_1026_5925_207 8 5.31E-10 3.24E-08 5.39E-09 7270 hsa-mir-194-1 hsa04520 Adherens junction 1460_1499_5595_5594_1387_4088_4087_2033 8 8.52E-10 5.20E-08 7.43E-09 7271 hsa-mir-194-1 hsa05221 Acute myeloid leukemia 5595_5594_7704_6774_6688_4609_207 7 3.37E-09 2.06E-07 2.57E-08 7272 hsa-mir-194-1 hsa05218 Melanoma 5595_5594_4286_1019_1026_5925_207 7 1.11E-08 6.74E-07 7.49E-08 7273 hsa-mir-194-1 hsa05219 Bladder cancer 5595_5594_1019_4609_1026_5925 6 1.70E-08 1.04E-06 1.04E-07 7274 hsa-mir-194-1 hsa05210 Colorectal cancer 1499_5595_5594_4088_4609_4087_207 7 3.26E-08 1.99E-06 1.81E-07 7275 hsa-mir-194-1 hsa05214 Glioma 5595_5594_1019_1026_5925_207 6 1.86E-07 1.13E-05 9.44E-07 7276 hsa-mir-194-1 hsa05222 Small cell lung cancer 1019_1017_4609_5925_207_8554 6 8.71E-07 5.32E-05 4.09E-06 7277 hsa-mir-194-1 hsa04310 Wnt signaling pathway 1460_1499_1387_4088_4609_4087_2033 7 1.48E-06 9.03E-05 6.45E-06 7278 hsa-mir-194-1 hsa05213 Endometrial cancer 1499_5595_5594_4609_207 5 1.70E-06 0.000103669 6.91E-06 7279 hsa-mir-194-1 hsa05223 Non-small cell lung cancer 5595_5594_1019_5925_207 5 2.02E-06 0.00012327 7.70E-06 7280 hsa-mir-194-1 hsa04916 Melanogenesis 1499_5595_5594_1387_4286_2033 6 2.49E-06 0.000151766 8.93E-06 7281 hsa-mir-194-1 hsa05216 Thyroid cancer 1499_5595_5594_4609 4 5.29E-06 0.000322586 1.79E-05 7282 hsa-mir-194-1 hsa05211 Renal cell carcinoma 5595_5594_1387_2033_207 5 7.59E-06 0.000462883 2.44E-05 7283 hsa-mir-194-1 hsa04720 Long-term potentiation 5595_5594_1387_468_2033 5 9.16E-06 0.000558559 2.79E-05 7284 hsa-mir-194-1 hsa04012 ErbB signaling pathway 5595_5594_4609_1026_207 5 1.81E-05 0.001105379 5.26E-05 7285 hsa-mir-194-1 hsa04630 Jak-STAT signaling pathway 1387_6774_4609_2033_207_8554 6 2.22E-05 0.001351467 6.14E-05 7286 hsa-mir-194-1 hsa04660 T cell receptor signaling pathway 5595_5594_1019_1739_207 5 5.31E-05 0.003237737 0.000140771 7287 hsa-mir-194-1 hsa04010 MAPK signaling pathway 5595_5594_1386_468_4609_1649_207 7 5.85E-05 0.003566219 0.000148592 7288 hsa-mir-194-1 hsa04530 Tight junction 1460_10207_1499_1019_207 5 0.000143856 0.008775203 0.000351008 7289 hsa-mir-194-1 hsa04510 Focal adhesion 1499_5595_5594_1729_207 5 0.000882661 0.053842305 0.002070858 7290 hsa-mir-194-1 hsa04150 mTOR signaling pathway 5595_5594_207 3 0.000948017 0.057829031 0.002141816 7291 hsa-mir-194-1 hsa04115 p53 signaling pathway 1019_1017_1026 3 0.002064674 0.125945137 0.004498041 7292 hsa-mir-194-1 hsa04662 B cell receptor signaling pathway 5595_5594_207 3 0.002594185 0.158245298 0.005456734 7293 hsa-mir-194-1 hsa04370 VEGF signaling pathway 5595_5594_207 3 0.002787586 0.170042721 0.005668091 7294 hsa-mir-194-1 hsa04664 Fc epsilon RI signaling pathway 5595_5594_207 3 0.002989651 0.182368727 0.005882862 7295 hsa-mir-194-1 hsa05010 Alzheimer's disease 22926_5595_5594_4716 4 0.003768853 0.229900034 0.007184376 7296 hsa-mir-194-1 hsa05016 Huntington's disease 1387_6908_2033_4716 4 0.004644182 0.28329512 0.008584701 7297 hsa-mir-194-1 hsa04062 Chemokine signaling pathway 5595_5594_6774_207 4 0.005083743 0.310108294 0.009120832 7298 hsa-mir-194-1 hsa04620 Toll-like receptor signaling pathway 5595_5594_207 3 0.005973302 0.364371422 0.010410612 7299 hsa-mir-194-1 hsa04912 GnRH signaling pathway 5595_5594_468 3 0.006962574 0.424716999 0.011797694 7300 hsa-mir-194-1 hsa03022 Basal transcription factors 6908_2959 2 0.00820835 0.500709328 0.013532685 7301 hsa-mir-194-1 hsa04360 Axon guidance 5998_5595_5594 3 0.011619724 0.708803147 0.018394131 7302 hsa-mir-194-1 hsa04930 Type II diabetes mellitus 5595_5594 2 0.011760182 0.717371096 0.018394131 7303 hsa-mir-194-1 hsa04330 Notch signaling pathway 1387_2033 2 0.012736087 0.776901279 0.019422532 7304 hsa-mir-194-1 hsa04910 Insulin signaling pathway 5595_5594_207 3 0.013318293 0.812415846 0.019815021 7305 hsa-mir-194-1 hsa04920 Adipocytokine signaling pathway 6774_207 2 0.024289515 1 0.035277629 7306 hsa-mir-194-1 hsa04730 Long-term depression 5595_5594 2 0.02696631 1 0.038254533 7307 hsa-mir-194-1 hsa04612 Antigen processing and presentation 4800_4801 2 0.040362465 1 0.055957053 7308 hsa-mir-194-1 hsa04810 Regulation of actin cytoskeleton 5595_5594_1729 3 0.042874351 1 0.057842421 7309 hsa-mir-194-1 hsa04540 Gap junction 5595_5594 2 0.043618875 1 0.057842421 7310 hsa-mir-194-2 hsa05200 Pathways in cancer 3320_4149_5371_7046_5595_5599_1387_5604_2932_6502_6772_5970_5894_4088_1029_4087_4292_1050_5925_2033 20 1.61E-19 9.48E-18 9.48E-18 7311 hsa-mir-194-2 hsa04110 Cell cycle 990_1387_983_2932_8454_6502_6500_4088_1029_4087_5925_2033_5933 13 4.14E-16 2.44E-14 1.22E-14 7312 hsa-mir-194-2 hsa04350 TGF-beta signaling pathway 7046_5595_1387_6667_8454_6500_4088_4087_2033_5933 10 7.50E-13 4.42E-11 1.47E-11 7313 hsa-mir-194-2 hsa04540 Gap junction 5595_5598_983_5604_7277_7278_10376_5894_7846_51807 10 1.38E-12 8.17E-11 2.04E-11 7314 hsa-mir-194-2 hsa04520 Adherens junction 4301_7046_5595_1387_4088_1457_1459_4087_2033 9 1.32E-11 7.78E-10 1.56E-10 7315 hsa-mir-194-2 hsa05210 Colorectal cancer 7046_5595_5599_5604_2932_5894_4088_4087_4292 9 1.98E-11 1.17E-09 1.94E-10 7316 hsa-mir-194-2 hsa05215 Prostate cancer 3320_5595_1387_5604_2932_5970_5894_5925_2033 9 2.90E-11 1.71E-09 2.35E-10 7317 hsa-mir-194-2 hsa05212 Pancreatic cancer 3320_5595_1387_5604_2932_5970_5894_5925_2033 9 3.19E-11 1.88E-09 2.35E-10 7318 hsa-mir-194-2 hsa04310 Wnt signaling pathway 5599_1387_2932_8454_6500_4088_1457_1459_4087_2033 10 1.30E-10 7.66E-09 8.51E-10 7319 hsa-mir-194-2 hsa05220 Chronic myeloid leukemia 7046_5595_5604_5970_5894_4088_1029_5925 8 2.80E-10 1.65E-08 1.65E-09 7320 hsa-mir-194-2 hsa05131 Shigellosis 7277_7278_10376_7846_51807_4691 6 5.09E-08 3.00E-06 2.50E-07 7321 hsa-mir-194-2 hsa05130 Pathogenic Escherichia coli infection 7277_7278_10376_7846_51807_4691 6 5.09E-08 3.00E-06 2.50E-07 7322 hsa-mir-194-2 hsa05221 Acute myeloid leukemia 5371_5595_5604_5970_5894_1050 6 6.79E-08 4.01E-06 3.08E-07 7323 hsa-mir-194-2 hsa04010 MAPK signaling pathway 4149_7046_5595_5599_5598_5604_1386_5970_5894 9 3.41E-07 2.01E-05 1.44E-06 7324 hsa-mir-194-2 hsa05219 Bladder cancer 5595_5604_5894_1029_5925 5 4.32E-07 2.55E-05 1.70E-06 7325 hsa-mir-194-2 hsa05213 Endometrial cancer 5595_5604_2932_5894_4292 5 1.15E-06 6.78E-05 4.24E-06 7326 hsa-mir-194-2 hsa05223 Non-small cell lung cancer 5595_5604_5894_1029_5925 5 1.37E-06 8.06E-05 4.74E-06 7327 hsa-mir-194-2 hsa04916 Melanogenesis 5595_1387_5604_2932_5894_2033 6 1.57E-06 9.24E-05 5.13E-06 7328 hsa-mir-194-2 hsa05214 Glioma 5595_5604_5894_1029_5925 5 3.21E-06 0.000189559 9.98E-06 7329 hsa-mir-194-2 hsa04062 Chemokine signaling pathway 5595_5604_2932_6772_5970_5894_7074 7 3.99E-06 0.000235511 1.18E-05 7330 hsa-mir-194-2 hsa05218 Melanoma 5595_5604_5894_1029_5925 5 4.83E-06 0.000284973 1.36E-05 7331 hsa-mir-194-2 hsa05211 Renal cell carcinoma 5595_1387_5604_5894_2033 5 5.15E-06 0.000303989 1.38E-05 7332 hsa-mir-194-2 hsa04720 Long-term potentiation 5595_1387_5604_5894_2033 5 6.22E-06 0.000367064 1.53E-05 7333 hsa-mir-194-2 hsa04662 B cell receptor signaling pathway 5595_5604_2932_5970_5894 5 6.22E-06 0.000367064 1.53E-05 7334 hsa-mir-194-2 hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_8454_6502_6500 6 7.77E-06 0.000458215 1.83E-05 7335 hsa-mir-194-2 hsa04012 ErbB signaling pathway 5595_5599_5604_2932_5894 5 1.23E-05 0.000728325 2.80E-05 7336 hsa-mir-194-2 hsa04620 Toll-like receptor signaling pathway 5595_5599_5604_6772_5970 5 2.57E-05 0.001515602 5.61E-05 7337 hsa-mir-194-2 hsa04912 GnRH signaling pathway 5595_5599_5598_5604_5894 5 3.34E-05 0.001970878 7.04E-05 7338 hsa-mir-194-2 hsa04660 T cell receptor signaling pathway 5595_5604_2932_5970_5894 5 3.63E-05 0.002144069 7.39E-05 7339 hsa-mir-194-2 hsa04910 Insulin signaling pathway 5595_5599_5604_2932_5894 5 0.000102403 0.006041771 0.000201392 7340 hsa-mir-194-2 hsa04664 Fc epsilon RI signaling pathway 5595_5599_5604_5894 4 0.000153275 0.009043226 0.000291717 7341 hsa-mir-194-2 hsa05222 Small cell lung cancer 4149_6502_5970_5925 4 0.000209489 0.012359871 0.000386246 7342 hsa-mir-194-2 hsa03022 Basal transcription factors 2962_2969_6908 3 0.000294034 0.01734803 0.000525698 7343 hsa-mir-194-2 hsa04330 Notch signaling pathway 1387_2033_2648 3 0.000569859 0.033621663 0.000988872 7344 hsa-mir-194-2 hsa04510 Focal adhesion 5595_5599_5604_2932_5894 5 0.000617023 0.036404341 0.001040124 7345 hsa-mir-194-2 hsa04115 p53 signaling pathway 983_7161_1029 3 0.001647445 0.097199274 0.00269998 7346 hsa-mir-194-2 hsa04730 Long-term depression 5595_5604_5894 3 0.001782342 0.105158149 0.002842112 7347 hsa-mir-194-2 hsa04370 VEGF signaling pathway 5595_5604_5894 3 0.002227738 0.131436524 0.003458856 7348 hsa-mir-194-2 hsa04612 Antigen processing and presentation 3320_4801_4802 3 0.003311588 0.195383709 0.005009839 7349 hsa-mir-194-2 hsa05016 Huntington's disease 1387_6908_6667_2033 4 0.003504524 0.206766911 0.005169173 7350 hsa-mir-194-2 hsa05216 Thyroid cancer 5595_5604 2 0.004498013 0.265382763 0.00647275 7351 hsa-mir-194-2 hsa04810 Regulation of actin cytoskeleton 5595_5604_5894_7074 4 0.005939985 0.350459098 0.008344264 7352 hsa-mir-194-2 hsa04270 Vascular smooth muscle contraction 5595_5604_5894 3 0.00710151 0.418989074 0.009743932 7353 hsa-mir-194-2 hsa04930 Type II diabetes mellitus 5595_5599 2 0.01011309 0.596672308 0.013560734 7354 hsa-mir-194-2 hsa04530 Tight junction 4301_1457_1459 3 0.010564315 0.623294577 0.01381262 7355 hsa-mir-194-2 hsa04650 Natural killer cell mediated cytotoxicity 5595_5604_5894 3 0.010769162 0.635380532 0.01381262 7356 hsa-mir-194-2 hsa04630 Jak-STAT signaling pathway 1387_6772_2033 3 0.014606052 0.861757064 0.018335257 7357 hsa-mir-194-2 hsa04920 Adipocytokine signaling pathway 5599_5970 2 0.020966666 1 0.025771526 7358 hsa-mir-194-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5970 2 0.023293146 1 0.02804685 7359 hsa-mir-195 hsa05200 Pathways in cancer 4149_1499_595_1019_1017_8517_4193_3551_5578_6502_3091_2736_2737_4087_7175_3066_3065_5925_1050_5468_2034_2308_1870_1871_2113_10401_5894_861_207_9915_1147_367_5595_5594_5599_6258_1387_6257_6256_4286_2932_6774_6772_5970_7157_6688_1869_3725_2735_4088_4089_2033_4790_4791_4792_3320_3326_5371_5604_5601_4292_8031_4609_1029_2353_8554 66 8.48E-34 7.12E-32 7.12E-32 7360 hsa-mir-195 hsa04010 MAPK signaling pathway 6722_4149_6195_6197_8517_9252_3551_5578_4773_9020_4616_3305_3303_1432_4342_5894_1616_207_1147_3727_5595_5594_5599_5598_1386_3312_1649_5971_5970_3310_7157_10912_3725_6196_5058_4790_4791_9261_1326_5604_5601_5600_5603_5608_5566_6885_4609_2353_8986_8550 50 1.92E-24 1.62E-22 8.08E-23 7361 hsa-mir-195 hsa04110 Cell cycle 595_1019_1017_4193_6502_6500_4087_3066_3065_4616_5925_1870_1871_5933_5591_1387_7533_7532_2932_7534_7157_5111_10912_1869_4088_4089_2033_891_894_896_983_8454_1029_1028_1111_990 36 3.77E-24 3.16E-22 1.05E-22 7362 hsa-mir-195 hsa05215 Prostate cancer 1499_595_1017_8517_4193_3551_5925_2308_1870_1871_5894_207_9586_1147_367_5595_5594_1385_1387_2932_5970_7157_1869_2033_4790_4792_3320_3326_5604 29 1.46E-20 1.23E-18 3.06E-19 7363 hsa-mir-195 hsa05212 Pancreatic cancer 1499_595_1017_8517_4193_3551_5925_2308_1870_1871_5894_207_9586_1147_367_5595_5594_1385_1387_2932_5970_7157_1869_2033_4790_4792_3320_3326_5604 29 1.89E-20 1.59E-18 3.17E-19 7364 hsa-mir-195 hsa05220 Chronic myeloid leukemia 595_1019_8517_4193_3551_3066_3065_5925_1870_1871_5894_861_207_1147_5595_5594_5970_7157_1869_4088_4089_4790_4792_5604_4609_1029 26 5.03E-19 4.23E-17 7.05E-18 7365 hsa-mir-195 hsa04660 T cell receptor signaling pathway 1019_8517_3551_4773_9020_1432_5894_207_1147_5595_5594_2932_5970_3725_5058_4794_4790_4792_4793_1326_5604_5601_5600_5603_6885_2353 26 1.30E-15 1.09E-13 1.56E-14 7366 hsa-mir-195 hsa04310 Wnt signaling pathway 1499_595_5578_6500_8945_4087_4773_23291_8607_5599_1387_2932_7157_8061_3725_1457_1459_4088_4089_2033_894_896_5519_5515_5601_5566_8454_6885_4609 29 3.98E-15 3.35E-13 4.18E-14 7367 hsa-mir-195 hsa05222 Small cell lung cancer 4149_595_1019_1017_8517_3551_6502_5925_1870_1871_10401_207_1147_6258_6257_6256_5970_7157_1869_4790_4792_4609_8554 23 6.03E-15 5.07E-13 5.63E-14 7368 hsa-mir-195 hsa04620 Toll-like receptor signaling pathway 8517_3551_3661_1432_207_1147_29110_5595_5594_5599_6772_5970_3725_4790_4792_1326_5604_5601_5600_5603_5608_9641_6885_2353 24 1.77E-14 1.48E-12 1.48E-13 7369 hsa-mir-195 hsa04920 Adipocytokine signaling pathway 10891_5465_8517_3551_2538_8471_207_1147_5599_6258_6257_6256_6774_5970_4794_4790_4792_4793_5601_5563 20 6.25E-14 5.25E-12 4.77E-13 7370 hsa-mir-195 hsa05223 Non-small cell lung cancer 595_1019_5578_5925_1870_1871_5894_207_5595_5594_6258_6257_6256_7157_1869_5604_1029 17 2.34E-12 1.97E-10 1.64E-11 7371 hsa-mir-195 hsa05214 Glioma 595_1019_4193_5578_5925_1870_1871_5894_207_5595_5594_7157_1869_808_801_805_5604_1029 18 3.27E-12 2.74E-10 2.11E-11 7372 hsa-mir-195 hsa04350 TGF-beta signaling pathway 6500_4087_6667_3397_3399_3398_5933_3400_5595_5594_1387_4088_4089_2033_5519_5515_4093_8454_4609_4092 20 3.88E-12 3.26E-10 2.33E-11 7373 hsa-mir-195 hsa05221 Acute myeloid leukemia 595_8517_3551_1050_5894_861_207_1147_5595_5594_6774_5970_6688_4790_5371_5604_4609 17 7.67E-12 6.44E-10 4.30E-11 7374 hsa-mir-195 hsa05219 Bladder cancer 595_1019_9252_4193_5925_1870_1871_5894_5595_5594_7157_1869_5604_4609_1029 15 1.05E-11 8.80E-10 5.50E-11 7375 hsa-mir-195 hsa04662 B cell receptor signaling pathway 8517_3551_4773_5894_207_1147_695_5595_5594_2932_5970_3725_4794_4790_4792_4793_5604_2353 18 2.50E-11 2.10E-09 1.21E-10 7376 hsa-mir-195 hsa05216 Thyroid cancer 1499_595_7175_5468_5595_5594_6258_6257_6256_7157_5604_8031_4609 13 2.59E-11 2.17E-09 1.21E-10 7377 hsa-mir-195 hsa04540 Gap junction 5578_10382_51807_6714_5894_5592_5595_5594_5598_7846_203068_347733_983_5604_5566_7277_7278_84617_10376 19 7.84E-11 6.59E-09 3.47E-10 7378 hsa-mir-195 hsa05210 Colorectal cancer 1499_595_4087_5894_207_5595_5594_5599_2932_7157_3725_4088_4089_5604_5601_4292_4609_2353 18 1.25E-10 1.05E-08 5.26E-10 7379 hsa-mir-195 hsa04910 Insulin signaling pathway 10891_6720_3551_2538_2308_5894_8471_207_8651_5590_5595_5594_5599_2932_808_801_805_5604_5601_5566_5563 21 9.88E-10 8.30E-08 3.95E-09 7380 hsa-mir-195 hsa05131 Shigellosis 1499_5578_10382_51807_71_7534_7846_203068_347733_7277_7278_84617_4691_10376 14 2.60E-09 2.19E-07 9.51E-09 7381 hsa-mir-195 hsa05130 Pathogenic Escherichia coli infection 1499_5578_10382_51807_71_7534_7846_203068_347733_7277_7278_84617_4691_10376 14 2.60E-09 2.19E-07 9.51E-09 7382 hsa-mir-195 hsa04912 GnRH signaling pathway 5578_6714_1432_5894_5595_5594_5599_5598_3725_808_801_805_5604_5601_5600_5603_5608_5566 18 4.34E-09 3.65E-07 1.52E-08 7383 hsa-mir-195 hsa05218 Melanoma 595_1019_4193_5925_1870_1871_5894_207_5595_5594_4286_7157_1869_5604_1029 15 5.17E-09 4.34E-07 1.67E-08 7384 hsa-mir-195 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 8517_3551_9020_6714_1432_1147_5599_5970_3725_5058_4790_4792_5601_5600_5603 15 5.17E-09 4.34E-07 1.67E-08 7385 hsa-mir-195 hsa04720 Long-term potentiation 814_6195_6197_5578_5894_5595_5594_1387_6196_2033_808_801_805_5604_5566 15 9.88E-09 8.30E-07 3.07E-08 7386 hsa-mir-195 hsa04115 p53 signaling pathway 595_1019_1017_4193_4616_7157_10912_891_894_896_983_7161_1029_1111 14 2.61E-08 2.20E-06 7.84E-08 7387 hsa-mir-195 hsa04120 Ubiquitin mediated proteolysis 55294_4193_6502_6500_3093_8945_23291_10401_10273_7325_7323_7329_51366_8651_997_5371_672_8454_8554 19 2.92E-08 2.46E-06 8.47E-08 7388 hsa-mir-195 hsa05211 Renal cell carcinoma 3091_2034_2113_5894_207_9915_5595_5594_1387_3725_5058_2033_5604 13 2.70E-07 2.27E-05 7.56E-07 7389 hsa-mir-195 hsa04916 Melanogenesis 1499_5578_5894_5595_5594_1385_1387_4286_2932_2033_808_801_805_5604_5566 15 4.47E-07 3.76E-05 1.21E-06 7390 hsa-mir-195 hsa05016 Huntington's disease 10891_292_293_1537_3066_3065_3064_498_5468_6667_5441_9586_1385_1387_5437_7157_1213_25942_2033_6908 20 5.21E-07 4.38E-05 1.37E-06 7391 hsa-mir-195 hsa05213 Endometrial cancer 1499_595_5894_207_5595_5594_2932_7157_5604_4292_4609 11 5.68E-07 4.77E-05 1.45E-06 7392 hsa-mir-195 hsa04664 Fc epsilon RI signaling pathway 5578_1432_5894_207_695_5595_5594_5599_5604_5601_5600_5603_5608 13 6.92E-07 5.81E-05 1.71E-06 7393 hsa-mir-195 hsa04062 Chemokine signaling pathway 8517_3551_653361_7074_5894_207_1147_5590_5595_5594_2932_6774_6772_5970_5058_4790_4792_4793_5604_5566 20 7.61E-07 6.39E-05 1.83E-06 7394 hsa-mir-195 hsa04520 Adherens junction 1499_4087_6714_71_5595_5594_1387_1457_1459_4088_4089_2033_6885 13 7.85E-07 6.60E-05 1.83E-06 7395 hsa-mir-195 hsa04012 ErbB signaling pathway 5578_6714_5894_207_5595_5594_5599_2932_3725_5058_5604_5601_4609 13 1.82E-06 0.000153196 4.14E-06 7396 hsa-mir-195 hsa04370 VEGF signaling pathway 5578_4773_6714_1432_5894_207_5595_5594_9261_5604_5600_5603 12 3.07E-06 0.000257572 6.78E-06 7397 hsa-mir-195 hsa04930 Type II diabetes mellitus 3651_3551_8471_8651_5590_5595_5594_5599_5601 9 9.06E-06 0.000761119 1.95E-05 7398 hsa-mir-195 hsa04210 Apoptosis 8517_3551_9020_8837_207_1147_5970_7157_9131_4790_4792_5566 12 1.16E-05 0.000976014 2.44E-05 7399 hsa-mir-195 hsa03022 Basal transcription factors 6872_2963_2962_2969_6878_6908_6882_2959 8 1.75E-05 0.001467812 3.58E-05 7400 hsa-mir-195 hsa04510 Focal adhesion 1499_595_5578_6714_10627_5894_207_71_5595_5594_5599_2932_3725_5058_894_896_5604_5601 18 2.31E-05 0.001941568 4.62E-05 7401 hsa-mir-195 hsa04530 Tight junction 1499_1019_5578_6714_4627_4628_10627_207_71_5590_1457_1459_5519_5515 14 3.90E-05 0.003272058 7.61E-05 7402 hsa-mir-195 hsa04612 Antigen processing and presentation 3308_3309_3305_3303_1385_3312_3310_3320_3326_4802_4801 11 5.51E-05 0.004626425 0.000105146 7403 hsa-mir-195 hsa04330 Notch signaling pathway 9612_3066_3065_1387_2033_8850_2648_4851 8 7.87E-05 0.006608545 0.000146857 7404 hsa-mir-195 hsa04630 Jak-STAT signaling pathway 3559_595_10401_207_8651_1387_6778_6774_6772_2033_894_896_4609_8554 14 0.000132003 0.011088231 0.000241049 7405 hsa-mir-195 hsa04150 mTOR signaling pathway 6195_6197_3091_207_5595_5594_6196_5563 8 0.000147641 0.012401866 0.000263869 7406 hsa-mir-195 hsa03010 Ribosome 6155_6156_6207_6202_9349_6141_6217_6222_6128_6188_6231 11 0.000167183 0.014043403 0.000292571 7407 hsa-mir-195 hsa03020 RNA polymerase 25885_64425_51082_5441_5437_84172 6 0.000247121 0.020758154 0.000423636 7408 hsa-mir-195 hsa04340 Hedgehog signaling pathway 2736_2737_8945_23291_53944_2932_2735_5566 8 0.000260146 0.021852284 0.000437046 7409 hsa-mir-195 hsa04270 Vascular smooth muscle contraction 5578_5894_5592_5595_5594_4637_808_801_805_5604_5566 11 0.000528245 0.044372583 0.000870051 7410 hsa-mir-195 hsa04730 Long-term depression 5578_5894_5592_5595_5594_5519_5515_5604 8 0.000981101 0.082412502 0.001584856 7411 hsa-mir-195 hsa03320 PPAR signaling pathway 5465_2168_10062_5468_6258_6257_6256 7 0.003719801 0.312463285 0.005895534 7412 hsa-mir-195 hsa05217 Basal cell carcinoma 1499_2736_2737_2932_7157_2735 6 0.004804453 0.403574082 0.007473594 7413 hsa-mir-195 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_1616_7157_5600_5603_5608 6 0.005205713 0.437279877 0.007950543 7414 hsa-mir-195 hsa04950 Maturity onset diabetes of the young 3651_6927_168620_3172 4 0.005488683 0.461049387 0.008233025 7415 hsa-mir-195 hsa04670 Leukocyte transendothelial migration 1499_5578_653361_1432_10627_71_5600_5603 8 0.019651977 1 0.028485255 7416 hsa-mir-195 hsa04810 Regulation of actin cytoskeleton 7074_4627_4628_4342_10627_5894_71_5595_5594_5058_5604_10788 12 0.019668391 1 0.028485255 7417 hsa-mir-195 hsa03430 Mismatch repair 5981_5111_4292 3 0.02857349 1 0.0406809 7418 hsa-mir-196a-2 hsa05200 Pathways in cancer 4286_3716_5925_2249_675_1871_1956_5595_5594_861_5914_1387_6256_5159_595_1029_5156_1487_1488_836_207_1399_1398_367_1017_3815_2932_2353_6776_6777_6772_7157_2308_5970_7046_1870_2113_1869_3725_4088_1026_867_6774_2736_4087_4089_1050_2033_4149_898 50 2.50E-36 1.82E-34 1.82E-34 7419 hsa-mir-196a-2 hsa05220 Chronic myeloid leukemia 5925_1871_5595_5594_861_595_1029_1487_1488_207_1399_1398_6776_6777_7157_5970_7046_1870_5781_1869_4088_1026_867_4089_6464 25 6.10E-26 4.46E-24 2.23E-24 7420 hsa-mir-196a-2 hsa04110 Cell cycle 5925_1871_1387_595_1029_1017_7532_5001_2932_7157_1870_1869_4174_4088_1026_4172_4173_4087_4089_2033_5933_890_894_896_898_5934_4998_4999 28 2.29E-25 1.67E-23 5.58E-24 7421 hsa-mir-196a-2 hsa05215 Prostate cancer 5925_1871_1956_5595_5594_1387_5159_595_5156_207_367_1017_2932_7157_2308_5970_1870_1869_1026_2033_898 21 1.95E-19 1.42E-17 3.48E-18 7422 hsa-mir-196a-2 hsa05212 Pancreatic cancer 5925_1871_1956_5595_5594_1387_5159_595_5156_207_367_1017_2932_7157_2308_5970_1870_1869_1026_2033_898 21 2.38E-19 1.74E-17 3.48E-18 7423 hsa-mir-196a-2 hsa04630 Jak-STAT signaling pathway 3717_3716_3718_85480_3560_3561_1387_595_207_3575_6776_6777_6772_2057_5781_867_6774_2690_2033_3977_894_896 22 4.57E-16 3.33E-14 5.56E-15 7424 hsa-mir-196a-2 hsa04010 MAPK signaling pathway 2249_1956_5595_5594_5598_5159_9261_5156_836_207_1399_1398_9252_2353_1432_7157_5970_7046_6722_1616_3725_6195_6196_8986_4149_6197 26 6.14E-15 4.48E-13 6.40E-14 7425 hsa-mir-196a-2 hsa05218 Melanoma 4286_5925_2249_1871_1956_5595_5594_5159_595_1029_5156_207_7157_1870_1869_1026 16 8.84E-15 6.45E-13 8.06E-14 7426 hsa-mir-196a-2 hsa05214 Glioma 5925_1871_1956_5595_5594_5159_595_1029_5156_207_7157_1870_1869_1026_6464 15 4.54E-14 3.31E-12 3.68E-13 7427 hsa-mir-196a-2 hsa05210 Colorectal cancer 1956_5595_5594_5159_595_5156_836_207_2932_2353_7157_7046_3725_4088_4087_4089 16 8.70E-14 6.35E-12 6.35E-13 7428 hsa-mir-196a-2 hsa04350 TGF-beta signaling pathway 5515_5595_5594_1387_6667_3399_3398_7046_1874_1875_4088_4087_4089_2033_5933_5934 16 1.40E-13 1.03E-11 9.32E-13 7429 hsa-mir-196a-2 hsa04012 ErbB signaling pathway 1956_6714_5595_5594_2066_207_1399_1398_2932_6776_6777_3725_1026_867_6464 15 1.87E-12 1.37E-10 1.06E-11 7430 hsa-mir-196a-2 hsa05219 Bladder cancer 5925_1871_1956_5595_5594_595_1029_9252_7157_1870_1869_1026 12 1.88E-12 1.37E-10 1.06E-11 7431 hsa-mir-196a-2 hsa04520 Adherens junction 4301_1460_1956_6714_3643_5595_5594_1387_5770_7046_4088_4087_4089_2033 14 8.66E-12 6.32E-10 4.51E-11 7432 hsa-mir-196a-2 hsa05223 Non-small cell lung cancer 5925_1871_1956_5595_5594_6256_595_1029_207_7157_1870_1869 12 2.37E-11 1.73E-09 1.15E-10 7433 hsa-mir-196a-2 hsa05221 Acute myeloid leukemia 5595_5594_861_5914_595_207_3815_6776_6777_5970_6774_1050 12 5.83E-11 4.25E-09 2.66E-10 7434 hsa-mir-196a-2 hsa04910 Insulin signaling pathway 10891_3643_5595_5594_23265_5499_207_1399_1398_2932_5770_2308_5563_867_6464 15 6.81E-10 4.97E-08 2.92E-09 7435 hsa-mir-196a-2 hsa04310 Wnt signaling pathway 5515_1460_1387_595_1487_1488_2932_7157_3725_4088_4087_4089_2033_894_896 15 2.31E-09 1.68E-07 9.36E-09 7436 hsa-mir-196a-2 hsa04510 Focal adhesion 1956_6714_5595_5594_5159_595_5156_5499_207_1399_1398_2932_3725_1729_894_896_6464 17 2.46E-09 1.80E-07 9.46E-09 7437 hsa-mir-196a-2 hsa05222 Small cell lung cancer 5925_1871_6256_595_207_1017_7157_5970_1870_1869_4149_898 12 2.76E-09 2.01E-07 1.01E-08 7438 hsa-mir-196a-2 hsa04660 T cell receptor signaling pathway 5595_5594_207_919_2932_2353_1432_5970_1739_3725_867_3932_1493 13 3.76E-09 2.74E-07 1.31E-08 7439 hsa-mir-196a-2 hsa05211 Renal cell carcinoma 5595_5594_1387_207_1399_1398_5781_2113_3725_2033 10 6.11E-08 4.46E-06 2.03E-07 7440 hsa-mir-196a-2 hsa04062 Chemokine signaling pathway 3717_3718_5595_5594_207_1399_1398_1234_2932_6777_6772_5970_6774_6464 14 2.80E-07 2.04E-05 8.89E-07 7441 hsa-mir-196a-2 hsa04115 p53 signaling pathway 595_1029_836_1017_7157_1026_894_896_898 9 4.57E-07 3.33E-05 1.39E-06 7442 hsa-mir-196a-2 hsa04662 B cell receptor signaling pathway 695_5595_5594_6850_207_2932_2353_5970_3725 9 8.65E-07 6.31E-05 2.52E-06 7443 hsa-mir-196a-2 hsa05016 Huntington's disease 10891_25942_1387_6908_836_4724_6667_7157_23186_3064_4697_2033_4716 13 1.24E-06 9.02E-05 3.47E-06 7444 hsa-mir-196a-2 hsa04920 Adipocytokine signaling pathway 3717_10891_6256_207_5970_5781_5563_6774 8 3.66E-06 0.000266932 9.89E-06 7445 hsa-mir-196a-2 hsa05213 Endometrial cancer 1956_5595_5594_595_207_2932_7157 7 7.32E-06 0.000534456 1.84E-05 7446 hsa-mir-196a-2 hsa04150 mTOR signaling pathway 5595_5594_207_5563_6195_6196_6197 7 7.32E-06 0.000534456 1.84E-05 7447 hsa-mir-196a-2 hsa04720 Long-term potentiation 5595_5594_1387_5499_6195_6196_2033_6197 8 7.86E-06 0.000573601 1.91E-05 7448 hsa-mir-196a-2 hsa04540 Gap junction 5592_1956_6714_5595_5594_5598_5159_5156 8 3.33E-05 0.002431826 7.84E-05 7449 hsa-mir-196a-2 hsa04060 Cytokine-cytokine receptor interaction 85480_1956_3560_3561_5159_5156_3575_1234_3815_7046_2057_2690_3977 13 3.63E-05 0.002647666 8.27E-05 7450 hsa-mir-196a-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_836_1432_5970_5781_3725 7 4.65E-05 0.00339731 0.000102949 7451 hsa-mir-196a-2 hsa05216 Thyroid cancer 5595_5594_6256_595_7157 5 5.37E-05 0.003918268 0.000115243 7452 hsa-mir-196a-2 hsa04620 Toll-like receptor signaling pathway 5595_5594_207_2353_1432_6772_5970_3725 8 6.14E-05 0.004485275 0.000128151 7453 hsa-mir-196a-2 hsa05340 Primary immunodeficiency 3718_695_3561_3575_3932 5 0.000119569 0.008728548 0.00024246 7454 hsa-mir-196a-2 hsa04330 Notch signaling pathway 1387_1487_1488_9612_2033 5 0.000419222 0.030603206 0.000811093 7455 hsa-mir-196a-2 hsa04916 Melanogenesis 4286_5595_5594_1387_3815_2932_2033 7 0.000425229 0.031041742 0.000811093 7456 hsa-mir-196a-2 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_6850_836_919_5781_3932_6464 8 0.000433324 0.031632637 0.000811093 7457 hsa-mir-196a-2 hsa05010 Alzheimer's disease 5595_5594_836_4724_2932_840_1020_4697_4716 9 0.000480347 0.035065297 0.000876632 7458 hsa-mir-196a-2 hsa04912 GnRH signaling pathway 1956_6714_5595_5594_5598_1432_3725 7 0.000526385 0.03842612 0.000902094 7459 hsa-mir-196a-2 hsa04370 VEGF signaling pathway 6714_5595_5594_9261_207_1432 6 0.000530964 0.038760375 0.000902094 7460 hsa-mir-196a-2 hsa04810 Regulation of actin cytoskeleton 2249_1956_5595_5594_5159_5156_5499_1399_1398_1729 10 0.000531371 0.038790058 0.000902094 7461 hsa-mir-196a-2 hsa04664 Fc epsilon RI signaling pathway 695_5595_5594_6850_207_1432 6 0.000602889 0.044010924 0.001000248 7462 hsa-mir-196a-2 hsa03030 DNA replication 79621_4174_4172_4173 4 0.001387516 0.101288665 0.002250859 7463 hsa-mir-196a-2 hsa04930 Type II diabetes mellitus 3643_5595_5594_3651 4 0.002952922 0.215563274 0.004686158 7464 hsa-mir-196a-2 hsa04210 Apoptosis 836_207_840_7157_5970 5 0.005854878 0.427406116 0.009093747 7465 hsa-mir-196a-2 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432_7157_1616 4 0.006123928 0.447046714 0.009313473 7466 hsa-mir-196a-2 hsa04530 Tight junction 5515_4301_1460_10207_6714_207 6 0.008212079 0.599481733 0.012234321 7467 hsa-mir-196a-2 hsa03022 Basal transcription factors 2963_6908_2959 3 0.012609716 0.920509259 0.018410185 7468 hsa-mir-196a-2 hsa04730 Long-term depression 5515_5592_5595_5594 4 0.013253826 0.967529275 0.018971162 7469 hsa-mir-196a-2 hsa04360 Axon guidance 5998_5595_5594_2932_1020 5 0.025531577 1 0.035842407 7470 hsa-mir-196a-2 hsa04120 Ubiquitin mediated proteolysis 11059_55294_672_867_7329 5 0.031590971 1 0.043512092 7471 hsa-mir-196a-2 hsa05217 Basal cell carcinoma 2932_7157_2736 3 0.033595722 1 0.045416439 7472 hsa-mir-196a-2 hsa04950 Maturity onset diabetes of the young 6927_3651 2 0.039497441 1 0.052423877 7473 hsa-mir-196a-2 hsa03010 Ribosome 6124_6129_6143_6130 4 0.040583893 1 0.052904003 7474 hsa-mir-196b hsa05200 Pathways in cancer 1869_3716_5371_1956_367_1499_5595_5594_1387_6256_4846_595_2308_836_1019_1017_2932_5914_7704_841_6776_51588_3091_5970_7428_1870_1871_7157_4087_6688_2113_4609_3725_4088_1026_861_4089_3066_3065_1050_5925_2034_2033_207_8554_4790_4792_7189_7046 49 6.39E-42 4.86E-40 4.86E-40 7475 hsa-mir-196b hsa05220 Chronic myeloid leukemia 1869_5595_5594_595_1019_6776_5970_1870_1871_7157_4609_4088_1026_861_4089_3066_3065_5925_207_4790_4792_6464_7046 23 2.26E-26 1.72E-24 8.59E-25 7476 hsa-mir-196b hsa05215 Prostate cancer 1869_1956_367_1499_5595_5594_1385_1387_595_2308_1017_2932_5970_1870_1871_7157_468_1026_5925_2033_207_4790_4792 23 5.10E-25 3.88E-23 1.21E-23 7477 hsa-mir-196b hsa05212 Pancreatic cancer 1869_1956_367_1499_5595_5594_1385_1387_595_2308_1017_2932_5970_1870_1871_7157_468_1026_5925_2033_207_4790_4792 23 6.37E-25 4.84E-23 1.21E-23 7478 hsa-mir-196b hsa04110 Cell cycle 1869_5591_1387_595_1019_7534_1017_7532_2932_7027_1870_1871_7157_4087_4088_1026_4089_3066_3065_5925_2033_5933 22 4.01E-21 3.05E-19 6.10E-20 7479 hsa-mir-196b hsa05222 Small cell lung cancer 1869_6256_4846_595_1019_1017_51588_5970_1870_1871_7157_4609_5925_207_8554_4790_4792_7189 18 2.42E-18 1.84E-16 3.06E-17 7480 hsa-mir-196b hsa04010 MAPK signaling pathway 6722_1956_5595_5594_1386_4208_836_5566_9252_1649_5970_3312_7157_468_4609_3725_6195_6196_4763_5058_207_4790_2002_7189_7046 25 3.55E-17 2.70E-15 3.86E-16 7481 hsa-mir-196b hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_5518_7027_3399_1874_4087_658_659_4609_4088_4089_2033_7046_5933 17 5.93E-17 4.50E-15 5.63E-16 7482 hsa-mir-196b hsa05219 Bladder cancer 1869_1956_5595_5594_595_1019_9252_1870_1871_7157_4609_1026_5925 13 1.76E-15 1.34E-13 1.49E-14 7483 hsa-mir-196b hsa05221 Acute myeloid leukemia 5371_5595_5594_595_5914_7704_6776_5970_6688_4609_861_1050_207_4790 14 3.33E-15 2.53E-13 2.53E-14 7484 hsa-mir-196b hsa05214 Glioma 1869_815_1956_5595_5594_595_1019_1870_1871_7157_1026_5925_207_6464 14 1.07E-14 8.11E-13 7.38E-14 7485 hsa-mir-196b hsa05210 Colorectal cancer 1956_1499_5595_5594_595_836_2932_7157_4087_4609_3725_4088_4089_207_7046 15 1.34E-14 1.02E-12 8.51E-14 7486 hsa-mir-196b hsa04620 Toll-like receptor signaling pathway 3654_5595_5594_353376_3661_148022_841_5970_3725_4615_6348_207_4790_4792_7189 15 1.71E-13 1.30E-11 9.99E-13 7487 hsa-mir-196b hsa04012 ErbB signaling pathway 815_1956_6714_5595_5594_2932_6776_4609_3725_1026_5058_207_6464_2002 14 3.70E-13 2.81E-11 2.01E-12 7488 hsa-mir-196b hsa05223 Non-small cell lung cancer 1869_1956_5595_5594_6256_595_1019_1870_1871_7157_5925_207 12 6.37E-13 4.84E-11 3.23E-12 7489 hsa-mir-196b hsa04520 Adherens junction 1956_1499_6714_5595_5594_1387_5777_4087_4088_1457_4089_2033_7046 13 2.33E-12 1.77E-10 1.11E-11 7490 hsa-mir-196b hsa05218 Melanoma 1869_1956_5595_5594_595_1019_1870_1871_7157_1026_5925_207 12 1.10E-11 8.33E-10 4.90E-11 7491 hsa-mir-196b hsa04310 Wnt signaling pathway 815_1499_1387_595_5566_5518_2932_7157_4087_4609_3725_4088_1457_4089_2033 15 3.19E-11 2.43E-09 1.35E-10 7492 hsa-mir-196b hsa05213 Endometrial cancer 1956_1499_5595_5594_595_2932_7157_4609_207_2002 10 1.93E-10 1.47E-08 7.72E-10 7493 hsa-mir-196b hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2113_3725_5058_2034_2033_207 11 2.12E-10 1.61E-08 8.07E-10 7494 hsa-mir-196b hsa04630 Jak-STAT signaling pathway 3716_3566_1387_595_5777_6778_6776_6773_51588_4609_2033_207_8554 13 4.20E-09 3.19E-07 1.52E-08 7495 hsa-mir-196b hsa04720 Long-term potentiation 815_5595_5594_1387_2902_5566_468_6195_6196_2033 10 4.69E-09 3.57E-07 1.62E-08 7496 hsa-mir-196b hsa04910 Insulin signaling pathway 6720_5590_5595_5594_2308_5566_2932_23265_207_6464_2002_2538 12 1.15E-08 8.75E-07 3.80E-08 7497 hsa-mir-196b hsa04660 T cell receptor signaling pathway 5595_5594_1019_2932_5777_5970_3725_5058_207_4790_4792 11 1.25E-08 9.47E-07 3.94E-08 7498 hsa-mir-196b hsa04210 Apoptosis 3654_836_5566_841_5970_7157_4615_207_4790_4792 10 2.09E-08 1.59E-06 6.36E-08 7499 hsa-mir-196b hsa05216 Thyroid cancer 1499_5595_5594_6256_595_7157_4609 7 2.78E-08 2.11E-06 8.13E-08 7500 hsa-mir-196b hsa04062 Chemokine signaling pathway 5590_5595_5594_5566_2932_6773_5970_5058_6348_207_4790_4792_6464 13 4.82E-08 3.67E-06 1.36E-07 7501 hsa-mir-196b hsa04662 B cell receptor signaling pathway 5595_5594_2932_5777_5970_3725_207_4790_4792 9 6.42E-08 4.88E-06 1.74E-07 7502 hsa-mir-196b hsa05016 Huntington's disease 6874_1385_1387_2902_836_6667_841_7157_3066_3065_3064_2033 12 2.75E-07 2.09E-05 7.21E-07 7503 hsa-mir-196b hsa04330 Notch signaling pathway 1387_9612_3066_3065_2033_2648_8850 7 5.15E-07 3.91E-05 1.30E-06 7504 hsa-mir-196b hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_836_5970_3725_5058_4790_4792 8 5.45E-07 4.14E-05 1.34E-06 7505 hsa-mir-196b hsa04510 Focal adhesion 1956_1499_6714_5595_5594_595_2932_3725_5058_207_6464_2002 12 6.91E-07 5.25E-05 1.64E-06 7506 hsa-mir-196b hsa04916 Melanogenesis 815_1499_5595_5594_1385_1387_5566_2932_2033 9 8.32E-07 6.32E-05 1.92E-06 7507 hsa-mir-196b hsa04912 GnRH signaling pathway 815_1956_6714_5595_5594_5566_468_3725_2002 9 1.12E-06 8.48E-05 2.49E-06 7508 hsa-mir-196b hsa04115 p53 signaling pathway 595_836_1019_1017_841_7157_1026 7 5.38E-06 0.000408528 1.17E-05 7509 hsa-mir-196b hsa04150 mTOR signaling pathway 5595_5594_3091_6195_6196_207 6 1.31E-05 0.000993383 2.76E-05 7510 hsa-mir-196b hsa04920 Adipocytokine signaling pathway 6256_5970_207_4790_4792_2538 6 4.92E-05 0.003736486 0.000100986 7511 hsa-mir-196b hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_51588_7428_7329_8554_7189 8 5.53E-05 0.004201751 0.000110572 7512 hsa-mir-196b hsa05014 Amyotrophic lateral sclerosis (ALS) 4846_2902_836_834_7157 5 0.000215276 0.016360942 0.000419511 7513 hsa-mir-196b hsa04530 Tight junction 5590_1499_6714_1019_5518_1457_207 7 0.000323193 0.024562661 0.000614067 7514 hsa-mir-196b hsa04370 VEGF signaling pathway 6714_5595_5594_4846_207 5 0.000848268 0.064468346 0.001572399 7515 hsa-mir-196b hsa05010 Alzheimer's disease 5595_5594_4846_2902_836_2932_841 7 0.001375404 0.104530703 0.002488826 7516 hsa-mir-196b hsa04950 Maturity onset diabetes of the young 6927_3172_4760 3 0.001751986 0.133150958 0.003096534 7517 hsa-mir-196b hsa04540 Gap junction 1956_6714_5595_5594_5566 5 0.001881491 0.142993353 0.003214847 7518 hsa-mir-196b hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_5777_5058_6464 6 0.001903528 0.144668104 0.003214847 7519 hsa-mir-196b hsa04730 Long-term depression 5595_5594_4846_5518 4 0.004582488 0.348269111 0.007571068 7520 hsa-mir-196b hsa04930 Type II diabetes mellitus 5590_5595_5594 3 0.009030201 0.686295282 0.014602027 7521 hsa-mir-196b hsa04612 Antigen processing and presentation 1385_4800_3312_4801 4 0.00972331 0.738971571 0.015395241 7522 hsa-mir-196b hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.015096814 1 0.023415466 7523 hsa-mir-196b hsa04340 Hedgehog signaling pathway 53944_5566_2932 3 0.016527236 1 0.025121398 7524 hsa-mir-196b hsa04020 Calcium signaling pathway 815_1956_4846_2902_5566 5 0.027631821 1 0.041176831 7525 hsa-mir-196b hsa04360 Axon guidance 5595_5594_2932_5058 4 0.033082473 1 0.048351306 7526 hsa-mir-196b hsa04060 Cytokine-cytokine receptor interaction 1956_3566_658_659_6348_7046 6 0.033724864 1 0.048360182 7527 hsa-mir-196b hsa04664 Fc epsilon RI signaling pathway 5595_5594_207 3 0.03712197 1 0.052245735 7528 hsa-mir-196b hsa03022 Basal transcription factors 6874_6880 2 0.047319708 1 0.065387233 7529 hsa-mir-199a-1 hsa04630 Jak-STAT signaling pathway 3595_3594_9063_1387 4 6.20E-06 0.000179815 0.000179815 7530 hsa-mir-199a-1 hsa04620 Toll-like receptor signaling pathway 5608_3725_1432 3 7.00E-05 0.002028736 0.000797784 7531 hsa-mir-199a-1 hsa04912 GnRH signaling pathway 5608_3725_1432 3 8.25E-05 0.002393351 0.000797784 7532 hsa-mir-199a-1 hsa04120 Ubiquitin mediated proteolysis 11059_9063_4734 3 0.000171151 0.004963372 0.001240843 7533 hsa-mir-199a-1 hsa05014 Amyotrophic lateral sclerosis (ALS) 5608_1432 2 0.000904057 0.026217656 0.005243531 7534 hsa-mir-199a-1 hsa04010 MAPK signaling pathway 5608_3725_1432 3 0.001187666 0.034442313 0.005315221 7535 hsa-mir-199a-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1432 2 0.001427303 0.041391787 0.005315221 7536 hsa-mir-199a-1 hsa05211 Renal cell carcinoma 3725_1387 2 0.001466268 0.042521767 0.005315221 7537 hsa-mir-199a-1 hsa04664 Fc epsilon RI signaling pathway 5608_1432 2 0.001753151 0.050841375 0.005329972 7538 hsa-mir-199a-1 hsa05200 Pathways in cancer 9063_3725_1387 3 0.002066146 0.059918226 0.005329972 7539 hsa-mir-199a-1 hsa05215 Prostate cancer 90993_1387 2 0.002158036 0.062583051 0.005329972 7540 hsa-mir-199a-1 hsa05212 Pancreatic cancer 90993_1387 2 0.002205505 0.063959659 0.005329972 7541 hsa-mir-199a-1 hsa04916 Melanogenesis 90993_1387 2 0.002976396 0.086315471 0.006639652 7542 hsa-mir-199a-1 hsa04660 T cell receptor signaling pathway 3725_1432 2 0.00331532 0.096144272 0.006867448 7543 hsa-mir-199a-1 hsa04310 Wnt signaling pathway 3725_1387 2 0.006162064 0.178699856 0.011913324 7544 hsa-mir-199a-1 hsa05016 Huntington's disease 90993_1387 2 0.009235897 0.267841026 0.016740064 7545 hsa-mir-199a-1 hsa04060 Cytokine-cytokine receptor interaction 3595_3594 2 0.01725636 0.500434448 0.02943732 7546 hsa-mir-199a-1 hsa04330 Notch signaling pathway 1387 1 0.036145313 1 0.058234116 7547 hsa-mir-199a-2 hsa05200 Pathways in cancer 3725_3551_5468_5914_8517_6934_3091_4089_3066_3065_5925_25_4824_2113_10401_861_207_3716_1147_2249_5595_5599_6258_1387_6256_836_367_2932_6774_6776_6777_6772_5970_6688_2736_4087_4088_2033_4790_4791_4792_3320_3326_5371_5601_5602_842_841_4609_2353_8554 51 2.74E-29 2.14E-27 2.14E-27 7548 hsa-mir-199a-2 hsa04010 MAPK signaling pathway 6722_3725_3727_3551_6195_6197_8517_9252_4773_9020_8986_3305_3303_1432_1616_207_1147_2249_5595_5599_1386_1649_836_3312_5971_5970_468_6196_4790_4791_9261_1326_5601_5600_5602_5608_6885_4609_2353_8550_2002_2005_5566 43 3.16E-25 2.47E-23 1.23E-23 7549 hsa-mir-199a-2 hsa04620 Toll-like receptor signaling pathway 3725_3551_8517_3454_3455_3661_1432_207_1147_29110_5595_5599_6772_5970_4790_4792_1326_5601_5600_5602_5608_9641_841_6885_2353 25 3.84E-19 2.99E-17 9.98E-18 7550 hsa-mir-199a-2 hsa05215 Prostate cancer 3551_8517_6934_5925_4824_9586_207_1147_5595_1385_1387_367_2932_5970_468_2033_4790_4792_3320_3326_842 21 4.31E-16 3.36E-14 8.17E-15 7551 hsa-mir-199a-2 hsa05212 Pancreatic cancer 3551_8517_6934_5925_4824_9586_207_1147_5595_1385_1387_367_2932_5970_468_2033_4790_4792_3320_3326_842 21 5.24E-16 4.09E-14 8.17E-15 7552 hsa-mir-199a-2 hsa04310 Wnt signaling pathway 3725_815_8607_6934_6500_8945_4089_4773_23291_5599_1387_2932_1457_4087_4088_2033_5519_5515_5601_5602_8454_6885_4609_8061_5566 25 1.44E-15 1.12E-13 1.87E-14 7553 hsa-mir-199a-2 hsa04920 Adipocytokine signaling pathway 3551_5465_8517_8471_207_3717_1147_5599_6258_6256_6774_5970_4794_4790_4792_4793_5601_5602 18 9.55E-15 7.45E-13 1.06E-13 7554 hsa-mir-199a-2 hsa05220 Chronic myeloid leukemia 3551_8517_4089_3066_3065_5925_25_861_207_1147_5595_6776_6777_5970_4088_4790_4792_4609 18 5.06E-14 3.95E-12 4.93E-13 7555 hsa-mir-199a-2 hsa04660 T cell receptor signaling pathway 3725_3551_8517_4773_9020_1432_207_1147_5595_2932_5970_4794_4790_4792_4793_1326_5601_5600_6885_2353 20 1.93E-13 1.50E-11 1.67E-12 7556 hsa-mir-199a-2 hsa05221 Acute myeloid leukemia 3551_5914_8517_6934_861_207_1147_5595_6774_6776_6777_5970_6688_4790_5371_4609 16 2.60E-13 2.03E-11 2.03E-12 7557 hsa-mir-199a-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_3551_8517_9020_6714_1432_1147_5599_836_5970_4790_4792_5601_5600_5602 15 3.16E-11 2.47E-09 2.24E-10 7558 hsa-mir-199a-2 hsa04110 Cell cycle 6500_4089_3066_3065_5925_25_993_5591_1387_7533_2932_5111_4087_4088_2033_983_8454_1111 18 4.74E-11 3.70E-09 3.08E-10 7559 hsa-mir-199a-2 hsa04630 Jak-STAT signaling pathway 3454_3455_10401_3977_207_3717_3716_8651_1387_6778_6774_6775_6776_6777_6772_7297_2033_4609_8554_10379 20 5.30E-11 4.14E-09 3.18E-10 7560 hsa-mir-199a-2 hsa04210 Apoptosis 3551_8517_9020_823_207_1147_836_839_5970_9131_4790_4792_842_841_840_5566 16 5.84E-11 4.55E-09 3.24E-10 7561 hsa-mir-199a-2 hsa04662 B cell receptor signaling pathway 3725_3551_8517_4773_207_1147_695_5595_2932_5970_4794_4790_4792_4793_2353 15 6.23E-11 4.86E-09 3.24E-10 7562 hsa-mir-199a-2 hsa05210 Colorectal cancer 3725_6934_4089_207_5595_5599_836_2932_4087_4088_5601_5602_842_4609_2353 15 2.53E-10 1.97E-08 1.23E-09 7563 hsa-mir-199a-2 hsa04912 GnRH signaling pathway 3725_815_6714_1432_5595_5599_468_808_801_805_5601_5600_5602_5608_2002_5566 16 7.43E-10 5.80E-08 3.41E-09 7564 hsa-mir-199a-2 hsa05222 Small cell lung cancer 3551_8517_5925_10401_207_1147_6258_6256_5970_4790_4792_842_4609_8554 14 2.91E-09 2.27E-07 1.26E-08 7565 hsa-mir-199a-2 hsa04350 TGF-beta signaling pathway 6667_6500_4089_3399_3398_5595_1387_4087_4088_2033_5519_5515_8454_4609 14 3.32E-09 2.59E-07 1.30E-08 7566 hsa-mir-199a-2 hsa04012 ErbB signaling pathway 3725_815_25_6714_207_5595_5599_2932_6776_6777_5601_5602_4609_2002 14 3.32E-09 2.59E-07 1.30E-08 7567 hsa-mir-199a-2 hsa04720 Long-term potentiation 814_815_6195_6197_5595_1387_468_6196_2033_808_801_805_5566 13 5.47E-09 4.27E-07 2.03E-08 7568 hsa-mir-199a-2 hsa05016 Huntington's disease 6667_5468_292_293_3066_3065_3064_498_9586_5441_1385_1387_836_5437_1213_2033_6908_842_841 19 6.60E-09 5.15E-07 2.34E-08 7569 hsa-mir-199a-2 hsa04062 Chemokine signaling pathway 3551_8517_653361_7852_207_3717_1147_5590_5595_2932_6774_6777_6772_5970_4790_4792_4793_5566 18 5.12E-08 3.99E-06 1.73E-07 7570 hsa-mir-199a-2 hsa04910 Insulin signaling pathway 3551_8471_207_8651_5590_5595_5599_2932_808_801_805_5601_5602_2002_5566 15 1.08E-07 8.43E-06 3.51E-07 7571 hsa-mir-199a-2 hsa04930 Type II diabetes mellitus 3551_8471_3651_8651_5590_5595_5599_5601_5602 9 4.34E-07 3.38E-05 1.35E-06 7572 hsa-mir-199a-2 hsa04520 Adherens junction 6934_4089_6714_71_5595_1387_1457_4087_4088_2033_6885 11 6.65E-07 5.19E-05 1.93E-06 7573 hsa-mir-199a-2 hsa04120 Ubiquitin mediated proteolysis 55294_6500_8945_7329_23291_10401_51366_83737_8651_64326_5371_672_8454_8554 14 6.68E-07 5.21E-05 1.93E-06 7574 hsa-mir-199a-2 hsa03022 Basal transcription factors 2963_2962_2969_6878_6872_6908_6882_2959 8 1.15E-06 8.94E-05 3.19E-06 7575 hsa-mir-199a-2 hsa04916 Melanogenesis 815_6934_5595_1385_1387_2932_2033_808_801_805_5566 11 6.82E-06 0.000531886 1.83E-05 7576 hsa-mir-199a-2 hsa04540 Gap junction 10382_6714_5592_5595_7846_203068_347733_983_7278_5566 10 1.56E-05 0.001217587 4.06E-05 7577 hsa-mir-199a-2 hsa05131 Shigellosis 10382_25_71_7846_203068_347733_7278_4691 8 1.75E-05 0.001365407 4.27E-05 7578 hsa-mir-199a-2 hsa05130 Pathogenic Escherichia coli infection 10382_25_71_7846_203068_347733_7278_4691 8 1.75E-05 0.001365407 4.27E-05 7579 hsa-mir-199a-2 hsa04664 Fc epsilon RI signaling pathway 1432_207_695_5595_5599_5601_5600_5602_5608 9 2.73E-05 0.002129596 6.45E-05 7580 hsa-mir-199a-2 hsa03020 RNA polymerase 64425_25885_51082_5441_5437_84172 6 3.22E-05 0.002508901 7.17E-05 7581 hsa-mir-199a-2 hsa05216 Thyroid cancer 5468_6934_5595_6258_6256_4609 6 3.22E-05 0.002508901 7.17E-05 7582 hsa-mir-199a-2 hsa05010 Alzheimer's disease 498_823_22926_5595_836_2932_808_801_805_842_841_840_9451 13 3.91E-05 0.00304785 8.47E-05 7583 hsa-mir-199a-2 hsa04330 Notch signaling pathway 9612_3066_3065_1387_2033_8850_4851 7 4.64E-05 0.003620012 9.78E-05 7584 hsa-mir-199a-2 hsa04612 Antigen processing and presentation 3309_3305_3303_1385_3312_1514_3320_3326_4800 9 6.43E-05 0.005015054 0.000131975 7585 hsa-mir-199a-2 hsa05213 Endometrial cancer 6934_207_5595_2932_842_4609_2002 7 8.28E-05 0.006459759 0.000165635 7586 hsa-mir-199a-2 hsa04370 VEGF signaling pathway 4773_6714_1432_207_5595_9261_5600_842 8 0.000137445 0.010720683 0.000268017 7587 hsa-mir-199a-2 hsa03010 Ribosome 6155_6156_6207_6141_6217_6128_9349_6142_6188 9 0.000168485 0.013141804 0.000320532 7588 hsa-mir-199a-2 hsa05214 Glioma 815_5925_207_5595_808_801_805 7 0.000293258 0.022874104 0.000544622 7589 hsa-mir-199a-2 hsa05211 Renal cell carcinoma 3725_3091_2113_207_5595_1387_2033 7 0.000518748 0.04046235 0.000940985 7590 hsa-mir-199a-2 hsa04150 mTOR signaling pathway 6195_6197_3091_207_5595_6196 6 0.000568075 0.044309888 0.001007043 7591 hsa-mir-199a-2 hsa05223 Non-small cell lung cancer 5925_207_5595_6258_6256_842 6 0.000681974 0.053194009 0.001182089 7592 hsa-mir-199a-2 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_1616_836_5600_5608_842 6 0.000812787 0.063397352 0.001378203 7593 hsa-mir-199a-2 hsa04115 p53 signaling pathway 836_64326_983_842_841_1111 6 0.002193941 0.171127432 0.003641009 7594 hsa-mir-199a-2 hsa04530 Tight junction 6714_4628_207_71_5590_1457_5519_5515 8 0.004524847 0.352938097 0.007352877 7595 hsa-mir-199a-2 hsa04340 Hedgehog signaling pathway 8945_23291_2932_2736_5566 5 0.004906566 0.382712174 0.007810453 7596 hsa-mir-199a-2 hsa03410 Base excision repair 3146_142_5111_6996 4 0.005441472 0.424434851 0.008487837 7597 hsa-mir-199a-2 hsa04510 Focal adhesion 3725_6714_207_71_5595_5599_2932_5601_5602_2002 10 0.005549739 0.432879674 0.008487837 7598 hsa-mir-199a-2 hsa05219 Bladder cancer 9252_5925_5595_4609 4 0.008939516 0.697282284 0.013409275 7599 hsa-mir-199a-2 hsa03320 PPAR signaling pathway 5465_5468_10062_6258_6256 5 0.010855932 0.846762689 0.015976655 7600 hsa-mir-199a-2 hsa04950 Maturity onset diabetes of the young 6927_3087_3651 3 0.011904625 0.928560784 0.01719557 7601 hsa-mir-199a-2 hsa04020 Calcium signaling pathway 814_815_292_293_808_801_805_5566 8 0.022033862 1 0.031248023 7602 hsa-mir-199a-2 hsa04270 Vascular smooth muscle contraction 5592_5595_808_801_805_5566 6 0.023669132 1 0.03296772 7603 hsa-mir-199a-2 hsa03450 Non-homologous end-joining 2547_5591 2 0.032110193 1 0.043940264 7604 hsa-mir-199a-2 hsa05012 Parkinson's disease 292_293_498_7314_836_842 6 0.041773986 1 0.056178808 7605 hsa-mir-199a-2 hsa05218 Melanoma 5925_207_2249_5595 4 0.044728436 1 0.058146967 7606 hsa-mir-199a-2 hsa04730 Long-term depression 5592_5595_5519_5515 4 0.044728436 1 0.058146967 7607 hsa-mir-199b hsa05200 Pathways in cancer 3320_3326_1147_5371_3551_1499_5595_5594_6258_1387_6256_836_367_8517_2932_7704_842_841_6774_5970_4824_6688_2113_1869_862_6502_2353_3065_7175_5925_2033_207_4791_4792 34 2.48E-23 1.86E-21 1.86E-21 7608 hsa-mir-199b hsa05215 Prostate cancer 3320_3326_1147_3551_1499_5595_5594_1385_1387_367_8517_2932_842_5970_4824_1869_5925_2033_207_4792 20 3.42E-20 2.56E-18 1.04E-18 7609 hsa-mir-199b hsa05212 Pancreatic cancer 3320_3326_1147_3551_1499_5595_5594_1385_1387_367_8517_2932_842_5970_4824_1869_5925_2033_207_4792 20 4.15E-20 3.11E-18 1.04E-18 7610 hsa-mir-199b hsa04010 MAPK signaling pathway 6722_1147_3551_5595_5594_9261_1326_4208_3305_3303_836_5566_8517_7867_3310_3312_1432_5971_5970_6195_2353_207_4791_2002_2005 25 2.23E-16 1.68E-14 4.19E-15 7611 hsa-mir-199b hsa05221 Acute myeloid leukemia 1147_5371_3551_5595_5594_8517_7704_6774_5970_6688_862_207 12 3.96E-12 2.97E-10 5.94E-11 7612 hsa-mir-199b hsa04660 T cell receptor signaling pathway 1147_3551_5595_5594_1326_8517_2932_1432_5970_4794_2353_207_4792_4793 14 1.85E-11 1.38E-09 2.21E-10 7613 hsa-mir-199b hsa04210 Apoptosis 1147_3551_836_5566_839_8517_842_841_840_5970_8837_207_4792 13 2.07E-11 1.55E-09 2.21E-10 7614 hsa-mir-199b hsa04662 B cell receptor signaling pathway 1147_3551_5595_5594_8517_2932_5970_4794_2353_207_4792_4793 12 4.79E-11 3.59E-09 4.49E-10 7615 hsa-mir-199b hsa05222 Small cell lung cancer 1147_3551_6258_6256_8517_842_5970_1869_6502_5925_207_4792 12 2.00E-10 1.50E-08 1.66E-09 7616 hsa-mir-199b hsa04920 Adipocytokine signaling pathway 1147_3551_6258_6256_8517_6774_5970_4794_207_4792_4793 11 2.43E-10 1.82E-08 1.82E-09 7617 hsa-mir-199b hsa05220 Chronic myeloid leukemia 1147_3551_5595_5594_8517_5970_1869_3065_5925_207_4792 11 7.13E-10 5.35E-08 4.86E-09 7618 hsa-mir-199b hsa04620 Toll-like receptor signaling pathway 1147_3551_5595_5594_1326_8517_1432_841_5970_2353_207_4792 12 1.18E-09 8.87E-08 7.39E-09 7619 hsa-mir-199b hsa04916 Melanogenesis 815_1499_5595_5594_1385_1387_5566_2932_2033_808_801_805 12 1.45E-09 1.09E-07 8.36E-09 7620 hsa-mir-199b hsa04720 Long-term potentiation 815_5595_5594_1387_5566_6195_2033_808_801_805 10 9.83E-09 7.37E-07 5.27E-08 7621 hsa-mir-199b hsa04120 Ubiquitin mediated proteolysis 55294_5371_23291_672_8454_3093_10273_8945_6502_6500_7323_7329 12 2.92E-08 2.19E-06 1.46E-07 7622 hsa-mir-199b hsa04350 TGF-beta signaling pathway 3399_5595_5594_1387_6667_8454_3398_6500_2033_3397 10 3.57E-08 2.68E-06 1.67E-07 7623 hsa-mir-199b hsa05214 Glioma 815_5595_5594_1869_5925_207_808_801_805 9 4.06E-08 3.04E-06 1.79E-07 7624 hsa-mir-199b hsa04310 Wnt signaling pathway 815_23291_1499_1387_5566_1457_2932_8454_8945_8607_6500_2033 12 7.31E-08 5.48E-06 3.05E-07 7625 hsa-mir-199b hsa05016 Huntington's disease 1385_1387_292_836_6667_842_841_293_1213_5437_3065_2033_5441 13 8.93E-08 6.70E-06 3.52E-07 7626 hsa-mir-199b hsa04062 Chemokine signaling pathway 1147_3551_5595_5594_5566_8517_2932_6774_5970_653361_207_4792_4793 13 1.19E-07 8.92E-06 4.46E-07 7627 hsa-mir-199b hsa05223 Non-small cell lung cancer 5595_5594_6258_6256_842_1869_5925_207 8 1.46E-07 1.09E-05 5.21E-07 7628 hsa-mir-199b hsa04912 GnRH signaling pathway 815_6714_5595_5594_5566_1432_2002_808_801_805 10 2.31E-07 1.74E-05 7.67E-07 7629 hsa-mir-199b hsa04910 Insulin signaling pathway 3551_5595_5594_5566_2932_23265_207_2002_808_801_805 11 2.35E-07 1.76E-05 7.67E-07 7630 hsa-mir-199b hsa04612 Antigen processing and presentation 3320_3326_1385_3309_3305_3303_4800_3310_3312 9 4.72E-07 3.54E-05 1.48E-06 7631 hsa-mir-199b hsa04110 Cell cycle 5591_1387_2932_8454_1869_6502_6500_3065_5925_2033 10 5.32E-07 3.99E-05 1.60E-06 7632 hsa-mir-199b hsa04540 Gap junction 6714_5595_5594_5566_7278_347733_10382_84617_203068 9 6.65E-07 4.99E-05 1.92E-06 7633 hsa-mir-199b hsa04330 Notch signaling pathway 388585_1387_4851_9612_3065_2033_8850 7 8.65E-07 6.49E-05 2.40E-06 7634 hsa-mir-199b hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_3551_6714_836_8517_1432_5970_4792 8 9.77E-07 7.33E-05 2.44E-06 7635 hsa-mir-199b hsa03020 RNA polymerase 64425_5437_25885_51082_84172_5441 6 9.78E-07 7.33E-05 2.44E-06 7636 hsa-mir-199b hsa05216 Thyroid cancer 1499_5595_5594_6258_6256_7175 6 9.78E-07 7.33E-05 2.44E-06 7637 hsa-mir-199b hsa05213 Endometrial cancer 1499_5595_5594_2932_842_207_2002 7 1.60E-06 0.000119951 3.87E-06 7638 hsa-mir-199b hsa04370 VEGF signaling pathway 6714_5595_5594_9261_7867_1432_842_207 8 1.71E-06 0.000128583 4.02E-06 7639 hsa-mir-199b hsa04520 Adherens junction 1499_6714_5595_5594_1387_1457_2033_71 8 2.23E-06 0.000167508 5.08E-06 7640 hsa-mir-199b hsa05010 Alzheimer's disease 22926_5595_5594_836_2932_842_841_840_808_801_805 11 2.36E-06 0.000177029 5.21E-06 7641 hsa-mir-199b hsa05131 Shigellosis 1499_7278_347733_10382_84617_203068_71 7 2.51E-06 0.000188242 5.23E-06 7642 hsa-mir-199b hsa05130 Pathogenic Escherichia coli infection 1499_7278_347733_10382_84617_203068_71 7 2.51E-06 0.000188242 5.23E-06 7643 hsa-mir-199b hsa05210 Colorectal cancer 1499_5595_5594_836_2932_842_2353_207 8 3.13E-06 0.000234638 6.34E-06 7644 hsa-mir-199b hsa04012 ErbB signaling pathway 815_6714_5595_5594_2932_207_2002 7 3.60E-05 0.002700591 7.11E-05 7645 hsa-mir-199b hsa04530 Tight junction 1499_6714_1457_4627_4628_10627_207_71 8 8.62E-05 0.006467493 0.000165833 7646 hsa-mir-199b hsa05211 Renal cell carcinoma 5595_5594_1387_2113_2033_207 6 0.000109392 0.008204377 0.000205109 7647 hsa-mir-199b hsa04270 Vascular smooth muscle contraction 5595_5594_4637_5566_808_801_805 7 0.000217736 0.016330169 0.000398297 7648 hsa-mir-199b hsa04510 Focal adhesion 1499_6714_5595_5594_2932_10627_207_71_2002 9 0.000257518 0.019313847 0.000459853 7649 hsa-mir-199b hsa05218 Melanoma 5595_5594_1869_5925_207 5 0.000849922 0.063744155 0.001482422 7650 hsa-mir-199b hsa05219 Bladder cancer 5595_5594_1869_5925 4 0.001003692 0.075276877 0.001710838 7651 hsa-mir-199b hsa04930 Type II diabetes mellitus 3651_3551_5595_5594 4 0.001274041 0.095553101 0.002123402 7652 hsa-mir-199b hsa04150 mTOR signaling pathway 5595_5594_6195_207 4 0.002095263 0.157144704 0.003416189 7653 hsa-mir-199b hsa04950 Maturity onset diabetes of the young 3651_168620_4760 3 0.002184742 0.163855667 0.003486291 7654 hsa-mir-199b hsa04020 Calcium signaling pathway 815_292_5566_293_808_801_805 7 0.002630469 0.197285182 0.004110108 7655 hsa-mir-199b hsa04340 Hedgehog signaling pathway 23291_5566_2932_8945 4 0.002867305 0.215047877 0.004388732 7656 hsa-mir-199b hsa04630 Jak-STAT signaling pathway 3559_1387_6774_6778_2033_207 6 0.004834055 0.362554113 0.007251082 7657 hsa-mir-199b hsa04810 Regulation of actin cytoskeleton 5595_5594_4627_4628_10788_10627_71 7 0.006555641 0.491673087 0.009640649 7658 hsa-mir-199b hsa04670 Leukocyte transendothelial migration 1499_1432_653361_10627_71 5 0.007872998 0.590474825 0.011355285 7659 hsa-mir-199b hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432_207 4 0.008565655 0.642424134 0.01212121 7660 hsa-mir-199b hsa05012 Parkinson's disease 7314_292_836_842_293 5 0.012019639 0.901472943 0.016693943 7661 hsa-mir-199b hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432_842 3 0.019379084 1 0.026148668 7662 hsa-mir-199b hsa03010 Ribosome 6156_6128_6207_6202 4 0.019524339 1 0.026148668 7663 hsa-mir-199b hsa04115 p53 signaling pathway 836_842_841 3 0.032473573 1 0.042728386 7664 hsa-mir-199b hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.041018859 1 0.053041627 7665 hsa-mir-19a hsa05200 Pathways in cancer 4149_3551_1398_1499_5914_595_596_598_3815_1017_8517_4193_6934_5578_3091_2735_2064_3066_3065_5925_1050_613_5743_5747_10342_25_405_9063_1956_1487_6789_7046_4436_1870_1871_2113_6774_867_10401_207_208_9915_7187_4286_3716_1147_5879_2249_998_1488_2261_5595_5594_5599_861_1387_6256_836_367_2932_6777_6772_5970_7157_7849_1869_3725_5467_6776_4087_4088_4089_5888_5728_2034_2033_5468_4846_3910_898_4790_4791_4792_3320_3326_51176_5371_675_5159_5156_5604_5601_5602_1856_1399_3265_51588_7428_8772_4609_2956_1026_2736_2353_7704_2737_8554 107 1.09E-45 9.69E-44 9.69E-44 7666 hsa-mir-19a hsa04010 MAPK signaling pathway 6722_4149_3551_1398_6195_6197_2264_8517_9252_5578_1845_7132_4773_9020_5923_1956_3304_3305_3303_6789_1432_7046_22800_4763_1616_207_208_1147_5879_2249_998_3727_2261_5595_5594_5599_5598_8986_1386_1649_836_3310_3312_3315_5971_5970_3164_7157_3725_6196_5058_4790_4791_5159_9261_1326_5156_5604_4208_5601_5600_5603_5602_5608_1399_3265_6885_4609_2353_2002_8550_5566 72 1.47E-26 1.31E-24 6.54E-25 7667 hsa-mir-19a hsa05220 Chronic myeloid leukemia 3551_1398_595_598_8517_4193_3066_3065_5925_613_25_1487_7046_1870_1871_867_207_208_1147_1488_5595_5594_861_6777_5970_7157_1869_6776_4088_4089_4790_4792_5604_1399_3265_5781_4609_1026_6464 39 2.88E-23 2.56E-21 8.53E-22 7668 hsa-mir-19a hsa04110 Cell cycle 4174_4172_595_1017_4193_902_6500_3066_3065_5925_25_1870_1871_5111_9232_5934_5933_545_995_5347_7534_5591_1387_11200_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_898_1031_983_8454_1026_1022_1111_8556_8555_472 44 2.18E-21 1.94E-19 4.85E-20 7669 hsa-mir-19a hsa05215 Prostate cancer 3551_1499_595_596_1017_8517_4193_6934_2064_5925_1956_1870_1871_207_208_9586_1147_5595_5594_1387_367_2932_5970_7157_1869_5728_2033_898_4790_4792_3320_3326_51176_5159_5156_5604_3265_1026 38 1.64E-20 1.46E-18 2.92E-19 7670 hsa-mir-19a hsa05212 Pancreatic cancer 3551_1499_595_596_1017_8517_4193_6934_2064_5925_1956_1870_1871_207_208_9586_1147_5595_5594_1387_367_2932_5970_7157_1869_5728_2033_898_4790_4792_3320_3326_51176_5159_5156_5604_3265_1026 38 2.24E-20 1.99E-18 3.32E-19 7671 hsa-mir-19a hsa04310 Wnt signaling pathway 818_817_1499_595_8607_6934_5578_6500_4772_4773_23291_1487_5879_1460_1488_5599_1387_1459_2932_7157_8061_3725_5467_1457_1452_4087_4088_4089_2033_51176_5519_5518_5515_5601_5602_1856_8454_8945_6885_4609_5527_5566 42 1.16E-16 1.03E-14 1.48E-15 7672 hsa-mir-19a hsa04660 T cell receptor signaling pathway 3551_1493_8517_5777_4772_4773_9020_2534_3932_4794_1432_867_207_208_1147_998_5595_5594_2932_5970_3725_5058_959_4790_4792_4793_1326_5604_5601_5600_5603_919_3265_6885_2353 35 1.17E-15 1.04E-13 1.30E-14 7673 hsa-mir-19a hsa05222 Small cell lung cancer 4149_3551_595_596_598_1017_8517_5925_5743_5747_9063_1870_1871_10401_207_208_7187_1147_6256_5970_7157_1869_5728_4846_3910_898_4790_4792_51588_4609_8554 31 3.05E-15 2.72E-13 3.02E-14 7674 hsa-mir-19a hsa05210 Colorectal cancer 1499_595_596_6934_1956_7046_4436_207_208_5879_5595_5594_5599_836_2932_7157_3725_4087_4088_4089_51176_5159_5156_5604_5601_5602_1856_4609_2956_2353 30 1.04E-14 9.26E-13 9.26E-14 7675 hsa-mir-19a hsa04012 ErbB signaling pathway 818_817_1398_5578_2064_5747_25_1956_6714_867_207_208_5595_5594_5599_2066_2932_6777_3725_6776_5058_5604_5601_5602_1399_3265_4609_1026_2002_6464 30 2.22E-14 1.98E-12 1.80E-13 7676 hsa-mir-19a hsa05221 Acute myeloid leukemia 3551_5914_595_3815_8517_6934_1050_6774_207_208_1147_5595_5594_861_6777_5970_5467_6776_4790_51176_5371_5604_3265_4609_7704 25 7.83E-14 6.97E-12 5.61E-13 7677 hsa-mir-19a hsa04630 Jak-STAT signaling pathway 3559_595_598_5777_3455_3594_9063_3560_3561_6773_1439_3595_2057_6774_867_2690_10401_3459_3977_207_208_3717_3716_8651_1387_6778_6777_6772_7297_6776_2033_51588_10379_5781_58985_4609_3575_8554 38 8.19E-14 7.29E-12 5.61E-13 7678 hsa-mir-19a hsa04920 Adipocytokine signaling pathway 3551_10891_5465_6794_8517_7132_8717_2538_4794_8471_6774_207_208_3717_1147_5599_6256_5970_4790_4792_4793_5601_5602_5563_5781_7133 26 1.29E-13 1.15E-11 8.15E-13 7679 hsa-mir-19a hsa04620 Toll-like receptor signaling pathway 3551_8517_3455_3665_3661_1432_207_208_7187_1147_5879_29110_5595_5594_5599_6772_5970_3725_4790_4792_1326_5604_5601_5600_5603_5602_5608_9641_8772_6885_2353 31 1.37E-13 1.22E-11 8.15E-13 7680 hsa-mir-19a hsa05214 Glioma 818_817_595_4193_5578_5925_1956_1870_1871_207_208_5595_5594_7157_1869_5728_808_801_805_5159_5156_5604_3265_1026_6464 25 4.48E-13 3.98E-11 2.49E-12 7681 hsa-mir-19a hsa04520 Adherens junction 1499_6934_5770_5777_2064_2534_1956_6714_7046_5879_1460_998_5595_5594_1387_1459_1457_4087_4088_4089_2033_51176_3643_71_8826_6885 26 3.59E-12 3.20E-10 1.88E-11 7682 hsa-mir-19a hsa04910 Insulin signaling pathway 3551_10891_1398_6720_5770_2538_5590_5499_8471_867_5211_207_208_8651_5595_5594_5599_2932_2194_808_801_805_3643_5604_5601_5602_5563_1399_3265_2002_6464_5566 32 2.57E-11 2.28E-09 1.27E-10 7683 hsa-mir-19a hsa04662 B cell receptor signaling pathway 3551_8517_5777_4772_4773_4794_207_208_1147_5879_695_5595_5594_1380_2932_6850_5970_3725_4790_4792_4793_5604_3265_2353 24 3.15E-11 2.80E-09 1.48E-10 7684 hsa-mir-19a hsa04350 TGF-beta signaling pathway 6500_90_4086_1875_6667_7046_1874_57154_5934_5933_5595_5594_1387_7027_4087_4088_4089_2033_5519_5518_5515_8454_4609_4093_4092 25 8.45E-11 7.52E-09 3.76E-10 7685 hsa-mir-19a hsa04115 p53 signaling pathway 595_1017_4194_4193_900_50484_51246_545_7161_11200_836_7157_6241_64326_5728_898_27113_25898_983_1026_1111_472 22 2.19E-10 1.95E-08 9.29E-10 7686 hsa-mir-19a hsa04510 Focal adhesion 1398_1499_595_596_5578_2064_5923_2534_5747_3791_1956_6714_5499_207_208_5879_998_5595_5594_5599_2932_3725_5058_5728_3910_2321_5159_5156_5604_5601_5602_1399_3265_71_2002_85366_6464 37 4.52E-10 4.03E-08 1.83E-09 7687 hsa-mir-19a hsa04062 Chemokine signaling pathway 3551_1398_8517_653361_5747_5580_5590_6773_2309_6362_6774_207_208_3717_1147_5879_998_5595_5594_1234_2932_6777_6772_5970_5058_4790_4792_4793_1230_5604_1399_3265_7852_6464_5566 35 1.06E-09 9.45E-08 4.11E-09 7688 hsa-mir-19a hsa05219 Bladder cancer 595_9252_4193_2064_5925_1956_1870_1871_2261_5595_5594_7157_1869_5604_3265_4609_1026 17 1.31E-09 1.16E-07 4.85E-09 7689 hsa-mir-19a hsa03010 Ribosome 6193_6204_6205_6207_6202_6141_9349_6217_6137_6135_6210_6155_6156_6191_6222_6223_6229_6129_6128_6125_6130_6181_6189_6188_6232 25 1.42E-09 1.26E-07 5.05E-09 7690 hsa-mir-19a hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3551_8517_9020_1956_6714_1432_1147_5879_998_5599_836_5970_3725_5058_4790_4792_5601_5600_5603_5602_5781 21 1.74E-09 1.55E-07 5.96E-09 7691 hsa-mir-19a hsa05211 Renal cell carcinoma 1398_3091_405_2113_207_208_9915_5879_998_5595_5594_1387_3725_5058_2034_2033_5604_1399_3265_7428_5781 21 2.15E-09 1.91E-07 7.08E-09 7692 hsa-mir-19a hsa05213 Endometrial cancer 1499_595_6934_2064_1956_2309_207_208_5595_5594_2932_7157_5728_51176_5604_3265_4609_2002 18 3.26E-09 2.90E-07 1.04E-08 7693 hsa-mir-19a hsa04912 GnRH signaling pathway 818_817_5578_5580_1956_6714_1432_998_5595_5594_5599_5598_3725_808_801_805_5604_5601_5600_5603_5602_5608_3265_2002_5566 25 3.86E-09 3.43E-07 1.18E-08 7694 hsa-mir-19a hsa05223 Non-small cell lung cancer 595_5578_2064_5925_1956_2309_6789_1870_1871_207_208_5595_5594_6256_7157_1869_5604_3265 18 5.31E-09 4.73E-07 1.58E-08 7695 hsa-mir-19a hsa04370 VEGF signaling pathway 5578_4772_4773_5743_5747_3791_6714_1432_207_208_5879_998_5595_5594_3315_4846_9261_5604_5600_5603_3265 21 5.87E-09 5.23E-07 1.69E-08 7696 hsa-mir-19a hsa05216 Thyroid cancer 1499_595_6934_10342_5595_5594_6256_7157_7849_5468_51176_5604_3265_4609 14 6.40E-09 5.70E-07 1.78E-08 7697 hsa-mir-19a hsa05218 Melanoma 595_4193_5925_1956_1870_1871_207_208_4286_2249_5595_5594_7157_1869_5728_5159_5156_5604_3265_1026 20 8.48E-09 7.55E-07 2.29E-08 7698 hsa-mir-19a hsa04210 Apoptosis 3551_596_598_8517_7132_8717_9020_823_1439_207_208_1147_836_5970_7157_9131_4790_4792_840_8772_472_5566 22 1.19E-08 1.06E-06 3.10E-08 7699 hsa-mir-19a hsa04720 Long-term potentiation 818_814_817_6195_6197_5578_2902_2906_5499_5595_5594_1387_6196_2033_808_801_805_5604_3265_5566 20 1.85E-08 1.65E-06 4.71E-08 7700 hsa-mir-19a hsa04120 Ubiquitin mediated proteolysis 4193_55294_6500_3093_23291_9063_7319_84447_867_10401_7329_8925_57154_8651_10055_51366_64326_7337_5371_672_25898_8454_8945_51588_7428_10075_8554 27 2.40E-08 2.13E-06 5.93E-08 7701 hsa-mir-19a hsa03022 Basal transcription factors 51616_6872_2965_2963_2969_6878_6874_6908_2958_2959_6880_2957_6882_9519 14 7.37E-08 6.56E-06 1.77E-07 7702 hsa-mir-19a hsa04664 Fc epsilon RI signaling pathway 5578_2534_5580_1432_207_208_5879_695_5595_5594_5599_6850_5604_5601_5600_5603_5602_5608_3265 19 1.67E-07 1.49E-05 3.91E-07 7703 hsa-mir-19a hsa04540 Gap junction 5592_5578_10382_1956_6714_5595_5594_5598_7846_1453_347733_5159_983_5156_5604_3265_7278_84617_203068_5566 20 3.78E-07 3.36E-05 8.62E-07 7704 hsa-mir-19a hsa04330 Notch signaling pathway 3066_3065_1840_9794_1487_2648_1488_1387_22938_9612_2033_8850_1856_4851 14 8.20E-07 7.30E-05 1.83E-06 7705 hsa-mir-19a hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_7132_2902_2906_1432_1616_5879_836_7157_4846_5600_5603_5608_7133 15 1.04E-06 9.28E-05 2.26E-06 7706 hsa-mir-19a hsa04916 Melanogenesis 818_817_1499_3815_6934_5578_4286_5595_5594_1387_2932_2033_808_801_805_51176_5604_1856_3265_5566 20 1.74E-06 0.000154611 3.68E-06 7707 hsa-mir-19a hsa05131 Shigellosis 1499_5578_10382_2534_25_998_7534_7846_347733_7278_71_84617_4691_203068 14 4.71E-06 0.00041917 9.53E-06 7708 hsa-mir-19a hsa05130 Pathogenic Escherichia coli infection 1499_5578_10382_2534_25_998_7534_7846_347733_7278_71_84617_4691_203068 14 4.71E-06 0.00041917 9.53E-06 7709 hsa-mir-19a hsa04530 Tight junction 1499_5578_5580_5590_6714_4627_4628_22800_8573_207_208_1460_998_1459_1457_5728_5519_5518_5515_3265_71_5520 22 7.30E-06 0.000649919 1.44E-05 7710 hsa-mir-19a hsa04930 Type II diabetes mellitus 3551_5580_5590_8471_3651_8651_5595_5594_5599_3643_5601_5602 12 1.29E-05 0.001144695 2.49E-05 7711 hsa-mir-19a hsa03050 Proteasome 5708_5709_5705_5706_5700_5684_5719_5717_5713_5687_5693_5707 12 2.23E-05 0.001983967 4.22E-05 7712 hsa-mir-19a hsa05322 Systemic lupus erythematosus 3021_3020_8366_9555_8349_8362_8365_8368_3018_8294_8370_6628_121504_8360_8363_8364_8367_959_8359_8361 20 0.000114962 0.010231574 0.000213158 7713 hsa-mir-19a hsa04650 Natural killer cell mediated cytotoxicity 5777_5578_3455_4772_4773_2534_3932_3459_5879_5595_5594_836_6850_5058_5604_919_3265_5781_6464 19 0.00018639 0.016588666 0.000338544 7714 hsa-mir-19a hsa03420 Nucleotide excision repair 5981_902_5111_5886_2965_4331_2071_2074_1022_6117 10 0.000208973 0.018598561 0.000371971 7715 hsa-mir-19a hsa03410 Base excision repair 4350_142_4913_252969_5111_3146_328_2237_6996 9 0.000234704 0.020888642 0.000404365 7716 hsa-mir-19a hsa05016 Huntington's disease 10891_293_292_3066_3065_3064_498_25942_2902_6667_9586_1387_836_5437_7157_1213_2033_5468_27113_6874_6908_5441_9519 23 0.000236258 0.021026969 0.000404365 7717 hsa-mir-19a hsa03450 Non-homologous end-joining 2547_10111_7520_2237_5591_4361 6 0.000254676 0.022666203 0.000427664 7718 hsa-mir-19a hsa04060 Cytokine-cytokine receptor interaction 3559_3815_7132_3455_90_3594_3791_1956_3560_3561_1439_7046_3595_2057_6362_2690_3459_3977_1234_959_2321_1230_5159_5156_7852_58985_3575_7133 28 0.000428557 0.038141597 0.000706326 7719 hsa-mir-19a hsa04150 mTOR signaling pathway 6794_6195_6197_3091_207_208_5595_5594_6196_5563 10 0.000664511 0.059141519 0.0010753 7720 hsa-mir-19a hsa04810 Regulation of actin cytoskeleton 10788_1398_2264_5747_1956_5499_4627_4628_22800_5879_2249_998_2261_5595_5594_5058_5159_5156_5604_1399_3265_71_8826_85366 24 0.000734187 0.065342612 0.001166832 7721 hsa-mir-19a hsa03030 DNA replication 5981_4174_4172_5111_2237_5557_6117_5422 8 0.001009998 0.089889789 0.001577014 7722 hsa-mir-19a hsa03440 Homologous recombination 641_10111_4361_4683_5888_675_6117 7 0.001154958 0.102791261 0.001772263 7723 hsa-mir-19a hsa04340 Hedgehog signaling pathway 2735_23291_53944_2932_1452_1453_8945_2736_2737_5566 10 0.001235803 0.10998646 0.001864177 7724 hsa-mir-19a hsa04020 Calcium signaling pathway 818_814_817_293_5578_292_2064_1956_2902_2906_147_2066_4846_808_801_805_5159_5156_85366_5566 20 0.002418527 0.215248871 0.003587481 7725 hsa-mir-19a hsa04740 Olfactory transduction 818_817_5592_808_801_805_5566 7 0.002690948 0.239494361 0.003926137 7726 hsa-mir-19a hsa05217 Basal cell carcinoma 1499_6934_2735_2932_7157_51176_1856_2736_2737 9 0.003243108 0.288636595 0.004655429 7727 hsa-mir-19a hsa04730 Long-term depression 5592_5578_5595_5594_4846_5519_5518_5515_5604_3265 10 0.005138341 0.457312374 0.007258927 7728 hsa-mir-19a hsa03020 RNA polymerase 64425_25885_51082_5437_84172_5441 6 0.005784676 0.514836197 0.008007755 7729 hsa-mir-19a hsa04270 Vascular smooth muscle contraction 5592_5578_5580_147_5499_59_5595_5594_808_801_805_5604_85366_5566 14 0.005848361 0.520504088 0.008007755 7730 hsa-mir-19a hsa03430 Mismatch repair 5981_4436_5111_2956_6117 5 0.00967112 0.860729705 0.013041359 7731 hsa-mir-19a hsa04360 Axon guidance 4772_4773_2534_5747_25_5879_998_5595_5594_2932_5058_3265_7852_1020 14 0.010520257 0.936302834 0.013974669 7732 hsa-mir-19a hsa04950 Maturity onset diabetes of the young 5080_6927_4760_3651_3172 5 0.011235995 1 0.014705934 7733 hsa-mir-19a hsa05340 Primary immunodeficiency 8517_3932_3561_695_959_3575 6 0.012581327 1 0.016228089 7734 hsa-mir-19a hsa05010 Alzheimer's disease 7132_498_823_2902_2906_5595_5594_836_2932_4846_808_351_801_805_840_8772_1020 17 0.016210182 1 0.020610088 7735 hsa-mir-19a hsa04612 Antigen processing and presentation 3309_3304_3305_3303_3310_3312_3320_3326_4800_4801 10 0.027680759 1 0.034698417 7736 hsa-mir-19a hsa04670 Leukocyte transendothelial migration 1499_5578_653361_5747_1432_5879_998_5600_5603_7852_71_5781 12 0.037827534 1 0.046535049 7737 hsa-mir-19a hsa04710 Circadian rhythm - mammal 8863_4862_1453 3 0.038169197 1 0.046535049 7738 hsa-mir-19b-1 hsa05200 Pathways in cancer 4149_3551_1398_1499_5914_595_596_598_3815_1017_8517_4193_6934_5578_3091_2735_2064_3066_3065_5925_1050_613_5743_5747_10342_25_405_9063_1956_1487_6789_7046_4436_1870_1871_2113_6774_867_10401_207_208_9915_7187_4286_3716_1147_5879_2249_998_1488_2261_5595_5594_5599_861_1387_6256_836_367_2932_6777_6772_5970_7157_7849_1869_3725_5467_6776_4087_4088_4089_5888_5728_2034_2033_5468_4846_3910_898_4790_4791_4792_3320_3326_51176_5371_675_5159_5156_5604_5601_5602_1856_1399_3265_51588_7428_8772_4609_2956_1026_2736_2353_7704_2737_8554 107 1.09E-45 9.69E-44 9.69E-44 7739 hsa-mir-19b-1 hsa04010 MAPK signaling pathway 6722_4149_3551_1398_6195_6197_2264_8517_9252_5578_1845_7132_4773_9020_5923_1956_3304_3305_3303_6789_1432_7046_22800_4763_1616_207_208_1147_5879_2249_998_3727_2261_5595_5594_5599_5598_8986_1386_1649_836_3310_3312_3315_5971_5970_3164_7157_3725_6196_5058_4790_4791_5159_9261_1326_5156_5604_4208_5601_5600_5603_5602_5608_1399_3265_6885_4609_2353_2002_8550_5566 72 1.47E-26 1.31E-24 6.54E-25 7740 hsa-mir-19b-1 hsa05220 Chronic myeloid leukemia 3551_1398_595_598_8517_4193_3066_3065_5925_613_25_1487_7046_1870_1871_867_207_208_1147_1488_5595_5594_861_6777_5970_7157_1869_6776_4088_4089_4790_4792_5604_1399_3265_5781_4609_1026_6464 39 2.88E-23 2.56E-21 8.53E-22 7741 hsa-mir-19b-1 hsa04110 Cell cycle 4174_4172_595_1017_4193_902_6500_3066_3065_5925_25_1870_1871_5111_9232_5934_5933_545_995_5347_7534_5591_1387_11200_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_898_1031_983_8454_1026_1022_1111_8556_8555_472 44 2.18E-21 1.94E-19 4.85E-20 7742 hsa-mir-19b-1 hsa05215 Prostate cancer 3551_1499_595_596_1017_8517_4193_6934_2064_5925_1956_1870_1871_207_208_9586_1147_5595_5594_1387_367_2932_5970_7157_1869_5728_2033_898_4790_4792_3320_3326_51176_5159_5156_5604_3265_1026 38 1.64E-20 1.46E-18 2.92E-19 7743 hsa-mir-19b-1 hsa05212 Pancreatic cancer 3551_1499_595_596_1017_8517_4193_6934_2064_5925_1956_1870_1871_207_208_9586_1147_5595_5594_1387_367_2932_5970_7157_1869_5728_2033_898_4790_4792_3320_3326_51176_5159_5156_5604_3265_1026 38 2.24E-20 1.99E-18 3.32E-19 7744 hsa-mir-19b-1 hsa04310 Wnt signaling pathway 818_817_1499_595_8607_6934_5578_6500_4772_4773_23291_1487_5879_1460_1488_5599_1387_1459_2932_7157_8061_3725_5467_1457_1452_4087_4088_4089_2033_51176_5519_5518_5515_5601_5602_1856_8454_8945_6885_4609_5527_5566 42 1.16E-16 1.03E-14 1.48E-15 7745 hsa-mir-19b-1 hsa04660 T cell receptor signaling pathway 3551_1493_8517_5777_4772_4773_9020_2534_3932_4794_1432_867_207_208_1147_998_5595_5594_2932_5970_3725_5058_959_4790_4792_4793_1326_5604_5601_5600_5603_919_3265_6885_2353 35 1.17E-15 1.04E-13 1.30E-14 7746 hsa-mir-19b-1 hsa05222 Small cell lung cancer 4149_3551_595_596_598_1017_8517_5925_5743_5747_9063_1870_1871_10401_207_208_7187_1147_6256_5970_7157_1869_5728_4846_3910_898_4790_4792_51588_4609_8554 31 3.05E-15 2.72E-13 3.02E-14 7747 hsa-mir-19b-1 hsa05210 Colorectal cancer 1499_595_596_6934_1956_7046_4436_207_208_5879_5595_5594_5599_836_2932_7157_3725_4087_4088_4089_51176_5159_5156_5604_5601_5602_1856_4609_2956_2353 30 1.04E-14 9.26E-13 9.26E-14 7748 hsa-mir-19b-1 hsa04012 ErbB signaling pathway 818_817_1398_5578_2064_5747_25_1956_6714_867_207_208_5595_5594_5599_2066_2932_6777_3725_6776_5058_5604_5601_5602_1399_3265_4609_1026_2002_6464 30 2.22E-14 1.98E-12 1.80E-13 7749 hsa-mir-19b-1 hsa05221 Acute myeloid leukemia 3551_5914_595_3815_8517_6934_1050_6774_207_208_1147_5595_5594_861_6777_5970_5467_6776_4790_51176_5371_5604_3265_4609_7704 25 7.83E-14 6.97E-12 5.61E-13 7750 hsa-mir-19b-1 hsa04630 Jak-STAT signaling pathway 3559_595_598_5777_3455_3594_9063_3560_3561_6773_1439_3595_2057_6774_867_2690_10401_3459_3977_207_208_3717_3716_8651_1387_6778_6777_6772_7297_6776_2033_51588_10379_5781_58985_4609_3575_8554 38 8.19E-14 7.29E-12 5.61E-13 7751 hsa-mir-19b-1 hsa04920 Adipocytokine signaling pathway 3551_10891_5465_6794_8517_7132_8717_2538_4794_8471_6774_207_208_3717_1147_5599_6256_5970_4790_4792_4793_5601_5602_5563_5781_7133 26 1.29E-13 1.15E-11 8.15E-13 7752 hsa-mir-19b-1 hsa04620 Toll-like receptor signaling pathway 3551_8517_3455_3665_3661_1432_207_208_7187_1147_5879_29110_5595_5594_5599_6772_5970_3725_4790_4792_1326_5604_5601_5600_5603_5602_5608_9641_8772_6885_2353 31 1.37E-13 1.22E-11 8.15E-13 7753 hsa-mir-19b-1 hsa05214 Glioma 818_817_595_4193_5578_5925_1956_1870_1871_207_208_5595_5594_7157_1869_5728_808_801_805_5159_5156_5604_3265_1026_6464 25 4.48E-13 3.98E-11 2.49E-12 7754 hsa-mir-19b-1 hsa04520 Adherens junction 1499_6934_5770_5777_2064_2534_1956_6714_7046_5879_1460_998_5595_5594_1387_1459_1457_4087_4088_4089_2033_51176_3643_71_8826_6885 26 3.59E-12 3.20E-10 1.88E-11 7755 hsa-mir-19b-1 hsa04910 Insulin signaling pathway 3551_10891_1398_6720_5770_2538_5590_5499_8471_867_5211_207_208_8651_5595_5594_5599_2932_2194_808_801_805_3643_5604_5601_5602_5563_1399_3265_2002_6464_5566 32 2.57E-11 2.28E-09 1.27E-10 7756 hsa-mir-19b-1 hsa04662 B cell receptor signaling pathway 3551_8517_5777_4772_4773_4794_207_208_1147_5879_695_5595_5594_1380_2932_6850_5970_3725_4790_4792_4793_5604_3265_2353 24 3.15E-11 2.80E-09 1.48E-10 7757 hsa-mir-19b-1 hsa04350 TGF-beta signaling pathway 6500_90_4086_1875_6667_7046_1874_57154_5934_5933_5595_5594_1387_7027_4087_4088_4089_2033_5519_5518_5515_8454_4609_4093_4092 25 8.45E-11 7.52E-09 3.76E-10 7758 hsa-mir-19b-1 hsa04115 p53 signaling pathway 595_1017_4194_4193_900_50484_51246_545_7161_11200_836_7157_6241_64326_5728_898_27113_25898_983_1026_1111_472 22 2.19E-10 1.95E-08 9.29E-10 7759 hsa-mir-19b-1 hsa04510 Focal adhesion 1398_1499_595_596_5578_2064_5923_2534_5747_3791_1956_6714_5499_207_208_5879_998_5595_5594_5599_2932_3725_5058_5728_3910_2321_5159_5156_5604_5601_5602_1399_3265_71_2002_85366_6464 37 4.52E-10 4.03E-08 1.83E-09 7760 hsa-mir-19b-1 hsa04062 Chemokine signaling pathway 3551_1398_8517_653361_5747_5580_5590_6773_2309_6362_6774_207_208_3717_1147_5879_998_5595_5594_1234_2932_6777_6772_5970_5058_4790_4792_4793_1230_5604_1399_3265_7852_6464_5566 35 1.06E-09 9.45E-08 4.11E-09 7761 hsa-mir-19b-1 hsa05219 Bladder cancer 595_9252_4193_2064_5925_1956_1870_1871_2261_5595_5594_7157_1869_5604_3265_4609_1026 17 1.31E-09 1.16E-07 4.85E-09 7762 hsa-mir-19b-1 hsa03010 Ribosome 6193_6204_6205_6207_6202_6141_9349_6217_6137_6135_6210_6155_6156_6191_6222_6223_6229_6129_6128_6125_6130_6181_6189_6188_6232 25 1.42E-09 1.26E-07 5.05E-09 7763 hsa-mir-19b-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3551_8517_9020_1956_6714_1432_1147_5879_998_5599_836_5970_3725_5058_4790_4792_5601_5600_5603_5602_5781 21 1.74E-09 1.55E-07 5.96E-09 7764 hsa-mir-19b-1 hsa05211 Renal cell carcinoma 1398_3091_405_2113_207_208_9915_5879_998_5595_5594_1387_3725_5058_2034_2033_5604_1399_3265_7428_5781 21 2.15E-09 1.91E-07 7.08E-09 7765 hsa-mir-19b-1 hsa05213 Endometrial cancer 1499_595_6934_2064_1956_2309_207_208_5595_5594_2932_7157_5728_51176_5604_3265_4609_2002 18 3.26E-09 2.90E-07 1.04E-08 7766 hsa-mir-19b-1 hsa04912 GnRH signaling pathway 818_817_5578_5580_1956_6714_1432_998_5595_5594_5599_5598_3725_808_801_805_5604_5601_5600_5603_5602_5608_3265_2002_5566 25 3.86E-09 3.43E-07 1.18E-08 7767 hsa-mir-19b-1 hsa05223 Non-small cell lung cancer 595_5578_2064_5925_1956_2309_6789_1870_1871_207_208_5595_5594_6256_7157_1869_5604_3265 18 5.31E-09 4.73E-07 1.58E-08 7768 hsa-mir-19b-1 hsa04370 VEGF signaling pathway 5578_4772_4773_5743_5747_3791_6714_1432_207_208_5879_998_5595_5594_3315_4846_9261_5604_5600_5603_3265 21 5.87E-09 5.23E-07 1.69E-08 7769 hsa-mir-19b-1 hsa05216 Thyroid cancer 1499_595_6934_10342_5595_5594_6256_7157_7849_5468_51176_5604_3265_4609 14 6.40E-09 5.70E-07 1.78E-08 7770 hsa-mir-19b-1 hsa05218 Melanoma 595_4193_5925_1956_1870_1871_207_208_4286_2249_5595_5594_7157_1869_5728_5159_5156_5604_3265_1026 20 8.48E-09 7.55E-07 2.29E-08 7771 hsa-mir-19b-1 hsa04210 Apoptosis 3551_596_598_8517_7132_8717_9020_823_1439_207_208_1147_836_5970_7157_9131_4790_4792_840_8772_472_5566 22 1.19E-08 1.06E-06 3.10E-08 7772 hsa-mir-19b-1 hsa04720 Long-term potentiation 818_814_817_6195_6197_5578_2902_2906_5499_5595_5594_1387_6196_2033_808_801_805_5604_3265_5566 20 1.85E-08 1.65E-06 4.71E-08 7773 hsa-mir-19b-1 hsa04120 Ubiquitin mediated proteolysis 4193_55294_6500_3093_23291_9063_7319_84447_867_10401_7329_8925_57154_8651_10055_51366_64326_7337_5371_672_25898_8454_8945_51588_7428_10075_8554 27 2.40E-08 2.13E-06 5.93E-08 7774 hsa-mir-19b-1 hsa03022 Basal transcription factors 51616_6872_2965_2963_2969_6878_6874_6908_2958_2959_6880_2957_6882_9519 14 7.37E-08 6.56E-06 1.77E-07 7775 hsa-mir-19b-1 hsa04664 Fc epsilon RI signaling pathway 5578_2534_5580_1432_207_208_5879_695_5595_5594_5599_6850_5604_5601_5600_5603_5602_5608_3265 19 1.67E-07 1.49E-05 3.91E-07 7776 hsa-mir-19b-1 hsa04540 Gap junction 5592_5578_10382_1956_6714_5595_5594_5598_7846_1453_347733_5159_983_5156_5604_3265_7278_84617_203068_5566 20 3.78E-07 3.36E-05 8.62E-07 7777 hsa-mir-19b-1 hsa04330 Notch signaling pathway 3066_3065_1840_9794_1487_2648_1488_1387_22938_9612_2033_8850_1856_4851 14 8.20E-07 7.30E-05 1.83E-06 7778 hsa-mir-19b-1 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_7132_2902_2906_1432_1616_5879_836_7157_4846_5600_5603_5608_7133 15 1.04E-06 9.28E-05 2.26E-06 7779 hsa-mir-19b-1 hsa04916 Melanogenesis 818_817_1499_3815_6934_5578_4286_5595_5594_1387_2932_2033_808_801_805_51176_5604_1856_3265_5566 20 1.74E-06 0.000154611 3.68E-06 7780 hsa-mir-19b-1 hsa05131 Shigellosis 1499_5578_10382_2534_25_998_7534_7846_347733_7278_71_84617_4691_203068 14 4.71E-06 0.00041917 9.53E-06 7781 hsa-mir-19b-1 hsa05130 Pathogenic Escherichia coli infection 1499_5578_10382_2534_25_998_7534_7846_347733_7278_71_84617_4691_203068 14 4.71E-06 0.00041917 9.53E-06 7782 hsa-mir-19b-1 hsa04530 Tight junction 1499_5578_5580_5590_6714_4627_4628_22800_8573_207_208_1460_998_1459_1457_5728_5519_5518_5515_3265_71_5520 22 7.30E-06 0.000649919 1.44E-05 7783 hsa-mir-19b-1 hsa04930 Type II diabetes mellitus 3551_5580_5590_8471_3651_8651_5595_5594_5599_3643_5601_5602 12 1.29E-05 0.001144695 2.49E-05 7784 hsa-mir-19b-1 hsa03050 Proteasome 5708_5709_5705_5706_5700_5684_5719_5717_5713_5687_5693_5707 12 2.23E-05 0.001983967 4.22E-05 7785 hsa-mir-19b-1 hsa05322 Systemic lupus erythematosus 3021_3020_8366_9555_8349_8362_8365_8368_3018_8294_8370_6628_121504_8360_8363_8364_8367_959_8359_8361 20 0.000114962 0.010231574 0.000213158 7786 hsa-mir-19b-1 hsa04650 Natural killer cell mediated cytotoxicity 5777_5578_3455_4772_4773_2534_3932_3459_5879_5595_5594_836_6850_5058_5604_919_3265_5781_6464 19 0.00018639 0.016588666 0.000338544 7787 hsa-mir-19b-1 hsa03420 Nucleotide excision repair 5981_902_5111_5886_2965_4331_2071_2074_1022_6117 10 0.000208973 0.018598561 0.000371971 7788 hsa-mir-19b-1 hsa03410 Base excision repair 4350_142_4913_252969_5111_3146_328_2237_6996 9 0.000234704 0.020888642 0.000404365 7789 hsa-mir-19b-1 hsa05016 Huntington's disease 10891_293_292_3066_3065_3064_498_25942_2902_6667_9586_1387_836_5437_7157_1213_2033_5468_27113_6874_6908_5441_9519 23 0.000236258 0.021026969 0.000404365 7790 hsa-mir-19b-1 hsa03450 Non-homologous end-joining 2547_10111_7520_2237_5591_4361 6 0.000254676 0.022666203 0.000427664 7791 hsa-mir-19b-1 hsa04060 Cytokine-cytokine receptor interaction 3559_3815_7132_3455_90_3594_3791_1956_3560_3561_1439_7046_3595_2057_6362_2690_3459_3977_1234_959_2321_1230_5159_5156_7852_58985_3575_7133 28 0.000428557 0.038141597 0.000706326 7792 hsa-mir-19b-1 hsa04150 mTOR signaling pathway 6794_6195_6197_3091_207_208_5595_5594_6196_5563 10 0.000664511 0.059141519 0.0010753 7793 hsa-mir-19b-1 hsa04810 Regulation of actin cytoskeleton 10788_1398_2264_5747_1956_5499_4627_4628_22800_5879_2249_998_2261_5595_5594_5058_5159_5156_5604_1399_3265_71_8826_85366 24 0.000734187 0.065342612 0.001166832 7794 hsa-mir-19b-1 hsa03030 DNA replication 5981_4174_4172_5111_2237_5557_6117_5422 8 0.001009998 0.089889789 0.001577014 7795 hsa-mir-19b-1 hsa03440 Homologous recombination 641_10111_4361_4683_5888_675_6117 7 0.001154958 0.102791261 0.001772263 7796 hsa-mir-19b-1 hsa04340 Hedgehog signaling pathway 2735_23291_53944_2932_1452_1453_8945_2736_2737_5566 10 0.001235803 0.10998646 0.001864177 7797 hsa-mir-19b-1 hsa04020 Calcium signaling pathway 818_814_817_293_5578_292_2064_1956_2902_2906_147_2066_4846_808_801_805_5159_5156_85366_5566 20 0.002418527 0.215248871 0.003587481 7798 hsa-mir-19b-1 hsa04740 Olfactory transduction 818_817_5592_808_801_805_5566 7 0.002690948 0.239494361 0.003926137 7799 hsa-mir-19b-1 hsa05217 Basal cell carcinoma 1499_6934_2735_2932_7157_51176_1856_2736_2737 9 0.003243108 0.288636595 0.004655429 7800 hsa-mir-19b-1 hsa04730 Long-term depression 5592_5578_5595_5594_4846_5519_5518_5515_5604_3265 10 0.005138341 0.457312374 0.007258927 7801 hsa-mir-19b-1 hsa03020 RNA polymerase 64425_25885_51082_5437_84172_5441 6 0.005784676 0.514836197 0.008007755 7802 hsa-mir-19b-1 hsa04270 Vascular smooth muscle contraction 5592_5578_5580_147_5499_59_5595_5594_808_801_805_5604_85366_5566 14 0.005848361 0.520504088 0.008007755 7803 hsa-mir-19b-1 hsa03430 Mismatch repair 5981_4436_5111_2956_6117 5 0.00967112 0.860729705 0.013041359 7804 hsa-mir-19b-1 hsa04360 Axon guidance 4772_4773_2534_5747_25_5879_998_5595_5594_2932_5058_3265_7852_1020 14 0.010520257 0.936302834 0.013974669 7805 hsa-mir-19b-1 hsa04950 Maturity onset diabetes of the young 5080_6927_4760_3651_3172 5 0.011235995 1 0.014705934 7806 hsa-mir-19b-1 hsa05340 Primary immunodeficiency 8517_3932_3561_695_959_3575 6 0.012581327 1 0.016228089 7807 hsa-mir-19b-1 hsa05010 Alzheimer's disease 7132_498_823_2902_2906_5595_5594_836_2932_4846_808_351_801_805_840_8772_1020 17 0.016210182 1 0.020610088 7808 hsa-mir-19b-1 hsa04612 Antigen processing and presentation 3309_3304_3305_3303_3310_3312_3320_3326_4800_4801 10 0.027680759 1 0.034698417 7809 hsa-mir-19b-1 hsa04670 Leukocyte transendothelial migration 1499_5578_653361_5747_1432_5879_998_5600_5603_7852_71_5781 12 0.037827534 1 0.046535049 7810 hsa-mir-19b-1 hsa04710 Circadian rhythm - mammal 8863_4862_1453 3 0.038169197 1 0.046535049 7811 hsa-mir-19b-2 hsa05200 Pathways in cancer 3320_4149_5371_5595_5594_5599_861_5914_1387_6256_595_836_6258_367_2932_4193_7704_842_6774_3091_5970_7428_1870_1871_7157_4824_4087_6688_5604_2113_5894_4609_1869_3725_841_1029_6502_4088_4089_3066_3065_4292_1050_5925_2034_2033_4846_207_9915 49 2.43E-39 1.63E-37 1.63E-37 7812 hsa-mir-19b-2 hsa05220 Chronic myeloid leukemia 5595_5594_861_595_4193_5970_1870_1871_7157_5604_5894_4609_1869_1029_4088_4089_3066_3065_5925_207_6464 21 2.12E-22 1.42E-20 7.10E-21 7813 hsa-mir-19b-2 hsa04110 Cell cycle 5591_1387_595_983_2932_4193_8454_6500_1870_1871_7157_4087_1869_1029_6502_4088_4089_3066_3065_5925_2033_5933_990 23 2.98E-21 2.00E-19 6.03E-20 7814 hsa-mir-19b-2 hsa05215 Prostate cancer 3320_5595_5594_1387_595_367_2932_4193_1385_842_5970_1870_1871_7157_4824_5604_5894_1869_5925_2033_207 21 3.67E-21 2.46E-19 6.03E-20 7815 hsa-mir-19b-2 hsa05212 Pancreatic cancer 3320_5595_5594_1387_595_367_2932_4193_1385_842_5970_1870_1871_7157_4824_5604_5894_1869_5925_2033_207 21 4.50E-21 3.02E-19 6.03E-20 7816 hsa-mir-19b-2 hsa05210 Colorectal cancer 5595_5594_5599_595_836_2932_842_7157_4087_5604_5894_4609_3725_4088_4089_4292_207 17 2.53E-16 1.69E-14 2.47E-15 7817 hsa-mir-19b-2 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_6258_842_1870_1871_7157_5604_5894_1869_1029_5925_207 15 2.58E-16 1.73E-14 2.47E-15 7818 hsa-mir-19b-2 hsa05221 Acute myeloid leukemia 5371_5595_5594_861_5914_595_7704_6774_5970_6688_5604_5894_4609_1050_207 15 7.95E-16 5.33E-14 6.66E-15 7819 hsa-mir-19b-2 hsa05214 Glioma 815_5595_5594_595_4193_1870_1871_7157_5604_5894_1869_1029_5925_207_6464 15 2.74E-15 1.84E-13 2.04E-14 7820 hsa-mir-19b-2 hsa05219 Bladder cancer 5595_5594_595_4193_1870_1871_7157_5604_5894_4609_1869_1029_5925 13 8.02E-15 5.38E-13 5.38E-14 7821 hsa-mir-19b-2 hsa05222 Small cell lung cancer 4149_6256_595_6258_842_5970_1870_1871_7157_4609_1869_6502_5925_4846_207 15 1.02E-13 6.82E-12 6.20E-13 7822 hsa-mir-19b-2 hsa04350 TGF-beta signaling pathway 3399_5595_5594_1387_6667_8454_3398_6500_4087_4609_4088_4089_2033_5933_4093 15 1.18E-13 7.92E-12 6.60E-13 7823 hsa-mir-19b-2 hsa04010 MAPK signaling pathway 4149_5595_5594_5599_5598_4208_836_3312_1386_5970_9261_7157_5604_5894_4609_3725_6195_4763_1616_207_2002_2005 22 3.71E-13 2.49E-11 1.91E-12 7824 hsa-mir-19b-2 hsa05213 Endometrial cancer 5595_5594_595_2932_842_7157_5604_5894_4609_4292_207_2002 12 1.72E-12 1.16E-10 8.25E-12 7825 hsa-mir-19b-2 hsa05218 Melanoma 5595_5594_595_4193_1870_1871_7157_5604_5894_1869_1029_5925_207 13 2.67E-12 1.79E-10 1.19E-11 7826 hsa-mir-19b-2 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_5604_2113_5894_3725_2034_2033_207_9915 13 3.12E-12 2.09E-10 1.31E-11 7827 hsa-mir-19b-2 hsa04310 Wnt signaling pathway 815_5599_1387_595_2932_8454_6500_7157_4087_4609_3725_1457_1459_4088_4089_2033 16 1.66E-11 1.11E-09 6.54E-11 7828 hsa-mir-19b-2 hsa04012 ErbB signaling pathway 815_6714_5595_5594_5599_2932_5604_5894_4609_3725_207_6464_2002 13 2.63E-11 1.76E-09 9.78E-11 7829 hsa-mir-19b-2 hsa04540 Gap junction 6714_5595_5594_5598_983_7277_7278_5604_5894_7846_51807_10376 12 7.11E-10 4.76E-08 2.51E-09 7830 hsa-mir-19b-2 hsa05216 Thyroid cancer 5595_5594_6256_595_6258_7157_5604_4609 8 2.81E-09 1.88E-07 9.40E-09 7831 hsa-mir-19b-2 hsa05016 Huntington's disease 6874_1387_2902_6908_836_6667_1385_842_7157_841_3066_3065_3064_2033 14 1.95E-08 1.31E-06 6.23E-08 7832 hsa-mir-19b-2 hsa04520 Adherens junction 6714_5595_5594_1387_4087_1457_1459_4088_4089_2033 10 2.51E-08 1.68E-06 7.64E-08 7833 hsa-mir-19b-2 hsa04115 p53 signaling pathway 595_983_836_4193_842_7157_841_7161_1029 9 9.09E-08 6.09E-06 2.65E-07 7834 hsa-mir-19b-2 hsa04720 Long-term potentiation 815_5595_5594_1387_2902_5604_5894_6195_2033 9 1.74E-07 1.17E-05 4.86E-07 7835 hsa-mir-19b-2 hsa04370 VEGF signaling pathway 6714_5595_5594_842_9261_5604_5894_4846_207 9 2.14E-07 1.43E-05 5.73E-07 7836 hsa-mir-19b-2 hsa04912 GnRH signaling pathway 815_6714_5595_5594_5599_5598_5604_5894_3725_2002 10 3.34E-07 2.24E-05 8.60E-07 7837 hsa-mir-19b-2 hsa04330 Notch signaling pathway 1387_2648_9612_3066_3065_2033_4851 7 1.13E-06 7.56E-05 2.80E-06 7838 hsa-mir-19b-2 hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_5604_5894_3725_207 8 1.92E-06 0.000128789 4.60E-06 7839 hsa-mir-19b-2 hsa04916 Melanogenesis 815_5595_5594_1387_2932_1385_5604_5894_2033 9 2.19E-06 0.000146809 5.06E-06 7840 hsa-mir-19b-2 hsa04510 Focal adhesion 6714_5595_5594_5599_595_2932_5604_5894_3725_207_6464_2002 12 2.35E-06 0.000157741 5.26E-06 7841 hsa-mir-19b-2 hsa04910 Insulin signaling pathway 6720_5595_5594_5599_2932_5604_5894_207_6464_2002 10 2.68E-06 0.000179494 5.79E-06 7842 hsa-mir-19b-2 hsa04210 Apoptosis 836_839_842_840_5970_7157_841_207 8 6.24E-06 0.000418 1.31E-05 7843 hsa-mir-19b-2 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5970_5604_3725_841_207 8 1.58E-05 0.00105898 3.21E-05 7844 hsa-mir-19b-2 hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_4193_8454_6500_7428_7329_6502 9 1.98E-05 0.001327234 3.90E-05 7845 hsa-mir-19b-2 hsa05010 Alzheimer's disease 22926_5595_5594_2902_836_2932_842_840_841_4846 10 2.11E-05 0.001411371 4.03E-05 7846 hsa-mir-19b-2 hsa04660 T cell receptor signaling pathway 5595_5594_2932_5970_5604_5894_3725_207 8 2.63E-05 0.001764511 4.90E-05 7847 hsa-mir-19b-2 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_842_7157_1616_4846 6 3.72E-05 0.002492517 6.39E-05 7848 hsa-mir-19b-2 hsa05131 Shigellosis 7277_7278_7846_51807_4691_10376 6 3.72E-05 0.002492517 6.39E-05 7849 hsa-mir-19b-2 hsa05130 Pathogenic Escherichia coli infection 7277_7278_7846_51807_4691_10376 6 3.72E-05 0.002492517 6.39E-05 7850 hsa-mir-19b-2 hsa04062 Chemokine signaling pathway 5595_5594_7074_2932_6774_5970_5604_5894_207_6464 10 4.24E-05 0.002842775 7.11E-05 7851 hsa-mir-19b-2 hsa03022 Basal transcription factors 2963_2962_6874_2969_6908 5 6.17E-05 0.004133438 0.000100816 7852 hsa-mir-19b-2 hsa04920 Adipocytokine signaling pathway 5599_6256_6258_6774_5970_207 6 9.39E-05 0.006293985 0.000149857 7853 hsa-mir-19b-2 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5604_5894_207 6 0.000218291 0.014625528 0.000340129 7854 hsa-mir-19b-2 hsa04150 mTOR signaling pathway 5595_5594_3091_6195_207 5 0.000268606 0.01799659 0.000409013 7855 hsa-mir-19b-2 hsa04612 Antigen processing and presentation 3320_4800_4801_4802_1385_3312 6 0.000399031 0.026735088 0.000594113 7856 hsa-mir-19b-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5599_836_5970_3725 5 0.001015243 0.068021288 0.001447261 7857 hsa-mir-19b-2 hsa04730 Long-term depression 5595_5594_5604_5894_4846 5 0.001015243 0.068021288 0.001447261 7858 hsa-mir-19b-2 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_5604_5894_6464 6 0.003405583 0.228174089 0.004753627 7859 hsa-mir-19b-2 hsa04630 Jak-STAT signaling pathway 1387_595_6774_4609_2033_207 6 0.005847068 0.391753523 0.00799497 7860 hsa-mir-19b-2 hsa04930 Type II diabetes mellitus 5595_5594_5599 3 0.012394706 0.830445275 0.016608905 7861 hsa-mir-19b-2 hsa04270 Vascular smooth muscle contraction 5595_5594_5604_5894 4 0.034753395 1 0.045656421 7862 hsa-mir-200a hsa05200 Pathways in cancer 3725_2249_1499_5595_5594_5914_1387_6256_367_6776_6777_5970_862_6502_2353_5925_2033 17 5.44E-15 3.92E-13 3.92E-13 7863 hsa-mir-200a hsa04350 TGF-beta signaling pathway 6667_5595_5594_1387_3397_3399_3398_2033 8 1.58E-09 1.14E-07 3.36E-08 7864 hsa-mir-200a hsa05215 Prostate cancer 1499_5595_5594_1387_367_5970_5925_2033 8 1.72E-09 1.24E-07 3.36E-08 7865 hsa-mir-200a hsa05212 Pancreatic cancer 1499_5595_5594_1387_367_5970_5925_2033 8 1.87E-09 1.34E-07 3.36E-08 7866 hsa-mir-200a hsa05221 Acute myeloid leukemia 5595_5594_5914_6776_6777_5970_862 7 3.37E-09 2.43E-07 4.85E-08 7867 hsa-mir-200a hsa04010 MAPK signaling pathway 6722_3725_2249_5595_5594_9261_4208_7867_1432_5970_2353 11 4.93E-09 3.55E-07 5.92E-08 7868 hsa-mir-200a hsa04916 Melanogenesis 1499_5595_5594_1387_2033_808_801_805 8 5.88E-09 4.24E-07 6.05E-08 7869 hsa-mir-200a hsa04720 Long-term potentiation 5595_5594_1387_2033_808_801_805 7 1.57E-08 1.13E-06 1.42E-07 7870 hsa-mir-200a hsa04912 GnRH signaling pathway 3725_5595_5594_1432_808_801_805 7 1.65E-07 1.19E-05 1.32E-06 7871 hsa-mir-200a hsa05214 Glioma 5595_5594_5925_808_801_805 6 1.86E-07 1.34E-05 1.34E-06 7872 hsa-mir-200a hsa05220 Chronic myeloid leukemia 5595_5594_6776_6777_5970_5925 6 4.09E-07 2.95E-05 2.68E-06 7873 hsa-mir-200a hsa04330 Notch signaling pathway 388585_1387_9612_2033_8850 5 1.07E-06 7.70E-05 6.42E-06 7874 hsa-mir-200a hsa04620 Toll-like receptor signaling pathway 3725_5595_5594_1432_5970_2353 6 2.24E-06 0.000160943 1.24E-05 7875 hsa-mir-200a hsa04660 T cell receptor signaling pathway 3725_5595_5594_1432_5970_2353 6 3.39E-06 0.000244007 1.74E-05 7876 hsa-mir-200a hsa05216 Thyroid cancer 1499_5595_5594_6256 4 5.29E-06 0.000380757 2.54E-05 7877 hsa-mir-200a hsa05211 Renal cell carcinoma 3725_5595_5594_1387_2033 5 7.59E-06 0.000546354 3.41E-05 7878 hsa-mir-200a hsa04662 B cell receptor signaling pathway 3725_5595_5594_5970_2353 5 9.16E-06 0.000659283 3.88E-05 7879 hsa-mir-200a hsa04370 VEGF signaling pathway 5595_5594_9261_7867_1432 5 1.03E-05 0.000744163 4.13E-05 7880 hsa-mir-200a hsa04520 Adherens junction 1499_5595_5594_1387_2033 5 1.23E-05 0.000887229 4.67E-05 7881 hsa-mir-200a hsa05210 Colorectal cancer 3725_1499_5595_5594_2353 5 1.54E-05 0.001110387 5.55E-05 7882 hsa-mir-200a hsa04012 ErbB signaling pathway 3725_5595_5594_6776_6777 5 1.81E-05 0.001304709 6.21E-05 7883 hsa-mir-200a hsa05010 Alzheimer's disease 5595_5594_1537_808_801_805 6 4.54E-05 0.003271175 0.00014869 7884 hsa-mir-200a hsa05223 Non-small cell lung cancer 5595_5594_6256_5925 4 5.13E-05 0.003692105 0.000160526 7885 hsa-mir-200a hsa04270 Vascular smooth muscle contraction 5595_5594_808_801_805 5 7.31E-05 0.005262928 0.000218759 7886 hsa-mir-200a hsa04110 Cell cycle 1387_6502_5925_2033_891 5 7.60E-05 0.005468974 0.000218759 7887 hsa-mir-200a hsa04950 Maturity onset diabetes of the young 3651_168620_6927 3 0.000113458 0.008168967 0.000314191 7888 hsa-mir-200a hsa05218 Melanoma 2249_5595_5594_5925 4 0.000140378 0.010107205 0.000374341 7889 hsa-mir-200a hsa04910 Insulin signaling pathway 5595_5594_808_801_805 5 0.000148658 0.010703401 0.000382264 7890 hsa-mir-200a hsa04630 Jak-STAT signaling pathway 1387_6776_6777_2033_3977 5 0.000250667 0.018048025 0.000622346 7891 hsa-mir-200a hsa05222 Small cell lung cancer 6256_5970_6502_5925 4 0.000283527 0.020413938 0.000680465 7892 hsa-mir-200a hsa05219 Bladder cancer 5595_5594_5925 3 0.000525888 0.037863942 0.001221417 7893 hsa-mir-200a hsa05016 Huntington's disease 6667_1387_6908_1537_2033 5 0.000591087 0.04255828 0.001329946 7894 hsa-mir-200a hsa04930 Type II diabetes mellitus 3651_5595_5594 3 0.000636154 0.045803071 0.001387972 7895 hsa-mir-200a hsa05213 Endometrial cancer 1499_5595_5594 3 0.000948017 0.068257217 0.002007565 7896 hsa-mir-200a hsa04120 Ubiquitin mediated proteolysis 672_7329_6502_7325 4 0.001609459 0.115881072 0.003310888 7897 hsa-mir-200a hsa04310 Wnt signaling pathway 3725_1499_1387_2033 4 0.002210042 0.159123 0.004345032 7898 hsa-mir-200a hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1432_5970 3 0.002232864 0.160766187 0.004345032 7899 hsa-mir-200a hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.00268981 0.193666332 0.005096482 7900 hsa-mir-200a hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432 3 0.002989651 0.215254891 0.005519356 7901 hsa-mir-200a hsa04062 Chemokine signaling pathway 5595_5594_6777_5970 4 0.005083743 0.366029462 0.009150737 7902 hsa-mir-200a hsa04510 Focal adhesion 3725_1499_5595_5594 4 0.006355191 0.457573765 0.011160336 7903 hsa-mir-200a hsa04150 mTOR signaling pathway 5595_5594 2 0.015324059 1 0.026269815 7904 hsa-mir-200a hsa04920 Adipocytokine signaling pathway 6256_5970 2 0.024289515 1 0.040670816 7905 hsa-mir-200a hsa04730 Long-term depression 5595_5594 2 0.02696631 1 0.044126689 7906 hsa-mir-200a hsa04020 Calcium signaling pathway 808_801_805 3 0.02786291 1 0.044580655 7907 hsa-mir-200a hsa04810 Regulation of actin cytoskeleton 2249_5595_5594 3 0.042874351 1 0.066820404 7908 hsa-mir-200a hsa04540 Gap junction 5595_5594 2 0.043618875 1 0.066820404 7909 hsa-mir-200c hsa05200 Pathways in cancer 5914_595_596_598_2261_4193_6934_7704_5578_3091_3066_3065_5925_613_5747_25_1956_1487_1488_6789_4824_4436_1870_1871_2885_2113_861_10401_207_4286_3716_1147_998_1026_4233_5595_5594_5599_6258_1387_2064_6256_3326_836_367_2932_6774_6776_6777_6772_5979_5879_7157_6688_1869_3725_2736_4087_4088_4089_9063_5888_5728_2034_2033_675_4846_3910_4790_4792_5970_1017_3320_5371_3480_5159_5156_5604_5601_5602_1856_842_841_51588_7428_4609_2353_1441_5743_8554 90 1.20E-57 1.04E-55 1.04E-55 7910 hsa-mir-200c hsa04010 MAPK signaling pathway 3925_6722_6197_2261_2264_9252_5578_4773_5923_8986_1956_3304_3303_6789_1432_2885_3305_4763_207_1147_998_5595_5594_5599_1386_836_3312_3315_1649_5879_3164_7157_468_3725_3727_6195_6196_9344_4790_51701_5970_1616_5159_9261_5156_5604_4208_5601_5600_5602_6885_4609_5606_2353_8550_2002_2005 57 1.67E-31 1.45E-29 7.25E-30 7911 hsa-mir-200c hsa05215 Prostate cancer 595_596_4193_6934_5925_1956_4824_1870_1871_2885_9586_207_1147_1026_5595_5594_1385_1387_2064_3326_367_2932_7157_468_1869_5728_2033_4790_4792_5970_1017_3320_3480_5159_5156_5604_842 37 9.08E-30 7.90E-28 2.63E-28 7912 hsa-mir-200c hsa05212 Pancreatic cancer 595_596_4193_6934_5925_1956_4824_1870_1871_2885_9586_207_1147_1026_5595_5594_1385_1387_2064_3326_367_2932_7157_468_1869_5728_2033_4790_4792_5970_1017_3320_3480_5159_5156_5604_842 37 1.26E-29 1.09E-27 2.73E-28 7913 hsa-mir-200c hsa04110 Cell cycle 595_4193_902_5347_1022_3066_3065_5925_25_1870_1871_5933_9232_545_995_1026_7534_5591_1387_11200_7533_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_1017_1031_983_472_1111_8556_8555 38 5.66E-27 4.93E-25 9.86E-26 7914 hsa-mir-200c hsa05220 Chronic myeloid leukemia 595_598_4193_3066_3065_5925_613_25_1487_1488_1870_1871_2885_861_207_1147_1026_5595_5594_6776_6777_7157_1869_4088_4089_4790_4792_5970_5604_5781_4609_6464 32 4.48E-26 3.89E-24 6.49E-25 7915 hsa-mir-200c hsa05210 Colorectal cancer 595_596_6934_1956_4436_2885_207_4233_5595_5594_5599_836_2932_5879_7157_3725_4087_4088_4089_3480_5159_5156_5604_5601_5602_1856_842_4609_2353 29 1.14E-21 9.91E-20 1.42E-20 7916 hsa-mir-200c hsa05222 Small cell lung cancer 595_596_598_5925_5747_1870_1871_10401_207_1147_6258_6256_7157_1869_9063_5728_4846_3910_4790_4792_5970_1017_842_51588_4609_5743_8554 27 2.18E-19 1.90E-17 2.37E-18 7917 hsa-mir-200c hsa04630 Jak-STAT signaling pathway 3559_595_598_3454_3455_3560_1439_2885_2690_10401_207_3717_3716_3718_85480_1387_3575_3570_3572_6774_6775_6776_6777_6772_9063_2033_149233_3953_51588_5781_4609_1441_8554 33 5.76E-19 5.01E-17 5.56E-18 7918 hsa-mir-200c hsa04115 p53 signaling pathway 595_4194_4193_50484_6241_27113_51246_545_1026_11200_836_7157_900_64326_5728_1017_25898_983_842_841_7161_472_1111 23 3.43E-17 2.99E-15 2.99E-16 7919 hsa-mir-200c hsa04310 Wnt signaling pathway 815_595_6934_5578_4773_1460_1487_1488_5599_1387_2932_5879_7157_8061_3725_1457_1452_4087_4088_4089_2033_51701_5518_5515_5601_5602_1856_6885_4609_5527 30 1.40E-16 1.22E-14 1.11E-15 7920 hsa-mir-200c hsa05214 Glioma 815_595_4193_5578_5925_1956_1870_1871_2885_207_1026_5595_5594_7157_1869_5728_3480_5159_5156_5604_6464 21 1.37E-15 1.19E-13 9.92E-15 7921 hsa-mir-200c hsa04012 ErbB signaling pathway 815_5578_5747_25_1956_6714_2885_207_1026_5595_5594_5599_2064_2932_6776_6777_3725_5604_5601_5602_4609_6464_2002 23 2.36E-15 2.05E-13 1.58E-14 7922 hsa-mir-200c hsa05221 Acute myeloid leukemia 5914_595_6934_7704_2885_861_207_1147_5595_5594_6774_6776_6777_6688_4790_5970_5371_5604_4609 19 3.25E-14 2.82E-12 2.02E-13 7923 hsa-mir-200c hsa04620 Toll-like receptor signaling pathway 3454_3455_1432_207_1147_3654_5595_5594_5599_6772_5879_3725_4790_4792_5970_5604_5601_5600_5602_841_6885_5606_2353 23 4.34E-14 3.77E-12 2.52E-13 7924 hsa-mir-200c hsa05223 Non-small cell lung cancer 595_5578_5925_1956_6789_1870_1871_2885_207_5595_5594_6258_2064_6256_7157_1869_5604_842 18 9.44E-14 8.21E-12 5.13E-13 7925 hsa-mir-200c hsa04510 Focal adhesion 595_596_5578_5923_5747_1956_6714_5499_2885_207_998_4233_5595_5594_5599_2064_2932_5879_3725_5728_3910_2321_3480_5159_5156_5604_5601_5602_6464_2002 30 1.80E-13 1.57E-11 9.22E-13 7926 hsa-mir-200c hsa04520 Adherens junction 6934_1460_1956_6714_2241_998_4233_5595_5594_1387_2064_5879_1457_4087_4088_4089_2033_51701_3480_6885 20 3.81E-13 3.32E-11 1.84E-12 7927 hsa-mir-200c hsa05219 Bladder cancer 595_2261_9252_4193_5925_1956_1870_1871_1026_5595_5594_2064_7157_1869_5604_4609 16 4.21E-13 3.66E-11 1.93E-12 7928 hsa-mir-200c hsa05218 Melanoma 595_4193_5925_1956_1870_1871_207_4286_1026_4233_5595_5594_7157_1869_5728_3480_5159_5156_5604 19 5.28E-13 4.59E-11 2.30E-12 7929 hsa-mir-200c hsa04062 Chemokine signaling pathway 1234_1230_5747_5580_7852_2885_6362_207_3055_3717_1147_3718_998_5590_5595_5594_2932_6774_6777_6772_5879_4790_4792_5970_5604_2185_6464 27 6.75E-12 5.87E-10 2.80E-11 7930 hsa-mir-200c hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_1432_1147_998_4233_5599_836_5879_3725_4790_4792_5970_5601_5600_5602_5781 17 3.98E-11 3.47E-09 1.58E-10 7931 hsa-mir-200c hsa04912 GnRH signaling pathway 815_5578_5580_1956_6714_1432_2885_998_5595_5594_5599_468_3725_5604_5601_5600_5602_2185_5606_2002 20 4.49E-11 3.90E-09 1.70E-10 7932 hsa-mir-200c hsa04660 T cell receptor signaling pathway 4773_3932_1432_2885_207_1147_998_5595_5594_2932_3725_4790_4792_5970_5604_5601_5600_6885_2353_959 20 6.00E-11 5.22E-09 2.12E-10 7933 hsa-mir-200c hsa05213 Endometrial cancer 595_6934_1956_2885_207_5595_5594_2064_2932_7157_5728_5604_842_4609_2002 15 6.08E-11 5.29E-09 2.12E-10 7934 hsa-mir-200c hsa04210 Apoptosis 3556_596_598_823_1439_207_1147_3654_836_839_7157_4790_4792_5970_842_841_840_472 18 1.19E-10 1.04E-08 3.85E-10 7935 hsa-mir-200c hsa04370 VEGF signaling pathway 5578_4773_5747_6714_1432_207_998_5595_5594_3315_5879_4846_9261_5604_5600_842_5743 17 1.19E-10 1.04E-08 3.85E-10 7936 hsa-mir-200c hsa04920 Adipocytokine signaling pathway 5563_6794_207_3717_1147_5599_6258_6256_6774_4790_4792_5970_5601_5602_3953_5781 16 1.54E-10 1.34E-08 4.80E-10 7937 hsa-mir-200c hsa05211 Renal cell carcinoma 3091_2885_2113_207_998_4233_5595_5594_1387_5879_3725_2034_2033_5604_7428_5781 16 3.86E-10 3.36E-08 1.16E-09 7938 hsa-mir-200c hsa04350 TGF-beta signaling pathway 6667_3397_3399_3398_5933_5595_5594_1387_7027_4086_4087_4088_4089_2033_5518_5515_4609 17 6.20E-10 5.40E-08 1.80E-09 7939 hsa-mir-200c hsa04662 B cell receptor signaling pathway 4773_6850_2885_207_1147_5595_5594_2932_5879_3725_4790_4792_5970_5604_2353_1380 16 6.49E-10 5.64E-08 1.82E-09 7940 hsa-mir-200c hsa03022 Basal transcription factors 6880_51616_2957_2965_2963_2962_2969_6874_6872_6908_2958_2959 12 1.66E-09 1.45E-07 4.52E-09 7941 hsa-mir-200c hsa04664 Fc epsilon RI signaling pathway 5578_5580_6850_1432_2885_207_5595_5594_5599_5879_5604_5601_5600_5602_5606 15 8.88E-09 7.72E-07 2.34E-08 7942 hsa-mir-200c hsa04120 Ubiquitin mediated proteolysis 55294_4193_3093_7319_84447_10401_7329_83737_10055_9063_64326_7337_5371_672_25898_10075_51588_7428_8554 19 1.24E-08 1.08E-06 3.16E-08 7943 hsa-mir-200c hsa05216 Thyroid cancer 595_6934_5595_5594_6258_6256_5979_7157_5604_4609 10 2.38E-08 2.07E-06 5.92E-08 7944 hsa-mir-200c hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_2902_1432_836_5879_7157_4846_1616_5600_842_5606 12 8.59E-08 7.48E-06 2.08E-07 7945 hsa-mir-200c hsa04330 Notch signaling pathway 9612_3066_3065_1487_1488_3280_1387_2033_8850_388585_1856 11 1.37E-07 1.19E-05 3.23E-07 7946 hsa-mir-200c hsa04060 Cytokine-cytokine receptor interaction 3556_3559_1234_1230_3454_3455_1956_3560_1439_7852_6362_2690_85480_4233_3575_3570_3572_2321_149233_5159_5156_3953_959_1441 24 1.86E-07 1.61E-05 4.25E-07 7947 hsa-mir-200c hsa04720 Long-term potentiation 815_6197_5578_2902_5499_5595_5594_1387_468_6195_6196_2033_5604 13 2.21E-07 1.92E-05 4.93E-07 7948 hsa-mir-200c hsa04910 Insulin signaling pathway 6720_5563_5499_2885_207_5590_5595_5594_5599_23265_2932_5604_5601_5602_6464_2002 16 1.28E-06 0.000111278 2.78E-06 7949 hsa-mir-200c hsa04650 Natural killer cell mediated cytotoxicity 5578_3454_3455_4773_3932_6850_2885_5595_5594_836_5879_5604_5781_2185_6464 15 5.61E-06 0.000488047 1.19E-05 7950 hsa-mir-200c hsa04540 Gap junction 5578_1956_6714_2885_5592_5595_5594_1453_5159_983_5156_5604 12 1.01E-05 0.000879877 2.09E-05 7951 hsa-mir-200c hsa05016 Huntington's disease 3066_3065_3064_25942_2902_6667_27113_9586_1385_1387_836_7157_2033_6874_6908_842_841 17 1.30E-05 0.001131432 2.63E-05 7952 hsa-mir-200c hsa04150 mTOR signaling pathway 5563_6794_6197_3091_207_5595_5594_6195_6196 9 1.64E-05 0.001428681 3.25E-05 7953 hsa-mir-200c hsa04916 Melanogenesis 815_6934_5578_4286_5595_5594_1385_1387_2932_2033_5604_1856 12 2.79E-05 0.002430086 5.40E-05 7954 hsa-mir-200c hsa04612 Antigen processing and presentation 3309_3304_3303_3305_1385_3326_3312_3320_4800_4801_2923 11 3.38E-05 0.002938282 6.39E-05 7955 hsa-mir-200c hsa03420 Nucleotide excision repair 2074_902_1022_6117_2965_4331_2071_6118 8 3.55E-05 0.003088865 6.57E-05 7956 hsa-mir-200c hsa04930 Type II diabetes mellitus 5580_3651_5590_5595_5594_5599_5601_5602 8 4.09E-05 0.003560763 7.42E-05 7957 hsa-mir-200c hsa04730 Long-term depression 5578_5592_5595_5594_4846_3480_5518_5515_5604 9 0.000145499 0.012658424 0.000258335 7958 hsa-mir-200c hsa04360 Axon guidance 4773_5747_25_7852_2242_998_4233_5595_5594_2932_5879_1020 12 0.000212439 0.018482162 0.000369643 7959 hsa-mir-200c hsa04530 Tight junction 5578_1460_5580_6714_207_998_5590_1457_5728_5518_5515_5520 12 0.000310851 0.027044052 0.000530276 7960 hsa-mir-200c hsa04950 Maturity onset diabetes of the young 6927_3087_3280_3651_3172 5 0.000625792 0.054443882 0.001046998 7961 hsa-mir-200c hsa05010 Alzheimer's disease 22926_823_2902_5595_5594_836_2932_6622_4846_842_841_840_1020 13 0.000846643 0.073657946 0.001389773 7962 hsa-mir-200c hsa03440 Homologous recombination 641_6117_5888_675_6118 5 0.001153983 0.100396488 0.001859194 7963 hsa-mir-200c hsa03410 Base excision repair 3146_4913_142_328_6996 5 0.003104111 0.270057652 0.004910139 7964 hsa-mir-200c hsa04670 Leukocyte transendothelial migration 5578_5747_1432_7852_998_5879_5600_5781_2185 9 0.004965859 0.432029728 0.007714817 7965 hsa-mir-200c hsa04710 Circadian rhythm - mammal 8863_1453_8553 3 0.006406951 0.557404769 0.009779031 7966 hsa-mir-200c hsa04740 Olfactory transduction 815_5592 2 0.007278785 0.633254337 0.010918178 7967 hsa-mir-200c hsa05340 Primary immunodeficiency 3932_3718_3575_959 4 0.014751249 1 0.021751842 7968 hsa-mir-200c hsa04810 Regulation of actin cytoskeleton 2261_2264_5747_1956_5499_998_5595_5594_5879_5159_5156_5604 12 0.015019307 1 0.021777996 7969 hsa-mir-200c hsa05217 Basal cell carcinoma 6934_2932_7157_2736_1856 5 0.015514577 1 0.022127348 7970 hsa-mir-200c hsa03030 DNA replication 6117_6118_5422_5557 4 0.016081323 1 0.022524859 7971 hsa-mir-200c hsa05131 Shigellosis 5578_25_998_7534_4691 5 0.016570011 1 0.022524859 7972 hsa-mir-200c hsa05130 Pathogenic Escherichia coli infection 5578_25_998_7534_4691 5 0.016570011 1 0.022524859 7973 hsa-mir-200c hsa03430 Mismatch repair 4436_6117_6118 3 0.024845243 1 0.033254402 7974 hsa-mir-200c hsa04640 Hematopoietic cell lineage 3559_3575_3570_914_1380_1441 6 0.026510024 1 0.034945032 7975 hsa-mir-200c hsa04270 Vascular smooth muscle contraction 5578_5580_5499_5592_5595_5594_5604 7 0.034007217 1 0.044158626 7976 hsa-mir-202 hsa05200 Pathways in cancer 6654_5914_595_4193_7704_4089_3065_1050_5925_7184_405_1956_2308_2064_8503_2885_10401_207_208_1147_5595_5594_5599_6258_1387_6257_6256_367_2932_5970_7157_6688_3725_6776_2736_4087_4088_5295_2033_4790_3320_3326_5371_3480_8031_5601_3265_4609_2353_8554 50 1.24E-31 9.67E-30 9.67E-30 7977 hsa-mir-202 hsa03022 Basal transcription factors 54457_2958_138474_2959_6881_6879_2965_2967_2961_2960_2963_2968_6878_6877_6874_6873_6872_6908_6884_6882_6883_6880_2957_9519 24 4.28E-28 3.34E-26 1.67E-26 7978 hsa-mir-202 hsa04010 MAPK signaling pathway 6722_6654_6197_4214_9252_4616_8986_1956_1432_627_2885_22800_2872_207_208_1147_994_5595_5594_5599_1386_3312_1649_5970_7157_10912_468_3725_3727_6195_6196_5058_4790_9261_5601_5600_5603_3265_4609_2353_8550_5566 42 4.99E-27 3.89E-25 1.01E-25 7979 hsa-mir-202 hsa05215 Prostate cancer 6654_595_4193_5925_7184_1956_2308_2064_8503_2885_9586_207_208_1147_5595_5594_1387_367_2932_5970_7157_468_5295_2033_4790_3320_3326_3480_3265 29 5.20E-27 4.06E-25 1.01E-25 7980 hsa-mir-202 hsa05212 Pancreatic cancer 6654_595_4193_5925_7184_1956_2308_2064_8503_2885_9586_207_208_1147_5595_5594_1387_367_2932_5970_7157_468_5295_2033_4790_3320_3326_3480_3265 29 6.80E-27 5.30E-25 1.06E-25 7981 hsa-mir-202 hsa05220 Chronic myeloid leukemia 6654_595_4193_4089_3065_5925_8503_2885_207_208_1147_5595_5594_5970_7157_6776_4088_5295_4790_3265_4609_6464 22 7.02E-20 5.48E-18 9.13E-19 7982 hsa-mir-202 hsa05221 Acute myeloid leukemia 6654_5914_595_7704_1050_8503_2885_207_208_1147_5595_5594_5970_6688_6776_5295_4790_5371_3265_4609 20 3.21E-19 2.50E-17 3.57E-18 7983 hsa-mir-202 hsa04660 T cell receptor signaling pathway 6654_5777_3932_1432_8503_2885_207_208_1147_5595_5594_56924_2932_5970_3725_5295_5058_4790_5601_5600_5603_3265_2353 23 6.55E-18 5.11E-16 6.38E-17 7984 hsa-mir-202 hsa05210 Colorectal cancer 6654_595_4089_1956_8503_2885_207_208_5595_5594_5599_2932_7157_3725_4087_4088_5295_3480_5601_4609_2353 21 7.91E-18 6.17E-16 6.86E-17 7985 hsa-mir-202 hsa04012 ErbB signaling pathway 6654_1956_6714_2064_8503_2885_207_208_5595_5594_5599_56924_2932_3725_6776_5295_5058_5601_3265_4609_6464 21 1.46E-17 1.14E-15 1.14E-16 7986 hsa-mir-202 hsa05214 Glioma 6654_595_4193_5925_1956_8503_2885_207_208_5595_5594_7157_5295_808_801_805_3480_3265_6464 19 2.53E-17 1.97E-15 1.65E-16 7987 hsa-mir-202 hsa05223 Non-small cell lung cancer 6654_595_5925_1956_2309_2064_8503_2885_207_208_5595_5594_6258_6257_6256_7157_5295_3265 18 2.53E-17 1.98E-15 1.65E-16 7988 hsa-mir-202 hsa04910 Insulin signaling pathway 6720_10891_6654_5770_2308_8503_2885_5211_2872_207_208_5595_5594_5599_7249_2932_5295_808_801_805_5601_3265_6464_5566 24 5.06E-17 3.95E-15 3.04E-16 7989 hsa-mir-202 hsa05213 Endometrial cancer 6654_595_1956_2309_2064_8503_2885_207_208_5595_5594_2932_7157_5295_3265_4609 16 4.32E-15 3.37E-13 2.41E-14 7990 hsa-mir-202 hsa04912 GnRH signaling pathway 6654_4214_1956_6714_1432_2885_5595_5594_5599_468_3725_808_801_805_5601_5600_5603_3265_5566 19 7.86E-14 6.13E-12 4.09E-13 7991 hsa-mir-202 hsa04110 Cell cycle 595_4193_902_4089_4171_3065_4616_5925_994_1387_7533_2932_7157_10912_4085_4087_4088_2033_1022 19 3.68E-13 2.87E-11 1.79E-12 7992 hsa-mir-202 hsa04662 B cell receptor signaling pathway 6654_5777_8503_2885_207_208_1147_5595_5594_2932_5970_3725_5295_4790_3265_2353 16 5.57E-13 4.34E-11 2.55E-12 7993 hsa-mir-202 hsa04510 Focal adhesion 6654_595_857_9564_1956_6714_2064_8503_2885_207_208_5595_5594_5599_56924_2932_3725_5295_5058_3480_5601_3265_6464 23 1.11E-12 8.63E-11 4.79E-12 7994 hsa-mir-202 hsa04520 Adherens junction 5770_5777_4089_1956_6714_2064_1459_1460_5595_5594_1387_1457_4087_4088_2033_3480 16 1.32E-12 1.03E-10 5.42E-12 7995 hsa-mir-202 hsa05222 Small cell lung cancer 595_5925_8503_10401_207_208_1147_6258_6257_6256_5970_7157_5295_4790_4609_8554 16 3.48E-12 2.72E-10 1.36E-11 7996 hsa-mir-202 hsa05211 Renal cell carcinoma 6654_405_8503_2885_207_208_5595_5594_56924_1387_3725_5295_5058_2033_3265 15 4.00E-12 3.12E-10 1.49E-11 7997 hsa-mir-202 hsa04720 Long-term potentiation 6197_2902_2906_5595_5594_1387_468_6195_6196_2033_808_801_805_3265_5566 15 6.68E-12 5.21E-10 2.37E-11 7998 hsa-mir-202 hsa04620 Toll-like receptor signaling pathway 1432_8503_207_208_1147_5595_5594_5599_5970_3725_5295_4790_5601_5600_5603_2353 16 3.42E-11 2.67E-09 1.16E-10 7999 hsa-mir-202 hsa04310 Wnt signaling pathway 595_4089_1459_8607_1460_5599_1387_2932_7157_8061_3725_1457_4087_4088_2033_5601_4609_5566 18 1.35E-10 1.06E-08 4.35E-10 8000 hsa-mir-202 hsa04664 Fc epsilon RI signaling pathway 6654_1432_8503_2885_207_208_5595_5594_5599_5295_5601_5600_5603_3265 14 1.40E-10 1.09E-08 4.35E-10 8001 hsa-mir-202 hsa05216 Thyroid cancer 595_5595_5594_6258_6257_6256_7157_8031_3265_4609 10 2.51E-10 1.96E-08 7.52E-10 8002 hsa-mir-202 hsa05219 Bladder cancer 595_9252_4193_5925_1956_2064_5595_5594_7157_3265_4609 11 3.73E-10 2.91E-08 1.08E-09 8003 hsa-mir-202 hsa05218 Melanoma 595_4193_5925_1956_8503_207_208_5595_5594_7157_5295_3480_3265 13 4.47E-10 3.49E-08 1.25E-09 8004 hsa-mir-202 hsa04062 Chemokine signaling pathway 6654_9564_2309_8503_2885_207_208_1147_5595_5594_2932_5970_5295_5058_4790_2770_3265_6464_5566 19 7.32E-10 5.71E-08 1.97E-09 8005 hsa-mir-202 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_1432_1147_5599_5970_3725_5058_4790_5601_5600_5603 12 4.70E-09 3.67E-07 1.22E-08 8006 hsa-mir-202 hsa04370 VEGF signaling pathway 6714_1432_8503_207_208_5595_5594_5295_9261_5600_5603_3265 12 1.06E-08 8.28E-07 2.67E-08 8007 hsa-mir-202 hsa04920 Adipocytokine signaling pathway 10891_207_208_1147_5599_6258_6257_6256_5970_4790_5601 11 2.71E-08 2.11E-06 6.60E-08 8008 hsa-mir-202 hsa04150 mTOR signaling pathway 6197_8503_207_208_5595_5594_7249_6195_6196_5295 10 3.11E-08 2.42E-06 7.34E-08 8009 hsa-mir-202 hsa05016 Huntington's disease 10891_3065_3064_2902_6667_627_9586_1387_9001_5430_7157_23186_2033_6874_6908_9519 16 1.05E-07 8.20E-06 2.41E-07 8010 hsa-mir-202 hsa04630 Jak-STAT signaling pathway 6654_595_5777_8503_2885_10401_207_208_1387_6776_5295_2033_4609_8554 14 3.38E-07 2.64E-05 7.53E-07 8011 hsa-mir-202 hsa04540 Gap junction 6654_10382_1956_6714_2885_5592_5595_5594_2770_3265_5566 11 5.45E-07 4.25E-05 1.18E-06 8012 hsa-mir-202 hsa04916 Melanogenesis 5595_5594_1387_2932_2033_808_801_805_2770_3265_5566 11 1.50E-06 0.000116846 3.16E-06 8013 hsa-mir-202 hsa03420 Nucleotide excision repair 902_5887_2965_2967_2968_4331_1022 7 1.15E-05 0.000895231 2.36E-05 8014 hsa-mir-202 hsa04930 Type II diabetes mellitus 3651_8503_5595_5594_5599_5295_5601 7 1.31E-05 0.001021081 2.62E-05 8015 hsa-mir-202 hsa04350 TGF-beta signaling pathway 4089_6667_5595_5594_1387_4087_4088_2033_4609 9 1.59E-05 0.00123765 3.09E-05 8016 hsa-mir-202 hsa04650 Natural killer cell mediated cytotoxicity 6654_5777_3932_8503_2885_5595_5594_5295_5058_3265_6464 11 1.83E-05 0.001429477 3.48E-05 8017 hsa-mir-202 hsa04210 Apoptosis 8503_207_208_1147_5970_7157_5295_4790_5566 9 1.88E-05 0.001462651 3.48E-05 8018 hsa-mir-202 hsa04530 Tight junction 6714_1459_22800_8573_207_208_1460_1457_2770_3265 10 8.74E-05 0.006814556 0.000158478 8019 hsa-mir-202 hsa03050 Proteasome 5705_5701_5702_5719_5710_5698 6 0.000164356 0.01281979 0.000291359 8020 hsa-mir-202 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906_1432_7157_5600_5603 6 0.000353292 0.027556761 0.000612372 8021 hsa-mir-202 hsa04810 Regulation of actin cytoskeleton 6654_9564_1956_8503_22800_5595_5594_56924_5295_5058_3265 11 0.000836141 0.065219021 0.001417805 8022 hsa-mir-202 hsa04115 p53 signaling pathway 595_4193_4616_7249_7157_10912 6 0.000981045 0.076521502 0.001628117 8023 hsa-mir-202 hsa04730 Long-term depression 5592_5595_5594_3480_2770_3265 6 0.00112623 0.087845973 0.001807429 8024 hsa-mir-202 hsa04330 Notch signaling pathway 3065_1387_9612_2033_8850 5 0.001135436 0.088564015 0.001807429 8025 hsa-mir-202 hsa04360 Axon guidance 5998_5595_5594_56924_2932_5058_2770_3265 8 0.001316187 0.102662616 0.002053252 8026 hsa-mir-202 hsa04120 Ubiquitin mediated proteolysis 4214_4193_10401_10273_7329_5371_672_8554 8 0.001876604 0.146375137 0.002870101 8027 hsa-mir-202 hsa05010 Alzheimer's disease 2902_2906_5595_5594_2932_808_351_801_805 9 0.002240974 0.174796006 0.003361462 8028 hsa-mir-202 hsa04270 Vascular smooth muscle contraction 5592_5595_5594_808_801_805_5566 7 0.003034004 0.2366523 0.004465138 8029 hsa-mir-202 hsa04670 Leukocyte transendothelial migration 9564_1432_8503_5295_2770_5600_5603 7 0.003612824 0.281800258 0.005218523 8030 hsa-mir-202 hsa04950 Maturity onset diabetes of the young 3651_3172_5080 3 0.007736592 0.603454174 0.010913076 8031 hsa-mir-202 hsa04070 Phosphatidylinositol signaling system 8503_5295_808_801_805 5 0.007835029 0.61113227 0.010913076 8032 hsa-mir-202 hsa04020 Calcium signaling pathway 1956_2902_2906_2064_808_801_805_5566 8 0.009286869 0.724375802 0.012708347 8033 hsa-mir-202 hsa04612 Antigen processing and presentation 6890_3312_3320_3326_4801 5 0.014324992 1 0.019264645 8034 hsa-mir-202 hsa03410 Base excision repair 4350_3146_6996 3 0.021155856 1 0.027968758 8035 hsa-mir-202 hsa03320 PPAR signaling pathway 2168_6258_6257_6256 4 0.026152582 1 0.033998357 8036 hsa-mir-203 hsa05200 Pathways in cancer 596_598_1017_4193_5578_3091_3065_5925_613_7184_5743_5747_25_6789_4436_2113_861_10401_3716_1147_998_5595_5594_5599_1387_6256_2932_6772_5970_7157_6688_1869_3725_4087_4088_4089_5888_5728_2033_3910_4792_3320_3326_5371_675_5601_5602_1856_51588_4609_1026_2353_8554 53 1.18E-33 1.02E-31 1.02E-31 8037 hsa-mir-203 hsa04110 Cell cycle 1017_4193_902_4171_3065_5925_25_9232_545_995_5347_5591_1387_11200_7534_7532_2932_7027_7157_1869_4085_4087_4088_4089_2033_890_1031_983_8555_1026_1022_1111_8556_472 34 4.24E-29 3.65E-27 1.31E-27 8038 hsa-mir-203 hsa03022 Basal transcription factors 54457_51616_138474_6883_6881_6879_2965_2967_2961_2960_2963_2969_2968_6878_6877_6874_6873_6872_6908_6884_2958_2959_6880_2957_6882 25 4.59E-29 3.94E-27 1.31E-27 8039 hsa-mir-203 hsa04115 p53 signaling pathway 1017_4194_4193_900_50484_6241_51246_545_7161_11200_7157_64326_5728_27113_25898_983_1026_1111_472 19 1.44E-16 1.24E-14 3.09E-15 8040 hsa-mir-203 hsa05215 Prostate cancer 596_1017_4193_5925_7184_1147_5595_5594_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_1026 19 6.65E-15 5.72E-13 9.77E-14 8041 hsa-mir-203 hsa05220 Chronic myeloid leukemia 598_4193_3065_5925_613_25_861_1147_5595_5594_5970_7157_1869_4088_4089_4792_4609_1026 18 7.06E-15 6.07E-13 9.77E-14 8042 hsa-mir-203 hsa05212 Pancreatic cancer 596_1017_4193_5925_7184_1147_5595_5594_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_1026 19 7.96E-15 6.84E-13 9.77E-14 8043 hsa-mir-203 hsa05222 Small cell lung cancer 596_598_1017_5925_5743_5747_10401_1147_6256_5970_7157_1869_5728_3910_4792_51588_4609_8554 18 5.49E-14 4.72E-12 5.90E-13 8044 hsa-mir-203 hsa04310 Wnt signaling pathway 8607_5578_1460_5599_1387_2932_7157_8061_3725_1457_1452_4087_4088_4089_2033_5518_5515_5601_5602_1856_4609_5527 22 7.36E-14 6.33E-12 7.03E-13 8045 hsa-mir-203 hsa05210 Colorectal cancer 596_4436_5595_5594_5599_2932_7157_3725_4087_4088_4089_5601_5602_1856_4609_2353 16 4.90E-12 4.21E-10 4.21E-11 8046 hsa-mir-203 hsa04010 MAPK signaling pathway 5578_5923_3304_3305_3303_6789_1616_1147_998_5595_5594_5599_1386_3312_3315_1649_5970_3164_7157_3725_3727_5601_5602_4609_2353 25 1.64E-11 1.41E-09 1.28E-10 8047 hsa-mir-203 hsa04350 TGF-beta signaling pathway 6667_3399_3398_5595_5594_1387_7027_4087_4088_4089_2033_5518_5515_4609 14 7.61E-10 6.54E-08 5.45E-09 8048 hsa-mir-203 hsa03420 Nucleotide excision repair 902_5887_2965_2967_2968_4331_2071_2074_1022_6117 10 1.17E-08 1.00E-06 7.71E-08 8049 hsa-mir-203 hsa04120 Ubiquitin mediated proteolysis 4193_3093_7319_84447_10401_7329_10055_64326_7337_5371_672_25898_51588_10075_8554 15 2.64E-08 2.27E-06 1.62E-07 8050 hsa-mir-203 hsa04620 Toll-like receptor signaling pathway 3454_3455_1147_5595_5594_5599_6772_5970_3725_4792_5601_5602_2353 13 3.81E-08 3.27E-06 2.18E-07 8051 hsa-mir-203 hsa04012 ErbB signaling pathway 5578_5747_25_5595_5594_5599_2932_3725_5601_5602_4609_1026 12 5.81E-08 5.00E-06 3.12E-07 8052 hsa-mir-203 hsa04630 Jak-STAT signaling pathway 598_3454_3455_10401_3717_3716_1387_6778_6772_7297_2033_51588_4609_8554_10379 15 9.87E-08 8.49E-06 4.99E-07 8053 hsa-mir-203 hsa04920 Adipocytokine signaling pathway 6794_3717_1147_5599_6256_5970_4792_5601_5602_5563 10 3.86E-07 3.32E-05 1.85E-06 8054 hsa-mir-203 hsa05219 Bladder cancer 4193_5925_5595_5594_7157_1869_4609_1026 8 1.12E-06 9.66E-05 5.08E-06 8055 hsa-mir-203 hsa04520 Adherens junction 1460_998_5595_5594_1387_1457_4087_4088_4089_2033 10 1.68E-06 0.000144173 7.21E-06 8056 hsa-mir-203 hsa05214 Glioma 4193_5578_5925_5595_5594_7157_1869_5728_1026 9 2.59E-06 0.000223097 1.06E-05 8057 hsa-mir-203 hsa04510 Focal adhesion 596_5578_5923_5747_5499_998_5595_5594_5599_2932_3725_5728_3910_5601_5602 15 2.82E-06 0.000242194 1.10E-05 8058 hsa-mir-203 hsa04660 T cell receptor signaling pathway 1147_998_5595_5594_2932_5970_3725_959_4792_5601_2353 11 3.76E-06 0.000323681 1.41E-05 8059 hsa-mir-203 hsa05223 Non-small cell lung cancer 5578_5925_6789_5595_5594_6256_7157_1869 8 5.99E-06 0.000515126 2.15E-05 8060 hsa-mir-203 hsa04662 B cell receptor signaling pathway 1147_5595_5594_1380_2932_5970_3725_4792_2353 9 7.51E-06 0.000646185 2.58E-05 8061 hsa-mir-203 hsa05221 Acute myeloid leukemia 861_1147_5595_5594_5970_6688_5371_4609 8 1.08E-05 0.000927331 3.57E-05 8062 hsa-mir-203 hsa04612 Antigen processing and presentation 3309_3304_3305_3303_3312_3320_3326_4800_4801 9 2.64E-05 0.002272173 8.42E-05 8063 hsa-mir-203 hsa05218 Melanoma 4193_5925_5595_5594_7157_1869_5728_1026 8 3.65E-05 0.003142906 0.000108376 8064 hsa-mir-203 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_998_5599_5970_3725_4792_5601_5602 8 3.65E-05 0.003142906 0.000108376 8065 hsa-mir-203 hsa05211 Renal cell carcinoma 3091_2113_998_5595_5594_1387_3725_2033 8 4.00E-05 0.003444291 0.00011481 8066 hsa-mir-203 hsa05016 Huntington's disease 3065_3064_25942_6667_1387_9001_5430_7157_2033_27113_6874_6908 12 9.11E-05 0.007838479 0.000252854 8067 hsa-mir-203 hsa04062 Chemokine signaling pathway 5747_7852_6362_3717_1147_998_5595_5594_2932_6772_5970_4792 12 0.000115157 0.009903461 0.000309483 8068 hsa-mir-203 hsa04210 Apoptosis 596_598_823_1147_5970_7157_4792_472 8 0.000158006 0.013588532 0.000411774 8069 hsa-mir-203 hsa05216 Thyroid cancer 5595_5594_6256_7157_4609 5 0.000186279 0.016020033 0.000471177 8070 hsa-mir-203 hsa03050 Proteasome 5705_5701_5702_5719_5710_5717 6 0.00020812 0.017898333 0.000511381 8071 hsa-mir-203 hsa05213 Endometrial cancer 5595_5594_2932_7157_5728_4609 6 0.000309233 0.026594025 0.000738723 8072 hsa-mir-203 hsa04370 VEGF signaling pathway 5578_5743_5747_998_5595_5594_3315 7 0.000380227 0.032699479 0.00088377 8073 hsa-mir-203 hsa05131 Shigellosis 5578_10382_25_998_7534_4691 6 0.000445323 0.038297811 0.000981995 8074 hsa-mir-203 hsa05130 Pathogenic Escherichia coli infection 5578_10382_25_998_7534_4691 6 0.000445323 0.038297811 0.000981995 8075 hsa-mir-203 hsa04912 GnRH signaling pathway 5578_998_5595_5594_5599_3725_5601_5602 8 0.000535197 0.046026912 0.001150673 8076 hsa-mir-203 hsa04910 Insulin signaling pathway 5499_5211_5595_5594_5599_2932_5601_5602_5563 9 0.000585088 0.050317542 0.001227257 8077 hsa-mir-203 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601_5602 5 0.001152469 0.099112303 0.002359817 8078 hsa-mir-203 hsa04330 Notch signaling pathway 3065_1387_2033_8850_1856 5 0.001377578 0.118471668 0.002755155 8079 hsa-mir-203 hsa03440 Homologous recombination 641_5888_675_6117 4 0.001574996 0.135449651 0.003078401 8080 hsa-mir-203 hsa04360 Axon guidance 5747_25_7852_998_5595_5594_2932_1020 8 0.001732093 0.148960011 0.003310222 8081 hsa-mir-203 hsa04720 Long-term potentiation 5578_5499_5595_5594_1387_2033 6 0.001827452 0.157160899 0.003416541 8082 hsa-mir-203 hsa04916 Melanogenesis 5578_5595_5594_1387_2932_2033_1856 7 0.001980818 0.170350308 0.003624475 8083 hsa-mir-203 hsa04150 mTOR signaling pathway 6794_3091_5595_5594_5563 5 0.002080624 0.178933689 0.003727785 8084 hsa-mir-203 hsa04530 Tight junction 5578_1460_998_1457_5728_5518_5515_5520 8 0.002257674 0.194160002 0.003962449 8085 hsa-mir-203 hsa04664 Fc epsilon RI signaling pathway 5578_5595_5594_5599_5601_5602 6 0.002335945 0.200891242 0.004017825 8086 hsa-mir-203 hsa03030 DNA replication 4171_5557_6117_5422 4 0.003623548 0.311625111 0.005992791 8087 hsa-mir-203 hsa03410 Base excision repair 3146_142_4913_328 4 0.003623548 0.311625111 0.005992791 8088 hsa-mir-203 hsa04540 Gap junction 5578_10382_5595_5594_1453_983 6 0.004977097 0.428030341 0.008076044 8089 hsa-mir-203 hsa04730 Long-term depression 5578_5595_5594_5518_5515 5 0.007192199 0.618529137 0.011454243 8090 hsa-mir-203 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_1616_7157 4 0.015105756 1 0.023619909 8091 hsa-mir-203 hsa03450 Non-homologous end-joining 2547_5591 2 0.025961168 1 0.039868936 8092 hsa-mir-204 hsa05200 Pathways in cancer 3320_5595_5599_1387_5601_1488_6772_1487_2735_2736_2737_4087_4088_4089_2033_836_7186 17 1.04E-14 6.53E-13 6.53E-13 8093 hsa-mir-204 hsa04310 Wnt signaling pathway 815_5599_1387_5601_1488_1457_1487_4087_4088_4089_2033 11 2.02E-11 1.27E-09 6.37E-10 8094 hsa-mir-204 hsa03022 Basal transcription factors 6879_6908_6872_2958_2959_6880 6 1.07E-08 6.75E-07 2.25E-07 8095 hsa-mir-204 hsa04110 Cell cycle 5591_1387_7534_7531_4087_4088_4089_2033 8 2.13E-08 1.34E-06 3.36E-07 8096 hsa-mir-204 hsa04520 Adherens junction 5595_1387_1457_4087_4088_4089_2033 7 3.09E-08 1.95E-06 3.89E-07 8097 hsa-mir-204 hsa05210 Colorectal cancer 5595_5599_5601_4087_4088_4089_836 7 4.23E-08 2.66E-06 4.44E-07 8098 hsa-mir-204 hsa04010 MAPK signaling pathway 5595_5599_5598_5601_3303_3312_1432_836_7186 9 9.19E-07 5.79E-05 8.27E-06 8099 hsa-mir-204 hsa04350 TGF-beta signaling pathway 5595_1387_4087_4088_4089_2033 6 1.16E-06 7.28E-05 9.11E-06 8100 hsa-mir-204 hsa04912 GnRH signaling pathway 815_5595_5599_5598_5601_1432 6 3.80E-06 0.000239685 2.66E-05 8101 hsa-mir-204 hsa05220 Chronic myeloid leukemia 5595_1488_1487_4088_4089 5 1.10E-05 0.000691756 6.92E-05 8102 hsa-mir-204 hsa03450 Non-homologous end-joining 5591_7520_2547 3 3.02E-05 0.001905358 0.000159435 8103 hsa-mir-204 hsa04930 Type II diabetes mellitus 3651_5595_5599_5601 4 3.04E-05 0.001913222 0.000159435 8104 hsa-mir-204 hsa04330 Notch signaling pathway 1387_1488_1487_2033 4 3.56E-05 0.002244052 0.000172619 8105 hsa-mir-204 hsa04620 Toll-like receptor signaling pathway 5595_5599_5601_1432_6772 5 4.49E-05 0.002831056 0.000202218 8106 hsa-mir-204 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5601_1432_836 4 0.000162067 0.01021025 0.000680683 8107 hsa-mir-204 hsa04720 Long-term potentiation 815_5595_1387_2033 4 0.000198131 0.01248224 0.00078014 8108 hsa-mir-204 hsa04664 Fc epsilon RI signaling pathway 5595_5599_5601_1432 4 0.000239648 0.015097806 0.000888106 8109 hsa-mir-204 hsa04012 ErbB signaling pathway 815_5595_5599_5601 4 0.000340902 0.021476811 0.001166623 8110 hsa-mir-204 hsa05215 Prostate cancer 3320_5595_1387_2033 4 0.000355411 0.022390885 0.001166623 8111 hsa-mir-204 hsa05212 Pancreatic cancer 3320_5595_1387_2033 4 0.000370357 0.023332466 0.001166623 8112 hsa-mir-204 hsa05010 Alzheimer's disease 5595_1020_840_836_10476 5 0.000537042 0.033833659 0.001611127 8113 hsa-mir-204 hsa04916 Melanogenesis 815_5595_1387_2033 4 0.000652122 0.041083675 0.00186744 8114 hsa-mir-204 hsa05016 Huntington's disease 1387_6908_2033_836_10476 5 0.000700159 0.044110005 0.001917826 8115 hsa-mir-204 hsa05217 Basal cell carcinoma 2735_2736_2737 3 0.001232051 0.077619237 0.003234135 8116 hsa-mir-204 hsa04340 Hedgehog signaling pathway 2735_2736_2737 3 0.001359227 0.08563132 0.003425253 8117 hsa-mir-204 hsa04530 Tight junction 4628_60412_8189_1457 4 0.001752569 0.110411863 0.00424661 8118 hsa-mir-204 hsa04920 Adipocytokine signaling pathway 5599_5601_7186 3 0.002118079 0.133438985 0.004942185 8119 hsa-mir-204 hsa05211 Renal cell carcinoma 5595_1387_2033 3 0.002578822 0.162465816 0.005802351 8120 hsa-mir-204 hsa04950 Maturity onset diabetes of the young 3651_5080 2 0.003987569 0.251216845 0.00866265 8121 hsa-mir-204 hsa04612 Antigen processing and presentation 3320_3303_3312 3 0.00458773 0.289026966 0.009323451 8122 hsa-mir-204 hsa04210 Apoptosis 840_836_7186 3 0.00458773 0.289026966 0.009323451 8123 hsa-mir-204 hsa04660 T cell receptor signaling pathway 5595_5601_1432 3 0.008098483 0.510204404 0.015943888 8124 hsa-mir-204 hsa04910 Insulin signaling pathway 5595_5599_5601 3 0.01471024 0.926745151 0.028083186 8125 hsa-mir-204 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_836 2 0.018814396 1 0.034861968 8126 hsa-mir-204 hsa04630 Jak-STAT signaling pathway 1387_6772_2033 3 0.019855076 1 0.035739138 8127 hsa-mir-204 hsa05214 Glioma 815_5595 2 0.024642719 1 0.043124759 8128 hsa-mir-204 hsa04370 VEGF signaling pathway 5595_1432 2 0.033394248 1 0.056860477 8129 hsa-mir-204 hsa04062 Chemokine signaling pathway 5595_2931_6772 3 0.034503711 1 0.057203521 8130 hsa-mir-204 hsa04510 Focal adhesion 5595_5599_5601 3 0.040504982 1 0.065431124 8131 hsa-mir-204 hsa04540 Gap junction 5595_5598 2 0.046634511 1 0.073449355 8132 hsa-mir-205 hsa04520 Adherens junction 4301_4087_7046 3 6.35E-05 0.001396103 0.001396103 8133 hsa-mir-205 hsa05200 Pathways in cancer 4087_5925_7046_6772 4 0.000254999 0.005609981 0.00280499 8134 hsa-mir-205 hsa05220 Chronic myeloid leukemia 5925_7046 2 0.002349537 0.051689821 0.013740597 8135 hsa-mir-205 hsa05210 Colorectal cancer 4087_7046 2 0.002919758 0.064234684 0.013740597 8136 hsa-mir-205 hsa04350 TGF-beta signaling pathway 4087_7046 2 0.003122863 0.068702987 0.013740597 8137 hsa-mir-205 hsa04110 Cell cycle 4087_5925 2 0.005684096 0.125050113 0.020841685 8138 hsa-mir-205 hsa03410 Base excision repair 3146 1 0.033948318 0.746862998 0.106694714 8139 hsa-mir-205 hsa05219 Bladder cancer 5925 1 0.039347665 0.865648632 0.108206079 8140 hsa-mir-206 hsa05200 Pathways in cancer 4087_5925_2033_7046_3725_6772_1387_7186 8 3.08E-08 1.11E-06 1.11E-06 8141 hsa-mir-206 hsa04520 Adherens junction 4301_4087_2033_7046_1387 5 1.60E-07 5.77E-06 2.88E-06 8142 hsa-mir-206 hsa04010 MAPK signaling pathway 3303_468_7046_3725_3727_7186 6 3.19E-06 0.000114843 3.83E-05 8143 hsa-mir-206 hsa04350 TGF-beta signaling pathway 4087_2033_7046_1387 4 9.74E-06 0.000350766 6.37E-05 8144 hsa-mir-206 hsa05215 Prostate cancer 5925_2033_468_1387 4 1.02E-05 0.00036632 6.37E-05 8145 hsa-mir-206 hsa05212 Pancreatic cancer 5925_2033_468_1387 4 1.06E-05 0.000382376 6.37E-05 8146 hsa-mir-206 hsa04110 Cell cycle 4087_5925_2033_1387 4 3.20E-05 0.001151613 0.000164516 8147 hsa-mir-206 hsa04310 Wnt signaling pathway 4087_2033_3725_1387 4 8.08E-05 0.002907402 0.000363425 8148 hsa-mir-206 hsa05211 Renal cell carcinoma 2033_3725_1387 3 0.000183836 0.006618081 0.000735342 8149 hsa-mir-206 hsa04720 Long-term potentiation 2033_468_1387 3 0.000206482 0.007433357 0.000743336 8150 hsa-mir-206 hsa05210 Colorectal cancer 4087_7046_3725 3 0.000285056 0.010262029 0.000932912 8151 hsa-mir-206 hsa04630 Jak-STAT signaling pathway 2033_6772_1387 3 0.001613462 0.058084625 0.004840385 8152 hsa-mir-206 hsa04330 Notch signaling pathway 2033_1387 2 0.002359579 0.084944836 0.006534218 8153 hsa-mir-206 hsa05220 Chronic myeloid leukemia 5925_7046 2 0.005720396 0.20593427 0.014709591 8154 hsa-mir-206 hsa05222 Small cell lung cancer 5925_7186 2 0.007408023 0.266688811 0.017779254 8155 hsa-mir-206 hsa04210 Apoptosis 823_7186 2 0.007902768 0.284499646 0.017781228 8156 hsa-mir-206 hsa04620 Toll-like receptor signaling pathway 3725_6772 2 0.010212875 0.367663516 0.021183634 8157 hsa-mir-206 hsa04916 Melanogenesis 2033_1387 2 0.010591817 0.381305409 0.021183634 8158 hsa-mir-206 hsa04912 GnRH signaling pathway 468_3725 2 0.011368171 0.409254165 0.021539693 8159 hsa-mir-206 hsa05010 Alzheimer's disease 9451_823 2 0.028351471 1 0.051032647 8160 hsa-mir-206 hsa05016 Huntington's disease 2033_1387 2 0.031632988 1 0.05422798 8161 hsa-mir-208a hsa05200 Pathways in cancer 4824_1499_5914_595_596_598_1017_4193_5578_3091_2064_3065_5925_613_7184_5743_5747_25_405_1956_2308_6789_8503_4436_2885_862_6502_207_208_1147_3725_998_1026_367_5595_5594_5599_6258_1387_6256_836_10401_2932_5970_6654_7157_6688_7704_1869_6776_4087_4088_4089_5295_5888_5728_2033_3480_3910_898_4790_4792_3320_3326_5371_675_8031_5601_5602_1856_842_841_6257_51588_4609_1029_2353_8554 78 2.70E-43 2.41E-41 2.41E-41 8162 hsa-mir-208a hsa04110 Cell cycle 4171_595_1017_5001_4193_902_4174_4172_4173_994_3065_4616_5925_25_8379_9232_7533_6502_545_995_1026_5591_1387_11200_7534_7532_2932_7027_7157_10912_1869_4087_4088_4089_2033_890_898_1031_983_4085_5347_1022_1029_1111_8556_8555_472_4998_4999 49 6.53E-37 5.82E-35 2.91E-35 8163 hsa-mir-208a hsa05215 Prostate cancer 4824_1499_595_596_1017_4193_2064_5925_7184_1956_2308_8503_2885_207_208_1147_1026_367_5595_5594_1385_1387_2932_5970_6654_7157_1869_5295_5728_2033_3480_898_4790_4792_3320_3326_842 37 2.01E-28 1.79E-26 5.96E-27 8164 hsa-mir-208a hsa05212 Pancreatic cancer 4824_1499_595_596_1017_4193_2064_5925_7184_1956_2308_8503_2885_207_208_1147_1026_367_5595_5594_1385_1387_2932_5970_6654_7157_1869_5295_5728_2033_3480_898_4790_4792_3320_3326_842 37 2.77E-28 2.47E-26 6.17E-27 8165 hsa-mir-208a hsa03022 Basal transcription factors 54457_6879_51616_138474_6883_6881_2965_2967_2961_2960_2963_2962_2969_2968_6878_6877_6874_6873_6872_6908_6884_2958_2959_6880_2957_6882 26 1.10E-24 9.81E-23 1.96E-23 8166 hsa-mir-208a hsa04010 MAPK signaling pathway 6722_3727_6195_6197_4214_7867_5578_5058_994_4616_5923_1956_3304_3305_3303_6789_1432_627_2885_2872_207_208_1147_3725_998_5595_5594_5599_5598_1386_836_3312_3315_5970_6654_3164_7157_10912_4790_1616_9261_4208_5601_5602_5566_4609_2353_2002_2005 49 5.01E-23 4.46E-21 7.43E-22 8167 hsa-mir-208a hsa04115 p53 signaling pathway 595_1017_4194_4193_900_4616_50484_6241_51246_545_1026_7161_11200_836_7249_7157_10912_64326_5728_898_27113_25898_983_842_841_1029_1111_472 28 1.69E-21 1.51E-19 2.15E-20 8168 hsa-mir-208a hsa05220 Chronic myeloid leukemia 595_598_4193_3065_5925_613_25_8503_2885_207_208_1147_1026_5595_5594_5970_6654_7157_1869_6776_4088_4089_5295_4790_4792_4609_1029_6464 28 1.03E-20 9.19E-19 1.15E-19 8169 hsa-mir-208a hsa05222 Small cell lung cancer 595_596_598_1017_5925_5743_5747_8503_6502_207_208_1147_6258_6256_10401_5970_7157_1869_5295_5728_3910_898_4790_4792_842_6257_51588_4609_8554 29 2.10E-20 1.87E-18 2.08E-19 8170 hsa-mir-208a hsa05210 Colorectal cancer 1499_595_596_1956_8503_4436_2885_207_208_3725_5595_5594_5599_836_2932_6654_7157_4087_4088_4089_5295_3480_5601_5602_1856_842_4609_2353 28 1.23E-19 1.09E-17 1.09E-18 8171 hsa-mir-208a hsa04012 ErbB signaling pathway 815_5578_2064_5058_5747_25_1956_6714_56924_8503_2885_207_208_3725_1026_5595_5594_5599_2932_6654_6776_5295_5601_5602_4609_2002_6464 27 2.51E-18 2.23E-16 2.03E-17 8172 hsa-mir-208a hsa05214 Glioma 815_595_4193_5578_5925_1956_8503_2885_207_208_1026_5595_5594_6654_7157_1869_5295_5728_3480_808_801_805_1029_6464 24 7.36E-18 6.55E-16 5.46E-17 8173 hsa-mir-208a hsa05223 Non-small cell lung cancer 595_5578_2064_5925_1956_2309_6789_8503_2885_207_208_5595_5594_6258_6256_6654_7157_1869_5295_842_6257_1029 22 3.26E-17 2.90E-15 2.23E-16 8174 hsa-mir-208a hsa04510 Focal adhesion 1499_595_596_5578_2064_5058_5923_5747_1956_6714_56924_5499_8503_2885_207_208_3725_998_5595_5594_5599_2932_6654_9564_5295_5728_3480_3910_5601_5602_857_2002_6464 33 1.14E-14 1.01E-12 7.23E-14 8175 hsa-mir-208a hsa05213 Endometrial cancer 1499_595_2064_1956_2309_8503_2885_207_208_5595_5594_2932_6654_7157_5295_5728_842_4609_2002 19 2.34E-14 2.08E-12 1.39E-13 8176 hsa-mir-208a hsa04910 Insulin signaling pathway 10891_6720_5770_5499_2308_8503_2885_5211_2872_207_208_5595_5594_5599_7249_2932_6654_5295_808_801_805_5601_5602_5566_5563_2002_6464 27 4.51E-14 4.02E-12 2.51E-13 8177 hsa-mir-208a hsa05221 Acute myeloid leukemia 5914_595_8503_2885_862_207_208_1147_5595_5594_5970_6654_6688_7704_6776_5295_4790_5371_4609 19 1.52E-13 1.35E-11 7.95E-13 8178 hsa-mir-208a hsa04660 T cell receptor signaling pathway 5777_5058_3932_56924_1432_8503_2885_207_208_1147_3725_998_5595_5594_2932_5970_6654_5295_959_4790_4792_5601_2353 23 1.03E-12 9.19E-11 5.10E-12 8179 hsa-mir-208a hsa04310 Wnt signaling pathway 815_1499_595_5578_3725_1460_5599_1387_2932_7157_1457_1452_4087_4088_4089_2033_8607_5518_5515_5601_5602_5566_1856_4609_5527 25 1.14E-11 1.02E-09 5.35E-11 8180 hsa-mir-208a hsa04912 GnRH signaling pathway 815_4214_5578_1956_6714_1432_2885_3725_998_5595_5594_5599_5598_6654_808_801_805_5601_5602_5566_2002 21 3.29E-11 2.93E-09 1.46E-10 8181 hsa-mir-208a hsa04210 Apoptosis 596_598_823_8503_207_208_1147_836_839_5970_7157_5295_4790_4792_5566_842_841_840_472 19 7.06E-11 6.28E-09 2.99E-10 8182 hsa-mir-208a hsa04662 B cell receptor signaling pathway 5777_8503_2885_207_208_1147_3725_5595_5594_1380_2932_5970_6654_5295_4790_4792_2353 17 3.17E-10 2.82E-08 1.28E-09 8183 hsa-mir-208a hsa04520 Adherens junction 1499_5770_5777_2064_1956_6714_1460_998_5595_5594_1387_1457_4087_4088_4089_2033_3480 17 7.50E-10 6.67E-08 2.90E-09 8184 hsa-mir-208a hsa05218 Melanoma 595_4193_5925_1956_8503_207_208_1026_5595_5594_7157_1869_5295_5728_3480_1029 16 1.13E-09 1.01E-07 4.19E-09 8185 hsa-mir-208a hsa05211 Renal cell carcinoma 3091_5058_405_56924_8503_2885_207_208_3725_998_5595_5594_1387_6654_5295_2033 16 1.35E-09 1.20E-07 4.80E-09 8186 hsa-mir-208a hsa04370 VEGF signaling pathway 7867_5578_5743_5747_6714_1432_8503_207_208_998_5595_5594_3315_5295_9261_842 16 3.13E-09 2.79E-07 1.07E-08 8187 hsa-mir-208a hsa04920 Adipocytokine signaling pathway 10891_6794_207_208_1147_5599_6258_6256_5970_4790_4792_5601_5602_5563_6257 15 4.03E-09 3.59E-07 1.33E-08 8188 hsa-mir-208a hsa04350 TGF-beta signaling pathway 3397_3398_3400_6667_3399_5595_5594_1387_7027_4087_4088_4089_2033_5518_5515_4609 16 1.44E-08 1.28E-06 4.44E-08 8189 hsa-mir-208a hsa05219 Bladder cancer 595_4193_2064_5925_1956_1026_5595_5594_7157_1869_4609_1029 12 1.45E-08 1.29E-06 4.44E-08 8190 hsa-mir-208a hsa04620 Toll-like receptor signaling pathway 1432_8503_207_208_1147_3725_5595_5594_5599_5970_5295_4790_4792_5601_5602_841_2353 17 1.87E-08 1.67E-06 5.56E-08 8191 hsa-mir-208a hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5058_1956_6714_1432_1147_3725_998_5599_836_5970_4790_4792_5601_5602 14 5.35E-08 4.77E-06 1.50E-07 8192 hsa-mir-208a hsa05216 Thyroid cancer 1499_595_5595_5594_6258_6256_7157_8031_6257_4609 10 5.38E-08 4.79E-06 1.50E-07 8193 hsa-mir-208a hsa04062 Chemokine signaling pathway 5058_5747_2309_8503_2885_6362_207_208_1147_998_5595_5594_2932_5970_6654_9564_5295_4790_4792_2770_5566_6464 22 8.31E-08 7.40E-06 2.24E-07 8194 hsa-mir-208a hsa04150 mTOR signaling pathway 6794_6195_6197_3091_8503_207_208_5595_5594_7249_5295_5563 12 1.09E-07 9.67E-06 2.84E-07 8195 hsa-mir-208a hsa04120 Ubiquitin mediated proteolysis 4214_4193_3093_7319_84447_10273_7329_6502_10055_10401_64326_7337_5371_672_25898_10075_51588_8554 18 2.26E-07 2.02E-05 5.76E-07 8196 hsa-mir-208a hsa04720 Long-term potentiation 815_6195_6197_5578_5499_5595_5594_1387_2033_808_801_805_5566 13 5.90E-07 5.25E-05 1.46E-06 8197 hsa-mir-208a hsa04916 Melanogenesis 815_1499_5578_5595_5594_1385_1387_2932_2033_808_801_805_2770_5566_1856 15 6.73E-07 5.99E-05 1.62E-06 8198 hsa-mir-208a hsa04664 Fc epsilon RI signaling pathway 5578_1432_8503_2885_207_208_5595_5594_5599_6654_5295_5601_5602 13 9.95E-07 8.85E-05 2.33E-06 8199 hsa-mir-208a hsa03420 Nucleotide excision repair 2071_902_5887_2965_2967_2968_4331_2074_1022_6117 10 1.41E-06 0.000125631 3.22E-06 8200 hsa-mir-208a hsa05016 Huntington's disease 10891_3065_3064_25942_6667_627_1385_1387_836_9001_5430_7157_2033_27113_6874_6908_842_841_4697 19 3.22E-06 0.000286347 7.16E-06 8201 hsa-mir-208a hsa04540 Gap junction 5578_10382_1956_6714_2885_5595_5594_5598_6654_1453_2770_983_5566 13 5.04E-06 0.000448292 1.09E-05 8202 hsa-mir-208a hsa04630 Jak-STAT signaling pathway 595_598_5777_8503_2885_207_208_1387_10401_6654_6776_5295_2033_51588_4609_8554 16 1.48E-05 0.001321069 3.15E-05 8203 hsa-mir-208a hsa04612 Antigen processing and presentation 6890_3309_3304_3305_3303_1385_3312_3320_3326_4800_4801 11 7.36E-05 0.006552851 0.000152127 8204 hsa-mir-208a hsa04930 Type II diabetes mellitus 8503_3651_5595_5594_5599_5295_5601_5602 8 7.52E-05 0.006693605 0.000152127 8205 hsa-mir-208a hsa03030 DNA replication 4171_4174_4172_4173_5557_6117_5422 7 0.000129584 0.011532958 0.000256288 8206 hsa-mir-208a hsa04530 Tight junction 1499_5578_6714_207_208_1460_998_1457_5728_5518_5515_2770_5520 13 0.000198864 0.017698935 0.000384759 8207 hsa-mir-208a hsa04330 Notch signaling pathway 9612_3065_1387_2033_8850_1856_388585 7 0.000552882 0.04920651 0.001046947 8208 hsa-mir-208a hsa03050 Proteasome 5705_5701_5702_5719_5717_5710_5698 7 0.000619133 0.055102819 0.001147975 8209 hsa-mir-208a hsa05010 Alzheimer's disease 823_22926_5595_5594_836_2932_808_801_805_842_841_840_1020_4697 14 0.00064086 0.05703651 0.00116401 8210 hsa-mir-208a hsa04650 Natural killer cell mediated cytotoxicity 5777_5578_5058_3932_8503_2885_5595_5594_836_6654_5295_6464 12 0.000711749 0.063345635 0.001266913 8211 hsa-mir-208a hsa03410 Base excision repair 3146_4350_142_4913_328_6996 6 0.000812046 0.072272133 0.001417101 8212 hsa-mir-208a hsa04950 Maturity onset diabetes of the young 5080_3651_3172_168620_4760 5 0.000924972 0.082322524 0.001583125 8213 hsa-mir-208a hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_1432_836_7157_1616_842 7 0.001405331 0.125074471 0.002274081 8214 hsa-mir-208a hsa05131 Shigellosis 1499_5578_10382_25_998_7534_4691 7 0.001405331 0.125074471 0.002274081 8215 hsa-mir-208a hsa05130 Pathogenic Escherichia coli infection 1499_5578_10382_25_998_7534_4691 7 0.001405331 0.125074471 0.002274081 8216 hsa-mir-208a hsa04360 Axon guidance 5058_5747_25_56924_998_5595_5594_2932_5998_2770_1020 11 0.00151807 0.135108212 0.002412647 8217 hsa-mir-208a hsa04730 Long-term depression 5578_5595_5594_3480_5518_5515_2770 7 0.004767605 0.42431683 0.007444155 8218 hsa-mir-208a hsa04070 Phosphatidylinositol signaling system 5578_8503_5295_5728_808_801_805 7 0.006689392 0.595355931 0.010264757 8219 hsa-mir-208a hsa04670 Leukocyte transendothelial migration 1499_5578_5747_1432_8503_998_9564_5295_2770 9 0.008566143 0.762386736 0.012921809 8220 hsa-mir-208a hsa03440 Homologous recombination 641_5888_675_6117 4 0.009937552 0.884442109 0.014740702 8221 hsa-mir-208a hsa04270 Vascular smooth muscle contraction 5578_5499_5595_5594_808_801_805_5566 8 0.019747596 1 0.028812066 8222 hsa-mir-208a hsa04810 Regulation of actin cytoskeleton 5058_5747_1956_56924_5499_8503_998_5595_5594_6654_9564_5295 12 0.035766743 1 0.051342583 8223 hsa-mir-208b hsa04110 Cell cycle 1869_25_5925_545_995_993_1026_1031_5591_1387_983_4088_7534_1017_2932_4193_7027_902_4087_9232_5347_1022_3065_7532_1111_2033_890_11200_8556_8555_472 31 3.54E-30 3.01E-28 3.01E-28 8224 hsa-mir-208b hsa05200 Pathways in cancer 1147_1869_5743_3326_5747_25_5925_675_998_1026_5594_5595_5599_1387_596_5601_6789_1856_4088_613_1017_2932_4193_5578_51588_8554_5371_6256_4436_3320_598_4087_3065_5888_5728_3091_2033_3910_4792_5602_7186 41 3.32E-28 2.82E-26 1.41E-26 8225 hsa-mir-208b hsa04115 p53 signaling pathway 545_6241_1026_25898_50484_983_1017_27113_4194_4193_900_7161_64326_5728_51246_1111_11200_472 18 4.98E-18 4.23E-16 1.41E-16 8226 hsa-mir-208b hsa05215 Prostate cancer 1147_1869_3326_5925_1026_5594_5595_1387_596_1017_2932_4193_3320_5728_2033_4792 16 4.95E-14 4.21E-12 9.83E-13 8227 hsa-mir-208b hsa05212 Pancreatic cancer 1147_1869_3326_5925_1026_5594_5595_1387_596_1017_2932_4193_3320_5728_2033_4792 16 5.78E-14 4.91E-12 9.83E-13 8228 hsa-mir-208b hsa05222 Small cell lung cancer 1147_1869_5743_5747_5925_596_1017_51588_8554_6256_598_5728_3910_4792_7186 15 5.27E-13 4.48E-11 7.47E-12 8229 hsa-mir-208b hsa05220 Chronic myeloid leukemia 1147_1869_25_5925_1026_5594_5595_4088_613_4193_598_3065_4792 13 2.05E-11 1.74E-09 2.48E-10 8230 hsa-mir-208b hsa04310 Wnt signaling pathway 1460_5518_5515_5599_1387_5601_1856_1457_4088_2932_5578_4087_1452_5527_2033_5602 16 8.98E-11 7.63E-09 9.54E-10 8231 hsa-mir-208b hsa04120 Ubiquitin mediated proteolysis 10055_672_7319_25898_84447_4193_3093_51588_8554_5371_64326_7329_10075_7337 14 2.31E-09 1.96E-07 2.18E-08 8232 hsa-mir-208b hsa05210 Colorectal cancer 5594_5595_5599_596_5601_1856_4088_2932_4436_4087_5602 11 1.04E-08 8.81E-07 8.81E-08 8233 hsa-mir-208b hsa04010 MAPK signaling pathway 1147_998_5594_5595_5599_5601_3304_3305_3303_6789_3315_5578_3164_1616_5923_5602_7186 17 3.88E-08 3.29E-06 2.99E-07 8234 hsa-mir-208b hsa04350 TGF-beta signaling pathway 5518_5515_5594_5595_1387_6667_4088_7027_4087_2033 10 1.49E-07 1.27E-05 9.76E-07 8235 hsa-mir-208b hsa04012 ErbB signaling pathway 5747_25_1026_5594_5595_5599_5601_2932_5578_5602 10 1.49E-07 1.27E-05 9.76E-07 8236 hsa-mir-208b hsa04920 Adipocytokine signaling pathway 1147_5563_6794_5599_5601_6256_4792_5602_7186 9 1.89E-07 1.61E-05 1.15E-06 8237 hsa-mir-208b hsa04510 Focal adhesion 5747_998_5594_5595_5599_596_5601_5499_2932_5578_5728_5923_3910_5602 14 2.30E-07 1.95E-05 1.30E-06 8238 hsa-mir-208b hsa03022 Basal transcription factors 2965_2957_2959_6908_51616_2958_6880 7 5.71E-07 4.85E-05 3.03E-06 8239 hsa-mir-208b hsa04520 Adherens junction 1460_998_5594_5595_1387_1457_4088_4087_2033 9 7.43E-07 6.32E-05 3.72E-06 8240 hsa-mir-208b hsa03420 Nucleotide excision repair 2965_4331_6117_2071_902_2074_1022 7 1.61E-06 0.000137091 7.47E-06 8241 hsa-mir-208b hsa05214 Glioma 1869_5925_1026_5594_5595_4193_5578_5728 8 1.67E-06 0.000141974 7.47E-06 8242 hsa-mir-208b hsa05223 Non-small cell lung cancer 1869_5925_5594_5595_6789_5578_6256 7 5.52E-06 0.00046922 2.35E-05 8243 hsa-mir-208b hsa05219 Bladder cancer 1869_5925_1026_5594_5595_4193 6 1.59E-05 0.001351504 6.44E-05 8244 hsa-mir-208b hsa04330 Notch signaling pathway 1387_1856_9612_3065_2033_8850 6 2.84E-05 0.002411872 0.000104937 8245 hsa-mir-208b hsa05218 Melanoma 1869_5925_1026_5594_5595_4193_5728 7 2.84E-05 0.00241356 0.000104937 8246 hsa-mir-208b hsa04370 VEGF signaling pathway 5743_5747_998_5594_5595_3315_5578 7 4.60E-05 0.003906655 0.000162777 8247 hsa-mir-208b hsa04660 T cell receptor signaling pathway 1147_998_5594_5595_5601_2932_959_4792 8 5.87E-05 0.004989469 0.000199579 8248 hsa-mir-208b hsa04612 Antigen processing and presentation 3326_3309_3304_3305_3303_1514_3320 7 0.000107824 0.009165048 0.000339446 8249 hsa-mir-208b hsa04210 Apoptosis 1147_823_596_598_4792_472_7186 7 0.000107824 0.009165048 0.000339446 8250 hsa-mir-208b hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_998_5599_5601_4792_5602 6 0.000233808 0.019873649 0.00066406 8251 hsa-mir-208b hsa04620 Toll-like receptor signaling pathway 1147_5594_5595_5599_5601_4792_5602 7 0.000238071 0.02023602 0.00066406 8252 hsa-mir-208b hsa04930 Type II diabetes mellitus 5594_5595_5599_5601_5602 5 0.000243679 0.020712724 0.00066406 8253 hsa-mir-208b hsa04530 Tight junction 1460_998_5518_5515_1457_5578_5728_5520 8 0.00024605 0.020914253 0.00066406 8254 hsa-mir-208b hsa05211 Renal cell carcinoma 998_5594_5595_1387_3091_2033 6 0.000250925 0.021328657 0.00066406 8255 hsa-mir-208b hsa04910 Insulin signaling pathway 5563_5594_5595_5599_5601_5499_2932_5602 8 0.000257812 0.021913983 0.00066406 8256 hsa-mir-208b hsa04916 Melanogenesis 5594_5595_1387_1856_2932_5578_2033 7 0.000266234 0.022629908 0.000665586 8257 hsa-mir-208b hsa04720 Long-term potentiation 5594_5595_1387_5499_5578_2033 6 0.000308253 0.026201494 0.000727819 8258 hsa-mir-208b hsa04662 B cell receptor signaling pathway 1147_5594_5595_1380_2932_4792 6 0.000308253 0.026201494 0.000727819 8259 hsa-mir-208b hsa04912 GnRH signaling pathway 998_5594_5595_5599_5601_5578_5602 7 0.000330593 0.028100392 0.00075947 8260 hsa-mir-208b hsa04664 Fc epsilon RI signaling pathway 5594_5595_5599_5601_5578_5602 6 0.000400115 0.03400976 0.000894994 8261 hsa-mir-208b hsa03440 Homologous recombination 675_6117_641_5888 4 0.000439649 0.037370154 0.000958209 8262 hsa-mir-208b hsa04150 mTOR signaling pathway 5563_5594_6794_5595_3091 5 0.000451649 0.038390206 0.000959755 8263 hsa-mir-208b hsa05131 Shigellosis 25_998_7534_5578_4691 5 0.00061866 0.052586121 0.00125205 8264 hsa-mir-208b hsa05130 Pathogenic Escherichia coli infection 25_998_7534_5578_4691 5 0.00061866 0.052586121 0.00125205 8265 hsa-mir-208b hsa04360 Axon guidance 5747_25_998_5594_5595_2932_1020 7 0.000982213 0.083488121 0.001941584 8266 hsa-mir-208b hsa03410 Base excision repair 3146_142_328_4913 4 0.001041172 0.088499584 0.002011354 8267 hsa-mir-208b hsa04730 Long-term depression 5518_5515_5594_5595_5578 5 0.001675508 0.142418208 0.003164849 8268 hsa-mir-208b hsa05016 Huntington's disease 25942_3064_1387_6908_6667_27113_3065_2033 8 0.001767694 0.150253992 0.003266391 8269 hsa-mir-208b hsa04062 Chemokine signaling pathway 1147_5747_998_5594_5595_2932_6362_4792 8 0.002068655 0.175835633 0.003741184 8270 hsa-mir-208b hsa05213 Endometrial cancer 5594_5595_2932_5728 4 0.003635703 0.309034713 0.006438223 8271 hsa-mir-208b hsa04540 Gap junction 5594_5595_983_1453_5578 5 0.005044265 0.428762505 0.008750255 8272 hsa-mir-208b hsa05216 Thyroid cancer 5594_5595_6256 3 0.005482746 0.46603342 0.009243651 8273 hsa-mir-208b hsa05221 Acute myeloid leukemia 1147_5594_5595_5371 4 0.005546191 0.471426193 0.009243651 8274 hsa-mir-208b hsa03030 DNA replication 6117_5557_5422 3 0.009535848 0.810547057 0.015587443 8275 hsa-mir-208b hsa03450 Non-homologous end-joining 5591_2547 2 0.013620105 1 0.021843565 8276 hsa-mir-208b hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_1616 3 0.028803734 1 0.045339211 8277 hsa-mir-208b hsa04340 Hedgehog signaling pathway 1453_2932_1452 3 0.030074408 1 0.04647863 8278 hsa-mir-208b hsa03430 Mismatch repair 6117_4436 2 0.031870175 1 0.048374373 8279 hsa-mir-208b hsa04630 Jak-STAT signaling pathway 1387_51588_8554_598_2033 5 0.034967828 1 0.052145006 8280 hsa-mir-208b hsa04270 Vascular smooth muscle contraction 5594_5595_5499_5578 4 0.049164344 1 0.072051193 8281 hsa-mir-20a hsa05200 Pathways in cancer 4149_3551_1398_1499_5914_595_596_598_3815_1017_8517_4193_6934_5578_3091_2735_2064_3066_3065_5925_1050_613_5743_5747_10342_25_405_9063_1956_1487_6789_7046_4436_1870_1871_2113_6774_867_10401_207_208_9915_7187_4286_3716_1147_5879_2249_998_1488_2261_5595_5594_5599_861_1387_6256_836_367_2932_6777_6772_5970_7157_7849_1869_3725_5467_6776_4087_4088_4089_5888_5728_2034_2033_5468_4846_3910_898_4790_4791_4792_3320_3326_51176_5371_675_5159_5156_5604_5601_5602_1856_1399_3265_51588_7428_8772_4609_2956_1026_2736_2353_7704_2737_8554 107 1.09E-45 9.69E-44 9.69E-44 8282 hsa-mir-20a hsa04010 MAPK signaling pathway 6722_4149_3551_1398_6195_6197_2264_8517_9252_5578_1845_7132_4773_9020_5923_1956_3304_3305_3303_6789_1432_7046_22800_4763_1616_207_208_1147_5879_2249_998_3727_2261_5595_5594_5599_5598_8986_1386_1649_836_3310_3312_3315_5971_5970_3164_7157_3725_6196_5058_4790_4791_5159_9261_1326_5156_5604_4208_5601_5600_5603_5602_5608_1399_3265_6885_4609_2353_2002_8550_5566 72 1.47E-26 1.31E-24 6.54E-25 8283 hsa-mir-20a hsa05220 Chronic myeloid leukemia 3551_1398_595_598_8517_4193_3066_3065_5925_613_25_1487_7046_1870_1871_867_207_208_1147_1488_5595_5594_861_6777_5970_7157_1869_6776_4088_4089_4790_4792_5604_1399_3265_5781_4609_1026_6464 39 2.88E-23 2.56E-21 8.53E-22 8284 hsa-mir-20a hsa04110 Cell cycle 4174_4172_595_1017_4193_902_6500_3066_3065_5925_25_1870_1871_5111_9232_5934_5933_545_995_5347_7534_5591_1387_11200_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_898_1031_983_8454_1026_1022_1111_8556_8555_472 44 2.18E-21 1.94E-19 4.85E-20 8285 hsa-mir-20a hsa05215 Prostate cancer 3551_1499_595_596_1017_8517_4193_6934_2064_5925_1956_1870_1871_207_208_9586_1147_5595_5594_1387_367_2932_5970_7157_1869_5728_2033_898_4790_4792_3320_3326_51176_5159_5156_5604_3265_1026 38 1.64E-20 1.46E-18 2.92E-19 8286 hsa-mir-20a hsa05212 Pancreatic cancer 3551_1499_595_596_1017_8517_4193_6934_2064_5925_1956_1870_1871_207_208_9586_1147_5595_5594_1387_367_2932_5970_7157_1869_5728_2033_898_4790_4792_3320_3326_51176_5159_5156_5604_3265_1026 38 2.24E-20 1.99E-18 3.32E-19 8287 hsa-mir-20a hsa04310 Wnt signaling pathway 818_817_1499_595_8607_6934_5578_6500_4772_4773_23291_1487_5879_1460_1488_5599_1387_1459_2932_7157_8061_3725_5467_1457_1452_4087_4088_4089_2033_51176_5519_5518_5515_5601_5602_1856_8454_8945_6885_4609_5527_5566 42 1.16E-16 1.03E-14 1.48E-15 8288 hsa-mir-20a hsa04660 T cell receptor signaling pathway 3551_1493_8517_5777_4772_4773_9020_2534_3932_4794_1432_867_207_208_1147_998_5595_5594_2932_5970_3725_5058_959_4790_4792_4793_1326_5604_5601_5600_5603_919_3265_6885_2353 35 1.17E-15 1.04E-13 1.30E-14 8289 hsa-mir-20a hsa05222 Small cell lung cancer 4149_3551_595_596_598_1017_8517_5925_5743_5747_9063_1870_1871_10401_207_208_7187_1147_6256_5970_7157_1869_5728_4846_3910_898_4790_4792_51588_4609_8554 31 3.05E-15 2.72E-13 3.02E-14 8290 hsa-mir-20a hsa05210 Colorectal cancer 1499_595_596_6934_1956_7046_4436_207_208_5879_5595_5594_5599_836_2932_7157_3725_4087_4088_4089_51176_5159_5156_5604_5601_5602_1856_4609_2956_2353 30 1.04E-14 9.26E-13 9.26E-14 8291 hsa-mir-20a hsa04012 ErbB signaling pathway 818_817_1398_5578_2064_5747_25_1956_6714_867_207_208_5595_5594_5599_2066_2932_6777_3725_6776_5058_5604_5601_5602_1399_3265_4609_1026_2002_6464 30 2.22E-14 1.98E-12 1.80E-13 8292 hsa-mir-20a hsa05221 Acute myeloid leukemia 3551_5914_595_3815_8517_6934_1050_6774_207_208_1147_5595_5594_861_6777_5970_5467_6776_4790_51176_5371_5604_3265_4609_7704 25 7.83E-14 6.97E-12 5.61E-13 8293 hsa-mir-20a hsa04630 Jak-STAT signaling pathway 3559_595_598_5777_3455_3594_9063_3560_3561_6773_1439_3595_2057_6774_867_2690_10401_3459_3977_207_208_3717_3716_8651_1387_6778_6777_6772_7297_6776_2033_51588_10379_5781_58985_4609_3575_8554 38 8.19E-14 7.29E-12 5.61E-13 8294 hsa-mir-20a hsa04920 Adipocytokine signaling pathway 3551_10891_5465_6794_8517_7132_8717_2538_4794_8471_6774_207_208_3717_1147_5599_6256_5970_4790_4792_4793_5601_5602_5563_5781_7133 26 1.29E-13 1.15E-11 8.15E-13 8295 hsa-mir-20a hsa04620 Toll-like receptor signaling pathway 3551_8517_3455_3665_3661_1432_207_208_7187_1147_5879_29110_5595_5594_5599_6772_5970_3725_4790_4792_1326_5604_5601_5600_5603_5602_5608_9641_8772_6885_2353 31 1.37E-13 1.22E-11 8.15E-13 8296 hsa-mir-20a hsa05214 Glioma 818_817_595_4193_5578_5925_1956_1870_1871_207_208_5595_5594_7157_1869_5728_808_801_805_5159_5156_5604_3265_1026_6464 25 4.48E-13 3.98E-11 2.49E-12 8297 hsa-mir-20a hsa04520 Adherens junction 1499_6934_5770_5777_2064_2534_1956_6714_7046_5879_1460_998_5595_5594_1387_1459_1457_4087_4088_4089_2033_51176_3643_71_8826_6885 26 3.59E-12 3.20E-10 1.88E-11 8298 hsa-mir-20a hsa04910 Insulin signaling pathway 3551_10891_1398_6720_5770_2538_5590_5499_8471_867_5211_207_208_8651_5595_5594_5599_2932_2194_808_801_805_3643_5604_5601_5602_5563_1399_3265_2002_6464_5566 32 2.57E-11 2.28E-09 1.27E-10 8299 hsa-mir-20a hsa04662 B cell receptor signaling pathway 3551_8517_5777_4772_4773_4794_207_208_1147_5879_695_5595_5594_1380_2932_6850_5970_3725_4790_4792_4793_5604_3265_2353 24 3.15E-11 2.80E-09 1.48E-10 8300 hsa-mir-20a hsa04350 TGF-beta signaling pathway 6500_90_4086_1875_6667_7046_1874_57154_5934_5933_5595_5594_1387_7027_4087_4088_4089_2033_5519_5518_5515_8454_4609_4093_4092 25 8.45E-11 7.52E-09 3.76E-10 8301 hsa-mir-20a hsa04115 p53 signaling pathway 595_1017_4194_4193_900_50484_51246_545_7161_11200_836_7157_6241_64326_5728_898_27113_25898_983_1026_1111_472 22 2.19E-10 1.95E-08 9.29E-10 8302 hsa-mir-20a hsa04510 Focal adhesion 1398_1499_595_596_5578_2064_5923_2534_5747_3791_1956_6714_5499_207_208_5879_998_5595_5594_5599_2932_3725_5058_5728_3910_2321_5159_5156_5604_5601_5602_1399_3265_71_2002_85366_6464 37 4.52E-10 4.03E-08 1.83E-09 8303 hsa-mir-20a hsa04062 Chemokine signaling pathway 3551_1398_8517_653361_5747_5580_5590_6773_2309_6362_6774_207_208_3717_1147_5879_998_5595_5594_1234_2932_6777_6772_5970_5058_4790_4792_4793_1230_5604_1399_3265_7852_6464_5566 35 1.06E-09 9.45E-08 4.11E-09 8304 hsa-mir-20a hsa05219 Bladder cancer 595_9252_4193_2064_5925_1956_1870_1871_2261_5595_5594_7157_1869_5604_3265_4609_1026 17 1.31E-09 1.16E-07 4.85E-09 8305 hsa-mir-20a hsa03010 Ribosome 6193_6204_6205_6207_6202_6141_9349_6217_6137_6135_6210_6155_6156_6191_6222_6223_6229_6129_6128_6125_6130_6181_6189_6188_6232 25 1.42E-09 1.26E-07 5.05E-09 8306 hsa-mir-20a hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3551_8517_9020_1956_6714_1432_1147_5879_998_5599_836_5970_3725_5058_4790_4792_5601_5600_5603_5602_5781 21 1.74E-09 1.55E-07 5.96E-09 8307 hsa-mir-20a hsa05211 Renal cell carcinoma 1398_3091_405_2113_207_208_9915_5879_998_5595_5594_1387_3725_5058_2034_2033_5604_1399_3265_7428_5781 21 2.15E-09 1.91E-07 7.08E-09 8308 hsa-mir-20a hsa05213 Endometrial cancer 1499_595_6934_2064_1956_2309_207_208_5595_5594_2932_7157_5728_51176_5604_3265_4609_2002 18 3.26E-09 2.90E-07 1.04E-08 8309 hsa-mir-20a hsa04912 GnRH signaling pathway 818_817_5578_5580_1956_6714_1432_998_5595_5594_5599_5598_3725_808_801_805_5604_5601_5600_5603_5602_5608_3265_2002_5566 25 3.86E-09 3.43E-07 1.18E-08 8310 hsa-mir-20a hsa05223 Non-small cell lung cancer 595_5578_2064_5925_1956_2309_6789_1870_1871_207_208_5595_5594_6256_7157_1869_5604_3265 18 5.31E-09 4.73E-07 1.58E-08 8311 hsa-mir-20a hsa04370 VEGF signaling pathway 5578_4772_4773_5743_5747_3791_6714_1432_207_208_5879_998_5595_5594_3315_4846_9261_5604_5600_5603_3265 21 5.87E-09 5.23E-07 1.69E-08 8312 hsa-mir-20a hsa05216 Thyroid cancer 1499_595_6934_10342_5595_5594_6256_7157_7849_5468_51176_5604_3265_4609 14 6.40E-09 5.70E-07 1.78E-08 8313 hsa-mir-20a hsa05218 Melanoma 595_4193_5925_1956_1870_1871_207_208_4286_2249_5595_5594_7157_1869_5728_5159_5156_5604_3265_1026 20 8.48E-09 7.55E-07 2.29E-08 8314 hsa-mir-20a hsa04210 Apoptosis 3551_596_598_8517_7132_8717_9020_823_1439_207_208_1147_836_5970_7157_9131_4790_4792_840_8772_472_5566 22 1.19E-08 1.06E-06 3.10E-08 8315 hsa-mir-20a hsa04720 Long-term potentiation 818_814_817_6195_6197_5578_2902_2906_5499_5595_5594_1387_6196_2033_808_801_805_5604_3265_5566 20 1.85E-08 1.65E-06 4.71E-08 8316 hsa-mir-20a hsa04120 Ubiquitin mediated proteolysis 4193_55294_6500_3093_23291_9063_7319_84447_867_10401_7329_8925_57154_8651_10055_51366_64326_7337_5371_672_25898_8454_8945_51588_7428_10075_8554 27 2.40E-08 2.13E-06 5.93E-08 8317 hsa-mir-20a hsa03022 Basal transcription factors 51616_6872_2965_2963_2969_6878_6874_6908_2958_2959_6880_2957_6882_9519 14 7.37E-08 6.56E-06 1.77E-07 8318 hsa-mir-20a hsa04664 Fc epsilon RI signaling pathway 5578_2534_5580_1432_207_208_5879_695_5595_5594_5599_6850_5604_5601_5600_5603_5602_5608_3265 19 1.67E-07 1.49E-05 3.91E-07 8319 hsa-mir-20a hsa04540 Gap junction 5592_5578_10382_1956_6714_5595_5594_5598_7846_1453_347733_5159_983_5156_5604_3265_7278_84617_203068_5566 20 3.78E-07 3.36E-05 8.62E-07 8320 hsa-mir-20a hsa04330 Notch signaling pathway 3066_3065_1840_9794_1487_2648_1488_1387_22938_9612_2033_8850_1856_4851 14 8.20E-07 7.30E-05 1.83E-06 8321 hsa-mir-20a hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_7132_2902_2906_1432_1616_5879_836_7157_4846_5600_5603_5608_7133 15 1.04E-06 9.28E-05 2.26E-06 8322 hsa-mir-20a hsa04916 Melanogenesis 818_817_1499_3815_6934_5578_4286_5595_5594_1387_2932_2033_808_801_805_51176_5604_1856_3265_5566 20 1.74E-06 0.000154611 3.68E-06 8323 hsa-mir-20a hsa05131 Shigellosis 1499_5578_10382_2534_25_998_7534_7846_347733_7278_71_84617_4691_203068 14 4.71E-06 0.00041917 9.53E-06 8324 hsa-mir-20a hsa05130 Pathogenic Escherichia coli infection 1499_5578_10382_2534_25_998_7534_7846_347733_7278_71_84617_4691_203068 14 4.71E-06 0.00041917 9.53E-06 8325 hsa-mir-20a hsa04530 Tight junction 1499_5578_5580_5590_6714_4627_4628_22800_8573_207_208_1460_998_1459_1457_5728_5519_5518_5515_3265_71_5520 22 7.30E-06 0.000649919 1.44E-05 8326 hsa-mir-20a hsa04930 Type II diabetes mellitus 3551_5580_5590_8471_3651_8651_5595_5594_5599_3643_5601_5602 12 1.29E-05 0.001144695 2.49E-05 8327 hsa-mir-20a hsa03050 Proteasome 5708_5709_5705_5706_5700_5684_5719_5717_5713_5687_5693_5707 12 2.23E-05 0.001983967 4.22E-05 8328 hsa-mir-20a hsa05322 Systemic lupus erythematosus 3021_3020_8366_9555_8349_8362_8365_8368_3018_8294_8370_6628_121504_8360_8363_8364_8367_959_8359_8361 20 0.000114962 0.010231574 0.000213158 8329 hsa-mir-20a hsa04650 Natural killer cell mediated cytotoxicity 5777_5578_3455_4772_4773_2534_3932_3459_5879_5595_5594_836_6850_5058_5604_919_3265_5781_6464 19 0.00018639 0.016588666 0.000338544 8330 hsa-mir-20a hsa03420 Nucleotide excision repair 5981_902_5111_5886_2965_4331_2071_2074_1022_6117 10 0.000208973 0.018598561 0.000371971 8331 hsa-mir-20a hsa03410 Base excision repair 4350_142_4913_252969_5111_3146_328_2237_6996 9 0.000234704 0.020888642 0.000404365 8332 hsa-mir-20a hsa05016 Huntington's disease 10891_293_292_3066_3065_3064_498_25942_2902_6667_9586_1387_836_5437_7157_1213_2033_5468_27113_6874_6908_5441_9519 23 0.000236258 0.021026969 0.000404365 8333 hsa-mir-20a hsa03450 Non-homologous end-joining 2547_10111_7520_2237_5591_4361 6 0.000254676 0.022666203 0.000427664 8334 hsa-mir-20a hsa04060 Cytokine-cytokine receptor interaction 3559_3815_7132_3455_90_3594_3791_1956_3560_3561_1439_7046_3595_2057_6362_2690_3459_3977_1234_959_2321_1230_5159_5156_7852_58985_3575_7133 28 0.000428557 0.038141597 0.000706326 8335 hsa-mir-20a hsa04150 mTOR signaling pathway 6794_6195_6197_3091_207_208_5595_5594_6196_5563 10 0.000664511 0.059141519 0.0010753 8336 hsa-mir-20a hsa04810 Regulation of actin cytoskeleton 10788_1398_2264_5747_1956_5499_4627_4628_22800_5879_2249_998_2261_5595_5594_5058_5159_5156_5604_1399_3265_71_8826_85366 24 0.000734187 0.065342612 0.001166832 8337 hsa-mir-20a hsa03030 DNA replication 5981_4174_4172_5111_2237_5557_6117_5422 8 0.001009998 0.089889789 0.001577014 8338 hsa-mir-20a hsa03440 Homologous recombination 641_10111_4361_4683_5888_675_6117 7 0.001154958 0.102791261 0.001772263 8339 hsa-mir-20a hsa04340 Hedgehog signaling pathway 2735_23291_53944_2932_1452_1453_8945_2736_2737_5566 10 0.001235803 0.10998646 0.001864177 8340 hsa-mir-20a hsa04020 Calcium signaling pathway 818_814_817_293_5578_292_2064_1956_2902_2906_147_2066_4846_808_801_805_5159_5156_85366_5566 20 0.002418527 0.215248871 0.003587481 8341 hsa-mir-20a hsa04740 Olfactory transduction 818_817_5592_808_801_805_5566 7 0.002690948 0.239494361 0.003926137 8342 hsa-mir-20a hsa05217 Basal cell carcinoma 1499_6934_2735_2932_7157_51176_1856_2736_2737 9 0.003243108 0.288636595 0.004655429 8343 hsa-mir-20a hsa04730 Long-term depression 5592_5578_5595_5594_4846_5519_5518_5515_5604_3265 10 0.005138341 0.457312374 0.007258927 8344 hsa-mir-20a hsa03020 RNA polymerase 64425_25885_51082_5437_84172_5441 6 0.005784676 0.514836197 0.008007755 8345 hsa-mir-20a hsa04270 Vascular smooth muscle contraction 5592_5578_5580_147_5499_59_5595_5594_808_801_805_5604_85366_5566 14 0.005848361 0.520504088 0.008007755 8346 hsa-mir-20a hsa03430 Mismatch repair 5981_4436_5111_2956_6117 5 0.00967112 0.860729705 0.013041359 8347 hsa-mir-20a hsa04360 Axon guidance 4772_4773_2534_5747_25_5879_998_5595_5594_2932_5058_3265_7852_1020 14 0.010520257 0.936302834 0.013974669 8348 hsa-mir-20a hsa04950 Maturity onset diabetes of the young 5080_6927_4760_3651_3172 5 0.011235995 1 0.014705934 8349 hsa-mir-20a hsa05340 Primary immunodeficiency 8517_3932_3561_695_959_3575 6 0.012581327 1 0.016228089 8350 hsa-mir-20a hsa05010 Alzheimer's disease 7132_498_823_2902_2906_5595_5594_836_2932_4846_808_351_801_805_840_8772_1020 17 0.016210182 1 0.020610088 8351 hsa-mir-20a hsa04612 Antigen processing and presentation 3309_3304_3305_3303_3310_3312_3320_3326_4800_4801 10 0.027680759 1 0.034698417 8352 hsa-mir-20a hsa04670 Leukocyte transendothelial migration 1499_5578_653361_5747_1432_5879_998_5600_5603_7852_71_5781 12 0.037827534 1 0.046535049 8353 hsa-mir-20a hsa04710 Circadian rhythm - mammal 8863_4862_1453 3 0.038169197 1 0.046535049 8354 hsa-mir-20b hsa05200 Pathways in cancer 3320_5371_1488_1017_5595_5594_5599_861_5914_1387_6256_595_6502_836_6258_367_2932_4193_4149_7704_842_6774_3091_5970_7428_1870_1871_7157_4824_4087_6688_5604_2113_4609_1869_3725_841_1029_1487_4088_4089_3066_3065_4292_1050_5925_2034_2033_4846_207_9915_5894 52 7.62E-41 5.11E-39 5.11E-39 8355 hsa-mir-20b hsa05220 Chronic myeloid leukemia 1488_5595_5594_861_595_4193_5970_1870_1871_7157_5604_4609_1869_1029_1487_4088_4089_3066_3065_5925_207_6464_5894 23 2.78E-24 1.86E-22 9.32E-23 8356 hsa-mir-20b hsa04110 Cell cycle 890_5591_1017_1387_595_983_6502_2932_4193_8454_6500_1870_1871_7157_4087_1869_1029_4088_4089_3066_3065_5925_2033_5933_5934_990 26 4.68E-24 3.13E-22 1.04E-22 8357 hsa-mir-20b hsa05215 Prostate cancer 3320_1017_5595_5594_1387_595_367_2932_4193_1385_842_5970_1870_1871_7157_4824_5604_1869_5925_2033_207_5894 22 1.24E-21 8.27E-20 2.04E-20 8358 hsa-mir-20b hsa05212 Pancreatic cancer 3320_1017_5595_5594_1387_595_367_2932_4193_1385_842_5970_1870_1871_7157_4824_5604_1869_5925_2033_207_5894 22 1.53E-21 1.02E-19 2.04E-20 8359 hsa-mir-20b hsa04350 TGF-beta signaling pathway 3399_5595_5594_1387_6667_8454_3398_6500_1874_1875_4087_4609_4088_4089_2033_5933_4093_5934 18 1.14E-16 7.67E-15 1.28E-15 8360 hsa-mir-20b hsa05223 Non-small cell lung cancer 5595_5594_6256_595_6258_842_1870_1871_7157_5604_1869_1029_5925_207_5894 15 9.82E-16 6.58E-14 9.40E-15 8361 hsa-mir-20b hsa05210 Colorectal cancer 5595_5594_5599_595_836_2932_842_7157_4087_5604_4609_3725_4088_4089_4292_207_5894 17 1.13E-15 7.56E-14 9.45E-15 8362 hsa-mir-20b hsa05221 Acute myeloid leukemia 5371_5595_5594_861_5914_595_7704_6774_5970_6688_5604_4609_1050_207_5894 15 3.01E-15 2.02E-13 2.24E-14 8363 hsa-mir-20b hsa05214 Glioma 815_5595_5594_595_4193_1870_1871_7157_5604_1869_1029_5925_207_6464_5894 15 1.03E-14 6.91E-13 6.91E-14 8364 hsa-mir-20b hsa05222 Small cell lung cancer 1017_6256_595_6502_6258_4149_842_5970_1870_1871_7157_4609_1869_5925_4846_207 16 2.51E-14 1.68E-12 1.43E-13 8365 hsa-mir-20b hsa05219 Bladder cancer 5595_5594_595_4193_1870_1871_7157_5604_4609_1869_1029_5925_5894 13 2.55E-14 1.71E-12 1.43E-13 8366 hsa-mir-20b hsa04310 Wnt signaling pathway 815_1488_5599_1387_595_2932_8454_6500_7157_4087_4609_3725_1457_1487_1459_4088_4089_2033 18 6.49E-13 4.35E-11 3.34E-12 8367 hsa-mir-20b hsa04010 MAPK signaling pathway 5595_5594_5599_5598_4208_836_4149_3312_1386_5970_9261_7157_5604_4609_3725_6195_4763_1616_207_2002_2005_5894 22 2.25E-12 1.51E-10 1.08E-11 8368 hsa-mir-20b hsa05213 Endometrial cancer 5595_5594_595_2932_842_7157_5604_4609_4292_207_2002_5894 12 4.95E-12 3.32E-10 2.21E-11 8369 hsa-mir-20b hsa05218 Melanoma 5595_5594_595_4193_1870_1871_7157_5604_1869_1029_5925_207_5894 13 8.28E-12 5.55E-10 3.47E-11 8370 hsa-mir-20b hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_5604_2113_3725_2034_2033_207_9915_5894 13 9.68E-12 6.48E-10 3.81E-11 8371 hsa-mir-20b hsa04012 ErbB signaling pathway 815_6714_5595_5594_5599_2932_5604_4609_3725_207_6464_2002_5894 13 8.04E-11 5.38E-09 2.99E-10 8372 hsa-mir-20b hsa04540 Gap junction 6714_5595_5594_5598_983_7277_7278_5604_7846_51807_10376_5894 12 1.97E-09 1.32E-07 6.95E-09 8373 hsa-mir-20b hsa05216 Thyroid cancer 5595_5594_6256_595_6258_7157_5604_4609 8 5.68E-09 3.80E-07 1.90E-08 8374 hsa-mir-20b hsa04330 Notch signaling pathway 1488_1387_2648_1487_9612_3066_3065_2033_4851 9 1.00E-08 6.71E-07 3.19E-08 8375 hsa-mir-20b hsa04115 p53 signaling pathway 1017_595_983_836_4193_842_7157_841_7161_1029 10 1.64E-08 1.10E-06 4.99E-08 8376 hsa-mir-20b hsa04520 Adherens junction 6714_5595_5594_1387_4087_1457_1459_4088_4089_2033 10 5.84E-08 3.92E-06 1.68E-07 8377 hsa-mir-20b hsa05016 Huntington's disease 6874_1387_2902_6908_836_6667_1385_842_7157_841_3066_3065_3064_2033 14 6.00E-08 4.02E-06 1.68E-07 8378 hsa-mir-20b hsa04720 Long-term potentiation 815_5595_5594_1387_2902_5604_6195_2033_5894 9 3.72E-07 2.49E-05 9.96E-07 8379 hsa-mir-20b hsa04370 VEGF signaling pathway 6714_5595_5594_842_9261_5604_4846_207_5894 9 4.55E-07 3.05E-05 1.17E-06 8380 hsa-mir-20b hsa04912 GnRH signaling pathway 815_6714_5595_5594_5599_5598_5604_3725_2002_5894 10 7.59E-07 5.09E-05 1.88E-06 8381 hsa-mir-20b hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_5604_3725_207_5894 8 3.74E-06 0.000250732 8.95E-06 8382 hsa-mir-20b hsa04916 Melanogenesis 815_5595_5594_1387_2932_1385_5604_2033_5894 9 4.56E-06 0.000305637 1.05E-05 8383 hsa-mir-20b hsa04510 Focal adhesion 6714_5595_5594_5599_595_2932_5604_3725_207_6464_2002_5894 12 5.92E-06 0.000396333 1.28E-05 8384 hsa-mir-20b hsa04910 Insulin signaling pathway 6720_5595_5594_5599_2932_5604_207_6464_2002_5894 10 5.94E-06 0.000397869 1.28E-05 8385 hsa-mir-20b hsa04210 Apoptosis 836_839_842_840_5970_7157_841_207 8 1.20E-05 0.000804339 2.51E-05 8386 hsa-mir-20b hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5970_5604_3725_841_207 8 3.01E-05 0.002015855 6.11E-05 8387 hsa-mir-20b hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_6502_4193_8454_6500_7428_7329 9 4.00E-05 0.002682995 7.89E-05 8388 hsa-mir-20b hsa05010 Alzheimer's disease 22926_5595_5594_2902_836_2932_842_840_841_4846 10 4.52E-05 0.003026732 8.65E-05 8389 hsa-mir-20b hsa04660 T cell receptor signaling pathway 5595_5594_2932_5970_5604_3725_207_5894 8 4.98E-05 0.003336698 9.27E-05 8390 hsa-mir-20b hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_842_7157_1616_4846 6 6.13E-05 0.004109065 0.000105361 8391 hsa-mir-20b hsa05131 Shigellosis 7277_7278_7846_51807_4691_10376 6 6.13E-05 0.004109065 0.000105361 8392 hsa-mir-20b hsa05130 Pathogenic Escherichia coli infection 7277_7278_7846_51807_4691_10376 6 6.13E-05 0.004109065 0.000105361 8393 hsa-mir-20b hsa04062 Chemokine signaling pathway 5595_5594_7074_2932_6774_5970_5604_207_6464_5894 10 8.98E-05 0.006014739 0.000150368 8394 hsa-mir-20b hsa03022 Basal transcription factors 2963_2962_6874_2969_6908 5 9.43E-05 0.006319284 0.000154129 8395 hsa-mir-20b hsa04920 Adipocytokine signaling pathway 5599_6256_6258_6774_5970_207 6 0.000153509 0.010285107 0.000244883 8396 hsa-mir-20b hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5604_207_5894 6 0.000353322 0.023672599 0.000550526 8397 hsa-mir-20b hsa04150 mTOR signaling pathway 5595_5594_3091_6195_207 5 0.000405884 0.027194253 0.000618051 8398 hsa-mir-20b hsa04612 Antigen processing and presentation 3320_4800_4801_4802_1385_3312 6 0.000640768 0.042931444 0.000954032 8399 hsa-mir-20b hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5599_836_5970_3725 5 0.001511809 0.101291179 0.002155131 8400 hsa-mir-20b hsa04730 Long-term depression 5595_5594_5604_4846_5894 5 0.001511809 0.101291179 0.002155131 8401 hsa-mir-20b hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_5604_6464_5894 6 0.005263344 0.352644071 0.007346751 8402 hsa-mir-20b hsa04630 Jak-STAT signaling pathway 1387_595_6774_4609_2033_207 6 0.008919457 0.597603604 0.012195992 8403 hsa-mir-20b hsa04930 Type II diabetes mellitus 5595_5594_5599 3 0.015755146 1 0.021111895 8404 hsa-mir-20b hsa04270 Vascular smooth muscle contraction 5595_5594_5604_5894 4 0.045810228 1 0.060182064 8405 hsa-mir-21 hsa05200 Pathways in cancer 1869_4149_2249_1499_5595_5594_5914_1387_6256_1019_367_1017_4193_7704_6774_6776_6777_5970_1870_1871_7157_4087_6688_4089_4609_3725_1026_1029_2353_4088_3066_1050_5925_2033_207_8554_836 37 2.05E-36 1.36E-34 1.36E-34 8406 hsa-mir-21 hsa05220 Chronic myeloid leukemia 1869_5595_5594_1019_4193_6776_6777_5970_1870_1871_7157_4089_4609_1026_1029_4088_3066_5925_207 19 5.01E-25 3.31E-23 1.65E-23 8407 hsa-mir-21 hsa04110 Cell cycle 1869_1387_1019_1017_4193_7027_1870_1871_7157_4087_4089_1026_1029_4088_3066_5925_2033_890_5934_5933 20 3.80E-23 2.51E-21 8.36E-22 8408 hsa-mir-21 hsa05215 Prostate cancer 1869_1499_5595_5594_1387_367_1017_4193_1385_5970_1870_1871_7157_468_1026_5925_2033_207 18 2.68E-22 1.77E-20 4.24E-21 8409 hsa-mir-21 hsa05212 Pancreatic cancer 1869_1499_5595_5594_1387_367_1017_4193_1385_5970_1870_1871_7157_468_1026_5925_2033_207 18 3.21E-22 2.12E-20 4.24E-21 8410 hsa-mir-21 hsa05219 Bladder cancer 1869_5595_5594_1019_4193_1870_1871_7157_4609_1026_1029_5925 12 9.25E-17 6.10E-15 1.02E-15 8411 hsa-mir-21 hsa04350 TGF-beta signaling pathway 5595_5594_1387_7027_1874_1875_4087_4089_4609_4088_2033_6667_5934_5933 14 2.70E-16 1.78E-14 2.55E-15 8412 hsa-mir-21 hsa05218 Melanoma 1869_2249_5595_5594_1019_4193_1870_1871_7157_1026_1029_5925_207 13 7.26E-16 4.79E-14 5.99E-15 8413 hsa-mir-21 hsa05221 Acute myeloid leukemia 5595_5594_5914_7704_6774_6776_6777_5970_6688_4609_1050_207 12 3.20E-15 2.11E-13 2.34E-14 8414 hsa-mir-21 hsa05222 Small cell lung cancer 1869_4149_6256_1019_1017_5970_1870_1871_7157_4609_5925_207_8554 13 6.71E-15 4.43E-13 4.43E-14 8415 hsa-mir-21 hsa05214 Glioma 1869_5595_5594_1019_4193_1870_1871_7157_1026_1029_5925_207 12 8.93E-15 5.89E-13 5.36E-14 8416 hsa-mir-21 hsa05223 Non-small cell lung cancer 1869_5595_5594_6256_1019_1870_1871_7157_1029_5925_207 11 4.62E-14 3.05E-12 2.54E-13 8417 hsa-mir-21 hsa05210 Colorectal cancer 1499_5595_5594_7157_4087_4089_4609_3725_2353_4088_207_836 12 1.39E-13 9.19E-12 7.07E-13 8418 hsa-mir-21 hsa04010 MAPK signaling pathway 4149_2249_5595_5594_5598_1386_1649_1432_5970_7157_468_4609_3725_2353_207_836 16 3.93E-12 2.60E-10 1.85E-11 8419 hsa-mir-21 hsa04520 Adherens junction 1499_5595_5594_1387_4087_4089_4088_2033 8 2.36E-08 1.56E-06 1.04E-07 8420 hsa-mir-21 hsa05216 Thyroid cancer 1499_5595_5594_6256_7157_4609 6 2.90E-08 1.91E-06 1.20E-07 8421 hsa-mir-21 hsa04012 ErbB signaling pathway 5595_5594_6776_6777_4609_3725_1026_207 8 4.32E-08 2.85E-06 1.68E-07 8422 hsa-mir-21 hsa04115 p53 signaling pathway 1019_1017_4193_7157_1026_1029_836 7 1.67E-07 1.10E-05 6.11E-07 8423 hsa-mir-21 hsa04310 Wnt signaling pathway 1499_1387_7157_4087_4089_4609_3725_4088_2033 9 2.13E-07 1.41E-05 7.40E-07 8424 hsa-mir-21 hsa04660 T cell receptor signaling pathway 5595_5594_1019_1432_5970_3725_2353_207 8 2.35E-07 1.55E-05 7.75E-07 8425 hsa-mir-21 hsa04630 Jak-STAT signaling pathway 1387_6774_6776_6777_4609_2033_3977_207_8554 9 2.49E-07 1.64E-05 7.83E-07 8426 hsa-mir-21 hsa05213 Endometrial cancer 1499_5595_5594_7157_4609_207 6 6.54E-07 4.31E-05 1.96E-06 8427 hsa-mir-21 hsa04620 Toll-like receptor signaling pathway 5595_5594_1432_5970_3725_2353_207 7 1.96E-06 0.000129529 5.63E-06 8428 hsa-mir-21 hsa05211 Renal cell carcinoma 5595_5594_1387_3725_2033_207 6 3.80E-06 0.00025091 1.05E-05 8429 hsa-mir-21 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725_2353_207 6 4.74E-06 0.000312907 1.25E-05 8430 hsa-mir-21 hsa04330 Notch signaling pathway 1387_9612_3066_2033_4851 5 8.39E-06 0.000553482 2.13E-05 8431 hsa-mir-21 hsa05016 Huntington's disease 1387_6908_1385_7157_3066_2033_836_6667 8 1.06E-05 0.000698632 2.59E-05 8432 hsa-mir-21 hsa04916 Melanogenesis 1499_5595_5594_1387_1385_2033 6 2.76E-05 0.001819745 6.50E-05 8433 hsa-mir-21 hsa04912 GnRH signaling pathway 5595_5594_5598_1432_468_3725 6 3.37E-05 0.002226717 7.68E-05 8434 hsa-mir-21 hsa04720 Long-term potentiation 5595_5594_1387_468_2033 5 6.88E-05 0.00454308 0.000151436 8435 hsa-mir-21 hsa04210 Apoptosis 840_5970_7157_207_836 5 0.000148076 0.009773035 0.000315259 8436 hsa-mir-21 hsa05010 Alzheimer's disease 22926_5595_5594_840_1020_836 6 0.000450144 0.029709507 0.000928422 8437 hsa-mir-21 hsa04920 Adipocytokine signaling pathway 6256_6774_5970_207 4 0.000562165 0.037102913 0.001124331 8438 hsa-mir-21 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_5970_3725_836 4 0.000691781 0.045657563 0.001318479 8439 hsa-mir-21 hsa04062 Chemokine signaling pathway 5595_5594_6774_6777_5970_207 6 0.000699194 0.046146773 0.001318479 8440 hsa-mir-21 hsa04370 VEGF signaling pathway 5595_5594_1432_207 4 0.000923915 0.060978373 0.001693844 8441 hsa-mir-21 hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432_207 4 0.001012145 0.066801564 0.001805448 8442 hsa-mir-21 hsa04150 mTOR signaling pathway 5595_5594_207 3 0.003140463 0.207270581 0.005454489 8443 hsa-mir-21 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_7157_836 3 0.003831847 0.252901878 0.006484664 8444 hsa-mir-21 hsa04510 Focal adhesion 1499_5595_5594_3725_207 5 0.00546662 0.360796919 0.009019923 8445 hsa-mir-21 hsa04910 Insulin signaling pathway 6720_5595_5594_207 4 0.007029953 0.463976878 0.011316509 8446 hsa-mir-21 hsa04540 Gap junction 5595_5594_5598 3 0.01461003 0.964261962 0.022958618 8447 hsa-mir-21 hsa03410 Base excision repair 3146_142 2 0.017350881 1 0.026631584 8448 hsa-mir-21 hsa03022 Basal transcription factors 2969_6908 2 0.018225853 1 0.02733878 8449 hsa-mir-21 hsa03420 Nucleotide excision repair 5981_4331 2 0.02485149 1 0.036448852 8450 hsa-mir-21 hsa04930 Type II diabetes mellitus 5595_5594 2 0.025867022 1 0.037113554 8451 hsa-mir-21 hsa04360 Axon guidance 5595_5594_1020 3 0.034697178 1 0.048723697 8452 hsa-mir-21 hsa05217 Basal cell carcinoma 1499_7157 2 0.036904237 1 0.050743326 8453 hsa-mir-21 hsa04530 Tight junction 1499_1019_207 3 0.038719998 1 0.051909025 8454 hsa-mir-21 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836 3 0.039412613 1 0.051909025 8455 hsa-mir-21 hsa04120 Ubiquitin mediated proteolysis 672_4193_8554 3 0.040111519 1 0.051909025 8456 hsa-mir-210 hsa05200 Pathways in cancer 4149_6654_5914_595_3815_4193_7704_6502_3091_3066_3065_1050_5925_405_1956_2308_6257_8503_1870_1871_2885_2113_10401_5894_867_207_208_3716_1147_5595_5594_5599_6258_1387_2064_6256_836_367_2932_6774_6776_6777_6772_5970_7157_1869_3725_4087_4088_4089_5295_2034_2033_675_4846_4790_3320_3326_5371_3480_5159_8031_5156_5604_1399_1398_4292_7428_4609_1029_2353_8554 72 7.37E-56 6.19E-54 6.19E-54 8457 hsa-mir-210 hsa05220 Chronic myeloid leukemia 6654_595_4193_3066_3065_5925_8503_1870_1871_2885_5894_867_207_208_1147_5595_5594_6776_6777_5970_7157_1869_4088_4089_5295_4790_5604_1399_1398_5781_4609_1029_6464 33 2.93E-34 2.46E-32 1.23E-32 8458 hsa-mir-210 hsa05215 Prostate cancer 6654_595_4193_5925_1956_2308_8503_1870_1871_2885_5894_207_208_1147_5595_5594_1387_2064_367_2932_5970_7157_1869_5295_2033_4790_3320_3326_3480_5159_5156_5604 32 3.97E-31 3.34E-29 1.11E-29 8459 hsa-mir-210 hsa05212 Pancreatic cancer 6654_595_4193_5925_1956_2308_8503_1870_1871_2885_5894_207_208_1147_5595_5594_1387_2064_367_2932_5970_7157_1869_5295_2033_4790_3320_3326_3480_5159_5156_5604 32 5.33E-31 4.47E-29 1.12E-29 8460 hsa-mir-210 hsa05214 Glioma 6654_595_4193_5925_1956_8503_1870_1871_2885_5894_207_208_5595_5594_7157_1869_5295_808_801_805_3480_5159_5156_5604_1029_6464 26 2.22E-26 1.87E-24 3.74E-25 8461 hsa-mir-210 hsa04010 MAPK signaling pathway 3727_4149_6654_4214_4616_1956_1432_627_2885_5894_4763_2872_207_208_1147_994_5595_5594_5599_5598_1386_836_3312_5970_7157_10912_3725_6195_6197_5058_4790_5159_5156_5604_4208_5566_1399_1398_4609_2353 40 1.82E-25 1.53E-23 2.55E-24 8462 hsa-mir-210 hsa04110 Cell cycle 595_4193_902_6502_6500_3066_3065_990_5925_4616_1870_1871_5933_994_5591_1387_7533_2932_7157_10912_1869_4087_4088_4089_2033_891_983_8454_1022_1029 30 2.56E-25 2.15E-23 3.07E-24 8463 hsa-mir-210 hsa05210 Colorectal cancer 6654_595_1956_8503_2885_5894_207_208_5595_5594_5599_836_2932_7157_3725_4087_4088_4089_5295_3480_5159_5156_5604_4292_4609_2353 26 5.03E-24 4.22E-22 5.21E-23 8464 hsa-mir-210 hsa05223 Non-small cell lung cancer 6654_595_5925_1956_2309_6257_8503_1870_1871_2885_5894_207_208_5595_5594_6258_2064_6256_7157_1869_5295_5604_1029 23 5.58E-24 4.69E-22 5.21E-23 8465 hsa-mir-210 hsa04012 ErbB signaling pathway 6654_1956_6714_8503_2885_5894_867_207_208_5595_5594_5599_56924_2064_2066_2932_6776_6777_3725_5295_5058_5604_1399_1398_4609_6464 26 1.07E-23 8.95E-22 8.95E-23 8466 hsa-mir-210 hsa05221 Acute myeloid leukemia 6654_5914_595_3815_7704_1050_8503_2885_5894_207_208_1147_5595_5594_6774_6776_6777_5970_5295_4790_5371_5604_4609 23 2.84E-23 2.39E-21 2.17E-22 8467 hsa-mir-210 hsa05211 Renal cell carcinoma 6654_3091_405_8503_2885_2113_5894_207_208_5595_5594_56924_1387_3725_5295_5058_2034_2033_5604_1399_1398_7428_5781 23 1.17E-21 9.85E-20 8.21E-21 8468 hsa-mir-210 hsa04910 Insulin signaling pathway 6720_10891_6654_5770_2308_8503_2885_5894_867_2872_207_208_5595_5594_5599_7249_2932_5295_808_801_805_3643_5604_5566_1399_1398_6464 27 2.05E-20 1.72E-18 1.32E-19 8469 hsa-mir-210 hsa04630 Jak-STAT signaling pathway 6654_595_5777_3560_3561_8503_2057_2885_10401_867_2690_207_208_3717_3716_3718_85480_1387_3575_6774_6776_6777_6772_5295_2033_5781_4609_8554 28 2.62E-20 2.20E-18 1.57E-19 8470 hsa-mir-210 hsa04660 T cell receptor signaling pathway 1493_6654_5777_3932_1432_8503_2885_5894_867_207_208_1147_5595_5594_56924_2932_5970_3725_5295_5058_4790_5604_919_2353 24 3.05E-19 2.56E-17 1.71E-18 8471 hsa-mir-210 hsa04062 Chemokine signaling pathway 6654_1234_7074_9564_2309_8503_2885_5894_207_208_3717_1147_3718_5595_5594_2932_6774_6777_6772_5970_5295_5058_4790_2770_5604_5566_1399_1398_6464 29 4.86E-19 4.08E-17 2.53E-18 8472 hsa-mir-210 hsa05222 Small cell lung cancer 4149_595_6502_5925_6257_8503_1870_1871_10401_207_208_1147_6258_6256_5970_7157_1869_5295_4846_4790_4609_8554 22 5.13E-19 4.31E-17 2.53E-18 8473 hsa-mir-210 hsa05218 Melanoma 595_4193_5925_1956_8503_1870_1871_5894_207_208_5595_5594_7157_1869_5295_3480_5159_5156_5604_1029 20 4.22E-18 3.54E-16 1.97E-17 8474 hsa-mir-210 hsa05213 Endometrial cancer 6654_595_1956_2309_8503_2885_5894_207_208_5595_5594_2064_2932_7157_5295_5604_4292_4609 18 9.60E-18 8.06E-16 4.24E-17 8475 hsa-mir-210 hsa04662 B cell receptor signaling pathway 6654_5777_6850_8503_2885_5894_207_208_1147_695_5595_5594_2932_5970_3725_5295_4790_5604_2353 19 1.55E-16 1.30E-14 6.52E-16 8476 hsa-mir-210 hsa04510 Focal adhesion 6654_595_857_9564_1956_6714_8503_2885_5894_207_208_5595_5594_5599_56924_2064_2932_3725_5295_5058_3480_5159_5156_5604_1399_1398_6464 27 1.80E-16 1.51E-14 7.19E-16 8477 hsa-mir-210 hsa05219 Bladder cancer 595_4193_5925_1956_1870_1871_5894_5595_5594_2064_7157_1869_5604_4609_1029 15 3.59E-15 3.01E-13 1.37E-14 8478 hsa-mir-210 hsa04540 Gap junction 6654_51807_1956_6714_2885_5894_5595_5594_5598_7846_5159_2770_983_5156_5604_5566_7277_7278_10376 19 4.73E-15 3.98E-13 1.73E-14 8479 hsa-mir-210 hsa04520 Adherens junction 1457_5770_5777_1956_6714_1460_5595_5594_1387_2064_1459_4087_4088_4089_2033_3643_3480 17 7.51E-14 6.31E-12 2.63E-13 8480 hsa-mir-210 hsa04912 GnRH signaling pathway 6654_4214_1956_6714_1432_2885_5894_5595_5594_5599_5598_3725_808_801_805_5604_5566 17 5.43E-12 4.57E-10 1.83E-11 8481 hsa-mir-210 hsa04310 Wnt signaling pathway 595_1457_6500_1460_5599_1387_2932_7157_3725_1459_4087_4088_4089_2033_5515_5566_8454_4609 18 9.22E-11 7.75E-09 2.98E-10 8482 hsa-mir-210 hsa04664 Fc epsilon RI signaling pathway 6654_6850_1432_8503_2885_5894_207_208_695_5595_5594_5599_5295_5604 14 1.02E-10 8.59E-09 3.18E-10 8483 hsa-mir-210 hsa04920 Adipocytokine signaling pathway 10891_6257_207_208_3717_1147_5599_6258_6256_6774_5970_4790_5781 13 1.78E-10 1.50E-08 5.34E-10 8484 hsa-mir-210 hsa05216 Thyroid cancer 595_6257_5595_5594_6258_6256_7157_8031_5604_4609 10 1.99E-10 1.67E-08 5.77E-10 8485 hsa-mir-210 hsa04620 Toll-like receptor signaling pathway 1432_8503_207_208_1147_5595_5594_5599_6772_5970_3725_5295_4790_5604_2353 15 2.29E-10 1.92E-08 6.40E-10 8486 hsa-mir-210 hsa04720 Long-term potentiation 2902_5894_5595_5594_1387_6195_6197_2033_808_801_805_5604_5566 13 6.09E-10 5.12E-08 1.65E-09 8487 hsa-mir-210 hsa04650 Natural killer cell mediated cytotoxicity 6654_5777_3932_6850_8503_2885_5894_5595_5594_836_5295_5058_5604_919_5781_6464 16 1.36E-09 1.14E-07 3.56E-09 8488 hsa-mir-210 hsa04350 TGF-beta signaling pathway 6500_6667_5933_5595_5594_1387_4087_4088_4089_2033_5515_8454_4609 13 3.07E-09 2.58E-07 7.82E-09 8489 hsa-mir-210 hsa04120 Ubiquitin mediated proteolysis 55294_4214_4193_6502_6500_10401_867_10273_7325_7329_5371_672_8454_7428_8554 15 1.08E-08 9.08E-07 2.67E-08 8490 hsa-mir-210 hsa04916 Melanogenesis 3815_5894_5595_5594_1387_2932_2033_808_801_805_2770_5604_5566 13 2.13E-08 1.79E-06 5.11E-08 8491 hsa-mir-210 hsa04150 mTOR signaling pathway 3091_8503_207_208_5595_5594_7249_6195_6197_5295 10 2.49E-08 2.09E-06 5.80E-08 8492 hsa-mir-210 hsa04115 p53 signaling pathway 595_4193_4616_836_7249_7157_10912_891_983_7161_1029 11 2.79E-08 2.34E-06 6.33E-08 8493 hsa-mir-210 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_1432_1147_5599_836_5970_3725_5058_4790_5781 11 3.63E-08 3.05E-06 8.02E-08 8494 hsa-mir-210 hsa04370 VEGF signaling pathway 6714_1432_8503_5894_207_208_5595_5594_5295_4846_5604 11 7.66E-08 6.43E-06 1.65E-07 8495 hsa-mir-210 hsa05016 Huntington's disease 10891_1537_3066_3065_3064_2902_4724_6667_627_1387_836_7157_2033_6874_6908 15 4.19E-07 3.52E-05 8.81E-07 8496 hsa-mir-210 hsa04810 Regulation of actin cytoskeleton 6654_7074_9564_1956_8503_5894_5595_5594_56924_5295_5058_5159_5156_5604_1399_1398 16 5.23E-07 4.39E-05 1.07E-06 8497 hsa-mir-210 hsa04210 Apoptosis 8503_207_208_1147_836_5970_7157_5295_4790_5566 10 2.21E-06 0.00018584 4.42E-06 8498 hsa-mir-210 hsa03022 Basal transcription factors 6881_2965_2962_2969_6874_6908_2959 7 3.56E-06 0.000299239 6.96E-06 8499 hsa-mir-210 hsa04730 Long-term depression 5894_5595_5594_4846_3480_5515_2770_5604 8 2.26E-05 0.001901923 4.32E-05 8500 hsa-mir-210 hsa05340 Primary immunodeficiency 6890_3932_3561_3718_695_3575 6 2.96E-05 0.00248577 5.52E-05 8501 hsa-mir-210 hsa04930 Type II diabetes mellitus 8503_5595_5594_5599_5295_3643 6 0.000104618 0.008787902 0.000191041 8502 hsa-mir-210 hsa05010 Alzheimer's disease 1537_2902_4724_5595_5594_836_2932_4846_808_801_805 11 0.000123111 0.01034136 0.000220029 8503 hsa-mir-210 hsa04330 Notch signaling pathway 9612_3066_3065_1387_2033_2648 6 0.000130078 0.010926565 0.000227637 8504 hsa-mir-210 hsa04020 Calcium signaling pathway 1956_2902_2064_2066_4846_808_801_805_5159_5156_5566 11 0.000169718 0.014256346 0.000290946 8505 hsa-mir-210 hsa05131 Shigellosis 51807_7846_7277_7278_4691_10376 6 0.000311412 0.026158645 0.000512915 8506 hsa-mir-210 hsa05130 Pathogenic Escherichia coli infection 51807_7846_7277_7278_4691_10376 6 0.000311412 0.026158645 0.000512915 8507 hsa-mir-210 hsa04612 Antigen processing and presentation 6890_3312_3320_3326_4800_4801_4802 7 0.00057283 0.04811776 0.000925342 8508 hsa-mir-210 hsa04270 Vascular smooth muscle contraction 5894_5595_5594_808_801_805_5604_5566 8 0.000596377 0.050095643 0.000945201 8509 hsa-mir-210 hsa04060 Cytokine-cytokine receptor interaction 3815_1234_8764_1956_3560_3561_2057_2690_85480_3575_5159_5156 12 0.000867387 0.072860497 0.001349268 8510 hsa-mir-210 hsa04530 Tight junction 1457_6714_207_208_1460_1459_5515_2770 8 0.001483888 0.124646619 0.002266302 8511 hsa-mir-210 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_1432_836_7157_4846 5 0.002098555 0.17627864 0.003147833 8512 hsa-mir-210 hsa04360 Axon guidance 5595_5594_56924_2932_5058_5998_2770 7 0.004596015 0.386065244 0.006773074 8513 hsa-mir-210 hsa03420 Nucleotide excision repair 902_2965_4331_1022 4 0.005524644 0.464070078 0.008001208 8514 hsa-mir-210 hsa04070 Phosphatidylinositol signaling system 8503_5295_808_801_805 5 0.00711037 0.59727107 0.010123238 8515 hsa-mir-210 hsa04670 Leukocyte transendothelial migration 9564_1432_8503_5295_2770_5781 6 0.01219496 1 0.017072943 8516 hsa-mir-210 hsa03410 Base excision repair 3146_4350_6996 3 0.019885656 1 0.027383527 8517 hsa-mir-210 hsa03010 Ribosome 6222_6124_6129_6143_6231 5 0.021662552 1 0.029349264 8518 hsa-mir-210 hsa03320 PPAR signaling pathway 2168_6257_6258_6256 4 0.024242294 1 0.032323058 8519 hsa-mir-210 hsa04640 Hematopoietic cell lineage 3815_2057_3575_914 4 0.046443331 1 0.060956872 8520 hsa-mir-211 hsa05200 Pathways in cancer 2249_367_3725_6776_6777_2353_5914_5970_6256 9 2.65E-10 1.03E-08 1.03E-08 8521 hsa-mir-211 hsa05221 Acute myeloid leukemia 6776_6777_5914_5970 4 1.10E-06 4.30E-05 2.15E-05 8522 hsa-mir-211 hsa05220 Chronic myeloid leukemia 6776_6777_5970 3 0.000122817 0.004789859 0.001197465 8523 hsa-mir-211 hsa04662 B cell receptor signaling pathway 3725_2353_5970 3 0.000122817 0.004789859 0.001197465 8524 hsa-mir-211 hsa04012 ErbB signaling pathway 3725_6776_6777 3 0.000187741 0.007321891 0.001464378 8525 hsa-mir-211 hsa04620 Toll-like receptor signaling pathway 3725_2353_5970 3 0.000295792 0.011535878 0.00179317 8526 hsa-mir-211 hsa04660 T cell receptor signaling pathway 3725_2353_5970 3 0.000366948 0.014310959 0.00179317 8527 hsa-mir-211 hsa04010 MAPK signaling pathway 2249_3725_2353_5970 4 0.00036783 0.014345358 0.00179317 8528 hsa-mir-211 hsa04630 Jak-STAT signaling pathway 3977_6776_6777 3 0.000973048 0.037948874 0.004216542 8529 hsa-mir-211 hsa04920 Adipocytokine signaling pathway 5970_6256 2 0.003288319 0.128244438 0.012824444 8530 hsa-mir-211 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5970 2 0.003672214 0.143216338 0.013019667 8531 hsa-mir-211 hsa05210 Colorectal cancer 3725_2353 2 0.005056231 0.197193018 0.014672017 8532 hsa-mir-211 hsa05222 Small cell lung cancer 5970_6256 2 0.005287381 0.206207862 0.014672017 8533 hsa-mir-211 hsa05215 Prostate cancer 367_5970 2 0.005523323 0.215409597 0.014672017 8534 hsa-mir-211 hsa05212 Pancreatic cancer 367_5970 2 0.005643084 0.22008026 0.014672017 8535 hsa-mir-211 hsa03450 Non-homologous end-joining 2547 1 0.018322969 0.714595793 0.044662237 8536 hsa-mir-211 hsa05016 Huntington's disease 6908_6667 2 0.022928457 0.894209814 0.052134377 8537 hsa-mir-211 hsa04062 Chemokine signaling pathway 6777_5970 2 0.02406202 0.938418786 0.052134377 8538 hsa-mir-211 hsa04950 Maturity onset diabetes of the young 6927 1 0.030356363 1 0.06231043 8539 hsa-mir-211 hsa05216 Thyroid cancer 6256 1 0.036319119 1 0.070822281 8540 hsa-mir-211 hsa04080 Neuroactive ligand-receptor interaction 2908_7067 2 0.040192254 1 0.074642758 8541 hsa-mir-211 hsa03410 Base excision repair 142 1 0.044607076 1 0.077636103 8542 hsa-mir-211 hsa03022 Basal transcription factors 6908 1 0.045785394 1 0.077636103 8543 hsa-mir-2113 hsa03022 Basal transcription factors 2961_2960_2963_6881_2969_2967_6879_6878_6877_6874_6872_2957_54457_2968_6908_2958_6873_6884_2959_6880_6882_138474_6883 23 1.41E-34 9.90E-33 9.90E-33 8544 hsa-mir-2113 hsa05200 Pathways in cancer 3716_5594_1387_6256_4286_367_4193_6688_2353_6772_5970_7157_3725_4609_10401_4088_3065_5925_2033_3326_8554_7184_7186 23 8.68E-16 6.07E-14 3.04E-14 8545 hsa-mir-2113 hsa04630 Jak-STAT signaling pathway 3717_3716_1387_6778_6772_3454_3455_7297_4609_10401_2033_8554_10379 13 2.13E-10 1.49E-08 4.96E-09 8546 hsa-mir-2113 hsa05215 Prostate cancer 5594_1387_367_4193_5970_7157_5925_2033_3326_7184 10 1.83E-09 1.28E-07 2.44E-08 8547 hsa-mir-2113 hsa05212 Pancreatic cancer 5594_1387_367_4193_5970_7157_5925_2033_3326_7184 10 2.02E-09 1.42E-07 2.44E-08 8548 hsa-mir-2113 hsa04110 Cell cycle 993_1387_983_4193_7157_4171_4085_4088_3065_5925_2033 11 2.09E-09 1.46E-07 2.44E-08 8549 hsa-mir-2113 hsa05220 Chronic myeloid leukemia 5594_4193_5970_7157_4609_4088_3065_5925 8 1.25E-07 8.73E-06 1.25E-06 8550 hsa-mir-2113 hsa05222 Small cell lung cancer 6256_5970_7157_4609_10401_5925_8554_7186 8 3.30E-07 2.31E-05 2.89E-06 8551 hsa-mir-2113 hsa05016 Huntington's disease 6874_1387_6908_9001_5430_7157_3064_3065_2033_4716 10 1.45E-06 0.000101168 1.12E-05 8552 hsa-mir-2113 hsa04010 MAPK signaling pathway 6722_5594_3303_2353_3312_5970_7157_3725_4609_3727_7186 11 5.63E-06 0.000394335 3.94E-05 8553 hsa-mir-2113 hsa04620 Toll-like receptor signaling pathway 5594_2353_6772_5970_3454_3455_3725 7 1.20E-05 0.000837646 7.61E-05 8554 hsa-mir-2113 hsa04310 Wnt signaling pathway 1460_1387_8607_7157_3725_4609_4088_2033 8 1.78E-05 0.001248111 0.000103109 8555 hsa-mir-2113 hsa05219 Bladder cancer 5594_4193_7157_4609_5925 5 1.91E-05 0.001340421 0.000103109 8556 hsa-mir-2113 hsa03050 Proteasome 5701_5705_5702_5719_5710 5 3.46E-05 0.002423866 0.000173133 8557 hsa-mir-2113 hsa05210 Colorectal cancer 5594_2353_7157_3725_4609_4088 6 4.13E-05 0.002891409 0.000192761 8558 hsa-mir-2113 hsa04612 Antigen processing and presentation 3303_4801_4802_3312_1514_3326 6 5.60E-05 0.003921059 0.000245066 8559 hsa-mir-2113 hsa05216 Thyroid cancer 5594_6256_7157_4609 4 8.07E-05 0.005651121 0.000332419 8560 hsa-mir-2113 hsa05218 Melanoma 5594_4286_4193_7157_5925 5 0.00019575 0.013702527 0.000761252 8561 hsa-mir-2113 hsa04520 Adherens junction 1460_5594_1387_4088_2033 5 0.000330353 0.023124715 0.00121709 8562 hsa-mir-2113 hsa04330 Notch signaling pathway 1387_3065_2033_8850 4 0.000446919 0.031284365 0.001564218 8563 hsa-mir-2113 hsa04350 TGF-beta signaling pathway 5594_1387_4609_4088_2033 5 0.000476133 0.033329319 0.00158711 8564 hsa-mir-2113 hsa05223 Non-small cell lung cancer 5594_6256_7157_5925 4 0.000730414 0.051128973 0.002324044 8565 hsa-mir-2113 hsa05221 Acute myeloid leukemia 5594_6688_5970_4609 4 0.000998005 0.069860363 0.003037407 8566 hsa-mir-2113 hsa04660 T cell receptor signaling pathway 5594_2353_5970_1739_3725 5 0.001305841 0.091408842 0.003808702 8567 hsa-mir-2113 hsa05214 Glioma 5594_4193_7157_5925 4 0.001402034 0.09814235 0.003925694 8568 hsa-mir-2113 hsa04920 Adipocytokine signaling pathway 3717_6256_5970_7186 4 0.00155879 0.109115324 0.004196743 8569 hsa-mir-2113 hsa05211 Renal cell carcinoma 5594_1387_3725_2033 4 0.002003278 0.140229451 0.005193683 8570 hsa-mir-2113 hsa04662 B cell receptor signaling pathway 5594_2353_5970_3725 4 0.002308274 0.161579147 0.005770684 8571 hsa-mir-2113 hsa03420 Nucleotide excision repair 2967_2968_5887 3 0.004343798 0.304065876 0.01048503 8572 hsa-mir-2113 hsa05213 Endometrial cancer 5594_7157_4609 3 0.006747264 0.472308473 0.015743616 8573 hsa-mir-2113 hsa04916 Melanogenesis 5594_1387_4286_2033 4 0.007041453 0.492901737 0.015900056 8574 hsa-mir-2113 hsa04062 Chemokine signaling pathway 3717_5594_6772_5970_7852 5 0.012917421 0.904219493 0.028256859 8575 hsa-mir-2113 hsa04115 p53 signaling pathway 983_4193_7157 3 0.014070953 0.984966689 0.029094649 8576 hsa-mir-2113 hsa04950 Maturity onset diabetes of the young 5080_4760 2 0.014131687 0.989218083 0.029094649 8577 hsa-mir-2113 hsa04720 Long-term potentiation 5594_1387_2033 3 0.017412706 1 0.034825412 8578 hsa-mir-2113 hsa04120 Ubiquitin mediated proteolysis 11059_4193_10401_8554 4 0.018197487 1 0.035384002 8579 hsa-mir-2113 hsa04012 ErbB signaling pathway 5594_3725_4609 3 0.025312442 1 0.047888403 8580 hsa-mir-2113 hsa04210 Apoptosis 5970_7157_7186 3 0.026787185 1 0.049344815 8581 hsa-mir-2113 hsa04540 Gap junction 5594_983_10382 3 0.029871757 1 0.053615973 8582 hsa-mir-2113 hsa03010 Ribosome 6229_9349_6130 3 0.037465514 1 0.06556465 8583 hsa-mir-2115 hsa04115 p53 signaling pathway 841_7157 2 0.000196566 0.004521022 0.003713493 8584 hsa-mir-2115 hsa04210 Apoptosis 841_7157 2 0.000322912 0.007426986 0.003713493 8585 hsa-mir-2115 hsa05016 Huntington's disease 841_7157 2 0.001394197 0.03206653 0.010688843 8586 hsa-mir-2115 hsa05200 Pathways in cancer 841_7157 2 0.004222399 0.097115179 0.024278795 8587 hsa-mir-2115 hsa05216 Thyroid cancer 7157 1 0.008962596 0.206139711 0.036088171 8588 hsa-mir-2115 hsa05219 Bladder cancer 7157 1 0.012824162 0.294955721 0.036088171 8589 hsa-mir-2115 hsa05213 Endometrial cancer 7157 1 0.01578549 0.363066264 0.036088171 8590 hsa-mir-2115 hsa05223 Non-small cell lung cancer 7157 1 0.016376807 0.376666557 0.036088171 8591 hsa-mir-2115 hsa05217 Basal cell carcinoma 7157 1 0.016672347 0.38346398 0.036088171 8592 hsa-mir-2115 hsa05014 Amyotrophic lateral sclerosis (ALS) 7157 1 0.016967808 0.390259587 0.036088171 8593 hsa-mir-2115 hsa05214 Glioma 7157 1 0.01962341 0.451338425 0.036088171 8594 hsa-mir-2115 hsa05218 Melanoma 7157 1 0.021390266 0.491976126 0.036088171 8595 hsa-mir-2115 hsa05220 Chronic myeloid leukemia 7157 1 0.022566598 0.519031746 0.036088171 8596 hsa-mir-2115 hsa05210 Colorectal cancer 7157 1 0.025208749 0.579801222 0.036088171 8597 hsa-mir-2115 hsa05222 Small cell lung cancer 7157 1 0.025795031 0.593285703 0.036088171 8598 hsa-mir-2115 hsa05215 Prostate cancer 7157 1 0.026380999 0.606762976 0.036088171 8599 hsa-mir-2115 hsa05212 Pancreatic cancer 7157 1 0.026673866 0.613498909 0.036088171 8600 hsa-mir-2115 hsa04620 Toll-like receptor signaling pathway 841 1 0.030474013 0.700902298 0.038939017 8601 hsa-mir-2115 hsa04110 Cell cycle 7157 1 0.035423534 0.814741292 0.042881121 8602 hsa-mir-2115 hsa04120 Ubiquitin mediated proteolysis 7329 1 0.041217736 0.948007926 0.047400396 8603 hsa-mir-2115 hsa04310 Wnt signaling pathway 7157 1 0.044967356 1 0.049249961 8604 hsa-mir-2116 hsa05200 Pathways in cancer 5371_9063_1499_6258_1387_6256_836_367_2932_4193_842_841_5970_1870_1871_7157_4824_4609_3725_1029_3066_2736_4088_4089_2033_207 26 8.68E-23 5.64E-21 5.64E-21 8605 hsa-mir-2116 hsa05215 Prostate cancer 1499_1385_1387_367_2932_4193_842_5970_1870_1871_7157_4824_2033_207 14 1.25E-16 8.14E-15 3.13E-15 8606 hsa-mir-2116 hsa05212 Pancreatic cancer 1499_1385_1387_367_2932_4193_842_5970_1870_1871_7157_4824_2033_207 14 1.44E-16 9.38E-15 3.13E-15 8607 hsa-mir-2116 hsa04010 MAPK signaling pathway 6722_8986_9261_5608_836_6197_9252_1386_1432_5970_7157_4609_3725_6195_6196_5058_207_2002_2005 19 5.37E-16 3.49E-14 8.73E-15 8608 hsa-mir-2116 hsa04110 Cell cycle 7534_5591_1387_7532_2932_4193_1870_1871_7157_1029_3066_4088_4089_2033 14 5.65E-15 3.67E-13 7.35E-14 8609 hsa-mir-2116 hsa05220 Chronic myeloid leukemia 4193_5970_1870_1871_7157_4609_1029_3066_4088_4089_207 11 5.66E-13 3.68E-11 6.14E-12 8610 hsa-mir-2116 hsa05210 Colorectal cancer 1499_836_2932_842_7157_4609_3725_4088_4089_207 10 4.34E-11 2.82E-09 4.03E-10 8611 hsa-mir-2116 hsa05222 Small cell lung cancer 9063_6258_6256_842_5970_1870_1871_7157_4609_207 10 5.37E-11 3.49E-09 4.36E-10 8612 hsa-mir-2116 hsa04310 Wnt signaling pathway 815_1499_1387_2932_7157_4609_3725_1457_4088_4089_2033 11 6.40E-10 4.16E-08 4.62E-09 8613 hsa-mir-2116 hsa05223 Non-small cell lung cancer 6258_6256_842_1870_1871_7157_1029_207 8 8.38E-10 5.45E-08 5.45E-09 8614 hsa-mir-2116 hsa05219 Bladder cancer 9252_4193_1870_1871_7157_4609_1029 7 4.73E-09 3.07E-07 2.79E-08 8615 hsa-mir-2116 hsa05213 Endometrial cancer 1499_2932_842_7157_4609_207_2002 7 1.80E-08 1.17E-06 9.75E-08 8616 hsa-mir-2116 hsa04012 ErbB signaling pathway 815_6714_2932_4609_3725_5058_207_2002 8 2.62E-08 1.70E-06 1.31E-07 8617 hsa-mir-2116 hsa04210 Apoptosis 836_839_842_841_840_5970_7157_207 8 3.09E-08 2.01E-06 1.44E-07 8618 hsa-mir-2116 hsa05016 Huntington's disease 1385_1387_836_6667_842_841_7157_3066_3064_2033 10 6.26E-08 4.07E-06 2.71E-07 8619 hsa-mir-2116 hsa05214 Glioma 815_4193_1870_1871_7157_1029_207 7 7.37E-08 4.79E-06 2.99E-07 8620 hsa-mir-2116 hsa04520 Adherens junction 1499_6714_1387_1457_4088_4089_2033 7 2.75E-07 1.78E-05 1.05E-06 8621 hsa-mir-2116 hsa05216 Thyroid cancer 1499_6258_6256_7157_4609 5 7.06E-07 4.59E-05 2.55E-06 8622 hsa-mir-2116 hsa04115 p53 signaling pathway 836_4193_842_841_7157_1029 6 2.08E-06 0.000135284 7.12E-06 8623 hsa-mir-2116 hsa05218 Melanoma 4193_1870_1871_7157_1029_207 6 2.43E-06 0.000157996 7.52E-06 8624 hsa-mir-2116 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_836_1432_5970_3725_5058 6 2.43E-06 0.000157996 7.52E-06 8625 hsa-mir-2116 hsa04720 Long-term potentiation 815_1387_6197_6195_6196_2033 6 3.27E-06 0.000212763 9.67E-06 8626 hsa-mir-2116 hsa04330 Notch signaling pathway 1387_3066_9612_2033_4851 5 6.14E-06 0.000398853 1.73E-05 8627 hsa-mir-2116 hsa04350 TGF-beta signaling pathway 1387_6667_4609_4088_4089_2033 6 7.32E-06 0.000475821 1.98E-05 8628 hsa-mir-2116 hsa05014 Amyotrophic lateral sclerosis (ALS) 5608_836_1432_842_7157 5 1.35E-05 0.000880726 3.52E-05 8629 hsa-mir-2116 hsa04620 Toll-like receptor signaling pathway 5608_1432_841_5970_3725_207 6 1.73E-05 0.001123601 4.22E-05 8630 hsa-mir-2116 hsa04630 Jak-STAT signaling pathway 9063_1387_3595_3594_4609_2033_207 7 1.75E-05 0.001140507 4.22E-05 8631 hsa-mir-2116 hsa04916 Melanogenesis 815_1499_1385_1387_2932_2033 6 1.92E-05 0.001247439 4.46E-05 8632 hsa-mir-2116 hsa04912 GnRH signaling pathway 815_6714_5608_1432_3725_2002 6 2.35E-05 0.001528125 5.27E-05 8633 hsa-mir-2116 hsa04660 T cell receptor signaling pathway 2932_1432_5970_3725_5058_207 6 2.59E-05 0.00168638 5.62E-05 8634 hsa-mir-2116 hsa04920 Adipocytokine signaling pathway 6258_6256_5970_207_2538 5 3.05E-05 0.001982302 6.39E-05 8635 hsa-mir-2116 hsa05211 Renal cell carcinoma 1387_3725_5058_2033_207 5 4.22E-05 0.002743948 8.57E-05 8636 hsa-mir-2116 hsa04370 VEGF signaling pathway 6714_9261_1432_842_207 5 5.71E-05 0.003714525 0.000112561 8637 hsa-mir-2116 hsa04510 Focal adhesion 1499_6714_2932_3725_5058_207_2002 7 9.97E-05 0.0064792 0.000190565 8638 hsa-mir-2116 hsa04150 mTOR signaling pathway 6197_6195_6196_207 4 0.000176783 0.011490919 0.000328312 8639 hsa-mir-2116 hsa05217 Basal cell carcinoma 1499_2932_7157_2736 4 0.000216543 0.014075269 0.00039098 8640 hsa-mir-2116 hsa05221 Acute myeloid leukemia 5371_5970_4609_207 4 0.000279076 0.018139964 0.000490269 8641 hsa-mir-2116 hsa05010 Alzheimer's disease 22926_836_2932_842_841_840 6 0.000319733 0.020782651 0.000546912 8642 hsa-mir-2116 hsa04662 B cell receptor signaling pathway 2932_5970_3725_207 4 0.00066193 0.043025429 0.001103216 8643 hsa-mir-2116 hsa04910 Insulin signaling pathway 6720_2932_207_2002_2538 5 0.000762989 0.049594316 0.001239858 8644 hsa-mir-2116 hsa03022 Basal transcription factors 2963_2962_2969 3 0.001041931 0.067725521 0.001651842 8645 hsa-mir-2116 hsa04340 Hedgehog signaling pathway 53944_2932_2736 3 0.003356373 0.218164245 0.005194387 8646 hsa-mir-2116 hsa04530 Tight junction 1499_6714_1457_207 4 0.005483775 0.3564454 0.008289428 8647 hsa-mir-2116 hsa04120 Ubiquitin mediated proteolysis 5371_9063_672_4193 4 0.005761106 0.374471871 0.008510724 8648 hsa-mir-2116 hsa04950 Maturity onset diabetes of the young 3651_3172 2 0.007388995 0.480284663 0.010672993 8649 hsa-mir-2116 hsa04664 Fc epsilon RI signaling pathway 5608_1432_207 3 0.008023376 0.521519455 0.011337379 8650 hsa-mir-2116 hsa04062 Chemokine signaling pathway 2932_5970_5058_207 4 0.017111379 1 0.023664673 8651 hsa-mir-2116 hsa05131 Shigellosis 7534_1499 2 0.033894092 1 0.044961551 8652 hsa-mir-2116 hsa05130 Pathogenic Escherichia coli infection 7534_1499 2 0.033894092 1 0.044961551 8653 hsa-mir-2117 hsa05200 Pathways in cancer 4088_3320_5604_4292_1050_4149_4087_5371_5925_2033_6502_2932_5894_1387_5595_1029_5599_5970 18 2.32E-19 1.32E-17 1.32E-17 8654 hsa-mir-2117 hsa04110 Cell cycle 6500_4088_983_4087_5925_2033_6502_990_2932_8454_1387_1029_5933 13 6.98E-18 3.98E-16 1.99E-16 8655 hsa-mir-2117 hsa04540 Gap junction 983_5604_51807_5894_10376_7846_5595_7277_7278_5598 10 6.38E-14 3.64E-12 1.21E-12 8656 hsa-mir-2117 hsa04350 TGF-beta signaling pathway 6500_4088_4087_6667_2033_8454_1387_5595_5933 9 1.69E-12 9.64E-11 1.94E-11 8657 hsa-mir-2117 hsa05215 Prostate cancer 3320_5604_5925_2033_2932_5894_1387_5595_5970 9 1.86E-12 1.06E-10 1.94E-11 8658 hsa-mir-2117 hsa05212 Pancreatic cancer 3320_5604_5925_2033_2932_5894_1387_5595_5970 9 2.05E-12 1.17E-10 1.94E-11 8659 hsa-mir-2117 hsa04310 Wnt signaling pathway 6500_4088_4087_2033_2932_8454_1387_5599_1457_1459 10 6.26E-12 3.57E-10 5.10E-11 8660 hsa-mir-2117 hsa05210 Colorectal cancer 4088_5604_4292_4087_2932_5894_5595_5599 8 5.73E-11 3.27E-09 4.09E-10 8661 hsa-mir-2117 hsa05220 Chronic myeloid leukemia 4088_5604_5925_5894_5595_1029_5970 7 1.10E-09 6.28E-08 6.98E-09 8662 hsa-mir-2117 hsa04520 Adherens junction 4088_4087_2033_1387_5595_1457_1459 7 1.68E-09 9.56E-08 9.56E-09 8663 hsa-mir-2117 hsa05131 Shigellosis 4691_51807_10376_7846_7277_7278 6 8.42E-09 4.80E-07 4.00E-08 8664 hsa-mir-2117 hsa05130 Pathogenic Escherichia coli infection 4691_51807_10376_7846_7277_7278 6 8.42E-09 4.80E-07 4.00E-08 8665 hsa-mir-2117 hsa05221 Acute myeloid leukemia 5604_1050_5371_5894_5595_5970 6 1.12E-08 6.41E-07 4.93E-08 8666 hsa-mir-2117 hsa05219 Bladder cancer 5604_5925_5894_5595_1029 5 9.69E-08 5.52E-06 3.95E-07 8667 hsa-mir-2117 hsa05213 Endometrial cancer 5604_4292_2932_5894_5595 5 2.60E-07 1.48E-05 9.55E-07 8668 hsa-mir-2117 hsa04916 Melanogenesis 5604_2033_2932_5894_1387_5595 6 2.68E-07 1.53E-05 9.55E-07 8669 hsa-mir-2117 hsa05223 Non-small cell lung cancer 5604_5925_5894_5595_1029 5 3.09E-07 1.76E-05 1.04E-06 8670 hsa-mir-2117 hsa04010 MAPK signaling pathway 5604_4149_5894_1386_5595_5599_5598_5970 8 3.75E-07 2.14E-05 1.19E-06 8671 hsa-mir-2117 hsa05214 Glioma 5604_5925_5894_5595_1029 5 7.33E-07 4.18E-05 2.20E-06 8672 hsa-mir-2117 hsa05218 Melanoma 5604_5925_5894_5595_1029 5 1.11E-06 6.30E-05 3.15E-06 8673 hsa-mir-2117 hsa05211 Renal cell carcinoma 5604_2033_5894_1387_5595 5 1.18E-06 6.73E-05 3.20E-06 8674 hsa-mir-2117 hsa04120 Ubiquitin mediated proteolysis 6500_55294_5371_6502_672_8454 6 1.36E-06 7.76E-05 3.39E-06 8675 hsa-mir-2117 hsa04720 Long-term potentiation 5604_2033_5894_1387_5595 5 1.43E-06 8.14E-05 3.39E-06 8676 hsa-mir-2117 hsa04662 B cell receptor signaling pathway 5604_2932_5894_5595_5970 5 1.43E-06 8.14E-05 3.39E-06 8677 hsa-mir-2117 hsa04012 ErbB signaling pathway 5604_2932_5894_5595_5599 5 2.86E-06 0.00016288 6.52E-06 8678 hsa-mir-2117 hsa04912 GnRH signaling pathway 5604_5894_5595_5599_5598 5 7.84E-06 0.000447149 1.72E-05 8679 hsa-mir-2117 hsa04062 Chemokine signaling pathway 5604_7074_2932_5894_5595_5970 6 8.46E-06 0.000482276 1.74E-05 8680 hsa-mir-2117 hsa04660 T cell receptor signaling pathway 5604_2932_5894_5595_5970 5 8.55E-06 0.000487108 1.74E-05 8681 hsa-mir-2117 hsa04910 Insulin signaling pathway 5604_2932_5894_5595_5599 5 2.45E-05 0.001399139 4.82E-05 8682 hsa-mir-2117 hsa04664 Fc epsilon RI signaling pathway 5604_5894_5595_5599 4 4.81E-05 0.002742172 9.14E-05 8683 hsa-mir-2117 hsa05222 Small cell lung cancer 4149_5925_6502_5970 4 6.61E-05 0.003765124 0.000121456 8684 hsa-mir-2117 hsa03022 Basal transcription factors 2962_2969_6908 3 0.000122002 0.006954124 0.000215512 8685 hsa-mir-2117 hsa04620 Toll-like receptor signaling pathway 5604_5595_5599_5970 4 0.00012477 0.007111903 0.000215512 8686 hsa-mir-2117 hsa04510 Focal adhesion 5604_2932_5894_5595_5599 5 0.000154898 0.008829165 0.000259681 8687 hsa-mir-2117 hsa04330 Notch signaling pathway 2033_2648_1387 3 0.000237911 0.0135609 0.000387454 8688 hsa-mir-2117 hsa04115 p53 signaling pathway 983_7161_1029 3 0.000697144 0.039737222 0.001103812 8689 hsa-mir-2117 hsa04730 Long-term depression 5604_5894_5595 3 0.000755151 0.043043634 0.001163341 8690 hsa-mir-2117 hsa04370 VEGF signaling pathway 5604_5894_5595 3 0.000947327 0.053997655 0.001420991 8691 hsa-mir-2117 hsa05016 Huntington's disease 6908_6667_2033_1387 4 0.001180746 0.067302537 0.001725706 8692 hsa-mir-2117 hsa04612 Antigen processing and presentation 3320_4802_4801 3 0.001418569 0.080858411 0.00202146 8693 hsa-mir-2117 hsa04810 Regulation of actin cytoskeleton 5604_7074_5894_5595 4 0.002041531 0.116367292 0.002838227 8694 hsa-mir-2117 hsa05216 Thyroid cancer 5604_5595 2 0.002513154 0.143249795 0.003410709 8695 hsa-mir-2117 hsa04270 Vascular smooth muscle contraction 5604_5894_5595 3 0.003096008 0.176472447 0.00410401 8696 hsa-mir-2117 hsa04650 Natural killer cell mediated cytotoxicity 5604_5894_5595 3 0.004751869 0.270856554 0.006155831 8697 hsa-mir-2117 hsa04930 Type II diabetes mellitus 5595_5599 2 0.005699896 0.324894068 0.007219868 8698 hsa-mir-2117 hsa04920 Adipocytokine signaling pathway 5599_5970 2 0.01195835 0.681625946 0.014817955 8699 hsa-mir-2117 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5970 2 0.01331381 0.758887192 0.016146536 8700 hsa-mir-2117 hsa04360 Axon guidance 2932_5595 2 0.040579599 1 0.048188274 8701 hsa-mir-2117 hsa04530 Tight junction 1457_1459 2 0.043936295 1 0.051109568 8702 hsa-mir-212 hsa05200 Pathways in cancer 595_2261_4193_6934_3091_3066_3065_1050_5925_7184_25_1956_2113_6774_861_10401_207_3716_1026_4233_5595_5594_5599_1387_2064_6256_3326_367_2932_6776_6777_6772_5979_5879_7157_6688_3725_2736_4087_4088_4089_2033_4790_5970_3320_5371_3480_5159_5156_5601_5602_4609_2353_1441_8554 55 5.64E-33 4.45E-31 4.45E-31 8703 hsa-mir-212 hsa03022 Basal transcription factors 54457_6879_2958_138474_6883_6880_6881_2967_2961_2960_2963_2969_2968_6878_6877_6874_6873_6872_6908_6884_6882_2959_2957 23 4.66E-25 3.68E-23 1.84E-23 8704 hsa-mir-212 hsa04010 MAPK signaling pathway 3925_6722_9479_6195_6197_2261_2264_9252_4773_8986_1956_1432_1616_207_5595_5594_5599_1386_3312_1649_5879_7157_468_3725_3727_6196_4790_51701_5970_5159_9261_5156_5601_5600_5603_5602_6885_4609_2353_8550 40 1.76E-22 1.39E-20 4.64E-21 8705 hsa-mir-212 hsa05215 Prostate cancer 595_4193_6934_5925_7184_1956_9586_207_1026_5595_5594_1387_2064_3326_367_2932_7157_468_2033_4790_5970_3320_3480_5159_5156 25 1.94E-20 1.53E-18 3.83E-19 8706 hsa-mir-212 hsa05212 Pancreatic cancer 595_4193_6934_5925_7184_1956_9586_207_1026_5595_5594_1387_2064_3326_367_2932_7157_468_2033_4790_5970_3320_3480_5159_5156 25 2.44E-20 1.93E-18 3.86E-19 8707 hsa-mir-212 hsa04630 Jak-STAT signaling pathway 3559_595_3454_3455_3560_1439_6774_2690_10401_207_3717_3716_3718_85480_1387_3575_3570_3572_6775_6776_6777_6772_2033_149233_3953_5781_4609_1441_8554 29 3.62E-19 2.86E-17 4.76E-18 8708 hsa-mir-212 hsa05210 Colorectal cancer 595_6934_1956_207_4233_5595_5594_5599_2932_5879_7157_3725_4087_4088_4089_3480_5159_5156_5601_5602_4609_2353 22 1.65E-17 1.30E-15 1.86E-16 8709 hsa-mir-212 hsa05220 Chronic myeloid leukemia 595_4193_3066_3065_5925_25_861_207_1026_5595_5594_6776_6777_7157_4088_4089_4790_5970_5781_4609 20 3.62E-16 2.86E-14 3.58E-15 8710 hsa-mir-212 hsa04520 Adherens junction 6934_1459_1460_1956_6714_2241_4233_5595_5594_1387_2064_5879_1457_4087_4088_4089_2033_51701_3480_6885 20 1.05E-15 8.26E-14 9.18E-15 8711 hsa-mir-212 hsa04310 Wnt signaling pathway 595_8607_6934_1459_4773_1460_5599_1387_2932_5879_7157_8061_3725_1457_4087_4088_4089_2033_51701_5601_5602_6423_6885_4609 24 1.24E-14 9.80E-13 9.80E-14 8712 hsa-mir-212 hsa04620 Toll-like receptor signaling pathway 3454_3455_1432_207_3654_5595_5594_5599_6772_5879_3725_4790_5970_5601_5600_5603_5602_6885_2353 19 5.47E-13 4.32E-11 3.93E-12 8713 hsa-mir-212 hsa05221 Acute myeloid leukemia 595_6934_1050_6774_861_207_5595_5594_6776_6777_6688_4790_5970_5371_4609 15 3.30E-12 2.61E-10 2.17E-11 8714 hsa-mir-212 hsa04012 ErbB signaling pathway 25_1956_6714_207_1026_5595_5594_5599_2064_2932_6776_6777_3725_5601_5602_4609 16 4.44E-11 3.51E-09 2.70E-10 8715 hsa-mir-212 hsa04110 Cell cycle 595_4193_4171_3066_3065_5925_25_1026_5591_1387_7533_2932_7157_4085_4087_4088_4089_2033 18 4.88E-11 3.86E-09 2.76E-10 8716 hsa-mir-212 hsa05219 Bladder cancer 595_2261_9252_4193_5925_1956_1026_5595_5594_2064_7157_4609 12 1.57E-10 1.24E-08 8.27E-10 8717 hsa-mir-212 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_1432_4233_5599_5879_3725_4790_5970_5601_5600_5603_5602_5781 14 3.27E-10 2.58E-08 1.61E-09 8718 hsa-mir-212 hsa05218 Melanoma 595_4193_5925_1956_207_1026_4233_5595_5594_7157_3480_5159_5156 13 3.11E-09 2.46E-07 1.44E-08 8719 hsa-mir-212 hsa04660 T cell receptor signaling pathway 4773_3932_1432_207_5595_5594_2932_3725_4790_5970_5601_5600_5603_6885_2353 15 7.14E-09 5.64E-07 3.13E-08 8720 hsa-mir-212 hsa04062 Chemokine signaling pathway 1234_1230_5580_7852_6774_207_3055_3717_3718_5590_5595_5594_2932_6777_6772_5879_4790_5970_2185 19 1.01E-08 7.95E-07 4.09E-08 8721 hsa-mir-212 hsa04060 Cytokine-cytokine receptor interaction 3556_3559_1234_1230_3454_3455_1956_3560_1439_7852_2690_85480_4233_3575_3570_3572_2321_149233_5159_5156_3953_1441 22 1.04E-08 8.18E-07 4.09E-08 8722 hsa-mir-212 hsa05214 Glioma 595_4193_5925_1956_207_1026_5595_5594_7157_3480_5159_5156 12 1.16E-08 9.17E-07 4.36E-08 8723 hsa-mir-212 hsa04912 GnRH signaling pathway 5580_1956_6714_1432_5595_5594_5599_468_3725_5601_5600_5603_5602_2185 14 4.03E-08 3.18E-06 1.45E-07 8724 hsa-mir-212 hsa04664 Fc epsilon RI signaling pathway 5580_6850_1432_207_5595_5594_5599_5879_5601_5600_5603_5602 12 7.95E-08 6.28E-06 2.73E-07 8725 hsa-mir-212 hsa04510 Focal adhesion 595_1956_6714_207_4233_5595_5594_5599_2064_2932_5879_3725_2321_3480_5159_5156_5601_5602 18 1.30E-07 1.03E-05 4.21E-07 8726 hsa-mir-212 hsa04920 Adipocytokine signaling pathway 6774_207_3717_5599_6256_4790_5970_5601_5602_3953_5781 11 1.37E-07 1.08E-05 4.21E-07 8727 hsa-mir-212 hsa05213 Endometrial cancer 595_6934_1956_207_5595_5594_2064_2932_7157_4609 10 1.39E-07 1.10E-05 4.21E-07 8728 hsa-mir-212 hsa04350 TGF-beta signaling pathway 6667_3399_3398_5595_5594_1387_4086_4087_4088_4089_2033_4609 12 2.05E-07 1.62E-05 5.99E-07 8729 hsa-mir-212 hsa05216 Thyroid cancer 595_6934_5595_5594_6256_5979_7157_4609 8 2.36E-07 1.86E-05 6.65E-07 8730 hsa-mir-212 hsa05211 Renal cell carcinoma 3091_2113_207_4233_5595_5594_1387_5879_3725_2033_5781 11 2.63E-07 2.07E-05 7.15E-07 8731 hsa-mir-212 hsa04662 B cell receptor signaling pathway 4773_6850_207_5595_5594_2932_5879_3725_4790_5970_2353 11 3.79E-07 3.00E-05 9.99E-07 8732 hsa-mir-212 hsa05223 Non-small cell lung cancer 595_5925_1956_207_5595_5594_2064_6256_7157 9 1.70E-06 0.000134306 4.33E-06 8733 hsa-mir-212 hsa04370 VEGF signaling pathway 4773_6714_1432_207_5595_5594_5879_9261_5600_5603 10 3.47E-06 0.00027377 8.56E-06 8734 hsa-mir-212 hsa04930 Type II diabetes mellitus 5580_3651_5590_5595_5594_5599_5601_5602 8 4.21E-06 0.000332978 1.01E-05 8735 hsa-mir-212 hsa04330 Notch signaling pathway 3066_3065_3280_388585_1387_9612_2033_8850 8 5.61E-06 0.000443374 1.30E-05 8736 hsa-mir-212 hsa05222 Small cell lung cancer 595_5925_10401_207_6256_7157_4790_5970_4609_8554 10 8.47E-06 0.000669136 1.91E-05 8737 hsa-mir-212 hsa04150 mTOR signaling pathway 6195_6197_3091_207_5595_5594_6196 7 8.38E-05 0.006616627 0.000183795 8738 hsa-mir-212 hsa04720 Long-term potentiation 6195_6197_5595_5594_1387_468_6196_2033 8 0.000117641 0.009293665 0.00025118 8739 hsa-mir-212 hsa04950 Maturity onset diabetes of the young 6927_3087_3280_3651_5080 5 0.000146705 0.011589659 0.000304991 8740 hsa-mir-212 hsa05016 Huntington's disease 3066_3065_3064_6667_9586_1387_9001_5430_7157_2033_6874_6908 12 0.000267991 0.021171314 0.000542854 8741 hsa-mir-212 hsa04650 Natural killer cell mediated cytotoxicity 3454_3455_4773_3932_6850_5595_5594_5879_5781_2185 10 0.00033621 0.026560601 0.000664015 8742 hsa-mir-212 hsa04210 Apoptosis 3556_823_1439_207_3654_7157_4790_5970 8 0.000347063 0.027417956 0.000668731 8743 hsa-mir-212 hsa04540 Gap junction 10382_1956_6714_5592_5595_5594_5159_5156 8 0.000456249 0.0360437 0.000858183 8744 hsa-mir-212 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_1616_5879_7157_5600_5603 6 0.000820426 0.064813671 0.001507295 8745 hsa-mir-212 hsa04360 Axon guidance 4773_25_7852_2242_4233_5595_5594_2932_5879 9 0.000941356 0.074367092 0.001690161 8746 hsa-mir-212 hsa04910 Insulin signaling pathway 5211_207_5590_5595_5594_5599_2932_5601_5602 9 0.001326597 0.104801127 0.002328914 8747 hsa-mir-212 hsa04120 Ubiquitin mediated proteolysis 55294_4193_10401_7329_83737_64326_5371_672_8554 9 0.001390722 0.10986706 0.002388414 8748 hsa-mir-212 hsa04612 Antigen processing and presentation 4801_3326_3312_3320_4800_4802_2923 7 0.001665144 0.131546399 0.00279886 8749 hsa-mir-212 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 0.002497594 0.197309952 0.004110624 8750 hsa-mir-212 hsa04670 Leukocyte transendothelial migration 1432_7852_5879_5600_5603_5781_2185 7 0.00848894 0.670626223 0.013686249 8751 hsa-mir-212 hsa04115 p53 signaling pathway 595_4193_1026_7157_64326 5 0.010353277 0.817908908 0.016159312 8752 hsa-mir-212 hsa03420 Nucleotide excision repair 5887_2967_2968_6118 4 0.010431961 0.824124921 0.016159312 8753 hsa-mir-212 hsa04916 Melanogenesis 6934_5595_5594_1387_2932_2033 6 0.014040667 1 0.021331013 8754 hsa-mir-212 hsa04530 Tight junction 1459_1460_5580_6714_207_5590_1457 7 0.014907186 1 0.022220146 8755 hsa-mir-212 hsa04740 Olfactory transduction 5592 1 0.017583959 1 0.02572468 8756 hsa-mir-212 hsa05217 Basal cell carcinoma 6934_2932_7157_2736 4 0.020961215 1 0.030107927 8757 hsa-mir-212 hsa05340 Primary immunodeficiency 3932_3718_3575 3 0.029897998 1 0.042177533 8758 hsa-mir-212 hsa04730 Long-term depression 5592_5595_5594_3480 4 0.044974292 1 0.06233279 8759 hsa-mir-214 hsa04110 Cell cycle 4088_4089_898_2033_7534_1017_7532_4174_5001_1026_4172_4173_1029_1387_4998_4999 16 2.51E-24 1.28E-22 1.28E-22 8760 hsa-mir-214 hsa05215 Prostate cancer 898_2033_1017_468_207_208_1499_1026_1387 9 4.57E-13 2.33E-11 8.54E-12 8761 hsa-mir-214 hsa05212 Pancreatic cancer 898_2033_1017_468_207_208_1499_1026_1387 9 5.02E-13 2.56E-11 8.54E-12 8762 hsa-mir-214 hsa05200 Pathways in cancer 4088_4089_3725_898_2033_1017_207_208_1499_1026_1029_1387 12 5.39E-12 2.75E-10 6.87E-11 8763 hsa-mir-214 hsa05220 Chronic myeloid leukemia 4088_4089_207_208_1026_1029 6 1.73E-08 8.81E-07 1.76E-07 8764 hsa-mir-214 hsa05210 Colorectal cancer 4088_4089_3725_207_208_1499 6 3.27E-08 1.67E-06 2.78E-07 8765 hsa-mir-214 hsa05211 Renal cell carcinoma 3725_2033_207_208_1387 5 5.58E-07 2.85E-05 4.06E-06 8766 hsa-mir-214 hsa04520 Adherens junction 4088_4089_2033_1499_1387 5 9.15E-07 4.66E-05 5.23E-06 8767 hsa-mir-214 hsa04310 Wnt signaling pathway 4088_4089_3725_2033_1499_1387 6 9.24E-07 4.71E-05 5.23E-06 8768 hsa-mir-214 hsa04010 MAPK signaling pathway 6722_3725_468_207_208_1649_3727 7 1.79E-06 9.14E-05 9.14E-06 8769 hsa-mir-214 hsa05214 Glioma 207_208_1026_1029 4 1.28E-05 0.000653909 5.94E-05 8770 hsa-mir-214 hsa04115 p53 signaling pathway 898_1017_1026_1029 4 1.60E-05 0.00081823 6.82E-05 8771 hsa-mir-214 hsa05218 Melanoma 207_208_1026_1029 4 1.79E-05 0.000910906 7.01E-05 8772 hsa-mir-214 hsa04720 Long-term potentiation 5499_2033_468_1387 4 2.19E-05 0.001119115 7.99E-05 8773 hsa-mir-214 hsa05222 Small cell lung cancer 898_1017_207_208 4 3.67E-05 0.001871222 0.000114956 8774 hsa-mir-214 hsa04350 TGF-beta signaling pathway 4088_4089_2033_1387 4 3.83E-05 0.001954244 0.000114956 8775 hsa-mir-214 hsa04012 ErbB signaling pathway 3725_207_208_1026 4 3.83E-05 0.001954244 0.000114956 8776 hsa-mir-214 hsa03030 DNA replication 4174_4172_4173 3 7.24E-05 0.003692562 0.000203841 8777 hsa-mir-214 hsa04510 Focal adhesion 5499_3725_207_208_1499 5 7.59E-05 0.003872979 0.000203841 8778 hsa-mir-214 hsa05213 Endometrial cancer 207_208_1499 3 0.000203018 0.010353942 0.000517697 8779 hsa-mir-214 hsa05223 Non-small cell lung cancer 207_208_1029 3 0.000225764 0.011513948 0.000548283 8780 hsa-mir-214 hsa04630 Jak-STAT signaling pathway 2033_207_208_1387 4 0.000331069 0.016884542 0.000767479 8781 hsa-mir-214 hsa04662 B cell receptor signaling pathway 3725_207_208 3 0.000569186 0.029028511 0.001262109 8782 hsa-mir-214 hsa04620 Toll-like receptor signaling pathway 3725_207_208 3 0.001348196 0.068757985 0.002864916 8783 hsa-mir-214 hsa04916 Melanogenesis 2033_1499_1387 3 0.001423319 0.072589253 0.00290357 8784 hsa-mir-214 hsa04660 T cell receptor signaling pathway 3725_207_208 3 0.00166431 0.084879795 0.003264607 8785 hsa-mir-214 hsa04530 Tight junction 207_208_1499 3 0.003058583 0.155987725 0.005683805 8786 hsa-mir-214 hsa04910 Insulin signaling pathway 5499_207_208 3 0.00312052 0.159146541 0.005683805 8787 hsa-mir-214 hsa05219 Bladder cancer 1026_1029 2 0.003744331 0.190960881 0.006584858 8788 hsa-mir-214 hsa04330 Notch signaling pathway 2033_1387 2 0.004623993 0.235823649 0.007860788 8789 hsa-mir-214 hsa04150 mTOR signaling pathway 207_208 2 0.005589569 0.285068032 0.009195743 8790 hsa-mir-214 hsa05131 Shigellosis 7534_1499 2 0.006422678 0.327556578 0.009925957 8791 hsa-mir-214 hsa05130 Pathogenic Escherichia coli infection 7534_1499 2 0.006422678 0.327556578 0.009925957 8792 hsa-mir-214 hsa05221 Acute myeloid leukemia 207_208 2 0.00708229 0.361196792 0.010568607 8793 hsa-mir-214 hsa05016 Huntington's disease 4697_2033_1387 3 0.007252965 0.36990123 0.010568607 8794 hsa-mir-214 hsa04920 Adipocytokine signaling pathway 207_208 2 0.00898392 0.458179897 0.012727219 8795 hsa-mir-214 hsa04370 VEGF signaling pathway 207_208 2 0.011644107 0.593849435 0.016049985 8796 hsa-mir-214 hsa04664 Fc epsilon RI signaling pathway 207_208 2 0.012212816 0.62285363 0.016390885 8797 hsa-mir-214 hsa04210 Apoptosis 207_208 2 0.015233915 0.776929641 0.019921273 8798 hsa-mir-214 hsa04912 GnRH signaling pathway 3725_468 2 0.021752801 1 0.027734821 8799 hsa-mir-214 hsa04710 Circadian rhythm - mammal 406 1 0.028495846 1 0.035446053 8800 hsa-mir-215 hsa05200 Pathways in cancer 1499_5595_5594_1387_4286_1019_1017_7704_6774_6688_4088_4609_1026_4087_5925_2033_207_8554 18 3.12E-16 1.90E-14 1.90E-14 8801 hsa-mir-215 hsa04350 TGF-beta signaling pathway 5595_5594_1387_7027_1874_4088_4609_4087_2033_5933 10 1.68E-12 1.02E-10 3.15E-11 8802 hsa-mir-215 hsa05215 Prostate cancer 1499_5595_5594_1387_1017_468_1026_5925_2033_207 10 1.86E-12 1.14E-10 3.15E-11 8803 hsa-mir-215 hsa05212 Pancreatic cancer 1499_5595_5594_1387_1017_468_1026_5925_2033_207 10 2.07E-12 1.26E-10 3.15E-11 8804 hsa-mir-215 hsa04110 Cell cycle 1387_1019_1017_7027_4088_1026_4087_5925_2033_5933 10 2.99E-11 1.83E-09 3.65E-10 8805 hsa-mir-215 hsa05220 Chronic myeloid leukemia 5595_5594_1019_4088_4609_1026_5925_207 8 5.31E-10 3.24E-08 5.39E-09 8806 hsa-mir-215 hsa04520 Adherens junction 1460_1499_5595_5594_1387_4088_4087_2033 8 8.52E-10 5.20E-08 7.43E-09 8807 hsa-mir-215 hsa05221 Acute myeloid leukemia 5595_5594_7704_6774_6688_4609_207 7 3.37E-09 2.06E-07 2.57E-08 8808 hsa-mir-215 hsa05218 Melanoma 5595_5594_4286_1019_1026_5925_207 7 1.11E-08 6.74E-07 7.49E-08 8809 hsa-mir-215 hsa05219 Bladder cancer 5595_5594_1019_4609_1026_5925 6 1.70E-08 1.04E-06 1.04E-07 8810 hsa-mir-215 hsa05210 Colorectal cancer 1499_5595_5594_4088_4609_4087_207 7 3.26E-08 1.99E-06 1.81E-07 8811 hsa-mir-215 hsa05214 Glioma 5595_5594_1019_1026_5925_207 6 1.86E-07 1.13E-05 9.44E-07 8812 hsa-mir-215 hsa05222 Small cell lung cancer 1019_1017_4609_5925_207_8554 6 8.71E-07 5.32E-05 4.09E-06 8813 hsa-mir-215 hsa04310 Wnt signaling pathway 1460_1499_1387_4088_4609_4087_2033 7 1.48E-06 9.03E-05 6.45E-06 8814 hsa-mir-215 hsa05213 Endometrial cancer 1499_5595_5594_4609_207 5 1.70E-06 0.000103669 6.91E-06 8815 hsa-mir-215 hsa05223 Non-small cell lung cancer 5595_5594_1019_5925_207 5 2.02E-06 0.00012327 7.70E-06 8816 hsa-mir-215 hsa04916 Melanogenesis 1499_5595_5594_1387_4286_2033 6 2.49E-06 0.000151766 8.93E-06 8817 hsa-mir-215 hsa05216 Thyroid cancer 1499_5595_5594_4609 4 5.29E-06 0.000322586 1.79E-05 8818 hsa-mir-215 hsa05211 Renal cell carcinoma 5595_5594_1387_2033_207 5 7.59E-06 0.000462883 2.44E-05 8819 hsa-mir-215 hsa04720 Long-term potentiation 5595_5594_1387_468_2033 5 9.16E-06 0.000558559 2.79E-05 8820 hsa-mir-215 hsa04012 ErbB signaling pathway 5595_5594_4609_1026_207 5 1.81E-05 0.001105379 5.26E-05 8821 hsa-mir-215 hsa04630 Jak-STAT signaling pathway 1387_6774_4609_2033_207_8554 6 2.22E-05 0.001351467 6.14E-05 8822 hsa-mir-215 hsa04660 T cell receptor signaling pathway 5595_5594_1019_1739_207 5 5.31E-05 0.003237737 0.000140771 8823 hsa-mir-215 hsa04010 MAPK signaling pathway 5595_5594_1386_468_4609_1649_207 7 5.85E-05 0.003566219 0.000148592 8824 hsa-mir-215 hsa04530 Tight junction 1460_10207_1499_1019_207 5 0.000143856 0.008775203 0.000351008 8825 hsa-mir-215 hsa04510 Focal adhesion 1499_5595_5594_1729_207 5 0.000882661 0.053842305 0.002070858 8826 hsa-mir-215 hsa04150 mTOR signaling pathway 5595_5594_207 3 0.000948017 0.057829031 0.002141816 8827 hsa-mir-215 hsa04115 p53 signaling pathway 1019_1017_1026 3 0.002064674 0.125945137 0.004498041 8828 hsa-mir-215 hsa04662 B cell receptor signaling pathway 5595_5594_207 3 0.002594185 0.158245298 0.005456734 8829 hsa-mir-215 hsa04370 VEGF signaling pathway 5595_5594_207 3 0.002787586 0.170042721 0.005668091 8830 hsa-mir-215 hsa04664 Fc epsilon RI signaling pathway 5595_5594_207 3 0.002989651 0.182368727 0.005882862 8831 hsa-mir-215 hsa05010 Alzheimer's disease 22926_5595_5594_4716 4 0.003768853 0.229900034 0.007184376 8832 hsa-mir-215 hsa05016 Huntington's disease 1387_6908_2033_4716 4 0.004644182 0.28329512 0.008584701 8833 hsa-mir-215 hsa04062 Chemokine signaling pathway 5595_5594_6774_207 4 0.005083743 0.310108294 0.009120832 8834 hsa-mir-215 hsa04620 Toll-like receptor signaling pathway 5595_5594_207 3 0.005973302 0.364371422 0.010410612 8835 hsa-mir-215 hsa04912 GnRH signaling pathway 5595_5594_468 3 0.006962574 0.424716999 0.011797694 8836 hsa-mir-215 hsa03022 Basal transcription factors 6908_2959 2 0.00820835 0.500709328 0.013532685 8837 hsa-mir-215 hsa04360 Axon guidance 5998_5595_5594 3 0.011619724 0.708803147 0.018394131 8838 hsa-mir-215 hsa04930 Type II diabetes mellitus 5595_5594 2 0.011760182 0.717371096 0.018394131 8839 hsa-mir-215 hsa04330 Notch signaling pathway 1387_2033 2 0.012736087 0.776901279 0.019422532 8840 hsa-mir-215 hsa04910 Insulin signaling pathway 5595_5594_207 3 0.013318293 0.812415846 0.019815021 8841 hsa-mir-215 hsa04920 Adipocytokine signaling pathway 6774_207 2 0.024289515 1 0.035277629 8842 hsa-mir-215 hsa04730 Long-term depression 5595_5594 2 0.02696631 1 0.038254533 8843 hsa-mir-215 hsa04612 Antigen processing and presentation 4800_4801 2 0.040362465 1 0.055957053 8844 hsa-mir-215 hsa04810 Regulation of actin cytoskeleton 5595_5594_1729 3 0.042874351 1 0.057842421 8845 hsa-mir-215 hsa04540 Gap junction 5595_5594 2 0.043618875 1 0.057842421 8846 hsa-mir-216a hsa04630 Jak-STAT signaling pathway 3717_3716_3718_867_6776_2057_3575_3559_5781_2033_85480_5777_3560_3561_6774_6777_6772_2690 18 1.68E-21 9.75E-20 9.75E-20 8847 hsa-mir-216a hsa05200 Pathways in cancer 5159_3716_867_6776_1399_1398_2033_2113_3815_675_1956_5156_5595_5594_6774_6777_6772_5914 18 5.24E-16 3.04E-14 1.52E-14 8848 hsa-mir-216a hsa04012 ErbB signaling pathway 867_6776_1399_1398_1956_6714_5595_5594_6777_6464_2066 11 6.48E-14 3.76E-12 1.25E-12 8849 hsa-mir-216a hsa04062 Chemokine signaling pathway 3717_3718_1399_1398_1234_7852_5595_5594_6774_6777_6464_6772 12 1.13E-11 6.56E-10 1.64E-10 8850 hsa-mir-216a hsa05220 Chronic myeloid leukemia 867_6776_5781_1399_1398_5595_5594_6777_6464 9 2.06E-11 1.19E-09 2.13E-10 8851 hsa-mir-216a hsa04060 Cytokine-cytokine receptor interaction 5159_2057_3575_3559_1234_85480_3815_1956_5156_7852_3560_3561_2690 13 2.21E-11 1.28E-09 2.13E-10 8852 hsa-mir-216a hsa04520 Adherens junction 2033_1956_5770_6714_3643_5777_5595_5594 8 1.07E-09 6.19E-08 8.85E-09 8853 hsa-mir-216a hsa05221 Acute myeloid leukemia 6776_3815_5595_5594_6774_6777_5914 7 4.11E-09 2.38E-07 2.98E-08 8854 hsa-mir-216a hsa05211 Renal cell carcinoma 5781_1399_1398_2033_2113_5595_5594 7 1.47E-08 8.53E-07 9.48E-08 8855 hsa-mir-216a hsa04910 Insulin signaling pathway 867_1399_1398_5770_3643_5595_5594_6464 8 5.89E-08 3.42E-06 3.11E-07 8856 hsa-mir-216a hsa04650 Natural killer cell mediated cytotoxicity 6850_919_5781_3932_5777_5595_5594_6464 8 5.89E-08 3.42E-06 3.11E-07 8857 hsa-mir-216a hsa04510 Focal adhesion 5159_1399_1398_1956_6714_5156_5595_5594_6464 9 8.66E-08 5.03E-06 4.19E-07 8858 hsa-mir-216a hsa05214 Glioma 5159_1956_5156_5595_5594_6464 6 2.19E-07 1.27E-05 9.33E-07 8859 hsa-mir-216a hsa04660 T cell receptor signaling pathway 867_919_3932_5777_5595_5594_1493 7 2.25E-07 1.31E-05 9.33E-07 8860 hsa-mir-216a hsa05340 Primary immunodeficiency 3718_695_3575_3932_3561 5 3.22E-07 1.87E-05 1.25E-06 8861 hsa-mir-216a hsa05215 Prostate cancer 5159_2033_1956_5156_5595_5594 6 1.17E-06 6.77E-05 4.23E-06 8862 hsa-mir-216a hsa05212 Pancreatic cancer 5159_2033_1956_5156_5595_5594 6 1.24E-06 7.20E-05 4.24E-06 8863 hsa-mir-216a hsa04540 Gap junction 5159_1956_6714_5156_5595_5594 6 1.58E-06 9.18E-05 5.10E-06 8864 hsa-mir-216a hsa05218 Melanoma 5159_1956_5156_5595_5594 5 8.16E-06 0.000473371 2.49E-05 8865 hsa-mir-216a hsa04662 B cell receptor signaling pathway 6850_695_5777_5595_5594 5 1.05E-05 0.000608998 3.04E-05 8866 hsa-mir-216a hsa05210 Colorectal cancer 5159_1956_5156_5595_5594 5 1.77E-05 0.001024937 4.73E-05 8867 hsa-mir-216a hsa04810 Regulation of actin cytoskeleton 5159_1399_1398_1956_5156_5595_5594 7 1.79E-05 0.001040531 4.73E-05 8868 hsa-mir-216a hsa04010 MAPK signaling pathway 5159_1399_1398_1956_5156_5595_5594 7 6.99E-05 0.004054374 0.000176277 8869 hsa-mir-216a hsa04664 Fc epsilon RI signaling pathway 6850_695_5595_5594 4 0.000231365 0.013419162 0.000559132 8870 hsa-mir-216a hsa04640 Hematopoietic cell lineage 2057_3575_3559_3815 4 0.000329188 0.019092903 0.000734342 8871 hsa-mir-216a hsa04350 TGF-beta signaling pathway 2033_5595_5594_5515 4 0.000329188 0.019092903 0.000734342 8872 hsa-mir-216a hsa05219 Bladder cancer 1956_5595_5594 3 0.000570774 0.033104872 0.001226106 8873 hsa-mir-216a hsa04916 Melanogenesis 2033_3815_5595_5594 4 0.000629993 0.036539574 0.001304985 8874 hsa-mir-216a hsa04930 Type II diabetes mellitus 3643_5595_5594 3 0.000690298 0.040037298 0.001380596 8875 hsa-mir-216a hsa04912 GnRH signaling pathway 1956_6714_5595_5594 4 0.000722158 0.041885147 0.001396172 8876 hsa-mir-216a hsa05213 Endometrial cancer 1956_5595_5594 3 0.001028176 0.059634183 0.001923683 8877 hsa-mir-216a hsa05223 Non-small cell lung cancer 1956_5595_5594 3 0.001140784 0.066165496 0.002067672 8878 hsa-mir-216a hsa04920 Adipocytokine signaling pathway 3717_5781_6774 3 0.002063389 0.119676561 0.003626562 8879 hsa-mir-216a hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5781_1956_6714 3 0.002418297 0.140261211 0.004007463 8880 hsa-mir-216a hsa04730 Long-term depression 5595_5594_5515 3 0.002418297 0.140261211 0.004007463 8881 hsa-mir-216a hsa04720 Long-term potentiation 2033_5595_5594 3 0.002808806 0.162910748 0.004525299 8882 hsa-mir-216a hsa04370 VEGF signaling pathway 6714_5595_5594 3 0.003017767 0.175030498 0.004730554 8883 hsa-mir-216a hsa04020 Calcium signaling pathway 5159_1956_5156_2066 4 0.004762786 0.276241598 0.007269516 8884 hsa-mir-216a hsa05216 Thyroid cancer 5595_5594 2 0.005538931 0.32125802 0.008237385 8885 hsa-mir-216a hsa03010 Ribosome 6143_6124_6129 3 0.006454838 0.374380578 0.009131234 8886 hsa-mir-216a hsa04620 Toll-like receptor signaling pathway 5595_5594_6772 3 0.006454838 0.374380578 0.009131234 8887 hsa-mir-216a hsa03022 Basal transcription factors 6908_2959 2 0.008663606 0.502489121 0.011964027 8888 hsa-mir-216a hsa04360 Axon guidance 7852_5595_5594 3 0.012530347 0.726760128 0.016901398 8889 hsa-mir-216a hsa04330 Notch signaling pathway 9612_2033 2 0.013433754 0.779157751 0.017708131 8890 hsa-mir-216a hsa04150 mTOR signaling pathway 5595_5594 2 0.01615828 0.937180232 0.020826227 8891 hsa-mir-216a hsa05010 Alzheimer's disease 4724_5595_5594 3 0.027159479 1 0.03424456 8892 hsa-mir-216a hsa05016 Huntington's disease 6908_4724_2033 3 0.031584625 1 0.038976772 8893 hsa-mir-216b hsa04950 Maturity onset diabetes of the young 3651_5080 2 0.000330014 0.002640114 0.002640114 8894 hsa-mir-216b hsa04530 Tight junction 60412_4628 2 0.00905837 0.072466958 0.036233479 8895 hsa-mir-216b hsa04930 Type II diabetes mellitus 3651 1 0.046431905 0.371455239 0.123818413 8896 hsa-mir-217 hsa05200 Pathways in cancer 4089_5970_6776_6688_5925_2033_1019_1017_1050_2308_1956_8554_4609_1499_4790_5595_4088_1026_5594_841_861_1387 22 4.64E-22 3.15E-20 3.15E-20 8897 hsa-mir-217 hsa05215 Prostate cancer 5970_5925_2033_1385_1017_468_2308_1956_1499_4790_5595_1026_5594_1387 14 3.13E-19 2.13E-17 8.18E-18 8898 hsa-mir-217 hsa05212 Pancreatic cancer 5970_5925_2033_1385_1017_468_2308_1956_1499_4790_5595_1026_5594_1387 14 3.61E-19 2.45E-17 8.18E-18 8899 hsa-mir-217 hsa05220 Chronic myeloid leukemia 4089_5970_6776_5925_1019_4609_4790_5595_4088_1026_5594_861 12 1.16E-16 7.92E-15 1.98E-15 8900 hsa-mir-217 hsa04350 TGF-beta signaling pathway 4089_1874_6667_2033_7027_4609_5595_4088_5594_5933_1387 11 2.43E-14 1.66E-12 3.31E-13 8901 hsa-mir-217 hsa04010 MAPK signaling pathway 6196_6722_5970_468_9252_1956_4609_4790_5595_5594_1649_2002_6195_5566_1386 15 3.75E-14 2.55E-12 4.25E-13 8902 hsa-mir-217 hsa05221 Acute myeloid leukemia 5970_6776_6688_1050_4609_4790_5595_5594_861 9 1.30E-12 8.87E-11 1.27E-11 8903 hsa-mir-217 hsa05219 Bladder cancer 5925_1019_9252_1956_4609_5595_1026_5594 8 4.92E-12 3.34E-10 4.18E-11 8904 hsa-mir-217 hsa04720 Long-term potentiation 6196_2033_815_468_5595_5594_6195_5566_1387 9 9.33E-12 6.34E-10 7.05E-11 8905 hsa-mir-217 hsa04110 Cell cycle 4089_5925_2033_1019_1017_7027_4088_1026_5933_1387 10 1.66E-11 1.13E-09 1.13E-10 8906 hsa-mir-217 hsa04520 Adherens junction 4089_2033_1956_1499_5595_4088_5594_1387 8 5.32E-10 3.61E-08 3.29E-09 8907 hsa-mir-217 hsa04012 ErbB signaling pathway 6776_815_1956_4609_5595_1026_5594_2002 8 9.86E-10 6.71E-08 5.59E-09 8908 hsa-mir-217 hsa04916 Melanogenesis 2033_1385_815_1499_5595_5594_5566_1387 8 3.69E-09 2.51E-07 1.93E-08 8909 hsa-mir-217 hsa05214 Glioma 5925_1019_815_1956_5595_1026_5594 7 4.15E-09 2.82E-07 2.02E-08 8910 hsa-mir-217 hsa05210 Colorectal cancer 4089_1956_4609_1499_5595_4088_5594 7 2.17E-08 1.47E-06 9.83E-08 8911 hsa-mir-217 hsa05222 Small cell lung cancer 5970_5925_1019_1017_8554_4609_4790 7 2.52E-08 1.72E-06 1.07E-07 8912 hsa-mir-217 hsa05213 Endometrial cancer 1956_4609_1499_5595_5594_2002 6 3.83E-08 2.60E-06 1.53E-07 8913 hsa-mir-217 hsa04310 Wnt signaling pathway 4089_2033_815_4609_1499_4088_5566_1387 8 6.08E-08 4.13E-06 2.30E-07 8914 hsa-mir-217 hsa04912 GnRH signaling pathway 815_468_1956_5595_5594_2002_5566 7 1.10E-07 7.49E-06 3.94E-07 8915 hsa-mir-217 hsa05218 Melanoma 5925_1019_1956_5595_1026_5594 6 2.13E-07 1.45E-05 7.25E-07 8916 hsa-mir-217 hsa05223 Non-small cell lung cancer 5925_1019_1956_5595_5594 5 1.51E-06 0.000102801 4.90E-06 8917 hsa-mir-217 hsa04620 Toll-like receptor signaling pathway 5970_4790_5595_5594_841_6348 6 1.59E-06 0.000107814 4.90E-06 8918 hsa-mir-217 hsa05216 Thyroid cancer 4609_1499_5595_5594 4 4.19E-06 0.000284719 1.24E-05 8919 hsa-mir-217 hsa04630 Jak-STAT signaling pathway 6776_2033_8554_4609_6778_1387 6 1.59E-05 0.001078191 4.49E-05 8920 hsa-mir-217 hsa04150 mTOR signaling pathway 6196_5595_5594_6195 4 3.55E-05 0.002411644 9.65E-05 8921 hsa-mir-217 hsa04660 T cell receptor signaling pathway 5970_1019_4790_5595_5594 5 4.01E-05 0.002725055 0.00010481 8922 hsa-mir-217 hsa04062 Chemokine signaling pathway 5970_4790_5595_5594_6348_5566 6 5.21E-05 0.003541582 0.00013117 8923 hsa-mir-217 hsa04115 p53 signaling pathway 1019_1017_1026_841 4 0.000100697 0.006847405 0.00024455 8924 hsa-mir-217 hsa04910 Insulin signaling pathway 2308_5595_5594_2002_5566 5 0.000112753 0.007667227 0.000264387 8925 hsa-mir-217 hsa05211 Renal cell carcinoma 2033_5595_5594_1387 4 0.000117804 0.008010652 0.000267022 8926 hsa-mir-217 hsa04662 B cell receptor signaling pathway 5970_4790_5595_5594 4 0.000136924 0.009310852 0.00030035 8927 hsa-mir-217 hsa04210 Apoptosis 5970_4790_841_5566 4 0.000256884 0.017468096 0.000545878 8928 hsa-mir-217 hsa04540 Gap junction 1956_5595_5594_5566 4 0.000301798 0.020522254 0.000621886 8929 hsa-mir-217 hsa05016 Huntington's disease 6667_2033_1385_841_1387 5 0.000451977 0.030734424 0.000903954 8930 hsa-mir-217 hsa04510 Focal adhesion 1956_1499_5595_5594_2002 5 0.000676894 0.046028771 0.001315108 8931 hsa-mir-217 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_1956_4790 3 0.001889083 0.128457661 0.003568268 8932 hsa-mir-217 hsa04270 Vascular smooth muscle contraction 5595_5594_5566 3 0.007509714 0.510660551 0.013801637 8933 hsa-mir-217 hsa04930 Type II diabetes mellitus 5595_5594 2 0.010514518 0.7149872 0.018815453 8934 hsa-mir-217 hsa04330 Notch signaling pathway 2033_1387 2 0.011390001 0.774520096 0.01985949 8935 hsa-mir-217 hsa05010 Alzheimer's disease 5595_5594_841 3 0.021704856 1 0.036120127 8936 hsa-mir-217 hsa04920 Adipocytokine signaling pathway 5970_4790 2 0.021778312 1 0.036120127 8937 hsa-mir-217 hsa04020 Calcium signaling pathway 815_1956_5566 3 0.023957609 1 0.038255099 8938 hsa-mir-217 hsa04730 Long-term depression 5595_5594 2 0.024190725 1 0.038255099 8939 hsa-mir-217 hsa04370 VEGF signaling pathway 5595_5594 2 0.028003564 1 0.043278236 8940 hsa-mir-217 hsa04664 Fc epsilon RI signaling pathway 5595_5594 2 0.029324767 1 0.044312981 8941 hsa-mir-217 hsa04612 Antigen processing and presentation 4800_1385 2 0.036290881 1 0.053597308 8942 hsa-mir-217 hsa04810 Regulation of actin cytoskeleton 1956_5595_5594 3 0.037045198 1 0.053597308 8943 hsa-mir-218-1 hsa05200 Pathways in cancer 861_7157_1499_5599_5925_2033_2113_6502_1387_5595_5594_862 12 1.44E-10 8.65E-09 8.65E-09 8944 hsa-mir-218-1 hsa04010 MAPK signaling pathway 9261_4208_1432_7157_5599_1616_9479_7867_5595_5594_6722 11 2.96E-10 1.77E-08 8.87E-09 8945 hsa-mir-218-1 hsa04916 Melanogenesis 1499_2033_1387_5595_5594_808_801_805 8 7.35E-10 4.41E-08 1.47E-08 8946 hsa-mir-218-1 hsa05214 Glioma 7157_5925_5595_5594_808_801_805 7 1.01E-09 6.05E-08 1.51E-08 8947 hsa-mir-218-1 hsa04720 Long-term potentiation 2033_1387_5595_5594_808_801_805 7 2.55E-09 1.53E-07 3.05E-08 8948 hsa-mir-218-1 hsa04350 TGF-beta signaling pathway 3398_2033_1387_5595_5594_3397_3399 7 6.68E-09 4.01E-07 5.81E-08 8949 hsa-mir-218-1 hsa05215 Prostate cancer 7157_1499_5925_2033_1387_5595_5594 7 7.19E-09 4.32E-07 5.81E-08 8950 hsa-mir-218-1 hsa05212 Pancreatic cancer 7157_1499_5925_2033_1387_5595_5594 7 7.74E-09 4.65E-07 5.81E-08 8951 hsa-mir-218-1 hsa04912 GnRH signaling pathway 1432_5599_5595_5594_808_801_805 7 2.73E-08 1.64E-06 1.82E-07 8952 hsa-mir-218-1 hsa05216 Thyroid cancer 7157_1499_5595_5594 4 1.88E-06 0.00011285 1.13E-05 8953 hsa-mir-218-1 hsa05211 Renal cell carcinoma 2033_2113_1387_5595_5594 5 2.12E-06 0.00012721 1.16E-05 8954 hsa-mir-218-1 hsa05220 Chronic myeloid leukemia 861_7157_5925_5595_5594 5 2.56E-06 0.000153808 1.21E-05 8955 hsa-mir-218-1 hsa04910 Insulin signaling pathway 5599_5595_5594_808_801_805 6 2.62E-06 0.000157085 1.21E-05 8956 hsa-mir-218-1 hsa04370 VEGF signaling pathway 9261_1432_7867_5595_5594 5 2.90E-06 0.000173838 1.24E-05 8957 hsa-mir-218-1 hsa04520 Adherens junction 1499_2033_1387_5595_5594 5 3.46E-06 0.000207669 1.38E-05 8958 hsa-mir-218-1 hsa05210 Colorectal cancer 7157_1499_5599_5595_5594 5 4.34E-06 0.000260587 1.58E-05 8959 hsa-mir-218-1 hsa04310 Wnt signaling pathway 7157_1499_5599_2033_6423_1387 6 4.48E-06 0.000268554 1.58E-05 8960 hsa-mir-218-1 hsa05219 Bladder cancer 7157_5925_5595_5594 4 7.30E-06 0.000438222 2.43E-05 8961 hsa-mir-218-1 hsa04930 Type II diabetes mellitus 3651_5599_5595_5594 4 9.42E-06 0.000565499 2.98E-05 8962 hsa-mir-218-1 hsa04330 Notch signaling pathway 2033_1387_388585_8850 4 1.11E-05 0.000664263 3.32E-05 8963 hsa-mir-218-1 hsa05213 Endometrial cancer 7157_1499_5595_5594 4 1.61E-05 0.000966371 4.60E-05 8964 hsa-mir-218-1 hsa05223 Non-small cell lung cancer 7157_5925_5595_5594 4 1.85E-05 0.001111737 5.05E-05 8965 hsa-mir-218-1 hsa04270 Vascular smooth muscle contraction 5595_5594_808_801_805 5 2.10E-05 0.001262991 5.47E-05 8966 hsa-mir-218-1 hsa04110 Cell cycle 7157_5925_2033_6502_1387 5 2.19E-05 0.001313298 5.47E-05 8967 hsa-mir-218-1 hsa05221 Acute myeloid leukemia 861_5595_5594_862 4 2.57E-05 0.001544987 6.18E-05 8968 hsa-mir-218-1 hsa05218 Melanoma 7157_5925_5595_5594 4 5.13E-05 0.003076211 0.000118316 8969 hsa-mir-218-1 hsa04664 Fc epsilon RI signaling pathway 1432_5599_5595_5594 4 7.63E-05 0.00457555 0.000169465 8970 hsa-mir-218-1 hsa05010 Alzheimer's disease 5595_5594_808_801_805 5 0.000135527 0.008131598 0.000290414 8971 hsa-mir-218-1 hsa04620 Toll-like receptor signaling pathway 1432_5599_5595_5594 4 0.000196708 0.011802502 0.000406983 8972 hsa-mir-218-1 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_7157_1616 3 0.00054848 0.032908782 0.001096959 8973 hsa-mir-218-1 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.001283587 0.077015214 0.002484362 8974 hsa-mir-218-1 hsa05222 Small cell lung cancer 7157_5925_6502 3 0.001808099 0.108485925 0.003294428 8975 hsa-mir-218-1 hsa05016 Huntington's disease 7157_6908_2033_1387 4 0.001824379 0.109462741 0.003294428 8976 hsa-mir-218-1 hsa04012 ErbB signaling pathway 5599_5595_5594 3 0.001866842 0.112010541 0.003294428 8977 hsa-mir-218-1 hsa04950 Maturity onset diabetes of the young 3651_168620 2 0.00223184 0.133910404 0.003826012 8978 hsa-mir-218-1 hsa04510 Focal adhesion 1499_5599_5595_5594 4 0.002524265 0.151455927 0.004207109 8979 hsa-mir-218-1 hsa04660 T cell receptor signaling pathway 1432_5595_5594 3 0.003559338 0.21356029 0.0057719 8980 hsa-mir-218-1 hsa04150 mTOR signaling pathway 5595_5594 2 0.009359782 0.56158694 0.014778604 8981 hsa-mir-218-1 hsa05217 Basal cell carcinoma 7157_1499 2 0.010384835 0.623090074 0.015976669 8982 hsa-mir-218-1 hsa04020 Calcium signaling pathway 808_801_805 3 0.014148381 0.848902841 0.021222571 8983 hsa-mir-218-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_5599 2 0.016632786 0.997967152 0.023761123 8984 hsa-mir-218-1 hsa04730 Long-term depression 5595_5594 2 0.016632786 0.997967152 0.023761123 8985 hsa-mir-218-1 hsa04662 B cell receptor signaling pathway 5595_5594 2 0.018391338 1 0.025662331 8986 hsa-mir-218-1 hsa04540 Gap junction 5595_5594 2 0.027207464 1 0.037101088 8987 hsa-mir-218-1 hsa04670 Leukocyte transendothelial migration 1432_1499 2 0.044214399 1 0.058952532 8988 hsa-mir-218-2 hsa05200 Pathways in cancer 3725_2249_367_1499_5595_5594_5599_5914_1387_6257_6256_8031_6258_2353_7704_6774_6776_6777_5970_6688_862_6502_2736_4088_5925_2033_207_2932_8554 29 6.77E-22 4.80E-20 4.80E-20 8989 hsa-mir-218-2 hsa04010 MAPK signaling pathway 6722_3725_2249_5595_5594_5599_4208_6195_9252_7867_2353_1432_5970_9261_10912_6196_6197_8986_4616_207 20 4.54E-14 3.22E-12 1.61E-12 8990 hsa-mir-218-2 hsa05221 Acute myeloid leukemia 5595_5594_5914_7704_6774_6776_6777_5970_6688_862_207 11 3.03E-12 2.15E-10 7.18E-11 8991 hsa-mir-218-2 hsa04720 Long-term potentiation 5595_5594_1387_6195_6196_6197_2033_808_801_805 10 5.80E-10 4.12E-08 1.03E-08 8992 hsa-mir-218-2 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_3397_3398_3399_659_4088_2033 10 2.16E-09 1.54E-07 2.68E-08 8993 hsa-mir-218-2 hsa05215 Prostate cancer 367_1499_5595_5594_1387_5970_5925_2033_207_2932 10 2.39E-09 1.70E-07 2.68E-08 8994 hsa-mir-218-2 hsa05212 Pancreatic cancer 367_1499_5595_5594_1387_5970_5925_2033_207_2932 10 2.65E-09 1.88E-07 2.68E-08 8995 hsa-mir-218-2 hsa05216 Thyroid cancer 1499_5595_5594_6257_6256_8031_6258 7 6.25E-09 4.44E-07 5.55E-08 8996 hsa-mir-218-2 hsa05210 Colorectal cancer 3725_1499_5595_5594_5599_2353_4088_207_2932 9 2.45E-08 1.74E-06 1.94E-07 8997 hsa-mir-218-2 hsa04110 Cell cycle 993_1387_983_10912_6502_4088_5925_2033_4616_2932 10 3.46E-08 2.46E-06 2.46E-07 8998 hsa-mir-218-2 hsa04920 Adipocytokine signaling pathway 10891_5599_6257_6256_6258_6774_5970_207 8 6.94E-08 4.93E-06 4.48E-07 8999 hsa-mir-218-2 hsa04916 Melanogenesis 1499_5595_5594_1387_2033_2932_808_801_805 9 1.35E-07 9.56E-06 7.96E-07 9000 hsa-mir-218-2 hsa05220 Chronic myeloid leukemia 5595_5594_6776_6777_5970_4088_5925_207 8 1.54E-07 1.10E-05 8.44E-07 9001 hsa-mir-218-2 hsa05223 Non-small cell lung cancer 5595_5594_6257_6256_6258_5925_207 7 2.81E-07 1.99E-05 1.42E-06 9002 hsa-mir-218-2 hsa05222 Small cell lung cancer 6257_6256_6258_5970_6502_5925_207_8554 8 4.07E-07 2.89E-05 1.93E-06 9003 hsa-mir-218-2 hsa04012 ErbB signaling pathway 3725_5595_5594_5599_6776_6777_207_2932 8 4.42E-07 3.14E-05 1.96E-06 9004 hsa-mir-218-2 hsa05214 Glioma 5595_5594_5925_207_808_801_805 7 8.87E-07 6.29E-05 3.70E-06 9005 hsa-mir-218-2 hsa04910 Insulin signaling pathway 10891_5595_5594_5599_207_2932_808_801_805 9 1.26E-06 8.93E-05 4.96E-06 9006 hsa-mir-218-2 hsa04620 Toll-like receptor signaling pathway 3725_5595_5594_5599_2353_1432_5970_207 8 1.36E-06 9.65E-05 5.08E-06 9007 hsa-mir-218-2 hsa04912 GnRH signaling pathway 3725_5595_5594_5599_1432_808_801_805 8 2.03E-06 0.000144232 7.21E-06 9008 hsa-mir-218-2 hsa04662 B cell receptor signaling pathway 3725_5595_5594_2353_5970_207_2932 7 2.15E-06 0.000152879 7.28E-06 9009 hsa-mir-218-2 hsa04660 T cell receptor signaling pathway 3725_5595_5594_2353_1432_5970_207_2932 8 2.31E-06 0.000164053 7.46E-06 9010 hsa-mir-218-2 hsa04150 mTOR signaling pathway 5595_5594_6195_6196_6197_207 6 3.79E-06 0.00026939 1.17E-05 9011 hsa-mir-218-2 hsa05211 Renal cell carcinoma 3725_5595_5594_1387_2033_207 6 2.14E-05 0.001517208 6.32E-05 9012 hsa-mir-218-2 hsa04630 Jak-STAT signaling pathway 1387_6774_6776_6777_2033_3977_207_8554 8 2.49E-05 0.001767103 7.07E-05 9013 hsa-mir-218-2 hsa04370 VEGF signaling pathway 5595_5594_7867_1432_9261_207 6 3.05E-05 0.002164112 8.32E-05 9014 hsa-mir-218-2 hsa04330 Notch signaling pathway 388585_1387_9612_2033_8850 5 3.60E-05 0.002557263 9.46E-05 9015 hsa-mir-218-2 hsa04520 Adherens junction 1499_5595_5594_1387_4088_2033 6 3.73E-05 0.002647918 9.46E-05 9016 hsa-mir-218-2 hsa05213 Endometrial cancer 1499_5595_5594_207_2932 5 5.64E-05 0.004001709 0.00013799 9017 hsa-mir-218-2 hsa04310 Wnt signaling pathway 3725_1499_5599_1387_4088_2033_2932 7 0.000158491 0.011252867 0.000375096 9018 hsa-mir-218-2 hsa05218 Melanoma 2249_5595_5594_5925_207 5 0.000222687 0.015810759 0.000510024 9019 hsa-mir-218-2 hsa04270 Vascular smooth muscle contraction 5592_5595_5594_808_801_805 6 0.000282621 0.020066084 0.000627065 9020 hsa-mir-218-2 hsa05219 Bladder cancer 5595_5594_9252_5925 4 0.000333283 0.023663064 0.000717063 9021 hsa-mir-218-2 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_1432_207 5 0.000355245 0.025222393 0.000741835 9022 hsa-mir-218-2 hsa04930 Type II diabetes mellitus 5595_5594_5599_3651 4 0.000425514 0.03021148 0.000863185 9023 hsa-mir-218-2 hsa04062 Chemokine signaling pathway 5595_5594_6774_6777_5970_207_2932 7 0.000634343 0.045038338 0.001251065 9024 hsa-mir-218-2 hsa04510 Focal adhesion 3725_1499_5595_5594_5599_207_2932 7 0.000917741 0.065159627 0.001757676 9025 hsa-mir-218-2 hsa04950 Maturity onset diabetes of the young 3651_168620_6927 3 0.000940728 0.066791685 0.001757676 9026 hsa-mir-218-2 hsa03320 PPAR signaling pathway 6257_6256_6258_2168 4 0.002009661 0.142685965 0.003658614 9027 hsa-mir-218-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5599_1432_5970 4 0.002111093 0.149887622 0.003713994 9028 hsa-mir-218-2 hsa05010 Alzheimer's disease 5595_5594_2932_808_801_805 6 0.002144701 0.152273749 0.003713994 9029 hsa-mir-218-2 hsa05016 Huntington's disease 10891_1387_6908_6667_3064_2033 6 0.002867016 0.203558147 0.004846623 9030 hsa-mir-218-2 hsa04540 Gap junction 5592_5595_5594_983 4 0.005325919 0.378140247 0.008793959 9031 hsa-mir-218-2 hsa05217 Basal cell carcinoma 1499_2736_2932 3 0.008431796 0.598657529 0.013605853 9032 hsa-mir-218-2 hsa04115 p53 signaling pathway 983_10912_4616 3 0.01515027 1 0.02390376 9033 hsa-mir-218-2 hsa04730 Long-term depression 5592_5595_5594 3 0.01629685 1 0.025153834 9034 hsa-mir-218-2 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.019371199 1 0.029262874 9035 hsa-mir-218-2 hsa04120 Ubiquitin mediated proteolysis 672_7329_6502_8554 4 0.01992794 1 0.029476745 9036 hsa-mir-218-2 hsa03410 Base excision repair 3146_142 2 0.030464273 1 0.04414211 9037 hsa-mir-218-2 hsa03022 Basal transcription factors 2963_6908 2 0.031961855 1 0.045385833 9038 hsa-mir-219-1 hsa05200 Pathways in cancer 5467_1499_6654_5914_595_1019_1017_4193_6934_7704_5578_3091_2064_3065_1050_5925_7184_5468_4087_25_405_1956_1487_1488_2308_1147_2885_8503_4824_2113_10401_5894_207_208_4286_5595_5594_5599_861_6258_1387_6257_6256_836_367_6776_6777_6772_5970_7157_6688_7849_3725_6774_4088_4089_5295_2034_2033_4790_4791_3320_51176_5371_3480_8031_5604_842_841_8554_4609_2956_1026_2353_3326 75 2.41E-36 1.98E-34 1.98E-34 9039 hsa-mir-219-1 hsa05215 Prostate cancer 1499_6654_595_1017_4193_6934_2064_5925_7184_1956_2308_1147_2885_8503_4824_5894_207_208_5595_5594_1385_1387_367_5970_7157_5295_10488_2033_4790_3320_51176_3480_5604_842_1026_468_3326 37 3.20E-26 2.63E-24 1.20E-24 9040 hsa-mir-219-1 hsa05212 Pancreatic cancer 1499_6654_595_1017_4193_6934_2064_5925_7184_1956_2308_1147_2885_8503_4824_5894_207_208_5595_5594_1385_1387_367_5970_7157_5295_10488_2033_4790_3320_51176_3480_5604_842_1026_468_3326 37 4.40E-26 3.61E-24 1.20E-24 9041 hsa-mir-219-1 hsa03022 Basal transcription factors 54457_2958_138474_6884_6883_6881_2965_2967_2961_2960_2963_2962_2969_2968_6879_6878_6877_6874_6873_6872_6908_6882_2959_6880_2957 25 5.80E-22 4.76E-20 1.19E-20 9042 hsa-mir-219-1 hsa05220 Chronic myeloid leukemia 6654_595_1019_4193_3065_5925_25_1487_1488_1147_2885_8503_5894_207_208_5595_5594_861_6776_6777_5970_7157_4088_4089_5295_4790_5604_4609_1026_6464 30 5.08E-21 4.17E-19 8.34E-20 9043 hsa-mir-219-1 hsa05221 Acute myeloid leukemia 5467_6654_5914_595_6934_7704_1050_1147_2885_8503_5894_207_208_5595_5594_861_6776_6777_5970_6688_6774_5295_4790_51176_5371_5604_4609 27 2.97E-20 2.44E-18 4.07E-19 9044 hsa-mir-219-1 hsa04010 MAPK signaling pathway 6722_6654_6195_6197_4214_9252_5578_4773_5058_4616_5536_1956_3303_1147_1432_2885_627_4342_5894_2872_207_208_994_5595_5594_5599_5598_1386_836_3312_1649_5970_3164_7157_3725_3727_4790_4791_9261_5604_4208_5566_10912_4609_2353_468_2002_2005 48 1.17E-19 9.62E-18 1.37E-18 9045 hsa-mir-219-1 hsa04110 Cell cycle 4171_595_1019_1017_4193_902_3065_4616_5925_4087_25_5934_5933_994_5591_1022_1387_7533_7027_7157_5111_4085_4088_4089_2033_894_896_10912_2810_1026_1028 31 3.17E-17 2.60E-15 3.25E-16 9046 hsa-mir-219-1 hsa05210 Colorectal cancer 1499_6654_595_6934_4087_1956_2885_8503_5894_207_208_5595_5594_5599_836_7157_3725_4088_4089_5295_51176_3480_5604_842_4609_2956_2353 27 4.36E-17 3.58E-15 3.97E-16 9047 hsa-mir-219-1 hsa05214 Glioma 815_6654_595_1019_4193_5578_5925_1956_2885_8503_5894_207_208_5595_5594_7157_5295_808_801_805_3480_5604_1026_6464 24 1.87E-16 1.53E-14 1.53E-15 9048 hsa-mir-219-1 hsa05223 Non-small cell lung cancer 6654_595_1019_5578_2064_5925_1956_2309_2885_8503_5894_207_208_5595_5594_6258_6257_6256_7157_5295_5604_842 22 6.45E-16 5.29E-14 4.81E-15 9049 hsa-mir-219-1 hsa04012 ErbB signaling pathway 815_6654_5578_2064_5058_25_1956_6714_2885_8503_5894_207_208_5595_5594_5599_56924_6776_6777_3725_5295_5604_4609_1026_6464_2002 26 7.18E-16 5.88E-14 4.90E-15 9050 hsa-mir-219-1 hsa05213 Endometrial cancer 1499_6654_595_6934_2064_1956_2309_2885_8503_5894_207_208_5595_5594_7157_5295_51176_5604_842_4609_2002 21 3.40E-15 2.78E-13 2.14E-14 9051 hsa-mir-219-1 hsa04660 T cell receptor signaling pathway 915_6654_1019_5777_4773_5058_3932_1147_1432_2885_8503_5894_207_208_5595_5594_56924_920_5970_3725_5295_4790_4772_5604_2353 25 5.10E-13 4.18E-11 2.99E-12 9052 hsa-mir-219-1 hsa04310 Wnt signaling pathway 815_5467_1499_595_8607_6934_5578_4773_4087_1487_1488_1460_5599_1387_7157_8061_3725_1457_4088_4089_2033_894_896_51176_4772_5566_4609_5527 28 1.83E-12 1.50E-10 9.58E-12 9053 hsa-mir-219-1 hsa05216 Thyroid cancer 1499_595_6934_5468_5595_5594_6258_6257_6256_7157_7849_51176_8031_5604_4609 15 1.87E-12 1.53E-10 9.58E-12 9054 hsa-mir-219-1 hsa05211 Renal cell carcinoma 6654_3091_5058_405_2885_8503_2113_5894_207_208_5595_5594_56924_1387_3725_5295_2034_2033_5604 19 3.52E-11 2.88E-09 1.70E-10 9055 hsa-mir-219-1 hsa04912 GnRH signaling pathway 815_6654_4214_5578_5580_1956_6714_1432_2885_5894_5595_5594_5599_5598_3725_808_801_805_5604_5566_468_2002 22 8.00E-11 6.56E-09 3.65E-10 9056 hsa-mir-219-1 hsa04350 TGF-beta signaling pathway 6667_4086_3397_4087_3399_3398_1874_1875_5934_5933_3400_5595_5594_1387_7027_4088_4089_2033_4609_4092 20 9.02E-11 7.39E-09 3.89E-10 9057 hsa-mir-219-1 hsa04910 Insulin signaling pathway 10891_6654_6720_5770_2308_2885_8503_5894_5211_2872_207_208_5595_5594_5599_7249_5295_808_801_805_5604_5566_6464_2002 24 1.98E-10 1.62E-08 8.10E-10 9058 hsa-mir-219-1 hsa04662 B cell receptor signaling pathway 6654_5777_4773_1147_2885_8503_5894_207_208_5595_5594_5970_3725_5295_4790_4772_5604_2353 18 4.31E-10 3.53E-08 1.68E-09 9059 hsa-mir-219-1 hsa05222 Small cell lung cancer 595_1019_1017_5925_1147_8503_10401_207_208_6258_6257_6256_5970_7157_5295_4790_842_8554_4609 19 4.74E-10 3.89E-08 1.77E-09 9060 hsa-mir-219-1 hsa04115 p53 signaling pathway 595_1019_1017_4194_4193_4616_836_7249_7157_894_896_842_841_10912_2810_1026_7161 17 9.30E-10 7.63E-08 3.32E-09 9061 hsa-mir-219-1 hsa04520 Adherens junction 1499_6934_5770_5777_2064_4087_1956_6714_1460_5595_5594_1387_1457_4088_4089_2033_51176_3480 18 1.05E-09 8.63E-08 3.53E-09 9062 hsa-mir-219-1 hsa05219 Bladder cancer 595_1019_9252_4193_2064_5925_1956_5894_5595_5594_7157_5604_4609_1026 14 1.08E-09 8.83E-08 3.53E-09 9063 hsa-mir-219-1 hsa05218 Melanoma 595_1019_4193_5925_1956_8503_5894_207_208_4286_5595_5594_7157_5295_3480_5604_1026 17 1.35E-09 1.11E-07 4.27E-09 9064 hsa-mir-219-1 hsa04510 Focal adhesion 1499_6654_595_5578_857_2064_5058_9564_1956_6714_2885_8503_5894_207_208_5595_5594_5599_56924_3725_5295_894_896_3480_5604_6464_2002 27 4.02E-09 3.30E-07 1.22E-08 9065 hsa-mir-219-1 hsa04916 Melanogenesis 815_1499_6934_5578_5894_4286_5595_5594_1385_1387_10488_2033_808_801_805_51176_2770_5604_5566 19 7.44E-09 6.10E-07 2.18E-08 9066 hsa-mir-219-1 hsa04620 Toll-like receptor signaling pathway 1147_3661_1432_8503_3665_207_208_5595_5594_5599_6772_5970_3725_5295_4790_5604_841_2353 18 2.95E-08 2.42E-06 8.33E-08 9067 hsa-mir-219-1 hsa04720 Long-term potentiation 815_6195_6197_5578_5894_5595_5594_1387_2033_808_801_805_5604_5566_468 15 9.96E-08 8.17E-06 2.72E-07 9068 hsa-mir-219-1 hsa04630 Jak-STAT signaling pathway 6654_595_5777_2885_8503_10401_207_208_1387_6778_6776_6777_6772_6774_5295_2033_894_896_3460_8554_4609 21 1.27E-07 1.04E-05 3.37E-07 9069 hsa-mir-219-1 hsa04370 VEGF signaling pathway 5578_4773_6714_1432_8503_5894_207_208_5595_5594_5295_4772_9261_5604_842 15 1.35E-07 1.10E-05 3.45E-07 9070 hsa-mir-219-1 hsa04330 Notch signaling pathway 1840_3065_22938_1487_1488_2648_1387_9612_2033_8850_9794_4851 12 1.98E-07 1.62E-05 4.92E-07 9071 hsa-mir-219-1 hsa04062 Chemokine signaling pathway 6654_5058_5580_9564_2309_1147_2885_8503_5894_207_208_5595_5594_6777_6772_5970_6774_5295_4790_2770_5604_5566_6464 23 2.64E-07 2.16E-05 6.37E-07 9072 hsa-mir-219-1 hsa04210 Apoptosis 840_823_1147_8503_207_208_836_839_5970_7157_5295_4790_5566_842_841 15 6.96E-07 5.71E-05 1.63E-06 9073 hsa-mir-219-1 hsa04664 Fc epsilon RI signaling pathway 6654_5578_5580_1432_2885_8503_5894_207_208_5595_5594_5599_5295_5604 14 9.58E-07 7.86E-05 2.18E-06 9074 hsa-mir-219-1 hsa05016 Huntington's disease 6667_10891_291_3065_3064_5468_25942_627_1385_1387_836_9001_5481_5430_7157_10488_2033_6874_6908_842_841 21 2.22E-06 0.000181855 4.91E-06 9075 hsa-mir-219-1 hsa05322 Systemic lupus erythematosus 3021_8368_8365_8340_8366_8364_3014_3015_8294_8370_3020_121504_8361_8360_8363_8362_8367_8359 18 2.80E-06 0.000229808 6.05E-06 9076 hsa-mir-219-1 hsa03420 Nucleotide excision repair 5981_902_1022_5111_5887_5886_2965_2967_2968_4331 10 5.07E-06 0.000415487 1.06E-05 9077 hsa-mir-219-1 hsa04920 Adipocytokine signaling pathway 10891_5465_1147_207_208_5599_6258_6257_6256_5970_6774_4790 12 5.15E-06 0.00042256 1.06E-05 9078 hsa-mir-219-1 hsa04650 Natural killer cell mediated cytotoxicity 6654_5777_5578_4773_5058_3932_2885_8503_5894_5595_5594_836_5295_4772_5604_3460_6464 17 6.27E-06 0.000513933 1.25E-05 9079 hsa-mir-219-1 hsa04150 mTOR signaling pathway 6195_6197_3091_8503_207_208_5595_5594_7249_5295 10 1.82E-05 0.001495074 3.56E-05 9080 hsa-mir-219-1 hsa04540 Gap junction 6654_5578_10382_1956_6714_2885_5894_5595_5594_5598_2770_5604_5566 13 2.31E-05 0.001892261 4.40E-05 9081 hsa-mir-219-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5058_1956_6714_1147_1432_5599_836_5970_3725_4790 10 0.000188362 0.015445704 0.000351039 9082 hsa-mir-219-1 hsa04950 Maturity onset diabetes of the young 6927_168620_4760_3172_5080_3175 6 0.000262846 0.021553388 0.000478964 9083 hsa-mir-219-1 hsa03410 Base excision repair 3146_4350_252969_328_2237_5111_6996 7 0.000312108 0.025592833 0.000556366 9084 hsa-mir-219-1 hsa04612 Antigen processing and presentation 811_6890_3303_920_1385_3312_3320_4800_4801_3326 10 0.000952337 0.078091638 0.001661524 9085 hsa-mir-219-1 hsa03450 Non-homologous end-joining 10111_2237_5591_4361 4 0.001927704 0.158071697 0.00329316 9086 hsa-mir-219-1 hsa04270 Vascular smooth muscle contraction 5578_5580_5894_5595_5594_808_801_805_59_5604_5566 11 0.002170845 0.178009255 0.003632842 9087 hsa-mir-219-1 hsa05010 Alzheimer's disease 840_3416_823_22926_1020_5595_5594_836_808_801_805_842_841_9451 14 0.002466238 0.20223153 0.004044631 9088 hsa-mir-219-1 hsa04930 Type II diabetes mellitus 5580_8503_5595_5594_5599_5295 6 0.004616304 0.378536965 0.007422293 9089 hsa-mir-219-1 hsa03050 Proteasome 5705_5701_5702_5719_5710_5698 6 0.006126978 0.502412179 0.009661773 9090 hsa-mir-219-1 hsa05340 Primary immunodeficiency 915_6890_3932_920_100 5 0.007346396 0.602404444 0.011366122 9091 hsa-mir-219-1 hsa03320 PPAR signaling pathway 5467_2168_5465_5468_6258_6257_6256 7 0.009489617 0.778148565 0.014410159 9092 hsa-mir-219-1 hsa04730 Long-term depression 5578_5894_5595_5594_3480_2770_5604 7 0.01015617 0.832805923 0.015141926 9093 hsa-mir-219-1 hsa04360 Axon guidance 4773_5058_25_1020_5595_5594_56924_4772_5998_2770 10 0.012031836 0.986610515 0.017618045 9094 hsa-mir-219-1 hsa04530 Tight junction 1499_1019_5578_5580_6714_207_208_1460_1457_2770 10 0.015737805 1 0.022640351 9095 hsa-mir-219-1 hsa04120 Ubiquitin mediated proteolysis 4214_4193_10401_10273_7329_8925_997_5371_672_8554 10 0.026552346 1 0.037539523 9096 hsa-mir-219-1 hsa03030 DNA replication 5981_4171_2237_5111 4 0.033852609 1 0.047049389 9097 hsa-mir-219-1 hsa04740 Olfactory transduction 815_808_801_805_5566 5 0.03741464 1 0.051133341 9098 hsa-mir-219-1 hsa05131 Shigellosis 1499_5578_10382_25_4691 5 0.039396911 1 0.052105592 9099 hsa-mir-219-1 hsa05130 Pathogenic Escherichia coli infection 1499_5578_10382_25_4691 5 0.039396911 1 0.052105592 9100 hsa-mir-219-1 hsa04070 Phosphatidylinositol signaling system 5578_8503_5295_808_801_805 6 0.040665061 1 0.052929127 9101 hsa-mir-219-1 hsa03430 Mismatch repair 5981_5111_2956 3 0.044589458 1 0.057130244 9102 hsa-mir-219-2 hsa05200 Pathways in cancer 1869_3725_5468_5914_595_1019_1017_8517_7704_3551_5578_3091_3066_3065_5925_1870_1871_4824_2113_10401_861_836_1147_2249_5595_5594_6258_1387_6256_4286_367_2932_6774_6776_6777_6772_5970_7157_4087_4088_4089_2034_2033_4846_4790_4791_4792_9915_3320_3326_5371_3265_842_841_7428_4609_2353_8554 58 2.00E-34 1.60E-32 1.60E-32 9103 hsa-mir-219-2 hsa05220 Chronic myeloid leukemia 1869_595_1019_8517_3551_3066_3065_5925_1870_1871_861_1147_5595_5594_6776_6777_5970_7157_4088_4089_4790_4792_3265_4609_6464 25 3.17E-21 2.54E-19 1.27E-19 9104 hsa-mir-219-2 hsa04010 MAPK signaling pathway 6722_3725_8517_9252_3551_5578_4773_9020_3305_3303_1432_4342_22800_4763_1616_836_1147_2249_5595_5594_3312_5971_5970_7157_6195_4790_4791_9261_1326_4208_5608_5566_3265_6885_4609_2353_2002_2005 38 7.84E-20 6.27E-18 1.61E-18 9105 hsa-mir-219-2 hsa05215 Prostate cancer 1869_595_1017_8517_3551_5925_1870_1871_4824_1147_5595_5594_1385_1387_367_2932_5970_7157_2033_4790_4792_3320_3326_3265_842 25 8.07E-20 6.46E-18 1.61E-18 9106 hsa-mir-219-2 hsa05212 Pancreatic cancer 1869_595_1017_8517_3551_5925_1870_1871_4824_1147_5595_5594_1385_1387_367_2932_5970_7157_2033_4790_4792_3320_3326_3265_842 25 1.02E-19 8.13E-18 1.63E-18 9107 hsa-mir-219-2 hsa04110 Cell cycle 1869_595_1019_1017_6500_5111_3066_3065_5925_1870_1871_5933_993_5591_1387_2932_7157_4087_4088_4089_2033_894_896_983_8454_1028_1111 27 3.83E-19 3.06E-17 5.10E-18 9108 hsa-mir-219-2 hsa05222 Small cell lung cancer 1869_595_1019_1017_8517_3551_5925_1870_1871_10401_1147_6258_6256_5970_7157_4846_4790_4792_842_4609_8554 21 9.79E-16 7.83E-14 1.12E-14 9109 hsa-mir-219-2 hsa04310 Wnt signaling pathway 3725_815_595_8607_5578_6500_8945_4773_23291_1387_2932_7157_1457_4087_4088_4089_2033_894_896_5519_5515_5566_8454_6885_4609 25 5.83E-15 4.66E-13 5.83E-14 9110 hsa-mir-219-2 hsa04350 TGF-beta signaling pathway 6667_6500_3397_3399_3398_5933_3400_5595_5594_1387_4087_4088_4089_2033_5519_5515_8454_4609_4093_4092 20 1.27E-14 1.02E-12 1.13E-13 9111 hsa-mir-219-2 hsa05221 Acute myeloid leukemia 5914_595_8517_7704_3551_861_1147_5595_5594_6774_6776_6777_5970_4790_5371_3265_4609 17 5.42E-14 4.34E-12 4.34E-13 9112 hsa-mir-219-2 hsa04660 T cell receptor signaling pathway 3725_1019_8517_3551_4773_9020_1432_4794_1147_5595_5594_2932_5970_4790_4792_4793_1326_3265_6885_2353 20 5.95E-13 4.76E-11 4.33E-12 9113 hsa-mir-219-2 hsa04620 Toll-like receptor signaling pathway 3725_8517_3551_3661_1432_1147_29110_5595_5594_6772_5970_4790_4792_1326_5608_9641_841_6885_2353 19 1.55E-12 1.24E-10 1.03E-11 9114 hsa-mir-219-2 hsa05214 Glioma 1869_815_595_1019_5578_5925_1870_1871_5595_5594_7157_808_801_805_3265_6464 16 2.34E-12 1.87E-10 1.44E-11 9115 hsa-mir-219-2 hsa05016 Huntington's disease 6667_5468_292_293_3066_3065_3064_498_25942_2902_836_1213_1385_1387_5437_7157_23186_2033_6874_842_841_5441_6908_9519 24 2.81E-12 2.25E-10 1.60E-11 9116 hsa-mir-219-2 hsa04662 B cell receptor signaling pathway 3725_8517_3551_4773_4794_1147_695_5595_5594_2932_5970_4790_4792_4793_3265_2353 16 1.52E-11 1.22E-09 8.12E-11 9117 hsa-mir-219-2 hsa05223 Non-small cell lung cancer 1869_595_1019_5578_5925_1870_1871_5595_5594_6258_6256_7157_3265_842 14 3.07E-11 2.46E-09 1.54E-10 9118 hsa-mir-219-2 hsa04720 Long-term potentiation 814_815_5578_2902_2906_5595_5594_1387_6195_2033_808_801_805_5566_3265 15 1.46E-10 1.17E-08 6.86E-10 9119 hsa-mir-219-2 hsa05219 Bladder cancer 1869_595_1019_9252_5925_1870_1871_5595_5594_7157_3265_4609 12 3.09E-10 2.48E-08 1.38E-09 9120 hsa-mir-219-2 hsa04210 Apoptosis 8517_3551_9020_836_1147_839_5970_7157_9131_4790_4792_5566_842_841_840 15 1.19E-09 9.54E-08 5.02E-09 9121 hsa-mir-219-2 hsa04920 Adipocytokine signaling pathway 5465_8517_3551_4794_8471_1147_6258_6256_6774_5970_4790_4792_4793 13 3.41E-09 2.73E-07 1.36E-08 9122 hsa-mir-219-2 hsa03022 Basal transcription factors 6872_2963_2962_2969_6878_6874_6882_2959_6908_9519 10 1.49E-08 1.19E-06 5.67E-08 9123 hsa-mir-219-2 hsa05216 Thyroid cancer 5468_595_5595_5594_6258_6256_7157_3265_4609 9 2.90E-08 2.32E-06 1.05E-07 9124 hsa-mir-219-2 hsa05210 Colorectal cancer 3725_595_836_5595_5594_2932_7157_4087_4088_4089_842_4609_2353 13 3.76E-08 3.01E-06 1.31E-07 9125 hsa-mir-219-2 hsa05218 Melanoma 1869_595_1019_5925_1870_1871_2249_5595_5594_4286_7157_3265 12 5.31E-08 4.25E-06 1.69E-07 9126 hsa-mir-219-2 hsa04012 ErbB signaling pathway 3725_815_5578_6714_5595_5594_2932_6776_6777_3265_4609_6464_2002 13 5.45E-08 4.36E-06 1.69E-07 9127 hsa-mir-219-2 hsa04916 Melanogenesis 815_5578_5595_5594_1385_1387_4286_2932_2033_808_801_805_5566_3265 14 5.48E-08 4.38E-06 1.69E-07 9128 hsa-mir-219-2 hsa04912 GnRH signaling pathway 3725_815_5578_6714_1432_5595_5594_808_801_805_5608_5566_3265_2002 14 8.38E-08 6.70E-06 2.48E-07 9129 hsa-mir-219-2 hsa04062 Chemokine signaling pathway 8517_3551_653361_1147_5590_5595_5594_2932_6774_6777_6772_5970_4790_4792_4793_5566_3265_6464 18 1.28E-07 1.02E-05 3.64E-07 9130 hsa-mir-219-2 hsa04910 Insulin signaling pathway 6720_3551_8471_8651_5590_5595_5594_2932_808_801_805_5566_3265_6464_2002 15 2.37E-07 1.90E-05 6.54E-07 9131 hsa-mir-219-2 hsa04115 p53 signaling pathway 595_1019_1017_836_7157_894_896_983_842_841_1111 11 3.23E-07 2.58E-05 8.61E-07 9132 hsa-mir-219-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_8517_3551_9020_6714_1432_836_1147_5970_4790_4792 11 4.17E-07 3.34E-05 1.08E-06 9133 hsa-mir-219-2 hsa05211 Renal cell carcinoma 3725_3091_2113_5595_5594_1387_2034_2033_9915_3265_7428 11 4.73E-07 3.78E-05 1.18E-06 9134 hsa-mir-219-2 hsa04540 Gap junction 5578_10382_6714_5595_5594_7846_347733_983_5566_3265_7278_203068 12 7.34E-07 5.87E-05 1.78E-06 9135 hsa-mir-219-2 hsa04630 Jak-STAT signaling pathway 595_10401_3977_8651_1387_6778_6774_6776_6777_6772_2033_894_896_4609_8554 15 9.23E-07 7.38E-05 2.12E-06 9136 hsa-mir-219-2 hsa05010 Alzheimer's disease 498_2902_2906_836_22926_5595_5594_2932_4846_808_351_801_805_842_841_840 16 9.29E-07 7.44E-05 2.12E-06 9137 hsa-mir-219-2 hsa04520 Adherens junction 6714_71_5595_5594_1387_1457_4087_4088_4089_2033_6885 11 1.21E-06 9.67E-05 2.69E-06 9138 hsa-mir-219-2 hsa04120 Ubiquitin mediated proteolysis 55294_6500_8945_23291_10401_7329_51366_8651_997_5371_672_8454_7428_8554 14 1.37E-06 0.000109916 2.97E-06 9139 hsa-mir-219-2 hsa05213 Endometrial cancer 595_5595_5594_2932_7157_3265_842_4609_2002 9 2.09E-06 0.000167544 4.41E-06 9140 hsa-mir-219-2 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906_1432_1616_836_7157_4846_5608_842 9 3.61E-06 0.000288823 7.41E-06 9141 hsa-mir-219-2 hsa04370 VEGF signaling pathway 5578_4773_6714_1432_5595_5594_4846_9261_3265_842 10 5.85E-06 0.000467763 1.17E-05 9142 hsa-mir-219-2 hsa04612 Antigen processing and presentation 3309_3305_3303_1385_3312_1514_3320_3326_4800_4801 10 1.86E-05 0.001487991 3.63E-05 9143 hsa-mir-219-2 hsa05131 Shigellosis 5578_10382_71_7846_347733_7278_4691_203068 8 2.71E-05 0.0021689 5.04E-05 9144 hsa-mir-219-2 hsa05130 Pathogenic Escherichia coli infection 5578_10382_71_7846_347733_7278_4691_203068 8 2.71E-05 0.0021689 5.04E-05 9145 hsa-mir-219-2 hsa04530 Tight junction 1019_5578_6714_4628_22800_8573_71_5590_1457_5519_5515_3265 12 2.82E-05 0.002253643 5.12E-05 9146 hsa-mir-219-2 hsa03020 RNA polymerase 64425_25885_51082_5437_84172_5441 6 4.53E-05 0.003620559 8.05E-05 9147 hsa-mir-219-2 hsa04330 Notch signaling pathway 3066_3065_1387_9612_2033_8850_4851 7 6.82E-05 0.005457309 0.000118637 9148 hsa-mir-219-2 hsa04510 Focal adhesion 3725_595_5578_6714_71_5595_5594_2932_894_896_3265_6464_2002 13 0.000297522 0.023801738 0.00050642 9149 hsa-mir-219-2 hsa04020 Calcium signaling pathway 814_815_292_293_5578_2902_2906_4846_808_801_805_5566 12 0.00038059 0.030447225 0.000634317 9150 hsa-mir-219-2 hsa04930 Type II diabetes mellitus 3551_8471_8651_5590_5595_5594 6 0.000388914 0.031113081 0.000634961 9151 hsa-mir-219-2 hsa04730 Long-term depression 5578_5595_5594_4846_5519_5515_3265 7 0.000689379 0.055150301 0.001103006 9152 hsa-mir-219-2 hsa03010 Ribosome 6155_6156_6207_9349_6141_6217_6128_6188 8 0.001178109 0.094248755 0.001848015 9153 hsa-mir-219-2 hsa04664 Fc epsilon RI signaling pathway 5578_1432_695_5595_5594_5608_3265 7 0.00123216 0.09857282 0.001895631 9154 hsa-mir-219-2 hsa04270 Vascular smooth muscle contraction 5578_5595_5594_808_801_805_5566 7 0.009787487 0.782998989 0.014773566 9155 hsa-mir-219-2 hsa03320 PPAR signaling pathway 5465_5468_10062_6258_6256 5 0.013846544 1 0.020513399 9156 hsa-mir-219-2 hsa04650 Natural killer cell mediated cytotoxicity 5578_4773_836_5595_5594_3265_6464 7 0.02063075 1 0.030008364 9157 hsa-mir-219-2 hsa04150 mTOR signaling pathway 3091_5595_5594_6195 4 0.021406996 1 0.030581423 9158 hsa-mir-219-2 hsa04340 Hedgehog signaling pathway 8945_23291_2932_5566 4 0.028276628 1 0.039686496 9159 hsa-mir-219-2 hsa04710 Circadian rhythm - mammal 8863_79365 2 0.031828464 1 0.04390133 9160 hsa-mir-219-2 hsa03450 Non-homologous end-joining 2547_5591 2 0.035927996 1 0.048715927 9161 hsa-mir-219-2 hsa03410 Base excision repair 3146_5111_142 3 0.037146627 1 0.049528835 9162 hsa-mir-219-2 hsa04810 Regulation of actin cytoskeleton 10788_4628_4342_22800_71_2249_5595_5594_3265 9 0.042849019 1 0.056195435 9163 hsa-mir-22 hsa05200 Pathways in cancer 3551_1499_5914_595_1019_2261_8517_4089_3066_3065_1050_5925_7187_10342_1956_1487_1488_6258_2885_4824_1017_10401_207_3716_1147_2249_4233_5595_5594_5599_1387_2064_6256_836_367_2932_6777_6772_5979_5879_6688_3725_6776_2735_2736_4087_4088_9063_2033_4790_4792_5970_3320_3326_5371_3480_5159_5156_5604_5601_842_841_4609_1026_2353_2737_1441_8554 68 4.58E-43 3.80E-41 3.80E-41 9164 hsa-mir-22 hsa04010 MAPK signaling pathway 3925_6722_3551_6197_2261_2264_8517_9252_9020_1956_3303_1432_2885_3305_207_1147_2249_5595_5594_5599_8986_1386_836_3310_3312_5971_5879_468_3725_3727_6195_6196_9344_1649_4790_51701_5970_5159_9261_1326_5156_5604_5606_5601_5600_6885_4609_2353_5603_8550_2002_2005 52 9.92E-32 8.23E-30 4.11E-30 9165 hsa-mir-22 hsa05215 Prostate cancer 3551_1499_595_8517_5925_1956_2885_4824_1017_9586_207_1147_5595_5594_1385_1387_2064_367_2932_468_2033_4790_4792_5970_3320_3326_3480_5159_5156_5604_842_1026 32 2.90E-27 2.41E-25 8.03E-26 9166 hsa-mir-22 hsa05212 Pancreatic cancer 3551_1499_595_8517_5925_1956_2885_4824_1017_9586_207_1147_5595_5594_1385_1387_2064_367_2932_468_2033_4790_4792_5970_3320_3326_3480_5159_5156_5604_842_1026 32 3.88E-27 3.22E-25 8.04E-26 9167 hsa-mir-22 hsa04620 Toll-like receptor signaling pathway 3551_8517_3454_3455_7187_1432_207_1147_3654_5595_5594_5599_6772_5879_3725_4790_4792_5970_1326_5604_5606_5601_5600_9641_841_6885_2353_5603 28 2.95E-21 2.45E-19 4.90E-20 9168 hsa-mir-22 hsa04630 Jak-STAT signaling pathway 3559_595_3454_3455_3560_1439_2885_2690_10401_3977_207_3717_3716_3718_85480_1387_3575_3570_3572_6777_6772_6776_9063_2033_894_896_149233_3953_5781_4609_1441_8554 32 7.10E-21 5.89E-19 9.47E-20 9169 hsa-mir-22 hsa05220 Chronic myeloid leukemia 3551_595_1019_8517_4089_3066_3065_5925_1487_1488_2885_207_1147_5595_5594_6777_6776_4088_4790_4792_5970_5604_5781_4609_1026 25 7.98E-21 6.63E-19 9.47E-20 9170 hsa-mir-22 hsa04310 Wnt signaling pathway 815_1499_595_8607_6500_1459_4089_23291_1487_1488_5599_1387_2932_5879_8061_3725_1457_4087_4088_2033_894_896_51701_5519_5518_5601_8454_8945_6885_4609 30 3.59E-19 2.98E-17 3.72E-18 9171 hsa-mir-22 hsa05210 Colorectal cancer 1499_595_4089_1956_2885_207_4233_5595_5594_5599_836_2932_5879_3725_4087_4088_3480_5159_5156_5604_5601_842_4609_2353 24 9.53E-19 7.91E-17 8.79E-18 9172 hsa-mir-22 hsa04660 T cell receptor signaling pathway 3551_1019_8517_9020_3932_1432_4794_2885_207_1147_5595_5594_2932_3725_4790_4792_4793_5970_1326_5604_5601_5600_6885_2353_5603 25 1.90E-17 1.57E-15 1.57E-16 9173 hsa-mir-22 hsa03010 Ribosome 6156_6204_6205_6207_6202_6141_6217_6210_6130_6137_6135_6191_6193_6222_6223_6229_6129_6128_6181_6189_6188_6231_6232 23 4.27E-16 3.54E-14 3.22E-15 9174 hsa-mir-22 hsa04520 Adherens junction 1499_1459_4089_1956_6714_71_2241_4233_5595_5594_1387_2064_5879_1457_4087_4088_2033_51701_3480_8826_6885 21 6.05E-16 5.03E-14 4.19E-15 9175 hsa-mir-22 hsa05221 Acute myeloid leukemia 3551_5914_595_8517_1050_2885_207_1147_5595_5594_6777_6688_6776_4790_5970_5371_5604_4609 18 8.20E-15 6.81E-13 5.24E-14 9176 hsa-mir-22 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3551_8517_9020_1956_6714_1432_1147_4233_5599_836_5879_3725_4790_4792_5970_5601_5600_5781_5603 19 1.10E-14 9.15E-13 6.53E-14 9177 hsa-mir-22 hsa04350 TGF-beta signaling pathway 6667_6500_4089_3397_3399_3398_1874_5933_5595_5594_1387_7027_4086_4087_4088_2033_5519_5518_8454_4609 20 2.61E-14 2.16E-12 1.44E-13 9178 hsa-mir-22 hsa04110 Cell cycle 595_1019_6500_4089_3066_3065_5925_1017_5933_5591_1387_7533_2932_7027_4087_4088_2033_891_894_896_8454_1026 22 6.61E-14 5.49E-12 3.43E-13 9179 hsa-mir-22 hsa04912 GnRH signaling pathway 815_5580_1956_6714_1432_2885_5595_5594_5599_468_3725_808_801_805_5604_5606_5601_5600_2185_5603_2002 21 1.04E-13 8.60E-12 5.06E-13 9180 hsa-mir-22 hsa05222 Small cell lung cancer 3551_595_1019_8517_5925_7187_6258_1017_10401_207_1147_6256_9063_4790_4792_5970_842_4609_8554 19 2.14E-13 1.78E-11 9.88E-13 9181 hsa-mir-22 hsa04662 B cell receptor signaling pathway 3551_8517_6850_4794_2885_207_1147_5595_5594_2932_5879_3725_4790_4792_4793_5970_5604_2353 18 2.73E-13 2.27E-11 1.19E-12 9182 hsa-mir-22 hsa05214 Glioma 815_595_1019_5925_1956_2885_207_5595_5594_808_801_805_3480_5159_5156_5604_1026 17 3.82E-13 3.17E-11 1.59E-12 9183 hsa-mir-22 hsa04062 Chemokine signaling pathway 3551_1234_8517_1230_5580_7852_2885_207_3055_3717_1147_3718_5590_5595_5594_2932_6777_6772_5879_4790_4792_4793_5970_5604_2185 25 1.70E-12 1.41E-10 6.71E-12 9184 hsa-mir-22 hsa04012 ErbB signaling pathway 815_1956_6714_2885_207_5595_5594_5599_2064_2932_6777_3725_6776_5604_5601_4609_1026_2002 18 2.42E-12 2.00E-10 9.11E-12 9185 hsa-mir-22 hsa04920 Adipocytokine signaling pathway 3551_8517_6258_4794_207_3717_1147_5599_6256_4790_4792_4793_5970_5601_3953_5781 16 6.17E-12 5.12E-10 2.14E-11 9186 hsa-mir-22 hsa04510 Focal adhesion 1499_595_1956_6714_2885_207_71_4233_5595_5594_5599_2064_2932_5879_3725_894_896_2321_3480_85366_5159_5156_5604_5601_2002 25 6.19E-12 5.14E-10 2.14E-11 9187 hsa-mir-22 hsa04210 Apoptosis 3556_3551_8517_9020_1439_207_1147_3654_836_839_9131_4790_4792_5970_842_841_840 17 2.98E-11 2.47E-09 9.89E-11 9188 hsa-mir-22 hsa05213 Endometrial cancer 1499_595_1956_2885_207_5595_5594_2064_2932_5604_842_4609_2002 13 3.67E-10 3.04E-08 1.17E-09 9189 hsa-mir-22 hsa05219 Bladder cancer 595_1019_2261_9252_5925_1956_5595_5594_2064_5604_4609_1026 12 4.78E-10 3.97E-08 1.47E-09 9190 hsa-mir-22 hsa05223 Non-small cell lung cancer 595_1019_5925_1956_6258_2885_207_5595_5594_2064_6256_5604_842 13 5.47E-10 4.54E-08 1.62E-09 9191 hsa-mir-22 hsa05218 Melanoma 595_1019_5925_1956_207_2249_4233_5595_5594_3480_5159_5156_5604_1026 14 1.15E-09 9.58E-08 3.30E-09 9192 hsa-mir-22 hsa03050 Proteasome 5708_5709_5705_5706_5700_5693_5719_5717_5684_5713_5687_5707 12 1.75E-09 1.45E-07 4.85E-09 9193 hsa-mir-22 hsa05216 Thyroid cancer 1499_595_10342_6258_5595_5594_6256_5979_5604_4609 10 3.02E-09 2.51E-07 8.08E-09 9194 hsa-mir-22 hsa04540 Gap junction 7846_10382_1956_6714_2885_5592_5595_5594_203068_347733_5159_5156_5604_7278_84617 15 3.42E-09 2.84E-07 8.87E-09 9195 hsa-mir-22 hsa04664 Fc epsilon RI signaling pathway 5580_6850_1432_2885_207_5595_5594_5599_5879_5604_5606_5601_5600_5603 14 3.90E-09 3.24E-07 9.82E-09 9196 hsa-mir-22 hsa04060 Cytokine-cytokine receptor interaction 3556_3559_1234_1230_3454_3455_1956_3560_1439_7852_2690_3977_85480_4233_3575_3570_3572_2321_149233_5159_5156_3953_1441 23 1.36E-08 1.13E-06 3.33E-08 9197 hsa-mir-22 hsa04720 Long-term potentiation 815_6197_5595_5594_1387_468_6195_6196_2033_808_801_805_5604 13 1.78E-08 1.47E-06 4.21E-08 9198 hsa-mir-22 hsa04910 Insulin signaling pathway 3551_2885_5211_207_5590_5595_5594_5599_2932_2194_808_801_805_5604_5601_2002 16 7.05E-08 5.85E-06 1.62E-07 9199 hsa-mir-22 hsa04115 p53 signaling pathway 595_1019_1017_836_64326_891_894_896_842_841_1026 11 4.71E-07 3.91E-05 1.06E-06 9200 hsa-mir-22 hsa05211 Renal cell carcinoma 2885_207_4233_5595_5594_1387_5879_3725_2033_5604_5781 11 6.88E-07 5.71E-05 1.50E-06 9201 hsa-mir-22 hsa05016 Huntington's disease 6667_1537_3066_3065_3064_25942_9586_1385_1387_836_5437_1213_2033_6908_842_841_5441 17 7.20E-07 5.98E-05 1.53E-06 9202 hsa-mir-22 hsa04370 VEGF signaling pathway 6714_1432_207_5595_5594_5879_9261_5604_5600_842_5603 11 1.25E-06 0.000103633 2.59E-06 9203 hsa-mir-22 hsa04330 Notch signaling pathway 9612_3066_3065_1487_1488_3280_388585_1387_2033 9 1.36E-06 0.000113192 2.76E-06 9204 hsa-mir-22 hsa04916 Melanogenesis 815_1499_5595_5594_1385_1387_2932_2033_808_801_805_5604 12 3.17E-06 0.000263499 6.27E-06 9205 hsa-mir-22 hsa05131 Shigellosis 7846_1499_10382_71_203068_347733_7278_84617_4691 9 4.92E-06 0.000408296 9.28E-06 9206 hsa-mir-22 hsa05130 Pathogenic Escherichia coli infection 7846_1499_10382_71_203068_347733_7278_84617_4691 9 4.92E-06 0.000408296 9.28E-06 9207 hsa-mir-22 hsa04930 Type II diabetes mellitus 3551_5580_3651_5590_5595_5594_5599_5601 8 8.60E-06 0.000714006 1.59E-05 9208 hsa-mir-22 hsa04120 Ubiquitin mediated proteolysis 55294_6500_23291_10401_7325_7329_9063_64326_5371_672_8454_8945_8554 13 1.03E-05 0.000856917 1.86E-05 9209 hsa-mir-22 hsa04612 Antigen processing and presentation 3309_3303_3305_1385_3310_3312_3320_3326_4800_2923 10 2.58E-05 0.002138288 4.55E-05 9210 hsa-mir-22 hsa04530 Tight junction 1499_1019_1459_5580_6714_4627_207_71_5590_1457_5519_5518 12 4.08E-05 0.003385398 7.05E-05 9211 hsa-mir-22 hsa04650 Natural killer cell mediated cytotoxicity 3454_3455_3932_6850_2885_5595_5594_836_5879_5604_5781_2185 12 4.36E-05 0.003615247 7.38E-05 9212 hsa-mir-22 hsa03020 RNA polymerase 25885_51082_64425_5437_84172_5441 6 5.60E-05 0.004644107 9.29E-05 9213 hsa-mir-22 hsa04810 Regulation of actin cytoskeleton 2261_2264_1956_4627_71_2249_5595_5594_5879_85366_5159_5156_5604_10788_8826 15 6.78E-05 0.005624734 0.000110289 9214 hsa-mir-22 hsa05010 Alzheimer's disease 1537_22926_6622_5595_5594_836_2932_808_801_805_842_841_840 13 0.000106468 0.008836806 0.000169939 9215 hsa-mir-22 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_836_5879_5606_5600_842_5603 7 0.000232422 0.019290999 0.000363981 9216 hsa-mir-22 hsa04730 Long-term depression 5592_5595_5594_3480_5519_5518_5604 7 0.000862134 0.071557132 0.001325132 9217 hsa-mir-22 hsa04270 Vascular smooth muscle contraction 5580_5592_5595_5594_808_801_805_85366_5604 9 0.000932841 0.077425844 0.001407743 9218 hsa-mir-22 hsa04150 mTOR signaling pathway 6197_207_5595_5594_6195_6196 6 0.000953028 0.079101353 0.001412524 9219 hsa-mir-22 hsa04670 Leukocyte transendothelial migration 1499_1432_7852_71_5879_5600_5781_2185_5603 9 0.001161715 0.096422308 0.001691619 9220 hsa-mir-22 hsa04340 Hedgehog signaling pathway 23291_2932_2735_2736_8945_2737 6 0.001473273 0.122281692 0.002108305 9221 hsa-mir-22 hsa03450 Non-homologous end-joining 2547_7520_5591 3 0.004174379 0.346473454 0.005872431 9222 hsa-mir-22 hsa04020 Calcium signaling pathway 815_1956_2064_808_801_805_85366_5159_5156_2185 10 0.005228407 0.433957764 0.007232629 9223 hsa-mir-22 hsa05217 Basal cell carcinoma 1499_2932_2735_2736_2737 5 0.006456716 0.535907427 0.008785368 9224 hsa-mir-22 hsa05340 Primary immunodeficiency 8517_3932_3718_3575 4 0.007030743 0.583551695 0.009412124 9225 hsa-mir-22 hsa03022 Basal transcription factors 2963_2962_2969_6908 4 0.008394708 0.696760733 0.011059694 9226 hsa-mir-22 hsa04950 Maturity onset diabetes of the young 6927_3280_3651 3 0.015533521 1 0.020145035 9227 hsa-mir-22 hsa04360 Axon guidance 7852_2242_4233_5595_5594_2932_5879 7 0.019500796 1 0.024901016 9228 hsa-mir-221 hsa05200 Pathways in cancer 2353_6777_3725_6688_5925_2033_1019_1017_2249_8554_4609_1499_5970_1026_6776_367_5914_1387_6256 19 2.43E-19 1.29E-17 1.29E-17 9229 hsa-mir-221 hsa05215 Prostate cancer 5925_2033_1017_468_1499_5970_1026_367_1387 9 8.67E-12 4.59E-10 1.68E-10 9230 hsa-mir-221 hsa05212 Pancreatic cancer 5925_2033_1017_468_1499_5970_1026_367_1387 9 9.52E-12 5.05E-10 1.68E-10 9231 hsa-mir-221 hsa04110 Cell cycle 5925_2033_1019_1017_7027_1026_5933_1387 8 2.96E-09 1.57E-07 3.79E-08 9232 hsa-mir-221 hsa05220 Chronic myeloid leukemia 6777_5925_1019_4609_5970_1026_6776 7 3.58E-09 1.90E-07 3.79E-08 9233 hsa-mir-221 hsa05222 Small cell lung cancer 5925_1019_1017_8554_4609_5970_6256 7 8.70E-09 4.61E-07 7.10E-08 9234 hsa-mir-221 hsa04350 TGF-beta signaling pathway 1874_6667_2033_7027_4609_5933_1387 7 9.37E-09 4.97E-07 7.10E-08 9235 hsa-mir-221 hsa05221 Acute myeloid leukemia 6777_6688_4609_5970_6776_5914 6 3.07E-08 1.63E-06 2.04E-07 9236 hsa-mir-221 hsa04630 Jak-STAT signaling pathway 6777_2033_3977_8554_4609_6776_1387 7 4.00E-07 2.12E-05 2.35E-06 9237 hsa-mir-221 hsa04010 MAPK signaling pathway 2353_3725_2249_468_4609_5970_1649_1386 8 1.35E-06 7.18E-05 7.18E-06 9238 hsa-mir-221 hsa04012 ErbB signaling pathway 6777_3725_4609_1026_6776 5 6.48E-06 0.000343404 3.12E-05 9239 hsa-mir-221 hsa05219 Bladder cancer 5925_1019_4609_1026 4 8.84E-06 0.000468757 3.91E-05 9240 hsa-mir-221 hsa05218 Melanoma 5925_1019_2249_1026 4 6.19E-05 0.003280514 0.000252347 9241 hsa-mir-221 hsa04310 Wnt signaling pathway 3725_2033_4609_1499_1387 5 8.51E-05 0.00450892 0.000322066 9242 hsa-mir-221 hsa05216 Thyroid cancer 4609_1499_6256 3 0.000101746 0.005392527 0.000359502 9243 hsa-mir-221 hsa05210 Colorectal cancer 2353_3725_4609_1499 4 0.000115484 0.006120655 0.000382541 9244 hsa-mir-221 hsa04660 T cell receptor signaling pathway 2353_3725_1019_5970 4 0.000312557 0.016565513 0.000974442 9245 hsa-mir-221 hsa04330 Notch signaling pathway 9612_2033_1387 3 0.000387578 0.020541659 0.001141203 9246 hsa-mir-221 hsa05223 Non-small cell lung cancer 5925_1019_6256 3 0.000570415 0.030232017 0.001591159 9247 hsa-mir-221 hsa05214 Glioma 5925_1019_1026 3 0.000955392 0.050635767 0.002531788 9248 hsa-mir-221 hsa04115 p53 signaling pathway 1019_1017_1026 3 0.001127754 0.059770946 0.002846236 9249 hsa-mir-221 hsa05211 Renal cell carcinoma 3725_2033_1387 3 0.0012691 0.067262313 0.003057378 9250 hsa-mir-221 hsa04720 Long-term potentiation 2033_468_1387 3 0.001421133 0.075320033 0.003138335 9251 hsa-mir-221 hsa04662 B cell receptor signaling pathway 2353_3725_5970 3 0.001421133 0.075320033 0.003138335 9252 hsa-mir-221 hsa04520 Adherens junction 2033_1499_1387 3 0.001699055 0.090049919 0.003601997 9253 hsa-mir-221 hsa05016 Huntington's disease 6667_2033_6908_1387 4 0.002175823 0.115318611 0.004435331 9254 hsa-mir-221 hsa04620 Toll-like receptor signaling pathway 2353_3725_5970 3 0.003315418 0.175717132 0.006508042 9255 hsa-mir-221 hsa04916 Melanogenesis 2033_1499_1387 3 0.003496234 0.185300423 0.006617872 9256 hsa-mir-221 hsa03022 Basal transcription factors 2959_6908 2 0.005462071 0.289489788 0.009982406 9257 hsa-mir-221 hsa03420 Nucleotide excision repair 5981_4331 2 0.007532326 0.399213302 0.01330711 9258 hsa-mir-221 hsa05213 Endometrial cancer 4609_1499 2 0.010263494 0.543965159 0.017547263 9259 hsa-mir-221 hsa04920 Adipocytokine signaling pathway 5970_6256 2 0.016373367 0.867788454 0.027118389 9260 hsa-mir-221 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5970 2 0.018208869 0.96507008 0.029244548 9261 hsa-mir-221 hsa04912 GnRH signaling pathway 3725_468 2 0.038852364 1 0.06056398 9262 hsa-mir-221 hsa03450 Non-homologous end-joining 2547 1 0.041561419 1 0.062935863 9263 hsa-mir-222 hsa03022 Basal transcription factors 2959_6908 2 8.98E-05 0.001257707 0.001257707 9264 hsa-mir-222 hsa05016 Huntington's disease 2033_6908 2 0.002112057 0.029568802 0.014784401 9265 hsa-mir-222 hsa04330 Notch signaling pathway 2033 1 0.01745641 0.244389747 0.050560262 9266 hsa-mir-222 hsa05211 Renal cell carcinoma 2033 1 0.026438148 0.370134075 0.050560262 9267 hsa-mir-222 hsa04720 Long-term potentiation 2033 1 0.027510926 0.385152959 0.050560262 9268 hsa-mir-222 hsa04520 Adherens junction 2033 1 0.0292965 0.410151002 0.050560262 9269 hsa-mir-222 hsa04350 TGF-beta signaling pathway 2033 1 0.031791298 0.445078165 0.050560262 9270 hsa-mir-222 hsa05215 Prostate cancer 2033 1 0.032147221 0.450061093 0.050560262 9271 hsa-mir-222 hsa05212 Pancreatic cancer 2033 1 0.032503025 0.455042355 0.050560262 9272 hsa-mir-222 hsa04916 Melanogenesis 2033 1 0.037825842 0.529561792 0.052956179 9273 hsa-mir-222 hsa04110 Cell cycle 2033 1 0.043122024 0.603708334 0.054882576 9274 hsa-mir-223 hsa04010 MAPK signaling pathway 468_1649_3725_3727 4 6.61E-06 0.000151965 7.59E-05 9275 hsa-mir-223 hsa05215 Prostate cancer 1387_468_10488 3 9.58E-06 0.000220325 7.59E-05 9276 hsa-mir-223 hsa05212 Pancreatic cancer 1387_468_10488 3 9.90E-06 0.000227689 7.59E-05 9277 hsa-mir-223 hsa05211 Renal cell carcinoma 1387_3725 2 0.000535339 0.012312799 0.002665566 9278 hsa-mir-223 hsa04720 Long-term potentiation 1387_468 2 0.000579471 0.013327829 0.002665566 9279 hsa-mir-223 hsa04916 Melanogenesis 1387_10488 2 0.001093622 0.02515331 0.00386686 9280 hsa-mir-223 hsa04912 GnRH signaling pathway 468_3725 2 0.00117687 0.027068019 0.00386686 9281 hsa-mir-223 hsa04310 Wnt signaling pathway 1387_3725 2 0.002285772 0.052572758 0.006571595 9282 hsa-mir-223 hsa05016 Huntington's disease 1387_10488 2 0.003450438 0.079360074 0.008817786 9283 hsa-mir-223 hsa04710 Circadian rhythm - mammal 406 1 0.00651193 0.14977438 0.014977438 9284 hsa-mir-223 hsa05200 Pathways in cancer 1387_3725 2 0.010285271 0.236561227 0.021505566 9285 hsa-mir-223 hsa04330 Notch signaling pathway 1387 1 0.022163042 0.509749955 0.042479163 9286 hsa-mir-223 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725 1 0.0330727 0.760672096 0.051472591 9287 hsa-mir-223 hsa04662 B cell receptor signaling pathway 3725 1 0.03487995 0.802238841 0.051472591 9288 hsa-mir-223 hsa04520 Adherens junction 1387 1 0.037134601 0.854095822 0.051472591 9289 hsa-mir-223 hsa05210 Colorectal cancer 3725 1 0.0389348 0.89550039 0.051472591 9290 hsa-mir-223 hsa04350 TGF-beta signaling pathway 1387 1 0.040282897 0.92650663 0.051472591 9291 hsa-mir-223 hsa04012 ErbB signaling pathway 3725 1 0.040282897 0.92650663 0.051472591 9292 hsa-mir-223 hsa04620 Toll-like receptor signaling pathway 3725 1 0.046997085 1 0.056891208 9293 hsa-mir-224 hsa05200 Pathways in cancer 3725_5467_1499_5914_595_1017_4193_6934_7704_6502_3091_4089_3066_3065_1050_5925_5468_25_405_9063_1487_1488_1870_1871_2113_861_862_10401_207_4286_5595_5594_1387_6256_836_367_6774_6776_6777_6772_5970_7157_7849_1869_4088_2034_2033_4846_51176_5371_5604_7428_4087_4609_2956 55 1.20E-39 9.08E-38 9.08E-38 9294 hsa-mir-224 hsa05220 Chronic myeloid leukemia 595_4193_4089_3066_3065_5925_25_1487_1488_1870_1871_861_207_5595_5594_6776_6777_5970_7157_1869_4088_5604_4609_6464 24 1.27E-23 9.64E-22 4.82E-22 9295 hsa-mir-224 hsa05221 Acute myeloid leukemia 5467_5914_595_6934_7704_1050_861_862_207_5595_5594_6774_6776_6777_5970_51176_5371_5604_4609 19 5.22E-19 3.97E-17 1.32E-17 9296 hsa-mir-224 hsa04110 Cell cycle 595_1017_4193_6502_5111_4089_3066_3065_5925_25_1870_1871_5934_5933_5591_1387_7157_1869_4088_2033_4087 21 2.86E-16 2.18E-14 4.51E-15 9297 hsa-mir-224 hsa05215 Prostate cancer 1499_595_1017_4193_6934_5925_1870_1871_207_5595_5594_1387_367_5970_7157_1869_2033_51176_5604 19 2.97E-16 2.26E-14 4.51E-15 9298 hsa-mir-224 hsa05212 Pancreatic cancer 1499_595_1017_4193_6934_5925_1870_1871_207_5595_5594_1387_367_5970_7157_1869_2033_51176_5604 19 3.56E-16 2.70E-14 4.51E-15 9299 hsa-mir-224 hsa04350 TGF-beta signaling pathway 4086_4089_6667_3397_3399_3398_1875_5934_5933_5595_5594_1387_4088_2033_4087_4609_4092 17 4.65E-14 3.54E-12 5.05E-13 9300 hsa-mir-224 hsa04330 Notch signaling pathway 1840_3066_3065_9794_22938_1487_1488_388585_1387_2033_8850_9612_2648_4851 14 5.84E-14 4.44E-12 5.54E-13 9301 hsa-mir-224 hsa05216 Thyroid cancer 1499_595_6934_5468_5595_5594_6256_7157_7849_51176_5604_4609 12 1.52E-13 1.16E-11 1.29E-12 9302 hsa-mir-224 hsa05214 Glioma 595_4193_5925_1870_1871_207_5595_5594_7157_1869_808_801_805_5604_6464 15 1.78E-13 1.35E-11 1.35E-12 9303 hsa-mir-224 hsa05210 Colorectal cancer 3725_1499_595_6934_4089_207_5595_5594_836_7157_4088_51176_5604_4087_4609_2956 16 3.69E-13 2.80E-11 2.55E-12 9304 hsa-mir-224 hsa04310 Wnt signaling pathway 3725_5467_1499_595_6934_4089_4772_4773_1487_1488_1387_7157_1457_4088_2033_51176_4087_4609_5527 19 1.95E-12 1.48E-10 1.23E-11 9305 hsa-mir-224 hsa05219 Bladder cancer 595_9252_4193_5925_1870_1871_5595_5594_7157_1869_5604_4609 12 5.65E-12 4.30E-10 3.31E-11 9306 hsa-mir-224 hsa05222 Small cell lung cancer 595_1017_6502_5925_9063_1870_1871_10401_207_6256_5970_7157_1869_4846_4609 15 6.19E-12 4.71E-10 3.36E-11 9307 hsa-mir-224 hsa05213 Endometrial cancer 1499_595_6934_2309_207_5595_5594_7157_51176_5604_4609_2002 12 4.80E-11 3.65E-09 2.43E-10 9308 hsa-mir-224 hsa05223 Non-small cell lung cancer 595_5925_2309_1870_1871_207_5595_5594_6256_7157_1869_5604 12 7.03E-11 5.34E-09 3.34E-10 9309 hsa-mir-224 hsa04010 MAPK signaling pathway 6722_3725_9252_7867_4773_1432_4763_207_5595_5594_1386_836_3312_5970_3164_7157_9261_5604_4208_5608_4609_2002 22 1.02E-10 7.74E-09 4.55E-10 9310 hsa-mir-224 hsa05218 Melanoma 595_4193_5925_1870_1871_207_4286_5595_5594_7157_1869_5604 12 1.13E-09 8.57E-08 4.76E-09 9311 hsa-mir-224 hsa05211 Renal cell carcinoma 3725_3091_405_2113_207_5595_5594_1387_2034_2033_5604_7428 12 1.30E-09 9.87E-08 5.20E-09 9312 hsa-mir-224 hsa05322 Systemic lupus erythematosus 3021_3020_8294_8370_121504_8361_8360_8363_8362_8365_8364_8367_8366_8368_8359 15 4.19E-09 3.18E-07 1.59E-08 9313 hsa-mir-224 hsa04520 Adherens junction 1499_6934_4089_5595_5594_1387_1457_4088_2033_51176_4087 11 3.82E-08 2.91E-06 1.38E-07 9314 hsa-mir-224 hsa04916 Melanogenesis 1499_6934_4286_5595_5594_1387_2033_808_801_805_51176_5604 12 5.39E-08 4.10E-06 1.86E-07 9315 hsa-mir-224 hsa04630 Jak-STAT signaling pathway 595_9063_3595_3594_10401_207_1387_6778_6774_6776_6777_6772_2033_4609 14 7.19E-08 5.47E-06 2.38E-07 9316 hsa-mir-224 hsa04012 ErbB signaling pathway 3725_25_207_5595_5594_6776_6777_5604_4609_6464_2002 11 8.33E-08 6.33E-06 2.64E-07 9317 hsa-mir-224 hsa04370 VEGF signaling pathway 7867_4772_4773_1432_207_5595_5594_4846_9261_5604 10 2.59E-07 1.97E-05 7.86E-07 9318 hsa-mir-224 hsa04620 Toll-like receptor signaling pathway 3725_3665_3661_1432_207_5595_5594_6772_5970_5604_5608 11 3.61E-07 2.75E-05 1.06E-06 9319 hsa-mir-224 hsa04912 GnRH signaling pathway 3725_5580_1432_5595_5594_808_801_805_5604_5608_2002 11 6.10E-07 4.64E-05 1.72E-06 9320 hsa-mir-224 hsa04720 Long-term potentiation 2902_5595_5594_1387_2033_808_801_805_5604 9 1.88E-06 0.000142856 5.10E-06 9321 hsa-mir-224 hsa05016 Huntington's disease 10891_3066_3065_3064_5468_2902_6667_1387_836_7157_2033_6874_6908 13 3.48E-06 0.000264478 9.12E-06 9322 hsa-mir-224 hsa04910 Insulin signaling pathway 6720_10891_207_5595_5594_808_801_805_5604_6464_2002 11 5.59E-06 0.000424566 1.42E-05 9323 hsa-mir-224 hsa04662 B cell receptor signaling pathway 3725_4772_4773_207_5595_5594_5970_5604 8 1.55E-05 0.001180471 3.81E-05 9324 hsa-mir-224 hsa03410 Base excision repair 4350_5111_252969_328_2237_6996 6 1.91E-05 0.001450307 4.53E-05 9325 hsa-mir-224 hsa04660 T cell receptor signaling pathway 3725_4772_4773_1432_207_5595_5594_5970_5604 9 3.28E-05 0.002491049 7.55E-05 9326 hsa-mir-224 hsa04950 Maturity onset diabetes of the young 6927_4760_3651_168620_5080 5 3.78E-05 0.00287008 8.44E-05 9327 hsa-mir-224 hsa04115 p53 signaling pathway 595_1017_4194_4193_836_7157_7161 7 7.11E-05 0.005407323 0.000154495 9328 hsa-mir-224 hsa03450 Non-homologous end-joining 10111_2237_5591_4361 4 8.26E-05 0.006280148 0.000174449 9329 hsa-mir-224 hsa04062 Chemokine signaling pathway 5580_2309_207_5595_5594_6774_6777_6772_5970_5604_6464 11 0.000102335 0.00777747 0.000210202 9330 hsa-mir-224 hsa04664 Fc epsilon RI signaling pathway 5580_1432_207_5595_5594_5604_5608 7 0.00015602 0.011857494 0.000312039 9331 hsa-mir-224 hsa04120 Ubiquitin mediated proteolysis 4193_6502_9063_10401_8925_7329_5371_672_7428 9 0.000176992 0.013451406 0.000339441 9332 hsa-mir-224 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_1432_836_7157_4846_5608 6 0.000178653 0.013577658 0.000339441 9333 hsa-mir-224 hsa04270 Vascular smooth muscle contraction 5580_5595_5594_808_801_805_59_5604 8 0.000300902 0.022868518 0.000557769 9334 hsa-mir-224 hsa04920 Adipocytokine signaling pathway 10891_5465_207_6256_6774_5970 6 0.00043744 0.033245472 0.000791559 9335 hsa-mir-224 hsa04510 Focal adhesion 3725_1499_595_207_5595_5594_5604_6464_2002 9 0.002536501 0.192774046 0.004483117 9336 hsa-mir-224 hsa04650 Natural killer cell mediated cytotoxicity 4772_4773_5595_5594_836_5604_6464 7 0.00343555 0.26110181 0.005934132 9337 hsa-mir-224 hsa05010 Alzheimer's disease 2902_5595_5594_836_4846_808_801_805 8 0.003556545 0.270297448 0.00600661 9338 hsa-mir-224 hsa04930 Type II diabetes mellitus 5580_3651_5595_5594 4 0.00413197 0.314029745 0.006826734 9339 hsa-mir-224 hsa04150 mTOR signaling pathway 3091_207_5595_5594 4 0.006659589 0.506128782 0.010768697 9340 hsa-mir-224 hsa05217 Basal cell carcinoma 1499_6934_7157_51176 4 0.007999157 0.60793591 0.012487107 9341 hsa-mir-224 hsa03440 Homologous recombination 10111_4683_4361 3 0.008050898 0.611868266 0.012487107 9342 hsa-mir-224 hsa03022 Basal transcription factors 6874_2959_6908 3 0.016205338 1 0.024632113 9343 hsa-mir-224 hsa04710 Circadian rhythm - mammal 8863_4862 2 0.01664803 1 0.02480883 9344 hsa-mir-224 hsa03320 PPAR signaling pathway 5465_5467_5468_6256 4 0.017318913 1 0.025312257 9345 hsa-mir-224 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1432_836_5970 4 0.018107285 1 0.025484327 9346 hsa-mir-224 hsa04730 Long-term depression 5595_5594_4846_5604 4 0.018107285 1 0.025484327 9347 hsa-mir-224 hsa04360 Axon guidance 4772_4773_25_5595_5594 5 0.036135824 1 0.049093231 9348 hsa-mir-224 hsa04210 Apoptosis 207_836_5970_7157 4 0.036173959 1 0.049093231 9349 hsa-mir-224 hsa03430 Mismatch repair 5111_2956 2 0.043591876 1 0.058122501 9350 hsa-mir-2276 hsa05200 Pathways in cancer 5371_2249_367_5595_5594_5914_6256_595_836_7704_6776_6777_3091_5970_7428_1870_1871_7157_4087_4089_2113_4609_1869_3725_2353_4088_3066_3065_5925_2034_2033_4846 32 3.20E-33 2.11E-31 2.11E-31 9351 hsa-mir-2276 hsa05220 Chronic myeloid leukemia 5595_5594_595_6776_6777_5970_1870_1871_7157_4089_4609_1869_4088_3066_3065_5925_6464 17 1.30E-23 8.56E-22 4.28E-22 9352 hsa-mir-2276 hsa04110 Cell cycle 5591_595_1870_1871_7157_4087_4089_1869_4088_3066_3065_5925_2033_5933 14 4.81E-16 3.17E-14 1.06E-14 9353 hsa-mir-2276 hsa05210 Colorectal cancer 5595_5594_595_836_7157_4087_4089_4609_3725_2353_4088 11 2.55E-13 1.68E-11 4.15E-12 9354 hsa-mir-2276 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_6776_6777_5970_4609 10 3.14E-13 2.07E-11 4.15E-12 9355 hsa-mir-2276 hsa05215 Prostate cancer 367_5595_5594_595_5970_1870_1871_7157_1869_5925_2033 11 4.05E-13 2.68E-11 4.28E-12 9356 hsa-mir-2276 hsa05212 Pancreatic cancer 367_5595_5594_595_5970_1870_1871_7157_1869_5925_2033 11 4.54E-13 3.00E-11 4.28E-12 9357 hsa-mir-2276 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5925 9 7.69E-13 5.07E-11 6.34E-12 9358 hsa-mir-2276 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925 9 5.73E-12 3.78E-10 4.20E-11 9359 hsa-mir-2276 hsa05222 Small cell lung cancer 6256_595_5970_1870_1871_7157_4609_1869_5925_4846 10 9.49E-12 6.26E-10 6.26E-11 9360 hsa-mir-2276 hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_6464 9 2.58E-11 1.70E-09 1.55E-10 9361 hsa-mir-2276 hsa05218 Melanoma 2249_5595_5594_595_1870_1871_7157_1869_5925 9 5.29E-11 3.49E-09 2.91E-10 9362 hsa-mir-2276 hsa04350 TGF-beta signaling pathway 6667_5595_5594_4087_4089_4609_4088_2033_5933 9 2.80E-10 1.85E-08 1.42E-09 9363 hsa-mir-2276 hsa05211 Renal cell carcinoma 5595_5594_3091_7428_2113_3725_2034_2033 8 1.68E-09 1.11E-07 7.94E-09 9364 hsa-mir-2276 hsa04010 MAPK signaling pathway 2249_5595_5594_4208_836_5970_3312_7157_4609_3725_2353_4763 12 3.05E-09 2.01E-07 1.34E-08 9365 hsa-mir-2276 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 6.98E-09 4.60E-07 2.88E-08 9366 hsa-mir-2276 hsa05016 Huntington's disease 6667_6874_2902_6908_836_7157_3066_3065_3064_2033 10 1.19E-08 7.86E-07 4.62E-08 9367 hsa-mir-2276 hsa04310 Wnt signaling pathway 595_7157_4087_4089_4609_3725_1457_4088_2033 9 2.74E-08 1.81E-06 1.01E-07 9368 hsa-mir-2276 hsa04520 Adherens junction 5595_5594_4087_4089_1457_4088_2033 7 8.38E-08 5.53E-06 2.91E-07 9369 hsa-mir-2276 hsa04012 ErbB signaling pathway 5595_5594_6776_6777_4609_3725_6464 7 1.43E-07 9.45E-06 4.73E-07 9370 hsa-mir-2276 hsa05213 Endometrial cancer 5595_5594_595_7157_4609 5 4.16E-06 0.000274327 1.31E-05 9371 hsa-mir-2276 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725_2353 5 2.21E-05 0.00145862 6.63E-05 9372 hsa-mir-2276 hsa04630 Jak-STAT signaling pathway 595_6776_6777_4609_2033_3977 6 6.16E-05 0.004065262 0.000172167 9373 hsa-mir-2276 hsa04330 Notch signaling pathway 9612_3066_3065_2033 4 6.26E-05 0.004132 0.000172167 9374 hsa-mir-2276 hsa04620 Toll-like receptor signaling pathway 5595_5594_5970_3725_2353 5 8.93E-05 0.005895247 0.00023581 9375 hsa-mir-2276 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_7157_4846 4 0.000118667 0.007832049 0.000301233 9376 hsa-mir-2276 hsa04660 T cell receptor signaling pathway 5595_5594_5970_3725_2353 5 0.000125565 0.00828729 0.000306937 9377 hsa-mir-2276 hsa04720 Long-term potentiation 5595_5594_2902_2033 4 0.000343927 0.022699159 0.000810684 9378 hsa-mir-2276 hsa05010 Alzheimer's disease 5595_5594_2902_836_4846 5 0.001031324 0.068067391 0.002347151 9379 hsa-mir-2276 hsa04062 Chemokine signaling pathway 5595_5594_6777_5970_6464 5 0.001497426 0.098830149 0.003294338 9380 hsa-mir-2276 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.001599028 0.105535861 0.003404383 9381 hsa-mir-2276 hsa04510 Focal adhesion 5595_5594_595_3725_6464 5 0.001977683 0.130527079 0.004008206 9382 hsa-mir-2276 hsa03450 Non-homologous end-joining 5591_2547 2 0.002004103 0.132270784 0.004008206 9383 hsa-mir-2276 hsa04910 Insulin signaling pathway 6720_5595_5594_6464 4 0.003036465 0.200406684 0.005725905 9384 hsa-mir-2276 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_6464 4 0.003036465 0.200406684 0.005725905 9385 hsa-mir-2276 hsa04115 p53 signaling pathway 595_836_7157 3 0.003452369 0.227856367 0.006329344 9386 hsa-mir-2276 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_5970_3725 3 0.003729799 0.246166745 0.006478072 9387 hsa-mir-2276 hsa04730 Long-term depression 5595_5594_4846 3 0.003729799 0.246166745 0.006478072 9388 hsa-mir-2276 hsa04370 VEGF signaling pathway 5595_5594_4846 3 0.004642225 0.306386869 0.007856074 9389 hsa-mir-2276 hsa04612 Antigen processing and presentation 4800_4801_3312 3 0.006842994 0.451637584 0.011015551 9390 hsa-mir-2276 hsa04210 Apoptosis 836_5970_7157 3 0.006842994 0.451637584 0.011015551 9391 hsa-mir-2276 hsa04916 Melanogenesis 5595_5594_2033 3 0.010337853 0.682298322 0.016245198 9392 hsa-mir-2276 hsa04912 GnRH signaling pathway 5595_5594_3725 3 0.011414862 0.753380898 0.017434942 9393 hsa-mir-2276 hsa03022 Basal transcription factors 6874_6908 2 0.011623295 0.767137438 0.017434942 9394 hsa-mir-2276 hsa04930 Type II diabetes mellitus 5595_5594 2 0.016592604 1 0.024335819 9395 hsa-mir-2276 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428 3 0.021909346 1 0.031435149 9396 hsa-mir-2276 hsa04080 Neuroactive ligand-receptor interaction 2902_2908_7068_7067 4 0.023940803 1 0.033619 9397 hsa-mir-2276 hsa04920 Adipocytokine signaling pathway 6256_5970 2 0.033934073 1 0.046659351 9398 hsa-mir-2276 hsa04664 Fc epsilon RI signaling pathway 5595_5594 2 0.045380775 1 0.061125125 9399 hsa-mir-2277 hsa04630 Jak-STAT signaling pathway 3717_3716_3560_3561_1387_6774_6776_6777_6773_58985_3455_3459_5781_7297_1439_2033_207_8554_10379 19 2.73E-24 1.61E-22 1.61E-22 9400 hsa-mir-2277 hsa05200 Pathways in cancer 3716_5747_1956_1387_2064_5159_5156_2261_3815_6774_6776_6777_5879_8772_3725_2353_4089_2033_207_8554_5970_7046 22 1.36E-22 8.00E-21 4.00E-21 9401 hsa-mir-2277 hsa04060 Cytokine-cytokine receptor interaction 2321_3791_1956_3560_3561_90_5159_5156_7133_7132_1234_1230_3815_7852_58985_3455_3459_1439_7046 19 2.83E-20 1.67E-18 5.57E-19 9402 hsa-mir-2277 hsa04010 MAPK signaling pathway 1956_5159_5156_7132_2261_2264_9252_1432_1845_5879_3725_2353_207_5970_7046 15 1.70E-14 1.00E-12 2.50E-13 9403 hsa-mir-2277 hsa04012 ErbB signaling pathway 5747_818_817_1956_6714_2064_6776_6777_3725_207 10 5.44E-13 3.21E-11 6.42E-12 9404 hsa-mir-2277 hsa04062 Chemokine signaling pathway 3717_5747_5580_1234_1230_6774_6777_6773_5879_7852_207_5970 12 2.11E-12 1.25E-10 2.08E-11 9405 hsa-mir-2277 hsa04510 Focal adhesion 5747_2321_3791_1956_6714_2064_5159_5156_5879_3725_207_2534 12 4.37E-12 2.58E-10 3.68E-11 9406 hsa-mir-2277 hsa04520 Adherens junction 1956_6714_1387_2064_5879_4089_2033_7046_2534 9 9.90E-12 5.84E-10 7.30E-11 9407 hsa-mir-2277 hsa05210 Colorectal cancer 1956_5159_5156_5879_3725_2353_4089_207_7046 9 1.48E-11 8.75E-10 9.72E-11 9408 hsa-mir-2277 hsa04920 Adipocytokine signaling pathway 3717_8717_7133_7132_6774_5781_207_5970 8 9.50E-11 5.61E-09 5.61E-10 9409 hsa-mir-2277 hsa05215 Prostate cancer 1956_1387_2064_5159_5156_2033_207_5970 8 7.08E-10 4.18E-08 3.78E-09 9410 hsa-mir-2277 hsa05212 Pancreatic cancer 1956_1387_2064_5159_5156_2033_207_5970 8 7.70E-10 4.54E-08 3.78E-09 9411 hsa-mir-2277 hsa04620 Toll-like receptor signaling pathway 1432_5879_3455_8772_3725_2353_207_5970 8 2.11E-09 1.25E-07 9.58E-09 9412 hsa-mir-2277 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_1432_5879_5781_3725_5970 7 5.10E-09 3.01E-07 2.15E-08 9413 hsa-mir-2277 hsa05220 Chronic myeloid leukemia 6776_6777_5781_4089_207_5970_7046 7 7.26E-09 4.28E-07 2.86E-08 9414 hsa-mir-2277 hsa05221 Acute myeloid leukemia 3815_6774_6776_6777_207_5970 6 5.62E-08 3.32E-06 2.07E-07 9415 hsa-mir-2277 hsa04912 GnRH signaling pathway 5580_818_817_1956_6714_1432_3725 7 7.70E-08 4.54E-06 2.67E-07 9416 hsa-mir-2277 hsa04660 T cell receptor signaling pathway 3932_1432_3725_2353_207_5970_2534 7 8.67E-08 5.11E-06 2.84E-07 9417 hsa-mir-2277 hsa05214 Glioma 818_817_1956_5159_5156_207 6 9.61E-08 5.67E-06 2.98E-07 9418 hsa-mir-2277 hsa05211 Renal cell carcinoma 1387_5879_5781_3725_2033_207 6 1.69E-07 9.99E-06 4.99E-07 9419 hsa-mir-2277 hsa04662 B cell receptor signaling pathway 6850_5879_3725_2353_207_5970 6 2.12E-07 1.25E-05 5.97E-07 9420 hsa-mir-2277 hsa04370 VEGF signaling pathway 5747_3791_6714_1432_5879_207 6 2.46E-07 1.45E-05 6.59E-07 9421 hsa-mir-2277 hsa04664 Fc epsilon RI signaling pathway 5580_6850_1432_5879_207_2534 6 2.83E-07 1.67E-05 7.27E-07 9422 hsa-mir-2277 hsa04650 Natural killer cell mediated cytotoxicity 3932_6850_5879_3455_3459_5781_2534 7 3.76E-07 2.22E-05 9.24E-07 9423 hsa-mir-2277 hsa04350 TGF-beta signaling pathway 1387_90_4089_2033_7046_57154 6 4.84E-07 2.86E-05 1.14E-06 9424 hsa-mir-2277 hsa04210 Apoptosis 8717_7132_8772_1439_207_5970 6 5.49E-07 3.24E-05 1.25E-06 9425 hsa-mir-2277 hsa04310 Wnt signaling pathway 818_817_1387_5879_3725_4089_2033 7 7.01E-07 4.13E-05 1.53E-06 9426 hsa-mir-2277 hsa04020 Calcium signaling pathway 818_817_1956_2064_5159_5156_147 7 2.39E-06 0.000140811 5.03E-06 9427 hsa-mir-2277 hsa04810 Regulation of actin cytoskeleton 5747_1956_5159_5156_2261_2264_5879 7 7.22E-06 0.0004259 1.47E-05 9428 hsa-mir-2277 hsa05219 Bladder cancer 1956_2064_2261_9252 4 1.32E-05 0.000777153 2.59E-05 9429 hsa-mir-2277 hsa04916 Melanogenesis 818_817_1387_3815_2033 5 2.41E-05 0.001424325 4.59E-05 9430 hsa-mir-2277 hsa05014 Amyotrophic lateral sclerosis (ALS) 7133_7132_1432_5879 4 3.81E-05 0.002245987 7.02E-05 9431 hsa-mir-2277 hsa04110 Cell cycle 1387_4174_4172_4089_2033 5 4.48E-05 0.002645668 8.02E-05 9432 hsa-mir-2277 hsa04670 Leukocyte transendothelial migration 5747_1432_5879_7852_5781 5 5.03E-05 0.002965481 8.72E-05 9433 hsa-mir-2277 hsa05218 Melanoma 1956_5159_5156_207 4 9.16E-05 0.005401521 0.000154329 9434 hsa-mir-2277 hsa04720 Long-term potentiation 818_817_1387_2033 4 0.000112099 0.006613853 0.000183718 9435 hsa-mir-2277 hsa05222 Small cell lung cancer 5747_207_8554_5970 4 0.00018571 0.010956877 0.000296132 9436 hsa-mir-2277 hsa04540 Gap junction 1956_6714_5159_5156 4 0.000247663 0.014612095 0.000384529 9437 hsa-mir-2277 hsa03022 Basal transcription factors 2969_6908_2959 3 0.000268136 0.015819999 0.000405641 9438 hsa-mir-2277 hsa05213 Endometrial cancer 1956_2064_207 3 0.000688286 0.04060889 0.001015222 9439 hsa-mir-2277 hsa05223 Non-small cell lung cancer 1956_2064_207 3 0.000764193 0.045087409 0.001099693 9440 hsa-mir-2277 hsa04360 Axon guidance 5747_5879_7852_2534 4 0.000864229 0.050989489 0.001214035 9441 hsa-mir-2277 hsa04120 Ubiquitin mediated proteolysis 672_7329_8554_57154 4 0.001070283 0.063146671 0.001468527 9442 hsa-mir-2277 hsa05340 Primary immunodeficiency 3932_3561 2 0.005987551 0.35326549 0.008028761 9443 hsa-mir-2277 hsa03030 DNA replication 4174_4172 2 0.006307415 0.372137514 0.008269723 9444 hsa-mir-2277 hsa04530 Tight junction 5580_6714_207 3 0.009704192 0.572547332 0.012446681 9445 hsa-mir-2277 hsa04330 Notch signaling pathway 1387_2033 2 0.010319289 0.608838073 0.012954002 9446 hsa-mir-2277 hsa05016 Huntington's disease 1387_6908_2033 3 0.022129709 1 0.027201101 9447 hsa-mir-2278 hsa04310 Wnt signaling pathway 4087_4088_1487_2033_1488 5 7.66E-11 1.15E-09 1.15E-09 9448 hsa-mir-2278 hsa05200 Pathways in cancer 4087_4088_1487_2033_1488 5 3.58E-09 5.36E-08 2.68E-08 9449 hsa-mir-2278 hsa04330 Notch signaling pathway 1487_2033_1488 3 1.52E-07 2.27E-06 7.58E-07 9450 hsa-mir-2278 hsa05220 Chronic myeloid leukemia 4088_1487_1488 3 5.87E-07 8.80E-06 2.13E-06 9451 hsa-mir-2278 hsa04520 Adherens junction 4087_4088_2033 3 7.09E-07 1.06E-05 2.13E-06 9452 hsa-mir-2278 hsa04350 TGF-beta signaling pathway 4087_4088_2033 3 9.05E-07 1.36E-05 2.26E-06 9453 hsa-mir-2278 hsa04110 Cell cycle 4087_4088_2033 3 2.27E-06 3.40E-05 4.86E-06 9454 hsa-mir-2278 hsa05210 Colorectal cancer 4087_4088 2 0.000168908 0.002533625 0.000316703 9455 hsa-mir-2278 hsa05211 Renal cell carcinoma 2033 1 0.016907255 0.253608829 0.026011491 9456 hsa-mir-2278 hsa04720 Long-term potentiation 2033 1 0.017596799 0.263951989 0.026011491 9457 hsa-mir-2278 hsa05215 Prostate cancer 2033 1 0.020580035 0.308700524 0.026011491 9458 hsa-mir-2278 hsa05212 Pancreatic cancer 2033 1 0.020809193 0.31213789 0.026011491 9459 hsa-mir-2278 hsa04916 Melanogenesis 2033 1 0.024241047 0.363615709 0.027970439 9460 hsa-mir-2278 hsa04630 Jak-STAT signaling pathway 2033 1 0.035832353 0.53748529 0.038391806 9461 hsa-mir-2278 hsa05016 Huntington's disease 2033 1 0.043269546 0.649043197 0.043269546 9462 hsa-mir-2355 hsa05200 Pathways in cancer 5467_1499_5914_595_1017_4193_6934_7704_3091_4089_3066_3065_1050_5925_5468_25_405_1487_1488_1870_1871_2113_10401_861_207_4286_5595_5594_5599_6258_1387_6257_6256_836_367_2932_6774_6776_6777_6772_5970_7157_7849_1869_3725_4088_2034_2033_4846_3320_51176_5371_8031_5604_7428_4087_4609_2956_2736_8554 60 1.32E-41 1.01E-39 1.01E-39 9463 hsa-mir-2355 hsa05220 Chronic myeloid leukemia 595_4193_4089_3066_3065_5925_25_1487_1488_1870_1871_861_207_5595_5594_6776_6777_5970_7157_1869_4088_5604_4609_6464 24 3.30E-22 2.51E-20 1.25E-20 9464 hsa-mir-2355 hsa05215 Prostate cancer 1499_595_1017_4193_6934_5925_1870_1871_207_5595_5594_1387_367_2932_5970_7157_1869_2033_3320_51176_5604 21 2.21E-17 1.68E-15 5.12E-16 9465 hsa-mir-2355 hsa05212 Pancreatic cancer 1499_595_1017_4193_6934_5925_1870_1871_207_5595_5594_1387_367_2932_5970_7157_1869_2033_3320_51176_5604 21 2.70E-17 2.05E-15 5.12E-16 9466 hsa-mir-2355 hsa04110 Cell cycle 595_1017_4193_5111_4089_3066_3065_4616_5925_25_1870_1871_5934_5933_5591_1387_2932_7157_10912_1869_4088_2033_4087 23 3.76E-17 2.86E-15 5.71E-16 9467 hsa-mir-2355 hsa05216 Thyroid cancer 1499_595_6934_5468_5595_5594_6258_6257_6256_7157_7849_51176_8031_5604_4609 15 7.42E-17 5.64E-15 9.40E-16 9468 hsa-mir-2355 hsa05221 Acute myeloid leukemia 5467_5914_595_6934_7704_1050_861_207_5595_5594_6774_6776_6777_5970_51176_5371_5604_4609 18 1.12E-16 8.53E-15 1.22E-15 9469 hsa-mir-2355 hsa05210 Colorectal cancer 1499_595_6934_4089_207_5595_5594_5599_836_2932_7157_3725_4088_51176_5604_4087_4609_2956 18 2.19E-14 1.66E-12 2.08E-13 9470 hsa-mir-2355 hsa04010 MAPK signaling pathway 6722_6195_6197_9252_4773_4616_8986_1432_4763_1616_207_5595_5594_5599_1386_836_3312_5970_3164_7157_10912_3725_6196_9261_5604_4208_4609_2002 28 3.37E-14 2.56E-12 2.85E-13 9471 hsa-mir-2355 hsa04310 Wnt signaling pathway 5467_1499_595_6934_4089_4772_4773_1487_1488_5599_1387_2932_7157_3725_1457_4088_2033_51176_4087_4609_5527 21 3.25E-13 2.47E-11 2.47E-12 9472 hsa-mir-2355 hsa04350 TGF-beta signaling pathway 4086_4089_6667_3399_3398_1875_5934_5933_4093_5595_5594_1387_4088_2033_4087_4609_4092 17 4.31E-13 3.28E-11 2.98E-12 9473 hsa-mir-2355 hsa05223 Non-small cell lung cancer 595_5925_2309_1870_1871_207_5595_5594_6258_6257_6256_7157_1869_5604 14 1.89E-12 1.43E-10 1.20E-11 9474 hsa-mir-2355 hsa05222 Small cell lung cancer 595_1017_5925_1870_1871_10401_207_6258_6257_6256_5970_7157_1869_4846_4609_8554 16 4.08E-12 3.10E-10 2.39E-11 9475 hsa-mir-2355 hsa04330 Notch signaling pathway 1840_3066_3065_9794_22938_1487_1488_1387_2033_8850_9612_2648_4851 13 5.86E-12 4.46E-10 3.18E-11 9476 hsa-mir-2355 hsa05213 Endometrial cancer 1499_595_6934_2309_207_5595_5594_2932_7157_51176_5604_4609_2002 13 1.74E-11 1.32E-09 8.81E-11 9477 hsa-mir-2355 hsa05219 Bladder cancer 595_9252_4193_5925_1870_1871_5595_5594_7157_1869_5604_4609 12 2.80E-11 2.13E-09 1.33E-10 9478 hsa-mir-2355 hsa05214 Glioma 595_4193_5925_1870_1871_207_5595_5594_7157_1869_5604_6464 12 2.18E-09 1.66E-07 9.75E-09 9479 hsa-mir-2355 hsa04012 ErbB signaling pathway 25_207_5595_5594_5599_2932_6776_6777_3725_5604_4609_6464_2002 13 4.63E-09 3.52E-07 1.95E-08 9480 hsa-mir-2355 hsa05218 Melanoma 595_4193_5925_1870_1871_207_4286_5595_5594_7157_1869_5604 12 5.29E-09 4.02E-07 2.12E-08 9481 hsa-mir-2355 hsa05211 Renal cell carcinoma 3091_405_2113_207_5595_5594_1387_3725_2034_2033_5604_7428 12 6.09E-09 4.63E-07 2.31E-08 9482 hsa-mir-2355 hsa04520 Adherens junction 1499_6934_4089_71_5595_5594_1387_1457_4088_2033_51176_4087 12 1.75E-08 1.33E-06 6.34E-08 9483 hsa-mir-2355 hsa05322 Systemic lupus erythematosus 3021_3020_8294_8370_121504_8361_8360_8363_8362_8365_8364_8367_8366_8368_8359 15 2.62E-08 1.99E-06 9.07E-08 9484 hsa-mir-2355 hsa04620 Toll-like receptor signaling pathway 3665_3661_1432_207_5595_5594_5599_6772_5970_3725_5604 11 1.39E-06 0.000105922 4.61E-06 9485 hsa-mir-2355 hsa04920 Adipocytokine signaling pathway 10891_5465_207_5599_6258_6257_6256_6774_5970 9 2.48E-06 0.000188705 7.86E-06 9486 hsa-mir-2355 hsa04115 p53 signaling pathway 595_1017_4194_4193_4616_836_7157_10912_7161 9 3.09E-06 0.00023511 9.40E-06 9487 hsa-mir-2355 hsa03410 Base excision repair 3146_4350_5111_328_2237_252969_6996 7 3.80E-06 0.000288938 1.11E-05 9488 hsa-mir-2355 hsa04720 Long-term potentiation 6195_6197_2902_5595_5594_1387_6196_2033_5604 9 5.76E-06 0.000437665 1.56E-05 9489 hsa-mir-2355 hsa04662 B cell receptor signaling pathway 4772_4773_207_5595_5594_2932_5970_3725_5604 9 5.76E-06 0.000437665 1.56E-05 9490 hsa-mir-2355 hsa04370 VEGF signaling pathway 4772_4773_1432_207_5595_5594_4846_9261_5604 9 7.00E-06 0.000532143 1.83E-05 9491 hsa-mir-2355 hsa04916 Melanogenesis 1499_6934_4286_5595_5594_1387_2932_2033_51176_5604 10 1.07E-05 0.000812358 2.71E-05 9492 hsa-mir-2355 hsa04630 Jak-STAT signaling pathway 595_10401_207_1387_6778_6774_6776_6777_6772_2033_4609_8554 12 1.12E-05 0.00085488 2.76E-05 9493 hsa-mir-2355 hsa05016 Huntington's disease 10891_3066_3065_3064_5468_2902_6667_1387_836_7157_2033_6874_6908 13 1.52E-05 0.001154611 3.61E-05 9494 hsa-mir-2355 hsa04660 T cell receptor signaling pathway 4772_4773_1432_207_5595_5594_2932_5970_3725_5604 10 1.68E-05 0.001276932 3.87E-05 9495 hsa-mir-2355 hsa04150 mTOR signaling pathway 6195_6197_3091_207_5595_5594_6196 7 3.26E-05 0.002476991 7.29E-05 9496 hsa-mir-2355 hsa04062 Chemokine signaling pathway 2309_207_5595_5594_2932_5580_6774_6777_6772_5970_5604_6464 12 8.44E-05 0.006413726 0.000183249 9497 hsa-mir-2355 hsa04910 Insulin signaling pathway 6720_10891_207_5595_5594_5599_2932_5604_6464_2002 10 0.000100836 0.007663544 0.000212876 9498 hsa-mir-2355 hsa03450 Non-homologous end-joining 10111_2237_5591_4361 4 0.000140611 0.010686441 0.000288823 9499 hsa-mir-2355 hsa04510 Focal adhesion 1499_595_207_71_5595_5594_5599_2932_3725_5604_6464_2002 12 0.000150692 0.01145257 0.000301383 9500 hsa-mir-2355 hsa03320 PPAR signaling pathway 5465_5467_5468_6258_6257_6256_2168 7 0.000181353 0.013782836 0.000353406 9501 hsa-mir-2355 hsa05217 Basal cell carcinoma 1499_6934_2932_7157_51176_2736 6 0.000341924 0.025986211 0.000649655 9502 hsa-mir-2355 hsa04664 Fc epsilon RI signaling pathway 1432_207_5595_5594_5599_5580_5604 7 0.000360141 0.027370723 0.000667579 9503 hsa-mir-2355 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_1432_1616_836_7157_4846 6 0.000373719 0.028402675 0.000676254 9504 hsa-mir-2355 hsa04912 GnRH signaling pathway 1432_5595_5594_5599_5580_3725_5604_2002 8 0.00043038 0.032708851 0.000760671 9505 hsa-mir-2355 hsa04950 Maturity onset diabetes of the young 6927_4760_3651_5080 4 0.000833461 0.063343035 0.001439614 9506 hsa-mir-2355 hsa04930 Type II diabetes mellitus 5595_5594_5599_5580_3651 5 0.000994702 0.075597353 0.001679941 9507 hsa-mir-2355 hsa04120 Ubiquitin mediated proteolysis 4193_10401_7329_8925_5371_672_7428_8554 8 0.002004092 0.152311023 0.003311109 9508 hsa-mir-2355 hsa03022 Basal transcription factors 2963_6874_6908_2959 4 0.003524765 0.267882166 0.005699621 9509 hsa-mir-2355 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_5599_836_5970_3725 5 0.00627512 0.476909111 0.009732839 9510 hsa-mir-2355 hsa04730 Long-term depression 5592_5595_5594_4846_5604 5 0.00627512 0.476909111 0.009732839 9511 hsa-mir-2355 hsa04650 Natural killer cell mediated cytotoxicity 4772_4773_5595_5594_836_5604_6464 7 0.007188444 0.546321738 0.010926435 9512 hsa-mir-2355 hsa03440 Homologous recombination 10111_4683_4361 3 0.011699704 0.889177481 0.017434853 9513 hsa-mir-2355 hsa04270 Vascular smooth muscle contraction 5592_5595_5594_5580_59_5604 6 0.012322036 0.93647475 0.01800913 9514 hsa-mir-2355 hsa04612 Antigen processing and presentation 3308_3312_3320_4800_4801 5 0.014932245 1 0.021412276 9515 hsa-mir-2355 hsa04360 Axon guidance 4772_4773_25_5595_5594_2932 6 0.019256788 1 0.027102146 9516 hsa-mir-2355 hsa04710 Circadian rhythm - mammal 8863_4862 2 0.021574729 1 0.029812353 9517 hsa-mir-2355 hsa05010 Alzheimer's disease 22926_2902_5595_5594_836_2932_4846 7 0.02384292 1 0.032358249 9518 hsa-mir-2355 hsa04740 Olfactory transduction 5592 1 0.034435939 1 0.045914586 9519 hsa-mir-23a hsa05200 Pathways in cancer 4088_4089_5601_1050_5371_5925_2033_367_4609_3725_5595_5599_2353_1387 14 6.71E-17 3.49E-15 3.49E-15 9520 hsa-mir-23a hsa04010 MAPK signaling pathway 1432_5601_5600_5603_9252_8550_4609_3725_3727_5595_5599_1649_2353 13 2.23E-16 1.16E-14 5.80E-15 9521 hsa-mir-23a hsa04310 Wnt signaling pathway 4088_4089_5601_2033_8061_4609_3725_5599_1457_1387_1459 11 7.37E-16 3.83E-14 1.28E-14 9522 hsa-mir-23a hsa05210 Colorectal cancer 4088_4089_5601_4609_3725_5595_5599_2353 8 1.11E-12 5.78E-11 1.45E-11 9523 hsa-mir-23a hsa04620 Toll-like receptor signaling pathway 1432_5601_5600_5603_3725_5595_5599_2353 8 4.80E-12 2.50E-10 4.99E-11 9524 hsa-mir-23a hsa04520 Adherens junction 4088_4089_2033_5595_1457_1387_1459 7 5.54E-11 2.88E-09 4.80E-10 9525 hsa-mir-23a hsa04912 GnRH signaling pathway 1432_5601_5600_5603_3725_5595_5599 7 4.03E-10 2.09E-08 2.96E-09 9526 hsa-mir-23a hsa04660 T cell receptor signaling pathway 1432_5601_5600_5603_3725_5595_2353 7 4.55E-10 2.36E-08 2.96E-09 9527 hsa-mir-23a hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_5601_5600_5603_3725_5599 6 1.75E-09 9.09E-08 1.01E-08 9528 hsa-mir-23a hsa04664 Fc epsilon RI signaling pathway 1432_5601_5600_5603_5595_5599 6 3.19E-09 1.66E-07 1.66E-08 9529 hsa-mir-23a hsa04350 TGF-beta signaling pathway 4088_4089_2033_4609_5595_1387 6 5.52E-09 2.87E-07 2.51E-08 9530 hsa-mir-23a hsa05215 Prostate cancer 5925_2033_367_9586_5595_1387 6 5.89E-09 3.06E-07 2.51E-08 9531 hsa-mir-23a hsa05212 Pancreatic cancer 5925_2033_367_9586_5595_1387 6 6.28E-09 3.26E-07 2.51E-08 9532 hsa-mir-23a hsa05220 Chronic myeloid leukemia 4088_4089_5925_4609_5595 5 1.33E-07 6.89E-06 4.92E-07 9533 hsa-mir-23a hsa04012 ErbB signaling pathway 5601_4609_3725_5595_5599 5 2.67E-07 1.39E-05 9.27E-07 9534 hsa-mir-23a hsa05219 Bladder cancer 5925_9252_4609_5595 4 6.84E-07 3.56E-05 2.22E-06 9535 hsa-mir-23a hsa04110 Cell cycle 4088_4089_5925_2033_1387 5 1.18E-06 6.15E-05 3.62E-06 9536 hsa-mir-23a hsa05221 Acute myeloid leukemia 1050_5371_4609_5595 4 2.45E-06 0.00012747 7.08E-06 9537 hsa-mir-23a hsa05211 Renal cell carcinoma 2033_3725_5595_1387 4 5.21E-06 0.000270685 1.42E-05 9538 hsa-mir-23a hsa04370 VEGF signaling pathway 1432_5600_5603_5595 4 6.71E-06 0.000349111 1.75E-05 9539 hsa-mir-23a hsa04930 Type II diabetes mellitus 5601_5595_5599 3 5.18E-05 0.00269356 0.000128265 9540 hsa-mir-23a hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_5600_5603 3 9.62E-05 0.005004767 0.000227489 9541 hsa-mir-23a hsa04720 Long-term potentiation 2033_5595_1387 3 0.000220797 0.011481436 0.000478393 9542 hsa-mir-23a hsa04662 B cell receptor signaling pathway 3725_5595_2353 3 0.000220797 0.011481436 0.000478393 9543 hsa-mir-23a hsa04510 Focal adhesion 5601_3725_5595_5599 4 0.000276073 0.014355785 0.000574231 9544 hsa-mir-23a hsa04916 Melanogenesis 2033_5595_1387 3 0.000558872 0.02906135 0.001117744 9545 hsa-mir-23a hsa04670 Leukocyte transendothelial migration 1432_5600_5603 3 0.000878033 0.045657691 0.001691026 9546 hsa-mir-23a hsa05216 Thyroid cancer 4609_5595 2 0.000992158 0.051592217 0.001842579 9547 hsa-mir-23a hsa04910 Insulin signaling pathway 5601_5595_5599 3 0.001242763 0.064623688 0.002228403 9548 hsa-mir-23a hsa04630 Jak-STAT signaling pathway 2033_4609_1387 3 0.001721922 0.089539941 0.002984665 9549 hsa-mir-23a hsa04330 Notch signaling pathway 2033_1387 2 0.002466602 0.128263312 0.004137526 9550 hsa-mir-23a hsa05016 Huntington's disease 2033_9586_1387 3 0.002948918 0.153343712 0.004707144 9551 hsa-mir-23a hsa05213 Endometrial cancer 4609_5595 2 0.002987226 0.155335766 0.004707144 9552 hsa-mir-23a hsa05223 Non-small cell lung cancer 5925_5595 2 0.003208663 0.166850499 0.004907368 9553 hsa-mir-23a hsa05214 Glioma 5925_5595 2 0.004558871 0.237061306 0.00677318 9554 hsa-mir-23a hsa04920 Adipocytokine signaling pathway 5601_5599 2 0.004828059 0.251059084 0.006973863 9555 hsa-mir-23a hsa05218 Melanoma 5925_5595 2 0.005387936 0.280172675 0.007572234 9556 hsa-mir-23a hsa05222 Small cell lung cancer 5925_4609 2 0.007737427 0.402346194 0.010588058 9557 hsa-mir-23a hsa04530 Tight junction 1457_1459 2 0.018474408 0.960669214 0.024632544 9558 hsa-mir-23a hsa04120 Ubiquitin mediated proteolysis 5371_7329 2 0.018976043 0.986754217 0.024668855 9559 hsa-mir-23a hsa05322 Systemic lupus erythematosus 8349_9555 2 0.020255115 1 0.025689415 9560 hsa-mir-23a hsa03440 Homologous recombination 4683 1 0.04255566 1 0.05268796 9561 hsa-mir-23b hsa04310 Wnt signaling pathway 4087_4088_1487_2033_1488 5 7.66E-11 1.15E-09 1.15E-09 9562 hsa-mir-23b hsa05200 Pathways in cancer 4087_4088_1487_2033_1488 5 3.58E-09 5.36E-08 2.68E-08 9563 hsa-mir-23b hsa04330 Notch signaling pathway 1487_2033_1488 3 1.52E-07 2.27E-06 7.58E-07 9564 hsa-mir-23b hsa05220 Chronic myeloid leukemia 4088_1487_1488 3 5.87E-07 8.80E-06 2.13E-06 9565 hsa-mir-23b hsa04520 Adherens junction 4087_4088_2033 3 7.09E-07 1.06E-05 2.13E-06 9566 hsa-mir-23b hsa04350 TGF-beta signaling pathway 4087_4088_2033 3 9.05E-07 1.36E-05 2.26E-06 9567 hsa-mir-23b hsa04110 Cell cycle 4087_4088_2033 3 2.27E-06 3.40E-05 4.86E-06 9568 hsa-mir-23b hsa05210 Colorectal cancer 4087_4088 2 0.000168908 0.002533625 0.000316703 9569 hsa-mir-23b hsa05211 Renal cell carcinoma 2033 1 0.016907255 0.253608829 0.026011491 9570 hsa-mir-23b hsa04720 Long-term potentiation 2033 1 0.017596799 0.263951989 0.026011491 9571 hsa-mir-23b hsa05215 Prostate cancer 2033 1 0.020580035 0.308700524 0.026011491 9572 hsa-mir-23b hsa05212 Pancreatic cancer 2033 1 0.020809193 0.31213789 0.026011491 9573 hsa-mir-23b hsa04916 Melanogenesis 2033 1 0.024241047 0.363615709 0.027970439 9574 hsa-mir-23b hsa04630 Jak-STAT signaling pathway 2033 1 0.035832353 0.53748529 0.038391806 9575 hsa-mir-23b hsa05016 Huntington's disease 2033 1 0.043269546 0.649043197 0.043269546 9576 hsa-mir-23c hsa05200 Pathways in cancer 4088_9915_4087_5371_5925_1487_2034_2033_3091_1488_1387 11 1.16E-11 3.59E-10 3.59E-10 9577 hsa-mir-23c hsa04330 Notch signaling pathway 9612_1487_2033_1488_1387_8850 6 3.81E-10 1.18E-08 5.90E-09 9578 hsa-mir-23c hsa04110 Cell cycle 4088_983_4087_5925_2033_993_1387 7 1.91E-09 5.93E-08 1.98E-08 9579 hsa-mir-23c hsa04310 Wnt signaling pathway 4088_4087_1487_2033_1488_1387_1457 7 9.68E-09 3.00E-07 7.50E-08 9580 hsa-mir-23c hsa05211 Renal cell carcinoma 9915_2034_2033_3091_1387 5 2.07E-07 6.43E-06 1.29E-06 9581 hsa-mir-23c hsa04520 Adherens junction 4088_4087_2033_1387_1457 5 3.41E-07 1.06E-05 1.76E-06 9582 hsa-mir-23c hsa04350 TGF-beta signaling pathway 4088_4087_2033_4093_1387 5 5.06E-07 1.57E-05 2.24E-06 9583 hsa-mir-23c hsa05220 Chronic myeloid leukemia 4088_5925_1487_1488 4 1.01E-05 0.00031193 3.90E-05 9584 hsa-mir-23c hsa05215 Prostate cancer 5925_2033_1387 3 0.000503521 0.015609164 0.001611608 9585 hsa-mir-23c hsa05212 Pancreatic cancer 5925_2033_1387 3 0.000519873 0.016116077 0.001611608 9586 hsa-mir-23c hsa04720 Long-term potentiation 2033_1387 2 0.007617797 0.236151716 0.021468338 9587 hsa-mir-23c hsa05210 Colorectal cancer 4088_4087 2 0.009423862 0.292139729 0.024344977 9588 hsa-mir-23c hsa04916 Melanogenesis 2033_1387 2 0.014042972 0.435332141 0.033487088 9589 hsa-mir-23c hsa04120 Ubiquitin mediated proteolysis 5371_7329 2 0.023988622 0.743647273 0.053117662 9590 hsa-mir-23c hsa04630 Jak-STAT signaling pathway 2033_1387 2 0.029258422 0.90701107 0.060467405 9591 hsa-mir-23c hsa05016 Huntington's disease 2033_1387 2 0.041415194 1 0.080241939 9592 hsa-mir-24-1 hsa04310 Wnt signaling pathway 4087_4088_1487_2033_1488 5 7.66E-11 1.15E-09 1.15E-09 9593 hsa-mir-24-1 hsa05200 Pathways in cancer 4087_4088_1487_2033_1488 5 3.58E-09 5.36E-08 2.68E-08 9594 hsa-mir-24-1 hsa04330 Notch signaling pathway 1487_2033_1488 3 1.52E-07 2.27E-06 7.58E-07 9595 hsa-mir-24-1 hsa05220 Chronic myeloid leukemia 4088_1487_1488 3 5.87E-07 8.80E-06 2.13E-06 9596 hsa-mir-24-1 hsa04520 Adherens junction 4087_4088_2033 3 7.09E-07 1.06E-05 2.13E-06 9597 hsa-mir-24-1 hsa04350 TGF-beta signaling pathway 4087_4088_2033 3 9.05E-07 1.36E-05 2.26E-06 9598 hsa-mir-24-1 hsa04110 Cell cycle 4087_4088_2033 3 2.27E-06 3.40E-05 4.86E-06 9599 hsa-mir-24-1 hsa05210 Colorectal cancer 4087_4088 2 0.000168908 0.002533625 0.000316703 9600 hsa-mir-24-1 hsa05211 Renal cell carcinoma 2033 1 0.016907255 0.253608829 0.026011491 9601 hsa-mir-24-1 hsa04720 Long-term potentiation 2033 1 0.017596799 0.263951989 0.026011491 9602 hsa-mir-24-1 hsa05215 Prostate cancer 2033 1 0.020580035 0.308700524 0.026011491 9603 hsa-mir-24-1 hsa05212 Pancreatic cancer 2033 1 0.020809193 0.31213789 0.026011491 9604 hsa-mir-24-1 hsa04916 Melanogenesis 2033 1 0.024241047 0.363615709 0.027970439 9605 hsa-mir-24-1 hsa04630 Jak-STAT signaling pathway 2033 1 0.035832353 0.53748529 0.038391806 9606 hsa-mir-24-1 hsa05016 Huntington's disease 2033 1 0.043269546 0.649043197 0.043269546 9607 hsa-mir-24-2 hsa05200 Pathways in cancer 1147_3320_3326_3725_3551_9063_6774_5468_5595_5599_1387_5601_367_8517_6772_6256_5371_4791_10401_4609_2353_4088_4089_3066_1050_3065_5925_2033_8554_4790_4792 31 2.50E-21 1.90E-19 1.90E-19 9608 hsa-mir-24-2 hsa04010 MAPK signaling pathway 1147_6722_3725_3551_5595_5599_1326_5601_5600_5603_3305_5608_5566_8517_9252_3312_1432_1649_5971_4791_6885_4609_3727_9020_2353_3303_8550_4790 28 2.36E-20 1.79E-18 8.96E-19 9609 hsa-mir-24-2 hsa04620 Toll-like receptor signaling pathway 1147_3725_3551_29110_5595_5599_1326_5601_5600_5603_5608_8517_3661_9641_1432_6772_6885_2353_4790_4792 20 8.71E-20 6.62E-18 2.21E-18 9610 hsa-mir-24-2 hsa04310 Wnt signaling pathway 3725_23291_5519_5515_5599_1387_8607_5601_5566_8454_6500_8945_8061_6885_4609_1457_1459_4088_4089_2033 20 9.31E-17 7.07E-15 1.77E-15 9611 hsa-mir-24-2 hsa04660 T cell receptor signaling pathway 1147_3725_3551_5595_1326_5601_5600_5603_8517_1432_4794_6885_9020_2353_4790_4792_4793 17 1.80E-15 1.37E-13 2.74E-14 9612 hsa-mir-24-2 hsa04920 Adipocytokine signaling pathway 1147_3551_6774_5465_5599_5601_8517_6256_4794_8471_4790_4792_4793 13 2.99E-13 2.27E-11 3.79E-12 9613 hsa-mir-24-2 hsa05215 Prostate cancer 1147_3320_3326_3551_5595_1387_367_8517_9586_5925_2033_4790_4792 13 6.57E-12 4.99E-10 7.09E-11 9614 hsa-mir-24-2 hsa05212 Pancreatic cancer 1147_3320_3326_3551_5595_1387_367_8517_9586_5925_2033_4790_4792 13 7.47E-12 5.68E-10 7.09E-11 9615 hsa-mir-24-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_3725_3551_5599_5601_5600_5603_8517_1432_9020_4790_4792 12 1.05E-11 7.98E-10 8.87E-11 9616 hsa-mir-24-2 hsa05220 Chronic myeloid leukemia 1147_3551_5595_8517_4609_4088_4089_3066_3065_5925_4790_4792 12 1.86E-11 1.42E-09 1.42E-10 9617 hsa-mir-24-2 hsa04662 B cell receptor signaling pathway 1147_3725_3551_695_5595_8517_4794_2353_4790_4792_4793 11 3.02E-10 2.30E-08 2.09E-09 9618 hsa-mir-24-2 hsa04912 GnRH signaling pathway 3725_5595_5599_5601_5600_5603_5608_5566_1432_808_801_805 12 8.55E-10 6.50E-08 5.42E-09 9619 hsa-mir-24-2 hsa05222 Small cell lung cancer 1147_3551_9063_8517_6256_10401_4609_5925_8554_4790_4792 11 1.13E-09 8.57E-08 6.38E-09 9620 hsa-mir-24-2 hsa04120 Ubiquitin mediated proteolysis 8651_23291_9063_672_51366_8454_55294_6500_5371_8945_10401_7329_8554 13 1.18E-09 8.96E-08 6.38E-09 9621 hsa-mir-24-2 hsa04350 TGF-beta signaling pathway 5519_5515_5595_1387_6667_8454_6500_4609_4088_4089_2033 11 1.26E-09 9.58E-08 6.38E-09 9622 hsa-mir-24-2 hsa04110 Cell cycle 5591_1387_8454_6500_5111_4088_4089_3066_3065_1111_5925_2033 12 2.36E-09 1.79E-07 1.12E-08 9623 hsa-mir-24-2 hsa05016 Huntington's disease 498_5468_1387_292_293_6667_1213_5437_9586_3066_3065_2033_6908_5441 14 4.21E-09 3.20E-07 1.88E-08 9624 hsa-mir-24-2 hsa05221 Acute myeloid leukemia 1147_3551_6774_5595_8517_5371_4609_1050_4790 9 9.43E-09 7.17E-07 3.98E-08 9625 hsa-mir-24-2 hsa04630 Jak-STAT signaling pathway 8651_9063_6774_1387_6772_3595_3594_10401_4609_2033_8554_6778 12 3.68E-08 2.79E-06 1.47E-07 9626 hsa-mir-24-2 hsa04520 Adherens junction 5595_1387_71_6885_1457_1459_4088_4089_2033 9 1.03E-07 7.86E-06 3.77E-07 9627 hsa-mir-24-2 hsa04910 Insulin signaling pathway 3551_8651_5590_5595_5599_5601_5566_8471_808_801_805 11 1.04E-07 7.91E-06 3.77E-07 9628 hsa-mir-24-2 hsa03022 Basal transcription factors 2963_2969_6878_6872_2959_6908_6882 7 1.17E-07 8.91E-06 4.05E-07 9629 hsa-mir-24-2 hsa04062 Chemokine signaling pathway 1147_3551_6774_5590_5595_5566_8517_6772_653361_4790_4792_4793 12 3.45E-07 2.62E-05 1.14E-06 9630 hsa-mir-24-2 hsa04930 Type II diabetes mellitus 3551_8651_5590_5595_5599_5601_8471 7 3.85E-07 2.93E-05 1.22E-06 9631 hsa-mir-24-2 hsa04330 Notch signaling pathway 1387_4851_9612_3066_3065_2033_8850 7 5.02E-07 3.82E-05 1.53E-06 9632 hsa-mir-24-2 hsa03020 RNA polymerase 25885_64425_5437_51082_84172_5441 6 6.09E-07 4.63E-05 1.78E-06 9633 hsa-mir-24-2 hsa04720 Long-term potentiation 814_5595_1387_5566_2033_808_801_805 8 7.78E-07 5.91E-05 2.19E-06 9634 hsa-mir-24-2 hsa04664 Fc epsilon RI signaling pathway 695_5595_5599_5601_5600_5603_5608_1432 8 1.12E-06 8.49E-05 3.03E-06 9635 hsa-mir-24-2 hsa05131 Shigellosis 7278_71_10382_203068_4691_347733_7846 7 1.47E-06 0.000111351 3.71E-06 9636 hsa-mir-24-2 hsa05130 Pathogenic Escherichia coli infection 7278_71_10382_203068_4691_347733_7846 7 1.47E-06 0.000111351 3.71E-06 9637 hsa-mir-24-2 hsa05210 Colorectal cancer 3725_5595_5599_5601_4609_2353_4088_4089 8 1.71E-06 0.000130179 4.20E-06 9638 hsa-mir-24-2 hsa04210 Apoptosis 1147_3551_5566_8517_9131_9020_4790_4792 8 2.56E-06 0.000194537 6.08E-06 9639 hsa-mir-24-2 hsa03010 Ribosome 6155_6156_6141_6207_9349_6128_6217_6188 8 6.57E-06 0.000499343 1.51E-05 9640 hsa-mir-24-2 hsa04540 Gap junction 5595_5566_7278_10382_203068_347733_7846 7 3.21E-05 0.002436602 7.17E-05 9641 hsa-mir-24-2 hsa04916 Melanogenesis 5595_1387_5566_2033_808_801_805 7 6.26E-05 0.004758896 0.000135968 9642 hsa-mir-24-2 hsa05216 Thyroid cancer 5468_5595_6256_4609 4 0.000203758 0.015485573 0.000429302 9643 hsa-mir-24-2 hsa04612 Antigen processing and presentation 3320_3326_3309_3305_3312_3303 6 0.000209002 0.015884184 0.000429302 9644 hsa-mir-24-2 hsa04530 Tight junction 5519_5515_5590_4628_71_1457_1459 7 0.000316115 0.024024713 0.000632229 9645 hsa-mir-24-2 hsa05214 Glioma 5595_5925_808_801_805 5 0.000403515 0.030667128 0.000786337 9646 hsa-mir-24-2 hsa05219 Bladder cancer 5595_9252_4609_5925 4 0.000742257 0.056411544 0.001410289 9647 hsa-mir-24-2 hsa04012 ErbB signaling pathway 3725_5595_5599_5601_4609 5 0.001399732 0.106379634 0.002594625 9648 hsa-mir-24-2 hsa04020 Calcium signaling pathway 814_292_293_5566_808_801_805 7 0.00166725 0.126710982 0.003016928 9649 hsa-mir-24-2 hsa05014 Amyotrophic lateral sclerosis (ALS) 5600_5603_5608_1432 4 0.002012833 0.152975337 0.003557566 9650 hsa-mir-24-2 hsa03320 PPAR signaling pathway 10062_5465_5468_6256 4 0.004311837 0.327699599 0.007447718 9651 hsa-mir-24-2 hsa05211 Renal cell carcinoma 3725_5595_1387_2033 4 0.004742017 0.360393324 0.008008741 9652 hsa-mir-24-2 hsa04270 Vascular smooth muscle contraction 5595_5566_808_801_805 5 0.004927788 0.374511888 0.008099045 9653 hsa-mir-24-2 hsa03410 Base excision repair 5111_3146_142 3 0.00500862 0.380655131 0.008099045 9654 hsa-mir-24-2 hsa04670 Leukocyte transendothelial migration 5600_5603_1432_71_653361 5 0.005635301 0.428282863 0.00892256 9655 hsa-mir-24-2 hsa04370 VEGF signaling pathway 5595_5600_5603_1432 4 0.005941398 0.451546269 0.00921523 9656 hsa-mir-24-2 hsa05223 Non-small cell lung cancer 5595_6256_5925 3 0.014268924 1 0.021688764 9657 hsa-mir-24-2 hsa04340 Hedgehog signaling pathway 23291_5566_8945 3 0.016367688 1 0.024391064 9658 hsa-mir-24-2 hsa03430 Mismatch repair 5981_5111 2 0.020633747 1 0.030157015 9659 hsa-mir-24-2 hsa05010 Alzheimer's disease 498_5595_808_801_805 5 0.023656098 1 0.033921951 9660 hsa-mir-24-2 hsa04730 Long-term depression 5519_5515_5595 3 0.028337116 1 0.039881867 9661 hsa-mir-24-2 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.033479935 1 0.046263183 9662 hsa-mir-24-2 hsa05012 Parkinson's disease 498_7314_292_293 4 0.036630056 1 0.049712218 9663 hsa-mir-24-2 hsa04510 Focal adhesion 3725_5595_5599_5601_71 5 0.040760261 1 0.054347015 9664 hsa-mir-24-2 hsa05340 Primary immunodeficiency 695_8517 2 0.042739664 1 0.056003698 9665 hsa-mir-24-2 hsa03030 DNA replication 5981_5111 2 0.044855559 1 0.057780042 9666 hsa-mir-25 hsa05200 Pathways in cancer 3320_5371_9063_5595_5594_5599_5914_1387_6256_595_1487_1488_836_367_1017_2932_2353_4149_7704_3091_5970_7428_1870_1871_2885_7157_2113_4609_1869_3725_5604_1029_5601_4087_4088_4089_3066_3065_4292_1050_5925_2034_2033_4846_6502_5894_7186 47 1.41E-42 9.43E-41 9.43E-41 9667 hsa-mir-25 hsa04110 Cell cycle 990_5591_1387_595_983_1017_2932_8454_6500_1870_1871_7157_1869_1029_4087_4088_4089_3066_3065_5925_2033_5933_890_6502_5934 25 1.15E-26 7.69E-25 3.85E-25 9668 hsa-mir-25 hsa05220 Chronic myeloid leukemia 5595_5594_595_1487_1488_5970_1870_1871_2885_7157_4609_1869_5604_1029_4088_4089_3066_3065_5925_6464_5894 21 7.91E-25 5.30E-23 1.77E-23 9669 hsa-mir-25 hsa04010 MAPK signaling pathway 6722_5595_5594_5599_5598_4208_5600_3303_836_2353_4149_3312_1386_1432_5970_9344_2885_7157_4609_3725_5604_5606_5601_4763_2005_5894_7186 27 6.41E-21 4.29E-19 1.07E-19 9670 hsa-mir-25 hsa05210 Colorectal cancer 5595_5594_5599_595_836_2932_2353_2885_7157_4609_3725_5604_5601_4087_4088_4089_4292_5894 18 1.21E-19 8.10E-18 1.62E-18 9671 hsa-mir-25 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_8454_3397_3399_3398_6500_1874_1875_4609_4087_4088_4089_2033_5933_5934 18 2.10E-19 1.40E-17 2.34E-18 9672 hsa-mir-25 hsa05215 Prostate cancer 3320_5595_5594_1387_595_367_1017_2932_5970_1870_1871_2885_7157_1869_5604_5925_2033_5894 18 2.51E-19 1.68E-17 2.40E-18 9673 hsa-mir-25 hsa05212 Pancreatic cancer 3320_5595_5594_1387_595_367_1017_2932_5970_1870_1871_2885_7157_1869_5604_5925_2033_5894 18 3.00E-19 2.01E-17 2.51E-18 9674 hsa-mir-25 hsa04310 Wnt signaling pathway 5599_1387_595_1487_1488_1459_2932_8454_6500_7157_8061_4609_3725_1457_5601_4087_4088_4089_2033 19 9.34E-17 6.26E-15 6.95E-16 9675 hsa-mir-25 hsa05222 Small cell lung cancer 9063_6256_595_1017_4149_5970_1870_1871_7157_4609_1869_5925_4846_6502_7186 15 2.11E-15 1.42E-13 1.42E-14 9676 hsa-mir-25 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_2885_7157_1869_5604_1029_5925_5894 13 4.24E-15 2.84E-13 2.58E-14 9677 hsa-mir-25 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5604_1029_5925_5894 12 8.51E-15 5.70E-13 4.75E-14 9678 hsa-mir-25 hsa05214 Glioma 5595_5594_595_1870_1871_2885_7157_1869_5604_1029_5925_6464_5894 13 3.42E-14 2.29E-12 1.76E-13 9679 hsa-mir-25 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_5970_2885_4609_5604_1050_5894 12 2.83E-13 1.90E-11 1.36E-12 9680 hsa-mir-25 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2885_2113_3725_5604_2034_2033_5894 12 2.29E-12 1.53E-10 1.02E-11 9681 hsa-mir-25 hsa04540 Gap junction 5595_5594_5598_983_7277_2885_7846_5604_7278_51807_10376_5894 12 3.43E-11 2.30E-09 1.44E-10 9682 hsa-mir-25 hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5604_1029_5925_5894 11 3.89E-11 2.61E-09 1.53E-10 9683 hsa-mir-25 hsa05213 Endometrial cancer 5595_5594_595_2932_2885_7157_4609_5604_4292_5894 10 4.61E-11 3.09E-09 1.72E-10 9684 hsa-mir-25 hsa04912 GnRH signaling pathway 5595_5594_5599_5598_5600_1432_2885_3725_5604_5606_5601_5894 12 1.67E-10 1.12E-08 5.90E-10 9685 hsa-mir-25 hsa04660 T cell receptor signaling pathway 5595_5594_5600_2932_2353_1432_5970_2885_3725_5604_5601_5894 12 2.03E-10 1.36E-08 6.81E-10 9686 hsa-mir-25 hsa04012 ErbB signaling pathway 5595_5594_5599_2932_2885_4609_3725_5604_5601_6464_5894 11 2.80E-10 1.87E-08 8.92E-10 9687 hsa-mir-25 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5600_2353_1432_5970_3725_5604_5606_5601 11 1.31E-09 8.79E-08 3.99E-09 9688 hsa-mir-25 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5600_1432_2885_5604_5606_5601_5894 10 1.82E-09 1.22E-07 5.30E-09 9689 hsa-mir-25 hsa04330 Notch signaling pathway 2648_1387_1487_1488_9612_3066_3065_2033 8 9.84E-09 6.59E-07 2.73E-08 9690 hsa-mir-25 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609_5604 7 1.02E-08 6.82E-07 2.73E-08 9691 hsa-mir-25 hsa04662 B cell receptor signaling pathway 5595_5594_2932_2353_5970_2885_3725_5604_5894 9 1.83E-08 1.23E-06 4.72E-08 9692 hsa-mir-25 hsa04520 Adherens junction 5595_5594_1387_1459_1457_4087_4088_4089_2033 9 3.06E-08 2.05E-06 7.59E-08 9693 hsa-mir-25 hsa04910 Insulin signaling pathway 6720_5595_5594_5599_2932_2885_5604_5601_6464_5894 10 2.45E-07 1.64E-05 5.87E-07 9694 hsa-mir-25 hsa05016 Huntington's disease 6874_1387_2902_6908_836_6667_7157_3066_3065_3064_2033 11 4.63E-07 3.10E-05 1.07E-06 9695 hsa-mir-25 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_5600_836_1432_7157_5606_4846 7 5.66E-07 3.79E-05 1.26E-06 9696 hsa-mir-25 hsa04510 Focal adhesion 5595_5594_5599_595_2932_2885_3725_5604_5601_6464_5894 11 1.09E-06 7.30E-05 2.35E-06 9697 hsa-mir-25 hsa04115 p53 signaling pathway 595_983_836_1017_7157_7161_1029 7 2.05E-06 0.000137564 4.30E-06 9698 hsa-mir-25 hsa04120 Ubiquitin mediated proteolysis 55294_5371_9063_672_8454_6500_7428_7329_6502 9 2.38E-06 0.000159424 4.83E-06 9699 hsa-mir-25 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5600_836_1432_5970_3725_5601 7 2.45E-06 0.000164083 4.83E-06 9700 hsa-mir-25 hsa04720 Long-term potentiation 5595_5594_1387_2902_5604_2033_5894 7 3.43E-06 0.000230036 6.57E-06 9701 hsa-mir-25 hsa04370 VEGF signaling pathway 5595_5594_5600_1432_5604_4846_5894 7 4.04E-06 0.000270509 7.51E-06 9702 hsa-mir-25 hsa05131 Shigellosis 7277_7846_7278_51807_4691_10376 6 8.42E-06 0.000564246 1.48E-05 9703 hsa-mir-25 hsa05130 Pathogenic Escherichia coli infection 7277_7846_7278_51807_4691_10376 6 8.42E-06 0.000564246 1.48E-05 9704 hsa-mir-25 hsa04916 Melanogenesis 5595_5594_1387_2932_5604_2033_5894 7 2.54E-05 0.001701205 4.36E-05 9705 hsa-mir-25 hsa04062 Chemokine signaling pathway 5595_5594_2932_5970_2885_5604_7074_6464_5894 9 2.92E-05 0.001957872 4.89E-05 9706 hsa-mir-25 hsa04612 Antigen processing and presentation 3320_3303_4800_4801_4802_3312 6 9.64E-05 0.006457281 0.000157495 9707 hsa-mir-25 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_2885_5604_6464_5894 7 0.00013836 0.009270124 0.000220717 9708 hsa-mir-25 hsa04920 Adipocytokine signaling pathway 5599_6256_5970_5601_7186 5 0.000239392 0.016039244 0.000373006 9709 hsa-mir-25 hsa03022 Basal transcription factors 2962_2969_6874_6908 4 0.000278325 0.018647788 0.000423813 9710 hsa-mir-25 hsa04730 Long-term depression 5595_5594_5604_4846_5894 5 0.000308313 0.020656972 0.000459044 9711 hsa-mir-25 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601 4 0.000554925 0.037179954 0.00080826 9712 hsa-mir-25 hsa05010 Alzheimer's disease 5595_5594_2902_836_2932_6622_4846 7 0.000587752 0.039379394 0.000837859 9713 hsa-mir-25 hsa04630 Jak-STAT signaling pathway 9063_1387_595_2885_4609_2033 6 0.001603795 0.10745425 0.00223863 9714 hsa-mir-25 hsa04210 Apoptosis 836_5970_7157_7186 4 0.005877447 0.393788966 0.00803651 9715 hsa-mir-25 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.008828926 0.591538067 0.011830761 9716 hsa-mir-25 hsa04270 Vascular smooth muscle contraction 5595_5594_5604_5894 4 0.014889906 0.997623676 0.019561249 9717 hsa-mir-25 hsa04810 Regulation of actin cytoskeleton 5595_5594_5604_7074_5894 5 0.030189739 1 0.038898317 9718 hsa-mir-26a-1 hsa05200 Pathways in cancer 3326_4149_5371_1871_1387_9915_1017_2932_3265_3091_1870_7157_2113_1869_861_4088_4089_3065_1050_5925_2034_2033 22 2.78E-23 1.50E-21 1.50E-21 9719 hsa-mir-26a-1 hsa04110 Cell cycle 890_1871_1387_1017_2932_1870_7157_1869_4088_4089_3065_5925_2033_5934_5933 15 5.79E-20 3.13E-18 1.56E-18 9720 hsa-mir-26a-1 hsa04350 TGF-beta signaling pathway 1387_6667_3399_1874_1875_3398_4088_4089_2033_4093_5934_5933 12 1.35E-16 7.30E-15 2.43E-15 9721 hsa-mir-26a-1 hsa05215 Prostate cancer 3326_1871_1387_1017_2932_3265_1870_7157_1869_5925_2033 11 7.17E-15 3.87E-13 8.68E-14 9722 hsa-mir-26a-1 hsa05212 Pancreatic cancer 3326_1871_1387_1017_2932_3265_1870_7157_1869_5925_2033 11 8.04E-15 4.34E-13 8.68E-14 9723 hsa-mir-26a-1 hsa05220 Chronic myeloid leukemia 1871_3265_1870_7157_1869_861_4088_4089_3065_5925 10 7.07E-14 3.82E-12 6.36E-13 9724 hsa-mir-26a-1 hsa05211 Renal cell carcinoma 1387_9915_3265_3091_2113_2034_2033 7 3.51E-09 1.89E-07 2.71E-08 9725 hsa-mir-26a-1 hsa05219 Bladder cancer 1871_3265_1870_7157_1869_5925 6 5.85E-09 3.16E-07 3.95E-08 9726 hsa-mir-26a-1 hsa05222 Small cell lung cancer 4149_1871_1017_1870_7157_1869_5925 7 1.11E-08 5.99E-07 6.66E-08 9727 hsa-mir-26a-1 hsa05223 Non-small cell lung cancer 1871_3265_1870_7157_1869_5925 6 2.32E-08 1.25E-06 1.25E-07 9728 hsa-mir-26a-1 hsa05214 Glioma 1871_3265_1870_7157_1869_5925 6 6.47E-08 3.50E-06 3.18E-07 9729 hsa-mir-26a-1 hsa05218 Melanoma 1871_3265_1870_7157_1869_5925 6 1.06E-07 5.71E-06 4.76E-07 9730 hsa-mir-26a-1 hsa05016 Huntington's disease 1387_2902_6908_6667_7157_3065_2033_9519 8 1.16E-07 6.25E-06 4.81E-07 9731 hsa-mir-26a-1 hsa04310 Wnt signaling pathway 1387_2932_7157_1457_4088_4089_2033 7 4.47E-07 2.41E-05 1.72E-06 9732 hsa-mir-26a-1 hsa04720 Long-term potentiation 1387_2902_2906_3265_2033 5 3.86E-06 0.00020837 1.39E-05 9733 hsa-mir-26a-1 hsa04520 Adherens junction 1387_1457_4088_4089_2033 5 5.20E-06 0.000281068 1.76E-05 9734 hsa-mir-26a-1 hsa03022 Basal transcription factors 2963_2969_6908_9519 4 6.37E-06 0.000343887 2.02E-05 9735 hsa-mir-26a-1 hsa04330 Notch signaling pathway 1387_9612_3065_2033 4 1.54E-05 0.000829883 4.61E-05 9736 hsa-mir-26a-1 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906_7157_1616 4 2.94E-05 0.00158721 8.35E-05 9737 hsa-mir-26a-1 hsa05221 Acute myeloid leukemia 5371_3265_861_1050 4 3.57E-05 0.001925925 9.63E-05 9738 hsa-mir-26a-1 hsa05210 Colorectal cancer 2932_7157_4088_4089 4 0.000132065 0.007131522 0.000339596 9739 hsa-mir-26a-1 hsa04010 MAPK signaling pathway 6722_4149_3265_7157_22800_1616 6 0.000172751 0.009328552 0.000424025 9740 hsa-mir-26a-1 hsa04916 Melanogenesis 1387_2932_3265_2033 4 0.000290317 0.015677108 0.000681613 9741 hsa-mir-26a-1 hsa05213 Endometrial cancer 2932_3265_7157 3 0.000568175 0.03068147 0.001278395 9742 hsa-mir-26a-1 hsa04530 Tight junction 3265_22800_8573_1457 4 0.000794378 0.042896401 0.001715856 9743 hsa-mir-26a-1 hsa05010 Alzheimer's disease 2902_2906_2932_351 4 0.001993377 0.107642337 0.00414009 9744 hsa-mir-26a-1 hsa05216 Thyroid cancer 3265_7157 2 0.003721614 0.200967157 0.007443228 9745 hsa-mir-26a-1 hsa05217 Basal cell carcinoma 2932_7157 2 0.012160915 0.656689409 0.023453193 9746 hsa-mir-26a-1 hsa04115 p53 signaling pathway 1017_7157 2 0.018442393 0.995889229 0.034341008 9747 hsa-mir-26a-1 hsa04662 B cell receptor signaling pathway 2932_3265 2 0.02147199 1 0.038649582 9748 hsa-mir-26a-1 hsa04512 ECM-receptor interaction 6383_9672 2 0.026372934 1 0.045939949 9749 hsa-mir-26a-1 hsa04012 ErbB signaling pathway 2932_3265 2 0.028097959 1 0.047415306 9750 hsa-mir-26a-1 hsa04612 Antigen processing and presentation 3326_4802 2 0.029272576 1 0.047900579 9751 hsa-mir-26a-1 hsa04660 T cell receptor signaling pathway 2932_3265 2 0.042726759 1 0.067860147 9752 hsa-mir-26b hsa05200 Pathways in cancer 3326_3065_5925_2249_2932_3265_367_3725_6776_6777_2353_5914_5970_6256 14 2.07E-15 1.22E-13 1.22E-13 9753 hsa-mir-26b hsa05220 Chronic myeloid leukemia 3065_5925_3265_6776_6777_5970 6 9.25E-09 5.46E-07 2.73E-07 9754 hsa-mir-26b hsa05215 Prostate cancer 3326_5925_2932_3265_367_5970 6 2.28E-08 1.34E-06 3.58E-07 9755 hsa-mir-26b hsa05212 Pancreatic cancer 3326_5925_2932_3265_367_5970 6 2.43E-08 1.43E-06 3.58E-07 9756 hsa-mir-26b hsa05221 Acute myeloid leukemia 3265_6776_6777_5914_5970 5 1.31E-07 7.74E-06 1.55E-06 9757 hsa-mir-26b hsa04662 B cell receptor signaling pathway 2932_3265_3725_2353_5970 5 4.04E-07 2.38E-05 3.97E-06 9758 hsa-mir-26b hsa04012 ErbB signaling pathway 2932_3265_3725_6776_6777 5 8.13E-07 4.80E-05 6.85E-06 9759 hsa-mir-26b hsa04660 T cell receptor signaling pathway 2932_3265_3725_2353_5970 5 2.46E-06 0.000144891 1.81E-05 9760 hsa-mir-26b hsa04010 MAPK signaling pathway 2249_22800_3265_3725_2353_5970 6 1.33E-05 0.000786843 8.74E-05 9761 hsa-mir-26b hsa05016 Huntington's disease 2902_6908_3065_6667_9519 5 3.04E-05 0.001790927 0.000179093 9762 hsa-mir-26b hsa05223 Non-small cell lung cancer 5925_3265_6256 3 0.000166909 0.009847645 0.00089524 9763 hsa-mir-26b hsa05218 Melanoma 5925_2249_3265 3 0.000361583 0.02133341 0.001660796 9764 hsa-mir-26b hsa05010 Alzheimer's disease 2902_2906_2932_351 4 0.000365938 0.021590344 0.001660796 9765 hsa-mir-26b hsa04720 Long-term potentiation 2902_2906_3265 3 0.000422116 0.02490482 0.001778916 9766 hsa-mir-26b hsa04062 Chemokine signaling pathway 2932_3265_6777_5970 4 0.000503702 0.029718432 0.001981229 9767 hsa-mir-26b hsa05210 Colorectal cancer 2932_3725_2353 3 0.000581195 0.034290489 0.002143156 9768 hsa-mir-26b hsa05222 Small cell lung cancer 5925_5970_6256 3 0.00062106 0.036642535 0.002155443 9769 hsa-mir-26b hsa04620 Toll-like receptor signaling pathway 3725_2353_5970 3 0.001003827 0.059225821 0.003290323 9770 hsa-mir-26b hsa04080 Neuroactive ligand-receptor interaction 2902_2906_2908_7067 4 0.001411949 0.08330501 0.004343654 9771 hsa-mir-26b hsa05216 Thyroid cancer 3265_6256 2 0.001531394 0.090352247 0.004343654 9772 hsa-mir-26b hsa04110 Cell cycle 3065_5925_2932 3 0.001546046 0.091216725 0.004343654 9773 hsa-mir-26b hsa04530 Tight junction 8573_22800_3265 3 0.002289053 0.135054151 0.006138825 9774 hsa-mir-26b hsa03022 Basal transcription factors 6908_9519 2 0.002417158 0.142612311 0.006200535 9775 hsa-mir-26b hsa05219 Bladder cancer 5925_3265 2 0.003067525 0.180983964 0.007540998 9776 hsa-mir-26b hsa04630 Jak-STAT signaling pathway 3977_6776_6777 3 0.003221557 0.190071834 0.007602873 9777 hsa-mir-26b hsa04330 Notch signaling pathway 9612_3065 2 0.003790671 0.223649579 0.008601907 9778 hsa-mir-26b hsa05213 Endometrial cancer 2932_3265 2 0.004585238 0.270529021 0.010019593 9779 hsa-mir-26b hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906 2 0.005271413 0.311013362 0.01110762 9780 hsa-mir-26b hsa05214 Glioma 5925_3265 2 0.006975796 0.411571943 0.013782348 9781 hsa-mir-26b hsa04510 Focal adhesion 2932_3265_3725 3 0.007007974 0.413470449 0.013782348 9782 hsa-mir-26b hsa04920 Adipocytokine signaling pathway 5970_6256 2 0.007384152 0.435664939 0.014053708 9783 hsa-mir-26b hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5970 2 0.008232541 0.485719942 0.014665281 9784 hsa-mir-26b hsa04810 Regulation of actin cytoskeleton 2249_22800_3265 3 0.008264411 0.487600228 0.014665281 9785 hsa-mir-26b hsa05211 Renal cell carcinoma 3265_3725 2 0.008451179 0.498619568 0.014665281 9786 hsa-mir-26b hsa04512 ECM-receptor interaction 6383_9672 2 0.011274447 0.665192391 0.019005497 9787 hsa-mir-26b hsa04612 Antigen processing and presentation 3326_4800 2 0.01255705 0.740865957 0.02057961 9788 hsa-mir-26b hsa04916 Melanogenesis 2932_3265 2 0.016764343 0.989096266 0.026732332 9789 hsa-mir-26b hsa04912 GnRH signaling pathway 3265_3725 2 0.017974488 1 0.027907757 9790 hsa-mir-26b hsa04360 Axon guidance 2932_3265 2 0.025613758 1 0.038749018 9791 hsa-mir-26b hsa04514 Cell adhesion molecules (CAMs) 6383_9672 2 0.026692257 1 0.039371079 9792 hsa-mir-26b hsa03450 Non-homologous end-joining 2547 1 0.027592596 1 0.039555996 9793 hsa-mir-26b hsa04910 Insulin signaling pathway 2932_3265 2 0.028158506 1 0.039555996 9794 hsa-mir-26b hsa04310 Wnt signaling pathway 2932_3725 2 0.033537225 1 0.046016193 9795 hsa-mir-26b hsa04950 Maturity onset diabetes of the young 6927 1 0.045570794 1 0.061106292 9796 hsa-mir-26b hsa04020 Calcium signaling pathway 2902_2906 2 0.04717411 1 0.0618505 9797 hsa-mir-27a hsa05200 Pathways in cancer 1147_3320_3326_3725_3551_9063_6774_5468_5595_5599_1387_5601_367_8517_6772_6256_5371_4791_10401_4609_2353_4088_4089_3066_1050_3065_5925_2033_8554_4790_4792 31 2.50E-21 1.90E-19 1.90E-19 9798 hsa-mir-27a hsa04010 MAPK signaling pathway 1147_6722_3725_3551_5595_5599_1326_5601_5600_5603_3305_5608_5566_8517_9252_3312_1432_1649_5971_4791_6885_4609_3727_9020_2353_3303_8550_4790 28 2.36E-20 1.79E-18 8.96E-19 9799 hsa-mir-27a hsa04620 Toll-like receptor signaling pathway 1147_3725_3551_29110_5595_5599_1326_5601_5600_5603_5608_8517_3661_9641_1432_6772_6885_2353_4790_4792 20 8.71E-20 6.62E-18 2.21E-18 9800 hsa-mir-27a hsa04310 Wnt signaling pathway 3725_23291_5519_5515_5599_1387_8607_5601_5566_8454_6500_8945_8061_6885_4609_1457_1459_4088_4089_2033 20 9.31E-17 7.07E-15 1.77E-15 9801 hsa-mir-27a hsa04660 T cell receptor signaling pathway 1147_3725_3551_5595_1326_5601_5600_5603_8517_1432_4794_6885_9020_2353_4790_4792_4793 17 1.80E-15 1.37E-13 2.74E-14 9802 hsa-mir-27a hsa04920 Adipocytokine signaling pathway 1147_3551_6774_5465_5599_5601_8517_6256_4794_8471_4790_4792_4793 13 2.99E-13 2.27E-11 3.79E-12 9803 hsa-mir-27a hsa05215 Prostate cancer 1147_3320_3326_3551_5595_1387_367_8517_9586_5925_2033_4790_4792 13 6.57E-12 4.99E-10 7.09E-11 9804 hsa-mir-27a hsa05212 Pancreatic cancer 1147_3320_3326_3551_5595_1387_367_8517_9586_5925_2033_4790_4792 13 7.47E-12 5.68E-10 7.09E-11 9805 hsa-mir-27a hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_3725_3551_5599_5601_5600_5603_8517_1432_9020_4790_4792 12 1.05E-11 7.98E-10 8.87E-11 9806 hsa-mir-27a hsa05220 Chronic myeloid leukemia 1147_3551_5595_8517_4609_4088_4089_3066_3065_5925_4790_4792 12 1.86E-11 1.42E-09 1.42E-10 9807 hsa-mir-27a hsa04662 B cell receptor signaling pathway 1147_3725_3551_695_5595_8517_4794_2353_4790_4792_4793 11 3.02E-10 2.30E-08 2.09E-09 9808 hsa-mir-27a hsa04912 GnRH signaling pathway 3725_5595_5599_5601_5600_5603_5608_5566_1432_808_801_805 12 8.55E-10 6.50E-08 5.42E-09 9809 hsa-mir-27a hsa05222 Small cell lung cancer 1147_3551_9063_8517_6256_10401_4609_5925_8554_4790_4792 11 1.13E-09 8.57E-08 6.38E-09 9810 hsa-mir-27a hsa04120 Ubiquitin mediated proteolysis 8651_23291_9063_672_51366_8454_55294_6500_5371_8945_10401_7329_8554 13 1.18E-09 8.96E-08 6.38E-09 9811 hsa-mir-27a hsa04350 TGF-beta signaling pathway 5519_5515_5595_1387_6667_8454_6500_4609_4088_4089_2033 11 1.26E-09 9.58E-08 6.38E-09 9812 hsa-mir-27a hsa04110 Cell cycle 5591_1387_8454_6500_5111_4088_4089_3066_3065_1111_5925_2033 12 2.36E-09 1.79E-07 1.12E-08 9813 hsa-mir-27a hsa05016 Huntington's disease 498_5468_1387_292_293_6667_1213_5437_9586_3066_3065_2033_6908_5441 14 4.21E-09 3.20E-07 1.88E-08 9814 hsa-mir-27a hsa05221 Acute myeloid leukemia 1147_3551_6774_5595_8517_5371_4609_1050_4790 9 9.43E-09 7.17E-07 3.98E-08 9815 hsa-mir-27a hsa04630 Jak-STAT signaling pathway 8651_9063_6774_1387_6772_3595_3594_10401_4609_2033_8554_6778 12 3.68E-08 2.79E-06 1.47E-07 9816 hsa-mir-27a hsa04520 Adherens junction 5595_1387_71_6885_1457_1459_4088_4089_2033 9 1.03E-07 7.86E-06 3.77E-07 9817 hsa-mir-27a hsa04910 Insulin signaling pathway 3551_8651_5590_5595_5599_5601_5566_8471_808_801_805 11 1.04E-07 7.91E-06 3.77E-07 9818 hsa-mir-27a hsa03022 Basal transcription factors 2963_2969_6878_6872_2959_6908_6882 7 1.17E-07 8.91E-06 4.05E-07 9819 hsa-mir-27a hsa04062 Chemokine signaling pathway 1147_3551_6774_5590_5595_5566_8517_6772_653361_4790_4792_4793 12 3.45E-07 2.62E-05 1.14E-06 9820 hsa-mir-27a hsa04930 Type II diabetes mellitus 3551_8651_5590_5595_5599_5601_8471 7 3.85E-07 2.93E-05 1.22E-06 9821 hsa-mir-27a hsa04330 Notch signaling pathway 1387_4851_9612_3066_3065_2033_8850 7 5.02E-07 3.82E-05 1.53E-06 9822 hsa-mir-27a hsa03020 RNA polymerase 25885_64425_5437_51082_84172_5441 6 6.09E-07 4.63E-05 1.78E-06 9823 hsa-mir-27a hsa04720 Long-term potentiation 814_5595_1387_5566_2033_808_801_805 8 7.78E-07 5.91E-05 2.19E-06 9824 hsa-mir-27a hsa04664 Fc epsilon RI signaling pathway 695_5595_5599_5601_5600_5603_5608_1432 8 1.12E-06 8.49E-05 3.03E-06 9825 hsa-mir-27a hsa05131 Shigellosis 7278_71_10382_203068_4691_347733_7846 7 1.47E-06 0.000111351 3.71E-06 9826 hsa-mir-27a hsa05130 Pathogenic Escherichia coli infection 7278_71_10382_203068_4691_347733_7846 7 1.47E-06 0.000111351 3.71E-06 9827 hsa-mir-27a hsa05210 Colorectal cancer 3725_5595_5599_5601_4609_2353_4088_4089 8 1.71E-06 0.000130179 4.20E-06 9828 hsa-mir-27a hsa04210 Apoptosis 1147_3551_5566_8517_9131_9020_4790_4792 8 2.56E-06 0.000194537 6.08E-06 9829 hsa-mir-27a hsa03010 Ribosome 6155_6156_6141_6207_9349_6128_6217_6188 8 6.57E-06 0.000499343 1.51E-05 9830 hsa-mir-27a hsa04540 Gap junction 5595_5566_7278_10382_203068_347733_7846 7 3.21E-05 0.002436602 7.17E-05 9831 hsa-mir-27a hsa04916 Melanogenesis 5595_1387_5566_2033_808_801_805 7 6.26E-05 0.004758896 0.000135968 9832 hsa-mir-27a hsa05216 Thyroid cancer 5468_5595_6256_4609 4 0.000203758 0.015485573 0.000429302 9833 hsa-mir-27a hsa04612 Antigen processing and presentation 3320_3326_3309_3305_3312_3303 6 0.000209002 0.015884184 0.000429302 9834 hsa-mir-27a hsa04530 Tight junction 5519_5515_5590_4628_71_1457_1459 7 0.000316115 0.024024713 0.000632229 9835 hsa-mir-27a hsa05214 Glioma 5595_5925_808_801_805 5 0.000403515 0.030667128 0.000786337 9836 hsa-mir-27a hsa05219 Bladder cancer 5595_9252_4609_5925 4 0.000742257 0.056411544 0.001410289 9837 hsa-mir-27a hsa04012 ErbB signaling pathway 3725_5595_5599_5601_4609 5 0.001399732 0.106379634 0.002594625 9838 hsa-mir-27a hsa04020 Calcium signaling pathway 814_292_293_5566_808_801_805 7 0.00166725 0.126710982 0.003016928 9839 hsa-mir-27a hsa05014 Amyotrophic lateral sclerosis (ALS) 5600_5603_5608_1432 4 0.002012833 0.152975337 0.003557566 9840 hsa-mir-27a hsa03320 PPAR signaling pathway 10062_5465_5468_6256 4 0.004311837 0.327699599 0.007447718 9841 hsa-mir-27a hsa05211 Renal cell carcinoma 3725_5595_1387_2033 4 0.004742017 0.360393324 0.008008741 9842 hsa-mir-27a hsa04270 Vascular smooth muscle contraction 5595_5566_808_801_805 5 0.004927788 0.374511888 0.008099045 9843 hsa-mir-27a hsa03410 Base excision repair 5111_3146_142 3 0.00500862 0.380655131 0.008099045 9844 hsa-mir-27a hsa04670 Leukocyte transendothelial migration 5600_5603_1432_71_653361 5 0.005635301 0.428282863 0.00892256 9845 hsa-mir-27a hsa04370 VEGF signaling pathway 5595_5600_5603_1432 4 0.005941398 0.451546269 0.00921523 9846 hsa-mir-27a hsa05223 Non-small cell lung cancer 5595_6256_5925 3 0.014268924 1 0.021688764 9847 hsa-mir-27a hsa04340 Hedgehog signaling pathway 23291_5566_8945 3 0.016367688 1 0.024391064 9848 hsa-mir-27a hsa03430 Mismatch repair 5981_5111 2 0.020633747 1 0.030157015 9849 hsa-mir-27a hsa05010 Alzheimer's disease 498_5595_808_801_805 5 0.023656098 1 0.033921951 9850 hsa-mir-27a hsa04730 Long-term depression 5519_5515_5595 3 0.028337116 1 0.039881867 9851 hsa-mir-27a hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.033479935 1 0.046263183 9852 hsa-mir-27a hsa05012 Parkinson's disease 498_7314_292_293 4 0.036630056 1 0.049712218 9853 hsa-mir-27a hsa04510 Focal adhesion 3725_5595_5599_5601_71 5 0.040760261 1 0.054347015 9854 hsa-mir-27a hsa05340 Primary immunodeficiency 695_8517 2 0.042739664 1 0.056003698 9855 hsa-mir-27a hsa03030 DNA replication 5981_5111 2 0.044855559 1 0.057780042 9856 hsa-mir-27b hsa04310 Wnt signaling pathway 4087_4088_1487_2033_1488 5 7.66E-11 1.15E-09 1.15E-09 9857 hsa-mir-27b hsa05200 Pathways in cancer 4087_4088_1487_2033_1488 5 3.58E-09 5.36E-08 2.68E-08 9858 hsa-mir-27b hsa04330 Notch signaling pathway 1487_2033_1488 3 1.52E-07 2.27E-06 7.58E-07 9859 hsa-mir-27b hsa05220 Chronic myeloid leukemia 4088_1487_1488 3 5.87E-07 8.80E-06 2.13E-06 9860 hsa-mir-27b hsa04520 Adherens junction 4087_4088_2033 3 7.09E-07 1.06E-05 2.13E-06 9861 hsa-mir-27b hsa04350 TGF-beta signaling pathway 4087_4088_2033 3 9.05E-07 1.36E-05 2.26E-06 9862 hsa-mir-27b hsa04110 Cell cycle 4087_4088_2033 3 2.27E-06 3.40E-05 4.86E-06 9863 hsa-mir-27b hsa05210 Colorectal cancer 4087_4088 2 0.000168908 0.002533625 0.000316703 9864 hsa-mir-27b hsa05211 Renal cell carcinoma 2033 1 0.016907255 0.253608829 0.026011491 9865 hsa-mir-27b hsa04720 Long-term potentiation 2033 1 0.017596799 0.263951989 0.026011491 9866 hsa-mir-27b hsa05215 Prostate cancer 2033 1 0.020580035 0.308700524 0.026011491 9867 hsa-mir-27b hsa05212 Pancreatic cancer 2033 1 0.020809193 0.31213789 0.026011491 9868 hsa-mir-27b hsa04916 Melanogenesis 2033 1 0.024241047 0.363615709 0.027970439 9869 hsa-mir-27b hsa04630 Jak-STAT signaling pathway 2033 1 0.035832353 0.53748529 0.038391806 9870 hsa-mir-27b hsa05016 Huntington's disease 2033 1 0.043269546 0.649043197 0.043269546 9871 hsa-mir-28 hsa05200 Pathways in cancer 4149_5914_595_596_598_1017_4193_5578_3091_2064_3066_3065_1050_5925_613_5743_5747_25_1956_6789_4436_1870_1871_2113_5879_9915_3716_1147_998_367_4233_2261_5595_5594_5599_861_1387_6256_836_10401_2932_6777_6772_5979_5970_7157_7704_1869_3725_6776_4087_4088_4089_5888_5728_2034_2033_3480_4846_3910_4790_4792_3320_3326_5371_675_5159_5156_5601_5602_1856_51588_7428_4609_1026_2353_1441_8554 78 1.43E-50 1.21E-48 1.21E-48 9872 hsa-mir-28 hsa04110 Cell cycle 595_1017_4193_902_3066_3065_5925_25_1870_1871_9232_5934_5933_545_995_5347_5591_1387_11200_7534_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_1031_983_1026_1022_1111_8556_8555_472 38 3.73E-29 3.17E-27 1.59E-27 9873 hsa-mir-28 hsa05215 Prostate cancer 595_596_1017_4193_2064_5925_1956_1870_1871_9586_1147_367_5595_5594_1387_2932_5970_7157_1869_5728_10488_2033_3480_4790_4792_3320_3326_5159_5156_1026_468 31 4.55E-25 3.86E-23 1.28E-23 9874 hsa-mir-28 hsa05212 Pancreatic cancer 595_596_1017_4193_2064_5925_1956_1870_1871_9586_1147_367_5595_5594_1387_2932_5970_7157_1869_5728_10488_2033_3480_4790_4792_3320_3326_5159_5156_1026_468 31 6.01E-25 5.11E-23 1.28E-23 9875 hsa-mir-28 hsa04010 MAPK signaling pathway 3925_4149_2264_9252_5578_5923_1956_3304_3305_3303_6789_1432_4763_5879_1147_998_2261_5595_5594_5599_1386_836_3312_3315_1649_5970_3164_7157_3725_3727_4790_51701_1616_5159_5156_4208_5601_5600_5603_5602_6885_4609_2353_468_8550 45 7.43E-24 6.32E-22 1.26E-22 9876 hsa-mir-28 hsa05220 Chronic myeloid leukemia 595_598_4193_3066_3065_5925_613_25_1870_1871_1147_5595_5594_861_6777_5970_7157_1869_6776_4088_4089_4790_4792_5781_4609_1026_6464 27 3.33E-22 2.83E-20 4.71E-21 9877 hsa-mir-28 hsa05210 Colorectal cancer 595_596_1956_4436_5879_4233_5595_5594_5599_836_2932_7157_3725_4087_4088_4089_3480_5159_5156_5601_5602_1856_4609_2353 24 5.87E-18 4.99E-16 7.13E-17 9878 hsa-mir-28 hsa05222 Small cell lung cancer 4149_595_596_598_1017_5925_5743_5747_1870_1871_1147_6256_10401_5970_7157_1869_5728_4846_3910_4790_4792_51588_4609_8554 24 9.25E-18 7.86E-16 9.83E-17 9879 hsa-mir-28 hsa04115 p53 signaling pathway 595_1017_4194_4193_900_50484_6241_51246_545_7161_11200_836_7157_64326_5728_27113_25898_983_1026_1111_472 21 2.40E-16 2.04E-14 2.27E-15 9880 hsa-mir-28 hsa04630 Jak-STAT signaling pathway 3559_595_598_3454_3455_3560_1439_2690_3717_3716_3718_85480_1387_3575_3570_3572_10401_6777_6772_6776_2033_149233_3953_51588_5781_4609_1441_8554 28 3.23E-16 2.74E-14 2.74E-15 9881 hsa-mir-28 hsa04310 Wnt signaling pathway 595_5578_1459_5879_1460_5599_1387_2932_7157_8061_3725_1457_1452_4087_4088_4089_2033_51701_5518_5515_5601_5602_1856_6885_4609_5527 26 1.17E-14 9.91E-13 9.01E-14 9882 hsa-mir-28 hsa04520 Adherens junction 1459_2241_2064_1956_6714_5879_1460_998_4233_5595_5594_1387_1457_4087_4088_4089_2033_3480_51701_6885 20 2.96E-14 2.51E-12 2.09E-13 9883 hsa-mir-28 hsa04350 TGF-beta signaling pathway 3398_1875_6667_3399_1874_5934_5933_5595_5594_1387_7027_4086_4087_4088_4089_2033_5518_5515_4609_4093 20 1.15E-13 9.76E-12 7.51E-13 9884 hsa-mir-28 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_1432_5879_1147_998_4233_5599_836_5970_3725_4790_4792_5601_5600_5603_5602_5781 18 4.69E-13 3.99E-11 2.85E-12 9885 hsa-mir-28 hsa05219 Bladder cancer 595_9252_4193_2064_5925_1956_1870_1871_2261_5595_5594_7157_1869_4609_1026 15 6.80E-13 5.78E-11 3.86E-12 9886 hsa-mir-28 hsa05214 Glioma 595_4193_5578_5925_1956_1870_1871_5595_5594_7157_1869_5728_3480_5159_5156_1026_6464 17 1.36E-12 1.16E-10 7.25E-12 9887 hsa-mir-28 hsa04620 Toll-like receptor signaling pathway 3454_3455_1432_5879_1147_3654_5595_5594_5599_6772_5970_3725_4790_4792_5601_5600_5603_5602_6885_2353 20 1.51E-12 1.28E-10 7.53E-12 9888 hsa-mir-28 hsa04510 Focal adhesion 595_596_5578_2064_5923_5747_1956_6714_5499_5879_998_4233_5595_5594_5599_2932_3725_5728_3480_3910_2321_5159_5156_5601_5602_6464 26 6.23E-12 5.29E-10 2.94E-11 9889 hsa-mir-28 hsa04012 ErbB signaling pathway 5578_2064_5747_25_1956_6714_5595_5594_5599_2932_6777_3725_6776_5601_5602_4609_1026_6464 18 9.04E-12 7.68E-10 4.04E-11 9890 hsa-mir-28 hsa05218 Melanoma 595_4193_5925_1956_1870_1871_4233_5595_5594_7157_1869_5728_3480_5159_5156_1026 16 4.28E-11 3.64E-09 1.82E-10 9891 hsa-mir-28 hsa04062 Chemokine signaling pathway 2185_1234_1230_5747_5580_5590_7852_6362_5879_3055_3717_1147_3718_998_5595_5594_2932_6777_6772_5970_4790_4792_6464 23 2.88E-10 2.45E-08 1.17E-09 9892 hsa-mir-28 hsa05221 Acute myeloid leukemia 5914_595_1050_1147_5595_5594_861_6777_5970_7704_6776_4790_5371_4609 14 3.94E-10 3.35E-08 1.52E-09 9893 hsa-mir-28 hsa05223 Non-small cell lung cancer 595_5578_2064_5925_1956_6789_1870_1871_5595_5594_6256_7157_1869 13 1.43E-09 1.22E-07 5.30E-09 9894 hsa-mir-28 hsa04660 T cell receptor signaling pathway 3932_1432_1147_998_5595_5594_2932_5970_3725_959_4790_4792_5601_5600_5603_6885_2353 17 1.85E-09 1.57E-07 6.55E-09 9895 hsa-mir-28 hsa05211 Renal cell carcinoma 3091_2113_5879_9915_998_4233_5595_5594_1387_3725_2034_2033_7428_5781 14 3.75E-09 3.19E-07 1.27E-08 9896 hsa-mir-28 hsa04912 GnRH signaling pathway 2185_5578_5580_1956_6714_1432_998_5595_5594_5599_3725_5601_5600_5603_5602_468 16 9.50E-09 8.07E-07 3.10E-08 9897 hsa-mir-28 hsa04920 Adipocytokine signaling pathway 6794_3717_1147_5599_6256_5970_4790_4792_5601_5602_5563_3953_5781 13 1.38E-08 1.18E-06 4.32E-08 9898 hsa-mir-28 hsa04060 Cytokine-cytokine receptor interaction 3556_3559_1234_1230_3454_3455_1956_7852_3560_1439_6362_2690_85480_4233_3575_3570_3572_959_2321_149233_5159_5156_3953_1441 24 1.42E-08 1.21E-06 4.32E-08 9899 hsa-mir-28 hsa04120 Ubiquitin mediated proteolysis 55294_4193_3093_7319_84447_7329_10055_10401_64326_7337_5371_672_25898_10075_51588_7428_8554 17 4.28E-08 3.64E-06 1.26E-07 9900 hsa-mir-28 hsa03022 Basal transcription factors 51616_2965_2963_2969_6874_6908_2958_6883_6880_2957 10 4.51E-08 3.83E-06 1.28E-07 9901 hsa-mir-28 hsa04370 VEGF signaling pathway 5578_5743_5747_6714_1432_5879_998_5595_5594_3315_4846_5600_5603 13 5.94E-08 5.05E-06 1.63E-07 9902 hsa-mir-28 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_2902_1432_5879_836_7157_4846_1616_5600_5603 11 1.62E-07 1.38E-05 4.30E-07 9903 hsa-mir-28 hsa04210 Apoptosis 3556_596_598_823_1439_1147_3654_836_5970_7157_4790_4792_472 13 2.68E-07 2.28E-05 6.90E-07 9904 hsa-mir-28 hsa04662 B cell receptor signaling pathway 6850_5879_1147_5595_5594_1380_2932_5970_3725_4790_4792_2353 12 3.21E-07 2.73E-05 8.04E-07 9905 hsa-mir-28 hsa04664 Fc epsilon RI signaling pathway 5578_5580_6850_1432_5879_5595_5594_5599_5601_5600_5603_5602 12 5.29E-07 4.50E-05 1.29E-06 9906 hsa-mir-28 hsa04330 Notch signaling pathway 3066_3065_3280_1387_9612_2033_8850_1856_388585 9 2.62E-06 0.000222733 6.19E-06 9907 hsa-mir-28 hsa05213 Endometrial cancer 595_2064_1956_5595_5594_2932_7157_5728_4609 9 5.46E-06 0.000463881 1.25E-05 9908 hsa-mir-28 hsa05216 Thyroid cancer 595_5595_5594_6256_5979_7157_4609 7 9.31E-06 0.000791733 2.08E-05 9909 hsa-mir-28 hsa03420 Nucleotide excision repair 902_2965_4331_2071_2074_6118_1022_6117 8 1.32E-05 0.001125405 2.89E-05 9910 hsa-mir-28 hsa05016 Huntington's disease 3066_3065_3064_25942_2902_6667_9586_1387_836_7157_10488_2033_27113_6874_6908 15 3.28E-05 0.002785167 6.96E-05 9911 hsa-mir-28 hsa04612 Antigen processing and presentation 3309_3304_3305_3303_3312_3320_3326_4800_4801_2923 10 5.04E-05 0.004284429 0.000104498 9912 hsa-mir-28 hsa03440 Homologous recombination 641_4683_5888_675_6118_6117 6 7.33E-05 0.006229062 0.000148311 9913 hsa-mir-28 hsa04530 Tight junction 5578_1459_5580_5590_6714_1460_998_1457_5728_5518_5515_5520 12 8.71E-05 0.007407591 0.00017227 9914 hsa-mir-28 hsa04910 Insulin signaling pathway 6720_5590_5499_5595_5594_5599_23265_2932_5601_5602_5563_6464 12 9.29E-05 0.007898829 0.00017553 9915 hsa-mir-28 hsa04650 Natural killer cell mediated cytotoxicity 2185_5578_3454_3455_3932_6850_5879_5595_5594_836_5781_6464 12 9.29E-05 0.007898829 0.00017553 9916 hsa-mir-28 hsa04930 Type II diabetes mellitus 5580_5590_5595_5594_5599_5601_5602 7 0.000111226 0.009454169 0.000205525 9917 hsa-mir-28 hsa04360 Axon guidance 5747_25_7852_5879_2242_998_4233_1020_5595_5594_2932 11 0.000239063 0.02032035 0.000432348 9918 hsa-mir-28 hsa04540 Gap junction 5578_1956_6714_5595_5594_1453_5159_983_5156 9 0.000333396 0.028338645 0.000590388 9919 hsa-mir-28 hsa04720 Long-term potentiation 5578_2902_5499_5595_5594_1387_2033_468 8 0.00038992 0.033143186 0.000676392 9920 hsa-mir-28 hsa04670 Leukocyte transendothelial migration 2185_5578_5747_7852_1432_5879_998_5600_5603_5781 10 0.000541006 0.045985503 0.00091971 9921 hsa-mir-28 hsa04730 Long-term depression 5578_5595_5594_3480_4846_5518_5515 7 0.001366068 0.116115783 0.00227678 9922 hsa-mir-28 hsa04916 Melanogenesis 5578_5595_5594_1387_2932_10488_2033_1856 8 0.00275355 0.234051713 0.004500994 9923 hsa-mir-28 hsa04710 Circadian rhythm - mammal 8863_1453_8553 3 0.004363092 0.370862849 0.006997412 9924 hsa-mir-28 hsa04150 mTOR signaling pathway 6794_3091_5595_5594_5563 5 0.007224531 0.614085175 0.011371948 9925 hsa-mir-28 hsa05340 Primary immunodeficiency 3932_3718_3575_959 4 0.009252791 0.786487195 0.014287389 9926 hsa-mir-28 hsa05131 Shigellosis 5578_25_998_7534_4691 5 0.009580955 0.814381181 0.014287389 9927 hsa-mir-28 hsa05130 Pathogenic Escherichia coli infection 5578_25_998_7534_4691 5 0.009580955 0.814381181 0.014287389 9928 hsa-mir-28 hsa03030 DNA replication 5557_6118_6117_5422 4 0.010111468 0.85947481 0.01456737 9929 hsa-mir-28 hsa03410 Base excision repair 3146_142_4913_328 4 0.010111468 0.85947481 0.01456737 9930 hsa-mir-28 hsa04810 Regulation of actin cytoskeleton 2264_5747_1956_5499_5879_998_2261_5595_5594_5159_5156 11 0.0106783 0.907655473 0.015127591 9931 hsa-mir-28 hsa04640 Hematopoietic cell lineage 3559_1380_3575_3570_914_1441 6 0.01451915 1 0.020231602 9932 hsa-mir-28 hsa03430 Mismatch repair 4436_6118_6117 3 0.017313415 1 0.023736134 9933 hsa-mir-28 hsa04950 Maturity onset diabetes of the young 6927_3280_3172 3 0.01917604 1 0.025872435 9934 hsa-mir-28 hsa03450 Non-homologous end-joining 2547_5591 2 0.044518985 1 0.059126777 9935 hsa-mir-2861 hsa05200 Pathways in cancer 3326_25_5371_5595_5594_861_5914_1387_6256_595_10401_836_367_1017_2932_4193_4149_7704_3091_3265_5970_7428_1870_1871_7157_4087_6688_2113_4609_1869_3725_2353_2736_4088_4089_3066_3065_7184_1050_5925_2034_2033_4846_207_8554_4286 46 4.45E-32 3.34E-30 3.34E-30 9936 hsa-mir-2861 hsa03022 Basal transcription factors 2967_2961_2960_2963_2968_6878_6877_6874_2957_54457_6879_6908_6873_6872_6884_6880_6882_2958_6883_6881_138474_9519_2959 23 6.46E-29 4.85E-27 2.42E-27 9937 hsa-mir-2861 hsa05220 Chronic myeloid leukemia 25_5595_5594_861_595_4193_3265_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_207_6464 20 2.08E-19 1.56E-17 3.94E-18 9938 hsa-mir-2861 hsa04110 Cell cycle 25_890_5591_1387_595_1017_2932_4193_4085_1870_1871_7157_4087_1869_4171_4088_4089_3066_3065_5925_2033_5933_5934 23 2.10E-19 1.58E-17 3.94E-18 9939 hsa-mir-2861 hsa05215 Prostate cancer 3326_5595_5594_1387_595_367_1017_2932_4193_3265_5970_1870_1871_7157_1869_7184_5925_2033_207_90993 20 3.10E-18 2.32E-16 4.65E-17 9940 hsa-mir-2861 hsa05212 Pancreatic cancer 3326_5595_5594_1387_595_367_1017_2932_4193_3265_5970_1870_1871_7157_1869_7184_5925_2033_207_90993 20 3.75E-18 2.81E-16 4.69E-17 9941 hsa-mir-2861 hsa04010 MAPK signaling pathway 6722_5595_5594_9261_4208_836_6195_6197_9252_4149_3312_1432_3265_5970_7157_22800_4773_4609_3725_3727_6196_2353_8986_4763_1616_207 26 5.76E-15 4.32E-13 6.17E-14 9942 hsa-mir-2861 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_3399_3398_1874_1875_4087_4609_4086_4088_4089_2033_5933_4093_5934 17 9.56E-15 7.17E-13 8.96E-14 9943 hsa-mir-2861 hsa05222 Small cell lung cancer 6256_595_10401_1017_4149_5970_1870_1871_7157_4609_1869_5925_4846_207_8554 15 1.55E-12 1.17E-10 1.30E-11 9944 hsa-mir-2861 hsa05219 Bladder cancer 5595_5594_595_9252_4193_3265_1870_1871_7157_4609_1869_5925 12 1.82E-12 1.37E-10 1.37E-11 9945 hsa-mir-2861 hsa05221 Acute myeloid leukemia 5371_5595_5594_861_5914_595_7704_3265_5970_6688_4609_1050_207 13 3.66E-12 2.75E-10 2.50E-11 9946 hsa-mir-2861 hsa05214 Glioma 5595_5594_595_4193_3265_1870_1871_7157_1869_5925_207_6464 12 1.52E-10 1.14E-08 9.50E-10 9947 hsa-mir-2861 hsa05210 Colorectal cancer 5595_5594_595_836_2932_7157_4087_4609_3725_2353_4088_4089_207 13 1.83E-10 1.37E-08 1.06E-09 9948 hsa-mir-2861 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_3265_1870_1871_7157_1869_5925_207 11 3.56E-10 2.67E-08 1.88E-09 9949 hsa-mir-2861 hsa05218 Melanoma 5595_5594_595_4193_3265_1870_1871_7157_1869_5925_207_4286 12 3.75E-10 2.81E-08 1.88E-09 9950 hsa-mir-2861 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_3265_7428_2113_3725_2034_2033_207 11 5.28E-09 3.96E-07 2.47E-08 9951 hsa-mir-2861 hsa04310 Wnt signaling pathway 1460_1387_595_8607_2932_7157_4087_4773_4609_3725_1457_4088_4089_2033 14 1.72E-08 1.29E-06 7.59E-08 9952 hsa-mir-2861 hsa05016 Huntington's disease 6874_1387_9001_2902_6908_836_6667_5430_7157_3066_3065_3064_2033_90993_9519 15 3.16E-08 2.37E-06 1.32E-07 9953 hsa-mir-2861 hsa04720 Long-term potentiation 5595_5594_1387_2902_2906_6195_6197_3265_6196_2033 10 8.44E-08 6.33E-06 3.33E-07 9954 hsa-mir-2861 hsa05216 Thyroid cancer 5595_5594_6256_595_3265_7157_4609 7 2.24E-07 1.68E-05 8.39E-07 9955 hsa-mir-2861 hsa05213 Endometrial cancer 5595_5594_595_2932_3265_7157_4609_207 8 6.37E-07 4.78E-05 2.27E-06 9956 hsa-mir-2861 hsa04662 B cell receptor signaling pathway 5595_5594_2932_3265_5970_4773_3725_2353_207 9 8.46E-07 6.34E-05 2.88E-06 9957 hsa-mir-2861 hsa04520 Adherens junction 1460_5595_5594_1387_4087_1457_4088_4089_2033 9 1.38E-06 0.000103834 4.51E-06 9958 hsa-mir-2861 hsa04660 T cell receptor signaling pathway 5595_5594_2932_1432_3265_5970_4773_3725_2353_207 10 2.15E-06 0.000161476 6.73E-06 9959 hsa-mir-2861 hsa04012 ErbB signaling pathway 25_5595_5594_2932_3265_4609_3725_207_6464 9 2.62E-06 0.000196622 7.86E-06 9960 hsa-mir-2861 hsa04150 mTOR signaling pathway 5595_5594_6195_6197_3091_6196_207 7 7.19E-06 0.000539607 2.08E-05 9961 hsa-mir-2861 hsa04370 VEGF signaling pathway 5595_5594_9261_1432_3265_4773_4846_207 8 9.21E-06 0.000690488 2.56E-05 9962 hsa-mir-2861 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906_836_1432_7157_1616_4846 7 1.12E-05 0.000839547 3.00E-05 9963 hsa-mir-2861 hsa04330 Notch signaling pathway 1387_9612_3066_3065_2033_8850 6 4.32E-05 0.003237888 0.000111651 9964 hsa-mir-2861 hsa03050 Proteasome 5684_5719_5705_5701_5702_5710 6 4.81E-05 0.003605743 0.000120191 9965 hsa-mir-2861 hsa04916 Melanogenesis 5595_5594_1387_2932_3265_2033_4286_90993 8 6.85E-05 0.005140178 0.000165812 9966 hsa-mir-2861 hsa04120 Ubiquitin mediated proteolysis 11059_5371_672_4734_10401_4193_7428_7329_8554 9 8.54E-05 0.006405474 0.000200171 9967 hsa-mir-2861 hsa04620 Toll-like receptor signaling pathway 5595_5594_1432_5970_3725_2353_207 7 0.00037478 0.028108468 0.000851772 9968 hsa-mir-2861 hsa04910 Insulin signaling pathway 6720_5595_5594_5211_2932_3265_207_6464 8 0.000425723 0.031929218 0.000939095 9969 hsa-mir-2861 hsa05010 Alzheimer's disease 5595_5594_2902_2906_836_2932_4846_351 8 0.001967254 0.147544085 0.004215545 9970 hsa-mir-2861 hsa04115 p53 signaling pathway 595_836_1017_4193_7157 5 0.002066679 0.15500092 0.004305581 9971 hsa-mir-2861 hsa04730 Long-term depression 5592_5595_5594_3265_4846 5 0.002324157 0.174311764 0.004711129 9972 hsa-mir-2861 hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432_3265_207 5 0.003590866 0.269314931 0.007087235 9973 hsa-mir-2861 hsa04630 Jak-STAT signaling pathway 1387_595_10401_4609_2033_207_8554 7 0.003723552 0.279266405 0.007160677 9974 hsa-mir-2861 hsa04510 Focal adhesion 5595_5594_595_2932_3265_3725_207_6464 8 0.004773266 0.357994967 0.008949874 9975 hsa-mir-2861 hsa04360 Axon guidance 25_5595_5594_2932_3265_4773 6 0.006626489 0.49698671 0.012121627 9976 hsa-mir-2861 hsa04540 Gap junction 5592_5595_5594_3265_10382 5 0.006889617 0.516721275 0.012302888 9977 hsa-mir-2861 hsa04530 Tight junction 8573_1460_3265_22800_1457_207 6 0.0081104 0.608279964 0.014146046 9978 hsa-mir-2861 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_3265_4773_6464 6 0.008379134 0.628435033 0.014282614 9979 hsa-mir-2861 hsa04062 Chemokine signaling pathway 5595_5594_2932_3265_5970_207_6464 7 0.011350669 0.851300188 0.018917782 9980 hsa-mir-2861 hsa04912 GnRH signaling pathway 5595_5594_1432_3265_3725 5 0.012308317 0.923123756 0.020067908 9981 hsa-mir-2861 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_1432_5970_3725 4 0.01313564 0.985173014 0.020961128 9982 hsa-mir-2861 hsa03420 Nucleotide excision repair 2967_2968_5887 3 0.019314716 1 0.030179243 9983 hsa-mir-2861 hsa04930 Type II diabetes mellitus 5595_5594_3651 3 0.020421597 1 0.031257547 9984 hsa-mir-2861 hsa04612 Antigen processing and presentation 3326_4800_4801_3312 4 0.02668127 1 0.039237162 9985 hsa-mir-2861 hsa04210 Apoptosis 836_5970_7157_207 4 0.02668127 1 0.039237162 9986 hsa-mir-2861 hsa05217 Basal cell carcinoma 2932_7157_2736 3 0.033369496 1 0.048129081 9987 hsa-mir-2861 hsa04950 Maturity onset diabetes of the young 3651_5080 2 0.039306083 1 0.055621816 9988 hsa-mir-2909 hsa05200 Pathways in cancer 5371_1499_5595_5594_5599_1387_1487_1488_9915_1019_1017_2932_3091_4087_6688_4609_1026_2353_4088_5925_2034_2033_8554 23 5.92E-22 3.85E-20 3.85E-20 9989 hsa-mir-2909 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_7027_3399_3398_1874_4087_4609_4088_2033_4093_5933 14 2.12E-18 1.38E-16 6.90E-17 9990 hsa-mir-2909 hsa04310 Wnt signaling pathway 1499_5599_1387_1487_1488_2932_6423_4087_8061_4609_1457_4088_2033 13 6.67E-14 4.34E-12 1.45E-12 9991 hsa-mir-2909 hsa04110 Cell cycle 1387_1019_1017_2932_7027_4087_1026_4088_5925_2033_891_5933 12 1.04E-13 6.77E-12 1.69E-12 9992 hsa-mir-2909 hsa05215 Prostate cancer 1499_5595_5594_1387_1017_2932_468_1026_5925_2033 10 4.28E-12 2.78E-10 5.14E-11 9993 hsa-mir-2909 hsa05212 Pancreatic cancer 1499_5595_5594_1387_1017_2932_468_1026_5925_2033 10 4.75E-12 3.09E-10 5.14E-11 9994 hsa-mir-2909 hsa05220 Chronic myeloid leukemia 5595_5594_1487_1488_1019_4609_1026_4088_5925 9 3.36E-11 2.19E-09 3.12E-10 9995 hsa-mir-2909 hsa05210 Colorectal cancer 1499_5595_5594_5599_2932_4087_4609_2353_4088 9 8.54E-11 5.55E-09 6.94E-10 9996 hsa-mir-2909 hsa04520 Adherens junction 1499_5595_5594_1387_4087_1457_4088_2033 8 1.64E-09 1.07E-07 1.19E-08 9997 hsa-mir-2909 hsa05211 Renal cell carcinoma 5595_5594_1387_9915_3091_2034_2033 7 2.14E-08 1.39E-06 1.39E-07 9998 hsa-mir-2909 hsa05219 Bladder cancer 5595_5594_1019_4609_1026_5925 6 2.78E-08 1.81E-06 1.64E-07 9999 hsa-mir-2909 hsa04010 MAPK signaling pathway 9479_5595_5594_5599_1386_1649_468_4609_2353 9 1.34E-06 8.71E-05 7.26E-06 10000 hsa-mir-2909 hsa04012 ErbB signaling pathway 5595_5594_5599_2932_4609_1026 6 1.50E-06 9.77E-05 7.45E-06 10001 hsa-mir-2909 hsa04330 Notch signaling pathway 1387_1487_1488_9612_2033 5 1.60E-06 0.000104314 7.45E-06 10002 hsa-mir-2909 hsa05213 Endometrial cancer 1499_5595_5594_2932_4609 5 2.55E-06 0.000165545 1.10E-05 10003 hsa-mir-2909 hsa04916 Melanogenesis 1499_5595_5594_1387_2932_2033 6 4.01E-06 0.000260514 1.63E-05 10004 hsa-mir-2909 hsa05221 Acute myeloid leukemia 5371_5595_5594_6688_4609 5 4.54E-06 0.000295161 1.74E-05 10005 hsa-mir-2909 hsa05214 Glioma 5595_5594_1019_1026_5925 5 7.08E-06 0.000460148 2.51E-05 10006 hsa-mir-2909 hsa05216 Thyroid cancer 1499_5595_5594_4609 4 7.32E-06 0.000475962 2.51E-05 10007 hsa-mir-2909 hsa05218 Melanoma 5595_5594_1019_1026_5925 5 1.06E-05 0.000689832 3.45E-05 10008 hsa-mir-2909 hsa04720 Long-term potentiation 5595_5594_1387_468_2033 5 1.36E-05 0.000886894 4.22E-05 10009 hsa-mir-2909 hsa05222 Small cell lung cancer 1019_1017_4609_5925_8554 5 2.55E-05 0.001659846 7.54E-05 10010 hsa-mir-2909 hsa05223 Non-small cell lung cancer 5595_5594_1019_5925 4 7.06E-05 0.004588032 0.00019948 10011 hsa-mir-2909 hsa04660 T cell receptor signaling pathway 5595_5594_1019_2932_2353 5 7.84E-05 0.005096948 0.000212373 10012 hsa-mir-2909 hsa04115 p53 signaling pathway 1019_1017_1026_891 4 0.000173348 0.011267588 0.000450704 10013 hsa-mir-2909 hsa04910 Insulin signaling pathway 5595_5594_5599_23265_2932 5 0.000218123 0.014178018 0.000542374 10014 hsa-mir-2909 hsa04120 Ubiquitin mediated proteolysis 55294_5371_7325_7329_8554 5 0.000225294 0.014644089 0.000542374 10015 hsa-mir-2909 hsa04662 B cell receptor signaling pathway 5595_5594_2932_2353 4 0.000235157 0.015285224 0.000545901 10016 hsa-mir-2909 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_2353 4 0.000718912 0.046729281 0.001611355 10017 hsa-mir-2909 hsa04930 Type II diabetes mellitus 5595_5594_5599 3 0.000807176 0.052466472 0.001748882 10018 hsa-mir-2909 hsa04912 GnRH signaling pathway 5595_5594_5599_468 4 0.000883329 0.057416411 0.001852142 10019 hsa-mir-2909 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.001201026 0.078066712 0.002439585 10020 hsa-mir-2909 hsa04510 Focal adhesion 1499_5595_5594_5599_2932 5 0.001273933 0.08280563 0.002509262 10021 hsa-mir-2909 hsa04630 Jak-STAT signaling pathway 1387_4609_2033_8554 4 0.003183368 0.206918911 0.00608585 10022 hsa-mir-2909 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599 3 0.003765204 0.244738259 0.006992522 10023 hsa-mir-2909 hsa05010 Alzheimer's disease 5595_5594_2932_1537 4 0.00504129 0.327683878 0.00910233 10024 hsa-mir-2909 hsa05016 Huntington's disease 1387_6667_1537_2033 4 0.006196521 0.40277384 0.010885779 10025 hsa-mir-2909 hsa03022 Basal transcription factors 2963_2969 2 0.009607087 0.624460639 0.016433175 10026 hsa-mir-2909 hsa04360 Axon guidance 5595_5594_2932 3 0.014470686 0.940594612 0.024117811 10027 hsa-mir-2909 hsa04530 Tight junction 1499_1019_1457 3 0.016252787 1 0.026410778 10028 hsa-mir-2909 hsa05217 Basal cell carcinoma 1499_2932 2 0.019799525 1 0.031389491 10029 hsa-mir-2909 hsa04730 Long-term depression 5595_5594 2 0.031355262 1 0.048526001 10030 hsa-mir-2909 hsa04370 VEGF signaling pathway 5595_5594 2 0.036228197 1 0.054763554 10031 hsa-mir-2909 hsa04062 Chemokine signaling pathway 5595_5594_2932 3 0.038596403 1 0.057017413 10032 hsa-mir-297 hsa05200 Pathways in cancer 4087_4088_4089_6688_836_2033_207_208_2932_367_1499_1387_2113 13 2.40E-13 1.27E-11 1.27E-11 10033 hsa-mir-297 hsa05210 Colorectal cancer 4087_4088_4089_836_207_208_2932_1499 8 1.66E-11 8.82E-10 4.41E-10 10034 hsa-mir-297 hsa04110 Cell cycle 4087_4088_4089_2033_7534_7532_2932_1387 8 2.27E-10 1.20E-08 4.00E-09 10035 hsa-mir-297 hsa04520 Adherens junction 4087_4088_4089_2033_1499_6714_1387 7 5.75E-10 3.05E-08 7.61E-09 10036 hsa-mir-297 hsa05215 Prostate cancer 2033_207_208_2932_367_1499_1387 7 1.07E-09 5.69E-08 1.02E-08 10037 hsa-mir-297 hsa05212 Pancreatic cancer 2033_207_208_2932_367_1499_1387 7 1.16E-09 6.12E-08 1.02E-08 10038 hsa-mir-297 hsa05211 Renal cell carcinoma 5058_2033_207_208_1387_2113 6 1.37E-08 7.28E-07 1.04E-07 10039 hsa-mir-297 hsa04310 Wnt signaling pathway 4087_4088_4089_2033_2932_1499_1387 7 3.91E-08 2.07E-06 2.59E-07 10040 hsa-mir-297 hsa04350 TGF-beta signaling pathway 4087_4088_4089_2033_1387 5 1.36E-06 7.19E-05 7.19E-06 10041 hsa-mir-297 hsa04012 ErbB signaling pathway 5058_207_208_2932_6714 5 1.36E-06 7.19E-05 7.19E-06 10042 hsa-mir-297 hsa04010 MAPK signaling pathway 6722_5058_836_207_208_1432_5598 7 1.79E-06 9.49E-05 8.63E-06 10043 hsa-mir-297 hsa04660 T cell receptor signaling pathway 5058_207_208_2932_1432 5 4.08E-06 0.000216292 1.80E-05 10044 hsa-mir-297 hsa04510 Focal adhesion 5058_207_208_2932_1499_6714 6 5.07E-06 0.000268647 2.07E-05 10045 hsa-mir-297 hsa05213 Endometrial cancer 207_208_2932_1499 4 5.56E-06 0.000294557 2.10E-05 10046 hsa-mir-297 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5058_836_6714_1432 4 1.79E-05 0.000946628 6.31E-05 10047 hsa-mir-297 hsa05220 Chronic myeloid leukemia 4088_4089_207_208 4 2.19E-05 0.001163002 7.27E-05 10048 hsa-mir-297 hsa04370 VEGF signaling pathway 207_208_6714_1432 4 2.42E-05 0.001283847 7.55E-05 10049 hsa-mir-297 hsa04210 Apoptosis 836_207_208_840 4 4.17E-05 0.002211797 0.000122878 10050 hsa-mir-297 hsa04916 Melanogenesis 2033_2932_1499_1387 4 7.48E-05 0.003967036 0.000208791 10051 hsa-mir-297 hsa04530 Tight junction 207_208_1499_6714 4 0.000209455 0.0111011 0.000543111 10052 hsa-mir-297 hsa04910 Insulin signaling pathway 207_208_2932_2538 4 0.000215195 0.011405331 0.000543111 10053 hsa-mir-297 hsa05221 Acute myeloid leukemia 6688_207_208 3 0.000289678 0.01535293 0.00069786 10054 hsa-mir-297 hsa04630 Jak-STAT signaling pathway 2033_207_208_1387 4 0.000331069 0.01754668 0.000762899 10055 hsa-mir-297 hsa04920 Adipocytokine signaling pathway 207_208_2538 3 0.000414385 0.021962386 0.000915099 10056 hsa-mir-297 hsa05010 Alzheimer's disease 836_2932_1020_840 4 0.000540008 0.028620408 0.001144816 10057 hsa-mir-297 hsa04662 B cell receptor signaling pathway 207_208_2932 3 0.000569186 0.030166884 0.001160265 10058 hsa-mir-297 hsa04664 Fc epsilon RI signaling pathway 207_208_1432 3 0.000658718 0.034912067 0.00129304 10059 hsa-mir-297 hsa04062 Chemokine signaling pathway 5058_207_208_2932 4 0.000741443 0.039296475 0.001403446 10060 hsa-mir-297 hsa04620 Toll-like receptor signaling pathway 207_208_1432 3 0.001348196 0.071454377 0.002463944 10061 hsa-mir-297 hsa04912 GnRH signaling pathway 6714_1432_5598 3 0.001581343 0.083811196 0.002793707 10062 hsa-mir-297 hsa04360 Axon guidance 5058_2932_1020 3 0.002702895 0.14325345 0.004621079 10063 hsa-mir-297 hsa04330 Notch signaling pathway 2033_1387 2 0.004623993 0.245071636 0.007658489 10064 hsa-mir-297 hsa04150 mTOR signaling pathway 207_208 2 0.005589569 0.296247171 0.008957946 10065 hsa-mir-297 hsa05223 Non-small cell lung cancer 207_208 2 0.005999452 0.317970936 0.008957946 10066 hsa-mir-297 hsa05217 Basal cell carcinoma 2932_1499 2 0.006209404 0.329098407 0.008957946 10067 hsa-mir-297 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432 2 0.006422678 0.340401935 0.008957946 10068 hsa-mir-297 hsa05131 Shigellosis 7534_1499 2 0.006422678 0.340401935 0.008957946 10069 hsa-mir-297 hsa05130 Pathogenic Escherichia coli infection 7534_1499 2 0.006422678 0.340401935 0.008957946 10070 hsa-mir-297 hsa04340 Hedgehog signaling pathway 2932_53944 2 0.00663926 0.351880769 0.009022584 10071 hsa-mir-297 hsa05016 Huntington's disease 836_2033_1387 3 0.007252965 0.384407161 0.009610179 10072 hsa-mir-297 hsa05214 Glioma 207_208 2 0.008489308 0.44993331 0.010973983 10073 hsa-mir-297 hsa05218 Melanoma 207_208 2 0.010010894 0.530577359 0.012632794 10074 hsa-mir-297 hsa04720 Long-term potentiation 2033_1387 2 0.011087479 0.587636364 0.013665962 10075 hsa-mir-297 hsa05222 Small cell lung cancer 207_208 2 0.014296924 0.757736969 0.017221295 10076 hsa-mir-297 hsa04540 Gap junction 6714_5598 2 0.016523277 0.875733656 0.019460748 10077 hsa-mir-297 hsa04670 Leukocyte transendothelial migration 1499_1432 2 0.027168235 1 0.031302531 10078 hsa-mir-297 hsa04650 Natural killer cell mediated cytotoxicity 5058_836 2 0.033946848 1 0.038280488 10079 hsa-mir-298 hsa04916 Melanogenesis 1499_2033_1387_5595_5594_808_801_805 8 1.99E-10 1.17E-08 1.17E-08 10080 hsa-mir-298 hsa04720 Long-term potentiation 2033_1387_5595_5594_808_801_805 7 8.13E-10 4.80E-08 2.40E-08 10081 hsa-mir-298 hsa04350 TGF-beta signaling pathway 3398_2033_1387_5595_5594_3397_3399 7 2.14E-09 1.26E-07 2.93E-08 10082 hsa-mir-298 hsa05215 Prostate cancer 3320_1499_5925_2033_1387_5595_5594 7 2.31E-09 1.36E-07 2.93E-08 10083 hsa-mir-298 hsa05212 Pancreatic cancer 3320_1499_5925_2033_1387_5595_5594 7 2.48E-09 1.47E-07 2.93E-08 10084 hsa-mir-298 hsa05200 Pathways in cancer 3320_1499_5925_2033_6502_8554_1387_5595_5594_862 10 5.96E-09 3.52E-07 5.86E-08 10085 hsa-mir-298 hsa05214 Glioma 5925_5595_5594_808_801_805 6 1.49E-08 8.78E-07 1.25E-07 10086 hsa-mir-298 hsa04520 Adherens junction 1499_2033_71_1387_5595_5594 6 4.76E-08 2.81E-06 3.51E-07 10087 hsa-mir-298 hsa04912 GnRH signaling pathway 1432_5595_5594_808_801_805 6 2.57E-07 1.51E-05 1.68E-06 10088 hsa-mir-298 hsa04370 VEGF signaling pathway 9261_1432_7867_5595_5594 5 1.31E-06 7.71E-05 7.71E-06 10089 hsa-mir-298 hsa04010 MAPK signaling pathway 9261_4208_1432_7867_5595_5594_6722 7 3.71E-06 0.000218996 1.99E-05 10090 hsa-mir-298 hsa04330 Notch signaling pathway 2033_1387_388585_8850 4 5.85E-06 0.00034507 2.88E-05 10091 hsa-mir-298 hsa04270 Vascular smooth muscle contraction 5595_5594_808_801_805 5 9.62E-06 0.000567571 4.37E-05 10092 hsa-mir-298 hsa04910 Insulin signaling pathway 5595_5594_808_801_805 5 2.00E-05 0.001177207 8.41E-05 10093 hsa-mir-298 hsa05211 Renal cell carcinoma 2033_1387_5595_5594 4 2.88E-05 0.00169674 0.000113116 10094 hsa-mir-298 hsa05216 Thyroid cancer 1499_5595_5594 3 5.47E-05 0.003226449 0.000201653 10095 hsa-mir-298 hsa05010 Alzheimer's disease 5595_5594_808_801_805 5 6.31E-05 0.003725655 0.000219156 10096 hsa-mir-298 hsa05219 Bladder cancer 5925_5595_5594 3 0.000153143 0.009035457 0.00050197 10097 hsa-mir-298 hsa04930 Type II diabetes mellitus 3651_5595_5594 3 0.000185747 0.010959088 0.000553615 10098 hsa-mir-298 hsa04110 Cell cycle 5925_2033_6502_1387 4 0.000187666 0.011072304 0.000553615 10099 hsa-mir-298 hsa05213 Endometrial cancer 1499_5595_5594 3 0.000278528 0.016433155 0.000782531 10100 hsa-mir-298 hsa05223 Non-small cell lung cancer 5925_5595_5594 3 0.000309626 0.018267931 0.000830361 10101 hsa-mir-298 hsa05221 Acute myeloid leukemia 5595_5594_862 3 0.000396939 0.02341939 0.001018234 10102 hsa-mir-298 hsa05218 Melanoma 5925_5595_5594 3 0.000667111 0.03935952 0.00163998 10103 hsa-mir-298 hsa05220 Chronic myeloid leukemia 5925_5595_5594 3 0.000777795 0.045889882 0.001831665 10104 hsa-mir-298 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.000807174 0.047623293 0.001831665 10105 hsa-mir-298 hsa04664 Fc epsilon RI signaling pathway 1432_5595_5594 3 0.000899521 0.053071722 0.001965619 10106 hsa-mir-298 hsa05210 Colorectal cancer 1499_5595_5594 3 0.001067839 0.063002494 0.002250089 10107 hsa-mir-298 hsa05222 Small cell lung cancer 5925_6502_8554 3 0.001140355 0.067280963 0.002320033 10108 hsa-mir-298 hsa04510 Focal adhesion 1499_71_5595_5594 4 0.001401685 0.082699443 0.002756648 10109 hsa-mir-298 hsa04950 Maturity onset diabetes of the young 3651_168620 2 0.001627612 0.09602912 0.003097714 10110 hsa-mir-298 hsa04620 Toll-like receptor signaling pathway 1432_5595_5594 3 0.001833794 0.108193822 0.003381057 10111 hsa-mir-298 hsa04660 T cell receptor signaling pathway 1432_5595_5594 3 0.002260671 0.133379568 0.004041805 10112 hsa-mir-298 hsa04670 Leukocyte transendothelial migration 1432_1499_71 3 0.003008522 0.177502813 0.005220671 10113 hsa-mir-298 hsa04120 Ubiquitin mediated proteolysis 6502_8554_7329 3 0.004302532 0.253849384 0.00725284 10114 hsa-mir-298 hsa04310 Wnt signaling pathway 1499_2033_1387 3 0.005488421 0.323816823 0.008994912 10115 hsa-mir-298 hsa04630 Jak-STAT signaling pathway 2033_8554_1387 3 0.005787178 0.341443489 0.00919318 10116 hsa-mir-298 hsa03050 Proteasome 5710_5705 2 0.005921031 0.34934084 0.00919318 10117 hsa-mir-298 hsa04150 mTOR signaling pathway 5595_5594 2 0.006876051 0.405687031 0.010402232 10118 hsa-mir-298 hsa05131 Shigellosis 1499_71 2 0.007896093 0.465869488 0.01136267 10119 hsa-mir-298 hsa05130 Pathogenic Escherichia coli infection 1499_71 2 0.007896093 0.465869488 0.01136267 10120 hsa-mir-298 hsa04020 Calcium signaling pathway 808_801_805 3 0.009180531 0.54165135 0.012896461 10121 hsa-mir-298 hsa04730 Long-term depression 5595_5594 2 0.012279473 0.724488879 0.016848579 10122 hsa-mir-298 hsa04662 B cell receptor signaling pathway 5595_5594 2 0.013591793 0.801915758 0.018225358 10123 hsa-mir-298 hsa04810 Regulation of actin cytoskeleton 71_5595_5594 3 0.014551597 0.858544228 0.019078761 10124 hsa-mir-298 hsa04012 ErbB signaling pathway 5595_5594 2 0.01787309 1 0.02292418 10125 hsa-mir-298 hsa04612 Antigen processing and presentation 3308_3320 2 0.018635375 1 0.023393343 10126 hsa-mir-298 hsa04540 Gap junction 5595_5594 2 0.020200472 1 0.024829747 10127 hsa-mir-298 hsa04360 Axon guidance 5595_5594 2 0.037571033 1 0.045238591 10128 hsa-mir-298 hsa04530 Tight junction 1499_71 2 0.040694288 1 0.047690655 10129 hsa-mir-298 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594 2 0.041224126 1 0.047690655 10130 hsa-mir-299 hsa05200 Pathways in cancer 3320_5371_5595_5594_5599_1387_6257_6256_595_5601_836_6258_367_7704_842_6774_5970_8031_4824_6688_4609_3725_841_2353_2736_3065_4088_4089_1050_5925_2033_207_2932_8554 34 1.98E-23 1.41E-21 1.41E-21 10131 hsa-mir-299 hsa04010 MAPK signaling pathway 6722_5595_5594_5599_5603_5601_5600_836_9252_1386_1432_1649_5970_10912_9261_468_4609_3725_3727_6195_6196_2353_8986_4616_6197_207_8550_2002_2005 29 1.60E-20 1.13E-18 5.67E-19 10132 hsa-mir-299 hsa05215 Prostate cancer 3320_10488_5595_5594_1385_1387_595_367_842_5970_4824_468_9586_5925_2033_207_2932 17 2.29E-16 1.63E-14 4.81E-15 10133 hsa-mir-299 hsa05212 Pancreatic cancer 3320_10488_5595_5594_1385_1387_595_367_842_5970_4824_468_9586_5925_2033_207_2932 17 2.71E-16 1.92E-14 4.81E-15 10134 hsa-mir-299 hsa04110 Cell cycle 993_5591_1387_595_983_896_7533_10912_3065_4088_4089_4616_5925_2033_894_2932 16 2.74E-13 1.94E-11 3.89E-12 10135 hsa-mir-299 hsa05210 Colorectal cancer 5595_5594_5599_595_5601_836_842_4609_3725_2353_4088_4089_207_2932 14 6.31E-13 4.48E-11 7.47E-12 10136 hsa-mir-299 hsa04310 Wnt signaling pathway 5599_1387_595_5601_896_8061_4609_3725_815_1457_1459_4088_4089_2033_894_2932 16 8.24E-12 5.85E-10 8.35E-11 10137 hsa-mir-299 hsa05221 Acute myeloid leukemia 5371_5595_5594_595_7704_6774_5970_6688_4609_1050_207 11 6.72E-11 4.77E-09 5.97E-10 10138 hsa-mir-299 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5603_5601_5600_1432_5970_3725_841_2353_207 12 1.10E-09 7.78E-08 8.64E-09 10139 hsa-mir-299 hsa05216 Thyroid cancer 5595_5594_6257_6256_595_6258_8031_4609 8 1.95E-09 1.38E-07 1.28E-08 10140 hsa-mir-299 hsa04912 GnRH signaling pathway 6714_5595_5594_5599_5603_5601_5600_1432_468_3725_815_2002 12 1.99E-09 1.41E-07 1.28E-08 10141 hsa-mir-299 hsa04012 ErbB signaling pathway 6714_5595_5594_5599_5601_4609_3725_815_207_2932_2002 11 2.75E-09 1.95E-07 1.63E-08 10142 hsa-mir-299 hsa05223 Non-small cell lung cancer 5595_5594_6257_6256_595_6258_842_5925_207 9 8.99E-09 6.38E-07 4.67E-08 10143 hsa-mir-299 hsa05220 Chronic myeloid leukemia 5595_5594_595_5970_4609_3065_4088_4089_5925_207 10 9.21E-09 6.54E-07 4.67E-08 10144 hsa-mir-299 hsa04520 Adherens junction 6714_5595_5594_1387_71_1457_1459_4088_4089_2033 10 1.61E-08 1.15E-06 7.64E-08 10145 hsa-mir-299 hsa04660 T cell receptor signaling pathway 5595_5594_5603_5601_5600_1432_5970_3725_2353_207_2932 11 2.58E-08 1.83E-06 1.14E-07 10146 hsa-mir-299 hsa05222 Small cell lung cancer 6257_6256_595_6258_842_5970_4609_5925_207_8554 10 3.03E-08 2.15E-06 1.26E-07 10147 hsa-mir-299 hsa04920 Adipocytokine signaling pathway 10891_5599_6257_6256_5601_6258_6774_5970_207 9 4.85E-08 3.45E-06 1.91E-07 10148 hsa-mir-299 hsa04115 p53 signaling pathway 595_983_836_896_842_10912_841_4616_894 9 6.11E-08 4.34E-06 2.28E-07 10149 hsa-mir-299 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5599_5603_5601_5600_836_1432_5970_3725 9 7.64E-08 5.43E-06 2.71E-07 10150 hsa-mir-299 hsa05016 Huntington's disease 6874_10488_10891_25942_1385_1387_836_842_9586_841_3065_3064_2033 13 8.25E-08 5.86E-06 2.79E-07 10151 hsa-mir-299 hsa05213 Endometrial cancer 5595_5594_595_842_4609_207_2932_2002 8 1.07E-07 7.57E-06 3.44E-07 10152 hsa-mir-299 hsa04720 Long-term potentiation 5595_5594_1387_468_815_6195_6196_6197_2033 9 1.17E-07 8.33E-06 3.62E-07 10153 hsa-mir-299 hsa04370 VEGF signaling pathway 6714_5595_5594_5603_5600_1432_842_9261_207 9 1.44E-07 1.02E-05 4.26E-07 10154 hsa-mir-299 hsa04510 Focal adhesion 6714_5595_5594_5599_595_5601_896_71_3725_894_207_2932_2002 13 2.23E-07 1.58E-05 6.34E-07 10155 hsa-mir-299 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5603_5601_5600_1432_207 8 1.95E-06 0.0001382 5.32E-06 10156 hsa-mir-299 hsa05219 Bladder cancer 5595_5594_595_9252_4609_5925 6 6.40E-06 0.000454549 1.68E-05 10157 hsa-mir-299 hsa04916 Melanogenesis 10488_5595_5594_1385_1387_815_2033_2932 8 1.29E-05 0.000914987 3.27E-05 10158 hsa-mir-299 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725_2353_207_2932 7 1.41E-05 0.001002698 3.46E-05 10159 hsa-mir-299 hsa04150 mTOR signaling pathway 5595_5594_6195_6196_6197_207 6 1.95E-05 0.001383765 4.61E-05 10160 hsa-mir-299 hsa04630 Jak-STAT signaling pathway 1387_595_896_6774_4609_2033_894_207_8554 9 3.10E-05 0.002198581 7.09E-05 10161 hsa-mir-299 hsa04350 TGF-beta signaling pathway 5595_5594_1387_4609_4088_4089_2033 7 3.45E-05 0.002448505 7.65E-05 10162 hsa-mir-299 hsa04210 Apoptosis 836_839_842_840_5970_841_207 7 3.95E-05 0.002805181 8.50E-05 10163 hsa-mir-299 hsa03022 Basal transcription factors 2963_2962_2969_6874_6883 5 4.95E-05 0.003511982 0.000103294 10164 hsa-mir-299 hsa05214 Glioma 5595_5594_595_815_5925_207 6 6.22E-05 0.004412651 0.000126076 10165 hsa-mir-299 hsa04910 Insulin signaling pathway 10891_5595_5594_5599_5601_207_2932_2002 8 8.63E-05 0.006128283 0.00017023 10166 hsa-mir-299 hsa05211 Renal cell carcinoma 5595_5594_1387_3725_2033_207 6 0.000105399 0.007483358 0.000202253 10167 hsa-mir-299 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601_3651 5 0.000115742 0.008217666 0.000216254 10168 hsa-mir-299 hsa04330 Notch signaling pathway 1387_9612_3065_2033_8850 5 0.000139776 0.009924127 0.000254465 10169 hsa-mir-299 hsa05014 Amyotrophic lateral sclerosis (ALS) 5603_5600_836_1432_842 5 0.000298293 0.021178798 0.00052947 10170 hsa-mir-299 hsa05010 Alzheimer's disease 22926_5595_5594_836_842_840_841_2932 8 0.000434417 0.030843626 0.000752284 10171 hsa-mir-299 hsa05218 Melanoma 5595_5594_595_5925_207 5 0.000824445 0.0585356 0.001393705 10172 hsa-mir-299 hsa04612 Antigen processing and presentation 3320_1385_4800_1514_3308 5 0.002131006 0.151301409 0.003518637 10173 hsa-mir-299 hsa04540 Gap junction 6714_5592_5595_5594_983 5 0.002556311 0.181498076 0.004124956 10174 hsa-mir-299 hsa03320 PPAR signaling pathway 6257_6256_6258_2168 4 0.005601077 0.397676441 0.008837254 10175 hsa-mir-299 hsa04530 Tight junction 6714_71_1457_1459_207 5 0.012033724 0.854394406 0.018573791 10176 hsa-mir-299 hsa04062 Chemokine signaling pathway 5595_5594_6774_5970_207_2932 6 0.012613522 0.895560096 0.01905447 10177 hsa-mir-299 hsa04670 Leukocyte transendothelial migration 5603_5600_1432_71 4 0.033242411 1 0.049171066 10178 hsa-mir-299 hsa04730 Long-term depression 5592_5595_5594 3 0.034219304 1 0.049583073 10179 hsa-mir-299 hsa04120 Ubiquitin mediated proteolysis 5371_672_7329_8554 4 0.049029866 1 0.069622409 10180 hsa-mir-29a hsa05200 Pathways in cancer 4087_4088_3320_2033_8554_4609 6 1.38E-06 4.82E-05 2.54E-05 10181 hsa-mir-29a hsa04520 Adherens junction 71_4087_4088_2033 4 1.93E-06 6.75E-05 2.54E-05 10182 hsa-mir-29a hsa04350 TGF-beta signaling pathway 4087_4088_2033_4609 4 2.66E-06 9.30E-05 2.54E-05 10183 hsa-mir-29a hsa04612 Antigen processing and presentation 3320_3308_4800_4801 4 2.90E-06 0.000101473 2.54E-05 10184 hsa-mir-29a hsa04310 Wnt signaling pathway 4087_4088_2033_4609 4 2.25E-05 0.000787151 0.00015743 10185 hsa-mir-29a hsa05210 Colorectal cancer 4087_4088_4609 3 0.000109597 0.003835912 0.000639319 10186 hsa-mir-29a hsa04110 Cell cycle 4087_4088_2033 3 0.000297647 0.010417648 0.001488235 10187 hsa-mir-29a hsa04630 Jak-STAT signaling pathway 2033_8554_4609 3 0.000633524 0.022173346 0.002771668 10188 hsa-mir-29a hsa03022 Basal transcription factors 6908_2959 2 0.00079521 0.027832339 0.003092482 10189 hsa-mir-29a hsa05220 Chronic myeloid leukemia 4088_4609 2 0.003061815 0.107163521 0.010716352 10190 hsa-mir-29a hsa05222 Small cell lung cancer 8554_4609 2 0.003976572 0.139180032 0.011430152 10191 hsa-mir-29a hsa05215 Prostate cancer 3320_2033 2 0.004154931 0.14542257 0.011430152 10192 hsa-mir-29a hsa05212 Pancreatic cancer 3320_2033 2 0.004245485 0.14859198 0.011430152 10193 hsa-mir-29a hsa05016 Huntington's disease 6908_2033 2 0.017436156 0.610265469 0.043590391 10194 hsa-mir-29a hsa05216 Thyroid cancer 4609 1 0.031491874 1 0.073481039 10195 hsa-mir-29a hsa05219 Bladder cancer 4609 1 0.044838005 1 0.094381384 10196 hsa-mir-29a hsa04330 Notch signaling pathway 2033 1 0.049923545 1 0.094381384 10197 hsa-mir-29c hsa05211 Renal cell carcinoma 9915_2034_2033_3091 4 6.36E-07 1.15E-05 1.15E-05 10198 hsa-mir-29c hsa05200 Pathways in cancer 9915_5371_2034_2033_3091 5 1.14E-05 0.000205052 0.000102526 10199 hsa-mir-29c hsa04330 Notch signaling pathway 9612_2033 2 0.000892099 0.016057782 0.005352594 10200 hsa-mir-29c hsa04520 Adherens junction 2033_1457 2 0.002473657 0.044525826 0.010460059 10201 hsa-mir-29c hsa04350 TGF-beta signaling pathway 2033_4093 2 0.002905572 0.052300293 0.010460059 10202 hsa-mir-29c hsa04120 Ubiquitin mediated proteolysis 5371_7329 2 0.007115914 0.128086445 0.021347741 10203 hsa-mir-29c hsa04310 Wnt signaling pathway 2033_1457 2 0.008432989 0.151793802 0.021684829 10204 hsa-mir-29c hsa03022 Basal transcription factors 2963 1 0.033627306 0.605291512 0.075661439 10205 hsa-mir-29c hsa04150 mTOR signaling pathway 3091 1 0.046599202 0.838785631 0.093198403 10206 hsa-mir-300 hsa04110 Cell cycle 4174_5591_1387_10971_7534_1017_7533_7532_5001_1026_4172_4173_1029_898_4998_4999 16 1.73E-20 1.07E-18 1.07E-18 10207 hsa-mir-300 hsa05200 Pathways in cancer 3320_5371_6258_1387_6256_836_1017_842_841_5970_4824_1026_1029_898_8554 15 1.02E-12 6.31E-11 3.16E-11 10208 hsa-mir-300 hsa05215 Prostate cancer 3320_1385_1387_1017_842_5970_4824_1026_898 9 5.01E-11 3.11E-09 8.53E-10 10209 hsa-mir-300 hsa05212 Pancreatic cancer 3320_1385_1387_1017_842_5970_4824_1026_898 9 5.50E-11 3.41E-09 8.53E-10 10210 hsa-mir-300 hsa04115 p53 signaling pathway 836_1017_842_841_1026_1029_898 7 8.04E-09 4.99E-07 9.97E-08 10211 hsa-mir-300 hsa05222 Small cell lung cancer 6258_6256_1017_842_5970_898_8554 7 3.32E-08 2.06E-06 3.43E-07 10212 hsa-mir-300 hsa04210 Apoptosis 836_839_842_841_840_5970 6 9.41E-07 5.83E-05 8.33E-06 10213 hsa-mir-300 hsa05010 Alzheimer's disease 22926_836_842_841_840_4697 6 4.08E-05 0.002528801 0.0003161 10214 hsa-mir-300 hsa05223 Non-small cell lung cancer 6258_6256_842_1029 4 4.76E-05 0.002949759 0.000318087 10215 hsa-mir-300 hsa04010 MAPK signaling pathway 9261_836_1432_5970_6195_2002_2005 7 5.17E-05 0.003206819 0.000318087 10216 hsa-mir-300 hsa05016 Huntington's disease 1385_1387_836_842_841_4697 6 5.64E-05 0.00349896 0.000318087 10217 hsa-mir-300 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_836_1432_5970 4 0.000130358 0.008082224 0.000673519 10218 hsa-mir-300 hsa04720 Long-term potentiation 815_1387_5499_6195 4 0.000159466 0.009886891 0.00076053 10219 hsa-mir-300 hsa04370 VEGF signaling pathway 6714_9261_1432_842 4 0.000175657 0.01089072 0.000777909 10220 hsa-mir-300 hsa04520 Adherens junction 6714_1387_71_1457 4 0.000202122 0.01253159 0.000835439 10221 hsa-mir-300 hsa04012 ErbB signaling pathway 815_6714_1026_2002 4 0.000274892 0.017043292 0.001065206 10222 hsa-mir-300 hsa04612 Antigen processing and presentation 3320_1385_3308_4800 4 0.000298737 0.018521673 0.00108951 10223 hsa-mir-300 hsa03030 DNA replication 4174_4172_4173 3 0.000325059 0.02015368 0.001119649 10224 hsa-mir-300 hsa04912 GnRH signaling pathway 815_6714_1432_2002 4 0.000604695 0.037491089 0.001973215 10225 hsa-mir-300 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432_842 3 0.00110037 0.068222937 0.003101043 10226 hsa-mir-300 hsa05131 Shigellosis 10971_7534_71 3 0.00110037 0.068222937 0.003101043 10227 hsa-mir-300 hsa05130 Pathogenic Escherichia coli infection 10971_7534_71 3 0.00110037 0.068222937 0.003101043 10228 hsa-mir-300 hsa05214 Glioma 815_1026_1029 3 0.001658991 0.102857472 0.004472064 10229 hsa-mir-300 hsa04920 Adipocytokine signaling pathway 6258_6256_5970 3 0.001803126 0.111793793 0.004658075 10230 hsa-mir-300 hsa04310 Wnt signaling pathway 815_1387_1457_1452 4 0.002060946 0.12777866 0.005111146 10231 hsa-mir-300 hsa05220 Chronic myeloid leukemia 5970_1026_1029 3 0.002456909 0.152328368 0.005858783 10232 hsa-mir-300 hsa05216 Thyroid cancer 6258_6256 2 0.005053384 0.313309782 0.011604066 10233 hsa-mir-300 hsa04620 Toll-like receptor signaling pathway 1432_841_5970 3 0.005664606 0.351205588 0.012334589 10234 hsa-mir-300 hsa04510 Focal adhesion 6714_5499_71_2002 4 0.005942821 0.368454915 0.012334589 10235 hsa-mir-300 hsa04916 Melanogenesis 815_1385_1387 3 0.00596835 0.37003768 0.012334589 10236 hsa-mir-300 hsa03022 Basal transcription factors 2962_2969 2 0.007911016 0.490482979 0.015822032 10237 hsa-mir-300 hsa05219 Bladder cancer 1026_1029 2 0.009988296 0.619274331 0.019352323 10238 hsa-mir-300 hsa05012 Parkinson's disease 836_842_4697 3 0.012176634 0.754951302 0.021988554 10239 hsa-mir-300 hsa04330 Notch signaling pathway 1387_9612 2 0.012280051 0.761363135 0.021988554 10240 hsa-mir-300 hsa04530 Tight junction 6714_71_1457 3 0.012412893 0.769599388 0.021988554 10241 hsa-mir-300 hsa05213 Endometrial cancer 842_2002 2 0.014778537 0.916269282 0.025451924 10242 hsa-mir-300 hsa05221 Acute myeloid leukemia 5371_5970 2 0.018609394 1 0.031183308 10243 hsa-mir-300 hsa03320 PPAR signaling pathway 6258_6256 2 0.025370098 1 0.041376994 10244 hsa-mir-300 hsa05218 Melanoma 1026_1029 2 0.026027464 1 0.041376994 10245 hsa-mir-300 hsa05210 Colorectal cancer 836_842 2 0.035180753 1 0.054530167 10246 hsa-mir-301a hsa05210 Colorectal cancer 4087_4088_4609 3 1.95E-06 3.32E-05 1.84E-05 10247 hsa-mir-301a hsa04350 TGF-beta signaling pathway 4087_4088_4609 3 2.16E-06 3.68E-05 1.84E-05 10248 hsa-mir-301a hsa04310 Wnt signaling pathway 4087_4088_4609 3 1.11E-05 0.000188646 6.29E-05 10249 hsa-mir-301a hsa05200 Pathways in cancer 4087_4088_4609 3 0.000110184 0.00187313 0.000468282 10250 hsa-mir-301a hsa05220 Chronic myeloid leukemia 4088_4609 2 0.000231234 0.003930974 0.000743029 10251 hsa-mir-301a hsa04520 Adherens junction 4087_4088 2 0.000262245 0.004458172 0.000743029 10252 hsa-mir-301a hsa04612 Antigen processing and presentation 4800_4801 2 0.000322912 0.005489511 0.000784216 10253 hsa-mir-301a hsa04110 Cell cycle 4087_4088 2 0.000569823 0.00968699 0.001210874 10254 hsa-mir-301a hsa05216 Thyroid cancer 4609 1 0.008962596 0.152364134 0.016929348 10255 hsa-mir-301a hsa05219 Bladder cancer 4609 1 0.012824162 0.218010751 0.021801075 10256 hsa-mir-301a hsa05213 Endometrial cancer 4609 1 0.01578549 0.268353325 0.024395757 10257 hsa-mir-301a hsa05221 Acute myeloid leukemia 4609 1 0.017853718 0.303513211 0.025292768 10258 hsa-mir-301a hsa05222 Small cell lung cancer 4609 1 0.025795031 0.43851552 0.031678351 10259 hsa-mir-301a hsa04012 ErbB signaling pathway 4609 1 0.026088054 0.443496917 0.031678351 10260 hsa-mir-301a hsa04630 Jak-STAT signaling pathway 4609 1 0.0458308 0.779123593 0.051941573 10261 hsa-mir-301b hsa05210 Colorectal cancer 4087_4088_4089_836_4609 5 1.57E-08 6.11E-07 3.61E-07 10262 hsa-mir-301b hsa04350 TGF-beta signaling pathway 4087_4088_4089_2033_4609 5 1.85E-08 7.22E-07 3.61E-07 10263 hsa-mir-301b hsa04310 Wnt signaling pathway 4087_4088_4089_2033_4609 5 2.70E-07 1.05E-05 3.51E-06 10264 hsa-mir-301b hsa05200 Pathways in cancer 4087_4088_4089_836_2033_4609 6 4.72E-07 1.84E-05 4.60E-06 10265 hsa-mir-301b hsa04520 Adherens junction 4087_4088_4089_2033 4 9.52E-07 3.71E-05 7.43E-06 10266 hsa-mir-301b hsa04110 Cell cycle 4087_4088_4089_2033 4 4.37E-06 0.000170579 2.84E-05 10267 hsa-mir-301b hsa05010 Alzheimer's disease 836_22926_1020_840 4 2.01E-05 0.000784281 0.00011204 10268 hsa-mir-301b hsa05220 Chronic myeloid leukemia 4088_4089_4609 3 4.72E-05 0.001838964 0.000229871 10269 hsa-mir-301b hsa04010 MAPK signaling pathway 836_4609_1432_5598 4 0.000105217 0.004103469 0.000455941 10270 hsa-mir-301b hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432 2 0.001247709 0.048660647 0.004866065 10271 hsa-mir-301b hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_1432 2 0.001967247 0.076722635 0.006974785 10272 hsa-mir-301b hsa04612 Antigen processing and presentation 4800_4801 2 0.003035026 0.118366026 0.009105079 10273 hsa-mir-301b hsa04210 Apoptosis 836_840 2 0.003035026 0.118366026 0.009105079 10274 hsa-mir-301b hsa04912 GnRH signaling pathway 1432_5598 2 0.004396796 0.171475058 0.012248218 10275 hsa-mir-301b hsa04630 Jak-STAT signaling pathway 2033_4609 2 0.008751354 0.34130281 0.022753521 10276 hsa-mir-301b hsa05016 Huntington's disease 836_2033 2 0.012600013 0.491400493 0.030712531 10277 hsa-mir-301b hsa05216 Thyroid cancer 4609 1 0.026639638 1 0.061114465 10278 hsa-mir-301b hsa05219 Bladder cancer 4609 1 0.037970041 1 0.082268423 10279 hsa-mir-301b hsa04330 Notch signaling pathway 2033 1 0.04229398 1 0.08681396 10280 hsa-mir-301b hsa05213 Endometrial cancer 4609 1 0.046599202 1 0.090868443 10281 hsa-mir-302e hsa04110 Cell cycle 1017_7532_4174_5001_898_1026_4172_4173_1029_4998_4999 11 2.10E-19 4.42E-18 4.42E-18 10282 hsa-mir-302e hsa04115 p53 signaling pathway 1017_898_1026_1029 4 7.29E-07 1.53E-05 7.65E-06 10283 hsa-mir-302e hsa03030 DNA replication 4174_4172_4173 3 7.23E-06 0.000151811 5.06E-05 10284 hsa-mir-302e hsa05215 Prostate cancer 1017_898_1026 3 9.29E-05 0.001951069 0.000403106 10285 hsa-mir-302e hsa05212 Pancreatic cancer 1017_898_1026 3 9.60E-05 0.002015528 0.000403106 10286 hsa-mir-302e hsa05200 Pathways in cancer 1017_898_1026_1029 4 0.000293168 0.006156518 0.001026086 10287 hsa-mir-302e hsa05219 Bladder cancer 1026_1029 2 0.000830718 0.017445073 0.002492153 10288 hsa-mir-302e hsa05214 Glioma 1026_1029 2 0.001915038 0.040215803 0.005026975 10289 hsa-mir-302e hsa05218 Melanoma 1026_1029 2 0.002268072 0.047629517 0.005290385 10290 hsa-mir-302e hsa05220 Chronic myeloid leukemia 1026_1029 2 0.002519231 0.05290385 0.005290385 10291 hsa-mir-302e hsa05222 Small cell lung cancer 1017_898 2 0.003274256 0.068759368 0.006250852 10292 hsa-mir-3065 hsa05200 Pathways in cancer 4088_2113_1871_7157_1869_1870_8031_1050_4149_5925_1017_4089_2033_8554_5970_5594_5599_861_6258_1387_6257_6256 22 9.67E-26 5.03E-24 5.03E-24 10293 hsa-mir-3065 hsa04110 Cell cycle 890_4088_1871_7157_1869_1870_4616_5925_5934_10912_1017_4089_2033_5933_1387 15 1.42E-21 7.38E-20 3.69E-20 10294 hsa-mir-3065 hsa05222 Small cell lung cancer 1871_7157_1869_1870_4149_5925_1017_8554_5970_6258_6257_6256 12 6.51E-18 3.39E-16 1.13E-16 10295 hsa-mir-3065 hsa04350 TGF-beta signaling pathway 4088_1874_1875_5934_4089_2033_3399_5594_3398_5933_1387 11 4.56E-16 2.37E-14 5.93E-15 10296 hsa-mir-3065 hsa05220 Chronic myeloid leukemia 4088_1871_7157_1869_1870_5925_4089_5970_5594_861 10 6.51E-15 3.39E-13 6.77E-14 10297 hsa-mir-3065 hsa05223 Non-small cell lung cancer 1871_7157_1869_1870_5925_5594_6258_6257_6256 9 2.52E-14 1.31E-12 2.05E-13 10298 hsa-mir-3065 hsa05215 Prostate cancer 1871_7157_1869_1870_5925_1017_2033_5970_5594_1387 10 2.85E-14 1.48E-12 2.05E-13 10299 hsa-mir-3065 hsa05212 Pancreatic cancer 1871_7157_1869_1870_5925_1017_2033_5970_5594_1387 10 3.16E-14 1.64E-12 2.05E-13 10300 hsa-mir-3065 hsa05216 Thyroid cancer 7157_8031_5594_6258_6257_6256 6 1.97E-10 1.02E-08 1.14E-09 10301 hsa-mir-3065 hsa05219 Bladder cancer 1871_7157_1869_1870_5925_5594 6 1.45E-09 7.55E-08 7.55E-09 10302 hsa-mir-3065 hsa05214 Glioma 1871_7157_1869_1870_5925_5594 6 1.63E-08 8.45E-07 7.68E-08 10303 hsa-mir-3065 hsa04920 Adipocytokine signaling pathway 10891_5970_5599_6258_6257_6256 6 1.92E-08 1.00E-06 8.34E-08 10304 hsa-mir-3065 hsa05218 Melanoma 1871_7157_1869_1870_5925_5594 6 2.66E-08 1.38E-06 1.06E-07 10305 hsa-mir-3065 hsa04010 MAPK signaling pathway 7157_4616_4149_1616_10912_5970_5594_5599 8 3.01E-07 1.57E-05 1.12E-06 10306 hsa-mir-3065 hsa04520 Adherens junction 4088_4089_2033_5594_1387 5 1.68E-06 8.73E-05 5.82E-06 10307 hsa-mir-3065 hsa04310 Wnt signaling pathway 4088_7157_4089_2033_5599_1387 6 1.90E-06 9.88E-05 6.18E-06 10308 hsa-mir-3065 hsa05210 Colorectal cancer 4088_7157_4089_5594_5599 5 2.11E-06 0.000109639 6.45E-06 10309 hsa-mir-3065 hsa05221 Acute myeloid leukemia 1050_5970_5594_861 4 1.45E-05 0.000751817 4.18E-05 10310 hsa-mir-3065 hsa04115 p53 signaling pathway 7157_4616_10912_1017 4 2.60E-05 0.001349894 7.10E-05 10311 hsa-mir-3065 hsa03320 PPAR signaling pathway 6258_2168_6257_6256 4 2.74E-05 0.001424533 7.12E-05 10312 hsa-mir-3065 hsa05211 Renal cell carcinoma 2113_2033_5594_1387 4 3.04E-05 0.001582832 7.54E-05 10313 hsa-mir-3065 hsa05016 Huntington's disease 7157_10891_2033_6908_1387 5 8.92E-05 0.004640749 0.000210943 10314 hsa-mir-3065 hsa04330 Notch signaling pathway 9612_2033_1387 3 0.000218917 0.011383709 0.000494944 10315 hsa-mir-3065 hsa04720 Long-term potentiation 2033_5594_1387 3 0.000811033 0.042173739 0.001757239 10316 hsa-mir-3065 hsa04620 Toll-like receptor signaling pathway 5970_5594_5599 3 0.001910896 0.099366613 0.003974665 10317 hsa-mir-3065 hsa04916 Melanogenesis 2033_5594_1387 3 0.002016585 0.104862401 0.004033169 10318 hsa-mir-3065 hsa04910 Insulin signaling pathway 10891_5594_5599 3 0.004392017 0.228384872 0.008458699 10319 hsa-mir-3065 hsa04930 Type II diabetes mellitus 5594_5599 2 0.005396846 0.280635988 0.010022714 10320 hsa-mir-3065 hsa04630 Jak-STAT signaling pathway 2033_8554_1387 3 0.006022749 0.313182929 0.010799411 10321 hsa-mir-3065 hsa05213 Endometrial cancer 7157_5594 2 0.007069741 0.367626545 0.012254218 10322 hsa-mir-3065 hsa05014 Amyotrophic lateral sclerosis (ALS) 7157_1616 2 0.00811781 0.422126144 0.013616972 10323 hsa-mir-3065 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_5599 2 0.012620172 0.656248948 0.02050778 10324 hsa-mir-3065 hsa04662 B cell receptor signaling pathway 5970_5594 2 0.013967697 0.726320254 0.022009705 10325 hsa-mir-3065 hsa04664 Fc epsilon RI signaling pathway 5594_5599 2 0.015374743 0.799486612 0.023514312 10326 hsa-mir-3065 hsa04012 ErbB signaling pathway 5594_5599 2 0.018362659 0.95485829 0.027281665 10327 hsa-mir-3065 hsa04210 Apoptosis 7157_5970 2 0.019145003 0.995540142 0.027653893 10328 hsa-mir-3065 hsa04912 GnRH signaling pathway 5594_5599 2 0.027248656 1 0.038295408 10329 hsa-mir-3065 hsa04660 T cell receptor signaling pathway 5970_5594 2 0.028169572 1 0.038547835 10330 hsa-mir-30a hsa03022 Basal transcription factors 2967_2961_2963_6881_54457_2968_6879_6878_6877_6874_2960_138474_6908_6873_2958_6872_6884_2959_6880_6882_2957_6883 22 5.97E-28 4.18E-26 2.31E-26 10331 hsa-mir-30a hsa05200 Pathways in cancer 1147_5925_3551_2249_367_1499_5595_5594_5599_5914_1387_6257_6256_8031_10401_1487_1488_6258_2932_4193_7704_6774_6776_6777_7184_5970_7157_6688_4609_3725_2353_4087_4088_4089_5881_1050_2033_207_3326_5601_8554 41 6.60E-28 4.62E-26 2.31E-26 10332 hsa-mir-30a hsa05215 Prostate cancer 1147_5925_3551_367_1499_5595_5594_1387_2932_4193_7184_5970_7157_2033_207_3326_90993 17 4.35E-15 3.05E-13 8.97E-14 10333 hsa-mir-30a hsa05212 Pancreatic cancer 1147_5925_3551_367_1499_5595_5594_1387_2932_4193_7184_5970_7157_2033_207_3326_90993 17 5.13E-15 3.59E-13 8.97E-14 10334 hsa-mir-30a hsa05220 Chronic myeloid leukemia 1147_5925_3551_5595_5594_1487_1488_4193_6776_6777_5970_7157_4609_4088_4089_207 16 7.25E-15 5.07E-13 1.01E-13 10335 hsa-mir-30a hsa05221 Acute myeloid leukemia 1147_3551_5595_5594_5914_7704_6774_6776_6777_5970_6688_4609_1050_207 14 1.01E-13 7.08E-12 1.18E-12 10336 hsa-mir-30a hsa05210 Colorectal cancer 1499_5595_5594_5599_2932_7157_4609_3725_2353_4087_4088_4089_5881_207_5601 15 4.99E-13 3.50E-11 4.99E-12 10337 hsa-mir-30a hsa04310 Wnt signaling pathway 1460_1499_5599_1387_1487_1488_2932_7157_8061_4609_3725_4087_4088_4089_5881_2033_5601_8607 18 1.29E-12 9.02E-11 1.13E-11 10338 hsa-mir-30a hsa04010 MAPK signaling pathway 1147_3551_2249_3727_5595_5594_5599_1386_1649_3312_5970_7157_10912_4609_3725_2353_5881_5058_4616_207_5601 21 3.49E-11 2.44E-09 2.71E-10 10339 hsa-mir-30a hsa04110 Cell cycle 5925_4171_1387_7534_7532_2932_4193_7157_10912_4085_4087_4088_4089_2033_4616 15 4.42E-11 3.09E-09 3.09E-10 10340 hsa-mir-30a hsa04920 Adipocytokine signaling pathway 1147_3551_10891_5599_6257_6256_6258_6774_5970_207_5601_2538 12 1.07E-10 7.46E-09 6.78E-10 10341 hsa-mir-30a hsa05216 Thyroid cancer 1499_5595_5594_6257_6256_8031_6258_7157_4609 9 3.67E-10 2.57E-08 2.14E-09 10342 hsa-mir-30a hsa05222 Small cell lung cancer 1147_5925_3551_6257_6256_10401_6258_5970_7157_4609_207_8554 12 1.39E-09 9.74E-08 7.49E-09 10343 hsa-mir-30a hsa04012 ErbB signaling pathway 6714_5595_5594_5599_2932_6776_6777_4609_3725_5058_207_5601 12 1.57E-09 1.10E-07 7.84E-09 10344 hsa-mir-30a hsa04520 Adherens junction 1460_1499_6714_5595_5594_1387_4087_4088_4089_5881_2033 11 7.81E-09 5.47E-07 3.65E-08 10345 hsa-mir-30a hsa04662 B cell receptor signaling pathway 1147_3551_5595_5594_2932_5970_3725_2353_5881_207 10 4.91E-08 3.44E-06 2.15E-07 10346 hsa-mir-30a hsa04660 T cell receptor signaling pathway 1147_3551_5595_5594_2932_5970_3725_2353_5058_207_5601 11 1.55E-07 1.09E-05 6.40E-07 10347 hsa-mir-30a hsa04350 TGF-beta signaling pathway 6667_5595_5594_1387_659_4609_4087_4088_4089_2033 10 1.75E-07 1.22E-05 6.80E-07 10348 hsa-mir-30a hsa05223 Non-small cell lung cancer 5925_5595_5594_6257_6256_6258_7157_207 8 5.33E-07 3.73E-05 1.96E-06 10349 hsa-mir-30a hsa04620 Toll-like receptor signaling pathway 1147_3551_5595_5594_5599_5970_3725_2353_207_5601 10 6.77E-07 4.74E-05 2.37E-06 10350 hsa-mir-30a hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_3551_6714_5599_5970_3725_5058_5601 8 3.47E-06 0.000243034 1.16E-05 10351 hsa-mir-30a hsa05213 Endometrial cancer 1499_5595_5594_2932_7157_4609_207 7 4.93E-06 0.000344837 1.57E-05 10352 hsa-mir-30a hsa04910 Insulin signaling pathway 3551_10891_5595_5594_5599_2932_5211_207_5601_2538 10 8.47E-06 0.000593157 2.58E-05 10353 hsa-mir-30a hsa05219 Bladder cancer 5925_5595_5594_4193_7157_4609 6 1.75E-05 0.001226601 5.11E-05 10354 hsa-mir-30a hsa05016 Huntington's disease 6667_6874_10891_3064_1387_6908_9001_5430_7157_2033_90993 11 2.02E-05 0.001416835 5.67E-05 10355 hsa-mir-30a hsa04630 Jak-STAT signaling pathway 1387_10401_6774_6776_6777_4609_2033_3977_207_8554 10 2.19E-05 0.001532346 5.89E-05 10356 hsa-mir-30a hsa04330 Notch signaling pathway 1387_1487_1488_9612_2033_8850 6 3.12E-05 0.002187154 7.92E-05 10357 hsa-mir-30a hsa05218 Melanoma 5925_2249_5595_5594_4193_7157_207 7 3.17E-05 0.002217984 7.92E-05 10358 hsa-mir-30a hsa05211 Renal cell carcinoma 5595_5594_1387_3725_5058_2033_207 7 3.44E-05 0.002409993 8.31E-05 10359 hsa-mir-30a hsa04510 Focal adhesion 1499_6714_5595_5594_5599_2932_3725_5881_5058_207_5601 11 4.48E-05 0.003135873 0.000104529 10360 hsa-mir-30a hsa04062 Chemokine signaling pathway 1147_3551_5595_5594_2932_6774_6777_5970_5058_207 10 0.000125263 0.008768381 0.000282851 10361 hsa-mir-30a hsa05214 Glioma 5925_5595_5594_4193_7157_207 6 0.000164046 0.011483248 0.000358851 10362 hsa-mir-30a hsa04930 Type II diabetes mellitus 3551_5595_5594_5599_5601 5 0.000263821 0.018467488 0.000559621 10363 hsa-mir-30a hsa04950 Maturity onset diabetes of the young 6928_6927_3172_5080 4 0.000276908 0.019383527 0.000570104 10364 hsa-mir-30a hsa04916 Melanogenesis 1499_5595_5594_1387_2932_2033_90993 7 0.000295446 0.020681229 0.000590892 10365 hsa-mir-30a hsa03050 Proteasome 5705_5701_5702_5719_5710 5 0.000347465 0.024322584 0.000675627 10366 hsa-mir-30a hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5881_207_5601 6 0.000438268 0.030678736 0.000829155 10367 hsa-mir-30a hsa04120 Ubiquitin mediated proteolysis 11059_672_4734_10401_4193_64326_8554 7 0.001503072 0.10521503 0.002768817 10368 hsa-mir-30a hsa04115 p53 signaling pathway 4193_7157_10912_64326_4616 5 0.001604609 0.11232263 0.002880067 10369 hsa-mir-30a hsa03320 PPAR signaling pathway 10062_6257_6256_6258_2168 5 0.001703368 0.119235727 0.002980893 10370 hsa-mir-30a hsa04912 GnRH signaling pathway 6714_5595_5594_5599_3725_5601 6 0.00202863 0.142004097 0.003463515 10371 hsa-mir-30a hsa03420 Nucleotide excision repair 2967_2968_5887_4331 4 0.002199255 0.153947832 0.003665425 10372 hsa-mir-30a hsa04370 VEGF signaling pathway 6714_5595_5594_5881_207 5 0.002523925 0.176674731 0.004108715 10373 hsa-mir-30a hsa04210 Apoptosis 1147_3551_5970_7157_207 5 0.004545178 0.318162433 0.007230964 10374 hsa-mir-30a hsa04720 Long-term potentiation 5595_5594_1387_2033 4 0.012894957 0.902646996 0.020058822 10375 hsa-mir-30a hsa04360 Axon guidance 5595_5594_2932_5881_5058 5 0.020292534 1 0.030879943 10376 hsa-mir-30a hsa04612 Antigen processing and presentation 4800_3312_4801_3326 4 0.022154354 1 0.032995847 10377 hsa-mir-30a hsa04150 mTOR signaling pathway 5595_5594_207 3 0.025104668 1 0.036264232 10378 hsa-mir-30a hsa04540 Gap junction 6714_5595_5594_10382 4 0.025384962 1 0.036264232 10379 hsa-mir-30a hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.028802402 1 0.040323363 10380 hsa-mir-30a hsa05131 Shigellosis 1499_10382_7534 3 0.030095561 1 0.040513256 10381 hsa-mir-30a hsa05130 Pathogenic Escherichia coli infection 1499_10382_7534 3 0.030095561 1 0.040513256 10382 hsa-mir-30c-1 hsa05200 Pathways in cancer 5371_5595_5594_6256_595_4286_367_5914_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_4088_4089_3066_3065_5925_2034_2033_4846_836 29 4.64E-33 2.87E-31 2.87E-31 10383 hsa-mir-30c-1 hsa05220 Chronic myeloid leukemia 5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464 15 3.09E-22 1.91E-20 9.57E-21 10384 hsa-mir-30c-1 hsa04110 Cell cycle 5591_595_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933 14 6.94E-18 4.30E-16 1.43E-16 10385 hsa-mir-30c-1 hsa05215 Prostate cancer 5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033 11 1.52E-14 9.42E-13 2.11E-13 10386 hsa-mir-30c-1 hsa05212 Pancreatic cancer 5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033 11 1.70E-14 1.06E-12 2.11E-13 10387 hsa-mir-30c-1 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5925 9 5.22E-14 3.24E-12 5.39E-13 10388 hsa-mir-30c-1 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925 9 3.94E-13 2.44E-11 3.05E-12 10389 hsa-mir-30c-1 hsa05210 Colorectal cancer 5595_5594_595_7157_4087_4609_3725_4088_4089_836 10 3.94E-13 2.44E-11 3.05E-12 10390 hsa-mir-30c-1 hsa05222 Small cell lung cancer 6256_595_5970_1870_1871_7157_4609_1869_5925_4846 10 4.89E-13 3.03E-11 3.37E-12 10391 hsa-mir-30c-1 hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_6464 9 1.79E-12 1.11E-10 1.11E-11 10392 hsa-mir-30c-1 hsa05218 Melanoma 5595_5594_595_4286_1870_1871_7157_1869_5925 9 3.69E-12 2.29E-10 2.08E-11 10393 hsa-mir-30c-1 hsa05221 Acute myeloid leukemia 5371_5595_5594_595_5914_7704_5970_4609 8 3.75E-11 2.32E-09 1.94E-10 10394 hsa-mir-30c-1 hsa05211 Renal cell carcinoma 5595_5594_3091_7428_2113_3725_2034_2033 8 1.61E-10 9.99E-09 7.69E-10 10395 hsa-mir-30c-1 hsa04350 TGF-beta signaling pathway 5595_5594_4087_4609_4088_4089_2033_5933 8 6.51E-10 4.03E-08 2.88E-09 10396 hsa-mir-30c-1 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 1.19E-09 7.39E-08 4.93E-09 10397 hsa-mir-30c-1 hsa04310 Wnt signaling pathway 595_7157_4087_4609_3725_1457_4088_4089_2033 9 2.07E-09 1.28E-07 8.01E-09 10398 hsa-mir-30c-1 hsa04520 Adherens junction 5595_5594_4087_1457_4088_4089_2033 7 1.10E-08 6.83E-07 4.02E-08 10399 hsa-mir-30c-1 hsa04010 MAPK signaling pathway 5595_5594_4208_3312_5970_7157_4609_3725_4763_836 10 2.08E-08 1.29E-06 7.17E-08 10400 hsa-mir-30c-1 hsa05016 Huntington's disease 6874_2902_7157_3066_3065_3064_2033_836 8 1.93E-07 1.20E-05 6.31E-07 10401 hsa-mir-30c-1 hsa05213 Endometrial cancer 5595_5594_595_7157_4609 5 9.83E-07 6.10E-05 3.05E-06 10402 hsa-mir-30c-1 hsa04012 ErbB signaling pathway 5595_5594_4609_3725_6464 5 1.06E-05 0.000656913 3.13E-05 10403 hsa-mir-30c-1 hsa04330 Notch signaling pathway 9612_3066_3065_2033 4 1.99E-05 0.001235796 5.62E-05 10404 hsa-mir-30c-1 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_7157_4846_836 4 3.81E-05 0.00236019 0.000102617 10405 hsa-mir-30c-1 hsa04720 Long-term potentiation 5595_5594_2902_2033 4 0.000112099 0.006950151 0.000278006 10406 hsa-mir-30c-1 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725 4 0.000112099 0.006950151 0.000278006 10407 hsa-mir-30c-1 hsa05010 Alzheimer's disease 5595_5594_2902_4846_836 5 0.000272005 0.016864338 0.000648628 10408 hsa-mir-30c-1 hsa04620 Toll-like receptor signaling pathway 5595_5594_5970_3725 4 0.000347565 0.021549049 0.000798113 10409 hsa-mir-30c-1 hsa04916 Melanogenesis 5595_5594_4286_2033 4 0.000373172 0.023136643 0.000826309 10410 hsa-mir-30c-1 hsa04660 T cell receptor signaling pathway 5595_5594_5970_3725 4 0.000458077 0.028400745 0.000979336 10411 hsa-mir-30c-1 hsa04510 Focal adhesion 5595_5594_595_3725_6464 5 0.000534758 0.033154988 0.001105166 10412 hsa-mir-30c-1 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.000688286 0.042673748 0.001376573 10413 hsa-mir-30c-1 hsa04910 Insulin signaling pathway 6720_5595_5594_6464 4 0.001042813 0.064654432 0.001959225 10414 hsa-mir-30c-1 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_6464 4 0.001042813 0.064654432 0.001959225 10415 hsa-mir-30c-1 hsa04115 p53 signaling pathway 595_7157_836 3 0.001505878 0.093364444 0.002746013 10416 hsa-mir-30c-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_3725_836 3 0.001629421 0.101024104 0.002806225 10417 hsa-mir-30c-1 hsa04730 Long-term depression 5595_5594_4846 3 0.001629421 0.101024104 0.002806225 10418 hsa-mir-30c-1 hsa04370 VEGF signaling pathway 5595_5594_4846 3 0.002037497 0.126324804 0.003414184 10419 hsa-mir-30c-1 hsa04612 Antigen processing and presentation 4800_4801_3312 3 0.003031441 0.18794936 0.004819214 10420 hsa-mir-30c-1 hsa04210 Apoptosis 5970_7157_836 3 0.003031441 0.18794936 0.004819214 10421 hsa-mir-30c-1 hsa04062 Chemokine signaling pathway 5595_5594_5970_6464 4 0.003432618 0.212822338 0.005320558 10422 hsa-mir-30c-1 hsa04912 GnRH signaling pathway 5595_5594_3725 3 0.005131225 0.318135948 0.007759413 10423 hsa-mir-30c-1 hsa04930 Type II diabetes mellitus 5595_5594 2 0.009524046 0.590490858 0.014059306 10424 hsa-mir-30c-1 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428 3 0.010084082 0.625213079 0.014539839 10425 hsa-mir-30c-1 hsa04630 Jak-STAT signaling pathway 595_4609_2033 3 0.01343412 0.832915445 0.018929896 10426 hsa-mir-30c-1 hsa04920 Adipocytokine signaling pathway 6256_5970 2 0.019773498 1 0.027243487 10427 hsa-mir-30c-1 hsa04664 Fc epsilon RI signaling pathway 5595_5594 2 0.026659315 1 0.035932121 10428 hsa-mir-30c-1 hsa04540 Gap junction 5595_5594 2 0.035724885 1 0.047126445 10429 hsa-mir-30c-1 hsa04710 Circadian rhythm - mammal 8863 1 0.042861871 1 0.055363251 10430 hsa-mir-30c-1 hsa03450 Non-homologous end-joining 5591 1 0.045852928 1 0.058017991 10431 hsa-mir-30c-2 hsa05200 Pathways in cancer 2249_367_3725_6776_6777_2353_5914_5970_6256 9 2.03E-10 7.70E-09 7.70E-09 10432 hsa-mir-30c-2 hsa05221 Acute myeloid leukemia 6776_6777_5914_5970 4 9.84E-07 3.74E-05 1.87E-05 10433 hsa-mir-30c-2 hsa05220 Chronic myeloid leukemia 6776_6777_5970 3 0.000113081 0.004297074 0.001074269 10434 hsa-mir-30c-2 hsa04662 B cell receptor signaling pathway 3725_2353_5970 3 0.000113081 0.004297074 0.001074269 10435 hsa-mir-30c-2 hsa04012 ErbB signaling pathway 3725_6776_6777 3 0.00017291 0.006570564 0.001314113 10436 hsa-mir-30c-2 hsa04620 Toll-like receptor signaling pathway 3725_2353_5970 3 0.000272526 0.010355982 0.001606221 10437 hsa-mir-30c-2 hsa04010 MAPK signaling pathway 2249_3725_2353_5970 4 0.000330487 0.012558499 0.001606221 10438 hsa-mir-30c-2 hsa04660 T cell receptor signaling pathway 3725_2353_5970 3 0.000338152 0.012849769 0.001606221 10439 hsa-mir-30c-2 hsa04630 Jak-STAT signaling pathway 3977_6776_6777 3 0.000897685 0.03411204 0.003790227 10440 hsa-mir-30c-2 hsa04920 Adipocytokine signaling pathway 5970_6256 2 0.003115381 0.11838449 0.011838449 10441 hsa-mir-30c-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5970 2 0.003479392 0.132216888 0.012019717 10442 hsa-mir-30c-2 hsa05210 Colorectal cancer 3725_2353 2 0.004792101 0.18209983 0.0135505 10443 hsa-mir-30c-2 hsa05222 Small cell lung cancer 5970_6256 2 0.005011395 0.190433006 0.0135505 10444 hsa-mir-30c-2 hsa05215 Prostate cancer 367_5970 2 0.00523525 0.198939509 0.0135505 10445 hsa-mir-30c-2 hsa05212 Pancreatic cancer 367_5970 2 0.005348882 0.203257498 0.0135505 10446 hsa-mir-30c-2 hsa03450 Non-homologous end-joining 2547 1 0.01783249 0.677634628 0.042352164 10447 hsa-mir-30c-2 hsa05016 Huntington's disease 6908_6667 2 0.021779742 0.827630199 0.048257818 10448 hsa-mir-30c-2 hsa04062 Chemokine signaling pathway 6777_5970 2 0.022858967 0.868640727 0.048257818 10449 hsa-mir-30c-2 hsa04950 Maturity onset diabetes of the young 6927 1 0.02954865 1 0.0590973 10450 hsa-mir-30c-2 hsa05216 Thyroid cancer 6256 1 0.035355663 1 0.067175759 10451 hsa-mir-30c-2 hsa04080 Neuroactive ligand-receptor interaction 2908_7067 2 0.038234048 1 0.06918542 10452 hsa-mir-30c-2 hsa03410 Base excision repair 142 1 0.043428758 1 0.073648431 10453 hsa-mir-30c-2 hsa03022 Basal transcription factors 6908 1 0.044576682 1 0.073648431 10454 hsa-mir-30e hsa05200 Pathways in cancer 5371_5595_5594_6256_595_4286_367_5914_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_4088_4089_3066_3065_5925_2034_2033_4846_836 29 4.64E-33 2.87E-31 2.87E-31 10455 hsa-mir-30e hsa05220 Chronic myeloid leukemia 5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464 15 3.09E-22 1.91E-20 9.57E-21 10456 hsa-mir-30e hsa04110 Cell cycle 5591_595_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933 14 6.94E-18 4.30E-16 1.43E-16 10457 hsa-mir-30e hsa05215 Prostate cancer 5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033 11 1.52E-14 9.42E-13 2.11E-13 10458 hsa-mir-30e hsa05212 Pancreatic cancer 5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033 11 1.70E-14 1.06E-12 2.11E-13 10459 hsa-mir-30e hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5925 9 5.22E-14 3.24E-12 5.39E-13 10460 hsa-mir-30e hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925 9 3.94E-13 2.44E-11 3.05E-12 10461 hsa-mir-30e hsa05210 Colorectal cancer 5595_5594_595_7157_4087_4609_3725_4088_4089_836 10 3.94E-13 2.44E-11 3.05E-12 10462 hsa-mir-30e hsa05222 Small cell lung cancer 6256_595_5970_1870_1871_7157_4609_1869_5925_4846 10 4.89E-13 3.03E-11 3.37E-12 10463 hsa-mir-30e hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_6464 9 1.79E-12 1.11E-10 1.11E-11 10464 hsa-mir-30e hsa05218 Melanoma 5595_5594_595_4286_1870_1871_7157_1869_5925 9 3.69E-12 2.29E-10 2.08E-11 10465 hsa-mir-30e hsa05221 Acute myeloid leukemia 5371_5595_5594_595_5914_7704_5970_4609 8 3.75E-11 2.32E-09 1.94E-10 10466 hsa-mir-30e hsa05211 Renal cell carcinoma 5595_5594_3091_7428_2113_3725_2034_2033 8 1.61E-10 9.99E-09 7.69E-10 10467 hsa-mir-30e hsa04350 TGF-beta signaling pathway 5595_5594_4087_4609_4088_4089_2033_5933 8 6.51E-10 4.03E-08 2.88E-09 10468 hsa-mir-30e hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 1.19E-09 7.39E-08 4.93E-09 10469 hsa-mir-30e hsa04310 Wnt signaling pathway 595_7157_4087_4609_3725_1457_4088_4089_2033 9 2.07E-09 1.28E-07 8.01E-09 10470 hsa-mir-30e hsa04520 Adherens junction 5595_5594_4087_1457_4088_4089_2033 7 1.10E-08 6.83E-07 4.02E-08 10471 hsa-mir-30e hsa04010 MAPK signaling pathway 5595_5594_4208_3312_5970_7157_4609_3725_4763_836 10 2.08E-08 1.29E-06 7.17E-08 10472 hsa-mir-30e hsa05016 Huntington's disease 6874_2902_7157_3066_3065_3064_2033_836 8 1.93E-07 1.20E-05 6.31E-07 10473 hsa-mir-30e hsa05213 Endometrial cancer 5595_5594_595_7157_4609 5 9.83E-07 6.10E-05 3.05E-06 10474 hsa-mir-30e hsa04012 ErbB signaling pathway 5595_5594_4609_3725_6464 5 1.06E-05 0.000656913 3.13E-05 10475 hsa-mir-30e hsa04330 Notch signaling pathway 9612_3066_3065_2033 4 1.99E-05 0.001235796 5.62E-05 10476 hsa-mir-30e hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_7157_4846_836 4 3.81E-05 0.00236019 0.000102617 10477 hsa-mir-30e hsa04720 Long-term potentiation 5595_5594_2902_2033 4 0.000112099 0.006950151 0.000278006 10478 hsa-mir-30e hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725 4 0.000112099 0.006950151 0.000278006 10479 hsa-mir-30e hsa05010 Alzheimer's disease 5595_5594_2902_4846_836 5 0.000272005 0.016864338 0.000648628 10480 hsa-mir-30e hsa04620 Toll-like receptor signaling pathway 5595_5594_5970_3725 4 0.000347565 0.021549049 0.000798113 10481 hsa-mir-30e hsa04916 Melanogenesis 5595_5594_4286_2033 4 0.000373172 0.023136643 0.000826309 10482 hsa-mir-30e hsa04660 T cell receptor signaling pathway 5595_5594_5970_3725 4 0.000458077 0.028400745 0.000979336 10483 hsa-mir-30e hsa04510 Focal adhesion 5595_5594_595_3725_6464 5 0.000534758 0.033154988 0.001105166 10484 hsa-mir-30e hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.000688286 0.042673748 0.001376573 10485 hsa-mir-30e hsa04910 Insulin signaling pathway 6720_5595_5594_6464 4 0.001042813 0.064654432 0.001959225 10486 hsa-mir-30e hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_6464 4 0.001042813 0.064654432 0.001959225 10487 hsa-mir-30e hsa04115 p53 signaling pathway 595_7157_836 3 0.001505878 0.093364444 0.002746013 10488 hsa-mir-30e hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_3725_836 3 0.001629421 0.101024104 0.002806225 10489 hsa-mir-30e hsa04730 Long-term depression 5595_5594_4846 3 0.001629421 0.101024104 0.002806225 10490 hsa-mir-30e hsa04370 VEGF signaling pathway 5595_5594_4846 3 0.002037497 0.126324804 0.003414184 10491 hsa-mir-30e hsa04612 Antigen processing and presentation 4800_4801_3312 3 0.003031441 0.18794936 0.004819214 10492 hsa-mir-30e hsa04210 Apoptosis 5970_7157_836 3 0.003031441 0.18794936 0.004819214 10493 hsa-mir-30e hsa04062 Chemokine signaling pathway 5595_5594_5970_6464 4 0.003432618 0.212822338 0.005320558 10494 hsa-mir-30e hsa04912 GnRH signaling pathway 5595_5594_3725 3 0.005131225 0.318135948 0.007759413 10495 hsa-mir-30e hsa04930 Type II diabetes mellitus 5595_5594 2 0.009524046 0.590490858 0.014059306 10496 hsa-mir-30e hsa04120 Ubiquitin mediated proteolysis 5371_672_7428 3 0.010084082 0.625213079 0.014539839 10497 hsa-mir-30e hsa04630 Jak-STAT signaling pathway 595_4609_2033 3 0.01343412 0.832915445 0.018929896 10498 hsa-mir-30e hsa04920 Adipocytokine signaling pathway 6256_5970 2 0.019773498 1 0.027243487 10499 hsa-mir-30e hsa04664 Fc epsilon RI signaling pathway 5595_5594 2 0.026659315 1 0.035932121 10500 hsa-mir-30e hsa04540 Gap junction 5595_5594 2 0.035724885 1 0.047126445 10501 hsa-mir-30e hsa04710 Circadian rhythm - mammal 8863 1 0.042861871 1 0.055363251 10502 hsa-mir-30e hsa03450 Non-homologous end-joining 5591 1 0.045852928 1 0.058017991 10503 hsa-mir-31 hsa05200 Pathways in cancer 5371_5595_5594_5914_6256_595_1871_836_367_7704_841_3091_5970_7428_1870_7157_4087_2113_4609_1869_3725_4088_4089_3066_3065_5925_2034_2033_4846 29 3.60E-32 2.23E-30 2.23E-30 10504 hsa-mir-31 hsa05220 Chronic myeloid leukemia 5595_5594_595_1871_5970_1870_7157_4609_1869_4088_4089_3066_3065_5925_6464 15 8.27E-22 5.13E-20 2.56E-20 10505 hsa-mir-31 hsa04110 Cell cycle 5591_595_1871_7533_1870_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933 15 4.39E-19 2.72E-17 9.08E-18 10506 hsa-mir-31 hsa05215 Prostate cancer 5595_5594_595_1871_367_5970_1870_7157_1869_5925_2033 11 3.06E-14 1.90E-12 4.25E-13 10507 hsa-mir-31 hsa05212 Pancreatic cancer 5595_5594_595_1871_367_5970_1870_7157_1869_5925_2033 11 3.43E-14 2.13E-12 4.25E-13 10508 hsa-mir-31 hsa05219 Bladder cancer 5595_5594_595_1871_1870_7157_4609_1869_5925 9 9.25E-14 5.73E-12 9.55E-13 10509 hsa-mir-31 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1871_1870_7157_1869_5925 9 6.96E-13 4.32E-11 5.74E-12 10510 hsa-mir-31 hsa05210 Colorectal cancer 5595_5594_595_836_7157_4087_4609_3725_4088_4089 10 7.41E-13 4.60E-11 5.74E-12 10511 hsa-mir-31 hsa05222 Small cell lung cancer 6256_595_1871_5970_1870_7157_4609_1869_5925_4846 10 9.20E-13 5.70E-11 6.34E-12 10512 hsa-mir-31 hsa05214 Glioma 5595_5594_595_1871_1870_7157_1869_5925_6464 9 3.15E-12 1.96E-10 1.96E-11 10513 hsa-mir-31 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_5970_4609 8 6.19E-11 3.84E-09 3.49E-10 10514 hsa-mir-31 hsa05218 Melanoma 5595_5594_595_1871_1870_7157_1869_5925 8 2.40E-10 1.49E-08 1.24E-09 10515 hsa-mir-31 hsa05211 Renal cell carcinoma 5595_5594_3091_7428_2113_3725_2034_2033 8 2.66E-10 1.65E-08 1.27E-09 10516 hsa-mir-31 hsa04350 TGF-beta signaling pathway 5595_5594_4087_4609_4088_4089_2033_5933 8 1.07E-09 6.63E-08 4.74E-09 10517 hsa-mir-31 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 1.73E-09 1.08E-07 7.17E-09 10518 hsa-mir-31 hsa04310 Wnt signaling pathway 595_7157_4087_4609_3725_1457_4088_4089_2033 9 3.59E-09 2.23E-07 1.39E-08 10519 hsa-mir-31 hsa04520 Adherens junction 5595_5594_4087_1457_4088_4089_2033 7 1.70E-08 1.05E-06 6.19E-08 10520 hsa-mir-31 hsa05016 Huntington's disease 6874_2902_836_841_7157_3066_3065_3064_2033 9 2.09E-08 1.29E-06 7.19E-08 10521 hsa-mir-31 hsa04010 MAPK signaling pathway 5595_5594_4208_836_5970_3312_7157_4609_3725_4763 10 3.79E-08 2.35E-06 1.24E-07 10522 hsa-mir-31 hsa05213 Endometrial cancer 5595_5594_595_7157_4609 5 1.34E-06 8.28E-05 4.14E-06 10523 hsa-mir-31 hsa04012 ErbB signaling pathway 5595_5594_4609_3725_6464 5 1.43E-05 0.000887268 4.23E-05 10524 hsa-mir-31 hsa04330 Notch signaling pathway 9612_3066_3065_2033 4 2.54E-05 0.00157599 7.16E-05 10525 hsa-mir-31 hsa04620 Toll-like receptor signaling pathway 5595_5594_841_5970_3725 5 2.97E-05 0.001844083 8.02E-05 10526 hsa-mir-31 hsa05010 Alzheimer's disease 5595_5594_2902_836_841_4846 6 3.45E-05 0.002141384 8.92E-05 10527 hsa-mir-31 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_7157_4846 4 4.85E-05 0.003005635 0.000120225 10528 hsa-mir-31 hsa04115 p53 signaling pathway 595_836_841_7157 4 0.000104688 0.006490661 0.000249641 10529 hsa-mir-31 hsa04720 Long-term potentiation 5595_5594_2902_2033 4 0.000142329 0.008824377 0.000315156 10530 hsa-mir-31 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725 4 0.000142329 0.008824377 0.000315156 10531 hsa-mir-31 hsa04210 Apoptosis 836_841_5970_7157 4 0.000266925 0.016549361 0.000570668 10532 hsa-mir-31 hsa04660 T cell receptor signaling pathway 5595_5594_5970_3725 4 0.000578425 0.035862332 0.001195411 10533 hsa-mir-31 hsa04510 Focal adhesion 5595_5594_595_3725_6464 5 0.000708406 0.04392116 0.001416812 10534 hsa-mir-31 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.000823423 0.05105221 0.001595382 10535 hsa-mir-31 hsa04910 Insulin signaling pathway 6720_5595_5594_6464 4 0.001311061 0.081285771 0.002383257 10536 hsa-mir-31 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_6464 4 0.001311061 0.081285771 0.002383257 10537 hsa-mir-31 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428_7329 4 0.001345387 0.083414005 0.002383257 10538 hsa-mir-31 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_5970_3725 3 0.001943911 0.120522494 0.003257365 10539 hsa-mir-31 hsa04730 Long-term depression 5595_5594_4846 3 0.001943911 0.120522494 0.003257365 10540 hsa-mir-31 hsa04370 VEGF signaling pathway 5595_5594_4846 3 0.002428618 0.150574323 0.003962482 10541 hsa-mir-31 hsa04612 Antigen processing and presentation 4800_4801_3312 3 0.003607048 0.223637005 0.005734282 10542 hsa-mir-31 hsa04062 Chemokine signaling pathway 5595_5594_5970_6464 4 0.004279147 0.265307098 0.006632677 10543 hsa-mir-31 hsa04916 Melanogenesis 5595_5594_2033 3 0.005500547 0.341033909 0.0083179 10544 hsa-mir-31 hsa04912 GnRH signaling pathway 5595_5594_3725 3 0.006088739 0.377501827 0.008988139 10545 hsa-mir-31 hsa04930 Type II diabetes mellitus 5595_5594 2 0.010717833 0.664505637 0.015453619 10546 hsa-mir-31 hsa04630 Jak-STAT signaling pathway 595_4609_2033 3 0.015833906 0.981702163 0.022311413 10547 hsa-mir-31 hsa04920 Adipocytokine signaling pathway 6256_5970 2 0.022188944 1 0.030571434 10548 hsa-mir-31 hsa04664 Fc epsilon RI signaling pathway 5595_5594 2 0.029870062 1 0.040259649 10549 hsa-mir-31 hsa04540 Gap junction 5595_5594 2 0.039956421 1 0.052708471 10550 hsa-mir-31 hsa04710 Circadian rhythm - mammal 8863 1 0.045530072 1 0.058809676 10551 hsa-mir-31 hsa03450 Non-homologous end-joining 5591 1 0.048702544 1 0.061623627 10552 hsa-mir-3116-1 hsa05210 Colorectal cancer 4088_4089_5601_3725_5595_5594_5599_2353 8 5.62E-14 2.59E-12 2.59E-12 10553 hsa-mir-3116-1 hsa04010 MAPK signaling pathway 5601_3725_5595_5594_5599_1649_2353_1386 8 4.60E-10 2.12E-08 1.06E-08 10554 hsa-mir-3116-1 hsa04620 Toll-like receptor signaling pathway 5601_3725_5595_5594_5599_2353 6 1.58E-09 7.26E-08 2.37E-08 10555 hsa-mir-3116-1 hsa05200 Pathways in cancer 4088_4089_5601_3725_5595_5594_5599_2353 8 2.06E-09 9.49E-08 2.37E-08 10556 hsa-mir-3116-1 hsa04310 Wnt signaling pathway 4088_4089_5601_8061_3725_5599 6 1.56E-08 7.18E-07 1.44E-07 10557 hsa-mir-3116-1 hsa04012 ErbB signaling pathway 5601_3725_5595_5594_5599 5 4.56E-08 2.10E-06 3.50E-07 10558 hsa-mir-3116-1 hsa04912 GnRH signaling pathway 5601_3725_5595_5594_5599 5 1.28E-07 5.89E-06 8.04E-07 10559 hsa-mir-3116-1 hsa04660 T cell receptor signaling pathway 5601_3725_5595_5594_2353 5 1.40E-07 6.43E-06 8.04E-07 10560 hsa-mir-3116-1 hsa04930 Type II diabetes mellitus 5601_5595_5594_5599 4 2.17E-07 1.00E-05 1.11E-06 10561 hsa-mir-3116-1 hsa05220 Chronic myeloid leukemia 4088_4089_5595_5594 4 1.51E-06 6.94E-05 6.30E-06 10562 hsa-mir-3116-1 hsa04662 B cell receptor signaling pathway 3725_5595_5594_2353 4 1.51E-06 6.94E-05 6.30E-06 10563 hsa-mir-3116-1 hsa04664 Fc epsilon RI signaling pathway 5601_5595_5594_5599 4 1.84E-06 8.46E-05 6.83E-06 10564 hsa-mir-3116-1 hsa04520 Adherens junction 4088_4089_5595_5594 4 1.93E-06 8.87E-05 6.83E-06 10565 hsa-mir-3116-1 hsa04350 TGF-beta signaling pathway 4088_4089_5595_5594 4 2.66E-06 0.000122262 8.64E-06 10566 hsa-mir-3116-1 hsa04510 Focal adhesion 5601_3725_5595_5594_5599 5 2.82E-06 0.000129587 8.64E-06 10567 hsa-mir-3116-1 hsa04910 Insulin signaling pathway 5601_5595_5594_5599 4 1.55E-05 0.000714931 4.47E-05 10568 hsa-mir-3116-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5601_3725_5599 3 6.77E-05 0.00311238 0.000179984 10569 hsa-mir-3116-1 hsa05211 Renal cell carcinoma 3725_5595_5594 3 7.04E-05 0.003239718 0.000179984 10570 hsa-mir-3116-1 hsa05216 Thyroid cancer 5595_5594 2 0.00050168 0.023077275 0.001214593 10571 hsa-mir-3116-1 hsa05219 Bladder cancer 5595_5594 2 0.001011839 0.046544573 0.002327229 10572 hsa-mir-3116-1 hsa05213 Endometrial cancer 5595_5594 2 0.001520457 0.069941041 0.003179138 10573 hsa-mir-3116-1 hsa04150 mTOR signaling pathway 5595_5594 2 0.001520457 0.069941041 0.003179138 10574 hsa-mir-3116-1 hsa05223 Non-small cell lung cancer 5595_5594 2 0.001634099 0.075168571 0.003268199 10575 hsa-mir-3116-1 hsa05221 Acute myeloid leukemia 5595_5594 2 0.001935383 0.089027617 0.003709484 10576 hsa-mir-3116-1 hsa05214 Glioma 5595_5594 2 0.002329029 0.107135322 0.004285413 10577 hsa-mir-3116-1 hsa04920 Adipocytokine signaling pathway 5601_5599 2 0.002467957 0.113526044 0.004366386 10578 hsa-mir-3116-1 hsa05218 Melanoma 5595_5594 2 0.002757289 0.126835315 0.004529833 10579 hsa-mir-3116-1 hsa04730 Long-term depression 5595_5594 2 0.002757289 0.126835315 0.004529833 10580 hsa-mir-3116-1 hsa04720 Long-term potentiation 5595_5594 2 0.003061815 0.140843484 0.004856672 10581 hsa-mir-3116-1 hsa04370 VEGF signaling pathway 5595_5594 2 0.003219736 0.148107839 0.004936928 10582 hsa-mir-3116-1 hsa05215 Prostate cancer 5595_5594 2 0.004154931 0.191126806 0.006102885 10583 hsa-mir-3116-1 hsa05212 Pancreatic cancer 5595_5594 2 0.004245485 0.195292317 0.006102885 10584 hsa-mir-3116-1 hsa04540 Gap junction 5595_5594 2 0.004616828 0.212374111 0.006435579 10585 hsa-mir-3116-1 hsa04916 Melanogenesis 5595_5594 2 0.005712461 0.262773204 0.007728624 10586 hsa-mir-3116-1 hsa04270 Vascular smooth muscle contraction 5595_5594 2 0.007261598 0.334033489 0.009428413 10587 hsa-mir-3116-1 hsa04110 Cell cycle 4088_4089 2 0.007378758 0.33942288 0.009428413 10588 hsa-mir-3116-1 hsa04360 Axon guidance 5595_5594 2 0.008851074 0.407149384 0.011004037 10589 hsa-mir-3116-1 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594 2 0.009765715 0.449222896 0.011676552 10590 hsa-mir-3116-1 hsa04120 Ubiquitin mediated proteolysis 64326_672 2 0.009899686 0.455385547 0.011676552 10591 hsa-mir-3116-1 hsa05010 Alzheimer's disease 5595_5594 2 0.015583186 0.716826541 0.017920664 10592 hsa-mir-3116-1 hsa04062 Chemokine signaling pathway 5595_5594 2 0.018308028 0.842169269 0.020540714 10593 hsa-mir-3116-1 hsa04810 Regulation of actin cytoskeleton 5595_5594 2 0.023130806 1 0.025333739 10594 hsa-mir-3116-1 hsa03022 Basal transcription factors 6908 1 0.039726098 1 0.042497686 10595 hsa-mir-3116-2 hsa04010 MAPK signaling pathway 2353_5601_468_22800_3265_3725_3727_1649_1386 9 3.28E-10 1.67E-08 1.67E-08 10596 hsa-mir-3116-2 hsa05200 Pathways in cancer 2353_5601_3065_1050_5925_3326_2932_3265_3725 9 1.74E-09 8.87E-08 4.44E-08 10597 hsa-mir-3116-2 hsa05215 Prostate cancer 5925_468_3326_2932_3265 5 2.82E-07 1.44E-05 3.80E-06 10598 hsa-mir-3116-2 hsa05212 Pancreatic cancer 5925_468_3326_2932_3265 5 2.98E-07 1.52E-05 3.80E-06 10599 hsa-mir-3116-2 hsa04660 T cell receptor signaling pathway 2353_5601_2932_3265_3725 5 8.14E-07 4.15E-05 8.30E-06 10600 hsa-mir-3116-2 hsa04720 Long-term potentiation 2902_2906_468_3265 4 6.08E-06 0.000309889 4.43E-05 10601 hsa-mir-3116-2 hsa04662 B cell receptor signaling pathway 2353_2932_3265_3725 4 6.08E-06 0.000309889 4.43E-05 10602 hsa-mir-3116-2 hsa05210 Colorectal cancer 2353_5601_2932_3725 4 9.34E-06 0.000476251 5.44E-05 10603 hsa-mir-3116-2 hsa05016 Huntington's disease 2902_3065_6874_6667_9519 5 1.03E-05 0.000525207 5.44E-05 10604 hsa-mir-3116-2 hsa04012 ErbB signaling pathway 5601_2932_3265_3725 4 1.07E-05 0.000544067 5.44E-05 10605 hsa-mir-3116-2 hsa04912 GnRH signaling pathway 5601_468_3265_3725 4 2.42E-05 0.001235694 0.000112336 10606 hsa-mir-3116-2 hsa03022 Basal transcription factors 6874_6883_9519 3 2.98E-05 0.001521749 0.000126812 10607 hsa-mir-3116-2 hsa04310 Wnt signaling pathway 5601_2932_8061_3725 4 8.83E-05 0.004501888 0.000346299 10608 hsa-mir-3116-2 hsa05010 Alzheimer's disease 2902_2906_2932_351 4 0.000156515 0.007982273 0.000570162 10609 hsa-mir-3116-2 hsa05220 Chronic myeloid leukemia 3065_5925_3265 3 0.000220797 0.011260639 0.000750709 10610 hsa-mir-3116-2 hsa04510 Focal adhesion 5601_2932_3265_3725 4 0.000276073 0.014079712 0.000879982 10611 hsa-mir-3116-2 hsa04620 Toll-like receptor signaling pathway 2353_5601_3725 3 0.000528933 0.026975568 0.001586798 10612 hsa-mir-3116-2 hsa04110 Cell cycle 3065_5925_2932 3 0.000818389 0.041737832 0.002318768 10613 hsa-mir-3116-2 hsa04530 Tight junction 22800_3265_8573 3 0.00121759 0.062097104 0.003169046 10614 hsa-mir-3116-2 hsa04910 Insulin signaling pathway 5601_2932_3265 3 0.001242763 0.063380925 0.003169046 10615 hsa-mir-3116-2 hsa05219 Bladder cancer 5925_3265 2 0.001993642 0.101675751 0.004841702 10616 hsa-mir-3116-2 hsa05213 Endometrial cancer 2932_3265 2 0.002987226 0.15234854 0.006924934 10617 hsa-mir-3116-2 hsa05223 Non-small cell lung cancer 5925_3265 2 0.003208663 0.163641836 0.007114862 10618 hsa-mir-3116-2 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906 2 0.003437569 0.175316017 0.007304834 10619 hsa-mir-3116-2 hsa05221 Acute myeloid leukemia 1050_3265 2 0.003794833 0.193536468 0.007741459 10620 hsa-mir-3116-2 hsa05214 Glioma 5925_3265 2 0.004558871 0.232502435 0.008942401 10621 hsa-mir-3116-2 hsa05218 Melanoma 5925_3265 2 0.005387936 0.274784739 0.00972931 10622 hsa-mir-3116-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5601_3725 2 0.005387936 0.274784739 0.00972931 10623 hsa-mir-3116-2 hsa05211 Renal cell carcinoma 3265_3725 2 0.005532353 0.28215 0.00972931 10624 hsa-mir-3116-2 hsa04664 Fc epsilon RI signaling pathway 5601_3265 2 0.006592482 0.336216605 0.01120722 10625 hsa-mir-3116-2 hsa04512 ECM-receptor interaction 6383_9672 2 0.007401751 0.377489304 0.012177074 10626 hsa-mir-3116-2 hsa04916 Melanogenesis 2932_3265 2 0.011058466 0.563981742 0.017624429 10627 hsa-mir-3116-2 hsa04360 Axon guidance 2932_3265 2 0.017004256 0.867217054 0.026279305 10628 hsa-mir-3116-2 hsa04514 Cell adhesion molecules (CAMs) 6383_9672 2 0.017732781 0.904371817 0.026599171 10629 hsa-mir-3116-2 hsa04020 Calcium signaling pathway 2902_2906 2 0.031708722 1 0.046204137 10630 hsa-mir-3116-2 hsa04062 Chemokine signaling pathway 2932_3265 2 0.034567474 1 0.048970588 10631 hsa-mir-3116-2 hsa04810 Regulation of actin cytoskeleton 22800_3265 2 0.043359483 1 0.059040634 10632 hsa-mir-3116-2 hsa05216 Thyroid cancer 3265 1 0.043991061 1 0.059040634 10633 hsa-mir-3117 hsa05200 Pathways in cancer 4149_7046_5467_5468_5914_595_1019_1017_4193_6934_7704_6502_3091_4087_4089_3066_3065_1050_5925_7186_1499_25_405_9063_1487_1488_2885_1870_1871_2113_861_10401_207_9915_5894_2249_3320_5595_5594_5599_6258_1387_6257_6256_836_367_2932_6774_6777_6772_5970_7157_6688_7849_1869_3725_4286_6776_4088_2034_2033_4846_51176_5371_8031_5604_5601_5602_4292_7428_4609_2956_1026_1029_2353_8554 76 9.19E-41 7.08E-39 7.08E-39 10634 hsa-mir-3117 hsa05220 Chronic myeloid leukemia 7046_595_1019_4193_4089_3066_3065_5925_25_1487_1488_2885_1870_1871_861_207_5894_5595_5594_6777_5970_7157_1869_6776_4088_5604_4609_1026_1029_6464 30 1.73E-22 1.33E-20 6.66E-21 10635 hsa-mir-3117 hsa04110 Cell cycle 595_1019_1017_4193_6502_4087_4089_3066_3065_990_5925_4616_25_6500_1870_1871_5934_5933_5591_1387_7533_2932_7027_7157_5111_10912_1869_4088_2033_8454_983_1026_1029 33 1.67E-20 1.29E-18 4.29E-19 10636 hsa-mir-3117 hsa05215 Prostate cancer 595_1017_4193_6934_5925_1499_2885_1870_1871_9586_207_5894_3320_5595_5594_1387_367_2932_5970_7157_468_1869_2033_51176_5604_1026 26 5.25E-17 4.04E-15 1.01E-15 10637 hsa-mir-3117 hsa05212 Pancreatic cancer 595_1017_4193_6934_5925_1499_2885_1870_1871_9586_207_5894_3320_5595_5594_1387_367_2932_5970_7157_468_1869_2033_51176_5604_1026 26 6.61E-17 5.09E-15 1.02E-15 10638 hsa-mir-3117 hsa04010 MAPK signaling pathway 6722_3727_4149_7046_9252_4773_4616_7186_3303_9344_1432_2885_4763_207_5894_2249_5595_5594_5599_5598_1386_836_3312_5970_3164_7157_10912_468_3725_1649_5604_4208_5601_5600_5602_4609_5606_2353_2005_8550_2002 41 1.18E-16 9.11E-15 1.52E-15 10639 hsa-mir-3117 hsa05210 Colorectal cancer 7046_595_6934_4087_4089_1499_2885_207_5894_5595_5594_5599_836_2932_7157_3725_4088_51176_5604_5601_5602_4292_4609_2956_2353 25 1.82E-16 1.40E-14 2.00E-15 10640 hsa-mir-3117 hsa05221 Acute myeloid leukemia 5467_5914_595_6934_7704_1050_2885_861_207_5894_5595_5594_6774_6777_5970_6688_6776_51176_5371_5604_4609 21 2.50E-15 1.93E-13 2.41E-14 10641 hsa-mir-3117 hsa04350 TGF-beta signaling pathway 7046_4086_4087_4089_6667_6500_3397_3399_3398_1874_1875_5934_5933_5595_5594_1387_7027_4088_2033_4093_8454_4609_4092 23 2.48E-14 1.91E-12 2.12E-13 10642 hsa-mir-3117 hsa05216 Thyroid cancer 5468_595_6934_1499_5595_5594_6258_6257_6256_7157_7849_51176_8031_5604_4609 15 3.39E-13 2.61E-11 2.61E-12 10643 hsa-mir-3117 hsa04310 Wnt signaling pathway 5467_595_6934_4087_4089_4772_4773_1499_1487_1488_6500_5599_1387_1459_2932_7157_8061_3725_1457_4088_2033_51176_5601_5602_8454_4609_5527 27 6.12E-13 4.71E-11 3.96E-12 10644 hsa-mir-3117 hsa05223 Non-small cell lung cancer 595_1019_5925_2309_2885_1870_1871_207_5894_5595_5594_6258_6257_6256_7157_1869_5604_1029 18 6.17E-13 4.75E-11 3.96E-12 10645 hsa-mir-3117 hsa05222 Small cell lung cancer 4149_595_1019_1017_6502_5925_7186_9063_1870_1871_10401_207_6258_6257_6256_5970_7157_1869_4846_4609_8554 21 1.23E-12 9.44E-11 7.26E-12 10646 hsa-mir-3117 hsa05219 Bladder cancer 595_1019_9252_4193_5925_1870_1871_5894_5595_5594_7157_1869_5604_4609_1026_1029 16 2.27E-12 1.75E-10 1.25E-11 10647 hsa-mir-3117 hsa05213 Endometrial cancer 595_6934_1499_2309_2885_207_5894_5595_5594_2932_7157_51176_5604_4292_4609_2002 16 3.23E-11 2.49E-09 1.66E-10 10648 hsa-mir-3117 hsa05214 Glioma 595_1019_4193_5925_2885_1870_1871_207_5894_5595_5594_7157_1869_5604_1026_1029_6464 17 6.83E-11 5.26E-09 3.29E-10 10649 hsa-mir-3117 hsa05218 Melanoma 595_1019_4193_5925_1870_1871_207_5894_2249_5595_5594_7157_1869_4286_5604_1026_1029 17 2.22E-10 1.71E-08 1.00E-09 10650 hsa-mir-3117 hsa04012 ErbB signaling pathway 25_2885_207_5894_5595_5594_5599_2932_6777_3725_6776_5604_5601_5602_4609_1026_6464_2002 18 5.13E-10 3.95E-08 2.20E-09 10651 hsa-mir-3117 hsa04330 Notch signaling pathway 1840_9612_3066_3065_9794_22938_1487_1488_2648_1387_2033_8850_4851 13 6.75E-09 5.20E-07 2.74E-08 10652 hsa-mir-3117 hsa05211 Renal cell carcinoma 3091_405_2885_2113_207_9915_5894_5595_5594_1387_3725_2034_2033_5604_7428 15 1.31E-08 1.00E-06 5.02E-08 10653 hsa-mir-3117 hsa04115 p53 signaling pathway 595_1019_1017_4194_4193_4616_836_7157_10912_64326_983_1026_7161_1029 14 5.30E-08 4.08E-06 1.94E-07 10654 hsa-mir-3117 hsa04620 Toll-like receptor signaling pathway 3665_3661_1432_207_5595_5594_5599_6772_5970_3725_5604_5601_5600_5602_5606_2353 16 1.44E-07 1.11E-05 5.03E-07 10655 hsa-mir-3117 hsa04520 Adherens junction 7046_6934_4087_4089_1499_4301_5595_5594_1387_1459_1457_4088_2033_51176 14 2.65E-07 2.04E-05 8.87E-07 10656 hsa-mir-3117 hsa04912 GnRH signaling pathway 5580_1432_2885_5894_5595_5594_5599_5598_468_3725_5604_5601_5600_5602_5606_2002 16 2.88E-07 2.22E-05 9.25E-07 10657 hsa-mir-3117 hsa04660 T cell receptor signaling pathway 1019_4772_4773_1432_2885_207_5894_5595_5594_2932_5970_3725_5604_5601_5600_2353 16 3.60E-07 2.77E-05 1.11E-06 10658 hsa-mir-3117 hsa04664 Fc epsilon RI signaling pathway 5580_1432_2885_207_5894_5595_5594_5599_5604_5601_5600_5602_5606 13 1.31E-06 0.000100577 3.87E-06 10659 hsa-mir-3117 hsa04920 Adipocytokine signaling pathway 10891_5465_7186_207_5599_6258_6257_6256_6774_5970_5601_5602 12 1.52E-06 0.000116849 4.33E-06 10660 hsa-mir-3117 hsa04662 B cell receptor signaling pathway 4772_4773_2885_207_5894_5595_5594_2932_5970_3725_5604_2353 12 4.31E-06 0.00033158 1.18E-05 10661 hsa-mir-3117 hsa04630 Jak-STAT signaling pathway 595_9063_2885_10401_3977_207_1387_6778_6774_6775_6777_6772_6776_2033_4609_8554 16 2.00E-05 0.001541487 5.32E-05 10662 hsa-mir-3117 hsa04120 Ubiquitin mediated proteolysis 55294_4193_6502_9063_6500_10401_7329_8925_83737_64326_5371_672_8454_7428_8554 15 2.25E-05 0.001729837 5.77E-05 10663 hsa-mir-3117 hsa03022 Basal transcription factors 2959_2963_2962_2969_6874_6872_6908_6883 8 2.63E-05 0.002024628 6.53E-05 10664 hsa-mir-3117 hsa04540 Gap junction 7278_51807_2885_5894_5595_5594_5598_7846_5604_7277_983_10376 12 3.03E-05 0.002332387 7.29E-05 10665 hsa-mir-3117 hsa05322 Systemic lupus erythematosus 3021_3020_8366_8368_8294_8370_121504_8361_8360_8363_8362_8365_8364_8367_8359 15 3.27E-05 0.002520672 7.64E-05 10666 hsa-mir-3117 hsa04910 Insulin signaling pathway 6720_10891_2885_207_5894_5595_5594_5599_2932_5604_5601_5602_6464_2002 14 7.71E-05 0.005936252 0.000174596 10667 hsa-mir-3117 hsa03450 Non-homologous end-joining 2547_10111_2237_5591_4361 5 0.00012671 0.009756705 0.000278763 10668 hsa-mir-3117 hsa04370 VEGF signaling pathway 4772_4773_1432_207_5894_5595_5594_4846_5604_5600 10 0.000130916 0.010080497 0.000280014 10669 hsa-mir-3117 hsa03410 Base excision repair 4350_142_252969_328_2237_5111_6996 7 0.000150794 0.011611142 0.000313815 10670 hsa-mir-3117 hsa04916 Melanogenesis 6934_1499_5894_5595_5594_1387_2932_4286_2033_51176_5604 11 0.000317993 0.02448543 0.000644353 10671 hsa-mir-3117 hsa05131 Shigellosis 7278_51807_1499_25_7846_7277_4691_10376 8 0.000342299 0.026357017 0.000658925 10672 hsa-mir-3117 hsa05130 Pathogenic Escherichia coli infection 7278_51807_1499_25_7846_7277_4691_10376 8 0.000342299 0.026357017 0.000658925 10673 hsa-mir-3117 hsa04062 Chemokine signaling pathway 7074_5580_2309_2885_207_5894_5595_5594_2932_6774_6777_6772_5970_5604_6464 15 0.000636292 0.048994489 0.001194988 10674 hsa-mir-3117 hsa04510 Focal adhesion 595_1499_2885_207_5894_5595_5594_5599_2932_3725_5604_5601_5602_6464_2002 15 0.001178684 0.090758635 0.00216092 10675 hsa-mir-3117 hsa05016 Huntington's disease 10891_5468_3066_3065_3064_2902_6667_9586_1387_836_7157_2033_6874_6908 14 0.001391632 0.107155628 0.002469347 10676 hsa-mir-3117 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_5599_836_5970_3725_5601_5600_5602 8 0.001411055 0.108651255 0.002469347 10677 hsa-mir-3117 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_1432_836_7157_4846_5600_5606 7 0.001616801 0.124493668 0.002766526 10678 hsa-mir-3117 hsa04720 Long-term potentiation 2902_5894_5595_5594_1387_468_2033_5604 8 0.001940014 0.149381087 0.003247415 10679 hsa-mir-3117 hsa04930 Type II diabetes mellitus 5580_5595_5594_5599_5601_5602 6 0.002573897 0.198190069 0.00421681 10680 hsa-mir-3117 hsa03320 PPAR signaling pathway 5465_5467_5468_6258_6257_6256_2168 7 0.005067588 0.390204292 0.008129256 10681 hsa-mir-3117 hsa03430 Mismatch repair 5981_5111_4292_2956 4 0.005870412 0.452021694 0.009224933 10682 hsa-mir-3117 hsa04950 Maturity onset diabetes of the young 5080_6927_3087_4760 4 0.006703176 0.516144552 0.010322891 10683 hsa-mir-3117 hsa04650 Natural killer cell mediated cytotoxicity 4772_4773_2885_5894_5595_5594_836_5604_6464 9 0.01984783 1 0.029966332 10684 hsa-mir-3117 hsa05217 Basal cell carcinoma 6934_1499_2932_7157_51176 5 0.023821619 1 0.035274321 10685 hsa-mir-3117 hsa03420 Nucleotide excision repair 5981_5111_5886_4331 4 0.04164463 1 0.060502576 10686 hsa-mir-3117 hsa04612 Antigen processing and presentation 3303_3320_3312_4800_4801_4802 6 0.045870076 1 0.06540733 10687 hsa-mir-3119-2 hsa05200 Pathways in cancer 2034_3320_5371_2249_7046_1499_5594_5599_5914_1387_6256_1019_367_1017_4193_2353_7704_6774_6776_6777_7157_51588_3091_5970_8554_6688_2113_5894_4609_3725_1026_1029_4088_5925_2033_1050_898_4790_4791_9915_7189 41 2.18E-33 1.66E-31 1.66E-31 10688 hsa-mir-3119-2 hsa04110 Cell cycle 5591_1387_1019_1017_7533_7532_5001_4193_7027_7157_4174_1026_4172_4173_1029_4088_5925_2033_898_2810_5933_4998_4999 23 5.04E-23 3.83E-21 1.92E-21 10689 hsa-mir-3119-2 hsa05215 Prostate cancer 3320_1499_5594_1387_367_1017_4193_7157_5970_1385_468_5894_1026_5925_2033_898_4790 17 2.53E-17 1.93E-15 5.69E-16 10690 hsa-mir-3119-2 hsa05212 Pancreatic cancer 3320_1499_5594_1387_367_1017_4193_7157_5970_1385_468_5894_1026_5925_2033_898_4790 17 2.99E-17 2.28E-15 5.69E-16 10691 hsa-mir-3119-2 hsa05220 Chronic myeloid leukemia 7046_5594_1019_4193_6776_6777_7157_5970_5894_4609_1026_1029_4088_5925_4790 15 1.25E-15 9.52E-14 1.90E-14 10692 hsa-mir-3119-2 hsa05221 Acute myeloid leukemia 5371_5594_5914_7704_6774_6776_6777_5970_6688_5894_4609_1050_4790 13 3.46E-14 2.63E-12 4.38E-13 10693 hsa-mir-3119-2 hsa04010 MAPK signaling pathway 2249_7046_5594_5599_1386_3303_5566_2353_1649_7157_5970_468_5894_4609_3725_5536_4790_4791_7189 19 7.53E-12 5.72E-10 8.18E-11 10694 hsa-mir-3119-2 hsa05222 Small cell lung cancer 6256_1019_1017_7157_51588_5970_8554_4609_5925_898_4790_7189 12 4.05E-11 3.08E-09 3.48E-10 10695 hsa-mir-3119-2 hsa05214 Glioma 5594_1019_4193_7157_5894_1026_1029_5925_808_805_801 11 4.16E-11 3.16E-09 3.48E-10 10696 hsa-mir-3119-2 hsa04350 TGF-beta signaling pathway 7046_5594_1387_4093_6667_7027_1874_658_4609_4088_2033_5933 12 4.58E-11 3.48E-09 3.48E-10 10697 hsa-mir-3119-2 hsa04620 Toll-like receptor signaling pathway 3654_5594_5599_353376_3661_148022_2353_5970_3725_4615_4790_7189 12 2.45E-10 1.86E-08 1.69E-09 10698 hsa-mir-3119-2 hsa05219 Bladder cancer 5594_1019_4193_7157_5894_4609_1026_1029_5925 9 4.02E-10 3.06E-08 2.55E-09 10699 hsa-mir-3119-2 hsa04720 Long-term potentiation 5594_1387_5499_5566_468_5894_2033_808_805_801 10 2.63E-09 2.00E-07 1.53E-08 10700 hsa-mir-3119-2 hsa05210 Colorectal cancer 7046_1499_5594_5599_2353_7157_5894_4609_3725_4088 10 7.10E-09 5.40E-07 3.85E-08 10701 hsa-mir-3119-2 hsa05218 Melanoma 2249_5594_1019_4193_7157_5894_1026_1029_5925 9 2.48E-08 1.89E-06 1.26E-07 10702 hsa-mir-3119-2 hsa05211 Renal cell carcinoma 2034_5594_1387_3091_2113_5894_3725_2033_9915 9 2.77E-08 2.11E-06 1.32E-07 10703 hsa-mir-3119-2 hsa04916 Melanogenesis 1499_5594_1387_5566_1385_5894_2033_808_805_801 10 4.62E-08 3.51E-06 2.06E-07 10704 hsa-mir-3119-2 hsa04660 T cell receptor signaling pathway 5594_920_1019_915_2353_5970_5894_3725_3932_4790 10 7.53E-08 5.72E-06 3.18E-07 10705 hsa-mir-3119-2 hsa04115 p53 signaling pathway 1019_1017_4193_7157_1026_1029_898_2810 8 2.82E-07 2.14E-05 1.13E-06 10706 hsa-mir-3119-2 hsa04912 GnRH signaling pathway 5594_5599_5566_468_5894_3725_808_805_801 9 6.75E-07 5.13E-05 2.57E-06 10707 hsa-mir-3119-2 hsa04520 Adherens junction 7046_1499_5594_1387_1457_4088_2033_71 8 7.96E-07 6.05E-05 2.77E-06 10708 hsa-mir-3119-2 hsa05223 Non-small cell lung cancer 5594_6256_1019_7157_5894_1029_5925 7 8.02E-07 6.10E-05 2.77E-06 10709 hsa-mir-3119-2 hsa04310 Wnt signaling pathway 1499_5599_1387_5566_7157_4609_3725_1457_4088_2033 10 1.23E-06 9.37E-05 4.07E-06 10710 hsa-mir-3119-2 hsa04012 ErbB signaling pathway 5594_5599_6776_6777_5894_4609_3725_1026 8 1.43E-06 0.000108803 4.43E-06 10711 hsa-mir-3119-2 hsa04630 Jak-STAT signaling pathway 1387_3460_6774_6776_6777_51588_8554_4609_2033_3977 10 1.46E-06 0.000110702 4.43E-06 10712 hsa-mir-3119-2 hsa04910 Insulin signaling pathway 10891_5594_5599_5499_5566_5894_808_805_801 9 4.52E-06 0.000343626 1.32E-05 10713 hsa-mir-3119-2 hsa05016 Huntington's disease 10891_1387_291_6908_6667_5481_7157_1385_4697_2033 10 7.43E-06 0.000564438 2.09E-05 10714 hsa-mir-3119-2 hsa05216 Thyroid cancer 1499_5594_6256_7157_4609 5 9.14E-06 0.00069498 2.48E-05 10715 hsa-mir-3119-2 hsa04612 Antigen processing and presentation 3320_920_3308_3303_4800_811_1385 7 1.71E-05 0.001298445 4.48E-05 10716 hsa-mir-3119-2 hsa04920 Adipocytokine signaling pathway 10891_5599_6256_6774_5970_4790 6 3.51E-05 0.002667875 8.89E-05 10717 hsa-mir-3119-2 hsa04662 B cell receptor signaling pathway 5594_2353_5970_5894_3725_4790 6 6.33E-05 0.004809643 0.00015515 10718 hsa-mir-3119-2 hsa04330 Notch signaling pathway 1387_9612_2033_2648_8850 5 7.55E-05 0.005739473 0.000179359 10719 hsa-mir-3119-2 hsa04270 Vascular smooth muscle contraction 5594_5499_5566_5894_808_805_801 7 9.30E-05 0.007069893 0.000214239 10720 hsa-mir-3119-2 hsa05213 Endometrial cancer 1499_5594_7157_5894_4609 5 0.000117586 0.008936531 0.000262839 10721 hsa-mir-3119-2 hsa04210 Apoptosis 3654_5566_7157_5970_4615_4790 6 0.000153699 0.011681149 0.000333747 10722 hsa-mir-3119-2 hsa04120 Ubiquitin mediated proteolysis 5371_672_4193_51588_8554_7329_7189 7 0.000243751 0.01852504 0.000514584 10723 hsa-mir-3119-2 hsa05340 Primary immunodeficiency 920_915_100_3932 4 0.00031676 0.024073791 0.000650643 10724 hsa-mir-3119-2 hsa03030 DNA replication 5981_4174_4172_4173 4 0.00034965 0.026573398 0.0006993 10725 hsa-mir-3119-2 hsa04062 Chemokine signaling pathway 5594_5566_6774_6777_5970_5894_4790 7 0.00156888 0.119234887 0.003057305 10726 hsa-mir-3119-2 hsa04510 Focal adhesion 1499_5594_5599_5499_5894_3725_71 7 0.002239848 0.170228428 0.004255711 10727 hsa-mir-3119-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5970_3725_4790 4 0.003698651 0.281097479 0.006856036 10728 hsa-mir-3119-2 hsa05010 Alzheimer's disease 5594_3416_4697_808_805_801 6 0.004616257 0.350835563 0.008353228 10729 hsa-mir-3119-2 hsa04020 Calcium signaling pathway 291_5566_5481_808_805_801 6 0.005527679 0.420103589 0.009769851 10730 hsa-mir-3119-2 hsa03450 Non-homologous end-joining 5591_2547 2 0.007796046 0.592499534 0.013465898 10731 hsa-mir-3119-2 hsa05131 Shigellosis 1499_4691_71 3 0.013456154 1 0.022231906 10732 hsa-mir-3119-2 hsa05130 Pathogenic Escherichia coli infection 1499_4691_71 3 0.013456154 1 0.022231906 10733 hsa-mir-3119-2 hsa04950 Maturity onset diabetes of the young 6927_3175 2 0.019984667 1 0.032315632 10734 hsa-mir-3119-2 hsa04070 Phosphatidylinositol signaling system 808_805_801 3 0.028988423 1 0.045898336 10735 hsa-mir-3119-2 hsa05012 Parkinson's disease 7314_291_5481_4697 4 0.030680943 1 0.046886317 10736 hsa-mir-3119-2 hsa04530 Tight junction 1499_1019_1457_71 4 0.031375921 1 0.046886317 10737 hsa-mir-3119-2 hsa04664 Fc epsilon RI signaling pathway 5594_5599_5894 3 0.031880767 1 0.046886317 10738 hsa-mir-3119-2 hsa04650 Natural killer cell mediated cytotoxicity 5594_3460_5894_3932 4 0.032080112 1 0.046886317 10739 hsa-mir-3119-2 hsa03410 Base excision repair 3146_142 2 0.040488829 1 0.057975057 10740 hsa-mir-3119-2 hsa04810 Regulation of actin cytoskeleton 2249_5594_5499_5894_71 5 0.041192804 1 0.057975057 10741 hsa-mir-3119-2 hsa03022 Basal transcription factors 2963_6908 2 0.042446281 1 0.058653043 10742 hsa-mir-3119-2 hsa04540 Gap junction 5594_5566_5894 3 0.047279045 1 0.064164418 10743 hsa-mir-3122 hsa05200 Pathways in cancer 1869_3716_3066_3725_4149_5371_675_1956_1499_5595_5594_5599_1387_5159_5156_5601_2308_1019_1399_1398_367_1017_3815_2932_4193_841_6774_6776_6777_6772_5970_1870_1871_7157_6688_4609_4088_1026_861_1029_867_2353_2736_4089_1050_5925_2033_207_8554_4790 50 4.89E-42 3.72E-40 3.72E-40 10744 hsa-mir-3122 hsa05220 Chronic myeloid leukemia 1869_3066_5595_5594_1019_1399_1398_4193_6776_6777_5970_1870_1871_7157_5781_4609_4088_1026_861_1029_867_4089_5925_207_4790_6464 26 2.97E-30 2.25E-28 1.13E-28 10745 hsa-mir-3122 hsa05215 Prostate cancer 1869_1956_1499_5595_5594_1385_1387_5159_5156_2308_367_1017_2932_4193_5970_1870_1871_7157_468_1026_5925_2033_207_4790_9586 25 2.56E-27 1.94E-25 6.17E-26 10746 hsa-mir-3122 hsa05212 Pancreatic cancer 1869_1956_1499_5595_5594_1385_1387_5159_5156_2308_367_1017_2932_4193_5970_1870_1871_7157_468_1026_5925_2033_207_4790_9586 25 3.25E-27 2.47E-25 6.17E-26 10747 hsa-mir-3122 hsa04010 MAPK signaling pathway 6722_8986_3725_4149_1956_5595_5594_5599_1386_5159_9261_5156_5601_5600_5566_1399_1398_9252_1649_5970_7157_468_4609_1432_3727_6195_6196_6197_2353_5603_207_8550_4790_2002 34 2.99E-26 2.27E-24 4.54E-25 10748 hsa-mir-3122 hsa04012 ErbB signaling pathway 3725_815_1956_6714_5595_5594_5599_2066_5601_1399_1398_2932_6776_6777_4609_1026_867_207_6464_2002 20 1.62E-20 1.23E-18 2.06E-19 10749 hsa-mir-3122 hsa05214 Glioma 1869_815_1956_5595_5594_5159_5156_1019_4193_1870_1871_7157_1026_1029_5925_207_6464 17 1.95E-18 1.48E-16 2.11E-17 10750 hsa-mir-3122 hsa04110 Cell cycle 1869_3066_1387_1019_1017_2932_4193_7027_1870_1871_7157_4088_1026_1029_4089_5925_5934_2033_890_5933 20 3.69E-18 2.80E-16 3.50E-17 10751 hsa-mir-3122 hsa04630 Jak-STAT signaling pathway 3717_3716_3718_85480_3560_3561_1387_3575_6778_6774_6776_6777_6772_2057_5781_4609_867_2690_2033_207_8554 21 2.72E-17 2.07E-15 2.30E-16 10752 hsa-mir-3122 hsa05219 Bladder cancer 1869_1956_5595_5594_1019_9252_4193_1870_1871_7157_4609_1026_1029_5925 14 1.20E-16 9.15E-15 9.15E-16 10753 hsa-mir-3122 hsa05210 Colorectal cancer 3725_1956_1499_5595_5594_5599_5159_5156_5601_2932_7157_4609_4088_2353_4089_207 16 1.56E-15 1.18E-13 1.08E-14 10754 hsa-mir-3122 hsa05218 Melanoma 1869_1956_5595_5594_5159_5156_1019_4193_1870_1871_7157_1026_1029_5925_207 15 3.16E-15 2.40E-13 2.00E-14 10755 hsa-mir-3122 hsa04660 T cell receptor signaling pathway 3725_3932_5595_5594_5601_5600_919_1019_2932_5970_1432_867_2353_5603_207_4790_1493 17 4.39E-15 3.34E-13 2.57E-14 10756 hsa-mir-3122 hsa05221 Acute myeloid leukemia 5371_5595_5594_3815_6774_6776_6777_5970_6688_4609_861_1050_207_4790 14 6.65E-15 5.06E-13 3.61E-14 10757 hsa-mir-3122 hsa04620 Toll-like receptor signaling pathway 3725_5595_5594_5599_5601_5600_841_6772_5970_1432_2353_5603_6348_207_4790 15 3.54E-13 2.69E-11 1.79E-12 10758 hsa-mir-3122 hsa04310 Wnt signaling pathway 3725_5515_815_1499_5599_1387_5601_5566_1457_2932_1459_7157_8061_4609_4088_4089_2033 17 5.31E-13 4.03E-11 2.52E-12 10759 hsa-mir-3122 hsa04350 TGF-beta signaling pathway 5515_5595_5594_1387_6667_7027_1874_1875_4609_4088_4089_5934_2033_5933 14 7.31E-13 5.55E-11 3.27E-12 10760 hsa-mir-3122 hsa04910 Insulin signaling pathway 3643_5595_5594_5599_6720_5601_2308_5566_1399_1398_2932_5770_867_207_6464_2002 16 1.57E-12 1.19E-10 6.63E-12 10761 hsa-mir-3122 hsa04520 Adherens junction 1956_1499_6714_3643_5595_5594_1387_1457_5770_1459_4088_4089_2033 13 4.38E-12 3.33E-10 1.75E-11 10762 hsa-mir-3122 hsa05222 Small cell lung cancer 1869_4149_1019_1017_5970_1870_1871_7157_4609_5925_207_8554_4790 13 9.94E-12 7.55E-10 3.70E-11 10763 hsa-mir-3122 hsa04912 GnRH signaling pathway 3725_815_1956_6714_5595_5594_5599_5601_5600_5566_468_1432_5603_2002 14 1.02E-11 7.77E-10 3.70E-11 10764 hsa-mir-3122 hsa04062 Chemokine signaling pathway 3717_3718_5595_5594_5566_1399_1398_1234_2932_6774_6777_6772_5970_6348_207_4790_6464 17 1.79E-11 1.36E-09 6.17E-11 10765 hsa-mir-3122 hsa05223 Non-small cell lung cancer 1869_1956_5595_5594_1019_1870_1871_7157_1029_5925_207 11 2.32E-11 1.77E-09 7.68E-11 10766 hsa-mir-3122 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1956_6714_5599_5601_5600_5970_5781_1432_5603_4790 11 3.16E-10 2.40E-08 1.00E-09 10767 hsa-mir-3122 hsa04510 Focal adhesion 3725_1956_1499_6714_5595_5594_5599_5159_5156_5601_1399_1398_2932_207_6464_2002 16 3.98E-10 3.03E-08 1.21E-09 10768 hsa-mir-3122 hsa05213 Endometrial cancer 1956_1499_5595_5594_2932_7157_4609_207_2002 9 5.60E-09 4.25E-07 1.64E-08 10769 hsa-mir-3122 hsa04720 Long-term potentiation 815_5595_5594_1387_5566_468_6195_6196_6197_2033 10 7.57E-09 5.75E-07 2.05E-08 10770 hsa-mir-3122 hsa04662 B cell receptor signaling pathway 3725_695_5595_5594_2932_5970_6850_2353_207_4790 10 7.57E-09 5.75E-07 2.05E-08 10771 hsa-mir-3122 hsa04664 Fc epsilon RI signaling pathway 695_5595_5594_5599_5601_5600_6850_1432_5603_207 10 1.19E-08 9.04E-07 3.12E-08 10772 hsa-mir-3122 hsa05211 Renal cell carcinoma 3725_5595_5594_1387_1399_1398_5781_2033_207 9 7.15E-08 5.43E-06 1.81E-07 10773 hsa-mir-3122 hsa04916 Melanogenesis 815_1499_5595_5594_1385_1387_5566_3815_2932_2033 10 1.30E-07 9.85E-06 3.18E-07 10774 hsa-mir-3122 hsa04920 Adipocytokine signaling pathway 3717_5599_5601_6774_5970_5781_207_4790 8 5.31E-07 4.04E-05 1.26E-06 10775 hsa-mir-3122 hsa04370 VEGF signaling pathway 6714_5595_5594_9261_5600_1432_5603_207 8 1.40E-06 0.000106153 3.22E-06 10776 hsa-mir-3122 hsa04540 Gap junction 5592_1956_6714_5595_5594_5159_5156_5566 8 5.15E-06 0.00039171 1.15E-05 10777 hsa-mir-3122 hsa04115 p53 signaling pathway 1019_1017_4193_841_7157_1026_1029 7 7.45E-06 0.000566465 1.62E-05 10778 hsa-mir-3122 hsa04930 Type II diabetes mellitus 3651_3643_5595_5594_5599_5601 6 8.15E-06 0.000619639 1.72E-05 10779 hsa-mir-3122 hsa04060 Cytokine-cytokine receptor interaction 85480_1956_3560_3561_5159_5156_3575_1234_3815_2057_2690_6348 12 1.22E-05 0.000926086 2.50E-05 10780 hsa-mir-3122 hsa05216 Thyroid cancer 1499_5595_5594_7157_4609 5 1.56E-05 0.001185059 3.12E-05 10781 hsa-mir-3122 hsa04150 mTOR signaling pathway 5595_5594_6195_6196_6197_207 6 1.73E-05 0.001318178 3.38E-05 10782 hsa-mir-3122 hsa05016 Huntington's disease 3066_1385_1387_6667_841_7157_3064_2033_4724_9586 10 1.94E-05 0.001471493 3.68E-05 10783 hsa-mir-3122 hsa05340 Primary immunodeficiency 3718_695_3932_3561_3575 5 3.52E-05 0.002676497 6.53E-05 10784 hsa-mir-3122 hsa04330 Notch signaling pathway 3066_1387_9612_2033_4851 5 0.000126905 0.009644745 0.000229637 10785 hsa-mir-3122 hsa05014 Amyotrophic lateral sclerosis (ALS) 5600_834_7157_1432_5603 5 0.000271216 0.020612435 0.000479359 10786 hsa-mir-3122 hsa04210 Apoptosis 5566_841_5970_7157_207_4790 6 0.00027886 0.021193351 0.000481667 10787 hsa-mir-3122 hsa04530 Tight junction 5515_1499_6714_1457_1019_1459_207 7 0.0004363 0.033158789 0.000736862 10788 hsa-mir-3122 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_919_6850_5781_6464 7 0.000454818 0.034566168 0.000751438 10789 hsa-mir-3122 hsa05217 Basal cell carcinoma 1499_2932_7157_2736 4 0.002298655 0.174697781 0.003716974 10790 hsa-mir-3122 hsa04120 Ubiquitin mediated proteolysis 5371_672_4193_867_7329_8554 6 0.002529849 0.192268557 0.004005595 10791 hsa-mir-3122 hsa04730 Long-term depression 5592_5515_5595_5594 4 0.005463303 0.415211018 0.008473694 10792 hsa-mir-3122 hsa04810 Regulation of actin cytoskeleton 1956_5595_5594_5159_5156_1399_1398 7 0.005667122 0.430701252 0.008614025 10793 hsa-mir-3122 hsa03022 Basal transcription factors 2963_2969_6880 3 0.006240207 0.47425574 0.009299132 10794 hsa-mir-3122 hsa04670 Leukocyte transendothelial migration 1499_5600_5781_1432_5603 5 0.007035282 0.534681446 0.010282336 10795 hsa-mir-3122 hsa05010 Alzheimer's disease 22926_5595_5594_2932_841_4724 6 0.007798771 0.592706595 0.011183143 10796 hsa-mir-3122 hsa04020 Calcium signaling pathway 815_1956_2066_5159_5156_5566 6 0.009286769 0.705794419 0.013070267 10797 hsa-mir-3122 hsa04340 Hedgehog signaling pathway 5566_2932_2736 3 0.018852027 1 0.026050073 10798 hsa-mir-3122 hsa04950 Maturity onset diabetes of the young 3651_6927 2 0.024560469 1 0.033332065 10799 hsa-mir-3122 hsa04270 Vascular smooth muscle contraction 5592_5595_5594_5566 4 0.028134809 1 0.037513079 10800 hsa-mir-3122 hsa03440 Homologous recombination 675_4683 2 0.03208018 1 0.042036097 10801 hsa-mir-3123 hsa04110 Cell cycle 1387_993_983_5925 4 6.13E-07 1.53E-05 1.53E-05 10802 hsa-mir-3123 hsa04330 Notch signaling pathway 1387_8850 2 0.000349508 0.008737699 0.004368849 10803 hsa-mir-3123 hsa05215 Prostate cancer 1387_5925 2 0.001174155 0.029353887 0.007500885 10804 hsa-mir-3123 hsa05212 Pancreatic cancer 1387_5925 2 0.001200142 0.03000354 0.007500885 10805 hsa-mir-3123 hsa05200 Pathways in cancer 1387_5925 2 0.015034947 0.37587367 0.064921185 10806 hsa-mir-3123 hsa03410 Base excision repair 3146 1 0.020754901 0.518872528 0.064921185 10807 hsa-mir-3123 hsa05219 Bladder cancer 5925 1 0.024082113 0.60205283 0.064921185 10808 hsa-mir-3123 hsa05223 Non-small cell lung cancer 5925 1 0.030704643 0.767616075 0.064921185 10809 hsa-mir-3123 hsa05214 Glioma 5925 1 0.036738118 0.918452946 0.064921185 10810 hsa-mir-3123 hsa04115 p53 signaling pathway 983 1 0.038923332 0.97308329 0.064921185 10811 hsa-mir-3123 hsa05218 Melanoma 5925 1 0.040014188 1 0.064921185 10812 hsa-mir-3123 hsa05211 Renal cell carcinoma 1387 1 0.040559179 1 0.064921185 10813 hsa-mir-3123 hsa04720 Long-term potentiation 1387 1 0.042192406 1 0.064921185 10814 hsa-mir-3123 hsa05220 Chronic myeloid leukemia 5925 1 0.042192406 1 0.064921185 10815 hsa-mir-3123 hsa04520 Adherens junction 1387 1 0.044908637 1 0.064921185 10816 hsa-mir-3123 hsa04512 ECM-receptor interaction 9672 1 0.0470764 1 0.064921185 10817 hsa-mir-3123 hsa05222 Small cell lung cancer 5925 1 0.048158544 1 0.064921185 10818 hsa-mir-3123 hsa04350 TGF-beta signaling pathway 1387 1 0.048699183 1 0.064921185 10819 hsa-mir-3123 hsa04612 Antigen processing and presentation 1514 1 0.049779592 1 0.064921185 10820 hsa-mir-3124 hsa05200 Pathways in cancer 3066_3320_1029_1870_1499_5594_5599_1387_595_1487_1488_207_1019_367_1017_2932_4193_7704_6774_6776_6777_5970_7157_4087_6688_2113_5894_4609_3725_1026_2353_2736_4088_5925_2033_1871_1050_8554_4790_4791 40 1.20E-33 8.85E-32 8.85E-32 10821 hsa-mir-3124 hsa05220 Chronic myeloid leukemia 3066_1029_1870_5594_595_1487_1488_207_1019_4193_6776_6777_5970_7157_5894_4609_1026_4088_5925_1871_4790 21 8.67E-25 6.41E-23 3.21E-23 10822 hsa-mir-3124 hsa04110 Cell cycle 3066_1029_1870_5591_1387_595_1019_1017_7533_2932_4193_7027_2810_7157_4087_1026_4088_5925_2033_1871_894_896_5933 23 7.64E-24 5.66E-22 1.89E-22 10823 hsa-mir-3124 hsa05215 Prostate cancer 3320_1870_1499_5594_1385_1387_595_207_367_1017_2932_4193_5970_7157_468_5894_1026_5925_2033_1871_4790 21 1.55E-23 1.14E-21 2.81E-22 10824 hsa-mir-3124 hsa05212 Pancreatic cancer 3320_1870_1499_5594_1385_1387_595_207_367_1017_2932_4193_5970_7157_468_5894_1026_5925_2033_1871_4790 21 1.90E-23 1.40E-21 2.81E-22 10825 hsa-mir-3124 hsa04010 MAPK signaling pathway 5594_6722_5599_1386_9261_3303_207_6195_5566_9252_1432_1649_5970_7157_468_5894_4609_3725_6196_6197_2353_8986_5536_4790_4791 25 1.17E-18 8.62E-17 1.44E-17 10826 hsa-mir-3124 hsa05214 Glioma 1029_1870_5594_595_207_1019_4193_7157_5894_1026_5925_1871_808_801_805 15 5.79E-17 4.28E-15 6.12E-16 10827 hsa-mir-3124 hsa05219 Bladder cancer 1029_1870_5594_595_1019_9252_4193_7157_5894_4609_1026_5925_1871 13 2.78E-16 2.06E-14 2.57E-15 10828 hsa-mir-3124 hsa05221 Acute myeloid leukemia 5594_595_207_7704_6774_6776_6777_5970_6688_5894_4609_1050_4790 13 1.21E-14 8.96E-13 9.96E-14 10829 hsa-mir-3124 hsa04310 Wnt signaling pathway 1499_5599_1387_595_1487_1488_5566_2932_7157_4087_4609_3725_4088_2033_894_896 16 3.22E-13 2.38E-11 2.38E-12 10830 hsa-mir-3124 hsa05210 Colorectal cancer 1499_5594_5599_595_207_2932_7157_4087_5894_4609_3725_2353_4088 13 6.71E-13 4.97E-11 4.52E-12 10831 hsa-mir-3124 hsa05218 Melanoma 1029_1870_5594_595_207_1019_4193_7157_5894_1026_5925_1871 12 2.08E-12 1.54E-10 1.28E-11 10832 hsa-mir-3124 hsa04720 Long-term potentiation 5594_1387_6195_5566_468_5894_6196_6197_2033_808_801_805 12 3.70E-12 2.74E-10 2.11E-11 10833 hsa-mir-3124 hsa04660 T cell receptor signaling pathway 3932_5594_920_207_1019_915_2932_1432_5970_5894_3725_2353_4790 13 1.48E-11 1.10E-09 7.76E-11 10834 hsa-mir-3124 hsa05222 Small cell lung cancer 1870_595_207_1019_1017_5970_7157_4609_5925_1871_8554_4790 12 1.57E-11 1.16E-09 7.76E-11 10835 hsa-mir-3124 hsa05223 Non-small cell lung cancer 1029_1870_5594_595_207_1019_7157_5894_5925_1871 10 6.68E-11 4.95E-09 3.09E-10 10836 hsa-mir-3124 hsa04115 p53 signaling pathway 1029_595_1019_1017_4193_2810_7157_1026_894_896 10 5.75E-10 4.25E-08 2.50E-09 10837 hsa-mir-3124 hsa04916 Melanogenesis 1499_5594_1385_1387_5566_2932_5894_2033_808_801_805 11 1.66E-09 1.23E-07 6.81E-09 10838 hsa-mir-3124 hsa04350 TGF-beta signaling pathway 5594_1387_6667_7027_1874_4087_4609_4088_2033_5933 10 4.44E-09 3.29E-07 1.64E-08 10839 hsa-mir-3124 hsa04012 ErbB signaling pathway 5594_5599_207_2932_6776_6777_5894_4609_3725_1026 10 4.44E-09 3.29E-07 1.64E-08 10840 hsa-mir-3124 hsa05016 Huntington's disease 3066_10891_25942_1385_1387_291_6908_6667_5481_7157_23186_3064_2033 13 6.70E-09 4.96E-07 2.36E-08 10841 hsa-mir-3124 hsa04630 Jak-STAT signaling pathway 1387_595_207_3460_6774_6776_6777_4609_2033_894_896_8554 12 7.94E-09 5.88E-07 2.67E-08 10842 hsa-mir-3124 hsa05213 Endometrial cancer 1499_5594_595_207_2932_7157_5894_4609 8 2.07E-08 1.53E-06 6.65E-08 10843 hsa-mir-3124 hsa04910 Insulin signaling pathway 10891_6720_5594_5599_207_5566_2932_5894_808_801_805 11 2.55E-08 1.89E-06 7.86E-08 10844 hsa-mir-3124 hsa04912 GnRH signaling pathway 5594_5599_5566_1432_468_5894_3725_808_801_805 10 2.99E-08 2.21E-06 8.84E-08 10845 hsa-mir-3124 hsa04330 Notch signaling pathway 3066_1387_1487_1488_4851_9612_2033 7 1.98E-07 1.46E-05 5.63E-07 10846 hsa-mir-3124 hsa04662 B cell receptor signaling pathway 5594_207_2932_5970_5894_3725_2353_4790 8 2.73E-07 2.02E-05 7.49E-07 10847 hsa-mir-3124 hsa04620 Toll-like receptor signaling pathway 5594_5599_207_1432_5970_3725_2353_4790 8 2.37E-06 0.00017571 6.28E-06 10848 hsa-mir-3124 hsa05211 Renal cell carcinoma 5594_1387_207_2113_5894_3725_2033 7 2.75E-06 0.000203176 7.01E-06 10849 hsa-mir-3124 hsa05216 Thyroid cancer 1499_5594_595_7157_4609 5 6.16E-06 0.0004562 1.52E-05 10850 hsa-mir-3124 hsa04510 Focal adhesion 1499_5594_5599_595_207_2932_5894_3725_894_896 10 7.82E-06 0.000578682 1.87E-05 10851 hsa-mir-3124 hsa04920 Adipocytokine signaling pathway 10891_5599_207_6774_5970_4790 6 2.23E-05 0.001647045 5.15E-05 10852 hsa-mir-3124 hsa04062 Chemokine signaling pathway 5594_207_5566_2932_6774_6777_5970_5894_4790 9 3.02E-05 0.002235531 6.77E-05 10853 hsa-mir-3124 hsa04270 Vascular smooth muscle contraction 5594_5592_5566_5894_808_801_805 7 5.59E-05 0.004136761 0.000119543 10854 hsa-mir-3124 hsa04520 Adherens junction 1499_5594_1387_4087_4088_2033 6 5.65E-05 0.004184022 0.000119543 10855 hsa-mir-3124 hsa04150 mTOR signaling pathway 5594_207_6195_6196_6197 5 8.03E-05 0.005939755 0.000164993 10856 hsa-mir-3124 hsa04612 Antigen processing and presentation 3320_811_920_1385_3303_4800 6 9.86E-05 0.007299937 0.000197296 10857 hsa-mir-3124 hsa05340 Primary immunodeficiency 3932_920_915_100 4 0.000232531 0.017207317 0.000452824 10858 hsa-mir-3124 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_1432_5970_3725_4790 5 0.000314385 0.023264497 0.000596526 10859 hsa-mir-3124 hsa04370 VEGF signaling pathway 5594_9261_207_1432_5894 5 0.000447205 0.033093153 0.000827329 10860 hsa-mir-3124 hsa04664 Fc epsilon RI signaling pathway 5594_5599_207_1432_5894 5 0.000499702 0.036977959 0.000901901 10861 hsa-mir-3124 hsa05010 Alzheimer's disease 5594_3416_2932_808_22926_801_805 7 0.000602699 0.044599762 0.001061899 10862 hsa-mir-3124 hsa04210 Apoptosis 207_5566_5970_7157_4790 5 0.000834684 0.0617666 0.001436433 10863 hsa-mir-3124 hsa05217 Basal cell carcinoma 1499_2932_7157_2736 4 0.001140251 0.0843786 0.001917695 10864 hsa-mir-3124 hsa04950 Maturity onset diabetes of the young 3651_6927_3175 3 0.001167043 0.086361167 0.001919137 10865 hsa-mir-3124 hsa03022 Basal transcription factors 2963_2969_6908 3 0.003661225 0.270930637 0.005881685 10866 hsa-mir-3124 hsa04020 Calcium signaling pathway 291_5566_5481_808_801_805 6 0.003735665 0.276439181 0.005881685 10867 hsa-mir-3124 hsa04930 Type II diabetes mellitus 3651_5594_5599 3 0.006125559 0.453291333 0.009443569 10868 hsa-mir-3124 hsa04540 Gap junction 5594_5592_5566_5894 4 0.006911789 0.511472379 0.010438212 10869 hsa-mir-3124 hsa04340 Hedgehog signaling pathway 5566_2932_2736 3 0.01132637 0.838151382 0.016763028 10870 hsa-mir-3124 hsa04730 Long-term depression 5594_5592_5894 3 0.019835178 1 0.028780455 10871 hsa-mir-3124 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.023530222 1 0.033485315 10872 hsa-mir-3124 hsa04650 Natural killer cell mediated cytotoxicity 3932_5594_3460_5894 4 0.024800787 1 0.034627514 10873 hsa-mir-3124 hsa04120 Ubiquitin mediated proteolysis 672_4193_7329_8554 4 0.025364622 1 0.034758927 10874 hsa-mir-3125 hsa05200 Pathways in cancer 3716_3320_5371_3551_1499_5595_5594_861_5914_1387_6256_595_836_1017_1147_8517_2932_367_7704_3091_5970_7428_1870_1871_7157_4087_6688_2113_4609_1869_3725_6774_3065_4088_4089_7175_3066_1050_5925_2034_2033_4846_4149_207_208_3326_4286_4790_4791_4792_2353 51 1.52E-37 1.18E-35 1.18E-35 10875 hsa-mir-3125 hsa05220 Chronic myeloid leukemia 3551_5595_5594_861_595_1147_8517_5970_1870_1871_7157_4609_1869_3065_4088_4089_3066_5925_207_208_4790_4792_6464 23 2.52E-23 1.97E-21 7.09E-22 10876 hsa-mir-3125 hsa05215 Prostate cancer 3320_3551_1499_5595_5594_1387_595_1017_1147_8517_2932_367_5970_1870_1871_7157_1869_5925_2033_207_208_3326_4790_4792 24 2.90E-23 2.26E-21 7.09E-22 10877 hsa-mir-3125 hsa05212 Pancreatic cancer 3320_3551_1499_5595_5594_1387_595_1017_1147_8517_2932_367_5970_1870_1871_7157_1869_5925_2033_207_208_3326_4790_4792 24 3.64E-23 2.84E-21 7.09E-22 10878 hsa-mir-3125 hsa04110 Cell cycle 993_5591_1387_595_983_7534_1017_7532_2932_8454_1870_1871_7157_4087_1869_6500_3065_4088_4089_3066_5925_2033_890_5934_5933 25 8.74E-22 6.82E-20 1.36E-20 10879 hsa-mir-3125 hsa04010 MAPK signaling pathway 1432_6722_3303_5598_3551_5595_5594_4208_3305_836_5566_1147_8517_5971_5970_1326_3312_7157_4609_3725_3310_4763_5058_1616_4149_207_208_4790_4791_2353 30 1.08E-18 8.45E-17 1.41E-17 10880 hsa-mir-3125 hsa05221 Acute myeloid leukemia 5371_3551_5595_5594_861_5914_595_1147_8517_7704_5970_6688_4609_6774_1050_207_208_4790 18 1.71E-18 1.33E-16 1.90E-17 10881 hsa-mir-3125 hsa05222 Small cell lung cancer 3551_6256_595_1017_1147_8517_5970_1870_1871_7157_4609_1869_5925_4846_4149_207_208_4790_4792 19 3.27E-17 2.55E-15 3.19E-16 10882 hsa-mir-3125 hsa04660 T cell receptor signaling pathway 1432_3551_5595_5594_1147_8517_2932_5777_5970_4794_1326_3725_5058_207_208_4790_4792_4793_2353 19 1.77E-15 1.38E-13 1.53E-14 10883 hsa-mir-3125 hsa04662 B cell receptor signaling pathway 3551_5595_5594_1147_8517_2932_5777_5970_4794_3725_207_208_4790_4792_4793_2353 16 1.71E-14 1.33E-12 1.33E-13 10884 hsa-mir-3125 hsa04350 TGF-beta signaling pathway 5595_5594_1387_8454_3399_3398_1874_1875_4087_4609_6500_4088_4089_2033_5934_5933 16 1.29E-13 1.01E-11 9.17E-13 10885 hsa-mir-3125 hsa05214 Glioma 5595_5594_595_808_1870_1871_7157_1869_5925_207_208_6464_801_805 14 6.78E-13 5.29E-11 4.40E-12 10886 hsa-mir-3125 hsa05210 Colorectal cancer 1499_5595_5594_595_836_2932_7157_4087_4609_3725_4088_4089_207_208_2353 15 1.11E-12 8.63E-11 6.64E-12 10887 hsa-mir-3125 hsa04310 Wnt signaling pathway 23291_1499_1387_595_8607_5566_2932_8454_7157_4087_8945_4609_3725_1457_6500_4088_4089_2033 18 3.26E-12 2.54E-10 1.81E-11 10888 hsa-mir-3125 hsa04920 Adipocytokine signaling pathway 3551_6256_1147_8517_5970_4794_6774_207_208_4790_4792_4793_2538 13 1.44E-11 1.13E-09 7.50E-11 10889 hsa-mir-3125 hsa04062 Chemokine signaling pathway 3551_5590_5595_5594_5566_1147_8517_2932_6773_5970_653361_6774_5058_207_208_4790_4792_4793_6464 19 1.57E-11 1.22E-09 7.65E-11 10890 hsa-mir-3125 hsa04620 Toll-like receptor signaling pathway 1432_3551_5595_5594_1147_8517_5970_1326_3725_207_208_4790_4792_2353 14 1.47E-10 1.15E-08 6.76E-10 10891 hsa-mir-3125 hsa04210 Apoptosis 3551_836_5566_1147_8517_8837_840_5970_7157_207_208_4790_4792 13 3.37E-10 2.63E-08 1.42E-09 10892 hsa-mir-3125 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925_207_208 11 3.46E-10 2.70E-08 1.42E-09 10893 hsa-mir-3125 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2113_3725_5058_2034_2033_207_208 12 4.20E-10 3.28E-08 1.64E-09 10894 hsa-mir-3125 hsa04520 Adherens junction 1499_6714_5595_5594_1387_5777_4087_1457_4088_4089_2033_71 12 1.24E-09 9.65E-08 4.59E-09 10895 hsa-mir-3125 hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5925_207_208_4286 11 4.50E-09 3.51E-07 1.53E-08 10896 hsa-mir-3125 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_3551_6714_836_1147_8517_5970_3725_5058_4790_4792 11 4.50E-09 3.51E-07 1.53E-08 10897 hsa-mir-3125 hsa04910 Insulin signaling pathway 6720_3551_5590_5595_5594_5566_2932_808_207_208_6464_2538_801_805 14 5.35E-09 4.17E-07 1.74E-08 10898 hsa-mir-3125 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5925 9 9.70E-09 7.57E-07 3.03E-08 10899 hsa-mir-3125 hsa05216 Thyroid cancer 1499_5595_5594_6256_595_7157_4609_7175 8 1.20E-08 9.35E-07 3.60E-08 10900 hsa-mir-3125 hsa05016 Huntington's disease 6874_1387_292_2902_6908_836_5437_7157_1213_5441_3065_3066_3064_293_2033 15 3.05E-08 2.38E-06 8.81E-08 10901 hsa-mir-3125 hsa05213 Endometrial cancer 1499_5595_5594_595_2932_7157_4609_207_208 9 4.97E-08 3.88E-06 1.39E-07 10902 hsa-mir-3125 hsa04540 Gap junction 5598_6714_5595_5594_203068_983_5566_7278_347733_10382_84617 11 5.66E-08 4.41E-06 1.52E-07 10903 hsa-mir-3125 hsa04630 Jak-STAT signaling pathway 3716_3559_1387_595_5777_6778_6773_4609_6774_3566_2033_207_208 13 1.49E-07 1.16E-05 3.88E-07 10904 hsa-mir-3125 hsa04916 Melanogenesis 1499_5595_5594_1387_5566_2932_808_2033_4286_801_805 11 1.60E-07 1.25E-05 4.04E-07 10905 hsa-mir-3125 hsa04012 ErbB signaling pathway 6714_5595_5594_2932_4609_3725_5058_207_208_6464 10 2.91E-07 2.27E-05 7.10E-07 10906 hsa-mir-3125 hsa04612 Antigen processing and presentation 3320_3303_3309_3305_4800_3312_1514_3310_4801_3326 10 3.53E-07 2.75E-05 8.34E-07 10907 hsa-mir-3125 hsa04720 Long-term potentiation 5595_5594_1387_2902_5566_808_2033_801_805 9 8.27E-07 6.45E-05 1.90E-06 10908 hsa-mir-3125 hsa05131 Shigellosis 1499_203068_7534_7278_347733_10382_84617_71 8 1.04E-06 8.07E-05 2.24E-06 10909 hsa-mir-3125 hsa05130 Pathogenic Escherichia coli infection 1499_203068_7534_7278_347733_10382_84617_71 8 1.04E-06 8.07E-05 2.24E-06 10910 hsa-mir-3125 hsa04912 GnRH signaling pathway 1432_5598_6714_5595_5594_5566_808_3725_801_805 10 1.80E-06 0.000140635 3.80E-06 10911 hsa-mir-3125 hsa04510 Focal adhesion 1499_6714_5595_5594_595_2932_10627_3725_5058_207_208_71_6464 13 3.02E-06 0.000235544 6.20E-06 10912 hsa-mir-3125 hsa03020 RNA polymerase 64425_5437_25885_5441_51082_84172 6 3.61E-06 0.000281671 7.22E-06 10913 hsa-mir-3125 hsa04330 Notch signaling pathway 1387_9612_3065_3066_2033_4851_8850 7 3.87E-06 0.000301492 7.54E-06 10914 hsa-mir-3125 hsa04530 Tight junction 1499_6714_5590_4627_4628_10627_1457_207_208_71 10 1.29E-05 0.00100595 2.45E-05 10915 hsa-mir-3125 hsa04120 Ubiquitin mediated proteolysis 5371_23291_672_8454_7428_10273_8945_6500_3093_7323 10 1.45E-05 0.001132103 2.70E-05 10916 hsa-mir-3125 hsa05010 Alzheimer's disease 1020_5595_5594_2902_836_2932_840_808_4846_801_805 11 1.99E-05 0.001549622 3.60E-05 10917 hsa-mir-3125 hsa04370 VEGF signaling pathway 1432_6714_5595_5594_4846_207_208 7 7.25E-05 0.005655178 0.000128527 10918 hsa-mir-3125 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_2902_836_7157_1616_4846 6 0.000103957 0.00810862 0.000180192 10919 hsa-mir-3125 hsa04150 mTOR signaling pathway 5595_5594_3091_207_208 5 0.000627405 0.048937577 0.00106386 10920 hsa-mir-3125 hsa04270 Vascular smooth muscle contraction 5595_5594_5566_808_4637_801_805 7 0.000837666 0.06533792 0.001390169 10921 hsa-mir-3125 hsa04340 Hedgehog signaling pathway 23291_53944_5566_2932_8945 5 0.000923095 0.072001433 0.00150003 10922 hsa-mir-3125 hsa04115 p53 signaling pathway 595_983_836_1017_7157 5 0.002042714 0.159331687 0.003251667 10923 hsa-mir-3125 hsa04020 Calcium signaling pathway 292_2902_5566_808_293_4846_801_805 8 0.002436338 0.190034371 0.003800687 10924 hsa-mir-3125 hsa04930 Type II diabetes mellitus 3551_5590_5595_5594 4 0.002896643 0.225938189 0.004430161 10925 hsa-mir-3125 hsa04664 Fc epsilon RI signaling pathway 1432_5595_5594_207_208 5 0.003550154 0.276912035 0.005325231 10926 hsa-mir-3125 hsa04810 Regulation of actin cytoskeleton 5595_5594_4627_4628_10788_10627_5058_71 8 0.006640158 0.517932347 0.009772308 10927 hsa-mir-3125 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_5777_5058_6464 6 0.008275236 0.645468438 0.011953119 10928 hsa-mir-3125 hsa03022 Basal transcription factors 6874_6908_2969 3 0.012429812 0.969525321 0.017627733 10929 hsa-mir-3125 hsa04670 Leukocyte transendothelial migration 1432_1499_653361_10627_71 5 0.019270714 1 0.026841351 10930 hsa-mir-3125 hsa04360 Axon guidance 1020_5595_5594_2932_5058 5 0.025023153 1 0.03424221 10931 hsa-mir-3125 hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.033144062 1 0.044573049 10932 hsa-mir-3125 hsa03010 Ribosome 6207_6156_6128_6202 4 0.039922106 1 0.052778378 10933 hsa-mir-3127 hsa05200 Pathways in cancer 3320_5371_5595_5594_5914_1387_6256_595_5601_836_207_1019_367_1017_2932_861_7704_5578_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_6774_2353_2736_4088_4089_3066_3065_1050_5925_2034_2033_4846_4286 42 1.85E-33 1.35E-31 1.35E-31 10934 hsa-mir-3127 hsa04110 Cell cycle 993_5591_1387_595_983_1019_1017_2932_1870_1871_7157_4087_1869_1028_4088_4089_3066_3065_5925_2033_894_896_5933 23 2.03E-22 1.49E-20 7.43E-21 10935 hsa-mir-3127 hsa04010 MAPK signaling pathway 6722_5595_5594_4208_5601_8986_836_207_4342_6197_6195_9252_1386_1432_5578_1649_5970_9261_3312_7157_468_4609_3725_3727_6196_2353_4763_1616 28 2.61E-20 1.90E-18 6.34E-19 10936 hsa-mir-3127 hsa05220 Chronic myeloid leukemia 5595_5594_595_207_1019_861_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464 18 2.89E-19 2.11E-17 5.28E-18 10937 hsa-mir-3127 hsa05215 Prostate cancer 3320_5595_5594_1387_595_207_367_1017_2932_5970_1870_1871_7157_468_1869_5925_2033 17 7.02E-17 5.12E-15 1.01E-15 10938 hsa-mir-3127 hsa05212 Pancreatic cancer 3320_5595_5594_1387_595_207_367_1017_2932_5970_1870_1871_7157_468_1869_5925_2033 17 8.29E-17 6.05E-15 1.01E-15 10939 hsa-mir-3127 hsa05214 Glioma 5595_5594_595_207_1019_5578_1870_1871_7157_1869_5925_6464_808_801_805 15 4.82E-16 3.52E-14 5.02E-15 10940 hsa-mir-3127 hsa04350 TGF-beta signaling pathway 3400_5595_5594_1387_6667_3397_3399_3398_4087_659_4609_4088_4089_2033_4092_5933 16 1.15E-15 8.42E-14 1.05E-14 10941 hsa-mir-3127 hsa05210 Colorectal cancer 5595_5594_595_5601_836_207_2932_7157_4087_4609_3725_2353_4088_4089 14 2.41E-13 1.76E-11 1.95E-12 10942 hsa-mir-3127 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_207_1019_5578_1870_1871_7157_1869_5925 12 6.37E-13 4.65E-11 4.65E-12 10943 hsa-mir-3127 hsa04720 Long-term potentiation 5595_5594_1387_2902_6197_6195_5578_468_6196_2033_808_801_805 13 1.12E-12 8.19E-11 7.44E-12 10944 hsa-mir-3127 hsa05219 Bladder cancer 5595_5594_595_1019_9252_1870_1871_7157_4609_1869_5925 11 1.27E-12 9.26E-11 7.72E-12 10945 hsa-mir-3127 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_207_861_7704_5970_4609_6774_1050 12 1.59E-12 1.16E-10 8.95E-12 10946 hsa-mir-3127 hsa04310 Wnt signaling pathway 1387_595_5601_2932_5578_7157_4087_8061_4609_3725_1457_4088_4089_2033_894_896 16 2.82E-12 2.06E-10 1.47E-11 10947 hsa-mir-3127 hsa05222 Small cell lung cancer 6256_595_207_1019_1017_5970_1870_1871_7157_4609_1869_5925_4846 13 5.30E-12 3.87E-10 2.58E-11 10948 hsa-mir-3127 hsa05218 Melanoma 5595_5594_595_207_1019_1870_1871_7157_1869_5925_4286 11 1.86E-10 1.35E-08 8.47E-10 10949 hsa-mir-3127 hsa05211 Renal cell carcinoma 5595_5594_1387_207_3091_7428_2113_3725_2034_2033 10 3.28E-09 2.40E-07 1.41E-08 10950 hsa-mir-3127 hsa04916 Melanogenesis 5595_5594_1387_2932_5578_2033_4286_808_801_805 10 8.13E-08 5.94E-06 3.30E-07 10951 hsa-mir-3127 hsa04912 GnRH signaling pathway 5595_5594_5601_1432_5578_468_3725_808_801_805 10 1.13E-07 8.24E-06 4.34E-07 10952 hsa-mir-3127 hsa04660 T cell receptor signaling pathway 5595_5594_5601_207_1019_2932_1432_5970_3725_2353 10 1.32E-07 9.66E-06 4.83E-07 10953 hsa-mir-3127 hsa04012 ErbB signaling pathway 5595_5594_5601_207_2932_5578_4609_3725_6464 9 2.06E-07 1.50E-05 7.17E-07 10954 hsa-mir-3127 hsa05016 Huntington's disease 6874_25942_1387_2902_836_6667_7157_3066_3065_3064_2033_6908 12 2.75E-07 2.01E-05 9.13E-07 10955 hsa-mir-3127 hsa04115 p53 signaling pathway 595_983_836_1019_1017_7157_894_896 8 4.47E-07 3.26E-05 1.42E-06 10956 hsa-mir-3127 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 6.22E-07 4.54E-05 1.89E-06 10957 hsa-mir-3127 hsa04910 Insulin signaling pathway 5595_5594_5601_207_6720_2932_6464_808_801_805 10 9.33E-07 6.81E-05 2.58E-06 10958 hsa-mir-3127 hsa05213 Endometrial cancer 5595_5594_595_207_2932_7157_4609 7 9.54E-07 6.97E-05 2.58E-06 10959 hsa-mir-3127 hsa04150 mTOR signaling pathway 5595_5594_207_6197_6195_3091_6196 7 9.54E-07 6.97E-05 2.58E-06 10960 hsa-mir-3127 hsa04520 Adherens junction 5595_5594_1387_4087_1457_4088_4089_2033 8 1.25E-06 9.15E-05 3.27E-06 10961 hsa-mir-3127 hsa04510 Focal adhesion 5595_5594_595_5601_207_2932_5578_3725_894_896_6464 11 4.47E-06 0.000326412 1.13E-05 10962 hsa-mir-3127 hsa04620 Toll-like receptor signaling pathway 5595_5594_5601_207_1432_5970_3725_2353 8 6.75E-06 0.000492683 1.64E-05 10963 hsa-mir-3127 hsa04330 Notch signaling pathway 1387_8850_9612_3066_3065_2033 6 7.70E-06 0.000561758 1.81E-05 10964 hsa-mir-3127 hsa04662 B cell receptor signaling pathway 5595_5594_207_2932_5970_3725_2353 7 8.93E-06 0.000652046 2.04E-05 10965 hsa-mir-3127 hsa04370 VEGF signaling pathway 5595_5594_207_1432_5578_9261_4846 7 1.05E-05 0.000765157 2.32E-05 10966 hsa-mir-3127 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_1432_7157_1616_4846 6 1.93E-05 0.001406653 4.14E-05 10967 hsa-mir-3127 hsa05010 Alzheimer's disease 5595_5594_2902_836_2932_4846_808_801_805 9 4.78E-05 0.003490332 9.97E-05 10968 hsa-mir-3127 hsa04630 Jak-STAT signaling pathway 1387_595_207_4609_6774_2033_894_896 8 0.000113999 0.008321954 0.000227952 10969 hsa-mir-3127 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5601_207_1432_5578 6 0.000115537 0.008434215 0.000227952 10970 hsa-mir-3127 hsa04270 Vascular smooth muscle contraction 5592_5595_5594_5578_808_801_805 7 0.000135361 0.009881357 0.000260036 10971 hsa-mir-3127 hsa04920 Adipocytokine signaling pathway 6256_5601_207_5970_6774 5 0.000467554 0.034131426 0.000875165 10972 hsa-mir-3127 hsa03022 Basal transcription factors 2963_6874_6883_6908 4 0.00048357 0.035300635 0.000882516 10973 hsa-mir-3127 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5601_836_1432_5970_3725 5 0.000599782 0.043784121 0.001042479 10974 hsa-mir-3127 hsa04730 Long-term depression 5592_5595_5594_5578_4846 5 0.000599782 0.043784121 0.001042479 10975 hsa-mir-3127 hsa04930 Type II diabetes mellitus 3651_5595_5594_5601 4 0.000956803 0.069846608 0.00162434 10976 hsa-mir-3127 hsa04612 Antigen processing and presentation 3320_1514_4800_4801_3312 5 0.001565158 0.114256534 0.002596739 10977 hsa-mir-3127 hsa04540 Gap junction 5592_5595_5594_983_5578 5 0.001881491 0.137348878 0.003052197 10978 hsa-mir-3127 hsa04062 Chemokine signaling pathway 5595_5594_207_2932_5970_6774_6464 7 0.002208073 0.16118935 0.003504116 10979 hsa-mir-3127 hsa04070 Phosphatidylinositol signaling system 5578_808_801_805 4 0.005760423 0.420510843 0.008947039 10980 hsa-mir-3127 hsa04020 Calcium signaling pathway 2902_5578_4846_808_801_805 6 0.007358252 0.537152372 0.011190674 10981 hsa-mir-3127 hsa04710 Circadian rhythm - mammal 8863_79365 2 0.007709297 0.562778714 0.01148528 10982 hsa-mir-3127 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_5578_6464 5 0.009323647 0.680626209 0.013612524 10983 hsa-mir-3127 hsa04210 Apoptosis 836_207_5970_7157 4 0.00972331 0.70980164 0.013917679 10984 hsa-mir-3127 hsa05217 Basal cell carcinoma 2932_7157_2736 3 0.015096814 1 0.021193604 10985 hsa-mir-3127 hsa04950 Maturity onset diabetes of the young 3651_168620 2 0.022376735 1 0.030820786 10986 hsa-mir-3127 hsa04530 Tight junction 207_1019_5578_1457 4 0.037873093 1 0.051198811 10987 hsa-mir-3127 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428_997 4 0.039553798 1 0.052498678 10988 hsa-mir-3128 hsa05200 Pathways in cancer 3320_4149_5371_1870_4292_7046_1499_5595_5594_5599_6258_1387_6256_836_1017_2932_842_841_6772_5970_1871_7157_4824_5604_5894_1869_4088_862_1029_6502_4087_4089_1050_5925_2033 35 2.67E-27 1.79E-25 1.79E-25 10989 hsa-mir-3128 hsa04110 Cell cycle 1870_990_5591_1387_890_983_1017_2932_8454_6500_1871_7157_1869_4088_1029_6502_4087_4089_5925_2033_5934_5933 22 3.07E-22 2.06E-20 1.03E-20 10990 hsa-mir-3128 hsa05215 Prostate cancer 3320_1870_1499_5595_5594_1385_1387_1017_2932_842_5970_1871_7157_4824_5604_5894_1869_5925_2033 19 1.76E-20 1.18E-18 3.56E-19 10991 hsa-mir-3128 hsa05212 Pancreatic cancer 3320_1870_1499_5595_5594_1385_1387_1017_2932_842_5970_1871_7157_4824_5604_5894_1869_5925_2033 19 2.13E-20 1.42E-18 3.56E-19 10992 hsa-mir-3128 hsa04350 TGF-beta signaling pathway 7046_5595_5594_1387_8454_3399_3398_6500_1874_1875_4088_4087_4089_2033_3397_5934_6667_5933 18 3.56E-19 2.39E-17 4.77E-18 10993 hsa-mir-3128 hsa05214 Glioma 1870_815_5595_5594_1871_7157_5604_5894_1869_1029_5925_808_801_805 14 2.12E-15 1.42E-13 2.29E-14 10994 hsa-mir-3128 hsa05210 Colorectal cancer 4292_7046_1499_5595_5594_5599_836_2932_842_7157_5604_5894_4088_4087_4089 15 2.40E-15 1.61E-13 2.29E-14 10995 hsa-mir-3128 hsa05223 Non-small cell lung cancer 1870_5595_5594_6258_6256_842_1871_7157_5604_5894_1869_1029_5925 13 6.21E-15 4.16E-13 5.20E-14 10996 hsa-mir-3128 hsa05220 Chronic myeloid leukemia 1870_7046_5595_5594_5970_1871_7157_5604_5894_1869_4088_1029_4089_5925 14 1.21E-14 8.11E-13 9.01E-14 10997 hsa-mir-3128 hsa04010 MAPK signaling pathway 9479_6722_4149_7046_5595_5594_5599_5598_9261_4208_836_7867_1386_1432_5970_7157_5604_5894_6195_2002_2005 21 3.08E-14 2.06E-12 2.06E-13 10998 hsa-mir-3128 hsa04310 Wnt signaling pathway 815_1499_5599_1387_2932_8454_6500_7157_6423_8061_4088_1457_1459_4087_4089_2033 16 4.74E-13 3.17E-11 2.89E-12 10999 hsa-mir-3128 hsa04520 Adherens junction 4301_7046_1499_6714_5595_5594_1387_4088_1457_1459_4087_4089_2033 13 5.29E-13 3.55E-11 2.96E-12 11000 hsa-mir-3128 hsa05219 Bladder cancer 1870_5595_5594_1871_7157_5604_5894_1869_1029_5925 10 9.71E-12 6.50E-10 5.00E-11 11001 hsa-mir-3128 hsa04916 Melanogenesis 815_1499_5595_5594_1385_1387_2932_5604_5894_2033_808_801_805 13 1.07E-11 7.15E-10 5.11E-11 11002 hsa-mir-3128 hsa04912 GnRH signaling pathway 815_6714_5595_5594_5599_5598_1432_5604_5894_2002_808_801_805 13 1.65E-11 1.10E-09 7.35E-11 11003 hsa-mir-3128 hsa05222 Small cell lung cancer 4149_1870_6258_6256_1017_842_5970_1871_7157_1869_6502_5925 12 2.11E-11 1.41E-09 8.83E-11 11004 hsa-mir-3128 hsa04540 Gap junction 6714_5595_5594_5598_983_7277_7278_5604_5894_7846_51807_10376 12 4.82E-11 3.23E-09 1.90E-10 11005 hsa-mir-3128 hsa05213 Endometrial cancer 4292_1499_5595_5594_2932_842_7157_5604_5894_2002 10 6.16E-11 4.12E-09 2.29E-10 11006 hsa-mir-3128 hsa04720 Long-term potentiation 815_5595_5594_1387_5604_5894_6195_2033_808_801_805 11 9.07E-11 6.07E-09 3.20E-10 11007 hsa-mir-3128 hsa05218 Melanoma 1870_5595_5594_1871_7157_5604_5894_1869_1029_5925 10 9.43E-10 6.32E-08 3.16E-09 11008 hsa-mir-3128 hsa05216 Thyroid cancer 1499_5595_5594_6258_6256_7157_5604 7 1.25E-08 8.35E-07 3.98E-08 11009 hsa-mir-3128 hsa04370 VEGF signaling pathway 6714_5595_5594_9261_7867_1432_842_5604_5894 9 2.91E-08 1.95E-06 8.85E-08 11010 hsa-mir-3128 hsa05221 Acute myeloid leukemia 5371_5595_5594_5970_5604_5894_862_1050 8 6.10E-08 4.09E-06 1.78E-07 11011 hsa-mir-3128 hsa04012 ErbB signaling pathway 815_6714_5595_5594_5599_2932_5604_5894_2002 9 7.65E-08 5.13E-06 2.14E-07 11012 hsa-mir-3128 hsa04115 p53 signaling pathway 7161_983_836_1017_842_841_7157_1029 8 1.84E-07 1.23E-05 4.93E-07 11013 hsa-mir-3128 hsa04910 Insulin signaling pathway 5595_5594_5599_2932_5604_5894_2002_808_801_805 10 3.22E-07 2.15E-05 8.29E-07 11014 hsa-mir-3128 hsa05010 Alzheimer's disease 22926_5595_5594_836_2932_842_841_840_808_801_805 11 3.52E-07 2.36E-05 8.73E-07 11015 hsa-mir-3128 hsa05131 Shigellosis 1499_7277_7278_7846_51807_4691_10376 7 6.89E-07 4.62E-05 1.59E-06 11016 hsa-mir-3128 hsa05130 Pathogenic Escherichia coli infection 1499_7277_7278_7846_51807_4691_10376 7 6.89E-07 4.62E-05 1.59E-06 11017 hsa-mir-3128 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_1432_841_6772_5970_5604 8 2.86E-06 0.000191643 6.39E-06 11018 hsa-mir-3128 hsa04330 Notch signaling pathway 388585_1387_9612_2033_2648_8850 6 3.95E-06 0.00026432 8.53E-06 11019 hsa-mir-3128 hsa04210 Apoptosis 836_839_842_841_840_5970_7157 7 1.19E-05 0.000796347 2.49E-05 11020 hsa-mir-3128 hsa05016 Huntington's disease 1385_1387_6908_836_842_841_7157_2033_6667 9 3.02E-05 0.002023923 6.13E-05 11021 hsa-mir-3128 hsa05211 Renal cell carcinoma 5595_5594_1387_5604_5894_2033 6 3.74E-05 0.002506785 7.37E-05 11022 hsa-mir-3128 hsa04660 T cell receptor signaling pathway 5595_5594_2932_1432_5970_5604_5894 7 4.30E-05 0.002878099 8.22E-05 11023 hsa-mir-3128 hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_5604_5894 6 4.63E-05 0.003105316 8.63E-05 11024 hsa-mir-3128 hsa04510 Focal adhesion 1499_6714_5595_5594_5599_2932_5604_5894_2002 9 5.96E-05 0.003993454 0.000107258 11025 hsa-mir-3128 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_1432_5604_5894 6 6.08E-05 0.004075788 0.000107258 11026 hsa-mir-3128 hsa04270 Vascular smooth muscle contraction 5595_5594_5604_5894_808_801_805 7 6.55E-05 0.004386051 0.000112463 11027 hsa-mir-3128 hsa04120 Ubiquitin mediated proteolysis 7329_55294_5371_8454_6500_6502_672 7 0.000172954 0.011587905 0.000289698 11028 hsa-mir-3128 hsa04062 Chemokine signaling pathway 5595_5594_2932_6772_5970_5604_5894_7074 8 0.000216173 0.014483567 0.000353258 11029 hsa-mir-3128 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5599_836_1432_5970 5 0.000352735 0.023633265 0.000562697 11030 hsa-mir-3128 hsa04930 Type II diabetes mellitus 3651_5595_5594_5599 4 0.000619453 0.041503367 0.000965195 11031 hsa-mir-3128 hsa04612 Antigen processing and presentation 3320_1385_4800_4801_4802 5 0.000933805 0.062564915 0.00142193 11032 hsa-mir-3128 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432_842_7157 4 0.001331877 0.089235769 0.001983017 11033 hsa-mir-3128 hsa04920 Adipocytokine signaling pathway 5599_6258_6256_5970 4 0.002479702 0.166140055 0.00361174 11034 hsa-mir-3128 hsa04730 Long-term depression 5595_5594_5604_5894 4 0.003026477 0.202773939 0.004314339 11035 hsa-mir-3128 hsa03022 Basal transcription factors 2962_2969_6908 3 0.00392772 0.263157224 0.005482442 11036 hsa-mir-3128 hsa04530 Tight junction 4301_1499_6714_1457_1459 5 0.005614363 0.376162353 0.007676783 11037 hsa-mir-3128 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_5604_5894 5 0.005781015 0.387328029 0.007746561 11038 hsa-mir-3128 hsa04150 mTOR signaling pathway 5595_5594_6195 3 0.00956094 0.640582949 0.01256045 11039 hsa-mir-3128 hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.011051817 0.740471728 0.014239841 11040 hsa-mir-3128 hsa04950 Maturity onset diabetes of the young 3651_168620 2 0.017985045 1 0.022735812 11041 hsa-mir-3128 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.02510367 1 0.031147147 11042 hsa-mir-3128 hsa04810 Regulation of actin cytoskeleton 5595_5594_5604_5894_7074 5 0.033624525 1 0.040960785 11043 hsa-mir-3129 hsa05215 Prostate cancer 1147_3551_2033_208_207_2932_367_1499_1387 9 4.81E-14 2.45E-12 1.35E-12 11044 hsa-mir-3129 hsa05212 Pancreatic cancer 1147_3551_2033_208_207_2932_367_1499_1387 9 5.28E-14 2.70E-12 1.35E-12 11045 hsa-mir-3129 hsa05200 Pathways in cancer 1147_4087_4088_4089_3551_2033_208_207_2932_367_1499_1387 12 2.64E-13 1.35E-11 4.49E-12 11046 hsa-mir-3129 hsa04110 Cell cycle 4087_4088_4089_2033_7534_7532_2932_1387 8 3.18E-11 1.62E-09 4.05E-10 11047 hsa-mir-3129 hsa04520 Adherens junction 4087_4088_4089_2033_1499_6714_1387 7 1.04E-10 5.29E-09 1.06E-09 11048 hsa-mir-3129 hsa05210 Colorectal cancer 4087_4088_4089_208_207_2932_1499 7 1.43E-10 7.29E-09 1.22E-09 11049 hsa-mir-3129 hsa05220 Chronic myeloid leukemia 1147_4088_4089_3551_208_207 6 4.05E-09 2.07E-07 2.95E-08 11050 hsa-mir-3129 hsa04310 Wnt signaling pathway 4087_4088_4089_2033_2932_1499_1387 7 7.25E-09 3.70E-07 4.62E-08 11051 hsa-mir-3129 hsa04660 T cell receptor signaling pathway 1147_5058_3551_208_207_2932 6 3.55E-08 1.81E-06 2.01E-07 11052 hsa-mir-3129 hsa04920 Adipocytokine signaling pathway 1147_3551_208_207_2538 5 1.20E-07 6.14E-06 6.14E-07 11053 hsa-mir-3129 hsa05211 Renal cell carcinoma 5058_2033_208_207_1387 5 1.69E-07 8.62E-06 7.84E-07 11054 hsa-mir-3129 hsa04662 B cell receptor signaling pathway 1147_3551_208_207_2932 5 2.05E-07 1.05E-05 8.71E-07 11055 hsa-mir-3129 hsa04350 TGF-beta signaling pathway 4087_4088_4089_2033_1387 5 4.13E-07 2.11E-05 1.51E-06 11056 hsa-mir-3129 hsa04012 ErbB signaling pathway 5058_208_207_2932_6714 5 4.13E-07 2.11E-05 1.51E-06 11057 hsa-mir-3129 hsa04062 Chemokine signaling pathway 1147_5058_3551_208_207_2932 6 8.63E-07 4.40E-05 2.93E-06 11058 hsa-mir-3129 hsa04510 Focal adhesion 5058_208_207_2932_1499_6714 6 1.25E-06 6.36E-05 3.98E-06 11059 hsa-mir-3129 hsa05213 Endometrial cancer 208_207_2932_1499 4 2.15E-06 0.000109794 6.46E-06 11060 hsa-mir-3129 hsa05221 Acute myeloid leukemia 1147_3551_208_207 4 3.46E-06 0.000176576 9.81E-06 11061 hsa-mir-3129 hsa04910 Insulin signaling pathway 3551_208_207_2932_2538 5 3.67E-06 0.000186948 9.84E-06 11062 hsa-mir-3129 hsa04010 MAPK signaling pathway 1147_6722_5058_3551_208_207 6 6.07E-06 0.00030971 1.55E-05 11063 hsa-mir-3129 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_5058_3551_6714 4 6.96E-06 0.000355163 1.69E-05 11064 hsa-mir-3129 hsa05222 Small cell lung cancer 1147_3551_208_207 4 1.44E-05 0.00073336 3.33E-05 11065 hsa-mir-3129 hsa04210 Apoptosis 1147_3551_208_207 4 1.64E-05 0.000834985 3.63E-05 11066 hsa-mir-3129 hsa04620 Toll-like receptor signaling pathway 1147_3551_208_207 4 2.74E-05 0.001398736 5.83E-05 11067 hsa-mir-3129 hsa04916 Melanogenesis 2033_2932_1499_1387 4 2.95E-05 0.001505338 6.02E-05 11068 hsa-mir-3129 hsa04530 Tight junction 208_207_1499_6714 4 8.35E-05 0.004260277 0.000163857 11069 hsa-mir-3129 hsa04630 Jak-STAT signaling pathway 2033_208_207_1387 4 0.000132851 0.006775404 0.000250941 11070 hsa-mir-3129 hsa04370 VEGF signaling pathway 208_207_6714 3 0.000306481 0.015630512 0.000558233 11071 hsa-mir-3129 hsa04330 Notch signaling pathway 2033_1387 2 0.00291712 0.148773115 0.005130107 11072 hsa-mir-3129 hsa04150 mTOR signaling pathway 208_207 2 0.003531285 0.180095551 0.006003185 11073 hsa-mir-3129 hsa05223 Non-small cell lung cancer 208_207 2 0.003792388 0.19341177 0.006093336 11074 hsa-mir-3129 hsa05217 Basal cell carcinoma 2932_1499 2 0.003926218 0.200237103 0.006093336 11075 hsa-mir-3129 hsa05131 Shigellosis 7534_1499 2 0.004062224 0.20717343 0.006093336 11076 hsa-mir-3129 hsa05130 Pathogenic Escherichia coli infection 7534_1499 2 0.004062224 0.20717343 0.006093336 11077 hsa-mir-3129 hsa04340 Hedgehog signaling pathway 2932_53944 2 0.0042004 0.214220386 0.006120582 11078 hsa-mir-3129 hsa05214 Glioma 208_207 2 0.005383042 0.27453516 0.007625977 11079 hsa-mir-3129 hsa05218 Melanoma 208_207 2 0.006358656 0.324291439 0.008764633 11080 hsa-mir-3129 hsa04720 Long-term potentiation 2033_1387 2 0.007050434 0.359572129 0.009462424 11081 hsa-mir-3129 hsa04664 Fc epsilon RI signaling pathway 208_207 2 0.007774794 0.396514501 0.010167038 11082 hsa-mir-3129 hsa04360 Axon guidance 5058_2932 2 0.019963764 1 0.0254538 11083 hsa-mir-3129 hsa05016 Huntington's disease 2033_1387 2 0.038516907 1 0.047911274 11084 hsa-mir-3129 hsa04950 Maturity onset diabetes of the young 3172 1 0.03999457 1 0.048564835 11085 hsa-mir-3129 hsa05216 Thyroid cancer 1499 1 0.047803337 1 0.056696981 11086 hsa-mir-3130-2 hsa05200 Pathways in cancer 3716_5747_3725_5594_5914_1387_2064_5159_5156_1487_1399_1398_2261_3815_6774_6776_6777_6772_5879_7046_2113_8772_867_2353_4087_4088_4089_1488_2033_207_8554_5970_1956 33 6.08E-34 3.83E-32 3.83E-32 11087 hsa-mir-3130-2 hsa04630 Jak-STAT signaling pathway 3717_3716_3559_3560_3561_1387_3575_5777_6774_6776_6777_6772_6773_58985_2057_3455_3459_5781_7297_867_2690_1439_2033_207_8554_10379 26 3.84E-32 2.42E-30 1.21E-30 11088 hsa-mir-3130-2 hsa04060 Cytokine-cytokine receptor interaction 2321_3791_3559_90_3560_3561_5159_5156_7133_7132_3575_1234_1230_3815_7046_7852_58985_2057_3455_3459_2690_1439_1956 23 1.35E-22 8.52E-21 2.84E-21 11089 hsa-mir-3130-2 hsa04012 ErbB signaling pathway 5747_3725_818_817_6714_5594_2064_2066_1399_1398_6776_6777_867_207_6464_1956 16 1.17E-20 7.39E-19 1.85E-19 11090 hsa-mir-3130-2 hsa05220 Chronic myeloid leukemia 5594_1487_1399_1398_6776_6777_7046_5781_867_4088_4089_1488_207_5970_6464 15 6.42E-20 4.05E-18 8.09E-19 11091 hsa-mir-3130-2 hsa04520 Adherens junction 6714_3643_5594_1387_2064_5770_5777_5879_7046_4087_4088_4089_2033_1956_2534 15 1.52E-19 9.58E-18 1.60E-18 11092 hsa-mir-3130-2 hsa04062 Chemokine signaling pathway 3717_5747_5580_5594_1399_1398_1234_1230_6774_6777_6772_6773_5879_7852_207_5970_6464 17 5.96E-17 3.75E-15 5.36E-16 11093 hsa-mir-3130-2 hsa04010 MAPK signaling pathway 3725_5594_5159_5156_7132_1399_1398_2261_2264_9252_1432_5879_7046_2353_1845_207_5970_1956 18 8.06E-16 5.08E-14 6.35E-15 11094 hsa-mir-3130-2 hsa04510 Focal adhesion 5747_3725_2321_3791_6714_5594_2064_5159_5156_1399_1398_5879_207_6464_1956_2534 16 3.24E-15 2.04E-13 2.27E-14 11095 hsa-mir-3130-2 hsa05210 Colorectal cancer 3725_5594_5159_5156_5879_7046_2353_4087_4088_4089_207_1956 12 1.37E-14 8.64E-13 8.64E-14 11096 hsa-mir-3130-2 hsa04660 T cell receptor signaling pathway 3725_3932_1493_5594_919_5777_1432_867_2353_207_5970_2534 12 2.59E-13 1.63E-11 1.48E-12 11097 hsa-mir-3130-2 hsa05211 Renal cell carcinoma 3725_5594_1387_1399_1398_5879_5781_2113_2033_207 10 3.02E-12 1.90E-10 1.58E-11 11098 hsa-mir-3130-2 hsa04310 Wnt signaling pathway 3725_5515_818_817_1387_1487_5879_4087_4088_4089_1488_2033 12 8.94E-12 5.63E-10 4.33E-11 11099 hsa-mir-3130-2 hsa04350 TGF-beta signaling pathway 5515_90_5594_1387_7046_4087_4088_4089_2033_57154 10 1.68E-11 1.06E-09 7.55E-11 11100 hsa-mir-3130-2 hsa04650 Natural killer cell mediated cytotoxicity 3932_5594_6850_919_5777_5879_3455_3459_5781_6464_2534 11 6.17E-11 3.89E-09 2.59E-10 11101 hsa-mir-3130-2 hsa04620 Toll-like receptor signaling pathway 3725_5594_1432_6772_5879_3455_8772_2353_207_5970 10 7.14E-11 4.50E-09 2.81E-10 11102 hsa-mir-3130-2 hsa05215 Prostate cancer 5594_1387_2064_5159_5156_2033_207_5970_1956 9 4.65E-10 2.93E-08 1.72E-09 11103 hsa-mir-3130-2 hsa05212 Pancreatic cancer 5594_1387_2064_5159_5156_2033_207_5970_1956 9 5.11E-10 3.22E-08 1.79E-09 11104 hsa-mir-3130-2 hsa05221 Acute myeloid leukemia 5594_5914_3815_6774_6776_6777_207_5970 8 5.75E-10 3.62E-08 1.91E-09 11105 hsa-mir-3130-2 hsa05214 Glioma 818_817_5594_5159_5156_207_6464_1956 8 1.16E-09 7.30E-08 3.65E-09 11106 hsa-mir-3130-2 hsa04920 Adipocytokine signaling pathway 3717_8717_7133_7132_6774_5781_207_5970 8 1.44E-09 9.09E-08 4.33E-09 11107 hsa-mir-3130-2 hsa04662 B cell receptor signaling pathway 3725_5594_6850_5777_5879_2353_207_5970 8 3.28E-09 2.06E-07 9.38E-09 11108 hsa-mir-3130-2 hsa04912 GnRH signaling pathway 3725_5580_818_817_6714_5594_1432_1956 8 4.68E-08 2.95E-06 1.28E-07 11109 hsa-mir-3130-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_6714_1432_5879_5781_5970_1956 7 5.38E-08 3.39E-06 1.41E-07 11110 hsa-mir-3130-2 hsa04810 Regulation of actin cytoskeleton 5747_5594_5159_5156_1399_1398_2261_2264_5879_1956 10 7.34E-08 4.62E-06 1.85E-07 11111 hsa-mir-3130-2 hsa04370 VEGF signaling pathway 5747_3791_6714_5594_1432_5879_207 7 9.02E-08 5.69E-06 2.19E-07 11112 hsa-mir-3130-2 hsa04664 Fc epsilon RI signaling pathway 5580_5594_6850_1432_5879_207_2534 7 1.06E-07 6.70E-06 2.48E-07 11113 hsa-mir-3130-2 hsa04910 Insulin signaling pathway 3643_5594_1399_1398_5770_867_207_6464 8 2.78E-07 1.75E-05 6.25E-07 11114 hsa-mir-3130-2 hsa04110 Cell cycle 1387_4174_4172_4087_4088_4089_2033 7 1.44E-06 9.10E-05 3.14E-06 11115 hsa-mir-3130-2 hsa05219 Bladder cancer 5594_2064_2261_9252_1956 5 1.98E-06 0.000124637 4.15E-06 11116 hsa-mir-3130-2 hsa04020 Calcium signaling pathway 818_817_2064_2066_5159_5156_147_1956 8 2.20E-06 0.000138825 4.48E-06 11117 hsa-mir-3130-2 hsa04330 Notch signaling pathway 1387_1487_9612_1488_2033 5 3.29E-06 0.000207503 6.48E-06 11118 hsa-mir-3130-2 hsa04210 Apoptosis 8717_7132_8772_1439_207_5970 6 3.98E-06 0.000250802 7.60E-06 11119 hsa-mir-3130-2 hsa04916 Melanogenesis 818_817_5594_1387_3815_2033 6 9.30E-06 0.000585816 1.72E-05 11120 hsa-mir-3130-2 hsa05218 Melanoma 5594_5159_5156_207_1956 5 2.15E-05 0.001356081 3.87E-05 11121 hsa-mir-3130-2 hsa04720 Long-term potentiation 818_817_5594_1387_2033 5 2.76E-05 0.001740042 4.83E-05 11122 hsa-mir-3130-2 hsa04540 Gap junction 6714_5594_5159_5156_1956 5 7.33E-05 0.004615609 0.000124746 11123 hsa-mir-3130-2 hsa05213 Endometrial cancer 5594_2064_207_1956 4 0.000108319 0.006824075 0.000179581 11124 hsa-mir-3130-2 hsa05223 Non-small cell lung cancer 5594_2064_207_1956 4 0.000124279 0.007829574 0.000200758 11125 hsa-mir-3130-2 hsa05014 Amyotrophic lateral sclerosis (ALS) 7133_7132_1432_5879 4 0.000141877 0.008938249 0.000223456 11126 hsa-mir-3130-2 hsa04670 Leukocyte transendothelial migration 5747_1432_5879_7852_5781 5 0.000247869 0.015615777 0.000380873 11127 hsa-mir-3130-2 hsa04360 Axon guidance 5747_5594_5879_7852_2534 5 0.000340091 0.02142573 0.000510136 11128 hsa-mir-3130-2 hsa04120 Ubiquitin mediated proteolysis 672_7329_867_8554_57154 5 0.000442006 0.027846377 0.00064759 11129 hsa-mir-3130-2 hsa05340 Primary immunodeficiency 3932_3561_3575 3 0.00061966 0.03903856 0.00088724 11130 hsa-mir-3130-2 hsa05222 Small cell lung cancer 5747_207_8554_5970 4 0.000671822 0.042324791 0.000940551 11131 hsa-mir-3130-2 hsa04640 Hematopoietic cell lineage 3559_3575_3815_2057 4 0.000700347 0.044121839 0.00095917 11132 hsa-mir-3130-2 hsa04930 Type II diabetes mellitus 5580_3643_5594 3 0.001230552 0.077524753 0.001649463 11133 hsa-mir-3130-2 hsa04530 Tight junction 5580_5515_6714_207 4 0.003495186 0.220196722 0.004587432 11134 hsa-mir-3130-2 hsa03030 DNA replication 4174_4172 2 0.012077852 0.760904657 0.015528666 11135 hsa-mir-3130-2 hsa04270 Vascular smooth muscle contraction 5580_5594_147 3 0.016261785 1 0.020489849 11136 hsa-mir-3130-2 hsa04150 mTOR signaling pathway 5594_207 2 0.0234939 1 0.029021876 11137 hsa-mir-3130-2 hsa04730 Long-term depression 5515_5594 2 0.040894959 1 0.049545816 11138 hsa-mir-3130-2 hsa05010 Alzheimer's disease 5594_7132_8772 3 0.044898723 1 0.05337018 11139 hsa-mir-3131 hsa05200 Pathways in cancer 4149_7046_1499_1019_2261_4193_7704_6502_3091_3065_1050_5925_7184_5747_1956_1487_1488_1870_1871_2113_861_862_10401_836_324_207_9915_3716_4609_367_1017_5595_5594_5599_6258_1387_2064_6256_4286_2932_6774_6776_6777_5879_7157_6688_6257_1869_3725_4088_4089_5881_2034_2033_5970_3326_5371_5159_8031_5156_3815_3265_4087_8772_1026_2353_8554 67 1.42E-45 1.11E-43 1.11E-43 11140 hsa-mir-3131 hsa03022 Basal transcription factors 6881_54457_2958_138474_6883_2960_2957_6879_2967_2961_2963_2969_2968_6878_6877_6874_6873_6872_6908_6884_6882_2959_6880_9519 24 1.10E-26 8.55E-25 4.27E-25 11141 hsa-mir-3131 hsa04110 Cell cycle 4171_1019_4193_6502_4174_4172_3065_4616_5925_1870_1871_5934_5933_1017_1387_7534_7532_2932_7027_7157_10912_1869_4085_4088_4089_2033_890_4087_1026 29 3.17E-22 2.47E-20 8.24E-21 11142 hsa-mir-3131 hsa04010 MAPK signaling pathway 6722_3727_4149_7046_2261_2264_7867_1845_4616_1956_1432_22800_836_1616_207_4609_5595_5594_5599_1386_9252_3312_1649_5879_7157_10912_468_3725_5881_5058_5970_5159_9261_5156_4208_3265_2353_7132 38 4.18E-21 3.26E-19 8.15E-20 11143 hsa-mir-3131 hsa05220 Chronic myeloid leukemia 7046_1019_4193_3065_5925_1487_1488_1870_1871_861_207_4609_5595_5594_6776_6777_7157_1869_4088_4089_5970_3265_5781_1026 24 6.07E-21 4.74E-19 9.47E-20 11144 hsa-mir-3131 hsa05215 Prostate cancer 1499_4193_5925_7184_1956_1870_1871_207_367_1017_5595_5594_1387_2064_2932_7157_468_1869_2033_5970_3326_5159_5156_3265_1026 25 1.05E-20 8.16E-19 1.36E-19 11145 hsa-mir-3131 hsa05212 Pancreatic cancer 1499_4193_5925_7184_1956_1870_1871_207_367_1017_5595_5594_1387_2064_2932_7157_468_1869_2033_5970_3326_5159_5156_3265_1026 25 1.32E-20 1.03E-18 1.47E-19 11146 hsa-mir-3131 hsa05214 Glioma 818_817_1019_4193_5925_1956_1870_1871_207_5595_5594_7157_1869_808_801_805_5159_5156_3265_1026 20 2.14E-17 1.67E-15 2.09E-16 11147 hsa-mir-3131 hsa05210 Colorectal cancer 7046_1499_1956_836_324_207_4609_5595_5594_5599_2932_5879_7157_3725_4088_4089_5881_5159_5156_4087_2353 21 1.20E-16 9.35E-15 1.04E-15 11148 hsa-mir-3131 hsa04350 TGF-beta signaling pathway 6667_7046_90_57154_3397_3399_3398_1874_1875_5934_5933_4609_5595_5594_1387_7027_4088_4089_2033_4087_4093 21 2.20E-16 1.72E-14 1.72E-15 11149 hsa-mir-3131 hsa05219 Bladder cancer 1019_2261_4193_5925_1956_1870_1871_4609_5595_5594_2064_9252_7157_1869_3265_1026 16 2.22E-15 1.73E-13 1.58E-14 11150 hsa-mir-3131 hsa05221 Acute myeloid leukemia 7704_1050_861_862_207_4609_5595_5594_6774_6776_6777_6688_5970_5371_3815_3265 16 1.81E-13 1.41E-11 1.18E-12 11151 hsa-mir-3131 hsa05222 Small cell lung cancer 4149_1019_6502_5925_5747_1870_1871_10401_207_4609_1017_6258_6256_7157_6257_1869_5970_8554 18 2.58E-13 2.01E-11 1.55E-12 11152 hsa-mir-3131 hsa04012 ErbB signaling pathway 818_817_5747_1956_6714_207_4609_5595_5594_5599_2064_2932_6776_6777_3725_5058_3265_1026 18 3.06E-13 2.39E-11 1.71E-12 11153 hsa-mir-3131 hsa05223 Non-small cell lung cancer 1019_5925_1956_1870_1871_207_5595_5594_6258_2064_6256_7157_6257_1869_3265 15 7.72E-13 6.02E-11 4.02E-12 11154 hsa-mir-3131 hsa04520 Adherens junction 7046_1499_2534_1956_6714_1460_5595_5594_1387_2064_5879_1457_4088_4089_5881_2033_4087 17 9.62E-13 7.51E-11 4.69E-12 11155 hsa-mir-3131 hsa05218 Melanoma 1019_4193_5925_1956_1870_1871_207_5595_5594_4286_7157_1869_5159_5156_3265_1026 16 2.07E-12 1.62E-10 9.51E-12 11156 hsa-mir-3131 hsa04310 Wnt signaling pathway 818_817_1499_1487_1488_8607_324_4609_1460_5599_1387_2932_5879_7157_3725_1457_4088_4089_5881_2033_4087 21 3.48E-12 2.71E-10 1.51E-11 11157 hsa-mir-3131 hsa04630 Jak-STAT signaling pathway 58985_3455_3560_3561_1439_10401_207_3717_3716_4609_1387_6774_6776_6777_6773_7297_2033_3459_5781_8554_10379 21 4.86E-12 3.79E-10 2.00E-11 11158 hsa-mir-3131 hsa04920 Adipocytokine signaling pathway 10891_2538_7133_207_3717_8717_5599_6258_6256_6774_6257_5970_5781_7132 14 1.20E-10 9.34E-09 4.67E-10 11159 hsa-mir-3131 hsa05211 Renal cell carcinoma 3091_2113_207_9915_5595_5594_1387_5879_3725_5058_2034_2033_3265_5781 14 2.75E-10 2.15E-08 1.02E-09 11160 hsa-mir-3131 hsa05216 Thyroid cancer 1499_4609_5595_5594_6258_6256_7157_6257_8031_3265 10 9.25E-10 7.21E-08 3.28E-09 11161 hsa-mir-3131 hsa04510 Focal adhesion 1499_2534_5747_3791_1956_6714_207_5595_5594_5599_2064_2932_5879_3725_5881_5058_2321_5159_5156_3265 20 3.32E-09 2.59E-07 1.13E-08 11162 hsa-mir-3131 hsa04912 GnRH signaling pathway 818_817_5580_1956_6714_1432_5595_5594_5599_468_3725_808_801_805_3265 15 4.05E-09 3.16E-07 1.29E-08 11163 hsa-mir-3131 hsa04720 Long-term potentiation 818_817_2902_5595_5594_1387_468_2033_808_801_805_3265_2906 13 4.12E-09 3.21E-07 1.29E-08 11164 hsa-mir-3131 hsa05213 Endometrial cancer 1499_1956_324_207_4609_5595_5594_2064_2932_7157_3265 11 1.06E-08 8.28E-07 3.18E-08 11165 hsa-mir-3131 hsa04916 Melanogenesis 818_817_1499_5595_5594_1387_4286_2932_2033_808_801_805_3815_3265 14 1.91E-08 1.49E-06 5.51E-08 11166 hsa-mir-3131 hsa04370 VEGF signaling pathway 7867_5747_3791_6714_1432_207_5595_5594_5879_5881_9261_3265 12 4.68E-08 3.65E-06 1.30E-07 11167 hsa-mir-3131 hsa04062 Chemokine signaling pathway 1234_1230_5747_5580_7852_207_3717_5595_5594_2932_6774_6777_6773_5879_5058_5970_3265 17 1.82E-07 1.42E-05 4.91E-07 11168 hsa-mir-3131 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_7133_1432_836_1616_834_5879_7157_2906_7132 10 2.02E-07 1.57E-05 5.24E-07 11169 hsa-mir-3131 hsa04660 T cell receptor signaling pathway 1019_2534_3932_1432_207_5595_5594_2932_3725_5058_5970_3265_2353 13 2.43E-07 1.89E-05 6.11E-07 11170 hsa-mir-3131 hsa04662 B cell receptor signaling pathway 6850_207_5595_5594_2932_5879_3725_5881_5970_3265_2353 11 2.94E-07 2.30E-05 7.18E-07 11171 hsa-mir-3131 hsa04664 Fc epsilon RI signaling pathway 2534_5580_6850_1432_207_5595_5594_5599_5879_5881_3265 11 4.70E-07 3.67E-05 1.11E-06 11172 hsa-mir-3131 hsa04060 Cytokine-cytokine receptor interaction 7046_1234_1230_58985_3455_90_3791_1956_7852_3560_3561_7133_1439_2321_5159_5156_3815_3459_7132 19 5.77E-07 4.50E-05 1.32E-06 11173 hsa-mir-3131 hsa05016 Huntington's disease 6667_10891_3092_3065_3064_2902_836_1387_9001_5430_7157_1213_2033_6874_6908_9519 16 6.39E-07 4.98E-05 1.42E-06 11174 hsa-mir-3131 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_1432_836_5599_5879_3725_5058_5970_5781 10 1.42E-06 0.000111023 3.08E-06 11175 hsa-mir-3131 hsa04650 Natural killer cell mediated cytotoxicity 3455_2534_3932_6850_836_5595_5594_5879_5881_5058_3265_3459_5781 13 2.55E-06 0.00019867 5.37E-06 11176 hsa-mir-3131 hsa04620 Toll-like receptor signaling pathway 3455_1432_207_5595_5594_5599_5879_3725_5970_8772_2353 11 4.59E-06 0.000358245 9.31E-06 11177 hsa-mir-3131 hsa04330 Notch signaling pathway 3065_1487_1488_388585_1387_9612_2033_8850 8 4.65E-06 0.000362978 9.31E-06 11178 hsa-mir-3131 hsa04950 Maturity onset diabetes of the young 6928_6927_3651_168620_5080_3172 6 1.11E-05 0.000864767 2.16E-05 11179 hsa-mir-3131 hsa04910 Insulin signaling pathway 10891_2538_5211_207_5595_5594_5599_2932_808_801_805_3265 12 1.31E-05 0.001018892 2.49E-05 11180 hsa-mir-3131 hsa04210 Apoptosis 1439_836_207_8717_839_7157_5970_8772_7132 9 5.36E-05 0.004179096 9.95E-05 11181 hsa-mir-3131 hsa04115 p53 signaling pathway 1019_4193_4616_836_1017_7157_10912_1026 8 5.76E-05 0.004493941 0.000103895 11182 hsa-mir-3131 hsa04530 Tight junction 1499_1019_5580_6714_22800_8573_207_1460_1457_9223_3265 11 5.86E-05 0.004571378 0.000103895 11183 hsa-mir-3131 hsa04810 Regulation of actin cytoskeleton 2261_2264_5747_1956_22800_324_5595_5594_5879_5881_5058_5159_5156_3265 14 6.38E-05 0.004978824 0.000110641 11184 hsa-mir-3131 hsa05010 Alzheimer's disease 2902_836_5595_5594_2932_808_351_801_805_2906_8772_7132 12 0.000125263 0.009770497 0.000212402 11185 hsa-mir-3131 hsa04020 Calcium signaling pathway 818_817_147_1956_2902_2064_808_801_805_5159_5156_2906 12 0.000176088 0.013734835 0.000292231 11186 hsa-mir-3131 hsa04360 Axon guidance 2534_5747_7852_5595_5594_2932_5879_5881_5058_3265 10 0.000185457 0.014465649 0.000301368 11187 hsa-mir-3131 hsa04120 Ubiquitin mediated proteolysis 4193_6502_57154_10401_7329_11059_11060_5371_672_8554 10 0.000289985 0.022618856 0.000461609 11188 hsa-mir-3131 hsa04540 Gap junction 10382_1956_6714_5595_5594_5159_5156_3265 8 0.000385239 0.030048633 0.000600973 11189 hsa-mir-3131 hsa04930 Type II diabetes mellitus 5580_3651_5595_5594_5599 5 0.001722501 0.134355101 0.002634414 11190 hsa-mir-3131 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 0.002235973 0.174405921 0.00335396 11191 hsa-mir-3131 hsa03030 DNA replication 5981_4171_4174_4172 4 0.005005346 0.390416978 0.007366358 11192 hsa-mir-3131 hsa04270 Vascular smooth muscle contraction 147_5580_5595_5594_808_801_805 7 0.006285869 0.4902978 0.009079589 11193 hsa-mir-3131 hsa03420 Nucleotide excision repair 5981_5887_2967_2968 4 0.009561812 0.745821365 0.013560388 11194 hsa-mir-3131 hsa04150 mTOR signaling pathway 3091_207_5595_5594 4 0.01620335 1 0.022568951 11195 hsa-mir-3131 hsa05217 Basal cell carcinoma 1499_324_2932_7157 4 0.019285234 1 0.02639032 11196 hsa-mir-3131 hsa05131 Shigellosis 1499_10382_2534_7534 4 0.020387405 1 0.026952841 11197 hsa-mir-3131 hsa05130 Pathogenic Escherichia coli infection 1499_10382_2534_7534 4 0.020387405 1 0.026952841 11198 hsa-mir-3131 hsa04670 Leukocyte transendothelial migration 1499_5747_7852_1432_5879_5781 6 0.024515549 1 0.031870213 11199 hsa-mir-3131 hsa03320 PPAR signaling pathway 2168_6258_6256_6257 4 0.039908044 1 0.051029958 11200 hsa-mir-3132 hsa05200 Pathways in cancer 6654_5914_595_596_598_1017_4193_5578_3091_4087_2064_3065_5925_5743_5747_25_405_1956_1487_1488_2308_6789_613_6257_8503_4436_2885_10401_207_208_5602_1147_998_367_5595_5594_5599_6258_1387_6256_9915_2932_5970_7157_7704_1869_3725_6776_4088_4089_5295_5888_5728_2033_675_3910_4790_4792_3320_3326_5371_3480_8031_5601_1856_51588_1026_2034_8554 69 3.63E-48 3.23E-46 3.23E-46 11201 hsa-mir-3132 hsa04110 Cell cycle 595_1017_4193_902_4087_994_3065_4616_5925_25_9232_545_995_5347_5591_1387_11200_7534_7533_7532_2932_7027_7157_10912_1869_4088_4089_2033_890_1031_983_1026_1022_1111_8556_8555_472 37 1.64E-31 1.46E-29 7.32E-30 11202 hsa-mir-3132 hsa05215 Prostate cancer 6654_595_596_1017_4193_2064_5925_1956_2308_8503_2885_207_208_1147_367_5595_5594_1387_2932_5970_7157_1869_5295_5728_2033_4790_4792_3320_3326_3480_1026 31 5.93E-28 5.28E-26 1.75E-26 11203 hsa-mir-3132 hsa05212 Pancreatic cancer 6654_595_596_1017_4193_2064_5925_1956_2308_8503_2885_207_208_1147_367_5595_5594_1387_2932_5970_7157_1869_5295_5728_2033_4790_4792_3320_3326_3480_1026 31 7.88E-28 7.01E-26 1.75E-26 11204 hsa-mir-3132 hsa05220 Chronic myeloid leukemia 6654_595_598_4193_3065_5925_25_1487_1488_613_8503_2885_207_208_1147_5595_5594_5970_7157_1869_6776_4088_4089_5295_4790_4792_1026_6464 28 6.19E-26 5.51E-24 1.10E-24 11205 hsa-mir-3132 hsa05222 Small cell lung cancer 595_596_598_1017_5925_5743_5747_6257_8503_10401_207_208_1147_6258_6256_5970_7157_1869_5295_5728_3910_4790_4792_51588_8554 25 4.35E-21 3.87E-19 6.45E-20 11206 hsa-mir-3132 hsa04115 p53 signaling pathway 595_1017_4194_4193_900_4616_50484_6241_51246_545_7161_11200_7249_7157_10912_64326_5728_27113_25898_983_1026_1111_472 23 1.28E-20 1.14E-18 1.63E-19 11207 hsa-mir-3132 hsa04010 MAPK signaling pathway 6654_6195_6197_4214_5578_994_4616_5923_1956_3304_3303_6789_1432_627_2885_1616_2872_207_208_5602_1147_998_5595_5594_5599_3315_5970_3164_7157_10912_3725_3727_5058_4790_5601_5566_3305 37 1.78E-20 1.59E-18 1.98E-19 11208 hsa-mir-3132 hsa05214 Glioma 6654_595_4193_5578_5925_1956_8503_2885_207_208_5595_5594_7157_1869_5295_5728_808_801_805_3480_1026_6464 22 6.74E-20 6.00E-18 6.67E-19 11209 hsa-mir-3132 hsa04012 ErbB signaling pathway 6654_5578_2064_5747_25_1956_6714_56924_8503_2885_207_208_5602_5595_5594_5599_2932_3725_6776_5295_5058_5601_1026_6464 24 7.55E-20 6.72E-18 6.72E-19 11210 hsa-mir-3132 hsa05210 Colorectal cancer 6654_595_596_4087_1956_8503_4436_2885_207_208_5602_5595_5594_5599_2932_7157_3725_4088_4089_5295_3480_5601_1856 23 5.15E-19 4.58E-17 4.16E-18 11211 hsa-mir-3132 hsa05223 Non-small cell lung cancer 6654_595_5578_2064_5925_1956_2309_6789_6257_8503_2885_207_208_5595_5594_6258_6256_7157_1869_5295 20 7.72E-19 6.87E-17 5.72E-18 11212 hsa-mir-3132 hsa04510 Focal adhesion 6654_595_596_5578_2064_5923_5747_1956_6714_56924_5499_8503_2885_207_208_5602_998_5595_5594_5599_2932_9564_3725_5295_5058_5728_3910_3480_5601_857_6464 31 1.64E-18 1.46E-16 1.12E-17 11213 hsa-mir-3132 hsa04910 Insulin signaling pathway 6720_10891_6654_5770_5499_2308_8503_2885_2872_207_208_5602_5595_5594_5599_7249_2932_5295_808_801_805_5601_5566_5563_6464 25 7.63E-17 6.79E-15 4.85E-16 11214 hsa-mir-3132 hsa04660 T cell receptor signaling pathway 6654_5777_3932_56924_1432_8503_2885_207_208_1147_998_5595_5594_2932_5970_3725_5295_5058_959_4790_4792_5601 22 9.13E-16 8.13E-14 5.42E-15 11215 hsa-mir-3132 hsa05211 Renal cell carcinoma 6654_3091_405_56924_8503_2885_207_208_998_5595_5594_1387_9915_3725_5295_5058_2033_2034 18 1.38E-14 1.23E-12 7.68E-14 11216 hsa-mir-3132 hsa04310 Wnt signaling pathway 595_5578_4087_1487_1488_5602_1460_5599_1387_2932_7157_3725_1457_1452_4088_4089_2033_5518_5515_5601_5566_1856_5527 23 4.08E-14 3.63E-12 2.14E-13 11217 hsa-mir-3132 hsa05221 Acute myeloid leukemia 6654_5914_595_8503_2885_207_208_1147_5595_5594_5970_7704_6776_5295_4790_5371 16 1.40E-13 1.25E-11 6.93E-13 11218 hsa-mir-3132 hsa05213 Endometrial cancer 6654_595_2064_1956_2309_8503_2885_207_208_5595_5594_2932_7157_5295_5728 15 3.82E-13 3.40E-11 1.79E-12 11219 hsa-mir-3132 hsa04662 B cell receptor signaling pathway 6654_5777_8503_2885_207_208_1147_5595_5594_1380_2932_5970_3725_5295_4790_4792 16 3.32E-12 2.96E-10 1.48E-11 11220 hsa-mir-3132 hsa04912 GnRH signaling pathway 6654_4214_5578_1956_6714_1432_2885_5602_998_5595_5594_5599_3725_808_801_805_5601_5566 18 5.78E-12 5.15E-10 2.45E-11 11221 hsa-mir-3132 hsa04520 Adherens junction 5770_5777_4087_2064_1956_6714_1460_998_5595_5594_1387_1457_4088_4089_2033_3480 16 7.81E-12 6.95E-10 3.16E-11 11222 hsa-mir-3132 hsa04920 Adipocytokine signaling pathway 10891_6794_6257_207_208_5602_1147_5599_6258_6256_5970_4790_4792_5601_5563 15 8.71E-12 7.75E-10 3.37E-11 11223 hsa-mir-3132 hsa05218 Melanoma 595_4193_5925_1956_8503_207_208_5595_5594_7157_1869_5295_5728_3480_1026 15 1.79E-11 1.59E-09 6.63E-11 11224 hsa-mir-3132 hsa04062 Chemokine signaling pathway 6654_5747_2309_8503_2885_6362_207_208_1147_998_5595_5594_2932_5970_9564_5295_5058_4790_4792_2770_5566_6464 22 2.37E-11 2.11E-09 8.45E-11 11225 hsa-mir-3132 hsa04150 mTOR signaling pathway 6794_6195_6197_3091_8503_207_208_5595_5594_7249_5295_5563 12 7.92E-10 7.05E-08 2.71E-09 11226 hsa-mir-3132 hsa04620 Toll-like receptor signaling pathway 1432_8503_207_208_5602_1147_5595_5594_5599_5970_3725_5295_4790_4792_5601 15 1.60E-09 1.42E-07 5.26E-09 11227 hsa-mir-3132 hsa04120 Ubiquitin mediated proteolysis 4214_4193_3093_7319_84447_10273_10401_7329_10055_64326_7337_5371_672_25898_51588_10075_8554 17 1.69E-09 1.50E-07 5.36E-09 11228 hsa-mir-3132 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_1432_5602_1147_998_5599_5970_3725_5058_4790_4792_5601 13 1.87E-09 1.66E-07 5.73E-09 11229 hsa-mir-3132 hsa04210 Apoptosis 596_598_823_8503_207_208_1147_5970_7157_5295_4790_4792_5566_472 14 2.57E-09 2.29E-07 7.64E-09 11230 hsa-mir-3132 hsa04370 VEGF signaling pathway 5578_5743_5747_6714_1432_8503_207_208_998_5595_5594_3315_5295 13 4.47E-09 3.98E-07 1.28E-08 11231 hsa-mir-3132 hsa04664 Fc epsilon RI signaling pathway 6654_5578_1432_8503_2885_207_208_5602_5595_5594_5599_5295_5601 13 5.89E-09 5.24E-07 1.64E-08 11232 hsa-mir-3132 hsa05219 Bladder cancer 595_4193_2064_5925_1956_5595_5594_7157_1869_1026 10 1.60E-08 1.43E-06 4.33E-08 11233 hsa-mir-3132 hsa04720 Long-term potentiation 6195_6197_5578_5499_5595_5594_1387_2033_808_801_805_5566 12 3.00E-08 2.67E-06 7.85E-08 11234 hsa-mir-3132 hsa03022 Basal transcription factors 51616_6881_2965_2963_6908_2958_2959_6880_2957 9 7.22E-08 6.43E-06 1.84E-07 11235 hsa-mir-3132 hsa04350 TGF-beta signaling pathway 4087_6667_5595_5594_1387_7027_4088_4089_2033_5518_5515_4093 12 1.30E-07 1.16E-05 3.21E-07 11236 hsa-mir-3132 hsa05216 Thyroid cancer 595_6257_5595_5594_6258_6256_7157_8031 8 1.71E-07 1.52E-05 4.11E-07 11237 hsa-mir-3132 hsa04630 Jak-STAT signaling pathway 6654_595_598_5777_8503_2885_10401_207_208_1387_6776_5295_2033_51588_8554 15 2.56E-07 2.28E-05 6.00E-07 11238 hsa-mir-3132 hsa04916 Melanogenesis 5578_5595_5594_1387_2932_2033_808_801_805_2770_5566_1856 12 7.44E-07 6.62E-05 1.70E-06 11239 hsa-mir-3132 hsa04540 Gap junction 6654_5578_1956_6714_2885_5595_5594_1453_2770_983_5566 11 1.72E-06 0.000153411 3.84E-06 11240 hsa-mir-3132 hsa04330 Notch signaling pathway 3065_1487_1488_1387_9612_2033_8850_1856 8 4.11E-06 0.00036609 8.93E-06 11241 hsa-mir-3132 hsa04530 Tight junction 5578_6714_207_208_1460_998_1457_5728_5518_5515_2770_5520 12 1.03E-05 0.000918955 2.19E-05 11242 hsa-mir-3132 hsa03420 Nucleotide excision repair 902_2965_4331_2071_2074_1022_6117 7 2.45E-05 0.002182681 5.08E-05 11243 hsa-mir-3132 hsa04930 Type II diabetes mellitus 8503_5602_5595_5594_5599_5295_5601 7 2.79E-05 0.002485398 5.65E-05 11244 hsa-mir-3132 hsa04360 Axon guidance 5747_25_5998_56924_998_5595_5594_2932_5058_2770_1020 11 3.45E-05 0.003067585 6.82E-05 11245 hsa-mir-3132 hsa04650 Natural killer cell mediated cytotoxicity 6654_5777_5578_3932_8503_2885_5595_5594_5295_5058_6464 11 5.36E-05 0.004771402 0.000103726 11246 hsa-mir-3132 hsa03410 Base excision repair 3146_4350_142_4913_328_6996 6 7.49E-05 0.006662428 0.000141754 11247 hsa-mir-3132 hsa04730 Long-term depression 5578_5595_5594_3480_5518_5515_2770 7 0.000376758 0.033531432 0.000698571 11248 hsa-mir-3132 hsa04070 Phosphatidylinositol signaling system 5578_8503_5295_5728_808_801_805 7 0.000550431 0.048988393 0.000999763 11249 hsa-mir-3132 hsa05016 Huntington's disease 10891_3065_3064_25942_6667_627_1387_7157_2033_27113_6908 11 0.000666556 0.059323508 0.001168565 11250 hsa-mir-3132 hsa04810 Regulation of actin cytoskeleton 6654_5747_1956_56924_5499_8503_998_5595_5594_9564_5295_5058 12 0.000669627 0.059596807 0.001168565 11251 hsa-mir-3132 hsa04612 Antigen processing and presentation 6890_3309_3304_3303_3320_3326_3305 7 0.001307691 0.116384514 0.002238164 11252 hsa-mir-3132 hsa04270 Vascular smooth muscle contraction 5578_5499_5595_5594_808_801_805_5566 8 0.001480454 0.131760407 0.002486045 11253 hsa-mir-3132 hsa04670 Leukocyte transendothelial migration 5578_5747_1432_8503_998_9564_5295_2770 8 0.001805165 0.160659679 0.002975179 11254 hsa-mir-3132 hsa03440 Homologous recombination 641_5888_675_6117 4 0.00206622 0.183893596 0.00334352 11255 hsa-mir-3132 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_1432_1616_7157 5 0.003856095 0.343192421 0.005917111 11256 hsa-mir-3132 hsa05131 Shigellosis 5578_25_998_7534_4691 5 0.003856095 0.343192421 0.005917111 11257 hsa-mir-3132 hsa05130 Pathogenic Escherichia coli infection 5578_25_998_7534_4691 5 0.003856095 0.343192421 0.005917111 11258 hsa-mir-3132 hsa05010 Alzheimer's disease 823_5595_5594_2932_808_801_805_1020 8 0.014532784 1 0.021922335 11259 hsa-mir-3132 hsa04340 Hedgehog signaling pathway 2932_1452_1453_5566 4 0.020383826 1 0.030236008 11260 hsa-mir-3132 hsa05340 Primary immunodeficiency 6890_3932_959 3 0.026823604 1 0.039136078 11261 hsa-mir-3132 hsa03030 DNA replication 5557_6117_5422 3 0.028700335 1 0.041198867 11262 hsa-mir-3132 hsa03450 Non-homologous end-joining 2547_5591 2 0.029796025 1 0.042092797 11263 hsa-mir-3132 hsa03320 PPAR signaling pathway 2168_6257_6258_6256 4 0.037893832 1 0.05269611 11264 hsa-mir-3132 hsa04020 Calcium signaling pathway 5578_2064_1956_808_801_805_5566 7 0.046339767 1 0.063449835 11265 hsa-mir-3133 hsa05200 Pathways in cancer 5371_5595_5594_5914_6256_595_836_367_7704_3091_5970_7428_1870_1871_7157_2113_4609_1869_3725_4087_4088_4089_3066_3065_5925_2034_2033_4846 28 1.20E-30 7.53E-29 7.53E-29 11266 hsa-mir-3133 hsa05220 Chronic myeloid leukemia 5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464 15 8.27E-22 5.21E-20 2.61E-20 11267 hsa-mir-3133 hsa04110 Cell cycle 5591_595_1870_1871_7157_1869_4087_4088_4089_3066_3065_5925_2033_5933 14 1.72E-17 1.08E-15 3.60E-16 11268 hsa-mir-3133 hsa05215 Prostate cancer 5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033 11 3.06E-14 1.93E-12 4.32E-13 11269 hsa-mir-3133 hsa05212 Pancreatic cancer 5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033 11 3.43E-14 2.16E-12 4.32E-13 11270 hsa-mir-3133 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5925 9 9.25E-14 5.82E-12 9.71E-13 11271 hsa-mir-3133 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925 9 6.96E-13 4.39E-11 5.84E-12 11272 hsa-mir-3133 hsa05210 Colorectal cancer 5595_5594_595_836_7157_4609_3725_4087_4088_4089 10 7.41E-13 4.67E-11 5.84E-12 11273 hsa-mir-3133 hsa05222 Small cell lung cancer 6256_595_5970_1870_1871_7157_4609_1869_5925_4846 10 9.20E-13 5.79E-11 6.44E-12 11274 hsa-mir-3133 hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_6464 9 3.15E-12 1.99E-10 1.99E-11 11275 hsa-mir-3133 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_5970_4609 8 6.19E-11 3.90E-09 3.55E-10 11276 hsa-mir-3133 hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5925 8 2.40E-10 1.51E-08 1.26E-09 11277 hsa-mir-3133 hsa05211 Renal cell carcinoma 5595_5594_3091_7428_2113_3725_2034_2033 8 2.66E-10 1.67E-08 1.29E-09 11278 hsa-mir-3133 hsa04350 TGF-beta signaling pathway 5595_5594_4609_4087_4088_4089_2033_5933 8 1.07E-09 6.74E-08 4.81E-09 11279 hsa-mir-3133 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 1.73E-09 1.09E-07 7.28E-09 11280 hsa-mir-3133 hsa04310 Wnt signaling pathway 595_7157_4609_3725_1457_4087_4088_4089_2033 9 3.59E-09 2.26E-07 1.41E-08 11281 hsa-mir-3133 hsa04520 Adherens junction 5595_5594_1457_4087_4088_4089_2033 7 1.70E-08 1.07E-06 6.29E-08 11282 hsa-mir-3133 hsa04010 MAPK signaling pathway 5595_5594_4208_836_3312_5970_7157_4609_3725_4763 10 3.79E-08 2.39E-06 1.33E-07 11283 hsa-mir-3133 hsa05016 Huntington's disease 6874_2902_836_7157_3066_3065_3064_2033 8 3.12E-07 1.97E-05 1.04E-06 11284 hsa-mir-3133 hsa05213 Endometrial cancer 5595_5594_595_7157_4609 5 1.34E-06 8.42E-05 4.21E-06 11285 hsa-mir-3133 hsa04012 ErbB signaling pathway 5595_5594_4609_3725_6464 5 1.43E-05 0.000901579 4.29E-05 11286 hsa-mir-3133 hsa04330 Notch signaling pathway 9612_3066_3065_2033 4 2.54E-05 0.001601409 7.28E-05 11287 hsa-mir-3133 hsa05010 Alzheimer's disease 22926_5595_5594_2902_836_4846 6 3.45E-05 0.002175922 9.46E-05 11288 hsa-mir-3133 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_7157_4846 4 4.85E-05 0.003054113 0.000127255 11289 hsa-mir-3133 hsa04720 Long-term potentiation 5595_5594_2902_2033 4 0.000142329 0.008966706 0.000344873 11290 hsa-mir-3133 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725 4 0.000142329 0.008966706 0.000344873 11291 hsa-mir-3133 hsa04620 Toll-like receptor signaling pathway 5595_5594_5970_3725 4 0.000439428 0.02768398 0.001025333 11292 hsa-mir-3133 hsa04660 T cell receptor signaling pathway 5595_5594_5970_3725 4 0.000578425 0.036440756 0.001301456 11293 hsa-mir-3133 hsa04510 Focal adhesion 5595_5594_595_3725_6464 5 0.000708406 0.044629566 0.001538951 11294 hsa-mir-3133 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.000823423 0.051875633 0.001729188 11295 hsa-mir-3133 hsa04910 Insulin signaling pathway 6720_5595_5594_6464 4 0.001311061 0.082596831 0.002581151 11296 hsa-mir-3133 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_6464 4 0.001311061 0.082596831 0.002581151 11297 hsa-mir-3133 hsa04115 p53 signaling pathway 595_836_7157 3 0.001797049 0.113214116 0.003430731 11298 hsa-mir-3133 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_5970_3725 3 0.001943911 0.122466406 0.00349904 11299 hsa-mir-3133 hsa04730 Long-term depression 5595_5594_4846 3 0.001943911 0.122466406 0.00349904 11300 hsa-mir-3133 hsa04370 VEGF signaling pathway 5595_5594_4846 3 0.002428618 0.153002941 0.004250082 11301 hsa-mir-3133 hsa04612 Antigen processing and presentation 4800_4801_3312 3 0.003607048 0.227244053 0.005980107 11302 hsa-mir-3133 hsa04210 Apoptosis 836_5970_7157 3 0.003607048 0.227244053 0.005980107 11303 hsa-mir-3133 hsa04062 Chemokine signaling pathway 5595_5594_5970_6464 4 0.004279147 0.269586244 0.006912468 11304 hsa-mir-3133 hsa04916 Melanogenesis 5595_5594_2033 3 0.005500547 0.346534456 0.008663361 11305 hsa-mir-3133 hsa04912 GnRH signaling pathway 5595_5594_3725 3 0.006088739 0.383590566 0.009355867 11306 hsa-mir-3133 hsa04930 Type II diabetes mellitus 5595_5594 2 0.010717833 0.67522347 0.016076749 11307 hsa-mir-3133 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428 3 0.0119126 0.750493775 0.017453344 11308 hsa-mir-3133 hsa04630 Jak-STAT signaling pathway 595_4609_2033 3 0.015833906 0.997536069 0.022671274 11309 hsa-mir-3133 hsa04920 Adipocytokine signaling pathway 6256_5970 2 0.022188944 1 0.031064522 11310 hsa-mir-3133 hsa04664 Fc epsilon RI signaling pathway 5595_5594 2 0.029870062 1 0.040908998 11311 hsa-mir-3133 hsa04540 Gap junction 5595_5594 2 0.039956421 1 0.053558607 11312 hsa-mir-3133 hsa04710 Circadian rhythm - mammal 8863 1 0.045530072 1 0.05975822 11313 hsa-mir-3133 hsa03450 Non-homologous end-joining 5591 1 0.048702544 1 0.062617557 11314 hsa-mir-3137 hsa04110 Cell cycle 10971_7534_1387 3 1.30E-06 3.25E-05 3.25E-05 11315 hsa-mir-3137 hsa05131 Shigellosis 10971_7534 2 5.48E-05 0.001370156 0.000456719 11316 hsa-mir-3137 hsa05130 Pathogenic Escherichia coli infection 10971_7534 2 5.48E-05 0.001370156 0.000456719 11317 hsa-mir-3137 hsa04310 Wnt signaling pathway 1452_1387 2 0.000387283 0.009682071 0.002420518 11318 hsa-mir-3137 hsa04330 Notch signaling pathway 1387 1 0.009560571 0.239014273 0.027491398 11319 hsa-mir-3137 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432 1 0.01134467 0.283616744 0.027491398 11320 hsa-mir-3137 hsa04340 Hedgehog signaling pathway 1452 1 0.011542738 0.288568439 0.027491398 11321 hsa-mir-3137 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432 1 0.014312216 0.357805407 0.027491398 11322 hsa-mir-3137 hsa05211 Renal cell carcinoma 1387 1 0.014509789 0.362744713 0.027491398 11323 hsa-mir-3137 hsa04720 Long-term potentiation 1387 1 0.015102307 0.377557679 0.027491398 11324 hsa-mir-3137 hsa04370 VEGF signaling pathway 1432 1 0.015497155 0.387428866 0.027491398 11325 hsa-mir-3137 hsa04664 Fc epsilon RI signaling pathway 1432 1 0.01589187 0.397296755 0.027491398 11326 hsa-mir-3137 hsa04520 Adherens junction 1387 1 0.016089179 0.402229463 0.027491398 11327 hsa-mir-3137 hsa04350 TGF-beta signaling pathway 1387 1 0.017469414 0.436735348 0.027491398 11328 hsa-mir-3137 hsa05215 Prostate cancer 1387 1 0.017666459 0.441661466 0.027491398 11329 hsa-mir-3137 hsa05212 Pancreatic cancer 1387 1 0.01786347 0.44658676 0.027491398 11330 hsa-mir-3137 hsa04620 Toll-like receptor signaling pathway 1432 1 0.020421629 0.510540716 0.027491398 11331 hsa-mir-3137 hsa04916 Melanogenesis 1387 1 0.020814698 0.520367454 0.027491398 11332 hsa-mir-3137 hsa04912 GnRH signaling pathway 1432 1 0.021600443 0.540011072 0.027491398 11333 hsa-mir-3137 hsa04660 T cell receptor signaling pathway 1432 1 0.021993118 0.549827954 0.027491398 11334 hsa-mir-3137 hsa04670 Leukocyte transendothelial migration 1432 1 0.024346413 0.608660324 0.028983825 11335 hsa-mir-3137 hsa04630 Jak-STAT signaling pathway 1387 1 0.030793655 0.769841385 0.03499279 11336 hsa-mir-3137 hsa05016 Huntington's disease 1387 1 0.037205355 0.930133879 0.040440603 11337 hsa-mir-3139 hsa04110 Cell cycle 4088_4089_1871_3065_7157_5925_1870_1017_890_2932_1869_5934_5933 13 2.84E-21 1.42E-19 1.42E-19 11338 hsa-mir-3139 hsa05200 Pathways in cancer 4088_4089_1871_3065_1050_4149_7157_5925_1870_1017_3326_2932_3265_1869 14 2.20E-17 1.10E-15 5.49E-16 11339 hsa-mir-3139 hsa05220 Chronic myeloid leukemia 4088_4089_1871_3065_7157_5925_1870_3265_1869 9 2.78E-15 1.39E-13 4.63E-14 11340 hsa-mir-3139 hsa05215 Prostate cancer 1871_7157_5925_1870_1017_3326_2932_3265_1869 9 1.06E-14 5.32E-13 1.17E-13 11341 hsa-mir-3139 hsa05212 Pancreatic cancer 1871_7157_5925_1870_1017_3326_2932_3265_1869 9 1.17E-14 5.86E-13 1.17E-13 11342 hsa-mir-3139 hsa05222 Small cell lung cancer 1871_4149_7157_5925_1870_1017_1869 7 5.35E-11 2.67E-09 3.78E-10 11343 hsa-mir-3139 hsa04350 TGF-beta signaling pathway 4088_4089_1874_1875_6667_5934_5933 7 5.77E-11 2.89E-09 3.78E-10 11344 hsa-mir-3139 hsa05219 Bladder cancer 1871_7157_5925_1870_3265_1869 6 6.04E-11 3.02E-09 3.78E-10 11345 hsa-mir-3139 hsa05223 Non-small cell lung cancer 1871_7157_5925_1870_3265_1869 6 2.43E-10 1.22E-08 1.35E-09 11346 hsa-mir-3139 hsa05214 Glioma 1871_7157_5925_1870_3265_1869 6 6.89E-10 3.44E-08 3.44E-09 11347 hsa-mir-3139 hsa05218 Melanoma 1871_7157_5925_1870_3265_1869 6 1.13E-09 5.66E-08 5.15E-09 11348 hsa-mir-3139 hsa05210 Colorectal cancer 4088_4089_7157_2932 4 7.07E-06 0.000353257 2.80E-05 11349 hsa-mir-3139 hsa05016 Huntington's disease 2902_3065_7157_6667_9519 5 7.29E-06 0.000364329 2.80E-05 11350 hsa-mir-3139 hsa05213 Endometrial cancer 7157_2932_3265 3 6.34E-05 0.003168268 0.00022382 11351 hsa-mir-3139 hsa04310 Wnt signaling pathway 4088_4089_7157_2932 4 6.71E-05 0.003357305 0.00022382 11352 hsa-mir-3139 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906_7157 3 7.82E-05 0.00391071 0.000244419 11353 hsa-mir-3139 hsa05010 Alzheimer's disease 2902_2906_2932_351 4 0.000119292 0.005964593 0.000350858 11354 hsa-mir-3139 hsa04720 Long-term potentiation 2902_2906_3265 3 0.000179685 0.008984239 0.000499124 11355 hsa-mir-3139 hsa04010 MAPK signaling pathway 4149_7157_22800_3265 4 0.00060089 0.030044497 0.001581289 11356 hsa-mir-3139 hsa05216 Thyroid cancer 7157_3265 2 0.000864711 0.043235572 0.002161779 11357 hsa-mir-3139 hsa04530 Tight junction 22800_3265_8573 3 0.000995433 0.049771635 0.002370078 11358 hsa-mir-3139 hsa05217 Basal cell carcinoma 7157_2932 2 0.002900408 0.145020418 0.006591837 11359 hsa-mir-3139 hsa05221 Acute myeloid leukemia 1050_3265 2 0.003313921 0.165696049 0.007204176 11360 hsa-mir-3139 hsa04115 p53 signaling pathway 7157_1017 2 0.004460482 0.223024118 0.009292672 11361 hsa-mir-3139 hsa04662 B cell receptor signaling pathway 2932_3265 2 0.005224323 0.261216146 0.010448646 11362 hsa-mir-3139 hsa04520 Adherens junction 4088_4089 2 0.005903493 0.29517465 0.011352871 11363 hsa-mir-3139 hsa04512 ECM-receptor interaction 6383_9672 2 0.006474344 0.323717194 0.011989526 11364 hsa-mir-3139 hsa04012 ErbB signaling pathway 2932_3265 2 0.006918351 0.345917539 0.012354198 11365 hsa-mir-3139 hsa04916 Melanogenesis 2932_3265 2 0.009685517 0.484275849 0.016699167 11366 hsa-mir-3139 hsa04660 T cell receptor signaling pathway 2932_3265 2 0.010761582 0.538079084 0.017935969 11367 hsa-mir-3139 hsa04360 Axon guidance 2932_3265 2 0.014919237 0.745961838 0.024063285 11368 hsa-mir-3139 hsa04514 Cell adhesion molecules (CAMs) 6383_9672 2 0.015561451 0.778072558 0.024314767 11369 hsa-mir-3139 hsa04910 Insulin signaling pathway 2932_3265 2 0.016435992 0.821799595 0.024903018 11370 hsa-mir-3139 hsa04020 Calcium signaling pathway 2902_2906 2 0.027915681 1 0.041052472 11371 hsa-mir-3139 hsa04062 Chemokine signaling pathway 2932_3265 2 0.030449963 1 0.043499947 11372 hsa-mir-3139 hsa04510 Focal adhesion 2932_3265 2 0.034265662 1 0.047591197 11373 hsa-mir-3139 hsa04810 Regulation of actin cytoskeleton 22800_3265 2 0.038257928 1 0.051699902 11374 hsa-mir-3140 hsa05200 Pathways in cancer 3320_1869_4149_5371_4292_7046_1499_5595_5594_5599_861_5914_1387_6256_595_5601_836_1019_367_1017_2932_7704_6772_3091_5970_7428_2736_1870_1871_7157_4087_6688_2113_4286_5894_4609_3725_1026_5604_1029_6502_2353_4088_4089_3066_3065_1050_5925_2034_2033_4846_207_8554_9915 54 1.27E-38 9.68E-37 9.68E-37 11375 hsa-mir-3140 hsa04110 Cell cycle 1869_890_5591_7533_1387_595_983_1019_1017_2932_8454_7027_7534_1870_1871_7157_4087_1026_1029_6502_6500_4088_4089_3066_3065_5925_2033_891_5934_5933_10971_990 32 3.93E-29 2.99E-27 1.49E-27 11376 hsa-mir-3140 hsa05220 Chronic myeloid leukemia 1869_7046_5595_5594_861_595_1019_5970_1870_1871_7157_5894_4609_1026_5604_1029_4088_4089_3066_3065_5925_207_6464 23 2.31E-22 1.75E-20 5.85E-21 11377 hsa-mir-3140 hsa04010 MAPK signaling pathway 4149_7046_5595_5594_6722_5599_9252_5598_4208_5601_836_6197_1386_1432_1649_5970_3312_7157_9261_468_5894_4609_3725_3727_5604_6195_6196_2353_8986_4763_1616_207 32 2.32E-19 1.77E-17 4.42E-18 11378 hsa-mir-3140 hsa05215 Prostate cancer 3320_1869_1499_5595_5594_1387_595_367_1017_2932_5970_1870_1871_7157_468_5894_1026_5604_5925_2033_207 21 1.28E-18 9.74E-17 1.95E-17 11379 hsa-mir-3140 hsa05212 Pancreatic cancer 3320_1869_1499_5595_5594_1387_595_367_1017_2932_5970_1870_1871_7157_468_5894_1026_5604_5925_2033_207 21 1.56E-18 1.19E-16 1.98E-17 11380 hsa-mir-3140 hsa05210 Colorectal cancer 4292_7046_1499_5595_5594_5599_595_5601_836_2932_7157_4087_5894_4609_3725_5604_2353_4088_4089_207 20 8.90E-18 6.76E-16 9.66E-17 11381 hsa-mir-3140 hsa04350 TGF-beta signaling pathway 7046_5595_5594_1387_6667_8454_7027_3399_3398_1874_1875_4087_4609_6500_4088_4089_2033_4093_5934_5933 20 1.61E-17 1.22E-15 1.53E-16 11382 hsa-mir-3140 hsa05219 Bladder cancer 1869_5595_5594_9252_595_1019_1870_1871_7157_5894_4609_1026_5604_1029_5925 15 7.55E-16 5.74E-14 6.38E-15 11383 hsa-mir-3140 hsa05214 Glioma 1869_5595_5594_595_1019_1870_1871_7157_5894_1026_5604_1029_5925_207_6464 15 1.72E-13 1.31E-11 1.31E-12 11384 hsa-mir-3140 hsa05223 Non-small cell lung cancer 1869_5595_5594_6256_595_1019_1870_1871_7157_5894_5604_1029_5925_207 14 2.84E-13 2.16E-11 1.96E-12 11385 hsa-mir-3140 hsa05222 Small cell lung cancer 1869_4149_6256_595_1019_1017_5970_1870_1871_7157_4609_6502_5925_4846_207_8554 16 4.89E-13 3.71E-11 3.07E-12 11386 hsa-mir-3140 hsa05218 Melanoma 1869_5595_5594_595_1019_1870_1871_7157_4286_5894_1026_5604_1029_5925_207 15 5.25E-13 3.99E-11 3.07E-12 11387 hsa-mir-3140 hsa05221 Acute myeloid leukemia 5371_5595_5594_861_5914_595_7704_5970_6688_5894_4609_5604_1050_207 14 8.02E-13 6.10E-11 4.36E-12 11388 hsa-mir-3140 hsa04310 Wnt signaling pathway 1499_5599_1387_595_5601_2932_8454_7157_4087_8061_4609_3725_1457_1452_1459_6500_4088_4089_2033 19 1.87E-12 1.42E-10 9.47E-12 11389 hsa-mir-3140 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2113_5894_3725_5604_2034_2033_207_9915 13 1.07E-10 8.10E-09 5.06E-10 11390 hsa-mir-3140 hsa05213 Endometrial cancer 4292_1499_5595_5594_595_2932_7157_5894_4609_5604_207 11 6.77E-10 5.15E-08 3.03E-09 11391 hsa-mir-3140 hsa04520 Adherens junction 4301_7046_1499_5595_5594_1387_4087_1457_1459_4088_4089_2033 12 3.69E-09 2.80E-07 1.56E-08 11392 hsa-mir-3140 hsa04012 ErbB signaling pathway 5595_5594_5599_5601_2932_5894_4609_3725_1026_5604_207_6464 12 8.64E-09 6.57E-07 3.46E-08 11393 hsa-mir-3140 hsa04540 Gap junction 7846_5592_5595_5594_5598_983_7277_7278_5894_5604_51807_10376 12 1.70E-08 1.29E-06 6.45E-08 11394 hsa-mir-3140 hsa04720 Long-term potentiation 5595_5594_1387_2902_6197_468_5894_5604_6195_6196_2033 11 2.05E-08 1.55E-06 7.40E-08 11395 hsa-mir-3140 hsa05216 Thyroid cancer 1499_5595_5594_6256_595_7157_4609_5604 8 2.55E-08 1.94E-06 8.80E-08 11396 hsa-mir-3140 hsa04660 T cell receptor signaling pathway 5595_5594_5601_1019_2932_1432_5970_5894_3725_5604_2353_207 12 9.22E-08 7.01E-06 3.05E-07 11397 hsa-mir-3140 hsa04115 p53 signaling pathway 7161_595_983_836_1019_1017_7157_1026_1029_891 10 1.00E-07 7.61E-06 3.17E-07 11398 hsa-mir-3140 hsa05131 Shigellosis 7846_1499_4691_7277_7534_7278_51807_10376_10971 9 2.00E-07 1.52E-05 5.84E-07 11399 hsa-mir-3140 hsa05130 Pathogenic Escherichia coli infection 7846_1499_4691_7277_7534_7278_51807_10376_10971 9 2.00E-07 1.52E-05 5.84E-07 11400 hsa-mir-3140 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5601_1432_6772_5970_3725_5604_2353_207 11 3.53E-07 2.68E-05 9.93E-07 11401 hsa-mir-3140 hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_5894_3725_5604_2353_207 9 1.84E-06 0.000140039 5.00E-06 11402 hsa-mir-3140 hsa04912 GnRH signaling pathway 5595_5594_5599_5598_5601_1432_468_5894_3725_5604 10 4.27E-06 0.000324775 1.12E-05 11403 hsa-mir-3140 hsa04150 mTOR signaling pathway 5595_5594_6197_3091_6195_6196_207 7 1.33E-05 0.001008904 3.36E-05 11404 hsa-mir-3140 hsa05016 Huntington's disease 6874_1387_2902_6908_836_6667_1537_7157_3066_3065_3064_2033 12 1.71E-05 0.001301512 4.20E-05 11405 hsa-mir-3140 hsa04370 VEGF signaling pathway 5595_5594_1432_9261_5894_5604_4846_207 8 1.82E-05 0.001382986 4.32E-05 11406 hsa-mir-3140 hsa04916 Melanogenesis 1499_5595_5594_1387_2932_4286_5894_5604_2033 9 2.13E-05 0.00161812 4.70E-05 11407 hsa-mir-3140 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5601_1432_5894_5604_207 8 2.16E-05 0.001640866 4.70E-05 11408 hsa-mir-3140 hsa03022 Basal transcription factors 2963_2962_6874_2969_6908_6883 6 2.16E-05 0.001644022 4.70E-05 11409 hsa-mir-3140 hsa04910 Insulin signaling pathway 6720_5595_5594_5599_5601_2932_5894_5604_207_6464 10 3.14E-05 0.002384395 6.62E-05 11410 hsa-mir-3140 hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_8454_7428_6502_6500_7329_7325_8554 10 3.32E-05 0.002526084 6.83E-05 11411 hsa-mir-3140 hsa04510 Focal adhesion 1499_5595_5594_5599_595_5601_2932_5894_3725_5604_207_6464 12 4.00E-05 0.003040849 8.00E-05 11412 hsa-mir-3140 hsa04330 Notch signaling pathway 1387_2648_9612_3066_3065_2033 6 7.28E-05 0.005534369 0.000141907 11413 hsa-mir-3140 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_1432_7157_1616_4846 6 0.000176322 0.013400466 0.000335012 11414 hsa-mir-3140 hsa04062 Chemokine signaling pathway 5595_5594_2932_6772_5970_5894_5604_207_6464_7074 10 0.000422918 0.032141732 0.000783945 11415 hsa-mir-3140 hsa04930 Type II diabetes mellitus 3651_5595_5594_5599_5601 5 0.000529621 0.040251233 0.000958363 11416 hsa-mir-3140 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5601_836_1432_5970_3725 6 0.000575281 0.043721366 0.000993667 11417 hsa-mir-3140 hsa04730 Long-term depression 5592_5595_5594_5894_5604_4846 6 0.000575281 0.043721366 0.000993667 11418 hsa-mir-3140 hsa05010 Alzheimer's disease 5595_5594_823_2902_836_2932_1537_9451_4846 9 0.000921438 0.07002926 0.001556206 11419 hsa-mir-3140 hsa04920 Adipocytokine signaling pathway 5599_6256_5601_5970_207 5 0.002755681 0.209431737 0.004552864 11420 hsa-mir-3140 hsa04630 Jak-STAT signaling pathway 1387_595_6772_4609_2033_207_8554 7 0.006184414 0.470015438 0.010000328 11421 hsa-mir-3140 hsa05217 Basal cell carcinoma 1499_2932_2736_7157 4 0.007932544 0.602873356 0.012559862 11422 hsa-mir-3140 hsa04612 Antigen processing and presentation 3320_4800_4801_4802_3312 5 0.008533722 0.648562908 0.012971258 11423 hsa-mir-3140 hsa04210 Apoptosis 823_836_5970_7157_207 5 0.008533722 0.648562908 0.012971258 11424 hsa-mir-3140 hsa04530 Tight junction 4301_1499_1019_1457_1459_207 6 0.012509846 0.950748322 0.018642124 11425 hsa-mir-3140 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_5894_5604_6464 6 0.012911887 0.981303388 0.018871219 11426 hsa-mir-3140 hsa04270 Vascular smooth muscle contraction 5592_5595_5594_5894_5604 5 0.024666694 1 0.035371109 11427 hsa-mir-3140 hsa03430 Mismatch repair 5981_4292 2 0.043401233 1 0.061083216 11428 hsa-mir-3140 hsa04340 Hedgehog signaling pathway 2932_2736_1452 3 0.045979154 1 0.063260692 11429 hsa-mir-3140 hsa04950 Maturity onset diabetes of the young 3651_6927 2 0.046613142 1 0.063260692 11430 hsa-mir-3143 hsa03022 Basal transcription factors 2967_2961_2963_54457_2968_6877_2960_2957_6879_6878_6883_2959_6908_6874_6873_6872_6884_6880_6882_2958_6881_138474_9519 23 2.17E-29 1.59E-27 1.59E-27 11431 hsa-mir-3143 hsa05200 Pathways in cancer 4609_3326_3725_25_1499_5595_5594_1387_6256_1871_6502_4286_1017_2932_4193_6688_3265_4149_10401_3091_5970_5371_1870_7157_2113_1869_861_862_2353_3065_4087_4088_4089_7184_1050_5925_2034_2033_207_208_8554_9915 42 9.52E-29 6.95E-27 3.47E-27 11432 hsa-mir-3143 hsa04110 Cell cycle 25_1387_1871_6502_7534_1017_2932_4193_4085_1870_7157_1869_4171_3065_4087_4088_4089_5925_2033_890_5934_5933 22 1.10E-18 8.05E-17 2.68E-17 11433 hsa-mir-3143 hsa05215 Prostate cancer 3326_1499_5595_5594_1387_1871_1017_2932_4193_3265_5970_1870_7157_1869_7184_5925_2033_207_208 19 2.10E-17 1.53E-15 3.57E-16 11434 hsa-mir-3143 hsa05212 Pancreatic cancer 3326_1499_5595_5594_1387_1871_1017_2932_4193_3265_5970_1870_7157_1869_7184_5925_2033_207_208 19 2.52E-17 1.84E-15 3.57E-16 11435 hsa-mir-3143 hsa05220 Chronic myeloid leukemia 4609_25_5595_5594_1871_4193_3265_5970_1870_7157_1869_861_3065_4088_4089_5925_207_208 18 2.94E-17 2.14E-15 3.57E-16 11436 hsa-mir-3143 hsa04350 TGF-beta signaling pathway 4609_5595_5594_1387_6667_3397_3399_3398_1874_1875_4086_4087_4088_4089_2033_4093_5934_5933 18 2.85E-16 2.08E-14 2.97E-15 11437 hsa-mir-3143 hsa05214 Glioma 5595_5594_1871_4193_3265_808_1870_7157_1869_5925_207_208_801_805 14 3.73E-13 2.72E-11 3.41E-12 11438 hsa-mir-3143 hsa05222 Small cell lung cancer 4609_6256_1871_6502_1017_4149_10401_5970_1870_7157_1869_5925_207_208_8554 15 7.95E-13 5.81E-11 6.45E-12 11439 hsa-mir-3143 hsa05221 Acute myeloid leukemia 4609_5595_5594_6688_3265_5970_5371_861_862_1050_207_208 12 3.30E-11 2.41E-09 2.41E-10 11440 hsa-mir-3143 hsa04010 MAPK signaling pathway 4609_6722_3725_5595_5594_4208_7867_3265_4149_3312_1432_5970_9261_7157_22800_4773_3727_2353_1616_207_208 21 4.30E-11 3.14E-09 2.86E-10 11441 hsa-mir-3143 hsa05210 Colorectal cancer 4609_3725_1499_5595_5594_2932_7157_2353_4087_4088_4089_207_208 13 1.03E-10 7.53E-09 6.28E-10 11442 hsa-mir-3143 hsa05223 Non-small cell lung cancer 5595_5594_6256_1871_3265_1870_7157_1869_5925_207_208 11 2.17E-10 1.58E-08 1.15E-09 11443 hsa-mir-3143 hsa05218 Melanoma 5595_5594_1871_4286_4193_3265_1870_7157_1869_5925_207_208 12 2.20E-10 1.61E-08 1.15E-09 11444 hsa-mir-3143 hsa05211 Renal cell carcinoma 3725_5595_5594_1387_3265_3091_2113_2034_2033_207_208_9915 12 2.54E-10 1.86E-08 1.24E-09 11445 hsa-mir-3143 hsa05219 Bladder cancer 4609_5595_5594_1871_4193_3265_1870_7157_1869_5925 10 3.87E-10 2.83E-08 1.77E-09 11446 hsa-mir-3143 hsa04310 Wnt signaling pathway 4609_3725_1460_1499_1387_8607_2932_7157_4773_1457_4087_4088_4089_2033 14 9.56E-09 6.98E-07 4.10E-08 11447 hsa-mir-3143 hsa04660 T cell receptor signaling pathway 3725_5595_5594_2932_3265_1432_5970_1739_4773_2353_207_208 12 1.97E-08 1.44E-06 8.00E-08 11448 hsa-mir-3143 hsa05213 Endometrial cancer 4609_1499_5595_5594_2932_3265_7157_207_208 9 3.41E-08 2.49E-06 1.31E-07 11449 hsa-mir-3143 hsa04720 Long-term potentiation 5595_5594_1387_2902_2906_3265_808_2033_801_805 10 5.46E-08 3.99E-06 1.90E-07 11450 hsa-mir-3143 hsa04662 B cell receptor signaling pathway 3725_5595_5594_2932_3265_5970_4773_2353_207_208 10 5.46E-08 3.99E-06 1.90E-07 11451 hsa-mir-3143 hsa04520 Adherens junction 1460_1499_5595_5594_1387_1457_4087_4088_4089_2033 10 9.49E-08 6.93E-06 3.15E-07 11452 hsa-mir-3143 hsa04916 Melanogenesis 1499_5595_5594_1387_4286_2932_3265_808_2033_801_805 11 1.03E-07 7.53E-06 3.27E-07 11453 hsa-mir-3143 hsa05016 Huntington's disease 1387_2902_6908_6874_6667_9001_5430_7157_3065_23186_3064_2033_4716_9519 14 1.14E-07 8.31E-06 3.46E-07 11454 hsa-mir-3143 hsa05216 Thyroid cancer 4609_1499_5595_5594_6256_3265_7157 7 1.63E-07 1.19E-05 4.76E-07 11455 hsa-mir-3143 hsa04370 VEGF signaling pathway 5595_5594_7867_3265_1432_9261_4773_207_208 9 7.02E-07 5.13E-05 1.97E-06 11456 hsa-mir-3143 hsa04012 ErbB signaling pathway 4609_3725_25_5595_5594_2932_3265_207_208 9 1.79E-06 0.000130613 4.84E-06 11457 hsa-mir-3143 hsa04910 Insulin signaling pathway 5595_5594_2932_3265_808_5211_207_208_801_805 10 9.35E-06 0.000682584 2.44E-05 11458 hsa-mir-3143 hsa05010 Alzheimer's disease 22926_5595_5594_2902_2906_2932_808_4716_351_801_805 11 1.32E-05 0.000965272 3.33E-05 11459 hsa-mir-3143 hsa04330 Notch signaling pathway 388585_1387_9612_3065_2033_8850 6 3.33E-05 0.002429748 8.10E-05 11460 hsa-mir-3143 hsa03050 Proteasome 5684_5705_5701_5702_5719_5710 6 3.71E-05 0.002707062 8.73E-05 11461 hsa-mir-3143 hsa04620 Toll-like receptor signaling pathway 3725_5595_5594_1432_5970_2353_207_208 8 4.35E-05 0.003172477 9.91E-05 11462 hsa-mir-3143 hsa04530 Tight junction 1460_10207_1499_3265_22800_8573_1457_207_208 9 5.38E-05 0.003927022 0.000119001 11463 hsa-mir-3143 hsa04912 GnRH signaling pathway 3725_5595_5594_3265_1432_808_801_805 8 6.35E-05 0.004633326 0.000136274 11464 hsa-mir-3143 hsa04664 Fc epsilon RI signaling pathway 5595_5594_3265_1432_207_208 6 0.000465233 0.033961984 0.000970342 11465 hsa-mir-3143 hsa04150 mTOR signaling pathway 5595_5594_3091_207_208 5 0.000514175 0.037534755 0.001042632 11466 hsa-mir-3143 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906_1432_7157_1616 5 0.000703557 0.051359687 0.0013881 11467 hsa-mir-3143 hsa04510 Focal adhesion 3725_1499_5595_5594_2932_3265_1729_207_208 9 0.000951122 0.069431901 0.001827155 11468 hsa-mir-3143 hsa04360 Axon guidance 25_5998_5595_5594_2932_3265_4773 7 0.001158265 0.084553319 0.002168034 11469 hsa-mir-3143 hsa04120 Ubiquitin mediated proteolysis 11059_6502_4193_10401_5371_7329_8554 7 0.001602995 0.117018634 0.002925466 11470 hsa-mir-3143 hsa04630 Jak-STAT signaling pathway 4609_1387_10401_2033_207_208_8554 7 0.002882101 0.210393371 0.005131546 11471 hsa-mir-3143 hsa04950 Maturity onset diabetes of the young 5080_3651_168620 3 0.003650941 0.266518725 0.006345684 11472 hsa-mir-3143 hsa05131 Shigellosis 25_1499_7534_10382 4 0.005153116 0.376177484 0.008549488 11473 hsa-mir-3143 hsa05130 Pathogenic Escherichia coli infection 25_1499_7534_10382 4 0.005153116 0.376177484 0.008549488 11474 hsa-mir-3143 hsa04062 Chemokine signaling pathway 5595_5594_2932_3265_5970_207_208 7 0.008939221 0.652563126 0.014501403 11475 hsa-mir-3143 hsa04920 Adipocytokine signaling pathway 6256_5970_207_208 4 0.009302626 0.679091707 0.014762863 11476 hsa-mir-3143 hsa04270 Vascular smooth muscle contraction 5595_5594_808_801_805 5 0.014337139 1 0.022268323 11477 hsa-mir-3143 hsa03420 Nucleotide excision repair 2967_2968_5887 3 0.017085028 1 0.02598348 11478 hsa-mir-3143 hsa04930 Type II diabetes mellitus 5595_5594_3651 3 0.018071282 1 0.026922522 11479 hsa-mir-3143 hsa04612 Antigen processing and presentation 3326_4800_4801_3312 4 0.022977677 1 0.032889617 11480 hsa-mir-3143 hsa04210 Apoptosis 5970_7157_207_208 4 0.022977677 1 0.032889617 11481 hsa-mir-3143 hsa04540 Gap junction 5595_5594_3265_10382 4 0.026318124 1 0.036946597 11482 hsa-mir-3143 hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.029645193 1 0.040832058 11483 hsa-mir-3145 hsa05200 Pathways in cancer 5371_1499_5595_5594_5914_1387_6256_595_836_367_7704_6774_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_2353_3065_4088_4089_5881_3066_1050_5925_2034_2033_4846 34 5.07E-36 3.45E-34 3.45E-34 11484 hsa-mir-3145 hsa05220 Chronic myeloid leukemia 5595_5594_595_5970_1870_1871_7157_4609_1869_3065_4088_4089_3066_5925_6464 15 3.53E-20 2.40E-18 1.20E-18 11485 hsa-mir-3145 hsa04110 Cell cycle 5591_1387_595_1870_1871_7157_4087_1869_3065_4088_4089_3066_5925_2033_5933 15 1.81E-17 1.23E-15 4.09E-16 11486 hsa-mir-3145 hsa05210 Colorectal cancer 1499_5595_5594_595_836_7157_4087_4609_3725_2353_4088_4089_5881 13 2.44E-16 1.66E-14 4.16E-15 11487 hsa-mir-3145 hsa05215 Prostate cancer 1499_5595_5594_1387_595_367_5970_1870_1871_7157_1869_5925_2033 13 4.22E-16 2.87E-14 5.46E-15 11488 hsa-mir-3145 hsa05212 Pancreatic cancer 1499_5595_5594_1387_595_367_5970_1870_1871_7157_1869_5925_2033 13 4.82E-16 3.28E-14 5.46E-15 11489 hsa-mir-3145 hsa04520 Adherens junction 1499_6714_5595_5594_1387_4087_1457_4088_4089_5881_2033 11 1.71E-13 1.16E-11 1.66E-12 11490 hsa-mir-3145 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_6774_5970_4609_1050 10 3.41E-13 2.32E-11 2.89E-12 11491 hsa-mir-3145 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5925 9 8.26E-13 5.62E-11 6.24E-12 11492 hsa-mir-3145 hsa04310 Wnt signaling pathway 1499_1387_595_7157_4087_4609_3725_1457_4088_4089_5881_2033 12 5.65E-12 3.84E-10 3.81E-11 11493 hsa-mir-3145 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925 9 6.16E-12 4.19E-10 3.81E-11 11494 hsa-mir-3145 hsa05222 Small cell lung cancer 6256_595_5970_1870_1871_7157_4609_1869_5925_4846 10 1.03E-11 6.98E-10 5.82E-11 11495 hsa-mir-3145 hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_6464 9 2.77E-11 1.88E-09 1.45E-10 11496 hsa-mir-3145 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2113_3725_2034_2033 9 6.37E-11 4.33E-09 3.09E-10 11497 hsa-mir-3145 hsa05216 Thyroid cancer 1499_5595_5594_6256_595_7157_4609 7 1.51E-10 1.03E-08 6.84E-10 11498 hsa-mir-3145 hsa04350 TGF-beta signaling pathway 5595_5594_1387_4087_4609_4088_4089_2033_5933 9 3.00E-10 2.04E-08 1.28E-09 11499 hsa-mir-3145 hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5925 8 1.62E-09 1.10E-07 6.48E-09 11500 hsa-mir-3145 hsa04010 MAPK signaling pathway 5595_5594_4208_836_5970_3312_7157_4609_3725_4763_2353_5881 12 3.33E-09 2.27E-07 1.26E-08 11501 hsa-mir-3145 hsa04330 Notch signaling pathway 1387_9612_3065_3066_2033_8850 6 9.72E-08 6.61E-06 3.48E-07 11502 hsa-mir-3145 hsa05016 Huntington's disease 6874_1387_2902_836_7157_3065_3066_3064_2033 9 1.66E-07 1.13E-05 5.46E-07 11503 hsa-mir-3145 hsa05213 Endometrial cancer 1499_5595_5594_595_7157_4609 6 1.69E-07 1.15E-05 5.46E-07 11504 hsa-mir-3145 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725_2353_5881 6 1.25E-06 8.49E-05 3.86E-06 11505 hsa-mir-3145 hsa04012 ErbB signaling pathway 6714_5595_5594_4609_3725_6464 6 2.81E-06 0.00019133 8.32E-06 11506 hsa-mir-3145 hsa04510 Focal adhesion 1499_6714_5595_5594_595_3725_5881_6464 8 3.69E-06 0.000251228 1.05E-05 11507 hsa-mir-3145 hsa04720 Long-term potentiation 5595_5594_1387_2902_2033 5 2.30E-05 0.001560933 6.24E-05 11508 hsa-mir-3145 hsa04370 VEGF signaling pathway 6714_5595_5594_5881_4846 5 2.59E-05 0.001759778 6.77E-05 11509 hsa-mir-3145 hsa04620 Toll-like receptor signaling pathway 5595_5594_5970_3725_2353 5 9.27E-05 0.006304124 0.000233486 11510 hsa-mir-3145 hsa04916 Melanogenesis 1499_5595_5594_1387_2033 5 0.0001012 0.006881603 0.000245772 11511 hsa-mir-3145 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_7157_4846 4 0.00012233 0.008318412 0.000286842 11512 hsa-mir-3145 hsa04660 T cell receptor signaling pathway 5595_5594_5970_3725_2353 5 0.000130296 0.008860149 0.000295338 11513 hsa-mir-3145 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_836_5970_3725 4 0.000290409 0.019747816 0.000637026 11514 hsa-mir-3145 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_5881_6464 5 0.000358886 0.024404262 0.000762633 11515 hsa-mir-3145 hsa04630 Jak-STAT signaling pathway 1387_595_6774_4609_2033 5 0.000599072 0.040736871 0.001234451 11516 hsa-mir-3145 hsa05010 Alzheimer's disease 5595_5594_2902_836_4846 5 0.001068255 0.072641371 0.002136511 11517 hsa-mir-3145 hsa04912 GnRH signaling pathway 6714_5595_5594_3725 4 0.001316376 0.089513572 0.002557531 11518 hsa-mir-3145 hsa04062 Chemokine signaling pathway 5595_5594_6774_5970_6464 5 0.001550386 0.105426279 0.002928508 11519 hsa-mir-3145 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.001635456 0.111211008 0.003005703 11520 hsa-mir-3145 hsa04910 Insulin signaling pathway 6720_5595_5594_6464 4 0.003123541 0.212400764 0.005589494 11521 hsa-mir-3145 hsa04920 Adipocytokine signaling pathway 6256_6774_5970 3 0.003259417 0.221640351 0.005683086 11522 hsa-mir-3145 hsa04115 p53 signaling pathway 595_836_7157 3 0.003529561 0.240010182 0.006000255 11523 hsa-mir-3145 hsa04730 Long-term depression 5595_5594_4846 3 0.00381301 0.259284695 0.006324017 11524 hsa-mir-3145 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5881 3 0.005083656 0.345688633 0.008230682 11525 hsa-mir-3145 hsa04950 Maturity onset diabetes of the young 6928_3172 2 0.005362843 0.364673315 0.008480775 11526 hsa-mir-3145 hsa04612 Antigen processing and presentation 4800_4801_3312 3 0.006992629 0.475498774 0.010566639 11527 hsa-mir-3145 hsa04210 Apoptosis 836_5970_7157 3 0.006992629 0.475498774 0.010566639 11528 hsa-mir-3145 hsa04540 Gap junction 6714_5595_5594 3 0.007859797 0.53446622 0.011618831 11529 hsa-mir-3145 hsa04930 Type II diabetes mellitus 5595_5594 2 0.01684046 1 0.024364921 11530 hsa-mir-3145 hsa04360 Axon guidance 5595_5594_5881 3 0.019225159 1 0.027235642 11531 hsa-mir-3145 hsa04530 Tight junction 1499_6714_1457 3 0.021553129 1 0.029910465 11532 hsa-mir-3145 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428 3 0.022361917 1 0.030412207 11533 hsa-mir-3145 hsa05217 Basal cell carcinoma 1499_7157 2 0.024195025 1 0.032260034 11534 hsa-mir-3146 hsa05200 Pathways in cancer 4089_5970_6776_6688_5925_2033_1019_1017_1050_2308_1956_8554_4609_1499_4790_5595_4088_1026_5594_841_861_1387 22 4.64E-22 3.15E-20 3.15E-20 11535 hsa-mir-3146 hsa05215 Prostate cancer 5970_5925_2033_1385_1017_468_2308_1956_1499_4790_5595_1026_5594_1387 14 3.13E-19 2.13E-17 8.18E-18 11536 hsa-mir-3146 hsa05212 Pancreatic cancer 5970_5925_2033_1385_1017_468_2308_1956_1499_4790_5595_1026_5594_1387 14 3.61E-19 2.45E-17 8.18E-18 11537 hsa-mir-3146 hsa05220 Chronic myeloid leukemia 4089_5970_6776_5925_1019_4609_4790_5595_4088_1026_5594_861 12 1.16E-16 7.92E-15 1.98E-15 11538 hsa-mir-3146 hsa04350 TGF-beta signaling pathway 4089_1874_6667_2033_7027_4609_5595_4088_5594_5933_1387 11 2.43E-14 1.66E-12 3.31E-13 11539 hsa-mir-3146 hsa04010 MAPK signaling pathway 6196_6722_5970_468_9252_1956_4609_4790_5595_5594_1649_2002_6195_5566_1386 15 3.75E-14 2.55E-12 4.25E-13 11540 hsa-mir-3146 hsa05221 Acute myeloid leukemia 5970_6776_6688_1050_4609_4790_5595_5594_861 9 1.30E-12 8.87E-11 1.27E-11 11541 hsa-mir-3146 hsa05219 Bladder cancer 5925_1019_9252_1956_4609_5595_1026_5594 8 4.92E-12 3.34E-10 4.18E-11 11542 hsa-mir-3146 hsa04720 Long-term potentiation 6196_2033_815_468_5595_5594_6195_5566_1387 9 9.33E-12 6.34E-10 7.05E-11 11543 hsa-mir-3146 hsa04110 Cell cycle 4089_5925_2033_1019_1017_7027_4088_1026_5933_1387 10 1.66E-11 1.13E-09 1.13E-10 11544 hsa-mir-3146 hsa04520 Adherens junction 4089_2033_1956_1499_5595_4088_5594_1387 8 5.32E-10 3.61E-08 3.29E-09 11545 hsa-mir-3146 hsa04012 ErbB signaling pathway 6776_815_1956_4609_5595_1026_5594_2002 8 9.86E-10 6.71E-08 5.59E-09 11546 hsa-mir-3146 hsa04916 Melanogenesis 2033_1385_815_1499_5595_5594_5566_1387 8 3.69E-09 2.51E-07 1.93E-08 11547 hsa-mir-3146 hsa05214 Glioma 5925_1019_815_1956_5595_1026_5594 7 4.15E-09 2.82E-07 2.02E-08 11548 hsa-mir-3146 hsa05210 Colorectal cancer 4089_1956_4609_1499_5595_4088_5594 7 2.17E-08 1.47E-06 9.83E-08 11549 hsa-mir-3146 hsa05222 Small cell lung cancer 5970_5925_1019_1017_8554_4609_4790 7 2.52E-08 1.72E-06 1.07E-07 11550 hsa-mir-3146 hsa05213 Endometrial cancer 1956_4609_1499_5595_5594_2002 6 3.83E-08 2.60E-06 1.53E-07 11551 hsa-mir-3146 hsa04310 Wnt signaling pathway 4089_2033_815_4609_1499_4088_5566_1387 8 6.08E-08 4.13E-06 2.30E-07 11552 hsa-mir-3146 hsa04912 GnRH signaling pathway 815_468_1956_5595_5594_2002_5566 7 1.10E-07 7.49E-06 3.94E-07 11553 hsa-mir-3146 hsa05218 Melanoma 5925_1019_1956_5595_1026_5594 6 2.13E-07 1.45E-05 7.25E-07 11554 hsa-mir-3146 hsa05223 Non-small cell lung cancer 5925_1019_1956_5595_5594 5 1.51E-06 0.000102801 4.90E-06 11555 hsa-mir-3146 hsa04620 Toll-like receptor signaling pathway 5970_4790_5595_5594_841_6348 6 1.59E-06 0.000107814 4.90E-06 11556 hsa-mir-3146 hsa05216 Thyroid cancer 4609_1499_5595_5594 4 4.19E-06 0.000284719 1.24E-05 11557 hsa-mir-3146 hsa04630 Jak-STAT signaling pathway 6776_2033_8554_4609_6778_1387 6 1.59E-05 0.001078191 4.49E-05 11558 hsa-mir-3146 hsa04150 mTOR signaling pathway 6196_5595_5594_6195 4 3.55E-05 0.002411644 9.65E-05 11559 hsa-mir-3146 hsa04660 T cell receptor signaling pathway 5970_1019_4790_5595_5594 5 4.01E-05 0.002725055 0.00010481 11560 hsa-mir-3146 hsa04062 Chemokine signaling pathway 5970_4790_5595_5594_6348_5566 6 5.21E-05 0.003541582 0.00013117 11561 hsa-mir-3146 hsa04115 p53 signaling pathway 1019_1017_1026_841 4 0.000100697 0.006847405 0.00024455 11562 hsa-mir-3146 hsa04910 Insulin signaling pathway 2308_5595_5594_2002_5566 5 0.000112753 0.007667227 0.000264387 11563 hsa-mir-3146 hsa05211 Renal cell carcinoma 2033_5595_5594_1387 4 0.000117804 0.008010652 0.000267022 11564 hsa-mir-3146 hsa04662 B cell receptor signaling pathway 5970_4790_5595_5594 4 0.000136924 0.009310852 0.00030035 11565 hsa-mir-3146 hsa04210 Apoptosis 5970_4790_841_5566 4 0.000256884 0.017468096 0.000545878 11566 hsa-mir-3146 hsa04540 Gap junction 1956_5595_5594_5566 4 0.000301798 0.020522254 0.000621886 11567 hsa-mir-3146 hsa05016 Huntington's disease 6667_2033_1385_841_1387 5 0.000451977 0.030734424 0.000903954 11568 hsa-mir-3146 hsa04510 Focal adhesion 1956_1499_5595_5594_2002 5 0.000676894 0.046028771 0.001315108 11569 hsa-mir-3146 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_1956_4790 3 0.001889083 0.128457661 0.003568268 11570 hsa-mir-3146 hsa04270 Vascular smooth muscle contraction 5595_5594_5566 3 0.007509714 0.510660551 0.013801637 11571 hsa-mir-3146 hsa04930 Type II diabetes mellitus 5595_5594 2 0.010514518 0.7149872 0.018815453 11572 hsa-mir-3146 hsa04330 Notch signaling pathway 2033_1387 2 0.011390001 0.774520096 0.01985949 11573 hsa-mir-3146 hsa05010 Alzheimer's disease 5595_5594_841 3 0.021704856 1 0.036120127 11574 hsa-mir-3146 hsa04920 Adipocytokine signaling pathway 5970_4790 2 0.021778312 1 0.036120127 11575 hsa-mir-3146 hsa04020 Calcium signaling pathway 815_1956_5566 3 0.023957609 1 0.038255099 11576 hsa-mir-3146 hsa04730 Long-term depression 5595_5594 2 0.024190725 1 0.038255099 11577 hsa-mir-3146 hsa04370 VEGF signaling pathway 5595_5594 2 0.028003564 1 0.043278236 11578 hsa-mir-3146 hsa04664 Fc epsilon RI signaling pathway 5595_5594 2 0.029324767 1 0.044312981 11579 hsa-mir-3146 hsa04612 Antigen processing and presentation 4800_1385 2 0.036290881 1 0.053597308 11580 hsa-mir-3146 hsa04810 Regulation of actin cytoskeleton 1956_5595_5594 3 0.037045198 1 0.053597308 11581 hsa-mir-3149 hsa05200 Pathways in cancer 5371_5595_5594_5599_6258_1387_6256_5601_4286_367_7704_842_6774_5970_6688_4824_4088_4089_4609_3725_841_2353_1050_5925_2033_207_836 27 1.52E-22 9.44E-21 9.44E-21 11582 hsa-mir-3149 hsa04010 MAPK signaling pathway 5595_5594_5599_5601_5600_5603_9252_1432_5970_9261_468_4609_3725_3727_6195_2353_1649_207_8550_836_2002_2005 22 1.92E-18 1.19E-16 5.94E-17 11583 hsa-mir-3149 hsa05215 Prostate cancer 10488_5595_5594_1385_1387_367_842_5970_4824_468_9586_5925_2033_207 14 7.31E-16 4.53E-14 1.30E-14 11584 hsa-mir-3149 hsa05212 Pancreatic cancer 10488_5595_5594_1385_1387_367_842_5970_4824_468_9586_5925_2033_207 14 8.42E-16 5.22E-14 1.30E-14 11585 hsa-mir-3149 hsa05210 Colorectal cancer 5595_5594_5599_5601_842_4088_4089_4609_3725_2353_207_836 12 2.87E-13 1.78E-11 3.56E-12 11586 hsa-mir-3149 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5601_5600_5603_1432_5970_3725_841_2353_207 12 2.32E-12 1.44E-10 2.40E-11 11587 hsa-mir-3149 hsa04912 GnRH signaling pathway 6714_5595_5594_5599_5601_5600_5603_1432_468_3725_815_2002 12 4.31E-12 2.67E-10 3.82E-11 11588 hsa-mir-3149 hsa05221 Acute myeloid leukemia 5371_5595_5594_7704_6774_5970_6688_4609_1050_207 10 6.31E-12 3.91E-10 4.89E-11 11589 hsa-mir-3149 hsa04310 Wnt signaling pathway 1460_5599_1387_5601_4088_4089_8061_4609_3725_815_1457_1459_2033 13 1.15E-11 7.13E-10 7.92E-11 11590 hsa-mir-3149 hsa04520 Adherens junction 1460_6714_5595_5594_1387_4088_4089_1457_1459_2033 10 9.59E-11 5.95E-09 5.53E-10 11591 hsa-mir-3149 hsa04660 T cell receptor signaling pathway 5595_5594_5601_5600_5603_1432_5970_1739_3725_2353_207 11 9.81E-11 6.08E-09 5.53E-10 11592 hsa-mir-3149 hsa04012 ErbB signaling pathway 6714_5595_5594_5599_5601_4609_3725_815_207_2002 10 2.04E-10 1.26E-08 1.05E-09 11593 hsa-mir-3149 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5599_5601_5600_5603_1432_5970_3725_836 9 7.62E-10 4.72E-08 3.63E-09 11594 hsa-mir-3149 hsa04370 VEGF signaling pathway 6714_5595_5594_5600_5603_1432_842_9261_207 9 1.47E-09 9.10E-08 6.50E-09 11595 hsa-mir-3149 hsa05220 Chronic myeloid leukemia 5595_5594_5970_4088_4089_4609_5925_207 8 2.37E-08 1.47E-06 9.80E-08 11596 hsa-mir-3149 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5601_5600_5603_1432_207 8 3.45E-08 2.14E-06 1.34E-07 11597 hsa-mir-3149 hsa05223 Non-small cell lung cancer 5595_5594_6258_6256_842_5925_207 7 5.38E-08 3.34E-06 1.96E-07 11598 hsa-mir-3149 hsa05016 Huntington's disease 10488_1385_1387_6908_842_9586_841_2033_836_4716 10 2.02E-07 1.25E-05 6.81E-07 11599 hsa-mir-3149 hsa04920 Adipocytokine signaling pathway 5599_6258_6256_5601_6774_5970_207 7 2.09E-07 1.29E-05 6.81E-07 11600 hsa-mir-3149 hsa04916 Melanogenesis 10488_5595_5594_1385_1387_4286_815_2033 8 2.49E-07 1.54E-05 7.72E-07 11601 hsa-mir-3149 hsa04720 Long-term potentiation 5595_5594_1387_468_815_6195_2033 7 4.25E-07 2.63E-05 1.25E-06 11602 hsa-mir-3149 hsa05213 Endometrial cancer 5595_5594_842_4609_207_2002 6 9.30E-07 5.77E-05 2.62E-06 11603 hsa-mir-3149 hsa05222 Small cell lung cancer 6258_6256_842_5970_4609_5925_207 7 1.00E-06 6.23E-05 2.71E-06 11604 hsa-mir-3149 hsa04350 TGF-beta signaling pathway 5595_5594_1387_4088_4089_4609_2033 7 1.08E-06 6.70E-05 2.79E-06 11605 hsa-mir-3149 hsa04210 Apoptosis 839_842_5970_841_840_207_836 7 1.25E-06 7.73E-05 3.09E-06 11606 hsa-mir-3149 hsa05216 Thyroid cancer 5595_5594_6258_6256_4609 5 1.31E-06 8.09E-05 3.11E-06 11607 hsa-mir-3149 hsa03022 Basal transcription factors 2963_2962_2969_6908_2959 5 3.85E-06 0.000238568 8.68E-06 11608 hsa-mir-3149 hsa04510 Focal adhesion 6714_5595_5594_5599_5601_1729_3725_207_2002 9 3.92E-06 0.000243125 8.68E-06 11609 hsa-mir-3149 hsa05211 Renal cell carcinoma 5595_5594_1387_3725_2033_207 6 5.38E-06 0.000333501 1.15E-05 11610 hsa-mir-3149 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725_2353_207 6 6.70E-06 0.000415556 1.36E-05 11611 hsa-mir-3149 hsa05219 Bladder cancer 5595_5594_9252_4609_5925 5 6.78E-06 0.000420514 1.36E-05 11612 hsa-mir-3149 hsa05010 Alzheimer's disease 22926_5595_5594_842_841_840_836_4716 8 1.08E-05 0.000669273 2.09E-05 11613 hsa-mir-3149 hsa05014 Amyotrophic lateral sclerosis (ALS) 5600_5603_1432_842_836 5 2.47E-05 0.001530355 4.64E-05 11614 hsa-mir-3149 hsa05214 Glioma 5595_5594_815_5925_207 5 4.82E-05 0.002988739 8.79E-05 11615 hsa-mir-3149 hsa05218 Melanoma 5595_5594_4286_5925_207 5 7.16E-05 0.004439729 0.000126849 11616 hsa-mir-3149 hsa04110 Cell cycle 5591_1387_4088_4089_5925_2033 6 7.90E-05 0.004897403 0.000136039 11617 hsa-mir-3149 hsa04530 Tight junction 1460_10207_6714_1457_1459_207 6 0.000165467 0.010258939 0.000273221 11618 hsa-mir-3149 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601 4 0.000169163 0.010488126 0.000273221 11619 hsa-mir-3149 hsa04910 Insulin signaling pathway 5595_5594_5599_5601_207_2002 6 0.000171865 0.010655608 0.000273221 11620 hsa-mir-3149 hsa04150 mTOR signaling pathway 5595_5594_6195_207 4 0.000284397 0.017632607 0.000440815 11621 hsa-mir-3149 hsa04630 Jak-STAT signaling pathway 1387_6774_4609_2033_207 5 0.002176777 0.134960184 0.003291712 11622 hsa-mir-3149 hsa04330 Notch signaling pathway 1387_9612_2033 3 0.002836579 0.17586792 0.004187331 11623 hsa-mir-3149 hsa04062 Chemokine signaling pathway 5595_5594_6774_5970_207 5 0.005394474 0.334457362 0.007778078 11624 hsa-mir-3149 hsa04115 p53 signaling pathway 842_841_836 3 0.007887148 0.489003178 0.011113709 11625 hsa-mir-3149 hsa05012 Parkinson's disease 7314_842_836_4716 4 0.008241521 0.510974316 0.011354985 11626 hsa-mir-3149 hsa04540 Gap junction 6714_5595_5594 3 0.017135987 1 0.023096331 11627 hsa-mir-3149 hsa04670 Leukocyte transendothelial migration 5600_5603_1432 3 0.033894112 1 0.044711382 11628 hsa-mir-3149 hsa04360 Axon guidance 5998_5595_5594 3 0.040337584 1 0.052102712 11629 hsa-mir-3149 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836 3 0.045746043 1 0.057717796 11630 hsa-mir-3149 hsa04120 Ubiquitin mediated proteolysis 11059_5371_7329 3 0.04654661 1 0.057717796 11631 hsa-mir-3152 hsa05215 Prostate cancer 5925_2033_468_3326_2932_3265 6 3.84E-08 2.15E-06 1.15E-06 11632 hsa-mir-3152 hsa05212 Pancreatic cancer 5925_2033_468_3326_2932_3265 6 4.10E-08 2.29E-06 1.15E-06 11633 hsa-mir-3152 hsa05010 Alzheimer's disease 2902_2906_9451_2932_4716_351_823 7 9.48E-08 5.31E-06 1.77E-06 11634 hsa-mir-3152 hsa05016 Huntington's disease 2902_3065_6908_6667_2033_4716_9519 7 1.41E-07 7.88E-06 1.97E-06 11635 hsa-mir-3152 hsa05200 Pathways in cancer 3065_4286_5925_2033_3326_2932_3265_3725 8 4.31E-07 2.41E-05 4.83E-06 11636 hsa-mir-3152 hsa04720 Long-term potentiation 2902_2906_2033_468_3265 5 6.22E-07 3.49E-05 5.81E-06 11637 hsa-mir-3152 hsa04530 Tight junction 1460_22800_3265_8573_10207 5 1.05E-05 0.000590137 8.43E-05 11638 hsa-mir-3152 hsa04916 Melanogenesis 4286_2033_2932_3265 4 7.02E-05 0.00393249 0.000491561 11639 hsa-mir-3152 hsa04660 T cell receptor signaling pathway 1739_2932_3265_3725 4 8.66E-05 0.004852311 0.000539146 11640 hsa-mir-3152 hsa04110 Cell cycle 3065_5925_2033_2932 4 0.000116294 0.006512485 0.000651248 11641 hsa-mir-3152 hsa04010 MAPK signaling pathway 468_22800_3265_3725_3727 5 0.00025428 0.01423968 0.001294516 11642 hsa-mir-3152 hsa04310 Wnt signaling pathway 2033_1460_2932_3725 4 0.000289299 0.016200726 0.00135006 11643 hsa-mir-3152 hsa05218 Melanoma 4286_5925_3265 3 0.000465111 0.026046202 0.001899474 11644 hsa-mir-3152 hsa05211 Renal cell carcinoma 2033_3265_3725 3 0.000483793 0.027092395 0.001899474 11645 hsa-mir-3152 hsa05220 Chronic myeloid leukemia 3065_5925_3265 3 0.000542707 0.030391591 0.001899474 11646 hsa-mir-3152 hsa04662 B cell receptor signaling pathway 2932_3265_3725 3 0.000542707 0.030391591 0.001899474 11647 hsa-mir-3152 hsa04012 ErbB signaling pathway 2932_3265_3725 3 0.000823716 0.046128115 0.002713419 11648 hsa-mir-3152 hsa04510 Focal adhesion 2932_3265_3725_1729 4 0.000884532 0.049533803 0.002751878 11649 hsa-mir-3152 hsa04950 Maturity onset diabetes of the young 4760_5080 2 0.001275693 0.071438782 0.003759936 11650 hsa-mir-3152 hsa04912 GnRH signaling pathway 468_3265_3725 3 0.001508998 0.084503906 0.004225195 11651 hsa-mir-3152 hsa04360 Axon guidance 2932_3265_5998 3 0.002580689 0.144518597 0.006881838 11652 hsa-mir-3152 hsa03022 Basal transcription factors 6908_9519 2 0.002859692 0.160142751 0.007279216 11653 hsa-mir-3152 hsa05219 Bladder cancer 5925_3265 2 0.003627141 0.203119882 0.008831299 11654 hsa-mir-3152 hsa04330 Notch signaling pathway 3065_2033 2 0.004479761 0.250866605 0.010452775 11655 hsa-mir-3152 hsa05213 Endometrial cancer 2932_3265 2 0.00541581 0.303285335 0.012131413 11656 hsa-mir-3152 hsa05223 Non-small cell lung cancer 5925_3265 2 0.005813204 0.325539403 0.012520746 11657 hsa-mir-3152 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906 2 0.006223563 0.3485195 0.01290813 11658 hsa-mir-3152 hsa05214 Glioma 5925_3265 2 0.008227733 0.460753055 0.016455466 11659 hsa-mir-3152 hsa04810 Regulation of actin cytoskeleton 22800_3265_1729 3 0.010440895 0.584690115 0.020161728 11660 hsa-mir-3152 hsa04520 Adherens junction 2033_1460 2 0.012120403 0.678742548 0.022624752 11661 hsa-mir-3152 hsa04512 ECM-receptor interaction 6383_9672 2 0.013270495 0.743147702 0.023223366 11662 hsa-mir-3152 hsa05210 Colorectal cancer 2932_3725 2 0.013270495 0.743147702 0.023223366 11663 hsa-mir-3152 hsa04350 TGF-beta signaling pathway 6667_2033 2 0.014163055 0.793131083 0.024034275 11664 hsa-mir-3152 hsa04514 Cell adhesion molecules (CAMs) 6383_9672 2 0.031249864 1 0.051470364 11665 hsa-mir-3152 hsa04910 Insulin signaling pathway 2932_3265 2 0.03295245 1 0.052723921 11666 hsa-mir-3153 hsa05200 Pathways in cancer 3320_4149_5371_5595_5599_1387_5604_9915_2932_6502_3091_5970_4087_5894_4609_1029_4088_4292_5925_2034_2033_1050 22 3.56E-21 2.03E-19 2.03E-19 11667 hsa-mir-3153 hsa04110 Cell cycle 1387_983_2932_8454_6502_6500_4087_1029_4088_5925_2033_5933_990 13 1.75E-15 9.96E-14 4.98E-14 11668 hsa-mir-3153 hsa04350 TGF-beta signaling pathway 5595_1387_6667_8454_6500_4087_4609_4088_2033_4093_5933 11 6.48E-14 3.70E-12 1.23E-12 11669 hsa-mir-3153 hsa04540 Gap junction 5595_5598_983_5604_7277_7278_10376_5894_7846_51807 10 4.12E-12 2.35E-10 5.87E-11 11670 hsa-mir-3153 hsa04310 Wnt signaling pathway 5599_1387_2932_8454_6500_4087_4609_1457_1459_4088_2033 11 1.83E-11 1.04E-09 2.08E-10 11671 hsa-mir-3153 hsa05210 Colorectal cancer 5595_5599_5604_2932_4087_5894_4609_4088_4292 9 5.24E-11 2.99E-09 4.98E-10 11672 hsa-mir-3153 hsa05215 Prostate cancer 3320_5595_1387_5604_2932_5970_5894_5925_2033 9 7.70E-11 4.39E-09 6.02E-10 11673 hsa-mir-3153 hsa05212 Pancreatic cancer 3320_5595_1387_5604_2932_5970_5894_5925_2033 9 8.45E-11 4.82E-09 6.02E-10 11674 hsa-mir-3153 hsa05211 Renal cell carcinoma 5595_1387_5604_9915_3091_5894_2034_2033 8 4.93E-10 2.81E-08 3.12E-09 11675 hsa-mir-3153 hsa05220 Chronic myeloid leukemia 5595_5604_5970_5894_4609_1029_4088_5925 8 6.65E-10 3.79E-08 3.79E-09 11676 hsa-mir-3153 hsa05221 Acute myeloid leukemia 5371_5595_5604_5970_5894_4609_1050 7 4.11E-09 2.34E-07 2.13E-08 11677 hsa-mir-3153 hsa05219 Bladder cancer 5595_5604_5894_4609_1029_5925 6 2.01E-08 1.15E-06 9.55E-08 11678 hsa-mir-3153 hsa04520 Adherens junction 5595_1387_4087_1457_1459_4088_2033 7 2.90E-08 1.65E-06 1.27E-07 11679 hsa-mir-3153 hsa05213 Endometrial cancer 5595_5604_2932_5894_4609_4292 6 6.44E-08 3.67E-06 2.62E-07 11680 hsa-mir-3153 hsa05131 Shigellosis 7277_7278_10376_7846_51807_4691 6 9.67E-08 5.51E-06 3.44E-07 11681 hsa-mir-3153 hsa05130 Pathogenic Escherichia coli infection 7277_7278_10376_7846_51807_4691 6 9.67E-08 5.51E-06 3.44E-07 11682 hsa-mir-3153 hsa04010 MAPK signaling pathway 4149_5595_5599_5598_5604_1386_5970_5894_4609 9 8.50E-07 4.85E-05 2.85E-06 11683 hsa-mir-3153 hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_8454_6502_6500_7329 7 1.01E-06 5.76E-05 3.20E-06 11684 hsa-mir-3153 hsa04012 ErbB signaling pathway 5595_5599_5604_2932_5894_4609 6 1.10E-06 6.24E-05 3.29E-06 11685 hsa-mir-3153 hsa05223 Non-small cell lung cancer 5595_5604_5894_1029_5925 5 2.32E-06 0.000132313 6.62E-06 11686 hsa-mir-3153 hsa04916 Melanogenesis 5595_1387_5604_2932_5894_2033 6 2.93E-06 0.000167037 7.95E-06 11687 hsa-mir-3153 hsa05214 Glioma 5595_5604_5894_1029_5925 5 5.44E-06 0.000310009 1.41E-05 11688 hsa-mir-3153 hsa05218 Melanoma 5595_5604_5894_1029_5925 5 8.16E-06 0.00046521 2.02E-05 11689 hsa-mir-3153 hsa04720 Long-term potentiation 5595_1387_5604_5894_2033 5 1.05E-05 0.000598498 2.39E-05 11690 hsa-mir-3153 hsa04662 B cell receptor signaling pathway 5595_5604_2932_5970_5894 5 1.05E-05 0.000598498 2.39E-05 11691 hsa-mir-3153 hsa03022 Basal transcription factors 2963_2962_2969_6908 4 1.43E-05 0.000815862 3.14E-05 11692 hsa-mir-3153 hsa05222 Small cell lung cancer 4149_6502_5970_4609_5925 5 1.97E-05 0.001122127 4.16E-05 11693 hsa-mir-3153 hsa04330 Notch signaling pathway 1387_2648_9612_2033 4 3.44E-05 0.001958517 6.99E-05 11694 hsa-mir-3153 hsa04912 GnRH signaling pathway 5595_5599_5598_5604_5894 5 5.58E-05 0.003181786 0.000109717 11695 hsa-mir-3153 hsa04660 T cell receptor signaling pathway 5595_5604_2932_5970_5894 5 6.07E-05 0.00345931 0.00011531 11696 hsa-mir-3153 hsa04062 Chemokine signaling pathway 5595_5604_2932_5970_5894_7074 6 8.45E-05 0.004818619 0.000155439 11697 hsa-mir-3153 hsa04910 Insulin signaling pathway 5595_5599_5604_2932_5894 5 0.00016959 0.009666639 0.000302082 11698 hsa-mir-3153 hsa05216 Thyroid cancer 5595_5604_4609 3 0.000206383 0.011763811 0.000356479 11699 hsa-mir-3153 hsa04664 Fc epsilon RI signaling pathway 5595_5599_5604_5894 4 0.000231365 0.013187797 0.000387876 11700 hsa-mir-3153 hsa04612 Antigen processing and presentation 3320_4800_4801_4802 4 0.000357649 0.020386013 0.000582458 11701 hsa-mir-3153 hsa04620 Toll-like receptor signaling pathway 5595_5599_5604_5970 4 0.000587191 0.033469909 0.00092972 11702 hsa-mir-3153 hsa04510 Focal adhesion 5595_5599_5604_2932_5894 5 0.001001419 0.05708088 0.001542726 11703 hsa-mir-3153 hsa04115 p53 signaling pathway 983_7161_1029 3 0.002236466 0.127478567 0.003354699 11704 hsa-mir-3153 hsa04730 Long-term depression 5595_5604_5894 3 0.002418297 0.137842914 0.003534434 11705 hsa-mir-3153 hsa04370 VEGF signaling pathway 5595_5604_5894 3 0.003017767 0.172012731 0.004300318 11706 hsa-mir-3153 hsa05016 Huntington's disease 1387_6908_6667_2033 4 0.005128669 0.292334144 0.007130101 11707 hsa-mir-3153 hsa04810 Regulation of actin cytoskeleton 5595_5604_5894_7074 4 0.00861784 0.49121686 0.01169564 11708 hsa-mir-3153 hsa04270 Vascular smooth muscle contraction 5595_5604_5894 3 0.009515857 0.54240384 0.012614043 11709 hsa-mir-3153 hsa04930 Type II diabetes mellitus 5595_5599 2 0.012405995 0.707141698 0.016071402 11710 hsa-mir-3153 hsa04650 Natural killer cell mediated cytotoxicity 5595_5604_5894 3 0.014354869 0.818227521 0.018182834 11711 hsa-mir-3153 hsa04150 mTOR signaling pathway 5595_3091 2 0.01615828 0.921021952 0.020022216 11712 hsa-mir-3153 hsa04630 Jak-STAT signaling pathway 1387_4609_2033 3 0.019383194 1 0.023507278 11713 hsa-mir-3153 hsa04920 Adipocytokine signaling pathway 5599_5970 2 0.025587179 1 0.030384775 11714 hsa-mir-3153 hsa05010 Alzheimer's disease 22926_5595_2932 3 0.027159479 1 0.031593679 11715 hsa-mir-3153 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5970 2 0.028399738 1 0.032375701 11716 hsa-mir-3154 hsa05200 Pathways in cancer 3320_3326_1147_5371_3551_1499_5595_5594_6258_1387_6256_836_367_8517_2932_7704_842_841_6774_5970_4824_6688_2113_1869_862_6502_2353_3065_7175_5925_2033_207_4791_4792 34 2.48E-23 1.86E-21 1.86E-21 11717 hsa-mir-3154 hsa05215 Prostate cancer 3320_3326_1147_3551_1499_5595_5594_1385_1387_367_8517_2932_842_5970_4824_1869_5925_2033_207_4792 20 3.42E-20 2.56E-18 1.04E-18 11718 hsa-mir-3154 hsa05212 Pancreatic cancer 3320_3326_1147_3551_1499_5595_5594_1385_1387_367_8517_2932_842_5970_4824_1869_5925_2033_207_4792 20 4.15E-20 3.11E-18 1.04E-18 11719 hsa-mir-3154 hsa04010 MAPK signaling pathway 6722_1147_3551_5595_5594_9261_1326_4208_3305_3303_836_5566_8517_7867_3310_3312_1432_5971_5970_6195_2353_207_4791_2002_2005 25 2.23E-16 1.68E-14 4.19E-15 11720 hsa-mir-3154 hsa05221 Acute myeloid leukemia 1147_5371_3551_5595_5594_8517_7704_6774_5970_6688_862_207 12 3.96E-12 2.97E-10 5.94E-11 11721 hsa-mir-3154 hsa04660 T cell receptor signaling pathway 1147_3551_5595_5594_1326_8517_2932_1432_5970_4794_2353_207_4792_4793 14 1.85E-11 1.38E-09 2.21E-10 11722 hsa-mir-3154 hsa04210 Apoptosis 1147_3551_836_5566_839_8517_842_841_840_5970_8837_207_4792 13 2.07E-11 1.55E-09 2.21E-10 11723 hsa-mir-3154 hsa04662 B cell receptor signaling pathway 1147_3551_5595_5594_8517_2932_5970_4794_2353_207_4792_4793 12 4.79E-11 3.59E-09 4.49E-10 11724 hsa-mir-3154 hsa05222 Small cell lung cancer 1147_3551_6258_6256_8517_842_5970_1869_6502_5925_207_4792 12 2.00E-10 1.50E-08 1.66E-09 11725 hsa-mir-3154 hsa04920 Adipocytokine signaling pathway 1147_3551_6258_6256_8517_6774_5970_4794_207_4792_4793 11 2.43E-10 1.82E-08 1.82E-09 11726 hsa-mir-3154 hsa05220 Chronic myeloid leukemia 1147_3551_5595_5594_8517_5970_1869_3065_5925_207_4792 11 7.13E-10 5.35E-08 4.86E-09 11727 hsa-mir-3154 hsa04620 Toll-like receptor signaling pathway 1147_3551_5595_5594_1326_8517_1432_841_5970_2353_207_4792 12 1.18E-09 8.87E-08 7.39E-09 11728 hsa-mir-3154 hsa04916 Melanogenesis 815_1499_5595_5594_1385_1387_5566_2932_2033_808_801_805 12 1.45E-09 1.09E-07 8.36E-09 11729 hsa-mir-3154 hsa04720 Long-term potentiation 815_5595_5594_1387_5566_6195_2033_808_801_805 10 9.83E-09 7.37E-07 5.27E-08 11730 hsa-mir-3154 hsa04120 Ubiquitin mediated proteolysis 55294_5371_23291_672_8454_3093_10273_8945_6502_6500_7323_7329 12 2.92E-08 2.19E-06 1.46E-07 11731 hsa-mir-3154 hsa04350 TGF-beta signaling pathway 3399_5595_5594_1387_6667_8454_3398_6500_2033_3397 10 3.57E-08 2.68E-06 1.67E-07 11732 hsa-mir-3154 hsa05214 Glioma 815_5595_5594_1869_5925_207_808_801_805 9 4.06E-08 3.04E-06 1.79E-07 11733 hsa-mir-3154 hsa04310 Wnt signaling pathway 815_23291_1499_1387_5566_1457_2932_8454_8945_8607_6500_2033 12 7.31E-08 5.48E-06 3.05E-07 11734 hsa-mir-3154 hsa05016 Huntington's disease 1385_1387_292_836_6667_842_841_293_1213_5437_3065_2033_5441 13 8.93E-08 6.70E-06 3.52E-07 11735 hsa-mir-3154 hsa04062 Chemokine signaling pathway 1147_3551_5595_5594_5566_8517_2932_6774_5970_653361_207_4792_4793 13 1.19E-07 8.92E-06 4.46E-07 11736 hsa-mir-3154 hsa05223 Non-small cell lung cancer 5595_5594_6258_6256_842_1869_5925_207 8 1.46E-07 1.09E-05 5.21E-07 11737 hsa-mir-3154 hsa04912 GnRH signaling pathway 815_6714_5595_5594_5566_1432_2002_808_801_805 10 2.31E-07 1.74E-05 7.67E-07 11738 hsa-mir-3154 hsa04910 Insulin signaling pathway 3551_5595_5594_5566_2932_23265_207_2002_808_801_805 11 2.35E-07 1.76E-05 7.67E-07 11739 hsa-mir-3154 hsa04612 Antigen processing and presentation 3320_3326_1385_3309_3305_3303_4800_3310_3312 9 4.72E-07 3.54E-05 1.48E-06 11740 hsa-mir-3154 hsa04110 Cell cycle 5591_1387_2932_8454_1869_6502_6500_3065_5925_2033 10 5.32E-07 3.99E-05 1.60E-06 11741 hsa-mir-3154 hsa04540 Gap junction 6714_5595_5594_5566_7278_347733_10382_84617_203068 9 6.65E-07 4.99E-05 1.92E-06 11742 hsa-mir-3154 hsa04330 Notch signaling pathway 388585_1387_4851_9612_3065_2033_8850 7 8.65E-07 6.49E-05 2.40E-06 11743 hsa-mir-3154 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_3551_6714_836_8517_1432_5970_4792 8 9.77E-07 7.33E-05 2.44E-06 11744 hsa-mir-3154 hsa03020 RNA polymerase 64425_5437_25885_51082_84172_5441 6 9.78E-07 7.33E-05 2.44E-06 11745 hsa-mir-3154 hsa05216 Thyroid cancer 1499_5595_5594_6258_6256_7175 6 9.78E-07 7.33E-05 2.44E-06 11746 hsa-mir-3154 hsa05213 Endometrial cancer 1499_5595_5594_2932_842_207_2002 7 1.60E-06 0.000119951 3.87E-06 11747 hsa-mir-3154 hsa04370 VEGF signaling pathway 6714_5595_5594_9261_7867_1432_842_207 8 1.71E-06 0.000128583 4.02E-06 11748 hsa-mir-3154 hsa04520 Adherens junction 1499_6714_5595_5594_1387_1457_2033_71 8 2.23E-06 0.000167508 5.08E-06 11749 hsa-mir-3154 hsa05010 Alzheimer's disease 22926_5595_5594_836_2932_842_841_840_808_801_805 11 2.36E-06 0.000177029 5.21E-06 11750 hsa-mir-3154 hsa05131 Shigellosis 1499_7278_347733_10382_84617_203068_71 7 2.51E-06 0.000188242 5.23E-06 11751 hsa-mir-3154 hsa05130 Pathogenic Escherichia coli infection 1499_7278_347733_10382_84617_203068_71 7 2.51E-06 0.000188242 5.23E-06 11752 hsa-mir-3154 hsa05210 Colorectal cancer 1499_5595_5594_836_2932_842_2353_207 8 3.13E-06 0.000234638 6.34E-06 11753 hsa-mir-3154 hsa04012 ErbB signaling pathway 815_6714_5595_5594_2932_207_2002 7 3.60E-05 0.002700591 7.11E-05 11754 hsa-mir-3154 hsa04530 Tight junction 1499_6714_1457_4627_4628_10627_207_71 8 8.62E-05 0.006467493 0.000165833 11755 hsa-mir-3154 hsa05211 Renal cell carcinoma 5595_5594_1387_2113_2033_207 6 0.000109392 0.008204377 0.000205109 11756 hsa-mir-3154 hsa04270 Vascular smooth muscle contraction 5595_5594_4637_5566_808_801_805 7 0.000217736 0.016330169 0.000398297 11757 hsa-mir-3154 hsa04510 Focal adhesion 1499_6714_5595_5594_2932_10627_207_71_2002 9 0.000257518 0.019313847 0.000459853 11758 hsa-mir-3154 hsa05218 Melanoma 5595_5594_1869_5925_207 5 0.000849922 0.063744155 0.001482422 11759 hsa-mir-3154 hsa05219 Bladder cancer 5595_5594_1869_5925 4 0.001003692 0.075276877 0.001710838 11760 hsa-mir-3154 hsa04930 Type II diabetes mellitus 3651_3551_5595_5594 4 0.001274041 0.095553101 0.002123402 11761 hsa-mir-3154 hsa04150 mTOR signaling pathway 5595_5594_6195_207 4 0.002095263 0.157144704 0.003416189 11762 hsa-mir-3154 hsa04950 Maturity onset diabetes of the young 3651_168620_4760 3 0.002184742 0.163855667 0.003486291 11763 hsa-mir-3154 hsa04020 Calcium signaling pathway 815_292_5566_293_808_801_805 7 0.002630469 0.197285182 0.004110108 11764 hsa-mir-3154 hsa04340 Hedgehog signaling pathway 23291_5566_2932_8945 4 0.002867305 0.215047877 0.004388732 11765 hsa-mir-3154 hsa04630 Jak-STAT signaling pathway 3559_1387_6774_6778_2033_207 6 0.004834055 0.362554113 0.007251082 11766 hsa-mir-3154 hsa04810 Regulation of actin cytoskeleton 5595_5594_4627_4628_10788_10627_71 7 0.006555641 0.491673087 0.009640649 11767 hsa-mir-3154 hsa04670 Leukocyte transendothelial migration 1499_1432_653361_10627_71 5 0.007872998 0.590474825 0.011355285 11768 hsa-mir-3154 hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432_207 4 0.008565655 0.642424134 0.01212121 11769 hsa-mir-3154 hsa05012 Parkinson's disease 7314_292_836_842_293 5 0.012019639 0.901472943 0.016693943 11770 hsa-mir-3154 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432_842 3 0.019379084 1 0.026148668 11771 hsa-mir-3154 hsa03010 Ribosome 6156_6128_6207_6202 4 0.019524339 1 0.026148668 11772 hsa-mir-3154 hsa04115 p53 signaling pathway 836_842_841 3 0.032473573 1 0.042728386 11773 hsa-mir-3154 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.041018859 1 0.053041627 11774 hsa-mir-3155 hsa04010 MAPK signaling pathway 9261_6722_8986_6195_7157_207_9252_1432_6196_6197 10 4.07E-12 2.24E-10 2.24E-10 11775 hsa-mir-3155 hsa04150 mTOR signaling pathway 6195_207_6196_6197 4 1.04E-06 5.73E-05 2.86E-05 11776 hsa-mir-3155 hsa04720 Long-term potentiation 6195_6196_6197_1387 4 4.17E-06 0.000229087 7.64E-05 11777 hsa-mir-3155 hsa05215 Prostate cancer 7157_207_2932_1387 4 7.65E-06 0.000420607 8.78E-05 11778 hsa-mir-3155 hsa05212 Pancreatic cancer 7157_207_2932_1387 4 7.98E-06 0.000439078 8.78E-05 11779 hsa-mir-3155 hsa05213 Endometrial cancer 7157_207_2932 3 5.89E-05 0.003240675 0.000540113 11780 hsa-mir-3155 hsa05217 Basal cell carcinoma 2736_7157_2932 3 6.91E-05 0.003800666 0.000542952 11781 hsa-mir-3155 hsa05200 Pathways in cancer 2736_7157_207_2932_1387 5 9.28E-05 0.005102593 0.000637824 11782 hsa-mir-3155 hsa04370 VEGF signaling pathway 9261_207_1432 3 0.000180207 0.009911358 0.001101262 11783 hsa-mir-3155 hsa05210 Colorectal cancer 7157_207_2932 3 0.00023095 0.01270226 0.001270226 11784 hsa-mir-3155 hsa04660 T cell receptor signaling pathway 207_2932_1432 3 0.000497762 0.027376896 0.002488809 11785 hsa-mir-3155 hsa04110 Cell cycle 7157_2932_1387 3 0.000622349 0.034229216 0.002852435 11786 hsa-mir-3155 hsa04310 Wnt signaling pathway 7157_2932_1387 3 0.001243705 0.068403754 0.005261827 11787 hsa-mir-3155 hsa05219 Bladder cancer 7157_9252 2 0.00165788 0.091183415 0.006513101 11788 hsa-mir-3155 hsa05016 Huntington's disease 3064_7157_1387 3 0.00225776 0.124176794 0.008278453 11789 hsa-mir-3155 hsa05223 Non-small cell lung cancer 7157_207 2 0.002671087 0.14690978 0.009044499 11790 hsa-mir-3155 hsa05014 Amyotrophic lateral sclerosis (ALS) 7157_1432 2 0.002862144 0.157417918 0.009044499 11791 hsa-mir-3155 hsa04340 Hedgehog signaling pathway 2736_2932 2 0.002960018 0.162800986 0.009044499 11792 hsa-mir-3155 hsa05214 Glioma 7157_207 2 0.003798743 0.208930865 0.010996361 11793 hsa-mir-3155 hsa05218 Melanoma 7157_207 2 0.00449193 0.247056165 0.011918505 11794 hsa-mir-3155 hsa05211 Renal cell carcinoma 207_1387 2 0.004612734 0.253700375 0.011918505 11795 hsa-mir-3155 hsa05220 Chronic myeloid leukemia 7157_207 2 0.004984102 0.274125613 0.011918505 11796 hsa-mir-3155 hsa04662 B cell receptor signaling pathway 207_2932 2 0.004984102 0.274125613 0.011918505 11797 hsa-mir-3155 hsa04664 Fc epsilon RI signaling pathway 207_1432 2 0.005500005 0.302500278 0.012604178 11798 hsa-mir-3155 hsa05222 Small cell lung cancer 7157_207 2 0.006459157 0.355253626 0.013965697 11799 hsa-mir-3155 hsa04012 ErbB signaling pathway 207_2932 2 0.006601966 0.36310811 0.013965697 11800 hsa-mir-3155 hsa04210 Apoptosis 7157_207 2 0.006891884 0.379053594 0.014039022 11801 hsa-mir-3155 hsa04620 Toll-like receptor signaling pathway 207_1432 2 0.008914052 0.490272854 0.017509745 11802 hsa-mir-3155 hsa04916 Melanogenesis 2932_1387 2 0.009246006 0.508530339 0.017535529 11803 hsa-mir-3155 hsa04910 Insulin signaling pathway 207_2932 2 0.015701711 0.863594091 0.028234536 11804 hsa-mir-3155 hsa04120 Ubiquitin mediated proteolysis 7329_672 2 0.015914011 0.87527061 0.028234536 11805 hsa-mir-3155 hsa04630 Jak-STAT signaling pathway 207_1387 2 0.019476692 1 0.033475564 11806 hsa-mir-3155 hsa04062 Chemokine signaling pathway 207_2932 2 0.029123937 1 0.048539896 11807 hsa-mir-3155 hsa04510 Focal adhesion 207_2932 2 0.032782543 1 0.052768935 11808 hsa-mir-3155 hsa04950 Maturity onset diabetes of the young 3651 1 0.033580231 1 0.052768935 11809 hsa-mir-3155 hsa05216 Thyroid cancer 7157 1 0.04016301 1 0.061360155 11810 hsa-mir-3155 hsa04080 Neuroactive ligand-receptor interaction 2908_7067 2 0.048387708 1 0.071927674 11811 hsa-mir-3158-1 hsa05200 Pathways in cancer 3716_3320_3326_5371_9063_3480_1956_4233_1017_5595_5594_5599_10401_1387_2064_6256_5159_595_5156_5601_1488_1487_1019_367_2261_5578_6776_6777_6772_5979_5879_2885_4609_3725_1026_5604_6774_2353_4087_4088_4089_3066_3065_5925_2033_1441_4790_5970_7046 49 6.32E-47 4.61E-45 4.61E-45 11812 hsa-mir-3158-1 hsa04630 Jak-STAT signaling pathway 3717_3716_3718_3559_9063_85480_3560_149233_10401_1387_595_3575_3570_3572_3953_6776_6777_6772_1439_3455_3454_2885_5781_4609_6774_2690_2033_1441 28 4.38E-29 3.19E-27 1.60E-27 11813 hsa-mir-3158-1 hsa05220 Chronic myeloid leukemia 5595_5594_595_1488_1487_1019_6776_6777_2885_5781_4609_1026_5604_4088_4089_3066_3065_5925_4790_5970_7046 21 1.57E-25 1.15E-23 3.83E-24 11814 hsa-mir-3158-1 hsa04010 MAPK signaling pathway 3925_6722_1956_5595_5594_5599_5159_5156_5606_5601_5600_2261_2264_9252_1432_5578_5879_4342_2885_6885_4609_3725_5604_2353_9344_4790_51701_5970_7046_2005 30 2.39E-25 1.75E-23 4.36E-24 11815 hsa-mir-3158-1 hsa05210 Colorectal cancer 3480_1956_4233_5595_5594_5599_5159_595_5156_5601_5879_2885_4609_3725_5604_2353_4087_4088_4089_7046 20 3.74E-23 2.73E-21 5.46E-22 11816 hsa-mir-3158-1 hsa05215 Prostate cancer 3320_3326_3480_1956_1017_5595_5594_1387_2064_5159_595_5156_367_2885_1026_5604_5925_2033_4790_5970 20 8.39E-23 6.12E-21 1.02E-21 11817 hsa-mir-3158-1 hsa05212 Pancreatic cancer 3320_3326_3480_1956_1017_5595_5594_1387_2064_5159_595_5156_367_2885_1026_5604_5925_2033_4790_5970 20 1.02E-22 7.45E-21 1.06E-21 11818 hsa-mir-3158-1 hsa04520 Adherens junction 2241_3480_1956_6714_4233_5595_5594_1387_2064_5879_6885_4087_4088_4089_2033_51701_4301_7046 18 1.44E-20 1.05E-18 1.31E-19 11819 hsa-mir-3158-1 hsa05214 Glioma 3480_1956_5595_5594_5159_595_5156_1019_5578_808_2885_1026_5604_5925_801_805 16 5.91E-19 4.31E-17 4.79E-18 11820 hsa-mir-3158-1 hsa04620 Toll-like receptor signaling pathway 3654_5595_5594_5599_5606_5601_5600_1432_6772_5879_3455_3454_6885_3725_5604_2353_4790_5970 18 6.63E-19 4.84E-17 4.84E-18 11821 hsa-mir-3158-1 hsa04912 GnRH signaling pathway 5580_1956_6714_5595_5594_5599_5606_5601_5600_1432_5578_808_2885_2185_3725_5604_801_805 18 1.64E-18 1.20E-16 1.09E-17 11822 hsa-mir-3158-1 hsa04060 Cytokine-cytokine receptor interaction 3556_2321_3559_85480_1956_4233_3560_149233_5159_5156_3575_3570_3572_1234_1230_3953_1439_7852_3455_3454_2690_1441_7046 23 1.19E-17 8.68E-16 7.23E-17 11823 hsa-mir-3158-1 hsa04350 TGF-beta signaling pathway 3400_5595_5594_1387_3397_3399_3398_4609_4086_4087_4088_4089_2033_4092_6667_7046 16 3.44E-17 2.51E-15 1.93E-16 11824 hsa-mir-3158-1 hsa04012 ErbB signaling pathway 1956_6714_5595_5594_5599_2064_5601_5578_6776_6777_2885_4609_3725_1026_5604 15 8.03E-16 5.86E-14 4.19E-15 11825 hsa-mir-3158-1 hsa04062 Chemokine signaling pathway 3717_3718_5580_5590_5595_5594_1234_1230_6777_6772_5879_7852_2885_2185_5604_6774_3055_4790_5970 19 1.29E-15 9.43E-14 6.28E-15 11826 hsa-mir-3158-1 hsa05219 Bladder cancer 1956_5595_5594_2064_595_1019_2261_9252_4609_1026_5604_5925 12 3.45E-15 2.52E-13 1.57E-14 11827 hsa-mir-3158-1 hsa04510 Focal adhesion 2321_3480_1956_6714_4233_5595_5594_5599_2064_5159_595_5156_5601_5578_5879_2885_3725_5604 18 4.98E-14 3.63E-12 2.14E-13 11828 hsa-mir-3158-1 hsa04310 Wnt signaling pathway 5599_1387_595_5601_1488_1487_5578_5879_6885_4609_3725_4087_4088_4089_2033_51701 16 9.40E-14 6.86E-12 3.81E-13 11829 hsa-mir-3158-1 hsa05221 Acute myeloid leukemia 5371_5595_5594_595_6776_6777_2885_4609_5604_6774_4790_5970 12 1.16E-13 8.45E-12 4.39E-13 11830 hsa-mir-3158-1 hsa04664 Fc epsilon RI signaling pathway 5580_5595_5594_5599_6850_5606_5601_5600_1432_5578_5879_2885_5604 13 1.20E-13 8.78E-12 4.39E-13 11831 hsa-mir-3158-1 hsa04660 T cell receptor signaling pathway 3932_5595_5594_5601_5600_1019_1432_2885_6885_3725_5604_2353_4790_5970 14 3.24E-13 2.37E-11 1.13E-12 11832 hsa-mir-3158-1 hsa05218 Melanoma 3480_1956_4233_5595_5594_5159_595_5156_1019_1026_5604_5925 12 8.12E-13 5.93E-11 2.58E-12 11833 hsa-mir-3158-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_4233_5599_5601_5600_1432_5879_5781_3725_4790_5970 12 8.12E-13 5.93E-11 2.58E-12 11834 hsa-mir-3158-1 hsa05223 Non-small cell lung cancer 1956_5595_5594_2064_6256_595_1019_5578_2885_5604_5925 11 1.23E-12 8.99E-11 3.74E-12 11835 hsa-mir-3158-1 hsa04330 Notch signaling pathway 388585_1387_1488_1487_9612_3280_3066_3065_2033_8850 10 9.11E-12 6.65E-10 2.66E-11 11836 hsa-mir-3158-1 hsa04110 Cell cycle 1017_1387_595_1019_1026_1028_4087_4088_4089_3066_3065_5925_2033 13 1.35E-11 9.86E-10 3.79E-11 11837 hsa-mir-3158-1 hsa05211 Renal cell carcinoma 4233_5595_5594_1387_5879_2885_5781_3725_5604_2033 10 3.86E-10 2.82E-08 1.04E-09 11838 hsa-mir-3158-1 hsa04662 B cell receptor signaling pathway 5595_5594_6850_5879_2885_3725_5604_2353_4790_5970 10 5.55E-10 4.05E-08 1.45E-09 11839 hsa-mir-3158-1 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6850_5578_5879_3455_3454_2885_5781_2185_5604 12 9.51E-10 6.95E-08 2.40E-09 11840 hsa-mir-3158-1 hsa05222 Small cell lung cancer 9063_1017_10401_6256_595_1019_4609_5925_4790_5970 10 1.87E-09 1.36E-07 4.54E-09 11841 hsa-mir-3158-1 hsa04920 Adipocytokine signaling pathway 3717_5599_6256_5601_3953_5781_6774_4790_5970 9 3.88E-09 2.83E-07 9.14E-09 11842 hsa-mir-3158-1 hsa05216 Thyroid cancer 5595_5594_6256_595_5979_4609_5604 7 6.06E-09 4.42E-07 1.38E-08 11843 hsa-mir-3158-1 hsa04720 Long-term potentiation 5595_5594_1387_5578_808_5604_2033_801_805 9 9.55E-09 6.97E-07 2.11E-08 11844 hsa-mir-3158-1 hsa05213 Endometrial cancer 1956_5595_5594_2064_595_2885_4609_5604 8 1.11E-08 8.13E-07 2.39E-08 11845 hsa-mir-3158-1 hsa04540 Gap junction 1956_6714_5595_5594_5159_5156_5578_2885_5604 9 5.32E-08 3.88E-06 1.11E-07 11846 hsa-mir-3158-1 hsa04910 Insulin signaling pathway 5590_5595_5594_5599_5601_808_2885_5604_801_805 10 1.22E-07 8.91E-06 2.48E-07 11847 hsa-mir-3158-1 hsa04916 Melanogenesis 5595_5594_1387_5578_808_5604_2033_801_805 9 1.29E-07 9.45E-06 2.55E-07 11848 hsa-mir-3158-1 hsa04370 VEGF signaling pathway 6714_5595_5594_5600_1432_5578_5879_5604 8 1.80E-07 1.31E-05 3.45E-07 11849 hsa-mir-3158-1 hsa04930 Type II diabetes mellitus 5580_5590_5595_5594_5599_5601 6 1.71E-06 0.000125136 3.21E-06 11850 hsa-mir-3158-1 hsa04270 Vascular smooth muscle contraction 5580_5595_5594_5578_808_5604_801_805 8 3.65E-06 0.000266547 6.66E-06 11851 hsa-mir-3158-1 hsa04670 Leukocyte transendothelial migration 5600_1432_5578_5879_7852_5781_2185_4301 8 4.61E-06 0.000336395 8.20E-06 11852 hsa-mir-3158-1 hsa04810 Regulation of actin cytoskeleton 1956_5595_5594_5159_5156_2261_2264_5879_4342_5604 10 6.50E-06 0.000474789 1.13E-05 11853 hsa-mir-3158-1 hsa04020 Calcium signaling pathway 1956_2064_5159_5156_5578_808_2185_801_805 9 1.12E-05 0.000819924 1.91E-05 11854 hsa-mir-3158-1 hsa04730 Long-term depression 3480_5595_5594_5578_5604 5 0.000218013 0.015914944 0.000361703 11855 hsa-mir-3158-1 hsa05010 Alzheimer's disease 5595_5594_808_6622_22926_801_805 7 0.000375494 0.027411033 0.000609134 11856 hsa-mir-3158-1 hsa04360 Axon guidance 2242_4233_5595_5594_5879_7852 6 0.000470082 0.034315976 0.000745999 11857 hsa-mir-3158-1 hsa04612 Antigen processing and presentation 3320_3326_4800_4801_2923 5 0.000583861 0.042621868 0.0008784 11858 hsa-mir-3158-1 hsa04210 Apoptosis 3654_3556_1439_4790_5970 5 0.000583861 0.042621868 0.0008784 11859 hsa-mir-3158-1 hsa04530 Tight junction 5580_6714_5590_1019_5578_4301 6 0.000589611 0.043041617 0.0008784 11860 hsa-mir-3158-1 hsa04120 Ubiquitin mediated proteolysis 5371_9063_672_10401_997_7329 6 0.000634291 0.046303214 0.000926064 11861 hsa-mir-3158-1 hsa05014 Amyotrophic lateral sclerosis (ALS) 5606_5600_1432_5879 4 0.000905343 0.066090007 0.001295882 11862 hsa-mir-3158-1 hsa04950 Maturity onset diabetes of the young 168620_6927_3280 3 0.000928362 0.067770435 0.001303278 11863 hsa-mir-3158-1 hsa04115 p53 signaling pathway 1017_595_1019_1026 4 0.001880032 0.137242361 0.002589479 11864 hsa-mir-3158-1 hsa05340 Primary immunodeficiency 3718_3932_3575 3 0.002527249 0.184489152 0.003416466 11865 hsa-mir-3158-1 hsa04070 Phosphatidylinositol signaling system 5578_808_801_805 4 0.002627924 0.191838442 0.003487972 11866 hsa-mir-3158-1 hsa04640 Hematopoietic cell lineage 3559_3575_3570_1441 4 0.004178838 0.305055154 0.005447413 11867 hsa-mir-3158-1 hsa04710 Circadian rhythm - mammal 79365_8553 2 0.005023329 0.366703009 0.006433386 11868 hsa-mir-3158-1 hsa05016 Huntington's disease 1387_3066_3065_2033_6667 5 0.012798598 0.934297627 0.01610858 11869 hsa-mir-3158-2 hsa05200 Pathways in cancer 2249_1499_5595_5594_5599_5914_1387_6256_1019_367_1017_2932_6776_6777_5970_6688_2113_4609_3725_1026_6774_2353_4087_4088_4089_5881_1050_5925_2033_207_208_8554_836_7186 34 2.62E-30 1.76E-28 1.76E-28 11870 hsa-mir-3158-2 hsa05210 Colorectal cancer 1499_5595_5594_5599_2932_4609_3725_2353_4087_4088_4089_5881_207_208_836 15 3.91E-17 2.62E-15 1.31E-15 11871 hsa-mir-3158-2 hsa04010 MAPK signaling pathway 9479_6722_2249_5595_5594_5598_5599_1386_1649_3303_1432_5970_468_4609_3725_2353_5881_207_208_836_7186 21 1.18E-16 7.88E-15 2.63E-15 11872 hsa-mir-3158-2 hsa04350 TGF-beta signaling pathway 5595_5594_1387_7027_3399_3398_1874_4609_4087_4088_4089_2033_6667_5933 14 1.65E-15 1.10E-13 2.44E-14 11873 hsa-mir-3158-2 hsa05215 Prostate cancer 1499_5595_5594_1387_367_1017_2932_5970_468_1026_5925_2033_207_208 14 1.90E-15 1.27E-13 2.44E-14 11874 hsa-mir-3158-2 hsa05212 Pancreatic cancer 1499_5595_5594_1387_367_1017_2932_5970_468_1026_5925_2033_207_208 14 2.18E-15 1.46E-13 2.44E-14 11875 hsa-mir-3158-2 hsa05220 Chronic myeloid leukemia 5595_5594_1019_6776_6777_5970_4609_1026_4088_4089_5925_207_208 13 7.32E-15 4.90E-13 7.00E-14 11876 hsa-mir-3158-2 hsa05221 Acute myeloid leukemia 5595_5594_5914_6776_6777_5970_6688_4609_6774_1050_207_208 12 1.51E-14 1.01E-12 1.26E-13 11877 hsa-mir-3158-2 hsa04012 ErbB signaling pathway 6714_5595_5594_5599_2932_6776_6777_4609_3725_1026_207_208 12 9.39E-13 6.29E-11 6.99E-12 11878 hsa-mir-3158-2 hsa04110 Cell cycle 7534_1387_1019_1017_2932_7027_1026_4087_4088_4089_5925_2033_5933 13 1.56E-12 1.05E-10 1.05E-11 11879 hsa-mir-3158-2 hsa04520 Adherens junction 1499_6714_5595_5594_1387_4087_4088_4089_5881_2033 10 1.87E-10 1.25E-08 1.14E-09 11880 hsa-mir-3158-2 hsa05222 Small cell lung cancer 6256_1019_1017_5970_4609_5925_207_208_8554_7186 10 3.57E-10 2.39E-08 1.95E-09 11881 hsa-mir-3158-2 hsa04310 Wnt signaling pathway 1499_5599_1387_2932_6423_4609_3725_4087_4088_4089_5881_2033 12 3.79E-10 2.54E-08 1.95E-09 11882 hsa-mir-3158-2 hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_3725_2353_5881_207_208 9 2.16E-09 1.45E-07 1.03E-08 11883 hsa-mir-3158-2 hsa04660 T cell receptor signaling pathway 5595_5594_1019_2932_1432_5970_3725_2353_207_208 10 3.25E-09 2.17E-07 1.45E-08 11884 hsa-mir-3158-2 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_1432_5970_3725_2353_207_208 9 2.58E-08 1.73E-06 1.07E-07 11885 hsa-mir-3158-2 hsa05218 Melanoma 2249_5595_5594_1019_1026_5925_207_208 8 2.71E-08 1.82E-06 1.07E-07 11886 hsa-mir-3158-2 hsa05211 Renal cell carcinoma 5595_5594_1387_2113_3725_2033_207_208 8 3.00E-08 2.01E-06 1.12E-07 11887 hsa-mir-3158-2 hsa05213 Endometrial cancer 1499_5595_5594_2932_4609_207_208 7 6.76E-08 4.53E-06 2.32E-07 11888 hsa-mir-3158-2 hsa04630 Jak-STAT signaling pathway 1387_6776_6777_4609_6774_2033_3977_207_208_8554 10 6.91E-08 4.63E-06 2.32E-07 11889 hsa-mir-3158-2 hsa05223 Non-small cell lung cancer 5595_5594_6256_1019_5925_207_208 7 8.56E-08 5.74E-06 2.73E-07 11890 hsa-mir-3158-2 hsa05214 Glioma 5595_5594_1019_1026_5925_207_208 7 2.73E-07 1.83E-05 8.32E-07 11891 hsa-mir-3158-2 hsa04920 Adipocytokine signaling pathway 5599_6256_5970_6774_207_208_7186 7 3.31E-07 2.21E-05 9.63E-07 11892 hsa-mir-3158-2 hsa05219 Bladder cancer 5595_5594_1019_4609_1026_5925 6 4.40E-07 2.95E-05 1.23E-06 11893 hsa-mir-3158-2 hsa04912 GnRH signaling pathway 6714_5595_5594_5598_5599_1432_468_3725 8 5.47E-07 3.66E-05 1.46E-06 11894 hsa-mir-3158-2 hsa04370 VEGF signaling pathway 6714_5595_5594_1432_5881_207_208 7 7.91E-07 5.30E-05 2.04E-06 11895 hsa-mir-3158-2 hsa04510 Focal adhesion 1499_6714_5595_5594_5599_2932_3725_5881_207_208 10 8.38E-07 5.62E-05 2.08E-06 11896 hsa-mir-3158-2 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_1432_5881_207_208 7 9.29E-07 6.22E-05 2.22E-06 11897 hsa-mir-3158-2 hsa05216 Thyroid cancer 1499_5595_5594_6256_4609 5 1.82E-06 0.000122069 4.21E-06 11898 hsa-mir-3158-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5599_1432_5970_3725_836 6 7.36E-06 0.000493036 1.64E-05 11899 hsa-mir-3158-2 hsa04210 Apoptosis 5970_840_207_208_836_7186 6 2.47E-05 0.001652357 5.33E-05 11900 hsa-mir-3158-2 hsa04910 Insulin signaling pathway 5595_5594_5599_2932_23265_207_208 7 2.96E-05 0.001983635 6.20E-05 11901 hsa-mir-3158-2 hsa04062 Chemokine signaling pathway 5595_5594_2932_6777_5970_6774_207_208 8 3.20E-05 0.002142668 6.49E-05 11902 hsa-mir-3158-2 hsa04916 Melanogenesis 1499_5595_5594_1387_2932_2033 6 5.64E-05 0.003779426 0.00011116 11903 hsa-mir-3158-2 hsa04720 Long-term potentiation 5595_5594_1387_468_2033 5 0.000125812 0.008429417 0.00024084 11904 hsa-mir-3158-2 hsa04330 Notch signaling pathway 1387_9612_2033_8850 4 0.000256199 0.017165327 0.000476815 11905 hsa-mir-3158-2 hsa04150 mTOR signaling pathway 5595_5594_207_208 4 0.000367822 0.024644087 0.000666056 11906 hsa-mir-3158-2 hsa04950 Maturity onset diabetes of the young 6928_6927_3172 3 0.000567054 0.037992593 0.000999805 11907 hsa-mir-3158-2 hsa05010 Alzheimer's disease 5595_5594_2932_1020_840_836 6 0.000880966 0.059024737 0.001513455 11908 hsa-mir-3158-2 hsa04115 p53 signaling pathway 1019_1017_1026_836 4 0.001006654 0.067445818 0.001686145 11909 hsa-mir-3158-2 hsa04360 Axon guidance 5595_5594_2932_1020_5881 5 0.001436542 0.096248289 0.002347519 11910 hsa-mir-3158-2 hsa04530 Tight junction 1499_6714_1019_207_208 5 0.001737347 0.11640226 0.002771482 11911 hsa-mir-3158-2 hsa04540 Gap junction 6714_5595_5594_5598 4 0.002865342 0.191977906 0.004464602 11912 hsa-mir-3158-2 hsa04930 Type II diabetes mellitus 5595_5594_5599 3 0.003056093 0.204758261 0.004653597 11913 hsa-mir-3158-2 hsa05016 Huntington's disease 1387_6908_2033_836_6667 5 0.006429069 0.430747593 0.009572169 11914 hsa-mir-3158-2 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_5881_836 4 0.0109006 0.730340198 0.015876961 11915 hsa-mir-3158-2 hsa04120 Ubiquitin mediated proteolysis 55294_672_7329_8554 4 0.011162728 0.747902791 0.015912825 11916 hsa-mir-3158-2 hsa03022 Basal transcription factors 6908_2959 2 0.023153707 1 0.032318715 11917 hsa-mir-3158-2 hsa03420 Nucleotide excision repair 5981_4331 2 0.03146772 1 0.043027291 11918 hsa-mir-3158-2 hsa05217 Basal cell carcinoma 1499_2932 2 0.046491987 1 0.059513462 11919 hsa-mir-3158-2 hsa04810 Regulation of actin cytoskeleton 2249_5595_5594_5881 4 0.046512028 1 0.059513462 11920 hsa-mir-3158-2 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_836 2 0.047966074 1 0.059513462 11921 hsa-mir-3158-2 hsa05131 Shigellosis 7534_1499 2 0.047966074 1 0.059513462 11922 hsa-mir-3158-2 hsa05130 Pathogenic Escherichia coli infection 7534_1499 2 0.047966074 1 0.059513462 11923 hsa-mir-3160-1 hsa04110 Cell cycle 5925_2033_1019_1017_7027_1026_5933_1387 8 3.59E-12 1.47E-10 1.47E-10 11924 hsa-mir-3160-1 hsa05200 Pathways in cancer 6688_5925_2033_1019_1017_8554_4609_1499_1026_1387 10 1.14E-11 4.69E-10 2.34E-10 11925 hsa-mir-3160-1 hsa05215 Prostate cancer 5925_2033_1017_468_1499_1026_1387 7 2.94E-11 1.21E-09 3.25E-10 11926 hsa-mir-3160-1 hsa05212 Pancreatic cancer 5925_2033_1017_468_1499_1026_1387 7 3.17E-11 1.30E-09 3.25E-10 11927 hsa-mir-3160-1 hsa04350 TGF-beta signaling pathway 1874_2033_7027_4609_5933_1387 6 1.91E-09 7.81E-08 1.56E-08 11928 hsa-mir-3160-1 hsa05222 Small cell lung cancer 5925_1019_1017_8554_4609 5 1.06E-07 4.34E-06 7.24E-07 11929 hsa-mir-3160-1 hsa05219 Bladder cancer 5925_1019_4609_1026 4 3.42E-07 1.40E-05 2.00E-06 11930 hsa-mir-3160-1 hsa05220 Chronic myeloid leukemia 5925_1019_4609_1026 4 3.06E-06 0.000125273 1.57E-05 11931 hsa-mir-3160-1 hsa04310 Wnt signaling pathway 2033_4609_1499_1387 4 4.50E-05 0.001846021 0.000198824 11932 hsa-mir-3160-1 hsa04630 Jak-STAT signaling pathway 2033_8554_4609_1387 4 4.85E-05 0.001988237 0.000198824 11933 hsa-mir-3160-1 hsa05214 Glioma 5925_1019_1026 3 8.84E-05 0.003625945 0.000329631 11934 hsa-mir-3160-1 hsa04115 p53 signaling pathway 1019_1017_1026 3 0.000104878 0.004299984 0.000358332 11935 hsa-mir-3160-1 hsa05218 Melanoma 5925_1019_1026 3 0.000113795 0.004665597 0.000358892 11936 hsa-mir-3160-1 hsa04720 Long-term potentiation 2033_468_1387 3 0.000133082 0.005456369 0.000389741 11937 hsa-mir-3160-1 hsa04520 Adherens junction 2033_1499_1387 3 0.000160031 0.006561269 0.000437418 11938 hsa-mir-3160-1 hsa04916 Melanogenesis 2033_1499_1387 3 0.000338547 0.013880445 0.000867528 11939 hsa-mir-3160-1 hsa04010 MAPK signaling pathway 468_4609_1649_1386 4 0.000408091 0.016731749 0.000984221 11940 hsa-mir-3160-1 hsa05216 Thyroid cancer 4609_1499 2 0.000708033 0.029029369 0.001612743 11941 hsa-mir-3160-1 hsa04330 Notch signaling pathway 2033_1387 2 0.001765131 0.072370374 0.003808967 11942 hsa-mir-3160-1 hsa05213 Endometrial cancer 4609_1499 2 0.002139341 0.087712962 0.004385648 11943 hsa-mir-3160-1 hsa05223 Non-small cell lung cancer 5925_1019 2 0.002298632 0.094243913 0.004487805 11944 hsa-mir-3160-1 hsa05221 Acute myeloid leukemia 6688_4609 2 0.002720642 0.111546321 0.005070287 11945 hsa-mir-3160-1 hsa05211 Renal cell carcinoma 2033_1387 2 0.00397424 0.162943843 0.007084515 11946 hsa-mir-3160-1 hsa05210 Colorectal cancer 4609_1499 2 0.005326912 0.218403407 0.009100142 11947 hsa-mir-3160-1 hsa04012 ErbB signaling pathway 4609_1026 2 0.00569372 0.233442528 0.009337701 11948 hsa-mir-3160-1 hsa04530 Tight junction 1019_1499 2 0.01340317 0.549529986 0.021135769 11949 hsa-mir-3160-1 hsa05016 Huntington's disease 2033_1387 2 0.024101573 0.988164496 0.036598685 11950 hsa-mir-3160-1 hsa03430 Mismatch repair 5981 1 0.029935202 1 0.043833689 11951 hsa-mir-3160-1 hsa04950 Maturity onset diabetes of the young 6927 1 0.031163378 1 0.044058568 11952 hsa-mir-3160-1 hsa03030 DNA replication 5981 1 0.045783903 1 0.062571334 11953 hsa-mir-3160-2 hsa05200 Pathways in cancer 2249_367_3725_6776_6777_2353_5914_5970_6256 9 3.19E-09 1.28E-07 1.28E-07 11954 hsa-mir-3160-2 hsa05221 Acute myeloid leukemia 6776_6777_5914_5970 4 3.19E-06 0.000127402 6.37E-05 11955 hsa-mir-3160-2 hsa04010 MAPK signaling pathway 2249_468_3725_3727_2353_5970 6 5.37E-06 0.00021487 7.16E-05 11956 hsa-mir-3160-2 hsa05220 Chronic myeloid leukemia 6776_6777_5970 3 0.000267546 0.010701839 0.002140368 11957 hsa-mir-3160-2 hsa04662 B cell receptor signaling pathway 3725_2353_5970 3 0.000267546 0.010701839 0.002140368 11958 hsa-mir-3160-2 hsa04012 ErbB signaling pathway 3725_6776_6777 3 0.000407643 0.01630574 0.002173877 11959 hsa-mir-3160-2 hsa05215 Prostate cancer 468_367_5970 3 0.000421069 0.016842758 0.002173877 11960 hsa-mir-3160-2 hsa05212 Pancreatic cancer 468_367_5970 3 0.000434775 0.017391019 0.002173877 11961 hsa-mir-3160-2 hsa04620 Toll-like receptor signaling pathway 3725_2353_5970 3 0.000639643 0.025585712 0.002842857 11962 hsa-mir-3160-2 hsa04660 T cell receptor signaling pathway 3725_2353_5970 3 0.000791795 0.031671791 0.003167179 11963 hsa-mir-3160-2 hsa03410 Base excision repair 3146_142 2 0.001693327 0.067733085 0.006157553 11964 hsa-mir-3160-2 hsa04630 Jak-STAT signaling pathway 3977_6776_6777 3 0.002074218 0.08296874 0.006914062 11965 hsa-mir-3160-2 hsa04920 Adipocytokine signaling pathway 5970_6256 2 0.005475681 0.219027224 0.016848248 11966 hsa-mir-3160-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5970 2 0.006109057 0.244362264 0.017454447 11967 hsa-mir-3160-2 hsa05210 Colorectal cancer 3725_2353 2 0.008385271 0.33541083 0.021911015 11968 hsa-mir-3160-2 hsa05222 Small cell lung cancer 5970_6256 2 0.008764406 0.350576237 0.021911015 11969 hsa-mir-3160-2 hsa04210 Apoptosis 5970_823 2 0.009347298 0.373891916 0.021993642 11970 hsa-mir-3160-2 hsa04912 GnRH signaling pathway 468_3725 2 0.013423987 0.536959477 0.029831082 11971 hsa-mir-3160-2 hsa03450 Non-homologous end-joining 2547 1 0.023701026 0.948041026 0.049896896 11972 hsa-mir-3160-2 hsa05010 Alzheimer's disease 9451_823 2 0.033280789 1 0.066561578 11973 hsa-mir-3160-2 hsa05016 Huntington's disease 6908_6667 2 0.037098133 1 0.068165573 11974 hsa-mir-3160-2 hsa04062 Chemokine signaling pathway 6777_5970 2 0.038886641 1 0.068165573 11975 hsa-mir-3160-2 hsa04950 Maturity onset diabetes of the young 6927 1 0.039195205 1 0.068165573 11976 hsa-mir-3160-2 hsa05216 Thyroid cancer 6256 1 0.046851743 1 0.078086239 11977 hsa-mir-3161 hsa05200 Pathways in cancer 3320_25_4149_5371_5595_5594_5599_5914_1387_6257_6256_595_1870_5604_1488_836_6258_367_2932_861_7704_6502_4292_3091_5970_7428_1871_7157_2113_5894_4609_1869_3725_1029_1487_4087_4088_4089_3066_3065_1050_5925_8031_2034_2033_4846_8554_4286 48 1.33E-43 9.01E-42 9.01E-42 11978 hsa-mir-3161 hsa04110 Cell cycle 25_990_5591_1387_595_1870_983_2932_8454_6502_6500_1871_7157_10912_1869_1029_4087_4088_4089_3066_3065_5925_2033_4616_5933 25 1.59E-26 1.08E-24 5.40E-25 11979 hsa-mir-3161 hsa05220 Chronic myeloid leukemia 25_5595_5594_595_1870_5604_1488_861_5970_1871_7157_5894_4609_1869_1029_1487_4088_4089_3066_3065_5925_6464 22 3.26E-26 2.22E-24 7.39E-25 11980 hsa-mir-3161 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_8454_3399_6500_4609_3398_4086_4087_4088_4089_2033_4093_5933 16 1.40E-16 9.51E-15 1.87E-15 11981 hsa-mir-3161 hsa05215 Prostate cancer 3320_5595_5594_1387_595_1870_5604_367_2932_5970_1871_7157_5894_1869_5925_2033 16 1.64E-16 1.12E-14 1.87E-15 11982 hsa-mir-3161 hsa05223 Non-small cell lung cancer 5595_5594_6257_6256_595_1870_5604_6258_1871_7157_5894_1869_1029_5925 14 1.79E-16 1.22E-14 1.87E-15 11983 hsa-mir-3161 hsa05212 Pancreatic cancer 3320_5595_5594_1387_595_1870_5604_367_2932_5970_1871_7157_5894_1869_5925_2033 16 1.92E-16 1.31E-14 1.87E-15 11984 hsa-mir-3161 hsa05210 Colorectal cancer 5595_5594_5599_595_5604_836_2932_4292_7157_5894_4609_3725_4087_4088_4089 15 1.87E-15 1.27E-13 1.59E-14 11985 hsa-mir-3161 hsa05222 Small cell lung cancer 4149_6257_6256_595_1870_6258_6502_5970_1871_7157_4609_1869_5925_4846_8554 15 2.55E-15 1.73E-13 1.93E-14 11986 hsa-mir-3161 hsa05219 Bladder cancer 5595_5594_595_1870_5604_1871_7157_5894_4609_1869_1029_5925 12 9.91E-15 6.74E-13 6.74E-14 11987 hsa-mir-3161 hsa04310 Wnt signaling pathway 5599_1387_595_1488_2932_8454_6500_7157_4609_3725_1457_1487_1459_4087_4088_4089_2033 17 2.66E-14 1.81E-12 1.64E-13 11988 hsa-mir-3161 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_5604_861_7704_5970_5894_4609_1050 12 3.29E-13 2.24E-11 1.87E-12 11989 hsa-mir-3161 hsa05216 Thyroid cancer 5595_5594_6257_6256_595_5604_6258_7157_4609_8031 10 3.61E-13 2.46E-11 1.89E-12 11990 hsa-mir-3161 hsa05214 Glioma 5595_5594_595_1870_5604_1871_7157_5894_1869_1029_5925_6464 12 9.07E-13 6.17E-11 4.41E-12 11991 hsa-mir-3161 hsa04010 MAPK signaling pathway 4149_5595_5594_5599_5598_1386_5604_4208_836_5970_3312_7157_10912_5894_4609_3725_4763_4616_1616 19 2.08E-12 1.42E-10 9.44E-12 11992 hsa-mir-3161 hsa05218 Melanoma 5595_5594_595_1870_5604_1871_7157_5894_1869_1029_5925_4286 12 2.29E-12 1.56E-10 9.75E-12 11993 hsa-mir-3161 hsa05211 Renal cell carcinoma 5595_5594_1387_5604_3091_7428_2113_5894_3725_2034_2033 11 5.11E-11 3.47E-09 2.04E-10 11994 hsa-mir-3161 hsa04540 Gap junction 5595_5594_5598_983_5604_7277_7278_10376_5894_7846_51807 11 6.11E-10 4.16E-08 2.31E-09 11995 hsa-mir-3161 hsa05213 Endometrial cancer 5595_5594_595_5604_2932_4292_7157_5894_4609 9 1.12E-09 7.65E-08 4.03E-09 11996 hsa-mir-3161 hsa04012 ErbB signaling pathway 25_5595_5594_5599_5604_2932_5894_4609_3725_6464 10 4.82E-09 3.28E-07 1.64E-08 11997 hsa-mir-3161 hsa04330 Notch signaling pathway 1387_2648_1488_9612_1487_3066_3065_2033 8 1.09E-08 7.38E-07 3.52E-08 11998 hsa-mir-3161 hsa04520 Adherens junction 5595_5594_1387_1457_1459_4087_4088_4089_2033 9 3.41E-08 2.32E-06 1.05E-07 11999 hsa-mir-3161 hsa05016 Huntington's disease 10891_1387_6908_6874_836_6667_2902_7157_3066_3065_3064_2033 12 6.49E-08 4.41E-06 1.92E-07 12000 hsa-mir-3161 hsa04115 p53 signaling pathway 595_983_836_7157_10912_7161_1029_4616 8 1.62E-07 1.10E-05 4.59E-07 12001 hsa-mir-3161 hsa05131 Shigellosis 25_7277_7278_10376_7846_51807_4691 7 6.16E-07 4.19E-05 1.61E-06 12002 hsa-mir-3161 hsa05130 Pathogenic Escherichia coli infection 25_7277_7278_10376_7846_51807_4691 7 6.16E-07 4.19E-05 1.61E-06 12003 hsa-mir-3161 hsa04910 Insulin signaling pathway 6720_10891_5595_5594_5599_5604_2932_5894_6464 9 2.50E-06 0.000169752 6.29E-06 12004 hsa-mir-3161 hsa04916 Melanogenesis 5595_5594_1387_5604_2932_5894_2033_4286 8 2.89E-06 0.000196854 7.03E-06 12005 hsa-mir-3161 hsa04720 Long-term potentiation 5595_5594_1387_5604_2902_5894_2033 7 3.73E-06 0.000253818 8.46E-06 12006 hsa-mir-3161 hsa04662 B cell receptor signaling pathway 5595_5594_5604_2932_5970_5894_3725 7 3.73E-06 0.000253818 8.46E-06 12007 hsa-mir-3161 hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_8454_6502_6500_7428_8554 8 2.15E-05 0.001460016 4.71E-05 12008 hsa-mir-3161 hsa04920 Adipocytokine signaling pathway 10891_5599_6257_6256_6258_5970 6 2.33E-05 0.001587057 4.96E-05 12009 hsa-mir-3161 hsa04912 GnRH signaling pathway 5595_5594_5599_5598_5604_5894_3725 7 3.46E-05 0.00235264 7.13E-05 12010 hsa-mir-3161 hsa04660 T cell receptor signaling pathway 5595_5594_5604_2932_5970_5894_3725 7 3.86E-05 0.002628188 7.73E-05 12011 hsa-mir-3161 hsa04510 Focal adhesion 5595_5594_5599_595_5604_2932_5894_3725_6464 9 5.24E-05 0.003564375 0.000101839 12012 hsa-mir-3161 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_2902_7157_4846_1616 5 0.000115702 0.007867736 0.000218548 12013 hsa-mir-3161 hsa04062 Chemokine signaling pathway 5595_5594_5604_2932_5970_5894_7074_6464 8 0.000193057 0.013127872 0.000354807 12014 hsa-mir-3161 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5604_5970_3725 6 0.000209125 0.014220518 0.000374224 12015 hsa-mir-3161 hsa03022 Basal transcription factors 2962_2969_6908_6874 4 0.000292069 0.019860706 0.000509249 12016 hsa-mir-3161 hsa04730 Long-term depression 5595_5594_5604_5894_4846 5 0.0003268 0.022222381 0.00055556 12017 hsa-mir-3161 hsa04370 VEGF signaling pathway 5595_5594_5604_5894_4846 5 0.000464715 0.03160061 0.000770747 12018 hsa-mir-3161 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5604_5894 5 0.000519212 0.035306429 0.000840629 12019 hsa-mir-3161 hsa04612 Antigen processing and presentation 3320_4800_4801_4802_3312 5 0.00086681 0.058943081 0.001370769 12020 hsa-mir-3161 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_5604_836_5894_6464 6 0.000965503 0.065654225 0.001492141 12021 hsa-mir-3161 hsa03320 PPAR signaling pathway 6257_6256_6258_2168 4 0.002715247 0.18463678 0.00410304 12022 hsa-mir-3161 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_836_5970_3725 4 0.002850909 0.193861845 0.004214388 12023 hsa-mir-3161 hsa05010 Alzheimer's disease 5595_5594_836_2932_2902_4846 6 0.003239569 0.220290672 0.004687036 12024 hsa-mir-3161 hsa04930 Type II diabetes mellitus 5595_5594_5599 3 0.006269662 0.426337018 0.008882021 12025 hsa-mir-3161 hsa04630 Jak-STAT signaling pathway 1387_595_4609_2033_8554 5 0.008573703 0.583011836 0.011898201 12026 hsa-mir-3161 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.009138482 0.621416761 0.012428335 12027 hsa-mir-3161 hsa04270 Vascular smooth muscle contraction 5595_5594_5604_5894 4 0.015529279 1 0.020705705 12028 hsa-mir-3161 hsa04360 Axon guidance 25_5595_5594_2932 4 0.021650688 1 0.028312439 12029 hsa-mir-3161 hsa04810 Regulation of actin cytoskeleton 5595_5594_5604_5894_7074 5 0.031633571 1 0.040586469 12030 hsa-mir-3161 hsa04210 Apoptosis 836_5970_7157 3 0.035502023 1 0.044706251 12031 hsa-mir-3162 hsa04110 Cell cycle 1869_4087_4088_4089_1870_1871_7157_5925_5934_983_5933_1017_7533_890_993_1387 16 4.34E-22 1.78E-20 1.78E-20 12032 hsa-mir-3162 hsa04350 TGF-beta signaling pathway 4087_4088_4089_1875_5934_5933_4609_1387_1874 9 6.33E-12 2.59E-10 1.30E-10 12033 hsa-mir-3162 hsa05200 Pathways in cancer 1869_4087_4088_4089_1870_1871_7157_5925_1017_1050_4149_4609_1387 13 1.22E-11 4.99E-10 1.66E-10 12034 hsa-mir-3162 hsa05220 Chronic myeloid leukemia 1869_4088_4089_1870_1871_7157_5925_4609 8 7.93E-11 3.25E-09 8.12E-10 12035 hsa-mir-3162 hsa05222 Small cell lung cancer 1869_1870_1871_7157_5925_1017_4149_4609 8 2.18E-10 8.95E-09 1.79E-09 12036 hsa-mir-3162 hsa05219 Bladder cancer 1869_1870_1871_7157_5925_4609 6 4.11E-09 1.68E-07 2.81E-08 12037 hsa-mir-3162 hsa05215 Prostate cancer 1869_1870_1871_7157_5925_1017_1387 7 8.54E-09 3.50E-07 4.71E-08 12038 hsa-mir-3162 hsa05212 Pancreatic cancer 1869_1870_1871_7157_5925_1017_1387 7 9.19E-09 3.77E-07 4.71E-08 12039 hsa-mir-3162 hsa05223 Non-small cell lung cancer 1869_1870_1871_7157_5925 5 6.30E-07 2.58E-05 2.87E-06 12040 hsa-mir-3162 hsa05214 Glioma 1869_1870_1871_7157_5925 5 1.49E-06 6.10E-05 6.10E-06 12041 hsa-mir-3162 hsa05218 Melanoma 1869_1870_1871_7157_5925 5 2.24E-06 9.19E-05 8.36E-06 12042 hsa-mir-3162 hsa05210 Colorectal cancer 4087_4088_4089_7157_4609 5 4.90E-06 0.000200787 1.63E-05 12043 hsa-mir-3162 hsa04310 Wnt signaling pathway 4087_4088_4089_7157_4609_1387 6 5.16E-06 0.000211513 1.63E-05 12044 hsa-mir-3162 hsa04520 Adherens junction 4087_4088_4089_1387 4 8.79E-05 0.003602446 0.000257318 12045 hsa-mir-3162 hsa04115 p53 signaling pathway 7157_983_1017 3 0.001052888 0.043168409 0.002877894 12046 hsa-mir-3162 hsa04612 Antigen processing and presentation 1514_4800_4801 3 0.002130942 0.087368604 0.005460538 12047 hsa-mir-3162 hsa04950 Maturity onset diabetes of the young 3651_5080 2 0.002341331 0.095994588 0.00564674 12048 hsa-mir-3162 hsa05216 Thyroid cancer 7157_4609 2 0.003320101 0.136124139 0.007562452 12049 hsa-mir-3162 hsa04010 MAPK signaling pathway 6722_7157_4149_4609 4 0.007317287 0.300008776 0.015789936 12050 hsa-mir-3162 hsa04330 Notch signaling pathway 1387_8850 2 0.008131417 0.333388079 0.016669404 12051 hsa-mir-3162 hsa05213 Endometrial cancer 7157_4609 2 0.009806988 0.402086493 0.019146976 12052 hsa-mir-3162 hsa05221 Acute myeloid leukemia 1050_4609 2 0.012386419 0.507843177 0.023083781 12053 hsa-mir-3162 hsa05016 Huntington's disease 7157_10476_1387 3 0.015967273 0.654658202 0.0284634 12054 hsa-mir-3163 hsa05200 Pathways in cancer 3320_25_4149_5371_2034_7046_1499_5595_5594_5599_1387_6256_862_595_1870_5604_1488_836_367_2932_5914_7704_6502_6772_4292_3091_5970_7428_1871_7157_2113_5894_4609_1869_3725_1029_1487_4087_4088_4089_3066_3065_5925_2033_4846_1050_9915 47 1.16E-36 8.36E-35 8.36E-35 12055 hsa-mir-3163 hsa05220 Chronic myeloid leukemia 25_7046_5595_5594_595_1870_5604_1488_5970_1871_7157_5894_4609_1869_1029_1487_4088_4089_3066_3065_5925_6464 22 1.25E-23 8.99E-22 4.49E-22 12056 hsa-mir-3163 hsa04110 Cell cycle 25_990_5591_1387_595_1870_983_2932_8454_6502_6500_1871_7157_1869_1029_4087_4088_4089_3066_3065_5925_2033_5933 23 4.30E-21 3.10E-19 1.03E-19 12057 hsa-mir-3163 hsa04350 TGF-beta signaling pathway 7046_5595_5594_1387_6667_8454_3399_6500_4609_3397_3398_4086_4087_4088_4089_2033_4093_5933 18 3.11E-17 2.24E-15 5.59E-16 12058 hsa-mir-3163 hsa05210 Colorectal cancer 7046_1499_5595_5594_5599_595_5604_836_2932_4292_7157_5894_4609_3725_4087_4088_4089 17 3.30E-16 2.38E-14 4.76E-15 12059 hsa-mir-3163 hsa05215 Prostate cancer 3320_1499_5595_5594_1387_595_1870_5604_367_2932_5970_1871_7157_5894_1869_5925_2033 17 6.53E-16 4.70E-14 7.84E-15 12060 hsa-mir-3163 hsa05212 Pancreatic cancer 3320_1499_5595_5594_1387_595_1870_5604_367_2932_5970_1871_7157_5894_1869_5925_2033 17 7.71E-16 5.55E-14 7.93E-15 12061 hsa-mir-3163 hsa05214 Glioma 805_5595_5594_595_1870_5604_808_1871_7157_5894_1869_1029_5925_6464_801 15 3.48E-15 2.50E-13 3.13E-14 12062 hsa-mir-3163 hsa04310 Wnt signaling pathway 1499_5599_1387_595_1488_2932_8454_6500_7157_4609_3725_1457_1487_1459_4087_4088_4089_2033 18 1.85E-13 1.33E-11 1.48E-12 12063 hsa-mir-3163 hsa05219 Bladder cancer 5595_5594_595_1870_5604_1871_7157_5894_4609_1869_1029_5925 12 2.38E-13 1.72E-11 1.72E-12 12064 hsa-mir-3163 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_5604_1871_7157_5894_1869_1029_5925 12 3.07E-12 2.21E-10 2.01E-11 12065 hsa-mir-3163 hsa04010 MAPK signaling pathway 6722_4149_7046_5595_5594_5599_5598_5604_4208_836_7867_1386_1432_5970_9261_3312_7157_5894_4609_3725_4763 21 4.02E-12 2.89E-10 2.41E-11 12066 hsa-mir-3163 hsa05221 Acute myeloid leukemia 5371_5595_5594_862_595_5604_5914_7704_5970_5894_4609_1050 12 7.62E-12 5.49E-10 4.22E-11 12067 hsa-mir-3163 hsa05211 Renal cell carcinoma 2034_5595_5594_1387_5604_3091_7428_2113_5894_3725_2033_9915 12 5.98E-11 4.31E-09 3.08E-10 12068 hsa-mir-3163 hsa04520 Adherens junction 4301_7046_1499_5595_5594_1387_1457_1459_4087_4088_4089_2033 12 1.79E-10 1.29E-08 8.57E-10 12069 hsa-mir-3163 hsa04330 Notch signaling pathway 388585_1387_2648_1488_9612_1487_3066_3065_2033_8850 10 2.97E-10 2.14E-08 1.33E-09 12070 hsa-mir-3163 hsa05222 Small cell lung cancer 4149_6256_595_1870_6502_5970_1871_7157_4609_1869_5925_4846 12 3.79E-10 2.73E-08 1.60E-09 12071 hsa-mir-3163 hsa05213 Endometrial cancer 1499_5595_5594_595_5604_2932_4292_7157_5894_4609 10 7.06E-10 5.08E-08 2.82E-09 12072 hsa-mir-3163 hsa05218 Melanoma 5595_5594_595_1870_5604_1871_7157_5894_1869_1029_5925 11 7.62E-10 5.49E-08 2.89E-09 12073 hsa-mir-3163 hsa05216 Thyroid cancer 1499_5595_5594_6256_595_5604_7157_4609 8 3.18E-09 2.29E-07 1.15E-08 12074 hsa-mir-3163 hsa04540 Gap junction 5595_5594_5598_983_5604_7277_7278_10376_5894_7846_51807 11 9.96E-09 7.17E-07 3.41E-08 12075 hsa-mir-3163 hsa04720 Long-term potentiation 805_5595_5594_1387_5604_808_2902_5894_2033_801 10 1.67E-08 1.20E-06 5.47E-08 12076 hsa-mir-3163 hsa04916 Melanogenesis 805_1499_5595_5594_1387_5604_2932_808_5894_2033_801 11 2.88E-08 2.07E-06 9.00E-08 12077 hsa-mir-3163 hsa04912 GnRH signaling pathway 805_5595_5594_5599_5598_5604_1432_808_5894_3725_801 11 4.11E-08 2.96E-06 1.23E-07 12078 hsa-mir-3163 hsa04012 ErbB signaling pathway 25_5595_5594_5599_5604_2932_5894_4609_3725_6464 10 6.03E-08 4.34E-06 1.74E-07 12079 hsa-mir-3163 hsa05131 Shigellosis 25_1499_7277_7278_10376_7846_51807_4691 8 2.88E-07 2.07E-05 7.67E-07 12080 hsa-mir-3163 hsa05130 Pathogenic Escherichia coli infection 25_1499_7277_7278_10376_7846_51807_4691 8 2.88E-07 2.07E-05 7.67E-07 12081 hsa-mir-3163 hsa04910 Insulin signaling pathway 6720_805_5595_5594_5599_5604_2932_808_5894_6464_801 11 4.10E-07 2.95E-05 1.06E-06 12082 hsa-mir-3163 hsa05016 Huntington's disease 1387_6908_6874_836_6667_2902_7157_23186_3066_3065_3064_2033 12 1.13E-06 8.14E-05 2.81E-06 12083 hsa-mir-3163 hsa04370 VEGF signaling pathway 5595_5594_5604_7867_1432_9261_5894_4846 8 2.60E-06 0.000187027 6.23E-06 12084 hsa-mir-3163 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5604_1432_6772_5970_3725 8 1.77E-05 0.001277873 4.12E-05 12085 hsa-mir-3163 hsa04662 B cell receptor signaling pathway 5595_5594_5604_2932_5970_5894_3725 7 2.11E-05 0.001522442 4.76E-05 12086 hsa-mir-3163 hsa05010 Alzheimer's disease 805_5595_5594_836_2932_808_2902_4846_22926_801 10 2.42E-05 0.001740656 5.27E-05 12087 hsa-mir-3163 hsa04660 T cell receptor signaling pathway 5595_5594_5604_2932_1432_5970_5894_3725 8 2.95E-05 0.002126802 6.26E-05 12088 hsa-mir-3163 hsa03022 Basal transcription factors 2963_2962_2969_6908_6874 5 6.66E-05 0.004793817 0.000136966 12089 hsa-mir-3163 hsa04510 Focal adhesion 1499_5595_5594_5599_595_5604_2932_5894_3725_6464 10 8.16E-05 0.005875636 0.000163212 12090 hsa-mir-3163 hsa04115 p53 signaling pathway 595_983_836_7157_7161_1029 6 0.000119333 0.008591965 0.000232215 12091 hsa-mir-3163 hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_8454_6502_6500_7428_7329 8 0.000139512 0.0100449 0.000264339 12092 hsa-mir-3163 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5604_1432_5894 6 0.000238061 0.017140406 0.000439498 12093 hsa-mir-3163 hsa04062 Chemokine signaling pathway 5595_5594_5604_2932_6772_5970_5894_7074_6464 9 0.00024527 0.017659458 0.000441486 12094 hsa-mir-3163 hsa04270 Vascular smooth muscle contraction 805_5595_5594_5604_808_5894_801 7 0.000305676 0.022008707 0.000536798 12095 hsa-mir-3163 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432_2902_7157_4846 5 0.000397636 0.028629793 0.000681662 12096 hsa-mir-3163 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_836_1432_5970_3725 5 0.001090708 0.078530972 0.001784795 12097 hsa-mir-3163 hsa04730 Long-term depression 5595_5594_5604_5894_4846 5 0.001090708 0.078530972 0.001784795 12098 hsa-mir-3163 hsa04930 Type II diabetes mellitus 5595_5594_5599_3651 4 0.001564508 0.112644605 0.002503213 12099 hsa-mir-3163 hsa04950 Maturity onset diabetes of the young 3651_4760_168620 3 0.002560456 0.184352804 0.00400767 12100 hsa-mir-3163 hsa04612 Antigen processing and presentation 3320_4800_4801_4802_3312 5 0.002793908 0.201161395 0.00428003 12101 hsa-mir-3163 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_5604_836_5894_6464 6 0.00368447 0.265281862 0.005526705 12102 hsa-mir-3163 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.018636977 1 0.027384945 12103 hsa-mir-3163 hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.021438624 1 0.030871618 12104 hsa-mir-3163 hsa04630 Jak-STAT signaling pathway 1387_595_6772_4609_2033 5 0.024388844 1 0.03443131 12105 hsa-mir-3163 hsa04920 Adipocytokine signaling pathway 5599_6256_5970 3 0.034815549 1 0.048206145 12106 hsa-mir-3163 hsa04020 Calcium signaling pathway 805_808_2902_4846_801 5 0.044868703 1 0.06095371 12107 hsa-mir-3163 hsa04070 Phosphatidylinositol signaling system 805_808_801 3 0.047087748 1 0.062783665 12108 hsa-mir-3163 hsa04360 Axon guidance 25_5595_5594_2932 4 0.049781774 1 0.065168868 12109 hsa-mir-3164 hsa05200 Pathways in cancer 5371_5595_5594_6256_595_4286_367_5914_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_4088_4089_3066_3065_5925_2034_2033_4846_836 29 4.64E-33 2.87E-31 2.87E-31 12110 hsa-mir-3164 hsa05220 Chronic myeloid leukemia 5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464 15 3.09E-22 1.91E-20 9.57E-21 12111 hsa-mir-3164 hsa04110 Cell cycle 5591_595_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933 14 6.94E-18 4.30E-16 1.43E-16 12112 hsa-mir-3164 hsa05215 Prostate cancer 5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033 11 1.52E-14 9.42E-13 2.11E-13 12113 hsa-mir-3164 hsa05212 Pancreatic cancer 5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033 11 1.70E-14 1.06E-12 2.11E-13 12114 hsa-mir-3164 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5925 9 5.22E-14 3.24E-12 5.39E-13 12115 hsa-mir-3164 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925 9 3.94E-13 2.44E-11 3.05E-12 12116 hsa-mir-3164 hsa05210 Colorectal cancer 5595_5594_595_7157_4087_4609_3725_4088_4089_836 10 3.94E-13 2.44E-11 3.05E-12 12117 hsa-mir-3164 hsa05222 Small cell lung cancer 6256_595_5970_1870_1871_7157_4609_1869_5925_4846 10 4.89E-13 3.03E-11 3.37E-12 12118 hsa-mir-3164 hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_6464 9 1.79E-12 1.11E-10 1.11E-11 12119 hsa-mir-3164 hsa05218 Melanoma 5595_5594_595_4286_1870_1871_7157_1869_5925 9 3.69E-12 2.29E-10 2.08E-11 12120 hsa-mir-3164 hsa05221 Acute myeloid leukemia 5371_5595_5594_595_5914_7704_5970_4609 8 3.75E-11 2.32E-09 1.94E-10 12121 hsa-mir-3164 hsa05211 Renal cell carcinoma 5595_5594_3091_7428_2113_3725_2034_2033 8 1.61E-10 9.99E-09 7.69E-10 12122 hsa-mir-3164 hsa04350 TGF-beta signaling pathway 5595_5594_4087_4609_4088_4089_2033_5933 8 6.51E-10 4.03E-08 2.88E-09 12123 hsa-mir-3164 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 1.19E-09 7.39E-08 4.93E-09 12124 hsa-mir-3164 hsa04310 Wnt signaling pathway 595_7157_4087_4609_3725_1457_4088_4089_2033 9 2.07E-09 1.28E-07 8.01E-09 12125 hsa-mir-3164 hsa04520 Adherens junction 5595_5594_4087_1457_4088_4089_2033 7 1.10E-08 6.83E-07 4.02E-08 12126 hsa-mir-3164 hsa04010 MAPK signaling pathway 5595_5594_4208_3312_5970_7157_4609_3725_4763_836 10 2.08E-08 1.29E-06 7.17E-08 12127 hsa-mir-3164 hsa05016 Huntington's disease 6874_2902_7157_3066_3065_3064_2033_836 8 1.93E-07 1.20E-05 6.31E-07 12128 hsa-mir-3164 hsa05213 Endometrial cancer 5595_5594_595_7157_4609 5 9.83E-07 6.10E-05 3.05E-06 12129 hsa-mir-3164 hsa04012 ErbB signaling pathway 5595_5594_4609_3725_6464 5 1.06E-05 0.000656913 3.13E-05 12130 hsa-mir-3164 hsa04330 Notch signaling pathway 9612_3066_3065_2033 4 1.99E-05 0.001235796 5.62E-05 12131 hsa-mir-3164 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_7157_4846_836 4 3.81E-05 0.00236019 0.000102617 12132 hsa-mir-3164 hsa04720 Long-term potentiation 5595_5594_2902_2033 4 0.000112099 0.006950151 0.000278006 12133 hsa-mir-3164 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725 4 0.000112099 0.006950151 0.000278006 12134 hsa-mir-3164 hsa05010 Alzheimer's disease 5595_5594_2902_4846_836 5 0.000272005 0.016864338 0.000648628 12135 hsa-mir-3164 hsa04620 Toll-like receptor signaling pathway 5595_5594_5970_3725 4 0.000347565 0.021549049 0.000798113 12136 hsa-mir-3164 hsa04916 Melanogenesis 5595_5594_4286_2033 4 0.000373172 0.023136643 0.000826309 12137 hsa-mir-3164 hsa04660 T cell receptor signaling pathway 5595_5594_5970_3725 4 0.000458077 0.028400745 0.000979336 12138 hsa-mir-3164 hsa04510 Focal adhesion 5595_5594_595_3725_6464 5 0.000534758 0.033154988 0.001105166 12139 hsa-mir-3164 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.000688286 0.042673748 0.001376573 12140 hsa-mir-3164 hsa04910 Insulin signaling pathway 6720_5595_5594_6464 4 0.001042813 0.064654432 0.001959225 12141 hsa-mir-3164 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_6464 4 0.001042813 0.064654432 0.001959225 12142 hsa-mir-3164 hsa04115 p53 signaling pathway 595_7157_836 3 0.001505878 0.093364444 0.002746013 12143 hsa-mir-3164 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_3725_836 3 0.001629421 0.101024104 0.002806225 12144 hsa-mir-3164 hsa04730 Long-term depression 5595_5594_4846 3 0.001629421 0.101024104 0.002806225 12145 hsa-mir-3164 hsa04370 VEGF signaling pathway 5595_5594_4846 3 0.002037497 0.126324804 0.003414184 12146 hsa-mir-3164 hsa04612 Antigen processing and presentation 4800_4801_3312 3 0.003031441 0.18794936 0.004819214 12147 hsa-mir-3164 hsa04210 Apoptosis 5970_7157_836 3 0.003031441 0.18794936 0.004819214 12148 hsa-mir-3164 hsa04062 Chemokine signaling pathway 5595_5594_5970_6464 4 0.003432618 0.212822338 0.005320558 12149 hsa-mir-3164 hsa04912 GnRH signaling pathway 5595_5594_3725 3 0.005131225 0.318135948 0.007759413 12150 hsa-mir-3164 hsa04930 Type II diabetes mellitus 5595_5594 2 0.009524046 0.590490858 0.014059306 12151 hsa-mir-3164 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428 3 0.010084082 0.625213079 0.014539839 12152 hsa-mir-3164 hsa04630 Jak-STAT signaling pathway 595_4609_2033 3 0.01343412 0.832915445 0.018929896 12153 hsa-mir-3164 hsa04920 Adipocytokine signaling pathway 6256_5970 2 0.019773498 1 0.027243487 12154 hsa-mir-3164 hsa04664 Fc epsilon RI signaling pathway 5595_5594 2 0.026659315 1 0.035932121 12155 hsa-mir-3164 hsa04540 Gap junction 5595_5594 2 0.035724885 1 0.047126445 12156 hsa-mir-3164 hsa04710 Circadian rhythm - mammal 8863 1 0.042861871 1 0.055363251 12157 hsa-mir-3164 hsa03450 Non-homologous end-joining 5591 1 0.045852928 1 0.058017991 12158 hsa-mir-3165 hsa05200 Pathways in cancer 3725_5371_9063_5595_5594_5599_861_5914_1387_6257_6256_595_5601_1488_836_1487_6258_367_7704_3091_5970_7428_1870_1871_2885_7157_2113_4609_1869_5604_2353_4087_4088_4089_3066_3065_5925_8031_2034_2033_4846_8554 42 7.04E-36 4.58E-34 4.58E-34 12159 hsa-mir-3165 hsa05220 Chronic myeloid leukemia 5595_5594_861_595_1488_1487_5970_1870_1871_2885_7157_4609_1869_5604_4088_4089_3066_3065_5925_6464 20 3.46E-23 2.25E-21 1.12E-21 12160 hsa-mir-3165 hsa04010 MAPK signaling pathway 6722_3725_5595_5594_5599_4208_5601_5600_836_3312_1432_1649_5970_9344_2885_7157_10912_4609_5604_5606_1386_2353_4763_1616_4616_2005 26 1.29E-19 8.36E-18 2.79E-18 12161 hsa-mir-3165 hsa04110 Cell cycle 993_5591_1387_595_983_1870_1871_7157_10912_1869_4087_4088_4089_3066_3065_5925_2033_5933_4616 19 2.11E-18 1.37E-16 3.42E-17 12162 hsa-mir-3165 hsa05210 Colorectal cancer 3725_5595_5594_5599_595_5601_836_2885_7157_4609_5604_2353_4087_4088_4089 15 1.99E-15 1.29E-13 2.59E-14 12163 hsa-mir-3165 hsa05223 Non-small cell lung cancer 5595_5594_6257_6256_595_6258_1870_1871_2885_7157_1869_5604_5925 13 5.28E-15 3.43E-13 5.72E-14 12164 hsa-mir-3165 hsa05222 Small cell lung cancer 9063_6257_6256_595_6258_5970_1870_1871_7157_4609_1869_5925_4846_8554 14 5.46E-14 3.55E-12 5.07E-13 12165 hsa-mir-3165 hsa05215 Prostate cancer 5595_5594_1387_595_367_5970_1870_1871_2885_7157_1869_5604_5925_2033 14 7.25E-14 4.71E-12 5.89E-13 12166 hsa-mir-3165 hsa05212 Pancreatic cancer 5595_5594_1387_595_367_5970_1870_1871_2885_7157_1869_5604_5925_2033 14 8.33E-14 5.42E-12 6.02E-13 12167 hsa-mir-3165 hsa05216 Thyroid cancer 5595_5594_6257_6256_595_6258_7157_4609_5604_8031 10 3.77E-13 2.45E-11 2.45E-12 12168 hsa-mir-3165 hsa04310 Wnt signaling pathway 3725_5599_1387_595_5601_1488_1487_7157_8061_4609_1457_4087_4088_4089_2033 15 5.07E-12 3.29E-10 2.99E-11 12169 hsa-mir-3165 hsa05221 Acute myeloid leukemia 5371_5595_5594_861_5914_595_7704_5970_2885_4609_5604 11 7.83E-12 5.09E-10 4.24E-11 12170 hsa-mir-3165 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5604_5925 10 8.58E-12 5.58E-10 4.29E-11 12171 hsa-mir-3165 hsa05214 Glioma 5595_5594_595_1870_1871_2885_7157_1869_5604_5925_6464 11 1.99E-11 1.29E-09 8.93E-11 12172 hsa-mir-3165 hsa04350 TGF-beta signaling pathway 5595_5594_1387_3397_3399_3398_4609_4087_4088_4089_2033_5933 12 2.06E-11 1.34E-09 8.93E-11 12173 hsa-mir-3165 hsa05211 Renal cell carcinoma 3725_5595_5594_1387_3091_7428_2885_2113_5604_2034_2033 11 5.34E-11 3.47E-09 2.17E-10 12174 hsa-mir-3165 hsa04620 Toll-like receptor signaling pathway 3725_5595_5594_5599_5601_5600_1432_5970_5604_5606_2353 11 1.57E-09 1.02E-07 5.99E-09 12175 hsa-mir-3165 hsa04330 Notch signaling pathway 1387_1488_1487_8850_9612_3066_3065_2033 8 1.12E-08 7.29E-07 4.05E-08 12176 hsa-mir-3165 hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5604_5925 9 1.37E-08 8.91E-07 4.69E-08 12177 hsa-mir-3165 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5601_5600_1432_2885_5604_5606 9 3.20E-08 2.08E-06 1.04E-07 12178 hsa-mir-3165 hsa04912 GnRH signaling pathway 3725_5595_5594_5599_5601_5600_1432_2885_5604_5606 10 3.37E-08 2.19E-06 1.04E-07 12179 hsa-mir-3165 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_5600_836_1432_7157_5606_1616_4846 8 3.84E-08 2.50E-06 1.12E-07 12180 hsa-mir-3165 hsa04660 T cell receptor signaling pathway 3725_5595_5594_5601_5600_1432_5970_2885_5604_2353 10 3.95E-08 2.57E-06 1.12E-07 12181 hsa-mir-3165 hsa04012 ErbB signaling pathway 3725_5595_5594_5599_5601_2885_4609_5604_6464 9 6.88E-08 4.47E-06 1.86E-07 12182 hsa-mir-3165 hsa05213 Endometrial cancer 5595_5594_595_2885_7157_4609_5604 7 4.01E-07 2.61E-05 1.04E-06 12183 hsa-mir-3165 hsa04520 Adherens junction 5595_5594_1387_1457_4087_4088_4089_2033 8 4.74E-07 3.08E-05 1.19E-06 12184 hsa-mir-3165 hsa05016 Huntington's disease 6874_10891_1387_2902_6908_836_7157_3066_3065_3064_2033 11 5.48E-07 3.56E-05 1.32E-06 12185 hsa-mir-3165 hsa04920 Adipocytokine signaling pathway 10891_5599_6257_6256_5601_6258_5970 7 1.92E-06 0.0001245 4.45E-06 12186 hsa-mir-3165 hsa04115 p53 signaling pathway 595_983_836_7157_10912_64326_4616 7 2.30E-06 0.000149251 5.15E-06 12187 hsa-mir-3165 hsa04910 Insulin signaling pathway 6720_10891_5595_5594_5599_5601_2885_5604_6464 9 2.58E-06 0.000167932 5.60E-06 12188 hsa-mir-3165 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5599_5601_5600_836_1432_5970 7 2.74E-06 0.000177983 5.74E-06 12189 hsa-mir-3165 hsa04662 B cell receptor signaling pathway 3725_5595_5594_5970_2885_5604_2353 7 3.84E-06 0.000249408 7.79E-06 12190 hsa-mir-3165 hsa04720 Long-term potentiation 5595_5594_1387_2902_5604_2033 6 4.32E-05 0.002810716 8.52E-05 12191 hsa-mir-3165 hsa04370 VEGF signaling pathway 5595_5594_5600_1432_5604_4846 6 4.96E-05 0.003226613 9.49E-05 12192 hsa-mir-3165 hsa04510 Focal adhesion 3725_5595_5594_5599_595_5601_2885_5604_6464 9 5.41E-05 0.003519205 0.000100549 12193 hsa-mir-3165 hsa04120 Ubiquitin mediated proteolysis 5371_9063_672_7428_7329_64326_8554 7 0.0001602 0.010413029 0.000289251 12194 hsa-mir-3165 hsa04630 Jak-STAT signaling pathway 9063_1387_595_2885_4609_2033_8554 7 0.000302923 0.019689986 0.000532162 12195 hsa-mir-3165 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601 4 0.000591183 0.038426897 0.001011234 12196 hsa-mir-3165 hsa05010 Alzheimer's disease 22926_5595_5594_2902_836_6622_4846 7 0.000649356 0.04220811 0.001082259 12197 hsa-mir-3165 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_2885_5604_6464 6 0.000986594 0.06412858 0.001603215 12198 hsa-mir-3165 hsa04540 Gap junction 5595_5594_983_2885_5604 5 0.001065438 0.069253472 0.001689109 12199 hsa-mir-3165 hsa04916 Melanogenesis 5595_5594_1387_5604_2033 5 0.001710003 0.111150223 0.002646434 12200 hsa-mir-3165 hsa03320 PPAR signaling pathway 6257_6256_6258_2168 4 0.002756484 0.179171428 0.004166777 12201 hsa-mir-3165 hsa04730 Long-term depression 5595_5594_5604_4846 4 0.002894133 0.18811864 0.004275424 12202 hsa-mir-3165 hsa03022 Basal transcription factors 6874_6908_2959 3 0.00379305 0.246548231 0.00547885 12203 hsa-mir-3165 hsa04062 Chemokine signaling pathway 5595_5594_5970_2885_5604_6464 6 0.004967721 0.322901885 0.007019606 12204 hsa-mir-3165 hsa04612 Antigen processing and presentation 4800_4801_1514_3312 4 0.006233439 0.405173533 0.008620713 12205 hsa-mir-3165 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.009243053 0.600798471 0.012516635 12206 hsa-mir-3165 hsa04210 Apoptosis 836_5970_7157 3 0.035877261 1 0.047592285 12207 hsa-mir-3166 hsa05200 Pathways in cancer 3725_1499_595_2261_8517_3551_6502_3066_3065_5925_7187_5468_10342_1956_6774_862_3716_1147_4233_5595_5594_5599_6258_1387_2064_6256_4286_367_10401_6776_6777_6772_5979_5879_2033_898_4790_4791_4792_5970_3320_3326_5371_3480_5159_5156_6257_8031_4609_1026_2353_1441_8554 53 9.20E-27 7.55E-25 7.55E-25 12208 hsa-mir-3166 hsa04010 MAPK signaling pathway 3925_6722_3725_2261_2264_8517_9252_7867_3551_9020_4616_1956_3305_3303_1432_1147_3727_5595_5594_5599_3310_3312_5971_5879_10912_468_4790_4791_51701_5970_5159_9261_1326_5156_4208_5608_5566_6885_4609_2353 40 2.75E-19 2.26E-17 1.13E-17 12209 hsa-mir-3166 hsa05215 Prostate cancer 1499_595_8517_3551_5925_1956_1147_5595_5594_1387_2064_367_468_2033_898_4790_4792_5970_3320_3326_3480_5159_5156_1026 24 2.64E-17 2.16E-15 6.72E-16 12210 hsa-mir-3166 hsa05212 Pancreatic cancer 1499_595_8517_3551_5925_1956_1147_5595_5594_1387_2064_367_468_2033_898_4790_4792_5970_3320_3326_3480_5159_5156_1026 24 3.28E-17 2.69E-15 6.72E-16 12211 hsa-mir-3166 hsa04630 Jak-STAT signaling pathway 3559_595_3454_3455_3560_1439_6774_2690_3717_3716_3718_8651_85480_1387_3575_3570_3572_10401_6778_6776_6777_6772_2033_149233_3953_5781_4609_1441_8554 29 8.42E-17 6.91E-15 1.38E-15 12212 hsa-mir-3166 hsa03010 Ribosome 6155_6156_6128_6204_6205_6207_6202_6141_6217_6130_6137_6135_6210_6191_6193_9349_6222_6223_6229_6129_6181_6232_6189_6188 24 4.59E-16 3.76E-14 5.37E-15 12213 hsa-mir-3166 hsa04620 Toll-like receptor signaling pathway 3725_8517_3551_3454_3455_7187_3661_1432_1147_3654_29110_5595_5594_5599_6772_5879_4790_4792_5970_1326_5608_9641_6885_2353 24 4.59E-16 3.76E-14 5.37E-15 12214 hsa-mir-3166 hsa04920 Adipocytokine signaling pathway 10891_5465_8517_3551_4794_8471_6774_3717_1147_5599_6258_6256_4790_4792_4793_5970_3953_6257_5781 19 3.04E-14 2.49E-12 3.12E-13 12215 hsa-mir-3166 hsa04520 Adherens junction 1499_1460_1956_6714_71_2241_4233_5595_5594_1387_2064_5879_1457_2033_51701_3480_8826_6885 18 4.14E-12 3.40E-10 3.78E-11 12216 hsa-mir-3166 hsa05220 Chronic myeloid leukemia 595_8517_3551_3066_3065_5925_1147_5595_5594_6776_6777_4790_4792_5970_5781_4609_1026 17 1.48E-11 1.21E-09 1.21E-10 12217 hsa-mir-3166 hsa05216 Thyroid cancer 1499_595_5468_10342_5595_5594_6258_6256_5979_6257_8031_4609 12 4.74E-11 3.89E-09 3.54E-10 12218 hsa-mir-3166 hsa04062 Chemokine signaling pathway 8517_3551_653361_5580_7852_6774_3055_3717_1147_3718_5590_5595_5594_1234_1230_6777_6772_5879_4790_4792_4793_5970_5566_2185 24 9.20E-11 7.54E-09 6.09E-10 12219 hsa-mir-3166 hsa05222 Small cell lung cancer 595_8517_3551_6502_5925_7187_1147_6258_6256_10401_898_4790_4792_5970_6257_4609_8554 17 9.65E-11 7.92E-09 6.09E-10 12220 hsa-mir-3166 hsa04310 Wnt signaling pathway 3725_1499_595_6500_8945_1460_23291_8607_5599_1387_5879_1457_2033_51701_5519_5518_5515_5566_8454_6885_4609 21 2.44E-10 2.00E-08 1.43E-09 12221 hsa-mir-3166 hsa04660 T cell receptor signaling pathway 3725_8517_3551_9020_3932_1432_4794_1147_5595_5594_4790_4792_4793_5970_1326_1739_6885_2353 18 4.16E-10 3.41E-08 2.27E-09 12222 hsa-mir-3166 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_8517_3551_9020_1956_6714_1432_1147_4233_5599_5879_4790_4792_5970_5781 15 5.48E-10 4.49E-08 2.63E-09 12223 hsa-mir-3166 hsa05221 Acute myeloid leukemia 595_8517_3551_6774_862_1147_5595_5594_6776_6777_4790_5970_5371_4609 14 5.56E-10 4.56E-08 2.63E-09 12224 hsa-mir-3166 hsa03050 Proteasome 5709_5705_5706_5707_5700_5693_5719_5717_5713_5710_5684_5687_5708 13 5.77E-10 4.73E-08 2.63E-09 12225 hsa-mir-3166 hsa04662 B cell receptor signaling pathway 3725_8517_3551_6850_4794_1147_695_5595_5594_5879_4790_4792_4793_5970_2353 15 1.06E-09 8.71E-08 4.59E-09 12226 hsa-mir-3166 hsa04350 TGF-beta signaling pathway 6667_6500_3397_3399_3398_5595_5594_1387_4086_2033_5519_5518_5515_8454_4609 15 6.36E-09 5.21E-07 2.61E-08 12227 hsa-mir-3166 hsa05210 Colorectal cancer 3725_1499_595_1956_4233_5595_5594_5599_5879_3480_5159_5156_4609_2353 14 2.97E-08 2.43E-06 1.16E-07 12228 hsa-mir-3166 hsa04110 Cell cycle 595_6502_6500_5111_3066_3065_4616_5925_5591_1387_10912_2033_898_8454_1026_1111 16 4.68E-08 3.84E-06 1.75E-07 12229 hsa-mir-3166 hsa04912 GnRH signaling pathway 3725_5580_1956_6714_1432_5595_5594_5599_468_808_801_805_5608_5566_2185 15 8.38E-08 6.87E-06 2.99E-07 12230 hsa-mir-3166 hsa05214 Glioma 595_5925_1956_5595_5594_808_801_805_3480_5159_5156_1026 12 1.08E-07 8.83E-06 3.68E-07 12231 hsa-mir-3166 hsa05219 Bladder cancer 595_2261_9252_5925_1956_5595_5594_2064_4609_1026 10 1.60E-07 1.31E-05 5.26E-07 12232 hsa-mir-3166 hsa04060 Cytokine-cytokine receptor interaction 3556_3559_3454_3455_1956_3560_1439_7852_2690_85480_4233_1234_1230_3575_3570_3572_2321_149233_5159_5156_3953_1441 22 3.61E-07 2.96E-05 1.10E-06 12233 hsa-mir-3166 hsa04210 Apoptosis 3556_8517_3551_9020_823_1439_1147_3654_9131_4790_4792_5970_5566 13 3.62E-07 2.97E-05 1.10E-06 12234 hsa-mir-3166 hsa04540 Gap junction 7846_10382_1956_6714_5595_5594_203068_347733_5159_5156_5566_7278_84617 13 5.69E-07 4.66E-05 1.67E-06 12235 hsa-mir-3166 hsa05218 Melanoma 595_5925_1956_4233_5595_5594_4286_3480_5159_5156_1026 11 1.71E-06 0.000140256 4.84E-06 12236 hsa-mir-3166 hsa04930 Type II diabetes mellitus 3551_5580_8471_3651_8651_5590_5595_5594_5599 9 2.38E-06 0.000194757 6.48E-06 12237 hsa-mir-3166 hsa04510 Focal adhesion 3725_1499_595_1956_6714_71_4233_5595_5594_5599_2064_1729_5879_2321_3480_5159_5156_85366 18 2.45E-06 0.000201014 6.48E-06 12238 hsa-mir-3166 hsa04330 Notch signaling pathway 3066_3065_3280_1387_9612_2033_8850_388585_4851 9 3.25E-06 0.000266879 8.34E-06 12239 hsa-mir-3166 hsa04910 Insulin signaling pathway 10891_3551_8471_5211_8651_5590_5595_5594_5599_2194_808_801_805_5566 14 6.72E-06 0.000550779 1.67E-05 12240 hsa-mir-3166 hsa04120 Ubiquitin mediated proteolysis 55294_6502_6500_8945_23291_7329_51366_11059_8651_10401_5371_672_8454_8554 14 7.25E-06 0.000594274 1.75E-05 12241 hsa-mir-3166 hsa05223 Non-small cell lung cancer 595_5925_1956_5595_5594_6258_2064_6256_6257 9 8.88E-06 0.000727826 2.08E-05 12242 hsa-mir-3166 hsa04012 ErbB signaling pathway 3725_1956_6714_5595_5594_5599_2064_6776_6777_4609_1026 11 9.99E-06 0.000818875 2.27E-05 12243 hsa-mir-3166 hsa05131 Shigellosis 7846_1499_10382_71_203068_347733_7278_84617_4691 9 1.15E-05 0.000945644 2.49E-05 12244 hsa-mir-3166 hsa05130 Pathogenic Escherichia coli infection 7846_1499_10382_71_203068_347733_7278_84617_4691 9 1.15E-05 0.000945644 2.49E-05 12245 hsa-mir-3166 hsa04720 Long-term potentiation 814_5595_5594_1387_468_2033_808_801_805_5566 10 1.66E-05 0.001361535 3.49E-05 12246 hsa-mir-3166 hsa04530 Tight junction 10207_1499_1460_5580_6714_4627_4628_71_5590_1457_5519_5518_5515 13 2.73E-05 0.002235805 5.59E-05 12247 hsa-mir-3166 hsa05016 Huntington's disease 6667_10891_292_293_3066_3065_498_5468_4716_1387_5437_2033_6908_5441_1213 15 4.43E-05 0.003635406 8.87E-05 12248 hsa-mir-3166 hsa03020 RNA polymerase 64425_25885_51082_5437_84172_5441 6 0.00010053 0.008243427 0.000196272 12249 hsa-mir-3166 hsa04664 Fc epsilon RI signaling pathway 5580_6850_1432_695_5595_5594_5599_5879_5608 9 0.000132116 0.010833481 0.000251941 12250 hsa-mir-3166 hsa04916 Melanogenesis 1499_5595_5594_1387_4286_2033_808_801_805_5566 10 0.000205279 0.016832902 0.000382566 12251 hsa-mir-3166 hsa04810 Regulation of actin cytoskeleton 2261_2264_1956_4627_4628_71_5595_5594_1729_5879_5159_5156_10788_8826_85366 15 0.000216419 0.017746381 0.000394364 12252 hsa-mir-3166 hsa05213 Endometrial cancer 1499_595_1956_5595_5594_2064_4609 7 0.000293116 0.024035485 0.000522511 12253 hsa-mir-3166 hsa03022 Basal transcription factors 2969_6878_6872_6908_6882_2959 6 0.000325648 0.026703139 0.000568152 12254 hsa-mir-3166 hsa05211 Renal cell carcinoma 3725_4233_5595_5594_1387_5879_2033_5781 8 0.000361788 0.029666577 0.000618054 12255 hsa-mir-3166 hsa04020 Calcium signaling pathway 814_292_293_1956_2064_808_801_805_5159_5156_5566_2185_85366 13 0.000424037 0.03477105 0.000709613 12256 hsa-mir-3166 hsa04612 Antigen processing and presentation 3309_3305_3303_3310_3312_3320_3326_2923 8 0.00130615 0.1071043 0.002142086 12257 hsa-mir-3166 hsa03320 PPAR signaling pathway 5465_2168_10062_5468_6258_6256_6257 7 0.001474676 0.120923429 0.002371048 12258 hsa-mir-3166 hsa05340 Primary immunodeficiency 8517_3932_3718_695_3575 5 0.00171376 0.140528305 0.002702467 12259 hsa-mir-3166 hsa04370 VEGF signaling pathway 7867_6714_1432_5595_5594_5879_9261 7 0.002437527 0.199877226 0.003771268 12260 hsa-mir-3166 hsa04950 Maturity onset diabetes of the young 6927_3280_3651_168620 4 0.003045938 0.249766931 0.004625314 12261 hsa-mir-3166 hsa04650 Natural killer cell mediated cytotoxicity 3454_3455_3932_6850_5595_5594_5879_5781_2185 9 0.005141198 0.421578272 0.007665059 12262 hsa-mir-3166 hsa04115 p53 signaling pathway 595_4616_10912_898_1026_1111 6 0.005982408 0.490557463 0.008759955 12263 hsa-mir-3166 hsa04270 Vascular smooth muscle contraction 5580_5595_5594_808_801_805_5566_85366 8 0.006570635 0.538792045 0.009452492 12264 hsa-mir-3166 hsa04730 Long-term depression 5595_5594_3480_5519_5518_5515 6 0.006792484 0.556983692 0.009603167 12265 hsa-mir-3166 hsa04670 Leukocyte transendothelial migration 1499_653361_1432_7852_71_5879_5781_2185 8 0.00788339 0.64643794 0.010956575 12266 hsa-mir-3166 hsa03430 Mismatch repair 5981_5111_6118 3 0.018573268 1 0.025383467 12267 hsa-mir-3166 hsa05010 Alzheimer's disease 498_823_4716_5595_5594_808_801_805_9451 9 0.021581665 1 0.029011418 12268 hsa-mir-3166 hsa04360 Axon guidance 5998_7852_2242_4233_5595_5594_5879 7 0.032243519 1 0.042644654 12269 hsa-mir-3166 hsa03450 Non-homologous end-joining 5591_7520 2 0.046709197 1 0.060796097 12270 hsa-mir-3167 hsa05200 Pathways in cancer 1956_1499_5595_5594_1387_6256_2308_4286_841_6776_5970_836_7157_6688_4609_861_2736_4087_4088_4089_1050_5925_2033_207_208_2932_4790 27 3.85E-19 2.62E-17 2.62E-17 12271 hsa-mir-3167 hsa04010 MAPK signaling pathway 6722_1956_5595_5594_5598_8986_1386_9261_5566_9252_1649_5970_836_7157_468_4609_1432_6195_6196_6197_207_208_4790_2002 24 7.68E-18 5.22E-16 2.61E-16 12272 hsa-mir-3167 hsa05215 Prostate cancer 1956_1499_5595_5594_1385_1387_2308_5970_7157_468_5925_2033_207_208_2932_4790 16 9.52E-17 6.48E-15 1.90E-15 12273 hsa-mir-3167 hsa05212 Pancreatic cancer 1956_1499_5595_5594_1385_1387_2308_5970_7157_468_5925_2033_207_208_2932_4790 16 1.12E-16 7.59E-15 1.90E-15 12274 hsa-mir-3167 hsa05220 Chronic myeloid leukemia 5595_5594_6776_5970_7157_4609_861_4088_4089_5925_207_208_4790 13 1.32E-13 8.99E-12 1.80E-12 12275 hsa-mir-3167 hsa05210 Colorectal cancer 1956_1499_5595_5594_836_7157_4609_4087_4088_4089_207_208_2932 13 4.83E-13 3.29E-11 5.48E-12 12276 hsa-mir-3167 hsa05221 Acute myeloid leukemia 5595_5594_6776_5970_6688_4609_861_1050_207_208_4790 11 5.17E-12 3.51E-10 5.02E-11 12277 hsa-mir-3167 hsa05213 Endometrial cancer 1956_1499_5595_5594_7157_4609_207_208_2932_2002 10 3.73E-11 2.54E-09 3.17E-10 12278 hsa-mir-3167 hsa04720 Long-term potentiation 815_5595_5594_1387_5566_468_6195_6196_6197_2033 10 9.34E-10 6.35E-08 7.06E-09 12279 hsa-mir-3167 hsa04520 Adherens junction 1956_1499_5595_5594_1387_1460_4087_4088_4089_2033 10 1.65E-09 1.12E-07 1.12E-08 12280 hsa-mir-3167 hsa04012 ErbB signaling pathway 815_1956_5595_5594_6776_4609_207_208_2932_2002 10 3.47E-09 2.36E-07 2.14E-08 12281 hsa-mir-3167 hsa04310 Wnt signaling pathway 815_1499_1387_5566_7157_4609_1460_4087_4088_4089_2033_2932 12 4.85E-09 3.30E-07 2.75E-08 12282 hsa-mir-3167 hsa04916 Melanogenesis 815_1499_5595_5594_1385_1387_4286_5566_2033_2932 10 1.68E-08 1.14E-06 8.78E-08 12283 hsa-mir-3167 hsa05223 Non-small cell lung cancer 1956_5595_5594_6256_7157_5925_207_208 8 2.21E-08 1.50E-06 1.07E-07 12284 hsa-mir-3167 hsa04350 TGF-beta signaling pathway 5595_5594_1387_4609_4087_4088_4089_2033_6667 9 4.95E-08 3.37E-06 2.24E-07 12285 hsa-mir-3167 hsa04210 Apoptosis 5566_841_5970_836_7157_840_207_208_4790 9 5.93E-08 4.03E-06 2.52E-07 12286 hsa-mir-3167 hsa05214 Glioma 815_1956_5595_5594_7157_5925_207_208 8 8.17E-08 5.56E-06 3.14E-07 12287 hsa-mir-3167 hsa05219 Bladder cancer 1956_5595_5594_9252_7157_4609_5925 7 8.31E-08 5.65E-06 3.14E-07 12288 hsa-mir-3167 hsa05218 Melanoma 1956_5595_5594_4286_7157_5925_207_208 8 1.53E-07 1.04E-05 5.46E-07 12289 hsa-mir-3167 hsa04620 Toll-like receptor signaling pathway 5595_5594_841_5970_1432_6348_207_208_4790 9 1.75E-07 1.19E-05 5.95E-07 12290 hsa-mir-3167 hsa05216 Thyroid cancer 1499_5595_5594_6256_7157_4609 6 2.33E-07 1.58E-05 7.55E-07 12291 hsa-mir-3167 hsa04912 GnRH signaling pathway 815_1956_5595_5594_5598_5566_468_1432_2002 9 2.75E-07 1.87E-05 8.50E-07 12292 hsa-mir-3167 hsa04150 mTOR signaling pathway 5595_5594_6195_6196_6197_207_208 7 3.10E-07 2.11E-05 9.01E-07 12293 hsa-mir-3167 hsa04660 T cell receptor signaling pathway 5595_5594_1739_5970_1432_207_208_2932_4790 9 3.18E-07 2.16E-05 9.01E-07 12294 hsa-mir-3167 hsa05222 Small cell lung cancer 6256_5970_7157_4609_5925_207_208_4790 8 5.91E-07 4.02E-05 1.55E-06 12295 hsa-mir-3167 hsa04110 Cell cycle 1387_7534_7157_4087_4088_4089_5925_2033_2932 9 5.91E-07 4.02E-05 1.55E-06 12296 hsa-mir-3167 hsa05016 Huntington's disease 1385_1387_6908_841_836_7157_3064_2033_6667_4716 10 2.88E-06 0.000195994 7.23E-06 12297 hsa-mir-3167 hsa04662 B cell receptor signaling pathway 5595_5594_5970_207_208_2932_4790 7 2.98E-06 0.000202576 7.23E-06 12298 hsa-mir-3167 hsa04910 Insulin signaling pathway 5595_5594_2308_5566_207_208_2932_2002 8 1.60E-05 0.001086799 3.75E-05 12299 hsa-mir-3167 hsa04062 Chemokine signaling pathway 5595_5594_5566_5970_6348_207_208_2932_4790 9 2.47E-05 0.001678395 5.59E-05 12300 hsa-mir-3167 hsa05211 Renal cell carcinoma 5595_5594_1387_2033_207_208 6 2.82E-05 0.001914288 6.18E-05 12301 hsa-mir-3167 hsa04370 VEGF signaling pathway 5595_5594_9261_1432_207_208 6 4.01E-05 0.002726323 8.29E-05 12302 hsa-mir-3167 hsa04510 Focal adhesion 1956_1499_5595_5594_1729_207_208_2932_2002 9 4.02E-05 0.002734453 8.29E-05 12303 hsa-mir-3167 hsa05010 Alzheimer's disease 1020_5595_5594_841_836_840_2932_4716 8 8.62E-05 0.005859896 0.00017235 12304 hsa-mir-3167 hsa04540 Gap junction 1956_5592_5595_5594_5598_5566 6 0.000107686 0.007322623 0.000209218 12305 hsa-mir-3167 hsa04920 Adipocytokine signaling pathway 6256_5970_207_208_4790 5 0.000216725 0.014737299 0.000409369 12306 hsa-mir-3167 hsa04630 Jak-STAT signaling pathway 1387_6778_6776_4609_2033_207_208 7 0.000240018 0.016321257 0.000441115 12307 hsa-mir-3167 hsa03022 Basal transcription factors 2963_6908_2959_6880 4 0.000256456 0.017438986 0.000458921 12308 hsa-mir-3167 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_5970_836_1432_4790 5 0.000279271 0.018990394 0.000486933 12309 hsa-mir-3167 hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432_207_208 5 0.00044446 0.030223299 0.000755582 12310 hsa-mir-3167 hsa05217 Basal cell carcinoma 1499_7157_2736_2932 4 0.001036721 0.070497001 0.001719439 12311 hsa-mir-3167 hsa04950 Maturity onset diabetes of the young 3651_3172_4760 3 0.001083653 0.073688392 0.001746287 12312 hsa-mir-3167 hsa05014 Amyotrophic lateral sclerosis (ALS) 834_836_7157_1432 4 0.00110427 0.075090344 0.001746287 12313 hsa-mir-3167 hsa04360 Axon guidance 5998_1020_5595_5594_2932 5 0.003780635 0.257083182 0.0058428 12314 hsa-mir-3167 hsa04530 Tight junction 10207_1499_1460_207_208 5 0.004539158 0.308662778 0.006859173 12315 hsa-mir-3167 hsa04930 Type II diabetes mellitus 5595_5594_3651 3 0.005705176 0.387951982 0.008433739 12316 hsa-mir-3167 hsa04330 Notch signaling pathway 1387_9612_2033 3 0.006394346 0.434815555 0.009251395 12317 hsa-mir-3167 hsa04340 Hedgehog signaling pathway 5566_2736_2932 3 0.010567157 0.718566695 0.014970139 12318 hsa-mir-3167 hsa04270 Vascular smooth muscle contraction 5592_5595_5594_5566 4 0.01386158 0.942587452 0.019236479 12319 hsa-mir-3167 hsa04115 p53 signaling pathway 841_836_7157 3 0.017246575 1 0.023455343 12320 hsa-mir-3167 hsa04730 Long-term depression 5592_5595_5594 3 0.018542228 1 0.024722971 12321 hsa-mir-3169 hsa03022 Basal transcription factors 2967_2961_2960_2963_6881_54457_2968_6879_6878_6877_6874_6872_2957_6873_2958_6884_2959_6880_6882_138474_6883 21 5.68E-31 3.92E-29 3.92E-29 12322 hsa-mir-3169 hsa05200 Pathways in cancer 1499_5594_1387_6256_595_10401_836_367_4193_2353_6774_5970_7157_4087_6688_4609_3725_4089_5881_1050_5925_2033_3326_8554_7184 25 8.06E-18 5.56E-16 2.78E-16 12323 hsa-mir-3169 hsa04110 Cell cycle 993_4171_1387_595_983_894_4193_4085_7157_4087_4089_5925_2033_896 14 6.69E-13 4.62E-11 1.54E-11 12324 hsa-mir-3169 hsa05215 Prostate cancer 1499_5594_1387_595_367_4193_5970_7157_5925_2033_3326_7184 12 6.37E-12 4.40E-10 9.92E-11 12325 hsa-mir-3169 hsa05212 Pancreatic cancer 1499_5594_1387_595_367_4193_5970_7157_5925_2033_3326_7184 12 7.19E-12 4.96E-10 9.92E-11 12326 hsa-mir-3169 hsa04310 Wnt signaling pathway 1460_1499_1387_595_8607_894_7157_4087_4609_3725_4089_5881_2033_896 14 1.41E-11 9.70E-10 1.62E-10 12327 hsa-mir-3169 hsa05210 Colorectal cancer 1499_5594_595_836_2353_7157_4087_4609_3725_4089_5881 11 7.30E-11 5.04E-09 7.20E-10 12328 hsa-mir-3169 hsa04520 Adherens junction 1460_1499_6714_5594_1387_4087_4089_5881_2033 9 1.36E-08 9.39E-07 1.17E-07 12329 hsa-mir-3169 hsa05220 Chronic myeloid leukemia 5594_595_4193_5970_7157_4609_4089_5925 8 1.29E-07 8.93E-06 9.92E-07 12330 hsa-mir-3169 hsa05216 Thyroid cancer 1499_5594_6256_595_7157_4609 6 1.52E-07 1.05E-05 1.05E-06 12331 hsa-mir-3169 hsa05222 Small cell lung cancer 6256_595_10401_5970_7157_4609_5925_8554 8 3.42E-07 2.36E-05 2.14E-06 12332 hsa-mir-3169 hsa05221 Acute myeloid leukemia 5594_595_6774_5970_6688_4609_1050 7 4.16E-07 2.87E-05 2.39E-06 12333 hsa-mir-3169 hsa04010 MAPK signaling pathway 3727_5594_5598_836_2353_3312_1432_5970_7157_4609_3725_5881 12 9.26E-07 6.39E-05 4.92E-06 12334 hsa-mir-3169 hsa05219 Bladder cancer 5594_595_4193_7157_4609_5925 6 1.07E-06 7.37E-05 5.06E-06 12335 hsa-mir-3169 hsa04115 p53 signaling pathway 595_983_894_836_4193_7157_896 7 1.10E-06 7.59E-05 5.06E-06 12336 hsa-mir-3169 hsa04630 Jak-STAT signaling pathway 1387_595_10401_894_6774_4609_2033_896_8554 9 2.57E-06 0.00017762 1.11E-05 12337 hsa-mir-3169 hsa05016 Huntington's disease 6874_25942_1387_836_9001_5430_7157_3064_2033 9 1.14E-05 0.000787382 4.63E-05 12338 hsa-mir-3169 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 3.54E-05 0.002443335 0.000135741 12339 hsa-mir-3169 hsa05213 Endometrial cancer 1499_5594_595_7157_4609 5 5.05E-05 0.003484846 0.000175991 12340 hsa-mir-3169 hsa04350 TGF-beta signaling pathway 5594_1387_4087_4609_4089_2033 6 5.10E-05 0.003519823 0.000175991 12341 hsa-mir-3169 hsa05223 Non-small cell lung cancer 5594_6256_595_7157_5925 5 5.97E-05 0.004119615 0.000196172 12342 hsa-mir-3169 hsa05214 Glioma 5594_595_4193_7157_5925 5 0.000135596 0.009356138 0.000425279 12343 hsa-mir-3169 hsa04510 Focal adhesion 1499_6714_5594_595_894_3725_5881_896 8 0.000143229 0.009882788 0.000429686 12344 hsa-mir-3169 hsa05218 Melanoma 5594_595_4193_7157_5925 5 0.000200058 0.013804003 0.00055216 12345 hsa-mir-3169 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_836_1432_5970_3725 5 0.000200058 0.013804003 0.00055216 12346 hsa-mir-3169 hsa04662 B cell receptor signaling pathway 5594_2353_5970_3725_5881 5 0.000254487 0.017559581 0.000675369 12347 hsa-mir-3169 hsa04330 Notch signaling pathway 1387_9612_2033_8850 4 0.000454894 0.031387676 0.001162507 12348 hsa-mir-3169 hsa04540 Gap junction 6714_5594_5598_983_10382 5 0.000649296 0.044801436 0.001600051 12349 hsa-mir-3169 hsa04950 Maturity onset diabetes of the young 5080_6928_3172 3 0.000879927 0.06071495 0.002093619 12350 hsa-mir-3169 hsa04620 Toll-like receptor signaling pathway 5594_2353_1432_5970_3725 5 0.000966063 0.06665837 0.002221946 12351 hsa-mir-3169 hsa04912 GnRH signaling pathway 6714_5594_5598_1432_3725 5 0.001233109 0.085084551 0.002744663 12352 hsa-mir-3169 hsa04660 T cell receptor signaling pathway 5594_2353_1432_5970_3725 5 0.001333186 0.091989805 0.002874681 12353 hsa-mir-3169 hsa05211 Renal cell carcinoma 5594_1387_3725_2033 4 0.002037711 0.140602077 0.004260669 12354 hsa-mir-3169 hsa04370 VEGF signaling pathway 6714_5594_1432_5881 4 0.002571617 0.177441592 0.00521887 12355 hsa-mir-3169 hsa04012 ErbB signaling pathway 6714_5594_4609_3725 4 0.003912912 0.269990962 0.007714027 12356 hsa-mir-3169 hsa04612 Antigen processing and presentation 4801_3312_1514_3326 4 0.004228552 0.291770065 0.007885677 12357 hsa-mir-3169 hsa04210 Apoptosis 836_840_5970_7157 4 0.004228552 0.291770065 0.007885677 12358 hsa-mir-3169 hsa03420 Nucleotide excision repair 2967_2968_5887 3 0.004400981 0.303667698 0.007991255 12359 hsa-mir-3169 hsa04916 Melanogenesis 1499_5594_1387_2033 4 0.007156678 0.493810813 0.012661816 12360 hsa-mir-3169 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432_7157 3 0.008297951 0.572558646 0.014313966 12361 hsa-mir-3169 hsa04920 Adipocytokine signaling pathway 6256_6774_5970 3 0.013210766 0.911542837 0.022232752 12362 hsa-mir-3169 hsa04720 Long-term potentiation 5594_1387_2033 3 0.017628949 1 0.028961845 12363 hsa-mir-3169 hsa04664 Fc epsilon RI signaling pathway 5594_1432_5881 3 0.02011006 1 0.032269632 12364 hsa-mir-3169 hsa05010 Alzheimer's disease 5594_836_840_1020 4 0.039089631 1 0.061299649 12365 hsa-mir-3170 hsa05200 Pathways in cancer 3320_5371_5595_5594_5599_6258_1387_6256_595_5601_1488_836_1487_1019_367_1017_5914_7704_842_841_5578_3091_5970_2735_1870_1871_2885_7157_4824_4087_5604_2113_4609_1869_3725_6774_2736_2737_3065_4088_4089_9063_3066_7428_5925_2034_2033_4846_2353 49 8.07E-45 5.65E-43 5.65E-43 12366 hsa-mir-3170 hsa05220 Chronic myeloid leukemia 5595_5594_595_1488_1487_1019_5970_1870_1871_2885_7157_5604_4609_1869_3065_4088_4089_3066_5925_6464 20 3.46E-23 2.42E-21 1.21E-21 12367 hsa-mir-3170 hsa05215 Prostate cancer 3320_5595_5594_1385_1387_595_367_1017_842_5970_1870_1871_2885_7157_4824_5604_1869_5925_2033 19 1.39E-20 9.73E-19 2.93E-19 12368 hsa-mir-3170 hsa05212 Pancreatic cancer 3320_5595_5594_1385_1387_595_367_1017_842_5970_1870_1871_2885_7157_4824_5604_1869_5925_2033 19 1.67E-20 1.17E-18 2.93E-19 12369 hsa-mir-3170 hsa05214 Glioma 815_5595_5594_595_1019_5578_1870_1871_2885_7157_5604_1869_5925_6464_808_801_805 17 9.19E-20 6.43E-18 1.29E-18 12370 hsa-mir-3170 hsa04010 MAPK signaling pathway 6722_5595_5594_5599_9261_4208_5601_5600_836_1432_5578_5970_9344_4342_3312_2885_7157_5604_4609_3725_6195_5606_4763_2353_2002_2005 26 1.29E-19 9.00E-18 1.50E-18 12371 hsa-mir-3170 hsa05223 Non-small cell lung cancer 5595_5594_6258_6256_595_1019_842_5578_1870_1871_2885_7157_5604_1869_5925 15 6.45E-18 4.52E-16 6.45E-17 12372 hsa-mir-3170 hsa04110 Cell cycle 5591_1387_595_1019_1017_1870_1871_7157_4087_1869_1028_3065_4088_4089_3066_5925_2033_5933 18 4.00E-17 2.80E-15 3.50E-16 12373 hsa-mir-3170 hsa05210 Colorectal cancer 5595_5594_5599_595_5601_836_842_2885_7157_4087_5604_4609_3725_4088_4089_2353 16 9.15E-17 6.40E-15 7.11E-16 12374 hsa-mir-3170 hsa04912 GnRH signaling pathway 815_6714_5595_5594_5599_5601_5600_1432_5578_2885_5604_3725_5606_2002_808_801_805 17 1.68E-16 1.18E-14 1.18E-15 12375 hsa-mir-3170 hsa05222 Small cell lung cancer 6258_6256_595_1019_1017_842_5970_1870_1871_7157_4609_1869_9063_5925_4846 15 2.71E-15 1.90E-13 1.73E-14 12376 hsa-mir-3170 hsa04350 TGF-beta signaling pathway 6667_3400_5595_5594_1387_3399_3398_4087_4609_3397_4088_4089_2033_5933_4092 15 3.16E-15 2.21E-13 1.84E-14 12377 hsa-mir-3170 hsa05219 Bladder cancer 5595_5594_595_1019_1870_1871_7157_5604_4609_1869_5925 11 3.10E-13 2.17E-11 1.67E-12 12378 hsa-mir-3170 hsa04310 Wnt signaling pathway 815_5599_1387_595_5601_1488_1487_5578_7157_4087_4609_3725_1457_4088_4089_2033 16 3.91E-13 2.74E-11 1.96E-12 12379 hsa-mir-3170 hsa04012 ErbB signaling pathway 815_6714_5595_5594_5599_5601_5578_2885_5604_4609_3725_6464_2002 13 1.18E-12 8.25E-11 5.50E-12 12380 hsa-mir-3170 hsa04720 Long-term potentiation 815_5595_5594_1387_2902_5578_5604_6195_2033_808_801_805 12 4.29E-12 3.01E-10 1.88E-11 12381 hsa-mir-3170 hsa05221 Acute myeloid leukemia 5371_5595_5594_595_5914_7704_5970_2885_5604_4609_6774 11 7.83E-12 5.48E-10 3.23E-11 12382 hsa-mir-3170 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_2885_5604_2113_3725_7428_2034_2033 11 5.34E-11 3.74E-09 2.08E-10 12383 hsa-mir-3170 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5601_5600_1432_841_5970_5604_3725_5606_2353 12 1.11E-10 7.77E-09 4.09E-10 12384 hsa-mir-3170 hsa05216 Thyroid cancer 5595_5594_6258_6256_595_7157_5604_4609 8 4.02E-10 2.81E-08 1.41E-09 12385 hsa-mir-3170 hsa05218 Melanoma 5595_5594_595_1019_1870_1871_7157_5604_1869_5925 10 8.35E-10 5.85E-08 2.78E-09 12386 hsa-mir-3170 hsa05213 Endometrial cancer 5595_5594_595_842_2885_7157_5604_4609_2002 9 1.17E-09 8.17E-08 3.71E-09 12387 hsa-mir-3170 hsa04370 VEGF signaling pathway 6714_5595_5594_9261_5600_1432_842_5578_5604_4846 10 1.71E-09 1.20E-07 5.20E-09 12388 hsa-mir-3170 hsa04916 Melanogenesis 815_5595_5594_1385_1387_5578_5604_2033_808_801_805 11 1.89E-09 1.32E-07 5.51E-09 12389 hsa-mir-3170 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5601_5600_1432_5578_2885_5604_5606 10 2.14E-09 1.50E-07 6.00E-09 12390 hsa-mir-3170 hsa04910 Insulin signaling pathway 6720_5595_5594_5599_5601_2885_5604_6464_2002_808_801_805 12 2.71E-09 1.89E-07 7.28E-09 12391 hsa-mir-3170 hsa04660 T cell receptor signaling pathway 5595_5594_5601_5600_1019_1432_5970_2885_5604_3725_2353 11 3.26E-09 2.28E-07 8.44E-09 12392 hsa-mir-3170 hsa05010 Alzheimer's disease 6622_22926_5595_5594_2902_836_842_841_840_4846_808_801_805 13 3.95E-09 2.77E-07 9.88E-09 12393 hsa-mir-3170 hsa05016 Huntington's disease 6667_6874_1385_1387_2902_836_842_841_7157_3065_3066_3064_2033 13 7.80E-09 5.46E-07 1.88E-08 12394 hsa-mir-3170 hsa04330 Notch signaling pathway 1387_1488_1487_9612_3065_3066_2033_8850 8 1.12E-08 7.85E-07 2.62E-08 12395 hsa-mir-3170 hsa04520 Adherens junction 6714_5595_5594_1387_4087_1457_4088_4089_2033 9 3.54E-08 2.48E-06 7.99E-08 12396 hsa-mir-3170 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_5600_836_1432_842_7157_5606_4846 8 3.84E-08 2.69E-06 8.40E-08 12397 hsa-mir-3170 hsa04510 Focal adhesion 6714_5595_5594_5599_595_5601_5578_2885_5604_3725_6464_2002 12 1.74E-07 1.22E-05 3.68E-07 12398 hsa-mir-3170 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5599_5601_5600_836_1432_5970_3725 8 2.05E-07 1.43E-05 4.21E-07 12399 hsa-mir-3170 hsa04115 p53 signaling pathway 595_836_1019_1017_842_841_7157 7 2.30E-06 0.000160732 4.59E-06 12400 hsa-mir-3170 hsa04662 B cell receptor signaling pathway 5595_5594_5970_2885_5604_3725_2353 7 3.84E-06 0.000268594 7.46E-06 12401 hsa-mir-3170 hsa04210 Apoptosis 836_839_842_841_5970_7157_840 7 1.10E-05 0.000767398 2.07E-05 12402 hsa-mir-3170 hsa04920 Adipocytokine signaling pathway 5599_6258_6256_5601_5970_6774 6 2.39E-05 0.001672687 4.40E-05 12403 hsa-mir-3170 hsa04270 Vascular smooth muscle contraction 5595_5594_5578_5604_808_801_805 7 6.05E-05 0.004237025 0.000108642 12404 hsa-mir-3170 hsa04540 Gap junction 6714_5595_5594_5578_2885_5604 6 0.000132798 0.00929585 0.000232396 12405 hsa-mir-3170 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_5578_2885_5604_6464 7 0.000153529 0.01074706 0.000262123 12406 hsa-mir-3170 hsa04630 Jak-STAT signaling pathway 1387_595_2885_4609_6774_9063_2033 7 0.000302923 0.0212046 0.000504871 12407 hsa-mir-3170 hsa04730 Long-term depression 5595_5594_5578_5604_4846 5 0.000333144 0.023320081 0.000542327 12408 hsa-mir-3170 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601 4 0.000591183 0.041382812 0.000940518 12409 hsa-mir-3170 hsa04020 Calcium signaling pathway 815_2902_5578_4846_808_801_805 7 0.000808865 0.056620545 0.001258234 12410 hsa-mir-3170 hsa04612 Antigen processing and presentation 3320_1385_4800_4801_3312 5 0.000883213 0.061824906 0.00134402 12411 hsa-mir-3170 hsa04150 mTOR signaling pathway 5595_5594_3091_6195 4 0.000981895 0.068732672 0.001462397 12412 hsa-mir-3170 hsa04120 Ubiquitin mediated proteolysis 5371_997_672_7329_9063_7428 6 0.001022553 0.07157872 0.001491223 12413 hsa-mir-3170 hsa04062 Chemokine signaling pathway 5595_5594_5970_2885_5604_6774_6464 7 0.001057767 0.074043676 0.001511095 12414 hsa-mir-3170 hsa05217 Basal cell carcinoma 2735_7157_2736_2737 4 0.001194629 0.083624063 0.001672481 12415 hsa-mir-3170 hsa04070 Phosphatidylinositol signaling system 5578_808_801_805 4 0.003653287 0.255730093 0.005014316 12416 hsa-mir-3170 hsa03022 Basal transcription factors 2962_2969_6874 3 0.00379305 0.265513479 0.005106028 12417 hsa-mir-3170 hsa04710 Circadian rhythm - mammal 8863_79365 2 0.006005746 0.4204022 0.007932117 12418 hsa-mir-3170 hsa04340 Hedgehog signaling pathway 2735_2736_2737 3 0.011717403 0.820218196 0.015189226 12419 hsa-mir-3170 hsa04530 Tight junction 6714_1019_5578_1457 4 0.025244824 1 0.032129776 12420 hsa-mir-3171 hsa05200 Pathways in cancer 3725_1499_5914_595_2261_4193_7704_6502_3066_3065_1050_5925_7046_5747_1956_2113_5894_862_867_10401_207_3716_4233_5595_5594_5599_6258_1387_2064_6256_367_6774_6776_6777_6772_5979_5879_7157_4088_4089_2033_4790_4791_5970_3320_3326_5371_3480_5159_8031_5156_1399_1398_3815_6257_8554_8772_1026_2353_1441 60 3.35E-39 2.71E-37 2.71E-37 12421 hsa-mir-3171 hsa04630 Jak-STAT signaling pathway 3559_595_5777_58985_3454_3455_3459_3560_3561_1439_2057_867_2690_10401_207_3717_3716_3718_85480_1387_3575_3570_3572_6774_6776_6777_6772_6773_7297_2033_149233_3953_3460_8554_5781_1441_10379 37 3.22E-28 2.61E-26 1.30E-26 12422 hsa-mir-3171 hsa04010 MAPK signaling pathway 3925_6722_3725_2261_2264_7867_1845_4773_4616_5536_7046_1956_7132_3303_1432_5894_207_5595_5594_5599_9252_5879_7157_10912_4790_4791_51701_5970_5159_9261_5156_4208_5566_1399_1398_6885_2353 37 1.14E-20 9.21E-19 3.07E-19 12423 hsa-mir-3171 hsa05220 Chronic myeloid leukemia 595_4193_3066_3065_5925_7046_5894_867_207_5595_5594_6776_6777_7157_4088_4089_4790_5970_1399_1398_5781_1026_6464 23 4.53E-20 3.67E-18 9.17E-19 12424 hsa-mir-3171 hsa04520 Adherens junction 1499_5770_5777_7046_2534_1956_6714_71_2241_4233_5595_5594_1387_2064_5879_1457_4088_4089_2033_51701_3643_3480_6885 23 1.53E-19 1.24E-17 2.47E-18 12425 hsa-mir-3171 hsa05215 Prostate cancer 1499_595_4193_5925_1956_5894_207_5595_5594_1385_1387_2064_367_7157_2033_4790_5970_3320_3326_3480_5159_5156_1026 23 9.25E-19 7.50E-17 1.25E-17 12426 hsa-mir-3171 hsa05212 Pancreatic cancer 1499_595_4193_5925_1956_5894_207_5595_5594_1385_1387_2064_367_7157_2033_4790_5970_3320_3326_3480_5159_5156_1026 23 1.15E-18 9.29E-17 1.33E-17 12427 hsa-mir-3171 hsa04060 Cytokine-cytokine receptor interaction 3556_3559_1234_58985_3454_3455_3459_90_7046_3791_1956_3560_3561_7133_7132_1439_7852_2057_2690_85480_4233_1230_3575_3570_3572_2321_149233_5159_5156_3815_3953_3460_1441 33 1.05E-17 8.53E-16 1.07E-16 12428 hsa-mir-3171 hsa05214 Glioma 818_817_595_4193_5925_1956_5894_207_5595_5594_7157_808_801_805_3480_5159_5156_1026_6464 19 1.74E-16 1.41E-14 1.56E-15 12429 hsa-mir-3171 hsa04012 ErbB signaling pathway 3725_818_817_5747_1956_6714_5894_867_207_5595_5594_5599_2064_2066_6776_6777_1399_1398_1026_6464 20 1.45E-15 1.17E-13 1.17E-14 12430 hsa-mir-3171 hsa05210 Colorectal cancer 3725_1499_595_7046_1956_5894_207_4233_5595_5594_5599_5879_7157_4088_4089_3480_5159_5156_2353 19 9.61E-15 7.78E-13 7.07E-14 12431 hsa-mir-3171 hsa04110 Cell cycle 595_4193_6502_4174_4172_3066_3065_4616_993_5925_5591_1387_7533_7157_10912_4088_4089_2033_983_2810_1026 21 2.82E-14 2.28E-12 1.90E-13 12432 hsa-mir-3171 hsa04062 Chemokine signaling pathway 1234_5747_5580_7852_5894_207_3055_3717_3718_5590_5595_5594_1230_6774_6777_6772_6773_5879_4790_5970_5566_1399_1398_2185_6464 25 5.68E-14 4.60E-12 3.54E-13 12433 hsa-mir-3171 hsa05221 Acute myeloid leukemia 5914_595_7704_1050_5894_862_207_5595_5594_6774_6776_6777_4790_5970_5371_3815 16 1.14E-13 9.26E-12 6.61E-13 12434 hsa-mir-3171 hsa04660 T cell receptor signaling pathway 3725_1493_5777_4773_919_2534_3932_1432_5894_867_207_5595_5594_920_4790_5970_915_6885_2353 19 6.73E-13 5.45E-11 3.63E-12 12435 hsa-mir-3171 hsa04510 Focal adhesion 3725_1499_595_2534_5747_3791_1956_6714_5894_207_71_4233_5595_5594_5599_2064_5879_2321_3480_5159_5156_1399_1398_6464 24 1.44E-12 1.17E-10 7.31E-12 12436 hsa-mir-3171 hsa04920 Adipocytokine signaling pathway 10891_7133_7132_207_3717_8717_5599_6258_6256_6774_4790_5970_3953_6257_5781 15 7.21E-12 5.84E-10 3.44E-11 12437 hsa-mir-3171 hsa05219 Bladder cancer 595_2261_4193_5925_1956_5894_5595_5594_2064_9252_7157_1026 12 8.29E-11 6.72E-09 3.73E-10 12438 hsa-mir-3171 hsa05218 Melanoma 595_4193_5925_1956_5894_207_4233_5595_5594_7157_3480_5159_5156_1026 14 1.58E-10 1.28E-08 6.49E-10 12439 hsa-mir-3171 hsa04620 Toll-like receptor signaling pathway 3725_3454_3455_1432_207_3654_5595_5594_5599_6772_5879_4790_5970_8772_6885_2353 16 1.60E-10 1.30E-08 6.49E-10 12440 hsa-mir-3171 hsa04350 TGF-beta signaling pathway 6667_90_7046_57154_3397_3399_3398_5595_5594_1387_4086_4088_4089_2033_5515 15 1.85E-10 1.50E-08 7.15E-10 12441 hsa-mir-3171 hsa04912 GnRH signaling pathway 3725_818_817_5580_1956_6714_1432_5894_5595_5594_5599_808_801_805_5566_2185 16 3.41E-10 2.76E-08 1.25E-09 12442 hsa-mir-3171 hsa05216 Thyroid cancer 1499_595_5595_5594_6258_6256_5979_7157_8031_6257 10 6.92E-10 5.60E-08 2.44E-09 12443 hsa-mir-3171 hsa04310 Wnt signaling pathway 3725_818_817_1499_595_4773_5599_1387_5879_7157_1457_4088_4089_2033_51701_5515_5566_6885 18 7.26E-10 5.88E-08 2.45E-09 12444 hsa-mir-3171 hsa05223 Non-small cell lung cancer 595_5925_1956_5894_207_5595_5594_6258_2064_6256_7157_6257 12 9.91E-10 8.03E-08 3.21E-09 12445 hsa-mir-3171 hsa04910 Insulin signaling pathway 10891_5770_5894_867_207_5590_5595_5594_5599_808_801_805_3643_5566_1399_1398_6464 17 1.25E-09 1.01E-07 3.75E-09 12446 hsa-mir-3171 hsa04650 Natural killer cell mediated cytotoxicity 5777_3454_3455_3459_4773_919_2534_3932_6850_5894_5595_5594_5879_3460_5781_2185_6464 17 1.25E-09 1.01E-07 3.75E-09 12447 hsa-mir-3171 hsa05211 Renal cell carcinoma 3725_2113_5894_207_4233_5595_5594_1387_5879_2033_1399_1398_5781 13 1.85E-09 1.50E-07 5.36E-09 12448 hsa-mir-3171 hsa05222 Small cell lung cancer 595_6502_5925_5747_10401_207_6258_6256_7157_4790_5970_6257_8554 13 1.25E-08 1.01E-06 3.50E-08 12449 hsa-mir-3171 hsa04916 Melanogenesis 818_817_1499_5894_5595_5594_1385_1387_2033_808_801_805_5566_3815 14 1.31E-08 1.06E-06 3.53E-08 12450 hsa-mir-3171 hsa04662 B cell receptor signaling pathway 3725_5777_4773_6850_5894_207_5595_5594_5879_4790_5970_2353 12 2.59E-08 2.10E-06 6.78E-08 12451 hsa-mir-3171 hsa04370 VEGF signaling pathway 7867_4773_5747_3791_6714_1432_5894_207_5595_5594_5879_9261 12 3.37E-08 2.73E-06 8.52E-08 12452 hsa-mir-3171 hsa04720 Long-term potentiation 818_817_5894_5595_5594_1387_2033_808_801_805_5566 11 2.18E-07 1.77E-05 5.36E-07 12453 hsa-mir-3171 hsa05213 Endometrial cancer 1499_595_1956_5894_207_5595_5594_2064_7157 9 8.12E-07 6.57E-05 1.93E-06 12454 hsa-mir-3171 hsa04210 Apoptosis 3556_7132_1439_207_3654_8717_7157_4790_5970_5566_8772 11 1.02E-06 8.28E-05 2.37E-06 12455 hsa-mir-3171 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1956_6714_1432_4233_5599_5879_4790_5970_5781 10 1.09E-06 8.80E-05 2.44E-06 12456 hsa-mir-3171 hsa04020 Calcium signaling pathway 818_817_291_147_1956_2064_2066_5481_808_801_805_5159_5156_5566_2185 15 1.62E-06 0.000131162 3.54E-06 12457 hsa-mir-3171 hsa04664 Fc epsilon RI signaling pathway 2534_5580_6850_1432_5894_207_5595_5594_5599_5879 10 2.61E-06 0.000211198 5.56E-06 12458 hsa-mir-3171 hsa04330 Notch signaling pathway 3066_3065_3280_1387_9612_2033_8850_388585 8 3.73E-06 0.000302191 7.75E-06 12459 hsa-mir-3171 hsa05340 Primary immunodeficiency 3932_3561_3718_920_3575_100_915 7 5.98E-06 0.000484591 1.21E-05 12460 hsa-mir-3171 hsa04950 Maturity onset diabetes of the young 6927_3280_3651_168620_5080_3175 6 9.34E-06 0.000756891 1.85E-05 12461 hsa-mir-3171 hsa04930 Type II diabetes mellitus 5580_3651_5590_5595_5594_5599_3643 7 2.57E-05 0.002078258 4.95E-05 12462 hsa-mir-3171 hsa04612 Antigen processing and presentation 811_3308_3303_920_1385_1514_3320_3326_2923 9 4.25E-05 0.003441374 8.00E-05 12463 hsa-mir-3171 hsa04810 Regulation of actin cytoskeleton 2261_2264_5747_1956_4628_5894_71_5595_5594_5879_5159_5156_1399_1398 14 4.63E-05 0.00374736 8.40E-05 12464 hsa-mir-3171 hsa04115 p53 signaling pathway 595_4193_4616_7157_10912_983_2810_1026 8 4.67E-05 0.003778951 8.40E-05 12465 hsa-mir-3171 hsa04540 Gap junction 1956_6714_5894_5595_5594_5159_983_5156_5566 9 5.83E-05 0.004720536 0.00010262 12466 hsa-mir-3171 hsa05016 Huntington's disease 6667_10891_291_3066_3065_10476_1385_1387_5481_7157_2033_6908 12 0.00016109 0.013048265 0.000277623 12467 hsa-mir-3171 hsa04530 Tight junction 1499_5580_6714_4628_207_71_5590_60412_1457_5515 10 0.000204607 0.016573144 0.000342243 12468 hsa-mir-3171 hsa04640 Hematopoietic cell lineage 3559_2057_920_3575_3570_915_3815_1441 8 0.000207036 0.016769917 0.000342243 12469 hsa-mir-3171 hsa04270 Vascular smooth muscle contraction 147_5580_5894_5595_5594_808_801_805_5566 9 0.000311611 0.025240524 0.00050481 12470 hsa-mir-3171 hsa04360 Axon guidance 4773_2534_5747_7852_2242_4233_5595_5594_5879 9 0.000635758 0.05149642 0.001009734 12471 hsa-mir-3171 hsa04120 Ubiquitin mediated proteolysis 4193_6502_57154_867_10401_5371_672_8554_7329 9 0.000945562 0.076590508 0.001472894 12472 hsa-mir-3171 hsa04670 Leukocyte transendothelial migration 1499_5747_1432_7852_71_5879_5781_2185 8 0.001661535 0.134584331 0.002539327 12473 hsa-mir-3171 hsa05014 Amyotrophic lateral sclerosis (ALS) 7133_7132_1432_5879_7157 5 0.003644895 0.295236478 0.005467342 12474 hsa-mir-3171 hsa05010 Alzheimer's disease 3416_7132_10476_5595_5594_808_801_805_8772 9 0.00446387 0.361573454 0.006574063 12475 hsa-mir-3171 hsa04730 Long-term depression 5894_5595_5594_3480_5515 5 0.009225695 0.747281298 0.013344309 12476 hsa-mir-3171 hsa05131 Shigellosis 1499_2534_71_4691 4 0.018479433 1 0.025807484 12477 hsa-mir-3171 hsa05130 Pathogenic Escherichia coli infection 1499_2534_71_4691 4 0.018479433 1 0.025807484 12478 hsa-mir-3171 hsa03030 DNA replication 4174_4172_6118 3 0.027741021 1 0.03808513 12479 hsa-mir-3171 hsa03022 Basal transcription factors 2969_6908_2959 3 0.029625322 1 0.039994185 12480 hsa-mir-3171 hsa03320 PPAR signaling pathway 2168_6258_6256_6257 4 0.03636815 1 0.048292134 12481 hsa-mir-3174 hsa05200 Pathways in cancer 4149_7046_5467_5468_595_1017_8517_4193_6934_4436_7704_3551_5578_6502_3091_4089_7175_3065_1050_5925_7186_5743_1499_25_405_1956_1487_1488_2308_613_596_598_2113_10401_5894_861_862_207_9915_1147_998_1026_5595_5594_5599_1387_6256_5747_4286_367_2932_6774_6776_6777_6772_5970_7157_6688_7849_1869_3725_4088_5888_5728_2034_2033_3910_4790_4791_4792_3320_3326_51176_5371_675_5604_5601_5602_1856_3265_841_4292_51588_4087_4609_2956_1029_2736_2353_8554_6789 91 1.00E-44 8.91E-43 8.91E-43 12482 hsa-mir-3174 hsa04110 Cell cycle 595_1017_4193_902_6502_4089_995_1022_3065_990_5925_25_6500_5934_5933_9232_545_1026_7534_5591_1387_11200_7532_2932_7027_7157_1869_5111_4088_2033_890_1031_983_8454_4087_5347_1029_472_1111_8556_8555 41 7.46E-24 6.64E-22 3.32E-22 12483 hsa-mir-3174 hsa04010 MAPK signaling pathway 6722_4149_7046_6197_8517_9252_7867_3551_5578_4773_5923_7186_1956_3304_3303_1432_22800_5894_3305_207_1147_998_5595_5594_5599_5598_8986_1386_3310_3312_3315_1649_5971_5970_3164_7157_468_3725_6195_6196_5058_4790_4791_1616_9261_1326_5604_4208_5601_5602_5566_3265_4609_2353_2002_6789 56 1.38E-22 1.23E-20 4.09E-21 12484 hsa-mir-3174 hsa05215 Prostate cancer 595_1017_8517_4193_6934_3551_5925_1499_1956_2308_596_5894_207_1147_1026_5595_5594_1385_1387_367_2932_5970_7157_468_1869_5728_2033_4790_4792_3320_3326_51176_5604_3265 34 2.71E-21 2.42E-19 5.50E-20 12485 hsa-mir-3174 hsa05212 Pancreatic cancer 595_1017_8517_4193_6934_3551_5925_1499_1956_2308_596_5894_207_1147_1026_5595_5594_1385_1387_367_2932_5970_7157_468_1869_5728_2033_4790_4792_3320_3326_51176_5604_3265 34 3.63E-21 3.23E-19 5.50E-20 12486 hsa-mir-3174 hsa05220 Chronic myeloid leukemia 7046_595_8517_4193_3551_4089_3065_5925_25_1487_1488_613_598_5894_861_207_1147_1026_5595_5594_6776_6777_5970_7157_1869_4088_4790_4792_5604_3265_4609_1029 32 3.71E-21 3.30E-19 5.50E-20 12487 hsa-mir-3174 hsa04310 Wnt signaling pathway 815_5467_595_8607_6934_5578_8945_4089_4772_4773_1499_23291_1487_1488_6500_1460_5599_1387_2932_7157_3725_1457_1452_1459_4088_2033_51176_5518_5515_5601_5602_5566_1856_8454_4087_4609_5527 37 1.96E-17 1.74E-15 2.49E-16 12488 hsa-mir-3174 hsa05221 Acute myeloid leukemia 5467_595_8517_6934_7704_3551_1050_5894_861_862_207_1147_5595_5594_6774_6776_6777_5970_6688_4790_51176_5371_5604_3265_4609 25 8.88E-17 7.91E-15 9.88E-16 12489 hsa-mir-3174 hsa05210 Colorectal cancer 7046_595_6934_4436_4089_1499_1956_596_5894_207_5595_5594_5599_2932_7157_3725_4088_51176_5604_5601_5602_1856_4292_4087_4609_2956_2353 27 1.45E-15 1.29E-13 1.43E-14 12490 hsa-mir-3174 hsa05222 Small cell lung cancer 4149_595_1017_8517_3551_6502_5925_7186_5743_596_598_10401_207_1147_6256_5747_5970_7157_1869_5728_3910_4790_4792_51588_4609_8554 26 1.62E-14 1.44E-12 1.44E-13 12491 hsa-mir-3174 hsa04350 TGF-beta signaling pathway 6667_7046_4086_4089_6500_3397_3399_3398_1875_5934_5933_3400_5595_5594_1387_7027_4088_2033_5518_5515_4093_8454_4087_4609_4092 25 1.35E-13 1.20E-11 1.09E-12 12492 hsa-mir-3174 hsa04115 p53 signaling pathway 595_1017_4194_4193_50484_6241_545_1026_11200_7157_900_51246_64326_5728_27113_25898_983_841_7161_1029_472_1111 22 6.94E-13 6.17E-11 5.14E-12 12493 hsa-mir-3174 hsa04012 ErbB signaling pathway 815_5578_25_1956_6714_5894_207_1026_5595_5594_5599_5747_2932_6776_6777_3725_5058_5604_5601_5602_3265_4609_2002 23 5.43E-12 4.83E-10 3.72E-11 12494 hsa-mir-3174 hsa04660 T cell receptor signaling pathway 8517_3551_4772_4773_1432_4794_5894_207_1147_998_5595_5594_2932_5970_3725_5058_959_4790_4792_4793_1326_5604_5601_3265_2353 25 1.12E-11 9.98E-10 7.13E-11 12495 hsa-mir-3174 hsa05214 Glioma 815_595_4193_5578_5925_1956_5894_207_1026_5595_5594_7157_1869_5728_808_801_805_5604_3265_1029 20 1.32E-11 1.17E-09 7.81E-11 12496 hsa-mir-3174 hsa04920 Adipocytokine signaling pathway 10891_5465_6794_8517_3551_2538_7186_4794_207_1147_5599_6256_6774_5970_4790_4792_4793_5601_5602_5563 20 2.08E-11 1.85E-09 1.16E-10 12497 hsa-mir-3174 hsa05213 Endometrial cancer 595_6934_1499_1956_2309_5894_207_5595_5594_2932_7157_5728_51176_5604_3265_4292_4609_2002 18 2.79E-11 2.48E-09 1.46E-10 12498 hsa-mir-3174 hsa04540 Gap junction 7846_1453_5578_10382_7278_51807_203068_1956_6714_5894_5592_5595_5594_5598_347733_983_5604_5566_3265_7277_84617_10376 22 9.88E-11 8.80E-09 4.89E-10 12499 hsa-mir-3174 hsa04720 Long-term potentiation 815_6197_5578_2902_2906_5499_5894_5595_5594_1387_468_6195_6196_2033_808_801_805_5604_5566_3265 20 1.15E-10 1.02E-08 5.10E-10 12500 hsa-mir-3174 hsa04662 B cell receptor signaling pathway 8517_3551_4772_4773_4794_5894_207_1147_5595_5594_1380_2932_5970_3725_4790_4792_4793_5604_3265_2353 20 1.15E-10 1.02E-08 5.10E-10 12501 hsa-mir-3174 hsa05216 Thyroid cancer 5468_595_6934_7175_1499_5595_5594_6256_7157_7849_51176_5604_3265_4609 14 1.38E-10 1.22E-08 5.83E-10 12502 hsa-mir-3174 hsa04912 GnRH signaling pathway 815_5578_1956_6714_1432_5894_998_5595_5594_5599_5598_5580_468_3725_808_801_805_5604_5601_5602_5566_3265_2002 23 2.27E-10 2.02E-08 9.18E-10 12503 hsa-mir-3174 hsa04620 Toll-like receptor signaling pathway 3665_8517_3551_3661_1432_207_1147_5595_5594_5599_6772_5970_3725_4790_4792_1326_5604_5601_5602_841_2353_6348 22 4.52E-10 4.02E-08 1.75E-09 12504 hsa-mir-3174 hsa05219 Bladder cancer 595_9252_4193_5925_1956_5894_1026_5595_5594_7157_1869_5604_3265_4609_1029 15 8.77E-10 7.81E-08 3.25E-09 12505 hsa-mir-3174 hsa04520 Adherens junction 7046_6934_4089_1499_1956_6714_71_4301_1460_998_5595_5594_1387_1457_1459_4088_2033_51176_4087 19 1.75E-09 1.56E-07 6.23E-09 12506 hsa-mir-3174 hsa05223 Non-small cell lung cancer 595_5578_5925_1956_2309_5894_207_5595_5594_6256_7157_1869_5604_3265_1029_6789 16 2.30E-09 2.05E-07 7.88E-09 12507 hsa-mir-3174 hsa05131 Shigellosis 7846_5578_10382_7278_51807_1499_25_203068_71_998_7534_347733_7277_84617_4691_10376 16 3.58E-09 3.18E-07 1.14E-08 12508 hsa-mir-3174 hsa05130 Pathogenic Escherichia coli infection 7846_5578_10382_7278_51807_1499_25_203068_71_998_7534_347733_7277_84617_4691_10376 16 3.58E-09 3.18E-07 1.14E-08 12509 hsa-mir-3174 hsa04120 Ubiquitin mediated proteolysis 55294_4193_6502_3093_8945_23291_7319_84447_6500_10401_7323_7329_8925_10055_10273_64326_7337_5371_672_25898_8454_51588_10075_8554 24 3.75E-09 3.33E-07 1.15E-08 12510 hsa-mir-3174 hsa04916 Melanogenesis 815_6934_5578_1499_5894_5595_5594_1385_1387_4286_2932_2033_808_801_805_51176_5604_5566_1856_3265 20 1.52E-08 1.35E-06 4.51E-08 12511 hsa-mir-3174 hsa04330 Notch signaling pathway 1840_3065_22938_1487_1488_9612_2648_388585_1387_2033_8850_1856_9794_4851 14 2.18E-08 1.94E-06 6.25E-08 12512 hsa-mir-3174 hsa04062 Chemokine signaling pathway 8517_3551_653361_7074_2309_6362_5894_207_1147_998_5595_5594_5747_2932_5580_6774_6777_6772_5970_5058_4790_4792_4793_5604_5566_3265_6348 27 2.26E-08 2.01E-06 6.30E-08 12513 hsa-mir-3174 hsa04370 VEGF signaling pathway 7867_5578_4772_4773_5743_6714_1432_5894_207_998_5595_5594_5747_3315_9261_5604_3265 17 3.16E-08 2.81E-06 8.52E-08 12514 hsa-mir-3174 hsa05218 Melanoma 595_4193_5925_1956_5894_207_1026_5595_5594_4286_7157_1869_5728_5604_3265_1029 16 6.25E-08 5.56E-06 1.64E-07 12515 hsa-mir-3174 hsa05211 Renal cell carcinoma 3091_405_2113_5894_207_9915_998_5595_5594_1387_3725_5058_2034_2033_5604_3265 16 7.39E-08 6.58E-06 1.87E-07 12516 hsa-mir-3174 hsa04510 Focal adhesion 595_5578_5923_1499_1956_6714_5499_596_5894_10627_207_71_998_5595_5594_5599_5747_2932_3725_5058_5728_3910_5604_5601_5602_3265_2002 27 7.57E-08 6.74E-06 1.87E-07 12517 hsa-mir-3174 hsa04530 Tight junction 5578_4627_1499_6714_4628_22800_8573_10627_207_71_4301_1460_998_5580_1457_1459_5728_5518_5515_3265_5520 21 2.09E-07 1.86E-05 5.04E-07 12518 hsa-mir-3174 hsa04910 Insulin signaling pathway 10891_3551_2538_5499_2308_5894_207_5595_5594_5599_2932_808_801_805_5604_5601_5602_5566_5563_3265_2002 21 2.33E-07 2.08E-05 5.46E-07 12519 hsa-mir-3174 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 8517_3551_1956_6714_1432_1147_998_5599_5970_3725_5058_4790_4792_5601_5602 15 3.31E-07 2.95E-05 7.56E-07 12520 hsa-mir-3174 hsa03022 Basal transcription factors 51616_2965_2957_2963_2962_2969_6908_2958_2959_6880_9519 11 7.19E-07 6.40E-05 1.60E-06 12521 hsa-mir-3174 hsa04210 Apoptosis 8517_3551_8837_7186_823_596_598_207_1147_5970_7157_4790_4792_5566_841_472 16 9.09E-07 8.09E-05 1.97E-06 12522 hsa-mir-3174 hsa03410 Base excision repair 3146_4350_4913_142_252969_328_2237_5111_6996 9 2.41E-05 0.002142604 5.10E-05 12523 hsa-mir-3174 hsa05016 Huntington's disease 6667_10891_5468_293_1213_292_3065_3064_2902_5441_1385_1387_5437_7157_25942_2033_27113_6908_841_9519 20 5.62E-05 0.005005068 0.000116397 12524 hsa-mir-3174 hsa05322 Systemic lupus erythematosus 3021_3020_8365_8294_6628_8370_121504_8361_8360_8363_8362_8364_8367_8366_8368_959_8359 17 6.24E-05 0.005556242 0.000126278 12525 hsa-mir-3174 hsa04664 Fc epsilon RI signaling pathway 5578_1432_5894_207_5595_5594_5599_5580_5604_5601_5602_3265 12 8.91E-05 0.007933474 0.000176299 12526 hsa-mir-3174 hsa03420 Nucleotide excision repair 902_1022_2965_6117_5111_5886_4331_2071_2074 9 9.34E-05 0.008311872 0.000180693 12527 hsa-mir-3174 hsa03440 Homologous recombination 641_10111_6117_4683_5888_675_4361 7 0.000194885 0.017344744 0.000369037 12528 hsa-mir-3174 hsa04612 Antigen processing and presentation 3308_3309_3304_3303_3305_1385_3310_3312_3320_3326_4801_4802 12 0.000243731 0.021692061 0.000451918 12529 hsa-mir-3174 hsa04270 Vascular smooth muscle contraction 5578_5499_5894_5592_5595_5594_5580_4637_808_801_805_59_5604_5566 14 0.00025765 0.022930876 0.000467977 12530 hsa-mir-3174 hsa04150 mTOR signaling pathway 6794_6197_3091_207_5595_5594_6195_6196_5563 9 0.000283723 0.025251382 0.000505028 12531 hsa-mir-3174 hsa03450 Non-homologous end-joining 2547_10111_2237_5591_4361 5 0.000426597 0.037967147 0.000744454 12532 hsa-mir-3174 hsa04930 Type II diabetes mellitus 3551_3651_5595_5594_5599_5580_5601_5602 8 0.000523913 0.046628298 0.000896698 12533 hsa-mir-3174 hsa04950 Maturity onset diabetes of the young 6927_3651_3172_168620_4760_5080 6 0.000560994 0.049928455 0.000942046 12534 hsa-mir-3174 hsa04630 Jak-STAT signaling pathway 3559_595_598_10401_207_1387_6778_6774_6776_6777_6772_2033_51588_4609_8554 15 0.00111753 0.099460169 0.001841855 12535 hsa-mir-3174 hsa03020 RNA polymerase 64425_25885_51082_5441_5437_84172 6 0.001318886 0.11738087 0.002134198 12536 hsa-mir-3174 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906_1432_596_598_834_7157_1616 8 0.001858259 0.165385059 0.002953305 12537 hsa-mir-3174 hsa04340 Hedgehog signaling pathway 1453_8945_23291_53944_2932_1452_5566_2736 8 0.002054371 0.182839051 0.003202026 12538 hsa-mir-3174 hsa04730 Long-term depression 5578_5894_5592_5595_5594_5518_5515_5604_3265 9 0.002086714 0.185717537 0.003202026 12539 hsa-mir-3174 hsa03430 Mismatch repair 4436_6117_5111_4292_2956 5 0.002767818 0.246335835 0.004175184 12540 hsa-mir-3174 hsa03030 DNA replication 79621_2237_6117_5557_5111_5422 6 0.003454544 0.307454443 0.005124241 12541 hsa-mir-3174 hsa05217 Basal cell carcinoma 6934_1499_2932_7157_51176_1856_2736 7 0.006235019 0.554916705 0.009096995 12542 hsa-mir-3174 hsa04810 Regulation of actin cytoskeleton 4627_7074_1956_5499_4628_22800_5894_10627_71_998_5595_5594_5747_5058_5604_3265_10788 17 0.006595417 0.586992107 0.009467615 12543 hsa-mir-3174 hsa04360 Axon guidance 4772_4773_25_998_5595_5594_5747_2932_5058_3265_1020 11 0.01838932 1 0.025978563 12544 hsa-mir-3174 hsa04740 Olfactory transduction 815_5592_808_801_805_5566 6 0.026797249 1 0.037264925 12545 hsa-mir-3174 hsa05010 Alzheimer's disease 823_2902_2906_5595_5594_2932_808_351_801_805_841_1020 12 0.046171394 1 0.063219293 12546 hsa-mir-3175 hsa03022 Basal transcription factors 2967_2961_2960_2963_6881_2969_2968_6879_6878_6877_6874_2957_54457_6873_6872_2958_2959_6880_6882_138474_6884_6883 22 2.75E-32 1.87E-30 1.87E-30 12547 hsa-mir-3175 hsa05200 Pathways in cancer 5925_5371_5595_5594_1387_6256_3326_10401_9915_2932_4193_3091_5970_3725_7157_6688_4609_2353_2735_2736_2737_2034_2033_8554_7184 25 2.44E-17 1.66E-15 8.29E-16 12548 hsa-mir-3175 hsa05215 Prostate cancer 5925_5595_5594_1387_3326_2932_4193_5970_7157_2033_7184 11 1.88E-10 1.28E-08 3.56E-09 12549 hsa-mir-3175 hsa05212 Pancreatic cancer 5925_5595_5594_1387_3326_2932_4193_5970_7157_2033_7184 11 2.09E-10 1.42E-08 3.56E-09 12550 hsa-mir-3175 hsa04110 Cell cycle 5925_4171_1387_10971_7534_2932_4193_7157_4085_2033 10 4.29E-08 2.92E-06 5.83E-07 12551 hsa-mir-3175 hsa05211 Renal cell carcinoma 5595_5594_1387_9915_3091_3725_2034_2033 8 1.38E-07 9.35E-06 1.56E-06 12552 hsa-mir-3175 hsa04310 Wnt signaling pathway 1460_1387_1457_1452_2932_3725_7157_8607_4609_2033 10 3.65E-07 2.48E-05 3.55E-06 12553 hsa-mir-3175 hsa04350 TGF-beta signaling pathway 6667_5595_5594_1387_3399_4609_2033_4093 8 5.25E-07 3.57E-05 4.46E-06 12554 hsa-mir-3175 hsa05219 Bladder cancer 5925_5595_5594_4193_7157_4609 6 1.39E-06 9.47E-05 1.05E-05 12555 hsa-mir-3175 hsa05220 Chronic myeloid leukemia 5925_5595_5594_4193_5970_7157_4609 7 2.50E-06 0.000170072 1.70E-05 12556 hsa-mir-3175 hsa05216 Thyroid cancer 5595_5594_6256_7157_4609 5 4.78E-06 0.000325167 2.85E-05 12557 hsa-mir-3175 hsa05210 Colorectal cancer 5595_5594_2932_3725_7157_4609_2353 7 5.04E-06 0.000342407 2.85E-05 12558 hsa-mir-3175 hsa05222 Small cell lung cancer 5925_6256_10401_5970_7157_4609_8554 7 5.82E-06 0.000395827 3.04E-05 12559 hsa-mir-3175 hsa05221 Acute myeloid leukemia 5371_5595_5594_5970_6688_4609 6 8.45E-06 0.000574477 4.10E-05 12560 hsa-mir-3175 hsa04010 MAPK signaling pathway 6722_5595_5594_3312_1432_5970_3725_7157_4609_3727_2353 11 9.09E-06 0.000617917 4.12E-05 12561 hsa-mir-3175 hsa05016 Huntington's disease 6667_6874_1387_9001_5430_7157_3064_10476_2033 9 1.64E-05 0.001117012 6.98E-05 12562 hsa-mir-3175 hsa04660 T cell receptor signaling pathway 5595_5594_2932_1432_5970_3725_2353 7 2.63E-05 0.00178571 0.000105042 12563 hsa-mir-3175 hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_3725_2353 6 3.01E-05 0.002047192 0.000113733 12564 hsa-mir-3175 hsa04520 Adherens junction 1460_5595_5594_1387_1457_2033 6 4.23E-05 0.002876697 0.000149698 12565 hsa-mir-3175 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 4.40E-05 0.002993956 0.000149698 12566 hsa-mir-3175 hsa05213 Endometrial cancer 5595_5594_2932_7157_4609 5 6.27E-05 0.004265551 0.000203121 12567 hsa-mir-3175 hsa05223 Non-small cell lung cancer 5925_5595_5594_6256_7157 5 7.41E-05 0.005039796 0.000229082 12568 hsa-mir-3175 hsa05217 Basal cell carcinoma 2932_7157_2735_2736_2737 5 8.04E-05 0.005465323 0.000237623 12569 hsa-mir-3175 hsa04340 Hedgehog signaling pathway 1452_2932_2735_2736_2737 5 9.41E-05 0.006398886 0.00026662 12570 hsa-mir-3175 hsa04620 Toll-like receptor signaling pathway 5595_5594_1432_5970_3725_2353 6 0.000150603 0.010240988 0.00040964 12571 hsa-mir-3175 hsa05214 Glioma 5925_5595_5594_4193_7157 5 0.000167824 0.011412016 0.000438924 12572 hsa-mir-3175 hsa05218 Melanoma 5925_5595_5594_4193_7157 5 0.000247207 0.016810049 0.000622594 12573 hsa-mir-3175 hsa04330 Notch signaling pathway 1387_9612_2033_8850 4 0.000540286 0.036739431 0.001312123 12574 hsa-mir-3175 hsa04012 ErbB signaling pathway 5595_5594_2932_3725_4609 5 0.00059846 0.040695298 0.001403286 12575 hsa-mir-3175 hsa04120 Ubiquitin mediated proteolysis 55294_5371_10401_4193_7329_8554 6 0.000730981 0.049706696 0.00165689 12576 hsa-mir-3175 hsa04916 Melanogenesis 5595_5594_1387_2932_2033 5 0.001285755 0.087431322 0.002820365 12577 hsa-mir-3175 hsa04720 Long-term potentiation 5595_5594_1387_2033 4 0.002768511 0.18825877 0.005883087 12578 hsa-mir-3175 hsa04910 Insulin signaling pathway 5595_5594_2932_23265_5211 5 0.004182899 0.28443715 0.008619308 12579 hsa-mir-3175 hsa04612 Antigen processing and presentation 3326_4802_3312_4801 4 0.004968652 0.33786834 0.009710167 12580 hsa-mir-3175 hsa03420 Nucleotide excision repair 2967_2968_5887 3 0.00499788 0.339855832 0.009710167 12581 hsa-mir-3175 hsa04930 Type II diabetes mellitus 3651_5595_5594 3 0.00530254 0.360572722 0.010015909 12582 hsa-mir-3175 hsa04630 Jak-STAT signaling pathway 1387_10401_4609_2033_8554 5 0.006689911 0.45491397 0.012294972 12583 hsa-mir-3175 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.007746923 0.526790743 0.013862914 12584 hsa-mir-3175 hsa05131 Shigellosis 10971_7534_10382 3 0.009396412 0.638956007 0.015743171 12585 hsa-mir-3175 hsa05130 Pathogenic Escherichia coli infection 10971_7534_10382 3 0.009396412 0.638956007 0.015743171 12586 hsa-mir-3175 hsa04912 GnRH signaling pathway 5595_5594_1432_3725 4 0.009492206 0.645470021 0.015743171 12587 hsa-mir-3175 hsa04950 Maturity onset diabetes of the young 3651_5080 2 0.015546473 1 0.02517048 12588 hsa-mir-3175 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_5970_3725 3 0.01729744 1 0.027354091 12589 hsa-mir-3175 hsa04530 Tight junction 1460_1457_4628_60412 4 0.020485556 1 0.031659495 12590 hsa-mir-3175 hsa04370 VEGF signaling pathway 5595_5594_1432 3 0.021236204 1 0.032090264 12591 hsa-mir-3175 hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432 3 0.02264912 1 0.033481308 12592 hsa-mir-3175 hsa04540 Gap junction 5595_5594_10382 3 0.033936461 1 0.049099561 12593 hsa-mir-3175 hsa05010 Alzheimer's disease 5595_5594_2932_10476 4 0.044946076 1 0.063673608 12594 hsa-mir-3176 hsa05200 Pathways in cancer 3320_4149_5371_5595_5599_1387_5604_9915_2932_6502_3091_5970_4087_5894_1029_2736_4088_4292_1050_5925_2034_2033_207 23 3.38E-20 2.10E-18 2.10E-18 12595 hsa-mir-3176 hsa04010 MAPK signaling pathway 6722_8986_4149_5595_5599_5598_9261_5604_6197_9252_1386_1432_5970_5894_6195_6196_207 17 1.90E-14 1.18E-12 5.88E-13 12596 hsa-mir-3176 hsa04110 Cell cycle 1387_983_2932_8454_6502_6500_4087_1029_4088_5925_2033_5933_990 13 3.32E-14 2.06E-12 6.87E-13 12597 hsa-mir-3176 hsa04540 Gap junction 7277_5592_5595_5598_983_5604_7278_5894_7846_51807_10376 11 1.51E-12 9.35E-11 2.34E-11 12598 hsa-mir-3176 hsa04350 TGF-beta signaling pathway 5595_1387_6667_8454_6500_4087_4088_2033_4093_5933 10 2.10E-11 1.30E-09 2.28E-10 12599 hsa-mir-3176 hsa05215 Prostate cancer 3320_5595_1387_5604_2932_5970_5894_5925_2033_207 10 2.33E-11 1.44E-09 2.28E-10 12600 hsa-mir-3176 hsa05212 Pancreatic cancer 3320_5595_1387_5604_2932_5970_5894_5925_2033_207 10 2.58E-11 1.60E-09 2.28E-10 12601 hsa-mir-3176 hsa05211 Renal cell carcinoma 5595_1387_5604_9915_3091_5894_2034_2033_207 9 1.10E-10 6.83E-09 8.54E-10 12602 hsa-mir-3176 hsa05210 Colorectal cancer 5595_5599_5604_2932_4087_5894_4088_4292_207 9 3.88E-10 2.41E-08 2.67E-09 12603 hsa-mir-3176 hsa04310 Wnt signaling pathway 5599_1387_2932_8454_6500_4087_1457_1459_4088_2033 10 3.37E-09 2.09E-07 2.02E-08 12604 hsa-mir-3176 hsa04720 Long-term potentiation 5595_1387_5604_6197_5894_6195_6196_2033 8 3.91E-09 2.43E-07 2.02E-08 12605 hsa-mir-3176 hsa05220 Chronic myeloid leukemia 5595_5604_5970_5894_1029_4088_5925_207 8 3.91E-09 2.43E-07 2.02E-08 12606 hsa-mir-3176 hsa05221 Acute myeloid leukemia 5371_5595_5604_5970_5894_1050_207 7 1.93E-08 1.20E-06 9.23E-08 12607 hsa-mir-3176 hsa05219 Bladder cancer 5595_5604_9252_5894_1029_5925 6 7.60E-08 4.71E-06 3.37E-07 12608 hsa-mir-3176 hsa04520 Adherens junction 5595_1387_4087_1457_1459_4088_2033 7 1.34E-07 8.32E-06 5.55E-07 12609 hsa-mir-3176 hsa05213 Endometrial cancer 5595_5604_2932_5894_4292_207 6 2.42E-07 1.50E-05 8.81E-07 12610 hsa-mir-3176 hsa04150 mTOR signaling pathway 5595_6197_3091_6195_6196_207 6 2.42E-07 1.50E-05 8.81E-07 12611 hsa-mir-3176 hsa05223 Non-small cell lung cancer 5595_5604_5894_1029_5925_207 6 2.97E-07 1.84E-05 1.02E-06 12612 hsa-mir-3176 hsa05131 Shigellosis 7277_7278_7846_51807_4691_10376 6 3.62E-07 2.24E-05 1.12E-06 12613 hsa-mir-3176 hsa05130 Pathogenic Escherichia coli infection 7277_7278_7846_51807_4691_10376 6 3.62E-07 2.24E-05 1.12E-06 12614 hsa-mir-3176 hsa05214 Glioma 5595_5604_5894_1029_5925_207 6 8.15E-07 5.05E-05 2.41E-06 12615 hsa-mir-3176 hsa04660 T cell receptor signaling pathway 5595_5604_2932_1432_5970_5894_207 7 1.02E-06 6.32E-05 2.87E-06 12616 hsa-mir-3176 hsa05218 Melanoma 5595_5604_5894_1029_5925_207 6 1.32E-06 8.18E-05 3.56E-06 12617 hsa-mir-3176 hsa04662 B cell receptor signaling pathway 5595_5604_2932_5970_5894_207 6 1.78E-06 0.000110405 4.60E-06 12618 hsa-mir-3176 hsa04370 VEGF signaling pathway 5595_9261_5604_1432_5894_207 6 2.06E-06 0.000127466 5.10E-06 12619 hsa-mir-3176 hsa04664 Fc epsilon RI signaling pathway 5595_5599_5604_1432_5894_207 6 2.36E-06 0.000146619 5.64E-06 12620 hsa-mir-3176 hsa04012 ErbB signaling pathway 5595_5599_5604_2932_5894_207 6 4.00E-06 0.00024816 9.19E-06 12621 hsa-mir-3176 hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_8454_6502_6500_7329 7 4.47E-06 0.00027743 9.91E-06 12622 hsa-mir-3176 hsa04620 Toll-like receptor signaling pathway 5595_5599_5604_1432_5970_207 6 9.51E-06 0.000589713 2.03E-05 12623 hsa-mir-3176 hsa04916 Melanogenesis 5595_1387_5604_2932_5894_2033 6 1.06E-05 0.000655259 2.18E-05 12624 hsa-mir-3176 hsa04912 GnRH signaling pathway 5595_5599_5598_5604_1432_5894 6 1.30E-05 0.000804048 2.59E-05 12625 hsa-mir-3176 hsa03022 Basal transcription factors 2963_2962_2969_6908 4 3.43E-05 0.002126529 6.48E-05 12626 hsa-mir-3176 hsa04062 Chemokine signaling pathway 5595_5604_2932_5970_5894_7074_207 7 3.45E-05 0.002139684 6.48E-05 12627 hsa-mir-3176 hsa04910 Insulin signaling pathway 5595_5599_5604_2932_5894_207 6 4.86E-05 0.003010842 8.86E-05 12628 hsa-mir-3176 hsa05222 Small cell lung cancer 4149_6502_5970_5925_207 5 5.72E-05 0.003545841 0.00010131 12629 hsa-mir-3176 hsa04330 Notch signaling pathway 1387_2648_9612_2033 4 8.18E-05 0.00506875 0.000140799 12630 hsa-mir-3176 hsa04730 Long-term depression 5592_5595_5604_5894 4 0.000365951 0.022688943 0.000613215 12631 hsa-mir-3176 hsa04510 Focal adhesion 5595_5599_5604_2932_5894_207 6 0.000399375 0.024761246 0.000651612 12632 hsa-mir-3176 hsa04930 Type II diabetes mellitus 3651_5595_5599 3 0.001312282 0.081361512 0.002086193 12633 hsa-mir-3176 hsa05016 Huntington's disease 1387_6908_6667_3064_2033 5 0.001811206 0.112294756 0.002807369 12634 hsa-mir-3176 hsa04270 Vascular smooth muscle contraction 5592_5595_5604_5894 4 0.002249359 0.139460263 0.00340147 12635 hsa-mir-3176 hsa04920 Adipocytokine signaling pathway 5599_5970_207 3 0.003866251 0.239707536 0.005707322 12636 hsa-mir-3176 hsa04115 p53 signaling pathway 983_7161_1029 3 0.004185072 0.259474454 0.00603429 12637 hsa-mir-3176 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_1432_5970 3 0.004519416 0.280203823 0.006368269 12638 hsa-mir-3176 hsa04612 Antigen processing and presentation 3320_4802_4801 3 0.008259463 0.512086711 0.011379705 12639 hsa-mir-3176 hsa05216 Thyroid cancer 5595_5604 2 0.008508041 0.52749855 0.01146736 12640 hsa-mir-3176 hsa04810 Regulation of actin cytoskeleton 5595_5604_5894_7074 4 0.018203288 1 0.024012848 12641 hsa-mir-3176 hsa04530 Tight junction 1457_1459_207 3 0.025227561 1 0.032510383 12642 hsa-mir-3176 hsa04650 Natural killer cell mediated cytotoxicity 5595_5604_5894 3 0.02569369 1 0.032510383 12643 hsa-mir-3176 hsa05217 Basal cell carcinoma 2932_2736 2 0.027078084 1 0.033576824 12644 hsa-mir-3176 hsa04340 Hedgehog signaling pathway 2932_2736 2 0.028861931 1 0.035087054 12645 hsa-mir-3176 hsa04630 Jak-STAT signaling pathway 1387_2033_207 3 0.034322931 1 0.040923495 12646 hsa-mir-3177 hsa05200 Pathways in cancer 3716_1147_3320_3326_3725_10342_5371_5747_3480_1956_4233_5595_5594_5599_1387_2064_5159_595_5156_898_367_2261_8517_3815_3551_6774_6776_6777_6772_5979_5879_8772_1026_2353_10401_4089_3066_3065_2033_1441_207_8554_4790_4791_4792_5970_7046_7187 48 5.46E-32 4.37E-30 4.37E-30 12647 hsa-mir-3177 hsa04630 Jak-STAT signaling pathway 3717_3716_3718_3559_85480_3560_3561_149233_1387_595_3575_3570_3572_3953_6774_6776_6777_6772_1439_58985_3454_3455_3459_5781_7297_2690_10401_6773_2033_1441_207_8554_10379 33 5.54E-27 4.43E-25 2.22E-25 12648 hsa-mir-3177 hsa04010 MAPK signaling pathway 1147_3925_3725_1956_5595_5594_5599_5159_5156_7132_3303_2261_2264_8517_9252_3310_3312_1432_3551_5971_5879_1326_6885_9020_1845_2353_3305_207_4790_4791_51701_5970_7046 33 4.16E-20 3.33E-18 1.11E-18 12649 hsa-mir-3177 hsa05215 Prostate cancer 1147_3320_3326_3480_1956_5595_5594_1387_2064_5159_595_5156_898_367_8517_3551_1026_2033_207_4790_4792_5970 22 1.11E-19 8.84E-18 1.82E-18 12650 hsa-mir-3177 hsa04620 Toll-like receptor signaling pathway 1147_3725_3654_5595_5594_5599_8517_9641_1432_3551_6772_5879_1326_3454_3455_8772_6885_2353_207_4790_4792_5970_7187 23 1.18E-19 9.48E-18 1.82E-18 12651 hsa-mir-3177 hsa05212 Pancreatic cancer 1147_3320_3326_3480_1956_5595_5594_1387_2064_5159_595_5156_898_367_8517_3551_1026_2033_207_4790_4792_5970 22 1.36E-19 1.09E-17 1.82E-18 12652 hsa-mir-3177 hsa04060 Cytokine-cytokine receptor interaction 3556_2321_3559_85480_1956_4233_3560_3561_149233_90_5159_5156_7133_7132_3575_3570_3572_1234_1230_3815_3953_1439_3791_7852_58985_3454_3455_3459_2690_1441_7046 31 1.02E-18 8.20E-17 1.17E-17 12653 hsa-mir-3177 hsa03010 Ribosome 6129_6232_6193_6181_6156_6141_6188_6191_6210_6204_6207_6202_6128_6217_6137_6222_6223_6229_6189_6205_6130_6135 22 1.70E-18 1.36E-16 1.70E-17 12654 hsa-mir-3177 hsa04062 Chemokine signaling pathway 3717_1147_3718_5580_5747_5590_5595_5594_1234_8517_1230_3551_6774_6777_6772_5879_7852_4793_2185_6773_207_3055_4790_4792_5970 25 3.71E-16 2.97E-14 3.30E-15 12655 hsa-mir-3177 hsa05220 Chronic myeloid leukemia 1147_5595_5594_595_8517_3551_6776_6777_5781_1026_4089_3066_3065_207_4790_4792_5970_7046 18 4.50E-16 3.60E-14 3.60E-15 12656 hsa-mir-3177 hsa04520 Adherens junction 2241_3480_1956_6714_4233_5595_5594_1387_2064_5879_71_8826_6885_4089_2033_51701_7046_2534 18 1.20E-15 9.57E-14 8.70E-15 12657 hsa-mir-3177 hsa04920 Adipocytokine signaling pathway 3717_1147_8717_5599_7133_7132_8517_3953_3551_6774_4794_5781_4793_207_4790_4792_5970 17 1.35E-15 1.08E-13 8.97E-15 12658 hsa-mir-3177 hsa04660 T cell receptor signaling pathway 1147_3725_3932_5595_5594_8517_1432_3551_4794_1326_4793_6885_9020_2353_207_4790_4792_5970_2534 19 1.34E-14 1.07E-12 8.23E-14 12659 hsa-mir-3177 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_3725_1956_6714_4233_5599_8517_1432_3551_5879_5781_9020_4790_4792_5970 15 6.47E-13 5.18E-11 3.70E-12 12660 hsa-mir-3177 hsa05221 Acute myeloid leukemia 1147_5371_5595_5594_595_8517_3815_3551_6774_6776_6777_207_4790_5970 14 9.76E-13 7.81E-11 5.20E-12 12661 hsa-mir-3177 hsa04662 B cell receptor signaling pathway 1147_3725_5595_5594_6850_8517_3551_5879_4794_4793_2353_207_4790_4792_5970 15 1.29E-12 1.04E-10 6.47E-12 12662 hsa-mir-3177 hsa05214 Glioma 818_817_3480_1956_5595_5594_5159_595_5156_1026_808_207_805_801 14 3.05E-12 2.44E-10 1.44E-11 12663 hsa-mir-3177 hsa05210 Colorectal cancer 3725_3480_1956_4233_5595_5594_5599_5159_595_5156_5879_2353_4089_207_7046 15 5.45E-12 4.36E-10 2.42E-11 12664 hsa-mir-3177 hsa04210 Apoptosis 1147_3654_3556_8717_7132_8517_3551_1439_9131_8772_9020_207_4790_4792_5970 15 1.14E-11 9.09E-10 4.78E-11 12665 hsa-mir-3177 hsa04310 Wnt signaling pathway 3725_818_817_5519_5518_5599_1387_595_8607_8454_5879_23291_6885_6500_4089_2033_51701_8945 18 2.07E-11 1.66E-09 8.28E-11 12666 hsa-mir-3177 hsa03050 Proteasome 5706_5684_5693_5687_5707_5709_5705_5700_5719_5717_5713_5708 12 2.47E-11 1.97E-09 9.40E-11 12667 hsa-mir-3177 hsa04510 Focal adhesion 3725_2321_5747_3480_1956_6714_4233_5595_5594_5599_2064_5159_595_5156_5879_71_3791_85366_207_2534 20 4.28E-11 3.43E-09 1.56E-10 12668 hsa-mir-3177 hsa04350 TGF-beta signaling pathway 5519_5518_5595_5594_1387_90_8454_6500_4086_4089_2033_6667_7046_57154 14 9.61E-11 7.69E-09 3.20E-10 12669 hsa-mir-3177 hsa04012 ErbB signaling pathway 3725_818_817_5747_1956_6714_5595_5594_5599_2064_6776_6777_1026_207 14 9.61E-11 7.69E-09 3.20E-10 12670 hsa-mir-3177 hsa05222 Small cell lung cancer 1147_5747_595_898_8517_3551_10401_207_8554_4790_4792_5970_7187 13 8.99E-10 7.19E-08 2.88E-09 12671 hsa-mir-3177 hsa04912 GnRH signaling pathway 3725_5580_818_817_1956_6714_5595_5594_5599_1432_2185_808_805_801 14 1.24E-09 9.91E-08 3.81E-09 12672 hsa-mir-3177 hsa04540 Gap junction 347733_1956_6714_5595_5594_5159_5156_10382_84617_7278_203068_7846 12 1.99E-08 1.59E-06 5.90E-08 12673 hsa-mir-3177 hsa04110 Cell cycle 5591_1387_595_898_8454_4174_1026_4172_6500_4089_3066_3065_2033 13 3.13E-08 2.50E-06 8.94E-08 12674 hsa-mir-3177 hsa05218 Melanoma 3480_1956_4233_5595_5594_5159_595_5156_1026_207 10 1.46E-07 1.17E-05 4.02E-07 12675 hsa-mir-3177 hsa05131 Shigellosis 347733_4691_71_10382_84617_7278_203068_7846_2534 9 2.26E-07 1.81E-05 5.83E-07 12676 hsa-mir-3177 hsa05130 Pathogenic Escherichia coli infection 347733_4691_71_10382_84617_7278_203068_7846_2534 9 2.26E-07 1.81E-05 5.83E-07 12677 hsa-mir-3177 hsa05219 Bladder cancer 1956_5595_5594_2064_595_2261_9252_1026 8 3.40E-07 2.72E-05 8.50E-07 12678 hsa-mir-3177 hsa05211 Renal cell carcinoma 3725_4233_5595_5594_1387_5879_5781_2033_207 9 1.52E-06 0.0001219 3.69E-06 12679 hsa-mir-3177 hsa04720 Long-term potentiation 818_817_5595_5594_1387_2033_808_805_801 9 2.07E-06 0.000165988 4.88E-06 12680 hsa-mir-3177 hsa04664 Fc epsilon RI signaling pathway 5580_5595_5594_5599_6850_1432_5879_207_2534 9 3.07E-06 0.00024566 7.02E-06 12681 hsa-mir-3177 hsa04916 Melanogenesis 818_817_5595_5594_1387_3815_2033_808_805_801 10 3.56E-06 0.000284526 7.90E-06 12682 hsa-mir-3177 hsa04810 Regulation of actin cytoskeleton 5747_1956_5595_5594_5159_5156_2261_2264_4627_5879_71_10788_8826_85366 14 4.00E-06 0.000320293 8.66E-06 12683 hsa-mir-3177 hsa04910 Insulin signaling pathway 5590_5595_5594_5599_2194_3551_5211_808_207_805_801 11 6.26E-06 0.000500855 1.28E-05 12684 hsa-mir-3177 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6850_5879_3454_3455_3459_5781_2185_2534 11 6.26E-06 0.000500855 1.28E-05 12685 hsa-mir-3177 hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_8454_23291_7329_6500_10401_8554_8945_57154 11 6.68E-06 0.000534031 1.34E-05 12686 hsa-mir-3177 hsa03020 RNA polymerase 51082_64425_5441_5437_25885_84172 6 6.84E-06 0.000547558 1.34E-05 12687 hsa-mir-3177 hsa04330 Notch signaling pathway 388585_1387_4851_3280_3066_3065_2033 7 8.02E-06 0.00064146 1.53E-05 12688 hsa-mir-3177 hsa04020 Calcium signaling pathway 818_817_1956_2064_5159_5156_2185_85366_808_147_805_801 12 1.62E-05 0.001292267 3.01E-05 12689 hsa-mir-3177 hsa04370 VEGF signaling pathway 5747_6714_5595_5594_1432_5879_3791_207 8 2.02E-05 0.001614931 3.67E-05 12690 hsa-mir-3177 hsa04612 Antigen processing and presentation 3320_3326_3309_3303_3310_3312_2923_3305 8 5.27E-05 0.004213345 9.36E-05 12691 hsa-mir-3177 hsa04930 Type II diabetes mellitus 5580_5590_5595_5594_5599_3551 6 6.33E-05 0.005063231 0.00011007 12692 hsa-mir-3177 hsa05216 Thyroid cancer 10342_5595_5594_595_5979 5 8.87E-05 0.007092445 0.000150903 12693 hsa-mir-3177 hsa05213 Endometrial cancer 1956_5595_5594_2064_595_207 6 0.000131371 0.010509653 0.000218951 12694 hsa-mir-3177 hsa05223 Non-small cell lung cancer 1956_5595_5594_2064_595_207 6 0.000158846 0.012707711 0.000259341 12695 hsa-mir-3177 hsa05340 Primary immunodeficiency 3718_3932_3561_3575_8517 5 0.000196163 0.015693045 0.000313861 12696 hsa-mir-3177 hsa04270 Vascular smooth muscle contraction 5580_5595_5594_85366_808_147_805_801 8 0.000326138 0.026091076 0.00051159 12697 hsa-mir-3177 hsa04360 Axon guidance 2242_5747_4233_5595_5594_5879_7852_2534 8 0.000628334 0.050266751 0.000966668 12698 hsa-mir-3177 hsa04530 Tight junction 5580_5519_5518_6714_5590_4627_71_207 8 0.000828844 0.06630748 0.001251085 12699 hsa-mir-3177 hsa05016 Huntington's disease 1387_5441_1213_5437_6908_3066_3065_2033_6667 9 0.001520067 0.121605389 0.002251952 12700 hsa-mir-3177 hsa04670 Leukocyte transendothelial migration 5747_1432_5879_71_7852_5781_2185 7 0.001907218 0.152577443 0.002774135 12701 hsa-mir-3177 hsa04730 Long-term depression 3480_5519_5518_5595_5594 5 0.003706197 0.296495759 0.005294567 12702 hsa-mir-3177 hsa04640 Hematopoietic cell lineage 3559_3575_3570_3815_1441 5 0.008286114 0.662889098 0.011629633 12703 hsa-mir-3177 hsa05014 Amyotrophic lateral sclerosis (ALS) 7133_7132_1432_5879 4 0.008839968 0.70719741 0.012193059 12704 hsa-mir-3177 hsa05010 Alzheimer's disease 5595_5594_7132_8772_808_805_801 7 0.012894887 1 0.017484592 12705 hsa-mir-3177 hsa03030 DNA replication 4174_6118_4172 3 0.015628989 1 0.020838652 12706 hsa-mir-3177 hsa03022 Basal transcription factors 2969_6908_2959 3 0.016730336 1 0.021941424 12707 hsa-mir-3177 hsa03450 Non-homologous end-joining 5591_7520 2 0.019292756 1 0.024893879 12708 hsa-mir-3177 hsa04150 mTOR signaling pathway 5595_5594_207 3 0.038347873 1 0.048695711 12709 hsa-mir-3177 hsa04950 Maturity onset diabetes of the young 6927_3280 2 0.047840657 1 0.059800821 12710 hsa-mir-3180-5 hsa05200 Pathways in cancer 5371_5595_5594_5914_6256_595_836_367_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_4088_4089_3066_3065_5925_2034_2033_4846 28 4.16E-32 2.58E-30 2.58E-30 12711 hsa-mir-3180-5 hsa05220 Chronic myeloid leukemia 5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464 15 1.54E-22 9.54E-21 4.77E-21 12712 hsa-mir-3180-5 hsa04110 Cell cycle 5591_595_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933 14 3.66E-18 2.27E-16 7.56E-17 12713 hsa-mir-3180-5 hsa05215 Prostate cancer 5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033 11 9.26E-15 5.74E-13 1.29E-13 12714 hsa-mir-3180-5 hsa05212 Pancreatic cancer 5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033 11 1.04E-14 6.44E-13 1.29E-13 12715 hsa-mir-3180-5 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5925 9 3.49E-14 2.16E-12 3.60E-13 12716 hsa-mir-3180-5 hsa05210 Colorectal cancer 5595_5594_595_836_7157_4087_4609_3725_4088_4089 10 2.52E-13 1.56E-11 2.04E-12 12717 hsa-mir-3180-5 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925 9 2.63E-13 1.63E-11 2.04E-12 12718 hsa-mir-3180-5 hsa05222 Small cell lung cancer 6256_595_5970_1870_1871_7157_4609_1869_5925_4846 10 3.13E-13 1.94E-11 2.16E-12 12719 hsa-mir-3180-5 hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_6464 9 1.20E-12 7.43E-11 7.43E-12 12720 hsa-mir-3180-5 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_5970_4609 8 2.63E-11 1.63E-09 1.48E-10 12721 hsa-mir-3180-5 hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5925 8 1.02E-10 6.34E-09 5.28E-10 12722 hsa-mir-3180-5 hsa05211 Renal cell carcinoma 5595_5594_3091_7428_2113_3725_2034_2033 8 1.13E-10 7.03E-09 5.40E-10 12723 hsa-mir-3180-5 hsa04350 TGF-beta signaling pathway 5595_5594_4087_4609_4088_4089_2033_5933 8 4.58E-10 2.84E-08 2.03E-09 12724 hsa-mir-3180-5 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 9.15E-10 5.67E-08 3.78E-09 12725 hsa-mir-3180-5 hsa04310 Wnt signaling pathway 595_7157_4087_4609_3725_1457_4088_4089_2033 9 1.40E-09 8.68E-08 5.42E-09 12726 hsa-mir-3180-5 hsa04520 Adherens junction 5595_5594_4087_1457_4088_4089_2033 7 8.13E-09 5.04E-07 2.96E-08 12727 hsa-mir-3180-5 hsa04010 MAPK signaling pathway 5595_5594_4208_836_3312_5970_7157_4609_3725_4763 10 1.36E-08 8.45E-07 4.69E-08 12728 hsa-mir-3180-5 hsa05016 Huntington's disease 6874_2902_836_7157_3066_3065_3064_2033 8 1.38E-07 8.55E-06 4.50E-07 12729 hsa-mir-3180-5 hsa05213 Endometrial cancer 5595_5594_595_7157_4609 5 7.92E-07 4.91E-05 2.46E-06 12730 hsa-mir-3180-5 hsa04012 ErbB signaling pathway 5595_5594_4609_3725_6464 5 8.57E-06 0.000531387 2.53E-05 12731 hsa-mir-3180-5 hsa04330 Notch signaling pathway 9612_3066_3065_2033 4 1.68E-05 0.001041198 4.73E-05 12732 hsa-mir-3180-5 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_7157_4846 4 3.21E-05 0.001990422 8.65E-05 12733 hsa-mir-3180-5 hsa04720 Long-term potentiation 5595_5594_2902_2033 4 9.47E-05 0.005872995 0.00023492 12734 hsa-mir-3180-5 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725 4 9.47E-05 0.005872995 0.00023492 12735 hsa-mir-3180-5 hsa05010 Alzheimer's disease 5595_5594_2902_836_4846 5 0.000222199 0.013776311 0.000529858 12736 hsa-mir-3180-5 hsa04620 Toll-like receptor signaling pathway 5595_5594_5970_3725 4 0.00029453 0.018260834 0.000676327 12737 hsa-mir-3180-5 hsa04660 T cell receptor signaling pathway 5595_5594_5970_3725 4 0.000388502 0.024087104 0.000860254 12738 hsa-mir-3180-5 hsa04510 Focal adhesion 5595_5594_595_3725_6464 5 0.000438211 0.027169068 0.000936864 12739 hsa-mir-3180-5 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.000606587 0.037608391 0.001253613 12740 hsa-mir-3180-5 hsa04910 Insulin signaling pathway 6720_5595_5594_6464 4 0.000887004 0.054994227 0.00171857 12741 hsa-mir-3180-5 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_6464 4 0.000887004 0.054994227 0.00171857 12742 hsa-mir-3180-5 hsa04115 p53 signaling pathway 595_836_7157 3 0.001329343 0.082419271 0.002497554 12743 hsa-mir-3180-5 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_5970_3725 3 0.001438684 0.089198411 0.002548526 12744 hsa-mir-3180-5 hsa04730 Long-term depression 5595_5594_4846 3 0.001438684 0.089198411 0.002548526 12745 hsa-mir-3180-5 hsa04370 VEGF signaling pathway 5595_5594_4846 3 0.001800045 0.11160278 0.003100077 12746 hsa-mir-3180-5 hsa04612 Antigen processing and presentation 4800_4801_3312 3 0.002681283 0.166239573 0.004374726 12747 hsa-mir-3180-5 hsa04210 Apoptosis 836_5970_7157 3 0.002681283 0.166239573 0.004374726 12748 hsa-mir-3180-5 hsa04062 Chemokine signaling pathway 5595_5594_5970_6464 4 0.002936341 0.182053166 0.00466803 12749 hsa-mir-3180-5 hsa04916 Melanogenesis 5595_5594_2033 3 0.004103678 0.25442802 0.0063607 12750 hsa-mir-3180-5 hsa04912 GnRH signaling pathway 5595_5594_3725 3 0.004546884 0.281906832 0.006875776 12751 hsa-mir-3180-5 hsa04930 Type II diabetes mellitus 5595_5594 2 0.008763359 0.543328272 0.012922499 12752 hsa-mir-3180-5 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428 3 0.008962379 0.555667472 0.012922499 12753 hsa-mir-3180-5 hsa04630 Jak-STAT signaling pathway 595_4609_2033 3 0.011958015 0.741396911 0.01684993 12754 hsa-mir-3180-5 hsa04920 Adipocytokine signaling pathway 6256_5970 2 0.018228702 1 0.025115101 12755 hsa-mir-3180-5 hsa04664 Fc epsilon RI signaling pathway 5595_5594 2 0.024601767 1 0.033158903 12756 hsa-mir-3180-5 hsa04540 Gap junction 5595_5594 2 0.033006835 1 0.043540931 12757 hsa-mir-3180-5 hsa04710 Circadian rhythm - mammal 8863 1 0.041078632 1 0.0530599 12758 hsa-mir-3180-5 hsa03450 Non-homologous end-joining 5591 1 0.043948127 1 0.055607834 12759 hsa-mir-3181 hsa05200 Pathways in cancer 3716_3326_675_1956_5595_5594_5599_6258_1387_6257_6256_5159_8031_5156_5601_1399_1398_367_3815_2932_3265_6774_6777_6772_5970_5371_4609_3725_867_2353_4087_4088_4089_3065_1050_5925_2033_8554 38 2.45E-35 1.72E-33 1.72E-33 12760 hsa-mir-3181 hsa04010 MAPK signaling pathway 3727_1956_5595_5594_5599_5159_5156_5601_5600_1399_1398_3265_1432_1649_5970_10912_22800_4609_3725_2353_5603_4616_8550_9252 24 4.96E-20 3.47E-18 1.74E-18 12761 hsa-mir-3181 hsa04012 ErbB signaling pathway 1956_6714_5595_5594_5599_2066_5601_1399_1398_2932_3265_6777_4609_3725_867_6464 16 2.65E-18 1.86E-16 6.19E-17 12762 hsa-mir-3181 hsa05220 Chronic myeloid leukemia 5595_5594_1399_1398_3265_6777_5970_5781_4609_867_4088_4089_3065_5925_6464 15 1.03E-17 7.19E-16 1.80E-16 12763 hsa-mir-3181 hsa04630 Jak-STAT signaling pathway 3717_3716_3718_85480_3560_3561_1387_3575_6774_6777_6772_2057_5781_4609_867_2690_2033_8554 18 3.08E-17 2.15E-15 4.31E-16 12764 hsa-mir-3181 hsa05210 Colorectal cancer 1956_5595_5594_5599_5159_5156_5601_2932_4609_3725_2353_4087_4088_4089 14 1.24E-15 8.67E-14 1.44E-14 12765 hsa-mir-3181 hsa04660 T cell receptor signaling pathway 3932_5595_5594_5601_5600_919_2932_3265_1432_5970_3725_867_2353_5603_1493 15 1.69E-15 1.18E-13 1.69E-14 12766 hsa-mir-3181 hsa05215 Prostate cancer 3326_1956_5595_5594_1387_5159_5156_367_2932_3265_5970_9586_5925_2033 14 2.21E-15 1.55E-13 1.93E-14 12767 hsa-mir-3181 hsa05212 Pancreatic cancer 3326_1956_5595_5594_1387_5159_5156_367_2932_3265_5970_9586_5925_2033 14 2.54E-15 1.78E-13 1.98E-14 12768 hsa-mir-3181 hsa04520 Adherens junction 1956_6714_3643_5595_5594_1387_5770_1457_1459_4087_4088_4089_2033 13 1.77E-14 1.24E-12 1.24E-13 12769 hsa-mir-3181 hsa04310 Wnt signaling pathway 5515_5599_1387_5601_2932_8061_4609_3725_1457_1459_4087_4088_4089_2033 14 2.09E-12 1.46E-10 1.33E-11 12770 hsa-mir-3181 hsa04910 Insulin signaling pathway 10891_3643_5595_5594_5599_5601_1399_1398_2932_3265_5770_867_6464 13 1.01E-11 7.06E-10 5.88E-11 12771 hsa-mir-3181 hsa05221 Acute myeloid leukemia 5595_5594_3815_3265_6774_6777_5970_5371_4609_1050 10 1.38E-11 9.66E-10 7.43E-11 12772 hsa-mir-3181 hsa04062 Chemokine signaling pathway 3717_3718_5595_5594_1399_1398_1234_2932_3265_6774_6777_6772_5970_6464 14 4.14E-11 2.90E-09 1.99E-10 12773 hsa-mir-3181 hsa04920 Adipocytokine signaling pathway 3717_10891_5599_6258_6257_6256_5601_6774_5970_5781 10 4.27E-11 2.99E-09 1.99E-10 12774 hsa-mir-3181 hsa05216 Thyroid cancer 5595_5594_6258_6257_6256_8031_3265_4609 8 5.43E-11 3.80E-09 2.38E-10 12775 hsa-mir-3181 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_5599_5601_5600_1432_5970_5781_3725_5603 10 7.16E-11 5.01E-09 2.95E-10 12776 hsa-mir-3181 hsa04510 Focal adhesion 1956_6714_5595_5594_5599_5159_5156_5601_1399_1398_2932_3265_3725_6464 14 9.33E-11 6.53E-09 3.63E-10 12777 hsa-mir-3181 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5601_5600_1432_6772_5970_3725_2353_5603 11 1.08E-10 7.59E-09 3.99E-10 12778 hsa-mir-3181 hsa04664 Fc epsilon RI signaling pathway 695_5595_5594_5599_6850_5601_5600_3265_1432_5603 10 1.86E-10 1.30E-08 6.35E-10 12779 hsa-mir-3181 hsa04912 GnRH signaling pathway 1956_6714_5595_5594_5599_5601_5600_3265_1432_3725_5603 11 1.90E-10 1.33E-08 6.35E-10 12780 hsa-mir-3181 hsa04350 TGF-beta signaling pathway 5515_5595_5594_1387_6667_4609_4087_4088_4089_2033 10 4.41E-10 3.08E-08 1.40E-09 12781 hsa-mir-3181 hsa04110 Cell cycle 1387_2932_10912_4087_4088_4089_3065_4616_5925_2033_891 11 4.95E-10 3.47E-08 1.51E-09 12782 hsa-mir-3181 hsa05211 Renal cell carcinoma 5595_5594_1387_1399_1398_3265_5781_3725_2033 9 1.71E-09 1.20E-07 4.98E-09 12783 hsa-mir-3181 hsa04662 B cell receptor signaling pathway 695_5595_5594_6850_2932_3265_5970_3725_2353 9 2.37E-09 1.66E-07 6.64E-09 12784 hsa-mir-3181 hsa05223 Non-small cell lung cancer 1956_5595_5594_6258_6257_6256_3265_5925 8 4.18E-09 2.92E-07 1.12E-08 12785 hsa-mir-3181 hsa05214 Glioma 1956_5595_5594_5159_5156_3265_5925_6464 8 1.57E-08 1.10E-06 4.07E-08 12786 hsa-mir-3181 hsa05219 Bladder cancer 1956_5595_5594_3265_4609_5925_9252 7 1.93E-08 1.35E-06 4.83E-08 12787 hsa-mir-3181 hsa05016 Huntington's disease 10891_1387_2902_4724_6667_1537_9586_3065_2033_9519 10 4.18E-07 2.93E-05 1.01E-06 12788 hsa-mir-3181 hsa05218 Melanoma 1956_5595_5594_5159_5156_3265_5925 7 5.12E-07 3.58E-05 1.19E-06 12789 hsa-mir-3181 hsa04720 Long-term potentiation 5595_5594_1387_2902_3265_2906_2033 7 7.21E-07 5.05E-05 1.63E-06 12790 hsa-mir-3181 hsa04370 VEGF signaling pathway 6714_5595_5594_5600_3265_1432_5603 7 8.51E-07 5.95E-05 1.86E-06 12791 hsa-mir-3181 hsa04060 Cytokine-cytokine receptor interaction 85480_1956_3560_3561_5159_5156_3575_1234_3815_2057_2690 11 1.03E-06 7.21E-05 2.19E-06 12792 hsa-mir-3181 hsa05213 Endometrial cancer 1956_5595_5594_2932_3265_4609 6 1.47E-06 0.00010298 3.03E-06 12793 hsa-mir-3181 hsa05222 Small cell lung cancer 6258_6257_6256_5970_4609_5925_8554 7 1.70E-06 0.000118936 3.40E-06 12794 hsa-mir-3181 hsa05010 Alzheimer's disease 22926_5595_5594_2902_4724_2932_1537_2906_351 9 2.28E-06 0.000159882 4.44E-06 12795 hsa-mir-3181 hsa04540 Gap junction 1956_6714_5595_5594_5159_5156_3265 7 2.77E-06 0.000193892 5.24E-06 12796 hsa-mir-3181 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6850_919_3265_5781_6464 8 3.37E-06 0.000235868 6.21E-06 12797 hsa-mir-3181 hsa05340 Primary immunodeficiency 3718_695_3932_3561_3575 5 4.41E-06 0.000308824 7.92E-06 12798 hsa-mir-3181 hsa04916 Melanogenesis 5595_5594_1387_3815_2932_3265_2033 7 5.56E-06 0.00038887 9.72E-06 12799 hsa-mir-3181 hsa04810 Regulation of actin cytoskeleton 1956_5595_5594_5159_5156_1399_1398_3265_22800 9 1.19E-05 0.000832906 2.03E-05 12800 hsa-mir-3181 hsa04930 Type II diabetes mellitus 3643_5595_5594_5599_5601 5 1.35E-05 0.000946547 2.25E-05 12801 hsa-mir-3181 hsa04530 Tight junction 8573_5515_6714_3265_22800_1457_1459 7 3.04E-05 0.002124984 4.94E-05 12802 hsa-mir-3181 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_5600_1432_2906_5603 5 3.60E-05 0.00251758 5.72E-05 12803 hsa-mir-3181 hsa04330 Notch signaling pathway 1387_9612_3065_2033 4 0.000267014 0.018690985 0.000415125 12804 hsa-mir-3181 hsa04120 Ubiquitin mediated proteolysis 672_5371_867_7325_7329_8554 6 0.000272796 0.019095749 0.000415125 12805 hsa-mir-3181 hsa03010 Ribosome 6124_6129_6143_6222_6231 5 0.000512798 0.035895831 0.000763741 12806 hsa-mir-3181 hsa03320 PPAR signaling pathway 6258_6257_6256_2168 4 0.001102618 0.077183237 0.001607984 12807 hsa-mir-3181 hsa04020 Calcium signaling pathway 1956_2066_5159_2902_5156_2906 6 0.001130747 0.079152268 0.001615352 12808 hsa-mir-3181 hsa04730 Long-term depression 5515_5595_5594_3265 4 0.00115925 0.081147481 0.00162295 12809 hsa-mir-3181 hsa04670 Leukocyte transendothelial migration 5600_1432_5781_5603 4 0.007512331 0.525863203 0.010311043 12810 hsa-mir-3181 hsa04360 Axon guidance 5595_5594_2932_3265 4 0.009523115 0.666618082 0.012819578 12811 hsa-mir-3181 hsa04115 p53 signaling pathway 10912_4616_891 3 0.009767921 0.683754453 0.012901027 12812 hsa-mir-3181 hsa03440 Homologous recombination 675_4683 2 0.014373287 1 0.018632039 12813 hsa-mir-3181 hsa04640 Hematopoietic cell lineage 3575_3815_2057 3 0.017773623 1 0.022620975 12814 hsa-mir-3181 hsa04612 Antigen processing and presentation 3326_4800_4801 3 0.018832862 1 0.023541078 12815 hsa-mir-3181 hsa03022 Basal transcription factors 2963_9519 2 0.023625781 1 0.029014117 12816 hsa-mir-3181 hsa04150 mTOR signaling pathway 5595_5594 2 0.043006386 1 0.051904259 12817 hsa-mir-3182 hsa05200 Pathways in cancer 5371_5595_5594_1488_4286_1487_2932_1387_3091_4087_4088_3725_2353_1050_5925_2034_2033_9915 18 4.36E-14 2.53E-12 2.53E-12 12818 hsa-mir-3182 hsa04310 Wnt signaling pathway 1460_1488_1487_2932_1387_4087_4088_8061_3725_1457_2033 11 2.62E-10 1.52E-08 7.61E-09 12819 hsa-mir-3182 hsa04350 TGF-beta signaling pathway 5595_5594_6667_1387_3399_4087_4088_2033_4093 9 6.29E-10 3.65E-08 1.22E-08 12820 hsa-mir-3182 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_3725_2034_2033_9915 8 3.46E-09 2.01E-07 5.01E-08 12821 hsa-mir-3182 hsa04520 Adherens junction 1460_5595_5594_1387_4087_4088_1457_2033 8 7.44E-09 4.31E-07 8.63E-08 12822 hsa-mir-3182 hsa05215 Prostate cancer 5595_5594_2932_1387_468_10488_5925_2033 8 1.49E-08 8.63E-07 1.34E-07 12823 hsa-mir-3182 hsa05212 Pancreatic cancer 5595_5594_2932_1387_468_10488_5925_2033 8 1.62E-08 9.37E-07 1.34E-07 12824 hsa-mir-3182 hsa04110 Cell cycle 993_983_2932_1387_4087_4088_5925_2033 8 1.34E-07 7.75E-06 9.68E-07 12825 hsa-mir-3182 hsa04330 Notch signaling pathway 1488_1487_1387_9612_2033_8850 6 1.59E-07 9.22E-06 1.02E-06 12826 hsa-mir-3182 hsa05210 Colorectal cancer 5595_5594_2932_4087_4088_3725_2353 7 2.13E-07 1.23E-05 1.23E-06 12827 hsa-mir-3182 hsa04916 Melanogenesis 5595_5594_4286_2932_1387_10488_2033 7 8.27E-07 4.80E-05 4.36E-06 12828 hsa-mir-3182 hsa04660 T cell receptor signaling pathway 5595_5594_2932_1432_1739_3725_2353 7 1.18E-06 6.85E-05 5.71E-06 12829 hsa-mir-3182 hsa05220 Chronic myeloid leukemia 5595_5594_1488_1487_4088_5925 6 2.02E-06 0.000117314 9.02E-06 12830 hsa-mir-3182 hsa04720 Long-term potentiation 5595_5594_1387_468_2033 5 3.42E-05 0.001980794 0.000132053 12831 hsa-mir-3182 hsa04662 B cell receptor signaling pathway 5595_5594_2932_3725_2353 5 3.42E-05 0.001980794 0.000132053 12832 hsa-mir-3182 hsa04010 MAPK signaling pathway 5595_5594_1386_1432_468_3725_3727_2353 8 4.82E-05 0.002795191 0.000174699 12833 hsa-mir-3182 hsa04620 Toll-like receptor signaling pathway 5595_5594_1432_3725_2353 5 0.000136818 0.007935473 0.000466793 12834 hsa-mir-3182 hsa04912 GnRH signaling pathway 5595_5594_1432_468_3725 5 0.000176732 0.010250434 0.000569469 12835 hsa-mir-3182 hsa05221 Acute myeloid leukemia 5371_5595_5594_1050 4 0.00020329 0.011790794 0.000620568 12836 hsa-mir-3182 hsa05016 Huntington's disease 6908_6667_1387_10488_2033_4716 6 0.00027985 0.016231281 0.000811564 12837 hsa-mir-3182 hsa05218 Melanoma 5595_5594_4286_5925 4 0.000397583 0.023059813 0.001098086 12838 hsa-mir-3182 hsa03022 Basal transcription factors 2963_6908_2959 3 0.000819805 0.047548684 0.00208362 12839 hsa-mir-3182 hsa04012 ErbB signaling pathway 5595_5594_2932_3725 4 0.000826263 0.047923268 0.00208362 12840 hsa-mir-3182 hsa05219 Bladder cancer 5595_5594_5925 3 0.001157938 0.067160426 0.002798351 12841 hsa-mir-3182 hsa05213 Endometrial cancer 5595_5594_2932 3 0.002070646 0.120097452 0.004619133 12842 hsa-mir-3182 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.002070646 0.120097452 0.004619133 12843 hsa-mir-3182 hsa05223 Non-small cell lung cancer 5595_5594_5925 3 0.002294072 0.133056174 0.004928006 12844 hsa-mir-3182 hsa04510 Focal adhesion 5595_5594_2932_1729_3725 5 0.002929597 0.169916635 0.006068451 12845 hsa-mir-3182 hsa04360 Axon guidance 5998_5595_5594_2932 4 0.003504913 0.203284965 0.007009826 12846 hsa-mir-3182 hsa05214 Glioma 5595_5594_5925 3 0.003788131 0.219711576 0.007323719 12847 hsa-mir-3182 hsa04910 Insulin signaling pathway 5595_5594_23265_2932 4 0.004195838 0.243358588 0.007796472 12848 hsa-mir-3182 hsa04120 Ubiquitin mediated proteolysis 11059_5371_55294_7329 4 0.004301502 0.249487106 0.007796472 12849 hsa-mir-3182 hsa04370 VEGF signaling pathway 5595_5594_1432 3 0.005967926 0.346139692 0.010489082 12850 hsa-mir-3182 hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432 3 0.006390341 0.370639764 0.01090117 12851 hsa-mir-3182 hsa05216 Thyroid cancer 5595_5594 2 0.008873156 0.51464302 0.014704086 12852 hsa-mir-3182 hsa05010 Alzheimer's disease 5595_5594_2932_4716 4 0.009756255 0.565862778 0.015430617 12853 hsa-mir-3182 hsa04540 Gap junction 5595_5594_983 3 0.00984367 0.570932841 0.015430617 12854 hsa-mir-3182 hsa04930 Type II diabetes mellitus 5595_5594 2 0.01966921 1 0.030021426 12855 hsa-mir-3182 hsa04530 Tight junction 1460_10207_1457 3 0.026686424 1 0.039687502 12856 hsa-mir-3182 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_3725 2 0.04428624 1 0.062648828 12857 hsa-mir-3182 hsa04730 Long-term depression 5595_5594 2 0.04428624 1 0.062648828 12858 hsa-mir-3183 hsa04010 MAPK signaling pathway 9261_6722_8986_5601_6195_468_207_9252_3725_3727_1386_1432_1649_6196_6197_2353 16 1.79E-17 1.00E-15 1.00E-15 12859 hsa-mir-3183 hsa05200 Pathways in cancer 2736_4089_5601_1050_207_2932_3725_25_2353_1387 10 1.37E-08 7.65E-07 3.82E-07 12860 hsa-mir-3183 hsa05210 Colorectal cancer 4089_5601_207_2932_3725_2353 6 1.03E-07 5.79E-06 1.93E-06 12861 hsa-mir-3183 hsa04660 T cell receptor signaling pathway 5601_207_2932_3725_1432_2353 6 4.68E-07 2.62E-05 6.56E-06 12862 hsa-mir-3183 hsa04720 Long-term potentiation 6195_468_6196_6197_1387 5 1.75E-06 9.80E-05 1.96E-05 12863 hsa-mir-3183 hsa04310 Wnt signaling pathway 4089_5601_2932_8061_3725_1387 6 2.85E-06 0.000159782 2.66E-05 12864 hsa-mir-3183 hsa04012 ErbB signaling pathway 5601_207_2932_3725_25 5 3.50E-06 0.000195882 2.80E-05 12865 hsa-mir-3183 hsa04620 Toll-like receptor signaling pathway 5601_207_3725_1432_2353 5 7.35E-06 0.000411323 5.14E-05 12866 hsa-mir-3183 hsa04150 mTOR signaling pathway 6195_207_6196_6197 4 1.19E-05 0.000664919 7.39E-05 12867 hsa-mir-3183 hsa04662 B cell receptor signaling pathway 207_2932_3725_2353 4 4.65E-05 0.002604665 0.000260466 12868 hsa-mir-3183 hsa04350 TGF-beta signaling pathway 4089_4086_4093_1387 4 8.09E-05 0.004529718 0.00037922 12869 hsa-mir-3183 hsa05215 Prostate cancer 468_207_2932_1387 4 8.44E-05 0.004726711 0.00037922 12870 hsa-mir-3183 hsa05212 Pancreatic cancer 468_207_2932_1387 4 8.80E-05 0.004929861 0.00037922 12871 hsa-mir-3183 hsa03022 Basal transcription factors 2963_6874_6883 3 0.000137711 0.007711795 0.000550842 12872 hsa-mir-3183 hsa04912 GnRH signaling pathway 5601_468_3725_1432 4 0.000180689 0.010118607 0.000674574 12873 hsa-mir-3183 hsa04110 Cell cycle 4089_2932_25_1387 4 0.000258718 0.014488209 0.000905513 12874 hsa-mir-3183 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5601_3725_1432 3 0.000850242 0.047613532 0.002750498 12875 hsa-mir-3183 hsa05211 Renal cell carcinoma 207_3725_1387 3 0.000884089 0.049508972 0.002750498 12876 hsa-mir-3183 hsa05220 Chronic myeloid leukemia 4089_207_25 3 0.000990726 0.055480665 0.002920035 12877 hsa-mir-3183 hsa04370 VEGF signaling pathway 9261_207_1432 3 0.001066146 0.05970416 0.002985208 12878 hsa-mir-3183 hsa04664 Fc epsilon RI signaling pathway 5601_207_1432 3 0.001145102 0.064125718 0.003053606 12879 hsa-mir-3183 hsa04510 Focal adhesion 5601_207_2932_3725 4 0.001906303 0.10675298 0.004852408 12880 hsa-mir-3183 hsa04910 Insulin signaling pathway 5601_207_2932 3 0.005324099 0.298149548 0.012963024 12881 hsa-mir-3183 hsa04930 Type II diabetes mellitus 5601_3651 2 0.006168711 0.345447801 0.014393658 12882 hsa-mir-3183 hsa05213 Endometrial cancer 207_2932 2 0.008074715 0.452184033 0.018087361 12883 hsa-mir-3183 hsa05217 Basal cell carcinoma 2736_2932 2 0.008962526 0.501901481 0.019303903 12884 hsa-mir-3183 hsa04340 Hedgehog signaling pathway 2736_2932 2 0.00957756 0.536343361 0.019864569 12885 hsa-mir-3183 hsa05221 Acute myeloid leukemia 1050_207 2 0.010210894 0.571810088 0.020421789 12886 hsa-mir-3183 hsa05016 Huntington's disease 3064_6874_1387 3 0.012182322 0.682210021 0.023524483 12887 hsa-mir-3183 hsa04920 Adipocytokine signaling pathway 5601_207 2 0.012923411 0.723711005 0.0241237 12888 hsa-mir-3183 hsa04520 Adherens junction 4089_1387 2 0.017918221 1 0.032368399 12889 hsa-mir-3183 hsa04916 Melanogenesis 2932_1387 2 0.028899537 1 0.050574189 12890 hsa-mir-3183 hsa04360 Axon guidance 2932_25 2 0.043675355 1 0.074115755 12891 hsa-mir-3184 hsa04310 Wnt signaling pathway 4087_4088_1487_2033_1488 5 7.66E-11 1.15E-09 1.15E-09 12892 hsa-mir-3184 hsa05200 Pathways in cancer 4087_4088_1487_2033_1488 5 3.58E-09 5.36E-08 2.68E-08 12893 hsa-mir-3184 hsa04330 Notch signaling pathway 1487_2033_1488 3 1.52E-07 2.27E-06 7.58E-07 12894 hsa-mir-3184 hsa05220 Chronic myeloid leukemia 4088_1487_1488 3 5.87E-07 8.80E-06 2.13E-06 12895 hsa-mir-3184 hsa04520 Adherens junction 4087_4088_2033 3 7.09E-07 1.06E-05 2.13E-06 12896 hsa-mir-3184 hsa04350 TGF-beta signaling pathway 4087_4088_2033 3 9.05E-07 1.36E-05 2.26E-06 12897 hsa-mir-3184 hsa04110 Cell cycle 4087_4088_2033 3 2.27E-06 3.40E-05 4.86E-06 12898 hsa-mir-3184 hsa05210 Colorectal cancer 4087_4088 2 0.000168908 0.002533625 0.000316703 12899 hsa-mir-3184 hsa05211 Renal cell carcinoma 2033 1 0.016907255 0.253608829 0.026011491 12900 hsa-mir-3184 hsa04720 Long-term potentiation 2033 1 0.017596799 0.263951989 0.026011491 12901 hsa-mir-3184 hsa05215 Prostate cancer 2033 1 0.020580035 0.308700524 0.026011491 12902 hsa-mir-3184 hsa05212 Pancreatic cancer 2033 1 0.020809193 0.31213789 0.026011491 12903 hsa-mir-3184 hsa04916 Melanogenesis 2033 1 0.024241047 0.363615709 0.027970439 12904 hsa-mir-3184 hsa04630 Jak-STAT signaling pathway 2033 1 0.035832353 0.53748529 0.038391806 12905 hsa-mir-3184 hsa05016 Huntington's disease 2033 1 0.043269546 0.649043197 0.043269546 12906 hsa-mir-3185 hsa03022 Basal transcription factors 2959_6908 2 7.36E-05 0.001029947 0.001029947 12907 hsa-mir-3185 hsa05016 Huntington's disease 2033_6908 2 0.001735379 0.024295305 0.012147652 12908 hsa-mir-3185 hsa04330 Notch signaling pathway 2033 1 0.015882399 0.222353592 0.046033355 12909 hsa-mir-3185 hsa05211 Renal cell carcinoma 2033 1 0.024064242 0.336899383 0.046033355 12910 hsa-mir-3185 hsa04720 Long-term potentiation 2033 1 0.025041937 0.35058712 0.046033355 12911 hsa-mir-3185 hsa04520 Adherens junction 2033 1 0.026669471 0.373372593 0.046033355 12912 hsa-mir-3185 hsa04350 TGF-beta signaling pathway 2033 1 0.02894391 0.405214745 0.046033355 12913 hsa-mir-3185 hsa05215 Prostate cancer 2033 1 0.029268439 0.409758153 0.046033355 12914 hsa-mir-3185 hsa05212 Pancreatic cancer 2033 1 0.029592871 0.414300194 0.046033355 12915 hsa-mir-3185 hsa04916 Melanogenesis 2033 1 0.034447648 0.482267068 0.048226707 12916 hsa-mir-3185 hsa04110 Cell cycle 2033 1 0.039280555 0.549927764 0.049993433 12917 hsa-mir-3185 hsa04310 Wnt signaling pathway 2033 1 0.049836399 0.697709593 0.054697813 12918 hsa-mir-3186 hsa05200 Pathways in cancer 3320_3326_4149_2249_4292_7046_1499_5594_5595_5599_5914_1387_6256_367_2932_3265_6776_6777_6772_2308_5970_8554_5371_7157_4089_5894_3725_4088_5604_862_1029_6502_2353_4087_3065_1050_5925_2033 38 2.53E-28 2.00E-26 2.00E-26 12919 hsa-mir-3186 hsa05215 Prostate cancer 3320_3326_1499_5594_5595_1387_367_2932_3265_2308_5970_7157_5894_5604_5925_2033 16 2.25E-15 1.78E-13 6.94E-14 12920 hsa-mir-3186 hsa05212 Pancreatic cancer 3320_3326_1499_5594_5595_1387_367_2932_3265_2308_5970_7157_5894_5604_5925_2033 16 2.64E-15 2.08E-13 6.94E-14 12921 hsa-mir-3186 hsa05220 Chronic myeloid leukemia 7046_5594_5595_3265_6776_6777_5970_7157_4089_5894_4088_5604_1029_3065_5925 15 4.96E-15 3.92E-13 9.80E-14 12922 hsa-mir-3186 hsa04110 Cell cycle 1387_983_2932_8454_6500_990_7157_4089_4088_1029_6502_4087_3065_5925_2033_891_5933 17 1.06E-14 8.34E-13 1.67E-13 12923 hsa-mir-3186 hsa05210 Colorectal cancer 4292_7046_1499_5594_5595_5599_2932_7157_4089_5894_3725_4088_5604_2353_4087 15 2.17E-14 1.71E-12 2.85E-13 12924 hsa-mir-3186 hsa04350 TGF-beta signaling pathway 6667_7046_5594_5595_1387_8454_6500_3397_3399_3398_4089_4088_4087_2033_5933 15 3.42E-14 2.70E-12 3.86E-13 12925 hsa-mir-3186 hsa04010 MAPK signaling pathway 6722_4149_2249_7046_5594_5595_5599_9261_4208_7867_3265_1386_1432_5970_7157_5894_3725_5604_2353_22800_5598 21 5.76E-13 4.55E-11 5.68E-12 12926 hsa-mir-3186 hsa05221 Acute myeloid leukemia 5594_5595_5914_3265_6776_6777_5970_5371_5894_5604_862_1050 12 2.33E-12 1.84E-10 2.05E-11 12927 hsa-mir-3186 hsa04520 Adherens junction 4301_7046_1499_5594_5595_1387_4089_4088_1457_4087_1459_2033_71 13 3.51E-12 2.77E-10 2.77E-11 12928 hsa-mir-3186 hsa04720 Long-term potentiation 5594_5595_1387_2902_2906_3265_5894_5604_2033_808_801_805 12 2.84E-11 2.24E-09 2.04E-10 12929 hsa-mir-3186 hsa05214 Glioma 5594_5595_3265_7157_5894_5604_1029_5925_808_801_805 11 1.13E-10 8.89E-09 7.41E-10 12930 hsa-mir-3186 hsa04540 Gap junction 5594_5595_983_7277_3265_5894_7846_5604_7278_51807_10376_5598 12 2.70E-10 2.13E-08 1.64E-09 12931 hsa-mir-3186 hsa04310 Wnt signaling pathway 1499_5599_1387_2932_8454_6500_7157_4089_3725_4088_1457_4087_1459_2033 14 5.18E-10 4.10E-08 2.93E-09 12932 hsa-mir-3186 hsa04916 Melanogenesis 1499_5594_5595_1387_2932_3265_5894_5604_2033_808_801_805 12 8.69E-10 6.86E-08 4.58E-09 12933 hsa-mir-3186 hsa04912 GnRH signaling pathway 5594_5595_5599_3265_1432_5894_3725_5604_808_5598_801_805 12 1.29E-09 1.02E-07 6.36E-09 12934 hsa-mir-3186 hsa04910 Insulin signaling pathway 10891_5594_5595_5599_2932_3265_2308_5563_5894_5604_808_801_805 13 1.69E-09 1.33E-07 7.83E-09 12935 hsa-mir-3186 hsa05213 Endometrial cancer 4292_1499_5594_5595_2932_3265_7157_5894_5604 9 4.80E-09 3.79E-07 2.11E-08 12936 hsa-mir-3186 hsa05223 Non-small cell lung cancer 5594_5595_6256_3265_7157_5894_5604_1029_5925 9 6.45E-09 5.09E-07 2.68E-08 12937 hsa-mir-3186 hsa05219 Bladder cancer 5594_5595_3265_7157_5894_5604_1029_5925 8 1.81E-08 1.43E-06 7.13E-08 12938 hsa-mir-3186 hsa04012 ErbB signaling pathway 5594_5595_5599_2932_3265_6776_6777_5894_3725_5604 10 2.33E-08 1.84E-06 8.78E-08 12939 hsa-mir-3186 hsa05216 Thyroid cancer 1499_5594_5595_6256_3265_7157_5604 7 3.47E-08 2.74E-06 1.25E-07 12940 hsa-mir-3186 hsa05218 Melanoma 2249_5594_5595_3265_7157_5894_5604_1029_5925 9 5.51E-08 4.35E-06 1.89E-07 12941 hsa-mir-3186 hsa04662 B cell receptor signaling pathway 5594_5595_2932_3265_5970_5894_3725_5604_2353 9 8.47E-08 6.69E-06 2.79E-07 12942 hsa-mir-3186 hsa05131 Shigellosis 1499_4691_7277_7846_7278_51807_71_10376 8 1.33E-07 1.05E-05 4.04E-07 12943 hsa-mir-3186 hsa05130 Pathogenic Escherichia coli infection 1499_4691_7277_7846_7278_51807_71_10376 8 1.33E-07 1.05E-05 4.04E-07 12944 hsa-mir-3186 hsa04660 T cell receptor signaling pathway 5594_5595_2932_3265_1432_5970_5894_3725_5604_2353 10 1.79E-07 1.41E-05 5.23E-07 12945 hsa-mir-3186 hsa04330 Notch signaling pathway 388585_1387_9612_3065_2033_2648_8850 7 6.40E-07 5.05E-05 1.81E-06 12946 hsa-mir-3186 hsa05211 Renal cell carcinoma 5594_5595_1387_3265_5894_3725_5604_2033 8 7.68E-07 6.06E-05 2.09E-06 12947 hsa-mir-3186 hsa04620 Toll-like receptor signaling pathway 5594_5595_5599_1432_6772_5970_3725_5604_2353 9 9.37E-07 7.40E-05 2.47E-06 12948 hsa-mir-3186 hsa04370 VEGF signaling pathway 5594_5595_9261_7867_3265_1432_5894_5604 8 1.22E-06 9.68E-05 3.12E-06 12949 hsa-mir-3186 hsa04120 Ubiquitin mediated proteolysis 672_8454_6500_55294_8554_5371_6502_7325_7329 9 1.01E-05 0.000797844 2.42E-05 12950 hsa-mir-3186 hsa05010 Alzheimer's disease 5594_5595_2902_2906_2932_1537_351_808_801_805 10 1.01E-05 0.00080016 2.42E-05 12951 hsa-mir-3186 hsa04664 Fc epsilon RI signaling pathway 5594_5595_5599_3265_1432_5894_5604 7 1.51E-05 0.001193227 3.51E-05 12952 hsa-mir-3186 hsa05016 Huntington's disease 6667_10891_1387_2902_6908_1537_7157_3065_2033_9519 10 1.66E-05 0.0013152 3.76E-05 12953 hsa-mir-3186 hsa04062 Chemokine signaling pathway 5594_5595_2932_3265_6777_6772_5970_5894_5604_7074 10 2.06E-05 0.00163062 4.53E-05 12954 hsa-mir-3186 hsa05222 Small cell lung cancer 4149_6256_5970_8554_7157_6502_5925 7 2.52E-05 0.001991667 5.38E-05 12955 hsa-mir-3186 hsa04510 Focal adhesion 1499_5594_5595_5599_2932_3265_5894_3725_5604_71 10 3.51E-05 0.00277037 7.29E-05 12956 hsa-mir-3186 hsa04530 Tight junction 4301_1499_3265_8573_1457_1459_71_22800 8 6.30E-05 0.004976997 0.000127615 12957 hsa-mir-3186 hsa04270 Vascular smooth muscle contraction 5594_5595_5894_5604_808_801_805 7 0.000165291 0.013058017 0.00032645 12958 hsa-mir-3186 hsa04612 Antigen processing and presentation 3320_3326_3308_4800_4801_4802 6 0.000253806 0.020050646 0.00048904 12959 hsa-mir-3186 hsa04810 Regulation of actin cytoskeleton 2249_5594_5595_3265_5894_5604_71_22800_7074 9 0.000284927 0.022509267 0.000535935 12960 hsa-mir-3186 hsa04920 Adipocytokine signaling pathway 10891_5599_6256_5970_5563 5 0.00054177 0.042799823 0.000980887 12961 hsa-mir-3186 hsa03022 Basal transcription factors 2962_2969_6908_9519 4 0.000546317 0.043159029 0.000980887 12962 hsa-mir-3186 hsa04115 p53 signaling pathway 7161_983_7157_1029_891 5 0.000614505 0.048545867 0.001078797 12963 hsa-mir-3186 hsa04730 Long-term depression 5594_5595_3265_5894_5604 5 0.000694321 0.054851345 0.001192421 12964 hsa-mir-3186 hsa04630 Jak-STAT signaling pathway 1387_6776_6777_6772_8554_2033_3977 7 0.000792053 0.062572206 0.001331324 12965 hsa-mir-3186 hsa04930 Type II diabetes mellitus 5594_5595_5599_3651 4 0.001078954 0.08523733 0.001775778 12966 hsa-mir-3186 hsa04950 Maturity onset diabetes of the young 3651_168620_6927 3 0.00192188 0.15182855 0.003098542 12967 hsa-mir-3186 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906_1432_7157 4 0.002294469 0.181263031 0.003625261 12968 hsa-mir-3186 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_1432_5970_3725 4 0.005136844 0.405810652 0.007957072 12969 hsa-mir-3186 hsa04650 Natural killer cell mediated cytotoxicity 5594_5595_3265_5894_5604 5 0.010624241 0.839315025 0.016140674 12970 hsa-mir-3186 hsa04150 mTOR signaling pathway 5594_5595_5563 3 0.014271145 1 0.021272084 12971 hsa-mir-3186 hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.016451059 1 0.02406729 12972 hsa-mir-3186 hsa04670 Leukocyte transendothelial migration 4301_1499_1432_71 4 0.029480974 1 0.0423454 12973 hsa-mir-3186 hsa04020 Calcium signaling pathway 2902_2906_808_801_805 5 0.031157988 1 0.043955019 12974 hsa-mir-3186 hsa04360 Axon guidance 5594_5595_2932_3265 4 0.036594341 1 0.049935606 12975 hsa-mir-3186 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.036661584 1 0.049935606 12976 hsa-mir-3187 hsa05200 Pathways in cancer 3725_5371_1499_5595_5594_1387_9915_3091_2113_861_862_6502_5925_2034_2033 15 7.43E-11 4.38E-09 3.96E-09 12977 hsa-mir-3187 hsa05211 Renal cell carcinoma 3725_5595_5594_1387_9915_3091_2113_2034_2033 9 1.34E-10 7.91E-09 3.96E-09 12978 hsa-mir-3187 hsa04720 Long-term potentiation 5595_5594_1387_468_2033_808_801_805 8 4.65E-09 2.74E-07 9.15E-08 12979 hsa-mir-3187 hsa04350 TGF-beta signaling pathway 5595_5594_1387_3397_3399_3398_2033_4093 8 1.37E-08 8.08E-07 2.02E-07 12980 hsa-mir-3187 hsa04916 Melanogenesis 1499_5595_5594_1387_2033_808_801_805 8 5.02E-08 2.96E-06 5.92E-07 12981 hsa-mir-3187 hsa04912 GnRH signaling pathway 3725_5595_5594_1432_468_808_801_805 8 6.60E-08 3.90E-06 6.49E-07 12982 hsa-mir-3187 hsa04010 MAPK signaling pathway 6722_3725_5595_5594_4208_7867_1432_9261_468_3727_1616 11 8.56E-08 5.05E-06 7.22E-07 12983 hsa-mir-3187 hsa05215 Prostate cancer 1499_5595_5594_1387_468_5925_2033 7 2.86E-07 1.69E-05 2.01E-06 12984 hsa-mir-3187 hsa05212 Pancreatic cancer 1499_5595_5594_1387_468_5925_2033 7 3.07E-07 1.81E-05 2.01E-06 12985 hsa-mir-3187 hsa05214 Glioma 5595_5594_5925_808_801_805 6 9.27E-07 5.47E-05 5.47E-06 12986 hsa-mir-3187 hsa04520 Adherens junction 1499_5595_5594_1387_1457_2033 6 2.88E-06 0.000169673 1.54E-05 12987 hsa-mir-3187 hsa04330 Notch signaling pathway 388585_1387_9612_2033_8850 5 4.09E-06 0.000241391 2.01E-05 12988 hsa-mir-3187 hsa05221 Acute myeloid leukemia 5371_5595_5594_861_862 5 1.15E-05 0.000677656 5.21E-05 12989 hsa-mir-3187 hsa05010 Alzheimer's disease 5595_5594_823_9451_808_801_805 7 2.33E-05 0.001375245 9.82E-05 12990 hsa-mir-3187 hsa04370 VEGF signaling pathway 5595_5594_7867_1432_9261 5 3.85E-05 0.002270265 0.000151351 12991 hsa-mir-3187 hsa04310 Wnt signaling pathway 3725_1499_1387_8061_1457_2033 6 9.17E-05 0.005412 0.00033825 12992 hsa-mir-3187 hsa04270 Vascular smooth muscle contraction 5595_5594_808_801_805 5 0.000262301 0.015475734 0.000910337 12993 hsa-mir-3187 hsa05216 Thyroid cancer 1499_5595_5594 3 0.000422719 0.024940415 0.001385579 12994 hsa-mir-3187 hsa05220 Chronic myeloid leukemia 5595_5594_861_5925 4 0.000484586 0.028590594 0.001504768 12995 hsa-mir-3187 hsa04910 Insulin signaling pathway 5595_5594_808_801_805 5 0.00052401 0.03091661 0.001545831 12996 hsa-mir-3187 hsa05210 Colorectal cancer 3725_1499_5595_5594 4 0.000728575 0.04298592 0.002046949 12997 hsa-mir-3187 hsa03022 Basal transcription factors 2963_2969_6908 3 0.000819805 0.048368489 0.002198568 12998 hsa-mir-3187 hsa05219 Bladder cancer 5595_5594_5925 3 0.001157938 0.068318365 0.002970364 12999 hsa-mir-3187 hsa04930 Type II diabetes mellitus 3651_5595_5594 3 0.00139734 0.082443052 0.003435127 13000 hsa-mir-3187 hsa04620 Toll-like receptor signaling pathway 3725_5595_5594_1432 4 0.001456767 0.085949278 0.003437971 13001 hsa-mir-3187 hsa04660 T cell receptor signaling pathway 3725_5595_5594_1432 4 0.001902544 0.112250105 0.004317312 13002 hsa-mir-3187 hsa05213 Endometrial cancer 1499_5595_5594 3 0.002070646 0.122168097 0.004363146 13003 hsa-mir-3187 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.002070646 0.122168097 0.004363146 13004 hsa-mir-3187 hsa05223 Non-small cell lung cancer 5595_5594_5925 3 0.002294072 0.135350246 0.00466725 13005 hsa-mir-3187 hsa04110 Cell cycle 1387_6502_5925_2033 4 0.002507941 0.147968532 0.004932284 13006 hsa-mir-3187 hsa05218 Melanoma 5595_5594_5925 3 0.004803259 0.283392277 0.009141686 13007 hsa-mir-3187 hsa04662 B cell receptor signaling pathway 3725_5595_5594 3 0.005562736 0.328201438 0.010256295 13008 hsa-mir-3187 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.00576319 0.340028181 0.010303884 13009 hsa-mir-3187 hsa04950 Maturity onset diabetes of the young 3651_168620 2 0.006294928 0.371400779 0.010772289 13010 hsa-mir-3187 hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432 3 0.006390341 0.377030105 0.010772289 13011 hsa-mir-3187 hsa04012 ErbB signaling pathway 3725_5595_5594 3 0.008255751 0.487089331 0.013530259 13012 hsa-mir-3187 hsa04510 Focal adhesion 3725_1499_5595_5594 4 0.016059325 0.947500161 0.025608112 13013 hsa-mir-3187 hsa04120 Ubiquitin mediated proteolysis 7329_5371_6502 3 0.027673617 1 0.042966932 13014 hsa-mir-3187 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_1616 2 0.029113767 1 0.044043903 13015 hsa-mir-3187 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1432 2 0.04428624 1 0.06372898 13016 hsa-mir-3187 hsa04730 Long-term depression 5595_5594 2 0.04428624 1 0.06372898 13017 hsa-mir-3188 hsa05200 Pathways in cancer 4149_3551_1398_5467_1499_5914_595_3815_1019_1017_8517_4193_6934_7704_3091_2735_4089_3066_3065_1050_5925_7184_5468_25_405_1956_1487_1488_1870_1871_2113_10401_5894_861_862_867_324_207_208_836_3716_1147_4609_3320_5595_5594_5599_1387_6256_9915_367_2932_6776_6777_6772_5970_7157_6688_7849_1869_3725_4286_6774_6502_4087_4088_2034_2033_4846_898_4790_4791_4792_3326_51176_5371_675_5159_5156_5604_5601_1399_4292_7428_2956_1026_1029_2736_2353_2737_8554 91 2.41E-43 2.05E-41 2.05E-41 13018 hsa-mir-3188 hsa05220 Chronic myeloid leukemia 3551_1398_595_1019_8517_4193_4089_3066_3065_5925_25_1487_1488_1870_1871_5894_861_867_207_208_1147_4609_5595_5594_6776_6777_5970_7157_1869_4088_4790_4792_5604_1399_5781_1026_1029_6464 38 2.24E-26 1.91E-24 9.54E-25 13019 hsa-mir-3188 hsa05215 Prostate cancer 3551_1499_595_1017_8517_4193_6934_5925_7184_1956_1870_1871_5894_9586_207_208_1147_3320_5595_5594_1387_367_2932_5970_7157_468_1869_2033_898_4790_4792_3326_51176_5159_5156_5604_1026 37 1.70E-23 1.45E-21 4.82E-22 13020 hsa-mir-3188 hsa05212 Pancreatic cancer 3551_1499_595_1017_8517_4193_6934_5925_7184_1956_1870_1871_5894_9586_207_208_1147_3320_5595_5594_1387_367_2932_5970_7157_468_1869_2033_898_4790_4792_3326_51176_5159_5156_5604_1026 37 2.32E-23 1.97E-21 4.94E-22 13021 hsa-mir-3188 hsa04010 MAPK signaling pathway 6722_4149_3551_1398_6197_8517_9252_4773_9020_1956_3303_1432_5894_3305_4763_1616_207_208_836_1147_4609_5595_5594_5599_5598_8986_1386_3312_1649_5971_5970_3164_7157_468_3725_3727_6195_6196_4790_4791_5159_9261_1326_5156_5604_4208_5601_5600_5603_5608_1399_6885_2353_8550_2002_5566 56 8.57E-22 7.28E-20 1.46E-20 13022 hsa-mir-3188 hsa04110 Cell cycle 595_1019_1017_4193_4089_4171_3066_3065_990_5925_25_6500_1870_1871_5934_5933_7534_5591_1387_2932_7027_7157_5111_1869_6502_4085_4087_4088_2033_891_898_983_8454_1026_1029_1111 36 4.97E-19 4.22E-17 6.12E-18 13023 hsa-mir-3188 hsa03022 Basal transcription factors 54457_138474_6882_6883_6879_2967_2961_2960_2963_2962_2969_2968_6878_6877_6874_6873_6872_6884_2958_2959_6880_6881_2957_6908 24 5.04E-19 4.28E-17 6.12E-18 13024 hsa-mir-3188 hsa05221 Acute myeloid leukemia 3551_5467_5914_595_3815_8517_6934_7704_1050_5894_861_862_207_208_1147_4609_5595_5594_6776_6777_5970_6688_6774_4790_51176_5371_5604 27 2.93E-18 2.49E-16 3.11E-17 13025 hsa-mir-3188 hsa04660 T cell receptor signaling pathway 3551_1493_1019_8517_4773_9020_3932_4793_1432_4794_5894_867_207_208_1147_5595_5594_2932_5970_3725_4790_4792_4772_1326_5604_5601_5600_5603_919_6885_2353 31 7.30E-16 6.20E-14 6.89E-15 13026 hsa-mir-3188 hsa04310 Wnt signaling pathway 5467_1499_595_8607_6934_8945_4089_4773_23291_1487_1488_6500_324_4609_1460_5599_1387_2932_7157_8061_3725_1457_1459_4087_4088_2033_51176_4772_5515_5519_5601_8454_6885_5527_5566 35 1.98E-15 1.68E-13 1.68E-14 13027 hsa-mir-3188 hsa05210 Colorectal cancer 1499_595_6934_4089_1956_5894_324_207_208_836_4609_5595_5594_5599_2932_7157_3725_4087_4088_51176_5159_5156_5604_5601_4292_2956_2353 27 3.69E-15 3.14E-13 2.85E-14 13028 hsa-mir-3188 hsa05214 Glioma 595_1019_4193_5925_1956_1870_1871_5894_207_208_5595_5594_7157_1869_808_801_805_5159_5156_5604_1026_1029_6464 23 7.63E-14 6.48E-12 5.40E-13 13029 hsa-mir-3188 hsa04350 TGF-beta signaling pathway 4086_4089_6667_6500_3397_3399_3398_1874_1875_5934_5933_4093_4609_3400_5595_5594_1387_7027_4087_4088_2033_5515_5519_8454_4092 25 3.17E-13 2.69E-11 2.07E-12 13030 hsa-mir-3188 hsa04620 Toll-like receptor signaling pathway 3551_8517_3665_3661_1432_207_208_1147_29110_5595_5594_5599_6772_5970_3725_4790_4792_1326_5604_5601_5600_5603_5608_9641_6885_2353 26 1.11E-12 9.41E-11 6.72E-12 13031 hsa-mir-3188 hsa05222 Small cell lung cancer 4149_3551_595_1019_1017_8517_5925_1870_1871_10401_207_208_1147_4609_6256_5970_7157_1869_6502_4846_898_4790_4792_8554 24 1.60E-12 1.36E-10 9.04E-12 13032 hsa-mir-3188 hsa04012 ErbB signaling pathway 1398_25_1956_6714_5894_867_207_208_4609_5595_5594_5599_2066_2932_6776_6777_3725_5604_5601_1399_1026_6464_2002 23 1.18E-11 1.00E-09 6.27E-11 13033 hsa-mir-3188 hsa04910 Insulin signaling pathway 3551_10891_1398_6720_5770_23265_5590_5894_8471_867_5211_207_208_8651_5595_5594_5599_2932_808_801_805_3643_5604_5601_1399_6464_2002_5566 28 1.72E-11 1.47E-09 8.62E-11 13034 hsa-mir-3188 hsa05219 Bladder cancer 595_1019_9252_4193_5925_1956_1870_1871_5894_4609_5595_5594_7157_1869_5604_1026_1029 17 2.45E-11 2.08E-09 1.16E-10 13035 hsa-mir-3188 hsa04662 B cell receptor signaling pathway 3551_8517_4773_6850_4793_4794_5894_207_208_1147_695_5595_5594_2932_5970_3725_4790_4792_4772_5604_2353 21 3.71E-11 3.16E-09 1.66E-10 13036 hsa-mir-3188 hsa05213 Endometrial cancer 1499_595_6934_1956_2309_5894_324_207_208_4609_5595_5594_2932_7157_51176_5604_4292_2002 18 5.22E-11 4.44E-09 2.22E-10 13037 hsa-mir-3188 hsa05218 Melanoma 595_1019_4193_5925_1956_1870_1871_5894_207_208_5595_5594_7157_1869_4286_5159_5156_5604_1026_1029 20 9.89E-11 8.40E-09 4.00E-10 13038 hsa-mir-3188 hsa04920 Adipocytokine signaling pathway 3551_10891_5465_8517_4793_4794_8471_207_208_3717_1147_5599_6256_5970_6774_4790_4792_5601_5781 19 2.63E-10 2.24E-08 1.02E-09 13039 hsa-mir-3188 hsa05223 Non-small cell lung cancer 595_1019_5925_1956_2309_1870_1871_5894_207_208_5595_5594_6256_7157_1869_5604_1029 17 6.02E-10 5.11E-08 2.22E-09 13040 hsa-mir-3188 hsa04520 Adherens junction 1499_6934_5770_4089_1956_6714_71_1460_5595_5594_1387_1457_1459_4087_4088_2033_51176_3643_6885 19 3.28E-09 2.79E-07 1.16E-08 13041 hsa-mir-3188 hsa04062 Chemokine signaling pathway 3551_1398_8517_653361_7074_5580_5590_4793_2309_5894_207_208_3717_1147_3718_5595_5594_1234_2932_6777_6772_5970_6774_4790_4792_5604_1399_6464_5566 29 3.85E-09 3.28E-07 1.31E-08 13042 hsa-mir-3188 hsa05211 Renal cell carcinoma 1398_3091_405_2113_5894_207_208_5595_5594_1387_9915_3725_2034_2033_5604_1399_7428_5781 18 4.25E-09 3.61E-07 1.39E-08 13043 hsa-mir-3188 hsa04540 Gap junction 10382_7278_51807_1956_6714_5894_5592_5595_5594_5598_7846_347733_5159_983_5156_5604_7277_203068_10376_5566 20 5.56E-09 4.73E-07 1.75E-08 13044 hsa-mir-3188 hsa04912 GnRH signaling pathway 5580_1956_6714_1432_5894_5595_5594_5599_5598_468_3725_808_801_805_5604_5601_5600_5603_5608_2002_5566 21 1.10E-08 9.34E-07 3.34E-08 13045 hsa-mir-3188 hsa04630 Jak-STAT signaling pathway 595_85480_3560_3561_2057_10401_867_2690_207_208_3575_3717_3716_4609_3718_8651_1387_6778_6776_6777_6772_6774_2033_5781_8554 25 1.30E-08 1.10E-06 3.81E-08 13046 hsa-mir-3188 hsa05216 Thyroid cancer 1499_595_6934_5468_4609_5595_5594_6256_7157_7849_51176_5604 12 1.74E-08 1.48E-06 4.94E-08 13047 hsa-mir-3188 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3551_8517_9020_1956_6714_1432_836_1147_5599_5970_3725_4790_4792_5601_5600_5603_5781 17 1.97E-08 1.68E-06 5.41E-08 13048 hsa-mir-3188 hsa04720 Long-term potentiation 814_6197_2902_5894_5595_5594_1387_468_6195_6196_2033_808_801_805_5604_5566 16 2.02E-07 1.72E-05 5.38E-07 13049 hsa-mir-3188 hsa04330 Notch signaling pathway 1840_9612_3066_3065_9794_22938_1487_1488_2648_1387_2033_8850_4851 13 2.23E-07 1.90E-05 5.75E-07 13050 hsa-mir-3188 hsa05016 Huntington's disease 10891_293_1537_292_3066_3065_3064_498_5468_2902_6667_9586_836_1213_1387_9001_5430_5437_7157_3092_2033_6874_5441_6908_4724 25 3.64E-07 3.09E-05 9.09E-07 13051 hsa-mir-3188 hsa05131 Shigellosis 1499_10382_7278_51807_25_71_7534_7846_347733_7277_4691_203068_10376 13 1.23E-06 0.000104482 2.90E-06 13052 hsa-mir-3188 hsa05130 Pathogenic Escherichia coli infection 1499_10382_7278_51807_25_71_7534_7846_347733_7277_4691_203068_10376 13 1.23E-06 0.000104482 2.90E-06 13053 hsa-mir-3188 hsa04664 Fc epsilon RI signaling pathway 5580_6850_1432_5894_207_208_695_5595_5594_5599_5604_5601_5600_5603_5608 15 1.75E-06 0.000148506 3.98E-06 13054 hsa-mir-3188 hsa04120 Ubiquitin mediated proteolysis 4193_55294_8945_23291_6500_10401_867_7325_7329_8925_51366_11059_8651_11060_6502_5371_672_8454_7428_8554 20 1.78E-06 0.000151215 3.98E-06 13055 hsa-mir-3188 hsa04115 p53 signaling pathway 595_1019_1017_4194_4193_836_7157_891_898_983_1026_7161_1029_1111 14 1.95E-06 0.000165333 4.24E-06 13056 hsa-mir-3188 hsa05322 Systemic lupus erythematosus 8363_8364_3021_3020_8366_9555_8368_3014_3015_8294_8370_121504_8361_8360_8362_8365_8367_8349_8359_8340 20 2.89E-06 0.000245629 6.14E-06 13057 hsa-mir-3188 hsa04930 Type II diabetes mellitus 3551_5580_5590_8471_3651_8651_5595_5594_5599_3643_5601 11 5.28E-06 0.000448637 1.09E-05 13058 hsa-mir-3188 hsa04370 VEGF signaling pathway 4773_6714_1432_5894_207_208_5595_5594_4846_4772_9261_5604_5600_5603 14 5.98E-06 0.000507937 1.21E-05 13059 hsa-mir-3188 hsa04916 Melanogenesis 1499_3815_6934_5894_5595_5594_1387_2932_4286_2033_808_801_805_51176_5604_5566 16 8.88E-06 0.000755001 1.76E-05 13060 hsa-mir-3188 hsa04210 Apoptosis 3551_8517_9020_207_208_836_1147_839_5970_7157_9131_4790_4792_5566 14 2.56E-05 0.002172398 4.94E-05 13061 hsa-mir-3188 hsa03010 Ribosome 6155_6207_6156_6141_6217_6129_6128_9349_6222_6229_6124_6143_6188_6231 14 9.66E-05 0.00820975 0.000182439 13062 hsa-mir-3188 hsa04510 Focal adhesion 1398_1499_595_1956_6714_5894_207_208_71_5595_5594_5599_2932_3725_5159_5156_5604_5601_1399_6464_2002 21 0.000111503 0.009477717 0.000206037 13063 hsa-mir-3188 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_1432_1616_836_834_7157_4846_5600_5603_5608 10 0.000143776 0.012220938 0.00026002 13064 hsa-mir-3188 hsa03410 Base excision repair 3146_4350_142_252969_328_2237_5111_6996 8 0.000180733 0.015362315 0.000320048 13065 hsa-mir-3188 hsa03020 RNA polymerase 64425_25885_51082_5430_5437_84172_5441 7 0.000296592 0.025210282 0.000514496 13066 hsa-mir-3188 hsa04530 Tight junction 1499_1019_5580_5590_6714_4628_207_208_71_1460_1457_1459_9223_5515_5519 15 0.000518221 0.044048811 0.000880976 13067 hsa-mir-3188 hsa05217 Basal cell carcinoma 1499_6934_2735_324_2932_7157_51176_2736_2737 9 0.000541392 0.046018348 0.000902321 13068 hsa-mir-3188 hsa04150 mTOR signaling pathway 6197_3091_207_208_5595_5594_6195_6196 8 0.001552919 0.131998119 0.002538425 13069 hsa-mir-3188 hsa03420 Nucleotide excision repair 5981_5111_5887_5886_2967_2968_4331 7 0.002548288 0.216604514 0.004086878 13070 hsa-mir-3188 hsa05340 Primary immunodeficiency 8517_3932_3561_3575_3718_695 6 0.003688467 0.313519677 0.005738582 13071 hsa-mir-3188 hsa03450 Non-homologous end-joining 10111_2237_5591_4361 4 0.0037132 0.315622032 0.005738582 13072 hsa-mir-3188 hsa04740 Olfactory transduction 5592_808_801_805_5566 5 0.006524186 0.554555773 0.009902782 13073 hsa-mir-3188 hsa04270 Vascular smooth muscle contraction 5580_5894_5592_5595_5594_808_801_805_59_5604_5566 11 0.00830058 0.705549329 0.012378058 13074 hsa-mir-3188 hsa04730 Long-term depression 5894_5592_5595_5594_4846_5515_5519_5604 8 0.008601469 0.731124837 0.012605601 13075 hsa-mir-3188 hsa04340 Hedgehog signaling pathway 2735_8945_23291_2932_2736_2737_5566 7 0.009064166 0.770454073 0.013058544 13076 hsa-mir-3188 hsa04612 Antigen processing and presentation 3303_3309_3305_3320_3312_3326_4800_4801_4802 9 0.010236092 0.870067793 0.01450113 13077 hsa-mir-3188 hsa04650 Natural killer cell mediated cytotoxicity 4773_3932_6850_5894_836_5595_5594_4772_5604_919_5781_6464 12 0.013301413 1 0.018534755 13078 hsa-mir-3188 hsa03430 Mismatch repair 5981_5111_4292_2956 4 0.01638733 1 0.0224665 13079 hsa-mir-3188 hsa04950 Maturity onset diabetes of the young 6927_3651_4760_5080 4 0.018573894 1 0.025060015 13080 hsa-mir-3188 hsa03440 Homologous recombination 10111_4683_675_4361 4 0.029072334 1 0.038611693 13081 hsa-mir-3188 hsa04020 Calcium signaling pathway 814_293_292_1956_2902_2066_4846_808_801_805_5159_5156_5566 13 0.036456955 1 0.04767448 13082 hsa-mir-3188 hsa03050 Proteasome 5701_5702_5719_5710_5705 5 0.045098766 1 0.058081744 13083 hsa-mir-3192 hsa05200 Pathways in cancer 3716_2249_675_5595_5594_5914_6256_5159_5156_1399_1398_367_3815_6774_6777_6772_5970_3725_867_2353_6776_2735_2736_2737_2033_1956 26 6.08E-27 4.14E-25 4.14E-25 13084 hsa-mir-3192 hsa04630 Jak-STAT signaling pathway 3717_3716_3718_85480_3560_3561_3575_6774_6777_6772_2057_5781_867_6776_2690_2033_3977 17 4.13E-20 2.81E-18 1.40E-18 13085 hsa-mir-3192 hsa04012 ErbB signaling pathway 6714_5595_5594_2066_1399_1398_6777_3725_867_6776_6464_1956 12 1.37E-15 9.32E-14 3.11E-14 13086 hsa-mir-3192 hsa05220 Chronic myeloid leukemia 5595_5594_1399_1398_6777_5970_5781_867_6776_6464 10 4.76E-13 3.24E-11 8.10E-12 13087 hsa-mir-3192 hsa04062 Chemokine signaling pathway 3717_3718_5595_5594_1399_1398_1234_6774_6777_6772_5970_6464 12 9.03E-12 6.14E-10 1.23E-10 13088 hsa-mir-3192 hsa05221 Acute myeloid leukemia 5595_5594_5914_3815_6774_6777_5970_6776 8 9.91E-11 6.74E-09 1.12E-09 13089 hsa-mir-3192 hsa04060 Cytokine-cytokine receptor interaction 85480_3560_3561_5159_5156_3575_1234_3815_2057_2690_3977_1956 12 2.62E-10 1.78E-08 2.54E-09 13090 hsa-mir-3192 hsa04660 T cell receptor signaling pathway 1493_5595_5594_919_5970_3725_867_2353_3932 9 4.13E-10 2.81E-08 3.51E-09 13091 hsa-mir-3192 hsa05215 Prostate cancer 5595_5594_5159_5156_367_5970_2033_1956 8 1.85E-09 1.26E-07 1.37E-08 13092 hsa-mir-3192 hsa05212 Pancreatic cancer 5595_5594_5159_5156_367_5970_2033_1956 8 2.01E-09 1.37E-07 1.37E-08 13093 hsa-mir-3192 hsa04510 Focal adhesion 6714_5595_5594_5159_5156_1399_1398_3725_6464_1956 10 5.13E-09 3.49E-07 3.09E-08 13094 hsa-mir-3192 hsa04010 MAPK signaling pathway 2249_5595_5594_5159_5156_1399_1398_5970_3725_2353_1956 11 5.46E-09 3.71E-07 3.09E-08 13095 hsa-mir-3192 hsa05211 Renal cell carcinoma 5595_5594_1399_1398_5781_3725_2033 7 1.29E-08 8.78E-07 6.76E-08 13096 hsa-mir-3192 hsa04662 B cell receptor signaling pathway 695_5595_5594_6850_5970_3725_2353 7 1.68E-08 1.14E-06 8.16E-08 13097 hsa-mir-3192 hsa04520 Adherens junction 6714_3643_5595_5594_5770_2033_1956 7 2.54E-08 1.73E-06 1.15E-07 13098 hsa-mir-3192 hsa05210 Colorectal cancer 5595_5594_5159_5156_3725_2353_1956 7 3.48E-08 2.37E-06 1.48E-07 13099 hsa-mir-3192 hsa04910 Insulin signaling pathway 3643_5595_5594_1399_1398_5770_867_6464 8 5.09E-08 3.46E-06 2.04E-07 13100 hsa-mir-3192 hsa05214 Glioma 5595_5594_5159_5156_6464_1956 6 1.96E-07 1.34E-05 7.42E-07 13101 hsa-mir-3192 hsa05340 Primary immunodeficiency 3718_695_3561_3575_3932 5 2.93E-07 2.00E-05 1.05E-06 13102 hsa-mir-3192 hsa05218 Melanoma 2249_5595_5594_5159_5156_1956 6 3.20E-07 2.17E-05 1.09E-06 13103 hsa-mir-3192 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_6850_919_5781_3932_6464 7 8.51E-07 5.78E-05 2.75E-06 13104 hsa-mir-3192 hsa04540 Gap junction 6714_5595_5594_5159_5156_1956 6 1.42E-06 9.65E-05 4.36E-06 13105 hsa-mir-3192 hsa04810 Regulation of actin cytoskeleton 2249_5595_5594_5159_5156_1399_1398_1956 8 1.48E-06 0.000100391 4.36E-06 13106 hsa-mir-3192 hsa04620 Toll-like receptor signaling pathway 5595_5594_6772_5970_3725_2353 6 2.36E-06 0.000160625 6.69E-06 13107 hsa-mir-3192 hsa04920 Adipocytokine signaling pathway 3717_6256_6774_5970_5781 5 5.71E-06 0.000388049 1.55E-05 13108 hsa-mir-3192 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5970_5781_3725_1956 5 7.45E-06 0.000506705 1.95E-05 13109 hsa-mir-3192 hsa04350 TGF-beta signaling pathway 6667_5515_5595_5594_2033 5 1.90E-05 0.001289921 4.78E-05 13110 hsa-mir-3192 hsa04912 GnRH signaling pathway 6714_5595_5594_3725_1956 5 5.11E-05 0.003472603 0.000124022 13111 hsa-mir-3192 hsa05223 Non-small cell lung cancer 5595_5594_6256_1956 4 5.32E-05 0.003618086 0.000124762 13112 hsa-mir-3192 hsa05216 Thyroid cancer 5595_5594_6256 3 0.000195344 0.01328336 0.000442779 13113 hsa-mir-3192 hsa04664 Fc epsilon RI signaling pathway 695_5595_5594_6850 4 0.000215419 0.014648471 0.000472531 13114 hsa-mir-3192 hsa05219 Bladder cancer 5595_5594_1956 3 0.000540589 0.036760085 0.001148753 13115 hsa-mir-3192 hsa04916 Melanogenesis 5595_5594_3815_2033 4 0.000587337 0.039938883 0.001210269 13116 hsa-mir-3192 hsa04930 Type II diabetes mellitus 3643_5595_5594 3 0.00065389 0.044464489 0.001307779 13117 hsa-mir-3192 hsa05213 Endometrial cancer 5595_5594_1956 3 0.00097428 0.066251052 0.001892887 13118 hsa-mir-3192 hsa05217 Basal cell carcinoma 2735_2736_2737 3 0.001137158 0.077326776 0.002147966 13119 hsa-mir-3192 hsa04340 Hedgehog signaling pathway 2735_2736_2737 3 0.001254723 0.085321177 0.002305978 13120 hsa-mir-3192 hsa04730 Long-term depression 5515_5595_5594 3 0.002293658 0.155968749 0.004104441 13121 hsa-mir-3192 hsa04720 Long-term potentiation 5595_5594_2033 3 0.002664558 0.181189963 0.004645896 13122 hsa-mir-3192 hsa04370 VEGF signaling pathway 6714_5595_5594 3 0.002863066 0.194688492 0.004867212 13123 hsa-mir-3192 hsa04640 Hematopoietic cell lineage 3575_3815_2057 3 0.00399128 0.271407008 0.006619683 13124 hsa-mir-3192 hsa04020 Calcium signaling pathway 2066_5159_5156_1956 4 0.004458614 0.303185776 0.007218709 13125 hsa-mir-3192 hsa05016 Huntington's disease 6667_6908_4724_2033 4 0.004802108 0.326543361 0.007594032 13126 hsa-mir-3192 hsa03010 Ribosome 6124_6129_6143 3 0.006131339 0.416931029 0.009475705 13127 hsa-mir-3192 hsa03022 Basal transcription factors 6908_2959 2 0.008358871 0.568403237 0.012631183 13128 hsa-mir-3192 hsa04330 Notch signaling pathway 9612_2033 2 0.012966834 0.881744709 0.019168363 13129 hsa-mir-3192 hsa04150 mTOR signaling pathway 5595_5594 2 0.015600016 1 0.022570236 13130 hsa-mir-3192 hsa04310 Wnt signaling pathway 5515_3725_2033 3 0.017551819 1 0.024865077 13131 hsa-mir-3192 hsa05010 Alzheimer's disease 5595_5594_4724 3 0.025890185 1 0.035929236 13132 hsa-mir-3192 hsa05222 Small cell lung cancer 6256_5970 2 0.038640161 1 0.052550619 13133 hsa-mir-3193 hsa03022 Basal transcription factors 2967_2961_2960_2963_2969_2968_6878_6877_6874_6872_2957_54457_6879_6908_2958_6873_6884_2959_6880_6882_6881_138474_9519_6883 24 2.33E-32 1.67E-30 1.67E-30 13134 hsa-mir-3193 hsa05200 Pathways in cancer 3326_1871_5595_5594_1387_6256_4286_367_1017_3725_2932_4193_4149_10401_7704_6774_3091_3265_5970_5371_4436_1870_7157_6688_4609_1869_2353_4088_4089_3065_1050_5925_2034_2033_207_8554_9915_7184 38 8.79E-27 6.33E-25 3.17E-25 13135 hsa-mir-3193 hsa04110 Cell cycle 1871_1387_1017_2932_4193_7027_4085_1870_7157_8379_1869_4171_4088_4089_3065_5925_2033_890_5934_5933 20 1.67E-17 1.20E-15 4.00E-16 13136 hsa-mir-3193 hsa05215 Prostate cancer 3326_1871_5595_5594_1387_367_1017_2932_4193_3265_5970_1870_7157_1869_5925_2033_207_7184 18 3.31E-17 2.38E-15 5.68E-16 13137 hsa-mir-3193 hsa05212 Pancreatic cancer 3326_1871_5595_5594_1387_367_1017_2932_4193_3265_5970_1870_7157_1869_5925_2033_207_7184 18 3.94E-17 2.84E-15 5.68E-16 13138 hsa-mir-3193 hsa05220 Chronic myeloid leukemia 1871_5595_5594_4193_3265_5970_1870_7157_4609_1869_4088_4089_3065_5925_207 15 1.99E-14 1.44E-12 2.39E-13 13139 hsa-mir-3193 hsa04350 TGF-beta signaling pathway 5595_5594_1875_1387_6667_7027_1874_4609_4088_4089_2033_4093_5934_5933 14 2.07E-12 1.49E-10 2.13E-11 13140 hsa-mir-3193 hsa05222 Small cell lung cancer 1871_6256_1017_4149_10401_5970_1870_7157_4609_1869_5925_207_8554 13 2.60E-11 1.87E-09 2.34E-10 13141 hsa-mir-3193 hsa05219 Bladder cancer 1871_5595_5594_4193_3265_1870_7157_4609_1869_5925 10 1.07E-10 7.69E-09 8.54E-10 13142 hsa-mir-3193 hsa05221 Acute myeloid leukemia 5595_5594_7704_6774_3265_5970_5371_6688_4609_1050_207 11 1.23E-10 8.83E-09 8.83E-10 13143 hsa-mir-3193 hsa05218 Melanoma 1871_5595_5594_4286_4193_3265_1870_7157_1869_5925_207 11 7.12E-10 5.13E-08 4.66E-09 13144 hsa-mir-3193 hsa05223 Non-small cell lung cancer 1871_5595_5594_6256_3265_1870_7157_1869_5925_207 10 9.18E-10 6.61E-08 5.51E-09 13145 hsa-mir-3193 hsa05210 Colorectal cancer 5595_5594_3725_2932_4436_7157_4609_2353_4088_4089_207 11 3.54E-09 2.55E-07 1.96E-08 13146 hsa-mir-3193 hsa05214 Glioma 1871_5595_5594_4193_3265_1870_7157_1869_5925_207 10 4.55E-09 3.28E-07 2.34E-08 13147 hsa-mir-3193 hsa05211 Renal cell carcinoma 5595_5594_1387_3725_3091_3265_2034_2033_207_9915 10 1.10E-08 7.95E-07 5.30E-08 13148 hsa-mir-3193 hsa04310 Wnt signaling pathway 1460_1387_8607_3725_2932_7157_4609_1457_4088_4089_2033_8061 12 1.25E-07 9.01E-06 5.63E-07 13149 hsa-mir-3193 hsa05016 Huntington's disease 6874_1387_2902_6908_6667_9001_5430_7157_3064_3065_2033_4716_9519 13 1.58E-07 1.14E-05 6.70E-07 13150 hsa-mir-3193 hsa04660 T cell receptor signaling pathway 5595_5594_3725_2932_1432_3265_5970_1739_2353_207 10 4.27E-07 3.07E-05 1.71E-06 13151 hsa-mir-3193 hsa05216 Thyroid cancer 5595_5594_6256_3265_7157_4609 6 1.30E-06 9.39E-05 4.94E-06 13152 hsa-mir-3193 hsa04010 MAPK signaling pathway 5595_3727_5594_3725_4149_3312_1432_3265_5970_7157_22800_4609_2353_207 14 1.61E-06 0.000115682 5.78E-06 13153 hsa-mir-3193 hsa04662 B cell receptor signaling pathway 5595_5594_3725_2932_3265_5970_2353_207 8 2.07E-06 0.000148753 7.08E-06 13154 hsa-mir-3193 hsa05213 Endometrial cancer 5595_5594_2932_3265_7157_4609_207 7 2.22E-06 0.000159918 7.27E-06 13155 hsa-mir-3193 hsa04520 Adherens junction 1460_5595_5594_1387_1457_4088_4089_2033 8 3.22E-06 0.000232031 1.01E-05 13156 hsa-mir-3193 hsa04720 Long-term potentiation 5595_5594_1387_2902_2906_3265_2033 7 2.03E-05 0.001461052 6.09E-05 13157 hsa-mir-3193 hsa04012 ErbB signaling pathway 5595_5594_3725_2932_3265_4609_207 7 4.93E-05 0.003547282 0.000141891 13158 hsa-mir-3193 hsa04620 Toll-like receptor signaling pathway 5595_5594_3725_1432_5970_2353_207 7 0.000126058 0.009076179 0.000349084 13159 hsa-mir-3193 hsa04916 Melanogenesis 5595_5594_1387_4286_2932_3265_2033 7 0.000141238 0.010169161 0.000376636 13160 hsa-mir-3193 hsa04330 Notch signaling pathway 1387_9612_3065_2033_8850 5 0.000181688 0.013081522 0.000467197 13161 hsa-mir-3193 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 0.000198965 0.014325465 0.000493982 13162 hsa-mir-3193 hsa05010 Alzheimer's disease 5595_5594_2902_2906_2932_840_351_4716 8 0.000629027 0.045289936 0.001509665 13163 hsa-mir-3193 hsa04530 Tight junction 8573_1460_10207_3265_22800_1457_207 7 0.00068849 0.049571288 0.001599074 13164 hsa-mir-3193 hsa04630 Jak-STAT signaling pathway 1387_10401_6774_4609_2033_207_8554 7 0.001369163 0.09857977 0.003080618 13165 hsa-mir-3193 hsa04370 VEGF signaling pathway 5595_5594_1432_3265_207 5 0.001490405 0.107309161 0.003251793 13166 hsa-mir-3193 hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432_3265_207 5 0.001658917 0.119442028 0.003513001 13167 hsa-mir-3193 hsa04150 mTOR signaling pathway 5595_5594_3091_207 4 0.002506474 0.180466156 0.005156176 13168 hsa-mir-3193 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906_1432_7157 4 0.00322434 0.232152502 0.006448681 13169 hsa-mir-3193 hsa04910 Insulin signaling pathway 5595_5594_2932_3265_5211_207 6 0.003570964 0.257109385 0.006948902 13170 hsa-mir-3193 hsa04120 Ubiquitin mediated proteolysis 7329_11059_4193_10401_5371_8554 6 0.003694145 0.265978466 0.006999433 13171 hsa-mir-3193 hsa04062 Chemokine signaling pathway 5595_5594_2932_6774_3265_5970_207 7 0.004443337 0.319920254 0.008203083 13172 hsa-mir-3193 hsa04920 Adipocytokine signaling pathway 6256_6774_5970_207 4 0.005891848 0.424213036 0.010454527 13173 hsa-mir-3193 hsa04912 GnRH signaling pathway 5595_5594_3725_1432_3265 5 0.005953273 0.428635624 0.010454527 13174 hsa-mir-3193 hsa04510 Focal adhesion 5595_5594_3725_2932_3265_1729_207 7 0.00622582 0.448259053 0.010672835 13175 hsa-mir-3193 hsa03420 Nucleotide excision repair 2967_2968_5887 3 0.012014559 0.86504823 0.020117401 13176 hsa-mir-3193 hsa04360 Axon guidance 5595_5998_5594_2932_3265 5 0.012670266 0.912259138 0.020733162 13177 hsa-mir-3193 hsa04612 Antigen processing and presentation 3326_4800_4801_3312 4 0.014905486 1 0.023330326 13178 hsa-mir-3193 hsa04210 Apoptosis 840_5970_7157_207 4 0.014905486 1 0.023330326 13179 hsa-mir-3193 hsa04540 Gap junction 5595_5594_3265_10382 4 0.017145956 1 0.026266145 13180 hsa-mir-3193 hsa04950 Maturity onset diabetes of the young 3172_5080 2 0.028325172 1 0.042487759 13181 hsa-mir-3193 hsa04115 p53 signaling pathway 1017_4193_7157 3 0.036783871 1 0.05404977 13182 hsa-mir-3193 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1432_5970 3 0.039403013 1 0.055627782 13183 hsa-mir-3193 hsa04730 Long-term depression 5595_5594_3265 3 0.039403013 1 0.055627782 13184 hsa-mir-3195 hsa05200 Pathways in cancer 3716_1147_3320_4149_405_4292_3480_2064_1956_5595_5594_5599_6654_6258_1387_6257_6256_8031_3326_10401_5604_1019_208_367_1017_2932_4193_3265_5914_7704_5578_5970_8503_5371_2885_7157_595_2113_5894_3725_1029_6774_6502_4087_4088_4089_5295_3065_6776_1050_5925_2033_207_2308_8554_4790_4792 57 6.04E-45 4.77E-43 4.77E-43 13185 hsa-mir-3195 hsa05215 Prostate cancer 1147_3320_3480_2064_1956_5595_5594_6654_1387_3326_5604_208_367_1017_2932_4193_3265_5970_8503_2885_7157_595_5894_5295_5925_2033_207_2308_4790_4792 30 1.54E-31 1.22E-29 5.37E-30 13186 hsa-mir-3195 hsa05212 Pancreatic cancer 1147_3320_3480_2064_1956_5595_5594_6654_1387_3326_5604_208_367_1017_2932_4193_3265_5970_8503_2885_7157_595_5894_5295_5925_2033_207_2308_4790_4792 30 2.04E-31 1.61E-29 5.37E-30 13187 hsa-mir-3195 hsa05220 Chronic myeloid leukemia 1147_5595_5594_6654_5604_1019_208_4193_3265_5970_8503_2885_7157_595_5894_1029_4088_4089_5295_3065_6776_5925_207_4790_4792_6464 26 1.23E-27 9.75E-26 2.44E-26 13188 hsa-mir-3195 hsa05223 Non-small cell lung cancer 2064_1956_5595_5594_6654_6258_6257_6256_5604_2309_1019_208_3265_5578_8503_2885_7157_595_5894_1029_5295_5925_207 23 2.98E-26 2.35E-24 4.70E-25 13189 hsa-mir-3195 hsa05214 Glioma 3480_1956_5595_5594_6654_5604_1019_208_4193_3265_5578_8503_2885_7157_595_5894_1029_5295_5925_207_6464_808_801_805 24 3.88E-26 3.06E-24 5.11E-25 13190 hsa-mir-3195 hsa04110 Cell cycle 994_990_1387_983_1019_1017_7533_2932_4193_8454_902_6500_7157_10912_595_1022_1029_1028_6502_4087_4088_4089_3065_4616_5925_2033_5933 27 1.74E-24 1.38E-22 1.97E-23 13191 hsa-mir-3195 hsa04010 MAPK signaling pathway 1147_6722_627_4149_994_1956_5595_3727_5594_5599_6654_5598_5604_6195_5566_208_4214_3265_1386_1432_5578_5970_4342_2885_7157_10912_22800_5894_3725_5058_4616_6197_2872_207_4790 35 5.54E-24 4.37E-22 5.47E-23 13192 hsa-mir-3195 hsa05221 Acute myeloid leukemia 1147_5595_5594_6654_5604_208_3265_5914_7704_5970_8503_5371_2885_595_5894_6774_5295_6776_1050_207_4790 21 9.51E-23 7.51E-21 8.35E-22 13193 hsa-mir-3195 hsa04012 ErbB signaling pathway 2064_1956_5595_6714_5594_5599_6654_56924_5604_208_2932_3265_5578_8503_2885_5894_3725_5295_5058_6776_207_6464 22 4.73E-21 3.74E-19 3.74E-20 13194 hsa-mir-3195 hsa04910 Insulin signaling pathway 6720_10891_5595_5590_5594_5599_6654_5604_5566_7249_208_2932_3265_5770_8503_2885_5894_5295_2872_207_2308_6464_808_801_805 25 1.14E-20 9.00E-19 8.18E-20 13195 hsa-mir-3195 hsa04660 T cell receptor signaling pathway 1147_3932_5595_5594_6654_56924_5604_1019_208_2932_3265_5777_1432_5970_8503_2885_5894_3725_5295_5058_207_4790_4792 23 2.44E-20 1.93E-18 1.61E-19 13196 hsa-mir-3195 hsa05210 Colorectal cancer 4292_3480_1956_5595_5594_5599_6654_5604_208_2932_8503_2885_7157_595_5894_3725_4087_4088_4089_5295_207 21 4.61E-20 3.64E-18 2.80E-19 13197 hsa-mir-3195 hsa05213 Endometrial cancer 4292_2064_1956_5595_5594_6654_5604_2309_208_2932_3265_8503_2885_7157_595_5894_5295_207 18 1.69E-19 1.33E-17 9.51E-19 13198 hsa-mir-3195 hsa05222 Small cell lung cancer 1147_4149_6258_6257_6256_10401_1019_208_1017_5970_8503_7157_595_6502_5295_5925_207_8554_4790_4792 20 1.23E-18 9.73E-17 6.49E-18 13199 hsa-mir-3195 hsa04062 Chemokine signaling pathway 1147_9564_5595_5590_5594_2770_6654_5604_2309_5566_208_2932_3265_6773_5970_8503_2885_5894_6774_5295_5058_7074_207_4790_4792_6464 26 1.41E-18 1.11E-16 6.94E-18 13200 hsa-mir-3195 hsa05211 Renal cell carcinoma 405_5595_5594_6654_56924_1387_5604_208_3265_8503_2885_2113_5894_3725_5295_5058_2033_207 18 2.22E-17 1.76E-15 1.03E-16 13201 hsa-mir-3195 hsa04662 B cell receptor signaling pathway 1147_5595_5594_6654_5604_208_2932_3265_5777_5970_8503_2885_5894_3725_5295_207_4790_4792 18 4.14E-17 3.27E-15 1.82E-16 13202 hsa-mir-3195 hsa04510 Focal adhesion 9564_3480_2064_1956_5595_6714_5594_5599_6654_56924_5604_208_2932_3265_5578_8503_857_2885_595_5894_3725_5295_5058_207_6464 25 6.11E-17 4.82E-15 2.54E-16 13203 hsa-mir-3195 hsa04540 Gap junction 1956_5595_6714_5594_2770_6654_5598_983_5604_5566_7277_3265_5578_7278_2885_5894_7846_51807_10376 19 7.38E-17 5.83E-15 2.91E-16 13204 hsa-mir-3195 hsa05218 Melanoma 3480_1956_5595_5594_5604_1019_208_4193_3265_8503_7157_595_5894_1029_5295_5925_207 17 3.24E-16 2.56E-14 1.22E-15 13205 hsa-mir-3195 hsa04912 GnRH signaling pathway 1956_5595_6714_5594_5599_6654_5598_5604_5566_4214_3265_1432_5578_2885_5894_3725_808_801_805 19 8.38E-16 6.62E-14 3.01E-15 13206 hsa-mir-3195 hsa04720 Long-term potentiation 5595_5594_1387_2902_5604_6195_5566_3265_5578_2906_5894_6197_2033_808_801_805 16 1.17E-14 9.24E-13 4.02E-14 13207 hsa-mir-3195 hsa04520 Adherens junction 1460_3480_2064_1956_5595_6714_5594_1387_5770_5777_1457_1459_4087_4088_4089_2033 16 2.82E-14 2.23E-12 9.28E-14 13208 hsa-mir-3195 hsa05219 Bladder cancer 2064_1956_5595_5594_5604_1019_4193_3265_7157_595_5894_1029_5925 13 6.38E-14 5.04E-12 2.01E-13 13209 hsa-mir-3195 hsa04350 TGF-beta signaling pathway 3400_5595_5594_1387_8454_3397_3399_3398_6500_4087_4088_4089_2033_4092_6667_5933 16 8.88E-14 7.01E-12 2.70E-13 13210 hsa-mir-3195 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_6654_5604_208_3265_1432_5578_8503_2885_5894_5295_207 14 5.00E-12 3.95E-10 1.46E-11 13211 hsa-mir-3195 hsa04310 Wnt signaling pathway 1460_5599_1387_5566_2932_8454_5578_6500_7157_595_3725_1457_1459_4087_4088_4089_2033 17 2.04E-11 1.61E-09 5.75E-11 13212 hsa-mir-3195 hsa05216 Thyroid cancer 5595_5594_6258_6257_6256_8031_5604_3265_7157_595 10 2.15E-11 1.70E-09 5.87E-11 13213 hsa-mir-3195 hsa04630 Jak-STAT signaling pathway 3716_3566_6654_1387_10401_208_5777_6773_8503_2885_595_6774_5295_6776_2033_207_8554 17 2.70E-11 2.13E-09 7.11E-11 13214 hsa-mir-3195 hsa04620 Toll-like receptor signaling pathway 1147_5595_5594_5599_5604_208_1432_5970_8503_3725_5295_207_4790_4792 14 1.07E-10 8.44E-09 2.72E-10 13215 hsa-mir-3195 hsa04916 Melanogenesis 5595_5594_2770_1387_5604_5566_2932_3265_5578_5894_2033_808_801_805 14 1.35E-10 1.06E-08 3.33E-10 13216 hsa-mir-3195 hsa04920 Adipocytokine signaling pathway 1147_10891_5599_6258_6257_6256_208_5970_6774_207_4790_4792 12 1.52E-10 1.20E-08 3.63E-10 13217 hsa-mir-3195 hsa04370 VEGF signaling pathway 5595_6714_5594_5604_208_3265_1432_5578_8503_5894_5295_207 12 6.33E-10 5.00E-08 1.47E-09 13218 hsa-mir-3195 hsa04115 p53 signaling pathway 983_7249_1019_1017_4193_7157_10912_595_7161_1029_4616 11 2.67E-09 2.11E-07 6.02E-09 13219 hsa-mir-3195 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6654_5604_3265_5777_5578_8503_2885_5894_5295_5058_6464 14 3.91E-09 3.09E-07 8.59E-09 13220 hsa-mir-3195 hsa04530 Tight junction 1460_6714_5590_2770_1019_208_3265_5578_22800_8573_1457_1459_207 13 2.94E-08 2.32E-06 6.28E-08 13221 hsa-mir-3195 hsa04120 Ubiquitin mediated proteolysis 997_672_10401_4214_4193_8454_55294_6500_5371_10273_6502_7329_8554 13 3.45E-08 2.72E-06 7.16E-08 13222 hsa-mir-3195 hsa04150 mTOR signaling pathway 5595_5594_6195_7249_208_8503_5295_6197_207 9 4.03E-08 3.19E-06 8.10E-08 13223 hsa-mir-3195 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_1956_6714_5599_1432_5970_3725_5058_4790_4792 10 4.10E-08 3.24E-06 8.10E-08 13224 hsa-mir-3195 hsa04810 Regulation of actin cytoskeleton 9564_1956_5595_5594_6654_56924_5604_3265_8503_4342_22800_5894_5295_5058_7074 15 1.44E-07 1.14E-05 2.77E-07 13225 hsa-mir-3195 hsa04210 Apoptosis 1147_5566_208_5970_8503_7157_5295_207_4790_4792 10 2.82E-07 2.23E-05 5.30E-07 13226 hsa-mir-3195 hsa03022 Basal transcription factors 2962_6881_2969_2959_2965_6908_9519 7 7.88E-07 6.22E-05 1.45E-06 13227 hsa-mir-3195 hsa04730 Long-term depression 3480_5595_5594_2770_5604_3265_5578_5894 8 4.36E-06 0.000344047 7.82E-06 13228 hsa-mir-3195 hsa05131 Shigellosis 4691_7277_5578_7278_7846_51807_10376 7 9.39E-06 0.000741475 1.61E-05 13229 hsa-mir-3195 hsa05130 Pathogenic Escherichia coli infection 4691_7277_5578_7278_7846_51807_10376 7 9.39E-06 0.000741475 1.61E-05 13230 hsa-mir-3195 hsa04270 Vascular smooth muscle contraction 5595_5594_5604_5566_5578_5894_808_801_805 9 2.08E-05 0.001646596 3.50E-05 13231 hsa-mir-3195 hsa04930 Type II diabetes mellitus 5595_5590_5594_5599_8503_5295 6 2.97E-05 0.00234571 4.89E-05 13232 hsa-mir-3195 hsa04330 Notch signaling pathway 1387_9612_3065_2033_2648_8850 6 3.71E-05 0.00293154 5.98E-05 13233 hsa-mir-3195 hsa05016 Huntington's disease 627_10891_1387_2902_7157_3065_2033_6908_6667_9519 10 0.000131229 0.010367074 0.000207341 13234 hsa-mir-3195 hsa04360 Axon guidance 5595_5998_5594_2770_56924_2932_3265_5058 8 0.000255034 0.020147702 0.000395053 13235 hsa-mir-3195 hsa05010 Alzheimer's disease 5595_5594_2902_2932_2906_808_351_801_805 9 0.000387176 0.030586938 0.00058821 13236 hsa-mir-3195 hsa04070 Phosphatidylinositol signaling system 5578_8503_5295_808_801_805 6 0.000425094 0.033582414 0.00063363 13237 hsa-mir-3195 hsa04020 Calcium signaling pathway 2064_1956_2902_5566_5578_2906_808_801_805 9 0.000506244 0.039993314 0.000740617 13238 hsa-mir-3195 hsa03420 Nucleotide excision repair 902_4331_1022_2965 4 0.00245843 0.19421598 0.0035312 13239 hsa-mir-3195 hsa04670 Leukocyte transendothelial migration 9564_2770_1432_5578_8503_5295 6 0.004196869 0.331552618 0.005920582 13240 hsa-mir-3195 hsa04612 Antigen processing and presentation 3320_3326_4801_4802_6890 5 0.005170869 0.408498687 0.007166644 13241 hsa-mir-3195 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_1432_2906_7157 4 0.005517481 0.435881029 0.00751519 13242 hsa-mir-3195 hsa03320 PPAR signaling pathway 6258_6257_6256_2168 4 0.011454832 0.904931763 0.015337826 13243 hsa-mir-3195 hsa03050 Proteasome 5705_5710_5698 3 0.022319398 1 0.029387207 13244 hsa-mir-3195 hsa04950 Maturity onset diabetes of the young 168620_3172 2 0.037411893 1 0.048451468 13245 hsa-mir-3197 hsa05200 Pathways in cancer 5371_2249_6258_1387_6256_836_367_5914_842_841_6776_6777_5970_4824_4089_3725_2353_4087_5925_2033 20 4.26E-17 2.64E-15 2.64E-15 13246 hsa-mir-3197 hsa05215 Prostate cancer 1385_1387_367_842_5970_4824_5925_2033 8 7.76E-09 4.81E-07 1.74E-07 13247 hsa-mir-3197 hsa05212 Pancreatic cancer 1385_1387_367_842_5970_4824_5925_2033 8 8.42E-09 5.22E-07 1.74E-07 13248 hsa-mir-3197 hsa04010 MAPK signaling pathway 2249_5598_9261_836_1432_5970_3725_6195_2353_2002_2005 11 3.64E-08 2.26E-06 5.64E-07 13249 hsa-mir-3197 hsa04110 Cell cycle 993_5591_1387_983_4089_4087_5925_2033 8 7.03E-08 4.36E-06 8.72E-07 13250 hsa-mir-3197 hsa04520 Adherens junction 6714_1387_4089_1457_4087_2033 6 1.78E-06 0.000110219 1.70E-05 13251 hsa-mir-3197 hsa05016 Huntington's disease 6667_1385_1387_6908_836_842_841_2033 8 1.92E-06 0.00011933 1.70E-05 13252 hsa-mir-3197 hsa05210 Colorectal cancer 836_842_4089_3725_2353_4087 6 2.32E-06 0.000143968 1.80E-05 13253 hsa-mir-3197 hsa04012 ErbB signaling pathway 815_6714_6776_6777_3725_2002 6 2.81E-06 0.000174448 1.94E-05 13254 hsa-mir-3197 hsa04210 Apoptosis 836_839_842_841_840_5970 6 3.19E-06 0.000197542 1.98E-05 13255 hsa-mir-3197 hsa04310 Wnt signaling pathway 815_1387_4089_3725_1457_4087_2033 7 5.25E-06 0.000325623 2.96E-05 13256 hsa-mir-3197 hsa05221 Acute myeloid leukemia 5371_5914_6776_6777_5970 5 7.68E-06 0.00047635 3.97E-05 13257 hsa-mir-3197 hsa04912 GnRH signaling pathway 815_6714_5598_1432_3725_2002 6 9.16E-06 0.000567889 4.37E-05 13258 hsa-mir-3197 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_836_1432_5970_3725 5 1.79E-05 0.001108551 7.92E-05 13259 hsa-mir-3197 hsa05220 Chronic myeloid leukemia 6776_6777_5970_4089_5925 5 2.30E-05 0.001423203 9.49E-05 13260 hsa-mir-3197 hsa05222 Small cell lung cancer 6258_6256_842_5970_5925 5 4.28E-05 0.002653188 0.000164486 13261 hsa-mir-3197 hsa04350 TGF-beta signaling pathway 6667_1387_4089_4087_2033 5 4.51E-05 0.002796259 0.000164486 13262 hsa-mir-3197 hsa04330 Notch signaling pathway 1387_9612_2033_8850 4 6.46E-05 0.004002308 0.00022235 13263 hsa-mir-3197 hsa04620 Toll-like receptor signaling pathway 1432_841_5970_3725_2353 5 9.27E-05 0.005747877 0.00030252 13264 hsa-mir-3197 hsa05223 Non-small cell lung cancer 6258_6256_842_5925 4 0.000107128 0.006641945 0.000332097 13265 hsa-mir-3197 hsa05010 Alzheimer's disease 22926_1020_836_842_841_840 6 0.000130199 0.008072341 0.000384397 13266 hsa-mir-3197 hsa04115 p53 signaling pathway 983_836_842_841 4 0.000261754 0.016228744 0.00073767 13267 hsa-mir-3197 hsa04720 Long-term potentiation 815_1387_6195_2033 4 0.000354365 0.021970615 0.000955244 13268 hsa-mir-3197 hsa04370 VEGF signaling pathway 6714_9261_1432_842 4 0.000389855 0.024171035 0.001007126 13269 hsa-mir-3197 hsa04630 Jak-STAT signaling pathway 1387_6776_6777_2033_3977 5 0.000599072 0.037142441 0.001485698 13270 hsa-mir-3197 hsa03022 Basal transcription factors 2962_2969_6908 3 0.000644903 0.039983992 0.001537846 13271 hsa-mir-3197 hsa04916 Melanogenesis 815_1385_1387_2033 4 0.001150635 0.07133934 0.002642198 13272 hsa-mir-3197 hsa04660 T cell receptor signaling pathway 1432_5970_3725_2353 4 0.001405198 0.087122305 0.003111511 13273 hsa-mir-3197 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432_842 3 0.002001903 0.124118001 0.004206506 13274 hsa-mir-3197 hsa03450 Non-homologous end-joining 5591_2547 2 0.002035406 0.126195182 0.004206506 13275 hsa-mir-3197 hsa04920 Adipocytokine signaling pathway 6258_6256_5970 3 0.003259417 0.202083849 0.006518834 13276 hsa-mir-3197 hsa05211 Renal cell carcinoma 1387_3725_2033 3 0.003959785 0.245506687 0.007672084 13277 hsa-mir-3197 hsa04662 B cell receptor signaling pathway 5970_3725_2353 3 0.004420597 0.274077036 0.008305365 13278 hsa-mir-3197 hsa04950 Maturity onset diabetes of the young 6927_5080 2 0.005362843 0.332496258 0.009779302 13279 hsa-mir-3197 hsa04612 Antigen processing and presentation 1514_1385_4800 3 0.006992629 0.433543 0.012386943 13280 hsa-mir-3197 hsa05216 Thyroid cancer 6258_6256 2 0.007568335 0.469236787 0.013034355 13281 hsa-mir-3197 hsa04540 Gap junction 6714_5598_983 3 0.007859797 0.487307436 0.013170471 13282 hsa-mir-3197 hsa03410 Base excision repair 3146_142 2 0.01122456 0.695922729 0.018313756 13283 hsa-mir-3197 hsa05213 Endometrial cancer 842_2002 2 0.021871528 1 0.034770122 13284 hsa-mir-3197 hsa05214 Glioma 815_5925 2 0.032620238 1 0.050561369 13285 hsa-mir-3197 hsa03320 PPAR signaling pathway 6258_6256 2 0.037202918 1 0.056258071 13286 hsa-mir-3197 hsa05218 Melanoma 2249_5925 2 0.038147518 1 0.056313003 13287 hsa-mir-3199-2 hsa05220 Chronic myeloid leukemia 3066_1870_1871_7157_4193_4609_1029 7 9.11E-11 3.10E-09 3.10E-09 13288 hsa-mir-3199-2 hsa05219 Bladder cancer 1870_1871_7157_4193_4609_1029 6 2.05E-10 6.96E-09 3.48E-09 13289 hsa-mir-3199-2 hsa04110 Cell cycle 3066_1870_1871_7157_2033_4193_1029 7 1.91E-09 6.50E-08 2.17E-08 13290 hsa-mir-3199-2 hsa05215 Prostate cancer 1870_1871_7157_2033_4193_1385 6 1.28E-08 4.36E-07 9.29E-08 13291 hsa-mir-3199-2 hsa05212 Pancreatic cancer 1870_1871_7157_2033_4193_1385 6 1.37E-08 4.64E-07 9.29E-08 13292 hsa-mir-3199-2 hsa05200 Pathways in cancer 3066_1870_1871_7157_2033_4193_4609_1029 8 1.03E-07 3.51E-06 5.84E-07 13293 hsa-mir-3199-2 hsa05214 Glioma 1870_1871_7157_4193_1029 5 1.28E-07 4.36E-06 6.23E-07 13294 hsa-mir-3199-2 hsa05218 Melanoma 1870_1871_7157_4193_1029 5 1.94E-07 6.60E-06 8.25E-07 13295 hsa-mir-3199-2 hsa05223 Non-small cell lung cancer 1870_1871_7157_1029 4 2.92E-06 9.92E-05 1.10E-05 13296 hsa-mir-3199-2 hsa05222 Small cell lung cancer 1870_1871_7157_4609 4 1.69E-05 0.00057387 5.74E-05 13297 hsa-mir-3199-2 hsa05016 Huntington's disease 3066_7157_6667_2033_1385 5 1.92E-05 0.000651902 5.93E-05 13298 hsa-mir-3199-2 hsa04330 Notch signaling pathway 3066_2033_4851 3 8.53E-05 0.00290067 0.000241723 13299 hsa-mir-3199-2 hsa04115 p53 signaling pathway 7157_4193_1029 3 0.000252862 0.008597294 0.00066133 13300 hsa-mir-3199-2 hsa04350 TGF-beta signaling pathway 6667_2033_4609 3 0.000487503 0.016575105 0.001183936 13301 hsa-mir-3199-2 hsa05216 Thyroid cancer 7157_4609 2 0.001272366 0.043260437 0.002884029 13302 hsa-mir-3199-2 hsa04310 Wnt signaling pathway 7157_2033_4609 3 0.002337693 0.079481546 0.004967597 13303 hsa-mir-3199-2 hsa05213 Endometrial cancer 7157_4609 2 0.003819289 0.129855826 0.007638578 13304 hsa-mir-3199-2 hsa05210 Colorectal cancer 7157_4609 2 0.009423862 0.320411315 0.017800629 13305 hsa-mir-3199-2 hsa04010 MAPK signaling pathway 7157_4609_1386 3 0.011534455 0.392171469 0.020640604 13306 hsa-mir-3199-2 hsa04916 Melanogenesis 2033_1385 2 0.014042972 0.477461057 0.023873053 13307 hsa-mir-3199-2 hsa04120 Ubiquitin mediated proteolysis 4193_672 2 0.023988622 0.815613138 0.038838721 13308 hsa-mir-3199-2 hsa04630 Jak-STAT signaling pathway 2033_4609 2 0.029258422 0.994786334 0.045217561 13309 hsa-mir-32 hsa05200 Pathways in cancer 25_5371_5595_5599_861_1387_5601_5602_367_6934_6774_6772_3091_5970_6688_2113_2353_4087_4088_4089_5925_2033_8554 23 5.67E-20 3.57E-18 3.57E-18 13310 hsa-mir-32 hsa04310 Wnt signaling pathway 5599_1387_5601_5602_6934_8061_4773_1457_4087_4088_4089_2033 12 1.51E-11 9.53E-10 4.76E-10 13311 hsa-mir-32 hsa05210 Colorectal cancer 5595_5599_5601_5602_6934_2353_4087_4088_4089 9 4.72E-10 2.97E-08 8.30E-09 13312 hsa-mir-32 hsa05215 Prostate cancer 5595_1387_367_6934_5970_468_9586_5925_2033 9 6.91E-10 4.35E-08 8.30E-09 13313 hsa-mir-32 hsa05212 Pancreatic cancer 5595_1387_367_6934_5970_468_9586_5925_2033 9 7.58E-10 4.77E-08 8.30E-09 13314 hsa-mir-32 hsa04010 MAPK signaling pathway 5595_5599_1386_5601_5600_5602_1649_5970_468_4773_3727_2353_8550 13 7.90E-10 4.98E-08 8.30E-09 13315 hsa-mir-32 hsa04520 Adherens junction 5595_1387_6934_1457_4087_4088_4089_2033 8 7.44E-09 4.69E-07 6.44E-08 13316 hsa-mir-32 hsa04110 Cell cycle 25_5591_1387_7533_4087_4088_4089_5925_2033 9 8.17E-09 5.15E-07 6.44E-08 13317 hsa-mir-32 hsa05221 Acute myeloid leukemia 5371_5595_861_6934_6774_5970_6688 7 2.25E-08 1.42E-06 1.58E-07 13318 hsa-mir-32 hsa04620 Toll-like receptor signaling pathway 5595_5599_5601_5600_5602_6772_5970_2353 8 4.36E-08 2.74E-06 2.74E-07 13319 hsa-mir-32 hsa05220 Chronic myeloid leukemia 25_5595_861_5970_4088_4089_5925 7 1.03E-07 6.51E-06 5.92E-07 13320 hsa-mir-32 hsa04350 TGF-beta signaling pathway 5595_1387_6667_4087_4088_4089_2033 7 2.66E-07 1.68E-05 1.40E-06 13321 hsa-mir-32 hsa04120 Ubiquitin mediated proteolysis 5371_83737_672_55294_7329_64326_8554 7 5.17E-06 0.000325771 2.51E-05 13322 hsa-mir-32 hsa04912 GnRH signaling pathway 5595_5599_5601_5600_5602_468 6 1.47E-05 0.000925442 6.61E-05 13323 hsa-mir-32 hsa04660 T cell receptor signaling pathway 5595_5601_5600_5970_4773_2353 6 1.62E-05 0.001021968 6.81E-05 13324 hsa-mir-32 hsa04920 Adipocytokine signaling pathway 5599_5601_5602_6774_5970 5 2.05E-05 0.001289475 8.06E-05 13325 hsa-mir-32 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5601_5600_5602_5970 5 2.66E-05 0.001677883 9.87E-05 13326 hsa-mir-32 hsa05211 Renal cell carcinoma 5595_1387_3091_2113_2033 5 2.84E-05 0.00178784 9.93E-05 13327 hsa-mir-32 hsa03022 Basal transcription factors 2963_6872_6908_2959 4 3.74E-05 0.002353873 0.000123888 13328 hsa-mir-32 hsa04664 Fc epsilon RI signaling pathway 5595_5599_5601_5600_5602 5 4.32E-05 0.002722828 0.000136141 13329 hsa-mir-32 hsa04012 ErbB signaling pathway 25_5595_5599_5601_5602 5 6.69E-05 0.004212125 0.000200577 13330 hsa-mir-32 hsa04930 Type II diabetes mellitus 5595_5599_5601_5602 4 7.60E-05 0.00478701 0.000217591 13331 hsa-mir-32 hsa04630 Jak-STAT signaling pathway 1387_6774_6775_6772_2033_8554 6 0.000101729 0.006408924 0.000278649 13332 hsa-mir-32 hsa04720 Long-term potentiation 5595_1387_468_2033 4 0.000484586 0.030528939 0.001221158 13333 hsa-mir-32 hsa04662 B cell receptor signaling pathway 5595_5970_4773_2353 4 0.000484586 0.030528939 0.001221158 13334 hsa-mir-32 hsa04916 Melanogenesis 5595_1387_6934_2033 4 0.001560531 0.098313457 0.003670227 13335 hsa-mir-32 hsa04330 Notch signaling pathway 1387_9612_2033 3 0.001572955 0.099096136 0.003670227 13336 hsa-mir-32 hsa05016 Huntington's disease 1387_6908_6667_9586_2033 5 0.001993192 0.125571093 0.004484682 13337 hsa-mir-32 hsa04910 Insulin signaling pathway 5595_5599_5601_5602 4 0.004195838 0.264337777 0.009115096 13338 hsa-mir-32 hsa04370 VEGF signaling pathway 5595_5600_4773 3 0.005967926 0.375979321 0.012532644 13339 hsa-mir-32 hsa05222 Small cell lung cancer 5970_5925_8554 3 0.008006984 0.504439998 0.016272258 13340 hsa-mir-32 hsa05216 Thyroid cancer 5595_6934 2 0.008873156 0.559008797 0.017469025 13341 hsa-mir-32 hsa04062 Chemokine signaling pathway 5595_6774_6772_5970 4 0.012985729 0.818100953 0.024790938 13342 hsa-mir-32 hsa04510 Focal adhesion 5595_5599_5601_5602 4 0.016059325 1 0.029756984 13343 hsa-mir-32 hsa05219 Bladder cancer 5595_5925 2 0.017366711 1 0.03126008 13344 hsa-mir-32 hsa04360 Axon guidance 25_5595_4773 3 0.023840797 1 0.041721395 13345 hsa-mir-32 hsa05213 Endometrial cancer 5595_6934 2 0.025503437 1 0.042282014 13346 hsa-mir-32 hsa04150 mTOR signaling pathway 5595_3091 2 0.025503437 1 0.042282014 13347 hsa-mir-32 hsa05223 Non-small cell lung cancer 5595_5925 2 0.027284253 1 0.044074563 13348 hsa-mir-32 hsa05214 Glioma 5595_5925 2 0.037922065 1 0.059727252 13349 hsa-mir-32 hsa05218 Melanoma 5595_5925 2 0.04428624 1 0.068049589 13350 hsa-mir-3202-1 hsa05200 Pathways in cancer 4149_7046_1499_5970_5914_595_2261_8517_4193_7704_3551_6502_3091_7175_3066_3065_1050_5925_5747_1956_1487_1488_1870_1871_2885_2113_5894_861_10401_207_208_4286_3716_1147_4233_1017_5595_5594_5599_1387_2064_6256_836_367_2932_6774_6776_6777_6772_5979_5879_7157_6688_1869_3725_4088_4089_9063_2034_2033_4846_4790_4791_4792_9915_3320_3326_5371_3480_5159_5156_5604_5601_3815_3265_4292_7428_4087_8772_4609_1026_1029_2353_1441_8554 85 1.17E-55 9.72E-54 9.72E-54 13351 hsa-mir-3202-1 hsa05220 Chronic myeloid leukemia 7046_5970_595_8517_4193_3551_3066_3065_5925_1487_1488_1870_1871_2885_5894_861_207_208_1147_5595_5594_6776_6777_7157_1869_4088_4089_4790_4792_5604_3265_5781_4609_1026_1029_6464 36 7.78E-32 6.46E-30 3.23E-30 13352 hsa-mir-3202-1 hsa04010 MAPK signaling pathway 3925_6722_4149_7046_5970_2261_2264_8517_3551_1845_22800_1956_3303_1432_2885_5894_3305_4763_207_208_1147_5595_5594_5599_5598_1386_836_9252_3310_3312_5971_5879_7157_3725_9344_5058_4790_4791_51701_1616_5159_1326_5156_5604_4208_5601_5600_5566_3265_6885_4609_5606_2353_7132_2005 55 1.52E-31 1.26E-29 4.20E-30 13353 hsa-mir-3202-1 hsa05215 Prostate cancer 1499_5970_595_8517_4193_3551_5925_1956_1870_1871_2885_5894_207_208_1147_1017_5595_5594_1385_1387_2064_367_2932_7157_1869_2033_4790_4792_3320_3326_3480_5159_5156_5604_3265_1026 36 6.77E-30 5.62E-28 1.40E-28 13354 hsa-mir-3202-1 hsa05212 Pancreatic cancer 1499_5970_595_8517_4193_3551_5925_1956_1870_1871_2885_5894_207_208_1147_1017_5595_5594_1385_1387_2064_367_2932_7157_1869_2033_4790_4792_3320_3326_3480_5159_5156_5604_3265_1026 36 9.31E-30 7.72E-28 1.54E-28 13355 hsa-mir-3202-1 hsa04630 Jak-STAT signaling pathway 3559_595_58985_3454_3455_3459_3560_3561_1439_2885_2690_10401_207_208_3717_3716_3718_85480_1387_3575_3570_3572_6778_6774_6776_6777_6772_6773_7297_9063_2033_149233_3953_5781_4609_1441_8554_10379 38 9.48E-25 7.87E-23 1.31E-23 13356 hsa-mir-3202-1 hsa05214 Glioma 818_817_595_4193_5925_1956_1870_1871_2885_5894_207_208_5595_5594_7157_1869_808_801_805_3480_5159_5156_5604_3265_1026_1029_6464 27 6.98E-23 5.79E-21 8.28E-22 13357 hsa-mir-3202-1 hsa04110 Cell cycle 595_4193_6502_6500_4174_4172_3066_3065_990_5925_1870_1871_5934_5933_7534_5591_1017_1387_7533_7532_2932_7157_1869_4088_4089_2033_890_983_8454_4087_1026_1029 32 4.46E-22 3.70E-20 4.63E-21 13358 hsa-mir-3202-1 hsa05210 Colorectal cancer 7046_1499_595_1956_2885_5894_207_208_4233_5595_5594_5599_836_2932_5879_7157_3725_4088_4089_3480_5159_5156_5604_5601_4292_4087_4609_2353 28 1.43E-21 1.19E-19 1.32E-20 13359 hsa-mir-3202-1 hsa05221 Acute myeloid leukemia 5970_5914_595_8517_7704_3551_1050_2885_5894_861_207_208_1147_5595_5594_6774_6776_6777_6688_4790_5371_5604_3815_3265_4609 25 1.87E-21 1.55E-19 1.55E-20 13360 hsa-mir-3202-1 hsa04062 Chemokine signaling pathway 5970_1234_8517_1230_3551_653361_7074_5747_5580_7852_2885_5894_207_208_3055_3717_1147_3718_5590_5595_5594_2932_6774_6777_6772_6773_5879_5058_4790_4792_4793_5604_5566_3265_2185_6464 36 4.50E-20 3.73E-18 3.39E-19 13361 hsa-mir-3202-1 hsa04660 T cell receptor signaling pathway 5970_8517_3551_2534_3932_1432_4794_2885_5894_207_208_1147_5595_5594_2932_3725_5058_4790_4792_4793_1326_5604_5601_5600_3265_6885_2353 27 5.65E-18 4.69E-16 3.91E-17 13362 hsa-mir-3202-1 hsa04620 Toll-like receptor signaling pathway 5970_8517_3551_3454_3455_1432_207_208_1147_3654_5595_5594_5599_6772_5879_3725_4790_4792_1326_5604_5601_5600_8772_6885_5606_2353 26 1.06E-17 8.78E-16 6.76E-17 13363 hsa-mir-3202-1 hsa05222 Small cell lung cancer 4149_5970_595_8517_3551_6502_5925_5747_1870_1871_10401_207_208_1147_1017_6256_7157_1869_9063_4846_4790_4792_4609_8554 24 3.34E-17 2.77E-15 1.98E-16 13364 hsa-mir-3202-1 hsa04012 ErbB signaling pathway 818_817_5747_1956_6714_2885_5894_207_208_5595_5594_5599_2064_2932_6776_6777_3725_5058_5604_5601_3265_4609_1026_6464 24 4.17E-17 3.46E-15 2.31E-16 13365 hsa-mir-3202-1 hsa05219 Bladder cancer 595_2261_4193_5925_1956_1870_1871_5894_5595_5594_2064_9252_7157_1869_5604_3265_4609_1026_1029 19 4.79E-17 3.97E-15 2.48E-16 13366 hsa-mir-3202-1 hsa05218 Melanoma 595_4193_5925_1956_1870_1871_5894_207_208_4286_4233_5595_5594_7157_1869_3480_5159_5156_5604_3265_1026_1029 22 1.11E-16 9.18E-15 5.40E-16 13367 hsa-mir-3202-1 hsa04350 TGF-beta signaling pathway 7046_6500_90_57154_6667_3397_3399_3398_1874_1875_5934_5933_5595_5594_1387_4086_4088_4089_2033_8454_4087_4609_4093 23 4.14E-16 3.44E-14 1.91E-15 13368 hsa-mir-3202-1 hsa04920 Adipocytokine signaling pathway 5970_8517_3551_2538_7133_4794_207_208_3717_1147_8717_5599_6256_6774_4790_4792_4793_5601_3953_5781_7132 21 4.54E-16 3.76E-14 1.98E-15 13369 hsa-mir-3202-1 hsa04310 Wnt signaling pathway 818_817_1499_595_6500_23291_1487_1488_8945_8607_5599_1387_2932_5879_7157_3725_1457_1459_4088_4089_2033_51701_5601_5566_8454_4087_6885_4609 28 8.74E-16 7.26E-14 3.57E-15 13370 hsa-mir-3202-1 hsa04520 Adherens junction 7046_1499_2534_1956_6714_71_2241_4233_5595_5594_1387_2064_5879_1457_1459_4088_4089_2033_51701_3480_4087_6885 22 9.04E-16 7.50E-14 3.57E-15 13371 hsa-mir-3202-1 hsa04662 B cell receptor signaling pathway 5970_8517_3551_6850_4794_2885_5894_207_208_1147_5595_5594_2932_5879_3725_4790_4792_4793_5604_3265_2353 21 3.01E-15 2.50E-13 1.14E-14 13372 hsa-mir-3202-1 hsa04540 Gap junction 10382_51807_203068_1956_6714_2885_5894_5595_5594_5598_7846_347733_5159_983_5156_5604_5566_3265_7277_7278_84617_10376 22 1.29E-14 1.07E-12 4.67E-14 13373 hsa-mir-3202-1 hsa05211 Renal cell carcinoma 3091_2885_2113_5894_207_208_4233_5595_5594_1387_5879_3725_5058_2034_2033_9915_5604_3265_7428_5781 20 1.57E-14 1.30E-12 5.42E-14 13374 hsa-mir-3202-1 hsa04510 Focal adhesion 1499_595_2534_5747_3791_1956_6714_2885_5894_10627_207_208_71_4233_5595_5594_5599_2064_2932_5879_3725_5058_2321_3480_5159_5156_5604_5601_3265_6464 30 2.20E-14 1.83E-12 7.21E-14 13375 hsa-mir-3202-1 hsa04912 GnRH signaling pathway 818_817_5580_1956_6714_1432_2885_5894_5595_5594_5599_5598_3725_808_801_805_5604_5601_5600_5566_3265_2185_5606 23 2.26E-14 1.88E-12 7.21E-14 13376 hsa-mir-3202-1 hsa05223 Non-small cell lung cancer 595_5925_1956_1870_1871_2885_5894_207_208_5595_5594_2064_6256_7157_1869_5604_3265_1029 18 2.37E-14 1.97E-12 7.28E-14 13377 hsa-mir-3202-1 hsa04060 Cytokine-cytokine receptor interaction 3556_3559_7046_8600_1234_1230_58985_3454_3455_3459_90_3791_1956_3560_3561_7133_1439_7852_2690_85480_4233_3575_3570_3572_2321_149233_5159_5156_3815_3953_7132_1441 32 2.38E-13 1.97E-11 7.05E-13 13378 hsa-mir-3202-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_8517_3551_1956_6714_1432_1147_4233_5599_836_5879_3725_5058_4790_4792_5601_5600_5781 18 1.21E-12 1.01E-10 3.48E-12 13379 hsa-mir-3202-1 hsa05213 Endometrial cancer 1499_595_1956_2885_5894_207_208_5595_5594_2064_2932_7157_5604_3265_4292_4609 16 1.82E-12 1.51E-10 5.04E-12 13380 hsa-mir-3202-1 hsa04210 Apoptosis 3556_5970_8517_3551_8837_1439_207_208_1147_3654_8717_836_7157_4790_4792_5566_8772_7132 18 3.19E-11 2.65E-09 8.53E-11 13381 hsa-mir-3202-1 hsa04664 Fc epsilon RI signaling pathway 2534_5580_6850_1432_2885_5894_207_208_5595_5594_5599_5879_5604_5601_5600_3265_5606 17 4.82E-11 4.00E-09 1.25E-10 13382 hsa-mir-3202-1 hsa04910 Insulin signaling pathway 6720_3551_2538_2885_5894_207_208_5590_5595_5594_5599_23265_2932_808_801_805_5604_5601_5566_3265_6464 21 8.53E-11 7.08E-09 2.15E-10 13383 hsa-mir-3202-1 hsa04916 Melanogenesis 818_817_1499_5894_4286_5595_5594_1385_1387_2932_2033_808_801_805_5604_5566_3815_3265 18 3.01E-10 2.49E-08 7.34E-10 13384 hsa-mir-3202-1 hsa05131 Shigellosis 1499_10382_51807_2534_203068_71_7534_7846_347733_7277_7278_84617_4691_10376 14 4.56E-10 3.79E-08 1.05E-09 13385 hsa-mir-3202-1 hsa05130 Pathogenic Escherichia coli infection 1499_10382_51807_2534_203068_71_7534_7846_347733_7277_7278_84617_4691_10376 14 4.56E-10 3.79E-08 1.05E-09 13386 hsa-mir-3202-1 hsa05216 Thyroid cancer 1499_595_7175_5595_5594_6256_5979_7157_5604_3265_4609 11 8.89E-10 7.38E-08 1.99E-09 13387 hsa-mir-3202-1 hsa04720 Long-term potentiation 818_817_2902_5894_5595_5594_1387_2033_808_801_805_5604_5566_3265_2906 15 1.60E-09 1.33E-07 3.50E-09 13388 hsa-mir-3202-1 hsa04370 VEGF signaling pathway 5747_3791_6714_1432_5894_207_208_5595_5594_5879_4846_5604_5600_3265 14 1.63E-08 1.35E-06 3.45E-08 13389 hsa-mir-3202-1 hsa04650 Natural killer cell mediated cytotoxicity 3454_3455_3459_2534_3932_6850_2885_5894_5595_5594_836_5879_5058_5604_3265_5781_2185_6464 18 1.66E-08 1.38E-06 3.45E-08 13390 hsa-mir-3202-1 hsa04120 Ubiquitin mediated proteolysis 55294_4193_6502_6500_3093_57154_23291_8945_10401_7323_10273_9063_5371_672_8454_7428_7329_8554 18 1.84E-08 1.53E-06 3.72E-08 13391 hsa-mir-3202-1 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_7133_1432_836_5879_7157_4846_1616_5600_2906_5606_7132 12 3.55E-08 2.95E-06 7.02E-08 13392 hsa-mir-3202-1 hsa04330 Notch signaling pathway 9612_3066_3065_1487_1488_3280_1387_2033_388585_2648_4851 11 6.06E-08 5.03E-06 1.17E-07 13393 hsa-mir-3202-1 hsa04810 Regulation of actin cytoskeleton 2261_2264_10788_22800_7074_5747_1956_4627_4628_5894_10627_71_5595_5594_5879_5058_5159_5156_5604_3265 20 5.77E-07 4.79E-05 1.09E-06 13394 hsa-mir-3202-1 hsa05016 Huntington's disease 292_293_3066_3065_3064_2902_6667_1385_1387_836_5437_7157_1213_2033_6874_6908_5441_9519 18 1.13E-06 9.35E-05 2.08E-06 13395 hsa-mir-3202-1 hsa04530 Tight junction 1499_22800_5580_6714_4627_4628_10627_207_208_71_8573_5590_1457_1459_3265 15 1.93E-06 0.000160482 3.49E-06 13396 hsa-mir-3202-1 hsa04612 Antigen processing and presentation 3309_3303_3305_1385_3310_3312_3320_3326_4800_4802_2923_4801 12 2.96E-06 0.000245505 5.22E-06 13397 hsa-mir-3202-1 hsa04020 Calcium signaling pathway 818_817_292_293_147_1956_2902_2064_4846_808_801_805_5159_5156_5566_2906_2185 17 3.47E-06 0.000287693 5.99E-06 13398 hsa-mir-3202-1 hsa05010 Alzheimer's disease 22926_2902_6622_5595_5594_836_2932_4846_808_351_801_805_2906_8772_7132 15 3.28E-05 0.002722424 5.56E-05 13399 hsa-mir-3202-1 hsa04115 p53 signaling pathway 595_4193_1017_836_7157_983_1026_7161_1029 9 6.45E-05 0.005351159 0.000107023 13400 hsa-mir-3202-1 hsa03020 RNA polymerase 25885_51082_64425_5437_84172_5441 6 0.000118562 0.009840642 0.000192954 13401 hsa-mir-3202-1 hsa04930 Type II diabetes mellitus 3551_5580_5590_5595_5594_5599_5601 7 0.000157894 0.013105189 0.000252023 13402 hsa-mir-3202-1 hsa04270 Vascular smooth muscle contraction 147_5580_5894_5595_5594_4637_808_801_805_5604_5566 11 0.00016766 0.013915806 0.000262562 13403 hsa-mir-3202-1 hsa04670 Leukocyte transendothelial migration 1499_653361_5747_1432_7852_10627_71_5879_5600_5781_2185 11 0.000219359 0.018206767 0.000337162 13404 hsa-mir-3202-1 hsa03022 Basal transcription factors 2963_2962_2969_6874_6908_9519 6 0.000382318 0.031732376 0.000572922 13405 hsa-mir-3202-1 hsa04360 Axon guidance 2534_5747_7852_2242_4233_5595_5594_2932_5879_5058_3265 11 0.000386549 0.032083608 0.000572922 13406 hsa-mir-3202-1 hsa04730 Long-term depression 5894_5595_5594_4846_3480_5604_3265 7 0.001886271 0.156560464 0.002746675 13407 hsa-mir-3202-1 hsa05340 Primary immunodeficiency 8517_3932_3561_3718_3575 5 0.00195526 0.1622866 0.002798045 13408 hsa-mir-3202-1 hsa04950 Maturity onset diabetes of the young 6927_3280_4760_3172 4 0.003393776 0.281683371 0.004774294 13409 hsa-mir-3202-1 hsa04150 mTOR signaling pathway 3091_207_208_5595_5594 5 0.009108214 0.75598173 0.012599695 13410 hsa-mir-3202-1 hsa04340 Hedgehog signaling pathway 23291_8945_53944_2932_5566 5 0.012850889 1 0.017485636 13411 hsa-mir-3202-1 hsa04640 Hematopoietic cell lineage 3559_3575_3570_914_3815_1441 6 0.018669285 1 0.024992753 13412 hsa-mir-3202-1 hsa04710 Circadian rhythm - mammal 8863_8553 2 0.043786735 1 0.057687286 13413 hsa-mir-3202-2 hsa05200 Pathways in cancer 5970_595_2033_367_3725_4790_1387_6772_2353 9 1.15E-10 4.04E-09 4.04E-09 13414 hsa-mir-3202-2 hsa05215 Prostate cancer 5970_595_2033_367_4790_1387 6 1.00E-09 3.51E-08 1.25E-08 13415 hsa-mir-3202-2 hsa05212 Pancreatic cancer 5970_595_2033_367_4790_1387 6 1.07E-09 3.74E-08 1.25E-08 13416 hsa-mir-3202-2 hsa04310 Wnt signaling pathway 595_2033_894_896_3725_1387 6 2.29E-08 8.03E-07 1.80E-07 13417 hsa-mir-3202-2 hsa04630 Jak-STAT signaling pathway 595_2033_894_896_1387_6772 6 2.57E-08 8.98E-07 1.80E-07 13418 hsa-mir-3202-2 hsa04620 Toll-like receptor signaling pathway 5970_3725_4790_6772_2353 5 1.34E-07 4.68E-06 7.81E-07 13419 hsa-mir-3202-2 hsa04110 Cell cycle 595_2033_894_896_1387 5 2.80E-07 9.79E-06 1.40E-06 13420 hsa-mir-3202-2 hsa04330 Notch signaling pathway 8850_9612_2033_1387 4 3.29E-07 1.15E-05 1.44E-06 13421 hsa-mir-3202-2 hsa04662 B cell receptor signaling pathway 5970_3725_4790_2353 4 1.94E-06 6.78E-05 7.53E-06 13422 hsa-mir-3202-2 hsa04660 T cell receptor signaling pathway 5970_3725_4790_2353 4 8.36E-06 0.000292642 2.93E-05 13423 hsa-mir-3202-2 hsa05221 Acute myeloid leukemia 5970_595_4790 3 4.79E-05 0.001676122 0.000152375 13424 hsa-mir-3202-2 hsa04115 p53 signaling pathway 595_894_896 3 7.49E-05 0.00262279 0.000208132 13425 hsa-mir-3202-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_3725_4790 3 8.13E-05 0.002846362 0.000208132 13426 hsa-mir-3202-2 hsa05211 Renal cell carcinoma 2033_3725_1387 3 8.46E-05 0.002962669 0.000208132 13427 hsa-mir-3202-2 hsa04510 Focal adhesion 595_894_896_3725 4 9.14E-05 0.003198242 0.000208132 13428 hsa-mir-3202-2 hsa05220 Chronic myeloid leukemia 5970_595_4790 3 9.51E-05 0.003330113 0.000208132 13429 hsa-mir-3202-2 hsa05210 Colorectal cancer 595_3725_2353 3 0.000131646 0.004607609 0.000271036 13430 hsa-mir-3202-2 hsa05222 Small cell lung cancer 5970_595_4790 3 0.000140829 0.004929009 0.000273834 13431 hsa-mir-3202-2 hsa04010 MAPK signaling pathway 5970_3725_4790_2353 4 0.000264052 0.009241809 0.000486411 13432 hsa-mir-3202-2 hsa05016 Huntington's disease 2033_25942_1387 3 0.001310272 0.045859537 0.002292977 13433 hsa-mir-3202-2 hsa04062 Chemokine signaling pathway 5970_4790_6772 3 0.001411016 0.049385555 0.002351693 13434 hsa-mir-3202-2 hsa04920 Adipocytokine signaling pathway 5970_4790 2 0.002782761 0.097396631 0.00442712 13435 hsa-mir-3202-2 hsa04720 Long-term potentiation 2033_1387 2 0.003451156 0.120790453 0.005251759 13436 hsa-mir-3202-2 hsa04520 Adherens junction 2033_1387 2 0.003903226 0.136612927 0.005692205 13437 hsa-mir-3202-2 hsa04350 TGF-beta signaling pathway 2033_1387 2 0.004579825 0.16029388 0.006411755 13438 hsa-mir-3202-2 hsa04210 Apoptosis 5970_4790 2 0.004782406 0.167384193 0.006437854 13439 hsa-mir-3202-2 hsa04916 Melanogenesis 2033_1387 2 0.006430687 0.225074031 0.008336075 13440 hsa-mir-3202-2 hsa05216 Thyroid cancer 595 1 0.033425763 1 0.041782204 13441 hsa-mir-3202-2 hsa05219 Bladder cancer 595 1 0.047571124 1 0.057413425 13442 hsa-mir-320a hsa05200 Pathways in cancer 5371_9063_5595_5594_5599_861_5914_1387_6256_595_5601_836_367_2932_4193_7704_3091_5970_7428_1870_1871_2885_7157_2113_4609_1869_3725_5604_1029_2353_2736_4087_4088_4089_3066_3065_5925_2034_2033_4846_207 41 4.48E-38 2.95E-36 2.95E-36 13443 hsa-mir-320a hsa04010 MAPK signaling pathway 6722_5595_5594_5599_9261_4208_5601_5600_836_6195_6197_9252_3312_1386_1432_5970_9344_2885_7157_4609_3725_5604_6196_5606_2353_8986_4763_1616_207_2005 30 1.47E-26 9.68E-25 4.80E-25 13444 hsa-mir-320a hsa05220 Chronic myeloid leukemia 5595_5594_861_595_4193_5970_1870_1871_2885_7157_4609_1869_5604_1029_4088_4089_3066_3065_5925_207_6464 21 2.18E-26 1.44E-24 4.80E-25 13445 hsa-mir-320a hsa05215 Prostate cancer 5595_5594_1387_595_367_2932_4193_1385_5970_1870_1871_2885_7157_1869_5604_5925_2033_207 18 1.22E-20 8.02E-19 1.92E-19 13446 hsa-mir-320a hsa05212 Pancreatic cancer 5595_5594_1387_595_367_2932_4193_1385_5970_1870_1871_2885_7157_1869_5604_5925_2033_207 18 1.45E-20 9.59E-19 1.92E-19 13447 hsa-mir-320a hsa05210 Colorectal cancer 5595_5594_5599_595_5601_836_2932_2885_7157_4609_3725_5604_2353_4087_4088_4089_207 17 1.72E-19 1.14E-17 1.90E-18 13448 hsa-mir-320a hsa04110 Cell cycle 5591_1387_595_2932_4193_1870_1871_7157_1869_1029_4087_4088_4089_3066_3065_5925_2033_5933 18 1.48E-18 9.80E-17 1.40E-17 13449 hsa-mir-320a hsa05219 Bladder cancer 5595_5594_595_9252_4193_1870_1871_7157_4609_1869_5604_1029_5925 13 2.97E-17 1.96E-15 2.45E-16 13450 hsa-mir-320a hsa05214 Glioma 5595_5594_595_4193_1870_1871_2885_7157_1869_5604_1029_5925_207_6464 14 1.36E-16 8.98E-15 9.98E-16 13451 hsa-mir-320a hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_2885_7157_1869_5604_1029_5925_207 13 4.84E-16 3.20E-14 3.20E-15 13452 hsa-mir-320a hsa05221 Acute myeloid leukemia 5371_5595_5594_861_5914_595_7704_5970_2885_4609_5604_207 12 3.88E-14 2.56E-12 2.33E-13 13453 hsa-mir-320a hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_3397_3399_3398_4609_4087_4088_4089_2033_5933 13 1.13E-13 7.43E-12 6.19E-13 13454 hsa-mir-320a hsa05218 Melanoma 5595_5594_595_4193_1870_1871_7157_1869_5604_1029_5925_207 12 2.74E-13 1.81E-11 1.39E-12 13455 hsa-mir-320a hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2885_2113_3725_5604_2034_2033_207 12 3.18E-13 2.10E-11 1.50E-12 13456 hsa-mir-320a hsa05222 Small cell lung cancer 9063_6256_595_5970_1870_1871_7157_4609_1869_5925_4846_207 12 2.11E-12 1.39E-10 9.29E-12 13457 hsa-mir-320a hsa04310 Wnt signaling pathway 5599_1387_595_5601_2932_7157_8061_4609_3725_1457_4087_4088_4089_2033 14 5.25E-12 3.47E-10 2.17E-11 13458 hsa-mir-320a hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5601_5600_1432_5970_3725_5604_5606_2353_207 12 1.31E-11 8.65E-10 5.09E-11 13459 hsa-mir-320a hsa04660 T cell receptor signaling pathway 5595_5594_5601_5600_2932_1432_5970_2885_3725_5604_2353_207 12 2.94E-11 1.94E-09 1.08E-10 13460 hsa-mir-320a hsa04012 ErbB signaling pathway 5595_5594_5599_5601_2932_2885_4609_3725_5604_207_6464 11 4.70E-11 3.10E-09 1.63E-10 13461 hsa-mir-320a hsa05213 Endometrial cancer 5595_5594_595_2932_2885_7157_4609_5604_207 9 2.31E-10 1.52E-08 7.61E-10 13462 hsa-mir-320a hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5601_5600_1432_2885_5604_5606_207 10 3.61E-10 2.38E-08 1.13E-09 13463 hsa-mir-320a hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609_5604 7 3.21E-09 2.12E-07 9.64E-09 13464 hsa-mir-320a hsa04720 Long-term potentiation 5595_5594_1387_2902_6195_6197_5604_6196_2033 9 4.30E-09 2.84E-07 1.18E-08 13465 hsa-mir-320a hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_2885_3725_5604_2353_207 9 4.30E-09 2.84E-07 1.18E-08 13466 hsa-mir-320a hsa04912 GnRH signaling pathway 5595_5594_5599_5601_5600_1432_2885_3725_5604_5606 10 5.88E-09 3.88E-07 1.55E-08 13467 hsa-mir-320a hsa05016 Huntington's disease 6874_1387_2902_6908_836_6667_1385_7157_3066_3065_3064_2033 12 8.90E-09 5.87E-07 2.25E-08 13468 hsa-mir-320a hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_5600_836_1432_7157_5606_1616_4846 8 9.21E-09 6.08E-07 2.25E-08 13469 hsa-mir-320a hsa04910 Insulin signaling pathway 6720_5595_5594_5599_5601_2932_2885_5604_207_6464 10 5.18E-08 3.42E-06 1.22E-07 13470 hsa-mir-320a hsa04370 VEGF signaling pathway 5595_5594_9261_5600_1432_5604_4846_207 8 8.91E-08 5.88E-06 2.03E-07 13471 hsa-mir-320a hsa04150 mTOR signaling pathway 5595_5594_6195_6197_3091_6196_207 7 1.16E-07 7.64E-06 2.49E-07 13472 hsa-mir-320a hsa04520 Adherens junction 5595_5594_1387_1457_4087_4088_4089_2033 8 1.17E-07 7.73E-06 2.49E-07 13473 hsa-mir-320a hsa04510 Focal adhesion 5595_5594_5599_595_5601_2932_2885_3725_5604_207_6464 11 2.08E-07 1.37E-05 4.30E-07 13474 hsa-mir-320a hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5601_5600_836_1432_5970_3725 7 8.07E-07 5.33E-05 1.61E-06 13475 hsa-mir-320a hsa04330 Notch signaling pathway 1387_9612_3066_3065_2033_4851 6 1.27E-06 8.39E-05 2.47E-06 13476 hsa-mir-320a hsa04916 Melanogenesis 5595_5594_1387_2932_1385_5604_2033 7 8.66E-06 0.000571413 1.63E-05 13477 hsa-mir-320a hsa04930 Type II diabetes mellitus 3651_5595_5594_5599_5601 5 1.87E-05 0.001237408 3.44E-05 13478 hsa-mir-320a hsa05010 Alzheimer's disease 22926_5595_5594_2902_836_2932_6622_4846 8 3.10E-05 0.002048192 5.54E-05 13479 hsa-mir-320a hsa04062 Chemokine signaling pathway 5595_5594_2932_5970_2885_5604_207_6464 8 5.58E-05 0.003685523 9.70E-05 13480 hsa-mir-320a hsa04630 Jak-STAT signaling pathway 9063_1387_595_2885_4609_2033_207 7 9.82E-05 0.006482845 0.000166227 13481 hsa-mir-320a hsa04920 Adipocytokine signaling pathway 5599_6256_5601_5970_207 5 0.000110243 0.007276015 0.0001819 13482 hsa-mir-320a hsa04115 p53 signaling pathway 595_836_4193_7157_1029 5 0.000125595 0.008289255 0.000202177 13483 hsa-mir-320a hsa04730 Long-term depression 5592_5595_5594_5604_4846 5 0.000142533 0.009407205 0.000223981 13484 hsa-mir-320a hsa03022 Basal transcription factors 2963_6874_2969_6908 4 0.000147289 0.009721048 0.000226071 13485 hsa-mir-320a hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_2885_5604_6464 6 0.000377591 0.024921026 0.000566387 13486 hsa-mir-320a hsa04120 Ubiquitin mediated proteolysis 5371_9063_672_4193_7428_7329 6 0.000391782 0.025857613 0.000574614 13487 hsa-mir-320a hsa04540 Gap junction 5592_5595_5594_2885_5604 5 0.000466716 0.03080327 0.000669636 13488 hsa-mir-320a hsa04612 Antigen processing and presentation 4800_4801_1385_3312 4 0.003263375 0.215382748 0.004487141 13489 hsa-mir-320a hsa04210 Apoptosis 836_5970_7157_207 4 0.003263375 0.215382748 0.004487141 13490 hsa-mir-320a hsa05217 Basal cell carcinoma 2932_7157_2736 3 0.006483556 0.427914694 0.008732953 13491 hsa-mir-320a hsa04270 Vascular smooth muscle contraction 5592_5595_5594_5604 4 0.008486958 0.560139205 0.011202784 13492 hsa-mir-320b-2 hsa04950 Maturity onset diabetes of the young 3651_5080 2 0.000330014 0.002640114 0.002640114 13493 hsa-mir-320b-2 hsa04530 Tight junction 60412_4628 2 0.00905837 0.072466958 0.036233479 13494 hsa-mir-320b-2 hsa04930 Type II diabetes mellitus 3651 1 0.046431905 0.371455239 0.123818413 13495 hsa-mir-320d-2 hsa05200 Pathways in cancer 1956_5595_5594_1387_2308_841_6776_5970_6688_4609_861_4088_4089_1050_5925_2033_4790 17 6.53E-16 3.79E-14 3.79E-14 13496 hsa-mir-320d-2 hsa05215 Prostate cancer 1956_5595_5594_1385_1387_2308_5970_468_5925_2033_4790 11 1.35E-14 7.80E-13 2.19E-13 13497 hsa-mir-320d-2 hsa04010 MAPK signaling pathway 6722_1956_5595_5594_1386_5566_9252_1649_5970_468_4609_6195_6196_4790_2002 15 1.44E-14 8.34E-13 2.19E-13 13498 hsa-mir-320d-2 hsa05212 Pancreatic cancer 1956_5595_5594_1385_1387_2308_5970_468_5925_2033_4790 11 1.51E-14 8.74E-13 2.19E-13 13499 hsa-mir-320d-2 hsa05220 Chronic myeloid leukemia 5595_5594_6776_5970_4609_861_4088_4089_5925_4790 10 1.25E-13 7.25E-12 1.45E-12 13500 hsa-mir-320d-2 hsa05221 Acute myeloid leukemia 5595_5594_6776_5970_6688_4609_861_1050_4790 9 7.33E-13 4.25E-11 7.09E-12 13501 hsa-mir-320d-2 hsa04720 Long-term potentiation 815_5595_5594_1387_5566_468_6195_6196_2033 9 5.26E-12 3.05E-10 4.36E-11 13502 hsa-mir-320d-2 hsa04350 TGF-beta signaling pathway 5595_5594_1387_4609_4088_4089_2033_6667 8 5.97E-10 3.46E-08 4.33E-09 13503 hsa-mir-320d-2 hsa05219 Bladder cancer 1956_5595_5594_9252_4609_5925 6 8.18E-09 4.74E-07 5.27E-08 13504 hsa-mir-320d-2 hsa04520 Adherens junction 1956_5595_5594_1387_4088_4089_2033 7 1.02E-08 5.93E-07 5.93E-08 13505 hsa-mir-320d-2 hsa04012 ErbB signaling pathway 815_1956_5595_5594_6776_4609_2002 7 1.76E-08 1.02E-06 9.28E-08 13506 hsa-mir-320d-2 hsa04916 Melanogenesis 815_5595_5594_1385_1387_5566_2033 7 5.60E-08 3.25E-06 2.71E-07 13507 hsa-mir-320d-2 hsa04912 GnRH signaling pathway 815_1956_5595_5594_5566_468_2002 7 7.15E-08 4.15E-06 3.19E-07 13508 hsa-mir-320d-2 hsa05210 Colorectal cancer 1956_5595_5594_4609_4088_4089 6 3.74E-07 2.17E-05 1.55E-06 13509 hsa-mir-320d-2 hsa04310 Wnt signaling pathway 815_1387_5566_4609_4088_4089_2033 7 6.52E-07 3.78E-05 2.52E-06 13510 hsa-mir-320d-2 hsa05213 Endometrial cancer 1956_5595_5594_4609_2002 5 9.32E-07 5.41E-05 3.38E-06 13511 hsa-mir-320d-2 hsa04620 Toll-like receptor signaling pathway 5595_5594_841_5970_6348_4790 6 1.10E-06 6.37E-05 3.75E-06 13512 hsa-mir-320d-2 hsa05214 Glioma 815_1956_5595_5594_5925 5 2.61E-06 0.000151457 8.41E-06 13513 hsa-mir-320d-2 hsa04150 mTOR signaling pathway 5595_5594_6195_6196 4 2.78E-05 0.001609951 8.47E-05 13514 hsa-mir-320d-2 hsa05223 Non-small cell lung cancer 1956_5595_5594_5925 4 3.19E-05 0.001850955 9.25E-05 13515 hsa-mir-320d-2 hsa04062 Chemokine signaling pathway 5595_5594_5566_5970_6348_4790 6 3.67E-05 0.002125746 0.000101226 13516 hsa-mir-320d-2 hsa04110 Cell cycle 1387_4088_4089_5925_2033 5 4.26E-05 0.002470964 0.000112317 13517 hsa-mir-320d-2 hsa04910 Insulin signaling pathway 5595_5594_2308_5566_2002 5 8.39E-05 0.004866058 0.000211568 13518 hsa-mir-320d-2 hsa05218 Melanoma 1956_5595_5594_5925 4 8.78E-05 0.005094232 0.00021226 13519 hsa-mir-320d-2 hsa05211 Renal cell carcinoma 5595_5594_1387_2033 4 9.25E-05 0.005364587 0.000214583 13520 hsa-mir-320d-2 hsa04662 B cell receptor signaling pathway 5595_5594_5970_4790 4 0.000107556 0.00623825 0.000239933 13521 hsa-mir-320d-2 hsa05216 Thyroid cancer 5595_5594_4609 3 0.000132802 0.007702527 0.000285279 13522 hsa-mir-320d-2 hsa04630 Jak-STAT signaling pathway 1387_6778_6776_4609_2033 5 0.000142253 0.008250688 0.000294667 13523 hsa-mir-320d-2 hsa05222 Small cell lung cancer 5970_4609_5925_4790 4 0.000178235 0.01033761 0.000356469 13524 hsa-mir-320d-2 hsa04210 Apoptosis 5566_841_5970_4790 4 0.00020223 0.01172934 0.000390978 13525 hsa-mir-320d-2 hsa04540 Gap junction 1956_5595_5594_5566 4 0.000237737 0.013788764 0.000444799 13526 hsa-mir-320d-2 hsa05016 Huntington's disease 1385_1387_841_2033_6667 5 0.000339053 0.019665086 0.000614534 13527 hsa-mir-320d-2 hsa04660 T cell receptor signaling pathway 5595_5594_5970_4790 4 0.000439914 0.025514994 0.000773182 13528 hsa-mir-320d-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_5970_4790 3 0.00158034 0.091659724 0.002695874 13529 hsa-mir-320d-2 hsa04510 Focal adhesion 1956_5595_5594_2002 4 0.00414627 0.240483644 0.006870961 13530 hsa-mir-320d-2 hsa04270 Vascular smooth muscle contraction 5595_5594_5566 3 0.006325394 0.366872834 0.010190912 13531 hsa-mir-320d-2 hsa04930 Type II diabetes mellitus 5595_5594 2 0.009331215 0.541210481 0.01462731 13532 hsa-mir-320d-2 hsa04330 Notch signaling pathway 1387_2033 2 0.010110795 0.586426104 0.015432266 13533 hsa-mir-320d-2 hsa05010 Alzheimer's disease 5595_5594_841 3 0.018436487 1 0.027418365 13534 hsa-mir-320d-2 hsa04920 Adipocytokine signaling pathway 5970_4790 2 0.019382326 1 0.028104373 13535 hsa-mir-320d-2 hsa04020 Calcium signaling pathway 815_1956_5566 3 0.020370124 1 0.028816273 13536 hsa-mir-320d-2 hsa04730 Long-term depression 5595_5594 2 0.021540369 1 0.029746224 13537 hsa-mir-320d-2 hsa04370 VEGF signaling pathway 5595_5594 2 0.024954597 1 0.033659689 13538 hsa-mir-320d-2 hsa04664 Fc epsilon RI signaling pathway 5595_5594 2 0.026138614 1 0.034455446 13539 hsa-mir-320d-2 hsa04810 Regulation of actin cytoskeleton 1956_5595_5594 3 0.031652702 1 0.040796815 13540 hsa-mir-320e hsa05200 Pathways in cancer 3716_25_5371_1499_5595_5594_1387_1487_1488_4286_2932_6772_3091_7157_4087_2113_861_862_6502_4088_4089_3065_5925_2034_2033_9915 26 2.04E-21 1.28E-19 1.28E-19 13541 hsa-mir-320e hsa04350 TGF-beta signaling pathway 3400_5595_5594_1387_6667_3397_3399_3398_4087_4086_4088_4089_2033_4093 14 5.83E-16 3.67E-14 1.84E-14 13542 hsa-mir-320e hsa05220 Chronic myeloid leukemia 25_5595_5594_1487_1488_7157_861_4088_4089_3065_5925 11 2.09E-12 1.32E-10 4.39E-11 13543 hsa-mir-320e hsa04110 Cell cycle 25_1387_2932_7157_4087_6502_4088_4089_3065_5925_2033 11 2.01E-10 1.26E-08 3.16E-09 13544 hsa-mir-320e hsa04330 Notch signaling pathway 388585_1387_1487_1488_9612_3065_2033_8850 8 7.99E-10 5.03E-08 1.01E-08 13545 hsa-mir-320e hsa04916 Melanogenesis 1499_5595_5594_1387_4286_2932_2033_808_801_805 10 9.60E-10 6.04E-08 1.01E-08 13546 hsa-mir-320e hsa04520 Adherens junction 1499_5595_5594_1387_4087_1457_4088_4089_2033 9 1.90E-09 1.20E-07 1.71E-08 13547 hsa-mir-320e hsa04310 Wnt signaling pathway 1499_1387_1487_1488_2932_7157_4087_1457_4088_4089_2033 11 2.26E-09 1.42E-07 1.78E-08 13548 hsa-mir-320e hsa05211 Renal cell carcinoma 5595_5594_1387_3091_2113_2034_2033_9915 8 1.69E-08 1.06E-06 1.18E-07 13549 hsa-mir-320e hsa04630 Jak-STAT signaling pathway 3717_3716_1387_6778_6772_3454_3455_7297_2033_10379 10 3.45E-08 2.17E-06 2.17E-07 13550 hsa-mir-320e hsa05210 Colorectal cancer 1499_5595_5594_2932_7157_4087_4088_4089 8 5.12E-08 3.23E-06 2.93E-07 13551 hsa-mir-320e hsa05215 Prostate cancer 1499_5595_5594_1387_2932_7157_5925_2033 8 7.16E-08 4.51E-06 3.76E-07 13552 hsa-mir-320e hsa05212 Pancreatic cancer 1499_5595_5594_1387_2932_7157_5925_2033 8 7.77E-08 4.89E-06 3.76E-07 13553 hsa-mir-320e hsa05214 Glioma 5595_5594_7157_5925_808_801_805 7 1.66E-07 1.04E-05 7.46E-07 13554 hsa-mir-320e hsa04720 Long-term potentiation 5595_5594_1387_2033_808_801_805 7 4.08E-07 2.57E-05 1.71E-06 13555 hsa-mir-320e hsa05213 Endometrial cancer 1499_5595_5594_2932_7157 5 1.72E-05 0.001083473 6.77E-05 13556 hsa-mir-320e hsa04910 Insulin signaling pathway 5595_5594_23265_2932_808_801_805 7 1.84E-05 0.001161878 6.83E-05 13557 hsa-mir-320e hsa05221 Acute myeloid leukemia 5371_5595_5594_861_862 5 3.03E-05 0.001911575 0.000102756 13558 hsa-mir-320e hsa04010 MAPK signaling pathway 6722_5595_5594_4208_7867_9261_7157_1432_1616 9 3.25E-05 0.002048542 0.000102756 13559 hsa-mir-320e hsa04620 Toll-like receptor signaling pathway 5595_5594_6772_3454_3455_1432 6 3.37E-05 0.002125484 0.000102756 13560 hsa-mir-320e hsa05216 Thyroid cancer 1499_5595_5594_7157 4 3.43E-05 0.002157881 0.000102756 13561 hsa-mir-320e hsa04912 GnRH signaling pathway 5595_5594_1432_808_801_805 6 4.57E-05 0.002881528 0.000130979 13562 hsa-mir-320e hsa05218 Melanoma 5595_5594_4286_7157_5925 5 6.96E-05 0.004387894 0.000190778 13563 hsa-mir-320e hsa04370 VEGF signaling pathway 5595_5594_7867_9261_1432 5 0.000100121 0.006307609 0.000262817 13564 hsa-mir-320e hsa05219 Bladder cancer 5595_5594_7157_5925 4 0.000129065 0.008131117 0.000325245 13565 hsa-mir-320e hsa05223 Non-small cell lung cancer 5595_5594_7157_5925 4 0.000318486 0.020064634 0.000771717 13566 hsa-mir-320e hsa04950 Maturity onset diabetes of the young 3651_168620_4760 3 0.000457527 0.028824232 0.001067564 13567 hsa-mir-320e hsa05010 Alzheimer's disease 5595_5594_2932_808_801_805 6 0.00059986 0.037791184 0.001349685 13568 hsa-mir-320e hsa04270 Vascular smooth muscle contraction 5595_5594_808_801_805 5 0.000659456 0.04154575 0.001432612 13569 hsa-mir-320e hsa05016 Huntington's disease 1387_6908_6667_7157_3065_2033 6 0.000813477 0.051249076 0.001708303 13570 hsa-mir-320e hsa04062 Chemokine signaling pathway 3717_5595_5594_2932_6772_7852 6 0.00092807 0.058468436 0.001886079 13571 hsa-mir-320e hsa04360 Axon guidance 25_5595_5594_2932_7852 5 0.001036392 0.065292683 0.002040396 13572 hsa-mir-320e hsa04012 ErbB signaling pathway 25_5595_5594_2932 4 0.001738834 0.109546573 0.003319593 13573 hsa-mir-320e hsa04930 Type II diabetes mellitus 5595_5594_3651 3 0.002482253 0.156381918 0.004599468 13574 hsa-mir-320e hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.003659012 0.230517726 0.006586221 13575 hsa-mir-320e hsa04660 T cell receptor signaling pathway 5595_5594_2932_1432 4 0.003931255 0.247669049 0.006879696 13576 hsa-mir-320e hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.004251162 0.267823197 0.007238465 13577 hsa-mir-320e hsa05014 Amyotrophic lateral sclerosis (ALS) 7157_1432_1616 3 0.004460679 0.281022805 0.007395337 13578 hsa-mir-320e hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_3454_3455 4 0.008480799 0.534290309 0.013682913 13579 hsa-mir-320e hsa04120 Ubiquitin mediated proteolysis 7329_55294_5371_6502 4 0.008687564 0.547316512 0.013682913 13580 hsa-mir-320e hsa04662 B cell receptor signaling pathway 5595_5594_2932 3 0.009662622 0.608745165 0.014847443 13581 hsa-mir-320e hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.010003398 0.63021405 0.015005096 13582 hsa-mir-320e hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432 3 0.011067361 0.697243746 0.016214971 13583 hsa-mir-320e hsa05222 Small cell lung cancer 7157_6502_5925 3 0.013795727 0.869130804 0.019752973 13584 hsa-mir-320e hsa03022 Basal transcription factors 2963_6908 2 0.020182182 1 0.028255055 13585 hsa-mir-320e hsa04510 Focal adhesion 1499_5595_5594_2932 4 0.030798335 1 0.042180328 13586 hsa-mir-320e hsa04670 Leukocyte transendothelial migration 1499_7852_1432 3 0.033396856 1 0.044765998 13587 hsa-mir-320e hsa05131 Shigellosis 25_1499 2 0.042028313 1 0.054036402 13588 hsa-mir-320e hsa05130 Pathogenic Escherichia coli infection 25_1499 2 0.042028313 1 0.054036402 13589 hsa-mir-323 hsa05200 Pathways in cancer 3725_4149_1499_5914_2261_6934_7704_6502_3091_842_3065_1050_5925_7046_5747_25_1956_4824_2113_5894_861_862_867_207_3716_367_5595_5594_5599_6258_1387_2064_6256_836_2932_6774_6776_6777_6772_5970_7157_6688_2736_4087_4088_4089_2033_4790_4792_5879_3320_3326_5371_675_5159_5156_5604_5601_5602_1399_1398_3815_3265_841_4292_8772_1029_2353_8554 69 6.05E-40 4.84E-38 4.84E-38 13590 hsa-mir-323 hsa04010 MAPK signaling pathway 6722_3725_3727_4149_6197_2261_2264_7867_1845_4773_7046_8986_1956_7132_3303_1432_5894_207_22800_5595_5594_5599_5598_1386_836_9252_3312_1649_5970_7157_468_6195_6196_4790_5879_5159_9261_5156_5604_4208_5601_5600_5602_1399_1398_3265_2353_2005_8550_2002 50 5.83E-27 4.66E-25 2.33E-25 13591 hsa-mir-323 hsa05215 Prostate cancer 1499_6934_842_5925_1956_4824_5894_207_9586_367_5595_5594_1385_1387_2064_2932_5970_7157_468_2033_4790_4792_3320_3326_5159_5156_5604_3265 28 4.86E-21 3.89E-19 1.25E-19 13592 hsa-mir-323 hsa05212 Pancreatic cancer 1499_6934_842_5925_1956_4824_5894_207_9586_367_5595_5594_1385_1387_2064_2932_5970_7157_468_2033_4790_4792_3320_3326_5159_5156_5604_3265 28 6.26E-21 5.00E-19 1.25E-19 13593 hsa-mir-323 hsa04012 ErbB signaling pathway 3725_818_815_817_5747_25_1956_6714_5894_867_207_5595_5594_5599_2064_2066_2932_6776_6777_5604_5601_5602_1399_1398_3265_6464_2002 27 4.20E-20 3.36E-18 6.73E-19 13594 hsa-mir-323 hsa05220 Chronic myeloid leukemia 3065_5925_7046_25_5894_861_867_207_5595_5594_6776_6777_5970_7157_4088_4089_4790_4792_5604_1399_1398_3265_5781_1029_6464 25 2.48E-19 1.99E-17 3.31E-18 13595 hsa-mir-323 hsa05210 Colorectal cancer 3725_1499_6934_842_7046_1956_5894_207_5595_5594_5599_836_2932_7157_4087_4088_4089_5879_5159_5156_5604_5601_5602_4292_2353 25 2.38E-18 1.90E-16 2.72E-17 13596 hsa-mir-323 hsa04630 Jak-STAT signaling pathway 3559_5777_58985_3455_3459_3560_3561_3566_1439_2057_867_2690_207_3717_3716_3718_85480_1387_3575_6774_6775_6776_6777_6772_6773_7297_2033_5781_8554_10379 30 3.00E-17 2.40E-15 3.00E-16 13597 hsa-mir-323 hsa05221 Acute myeloid leukemia 5914_6934_7704_1050_5894_861_862_207_5595_5594_6774_6776_6777_5970_6688_4790_5371_5604_3815_3265 20 7.48E-16 5.98E-14 6.65E-15 13598 hsa-mir-323 hsa04520 Adherens junction 4301_1499_6934_5770_5777_7046_2534_1956_6714_5595_5594_1387_2064_1457_1459_4087_4088_4089_2033_5879_3643 21 1.03E-14 8.20E-13 8.20E-14 13599 hsa-mir-323 hsa04110 Cell cycle 6502_6500_4174_4172_3065_993_5925_25_5933_990_5591_1387_7534_7531_7533_2932_7157_4087_4088_4089_2033_983_8454_1029 24 2.05E-14 1.64E-12 1.49E-13 13600 hsa-mir-323 hsa04912 GnRH signaling pathway 3725_818_815_817_5580_1956_6714_1432_5894_5595_5594_5599_5598_468_808_801_805_5604_5601_5600_5602_3265_2002 23 2.62E-14 2.10E-12 1.75E-13 13601 hsa-mir-323 hsa05214 Glioma 818_815_817_5925_1956_5894_207_5595_5594_7157_808_801_805_5159_5156_5604_3265_1029_6464 19 3.72E-14 2.98E-12 2.29E-13 13602 hsa-mir-323 hsa04062 Chemokine signaling pathway 1234_7074_5747_5580_7852_5894_207_3717_3718_5590_5595_5594_1230_2932_2931_6774_6777_6772_6773_5970_4790_4792_5879_5604_1399_1398_3265_6464 28 2.10E-13 1.68E-11 1.20E-12 13603 hsa-mir-323 hsa04660 T cell receptor signaling pathway 3725_919_1493_5777_4773_2534_3932_1432_5894_867_207_5595_5594_2932_5970_4790_4792_5604_5601_5600_3265_2353 22 2.90E-13 2.32E-11 1.55E-12 13604 hsa-mir-323 hsa04720 Long-term potentiation 818_815_817_6197_2902_5894_5595_5594_1387_468_6195_6196_2033_808_801_805_5604_3265_2906 19 3.29E-13 2.63E-11 1.64E-12 13605 hsa-mir-323 hsa04310 Wnt signaling pathway 3725_818_815_817_1499_6934_6500_4773_5599_1387_2932_7157_8061_1457_1459_4087_4088_4089_2033_5879_5515_5601_5602_8454 24 2.22E-12 1.77E-10 1.04E-11 13606 hsa-mir-323 hsa05213 Endometrial cancer 1499_6934_842_1956_5894_207_5595_5594_2064_2932_7157_5604_3265_4292_2002 15 2.15E-11 1.72E-09 9.57E-11 13607 hsa-mir-323 hsa04510 Focal adhesion 3725_1499_2534_5747_3791_1956_6714_5894_207_5595_5594_5599_2064_2932_5879_2321_5159_5156_5604_5601_5602_1399_1398_3265_6464_2002 26 2.55E-11 2.04E-09 1.01E-10 13608 hsa-mir-323 hsa04350 TGF-beta signaling pathway 6500_90_3397_7046_57154_6667_3399_3398_5933_5595_5594_1387_4087_4088_4089_2033_5515_8454 18 2.58E-11 2.06E-09 1.01E-10 13609 hsa-mir-323 hsa04662 B cell receptor signaling pathway 3725_5777_4773_6850_5894_207_695_5595_5594_2932_5970_4790_4792_5879_5604_3265_2353 17 2.64E-11 2.12E-09 1.01E-10 13610 hsa-mir-323 hsa04620 Toll-like receptor signaling pathway 3725_3455_1432_207_5595_5594_5599_6772_5970_4790_4792_5879_5604_5601_5600_5602_841_8772_2353 19 3.57E-11 2.86E-09 1.30E-10 13611 hsa-mir-323 hsa04910 Insulin signaling pathway 5770_5894_867_207_5590_5595_5594_5599_2932_808_801_805_3643_5604_5601_5602_1399_1398_3265_6464_2002 21 9.70E-11 7.76E-09 3.38E-10 13612 hsa-mir-323 hsa04370 VEGF signaling pathway 7867_4773_842_5747_3791_6714_1432_5894_207_5595_5594_5879_9261_5604_5600_3265 16 3.10E-10 2.48E-08 1.03E-09 13613 hsa-mir-323 hsa05223 Non-small cell lung cancer 842_5925_1956_5894_207_5595_5594_6258_2064_6256_7157_5604_3265_1029 14 3.32E-10 2.66E-08 1.03E-09 13614 hsa-mir-323 hsa04916 Melanogenesis 818_815_817_1499_6934_5894_5595_5594_1385_1387_2932_2033_808_801_805_5604_3815_3265 18 3.36E-10 2.69E-08 1.03E-09 13615 hsa-mir-323 hsa04664 Fc epsilon RI signaling pathway 2534_5580_6850_1432_5894_207_695_5595_5594_5599_5879_5604_5601_5600_5602_3265 16 4.31E-10 3.45E-08 1.28E-09 13616 hsa-mir-323 hsa04920 Adipocytokine signaling pathway 7133_7132_207_3717_8717_5599_6258_6256_6774_5970_4790_4792_5601_5602_5781 15 4.53E-10 3.63E-08 1.29E-09 13617 hsa-mir-323 hsa04540 Gap junction 51807_1956_6714_5894_5592_5595_5594_5598_7846_5159_983_5156_5604_3265_7277_7278_10376 17 4.96E-10 3.97E-08 1.37E-09 13618 hsa-mir-323 hsa05211 Renal cell carcinoma 3725_3091_2113_5894_207_5595_5594_1387_2033_5879_5604_1399_1398_3265_5781 15 1.08E-09 8.62E-08 2.87E-09 13619 hsa-mir-323 hsa05219 Bladder cancer 2261_5925_1956_5894_5595_5594_2064_9252_7157_5604_3265_1029 12 2.41E-09 1.93E-07 6.23E-09 13620 hsa-mir-323 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1956_6714_1432_5599_836_5970_4790_4792_5879_5601_5600_5602_5781 14 7.18E-09 5.75E-07 1.80E-08 13621 hsa-mir-323 hsa04060 Cytokine-cytokine receptor interaction 3559_1234_58985_3455_3459_90_7046_3791_1956_3560_3561_3566_7133_7132_1439_7852_2057_2690_85480_1230_3575_2321_5159_5156_3815 25 1.19E-08 9.50E-07 2.88E-08 13622 hsa-mir-323 hsa03022 Basal transcription factors 6879_2963_2962_2969_6872_6908_2958_2959_6880_9519 10 8.18E-08 6.55E-06 1.93E-07 13623 hsa-mir-323 hsa04210 Apoptosis 842_7132_1439_207_8717_836_839_5970_7157_4790_4792_841_840_8772 14 8.94E-08 7.15E-06 2.04E-07 13624 hsa-mir-323 hsa04650 Natural killer cell mediated cytotoxicity 919_5777_3455_3459_4773_2534_3932_6850_5894_5595_5594_836_5879_5604_3265_5781_6464 17 9.71E-08 7.77E-06 2.16E-07 13625 hsa-mir-323 hsa05216 Thyroid cancer 1499_6934_5595_5594_6258_6256_7157_5604_3265 9 1.36E-07 1.09E-05 2.95E-07 13626 hsa-mir-323 hsa05218 Melanoma 5925_1956_5894_207_5595_5594_7157_5159_5156_5604_3265_1029 12 3.74E-07 2.99E-05 7.88E-07 13627 hsa-mir-323 hsa05222 Small cell lung cancer 4149_6502_842_5925_5747_207_6258_6256_5970_7157_4790_4792_8554 13 3.87E-07 3.10E-05 7.95E-07 13628 hsa-mir-323 hsa05014 Amyotrophic lateral sclerosis (ALS) 842_2902_7133_7132_1432_836_7157_5879_5600_2906 10 2.26E-06 0.000181049 4.31E-06 13629 hsa-mir-323 hsa05131 Shigellosis 1499_51807_2534_25_7534_7846_7277_7278_4691_10376 10 2.26E-06 0.000181049 4.31E-06 13630 hsa-mir-323 hsa05130 Pathogenic Escherichia coli infection 1499_51807_2534_25_7534_7846_7277_7278_4691_10376 10 2.26E-06 0.000181049 4.31E-06 13631 hsa-mir-323 hsa05010 Alzheimer's disease 842_2902_7132_22926_5595_5594_836_2932_808_351_801_805_841_840_2906_8772_4724 17 2.35E-06 0.000187997 4.37E-06 13632 hsa-mir-323 hsa04930 Type II diabetes mellitus 5580_3651_5590_5595_5594_5599_3643_5601_5602 9 3.22E-06 0.00025728 5.85E-06 13633 hsa-mir-323 hsa04530 Tight junction 4301_1499_5580_6714_8573_8189_207_22800_5590_1457_1459_5515_3265 13 4.00E-05 0.003197057 7.10E-05 13634 hsa-mir-323 hsa04120 Ubiquitin mediated proteolysis 55294_6502_6500_57154_867_10273_7329_83737_64326_5371_672_8454_8554 13 4.59E-05 0.003671027 7.98E-05 13635 hsa-mir-323 hsa05016 Huntington's disease 842_3065_3064_2902_6667_9586_1385_1387_836_7157_2033_6908_841_4724_9519 15 6.73E-05 0.005384978 0.000114574 13636 hsa-mir-323 hsa04810 Regulation of actin cytoskeleton 2261_2264_7074_5747_1956_5894_22800_5595_5594_5879_5159_5156_5604_1399_1398_3265 16 0.000102803 0.00822422 0.000171338 13637 hsa-mir-323 hsa04020 Calcium signaling pathway 818_815_817_147_1956_2902_2064_2066_808_801_805_5159_5156_2906 14 0.000185064 0.014805155 0.000302146 13638 hsa-mir-323 hsa04330 Notch signaling pathway 9612_3065_1387_2033_8850_388585_2648 7 0.000209883 0.016790643 0.000335813 13639 hsa-mir-323 hsa04115 p53 signaling pathway 842_836_7157_64326_983_841_7161_1029 8 0.00035649 0.028519178 0.0005592 13640 hsa-mir-323 hsa04150 mTOR signaling pathway 6197_3091_207_5595_5594_6195_6196 7 0.000366689 0.029335121 0.000564137 13641 hsa-mir-323 hsa04612 Antigen processing and presentation 3303_1385_3312_1514_3320_3326_4800_4801_4802 9 0.000393397 0.031471728 0.000593806 13642 hsa-mir-323 hsa04270 Vascular smooth muscle contraction 147_5580_5894_5592_5595_5594_808_801_805_5604 10 0.000694227 0.055538148 0.001028484 13643 hsa-mir-323 hsa04360 Axon guidance 4773_2534_5747_25_7852_5595_5594_2932_5879_3265 10 0.001455686 0.116454903 0.002117362 13644 hsa-mir-323 hsa04730 Long-term depression 5894_5592_5595_5594_5515_5604_3265 7 0.001962667 0.157013378 0.00280381 13645 hsa-mir-323 hsa05340 Primary immunodeficiency 3932_3561_3718_695_3575 5 0.002016214 0.161297096 0.002829774 13646 hsa-mir-323 hsa03450 Non-homologous end-joining 2547_7520_5591 3 0.006225789 0.498063081 0.008587295 13647 hsa-mir-323 hsa04670 Leukocyte transendothelial migration 4301_1499_5747_1432_7852_5879_5600_5781 8 0.009735086 0.778806859 0.013200116 13648 hsa-mir-323 hsa05217 Basal cell carcinoma 1499_6934_2932_7157_2736 5 0.011569203 0.925536241 0.015425604 13649 hsa-mir-323 hsa04950 Maturity onset diabetes of the young 3087_3651_168620 3 0.022659376 1 0.029717214 13650 hsa-mir-323b hsa05200 Pathways in cancer 4436_3551_5467_1499_5914_595_1017_4193_6934_7704_3091_4089_3065_1050_5925_5468_25_405_1956_1487_1488_2113_10401_861_867_207_3716_1147_2249_5595_5594_5599_1387_6256_4286_367_6774_6776_6777_6772_5970_7157_7849_3725_4088_2034_2033_3320_51176_5371_675_5159_5156_5604_5601_1399_1398_3815_841_4087_4609_2956_2353_8554 64 7.97E-39 6.29E-37 6.29E-37 13651 hsa-mir-323b hsa05220 Chronic myeloid leukemia 3551_595_4193_4089_3065_5925_25_1487_1488_861_867_207_1147_5595_5594_6776_6777_5970_7157_4088_5604_1399_1398_5781_4609_6464 26 8.09E-22 6.39E-20 3.20E-20 13652 hsa-mir-323b hsa05221 Acute myeloid leukemia 3551_5467_5914_595_6934_7704_1050_861_207_1147_5595_5594_6774_6776_6777_5970_51176_5371_5604_3815_4609 21 4.52E-18 3.57E-16 1.19E-16 13653 hsa-mir-323b hsa05215 Prostate cancer 3551_1499_595_1017_4193_6934_5925_1956_207_9586_1147_5595_5594_1387_367_5970_7157_2033_3320_51176_5159_5156_5604 23 3.55E-17 2.80E-15 6.92E-16 13654 hsa-mir-323b hsa05212 Pancreatic cancer 3551_1499_595_1017_4193_6934_5925_1956_207_9586_1147_5595_5594_1387_367_5970_7157_2033_3320_51176_5159_5156_5604 23 4.38E-17 3.46E-15 6.92E-16 13655 hsa-mir-323b hsa04630 Jak-STAT signaling pathway 3559_595_5777_3560_3561_2057_10401_867_2690_3977_207_3575_3717_3716_3718_85480_1387_6778_6774_6776_6777_6772_2033_894_896_5781_4609_8554 28 5.87E-17 4.64E-15 7.73E-16 13656 hsa-mir-323b hsa05210 Colorectal cancer 4436_1499_595_6934_4089_1956_207_5595_5594_5599_7157_3725_4088_51176_5159_5156_5604_5601_4087_4609_2956_2353 22 1.67E-16 1.32E-14 1.88E-15 13657 hsa-mir-323b hsa04310 Wnt signaling pathway 5467_1499_595_6934_4089_4772_4773_1487_1488_1459_5599_1387_7157_8061_3725_1457_4088_2033_894_896_51176_5515_5601_4087_4609_5527 26 2.43E-15 1.92E-13 2.40E-14 13658 hsa-mir-323b hsa04110 Cell cycle 595_1017_4193_4089_3065_993_5925_25_8379_5934_7534_1387_7532_7027_7157_5111_4088_2033_894_896_983_4087 22 8.58E-14 6.78E-12 7.53E-13 13659 hsa-mir-323b hsa04010 MAPK signaling pathway 3727_3551_9252_4773_1956_1432_207_1147_2249_5595_5594_5599_1386_1649_5970_3164_7157_3725_5159_5156_5604_4208_5601_5600_1399_1398_4609_2353_5603_8550_2002 31 1.27E-13 1.00E-11 1.00E-12 13660 hsa-mir-323b hsa04012 ErbB signaling pathway 25_1956_6714_867_207_5595_5594_5599_2066_6776_6777_3725_5604_5601_1399_1398_4609_6464_2002 19 3.22E-13 2.54E-11 2.31E-12 13661 hsa-mir-323b hsa04520 Adherens junction 1499_6934_5770_5777_4089_1956_6714_1459_71_5595_5594_1387_1457_4088_2033_51176_3643_4087 18 8.75E-13 6.91E-11 5.76E-12 13662 hsa-mir-323b hsa04660 T cell receptor signaling pathway 3551_1493_5777_4772_4773_3932_1432_867_207_1147_5595_5594_5970_3725_5604_5601_5600_919_2353_5603 20 1.52E-12 1.20E-10 9.22E-12 13663 hsa-mir-323b hsa05216 Thyroid cancer 1499_595_6934_5468_5595_5594_6256_7157_7849_51176_5604_4609 12 1.61E-11 1.27E-09 9.10E-11 13664 hsa-mir-323b hsa04620 Toll-like receptor signaling pathway 3551_3665_3661_1432_207_1147_5595_5594_5599_6772_5970_3725_5604_5601_5600_841_2353_5603 18 3.08E-11 2.43E-09 1.62E-10 13665 hsa-mir-323b hsa05213 Endometrial cancer 1499_595_6934_1956_2309_207_5595_5594_7157_51176_5604_4609_2002 13 4.30E-10 3.39E-08 2.12E-09 13666 hsa-mir-323b hsa05211 Renal cell carcinoma 3091_405_2113_207_5595_5594_1387_3725_2034_2033_5604_1399_1398_5781 14 1.60E-09 1.26E-07 7.24E-09 13667 hsa-mir-323b hsa04330 Notch signaling pathway 1840_3065_22938_1487_1488_1387_2033_8850_2648_4851_9612_9794 12 1.65E-09 1.30E-07 7.24E-09 13668 hsa-mir-323b hsa04350 TGF-beta signaling pathway 4086_4089_6667_1875_5934_5595_5594_1387_7027_4088_2033_5515_4087_4609_4092 15 1.81E-09 1.43E-07 7.52E-09 13669 hsa-mir-323b hsa04662 B cell receptor signaling pathway 3551_5777_4772_4773_6850_207_1147_695_5595_5594_5970_3725_5604_2353 14 2.55E-09 2.01E-07 1.01E-08 13670 hsa-mir-323b hsa05218 Melanoma 595_4193_5925_1956_207_2249_5595_5594_4286_7157_5159_5156_5604 13 1.16E-08 9.16E-07 4.36E-08 13671 hsa-mir-323b hsa05322 Systemic lupus erythematosus 3021_3020_9555_8349_8365_8294_8370_121504_8361_8360_8363_8362_8364_8367_8366_8368_8359 17 2.61E-08 2.06E-06 9.38E-08 13672 hsa-mir-323b hsa04510 Focal adhesion 1499_595_1956_6714_207_71_5595_5594_5599_3725_894_896_5159_5156_5604_5601_1399_1398_6464_2002 20 3.22E-08 2.54E-06 1.11E-07 13673 hsa-mir-323b hsa05214 Glioma 595_4193_5925_1956_207_5595_5594_7157_5159_5156_5604_6464 12 3.91E-08 3.09E-06 1.29E-07 13674 hsa-mir-323b hsa04920 Adipocytokine signaling pathway 3551_10891_5465_207_3717_1147_5599_6256_6774_5970_5601_5781 12 5.26E-08 4.15E-06 1.66E-07 13675 hsa-mir-323b hsa04062 Chemokine signaling pathway 3551_1234_2309_7852_207_3717_1147_3718_5595_5594_5580_6774_6777_6772_5970_5604_1399_1398_6464 19 5.80E-08 4.58E-06 1.76E-07 13676 hsa-mir-323b hsa05219 Bladder cancer 595_9252_4193_5925_1956_5595_5594_7157_5604_4609 10 6.74E-08 5.32E-06 1.97E-07 13677 hsa-mir-323b hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3551_1956_6714_1432_1147_5599_5970_3725_5601_5600_5781_5603 12 9.25E-08 7.31E-06 2.61E-07 13678 hsa-mir-323b hsa04664 Fc epsilon RI signaling pathway 6850_1432_207_695_5595_5594_5599_5580_5604_5601_5600_5603 12 2.61E-07 2.06E-05 7.10E-07 13679 hsa-mir-323b hsa04910 Insulin signaling pathway 3551_10891_5770_867_207_5595_5594_5599_3643_5604_5601_1399_1398_6464_2002 15 4.53E-07 3.58E-05 1.19E-06 13680 hsa-mir-323b hsa05223 Non-small cell lung cancer 595_5925_1956_2309_207_5595_5594_6256_7157_5604 10 5.21E-07 4.11E-05 1.32E-06 13681 hsa-mir-323b hsa04115 p53 signaling pathway 595_1017_4194_4193_7157_64326_894_896_841_983_7161 11 5.35E-07 4.23E-05 1.32E-06 13682 hsa-mir-323b hsa05222 Small cell lung cancer 3551_595_1017_5925_10401_207_1147_6256_5970_7157_4609_8554 12 5.92E-07 4.68E-05 1.42E-06 13683 hsa-mir-323b hsa04912 GnRH signaling pathway 1956_6714_1432_5595_5594_5599_5580_3725_5604_5601_5600_5603_2002 13 9.29E-07 7.34E-05 2.16E-06 13684 hsa-mir-323b hsa03410 Base excision repair 3146_4350_142_252969_328_2237_5111_6996 8 2.21E-06 0.000174696 4.99E-06 13685 hsa-mir-323b hsa04370 VEGF signaling pathway 4772_4773_6714_1432_207_5595_5594_5604_5600_5603 10 9.14E-06 0.00072175 2.00E-05 13686 hsa-mir-323b hsa04930 Type II diabetes mellitus 3551_5595_5594_5599_5580_3643_5601 7 7.34E-05 0.005798642 0.00015672 13687 hsa-mir-323b hsa04916 Melanogenesis 1499_6934_5595_5594_1387_4286_2033_51176_5604_3815 10 9.63E-05 0.007607918 0.000200208 13688 hsa-mir-323b hsa04650 Natural killer cell mediated cytotoxicity 5777_4772_4773_3932_6850_5595_5594_5604_919_5781_6464 11 0.000205369 0.016224178 0.000416005 13689 hsa-mir-323b hsa03450 Non-homologous end-joining 2547_10111_2237_4361 4 0.000380263 0.030040789 0.00075102 13690 hsa-mir-323b hsa05016 Huntington's disease 10891_3065_5468_25942_4724_6667_9586_1387_7157_2033_6908_841 12 0.000715123 0.05649473 0.00137792 13691 hsa-mir-323b hsa04540 Gap junction 1956_6714_5595_5594_5159_5156_5604_983 8 0.000937112 0.07403183 0.001762663 13692 hsa-mir-323b hsa05340 Primary immunodeficiency 3932_3561_3575_3718_695 5 0.001135054 0.089669253 0.002085331 13693 hsa-mir-323b hsa04060 Cytokine-cytokine receptor interaction 3559_1234_1956_3560_3561_7852_2057_2690_3977_3575_85480_5159_5156_3815 14 0.001381957 0.109174624 0.002481241 13694 hsa-mir-323b hsa04120 Ubiquitin mediated proteolysis 4193_10401_867_7329_8925_64326_5371_672_8554 9 0.00293087 0.231538766 0.005145306 13695 hsa-mir-323b hsa04210 Apoptosis 3551_207_1147_5970_7157_841_840 7 0.003090363 0.244138695 0.005307363 13696 hsa-mir-323b hsa03440 Homologous recombination 10111_4683_675_4361 4 0.003585883 0.283284767 0.006027335 13697 hsa-mir-323b hsa04530 Tight junction 1499_6714_1459_207_71_5580_1457_5515 8 0.00868823 0.686370142 0.014149741 13698 hsa-mir-323b hsa03022 Basal transcription factors 2963_2969_6908_2959 4 0.008776422 0.693337328 0.014149741 13699 hsa-mir-323b hsa03430 Mismatch repair 4436_5111_2956 3 0.014500851 1 0.022911344 13700 hsa-mir-323b hsa04670 Leukocyte transendothelial migration 1499_1432_7852_71_5600_5781_5603 7 0.014880556 1 0.023050273 13701 hsa-mir-323b hsa04950 Maturity onset diabetes of the young 6927_4760_5080 3 0.016076869 1 0.024424474 13702 hsa-mir-323b hsa03320 PPAR signaling pathway 5465_5467_10062_5468_6256 5 0.01691581 1 0.025214131 13703 hsa-mir-323b hsa04720 Long-term potentiation 5595_5594_1387_2033_5604 5 0.021753624 1 0.031824746 13704 hsa-mir-323b hsa04150 mTOR signaling pathway 3091_207_5595_5594 4 0.02524667 1 0.036263399 13705 hsa-mir-323b hsa04810 Regulation of actin cytoskeleton 1956_71_2249_5595_5594_5159_5156_5604_1399_1398 10 0.026820118 1 0.037835524 13706 hsa-mir-323b hsa05217 Basal cell carcinoma 1499_6934_7157_51176 4 0.029877299 1 0.041408888 13707 hsa-mir-323b hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_7157_5600_5603 4 0.031524892 1 0.041507774 13708 hsa-mir-323b hsa05131 Shigellosis 1499_25_71_7534 4 0.031524892 1 0.041507774 13709 hsa-mir-323b hsa05130 Pathogenic Escherichia coli infection 1499_25_71_7534 4 0.031524892 1 0.041507774 13710 hsa-mir-323b hsa04612 Antigen processing and presentation 3308_1514_3320_4800_4801 5 0.039773268 1 0.051509642 13711 hsa-mir-324 hsa05200 Pathways in cancer 4609_3320_3326_5595_5599_1387_1487_1488_2932_4193_3265_6772_8554_1870_7157_1029_5601_3066_2736_4087_4088_3065_5925_2033_1871_207 26 5.69E-22 3.75E-20 3.75E-20 13712 hsa-mir-324 hsa05220 Chronic myeloid leukemia 4609_5595_1487_1488_4193_3265_1870_7157_1029_3066_4088_3065_5925_1871_207 15 1.36E-18 8.96E-17 4.48E-17 13713 hsa-mir-324 hsa04110 Cell cycle 5591_1387_7534_7531_2932_4193_1870_7157_1029_3066_4087_4088_3065_5925_2033_1871 16 2.71E-17 1.79E-15 5.97E-16 13714 hsa-mir-324 hsa05215 Prostate cancer 3320_3326_5595_1385_1387_2932_4193_3265_1870_7157_5925_2033_1871_207 14 3.40E-16 2.25E-14 5.17E-15 13715 hsa-mir-324 hsa05212 Pancreatic cancer 3320_3326_5595_1385_1387_2932_4193_3265_1870_7157_5925_2033_1871_207 14 3.92E-16 2.59E-14 5.17E-15 13716 hsa-mir-324 hsa04010 MAPK signaling pathway 4609_6722_8986_5595_5599_9261_3303_9252_3265_1386_1432_3312_7157_22800_6195_6196_6197_5601_207 19 2.03E-15 1.34E-13 2.23E-14 13717 hsa-mir-324 hsa05219 Bladder cancer 4609_5595_9252_4193_3265_1870_7157_1029_5925_1871 10 1.85E-13 1.22E-11 1.74E-12 13718 hsa-mir-324 hsa04310 Wnt signaling pathway 4609_815_5518_5599_1387_1487_1488_1457_2932_7157_5601_4087_4088_2033 14 3.36E-13 2.22E-11 2.78E-12 13719 hsa-mir-324 hsa03022 Basal transcription factors 2963_2969_6879_6908_6872_2958_2959_6880_9519 9 2.61E-12 1.72E-10 1.92E-11 13720 hsa-mir-324 hsa05214 Glioma 815_5595_4193_3265_1870_7157_1029_5925_1871_207 10 8.72E-12 5.75E-10 5.75E-11 13721 hsa-mir-324 hsa04720 Long-term potentiation 815_5595_1387_2902_2906_3265_6195_6196_6197_2033 10 3.14E-11 2.07E-09 1.89E-10 13722 hsa-mir-324 hsa05218 Melanoma 5595_4193_3265_1870_7157_1029_5925_1871_207 9 4.71E-10 3.11E-08 2.59E-09 13723 hsa-mir-324 hsa05223 Non-small cell lung cancer 5595_3265_1870_7157_1029_5925_1871_207 8 1.46E-09 9.67E-08 7.44E-09 13724 hsa-mir-324 hsa05210 Colorectal cancer 4609_5595_5599_2932_7157_5601_4087_4088_207 9 1.84E-09 1.22E-07 8.69E-09 13725 hsa-mir-324 hsa05016 Huntington's disease 1385_1387_2902_6908_6667_7157_3066_3065_3064_2033_9519 11 1.10E-08 7.26E-07 4.84E-08 13726 hsa-mir-324 hsa04330 Notch signaling pathway 1387_1487_1488_3066_3065_2033_4851 7 1.55E-08 1.03E-06 6.41E-08 13727 hsa-mir-324 hsa04350 TGF-beta signaling pathway 4609_5518_5595_1387_6667_4087_4088_2033 8 4.54E-08 3.00E-06 1.66E-07 13728 hsa-mir-324 hsa04012 ErbB signaling pathway 4609_815_5595_5599_2932_3265_5601_207 8 4.54E-08 3.00E-06 1.66E-07 13729 hsa-mir-324 hsa04520 Adherens junction 5595_1387_1457_4087_4088_2033_71 7 4.42E-07 2.92E-05 1.54E-06 13730 hsa-mir-324 hsa05213 Endometrial cancer 4609_5595_2932_3265_7157_207 6 6.78E-07 4.47E-05 2.19E-06 13731 hsa-mir-324 hsa05222 Small cell lung cancer 4609_8554_1870_7157_5925_1871_207 7 6.98E-07 4.61E-05 2.19E-06 13732 hsa-mir-324 hsa04530 Tight junction 5518_1457_3265_22800_8573_8189_207_71 8 1.19E-06 7.83E-05 3.56E-06 13733 hsa-mir-324 hsa04916 Melanogenesis 815_5595_1385_1387_2932_3265_2033 7 2.31E-06 0.000152499 6.63E-06 13734 hsa-mir-324 hsa04664 Fc epsilon RI signaling pathway 5595_5599_3265_1432_5601_207 6 6.51E-06 0.000429375 1.79E-05 13735 hsa-mir-324 hsa04612 Antigen processing and presentation 3320_3326_1385_3308_3303_3312 6 1.24E-05 0.000816598 3.27E-05 13736 hsa-mir-324 hsa04910 Insulin signaling pathway 5595_5599_6720_2932_3265_5601_207 7 1.35E-05 0.000890782 3.33E-05 13737 hsa-mir-324 hsa04150 mTOR signaling pathway 5595_6195_6196_6197_207 5 1.36E-05 0.000899395 3.33E-05 13738 hsa-mir-324 hsa04620 Toll-like receptor signaling pathway 5595_5599_1432_6772_5601_207 6 2.57E-05 0.001698268 6.07E-05 13739 hsa-mir-324 hsa05216 Thyroid cancer 4609_5595_3265_7157 4 2.84E-05 0.001872097 6.46E-05 13740 hsa-mir-324 hsa04912 GnRH signaling pathway 815_5595_5599_3265_1432_5601 6 3.49E-05 0.002305432 7.68E-05 13741 hsa-mir-324 hsa04660 T cell receptor signaling pathway 5595_2932_3265_1432_5601_207 6 3.85E-05 0.002542623 8.20E-05 13742 hsa-mir-324 hsa05211 Renal cell carcinoma 5595_1387_3265_2033_207 5 5.90E-05 0.003894751 0.000121711 13743 hsa-mir-324 hsa04370 VEGF signaling pathway 5595_9261_3265_1432_207 5 7.98E-05 0.005264515 0.000159531 13744 hsa-mir-324 hsa03450 Non-homologous end-joining 5591_7520_2547 3 9.61E-05 0.006341633 0.000186519 13745 hsa-mir-324 hsa04930 Type II diabetes mellitus 3651_5595_5599_5601 4 0.000137432 0.009070527 0.000259158 13746 hsa-mir-324 hsa04510 Focal adhesion 5595_5599_2932_3265_5601_207_71 7 0.000154428 0.01019223 0.000283118 13747 hsa-mir-324 hsa04630 Jak-STAT signaling pathway 4609_1387_6772_8554_2033_207 6 0.000234736 0.015492552 0.000418718 13748 hsa-mir-324 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906_1432_7157 4 0.000302214 0.01994612 0.000524898 13749 hsa-mir-324 hsa05221 Acute myeloid leukemia 4609_5595_3265_207 4 0.000364612 0.024064404 0.000617036 13750 hsa-mir-324 hsa05010 Alzheimer's disease 22926_5595_2902_2906_2932_351 6 0.000465167 0.030701012 0.000767525 13751 hsa-mir-324 hsa04730 Long-term depression 5518_5595_5592_3265 4 0.000707994 0.046727629 0.001134902 13752 hsa-mir-324 hsa04062 Chemokine signaling pathway 5595_2932_3265_2931_6772_207 6 0.000722211 0.047665898 0.001134902 13753 hsa-mir-324 hsa04662 B cell receptor signaling pathway 5595_2932_3265_207 4 0.000860871 0.056817466 0.001321336 13754 hsa-mir-324 hsa04120 Ubiquitin mediated proteolysis 7329_672_4193_8554_10273 5 0.001078927 0.071209197 0.001618391 13755 hsa-mir-324 hsa05217 Basal cell carcinoma 2932_7157_2736 3 0.003715019 0.245191283 0.005448695 13756 hsa-mir-324 hsa04920 Adipocytokine signaling pathway 5599_5601_207 3 0.006290891 0.415198825 0.009026061 13757 hsa-mir-324 hsa04115 p53 signaling pathway 4193_7157_1029 3 0.006801146 0.448875617 0.009550545 13758 hsa-mir-324 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_1432_5601 3 0.00733532 0.48413113 0.010086065 13759 hsa-mir-324 hsa04540 Gap junction 5595_5592_3265 3 0.014852436 0.980260747 0.020005321 13760 hsa-mir-324 hsa04810 Regulation of actin cytoskeleton 5595_3265_22800_71 4 0.031956226 1 0.042182219 13761 hsa-mir-324 hsa04360 Axon guidance 5595_2932_3265 3 0.035241602 1 0.045606778 13762 hsa-mir-324 hsa05131 Shigellosis 7534_71 2 0.038521951 1 0.047970731 13763 hsa-mir-324 hsa05130 Pathogenic Escherichia coli infection 7534_71 2 0.038521951 1 0.047970731 13764 hsa-mir-324 hsa04340 Hedgehog signaling pathway 2932_2736 2 0.039736796 1 0.048567195 13765 hsa-mir-325 hsa04110 Cell cycle 5925_2033_1019_1017_7027_1026_5933_1387 8 2.23E-11 9.37E-10 9.37E-10 13766 hsa-mir-325 hsa05200 Pathways in cancer 6688_5925_2033_1019_1017_8554_4609_1499_1026_1387 10 1.14E-10 4.79E-09 1.29E-09 13767 hsa-mir-325 hsa04350 TGF-beta signaling pathway 1874_2033_7027_4609_5518_5933_1387 7 1.33E-10 5.57E-09 1.29E-09 13768 hsa-mir-325 hsa05215 Prostate cancer 5925_2033_1017_468_1499_1026_1387 7 1.43E-10 6.01E-09 1.29E-09 13769 hsa-mir-325 hsa05212 Pancreatic cancer 5925_2033_1017_468_1499_1026_1387 7 1.54E-10 6.47E-09 1.29E-09 13770 hsa-mir-325 hsa05222 Small cell lung cancer 5925_1019_1017_8554_4609 5 3.16E-07 1.33E-05 2.21E-06 13771 hsa-mir-325 hsa05219 Bladder cancer 5925_1019_4609_1026 4 8.17E-07 3.43E-05 4.90E-06 13772 hsa-mir-325 hsa04310 Wnt signaling pathway 2033_4609_1499_5518_1387 5 4.69E-06 0.000197171 2.46E-05 13773 hsa-mir-325 hsa05220 Chronic myeloid leukemia 5925_1019_4609_1026 4 7.24E-06 0.000304213 3.38E-05 13774 hsa-mir-325 hsa04630 Jak-STAT signaling pathway 2033_8554_4609_1387 4 0.00011279 0.004737199 0.00047372 13775 hsa-mir-325 hsa05214 Glioma 5925_1019_1026 3 0.000167382 0.00703003 0.000639094 13776 hsa-mir-325 hsa04115 p53 signaling pathway 1019_1017_1026 3 0.00019832 0.008329431 0.000694119 13777 hsa-mir-325 hsa05218 Melanoma 5925_1019_1026 3 0.000215086 0.009033626 0.000694894 13778 hsa-mir-325 hsa04720 Long-term potentiation 2033_468_1387 3 0.000251317 0.01055532 0.000753951 13779 hsa-mir-325 hsa04520 Adherens junction 2033_1499_1387 3 0.000301872 0.012678614 0.000845241 13780 hsa-mir-325 hsa04916 Melanogenesis 2033_1499_1387 3 0.000635214 0.026678973 0.001667436 13781 hsa-mir-325 hsa04950 Maturity onset diabetes of the young 5080_6927 2 0.00075989 0.031915373 0.001877375 13782 hsa-mir-325 hsa04010 MAPK signaling pathway 468_4609_1649_1386 4 0.000923057 0.038768392 0.0021538 13783 hsa-mir-325 hsa05216 Thyroid cancer 4609_1499 2 0.001081824 0.045436605 0.0023914 13784 hsa-mir-325 hsa04530 Tight junction 1019_1499_5518 3 0.001381668 0.058030046 0.002901502 13785 hsa-mir-325 hsa04330 Notch signaling pathway 2033_1387 2 0.002687392 0.112870451 0.005374783 13786 hsa-mir-325 hsa05213 Endometrial cancer 4609_1499 2 0.003253904 0.13666396 0.006211998 13787 hsa-mir-325 hsa05223 Non-small cell lung cancer 5925_1019 2 0.003494803 0.146781719 0.006381814 13788 hsa-mir-325 hsa05221 Acute myeloid leukemia 6688_4609 2 0.00413234 0.173558271 0.007231595 13789 hsa-mir-325 hsa05211 Renal cell carcinoma 2033_1387 2 0.00602097 0.252880737 0.010115229 13790 hsa-mir-325 hsa05210 Colorectal cancer 4609_1499 2 0.008051261 0.338152948 0.013005883 13791 hsa-mir-325 hsa04012 ErbB signaling pathway 4609_1026 2 0.008600602 0.361225286 0.013378714 13792 hsa-mir-325 hsa04120 Ubiquitin mediated proteolysis 8554_7329 2 0.020592165 0.864870924 0.030888247 13793 hsa-mir-325 hsa05016 Huntington's disease 2033_1387 2 0.035700031 1 0.051642398 13794 hsa-mir-325 hsa03430 Mismatch repair 5981 1 0.036887427 1 0.051642398 13795 hsa-mir-326 hsa05200 Pathways in cancer 4088_4089_1869_1870_1871_2308_9915_7157_4087_5371_2034_2033_1017_1050_3091_4149_5594_1387 18 8.67E-19 4.86E-17 4.86E-17 13796 hsa-mir-326 hsa04110 Cell cycle 4088_4089_1869_1870_1871_7157_4087_2033_1017_890_5934_1387_5933 13 1.77E-17 9.92E-16 4.96E-16 13797 hsa-mir-326 hsa04350 TGF-beta signaling pathway 4088_4089_1875_4087_2033_4093_5594_1874_5934_1387_5933 11 1.38E-15 7.72E-14 2.57E-14 13798 hsa-mir-326 hsa05215 Prostate cancer 1869_1870_1871_2308_7157_2033_1017_5594_1387 9 3.48E-12 1.95E-10 4.28E-11 13799 hsa-mir-326 hsa05212 Pancreatic cancer 1869_1870_1871_2308_7157_2033_1017_5594_1387 9 3.82E-12 2.14E-10 4.28E-11 13800 hsa-mir-326 hsa05220 Chronic myeloid leukemia 4088_4089_1869_1870_1871_7157_5594 7 1.78E-09 9.95E-08 1.66E-08 13801 hsa-mir-326 hsa04520 Adherens junction 4088_4089_4087_2033_5594_1457_1387 7 2.70E-09 1.51E-07 2.16E-08 13802 hsa-mir-326 hsa05211 Renal cell carcinoma 9915_2034_2033_3091_5594_1387 6 5.12E-08 2.87E-06 3.59E-07 13803 hsa-mir-326 hsa05219 Bladder cancer 1869_1870_1871_7157_5594 5 1.36E-07 7.61E-06 7.74E-07 13804 hsa-mir-326 hsa05222 Small cell lung cancer 1869_1870_1871_7157_1017_4149 6 1.38E-07 7.74E-06 7.74E-07 13805 hsa-mir-326 hsa04310 Wnt signaling pathway 4088_4089_7157_4087_2033_1457_1387 7 1.78E-07 9.98E-06 9.07E-07 13806 hsa-mir-326 hsa05223 Non-small cell lung cancer 1869_1870_1871_7157_5594 5 4.33E-07 2.43E-05 2.02E-06 13807 hsa-mir-326 hsa05214 Glioma 1869_1870_1871_7157_5594 5 1.02E-06 5.74E-05 4.41E-06 13808 hsa-mir-326 hsa05218 Melanoma 1869_1870_1871_7157_5594 5 1.55E-06 8.65E-05 6.18E-06 13809 hsa-mir-326 hsa05210 Colorectal cancer 4088_4089_7157_4087_5594 5 3.38E-06 0.000189425 1.26E-05 13810 hsa-mir-326 hsa04330 Notch signaling pathway 9612_2033_1387 3 0.000289963 0.016237921 0.00101487 13811 hsa-mir-326 hsa04150 mTOR signaling pathway 5563_3091_5594 3 0.00038457 0.021535934 0.00126682 13812 hsa-mir-326 hsa04910 Insulin signaling pathway 2308_10891_5563_5594 4 0.00049332 0.027625907 0.001534773 13813 hsa-mir-326 hsa05221 Acute myeloid leukemia 5371_1050_5594 3 0.000547307 0.0306492 0.001613116 13814 hsa-mir-326 hsa04720 Long-term potentiation 2033_5594_1387 3 0.001069071 0.059867951 0.002993398 13815 hsa-mir-326 hsa05016 Huntington's disease 7157_10891_2033_1387 4 0.001514293 0.084800419 0.004038115 13816 hsa-mir-326 hsa04916 Melanogenesis 2033_5594_1387 3 0.002645019 0.148121052 0.006732775 13817 hsa-mir-326 hsa05216 Thyroid cancer 7157_5594 2 0.002866822 0.16054204 0.006980089 13818 hsa-mir-326 hsa04010 MAPK signaling pathway 7157_4149_5594_1432 4 0.005627865 0.315160458 0.013131686 13819 hsa-mir-326 hsa05213 Endometrial cancer 7157_5594 2 0.008493571 0.475639981 0.019025599 13820 hsa-mir-326 hsa05014 Amyotrophic lateral sclerosis (ALS) 7157_1432 2 0.009746794 0.545820482 0.020993095 13821 hsa-mir-326 hsa04920 Adipocytokine signaling pathway 10891_5563 2 0.013584961 0.760757831 0.028176216 13822 hsa-mir-326 hsa04115 p53 signaling pathway 7157_1017 2 0.014342661 0.803189027 0.028685322 13823 hsa-mir-326 hsa04370 VEGF signaling pathway 5594_1432 2 0.017550615 0.98283442 0.033890842 13824 hsa-mir-326 hsa04664 Fc epsilon RI signaling pathway 5594_1432 2 0.018395913 1 0.034339037 13825 hsa-mir-326 hsa04620 Toll-like receptor signaling pathway 5594_1432 2 0.02928715 1 0.052905819 13826 hsa-mir-326 hsa04912 GnRH signaling pathway 5594_1432 2 0.032461998 1 0.056808497 13827 hsa-mir-326 hsa04660 T cell receptor signaling pathway 5594_1432 2 0.033549138 1 0.05693187 13828 hsa-mir-328 hsa05200 Pathways in cancer 3716_3320_3326_5747_2249_675_1956_1499_5594_2261_5595_5914_1387_6256_5159_862_5156_5601_1019_1399_1398_367_1017_3815_6774_2064_6776_6777_3265_5970_8554_6688_4089_8772_4609_3725_1026_867_2353_6772_3065_1050_5925_2033_6502_207_2932_5879_7046 49 1.85E-37 1.48E-35 1.48E-35 13829 hsa-mir-328 hsa04630 Jak-STAT signaling pathway 2690_3717_3716_3718_85480_3560_1387_3575_6774_6776_6777_6773_8554_3455_58985_2057_3459_5781_7297_4609_867_3561_6772_1439_2033_3977_207_10379 28 7.21E-24 5.77E-22 2.88E-22 13830 hsa-mir-328 hsa04010 MAPK signaling pathway 6722_2249_1956_5594_2261_5595_1386_5159_9261_5156_4208_5601_1649_7132_1399_1398_2264_9252_7867_1432_1845_3265_5970_468_4609_3725_3727_2353_207_5879_22800_7046 32 6.17E-22 4.94E-20 1.65E-20 13831 hsa-mir-328 hsa04012 ErbB signaling pathway 5747_818_817_1956_6714_5594_5595_5601_1399_1398_2064_6776_6777_2066_3265_4609_3725_1026_867_207_2932_6464 22 9.35E-22 7.48E-20 1.87E-20 13832 hsa-mir-328 hsa05215 Prostate cancer 3320_3326_1956_1499_5594_5595_1387_5159_5156_367_1017_2064_3265_5970_468_1026_5925_2033_207_2932 20 4.22E-19 3.37E-17 6.51E-18 13833 hsa-mir-328 hsa05212 Pancreatic cancer 3320_3326_1956_1499_5594_5595_1387_5159_5156_367_1017_2064_3265_5970_468_1026_5925_2033_207_2932 20 5.11E-19 4.09E-17 6.51E-18 13834 hsa-mir-328 hsa05220 Chronic myeloid leukemia 5594_5595_1019_1399_1398_6776_6777_3265_5970_5781_4089_4609_1026_867_3065_5925_207_6464_7046 19 5.70E-19 4.56E-17 6.51E-18 13835 hsa-mir-328 hsa05214 Glioma 818_817_1956_5594_5595_5159_5156_1019_3265_1026_5925_808_207_6464_805_801 16 5.22E-16 4.18E-14 5.22E-15 13836 hsa-mir-328 hsa04350 TGF-beta signaling pathway 5515_5594_5595_1387_90_7027_3397_1874_4089_4609_3399_3398_2033_6667_7046_5933_57154 17 1.79E-15 1.43E-13 1.59E-14 13837 hsa-mir-328 hsa04510 Focal adhesion 5747_2321_3791_1956_1499_6714_5594_5595_5159_5156_5601_1399_1398_2064_3265_3725_207_2932_71_5879_6464_2534 22 1.11E-14 8.90E-13 8.90E-14 13838 hsa-mir-328 hsa04060 Cytokine-cytokine receptor interaction 2690_2321_3791_85480_1956_3560_90_5159_1234_5156_7133_7132_3575_1230_3815_7852_3455_58985_2057_3459_3561_1439_3977_7046 24 1.54E-14 1.23E-12 1.12E-13 13839 hsa-mir-328 hsa04062 Chemokine signaling pathway 3717_3718_5747_5594_5595_1234_1399_1398_1230_5580_6774_6777_6773_3265_5970_7852_6772_207_2932_5879_6464 21 3.24E-14 2.59E-12 2.16E-13 13840 hsa-mir-328 hsa05221 Acute myeloid leukemia 5594_5595_5914_862_3815_6774_6776_6777_3265_5970_6688_4609_1050_207 14 5.57E-14 4.46E-12 3.43E-13 13841 hsa-mir-328 hsa04520 Adherens junction 1956_1499_6714_3643_5594_5595_1387_2064_4089_5770_2033_71_5879_7046_2534 15 1.42E-13 1.13E-11 8.10E-13 13842 hsa-mir-328 hsa05210 Colorectal cancer 1956_1499_5594_5595_5159_5156_5601_4089_4609_3725_2353_207_2932_5879_7046 15 2.66E-13 2.13E-11 1.42E-12 13843 hsa-mir-328 hsa04660 T cell receptor signaling pathway 5594_5595_5601_1019_1432_3265_5970_1493_3725_867_2353_919_207_2932_3932_2534 16 7.13E-13 5.70E-11 3.56E-12 13844 hsa-mir-328 hsa04912 GnRH signaling pathway 818_817_1956_6714_5594_5595_5601_1432_5580_3265_468_3725_808_805_801 15 6.83E-12 5.47E-10 3.22E-11 13845 hsa-mir-328 hsa05219 Bladder cancer 1956_5594_2261_5595_1019_9252_2064_3265_4609_1026_5925 11 1.16E-11 9.27E-10 5.15E-11 13846 hsa-mir-328 hsa04720 Long-term potentiation 818_817_5594_5595_1387_3265_2902_468_2906_808_2033_805_801 13 1.47E-11 1.18E-09 6.20E-11 13847 hsa-mir-328 hsa04910 Insulin signaling pathway 3643_5594_5595_5601_1399_1398_3265_5770_867_808_207_2932_6464_805_801 15 1.61E-10 1.29E-08 6.44E-10 13848 hsa-mir-328 hsa04110 Cell cycle 1387_1019_1017_7027_4089_4174_1026_4172_3065_5925_2033_6502_2932_5933 14 2.56E-10 2.05E-08 9.74E-10 13849 hsa-mir-328 hsa04916 Melanogenesis 818_817_1499_5594_5595_1387_3815_3265_808_2033_2932_805_801 13 5.71E-10 4.57E-08 2.08E-09 13850 hsa-mir-328 hsa05218 Melanoma 2249_1956_5594_5595_5159_5156_1019_3265_1026_5925_207 11 1.61E-09 1.28E-07 5.58E-09 13851 hsa-mir-328 hsa05211 Renal cell carcinoma 5594_5595_1387_1399_1398_3265_5781_3725_2033_207_5879 11 1.83E-09 1.47E-07 6.11E-09 13852 hsa-mir-328 hsa04662 B cell receptor signaling pathway 5594_5595_695_3265_5970_6850_3725_2353_207_2932_5879 11 2.70E-09 2.16E-07 8.63E-09 13853 hsa-mir-328 hsa04370 VEGF signaling pathway 5747_3791_6714_5594_5595_9261_7867_1432_3265_207_5879 11 3.46E-09 2.77E-07 1.07E-08 13854 hsa-mir-328 hsa04664 Fc epsilon RI signaling pathway 5594_5595_695_5601_1432_5580_3265_6850_207_5879_2534 11 4.41E-09 3.53E-07 1.31E-08 13855 hsa-mir-328 hsa04620 Toll-like receptor signaling pathway 5594_5595_5601_1432_5970_3455_8772_3725_2353_6772_207_5879 12 4.94E-09 3.95E-07 1.41E-08 13856 hsa-mir-328 hsa04920 Adipocytokine signaling pathway 3717_8717_6256_5601_7133_7132_6774_5970_5781_207 10 1.24E-08 9.89E-07 3.41E-08 13857 hsa-mir-328 hsa05213 Endometrial cancer 1956_1499_5594_5595_2064_3265_4609_207_2932 9 2.13E-08 1.70E-06 5.68E-08 13858 hsa-mir-328 hsa05223 Non-small cell lung cancer 1956_5594_5595_6256_1019_2064_3265_5925_207 9 2.85E-08 2.28E-06 7.35E-08 13859 hsa-mir-328 hsa04310 Wnt signaling pathway 5515_818_817_1499_1387_5601_4089_8061_4609_3725_2033_2932_5879 13 3.83E-08 3.06E-06 9.58E-08 13860 hsa-mir-328 hsa04810 Regulation of actin cytoskeleton 5747_2249_1956_5594_2261_5595_5159_5156_1399_1398_2264_3265_71_5879_22800 15 5.47E-08 4.37E-06 1.32E-07 13861 hsa-mir-328 hsa05222 Small cell lung cancer 5747_6256_1019_1017_5970_8554_4609_5925_6502_207 10 1.06E-07 8.46E-06 2.48E-07 13862 hsa-mir-328 hsa04650 Natural killer cell mediated cytotoxicity 5594_5595_3265_6850_3455_3459_5781_919_3932_5879_6464_2534 12 1.09E-07 8.68E-06 2.48E-07 13863 hsa-mir-328 hsa04020 Calcium signaling pathway 818_817_1956_5159_147_5156_2064_2066_2902_2906_808_805_801 13 3.04E-07 2.43E-05 6.76E-07 13864 hsa-mir-328 hsa05010 Alzheimer's disease 5594_5595_7132_2902_8772_2906_808_351_2932_805_4724_801 12 1.31E-06 0.0001046 2.83E-06 13865 hsa-mir-328 hsa05216 Thyroid cancer 1499_5594_5595_6256_3265_4609 6 2.04E-06 0.000163323 4.30E-06 13866 hsa-mir-328 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_5601_1432_5970_5781_3725_5879 8 2.52E-06 0.000201217 5.16E-06 13867 hsa-mir-328 hsa04530 Tight junction 8573_5515_1499_6714_1019_5580_3265_207_71_22800 10 5.45E-06 0.000435742 1.09E-05 13868 hsa-mir-328 hsa04930 Type II diabetes mellitus 3643_5594_5595_5601_3651_5580 6 1.96E-05 0.001564112 3.81E-05 13869 hsa-mir-328 hsa04330 Notch signaling pathway 1387_388585_8850_9612_3065_2033 6 2.45E-05 0.001957558 4.66E-05 13870 hsa-mir-328 hsa05014 Amyotrophic lateral sclerosis (ALS) 7133_7132_1432_2902_2906_5879 6 6.03E-05 0.004826438 0.000112243 13871 hsa-mir-328 hsa05340 Primary immunodeficiency 3718_695_3575_3561_3932 5 7.32E-05 0.005859558 0.000133172 13872 hsa-mir-328 hsa03022 Basal transcription factors 2969_6874_6908_6883_9519 5 9.30E-05 0.007440822 0.000165352 13873 hsa-mir-328 hsa04540 Gap junction 1956_6714_5594_5595_5159_5156_3265 7 0.000118404 0.009472345 0.000205921 13874 hsa-mir-328 hsa04360 Axon guidance 5747_5594_5595_3265_7852_2932_5879_2534 8 0.000153991 0.01231928 0.000262112 13875 hsa-mir-328 hsa05016 Huntington's disease 6874_1387_6908_2902_3065_2033_6667_4724_9519 9 0.000343023 0.027441812 0.000571704 13876 hsa-mir-328 hsa04270 Vascular smooth muscle contraction 5594_5595_147_5580_808_805_801 7 0.000467618 0.037409433 0.000763458 13877 hsa-mir-328 hsa04670 Leukocyte transendothelial migration 5747_1499_1432_7852_5781_71_5879 7 0.000564801 0.045184062 0.000903681 13878 hsa-mir-328 hsa04210 Apoptosis 8717_7132_5970_8772_1439_207 6 0.000630902 0.050472161 0.00098965 13879 hsa-mir-328 hsa04950 Maturity onset diabetes of the young 3651_168620_6927 3 0.003128373 0.250269848 0.004812882 13880 hsa-mir-328 hsa04120 Ubiquitin mediated proteolysis 672_8554_7329_867_6502_57154 6 0.005364562 0.42916494 0.008097452 13881 hsa-mir-328 hsa03030 DNA replication 5981_4174_4172 3 0.008875521 0.710041659 0.01314892 13882 hsa-mir-328 hsa04730 Long-term depression 5515_5594_5595_3265 4 0.009316994 0.74535952 0.013551991 13883 hsa-mir-328 hsa04612 Antigen processing and presentation 3320_3326_3308_4800 4 0.019228082 1 0.027468689 13884 hsa-mir-328 hsa04150 mTOR signaling pathway 5594_5595_207 3 0.022426377 1 0.031475617 13885 hsa-mir-328 hsa05131 Shigellosis 1499_71_2534 3 0.026922084 1 0.036504521 13886 hsa-mir-328 hsa05130 Pathogenic Escherichia coli infection 1499_71_2534 3 0.026922084 1 0.036504521 13887 hsa-mir-328 hsa04115 p53 signaling pathway 1019_1017_1026 3 0.044576885 1 0.059435847 13888 hsa-mir-329-1 hsa05200 Pathways in cancer 4149_7046_1499_5914_1017_3065_1050_5925_5747_25_1956_1870_1871_4824_2113_5894_862_867_6502_207_4286_3716_2261_5595_5594_5599_6258_1387_2064_6256_836_2932_6774_6777_6772_5970_7157_1869_3725_6776_2735_2736_2737_4087_4088_4089_2033_898_4790_4792_5879_3320_3326_5371_675_5159_5156_5604_5601_1399_1398_3815_3265_842_841_4292_8772_1026_1029_2353_8554 71 4.91E-48 3.88E-46 3.88E-46 13889 hsa-mir-329-1 hsa04110 Cell cycle 1017_5001_6500_4174_4172_4173_3065_5925_25_1870_1871_6502_5934_5933_990_5591_1387_7534_7531_7533_7532_2932_7157_1869_4087_4088_4089_2033_890_898_983_8454_1026_1029_4998_4999 36 3.34E-29 2.64E-27 1.32E-27 13890 hsa-mir-329-1 hsa05215 Prostate cancer 1499_1017_5925_1956_1870_1871_4824_5894_207_5595_5594_1385_1387_2064_2932_5970_7157_1869_2033_898_4790_4792_3320_3326_5159_5156_5604_3265_842_1026 30 8.49E-26 6.71E-24 2.20E-24 13891 hsa-mir-329-1 hsa05212 Pancreatic cancer 1499_1017_5925_1956_1870_1871_4824_5894_207_5595_5594_1385_1387_2064_2932_5970_7157_1869_2033_898_4790_4792_3320_3326_5159_5156_5604_3265_842_1026 30 1.12E-25 8.82E-24 2.20E-24 13892 hsa-mir-329-1 hsa05220 Chronic myeloid leukemia 7046_3065_5925_25_1870_1871_5894_867_207_5595_5594_6777_5970_7157_1869_6776_4088_4089_4790_4792_5604_1399_1398_3265_5781_1026_1029_6464 28 4.76E-25 3.76E-23 7.53E-24 13893 hsa-mir-329-1 hsa04012 ErbB signaling pathway 818_815_817_5747_25_1956_6714_5894_867_207_5595_5594_5599_2064_2066_2932_6777_3725_6776_5604_5601_1399_1398_3265_1026_6464_2002 27 1.87E-22 1.48E-20 2.47E-21 13894 hsa-mir-329-1 hsa04010 MAPK signaling pathway 6722_4149_7046_2264_9252_7867_1845_1956_7132_3303_1432_5894_207_22800_2261_5595_5594_5599_5598_1386_836_3312_5970_7157_3725_6195_4790_5879_5159_9261_5156_5604_4208_5601_1399_1398_3265_2353_2005_2002 40 5.68E-22 4.49E-20 6.41E-21 13895 hsa-mir-329-1 hsa05214 Glioma 818_815_817_5925_1956_1870_1871_5894_207_5595_5594_7157_1869_808_801_805_5159_5156_5604_3265_1026_1029_6464 23 2.23E-20 1.76E-18 2.20E-19 13896 hsa-mir-329-1 hsa04630 Jak-STAT signaling pathway 3559_5777_58985_3455_3560_3561_3566_1439_2057_867_2690_207_3717_3716_3718_85480_1387_3575_6774_6777_6772_6773_7297_6776_2033_3459_5781_8554_10379 29 8.57E-19 6.77E-17 7.53E-18 13897 hsa-mir-329-1 hsa05210 Colorectal cancer 7046_1499_1956_5894_207_5595_5594_5599_836_2932_7157_3725_4087_4088_4089_5879_5159_5156_5604_5601_842_4292_2353 23 2.65E-18 2.10E-16 2.10E-17 13898 hsa-mir-329-1 hsa04350 TGF-beta signaling pathway 7046_6500_90_3397_57154_6667_3399_3398_1874_1875_5934_5933_5595_5594_1387_4086_4087_4088_4089_2033_5515_4093_8454 23 5.13E-18 4.05E-16 3.69E-17 13899 hsa-mir-329-1 hsa04062 Chemokine signaling pathway 1234_1230_7074_5747_5580_7852_5894_207_3717_3718_5590_5595_5594_2932_2931_6774_6777_6772_6773_5970_4790_4792_5879_5604_1399_1398_3265_6464 28 1.18E-15 9.29E-14 7.74E-15 13900 hsa-mir-329-1 hsa04520 Adherens junction 7046_1499_5770_5777_2534_1956_6714_1460_5595_5594_1387_2064_1459_1457_4087_4088_4089_2033_5879_3643 20 1.92E-15 1.51E-13 1.16E-14 13901 hsa-mir-329-1 hsa05219 Bladder cancer 9252_5925_1956_1870_1871_5894_2261_5595_5594_2064_7157_1869_5604_3265_1026_1029 16 5.43E-15 4.29E-13 3.06E-14 13902 hsa-mir-329-1 hsa05223 Non-small cell lung cancer 5925_1956_1870_1871_5894_207_5595_5594_6258_2064_6256_7157_1869_5604_3265_842_1029 17 1.02E-14 8.09E-13 5.39E-14 13903 hsa-mir-329-1 hsa04510 Focal adhesion 1499_2534_5747_3791_1956_6714_5499_5894_207_5595_5594_5599_2064_2932_1729_3725_5879_2321_5159_5156_5604_5601_1399_1398_3265_6464_2002 27 3.53E-14 2.79E-12 1.74E-13 13904 hsa-mir-329-1 hsa04660 T cell receptor signaling pathway 919_5777_1493_2534_3932_1432_5894_867_207_5595_5594_2932_5970_3725_4790_4792_5604_5601_3265_1739_2353 21 3.97E-14 3.14E-12 1.84E-13 13905 hsa-mir-329-1 hsa04912 GnRH signaling pathway 818_815_817_5580_1956_6714_1432_5894_5595_5594_5599_5598_3725_808_801_805_5604_5601_3265_2002 20 2.66E-13 2.10E-11 1.17E-12 13906 hsa-mir-329-1 hsa05221 Acute myeloid leukemia 5914_1050_5894_862_207_5595_5594_6774_6777_5970_6776_4790_5371_5604_3815_3265 16 4.35E-13 3.44E-11 1.79E-12 13907 hsa-mir-329-1 hsa05218 Melanoma 5925_1956_1870_1871_5894_207_4286_5595_5594_7157_1869_5159_5156_5604_3265_1026_1029 17 4.54E-13 3.59E-11 1.79E-12 13908 hsa-mir-329-1 hsa05222 Small cell lung cancer 4149_1017_5925_5747_1870_1871_6502_207_6258_6256_5970_7157_1869_898_4790_4792_842_8554 18 6.79E-13 5.36E-11 2.55E-12 13909 hsa-mir-329-1 hsa04720 Long-term potentiation 818_815_817_2902_5499_5894_5595_5594_1387_6195_2033_808_801_805_5604_3265_2906 17 9.76E-13 7.71E-11 3.50E-12 13910 hsa-mir-329-1 hsa04310 Wnt signaling pathway 818_815_817_1499_6500_1460_5599_1387_1459_2932_7157_8061_3725_1457_4087_4088_4089_2033_5879_5515_5601_8454 22 1.43E-12 1.13E-10 4.92E-12 13911 hsa-mir-329-1 hsa04910 Insulin signaling pathway 5770_5499_5894_867_207_5590_5595_5594_5599_2932_808_801_805_3643_5604_5601_1399_1398_3265_6464_2002 21 1.97E-12 1.55E-10 6.47E-12 13912 hsa-mir-329-1 hsa04662 B cell receptor signaling pathway 5777_6850_5894_207_695_5595_5594_2932_5970_3725_4790_4792_5879_5604_3265_2353 16 1.01E-11 7.99E-10 3.19E-11 13913 hsa-mir-329-1 hsa04916 Melanogenesis 818_815_817_1499_5894_4286_5595_5594_1385_1387_2932_2033_808_801_805_5604_3815_3265 18 1.13E-11 8.91E-10 3.43E-11 13914 hsa-mir-329-1 hsa05213 Endometrial cancer 1499_1956_5894_207_5595_5594_2064_2932_7157_5604_3265_842_4292_2002 14 1.39E-11 1.10E-09 4.06E-11 13915 hsa-mir-329-1 hsa04620 Toll-like receptor signaling pathway 3455_1432_207_5595_5594_5599_6772_5970_3725_4790_4792_5879_5604_5601_841_8772_2353 17 7.14E-11 5.64E-09 2.01E-10 13916 hsa-mir-329-1 hsa04060 Cytokine-cytokine receptor interaction 3559_7046_1234_1230_58985_3455_90_3791_1956_3560_3561_3566_7133_7132_1439_7852_2057_2690_85480_3575_2321_5159_5156_3815_3459 25 1.70E-10 1.34E-08 4.50E-10 13917 hsa-mir-329-1 hsa04540 Gap junction 7277_51807_1956_6714_5894_5595_5594_5598_7846_5159_983_5156_5604_3265_7278_10376 16 1.71E-10 1.35E-08 4.50E-10 13918 hsa-mir-329-1 hsa04920 Adipocytokine signaling pathway 7133_7132_207_3717_8717_5599_6258_6256_6774_5970_4790_4792_5601_5781 14 2.54E-10 2.01E-08 6.47E-10 13919 hsa-mir-329-1 hsa05211 Renal cell carcinoma 2113_5894_207_5595_5594_1387_3725_2033_5879_5604_1399_1398_3265_5781 14 5.81E-10 4.59E-08 1.43E-09 13920 hsa-mir-329-1 hsa04370 VEGF signaling pathway 7867_5747_3791_6714_1432_5894_207_5595_5594_5879_9261_5604_3265_842 14 1.26E-09 9.93E-08 3.01E-09 13921 hsa-mir-329-1 hsa04664 Fc epsilon RI signaling pathway 2534_5580_6850_1432_5894_207_695_5595_5594_5599_5879_5604_5601_3265 14 1.69E-09 1.33E-07 3.92E-09 13922 hsa-mir-329-1 hsa05010 Alzheimer's disease 2902_7132_4724_4716_22926_5595_5594_836_2932_808_351_801_805_842_841_840_2906_8772_4697 19 4.62E-09 3.65E-07 1.04E-08 13923 hsa-mir-329-1 hsa04210 Apoptosis 7132_1439_207_8717_836_839_5970_7157_4790_4792_842_841_840_8772 14 6.62E-09 5.23E-07 1.45E-08 13924 hsa-mir-329-1 hsa04650 Natural killer cell mediated cytotoxicity 919_5777_3455_2534_3932_6850_5894_5595_5594_836_5879_5604_3265_3459_5781_6464 16 2.86E-08 2.26E-06 6.10E-08 13925 hsa-mir-329-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_1432_5599_836_5970_3725_4790_4792_5879_5601_5781 12 3.94E-08 3.11E-06 8.18E-08 13926 hsa-mir-329-1 hsa03022 Basal transcription factors 6879_2962_2969_6872_6908_2958_2959_6880_9519 9 1.36E-07 1.07E-05 2.75E-07 13927 hsa-mir-329-1 hsa05216 Thyroid cancer 1499_5595_5594_6258_6256_7157_5604_3265 8 3.00E-07 2.37E-05 5.93E-07 13928 hsa-mir-329-1 hsa05131 Shigellosis 1499_7277_51807_2534_25_7534_7846_7278_4691_10376 10 3.42E-07 2.70E-05 6.43E-07 13929 hsa-mir-329-1 hsa05130 Pathogenic Escherichia coli infection 1499_7277_51807_2534_25_7534_7846_7278_4691_10376 10 3.42E-07 2.70E-05 6.43E-07 13930 hsa-mir-329-1 hsa04810 Regulation of actin cytoskeleton 2264_7074_5747_1956_5499_5894_22800_2261_5595_5594_1729_5879_5159_5156_5604_1399_1398_3265 18 4.81E-07 3.80E-05 8.83E-07 13931 hsa-mir-329-1 hsa04530 Tight junction 10207_1499_5580_6714_8573_8189_207_22800_1460_5590_1459_1457_5515_3265 14 8.48E-07 6.70E-05 1.52E-06 13932 hsa-mir-329-1 hsa04115 p53 signaling pathway 1017_836_7157_898_983_842_841_1026_7161_1029 10 1.89E-06 0.000148976 3.31E-06 13933 hsa-mir-329-1 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_7133_7132_1432_836_7157_5879_842_2906 9 2.89E-06 0.000228058 4.96E-06 13934 hsa-mir-329-1 hsa04930 Type II diabetes mellitus 5580_3651_5590_5595_5594_5599_3643_5601 8 5.33E-06 0.000420789 8.95E-06 13935 hsa-mir-329-1 hsa05016 Huntington's disease 3065_2902_4724_6667_4716_1385_1387_836_7157_2033_6908_842_841_4697_9519 15 5.99E-06 0.000473073 9.86E-06 13936 hsa-mir-329-1 hsa04020 Calcium signaling pathway 818_815_817_147_1956_2902_2064_2066_808_801_805_5159_5156_2906 14 2.00E-05 0.001577899 3.22E-05 13937 hsa-mir-329-1 hsa04120 Ubiquitin mediated proteolysis 55294_6500_57154_867_10273_6502_11059_7329_5371_672_8454_8554 12 2.46E-05 0.001943198 3.89E-05 13938 hsa-mir-329-1 hsa04330 Notch signaling pathway 9612_3065_388585_1387_2033_8850_2648 7 5.74E-05 0.004534474 8.89E-05 13939 hsa-mir-329-1 hsa04270 Vascular smooth muscle contraction 147_5580_5499_5894_5595_5594_808_801_805_5604 10 0.000133172 0.010520602 0.000202319 13940 hsa-mir-329-1 hsa04360 Axon guidance 2534_5747_25_5998_7852_5595_5594_2932_5879_3265 10 0.000293316 0.023171948 0.000437207 13941 hsa-mir-329-1 hsa04612 Antigen processing and presentation 3303_1385_3312_3320_3326_4800_4801_4802 8 0.000428904 0.033883448 0.000627471 13942 hsa-mir-329-1 hsa05340 Primary immunodeficiency 3932_3561_3718_695_3575 5 0.000798801 0.063105316 0.001147369 13943 hsa-mir-329-1 hsa05217 Basal cell carcinoma 1499_2932_7157_2735_2736_2737 6 0.00088755 0.070116428 0.001252079 13944 hsa-mir-329-1 hsa04730 Long-term depression 5894_5595_5594_5515_5604_3265 6 0.002962743 0.234056707 0.004106258 13945 hsa-mir-329-1 hsa03450 Non-homologous end-joining 2547_7520_5591 3 0.003470584 0.274176102 0.004727174 13946 hsa-mir-329-1 hsa04150 mTOR signaling pathway 207_5595_5594_6195 4 0.01957342 1 0.026208478 13947 hsa-mir-329-1 hsa04340 Hedgehog signaling pathway 2932_2735_2736_2737 4 0.025904499 1 0.03410759 13948 hsa-mir-329-1 hsa04640 Hematopoietic cell lineage 3559_3566_2057_3575_3815 5 0.027541558 1 0.035668575 13949 hsa-mir-329-1 hsa04670 Leukocyte transendothelial migration 1499_5747_1432_7852_5879_5781 6 0.031251392 1 0.039820322 13950 hsa-mir-329-1 hsa03030 DNA replication 4174_4172_4173 3 0.034662444 1 0.043465605 13951 hsa-mir-329-1 hsa05012 Parkinson's disease 7314_4724_4716_836_842_4697 6 0.047813949 1 0.059020343 13952 hsa-mir-329-2 hsa05200 Pathways in cancer 4149_7046_1017_842_3065_1050_5925_5747_25_1956_1487_1870_1871_4824_2113_5894_867_6502_207_4286_3716_2261_5595_5594_5599_6258_1387_2064_6256_836_2932_6774_6777_6772_5970_7157_1869_3725_6776_2735_2736_2737_4087_4088_4089_2033_898_4790_4792_5879_3320_3326_5371_675_5159_5156_5604_1399_1398_3815_3265_841_4292_8772_1026_1029_2353_1488_8554 69 4.93E-53 3.75E-51 3.75E-51 13953 hsa-mir-329-2 hsa05220 Chronic myeloid leukemia 7046_3065_5925_25_1487_1870_1871_5894_867_207_5595_5594_6777_5970_7157_1869_6776_4088_4089_4790_4792_5604_1399_1398_3265_5781_1026_1029_1488_6464 30 1.63E-30 1.24E-28 5.75E-29 13954 hsa-mir-329-2 hsa04110 Cell cycle 1017_5001_6500_4174_4172_4173_3065_5925_25_1870_1871_6502_5934_5933_990_5591_1387_7533_7532_2932_7157_1869_4087_4088_4089_2033_890_898_983_8454_1026_1029_4998_4999 34 2.27E-30 1.72E-28 5.75E-29 13955 hsa-mir-329-2 hsa05215 Prostate cancer 1017_842_5925_1956_1870_1871_4824_5894_207_5595_5594_1385_1387_2064_2932_5970_7157_1869_2033_898_4790_4792_3320_3326_5159_5156_5604_3265_1026 29 1.49E-27 1.13E-25 2.83E-26 13956 hsa-mir-329-2 hsa05212 Pancreatic cancer 1017_842_5925_1956_1870_1871_4824_5894_207_5595_5594_1385_1387_2064_2932_5970_7157_1869_2033_898_4790_4792_3320_3326_5159_5156_5604_3265_1026 29 1.95E-27 1.48E-25 2.96E-26 13957 hsa-mir-329-2 hsa04012 ErbB signaling pathway 818_815_817_5747_25_1956_6714_5894_867_207_5595_5594_5599_2064_2066_2932_6777_3725_6776_5604_1399_1398_3265_1026_6464_2002 26 6.42E-24 4.88E-22 8.13E-23 13958 hsa-mir-329-2 hsa04010 MAPK signaling pathway 6722_4149_7046_2264_9252_1845_1956_7132_1432_5894_207_22800_2261_5595_5594_5599_5598_1386_836_5970_7157_3725_6195_4790_5879_5159_9261_5156_5604_1399_1398_3265_2353_2005_2002 35 5.39E-21 4.10E-19 5.85E-20 13959 hsa-mir-329-2 hsa04630 Jak-STAT signaling pathway 5777_58985_3455_3459_3560_3561_3566_1439_2057_867_2690_207_3717_3716_3718_85480_1387_3575_6774_6777_6772_6773_7297_6776_2033_5781_8554_10379 28 1.54E-20 1.17E-18 1.46E-19 13960 hsa-mir-329-2 hsa05214 Glioma 818_815_817_5925_1956_1870_1871_5894_207_5595_5594_7157_1869_5159_5156_5604_3265_1026_1029_6464 20 6.67E-19 5.07E-17 5.63E-18 13961 hsa-mir-329-2 hsa05210 Colorectal cancer 7046_842_1956_5894_207_5595_5594_5599_836_2932_7157_3725_4087_4088_4089_5879_5159_5156_5604_4292_2353 21 3.27E-18 2.48E-16 2.48E-17 13962 hsa-mir-329-2 hsa04062 Chemokine signaling pathway 1234_1230_7074_5747_5580_7852_5894_207_3717_3718_5590_5595_5594_2932_6774_6777_6772_6773_5970_4790_4792_5879_5604_1399_1398_3265_6464 27 2.51E-17 1.91E-15 1.74E-16 13963 hsa-mir-329-2 hsa04350 TGF-beta signaling pathway 7046_6500_90_57154_6667_1874_1875_5934_5933_5595_5594_1387_4086_4087_4088_4089_2033_5515_4093_8454 20 8.48E-17 6.45E-15 5.37E-16 13964 hsa-mir-329-2 hsa05219 Bladder cancer 9252_5925_1956_1870_1871_5894_2261_5595_5594_2064_7157_1869_5604_3265_1026_1029 16 1.36E-16 1.04E-14 7.97E-16 13965 hsa-mir-329-2 hsa05223 Non-small cell lung cancer 842_5925_1956_1870_1871_5894_207_5595_5594_6258_2064_6256_7157_1869_5604_3265_1029 17 2.11E-16 1.60E-14 1.14E-15 13966 hsa-mir-329-2 hsa04520 Adherens junction 7046_5770_5777_2534_1956_6714_1460_5595_5594_1387_2064_1459_1457_4087_4088_4089_2033_5879_3643 19 3.00E-16 2.28E-14 1.52E-15 13967 hsa-mir-329-2 hsa04660 T cell receptor signaling pathway 919_5777_1493_2534_3932_1432_5894_867_207_5595_5594_2932_5970_3725_4790_4792_5604_3265_1739_2353 20 4.37E-15 3.32E-13 2.08E-14 13968 hsa-mir-329-2 hsa04510 Focal adhesion 2534_5747_3791_1956_6714_5499_5894_207_5595_5594_5599_2064_2932_1729_3725_5879_2321_5159_5156_5604_1399_1398_3265_6464_2002 25 7.56E-15 5.75E-13 3.38E-14 13969 hsa-mir-329-2 hsa05218 Melanoma 5925_1956_1870_1871_5894_207_4286_5595_5594_7157_1869_5159_5156_5604_3265_1026_1029 17 9.95E-15 7.56E-13 4.20E-14 13970 hsa-mir-329-2 hsa05222 Small cell lung cancer 4149_1017_842_5925_5747_1870_1871_6502_207_6258_6256_5970_7157_1869_898_4790_4792_8554 18 1.23E-14 9.37E-13 4.75E-14 13971 hsa-mir-329-2 hsa04310 Wnt signaling pathway 818_815_817_6500_1487_1460_5599_1387_1459_2932_7157_8061_3725_1457_4087_4088_4089_2033_5879_5515_8454_1488 22 1.25E-14 9.50E-13 4.75E-14 13972 hsa-mir-329-2 hsa04662 B cell receptor signaling pathway 5777_6850_5894_207_695_5595_5594_2932_5970_3725_4790_4792_5879_5604_3265_2353 16 2.87E-13 2.18E-11 1.04E-12 13973 hsa-mir-329-2 hsa05221 Acute myeloid leukemia 1050_5894_207_5595_5594_6774_6777_5970_6776_4790_5371_5604_3815_3265 14 2.56E-12 1.94E-10 8.84E-12 13974 hsa-mir-329-2 hsa04540 Gap junction 51807_1956_6714_5894_5595_5594_5598_7846_5159_983_5156_5604_3265_7277_7278_10376 16 5.17E-12 3.93E-10 1.71E-11 13975 hsa-mir-329-2 hsa04060 Cytokine-cytokine receptor interaction 7046_1234_1230_58985_3455_3459_90_3791_1956_7852_3560_3561_3566_7133_7132_1439_2057_2690_85480_3575_2321_5159_5156_3815 24 6.78E-12 5.15E-10 2.15E-11 13976 hsa-mir-329-2 hsa05213 Endometrial cancer 842_1956_5894_207_5595_5594_2064_2932_7157_5604_3265_4292_2002 13 8.85E-12 6.73E-10 2.69E-11 13977 hsa-mir-329-2 hsa04620 Toll-like receptor signaling pathway 3455_1432_207_5595_5594_5599_6772_5970_3725_4790_4792_5879_5604_841_8772_2353 16 1.79E-11 1.36E-09 5.24E-11 13978 hsa-mir-329-2 hsa05211 Renal cell carcinoma 2113_5894_207_5595_5594_1387_3725_2033_5879_5604_1399_1398_3265_5781 14 2.64E-11 2.01E-09 7.44E-11 13979 hsa-mir-329-2 hsa04912 GnRH signaling pathway 818_815_817_5580_1956_6714_1432_5894_5595_5594_5599_5598_3725_5604_3265_2002 16 3.86E-11 2.94E-09 1.05E-10 13980 hsa-mir-329-2 hsa04720 Long-term potentiation 818_815_817_2902_5499_5894_5595_5594_1387_6195_2033_5604_3265_2906 14 4.28E-11 3.25E-09 1.12E-10 13981 hsa-mir-329-2 hsa04910 Insulin signaling pathway 5770_5499_5894_867_207_5590_5595_5594_5599_2932_3643_5604_1399_1398_3265_6464_2002 17 1.30E-10 9.88E-09 3.29E-10 13982 hsa-mir-329-2 hsa04920 Adipocytokine signaling pathway 7133_7132_207_3717_8717_5599_6258_6256_6774_5970_4790_4792_5781 13 1.40E-10 1.06E-08 3.42E-10 13983 hsa-mir-329-2 hsa04210 Apoptosis 842_7132_1439_207_8717_836_839_5970_7157_4790_4792_841_840_8772 14 3.20E-10 2.44E-08 7.61E-10 13984 hsa-mir-329-2 hsa04370 VEGF signaling pathway 842_5747_3791_6714_1432_5894_207_5595_5594_5879_9261_5604_3265 13 6.38E-10 4.85E-08 1.47E-09 13985 hsa-mir-329-2 hsa04664 Fc epsilon RI signaling pathway 2534_5580_6850_1432_5894_207_695_5595_5594_5599_5879_5604_3265 13 8.44E-10 6.42E-08 1.89E-09 13986 hsa-mir-329-2 hsa04650 Natural killer cell mediated cytotoxicity 919_5777_3455_3459_2534_3932_6850_5894_5595_5594_836_5879_5604_3265_5781_6464 16 1.02E-09 7.76E-08 2.22E-09 13987 hsa-mir-329-2 hsa04916 Melanogenesis 818_815_817_5894_4286_5595_5594_1385_1387_2932_2033_5604_3815_3265 14 1.99E-09 1.52E-07 4.21E-09 13988 hsa-mir-329-2 hsa05010 Alzheimer's disease 842_2902_7132_4724_4716_22926_5595_5594_836_2932_351_841_840_2906_8772_1020_4697 17 4.25E-09 3.23E-07 8.73E-09 13989 hsa-mir-329-2 hsa04810 Regulation of actin cytoskeleton 2264_7074_5747_1956_5499_5894_22800_2261_5595_5594_1729_5879_5159_5156_5604_1399_1398_3265 18 1.42E-08 1.08E-06 2.85E-08 13990 hsa-mir-329-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_1432_5599_836_5970_3725_4790_4792_5879_5781 11 2.96E-08 2.25E-06 5.78E-08 13991 hsa-mir-329-2 hsa04115 p53 signaling pathway 1017_842_836_7157_898_983_841_1026_7161_1029 10 2.22E-07 1.69E-05 4.22E-07 13992 hsa-mir-329-2 hsa05016 Huntington's disease 842_3065_2902_4724_6667_4716_1385_1387_836_7157_2033_6908_841_4697_9519 15 3.26E-07 2.48E-05 6.05E-07 13993 hsa-mir-329-2 hsa05014 Amyotrophic lateral sclerosis (ALS) 842_2902_7133_7132_1432_836_7157_5879_2906 9 4.12E-07 3.13E-05 7.45E-07 13994 hsa-mir-329-2 hsa05216 Thyroid cancer 5595_5594_6258_6256_7157_5604_3265 7 7.53E-07 5.72E-05 1.33E-06 13995 hsa-mir-329-2 hsa04530 Tight junction 10207_5580_6714_8573_207_22800_1460_5590_1459_1457_5515_3265 12 2.00E-06 0.000152001 3.45E-06 13996 hsa-mir-329-2 hsa05131 Shigellosis 51807_2534_25_7846_7277_7278_4691_10376 8 4.03E-06 0.00030626 6.66E-06 13997 hsa-mir-329-2 hsa05130 Pathogenic Escherichia coli infection 51807_2534_25_7846_7277_7278_4691_10376 8 4.03E-06 0.00030626 6.66E-06 13998 hsa-mir-329-2 hsa04360 Axon guidance 2534_5747_25_5998_7852_5595_5594_2932_5879_3265_1020 11 7.75E-06 0.000588813 1.25E-05 13999 hsa-mir-329-2 hsa04330 Notch signaling pathway 9612_3065_1487_1387_2033_1488_2648 7 1.28E-05 0.000969219 2.02E-05 14000 hsa-mir-329-2 hsa04120 Ubiquitin mediated proteolysis 55294_6500_57154_867_7329_6502_11059_5371_672_8454_8554 11 1.30E-05 0.000991493 2.02E-05 14001 hsa-mir-329-2 hsa04930 Type II diabetes mellitus 5580_5590_5595_5594_5599_3643 6 9.39E-05 0.007132674 0.000142653 14002 hsa-mir-329-2 hsa04020 Calcium signaling pathway 818_815_817_147_1956_2902_2064_2066_5159_5156_2906 11 0.000142889 0.010859571 0.000212933 14003 hsa-mir-329-2 hsa05340 Primary immunodeficiency 3932_3561_3718_695_3575 5 0.000273101 0.02075568 0.000399148 14004 hsa-mir-329-2 hsa04730 Long-term depression 5894_5595_5594_5515_5604_3265 6 0.000900255 0.068419354 0.001290931 14005 hsa-mir-329-2 hsa05217 Basal cell carcinoma 2932_7157_2735_2736_2737 5 0.001788288 0.135909889 0.00251685 14006 hsa-mir-329-2 hsa04270 Vascular smooth muscle contraction 147_5580_5499_5894_5595_5594_5604 7 0.002383435 0.181141091 0.003293474 14007 hsa-mir-329-2 hsa04612 Antigen processing and presentation 1385_3320_3326_4800_4801_4802 6 0.00265413 0.201713893 0.003602034 14008 hsa-mir-329-2 hsa03022 Basal transcription factors 2962_2969_6908_9519 4 0.002903942 0.220699622 0.003871923 14009 hsa-mir-329-2 hsa04150 mTOR signaling pathway 207_5595_5594_6195 4 0.008886088 0.675342712 0.01164384 14010 hsa-mir-329-2 hsa04340 Hedgehog signaling pathway 2932_2735_2736_2737 4 0.011933866 0.906973798 0.015372437 14011 hsa-mir-329-2 hsa05012 Parkinson's disease 842_7314_4724_4716_836_4697 6 0.017792307 1 0.022536922 14012 hsa-mir-329-2 hsa03030 DNA replication 4174_4172_4173 3 0.018878379 1 0.023520604 14013 hsa-mir-329-2 hsa04670 Leukocyte transendothelial migration 5747_7852_1432_5879_5781 5 0.038133046 1 0.046743734 14014 hsa-mir-329-2 hsa04640 Hematopoietic cell lineage 3566_2057_3575_3815 4 0.0437319 1 0.052755943 14015 hsa-mir-330 hsa05200 Pathways in cancer 5371_9063_5595_5594_5599_5914_1387_6257_6256_8031_1871_5601_836_6258_367_7704_3091_5970_7428_1870_2885_7157_4087_2113_595_4609_1869_3725_5604_2353_4088_4089_3066_3065_5925_2034_2033_4846_8554 39 3.57E-40 2.25E-38 2.25E-38 14016 hsa-mir-330 hsa05220 Chronic myeloid leukemia 5595_5594_1871_5970_1870_2885_7157_595_4609_1869_5604_4088_4089_3066_3065_5925_6464 17 3.57E-22 2.25E-20 1.12E-20 14017 hsa-mir-330 hsa04010 MAPK signaling pathway 6722_5595_5594_5599_4208_5606_5601_5600_836_1432_5970_3312_2885_7157_10912_4609_3725_5604_2353_9344_4763_4616_2005 23 9.07E-21 5.71E-19 1.90E-19 14018 hsa-mir-330 hsa04110 Cell cycle 5591_1387_1871_1870_7157_4087_10912_595_1869_4088_4089_3066_3065_4616_5925_2033_5933 17 3.87E-19 2.44E-17 6.10E-18 14019 hsa-mir-330 hsa05210 Colorectal cancer 5595_5594_5599_5601_836_2885_7157_4087_595_4609_3725_5604_2353_4088_4089 15 2.55E-18 1.61E-16 3.21E-17 14020 hsa-mir-330 hsa05223 Non-small cell lung cancer 5595_5594_6257_6256_1871_6258_1870_2885_7157_595_1869_5604_5925 13 1.62E-17 1.02E-15 1.70E-16 14021 hsa-mir-330 hsa05222 Small cell lung cancer 9063_6257_6256_1871_6258_5970_1870_7157_595_4609_1869_5925_4846_8554 14 1.13E-16 7.13E-15 1.02E-15 14022 hsa-mir-330 hsa05215 Prostate cancer 5595_5594_1387_1871_367_5970_1870_2885_7157_595_1869_5604_5925_2033 14 1.51E-16 9.52E-15 1.19E-15 14023 hsa-mir-330 hsa05212 Pancreatic cancer 5595_5594_1387_1871_367_5970_1870_2885_7157_595_1869_5604_5925_2033 14 1.74E-16 1.10E-14 1.22E-15 14024 hsa-mir-330 hsa05216 Thyroid cancer 5595_5594_6257_6256_8031_6258_7157_595_4609_5604 10 4.40E-15 2.77E-13 2.77E-14 14025 hsa-mir-330 hsa05219 Bladder cancer 5595_5594_1871_1870_7157_595_4609_1869_5604_5925 10 1.04E-13 6.53E-12 5.77E-13 14026 hsa-mir-330 hsa04350 TGF-beta signaling pathway 5595_5594_1387_3397_3399_3398_4087_4609_4088_4089_2033_5933 12 1.10E-13 6.93E-12 5.77E-13 14027 hsa-mir-330 hsa05214 Glioma 5595_5594_1871_1870_2885_7157_595_1869_5604_5925_6464 11 1.60E-13 1.01E-11 7.76E-13 14028 hsa-mir-330 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2885_2113_3725_5604_2034_2033 11 4.38E-13 2.76E-11 1.97E-12 14029 hsa-mir-330 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_7704_5970_2885_595_4609_5604 10 2.07E-12 1.30E-10 8.70E-12 14030 hsa-mir-330 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5606_5601_5600_1432_5970_3725_5604_2353 11 1.39E-11 8.73E-10 5.46E-11 14031 hsa-mir-330 hsa04310 Wnt signaling pathway 5599_1387_5601_7157_4087_595_4609_3725_1457_4088_4089_2033 12 4.71E-11 2.97E-09 1.74E-10 14032 hsa-mir-330 hsa05218 Melanoma 5595_5594_1871_1870_7157_595_1869_5604_5925 9 2.83E-10 1.78E-08 9.91E-10 14033 hsa-mir-330 hsa04912 GnRH signaling pathway 5595_5594_5599_5606_5601_5600_1432_2885_3725_5604 10 4.81E-10 3.03E-08 1.59E-09 14034 hsa-mir-330 hsa04660 T cell receptor signaling pathway 5595_5594_5601_5600_1432_5970_2885_3725_5604_2353 10 5.68E-10 3.58E-08 1.79E-09 14035 hsa-mir-330 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5606_5601_5600_1432_2885_5604 9 6.74E-10 4.25E-08 2.02E-09 14036 hsa-mir-330 hsa04012 ErbB signaling pathway 5595_5594_5599_5601_2885_4609_3725_5604_6464 9 1.48E-09 9.31E-08 4.23E-09 14037 hsa-mir-330 hsa04520 Adherens junction 5595_5594_1387_4087_1457_4088_4089_2033 8 1.58E-08 9.98E-07 4.34E-08 14038 hsa-mir-330 hsa05213 Endometrial cancer 5595_5594_2885_7157_595_4609_5604 7 1.97E-08 1.24E-06 5.18E-08 14039 hsa-mir-330 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_5606_5600_836_1432_7157_4846 7 3.14E-08 1.98E-06 7.92E-08 14040 hsa-mir-330 hsa04910 Insulin signaling pathway 6720_10891_5595_5594_5599_5601_2885_5604_6464 9 6.31E-08 3.97E-06 1.53E-07 14041 hsa-mir-330 hsa05016 Huntington's disease 6874_10891_1387_2902_836_7157_3066_3065_3064_2033 10 7.10E-08 4.47E-06 1.66E-07 14042 hsa-mir-330 hsa04920 Adipocytokine signaling pathway 10891_5599_6257_6256_5601_6258_5970 7 9.77E-08 6.15E-06 2.20E-07 14043 hsa-mir-330 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5601_5600_836_1432_5970_3725 7 1.41E-07 8.88E-06 3.06E-07 14044 hsa-mir-330 hsa04662 B cell receptor signaling pathway 5595_5594_5970_2885_3725_5604_2353 7 1.99E-07 1.26E-05 4.19E-07 14045 hsa-mir-330 hsa04510 Focal adhesion 5595_5594_5599_5601_2885_595_3725_5604_6464 9 1.57E-06 9.86E-05 3.18E-06 14046 hsa-mir-330 hsa04720 Long-term potentiation 5595_5594_1387_2902_5604_2033 6 3.53E-06 0.000222541 6.95E-06 14047 hsa-mir-330 hsa04370 VEGF signaling pathway 5595_5594_5600_1432_5604_4846 6 4.07E-06 0.000256686 7.78E-06 14048 hsa-mir-330 hsa04330 Notch signaling pathway 1387_9612_3066_3065_2033 5 6.54E-06 0.000412216 1.21E-05 14049 hsa-mir-330 hsa04630 Jak-STAT signaling pathway 9063_1387_2885_595_4609_2033_8554 7 1.91E-05 0.001203766 3.44E-05 14050 hsa-mir-330 hsa04115 p53 signaling pathway 836_7157_10912_595_4616 5 3.71E-05 0.002337163 6.49E-05 14051 hsa-mir-330 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_2885_5604_6464 6 9.35E-05 0.005889716 0.000159182 14052 hsa-mir-330 hsa04120 Ubiquitin mediated proteolysis 5371_9063_672_7428_7329_8554 6 9.71E-05 0.006118666 0.000161018 14053 hsa-mir-330 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601 4 0.000110239 0.00694504 0.000178078 14054 hsa-mir-330 hsa04916 Melanogenesis 5595_5594_1387_5604_2033 5 0.000233582 0.014715665 0.000367892 14055 hsa-mir-330 hsa05010 Alzheimer's disease 5595_5594_2902_836_6622_4846 6 0.000343089 0.021614602 0.000527185 14056 hsa-mir-330 hsa04062 Chemokine signaling pathway 5595_5594_5970_2885_5604_6464 6 0.000534787 0.033691608 0.000795572 14057 hsa-mir-330 hsa03320 PPAR signaling pathway 6257_6256_6258_2168 4 0.000543009 0.034209595 0.000795572 14058 hsa-mir-330 hsa04730 Long-term depression 5595_5594_5604_4846 4 0.000571371 0.035996389 0.0008181 14059 hsa-mir-330 hsa04540 Gap junction 5595_5594_2885_5604 4 0.001495227 0.094199329 0.002093318 14060 hsa-mir-330 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.002719619 0.171336027 0.003724696 14061 hsa-mir-330 hsa04612 Antigen processing and presentation 4800_4801_3312 3 0.011372034 0.716438153 0.014925795 14062 hsa-mir-330 hsa04210 Apoptosis 836_5970_7157 3 0.011372034 0.716438153 0.014925795 14063 hsa-mir-330 hsa04270 Vascular smooth muscle contraction 5595_5594_5604 3 0.023476777 1 0.030184427 14064 hsa-mir-338 hsa04110 Cell cycle 4088_4089_1870_1871_7157_4087_2033_1017_890_1869_5934_5933 12 1.43E-20 4.15E-19 4.15E-19 14065 hsa-mir-338 hsa05200 Pathways in cancer 4088_4089_1487_1870_1871_1488_1050_4149_7157_4087_2033_1017_1869 13 3.61E-17 1.05E-15 5.24E-16 14066 hsa-mir-338 hsa05220 Chronic myeloid leukemia 4088_4089_1487_1870_1871_1488_7157_1869 8 4.12E-14 1.19E-12 3.98E-13 14067 hsa-mir-338 hsa04350 TGF-beta signaling pathway 4088_4089_1874_1875_4087_2033_5934_5933 8 1.26E-13 3.65E-12 9.12E-13 14068 hsa-mir-338 hsa04310 Wnt signaling pathway 4088_4089_1487_1488_7157_4087_2033 7 4.87E-10 1.41E-08 2.82E-09 14069 hsa-mir-338 hsa05222 Small cell lung cancer 1870_1871_4149_7157_1017_1869 6 8.79E-10 2.55E-08 3.87E-09 14070 hsa-mir-338 hsa05215 Prostate cancer 1870_1871_7157_2033_1017_1869 6 1.00E-09 2.90E-08 3.87E-09 14071 hsa-mir-338 hsa05212 Pancreatic cancer 1870_1871_7157_2033_1017_1869 6 1.07E-09 3.10E-08 3.87E-09 14072 hsa-mir-338 hsa05219 Bladder cancer 1870_1871_7157_1869 4 2.16E-07 6.26E-06 6.96E-07 14073 hsa-mir-338 hsa05223 Non-small cell lung cancer 1870_1871_7157_1869 4 5.56E-07 1.61E-05 1.61E-06 14074 hsa-mir-338 hsa05214 Glioma 1870_1871_7157_1869 4 1.12E-06 3.26E-05 2.96E-06 14075 hsa-mir-338 hsa05218 Melanoma 1870_1871_7157_1869 4 1.57E-06 4.56E-05 3.80E-06 14076 hsa-mir-338 hsa04520 Adherens junction 4088_4089_4087_2033 4 2.48E-06 7.18E-05 5.52E-06 14077 hsa-mir-338 hsa05210 Colorectal cancer 4088_4089_7157_4087 4 2.98E-06 8.65E-05 6.18E-06 14078 hsa-mir-338 hsa04330 Notch signaling pathway 1487_1488_2033 3 2.50E-05 0.000726442 4.84E-05 14079 hsa-mir-338 hsa04115 p53 signaling pathway 7157_1017 2 0.002943471 0.085360656 0.005335041 14080 hsa-mir-338 hsa05016 Huntington's disease 7157_2033 2 0.019556962 0.567151887 0.033361876 14081 hsa-mir-338 hsa05216 Thyroid cancer 7157 1 0.033425763 0.969347133 0.053852619 14082 hsa-mir-338 hsa04010 MAPK signaling pathway 4149_7157 2 0.038666791 1 0.059017734 14083 hsa-mir-339 hsa04010 MAPK signaling pathway 9261_6722_8986_6195_207_9252_1432_6196_6197 9 8.89E-10 4.98E-08 4.98E-08 14084 hsa-mir-339 hsa04150 mTOR signaling pathway 6195_207_6196_6197 4 2.34E-06 0.000130843 6.54E-05 14085 hsa-mir-339 hsa04720 Long-term potentiation 6195_6196_6197_1387 4 9.29E-06 0.000520396 0.000173465 14086 hsa-mir-339 hsa04350 TGF-beta signaling pathway 4089_4086_4093_1387 4 1.63E-05 0.000912199 0.000227229 14087 hsa-mir-339 hsa05200 Pathways in cancer 2736_4089_207_2932_25_1387 6 2.03E-05 0.001136143 0.000227229 14088 hsa-mir-339 hsa04110 Cell cycle 4089_2932_25_1387 4 5.32E-05 0.002979719 0.00049662 14089 hsa-mir-339 hsa05220 Chronic myeloid leukemia 4089_207_25 3 0.000301998 0.016911898 0.002277716 14090 hsa-mir-339 hsa04370 VEGF signaling pathway 9261_207_1432 3 0.000325388 0.018221729 0.002277716 14091 hsa-mir-339 hsa05210 Colorectal cancer 4089_207_2932 3 0.000416364 0.023316377 0.00228864 14092 hsa-mir-339 hsa04012 ErbB signaling pathway 207_2932_25 3 0.000459864 0.025752365 0.00228864 14093 hsa-mir-339 hsa05215 Prostate cancer 207_2932_1387 3 0.000474986 0.026599189 0.00228864 14094 hsa-mir-339 hsa05212 Pancreatic cancer 207_2932_1387 3 0.000490423 0.027463684 0.00228864 14095 hsa-mir-339 hsa04660 T cell receptor signaling pathway 207_2932_1432 3 0.000892214 0.049963992 0.003843384 14096 hsa-mir-339 hsa04310 Wnt signaling pathway 4089_2932_1387 3 0.002208676 0.12368584 0.008834703 14097 hsa-mir-339 hsa05213 Endometrial cancer 207_2932 2 0.003673964 0.205742011 0.013716134 14098 hsa-mir-339 hsa05217 Basal cell carcinoma 2736_2932 2 0.004084586 0.228736793 0.01429605 14099 hsa-mir-339 hsa04340 Hedgehog signaling pathway 2736_2932 2 0.004369636 0.244699606 0.014394094 14100 hsa-mir-339 hsa05211 Renal cell carcinoma 207_1387 2 0.006789335 0.380202776 0.021122376 14101 hsa-mir-339 hsa04662 B cell receptor signaling pathway 207_2932 2 0.007331619 0.410570649 0.021608982 14102 hsa-mir-339 hsa04664 Fc epsilon RI signaling pathway 207_1432 2 0.008084164 0.452713189 0.022073387 14103 hsa-mir-339 hsa04520 Adherens junction 4089_1387 2 0.00827752 0.463541136 0.022073387 14104 hsa-mir-339 hsa04620 Toll-like receptor signaling pathway 207_1432 2 0.013043465 0.730434054 0.032927803 14105 hsa-mir-339 hsa04916 Melanogenesis 2932_1387 2 0.013523919 0.757339471 0.032927803 14106 hsa-mir-339 hsa04360 Axon guidance 2932_25 2 0.02073484 1 0.048381293 14107 hsa-mir-339 hsa04910 Insulin signaling pathway 207_2932 2 0.02281534 1 0.051106362 14108 hsa-mir-339 hsa04630 Jak-STAT signaling pathway 207_1387 2 0.028207824 1 0.060755313 14109 hsa-mir-339 hsa05016 Huntington's disease 3064_1387 2 0.039956032 1 0.080859112 14110 hsa-mir-339 hsa04950 Maturity onset diabetes of the young 3651 1 0.040793243 1 0.080859112 14111 hsa-mir-339 hsa04062 Chemokine signaling pathway 207_2932 2 0.041873469 1 0.080859112 14112 hsa-mir-339 hsa04510 Focal adhesion 207_2932 2 0.047017038 1 0.087765137 14113 hsa-mir-33a hsa05200 Pathways in cancer 1869_5371_2249_1871_1956_5595_5594_1387_6256_4846_595_5601_2308_367_2932_5914_5599_7704_841_6776_6777_3091_5970_7428_1870_7157_4087_6688_2113_4609_3725_861_2353_2736_4088_4089_3066_3065_1050_5925_2034_2033_207_836_4790 45 4.65E-34 3.40E-32 3.40E-32 14114 hsa-mir-33a hsa04010 MAPK signaling pathway 6722_1432_2249_1956_5595_5594_1386_9261_4208_5601_1649_5566_9252_1616_5599_5970_3312_7157_468_4609_3725_3727_6195_6196_2353_5603_8986_4763_6197_5600_207_8550_836_4790_2002 35 6.78E-26 4.95E-24 2.47E-24 14115 hsa-mir-33a hsa05215 Prostate cancer 1869_1871_1956_5595_5594_1385_1387_595_2308_367_2932_5970_10488_1870_7157_468_9586_5925_2033_207_4790 21 7.17E-21 5.23E-19 1.37E-19 14116 hsa-mir-33a hsa05212 Pancreatic cancer 1869_1871_1956_5595_5594_1385_1387_595_2308_367_2932_5970_10488_1870_7157_468_9586_5925_2033_207_4790 21 8.77E-21 6.41E-19 1.37E-19 14117 hsa-mir-33a hsa05220 Chronic myeloid leukemia 1869_1871_5595_5594_595_6776_6777_5970_1870_7157_4609_861_4088_4089_3066_3065_5925_207_4790_6464 20 9.35E-21 6.83E-19 1.37E-19 14118 hsa-mir-33a hsa05221 Acute myeloid leukemia 5371_5595_5594_595_5914_7704_6776_6777_5970_6688_4609_861_1050_207_4790 15 1.28E-15 9.32E-14 1.55E-14 14119 hsa-mir-33a hsa05210 Colorectal cancer 1956_5595_5594_595_5601_2932_5599_7157_4087_4609_3725_2353_4088_4089_207_836 16 7.37E-15 5.38E-13 7.68E-14 14120 hsa-mir-33a hsa04110 Cell cycle 1869_1871_5591_1387_595_2932_1870_7157_4087_4088_4089_3066_3065_5925_2033_5933 16 9.12E-13 6.66E-11 8.32E-12 14121 hsa-mir-33a hsa04310 Wnt signaling pathway 815_1387_595_5601_5566_1457_2932_5599_7157_4087_8061_4609_3725_1459_4088_4089_2033 17 2.62E-12 1.91E-10 2.04E-11 14122 hsa-mir-33a hsa04012 ErbB signaling pathway 815_1956_5595_5594_5601_2932_5599_6776_6777_4609_3725_207_6464_2002 14 2.80E-12 2.04E-10 2.04E-11 14123 hsa-mir-33a hsa05219 Bladder cancer 1869_1871_1956_5595_5594_595_9252_1870_7157_4609_5925 11 6.40E-12 4.67E-10 4.25E-11 14124 hsa-mir-33a hsa04620 Toll-like receptor signaling pathway 1432_5595_5594_5601_5599_841_5970_3725_2353_5603_6348_5600_207_4790 14 1.92E-11 1.40E-09 1.17E-10 14125 hsa-mir-33a hsa05214 Glioma 1869_815_1871_1956_5595_5594_595_1870_7157_5925_207_6464 12 2.49E-11 1.82E-09 1.40E-10 14126 hsa-mir-33a hsa05223 Non-small cell lung cancer 1869_1871_1956_5595_5594_6256_595_1870_7157_5925_207 11 6.73E-11 4.91E-09 3.51E-10 14127 hsa-mir-33a hsa04912 GnRH signaling pathway 1432_815_1956_5595_5594_5601_5566_5599_468_3725_5603_5600_2002 13 4.45E-10 3.25E-08 2.07E-09 14128 hsa-mir-33a hsa05222 Small cell lung cancer 1869_1871_6256_4846_595_5970_1870_7157_4609_5925_207_4790 12 4.54E-10 3.31E-08 2.07E-09 14129 hsa-mir-33a hsa04350 TGF-beta signaling pathway 6667_5595_5594_1387_3399_3398_4087_4609_4088_4089_2033_5933 12 5.12E-10 3.74E-08 2.20E-09 14130 hsa-mir-33a hsa05218 Melanoma 1869_2249_1871_1956_5595_5594_595_1870_7157_5925_207 11 9.01E-10 6.58E-08 3.65E-09 14131 hsa-mir-33a hsa04720 Long-term potentiation 815_5595_5594_1387_2902_5566_468_6195_6196_6197_2033 11 1.52E-09 1.11E-07 5.83E-09 14132 hsa-mir-33a hsa05016 Huntington's disease 6667_6874_1385_1387_2902_6908_841_10488_7157_9586_3066_3065_3064_2033_836 15 3.90E-09 2.84E-07 1.42E-08 14133 hsa-mir-33a hsa04660 T cell receptor signaling pathway 1432_5595_5594_5601_2932_5970_3725_2353_5603_5600_207_4790 12 5.81E-09 4.24E-07 2.02E-08 14134 hsa-mir-33a hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_1956_5601_5599_5970_3725_5603_5600_836_4790 10 1.21E-08 8.83E-07 4.01E-08 14135 hsa-mir-33a hsa05213 Endometrial cancer 1956_5595_5594_595_2932_7157_4609_207_2002 9 1.32E-08 9.66E-07 4.15E-08 14136 hsa-mir-33a hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2113_3725_2034_2033_207 10 1.36E-08 9.96E-07 4.15E-08 14137 hsa-mir-33a hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_4846_2902_834_1616_7157_5603_5600_836 9 2.35E-08 1.72E-06 6.87E-08 14138 hsa-mir-33a hsa04520 Adherens junction 1956_5595_5594_1387_1457_4087_1459_4088_4089_2033 10 3.39E-08 2.48E-06 9.52E-08 14139 hsa-mir-33a hsa04910 Insulin signaling pathway 6720_5595_5594_23265_5601_2308_5566_2932_5599_207_6464_2002 12 5.97E-08 4.36E-06 1.61E-07 14140 hsa-mir-33a hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 1.48E-06 0.000108344 3.87E-06 14141 hsa-mir-33a hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_3725_2353_207_4790 8 2.44E-06 0.000177931 6.14E-06 14142 hsa-mir-33a hsa04150 mTOR signaling pathway 5595_5594_3091_6195_6196_6197_207 7 2.57E-06 0.000187874 6.26E-06 14143 hsa-mir-33a hsa04916 Melanogenesis 815_5595_5594_1385_1387_5566_2932_10488_2033 9 2.85E-06 0.000207777 6.66E-06 14144 hsa-mir-33a hsa04370 VEGF signaling pathway 1432_5595_5594_4846_9261_5603_5600_207 8 2.92E-06 0.00021324 6.66E-06 14145 hsa-mir-33a hsa04664 Fc epsilon RI signaling pathway 1432_5595_5594_5601_5599_5603_5600_207 8 3.48E-06 0.000254325 7.71E-06 14146 hsa-mir-33a hsa04210 Apoptosis 823_5566_841_5970_7157_207_836_4790 8 7.88E-06 0.000575176 1.69E-05 14147 hsa-mir-33a hsa04510 Focal adhesion 1956_5595_5594_595_5601_2932_5599_3725_207_6464_2002 11 1.82E-05 0.001327374 3.79E-05 14148 hsa-mir-33a hsa04062 Chemokine signaling pathway 5595_5594_5566_2932_6777_5970_6348_207_4790_6464 10 5.55E-05 0.004049761 0.000112349 14149 hsa-mir-33a hsa04630 Jak-STAT signaling pathway 1387_595_6778_6776_6777_4609_2033_3977_207 9 5.69E-05 0.004156916 0.000112349 14150 hsa-mir-33a hsa04920 Adipocytokine signaling pathway 6256_5601_5599_5970_207_4790 6 0.000111917 0.008169937 0.000214998 14151 hsa-mir-33a hsa05010 Alzheimer's disease 5595_5594_823_4846_2902_2932_841_9451_836 9 0.000149029 0.010879129 0.000278952 14152 hsa-mir-33a hsa04930 Type II diabetes mellitus 5595_5594_5601_3651_5599 5 0.000167046 0.012194364 0.000304859 14153 hsa-mir-33a hsa04330 Notch signaling pathway 1387_9612_3066_3065_2033 5 0.000201474 0.014707638 0.000358723 14154 hsa-mir-33a hsa03022 Basal transcription factors 2963_6874_6908_6880 4 0.000845546 0.061724878 0.00146964 14155 hsa-mir-33a hsa04540 Gap junction 1956_5592_5595_5594_5566 5 0.003578362 0.261220417 0.006074893 14156 hsa-mir-33a hsa04115 p53 signaling pathway 595_841_7157_836 4 0.007019226 0.512403485 0.011645534 14157 hsa-mir-33a hsa04730 Long-term depression 5592_5595_5594_4846 4 0.007713627 0.563094737 0.012513216 14158 hsa-mir-33a hsa03450 Non-homologous end-joining 5591_2547 2 0.011661332 0.8512772 0.018506026 14159 hsa-mir-33a hsa04612 Antigen processing and presentation 1385_4800_3312_4801 4 0.016047121 1 0.024924251 14160 hsa-mir-33a hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_7428_7329 5 0.017309318 1 0.026324589 14161 hsa-mir-33a hsa05217 Basal cell carcinoma 2932_7157_2736 3 0.022340828 1 0.033283274 14162 hsa-mir-33a hsa04340 Hedgehog signaling pathway 5566_2932_2736 3 0.024407481 1 0.035634923 14163 hsa-mir-33a hsa04950 Maturity onset diabetes of the young 3651_6927 2 0.029513345 1 0.042244592 14164 hsa-mir-33a hsa04270 Vascular smooth muscle contraction 5592_5595_5594_5566 4 0.03837061 1 0.053866433 14165 hsa-mir-33a hsa04020 Calcium signaling pathway 815_1956_4846_2902_5566 5 0.047451486 1 0.065357707 14166 hsa-mir-33b hsa04350 TGF-beta signaling pathway 4093_4086_4089 3 9.27E-06 0.000111193 0.000111193 14167 hsa-mir-33b hsa05220 Chronic myeloid leukemia 25_4089 2 0.000579471 0.00695365 0.003476825 14168 hsa-mir-33b hsa04110 Cell cycle 25_4089 2 0.001421032 0.017052378 0.005684126 14169 hsa-mir-33b hsa05200 Pathways in cancer 25_4089 2 0.010285271 0.123423249 0.030855812 14170 hsa-mir-33b hsa03410 Base excision repair 3146 1 0.01712468 0.205496154 0.041099231 14171 hsa-mir-33b hsa05131 Shigellosis 25 1 0.026267488 0.315209858 0.04502998 14172 hsa-mir-33b hsa05130 Pathogenic Escherichia coli infection 25 1 0.026267488 0.315209858 0.04502998 14173 hsa-mir-33b hsa04520 Adherens junction 4089 1 0.037134601 0.445615212 0.048339476 14174 hsa-mir-33b hsa05210 Colorectal cancer 4089 1 0.0389348 0.467217595 0.048339476 14175 hsa-mir-33b hsa04012 ErbB signaling pathway 25 1 0.040282897 0.483394763 0.048339476 14176 hsa-mir-342 hsa03022 Basal transcription factors 2961_2960_2963_6881_54457_2967_6879_6878_6877_6874_6872_2957_2968_6873_2958_6884_2959_6880_6882_138474_6883 21 8.51E-31 5.96E-29 5.96E-29 14177 hsa-mir-342 hsa05200 Pathways in cancer 3716_1499_5594_1387_6256_2932_4193_2353_367_6772_5970_7157_6688_4609_3725_10401_4088_4089_3065_5925_2033_207_208_3326_8554_7184 26 1.11E-18 7.76E-17 3.88E-17 14178 hsa-mir-342 hsa05215 Prostate cancer 1499_5594_1387_2932_4193_367_5970_7157_468_5925_2033_207_208_3326_7184 15 9.34E-16 6.54E-14 1.90E-14 14179 hsa-mir-342 hsa05212 Pancreatic cancer 1499_5594_1387_2932_4193_367_5970_7157_468_5925_2033_207_208_3326_7184 15 1.08E-15 7.59E-14 1.90E-14 14180 hsa-mir-342 hsa04110 Cell cycle 993_7534_4171_1387_983_7532_2932_4193_4085_7157_4088_4089_3065_5925_2033_10971 16 2.89E-15 2.03E-13 4.05E-14 14181 hsa-mir-342 hsa04630 Jak-STAT signaling pathway 3717_3716_1387_6778_6772_3454_3455_7297_4609_10401_2033_207_208_8554_10379 15 1.74E-12 1.22E-10 2.03E-11 14182 hsa-mir-342 hsa05220 Chronic myeloid leukemia 5594_4193_5970_7157_4609_4088_4089_3065_5925_207_208 11 2.95E-11 2.07E-09 2.95E-10 14183 hsa-mir-342 hsa05210 Colorectal cancer 1499_5594_2932_2353_7157_4609_3725_4088_4089_207_208 11 8.91E-11 6.24E-09 7.79E-10 14184 hsa-mir-342 hsa04310 Wnt signaling pathway 1460_1499_1387_8607_2932_7157_4609_3725_1452_4088_4089_2033 12 2.65E-09 1.85E-07 2.06E-08 14185 hsa-mir-342 hsa04620 Toll-like receptor signaling pathway 5594_2353_1432_6772_5970_3454_3455_3725_207_208 10 8.48E-09 5.94E-07 5.94E-08 14186 hsa-mir-342 hsa04010 MAPK signaling pathway 6722_5594_2353_3312_1432_5970_7157_468_4609_3725_3727_5058_207_208 14 2.30E-08 1.61E-06 1.46E-07 14187 hsa-mir-342 hsa05222 Small cell lung cancer 6256_5970_7157_4609_10401_5925_207_208_8554 9 2.85E-08 1.99E-06 1.66E-07 14188 hsa-mir-342 hsa04660 T cell receptor signaling pathway 5594_2932_2353_1432_5970_3725_5058_207_208 9 2.02E-07 1.42E-05 1.08E-06 14189 hsa-mir-342 hsa05213 Endometrial cancer 1499_5594_2932_7157_4609_207_208 7 2.15E-07 1.51E-05 1.08E-06 14190 hsa-mir-342 hsa04520 Adherens junction 1460_1499_6714_5594_1387_4088_4089_2033 8 2.36E-07 1.65E-05 1.10E-06 14191 hsa-mir-342 hsa04012 ErbB signaling pathway 6714_5594_2932_4609_3725_5058_207_208 8 4.27E-07 2.99E-05 1.87E-06 14192 hsa-mir-342 hsa05211 Renal cell carcinoma 5594_1387_3725_5058_2033_207_208 7 1.62E-06 0.000113522 6.68E-06 14193 hsa-mir-342 hsa04662 B cell receptor signaling pathway 5594_2932_2353_5970_3725_207_208 7 2.09E-06 0.000146212 8.12E-06 14194 hsa-mir-342 hsa05216 Thyroid cancer 1499_5594_6256_7157_4609 5 4.19E-06 0.000293192 1.54E-05 14195 hsa-mir-342 hsa05223 Non-small cell lung cancer 5594_6256_7157_5925_207_208 6 4.52E-06 0.000316181 1.58E-05 14196 hsa-mir-342 hsa05221 Acute myeloid leukemia 5594_5970_6688_4609_207_208 6 7.23E-06 0.000506387 2.41E-05 14197 hsa-mir-342 hsa05214 Glioma 5594_4193_7157_5925_207_208 6 1.21E-05 0.000847292 3.85E-05 14198 hsa-mir-342 hsa05016 Huntington's disease 6874_1387_9001_5430_7157_23186_3065_3064_2033 9 1.32E-05 0.000926306 4.03E-05 14199 hsa-mir-342 hsa04920 Adipocytokine signaling pathway 3717_6256_5970_207_208_2538 6 1.42E-05 0.000995208 4.15E-05 14200 hsa-mir-342 hsa04062 Chemokine signaling pathway 3717_5594_2932_6772_5970_7852_5058_207_208 9 1.62E-05 0.001130862 4.52E-05 14201 hsa-mir-342 hsa05218 Melanoma 5594_4193_7157_5925_207_208 6 1.93E-05 0.00135359 5.21E-05 14202 hsa-mir-342 hsa05219 Bladder cancer 5594_4193_7157_4609_5925 5 2.14E-05 0.001498735 5.55E-05 14203 hsa-mir-342 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 3.87E-05 0.002707934 9.67E-05 14204 hsa-mir-342 hsa04350 TGF-beta signaling pathway 5594_1387_4609_4088_4089_2033 6 5.65E-05 0.003957946 0.000136481 14205 hsa-mir-342 hsa04510 Focal adhesion 1499_6714_5594_2932_3725_5058_207_208 8 0.000162641 0.011384903 0.000379497 14206 hsa-mir-342 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_1432_5970_3725_5058 5 0.000218013 0.015260905 0.000492287 14207 hsa-mir-342 hsa04370 VEGF signaling pathway 6714_5594_1432_207_208 5 0.000311018 0.021771257 0.000680352 14208 hsa-mir-342 hsa04330 Notch signaling pathway 1387_3065_2033_8850 4 0.000487804 0.034146272 0.001034736 14209 hsa-mir-342 hsa04210 Apoptosis 823_5970_7157_207_208 5 0.000583861 0.040870284 0.001202067 14210 hsa-mir-342 hsa04910 Insulin signaling pathway 5594_2932_5211_207_208_2538 6 0.000611634 0.042814412 0.001223269 14211 hsa-mir-342 hsa05131 Shigellosis 7534_1499_10382_10971 4 0.000905343 0.063373979 0.00171281 14212 hsa-mir-342 hsa05130 Pathogenic Escherichia coli infection 7534_1499_10382_10971 4 0.000905343 0.063373979 0.00171281 14213 hsa-mir-342 hsa04916 Melanogenesis 1499_5594_1387_2932_2033 5 0.001139931 0.079795169 0.002099873 14214 hsa-mir-342 hsa04912 GnRH signaling pathway 6714_5594_1432_468_3725 5 0.001338473 0.0936931 0.002402387 14215 hsa-mir-342 hsa04720 Long-term potentiation 5594_1387_468_2033 4 0.002510388 0.175727162 0.004393179 14216 hsa-mir-342 hsa04664 Fc epsilon RI signaling pathway 5594_1432_207_208 4 0.003003083 0.210215806 0.005127215 14217 hsa-mir-342 hsa04530 Tight junction 1460_1499_6714_207_208 5 0.003618749 0.253312418 0.006031248 14218 hsa-mir-342 hsa04612 Antigen processing and presentation 3312_1514_3326_4801 4 0.004515013 0.31605091 0.007350021 14219 hsa-mir-342 hsa03420 Nucleotide excision repair 2967_5887_2968 3 0.004634251 0.324397602 0.007372673 14220 hsa-mir-342 hsa04540 Gap junction 6714_5594_983_10382 4 0.005241028 0.366871995 0.008152711 14221 hsa-mir-342 hsa04150 mTOR signaling pathway 5594_207_208 3 0.007191535 0.503407481 0.010943641 14222 hsa-mir-342 hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.008327176 0.582902349 0.012402178 14223 hsa-mir-342 hsa04340 Hedgehog signaling pathway 53944_2932_1452 3 0.009139461 0.639762304 0.013328381 14224 hsa-mir-342 hsa04950 Maturity onset diabetes of the young 3172_5080 2 0.014767562 1 0.020954147 14225 hsa-mir-342 hsa04115 p53 signaling pathway 983_4193_7157 3 0.014967248 1 0.020954147 14226 hsa-mir-342 hsa04360 Axon guidance 5594_2932_7852_5058 4 0.016249046 1 0.022302612 14227 hsa-mir-342 hsa04650 Natural killer cell mediated cytotoxicity 5594_3454_3455_5058 4 0.019187912 1 0.025829881 14228 hsa-mir-342 hsa05010 Alzheimer's disease 5594_823_2932_9451 4 0.04137683 1 0.054648643 14229 hsa-mir-345 hsa03010 Ribosome 6129_6156_6141_6188_6128_6191_6193_6205_6204_6207_6202_6210_6217_6222_6223_6181_6229_6189_6130_6137_6135_6232 22 2.89E-26 1.76E-24 1.76E-24 14230 hsa-mir-345 hsa03050 Proteasome 5693_5684_5687_5706_5708_5709_5705_5707_5700_5719_5717_5713 12 1.63E-15 9.95E-14 4.97E-14 14231 hsa-mir-345 hsa04310 Wnt signaling pathway 2033_5519_5518_8607_1487_8454_6500_8945_4609_23291_4087_4088_1488 13 2.53E-11 1.54E-09 5.14E-10 14232 hsa-mir-345 hsa05220 Chronic myeloid leukemia 1147_3551_1487_8517_5970_4609_4088_1488_4790_4792 10 9.94E-11 6.06E-09 1.52E-09 14233 hsa-mir-345 hsa05200 Pathways in cancer 1147_3320_3326_10342_3551_2033_1487_8517_5970_4609_4087_4088_1488_4790_4792_7187 16 3.97E-10 2.42E-08 4.85E-09 14234 hsa-mir-345 hsa04660 T cell receptor signaling pathway 1147_3551_1326_8517_5970_4794_4793_9020_4790_4792 10 3.08E-09 1.88E-07 3.13E-08 14235 hsa-mir-345 hsa05131 Shigellosis 347733_7278_10382_84617_7846_4691_203068_71 8 4.76E-09 2.90E-07 3.63E-08 14236 hsa-mir-345 hsa05130 Pathogenic Escherichia coli infection 347733_7278_10382_84617_7846_4691_203068_71 8 4.76E-09 2.90E-07 3.63E-08 14237 hsa-mir-345 hsa05215 Prostate cancer 1147_3320_3326_3551_2033_8517_5970_4790_4792 9 7.46E-09 4.55E-07 4.53E-08 14238 hsa-mir-345 hsa04612 Antigen processing and presentation 3320_3326_3309_3305_3303_4800_4801_3310_3312 9 8.18E-09 4.99E-07 4.53E-08 14239 hsa-mir-345 hsa05212 Pancreatic cancer 1147_3320_3326_3551_2033_8517_5970_4790_4792 9 8.18E-09 4.99E-07 4.53E-08 14240 hsa-mir-345 hsa04920 Adipocytokine signaling pathway 1147_3551_8517_5970_4794_4793_4790_4792 8 1.72E-08 1.05E-06 8.72E-08 14241 hsa-mir-345 hsa04010 MAPK signaling pathway 1147_3551_1326_3305_3303_8517_3310_3312_5971_5970_4609_9020_4790 13 2.12E-08 1.29E-06 9.94E-08 14242 hsa-mir-345 hsa04620 Toll-like receptor signaling pathway 1147_3551_1326_8517_9641_5970_4790_4792_7187 9 2.46E-08 1.50E-06 1.07E-07 14243 hsa-mir-345 hsa04662 B cell receptor signaling pathway 1147_3551_8517_5970_4794_4793_4790_4792 8 3.85E-08 2.35E-06 1.57E-07 14244 hsa-mir-345 hsa03020 RNA polymerase 25885_64425_5437_5441_51082_84172 6 6.01E-08 3.67E-06 2.29E-07 14245 hsa-mir-345 hsa05222 Small cell lung cancer 1147_3551_8517_5970_4609_4790_4792_7187 8 1.03E-07 6.27E-06 3.69E-07 14246 hsa-mir-345 hsa04350 TGF-beta signaling pathway 2033_5519_5518_8454_6500_4609_4087_4088 8 1.12E-07 6.81E-06 3.78E-07 14247 hsa-mir-345 hsa04210 Apoptosis 1147_3551_8517_5970_9131_9020_4790_4792 8 1.31E-07 8.02E-06 4.22E-07 14248 hsa-mir-345 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_3551_8517_5970_9020_4790_4792 7 4.58E-07 2.80E-05 1.40E-06 14249 hsa-mir-345 hsa05221 Acute myeloid leukemia 1147_3551_8517_5970_4609_4790 6 2.64E-06 0.000160851 7.66E-06 14250 hsa-mir-345 hsa04540 Gap junction 347733_7278_10382_84617_7846_203068 6 3.02E-05 0.001843868 8.38E-05 14251 hsa-mir-345 hsa04110 Cell cycle 2033_5591_8454_6500_4087_4088 6 0.000111281 0.006788117 0.000295136 14252 hsa-mir-345 hsa04520 Adherens junction 2033_8826_4087_4088_71 5 0.000163328 0.009963025 0.000415126 14253 hsa-mir-345 hsa04062 Chemokine signaling pathway 1147_3551_8517_5970_4793_4790_4792 7 0.000214733 0.013098691 0.000523948 14254 hsa-mir-345 hsa04910 Insulin signaling pathway 3551_2194_5211_808_805_801 6 0.000240724 0.014684155 0.000564775 14255 hsa-mir-345 hsa04720 Long-term potentiation 2033_808_805_801 4 0.001324291 0.080781731 0.002991916 14256 hsa-mir-345 hsa04120 Ubiquitin mediated proteolysis 55294_8454_6500_8945_23291 5 0.001803496 0.11001328 0.003929046 14257 hsa-mir-345 hsa04330 Notch signaling pathway 2033_1487_1488 3 0.003380479 0.206209242 0.007110664 14258 hsa-mir-345 hsa03450 Non-homologous end-joining 5591_7520 2 0.004061291 0.24773876 0.008127137 14259 hsa-mir-345 hsa04916 Melanogenesis 2033_808_805_801 4 0.004130185 0.251941256 0.008127137 14260 hsa-mir-345 hsa04270 Vascular smooth muscle contraction 85366_808_805_801 4 0.006346262 0.387121983 0.012097562 14261 hsa-mir-345 hsa05214 Glioma 808_805_801 3 0.007990568 0.487424671 0.014770445 14262 hsa-mir-345 hsa04530 Tight junction 5519_5518_4627_71 4 0.010446763 0.637252541 0.018742722 14263 hsa-mir-345 hsa04810 Regulation of actin cytoskeleton 4627_10788_8826_85366_71 5 0.011509069 0.702053231 0.020058664 14264 hsa-mir-345 hsa04070 Phosphatidylinositol signaling system 808_805_801 3 0.012019878 0.733212579 0.020367016 14265 hsa-mir-345 hsa05216 Thyroid cancer 10342_4609 2 0.014838299 0.905136237 0.024463142 14266 hsa-mir-345 hsa05210 Colorectal cancer 4609_4087_4088 3 0.015562076 0.949286657 0.024981228 14267 hsa-mir-345 hsa05010 Alzheimer's disease 22926_808_805_801 4 0.023859237 1 0.037318294 14268 hsa-mir-345 hsa04020 Calcium signaling pathway 85366_808_805_801 4 0.026934423 1 0.041074995 14269 hsa-mir-345 hsa05016 Huntington's disease 2033_5437_1213_5441 4 0.028793358 1 0.042648624 14270 hsa-mir-345 hsa04912 GnRH signaling pathway 808_805_801 3 0.029364626 1 0.042648624 14271 hsa-mir-345 hsa04340 Hedgehog signaling pathway 8945_23291 2 0.048976606 1 0.069478442 14272 hsa-mir-346 hsa05200 Pathways in cancer 1499_25_5371_405_5467_5468_5595_5594_5599_861_2736_5914_1387_6256_595_1487_1488_836_367_1017_4193_7704_6776_6772_3091_5970_7428_6934_1870_1871_7157_4087_2113_10401_7849_4609_1869_3725_2956_5604_6774_4088_4089_3066_3065_1050_5925_2034_2033_6777_4846_207_2932_4286_51176 55 1.79E-40 1.34E-38 1.34E-38 14273 hsa-mir-346 hsa05220 Chronic myeloid leukemia 25_5595_5594_861_595_1487_1488_4193_6776_5970_1870_1871_7157_4609_1869_5604_4088_4089_3066_3065_5925_6777_207_6464 24 5.57E-24 4.18E-22 2.09E-22 14274 hsa-mir-346 hsa05221 Acute myeloid leukemia 5371_5467_5595_5594_861_5914_595_7704_6776_5970_6934_4609_5604_6774_1050_6777_207_51176 18 5.40E-18 4.05E-16 1.35E-16 14275 hsa-mir-346 hsa05215 Prostate cancer 1499_5595_5594_1387_595_367_1017_4193_5970_6934_1870_1871_7157_1869_5604_5925_2033_207_2932_51176 20 1.04E-17 7.82E-16 1.89E-16 14276 hsa-mir-346 hsa05212 Pancreatic cancer 1499_5595_5594_1387_595_367_1017_4193_5970_6934_1870_1871_7157_1869_5604_5925_2033_207_2932_51176 20 1.26E-17 9.47E-16 1.89E-16 14277 hsa-mir-346 hsa04110 Cell cycle 25_5591_1387_595_1017_4193_5934_1870_1871_7157_5111_4087_1869_4088_4089_3066_3065_5925_2033_5933_2932 21 1.43E-16 1.07E-14 1.79E-15 14278 hsa-mir-346 hsa04310 Wnt signaling pathway 1499_4772_5467_5599_1387_595_1487_1488_6934_7157_4087_4609_3725_1457_6423_4088_4089_5527_2033_2932_51176_4773 22 1.09E-15 8.21E-14 1.05E-14 14279 hsa-mir-346 hsa05210 Colorectal cancer 1499_5595_5594_5599_595_836_6934_7157_4087_4609_3725_2956_5604_4088_4089_207_2932_51176 18 1.12E-15 8.37E-14 1.05E-14 14280 hsa-mir-346 hsa04010 MAPK signaling pathway 1432_9479_5595_5594_6722_5599_9261_4208_3164_836_9252_3312_1386_5970_6195_7157_4609_3725_5604_6196_8986_4763_1616_207_6197_2002_4773 27 3.37E-15 2.53E-13 2.81E-14 14281 hsa-mir-346 hsa05216 Thyroid cancer 1499_5468_5595_5594_6256_595_6934_7157_7849_4609_5604_51176 12 1.01E-13 7.58E-12 7.58E-13 14282 hsa-mir-346 hsa04350 TGF-beta signaling pathway 5595_5594_1387_4092_6667_3399_3398_5934_1875_4087_4609_4088_4089_4086_2033_5933 16 3.50E-13 2.63E-11 2.39E-12 14283 hsa-mir-346 hsa04330 Notch signaling pathway 22938_2648_1387_1487_1488_9612_3066_3065_2033_9794_1840_8850_4851 13 6.70E-13 5.03E-11 4.19E-12 14284 hsa-mir-346 hsa05213 Endometrial cancer 1499_5595_5594_595_6934_7157_4609_5604_2309_207_2932_51176_2002 13 2.01E-12 1.51E-10 1.16E-11 14285 hsa-mir-346 hsa05219 Bladder cancer 5595_5594_595_9252_4193_1870_1871_7157_4609_1869_5604_5925 12 3.78E-12 2.83E-10 2.02E-11 14286 hsa-mir-346 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5604_5925_2309_207 12 4.72E-11 3.54E-09 2.36E-10 14287 hsa-mir-346 hsa05214 Glioma 5595_5594_595_4193_1870_1871_7157_1869_5604_5925_207_6464 12 3.10E-10 2.32E-08 1.45E-09 14288 hsa-mir-346 hsa05222 Small cell lung cancer 6256_595_1017_5970_1870_1871_7157_10401_4609_1869_5925_4846_207 13 5.10E-10 3.82E-08 2.25E-09 14289 hsa-mir-346 hsa04012 ErbB signaling pathway 25_5595_5594_5599_6776_4609_3725_5604_6777_207_2932_6464_2002 13 5.79E-10 4.34E-08 2.41E-09 14290 hsa-mir-346 hsa05218 Melanoma 5595_5594_595_4193_1870_1871_7157_1869_5604_5925_207_4286 12 7.62E-10 5.71E-08 3.01E-09 14291 hsa-mir-346 hsa05211 Renal cell carcinoma 405_5595_5594_1387_3091_7428_2113_3725_5604_2034_2033_207 12 8.79E-10 6.59E-08 3.30E-09 14292 hsa-mir-346 hsa05322 Systemic lupus erythematosus 8366_3021_3020_8359_8360_8294_8365_8368_8370_121504_8361_8363_8362_8364_8367 15 2.63E-09 1.97E-07 9.38E-09 14293 hsa-mir-346 hsa04520 Adherens junction 1499_5595_5594_1387_6934_4087_1457_4088_4089_2033_51176 11 2.69E-08 2.02E-06 9.16E-08 14294 hsa-mir-346 hsa04620 Toll-like receptor signaling pathway 1432_5595_5594_5599_3665_3661_6772_5970_3725_5604_207 11 2.56E-07 1.92E-05 8.36E-07 14295 hsa-mir-346 hsa04720 Long-term potentiation 5595_5594_1387_2902_6195_5604_6196_2033_6197 9 1.41E-06 0.000106113 4.24E-06 14296 hsa-mir-346 hsa04662 B cell receptor signaling pathway 4772_5595_5594_5970_3725_5604_207_2932_4773 9 1.41E-06 0.000106113 4.24E-06 14297 hsa-mir-346 hsa04370 VEGF signaling pathway 1432_4772_5595_5594_9261_5604_4846_207_4773 9 1.73E-06 0.000129581 4.98E-06 14298 hsa-mir-346 hsa04916 Melanogenesis 1499_5595_5594_1387_6934_5604_2033_2932_4286_51176 10 2.35E-06 0.000176319 6.39E-06 14299 hsa-mir-346 hsa05016 Huntington's disease 6874_10891_5468_1387_2902_6908_836_6667_7157_3066_3065_3064_2033 13 2.39E-06 0.000178899 6.39E-06 14300 hsa-mir-346 hsa04660 T cell receptor signaling pathway 1432_4772_5595_5594_5970_3725_5604_207_2932_4773 10 3.74E-06 0.000280812 9.68E-06 14301 hsa-mir-346 hsa04150 mTOR signaling pathway 5595_5594_3091_6195_6196_207_6197 7 1.08E-05 0.000808765 2.70E-05 14302 hsa-mir-346 hsa04630 Jak-STAT signaling pathway 1387_595_6778_6776_6772_10401_4609_6774_2033_6777_207 11 1.13E-05 0.000847935 2.74E-05 14303 hsa-mir-346 hsa03410 Base excision repair 6996_252969_4350_5111_328_2237 6 1.57E-05 0.001177609 3.62E-05 14304 hsa-mir-346 hsa04062 Chemokine signaling pathway 5580_5595_5594_6772_5970_5604_6774_6777_2309_207_2932_6464 12 1.59E-05 0.001195784 3.62E-05 14305 hsa-mir-346 hsa04910 Insulin signaling pathway 6720_10891_5595_5594_5599_5604_207_2932_6464_2002 10 2.39E-05 0.001791179 5.27E-05 14306 hsa-mir-346 hsa04920 Adipocytokine signaling pathway 10891_5465_5599_6256_5970_6774_207 7 4.82E-05 0.003615011 0.000103286 14307 hsa-mir-346 hsa04115 p53 signaling pathway 595_836_1017_4194_4193_7157_7161 7 5.73E-05 0.004295848 0.000119329 14308 hsa-mir-346 hsa03450 Non-homologous end-joining 10111_5591_4361_2237 4 7.23E-05 0.005420621 0.000146503 14309 hsa-mir-346 hsa04664 Fc epsilon RI signaling pathway 1432_5580_5595_5594_5599_5604_207 7 0.000126095 0.009457104 0.000247415 14310 hsa-mir-346 hsa04510 Focal adhesion 1499_5595_5594_5599_595_3725_5604_207_2932_6464_2002 11 0.000130379 0.00977844 0.000247415 14311 hsa-mir-346 hsa04912 GnRH signaling pathway 1432_5580_5595_5594_5599_3725_5604_2002 8 0.000134889 0.01011665 0.000247415 14312 hsa-mir-346 hsa05217 Basal cell carcinoma 1499_2736_6934_7157_2932_51176 6 0.000135253 0.010143998 0.000247415 14313 hsa-mir-346 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_2902_836_7157_1616_4846 6 0.000148133 0.011110012 0.000264524 14314 hsa-mir-346 hsa04950 Maturity onset diabetes of the young 3651_5080_6927_4760 4 0.000436759 0.032756958 0.00076179 14315 hsa-mir-346 hsa04930 Type II diabetes mellitus 3651_5580_5595_5594_5599 5 0.000457662 0.034324665 0.000780106 14316 hsa-mir-346 hsa03022 Basal transcription factors 2963_6874_6908_2959 4 0.00189349 0.142011759 0.003155817 14317 hsa-mir-346 hsa04650 Natural killer cell mediated cytotoxicity 4772_5595_5594_836_5604_6464_4773 7 0.002840355 0.213026618 0.004631013 14318 hsa-mir-346 hsa04120 Ubiquitin mediated proteolysis 5371_672_4193_7428_10401_7329_8925 7 0.002951124 0.221334269 0.004650641 14319 hsa-mir-346 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_5599_836_5970_3725 5 0.003038419 0.227881402 0.004650641 14320 hsa-mir-346 hsa04730 Long-term depression 5592_5595_5594_5604_4846 5 0.003038419 0.227881402 0.004650641 14321 hsa-mir-346 hsa04270 Vascular smooth muscle contraction 5580_5592_5595_5594_59_5604 6 0.005530752 0.414806397 0.008296128 14322 hsa-mir-346 hsa03440 Homologous recombination 10111_4361_4683 3 0.007323529 0.549264656 0.010769895 14323 hsa-mir-346 hsa04360 Axon guidance 25_4772_5595_5594_2932_4773 6 0.008865428 0.664907117 0.012786675 14324 hsa-mir-346 hsa03320 PPAR signaling pathway 5465_5467_5468_6256 4 0.015450574 1 0.021657842 14325 hsa-mir-346 hsa04710 Circadian rhythm - mammal 8863_4862 2 0.015593646 1 0.021657842 14326 hsa-mir-346 hsa05010 Alzheimer's disease 5595_5594_2902_836_4846_2932 6 0.031901762 1 0.043500092 14327 hsa-mir-346 hsa04210 Apoptosis 836_5970_7157_207 4 0.032480068 1 0.043500092 14328 hsa-mir-346 hsa04540 Gap junction 5592_5595_5594_5604 4 0.037055273 1 0.048756938 14329 hsa-mir-346 hsa03430 Mismatch repair 5111_2956 2 0.040951137 1 0.052954056 14330 hsa-mir-34c hsa05200 Pathways in cancer 1488_1499_207_4087_4088_208_1487_2033_4089_1387 10 2.72E-15 1.12E-13 1.12E-13 14331 hsa-mir-34c hsa04310 Wnt signaling pathway 1488_1499_4087_4088_1487_2033_4089_1387 8 3.93E-14 1.61E-12 8.05E-13 14332 hsa-mir-34c hsa05220 Chronic myeloid leukemia 1488_207_4088_208_1487_4089 6 8.43E-12 3.46E-10 1.15E-10 14333 hsa-mir-34c hsa04520 Adherens junction 1499_4087_4088_2033_4089_1387 6 1.22E-11 5.00E-10 1.25E-10 14334 hsa-mir-34c hsa05210 Colorectal cancer 1499_207_4087_4088_208_4089 6 1.61E-11 6.61E-10 1.32E-10 14335 hsa-mir-34c hsa04110 Cell cycle 4087_4088_2033_4089_7534_1387 6 1.20E-10 4.91E-09 8.19E-10 14336 hsa-mir-34c hsa04350 TGF-beta signaling pathway 4087_4088_2033_4089_1387 5 2.72E-09 1.12E-07 1.38E-08 14337 hsa-mir-34c hsa05215 Prostate cancer 1499_207_208_2033_1387 5 2.88E-09 1.18E-07 1.38E-08 14338 hsa-mir-34c hsa05212 Pancreatic cancer 1499_207_208_2033_1387 5 3.04E-09 1.24E-07 1.38E-08 14339 hsa-mir-34c hsa04330 Notch signaling pathway 1488_1487_2033_1387 4 2.81E-08 1.15E-06 1.15E-07 14340 hsa-mir-34c hsa05211 Renal cell carcinoma 207_208_2033_1387 4 1.43E-07 5.86E-06 5.32E-07 14341 hsa-mir-34c hsa04630 Jak-STAT signaling pathway 207_208_2033_1387 4 2.76E-06 0.00011319 9.43E-06 14342 hsa-mir-34c hsa05213 Endometrial cancer 1499_207_208 3 5.52E-06 0.000226446 1.74E-05 14343 hsa-mir-34c hsa04916 Melanogenesis 1499_2033_1387 3 4.09E-05 0.001677957 0.000119854 14344 hsa-mir-34c hsa04530 Tight junction 1499_207_208 3 9.11E-05 0.003734163 0.000248944 14345 hsa-mir-34c hsa04510 Focal adhesion 1499_207_208 3 0.000296883 0.012172214 0.000760763 14346 hsa-mir-34c hsa04150 mTOR signaling pathway 207_208 2 0.000532555 0.021834751 0.001259204 14347 hsa-mir-34c hsa05223 Non-small cell lung cancer 207_208 2 0.000572688 0.023480195 0.001259204 14348 hsa-mir-34c hsa05131 Shigellosis 1499_7534 2 0.000614246 0.025184088 0.001259204 14349 hsa-mir-34c hsa05130 Pathogenic Escherichia coli infection 1499_7534 2 0.000614246 0.025184088 0.001259204 14350 hsa-mir-34c hsa04010 MAPK signaling pathway 207_208_6722 3 0.000667981 0.02738724 0.001265874 14351 hsa-mir-34c hsa05221 Acute myeloid leukemia 207_208 2 0.000679249 0.027849222 0.001265874 14352 hsa-mir-34c hsa05214 Glioma 207_208 2 0.000818812 0.033571292 0.001459621 14353 hsa-mir-34c hsa04920 Adipocytokine signaling pathway 207_208 2 0.000868152 0.035594246 0.001483094 14354 hsa-mir-34c hsa05218 Melanoma 207_208 2 0.000971043 0.039812747 0.00159251 14355 hsa-mir-34c hsa04720 Long-term potentiation 2033_1387 2 0.001079524 0.044260484 0.001639277 14356 hsa-mir-34c hsa04662 B cell receptor signaling pathway 207_208 2 0.001079524 0.044260484 0.001639277 14357 hsa-mir-34c hsa04370 VEGF signaling pathway 207_208 2 0.001135853 0.046569983 0.001663214 14358 hsa-mir-34c hsa04664 Fc epsilon RI signaling pathway 207_208 2 0.001193571 0.048936393 0.001687462 14359 hsa-mir-34c hsa05222 Small cell lung cancer 207_208 2 0.001406466 0.057665088 0.001902209 14360 hsa-mir-34c hsa04012 ErbB signaling pathway 207_208 2 0.001438256 0.058968493 0.001902209 14361 hsa-mir-34c hsa04210 Apoptosis 207_208 2 0.001502865 0.061617474 0.001925546 14362 hsa-mir-34c hsa04620 Toll-like receptor signaling pathway 207_208 2 0.001956047 0.080197914 0.00243024 14363 hsa-mir-34c hsa04660 T cell receptor signaling pathway 207_208 2 0.002263293 0.092795006 0.002729265 14364 hsa-mir-34c hsa04910 Insulin signaling pathway 207_208 2 0.003505608 0.143729922 0.004106569 14365 hsa-mir-34c hsa05016 Huntington's disease 2033_1387 2 0.006348427 0.260285518 0.007230153 14366 hsa-mir-34c hsa04062 Chemokine signaling pathway 207_208 2 0.006675298 0.273687208 0.007396952 14367 hsa-mir-34c hsa04950 Maturity onset diabetes of the young 5080 1 0.015709945 0.644107757 0.016950204 14368 hsa-mir-34c hsa05216 Thyroid cancer 1499 1 0.018823748 0.771773648 0.019789068 14369 hsa-mir-34c hsa05217 Basal cell carcinoma 1499 1 0.034865656 1 0.035737298 14370 hsa-mir-3606 hsa03022 Basal transcription factors 2967_2961_2960_2963_2962_6881_2969_2968_6879_6878_6877_6874_6872_2957_54457_2958_6873_6884_2959_6880_6882_138474_6883 23 1.05E-32 7.46E-31 7.46E-31 14371 hsa-mir-3606 hsa05200 Pathways in cancer 5371_1499_5594_6258_1387_6256_836_1019_1017_4193_5914_7704_842_841_6774_3091_5970_4824_7157_6688_2113_4609_3725_1026_2353_10401_1050_5925_2033_207_3326_8554_7184 33 2.75E-24 1.95E-22 9.77E-23 14372 hsa-mir-3606 hsa05215 Prostate cancer 1499_5594_1385_1387_1017_4193_842_5970_4824_7157_468_1026_5925_2033_207_3326_7184 17 2.37E-17 1.68E-15 4.98E-16 14373 hsa-mir-3606 hsa05212 Pancreatic cancer 1499_5594_1385_1387_1017_4193_842_5970_4824_7157_468_1026_5925_2033_207_3326_7184 17 2.80E-17 1.99E-15 4.98E-16 14374 hsa-mir-3606 hsa05222 Small cell lung cancer 6258_6256_1019_1017_842_5970_7157_4609_10401_5925_207_8554 12 3.87E-11 2.75E-09 5.50E-10 14375 hsa-mir-3606 hsa04110 Cell cycle 4171_5591_1387_1019_1017_4193_7027_7157_1026_4085_5925_2033_5933 13 9.58E-11 6.80E-09 1.13E-09 14376 hsa-mir-3606 hsa05221 Acute myeloid leukemia 5371_5594_5914_7704_6774_5970_6688_4609_1050_207 10 3.09E-10 2.19E-08 3.13E-09 14377 hsa-mir-3606 hsa04010 MAPK signaling pathway 5594_1386_9261_836_3312_1649_5970_7157_468_4609_3725_3727_6195_2353_207_2002_2005 17 4.65E-10 3.30E-08 4.13E-09 14378 hsa-mir-3606 hsa05220 Chronic myeloid leukemia 5594_1019_4193_5970_7157_4609_1026_5925_207 9 3.70E-08 2.63E-06 2.92E-07 14379 hsa-mir-3606 hsa05223 Non-small cell lung cancer 5594_6258_6256_1019_842_7157_5925_207 8 4.90E-08 3.48E-06 3.48E-07 14380 hsa-mir-3606 hsa05210 Colorectal cancer 1499_5594_836_842_7157_4609_3725_2353_207 9 9.06E-08 6.43E-06 5.85E-07 14381 hsa-mir-3606 hsa05219 Bladder cancer 5594_1019_4193_7157_4609_1026_5925 7 1.68E-07 1.19E-05 9.84E-07 14382 hsa-mir-3606 hsa05214 Glioma 815_5594_1019_4193_7157_1026_5925_207 8 1.80E-07 1.28E-05 9.84E-07 14383 hsa-mir-3606 hsa04115 p53 signaling pathway 836_1019_1017_4193_842_841_7157_1026 8 2.74E-07 1.95E-05 1.39E-06 14384 hsa-mir-3606 hsa05216 Thyroid cancer 1499_5594_6258_6256_7157_4609 6 4.27E-07 3.03E-05 2.02E-06 14385 hsa-mir-3606 hsa05213 Endometrial cancer 1499_5594_842_7157_4609_207_2002 7 6.20E-07 4.40E-05 2.75E-06 14386 hsa-mir-3606 hsa05016 Huntington's disease 6874_3064_1385_1387_836_9001_842_841_5430_7157_2033 11 1.04E-06 7.35E-05 4.33E-06 14387 hsa-mir-3606 hsa04310 Wnt signaling pathway 815_1499_1387_8607_7157_4609_3725_1460_1457_2033 10 1.19E-06 8.45E-05 4.69E-06 14388 hsa-mir-3606 hsa04012 ErbB signaling pathway 815_6714_5594_4609_3725_1026_207_2002 8 1.39E-06 9.87E-05 5.20E-06 14389 hsa-mir-3606 hsa04210 Apoptosis 836_839_842_841_840_5970_7157_207 8 1.63E-06 0.0001157 5.79E-06 14390 hsa-mir-3606 hsa05218 Melanoma 5594_1019_4193_7157_1026_5925_207 7 4.20E-06 0.000297876 1.42E-05 14391 hsa-mir-3606 hsa05211 Renal cell carcinoma 5594_1387_3091_2113_3725_2033_207 7 4.57E-06 0.000324525 1.48E-05 14392 hsa-mir-3606 hsa04520 Adherens junction 1499_6714_5594_1387_1460_1457_2033 7 8.71E-06 0.000618096 2.69E-05 14393 hsa-mir-3606 hsa04350 TGF-beta signaling pathway 5594_1387_7027_1874_4609_2033_5933 7 1.45E-05 0.001030316 4.29E-05 14394 hsa-mir-3606 hsa04720 Long-term potentiation 815_5594_1387_468_6195_2033 6 6.19E-05 0.004397178 0.000175887 14395 hsa-mir-3606 hsa03050 Proteasome 5710_5705_5701_5702_5719 5 8.13E-05 0.005772881 0.000222034 14396 hsa-mir-3606 hsa04620 Toll-like receptor signaling pathway 5594_841_5970_3725_2353_207 6 0.000302727 0.021493651 0.000796061 14397 hsa-mir-3606 hsa04916 Melanogenesis 815_1499_5594_1385_1387_2033 6 0.00033418 0.023726782 0.000847385 14398 hsa-mir-3606 hsa04920 Adipocytokine signaling pathway 6258_6256_6774_5970_207 5 0.000348471 0.024741415 0.000853152 14399 hsa-mir-3606 hsa04912 GnRH signaling pathway 815_6714_5594_468_3725_2002 6 0.000404732 0.02873596 0.000957865 14400 hsa-mir-3606 hsa04660 T cell receptor signaling pathway 5594_1019_5970_3725_2353_207 6 0.000444109 0.031531716 0.000991508 14401 hsa-mir-3606 hsa04630 Jak-STAT signaling pathway 1387_6774_4609_10401_2033_207_8554 7 0.000446877 0.031728262 0.000991508 14402 hsa-mir-3606 hsa04662 B cell receptor signaling pathway 5594_5970_3725_2353_207 5 0.000567175 0.040269426 0.001220286 14403 hsa-mir-3606 hsa04370 VEGF signaling pathway 6714_5594_9261_842_207 5 0.000635094 0.045091651 0.001326225 14404 hsa-mir-3606 hsa03420 Nucleotide excision repair 2967_2968_5981_5887 4 0.00069612 0.049424507 0.001412129 14405 hsa-mir-3606 hsa04330 Notch signaling pathway 1387_9612_2033_8850 4 0.000876686 0.062244714 0.00172902 14406 hsa-mir-3606 hsa04612 Antigen processing and presentation 1385_4800_4801_3312_3326 5 0.001178189 0.083651441 0.00226085 14407 hsa-mir-3606 hsa04150 mTOR signaling pathway 5594_3091_6195_207 4 0.001247161 0.088548446 0.002330222 14408 hsa-mir-3606 hsa04530 Tight junction 1499_6714_1019_1460_1457_207 6 0.001326322 0.094168894 0.002414587 14409 hsa-mir-3606 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_836_5970_3725 4 0.003647584 0.25897844 0.006474461 14410 hsa-mir-3606 hsa05010 Alzheimer's disease 22926_5594_836_842_841_840 6 0.004530135 0.32163956 0.007844867 14411 hsa-mir-3606 hsa04510 Focal adhesion 1499_6714_5594_3725_207_2002 6 0.009084279 0.644983837 0.015356758 14412 hsa-mir-3606 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_842_7157 3 0.013316551 0.945475102 0.021987793 14413 hsa-mir-3606 hsa04950 Maturity onset diabetes of the young 5080_6927 2 0.019838911 1 0.032012789 14414 hsa-mir-3606 hsa04910 Insulin signaling pathway 5594_5211_207_2002 4 0.031689699 1 0.049999302 14415 hsa-mir-3606 hsa04120 Ubiquitin mediated proteolysis 5371_4193_10401_8554 4 0.032395215 1 0.050001311 14416 hsa-mir-3606 hsa03030 DNA replication 5981_4171 2 0.040203688 1 0.060733231 14417 hsa-mir-3606 hsa04540 Gap junction 6714_5594_10382 3 0.046828596 1 0.069267299 14418 hsa-mir-3607 hsa05200 Pathways in cancer 4087_5925_6688_207_7046_7704_5595_5594_6774_6772_1387 11 2.01E-12 9.83E-11 9.83E-11 14419 hsa-mir-3607 hsa05221 Acute myeloid leukemia 6688_207_7704_5595_5594_6774 6 5.36E-10 2.62E-08 1.31E-08 14420 hsa-mir-3607 hsa04520 Adherens junction 4301_4087_7046_5595_5594_1387 6 2.98E-09 1.46E-07 4.87E-08 14421 hsa-mir-3607 hsa05220 Chronic myeloid leukemia 5925_207_7046_5595_5594 5 1.18E-07 5.78E-06 1.45E-06 14422 hsa-mir-3607 hsa05210 Colorectal cancer 4087_207_7046_5595_5594 5 2.02E-07 9.89E-06 1.63E-06 14423 hsa-mir-3607 hsa04350 TGF-beta signaling pathway 4087_7046_5595_5594_1387 5 2.38E-07 1.17E-05 1.63E-06 14424 hsa-mir-3607 hsa05215 Prostate cancer 5925_207_5595_5594_1387 5 2.52E-07 1.23E-05 1.63E-06 14425 hsa-mir-3607 hsa05212 Pancreatic cancer 5925_207_5595_5594_1387 5 2.65E-07 1.30E-05 1.63E-06 14426 hsa-mir-3607 hsa05223 Non-small cell lung cancer 5925_207_5595_5594 4 1.60E-06 7.85E-05 8.72E-06 14427 hsa-mir-3607 hsa05214 Glioma 5925_207_5595_5594 4 3.23E-06 0.000158089 1.58E-05 14428 hsa-mir-3607 hsa05218 Melanoma 5925_207_5595_5594 4 4.51E-06 0.000220851 1.94E-05 14429 hsa-mir-3607 hsa05211 Renal cell carcinoma 207_5595_5594_1387 4 4.75E-06 0.000232872 1.94E-05 14430 hsa-mir-3607 hsa04062 Chemokine signaling pathway 207_5595_5594_6774_6772 5 1.04E-05 0.000510388 3.93E-05 14431 hsa-mir-3607 hsa04620 Toll-like receptor signaling pathway 207_5595_5594_6772 4 1.78E-05 0.00087335 6.24E-05 14432 hsa-mir-3607 hsa05219 Bladder cancer 5925_5595_5594 3 3.98E-05 0.001951887 0.000130126 14433 hsa-mir-3607 hsa05213 Endometrial cancer 207_5595_5594 3 7.29E-05 0.003572024 0.000210119 14434 hsa-mir-3607 hsa04150 mTOR signaling pathway 207_5595_5594 3 7.29E-05 0.003572024 0.000210119 14435 hsa-mir-3607 hsa04630 Jak-STAT signaling pathway 207_6774_6772_1387 4 8.69E-05 0.00426014 0.000236674 14436 hsa-mir-3607 hsa04720 Long-term potentiation 5595_5594_1387 3 0.000206482 0.010117625 0.000505881 14437 hsa-mir-3607 hsa04662 B cell receptor signaling pathway 207_5595_5594 3 0.000206482 0.010117625 0.000505881 14438 hsa-mir-3607 hsa04370 VEGF signaling pathway 207_5595_5594 3 0.00022254 0.010904472 0.000519261 14439 hsa-mir-3607 hsa04664 Fc epsilon RI signaling pathway 207_5595_5594 3 0.000239386 0.011729924 0.000533178 14440 hsa-mir-3607 hsa04012 ErbB signaling pathway 207_5595_5594 3 0.000314978 0.015433907 0.000671039 14441 hsa-mir-3607 hsa04916 Melanogenesis 5595_5594_1387 3 0.000523014 0.025627678 0.00106782 14442 hsa-mir-3607 hsa04660 T cell receptor signaling pathway 207_5595_5594 3 0.000613193 0.030046462 0.001201858 14443 hsa-mir-3607 hsa04010 MAPK signaling pathway 207_7046_5595_5594 4 0.000718152 0.035189431 0.00135344 14444 hsa-mir-3607 hsa04110 Cell cycle 4087_5925_1387 3 0.000766163 0.037541967 0.001390443 14445 hsa-mir-3607 hsa05216 Thyroid cancer 5595_5594 2 0.000948733 0.04648794 0.001660284 14446 hsa-mir-3607 hsa04910 Insulin signaling pathway 207_5595_5594 3 0.001163999 0.057035938 0.001966756 14447 hsa-mir-3607 hsa04930 Type II diabetes mellitus 5595_5594 2 0.002172998 0.106476914 0.00354923 14448 hsa-mir-3607 hsa04510 Focal adhesion 207_5595_5594 3 0.003562484 0.174561699 0.005631023 14449 hsa-mir-3607 hsa04920 Adipocytokine signaling pathway 207_6774 2 0.004620599 0.226409362 0.007075293 14450 hsa-mir-3607 hsa04730 Long-term depression 5595_5594 2 0.005156869 0.252686584 0.007657169 14451 hsa-mir-3607 hsa05222 Small cell lung cancer 5925_207 2 0.007408023 0.362993105 0.010676268 14452 hsa-mir-3607 hsa04540 Gap junction 5595_5594 2 0.008585006 0.420665292 0.012019008 14453 hsa-mir-3607 hsa04912 GnRH signaling pathway 5595_5594 2 0.011368171 0.557040392 0.015473344 14454 hsa-mir-3607 hsa04270 Vascular smooth muscle contraction 5595_5594 2 0.013415061 0.657337978 0.017765891 14455 hsa-mir-3607 hsa04360 Axon guidance 5595_5594 2 0.016296214 0.798514491 0.021013539 14456 hsa-mir-3607 hsa04530 Tight junction 4301_207 2 0.017707438 0.867664476 0.021985737 14457 hsa-mir-3607 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594 2 0.01794754 0.879429479 0.021985737 14458 hsa-mir-3607 hsa04310 Wnt signaling pathway 4087_1387 2 0.021452697 1 0.025638589 14459 hsa-mir-3607 hsa05010 Alzheimer's disease 5595_5594 2 0.028351471 1 0.033076716 14460 hsa-mir-3607 hsa04810 Regulation of actin cytoskeleton 5595_5594 2 0.041632108 1 0.047441239 14461 hsa-mir-3609 hsa04520 Adherens junction 4089_4087_2033 3 1.61E-05 0.000516523 0.000219567 14462 hsa-mir-3609 hsa05210 Colorectal cancer 836_4089_4087 3 1.86E-05 0.000594974 0.000219567 14463 hsa-mir-3609 hsa04350 TGF-beta signaling pathway 4089_4087_2033 3 2.06E-05 0.000658701 0.000219567 14464 hsa-mir-3609 hsa05200 Pathways in cancer 836_4089_4087_2033 4 4.17E-05 0.001333782 0.000327129 14465 hsa-mir-3609 hsa04110 Cell cycle 4089_4087_2033 3 5.11E-05 0.001635644 0.000327129 14466 hsa-mir-3609 hsa04310 Wnt signaling pathway 4089_4087_2033 3 0.000104084 0.003330676 0.000555113 14467 hsa-mir-3609 hsa05010 Alzheimer's disease 836_1020_840 3 0.000161925 0.005181589 0.000740227 14468 hsa-mir-3609 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432 2 0.000550308 0.01760985 0.002013879 14469 hsa-mir-3609 hsa04010 MAPK signaling pathway 836_1432_5598 3 0.000566403 0.018124907 0.002013879 14470 hsa-mir-3609 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_1432 2 0.000870253 0.027848104 0.00278481 14471 hsa-mir-3609 hsa04210 Apoptosis 836_840 2 0.001347411 0.043117149 0.003919741 14472 hsa-mir-3609 hsa04912 GnRH signaling pathway 1432_5598 2 0.001959333 0.062698645 0.005224887 14473 hsa-mir-3609 hsa05016 Huntington's disease 836_2033 2 0.005704163 0.182533223 0.014041017 14474 hsa-mir-3609 hsa04330 Notch signaling pathway 2033 1 0.028402771 0.908888669 0.064920619 14475 hsa-mir-3609 hsa04115 p53 signaling pathway 836 1 0.041164499 1 0.075060481 14476 hsa-mir-3609 hsa05211 Renal cell carcinoma 2033 1 0.042892419 1 0.075060481 14477 hsa-mir-3609 hsa04720 Long-term potentiation 2033 1 0.044617397 1 0.075060481 14478 hsa-mir-3609 hsa05220 Chronic myeloid leukemia 4089 1 0.044617397 1 0.075060481 14479 hsa-mir-3609 hsa04370 VEGF signaling pathway 1432 1 0.045765751 1 0.075060481 14480 hsa-mir-3609 hsa04664 Fc epsilon RI signaling pathway 1432 1 0.046912801 1 0.075060481 14481 hsa-mir-3611 hsa05200 Pathways in cancer 4089_5970_6776_6688_5925_2033_1019_1017_1050_2308_1956_8554_4609_1499_4790_5595_4088_1026_5594_841_861_1387 22 4.64E-22 3.15E-20 3.15E-20 14482 hsa-mir-3611 hsa05215 Prostate cancer 5970_5925_2033_1385_1017_468_2308_1956_1499_4790_5595_1026_5594_1387 14 3.13E-19 2.13E-17 8.18E-18 14483 hsa-mir-3611 hsa05212 Pancreatic cancer 5970_5925_2033_1385_1017_468_2308_1956_1499_4790_5595_1026_5594_1387 14 3.61E-19 2.45E-17 8.18E-18 14484 hsa-mir-3611 hsa05220 Chronic myeloid leukemia 4089_5970_6776_5925_1019_4609_4790_5595_4088_1026_5594_861 12 1.16E-16 7.92E-15 1.98E-15 14485 hsa-mir-3611 hsa04350 TGF-beta signaling pathway 4089_1874_6667_2033_7027_4609_5595_4088_5594_5933_1387 11 2.43E-14 1.66E-12 3.31E-13 14486 hsa-mir-3611 hsa04010 MAPK signaling pathway 6196_6722_5970_468_9252_1956_4609_4790_5595_5594_1649_2002_6195_5566_1386 15 3.75E-14 2.55E-12 4.25E-13 14487 hsa-mir-3611 hsa05221 Acute myeloid leukemia 5970_6776_6688_1050_4609_4790_5595_5594_861 9 1.30E-12 8.87E-11 1.27E-11 14488 hsa-mir-3611 hsa05219 Bladder cancer 5925_1019_9252_1956_4609_5595_1026_5594 8 4.92E-12 3.34E-10 4.18E-11 14489 hsa-mir-3611 hsa04720 Long-term potentiation 6196_2033_815_468_5595_5594_6195_5566_1387 9 9.33E-12 6.34E-10 7.05E-11 14490 hsa-mir-3611 hsa04110 Cell cycle 4089_5925_2033_1019_1017_7027_4088_1026_5933_1387 10 1.66E-11 1.13E-09 1.13E-10 14491 hsa-mir-3611 hsa04520 Adherens junction 4089_2033_1956_1499_5595_4088_5594_1387 8 5.32E-10 3.61E-08 3.29E-09 14492 hsa-mir-3611 hsa04012 ErbB signaling pathway 6776_815_1956_4609_5595_1026_5594_2002 8 9.86E-10 6.71E-08 5.59E-09 14493 hsa-mir-3611 hsa04916 Melanogenesis 2033_1385_815_1499_5595_5594_5566_1387 8 3.69E-09 2.51E-07 1.93E-08 14494 hsa-mir-3611 hsa05214 Glioma 5925_1019_815_1956_5595_1026_5594 7 4.15E-09 2.82E-07 2.02E-08 14495 hsa-mir-3611 hsa05210 Colorectal cancer 4089_1956_4609_1499_5595_4088_5594 7 2.17E-08 1.47E-06 9.83E-08 14496 hsa-mir-3611 hsa05222 Small cell lung cancer 5970_5925_1019_1017_8554_4609_4790 7 2.52E-08 1.72E-06 1.07E-07 14497 hsa-mir-3611 hsa05213 Endometrial cancer 1956_4609_1499_5595_5594_2002 6 3.83E-08 2.60E-06 1.53E-07 14498 hsa-mir-3611 hsa04310 Wnt signaling pathway 4089_2033_815_4609_1499_4088_5566_1387 8 6.08E-08 4.13E-06 2.30E-07 14499 hsa-mir-3611 hsa04912 GnRH signaling pathway 815_468_1956_5595_5594_2002_5566 7 1.10E-07 7.49E-06 3.94E-07 14500 hsa-mir-3611 hsa05218 Melanoma 5925_1019_1956_5595_1026_5594 6 2.13E-07 1.45E-05 7.25E-07 14501 hsa-mir-3611 hsa05223 Non-small cell lung cancer 5925_1019_1956_5595_5594 5 1.51E-06 0.000102801 4.90E-06 14502 hsa-mir-3611 hsa04620 Toll-like receptor signaling pathway 5970_4790_5595_5594_841_6348 6 1.59E-06 0.000107814 4.90E-06 14503 hsa-mir-3611 hsa05216 Thyroid cancer 4609_1499_5595_5594 4 4.19E-06 0.000284719 1.24E-05 14504 hsa-mir-3611 hsa04630 Jak-STAT signaling pathway 6776_2033_8554_4609_6778_1387 6 1.59E-05 0.001078191 4.49E-05 14505 hsa-mir-3611 hsa04150 mTOR signaling pathway 6196_5595_5594_6195 4 3.55E-05 0.002411644 9.65E-05 14506 hsa-mir-3611 hsa04660 T cell receptor signaling pathway 5970_1019_4790_5595_5594 5 4.01E-05 0.002725055 0.00010481 14507 hsa-mir-3611 hsa04062 Chemokine signaling pathway 5970_4790_5595_5594_6348_5566 6 5.21E-05 0.003541582 0.00013117 14508 hsa-mir-3611 hsa04115 p53 signaling pathway 1019_1017_1026_841 4 0.000100697 0.006847405 0.00024455 14509 hsa-mir-3611 hsa04910 Insulin signaling pathway 2308_5595_5594_2002_5566 5 0.000112753 0.007667227 0.000264387 14510 hsa-mir-3611 hsa05211 Renal cell carcinoma 2033_5595_5594_1387 4 0.000117804 0.008010652 0.000267022 14511 hsa-mir-3611 hsa04662 B cell receptor signaling pathway 5970_4790_5595_5594 4 0.000136924 0.009310852 0.00030035 14512 hsa-mir-3611 hsa04210 Apoptosis 5970_4790_841_5566 4 0.000256884 0.017468096 0.000545878 14513 hsa-mir-3611 hsa04540 Gap junction 1956_5595_5594_5566 4 0.000301798 0.020522254 0.000621886 14514 hsa-mir-3611 hsa05016 Huntington's disease 6667_2033_1385_841_1387 5 0.000451977 0.030734424 0.000903954 14515 hsa-mir-3611 hsa04510 Focal adhesion 1956_1499_5595_5594_2002 5 0.000676894 0.046028771 0.001315108 14516 hsa-mir-3611 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_1956_4790 3 0.001889083 0.128457661 0.003568268 14517 hsa-mir-3611 hsa04270 Vascular smooth muscle contraction 5595_5594_5566 3 0.007509714 0.510660551 0.013801637 14518 hsa-mir-3611 hsa04930 Type II diabetes mellitus 5595_5594 2 0.010514518 0.7149872 0.018815453 14519 hsa-mir-3611 hsa04330 Notch signaling pathway 2033_1387 2 0.011390001 0.774520096 0.01985949 14520 hsa-mir-3611 hsa05010 Alzheimer's disease 5595_5594_841 3 0.021704856 1 0.036120127 14521 hsa-mir-3611 hsa04920 Adipocytokine signaling pathway 5970_4790 2 0.021778312 1 0.036120127 14522 hsa-mir-3611 hsa04020 Calcium signaling pathway 815_1956_5566 3 0.023957609 1 0.038255099 14523 hsa-mir-3611 hsa04730 Long-term depression 5595_5594 2 0.024190725 1 0.038255099 14524 hsa-mir-3611 hsa04370 VEGF signaling pathway 5595_5594 2 0.028003564 1 0.043278236 14525 hsa-mir-3611 hsa04664 Fc epsilon RI signaling pathway 5595_5594 2 0.029324767 1 0.044312981 14526 hsa-mir-3611 hsa04612 Antigen processing and presentation 4800_1385 2 0.036290881 1 0.053597308 14527 hsa-mir-3611 hsa04810 Regulation of actin cytoskeleton 1956_5595_5594 3 0.037045198 1 0.053597308 14528 hsa-mir-3613 hsa05200 Pathways in cancer 4149_1499_595_2261_8517_4193_3551_3091_3066_3065_1050_5925_7184_1956_4436_1487_1488_1870_1871_10401_207_208_836_3716_1147_4233_5595_5594_5599_1387_2064_6256_9915_367_2932_6776_6777_6772_5979_5879_7157_6688_1869_3725_4286_2736_4087_4088_4089_2034_2033_898_4790_4791_4792_5970_1017_3320_3326_5371_3480_5159_5156_3265_4609_1026_2353_1441_8554 69 1.20E-46 9.71E-45 9.71E-45 14529 hsa-mir-3613 hsa05215 Prostate cancer 1499_595_8517_4193_3551_5925_7184_1956_1870_1871_207_208_1147_5595_5594_1387_2064_367_2932_7157_1869_2033_898_4790_4792_5970_1017_3320_3326_3480_5159_5156_3265_1026 34 6.83E-31 5.53E-29 2.51E-29 14530 hsa-mir-3613 hsa05212 Pancreatic cancer 1499_595_8517_4193_3551_5925_7184_1956_1870_1871_207_208_1147_5595_5594_1387_2064_367_2932_7157_1869_2033_898_4790_4792_5970_1017_3320_3326_3480_5159_5156_3265_1026 34 9.28E-31 7.52E-29 2.51E-29 14531 hsa-mir-3613 hsa05220 Chronic myeloid leukemia 595_8517_4193_3551_3066_3065_5925_1487_1488_1870_1871_207_208_1147_5595_5594_6776_6777_7157_1869_4088_4089_4790_4792_5970_3265_5781_4609_1026 29 1.56E-26 1.26E-24 3.15E-25 14532 hsa-mir-3613 hsa03022 Basal transcription factors 6880_54457_2958_138474_6883_6881_2957_6879_2967_2961_2960_2963_2969_2968_6878_6877_6874_6873_6872_6908_6884_6882_2959_9519 24 2.50E-26 2.03E-24 4.06E-25 14533 hsa-mir-3613 hsa04010 MAPK signaling pathway 3925_6722_4149_2261_2264_8517_9252_3551_9020_8986_1956_1432_22800_207_208_836_1147_5595_5594_5599_5598_3312_5971_5879_7157_3725_3727_6195_6196_6197_5058_4790_4791_51701_5970_5159_9261_1326_5156_3265_6885_4609_2353 43 4.86E-25 3.94E-23 6.57E-24 14534 hsa-mir-3613 hsa04110 Cell cycle 4171_595_4193_6500_3066_3065_5925_1870_1871_8379_5934_5933_7534_1387_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_898_1017_8454_4085_1026 29 8.27E-22 6.70E-20 9.57E-21 14535 hsa-mir-3613 hsa04630 Jak-STAT signaling pathway 3559_595_3454_3455_3560_1439_10401_2690_207_208_3717_3716_3718_85480_1387_3575_3570_3572_6778_6776_6777_6772_7297_2033_149233_3953_5781_4609_1441_8554_10379 31 4.96E-21 4.02E-19 5.02E-20 14536 hsa-mir-3613 hsa05210 Colorectal cancer 1499_595_1956_4436_207_208_836_4233_5595_5594_5599_2932_5879_7157_3725_4087_4088_4089_3480_5159_5156_4609_2353 23 1.60E-18 1.30E-16 1.44E-17 14537 hsa-mir-3613 hsa05214 Glioma 595_4193_5925_1956_1870_1871_207_208_5595_5594_7157_1869_808_801_805_3480_5159_5156_3265_1026 20 4.17E-17 3.38E-15 3.38E-16 14538 hsa-mir-3613 hsa05222 Small cell lung cancer 4149_595_8517_3551_5925_1870_1871_10401_207_208_1147_6256_7157_1869_898_4790_4792_5970_1017_4609_8554 21 3.59E-16 2.91E-14 2.64E-15 14539 hsa-mir-3613 hsa04620 Toll-like receptor signaling pathway 8517_3551_3454_3455_1432_207_208_1147_3654_5595_5594_5599_6772_5879_3725_4790_4792_5970_1326_9641_6885_2353 22 6.69E-16 5.42E-14 4.52E-15 14540 hsa-mir-3613 hsa04520 Adherens junction 1499_1457_1460_1956_6714_71_2241_4233_5595_5594_1387_2064_5879_4087_4088_4089_2033_51701_3480_6885 20 1.24E-15 1.00E-13 7.72E-15 14541 hsa-mir-3613 hsa05218 Melanoma 595_4193_5925_1956_1870_1871_207_208_4233_5595_5594_7157_1869_4286_3480_5159_5156_3265_1026 19 2.22E-15 1.80E-13 1.29E-14 14542 hsa-mir-3613 hsa04660 T cell receptor signaling pathway 8517_3551_9020_3932_1432_207_208_1147_5595_5594_2932_3725_5058_4794_4790_4792_4793_5970_1326_3265_6885_2353 22 2.63E-15 2.13E-13 1.42E-14 14543 hsa-mir-3613 hsa05219 Bladder cancer 595_2261_9252_4193_5925_1956_1870_1871_5595_5594_2064_7157_1869_3265_4609_1026 16 3.80E-15 3.08E-13 1.92E-14 14544 hsa-mir-3613 hsa05221 Acute myeloid leukemia 595_8517_3551_1050_207_208_1147_5595_5594_6776_6777_6688_4790_5970_5371_3265_4609 17 2.39E-14 1.94E-12 1.14E-13 14545 hsa-mir-3613 hsa04062 Chemokine signaling pathway 8517_1230_3551_7852_207_208_3055_3717_1147_3718_5590_5595_5594_1234_2932_5580_6777_6772_5879_5058_4790_4792_4793_5970_3265_2185 26 3.48E-14 2.82E-12 1.57E-13 14546 hsa-mir-3613 hsa04662 B cell receptor signaling pathway 8517_3551_6850_207_208_1147_5595_5594_2932_5879_3725_4794_4790_4792_4793_5970_3265_2353 18 6.08E-14 4.92E-12 2.59E-13 14547 hsa-mir-3613 hsa04310 Wnt signaling pathway 1499_595_8607_1457_6500_1460_23291_1487_1488_5599_1387_2932_5879_7157_3725_4087_4088_4089_2033_51701_8454_6885_4609 23 1.20E-13 9.68E-12 4.84E-13 14548 hsa-mir-3613 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 8517_3551_9020_1956_6714_1432_836_1147_4233_5599_5879_3725_5058_4790_4792_5970_5781 17 3.14E-13 2.55E-11 1.21E-12 14549 hsa-mir-3613 hsa04350 TGF-beta signaling pathway 6500_6667_1874_1875_5934_5933_5595_5594_1387_7027_4086_4087_4088_4089_2033_8454_4609_4093 18 5.48E-13 4.44E-11 2.02E-12 14550 hsa-mir-3613 hsa04920 Adipocytokine signaling pathway 8517_3551_2538_207_208_3717_1147_5599_6256_4794_4790_4792_4793_5970_3953_5781 16 1.63E-12 1.32E-10 5.73E-12 14551 hsa-mir-3613 hsa05223 Non-small cell lung cancer 595_5925_1956_1870_1871_207_208_5595_5594_2064_6256_7157_1869_3265 14 1.58E-11 1.28E-09 5.32E-11 14552 hsa-mir-3613 hsa05211 Renal cell carcinoma 3091_207_208_4233_5595_5594_1387_9915_5879_3725_5058_2034_2033_3265_5781 15 4.37E-11 3.54E-09 1.42E-10 14553 hsa-mir-3613 hsa04012 ErbB signaling pathway 1956_6714_207_208_5595_5594_5599_2064_2932_6776_6777_3725_5058_3265_4609_1026 16 5.07E-11 4.11E-09 1.58E-10 14554 hsa-mir-3613 hsa04210 Apoptosis 3556_8517_3551_9020_1439_207_208_836_1147_3654_7157_4790_4792_5970_840 15 5.98E-10 4.85E-08 1.80E-09 14555 hsa-mir-3613 hsa04510 Focal adhesion 1499_595_1956_6714_207_208_71_4233_5595_5594_5599_2064_2932_5879_3725_5058_2321_3480_5159_5156_3265 21 1.11E-09 9.01E-08 3.22E-09 14556 hsa-mir-3613 hsa05213 Endometrial cancer 1499_595_1956_207_208_5595_5594_2064_2932_7157_3265_4609 12 1.42E-09 1.15E-07 3.95E-09 14557 hsa-mir-3613 hsa04330 Notch signaling pathway 3066_3065_1487_1488_3280_1387_9612_2033_8850_388585_4851 11 6.07E-09 4.91E-07 1.62E-08 14558 hsa-mir-3613 hsa04720 Long-term potentiation 2902_5595_5594_1387_6195_6196_6197_2033_808_801_805_3265_2906 13 6.22E-09 5.04E-07 1.62E-08 14559 hsa-mir-3613 hsa04060 Cytokine-cytokine receptor interaction 3556_3559_1230_3454_3455_1956_7852_3560_1439_2690_85480_4233_1234_3575_3570_3572_2321_149233_5159_5156_3953_1441 22 1.22E-08 9.85E-07 3.08E-08 14560 hsa-mir-3613 hsa05216 Thyroid cancer 1499_595_5595_5594_6256_5979_7157_3265_4609 9 1.88E-08 1.52E-06 4.61E-08 14561 hsa-mir-3613 hsa04912 GnRH signaling pathway 1956_6714_1432_5595_5594_5599_5598_5580_3725_808_801_805_3265_2185 14 4.50E-08 3.65E-06 1.07E-07 14562 hsa-mir-3613 hsa04910 Insulin signaling pathway 3551_2538_5211_207_208_5590_5595_5594_5599_2932_808_801_805_3265 14 7.00E-07 5.67E-05 1.62E-06 14563 hsa-mir-3613 hsa05016 Huntington's disease 3066_3065_3064_2902_6667_836_5441_1387_9001_5430_5437_7157_2033_6874_6908_9519 16 1.00E-06 8.14E-05 2.26E-06 14564 hsa-mir-3613 hsa03020 RNA polymerase 64425_25885_51082_5441_5430_5437_84172 7 3.10E-06 0.000250745 6.78E-06 14565 hsa-mir-3613 hsa04664 Fc epsilon RI signaling pathway 6850_1432_207_208_5595_5594_5599_5580_5879_3265 10 4.62E-06 0.000374035 9.84E-06 14566 hsa-mir-3613 hsa04916 Melanogenesis 1499_5595_5594_1387_2932_4286_2033_808_801_805_3265 11 7.55E-06 0.000611263 1.57E-05 14567 hsa-mir-3613 hsa04150 mTOR signaling pathway 3091_207_208_5595_5594_6195_6196_6197 8 1.16E-05 0.000942928 2.36E-05 14568 hsa-mir-3613 hsa04540 Gap junction 10382_1956_6714_5592_5595_5594_5598_5159_5156_3265 10 1.71E-05 0.001386912 3.31E-05 14569 hsa-mir-3613 hsa04530 Tight junction 1499_1457_1460_6714_22800_8573_207_208_71_5590_5580_3265 12 1.72E-05 0.001391949 3.31E-05 14570 hsa-mir-3613 hsa04650 Natural killer cell mediated cytotoxicity 3454_3455_3932_6850_836_5595_5594_5879_5058_3265_5781_2185 12 1.84E-05 0.001488712 3.46E-05 14571 hsa-mir-3613 hsa04370 VEGF signaling pathway 6714_1432_207_208_5595_5594_5879_9261_3265 9 2.47E-05 0.001998491 4.54E-05 14572 hsa-mir-3613 hsa04930 Type II diabetes mellitus 3551_3651_5590_5595_5594_5599_5580 7 3.87E-05 0.00313521 6.97E-05 14573 hsa-mir-3613 hsa04950 Maturity onset diabetes of the young 6927_3280_3651_5080_3172 5 0.000152977 0.012391103 0.000269372 14574 hsa-mir-3613 hsa05010 Alzheimer's disease 2902_836_5595_5594_2932_808_351_801_805_840_2906_1020 12 0.00017248 0.013970854 0.000297252 14575 hsa-mir-3613 hsa04360 Axon guidance 7852_2242_4233_5595_5594_2932_5879_5058_3265_1020 10 0.00024449 0.01980365 0.000412576 14576 hsa-mir-3613 hsa04810 Regulation of actin cytoskeleton 2261_2264_1956_22800_71_5595_5594_5879_5058_5159_5156_3265_10788 13 0.000320354 0.025948701 0.000529565 14577 hsa-mir-3613 hsa04120 Ubiquitin mediated proteolysis 55294_4193_6500_23291_10401_7329_5371_672_8454_8554 10 0.000380639 0.030831791 0.000616636 14578 hsa-mir-3613 hsa04115 p53 signaling pathway 595_4193_836_7157_898_1017_1026 7 0.000436716 0.035374001 0.000693608 14579 hsa-mir-3613 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_1432_836_5879_7157_2906 6 0.000859454 0.069615793 0.001338765 14580 hsa-mir-3613 hsa04612 Antigen processing and presentation 3308_3312_3320_3326_4802_2923_4801 7 0.001751982 0.141910549 0.002677558 14581 hsa-mir-3613 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 0.002596161 0.210289076 0.003894242 14582 hsa-mir-3613 hsa04020 Calcium signaling pathway 1956_2902_2064_808_801_805_5159_5156_2906_2185 10 0.002813104 0.227861426 0.004142935 14583 hsa-mir-3613 hsa05340 Primary immunodeficiency 8517_3932_3718_3575 4 0.005157931 0.417792427 0.007460579 14584 hsa-mir-3613 hsa04270 Vascular smooth muscle contraction 5592_5595_5594_5580_808_801_805 7 0.007537347 0.610525123 0.010710967 14585 hsa-mir-3613 hsa04670 Leukocyte transendothelial migration 1499_7852_1432_71_5879_5781_2185 7 0.008892269 0.720273797 0.012418514 14586 hsa-mir-3613 hsa03420 Nucleotide excision repair 5887_2967_2968_6118 4 0.010754591 0.871121876 0.014764778 14587 hsa-mir-3613 hsa04730 Long-term depression 5592_5595_5594_3480_3265 5 0.011957968 0.968595402 0.016143257 14588 hsa-mir-3613 hsa05217 Basal cell carcinoma 1499_2932_7157_2736 4 0.021580514 1 0.028656093 14589 hsa-mir-3613 hsa05131 Shigellosis 1499_10382_71_7534 4 0.022803379 1 0.029318631 14590 hsa-mir-3613 hsa05130 Pathogenic Escherichia coli infection 1499_10382_71_7534 4 0.022803379 1 0.029318631 14591 hsa-mir-3613 hsa04340 Hedgehog signaling pathway 23291_53944_2932_2736 4 0.024067596 1 0.030460552 14592 hsa-mir-3613 hsa03010 Ribosome 6156_6128_6207_9349_6229 5 0.044099579 1 0.054954859 14593 hsa-mir-3614 hsa05200 Pathways in cancer 3320_4149_5371_5595_5594_5599_6258_1387_6257_6256_8031_5604_2932_2353_6502_4292_5970_5894_3725_1029_5601_4087_4088_4089_1050_5925_2033_8554 28 3.99E-24 2.35E-22 2.35E-22 14594 hsa-mir-3614 hsa04110 Cell cycle 990_1387_983_2932_8454_6502_6500_10912_1029_4087_4088_4089_4616_5925_2033_5933 16 4.03E-17 2.38E-15 1.19E-15 14595 hsa-mir-3614 hsa05210 Colorectal cancer 5595_5594_5599_5604_2932_2353_4292_5894_3725_5601_4087_4088_4089 13 7.61E-15 4.49E-13 1.50E-13 14596 hsa-mir-3614 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_8454_3399_6500_4087_4088_4089_2033_5933 12 2.93E-13 1.73E-11 4.33E-12 14597 hsa-mir-3614 hsa04310 Wnt signaling pathway 5599_1387_2932_8454_6500_8061_3725_1457_5601_1459_4087_4088_4089_2033 14 4.72E-13 2.78E-11 5.56E-12 14598 hsa-mir-3614 hsa04540 Gap junction 5595_5594_5598_983_5604_7277_7278_10376_5894_7846_51807 11 1.35E-11 7.95E-10 1.33E-10 14599 hsa-mir-3614 hsa05223 Non-small cell lung cancer 5595_5594_6258_6257_6256_5604_5894_1029_5925 9 6.47E-11 3.82E-09 5.16E-10 14600 hsa-mir-3614 hsa04010 MAPK signaling pathway 4149_5595_5594_5599_5598_5604_2353_1386_1649_5970_10912_5894_3725_5601_4616 15 6.99E-11 4.12E-09 5.16E-10 14601 hsa-mir-3614 hsa05215 Prostate cancer 3320_5595_5594_1387_5604_2932_5970_5894_5925_2033 10 1.69E-10 9.95E-09 1.10E-09 14602 hsa-mir-3614 hsa05212 Pancreatic cancer 3320_5595_5594_1387_5604_2932_5970_5894_5925_2033 10 1.87E-10 1.10E-08 1.10E-09 14603 hsa-mir-3614 hsa05220 Chronic myeloid leukemia 5595_5594_5604_5970_5894_1029_4088_4089_5925 9 9.12E-10 5.38E-08 4.63E-09 14604 hsa-mir-3614 hsa05216 Thyroid cancer 5595_5594_6258_6257_6256_8031_5604 7 9.42E-10 5.56E-08 4.63E-09 14605 hsa-mir-3614 hsa04520 Adherens junction 5595_5594_1387_1457_1459_4087_4088_4089_2033 9 1.54E-09 9.08E-08 6.98E-09 14606 hsa-mir-3614 hsa04662 B cell receptor signaling pathway 5595_5594_5604_2932_2353_5970_5894_3725 8 1.88E-08 1.11E-06 7.93E-08 14607 hsa-mir-3614 hsa04660 T cell receptor signaling pathway 5595_5594_5604_2932_2353_5970_5894_3725_5601 9 2.04E-08 1.20E-06 8.01E-08 14608 hsa-mir-3614 hsa05222 Small cell lung cancer 4149_6258_6257_6256_6502_5970_5925_8554 8 5.05E-08 2.98E-06 1.86E-07 14609 hsa-mir-3614 hsa04012 ErbB signaling pathway 5595_5594_5599_5604_2932_5894_3725_5601 8 5.48E-08 3.24E-06 1.90E-07 14610 hsa-mir-3614 hsa05221 Acute myeloid leukemia 5371_5595_5594_5604_5970_5894_1050 7 7.66E-08 4.52E-06 2.51E-07 14611 hsa-mir-3614 hsa04910 Insulin signaling pathway 10891_5595_5594_5599_5604_23265_2932_5894_5601 9 1.27E-07 7.50E-06 3.95E-07 14612 hsa-mir-3614 hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_8454_6502_6500_64326_7329_8554 9 1.35E-07 7.95E-06 3.97E-07 14613 hsa-mir-3614 hsa04920 Adipocytokine signaling pathway 10891_5599_6258_6257_6256_5970_5601 7 1.71E-07 1.01E-05 4.63E-07 14614 hsa-mir-3614 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5604_2353_5970_3725_5601 8 1.72E-07 1.02E-05 4.63E-07 14615 hsa-mir-3614 hsa05219 Bladder cancer 5595_5594_5604_5894_1029_5925 6 2.48E-07 1.46E-05 6.34E-07 14616 hsa-mir-3614 hsa04912 GnRH signaling pathway 5595_5594_5599_5598_5604_5894_3725_5601 8 2.60E-07 1.53E-05 6.34E-07 14617 hsa-mir-3614 hsa05211 Renal cell carcinoma 5595_5594_1387_5604_5894_3725_2033 7 2.68E-07 1.58E-05 6.34E-07 14618 hsa-mir-3614 hsa05213 Endometrial cancer 5595_5594_5604_2932_4292_5894 6 7.82E-07 4.61E-05 1.77E-06 14619 hsa-mir-3614 hsa05131 Shigellosis 7277_7278_10376_7846_51807_4691 6 1.17E-06 6.88E-05 2.46E-06 14620 hsa-mir-3614 hsa05130 Pathogenic Escherichia coli infection 7277_7278_10376_7846_51807_4691 6 1.17E-06 6.88E-05 2.46E-06 14621 hsa-mir-3614 hsa05214 Glioma 5595_5594_5604_5894_1029_5925 6 2.61E-06 0.000153974 5.31E-06 14622 hsa-mir-3614 hsa04916 Melanogenesis 5595_5594_1387_5604_2932_5894_2033 7 2.72E-06 0.000160318 5.34E-06 14623 hsa-mir-3614 hsa04115 p53 signaling pathway 983_10912_7161_1029_64326_4616 6 3.60E-06 0.000212612 6.86E-06 14624 hsa-mir-3614 hsa05218 Melanoma 5595_5594_5604_5894_1029_5925 6 4.21E-06 0.000248096 7.75E-06 14625 hsa-mir-3614 hsa04720 Long-term potentiation 5595_5594_1387_5604_5894_2033 6 5.65E-06 0.000333534 1.01E-05 14626 hsa-mir-3614 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5604_5894_5601 6 7.48E-06 0.000441447 1.30E-05 14627 hsa-mir-3614 hsa04510 Focal adhesion 5595_5594_5599_5604_2932_5894_3725_5601 8 2.49E-05 0.001468721 4.20E-05 14628 hsa-mir-3614 hsa04062 Chemokine signaling pathway 5595_5594_5604_2932_5970_5894_7074 7 0.000121755 0.00718357 0.000199544 14629 hsa-mir-3614 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601 4 0.00015095 0.008906034 0.000240704 14630 hsa-mir-3614 hsa04330 Notch signaling pathway 1387_9612_2033_2648 4 0.000176533 0.010415449 0.000274091 14631 hsa-mir-3614 hsa03320 PPAR signaling pathway 6258_6257_6256_2168 4 0.000737285 0.043499819 0.00111538 14632 hsa-mir-3614 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5970_3725_5601 4 0.000775533 0.045756451 0.001116011 14633 hsa-mir-3614 hsa04730 Long-term depression 5595_5594_5604_5894 4 0.000775533 0.045756451 0.001116011 14634 hsa-mir-3614 hsa04370 VEGF signaling pathway 5595_5594_5604_5894 4 0.001034968 0.061063115 0.001453884 14635 hsa-mir-3614 hsa03022 Basal transcription factors 2962_2969_6908 3 0.001368465 0.080739408 0.001877661 14636 hsa-mir-3614 hsa05016 Huntington's disease 10891_1387_6908_6667_2033 5 0.004278384 0.252424636 0.005736924 14637 hsa-mir-3614 hsa04270 Vascular smooth muscle contraction 5595_5594_5604_5894 4 0.004597164 0.271232698 0.006027393 14638 hsa-mir-3614 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_5604_5894 4 0.007813955 0.461023367 0.009962328 14639 hsa-mir-3614 hsa04810 Regulation of actin cytoskeleton 5595_5594_5604_5894_7074 5 0.007936091 0.468229398 0.009962328 14640 hsa-mir-3614 hsa04612 Antigen processing and presentation 3320_4801_4802 3 0.014147568 0.834706496 0.017389719 14641 hsa-mir-3614 hsa04150 mTOR signaling pathway 5595_5594 2 0.035348487 1 0.042562464 14642 hsa-mir-3614 hsa04360 Axon guidance 5595_5594_2932 3 0.037463024 1 0.044206368 14643 hsa-mir-3615 hsa05200 Pathways in cancer 1147_3320_3326_405_3480_1956_5595_5594_6654_5914_2064_6256_595_2308_208_367_4193_7704_1387_6774_6776_5970_8503_2885_7157_4087_6688_10401_3725_4088_4089_5295_2033_207_8554_4790 36 5.13E-32 3.64E-30 3.64E-30 14644 hsa-mir-3615 hsa05215 Prostate cancer 1147_3320_3326_3480_1956_5595_5594_6654_2064_595_2308_208_367_4193_1387_5970_8503_2885_7157_5295_2033_207_4790 23 1.76E-28 1.25E-26 5.21E-27 14645 hsa-mir-3615 hsa05212 Pancreatic cancer 1147_3320_3326_3480_1956_5595_5594_6654_2064_595_2308_208_367_4193_1387_5970_8503_2885_7157_5295_2033_207_4790 23 2.20E-28 1.56E-26 5.21E-27 14646 hsa-mir-3615 hsa05221 Acute myeloid leukemia 1147_5595_5594_6654_5914_595_208_7704_6774_6776_5970_8503_2885_6688_5295_207_4790 17 6.09E-22 4.32E-20 8.76E-21 14647 hsa-mir-3615 hsa05220 Chronic myeloid leukemia 1147_5595_5594_6654_595_208_4193_6776_5970_8503_2885_7157_4088_4089_5295_207_4790_6464 18 6.17E-22 4.38E-20 8.76E-21 14648 hsa-mir-3615 hsa05214 Glioma 3480_1956_5595_5594_6654_595_208_4193_8503_2885_7157_5295_207_801_6464_808_805 17 2.50E-21 1.77E-19 2.96E-20 14649 hsa-mir-3615 hsa04010 MAPK signaling pathway 1147_994_1956_5595_5594_6654_5566_208_4214_1432_5970_627_2885_7157_10912_3725_3727_6195_6197_5058_4616_2872_207_4790 24 1.37E-19 9.70E-18 1.39E-18 14650 hsa-mir-3615 hsa04910 Insulin signaling pathway 6720_10891_5595_5594_6654_2308_5566_7249_208_5770_8503_2885_5295_2872_207_801_6464_808_805 19 4.83E-19 3.43E-17 4.29E-18 14651 hsa-mir-3615 hsa05210 Colorectal cancer 3480_1956_5595_5594_6654_595_208_8503_2885_7157_4087_3725_4088_4089_5295_207 16 3.20E-18 2.27E-16 2.53E-17 14652 hsa-mir-3615 hsa04012 ErbB signaling pathway 1956_6714_5595_5594_6654_56924_2064_208_6776_8503_2885_3725_5295_5058_207_6464 16 5.25E-18 3.73E-16 3.73E-17 14653 hsa-mir-3615 hsa04660 T cell receptor signaling pathway 1147_3932_5595_5594_6654_56924_208_5777_1432_5970_8503_2885_3725_5295_5058_207_4790 17 6.42E-18 4.56E-16 4.14E-17 14654 hsa-mir-3615 hsa05223 Non-small cell lung cancer 1956_5595_5594_6654_2064_6256_595_2309_208_8503_2885_7157_5295_207 14 9.99E-18 7.09E-16 5.91E-17 14655 hsa-mir-3615 hsa05213 Endometrial cancer 1956_5595_5594_6654_2064_595_2309_208_8503_2885_7157_5295_207 13 2.27E-16 1.61E-14 1.24E-15 14656 hsa-mir-3615 hsa05211 Renal cell carcinoma 405_5595_5594_6654_56924_208_1387_8503_2885_3725_5295_5058_2033_207 14 3.33E-16 2.36E-14 1.69E-15 14657 hsa-mir-3615 hsa04510 Focal adhesion 9564_3480_1956_6714_5595_5594_6654_56924_2064_595_208_8503_857_2885_3725_5295_5058_207_6464 19 4.41E-16 3.13E-14 2.09E-15 14658 hsa-mir-3615 hsa04520 Adherens junction 1460_3480_1956_6714_5595_5594_2064_5770_5777_1387_4087_4088_4089_2033 14 1.22E-15 8.69E-14 5.43E-15 14659 hsa-mir-3615 hsa04062 Chemokine signaling pathway 1147_9564_5595_5594_6654_2770_2309_5566_208_6774_5970_8503_2885_5295_5058_207_4790_6464 18 2.26E-15 1.60E-13 9.42E-15 14660 hsa-mir-3615 hsa04662 B cell receptor signaling pathway 1147_5595_5594_6654_208_5777_5970_8503_2885_3725_5295_207_4790 13 1.46E-14 1.04E-12 5.76E-14 14661 hsa-mir-3615 hsa04110 Cell cycle 994_595_7533_4193_902_1387_7157_4087_10912_1022_4088_4089_4616_2033 14 1.73E-13 1.23E-11 6.47E-13 14662 hsa-mir-3615 hsa04912 GnRH signaling pathway 1956_6714_5595_5594_6654_5566_4214_1432_2885_3725_801_808_805 13 9.95E-13 7.06E-11 3.53E-12 14663 hsa-mir-3615 hsa05222 Small cell lung cancer 1147_6256_595_208_5970_8503_7157_10401_5295_207_8554_4790 12 1.56E-12 1.11E-10 5.27E-12 14664 hsa-mir-3615 hsa04630 Jak-STAT signaling pathway 6654_595_208_5777_1387_6774_6776_8503_2885_10401_5295_2033_207_8554 14 4.74E-12 3.37E-10 1.50E-11 14665 hsa-mir-3615 hsa05218 Melanoma 3480_1956_5595_5594_595_208_4193_8503_7157_5295_207 11 4.87E-12 3.46E-10 1.50E-11 14666 hsa-mir-3615 hsa04620 Toll-like receptor signaling pathway 1147_5595_5594_208_1432_5970_8503_3725_5295_207_4790 11 1.71E-10 1.21E-08 5.02E-10 14667 hsa-mir-3615 hsa04720 Long-term potentiation 5595_5594_5566_1387_6195_6197_2033_801_808_805 10 1.77E-10 1.26E-08 5.02E-10 14668 hsa-mir-3615 hsa04150 mTOR signaling pathway 5595_5594_7249_208_8503_6195_6197_5295_207 9 1.84E-10 1.30E-08 5.02E-10 14669 hsa-mir-3615 hsa04664 Fc epsilon RI signaling pathway 5595_5594_6654_208_1432_8503_2885_5295_207 9 5.22E-09 3.71E-07 1.37E-08 14670 hsa-mir-3615 hsa04210 Apoptosis 1147_5566_208_5970_8503_7157_5295_207_4790 9 1.36E-08 9.67E-07 3.45E-08 14671 hsa-mir-3615 hsa05219 Bladder cancer 1956_5595_5594_2064_595_4193_7157 7 2.58E-08 1.83E-06 6.32E-08 14672 hsa-mir-3615 hsa04920 Adipocytokine signaling pathway 1147_10891_6256_208_6774_5970_207_4790 8 2.71E-08 1.92E-06 6.41E-08 14673 hsa-mir-3615 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6654_5777_8503_2885_5295_5058_6464 10 4.07E-08 2.89E-06 9.09E-08 14674 hsa-mir-3615 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_1956_6714_1432_5970_3725_5058_4790 8 4.10E-08 2.91E-06 9.09E-08 14675 hsa-mir-3615 hsa04916 Melanogenesis 5595_5594_2770_5566_1387_2033_801_808_805 9 4.76E-08 3.38E-06 1.02E-07 14676 hsa-mir-3615 hsa04370 VEGF signaling pathway 6714_5595_5594_208_1432_8503_5295_207 8 7.32E-08 5.20E-06 1.53E-07 14677 hsa-mir-3615 hsa04310 Wnt signaling pathway 1460_595_5566_1387_7157_4087_3725_4088_4089_2033 10 9.58E-08 6.80E-06 1.94E-07 14678 hsa-mir-3615 hsa04350 TGF-beta signaling pathway 5595_5594_6667_1387_4087_4088_4089_2033 8 1.75E-07 1.24E-05 3.45E-07 14679 hsa-mir-3615 hsa04540 Gap junction 1956_6714_5595_5594_6654_2770_5566_2885 8 2.82E-07 2.00E-05 5.41E-07 14680 hsa-mir-3615 hsa05216 Thyroid cancer 5595_5594_6256_595_7157 5 2.36E-06 0.000167889 4.42E-06 14681 hsa-mir-3615 hsa04115 p53 signaling pathway 595_7249_4193_7157_10912_4616 6 8.55E-06 0.000607315 1.56E-05 14682 hsa-mir-3615 hsa04810 Regulation of actin cytoskeleton 9564_1956_5595_5594_6654_56924_8503_5295_5058 9 1.67E-05 0.001183772 2.96E-05 14683 hsa-mir-3615 hsa04120 Ubiquitin mediated proteolysis 7329_672_4214_4193_10401_10273_8554 7 4.34E-05 0.003081466 7.52E-05 14684 hsa-mir-3615 hsa03022 Basal transcription factors 2965_6908_2959_6881 4 0.000133524 0.009480196 0.000225719 14685 hsa-mir-3615 hsa04270 Vascular smooth muscle contraction 5595_5594_5566_801_808_805 6 0.00014665 0.010412128 0.000242143 14686 hsa-mir-3615 hsa04070 Phosphatidylinositol signaling system 8503_5295_801_808_805 5 0.000170989 0.012140202 0.000275914 14687 hsa-mir-3615 hsa03420 Nucleotide excision repair 2965_902_1022_4331 4 0.000247803 0.017593983 0.000389171 14688 hsa-mir-3615 hsa04360 Axon guidance 5998_5595_5594_56924_2770_5058 6 0.000252139 0.017901871 0.000389171 14689 hsa-mir-3615 hsa05016 Huntington's disease 10891_6908_6667_1387_627_7157_2033 7 0.000263122 0.018681634 0.000397151 14690 hsa-mir-3615 hsa04930 Type II diabetes mellitus 5595_5594_8503_5295 4 0.000268496 0.019063229 0.000397151 14691 hsa-mir-3615 hsa04670 Leukocyte transendothelial migration 9564_2770_1432_8503_5295 5 0.001341251 0.09522884 0.001923523 14692 hsa-mir-3615 hsa04730 Long-term depression 3480_5595_5594_2770 4 0.001354594 0.09617614 0.001923523 14693 hsa-mir-3615 hsa04020 Calcium signaling pathway 1956_2064_5566_801_808_805 6 0.001403753 0.099666452 0.001954244 14694 hsa-mir-3615 hsa04530 Tight junction 1460_6714_2770_208_207 5 0.00219021 0.155504904 0.002990479 14695 hsa-mir-3615 hsa04330 Notch signaling pathway 1387_9612_2033 3 0.003983769 0.282847604 0.005336747 14696 hsa-mir-3615 hsa05010 Alzheimer's disease 5595_5594_801_808_805 5 0.006283988 0.446163138 0.00826228 14697 hsa-mir-3615 hsa04612 Antigen processing and presentation 3320_3326_6890 3 0.021030892 1 0.02714897 14698 hsa-mir-3615 hsa05340 Primary immunodeficiency 3932_6890 2 0.02315701 1 0.02935978 14699 hsa-mir-3615 hsa03410 Base excision repair 6996_4350 2 0.024342786 1 0.030321715 14700 hsa-mir-3615 hsa03050 Proteasome 5698_5705 2 0.04037437 1 0.049423798 14701 hsa-mir-3618 hsa05200 Pathways in cancer 2113_7157_861_5925_1387 5 1.32E-06 3.95E-05 3.95E-05 14702 hsa-mir-3618 hsa05220 Chronic myeloid leukemia 7157_861_5925 3 1.34E-05 0.000401696 0.000131923 14703 hsa-mir-3618 hsa04350 TGF-beta signaling pathway 3398_3399_1387 3 2.06E-05 0.000617532 0.000131923 14704 hsa-mir-3618 hsa05215 Prostate cancer 7157_5925_1387 3 2.13E-05 0.000638345 0.000131923 14705 hsa-mir-3618 hsa05212 Pancreatic cancer 7157_5925_1387 3 2.20E-05 0.000659615 0.000131923 14706 hsa-mir-3618 hsa04110 Cell cycle 7157_5925_1387 3 5.11E-05 0.001533416 0.000255569 14707 hsa-mir-3618 hsa05016 Huntington's disease 7157_1387_6908 3 0.000192852 0.005785569 0.00082651 14708 hsa-mir-3618 hsa05219 Bladder cancer 7157_5925 2 0.000316507 0.009495202 0.0011869 14709 hsa-mir-3618 hsa05223 Non-small cell lung cancer 7157_5925 2 0.000513053 0.01539158 0.001650923 14710 hsa-mir-3618 hsa05014 Amyotrophic lateral sclerosis (ALS) 7157_1616 2 0.000550308 0.016509235 0.001650923 14711 hsa-mir-3618 hsa05214 Glioma 7157_5925 2 0.000733726 0.022011783 0.002001071 14712 hsa-mir-3618 hsa05218 Melanoma 7157_5925 2 0.000870253 0.026107597 0.00206333 14713 hsa-mir-3618 hsa05211 Renal cell carcinoma 2113_1387 2 0.00089411 0.026823286 0.00206333 14714 hsa-mir-3618 hsa05222 Small cell lung cancer 7157_5925 2 0.001260899 0.037826976 0.002701927 14715 hsa-mir-3618 hsa04310 Wnt signaling pathway 7157_1387 2 0.003790764 0.11372293 0.007581529 14716 hsa-mir-3618 hsa04010 MAPK signaling pathway 7157_1616 2 0.011614496 0.348434866 0.021777179 14717 hsa-mir-3618 hsa05216 Thyroid cancer 7157 1 0.017842211 0.535266341 0.031486255 14718 hsa-mir-3618 hsa03022 Basal transcription factors 6908 1 0.022549107 0.676473219 0.037581845 14719 hsa-mir-3618 hsa04330 Notch signaling pathway 1387 1 0.028402771 0.852083127 0.04484648 14720 hsa-mir-3618 hsa05213 Endometrial cancer 7157 1 0.031317172 0.939515157 0.046975758 14721 hsa-mir-3618 hsa05217 Basal cell carcinoma 7157 1 0.033061847 0.991855421 0.047231211 14722 hsa-mir-3618 hsa05221 Acute myeloid leukemia 861 1 0.035383465 1 0.04825018 14723 hsa-mir-3618 hsa04115 p53 signaling pathway 7157 1 0.041164499 1 0.053692825 14724 hsa-mir-3618 hsa04720 Long-term potentiation 1387 1 0.044617397 1 0.055771746 14725 hsa-mir-3618 hsa04520 Adherens junction 1387 1 0.047485837 1 0.056983005 14726 hsa-mir-3618 hsa05210 Colorectal cancer 7157 1 0.049774731 1 0.057432382 14727 hsa-mir-3619 hsa04110 Cell cycle 1869_25_5925_545_995_1871_1026_5591_1870_983_4088_7534_1017_2932_4193_7027_902_1387_3066_7157_1031_9232_5347_1022_1029_4087_7532_3065_1111_2033_890_11200_8556_8555_472 35 7.96E-36 6.69E-34 6.69E-34 14728 hsa-mir-3619 hsa05200 Pathways in cancer 1147_3320_1869_5743_3326_5747_25_5925_675_998_1871_1026_5594_5595_5599_1870_596_5601_6789_1856_4088_613_1017_2932_4193_367_1387_5578_51588_8554_5371_3066_4436_7157_598_4609_1029_4087_5888_5728_3065_3091_2033_3910_4792_5602 46 5.71E-34 4.80E-32 2.40E-32 14729 hsa-mir-3619 hsa04115 p53 signaling pathway 50484_545_6241_1026_25898_983_1017_27113_4194_4193_900_7157_7161_1029_64326_5728_51246_1111_11200_472 20 7.73E-21 6.49E-19 2.16E-19 14730 hsa-mir-3619 hsa05215 Prostate cancer 1147_3320_1869_3326_5925_1871_1026_5594_5595_1385_1870_596_1017_2932_4193_367_1387_7157_5728_2033_4792 21 2.55E-20 2.14E-18 5.24E-19 14731 hsa-mir-3619 hsa05212 Pancreatic cancer 1147_3320_1869_3326_5925_1871_1026_5594_5595_1385_1870_596_1017_2932_4193_367_1387_7157_5728_2033_4792 21 3.12E-20 2.62E-18 5.24E-19 14732 hsa-mir-3619 hsa05220 Chronic myeloid leukemia 1147_1869_25_5925_1871_1026_5594_5595_1870_4088_613_4193_3066_7157_598_4609_1029_3065_4792 19 6.37E-19 5.35E-17 8.91E-18 14733 hsa-mir-3619 hsa05222 Small cell lung cancer 1147_1869_5743_5747_5925_1871_1870_596_1017_51588_8554_7157_598_4609_5728_3910_4792 17 1.67E-15 1.40E-13 2.00E-14 14734 hsa-mir-3619 hsa04310 Wnt signaling pathway 1460_5518_5515_5599_5601_1856_1457_4088_2932_1387_5578_7157_4609_1452_4087_5527_2033_5602 18 6.82E-13 5.73E-11 7.16E-12 14735 hsa-mir-3619 hsa05219 Bladder cancer 1869_5925_1871_1026_5594_5595_1870_4193_7157_4609_1029 11 1.24E-11 1.04E-09 1.15E-10 14736 hsa-mir-3619 hsa05214 Glioma 1869_5925_1871_1026_5594_5595_1870_4193_5578_7157_1029_5728 12 5.05E-11 4.24E-09 4.24E-10 14737 hsa-mir-3619 hsa05210 Colorectal cancer 5594_5595_5599_596_5601_1856_4088_2932_4436_7157_4609_4087_5602 13 5.63E-11 4.73E-09 4.30E-10 14738 hsa-mir-3619 hsa04010 MAPK signaling pathway 1147_998_5594_5595_5599_5601_3304_3305_3303_6789_3315_5578_3164_7157_4609_1386_1616_5923_5602 19 7.78E-10 6.53E-08 5.44E-09 14739 hsa-mir-3619 hsa05218 Melanoma 1869_5925_1871_1026_5594_5595_1870_4193_7157_1029_5728 11 1.71E-09 1.44E-07 1.06E-08 14740 hsa-mir-3619 hsa04120 Ubiquitin mediated proteolysis 10055_672_7319_25898_84447_4193_3093_51588_8554_5371_64326_7329_10075_7337 14 1.77E-09 1.49E-07 1.06E-08 14741 hsa-mir-3619 hsa05223 Non-small cell lung cancer 1869_5925_1871_5594_5595_1870_6789_5578_7157_1029 10 2.05E-09 1.72E-07 1.15E-08 14742 hsa-mir-3619 hsa04350 TGF-beta signaling pathway 5518_5515_5594_5595_6667_4088_7027_1387_4609_4087_2033 11 1.17E-08 9.82E-07 5.78E-08 14743 hsa-mir-3619 hsa04012 ErbB signaling pathway 5747_25_1026_5594_5595_5599_5601_2932_5578_4609_5602 11 1.17E-08 9.82E-07 5.78E-08 14744 hsa-mir-3619 hsa04330 Notch signaling pathway 1856_1387_3066_9612_3065_2033_8850_4851 8 1.54E-07 1.30E-05 7.20E-07 14745 hsa-mir-3619 hsa04510 Focal adhesion 5747_998_5594_5595_5599_596_5601_5499_2932_5578_5728_5923_3910_5602 14 1.79E-07 1.50E-05 7.91E-07 14746 hsa-mir-3619 hsa03022 Basal transcription factors 2965_2969_2957_6908_51616_2958_6880 7 4.98E-07 4.18E-05 2.09E-06 14747 hsa-mir-3619 hsa04520 Adherens junction 1460_998_5594_5595_1457_4088_1387_4087_2033 9 6.27E-07 5.26E-05 2.51E-06 14748 hsa-mir-3619 hsa03420 Nucleotide excision repair 2965_4331_2074_6117_2071_902_1022 7 1.41E-06 0.000118244 5.37E-06 14749 hsa-mir-3619 hsa05016 Huntington's disease 25942_3064_1385_6908_6667_27113_1387_3066_7157_3065_2033 11 1.43E-05 0.001199644 5.22E-05 14750 hsa-mir-3619 hsa04920 Adipocytokine signaling pathway 1147_5563_6794_5599_5601_4792_5602 7 1.76E-05 0.001480208 6.17E-05 14751 hsa-mir-3619 hsa04916 Melanogenesis 5594_5595_1385_1856_2932_1387_5578_2033 8 3.50E-05 0.002939104 0.000117564 14752 hsa-mir-3619 hsa04910 Insulin signaling pathway 5563_5594_5595_5599_5601_5499_6720_2932_5602 9 3.89E-05 0.003263685 0.000125526 14753 hsa-mir-3619 hsa04370 VEGF signaling pathway 5743_5747_998_5594_5595_3315_5578 7 4.04E-05 0.003391646 0.000125617 14754 hsa-mir-3619 hsa05213 Endometrial cancer 5594_5595_2932_7157_4609_5728 6 4.26E-05 0.003577475 0.000127767 14755 hsa-mir-3619 hsa04660 T cell receptor signaling pathway 1147_998_5594_5595_5601_2932_959_4792 8 5.08E-05 0.004271252 0.000147285 14756 hsa-mir-3619 hsa04612 Antigen processing and presentation 3320_3326_1385_3309_3304_3305_3303 7 9.49E-05 0.007975609 0.000257278 14757 hsa-mir-3619 hsa04210 Apoptosis 1147_823_596_7157_598_4792_472 7 9.49E-05 0.007975609 0.000257278 14758 hsa-mir-3619 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_998_5599_5601_4792_5602 6 0.000209418 0.017591088 0.000524517 14759 hsa-mir-3619 hsa04620 Toll-like receptor signaling pathway 1147_5594_5595_5599_5601_4792_5602 7 0.000210174 0.017654611 0.000524517 14760 hsa-mir-3619 hsa04530 Tight junction 1460_998_5518_5515_1457_5578_5728_5520 8 0.000214284 0.017999885 0.000524517 14761 hsa-mir-3619 hsa04930 Type II diabetes mellitus 5594_5595_5599_5601_5602 5 0.000221676 0.018620779 0.000524517 14762 hsa-mir-3619 hsa05211 Renal cell carcinoma 998_5594_5595_1387_3091_2033 6 0.000224793 0.018882604 0.000524517 14763 hsa-mir-3619 hsa04720 Long-term potentiation 5594_5595_5499_1387_5578_2033 6 0.000276309 0.02320994 0.000610788 14764 hsa-mir-3619 hsa04662 B cell receptor signaling pathway 1147_5594_5595_1380_2932_4792 6 0.000276309 0.02320994 0.000610788 14765 hsa-mir-3619 hsa04912 GnRH signaling pathway 998_5594_5595_5599_5601_5578_5602 7 0.000292196 0.024544437 0.000629345 14766 hsa-mir-3619 hsa04664 Fc epsilon RI signaling pathway 5594_5595_5599_5601_5578_5602 6 0.000358926 0.030149756 0.000753744 14767 hsa-mir-3619 hsa03440 Homologous recombination 675_6117_641_5888 4 0.000406941 0.034183052 0.000822811 14768 hsa-mir-3619 hsa04150 mTOR signaling pathway 5563_5594_6794_5595_3091 5 0.000411406 0.034558069 0.000822811 14769 hsa-mir-3619 hsa05216 Thyroid cancer 5594_5595_7157_4609 4 0.00045908 0.038562682 0.000896807 14770 hsa-mir-3619 hsa05131 Shigellosis 25_998_7534_5578_4691 5 0.000563955 0.047372238 0.001052716 14771 hsa-mir-3619 hsa05130 Pathogenic Escherichia coli infection 25_998_7534_5578_4691 5 0.000563955 0.047372238 0.001052716 14772 hsa-mir-3619 hsa05221 Acute myeloid leukemia 1147_5594_5595_5371_4609 5 0.00070362 0.059104072 0.001284871 14773 hsa-mir-3619 hsa04360 Axon guidance 5747_25_998_5594_5595_2932_1020 7 0.000872009 0.073248742 0.001558484 14774 hsa-mir-3619 hsa03410 Base excision repair 142_3146_328_4913 4 0.000965101 0.081068472 0.001688927 14775 hsa-mir-3619 hsa04730 Long-term depression 5518_5515_5594_5595_5578 5 0.001531602 0.128654553 0.002625603 14776 hsa-mir-3619 hsa04062 Chemokine signaling pathway 1147_5747_998_5594_5595_2932_6362_4792 8 0.001821434 0.153000495 0.00306001 14777 hsa-mir-3619 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_7157_598_1616 4 0.004335778 0.364205335 0.007141281 14778 hsa-mir-3619 hsa04540 Gap junction 5594_5595_983_1453_5578 5 0.004629628 0.388888738 0.00747863 14779 hsa-mir-3619 hsa03030 DNA replication 6117_5557_5422 3 0.009019878 0.757669732 0.01406608 14780 hsa-mir-3619 hsa04630 Jak-STAT signaling pathway 1387_51588_8554_598_4609_2033 6 0.00904248 0.759568339 0.01406608 14781 hsa-mir-3619 hsa03450 Non-homologous end-joining 5591_2547 2 0.013099625 1 0.0200067 14782 hsa-mir-3619 hsa05010 Alzheimer's disease 22926_5594_5595_823_2932_1020 6 0.016179838 1 0.024269757 14783 hsa-mir-3619 hsa05217 Basal cell carcinoma 1856_2932_7157 3 0.026152051 1 0.038539865 14784 hsa-mir-3619 hsa04340 Hedgehog signaling pathway 1453_2932_1452 3 0.028544853 1 0.041340822 14785 hsa-mir-3619 hsa03430 Mismatch repair 6117_4436 2 0.03069316 1 0.043698736 14786 hsa-mir-3619 hsa04270 Vascular smooth muscle contraction 5594_5595_5499_5578 4 0.046222328 1 0.06471126 14787 hsa-mir-3621 hsa05200 Pathways in cancer 3725_4149_5467_1499_595_1017_4193_6934_7704_6502_3091_3065_1050_5925_5468_25_405_1487_1488_2308_1870_1871_2113_861_862_10401_207_4286_5595_5594_1387_9915_367_2932_6774_6776_6777_6772_5970_7157_7849_1869_4087_4088_4089_2034_2033_3326_51176_5371_5604_3265_4609_2956_2353 55 2.30E-38 1.75E-36 1.75E-36 14788 hsa-mir-3621 hsa05220 Chronic myeloid leukemia 595_4193_3065_5925_25_1487_1488_1870_1871_861_207_5595_5594_6776_6777_5970_7157_1869_4088_4089_5604_3265_4609 23 8.35E-22 6.34E-20 3.17E-20 14789 hsa-mir-3621 hsa05215 Prostate cancer 1499_595_1017_4193_6934_5925_2308_1870_1871_207_5595_5594_1387_367_2932_5970_7157_1869_2033_3326_51176_5604_3265 23 1.77E-20 1.34E-18 4.17E-19 14790 hsa-mir-3621 hsa05212 Pancreatic cancer 1499_595_1017_4193_6934_5925_2308_1870_1871_207_5595_5594_1387_367_2932_5970_7157_1869_2033_3326_51176_5604_3265 23 2.19E-20 1.67E-18 4.17E-19 14791 hsa-mir-3621 hsa05221 Acute myeloid leukemia 5467_595_6934_7704_1050_861_862_207_5595_5594_6774_6776_6777_5970_51176_5371_5604_3265_4609 19 1.44E-18 1.09E-16 2.19E-17 14792 hsa-mir-3621 hsa04110 Cell cycle 595_1017_4193_6502_5111_3065_5925_25_1870_1871_5934_5933_1387_2932_7157_1869_4087_4088_4089_2033_890_894_896 23 6.02E-18 4.58E-16 7.63E-17 14793 hsa-mir-3621 hsa04350 TGF-beta signaling pathway 6667_4086_3397_3399_3398_1874_1875_5934_5933_4093_3400_5595_5594_1387_4087_4088_4089_2033_4609_4092 20 4.81E-17 3.66E-15 5.23E-16 14794 hsa-mir-3621 hsa04310 Wnt signaling pathway 3725_5467_1499_595_6934_4772_4773_1487_1488_1387_2932_7157_1457_4087_4088_4089_2033_894_896_51176_4609_5527 22 6.85E-15 5.21E-13 6.51E-14 14795 hsa-mir-3621 hsa05210 Colorectal cancer 3725_1499_595_6934_207_5595_5594_2932_7157_4087_4088_4089_51176_5604_4609_2956_2353 17 6.79E-14 5.16E-12 5.73E-13 14796 hsa-mir-3621 hsa05216 Thyroid cancer 1499_595_6934_5468_5595_5594_7157_7849_51176_5604_3265_4609 12 2.89E-13 2.20E-11 2.20E-12 14797 hsa-mir-3621 hsa05214 Glioma 595_4193_5925_1870_1871_207_5595_5594_7157_1869_808_801_805_5604_3265 15 3.90E-13 2.96E-11 2.50E-12 14798 hsa-mir-3621 hsa05213 Endometrial cancer 1499_595_6934_2309_207_5595_5594_2932_7157_51176_5604_3265_4609_2002 14 3.95E-13 3.00E-11 2.50E-12 14799 hsa-mir-3621 hsa05219 Bladder cancer 595_9252_4193_5925_1870_1871_5595_5594_7157_1869_5604_3265_4609 13 6.16E-13 4.68E-11 3.60E-12 14800 hsa-mir-3621 hsa04330 Notch signaling pathway 1840_3065_22938_1487_1488_1387_2033_8850_388585_9612_9794_2648_4851 13 2.06E-12 1.56E-10 1.12E-11 14801 hsa-mir-3621 hsa05223 Non-small cell lung cancer 595_5925_2309_1870_1871_207_5595_5594_7157_1869_5604_3265 12 1.31E-10 9.96E-09 6.64E-10 14802 hsa-mir-3621 hsa05218 Melanoma 595_4193_5925_1870_1871_207_4286_5595_5594_7157_1869_5604_3265 13 1.83E-10 1.39E-08 8.71E-10 14803 hsa-mir-3621 hsa05211 Renal cell carcinoma 3725_3091_405_2113_207_5595_5594_1387_9915_2034_2033_5604_3265 13 2.14E-10 1.62E-08 9.56E-10 14804 hsa-mir-3621 hsa04010 MAPK signaling pathway 6722_3725_4149_9252_7867_4773_1432_22800_207_5595_5594_1386_5970_3164_7157_9261_5604_4208_3265_4609_2353_2002 22 2.85E-10 2.17E-08 1.20E-09 14805 hsa-mir-3621 hsa04916 Melanogenesis 1499_6934_4286_5595_5594_1387_2932_2033_808_801_805_51176_5604_3265 14 1.37E-09 1.04E-07 5.47E-09 14806 hsa-mir-3621 hsa05222 Small cell lung cancer 4149_595_1017_6502_5925_1870_1871_10401_207_5970_7157_1869_4609 13 1.50E-09 1.14E-07 5.69E-09 14807 hsa-mir-3621 hsa05322 Systemic lupus erythematosus 3021_3020_8366_8368_8294_8370_121504_8361_8360_8363_8362_8365_8364_8367_8359 15 8.67E-09 6.59E-07 3.14E-08 14808 hsa-mir-3621 hsa04012 ErbB signaling pathway 3725_25_207_5595_5594_2932_6776_6777_5604_3265_4609_2002 12 1.62E-08 1.23E-06 5.59E-08 14809 hsa-mir-3621 hsa04720 Long-term potentiation 2902_2906_5595_5594_1387_2033_808_801_805_5604_3265 11 3.65E-08 2.77E-06 1.16E-07 14810 hsa-mir-3621 hsa04662 B cell receptor signaling pathway 3725_4772_4773_207_5595_5594_2932_5970_5604_3265_2353 11 3.65E-08 2.77E-06 1.16E-07 14811 hsa-mir-3621 hsa04520 Adherens junction 1499_6934_5595_5594_1387_1457_4087_4088_4089_2033_51176 11 6.63E-08 5.04E-06 2.01E-07 14812 hsa-mir-3621 hsa04660 T cell receptor signaling pathway 3725_4772_4773_1432_207_5595_5594_2932_5970_5604_3265_2353 12 1.70E-07 1.29E-05 4.97E-07 14813 hsa-mir-3621 hsa04910 Insulin signaling pathway 10891_2308_207_5595_5594_2932_808_801_805_5604_5563_3265_2002 13 2.50E-07 1.90E-05 7.04E-07 14814 hsa-mir-3621 hsa04370 VEGF signaling pathway 7867_4772_4773_1432_207_5595_5594_9261_5604_3265 10 4.25E-07 3.23E-05 1.15E-06 14815 hsa-mir-3621 hsa04620 Toll-like receptor signaling pathway 3725_3665_3661_1432_207_5595_5594_6772_5970_5604_2353 11 6.17E-07 4.69E-05 1.62E-06 14816 hsa-mir-3621 hsa04630 Jak-STAT signaling pathway 595_10401_207_1387_6778_6774_6776_6777_6772_2033_894_896_4609 13 8.53E-07 6.48E-05 2.16E-06 14817 hsa-mir-3621 hsa04912 GnRH signaling pathway 3725_5580_1432_5595_5594_808_801_805_5604_3265_2002 11 1.04E-06 7.88E-05 2.54E-06 14818 hsa-mir-3621 hsa04115 p53 signaling pathway 595_1017_4194_4193_7157_894_896_7161 8 1.32E-05 0.000999838 3.12E-05 14819 hsa-mir-3621 hsa03410 Base excision repair 4350_5111_252969_328_2237_6996 6 2.59E-05 0.001967503 5.96E-05 14820 hsa-mir-3621 hsa04062 Chemokine signaling pathway 5580_2309_207_5595_5594_2932_6774_6777_6772_5970_5604_3265 12 3.80E-05 0.002889068 8.50E-05 14821 hsa-mir-3621 hsa04950 Maturity onset diabetes of the young 6927_4760_3651_168620_5080 5 4.89E-05 0.003715191 0.000106148 14822 hsa-mir-3621 hsa04510 Focal adhesion 3725_1499_595_207_5595_5594_2932_894_896_5604_3265_2002 12 6.89E-05 0.005233762 0.000145382 14823 hsa-mir-3621 hsa05016 Huntington's disease 6667_10891_3065_5468_25942_2902_1387_7157_2033_6908_9519 11 0.000132231 0.010049567 0.00027161 14824 hsa-mir-3621 hsa04664 Fc epsilon RI signaling pathway 5580_1432_207_5595_5594_5604_3265 7 0.000217417 0.016523682 0.000434834 14825 hsa-mir-3621 hsa04270 Vascular smooth muscle contraction 5580_5595_5594_808_801_805_59_5604 8 0.000431626 0.032803592 0.000841118 14826 hsa-mir-3621 hsa04920 Adipocytokine signaling pathway 10891_5465_207_6774_5970_5563 6 0.000581958 0.044228775 0.001105719 14827 hsa-mir-3621 hsa04150 mTOR signaling pathway 3091_207_5595_5594_5563 5 0.001247712 0.094826104 0.002312832 14828 hsa-mir-3621 hsa05010 Alzheimer's disease 2902_2906_5595_5594_2932_808_351_801_805 9 0.001365673 0.103791169 0.002471218 14829 hsa-mir-3621 hsa05217 Basal cell carcinoma 1499_6934_2932_7157_51176 5 0.001572394 0.119501918 0.002779114 14830 hsa-mir-3621 hsa03450 Non-homologous end-joining 10111_2237_4361 3 0.001633511 0.124146824 0.002821519 14831 hsa-mir-3621 hsa03022 Basal transcription factors 2963_2959_6908_9519 4 0.002612579 0.198555985 0.004412355 14832 hsa-mir-3621 hsa04360 Axon guidance 4772_4773_25_5595_5594_2932_3265 7 0.003518746 0.267424698 0.00581358 14833 hsa-mir-3621 hsa04530 Tight junction 1499_5580_22800_8573_207_1457_3265 7 0.004442613 0.337638562 0.007183799 14834 hsa-mir-3621 hsa04120 Ubiquitin mediated proteolysis 4193_6502_7329_10401_8925_5371_672 7 0.00478796 0.36388499 0.007580937 14835 hsa-mir-3621 hsa04930 Type II diabetes mellitus 5580_3651_5595_5594 4 0.005004603 0.380349859 0.007762242 14836 hsa-mir-3621 hsa03440 Homologous recombination 10111_4683_4361 3 0.00933433 0.709409099 0.014188182 14837 hsa-mir-3621 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906_1432_7157 4 0.010208817 0.77587009 0.015213139 14838 hsa-mir-3621 hsa04650 Natural killer cell mediated cytotoxicity 4772_4773_5595_5594_5604_3265 6 0.016630857 1 0.024306637 14839 hsa-mir-3621 hsa03030 DNA replication 5111_79621_2237 3 0.017474221 1 0.025057374 14840 hsa-mir-3621 hsa04730 Long-term depression 5595_5594_5604_3265 4 0.021609505 1 0.030413378 14841 hsa-mir-3621 hsa03430 Mismatch repair 5111_2956 2 0.048060165 1 0.065946363 14842 hsa-mir-3621 hsa04540 Gap junction 5595_5594_5604_3265 4 0.048592057 1 0.065946363 14843 hsa-mir-3622b hsa04110 Cell cycle 4087_4088_4089_7534_2033_7532 6 2.24E-11 9.20E-10 9.20E-10 14844 hsa-mir-3622b hsa05200 Pathways in cancer 1147_3551_4087_4088_4089_207_2033 7 1.31E-10 5.38E-09 2.69E-09 14845 hsa-mir-3622b hsa05220 Chronic myeloid leukemia 1147_3551_4088_4089_207 5 3.48E-10 1.43E-08 4.76E-09 14846 hsa-mir-3622b hsa04520 Adherens junction 4087_4088_4089_2033 4 7.61E-08 3.12E-06 5.89E-07 14847 hsa-mir-3622b hsa05210 Colorectal cancer 4087_4088_4089_207 4 9.19E-08 3.77E-06 5.89E-07 14848 hsa-mir-3622b hsa04350 TGF-beta signaling pathway 4087_4088_4089_2033 4 1.05E-07 4.31E-06 5.89E-07 14849 hsa-mir-3622b hsa05215 Prostate cancer 1147_3551_207_2033 4 1.10E-07 4.51E-06 5.89E-07 14850 hsa-mir-3622b hsa05212 Pancreatic cancer 1147_3551_207_2033 4 1.15E-07 4.71E-06 5.89E-07 14851 hsa-mir-3622b hsa04310 Wnt signaling pathway 4087_4088_4089_2033 4 9.17E-07 3.76E-05 4.18E-06 14852 hsa-mir-3622b hsa05221 Acute myeloid leukemia 1147_3551_207 3 3.75E-06 0.000153819 1.54E-05 14853 hsa-mir-3622b hsa04920 Adipocytokine signaling pathway 1147_3551_207 3 5.42E-06 0.000222101 2.02E-05 14854 hsa-mir-3622b hsa04662 B cell receptor signaling pathway 1147_3551_207 3 7.51E-06 0.000307929 2.57E-05 14855 hsa-mir-3622b hsa05222 Small cell lung cancer 1147_3551_207 3 1.12E-05 0.000458153 3.52E-05 14856 hsa-mir-3622b hsa04210 Apoptosis 1147_3551_207 3 1.23E-05 0.000506173 3.62E-05 14857 hsa-mir-3622b hsa04620 Toll-like receptor signaling pathway 1147_3551_207 3 1.84E-05 0.00075265 5.02E-05 14858 hsa-mir-3622b hsa04660 T cell receptor signaling pathway 1147_3551_207 3 2.29E-05 0.000937799 5.86E-05 14859 hsa-mir-3622b hsa04062 Chemokine signaling pathway 1147_3551_207 3 0.000117754 0.00482793 0.000283996 14860 hsa-mir-3622b hsa04010 MAPK signaling pathway 1147_3551_207 3 0.000322434 0.013219805 0.000734434 14861 hsa-mir-3622b hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_3551 2 0.000600179 0.02460733 0.001264179 14862 hsa-mir-3622b hsa05211 Renal cell carcinoma 207_2033 2 0.000616672 0.02528357 0.001264179 14863 hsa-mir-3622b hsa04910 Insulin signaling pathway 3551_207 2 0.002179588 0.089363126 0.004255387 14864 hsa-mir-3622b hsa04630 Jak-STAT signaling pathway 207_2033 2 0.002729777 0.111920874 0.005087312 14865 hsa-mir-3622b hsa04950 Maturity onset diabetes of the young 4760 1 0.012424052 0.509386151 0.022147224 14866 hsa-mir-3622b hsa04930 Type II diabetes mellitus 3551 1 0.022748765 0.932699372 0.038426096 14867 hsa-mir-3622b hsa04330 Notch signaling pathway 2033 1 0.023726799 0.97279875 0.038426096 14868 hsa-mir-3622b hsa05213 Endometrial cancer 207 1 0.026167887 1 0.038426096 14869 hsa-mir-3622b hsa04150 mTOR signaling pathway 207 1 0.026167887 1 0.038426096 14870 hsa-mir-3622b hsa05223 Non-small cell lung cancer 207 1 0.027142727 1 0.038426096 14871 hsa-mir-3622b hsa05131 Shigellosis 7534 1 0.028116655 1 0.038426096 14872 hsa-mir-3622b hsa05130 Pathogenic Escherichia coli infection 7534 1 0.028116655 1 0.038426096 14873 hsa-mir-3622b hsa05214 Glioma 207 1 0.032488083 1 0.04296811 14874 hsa-mir-3622b hsa03320 PPAR signaling pathway 10062 1 0.034908718 1 0.043972085 14875 hsa-mir-3622b hsa05218 Melanoma 207 1 0.035392166 1 0.043972085 14876 hsa-mir-3622b hsa04720 Long-term potentiation 2033 1 0.037323699 1 0.044703235 14877 hsa-mir-3622b hsa04370 VEGF signaling pathway 207 1 0.038288111 1 0.044703235 14878 hsa-mir-3622b hsa04664 Fc epsilon RI signaling pathway 207 1 0.039251621 1 0.044703235 14879 hsa-mir-3622b hsa04012 ErbB signaling pathway 207 1 0.04309666 1 0.047755759 14880 hsa-mir-363 hsa05200 Pathways in cancer 5914_595_596_598_1017_4193_7704_5578_3091_3066_3065_5925_613_5743_5747_25_6789_4824_4436_1870_1871_2113_207_1147_2249_998_367_5595_5594_5599_6258_1387_6256_836_2932_6774_6777_5970_7157_6688_1869_3725_6776_4087_4088_4089_5888_5728_2034_2033_4846_3910_4792_3320_3326_5371_675_5601_5602_1856_842_841_51588_7428_4609_1026_1029_2353_8554 69 8.63E-49 7.42E-47 7.42E-47 14881 hsa-mir-363 hsa04110 Cell cycle 595_1017_4193_902_3066_3065_5925_25_1870_1871_9232_5933_545_995_5347_5591_1387_11200_7534_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_1031_983_1026_1022_1029_1111_8556_8555_472 38 4.93E-33 4.24E-31 2.12E-31 14882 hsa-mir-363 hsa05220 Chronic myeloid leukemia 595_598_4193_3066_3065_5925_613_25_1870_1871_207_1147_5595_5594_6777_5970_7157_1869_6776_4088_4089_4792_4609_1026_1029_6464 26 9.92E-24 8.53E-22 2.84E-22 14883 hsa-mir-363 hsa05215 Prostate cancer 595_596_1017_4193_5925_4824_1870_1871_207_1147_367_5595_5594_1385_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_842_1026 26 2.93E-22 2.52E-20 6.30E-21 14884 hsa-mir-363 hsa05212 Pancreatic cancer 595_596_1017_4193_5925_4824_1870_1871_207_1147_367_5595_5594_1385_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_842_1026 26 3.73E-22 3.21E-20 6.41E-21 14885 hsa-mir-363 hsa04115 p53 signaling pathway 595_1017_4194_4193_50484_51246_545_7161_11200_836_7157_900_6241_64326_5728_27113_25898_983_842_841_1026_1029_1111_472 24 4.96E-22 4.26E-20 7.11E-21 14886 hsa-mir-363 hsa05222 Small cell lung cancer 595_596_598_1017_5925_5743_5747_1870_1871_207_1147_6258_6256_5970_7157_1869_5728_4846_3910_4792_842_51588_4609_8554 24 3.70E-20 3.18E-18 4.54E-19 14887 hsa-mir-363 hsa04010 MAPK signaling pathway 6195_5578_5923_3304_3305_3303_6789_4763_1616_207_1147_2249_998_5595_5594_5599_1386_836_3312_3315_5970_3164_7157_3725_9261_4208_5601_5602_4609_2353_2002_2005 32 1.74E-16 1.50E-14 1.87E-15 14888 hsa-mir-363 hsa05210 Colorectal cancer 595_596_4436_207_5595_5594_5599_836_2932_7157_3725_4087_4088_4089_5601_5602_1856_842_4609_2353 20 7.00E-16 6.02E-14 6.69E-15 14889 hsa-mir-363 hsa04012 ErbB signaling pathway 815_5578_5747_25_6714_207_5595_5594_5599_2932_6777_3725_6776_5601_5602_4609_1026_2002_6464 19 1.45E-14 1.25E-12 1.25E-13 14890 hsa-mir-363 hsa04310 Wnt signaling pathway 815_595_5578_1460_5599_1387_2932_7157_3725_1457_1452_4087_4088_4089_2033_5518_5515_5601_5602_1856_4609_5527 22 2.16E-13 1.85E-11 1.69E-12 14891 hsa-mir-363 hsa05214 Glioma 815_595_4193_5578_5925_1870_1871_207_5595_5594_7157_1869_5728_1026_1029_6464 16 3.64E-13 3.13E-11 2.61E-12 14892 hsa-mir-363 hsa05223 Non-small cell lung cancer 595_5578_5925_6789_1870_1871_207_5595_5594_6258_6256_7157_1869_842_1029 15 4.49E-13 3.86E-11 2.97E-12 14893 hsa-mir-363 hsa05221 Acute myeloid leukemia 5914_595_7704_207_1147_5595_5594_6774_6777_5970_6688_6776_5371_4609 14 1.67E-11 1.44E-09 1.03E-10 14894 hsa-mir-363 hsa05219 Bladder cancer 595_4193_5925_1870_1871_5595_5594_7157_1869_4609_1026_1029 12 7.59E-11 6.53E-09 4.35E-10 14895 hsa-mir-363 hsa05218 Melanoma 595_4193_5925_1870_1871_207_2249_5595_5594_7157_1869_5728_1026_1029 14 1.43E-10 1.23E-08 7.69E-10 14896 hsa-mir-363 hsa04510 Focal adhesion 595_596_5578_5923_5747_6714_5499_207_998_5595_5594_5599_2932_3725_5728_3910_5601_5602_2002_6464 20 1.75E-09 1.50E-07 8.84E-09 14897 hsa-mir-363 hsa04210 Apoptosis 596_598_823_207_1147_836_839_5970_7157_4792_842_841_840_472 14 1.97E-09 1.69E-07 9.41E-09 14898 hsa-mir-363 hsa04920 Adipocytokine signaling pathway 6794_207_1147_5599_6258_6256_6774_5970_4792_5601_5602_5563 12 7.77E-09 6.68E-07 3.52E-08 14899 hsa-mir-363 hsa04350 TGF-beta signaling pathway 6667_5933_5595_5594_1387_7027_4087_4088_4089_2033_5518_5515_4609 13 1.29E-08 1.11E-06 5.56E-08 14900 hsa-mir-363 hsa04370 VEGF signaling pathway 5578_5743_5747_6714_207_998_5595_5594_3315_4846_9261_842 12 3.10E-08 2.66E-06 1.27E-07 14901 hsa-mir-363 hsa04120 Ubiquitin mediated proteolysis 4193_3093_7319_84447_7329_10055_64326_7337_5371_672_25898_51588_7428_10075_8554 15 5.31E-08 4.57E-06 2.08E-07 14902 hsa-mir-363 hsa03022 Basal transcription factors 51616_2965_2962_2969_6874_6908_2958_6880_2957 9 6.04E-08 5.20E-06 2.26E-07 14903 hsa-mir-363 hsa05213 Endometrial cancer 595_207_5595_5594_2932_7157_5728_842_4609_2002 10 7.70E-08 6.62E-06 2.76E-07 14904 hsa-mir-363 hsa05211 Renal cell carcinoma 3091_2113_207_998_5595_5594_1387_3725_2034_2033_7428 11 1.40E-07 1.20E-05 4.80E-07 14905 hsa-mir-363 hsa04520 Adherens junction 6714_1460_998_5595_5594_1387_1457_4087_4088_4089_2033 11 3.63E-07 3.12E-05 1.20E-06 14906 hsa-mir-363 hsa05016 Huntington's disease 3066_3065_3064_25942_2902_6667_1385_1387_836_7157_2033_27113_6874_6908_842_841 16 3.88E-07 3.34E-05 1.24E-06 14907 hsa-mir-363 hsa04620 Toll-like receptor signaling pathway 207_1147_5595_5594_5599_5970_3725_4792_5601_5602_841_2353 12 4.94E-07 4.25E-05 1.52E-06 14908 hsa-mir-363 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_1147_998_5599_836_5970_3725_4792_5601_5602 10 1.01E-06 8.72E-05 2.95E-06 14909 hsa-mir-363 hsa04660 T cell receptor signaling pathway 207_1147_998_5595_5594_2932_5970_3725_959_4792_5601_2353 12 1.03E-06 8.85E-05 2.95E-06 14910 hsa-mir-363 hsa04662 B cell receptor signaling pathway 207_1147_5595_5594_1380_2932_5970_3725_4792_2353 10 1.59E-06 0.000136801 4.41E-06 14911 hsa-mir-363 hsa05216 Thyroid cancer 595_5595_5594_6258_6256_7157_4609 7 1.92E-06 0.000165116 5.16E-06 14912 hsa-mir-363 hsa04330 Notch signaling pathway 3066_3065_1387_9612_2033_8850_1856_4851 8 3.53E-06 0.000303231 9.19E-06 14913 hsa-mir-363 hsa04912 GnRH signaling pathway 815_5578_6714_998_5595_5594_5599_3725_5601_5602_2002 11 5.31E-06 0.000457033 1.34E-05 14914 hsa-mir-363 hsa04612 Antigen processing and presentation 3309_3304_3305_3303_1385_3312_3320_3326_4800_4801 10 6.43E-06 0.000553002 1.58E-05 14915 hsa-mir-363 hsa04910 Insulin signaling pathway 6720_5499_207_5595_5594_5599_2932_5601_5602_5563_2002_6464 12 8.97E-06 0.000771049 2.14E-05 14916 hsa-mir-363 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_2902_1616_836_7157_4846_842 8 1.12E-05 0.000966505 2.61E-05 14917 hsa-mir-363 hsa04720 Long-term potentiation 815_6195_5578_2902_5499_5595_5594_1387_2033 9 1.15E-05 0.000989922 2.61E-05 14918 hsa-mir-363 hsa03420 Nucleotide excision repair 902_2965_4331_2071_2074_1022_6117 7 2.14E-05 0.001844571 4.73E-05 14919 hsa-mir-363 hsa04630 Jak-STAT signaling pathway 595_598_3977_207_1387_6774_6777_6776_2033_51588_4609_8554 12 2.64E-05 0.002270674 5.68E-05 14920 hsa-mir-363 hsa04062 Chemokine signaling pathway 5747_6362_207_1147_998_5595_5594_2932_6774_6777_5970_4792_6464 13 4.81E-05 0.004136478 0.00010089 14921 hsa-mir-363 hsa04150 mTOR signaling pathway 6794_6195_3091_207_5595_5594_5563 7 5.63E-05 0.004844579 0.000115347 14922 hsa-mir-363 hsa05010 Alzheimer's disease 823_2902_22926_5595_5594_836_2932_4846_842_841_840_1020 12 8.80E-05 0.007564259 0.000175913 14923 hsa-mir-363 hsa04916 Melanogenesis 815_5578_5595_5594_1385_1387_2932_2033_1856 9 0.000121853 0.010479324 0.000238166 14924 hsa-mir-363 hsa04530 Tight junction 5578_6714_207_1460_998_1457_5728_5518_5515_5520 10 0.000192402 0.016546599 0.000367702 14925 hsa-mir-363 hsa04664 Fc epsilon RI signaling pathway 5578_207_5595_5594_5599_5601_5602 7 0.000602735 0.051835201 0.001126852 14926 hsa-mir-363 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601_5602 5 0.001459402 0.125508576 0.002670395 14927 hsa-mir-363 hsa04730 Long-term depression 5578_5595_5594_4846_5518_5515 6 0.001844092 0.158591894 0.003303998 14928 hsa-mir-363 hsa03440 Homologous recombination 641_5888_675_6117 4 0.00191454 0.164650475 0.003360214 14929 hsa-mir-363 hsa05131 Shigellosis 5578_25_998_7534_4691 5 0.00352798 0.303406292 0.005949143 14930 hsa-mir-363 hsa05130 Pathogenic Escherichia coli infection 5578_25_998_7534_4691 5 0.00352798 0.303406292 0.005949143 14931 hsa-mir-363 hsa03410 Base excision repair 3146_142_4913_328 4 0.004380817 0.376750237 0.007245197 14932 hsa-mir-363 hsa04540 Gap junction 5578_6714_5595_5594_1453_983 6 0.006418622 0.552001495 0.010415123 14933 hsa-mir-363 hsa04360 Axon guidance 5747_25_998_5595_5594_2932_1020 7 0.008699687 0.748173107 0.013855058 14934 hsa-mir-363 hsa04740 Olfactory transduction 815 1 0.024886575 1 0.038913553 14935 hsa-mir-363 hsa04710 Circadian rhythm - mammal 8863_1453 2 0.025357797 1 0.038942332 14936 hsa-mir-363 hsa03030 DNA replication 5557_6117_5422 3 0.027200569 1 0.041039454 14937 hsa-mir-363 hsa03450 Non-homologous end-joining 2547_5591 2 0.028664479 1 0.042502503 14938 hsa-mir-3646 hsa03022 Basal transcription factors 2967_2961_2963_6881_54457_2968_6879_6878_6877_6874_6872_2960_2957_6873_2958_6884_2959_6880_6882_138474_6883 21 4.16E-32 2.83E-30 2.83E-30 14939 hsa-mir-3646 hsa05200 Pathways in cancer 5925_1499_5595_5594_6256_3326_2932_4193_7704_1387_6774_7157_6688_3725_4609_2353_10401_5881_1050_2033_207_8554_5970_7184 24 5.52E-18 3.75E-16 1.88E-16 14940 hsa-mir-3646 hsa05215 Prostate cancer 5925_1499_5595_5594_3326_2932_4193_1387_7157_2033_207_5970_7184 13 7.05E-14 4.80E-12 1.37E-12 14941 hsa-mir-3646 hsa05212 Pancreatic cancer 5925_1499_5595_5594_3326_2932_4193_1387_7157_2033_207_5970_7184 13 8.04E-14 5.47E-12 1.37E-12 14942 hsa-mir-3646 hsa05210 Colorectal cancer 1499_5595_5594_2932_7157_3725_4609_2353_5881_207 10 3.97E-10 2.70E-08 4.73E-09 14943 hsa-mir-3646 hsa05221 Acute myeloid leukemia 5595_5594_7704_6774_6688_4609_1050_207_5970 9 4.17E-10 2.84E-08 4.73E-09 14944 hsa-mir-3646 hsa05220 Chronic myeloid leukemia 5925_5595_5594_4193_7157_4609_207_5970 8 5.16E-08 3.51E-06 4.38E-07 14945 hsa-mir-3646 hsa04662 B cell receptor signaling pathway 5595_5594_2932_3725_2353_5881_207_5970 8 5.16E-08 3.51E-06 4.38E-07 14946 hsa-mir-3646 hsa05216 Thyroid cancer 1499_5595_5594_6256_7157_4609 6 7.52E-08 5.11E-06 4.78E-07 14947 hsa-mir-3646 hsa04310 Wnt signaling pathway 1460_1499_2932_1387_7157_3725_8607_4609_5881_2033 10 7.87E-08 5.35E-06 4.78E-07 14948 hsa-mir-3646 hsa04520 Adherens junction 1460_1499_6714_5595_5594_1387_5881_2033 8 8.19E-08 5.57E-06 4.78E-07 14949 hsa-mir-3646 hsa05213 Endometrial cancer 1499_5595_5594_2932_7157_4609_207 7 8.43E-08 5.73E-06 4.78E-07 14950 hsa-mir-3646 hsa05222 Small cell lung cancer 5925_6256_7157_4609_10401_207_8554_5970 8 1.37E-07 9.34E-06 7.18E-07 14951 hsa-mir-3646 hsa05219 Bladder cancer 5925_5595_5594_4193_7157_4609 6 5.32E-07 3.62E-05 2.58E-06 14952 hsa-mir-3646 hsa04110 Cell cycle 5925_2932_4193_1387_7157_4171_4085_2033 8 1.39E-06 9.44E-05 6.29E-06 14953 hsa-mir-3646 hsa04010 MAPK signaling pathway 3727_5595_5594_3312_7157_3725_4609_2353_5881_207_5970 11 1.87E-06 0.000126842 7.53E-06 14954 hsa-mir-3646 hsa05223 Non-small cell lung cancer 5925_5595_5594_6256_7157_207 6 2.04E-06 0.000138653 7.53E-06 14955 hsa-mir-3646 hsa04350 TGF-beta signaling pathway 5595_5594_6667_1387_4609_3399_2033 7 2.11E-06 0.000143158 7.53E-06 14956 hsa-mir-3646 hsa04012 ErbB signaling pathway 6714_5595_5594_2932_3725_4609_207 7 2.11E-06 0.000143158 7.53E-06 14957 hsa-mir-3646 hsa05214 Glioma 5925_5595_5594_4193_7157_207 6 5.51E-06 0.000374776 1.87E-05 14958 hsa-mir-3646 hsa05218 Melanoma 5925_5595_5594_4193_7157_207 6 8.85E-06 0.000601539 2.80E-05 14959 hsa-mir-3646 hsa04660 T cell receptor signaling pathway 5595_5594_2932_3725_2353_207_5970 7 9.04E-06 0.000615 2.80E-05 14960 hsa-mir-3646 hsa05211 Renal cell carcinoma 5595_5594_1387_3725_2033_207 6 9.53E-06 0.000648319 2.82E-05 14961 hsa-mir-3646 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 2.00E-05 0.001359946 5.67E-05 14962 hsa-mir-3646 hsa05016 Huntington's disease 6874_6667_9001_1387_5430_7157_3064_2033 8 3.36E-05 0.002287096 9.15E-05 14963 hsa-mir-3646 hsa04620 Toll-like receptor signaling pathway 5595_5594_3725_2353_207_5970 6 6.09E-05 0.004139298 0.00015752 14964 hsa-mir-3646 hsa04510 Focal adhesion 1499_6714_5595_5594_2932_3725_5881_207 8 6.25E-05 0.004253041 0.00015752 14965 hsa-mir-3646 hsa04916 Melanogenesis 1499_5595_5594_2932_1387_2033 6 6.74E-05 0.004585786 0.000163778 14966 hsa-mir-3646 hsa04630 Jak-STAT signaling pathway 1387_6774_4609_10401_2033_207_8554 7 7.35E-05 0.004995123 0.000172246 14967 hsa-mir-3646 hsa04370 VEGF signaling pathway 6714_5595_5594_5881_207 5 0.00016436 0.011176486 0.00037255 14968 hsa-mir-3646 hsa04910 Insulin signaling pathway 5595_5594_23265_2932_5211_207 6 0.000294724 0.020041237 0.000646492 14969 hsa-mir-3646 hsa04950 Maturity onset diabetes of the young 3172_5080_6928 3 0.00062275 0.042347018 0.001323344 14970 hsa-mir-3646 hsa04920 Adipocytokine signaling pathway 6256_6774_207_5970 4 0.001022216 0.069510677 0.002106384 14971 hsa-mir-3646 hsa04720 Long-term potentiation 5595_5594_1387_2033 4 0.001520868 0.103419008 0.003041736 14972 hsa-mir-3646 hsa04062 Chemokine signaling pathway 5595_5594_2932_6774_207_5970 6 0.00159662 0.108570177 0.003102005 14973 hsa-mir-3646 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5881_207 4 0.001824572 0.124070881 0.003446413 14974 hsa-mir-3646 hsa04120 Ubiquitin mediated proteolysis 55294_4193_10401_7329_8554 5 0.002125616 0.144541907 0.003906538 14975 hsa-mir-3646 hsa03420 Nucleotide excision repair 2967_2968_5887 3 0.003151179 0.214280149 0.005607709 14976 hsa-mir-3646 hsa04540 Gap junction 6714_5595_5594_10382 4 0.003216186 0.218700658 0.005607709 14977 hsa-mir-3646 hsa04330 Notch signaling pathway 1387_2033_8850 3 0.003757403 0.255503381 0.006387585 14978 hsa-mir-3646 hsa04150 mTOR signaling pathway 5595_5594_207 3 0.004916439 0.334317869 0.008154094 14979 hsa-mir-3646 hsa04912 GnRH signaling pathway 6714_5595_5594_3725 4 0.005364917 0.364814371 0.008686056 14980 hsa-mir-3646 hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.005704259 0.387889582 0.009020688 14981 hsa-mir-3646 hsa04360 Axon guidance 5595_5594_2932_5881 4 0.010241169 0.696399516 0.015827262 14982 hsa-mir-3646 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_3725_5970 3 0.01114724 0.758012323 0.016844718 14983 hsa-mir-3646 hsa04530 Tight junction 1460_1499_6714_207 4 0.011866344 0.806911389 0.017541552 14984 hsa-mir-3646 hsa04612 Antigen processing and presentation 3326_4801_3312 3 0.019915151 1 0.028213131 14985 hsa-mir-3646 hsa04210 Apoptosis 7157_207_5970 3 0.019915151 1 0.028213131 14986 hsa-mir-3646 hsa04930 Type II diabetes mellitus 5595_5594 2 0.034722181 1 0.048185884 14987 hsa-mir-3647 hsa05200 Pathways in cancer 1147_3320_3326_3725_3551_6774_5468_1387_367_8517_4193_6772_6256_5371_1870_1871_7157_4791_10401_4609_1029_2353_3065_3066_2033_8554_4790_4792 28 1.87E-18 1.31E-16 1.31E-16 14988 hsa-mir-3647 hsa05215 Prostate cancer 1147_3320_3326_3551_1387_367_8517_4193_1385_1870_1871_7157_2033_4790_4792 15 1.88E-14 1.32E-12 5.09E-13 14989 hsa-mir-3647 hsa05212 Pancreatic cancer 1147_3320_3326_3551_1387_367_8517_4193_1385_1870_1871_7157_2033_4790_4792 15 2.18E-14 1.53E-12 5.09E-13 14990 hsa-mir-3647 hsa04010 MAPK signaling pathway 1147_6722_3725_3551_1386_1326_3305_3303_5566_8517_9252_3312_5971_7157_4791_6885_4609_9020_2353_5608_4790 21 2.13E-13 1.49E-11 3.73E-12 14991 hsa-mir-3647 hsa05220 Chronic myeloid leukemia 1147_3551_8517_4193_1870_1871_7157_4609_1029_3065_3066_4790_4792 13 8.87E-13 6.21E-11 1.24E-11 14992 hsa-mir-3647 hsa04620 Toll-like receptor signaling pathway 1147_3725_3551_29110_1326_8517_3661_9641_6772_6885_2353_5608_4790_4792 14 2.02E-12 1.41E-10 2.35E-11 14993 hsa-mir-3647 hsa04110 Cell cycle 5591_1387_4193_8454_6500_1870_1871_5111_7157_1029_3065_3066_1111_2033 14 1.34E-11 9.36E-10 1.34E-10 14994 hsa-mir-3647 hsa04310 Wnt signaling pathway 3725_23291_5519_5515_1387_8607_5566_8454_6500_8945_7157_6885_4609_1457_2033 15 2.46E-11 1.72E-09 2.15E-10 14995 hsa-mir-3647 hsa05222 Small cell lung cancer 1147_3551_8517_6256_1870_1871_7157_10401_4609_8554_4790_4792 12 6.60E-11 4.62E-09 5.13E-10 14996 hsa-mir-3647 hsa04920 Adipocytokine signaling pathway 1147_3551_6774_5465_8517_6256_4794_8471_4790_4792_4793 11 8.73E-11 6.11E-09 6.11E-10 14997 hsa-mir-3647 hsa05016 Huntington's disease 5468_498_1387_292_293_6667_1385_1213_5437_7157_3065_3066_2033_6908_5441 15 3.90E-10 2.73E-08 2.48E-09 14998 hsa-mir-3647 hsa04660 T cell receptor signaling pathway 1147_3725_3551_1326_8517_4794_6885_9020_2353_4790_4792_4793 12 8.76E-10 6.13E-08 5.11E-09 14999 hsa-mir-3647 hsa04662 B cell receptor signaling pathway 1147_3725_3551_695_8517_4794_2353_4790_4792_4793 10 3.93E-09 2.75E-07 2.12E-08 15000 hsa-mir-3647 hsa04120 Ubiquitin mediated proteolysis 8651_23291_672_51366_4193_8454_55294_6500_5371_8945_10401_8554 12 1.01E-08 7.07E-07 5.05E-08 15001 hsa-mir-3647 hsa04210 Apoptosis 1147_3551_5566_8517_7157_9131_9020_4790_4792 9 2.11E-07 1.48E-05 9.83E-07 15002 hsa-mir-3647 hsa05219 Bladder cancer 9252_4193_1870_1871_7157_4609_1029 7 2.29E-07 1.60E-05 1.00E-06 15003 hsa-mir-3647 hsa05214 Glioma 4193_1870_1871_7157_1029_805_808_801 8 2.56E-07 1.79E-05 1.05E-06 15004 hsa-mir-3647 hsa04330 Notch signaling pathway 1387_9612_3065_3066_2033_8850_4851 7 4.54E-07 3.18E-05 1.77E-06 15005 hsa-mir-3647 hsa03020 RNA polymerase 25885_64425_5437_51082_84172_5441 6 5.59E-07 3.91E-05 2.06E-06 15006 hsa-mir-3647 hsa05131 Shigellosis 7278_71_10382_347733_7846_4691_203068 7 1.33E-06 9.29E-05 4.42E-06 15007 hsa-mir-3647 hsa05130 Pathogenic Escherichia coli infection 7278_71_10382_347733_7846_4691_203068 7 1.33E-06 9.29E-05 4.42E-06 15008 hsa-mir-3647 hsa05221 Acute myeloid leukemia 1147_3551_6774_8517_5371_4609_4790 7 1.83E-06 0.000127905 5.77E-06 15009 hsa-mir-3647 hsa04350 TGF-beta signaling pathway 5519_5515_1387_6667_8454_6500_4609_2033 8 1.96E-06 0.000137048 5.77E-06 15010 hsa-mir-3647 hsa03022 Basal transcription factors 2969_6878_6872_6882_2959_6908 6 1.98E-06 0.000138489 5.77E-06 15011 hsa-mir-3647 hsa04062 Chemokine signaling pathway 1147_3551_6774_5590_5566_8517_6772_653361_4790_4792_4793 11 2.06E-06 0.000144445 5.78E-06 15012 hsa-mir-3647 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_3725_3551_8517_9020_4790_4792 7 5.67E-06 0.000396824 1.53E-05 15013 hsa-mir-3647 hsa03010 Ribosome 6155_6156_6141_6128_6207_6217_9349_6188 8 5.89E-06 0.000412619 1.53E-05 15014 hsa-mir-3647 hsa04910 Insulin signaling pathway 6720_3551_8651_5590_5566_8471_805_808_801 9 6.35E-06 0.000444484 1.59E-05 15015 hsa-mir-3647 hsa04720 Long-term potentiation 814_1387_5566_805_2033_808_801 7 7.92E-06 0.000554303 1.91E-05 15016 hsa-mir-3647 hsa04630 Jak-STAT signaling pathway 8651_6774_1387_6778_6772_10401_4609_2033_8554 9 1.53E-05 0.001074136 3.58E-05 15017 hsa-mir-3647 hsa04612 Antigen processing and presentation 3320_3326_3309_3305_3303_1385_3312 7 2.24E-05 0.001566169 5.05E-05 15018 hsa-mir-3647 hsa04916 Melanogenesis 1387_5566_1385_805_2033_808_801 7 5.70E-05 0.003992857 0.000124777 15019 hsa-mir-3647 hsa05223 Non-small cell lung cancer 6256_1870_1871_7157_1029 5 0.000168659 0.011806161 0.000357762 15020 hsa-mir-3647 hsa05216 Thyroid cancer 5468_6256_7157_4609 4 0.000192526 0.013476805 0.000396377 15021 hsa-mir-3647 hsa04540 Gap junction 5566_7278_10382_347733_7846_203068 6 0.000241611 0.016912794 0.000483223 15022 hsa-mir-3647 hsa04912 GnRH signaling pathway 3725_5566_805_5608_808_801 6 0.000515698 0.036098853 0.001002746 15023 hsa-mir-3647 hsa05218 Melanoma 4193_1870_1871_7157_1029 5 0.000551612 0.038612867 0.001043591 15024 hsa-mir-3647 hsa04930 Type II diabetes mellitus 3551_8651_5590_8471 4 0.000893305 0.062531347 0.001645562 15025 hsa-mir-3647 hsa04520 Adherens junction 1387_71_6885_1457_2033 5 0.000918887 0.064322094 0.001649284 15026 hsa-mir-3647 hsa04020 Calcium signaling pathway 814_292_293_5566_805_808_801 7 0.001532363 0.107265434 0.002681636 15027 hsa-mir-3647 hsa04530 Tight junction 5519_5515_5590_4628_71_1457 6 0.001674039 0.117182729 0.002858115 15028 hsa-mir-3647 hsa04115 p53 signaling pathway 4193_7157_1029_1111 4 0.003896525 0.272756765 0.006494209 15029 hsa-mir-3647 hsa03320 PPAR signaling pathway 10062_5465_5468_6256 4 0.004091307 0.286391518 0.006660268 15030 hsa-mir-3647 hsa03410 Base excision repair 3146_142_5111 3 0.004806402 0.336448134 0.007646549 15031 hsa-mir-3647 hsa05210 Colorectal cancer 3725_7157_4609_2353 4 0.007541252 0.527887639 0.011730836 15032 hsa-mir-3647 hsa04340 Hedgehog signaling pathway 23291_5566_8945 3 0.015738157 1 0.023949369 15033 hsa-mir-3647 hsa03430 Mismatch repair 5981_5111 2 0.020068687 1 0.029889534 15034 hsa-mir-3647 hsa05010 Alzheimer's disease 498_805_808_22926_801 5 0.022365109 1 0.032285956 15035 hsa-mir-3647 hsa04270 Vascular smooth muscle contraction 5566_805_808_801 4 0.022600169 1 0.032285956 15036 hsa-mir-3647 hsa05211 Renal cell carcinoma 3725_1387_2033 3 0.028240689 1 0.039536964 15037 hsa-mir-3647 hsa04070 Phosphatidylinositol signaling system 805_808_801 3 0.032249093 1 0.044263461 15038 hsa-mir-3647 hsa05012 Parkinson's disease 7314_498_292_293 4 0.03498368 1 0.047093415 15039 hsa-mir-3647 hsa05340 Primary immunodeficiency 695_8517 2 0.041611213 1 0.054958205 15040 hsa-mir-3647 hsa03030 DNA replication 5981_5111 2 0.043674878 1 0.056615582 15041 hsa-mir-3649 hsa05221 Acute myeloid leukemia 6688_7704_5595_207_6774_5594 6 3.08E-12 1.45E-10 1.45E-10 15042 hsa-mir-3649 hsa05200 Pathways in cancer 6688_7704_5595_207_6774_1387_5594 7 1.50E-09 7.07E-08 3.53E-08 15043 hsa-mir-3649 hsa05211 Renal cell carcinoma 5595_207_1387_5594 4 1.78E-07 8.37E-06 2.79E-06 15044 hsa-mir-3649 hsa05215 Prostate cancer 5595_207_1387_5594 4 3.85E-07 1.81E-05 3.78E-06 15045 hsa-mir-3649 hsa05212 Pancreatic cancer 5595_207_1387_5594 4 4.03E-07 1.89E-05 3.78E-06 15046 hsa-mir-3649 hsa05213 Endometrial cancer 5595_207_5594 3 6.49E-06 0.000304967 4.19E-05 15047 hsa-mir-3649 hsa04150 mTOR signaling pathway 5595_207_5594 3 6.49E-06 0.000304967 4.19E-05 15048 hsa-mir-3649 hsa05223 Non-small cell lung cancer 5595_207_5594 3 7.23E-06 0.000339842 4.19E-05 15049 hsa-mir-3649 hsa04062 Chemokine signaling pathway 5595_207_6774_5594 4 8.03E-06 0.000377233 4.19E-05 15050 hsa-mir-3649 hsa05214 Glioma 5595_207_5594 3 1.23E-05 0.000579361 5.79E-05 15051 hsa-mir-3649 hsa05218 Melanoma 5595_207_5594 3 1.59E-05 0.000747484 6.21E-05 15052 hsa-mir-3649 hsa04720 Long-term potentiation 5595_1387_5594 3 1.86E-05 0.000875741 6.21E-05 15053 hsa-mir-3649 hsa05220 Chronic myeloid leukemia 5595_207_5594 3 1.86E-05 0.000875741 6.21E-05 15054 hsa-mir-3649 hsa04662 B cell receptor signaling pathway 5595_207_5594 3 1.86E-05 0.000875741 6.21E-05 15055 hsa-mir-3649 hsa04370 VEGF signaling pathway 5595_207_5594 3 2.01E-05 0.000944973 6.21E-05 15056 hsa-mir-3649 hsa04664 Fc epsilon RI signaling pathway 5595_207_5594 3 2.17E-05 0.001017718 6.21E-05 15057 hsa-mir-3649 hsa04520 Adherens junction 5595_1387_5594 3 2.25E-05 0.001055434 6.21E-05 15058 hsa-mir-3649 hsa05210 Colorectal cancer 5595_207_5594 3 2.59E-05 0.001215495 6.73E-05 15059 hsa-mir-3649 hsa04350 TGF-beta signaling pathway 5595_1387_5594 3 2.86E-05 0.001345483 6.73E-05 15060 hsa-mir-3649 hsa04012 ErbB signaling pathway 5595_207_5594 3 2.86E-05 0.001345483 6.73E-05 15061 hsa-mir-3649 hsa04620 Toll-like receptor signaling pathway 5595_207_5594 3 4.54E-05 0.002133318 0.000101587 15062 hsa-mir-3649 hsa04916 Melanogenesis 5595_1387_5594 3 4.80E-05 0.002256866 0.000102585 15063 hsa-mir-3649 hsa04660 T cell receptor signaling pathway 5595_207_5594 3 5.65E-05 0.002655458 0.000115455 15064 hsa-mir-3649 hsa04910 Insulin signaling pathway 5595_207_5594 3 0.000109048 0.005125273 0.000213553 15065 hsa-mir-3649 hsa04630 Jak-STAT signaling pathway 207_6774_1387 3 0.000152687 0.007176301 0.000287052 15066 hsa-mir-3649 hsa05216 Thyroid cancer 5595_5594 2 0.000193819 0.009109477 0.000350365 15067 hsa-mir-3649 hsa04510 Focal adhesion 5595_207_5594 3 0.000347452 0.016330251 0.000604824 15068 hsa-mir-3649 hsa05219 Bladder cancer 5595_5594 2 0.000392264 0.018436404 0.000658443 15069 hsa-mir-3649 hsa04930 Type II diabetes mellitus 5595_5594 2 0.000447706 0.021042163 0.000725592 15070 hsa-mir-3649 hsa04010 MAPK signaling pathway 5595_207_5594 3 0.000780462 0.036681733 0.001222724 15071 hsa-mir-3649 hsa04920 Adipocytokine signaling pathway 207_6774 2 0.000963119 0.045266591 0.001460213 15072 hsa-mir-3649 hsa04730 Long-term depression 5595_5594 2 0.001077169 0.050626949 0.001582092 15073 hsa-mir-3649 hsa04540 Gap junction 5595_5594 2 0.001814127 0.085263959 0.002583756 15074 hsa-mir-3649 hsa04912 GnRH signaling pathway 5595_5594 2 0.002421237 0.113798128 0.003347004 15075 hsa-mir-3649 hsa04270 Vascular smooth muscle contraction 5595_5594 2 0.002872201 0.134993433 0.003856955 15076 hsa-mir-3649 hsa04360 Axon guidance 5595_5594 2 0.003512868 0.165104811 0.004586245 15077 hsa-mir-3649 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594 2 0.003883003 0.182501157 0.004932464 15078 hsa-mir-3649 hsa05010 Alzheimer's disease 5595_5594 2 0.006259692 0.294205547 0.007742251 15079 hsa-mir-3649 hsa04810 Regulation of actin cytoskeleton 5595_5594 2 0.009393749 0.441506208 0.011320672 15080 hsa-mir-3649 hsa04330 Notch signaling pathway 1387 1 0.031507378 1 0.03702117 15081 hsa-mir-3650 hsa05200 Pathways in cancer 3320_2249_1956_1499_5594_5595_5599_1387_6256_1487_1488_2308_1019_367_1017_2932_4193_5914_7704_841_6774_6776_6777_6772_5970_7046_8554_7157_4087_6688_2113_5894_4609_3725_4088_1026_861_2353_4089_1050_5925_2033_207_4790_4791_7186 46 6.12E-35 4.65E-33 4.65E-33 15082 hsa-mir-3650 hsa05215 Prostate cancer 3320_1956_1499_5594_5595_1385_1387_2308_367_1017_2932_4193_5970_7157_468_5894_1026_10488_5925_2033_207_4790 22 4.56E-22 3.47E-20 1.43E-20 15083 hsa-mir-3650 hsa05212 Pancreatic cancer 3320_1956_1499_5594_5595_1385_1387_2308_367_1017_2932_4193_5970_7157_468_5894_1026_10488_5925_2033_207_4790 22 5.64E-22 4.28E-20 1.43E-20 15084 hsa-mir-3650 hsa05220 Chronic myeloid leukemia 5594_5595_1487_1488_1019_4193_6776_6777_5970_7046_7157_5894_4609_4088_1026_861_4089_5925_207_4790 20 1.20E-20 9.12E-19 2.28E-19 15085 hsa-mir-3650 hsa04010 MAPK signaling pathway 6722_2249_1956_5594_5595_5599_1386_3303_5566_9252_1649_5970_7046_7157_468_5894_4609_3725_6195_6196_2353_5058_207_5536_4790_4791_2002_7186 28 2.01E-18 1.53E-16 3.05E-17 15086 hsa-mir-3650 hsa04110 Cell cycle 7534_5591_1387_1019_1017_7533_7532_2932_4193_7027_2810_7157_4087_4088_1026_4089_5925_2033_5933 19 4.78E-16 3.64E-14 6.06E-15 15087 hsa-mir-3650 hsa05221 Acute myeloid leukemia 5594_5595_5914_7704_6774_6776_6777_5970_6688_5894_4609_861_1050_207_4790 15 1.54E-15 1.17E-13 1.67E-14 15088 hsa-mir-3650 hsa05210 Colorectal cancer 1956_1499_5594_5595_5599_2932_7046_7157_4087_5894_4609_3725_4088_2353_4089_207 16 8.95E-15 6.80E-13 8.51E-14 15089 hsa-mir-3650 hsa04012 ErbB signaling pathway 815_1956_6714_5594_5595_5599_2932_6776_6777_5894_4609_3725_1026_5058_207_2002 16 1.45E-14 1.10E-12 1.23E-13 15090 hsa-mir-3650 hsa05214 Glioma 815_1956_5594_5595_1019_4193_7157_5894_1026_5925_207_808_805_801 14 9.88E-14 7.51E-12 7.51E-13 15091 hsa-mir-3650 hsa05219 Bladder cancer 1956_5594_5595_1019_9252_4193_7157_5894_4609_1026_5925 11 7.33E-12 5.57E-10 5.06E-11 15092 hsa-mir-3650 hsa04720 Long-term potentiation 815_5594_5595_1387_5566_468_5894_6195_6196_2033_808_805_801 13 8.64E-12 6.56E-10 5.47E-11 15093 hsa-mir-3650 hsa04520 Adherens junction 4301_1956_1499_6714_5594_5595_1387_7046_4087_4088_4089_2033_71 13 1.78E-11 1.35E-09 1.04E-10 15094 hsa-mir-3650 hsa04916 Melanogenesis 815_1499_5594_5595_1385_1387_5566_2932_5894_10488_2033_808_805_801 14 2.87E-11 2.18E-09 1.56E-10 15095 hsa-mir-3650 hsa04912 GnRH signaling pathway 815_1956_6714_5594_5595_5599_5566_468_5894_3725_2002_808_805_801 14 4.53E-11 3.45E-09 2.17E-10 15096 hsa-mir-3650 hsa04350 TGF-beta signaling pathway 5594_5595_1387_6667_7027_7046_1874_4087_4609_4088_4089_2033_5933 13 4.57E-11 3.47E-09 2.17E-10 15097 hsa-mir-3650 hsa04660 T cell receptor signaling pathway 5594_5595_1019_915_2932_920_5970_5894_3725_2353_5058_207_3932_4790 14 5.66E-11 4.30E-09 2.53E-10 15098 hsa-mir-3650 hsa04310 Wnt signaling pathway 815_1499_5599_1387_1487_1488_5566_2932_7157_4087_4609_3725_4088_4089_2033 15 3.08E-10 2.34E-08 1.30E-09 15099 hsa-mir-3650 hsa04910 Insulin signaling pathway 5594_5595_5599_2308_5566_2932_10891_5894_207_2002_2538_808_805_801 14 8.70E-10 6.61E-08 3.48E-09 15100 hsa-mir-3650 hsa05213 Endometrial cancer 1956_1499_5594_5595_2932_7157_5894_4609_207_2002 10 9.29E-10 7.06E-08 3.53E-09 15101 hsa-mir-3650 hsa05218 Melanoma 2249_1956_5594_5595_1019_4193_7157_5894_1026_5925_207 11 1.03E-09 7.81E-08 3.72E-09 15102 hsa-mir-3650 hsa05222 Small cell lung cancer 6256_1019_1017_5970_8554_7157_4609_5925_207_4790_7186 11 6.35E-09 4.82E-07 2.19E-08 15103 hsa-mir-3650 hsa05223 Non-small cell lung cancer 1956_5594_5595_6256_1019_7157_5894_5925_207 9 1.98E-08 1.50E-06 6.53E-08 15104 hsa-mir-3650 hsa04620 Toll-like receptor signaling pathway 5594_5595_5599_841_6772_5970_3725_2353_6348_207_4790 11 3.20E-08 2.43E-06 1.01E-07 15105 hsa-mir-3650 hsa04920 Adipocytokine signaling pathway 5599_6256_6774_5970_10891_207_4790_2538_7186 9 1.06E-07 8.02E-06 3.21E-07 15106 hsa-mir-3650 hsa05211 Renal cell carcinoma 5594_5595_1387_2113_5894_3725_5058_2033_207 9 1.85E-07 1.40E-05 5.40E-07 15107 hsa-mir-3650 hsa04630 Jak-STAT signaling pathway 1387_6778_3460_6774_6776_6777_6772_8554_4609_2033_3977_207 12 2.22E-07 1.69E-05 6.24E-07 15108 hsa-mir-3650 hsa04662 B cell receptor signaling pathway 5594_5595_2932_5970_5894_3725_2353_207_4790 9 2.53E-07 1.93E-05 6.88E-07 15109 hsa-mir-3650 hsa04062 Chemokine signaling pathway 5594_5595_5566_2932_6774_6777_6772_5970_5894_5058_6348_207_4790 13 3.13E-07 2.38E-05 8.20E-07 15110 hsa-mir-3650 hsa04510 Focal adhesion 1956_1499_6714_5594_5595_5599_2932_5894_3725_5058_207_71_2002 13 6.28E-07 4.78E-05 1.59E-06 15111 hsa-mir-3650 hsa05216 Thyroid cancer 1499_5594_5595_6256_7157_4609 6 1.60E-06 0.000121279 3.91E-06 15112 hsa-mir-3650 hsa05016 Huntington's disease 1385_1387_291_6908_6667_5481_841_10891_7157_10488_2033 11 9.08E-06 0.000690122 2.16E-05 15113 hsa-mir-3650 hsa04115 p53 signaling pathway 1019_1017_4193_841_2810_7157_1026 7 1.54E-05 0.001169161 3.54E-05 15114 hsa-mir-3650 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_5599_5970_3725_5058_4790 7 1.83E-05 0.001387833 4.08E-05 15115 hsa-mir-3650 hsa04612 Antigen processing and presentation 3320_1385_3308_3303_4800_920_811 7 7.02E-05 0.005331752 0.000148104 15116 hsa-mir-3650 hsa04210 Apoptosis 5566_841_5970_7157_207_4790_7186 7 7.02E-05 0.005331752 0.000148104 15117 hsa-mir-3650 hsa04330 Notch signaling pathway 1387_1487_1488_9612_2033 5 0.000213492 0.016225367 0.000438523 15118 hsa-mir-3650 hsa04150 mTOR signaling pathway 5594_5595_6195_6196_207 5 0.000329567 0.025047059 0.000659133 15119 hsa-mir-3650 hsa04270 Vascular smooth muscle contraction 5594_5595_5566_5894_808_805_801 7 0.000362585 0.027556462 0.000706576 15120 hsa-mir-3650 hsa04540 Gap junction 1956_6714_5594_5595_5566_5894 6 0.000628403 0.047758601 0.001193965 15121 hsa-mir-3650 hsa05340 Primary immunodeficiency 915_920_100_3932 4 0.000731364 0.055583699 0.0013557 15122 hsa-mir-3650 hsa05010 Alzheimer's disease 5594_5595_3416_2932_841_808_805_801 8 0.000788571 0.059931424 0.001426939 15123 hsa-mir-3650 hsa04020 Calcium signaling pathway 815_1956_291_5566_5481_808_805_801 8 0.001002521 0.076191586 0.001771897 15124 hsa-mir-3650 hsa04370 VEGF signaling pathway 6714_5594_5595_5894_207 5 0.001735993 0.131935454 0.002998533 15125 hsa-mir-3650 hsa04664 Fc epsilon RI signaling pathway 5594_5595_5599_5894_207 5 0.001931152 0.146767576 0.003261502 15126 hsa-mir-3650 hsa04950 Maturity onset diabetes of the young 3175_6927_3172 3 0.002774397 0.210854209 0.004583787 15127 hsa-mir-3650 hsa05131 Shigellosis 7534_1499_4691_71 4 0.003650476 0.277436168 0.00577992 15128 hsa-mir-3650 hsa05130 Pathogenic Escherichia coli infection 7534_1499_4691_71 4 0.003650476 0.277436168 0.00577992 15129 hsa-mir-3650 hsa04530 Tight junction 4301_1499_6714_1019_207_71 6 0.004087492 0.310649365 0.006339783 15130 hsa-mir-3650 hsa04650 Natural killer cell mediated cytotoxicity 5594_5595_3460_5894_5058_3932 6 0.004228512 0.321366898 0.006427338 15131 hsa-mir-3650 hsa04810 Regulation of actin cytoskeleton 2249_1956_5594_5595_5894_5058_71 7 0.010160921 0.772230031 0.015141765 15132 hsa-mir-3650 hsa03450 Non-homologous end-joining 5591_2547 2 0.011943152 0.907679564 0.017455376 15133 hsa-mir-3650 hsa04930 Type II diabetes mellitus 5594_5595_5599 3 0.013960042 1 0.020018174 15134 hsa-mir-3650 hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.023077179 1 0.032478993 15135 hsa-mir-3650 hsa04340 Hedgehog signaling pathway 53944_5566_2932 3 0.025207277 1 0.034831873 15136 hsa-mir-3650 hsa04730 Long-term depression 5594_5595_5894 3 0.042955021 1 0.0582961 15137 hsa-mir-3651 hsa04110 Cell cycle 4087_4088_983_5925_993_1387 6 1.40E-07 5.31E-06 5.31E-06 15138 hsa-mir-3651 hsa04350 TGF-beta signaling pathway 4087_4088_4609_1387 4 2.75E-05 0.001043713 0.000521857 15139 hsa-mir-3651 hsa04310 Wnt signaling pathway 4087_4088_4609_1387 4 0.000222643 0.008460444 0.002820148 15140 hsa-mir-3651 hsa05220 Chronic myeloid leukemia 4088_5925_4609 3 0.000444694 0.016898373 0.00332308 15141 hsa-mir-3651 hsa05200 Pathways in cancer 4087_4088_5925_4609_1387 5 0.000446664 0.016973216 0.00332308 15142 hsa-mir-3651 hsa04520 Adherens junction 4087_4088_1387 3 0.000533489 0.020272596 0.00332308 15143 hsa-mir-3651 hsa05210 Colorectal cancer 4087_4088_4609 3 0.000612146 0.023261562 0.00332308 15144 hsa-mir-3651 hsa04612 Antigen processing and presentation 1514_4800_4801 3 0.000720408 0.027375505 0.003421938 15145 hsa-mir-3651 hsa04950 Maturity onset diabetes of the young 3651_5080 2 0.00111523 0.042378739 0.004708749 15146 hsa-mir-3651 hsa05219 Bladder cancer 5925_4609 2 0.003175918 0.120684892 0.012068489 15147 hsa-mir-3651 hsa04330 Notch signaling pathway 1387_8850 2 0.003924188 0.149119128 0.013556284 15148 hsa-mir-3651 hsa05222 Small cell lung cancer 5925_4609 2 0.012184709 0.463018938 0.035251714 15149 hsa-mir-3651 hsa05215 Prostate cancer 5925_1387 2 0.012717372 0.483260132 0.035251714 15150 hsa-mir-3651 hsa05212 Pancreatic cancer 5925_1387 2 0.012987473 0.493523992 0.035251714 15151 hsa-mir-3651 hsa04530 Tight junction 60412_4628 2 0.028711892 1 0.072736792 15152 hsa-mir-3651 hsa04630 Jak-STAT signaling pathway 4609_1387 2 0.035878331 1 0.085211036 15153 hsa-mir-3651 hsa05010 Alzheimer's disease 22926_10476 2 0.045464543 1 0.101626626 15154 hsa-mir-3652 hsa05200 Pathways in cancer 3716_2034_3326_5747_7046_1499_1488_5595_5594_5599_1387_2064_5159_5156_1487_9915_2261_3815_7704_6774_6776_6777_6772_3091_3265_5879_5371_6688_8772_3725_4088_862_2353_2736_4087_4089_3065_5925_2033_6502_207_2932_8554_5970_1956 45 1.24E-33 8.70E-32 8.70E-32 15155 hsa-mir-3652 hsa04010 MAPK signaling pathway 6722_8986_7046_5595_5594_5599_5159_5156_4208_7132_2261_6195_2264_9252_7867_1432_3265_5879_9261_9479_3725_6196_2353_1845_207_5970_22800_6197_1956 29 2.60E-19 1.82E-17 9.10E-18 15156 hsa-mir-3652 hsa04630 Jak-STAT signaling pathway 3717_3716_3560_3561_1439_1387_58985_6778_6774_6776_6777_6772_6773_3454_3455_3459_5781_7297_2033_207_8554_10379 22 2.53E-17 1.77E-15 5.90E-16 15157 hsa-mir-3652 hsa04520 Adherens junction 4301_7046_1499_6714_5595_5594_1387_2064_5879_4088_1457_4087_4089_2033_1956_2534 16 5.29E-15 3.70E-13 9.25E-14 15158 hsa-mir-3652 hsa05210 Colorectal cancer 7046_1499_5595_5594_5599_5159_5156_5879_3725_4088_2353_4087_4089_207_2932_1956 16 1.03E-14 7.24E-13 1.45E-13 15159 hsa-mir-3652 hsa04720 Long-term potentiation 818_817_5595_5594_1387_2902_808_6195_3265_2906_6196_2033_6197_805_801 15 3.80E-14 2.66E-12 3.80E-13 15160 hsa-mir-3652 hsa05220 Chronic myeloid leukemia 7046_1488_5595_5594_1487_6776_6777_3265_5781_4088_4089_3065_5925_207_5970 15 3.80E-14 2.66E-12 3.80E-13 15161 hsa-mir-3652 hsa04350 TGF-beta signaling pathway 7046_5595_5594_1387_90_6667_3397_3398_4088_3399_4087_4089_2033_4093_57154 15 2.58E-13 1.81E-11 2.01E-12 15162 hsa-mir-3652 hsa04012 ErbB signaling pathway 5747_818_817_6714_5595_5594_5599_2064_6776_6777_3265_3725_207_2932_1956 15 2.58E-13 1.81E-11 2.01E-12 15163 hsa-mir-3652 hsa05215 Prostate cancer 3326_1499_5595_5594_1387_2064_5159_5156_3265_5925_2033_207_2932_5970_1956 15 2.99E-13 2.10E-11 2.10E-12 15164 hsa-mir-3652 hsa05212 Pancreatic cancer 3326_1499_5595_5594_1387_2064_5159_5156_3265_5925_2033_207_2932_5970_1956 15 3.47E-13 2.43E-11 2.21E-12 15165 hsa-mir-3652 hsa05221 Acute myeloid leukemia 5595_5594_3815_7704_6774_6776_6777_3265_5371_6688_862_207_5970 13 6.67E-13 4.67E-11 3.89E-12 15166 hsa-mir-3652 hsa05214 Glioma 818_817_5595_5594_5159_5156_808_3265_5925_207_1956_805_801 13 1.96E-12 1.37E-10 1.05E-11 15167 hsa-mir-3652 hsa04060 Cytokine-cytokine receptor interaction 2321_3791_7046_3560_3561_1439_90_5159_5156_7132_1234_1230_3815_58985_7852_3454_3455_3459_7133_1956 20 2.97E-11 2.08E-09 1.48E-10 15168 hsa-mir-3652 hsa04310 Wnt signaling pathway 818_817_1499_1488_5599_1387_1487_6423_5879_3725_4088_1457_4087_4089_2033_2932 16 3.71E-11 2.59E-09 1.66E-10 15169 hsa-mir-3652 hsa04510 Focal adhesion 5747_2321_3791_1499_6714_5595_5594_5599_2064_5159_5156_3265_5879_3725_207_2932_1956_2534 18 3.79E-11 2.65E-09 1.66E-10 15170 hsa-mir-3652 hsa04912 GnRH signaling pathway 5580_818_817_6714_5595_5594_5599_808_1432_3265_3725_1956_805_801 14 5.13E-11 3.59E-09 2.11E-10 15171 hsa-mir-3652 hsa05211 Renal cell carcinoma 2034_5595_5594_1387_9915_3091_3265_5879_5781_3725_2033_207 12 9.23E-11 6.46E-09 3.59E-10 15172 hsa-mir-3652 hsa04062 Chemokine signaling pathway 3717_5747_5580_5595_5594_1234_1230_6774_6777_6772_6773_3265_5879_7852_207_2932_5970 17 1.19E-10 8.33E-09 4.38E-10 15173 hsa-mir-3652 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_1432_6772_5879_3454_3455_8772_3725_2353_207_5970 13 3.06E-10 2.14E-08 1.07E-09 15174 hsa-mir-3652 hsa04916 Melanogenesis 818_817_1499_5595_5594_1387_808_3815_3265_2033_2932_805_801 13 3.80E-10 2.66E-08 1.27E-09 15175 hsa-mir-3652 hsa04370 VEGF signaling pathway 5747_3791_6714_5595_5594_7867_1432_3265_5879_9261_207 11 2.45E-09 1.71E-07 7.79E-09 15176 hsa-mir-3652 hsa04662 B cell receptor signaling pathway 5595_5594_6850_3265_5879_3725_2353_207_2932_5970 10 2.39E-08 1.67E-06 7.26E-08 15177 hsa-mir-3652 hsa04664 Fc epsilon RI signaling pathway 5580_5595_5594_5599_6850_1432_3265_5879_207_2534 10 3.73E-08 2.61E-06 1.09E-07 15178 hsa-mir-3652 hsa05219 Bladder cancer 5595_5594_2064_2261_9252_3265_5925_1956 8 5.28E-08 3.69E-06 1.48E-07 15179 hsa-mir-3652 hsa04660 T cell receptor signaling pathway 3932_5595_5594_1432_3265_3725_2353_207_2932_5970_2534 11 7.16E-08 5.01E-06 1.93E-07 15180 hsa-mir-3652 hsa04920 Adipocytokine signaling pathway 3717_8717_5599_7132_6774_5781_7133_207_5970 9 1.14E-07 8.00E-06 2.86E-07 15181 hsa-mir-3652 hsa04330 Notch signaling pathway 388585_1488_1387_1487_9612_8850_3065_2033 8 1.14E-07 8.00E-06 2.86E-07 15182 hsa-mir-3652 hsa04110 Cell cycle 1387_4174_4088_4172_4087_4089_3065_5925_2033_6502_2932 11 1.50E-07 1.05E-05 3.62E-07 15183 hsa-mir-3652 hsa05213 Endometrial cancer 1499_5595_5594_2064_3265_207_2932_1956 8 2.29E-07 1.61E-05 5.35E-07 15184 hsa-mir-3652 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6850_3265_5879_3454_3455_3459_5781_2534 11 5.95E-07 4.17E-05 1.34E-06 15185 hsa-mir-3652 hsa04020 Calcium signaling pathway 818_817_2064_5159_2902_5156_808_2906_147_1956_805_801 12 1.35E-06 9.48E-05 2.96E-06 15186 hsa-mir-3652 hsa05218 Melanoma 5595_5594_5159_5156_3265_5925_207_1956 8 1.96E-06 0.000137547 4.05E-06 15187 hsa-mir-3652 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5599_1432_5879_5781_3725_5970_1956 8 1.96E-06 0.000137547 4.05E-06 15188 hsa-mir-3652 hsa04150 mTOR signaling pathway 5595_5594_6195_3091_6196_207_6197 7 2.97E-06 0.00020801 5.94E-06 15189 hsa-mir-3652 hsa05223 Non-small cell lung cancer 5595_5594_2064_3265_5925_207_1956 7 3.73E-06 0.00026124 7.26E-06 15190 hsa-mir-3652 hsa04910 Insulin signaling pathway 5595_5594_5599_23265_808_3265_207_2932_805_801 10 4.32E-06 0.00030212 8.17E-06 15191 hsa-mir-3652 hsa05010 Alzheimer's disease 5595_5594_2902_7132_808_2906_8772_351_2932_805_801 11 5.78E-06 0.000404286 1.06E-05 15192 hsa-mir-3652 hsa04540 Gap junction 5592_6714_5595_5594_5159_5156_3265_1956 8 1.24E-05 0.00087123 2.23E-05 15193 hsa-mir-3652 hsa04530 Tight junction 4301_5580_1499_6714_3265_8573_1457_207_22800 9 2.71E-05 0.001898764 4.75E-05 15194 hsa-mir-3652 hsa04810 Regulation of actin cytoskeleton 5747_5595_5594_5159_5156_2261_2264_3265_5879_22800_1956 11 3.79E-05 0.002652892 6.47E-05 15195 hsa-mir-3652 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_7132_1432_5879_2906_7133 6 5.02E-05 0.003512167 8.36E-05 15196 hsa-mir-3652 hsa04270 Vascular smooth muscle contraction 5592_5580_5595_5594_808_147_805_801 8 6.16E-05 0.004309669 0.000100225 15197 hsa-mir-3652 hsa04360 Axon guidance 5747_5595_5594_3265_5879_7852_2932_2534 8 0.000122592 0.008581462 0.000195033 15198 hsa-mir-3652 hsa04930 Type II diabetes mellitus 3651_5580_5595_5594_5599 5 0.000184843 0.012938995 0.000287533 15199 hsa-mir-3652 hsa05216 Thyroid cancer 1499_5595_5594_3265 4 0.000395928 0.02771493 0.000602498 15200 hsa-mir-3652 hsa05222 Small cell lung cancer 5747_5925_6502_207_8554_5970 6 0.000446439 0.031250736 0.000664909 15201 hsa-mir-3652 hsa04670 Leukocyte transendothelial migration 4301_5747_1499_1432_5879_7852_5781 7 0.000463558 0.032449039 0.000676022 15202 hsa-mir-3652 hsa04210 Apoptosis 8717_1439_7132_8772_207_5970 6 0.000529939 0.037095696 0.000757055 15203 hsa-mir-3652 hsa04120 Ubiquitin mediated proteolysis 55294_672_5371_7329_6502_8554_57154 7 0.000965821 0.067607479 0.00135215 15204 hsa-mir-3652 hsa05016 Huntington's disease 1387_2902_6667_3065_3064_2033_9519 7 0.004913802 0.343966118 0.006744434 15205 hsa-mir-3652 hsa04730 Long-term depression 5592_5595_5594_3265 4 0.008313811 0.58196678 0.011191669 15206 hsa-mir-3652 hsa03022 Basal transcription factors 2963_2969_9519 3 0.008695328 0.608672992 0.011484396 15207 hsa-mir-3652 hsa05217 Basal cell carcinoma 1499_2736_2932 3 0.023637948 1 0.030641784 15208 hsa-mir-3652 hsa04950 Maturity onset diabetes of the young 3651_168620 2 0.030720793 1 0.039099191 15209 hsa-mir-365-2 hsa05210 Colorectal cancer 4088_4089_207_208_1499 5 8.24E-08 3.30E-06 3.30E-06 15210 hsa-mir-365-2 hsa05220 Chronic myeloid leukemia 4088_4089_207_208 4 2.74E-06 0.000109585 3.50E-05 15211 hsa-mir-365-2 hsa05200 Pathways in cancer 4088_4089_207_208_1499_1387 6 3.36E-06 0.000134584 3.50E-05 15212 hsa-mir-365-2 hsa04520 Adherens junction 4088_4089_1499_1387 4 3.50E-06 0.000140111 3.50E-05 15213 hsa-mir-365-2 hsa05215 Prostate cancer 207_208_1499_1387 4 5.04E-06 0.000201477 3.51E-05 15214 hsa-mir-365-2 hsa05212 Pancreatic cancer 207_208_1499_1387 4 5.26E-06 0.000210348 3.51E-05 15215 hsa-mir-365-2 hsa04110 Cell cycle 4088_4089_7534_1387 4 1.59E-05 0.000637042 9.10E-05 15216 hsa-mir-365-2 hsa04310 Wnt signaling pathway 4088_4089_1499_1387 4 4.05E-05 0.001618145 0.000191945 15217 hsa-mir-365-2 hsa05213 Endometrial cancer 207_208_1499 3 4.32E-05 0.001727506 0.000191945 15218 hsa-mir-365-2 hsa05211 Renal cell carcinoma 207_208_1387 3 0.00010929 0.004371588 0.000437159 15219 hsa-mir-365-2 hsa04350 TGF-beta signaling pathway 4088_4089_1387 3 0.000187741 0.007509632 0.000682694 15220 hsa-mir-365-2 hsa04530 Tight junction 207_208_1499 3 0.000685622 0.027424876 0.002285406 15221 hsa-mir-365-2 hsa04630 Jak-STAT signaling pathway 207_208_1387 3 0.000973048 0.038921922 0.002993994 15222 hsa-mir-365-2 hsa04150 mTOR signaling pathway 207_208 2 0.002029208 0.081168324 0.00519281 15223 hsa-mir-365-2 hsa04510 Focal adhesion 207_208_1499 3 0.002167337 0.086693484 0.00519281 15224 hsa-mir-365-2 hsa05223 Non-small cell lung cancer 207_208 2 0.002180395 0.087215807 0.00519281 15225 hsa-mir-365-2 hsa05131 Shigellosis 7534_1499 2 0.002336765 0.093470588 0.00519281 15226 hsa-mir-365-2 hsa05130 Pathogenic Escherichia coli infection 7534_1499 2 0.002336765 0.093470588 0.00519281 15227 hsa-mir-365-2 hsa05221 Acute myeloid leukemia 207_208 2 0.002580981 0.103239253 0.005433645 15228 hsa-mir-365-2 hsa05214 Glioma 207_208 2 0.003103891 0.124155645 0.006207782 15229 hsa-mir-365-2 hsa04920 Adipocytokine signaling pathway 207_208 2 0.003288319 0.131532757 0.006263465 15230 hsa-mir-365-2 hsa05218 Melanoma 207_208 2 0.003672214 0.146888551 0.006676752 15231 hsa-mir-365-2 hsa04662 B cell receptor signaling pathway 207_208 2 0.004075998 0.16303993 0.007088693 15232 hsa-mir-365-2 hsa04370 VEGF signaling pathway 207_208 2 0.004285288 0.171411535 0.007142147 15233 hsa-mir-365-2 hsa04664 Fc epsilon RI signaling pathway 207_208 2 0.004499478 0.179979128 0.007199165 15234 hsa-mir-365-2 hsa04010 MAPK signaling pathway 207_208_6722 3 0.004733831 0.189353232 0.007282817 15235 hsa-mir-365-2 hsa05222 Small cell lung cancer 207_208 2 0.005287381 0.211495243 0.007721078 15236 hsa-mir-365-2 hsa04012 ErbB signaling pathway 207_208 2 0.005404755 0.216190181 0.007721078 15237 hsa-mir-365-2 hsa04210 Apoptosis 207_208 2 0.005643084 0.225723344 0.007783564 15238 hsa-mir-365-2 hsa04620 Toll-like receptor signaling pathway 207_208 2 0.007307116 0.292284622 0.009742821 15239 hsa-mir-365-2 hsa04916 Melanogenesis 1499_1387 2 0.007580548 0.303221932 0.009781353 15240 hsa-mir-365-2 hsa04660 T cell receptor signaling pathway 207_208 2 0.008428246 0.337129834 0.010535307 15241 hsa-mir-365-2 hsa04910 Insulin signaling pathway 207_208 2 0.012911436 0.516457457 0.015650226 15242 hsa-mir-365-2 hsa04062 Chemokine signaling pathway 207_208 2 0.02406202 0.962480806 0.028308259 15243 hsa-mir-365-2 hsa05216 Thyroid cancer 1499 1 0.036319119 1 0.041507564 15244 hsa-mir-3653 hsa04330 Notch signaling pathway 9612_2033_3065 3 9.47E-07 1.52E-05 1.52E-05 15245 hsa-mir-3653 hsa05200 Pathways in cancer 8554_2033_3065 3 0.000281397 0.00450235 0.002251175 15246 hsa-mir-3653 hsa04110 Cell cycle 2033_3065 2 0.001036227 0.016579635 0.005526545 15247 hsa-mir-3653 hsa04630 Jak-STAT signaling pathway 8554_2033 2 0.001733966 0.027743449 0.006935862 15248 hsa-mir-3653 hsa05016 Huntington's disease 2033_3065 2 0.002523767 0.040380264 0.008076053 15249 hsa-mir-3653 hsa05211 Renal cell carcinoma 2033 1 0.028806201 0.460899224 0.043574592 15250 hsa-mir-3653 hsa04720 Long-term potentiation 2033 1 0.02997358 0.479577273 0.043574592 15251 hsa-mir-3653 hsa05220 Chronic myeloid leukemia 3065 1 0.02997358 0.479577273 0.043574592 15252 hsa-mir-3653 hsa04520 Adherens junction 2033 1 0.031916352 0.510661626 0.043574592 15253 hsa-mir-3653 hsa05222 Small cell lung cancer 8554 1 0.03424297 0.547887517 0.043574592 15254 hsa-mir-3653 hsa04350 TGF-beta signaling pathway 2033 1 0.034630241 0.554083853 0.043574592 15255 hsa-mir-3653 hsa05215 Prostate cancer 2033 1 0.035017369 0.560277911 0.043574592 15256 hsa-mir-3653 hsa05212 Pancreatic cancer 2033 1 0.035404356 0.566469692 0.043574592 15257 hsa-mir-3653 hsa04916 Melanogenesis 2033 1 0.041192105 0.659073685 0.047076692 15258 hsa-mir-3654 hsa05210 Colorectal cancer 4087_4088_4609 3 5.08E-06 0.000106666 5.91E-05 15259 hsa-mir-3654 hsa04350 TGF-beta signaling pathway 4087_4088_4609 3 5.63E-06 0.000118144 5.91E-05 15260 hsa-mir-3654 hsa04310 Wnt signaling pathway 4087_4088_4609 3 2.87E-05 0.000603228 0.000201076 15261 hsa-mir-3654 hsa05200 Pathways in cancer 4087_4088_4609 3 0.000281397 0.005909334 0.001477334 15262 hsa-mir-3654 hsa05220 Chronic myeloid leukemia 4088_4609 2 0.000421732 0.008856381 0.001673467 15263 hsa-mir-3654 hsa04520 Adherens junction 4087_4088 2 0.000478134 0.010040804 0.001673467 15264 hsa-mir-3654 hsa04612 Antigen processing and presentation 4800_4801 2 0.000588391 0.012356212 0.001765173 15265 hsa-mir-3654 hsa04110 Cell cycle 4087_4088 2 0.001036227 0.021760772 0.002720096 15266 hsa-mir-3654 hsa05216 Thyroid cancer 4609 1 0.011931649 0.250564622 0.027840514 15267 hsa-mir-3654 hsa05219 Bladder cancer 4609 1 0.017061385 0.358289087 0.035828909 15268 hsa-mir-3654 hsa05213 Endometrial cancer 4609 1 0.020990711 0.440804938 0.040073176 15269 hsa-mir-3654 hsa05221 Acute myeloid leukemia 4609 1 0.023732667 0.498386002 0.041532167 15270 hsa-mir-3654 hsa05222 Small cell lung cancer 4609 1 0.03424297 0.719102366 0.046468217 15271 hsa-mir-3654 hsa04012 ErbB signaling pathway 4609 1 0.034630241 0.727235057 0.046468217 15272 hsa-mir-3654 hsa05215 Prostate cancer 10488 1 0.035017369 0.735364758 0.046468217 15273 hsa-mir-3654 hsa05212 Pancreatic cancer 10488 1 0.035404356 0.743491471 0.046468217 15274 hsa-mir-3654 hsa04916 Melanogenesis 10488 1 0.041192105 0.865034212 0.050884365 15275 hsa-mir-3655 hsa05200 Pathways in cancer 4087_4089_3065_836_2033_8554 6 2.00E-06 6.81E-05 4.23E-05 15276 hsa-mir-3655 hsa05016 Huntington's disease 3064_23186_3065_836_2033 5 2.49E-06 8.46E-05 4.23E-05 15277 hsa-mir-3655 hsa04110 Cell cycle 4087_4089_3065_2033 4 1.13E-05 0.000384001 0.000128 15278 hsa-mir-3655 hsa04330 Notch signaling pathway 9612_3065_2033 3 2.50E-05 0.000851691 0.000212923 15279 hsa-mir-3655 hsa04520 Adherens junction 4087_4089_2033 3 0.00011447 0.00389197 0.000707066 15280 hsa-mir-3655 hsa05210 Colorectal cancer 4087_4089_836 3 0.000131646 0.004475963 0.000707066 15281 hsa-mir-3655 hsa04350 TGF-beta signaling pathway 4087_4089_2033 3 0.000145572 0.004949464 0.000707066 15282 hsa-mir-3655 hsa04310 Wnt signaling pathway 4087_4089_2033 3 0.000717318 0.024388817 0.003048602 15283 hsa-mir-3655 hsa05010 Alzheimer's disease 836_1020_840 3 0.001104945 0.037568127 0.004174236 15284 hsa-mir-3655 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432 2 0.001976069 0.067186345 0.006718635 15285 hsa-mir-3655 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_1432 2 0.003108453 0.105687392 0.009607945 15286 hsa-mir-3655 hsa05220 Chronic myeloid leukemia 4089_3065 2 0.003451156 0.117339297 0.009732529 15287 hsa-mir-3655 hsa04010 MAPK signaling pathway 836_1432_5598 3 0.003721261 0.12652288 0.009732529 15288 hsa-mir-3655 hsa04210 Apoptosis 836_840 2 0.004782406 0.162601787 0.011614413 15289 hsa-mir-3655 hsa04912 GnRH signaling pathway 1432_5598 2 0.006908049 0.234873655 0.015658244 15290 hsa-mir-3655 hsa04630 Jak-STAT signaling pathway 2033_8554 2 0.013651484 0.464150459 0.029009404 15291 hsa-mir-3658 hsa05200 Pathways in cancer 1147_3320_3326_3725_3551_6774_5468_5599_1387_1487_367_8517_841_6772_6256_5970_5371_7157_4087_4791_10401_4609_2353_3065_4088_3066_1488_2033_898_8554_4790_4792 32 3.09E-21 2.17E-19 2.17E-19 15292 hsa-mir-3658 hsa04310 Wnt signaling pathway 3725_23291_5519_5515_5599_1387_8607_1487_5566_8454_6500_8945_7157_4087_6885_4609_1457_4088_1488_2033 20 4.79E-16 3.36E-14 1.68E-14 15293 hsa-mir-3658 hsa04620 Toll-like receptor signaling pathway 1147_3725_3551_29110_5599_1326_8517_3661_9641_841_6772_5970_6885_2353_5608_4790_4792 17 2.40E-15 1.68E-13 5.59E-14 15294 hsa-mir-3658 hsa04010 MAPK signaling pathway 1147_6722_3725_3551_5599_1326_3305_3303_5566_8517_9252_3312_5971_5970_7157_4791_6885_4609_9020_2353_5608_4790 22 1.77E-13 1.24E-11 3.10E-12 15295 hsa-mir-3658 hsa04920 Adipocytokine signaling pathway 1147_3551_6774_5465_5599_8517_6256_5970_4794_4793_8471_4790_4792 13 8.78E-13 6.14E-11 1.23E-11 15296 hsa-mir-3658 hsa05220 Chronic myeloid leukemia 1147_3551_1487_8517_5970_7157_4609_3065_4088_3066_1488_4790_4792 13 3.12E-12 2.18E-10 3.64E-11 15297 hsa-mir-3658 hsa05215 Prostate cancer 1147_3320_3326_3551_1387_367_8517_5970_7157_2033_898_4790_4792 13 1.90E-11 1.33E-09 1.89E-10 15298 hsa-mir-3658 hsa05212 Pancreatic cancer 1147_3320_3326_3551_1387_367_8517_5970_7157_2033_898_4790_4792 13 2.16E-11 1.51E-09 1.89E-10 15299 hsa-mir-3658 hsa05222 Small cell lung cancer 1147_3551_8517_6256_5970_7157_10401_4609_898_8554_4790_4792 12 2.07E-10 1.45E-08 1.61E-09 15300 hsa-mir-3658 hsa04660 T cell receptor signaling pathway 1147_3725_3551_1326_8517_5970_4794_4793_6885_9020_2353_4790_4792 13 2.36E-10 1.65E-08 1.65E-09 15301 hsa-mir-3658 hsa04110 Cell cycle 5591_1387_8454_6500_5111_7157_4087_3065_4088_3066_1111_2033_898 13 5.73E-10 4.01E-08 3.65E-09 15302 hsa-mir-3658 hsa04662 B cell receptor signaling pathway 1147_3725_3551_695_8517_5970_4794_4793_2353_4790_4792 11 7.39E-10 5.17E-08 4.31E-09 15303 hsa-mir-3658 hsa05016 Huntington's disease 498_5468_1387_292_293_6667_1213_841_5437_7157_3065_3066_2033_6908_5441 15 1.54E-09 1.08E-07 8.27E-09 15304 hsa-mir-3658 hsa04330 Notch signaling pathway 1387_4851_1487_9612_3065_3066_1488_2033_8850 9 3.33E-09 2.33E-07 1.67E-08 15305 hsa-mir-3658 hsa04210 Apoptosis 1147_3551_5566_8517_841_5970_7157_9131_9020_4790_4792 11 3.80E-09 2.66E-07 1.77E-08 15306 hsa-mir-3658 hsa04120 Ubiquitin mediated proteolysis 8651_23291_672_51366_8454_55294_6500_5371_8945_10401_7329_8554 12 3.04E-08 2.12E-06 1.33E-07 15307 hsa-mir-3658 hsa04350 TGF-beta signaling pathway 5519_5515_1387_6667_8454_6500_4087_4609_4088_2033 10 3.68E-08 2.58E-06 1.52E-07 15308 hsa-mir-3658 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_3725_3551_5599_8517_5970_9020_4790_4792 9 8.33E-08 5.83E-06 3.24E-07 15309 hsa-mir-3658 hsa05221 Acute myeloid leukemia 1147_3551_6774_8517_5970_5371_4609_4790 8 2.77E-07 1.94E-05 1.02E-06 15310 hsa-mir-3658 hsa04062 Chemokine signaling pathway 1147_3551_6774_5590_5566_8517_6772_5970_653361_4793_4790_4792 12 8.45E-07 5.92E-05 2.96E-06 15311 hsa-mir-3658 hsa03020 RNA polymerase 25885_64425_5437_51082_84172_5441 6 9.97E-07 6.98E-05 3.32E-06 15312 hsa-mir-3658 hsa05131 Shigellosis 7278_71_10382_347733_7846_4691_203068 7 2.57E-06 0.000179662 7.81E-06 15313 hsa-mir-3658 hsa05130 Pathogenic Escherichia coli infection 7278_71_10382_347733_7846_4691_203068 7 2.57E-06 0.000179662 7.81E-06 15314 hsa-mir-3658 hsa03022 Basal transcription factors 2969_6878_6872_6882_2959_6908 6 3.51E-06 0.000245733 1.02E-05 15315 hsa-mir-3658 hsa03010 Ribosome 6128_6155_6156_6141_6207_6217_9349_6188 8 1.22E-05 0.000850618 3.40E-05 15316 hsa-mir-3658 hsa04910 Insulin signaling pathway 3551_8651_5590_5599_5566_8471_808_801_805 9 1.41E-05 0.000984592 3.79E-05 15317 hsa-mir-3658 hsa04720 Long-term potentiation 814_1387_5566_2033_808_801_805 7 1.51E-05 0.001055673 3.91E-05 15318 hsa-mir-3658 hsa04520 Adherens junction 1387_71_4087_6885_1457_4088_2033 7 2.22E-05 0.001557202 5.56E-05 15319 hsa-mir-3658 hsa05210 Colorectal cancer 3725_5599_7157_4087_4609_2353_4088 7 2.98E-05 0.002087196 7.20E-05 15320 hsa-mir-3658 hsa04630 Jak-STAT signaling pathway 8651_6774_1387_6778_6772_10401_4609_2033_8554 9 3.35E-05 0.00234673 7.82E-05 15321 hsa-mir-3658 hsa04930 Type II diabetes mellitus 3551_8651_5590_5599_8471 5 0.00012139 0.008497307 0.000274107 15322 hsa-mir-3658 hsa04912 GnRH signaling pathway 3725_5599_5566_5608_808_801_805 7 0.000132547 0.009278308 0.000289947 15323 hsa-mir-3658 hsa05216 Thyroid cancer 5468_6256_7157_4609 4 0.000281251 0.019687558 0.000596593 15324 hsa-mir-3658 hsa04612 Antigen processing and presentation 3320_3326_3309_3305_3303_3312 6 0.0003288 0.023016034 0.000676942 15325 hsa-mir-3658 hsa04540 Gap junction 5566_7278_10382_347733_7846_203068 6 0.000410501 0.028735061 0.000821002 15326 hsa-mir-3658 hsa04916 Melanogenesis 1387_5566_2033_808_801_805 6 0.000718321 0.050282462 0.001396735 15327 hsa-mir-3658 hsa04020 Calcium signaling pathway 814_292_293_5566_808_801_805 7 0.002680322 0.187622557 0.005066931 15328 hsa-mir-3658 hsa04530 Tight junction 5519_5515_5590_4628_71_1457 6 0.00275062 0.192543375 0.005066931 15329 hsa-mir-3658 hsa05214 Glioma 7157_808_801_805 4 0.004527319 0.316912345 0.008125958 15330 hsa-mir-3658 hsa04115 p53 signaling pathway 841_7157_1111_898 4 0.005531495 0.387204638 0.009680116 15331 hsa-mir-3658 hsa03320 PPAR signaling pathway 10062_5465_5468_6256 4 0.005803909 0.406273602 0.009909112 15332 hsa-mir-3658 hsa03410 Base excision repair 3146_5111_142 3 0.006328611 0.443002746 0.010547684 15333 hsa-mir-3658 hsa05219 Bladder cancer 9252_7157_4609 3 0.009417937 0.659255584 0.015331525 15334 hsa-mir-3658 hsa04340 Hedgehog signaling pathway 23291_5566_8945 3 0.020436489 1 0.032512597 15335 hsa-mir-3658 hsa03430 Mismatch repair 5981_5111 2 0.024159108 1 0.037580835 15336 hsa-mir-3658 hsa04270 Vascular smooth muscle contraction 5566_808_801_805 4 0.031011853 1 0.04719195 15337 hsa-mir-3658 hsa05010 Alzheimer's disease 498_841_808_801_805 5 0.032402274 1 0.048258706 15338 hsa-mir-3658 hsa05211 Renal cell carcinoma 3725_1387_2033 3 0.036316085 1 0.052960957 15339 hsa-mir-3658 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.041364289 1 0.059091842 15340 hsa-mir-3658 hsa04664 Fc epsilon RI signaling pathway 695_5599_5608 3 0.045369769 1 0.063517677 15341 hsa-mir-3658 hsa05012 Parkinson's disease 498_7314_292_293 4 0.047425344 1 0.065093609 15342 hsa-mir-3658 hsa05340 Primary immunodeficiency 695_8517 2 0.049740652 1 0.06695857 15343 hsa-mir-3659 hsa05200 Pathways in cancer 3320_3326_5371_405_2249_3480_1956_1499_5594_5595_6654_5599_5914_1387_6257_6256_8031_2308_6258_208_367_1147_4193_7704_6774_2064_6776_6777_2885_3091_5970_8503_8554_595_7157_4089_10401_4087_3725_2353_2735_2736_2737_4088_5295_5881_1050_2034_2033_207_9915_4790 52 1.26E-43 9.23E-42 9.23E-42 15344 hsa-mir-3659 hsa05215 Prostate cancer 3320_3326_3480_1956_1499_5594_5595_6654_1387_2308_208_367_1147_4193_2064_2885_5970_8503_595_7157_5295_2033_207_4790 24 1.64E-25 1.19E-23 5.01E-24 15345 hsa-mir-3659 hsa05212 Pancreatic cancer 3320_3326_3480_1956_1499_5594_5595_6654_1387_2308_208_367_1147_4193_2064_2885_5970_8503_595_7157_5295_2033_207_4790 24 2.06E-25 1.50E-23 5.01E-24 15346 hsa-mir-3659 hsa05221 Acute myeloid leukemia 5371_5594_5595_6654_5914_208_1147_7704_6774_6776_6777_2885_5970_8503_595_5295_1050_207_4790 19 1.35E-21 9.84E-20 2.46E-20 15347 hsa-mir-3659 hsa05210 Colorectal cancer 3480_1956_1499_5594_5595_6654_5599_208_2885_8503_595_7157_4089_4087_3725_2353_4088_5295_5881_207 20 1.88E-20 1.37E-18 2.75E-19 15348 hsa-mir-3659 hsa05220 Chronic myeloid leukemia 5594_5595_6654_208_1147_4193_6776_6777_2885_5970_8503_595_7157_4089_4088_5295_207_4790_6464 19 6.30E-20 4.60E-18 7.66E-19 15349 hsa-mir-3659 hsa04010 MAPK signaling pathway 2249_994_1956_5594_3727_5595_6654_5599_208_1147_4214_1432_2885_5970_627_7157_10912_3725_6195_2353_5881_5058_6197_4616_2872_207_4790_5566 28 2.77E-19 2.03E-17 2.89E-18 15350 hsa-mir-3659 hsa05214 Glioma 3480_1956_5594_5595_6654_208_4193_2885_8503_595_7157_5295_207_801_6464_808_805 17 3.68E-18 2.68E-16 3.05E-17 15351 hsa-mir-3659 hsa04520 Adherens junction 1460_3480_1956_1499_6714_5594_5595_1387_5770_5777_2064_4089_4087_1457_4088_5881_2033_71 18 3.76E-18 2.75E-16 3.05E-17 15352 hsa-mir-3659 hsa05223 Non-small cell lung cancer 1956_5594_5595_6654_6257_6256_6258_208_2064_2885_8503_595_7157_5295_2309_207 16 6.72E-18 4.90E-16 4.90E-17 15353 hsa-mir-3659 hsa04012 ErbB signaling pathway 1956_6714_5594_5595_6654_56924_5599_208_2064_6776_6777_2885_8503_3725_5295_5058_207_6464 18 1.38E-17 1.01E-15 9.15E-17 15354 hsa-mir-3659 hsa05211 Renal cell carcinoma 405_5594_5595_6654_56924_1387_208_2885_3091_8503_3725_5295_5058_2034_2033_207_9915 17 1.62E-17 1.18E-15 9.84E-17 15355 hsa-mir-3659 hsa04510 Focal adhesion 9564_3480_1956_1499_6714_5594_5595_6654_56924_5599_208_2064_2885_8503_595_857_3725_5295_5881_5058_207_71_6464 23 8.87E-17 6.48E-15 4.98E-16 15356 hsa-mir-3659 hsa04910 Insulin signaling pathway 6720_10891_5594_5595_6654_5599_2308_7249_208_5770_2885_8503_5295_2872_207_801_6464_808_805_5566 20 1.01E-16 7.41E-15 5.29E-16 15357 hsa-mir-3659 hsa04660 T cell receptor signaling pathway 5594_5595_6654_56924_208_1147_5777_1432_2885_5970_8503_3725_2353_5295_5058_207_3932_4790 18 5.34E-16 3.90E-14 2.60E-15 15358 hsa-mir-3659 hsa05213 Endometrial cancer 1956_1499_5594_5595_6654_208_2064_2885_8503_595_7157_5295_2309_207 14 2.49E-15 1.82E-13 1.14E-14 15359 hsa-mir-3659 hsa04662 B cell receptor signaling pathway 5594_5595_6654_208_1147_5777_2885_5970_8503_3725_2353_5295_5881_207_4790 15 1.12E-14 8.16E-13 4.80E-14 15360 hsa-mir-3659 hsa04062 Chemokine signaling pathway 9564_5594_5595_6654_2770_208_1147_6774_6777_2885_5970_8503_5295_5058_2309_207_4790_6464_5566 19 3.55E-13 2.59E-11 1.44E-12 15361 hsa-mir-3659 hsa05222 Small cell lung cancer 6257_6256_6258_208_1147_5970_8503_8554_595_7157_10401_5295_207_4790 14 1.06E-12 7.72E-11 4.06E-12 15362 hsa-mir-3659 hsa04630 Jak-STAT signaling pathway 6654_1387_208_5777_6774_6776_6777_2885_8503_8554_595_10401_5295_2033_3977_207 16 1.39E-11 1.02E-09 5.08E-11 15363 hsa-mir-3659 hsa04912 GnRH signaling pathway 1956_6714_5594_5595_6654_5599_4214_1432_2885_3725_801_808_805_5566 14 1.69E-11 1.23E-09 5.87E-11 15364 hsa-mir-3659 hsa05218 Melanoma 2249_3480_1956_5594_5595_208_4193_8503_595_7157_5295_207 12 3.04E-11 2.22E-09 1.01E-10 15365 hsa-mir-3659 hsa04110 Cell cycle 994_1387_7533_4193_902_595_7157_10912_4089_4087_1022_4088_2033_4616 14 5.50E-11 4.01E-09 1.74E-10 15366 hsa-mir-3659 hsa05216 Thyroid cancer 1499_5594_5595_6257_6256_8031_6258_595_7157 9 8.87E-11 6.47E-09 2.70E-10 15367 hsa-mir-3659 hsa04620 Toll-like receptor signaling pathway 5594_5595_5599_208_1147_1432_5970_8503_3725_2353_5295_207_4790 13 1.09E-10 7.99E-09 3.19E-10 15368 hsa-mir-3659 hsa04920 Adipocytokine signaling pathway 10891_5599_6257_6256_6258_208_1147_6774_5970_207_4790 11 2.70E-10 1.97E-08 7.59E-10 15369 hsa-mir-3659 hsa04150 mTOR signaling pathway 5594_5595_7249_208_3091_8503_6195_5295_6197_207 10 4.53E-10 3.31E-08 1.22E-09 15370 hsa-mir-3659 hsa04310 Wnt signaling pathway 1460_1499_5599_1387_595_7157_4089_4087_3725_1457_4088_5881_2033_5566 14 1.06E-09 7.75E-08 2.77E-09 15371 hsa-mir-3659 hsa04664 Fc epsilon RI signaling pathway 5594_5595_6654_5599_208_1432_2885_8503_5295_5881_207 11 1.30E-09 9.52E-08 3.28E-09 15372 hsa-mir-3659 hsa04720 Long-term potentiation 5594_5595_1387_6195_6197_2033_801_808_805_5566 10 1.08E-08 7.90E-07 2.63E-08 15373 hsa-mir-3659 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_5599_1147_1432_5970_3725_5058_4790 9 8.83E-08 6.44E-06 2.08E-07 15374 hsa-mir-3659 hsa04370 VEGF signaling pathway 6714_5594_5595_208_1432_8503_5295_5881_207 9 1.66E-07 1.21E-05 3.79E-07 15375 hsa-mir-3659 hsa04916 Melanogenesis 1499_5594_5595_1387_2770_2033_801_808_805_5566 10 1.84E-07 1.34E-05 4.06E-07 15376 hsa-mir-3659 hsa04650 Natural killer cell mediated cytotoxicity 5594_5595_6654_5777_2885_8503_5295_5881_5058_3932_6464 11 2.60E-07 1.90E-05 5.59E-07 15377 hsa-mir-3659 hsa04350 TGF-beta signaling pathway 6667_5594_5595_1387_4089_4087_4088_2033_4093 9 4.31E-07 3.14E-05 8.98E-07 15378 hsa-mir-3659 hsa05219 Bladder cancer 1956_5594_5595_4193_2064_595_7157 7 4.68E-07 3.42E-05 9.49E-07 15379 hsa-mir-3659 hsa04210 Apoptosis 208_1147_5970_8503_7157_5295_207_4790_5566 9 5.14E-07 3.75E-05 1.01E-06 15380 hsa-mir-3659 hsa04810 Regulation of actin cytoskeleton 9564_2249_1956_5594_5595_6654_56924_8503_5295_5881_5058_71 12 3.16E-06 0.000230344 6.06E-06 15381 hsa-mir-3659 hsa04540 Gap junction 1956_6714_5594_5595_6654_2770_2885_5566 8 6.79E-06 0.000495399 1.27E-05 15382 hsa-mir-3659 hsa03022 Basal transcription factors 2965_2963_6881_6908_2959 5 5.36E-05 0.00391242 9.78E-05 15383 hsa-mir-3659 hsa04530 Tight junction 1460_1499_6714_2770_208_1457_207_71 8 9.25E-05 0.006752078 0.000161406 15384 hsa-mir-3659 hsa04115 p53 signaling pathway 7249_4193_595_7157_10912_4616 6 9.29E-05 0.006779042 0.000161406 15385 hsa-mir-3659 hsa04120 Ubiquitin mediated proteolysis 5371_672_4214_4193_8554_10273_10401_7329 8 0.000101773 0.007429439 0.000172778 15386 hsa-mir-3659 hsa04930 Type II diabetes mellitus 5594_5595_5599_8503_5295 5 0.000125271 0.00914478 0.000207836 15387 hsa-mir-3659 hsa04670 Leukocyte transendothelial migration 9564_1499_2770_1432_8503_5295_71 7 0.000280833 0.020500774 0.000455573 15388 hsa-mir-3659 hsa05217 Basal cell carcinoma 1499_7157_2735_2736_2737 5 0.000298304 0.021776159 0.000473395 15389 hsa-mir-3659 hsa04360 Axon guidance 5998_5594_5595_56924_2770_5881_5058 7 0.000422737 0.0308598 0.000656591 15390 hsa-mir-3659 hsa04070 Phosphatidylinositol signaling system 8503_5295_801_808_805 5 0.001185549 0.086545111 0.001803023 15391 hsa-mir-3659 hsa03420 Nucleotide excision repair 2965_4331_902_1022 4 0.001223651 0.089326508 0.00182299 15392 hsa-mir-3659 hsa04270 Vascular smooth muscle contraction 5594_5595_801_808_805_5566 6 0.001385322 0.10112849 0.00202257 15393 hsa-mir-3659 hsa04330 Notch signaling pathway 1387_9612_2033_8850 4 0.001536079 0.11213377 0.002198701 15394 hsa-mir-3659 hsa04950 Maturity onset diabetes of the young 3172_6928_6927 3 0.002248384 0.164132041 0.003156385 15395 hsa-mir-3659 hsa04612 Antigen processing and presentation 3320_3326_3308_4800_6890 5 0.002292993 0.167388474 0.003158273 15396 hsa-mir-3659 hsa04340 Hedgehog signaling pathway 2735_2736_2737_5566 4 0.002973227 0.21704554 0.004019362 15397 hsa-mir-3659 hsa05016 Huntington's disease 6667_10891_1387_6908_627_7157_2033 7 0.003120492 0.227795934 0.004141744 15398 hsa-mir-3659 hsa03320 PPAR signaling pathway 6257_6256_6258_2168 4 0.005941799 0.433751352 0.00774556 15399 hsa-mir-3659 hsa04730 Long-term depression 3480_5594_5595_2770 4 0.006229377 0.454744485 0.007977973 15400 hsa-mir-3659 hsa03410 Base excision repair 6996_4350_142 3 0.006446986 0.470629966 0.00811431 15401 hsa-mir-3659 hsa04020 Calcium signaling pathway 1956_2064_801_808_805_5566 6 0.011035458 0.805588417 0.013654041 15402 hsa-mir-3659 hsa05010 Alzheimer's disease 5594_5595_801_808_805 5 0.033210176 1 0.040405714 15403 hsa-mir-3660 hsa05200 Pathways in cancer 2249_1499_5914_1387_6256_1019_367_1017_6774_6776_5970_6688_4609_3725_1026_2353_6777_5881_1050_5925_2033_8554 22 5.79E-19 3.59E-17 3.59E-17 15404 hsa-mir-3660 hsa04110 Cell cycle 993_7534_1387_983_10971_1019_1017_7027_1026_5925_2033_5933 12 8.01E-13 4.97E-11 2.48E-11 15405 hsa-mir-3660 hsa05215 Prostate cancer 1499_1387_367_1017_5970_468_1026_5925_2033 9 5.68E-10 3.52E-08 8.52E-09 15406 hsa-mir-3660 hsa05212 Pancreatic cancer 1499_1387_367_1017_5970_468_1026_5925_2033 9 6.23E-10 3.87E-08 8.52E-09 15407 hsa-mir-3660 hsa05221 Acute myeloid leukemia 5914_6774_6776_5970_6688_4609_6777_1050 8 6.87E-10 4.26E-08 8.52E-09 15408 hsa-mir-3660 hsa04010 MAPK signaling pathway 6722_2249_1386_1649_1432_5970_468_4609_3725_2353_5881 11 6.84E-08 4.24E-06 7.06E-07 15409 hsa-mir-3660 hsa05220 Chronic myeloid leukemia 1019_6776_5970_4609_1026_6777_5925 7 8.90E-08 5.52E-06 7.88E-07 15410 hsa-mir-3660 hsa05222 Small cell lung cancer 6256_1019_1017_5970_4609_5925_8554 7 2.13E-07 1.32E-05 1.58E-06 15411 hsa-mir-3660 hsa04350 TGF-beta signaling pathway 1387_7027_1874_4609_2033_6667_5933 7 2.29E-07 1.42E-05 1.58E-06 15412 hsa-mir-3660 hsa04630 Jak-STAT signaling pathway 1387_6774_6776_4609_6777_2033_3977_8554 8 7.63E-07 4.73E-05 4.73E-06 15413 hsa-mir-3660 hsa04012 ErbB signaling pathway 6714_6776_4609_3725_1026_6777 6 4.00E-06 0.00024816 2.26E-05 15414 hsa-mir-3660 hsa04950 Maturity onset diabetes of the young 5080_6928_6927_3172 4 7.25E-06 0.000449795 3.74E-05 15415 hsa-mir-3660 hsa04310 Wnt signaling pathway 1499_1387_4609_3725_1452_5881_2033 7 7.84E-06 0.000486178 3.74E-05 15416 hsa-mir-3660 hsa04520 Adherens junction 1499_6714_1387_5881_2033 5 4.12E-05 0.002555312 0.000182522 15417 hsa-mir-3660 hsa05210 Colorectal cancer 1499_4609_3725_2353_5881 5 5.14E-05 0.003187577 0.000210485 15418 hsa-mir-3660 hsa05219 Bladder cancer 1019_4609_1026_5925 4 5.43E-05 0.003367755 0.000210485 15419 hsa-mir-3660 hsa04330 Notch signaling pathway 1387_9612_2033_8850 4 8.18E-05 0.00506875 0.000298162 15420 hsa-mir-3660 hsa04660 T cell receptor signaling pathway 1019_1432_5970_3725_2353 5 0.000173229 0.010740178 0.000596677 15421 hsa-mir-3660 hsa04115 p53 signaling pathway 983_1019_1017_1026 4 0.000329979 0.020458711 0.001076774 15422 hsa-mir-3660 hsa05218 Melanoma 2249_1019_1026_5925 4 0.000365951 0.022688943 0.001080426 15423 hsa-mir-3660 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_1432_5970_3725 4 0.000365951 0.022688943 0.001080426 15424 hsa-mir-3660 hsa05216 Thyroid cancer 1499_6256_4609 3 0.000396522 0.024584336 0.00111747 15425 hsa-mir-3660 hsa04662 B cell receptor signaling pathway 5970_3725_2353_5881 4 0.000446171 0.027662604 0.001202722 15426 hsa-mir-3660 hsa04620 Toll-like receptor signaling pathway 1432_5970_3725_2353 4 0.001344096 0.083333936 0.003472247 15427 hsa-mir-3660 hsa04912 GnRH signaling pathway 6714_1432_468_3725 4 0.001646129 0.102060029 0.004082401 15428 hsa-mir-3660 hsa05223 Non-small cell lung cancer 6256_1019_5925 3 0.002155846 0.133662426 0.005140863 15429 hsa-mir-3660 hsa05131 Shigellosis 7534_1499_10971 3 0.002379685 0.147540444 0.005269302 15430 hsa-mir-3660 hsa05130 Pathogenic Escherichia coli infection 7534_1499_10971 3 0.002379685 0.147540444 0.005269302 15431 hsa-mir-3660 hsa05214 Glioma 1019_1026_5925 3 0.003562728 0.220889157 0.007616867 15432 hsa-mir-3660 hsa04920 Adipocytokine signaling pathway 6256_6774_5970 3 0.003866251 0.239707536 0.007990251 15433 hsa-mir-3660 hsa05211 Renal cell carcinoma 1387_3725_2033 3 0.004692478 0.290933609 0.009384955 15434 hsa-mir-3660 hsa04720 Long-term potentiation 1387_468_2033 3 0.005235525 0.324602578 0.010143831 15435 hsa-mir-3660 hsa04370 VEGF signaling pathway 6714_1432_5881 3 0.005617691 0.348296842 0.01055445 15436 hsa-mir-3660 hsa05016 Huntington's disease 1387_6908_2033_6667 4 0.011063273 0.685922907 0.020174203 15437 hsa-mir-3660 hsa04916 Melanogenesis 1499_1387_2033 3 0.012437622 0.77113256 0.021705134 15438 hsa-mir-3660 hsa03410 Base excision repair 3146_142 2 0.012602981 0.781384816 0.021705134 15439 hsa-mir-3660 hsa03022 Basal transcription factors 6908_2959 2 0.013245625 0.821228727 0.022195371 15440 hsa-mir-3660 hsa04510 Focal adhesion 1499_6714_3725_5881 4 0.014934712 0.925952147 0.024367162 15441 hsa-mir-3660 hsa03420 Nucleotide excision repair 5981_4331 2 0.018128474 1 0.028819626 15442 hsa-mir-3660 hsa05213 Endometrial cancer 1499_4609 2 0.024490216 1 0.037959834 15443 hsa-mir-3660 hsa04530 Tight junction 1499_6714_1019 3 0.025227561 1 0.038148994 15444 hsa-mir-3661 hsa05210 Colorectal cancer 4088_4089_5601_3725_5595_5594_5599_2353 8 1.60E-13 7.36E-12 7.36E-12 15445 hsa-mir-3661 hsa05200 Pathways in cancer 4088_4089_5601_4286_3725_5595_5594_5599_2353 9 2.03E-10 9.33E-09 4.66E-09 15446 hsa-mir-3661 hsa04010 MAPK signaling pathway 5601_3725_5595_5594_5599_1649_2353_1386 8 1.28E-09 5.89E-08 1.96E-08 15447 hsa-mir-3661 hsa04620 Toll-like receptor signaling pathway 5601_3725_5595_5594_5599_2353 6 3.35E-09 1.54E-07 3.85E-08 15448 hsa-mir-3661 hsa04310 Wnt signaling pathway 4088_4089_5601_8061_3725_5599 6 3.29E-08 1.51E-06 3.03E-07 15449 hsa-mir-3661 hsa04012 ErbB signaling pathway 5601_3725_5595_5594_5599 5 8.45E-08 3.89E-06 6.48E-07 15450 hsa-mir-3661 hsa04912 GnRH signaling pathway 5601_3725_5595_5594_5599 5 2.37E-07 1.09E-05 1.49E-06 15451 hsa-mir-3661 hsa04660 T cell receptor signaling pathway 5601_3725_5595_5594_2353 5 2.58E-07 1.19E-05 1.49E-06 15452 hsa-mir-3661 hsa04930 Type II diabetes mellitus 5601_5595_5594_5599 4 3.54E-07 1.63E-05 1.81E-06 15453 hsa-mir-3661 hsa05220 Chronic myeloid leukemia 4088_4089_5595_5594 4 2.45E-06 0.000112638 1.02E-05 15454 hsa-mir-3661 hsa04662 B cell receptor signaling pathway 3725_5595_5594_2353 4 2.45E-06 0.000112638 1.02E-05 15455 hsa-mir-3661 hsa04664 Fc epsilon RI signaling pathway 5601_5595_5594_5599 4 2.98E-06 0.000137292 1.11E-05 15456 hsa-mir-3661 hsa04520 Adherens junction 4088_4089_5595_5594 4 3.13E-06 0.000144034 1.11E-05 15457 hsa-mir-3661 hsa04350 TGF-beta signaling pathway 4088_4089_5595_5594 4 4.31E-06 0.000198324 1.42E-05 15458 hsa-mir-3661 hsa04510 Focal adhesion 5601_3725_5595_5594_5599 5 5.15E-06 0.000236966 1.58E-05 15459 hsa-mir-3661 hsa04910 Insulin signaling pathway 5601_5595_5594_5599 4 2.51E-05 0.001153447 7.21E-05 15460 hsa-mir-3661 hsa05218 Melanoma 4286_5595_5594 3 9.67E-05 0.004446973 0.000243603 15461 hsa-mir-3661 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5601_3725_5599 3 9.67E-05 0.004446973 0.000243603 15462 hsa-mir-3661 hsa05211 Renal cell carcinoma 3725_5595_5594 3 0.000100619 0.004628454 0.000243603 15463 hsa-mir-3661 hsa04916 Melanogenesis 4286_5595_5594 3 0.00028808 0.013251671 0.000662584 15464 hsa-mir-3661 hsa05216 Thyroid cancer 5595_5594 2 0.00063541 0.029228881 0.001391851 15465 hsa-mir-3661 hsa05219 Bladder cancer 5595_5594 2 0.00128009 0.058884132 0.002676551 15466 hsa-mir-3661 hsa05213 Endometrial cancer 5595_5594 2 0.001921856 0.088405359 0.003683557 15467 hsa-mir-3661 hsa04150 mTOR signaling pathway 5595_5594 2 0.001921856 0.088405359 0.003683557 15468 hsa-mir-3661 hsa05223 Non-small cell lung cancer 5595_5594 2 0.002065135 0.094996219 0.003799849 15469 hsa-mir-3661 hsa05221 Acute myeloid leukemia 5595_5594 2 0.002444814 0.112461456 0.004325441 15470 hsa-mir-3661 hsa05214 Glioma 5595_5594 2 0.002940524 0.135264095 0.005009781 15471 hsa-mir-3661 hsa04920 Adipocytokine signaling pathway 5601_5599 2 0.003115381 0.143307541 0.005118126 15472 hsa-mir-3661 hsa04730 Long-term depression 5595_5594 2 0.003479392 0.160052023 0.005519035 15473 hsa-mir-3661 hsa04720 Long-term potentiation 5595_5594 2 0.003862313 0.177666388 0.005922213 15474 hsa-mir-3661 hsa04370 VEGF signaling pathway 5595_5594 2 0.004060809 0.1867972 0.006025716 15475 hsa-mir-3661 hsa05215 Prostate cancer 5595_5594 2 0.00523525 0.240821511 0.007456017 15476 hsa-mir-3661 hsa05212 Pancreatic cancer 5595_5594 2 0.005348882 0.246048551 0.007456017 15477 hsa-mir-3661 hsa04540 Gap junction 5595_5594 2 0.005814701 0.267476234 0.007866948 15478 hsa-mir-3661 hsa04270 Vascular smooth muscle contraction 5595_5594 2 0.009125735 0.419783809 0.011847765 15479 hsa-mir-3661 hsa04110 Cell cycle 4088_4089 2 0.009272164 0.426519558 0.011847765 15480 hsa-mir-3661 hsa04360 Axon guidance 5595_5594 2 0.011110669 0.511090772 0.013813264 15481 hsa-mir-3661 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594 2 0.012251355 0.563562341 0.014647281 15482 hsa-mir-3661 hsa04120 Ubiquitin mediated proteolysis 64326_672 2 0.012418347 0.571243944 0.014647281 15483 hsa-mir-3661 hsa05010 Alzheimer's disease 5595_5594 2 0.019483639 0.896247374 0.022406184 15484 hsa-mir-3661 hsa04062 Chemokine signaling pathway 5595_5594 2 0.022858967 1 0.025646645 15485 hsa-mir-3661 hsa04810 Regulation of actin cytoskeleton 5595_5594 2 0.028816167 1 0.031560564 15486 hsa-mir-3661 hsa03022 Basal transcription factors 6908 1 0.044576682 1 0.047686683 15487 hsa-mir-3665 hsa05200 Pathways in cancer 4149_1499_5914_596_598_1017_4193_4436_5578_3091_3065_1050_5925_613_5743_5747_25_6789_1870_1871_2113_861_862_6502_1147_2249_998_367_5595_5594_5599_1387_6256_2932_6777_5970_7157_1869_3725_6776_4087_4088_4089_5888_5728_2033_3910_4792_3320_3326_5371_675_5601_5602_1856_51588_1026_2353_8554 59 8.68E-43 7.46E-41 7.46E-41 15488 hsa-mir-3665 hsa04110 Cell cycle 1017_4193_902_3065_5925_25_1870_1871_9232_6502_5934_5933_545_995_5347_5591_1387_11200_7534_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_1031_983_1026_1022_1111_8556_8555_472 37 1.24E-34 1.07E-32 5.35E-33 15489 hsa-mir-3665 hsa05220 Chronic myeloid leukemia 598_4193_3065_5925_613_25_1870_1871_861_1147_5595_5594_6777_5970_7157_1869_6776_4088_4089_4792_1026 21 2.25E-19 1.93E-17 5.24E-18 15490 hsa-mir-3665 hsa05215 Prostate cancer 1499_596_1017_4193_5925_1870_1871_1147_367_5595_5594_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_1026 22 2.48E-19 2.13E-17 5.24E-18 15491 hsa-mir-3665 hsa05212 Pancreatic cancer 1499_596_1017_4193_5925_1870_1871_1147_367_5595_5594_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_1026 22 3.05E-19 2.62E-17 5.24E-18 15492 hsa-mir-3665 hsa04115 p53 signaling pathway 1017_4194_4193_900_50484_6241_51246_545_7161_11200_7157_64326_5728_27113_25898_983_1026_1111_472 19 1.54E-17 1.32E-15 2.21E-16 15493 hsa-mir-3665 hsa05222 Small cell lung cancer 4149_596_598_1017_5925_5743_5747_1870_1871_6502_1147_6256_5970_7157_1869_5728_3910_4792_51588_8554 20 3.63E-17 3.12E-15 4.46E-16 15494 hsa-mir-3665 hsa04350 TGF-beta signaling pathway 6667_3397_3399_3398_1874_1875_5934_5933_5595_5594_1387_7027_4086_4087_4088_4089_2033_5518_5515_4093 20 4.40E-17 3.79E-15 4.73E-16 15495 hsa-mir-3665 hsa04010 MAPK signaling pathway 6722_4149_7867_5578_5923_3304_3305_3303_6789_1432_1616_1147_2249_998_5595_5594_5599_3315_5970_3164_7157_3725_9261_4208_5601_5602_2353 27 2.62E-14 2.25E-12 2.51E-13 15496 hsa-mir-3665 hsa04310 Wnt signaling pathway 1499_5578_1460_5599_1387_2932_7157_3725_1457_1452_4087_4088_4089_2033_5518_5515_5601_5602_1856_5527 20 5.35E-13 4.60E-11 4.60E-12 15497 hsa-mir-3665 hsa05210 Colorectal cancer 1499_596_4436_5595_5594_5599_2932_7157_3725_4087_4088_4089_5601_5602_1856_2353 16 7.86E-13 6.76E-11 6.14E-12 15498 hsa-mir-3665 hsa05214 Glioma 4193_5578_5925_1870_1871_5595_5594_7157_1869_5728_808_801_805_1026 14 5.05E-12 4.34E-10 3.62E-11 15499 hsa-mir-3665 hsa04012 ErbB signaling pathway 5578_5747_25_5595_5594_5599_2932_6777_3725_6776_5601_5602_1026 13 1.61E-09 1.38E-07 1.06E-08 15500 hsa-mir-3665 hsa05221 Acute myeloid leukemia 5914_1050_861_862_1147_5595_5594_6777_5970_6776_5371 11 3.77E-09 3.24E-07 2.31E-08 15501 hsa-mir-3665 hsa04120 Ubiquitin mediated proteolysis 4193_3093_7319_84447_7329_6502_10055_64326_7337_5371_672_25898_51588_10075_8554 15 5.26E-09 4.52E-07 3.02E-08 15502 hsa-mir-3665 hsa05223 Non-small cell lung cancer 5578_5925_6789_1870_1871_5595_5594_6256_7157_1869 10 2.06E-08 1.77E-06 1.06E-07 15503 hsa-mir-3665 hsa05218 Melanoma 4193_5925_1870_1871_2249_5595_5594_7157_1869_5728_1026 11 2.10E-08 1.80E-06 1.06E-07 15504 hsa-mir-3665 hsa05219 Bladder cancer 4193_5925_1870_1871_5595_5594_7157_1869_1026 9 3.51E-08 3.02E-06 1.68E-07 15505 hsa-mir-3665 hsa04520 Adherens junction 1499_1460_998_5595_5594_1387_1457_4087_4088_4089_2033 11 6.33E-08 5.44E-06 2.86E-07 15506 hsa-mir-3665 hsa04510 Focal adhesion 1499_596_5578_5923_5747_5499_998_5595_5594_5599_2932_3725_5728_3910_5601_5602 16 1.18E-07 1.01E-05 5.06E-07 15507 hsa-mir-3665 hsa04912 GnRH signaling pathway 5578_1432_998_5595_5594_5599_3725_808_801_805_5601_5602 12 1.35E-07 1.16E-05 5.52E-07 15508 hsa-mir-3665 hsa04660 T cell receptor signaling pathway 1432_1147_998_5595_5594_2932_5970_3725_4792_5601_2353_959 12 1.62E-07 1.39E-05 6.32E-07 15509 hsa-mir-3665 hsa04370 VEGF signaling pathway 7867_5578_5743_5747_1432_998_5595_5594_3315_9261 10 4.08E-07 3.51E-05 1.52E-06 15510 hsa-mir-3665 hsa04620 Toll-like receptor signaling pathway 1432_1147_5595_5594_5599_5970_3725_4792_5601_5602_2353 11 5.90E-07 5.07E-05 2.11E-06 15511 hsa-mir-3665 hsa04916 Melanogenesis 1499_5578_5595_5594_1387_2932_2033_808_801_805_1856 11 7.04E-07 6.05E-05 2.42E-06 15512 hsa-mir-3665 hsa04920 Adipocytokine signaling pathway 6794_1147_5599_6256_5970_4792_5601_5602_5563 9 1.21E-06 0.000103633 3.99E-06 15513 hsa-mir-3665 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_1147_998_5599_5970_3725_4792_5601_5602 9 1.87E-06 0.000160556 5.95E-06 15514 hsa-mir-3665 hsa04720 Long-term potentiation 5578_5499_5595_5594_1387_2033_808_801_805 9 2.82E-06 0.000242595 8.37E-06 15515 hsa-mir-3665 hsa04662 B cell receptor signaling pathway 1147_5595_5594_1380_2932_5970_3725_4792_2353 9 2.82E-06 0.000242595 8.37E-06 15516 hsa-mir-3665 hsa03420 Nucleotide excision repair 902_2965_4331_2071_2074_1022_6117 7 6.94E-06 0.000596661 1.99E-05 15517 hsa-mir-3665 hsa04910 Insulin signaling pathway 5499_5595_5594_5599_2932_808_801_805_5601_5602_5563 11 8.92E-06 0.000766881 2.47E-05 15518 hsa-mir-3665 hsa04330 Notch signaling pathway 3065_1387_9612_2033_8850_1856_388585 7 1.02E-05 0.000880283 2.75E-05 15519 hsa-mir-3665 hsa05211 Renal cell carcinoma 3091_2113_998_5595_5594_1387_3725_2033 8 1.69E-05 0.001453553 4.40E-05 15520 hsa-mir-3665 hsa03022 Basal transcription factors 51616_2965_6908_2958_6880_2957 6 2.90E-05 0.002491855 7.33E-05 15521 hsa-mir-3665 hsa04210 Apoptosis 596_598_823_1147_5970_7157_4792_472 8 6.85E-05 0.005891331 0.000168324 15522 hsa-mir-3665 hsa04930 Type II diabetes mellitus 3651_5595_5594_5599_5601_5602 6 7.79E-05 0.006697009 0.000186028 15523 hsa-mir-3665 hsa05216 Thyroid cancer 1499_5595_5594_6256_7157 5 0.000105788 0.009097733 0.000245885 15524 hsa-mir-3665 hsa05213 Endometrial cancer 1499_5595_5594_2932_7157_5728 6 0.000161142 0.0138582 0.000364689 15525 hsa-mir-3665 hsa04664 Fc epsilon RI signaling pathway 5578_1432_5595_5594_5599_5601_5602 7 0.00021141 0.018181281 0.000466187 15526 hsa-mir-3665 hsa04530 Tight junction 1499_5578_1460_998_1457_5728_5518_5515_5520 9 0.000230905 0.019857863 0.000478076 15527 hsa-mir-3665 hsa05131 Shigellosis 1499_5578_25_998_7534_4691 6 0.000233479 0.020079203 0.000478076 15528 hsa-mir-3665 hsa05130 Pathogenic Escherichia coli infection 1499_5578_25_998_7534_4691 6 0.000233479 0.020079203 0.000478076 15529 hsa-mir-3665 hsa04612 Antigen processing and presentation 3309_3304_3305_3303_3320_3326_4800 7 0.000416073 0.035782318 0.000832147 15530 hsa-mir-3665 hsa05016 Huntington's disease 3065_3064_25942_6667_1387_7157_23186_2033_27113_6908 10 0.000521634 0.044860547 0.001019558 15531 hsa-mir-3665 hsa04950 Maturity onset diabetes of the young 6927_3651_3172_168620 4 0.000599632 0.051568386 0.001145964 15532 hsa-mir-3665 hsa04062 Chemokine signaling pathway 5747_6362_1147_998_5595_5594_2932_6777_5970_4792 10 0.000633076 0.054444559 0.001183577 15533 hsa-mir-3665 hsa03440 Homologous recombination 641_5888_675_6117 4 0.001007574 0.086651364 0.001843646 15534 hsa-mir-3665 hsa04150 mTOR signaling pathway 6794_3091_5595_5594_5563 5 0.001222573 0.105141257 0.002190443 15535 hsa-mir-3665 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_1432_1616_7157 5 0.001659489 0.142716067 0.002912573 15536 hsa-mir-3665 hsa04270 Vascular smooth muscle contraction 5578_5499_5595_5594_808_801_805 7 0.001970259 0.169442234 0.003388845 15537 hsa-mir-3665 hsa04630 Jak-STAT signaling pathway 598_3977_1387_6777_6776_2033_51588_8554 8 0.002214397 0.190438165 0.003734082 15538 hsa-mir-3665 hsa03410 Base excision repair 3146_142_4913_328 4 0.002344551 0.201631381 0.003877527 15539 hsa-mir-3665 hsa04360 Axon guidance 5747_25_998_5595_5594_2932_1020 7 0.003431293 0.295091181 0.005567758 15540 hsa-mir-3665 hsa04730 Long-term depression 5578_5595_5594_5518_5515 5 0.004344654 0.373640206 0.006919263 15541 hsa-mir-3665 hsa05010 Alzheimer's disease 823_5595_5594_2932_808_801_805_1020 8 0.004782114 0.411261767 0.007477487 15542 hsa-mir-3665 hsa04070 Phosphatidylinositol signaling system 5578_5728_808_801_805 5 0.005693223 0.489617186 0.008743164 15543 hsa-mir-3665 hsa05217 Basal cell carcinoma 1499_2932_7157_1856 4 0.009483119 0.815548269 0.014307864 15544 hsa-mir-3665 hsa04540 Gap junction 5578_5595_5594_1453_983 5 0.012454679 1 0.018467282 15545 hsa-mir-3665 hsa03030 DNA replication 5557_6117_5422 3 0.017263523 1 0.025163779 15546 hsa-mir-3665 hsa03450 Non-homologous end-joining 2547_5591 2 0.020704225 1 0.029676056 15547 hsa-mir-3665 hsa04670 Leukocyte transendothelial migration 1499_5578_5747_1432_998 5 0.033709631 1 0.047525053 15548 hsa-mir-3665 hsa03430 Mismatch repair 4436_6117 2 0.047665365 1 0.066116475 15549 hsa-mir-3666 hsa05200 Pathways in cancer 3716_3320_1147_5371_1499_5595_5594_5599_1387_862_3326_5601_1488_1487_367_8517_2932_3551_6772_6256_5970_6688_2113_4609_1869_3725_6774_6502_2353_4087_4088_4089_7175_3065_1050_5925_2033_207_4791_4792 40 2.89E-26 2.19E-24 2.19E-24 15550 hsa-mir-3666 hsa04010 MAPK signaling pathway 6722_1147_3727_5595_5594_5599_9261_1326_4208_5601_5600_5603_3303_5566_8517_9252_7867_3310_3312_1386_3551_1649_5971_5970_468_4609_3725_2353_3305_5058_1432_207_8550_4791 34 7.00E-23 5.32E-21 2.66E-21 15551 hsa-mir-3666 hsa05215 Prostate cancer 3320_1147_1499_5595_5594_1387_3326_367_8517_2932_3551_5970_468_9586_1869_10488_5925_2033_207_4792 20 2.03E-18 1.54E-16 4.67E-17 15552 hsa-mir-3666 hsa05212 Pancreatic cancer 3320_1147_1499_5595_5594_1387_3326_367_8517_2932_3551_5970_468_9586_1869_10488_5925_2033_207_4792 20 2.46E-18 1.87E-16 4.67E-17 15553 hsa-mir-3666 hsa04310 Wnt signaling pathway 23291_1499_5599_1387_8607_5601_1488_5566_1487_2932_8454_8061_4609_3725_1457_1459_6500_4087_4088_4089_2033_8945 22 1.90E-16 1.44E-14 2.89E-15 15554 hsa-mir-3666 hsa04620 Toll-like receptor signaling pathway 1147_5595_5594_5599_1326_5601_5600_5603_8517_3551_6772_5970_3454_3455_3725_2353_1432_207_4792 19 3.66E-16 2.78E-14 4.63E-15 15555 hsa-mir-3666 hsa04660 T cell receptor signaling pathway 1147_5595_5594_1326_5601_5600_5603_8517_2932_3551_5970_4794_3725_2353_5058_1432_207_4792_4793 19 1.25E-15 9.49E-14 1.36E-14 15556 hsa-mir-3666 hsa05220 Chronic myeloid leukemia 1147_5595_5594_1488_1487_8517_3551_5970_4609_1869_4088_4089_3065_5925_207_4792 16 1.27E-14 9.68E-13 1.21E-13 15557 hsa-mir-3666 hsa04920 Adipocytokine signaling pathway 3717_1147_5599_5601_8517_3551_6256_5970_4794_6774_207_4792_4793_2538 14 7.51E-13 5.71E-11 6.35E-12 15558 hsa-mir-3666 hsa05221 Acute myeloid leukemia 1147_5371_5595_5594_862_8517_3551_5970_6688_4609_6774_1050_207 13 2.79E-12 2.12E-10 2.12E-11 15559 hsa-mir-3666 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_6714_5599_5601_5600_5603_8517_3551_5970_3725_5058_1432_4792 13 2.17E-11 1.65E-09 1.50E-10 15560 hsa-mir-3666 hsa04662 B cell receptor signaling pathway 1147_5595_5594_8517_2932_3551_5970_4794_3725_2353_207_4792_4793 13 3.98E-11 3.03E-09 2.52E-10 15561 hsa-mir-3666 hsa04110 Cell cycle 7534_5591_1387_7532_2932_8454_1869_6502_6500_4087_4088_4089_3065_5925_2033 15 7.35E-11 5.59E-09 4.30E-10 15562 hsa-mir-3666 hsa05210 Colorectal cancer 1499_5595_5594_5599_5601_2932_4609_3725_2353_4087_4088_4089_207 13 1.40E-10 1.07E-08 7.62E-10 15563 hsa-mir-3666 hsa04350 TGF-beta signaling pathway 5595_5594_1387_3397_3399_3398_8454_4609_6500_4087_4088_4089_2033 13 2.07E-10 1.58E-08 1.05E-09 15564 hsa-mir-3666 hsa04912 GnRH signaling pathway 6714_5595_5594_5599_5601_5600_5603_5566_468_3725_1432_808_801_805 14 2.27E-10 1.73E-08 1.08E-09 15565 hsa-mir-3666 hsa04062 Chemokine signaling pathway 3717_1147_5595_5594_5566_8517_2932_3551_6772_5970_7852_653361_6774_5058_207_4792_4793 17 6.79E-10 5.16E-08 3.04E-09 15566 hsa-mir-3666 hsa04520 Adherens junction 1499_6714_5595_5594_1387_1457_1459_4087_4088_4089_2033_71 12 9.98E-10 7.58E-08 4.21E-09 15567 hsa-mir-3666 hsa04630 Jak-STAT signaling pathway 3717_3716_3559_1387_6778_6772_3454_3455_7297_4609_6774_2033_207_10379 14 1.65E-08 1.25E-06 6.59E-08 15568 hsa-mir-3666 hsa04330 Notch signaling pathway 388585_1387_4851_1488_1487_9612_3065_2033_8850 9 1.95E-08 1.48E-06 7.39E-08 15569 hsa-mir-3666 hsa05222 Small cell lung cancer 1147_8517_3551_6256_5970_4609_1869_6502_5925_207_4792 11 2.24E-08 1.70E-06 8.11E-08 15570 hsa-mir-3666 hsa04916 Melanogenesis 1499_5595_5594_1387_5566_2932_10488_2033_808_801_805 11 1.33E-07 1.01E-05 4.58E-07 15571 hsa-mir-3666 hsa04012 ErbB signaling pathway 6714_5595_5594_5599_5601_2932_4609_3725_5058_207 10 2.45E-07 1.86E-05 8.08E-07 15572 hsa-mir-3666 hsa04910 Insulin signaling pathway 5595_5594_5599_5601_5566_2932_3551_207_2538_808_801_805 12 2.56E-07 1.95E-05 8.12E-07 15573 hsa-mir-3666 hsa04612 Antigen processing and presentation 3320_3326_3309_3303_4800_4802_3310_3312_3305_4801 10 2.97E-07 2.25E-05 9.02E-07 15574 hsa-mir-3666 hsa04720 Long-term potentiation 5595_5594_1387_5566_468_2033_808_801_805 9 7.06E-07 5.37E-05 2.06E-06 15575 hsa-mir-3666 hsa04370 VEGF signaling pathway 6714_5595_5594_9261_5600_5603_7867_1432_207 9 8.64E-07 6.57E-05 2.35E-06 15576 hsa-mir-3666 hsa05131 Shigellosis 7534_1499_7278_347733_10382_84617_203068_71 8 8.98E-07 6.82E-05 2.35E-06 15577 hsa-mir-3666 hsa05130 Pathogenic Escherichia coli infection 7534_1499_7278_347733_10382_84617_203068_71 8 8.98E-07 6.82E-05 2.35E-06 15578 hsa-mir-3666 hsa04120 Ubiquitin mediated proteolysis 5371_23291_672_3093_8454_10273_7329_6502_6500_7323_8945 11 1.92E-06 0.000145828 4.86E-06 15579 hsa-mir-3666 hsa05214 Glioma 5595_5594_1869_5925_207_808_801_805 8 2.49E-06 0.000188865 6.09E-06 15580 hsa-mir-3666 hsa03020 RNA polymerase 64425_5437_25885_51082_84172_5441 6 3.24E-06 0.000246038 7.46E-06 15581 hsa-mir-3666 hsa05216 Thyroid cancer 1499_5595_5594_6256_4609_7175 6 3.24E-06 0.000246038 7.46E-06 15582 hsa-mir-3666 hsa04540 Gap junction 6714_5595_5594_5566_7278_347733_10382_84617_203068 9 3.64E-06 0.000277008 8.15E-06 15583 hsa-mir-3666 hsa05211 Renal cell carcinoma 5595_5594_1387_2113_3725_5058_2033_207 8 4.99E-06 0.00037899 1.08E-05 15584 hsa-mir-3666 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5601_5600_5603_1432_207 8 9.35E-06 0.000710947 1.97E-05 15585 hsa-mir-3666 hsa04510 Focal adhesion 1499_6714_5595_5594_5599_5601_2932_10627_3725_5058_207_71 12 1.28E-05 0.000973796 2.63E-05 15586 hsa-mir-3666 hsa04210 Apoptosis 1147_5566_8517_3551_5970_8837_207_4792 8 2.09E-05 0.001586791 4.18E-05 15587 hsa-mir-3666 hsa05219 Bladder cancer 5595_5594_9252_4609_1869_5925 6 2.15E-05 0.001633786 4.19E-05 15588 hsa-mir-3666 hsa05016 Huntington's disease 6874_1387_292_293_1213_5437_9586_3065_10488_2033_5441 11 2.82E-05 0.002145909 5.36E-05 15589 hsa-mir-3666 hsa04930 Type II diabetes mellitus 3651_5595_5594_5599_5601_3551 6 3.06E-05 0.002327106 5.68E-05 15590 hsa-mir-3666 hsa05213 Endometrial cancer 1499_5595_5594_2932_4609_207 6 6.42E-05 0.004878053 0.00011518 15591 hsa-mir-3666 hsa04530 Tight junction 1499_6714_4627_4628_10627_1457_1459_207_71 9 6.52E-05 0.00495275 0.00011518 15592 hsa-mir-3666 hsa05223 Non-small cell lung cancer 5595_5594_6256_1869_5925_207 6 7.78E-05 0.005914834 0.000134428 15593 hsa-mir-3666 hsa04670 Leukocyte transendothelial migration 1499_5600_5603_7852_653361_10627_1432_71 8 0.000167374 0.012720391 0.000282675 15594 hsa-mir-3666 hsa04950 Maturity onset diabetes of the young 3651_168620_3172_4760 4 0.000317851 0.024156702 0.000525146 15595 hsa-mir-3666 hsa04270 Vascular smooth muscle contraction 5595_5594_5566_4637_808_801_805 7 0.000749644 0.056972955 0.001212191 15596 hsa-mir-3666 hsa04340 Hedgehog signaling pathway 23291_53944_5566_2932_8945 5 0.000847945 0.064443792 0.001342579 15597 hsa-mir-3666 hsa03022 Basal transcription factors 2963_2969_6874_6883 4 0.001392744 0.105848522 0.002160174 15598 hsa-mir-3666 hsa05218 Melanoma 5595_5594_1869_5925_207 5 0.002115753 0.160797214 0.003215944 15599 hsa-mir-3666 hsa04810 Regulation of actin cytoskeleton 5595_5594_4627_4628_10788_10627_5058_71 8 0.005946497 0.451933782 0.008861447 15600 hsa-mir-3666 hsa05010 Alzheimer's disease 5595_5594_2932_808_22926_801_805 7 0.006582609 0.500278268 0.009620736 15601 hsa-mir-3666 hsa03010 Ribosome 6156_6128_6207_6202_6189 5 0.009052894 0.688019968 0.012981509 15602 hsa-mir-3666 hsa04360 Axon guidance 5595_5594_2932_7852_5058 5 0.023294731 1 0.032785177 15603 hsa-mir-3666 hsa04020 Calcium signaling pathway 292_293_5566_808_801_805 6 0.026256683 1 0.036281962 15604 hsa-mir-3666 hsa04150 mTOR signaling pathway 5595_5594_207 3 0.02755757 1 0.037399559 15605 hsa-mir-3666 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_3454_3455_5058 5 0.02813533 1 0.037513774 15606 hsa-mir-3666 hsa05014 Amyotrophic lateral sclerosis (ALS) 5600_5603_1432 3 0.032996618 1 0.043236948 15607 hsa-mir-3668 hsa03022 Basal transcription factors 2967_2961_2960_2963_6881_54457_2968_6879_6877_6874_2957_6878_6908_6872_2958_6873_6884_2959_6882_6883_6880_138474 22 3.19E-29 2.30E-27 2.30E-27 15608 hsa-mir-3668 hsa04110 Cell cycle 7534_1387_595_896_1019_1017_7532_2932_4193_7027_4085_4171_7157_4087_1026_6502_4088_4089_5925_2033_894_5933 22 5.18E-20 3.73E-18 1.86E-18 15609 hsa-mir-3668 hsa05200 Pathways in cancer 1499_5595_5594_1387_862_595_836_1019_367_1017_2932_4193_10401_6256_5970_7157_4087_6688_4609_3725_1026_6502_2353_4088_4089_5925_2033_207_3326_8554_7184 31 9.14E-20 6.58E-18 2.19E-18 15610 hsa-mir-3668 hsa05215 Prostate cancer 1499_5595_5594_1387_595_367_1017_2932_4193_5970_7157_468_1026_5925_2033_207_3326_7184 18 2.79E-17 2.01E-15 4.78E-16 15611 hsa-mir-3668 hsa05212 Pancreatic cancer 1499_5595_5594_1387_595_367_1017_2932_4193_5970_7157_468_1026_5925_2033_207_3326_7184 18 3.32E-17 2.39E-15 4.78E-16 15612 hsa-mir-3668 hsa05210 Colorectal cancer 1499_5595_5594_595_836_2932_7157_4087_4609_3725_2353_4088_4089_207 14 1.19E-12 8.55E-11 1.43E-11 15613 hsa-mir-3668 hsa04350 TGF-beta signaling pathway 5595_5594_1387_7027_3397_3399_3398_1874_4087_4609_4088_4089_2033_5933 14 1.82E-12 1.31E-10 1.87E-11 15614 hsa-mir-3668 hsa04010 MAPK signaling pathway 6722_3727_5595_5594_5598_1386_9261_4208_836_7867_3312_1432_1649_5970_7157_468_4609_3725_2353_5058_207 21 2.95E-12 2.13E-10 2.66E-11 15615 hsa-mir-3668 hsa05220 Chronic myeloid leukemia 5595_5594_595_1019_4193_5970_7157_4609_1026_4088_4089_5925_207 13 4.94E-12 3.56E-10 3.95E-11 15616 hsa-mir-3668 hsa05214 Glioma 5595_5594_595_1019_4193_7157_1026_5925_207_808_801_805 12 1.72E-11 1.24E-09 1.24E-10 15617 hsa-mir-3668 hsa04310 Wnt signaling pathway 1460_1499_1387_595_8607_896_2932_7157_4087_4609_3725_4088_4089_2033_894 15 1.66E-10 1.19E-08 1.09E-09 15618 hsa-mir-3668 hsa05222 Small cell lung cancer 595_1019_1017_10401_6256_5970_7157_4609_6502_5925_207_8554 12 3.15E-10 2.27E-08 1.89E-09 15619 hsa-mir-3668 hsa05219 Bladder cancer 5595_5594_595_1019_4193_7157_4609_1026_5925 9 1.92E-09 1.38E-07 1.06E-08 15620 hsa-mir-3668 hsa04520 Adherens junction 1460_1499_6714_5595_5594_1387_4087_4088_4089_2033 10 2.51E-08 1.81E-06 1.29E-07 15621 hsa-mir-3668 hsa05216 Thyroid cancer 1499_5595_5594_595_6256_7157_4609 7 6.21E-08 4.47E-06 2.98E-07 15622 hsa-mir-3668 hsa04115 p53 signaling pathway 595_836_896_1019_1017_4193_7157_1026_894 9 9.09E-08 6.55E-06 4.09E-07 15623 hsa-mir-3668 hsa05218 Melanoma 5595_5594_595_1019_4193_7157_1026_5925_207 9 1.14E-07 8.18E-06 4.81E-07 15624 hsa-mir-3668 hsa05213 Endometrial cancer 1499_5595_5594_595_2932_7157_4609_207 8 1.52E-07 1.10E-05 6.09E-07 15625 hsa-mir-3668 hsa05223 Non-small cell lung cancer 5595_5594_595_1019_6256_7157_5925_207 8 1.98E-07 1.42E-05 7.49E-07 15626 hsa-mir-3668 hsa04912 GnRH signaling pathway 6714_5595_5594_5598_1432_468_3725_808_801_805 10 3.34E-07 2.40E-05 1.20E-06 15627 hsa-mir-3668 hsa05221 Acute myeloid leukemia 5595_5594_862_595_5970_6688_4609_207 8 3.65E-07 2.63E-05 1.25E-06 15628 hsa-mir-3668 hsa04660 T cell receptor signaling pathway 5595_5594_1019_2932_1432_5970_3725_2353_5058_207 10 3.91E-07 2.81E-05 1.28E-06 15629 hsa-mir-3668 hsa04012 ErbB signaling pathway 6714_5595_5594_2932_4609_3725_1026_5058_207 9 5.52E-07 3.98E-05 1.73E-06 15630 hsa-mir-3668 hsa04720 Long-term potentiation 5595_5594_1387_468_2033_808_801_805 8 1.92E-06 0.0001384 5.77E-06 15631 hsa-mir-3668 hsa04916 Melanogenesis 1499_5595_5594_1387_2932_2033_808_801_805 9 2.19E-06 0.000157765 6.31E-06 15632 hsa-mir-3668 hsa04950 Maturity onset diabetes of the young 3651_5080_168620_6927_3172 5 9.58E-06 0.00068989 2.65E-05 15633 hsa-mir-3668 hsa04510 Focal adhesion 1499_6714_5595_5594_595_896_2932_3725_5058_894_207 11 1.35E-05 0.000973024 3.60E-05 15634 hsa-mir-3668 hsa05211 Renal cell carcinoma 5595_5594_1387_3725_5058_2033_207 7 1.49E-05 0.001073894 3.84E-05 15635 hsa-mir-3668 hsa04910 Insulin signaling pathway 5595_5594_2932_5211_2538_207_808_801_805 9 1.88E-05 0.001351278 4.58E-05 15636 hsa-mir-3668 hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_3725_2353_207 7 1.91E-05 0.001372797 4.58E-05 15637 hsa-mir-3668 hsa04370 VEGF signaling pathway 6714_5595_5594_9261_7867_1432_207 7 2.23E-05 0.001607841 5.19E-05 15638 hsa-mir-3668 hsa05016 Huntington's disease 6874_25942_1387_6908_836_9001_5430_7157_3064_2033 10 3.43E-05 0.002472996 7.73E-05 15639 hsa-mir-3668 hsa04630 Jak-STAT signaling pathway 1387_595_896_10401_4609_2033_894_207_8554 9 4.45E-05 0.003203338 9.71E-05 15640 hsa-mir-3668 hsa05010 Alzheimer's disease 1020_5595_5594_836_2932_840_808_801_805 9 0.000117176 0.008436681 0.000244211 15641 hsa-mir-3668 hsa04620 Toll-like receptor signaling pathway 5595_5594_1432_5970_3725_2353_207 7 0.000118714 0.008547389 0.000244211 15642 hsa-mir-3668 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_836_1432_5970_3725_5058 6 0.000126528 0.009110027 0.000253056 15643 hsa-mir-3668 hsa04330 Notch signaling pathway 388585_1387_9612_2033_8850 5 0.000173676 0.012504645 0.000337963 15644 hsa-mir-3668 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 0.000190206 0.013694834 0.00036039 15645 hsa-mir-3668 hsa03420 Nucleotide excision repair 2967_2968_5981_5887 4 0.001365032 0.098282329 0.00252006 15646 hsa-mir-3668 hsa04210 Apoptosis 836_840_5970_7157_207 5 0.002606776 0.187687845 0.004692196 15647 hsa-mir-3668 hsa04540 Gap junction 6714_5595_5594_5598_10382 5 0.003122444 0.224815965 0.005483316 15648 hsa-mir-3668 hsa04920 Adipocytokine signaling pathway 6256_5970_2538_207 4 0.005695447 0.410072168 0.009763623 15649 hsa-mir-3668 hsa04270 Vascular smooth muscle contraction 5595_5594_808_801_805 5 0.008122515 0.584821073 0.01360049 15650 hsa-mir-3668 hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432_207 4 0.009813529 0.706574105 0.016058502 15651 hsa-mir-3668 hsa04360 Axon guidance 1020_5595_5594_2932_5058 5 0.012191767 0.877807245 0.019400409 15652 hsa-mir-3668 hsa04930 Type II diabetes mellitus 3651_5595_5594 3 0.012394706 0.892418802 0.019400409 15653 hsa-mir-3668 hsa04612 Antigen processing and presentation 4800_3312_4801_3326 4 0.014432301 1 0.021699784 15654 hsa-mir-3668 hsa04530 Tight junction 1460_1499_6714_1019_207 5 0.014466523 1 0.021699784 15655 hsa-mir-3668 hsa04120 Ubiquitin mediated proteolysis 4193_10401_7329_6502_8554 5 0.015283882 1 0.022384425 15656 hsa-mir-3668 hsa04062 Chemokine signaling pathway 5595_5594_2932_5970_5058_207 6 0.01554474 1 0.022384425 15657 hsa-mir-3668 hsa04150 mTOR signaling pathway 5595_5594_207 3 0.017864053 1 0.02521984 15658 hsa-mir-3668 hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.020556692 1 0.028146776 15659 hsa-mir-3668 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432_7157 3 0.021501009 1 0.028146776 15660 hsa-mir-3668 hsa05131 Shigellosis 7534_1499_10382 3 0.021501009 1 0.028146776 15661 hsa-mir-3668 hsa05130 Pathogenic Escherichia coli infection 7534_1499_10382 3 0.021501009 1 0.028146776 15662 hsa-mir-3668 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.045259651 1 0.058190979 15663 hsa-mir-3671 hsa05200 Pathways in cancer 3320_1050_5594_5599_367_4193_7704_1387_6774_6776_6777_5970_7157_2113_5894_3725_2353_4088_4790_4791 20 1.61E-19 1.09E-17 1.09E-17 15664 hsa-mir-3671 hsa05215 Prostate cancer 3320_5594_1385_367_4193_1387_5970_7157_5894_4790 10 8.33E-13 5.66E-11 1.84E-11 15665 hsa-mir-3671 hsa05212 Pancreatic cancer 3320_5594_1385_367_4193_1387_5970_7157_5894_4790 10 9.24E-13 6.28E-11 1.84E-11 15666 hsa-mir-3671 hsa05221 Acute myeloid leukemia 1050_5594_7704_6774_6776_6777_5970_5894_4790 9 1.08E-12 7.35E-11 1.84E-11 15667 hsa-mir-3671 hsa05220 Chronic myeloid leukemia 5594_4193_6776_6777_5970_7157_5894_4088_4790 9 7.74E-12 5.26E-10 1.05E-10 15668 hsa-mir-3671 hsa04010 MAPK signaling pathway 5594_5599_3303_5566_5970_7157_5894_3725_2353_5536_4790_4791 12 1.44E-10 9.78E-09 1.63E-09 15669 hsa-mir-3671 hsa04660 T cell receptor signaling pathway 3932_5594_920_915_5970_5894_3725_2353_4790 9 1.85E-10 1.26E-08 1.80E-09 15670 hsa-mir-3671 hsa04916 Melanogenesis 5594_1385_5566_1387_5894_808_801_805 8 3.13E-09 2.13E-07 2.66E-08 15671 hsa-mir-3671 hsa05214 Glioma 5594_4193_7157_5894_808_801_805 7 3.60E-09 2.45E-07 2.72E-08 15672 hsa-mir-3671 hsa04912 GnRH signaling pathway 5594_5599_5566_5894_3725_808_801_805 8 4.14E-09 2.82E-07 2.82E-08 15673 hsa-mir-3671 hsa04720 Long-term potentiation 5594_5566_1387_5894_808_801_805 7 9.05E-09 6.15E-07 5.59E-08 15674 hsa-mir-3671 hsa05210 Colorectal cancer 5594_5599_7157_5894_3725_2353_4088 7 1.88E-08 1.28E-06 1.07E-07 15675 hsa-mir-3671 hsa04910 Insulin signaling pathway 10891_5594_5599_5566_5894_808_801_805 8 2.54E-08 1.73E-06 1.33E-07 15676 hsa-mir-3671 hsa04110 Cell cycle 5591_7533_4193_1387_7157_2810_4088 7 1.79E-07 1.22E-05 8.70E-07 15677 hsa-mir-3671 hsa04662 B cell receptor signaling pathway 5594_5970_5894_3725_2353_4790 6 2.56E-07 1.74E-05 1.16E-06 15678 hsa-mir-3671 hsa04012 ErbB signaling pathway 5594_5599_6776_6777_5894_3725 6 5.83E-07 3.96E-05 2.48E-06 15679 hsa-mir-3671 hsa04620 Toll-like receptor signaling pathway 5594_5599_5970_3725_2353_4790 6 1.41E-06 9.57E-05 5.63E-06 15680 hsa-mir-3671 hsa04270 Vascular smooth muscle contraction 5594_5566_5894_808_801_805 6 3.15E-06 0.000214197 1.19E-05 15681 hsa-mir-3671 hsa05016 Huntington's disease 10891_1385_291_6908_5481_1387_7157 7 3.38E-06 0.000229709 1.21E-05 15682 hsa-mir-3671 hsa04920 Adipocytokine signaling pathway 10891_5599_6774_5970_4790 5 3.70E-06 0.000251283 1.26E-05 15683 hsa-mir-3671 hsa04062 Chemokine signaling pathway 5594_5566_6774_6777_5970_5894_4790 7 3.99E-06 0.000271436 1.29E-05 15684 hsa-mir-3671 hsa05211 Renal cell carcinoma 5594_1387_2113_5894_3725 5 5.15E-06 0.000350361 1.59E-05 15685 hsa-mir-3671 hsa05340 Primary immunodeficiency 3932_920_915_100 4 7.65E-06 0.000519949 2.26E-05 15686 hsa-mir-3671 hsa04310 Wnt signaling pathway 5599_5566_1387_7157_3725_4088 6 1.27E-05 0.000862292 3.59E-05 15687 hsa-mir-3671 hsa04612 Antigen processing and presentation 3320_811_920_1385_3303 5 1.37E-05 0.00093221 3.73E-05 15688 hsa-mir-3671 hsa05219 Bladder cancer 5594_4193_7157_5894 4 1.49E-05 0.001013902 3.90E-05 15689 hsa-mir-3671 hsa04020 Calcium signaling pathway 291_5566_5481_808_801_805 6 3.59E-05 0.002440207 9.04E-05 15690 hsa-mir-3671 hsa05218 Melanoma 5594_4193_7157_5894 4 0.000103396 0.007030917 0.000242445 15691 hsa-mir-3671 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5970_3725_4790 4 0.000103396 0.007030917 0.000242445 15692 hsa-mir-3671 hsa04630 Jak-STAT signaling pathway 1387_3460_6774_6776_6777 5 0.00017331 0.011785048 0.000392835 15693 hsa-mir-3671 hsa04210 Apoptosis 5566_5970_7157_4790 4 0.000237618 0.016158014 0.000521226 15694 hsa-mir-3671 hsa05010 Alzheimer's disease 3416_5594_808_801_805 5 0.000314588 0.021391968 0.000668499 15695 hsa-mir-3671 hsa05213 Endometrial cancer 5594_7157_5894 3 0.000753932 0.051267387 0.001553557 15696 hsa-mir-3671 hsa05223 Non-small cell lung cancer 5594_7157_5894 3 0.000836956 0.056912995 0.001673912 15697 hsa-mir-3671 hsa04650 Natural killer cell mediated cytotoxicity 3932_5594_3460_5894 4 0.001171578 0.079667296 0.002276208 15698 hsa-mir-3671 hsa04115 p53 signaling pathway 4193_7157_2810 3 0.001647445 0.112026282 0.003111841 15699 hsa-mir-3671 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.002149181 0.146144317 0.003949846 15700 hsa-mir-3671 hsa04664 Fc epsilon RI signaling pathway 5594_5599_5894 3 0.00239015 0.162530214 0.004277111 15701 hsa-mir-3671 hsa04520 Adherens junction 5594_1387_4088 3 0.002474033 0.168234245 0.004313699 15702 hsa-mir-3671 hsa05222 Small cell lung cancer 5970_7157_4790 3 0.00301562 0.205062141 0.005126554 15703 hsa-mir-3671 hsa04350 TGF-beta signaling pathway 5594_1387_4088 3 0.003112383 0.211642033 0.005162001 15704 hsa-mir-3671 hsa04540 Gap junction 5594_5566_5894 3 0.003733039 0.253846679 0.006043969 15705 hsa-mir-3671 hsa05216 Thyroid cancer 5594_7157 2 0.004498013 0.305864879 0.007113137 15706 hsa-mir-3671 hsa04510 Focal adhesion 5594_5599_5894_3725 4 0.004813281 0.327303127 0.007438707 15707 hsa-mir-3671 hsa04930 Type II diabetes mellitus 5594_5599 2 0.01011309 0.687690117 0.015282003 15708 hsa-mir-3671 hsa05012 Parkinson's disease 7314_291_5481 3 0.010361759 0.704599609 0.015317383 15709 hsa-mir-3671 hsa04330 Notch signaling pathway 1387_9612 2 0.010956096 0.745014526 0.015851373 15710 hsa-mir-3671 hsa04730 Long-term depression 5594_5894 2 0.023293146 1 0.032998624 15711 hsa-mir-3671 hsa04370 VEGF signaling pathway 5594_5894 2 0.026971399 1 0.037429697 15712 hsa-mir-3671 hsa04640 Hematopoietic cell lineage 920_915 2 0.033580542 1 0.045669537 15713 hsa-mir-3671 hsa04740 Olfactory transduction 5566_808_801_805 4 0.03758689 1 0.050115854 15714 hsa-mir-3671 hsa03450 Non-homologous end-joining 5591 1 0.047278873 1 0.061826218 15715 hsa-mir-3677 hsa04350 TGF-beta signaling pathway 6667_1387_5595_5594_3399 5 1.46E-09 6.55E-08 6.55E-08 15716 hsa-mir-3677 hsa05215 Prostate cancer 1387_5595_5594_2932 4 1.91E-07 8.58E-06 2.99E-06 15717 hsa-mir-3677 hsa05212 Pancreatic cancer 1387_5595_5594_2932 4 1.99E-07 8.97E-06 2.99E-06 15718 hsa-mir-3677 hsa04916 Melanogenesis 1387_5595_5594_2932 4 3.64E-07 1.64E-05 4.09E-06 15719 hsa-mir-3677 hsa04910 Insulin signaling pathway 5595_5594_2932_23265 4 1.09E-06 4.90E-05 9.80E-06 15720 hsa-mir-3677 hsa05213 Endometrial cancer 5595_5594_2932 3 3.89E-06 0.000174901 2.92E-05 15721 hsa-mir-3677 hsa05211 Renal cell carcinoma 1387_5595_5594 3 9.93E-06 0.00044703 5.59E-05 15722 hsa-mir-3677 hsa04720 Long-term potentiation 1387_5595_5594 3 1.12E-05 0.000503111 5.59E-05 15723 hsa-mir-3677 hsa04662 B cell receptor signaling pathway 5595_5594_2932 3 1.12E-05 0.000503111 5.59E-05 15724 hsa-mir-3677 hsa04520 Adherens junction 1387_5595_5594 3 1.35E-05 0.000606571 6.07E-05 15725 hsa-mir-3677 hsa05210 Colorectal cancer 5595_5594_2932 3 1.55E-05 0.000698769 6.35E-05 15726 hsa-mir-3677 hsa04012 ErbB signaling pathway 5595_5594_2932 3 1.72E-05 0.00077367 6.45E-05 15727 hsa-mir-3677 hsa05200 Pathways in cancer 1387_5595_5594_2932 4 3.27E-05 0.00147198 0.000109254 15728 hsa-mir-3677 hsa04660 T cell receptor signaling pathway 5595_5594_2932 3 3.40E-05 0.001529551 0.000109254 15729 hsa-mir-3677 hsa04360 Axon guidance 5595_5594_2932 3 5.65E-05 0.002542627 0.000169508 15730 hsa-mir-3677 hsa05010 Alzheimer's disease 5595_5594_2932 3 0.000135548 0.006099643 0.000368018 15731 hsa-mir-3677 hsa05216 Thyroid cancer 5595_5594 2 0.000139029 0.006256313 0.000368018 15732 hsa-mir-3677 hsa04062 Chemokine signaling pathway 5595_5594_2932 3 0.000174263 0.007841852 0.000435658 15733 hsa-mir-3677 hsa04510 Focal adhesion 5595_5594_2932 3 0.000210531 0.009473916 0.000498627 15734 hsa-mir-3677 hsa05219 Bladder cancer 5595_5594 2 0.00028162 0.012672913 0.000633646 15735 hsa-mir-3677 hsa04930 Type II diabetes mellitus 5595_5594 2 0.000321488 0.014466956 0.000688903 15736 hsa-mir-3677 hsa04150 mTOR signaling pathway 5595_5594 2 0.000424587 0.019106402 0.000868473 15737 hsa-mir-3677 hsa05223 Non-small cell lung cancer 5595_5594 2 0.000456624 0.02054806 0.000893394 15738 hsa-mir-3677 hsa05221 Acute myeloid leukemia 5595_5594 2 0.000541709 0.024376889 0.001015704 15739 hsa-mir-3677 hsa05214 Glioma 5595_5594 2 0.000653185 0.029393313 0.001175733 15740 hsa-mir-3677 hsa05218 Melanoma 5595_5594 2 0.000774828 0.034867262 0.00129138 15741 hsa-mir-3677 hsa04730 Long-term depression 5595_5594 2 0.000774828 0.034867262 0.00129138 15742 hsa-mir-3677 hsa05220 Chronic myeloid leukemia 5595_5594 2 0.000861541 0.038769362 0.00138462 15743 hsa-mir-3677 hsa04370 VEGF signaling pathway 5595_5594 2 0.000906576 0.040795942 0.001406757 15744 hsa-mir-3677 hsa04664 Fc epsilon RI signaling pathway 5595_5594 2 0.000952728 0.042872739 0.001429091 15745 hsa-mir-3677 hsa04540 Gap junction 5595_5594 2 0.001306839 0.058807753 0.001897024 15746 hsa-mir-3677 hsa04620 Toll-like receptor signaling pathway 5595_5594 2 0.001562935 0.070332068 0.002197877 15747 hsa-mir-3677 hsa04912 GnRH signaling pathway 5595_5594 2 0.001745914 0.07856611 0.002380791 15748 hsa-mir-3677 hsa04270 Vascular smooth muscle contraction 5595_5594 2 0.002072466 0.09326096 0.002708481 15749 hsa-mir-3677 hsa04110 Cell cycle 1387_2932 2 0.002106596 0.094796841 0.002708481 15750 hsa-mir-3677 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594 2 0.002805524 0.126248575 0.003460069 15751 hsa-mir-3677 hsa04120 Ubiquitin mediated proteolysis 55294_7329 2 0.002844945 0.128022535 0.003460069 15752 hsa-mir-3677 hsa04310 Wnt signaling pathway 1387_2932 2 0.003381133 0.152150991 0.004003973 15753 hsa-mir-3677 hsa05016 Huntington's disease 6667_1387 2 0.005091795 0.229130791 0.005875148 15754 hsa-mir-3677 hsa04810 Regulation of actin cytoskeleton 5595_5594 2 0.006823388 0.307052456 0.007676311 15755 hsa-mir-3677 hsa04010 MAPK signaling pathway 5595_5594 2 0.01038693 0.467411838 0.011400289 15756 hsa-mir-3677 hsa04330 Notch signaling pathway 1387 1 0.026846659 1 0.028764278 15757 hsa-mir-3677 hsa05217 Basal cell carcinoma 2932 1 0.031254607 1 0.03270831 15758 hsa-mir-3677 hsa04340 Hedgehog signaling pathway 2932 1 0.032353654 1 0.033088964 15759 hsa-mir-3678 hsa04010 MAPK signaling pathway 6722_3727_4149_6195_6197_4214_9252_7867_3551_9020_4616_8986_1956_6654_3305_3303_9344_1432_627_2885_5894_1616_2872_207_208_1147_994_5595_5594_5599_5598_1386_8517_3310_3312_1649_5971_5970_7157_10912_468_3725_6196_5881_5058_4790_9261_1326_5604_4208_5606_5601_5600_2353_2005_5566 56 1.15E-34 8.97E-33 8.37E-33 15760 hsa-mir-3678 hsa05200 Pathways in cancer 4149_1499_5914_595_4193_7704_3551_6502_1050_5925_7187_10342_405_9063_1956_6654_2308_8503_2885_2113_10401_5894_861_862_6776_207_208_1147_5595_5594_5599_1387_2064_6256_8517_367_2932_6774_5970_7157_3725_2736_4087_4088_4089_5295_5881_2033_4790_4792_3320_3326_5371_3480_5604_5601_4292_1029_2353_8554 60 2.15E-34 1.67E-32 8.37E-33 15761 hsa-mir-3678 hsa05215 Prostate cancer 1499_595_4193_3551_5925_1956_6654_2308_8503_2885_5894_207_208_1147_5595_5594_1387_2064_8517_367_2932_5970_7157_468_5295_2033_4790_4792_3320_3326_3480_5604 32 1.01E-26 7.85E-25 2.62E-25 15762 hsa-mir-3678 hsa05212 Pancreatic cancer 1499_595_4193_3551_5925_1956_6654_2308_8503_2885_5894_207_208_1147_5595_5594_1387_2064_8517_367_2932_5970_7157_468_5295_2033_4790_4792_3320_3326_3480_5604 32 1.34E-26 1.05E-24 2.62E-25 15763 hsa-mir-3678 hsa04660 T cell receptor signaling pathway 5777_3551_9020_3932_6654_1432_8503_4794_2885_5894_207_208_1147_5595_5594_56924_8517_2932_5970_3725_5295_5058_4790_4792_4793_1326_5604_5601_5600_2353 30 4.06E-22 3.17E-20 6.34E-21 15764 hsa-mir-3678 hsa05220 Chronic myeloid leukemia 595_4193_3551_5925_6654_8503_2885_5894_861_6776_207_208_1147_5595_5594_8517_5970_7157_4088_4089_5295_4790_4792_5604_1029_6464 26 1.59E-21 1.24E-19 2.07E-20 15765 hsa-mir-3678 hsa05221 Acute myeloid leukemia 5914_595_7704_3551_1050_6654_8503_2885_5894_861_862_6776_207_208_1147_5595_5594_8517_6774_5970_5295_4790_5371_5604 24 2.72E-21 2.12E-19 3.03E-20 15766 hsa-mir-3678 hsa05210 Colorectal cancer 1499_595_1956_6654_8503_2885_5894_207_208_5595_5594_5599_2932_7157_3725_4087_4088_4089_5295_5881_3480_5604_5601_4292_2353 25 2.03E-19 1.59E-17 1.98E-18 15767 hsa-mir-3678 hsa04662 B cell receptor signaling pathway 5777_3551_6654_8503_4794_2885_5894_207_208_1147_5595_5594_8517_2932_5970_3725_5295_5881_4790_4792_4793_5604_2353 23 3.26E-18 2.54E-16 2.83E-17 15768 hsa-mir-3678 hsa05214 Glioma 595_4193_5925_1956_6654_8503_2885_5894_207_208_5595_5594_7157_5295_808_801_805_3480_5604_1029_6464 21 3.96E-17 3.09E-15 3.09E-16 15769 hsa-mir-3678 hsa04910 Insulin signaling pathway 6720_10891_5770_3551_6654_2308_8503_2885_5894_5211_2872_207_208_5595_5594_5599_7249_2932_2194_5295_808_801_805_5604_5601_6464_5566 27 7.18E-17 5.60E-15 5.09E-16 15770 hsa-mir-3678 hsa04620 Toll-like receptor signaling pathway 3551_7187_1432_8503_207_208_1147_5595_5594_5599_8517_5970_3725_5295_4790_4792_1326_5604_5606_5601_5600_9641_2353 23 1.00E-15 7.84E-14 6.53E-15 15771 hsa-mir-3678 hsa04540 Gap junction 10382_51807_203068_1956_6714_6654_2885_5894_5592_5595_5594_5598_7846_347733_2770_983_5604_7277_7278_84617_10376_5566 22 1.80E-15 1.40E-13 1.08E-14 15772 hsa-mir-3678 hsa04110 Cell cycle 595_4193_902_6502_6500_5925_4616_5933_994_990_5591_1387_7533_2932_7157_10912_4087_4088_4089_2033_983_8454_1022_1029 24 2.11E-15 1.64E-13 1.17E-14 15773 hsa-mir-3678 hsa05213 Endometrial cancer 1499_595_1956_6654_2309_8503_2885_5894_207_208_5595_5594_2064_2932_7157_5295_5604_4292 18 2.63E-15 2.05E-13 1.37E-14 15774 hsa-mir-3678 hsa05223 Non-small cell lung cancer 595_5925_1956_6654_2309_8503_2885_5894_207_208_5595_5594_2064_6256_7157_5295_5604_1029 18 4.53E-15 3.53E-13 2.21E-14 15775 hsa-mir-3678 hsa04012 ErbB signaling pathway 1956_6714_6654_8503_2885_5894_6776_207_208_5595_5594_5599_56924_2064_2932_3725_5295_5058_5604_5601_6464 21 5.58E-15 4.35E-13 2.56E-14 15776 hsa-mir-3678 hsa03010 Ribosome 6156_6204_6205_6207_6202_6141_6217_6210_6130_6137_6135_6191_6193_6222_6223_6229_6129_6128_6181_6189_6188_6232 22 9.38E-15 7.31E-13 4.06E-14 15777 hsa-mir-3678 hsa04520 Adherens junction 1499_5770_5777_1956_6714_71_1460_5595_5594_1387_2064_1457_1459_4087_4088_4089_5881_2033_3480_8826 20 1.40E-14 1.09E-12 5.76E-14 15778 hsa-mir-3678 hsa04310 Wnt signaling pathway 1499_595_6500_23291_8607_1460_5599_1387_2932_7157_8061_3725_1457_1459_4087_4088_4089_5881_2033_5519_5518_5601_8454_8945_5566 25 3.41E-14 2.66E-12 1.33E-13 15779 hsa-mir-3678 hsa05222 Small cell lung cancer 4149_595_3551_6502_5925_7187_9063_8503_10401_207_208_1147_6256_8517_5970_7157_5295_4790_4792_8554 20 4.54E-14 3.54E-12 1.69E-13 15780 hsa-mir-3678 hsa04510 Focal adhesion 1499_595_857_9564_1956_6714_6654_8503_2885_5894_207_208_71_5595_5594_5599_56924_2064_2932_3725_5295_5881_5058_3480_5604_5601_85366_6464 28 7.09E-14 5.53E-12 2.51E-13 15781 hsa-mir-3678 hsa04912 GnRH signaling pathway 4214_1956_6714_6654_1432_2885_5894_5595_5594_5599_5598_468_3725_808_801_805_5604_5606_5601_5600_5566 21 2.23E-13 1.74E-11 7.58E-13 15782 hsa-mir-3678 hsa04062 Chemokine signaling pathway 3551_7074_9564_6654_2309_8503_2885_5894_207_208_1147_5595_5594_8517_2932_6774_5970_5295_5058_4790_4792_4793_2770_5604_6464_5566 26 6.69E-13 5.22E-11 2.17E-12 15783 hsa-mir-3678 hsa05211 Renal cell carcinoma 405_6654_8503_2885_2113_5894_207_208_5595_5594_56924_1387_3725_5295_5058_2033_5604 17 2.97E-12 2.31E-10 9.25E-12 15784 hsa-mir-3678 hsa03050 Proteasome 5708_5709_5705_5706_5700_5693_5719_5713_5710_5684_5717_5687_5698_5707 14 2.27E-11 1.77E-09 6.81E-11 15785 hsa-mir-3678 hsa04350 TGF-beta signaling pathway 6667_6500_3397_3399_3398_5933_3400_5595_5594_1387_4087_4088_4089_2033_5519_5518_8454 17 4.05E-11 3.16E-09 1.17E-10 15786 hsa-mir-3678 hsa04664 Fc epsilon RI signaling pathway 6654_1432_8503_2885_5894_207_208_5595_5594_5599_5295_5881_5604_5606_5601_5600 16 9.52E-11 7.43E-09 2.65E-10 15787 hsa-mir-3678 hsa04920 Adipocytokine signaling pathway 10891_3551_4794_207_208_1147_5599_6256_8517_6774_5970_4790_4792_4793_5601 15 1.08E-10 8.46E-09 2.92E-10 15788 hsa-mir-3678 hsa05218 Melanoma 595_4193_5925_1956_8503_5894_207_208_5595_5594_7157_5295_3480_5604_1029 15 2.20E-10 1.71E-08 5.53E-10 15789 hsa-mir-3678 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3551_9020_1956_6714_1432_1147_5599_8517_5970_3725_5058_4790_4792_5601_5600 15 2.20E-10 1.71E-08 5.53E-10 15790 hsa-mir-3678 hsa05219 Bladder cancer 595_9252_4193_5925_1956_5894_5595_5594_2064_7157_5604_1029 12 7.51E-10 5.86E-08 1.83E-09 15791 hsa-mir-3678 hsa04720 Long-term potentiation 6195_6197_5894_5595_5594_1387_468_6196_2033_808_801_805_5604_5566 14 3.59E-09 2.80E-07 8.48E-09 15792 hsa-mir-3678 hsa04370 VEGF signaling pathway 7867_6714_1432_8503_5894_207_208_5595_5594_5295_5881_9261_5604_5600 14 4.84E-09 3.77E-07 1.11E-08 15793 hsa-mir-3678 hsa05131 Shigellosis 1499_10382_51807_203068_71_7846_347733_7277_7278_84617_4691_10376 12 1.23E-08 9.59E-07 2.66E-08 15794 hsa-mir-3678 hsa05130 Pathogenic Escherichia coli infection 1499_10382_51807_203068_71_7846_347733_7277_7278_84617_4691_10376 12 1.23E-08 9.59E-07 2.66E-08 15795 hsa-mir-3678 hsa04210 Apoptosis 3551_9020_8503_207_208_1147_8517_5970_7157_9131_5295_4790_4792_5566 14 2.49E-08 1.94E-06 5.25E-08 15796 hsa-mir-3678 hsa03022 Basal transcription factors 2959_2965_2963_2962_2969_6874_6908_6883_6881 9 3.30E-07 2.57E-05 6.78E-07 15797 hsa-mir-3678 hsa04150 mTOR signaling pathway 6195_6197_8503_207_208_5595_5594_7249_6196_5295 10 4.90E-07 3.82E-05 9.80E-07 15798 hsa-mir-3678 hsa04810 Regulation of actin cytoskeleton 7074_9564_1956_6654_4627_4628_8503_5894_71_5595_5594_56924_5295_5881_5058_5604_10788_8826_85366 19 5.33E-07 4.16E-05 1.04E-06 15799 hsa-mir-3678 hsa05216 Thyroid cancer 1499_595_10342_5595_5594_6256_7157_5604 8 6.67E-07 5.20E-05 1.27E-06 15800 hsa-mir-3678 hsa04120 Ubiquitin mediated proteolysis 55294_4214_4193_6502_6500_7329_23291_9063_10401_10273_5371_672_8454_8945_8554 15 6.91E-07 5.39E-05 1.28E-06 15801 hsa-mir-3678 hsa04916 Melanogenesis 1499_5894_5595_5594_1387_2932_2033_808_801_805_2770_5604_5566 13 8.52E-07 6.64E-05 1.54E-06 15802 hsa-mir-3678 hsa04630 Jak-STAT signaling pathway 595_5777_9063_6654_8503_2885_10401_6776_207_208_1387_6774_5295_2033_8554 15 2.42E-06 0.000188415 4.28E-06 15803 hsa-mir-3678 hsa04530 Tight junction 1499_6714_4627_4628_207_208_71_1460_60412_1457_1459_5519_5518_2770 14 2.91E-06 0.000227067 5.05E-06 15804 hsa-mir-3678 hsa04930 Type II diabetes mellitus 3551_8503_3651_5595_5594_5599_5295_5601 8 1.15E-05 0.000895938 1.95E-05 15805 hsa-mir-3678 hsa04650 Natural killer cell mediated cytotoxicity 5777_3932_6654_8503_2885_5894_5595_5594_5295_5881_5058_5604_6464 13 1.46E-05 0.001142467 2.43E-05 15806 hsa-mir-3678 hsa04950 Maturity onset diabetes of the young 6928_4760_3651_168620_5080_3172 6 2.78E-05 0.002170942 4.52E-05 15807 hsa-mir-3678 hsa04115 p53 signaling pathway 595_4193_4616_7249_7157_10912_983_7161_1029 9 3.06E-05 0.002385163 4.87E-05 15808 hsa-mir-3678 hsa04612 Antigen processing and presentation 6890_3309_3305_3303_3310_3312_3320_3326_4802_4801 10 3.61E-05 0.002815763 5.63E-05 15809 hsa-mir-3678 hsa04730 Long-term depression 5894_5592_5595_5594_3480_5519_5518_2770_5604 9 3.75E-05 0.002925349 5.74E-05 15810 hsa-mir-3678 hsa03020 RNA polymerase 64425_25885_51082_5437_84172_5441 6 6.98E-05 0.005441568 0.000104646 15811 hsa-mir-3678 hsa05016 Huntington's disease 6667_10891_3064_627_10476_1387_5437_7157_2033_6874_6908_5441_1213 13 0.000273912 0.021365164 0.000403116 15812 hsa-mir-3678 hsa04270 Vascular smooth muscle contraction 5894_5592_5595_5594_808_801_805_5604_85366_5566 10 0.000310315 0.024204589 0.000448233 15813 hsa-mir-3678 hsa04330 Notch signaling pathway 388585_1387_9612_2033_8850_2648 6 0.00072312 0.05640336 0.001025516 15814 hsa-mir-3678 hsa04670 Leukocyte transendothelial migration 1499_9564_1432_8503_71_5295_2770_5600 8 0.005365586 0.418515674 0.007473494 15815 hsa-mir-3678 hsa04360 Axon guidance 5998_5595_5594_56924_2932_5881_5058_2770 8 0.007942513 0.619515998 0.010868702 15816 hsa-mir-3678 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_1616_7157_5606_5600 5 0.008151387 0.635808174 0.01096221 15817 hsa-mir-3678 hsa04340 Hedgehog signaling pathway 23291_2932_2736_8945_5566 5 0.00872089 0.680229401 0.011529312 15818 hsa-mir-3678 hsa03420 Nucleotide excision repair 902_2965_4331_1022 4 0.016542953 1 0.021505839 15819 hsa-mir-3678 hsa04070 Phosphatidylinositol signaling system 8503_5295_808_801_805 5 0.025261345 1 0.032301392 15820 hsa-mir-3678 hsa05217 Basal cell carcinoma 1499_2932_7157_2736 4 0.032522026 1 0.040914807 15821 hsa-mir-3678 hsa03450 Non-homologous end-joining 7520_5591 2 0.041423231 1 0.051285905 15822 hsa-mir-3678 hsa05340 Primary immunodeficiency 6890_3932_8517 3 0.042269159 1 0.051515538 15823 hsa-mir-3678 hsa03410 Base excision repair 4350_142_6996 3 0.045119042 1 0.05414285 15824 hsa-mir-3685 hsa05200 Pathways in cancer 3716_4088_4089_2033_4792_367_2113_207_2932_1499_4790_5970_1387 13 4.39E-16 2.33E-14 2.33E-14 15825 hsa-mir-3685 hsa05215 Prostate cancer 2033_4792_367_207_2932_1499_4790_5970_1387 9 6.57E-15 3.48E-13 1.28E-13 15826 hsa-mir-3685 hsa05212 Pancreatic cancer 2033_4792_367_207_2932_1499_4790_5970_1387 9 7.22E-15 3.83E-13 1.28E-13 15827 hsa-mir-3685 hsa04520 Adherens junction 4088_4089_2033_1499_6714_5777_1387 7 2.30E-11 1.22E-09 3.05E-10 15828 hsa-mir-3685 hsa04660 T cell receptor signaling pathway 5058_4792_207_2932_4790_5777_5970 7 1.90E-10 1.01E-08 1.98E-09 15829 hsa-mir-3685 hsa04062 Chemokine signaling pathway 5590_5058_4792_207_2932_4790_5970_6773 8 2.24E-10 1.19E-08 1.98E-09 15830 hsa-mir-3685 hsa04110 Cell cycle 4088_4089_2033_7532_2932_7534_1387 7 3.21E-10 1.70E-08 2.43E-09 15831 hsa-mir-3685 hsa05220 Chronic myeloid leukemia 4088_4089_4792_207_4790_5970 6 1.14E-09 6.02E-08 6.69E-09 15832 hsa-mir-3685 hsa04662 B cell receptor signaling pathway 4792_207_2932_4790_5777_5970 6 1.14E-09 6.02E-08 6.69E-09 15833 hsa-mir-3685 hsa04630 Jak-STAT signaling pathway 3716_2033_207_5777_3566_6773_1387 7 1.87E-09 9.91E-08 9.91E-09 15834 hsa-mir-3685 hsa04920 Adipocytokine signaling pathway 4792_207_4790_5970_2538 5 4.23E-08 2.24E-06 2.04E-07 15835 hsa-mir-3685 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5058_4792_6714_4790_5970 5 5.57E-08 2.95E-06 2.41E-07 15836 hsa-mir-3685 hsa05211 Renal cell carcinoma 5058_2033_2113_207_1387 5 5.95E-08 3.15E-06 2.41E-07 15837 hsa-mir-3685 hsa04310 Wnt signaling pathway 4088_4089_2033_2932_1499_1387 6 6.37E-08 3.38E-06 2.41E-07 15838 hsa-mir-3685 hsa05210 Colorectal cancer 4088_4089_207_2932_1499 5 1.24E-07 6.55E-06 4.36E-07 15839 hsa-mir-3685 hsa05222 Small cell lung cancer 4792_207_4790_5970 4 6.34E-06 0.000335959 1.95E-05 15840 hsa-mir-3685 hsa04350 TGF-beta signaling pathway 4088_4089_2033_1387 4 6.62E-06 0.000351068 1.95E-05 15841 hsa-mir-3685 hsa04012 ErbB signaling pathway 5058_207_2932_6714 4 6.62E-06 0.000351068 1.95E-05 15842 hsa-mir-3685 hsa04210 Apoptosis 4792_207_4790_5970 4 7.22E-06 0.000382787 2.01E-05 15843 hsa-mir-3685 hsa04510 Focal adhesion 5058_207_2932_1499_6714 5 8.78E-06 0.000465491 2.33E-05 15844 hsa-mir-3685 hsa04620 Toll-like receptor signaling pathway 4792_207_4790_5970 4 1.21E-05 0.000643219 3.06E-05 15845 hsa-mir-3685 hsa04916 Melanogenesis 2033_2932_1499_1387 4 1.31E-05 0.00069257 3.15E-05 15846 hsa-mir-3685 hsa04530 Tight junction 5590_207_1499_6714 4 3.73E-05 0.001975491 8.46E-05 15847 hsa-mir-3685 hsa04910 Insulin signaling pathway 5590_207_2932_2538 4 3.83E-05 0.002030806 8.46E-05 15848 hsa-mir-3685 hsa05213 Endometrial cancer 207_2932_1499 3 5.47E-05 0.002898372 0.000115935 15849 hsa-mir-3685 hsa05221 Acute myeloid leukemia 207_4790_5970 3 7.83E-05 0.004151357 0.000159668 15850 hsa-mir-3685 hsa04010 MAPK signaling pathway 5058_207_4790_5970 4 0.000497883 0.026387782 0.000977325 15851 hsa-mir-3685 hsa04330 Notch signaling pathway 2033_1387 2 0.001954144 0.103569615 0.003698915 15852 hsa-mir-3685 hsa05217 Basal cell carcinoma 2932_1499 2 0.002634284 0.139617076 0.004660709 15853 hsa-mir-3685 hsa05131 Shigellosis 7534_1499 2 0.002726075 0.14448199 0.004660709 15854 hsa-mir-3685 hsa05130 Pathogenic Escherichia coli infection 7534_1499 2 0.002726075 0.14448199 0.004660709 15855 hsa-mir-3685 hsa04340 Hedgehog signaling pathway 2932_53944 2 0.002819358 0.14942598 0.004669562 15856 hsa-mir-3685 hsa04720 Long-term potentiation 2033_1387 2 0.00474913 0.251703898 0.007627391 15857 hsa-mir-3685 hsa04370 VEGF signaling pathway 207_6714 2 0.004992328 0.264593384 0.007782158 15858 hsa-mir-3685 hsa04360 Axon guidance 5058_2932 2 0.013595276 0.720549626 0.020587132 15859 hsa-mir-3685 hsa04650 Natural killer cell mediated cytotoxicity 5058_5777 2 0.014981961 0.794043922 0.022056776 15860 hsa-mir-3685 hsa05322 Systemic lupus erythematosus 333932_126961 2 0.016217116 0.859507158 0.023229923 15861 hsa-mir-3685 hsa05016 Huntington's disease 2033_1387 2 0.026519588 1 0.036987847 15862 hsa-mir-3685 hsa04950 Maturity onset diabetes of the young 3172 1 0.032775311 1 0.044540807 15863 hsa-mir-3685 hsa05216 Thyroid cancer 1499 1 0.039203525 1 0.051944671 15864 hsa-mir-3686 hsa04310 Wnt signaling pathway 4087_4088_1487_2033_1488 5 7.66E-11 1.15E-09 1.15E-09 15865 hsa-mir-3686 hsa05200 Pathways in cancer 4087_4088_1487_2033_1488 5 3.58E-09 5.36E-08 2.68E-08 15866 hsa-mir-3686 hsa04330 Notch signaling pathway 1487_2033_1488 3 1.52E-07 2.27E-06 7.58E-07 15867 hsa-mir-3686 hsa05220 Chronic myeloid leukemia 4088_1487_1488 3 5.87E-07 8.80E-06 2.13E-06 15868 hsa-mir-3686 hsa04520 Adherens junction 4087_4088_2033 3 7.09E-07 1.06E-05 2.13E-06 15869 hsa-mir-3686 hsa04350 TGF-beta signaling pathway 4087_4088_2033 3 9.05E-07 1.36E-05 2.26E-06 15870 hsa-mir-3686 hsa04110 Cell cycle 4087_4088_2033 3 2.27E-06 3.40E-05 4.86E-06 15871 hsa-mir-3686 hsa05210 Colorectal cancer 4087_4088 2 0.000168908 0.002533625 0.000316703 15872 hsa-mir-3686 hsa05211 Renal cell carcinoma 2033 1 0.016907255 0.253608829 0.026011491 15873 hsa-mir-3686 hsa04720 Long-term potentiation 2033 1 0.017596799 0.263951989 0.026011491 15874 hsa-mir-3686 hsa05215 Prostate cancer 2033 1 0.020580035 0.308700524 0.026011491 15875 hsa-mir-3686 hsa05212 Pancreatic cancer 2033 1 0.020809193 0.31213789 0.026011491 15876 hsa-mir-3686 hsa04916 Melanogenesis 2033 1 0.024241047 0.363615709 0.027970439 15877 hsa-mir-3686 hsa04630 Jak-STAT signaling pathway 2033 1 0.035832353 0.53748529 0.038391806 15878 hsa-mir-3686 hsa05016 Huntington's disease 2033 1 0.043269546 0.649043197 0.043269546 15879 hsa-mir-369 hsa04310 Wnt signaling pathway 1488_4087_4088_1487_2033_5518_3725 7 6.18E-11 1.73E-09 1.73E-09 15880 hsa-mir-369 hsa05200 Pathways in cancer 1488_4087_4088_1487_2033_3725 6 3.71E-07 1.04E-05 5.19E-06 15881 hsa-mir-369 hsa04350 TGF-beta signaling pathway 4087_4088_2033_5518 4 1.12E-06 3.14E-05 1.05E-05 15882 hsa-mir-369 hsa04330 Notch signaling pathway 1488_1487_2033 3 1.10E-05 0.000307866 7.70E-05 15883 hsa-mir-369 hsa05220 Chronic myeloid leukemia 1488_4088_1487 3 4.20E-05 0.001175898 0.000232844 15884 hsa-mir-369 hsa04520 Adherens junction 4087_4088_2033 3 5.06E-05 0.001416122 0.000232844 15885 hsa-mir-369 hsa05210 Colorectal cancer 4087_4088_3725 3 5.82E-05 0.001629907 0.000232844 15886 hsa-mir-369 hsa04110 Cell cycle 4087_4088_2033 3 0.000158917 0.004449667 0.000556208 15887 hsa-mir-369 hsa04010 MAPK signaling pathway 468_3725_3727 3 0.001708014 0.047824395 0.005159849 15888 hsa-mir-369 hsa05211 Renal cell carcinoma 2033_3725 2 0.001874193 0.0524774 0.005159849 15889 hsa-mir-369 hsa04720 Long-term potentiation 2033_468 2 0.002027084 0.05675834 0.005159849 15890 hsa-mir-369 hsa05215 Prostate cancer 2033_468 2 0.002755501 0.077154041 0.006065074 15891 hsa-mir-369 hsa05212 Pancreatic cancer 2033_468 2 0.002815927 0.078845957 0.006065074 15892 hsa-mir-369 hsa04912 GnRH signaling pathway 468_3725 2 0.004081092 0.114270588 0.008162185 15893 hsa-mir-369 hsa05010 Alzheimer's disease 9451_823 2 0.010455711 0.292759904 0.019517327 15894 hsa-mir-3691 hsa05220 Chronic myeloid leukemia 4089_3066_1870_1871_25_7157_4193_4609_1029 9 1.33E-15 5.06E-14 5.06E-14 15895 hsa-mir-3691 hsa04110 Cell cycle 4089_3066_1870_1871_25_7157_2033_4193_1029 9 6.62E-14 2.52E-12 1.26E-12 15896 hsa-mir-3691 hsa05200 Pathways in cancer 4089_3066_1870_1871_25_7157_2033_4193_4609_1029 10 1.52E-11 5.79E-10 1.93E-10 15897 hsa-mir-3691 hsa05219 Bladder cancer 1870_1871_7157_4193_4609_1029 6 3.77E-11 1.43E-09 3.58E-10 15898 hsa-mir-3691 hsa04350 TGF-beta signaling pathway 4086_4089_6667_2033_4093_4609 6 2.25E-09 8.54E-08 1.39E-08 15899 hsa-mir-3691 hsa05215 Prostate cancer 1870_1871_7157_2033_4193_1385 6 2.40E-09 9.11E-08 1.39E-08 15900 hsa-mir-3691 hsa05212 Pancreatic cancer 1870_1871_7157_2033_4193_1385 6 2.56E-09 9.71E-08 1.39E-08 15901 hsa-mir-3691 hsa05214 Glioma 1870_1871_7157_4193_1029 5 3.22E-08 1.22E-06 1.53E-07 15902 hsa-mir-3691 hsa05218 Melanoma 1870_1871_7157_4193_1029 5 4.88E-08 1.86E-06 2.06E-07 15903 hsa-mir-3691 hsa05223 Non-small cell lung cancer 1870_1871_7157_1029 4 9.78E-07 3.72E-05 3.72E-06 15904 hsa-mir-3691 hsa05016 Huntington's disease 3066_7157_6667_2033_1385 5 5.01E-06 0.000190449 1.73E-05 15905 hsa-mir-3691 hsa05222 Small cell lung cancer 1870_1871_7157_4609 4 5.72E-06 0.000217313 1.81E-05 15906 hsa-mir-3691 hsa04330 Notch signaling pathway 3066_2033_4851 3 3.80E-05 0.001444554 0.00011112 15907 hsa-mir-3691 hsa04310 Wnt signaling pathway 4089_7157_2033_4609 4 5.00E-05 0.001898558 0.000135611 15908 hsa-mir-3691 hsa04115 p53 signaling pathway 7157_4193_1029 3 0.000113411 0.004309626 0.000287308 15909 hsa-mir-3691 hsa05210 Colorectal cancer 4089_7157_4609 3 0.000198866 0.007556904 0.000472307 15910 hsa-mir-3691 hsa05216 Thyroid cancer 7157_4609 2 0.000745777 0.028339525 0.001667031 15911 hsa-mir-3691 hsa05213 Endometrial cancer 7157_4609 2 0.002252242 0.085585212 0.004754734 15912 hsa-mir-3691 hsa04520 Adherens junction 4089_2033 2 0.005108644 0.194128489 0.010217289 15913 hsa-mir-3691 hsa04010 MAPK signaling pathway 7157_4609_1386 3 0.005492376 0.208710283 0.010435514 15914 hsa-mir-3691 hsa04012 ErbB signaling pathway 25_4609 2 0.005989607 0.227605051 0.010838336 15915 hsa-mir-3691 hsa04916 Melanogenesis 2033_1385 2 0.008394617 0.318995449 0.014499793 15916 hsa-mir-3691 hsa04120 Ubiquitin mediated proteolysis 4193_672 2 0.014470556 0.549881128 0.023907875 15917 hsa-mir-3691 hsa04630 Jak-STAT signaling pathway 2033_4609 2 0.017722313 0.673447881 0.028060328 15918 hsa-mir-3691 hsa03410 Base excision repair 3146 1 0.046959242 1 0.070443395 15919 hsa-mir-3691 hsa03022 Basal transcription factors 2969 1 0.048198112 1 0.070443395 15920 hsa-mir-3692 hsa05200 Pathways in cancer 1487_9915_5371_5925_2034_2033_3091_2113_861_1387 10 5.96E-09 1.55E-07 1.55E-07 15921 hsa-mir-3692 hsa05211 Renal cell carcinoma 9915_2034_2033_3091_2113_1387 6 2.64E-08 6.86E-07 3.43E-07 15922 hsa-mir-3692 hsa04350 TGF-beta signaling pathway 2033_4093_3399_3398_1387 5 2.31E-06 6.01E-05 2.00E-05 15923 hsa-mir-3692 hsa04330 Notch signaling pathway 9612_1487_2033_1387 4 5.85E-06 0.000152065 3.80E-05 15924 hsa-mir-3692 hsa04310 Wnt signaling pathway 1487_2033_1457_1387 4 0.000463629 0.012054359 0.002410872 15925 hsa-mir-3692 hsa05220 Chronic myeloid leukemia 1487_5925_861 3 0.000777795 0.02022266 0.003370443 15926 hsa-mir-3692 hsa04520 Adherens junction 2033_1457_1387 3 0.000931727 0.024224892 0.003460699 15927 hsa-mir-3692 hsa05215 Prostate cancer 5925_2033_1387 3 0.00121591 0.03161367 0.0036251 15928 hsa-mir-3692 hsa05212 Pancreatic cancer 5925_2033_1387 3 0.001254842 0.032625903 0.0036251 15929 hsa-mir-3692 hsa04110 Cell cycle 5925_2033_1387 3 0.002809101 0.073036627 0.007303663 15930 hsa-mir-3692 hsa03022 Basal transcription factors 2963_6908 2 0.003640266 0.094646919 0.008604265 15931 hsa-mir-3692 hsa05221 Acute myeloid leukemia 5371_861 2 0.008703052 0.22627934 0.018856612 15932 hsa-mir-3692 hsa05016 Huntington's disease 2033_6908_1387 3 0.00972243 0.252783191 0.019444861 15933 hsa-mir-3692 hsa04720 Long-term potentiation 2033_1387 2 0.013591793 0.353386605 0.0252419 15934 hsa-mir-3692 hsa04916 Melanogenesis 2033_1387 2 0.024775233 0.644156061 0.042943737 15935 hsa-mir-3692 hsa04120 Ubiquitin mediated proteolysis 5371_7329 2 0.041756581 1 0.067854444 15936 hsa-mir-3713 hsa05215 Prostate cancer 10488_367 2 0.000132411 0.001456518 0.000744558 15937 hsa-mir-3713 hsa05212 Pancreatic cancer 10488_367 2 0.000135374 0.001489116 0.000744558 15938 hsa-mir-3713 hsa05200 Pathways in cancer 4088_367 2 0.001799018 0.019789195 0.006596398 15939 hsa-mir-3713 hsa05220 Chronic myeloid leukemia 4088 1 0.015102307 0.166125379 0.027451936 15940 hsa-mir-3713 hsa04520 Adherens junction 4088 1 0.016089179 0.176980964 0.027451936 15941 hsa-mir-3713 hsa05210 Colorectal cancer 4088 1 0.016878082 0.185658904 0.027451936 15942 hsa-mir-3713 hsa04350 TGF-beta signaling pathway 4088 1 0.017469414 0.192163553 0.027451936 15943 hsa-mir-3713 hsa04916 Melanogenesis 10488 1 0.020814698 0.22896168 0.02862021 15944 hsa-mir-3713 hsa04110 Cell cycle 4088 1 0.023758532 0.261343853 0.029038206 15945 hsa-mir-3713 hsa04310 Wnt signaling pathway 4088 1 0.030209014 0.332299149 0.033229915 15946 hsa-mir-3713 hsa05016 Huntington's disease 10488 1 0.037205355 0.409258907 0.037205355 15947 hsa-mir-3714 hsa05200 Pathways in cancer 4149_7046_5914_596_598_1017_4193_5578_3091_3065_1050_5925_613_5743_5747_25_6789_4436_1870_1871_2113_861_1147_2249_998_367_5595_5594_5599_1387_6256_2932_6777_6772_5970_7157_1869_3725_6776_4087_4088_4089_5888_5728_2033_3910_4792_3320_3326_5371_675_5601_5602_1856_51588_1026_2353_8554 58 1.07E-41 9.07E-40 9.07E-40 15948 hsa-mir-3714 hsa04110 Cell cycle 1017_4193_902_3065_5925_25_1870_1871_9232_5934_5933_545_995_5347_5591_1387_11200_7534_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_1031_983_1026_1022_1111_8556_8555_472 36 2.29E-33 1.94E-31 9.72E-32 15949 hsa-mir-3714 hsa05220 Chronic myeloid leukemia 7046_598_4193_3065_5925_613_25_1870_1871_861_1147_5595_5594_6777_5970_7157_1869_6776_4088_4089_4792_1026 22 1.32E-20 1.13E-18 3.75E-19 15950 hsa-mir-3714 hsa05215 Prostate cancer 596_1017_4193_5925_1870_1871_1147_367_5595_5594_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_1026_90993 22 2.48E-19 2.10E-17 5.18E-18 15951 hsa-mir-3714 hsa05212 Pancreatic cancer 596_1017_4193_5925_1870_1871_1147_367_5595_5594_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_1026_90993 22 3.05E-19 2.59E-17 5.18E-18 15952 hsa-mir-3714 hsa04115 p53 signaling pathway 1017_4194_4193_900_50484_6241_51246_545_7161_11200_7157_64326_5728_27113_25898_983_1026_1111_472 19 1.54E-17 1.31E-15 2.18E-16 15953 hsa-mir-3714 hsa05222 Small cell lung cancer 4149_596_598_1017_5925_5743_5747_1870_1871_1147_6256_5970_7157_1869_5728_3910_4792_51588_8554 19 5.10E-16 4.34E-14 6.19E-15 15954 hsa-mir-3714 hsa04350 TGF-beta signaling pathway 7046_1875_6667_3399_3398_1874_5934_5933_5595_5594_1387_7027_4087_4088_4089_2033_5518_5515 18 8.18E-15 6.95E-13 8.69E-14 15955 hsa-mir-3714 hsa04310 Wnt signaling pathway 5578_1460_5599_1387_2932_7157_8061_3725_1457_1452_4087_4088_4089_2033_5518_5515_5601_5602_1856_5527 20 5.35E-13 4.55E-11 5.05E-12 15956 hsa-mir-3714 hsa05210 Colorectal cancer 7046_596_4436_5595_5594_5599_2932_7157_3725_4087_4088_4089_5601_5602_1856_2353 16 7.86E-13 6.68E-11 6.68E-12 15957 hsa-mir-3714 hsa04010 MAPK signaling pathway 4149_7046_5578_5923_3304_3305_3303_6789_1616_1147_2249_998_5595_5594_5599_1386_1649_3315_5970_3164_7157_3725_5601_5602_2353 25 1.17E-12 9.94E-11 9.04E-12 15958 hsa-mir-3714 hsa04120 Ubiquitin mediated proteolysis 4193_3093_4734_7319_84447_7329_11059_10055_64326_7337_5371_672_25898_51588_10075_8554 16 6.88E-10 5.85E-08 4.87E-09 15959 hsa-mir-3714 hsa04012 ErbB signaling pathway 5578_5747_25_5595_5594_5599_2932_6777_3725_6776_5601_5602_1026 13 1.61E-09 1.37E-07 1.05E-08 15960 hsa-mir-3714 hsa04520 Adherens junction 7046_4301_1460_998_5595_5594_1387_1457_4087_4088_4089_2033 12 6.60E-09 5.61E-07 4.01E-08 15961 hsa-mir-3714 hsa05214 Glioma 4193_5578_5925_1870_1871_5595_5594_7157_1869_5728_1026 11 9.24E-09 7.86E-07 5.24E-08 15962 hsa-mir-3714 hsa05223 Non-small cell lung cancer 5578_5925_6789_1870_1871_5595_5594_6256_7157_1869 10 2.06E-08 1.75E-06 1.05E-07 15963 hsa-mir-3714 hsa05218 Melanoma 4193_5925_1870_1871_2249_5595_5594_7157_1869_5728_1026 11 2.10E-08 1.78E-06 1.05E-07 15964 hsa-mir-3714 hsa05219 Bladder cancer 4193_5925_1870_1871_5595_5594_7157_1869_1026 9 3.51E-08 2.98E-06 1.66E-07 15965 hsa-mir-3714 hsa05221 Acute myeloid leukemia 5914_1050_861_1147_5595_5594_6777_5970_6776_5371 10 4.34E-08 3.69E-06 1.94E-07 15966 hsa-mir-3714 hsa04620 Toll-like receptor signaling pathway 1147_5595_5594_5599_6772_5970_3725_4792_5601_5602_2353 11 5.90E-07 5.01E-05 2.51E-06 15967 hsa-mir-3714 hsa04510 Focal adhesion 596_5578_5923_5747_5499_998_5595_5594_5599_2932_3725_5728_3910_5601_5602 15 6.29E-07 5.35E-05 2.55E-06 15968 hsa-mir-3714 hsa04660 T cell receptor signaling pathway 1147_998_5595_5594_2932_5970_3725_959_4792_5601_2353 11 1.17E-06 9.96E-05 4.45E-06 15969 hsa-mir-3714 hsa04920 Adipocytokine signaling pathway 6794_1147_5599_6256_5970_4792_5601_5602_5563 9 1.21E-06 0.000102428 4.45E-06 15970 hsa-mir-3714 hsa04662 B cell receptor signaling pathway 1147_5595_5594_1380_2932_5970_3725_4792_2353 9 2.82E-06 0.000239774 9.99E-06 15971 hsa-mir-3714 hsa03420 Nucleotide excision repair 902_2965_4331_2071_2074_1022_6117 7 6.94E-06 0.000589724 2.36E-05 15972 hsa-mir-3714 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_998_5599_5970_3725_4792_5601_5602 8 1.54E-05 0.001308855 5.03E-05 15973 hsa-mir-3714 hsa05211 Renal cell carcinoma 3091_2113_998_5595_5594_1387_3725_2033 8 1.69E-05 0.001436651 5.32E-05 15974 hsa-mir-3714 hsa03022 Basal transcription factors 51616_2965_6908_2958_6880_2957 6 2.90E-05 0.00246288 8.80E-05 15975 hsa-mir-3714 hsa04210 Apoptosis 596_598_823_1147_5970_7157_4792_472 8 6.85E-05 0.005822827 0.000200787 15976 hsa-mir-3714 hsa04330 Notch signaling pathway 3065_1387_9612_2033_8850_1856 6 9.70E-05 0.00824084 0.000274695 15977 hsa-mir-3714 hsa04062 Chemokine signaling pathway 5747_6362_1147_998_5595_5594_2932_6777_6772_5970_4792 11 0.000157938 0.013424744 0.000433056 15978 hsa-mir-3714 hsa04370 VEGF signaling pathway 5578_5743_5747_998_5595_5594_3315 7 0.000182531 0.015515158 0.000483819 15979 hsa-mir-3714 hsa04916 Melanogenesis 5578_5595_5594_1387_2932_2033_1856_90993 8 0.000187835 0.015966017 0.000483819 15980 hsa-mir-3714 hsa04530 Tight junction 5578_4301_1460_998_1457_5728_5518_5515_5520 9 0.000230905 0.019626958 0.000577263 15981 hsa-mir-3714 hsa04912 GnRH signaling pathway 5578_998_5595_5594_5599_3725_5601_5602 8 0.000239078 0.02032166 0.000580619 15982 hsa-mir-3714 hsa04612 Antigen processing and presentation 3309_3304_3305_3303_3320_3326_4800 7 0.000416073 0.035366245 0.000982396 15983 hsa-mir-3714 hsa05016 Huntington's disease 3065_3064_25942_6667_1387_7157_2033_27113_6908_90993 10 0.000521634 0.044338912 0.001198349 15984 hsa-mir-3714 hsa04630 Jak-STAT signaling pathway 598_3977_1387_6777_6772_6776_2033_51588_8554 9 0.00054255 0.046116746 0.001213599 15985 hsa-mir-3714 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601_5602 5 0.000670244 0.056970705 0.001460787 15986 hsa-mir-3714 hsa04720 Long-term potentiation 5578_5499_5595_5594_1387_2033 6 0.000986073 0.083816197 0.002088873 15987 hsa-mir-3714 hsa03440 Homologous recombination 641_5888_675_6117 4 0.001007574 0.08564379 0.002088873 15988 hsa-mir-3714 hsa04910 Insulin signaling pathway 5499_5595_5594_5599_2932_5601_5602_5563 8 0.00110286 0.093743112 0.002231979 15989 hsa-mir-3714 hsa05216 Thyroid cancer 5595_5594_6256_7157 4 0.00113396 0.09638659 0.002241549 15990 hsa-mir-3714 hsa05213 Endometrial cancer 5595_5594_2932_7157_5728 5 0.001222573 0.103918684 0.002309304 15991 hsa-mir-3714 hsa04150 mTOR signaling pathway 6794_3091_5595_5594_5563 5 0.001222573 0.103918684 0.002309304 15992 hsa-mir-3714 hsa04664 Fc epsilon RI signaling pathway 5578_5595_5594_5599_5601_5602 6 0.001268044 0.107783713 0.002343124 15993 hsa-mir-3714 hsa05131 Shigellosis 5578_25_998_7534_4691 5 0.001659489 0.141056578 0.002938679 15994 hsa-mir-3714 hsa05130 Pathogenic Escherichia coli infection 5578_25_998_7534_4691 5 0.001659489 0.141056578 0.002938679 15995 hsa-mir-3714 hsa03410 Base excision repair 3146_142_4913_328 4 0.002344551 0.19928683 0.004067078 15996 hsa-mir-3714 hsa04360 Axon guidance 5747_25_998_5595_5594_2932_1020 7 0.003431293 0.291659888 0.005833198 15997 hsa-mir-3714 hsa04730 Long-term depression 5578_5595_5594_5518_5515 5 0.004344654 0.369295552 0.007241089 15998 hsa-mir-3714 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_1616_7157 4 0.010050417 0.854285428 0.016428566 15999 hsa-mir-3714 hsa04540 Gap junction 5578_5595_5594_1453_983 5 0.012454679 1 0.019974485 16000 hsa-mir-3714 hsa03030 DNA replication 5557_6117_5422 3 0.017263523 1 0.027174063 16001 hsa-mir-3714 hsa03450 Non-homologous end-joining 2547_5591 2 0.020704225 1 0.031997439 16002 hsa-mir-3714 hsa03430 Mismatch repair 4436_6117 2 0.047665365 1 0.071651208 16003 hsa-mir-3714 hsa05217 Basal cell carcinoma 2932_7157_1856 3 0.048048457 1 0.071651208 16004 hsa-mir-374c hsa03022 Basal transcription factors 2959_6908 2 7.36E-05 0.001029947 0.001029947 16005 hsa-mir-374c hsa05016 Huntington's disease 2033_6908 2 0.001735379 0.024295305 0.012147652 16006 hsa-mir-374c hsa04330 Notch signaling pathway 2033 1 0.015882399 0.222353592 0.046033355 16007 hsa-mir-374c hsa05211 Renal cell carcinoma 2033 1 0.024064242 0.336899383 0.046033355 16008 hsa-mir-374c hsa04720 Long-term potentiation 2033 1 0.025041937 0.35058712 0.046033355 16009 hsa-mir-374c hsa04520 Adherens junction 2033 1 0.026669471 0.373372593 0.046033355 16010 hsa-mir-374c hsa04350 TGF-beta signaling pathway 2033 1 0.02894391 0.405214745 0.046033355 16011 hsa-mir-374c hsa05215 Prostate cancer 2033 1 0.029268439 0.409758153 0.046033355 16012 hsa-mir-374c hsa05212 Pancreatic cancer 2033 1 0.029592871 0.414300194 0.046033355 16013 hsa-mir-374c hsa04916 Melanogenesis 2033 1 0.034447648 0.482267068 0.048226707 16014 hsa-mir-374c hsa04110 Cell cycle 2033 1 0.039280555 0.549927764 0.049993433 16015 hsa-mir-374c hsa04310 Wnt signaling pathway 2033 1 0.049836399 0.697709593 0.054697813 16016 hsa-mir-375 hsa05200 Pathways in cancer 3320_4149_5371_7046_1499_5595_5594_5599_1387_6256_862_1488_1487_1019_1017_2932_4193_10401_7704_6774_6772_51588_5970_7157_4087_6688_5604_5894_4609_3725_1026_1029_6502_2353_4088_5881_4292_5925_2033_1050_207_3326_8554_4790_7189_7184 46 5.09E-29 3.72E-27 3.17E-27 16017 hsa-mir-375 hsa03022 Basal transcription factors 2967_2961_2963_2962_6881_2969_2968_6874_2960_2957_54457_6879_6878_6877_6908_2958_6883_6873_6872_6884_6880_6882_2959_138474 24 8.68E-29 6.34E-27 3.17E-27 16018 hsa-mir-375 hsa05215 Prostate cancer 3320_1499_5595_5594_1387_1017_2932_4193_5970_7157_5604_468_5894_1026_5925_2033_207_3326_4790_7184 20 6.66E-17 4.86E-15 1.35E-15 16019 hsa-mir-375 hsa05212 Pancreatic cancer 3320_1499_5595_5594_1387_1017_2932_4193_5970_7157_5604_468_5894_1026_5925_2033_207_3326_4790_7184 20 8.05E-17 5.87E-15 1.35E-15 16020 hsa-mir-375 hsa04010 MAPK signaling pathway 9479_6722_4149_5598_7046_3727_5595_5594_5599_1386_4208_7867_3312_1432_1649_5970_9261_7157_5604_468_5894_4773_4609_3725_2353_5881_207_4790_51701_7189 30 9.28E-17 6.77E-15 1.35E-15 16021 hsa-mir-375 hsa04110 Cell cycle 990_1387_983_1019_1017_2932_4193_8454_7027_6500_4171_7157_4087_1026_1029_6502_4085_4088_5925_2033_5933 21 9.71E-16 7.09E-14 1.10E-14 16022 hsa-mir-375 hsa05220 Chronic myeloid leukemia 7046_5595_5594_1488_1487_1019_4193_5970_7157_5604_5894_4609_1026_1029_4088_5925_207_4790 18 1.06E-15 7.73E-14 1.10E-14 16023 hsa-mir-375 hsa04310 Wnt signaling pathway 1460_1499_5599_1387_8607_1488_1487_2932_8454_6500_7157_4087_6423_4773_4609_3725_1457_1459_4088_5881_2033_51701 22 7.88E-15 5.75E-13 7.19E-14 16024 hsa-mir-375 hsa04350 TGF-beta signaling pathway 7046_5595_5594_1387_8454_7027_3397_3398_6500_1874_4087_658_4609_3399_4088_2033_6667_5933 18 9.97E-15 7.28E-13 8.08E-14 16025 hsa-mir-375 hsa05210 Colorectal cancer 7046_1499_5595_5594_5599_2932_7157_4087_5604_5894_4609_3725_2353_4088_5881_4292_207 17 7.59E-14 5.54E-12 5.54E-13 16026 hsa-mir-375 hsa04620 Toll-like receptor signaling pathway 3654_5595_5594_5599_353376_3661_148022_1432_6772_5970_5604_3725_2353_4615_207_4790_7189 17 1.22E-12 8.94E-11 8.13E-12 16027 hsa-mir-375 hsa05221 Acute myeloid leukemia 5371_5595_5594_862_7704_6774_5970_6688_5604_5894_4609_1050_207_4790 14 1.89E-12 1.38E-10 1.15E-11 16028 hsa-mir-375 hsa05214 Glioma 5595_5594_1019_4193_7157_5604_5894_1026_1029_5925_207_808_801_805 14 5.89E-12 4.30E-10 3.31E-11 16029 hsa-mir-375 hsa05222 Small cell lung cancer 4149_6256_1019_1017_10401_51588_5970_7157_4609_6502_5925_207_8554_4790_7189 15 1.47E-11 1.07E-09 7.67E-11 16030 hsa-mir-375 hsa04520 Adherens junction 1460_7046_1499_6714_5595_5594_1387_4087_1457_1459_4088_5881_2033_51701 14 6.80E-11 4.96E-09 3.31E-10 16031 hsa-mir-375 hsa05219 Bladder cancer 5595_5594_1019_4193_7157_5604_5894_4609_1026_1029_5925 11 1.85E-10 1.35E-08 8.46E-10 16032 hsa-mir-375 hsa04540 Gap junction 5598_7277_6714_5595_5594_10382_983_7278_10376_5604_5894_7846_51807 13 3.83E-09 2.79E-07 1.58E-08 16033 hsa-mir-375 hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_5604_5894_4773_3725_2353_5881_207_4790 12 3.91E-09 2.85E-07 1.58E-08 16034 hsa-mir-375 hsa05213 Endometrial cancer 1499_5595_5594_2932_7157_5604_5894_4609_4292_207 10 1.67E-08 1.22E-06 6.41E-08 16035 hsa-mir-375 hsa04912 GnRH signaling pathway 5598_6714_5595_5594_5599_1432_5604_468_5894_3725_808_801_805 13 1.95E-08 1.42E-06 7.10E-08 16036 hsa-mir-375 hsa05223 Non-small cell lung cancer 5595_5594_6256_1019_7157_5604_5894_1029_5925_207 10 2.29E-08 1.67E-06 7.54E-08 16037 hsa-mir-375 hsa05218 Melanoma 5595_5594_1019_4193_7157_5604_5894_1026_1029_5925_207 11 2.36E-08 1.72E-06 7.54E-08 16038 hsa-mir-375 hsa04660 T cell receptor signaling pathway 5595_5594_1019_2932_1432_5970_5604_5894_4773_3725_2353_207_4790 13 2.37E-08 1.73E-06 7.54E-08 16039 hsa-mir-375 hsa04370 VEGF signaling pathway 6714_5595_5594_7867_1432_9261_5604_5894_4773_5881_207 11 4.99E-08 3.64E-06 1.52E-07 16040 hsa-mir-375 hsa04012 ErbB signaling pathway 6714_5595_5594_5599_2932_5604_5894_4609_3725_1026_207 11 1.54E-07 1.12E-05 4.49E-07 16041 hsa-mir-375 hsa04720 Long-term potentiation 5595_5594_1387_5604_468_5894_2033_808_801_805 10 3.63E-07 2.65E-05 1.02E-06 16042 hsa-mir-375 hsa05216 Thyroid cancer 1499_5595_5594_6256_7157_5604_4609 7 6.47E-07 4.73E-05 1.75E-06 16043 hsa-mir-375 hsa04916 Melanogenesis 1499_5595_5594_1387_2932_5604_5894_2033_808_801_805 11 7.87E-07 5.75E-05 2.05E-06 16044 hsa-mir-375 hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_4193_8454_10401_6500_51588_6502_7329_8554_7189 12 1.82E-06 0.000133122 4.59E-06 16045 hsa-mir-375 hsa05131 Shigellosis 7277_1499_10382_7278_10376_7846_51807_4691 8 3.41E-06 0.000249242 8.02E-06 16046 hsa-mir-375 hsa05130 Pathogenic Escherichia coli infection 7277_1499_10382_7278_10376_7846_51807_4691 8 3.41E-06 0.000249242 8.02E-06 16047 hsa-mir-375 hsa04950 Maturity onset diabetes of the young 3651_3172_168620_6928_6927_5080 6 3.52E-06 0.000256699 8.02E-06 16048 hsa-mir-375 hsa04910 Insulin signaling pathway 5595_5594_5599_2932_5604_5894_5211_207_808_801_805 11 9.93E-06 0.000724649 2.20E-05 16049 hsa-mir-375 hsa04330 Notch signaling pathway 1387_1488_1487_388585_2033_2648_8850 7 1.10E-05 0.000804792 2.37E-05 16050 hsa-mir-375 hsa04115 p53 signaling pathway 983_1019_1017_4193_7157_1026_1029_7161 8 1.38E-05 0.001009049 2.88E-05 16051 hsa-mir-375 hsa05211 Renal cell carcinoma 5595_5594_1387_5604_5894_3725_2033_207 8 1.83E-05 0.001339534 3.72E-05 16052 hsa-mir-375 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_1432_5604_5894_5881_207 8 3.39E-05 0.002476916 6.69E-05 16053 hsa-mir-375 hsa03050 Proteasome 5684_5705_5701_5702_5719_5710 6 0.000114755 0.008377081 0.000220449 16054 hsa-mir-375 hsa04062 Chemokine signaling pathway 5595_5594_2932_6774_6772_5970_5604_5894_7074_207_4790 11 0.000174415 0.012732325 0.00032647 16055 hsa-mir-375 hsa04510 Focal adhesion 1499_6714_5595_5594_5599_2932_5604_5894_3725_5881_207 11 0.000297178 0.02169401 0.00054235 16056 hsa-mir-375 hsa04210 Apoptosis 3654_823_5970_7157_4615_207_4790 7 0.000445515 0.032522559 0.000793233 16057 hsa-mir-375 hsa04630 Jak-STAT signaling pathway 1387_10401_6774_6772_51588_4609_2033_207_8554 9 0.000588835 0.04298497 0.001023452 16058 hsa-mir-375 hsa04920 Adipocytokine signaling pathway 5599_6256_6774_5970_207_4790 6 0.000603236 0.044036251 0.001024099 16059 hsa-mir-375 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5599_1432_5970_3725_4790 6 0.00080122 0.058489049 0.001329297 16060 hsa-mir-375 hsa04270 Vascular smooth muscle contraction 5595_5594_5604_5894_808_801_805 7 0.002101305 0.15339527 0.003365228 16061 hsa-mir-375 hsa05016 Huntington's disease 6874_1387_6908_9001_5430_7157_3064_2033_6667 9 0.002120554 0.154800471 0.003365228 16062 hsa-mir-375 hsa04612 Antigen processing and presentation 3320_4800_4801_4802_3312_3326 6 0.002373595 0.173272456 0.003686648 16063 hsa-mir-375 hsa04530 Tight junction 1460_1499_6714_1019_1457_1459_207 7 0.004609982 0.336528675 0.007011014 16064 hsa-mir-375 hsa03420 Nucleotide excision repair 2967_2968_5981_5887 4 0.0047607 0.347531095 0.007092471 16065 hsa-mir-375 hsa05010 Alzheimer's disease 5595_5594_823_2932_9451_808_801_805 8 0.005116392 0.373496632 0.007338298 16066 hsa-mir-375 hsa04930 Type II diabetes mellitus 3651_5595_5594_5599 4 0.005126756 0.374253176 0.007338298 16067 hsa-mir-375 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_5604_5894_4773_5881 6 0.017142154 1 0.024064947 16068 hsa-mir-375 hsa04730 Long-term depression 5595_5594_5604_5894 4 0.022094416 1 0.030431931 16069 hsa-mir-375 hsa04150 mTOR signaling pathway 5595_5594_207 3 0.043321583 1 0.058564363 16070 hsa-mir-375 hsa04360 Axon guidance 5595_5594_2932_4773_5881 5 0.04498222 1 0.059703674 16071 hsa-mir-375 hsa03430 Mismatch repair 5981_4292 2 0.048654555 1 0.063285111 16072 hsa-mir-375 hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.049414401 1 0.063285111 16073 hsa-mir-376a-1 hsa04110 Cell cycle 4174_5591_1387_10971_7534_1017_7533_7532_5001_1026_4172_4173_1029_898_4998_4999 16 1.75E-21 1.03E-19 1.03E-19 16074 hsa-mir-376a-1 hsa05200 Pathways in cancer 5371_6258_1387_6256_836_1017_842_841_5970_4824_1026_1029_898 13 3.51E-11 2.07E-09 1.04E-09 16075 hsa-mir-376a-1 hsa05215 Prostate cancer 1385_1387_1017_842_5970_4824_1026_898 8 4.99E-10 2.94E-08 8.00E-09 16076 hsa-mir-376a-1 hsa05212 Pancreatic cancer 1385_1387_1017_842_5970_4824_1026_898 8 5.42E-10 3.20E-08 8.00E-09 16077 hsa-mir-376a-1 hsa04115 p53 signaling pathway 836_1017_842_841_1026_1029_898 7 3.12E-09 1.84E-07 3.68E-08 16078 hsa-mir-376a-1 hsa05222 Small cell lung cancer 6258_6256_1017_842_5970_898 6 3.51E-07 2.07E-05 3.45E-06 16079 hsa-mir-376a-1 hsa04210 Apoptosis 836_839_842_841_840_5970 6 4.24E-07 2.50E-05 3.58E-06 16080 hsa-mir-376a-1 hsa05010 Alzheimer's disease 22926_836_842_841_840_4697 6 1.90E-05 0.001121177 0.000140147 16081 hsa-mir-376a-1 hsa04010 MAPK signaling pathway 9261_836_1432_5970_6195_2002_2005 7 2.17E-05 0.001278576 0.000142064 16082 hsa-mir-376a-1 hsa05016 Huntington's disease 1385_1387_836_842_841_4697 6 2.64E-05 0.001557539 0.000150502 16083 hsa-mir-376a-1 hsa05223 Non-small cell lung cancer 6258_6256_842_1029 4 2.81E-05 0.001655518 0.000150502 16084 hsa-mir-376a-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_836_1432_5970 4 7.73E-05 0.004562461 0.000380205 16085 hsa-mir-376a-1 hsa04720 Long-term potentiation 815_1387_5499_6195 4 9.47E-05 0.005588818 0.000429909 16086 hsa-mir-376a-1 hsa04370 VEGF signaling pathway 6714_9261_1432_842 4 0.000104414 0.006160453 0.000440032 16087 hsa-mir-376a-1 hsa04012 ErbB signaling pathway 815_6714_1026_2002 4 0.000163959 0.00967357 0.000644905 16088 hsa-mir-376a-1 hsa03030 DNA replication 4174_4172_4173 3 0.000218735 0.012905351 0.000806584 16089 hsa-mir-376a-1 hsa04912 GnRH signaling pathway 815_6714_1432_2002 4 0.000363247 0.021431571 0.001260681 16090 hsa-mir-376a-1 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432_842 3 0.000745192 0.043966355 0.002442575 16091 hsa-mir-376a-1 hsa05214 Glioma 815_1026_1029 3 0.001126722 0.066476623 0.00349877 16092 hsa-mir-376a-1 hsa04920 Adipocytokine signaling pathway 6258_6256_5970 3 0.001225391 0.072298046 0.00353022 16093 hsa-mir-376a-1 hsa04310 Wnt signaling pathway 815_1387_1457_1452 4 0.001256519 0.074134615 0.00353022 16094 hsa-mir-376a-1 hsa05220 Chronic myeloid leukemia 5970_1026_1029 3 0.001673937 0.098762257 0.004489193 16095 hsa-mir-376a-1 hsa04520 Adherens junction 6714_1387_1457 3 0.002000078 0.118004578 0.005130634 16096 hsa-mir-376a-1 hsa05216 Thyroid cancer 6258_6256 2 0.003888214 0.229404642 0.009186037 16097 hsa-mir-376a-1 hsa04620 Toll-like receptor signaling pathway 1432_841_5970 3 0.003892388 0.229650916 0.009186037 16098 hsa-mir-376a-1 hsa04916 Melanogenesis 815_1385_1387 3 0.004103678 0.242116987 0.009312192 16099 hsa-mir-376a-1 hsa03022 Basal transcription factors 2962_2969 2 0.00610075 0.359944238 0.013331268 16100 hsa-mir-376a-1 hsa05219 Bladder cancer 1026_1029 2 0.007713556 0.455099831 0.016253565 16101 hsa-mir-376a-1 hsa05012 Parkinson's disease 836_842_4697 3 0.008456344 0.49892431 0.017204287 16102 hsa-mir-376a-1 hsa04330 Notch signaling pathway 1387_9612 2 0.009496731 0.560307115 0.018676904 16103 hsa-mir-376a-1 hsa05213 Endometrial cancer 842_2002 2 0.011444965 0.675252961 0.021782354 16104 hsa-mir-376a-1 hsa05131 Shigellosis 10971_7534 2 0.013118905 0.774015396 0.023455012 16105 hsa-mir-376a-1 hsa05130 Pathogenic Escherichia coli infection 10971_7534 2 0.013118905 0.774015396 0.023455012 16106 hsa-mir-376a-1 hsa05221 Acute myeloid leukemia 5371_5970 2 0.014439935 0.851956184 0.025057535 16107 hsa-mir-376a-1 hsa03320 PPAR signaling pathway 6258_6256 2 0.019746238 1 0.03320963 16108 hsa-mir-376a-1 hsa05218 Melanoma 1026_1029 2 0.020263503 1 0.03320963 16109 hsa-mir-376a-1 hsa04510 Focal adhesion 6714_5499_2002 3 0.024955444 1 0.039793816 16110 hsa-mir-376a-1 hsa05210 Colorectal cancer 836_842 2 0.027488279 1 0.04267917 16111 hsa-mir-376a-1 hsa04612 Antigen processing and presentation 1385_4800 2 0.030504072 1 0.046147186 16112 hsa-mir-376a-1 hsa03450 Non-homologous end-joining 5591 1 0.043948127 1 0.064014771 16113 hsa-mir-376a-1 hsa04660 T cell receptor signaling pathway 1432_5970 2 0.044484841 1 0.064014771 16114 hsa-mir-376a-2 hsa04110 Cell cycle 10971_898_7534_1017_7533_7532_4174_5001_1026_4172_4173_1029_1387_4998_4999 15 1.26E-26 5.06E-25 5.06E-25 16115 hsa-mir-376a-2 hsa04115 p53 signaling pathway 898_1017_1026_1029 4 1.78E-06 7.13E-05 3.57E-05 16116 hsa-mir-376a-2 hsa05215 Prostate cancer 898_1017_1026_1387 4 4.50E-06 0.000180141 4.70E-05 16117 hsa-mir-376a-2 hsa05212 Pancreatic cancer 898_1017_1026_1387 4 4.70E-06 0.000188077 4.70E-05 16118 hsa-mir-376a-2 hsa03030 DNA replication 4174_4172_4173 3 1.40E-05 0.000561102 0.00011222 16119 hsa-mir-376a-2 hsa05200 Pathways in cancer 898_1017_1026_1029_1387 5 4.89E-05 0.001956047 0.000326008 16120 hsa-mir-376a-2 hsa05219 Bladder cancer 1026_1029 2 0.00128009 0.051203593 0.007314799 16121 hsa-mir-376a-2 hsa05131 Shigellosis 10971_7534 2 0.002213336 0.088533442 0.009837049 16122 hsa-mir-376a-2 hsa05130 Pathogenic Escherichia coli infection 10971_7534 2 0.002213336 0.088533442 0.009837049 16123 hsa-mir-376a-2 hsa05214 Glioma 1026_1029 2 0.002940524 0.117620952 0.011762095 16124 hsa-mir-376a-2 hsa05218 Melanoma 1026_1029 2 0.003479392 0.139175672 0.011884039 16125 hsa-mir-376a-2 hsa04720 Long-term potentiation 5499_1387 2 0.003862313 0.154492511 0.011884039 16126 hsa-mir-376a-2 hsa05220 Chronic myeloid leukemia 1026_1029 2 0.003862313 0.154492511 0.011884039 16127 hsa-mir-376a-2 hsa05222 Small cell lung cancer 898_1017 2 0.005011395 0.200455796 0.014318271 16128 hsa-mir-376a-2 hsa04310 Wnt signaling pathway 1452_1387 2 0.014679467 0.587178671 0.039145245 16129 hsa-mir-376a-2 hsa05016 Huntington's disease 4697_1387 2 0.021779742 0.871189683 0.054449355 16130 hsa-mir-376b hsa04110 Cell cycle 4174_5591_1387_10971_7534_1017_7533_7532_5001_1026_4172_4173_1029_898_4998_4999 16 1.75E-21 1.03E-19 1.03E-19 16131 hsa-mir-376b hsa05200 Pathways in cancer 5371_6258_1387_6256_836_1017_842_841_5970_4824_1026_1029_898 13 3.51E-11 2.07E-09 1.04E-09 16132 hsa-mir-376b hsa05215 Prostate cancer 1385_1387_1017_842_5970_4824_1026_898 8 4.99E-10 2.94E-08 8.00E-09 16133 hsa-mir-376b hsa05212 Pancreatic cancer 1385_1387_1017_842_5970_4824_1026_898 8 5.42E-10 3.20E-08 8.00E-09 16134 hsa-mir-376b hsa04115 p53 signaling pathway 836_1017_842_841_1026_1029_898 7 3.12E-09 1.84E-07 3.68E-08 16135 hsa-mir-376b hsa05222 Small cell lung cancer 6258_6256_1017_842_5970_898 6 3.51E-07 2.07E-05 3.45E-06 16136 hsa-mir-376b hsa04210 Apoptosis 836_839_842_841_840_5970 6 4.24E-07 2.50E-05 3.58E-06 16137 hsa-mir-376b hsa05010 Alzheimer's disease 22926_836_842_841_840_4697 6 1.90E-05 0.001121177 0.000140147 16138 hsa-mir-376b hsa04010 MAPK signaling pathway 9261_836_1432_5970_6195_2002_2005 7 2.17E-05 0.001278576 0.000142064 16139 hsa-mir-376b hsa05016 Huntington's disease 1385_1387_836_842_841_4697 6 2.64E-05 0.001557539 0.000150502 16140 hsa-mir-376b hsa05223 Non-small cell lung cancer 6258_6256_842_1029 4 2.81E-05 0.001655518 0.000150502 16141 hsa-mir-376b hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_836_1432_5970 4 7.73E-05 0.004562461 0.000380205 16142 hsa-mir-376b hsa04720 Long-term potentiation 815_1387_5499_6195 4 9.47E-05 0.005588818 0.000429909 16143 hsa-mir-376b hsa04370 VEGF signaling pathway 6714_9261_1432_842 4 0.000104414 0.006160453 0.000440032 16144 hsa-mir-376b hsa04012 ErbB signaling pathway 815_6714_1026_2002 4 0.000163959 0.00967357 0.000644905 16145 hsa-mir-376b hsa03030 DNA replication 4174_4172_4173 3 0.000218735 0.012905351 0.000806584 16146 hsa-mir-376b hsa04912 GnRH signaling pathway 815_6714_1432_2002 4 0.000363247 0.021431571 0.001260681 16147 hsa-mir-376b hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432_842 3 0.000745192 0.043966355 0.002442575 16148 hsa-mir-376b hsa05214 Glioma 815_1026_1029 3 0.001126722 0.066476623 0.00349877 16149 hsa-mir-376b hsa04920 Adipocytokine signaling pathway 6258_6256_5970 3 0.001225391 0.072298046 0.00353022 16150 hsa-mir-376b hsa04310 Wnt signaling pathway 815_1387_1457_1452 4 0.001256519 0.074134615 0.00353022 16151 hsa-mir-376b hsa05220 Chronic myeloid leukemia 5970_1026_1029 3 0.001673937 0.098762257 0.004489193 16152 hsa-mir-376b hsa04520 Adherens junction 6714_1387_1457 3 0.002000078 0.118004578 0.005130634 16153 hsa-mir-376b hsa05216 Thyroid cancer 6258_6256 2 0.003888214 0.229404642 0.009186037 16154 hsa-mir-376b hsa04620 Toll-like receptor signaling pathway 1432_841_5970 3 0.003892388 0.229650916 0.009186037 16155 hsa-mir-376b hsa04916 Melanogenesis 815_1385_1387 3 0.004103678 0.242116987 0.009312192 16156 hsa-mir-376b hsa03022 Basal transcription factors 2962_2969 2 0.00610075 0.359944238 0.013331268 16157 hsa-mir-376b hsa05219 Bladder cancer 1026_1029 2 0.007713556 0.455099831 0.016253565 16158 hsa-mir-376b hsa05012 Parkinson's disease 836_842_4697 3 0.008456344 0.49892431 0.017204287 16159 hsa-mir-376b hsa04330 Notch signaling pathway 1387_9612 2 0.009496731 0.560307115 0.018676904 16160 hsa-mir-376b hsa05213 Endometrial cancer 842_2002 2 0.011444965 0.675252961 0.021782354 16161 hsa-mir-376b hsa05131 Shigellosis 10971_7534 2 0.013118905 0.774015396 0.023455012 16162 hsa-mir-376b hsa05130 Pathogenic Escherichia coli infection 10971_7534 2 0.013118905 0.774015396 0.023455012 16163 hsa-mir-376b hsa05221 Acute myeloid leukemia 5371_5970 2 0.014439935 0.851956184 0.025057535 16164 hsa-mir-376b hsa03320 PPAR signaling pathway 6258_6256 2 0.019746238 1 0.03320963 16165 hsa-mir-376b hsa05218 Melanoma 1026_1029 2 0.020263503 1 0.03320963 16166 hsa-mir-376b hsa04510 Focal adhesion 6714_5499_2002 3 0.024955444 1 0.039793816 16167 hsa-mir-376b hsa05210 Colorectal cancer 836_842 2 0.027488279 1 0.04267917 16168 hsa-mir-376b hsa04612 Antigen processing and presentation 1385_4800 2 0.030504072 1 0.046147186 16169 hsa-mir-376b hsa03450 Non-homologous end-joining 5591 1 0.043948127 1 0.064014771 16170 hsa-mir-376b hsa04660 T cell receptor signaling pathway 1432_5970 2 0.044484841 1 0.064014771 16171 hsa-mir-377 hsa05200 Pathways in cancer 3716_4087_4088_2033_4792_2113_4609_4790_5970_2353_1387 11 8.53E-13 4.09E-11 4.09E-11 16172 hsa-mir-377 hsa04520 Adherens junction 4087_4088_6714_2033_5777_1387 6 1.91E-09 9.18E-08 3.59E-08 16173 hsa-mir-377 hsa04630 Jak-STAT signaling pathway 3716_2033_4609_5777_3566_6773_1387 7 2.24E-09 1.08E-07 3.59E-08 16174 hsa-mir-377 hsa05220 Chronic myeloid leukemia 4088_4792_4609_4790_5970 5 8.20E-08 3.94E-06 7.87E-07 16175 hsa-mir-377 hsa04662 B cell receptor signaling pathway 4792_4790_5777_5970_2353 5 8.20E-08 3.94E-06 7.87E-07 16176 hsa-mir-377 hsa04350 TGF-beta signaling pathway 4087_4088_2033_4609_1387 5 1.66E-07 7.96E-06 1.11E-06 16177 hsa-mir-377 hsa05215 Prostate cancer 2033_4792_4790_5970_1387 5 1.75E-07 8.40E-06 1.11E-06 16178 hsa-mir-377 hsa05212 Pancreatic cancer 2033_4792_4790_5970_1387 5 1.85E-07 8.86E-06 1.11E-06 16179 hsa-mir-377 hsa04660 T cell receptor signaling pathway 4792_4790_5777_5970_2353 5 5.06E-07 2.43E-05 2.70E-06 16180 hsa-mir-377 hsa04110 Cell cycle 4087_4088_2033_891_1387 5 7.35E-07 3.53E-05 3.53E-06 16181 hsa-mir-377 hsa04310 Wnt signaling pathway 4087_4088_2033_4609_1387 5 2.35E-06 0.000113013 1.03E-05 16182 hsa-mir-377 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_4792_4790_5970 4 3.38E-06 0.000162373 1.35E-05 16183 hsa-mir-377 hsa05210 Colorectal cancer 4087_4088_4609_2353 4 6.41E-06 0.000307555 2.34E-05 16184 hsa-mir-377 hsa05222 Small cell lung cancer 4792_4609_4790_5970 4 7.01E-06 0.000336344 2.34E-05 16185 hsa-mir-377 hsa04062 Chemokine signaling pathway 4792_4790_5590_5970_6773 5 7.31E-06 0.000350748 2.34E-05 16186 hsa-mir-377 hsa04620 Toll-like receptor signaling pathway 4792_4790_5970_2353 4 1.34E-05 0.000643683 4.02E-05 16187 hsa-mir-377 hsa05221 Acute myeloid leukemia 4609_4790_5970 3 8.44E-05 0.004050183 0.000238246 16188 hsa-mir-377 hsa04920 Adipocytokine signaling pathway 4792_4790_5970 3 0.000121207 0.005817918 0.000323218 16189 hsa-mir-377 hsa05211 Renal cell carcinoma 2033_2113_1387 3 0.000148809 0.007142848 0.000375939 16190 hsa-mir-377 hsa04210 Apoptosis 4792_4790_5970 3 0.000272332 0.01307194 0.000653597 16191 hsa-mir-377 hsa04010 MAPK signaling pathway 4609_4790_5970_2353 4 0.00054767 0.02628814 0.001251816 16192 hsa-mir-377 hsa05322 Systemic lupus erythematosus 333932_3015_126961 3 0.001067803 0.051254531 0.002329751 16193 hsa-mir-377 hsa04330 Notch signaling pathway 2033_1387 2 0.002052088 0.098500225 0.004282618 16194 hsa-mir-377 hsa05016 Huntington's disease 2033_1537_1387 3 0.00225776 0.108372475 0.00451552 16195 hsa-mir-377 hsa04720 Long-term potentiation 2033_1387 2 0.004984102 0.239236898 0.009569476 16196 hsa-mir-377 hsa04012 ErbB signaling pathway 6714_4609 2 0.006601966 0.31689435 0.012188244 16197 hsa-mir-377 hsa04612 Antigen processing and presentation 4800_4801 2 0.006891884 0.330810409 0.012252237 16198 hsa-mir-377 hsa03010 Ribosome 6222_6231 2 0.008914052 0.427874491 0.015281232 16199 hsa-mir-377 hsa04916 Melanogenesis 2033_1387 2 0.009246006 0.443808296 0.015303734 16200 hsa-mir-377 hsa04530 Tight junction 6714_5590 2 0.015490652 0.743551274 0.024785042 16201 hsa-mir-377 hsa05010 Alzheimer's disease 22926_1537 2 0.024866127 1 0.038502391 16202 hsa-mir-377 hsa05216 Thyroid cancer 4609 1 0.04016301 1 0.060244516 16203 hsa-mir-378 hsa05200 Pathways in cancer 3551_1499_5914_595_8517_4193_7704_6502_3091_4087_7175_3065_5925_7184_25_405_2034_1956_6654_2308_8503_2885_2113_862_10401_207_208_9915_3716_1147_5595_5594_4609_1387_2064_6256_4286_367_2932_6774_6776_6772_5970_7157_6688_1869_3725_2736_4088_4089_5295_2033_4790_4791_4792_3320_3326_5371_3480_2353_8554 61 7.49E-35 5.91E-33 5.91E-33 16204 hsa-mir-378 hsa05215 Prostate cancer 3551_1499_595_8517_4193_5925_7184_1956_6654_2308_8503_2885_207_208_1147_5595_5594_1387_2064_367_2932_5970_7157_468_1869_5295_2033_4790_4792_3320_3326_3480 32 1.79E-26 1.42E-24 6.29E-25 16205 hsa-mir-378 hsa05212 Pancreatic cancer 3551_1499_595_8517_4193_5925_7184_1956_6654_2308_8503_2885_207_208_1147_5595_5594_1387_2064_367_2932_5970_7157_468_1869_5295_2033_4790_4792_3320_3326_3480 32 2.39E-26 1.89E-24 6.29E-25 16206 hsa-mir-378 hsa03022 Basal transcription factors 54457_2958_138474_6883_6881_2960_2957_6879_6872_2965_2967_2961_2963_2969_2968_6878_6877_6874_6873_6908_6884_6882_2959_6880 24 8.33E-25 6.58E-23 1.65E-23 16207 hsa-mir-378 hsa04010 MAPK signaling pathway 6722_3551_8517_9252_7867_4616_8986_1956_6654_3305_3303_1432_627_2885_2872_207_208_1147_994_5595_5594_4609_4214_3310_3312_5971_5970_7157_10912_468_3725_3727_6195_6196_6197_5058_4790_4791_9261_1326_4208_5566_2353 43 1.60E-22 1.27E-20 2.53E-21 16208 hsa-mir-378 hsa05220 Chronic myeloid leukemia 3551_595_8517_4193_3065_5925_25_6654_8503_2885_207_208_1147_5595_5594_4609_6776_5970_7157_1869_4088_4089_5295_4790_4792_6464 26 2.53E-21 2.00E-19 3.34E-20 16209 hsa-mir-378 hsa05221 Acute myeloid leukemia 3551_5914_595_8517_7704_6654_8503_2885_862_207_208_1147_5595_5594_4609_6774_6776_5970_6688_5295_4790_5371 22 8.42E-19 6.65E-17 9.50E-18 16210 hsa-mir-378 hsa04660 T cell receptor signaling pathway 3551_8517_5777_3932_6654_1432_8503_2885_207_208_1147_5595_5594_56924_2932_5970_3725_5295_5058_4794_4790_4792_4793_1326_1739_2353 26 7.78E-18 6.15E-16 7.68E-17 16211 hsa-mir-378 hsa04110 Cell cycle 595_4193_902_6502_6500_4087_4171_3065_4616_5925_25_994_5591_1387_7533_2932_7157_10912_1869_4085_4088_4089_2033_8454_1022 25 3.66E-16 2.90E-14 3.22E-15 16212 hsa-mir-378 hsa04662 B cell receptor signaling pathway 3551_8517_5777_6654_8503_2885_207_208_1147_5595_5594_2932_5970_3725_5295_4794_4790_4792_4793_2353 20 6.99E-15 5.53E-13 5.53E-14 16213 hsa-mir-378 hsa05214 Glioma 595_4193_5925_1956_6654_8503_2885_207_208_5595_5594_7157_1869_5295_808_801_805_3480_6464 19 8.12E-15 6.41E-13 5.83E-14 16214 hsa-mir-378 hsa05210 Colorectal cancer 1499_595_4087_1956_6654_8503_2885_207_208_5595_5594_4609_2932_7157_3725_4088_4089_5295_3480_2353 20 4.38E-14 3.46E-12 2.89E-13 16215 hsa-mir-378 hsa04062 Chemokine signaling pathway 3551_8517_653361_6654_2309_8503_7852_2885_207_208_3717_1147_5595_5594_2932_6774_6772_5970_9564_5295_5058_4790_4792_4793_2770_5566_6464 27 1.66E-13 1.31E-11 1.01E-12 16216 hsa-mir-378 hsa05211 Renal cell carcinoma 3091_405_2034_6654_8503_2885_2113_207_208_9915_5595_5594_56924_1387_3725_5295_5058_2033 18 4.02E-13 3.18E-11 2.27E-12 16217 hsa-mir-378 hsa04630 Jak-STAT signaling pathway 3559_595_5777_3454_3455_6654_8503_2885_10401_207_208_3717_3716_4609_1387_6778_6774_6776_6772_7297_5295_2033_8554_10379 24 5.31E-13 4.20E-11 2.76E-12 16218 hsa-mir-378 hsa05213 Endometrial cancer 1499_595_1956_6654_2309_8503_2885_207_208_5595_5594_4609_2064_2932_7157_5295 16 5.60E-13 4.42E-11 2.76E-12 16219 hsa-mir-378 hsa05222 Small cell lung cancer 3551_595_8517_6502_5925_8503_10401_207_208_1147_4609_6256_5970_7157_1869_5295_4790_4792_8554 19 6.00E-13 4.74E-11 2.79E-12 16220 hsa-mir-378 hsa04012 ErbB signaling pathway 25_1956_6714_6654_8503_2885_207_208_5595_5594_56924_4609_2064_2932_6776_3725_5295_5058_6464 19 7.18E-13 5.67E-11 3.15E-12 16221 hsa-mir-378 hsa05223 Non-small cell lung cancer 595_5925_1956_6654_2309_8503_2885_207_208_5595_5594_2064_6256_7157_1869_5295 16 9.09E-13 7.18E-11 3.78E-12 16222 hsa-mir-378 hsa04910 Insulin signaling pathway 3551_10891_5770_6654_2308_8503_2885_5211_2872_207_208_5595_5594_7249_6720_2932_5295_808_801_805_5566_6464 22 2.96E-12 2.34E-10 1.17E-11 16223 hsa-mir-378 hsa04620 Toll-like receptor signaling pathway 3551_8517_3454_3455_1432_8503_207_208_1147_5595_5594_6772_5970_3725_5295_4790_4792_1326_2353 19 8.31E-12 6.56E-10 3.13E-11 16224 hsa-mir-378 hsa04520 Adherens junction 1499_1457_5770_5777_4087_1956_6714_71_1460_5595_5594_1387_2064_4088_4089_2033_3480 17 1.70E-11 1.34E-09 6.10E-11 16225 hsa-mir-378 hsa04510 Focal adhesion 1499_595_857_1956_6714_6654_8503_2885_10627_207_208_71_5595_5594_56924_2064_2932_1729_9564_3725_5295_5058_3480_6464 24 1.17E-10 9.27E-09 4.03E-10 16226 hsa-mir-378 hsa04350 TGF-beta signaling pathway 6667_6500_4087_3397_3399_3398_5595_5594_4609_1387_4086_4088_4089_2033_8454_4093 16 4.36E-10 3.45E-08 1.44E-09 16227 hsa-mir-378 hsa04310 Wnt signaling pathway 1499_595_8607_1457_6500_8945_4087_23291_1460_4609_1387_2932_7157_8061_3725_4088_4089_2033_5566_8454 20 6.15E-10 4.86E-08 1.94E-09 16228 hsa-mir-378 hsa04920 Adipocytokine signaling pathway 3551_10891_8517_207_208_3717_1147_6256_6774_5970_4794_4790_4792_4793 14 1.26E-09 9.99E-08 3.84E-09 16229 hsa-mir-378 hsa05218 Melanoma 595_4193_5925_1956_8503_207_208_5595_5594_4286_7157_1869_5295_3480 14 2.44E-09 1.93E-07 7.14E-09 16230 hsa-mir-378 hsa05219 Bladder cancer 595_9252_4193_5925_1956_5595_5594_4609_2064_7157_1869 11 1.01E-08 7.98E-07 2.85E-08 16231 hsa-mir-378 hsa04210 Apoptosis 3551_8517_8837_823_8503_207_208_1147_5970_7157_5295_4790_4792_5566 14 3.14E-08 2.48E-06 8.54E-08 16232 hsa-mir-378 hsa04540 Gap junction 10382_1956_6714_6654_2885_5592_5595_5594_347733_2770_5566_7278_84617_203068 14 5.13E-08 4.06E-06 1.35E-07 16233 hsa-mir-378 hsa04150 mTOR signaling pathway 3091_8503_207_208_5595_5594_7249_6195_6196_6197_5295 11 6.76E-08 5.34E-06 1.72E-07 16234 hsa-mir-378 hsa04120 Ubiquitin mediated proteolysis 4193_6502_6500_3093_8945_23291_10273_10401_7323_11059_4214_5371_672_8454_7329_8554 16 1.70E-07 1.35E-05 4.21E-07 16235 hsa-mir-378 hsa04720 Long-term potentiation 5595_5594_1387_468_6195_6196_6197_2033_808_801_805_5566 12 2.56E-07 2.03E-05 6.14E-07 16236 hsa-mir-378 hsa04912 GnRH signaling pathway 1956_6714_6654_1432_2885_5595_5594_4214_468_3725_808_801_805_5566 14 2.71E-07 2.14E-05 6.30E-07 16237 hsa-mir-378 hsa05016 Huntington's disease 6667_10891_292_293_1213_3065_3064_627_4716_1387_9001_5430_5437_7157_2033_6874_6908_5441 18 3.68E-07 2.90E-05 8.30E-07 16238 hsa-mir-378 hsa05216 Thyroid cancer 1499_595_7175_5595_5594_4609_6256_7157 8 7.67E-07 6.06E-05 1.68E-06 16239 hsa-mir-378 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3551_8517_1956_6714_1432_1147_5970_3725_5058_4790_4792 11 1.08E-06 8.50E-05 2.30E-06 16240 hsa-mir-378 hsa04916 Melanogenesis 1499_5595_5594_1387_4286_2932_2033_808_801_805_2770_5566 12 5.75E-06 0.000454413 1.20E-05 16241 hsa-mir-378 hsa03020 RNA polymerase 25885_64425_51082_5430_5437_84172_5441 7 8.11E-06 0.000641001 1.64E-05 16242 hsa-mir-378 hsa04370 VEGF signaling pathway 7867_6714_1432_8503_207_208_5595_5594_5295_9261 10 1.35E-05 0.001070004 2.68E-05 16243 hsa-mir-378 hsa04612 Antigen processing and presentation 6890_3309_3305_3303_3310_3312_3320_3326_4800_4801 10 4.22E-05 0.003333801 8.13E-05 16244 hsa-mir-378 hsa05131 Shigellosis 1499_10382_25_71_347733_7278_84617_203068 8 5.37E-05 0.004239776 9.86E-05 16245 hsa-mir-378 hsa05130 Pathogenic Escherichia coli infection 1499_10382_25_71_347733_7278_84617_203068 8 5.37E-05 0.004239776 9.86E-05 16246 hsa-mir-378 hsa04530 Tight junction 10207_1499_1457_6714_4627_4628_10627_207_208_71_1460_2770 12 7.13E-05 0.005633763 0.00012804 16247 hsa-mir-378 hsa04650 Natural killer cell mediated cytotoxicity 5777_3454_3455_3932_6654_8503_2885_5595_5594_5295_5058_6464 12 7.61E-05 0.006009804 0.000133551 16248 hsa-mir-378 hsa03420 Nucleotide excision repair 902_5887_4331_2965_2967_2968_1022 7 8.59E-05 0.006786095 0.000147524 16249 hsa-mir-378 hsa04664 Fc epsilon RI signaling pathway 6654_1432_8503_2885_207_208_5595_5594_5295 9 9.21E-05 0.007275199 0.000154791 16250 hsa-mir-378 hsa04330 Notch signaling pathway 3065_1387_9612_2033_8850_388585_4851 7 0.00012451 0.009836309 0.000204923 16251 hsa-mir-378 hsa04810 Regulation of actin cytoskeleton 1956_6654_4627_4628_8503_10627_71_5595_5594_56924_1729_9564_5295_5058_10788 15 0.000129135 0.010201677 0.000208197 16252 hsa-mir-378 hsa04670 Leukocyte transendothelial migration 1499_653361_1432_8503_7852_10627_71_9564_5295_2770 10 0.00045893 0.036255495 0.00072511 16253 hsa-mir-378 hsa04930 Type II diabetes mellitus 3551_3651_8503_5595_5594_5295 6 0.000647083 0.051119537 0.001002344 16254 hsa-mir-378 hsa03050 Proteasome 5705_5701_5702_5719_5710_5698 6 0.000880432 0.069554125 0.001337579 16255 hsa-mir-378 hsa04950 Maturity onset diabetes of the young 3651_168620_5080_3172 4 0.002563547 0.202520207 0.003821136 16256 hsa-mir-378 hsa04360 Axon guidance 25_5998_7852_5595_5594_56924_2932_5058_2770 9 0.002729062 0.215595868 0.003992516 16257 hsa-mir-378 hsa04115 p53 signaling pathway 595_4193_4616_7249_7157_10912 6 0.004759282 0.375983284 0.00683606 16258 hsa-mir-378 hsa04270 Vascular smooth muscle contraction 5592_5595_5594_4637_808_801_805_5566 8 0.004968058 0.392476567 0.00700851 16259 hsa-mir-378 hsa03010 Ribosome 6156_6207_6202_9349_6130_6229_6128 7 0.007879311 0.62246554 0.010920448 16260 hsa-mir-378 hsa04340 Hedgehog signaling pathway 8945_23291_2932_2736_5566 5 0.009402923 0.742830926 0.012592953 16261 hsa-mir-378 hsa03410 Base excision repair 3146_4350_142_6996 4 0.009404863 0.74298421 0.012592953 16262 hsa-mir-378 hsa05010 Alzheimer's disease 823_4716_5595_5594_2932_808_801_805_9451 9 0.016392779 1 0.021583826 16263 hsa-mir-378 hsa04730 Long-term depression 5592_5595_5594_3480_2770 5 0.021225944 1 0.027489337 16264 hsa-mir-378 hsa04070 Phosphatidylinositol signaling system 8503_5295_808_801_805 5 0.027082025 1 0.034507741 16265 hsa-mir-378 hsa05217 Basal cell carcinoma 1499_2932_7157_2736 4 0.034467721 1 0.043221427 16266 hsa-mir-378 hsa05340 Primary immunodeficiency 8517_6890_3932 3 0.044260429 1 0.054633967 16267 hsa-mir-378b hsa05215 Prostate cancer 3320_1499_5595_1387_208_367_5970_468_5925_2033_207_4790 12 4.70E-15 2.87E-13 1.62E-13 16268 hsa-mir-378b hsa05212 Pancreatic cancer 3320_1499_5595_1387_208_367_5970_468_5925_2033_207_4790 12 5.32E-15 3.25E-13 1.62E-13 16269 hsa-mir-378b hsa05200 Pathways in cancer 3320_1499_5595_5599_1387_5601_208_367_6772_5970_3725_4088_4089_5925_2033_207_4790 17 3.00E-14 1.83E-12 6.11E-13 16270 hsa-mir-378b hsa04010 MAPK signaling pathway 9479_6722_5595_5599_1386_5601_3303_208_3312_5970_468_3725_3727_207_4790 15 4.12E-13 2.51E-11 6.28E-12 16271 hsa-mir-378b hsa04310 Wnt signaling pathway 815_5518_1499_5599_1387_5601_6423_3725_1457_4088_4089_2033 12 1.91E-12 1.16E-10 2.33E-11 16272 hsa-mir-378b hsa04110 Cell cycle 993_7534_5591_1387_983_7531_4088_4089_5925_2033 10 8.11E-11 4.95E-09 8.25E-10 16273 hsa-mir-378b hsa05210 Colorectal cancer 1499_5595_5599_5601_208_3725_4088_4089_207 9 9.99E-11 6.09E-09 8.70E-10 16274 hsa-mir-378b hsa04620 Toll-like receptor signaling pathway 5595_5599_5601_208_6772_5970_3725_207_4790 9 4.95E-10 3.02E-08 3.78E-09 16275 hsa-mir-378b hsa05220 Chronic myeloid leukemia 5595_208_5970_4088_4089_5925_207_4790 8 1.18E-09 7.18E-08 7.97E-09 16276 hsa-mir-378b hsa03022 Basal transcription factors 6879_6872_6908_2958_2959_6880 6 1.56E-08 9.49E-07 9.49E-08 16277 hsa-mir-378b hsa04520 Adherens junction 1499_5595_1387_1457_4088_4089_2033 7 4.75E-08 2.90E-06 2.63E-07 16278 hsa-mir-378b hsa04350 TGF-beta signaling pathway 5518_5595_1387_3398_4088_4089_2033 7 8.13E-08 4.96E-06 3.82E-07 16279 hsa-mir-378b hsa04012 ErbB signaling pathway 815_5595_5599_5601_208_3725_207 7 8.13E-08 4.96E-06 3.82E-07 16280 hsa-mir-378b hsa04660 T cell receptor signaling pathway 5595_5601_208_5970_3725_207_4790 7 3.66E-07 2.23E-05 1.60E-06 16281 hsa-mir-378b hsa04920 Adipocytokine signaling pathway 5599_5601_208_5970_207_4790 6 3.95E-07 2.41E-05 1.61E-06 16282 hsa-mir-378b hsa05211 Renal cell carcinoma 5595_1387_208_3725_2033_207 6 5.87E-07 3.58E-05 2.24E-06 16283 hsa-mir-378b hsa04662 B cell receptor signaling pathway 5595_208_5970_3725_207_4790 6 7.35E-07 4.48E-05 2.64E-06 16284 hsa-mir-378b hsa05221 Acute myeloid leukemia 5595_208_5970_207_4790 5 4.94E-06 0.000301551 1.68E-05 16285 hsa-mir-378b hsa04912 GnRH signaling pathway 815_5595_5599_5601_468_3725 6 5.45E-06 0.000332391 1.75E-05 16286 hsa-mir-378b hsa05214 Glioma 815_5595_208_5925_207 5 7.70E-06 0.000469954 2.35E-05 16287 hsa-mir-378b hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5601_5970_3725_4790 5 1.15E-05 0.000704302 3.35E-05 16288 hsa-mir-378b hsa04062 Chemokine signaling pathway 5595_208_2931_6772_5970_207_4790 7 1.30E-05 0.000791521 3.60E-05 16289 hsa-mir-378b hsa04720 Long-term potentiation 815_5595_1387_468_2033 5 1.48E-05 0.0009053 3.94E-05 16290 hsa-mir-378b hsa04664 Fc epsilon RI signaling pathway 5595_5599_5601_208_207 5 1.88E-05 0.001148427 4.68E-05 16291 hsa-mir-378b hsa04510 Focal adhesion 1499_5595_5599_5601_208_3725_207 7 1.95E-05 0.001188303 4.68E-05 16292 hsa-mir-378b hsa04530 Tight junction 5518_1499_208_8189_1457_207 6 1.99E-05 0.001215798 4.68E-05 16293 hsa-mir-378b hsa05222 Small cell lung cancer 208_5970_5925_207_4790 5 2.78E-05 0.001693275 6.27E-05 16294 hsa-mir-378b hsa04210 Apoptosis 823_208_5970_207_4790 5 3.25E-05 0.001980375 7.07E-05 16295 hsa-mir-378b hsa03450 Non-homologous end-joining 5591_7520_2547 3 3.64E-05 0.002220409 7.66E-05 16296 hsa-mir-378b hsa05213 Endometrial cancer 1499_5595_208_207 4 6.58E-05 0.004010941 0.00012987 16297 hsa-mir-378b hsa04916 Melanogenesis 815_1499_5595_1387_2033 5 6.60E-05 0.004025985 0.00012987 16298 hsa-mir-378b hsa05223 Non-small cell lung cancer 5595_208_5925_207 4 7.55E-05 0.004605795 0.000143931 16299 hsa-mir-378b hsa05218 Melanoma 5595_208_5925_207 4 0.000205686 0.012546835 0.000380207 16300 hsa-mir-378b hsa04910 Insulin signaling pathway 5595_5599_5601_208_207 5 0.000236438 0.01442274 0.000424198 16301 hsa-mir-378b hsa04630 Jak-STAT signaling pathway 1387_208_6772_2033_207 5 0.00039667 0.024196856 0.000691339 16302 hsa-mir-378b hsa04612 Antigen processing and presentation 3320_3303_1514_3312 4 0.000468491 0.028577975 0.000793833 16303 hsa-mir-378b hsa04930 Type II diabetes mellitus 5595_5599_5601 3 0.000848743 0.051773332 0.001399279 16304 hsa-mir-378b hsa04330 Notch signaling pathway 1387_2033_8850 3 0.000956438 0.058342748 0.001535335 16305 hsa-mir-378b hsa04150 mTOR signaling pathway 5595_208_207 3 0.001262442 0.077008991 0.00197459 16306 hsa-mir-378b hsa04370 VEGF signaling pathway 5595_208_207 3 0.00368737 0.224929594 0.00562324 16307 hsa-mir-378b hsa05216 Thyroid cancer 1499_5595 2 0.006358195 0.387849897 0.009459754 16308 hsa-mir-378b hsa05219 Bladder cancer 5595_5925 2 0.012521396 0.763805163 0.018185837 16309 hsa-mir-378b hsa04120 Ubiquitin mediated proteolysis 672_10273_7329 3 0.017661862 1 0.0250552 16310 hsa-mir-378b hsa05131 Shigellosis 7534_1499 2 0.0211296 1 0.028642346 16311 hsa-mir-378b hsa05130 Pathogenic Escherichia coli infection 7534_1499 2 0.0211296 1 0.028642346 16312 hsa-mir-378b hsa04730 Long-term depression 5518_5595 2 0.032366155 1 0.04226048 16313 hsa-mir-378b hsa05010 Alzheimer's disease 5595_823_9451 3 0.032561353 1 0.04226048 16314 hsa-mir-378b hsa05016 Huntington's disease 1387_6908_2033 3 0.037789401 1 0.04802403 16315 hsa-mir-379 hsa04010 MAPK signaling pathway 6722_8986_5595_5594_5599_9261_5601_5600_5603_6197_9252_1432_1649_5970_10912_4609_3725_3727_6195_6196_2353_4616_207_8550 24 4.38E-25 2.63E-23 2.63E-23 16316 hsa-mir-379 hsa05200 Pathways in cancer 5371_5595_5594_5599_6258_1387_6257_6256_8031_5601_367_2932_5970_4609_3725_2353_2736_4088_4089_1050_5925_2033_207_8554 24 3.35E-23 2.01E-21 1.00E-21 16317 hsa-mir-379 hsa05210 Colorectal cancer 5595_5594_5599_5601_2932_4609_3725_2353_4088_4089_207 11 9.21E-14 5.53E-12 1.84E-12 16318 hsa-mir-379 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5601_5600_5603_1432_5970_3725_2353_207 11 6.48E-13 3.89E-11 9.72E-12 16319 hsa-mir-379 hsa04660 T cell receptor signaling pathway 5595_5594_5601_5600_5603_2932_1432_5970_3725_2353_207 11 1.39E-12 8.32E-11 1.66E-11 16320 hsa-mir-379 hsa04310 Wnt signaling pathway 5599_1387_5601_2932_8061_4609_3725_1457_1459_4088_4089_2033 12 1.72E-12 1.03E-10 1.72E-11 16321 hsa-mir-379 hsa05215 Prostate cancer 5595_5594_1387_367_2932_5970_9586_5925_2033_207 10 4.68E-12 2.81E-10 3.89E-11 16322 hsa-mir-379 hsa05212 Pancreatic cancer 5595_5594_1387_367_2932_5970_9586_5925_2033_207 10 5.19E-12 3.11E-10 3.89E-11 16323 hsa-mir-379 hsa05216 Thyroid cancer 5595_5594_6258_6257_6256_8031_4609 7 7.50E-11 4.50E-09 5.00E-10 16324 hsa-mir-379 hsa04920 Adipocytokine signaling pathway 10891_5599_6258_6257_6256_5601_5970_207 8 4.82E-10 2.89E-08 2.89E-09 16325 hsa-mir-379 hsa05220 Chronic myeloid leukemia 5595_5594_5970_4609_4088_4089_5925_207 8 1.10E-09 6.59E-08 5.99E-09 16326 hsa-mir-379 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5601_5600_5603_1432_207 8 1.61E-09 9.64E-08 8.03E-09 16327 hsa-mir-379 hsa04520 Adherens junction 5595_5594_1387_1457_1459_4088_4089_2033 8 1.76E-09 1.06E-07 8.13E-09 16328 hsa-mir-379 hsa05222 Small cell lung cancer 6258_6257_6256_5970_4609_5925_207_8554 8 2.99E-09 1.80E-07 1.28E-08 16329 hsa-mir-379 hsa04012 ErbB signaling pathway 5595_5594_5599_5601_2932_4609_3725_207 8 3.26E-09 1.95E-07 1.30E-08 16330 hsa-mir-379 hsa05223 Non-small cell lung cancer 5595_5594_6258_6257_6256_5925_207 7 3.62E-09 2.17E-07 1.36E-08 16331 hsa-mir-379 hsa05221 Acute myeloid leukemia 5371_5595_5594_5970_4609_1050_207 7 6.36E-09 3.82E-07 2.25E-08 16332 hsa-mir-379 hsa04912 GnRH signaling pathway 5595_5594_5599_5601_5600_5603_1432_3725 8 1.59E-08 9.56E-07 5.31E-08 16333 hsa-mir-379 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5601_5600_5603_1432_5970_3725 7 2.08E-08 1.25E-06 6.57E-08 16334 hsa-mir-379 hsa04720 Long-term potentiation 5595_5594_1387_6197_6195_6196_2033 7 2.95E-08 1.77E-06 8.44E-08 16335 hsa-mir-379 hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_3725_2353_207 7 2.95E-08 1.77E-06 8.44E-08 16336 hsa-mir-379 hsa04110 Cell cycle 1387_2932_10912_4088_4089_4616_5925_2033 8 3.25E-08 1.95E-06 8.85E-08 16337 hsa-mir-379 hsa04370 VEGF signaling pathway 5595_5594_9261_5600_5603_1432_207 7 3.50E-08 2.10E-06 9.13E-08 16338 hsa-mir-379 hsa04350 TGF-beta signaling pathway 5595_5594_1387_4609_4088_4089_2033 7 7.66E-08 4.60E-06 1.92E-07 16339 hsa-mir-379 hsa04150 mTOR signaling pathway 5595_5594_6197_6195_6196_207 6 9.36E-08 5.62E-06 2.25E-07 16340 hsa-mir-379 hsa05211 Renal cell carcinoma 5595_5594_1387_3725_2033_207 6 5.58E-07 3.35E-05 1.29E-06 16341 hsa-mir-379 hsa05219 Bladder cancer 5595_5594_9252_4609_5925 5 1.00E-06 6.02E-05 2.23E-06 16342 hsa-mir-379 hsa04930 Type II diabetes mellitus 3651_5595_5594_5599_5601 5 1.37E-06 8.24E-05 2.94E-06 16343 hsa-mir-379 hsa04910 Insulin signaling pathway 10891_5595_5594_5599_5601_2932_207 7 1.47E-06 8.83E-05 3.05E-06 16344 hsa-mir-379 hsa05213 Endometrial cancer 5595_5594_2932_4609_207 5 2.66E-06 0.000159502 5.32E-06 16345 hsa-mir-379 hsa04510 Focal adhesion 5595_5594_5599_5601_2932_3725_207 7 1.84E-05 0.001105086 3.56E-05 16346 hsa-mir-379 hsa04916 Melanogenesis 5595_5594_1387_2932_2033 5 6.33E-05 0.003800757 0.000118774 16347 hsa-mir-379 hsa05214 Glioma 5595_5594_5925_207 4 0.000144048 0.008642879 0.000261905 16348 hsa-mir-379 hsa03320 PPAR signaling pathway 6258_6257_6256_2168 4 0.000188932 0.011335908 0.000333409 16349 hsa-mir-379 hsa05218 Melanoma 5595_5594_5925_207 4 0.000198991 0.011939481 0.000341128 16350 hsa-mir-379 hsa04630 Jak-STAT signaling pathway 1387_4609_2033_207_8554 5 0.000381246 0.022874773 0.00063541 16351 hsa-mir-379 hsa05016 Huntington's disease 10891_1387_9586_3064_2033 5 0.000891044 0.05346266 0.001444937 16352 hsa-mir-379 hsa04330 Notch signaling pathway 1387_9612_2033 3 0.000932877 0.055972639 0.001472964 16353 hsa-mir-379 hsa04062 Chemokine signaling pathway 5595_5594_2932_5970_207 5 0.000998797 0.059927793 0.00153661 16354 hsa-mir-379 hsa05014 Amyotrophic lateral sclerosis (ALS) 5600_5603_1432 3 0.001509192 0.090551513 0.002263788 16355 hsa-mir-379 hsa04120 Ubiquitin mediated proteolysis 5371_672_7329_8554 4 0.002241587 0.134495207 0.003280371 16356 hsa-mir-379 hsa04730 Long-term depression 5592_5595_5594 3 0.002887137 0.173228218 0.004124481 16357 hsa-mir-379 hsa04540 Gap junction 5592_5595_5594 3 0.005989264 0.359355857 0.008357113 16358 hsa-mir-379 hsa04270 Vascular smooth muscle contraction 5592_5595_5594 3 0.011271142 0.676268533 0.015369739 16359 hsa-mir-379 hsa04670 Leukocyte transendothelial migration 5600_5603_1432 3 0.012300877 0.738052647 0.01640117 16360 hsa-mir-379 hsa04360 Axon guidance 5595_5594_2932 3 0.0148096 0.888576026 0.01931687 16361 hsa-mir-379 hsa04530 Tight junction 1457_1459_207 3 0.016631079 0.99786473 0.021231164 16362 hsa-mir-379 hsa05217 Basal cell carcinoma 2932_2736 2 0.020124536 1 0.02515567 16363 hsa-mir-379 hsa04340 Hedgehog signaling pathway 2932_2736 2 0.021468557 1 0.026288029 16364 hsa-mir-379 hsa04115 p53 signaling pathway 10912_4616 2 0.030273723 1 0.036328467 16365 hsa-mir-379 hsa05010 Alzheimer's disease 5595_5594_2932 3 0.031857832 1 0.037479802 16366 hsa-mir-379 hsa04210 Apoptosis 5970_207 2 0.047505391 1 0.054813912 16367 hsa-mir-380 hsa05200 Pathways in cancer 3716_4609_3320_25_5371_3065_5595_5594_5599_2736_1387_6256_5159_595_861_5156_5601_5602_836_3815_6258_1399_1398_367_4088_6934_5914_7704_842_6774_6776_6772_3091_5970_7046_8554_7157_4824_4087_6688_4089_2113_3725_841_867_2353_1050_5925_2033_207_2932_4790_4792_1956 54 7.87E-35 6.06E-33 6.06E-33 16368 hsa-mir-380 hsa04010 MAPK signaling pathway 4609_6722_5595_5594_5599_8986_1386_5159_5156_5601_5600_5602_836_1399_1398_9252_1432_1649_5970_7046_6196_9261_7157_468_3725_3727_6195_2353_6197_207_5603_8550_4790_2002_1956_2005_4773 37 1.07E-21 8.26E-20 4.13E-20 16369 hsa-mir-380 hsa05215 Prostate cancer 3320_5595_5594_1387_5159_595_5156_367_6934_842_5970_7157_4824_468_9586_1385_10488_5925_2033_207_2932_4790_4792_1956 24 1.39E-20 1.07E-18 3.35E-19 16370 hsa-mir-380 hsa05212 Pancreatic cancer 3320_5595_5594_1387_5159_595_5156_367_6934_842_5970_7157_4824_468_9586_1385_10488_5925_2033_207_2932_4790_4792_1956 24 1.74E-20 1.34E-18 3.35E-19 16371 hsa-mir-380 hsa05220 Chronic myeloid leukemia 4609_25_3065_5595_5594_595_861_1399_1398_4088_6776_5970_7046_7157_5781_4089_867_5925_207_4790_4792_6464 22 1.50E-19 1.16E-17 2.31E-18 16372 hsa-mir-380 hsa05210 Colorectal cancer 4609_5595_5594_5599_5159_595_5156_5601_5602_836_4088_6934_842_7046_7157_4087_4089_3725_2353_207_2932_1956 22 1.18E-18 9.06E-17 1.51E-17 16373 hsa-mir-380 hsa04012 ErbB signaling pathway 4609_25_5595_6714_5594_5599_2066_5601_5602_1399_1398_6776_3725_867_815_207_2932_6464_2002_1956 20 3.87E-16 2.98E-14 4.25E-15 16374 hsa-mir-380 hsa04630 Jak-STAT signaling pathway 3717_3716_4609_3559_3560_3566_1387_595_896_3575_5777_6774_6775_6776_6772_6773_2690_8554_2057_5781_867_2033_894_207 24 1.16E-15 8.91E-14 1.11E-14 16375 hsa-mir-380 hsa05221 Acute myeloid leukemia 4609_5371_5595_5594_595_861_3815_6934_5914_7704_6774_6776_5970_6688_1050_207_4790 17 2.68E-15 2.06E-13 2.29E-14 16376 hsa-mir-380 hsa04520 Adherens junction 4301_5595_6714_3643_5594_1387_4088_6934_5770_5777_7046_4087_4089_1459_2033_71_1457_1956 18 1.61E-14 1.24E-12 1.24E-13 16377 hsa-mir-380 hsa04310 Wnt signaling pathway 4609_5515_5599_1387_595_5601_5602_896_4088_6934_7157_4087_4089_8061_3725_815_1459_2033_894_2932_1457_4773 22 6.24E-14 4.80E-12 4.37E-13 16378 hsa-mir-380 hsa04660 T cell receptor signaling pathway 1493_5595_5594_5601_5600_919_5777_1432_5970_3725_867_2353_207_5603_2932_4790_4792_4773 18 1.93E-12 1.48E-10 1.24E-11 16379 hsa-mir-380 hsa04110 Cell cycle 25_993_3065_5591_1387_595_983_896_4088_7533_7157_4087_4089_5925_2033_894_2932 17 5.45E-11 4.19E-09 3.18E-10 16380 hsa-mir-380 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5601_5600_5602_1432_6772_5970_3725_841_2353_207_5603_4790_4792 16 5.79E-11 4.46E-09 3.18E-10 16381 hsa-mir-380 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5599_5601_5600_5602_836_1432_5970_5781_3725_5603_4790_4792_1956 14 6.38E-11 4.91E-09 3.27E-10 16382 hsa-mir-380 hsa04510 Focal adhesion 5595_6714_5594_5599_5159_595_5156_5601_5602_896_1399_1398_3725_894_207_2932_71_6464_2002_1956 20 6.05E-10 4.66E-08 2.91E-09 16383 hsa-mir-380 hsa05213 Endometrial cancer 4609_5595_5594_595_6934_842_7157_207_2932_2002_1956 11 3.80E-09 2.93E-07 1.67E-08 16384 hsa-mir-380 hsa04920 Adipocytokine signaling pathway 3717_5599_6256_5601_5602_6258_6774_5970_5781_207_4790_4792 12 3.91E-09 3.01E-07 1.67E-08 16385 hsa-mir-380 hsa04912 GnRH signaling pathway 5595_6714_5594_5599_5601_5600_5602_1432_468_3725_815_5603_2002_1956 14 8.45E-09 6.51E-07 3.43E-08 16386 hsa-mir-380 hsa04910 Insulin signaling pathway 5595_3643_5594_5590_5599_5601_5602_1399_1398_5770_867_207_2932_6464_2002 15 2.17E-08 1.67E-06 8.35E-08 16387 hsa-mir-380 hsa05214 Glioma 5595_5594_5159_595_5156_7157_815_5925_207_6464_1956 11 2.94E-08 2.27E-06 1.08E-07 16388 hsa-mir-380 hsa05222 Small cell lung cancer 4609_6256_595_6258_842_5970_8554_7157_5925_207_4790_4792 12 4.74E-08 3.65E-06 1.66E-07 16389 hsa-mir-380 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_6258_842_7157_5925_207_1956 10 5.94E-08 4.57E-06 1.99E-07 16390 hsa-mir-380 hsa05211 Renal cell carcinoma 5595_5594_1387_1399_1398_3091_5781_2113_3725_2033_207 11 7.52E-08 5.79E-06 2.41E-07 16391 hsa-mir-380 hsa05216 Thyroid cancer 4609_5595_5594_6256_595_6258_6934_7157 8 9.09E-08 7.00E-06 2.80E-07 16392 hsa-mir-380 hsa04662 B cell receptor signaling pathway 5595_5594_5777_5970_3725_2353_207_2932_4790_4792_4773 11 1.09E-07 8.41E-06 3.23E-07 16393 hsa-mir-380 hsa04062 Chemokine signaling pathway 3717_5595_5594_5590_1399_1398_6774_6772_6773_5970_7852_207_2932_4790_4792_6464 16 2.37E-07 1.82E-05 6.75E-07 16394 hsa-mir-380 hsa04350 TGF-beta signaling pathway 4609_5515_5595_5594_1387_6667_4088_7046_4087_4089_2033 11 4.22E-07 3.25E-05 1.16E-06 16395 hsa-mir-380 hsa03022 Basal transcription factors 2963_2962_2969_2959_6874_6908_6872_6883 8 4.54E-07 3.50E-05 1.21E-06 16396 hsa-mir-380 hsa05016 Huntington's disease 6874_25942_3065_1387_6908_836_6667_842_7157_9586_1385_841_10488_3064_2033 15 8.82E-07 6.79E-05 2.26E-06 16397 hsa-mir-380 hsa05219 Bladder cancer 4609_5595_5594_595_9252_7157_5925_1956 8 1.06E-06 8.13E-05 2.62E-06 16398 hsa-mir-380 hsa04370 VEGF signaling pathway 5595_6714_5594_5600_1432_842_9261_207_5603_4773 10 1.14E-06 8.75E-05 2.73E-06 16399 hsa-mir-380 hsa04930 Type II diabetes mellitus 5595_3643_5594_5590_5599_5601_5602_3651 8 1.67E-06 0.000128872 3.91E-06 16400 hsa-mir-380 hsa04210 Apoptosis 839_836_842_840_5970_7157_841_207_4790_4792 10 3.74E-06 0.000288121 8.33E-06 16401 hsa-mir-380 hsa04115 p53 signaling pathway 595_983_836_896_842_7157_841_64326_894 9 3.79E-06 0.000291688 8.33E-06 16402 hsa-mir-380 hsa05218 Melanoma 5595_5594_5159_595_5156_7157_5925_207_1956 9 4.69E-06 0.00036078 1.00E-05 16403 hsa-mir-380 hsa04720 Long-term potentiation 5595_5594_1387_6196_468_815_6195_6197_2033 9 7.04E-06 0.000541858 1.46E-05 16404 hsa-mir-380 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5601_5600_5602_1432_207_5603 9 1.03E-05 0.00079566 2.09E-05 16405 hsa-mir-380 hsa04916 Melanogenesis 5595_5594_1387_3815_6934_1385_815_10488_2033_2932 10 1.33E-05 0.001020952 2.62E-05 16406 hsa-mir-380 hsa04150 mTOR signaling pathway 5595_5594_3091_6196_6195_6197_207 7 3.82E-05 0.002939994 7.35E-05 16407 hsa-mir-380 hsa04540 Gap junction 5595_6714_5594_5592_5159_983_5156_1956 8 0.000197883 0.015237007 0.000371634 16408 hsa-mir-380 hsa05014 Amyotrophic lateral sclerosis (ALS) 5600_836_1432_842_7157_5603 6 0.000426501 0.032840598 0.000781919 16409 hsa-mir-380 hsa04330 Notch signaling pathway 3065_1387_9612_2033_8850 5 0.001328783 0.102316256 0.002379448 16410 hsa-mir-380 hsa04060 Cytokine-cytokine receptor interaction 3559_3560_3566_5159_5156_3575_3815_7046_2690_7852_2057_1956 12 0.001435451 0.110529762 0.00251204 16411 hsa-mir-380 hsa04530 Tight junction 4301_5515_6714_5590_1459_207_71_1457 8 0.00214664 0.165291304 0.00367314 16412 hsa-mir-380 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_919_5777_5781_6464_4773 8 0.002240632 0.172528661 0.003750623 16413 hsa-mir-380 hsa04120 Ubiquitin mediated proteolysis 55294_5371_83737_672_8554_7329_867_64326 8 0.002337824 0.180012451 0.003830052 16414 hsa-mir-380 hsa04670 Leukocyte transendothelial migration 4301_5600_1432_7852_5781_5603_71 7 0.004381591 0.337382491 0.007028802 16415 hsa-mir-380 hsa05010 Alzheimer's disease 22926_5595_5594_836_842_840_841_2932 8 0.009192498 0.707822383 0.014445355 16416 hsa-mir-380 hsa05217 Basal cell carcinoma 2736_6934_7157_2932 4 0.013888925 1 0.021388944 16417 hsa-mir-380 hsa04640 Hematopoietic cell lineage 3559_3566_3575_3815_2057 5 0.015121618 1 0.022830678 16418 hsa-mir-380 hsa04612 Antigen processing and presentation 3320_1514_3308_4800_1385 5 0.016458803 1 0.024371689 16419 hsa-mir-380 hsa04360 Axon guidance 25_5595_5594_7852_2932_4773 6 0.021460977 1 0.031179155 16420 hsa-mir-380 hsa04810 Regulation of actin cytoskeleton 5595_5594_5159_5156_1399_1398_71_1956 8 0.027800577 1 0.039641563 16421 hsa-mir-380 hsa04730 Long-term depression 5515_5595_5594_5592 4 0.030554841 1 0.042776778 16422 hsa-mir-381 hsa05200 Pathways in cancer 3716_3320_3326_3725_5371_5747_3480_1956_1499_4233_5595_5594_5599_5914_1387_2064_5159_595_5156_1399_1398_367_2261_3815_6774_6776_6777_6772_5979_5879_7046_4087_2113_8772_1026_862_867_6502_2353_10401_4089_3066_3065_5925_2033_1441_207_8554_4790_5970 50 1.58E-40 1.15E-38 1.15E-38 16423 hsa-mir-381 hsa04630 Jak-STAT signaling pathway 3717_3716_3718_3559_6773_85480_3560_3561_149233_1387_595_3575_3570_3572_3953_5777_2057_6774_6776_6777_6772_1439_3454_3455_5781_867_2690_10401_58985_7297_2033_1441_3459_207_8554_10379 36 3.58E-35 2.61E-33 1.31E-33 16424 hsa-mir-381 hsa04060 Cytokine-cytokine receptor interaction 3556_2321_3559_85480_1956_90_4233_3560_3561_149233_5159_5156_7132_3575_3570_3572_1234_1230_3815_3953_2057_1439_7046_3791_7852_3454_3455_2690_58985_7133_1441_3459 32 1.33E-23 9.72E-22 3.24E-22 16425 hsa-mir-381 hsa04520 Adherens junction 2534_3643_2241_3480_1956_1499_6714_4233_5595_5594_1387_2064_5770_5777_5879_7046_4087_6885_4089_2033_51701_4301 22 2.90E-23 2.11E-21 5.29E-22 16426 hsa-mir-381 hsa05220 Chronic myeloid leukemia 5595_5594_595_1399_1398_6776_6777_7046_5781_1026_867_4089_3066_3065_5925_207_4790_5970_6464 19 1.10E-19 8.06E-18 1.61E-18 16427 hsa-mir-381 hsa04010 MAPK signaling pathway 3925_6722_3725_1956_5595_5594_5599_5159_9261_5156_4208_7132_1399_1398_2261_2264_9252_7867_1432_5879_7046_6885_2353_1845_207_4790_51701_5970 28 6.15E-19 4.49E-17 7.48E-18 16428 hsa-mir-381 hsa04012 ErbB signaling pathway 3725_818_817_5747_1956_6714_5595_5594_5599_2064_2066_1399_1398_6776_6777_1026_867_207_6464 19 1.23E-18 8.98E-17 1.28E-17 16429 hsa-mir-381 hsa05215 Prostate cancer 3320_3326_3480_1956_1499_5595_5594_1387_2064_5159_595_5156_367_1026_5925_2033_207_4790_5970 19 1.48E-18 1.08E-16 1.35E-17 16430 hsa-mir-381 hsa05212 Pancreatic cancer 3320_3326_3480_1956_1499_5595_5594_1387_2064_5159_595_5156_367_1026_5925_2033_207_4790_5970 19 1.78E-18 1.30E-16 1.45E-17 16431 hsa-mir-381 hsa04062 Chemokine signaling pathway 3717_3718_5580_6773_5747_5590_5595_5594_1399_1398_1234_1230_6774_6777_6772_5879_7852_2185_207_3055_4790_5970_6464 23 4.65E-17 3.39E-15 3.39E-16 16432 hsa-mir-381 hsa05214 Glioma 818_817_3480_1956_5595_5594_5159_595_5156_1026_5925_808_207_6464_801_805 16 1.32E-16 9.66E-15 8.78E-16 16433 hsa-mir-381 hsa05210 Colorectal cancer 3725_3480_1956_1499_4233_5595_5594_5599_5159_595_5156_5879_7046_4087_2353_4089_207 17 2.53E-16 1.84E-14 1.54E-15 16434 hsa-mir-381 hsa04510 Focal adhesion 3725_2534_2321_5747_3480_1956_1499_6714_4233_5595_5594_5599_2064_5159_595_5156_1399_1398_5879_3791_207_6464 22 1.83E-15 1.34E-13 1.03E-14 16435 hsa-mir-381 hsa04620 Toll-like receptor signaling pathway 3725_3654_5595_5594_5599_1432_6772_5879_3454_3455_8772_6885_2353_207_4790_5970 16 6.58E-14 4.80E-12 3.43E-13 16436 hsa-mir-381 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_3815_6774_6776_6777_862_207_4790_5970 13 3.37E-13 2.46E-11 1.64E-12 16437 hsa-mir-381 hsa04350 TGF-beta signaling pathway 5515_57154_90_5595_5594_1387_3397_3398_7046_4087_3399_4086_4089_2033 14 1.82E-12 1.33E-10 8.30E-12 16438 hsa-mir-381 hsa04660 T cell receptor signaling pathway 3725_2534_3932_5595_5594_919_5777_1432_6885_867_2353_207_4790_5970_1493 15 2.50E-12 1.82E-10 1.07E-11 16439 hsa-mir-381 hsa04912 GnRH signaling pathway 3725_5580_818_817_1956_6714_5595_5594_5599_1432_2185_808_801_805 14 2.51E-11 1.83E-09 1.02E-10 16440 hsa-mir-381 hsa05211 Renal cell carcinoma 3725_4233_5595_5594_1387_1399_1398_5879_5781_2113_2033_207 12 4.96E-11 3.62E-09 1.91E-10 16441 hsa-mir-381 hsa04920 Adipocytokine signaling pathway 3717_8717_5599_7132_3953_6774_5781_7133_207_4790_5970 11 3.70E-10 2.70E-08 1.35E-09 16442 hsa-mir-381 hsa04910 Insulin signaling pathway 3643_5590_5595_5594_5599_1399_1398_5770_867_808_207_6464_801_805 14 4.88E-10 3.56E-08 1.62E-09 16443 hsa-mir-381 hsa04650 Natural killer cell mediated cytotoxicity 2534_3932_5595_5594_6850_919_5777_5879_3454_3455_5781_2185_3459_6464 14 4.88E-10 3.56E-08 1.62E-09 16444 hsa-mir-381 hsa05218 Melanoma 3480_1956_4233_5595_5594_5159_595_5156_1026_5925_207 11 6.43E-10 4.70E-08 2.04E-09 16445 hsa-mir-381 hsa04310 Wnt signaling pathway 5515_3725_818_817_1499_5599_1387_595_5879_4087_6885_4089_2033_51701 14 1.56E-09 1.14E-07 4.74E-09 16446 hsa-mir-381 hsa05219 Bladder cancer 1956_5595_5594_2064_595_2261_9252_1026_5925 9 1.92E-09 1.40E-07 5.61E-09 16447 hsa-mir-381 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1956_6714_4233_5599_1432_5879_5781_4790_5970 10 8.92E-09 6.51E-07 2.48E-08 16448 hsa-mir-381 hsa04110 Cell cycle 1387_595_4087_4174_1026_4172_6502_4089_3066_3065_5925_2033 12 9.16E-09 6.69E-07 2.48E-08 16449 hsa-mir-381 hsa04662 B cell receptor signaling pathway 3725_5595_5594_6850_5777_5879_2353_207_4790_5970 10 1.43E-08 1.05E-06 3.74E-08 16450 hsa-mir-381 hsa04370 VEGF signaling pathway 5747_6714_5595_5594_9261_7867_1432_5879_3791_207 10 1.80E-08 1.32E-06 4.54E-08 16451 hsa-mir-381 hsa04916 Melanogenesis 818_817_1499_5595_5594_1387_3815_808_2033_801_805 11 2.44E-08 1.78E-06 5.93E-08 16452 hsa-mir-381 hsa04330 Notch signaling pathway 388585_1387_3280_9612_3066_3065_2033_8850 8 7.57E-08 5.52E-06 1.78E-07 16453 hsa-mir-381 hsa04720 Long-term potentiation 818_817_5595_5594_1387_808_2033_801_805 9 1.74E-07 1.27E-05 3.97E-07 16454 hsa-mir-381 hsa04664 Fc epsilon RI signaling pathway 2534_5580_5595_5594_5599_6850_1432_5879_207 9 2.61E-07 1.91E-05 5.77E-07 16455 hsa-mir-381 hsa05222 Small cell lung cancer 5747_595_6502_10401_5925_207_8554_4790_5970 9 5.05E-07 3.69E-05 1.08E-06 16456 hsa-mir-381 hsa04210 Apoptosis 3654_3556_8717_7132_1439_8772_207_4790_5970 9 6.59E-07 4.81E-05 1.37E-06 16457 hsa-mir-381 hsa04020 Calcium signaling pathway 818_817_1956_2064_2066_5159_5156_2185_808_147_801_805 12 7.71E-07 5.63E-05 1.56E-06 16458 hsa-mir-381 hsa04930 Type II diabetes mellitus 3651_5580_3643_5590_5595_5594_5599 7 8.67E-07 6.33E-05 1.71E-06 16459 hsa-mir-381 hsa05213 Endometrial cancer 1956_1499_5595_5594_2064_595_207 7 2.08E-06 0.000152047 4.00E-06 16460 hsa-mir-381 hsa05223 Non-small cell lung cancer 1956_5595_5594_2064_595_5925_207 7 2.62E-06 0.00019114 4.90E-06 16461 hsa-mir-381 hsa05216 Thyroid cancer 1499_5595_5594_595_5979 5 2.15E-05 0.001573012 3.93E-05 16462 hsa-mir-381 hsa04810 Regulation of actin cytoskeleton 5747_1956_5595_5594_5159_5156_1399_1398_2261_2264_5879 11 2.32E-05 0.001692986 4.13E-05 16463 hsa-mir-381 hsa04670 Leukocyte transendothelial migration 5747_1499_1432_5879_7852_5781_2185_4301 8 5.27E-05 0.003848537 9.16E-05 16464 hsa-mir-381 hsa04360 Axon guidance 2534_2242_5747_4233_5595_5594_5879_7852 8 8.46E-05 0.006172465 0.000143546 16465 hsa-mir-381 hsa04120 Ubiquitin mediated proteolysis 5371_57154_672_7329_867_6502_10401_8554 8 0.0001249 0.00911768 0.00020722 16466 hsa-mir-381 hsa04950 Maturity onset diabetes of the young 3651_168620_6927_3280 4 0.000168116 0.012272452 0.000272721 16467 hsa-mir-381 hsa04270 Vascular smooth muscle contraction 5580_5595_5594_808_147_801_805 7 0.000277298 0.020242779 0.00044006 16468 hsa-mir-381 hsa04640 Hematopoietic cell lineage 3559_3575_3570_3815_2057_1441 6 0.000355858 0.025977652 0.000552716 16469 hsa-mir-381 hsa04540 Gap junction 1956_6714_5595_5594_5159_5156 6 0.000497584 0.036323618 0.000756742 16470 hsa-mir-381 hsa05340 Primary immunodeficiency 3718_3932_3561_3575 4 0.000619274 0.045207008 0.000922592 16471 hsa-mir-381 hsa04530 Tight junction 5515_5580_1499_6714_5590_207_4301 7 0.000650276 0.047470139 0.000949403 16472 hsa-mir-381 hsa05010 Alzheimer's disease 5595_5594_7132_8772_808_801_805 7 0.002665467 0.194579061 0.003815276 16473 hsa-mir-381 hsa05014 Amyotrophic lateral sclerosis (ALS) 7132_1432_5879_7133 4 0.003114266 0.227341433 0.004371951 16474 hsa-mir-381 hsa04730 Long-term depression 5515_3480_5595_5594 4 0.006906488 0.50417361 0.009457379 16475 hsa-mir-381 hsa03030 DNA replication 4174_6118_4172 3 0.006995869 0.510698455 0.009457379 16476 hsa-mir-381 hsa04150 mTOR signaling pathway 5595_5594_207 3 0.017864053 1 0.023710471 16477 hsa-mir-381 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.045259651 1 0.058999187 16478 hsa-mir-382 hsa05200 Pathways in cancer 8031_2033_8554_5970_5594_5599_6258_1387_6257_6256 10 3.31E-12 1.62E-10 1.62E-10 16479 hsa-mir-382 hsa04920 Adipocytokine signaling pathway 10891_5970_5599_6258_6257_6256 6 2.13E-10 1.04E-08 5.22E-09 16480 hsa-mir-382 hsa05216 Thyroid cancer 8031_5594_6258_6257_6256 5 3.72E-10 1.82E-08 6.07E-09 16481 hsa-mir-382 hsa05222 Small cell lung cancer 8554_5970_6258_6257_6256 5 5.93E-08 2.91E-06 7.27E-07 16482 hsa-mir-382 hsa05223 Non-small cell lung cancer 5594_6258_6257_6256 4 5.56E-07 2.72E-05 5.45E-06 16483 hsa-mir-382 hsa03320 PPAR signaling pathway 6258_2168_6257_6256 4 1.49E-06 7.29E-05 1.22E-05 16484 hsa-mir-382 hsa05215 Prostate cancer 2033_5970_5594_1387 4 3.56E-06 0.000174597 2.28E-05 16485 hsa-mir-382 hsa05212 Pancreatic cancer 2033_5970_5594_1387 4 3.72E-06 0.000182298 2.28E-05 16486 hsa-mir-382 hsa04110 Cell cycle 4616_10912_2033_1387 4 1.13E-05 0.000553413 6.15E-05 16487 hsa-mir-382 hsa04010 MAPK signaling pathway 4616_10912_5970_5594_5599 5 1.46E-05 0.000717326 7.17E-05 16488 hsa-mir-382 hsa04330 Notch signaling pathway 9612_2033_1387 3 2.50E-05 0.001227437 0.000111585 16489 hsa-mir-382 hsa05211 Renal cell carcinoma 2033_5594_1387 3 8.46E-05 0.004147737 0.000345645 16490 hsa-mir-382 hsa04720 Long-term potentiation 2033_5594_1387 3 9.51E-05 0.004662159 0.000358628 16491 hsa-mir-382 hsa04520 Adherens junction 2033_5594_1387 3 0.00011447 0.005609015 0.000400644 16492 hsa-mir-382 hsa04350 TGF-beta signaling pathway 2033_5594_1387 3 0.000145572 0.007133051 0.000475537 16493 hsa-mir-382 hsa04620 Toll-like receptor signaling pathway 5970_5594_5599 3 0.00022961 0.011250887 0.000699658 16494 hsa-mir-382 hsa04916 Melanogenesis 2033_5594_1387 3 0.000242739 0.01189419 0.000699658 16495 hsa-mir-382 hsa04910 Insulin signaling pathway 10891_5594_5599 3 0.00054478 0.026694224 0.001483012 16496 hsa-mir-382 hsa04310 Wnt signaling pathway 2033_5599_1387 3 0.000717318 0.035148589 0.001849926 16497 hsa-mir-382 hsa04630 Jak-STAT signaling pathway 2033_8554_1387 3 0.000758306 0.037156973 0.001857849 16498 hsa-mir-382 hsa04930 Type II diabetes mellitus 5594_5599 2 0.001302383 0.063816769 0.002918334 16499 hsa-mir-382 hsa05016 Huntington's disease 10891_2033_1387 3 0.001310272 0.064203352 0.002918334 16500 hsa-mir-382 hsa05221 Acute myeloid leukemia 5970_5594 2 0.002183021 0.106968027 0.004650784 16501 hsa-mir-382 hsa04115 p53 signaling pathway 4616_10912 2 0.002943471 0.144230074 0.006009586 16502 hsa-mir-382 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_5599 2 0.003108453 0.152314182 0.006092567 16503 hsa-mir-382 hsa05220 Chronic myeloid leukemia 5970_5594 2 0.003451156 0.169106634 0.006263209 16504 hsa-mir-382 hsa04662 B cell receptor signaling pathway 5970_5594 2 0.003451156 0.169106634 0.006263209 16505 hsa-mir-382 hsa04664 Fc epsilon RI signaling pathway 5594_5599 2 0.003810719 0.186725229 0.006668758 16506 hsa-mir-382 hsa05210 Colorectal cancer 5594_5599 2 0.004283653 0.209899019 0.007237897 16507 hsa-mir-382 hsa04012 ErbB signaling pathway 5594_5599 2 0.004579825 0.224411431 0.007480381 16508 hsa-mir-382 hsa04912 GnRH signaling pathway 5594_5599 2 0.006908049 0.338494385 0.010919174 16509 hsa-mir-382 hsa04660 T cell receptor signaling pathway 5970_5594 2 0.007152607 0.350477725 0.010952429 16510 hsa-mir-382 hsa04062 Chemokine signaling pathway 5970_5594 2 0.020530456 1 0.030484617 16511 hsa-mir-382 hsa04510 Focal adhesion 5594_5599 2 0.023154571 1 0.033369824 16512 hsa-mir-382 hsa05219 Bladder cancer 5594 1 0.047571124 1 0.066599573 16513 hsa-mir-383 hsa05200 Pathways in cancer 1499_3725_862_2249_367_5970_6776_6777_2353_5914_1387_6256 12 4.39E-12 2.59E-10 2.59E-10 16514 hsa-mir-383 hsa04350 TGF-beta signaling pathway 3399_6667_3400_3397_3398_1387 6 3.60E-08 2.13E-06 1.06E-06 16515 hsa-mir-383 hsa05221 Acute myeloid leukemia 862_5970_6776_6777_5914 5 2.02E-07 1.19E-05 3.98E-06 16516 hsa-mir-383 hsa04916 Melanogenesis 1499_808_801_1387_805 5 2.89E-06 0.000170624 4.07E-05 16517 hsa-mir-383 hsa04912 GnRH signaling pathway 3725_808_1432_801_805 5 3.45E-06 0.00020373 4.07E-05 16518 hsa-mir-383 hsa04720 Long-term potentiation 808_801_1387_805 4 2.06E-05 0.001213708 0.000202285 16519 hsa-mir-383 hsa05215 Prostate cancer 1499_367_5970_1387 4 3.75E-05 0.002213112 0.000288635 16520 hsa-mir-383 hsa05212 Pancreatic cancer 1499_367_5970_1387 4 3.91E-05 0.002309081 0.000288635 16521 hsa-mir-383 hsa04620 Toll-like receptor signaling pathway 3725_5970_1432_2353 4 6.53E-05 0.003852196 0.000428022 16522 hsa-mir-383 hsa04660 T cell receptor signaling pathway 3725_5970_1432_2353 4 8.66E-05 0.005112256 0.000511226 16523 hsa-mir-383 hsa05131 Shigellosis 1499_10971_7534 3 0.000238351 0.014062685 0.00115404 16524 hsa-mir-383 hsa05130 Pathogenic Escherichia coli infection 1499_10971_7534 3 0.000238351 0.014062685 0.00115404 16525 hsa-mir-383 hsa04010 MAPK signaling pathway 3725_2249_5970_1432_2353 5 0.00025428 0.01500252 0.00115404 16526 hsa-mir-383 hsa04310 Wnt signaling pathway 1499_3725_1452_1387 4 0.000289299 0.017068622 0.001219187 16527 hsa-mir-383 hsa04630 Jak-STAT signaling pathway 3977_6776_6777_1387 4 0.000311021 0.018350241 0.001223349 16528 hsa-mir-383 hsa05214 Glioma 808_801_805 3 0.000362704 0.021399546 0.001337472 16529 hsa-mir-383 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5970_1432 3 0.000465111 0.027441534 0.001614208 16530 hsa-mir-383 hsa05220 Chronic myeloid leukemia 5970_6776_6777 3 0.000542707 0.032019712 0.001661787 16531 hsa-mir-383 hsa04662 B cell receptor signaling pathway 3725_5970_2353 3 0.000542707 0.032019712 0.001661787 16532 hsa-mir-383 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.000563318 0.033235739 0.001661787 16533 hsa-mir-383 hsa05210 Colorectal cancer 1499_3725_2353 3 0.000746405 0.044037891 0.002097042 16534 hsa-mir-383 hsa04012 ErbB signaling pathway 3725_6776_6777 3 0.000823716 0.048599264 0.002209057 16535 hsa-mir-383 hsa04950 Maturity onset diabetes of the young 4760_6927 2 0.001275693 0.07526586 0.003272429 16536 hsa-mir-383 hsa05216 Thyroid cancer 1499_6256 2 0.001813354 0.106987892 0.004457829 16537 hsa-mir-383 hsa04270 Vascular smooth muscle contraction 808_801_805 3 0.001931176 0.113939362 0.004486315 16538 hsa-mir-383 hsa04110 Cell cycle 10971_7534_1387 3 0.00197702 0.11664418 0.004486315 16539 hsa-mir-383 hsa03410 Base excision repair 3146_142 2 0.002716578 0.160278099 0.005936226 16540 hsa-mir-383 hsa04910 Insulin signaling pathway 808_801_805 3 0.00297994 0.175816468 0.00627916 16541 hsa-mir-383 hsa04330 Notch signaling pathway 9612_1387 2 0.004479761 0.264305887 0.009113996 16542 hsa-mir-383 hsa05010 Alzheimer's disease 808_801_805 3 0.005890392 0.347533152 0.011584438 16543 hsa-mir-383 hsa04020 Calcium signaling pathway 808_801_805 3 0.006543058 0.38604043 0.012452917 16544 hsa-mir-383 hsa05016 Huntington's disease 6667_6908_1387 3 0.006934609 0.40914191 0.012785685 16545 hsa-mir-383 hsa04920 Adipocytokine signaling pathway 5970_6256 2 0.008707483 0.513741493 0.015567924 16546 hsa-mir-383 hsa05211 Renal cell carcinoma 3725_1387 2 0.009960326 0.587659241 0.017284095 16547 hsa-mir-383 hsa04520 Adherens junction 1499_1387 2 0.012120403 0.715103756 0.020431536 16548 hsa-mir-383 hsa05222 Small cell lung cancer 5970_6256 2 0.013862703 0.8178995 0.022719431 16549 hsa-mir-383 hsa04670 Leukocyte transendothelial migration 1499_1432 2 0.026363434 1 0.04203899 16550 hsa-mir-383 hsa03450 Non-homologous end-joining 2547 1 0.030016423 1 0.046604446 16551 hsa-mir-383 hsa04740 Olfactory transduction 808_801_805 3 0.044612805 1 0.067491167 16552 hsa-mir-384 hsa03022 Basal transcription factors 54457_6879_2958_138474_6883_6881_6873_2967_2961_2960_2963_2969_2968_6878_6877_6874_6872_6908_6884_6882_2959_6880_2957 23 8.19E-22 6.38E-20 6.38E-20 16553 hsa-mir-384 hsa05200 Pathways in cancer 3551_1499_5914_1017_8517_4193_6502_4089_3066_3065_5925_7184_7187_5468_10342_10401_862_836_1147_3725_2249_5595_5594_5599_1387_6256_4286_367_6776_6777_6772_5970_7157_6688_6774_4087_2033_898_4790_4791_4792_3320_3326_5371_4609_1026_1029_2353_8554 49 3.84E-21 3.00E-19 1.50E-19 16554 hsa-mir-384 hsa04110 Cell cycle 1017_4193_6502_6500_4089_4174_4171_4172_4173_3066_3065_5925_5591_1387_5001_7532_7157_5111_4085_4087_2033_898_8454_1026_1029_1111_4999_4998 28 4.16E-17 3.24E-15 1.08E-15 16555 hsa-mir-384 hsa03010 Ribosome 6155_6156_6204_6205_6207_6202_6141_6217_6130_6137_6135_6128_6210_6191_6193_9349_6222_6223_6229_6129_6232_6181_6189_6188 24 7.35E-15 5.74E-13 1.43E-13 16556 hsa-mir-384 hsa05215 Prostate cancer 3551_1499_1017_8517_4193_5925_7184_1147_5595_5594_1387_367_5970_7157_2033_898_4790_4792_3320_3326_1026 21 2.81E-13 2.19E-11 4.25E-12 16557 hsa-mir-384 hsa05212 Pancreatic cancer 3551_1499_1017_8517_4193_5925_7184_1147_5595_5594_1387_367_5970_7157_2033_898_4790_4792_3320_3326_1026 21 3.40E-13 2.65E-11 4.25E-12 16558 hsa-mir-384 hsa04010 MAPK signaling pathway 6722_3727_3551_8517_9252_7867_9020_3305_3303_1432_836_9479_1147_3725_2249_5595_5594_5599_5598_3310_3312_5971_5970_7157_4790_4791_9261_1326_4208_5608_5566_6885_4609_2353 34 3.81E-13 2.98E-11 4.25E-12 16559 hsa-mir-384 hsa05220 Chronic myeloid leukemia 3551_8517_4193_4089_3066_3065_5925_1147_5595_5594_6776_6777_5970_7157_4790_4792_4609_1026_1029 19 1.55E-12 1.21E-10 1.51E-11 16560 hsa-mir-384 hsa04620 Toll-like receptor signaling pathway 3551_8517_7187_3661_1432_1147_3725_29110_5595_5594_5599_6772_5970_4790_4792_1326_5608_9641_6885_2353 20 2.34E-11 1.82E-09 2.03E-10 16561 hsa-mir-384 hsa03050 Proteasome 5709_5705_5706_5700_5701_5702_5693_5719_5717_5713_5710_5684_5687_5707_5708 15 2.87E-11 2.24E-09 2.24E-10 16562 hsa-mir-384 hsa05221 Acute myeloid leukemia 3551_5914_8517_862_1147_5595_5594_6776_6777_5970_6688_6774_4790_5371_4609 15 3.33E-10 2.60E-08 2.36E-09 16563 hsa-mir-384 hsa04310 Wnt signaling pathway 1499_8607_6500_8945_4089_6423_23291_3725_1460_5599_1387_7157_1457_4087_2033_5519_5518_5515_5566_8454_6885_4609 22 4.37E-10 3.41E-08 2.84E-09 16564 hsa-mir-384 hsa04350 TGF-beta signaling pathway 6500_4089_6667_3397_3399_3398_3400_5595_5594_1387_4087_2033_5519_5518_5515_8454_4609 17 7.69E-10 6.00E-08 4.61E-09 16565 hsa-mir-384 hsa05222 Small cell lung cancer 3551_1017_8517_6502_5925_7187_10401_1147_6256_5970_7157_898_4790_4792_4609_8554 16 4.50E-09 3.51E-07 2.51E-08 16566 hsa-mir-384 hsa04660 T cell receptor signaling pathway 3551_8517_9020_1432_1147_3725_5595_5594_5970_4794_4790_4792_4793_1326_1739_6885_2353 17 1.76E-08 1.37E-06 9.14E-08 16567 hsa-mir-384 hsa05016 Huntington's disease 292_293_3066_3065_3064_498_5468_6667_836_4716_1387_9001_5430_5437_7157_1213_2033_6874_6908_5441_4697 21 6.64E-08 5.18E-06 3.24E-07 16568 hsa-mir-384 hsa04920 Adipocytokine signaling pathway 3551_5465_8517_8471_1147_5599_6256_5970_6774_4794_4790_4792_4793 13 8.18E-08 6.38E-06 3.75E-07 16569 hsa-mir-384 hsa04662 B cell receptor signaling pathway 3551_8517_1147_3725_695_5595_5594_5970_4794_4790_4792_4793_2353 13 2.60E-07 2.03E-05 1.13E-06 16570 hsa-mir-384 hsa05216 Thyroid cancer 1499_5468_10342_5595_5594_6256_7157_4609 8 2.79E-06 0.000217865 1.13E-05 16571 hsa-mir-384 hsa04520 Adherens junction 1499_4089_71_1460_5595_5594_1387_1457_4087_2033_8826_6885 12 2.90E-06 0.000226353 1.13E-05 16572 hsa-mir-384 hsa05219 Bladder cancer 9252_4193_5925_5595_5594_7157_4609_1026_1029 9 4.02E-06 0.000313315 1.49E-05 16573 hsa-mir-384 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3551_8517_9020_1432_836_1147_3725_5599_5970_4790_4792 11 5.68E-06 0.000442907 2.01E-05 16574 hsa-mir-384 hsa04120 Ubiquitin mediated proteolysis 4193_55294_6502_6500_8945_23291_10401_7329_51366_11059_8651_5371_672_8454_8554 15 7.19E-06 0.000561205 2.44E-05 16575 hsa-mir-384 hsa04210 Apoptosis 3551_8517_9020_836_1147_5970_7157_9131_4790_4792_5566_840 12 7.78E-06 0.000607191 2.53E-05 16576 hsa-mir-384 hsa05214 Glioma 4193_5925_5595_5594_7157_808_801_805_1026_1029 10 1.59E-05 0.001241173 4.96E-05 16577 hsa-mir-384 hsa05210 Colorectal cancer 1499_4089_836_3725_5595_5594_5599_7157_4087_4609_2353 11 2.37E-05 0.001846467 7.10E-05 16578 hsa-mir-384 hsa03020 RNA polymerase 64425_25885_51082_5430_5437_84172_5441 7 2.48E-05 0.001937942 7.18E-05 16579 hsa-mir-384 hsa04910 Insulin signaling pathway 3551_5499_8471_5211_8651_5590_5595_5594_5599_2194_808_801_805_5566 14 2.71E-05 0.002116416 7.56E-05 16580 hsa-mir-384 hsa05131 Shigellosis 1499_10382_71_7846_203068_347733_7278_84617_4691 9 3.10E-05 0.00241792 8.06E-05 16581 hsa-mir-384 hsa05130 Pathogenic Escherichia coli infection 1499_10382_71_7846_203068_347733_7278_84617_4691 9 3.10E-05 0.00241792 8.06E-05 16582 hsa-mir-384 hsa04930 Type II diabetes mellitus 3551_8471_3651_8651_5590_5595_5594_5599 8 4.52E-05 0.003527876 0.000113802 16583 hsa-mir-384 hsa04720 Long-term potentiation 814_5499_5595_5594_1387_2033_808_801_805_5566 10 4.81E-05 0.003752866 0.000117277 16584 hsa-mir-384 hsa04330 Notch signaling pathway 9612_3066_3065_1387_2033_8850_388585_4851 8 5.95E-05 0.004639983 0.000140606 16585 hsa-mir-384 hsa05218 Melanoma 4193_5925_2249_5595_5594_4286_7157_1026_1029 9 0.000161759 0.012617173 0.000371093 16586 hsa-mir-384 hsa04912 GnRH signaling pathway 1432_3725_5595_5594_5599_5598_808_801_805_5608_5566 11 0.000187169 0.014599179 0.000417119 16587 hsa-mir-384 hsa04062 Chemokine signaling pathway 3551_8517_653361_1147_5590_5595_5594_6777_6772_5970_6774_4790_4792_4793_5566 15 0.000231114 0.018026858 0.000500746 16588 hsa-mir-384 hsa04540 Gap junction 10382_5595_5594_5598_7846_203068_347733_5566_7278_84617 10 0.000243582 0.018999409 0.000513498 16589 hsa-mir-384 hsa04916 Melanogenesis 1499_5595_5594_1387_4286_2033_808_801_805_5566 10 0.000551372 0.043006991 0.001111218 16590 hsa-mir-384 hsa03030 DNA replication 5981_4174_4171_4172_4173_5111 6 0.000555609 0.043337518 0.001111218 16591 hsa-mir-384 hsa04115 p53 signaling pathway 1017_4193_836_7157_898_1026_1029_1111 8 0.000638166 0.049776932 0.001244423 16592 hsa-mir-384 hsa04950 Maturity onset diabetes of the young 6927_4760_3651_168620_5080 5 0.00066721 0.052042348 0.001269326 16593 hsa-mir-384 hsa04612 Antigen processing and presentation 3309_3305_3303_3310_3312_3320_3326_4800_4801 9 0.000740531 0.05776144 0.001375272 16594 hsa-mir-384 hsa04630 Jak-STAT signaling pathway 10401_3977_8651_1387_6778_6776_6777_6772_6774_2033_4609_8554 12 0.000976586 0.076173696 0.001771481 16595 hsa-mir-384 hsa04530 Tight junction 10207_1499_4627_4628_71_1460_5590_1457_5519_5518_5515 11 0.001192131 0.09298623 0.002113323 16596 hsa-mir-384 hsa03420 Nucleotide excision repair 5981_5111_5887_2967_2968_4331 6 0.001423867 0.111061607 0.002468036 16597 hsa-mir-384 hsa04012 ErbB signaling pathway 3725_5595_5594_5599_6776_6777_4609_1026 8 0.00250214 0.195166952 0.00424276 16598 hsa-mir-384 hsa05223 Non-small cell lung cancer 5925_5595_5594_6256_7157_1029 6 0.003643232 0.284172078 0.006046214 16599 hsa-mir-384 hsa05010 Alzheimer's disease 498_836_4716_1020_5595_5594_808_801_805_840_4697 11 0.007461332 0.581983878 0.012124664 16600 hsa-mir-384 hsa03450 Non-homologous end-joining 2547_5591_7520 3 0.007943583 0.619599506 0.012644888 16601 hsa-mir-384 hsa04270 Vascular smooth muscle contraction 5499_5595_5594_808_801_805_5566_85366 8 0.013345248 1 0.020416646 16602 hsa-mir-384 hsa05213 Endometrial cancer 1499_5595_5594_7157_4609 5 0.013349346 1 0.020416646 16603 hsa-mir-384 hsa04664 Fc epsilon RI signaling pathway 1432_695_5595_5594_5599_5608 6 0.019014743 1 0.028522115 16604 hsa-mir-384 hsa04060 Cytokine-cytokine receptor interaction 3977 1 0.024935266 1 0.036697184 16605 hsa-mir-384 hsa04810 Regulation of actin cytoskeleton 4627_5499_4628_71_2249_5595_5594_1729_10788_8826_85366 11 0.032104229 1 0.046372776 16606 hsa-mir-384 hsa04730 Long-term depression 5595_5594_5519_5518_5515 5 0.04036583 1 0.057246087 16607 hsa-mir-384 hsa05211 Renal cell carcinoma 3725_5595_5594_1387_2033 5 0.04232559 1 0.058953501 16608 hsa-mir-3907 hsa05016 Huntington's disease 3064_23186 2 0.000237349 0.000237349 0.000237349 16609 hsa-mir-3911 hsa03022 Basal transcription factors 2967_2961_2960_2963_6881_54457_2968_6879_6878_6877_6874_6872_2957_6908_6873_2958_6884_2959_6880_6882_138474_6883 22 1.28E-35 8.33E-34 8.33E-34 16610 hsa-mir-3911 hsa05200 Pathways in cancer 5925_5594_6256_3326_4193_1387_5970_7157_6688_3725_2113_4609_861_2353_10401_2033_8554_7184 18 5.19E-13 3.37E-11 1.69E-11 16611 hsa-mir-3911 hsa05215 Prostate cancer 5925_5594_3326_4193_1387_5970_7157_2033_90993_7184 10 1.17E-10 7.62E-09 2.11E-09 16612 hsa-mir-3911 hsa05212 Pancreatic cancer 5925_5594_3326_4193_1387_5970_7157_2033_90993_7184 10 1.30E-10 8.44E-09 2.11E-09 16613 hsa-mir-3911 hsa05220 Chronic myeloid leukemia 5925_5594_4193_5970_7157_4609_861 7 2.71E-07 1.76E-05 3.52E-06 16614 hsa-mir-3911 hsa05222 Small cell lung cancer 5925_6256_5970_7157_4609_10401_8554 7 6.42E-07 4.17E-05 6.96E-06 16615 hsa-mir-3911 hsa05016 Huntington's disease 6874_6908_9001_1387_5430_7157_3064_2033_90993 9 1.10E-06 7.17E-05 1.02E-05 16616 hsa-mir-3911 hsa05219 Bladder cancer 5925_5594_4193_7157_4609 5 4.90E-06 0.000318822 3.58E-05 16617 hsa-mir-3911 hsa04110 Cell cycle 5925_4193_1387_7157_4171_4085_2033 7 4.95E-06 0.000321766 3.58E-05 16618 hsa-mir-3911 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 8.95E-06 0.000581444 5.81E-05 16619 hsa-mir-3911 hsa04350 TGF-beta signaling pathway 5594_1387_3398_4609_3399_2033 6 1.02E-05 0.000662861 6.03E-05 16620 hsa-mir-3911 hsa04010 MAPK signaling pathway 3727_5594_3312_5970_7157_3725_4609_2353_1616 9 2.01E-05 0.001308838 0.000105314 16621 hsa-mir-3911 hsa04310 Wnt signaling pathway 1460_8607_1387_7157_3725_4609_2033 7 2.26E-05 0.001469807 0.000105314 16622 hsa-mir-3911 hsa05221 Acute myeloid leukemia 5594_5970_6688_4609_861 5 2.27E-05 0.001474402 0.000105314 16623 hsa-mir-3911 hsa05216 Thyroid cancer 5594_6256_7157_4609 4 2.70E-05 0.001756126 0.000117075 16624 hsa-mir-3911 hsa05211 Renal cell carcinoma 5594_1387_3725_2113_2033 5 5.56E-05 0.0036159 0.000225994 16625 hsa-mir-3911 hsa05210 Colorectal cancer 5594_7157_3725_4609_2353 5 0.00011108 0.007220184 0.000424717 16626 hsa-mir-3911 hsa05223 Non-small cell lung cancer 5925_5594_6256_7157 4 0.000252862 0.016436002 0.000913111 16627 hsa-mir-3911 hsa05214 Glioma 5925_5594_4193_7157 4 0.000492601 0.032019056 0.001685213 16628 hsa-mir-3911 hsa05218 Melanoma 5925_5594_4193_7157 4 0.000675832 0.043929077 0.002196454 16629 hsa-mir-3911 hsa04662 B cell receptor signaling pathway 5594_5970_3725_2353 4 0.000821933 0.053425675 0.00254408 16630 hsa-mir-3911 hsa04120 Ubiquitin mediated proteolysis 11059_4734_4193_10401_8554 5 0.001020766 0.066349773 0.002922867 16631 hsa-mir-3911 hsa04520 Adherens junction 1460_5594_1387_2033 4 0.001034245 0.067225949 0.002922867 16632 hsa-mir-3911 hsa04630 Jak-STAT signaling pathway 1387_4609_10401_2033_8554 5 0.001627803 0.105807188 0.004408633 16633 hsa-mir-3911 hsa03420 Nucleotide excision repair 2967_2968_5887 3 0.001966792 0.127841497 0.00511366 16634 hsa-mir-3911 hsa04330 Notch signaling pathway 1387_2033_8850 3 0.002350106 0.152756858 0.005862153 16635 hsa-mir-3911 hsa04620 Toll-like receptor signaling pathway 5594_5970_3725_2353 4 0.002435048 0.158278126 0.005862153 16636 hsa-mir-3911 hsa04916 Melanogenesis 5594_1387_2033_90993 4 0.002605685 0.169369507 0.006048911 16637 hsa-mir-3911 hsa05213 Endometrial cancer 5594_7157_4609 3 0.003085818 0.200578138 0.006860798 16638 hsa-mir-3911 hsa04660 T cell receptor signaling pathway 5594_5970_3725_2353 4 0.003166522 0.205823953 0.006860798 16639 hsa-mir-3911 hsa04720 Long-term potentiation 5594_1387_2033 3 0.008194041 0.532612663 0.017181054 16640 hsa-mir-3911 hsa04012 ErbB signaling pathway 5594_3725_4609 3 0.012087961 0.785717493 0.024553672 16641 hsa-mir-3911 hsa04612 Antigen processing and presentation 3326_4801_3312 3 0.012823466 0.833525269 0.025258341 16642 hsa-mir-3911 hsa05014 Amyotrophic lateral sclerosis (ALS) 7157_1616 2 0.0376636 1 0.072003942 16643 hsa-mir-3911 hsa05322 Systemic lupus erythematosus 3014_3015_8340 3 0.043032595 1 0.079917676 16644 hsa-mir-3912 hsa03022 Basal transcription factors 2967_2961_2960_2963_6881_54457_2968_6879_6878_6877_6872_2957_6908_6874_6873_2958_6884_2959_6880_6882_138474_6883 22 1.61E-33 1.08E-31 1.08E-31 16645 hsa-mir-3912 hsa05200 Pathways in cancer 25_5925_2249_5594_5914_1387_6256_3326_367_4193_6776_6777_5970_7157_6688_2113_4609_3725_861_2353_10401_4089_2033_8554_7184 25 1.20E-18 8.04E-17 4.02E-17 16646 hsa-mir-3912 hsa05220 Chronic myeloid leukemia 25_5925_5594_4193_6776_6777_5970_7157_4609_861_4089 11 1.04E-11 6.97E-10 2.32E-10 16647 hsa-mir-3912 hsa04350 TGF-beta signaling pathway 6667_5594_1387_3399_3398_4609_4086_4089_2033_4093 10 8.13E-10 5.44E-08 1.11E-08 16648 hsa-mir-3912 hsa05215 Prostate cancer 5925_5594_1387_3326_367_4193_5970_7157_2033_7184 10 9.00E-10 6.03E-08 1.11E-08 16649 hsa-mir-3912 hsa05212 Pancreatic cancer 5925_5594_1387_3326_367_4193_5970_7157_2033_7184 10 9.95E-10 6.67E-08 1.11E-08 16650 hsa-mir-3912 hsa05221 Acute myeloid leukemia 5594_5914_6776_6777_5970_6688_4609_861 8 1.28E-08 8.60E-07 1.23E-07 16651 hsa-mir-3912 hsa04110 Cell cycle 25_5925_1387_4193_7157_4171_4085_4089_2033 9 1.67E-07 1.12E-05 1.40E-06 16652 hsa-mir-3912 hsa05222 Small cell lung cancer 5925_6256_5970_7157_4609_10401_8554 7 2.58E-06 0.000172725 1.92E-05 16653 hsa-mir-3912 hsa05016 Huntington's disease 6667_1387_6908_6874_9001_5430_7157_3064_2033 9 6.10E-06 0.000408431 4.08E-05 16654 hsa-mir-3912 hsa04310 Wnt signaling pathway 1460_1387_8607_7157_4609_3725_4089_2033 8 1.05E-05 0.000703185 6.39E-05 16655 hsa-mir-3912 hsa04630 Jak-STAT signaling pathway 1387_6776_6777_4609_10401_2033_3977_8554 8 1.20E-05 0.000805142 6.71E-05 16656 hsa-mir-3912 hsa05219 Bladder cancer 5925_5594_4193_7157_4609 5 1.35E-05 0.0009017 6.94E-05 16657 hsa-mir-3912 hsa04010 MAPK signaling pathway 2249_5594_3312_5970_7157_4609_3725_3727_2353_1616 10 1.76E-05 0.001181842 8.44E-05 16658 hsa-mir-3912 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 2.44E-05 0.001634527 0.000108968 16659 hsa-mir-3912 hsa05210 Colorectal cancer 5594_7157_4609_3725_2353_4089 6 2.74E-05 0.001837354 0.000114835 16660 hsa-mir-3912 hsa04012 ErbB signaling pathway 25_5594_6776_6777_4609_3725 6 3.30E-05 0.002213476 0.000130204 16661 hsa-mir-3912 hsa05216 Thyroid cancer 5594_6256_7157_4609 4 6.08E-05 0.004072683 0.00022626 16662 hsa-mir-3912 hsa05218 Melanoma 5925_2249_5594_4193_7157 5 0.000139208 0.009326957 0.000490892 16663 hsa-mir-3912 hsa05211 Renal cell carcinoma 5594_1387_2113_3725_2033 5 0.000148098 0.00992256 0.000496128 16664 hsa-mir-3912 hsa04520 Adherens junction 1460_5594_1387_4089_2033 5 0.000235787 0.015797714 0.000752272 16665 hsa-mir-3912 hsa03420 Nucleotide excision repair 2967_2968_4331_5887 4 0.000267898 0.017949196 0.000815873 16666 hsa-mir-3912 hsa04330 Notch signaling pathway 1387_9612_2033_8850 4 0.000338883 0.02270519 0.000987182 16667 hsa-mir-3912 hsa05223 Non-small cell lung cancer 5925_5594_6256_7157 4 0.000555354 0.037208729 0.001550364 16668 hsa-mir-3912 hsa05214 Glioma 5925_5594_4193_7157 4 0.001070547 0.071726649 0.002869066 16669 hsa-mir-3912 hsa04662 B cell receptor signaling pathway 5594_5970_3725_2353 4 0.001769312 0.118543936 0.004559382 16670 hsa-mir-3912 hsa04612 Antigen processing and presentation 3326_4800_4801_3312 4 0.003204936 0.214730695 0.007952989 16671 hsa-mir-3912 hsa04620 Toll-like receptor signaling pathway 5594_5970_3725_2353 4 0.005109491 0.342335864 0.012226281 16672 hsa-mir-3912 hsa05213 Endometrial cancer 5594_7157_4609 3 0.005514109 0.369445327 0.012739494 16673 hsa-mir-3912 hsa04660 T cell receptor signaling pathway 5594_5970_3725_2353 4 0.006594615 0.441839232 0.014727974 16674 hsa-mir-3912 hsa04950 Maturity onset diabetes of the young 6927_5080 2 0.012297416 0.823926871 0.026578286 16675 hsa-mir-3912 hsa04120 Ubiquitin mediated proteolysis 672_4193_10401_8554 4 0.01428939 0.957389161 0.029129291 16676 hsa-mir-3912 hsa04720 Long-term potentiation 5594_1387_2033 3 0.014347263 0.961266609 0.029129291 16677 hsa-mir-3912 hsa03410 Base excision repair 3146_142 2 0.025284764 1 0.049825858 16678 hsa-mir-3912 hsa04916 Melanogenesis 5594_1387_2033 3 0.032689438 1 0.062576923 16679 hsa-mir-3913-1 hsa05200 Pathways in cancer 25_5371_1499_5595_5594_5914_1387_6256_595_836_1487_367_2932_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_862_6502_2736_4088_4089_3066_3065_5925_2034_2033_4846_207 37 2.04E-31 1.45E-29 1.45E-29 16680 hsa-mir-3913-1 hsa05220 Chronic myeloid leukemia 25_5595_5594_595_1487_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_207_6464 18 4.84E-21 3.43E-19 1.72E-19 16681 hsa-mir-3913-1 hsa04110 Cell cycle 25_993_5591_1387_595_983_2932_1870_1871_7157_4087_1869_6502_4088_4089_3066_3065_5925_2033_5933 20 1.52E-20 1.08E-18 3.60E-19 16682 hsa-mir-3913-1 hsa05215 Prostate cancer 1499_5595_5594_1387_595_367_2932_5970_1870_1871_7157_1869_5925_2033_207 15 8.72E-16 6.19E-14 1.44E-14 16683 hsa-mir-3913-1 hsa05212 Pancreatic cancer 1499_5595_5594_1387_595_367_2932_5970_1870_1871_7157_1869_5925_2033_207 15 1.01E-15 7.19E-14 1.44E-14 16684 hsa-mir-3913-1 hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_207_6464_808_801_805 13 1.22E-14 8.67E-13 1.45E-13 16685 hsa-mir-3913-1 hsa04350 TGF-beta signaling pathway 5595_5594_1387_3397_3399_3398_4087_4609_4086_4088_4089_2033_5933_4093 14 1.66E-14 1.18E-12 1.68E-13 16686 hsa-mir-3913-1 hsa04010 MAPK signaling pathway 6722_5595_5594_9261_4208_836_6195_6197_9252_7867_3312_1432_5970_7157_4609_3725_6196_8986_4763_207 20 3.81E-14 2.71E-12 3.38E-13 16687 hsa-mir-3913-1 hsa05210 Colorectal cancer 1499_5595_5594_595_836_2932_7157_4087_4609_3725_4088_4089_207 13 2.29E-13 1.63E-11 1.81E-12 16688 hsa-mir-3913-1 hsa05219 Bladder cancer 5595_5594_595_9252_1870_1871_7157_4609_1869_5925 10 3.29E-12 2.33E-10 2.33E-11 16689 hsa-mir-3913-1 hsa05222 Small cell lung cancer 6256_595_5970_1870_1871_7157_4609_1869_6502_5925_4846_207 12 5.88E-12 4.17E-10 3.79E-11 16690 hsa-mir-3913-1 hsa04720 Long-term potentiation 5595_5594_1387_2902_6195_6197_6196_2033_808_801_805 11 2.81E-11 1.99E-09 1.60E-10 16691 hsa-mir-3913-1 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925_207 10 2.92E-11 2.08E-09 1.60E-10 16692 hsa-mir-3913-1 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_5970_4609_862_207 10 6.36E-11 4.52E-09 3.23E-10 16693 hsa-mir-3913-1 hsa04310 Wnt signaling pathway 1499_1387_595_1487_2932_7157_4087_4609_3725_1457_4088_4089_2033 13 2.14E-10 1.52E-08 1.01E-09 16694 hsa-mir-3913-1 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2113_3725_2034_2033_207 10 3.69E-10 2.62E-08 1.64E-09 16695 hsa-mir-3913-1 hsa04330 Notch signaling pathway 388585_1387_1487_9612_3066_3065_2033_8850 8 5.27E-09 3.74E-07 2.20E-08 16696 hsa-mir-3913-1 hsa05216 Thyroid cancer 1499_5595_5594_6256_595_7157_4609 7 5.87E-09 4.17E-07 2.21E-08 16697 hsa-mir-3913-1 hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5925_207 9 5.92E-09 4.20E-07 2.21E-08 16698 hsa-mir-3913-1 hsa05213 Endometrial cancer 1499_5595_5594_595_2932_7157_4609_207 8 1.07E-08 7.63E-07 3.81E-08 16699 hsa-mir-3913-1 hsa04520 Adherens junction 1499_5595_5594_1387_4087_1457_4088_4089_2033 9 1.54E-08 1.09E-06 5.19E-08 16700 hsa-mir-3913-1 hsa04916 Melanogenesis 1499_5595_5594_1387_2932_2033_808_801_805 9 1.24E-07 8.84E-06 4.02E-07 16701 hsa-mir-3913-1 hsa04150 mTOR signaling pathway 5595_5594_6195_6197_3091_6196_207 7 2.09E-07 1.48E-05 6.44E-07 16702 hsa-mir-3913-1 hsa04012 ErbB signaling pathway 25_5595_5594_2932_4609_3725_207_6464 8 4.12E-07 2.93E-05 1.22E-06 16703 hsa-mir-3913-1 hsa04910 Insulin signaling pathway 6720_5595_5594_2932_207_6464_808_801_805 9 1.16E-06 8.27E-05 3.31E-06 16704 hsa-mir-3913-1 hsa04370 VEGF signaling pathway 5595_5594_9261_7867_1432_4846_207 7 2.38E-06 0.000169319 6.51E-06 16705 hsa-mir-3913-1 hsa05010 Alzheimer's disease 5595_5594_2902_836_2932_4846_808_801_805 9 8.04E-06 0.000571156 2.12E-05 16706 hsa-mir-3913-1 hsa05016 Huntington's disease 6874_1387_2902_836_7157_3066_3065_3064_2033 9 1.28E-05 0.000905664 3.23E-05 16707 hsa-mir-3913-1 hsa04912 GnRH signaling pathway 5595_5594_1432_3725_808_801_805 7 1.92E-05 0.001359761 4.69E-05 16708 hsa-mir-3913-1 hsa04660 T cell receptor signaling pathway 5595_5594_2932_1432_5970_3725_207 7 2.14E-05 0.001520828 5.07E-05 16709 hsa-mir-3913-1 hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_3725_207 6 2.52E-05 0.001788374 5.77E-05 16710 hsa-mir-3913-1 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_1432_7157_4846 5 7.49E-05 0.005319302 0.000166228 16711 hsa-mir-3913-1 hsa04620 Toll-like receptor signaling pathway 5595_5594_1432_5970_3725_207 6 0.000126666 0.008993265 0.000272523 16712 hsa-mir-3913-1 hsa04510 Focal adhesion 1499_5595_5594_595_2932_3725_207_6464 8 0.000157597 0.011189384 0.0003291 16713 hsa-mir-3913-1 hsa04270 Vascular smooth muscle contraction 5592_5595_5594_808_801_805 6 0.000269048 0.019102385 0.000545782 16714 hsa-mir-3913-1 hsa05217 Basal cell carcinoma 1499_2932_7157_2736 4 0.000835274 0.059304426 0.001647345 16715 hsa-mir-3913-1 hsa04115 p53 signaling pathway 595_983_836_7157 4 0.001848778 0.131263243 0.003547655 16716 hsa-mir-3913-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_1432_5970_3725 4 0.002041872 0.144972877 0.003717253 16717 hsa-mir-3913-1 hsa04730 Long-term depression 5592_5595_5594_4846 4 0.002041872 0.144972877 0.003717253 16718 hsa-mir-3913-1 hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432_207 4 0.002953912 0.209727767 0.005243194 16719 hsa-mir-3913-1 hsa04062 Chemokine signaling pathway 5595_5594_2932_5970_207_6464 6 0.003106247 0.220543513 0.00537911 16720 hsa-mir-3913-1 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428_7329_6502 5 0.003766397 0.267414196 0.006367005 16721 hsa-mir-3913-1 hsa04612 Antigen processing and presentation 4800_4801_3312_1514 4 0.004442214 0.315397186 0.007168118 16722 hsa-mir-3913-1 hsa04210 Apoptosis 836_5970_7157_207 4 0.004442214 0.315397186 0.007168118 16723 hsa-mir-3913-1 hsa04930 Type II diabetes mellitus 5595_5594_3651 3 0.004854964 0.344702432 0.007660054 16724 hsa-mir-3913-1 hsa04540 Gap junction 5592_5595_5594_983 4 0.005157045 0.366150172 0.007959786 16725 hsa-mir-3913-1 hsa04630 Jak-STAT signaling pathway 1387_595_4609_2033_207 5 0.00586596 0.416483161 0.008861344 16726 hsa-mir-3913-1 hsa04020 Calcium signaling pathway 2902_4846_808_801_805 5 0.011563001 0.820973045 0.017103605 16727 hsa-mir-3913-1 hsa04920 Adipocytokine signaling pathway 6256_5970_207 3 0.013711342 0.973505248 0.019867454 16728 hsa-mir-3913-1 hsa04950 Maturity onset diabetes of the young 3651_168620 2 0.014639421 1 0.020787978 16729 hsa-mir-3913-1 hsa04360 Axon guidance 25_5595_5594_2932 4 0.016003848 1 0.022279867 16730 hsa-mir-3913-1 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_6464 4 0.018901626 1 0.025333591 16731 hsa-mir-3913-1 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.01891099 1 0.025333591 16732 hsa-mir-3913-1 hsa03022 Basal transcription factors 2963_6874 2 0.031428273 1 0.041322359 16733 hsa-mir-3913-1 hsa03050 Proteasome 5705_5710 2 0.049394695 1 0.06376406 16734 hsa-mir-3914-2 hsa05200 Pathways in cancer 7046_596_598_1017_4193_5578_3091_2064_3065_5925_613_5743_5747_25_1956_6789_4824_4436_2113_6774_5879_207_9915_3716_1147_998_2261_5595_5594_5599_861_6258_1387_6256_836_2932_6777_5970_1869_3725_6776_4087_4088_4089_5888_5728_2034_2033_3910_4792_3320_3326_5371_675_5159_5156_5601_5602_1856_3815_842_841_51588_8772_1026_2353_8554 67 2.21E-48 1.92E-46 1.92E-46 16735 hsa-mir-3914-2 hsa04110 Cell cycle 1017_4193_902_4174_4172_3065_5925_25_891_9232_545_995_5347_5591_1387_11200_7534_7532_2932_7027_1869_4087_4088_4089_2033_890_1031_983_8555_1026_1022_1111_8556_472 34 3.45E-29 3.00E-27 1.50E-27 16736 hsa-mir-3914-2 hsa05215 Prostate cancer 596_1017_4193_2064_5925_1956_4824_207_1147_5595_5594_1385_1387_2932_5970_1869_5728_2033_4792_3320_3326_5159_5156_842_1026 25 9.89E-22 8.60E-20 2.17E-20 16737 hsa-mir-3914-2 hsa04010 MAPK signaling pathway 7046_6195_2264_9252_5578_1845_7132_5923_1956_3304_3305_3303_6789_1432_5879_1616_207_1147_998_2261_5595_5594_5599_836_3315_5970_3164_3725_5159_9261_5156_5601_5602_9479_2353_2002_2005 37 1.15E-21 1.00E-19 2.17E-20 16738 hsa-mir-3914-2 hsa05212 Pancreatic cancer 596_1017_4193_2064_5925_1956_4824_207_1147_5595_5594_1385_1387_2932_5970_1869_5728_2033_4792_3320_3326_5159_5156_842_1026 25 1.25E-21 1.09E-19 2.17E-20 16739 hsa-mir-3914-2 hsa04115 p53 signaling pathway 1017_4194_4193_900_50484_6241_891_51246_545_7161_11200_836_64326_5728_27113_25898_983_842_841_1026_1111_472 22 3.49E-20 3.04E-18 5.06E-19 16740 hsa-mir-3914-2 hsa05210 Colorectal cancer 7046_596_1956_4436_5879_207_5595_5594_5599_836_2932_3725_4087_4088_4089_5159_5156_5601_5602_1856_842_2353 22 1.23E-18 1.07E-16 1.53E-17 16741 hsa-mir-3914-2 hsa05220 Chronic myeloid leukemia 7046_598_4193_3065_5925_613_25_207_1147_5595_5594_861_6777_5970_1869_6776_4088_4089_4792_5781_1026 21 2.36E-18 2.06E-16 2.57E-17 16742 hsa-mir-3914-2 hsa04012 ErbB signaling pathway 818_815_817_5578_2064_5747_25_1956_6714_207_5595_5594_5599_2932_6777_3725_6776_5601_5602_1026_2002 21 3.12E-17 2.72E-15 3.02E-16 16743 hsa-mir-3914-2 hsa04510 Focal adhesion 596_5578_2064_5923_2534_5747_3791_1956_6714_5499_5879_207_998_5595_5594_5599_2932_3725_5728_3910_2321_5159_5156_5601_5602_2002 26 6.36E-15 5.53E-13 5.53E-14 16744 hsa-mir-3914-2 hsa04310 Wnt signaling pathway 818_815_817_5578_6423_5879_1460_5599_1387_2932_3725_1457_1452_4087_4088_4089_2033_5518_5515_5601_5602_1856_5527 23 7.44E-15 6.47E-13 5.88E-14 16745 hsa-mir-3914-2 hsa04920 Adipocytokine signaling pathway 6794_7132_8717_6774_207_3717_1147_5599_6258_6256_5970_4792_5601_5602_5563_5781_7133 17 1.65E-14 1.43E-12 1.20E-13 16746 hsa-mir-3914-2 hsa05222 Small cell lung cancer 596_598_1017_5925_5743_5747_207_1147_6258_6256_5970_1869_5728_3910_4792_842_51588_8554 18 4.94E-14 4.30E-12 3.31E-13 16747 hsa-mir-3914-2 hsa04350 TGF-beta signaling pathway 7046_90_3398_57154_6667_3399_5595_5594_1387_7027_4087_4088_4089_2033_5518_5515_4093 17 6.64E-13 5.78E-11 4.13E-12 16748 hsa-mir-3914-2 hsa04630 Jak-STAT signaling pathway 598_58985_3455_3459_3560_3561_1439_6774_207_3717_3716_1387_6777_6773_7297_6776_2033_51588_5781_8554_10379 21 7.67E-13 6.67E-11 4.45E-12 16749 hsa-mir-3914-2 hsa04210 Apoptosis 596_598_7132_8717_823_1439_207_1147_836_839_5970_4792_842_841_840_8772_472 17 9.17E-13 7.98E-11 4.99E-12 16750 hsa-mir-3914-2 hsa05214 Glioma 818_815_817_4193_5578_5925_1956_207_5595_5594_1869_5728_5159_5156_1026 15 1.90E-12 1.66E-10 9.74E-12 16751 hsa-mir-3914-2 hsa04520 Adherens junction 7046_2064_2534_1956_6714_5879_1460_998_5595_5594_1387_1457_4087_4088_4089_2033 16 2.33E-12 2.03E-10 1.13E-11 16752 hsa-mir-3914-2 hsa04620 Toll-like receptor signaling pathway 3455_1432_5879_207_1147_5595_5594_5599_5970_3725_4792_5601_5602_841_8772_2353 16 5.97E-11 5.19E-09 2.73E-10 16753 hsa-mir-3914-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_1432_5879_1147_998_5599_836_5970_3725_4792_5601_5602_5781 14 6.55E-11 5.70E-09 2.85E-10 16754 hsa-mir-3914-2 hsa04912 GnRH signaling pathway 818_815_817_5578_5580_1956_6714_1432_998_5595_5594_5599_3725_5601_5602_2002 16 1.28E-10 1.11E-08 5.29E-10 16755 hsa-mir-3914-2 hsa04370 VEGF signaling pathway 5578_5743_5747_3791_6714_1432_5879_207_998_5595_5594_3315_9261_842 14 1.69E-10 1.47E-08 6.68E-10 16756 hsa-mir-3914-2 hsa05223 Non-small cell lung cancer 5578_2064_5925_1956_6789_207_5595_5594_6258_6256_1869_842 12 4.63E-10 4.03E-08 1.75E-09 16757 hsa-mir-3914-2 hsa05211 Renal cell carcinoma 3091_2113_5879_207_9915_998_5595_5594_1387_3725_2034_2033_5781 13 8.22E-10 7.15E-08 2.98E-09 16758 hsa-mir-3914-2 hsa04660 T cell receptor signaling pathway 2534_3932_1432_207_1147_998_5595_5594_2932_5970_3725_959_4792_5601_2353 15 1.36E-09 1.18E-07 4.56E-09 16759 hsa-mir-3914-2 hsa04062 Chemokine signaling pathway 1234_1230_5747_5580_7852_6362_6774_5879_207_3717_1147_998_5595_5594_2932_6777_6773_5970_4792 19 1.36E-09 1.19E-07 4.56E-09 16760 hsa-mir-3914-2 hsa04120 Ubiquitin mediated proteolysis 4193_3093_57154_7319_84447_7325_10055_64326_7337_7329_5371_672_25898_51588_10075_8554 16 3.58E-09 3.12E-07 1.15E-08 16761 hsa-mir-3914-2 hsa04060 Cytokine-cytokine receptor interaction 7046_1234_1230_7132_58985_3455_3459_90_3791_1956_3560_3561_1439_7852_6362_959_2321_5159_5156_3815_7133 21 5.66E-09 4.92E-07 1.76E-08 16762 hsa-mir-3914-2 hsa05219 Bladder cancer 9252_4193_2064_5925_1956_2261_5595_5594_1869_1026 10 7.48E-09 6.51E-07 2.24E-08 16763 hsa-mir-3914-2 hsa05221 Acute myeloid leukemia 6774_207_1147_5595_5594_861_6777_5970_6776_5371_3815 11 1.24E-08 1.08E-06 3.47E-08 16764 hsa-mir-3914-2 hsa04662 B cell receptor signaling pathway 6850_5879_207_1147_5595_5594_1380_2932_5970_3725_4792_2353 12 1.24E-08 1.08E-06 3.47E-08 16765 hsa-mir-3914-2 hsa04664 Fc epsilon RI signaling pathway 5578_2534_5580_6850_1432_5879_207_5595_5594_5599_5601_5602 12 2.08E-08 1.81E-06 5.65E-08 16766 hsa-mir-3914-2 hsa03022 Basal transcription factors 51616_2965_2963_2962_2969_6908_2958_6880_2957 9 3.63E-08 3.16E-06 9.58E-08 16767 hsa-mir-3914-2 hsa05218 Melanoma 4193_5925_1956_207_5595_5594_1869_5728_5159_5156_1026 11 6.75E-08 5.87E-06 1.73E-07 16768 hsa-mir-3914-2 hsa04916 Melanogenesis 818_815_817_5578_5595_5594_1385_1387_2932_2033_1856_3815 12 3.18E-07 2.76E-05 7.90E-07 16769 hsa-mir-3914-2 hsa05213 Endometrial cancer 2064_1956_207_5595_5594_2932_5728_842_2002 9 4.64E-07 4.04E-05 1.12E-06 16770 hsa-mir-3914-2 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_7132_1432_5879_1616_836_842_7133 9 8.09E-07 7.04E-05 1.90E-06 16771 hsa-mir-3914-2 hsa04720 Long-term potentiation 818_815_817_6195_5578_5499_5595_5594_1387_2033 10 9.31E-07 8.10E-05 2.13E-06 16772 hsa-mir-3914-2 hsa05010 Alzheimer's disease 7132_823_22926_5595_5594_836_2932_1537_842_841_840_8772_1020 13 1.11E-05 0.000963126 2.47E-05 16773 hsa-mir-3914-2 hsa03420 Nucleotide excision repair 902_2965_4331_2071_2074_1022_6117 7 1.46E-05 0.00127273 3.18E-05 16774 hsa-mir-3914-2 hsa05016 Huntington's disease 3065_3064_25942_6667_1385_1387_836_1537_2033_27113_6908_842_841 13 2.02E-05 0.001753341 4.28E-05 16775 hsa-mir-3914-2 hsa04530 Tight junction 5578_5580_6714_207_1460_998_1457_5728_5518_5515_5520 11 2.43E-05 0.002114206 5.03E-05 16776 hsa-mir-3914-2 hsa04650 Natural killer cell mediated cytotoxicity 5578_3455_3459_2534_3932_6850_5879_5595_5594_836_5781 11 2.59E-05 0.002250896 5.23E-05 16777 hsa-mir-3914-2 hsa04540 Gap junction 5578_1956_6714_5595_5594_1453_5159_983_5156 9 3.47E-05 0.003017272 6.86E-05 16778 hsa-mir-3914-2 hsa04150 mTOR signaling pathway 6794_6195_3091_207_5595_5594_5563 7 3.87E-05 0.003365235 7.48E-05 16779 hsa-mir-3914-2 hsa04360 Axon guidance 2534_5747_25_7852_5879_998_5595_5594_2932_1020 10 8.40E-05 0.007309227 0.000158896 16780 hsa-mir-3914-2 hsa04910 Insulin signaling pathway 5499_207_5595_5594_5599_2932_5601_5602_5563_2002 10 0.000125697 0.010935651 0.000232673 16781 hsa-mir-3914-2 hsa04930 Type II diabetes mellitus 5580_5595_5594_5599_5601_5602 6 0.000146108 0.012711386 0.000264821 16782 hsa-mir-3914-2 hsa04612 Antigen processing and presentation 3309_3304_3305_3303_1385_3320_3326_4800 8 0.000151542 0.013184131 0.000269064 16783 hsa-mir-3914-2 hsa04330 Notch signaling pathway 3065_1387_9612_2033_8850_1856 6 0.000181377 0.015779837 0.000315597 16784 hsa-mir-3914-2 hsa05131 Shigellosis 5578_2534_25_998_7534_4691 6 0.000431148 0.037509856 0.000721343 16785 hsa-mir-3914-2 hsa05130 Pathogenic Escherichia coli infection 5578_2534_25_998_7534_4691 6 0.000431148 0.037509856 0.000721343 16786 hsa-mir-3914-2 hsa03030 DNA replication 4174_4172_5557_6117_5422 5 0.000445452 0.038754354 0.000731214 16787 hsa-mir-3914-2 hsa04810 Regulation of actin cytoskeleton 2264_5747_1956_5499_5879_998_2261_5595_5594_5159_5156 11 0.001131846 0.098470616 0.00182353 16788 hsa-mir-3914-2 hsa03440 Homologous recombination 641_5888_675_6117 4 0.001540045 0.133983956 0.002436072 16789 hsa-mir-3914-2 hsa05216 Thyroid cancer 5595_5594_6258_6256 4 0.001730887 0.150587207 0.002689057 16790 hsa-mir-3914-2 hsa03410 Base excision repair 3146_142_4913_328 4 0.003545286 0.308439866 0.005411226 16791 hsa-mir-3914-2 hsa04020 Calcium signaling pathway 818_815_817_5578_2064_147_1956_5159_5156 9 0.003674531 0.319684204 0.005511797 16792 hsa-mir-3914-2 hsa04670 Leukocyte transendothelial migration 5578_5747_1432_7852_5879_998_5781 7 0.004430353 0.385440739 0.006532894 16793 hsa-mir-3914-2 hsa04730 Long-term depression 5578_5595_5594_5518_5515 5 0.007013592 0.610182471 0.010169708 16794 hsa-mir-3914-2 hsa04270 Vascular smooth muscle contraction 5578_147_5580_5499_5595_5594 6 0.013914938 1 0.019845895 16795 hsa-mir-3914-2 hsa05340 Primary immunodeficiency 3932_3561_959 3 0.021781136 1 0.030563852 16796 hsa-mir-3914-2 hsa03450 Non-homologous end-joining 2547_5591 2 0.02566742 1 0.035445484 16797 hsa-mir-3915 hsa05200 Pathways in cancer 4087_4088_4089_2308_7157_2033_2249_367_3725_5594_5970_6776_6777_2353_5914_1387_6256 17 1.32E-16 8.19E-15 8.19E-15 16798 hsa-mir-3915 hsa05220 Chronic myeloid leukemia 4088_4089_7157_5594_5970_6776_6777 7 3.58E-09 2.22E-07 1.11E-07 16799 hsa-mir-3915 hsa05210 Colorectal cancer 4087_4088_4089_7157_3725_5594_2353 7 7.46E-09 4.63E-07 1.12E-07 16800 hsa-mir-3915 hsa04350 TGF-beta signaling pathway 4087_4088_4089_6667_2033_5594_1387 7 9.37E-09 5.81E-07 1.12E-07 16801 hsa-mir-3915 hsa05215 Prostate cancer 2308_7157_2033_367_5594_5970_1387 7 1.01E-08 6.26E-07 1.12E-07 16802 hsa-mir-3915 hsa05212 Pancreatic cancer 2308_7157_2033_367_5594_5970_1387 7 1.09E-08 6.74E-07 1.12E-07 16803 hsa-mir-3915 hsa04520 Adherens junction 4087_4088_4089_2033_5594_1387 6 1.67E-07 1.03E-05 1.48E-06 16804 hsa-mir-3915 hsa04310 Wnt signaling pathway 4087_4088_4089_7157_2033_3725_1387 7 3.52E-07 2.18E-05 2.73E-06 16805 hsa-mir-3915 hsa05221 Acute myeloid leukemia 5594_5970_6776_6777_5914 5 1.07E-06 6.63E-05 7.36E-06 16806 hsa-mir-3915 hsa04110 Cell cycle 4087_4088_4089_7157_2033_1387 6 1.52E-06 9.45E-05 9.45E-06 16807 hsa-mir-3915 hsa04620 Toll-like receptor signaling pathway 3725_5594_5970_1432_2353 5 1.35E-05 0.000840083 7.64E-05 16808 hsa-mir-3915 hsa04010 MAPK signaling pathway 7157_2249_3725_5594_5970_1432_2353 7 1.49E-05 0.000924384 7.70E-05 16809 hsa-mir-3915 hsa05016 Huntington's disease 6667_7157_10891_2033_6908_1387 6 1.91E-05 0.00118188 8.51E-05 16810 hsa-mir-3915 hsa04660 T cell receptor signaling pathway 3725_5594_5970_1432_2353 5 1.92E-05 0.00119156 8.51E-05 16811 hsa-mir-3915 hsa04920 Adipocytokine signaling pathway 10891_5563_5970_6256 4 4.99E-05 0.003094237 0.000206282 16812 hsa-mir-3915 hsa05211 Renal cell carcinoma 2033_3725_5594_1387 4 6.52E-05 0.004042095 0.000252631 16813 hsa-mir-3915 hsa04662 B cell receptor signaling pathway 3725_5594_5970_2353 4 7.59E-05 0.004703342 0.000276667 16814 hsa-mir-3915 hsa04630 Jak-STAT signaling pathway 2033_3977_6776_6777_1387 5 9.30E-05 0.005766929 0.000320385 16815 hsa-mir-3915 hsa05216 Thyroid cancer 7157_5594_6256 3 0.000101746 0.006308239 0.000332013 16816 hsa-mir-3915 hsa04012 ErbB signaling pathway 3725_5594_6776_6777 4 0.000131512 0.008153738 0.000407687 16817 hsa-mir-3915 hsa04330 Notch signaling pathway 9612_2033_1387 3 0.000387578 0.024029865 0.001144279 16818 hsa-mir-3915 hsa05223 Non-small cell lung cancer 7157_5594_6256 3 0.000570415 0.035365755 0.001607534 16819 hsa-mir-3915 hsa04910 Insulin signaling pathway 2308_10891_5563_5594 4 0.000716216 0.044405385 0.001930669 16820 hsa-mir-3915 hsa05218 Melanoma 7157_2249_5594 3 0.001220812 0.07569035 0.003027614 16821 hsa-mir-3915 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5970_1432 3 0.001220812 0.07569035 0.003027614 16822 hsa-mir-3915 hsa04720 Long-term potentiation 2033_5594_1387 3 0.001421133 0.088110228 0.003388855 16823 hsa-mir-3915 hsa05222 Small cell lung cancer 7157_5970_6256 3 0.002074625 0.128626741 0.004763953 16824 hsa-mir-3915 hsa04916 Melanogenesis 2033_5594_1387 3 0.003496234 0.216766532 0.007741662 16825 hsa-mir-3915 hsa04912 GnRH signaling pathway 3725_5594_1432 3 0.003875712 0.240294131 0.008286005 16826 hsa-mir-3915 hsa03410 Base excision repair 3146_142 2 0.005191443 0.321869457 0.010728982 16827 hsa-mir-3915 hsa03022 Basal transcription factors 6908_2959 2 0.005462071 0.338648431 0.010924143 16828 hsa-mir-3915 hsa05219 Bladder cancer 7157_5594 2 0.006909791 0.428407036 0.01338772 16829 hsa-mir-3915 hsa05213 Endometrial cancer 7157_5594 2 0.010263494 0.636336601 0.018715782 16830 hsa-mir-3915 hsa04150 mTOR signaling pathway 5563_5594 2 0.010263494 0.636336601 0.018715782 16831 hsa-mir-3915 hsa05014 Amyotrophic lateral sclerosis (ALS) 7157_1432 2 0.011769713 0.729722222 0.020849206 16832 hsa-mir-3915 hsa05214 Glioma 7157_5594 2 0.015487308 0.960213103 0.026672586 16833 hsa-mir-3915 hsa04062 Chemokine signaling pathway 5594_5970_6777 3 0.018200018 1 0.030497327 16834 hsa-mir-3915 hsa04370 VEGF signaling pathway 5594_1432 2 0.021116692 1 0.03445355 16835 hsa-mir-3915 hsa04664 Fc epsilon RI signaling pathway 5594_1432 2 0.022126162 1 0.035174924 16836 hsa-mir-3915 hsa04210 Apoptosis 7157_5970 2 0.027463742 1 0.0425688 16837 hsa-mir-3915 hsa03450 Non-homologous end-joining 2547 1 0.041561419 1 0.062848975 16838 hsa-mir-3917 hsa05200 Pathways in cancer 3725_1499_5914_595_4193_7704_6502_3091_4087_3066_3065_5925_7186_405_2034_1956_2308_4824_8503_4436_1870_1871_2885_2113_10401_862_207_208_1147_5595_5594_6258_1387_2064_6256_836_367_2932_6776_5970_6654_7157_1869_4088_4089_5295_2033_4846_4790_3320_3326_5371_3480_842_841_7428_4609_1029_8554 59 1.32E-40 1.03E-38 1.03E-38 16839 hsa-mir-3917 hsa05215 Prostate cancer 1499_595_4193_5925_1956_2308_4824_8503_1870_1871_2885_207_208_1147_5595_5594_1385_1387_2064_367_2932_5970_6654_7157_1869_5295_2033_4790_3320_3326_3480_842 32 1.11E-30 8.64E-29 3.86E-29 16840 hsa-mir-3917 hsa05212 Pancreatic cancer 1499_595_4193_5925_1956_2308_4824_8503_1870_1871_2885_207_208_1147_5595_5594_1385_1387_2064_367_2932_5970_6654_7157_1869_5295_2033_4790_3320_3326_3480_842 32 1.49E-30 1.16E-28 3.86E-29 16841 hsa-mir-3917 hsa05220 Chronic myeloid leukemia 595_4193_3066_3065_5925_8503_1870_1871_2885_207_208_1147_5595_5594_6776_5970_6654_7157_1869_4088_4089_5295_4790_4609_1029_6464 26 1.03E-24 8.02E-23 2.01E-23 16842 hsa-mir-3917 hsa04010 MAPK signaling pathway 6722_3725_6197_4214_7867_4773_994_4616_7186_1956_3303_1432_627_2885_4763_2872_207_208_1147_5595_5594_1386_836_3312_5970_6654_7157_10912_3727_6195_5058_4790_9261_4208_5566_4609_2002_2005 38 4.92E-23 3.84E-21 7.67E-22 16843 hsa-mir-3917 hsa05214 Glioma 815_595_4193_5925_1956_8503_1870_1871_2885_207_208_5595_5594_6654_7157_1869_5295_808_801_805_3480_1029_6464 23 3.56E-22 2.78E-20 4.63E-21 16844 hsa-mir-3917 hsa04110 Cell cycle 595_4193_902_6502_4087_994_3066_3065_4616_5925_1870_1871_8379_5933_5591_1387_7533_2932_7027_7157_10912_1869_4088_4089_2033_1022_1029 27 1.65E-21 1.29E-19 1.84E-20 16845 hsa-mir-3917 hsa05223 Non-small cell lung cancer 595_5925_1956_2309_8503_1870_1871_2885_207_208_5595_5594_6258_2064_6256_6654_7157_1869_5295_842_1029 21 4.72E-21 3.68E-19 4.60E-20 16846 hsa-mir-3917 hsa05210 Colorectal cancer 3725_1499_595_4087_1956_8503_4436_2885_207_208_5595_5594_836_2932_6654_7157_4088_4089_5295_3480_842_4609 22 6.62E-19 5.16E-17 5.74E-18 16847 hsa-mir-3917 hsa05222 Small cell lung cancer 595_6502_5925_7186_8503_1870_1871_10401_207_208_1147_6258_6256_5970_7157_1869_5295_4846_4790_842_4609_8554 22 1.02E-18 7.93E-17 7.93E-18 16848 hsa-mir-3917 hsa05213 Endometrial cancer 1499_595_1956_2309_8503_2885_207_208_5595_5594_2064_2932_6654_7157_5295_842_4609_2002 18 1.69E-17 1.32E-15 1.20E-16 16849 hsa-mir-3917 hsa05221 Acute myeloid leukemia 5914_595_7704_8503_2885_862_207_208_1147_5595_5594_6776_5970_6654_5295_4790_5371_4609 18 1.08E-16 8.44E-15 7.03E-16 16850 hsa-mir-3917 hsa04012 ErbB signaling pathway 3725_815_1956_6714_8503_2885_207_208_5595_5594_56924_2064_2932_6776_6654_5295_5058_4609_6464_2002 20 2.30E-16 1.80E-14 1.38E-15 16851 hsa-mir-3917 hsa05211 Renal cell carcinoma 3725_3091_405_2034_8503_2885_2113_207_208_5595_5594_56924_1387_6654_5295_5058_2033_7428 18 2.09E-15 1.63E-13 1.16E-14 16852 hsa-mir-3917 hsa04910 Insulin signaling pathway 10891_6720_5770_2308_8503_2885_23265_2872_207_208_5595_5594_7249_2932_6654_5295_808_801_805_5566_6464_2002 22 6.11E-15 4.76E-13 3.18E-14 16853 hsa-mir-3917 hsa04660 T cell receptor signaling pathway 3725_5777_4773_3932_1432_8503_2885_207_208_1147_5595_5594_56924_2932_5970_6654_5295_5058_4790 19 1.22E-13 9.55E-12 5.97E-13 16854 hsa-mir-3917 hsa05218 Melanoma 595_4193_5925_1956_8503_1870_1871_207_208_5595_5594_7157_1869_5295_3480_1029 16 3.05E-13 2.38E-11 1.40E-12 16855 hsa-mir-3917 hsa04520 Adherens junction 1499_5770_5777_4087_1956_6714_1460_5595_5594_1387_2064_1457_4088_4089_2033_3480 16 1.50E-12 1.17E-10 6.51E-12 16856 hsa-mir-3917 hsa05219 Bladder cancer 595_4193_5925_1956_1870_1871_5595_5594_2064_7157_1869_4609_1029 13 1.72E-12 1.34E-10 7.06E-12 16857 hsa-mir-3917 hsa04662 B cell receptor signaling pathway 3725_5777_4773_8503_2885_207_208_1147_5595_5594_2932_5970_6654_5295_4790 15 7.53E-12 5.88E-10 2.94E-11 16858 hsa-mir-3917 hsa04510 Focal adhesion 3725_1499_595_857_9564_1956_6714_8503_2885_207_208_5595_5594_56924_2064_2932_6654_5295_5058_3480_6464_2002 22 9.06E-12 7.07E-10 3.37E-11 16859 hsa-mir-3917 hsa04210 Apoptosis 7186_8503_207_208_1147_836_839_5970_7157_5295_4790_5566_842_841_840 15 6.46E-11 5.04E-09 2.29E-10 16860 hsa-mir-3917 hsa04350 TGF-beta signaling pathway 6667_4087_3397_3399_3398_5933_5595_5594_1387_7027_4088_4089_2033_4609 14 4.82E-10 3.76E-08 1.64E-09 16861 hsa-mir-3917 hsa04912 GnRH signaling pathway 3725_815_4214_1956_6714_1432_2885_5595_5594_6654_808_801_805_5566_2002 15 7.28E-10 5.68E-08 2.37E-09 16862 hsa-mir-3917 hsa04310 Wnt signaling pathway 3725_815_1499_595_4087_4773_1460_1387_2932_7157_8061_1457_4088_4089_2033_5566_4609 17 1.12E-09 8.72E-08 3.49E-09 16863 hsa-mir-3917 hsa04370 VEGF signaling pathway 7867_4773_6714_1432_8503_207_208_5595_5594_5295_4846_9261_842 13 1.20E-09 9.35E-08 3.59E-09 16864 hsa-mir-3917 hsa04062 Chemokine signaling pathway 9564_2309_8503_2885_207_208_1147_5595_5594_2932_5970_6654_5295_5058_4790_2770_5566_6464 18 5.15E-09 4.01E-07 1.49E-08 16865 hsa-mir-3917 hsa04720 Long-term potentiation 815_6197_2902_5595_5594_1387_6195_2033_808_801_805_5566 12 8.96E-09 6.99E-07 2.50E-08 16866 hsa-mir-3917 hsa04916 Melanogenesis 815_1499_5595_5594_1385_1387_2932_2033_808_801_805_2770_5566 13 3.11E-08 2.42E-06 8.35E-08 16867 hsa-mir-3917 hsa04150 mTOR signaling pathway 6197_3091_8503_207_208_5595_5594_7249_6195_5295 10 3.36E-08 2.62E-06 8.75E-08 16868 hsa-mir-3917 hsa05216 Thyroid cancer 1499_595_5595_5594_6258_6256_7157_4609 8 7.38E-08 5.76E-06 1.86E-07 16869 hsa-mir-3917 hsa05016 Huntington's disease 6667_10891_3066_3065_3064_2902_627_1385_1387_836_7157_2033_6874_6908_842_841 16 1.18E-07 9.20E-06 2.88E-07 16870 hsa-mir-3917 hsa04620 Toll-like receptor signaling pathway 3725_1432_8503_207_208_1147_5595_5594_5970_5295_4790_841 12 1.92E-07 1.50E-05 4.54E-07 16871 hsa-mir-3917 hsa04115 p53 signaling pathway 595_4193_4616_836_7249_7157_10912_842_841_1029 10 3.58E-07 2.79E-05 8.20E-07 16872 hsa-mir-3917 hsa04630 Jak-STAT signaling pathway 595_5777_8503_2885_10401_207_208_1387_6776_6654_5295_2033_4609_8554 14 3.74E-07 2.92E-05 8.34E-07 16873 hsa-mir-3917 hsa04330 Notch signaling pathway 9612_3066_3065_1387_2033_8850_388585_4851 8 1.83E-06 0.000142748 3.97E-06 16874 hsa-mir-3917 hsa04920 Adipocytokine signaling pathway 10891_7186_207_208_1147_6258_6256_5970_4790 9 2.44E-06 0.000190367 5.15E-06 16875 hsa-mir-3917 hsa04650 Natural killer cell mediated cytotoxicity 5777_4773_3932_8503_2885_5595_5594_836_6654_5295_5058_6464 12 3.66E-06 0.000285387 7.51E-06 16876 hsa-mir-3917 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1956_6714_1432_1147_836_5970_5058_4790 9 3.76E-06 0.0002936 7.53E-06 16877 hsa-mir-3917 hsa03022 Basal transcription factors 6881_2965_2962_2969_6874_6908_2959 7 4.40E-06 0.00034324 8.58E-06 16878 hsa-mir-3917 hsa05010 Alzheimer's disease 2902_22926_5595_5594_836_2932_4846_808_801_805_842_841_840 13 8.13E-06 0.000633773 1.55E-05 16879 hsa-mir-3917 hsa04664 Fc epsilon RI signaling pathway 1432_8503_2885_207_208_5595_5594_6654_5295 9 8.33E-06 0.000649448 1.55E-05 16880 hsa-mir-3917 hsa04120 Ubiquitin mediated proteolysis 55294_4214_4193_6502_10401_10273_5371_672_7428_7329_8554 11 2.11E-05 0.001645235 3.83E-05 16881 hsa-mir-3917 hsa04612 Antigen processing and presentation 6890_3303_1385_3312_3320_3326_4800_4801 8 0.000124174 0.009685585 0.000220127 16882 hsa-mir-3917 hsa04540 Gap junction 1956_6714_2885_5595_5594_6654_2770_5566 8 0.000164672 0.012844449 0.000285432 16883 hsa-mir-3917 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_1432_836_7157_4846_842 6 0.000369562 0.028825848 0.000626649 16884 hsa-mir-3917 hsa04930 Type II diabetes mellitus 8503_3651_5595_5594_5295 5 0.000985403 0.076861417 0.001635349 16885 hsa-mir-3917 hsa04360 Axon guidance 4773_5998_5595_5594_56924_2932_5058_2770 8 0.001388574 0.108308782 0.002256433 16886 hsa-mir-3917 hsa04020 Calcium signaling pathway 815_1956_2902_2064_4846_808_801_805_5566 9 0.003036288 0.23683044 0.004833274 16887 hsa-mir-3917 hsa03420 Nucleotide excision repair 902_2965_4331_1022 4 0.006182098 0.482203632 0.009513957 16888 hsa-mir-3917 hsa04730 Long-term depression 5595_5594_4846_3480_2770 5 0.006220664 0.485211789 0.009513957 16889 hsa-mir-3917 hsa04530 Tight junction 1499_6714_207_208_1460_1457_2770 7 0.006853881 0.534602698 0.010280821 16890 hsa-mir-3917 hsa04950 Maturity onset diabetes of the young 3651_168620_3172 3 0.007918275 0.617625413 0.011630358 16891 hsa-mir-3917 hsa04070 Phosphatidylinositol signaling system 8503_5295_808_801_805 5 0.008110718 0.632635996 0.011630358 16892 hsa-mir-3917 hsa03050 Proteasome 5705_5710_5684_5698 4 0.008200894 0.639669715 0.011630358 16893 hsa-mir-3917 hsa04810 Regulation of actin cytoskeleton 9564_1956_8503_5595_5594_56924_6654_5295_5058 9 0.008828493 0.688622426 0.012296829 16894 hsa-mir-3917 hsa04270 Vascular smooth muscle contraction 5595_5594_808_801_805_5566 6 0.012205041 0.951993221 0.016701635 16895 hsa-mir-3917 hsa04670 Leukocyte transendothelial migration 1499_9564_1432_8503_5295_2770 6 0.014096673 1 0.018957595 16896 hsa-mir-3917 hsa03410 Base excision repair 3146_4350_6996 3 0.021628402 1 0.028593481 16897 hsa-mir-3919 hsa05200 Pathways in cancer 3320_25_5925_5371_2249_9063_5595_5594_5914_1387_6256_5601_5602_4286_367_1017_2932_861_6934_5599_6776_6777_6772_2885_3091_5970_4087_4089_5604_2113_3725_6774_1026_1029_6688_2353_2736_4088_2033_207_898_8554 42 1.31E-25 9.46E-24 9.46E-24 16898 hsa-mir-3919 hsa04110 Cell cycle 25_5925_993_5591_7531_7534_1387_983_1017_7533_7532_5001_2932_4087_4089_4174_1026_4172_4173_1029_4088_2033_898_4998_4999 25 2.35E-20 1.69E-18 8.47E-19 16899 hsa-mir-3919 hsa04010 MAPK signaling pathway 6722_2249_3727_5595_5594_4773_9261_5601_5602_3303_6197_9252_5599_3312_1386_1432_2885_5970_9344_5604_468_3725_6195_6196_5606_2353_5600_8986_207_1649_8550_2005 32 7.22E-19 5.20E-17 1.73E-17 16900 hsa-mir-3919 hsa05215 Prostate cancer 3320_5925_5595_5594_1387_367_1017_2932_6934_9586_2885_5970_5604_468_1026_2033_207_898 18 7.65E-15 5.51E-13 1.31E-13 16901 hsa-mir-3919 hsa05212 Pancreatic cancer 3320_5925_5595_5594_1387_367_1017_2932_6934_9586_2885_5970_5604_468_1026_2033_207_898 18 9.09E-15 6.54E-13 1.31E-13 16902 hsa-mir-3919 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_861_6934_6776_6777_2885_5970_5604_6774_6688_207 14 1.34E-12 9.67E-11 1.61E-11 16903 hsa-mir-3919 hsa05220 Chronic myeloid leukemia 25_5925_5595_5594_861_6776_6777_2885_5970_4089_5604_1026_1029_4088_207 15 1.82E-12 1.31E-10 1.87E-11 16904 hsa-mir-3919 hsa05210 Colorectal cancer 5595_5594_5601_5602_2932_6934_5599_2885_4087_4089_5604_3725_2353_4088_207 15 7.63E-12 5.49E-10 6.87E-11 16905 hsa-mir-3919 hsa04012 ErbB signaling pathway 25_5595_5594_5601_5602_2932_5599_6776_6777_2885_5604_3725_1026_815_207 15 1.19E-11 8.57E-10 9.52E-11 16906 hsa-mir-3919 hsa04310 Wnt signaling pathway 1460_4773_1387_5601_5602_2932_1457_6934_5599_4087_4089_3725_815_5518_4088_8061_2033 17 2.44E-10 1.76E-08 1.76E-09 16907 hsa-mir-3919 hsa04620 Toll-like receptor signaling pathway 5595_5594_5601_5602_5599_1432_6772_5970_5604_3725_5606_2353_5600_207 14 8.57E-10 6.17E-08 5.61E-09 16908 hsa-mir-3919 hsa04660 T cell receptor signaling pathway 5595_5594_4773_5601_2932_1432_2885_5970_1739_5604_3725_2353_5600_207 14 2.08E-09 1.50E-07 1.25E-08 16909 hsa-mir-3919 hsa04350 TGF-beta signaling pathway 6667_5595_5594_1387_3397_3399_3398_4087_4089_5518_4088_2033 12 1.32E-08 9.50E-07 7.31E-08 16910 hsa-mir-3919 hsa04912 GnRH signaling pathway 5595_5594_5601_5602_5599_1432_2885_5604_468_3725_815_5606_5600 13 1.44E-08 1.04E-06 7.42E-08 16911 hsa-mir-3919 hsa04720 Long-term potentiation 5595_5594_1387_5499_6197_5604_468_815_6195_6196_2033 11 3.02E-08 2.18E-06 1.45E-07 16912 hsa-mir-3919 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5601_5602_5599_1432_2885_5604_5606_5600_207 11 4.89E-08 3.52E-06 2.20E-07 16913 hsa-mir-3919 hsa05211 Renal cell carcinoma 5595_5594_1387_2885_3091_5604_2113_3725_2033_207 10 2.04E-07 1.47E-05 8.64E-07 16914 hsa-mir-3919 hsa04662 B cell receptor signaling pathway 5595_5594_4773_2932_2885_5970_5604_3725_2353_207 10 2.88E-07 2.07E-05 1.15E-06 16915 hsa-mir-3919 hsa04520 Adherens junction 1460_5595_5594_1387_1457_6934_4087_4089_4088_2033 10 4.95E-07 3.56E-05 1.87E-06 16916 hsa-mir-3919 hsa05214 Glioma 5925_5595_5594_2885_5604_1026_1029_815_207 9 8.54E-07 6.15E-05 3.07E-06 16917 hsa-mir-3919 hsa05218 Melanoma 5925_2249_5595_5594_4286_5604_1026_1029_207 9 1.67E-06 0.000119898 5.71E-06 16918 hsa-mir-3919 hsa05223 Non-small cell lung cancer 5925_5595_5594_6256_2885_5604_1029_207 8 2.22E-06 0.000159505 7.13E-06 16919 hsa-mir-3919 hsa03022 Basal transcription factors 2963_6879_6908_6872_2958_2959_6880 7 2.28E-06 0.000164094 7.13E-06 16920 hsa-mir-3919 hsa04630 Jak-STAT signaling pathway 9063_1387_6776_6777_6772_2885_6774_6775_2033_3977_207_8554 12 4.02E-06 0.000289581 1.21E-05 16921 hsa-mir-3919 hsa05219 Bladder cancer 5925_5595_5594_9252_5604_1026_1029 7 4.81E-06 0.000346586 1.39E-05 16922 hsa-mir-3919 hsa05213 Endometrial cancer 5595_5594_2932_6934_2885_5604_207 7 1.70E-05 0.001222198 4.53E-05 16923 hsa-mir-3919 hsa04150 mTOR signaling pathway 5595_5594_6197_3091_6195_6196_207 7 1.70E-05 0.001222198 4.53E-05 16924 hsa-mir-3919 hsa04370 VEGF signaling pathway 5595_5594_4773_9261_1432_5604_5600_207 8 2.39E-05 0.001721228 6.15E-05 16925 hsa-mir-3919 hsa04916 Melanogenesis 5595_5594_1387_4286_2932_6934_5604_815_2033 9 2.87E-05 0.00206685 7.13E-05 16926 hsa-mir-3919 hsa04910 Insulin signaling pathway 5595_5594_5601_5499_5602_2932_5599_2885_5604_207 10 4.33E-05 0.003115344 0.000103092 16927 hsa-mir-3919 hsa04950 Maturity onset diabetes of the young 3172_3651_6927_3087_5080 5 4.48E-05 0.003223019 0.000103092 16928 hsa-mir-3919 hsa04120 Ubiquitin mediated proteolysis 64326_11059_5371_83737_9063_672_55294_10273_7329_8554 10 4.58E-05 0.00329894 0.000103092 16929 hsa-mir-3919 hsa05222 Small cell lung cancer 5925_9063_6256_1017_5970_207_898_8554 8 4.96E-05 0.003573445 0.000108286 16930 hsa-mir-3919 hsa04510 Focal adhesion 5595_5594_5601_5499_5602_2932_5599_1729_2885_5604_3725_207 12 5.77E-05 0.004155938 0.000122233 16931 hsa-mir-3919 hsa04930 Type II diabetes mellitus 5595_5594_5601_5602_3651_5599 6 7.21E-05 0.005192737 0.000148364 16932 hsa-mir-3919 hsa04920 Adipocytokine signaling pathway 6256_5601_5602_5599_5970_6774_207 7 7.50E-05 0.005396624 0.000149906 16933 hsa-mir-3919 hsa05216 Thyroid cancer 5595_5594_6256_6934_5604 5 9.91E-05 0.007134553 0.000192826 16934 hsa-mir-3919 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5601_5602_5599_1432_5970_3725_5600 7 0.000104948 0.007556262 0.000198849 16935 hsa-mir-3919 hsa04062 Chemokine signaling pathway 5595_5594_2932_2931_6777_6772_2885_5970_5604_6774_207 11 0.000139924 0.010074497 0.00025832 16936 hsa-mir-3919 hsa04115 p53 signaling pathway 64326_983_1017_1026_1029_898 6 0.000610311 0.043942377 0.001098559 16937 hsa-mir-3919 hsa04530 Tight junction 1460_10207_1457_4628_60412_8189_5518_207 8 0.000965112 0.069488034 0.00169483 16938 hsa-mir-3919 hsa03450 Non-homologous end-joining 5591_7520_2547 3 0.001549049 0.111531509 0.002655512 16939 hsa-mir-3919 hsa05016 Huntington's disease 6667_1387_6908_9586_10476_3064_4697_2033_4716 9 0.00178621 0.128607127 0.002990863 16940 hsa-mir-3919 hsa04540 Gap junction 5592_5595_5594_983_2885_5604 6 0.00257506 0.18540429 0.004213734 16941 hsa-mir-3919 hsa04730 Long-term depression 5592_5595_5594_5604_5518 5 0.004096764 0.294967032 0.006554823 16942 hsa-mir-3919 hsa04330 Notch signaling pathway 1387_9612_2033_8850 4 0.005411654 0.389639057 0.008470414 16943 hsa-mir-3919 hsa04612 Antigen processing and presentation 3320_1514_3303_4800_3312 5 0.009957487 0.716939045 0.015254022 16944 hsa-mir-3919 hsa04360 Axon guidance 25_5998_5595_5594_4773_2932 6 0.012232291 0.880724922 0.018348436 16945 hsa-mir-3919 hsa05010 Alzheimer's disease 5595_5594_2932_10476_6622_4697_4716 7 0.014514302 1 0.021327138 16946 hsa-mir-3919 hsa03030 DNA replication 4174_4172_4173 3 0.01663994 1 0.023491681 16947 hsa-mir-3919 hsa03410 Base excision repair 3146_142_6996 3 0.01663994 1 0.023491681 16948 hsa-mir-3919 hsa04270 Vascular smooth muscle contraction 5592_5595_5594_5499_5604 5 0.028447227 1 0.039388469 16949 hsa-mir-3919 hsa04810 Regulation of actin cytoskeleton 2249_5595_5594_5499_4628_1729_5604 7 0.038621466 1 0.052466897 16950 hsa-mir-3919 hsa05217 Basal cell carcinoma 2932_6934_2736 3 0.046433992 1 0.061184502 16951 hsa-mir-3919 hsa05012 Parkinson's disease 10476_6622_4697_7314_4716 5 0.046738162 1 0.061184502 16952 hsa-mir-3919 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_5606_5600 3 0.048437115 1 0.062042626 16953 hsa-mir-3919 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_4773_2885_5604 5 0.049117079 1 0.062042626 16954 hsa-mir-3920 hsa05200 Pathways in cancer 2249_367_3725_6776_6777_2353_5914_5970_6256 9 2.03E-10 7.70E-09 7.70E-09 16955 hsa-mir-3920 hsa05221 Acute myeloid leukemia 6776_6777_5914_5970 4 9.84E-07 3.74E-05 1.87E-05 16956 hsa-mir-3920 hsa05220 Chronic myeloid leukemia 6776_6777_5970 3 0.000113081 0.004297074 0.001074269 16957 hsa-mir-3920 hsa04662 B cell receptor signaling pathway 3725_2353_5970 3 0.000113081 0.004297074 0.001074269 16958 hsa-mir-3920 hsa04012 ErbB signaling pathway 3725_6776_6777 3 0.00017291 0.006570564 0.001314113 16959 hsa-mir-3920 hsa04620 Toll-like receptor signaling pathway 3725_2353_5970 3 0.000272526 0.010355982 0.001606221 16960 hsa-mir-3920 hsa04010 MAPK signaling pathway 2249_3725_2353_5970 4 0.000330487 0.012558499 0.001606221 16961 hsa-mir-3920 hsa04660 T cell receptor signaling pathway 3725_2353_5970 3 0.000338152 0.012849769 0.001606221 16962 hsa-mir-3920 hsa04630 Jak-STAT signaling pathway 3977_6776_6777 3 0.000897685 0.03411204 0.003790227 16963 hsa-mir-3920 hsa04920 Adipocytokine signaling pathway 5970_6256 2 0.003115381 0.11838449 0.011838449 16964 hsa-mir-3920 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5970 2 0.003479392 0.132216888 0.012019717 16965 hsa-mir-3920 hsa05210 Colorectal cancer 3725_2353 2 0.004792101 0.18209983 0.0135505 16966 hsa-mir-3920 hsa05222 Small cell lung cancer 5970_6256 2 0.005011395 0.190433006 0.0135505 16967 hsa-mir-3920 hsa05215 Prostate cancer 367_5970 2 0.00523525 0.198939509 0.0135505 16968 hsa-mir-3920 hsa05212 Pancreatic cancer 367_5970 2 0.005348882 0.203257498 0.0135505 16969 hsa-mir-3920 hsa03450 Non-homologous end-joining 2547 1 0.01783249 0.677634628 0.042352164 16970 hsa-mir-3920 hsa05016 Huntington's disease 6908_6667 2 0.021779742 0.827630199 0.048257818 16971 hsa-mir-3920 hsa04062 Chemokine signaling pathway 6777_5970 2 0.022858967 0.868640727 0.048257818 16972 hsa-mir-3920 hsa04950 Maturity onset diabetes of the young 6927 1 0.02954865 1 0.0590973 16973 hsa-mir-3920 hsa05216 Thyroid cancer 6256 1 0.035355663 1 0.067175759 16974 hsa-mir-3920 hsa04080 Neuroactive ligand-receptor interaction 2908_7067 2 0.038234048 1 0.06918542 16975 hsa-mir-3920 hsa03410 Base excision repair 142 1 0.043428758 1 0.073648431 16976 hsa-mir-3920 hsa03022 Basal transcription factors 6908 1 0.044576682 1 0.073648431 16977 hsa-mir-3921 hsa05200 Pathways in cancer 8031_2033_8554_5970_5594_5599_6258_1387_6257_6256 10 3.31E-12 1.62E-10 1.62E-10 16978 hsa-mir-3921 hsa04920 Adipocytokine signaling pathway 10891_5970_5599_6258_6257_6256 6 2.13E-10 1.04E-08 5.22E-09 16979 hsa-mir-3921 hsa05216 Thyroid cancer 8031_5594_6258_6257_6256 5 3.72E-10 1.82E-08 6.07E-09 16980 hsa-mir-3921 hsa05222 Small cell lung cancer 8554_5970_6258_6257_6256 5 5.93E-08 2.91E-06 7.27E-07 16981 hsa-mir-3921 hsa05223 Non-small cell lung cancer 5594_6258_6257_6256 4 5.56E-07 2.72E-05 5.45E-06 16982 hsa-mir-3921 hsa03320 PPAR signaling pathway 6258_2168_6257_6256 4 1.49E-06 7.29E-05 1.22E-05 16983 hsa-mir-3921 hsa05215 Prostate cancer 2033_5970_5594_1387 4 3.56E-06 0.000174597 2.28E-05 16984 hsa-mir-3921 hsa05212 Pancreatic cancer 2033_5970_5594_1387 4 3.72E-06 0.000182298 2.28E-05 16985 hsa-mir-3921 hsa04110 Cell cycle 4616_10912_2033_1387 4 1.13E-05 0.000553413 6.15E-05 16986 hsa-mir-3921 hsa04010 MAPK signaling pathway 4616_10912_5970_5594_5599 5 1.46E-05 0.000717326 7.17E-05 16987 hsa-mir-3921 hsa04330 Notch signaling pathway 9612_2033_1387 3 2.50E-05 0.001227437 0.000111585 16988 hsa-mir-3921 hsa05211 Renal cell carcinoma 2033_5594_1387 3 8.46E-05 0.004147737 0.000345645 16989 hsa-mir-3921 hsa04720 Long-term potentiation 2033_5594_1387 3 9.51E-05 0.004662159 0.000358628 16990 hsa-mir-3921 hsa04520 Adherens junction 2033_5594_1387 3 0.00011447 0.005609015 0.000400644 16991 hsa-mir-3921 hsa04350 TGF-beta signaling pathway 2033_5594_1387 3 0.000145572 0.007133051 0.000475537 16992 hsa-mir-3921 hsa04620 Toll-like receptor signaling pathway 5970_5594_5599 3 0.00022961 0.011250887 0.000699658 16993 hsa-mir-3921 hsa04916 Melanogenesis 2033_5594_1387 3 0.000242739 0.01189419 0.000699658 16994 hsa-mir-3921 hsa04910 Insulin signaling pathway 10891_5594_5599 3 0.00054478 0.026694224 0.001483012 16995 hsa-mir-3921 hsa04310 Wnt signaling pathway 2033_5599_1387 3 0.000717318 0.035148589 0.001849926 16996 hsa-mir-3921 hsa04630 Jak-STAT signaling pathway 2033_8554_1387 3 0.000758306 0.037156973 0.001857849 16997 hsa-mir-3921 hsa04930 Type II diabetes mellitus 5594_5599 2 0.001302383 0.063816769 0.002918334 16998 hsa-mir-3921 hsa05016 Huntington's disease 10891_2033_1387 3 0.001310272 0.064203352 0.002918334 16999 hsa-mir-3921 hsa05221 Acute myeloid leukemia 5970_5594 2 0.002183021 0.106968027 0.004650784 17000 hsa-mir-3921 hsa04115 p53 signaling pathway 4616_10912 2 0.002943471 0.144230074 0.006009586 17001 hsa-mir-3921 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_5599 2 0.003108453 0.152314182 0.006092567 17002 hsa-mir-3921 hsa05220 Chronic myeloid leukemia 5970_5594 2 0.003451156 0.169106634 0.006263209 17003 hsa-mir-3921 hsa04662 B cell receptor signaling pathway 5970_5594 2 0.003451156 0.169106634 0.006263209 17004 hsa-mir-3921 hsa04664 Fc epsilon RI signaling pathway 5594_5599 2 0.003810719 0.186725229 0.006668758 17005 hsa-mir-3921 hsa05210 Colorectal cancer 5594_5599 2 0.004283653 0.209899019 0.007237897 17006 hsa-mir-3921 hsa04012 ErbB signaling pathway 5594_5599 2 0.004579825 0.224411431 0.007480381 17007 hsa-mir-3921 hsa04912 GnRH signaling pathway 5594_5599 2 0.006908049 0.338494385 0.010919174 17008 hsa-mir-3921 hsa04660 T cell receptor signaling pathway 5970_5594 2 0.007152607 0.350477725 0.010952429 17009 hsa-mir-3921 hsa04062 Chemokine signaling pathway 5970_5594 2 0.020530456 1 0.030484617 17010 hsa-mir-3921 hsa04510 Focal adhesion 5594_5599 2 0.023154571 1 0.033369824 17011 hsa-mir-3921 hsa05219 Bladder cancer 5594 1 0.047571124 1 0.066599573 17012 hsa-mir-3922 hsa05200 Pathways in cancer 4149_5371_5594_1387_1017_2932_6772_5970_1870_1871_7157_6688_2113_1869_2736_4088_4089_2033_1050_207_4790 21 1.28E-21 7.58E-20 7.58E-20 17013 hsa-mir-3922 hsa04110 Cell cycle 1387_1017_2932_1870_1871_7157_1869_4088_4089_2033_890_5934_5933 13 1.50E-16 8.86E-15 3.39E-15 17014 hsa-mir-3922 hsa05215 Prostate cancer 5594_1387_1017_2932_5970_1870_1871_7157_1869_2033_207_4790 12 2.03E-16 1.20E-14 3.39E-15 17015 hsa-mir-3922 hsa05212 Pancreatic cancer 5594_1387_1017_2932_5970_1870_1871_7157_1869_2033_207_4790 12 2.30E-16 1.36E-14 3.39E-15 17016 hsa-mir-3922 hsa04010 MAPK signaling pathway 6722_4149_5594_8986_9261_6195_9252_1432_5970_7157_6196_6197_207_4790_51701 15 8.66E-15 5.11E-13 1.02E-13 17017 hsa-mir-3922 hsa05220 Chronic myeloid leukemia 5594_5970_1870_1871_7157_1869_4088_4089_207_4790 10 8.92E-14 5.26E-12 8.77E-13 17018 hsa-mir-3922 hsa05222 Small cell lung cancer 4149_1017_5970_1870_1871_7157_1869_207_4790 9 1.21E-11 7.14E-10 9.82E-11 17019 hsa-mir-3922 hsa04350 TGF-beta signaling pathway 5594_1387_1874_1875_4088_4089_2033_5934_5933 9 1.33E-11 7.86E-10 9.82E-11 17020 hsa-mir-3922 hsa05221 Acute myeloid leukemia 5371_5594_5970_6688_1050_207_4790 7 1.14E-09 6.72E-08 7.47E-09 17021 hsa-mir-3922 hsa05219 Bladder cancer 5594_9252_1870_1871_7157_1869 6 6.71E-09 3.96E-07 3.96E-08 17022 hsa-mir-3922 hsa04520 Adherens junction 5594_1387_1457_4088_4089_2033_51701 7 8.13E-09 4.79E-07 4.36E-08 17023 hsa-mir-3922 hsa05223 Non-small cell lung cancer 5594_1870_1871_7157_1869_207 6 2.66E-08 1.57E-06 1.30E-07 17024 hsa-mir-3922 hsa04310 Wnt signaling pathway 1387_1457_2932_7157_4088_4089_2033_51701 8 2.87E-08 1.69E-06 1.30E-07 17025 hsa-mir-3922 hsa05214 Glioma 5594_1870_1871_7157_1869_207 6 7.41E-08 4.37E-06 3.12E-07 17026 hsa-mir-3922 hsa05218 Melanoma 5594_1870_1871_7157_1869_207 6 1.21E-07 7.13E-06 4.75E-07 17027 hsa-mir-3922 hsa04720 Long-term potentiation 5594_1387_6195_6196_6197_2033 6 1.64E-07 9.67E-06 6.04E-07 17028 hsa-mir-3922 hsa05210 Colorectal cancer 5594_2932_7157_4088_4089_207 6 3.08E-07 1.82E-05 1.07E-06 17029 hsa-mir-3922 hsa04150 mTOR signaling pathway 5594_6195_6196_6197_207 5 7.92E-07 4.67E-05 2.60E-06 17030 hsa-mir-3922 hsa04620 Toll-like receptor signaling pathway 5594_1432_6772_5970_207_4790 6 9.06E-07 5.34E-05 2.81E-06 17031 hsa-mir-3922 hsa04660 T cell receptor signaling pathway 5594_2932_1432_5970_207_4790 6 1.38E-06 8.13E-05 4.07E-06 17032 hsa-mir-3922 hsa05211 Renal cell carcinoma 5594_1387_2113_2033_207 5 3.57E-06 0.000210452 1.00E-05 17033 hsa-mir-3922 hsa04662 B cell receptor signaling pathway 5594_2932_5970_207_4790 5 4.31E-06 0.000254265 1.16E-05 17034 hsa-mir-3922 hsa05213 Endometrial cancer 5594_2932_7157_207 4 2.44E-05 0.001439733 6.26E-05 17035 hsa-mir-3922 hsa04062 Chemokine signaling pathway 5594_2932_6772_5970_207_4790 6 3.04E-05 0.001796499 7.49E-05 17036 hsa-mir-3922 hsa04370 VEGF signaling pathway 5594_9261_1432_207 4 0.000104414 0.006160453 0.000246418 17037 hsa-mir-3922 hsa04210 Apoptosis 5970_7157_207_4790 4 0.000178302 0.010519827 0.000404609 17038 hsa-mir-3922 hsa04916 Melanogenesis 5594_1387_2932_2033 4 0.000316295 0.018661382 0.000691162 17039 hsa-mir-3922 hsa04330 Notch signaling pathway 1387_2033_8850 3 0.000458094 0.027027547 0.00096527 17040 hsa-mir-3922 hsa05217 Basal cell carcinoma 2932_7157_2736 3 0.000708828 0.041820873 0.001442099 17041 hsa-mir-3922 hsa04920 Adipocytokine signaling pathway 5970_207_4790 3 0.001225391 0.072298046 0.002409935 17042 hsa-mir-3922 hsa04630 Jak-STAT signaling pathway 1387_6772_2033_207 4 0.001347812 0.079520904 0.00256519 17043 hsa-mir-3922 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_5970_4790 3 0.001438684 0.084882358 0.002652574 17044 hsa-mir-3922 hsa04664 Fc epsilon RI signaling pathway 5594_1432_207 3 0.001931935 0.113984173 0.003454066 17045 hsa-mir-3922 hsa04012 ErbB signaling pathway 5594_2932_207 3 0.002519137 0.148629078 0.004371443 17046 hsa-mir-3922 hsa05016 Huntington's disease 1387_7157_3064_2033 4 0.002677317 0.157961678 0.004513191 17047 hsa-mir-3922 hsa05216 Thyroid cancer 5594_7157 2 0.003888214 0.229404642 0.006372351 17048 hsa-mir-3922 hsa04930 Type II diabetes mellitus 3651_5594 2 0.008763359 0.517038195 0.01355847 17049 hsa-mir-3922 hsa04910 Insulin signaling pathway 5594_2932_207 3 0.008791772 0.518714552 0.01355847 17050 hsa-mir-3922 hsa04120 Ubiquitin mediated proteolysis 7329_5371_672 3 0.008962379 0.528780336 0.01355847 17051 hsa-mir-3922 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_7157 2 0.013118905 0.774015396 0.019350385 17052 hsa-mir-3922 hsa04340 Hedgehog signaling pathway 2932_2736 2 0.01355307 0.799631152 0.019503199 17053 hsa-mir-3922 hsa04115 p53 signaling pathway 1017_7157 2 0.019234658 1 0.027020115 17054 hsa-mir-3922 hsa04730 Long-term depression 5592_5594 2 0.020263503 1 0.027803411 17055 hsa-mir-3922 hsa04510 Focal adhesion 5594_2932_207 3 0.024955444 1 0.033462982 17056 hsa-mir-3922 hsa04540 Gap junction 5592_5594 2 0.033006835 1 0.043275628 17057 hsa-mir-3922 hsa04912 GnRH signaling pathway 5594_1432 2 0.043066929 1 0.055238018 17058 hsa-mir-3925 hsa04950 Maturity onset diabetes of the young 3172 1 0.01488954 0.178674474 0.068650656 17059 hsa-mir-3925 hsa05216 Thyroid cancer 6256 1 0.017842211 0.214106536 0.068650656 17060 hsa-mir-3925 hsa03022 Basal transcription factors 2959 1 0.022549107 0.270589287 0.068650656 17061 hsa-mir-3925 hsa04330 Notch signaling pathway 9612 1 0.028402771 0.340833251 0.068650656 17062 hsa-mir-3925 hsa05223 Non-small cell lung cancer 6256 1 0.032480619 0.389767427 0.068650656 17063 hsa-mir-3925 hsa04920 Adipocytokine signaling pathway 6256 1 0.040010917 0.480130998 0.068650656 17064 hsa-mir-3925 hsa03320 PPAR signaling pathway 6256 1 0.041740799 0.500889592 0.068650656 17065 hsa-mir-3926-2 hsa05200 Pathways in cancer 3320_1050_5594_5599_367_4193_7704_1387_6774_6776_6777_5970_7157_2113_5894_3725_2353_4088_5925_2033_4790_4791 22 1.02E-19 7.15E-18 7.15E-18 17066 hsa-mir-3926-2 hsa05215 Prostate cancer 3320_5594_1385_367_4193_1387_5970_7157_5894_5925_2033_4790 12 1.17E-14 8.20E-13 3.09E-13 17067 hsa-mir-3926-2 hsa05212 Pancreatic cancer 3320_5594_1385_367_4193_1387_5970_7157_5894_5925_2033_4790 12 1.32E-14 9.27E-13 3.09E-13 17068 hsa-mir-3926-2 hsa05220 Chronic myeloid leukemia 5594_4193_6776_6777_5970_7157_5894_4088_5925_4790 10 2.52E-12 1.77E-10 4.42E-11 17069 hsa-mir-3926-2 hsa04110 Cell cycle 993_5591_7533_4193_1387_7157_983_2810_4088_5925_2033 11 7.68E-12 5.38E-10 1.08E-10 17070 hsa-mir-3926-2 hsa05221 Acute myeloid leukemia 1050_5594_7704_6774_6776_6777_5970_5894_4790 9 1.09E-11 7.64E-10 1.27E-10 17071 hsa-mir-3926-2 hsa05214 Glioma 5594_4193_7157_5894_5925_808_801_805 8 7.51E-10 5.26E-08 7.51E-09 17072 hsa-mir-3926-2 hsa04916 Melanogenesis 5594_1385_5566_1387_5894_2033_808_801_805 9 1.13E-09 7.92E-08 9.90E-09 17073 hsa-mir-3926-2 hsa04660 T cell receptor signaling pathway 3932_5594_920_915_5970_5894_3725_2353_4790 9 1.79E-09 1.26E-07 1.40E-08 17074 hsa-mir-3926-2 hsa04720 Long-term potentiation 5594_5566_1387_5894_2033_808_801_805 8 2.13E-09 1.49E-07 1.49E-08 17075 hsa-mir-3926-2 hsa04010 MAPK signaling pathway 5594_5599_3303_5566_5970_7157_5894_3725_2353_5536_4790_4791 12 2.78E-09 1.95E-07 1.77E-08 17076 hsa-mir-3926-2 hsa04912 GnRH signaling pathway 5594_5599_5566_5894_3725_808_801_805 8 3.06E-08 2.14E-06 1.79E-07 17077 hsa-mir-3926-2 hsa05210 Colorectal cancer 5594_5599_7157_5894_3725_2353_4088 7 1.08E-07 7.59E-06 5.84E-07 17078 hsa-mir-3926-2 hsa04910 Insulin signaling pathway 10891_5594_5599_5566_5894_808_801_805 8 1.83E-07 1.28E-05 9.15E-07 17079 hsa-mir-3926-2 hsa05211 Renal cell carcinoma 5594_1387_2113_5894_3725_2033 6 9.10E-07 6.37E-05 4.25E-06 17080 hsa-mir-3926-2 hsa04662 B cell receptor signaling pathway 5594_5970_5894_3725_2353_4790 6 1.14E-06 7.97E-05 4.98E-06 17081 hsa-mir-3926-2 hsa05219 Bladder cancer 5594_4193_7157_5894_5925 5 1.51E-06 0.000105979 6.23E-06 17082 hsa-mir-3926-2 hsa05016 Huntington's disease 10891_1385_291_6908_5481_1387_7157_2033 8 1.71E-06 0.000119599 6.64E-06 17083 hsa-mir-3926-2 hsa04012 ErbB signaling pathway 5594_5599_6776_6777_5894_3725 6 2.57E-06 0.00017967 9.46E-06 17084 hsa-mir-3926-2 hsa04612 Antigen processing and presentation 3320_811_920_1385_3303_1514 6 2.91E-06 0.000203479 1.02E-05 17085 hsa-mir-3926-2 hsa04310 Wnt signaling pathway 5599_5566_1387_7157_3725_4088_2033 7 4.73E-06 0.00033112 1.58E-05 17086 hsa-mir-3926-2 hsa04620 Toll-like receptor signaling pathway 5594_5599_5970_3725_2353_4790 6 6.13E-06 0.00042876 1.95E-05 17087 hsa-mir-3926-2 hsa04920 Adipocytokine signaling pathway 10891_5599_6774_5970_4790 5 1.27E-05 0.000889829 3.87E-05 17088 hsa-mir-3926-2 hsa04270 Vascular smooth muscle contraction 5594_5566_5894_808_801_805 6 1.35E-05 0.000947949 3.95E-05 17089 hsa-mir-3926-2 hsa05218 Melanoma 5594_4193_7157_5894_5925 5 1.66E-05 0.001159503 4.64E-05 17090 hsa-mir-3926-2 hsa05340 Primary immunodeficiency 3932_920_915_100 4 2.08E-05 0.00145337 5.46E-05 17091 hsa-mir-3926-2 hsa04062 Chemokine signaling pathway 5594_5566_6774_6777_5970_5894_4790 7 2.11E-05 0.001474431 5.46E-05 17092 hsa-mir-3926-2 hsa04630 Jak-STAT signaling pathway 1387_3460_6774_6776_6777_2033 6 5.89E-05 0.004125119 0.000146522 17093 hsa-mir-3926-2 hsa04330 Notch signaling pathway 1387_9612_2033_8850 4 6.07E-05 0.004249129 0.000146522 17094 hsa-mir-3926-2 hsa05223 Non-small cell lung cancer 5594_7157_5894_5925 4 0.000100773 0.00705414 0.000235138 17095 hsa-mir-3926-2 hsa04020 Calcium signaling pathway 291_5566_5481_808_801_805 6 0.000146496 0.010254707 0.000330797 17096 hsa-mir-3926-2 hsa04115 p53 signaling pathway 4193_7157_983_2810 4 0.00024642 0.017249405 0.000539044 17097 hsa-mir-3926-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5970_3725_4790 4 0.000273425 0.019139753 0.000579993 17098 hsa-mir-3926-2 hsa04520 Adherens junction 5594_1387_4088_2033 4 0.000421764 0.029523478 0.000868338 17099 hsa-mir-3926-2 hsa05222 Small cell lung cancer 5970_7157_5925_4790 4 0.000547945 0.038356164 0.00109589 17100 hsa-mir-3926-2 hsa04350 TGF-beta signaling pathway 5594_1387_4088_2033 4 0.000571314 0.039991969 0.001110888 17101 hsa-mir-3926-2 hsa04210 Apoptosis 5566_5970_7157_4790 4 0.000620161 0.043411254 0.001173277 17102 hsa-mir-3926-2 hsa04540 Gap junction 5594_5566_983_5894 4 0.000726623 0.050863581 0.001338515 17103 hsa-mir-3926-2 hsa05010 Alzheimer's disease 3416_5594_808_801_805 5 0.000995347 0.069674265 0.00178652 17104 hsa-mir-3926-2 hsa05213 Endometrial cancer 5594_7157_5894 3 0.001563112 0.10941783 0.002735446 17105 hsa-mir-3926-2 hsa04650 Natural killer cell mediated cytotoxicity 3932_5594_3460_5894 4 0.002951057 0.206573991 0.00503839 17106 hsa-mir-3926-2 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.00438356 0.306849184 0.007305933 17107 hsa-mir-3926-2 hsa04664 Fc epsilon RI signaling pathway 5594_5599_5894 3 0.004865142 0.340559947 0.007919999 17108 hsa-mir-3926-2 hsa05216 Thyroid cancer 5594_7157 2 0.007341198 0.513883836 0.011679178 17109 hsa-mir-3926-2 hsa04510 Focal adhesion 5594_5599_5894_3725 4 0.011549661 0.808476241 0.017966139 17110 hsa-mir-3926-2 hsa04930 Type II diabetes mellitus 5594_5599 2 0.016346322 1 0.024874838 17111 hsa-mir-3926-2 hsa05012 Parkinson's disease 7314_291_5481 3 0.020300532 1 0.030234835 17112 hsa-mir-3926-2 hsa04730 Long-term depression 5594_5894 2 0.037069087 1 0.054059085 17113 hsa-mir-3926-2 hsa04370 VEGF signaling pathway 5594_5894 2 0.042770543 1 0.061100776 17114 hsa-mir-3927 hsa05200 Pathways in cancer 4088_367 2 0.000730415 0.006573731 0.006573731 17115 hsa-mir-3927 hsa05220 Chronic myeloid leukemia 4088 1 0.010094054 0.090846483 0.015358008 17116 hsa-mir-3927 hsa04520 Adherens junction 4088 1 0.010755446 0.096799014 0.015358008 17117 hsa-mir-3927 hsa05210 Colorectal cancer 4088 1 0.011284321 0.101558891 0.015358008 17118 hsa-mir-3927 hsa04350 TGF-beta signaling pathway 4088 1 0.011680838 0.105127546 0.015358008 17119 hsa-mir-3927 hsa05215 Prostate cancer 367 1 0.011812984 0.106316859 0.015358008 17120 hsa-mir-3927 hsa05212 Pancreatic cancer 367 1 0.011945117 0.107506053 0.015358008 17121 hsa-mir-3927 hsa04110 Cell cycle 4088 1 0.015902938 0.143126446 0.017890806 17122 hsa-mir-3927 hsa04310 Wnt signaling pathway 4088 1 0.020242796 0.182185164 0.020242796 17123 hsa-mir-3928 hsa03022 Basal transcription factors 2967_2961_2960_2963_6881_2969_2968_6879_6878_6877_6874_6872_2957_54457_2958_6873_2959_6880_6882_138474_6884_6883 22 2.90E-30 2.03E-28 2.03E-28 17124 hsa-mir-3928 hsa05200 Pathways in cancer 5371_9063_1499_5595_5594_5599_1387_6256_10401_5604_5601_1488_1019_367_1017_2932_4193_2353_5970_2885_7157_6688_4609_3725_1026_1487_4087_4088_4089_1050_5925_2033_3326_8554_7184 35 2.28E-25 1.59E-23 7.97E-24 17125 hsa-mir-3928 hsa05215 Prostate cancer 1499_5595_5594_1387_5604_367_1017_2932_4193_5970_2885_7157_468_9586_1026_5925_2033_3326_7184 19 2.00E-19 1.40E-17 4.21E-18 17126 hsa-mir-3928 hsa05212 Pancreatic cancer 1499_5595_5594_1387_5604_367_1017_2932_4193_5970_2885_7157_468_9586_1026_5925_2033_3326_7184 19 2.40E-19 1.68E-17 4.21E-18 17127 hsa-mir-3928 hsa04010 MAPK signaling pathway 6722_5595_5594_5599_5604_5606_5601_5600_5603_9252_2353_3312_1386_1432_1649_5970_2885_7157_468_4609_3725_3727_9344_8550_2005 25 4.61E-17 3.23E-15 6.46E-16 17128 hsa-mir-3928 hsa04310 Wnt signaling pathway 1460_1499_5599_1387_5601_1488_1457_2932_7157_8061_4609_3725_1487_1459_4087_4088_4089_2033_8607 19 1.71E-15 1.20E-13 2.00E-14 17129 hsa-mir-3928 hsa05220 Chronic myeloid leukemia 5595_5594_5604_1488_1019_4193_5970_2885_7157_4609_1026_1487_4088_4089_5925 15 3.61E-15 2.53E-13 3.61E-14 17130 hsa-mir-3928 hsa05210 Colorectal cancer 1499_5595_5594_5599_5604_5601_2932_2353_2885_7157_4609_3725_4087_4088_4089 15 1.58E-14 1.11E-12 1.38E-13 17131 hsa-mir-3928 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_7027_3397_3399_3398_1874_4609_4087_4088_4089_2033_5933 15 2.50E-14 1.75E-12 1.94E-13 17132 hsa-mir-3928 hsa04110 Cell cycle 4171_1387_1019_1017_2932_4193_7027_4085_7157_1026_4087_4088_4089_5925_2033_5933 16 1.09E-13 7.62E-12 7.62E-13 17133 hsa-mir-3928 hsa05219 Bladder cancer 5595_5594_5604_1019_9252_4193_7157_4609_1026_5925 10 3.42E-11 2.39E-09 2.18E-10 17134 hsa-mir-3928 hsa04660 T cell receptor signaling pathway 5595_5594_5604_5601_5600_5603_1019_2932_2353_1432_5970_2885_3725 13 9.96E-11 6.97E-09 5.81E-10 17135 hsa-mir-3928 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5604_5606_5601_5600_5603_2353_1432_5970_3725 12 5.55E-10 3.88E-08 2.99E-09 17136 hsa-mir-3928 hsa04520 Adherens junction 1460_1499_5595_5594_1387_1457_1459_4087_4088_4089_2033 11 6.56E-10 4.59E-08 3.28E-09 17137 hsa-mir-3928 hsa04912 GnRH signaling pathway 5595_5594_5599_5604_5606_5601_5600_5603_1432_2885_468_3725 12 1.01E-09 7.07E-08 4.71E-09 17138 hsa-mir-3928 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5604_5606_5601_5600_5603_1432_2885 10 8.20E-09 5.74E-07 3.59E-08 17139 hsa-mir-3928 hsa05221 Acute myeloid leukemia 5371_5595_5594_5604_5970_2885_6688_4609_1050 9 1.07E-08 7.49E-07 4.41E-08 17140 hsa-mir-3928 hsa05222 Small cell lung cancer 9063_6256_10401_1019_1017_5970_7157_4609_5925_8554 10 1.72E-08 1.20E-06 6.69E-08 17141 hsa-mir-3928 hsa04012 ErbB signaling pathway 5595_5594_5599_5604_5601_2932_2885_4609_3725_1026 10 1.90E-08 1.33E-06 7.01E-08 17142 hsa-mir-3928 hsa05214 Glioma 5595_5594_5604_1019_4193_2885_7157_1026_5925 9 2.29E-08 1.60E-06 8.02E-08 17143 hsa-mir-3928 hsa05216 Thyroid cancer 1499_5595_5594_6256_5604_7157_4609 7 3.00E-08 2.10E-06 9.99E-08 17144 hsa-mir-3928 hsa05213 Endometrial cancer 1499_5595_5594_5604_2932_2885_7157_4609 8 6.73E-08 4.71E-06 2.14E-07 17145 hsa-mir-3928 hsa05223 Non-small cell lung cancer 5595_5594_6256_5604_1019_2885_7157_5925 8 8.76E-08 6.13E-06 2.67E-07 17146 hsa-mir-3928 hsa05218 Melanoma 5595_5594_5604_1019_4193_7157_1026_5925 8 5.92E-07 4.15E-05 1.73E-06 17147 hsa-mir-3928 hsa04662 B cell receptor signaling pathway 5595_5594_5604_2932_2353_5970_2885_3725 8 8.68E-07 6.08E-05 2.43E-06 17148 hsa-mir-3928 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5601_5600_5603_1432_5970_3725 7 6.87E-06 0.000481026 1.85E-05 17149 hsa-mir-3928 hsa05211 Renal cell carcinoma 5595_5594_1387_5604_2885_3725_2033 7 7.48E-06 0.000523762 1.94E-05 17150 hsa-mir-3928 hsa04910 Insulin signaling pathway 5595_5594_5599_5604_5601_2932_2885_23265_5211 9 8.05E-06 0.000563289 2.01E-05 17151 hsa-mir-3928 hsa04120 Ubiquitin mediated proteolysis 55294_5371_9063_672_10401_4193_7329_8554 8 5.97E-05 0.004178495 0.000144086 17152 hsa-mir-3928 hsa04916 Melanogenesis 1499_5595_5594_1387_5604_2932_2033 7 6.86E-05 0.004804098 0.000160137 17153 hsa-mir-3928 hsa05016 Huntington's disease 6874_1387_6667_9001_5430_7157_9586_3064_2033 9 8.10E-05 0.005669055 0.000182873 17154 hsa-mir-3928 hsa04720 Long-term potentiation 5595_5594_1387_5604_468_2033 6 9.38E-05 0.006564886 0.000205153 17155 hsa-mir-3928 hsa04330 Notch signaling pathway 1387_1488_1487_2033_8850 5 0.000105676 0.007397309 0.000221214 17156 hsa-mir-3928 hsa04370 VEGF signaling pathway 5595_5594_5604_5600_5603_1432 6 0.000107447 0.007521281 0.000221214 17157 hsa-mir-3928 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 0.000115831 0.008108139 0.000231661 17158 hsa-mir-3928 hsa04510 Focal adhesion 1499_5595_5594_5599_5604_5601_2932_2885_3725 9 0.000157082 0.01099572 0.000305437 17159 hsa-mir-3928 hsa05014 Amyotrophic lateral sclerosis (ALS) 5606_5600_5603_1432_7157 5 0.000226449 0.015851404 0.000428416 17160 hsa-mir-3928 hsa04115 p53 signaling pathway 1019_1017_4193_7157_1026 5 0.000557535 0.03902745 0.001027038 17161 hsa-mir-3928 hsa04630 Jak-STAT signaling pathway 9063_1387_10401_2885_4609_2033_8554 7 0.000698189 0.048873213 0.001253159 17162 hsa-mir-3928 hsa03420 Nucleotide excision repair 2967_2968_5981_5887 4 0.000921515 0.064506079 0.001612652 17163 hsa-mir-3928 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601 4 0.000996382 0.069746766 0.001701141 17164 hsa-mir-3928 hsa04540 Gap junction 5595_5594_5604_10382_2885 5 0.001973307 0.138131506 0.003288845 17165 hsa-mir-3928 hsa04920 Adipocytokine signaling pathway 5599_6256_5601_5970 4 0.003915237 0.274066573 0.006373641 17166 hsa-mir-3928 hsa04530 Tight junction 1460_1499_1457_1019_1459 5 0.009471493 0.663004485 0.014937261 17167 hsa-mir-3928 hsa04062 Chemokine signaling pathway 5595_5594_5604_2932_5970_2885 6 0.009602525 0.67217674 0.014937261 17168 hsa-mir-3928 hsa04612 Antigen processing and presentation 4800_4801_3312_3326 4 0.010091777 0.706424379 0.015357052 17169 hsa-mir-3928 hsa05322 Systemic lupus erythematosus 8349_3014_3015_9555_8340 5 0.011495396 0.804677753 0.017120803 17170 hsa-mir-3928 hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.015540969 1 0.022663913 17171 hsa-mir-3928 hsa04950 Maturity onset diabetes of the young 5080_6927 2 0.022837647 1 0.032625209 17172 hsa-mir-3928 hsa04670 Leukocyte transendothelial migration 1499_5600_5603_1432 4 0.02754058 1 0.038556811 17173 hsa-mir-3928 hsa04730 Long-term depression 5595_5594_5604 3 0.02941269 1 0.040370359 17174 hsa-mir-3928 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_5604_2885 4 0.04003105 1 0.053887952 17175 hsa-mir-3928 hsa03030 DNA replication 5981_4171 2 0.046047798 1 0.060817847 17176 hsa-mir-3934 hsa05200 Pathways in cancer 4087_836_2033_2249_4089_367_3725_6776_6777_2353_5914_5970_6256 13 3.71E-13 1.93E-11 1.93E-11 17177 hsa-mir-3934 hsa05210 Colorectal cancer 4087_836_4089_3725_2353 5 1.35E-06 7.01E-05 3.51E-05 17178 hsa-mir-3934 hsa04010 MAPK signaling pathway 836_2249_3725_1432_5598_2353_5970 7 2.23E-06 0.000115755 3.86E-05 17179 hsa-mir-3934 hsa05221 Acute myeloid leukemia 6776_6777_5914_5970 4 1.01E-05 0.000526315 0.000131579 17180 hsa-mir-3934 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_3725_1432_5970 4 2.03E-05 0.001053595 0.000210719 17181 hsa-mir-3934 hsa05220 Chronic myeloid leukemia 4089_6776_6777_5970 4 2.49E-05 0.001294146 0.000215691 17182 hsa-mir-3934 hsa04350 TGF-beta signaling pathway 4087_6667_2033_4089 4 4.34E-05 0.00225846 0.000322637 17183 hsa-mir-3934 hsa04620 Toll-like receptor signaling pathway 3725_1432_2353_5970 4 7.88E-05 0.004098742 0.000512343 17184 hsa-mir-3934 hsa04660 T cell receptor signaling pathway 3725_1432_2353_5970 4 0.000104539 0.005436014 0.000604002 17185 hsa-mir-3934 hsa04310 Wnt signaling pathway 4087_2033_4089_3725 4 0.000347879 0.018089689 0.001767582 17186 hsa-mir-3934 hsa04630 Jak-STAT signaling pathway 2033_3977_6776_6777 4 0.000373912 0.019443398 0.001767582 17187 hsa-mir-3934 hsa04662 B cell receptor signaling pathway 3725_2353_5970 3 0.000624588 0.03247856 0.002706547 17188 hsa-mir-3934 hsa04520 Adherens junction 4087_2033_4089 3 0.000748658 0.03893024 0.002820821 17189 hsa-mir-3934 hsa05016 Huntington's disease 6908_836_6667_2033 4 0.000759452 0.03949149 0.002820821 17190 hsa-mir-3934 hsa04012 ErbB signaling pathway 3725_6776_6777 3 0.000947156 0.049252092 0.002916048 17191 hsa-mir-3934 hsa05215 Prostate cancer 2033_367_5970 3 0.000977964 0.050854148 0.002916048 17192 hsa-mir-3934 hsa04210 Apoptosis 836_840_5970 3 0.001009401 0.052488871 0.002916048 17193 hsa-mir-3934 hsa05212 Pancreatic cancer 2033_367_5970 3 0.001009401 0.052488871 0.002916048 17194 hsa-mir-3934 hsa04912 GnRH signaling pathway 3725_1432_5598 3 0.001732455 0.090087642 0.004741455 17195 hsa-mir-3934 hsa04110 Cell cycle 4087_2033_4089 3 0.002267953 0.117933542 0.005896677 17196 hsa-mir-3934 hsa03022 Basal transcription factors 6908_2959 2 0.003142025 0.163385309 0.007780253 17197 hsa-mir-3934 hsa04330 Notch signaling pathway 9612_2033 2 0.004918812 0.255778238 0.011626284 17198 hsa-mir-3934 hsa05010 Alzheimer's disease 836_1020_840 3 0.006728729 0.349893895 0.014797246 17199 hsa-mir-3934 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432 2 0.006829498 0.355133899 0.014797246 17200 hsa-mir-3934 hsa04920 Adipocytokine signaling pathway 5970_6256 2 0.009548406 0.496517103 0.019860684 17201 hsa-mir-3934 hsa05211 Renal cell carcinoma 2033_3725 2 0.010918691 0.567771937 0.021837382 17202 hsa-mir-3934 hsa05222 Small cell lung cancer 5970_6256 2 0.015182762 0.789503641 0.029240876 17203 hsa-mir-3934 hsa03450 Non-homologous end-joining 2547 1 0.031467625 1 0.058439874 17204 hsa-mir-3935 hsa05200 Pathways in cancer 5371_5595_5594_5914_1387_6256_595_836_367_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_4088_4089_3066_3065_5925_2034_2033_4846 29 9.48E-32 5.88E-30 5.88E-30 17205 hsa-mir-3935 hsa05220 Chronic myeloid leukemia 5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464 15 1.32E-21 8.19E-20 4.10E-20 17206 hsa-mir-3935 hsa04110 Cell cycle 5591_1387_595_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933 15 6.99E-19 4.33E-17 1.44E-17 17207 hsa-mir-3935 hsa05215 Prostate cancer 5595_5594_1387_595_367_5970_1870_1871_7157_1869_5925_2033_90993 13 2.56E-17 1.59E-15 3.63E-16 17208 hsa-mir-3935 hsa05212 Pancreatic cancer 5595_5594_1387_595_367_5970_1870_1871_7157_1869_5925_2033_90993 13 2.93E-17 1.81E-15 3.63E-16 17209 hsa-mir-3935 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5925 9 1.21E-13 7.53E-12 1.25E-12 17210 hsa-mir-3935 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925 9 9.13E-13 5.66E-11 7.76E-12 17211 hsa-mir-3935 hsa05210 Colorectal cancer 5595_5594_595_836_7157_4087_4609_3725_4088_4089 10 1.00E-12 6.21E-11 7.76E-12 17212 hsa-mir-3935 hsa05222 Small cell lung cancer 6256_595_5970_1870_1871_7157_4609_1869_5925_4846 10 1.24E-12 7.70E-11 8.56E-12 17213 hsa-mir-3935 hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_6464 9 4.13E-12 2.56E-10 2.56E-11 17214 hsa-mir-3935 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2113_3725_2034_2033 9 9.57E-12 5.93E-10 5.39E-11 17215 hsa-mir-3935 hsa04350 TGF-beta signaling pathway 5595_5594_1387_4087_4609_4088_4089_2033_5933 9 4.56E-11 2.83E-09 2.36E-10 17216 hsa-mir-3935 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_5970_4609 8 7.86E-11 4.88E-09 3.75E-10 17217 hsa-mir-3935 hsa04310 Wnt signaling pathway 1387_595_7157_4087_4609_3725_1457_4088_4089_2033 10 2.36E-10 1.47E-08 1.05E-09 17218 hsa-mir-3935 hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5925 8 3.04E-10 1.89E-08 1.26E-09 17219 hsa-mir-3935 hsa04520 Adherens junction 5595_5594_1387_4087_1457_4088_4089_2033 8 7.31E-10 4.53E-08 2.83E-09 17220 hsa-mir-3935 hsa05016 Huntington's disease 6874_1387_2902_836_7157_3066_3065_3064_2033_90993 10 1.67E-09 1.04E-07 6.11E-09 17221 hsa-mir-3935 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 2.07E-09 1.29E-07 7.14E-09 17222 hsa-mir-3935 hsa04010 MAPK signaling pathway 5595_5594_4208_836_3312_5970_7157_4609_3725_4763 10 5.03E-08 3.12E-06 1.64E-07 17223 hsa-mir-3935 hsa04330 Notch signaling pathway 1387_9612_3066_3065_2033 5 9.73E-07 6.03E-05 3.01E-06 17224 hsa-mir-3935 hsa05213 Endometrial cancer 5595_5594_595_7157_4609 5 1.55E-06 9.58E-05 4.56E-06 17225 hsa-mir-3935 hsa04720 Long-term potentiation 5595_5594_1387_2902_2033 5 8.34E-06 0.000516989 2.35E-05 17226 hsa-mir-3935 hsa04012 ErbB signaling pathway 5595_5594_4609_3725_6464 5 1.65E-05 0.001023785 4.45E-05 17227 hsa-mir-3935 hsa04916 Melanogenesis 5595_5594_1387_2033_90993 5 3.75E-05 0.00232291 9.68E-05 17228 hsa-mir-3935 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_7157_4846 4 5.44E-05 0.003372571 0.000134903 17229 hsa-mir-3935 hsa04120 Ubiquitin mediated proteolysis 11059_5371_672_4734_7428 5 0.000140349 0.008701619 0.000334678 17230 hsa-mir-3935 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725 4 0.000159466 0.009886891 0.000366181 17231 hsa-mir-3935 hsa05010 Alzheimer's disease 5595_5594_2902_836_4846 5 0.000414675 0.025709879 0.00091821 17232 hsa-mir-3935 hsa04620 Toll-like receptor signaling pathway 5595_5594_5970_3725 4 0.000491299 0.030460516 0.001050363 17233 hsa-mir-3935 hsa04660 T cell receptor signaling pathway 5595_5594_5970_3725 4 0.000646299 0.040070533 0.001335684 17234 hsa-mir-3935 hsa04510 Focal adhesion 5595_5594_595_3725_6464 5 0.000809526 0.050190623 0.001619052 17235 hsa-mir-3935 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.000896844 0.055604329 0.001737635 17236 hsa-mir-3935 hsa04910 Insulin signaling pathway 6720_5595_5594_6464 4 0.001461722 0.090626737 0.002665492 17237 hsa-mir-3935 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_6464 4 0.001461722 0.090626737 0.002665492 17238 hsa-mir-3935 hsa04115 p53 signaling pathway 595_836_7157 3 0.001954848 0.12120056 0.003462873 17239 hsa-mir-3935 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_5970_3725 3 0.002114296 0.131086374 0.003542875 17240 hsa-mir-3935 hsa04730 Long-term depression 5595_5594_4846 3 0.002114296 0.131086374 0.003542875 17241 hsa-mir-3935 hsa04630 Jak-STAT signaling pathway 1387_595_4609_2033 4 0.002208463 0.136924734 0.003603282 17242 hsa-mir-3935 hsa04370 VEGF signaling pathway 5595_5594_4846 3 0.002640332 0.163700578 0.004197451 17243 hsa-mir-3935 hsa04612 Antigen processing and presentation 4800_4801_3312 3 0.003918069 0.242920304 0.005924885 17244 hsa-mir-3935 hsa04210 Apoptosis 836_5970_7157 3 0.003918069 0.242920304 0.005924885 17245 hsa-mir-3935 hsa04062 Chemokine signaling pathway 5595_5594_5970_6464 4 0.004750734 0.294545482 0.007012988 17246 hsa-mir-3935 hsa04912 GnRH signaling pathway 5595_5594_3725 3 0.006604658 0.409488823 0.009522996 17247 hsa-mir-3935 hsa04930 Type II diabetes mellitus 5595_5594 2 0.011338112 0.702962923 0.01597643 17248 hsa-mir-3935 hsa04920 Adipocytokine signaling pathway 6256_5970 2 0.023439873 1 0.032294935 17249 hsa-mir-3935 hsa04664 Fc epsilon RI signaling pathway 5595_5594 2 0.03152989 1 0.042496808 17250 hsa-mir-3935 hsa04540 Gap junction 5595_5594 2 0.042139387 1 0.055588127 17251 hsa-mir-3935 hsa04710 Circadian rhythm - mammal 8863 1 0.046861183 1 0.060529028 17252 hsa-mir-3936 hsa05200 Pathways in cancer 3320_3725_25_4149_1029_5371_4292_1871_1956_1499_5595_5594_5599_1387_6256_595_5604_6502_2308_1019_367_1017_2932_4193_841_6776_6772_1870_5970_4436_7157_4087_6688_4609_6774_4088_1026_861_2353_4089_3066_3065_1050_5925_2033_8554_4790_5578_7046_5894 50 1.60E-37 1.17E-35 1.17E-35 17253 hsa-mir-3936 hsa04110 Cell cycle 25_1029_990_1871_1387_595_6502_1019_1017_2932_4193_8454_7027_6500_1870_7157_4087_983_8379_4088_1026_1028_4089_3066_3065_5925_2033_894_896_5933 30 1.42E-28 1.03E-26 5.16E-27 17254 hsa-mir-3936 hsa05220 Chronic myeloid leukemia 25_1029_1871_5595_5594_595_5604_1019_4193_6776_1870_5970_7157_4609_4088_1026_861_4089_3066_3065_5925_4790_7046_5894 24 3.59E-25 2.62E-23 8.72E-24 17255 hsa-mir-3936 hsa05215 Prostate cancer 3320_1871_1956_1499_5595_5594_1385_1387_595_5604_2308_367_1017_2932_4193_1870_5970_7157_468_1026_5925_2033_4790_5894 24 8.87E-24 6.47E-22 1.62E-22 17256 hsa-mir-3936 hsa05212 Pancreatic cancer 3320_1871_1956_1499_5595_5594_1385_1387_595_5604_2308_367_1017_2932_4193_1870_5970_7157_468_1026_5925_2033_4790_5894 24 1.11E-23 8.13E-22 1.63E-22 17257 hsa-mir-3936 hsa04350 TGF-beta signaling pathway 3400_5595_5594_1387_6667_8454_7027_3399_6500_1874_4087_4609_4088_3397_4086_4089_3398_2033_4093_4092_7046_5933 22 2.74E-21 2.00E-19 3.33E-20 17258 hsa-mir-3936 hsa05214 Glioma 1029_815_1871_1956_5595_5594_595_5604_1019_4193_1870_808_7157_1026_5925_5578_5894_801_805 19 1.46E-19 1.07E-17 1.52E-18 17259 hsa-mir-3936 hsa05219 Bladder cancer 1029_1871_1956_5595_5594_595_5604_1019_9252_4193_1870_7157_4609_1026_5925_5894 16 3.42E-18 2.50E-16 3.12E-17 17260 hsa-mir-3936 hsa05210 Colorectal cancer 3725_4292_1956_1499_5595_5594_5599_595_5604_2932_4436_7157_4087_4609_4088_2353_4089_7046_5894 19 8.91E-18 6.50E-16 7.23E-17 17261 hsa-mir-3936 hsa04010 MAPK signaling pathway 6722_3725_4149_5598_1956_5595_5594_5599_1386_5604_5566_4342_9252_1649_5970_7157_468_4609_1432_3727_6195_6196_2353_4790_5578_2002_7046_5894 28 2.25E-17 1.65E-15 1.65E-16 17262 hsa-mir-3936 hsa04310 Wnt signaling pathway 3725_815_1499_5599_1387_595_5566_2932_8454_6500_1459_7157_4087_4609_4088_1457_4089_2033_894_896_5578 21 1.17E-15 8.51E-14 7.73E-15 17263 hsa-mir-3936 hsa05223 Non-small cell lung cancer 1029_1871_1956_5595_5594_6256_595_5604_1019_1870_7157_5925_5578_5894 14 3.84E-14 2.80E-12 2.33E-13 17264 hsa-mir-3936 hsa04912 GnRH signaling pathway 3725_5598_815_1956_5595_5594_5599_5604_5566_808_468_1432_5578_2002_5894_801_805 17 9.46E-14 6.90E-12 5.31E-13 17265 hsa-mir-3936 hsa05221 Acute myeloid leukemia 5371_5595_5594_595_5604_6776_5970_6688_4609_6774_861_1050_4790_5894 14 1.09E-13 7.98E-12 5.70E-13 17266 hsa-mir-3936 hsa04720 Long-term potentiation 815_5595_5594_1387_5604_5566_808_468_6195_6196_2033_5578_5894_801_805 15 1.27E-13 9.24E-12 6.16E-13 17267 hsa-mir-3936 hsa04012 ErbB signaling pathway 3725_25_815_1956_5595_5594_5599_5604_2932_6776_4609_1026_5578_2002_5894 15 8.51E-13 6.21E-11 3.88E-12 17268 hsa-mir-3936 hsa05218 Melanoma 1029_1871_1956_5595_5594_595_5604_1019_4193_1870_7157_1026_5925_5894 14 9.92E-13 7.24E-11 4.26E-12 17269 hsa-mir-3936 hsa04916 Melanogenesis 815_1499_5595_5594_1385_1387_5604_5566_2932_808_2033_5578_5894_801_805 15 8.47E-12 6.18E-10 3.27E-11 17270 hsa-mir-3936 hsa05213 Endometrial cancer 4292_1956_1499_5595_5594_595_5604_2932_7157_4609_2002_5894 12 8.51E-12 6.21E-10 3.27E-11 17271 hsa-mir-3936 hsa05222 Small cell lung cancer 4149_1871_6256_595_6502_1019_1017_1870_5970_7157_4609_5925_8554_4790 14 9.88E-12 7.21E-10 3.61E-11 17272 hsa-mir-3936 hsa04540 Gap junction 7846_5598_1956_5595_5594_5604_5566_7277_10376_983_7278_51807_5578_5894 14 2.53E-11 1.85E-09 8.79E-11 17273 hsa-mir-3936 hsa04520 Adherens junction 4301_1956_1499_5595_5594_1387_1459_4087_4088_1457_4089_2033_7046 13 5.59E-11 4.08E-09 1.85E-10 17274 hsa-mir-3936 hsa04115 p53 signaling pathway 1029_7161_595_1019_1017_4193_841_7157_983_1026_894_896 12 1.54E-10 1.12E-08 4.88E-10 17275 hsa-mir-3936 hsa05216 Thyroid cancer 1499_5595_5594_6256_595_5604_7157_4609 8 8.15E-09 5.95E-07 2.48E-08 17276 hsa-mir-3936 hsa04620 Toll-like receptor signaling pathway 3725_5595_5594_5599_5604_841_6772_5970_1432_2353_6348_4790 12 8.56E-09 6.25E-07 2.50E-08 17277 hsa-mir-3936 hsa04910 Insulin signaling pathway 5595_5594_5599_5604_2308_5566_6720_2932_808_2002_5894_801_805 13 2.37E-08 1.73E-06 6.66E-08 17278 hsa-mir-3936 hsa05131 Shigellosis 25_7846_1499_7277_4691_10376_7278_51807_5578 9 5.76E-08 4.20E-06 1.50E-07 17279 hsa-mir-3936 hsa05130 Pathogenic Escherichia coli infection 25_7846_1499_7277_4691_10376_7278_51807_5578 9 5.76E-08 4.20E-06 1.50E-07 17280 hsa-mir-3936 hsa04660 T cell receptor signaling pathway 3725_5595_5594_5604_1019_2932_5970_1432_2353_4790_5894 11 1.64E-07 1.20E-05 4.14E-07 17281 hsa-mir-3936 hsa04330 Notch signaling pathway 1387_2648_9612_4851_3066_3065_2033_8850 8 2.15E-07 1.57E-05 5.22E-07 17282 hsa-mir-3936 hsa04510 Focal adhesion 3725_1956_1499_5595_5594_5599_595_5604_2932_894_896_5578_2002_5894 14 3.03E-07 2.21E-05 7.13E-07 17283 hsa-mir-3936 hsa04662 B cell receptor signaling pathway 3725_5595_5594_5604_2932_5970_2353_4790_5894 9 5.47E-07 4.00E-05 1.25E-06 17284 hsa-mir-3936 hsa04630 Jak-STAT signaling pathway 1387_595_6778_6776_6772_4609_6774_2033_894_896_8554 11 3.83E-06 0.000279902 8.48E-06 17285 hsa-mir-3936 hsa04062 Chemokine signaling pathway 5595_5594_5604_5566_2932_6772_5970_6774_7074_6348_4790_5894 12 5.05E-06 0.000368777 1.08E-05 17286 hsa-mir-3936 hsa04270 Vascular smooth muscle contraction 5595_5594_5604_5566_808_5578_5894_801_805 9 1.71E-05 0.001248191 3.57E-05 17287 hsa-mir-3936 hsa05211 Renal cell carcinoma 3725_5595_5594_1387_5604_2033_5894 7 3.57E-05 0.002605453 7.24E-05 17288 hsa-mir-3936 hsa04120 Ubiquitin mediated proteolysis 5371_997_6502_4193_8454_55294_6500_672_8554 9 5.73E-05 0.004180112 0.000112976 17289 hsa-mir-3936 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5604_1432_5578_5894 7 6.18E-05 0.004509121 0.000118661 17290 hsa-mir-3936 hsa05016 Huntington's disease 25942_1385_1387_6667_841_7157_3066_3065_2033_6908 10 0.000106892 0.007803092 0.000200079 17291 hsa-mir-3936 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1956_5599_5970_1432_4790 6 0.000264351 0.019297642 0.000482441 17292 hsa-mir-3936 hsa05010 Alzheimer's disease 5595_5594_22926_2932_841_840_808_801_805 9 0.000322488 0.023541648 0.000574187 17293 hsa-mir-3936 hsa04370 VEGF signaling pathway 5595_5594_5604_1432_5578_5894 6 0.000397285 0.029001841 0.00069052 17294 hsa-mir-3936 hsa04210 Apoptosis 5566_841_840_5970_7157_4790 6 0.00081543 0.059526365 0.001384334 17295 hsa-mir-3936 hsa03022 Basal transcription factors 2962_2969_6880_6908 4 0.001244358 0.090838125 0.002064503 17296 hsa-mir-3936 hsa04920 Adipocytokine signaling pathway 5599_6256_5970_6774_4790 5 0.001455685 0.106265004 0.002361445 17297 hsa-mir-3936 hsa04730 Long-term depression 5595_5594_5604_5578_5894 5 0.001851793 0.135180854 0.002938714 17298 hsa-mir-3936 hsa03430 Mismatch repair 5981_4292_4436 3 0.003221514 0.235170511 0.005003628 17299 hsa-mir-3936 hsa04150 mTOR signaling pathway 5595_5594_6195_6196 4 0.003943955 0.287908744 0.005998099 17300 hsa-mir-3936 hsa04612 Antigen processing and presentation 3320_1385_4800_4802_4801 5 0.004654725 0.339794893 0.00693459 17301 hsa-mir-3936 hsa04530 Tight junction 4301_1499_1019_1459_1457_5578 6 0.006345258 0.463203821 0.009264076 17302 hsa-mir-3936 hsa04020 Calcium signaling pathway 815_1956_5566_808_5578_801_805 7 0.006823995 0.498151603 0.009767678 17303 hsa-mir-3936 hsa04710 Circadian rhythm - mammal 406_79365 2 0.012541854 0.915555375 0.017606834 17304 hsa-mir-3936 hsa04070 Phosphatidylinositol signaling system 808_5578_801_805 4 0.013711764 1 0.018886014 17305 hsa-mir-3936 hsa04810 Regulation of actin cytoskeleton 1956_5595_5594_5604_4342_7074_5894 7 0.016121136 1 0.021793387 17306 hsa-mir-3936 hsa04930 Type II diabetes mellitus 5595_5594_5599 3 0.017805182 1 0.023632333 17307 hsa-mir-3936 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_5604_5578_5894 5 0.025094432 1 0.032712385 17308 hsa-mir-3936 hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.029222196 1 0.037424917 17309 hsa-mir-3936 hsa05014 Amyotrophic lateral sclerosis (ALS) 834_7157_1432 3 0.030532799 1 0.038429212 17310 hsa-mir-3936 hsa04950 Maturity onset diabetes of the young 168620_6927 2 0.035737702 1 0.044217834 17311 hsa-mir-3937 hsa05200 Pathways in cancer 5970_595_5925_2033_2249_367_5914_3725_1387_6777_6256_2353_6776 13 7.49E-12 3.67E-10 3.67E-10 17312 hsa-mir-3937 hsa04110 Cell cycle 993_595_5925_2033_983_894_896_1387 8 1.82E-09 8.90E-08 4.45E-08 17313 hsa-mir-3937 hsa04630 Jak-STAT signaling pathway 595_2033_3977_894_896_1387_6777_6776 8 1.30E-08 6.38E-07 2.13E-07 17314 hsa-mir-3937 hsa05215 Prostate cancer 5970_595_5925_2033_367_1387 6 1.98E-07 9.68E-06 2.06E-06 17315 hsa-mir-3937 hsa05212 Pancreatic cancer 5970_595_5925_2033_367_1387 6 2.10E-07 1.03E-05 2.06E-06 17316 hsa-mir-3937 hsa05221 Acute myeloid leukemia 5970_595_5914_6777_6776 5 7.90E-07 3.87E-05 6.45E-06 17317 hsa-mir-3937 hsa05220 Chronic myeloid leukemia 5970_595_5925_6777_6776 5 2.41E-06 0.00011812 1.69E-05 17318 hsa-mir-3937 hsa04310 Wnt signaling pathway 595_2033_894_896_3725_1387 6 4.16E-06 0.000203991 2.55E-05 17319 hsa-mir-3937 hsa04330 Notch signaling pathway 9612_2033_8850_1387 4 1.05E-05 0.000516404 5.74E-05 17320 hsa-mir-3937 hsa04115 p53 signaling pathway 595_983_894_896 4 4.39E-05 0.002151562 0.000215156 17321 hsa-mir-3937 hsa05222 Small cell lung cancer 5970_595_5925_6256 4 9.96E-05 0.004880944 0.000443722 17322 hsa-mir-3937 hsa05016 Huntington's disease 6667_2033_25942_6908_1387 5 0.000168063 0.008235076 0.000686256 17323 hsa-mir-3937 hsa05223 Non-small cell lung cancer 595_5925_6256 3 0.00047791 0.023417595 0.001801353 17324 hsa-mir-3937 hsa05218 Melanoma 595_5925_2249 3 0.001024966 0.050223354 0.003481086 17325 hsa-mir-3937 hsa05211 Renal cell carcinoma 2033_3725_1387 3 0.001065638 0.052216286 0.003481086 17326 hsa-mir-3937 hsa04662 B cell receptor signaling pathway 5970_3725_2353 3 0.001193735 0.058493026 0.003655814 17327 hsa-mir-3937 hsa05210 Colorectal cancer 595_3725_2353 3 0.001634917 0.080110922 0.004646596 17328 hsa-mir-3937 hsa04350 TGF-beta signaling pathway 6667_2033_1387 3 0.001801741 0.08828533 0.004646596 17329 hsa-mir-3937 hsa04012 ErbB signaling pathway 3725_6777_6776 3 0.001801741 0.08828533 0.004646596 17330 hsa-mir-3937 hsa04510 Focal adhesion 595_894_896_3725 4 0.002412903 0.118232252 0.005911613 17331 hsa-mir-3937 hsa04620 Toll-like receptor signaling pathway 5970_3725_2353 3 0.002794091 0.136910483 0.006519547 17332 hsa-mir-3937 hsa05216 Thyroid cancer 595_6256 2 0.003089547 0.151387803 0.006881264 17333 hsa-mir-3937 hsa04660 T cell receptor signaling pathway 5970_3725_2353 3 0.003437139 0.168419807 0.0073226 17334 hsa-mir-3937 hsa03410 Base excision repair 142_3146 2 0.004614975 0.226133794 0.009422241 17335 hsa-mir-3937 hsa05219 Bladder cancer 595_5925 2 0.006146529 0.301179937 0.012047197 17336 hsa-mir-3937 hsa04010 MAPK signaling pathway 5970_2249_3725_2353 4 0.006435936 0.315360873 0.012129264 17337 hsa-mir-3937 hsa05214 Glioma 595_5925 2 0.01381089 0.676733617 0.025064208 17338 hsa-mir-3937 hsa04920 Adipocytokine signaling pathway 5970_6256 2 0.01460418 0.715604815 0.025557315 17339 hsa-mir-3937 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_3725 2 0.016248332 0.796168282 0.027454079 17340 hsa-mir-3937 hsa04720 Long-term potentiation 2033_1387 2 0.017967779 0.880421188 0.029347373 17341 hsa-mir-3937 hsa04520 Adherens junction 2033_1387 2 0.020220325 0.990795944 0.031961159 17342 hsa-mir-3937 hsa04612 Antigen processing and presentation 4800_1514 2 0.024553937 1 0.037598217 17343 hsa-mir-3937 hsa04916 Melanogenesis 2033_1387 2 0.032529158 1 0.048300871 17344 hsa-mir-3937 hsa03450 Non-homologous end-joining 2547 1 0.039168355 1 0.056448512 17345 hsa-mir-3938 hsa05200 Pathways in cancer 3716_675_1956_1499_5595_5594_5599_1387_5159_5156_5601_867_1399_1398_3815_6774_6777_6772_4436_4609_3725_862_6502_2353_4088_4089_5925_2033_7186 29 9.25E-21 6.57E-19 6.57E-19 17346 hsa-mir-3938 hsa04010 MAPK signaling pathway 1956_5595_5594_6722_5599_1386_5159_9261_5156_4208_5601_3303_1399_1398_7867_1432_4609_3725_2353_1649_7186 21 2.61E-14 1.85E-12 7.69E-13 17347 hsa-mir-3938 hsa04630 Jak-STAT signaling pathway 3717_3716_3718_85480_3560_3561_1387_867_3575_6774_6777_6772_2057_5781_4609_2690_2033 17 4.09E-14 2.90E-12 7.69E-13 17348 hsa-mir-3938 hsa05210 Colorectal cancer 1956_1499_5595_5594_5599_5159_5156_5601_4436_4609_3725_2353_4088_4089 14 4.33E-14 3.08E-12 7.69E-13 17349 hsa-mir-3938 hsa04012 ErbB signaling pathway 1956_6714_5595_5594_5599_2066_5601_867_1399_1398_6777_4609_3725_6464 14 6.67E-14 4.74E-12 9.47E-13 17350 hsa-mir-3938 hsa05220 Chronic myeloid leukemia 5595_5594_867_1399_1398_6777_5781_4609_4088_4089_5925_6464 12 4.51E-12 3.20E-10 5.34E-11 17351 hsa-mir-3938 hsa04520 Adherens junction 1956_1499_6714_3643_5595_5594_1387_1457_5770_4088_4089_2033 12 8.91E-12 6.33E-10 9.04E-11 17352 hsa-mir-3938 hsa04350 TGF-beta signaling pathway 5515_5595_5594_1387_7027_3397_3398_4609_3399_4088_4089_2033 12 2.16E-11 1.54E-09 1.92E-10 17353 hsa-mir-3938 hsa04910 Insulin signaling pathway 3643_5595_5594_5599_5601_867_1399_1398_5770_808_6464_805_801 13 2.46E-10 1.75E-08 1.94E-09 17354 hsa-mir-3938 hsa05214 Glioma 1956_5595_5594_5159_5156_5925_808_6464_805_801 10 4.00E-10 2.84E-08 2.84E-09 17355 hsa-mir-3938 hsa04912 GnRH signaling pathway 1956_6714_5595_5594_5599_5601_1432_3725_808_805_801 11 2.85E-09 2.02E-07 1.84E-08 17356 hsa-mir-3938 hsa04310 Wnt signaling pathway 5515_1499_5599_1387_5601_1457_8061_4609_3725_4088_4089_2033 12 7.81E-09 5.55E-07 4.62E-08 17357 hsa-mir-3938 hsa04510 Focal adhesion 1956_1499_6714_5595_5594_5599_5159_5156_5601_1399_1398_3725_6464 13 2.28E-08 1.62E-06 1.25E-07 17358 hsa-mir-3938 hsa04660 T cell receptor signaling pathway 3932_5595_5594_5601_867_919_1432_3725_2353_1493 10 4.11E-08 2.92E-06 2.09E-07 17359 hsa-mir-3938 hsa05215 Prostate cancer 1956_1499_5595_5594_1387_5159_5156_5925_2033 9 7.80E-08 5.54E-06 3.69E-07 17360 hsa-mir-3938 hsa05212 Pancreatic cancer 1956_1499_5595_5594_1387_5159_5156_5925_2033 9 8.54E-08 6.06E-06 3.79E-07 17361 hsa-mir-3938 hsa05211 Renal cell carcinoma 5595_5594_1387_1399_1398_5781_3725_2033 8 2.33E-07 1.65E-05 9.73E-07 17362 hsa-mir-3938 hsa04916 Melanogenesis 1499_5595_5594_1387_3815_808_2033_805_801 9 2.92E-07 2.08E-05 1.15E-06 17363 hsa-mir-3938 hsa04062 Chemokine signaling pathway 3717_3718_5595_5594_1399_1398_1234_6774_6777_6772_6464 11 7.29E-07 5.18E-05 2.73E-06 17364 hsa-mir-3938 hsa05221 Acute myeloid leukemia 5595_5594_3815_6774_6777_4609_862 7 8.99E-07 6.38E-05 3.19E-06 17365 hsa-mir-3938 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5601_1432_6772_3725_2353 8 2.69E-06 0.000190976 9.08E-06 17366 hsa-mir-3938 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_5599_5601_1432_5781_3725 7 2.81E-06 0.000199849 9.08E-06 17367 hsa-mir-3938 hsa04930 Type II diabetes mellitus 3651_3643_5595_5594_5599_5601 6 2.99E-06 0.000212264 9.23E-06 17368 hsa-mir-3938 hsa04720 Long-term potentiation 5595_5594_1387_808_2033_805_801 7 3.94E-06 0.000280018 1.17E-05 17369 hsa-mir-3938 hsa04664 Fc epsilon RI signaling pathway 695_5595_5594_5599_6850_5601_1432 7 5.43E-06 0.000385349 1.54E-05 17370 hsa-mir-3938 hsa04110 Cell cycle 1387_7027_6502_4088_4089_5925_2033_8379 8 7.85E-06 0.000557138 2.14E-05 17371 hsa-mir-3938 hsa04060 Cytokine-cytokine receptor interaction 85480_1956_3560_3561_5159_5156_3575_1234_3815_2057_2690 11 1.20E-05 0.000852628 3.16E-05 17372 hsa-mir-3938 hsa05340 Primary immunodeficiency 3718_695_3932_3561_3575 5 1.52E-05 0.001080733 3.86E-05 17373 hsa-mir-3938 hsa04920 Adipocytokine signaling pathway 3717_5599_5601_6774_5781_7186 6 2.45E-05 0.001736844 5.99E-05 17374 hsa-mir-3938 hsa05218 Melanoma 1956_5595_5594_5159_5156_5925 6 3.32E-05 0.002356516 7.77E-05 17375 hsa-mir-3938 hsa05219 Bladder cancer 1956_5595_5594_4609_5925 5 3.39E-05 0.002408955 7.77E-05 17376 hsa-mir-3938 hsa04662 B cell receptor signaling pathway 695_5595_5594_6850_3725_2353 6 4.43E-05 0.003142325 9.82E-05 17377 hsa-mir-3938 hsa04370 VEGF signaling pathway 6714_5595_5594_9261_7867_1432 6 5.08E-05 0.003607091 0.000109306 17378 hsa-mir-3938 hsa04330 Notch signaling pathway 388585_1387_9612_2033_8850 5 5.57E-05 0.003953023 0.000116265 17379 hsa-mir-3938 hsa05213 Endometrial cancer 1956_1499_5595_5594_4609 5 8.69E-05 0.006168291 0.000176237 17380 hsa-mir-3938 hsa05216 Thyroid cancer 1499_5595_5594_4609 4 0.000127982 0.009086732 0.000252409 17381 hsa-mir-3938 hsa04540 Gap junction 1956_6714_5595_5594_5159_5156 6 0.000135851 0.009645445 0.000260688 17382 hsa-mir-3938 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6850_919_5781_6464 7 0.000157524 0.011184219 0.000294322 17383 hsa-mir-3938 hsa05010 Alzheimer's disease 5595_5594_4724_840_808_805_801 7 0.000665527 0.047252383 0.0012116 17384 hsa-mir-3938 hsa04020 Calcium signaling pathway 1956_2066_5159_5156_808_805_801 7 0.000828847 0.058848152 0.001471204 17385 hsa-mir-3938 hsa05223 Non-small cell lung cancer 1956_5595_5594_5925 4 0.001137856 0.080787759 0.001970433 17386 hsa-mir-3938 hsa04810 Regulation of actin cytoskeleton 1956_5595_5594_5159_5156_1399_1398 7 0.002175144 0.154435219 0.003677029 17387 hsa-mir-3938 hsa04270 Vascular smooth muscle contraction 5595_5594_808_805_801 5 0.002948126 0.209316929 0.004867836 17388 hsa-mir-3938 hsa05222 Small cell lung cancer 4609_6502_5925_7186 4 0.005636766 0.400210386 0.009071911 17389 hsa-mir-3938 hsa04120 Ubiquitin mediated proteolysis 672_867_7329_6502_64326 5 0.005749803 0.408235985 0.009071911 17390 hsa-mir-3938 hsa04950 Maturity onset diabetes of the young 3651_168620 2 0.017706659 1 0.027329844 17391 hsa-mir-3938 hsa04730 Long-term depression 5515_5595_5594 3 0.020723923 1 0.031306351 17392 hsa-mir-3938 hsa04070 Phosphatidylinositol signaling system 808_805_801 3 0.024573077 1 0.036347677 17393 hsa-mir-3938 hsa04530 Tight junction 5515_1499_6714_1457 4 0.025583644 1 0.037070178 17394 hsa-mir-3938 hsa04640 Hematopoietic cell lineage 3575_3815_2057 3 0.034301302 1 0.048707849 17395 hsa-mir-3938 hsa03022 Basal transcription factors 2969_6908 2 0.037773192 1 0.052586208 17396 hsa-mir-3939 hsa04520 Adherens junction 2033_71_51701_5594_1457_1387 6 2.60E-10 1.35E-08 1.35E-08 17397 hsa-mir-3939 hsa05200 Pathways in cancer 3320_5371_2033_8554_5594_1387 6 9.20E-07 4.78E-05 2.39E-05 17398 hsa-mir-3939 hsa05215 Prostate cancer 3320_2033_5594_1387 4 2.13E-06 0.00011058 2.89E-05 17399 hsa-mir-3939 hsa05212 Pancreatic cancer 3320_2033_5594_1387 4 2.22E-06 0.00011547 2.89E-05 17400 hsa-mir-3939 hsa04310 Wnt signaling pathway 2033_51701_1457_1387 4 1.73E-05 0.000898726 0.000179745 17401 hsa-mir-3939 hsa05211 Renal cell carcinoma 2033_5594_1387 3 5.79E-05 0.003009135 0.000483336 17402 hsa-mir-3939 hsa04720 Long-term potentiation 2033_5594_1387 3 6.51E-05 0.003383351 0.000483336 17403 hsa-mir-3939 hsa04350 TGF-beta signaling pathway 2033_5594_1387 3 9.97E-05 0.005182661 0.000647833 17404 hsa-mir-3939 hsa04916 Melanogenesis 2033_5594_1387 3 0.000166472 0.008656549 0.000961839 17405 hsa-mir-3939 hsa04120 Ubiquitin mediated proteolysis 5371_7329_8554 3 0.000382708 0.0199008 0.00199008 17406 hsa-mir-3939 hsa04630 Jak-STAT signaling pathway 2033_8554_1387 3 0.000522683 0.027179522 0.002470866 17407 hsa-mir-3939 hsa04330 Notch signaling pathway 2033_1387 2 0.001101928 0.057300235 0.00477502 17408 hsa-mir-3939 hsa05131 Shigellosis 4691_71 2 0.001540262 0.080093634 0.005720974 17409 hsa-mir-3939 hsa05130 Pathogenic Escherichia coli infection 4691_71 2 0.001540262 0.080093634 0.005720974 17410 hsa-mir-3939 hsa05221 Acute myeloid leukemia 5371_5594 2 0.001702022 0.088505145 0.005900343 17411 hsa-mir-3939 hsa04612 Antigen processing and presentation 3308_3320 2 0.003738506 0.194402288 0.012150143 17412 hsa-mir-3939 hsa04110 Cell cycle 2033_1387 2 0.006506149 0.338319739 0.019901161 17413 hsa-mir-3939 hsa04530 Tight junction 71_1457 2 0.008500092 0.442004766 0.02455582 17414 hsa-mir-3939 hsa05016 Huntington's disease 2033_1387 2 0.01542031 0.801856103 0.042202953 17415 hsa-mir-3939 hsa04510 Focal adhesion 71_5594 2 0.018285312 0.950836242 0.047541812 17416 hsa-mir-3939 hsa04810 Regulation of actin cytoskeleton 71_5594 2 0.020483943 1 0.050722146 17417 hsa-mir-3939 hsa05216 Thyroid cancer 5594 1 0.029553986 1 0.069433804 17418 hsa-mir-3939 hsa04010 MAPK signaling pathway 51701_5594 2 0.030711106 1 0.069433804 17419 hsa-mir-3939 hsa05219 Bladder cancer 5594 1 0.04209686 1 0.091209863 17420 hsa-mir-3939 hsa04930 Type II diabetes mellitus 5594 1 0.044969036 1 0.093535594 17421 hsa-mir-3939 hsa03050 Proteasome 5705 1 0.047832886 1 0.095665771 17422 hsa-mir-3940 hsa05200 Pathways in cancer 3320_4149_5371_5595_5594_5599_1387_5604_9915_2932_3091_5970_4436_4087_4609_1029_6502_4088_4089_4292_1050_5925_2034_2033_5894 25 5.29E-22 3.12E-20 3.12E-20 17423 hsa-mir-3940 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_8454_7027_3399_6500_4087_4609_4088_4089_2033_4093_5933 15 1.78E-18 1.05E-16 5.27E-17 17424 hsa-mir-3940 hsa04110 Cell cycle 1387_983_2932_8454_7027_6500_4087_8379_1029_6502_4088_4089_5925_2033_5933_990 16 4.45E-18 2.63E-16 8.75E-17 17425 hsa-mir-3940 hsa05210 Colorectal cancer 5595_5594_5599_5604_2932_4436_4087_4609_4088_4089_4292_5894 12 3.93E-14 2.32E-12 5.79E-13 17426 hsa-mir-3940 hsa04540 Gap junction 5595_5594_5598_983_5604_7277_7278_10376_7846_51807_5894 11 3.06E-12 1.81E-10 3.61E-11 17427 hsa-mir-3940 hsa05220 Chronic myeloid leukemia 5595_5594_5604_5970_4609_1029_4088_4089_5925_5894 10 1.04E-11 6.14E-10 1.02E-10 17428 hsa-mir-3940 hsa04310 Wnt signaling pathway 5599_1387_2932_8454_6500_4087_4609_1457_1459_4088_4089_2033 12 2.50E-11 1.47E-09 2.10E-10 17429 hsa-mir-3940 hsa05215 Prostate cancer 3320_5595_5594_1387_5604_2932_5970_5925_2033_5894 10 4.42E-11 2.61E-09 3.21E-10 17430 hsa-mir-3940 hsa05212 Pancreatic cancer 3320_5595_5594_1387_5604_2932_5970_5925_2033_5894 10 4.89E-11 2.89E-09 3.21E-10 17431 hsa-mir-3940 hsa05211 Renal cell carcinoma 5595_5594_1387_5604_9915_3091_2034_2033_5894 9 1.96E-10 1.16E-08 1.16E-09 17432 hsa-mir-3940 hsa04520 Adherens junction 5595_5594_1387_4087_1457_1459_4088_4089_2033 9 4.62E-10 2.73E-08 2.48E-09 17433 hsa-mir-3940 hsa05221 Acute myeloid leukemia 5371_5595_5594_5604_5970_4609_1050_5894 8 1.15E-09 6.76E-08 5.63E-09 17434 hsa-mir-3940 hsa05219 Bladder cancer 5595_5594_5604_4609_1029_5925_5894 7 3.56E-09 2.10E-07 1.62E-08 17435 hsa-mir-3940 hsa05213 Endometrial cancer 5595_5594_5604_2932_4609_4292_5894 7 1.36E-08 8.02E-07 5.73E-08 17436 hsa-mir-3940 hsa04010 MAPK signaling pathway 4149_5595_5594_5599_5598_5604_1386_1432_5970_4609_5894 11 1.32E-07 7.80E-06 5.20E-07 17437 hsa-mir-3940 hsa04012 ErbB signaling pathway 5595_5594_5599_5604_2932_4609_5894 7 3.55E-07 2.09E-05 1.31E-06 17438 hsa-mir-3940 hsa05223 Non-small cell lung cancer 5595_5594_5604_1029_5925_5894 6 4.33E-07 2.56E-05 1.50E-06 17439 hsa-mir-3940 hsa05131 Shigellosis 7277_7278_10376_7846_51807_4691 6 5.28E-07 3.11E-05 1.64E-06 17440 hsa-mir-3940 hsa05130 Pathogenic Escherichia coli infection 7277_7278_10376_7846_51807_4691 6 5.28E-07 3.11E-05 1.64E-06 17441 hsa-mir-3940 hsa04916 Melanogenesis 5595_5594_1387_5604_2932_2033_5894 7 1.10E-06 6.49E-05 3.25E-06 17442 hsa-mir-3940 hsa05214 Glioma 5595_5594_5604_1029_5925_5894 6 1.19E-06 7.00E-05 3.34E-06 17443 hsa-mir-3940 hsa04912 GnRH signaling pathway 5595_5594_5599_5598_5604_1432_5894 7 1.40E-06 8.24E-05 3.75E-06 17444 hsa-mir-3940 hsa04660 T cell receptor signaling pathway 5595_5594_5604_2932_1432_5970_5894 7 1.57E-06 9.26E-05 4.02E-06 17445 hsa-mir-3940 hsa05218 Melanoma 5595_5594_5604_1029_5925_5894 6 1.92E-06 0.000113268 4.72E-06 17446 hsa-mir-3940 hsa04720 Long-term potentiation 5595_5594_1387_5604_2033_5894 6 2.59E-06 0.000152634 5.87E-06 17447 hsa-mir-3940 hsa04662 B cell receptor signaling pathway 5595_5594_5604_2932_5970_5894 6 2.59E-06 0.000152634 5.87E-06 17448 hsa-mir-3940 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5604_1432_5894 6 3.43E-06 0.000202494 7.50E-06 17449 hsa-mir-3940 hsa04910 Insulin signaling pathway 5595_5594_5599_5604_23265_2932_5894 7 6.53E-06 0.00038547 1.38E-05 17450 hsa-mir-3940 hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_8454_6500_6502_7329 7 6.84E-06 0.00040328 1.39E-05 17451 hsa-mir-3940 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5604_1432_5970 6 1.37E-05 0.000809727 2.70E-05 17452 hsa-mir-3940 hsa05216 Thyroid cancer 5595_5594_5604_4609 4 1.83E-05 0.001082613 3.49E-05 17453 hsa-mir-3940 hsa03022 Basal transcription factors 2963_2962_2969_6908 4 4.41E-05 0.002600988 8.13E-05 17454 hsa-mir-3940 hsa04370 VEGF signaling pathway 5595_5594_5604_1432_5894 5 4.71E-05 0.002779062 8.42E-05 17455 hsa-mir-3940 hsa04062 Chemokine signaling pathway 5595_5594_5604_2932_5970_7074_5894 7 5.20E-05 0.003067498 9.02E-05 17456 hsa-mir-3940 hsa05222 Small cell lung cancer 4149_5970_4609_6502_5925 5 7.76E-05 0.00457633 0.000130752 17457 hsa-mir-3940 hsa04330 Notch signaling pathway 1387_2648_9612_2033 4 0.000104831 0.00618505 0.000171807 17458 hsa-mir-3940 hsa04730 Long-term depression 5595_5594_5604_5894 4 0.000466614 0.027530255 0.000744061 17459 hsa-mir-3940 hsa04510 Focal adhesion 5595_5594_5599_5604_2932_5894 6 0.000561464 0.033126402 0.000871747 17460 hsa-mir-3940 hsa04930 Type II diabetes mellitus 5595_5594_5599 3 0.001577628 0.093080071 0.002386668 17461 hsa-mir-3940 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.002335419 0.137789719 0.003444743 17462 hsa-mir-3940 hsa04270 Vascular smooth muscle contraction 5595_5594_5604_5894 4 0.002836981 0.167381865 0.004082485 17463 hsa-mir-3940 hsa04810 Regulation of actin cytoskeleton 5595_5594_5604_7074_5894 5 0.00452214 0.266806259 0.00635253 17464 hsa-mir-3940 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_5604_5894 4 0.004873749 0.287551176 0.006687237 17465 hsa-mir-3940 hsa04115 p53 signaling pathway 983_7161_1029 3 0.005005035 0.295297065 0.006711297 17466 hsa-mir-3940 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_1432_5970 3 0.005402544 0.318750095 0.007083335 17467 hsa-mir-3940 hsa03430 Mismatch repair 4436_4292 2 0.006326156 0.373243175 0.008113982 17468 hsa-mir-3940 hsa04612 Antigen processing and presentation 3320_4801_4802 3 0.009835167 0.580274835 0.012346273 17469 hsa-mir-3940 hsa05010 Alzheimer's disease 5595_5594_2932_840 4 0.011265842 0.664684654 0.013847597 17470 hsa-mir-3940 hsa05016 Huntington's disease 1387_6908_6667_2033 4 0.013732914 0.810241897 0.016535549 17471 hsa-mir-3940 hsa04360 Axon guidance 5595_5594_2932 3 0.026587554 1 0.031373313 17472 hsa-mir-3940 hsa04630 Jak-STAT signaling pathway 1387_4609_2033 3 0.040305481 1 0.046627909 17473 hsa-mir-3940 hsa04920 Adipocytokine signaling pathway 5599_5970 2 0.043176117 1 0.048988287 17474 hsa-mir-3941 hsa05200 Pathways in cancer 25_5371_5595_5599_861_1387_5601_5602_836_367_6934_6774_6772_3091_5970_6688_2113_2353_4087_4088_4089_5925_2033_8554 24 3.45E-20 2.17E-18 2.17E-18 17475 hsa-mir-3941 hsa04010 MAPK signaling pathway 5595_5599_5598_1386_5601_5600_5602_836_1432_1649_5970_468_4773_3727_2353_8550 16 1.78E-12 1.12E-10 5.62E-11 17476 hsa-mir-3941 hsa04310 Wnt signaling pathway 5599_1387_5601_5602_6934_8061_4773_1457_4087_4088_4089_2033 12 4.71E-11 2.97E-09 7.79E-10 17477 hsa-mir-3941 hsa05210 Colorectal cancer 5595_5599_5601_5602_836_6934_2353_4087_4088_4089 10 4.95E-11 3.12E-09 7.79E-10 17478 hsa-mir-3941 hsa05215 Prostate cancer 5595_1387_367_6934_5970_468_9586_5925_2033 9 1.62E-09 1.02E-07 1.87E-08 17479 hsa-mir-3941 hsa05212 Pancreatic cancer 5595_1387_367_6934_5970_468_9586_5925_2033 9 1.78E-09 1.12E-07 1.87E-08 17480 hsa-mir-3941 hsa04620 Toll-like receptor signaling pathway 5595_5599_5601_5600_5602_1432_6772_5970_2353 9 5.40E-09 3.40E-07 4.86E-08 17481 hsa-mir-3941 hsa04520 Adherens junction 5595_1387_6934_1457_4087_4088_4089_2033 8 1.58E-08 9.98E-07 1.25E-07 17482 hsa-mir-3941 hsa04110 Cell cycle 25_5591_1387_7533_4087_4088_4089_5925_2033 9 1.90E-08 1.19E-06 1.33E-07 17483 hsa-mir-3941 hsa05221 Acute myeloid leukemia 5371_5595_861_6934_6774_5970_6688 7 4.37E-08 2.75E-06 2.75E-07 17484 hsa-mir-3941 hsa04912 GnRH signaling pathway 5595_5599_5598_5601_5600_5602_1432_468 8 1.39E-07 8.76E-06 7.40E-07 17485 hsa-mir-3941 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5601_5600_5602_836_1432_5970 7 1.41E-07 8.88E-06 7.40E-07 17486 hsa-mir-3941 hsa05220 Chronic myeloid leukemia 25_5595_861_5970_4088_4089_5925 7 1.99E-07 1.26E-05 9.67E-07 17487 hsa-mir-3941 hsa04350 TGF-beta signaling pathway 5595_1387_6667_4087_4088_4089_2033 7 5.11E-07 3.22E-05 2.30E-06 17488 hsa-mir-3941 hsa04660 T cell receptor signaling pathway 5595_5601_5600_1432_5970_4773_2353 7 2.25E-06 0.000141528 9.44E-06 17489 hsa-mir-3941 hsa04664 Fc epsilon RI signaling pathway 5595_5599_5601_5600_5602_1432 6 4.68E-06 0.000294973 1.84E-05 17490 hsa-mir-3941 hsa04120 Ubiquitin mediated proteolysis 5371_83737_672_55294_7329_64326_8554 7 9.72E-06 0.000612611 3.60E-05 17491 hsa-mir-3941 hsa04920 Adipocytokine signaling pathway 5599_5601_5602_6774_5970 5 3.25E-05 0.002046478 0.000113693 17492 hsa-mir-3941 hsa05211 Renal cell carcinoma 5595_1387_3091_2113_2033 5 4.50E-05 0.002832011 0.000149053 17493 hsa-mir-3941 hsa03022 Basal transcription factors 2963_6872_6908_2959 4 5.44E-05 0.003425057 0.000171253 17494 hsa-mir-3941 hsa04012 ErbB signaling pathway 25_5595_5599_5601_5602 5 0.000105305 0.006634205 0.000315684 17495 hsa-mir-3941 hsa04930 Type II diabetes mellitus 5595_5599_5601_5602 4 0.000110239 0.00694504 0.000315684 17496 hsa-mir-3941 hsa04630 Jak-STAT signaling pathway 1387_6774_6775_6772_2033_8554 6 0.000172188 0.010847863 0.000471646 17497 hsa-mir-3941 hsa05016 Huntington's disease 1387_6908_836_6667_9586_2033 6 0.000467663 0.029462792 0.001227616 17498 hsa-mir-3941 hsa04720 Long-term potentiation 5595_1387_468_2033 4 0.000695394 0.043809826 0.001684993 17499 hsa-mir-3941 hsa04662 B cell receptor signaling pathway 5595_5970_4773_2353 4 0.000695394 0.043809826 0.001684993 17500 hsa-mir-3941 hsa04370 VEGF signaling pathway 5595_5600_1432_4773 4 0.000764048 0.048135026 0.001782779 17501 hsa-mir-3941 hsa04330 Notch signaling pathway 1387_9612_2033 3 0.002069459 0.130375944 0.004656284 17502 hsa-mir-3941 hsa04916 Melanogenesis 5595_1387_6934_2033 4 0.002216072 0.139612555 0.004814226 17503 hsa-mir-3941 hsa05014 Amyotrophic lateral sclerosis (ALS) 5600_836_1432 3 0.00332092 0.209217983 0.006973933 17504 hsa-mir-3941 hsa04360 Axon guidance 25_5595_4773_1020 4 0.004929405 0.310552543 0.010017824 17505 hsa-mir-3941 hsa04910 Insulin signaling pathway 5595_5599_5601_5602 4 0.005886472 0.37084776 0.011588992 17506 hsa-mir-3941 hsa05222 Small cell lung cancer 5970_5925_8554 3 0.01039678 0.654997152 0.019765423 17507 hsa-mir-3941 hsa05216 Thyroid cancer 5595_6934 2 0.010667054 0.672024387 0.019765423 17508 hsa-mir-3941 hsa04210 Apoptosis 836_840_5970 3 0.011372034 0.716438153 0.020469662 17509 hsa-mir-3941 hsa05010 Alzheimer's disease 5595_836_840_1020 4 0.013500463 0.850529145 0.02362581 17510 hsa-mir-3941 hsa04062 Chemokine signaling pathway 5595_6774_6772_5970 4 0.017869317 1 0.030426134 17511 hsa-mir-3941 hsa05219 Bladder cancer 5595_5925 2 0.020796324 1 0.034478116 17512 hsa-mir-3941 hsa04510 Focal adhesion 5595_5599_5601_5602 4 0.021999397 1 0.035537487 17513 hsa-mir-3941 hsa05213 Endometrial cancer 5595_6934 2 0.030449097 1 0.046787637 17514 hsa-mir-3941 hsa04150 mTOR signaling pathway 5595_3091 2 0.030449097 1 0.046787637 17515 hsa-mir-3941 hsa05223 Non-small cell lung cancer 5595_5925 2 0.032555954 1 0.048833931 17516 hsa-mir-3941 hsa04650 Natural killer cell mediated cytotoxicity 5595_836_4773 3 0.0346902 1 0.050825177 17517 hsa-mir-3941 hsa05214 Glioma 5595_5925 2 0.04510272 1 0.064578894 17518 hsa-mir-3943 hsa04310 Wnt signaling pathway 8061_2033 2 0.002628396 0.042054332 0.042054332 17519 hsa-mir-3943 hsa03022 Basal transcription factors 2969 1 0.018827479 0.301239659 0.064080979 17520 hsa-mir-3943 hsa04330 Notch signaling pathway 2033 1 0.023726799 0.37962878 0.064080979 17521 hsa-mir-3943 hsa03050 Proteasome 5705 1 0.024215473 0.387447567 0.064080979 17522 hsa-mir-3943 hsa05211 Renal cell carcinoma 2033 1 0.035875388 0.574006202 0.064080979 17523 hsa-mir-3943 hsa04720 Long-term potentiation 2033 1 0.037323699 0.597179176 0.064080979 17524 hsa-mir-3943 hsa04520 Adherens junction 2033 1 0.039733038 0.635728613 0.064080979 17525 hsa-mir-3943 hsa04350 TGF-beta signaling pathway 2033 1 0.04309666 0.689546564 0.064080979 17526 hsa-mir-3943 hsa05215 Prostate cancer 2033 1 0.043576279 0.697220464 0.064080979 17527 hsa-mir-3943 hsa04612 Antigen processing and presentation 4800 1 0.044055673 0.704890774 0.064080979 17528 hsa-mir-3943 hsa05212 Pancreatic cancer 2033 1 0.044055673 0.704890774 0.064080979 17529 hsa-mir-409 hsa04010 MAPK signaling pathway 3727_468_3725 3 0.000667981 0.014027611 0.014027611 17530 hsa-mir-409 hsa04912 GnRH signaling pathway 468_3725 2 0.00218447 0.045873875 0.022936937 17531 hsa-mir-409 hsa04310 Wnt signaling pathway 5518_3725 2 0.004222252 0.088667291 0.029555764 17532 hsa-mir-409 hsa05010 Alzheimer's disease 9451_823 2 0.005656142 0.118778979 0.029694745 17533 hsa-mir-409 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725 1 0.044613757 0.936888905 0.077656404 17534 hsa-mir-409 hsa04730 Long-term depression 5518 1 0.044613757 0.936888905 0.077656404 17535 hsa-mir-409 hsa05211 Renal cell carcinoma 3725 1 0.045219906 0.94961803 0.077656404 17536 hsa-mir-409 hsa04720 Long-term potentiation 468 1 0.047036167 0.987759516 0.077656404 17537 hsa-mir-409 hsa04662 B cell receptor signaling pathway 3725 1 0.047036167 0.987759516 0.077656404 17538 hsa-mir-410 hsa04310 Wnt signaling pathway 4087_4088_1487_2033_3725_1488 6 3.41E-10 8.51E-09 8.51E-09 17539 hsa-mir-410 hsa05200 Pathways in cancer 4087_4088_1487_2033_3725_1488 6 3.23E-08 8.07E-07 4.04E-07 17540 hsa-mir-410 hsa04330 Notch signaling pathway 1487_2033_1488 3 3.49E-06 8.72E-05 2.91E-05 17541 hsa-mir-410 hsa05220 Chronic myeloid leukemia 4088_1487_1488 3 1.34E-05 0.000334746 7.35E-05 17542 hsa-mir-410 hsa04520 Adherens junction 4087_4088_2033 3 1.61E-05 0.000403534 7.35E-05 17543 hsa-mir-410 hsa05210 Colorectal cancer 4087_4088_3725 3 1.86E-05 0.000464823 7.35E-05 17544 hsa-mir-410 hsa04350 TGF-beta signaling pathway 4087_4088_2033 3 2.06E-05 0.00051461 7.35E-05 17545 hsa-mir-410 hsa04110 Cell cycle 4087_4088_2033 3 5.11E-05 0.001277847 0.000159731 17546 hsa-mir-410 hsa04010 MAPK signaling pathway 468_3725_3727 3 0.000566403 0.014160084 0.001573343 17547 hsa-mir-410 hsa05211 Renal cell carcinoma 2033_3725 2 0.00089411 0.022352738 0.002199001 17548 hsa-mir-410 hsa04720 Long-term potentiation 468_2033 2 0.00096756 0.024189008 0.002199001 17549 hsa-mir-410 hsa05215 Prostate cancer 468_2033 2 0.001318265 0.032956628 0.002591175 17550 hsa-mir-410 hsa05212 Pancreatic cancer 468_2033 2 0.001347411 0.033685273 0.002591175 17551 hsa-mir-410 hsa04912 GnRH signaling pathway 468_3725 2 0.001959333 0.048983316 0.003498808 17552 hsa-mir-410 hsa05010 Alzheimer's disease 9451_823 2 0.005080908 0.127022699 0.00846818 17553 hsa-mir-410 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725 1 0.042316772 1 0.065613819 17554 hsa-mir-410 hsa04662 B cell receptor signaling pathway 3725 1 0.044617397 1 0.065613819 17555 hsa-mir-411 hsa04010 MAPK signaling pathway 6722_8986_3727_5595_5594_5599_9261_5601_5600_5603_6195_1432_1649_5970_10912_4609_3725_6196_6197_2353_4616_207_8550_9252 24 1.76E-23 1.05E-21 1.05E-21 17556 hsa-mir-411 hsa05200 Pathways in cancer 5371_5595_5594_5599_6258_1387_6257_6256_8031_5601_367_2932_5970_4609_3725_2353_2736_4088_4089_3065_1050_5925_2033_207_8554 25 6.77E-23 4.06E-21 2.03E-21 17557 hsa-mir-411 hsa05210 Colorectal cancer 5595_5594_5599_5601_2932_4609_3725_2353_4088_4089_207 11 4.63E-13 2.78E-11 9.27E-12 17558 hsa-mir-411 hsa05215 Prostate cancer 5595_5594_1387_367_2932_5970_9586_10488_5925_2033_207 11 7.37E-13 4.42E-11 9.90E-12 17559 hsa-mir-411 hsa05212 Pancreatic cancer 5595_5594_1387_367_2932_5970_9586_10488_5925_2033_207 11 8.25E-13 4.95E-11 9.90E-12 17560 hsa-mir-411 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5601_5600_5603_1432_5970_3725_2353_207 11 3.23E-12 1.94E-10 3.23E-11 17561 hsa-mir-411 hsa04660 T cell receptor signaling pathway 5595_5594_5601_5600_5603_2932_1432_5970_3725_2353_207 11 6.88E-12 4.13E-10 5.90E-11 17562 hsa-mir-411 hsa04310 Wnt signaling pathway 5599_1387_5601_1457_2932_8061_4609_3725_1459_4088_4089_2033 12 9.77E-12 5.86E-10 7.33E-11 17563 hsa-mir-411 hsa05220 Chronic myeloid leukemia 5595_5594_5970_4609_4088_4089_3065_5925_207 9 1.35E-10 8.07E-09 8.97E-10 17564 hsa-mir-411 hsa05216 Thyroid cancer 5595_5594_6258_6257_6256_8031_4609 7 2.09E-10 1.25E-08 1.25E-09 17565 hsa-mir-411 hsa04920 Adipocytokine signaling pathway 10891_5599_6258_6257_6256_5601_5970_207 8 1.53E-09 9.19E-08 8.36E-09 17566 hsa-mir-411 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5601_5600_5603_1432_207 8 5.08E-09 3.05E-07 2.54E-08 17567 hsa-mir-411 hsa04520 Adherens junction 5595_5594_1387_1457_1459_4088_4089_2033 8 5.56E-09 3.34E-07 2.54E-08 17568 hsa-mir-411 hsa04110 Cell cycle 1387_2932_10912_4088_4089_3065_4616_5925_2033 9 5.92E-09 3.55E-07 2.54E-08 17569 hsa-mir-411 hsa05222 Small cell lung cancer 6258_6257_6256_5970_4609_5925_207_8554 8 9.43E-09 5.66E-07 3.62E-08 17570 hsa-mir-411 hsa05223 Non-small cell lung cancer 5595_5594_6258_6257_6256_5925_207 7 9.96E-09 5.97E-07 3.62E-08 17571 hsa-mir-411 hsa04012 ErbB signaling pathway 5595_5594_5599_5601_2932_4609_3725_207 8 1.03E-08 6.15E-07 3.62E-08 17572 hsa-mir-411 hsa05221 Acute myeloid leukemia 5371_5595_5594_5970_4609_1050_207 7 1.75E-08 1.05E-06 5.82E-08 17573 hsa-mir-411 hsa04912 GnRH signaling pathway 5595_5594_5599_5601_5600_5603_1432_3725 8 4.96E-08 2.98E-06 1.57E-07 17574 hsa-mir-411 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5601_5600_5603_1432_5970_3725 7 5.67E-08 3.40E-06 1.70E-07 17575 hsa-mir-411 hsa04720 Long-term potentiation 5595_5594_1387_6195_6196_6197_2033 7 8.03E-08 4.82E-06 2.19E-07 17576 hsa-mir-411 hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_3725_2353_207 7 8.03E-08 4.82E-06 2.19E-07 17577 hsa-mir-411 hsa04370 VEGF signaling pathway 5595_5594_9261_5600_5603_1432_207 7 9.50E-08 5.70E-06 2.48E-07 17578 hsa-mir-411 hsa04350 TGF-beta signaling pathway 5595_5594_1387_4609_4088_4089_2033 7 2.07E-07 1.24E-05 5.18E-07 17579 hsa-mir-411 hsa04150 mTOR signaling pathway 5595_5594_6195_6196_6197_207 6 2.21E-07 1.33E-05 5.31E-07 17580 hsa-mir-411 hsa05211 Renal cell carcinoma 5595_5594_1387_3725_2033_207 6 1.31E-06 7.84E-05 3.01E-06 17581 hsa-mir-411 hsa05219 Bladder cancer 5595_5594_4609_5925_9252 5 2.05E-06 0.000123176 4.56E-06 17582 hsa-mir-411 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601_3651 5 2.81E-06 0.000168343 6.01E-06 17583 hsa-mir-411 hsa04910 Insulin signaling pathway 10891_5595_5594_5599_5601_2932_207 7 3.87E-06 0.000232498 8.02E-06 17584 hsa-mir-411 hsa05213 Endometrial cancer 5595_5594_2932_4609_207 5 5.41E-06 0.000324551 1.08E-05 17585 hsa-mir-411 hsa04916 Melanogenesis 5595_5594_1387_2932_10488_2033 6 9.71E-06 0.000582449 1.88E-05 17586 hsa-mir-411 hsa05016 Huntington's disease 10891_1387_9586_3065_3064_10488_2033 7 2.67E-05 0.001601233 5.00E-05 17587 hsa-mir-411 hsa04510 Focal adhesion 5595_5594_5599_5601_2932_3725_207 7 4.68E-05 0.002808249 8.51E-05 17588 hsa-mir-411 hsa04330 Notch signaling pathway 1387_9612_3065_2033 4 7.72E-05 0.004630503 0.000136191 17589 hsa-mir-411 hsa05214 Glioma 5595_5594_5925_207 4 0.000251091 0.015065464 0.000430442 17590 hsa-mir-411 hsa03320 PPAR signaling pathway 6258_6257_6256_2168 4 0.000328556 0.01971335 0.000547593 17591 hsa-mir-411 hsa05218 Melanoma 5595_5594_5925_207 4 0.000345887 0.020753232 0.000560898 17592 hsa-mir-411 hsa04630 Jak-STAT signaling pathway 1387_4609_2033_207_8554 5 0.000737662 0.044259729 0.00116473 17593 hsa-mir-411 hsa04062 Chemokine signaling pathway 5595_5594_2932_5970_207 5 0.00189746 0.113847612 0.00291917 17594 hsa-mir-411 hsa05014 Amyotrophic lateral sclerosis (ALS) 5600_5603_1432 3 0.002281434 0.136886054 0.003422151 17595 hsa-mir-411 hsa04120 Ubiquitin mediated proteolysis 5371_672_7329_8554 4 0.003775086 0.226505155 0.005524516 17596 hsa-mir-411 hsa04730 Long-term depression 5592_5595_5594 3 0.004335969 0.260158126 0.006194241 17597 hsa-mir-411 hsa04540 Gap junction 5592_5595_5594 3 0.008909483 0.534568968 0.012431836 17598 hsa-mir-411 hsa04270 Vascular smooth muscle contraction 5592_5595_5594 3 0.016587875 0.995272505 0.02261983 17599 hsa-mir-411 hsa04670 Leukocyte transendothelial migration 5600_5603_1432 3 0.018072522 1 0.024096696 17600 hsa-mir-411 hsa04360 Axon guidance 5595_5594_2932 3 0.021675324 1 0.028272162 17601 hsa-mir-411 hsa04530 Tight junction 1457_1459_207 3 0.024279491 1 0.030995095 17602 hsa-mir-411 hsa05217 Basal cell carcinoma 2932_2736 2 0.026344952 1 0.03293119 17603 hsa-mir-411 hsa04340 Hedgehog signaling pathway 2932_2736 2 0.028082884 1 0.034387204 17604 hsa-mir-411 hsa04115 p53 signaling pathway 10912_4616 2 0.039420171 1 0.047304205 17605 hsa-mir-411 hsa05010 Alzheimer's disease 5595_5594_2932 3 0.045736304 1 0.053807416 17606 hsa-mir-412 hsa04010 MAPK signaling pathway 3727_468_3725 3 0.000667981 0.014027611 0.014027611 17607 hsa-mir-412 hsa04912 GnRH signaling pathway 468_3725 2 0.00218447 0.045873875 0.022936937 17608 hsa-mir-412 hsa04310 Wnt signaling pathway 5518_3725 2 0.004222252 0.088667291 0.029555764 17609 hsa-mir-412 hsa05010 Alzheimer's disease 9451_823 2 0.005656142 0.118778979 0.029694745 17610 hsa-mir-412 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725 1 0.044613757 0.936888905 0.077656404 17611 hsa-mir-412 hsa04730 Long-term depression 5518 1 0.044613757 0.936888905 0.077656404 17612 hsa-mir-412 hsa05211 Renal cell carcinoma 3725 1 0.045219906 0.94961803 0.077656404 17613 hsa-mir-412 hsa04720 Long-term potentiation 468 1 0.047036167 0.987759516 0.077656404 17614 hsa-mir-412 hsa04662 B cell receptor signaling pathway 3725 1 0.047036167 0.987759516 0.077656404 17615 hsa-mir-423 hsa05221 Acute myeloid leukemia 6688_7704_5595_207_6774_5594 6 3.08E-12 1.45E-10 1.45E-10 17616 hsa-mir-423 hsa05200 Pathways in cancer 6688_7704_5595_207_6774_1387_5594 7 1.50E-09 7.07E-08 3.53E-08 17617 hsa-mir-423 hsa05211 Renal cell carcinoma 5595_207_1387_5594 4 1.78E-07 8.37E-06 2.79E-06 17618 hsa-mir-423 hsa05215 Prostate cancer 5595_207_1387_5594 4 3.85E-07 1.81E-05 3.78E-06 17619 hsa-mir-423 hsa05212 Pancreatic cancer 5595_207_1387_5594 4 4.03E-07 1.89E-05 3.78E-06 17620 hsa-mir-423 hsa05213 Endometrial cancer 5595_207_5594 3 6.49E-06 0.000304967 4.19E-05 17621 hsa-mir-423 hsa04150 mTOR signaling pathway 5595_207_5594 3 6.49E-06 0.000304967 4.19E-05 17622 hsa-mir-423 hsa05223 Non-small cell lung cancer 5595_207_5594 3 7.23E-06 0.000339842 4.19E-05 17623 hsa-mir-423 hsa04062 Chemokine signaling pathway 5595_207_6774_5594 4 8.03E-06 0.000377233 4.19E-05 17624 hsa-mir-423 hsa05214 Glioma 5595_207_5594 3 1.23E-05 0.000579361 5.79E-05 17625 hsa-mir-423 hsa05218 Melanoma 5595_207_5594 3 1.59E-05 0.000747484 6.21E-05 17626 hsa-mir-423 hsa04720 Long-term potentiation 5595_1387_5594 3 1.86E-05 0.000875741 6.21E-05 17627 hsa-mir-423 hsa05220 Chronic myeloid leukemia 5595_207_5594 3 1.86E-05 0.000875741 6.21E-05 17628 hsa-mir-423 hsa04662 B cell receptor signaling pathway 5595_207_5594 3 1.86E-05 0.000875741 6.21E-05 17629 hsa-mir-423 hsa04370 VEGF signaling pathway 5595_207_5594 3 2.01E-05 0.000944973 6.21E-05 17630 hsa-mir-423 hsa04664 Fc epsilon RI signaling pathway 5595_207_5594 3 2.17E-05 0.001017718 6.21E-05 17631 hsa-mir-423 hsa04520 Adherens junction 5595_1387_5594 3 2.25E-05 0.001055434 6.21E-05 17632 hsa-mir-423 hsa05210 Colorectal cancer 5595_207_5594 3 2.59E-05 0.001215495 6.73E-05 17633 hsa-mir-423 hsa04350 TGF-beta signaling pathway 5595_1387_5594 3 2.86E-05 0.001345483 6.73E-05 17634 hsa-mir-423 hsa04012 ErbB signaling pathway 5595_207_5594 3 2.86E-05 0.001345483 6.73E-05 17635 hsa-mir-423 hsa04620 Toll-like receptor signaling pathway 5595_207_5594 3 4.54E-05 0.002133318 0.000101587 17636 hsa-mir-423 hsa04916 Melanogenesis 5595_1387_5594 3 4.80E-05 0.002256866 0.000102585 17637 hsa-mir-423 hsa04660 T cell receptor signaling pathway 5595_207_5594 3 5.65E-05 0.002655458 0.000115455 17638 hsa-mir-423 hsa04910 Insulin signaling pathway 5595_207_5594 3 0.000109048 0.005125273 0.000213553 17639 hsa-mir-423 hsa04630 Jak-STAT signaling pathway 207_6774_1387 3 0.000152687 0.007176301 0.000287052 17640 hsa-mir-423 hsa05216 Thyroid cancer 5595_5594 2 0.000193819 0.009109477 0.000350365 17641 hsa-mir-423 hsa04510 Focal adhesion 5595_207_5594 3 0.000347452 0.016330251 0.000604824 17642 hsa-mir-423 hsa05219 Bladder cancer 5595_5594 2 0.000392264 0.018436404 0.000658443 17643 hsa-mir-423 hsa04930 Type II diabetes mellitus 5595_5594 2 0.000447706 0.021042163 0.000725592 17644 hsa-mir-423 hsa04010 MAPK signaling pathway 5595_207_5594 3 0.000780462 0.036681733 0.001222724 17645 hsa-mir-423 hsa04920 Adipocytokine signaling pathway 207_6774 2 0.000963119 0.045266591 0.001460213 17646 hsa-mir-423 hsa04730 Long-term depression 5595_5594 2 0.001077169 0.050626949 0.001582092 17647 hsa-mir-423 hsa04540 Gap junction 5595_5594 2 0.001814127 0.085263959 0.002583756 17648 hsa-mir-423 hsa04912 GnRH signaling pathway 5595_5594 2 0.002421237 0.113798128 0.003347004 17649 hsa-mir-423 hsa04270 Vascular smooth muscle contraction 5595_5594 2 0.002872201 0.134993433 0.003856955 17650 hsa-mir-423 hsa04360 Axon guidance 5595_5594 2 0.003512868 0.165104811 0.004586245 17651 hsa-mir-423 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594 2 0.003883003 0.182501157 0.004932464 17652 hsa-mir-423 hsa05010 Alzheimer's disease 5595_5594 2 0.006259692 0.294205547 0.007742251 17653 hsa-mir-423 hsa04810 Regulation of actin cytoskeleton 5595_5594 2 0.009393749 0.441506208 0.011320672 17654 hsa-mir-423 hsa04330 Notch signaling pathway 1387 1 0.031507378 1 0.03702117 17655 hsa-mir-424 hsa05200 Pathways in cancer 5914_595_596_598_1017_4193_5578_3091_4087_3066_3065_1050_5925_613_5743_5747_25_6789_4436_1870_1871_2113_4286_1147_998_367_5595_5594_5599_1387_6256_836_2932_5970_7157_7704_1869_3725_4088_4089_5888_5728_2034_2033_4846_3910_4792_3320_3326_5371_675_5601_5602_1856_51588_7428_4609_1026_1029_2353_8554 61 6.92E-43 5.88E-41 5.88E-41 17656 hsa-mir-424 hsa04110 Cell cycle 595_1017_4193_902_4087_3066_3065_5925_25_1870_1871_5933_9232_545_995_993_5347_5591_1387_11200_7534_7532_2932_7027_7157_1869_4088_4089_2033_890_1031_983_1026_1022_1029_1111_8556_8555_472 39 7.76E-36 6.60E-34 3.30E-34 17657 hsa-mir-424 hsa05220 Chronic myeloid leukemia 595_598_4193_3066_3065_5925_613_25_1870_1871_1147_5595_5594_5970_7157_1869_4088_4089_4792_4609_1026_1029_6464 23 4.54E-21 3.86E-19 1.29E-19 17658 hsa-mir-424 hsa05215 Prostate cancer 595_596_1017_4193_5925_1870_1871_9586_1147_367_5595_5594_1385_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_1026 24 6.39E-21 5.43E-19 1.36E-19 17659 hsa-mir-424 hsa05212 Pancreatic cancer 595_596_1017_4193_5925_1870_1871_9586_1147_367_5595_5594_1385_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_1026 24 8.00E-21 6.80E-19 1.36E-19 17660 hsa-mir-424 hsa04115 p53 signaling pathway 595_1017_4194_4193_900_50484_6241_51246_545_7161_11200_836_7157_64326_5728_27113_25898_983_1026_1029_1111_472 22 1.63E-20 1.38E-18 2.31E-19 17661 hsa-mir-424 hsa04010 MAPK signaling pathway 9252_5578_5923_3304_3305_3303_6789_1432_4763_1616_1147_998_5595_5594_5599_1386_836_3312_3315_1649_5970_3164_7157_3725_3727_4208_5601_5600_5603_5602_4609_2353_8550 33 1.48E-18 1.26E-16 1.80E-17 17662 hsa-mir-424 hsa05222 Small cell lung cancer 595_596_598_1017_5925_5743_5747_1870_1871_1147_6256_5970_7157_1869_5728_4846_3910_4792_51588_4609_8554 21 1.25E-17 1.06E-15 1.32E-16 17663 hsa-mir-424 hsa04310 Wnt signaling pathway 595_5578_4087_1460_5599_1387_2932_7157_8061_3725_1457_1452_1459_4088_4089_2033_5518_5515_5601_5602_1856_4609_5527 23 3.50E-15 2.97E-13 3.30E-14 17664 hsa-mir-424 hsa05210 Colorectal cancer 595_596_4087_4436_5595_5594_5599_836_2932_7157_3725_4088_4089_5601_5602_1856_4609_2353 18 1.89E-14 1.61E-12 1.61E-13 17665 hsa-mir-424 hsa05219 Bladder cancer 595_9252_4193_5925_1870_1871_5595_5594_7157_1869_4609_1026_1029 13 1.59E-12 1.35E-10 1.23E-11 17666 hsa-mir-424 hsa05214 Glioma 595_4193_5578_5925_1870_1871_5595_5594_7157_1869_5728_1026_1029_6464 14 1.46E-11 1.24E-09 1.03E-10 17667 hsa-mir-424 hsa05223 Non-small cell lung cancer 595_5578_5925_6789_1870_1871_5595_5594_6256_7157_1869_1029 12 3.09E-10 2.63E-08 2.02E-09 17668 hsa-mir-424 hsa05218 Melanoma 595_4193_5925_1870_1871_4286_5595_5594_7157_1869_5728_1026_1029 13 4.59E-10 3.90E-08 2.79E-09 17669 hsa-mir-424 hsa04350 TGF-beta signaling pathway 4087_6667_5933_5595_5594_1387_7027_4088_4089_2033_5518_5515_4609 13 4.18E-09 3.56E-07 2.22E-08 17670 hsa-mir-424 hsa04012 ErbB signaling pathway 5578_5747_25_5595_5594_5599_2932_3725_5601_5602_4609_1026_6464 13 4.18E-09 3.56E-07 2.22E-08 17671 hsa-mir-424 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_1147_998_5599_836_5970_3725_4792_5601_5600_5603_5602 12 4.82E-09 4.09E-07 2.41E-08 17672 hsa-mir-424 hsa04660 T cell receptor signaling pathway 1432_1147_998_5595_5594_2932_5970_3725_959_4792_5601_5600_5603_2353 14 6.86E-09 5.83E-07 3.24E-08 17673 hsa-mir-424 hsa04120 Ubiquitin mediated proteolysis 4193_3093_7319_84447_7329_10055_64326_7337_5371_672_25898_51588_7428_10075_8554 15 1.52E-08 1.29E-06 6.81E-08 17674 hsa-mir-424 hsa04620 Toll-like receptor signaling pathway 1432_1147_5595_5594_5599_5970_3725_4792_5601_5600_5603_5602_2353 13 2.34E-08 1.99E-06 9.94E-08 17675 hsa-mir-424 hsa03022 Basal transcription factors 51616_2965_2963_2969_6874_6908_2958_6880_2957 9 2.68E-08 2.28E-06 1.09E-07 17676 hsa-mir-424 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_2902_1432_1616_836_7157_4846_5600_5603 10 5.89E-08 5.01E-06 2.28E-07 17677 hsa-mir-424 hsa04510 Focal adhesion 595_596_5578_5923_5747_5499_998_5595_5594_5599_2932_3725_5728_3910_5601_5602_6464 17 6.57E-08 5.59E-06 2.43E-07 17678 hsa-mir-424 hsa05221 Acute myeloid leukemia 5914_595_1050_1147_5595_5594_5970_7704_5371_4609 10 9.12E-08 7.75E-06 3.23E-07 17679 hsa-mir-424 hsa04370 VEGF signaling pathway 5578_5743_5747_1432_998_5595_5594_3315_4846_5600_5603 11 9.93E-08 8.44E-06 3.38E-07 17680 hsa-mir-424 hsa04520 Adherens junction 4087_1460_998_5595_5594_1387_1457_1459_4088_4089_2033 11 1.41E-07 1.20E-05 4.61E-07 17681 hsa-mir-424 hsa04612 Antigen processing and presentation 3309_3304_3305_3303_1385_3312_1514_3320_3326_4800_4801 11 3.73E-07 3.17E-05 1.18E-06 17682 hsa-mir-424 hsa05211 Renal cell carcinoma 3091_2113_998_5595_5594_1387_3725_2034_2033_7428 10 4.81E-07 4.09E-05 1.46E-06 17683 hsa-mir-424 hsa05016 Huntington's disease 3066_3065_3064_25942_2902_6667_9586_1385_1387_836_7157_2033_27113_6874_6908 15 5.81E-07 4.94E-05 1.70E-06 17684 hsa-mir-424 hsa04330 Notch signaling pathway 3066_3065_1387_9612_2033_8850_1856_4851 8 1.75E-06 0.000148388 4.95E-06 17685 hsa-mir-424 hsa04912 GnRH signaling pathway 5578_1432_998_5595_5594_5599_3725_5601_5600_5603_5602 11 2.15E-06 0.000182408 5.88E-06 17686 hsa-mir-424 hsa04920 Adipocytokine signaling pathway 6794_1147_5599_6256_5970_4792_5601_5602_5563 9 2.32E-06 0.000196966 6.16E-06 17687 hsa-mir-424 hsa04662 B cell receptor signaling pathway 1147_5595_5594_1380_2932_5970_3725_4792_2353 9 5.38E-06 0.000457246 1.39E-05 17688 hsa-mir-424 hsa04664 Fc epsilon RI signaling pathway 5578_1432_5595_5594_5599_5601_5600_5603_5602 9 7.91E-06 0.000672657 1.98E-05 17689 hsa-mir-424 hsa03420 Nucleotide excision repair 902_2965_4331_2071_2074_1022_6117 7 1.16E-05 0.000989083 2.83E-05 17690 hsa-mir-424 hsa05216 Thyroid cancer 595_5595_5594_6256_7157_4609 6 1.33E-05 0.001133074 3.15E-05 17691 hsa-mir-424 hsa04210 Apoptosis 596_598_823_1147_836_5970_7157_4792_472 9 1.91E-05 0.001620821 4.38E-05 17692 hsa-mir-424 hsa05213 Endometrial cancer 595_5595_5594_2932_7157_5728_4609 7 3.09E-05 0.002625242 6.91E-05 17693 hsa-mir-424 hsa04916 Melanogenesis 5578_4286_5595_5594_1385_1387_2932_2033_1856 9 5.92E-05 0.005033278 0.000129058 17694 hsa-mir-424 hsa04910 Insulin signaling pathway 6720_5499_5595_5594_5599_2932_5601_5602_5563_6464 10 9.41E-05 0.007996676 0.000199917 17695 hsa-mir-424 hsa03440 Homologous recombination 641_4683_5888_675_6117 5 0.00013259 0.01127013 0.000274881 17696 hsa-mir-424 hsa04720 Long-term potentiation 5578_2902_5499_5595_5594_1387_2033 7 0.000255106 0.021684042 0.000516287 17697 hsa-mir-424 hsa04530 Tight junction 5578_1460_998_1457_1459_5728_5518_5515_5520 9 0.000413071 0.035111069 0.000816536 17698 hsa-mir-424 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601_5602 5 0.00095789 0.081420665 0.00185047 17699 hsa-mir-424 hsa04730 Long-term depression 5578_5595_5594_4846_5518_5515 6 0.001138565 0.096778038 0.002138853 17700 hsa-mir-424 hsa04062 Chemokine signaling pathway 5747_6362_1147_998_5595_5594_2932_5970_4792_6464 10 0.001157497 0.098387226 0.002138853 17701 hsa-mir-424 hsa04150 mTOR signaling pathway 6794_3091_5595_5594_5563 5 0.001735703 0.147534786 0.003139038 17702 hsa-mir-424 hsa05010 Alzheimer's disease 823_2902_22926_5595_5594_836_2932_4846_1020 9 0.002273143 0.193217184 0.00399011 17703 hsa-mir-424 hsa05131 Shigellosis 5578_25_998_7534_4691 5 0.002347123 0.199505481 0.00399011 17704 hsa-mir-424 hsa05130 Pathogenic Escherichia coli infection 5578_25_998_7534_4691 5 0.002347123 0.199505481 0.00399011 17705 hsa-mir-424 hsa03410 Base excision repair 3146_142_4913_328 4 0.003123245 0.265475804 0.005205408 17706 hsa-mir-424 hsa04360 Axon guidance 5747_25_998_5595_5594_2932_1020 7 0.005278998 0.448714841 0.008629132 17707 hsa-mir-424 hsa04630 Jak-STAT signaling pathway 595_598_1387_2033_51588_4609_8554 7 0.012218457 1 0.019595638 17708 hsa-mir-424 hsa04670 Leukocyte transendothelial migration 5578_5747_1432_998_5600_5603 6 0.013700924 1 0.02156627 17709 hsa-mir-424 hsa04540 Gap junction 5578_5595_5594_1453_983 5 0.017022054 1 0.02630681 17710 hsa-mir-424 hsa04710 Circadian rhythm - mammal 8863_1453 2 0.021235556 1 0.03172358 17711 hsa-mir-424 hsa03030 DNA replication 5557_6117_5422 3 0.02127346 1 0.03172358 17712 hsa-mir-424 hsa03450 Non-homologous end-joining 2547_5591 2 0.024028373 1 0.035213995 17713 hsa-mir-425 hsa05200 Pathways in cancer 1869_3725_4149_7046_5468_5914_595_2261_8517_7704_3551_6502_3091_3066_3065_1050_5925_5747_1956_1487_1488_1870_1871_2885_2113_10401_5894_861_207_3716_1147_5595_5594_5599_1387_2064_6256_836_367_2932_6774_6776_6777_6772_5879_7157_2736_4088_4089_9063_2034_2033_4846_4790_4791_4792_5970_3320_3326_5371_5159_5156_5604_5601_3815_4292_7428_4087_8772_4609_1029_2353_8554 73 2.51E-48 2.01E-46 2.01E-46 17714 hsa-mir-425 hsa04010 MAPK signaling pathway 6722_3725_4149_7046_6195_6197_2261_2264_8517_3551_1845_4773_9020_8986_1956_3303_1432_2885_5894_3305_4763_1616_207_1147_5595_5594_5599_5598_1386_836_9252_3312_5971_5879_7157_6196_9344_4790_4791_5970_5159_9261_1326_5156_5604_4208_5601_5600_5608_5566_6885_4609_5606_2353_7132_2005 56 8.86E-36 7.09E-34 3.55E-34 17715 hsa-mir-425 hsa05220 Chronic myeloid leukemia 1869_7046_595_8517_3551_3066_3065_5925_1487_1488_1870_1871_2885_5894_861_207_1147_5595_5594_6776_6777_7157_4088_4089_4790_4792_5970_5604_5781_4609_1029_6464 32 3.90E-29 3.12E-27 1.04E-27 17716 hsa-mir-425 hsa05215 Prostate cancer 1869_595_8517_3551_90993_5925_1956_1870_1871_2885_5894_207_1147_5595_5594_1387_2064_367_2932_7157_2033_4790_4792_5970_3320_3326_5159_5156_5604 29 6.24E-24 4.99E-22 1.25E-22 17717 hsa-mir-425 hsa05212 Pancreatic cancer 1869_595_8517_3551_90993_5925_1956_1870_1871_2885_5894_207_1147_5595_5594_1387_2064_367_2932_7157_2033_4790_4792_5970_3320_3326_5159_5156_5604 29 8.12E-24 6.50E-22 1.30E-22 17718 hsa-mir-425 hsa04620 Toll-like receptor signaling pathway 3725_8517_3551_3455_3661_1432_207_1147_29110_5595_5594_5599_6772_5879_4790_4792_5970_1326_5604_5601_5600_5608_9641_8772_6885_5606_2353 27 2.74E-20 2.19E-18 3.66E-19 17719 hsa-mir-425 hsa05221 Acute myeloid leukemia 5914_595_8517_7704_3551_1050_2885_5894_861_207_1147_5595_5594_6774_6776_6777_4790_5970_5371_5604_3815_4609 22 2.04E-19 1.63E-17 2.33E-18 17720 hsa-mir-425 hsa04310 Wnt signaling pathway 3725_818_817_595_8607_6500_4773_23291_1487_1488_8945_5599_1387_2932_5879_7157_8061_1457_1459_4088_4089_2033_5519_5515_5601_5566_8454_4087_6885_4609 30 2.86E-19 2.29E-17 2.86E-18 17721 hsa-mir-425 hsa05210 Colorectal cancer 3725_7046_595_1956_2885_5894_207_5595_5594_5599_836_2932_5879_7157_4088_4089_5159_5156_5604_5601_4292_4087_4609_2353 24 7.90E-19 6.32E-17 7.03E-18 17722 hsa-mir-425 hsa05214 Glioma 1869_818_817_595_5925_1956_1870_1871_2885_5894_207_5595_5594_7157_808_801_805_5159_5156_5604_1029_6464 22 1.12E-18 8.95E-17 8.95E-18 17723 hsa-mir-425 hsa04660 T cell receptor signaling pathway 3725_8517_3551_4773_9020_2534_3932_1432_4794_2885_5894_207_1147_5595_5594_2932_4790_4792_4793_5970_1326_5604_5601_5600_6885_2353 26 1.53E-18 1.22E-16 1.11E-17 17724 hsa-mir-425 hsa04110 Cell cycle 1869_595_6502_6500_4174_4172_3066_3065_5925_1870_1871_5933_990_5591_1387_2932_7157_5111_4088_4089_2033_983_8454_4087_1029_1111 26 8.14E-18 6.51E-16 5.43E-17 17725 hsa-mir-425 hsa04062 Chemokine signaling pathway 1234_8517_1230_3551_653361_7074_5747_5580_7852_2885_5894_207_3717_1147_5590_5595_5594_2932_6774_6777_6772_6773_5879_4790_4792_4793_5970_5604_5566_6464 30 9.82E-17 7.86E-15 6.05E-16 17726 hsa-mir-425 hsa05222 Small cell lung cancer 1869_4149_595_8517_3551_6502_5925_5747_1870_1871_10401_207_1147_6256_7157_9063_4846_4790_4792_5970_4609_8554 22 1.64E-16 1.31E-14 9.12E-16 17727 hsa-mir-425 hsa04662 B cell receptor signaling pathway 3725_8517_3551_4773_6850_4794_2885_5894_207_1147_695_5595_5594_2932_5879_4790_4792_4793_5970_5604_2353 21 1.71E-16 1.37E-14 9.12E-16 17728 hsa-mir-425 hsa04630 Jak-STAT signaling pathway 595_58985_3455_3459_3560_3561_1439_2885_10401_207_3717_3716_8651_1387_6778_6774_6776_6777_6772_6773_7297_9063_2033_5781_4609_8554_10379 27 2.80E-16 2.24E-14 1.40E-15 17729 hsa-mir-425 hsa04920 Adipocytokine signaling pathway 5465_8517_3551_7133_4794_8471_207_3717_1147_8717_5599_6256_6774_4790_4792_4793_5970_5601_5781_7132 20 3.19E-16 2.55E-14 1.50E-15 17730 hsa-mir-425 hsa04540 Gap junction 10382_51807_1956_6714_2885_5894_5592_5595_5594_5598_7846_347733_5159_983_5156_5604_5566_7277_7278_203068_10376 21 6.79E-15 5.43E-13 3.02E-14 17731 hsa-mir-425 hsa04912 GnRH signaling pathway 3725_818_817_5580_1956_6714_1432_2885_5894_5595_5594_5599_5598_808_801_805_5604_5601_5600_5608_5566_5606 22 9.81E-15 7.85E-13 4.13E-14 17732 hsa-mir-425 hsa05219 Bladder cancer 1869_595_2261_5925_1956_1870_1871_5894_5595_5594_2064_9252_7157_5604_4609_1029 16 1.32E-14 1.06E-12 5.29E-14 17733 hsa-mir-425 hsa04350 TGF-beta signaling pathway 7046_6500_90_57154_6667_3397_3399_3398_5933_5595_5594_1387_4088_4089_2033_5519_5515_8454_4087_4609 20 2.24E-14 1.79E-12 8.13E-14 17734 hsa-mir-425 hsa04012 ErbB signaling pathway 3725_818_817_5747_1956_6714_2885_5894_207_5595_5594_5599_2064_2932_6776_6777_5604_5601_4609_6464 20 2.24E-14 1.79E-12 8.13E-14 17735 hsa-mir-425 hsa05223 Non-small cell lung cancer 1869_595_5925_1956_1870_1871_2885_5894_207_5595_5594_2064_6256_7157_5604_1029 16 3.31E-13 2.64E-11 1.15E-12 17736 hsa-mir-425 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_8517_3551_9020_1956_6714_1432_1147_5599_836_5879_4790_4792_5970_5601_5600_5781 17 1.14E-12 9.11E-11 3.80E-12 17737 hsa-mir-425 hsa04720 Long-term potentiation 818_814_817_6195_6197_2902_5894_5595_5594_1387_6196_2033_808_801_805_5604_5566 17 2.44E-12 1.95E-10 7.80E-12 17738 hsa-mir-425 hsa04664 Fc epsilon RI signaling pathway 2534_5580_6850_1432_2885_5894_207_695_5595_5594_5599_5879_5604_5601_5600_5608_5606 17 5.01E-12 4.01E-10 1.54E-11 17739 hsa-mir-425 hsa04520 Adherens junction 7046_2534_1956_6714_71_5595_5594_1387_2064_5879_1457_1459_4088_4089_2033_4087_6885 17 5.97E-12 4.78E-10 1.77E-11 17740 hsa-mir-425 hsa04210 Apoptosis 8517_3551_9020_1439_207_1147_8717_836_7157_9131_4790_4792_5970_5566_840_8772_7132 17 2.62E-11 2.10E-09 7.49E-11 17741 hsa-mir-425 hsa05218 Melanoma 1869_595_5925_1956_1870_1871_5894_207_5595_5594_7157_5159_5156_5604_1029 15 1.13E-10 9.04E-09 3.12E-10 17742 hsa-mir-425 hsa05211 Renal cell carcinoma 3725_3091_2885_2113_5894_207_5595_5594_1387_5879_2034_2033_5604_7428_5781 15 1.34E-10 1.07E-08 3.58E-10 17743 hsa-mir-425 hsa04510 Focal adhesion 3725_595_2534_5747_3791_1956_6714_2885_5894_207_71_5595_5594_5599_2064_2932_5879_2321_5159_5156_5604_5601_6464 23 1.67E-10 1.34E-08 4.32E-10 17744 hsa-mir-425 hsa04910 Insulin signaling pathway 6720_3551_2885_5894_8471_207_8651_5590_5595_5594_5599_2932_808_801_805_5604_5601_5566_6464 19 2.75E-10 2.20E-08 6.89E-10 17745 hsa-mir-425 hsa05213 Endometrial cancer 595_1956_2885_5894_207_5595_5594_2064_2932_7157_5604_4292_4609 13 3.32E-10 2.66E-08 8.05E-10 17746 hsa-mir-425 hsa04120 Ubiquitin mediated proteolysis 55294_4734_6502_6500_57154_23291_10401_8945_51366_11059_8651_9063_7329_5371_672_8454_7428_8554 18 1.96E-09 1.57E-07 4.62E-09 17747 hsa-mir-425 hsa04370 VEGF signaling pathway 4773_5747_3791_6714_1432_5894_207_5595_5594_5879_4846_9261_5604_5600 14 2.63E-09 2.10E-07 6.00E-09 17748 hsa-mir-425 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_7133_1432_1616_836_5879_7157_4846_5600_5608_5606_7132 12 7.22E-09 5.77E-07 1.60E-08 17749 hsa-mir-425 hsa04916 Melanogenesis 818_817_90993_5894_5595_5594_1387_2932_2033_808_801_805_5604_5566_3815 15 1.19E-08 9.51E-07 2.57E-08 17750 hsa-mir-425 hsa05016 Huntington's disease 5468_292_293_90993_3066_3065_3064_498_2902_6667_1387_836_5437_7157_1213_2033_6874_6908_5441 19 2.84E-08 2.27E-06 5.97E-08 17751 hsa-mir-425 hsa05131 Shigellosis 10382_51807_2534_71_7846_347733_7277_7278_4691_203068_10376 11 6.70E-08 5.36E-06 1.34E-07 17752 hsa-mir-425 hsa05130 Pathogenic Escherichia coli infection 10382_51807_2534_71_7846_347733_7277_7278_4691_203068_10376 11 6.70E-08 5.36E-06 1.34E-07 17753 hsa-mir-425 hsa04930 Type II diabetes mellitus 3551_5580_8471_3651_8651_5590_5595_5594_5599_5601 10 9.71E-08 7.77E-06 1.89E-07 17754 hsa-mir-425 hsa04330 Notch signaling pathway 9612_3066_3065_1487_1488_1387_2033_8850_2648_4851 10 1.38E-07 1.11E-05 2.64E-07 17755 hsa-mir-425 hsa03022 Basal transcription factors 6872_2963_2962_2969_6878_6874_6908_6882_2959 9 2.20E-07 1.76E-05 4.10E-07 17756 hsa-mir-425 hsa04650 Natural killer cell mediated cytotoxicity 3455_3459_4773_2534_3932_6850_2885_5894_5595_5594_836_5879_5604_5781_6464 15 3.47E-07 2.78E-05 6.31E-07 17757 hsa-mir-425 hsa05216 Thyroid cancer 5468_595_5595_5594_6256_7157_5604_4609 8 4.64E-07 3.71E-05 8.25E-07 17758 hsa-mir-425 hsa04020 Calcium signaling pathway 818_814_817_292_293_147_1956_2902_2064_4846_808_801_805_5159_5156_5566 16 2.19E-06 0.000175471 3.81E-06 17759 hsa-mir-425 hsa04060 Cytokine-cytokine receptor interaction 7046_1234_1230_58985_3455_3459_90_3791_1956_3560_3561_7133_1439_7852_2321_5159_5156_3815_7132 19 3.14E-06 0.000250895 5.34E-06 17760 hsa-mir-425 hsa05010 Alzheimer's disease 498_2902_6622_1020_5595_5594_836_2932_4846_808_801_805_840_8772_7132 15 6.05E-06 0.000484262 1.01E-05 17761 hsa-mir-425 hsa04270 Vascular smooth muscle contraction 147_5580_5894_5592_5595_5594_808_801_805_5604_5566 11 4.68E-05 0.003742459 7.64E-05 17762 hsa-mir-425 hsa03020 RNA polymerase 25885_51082_64425_5437_84172_5441 6 5.35E-05 0.004277804 8.56E-05 17763 hsa-mir-425 hsa04810 Regulation of actin cytoskeleton 2261_2264_10788_7074_5747_1956_4628_5894_71_5595_5594_5879_5159_5156_5604 15 6.18E-05 0.00494795 9.70E-05 17764 hsa-mir-425 hsa04612 Antigen processing and presentation 3309_3303_3305_3312_3320_3326_4800_4801_4802 9 0.000128451 0.010276077 0.000197617 17765 hsa-mir-425 hsa04150 mTOR signaling pathway 6195_6197_3091_207_5595_5594_6196 7 0.000145802 0.011664158 0.000220078 17766 hsa-mir-425 hsa04730 Long-term depression 5894_5592_5595_5594_4846_5519_5515_5604 8 0.000153246 0.012259708 0.000227032 17767 hsa-mir-425 hsa04530 Tight junction 5580_6714_4628_207_71_5590_1457_1459_5519_5515 10 0.000638828 0.051106208 0.000929204 17768 hsa-mir-425 hsa04115 p53 signaling pathway 595_836_7157_983_7161_1029_1111 7 0.000703236 0.056258856 0.001004622 17769 hsa-mir-425 hsa03010 Ribosome 6155_6156_6207_9349_6141_6217_6128_6188 8 0.0014248 0.113984024 0.00199972 17770 hsa-mir-425 hsa04360 Axon guidance 4773_2534_5747_7852_1020_5595_5594_2932_5879 9 0.001744441 0.139555271 0.002406125 17771 hsa-mir-425 hsa04670 Leukocyte transendothelial migration 653361_5747_1432_7852_71_5879_5600_5781 8 0.004036849 0.322947912 0.005473693 17772 hsa-mir-425 hsa05340 Primary immunodeficiency 8517_3932_3561_695 4 0.006833899 0.546711925 0.009111865 17773 hsa-mir-425 hsa04340 Hedgehog signaling pathway 23291_8945_2932_2736_5566 5 0.007165751 0.573260049 0.009397706 17774 hsa-mir-425 hsa03030 DNA replication 5981_4174_4172_5111 4 0.007478417 0.598273336 0.00964957 17775 hsa-mir-425 hsa03430 Mismatch repair 5981_5111_4292 3 0.013705098 1 0.017403299 17776 hsa-mir-425 hsa03410 Base excision repair 3146_142_5111 3 0.040045578 1 0.050056972 17777 hsa-mir-4251 hsa05200 Pathways in cancer 4149_1499_5914_595_3815_1019_1017_8517_7704_3551_3091_3066_3065_1050_5925_7187_10342_2034_1956_1487_1488_1870_1871_2113_5894_867_207_9915_3716_1147_5595_5594_5599_1387_6256_836_367_2932_6774_6777_6772_5970_7157_6688_1869_3725_6502_2736_4088_4089_2033_4846_4790_4792_3320_3326_5371_675_5159_5156_5604_1399_1398_3265_4292_7428_4087_4609_1026_1029_8554 71 2.15E-49 1.76E-47 1.76E-47 17778 hsa-mir-4251 hsa05220 Chronic myeloid leukemia 595_1019_8517_3551_3066_3065_5925_1487_1488_1870_1871_5894_867_207_1147_5595_5594_6777_5970_7157_1869_4088_4089_4790_4792_5604_1399_1398_3265_5781_4609_1026_1029_6464 34 4.45E-33 3.65E-31 1.82E-31 17779 hsa-mir-4251 hsa05215 Prostate cancer 1499_595_1017_8517_3551_5925_1956_1870_1871_5894_207_1147_5595_5594_1387_367_2932_5970_7157_468_1869_2033_4790_4792_3320_3326_5159_5156_5604_3265_1026 31 1.47E-27 1.20E-25 3.99E-26 17780 hsa-mir-4251 hsa05212 Pancreatic cancer 1499_595_1017_8517_3551_5925_1956_1870_1871_5894_207_1147_5595_5594_1387_367_2932_5970_7157_468_1869_2033_4790_4792_3320_3326_5159_5156_5604_3265_1026 31 1.95E-27 1.59E-25 3.99E-26 17781 hsa-mir-4251 hsa04010 MAPK signaling pathway 6722_4149_8517_9252_3551_9020_8986_1956_3303_1432_22800_5894_3305_4763_207_1147_5595_5594_5599_5598_1386_836_3310_3312_1649_5971_5970_7157_468_3725_6195_6196_6197_4790_5159_9261_1326_5156_5604_4208_1399_1398_3265_4609 44 2.40E-26 1.97E-24 3.94E-25 17782 hsa-mir-4251 hsa04110 Cell cycle 595_1019_1017_6500_3066_3065_5925_1870_1871_5934_5933_990_5591_1387_2932_7027_7157_1869_6502_4088_4089_2033_890_983_8454_4087_1026_1029 28 5.32E-21 4.36E-19 7.27E-20 17783 hsa-mir-4251 hsa05214 Glioma 595_1019_5925_1956_1870_1871_5894_207_5595_5594_7157_1869_808_801_805_5159_5156_5604_3265_1026_1029_6464 22 1.27E-19 1.04E-17 1.49E-18 17784 hsa-mir-4251 hsa05221 Acute myeloid leukemia 5914_595_3815_8517_7704_3551_1050_5894_207_1147_5595_5594_6774_6777_5970_6688_4790_5371_5604_3265_4609 21 3.69E-19 3.02E-17 3.78E-18 17785 hsa-mir-4251 hsa03010 Ribosome 6156_6193_6204_6205_6207_6202_6143_6141_6217_6210_6137_6135_6191_6222_6223_6229_6124_6129_6128_6189_6130_6181_6188_6232 24 3.46E-18 2.84E-16 3.16E-17 17786 hsa-mir-4251 hsa04660 T cell receptor signaling pathway 1493_1019_8517_3551_9020_3932_1432_4794_5894_867_207_1147_5595_5594_2932_5970_3725_4790_4792_4793_1326_5604_919_3265 24 1.55E-17 1.27E-15 1.27E-16 17787 hsa-mir-4251 hsa05222 Small cell lung cancer 4149_595_1019_1017_8517_3551_5925_7187_1870_1871_207_1147_6256_5970_7157_1869_6502_4846_4790_4792_4609_8554 22 1.93E-17 1.59E-15 1.44E-16 17788 hsa-mir-4251 hsa05219 Bladder cancer 595_1019_9252_5925_1956_1870_1871_5894_5595_5594_7157_1869_5604_3265_4609_1026_1029 17 1.61E-16 1.32E-14 1.10E-15 17789 hsa-mir-4251 hsa04540 Gap junction 10382_51807_1956_6714_5894_5592_5595_5594_5598_7846_203068_347733_5159_983_5156_5604_3265_7277_7278_84617_10376 21 9.03E-16 7.41E-14 5.70E-15 17790 hsa-mir-4251 hsa05210 Colorectal cancer 1499_595_1956_5894_207_5595_5594_5599_836_2932_7157_3725_4088_4089_5159_5156_5604_4292_4087_4609 20 1.83E-15 1.50E-13 1.07E-14 17791 hsa-mir-4251 hsa04350 TGF-beta signaling pathway 6500_6667_1874_1875_5934_5933_5595_5594_1387_7027_4088_4089_2033_5519_5518_5515_8454_4087_4609_4093 20 3.27E-15 2.68E-13 1.79E-14 17792 hsa-mir-4251 hsa04310 Wnt signaling pathway 1499_595_8607_1457_6500_23291_1487_1488_5599_1387_2932_7157_3725_1459_4088_4089_2033_5519_5518_5515_8454_8945_4087_4609 24 9.39E-15 7.70E-13 4.81E-14 17793 hsa-mir-4251 hsa05218 Melanoma 595_1019_5925_1956_1870_1871_5894_207_5595_5594_7157_1869_5159_5156_5604_3265_1026_1029 18 1.87E-14 1.53E-12 9.00E-14 17794 hsa-mir-4251 hsa04012 ErbB signaling pathway 1956_6714_5894_867_207_5595_5594_5599_2066_2932_6777_3725_5604_1399_1398_3265_4609_1026_6464 19 3.60E-14 2.96E-12 1.64E-13 17795 hsa-mir-4251 hsa04662 B cell receptor signaling pathway 8517_3551_6850_4794_5894_207_1147_695_5595_5594_2932_5970_3725_4790_4792_4793_5604_3265 18 4.20E-14 3.44E-12 1.81E-13 17796 hsa-mir-4251 hsa05223 Non-small cell lung cancer 595_1019_5925_1956_1870_1871_5894_207_5595_5594_6256_7157_1869_5604_3265_1029 16 6.93E-14 5.69E-12 2.84E-13 17797 hsa-mir-4251 hsa05211 Renal cell carcinoma 3091_2034_2113_5894_207_9915_5595_5594_1387_3725_2033_5604_1399_1398_3265_7428_5781 17 2.70E-13 2.21E-11 1.05E-12 17798 hsa-mir-4251 hsa04910 Insulin signaling pathway 6720_5770_3551_5894_867_5211_207_5595_5594_5599_2932_2194_808_801_805_3643_5604_1399_1398_3265_6464 21 8.42E-13 6.90E-11 3.14E-12 17799 hsa-mir-4251 hsa04062 Chemokine signaling pathway 1234_8517_3551_7074_5894_207_3717_1147_3718_5595_5594_2932_6774_6777_6772_5970_4790_4792_4793_5604_1399_1398_3265_6464 24 1.01E-12 8.31E-11 3.61E-12 17800 hsa-mir-4251 hsa04720 Long-term potentiation 2902_5894_5595_5594_1387_468_6195_6196_6197_2033_808_801_805_5604_3265_2906 16 5.19E-12 4.25E-10 1.77E-11 17801 hsa-mir-4251 hsa04520 Adherens junction 1499_1457_5770_1956_6714_71_5595_5594_1387_1459_4088_4089_2033_3643_8826_4087 16 1.22E-11 9.97E-10 3.99E-11 17802 hsa-mir-4251 hsa04620 Toll-like receptor signaling pathway 8517_3551_7187_1432_207_1147_5595_5594_5599_6772_5970_3725_4790_4792_1326_5604_9641 17 3.57E-11 2.93E-09 1.13E-10 17803 hsa-mir-4251 hsa04630 Jak-STAT signaling pathway 595_3560_3561_2057_867_2690_207_3717_3716_3718_85480_1387_3575_6774_6777_6772_2033_5781_4609_8554 20 4.37E-11 3.58E-09 1.33E-10 17804 hsa-mir-4251 hsa05213 Endometrial cancer 1499_595_1956_5894_207_5595_5594_2932_7157_5604_3265_4292_4609 13 9.49E-11 7.79E-09 2.78E-10 17805 hsa-mir-4251 hsa04920 Adipocytokine signaling pathway 8517_3551_4794_207_3717_1147_5599_6256_6774_5970_4790_4792_4793_5781 14 1.42E-10 1.16E-08 4.01E-10 17806 hsa-mir-4251 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 8517_3551_9020_1956_6714_1432_1147_5599_836_5970_3725_4790_4792_5781 14 2.77E-10 2.27E-08 7.57E-10 17807 hsa-mir-4251 hsa03050 Proteasome 5708_5709_5705_5706_5700_5693_5719_5717_5713_5684_5687_5707 12 5.03E-10 4.13E-08 1.33E-09 17808 hsa-mir-4251 hsa05216 Thyroid cancer 1499_595_10342_5595_5594_6256_7157_5604_3265_4609 10 1.05E-09 8.58E-08 2.68E-09 17809 hsa-mir-4251 hsa05131 Shigellosis 1499_10382_51807_71_7846_203068_347733_7277_7278_84617_4691_10376 12 2.31E-09 1.89E-07 5.56E-09 17810 hsa-mir-4251 hsa05130 Pathogenic Escherichia coli infection 1499_10382_51807_71_7846_203068_347733_7277_7278_84617_4691_10376 12 2.31E-09 1.89E-07 5.56E-09 17811 hsa-mir-4251 hsa04510 Focal adhesion 1499_595_1956_6714_5894_207_71_5595_5594_5599_2932_3725_5159_5156_5604_1399_1398_3265_85366_6464 20 4.13E-09 3.39E-07 9.68E-09 17812 hsa-mir-4251 hsa04912 GnRH signaling pathway 1956_6714_1432_5894_5595_5594_5599_5598_468_3725_808_801_805_5604_3265 15 4.81E-09 3.95E-07 1.10E-08 17813 hsa-mir-4251 hsa04916 Melanogenesis 1499_3815_5894_5595_5594_1387_2932_2033_808_801_805_5604_3265 13 1.56E-07 1.28E-05 3.45E-07 17814 hsa-mir-4251 hsa04530 Tight junction 1499_1457_1019_6714_4627_22800_8573_207_71_1459_5519_5518_5515_3265 14 4.99E-07 4.10E-05 1.08E-06 17815 hsa-mir-4251 hsa05016 Huntington's disease 3066_3065_3064_2902_6667_1387_5441_836_5437_7157_1213_2033_6874_6908_4724_9519 16 7.57E-07 6.21E-05 1.59E-06 17816 hsa-mir-4251 hsa04810 Regulation of actin cytoskeleton 10788_7074_1956_4627_22800_5894_71_5595_5594_5159_5156_5604_1399_1398_3265_8826_85366 17 1.13E-06 9.24E-05 2.31E-06 17817 hsa-mir-4251 hsa04210 Apoptosis 8517_3551_9020_207_1147_836_5970_7157_9131_4790_4792 11 1.55E-06 0.00012725 3.10E-06 17818 hsa-mir-4251 hsa04730 Long-term depression 5894_5592_5595_5594_4846_5519_5518_5515_5604_3265 10 1.60E-06 0.000130993 3.12E-06 17819 hsa-mir-4251 hsa04370 VEGF signaling pathway 6714_1432_5894_207_5595_5594_4846_9261_5604_3265 10 3.10E-06 0.000253943 5.91E-06 17820 hsa-mir-4251 hsa04664 Fc epsilon RI signaling pathway 6850_1432_5894_207_695_5595_5594_5599_5604_3265 10 3.81E-06 0.000312804 7.11E-06 17821 hsa-mir-4251 hsa04330 Notch signaling pathway 9612_3066_3065_1487_1488_1387_2033_2648 8 5.11E-06 0.00041935 9.32E-06 17822 hsa-mir-4251 hsa04115 p53 signaling pathway 595_1019_1017_836_7157_983_1026_7161_1029 9 9.35E-06 0.000766385 1.67E-05 17823 hsa-mir-4251 hsa04612 Antigen processing and presentation 3309_3303_3305_3310_3312_3320_3326_4800_4801_4802 10 9.99E-06 0.000819414 1.74E-05 17824 hsa-mir-4251 hsa04120 Ubiquitin mediated proteolysis 55294_6500_23291_867_7329_6502_5371_672_8454_8945_7428_8554 12 1.59E-05 0.001301178 2.71E-05 17825 hsa-mir-4251 hsa03020 RNA polymerase 25885_51082_64425_5441_5437_84172 6 3.03E-05 0.002481552 5.06E-05 17826 hsa-mir-4251 hsa04650 Natural killer cell mediated cytotoxicity 3932_6850_5894_5595_5594_836_5604_919_3265_5781_6464 11 6.99E-05 0.005729897 0.000114598 17827 hsa-mir-4251 hsa05340 Primary immunodeficiency 8517_3932_3561_3718_695_3575 6 7.67E-05 0.006287268 0.000122007 17828 hsa-mir-4251 hsa04150 mTOR signaling pathway 3091_207_5595_5594_6195_6196_6197 7 7.74E-05 0.006344381 0.000122007 17829 hsa-mir-4251 hsa03022 Basal transcription factors 2963_2962_2969_6874_6908_9519 6 0.000100915 0.008275056 0.000156133 17830 hsa-mir-4251 hsa05010 Alzheimer's disease 2902_5595_5594_836_2932_4846_808_351_801_805_2906_4724 12 0.000141177 0.011576502 0.00021438 17831 hsa-mir-4251 hsa04930 Type II diabetes mellitus 3551_3651_5595_5594_5599_3643 6 0.000264757 0.02171007 0.000394729 17832 hsa-mir-4251 hsa04270 Vascular smooth muscle contraction 5894_5592_5595_5594_808_801_805_5604_85366 9 0.000425664 0.034904442 0.000623294 17833 hsa-mir-4251 hsa04020 Calcium signaling pathway 1956_2902_2066_4846_808_801_805_5159_5156_2906_85366 11 0.000718587 0.058924161 0.001033757 17834 hsa-mir-4251 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_1432_836_7157_4846_2906 6 0.000768088 0.062983234 0.001085918 17835 hsa-mir-4251 hsa04060 Cytokine-cytokine receptor interaction 3815_1234_1956_3560_3561_2057_2690_85480_3575_5159_5156 11 0.009435784 0.773734322 0.013114141 17836 hsa-mir-4251 hsa05217 Basal cell carcinoma 1499_2932_7157_2736 4 0.020112562 1 0.027487168 17837 hsa-mir-4251 hsa04340 Hedgehog signaling pathway 23291_2932_2736_8945 4 0.022443474 1 0.030169916 17838 hsa-mir-4251 hsa03450 Non-homologous end-joining 7520_5591 2 0.031472383 1 0.041624764 17839 hsa-mir-4252 hsa05200 Pathways in cancer 8031_2033_8554_5970_5594_5599_6258_1387_6257_6256 10 3.31E-12 1.62E-10 1.62E-10 17840 hsa-mir-4252 hsa04920 Adipocytokine signaling pathway 10891_5970_5599_6258_6257_6256 6 2.13E-10 1.04E-08 5.22E-09 17841 hsa-mir-4252 hsa05216 Thyroid cancer 8031_5594_6258_6257_6256 5 3.72E-10 1.82E-08 6.07E-09 17842 hsa-mir-4252 hsa05222 Small cell lung cancer 8554_5970_6258_6257_6256 5 5.93E-08 2.91E-06 7.27E-07 17843 hsa-mir-4252 hsa05223 Non-small cell lung cancer 5594_6258_6257_6256 4 5.56E-07 2.72E-05 5.45E-06 17844 hsa-mir-4252 hsa03320 PPAR signaling pathway 6258_2168_6257_6256 4 1.49E-06 7.29E-05 1.22E-05 17845 hsa-mir-4252 hsa05215 Prostate cancer 2033_5970_5594_1387 4 3.56E-06 0.000174597 2.28E-05 17846 hsa-mir-4252 hsa05212 Pancreatic cancer 2033_5970_5594_1387 4 3.72E-06 0.000182298 2.28E-05 17847 hsa-mir-4252 hsa04110 Cell cycle 4616_10912_2033_1387 4 1.13E-05 0.000553413 6.15E-05 17848 hsa-mir-4252 hsa04010 MAPK signaling pathway 4616_10912_5970_5594_5599 5 1.46E-05 0.000717326 7.17E-05 17849 hsa-mir-4252 hsa04330 Notch signaling pathway 9612_2033_1387 3 2.50E-05 0.001227437 0.000111585 17850 hsa-mir-4252 hsa05211 Renal cell carcinoma 2033_5594_1387 3 8.46E-05 0.004147737 0.000345645 17851 hsa-mir-4252 hsa04720 Long-term potentiation 2033_5594_1387 3 9.51E-05 0.004662159 0.000358628 17852 hsa-mir-4252 hsa04520 Adherens junction 2033_5594_1387 3 0.00011447 0.005609015 0.000400644 17853 hsa-mir-4252 hsa04350 TGF-beta signaling pathway 2033_5594_1387 3 0.000145572 0.007133051 0.000475537 17854 hsa-mir-4252 hsa04620 Toll-like receptor signaling pathway 5970_5594_5599 3 0.00022961 0.011250887 0.000699658 17855 hsa-mir-4252 hsa04916 Melanogenesis 2033_5594_1387 3 0.000242739 0.01189419 0.000699658 17856 hsa-mir-4252 hsa04910 Insulin signaling pathway 10891_5594_5599 3 0.00054478 0.026694224 0.001483012 17857 hsa-mir-4252 hsa04310 Wnt signaling pathway 2033_5599_1387 3 0.000717318 0.035148589 0.001849926 17858 hsa-mir-4252 hsa04630 Jak-STAT signaling pathway 2033_8554_1387 3 0.000758306 0.037156973 0.001857849 17859 hsa-mir-4252 hsa04930 Type II diabetes mellitus 5594_5599 2 0.001302383 0.063816769 0.002918334 17860 hsa-mir-4252 hsa05016 Huntington's disease 10891_2033_1387 3 0.001310272 0.064203352 0.002918334 17861 hsa-mir-4252 hsa05221 Acute myeloid leukemia 5970_5594 2 0.002183021 0.106968027 0.004650784 17862 hsa-mir-4252 hsa04115 p53 signaling pathway 4616_10912 2 0.002943471 0.144230074 0.006009586 17863 hsa-mir-4252 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_5599 2 0.003108453 0.152314182 0.006092567 17864 hsa-mir-4252 hsa05220 Chronic myeloid leukemia 5970_5594 2 0.003451156 0.169106634 0.006263209 17865 hsa-mir-4252 hsa04662 B cell receptor signaling pathway 5970_5594 2 0.003451156 0.169106634 0.006263209 17866 hsa-mir-4252 hsa04664 Fc epsilon RI signaling pathway 5594_5599 2 0.003810719 0.186725229 0.006668758 17867 hsa-mir-4252 hsa05210 Colorectal cancer 5594_5599 2 0.004283653 0.209899019 0.007237897 17868 hsa-mir-4252 hsa04012 ErbB signaling pathway 5594_5599 2 0.004579825 0.224411431 0.007480381 17869 hsa-mir-4252 hsa04912 GnRH signaling pathway 5594_5599 2 0.006908049 0.338494385 0.010919174 17870 hsa-mir-4252 hsa04660 T cell receptor signaling pathway 5970_5594 2 0.007152607 0.350477725 0.010952429 17871 hsa-mir-4252 hsa04062 Chemokine signaling pathway 5970_5594 2 0.020530456 1 0.030484617 17872 hsa-mir-4252 hsa04510 Focal adhesion 5594_5599 2 0.023154571 1 0.033369824 17873 hsa-mir-4252 hsa05219 Bladder cancer 5594 1 0.047571124 1 0.066599573 17874 hsa-mir-4253 hsa05200 Pathways in cancer 4609_3326_5594_5914_1387_9915_2932_3265_7704_3091_5371_7157_6688_2113_3725_861_6774_4087_4088_3065_1050_5925_2034_2033_207 25 1.90E-26 1.10E-24 1.10E-24 17875 hsa-mir-4253 hsa05221 Acute myeloid leukemia 4609_5594_5914_3265_7704_5371_6688_861_6774_1050_207 11 4.51E-16 2.62E-14 1.31E-14 17876 hsa-mir-4253 hsa05211 Renal cell carcinoma 5594_1387_9915_3265_3091_2113_3725_2034_2033_207 10 1.47E-13 8.55E-12 2.85E-12 17877 hsa-mir-4253 hsa04350 TGF-beta signaling pathway 4609_5594_1387_6667_3399_3398_4087_4088_2033_4093 10 8.32E-13 4.83E-11 1.21E-11 17878 hsa-mir-4253 hsa05220 Chronic myeloid leukemia 4609_5594_3265_7157_861_4088_3065_5925_207 9 8.50E-12 4.93E-10 9.86E-11 17879 hsa-mir-4253 hsa05215 Prostate cancer 3326_5594_1387_2932_3265_7157_5925_2033_207 9 3.19E-11 1.85E-09 2.90E-10 17880 hsa-mir-4253 hsa05212 Pancreatic cancer 3326_5594_1387_2932_3265_7157_5925_2033_207 9 3.50E-11 2.03E-09 2.90E-10 17881 hsa-mir-4253 hsa05210 Colorectal cancer 4609_5594_2932_7157_3725_4087_4088_207 8 7.02E-10 4.07E-08 5.09E-09 17882 hsa-mir-4253 hsa05016 Huntington's disease 1387_2902_6908_6667_7157_23186_3065_3064_2033_9519 10 1.02E-09 5.94E-08 6.60E-09 17883 hsa-mir-4253 hsa04310 Wnt signaling pathway 4609_1387_2932_7157_3725_1457_4087_4088_2033 9 3.00E-09 1.74E-07 1.74E-08 17884 hsa-mir-4253 hsa04110 Cell cycle 1387_2932_7157_4087_4088_3065_5925_2033 8 9.21E-09 5.34E-07 4.86E-08 17885 hsa-mir-4253 hsa05213 Endometrial cancer 4609_5594_2932_3265_7157_207 6 3.60E-08 2.09E-06 1.74E-07 17886 hsa-mir-4253 hsa04720 Long-term potentiation 5594_1387_2902_2906_3265_2033 6 2.72E-07 1.58E-05 1.21E-06 17887 hsa-mir-4253 hsa04520 Adherens junction 5594_1387_1457_4087_4088_2033 6 3.89E-07 2.26E-05 1.61E-06 17888 hsa-mir-4253 hsa05219 Bladder cancer 4609_5594_3265_7157_5925 5 4.54E-07 2.64E-05 1.76E-06 17889 hsa-mir-4253 hsa04012 ErbB signaling pathway 4609_5594_2932_3265_3725_207 6 6.19E-07 3.59E-05 2.24E-06 17890 hsa-mir-4253 hsa05223 Non-small cell lung cancer 5594_3265_7157_5925_207 5 1.44E-06 8.34E-05 4.91E-06 17891 hsa-mir-4253 hsa05214 Glioma 5594_3265_7157_5925_207 5 3.38E-06 0.00019598 1.09E-05 17892 hsa-mir-4253 hsa04010 MAPK signaling pathway 4609_5594_3265_7157_22800_3725_1616_207 8 3.98E-06 0.000230679 1.17E-05 17893 hsa-mir-4253 hsa05216 Thyroid cancer 4609_5594_3265_7157 4 4.02E-06 0.000233247 1.17E-05 17894 hsa-mir-4253 hsa05218 Melanoma 5594_3265_7157_5925_207 5 5.08E-06 0.000294579 1.40E-05 17895 hsa-mir-4253 hsa04662 B cell receptor signaling pathway 5594_2932_3265_3725_207 5 6.54E-06 0.000379395 1.72E-05 17896 hsa-mir-4253 hsa04330 Notch signaling pathway 1387_9612_3065_2033 4 2.35E-05 0.001361898 5.92E-05 17897 hsa-mir-4253 hsa04916 Melanogenesis 5594_1387_2932_3265_2033 5 2.95E-05 0.001711451 7.13E-05 17898 hsa-mir-4253 hsa05010 Alzheimer's disease 22926_5594_2902_2906_2932_351 6 3.08E-05 0.001787404 7.15E-05 17899 hsa-mir-4253 hsa04660 T cell receptor signaling pathway 5594_2932_3265_3725_207 5 3.82E-05 0.002213973 8.52E-05 17900 hsa-mir-4253 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906_7157_1616 4 4.48E-05 0.002598562 9.62E-05 17901 hsa-mir-4253 hsa04530 Tight junction 3265_22800_8573_1457_207 5 0.000103991 0.006031454 0.000215409 17902 hsa-mir-4253 hsa04630 Jak-STAT signaling pathway 4609_1387_6774_2033_207 5 0.000181823 0.010545721 0.000363646 17903 hsa-mir-4253 hsa05222 Small cell lung cancer 4609_7157_5925_207 4 0.00021788 0.012637058 0.000421235 17904 hsa-mir-4253 hsa03022 Basal transcription factors 2963_6908_9519 3 0.000303012 0.017574674 0.000566925 17905 hsa-mir-4253 hsa04062 Chemokine signaling pathway 5594_2932_3265_6774_207 5 0.000484712 0.028113291 0.00087854 17906 hsa-mir-4253 hsa04510 Focal adhesion 5594_2932_3265_3725_207 5 0.00064644 0.037493538 0.001136168 17907 hsa-mir-4253 hsa04150 mTOR signaling pathway 5594_3091_207 3 0.000776664 0.045046525 0.001324898 17908 hsa-mir-4253 hsa04910 Insulin signaling pathway 5594_2932_3265_207 4 0.001216859 0.070577795 0.002016508 17909 hsa-mir-4253 hsa04370 VEGF signaling pathway 5594_3265_207 3 0.002293506 0.133023345 0.003695093 17910 hsa-mir-4253 hsa04664 Fc epsilon RI signaling pathway 5594_3265_207 3 0.002460594 0.142714427 0.003857147 17911 hsa-mir-4253 hsa04612 Antigen processing and presentation 3326_4800_4801 3 0.003408361 0.197684944 0.005202235 17912 hsa-mir-4253 hsa04620 Toll-like receptor signaling pathway 5594_3725_207 3 0.004935432 0.286255034 0.007339873 17913 hsa-mir-4253 hsa04912 GnRH signaling pathway 5594_3265_3725 3 0.005758634 0.33400079 0.00835002 17914 hsa-mir-4253 hsa04360 Axon guidance 5594_2932_3265 3 0.009647613 0.559561577 0.013647843 17915 hsa-mir-4253 hsa05217 Basal cell carcinoma 2932_7157 2 0.014909272 0.864737802 0.020588995 17916 hsa-mir-4253 hsa04920 Adipocytokine signaling pathway 6774_207 2 0.02137088 1 0.028825838 17917 hsa-mir-4253 hsa04730 Long-term depression 5594_3265 2 0.023740186 1 0.031293882 17918 hsa-mir-4253 hsa04512 ECM-receptor interaction 6383_9672 2 0.032133355 1 0.041416324 17919 hsa-mir-4253 hsa04210 Apoptosis 7157_207 2 0.035628577 1 0.044568572 17920 hsa-mir-4253 hsa04810 Regulation of actin cytoskeleton 5594_3265_22800 3 0.036115911 1 0.044568572 17921 hsa-mir-4253 hsa04540 Gap junction 5594_3265 2 0.038525738 1 0.046551934 17922 hsa-mir-4254 hsa05200 Pathways in cancer 4149_3551_1499_5914_596_598_1017_8517_4193_5578_3091_2736_2249_7175_3065_5925_1050_613_5743_5747_25_1487_6789_4436_1870_1871_2113_6502_207_5894_1147_998_367_5595_5594_5599_6258_1387_6256_2932_6774_6777_5970_7157_6688_6257_1869_3725_6776_4087_4088_4089_5888_5728_2033_3910_4791_4792_3320_3326_5371_675_5604_5601_5602_1856_4292_51588_8031_1026_1029_2353_1488_8554 74 2.26E-44 2.01E-42 2.01E-42 17923 hsa-mir-4254 hsa04110 Cell cycle 1017_4193_902_6500_3065_4616_5925_25_891_1870_1871_9232_6502_5934_5933_545_995_990_5347_5591_1387_11200_7534_7532_2932_7027_7157_10912_1869_4087_4088_4089_2033_890_1031_983_8454_1026_1022_1029_1111_8556_8555_472 44 1.79E-34 1.59E-32 7.97E-33 17924 hsa-mir-4254 hsa04010 MAPK signaling pathway 6722_4149_3551_6197_8517_9252_5578_2249_4616_5923_3304_3305_3303_6789_1432_1616_207_5894_9479_1147_998_5595_5594_5599_5598_1386_3310_3312_3315_5971_5970_3164_6195_7157_10912_3725_6196_4791_9261_1326_5604_5601_5602_8986_5566_2353 46 2.08E-23 1.85E-21 6.16E-22 17925 hsa-mir-4254 hsa05220 Chronic myeloid leukemia 3551_598_8517_4193_3065_5925_613_25_1487_1870_1871_207_5894_1147_5595_5594_6777_5970_7157_1869_6776_4088_4089_4792_5604_1026_1029_1488 28 1.75E-22 1.56E-20 3.90E-21 17926 hsa-mir-4254 hsa05215 Prostate cancer 3551_1499_596_1017_8517_4193_5925_1870_1871_207_5894_1147_367_5595_5594_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_5604_1026 27 6.66E-20 5.93E-18 1.19E-18 17927 hsa-mir-4254 hsa05212 Pancreatic cancer 3551_1499_596_1017_8517_4193_5925_1870_1871_207_5894_1147_367_5595_5594_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_5604_1026 27 8.50E-20 7.57E-18 1.26E-18 17928 hsa-mir-4254 hsa04310 Wnt signaling pathway 1499_8607_5578_6500_8945_23291_1487_1460_5599_1387_1459_2932_7157_8061_3725_1457_1452_4087_4088_4089_2033_5518_5515_5601_5602_5566_1856_8454_6423_1488_5527 31 3.05E-18 2.71E-16 3.88E-17 17929 hsa-mir-4254 hsa05222 Small cell lung cancer 4149_3551_596_598_1017_8517_5925_5743_5747_1870_1871_6502_207_1147_6258_6256_5970_7157_6257_1869_5728_3910_4792_51588_8554 25 4.63E-18 4.12E-16 5.16E-17 17930 hsa-mir-4254 hsa04115 p53 signaling pathway 1017_4194_4193_900_4616_50484_6241_891_545_11200_7157_10912_64326_5728_27113_51246_25898_983_1026_7161_1029_1111_472 23 8.18E-18 7.28E-16 8.09E-17 17931 hsa-mir-4254 hsa05210 Colorectal cancer 1499_596_4436_207_5894_5595_5594_5599_2932_7157_3725_4087_4088_4089_5604_5601_5602_1856_4292_2353 20 2.48E-13 2.20E-11 2.20E-12 17932 hsa-mir-4254 hsa05214 Glioma 4193_5578_5925_1870_1871_207_5894_5595_5594_7157_1869_5728_808_801_805_5604_1026_1029 18 4.40E-13 3.91E-11 3.56E-12 17933 hsa-mir-4254 hsa04920 Adipocytokine signaling pathway 5563_3551_10891_6794_8517_207_1147_5599_6258_6256_6774_5970_6257_4794_4792_4793_5601_5602 18 6.81E-13 6.06E-11 5.05E-12 17934 hsa-mir-4254 hsa04120 Ubiquitin mediated proteolysis 4193_6500_3093_8945_23291_7319_84447_10273_7325_7323_7329_6502_10055_64326_7337_55294_5371_672_25898_8454_51588_10075_8554 23 3.22E-12 2.86E-10 2.20E-11 17935 hsa-mir-4254 hsa05223 Non-small cell lung cancer 5578_5925_6789_1870_1871_207_5894_5595_5594_6258_6256_7157_6257_1869_5604_1029 16 3.72E-12 3.31E-10 2.36E-11 17936 hsa-mir-4254 hsa05131 Shigellosis 7846_1499_5578_10382_7277_51807_25_998_7534_203068_4691_347733_7278_71_84617_10376 16 5.91E-12 5.26E-10 3.29E-11 17937 hsa-mir-4254 hsa05130 Pathogenic Escherichia coli infection 7846_1499_5578_10382_7277_51807_25_998_7534_203068_4691_347733_7278_71_84617_10376 16 5.91E-12 5.26E-10 3.29E-11 17938 hsa-mir-4254 hsa04540 Gap junction 7846_5578_10382_7277_51807_5894_5592_5595_5594_5598_1453_203068_347733_983_5604_5566_7278_84617_10376 19 1.01E-11 9.00E-10 5.29E-11 17939 hsa-mir-4254 hsa05221 Acute myeloid leukemia 3551_5914_8517_1050_207_5894_1147_5595_5594_6774_6777_5970_6688_6776_5371_5604 16 1.15E-11 1.03E-09 5.70E-11 17940 hsa-mir-4254 hsa04660 T cell receptor signaling pathway 3551_8517_1432_207_5894_1147_998_5595_5594_2932_5970_3725_4794_4792_4793_1326_5604_5601_2353_959 20 1.86E-11 1.66E-09 8.73E-11 17941 hsa-mir-4254 hsa04350 TGF-beta signaling pathway 6500_3398_1875_6667_1874_5934_5933_5595_5594_1387_7027_4087_4088_4089_2033_5518_5515_8454 18 2.95E-11 2.63E-09 1.31E-10 17942 hsa-mir-4254 hsa04662 B cell receptor signaling pathway 3551_8517_207_5894_1147_5595_5594_1380_2932_5970_3725_4794_4792_4793_5604_2353 16 2.50E-10 2.23E-08 1.02E-09 17943 hsa-mir-4254 hsa05219 Bladder cancer 9252_4193_5925_1870_1871_5894_5595_5594_7157_1869_5604_1026_1029 13 2.51E-10 2.23E-08 1.02E-09 17944 hsa-mir-4254 hsa05218 Melanoma 4193_2249_5925_1870_1871_207_5894_5595_5594_7157_1869_5728_5604_1026_1029 15 1.02E-09 9.09E-08 3.95E-09 17945 hsa-mir-4254 hsa04012 ErbB signaling pathway 5578_5747_25_207_5894_5595_5594_5599_2932_6777_3725_6776_5604_5601_5602_1026 16 1.67E-09 1.49E-07 6.20E-09 17946 hsa-mir-4254 hsa04720 Long-term potentiation 6197_5578_5499_5894_5595_5594_1387_6195_6196_2033_808_801_805_5604_5566 15 1.97E-09 1.76E-07 7.02E-09 17947 hsa-mir-4254 hsa04620 Toll-like receptor signaling pathway 3551_8517_1432_207_1147_5595_5594_5599_5970_3725_4792_1326_5604_5601_5602_2353 16 1.26E-08 1.12E-06 4.22E-08 17948 hsa-mir-4254 hsa05216 Thyroid cancer 1499_7175_5595_5594_6258_6256_7157_6257_5604_8031 10 1.28E-08 1.14E-06 4.22E-08 17949 hsa-mir-4254 hsa04912 GnRH signaling pathway 5578_1432_5894_998_5595_5594_5599_5598_3725_808_801_805_5604_5601_5602_5566 16 2.59E-08 2.31E-06 8.25E-08 17950 hsa-mir-4254 hsa04510 Focal adhesion 1499_596_5578_5923_5747_5499_10627_207_5894_998_5595_5594_5599_2932_3725_5728_3910_5604_5601_5602_71 21 7.18E-08 6.39E-06 2.20E-07 17951 hsa-mir-4254 hsa04910 Insulin signaling pathway 5563_3551_10891_5499_207_5894_5595_5594_5599_2932_808_801_805_5604_5601_5602_5566 17 1.09E-07 9.74E-06 3.25E-07 17952 hsa-mir-4254 hsa04062 Chemokine signaling pathway 3551_8517_653361_7074_5747_6362_207_5894_1147_998_5595_5594_2932_6774_6777_5970_4792_4793_5604_5566 20 1.15E-07 1.02E-05 3.30E-07 17953 hsa-mir-4254 hsa04520 Adherens junction 1499_1460_998_5595_5594_1387_1459_1457_4087_4088_4089_2033_71 13 2.03E-07 1.80E-05 5.63E-07 17954 hsa-mir-4254 hsa04916 Melanogenesis 1499_5578_5894_5595_5594_1387_2932_2033_808_801_805_5604_5566_1856 14 5.48E-07 4.88E-05 1.48E-06 17955 hsa-mir-4254 hsa04330 Notch signaling pathway 3065_1487_1387_9612_2033_8850_1856_1488_2648_4851 10 6.00E-07 5.34E-05 1.54E-06 17956 hsa-mir-4254 hsa04210 Apoptosis 3551_596_598_8517_8837_823_207_1147_5970_7157_4792_5566_472 13 6.05E-07 5.38E-05 1.54E-06 17957 hsa-mir-4254 hsa03022 Basal transcription factors 51616_2965_2963_2962_2969_6908_2958_6880_2957 9 8.39E-07 7.47E-05 2.08E-06 17958 hsa-mir-4254 hsa04370 VEGF signaling pathway 5578_5743_5747_1432_207_5894_998_5595_5594_3315_9261_5604 12 8.85E-07 7.88E-05 2.13E-06 17959 hsa-mir-4254 hsa05213 Endometrial cancer 1499_207_5894_5595_5594_2932_7157_5728_5604_4292 10 1.35E-06 0.000120062 3.16E-06 17960 hsa-mir-4254 hsa04530 Tight junction 1499_5578_4627_4628_10627_207_1460_998_1459_1457_5728_5518_5515_71_5520 15 2.33E-06 0.000207778 5.33E-06 17961 hsa-mir-4254 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3551_8517_1432_1147_998_5599_5970_3725_4792_5601_5602 11 2.65E-06 0.000236001 5.90E-06 17962 hsa-mir-4254 hsa05211 Renal cell carcinoma 3091_2113_207_5894_998_5595_5594_1387_3725_2033_5604 11 2.99E-06 0.000266495 6.50E-06 17963 hsa-mir-4254 hsa04150 mTOR signaling pathway 5563_6794_6197_3091_207_5595_5594_6195_6196 9 9.74E-06 0.000866606 2.06E-05 17964 hsa-mir-4254 hsa04612 Antigen processing and presentation 3309_3304_3305_3303_3310_3312_3320_3326_4800_4801_4802 11 1.85E-05 0.001646692 3.83E-05 17965 hsa-mir-4254 hsa05016 Huntington's disease 10891_292_293_3065_3064_25942_6667_5441_1387_5437_7157_1213_1537_2033_27113_6908 16 2.08E-05 0.001850348 4.21E-05 17966 hsa-mir-4254 hsa04664 Fc epsilon RI signaling pathway 5578_1432_207_5894_5595_5594_5599_5604_5601_5602 10 3.67E-05 0.003265684 7.26E-05 17967 hsa-mir-4254 hsa04270 Vascular smooth muscle contraction 5578_5499_5894_5592_5595_5594_4637_808_801_805_5604_5566 12 4.59E-05 0.00408602 8.88E-05 17968 hsa-mir-4254 hsa03020 RNA polymerase 25885_64425_51082_5441_5437_84172 6 0.000128974 0.011478728 0.000244228 17969 hsa-mir-4254 hsa03420 Nucleotide excision repair 902_6117_4331_2965_2071_2074_1022 7 0.000153198 0.013634614 0.000284054 17970 hsa-mir-4254 hsa04930 Type II diabetes mellitus 3551_3651_5595_5594_5599_5601_5602 7 0.000173571 0.015447777 0.000315261 17971 hsa-mir-4254 hsa04730 Long-term depression 5578_5894_5592_5595_5594_5518_5515_5604 8 0.000449053 0.039965685 0.000799314 17972 hsa-mir-4254 hsa04630 Jak-STAT signaling pathway 3559_598_3977_207_1387_6778_6774_6777_6776_2033_51588_8554 12 0.000486952 0.043338702 0.000849778 17973 hsa-mir-4254 hsa04340 Hedgehog signaling pathway 2736_8945_23291_2932_1452_1453_5566 7 0.000636417 0.056641082 0.001089252 17974 hsa-mir-4254 hsa04810 Regulation of actin cytoskeleton 2249_7074_5747_5499_4627_4628_10627_5894_998_5595_5594_5604_10788_71 14 0.001023908 0.091127835 0.001719393 17975 hsa-mir-4254 hsa03440 Homologous recombination 641_6117_5888_675 4 0.005861182 0.521645196 0.009660096 17976 hsa-mir-4254 hsa04670 Leukocyte transendothelial migration 1499_5578_653361_5747_1432_10627_998_71 8 0.010204474 0.908198212 0.016512695 17977 hsa-mir-4254 hsa05217 Basal cell carcinoma 1499_2736_2932_7157_1856 5 0.011962522 1 0.019011866 17978 hsa-mir-4254 hsa03010 Ribosome 6156_6207_6202_6222_6128_6125_6231 7 0.012714541 1 0.01947295 17979 hsa-mir-4254 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_1432_1616_7157 5 0.012791991 1 0.01947295 17980 hsa-mir-4254 hsa03410 Base excision repair 3146_142_4913_328 4 0.012909034 1 0.01947295 17981 hsa-mir-4254 hsa03430 Mismatch repair 4436_6117_4292 3 0.020933356 1 0.031051144 17982 hsa-mir-4254 hsa04950 Maturity onset diabetes of the young 3651_6927_3172 3 0.023158799 1 0.033789067 17983 hsa-mir-4254 hsa04070 Phosphatidylinositol signaling system 5578_5728_808_801_805 5 0.038171561 1 0.05479466 17984 hsa-mir-4254 hsa04360 Axon guidance 5747_25_998_5595_5594_2932_1020 7 0.039679751 1 0.056055522 17985 hsa-mir-4254 hsa05010 Alzheimer's disease 823_5595_5594_2932_1537_808_801_805_1020 9 0.041208106 1 0.057305023 17986 hsa-mir-4256 hsa05200 Pathways in cancer 6688_2113 2 0.010285271 0.030855812 0.030855812 17987 hsa-mir-4256 hsa05221 Acute myeloid leukemia 6688 1 0.027632078 0.082896234 0.033524807 17988 hsa-mir-4256 hsa05211 Renal cell carcinoma 2113 1 0.033524807 0.10057442 0.033524807 17989 hsa-mir-4257 hsa05200 Pathways in cancer 5970_6772_2033_4790 4 5.26E-07 1.26E-05 7.74E-06 17990 hsa-mir-4257 hsa05215 Prostate cancer 5970_2033_4790 3 9.36E-07 2.25E-05 7.74E-06 17991 hsa-mir-4257 hsa05212 Pancreatic cancer 5970_2033_4790 3 9.67E-07 2.32E-05 7.74E-06 17992 hsa-mir-4257 hsa04620 Toll-like receptor signaling pathway 5970_6772_4790 3 1.44E-06 3.46E-05 8.65E-06 17993 hsa-mir-4257 hsa04062 Chemokine signaling pathway 5970_6772_4790 3 9.42E-06 0.000226126 4.52E-05 17994 hsa-mir-4257 hsa04330 Notch signaling pathway 2033_8850 2 5.46E-05 0.001309691 0.000218282 17995 hsa-mir-4257 hsa05221 Acute myeloid leukemia 5970_4790 2 8.48E-05 0.002035323 0.00029076 17996 hsa-mir-4257 hsa04920 Adipocytokine signaling pathway 5970_4790 2 0.000108621 0.002606897 0.000295319 17997 hsa-mir-4257 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_4790 2 0.000121623 0.00291896 0.000295319 17998 hsa-mir-4257 hsa05220 Chronic myeloid leukemia 5970_4790 2 0.000135355 0.003248508 0.000295319 17999 hsa-mir-4257 hsa04662 B cell receptor signaling pathway 5970_4790 2 0.000135355 0.003248508 0.000295319 18000 hsa-mir-4257 hsa05222 Small cell lung cancer 5970_4790 2 0.000176864 0.004244733 0.000349176 18001 hsa-mir-4257 hsa04210 Apoptosis 5970_4790 2 0.000189137 0.004539285 0.000349176 18002 hsa-mir-4257 hsa04660 T cell receptor signaling pathway 5970_4790 2 0.00028643 0.006874327 0.000491023 18003 hsa-mir-4257 hsa04630 Jak-STAT signaling pathway 6772_2033 2 0.000561472 0.013475319 0.000898355 18004 hsa-mir-4257 hsa04010 MAPK signaling pathway 5970_4790 2 0.001704826 0.040915813 0.002557238 18005 hsa-mir-4257 hsa05211 Renal cell carcinoma 2033 1 0.016907255 0.405774127 0.023462399 18006 hsa-mir-4257 hsa04720 Long-term potentiation 2033 1 0.017596799 0.422323182 0.023462399 18007 hsa-mir-4257 hsa04520 Adherens junction 2033 1 0.018745118 0.449882832 0.023678044 18008 hsa-mir-4257 hsa04350 TGF-beta signaling pathway 2033 1 0.020350831 0.488419951 0.024420998 18009 hsa-mir-4257 hsa04916 Melanogenesis 2033 1 0.024241047 0.581785134 0.027704054 18010 hsa-mir-4257 hsa04110 Cell cycle 2033 1 0.027662587 0.663902089 0.030177368 18011 hsa-mir-4257 hsa04310 Wnt signaling pathway 2033 1 0.035153794 0.84369105 0.03668222 18012 hsa-mir-4257 hsa05016 Huntington's disease 2033 1 0.043269546 1 0.043269546 18013 hsa-mir-4258 hsa05200 Pathways in cancer 7046_1499_5914_595_2261_8517_7704_3091_7175_3066_3065_5925_5747_2034_1956_1870_1871_2885_2113_207_3716_1147_3551_5595_5594_5599_1387_2064_6256_836_367_2932_6774_6776_6777_5879_7157_6688_1869_3725_4088_4089_9063_2033_4846_898_4790_4791_4792_5970_3320_3326_5371_5159_5156_5604_5601_3815_7428_4087_8772_4609_2353_8554 64 9.06E-48 7.25E-46 7.25E-46 18014 hsa-mir-4258 hsa04010 MAPK signaling pathway 6722_7046_2261_2264_8517_1845_9020_1956_7132_3303_1432_2885_4763_207_1147_3551_5595_5594_5599_836_9252_3310_3312_5971_5879_7157_3725_9344_4790_4791_5970_5159_1326_5156_5604_4208_5606_5601_5600_5566_4609_2353_3305_2005 44 4.56E-30 3.65E-28 1.82E-28 18015 hsa-mir-4258 hsa05215 Prostate cancer 1499_595_8517_5925_1956_1870_1871_2885_207_1147_3551_5595_5594_1387_2064_367_2932_7157_1869_2033_898_4790_4792_5970_3320_3326_5159_5156_5604 29 1.01E-27 8.09E-26 2.65E-26 18016 hsa-mir-4258 hsa05212 Pancreatic cancer 1499_595_8517_5925_1956_1870_1871_2885_207_1147_3551_5595_5594_1387_2064_367_2932_7157_1869_2033_898_4790_4792_5970_3320_3326_5159_5156_5604 29 1.32E-27 1.06E-25 2.65E-26 18017 hsa-mir-4258 hsa05220 Chronic myeloid leukemia 7046_595_8517_3066_3065_5925_1870_1871_2885_207_1147_3551_5595_5594_6776_6777_7157_1869_4088_4089_4790_4792_5970_5604_5781_4609_6464 27 9.74E-27 7.79E-25 1.56E-25 18018 hsa-mir-4258 hsa05210 Colorectal cancer 7046_1499_595_1956_2885_207_5595_5594_5599_836_2932_5879_7157_3725_4088_4089_5159_5156_5604_5601_4087_4609_2353 23 1.04E-20 8.28E-19 1.38E-19 18019 hsa-mir-4258 hsa05221 Acute myeloid leukemia 5914_595_8517_7704_2885_207_1147_3551_5595_5594_6774_6776_6777_6688_4790_5970_5371_5604_3815_4609 20 1.05E-19 8.38E-18 1.20E-18 18020 hsa-mir-4258 hsa05214 Glioma 818_817_595_5925_1956_1870_1871_2885_207_5595_5594_7157_1869_808_801_805_5159_5156_5604_6464 20 5.13E-19 4.10E-17 5.13E-18 18021 hsa-mir-4258 hsa04660 T cell receptor signaling pathway 8517_9020_2534_3932_1432_2885_207_1147_3551_5595_5594_2932_3725_4794_4790_4792_4793_5970_1326_5604_5601_5600_2353 23 1.86E-18 1.49E-16 1.66E-17 18022 hsa-mir-4258 hsa04620 Toll-like receptor signaling pathway 8517_3455_1432_207_1147_3551_5595_5594_5599_5879_3725_4790_4792_5970_1326_5604_5606_5601_5600_9641_8772_2353 22 5.85E-18 4.68E-16 4.68E-17 18023 hsa-mir-4258 hsa04630 Jak-STAT signaling pathway 3559_595_3455_3459_1439_3560_3561_2885_207_3717_3716_1387_6778_6774_6776_6777_6773_7297_9063_2033_58985_5781_4609_8554_10379 25 1.42E-17 1.14E-15 1.03E-16 18024 hsa-mir-4258 hsa05222 Small cell lung cancer 595_8517_5925_5747_1870_1871_207_1147_3551_6256_7157_1869_9063_4846_898_4790_4792_5970_4609_8554 20 5.39E-17 4.31E-15 3.59E-16 18025 hsa-mir-4258 hsa04110 Cell cycle 595_6500_4174_4172_3066_3065_5925_1870_1871_5933_5591_1387_2932_7157_1869_4088_4089_2033_891_898_8454_4087 22 1.02E-16 8.14E-15 6.26E-16 18026 hsa-mir-4258 hsa04062 Chemokine signaling pathway 8517_1230_653361_5747_5580_7852_2885_207_3717_1147_3551_5595_5594_1234_2932_6774_6777_6773_5879_4790_4792_4793_5970_5604_5566_6464 26 1.63E-16 1.30E-14 9.29E-16 18027 hsa-mir-4258 hsa04920 Adipocytokine signaling pathway 8517_7133_7132_207_3717_1147_8717_3551_5599_6256_6774_4794_4790_4792_4793_5970_5601_5781 18 2.28E-16 1.82E-14 1.22E-15 18028 hsa-mir-4258 hsa04012 ErbB signaling pathway 818_817_5747_1956_6714_2885_207_5595_5594_5599_2064_2932_6776_6777_3725_5604_5601_4609_6464 19 8.93E-16 7.14E-14 4.46E-15 18029 hsa-mir-4258 hsa04310 Wnt signaling pathway 818_817_1499_595_8607_6500_8945_23291_5599_1387_2932_5879_7157_3725_1457_4088_4089_2033_5601_5566_8454_4087_4609 23 9.84E-16 7.87E-14 4.63E-15 18030 hsa-mir-4258 hsa04662 B cell receptor signaling pathway 8517_6850_2885_207_1147_3551_5595_5594_2932_5879_3725_4794_4790_4792_4793_5970_5604_2353 18 1.24E-15 9.91E-14 5.51E-15 18031 hsa-mir-4258 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 8517_9020_1956_6714_1432_1147_3551_5599_836_5879_3725_4790_4792_5970_5601_5600_5781 17 7.99E-15 6.39E-13 3.36E-14 18032 hsa-mir-4258 hsa04350 TGF-beta signaling pathway 7046_6500_90_57154_6667_3397_3399_3398_5933_5595_5594_1387_4088_4089_2033_8454_4087_4609 18 1.17E-14 9.32E-13 4.66E-14 18033 hsa-mir-4258 hsa04912 GnRH signaling pathway 818_817_5580_1956_6714_1432_2885_5595_5594_5599_3725_808_801_805_5604_5606_5601_5600_5566 19 2.83E-14 2.27E-12 1.08E-13 18034 hsa-mir-4258 hsa05219 Bladder cancer 595_2261_5925_1956_1870_1871_5595_5594_2064_9252_7157_1869_5604_4609 14 4.18E-14 3.35E-12 1.52E-13 18035 hsa-mir-4258 hsa04510 Focal adhesion 1499_595_2534_5747_3791_1956_6714_2885_10627_207_71_5595_5594_5599_2064_2932_5879_3725_2321_5159_5156_5604_5601_6464 24 4.44E-14 3.55E-12 1.54E-13 18036 hsa-mir-4258 hsa04520 Adherens junction 7046_1499_2534_1956_6714_71_5595_5594_1387_2064_5879_1457_4088_4089_2033_4087 16 5.56E-13 4.45E-11 1.85E-12 18037 hsa-mir-4258 hsa05223 Non-small cell lung cancer 595_5925_1956_1870_1871_2885_207_5595_5594_2064_6256_7157_1869_5604 14 7.59E-13 6.07E-11 2.43E-12 18038 hsa-mir-4258 hsa04210 Apoptosis 8517_9020_8837_1439_7132_207_1147_8717_3551_836_7157_4790_4792_5970_5566_8772 16 2.34E-12 1.87E-10 7.19E-12 18039 hsa-mir-4258 hsa05211 Renal cell carcinoma 3091_2034_2885_2113_207_5595_5594_1387_5879_3725_2033_5604_7428_5781 14 2.21E-11 1.77E-09 6.56E-11 18040 hsa-mir-4258 hsa04664 Fc epsilon RI signaling pathway 2534_5580_6850_1432_2885_207_5595_5594_5599_5879_5604_5606_5601_5600 14 6.60E-11 5.28E-09 1.89E-10 18041 hsa-mir-4258 hsa05213 Endometrial cancer 1499_595_1956_2885_207_5595_5594_2064_2932_7157_5604_4609 12 1.08E-10 8.62E-09 2.97E-10 18042 hsa-mir-4258 hsa05218 Melanoma 595_5925_1956_1870_1871_207_5595_5594_7157_1869_5159_5156_5604 13 2.23E-10 1.78E-08 5.95E-10 18043 hsa-mir-4258 hsa04540 Gap junction 10382_1956_6714_2885_5595_5594_203068_347733_5159_5156_5604_5566_7278_84617 14 4.51E-10 3.61E-08 1.16E-09 18044 hsa-mir-4258 hsa04120 Ubiquitin mediated proteolysis 55294_6500_3093_8945_57154_23291_10273_7325_7323_9063_7329_5371_672_8454_7428_8554 16 9.26E-10 7.40E-08 2.31E-09 18045 hsa-mir-4258 hsa04060 Cytokine-cytokine receptor interaction 3559_7046_1230_3455_3459_90_1439_3791_1956_7852_3560_3561_7133_7132_8600_1234_2321_5159_5156_3815_58985 21 1.06E-09 8.48E-08 2.57E-09 18046 hsa-mir-4258 hsa04916 Melanogenesis 818_817_1499_5595_5594_1387_2932_2033_808_801_805_5604_5566_3815 14 1.68E-09 1.34E-07 3.95E-09 18047 hsa-mir-4258 hsa05216 Thyroid cancer 1499_595_7175_5595_5594_6256_7157_5604_4609 9 2.64E-09 2.11E-07 6.04E-09 18048 hsa-mir-4258 hsa04720 Long-term potentiation 818_817_2902_5595_5594_1387_2033_808_801_805_5604_5566 12 4.32E-09 3.46E-07 9.61E-09 18049 hsa-mir-4258 hsa04910 Insulin signaling pathway 6720_2885_207_3551_5595_5594_5599_2932_808_801_805_5604_5601_5566_6464 15 6.34E-09 5.07E-07 1.37E-08 18050 hsa-mir-4258 hsa05016 Huntington's disease 292_293_1537_3066_3065_3064_2902_6667_5441_1387_836_5437_7157_1213_2033_6874_6908 17 8.00E-09 6.40E-07 1.68E-08 18051 hsa-mir-4258 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_7133_7132_1432_836_5879_7157_4846_5606_5600 10 3.39E-08 2.71E-06 6.95E-08 18052 hsa-mir-4258 hsa04370 VEGF signaling pathway 5747_3791_6714_1432_207_5595_5594_5879_4846_5604_5600 11 5.47E-08 4.38E-06 1.09E-07 18053 hsa-mir-4258 hsa04020 Calcium signaling pathway 818_817_292_293_147_1956_2902_2064_4846_808_801_805_5159_5156_5566 15 2.13E-07 1.70E-05 4.15E-07 18054 hsa-mir-4258 hsa04650 Natural killer cell mediated cytotoxicity 3455_3459_2534_3932_6850_2885_5595_5594_836_5879_5604_5781_6464 13 3.00E-07 2.40E-05 5.71E-07 18055 hsa-mir-4258 hsa05010 Alzheimer's disease 1537_2902_7132_6622_22926_5595_5594_836_2932_4846_808_801_805_8772 14 7.56E-07 6.05E-05 1.41E-06 18056 hsa-mir-4258 hsa04612 Antigen processing and presentation 3309_3303_3310_3312_3320_3326_4800_4801_4802_3305 10 1.64E-06 0.000131466 2.96E-06 18057 hsa-mir-4258 hsa04810 Regulation of actin cytoskeleton 2261_2264_10788_5747_1956_4627_4628_10627_71_5595_5594_5879_5159_5156_5604 15 1.67E-06 0.000133235 2.96E-06 18058 hsa-mir-4258 hsa05131 Shigellosis 1499_10382_2534_71_203068_347733_7278_84617 8 3.65E-06 0.000292013 6.21E-06 18059 hsa-mir-4258 hsa05130 Pathogenic Escherichia coli infection 1499_10382_2534_71_203068_347733_7278_84617 8 3.65E-06 0.000292013 6.21E-06 18060 hsa-mir-4258 hsa03020 RNA polymerase 64425_25885_51082_5441_5437_84172 6 9.53E-06 0.000762568 1.59E-05 18061 hsa-mir-4258 hsa04270 Vascular smooth muscle contraction 147_5580_5595_5594_4637_808_801_805_5604_5566 10 1.66E-05 0.001324791 2.70E-05 18062 hsa-mir-4258 hsa04670 Leukocyte transendothelial migration 1499_653361_5747_7852_1432_10627_71_5879_5600_5781 10 2.17E-05 0.001732376 3.46E-05 18063 hsa-mir-4258 hsa04930 Type II diabetes mellitus 5580_3551_5595_5594_5599_5601 6 8.72E-05 0.006973991 0.000136745 18064 hsa-mir-4258 hsa04330 Notch signaling pathway 9612_3066_3065_1387_2033_4851 6 0.000108479 0.008678345 0.000166891 18065 hsa-mir-4258 hsa04530 Tight junction 1499_5580_6714_4627_4628_10627_207_71_1457 9 0.000268559 0.021484729 0.000405372 18066 hsa-mir-4258 hsa03022 Basal transcription factors 2969_6874_6908_2959 4 0.002766862 0.221348999 0.004099056 18067 hsa-mir-4258 hsa04360 Axon guidance 2534_5747_7852_5595_5594_2932_5879 7 0.003838185 0.307054801 0.005582815 18068 hsa-mir-4258 hsa04115 p53 signaling pathway 595_836_7157_891_898 5 0.004226402 0.338112143 0.006037717 18069 hsa-mir-4258 hsa03010 Ribosome 6156_6207_6202_6222_6128_6231 6 0.004684246 0.374739699 0.006574381 18070 hsa-mir-4258 hsa04150 mTOR signaling pathway 3091_207_5595_5594 4 0.00848571 0.678856766 0.011704427 18071 hsa-mir-4258 hsa04340 Hedgehog signaling pathway 8945_23291_2932_5566 4 0.01140462 0.912369567 0.015463891 18072 hsa-mir-4258 hsa05340 Primary immunodeficiency 8517_3932_3561 3 0.016997881 1 0.022663841 18073 hsa-mir-4258 hsa04730 Long-term depression 5595_5594_4846_5604 4 0.022751146 1 0.029837568 18074 hsa-mir-4259 hsa05200 Pathways in cancer 4089_25_7157_6688_2033_2113_3725_1387_5970 9 5.65E-10 2.54E-08 2.54E-08 18075 hsa-mir-4259 hsa04310 Wnt signaling pathway 4089_7157_2033_3725_1387_1457_4773 7 1.64E-09 7.38E-08 3.69E-08 18076 hsa-mir-4259 hsa04350 TGF-beta signaling pathway 4086_4089_6667_2033_4093_1387 6 2.64E-09 1.19E-07 3.95E-08 18077 hsa-mir-4259 hsa04110 Cell cycle 4089_25_7157_2033_1387 5 6.48E-07 2.91E-05 7.29E-06 18078 hsa-mir-4259 hsa05211 Renal cell carcinoma 2033_2113_3725_1387 4 3.23E-06 0.000145159 2.83E-05 18079 hsa-mir-4259 hsa05220 Chronic myeloid leukemia 4089_25_7157_5970 4 3.77E-06 0.000169509 2.83E-05 18080 hsa-mir-4259 hsa04520 Adherens junction 4089_2033_1387_1457 4 4.81E-06 0.000216641 3.09E-05 18081 hsa-mir-4259 hsa05215 Prostate cancer 7157_2033_1387_5970 4 6.92E-06 0.000311327 3.61E-05 18082 hsa-mir-4259 hsa05212 Pancreatic cancer 7157_2033_1387_5970 4 7.22E-06 0.000325008 3.61E-05 18083 hsa-mir-4259 hsa05016 Huntington's disease 7157_6667_2033_1387 4 0.000123454 0.005555442 0.000555544 18084 hsa-mir-4259 hsa04662 B cell receptor signaling pathway 3725_5970_4773 3 0.000155251 0.006986273 0.000635116 18085 hsa-mir-4259 hsa05210 Colorectal cancer 4089_7157_3725 3 0.00021452 0.00965341 0.000804451 18086 hsa-mir-4259 hsa04660 T cell receptor signaling pathway 3725_5970_4773 3 0.000462648 0.020819154 0.001600337 18087 hsa-mir-4259 hsa04010 MAPK signaling pathway 7157_3725_5970_4773 4 0.000497883 0.022404721 0.001600337 18088 hsa-mir-4259 hsa04330 Notch signaling pathway 2033_1387 2 0.001954144 0.087936465 0.005862431 18089 hsa-mir-4259 hsa05221 Acute myeloid leukemia 6688_5970 2 0.003010384 0.13546728 0.008466705 18090 hsa-mir-4259 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5970 2 0.004279787 0.192590413 0.011328848 18091 hsa-mir-4259 hsa04720 Long-term potentiation 2033_1387 2 0.00474913 0.213710857 0.011872825 18092 hsa-mir-4259 hsa05222 Small cell lung cancer 7157_5970 2 0.006156124 0.277025559 0.014076383 18093 hsa-mir-4259 hsa04012 ErbB signaling pathway 25_3725 2 0.00629237 0.283156636 0.014076383 18094 hsa-mir-4259 hsa04210 Apoptosis 7157_5970 2 0.006568979 0.295604036 0.014076383 18095 hsa-mir-4259 hsa04620 Toll-like receptor signaling pathway 3725_5970 2 0.008498808 0.38244637 0.017248074 18096 hsa-mir-4259 hsa04916 Melanogenesis 2033_1387 2 0.008815682 0.39670571 0.017248074 18097 hsa-mir-4259 hsa04360 Axon guidance 25_4773 2 0.013595276 0.611787418 0.025491142 18098 hsa-mir-4259 hsa04630 Jak-STAT signaling pathway 2033_1387 2 0.018590711 0.836581996 0.03346328 18099 hsa-mir-4259 hsa05216 Thyroid cancer 7157 1 0.039203525 1 0.067852255 18100 hsa-mir-4259 hsa03410 Base excision repair 3146 1 0.048133094 1 0.080221823 18101 hsa-mir-4260 hsa05200 Pathways in cancer 3551_7046_1499_8517_6934_3091_5925_1050_7187_10342_25_1487_2113_861_207_208_1147_5595_5599_1387_3326_4286_2932_6774_6772_5970_6688_3725_2736_4087_4088_4089_2033_898_4790_4791_4792_367_3320_5371_5601_5602_4609_2353_1488_8554 46 3.37E-26 2.56E-24 2.56E-24 18102 hsa-mir-4260 hsa04010 MAPK signaling pathway 6722_3551_7046_6195_6197_8517_9252_4773_9020_8986_3305_3303_1432_207_208_1147_5595_5599_1386_3310_3312_1649_5971_5970_468_3725_3727_6196_4790_4791_9261_1326_5601_5600_5603_5602_4609_2353_8550 39 8.55E-23 6.50E-21 3.25E-21 18103 hsa-mir-4260 hsa03010 Ribosome 6156_6204_6205_6207_6202_6142_6141_6217_6210_6137_6135_6191_6193_6222_6223_6229_6129_6128_6130_6181_6189_6188_6232 23 9.63E-18 7.32E-16 2.44E-16 18104 hsa-mir-4260 hsa04310 Wnt signaling pathway 1499_8607_6934_6500_4773_23291_1487_5599_1387_2932_8061_3725_1457_1459_4087_4088_4089_2033_5519_5518_5601_5602_8454_8945_4609_1488 26 2.72E-17 2.07E-15 5.18E-16 18105 hsa-mir-4260 hsa05215 Prostate cancer 3551_1499_8517_6934_5925_9586_207_208_1147_5595_1387_3326_2932_5970_468_2033_898_4790_4792_367_3320 21 9.61E-17 7.30E-15 1.46E-15 18106 hsa-mir-4260 hsa05212 Pancreatic cancer 3551_1499_8517_6934_5925_9586_207_208_1147_5595_1387_3326_2932_5970_468_2033_898_4790_4792_367_3320 21 1.17E-16 8.89E-15 1.48E-15 18107 hsa-mir-4260 hsa04620 Toll-like receptor signaling pathway 3551_8517_7187_1432_207_208_1147_5595_5599_6772_5970_3725_4790_4792_1326_5601_5600_5603_5602_9641_2353 21 1.26E-15 9.58E-14 1.37E-14 18108 hsa-mir-4260 hsa04660 T cell receptor signaling pathway 3551_8517_4773_9020_1432_207_208_1147_5595_2932_5970_3725_4794_4790_4792_4793_1326_5601_5600_5603_2353 21 4.71E-15 3.58E-13 4.48E-14 18109 hsa-mir-4260 hsa05220 Chronic myeloid leukemia 3551_7046_8517_5925_25_1487_861_207_208_1147_5595_5970_4088_4089_4790_4792_4609_1488 18 1.40E-14 1.06E-12 1.18E-13 18110 hsa-mir-4260 hsa05221 Acute myeloid leukemia 3551_8517_6934_1050_861_207_208_1147_5595_6774_5970_6688_4790_5371_4609 15 1.10E-12 8.38E-11 8.38E-12 18111 hsa-mir-4260 hsa05210 Colorectal cancer 7046_1499_6934_207_208_5595_5599_2932_3725_4087_4088_4089_5601_5602_4609_2353 16 8.90E-12 6.77E-10 6.15E-11 18112 hsa-mir-4260 hsa04662 B cell receptor signaling pathway 3551_8517_4773_207_208_1147_5595_2932_5970_3725_4794_4790_4792_4793_2353 15 2.17E-11 1.65E-09 1.38E-10 18113 hsa-mir-4260 hsa04920 Adipocytokine signaling pathway 3551_8517_207_208_1147_5599_6774_5970_4794_4790_4792_4793_5601_5602 14 6.11E-11 4.64E-09 3.57E-10 18114 hsa-mir-4260 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3551_8517_9020_1432_1147_5599_5970_3725_4790_4792_5601_5600_5603_5602 14 1.20E-10 9.11E-09 6.50E-10 18115 hsa-mir-4260 hsa03050 Proteasome 5708_5709_5705_5706_5707_5700_5693_5719_5713_5717_5684_5687 12 2.42E-10 1.84E-08 1.23E-09 18116 hsa-mir-4260 hsa04520 Adherens junction 7046_1499_6934_71_4301_5595_1387_1457_1459_4087_4088_4089_2033_8826 14 4.80E-10 3.65E-08 2.28E-09 18117 hsa-mir-4260 hsa04110 Cell cycle 6500_5925_25_7534_5591_1387_7533_7532_2932_4087_4088_4089_2033_898_8454 15 6.69E-09 5.08E-07 2.99E-08 18118 hsa-mir-4260 hsa05222 Small cell lung cancer 3551_8517_5925_7187_207_208_1147_5970_898_4790_4792_4609_8554 13 9.73E-09 7.40E-07 4.11E-08 18119 hsa-mir-4260 hsa04350 TGF-beta signaling pathway 7046_6500_6667_5595_1387_4087_4088_4089_2033_5519_5518_8454_4609 13 1.10E-08 8.38E-07 4.41E-08 18120 hsa-mir-4260 hsa05131 Shigellosis 7846_1499_10382_25_71_7534_347733_7278_84617_4691_203068 11 1.23E-08 9.34E-07 4.45E-08 18121 hsa-mir-4260 hsa05130 Pathogenic Escherichia coli infection 7846_1499_10382_25_71_7534_347733_7278_84617_4691_203068 11 1.23E-08 9.34E-07 4.45E-08 18122 hsa-mir-4260 hsa04912 GnRH signaling pathway 1432_5595_5599_468_3725_808_801_805_5601_5600_5603_5602 12 7.47E-07 5.68E-05 2.58E-06 18123 hsa-mir-4260 hsa04720 Long-term potentiation 6195_6197_5595_1387_468_6196_2033_808_801_805 10 1.41E-06 0.000107045 4.59E-06 18124 hsa-mir-4260 hsa04910 Insulin signaling pathway 3551_5211_207_208_5595_5599_2932_2194_808_801_805_5601_5602 13 1.45E-06 0.000110113 4.59E-06 18125 hsa-mir-4260 hsa04012 ErbB signaling pathway 25_207_208_5595_5599_2932_3725_5601_5602_4609 10 4.75E-06 0.000360738 1.44E-05 18126 hsa-mir-4260 hsa04210 Apoptosis 3551_8517_9020_207_208_1147_5970_9131_4790_4792 10 5.71E-06 0.000433951 1.67E-05 18127 hsa-mir-4260 hsa04664 Fc epsilon RI signaling pathway 1432_207_208_5595_5599_5601_5600_5603_5602 9 1.51E-05 0.001149863 4.26E-05 18128 hsa-mir-4260 hsa04916 Melanogenesis 1499_6934_5595_1387_4286_2932_2033_808_801_805 10 2.00E-05 0.001521706 5.43E-05 18129 hsa-mir-4260 hsa03020 RNA polymerase 25885_64425_51082_5441_5437_84172 6 2.11E-05 0.0016042 5.53E-05 18130 hsa-mir-4260 hsa04120 Ubiquitin mediated proteolysis 55294_6500_23291_7329_83737_64326_5371_672_8454_8945_8554 11 4.18E-05 0.003175633 0.000102679 18131 hsa-mir-4260 hsa04062 Chemokine signaling pathway 3551_8517_207_208_1147_5595_2932_6774_6772_5970_4790_4792_4793 13 4.19E-05 0.003183044 0.000102679 18132 hsa-mir-4260 hsa05213 Endometrial cancer 1499_6934_207_208_5595_2932_4609 7 5.17E-05 0.003930736 0.000118487 18133 hsa-mir-4260 hsa04150 mTOR signaling pathway 6195_6197_3091_207_208_5595_6196 7 5.17E-05 0.003930736 0.000118487 18134 hsa-mir-4260 hsa05211 Renal cell carcinoma 3091_2113_207_208_5595_1387_3725_2033 8 5.30E-05 0.004028548 0.000118487 18135 hsa-mir-4260 hsa04370 VEGF signaling pathway 4773_1432_207_208_5595_9261_5600_5603 8 8.19E-05 0.006225106 0.00017786 18136 hsa-mir-4260 hsa04530 Tight junction 1499_4627_207_208_71_4301_1457_1459_5519_5518 10 0.000172511 0.013110849 0.00036419 18137 hsa-mir-4260 hsa05214 Glioma 5925_207_208_5595_808_801_805 7 0.000185805 0.014121163 0.000374868 18138 hsa-mir-4260 hsa04930 Type II diabetes mellitus 3551_3651_5595_5599_5601_5602 6 0.000187434 0.014244987 0.000374868 18139 hsa-mir-4260 hsa04612 Antigen processing and presentation 3309_3305_3303_3326_3310_3312_3320_4800 8 0.000207131 0.015741926 0.000403639 18140 hsa-mir-4260 hsa05216 Thyroid cancer 1499_6934_10342_5595_4609 5 0.000224085 0.017030496 0.000425762 18141 hsa-mir-4260 hsa04330 Notch signaling pathway 1487_1387_9612_2033_1488_4851 6 0.000232388 0.01766147 0.000430768 18142 hsa-mir-4260 hsa04540 Gap junction 7846_10382_5592_5595_347733_7278_84617_203068 8 0.000273545 0.02078941 0.000494986 18143 hsa-mir-4260 hsa03022 Basal transcription factors 6872_2963_2969_6908_2959 5 0.00061479 0.046724021 0.001086605 18144 hsa-mir-4260 hsa04510 Focal adhesion 1499_207_208_71_5595_5599_2932_3725_5601_5602_85366 11 0.001023201 0.077763271 0.001767347 18145 hsa-mir-4260 hsa04630 Jak-STAT signaling pathway 207_208_1387_6774_6775_6772_2033_4609_8554 9 0.001671491 0.127033281 0.002822962 18146 hsa-mir-4260 hsa05016 Huntington's disease 3064_6667_9586_5441_1387_5437_1213_2033_6908 9 0.005640363 0.428667589 0.009318861 18147 hsa-mir-4260 hsa05219 Bladder cancer 9252_5925_5595_4609 4 0.00690028 0.52442131 0.0111579 18148 hsa-mir-4260 hsa05218 Melanoma 5925_207_208_5595_4286 5 0.008464112 0.6432725 0.01340151 18149 hsa-mir-4260 hsa05223 Non-small cell lung cancer 5925_207_208_5595 4 0.015382206 1 0.023858115 18150 hsa-mir-4260 hsa05217 Basal cell carcinoma 1499_6934_2932_2736 4 0.016291581 1 0.024763203 18151 hsa-mir-4260 hsa04270 Vascular smooth muscle contraction 5592_5595_808_801_805_85366 6 0.017072784 1 0.025441795 18152 hsa-mir-4260 hsa04340 Hedgehog signaling pathway 23291_2932_2736_8945 4 0.018209696 1 0.026614172 18153 hsa-mir-4260 hsa04670 Leukocyte transendothelial migration 1499_1432_71_4301_5600_5603 6 0.019643955 1 0.02816869 18154 hsa-mir-4260 hsa03450 Non-homologous end-joining 7520_5591 2 0.027953426 1 0.039341859 18155 hsa-mir-4260 hsa04730 Long-term depression 5592_5595_5519_5518 4 0.035509457 1 0.049067614 18156 hsa-mir-4261 hsa04916 Melanogenesis 1499_2033_1387_5595_5594_808_801_805 8 3.53E-11 1.98E-09 1.98E-09 18157 hsa-mir-4261 hsa04720 Long-term potentiation 2033_1387_5595_5594_808_801_805 7 1.80E-10 1.01E-08 5.05E-09 18158 hsa-mir-4261 hsa04350 TGF-beta signaling pathway 3398_2033_1387_5595_5594_3397_3399 7 4.77E-10 2.67E-08 8.91E-09 18159 hsa-mir-4261 hsa05214 Glioma 5925_5595_5594_808_801_805 6 4.14E-09 2.32E-07 5.80E-08 18160 hsa-mir-4261 hsa05215 Prostate cancer 1499_5925_2033_1387_5595_5594 6 2.28E-08 1.28E-06 2.27E-07 18161 hsa-mir-4261 hsa05212 Pancreatic cancer 1499_5925_2033_1387_5595_5594 6 2.43E-08 1.36E-06 2.27E-07 18162 hsa-mir-4261 hsa04912 GnRH signaling pathway 1432_5595_5594_808_801_805 6 7.25E-08 4.06E-06 5.80E-07 18163 hsa-mir-4261 hsa05200 Pathways in cancer 1499_5925_2033_6502_1387_5595_5594_862 8 2.19E-07 1.22E-05 1.53E-06 18164 hsa-mir-4261 hsa04370 VEGF signaling pathway 9261_1432_7867_5595_5594 5 4.57E-07 2.56E-05 2.85E-06 18165 hsa-mir-4261 hsa04520 Adherens junction 1499_2033_1387_5595_5594 5 5.48E-07 3.07E-05 3.07E-06 18166 hsa-mir-4261 hsa04010 MAPK signaling pathway 9261_4208_1432_7867_5595_5594_6722 7 8.87E-07 4.97E-05 4.52E-06 18167 hsa-mir-4261 hsa04330 Notch signaling pathway 2033_1387_388585_8850 4 2.53E-06 0.000141671 1.18E-05 18168 hsa-mir-4261 hsa04270 Vascular smooth muscle contraction 5595_5594_808_801_805 5 3.42E-06 0.000191436 1.47E-05 18169 hsa-mir-4261 hsa04910 Insulin signaling pathway 5595_5594_808_801_805 5 7.14E-06 0.000399907 2.86E-05 18170 hsa-mir-4261 hsa05211 Renal cell carcinoma 2033_1387_5595_5594 4 1.25E-05 0.00070262 4.68E-05 18171 hsa-mir-4261 hsa05010 Alzheimer's disease 5595_5594_808_801_805 5 2.29E-05 0.001283354 8.02E-05 18172 hsa-mir-4261 hsa05216 Thyroid cancer 1499_5595_5594 3 2.92E-05 0.001637605 9.63E-05 18173 hsa-mir-4261 hsa05219 Bladder cancer 5925_5595_5594 3 8.22E-05 0.004605255 0.000245233 18174 hsa-mir-4261 hsa04110 Cell cycle 5925_2033_6502_1387 4 8.32E-05 0.004659418 0.000245233 18175 hsa-mir-4261 hsa04930 Type II diabetes mellitus 3651_5595_5594 3 9.98E-05 0.005591099 0.000279555 18176 hsa-mir-4261 hsa05213 Endometrial cancer 1499_5595_5594 3 0.000150049 0.008402741 0.000400131 18177 hsa-mir-4261 hsa05223 Non-small cell lung cancer 5925_5595_5594 3 0.000166909 0.009346918 0.00042486 18178 hsa-mir-4261 hsa05221 Acute myeloid leukemia 5595_5594_862 3 0.00021432 0.012001947 0.000521824 18179 hsa-mir-4261 hsa05218 Melanoma 5925_5595_5594 3 0.000361583 0.020248661 0.000843694 18180 hsa-mir-4261 hsa05220 Chronic myeloid leukemia 5925_5595_5594 3 0.000422116 0.023638474 0.000943816 18181 hsa-mir-4261 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.0004382 0.024539225 0.000943816 18182 hsa-mir-4261 hsa04664 Fc epsilon RI signaling pathway 1432_5595_5594 3 0.000488802 0.027372927 0.001013812 18183 hsa-mir-4261 hsa05210 Colorectal cancer 1499_5595_5594 3 0.000581195 0.032546905 0.001162389 18184 hsa-mir-4261 hsa04620 Toll-like receptor signaling pathway 1432_5595_5594 3 0.001003827 0.056214339 0.001938425 18185 hsa-mir-4261 hsa04950 Maturity onset diabetes of the young 3651_168620 2 0.001076742 0.06029753 0.002009918 18186 hsa-mir-4261 hsa04660 T cell receptor signaling pathway 1432_5595_5594 3 0.001240655 0.06947669 0.002241184 18187 hsa-mir-4261 hsa04310 Wnt signaling pathway 1499_2033_1387 3 0.003052359 0.170932124 0.005341629 18188 hsa-mir-4261 hsa04150 mTOR signaling pathway 5595_5594 2 0.004585238 0.256773308 0.007781009 18189 hsa-mir-4261 hsa04020 Calcium signaling pathway 808_801_805 3 0.005157318 0.288809817 0.008494406 18190 hsa-mir-4261 hsa04510 Focal adhesion 1499_5595_5594 3 0.007007974 0.392446528 0.011212758 18191 hsa-mir-4261 hsa04730 Long-term depression 5595_5594 2 0.008232541 0.461022318 0.012806175 18192 hsa-mir-4261 hsa04662 B cell receptor signaling pathway 5595_5594 2 0.009122627 0.510867122 0.01380722 18193 hsa-mir-4261 hsa05222 Small cell lung cancer 5925_6502 2 0.011780126 0.659687068 0.017283404 18194 hsa-mir-4261 hsa04012 ErbB signaling pathway 5595_5594 2 0.012036656 0.674052763 0.017283404 18195 hsa-mir-4261 hsa04540 Gap junction 5595_5594 2 0.0136269 0.763106407 0.01907766 18196 hsa-mir-4261 hsa04670 Leukocyte transendothelial migration 1432_1499 2 0.022489694 1 0.030717631 18197 hsa-mir-4261 hsa04360 Axon guidance 5595_5594 2 0.025613758 1 0.034151677 18198 hsa-mir-4261 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594 2 0.028158506 1 0.036310981 18199 hsa-mir-4261 hsa04120 Ubiquitin mediated proteolysis 6502_7329 2 0.028530056 1 0.036310981 18200 hsa-mir-4261 hsa04630 Jak-STAT signaling pathway 2033_1387 2 0.034738292 1 0.043229875 18201 hsa-mir-4261 hsa04740 Olfactory transduction 808_801_805 3 0.03601627 1 0.043845895 18202 hsa-mir-4261 hsa05016 Huntington's disease 2033_1387 2 0.049000722 1 0.058383839 18203 hsa-mir-4263 hsa05200 Pathways in cancer 5371_2249_5595_5599_5914_1387_6256_5601_1488_1487_367_6776_6777_5970_4609_3725_2353_4087_4088_4089_1050_5925_2033 23 1.00E-22 6.11E-21 6.11E-21 18204 hsa-mir-4263 hsa04310 Wnt signaling pathway 5599_1387_5601_1488_1487_6423_8061_4609_3725_1457_1459_4087_4088_4089_2033 15 3.20E-17 1.95E-15 9.76E-16 18205 hsa-mir-4263 hsa04010 MAPK signaling pathway 9479_2249_5595_5599_5601_5600_5603_9252_1432_5970_468_4609_3725_3727_2353_1649_8550 17 2.99E-16 1.82E-14 6.08E-15 18206 hsa-mir-4263 hsa05220 Chronic myeloid leukemia 5595_1488_1487_6776_6777_5970_4609_4088_4089_5925 10 4.76E-13 2.91E-11 7.26E-12 18207 hsa-mir-4263 hsa05210 Colorectal cancer 5595_5599_5601_4609_3725_2353_4087_4088_4089 9 4.43E-11 2.70E-09 5.40E-10 18208 hsa-mir-4263 hsa04350 TGF-beta signaling pathway 6667_5595_1387_3398_4609_4087_4088_4089_2033 9 5.91E-11 3.61E-09 6.01E-10 18209 hsa-mir-4263 hsa05221 Acute myeloid leukemia 5371_5595_5914_6776_6777_5970_4609_1050 8 9.91E-11 6.05E-09 8.64E-10 18210 hsa-mir-4263 hsa04620 Toll-like receptor signaling pathway 5595_5599_5601_5600_5603_1432_5970_3725_2353 9 2.21E-10 1.35E-08 1.68E-09 18211 hsa-mir-4263 hsa04520 Adherens junction 5595_1387_1457_1459_4087_4088_4089_2033 8 9.19E-10 5.61E-08 6.23E-09 18212 hsa-mir-4263 hsa05215 Prostate cancer 5595_1387_367_5970_468_9586_5925_2033 8 1.85E-09 1.13E-07 1.12E-08 18213 hsa-mir-4263 hsa05212 Pancreatic cancer 5595_1387_367_5970_468_9586_5925_2033 8 2.01E-09 1.23E-07 1.12E-08 18214 hsa-mir-4263 hsa04912 GnRH signaling pathway 5595_5599_5601_5600_5603_1432_468_3725 8 8.38E-09 5.11E-07 4.26E-08 18215 hsa-mir-4263 hsa04660 T cell receptor signaling pathway 5595_5601_5600_5603_1432_5970_3725_2353 8 9.59E-09 5.85E-07 4.50E-08 18216 hsa-mir-4263 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5601_5600_5603_1432_5970_3725 7 1.18E-08 7.20E-07 5.14E-08 18217 hsa-mir-4263 hsa04012 ErbB signaling pathway 5595_5599_5601_6776_6777_4609_3725 7 4.37E-08 2.66E-06 1.78E-07 18218 hsa-mir-4263 hsa04664 Fc epsilon RI signaling pathway 5595_5599_5601_5600_5603_1432 6 5.76E-07 3.52E-05 2.20E-06 18219 hsa-mir-4263 hsa04330 Notch signaling pathway 1387_1488_1487_9612_2033 5 1.12E-06 6.84E-05 4.02E-06 18220 hsa-mir-4263 hsa04110 Cell cycle 1387_4087_4088_4089_5925_2033 6 5.52E-06 0.000336546 1.87E-05 18221 hsa-mir-4263 hsa05219 Bladder cancer 5595_9252_4609_5925 4 2.11E-05 0.001289512 6.79E-05 18222 hsa-mir-4263 hsa04630 Jak-STAT signaling pathway 1387_6776_6777_4609_2033_3977 6 2.34E-05 0.001426011 7.13E-05 18223 hsa-mir-4263 hsa04920 Adipocytokine signaling pathway 5599_6256_5601_5970 4 0.000117649 0.007176559 0.000341741 18224 hsa-mir-4263 hsa05211 Renal cell carcinoma 5595_1387_3725_2033 4 0.000153265 0.009349167 0.000424962 18225 hsa-mir-4263 hsa04720 Long-term potentiation 5595_1387_468_2033 4 0.000178043 0.010860648 0.000452527 18226 hsa-mir-4263 hsa04662 B cell receptor signaling pathway 5595_5970_3725_2353 4 0.000178043 0.010860648 0.000452527 18227 hsa-mir-4263 hsa05216 Thyroid cancer 5595_6256_4609 3 0.000195344 0.011915955 0.000460056 18228 hsa-mir-4263 hsa04370 VEGF signaling pathway 5595_5600_5603_1432 4 0.00019609 0.011961468 0.000460056 18229 hsa-mir-4263 hsa05222 Small cell lung cancer 6256_5970_4609_5925 4 0.00029394 0.017930351 0.000664087 18230 hsa-mir-4263 hsa05016 Huntington's disease 6667_1387_6908_9586_2033 5 0.00061707 0.03764129 0.001344332 18231 hsa-mir-4263 hsa04930 Type II diabetes mellitus 5595_5599_5601 3 0.00065389 0.039887262 0.001375423 18232 hsa-mir-4263 hsa05223 Non-small cell lung cancer 5595_6256_5925 3 0.001081092 0.065946613 0.00219822 18233 hsa-mir-4263 hsa05014 Amyotrophic lateral sclerosis (ALS) 5600_5603_1432 3 0.001195028 0.072896722 0.002351507 18234 hsa-mir-4263 hsa05218 Melanoma 2249_5595_5925 3 0.002293658 0.139913142 0.004372286 18235 hsa-mir-4263 hsa04916 Melanogenesis 5595_1387_2033 3 0.006459177 0.394009771 0.011784296 18236 hsa-mir-4263 hsa04510 Focal adhesion 5595_5599_5601_3725 4 0.006568296 0.400666063 0.011784296 18237 hsa-mir-4263 hsa03022 Basal transcription factors 2963_6908 2 0.008358871 0.509891139 0.014568318 18238 hsa-mir-4263 hsa04670 Leukocyte transendothelial migration 5600_5603_1432 3 0.009880792 0.602728319 0.016742453 18239 hsa-mir-4263 hsa04910 Insulin signaling pathway 5595_5599_5601 3 0.013658903 0.833193053 0.022343093 18240 hsa-mir-4263 hsa04120 Ubiquitin mediated proteolysis 5371_672_7329 3 0.013918648 0.849037543 0.022343093 18241 hsa-mir-4263 hsa05213 Endometrial cancer 5595_4609 2 0.015600016 0.95160099 0.024400025 18242 hsa-mir-4263 hsa05214 Glioma 5595_5925 2 0.023402323 1 0.035688542 18243 hsa-mir-4263 hsa05010 Alzheimer's disease 5595_823_9451 3 0.025890185 1 0.038519543 18244 hsa-mir-4263 hsa04062 Chemokine signaling pathway 5595_6777_5970 3 0.032161929 1 0.046711373 18245 hsa-mir-4263 hsa04210 Apoptosis 823_5970 2 0.041057034 1 0.058243699 18246 hsa-mir-4264 hsa05200 Pathways in cancer 2249_1499_5914_1387_6256_1019_367_1017_6774_6776_6777_5970_6688_836_4089_4609_3725_1026_2353_4087_5881_1050_5925_2033_8554_7186 26 7.26E-23 4.50E-21 4.50E-21 18247 hsa-mir-4264 hsa04010 MAPK signaling pathway 2249_5598_1386_1649_3303_1432_5970_836_468_4609_3725_2353_5881_7186 14 1.88E-10 1.17E-08 5.84E-09 18248 hsa-mir-4264 hsa04110 Cell cycle 1387_1019_1017_7027_4089_1026_4087_5925_2033_5933 10 9.54E-10 5.91E-08 1.33E-08 18249 hsa-mir-4264 hsa04350 TGF-beta signaling pathway 1387_7027_1874_4089_4609_4087_2033_6667_5933 9 1.24E-09 7.69E-08 1.33E-08 18250 hsa-mir-4264 hsa05215 Prostate cancer 1499_1387_367_1017_5970_468_1026_5925_2033 9 1.36E-09 8.44E-08 1.33E-08 18251 hsa-mir-4264 hsa05212 Pancreatic cancer 1499_1387_367_1017_5970_468_1026_5925_2033 9 1.49E-09 9.25E-08 1.33E-08 18252 hsa-mir-4264 hsa05221 Acute myeloid leukemia 5914_6774_6776_6777_5970_6688_4609_1050 8 1.50E-09 9.31E-08 1.33E-08 18253 hsa-mir-4264 hsa05220 Chronic myeloid leukemia 1019_6776_6777_5970_4089_4609_1026_5925 8 8.49E-09 5.27E-07 6.58E-08 18254 hsa-mir-4264 hsa05210 Colorectal cancer 1499_836_4089_4609_3725_2353_4087_5881 8 1.93E-08 1.20E-06 1.33E-07 18255 hsa-mir-4264 hsa05222 Small cell lung cancer 6256_1019_1017_5970_4609_5925_8554_7186 8 2.29E-08 1.42E-06 1.42E-07 18256 hsa-mir-4264 hsa04520 Adherens junction 1499_6714_1387_4089_4087_5881_2033 7 2.62E-07 1.63E-05 1.48E-06 18257 hsa-mir-4264 hsa04950 Maturity onset diabetes of the young 3651_6928_6927_3172_5080 5 2.97E-07 1.84E-05 1.54E-06 18258 hsa-mir-4264 hsa04310 Wnt signaling pathway 1499_1387_4089_4609_3725_4087_5881_2033 8 1.39E-06 8.64E-05 6.65E-06 18259 hsa-mir-4264 hsa04630 Jak-STAT signaling pathway 1387_6774_6776_6777_4609_2033_3977_8554 8 1.60E-06 9.94E-05 7.10E-06 18260 hsa-mir-4264 hsa04012 ErbB signaling pathway 6714_6776_6777_4609_3725_1026 6 7.05E-06 0.000436864 2.91E-05 18261 hsa-mir-4264 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_1432_5970_836_3725 5 3.84E-05 0.002380254 0.000148766 18262 hsa-mir-4264 hsa05219 Bladder cancer 1019_4609_1026_5925 4 7.96E-05 0.004932362 0.000290139 18263 hsa-mir-4264 hsa04330 Notch signaling pathway 1387_9612_2033_8850 4 0.000119516 0.007410018 0.000411668 18264 hsa-mir-4264 hsa04912 GnRH signaling pathway 6714_5598_1432_468_3725 5 0.000251959 0.015621476 0.000822183 18265 hsa-mir-4264 hsa04660 T cell receptor signaling pathway 1019_1432_5970_3725_2353 5 0.000273328 0.016946321 0.000847316 18266 hsa-mir-4264 hsa05016 Huntington's disease 1387_6908_836_10476_2033_6667 6 0.000420941 0.026098344 0.001213127 18267 hsa-mir-4264 hsa04920 Adipocytokine signaling pathway 6256_6774_5970_7186 4 0.000430464 0.026688791 0.001213127 18268 hsa-mir-4264 hsa04115 p53 signaling pathway 1019_1017_836_1026 4 0.000478539 0.029669402 0.001289974 18269 hsa-mir-4264 hsa05216 Thyroid cancer 1499_6256_4609 3 0.000528179 0.032747108 0.001315191 18270 hsa-mir-4264 hsa05218 Melanoma 2249_1019_1026_5925 4 0.000530319 0.032879779 0.001315191 18271 hsa-mir-4264 hsa04662 B cell receptor signaling pathway 5970_3725_2353_5881 4 0.000645632 0.040029161 0.001539583 18272 hsa-mir-4264 hsa04530 Tight junction 1499_6714_1019_4628_60412 5 0.000717384 0.044477786 0.001647325 18273 hsa-mir-4264 hsa04210 Apoptosis 840_5970_836_7186 4 0.00118943 0.073744674 0.002633738 18274 hsa-mir-4264 hsa04620 Toll-like receptor signaling pathway 1432_5970_3725_2353 4 0.001926079 0.119416926 0.004117825 18275 hsa-mir-4264 hsa05223 Non-small cell lung cancer 6256_1019_5925 3 0.002847237 0.176528722 0.005884291 18276 hsa-mir-4264 hsa05214 Glioma 1019_1026_5925 3 0.004687821 0.290644897 0.009375642 18277 hsa-mir-4264 hsa05211 Renal cell carcinoma 1387_3725_2033 3 0.006159785 0.381906685 0.011934584 18278 hsa-mir-4264 hsa04720 Long-term potentiation 1387_468_2033 3 0.00686571 0.425674032 0.012899213 18279 hsa-mir-4264 hsa04370 VEGF signaling pathway 6714_1432_5881 3 0.007361923 0.456439246 0.013424684 18280 hsa-mir-4264 hsa05010 Alzheimer's disease 1020_840_836_10476 4 0.012632224 0.783197893 0.022377083 18281 hsa-mir-4264 hsa04916 Melanogenesis 1499_1387_2033 3 0.016153293 1 0.02781956 18282 hsa-mir-4264 hsa04510 Focal adhesion 1499_6714_3725_5881 4 0.020628981 1 0.034567482 18283 hsa-mir-4264 hsa03420 Nucleotide excision repair 5981_4331 2 0.021784935 1 0.035543841 18284 hsa-mir-4264 hsa05213 Endometrial cancer 1499_4609 2 0.029359782 1 0.046674525 18285 hsa-mir-4264 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_836 2 0.033484839 1 0.0519015 18286 hsa-mir-4265 hsa04110 Cell cycle 1869_25_5925_545_995_1026_5591_983_4088_7534_1017_2932_4193_7027_902_1387_1031_9232_5347_1022_4087_4089_7532_3065_1111_2033_890_11200_8556_8555_472 31 2.76E-31 2.32E-29 2.32E-29 18287 hsa-mir-4265 hsa05200 Pathways in cancer 1147_3320_1869_5743_3326_5747_25_5925_675_998_1026_5594_5595_5599_596_5601_6789_1856_4088_613_1017_2932_4193_1387_5578_51588_8554_5371_4436_598_3725_4087_4089_5888_5728_3065_3091_2033_3910_4792_5602_2353 42 1.01E-30 8.49E-29 4.24E-29 18288 hsa-mir-4265 hsa04115 p53 signaling pathway 50484_545_6241_1026_25898_983_1017_27113_4194_4193_900_7161_64326_5728_51246_1111_11200_472 18 1.17E-18 9.80E-17 3.27E-17 18289 hsa-mir-4265 hsa05215 Prostate cancer 1147_3320_1869_3326_5925_1026_5594_5595_596_1017_2932_4193_1387_5728_2033_4792 16 1.40E-14 1.18E-12 2.75E-13 18290 hsa-mir-4265 hsa05212 Pancreatic cancer 1147_3320_1869_3326_5925_1026_5594_5595_596_1017_2932_4193_1387_5728_2033_4792 16 1.64E-14 1.37E-12 2.75E-13 18291 hsa-mir-4265 hsa04310 Wnt signaling pathway 1460_5518_5515_5599_5601_1856_1457_4088_2932_1387_5578_8061_3725_1452_4087_4089_5527_2033_5602 19 2.13E-14 1.79E-12 2.98E-13 18292 hsa-mir-4265 hsa05220 Chronic myeloid leukemia 1147_1869_25_5925_1026_5594_5595_4088_613_4193_598_4089_3065_4792 14 4.66E-13 3.91E-11 5.59E-12 18293 hsa-mir-4265 hsa05210 Colorectal cancer 5594_5595_5599_596_5601_1856_4088_2932_4436_3725_4087_4089_5602_2353 14 1.83E-12 1.54E-10 1.92E-11 18294 hsa-mir-4265 hsa05222 Small cell lung cancer 1147_1869_5743_5747_5925_596_1017_51588_8554_598_5728_3910_4792 13 3.44E-11 2.89E-09 3.21E-10 18295 hsa-mir-4265 hsa04010 MAPK signaling pathway 1147_998_5594_5595_5599_5601_3304_3305_3303_6789_3315_5578_1649_3164_3725_1386_1616_5923_5602_2353 20 3.99E-11 3.35E-09 3.35E-10 18296 hsa-mir-4265 hsa04120 Ubiquitin mediated proteolysis 10055_672_7319_25898_84447_4193_3093_51588_8554_5371_64326_7329_10075_7337 14 8.07E-10 6.78E-08 6.16E-09 18297 hsa-mir-4265 hsa04350 TGF-beta signaling pathway 5518_5515_5594_5595_6667_4088_7027_1387_4087_4089_2033 11 6.22E-09 5.23E-07 4.02E-08 18298 hsa-mir-4265 hsa04012 ErbB signaling pathway 5747_25_1026_5594_5595_5599_5601_2932_5578_3725_5602 11 6.22E-09 5.23E-07 4.02E-08 18299 hsa-mir-4265 hsa04510 Focal adhesion 5747_998_5594_5595_5599_596_5601_5499_2932_5578_3725_5728_5923_3910_5602 15 1.23E-08 1.04E-06 7.40E-08 18300 hsa-mir-4265 hsa04520 Adherens junction 1460_998_5594_5595_1457_4088_1387_4087_4089_2033 10 3.39E-08 2.85E-06 1.90E-07 18301 hsa-mir-4265 hsa04660 T cell receptor signaling pathway 1147_998_5594_5595_5601_2932_3725_959_4792_2353 10 5.23E-07 4.40E-05 2.75E-06 18302 hsa-mir-4265 hsa05214 Glioma 1869_5925_1026_5594_5595_4193_5578_5728 8 9.09E-07 7.63E-05 4.38E-06 18303 hsa-mir-4265 hsa03420 Nucleotide excision repair 2965_4331_2074_6117_2071_902_1022 7 9.38E-07 7.88E-05 4.38E-06 18304 hsa-mir-4265 hsa04662 B cell receptor signaling pathway 1147_5594_5595_1380_2932_3725_4792_2353 8 2.44E-06 0.000204742 1.03E-05 18305 hsa-mir-4265 hsa04620 Toll-like receptor signaling pathway 1147_5594_5595_5599_5601_3725_4792_5602_2353 9 2.45E-06 0.000206051 1.03E-05 18306 hsa-mir-4265 hsa03022 Basal transcription factors 2965_2957_6908_51616_2958_6880 6 5.20E-06 0.000436758 2.08E-05 18307 hsa-mir-4265 hsa05219 Bladder cancer 1869_5925_1026_5594_5595_4193 6 1.00E-05 0.00084175 3.83E-05 18308 hsa-mir-4265 hsa04920 Adipocytokine signaling pathway 1147_5563_6794_5599_5601_4792_5602 7 1.19E-05 0.000998768 4.34E-05 18309 hsa-mir-4265 hsa05218 Melanoma 1869_5925_1026_5594_5595_4193_5728 7 1.68E-05 0.00141538 5.66E-05 18310 hsa-mir-4265 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_998_5599_5601_3725_4792_5602 7 1.68E-05 0.00141538 5.66E-05 18311 hsa-mir-4265 hsa05211 Renal cell carcinoma 998_5594_5595_1387_3725_3091_2033 7 1.83E-05 0.001539341 5.92E-05 18312 hsa-mir-4265 hsa04370 VEGF signaling pathway 5743_5747_998_5594_5595_3315_5578 7 2.74E-05 0.002301459 8.52E-05 18313 hsa-mir-4265 hsa04912 GnRH signaling pathway 998_5594_5595_5599_5601_5578_3725_5602 8 2.92E-05 0.002455236 8.77E-05 18314 hsa-mir-4265 hsa05223 Non-small cell lung cancer 1869_5925_5594_5595_6789_5578 6 3.68E-05 0.003094336 0.000106701 18315 hsa-mir-4265 hsa04530 Tight junction 1460_998_5518_5515_1457_5578_5728_5520 8 0.000141478 0.011884131 0.000396138 18316 hsa-mir-4265 hsa04910 Insulin signaling pathway 5563_5594_5595_5599_5601_5499_2932_5602 8 0.000148354 0.012461718 0.000401991 18317 hsa-mir-4265 hsa04916 Melanogenesis 5594_5595_1856_2932_1387_5578_2033 7 0.000161985 0.013606722 0.000425208 18318 hsa-mir-4265 hsa04930 Type II diabetes mellitus 5594_5595_5599_5601_5602 5 0.000167046 0.014031871 0.000425208 18319 hsa-mir-4265 hsa04720 Long-term potentiation 5594_5595_5499_1387_5578_2033 6 0.000199108 0.016725048 0.000483539 18320 hsa-mir-4265 hsa04330 Notch signaling pathway 1856_1387_3065_2033_8850 5 0.000201474 0.016923857 0.000483539 18321 hsa-mir-4265 hsa04664 Fc epsilon RI signaling pathway 5594_5595_5599_5601_5578_5602 6 0.000259208 0.021773508 0.00060482 18322 hsa-mir-4265 hsa04150 mTOR signaling pathway 5563_5594_6794_5595_3091 5 0.000311182 0.026139307 0.000706468 18323 hsa-mir-4265 hsa03440 Homologous recombination 675_6117_641_5888 4 0.000323037 0.027135082 0.000714081 18324 hsa-mir-4265 hsa05131 Shigellosis 25_998_7534_5578_4691 5 0.00042748 0.035908331 0.000897708 18325 hsa-mir-4265 hsa05130 Pathogenic Escherichia coli infection 25_998_7534_5578_4691 5 0.00042748 0.035908331 0.000897708 18326 hsa-mir-4265 hsa04612 Antigen processing and presentation 3320_3326_3309_3304_3305_3303 6 0.000472532 0.039692662 0.000945063 18327 hsa-mir-4265 hsa04210 Apoptosis 1147_823_596_598_4792_472 6 0.000472532 0.039692662 0.000945063 18328 hsa-mir-4265 hsa04360 Axon guidance 5747_25_998_5594_5595_2932_1020 7 0.000609818 0.05122473 0.001191273 18329 hsa-mir-4265 hsa03410 Base excision repair 142_3146_328_4913 4 0.000769274 0.064619011 0.001468614 18330 hsa-mir-4265 hsa05016 Huntington's disease 25942_3064_6908_6667_27113_1387_3065_2033 8 0.001056428 0.088739962 0.001971999 18331 hsa-mir-4265 hsa04730 Long-term depression 5518_5515_5594_5595_5578 5 0.001170235 0.098299719 0.00213695 18332 hsa-mir-4265 hsa04062 Chemokine signaling pathway 1147_5747_998_5594_5595_2932_6362_4792 8 0.001240935 0.104238508 0.002217841 18333 hsa-mir-4265 hsa05213 Endometrial cancer 5594_5595_2932_5728 4 0.002715981 0.228142366 0.004752966 18334 hsa-mir-4265 hsa04540 Gap junction 5594_5595_983_1453_5578 5 0.003578362 0.300582398 0.006134335 18335 hsa-mir-4265 hsa05221 Acute myeloid leukemia 1147_5594_5595_5371 4 0.00416298 0.349690289 0.006993806 18336 hsa-mir-4265 hsa03030 DNA replication 6117_5557_5422 3 0.007637082 0.641514866 0.012578723 18337 hsa-mir-4265 hsa03450 Non-homologous end-joining 5591_2547 2 0.011661332 0.979551846 0.018837536 18338 hsa-mir-4265 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_1616 3 0.023361676 1 0.037026052 18339 hsa-mir-4265 hsa04340 Hedgehog signaling pathway 1453_2932_1452 3 0.024407481 1 0.037967193 18340 hsa-mir-4265 hsa04630 Jak-STAT signaling pathway 1387_51588_8554_598_2033 5 0.025885433 1 0.039534116 18341 hsa-mir-4265 hsa03430 Mismatch repair 6117_4436 2 0.027427603 1 0.041141404 18342 hsa-mir-4265 hsa04270 Vascular smooth muscle contraction 5594_5595_5499_5578 4 0.03837061 1 0.056546162 18343 hsa-mir-4265 hsa05216 Thyroid cancer 5594_5595 2 0.040829073 1 0.059093822 18344 hsa-mir-4265 hsa05010 Alzheimer's disease 5594_5595_823_2932_1020 5 0.041506375 1 0.059093822 18345 hsa-mir-4268 hsa03022 Basal transcription factors 2967_2961_2963_6881_54457_2968_6878_6877_6874_2960_2957_6879_6872_2958_6873_2959_6880_6882_138474_6884_6883 21 6.35E-29 4.45E-27 4.45E-27 18346 hsa-mir-4268 hsa04110 Cell cycle 993_4171_7532_983_1019_7534_1017_4193_1387_7027_4085_7157_1026_3065_4087_4088_4089_5925_2033_5933 20 8.86E-19 6.20E-17 3.10E-17 18347 hsa-mir-4268 hsa05200 Pathways in cancer 1147_3551_1499_5594_6256_10401_1019_1017_4193_2353_1387_5970_7157_6688_3725_4609_1026_3065_4087_4088_4089_5925_2033_207_208_3326_8554_7184 28 1.70E-18 1.19E-16 3.96E-17 18348 hsa-mir-4268 hsa05215 Prostate cancer 1147_3551_1499_5594_1017_4193_1387_5970_7157_468_1026_5925_2033_207_208_3326_7184 17 4.83E-17 3.38E-15 7.98E-16 18349 hsa-mir-4268 hsa05212 Pancreatic cancer 1147_3551_1499_5594_1017_4193_1387_5970_7157_468_1026_5925_2033_207_208_3326_7184 17 5.70E-17 3.99E-15 7.98E-16 18350 hsa-mir-4268 hsa05220 Chronic myeloid leukemia 1147_3551_5594_1019_4193_5970_7157_4609_1026_3065_4088_4089_5925_207_208 15 2.21E-15 1.55E-13 2.58E-14 18351 hsa-mir-4268 hsa05222 Small cell lung cancer 1147_3551_6256_10401_1019_1017_5970_7157_4609_5925_207_208_8554 13 4.00E-12 2.80E-10 4.00E-11 18352 hsa-mir-4268 hsa05210 Colorectal cancer 1499_5594_2353_7157_3725_4609_4087_4088_4089_207_208 11 7.39E-10 5.17E-08 6.47E-09 18353 hsa-mir-4268 hsa04010 MAPK signaling pathway 1147_6722_3551_5594_1386_2353_3312_1649_5970_7157_3725_468_4609_3727_207_208 16 6.35E-09 4.44E-07 4.94E-08 18354 hsa-mir-4268 hsa04350 TGF-beta signaling pathway 5594_1387_7027_1874_4609_4087_4088_4089_2033_5933 10 1.39E-08 9.73E-07 9.73E-08 18355 hsa-mir-4268 hsa05221 Acute myeloid leukemia 1147_3551_5594_5970_6688_4609_207_208 8 1.26E-07 8.83E-06 8.02E-07 18356 hsa-mir-4268 hsa04310 Wnt signaling pathway 1460_1499_8607_1387_7157_3725_4609_4087_4088_4089_2033 11 2.15E-07 1.51E-05 1.20E-06 18357 hsa-mir-4268 hsa05219 Bladder cancer 5594_1019_4193_7157_4609_1026_5925 7 2.23E-07 1.56E-05 1.20E-06 18358 hsa-mir-4268 hsa05214 Glioma 5594_1019_4193_7157_1026_5925_207_208 8 2.48E-07 1.74E-05 1.24E-06 18359 hsa-mir-4268 hsa05218 Melanoma 5594_1019_4193_7157_1026_5925_207_208 8 4.61E-07 3.23E-05 2.15E-06 18360 hsa-mir-4268 hsa04662 B cell receptor signaling pathway 1147_3551_5594_2353_5970_3725_207_208 8 6.76E-07 4.73E-05 2.96E-06 18361 hsa-mir-4268 hsa05223 Non-small cell lung cancer 5594_6256_1019_7157_5925_207_208 7 1.04E-06 7.25E-05 3.94E-06 18362 hsa-mir-4268 hsa04520 Adherens junction 1460_1499_5594_1387_4087_4088_4089_2033 8 1.06E-06 7.43E-05 3.94E-06 18363 hsa-mir-4268 hsa04660 T cell receptor signaling pathway 1147_3551_5594_1019_2353_5970_3725_207_208 9 1.07E-06 7.49E-05 3.94E-06 18364 hsa-mir-4268 hsa04620 Toll-like receptor signaling pathway 1147_3551_5594_2353_5970_3725_207_208 8 5.74E-06 0.000401458 2.01E-05 18365 hsa-mir-4268 hsa05216 Thyroid cancer 1499_5594_6256_7157_4609 5 1.10E-05 0.000770194 3.67E-05 18366 hsa-mir-4268 hsa05213 Endometrial cancer 1499_5594_7157_4609_207_208 6 1.15E-05 0.000806505 3.67E-05 18367 hsa-mir-4268 hsa04920 Adipocytokine signaling pathway 1147_3551_6256_5970_207_208 6 4.34E-05 0.003041163 0.000132224 18368 hsa-mir-4268 hsa04115 p53 signaling pathway 983_1019_1017_4193_7157_1026 6 5.06E-05 0.00354536 0.000147723 18369 hsa-mir-4268 hsa05016 Huntington's disease 6874_9001_1387_5430_7157_3065_3064_10476_2033 9 6.28E-05 0.004397272 0.000170188 18370 hsa-mir-4268 hsa05211 Renal cell carcinoma 5594_1387_3725_2033_207_208 6 6.32E-05 0.004424888 0.000170188 18371 hsa-mir-4268 hsa04330 Notch signaling pathway 1387_9612_3065_2033_8850 5 9.04E-05 0.006329672 0.000234432 18372 hsa-mir-4268 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 9.91E-05 0.006939593 0.000247843 18373 hsa-mir-4268 hsa04012 ErbB signaling pathway 5594_3725_4609_1026_207_208 6 0.000168243 0.01177704 0.000406105 18374 hsa-mir-4268 hsa04210 Apoptosis 1147_3551_5970_7157_207_208 6 0.000189069 0.013234848 0.000441162 18375 hsa-mir-4268 hsa04530 Tight junction 1460_1499_1019_4628_60412_207_208 7 0.00028256 0.019779186 0.000638038 18376 hsa-mir-4268 hsa04630 Jak-STAT signaling pathway 10401_1387_4609_2033_207_208_8554 7 0.00057409 0.040186289 0.001255822 18377 hsa-mir-4268 hsa03420 Nucleotide excision repair 2967_2968_5981_5887 4 0.000814586 0.057021049 0.001727911 18378 hsa-mir-4268 hsa04612 Antigen processing and presentation 4800_4801_3312_1514_3326 5 0.001419316 0.099352122 0.002922121 18379 hsa-mir-4268 hsa04950 Maturity onset diabetes of the young 3651_5080_6927 3 0.001644107 0.115087474 0.003288214 18380 hsa-mir-4268 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_3551_5970_3725 4 0.004236098 0.29652683 0.008236856 18381 hsa-mir-4268 hsa04720 Long-term potentiation 5594_1387_468_2033 4 0.005096872 0.356781047 0.009642731 18382 hsa-mir-4268 hsa04062 Chemokine signaling pathway 1147_3551_5594_5970_207_208 6 0.008234515 0.576416072 0.014909999 18383 hsa-mir-4268 hsa04930 Type II diabetes mellitus 3651_3551_5594 3 0.008499802 0.594986122 0.014909999 18384 hsa-mir-4268 hsa04910 Insulin signaling pathway 3551_5594_5211_207_208 5 0.008519999 0.59639996 0.014909999 18385 hsa-mir-4268 hsa04150 mTOR signaling pathway 5594_207_208 3 0.012331548 0.863208364 0.021053863 18386 hsa-mir-4268 hsa05131 Shigellosis 1499_7534_10382 3 0.014897859 1 0.023798203 18387 hsa-mir-4268 hsa05130 Pathogenic Escherichia coli infection 1499_7534_10382 3 0.014897859 1 0.023798203 18388 hsa-mir-4268 hsa04916 Melanogenesis 1499_5594_1387_2033 4 0.01495887 1 0.023798203 18389 hsa-mir-4268 hsa04370 VEGF signaling pathway 5594_207_208 3 0.032982125 1 0.051305528 18390 hsa-mir-4268 hsa04664 Fc epsilon RI signaling pathway 5594_207_208 3 0.035108239 1 0.053425581 18391 hsa-mir-4268 hsa04510 Focal adhesion 1499_5594_3725_207_208 5 0.038129785 1 0.056789041 18392 hsa-mir-4268 hsa03030 DNA replication 5981_4171 2 0.043381531 1 0.063264732 18393 hsa-mir-4271 hsa04950 Maturity onset diabetes of the young 3651_5080 2 0.000330014 0.002640114 0.002640114 18394 hsa-mir-4271 hsa04530 Tight junction 60412_4628 2 0.00905837 0.072466958 0.036233479 18395 hsa-mir-4271 hsa04930 Type II diabetes mellitus 3651 1 0.046431905 0.371455239 0.123818413 18396 hsa-mir-4274 hsa04350 TGF-beta signaling pathway 4087_3398_2033_7046_1387_5595_5594_3397_3399 9 4.50E-12 2.57E-10 2.57E-10 18397 hsa-mir-4274 hsa04520 Adherens junction 4301_1499_4087_2033_7046_1387_5595_5594 8 9.46E-11 5.39E-09 2.70E-09 18398 hsa-mir-4274 hsa04916 Melanogenesis 1499_2033_1387_5595_5594_808_801_805 8 6.65E-10 3.79E-08 1.26E-08 18399 hsa-mir-4274 hsa05200 Pathways in cancer 1499_4087_5925_2033_6502_7046_1387_5595_5594_862_6772 11 1.88E-09 1.07E-07 2.66E-08 18400 hsa-mir-4274 hsa04720 Long-term potentiation 2033_1387_5595_5594_808_801_805 7 2.33E-09 1.33E-07 2.66E-08 18401 hsa-mir-4274 hsa05214 Glioma 5925_5595_5594_808_801_805 6 3.65E-08 2.08E-06 3.47E-07 18402 hsa-mir-4274 hsa05215 Prostate cancer 1499_5925_2033_1387_5595_5594 6 1.98E-07 1.13E-05 1.50E-06 18403 hsa-mir-4274 hsa05212 Pancreatic cancer 1499_5925_2033_1387_5595_5594 6 2.10E-07 1.20E-05 1.50E-06 18404 hsa-mir-4274 hsa04912 GnRH signaling pathway 1432_5595_5594_808_801_805 6 6.21E-07 3.54E-05 3.93E-06 18405 hsa-mir-4274 hsa04010 MAPK signaling pathway 9261_4208_1432_7867_7046_5595_5594_6722 8 8.51E-07 4.85E-05 4.85E-06 18406 hsa-mir-4274 hsa04370 VEGF signaling pathway 9261_1432_7867_5595_5594 5 2.72E-06 0.000155308 1.41E-05 18407 hsa-mir-4274 hsa05210 Colorectal cancer 1499_4087_7046_5595_5594 5 4.09E-06 0.000232854 1.94E-05 18408 hsa-mir-4274 hsa04330 Notch signaling pathway 2033_1387_388585_8850 4 1.05E-05 0.000600715 4.62E-05 18409 hsa-mir-4274 hsa04270 Vascular smooth muscle contraction 5595_5594_808_801_805 5 1.98E-05 0.00112963 7.83E-05 18410 hsa-mir-4274 hsa04110 Cell cycle 4087_5925_2033_6502_1387 5 2.06E-05 0.001174657 7.83E-05 18411 hsa-mir-4274 hsa04910 Insulin signaling pathway 5595_5594_808_801_805 5 4.09E-05 0.002328901 0.000145556 18412 hsa-mir-4274 hsa05211 Renal cell carcinoma 2033_1387_5595_5594 4 5.14E-05 0.00293241 0.000172495 18413 hsa-mir-4274 hsa05220 Chronic myeloid leukemia 5925_7046_5595_5594 4 5.99E-05 0.003413469 0.000189637 18414 hsa-mir-4274 hsa05216 Thyroid cancer 1499_5595_5594 3 8.50E-05 0.004844033 0.000254949 18415 hsa-mir-4274 hsa05010 Alzheimer's disease 5595_5594_808_801_805 5 0.000127802 0.007284691 0.000364235 18416 hsa-mir-4274 hsa04620 Toll-like receptor signaling pathway 1432_5595_5594_6772 4 0.000187523 0.010688828 0.000508992 18417 hsa-mir-4274 hsa05219 Bladder cancer 5925_5595_5594 3 0.000237149 0.013517491 0.000614431 18418 hsa-mir-4274 hsa04930 Type II diabetes mellitus 3651_5595_5594 3 0.000287403 0.016381982 0.00071226 18419 hsa-mir-4274 hsa05213 Endometrial cancer 1499_5595_5594 3 0.000430143 0.024518172 0.001021591 18420 hsa-mir-4274 hsa05223 Non-small cell lung cancer 5925_5595_5594 3 0.00047791 0.027240876 0.001089635 18421 hsa-mir-4274 hsa05221 Acute myeloid leukemia 5595_5594_862 3 0.000611849 0.034875394 0.001341361 18422 hsa-mir-4274 hsa04310 Wnt signaling pathway 1499_4087_2033_1387 4 0.000810492 0.046198039 0.001711038 18423 hsa-mir-4274 hsa05218 Melanoma 5925_5595_5594 3 0.001024966 0.058423085 0.002086539 18424 hsa-mir-4274 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.001238492 0.070594069 0.002434278 18425 hsa-mir-4274 hsa04664 Fc epsilon RI signaling pathway 1432_5595_5594 3 0.001379069 0.078606917 0.002620231 18426 hsa-mir-4274 hsa04950 Maturity onset diabetes of the young 3651_168620 2 0.002178029 0.124147676 0.004004764 18427 hsa-mir-4274 hsa04660 T cell receptor signaling pathway 1432_5595_5594 3 0.003437139 0.195916918 0.006122404 18428 hsa-mir-4274 hsa04670 Leukocyte transendothelial migration 4301_1432_1499 3 0.004559537 0.25989361 0.007875564 18429 hsa-mir-4274 hsa04630 Jak-STAT signaling pathway 2033_1387_6772 3 0.008694134 0.49556563 0.01457546 18430 hsa-mir-4274 hsa04150 mTOR signaling pathway 5595_5594 2 0.009139691 0.520962366 0.014884639 18431 hsa-mir-4274 hsa04020 Calcium signaling pathway 808_801_805 3 0.013686942 0.78015571 0.021670992 18432 hsa-mir-4274 hsa04062 Chemokine signaling pathway 5595_5594_6772 3 0.015506494 0.883870138 0.023888382 18433 hsa-mir-4274 hsa04730 Long-term depression 5595_5594 2 0.016248332 0.926154941 0.024372498 18434 hsa-mir-4274 hsa04662 B cell receptor signaling pathway 5595_5594 2 0.017967779 1 0.026169788 18435 hsa-mir-4274 hsa04510 Focal adhesion 1499_5595_5594 3 0.018364764 1 0.026169788 18436 hsa-mir-4274 hsa05222 Small cell lung cancer 5925_6502 2 0.023070402 1 0.031975155 18437 hsa-mir-4274 hsa04012 ErbB signaling pathway 5595_5594 2 0.023560641 1 0.031975155 18438 hsa-mir-4274 hsa04540 Gap junction 5595_5594 2 0.026591091 1 0.035248656 18439 hsa-mir-4274 hsa04360 Axon guidance 5595_5594 2 0.049020994 1 0.063504469 18440 hsa-mir-4276 hsa05200 Pathways in cancer 4088_3065_5925_367_3326_2932_3265 7 6.45E-09 3.10E-07 1.75E-07 18441 hsa-mir-4276 hsa05215 Prostate cancer 5925_367_3326_2932_3265 5 1.04E-08 4.98E-07 1.75E-07 18442 hsa-mir-4276 hsa05212 Pancreatic cancer 5925_367_3326_2932_3265 5 1.10E-08 5.26E-07 1.75E-07 18443 hsa-mir-4276 hsa05220 Chronic myeloid leukemia 4088_3065_5925_3265 4 4.53E-07 2.18E-05 5.44E-06 18444 hsa-mir-4276 hsa04110 Cell cycle 4088_3065_5925_2932 4 2.67E-06 0.000128379 2.57E-05 18445 hsa-mir-4276 hsa05010 Alzheimer's disease 2902_2906_2932_351 4 1.24E-05 0.00059299 9.88E-05 18446 hsa-mir-4276 hsa05016 Huntington's disease 2902_3065_6667_9519 4 1.56E-05 0.000747867 0.000106838 18447 hsa-mir-4276 hsa04720 Long-term potentiation 2902_2906_3265 3 3.28E-05 0.001575437 0.00019693 18448 hsa-mir-4276 hsa04530 Tight junction 22800_3265_8573 3 0.000186924 0.008972364 0.000996929 18449 hsa-mir-4276 hsa05219 Bladder cancer 5925_3265 2 0.000567546 0.027242207 0.002724221 18450 hsa-mir-4276 hsa05213 Endometrial cancer 2932_3265 2 0.00085434 0.041008341 0.003636762 18451 hsa-mir-4276 hsa05223 Non-small cell lung cancer 5925_3265 2 0.00091852 0.04408894 0.003636762 18452 hsa-mir-4276 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906 2 0.000984956 0.047277903 0.003636762 18453 hsa-mir-4276 hsa05214 Glioma 5925_3265 2 0.001311678 0.06296052 0.00449718 18454 hsa-mir-4276 hsa05218 Melanoma 5925_3265 2 0.00155451 0.07461648 0.004974432 18455 hsa-mir-4276 hsa04662 B cell receptor signaling pathway 2932_3265 2 0.001727412 0.082915762 0.005182235 18456 hsa-mir-4276 hsa04512 ECM-receptor interaction 6383_9672 2 0.002148347 0.103120668 0.005516154 18457 hsa-mir-4276 hsa05210 Colorectal cancer 4088_2932 2 0.002148347 0.103120668 0.005516154 18458 hsa-mir-4276 hsa04350 TGF-beta signaling pathway 4088_6667 2 0.002298397 0.110323072 0.005516154 18459 hsa-mir-4276 hsa04012 ErbB signaling pathway 2932_3265 2 0.002298397 0.110323072 0.005516154 18460 hsa-mir-4276 hsa04916 Melanogenesis 2932_3265 2 0.00323931 0.155486863 0.007404136 18461 hsa-mir-4276 hsa04660 T cell receptor signaling pathway 2932_3265 2 0.003607696 0.173169426 0.007871338 18462 hsa-mir-4276 hsa04360 Axon guidance 2932_3265 2 0.005042869 0.242057706 0.010524248 18463 hsa-mir-4276 hsa04514 Cell adhesion molecules (CAMs) 6383_9672 2 0.005266126 0.252774038 0.010532252 18464 hsa-mir-4276 hsa04910 Insulin signaling pathway 2932_3265 2 0.00557079 0.267397906 0.010695916 18465 hsa-mir-4276 hsa04310 Wnt signaling pathway 4088_2932 2 0.006699323 0.321567497 0.012367981 18466 hsa-mir-4276 hsa04020 Calcium signaling pathway 2902_2906 2 0.009632848 0.462376684 0.017125062 18467 hsa-mir-4276 hsa04062 Chemokine signaling pathway 2932_3265 2 0.010544106 0.506117098 0.018075611 18468 hsa-mir-4276 hsa04510 Focal adhesion 2932_3265 2 0.011925285 0.572413677 0.019738403 18469 hsa-mir-4276 hsa04810 Regulation of actin cytoskeleton 22800_3265 2 0.013381755 0.642324243 0.021410808 18470 hsa-mir-4276 hsa04080 Neuroactive ligand-receptor interaction 2902_2906 2 0.017925396 0.860419014 0.027755452 18471 hsa-mir-4276 hsa04010 MAPK signaling pathway 22800_3265 2 0.020203537 0.969769757 0.030305305 18472 hsa-mir-4276 hsa05216 Thyroid cancer 3265 1 0.023716246 1 0.034496358 18473 hsa-mir-4276 hsa03022 Basal transcription factors 9519 1 0.029948963 1 0.042280889 18474 hsa-mir-4276 hsa04330 Notch signaling pathway 3065 1 0.037686248 1 0.051683997 18475 hsa-mir-4276 hsa05217 Basal cell carcinoma 2932 1 0.043833458 1 0.058444611 18476 hsa-mir-4276 hsa04340 Hedgehog signaling pathway 2932 1 0.04536437 1 0.058851075 18477 hsa-mir-4276 hsa05221 Acute myeloid leukemia 3265 1 0.046892934 1 0.059233179 18478 hsa-mir-4278 hsa05200 Pathways in cancer 5159_5156_1956_867_2033_1399_1398_2113_3815_7046_5594_6774_6772_7189_51588_5914_1387_6776 18 9.76E-22 5.46E-20 2.83E-20 18479 hsa-mir-4278 hsa04630 Jak-STAT signaling pathway 3717_867_2057_3575_3559_2033_5781_5777_3560_6774_6772_51588_1387_6776_2690 15 1.01E-21 5.66E-20 2.83E-20 18480 hsa-mir-4278 hsa04520 Adherens junction 1956_2033_7046_5770_6714_3643_5777_5594_1387 9 6.57E-14 3.68E-12 1.12E-12 18481 hsa-mir-4278 hsa04060 Cytokine-cytokine receptor interaction 5159_5156_7852_1956_2057_3575_3559_658_3815_7046_3560_2690 12 8.02E-14 4.49E-12 1.12E-12 18482 hsa-mir-4278 hsa04012 ErbB signaling pathway 1956_867_1399_1398_6714_5594_6464_6776_2066 9 1.33E-13 7.43E-12 1.49E-12 18483 hsa-mir-4278 hsa05220 Chronic myeloid leukemia 867_5781_1399_1398_7046_5594_6464_6776 8 2.62E-12 1.47E-10 2.45E-11 18484 hsa-mir-4278 hsa04620 Toll-like receptor signaling pathway 3654_4615_353376_3661_148022_5594_6772_7189 8 2.62E-11 1.47E-09 2.10E-10 18485 hsa-mir-4278 hsa05211 Renal cell carcinoma 2033_5781_1399_1398_2113_5594_1387 7 1.21E-10 6.78E-09 8.48E-10 18486 hsa-mir-4278 hsa04062 Chemokine signaling pathway 3717_7852_1399_1398_5594_6774_6464_6772 8 3.24E-09 1.81E-07 2.01E-08 18487 hsa-mir-4278 hsa04510 Focal adhesion 5159_5156_1956_1399_1398_6714_5594_6464 8 5.29E-09 2.96E-07 2.96E-08 18488 hsa-mir-4278 hsa04910 Insulin signaling pathway 867_1399_1398_5770_3643_5594_6464 7 8.79E-09 4.92E-07 4.48E-08 18489 hsa-mir-4278 hsa04350 TGF-beta signaling pathway 2033_658_7046_5594_5515_1387 6 1.91E-08 1.07E-06 8.70E-08 18490 hsa-mir-4278 hsa05215 Prostate cancer 5159_5156_1956_2033_5594_1387 6 2.04E-08 1.14E-06 8.70E-08 18491 hsa-mir-4278 hsa05212 Pancreatic cancer 5159_5156_1956_2033_5594_1387 6 2.17E-08 1.22E-06 8.70E-08 18492 hsa-mir-4278 hsa04330 Notch signaling pathway 9612_2033_2648_8850_1387 5 4.15E-08 2.32E-06 1.54E-07 18493 hsa-mir-4278 hsa04010 MAPK signaling pathway 5159_5156_1956_1399_1398_7046_5594_7189 8 4.40E-08 2.46E-06 1.54E-07 18494 hsa-mir-4278 hsa05221 Acute myeloid leukemia 3815_5594_6774_5914_6776 5 1.20E-07 6.70E-06 3.94E-07 18495 hsa-mir-4278 hsa05214 Glioma 5159_5156_1956_5594_6464 5 1.88E-07 1.05E-05 5.86E-07 18496 hsa-mir-4278 hsa05210 Colorectal cancer 5159_5156_1956_7046_5594 5 6.29E-07 3.52E-05 1.85E-06 18497 hsa-mir-4278 hsa04540 Gap junction 5159_5156_1956_6714_5594 5 1.02E-06 5.69E-05 2.85E-06 18498 hsa-mir-4278 hsa04660 T cell receptor signaling pathway 867_919_5777_5594_1493 5 2.24E-06 0.000125647 5.98E-06 18499 hsa-mir-4278 hsa04810 Regulation of actin cytoskeleton 5159_5156_1956_1399_1398_5594 6 3.51E-06 0.000196803 8.95E-06 18500 hsa-mir-4278 hsa04650 Natural killer cell mediated cytotoxicity 5781_919_5777_5594_6464 5 6.53E-06 0.000365652 1.59E-05 18501 hsa-mir-4278 hsa05218 Melanoma 5159_5156_1956_5594 4 1.11E-05 0.000620199 2.58E-05 18502 hsa-mir-4278 hsa04640 Hematopoietic cell lineage 2057_3575_3559_3815 4 2.38E-05 0.001334507 5.34E-05 18503 hsa-mir-4278 hsa04916 Melanogenesis 2033_3815_5594_1387 4 4.67E-05 0.002614959 0.000100575 18504 hsa-mir-4278 hsa04920 Adipocytokine signaling pathway 3717_5781_6774 3 0.000291018 0.016297013 0.000603593 18505 hsa-mir-4278 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_5781_6714 3 0.00034285 0.01919962 0.000685701 18506 hsa-mir-4278 hsa04020 Calcium signaling pathway 5159_5156_1956_2066 4 0.000394151 0.022072465 0.000747201 18507 hsa-mir-4278 hsa04720 Long-term potentiation 2033_5594_1387 3 0.000400286 0.022416025 0.000747201 18508 hsa-mir-4278 hsa04912 GnRH signaling pathway 1956_6714_5594 3 0.001118426 0.062631846 0.002020382 18509 hsa-mir-4278 hsa04120 Ubiquitin mediated proteolysis 867_7189_51588 3 0.002263347 0.126747449 0.003960858 18510 hsa-mir-4278 hsa04310 Wnt signaling pathway 2033_5515_1387 3 0.002899977 0.162398686 0.004876789 18511 hsa-mir-4278 hsa05219 Bladder cancer 1956_5594 2 0.002960907 0.165810813 0.004876789 18512 hsa-mir-4278 hsa04930 Type II diabetes mellitus 3643_5594 2 0.00337159 0.188809061 0.005394545 18513 hsa-mir-4278 hsa05213 Endometrial cancer 1956_5594 2 0.004426838 0.247902931 0.006886193 18514 hsa-mir-4278 hsa05223 Non-small cell lung cancer 1956_5594 2 0.00475291 0.266162934 0.007193593 18515 hsa-mir-4278 hsa04730 Long-term depression 5594_5515 2 0.007951436 0.445280402 0.011717905 18516 hsa-mir-4278 hsa04662 B cell receptor signaling pathway 5777_5594 2 0.008811895 0.493466099 0.012652977 18517 hsa-mir-4278 hsa04370 VEGF signaling pathway 6714_5594 2 0.009257089 0.518396995 0.012959925 18518 hsa-mir-4278 hsa05222 Small cell lung cancer 7189_51588 2 0.011381588 0.637368936 0.015545584 18519 hsa-mir-4278 hsa04210 Apoptosis 3654_4615 2 0.012133015 0.67944884 0.016177353 18520 hsa-mir-4278 hsa04110 Cell cycle 2033_1387 2 0.020774115 1 0.027054661 18521 hsa-mir-4278 hsa04670 Leukocyte transendothelial migration 7852_5781 2 0.021745683 1 0.027676323 18522 hsa-mir-4278 hsa04360 Axon guidance 7852_5594 2 0.024771162 1 0.030826335 18523 hsa-mir-4278 hsa04530 Tight junction 6714_5515 2 0.026878232 1 0.032721326 18524 hsa-mir-4278 hsa05016 Huntington's disease 2033_1387 2 0.047446003 1 0.056531408 18525 hsa-mir-4279 hsa05215 Prostate cancer 5925_3326_2932_3265 4 4.75E-07 2.28E-05 1.19E-05 18526 hsa-mir-4279 hsa05212 Pancreatic cancer 5925_3326_2932_3265 4 4.96E-07 2.38E-05 1.19E-05 18527 hsa-mir-4279 hsa05200 Pathways in cancer 3065_5925_3326_2932_3265 5 3.04E-06 0.000145807 4.86E-05 18528 hsa-mir-4279 hsa05010 Alzheimer's disease 2902_2906_2932_351 4 7.06E-06 0.000338886 8.47E-05 18529 hsa-mir-4279 hsa05016 Huntington's disease 2902_3065_6667_9519 4 8.91E-06 0.00042777 8.56E-05 18530 hsa-mir-4279 hsa04720 Long-term potentiation 2902_2906_3265 3 2.17E-05 0.001041381 0.000148769 18531 hsa-mir-4279 hsa05220 Chronic myeloid leukemia 3065_5925_3265 3 2.17E-05 0.001041381 0.000148769 18532 hsa-mir-4279 hsa04110 Cell cycle 3065_5925_2932 3 8.25E-05 0.003962273 0.000495284 18533 hsa-mir-4279 hsa04530 Tight junction 22800_3265_8573 3 0.000124132 0.005958337 0.000662037 18534 hsa-mir-4279 hsa05219 Bladder cancer 5925_3265 2 0.000433123 0.02078988 0.002078988 18535 hsa-mir-4279 hsa05213 Endometrial cancer 2932_3265 2 0.000652422 0.031316265 0.002777971 18536 hsa-mir-4279 hsa05223 Non-small cell lung cancer 5925_3265 2 0.000701526 0.033673248 0.002777971 18537 hsa-mir-4279 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906 2 0.000752367 0.036113627 0.002777971 18538 hsa-mir-4279 hsa05214 Glioma 5925_3265 2 0.001002534 0.048121611 0.003437258 18539 hsa-mir-4279 hsa05218 Melanoma 5925_3265 2 0.001188606 0.057053083 0.003803539 18540 hsa-mir-4279 hsa04662 B cell receptor signaling pathway 2932_3265 2 0.001321159 0.063415644 0.003963478 18541 hsa-mir-4279 hsa04512 ECM-receptor interaction 9672_6383 2 0.001644077 0.078915718 0.004444436 18542 hsa-mir-4279 hsa04350 TGF-beta signaling pathway 6667_659 2 0.001759256 0.084444284 0.004444436 18543 hsa-mir-4279 hsa04012 ErbB signaling pathway 2932_3265 2 0.001759256 0.084444284 0.004444436 18544 hsa-mir-4279 hsa04916 Melanogenesis 2932_3265 2 0.002482241 0.119147559 0.005957378 18545 hsa-mir-4279 hsa04660 T cell receptor signaling pathway 2932_3265 2 0.002765625 0.132750007 0.006321429 18546 hsa-mir-4279 hsa04360 Axon guidance 2932_3265 2 0.003871167 0.185815998 0.008438292 18547 hsa-mir-4279 hsa04514 Cell adhesion molecules (CAMs) 9672_6383 2 0.004043348 0.19408072 0.008438292 18548 hsa-mir-4279 hsa04910 Insulin signaling pathway 2932_3265 2 0.004278396 0.205363006 0.008556792 18549 hsa-mir-4279 hsa04020 Calcium signaling pathway 2902_2906 2 0.007420447 0.356181441 0.014247258 18550 hsa-mir-4279 hsa04062 Chemokine signaling pathway 2932_3265 2 0.008127201 0.390105638 0.015004063 18551 hsa-mir-4279 hsa04510 Focal adhesion 2932_3265 2 0.009199605 0.441581024 0.016354853 18552 hsa-mir-4279 hsa04810 Regulation of actin cytoskeleton 22800_3265 2 0.010331948 0.495933487 0.01771191 18553 hsa-mir-4279 hsa04080 Neuroactive ligand-receptor interaction 2902_2906 2 0.013873459 0.66592605 0.022962967 18554 hsa-mir-4279 hsa04010 MAPK signaling pathway 22800_3265 2 0.015653921 0.751388198 0.025046273 18555 hsa-mir-4279 hsa05216 Thyroid cancer 3265 1 0.02078378 0.997621448 0.032181337 18556 hsa-mir-4279 hsa03022 Basal transcription factors 9519 1 0.02625625 1 0.039384374 18557 hsa-mir-4279 hsa04330 Notch signaling pathway 3065 1 0.033055883 1 0.048081284 18558 hsa-mir-4279 hsa05217 Basal cell carcinoma 2932 1 0.038463006 1 0.054300714 18559 hsa-mir-4279 hsa04340 Hedgehog signaling pathway 2932 1 0.03981028 1 0.054596955 18560 hsa-mir-4279 hsa05221 Acute myeloid leukemia 3265 1 0.041155756 1 0.054874342 18561 hsa-mir-4279 hsa04730 Long-term depression 3265 1 0.049190984 1 0.062978127 18562 hsa-mir-4279 hsa05211 Renal cell carcinoma 3265 1 0.049857684 1 0.062978127 18563 hsa-mir-4280 hsa05200 Pathways in cancer 4087_6688_5925_2113_7046_6772 6 1.38E-06 3.17E-05 3.17E-05 18564 hsa-mir-4280 hsa04520 Adherens junction 4301_4087_7046 3 9.53E-05 0.002191418 0.001095709 18565 hsa-mir-4280 hsa05220 Chronic myeloid leukemia 5925_7046 2 0.003061815 0.070421742 0.018700345 18566 hsa-mir-4280 hsa05210 Colorectal cancer 4087_7046 2 0.003801895 0.087443585 0.018700345 18567 hsa-mir-4280 hsa04350 TGF-beta signaling pathway 4087_7046 2 0.004065292 0.093501723 0.018700345 18568 hsa-mir-4280 hsa04110 Cell cycle 4087_5925 2 0.007378758 0.16971144 0.02828524 18569 hsa-mir-4280 hsa05219 Bladder cancer 5925 1 0.044838005 1 0.140482443 18570 hsa-mir-4281 hsa05200 Pathways in cancer 3716_5371_367_5595_5594_5599_5914_1387_6257_6256_8031_836_6258_7704_3091_5970_7428_1870_1871_595_7157_4087_2113_4609_1869_3725_4088_4089_3066_3065_5925_2034_2033_4846_8554_4790_4792 37 2.18E-38 1.40E-36 1.40E-36 18571 hsa-mir-4281 hsa05220 Chronic myeloid leukemia 5595_5594_5970_1870_1871_595_7157_4609_1869_4088_4089_3066_3065_5925_4790_4792_6464 17 1.22E-22 7.81E-21 3.91E-21 18572 hsa-mir-4281 hsa04110 Cell cycle 5591_1387_1870_1871_595_7157_4087_10912_1869_4088_4089_3066_3065_4616_5925_2033_5933 17 1.34E-19 8.59E-18 2.86E-18 18573 hsa-mir-4281 hsa05222 Small cell lung cancer 6257_6256_6258_5970_1870_1871_595_7157_4609_1869_5925_4846_8554_4790_4792 15 1.37E-18 8.79E-17 2.20E-17 18574 hsa-mir-4281 hsa05215 Prostate cancer 367_5595_5594_1387_5970_1870_1871_595_7157_1869_5925_2033_4790_4792 14 6.35E-17 4.07E-15 7.81E-16 18575 hsa-mir-4281 hsa05212 Pancreatic cancer 367_5595_5594_1387_5970_1870_1871_595_7157_1869_5925_2033_4790_4792 14 7.32E-17 4.69E-15 7.81E-16 18576 hsa-mir-4281 hsa05223 Non-small cell lung cancer 5595_5594_6257_6256_6258_1870_1871_595_7157_1869_5925 11 1.33E-14 8.53E-13 1.22E-13 18577 hsa-mir-4281 hsa05216 Thyroid cancer 5595_5594_6257_6256_8031_6258_595_7157_4609 9 1.37E-13 8.75E-12 1.09E-12 18578 hsa-mir-4281 hsa05210 Colorectal cancer 5595_5594_5599_836_595_7157_4087_4609_3725_4088_4089 11 1.03E-12 6.59E-11 7.33E-12 18579 hsa-mir-4281 hsa05219 Bladder cancer 5595_5594_1870_1871_595_7157_4609_1869_5925 9 2.42E-12 1.55E-10 1.55E-11 18580 hsa-mir-4281 hsa04520 Adherens junction 6714_5595_5594_1387_5777_4087_1457_4088_4089_2033 10 1.74E-11 1.11E-09 1.01E-10 18581 hsa-mir-4281 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_7704_5970_595_4609_4790 9 3.67E-11 2.35E-09 1.96E-10 18582 hsa-mir-4281 hsa05214 Glioma 5595_5594_1870_1871_595_7157_1869_5925_6464 9 8.03E-11 5.14E-09 3.95E-10 18583 hsa-mir-4281 hsa04010 MAPK signaling pathway 5595_5594_5599_4208_836_5970_3312_7157_10912_4609_3725_4763_4616_4790 14 1.09E-10 6.96E-09 4.97E-10 18584 hsa-mir-4281 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2113_3725_2034_2033 9 1.84E-10 1.18E-08 7.86E-10 18585 hsa-mir-4281 hsa04310 Wnt signaling pathway 5599_1387_595_7157_4087_4609_3725_1457_4088_4089_2033 11 3.84E-10 2.46E-08 1.54E-09 18586 hsa-mir-4281 hsa04350 TGF-beta signaling pathway 5595_5594_1387_4087_4609_4088_4089_2033_5933 9 8.62E-10 5.52E-08 3.25E-09 18587 hsa-mir-4281 hsa04920 Adipocytokine signaling pathway 10891_5599_6257_6256_6258_5970_4790_4792 8 2.72E-09 1.74E-07 9.66E-09 18588 hsa-mir-4281 hsa05218 Melanoma 5595_5594_1870_1871_595_7157_1869_5925 8 4.14E-09 2.65E-07 1.39E-08 18589 hsa-mir-4281 hsa05016 Huntington's disease 6874_10891_1387_2902_836_7157_3066_3065_3064_2033 10 3.99E-08 2.55E-06 1.28E-07 18590 hsa-mir-4281 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5599_836_5970_3725_4790_4792 7 9.30E-08 5.95E-06 2.79E-07 18591 hsa-mir-4281 hsa04630 Jak-STAT signaling pathway 3716_3566_1387_5777_6773_595_4609_2033_8554 9 9.58E-08 6.13E-06 2.79E-07 18592 hsa-mir-4281 hsa04662 B cell receptor signaling pathway 5595_5594_5777_5970_3725_4790_4792 7 1.32E-07 8.43E-06 3.67E-07 18593 hsa-mir-4281 hsa04012 ErbB signaling pathway 6714_5595_5594_5599_4609_3725_6464 7 3.38E-07 2.17E-05 9.02E-07 18594 hsa-mir-4281 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5970_3725_4790_4792 7 9.29E-07 5.94E-05 2.38E-06 18595 hsa-mir-4281 hsa04660 T cell receptor signaling pathway 5595_5594_5777_5970_3725_4790_4792 7 1.50E-06 9.58E-05 3.69E-06 18596 hsa-mir-4281 hsa04330 Notch signaling pathway 1387_9612_3066_3065_2033 5 4.87E-06 0.000311379 1.15E-05 18597 hsa-mir-4281 hsa04062 Chemokine signaling pathway 5590_5595_5594_6773_5970_4790_4792_6464 8 5.60E-06 0.000358334 1.28E-05 18598 hsa-mir-4281 hsa04910 Insulin signaling pathway 6720_10891_5590_5595_5594_5599_6464 7 6.24E-06 0.000399488 1.38E-05 18599 hsa-mir-4281 hsa05213 Endometrial cancer 5595_5594_595_7157_4609 5 7.69E-06 0.000492194 1.64E-05 18600 hsa-mir-4281 hsa04115 p53 signaling pathway 836_595_7157_10912_4616 5 2.77E-05 0.001775013 5.73E-05 18601 hsa-mir-4281 hsa04720 Long-term potentiation 5595_5594_1387_2902_2033 5 4.05E-05 0.00258924 8.09E-05 18602 hsa-mir-4281 hsa04510 Focal adhesion 6714_5595_5594_5599_595_3725_6464 7 7.39E-05 0.004732639 0.000143413 18603 hsa-mir-4281 hsa04930 Type II diabetes mellitus 5590_5595_5594_5599 4 8.72E-05 0.00557878 0.000160172 18604 hsa-mir-4281 hsa04210 Apoptosis 836_5970_7157_4790_4792 5 8.76E-05 0.005606032 0.000160172 18605 hsa-mir-4281 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_7157_4846 4 0.000192677 0.012331303 0.000342536 18606 hsa-mir-4281 hsa04912 GnRH signaling pathway 6714_5595_5594_5599_3725 5 0.000208426 0.013339247 0.00036052 18607 hsa-mir-4281 hsa03320 PPAR signaling pathway 6257_6256_6258_2168 4 0.000431895 0.027641288 0.000727402 18608 hsa-mir-4281 hsa04370 VEGF signaling pathway 6714_5595_5594_4846 4 0.000608696 0.038956567 0.000984786 18609 hsa-mir-4281 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_5777_6464 5 0.000615491 0.039391453 0.000984786 18610 hsa-mir-4281 hsa04916 Melanogenesis 5595_5594_1387_2033 4 0.001776575 0.113700785 0.002745463 18611 hsa-mir-4281 hsa05010 Alzheimer's disease 5595_5594_2902_836_4846 5 0.00180171 0.115309467 0.002745463 18612 hsa-mir-4281 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.002289915 0.146554591 0.003408246 18613 hsa-mir-4281 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428_8554 4 0.004875161 0.312010307 0.007091143 18614 hsa-mir-4281 hsa04730 Long-term depression 5595_5594_4846 3 0.005299712 0.339181575 0.007537368 18615 hsa-mir-4281 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599 3 0.007044061 0.450819897 0.009800433 18616 hsa-mir-4281 hsa04612 Antigen processing and presentation 4800_4801_3312 3 0.009652121 0.617735765 0.013143314 18617 hsa-mir-4281 hsa04540 Gap junction 6714_5595_5594 3 0.010832533 0.693282096 0.014443377 18618 hsa-mir-4281 hsa04530 Tight junction 6714_5590_1457 3 0.029215631 1 0.038159191 18619 hsa-mir-4285 hsa04010 MAPK signaling pathway 9344_6722_5606_5601_5600_2885_4616_10912_5595_5970_1432_5594_5604_5599_2005_2353 16 5.40E-17 2.97E-15 2.97E-15 18620 hsa-mir-4285 hsa05200 Pathways in cancer 5601_8031_2885_2033_9063_8554_5595_5970_5594_5604_6256_5599_6258_2353_1387_6257 16 1.01E-15 5.54E-14 2.77E-14 18621 hsa-mir-4285 hsa04620 Toll-like receptor signaling pathway 5606_5601_5600_5595_5970_1432_5594_5604_5599_2353 10 4.50E-13 2.47E-11 8.25E-12 18622 hsa-mir-4285 hsa04664 Fc epsilon RI signaling pathway 5606_5601_5600_2885_5595_1432_5594_5604_5599 9 2.02E-12 1.11E-10 2.78E-11 18623 hsa-mir-4285 hsa05216 Thyroid cancer 8031_5595_5594_5604_6256_6258_6257 7 5.64E-12 3.10E-10 6.21E-11 18624 hsa-mir-4285 hsa04912 GnRH signaling pathway 5606_5601_5600_2885_5595_1432_5594_5604_5599 9 2.74E-11 1.51E-09 2.51E-10 18625 hsa-mir-4285 hsa04660 T cell receptor signaling pathway 5601_5600_2885_5595_5970_1432_5594_5604_2353 9 3.20E-11 1.76E-09 2.51E-10 18626 hsa-mir-4285 hsa04350 TGF-beta signaling pathway 6667_2033_5595_5594_3397_3399_3398_1387 8 1.76E-10 9.69E-09 1.21E-09 18627 hsa-mir-4285 hsa05223 Non-small cell lung cancer 2885_5595_5594_5604_6256_6258_6257 7 2.80E-10 1.54E-08 1.71E-09 18628 hsa-mir-4285 hsa04920 Adipocytokine signaling pathway 5601_5970_6256_5599_6258_6257_10891 7 1.12E-09 6.17E-08 6.17E-09 18629 hsa-mir-4285 hsa05210 Colorectal cancer 5601_2885_5595_5594_5604_5599_2353 7 4.87E-09 2.68E-07 2.43E-08 18630 hsa-mir-4285 hsa05215 Prostate cancer 2885_2033_5595_5970_5594_5604_1387 7 6.59E-09 3.62E-07 3.00E-08 18631 hsa-mir-4285 hsa05212 Pancreatic cancer 2885_2033_5595_5970_5594_5604_1387 7 7.09E-09 3.90E-07 3.00E-08 18632 hsa-mir-4285 hsa05211 Renal cell carcinoma 2885_2033_5595_5594_5604_1387 6 6.45E-08 3.55E-06 2.53E-07 18633 hsa-mir-4285 hsa04662 B cell receptor signaling pathway 2885_5595_5970_5594_5604_2353 6 8.10E-08 4.45E-06 2.97E-07 18634 hsa-mir-4285 hsa04910 Insulin signaling pathway 5601_2885_5595_5594_5604_5599_10891 7 1.24E-07 6.81E-06 4.26E-07 18635 hsa-mir-4285 hsa05222 Small cell lung cancer 9063_8554_5970_6256_6258_6257 6 1.74E-07 9.56E-06 5.62E-07 18636 hsa-mir-4285 hsa04012 ErbB signaling pathway 5601_2885_5595_5594_5604_5599 6 1.85E-07 1.02E-05 5.66E-07 18637 hsa-mir-4285 hsa05221 Acute myeloid leukemia 2885_5595_5970_5594_5604 5 7.90E-07 4.35E-05 2.29E-06 18638 hsa-mir-4285 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5601_5600_5970_1432_5599 5 1.87E-06 0.00010274 5.14E-06 18639 hsa-mir-4285 hsa04720 Long-term potentiation 2033_5595_5594_5604_1387 5 2.41E-06 0.000132583 6.03E-06 18640 hsa-mir-4285 hsa05220 Chronic myeloid leukemia 2885_5595_5970_5594_5604 5 2.41E-06 0.000132583 6.03E-06 18641 hsa-mir-4285 hsa04370 VEGF signaling pathway 5600_5595_1432_5594_5604 5 2.72E-06 0.000149858 6.52E-06 18642 hsa-mir-4285 hsa04930 Type II diabetes mellitus 5601_5595_5594_5599 4 8.97E-06 0.000493429 2.06E-05 18643 hsa-mir-4285 hsa04916 Melanogenesis 2033_5595_5594_5604_1387 5 1.10E-05 0.000606705 2.43E-05 18644 hsa-mir-4285 hsa05213 Endometrial cancer 2885_5595_5594_5604 4 1.53E-05 0.000843368 3.24E-05 18645 hsa-mir-4285 hsa04510 Focal adhesion 5601_2885_5595_5594_5604_5599 6 2.22E-05 0.001222382 4.53E-05 18646 hsa-mir-4285 hsa05214 Glioma 2885_5595_5594_5604 4 3.52E-05 0.001933692 6.91E-05 18647 hsa-mir-4285 hsa03320 PPAR signaling pathway 6256_6258_2168_6257 4 4.63E-05 0.00254788 8.79E-05 18648 hsa-mir-4285 hsa04630 Jak-STAT signaling pathway 2885_2033_9063_8554_1387 5 6.97E-05 0.003833249 0.000127775 18649 hsa-mir-4285 hsa04520 Adherens junction 2033_5595_5594_1387 4 7.61E-05 0.004187354 0.000135076 18650 hsa-mir-4285 hsa04540 Gap junction 2885_5595_5594_5604 4 0.000133183 0.007325054 0.000228908 18651 hsa-mir-4285 hsa04062 Chemokine signaling pathway 2885_5595_5970_5594_5604 5 0.000189278 0.010410289 0.000315463 18652 hsa-mir-4285 hsa05219 Bladder cancer 5595_5594_5604 3 0.000237149 0.013043193 0.000383623 18653 hsa-mir-4285 hsa04330 Notch signaling pathway 9612_2033_1387 3 0.000324445 0.01784445 0.000505986 18654 hsa-mir-4285 hsa04110 Cell cycle 2033_4616_10912_1387 4 0.000331191 0.018215501 0.000505986 18655 hsa-mir-4285 hsa05014 Amyotrophic lateral sclerosis (ALS) 5606_5600_1432 3 0.000528951 0.029092314 0.000786279 18656 hsa-mir-4285 hsa04650 Natural killer cell mediated cytotoxicity 2885_5595_5594_5604 4 0.000570069 0.031353776 0.000825099 18657 hsa-mir-4285 hsa04120 Ubiquitin mediated proteolysis 7329_9063_672_8554 4 0.000585298 0.032191376 0.00082542 18658 hsa-mir-4285 hsa04310 Wnt signaling pathway 5601_2033_5599_1387 4 0.000810492 0.044577055 0.001114426 18659 hsa-mir-4285 hsa05218 Melanoma 5595_5594_5604 3 0.001024966 0.056373152 0.001342218 18660 hsa-mir-4285 hsa04730 Long-term depression 5595_5594_5604 3 0.001024966 0.056373152 0.001342218 18661 hsa-mir-4285 hsa05016 Huntington's disease 6667_2033_1387_10891 4 0.001743085 0.095869656 0.002229527 18662 hsa-mir-4285 hsa04270 Vascular smooth muscle contraction 5595_5594_5604 3 0.004163839 0.229011154 0.005204799 18663 hsa-mir-4285 hsa04150 mTOR signaling pathway 5595_5594 2 0.009139691 0.502682984 0.011170733 18664 hsa-mir-4285 hsa05010 Alzheimer's disease 6622_5595_5594 3 0.012361031 0.679856721 0.014779494 18665 hsa-mir-4285 hsa04115 p53 signaling pathway 4616_10912 2 0.015416735 0.847920399 0.01804086 18666 hsa-mir-4285 hsa04810 Regulation of actin cytoskeleton 5595_5594_5604 3 0.021496806 1 0.024631756 18667 hsa-mir-4285 hsa04670 Leukocyte transendothelial migration 5600_1432 2 0.043239235 1 0.048533836 18668 hsa-mir-4285 hsa04360 Axon guidance 5595_5594 2 0.049020994 1 0.053923093 18669 hsa-mir-4287 hsa05211 Renal cell carcinoma 9915_2034_2033_3091 4 6.36E-07 1.15E-05 1.15E-05 18670 hsa-mir-4287 hsa05200 Pathways in cancer 9915_5371_2034_2033_3091 5 1.14E-05 0.000205052 0.000102526 18671 hsa-mir-4287 hsa04330 Notch signaling pathway 9612_2033 2 0.000892099 0.016057782 0.005352594 18672 hsa-mir-4287 hsa04520 Adherens junction 2033_1457 2 0.002473657 0.044525826 0.010460059 18673 hsa-mir-4287 hsa04350 TGF-beta signaling pathway 2033_4093 2 0.002905572 0.052300293 0.010460059 18674 hsa-mir-4287 hsa04120 Ubiquitin mediated proteolysis 5371_7329 2 0.007115914 0.128086445 0.021347741 18675 hsa-mir-4287 hsa04310 Wnt signaling pathway 2033_1457 2 0.008432989 0.151793802 0.021684829 18676 hsa-mir-4287 hsa03022 Basal transcription factors 2963 1 0.033627306 0.605291512 0.075661439 18677 hsa-mir-4287 hsa04150 mTOR signaling pathway 3091 1 0.046599202 0.838785631 0.093198403 18678 hsa-mir-4289 hsa05200 Pathways in cancer 5371_1499_5594_5599_6258_1387_6257_6256_595_836_367_842_841_6774_5970_8031_4824_3725_2353_5881_1050_2033_8554 23 5.39E-19 3.40E-17 3.40E-17 18679 hsa-mir-4289 hsa05215 Prostate cancer 1499_5594_1385_1387_595_367_842_5970_4824_2033 10 7.53E-11 4.75E-09 1.75E-09 18680 hsa-mir-4289 hsa05212 Pancreatic cancer 1499_5594_1385_1387_595_367_842_5970_4824_2033 10 8.34E-11 5.26E-09 1.75E-09 18681 hsa-mir-4289 hsa05216 Thyroid cancer 1499_5594_6258_6257_6256_595_8031 7 5.32E-10 3.35E-08 8.37E-09 18682 hsa-mir-4289 hsa04310 Wnt signaling pathway 815_1499_5599_1387_595_3725_1457_5881_2033_894_896 11 7.36E-10 4.64E-08 9.28E-09 18683 hsa-mir-4289 hsa05210 Colorectal cancer 1499_5594_5599_595_836_842_3725_2353_5881 9 1.11E-09 7.00E-08 1.17E-08 18684 hsa-mir-4289 hsa04010 MAPK signaling pathway 5594_5599_9261_836_5970_10912_3725_6195_2353_5881_4616_2002_2005 13 2.59E-09 1.63E-07 2.33E-08 18685 hsa-mir-4289 hsa04115 p53 signaling pathway 595_836_842_841_10912_4616_894_896 8 5.43E-09 3.42E-07 4.28E-08 18686 hsa-mir-4289 hsa04920 Adipocytokine signaling pathway 10891_5599_6258_6257_6256_6774_5970 7 9.77E-08 6.15E-06 6.84E-07 18687 hsa-mir-4289 hsa04510 Focal adhesion 1499_6714_5594_5599_595_3725_5881_894_896_2002 10 1.60E-07 1.01E-05 1.01E-06 18688 hsa-mir-4289 hsa04110 Cell cycle 5591_1387_595_10912_4616_2033_894_896 8 2.80E-07 1.76E-05 1.58E-06 18689 hsa-mir-4289 hsa04520 Adherens junction 1499_6714_5594_1387_1457_5881_2033 7 3.00E-07 1.89E-05 1.58E-06 18690 hsa-mir-4289 hsa05222 Small cell lung cancer 6258_6257_6256_595_842_5970_8554 7 4.75E-07 2.99E-05 2.30E-06 18691 hsa-mir-4289 hsa05223 Non-small cell lung cancer 5594_6258_6257_6256_595_842 6 5.94E-07 3.75E-05 2.68E-06 18692 hsa-mir-4289 hsa05016 Huntington's disease 10891_25942_1385_1387_6908_836_842_841_2033 9 7.58E-07 4.77E-05 3.18E-06 18693 hsa-mir-4289 hsa05221 Acute myeloid leukemia 5371_5594_595_6774_5970_1050 6 9.61E-07 6.05E-05 3.78E-06 18694 hsa-mir-4289 hsa04012 ErbB signaling pathway 815_6714_5594_5599_3725_2002 6 7.89E-06 0.000497352 2.93E-05 18695 hsa-mir-4289 hsa04210 Apoptosis 836_839_842_841_840_5970 6 8.93E-06 0.000562405 3.12E-05 18696 hsa-mir-4289 hsa05213 Endometrial cancer 1499_5594_595_842_2002 5 1.03E-05 0.000650784 3.43E-05 18697 hsa-mir-4289 hsa04620 Toll-like receptor signaling pathway 5594_5599_841_5970_3725_2353 6 1.86E-05 0.00117346 5.73E-05 18698 hsa-mir-4289 hsa04630 Jak-STAT signaling pathway 1387_595_6774_2033_894_896_8554 7 1.91E-05 0.001203766 5.73E-05 18699 hsa-mir-4289 hsa04916 Melanogenesis 815_1499_5594_1385_1387_2033 6 2.07E-05 0.001302647 5.92E-05 18700 hsa-mir-4289 hsa04912 GnRH signaling pathway 815_6714_5594_5599_3725_2002 6 2.53E-05 0.001595399 6.94E-05 18701 hsa-mir-4289 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5599_836_5970_3725 5 4.22E-05 0.002658848 0.000110785 18702 hsa-mir-4289 hsa04720 Long-term potentiation 815_5594_1387_6195_2033 5 5.40E-05 0.003404252 0.000126854 18703 hsa-mir-4289 hsa04662 B cell receptor signaling pathway 5594_5970_3725_2353_5881 5 5.40E-05 0.003404252 0.000126854 18704 hsa-mir-4289 hsa03022 Basal transcription factors 2962_2969_6908_2959 4 5.44E-05 0.003425057 0.000126854 18705 hsa-mir-4289 hsa04370 VEGF signaling pathway 6714_5594_9261_842_5881 5 6.08E-05 0.003832695 0.000136882 18706 hsa-mir-4289 hsa04330 Notch signaling pathway 1387_9612_2033_8850 4 0.00012901 0.008127616 0.000280263 18707 hsa-mir-4289 hsa05010 Alzheimer's disease 22926_5594_836_842_841_840 6 0.000343089 0.021614602 0.000720487 18708 hsa-mir-4289 hsa03320 PPAR signaling pathway 6258_6257_6256_2168 4 0.000543009 0.034209595 0.001103535 18709 hsa-mir-4289 hsa05211 Renal cell carcinoma 5594_1387_3725_2033 4 0.000600769 0.037848475 0.001182765 18710 hsa-mir-4289 hsa04660 T cell receptor signaling pathway 5594_5970_3725_2353 4 0.002695943 0.169844436 0.005146801 18711 hsa-mir-4289 hsa05214 Glioma 815_5594_595 3 0.004953543 0.312073225 0.009178624 18712 hsa-mir-4289 hsa04910 Insulin signaling pathway 10891_5594_5599_2002 4 0.005886472 0.37084776 0.01059565 18713 hsa-mir-4289 hsa05220 Chronic myeloid leukemia 5594_595_5970 3 0.007249661 0.456728641 0.012686907 18714 hsa-mir-4289 hsa04950 Maturity onset diabetes of the young 3172_6928 2 0.007579051 0.477480235 0.012904871 18715 hsa-mir-4289 hsa04664 Fc epsilon RI signaling pathway 5594_5599_5881 3 0.008317075 0.523975726 0.013788835 18716 hsa-mir-4289 hsa04350 TGF-beta signaling pathway 5594_1387_2033 3 0.010716218 0.675121765 0.017310814 18717 hsa-mir-4289 hsa05219 Bladder cancer 5594_595 2 0.020796324 1 0.03275421 18718 hsa-mir-4289 hsa04930 Type II diabetes mellitus 5594_5599 2 0.02353243 1 0.036159588 18719 hsa-mir-4289 hsa04150 mTOR signaling pathway 5594_6195 2 0.030449097 1 0.045673646 18720 hsa-mir-4289 hsa04530 Tight junction 1499_6714_1457 3 0.034074297 1 0.048605775 18721 hsa-mir-4289 hsa04650 Natural killer cell mediated cytotoxicity 5594_836_5881 3 0.0346902 1 0.048605775 18722 hsa-mir-4289 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_842 2 0.03471841 1 0.048605775 18723 hsa-mir-429 hsa05200 Pathways in cancer 3716_3725_2249_1499_5595_5594_5599_5914_1387_6257_6256_8031_6258_367_6776_6777_5970_2113_862_6502_2353_5925_2033_8554_4790_4792 26 3.46E-22 2.52E-20 2.52E-20 18724 hsa-mir-429 hsa04010 MAPK signaling pathway 6722_3725_2249_5595_5594_5599_9261_4208_7867_1432_5970_10912_2353_4616_4790 15 3.77E-11 2.75E-09 1.38E-09 18725 hsa-mir-429 hsa05215 Prostate cancer 1499_5595_5594_1387_367_5970_5925_2033_4790_4792 10 1.10E-10 8.05E-09 2.23E-09 18726 hsa-mir-429 hsa05212 Pancreatic cancer 1499_5595_5594_1387_367_5970_5925_2033_4790_4792 10 1.22E-10 8.91E-09 2.23E-09 18727 hsa-mir-429 hsa05216 Thyroid cancer 1499_5595_5594_6257_6256_8031_6258 7 6.96E-10 5.08E-08 1.02E-08 18728 hsa-mir-429 hsa05222 Small cell lung cancer 6257_6256_6258_5970_6502_5925_8554_4790_4792 9 1.89E-09 1.38E-07 2.30E-08 18729 hsa-mir-429 hsa05221 Acute myeloid leukemia 5595_5594_5914_6776_6777_5970_862_4790 8 2.38E-09 1.74E-07 2.49E-08 18730 hsa-mir-429 hsa04920 Adipocytokine signaling pathway 10891_5599_6257_6256_6258_5970_4790_4792 8 5.95E-09 4.34E-07 5.43E-08 18731 hsa-mir-429 hsa04620 Toll-like receptor signaling pathway 3725_5595_5594_5599_1432_5970_2353_4790_4792 9 7.57E-09 5.53E-07 6.14E-08 18732 hsa-mir-429 hsa04912 GnRH signaling pathway 3725_6714_5595_5594_5599_1432_808_801_805 9 1.21E-08 8.80E-07 7.86E-08 18733 hsa-mir-429 hsa05220 Chronic myeloid leukemia 5595_5594_6776_6777_5970_5925_4790_4792 8 1.34E-08 9.80E-07 7.86E-08 18734 hsa-mir-429 hsa04662 B cell receptor signaling pathway 3725_5595_5594_5777_5970_2353_4790_4792 8 1.34E-08 9.80E-07 7.86E-08 18735 hsa-mir-429 hsa04660 T cell receptor signaling pathway 3725_5595_5594_5777_1432_5970_2353_4790_4792 9 1.40E-08 1.02E-06 7.86E-08 18736 hsa-mir-429 hsa04630 Jak-STAT signaling pathway 3716_1387_5777_6776_6777_6773_3566_2033_3977_8554 10 1.82E-08 1.33E-06 9.50E-08 18737 hsa-mir-429 hsa04350 TGF-beta signaling pathway 6667_5595_5594_1387_3397_3399_3398_2033 8 3.92E-08 2.86E-06 1.91E-07 18738 hsa-mir-429 hsa04916 Melanogenesis 1499_5595_5594_1387_2033_808_801_805 8 1.42E-07 1.04E-05 6.50E-07 18739 hsa-mir-429 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_6714_5599_1432_5970_4790_4792 7 1.83E-07 1.34E-05 7.87E-07 18740 hsa-mir-429 hsa04720 Long-term potentiation 5595_5594_1387_2033_808_801_805 7 2.59E-07 1.89E-05 1.05E-06 18741 hsa-mir-429 hsa04520 Adherens junction 1499_6714_5595_5594_1387_5777_2033 7 3.90E-07 2.85E-05 1.50E-06 18742 hsa-mir-429 hsa04012 ErbB signaling pathway 3725_6714_5595_5594_5599_6776_6777 7 6.62E-07 4.83E-05 2.42E-06 18743 hsa-mir-429 hsa05223 Non-small cell lung cancer 5595_5594_6257_6256_6258_5925 6 7.45E-07 5.44E-05 2.59E-06 18744 hsa-mir-429 hsa04910 Insulin signaling pathway 10891_5590_5595_5594_5599_808_801_805 8 1.09E-06 7.92E-05 3.60E-06 18745 hsa-mir-429 hsa05214 Glioma 5595_5594_5925_808_801_805 6 2.03E-06 0.000148373 6.45E-06 18746 hsa-mir-429 hsa05211 Renal cell carcinoma 3725_5595_5594_1387_2113_2033 6 3.54E-06 0.000258185 1.08E-05 18747 hsa-mir-429 hsa04110 Cell cycle 1387_10912_6502_5925_2033_4616_891 7 4.75E-06 0.000346725 1.39E-05 18748 hsa-mir-429 hsa04370 VEGF signaling pathway 6714_5595_5594_9261_7867_1432 6 5.09E-06 0.000371318 1.43E-05 18749 hsa-mir-429 hsa04930 Type II diabetes mellitus 3651_5590_5595_5594_5599 5 6.49E-06 0.00047362 1.75E-05 18750 hsa-mir-429 hsa04330 Notch signaling pathway 388585_1387_9612_2033_8850 5 7.89E-06 0.000576081 2.05E-05 18751 hsa-mir-429 hsa05210 Colorectal cancer 3725_1499_5595_5594_5599_2353 6 8.14E-06 0.000594311 2.05E-05 18752 hsa-mir-429 hsa04062 Chemokine signaling pathway 5590_5595_5594_6777_6773_5970_4790_4792 8 1.16E-05 0.000846966 2.82E-05 18753 hsa-mir-429 hsa04950 Maturity onset diabetes of the young 3651_168620_6927 3 0.000376263 0.027467206 0.000886039 18754 hsa-mir-429 hsa05010 Alzheimer's disease 5595_5594_1537_808_801_805 6 0.000421232 0.030749946 0.000960936 18755 hsa-mir-429 hsa04270 Vascular smooth muscle contraction 5595_5594_808_801_805 5 0.000486802 0.035536562 0.001076866 18756 hsa-mir-429 hsa05016 Huntington's disease 6667_10891_1387_6908_1537_2033 6 0.000573138 0.041839084 0.001230561 18757 hsa-mir-429 hsa03320 PPAR signaling pathway 6257_6256_6258_2168 4 0.000627473 0.045805546 0.00130873 18758 hsa-mir-429 hsa05218 Melanoma 2249_5595_5594_5925 4 0.000660144 0.048190516 0.001338625 18759 hsa-mir-429 hsa04510 Focal adhesion 3725_1499_6714_5595_5594_5599 6 0.000909881 0.066421303 0.00179517 18760 hsa-mir-429 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_1432 4 0.000966256 0.070536679 0.001856228 18761 hsa-mir-429 hsa04120 Ubiquitin mediated proteolysis 672_7329_6502_7325_8554 5 0.000992572 0.072457727 0.00185789 18762 hsa-mir-429 hsa04310 Wnt signaling pathway 3725_1499_5599_1387_2033 5 0.001456889 0.106352893 0.002658822 18763 hsa-mir-429 hsa05219 Bladder cancer 5595_5594_5925 3 0.001703669 0.124367843 0.003033362 18764 hsa-mir-429 hsa05213 Endometrial cancer 1499_5595_5594 3 0.003031759 0.221318383 0.005269485 18765 hsa-mir-429 hsa04115 p53 signaling pathway 10912_4616_891 3 0.00646017 0.47159243 0.010967266 18766 hsa-mir-429 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.008341208 0.608908187 0.013838822 18767 hsa-mir-429 hsa04210 Apoptosis 5970_4790_4792 3 0.012609981 0.920528598 0.020456191 18768 hsa-mir-429 hsa04540 Gap junction 6714_5595_5594 3 0.014131989 1 0.022426852 18769 hsa-mir-429 hsa04150 mTOR signaling pathway 5595_5594 2 0.032674676 1 0.050750029 18770 hsa-mir-429 hsa04530 Tight junction 1499_6714_5590 3 0.03752998 1 0.05691477 18771 hsa-mir-429 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_5777 3 0.038203064 1 0.05691477 18772 hsa-mir-429 hsa05322 Systemic lupus erythematosus 333932_3015_126961 3 0.042370434 1 0.061860833 18773 hsa-mir-4291 hsa05210 Colorectal cancer 4088_4089_3725_207_208_2932_1499_2353 8 8.02E-11 4.33E-09 2.22E-09 18774 hsa-mir-4291 hsa05215 Prostate cancer 10488_468_207_208_2932_367_1499_1387 8 1.13E-10 6.12E-09 2.22E-09 18775 hsa-mir-4291 hsa05212 Pancreatic cancer 10488_468_207_208_2932_367_1499_1387 8 1.23E-10 6.65E-09 2.22E-09 18776 hsa-mir-4291 hsa05200 Pathways in cancer 4088_4089_3725_1050_207_208_2932_367_1499_1387_2353 11 9.25E-10 4.99E-08 1.25E-08 18777 hsa-mir-4291 hsa04010 MAPK signaling pathway 6722_5058_3725_468_207_208_3727_1432_2353_1386 10 2.25E-09 1.21E-07 2.43E-08 18778 hsa-mir-4291 hsa04310 Wnt signaling pathway 4088_4089_3725_2932_8061_1499_1387_1457 8 6.71E-09 3.62E-07 6.04E-08 18779 hsa-mir-4291 hsa04660 T cell receptor signaling pathway 5058_3725_207_208_2932_1432_2353 7 1.79E-08 9.69E-07 1.38E-07 18780 hsa-mir-4291 hsa04520 Adherens junction 4088_4089_1499_6714_1387_1457 6 7.87E-08 4.25E-06 5.31E-07 18781 hsa-mir-4291 hsa04012 ErbB signaling pathway 5058_3725_207_208_2932_6714 6 1.26E-07 6.80E-06 7.55E-07 18782 hsa-mir-4291 hsa04110 Cell cycle 4088_4089_7534_7532_2932_1387 6 7.28E-07 3.93E-05 3.93E-06 18783 hsa-mir-4291 hsa04510 Focal adhesion 5058_3725_207_208_2932_1499_6714 7 1.07E-06 5.77E-05 5.25E-06 18784 hsa-mir-4291 hsa05211 Renal cell carcinoma 5058_3725_207_208_1387 5 1.45E-06 7.81E-05 6.51E-06 18785 hsa-mir-4291 hsa04662 B cell receptor signaling pathway 3725_207_208_2932_2353 5 1.75E-06 9.45E-05 7.27E-06 18786 hsa-mir-4291 hsa04620 Toll-like receptor signaling pathway 3725_207_208_1432_2353 5 7.35E-06 0.000396633 2.83E-05 18787 hsa-mir-4291 hsa05213 Endometrial cancer 207_208_2932_1499 4 1.19E-05 0.000641172 4.27E-05 18788 hsa-mir-4291 hsa04530 Tight junction 207_208_1499_6714_1457 5 2.89E-05 0.001562261 9.76E-05 18789 hsa-mir-4291 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5058_3725_6714_1432 4 3.79E-05 0.00204716 0.000120421 18790 hsa-mir-4291 hsa05220 Chronic myeloid leukemia 4088_4089_207_208 4 4.65E-05 0.002511641 0.000139536 18791 hsa-mir-4291 hsa04370 VEGF signaling pathway 207_208_6714_1432 4 5.13E-05 0.00277072 0.000145827 18792 hsa-mir-4291 hsa04350 TGF-beta signaling pathway 4088_4089_659_1387 4 8.09E-05 0.004367942 0.000218397 18793 hsa-mir-4291 hsa04916 Melanogenesis 10488_2932_1499_1387 4 0.000157087 0.008482715 0.000403939 18794 hsa-mir-4291 hsa04912 GnRH signaling pathway 3725_468_6714_1432 4 0.000180689 0.009757228 0.00044351 18795 hsa-mir-4291 hsa04910 Insulin signaling pathway 207_208_2932_2538 4 0.000446429 0.024107153 0.001048137 18796 hsa-mir-4291 hsa05221 Acute myeloid leukemia 1050_207_208 3 0.000506801 0.027367233 0.001140301 18797 hsa-mir-4291 hsa04920 Adipocytokine signaling pathway 207_208_2538 3 0.000723125 0.039048729 0.001561949 18798 hsa-mir-4291 hsa04664 Fc epsilon RI signaling pathway 207_208_1432 3 0.001145102 0.061835514 0.002378289 18799 hsa-mir-4291 hsa04062 Chemokine signaling pathway 5058_207_208_2932 4 0.00150976 0.081527034 0.00301952 18800 hsa-mir-4291 hsa03022 Basal transcription factors 6908_2959 2 0.004283246 0.231295298 0.008260546 18801 hsa-mir-4291 hsa04630 Jak-STAT signaling pathway 207_208_1387 3 0.007285945 0.393441013 0.013566931 18802 hsa-mir-4291 hsa04150 mTOR signaling pathway 207_208 2 0.008074715 0.436034603 0.014534487 18803 hsa-mir-4291 hsa05223 Non-small cell lung cancer 207_208 2 0.008661933 0.467744384 0.014719357 18804 hsa-mir-4291 hsa05217 Basal cell carcinoma 2932_1499 2 0.008962526 0.483976428 0.014719357 18805 hsa-mir-4291 hsa05131 Shigellosis 7534_1499 2 0.009267744 0.500458151 0.014719357 18806 hsa-mir-4291 hsa05130 Pathogenic Escherichia coli infection 7534_1499 2 0.009267744 0.500458151 0.014719357 18807 hsa-mir-4291 hsa04340 Hedgehog signaling pathway 2932_53944 2 0.00957756 0.517188241 0.014776807 18808 hsa-mir-4291 hsa05016 Huntington's disease 6908_10488_1387 3 0.012182322 0.657845377 0.01783282 18809 hsa-mir-4291 hsa05214 Glioma 207_208 2 0.012218784 0.659814354 0.01783282 18810 hsa-mir-4291 hsa05218 Melanoma 207_208 2 0.014384535 0.776764883 0.020441181 18811 hsa-mir-4291 hsa04720 Long-term potentiation 468_1387 2 0.01591359 0.859333881 0.022034202 18812 hsa-mir-4291 hsa05222 Small cell lung cancer 207_208 2 0.020456947 1 0.027616878 18813 hsa-mir-4291 hsa04210 Apoptosis 207_208 2 0.021779404 1 0.028685068 18814 hsa-mir-4291 hsa04670 Leukocyte transendothelial migration 1499_1432 2 0.038487695 1 0.04948418 18815 hsa-mir-4291 hsa04360 Axon guidance 5058_2932 2 0.043675355 1 0.054848121 18816 hsa-mir-4292 hsa04110 Cell cycle 4088_4089_1870_1871_7157_4087_2033_1017_890_1869_5934_5933_1387 13 1.69E-22 5.07E-21 5.07E-21 18817 hsa-mir-4292 hsa05200 Pathways in cancer 4088_4089_1870_1871_1488_1050_4149_7157_4087_2033_1017_1869_1487_1387 14 1.04E-18 3.12E-17 1.56E-17 18818 hsa-mir-4292 hsa04350 TGF-beta signaling pathway 4088_4089_1874_1875_4087_2033_659_5934_5933_1387 10 1.31E-17 3.94E-16 1.31E-16 18819 hsa-mir-4292 hsa05220 Chronic myeloid leukemia 4088_4089_1870_1871_1488_7157_1869_1487 8 5.33E-14 1.60E-12 4.00E-13 18820 hsa-mir-4292 hsa04310 Wnt signaling pathway 4088_4089_1488_7157_4087_2033_1487_1387 8 1.13E-11 3.40E-10 6.79E-11 18821 hsa-mir-4292 hsa05215 Prostate cancer 1870_1871_7157_2033_1017_1869_1387 7 1.58E-11 4.75E-10 7.31E-11 18822 hsa-mir-4292 hsa05212 Pancreatic cancer 1870_1871_7157_2033_1017_1869_1387 7 1.70E-11 5.11E-10 7.31E-11 18823 hsa-mir-4292 hsa05222 Small cell lung cancer 1870_1871_4149_7157_1017_1869 6 1.06E-09 3.17E-08 3.97E-09 18824 hsa-mir-4292 hsa04520 Adherens junction 4088_4089_4087_2033_1387 5 4.89E-08 1.47E-06 1.63E-07 18825 hsa-mir-4292 hsa05219 Bladder cancer 1870_1871_7157_1869 4 2.43E-07 7.30E-06 7.30E-07 18826 hsa-mir-4292 hsa04330 Notch signaling pathway 1488_2033_1487_1387 4 3.71E-07 1.11E-05 1.01E-06 18827 hsa-mir-4292 hsa05223 Non-small cell lung cancer 1870_1871_7157_1869 4 6.27E-07 1.88E-05 1.57E-06 18828 hsa-mir-4292 hsa05214 Glioma 1870_1871_7157_1869 4 1.27E-06 3.80E-05 2.92E-06 18829 hsa-mir-4292 hsa05218 Melanoma 1870_1871_7157_1869 4 1.77E-06 5.31E-05 3.79E-06 18830 hsa-mir-4292 hsa05210 Colorectal cancer 4088_4089_7157_4087 4 3.36E-06 0.000100806 6.72E-06 18831 hsa-mir-4292 hsa05016 Huntington's disease 7157_2033_1387 3 0.001426308 0.042789231 0.002674327 18832 hsa-mir-4292 hsa04115 p53 signaling pathway 7157_1017 2 0.003116905 0.093507141 0.00550042 18833 hsa-mir-4292 hsa05211 Renal cell carcinoma 2033_1387 2 0.003380426 0.10141279 0.005634044 18834 hsa-mir-4292 hsa04720 Long-term potentiation 2033_1387 2 0.003654022 0.109620664 0.005769509 18835 hsa-mir-4292 hsa04916 Melanogenesis 2033_1387 2 0.006804378 0.204131332 0.010206567 18836 hsa-mir-4292 hsa04630 Jak-STAT signaling pathway 2033_1387 2 0.014428778 0.432863348 0.02061254 18837 hsa-mir-4292 hsa05216 Thyroid cancer 7157 1 0.034391211 1 0.046897106 18838 hsa-mir-4292 hsa04010 MAPK signaling pathway 4149_7157 2 0.04076524 1 0.052811184 18839 hsa-mir-4292 hsa03410 Base excision repair 3146 1 0.042248948 1 0.052811184 18840 hsa-mir-4293 hsa04120 Ubiquitin mediated proteolysis 672 1 0.041217736 0.082435472 0.079247362 18841 hsa-mir-4294 hsa05200 Pathways in cancer 4088_367 2 0.000730415 0.006573731 0.006573731 18842 hsa-mir-4294 hsa05220 Chronic myeloid leukemia 4088 1 0.010094054 0.090846483 0.015358008 18843 hsa-mir-4294 hsa04520 Adherens junction 4088 1 0.010755446 0.096799014 0.015358008 18844 hsa-mir-4294 hsa05210 Colorectal cancer 4088 1 0.011284321 0.101558891 0.015358008 18845 hsa-mir-4294 hsa04350 TGF-beta signaling pathway 4088 1 0.011680838 0.105127546 0.015358008 18846 hsa-mir-4294 hsa05215 Prostate cancer 367 1 0.011812984 0.106316859 0.015358008 18847 hsa-mir-4294 hsa05212 Pancreatic cancer 367 1 0.011945117 0.107506053 0.015358008 18848 hsa-mir-4294 hsa04110 Cell cycle 4088 1 0.015902938 0.143126446 0.017890806 18849 hsa-mir-4294 hsa04310 Wnt signaling pathway 4088 1 0.020242796 0.182185164 0.020242796 18850 hsa-mir-4296 hsa05200 Pathways in cancer 4149_7046_5467_5468_5914_595_3815_2261_4193_6934_7704_6502_3091_9915_3066_3065_1050_5925_1499_5747_25_405_1956_1487_1870_1871_2113_10401_5894_861_867_6776_207_4286_3716_1017_5595_5594_5599_1387_2064_6256_836_367_2932_6774_6777_6772_5879_7157_7849_1869_3725_4087_4088_4089_2034_2033_4846_5970_3320_51176_5371_675_5159_5156_5604_1399_1398_4292_7428_8772_4609_2956_1029_2353_1488_8554 78 5.53E-50 4.42E-48 4.42E-48 18851 hsa-mir-4296 hsa05220 Chronic myeloid leukemia 7046_595_4193_3066_3065_5925_25_1487_1870_1871_5894_861_867_6776_207_5595_5594_6777_7157_1869_4088_4089_5970_5604_1399_1398_5781_4609_1029_1488_6464 31 1.55E-26 1.24E-24 6.20E-25 18852 hsa-mir-4296 hsa05215 Prostate cancer 595_4193_6934_5925_1499_1956_1870_1871_5894_207_1017_5595_5594_1385_1387_2064_367_2932_7157_1869_2033_5970_3320_51176_5159_5156_5604 27 1.65E-20 1.32E-18 4.22E-19 18853 hsa-mir-4296 hsa05212 Pancreatic cancer 595_4193_6934_5925_1499_1956_1870_1871_5894_207_1017_5595_5594_1385_1387_2064_367_2932_7157_1869_2033_5970_3320_51176_5159_5156_5604 27 2.11E-20 1.69E-18 4.22E-19 18854 hsa-mir-4296 hsa05210 Colorectal cancer 7046_595_6934_1499_1956_5894_207_5595_5594_5599_836_2932_5879_7157_3725_4087_4088_4089_51176_5159_5156_5604_4292_4609_2956_2353 26 7.07E-20 5.65E-18 1.13E-18 18855 hsa-mir-4296 hsa04110 Cell cycle 595_4193_6502_6500_4174_4172_3066_3065_990_5925_25_1870_1871_5934_5933_5591_1017_1387_2932_7157_5111_1869_4087_4088_4089_2033_983_8454_1029 29 1.37E-19 1.09E-17 1.82E-18 18856 hsa-mir-4296 hsa04310 Wnt signaling pathway 818_817_5467_595_6934_6500_4772_4773_1499_1487_5599_1387_2932_5879_7157_8061_3725_1457_1459_4087_4088_4089_2033_51176_5515_8454_6423_4609_1488_5527 30 5.33E-18 4.26E-16 6.09E-17 18857 hsa-mir-4296 hsa04630 Jak-STAT signaling pathway 595_58985_3455_3459_3560_3561_1439_2057_10401_867_2690_6776_207_3717_3716_3718_85480_1387_3575_6778_6774_6777_6772_6773_7297_2033_5781_4609_8554_10379 30 8.55E-18 6.84E-16 8.55E-17 18858 hsa-mir-4296 hsa04012 ErbB signaling pathway 818_817_5747_25_1956_6714_5894_867_6776_207_5595_5594_5599_2064_2066_2932_6777_3725_5604_1399_1398_4609_6464_2002 24 1.73E-17 1.39E-15 1.54E-16 18859 hsa-mir-4296 hsa04350 TGF-beta signaling pathway 7046_6500_4086_90_57154_6667_3399_3398_1875_5934_5933_5595_5594_1387_4087_4088_4089_2033_5515_4093_8454_4609_4092 23 1.79E-16 1.43E-14 1.43E-15 18860 hsa-mir-4296 hsa04010 MAPK signaling pathway 4149_7046_2261_2264_1845_4773_1956_7132_1432_5894_4763_1616_207_5595_5594_5599_5598_1386_836_9252_3312_5879_3164_7157_3725_5970_5159_5156_5604_4208_1399_1398_9479_4609_2353_2002 36 2.64E-16 2.11E-14 1.92E-15 18861 hsa-mir-4296 hsa05221 Acute myeloid leukemia 5467_5914_595_3815_6934_7704_1050_5894_861_6776_207_5595_5594_6774_6777_5970_51176_5371_5604_4609 20 3.12E-16 2.49E-14 2.08E-15 18862 hsa-mir-4296 hsa05219 Bladder cancer 595_2261_4193_5925_1956_1870_1871_5894_5595_5594_2064_9252_7157_1869_5604_4609_1029 17 4.93E-15 3.94E-13 3.03E-14 18863 hsa-mir-4296 hsa05214 Glioma 818_817_595_4193_5925_1956_1870_1871_5894_207_5595_5594_7157_1869_5159_5156_5604_1029_6464 19 1.64E-14 1.31E-12 9.35E-14 18864 hsa-mir-4296 hsa04520 Adherens junction 7046_6934_5770_1499_2534_1956_6714_5595_5594_1387_2064_5879_1457_1459_4087_4088_4089_2033_51176_3643 20 4.12E-14 3.30E-12 2.20E-13 18865 hsa-mir-4296 hsa05213 Endometrial cancer 595_6934_1499_1956_2309_5894_207_5595_5594_2064_2932_7157_51176_5604_4292_4609_2002 17 8.66E-14 6.93E-12 4.33E-13 18866 hsa-mir-4296 hsa05211 Renal cell carcinoma 3091_9915_405_2113_5894_207_5595_5594_1387_5879_3725_2034_2033_5604_1399_1398_7428_5781 18 7.75E-13 6.20E-11 3.65E-12 18867 hsa-mir-4296 hsa05223 Non-small cell lung cancer 595_5925_1956_2309_1870_1871_5894_207_5595_5594_2064_6256_7157_1869_5604_1029 16 1.64E-12 1.31E-10 7.29E-12 18868 hsa-mir-4296 hsa05218 Melanoma 595_4193_5925_1956_1870_1871_5894_207_4286_5595_5594_7157_1869_5159_5156_5604_1029 17 6.08E-12 4.86E-10 2.56E-11 18869 hsa-mir-4296 hsa05216 Thyroid cancer 5468_595_6934_1499_5595_5594_6256_7157_7849_51176_5604_4609 12 4.29E-11 3.43E-09 1.71E-10 18870 hsa-mir-4296 hsa04062 Chemokine signaling pathway 1234_1230_7074_5747_5580_7852_2309_5894_207_3717_3718_5595_5594_2932_6774_6777_6772_6773_5879_5970_5604_1399_1398_6464 24 7.69E-11 6.15E-09 2.93E-10 18871 hsa-mir-4296 hsa05222 Small cell lung cancer 4149_595_6502_5925_5747_1870_1871_10401_207_1017_6256_7157_1869_4846_5970_4609_8554 17 8.43E-11 6.74E-09 3.06E-10 18872 hsa-mir-4296 hsa04510 Focal adhesion 595_1499_2534_5747_3791_1956_6714_5894_207_5595_5594_5599_2064_2932_5879_3725_2321_5159_5156_5604_1399_1398_6464_2002 24 2.58E-10 2.07E-08 8.98E-10 18873 hsa-mir-4296 hsa04330 Notch signaling pathway 9612_3066_3065_9794_22938_1487_1387_2033_8850_1840_1488_2648_4851 13 4.16E-10 3.33E-08 1.39E-09 18874 hsa-mir-4296 hsa04660 T cell receptor signaling pathway 919_1493_4772_4773_2534_3932_1432_5894_867_207_5595_5594_2932_3725_5970_5604_2353 17 2.42E-09 1.93E-07 7.73E-09 18875 hsa-mir-4296 hsa04662 B cell receptor signaling pathway 4772_4773_6850_5894_207_695_5595_5594_2932_5879_3725_5970_5604_2353 14 7.45E-09 5.96E-07 2.29E-08 18876 hsa-mir-4296 hsa04540 Gap junction 51807_1956_6714_5894_5595_5594_5598_7846_5159_983_5156_5604_7277_7278_10376 15 1.26E-08 1.01E-06 3.73E-08 18877 hsa-mir-4296 hsa04620 Toll-like receptor signaling pathway 3455_3665_3661_1432_207_5595_5594_5599_6772_5879_3725_5970_5604_8772_2353 15 3.79E-08 3.03E-06 1.08E-07 18878 hsa-mir-4296 hsa04916 Melanogenesis 818_817_3815_6934_1499_5894_4286_5595_5594_1385_1387_2932_2033_51176_5604 15 4.78E-08 3.82E-06 1.32E-07 18879 hsa-mir-4296 hsa04910 Insulin signaling pathway 6720_10891_5770_5894_867_207_5595_5594_5599_23265_2932_3643_5604_1399_1398_6464_2002 17 5.03E-08 4.03E-06 1.34E-07 18880 hsa-mir-4296 hsa04370 VEGF signaling pathway 4772_4773_5747_3791_6714_1432_5894_207_5595_5594_5879_4846_5604 13 7.30E-08 5.84E-06 1.88E-07 18881 hsa-mir-4296 hsa04060 Cytokine-cytokine receptor interaction 7046_3815_1234_1230_58985_3455_3459_90_3791_1956_7852_3560_3561_7133_7132_1439_2057_2690_85480_3575_2321_5159_5156 23 8.04E-08 6.43E-06 2.01E-07 18882 hsa-mir-4296 hsa04920 Adipocytokine signaling pathway 10891_5465_7133_7132_207_3717_8717_5599_6256_6774_5970_5781 12 1.31E-07 1.05E-05 3.18E-07 18883 hsa-mir-4296 hsa04650 Natural killer cell mediated cytotoxicity 919_3455_3459_4772_4773_2534_3932_6850_5894_5595_5594_836_5879_5604_5781_6464 16 2.63E-07 2.10E-05 6.19E-07 18884 hsa-mir-4296 hsa04912 GnRH signaling pathway 818_817_5580_1956_6714_1432_5894_5595_5594_5599_5598_3725_5604_2002 14 4.33E-07 3.47E-05 9.90E-07 18885 hsa-mir-4296 hsa04664 Fc epsilon RI signaling pathway 2534_5580_6850_1432_5894_207_695_5595_5594_5599_5879_5604 12 6.39E-07 5.11E-05 1.42E-06 18886 hsa-mir-4296 hsa05322 Systemic lupus erythematosus 8365_3021_3020_8368_8366_8294_8370_121504_8361_8360_8363_8362_8364_8367_8359 15 2.11E-06 0.000169155 4.57E-06 18887 hsa-mir-4296 hsa04120 Ubiquitin mediated proteolysis 55294_4193_6502_6500_57154_10401_867_8925_7329_5371_672_8454_7428_8554 14 6.56E-06 0.000524914 1.38E-05 18888 hsa-mir-4296 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_7133_7132_1432_1616_836_5879_7157_4846 9 1.08E-05 0.000860243 2.10E-05 18889 hsa-mir-4296 hsa05131 Shigellosis 51807_1499_2534_25_7846_7277_7278_4691_10376 9 1.08E-05 0.000860243 2.10E-05 18890 hsa-mir-4296 hsa05130 Pathogenic Escherichia coli infection 51807_1499_2534_25_7846_7277_7278_4691_10376 9 1.08E-05 0.000860243 2.10E-05 18891 hsa-mir-4296 hsa05016 Huntington's disease 10891_5468_3066_3065_3064_2902_4724_6667_1385_1387_836_7157_2033_6874_6908 15 4.01E-05 0.003210704 7.64E-05 18892 hsa-mir-4296 hsa04115 p53 signaling pathway 595_4194_4193_1017_836_7157_983_7161_1029 9 4.78E-05 0.003824092 8.89E-05 18893 hsa-mir-4296 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_1432_5599_836_5879_3725_5970_5781 9 5.85E-05 0.004680036 0.000106364 18894 hsa-mir-4296 hsa04720 Long-term potentiation 818_817_2902_5894_5595_5594_1387_2033_5604 9 8.60E-05 0.00688176 0.000152928 18895 hsa-mir-4296 hsa03410 Base excision repair 4350_252969_328_2237_5111_6996 6 0.000272308 0.021784634 0.000473579 18896 hsa-mir-4296 hsa03022 Basal transcription factors 2963_2962_2969_6874_6908_2959 6 0.000310725 0.024858027 0.000528894 18897 hsa-mir-4296 hsa03450 Non-homologous end-joining 10111_2237_5591_4361 4 0.00052349 0.04187919 0.000872483 18898 hsa-mir-4296 hsa04810 Regulation of actin cytoskeleton 2261_2264_7074_5747_1956_5894_5595_5594_5879_5159_5156_5604_1399_1398 14 0.000607221 0.048577697 0.000991382 18899 hsa-mir-4296 hsa04360 Axon guidance 4772_4773_2534_5747_25_7852_5595_5594_2932_5879 10 0.001033499 0.082679933 0.001653599 18900 hsa-mir-4296 hsa04210 Apoptosis 7132_1439_207_8717_836_7157_5970_8772 8 0.001235381 0.098830474 0.001937852 18901 hsa-mir-4296 hsa05340 Primary immunodeficiency 3932_3561_3718_695_3575 5 0.001648943 0.13191541 0.002536835 18902 hsa-mir-4296 hsa04950 Maturity onset diabetes of the young 5080_6927_4760_3172 4 0.002951173 0.236093857 0.004454601 18903 hsa-mir-4296 hsa04930 Type II diabetes mellitus 5580_5595_5594_5599_3643 5 0.004448633 0.355890629 0.006590567 18904 hsa-mir-4296 hsa03440 Homologous recombination 10111_4361_4683_675 4 0.004841576 0.387326071 0.007042292 18905 hsa-mir-4296 hsa04730 Long-term depression 5894_5595_5594_4846_5515_5604 6 0.006516395 0.521311577 0.009309135 18906 hsa-mir-4296 hsa05010 Alzheimer's disease 2902_7132_4724_5595_5594_836_2932_4846_22926_8772 10 0.007863169 0.629053542 0.011036027 18907 hsa-mir-4296 hsa05217 Basal cell carcinoma 6934_1499_2932_7157_51176 5 0.009618155 0.769452371 0.01326642 18908 hsa-mir-4296 hsa04020 Calcium signaling pathway 818_817_147_1956_2902_2064_2066_4846_5159_5156 10 0.010036593 0.802927441 0.01360894 18909 hsa-mir-4296 hsa03030 DNA replication 4174_4172_2237_5111 4 0.010743483 0.859478653 0.014324644 18910 hsa-mir-4296 hsa04612 Antigen processing and presentation 1385_3312_3320_4800_4801_4802 6 0.017295413 1 0.022682508 18911 hsa-mir-4296 hsa03430 Mismatch repair 5111_4292_2956 3 0.018147902 1 0.023416647 18912 hsa-mir-4296 hsa04270 Vascular smooth muscle contraction 147_5580_5894_5595_5594_59_5604 7 0.019281328 1 0.024484226 18913 hsa-mir-4296 hsa04740 Olfactory transduction 818_817 2 0.02034416 1 0.0254302 18914 hsa-mir-4296 hsa04150 mTOR signaling pathway 3091_207_5595_5594 4 0.033006733 1 0.040623671 18915 hsa-mir-4296 hsa04530 Tight junction 1499_5580_6714_207_1457_1459_5515 7 0.037675784 1 0.045667618 18916 hsa-mir-4296 hsa04710 Circadian rhythm - mammal 8863_4862 2 0.040801341 1 0.048718019 18917 hsa-mir-4297 hsa05200 Pathways in cancer 4149_5467_1499_595_1019_1017_4193_6934_7704_6502_3091_3065_1050_5925_7184_5468_25_405_3716_1956_1487_1488_2308_1870_1871_2113_10401_861_862_207_836_5595_5594_5599_1387_6256_4286_367_2932_6774_6776_6777_6772_5970_7157_6688_7849_1869_3725_4087_4088_4089_2034_2033_4790_4792_9915_3320_3326_51176_5371_5604_5601_5602_3265_841_4609_2956_1026_2736_2353_8554 72 3.88E-34 3.22E-32 3.22E-32 18918 hsa-mir-4297 hsa05215 Prostate cancer 1499_595_1017_4193_6934_5925_7184_1956_2308_1870_1871_9586_207_5595_5594_1385_1387_367_2932_5970_7157_468_1869_2033_4790_4792_3320_3326_51176_5604_3265_1026 32 2.08E-21 1.72E-19 7.59E-20 18919 hsa-mir-4297 hsa05212 Pancreatic cancer 1499_595_1017_4193_6934_5925_7184_1956_2308_1870_1871_9586_207_5595_5594_1385_1387_367_2932_5970_7157_468_1869_2033_4790_4792_3320_3326_51176_5604_3265_1026 32 2.74E-21 2.28E-19 7.59E-20 18920 hsa-mir-4297 hsa03022 Basal transcription factors 54457_2958_138474_2959_6881_2957_6879_2967_2961_2960_2963_2968_6878_6877_6874_6873_6872_6908_6884_6882_6883_6880_9519 23 8.73E-20 7.25E-18 1.81E-18 18921 hsa-mir-4297 hsa05220 Chronic myeloid leukemia 595_1019_4193_3065_5925_25_1487_1488_1870_1871_861_207_5595_5594_6776_6777_5970_7157_1869_4088_4089_4790_4792_5604_3265_4609_1026 27 3.45E-18 2.87E-16 5.73E-17 18922 hsa-mir-4297 hsa04010 MAPK signaling pathway 6722_3727_4149_6197_9252_7867_4773_1956_1432_22800_1616_207_836_9479_5595_5594_5599_5598_8986_1386_3312_1649_5970_3164_7157_468_3725_6195_6196_4790_9261_5604_4208_5601_5600_5602_5566_3265_4609_2353_8550_2002 42 1.18E-15 9.81E-14 1.64E-14 18923 hsa-mir-4297 hsa04110 Cell cycle 595_1019_1017_4193_6502_4171_3065_5925_25_1870_1871_5934_5933_5591_1387_7533_2932_7027_7157_1869_5111_4087_4088_4089_2033_890_4085_1026 28 8.16E-15 6.77E-13 9.67E-14 18924 hsa-mir-4297 hsa05221 Acute myeloid leukemia 5467_595_6934_7704_1050_861_862_207_5595_5594_6774_6776_6777_5970_6688_4790_51176_5371_5604_3265_4609 21 2.24E-14 1.86E-12 2.33E-13 18925 hsa-mir-4297 hsa04310 Wnt signaling pathway 815_5467_1499_595_8607_6934_4772_4773_1487_1488_1460_5599_1387_2932_7157_8061_3725_1457_4087_4088_4089_2033_51176_5601_5602_5566_6423_4609_5527 29 2.86E-13 2.37E-11 2.64E-12 18926 hsa-mir-4297 hsa05210 Colorectal cancer 1499_595_6934_1956_207_836_5595_5594_5599_2932_7157_3725_4087_4088_4089_51176_5604_5601_5602_4609_2956_2353 22 9.90E-13 8.21E-11 8.21E-12 18927 hsa-mir-4297 hsa05214 Glioma 815_595_1019_4193_5925_1956_1870_1871_207_5595_5594_7157_1869_808_801_805_5604_3265_1026 19 6.93E-12 5.75E-10 5.23E-11 18928 hsa-mir-4297 hsa05219 Bladder cancer 595_1019_9252_4193_5925_1956_1870_1871_5595_5594_7157_1869_5604_3265_4609_1026 16 1.21E-11 1.01E-09 8.40E-11 18929 hsa-mir-4297 hsa04350 TGF-beta signaling pathway 4086_6667_3397_3399_3398_1874_1875_5934_5933_5595_5594_1387_7027_4087_4088_4089_2033_4093_4609_4092 20 7.95E-11 6.60E-09 5.07E-10 18930 hsa-mir-4297 hsa05216 Thyroid cancer 1499_595_6934_5468_5595_5594_6256_7157_7849_51176_5604_3265_4609 13 2.08E-10 1.73E-08 1.23E-09 18931 hsa-mir-4297 hsa04912 GnRH signaling pathway 815_1956_6714_1432_5595_5594_5599_5598_5580_468_3725_808_801_805_5604_5601_5600_5602_5566_3265_2002 21 3.97E-10 3.30E-08 2.20E-09 18932 hsa-mir-4297 hsa04012 ErbB signaling pathway 815_25_1956_6714_207_5595_5594_5599_2932_6776_6777_3725_5604_5601_5602_3265_4609_1026_2002 19 4.98E-10 4.14E-08 2.59E-09 18933 hsa-mir-4297 hsa05213 Endometrial cancer 1499_595_6934_1956_2309_207_5595_5594_2932_7157_51176_5604_3265_4609_2002 15 1.32E-09 1.09E-07 6.44E-09 18934 hsa-mir-4297 hsa05223 Non-small cell lung cancer 595_1019_5925_1956_2309_1870_1871_207_5595_5594_6256_7157_1869_5604_3265 15 2.04E-09 1.70E-07 9.42E-09 18935 hsa-mir-4297 hsa04720 Long-term potentiation 815_6197_2902_2906_5595_5594_1387_468_6195_6196_2033_808_801_805_5604_5566_3265 17 2.49E-09 2.07E-07 1.06E-08 18936 hsa-mir-4297 hsa05222 Small cell lung cancer 4149_595_1019_1017_6502_5925_1870_1871_10401_207_6256_5970_7157_1869_4790_4792_4609_8554 18 2.56E-09 2.12E-07 1.06E-08 18937 hsa-mir-4297 hsa04620 Toll-like receptor signaling pathway 3665_3661_1432_207_5595_5594_5599_6772_5970_3725_4790_4792_5604_5601_5600_5602_841_2353_6348 19 5.02E-09 4.16E-07 1.98E-08 18938 hsa-mir-4297 hsa05218 Melanoma 595_1019_4193_5925_1956_1870_1871_207_5595_5594_4286_7157_1869_5604_3265_1026 16 7.86E-09 6.52E-07 2.97E-08 18939 hsa-mir-4297 hsa04330 Notch signaling pathway 1840_3065_22938_1487_1488_9612_2648_388585_1387_2033_8850_9794_4851 13 2.53E-08 2.10E-06 9.14E-08 18940 hsa-mir-4297 hsa04520 Adherens junction 1499_6934_5777_1956_6714_71_1460_5595_5594_1387_1457_4087_4088_4089_2033_51176 16 3.40E-08 2.82E-06 1.18E-07 18941 hsa-mir-4297 hsa04660 T cell receptor signaling pathway 1019_5777_4772_4773_1432_207_5595_5594_2932_5970_3725_4790_4792_5604_5601_5600_3265_2353 18 7.34E-08 6.09E-06 2.44E-07 18942 hsa-mir-4297 hsa05322 Systemic lupus erythematosus 3021_3020_8365_8368_333932_8366_3014_3015_8294_8370_121504_8361_8360_8363_8362_8364_8367_126961_8359_8340 20 1.57E-07 1.30E-05 5.02E-07 18943 hsa-mir-4297 hsa04916 Melanogenesis 815_1499_6934_5595_5594_1385_1387_4286_2932_2033_808_801_805_51176_5604_5566_3265 17 1.71E-07 1.42E-05 5.24E-07 18944 hsa-mir-4297 hsa04910 Insulin signaling pathway 10891_5590_2308_5211_207_5595_5594_5599_23265_2932_808_801_805_5604_5601_5602_5566_3265_2002 19 3.60E-07 2.99E-05 1.07E-06 18945 hsa-mir-4297 hsa04662 B cell receptor signaling pathway 5777_4772_4773_207_5595_5594_2932_5970_3725_4790_4792_5604_3265_2353 14 5.07E-07 4.21E-05 1.45E-06 18946 hsa-mir-4297 hsa05211 Renal cell carcinoma 3091_405_2113_207_5595_5594_1387_3725_2034_2033_9915_5604_3265 13 1.79E-06 0.000148752 4.96E-06 18947 hsa-mir-4297 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_1432_836_5599_5970_3725_4790_4792_5601_5600_5602 12 8.11E-06 0.000672811 2.17E-05 18948 hsa-mir-4297 hsa04370 VEGF signaling pathway 7867_4772_4773_6714_1432_207_5595_5594_9261_5604_5600_3265 12 1.68E-05 0.001394953 4.36E-05 18949 hsa-mir-4297 hsa05016 Huntington's disease 10891_3065_3064_5468_2902_6667_9586_836_1385_1387_9001_5430_7157_23186_2033_6874_6908_841_9519 19 2.19E-05 0.001816972 5.51E-05 18950 hsa-mir-4297 hsa04630 Jak-STAT signaling pathway 595_5777_3716_3566_10401_207_1387_6778_6774_6775_6776_6777_6772_6773_2033_4609_8554 17 2.27E-05 0.001881989 5.54E-05 18951 hsa-mir-4297 hsa04920 Adipocytokine signaling pathway 10891_5465_207_5599_6256_6774_5970_4790_4792_5601_5602 11 2.44E-05 0.002027949 5.79E-05 18952 hsa-mir-4297 hsa04115 p53 signaling pathway 595_1019_1017_4194_4193_836_7157_64326_841_1026_7161 11 3.11E-05 0.002584441 7.18E-05 18953 hsa-mir-4297 hsa04062 Chemokine signaling pathway 5590_2309_207_5595_5594_2932_5580_6774_6777_6772_6773_5970_4790_4792_5604_5566_3265_6348 18 9.26E-05 0.00768634 0.000204826 18954 hsa-mir-4297 hsa04664 Fc epsilon RI signaling pathway 1432_207_5595_5594_5599_5580_5604_5601_5600_5602_3265 11 9.38E-05 0.007783401 0.000204826 18955 hsa-mir-4297 hsa04930 Type II diabetes mellitus 5590_3651_5595_5594_5599_5580_5601_5602 8 0.000192534 0.015980283 0.000409751 18956 hsa-mir-4297 hsa04950 Maturity onset diabetes of the young 5080_6927_3087_3651_168620_4760 6 0.000252926 0.020992887 0.000524822 18957 hsa-mir-4297 hsa03410 Base excision repair 4350_252969_3146_328_2237_5111_6996 7 0.000298894 0.024808195 0.000605078 18958 hsa-mir-4297 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906_1432_1616_836_834_7157_5600 8 0.000716038 0.059431136 0.001415027 18959 hsa-mir-4297 hsa04540 Gap junction 10382_1956_6714_5592_5595_5594_5598_5604_5566_3265 10 0.001225294 0.101699435 0.002365103 18960 hsa-mir-4297 hsa04510 Focal adhesion 1499_595_1956_6714_207_71_5595_5594_5599_2932_3725_5604_5601_5602_3265_2002 16 0.001394449 0.11573926 0.002630438 18961 hsa-mir-4297 hsa03450 Non-homologous end-joining 10111_2237_5591_4361 4 0.00187789 0.155864905 0.003463665 18962 hsa-mir-4297 hsa04150 mTOR signaling pathway 6197_3091_207_5595_5594_6195_6196 7 0.002075732 0.172285723 0.003745342 18963 hsa-mir-4297 hsa04530 Tight junction 1499_1019_5590_6714_22800_8573_207_71_1460_5580_1457_3265 12 0.00213295 0.177034862 0.003766699 18964 hsa-mir-4297 hsa04210 Apoptosis 840_207_836_5970_7157_4790_4792_5566_841 9 0.003098927 0.257210904 0.005358561 18965 hsa-mir-4297 hsa03420 Nucleotide excision repair 5981_5886_5111_5887_2967_2968 6 0.004036995 0.335070547 0.006838174 18966 hsa-mir-4297 hsa04270 Vascular smooth muscle contraction 5592_5595_5594_5580_808_801_805_59_5604_5566 10 0.00598761 0.496971651 0.009939433 18967 hsa-mir-4297 hsa04120 Ubiquitin mediated proteolysis 55294_4193_6502_10401_7329_8925_83737_64326_5371_672_8554 11 0.006486609 0.538388516 0.010556638 18968 hsa-mir-4297 hsa05010 Alzheimer's disease 840_2902_2906_836_5595_5594_2932_808_351_801_805_841_1020 13 0.008514802 0.706728575 0.013590934 18969 hsa-mir-4297 hsa05217 Basal cell carcinoma 1499_6934_2932_7157_51176_2736 6 0.010647416 0.883735525 0.016674255 18970 hsa-mir-4297 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 0.022537115 1 0.03464038 18971 hsa-mir-4297 hsa04612 Antigen processing and presentation 3308_1385_3312_3320_3326_4800_4801 7 0.027754335 1 0.041883814 18972 hsa-mir-4297 hsa03030 DNA replication 5981_4171_2237_5111 4 0.033101077 1 0.049060525 18973 hsa-mir-4297 hsa03430 Mismatch repair 5981_5111_2956 3 0.043804707 1 0.063785802 18974 hsa-mir-4298 hsa04310 Wnt signaling pathway 4087_4088_1488_2033_1487 5 1.60E-06 3.52E-05 3.52E-05 18975 hsa-mir-4298 hsa04330 Notch signaling pathway 1488_2033_1487 3 3.51E-05 0.00077297 0.000386485 18976 hsa-mir-4298 hsa05200 Pathways in cancer 4087_4088_1488_2033_1487 5 6.39E-05 0.001405889 0.00046863 18977 hsa-mir-4298 hsa05220 Chronic myeloid leukemia 4088_1488_1487 3 0.000133082 0.002927808 0.000704136 18978 hsa-mir-4298 hsa04520 Adherens junction 4087_4088_2033 3 0.000160031 0.003520681 0.000704136 18979 hsa-mir-4298 hsa04350 TGF-beta signaling pathway 4087_4088_2033 3 0.000203372 0.004474185 0.000745698 18980 hsa-mir-4298 hsa04950 Maturity onset diabetes of the young 3651_5080 2 0.00049684 0.010930479 0.001366861 18981 hsa-mir-4298 hsa04110 Cell cycle 4087_4088_2033 3 0.00049704 0.01093489 0.001366861 18982 hsa-mir-4298 hsa05210 Colorectal cancer 4087_4088 2 0.005326912 0.117192072 0.013021341 18983 hsa-mir-4298 hsa04530 Tight junction 60412_4628 2 0.01340317 0.294869749 0.029486975 18984 hsa-mir-4298 hsa05016 Huntington's disease 2033_10476 2 0.024101573 0.530234608 0.048203146 18985 hsa-mir-4301 hsa05200 Pathways in cancer 5371_5595_5594_5914_6256_595_836_367_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_4088_4089_3066_3065_5925_2034_2033_4846 28 4.16E-32 2.58E-30 2.58E-30 18986 hsa-mir-4301 hsa05220 Chronic myeloid leukemia 5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464 15 1.54E-22 9.54E-21 4.77E-21 18987 hsa-mir-4301 hsa04110 Cell cycle 5591_595_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933 14 3.66E-18 2.27E-16 7.56E-17 18988 hsa-mir-4301 hsa05215 Prostate cancer 5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033 11 9.26E-15 5.74E-13 1.29E-13 18989 hsa-mir-4301 hsa05212 Pancreatic cancer 5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033 11 1.04E-14 6.44E-13 1.29E-13 18990 hsa-mir-4301 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5925 9 3.49E-14 2.16E-12 3.60E-13 18991 hsa-mir-4301 hsa05210 Colorectal cancer 5595_5594_595_836_7157_4087_4609_3725_4088_4089 10 2.52E-13 1.56E-11 2.04E-12 18992 hsa-mir-4301 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925 9 2.63E-13 1.63E-11 2.04E-12 18993 hsa-mir-4301 hsa05222 Small cell lung cancer 6256_595_5970_1870_1871_7157_4609_1869_5925_4846 10 3.13E-13 1.94E-11 2.16E-12 18994 hsa-mir-4301 hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_6464 9 1.20E-12 7.43E-11 7.43E-12 18995 hsa-mir-4301 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_5970_4609 8 2.63E-11 1.63E-09 1.48E-10 18996 hsa-mir-4301 hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5925 8 1.02E-10 6.34E-09 5.28E-10 18997 hsa-mir-4301 hsa05211 Renal cell carcinoma 5595_5594_3091_7428_2113_3725_2034_2033 8 1.13E-10 7.03E-09 5.40E-10 18998 hsa-mir-4301 hsa04350 TGF-beta signaling pathway 5595_5594_4087_4609_4088_4089_2033_5933 8 4.58E-10 2.84E-08 2.03E-09 18999 hsa-mir-4301 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 9.15E-10 5.67E-08 3.78E-09 19000 hsa-mir-4301 hsa04310 Wnt signaling pathway 595_7157_4087_4609_3725_1457_4088_4089_2033 9 1.40E-09 8.68E-08 5.42E-09 19001 hsa-mir-4301 hsa04520 Adherens junction 5595_5594_4087_1457_4088_4089_2033 7 8.13E-09 5.04E-07 2.96E-08 19002 hsa-mir-4301 hsa04010 MAPK signaling pathway 5595_5594_4208_836_3312_5970_7157_4609_3725_4763 10 1.36E-08 8.45E-07 4.69E-08 19003 hsa-mir-4301 hsa05016 Huntington's disease 6874_2902_836_7157_3066_3065_3064_2033 8 1.38E-07 8.55E-06 4.50E-07 19004 hsa-mir-4301 hsa05213 Endometrial cancer 5595_5594_595_7157_4609 5 7.92E-07 4.91E-05 2.46E-06 19005 hsa-mir-4301 hsa04012 ErbB signaling pathway 5595_5594_4609_3725_6464 5 8.57E-06 0.000531387 2.53E-05 19006 hsa-mir-4301 hsa04330 Notch signaling pathway 9612_3066_3065_2033 4 1.68E-05 0.001041198 4.73E-05 19007 hsa-mir-4301 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_7157_4846 4 3.21E-05 0.001990422 8.65E-05 19008 hsa-mir-4301 hsa04720 Long-term potentiation 5595_5594_2902_2033 4 9.47E-05 0.005872995 0.00023492 19009 hsa-mir-4301 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725 4 9.47E-05 0.005872995 0.00023492 19010 hsa-mir-4301 hsa05010 Alzheimer's disease 5595_5594_2902_836_4846 5 0.000222199 0.013776311 0.000529858 19011 hsa-mir-4301 hsa04620 Toll-like receptor signaling pathway 5595_5594_5970_3725 4 0.00029453 0.018260834 0.000676327 19012 hsa-mir-4301 hsa04660 T cell receptor signaling pathway 5595_5594_5970_3725 4 0.000388502 0.024087104 0.000860254 19013 hsa-mir-4301 hsa04510 Focal adhesion 5595_5594_595_3725_6464 5 0.000438211 0.027169068 0.000936864 19014 hsa-mir-4301 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.000606587 0.037608391 0.001253613 19015 hsa-mir-4301 hsa04910 Insulin signaling pathway 6720_5595_5594_6464 4 0.000887004 0.054994227 0.00171857 19016 hsa-mir-4301 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_6464 4 0.000887004 0.054994227 0.00171857 19017 hsa-mir-4301 hsa04115 p53 signaling pathway 595_836_7157 3 0.001329343 0.082419271 0.002497554 19018 hsa-mir-4301 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_5970_3725 3 0.001438684 0.089198411 0.002548526 19019 hsa-mir-4301 hsa04730 Long-term depression 5595_5594_4846 3 0.001438684 0.089198411 0.002548526 19020 hsa-mir-4301 hsa04370 VEGF signaling pathway 5595_5594_4846 3 0.001800045 0.11160278 0.003100077 19021 hsa-mir-4301 hsa04612 Antigen processing and presentation 4800_4801_3312 3 0.002681283 0.166239573 0.004374726 19022 hsa-mir-4301 hsa04210 Apoptosis 836_5970_7157 3 0.002681283 0.166239573 0.004374726 19023 hsa-mir-4301 hsa04062 Chemokine signaling pathway 5595_5594_5970_6464 4 0.002936341 0.182053166 0.00466803 19024 hsa-mir-4301 hsa04916 Melanogenesis 5595_5594_2033 3 0.004103678 0.25442802 0.0063607 19025 hsa-mir-4301 hsa04912 GnRH signaling pathway 5595_5594_3725 3 0.004546884 0.281906832 0.006875776 19026 hsa-mir-4301 hsa04930 Type II diabetes mellitus 5595_5594 2 0.008763359 0.543328272 0.012922499 19027 hsa-mir-4301 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428 3 0.008962379 0.555667472 0.012922499 19028 hsa-mir-4301 hsa04630 Jak-STAT signaling pathway 595_4609_2033 3 0.011958015 0.741396911 0.01684993 19029 hsa-mir-4301 hsa04920 Adipocytokine signaling pathway 6256_5970 2 0.018228702 1 0.025115101 19030 hsa-mir-4301 hsa04664 Fc epsilon RI signaling pathway 5595_5594 2 0.024601767 1 0.033158903 19031 hsa-mir-4301 hsa04540 Gap junction 5595_5594 2 0.033006835 1 0.043540931 19032 hsa-mir-4301 hsa04710 Circadian rhythm - mammal 8863 1 0.041078632 1 0.0530599 19033 hsa-mir-4301 hsa03450 Non-homologous end-joining 5591 1 0.043948127 1 0.055607834 19034 hsa-mir-4302 hsa05200 Pathways in cancer 2249_367_3725_6776_6777_2353_5914_5970_6256 9 4.43E-10 1.68E-08 1.68E-08 19035 hsa-mir-4302 hsa05221 Acute myeloid leukemia 6776_6777_5914_5970 4 1.37E-06 5.20E-05 2.60E-05 19036 hsa-mir-4302 hsa05220 Chronic myeloid leukemia 6776_6777_5970 3 0.000143889 0.005467791 0.001366948 19037 hsa-mir-4302 hsa04662 B cell receptor signaling pathway 3725_2353_5970 3 0.000143889 0.005467791 0.001366948 19038 hsa-mir-4302 hsa04012 ErbB signaling pathway 3725_6776_6777 3 0.000219822 0.008353225 0.001670645 19039 hsa-mir-4302 hsa04620 Toll-like receptor signaling pathway 3725_2353_5970 3 0.000346079 0.01315101 0.002144148 19040 hsa-mir-4302 hsa04660 T cell receptor signaling pathway 3725_2353_5970 3 0.000429163 0.016308178 0.002144148 19041 hsa-mir-4302 hsa04010 MAPK signaling pathway 2249_3725_2353_5970 4 0.0004514 0.017153187 0.002144148 19042 hsa-mir-4302 hsa03410 Base excision repair 3146_142 2 0.001121037 0.042599416 0.004078665 19043 hsa-mir-4302 hsa04630 Jak-STAT signaling pathway 3977_6776_6777 3 0.001135503 0.043149113 0.004078665 19044 hsa-mir-4302 hsa03022 Basal transcription factors 6908_2959 2 0.001180666 0.044865317 0.004078665 19045 hsa-mir-4302 hsa04920 Adipocytokine signaling pathway 5970_6256 2 0.003647342 0.13859898 0.011549915 19046 hsa-mir-4302 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5970 2 0.004072436 0.154752585 0.011904045 19047 hsa-mir-4302 hsa05210 Colorectal cancer 3725_2353 2 0.005604104 0.212955955 0.013977695 19048 hsa-mir-4302 hsa05222 Small cell lung cancer 5970_6256 2 0.005859788 0.22267195 0.013977695 19049 hsa-mir-4302 hsa05215 Prostate cancer 367_5970 2 0.006120738 0.232588047 0.013977695 19050 hsa-mir-4302 hsa05212 Pancreatic cancer 367_5970 2 0.006253179 0.237620807 0.013977695 19051 hsa-mir-4302 hsa03450 Non-homologous end-joining 2547 1 0.019303143 0.733519437 0.04075108 19052 hsa-mir-4302 hsa05016 Huntington's disease 6908_6667 2 0.025298734 0.961351911 0.050433212 19053 hsa-mir-4302 hsa04062 Chemokine signaling pathway 6777_5970 2 0.026543796 1 0.050433212 19054 hsa-mir-4302 hsa04950 Maturity onset diabetes of the young 6927 1 0.031969693 1 0.057849921 19055 hsa-mir-4302 hsa05216 Thyroid cancer 6256 1 0.038243049 1 0.066056175 19056 hsa-mir-4302 hsa04080 Neuroactive ligand-receptor interaction 2908_7067 2 0.044219007 1 0.07305749 19057 hsa-mir-4304 hsa05200 Pathways in cancer 4088_3320_5604_4292_1050_4149_4087_5371_5925_2033_6502_2932_5894_1387_5595_1029_5599_5970 18 2.32E-19 1.32E-17 1.32E-17 19058 hsa-mir-4304 hsa04110 Cell cycle 6500_4088_983_4087_5925_2033_6502_990_2932_8454_1387_1029_5933 13 6.98E-18 3.98E-16 1.99E-16 19059 hsa-mir-4304 hsa04540 Gap junction 983_5604_51807_5894_10376_7846_5595_7277_7278_5598 10 6.38E-14 3.64E-12 1.21E-12 19060 hsa-mir-4304 hsa04350 TGF-beta signaling pathway 6500_4088_4087_6667_2033_8454_1387_5595_5933 9 1.69E-12 9.64E-11 1.94E-11 19061 hsa-mir-4304 hsa05215 Prostate cancer 3320_5604_5925_2033_2932_5894_1387_5595_5970 9 1.86E-12 1.06E-10 1.94E-11 19062 hsa-mir-4304 hsa05212 Pancreatic cancer 3320_5604_5925_2033_2932_5894_1387_5595_5970 9 2.05E-12 1.17E-10 1.94E-11 19063 hsa-mir-4304 hsa04310 Wnt signaling pathway 6500_4088_4087_2033_2932_8454_1387_5599_1457_1459 10 6.26E-12 3.57E-10 5.10E-11 19064 hsa-mir-4304 hsa05210 Colorectal cancer 4088_5604_4292_4087_2932_5894_5595_5599 8 5.73E-11 3.27E-09 4.09E-10 19065 hsa-mir-4304 hsa05220 Chronic myeloid leukemia 4088_5604_5925_5894_5595_1029_5970 7 1.10E-09 6.28E-08 6.98E-09 19066 hsa-mir-4304 hsa04520 Adherens junction 4088_4087_2033_1387_5595_1457_1459 7 1.68E-09 9.56E-08 9.56E-09 19067 hsa-mir-4304 hsa05131 Shigellosis 4691_51807_10376_7846_7277_7278 6 8.42E-09 4.80E-07 4.00E-08 19068 hsa-mir-4304 hsa05130 Pathogenic Escherichia coli infection 4691_51807_10376_7846_7277_7278 6 8.42E-09 4.80E-07 4.00E-08 19069 hsa-mir-4304 hsa05221 Acute myeloid leukemia 5604_1050_5371_5894_5595_5970 6 1.12E-08 6.41E-07 4.93E-08 19070 hsa-mir-4304 hsa05219 Bladder cancer 5604_5925_5894_5595_1029 5 9.69E-08 5.52E-06 3.95E-07 19071 hsa-mir-4304 hsa05213 Endometrial cancer 5604_4292_2932_5894_5595 5 2.60E-07 1.48E-05 9.55E-07 19072 hsa-mir-4304 hsa04916 Melanogenesis 5604_2033_2932_5894_1387_5595 6 2.68E-07 1.53E-05 9.55E-07 19073 hsa-mir-4304 hsa05223 Non-small cell lung cancer 5604_5925_5894_5595_1029 5 3.09E-07 1.76E-05 1.04E-06 19074 hsa-mir-4304 hsa04010 MAPK signaling pathway 5604_4149_5894_1386_5595_5599_5598_5970 8 3.75E-07 2.14E-05 1.19E-06 19075 hsa-mir-4304 hsa05214 Glioma 5604_5925_5894_5595_1029 5 7.33E-07 4.18E-05 2.20E-06 19076 hsa-mir-4304 hsa05218 Melanoma 5604_5925_5894_5595_1029 5 1.11E-06 6.30E-05 3.15E-06 19077 hsa-mir-4304 hsa05211 Renal cell carcinoma 5604_2033_5894_1387_5595 5 1.18E-06 6.73E-05 3.20E-06 19078 hsa-mir-4304 hsa04120 Ubiquitin mediated proteolysis 6500_55294_5371_6502_672_8454 6 1.36E-06 7.76E-05 3.39E-06 19079 hsa-mir-4304 hsa04720 Long-term potentiation 5604_2033_5894_1387_5595 5 1.43E-06 8.14E-05 3.39E-06 19080 hsa-mir-4304 hsa04662 B cell receptor signaling pathway 5604_2932_5894_5595_5970 5 1.43E-06 8.14E-05 3.39E-06 19081 hsa-mir-4304 hsa04012 ErbB signaling pathway 5604_2932_5894_5595_5599 5 2.86E-06 0.00016288 6.52E-06 19082 hsa-mir-4304 hsa04912 GnRH signaling pathway 5604_5894_5595_5599_5598 5 7.84E-06 0.000447149 1.72E-05 19083 hsa-mir-4304 hsa04062 Chemokine signaling pathway 5604_7074_2932_5894_5595_5970 6 8.46E-06 0.000482276 1.74E-05 19084 hsa-mir-4304 hsa04660 T cell receptor signaling pathway 5604_2932_5894_5595_5970 5 8.55E-06 0.000487108 1.74E-05 19085 hsa-mir-4304 hsa04910 Insulin signaling pathway 5604_2932_5894_5595_5599 5 2.45E-05 0.001399139 4.82E-05 19086 hsa-mir-4304 hsa04664 Fc epsilon RI signaling pathway 5604_5894_5595_5599 4 4.81E-05 0.002742172 9.14E-05 19087 hsa-mir-4304 hsa05222 Small cell lung cancer 4149_5925_6502_5970 4 6.61E-05 0.003765124 0.000121456 19088 hsa-mir-4304 hsa03022 Basal transcription factors 2962_2969_6908 3 0.000122002 0.006954124 0.000215512 19089 hsa-mir-4304 hsa04620 Toll-like receptor signaling pathway 5604_5595_5599_5970 4 0.00012477 0.007111903 0.000215512 19090 hsa-mir-4304 hsa04510 Focal adhesion 5604_2932_5894_5595_5599 5 0.000154898 0.008829165 0.000259681 19091 hsa-mir-4304 hsa04330 Notch signaling pathway 2033_2648_1387 3 0.000237911 0.0135609 0.000387454 19092 hsa-mir-4304 hsa04115 p53 signaling pathway 983_7161_1029 3 0.000697144 0.039737222 0.001103812 19093 hsa-mir-4304 hsa04730 Long-term depression 5604_5894_5595 3 0.000755151 0.043043634 0.001163341 19094 hsa-mir-4304 hsa04370 VEGF signaling pathway 5604_5894_5595 3 0.000947327 0.053997655 0.001420991 19095 hsa-mir-4304 hsa05016 Huntington's disease 6908_6667_2033_1387 4 0.001180746 0.067302537 0.001725706 19096 hsa-mir-4304 hsa04612 Antigen processing and presentation 3320_4802_4801 3 0.001418569 0.080858411 0.00202146 19097 hsa-mir-4304 hsa04810 Regulation of actin cytoskeleton 5604_7074_5894_5595 4 0.002041531 0.116367292 0.002838227 19098 hsa-mir-4304 hsa05216 Thyroid cancer 5604_5595 2 0.002513154 0.143249795 0.003410709 19099 hsa-mir-4304 hsa04270 Vascular smooth muscle contraction 5604_5894_5595 3 0.003096008 0.176472447 0.00410401 19100 hsa-mir-4304 hsa04650 Natural killer cell mediated cytotoxicity 5604_5894_5595 3 0.004751869 0.270856554 0.006155831 19101 hsa-mir-4304 hsa04930 Type II diabetes mellitus 5595_5599 2 0.005699896 0.324894068 0.007219868 19102 hsa-mir-4304 hsa04920 Adipocytokine signaling pathway 5599_5970 2 0.01195835 0.681625946 0.014817955 19103 hsa-mir-4304 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5970 2 0.01331381 0.758887192 0.016146536 19104 hsa-mir-4304 hsa04360 Axon guidance 2932_5595 2 0.040579599 1 0.048188274 19105 hsa-mir-4304 hsa04530 Tight junction 1457_1459 2 0.043936295 1 0.051109568 19106 hsa-mir-4305 hsa04330 Notch signaling pathway 2033 1 0.020596727 0.308950909 0.071806667 19107 hsa-mir-4305 hsa03050 Proteasome 5705 1 0.021021631 0.315324466 0.071806667 19108 hsa-mir-4305 hsa05211 Renal cell carcinoma 2033 1 0.031168416 0.467526241 0.071806667 19109 hsa-mir-4305 hsa04720 Long-term potentiation 2033 1 0.032429915 0.486448731 0.071806667 19110 hsa-mir-4305 hsa04520 Adherens junction 2033 1 0.034529045 0.51793568 0.071806667 19111 hsa-mir-4305 hsa04350 TGF-beta signaling pathway 2033 1 0.037460766 0.561911483 0.071806667 19112 hsa-mir-4305 hsa05215 Prostate cancer 2033 1 0.037878911 0.568183668 0.071806667 19113 hsa-mir-4305 hsa05212 Pancreatic cancer 2033 1 0.038296889 0.574453339 0.071806667 19114 hsa-mir-4305 hsa04916 Melanogenesis 2033 1 0.044546479 0.668197191 0.074244132 19115 hsa-mir-4308 hsa05200 Pathways in cancer 1869_5468_595_8517_7704_3551_3091_4087_4089_3066_3065_5925_1050_1956_2308_5914_1870_1871_2113_10401_6774_861_836_1147_5595_5594_5599_6258_1387_6257_6256_367_6776_6772_5970_7157_6688_3725_4088_2034_2033_4846_4790_4791_4792_3320_3326_5371_841_7428_8031_4609_2353_8554 54 1.88E-38 1.47E-36 1.47E-36 19116 hsa-mir-4308 hsa04010 MAPK signaling pathway 6722_6195_8517_9252_3551_9020_4616_1956_3305_3303_4763_836_1147_5595_5594_5599_1386_3312_1649_5971_5970_7157_10912_468_3725_6196_4790_4791_1326_4208_5608_5566_6885_4609_2353_2002 36 4.31E-23 3.37E-21 1.68E-21 19117 hsa-mir-4308 hsa05220 Chronic myeloid leukemia 1869_595_8517_3551_4089_3066_3065_5925_1870_1871_861_1147_5595_5594_6776_5970_7157_4088_4790_4792_4609_6464 22 5.03E-21 3.92E-19 1.13E-19 19118 hsa-mir-4308 hsa05215 Prostate cancer 1869_595_8517_3551_5925_1956_2308_1870_1871_1147_5595_5594_1385_1387_367_5970_7157_468_2033_4790_4792_3320_3326 23 5.81E-21 4.53E-19 1.13E-19 19119 hsa-mir-4308 hsa05212 Pancreatic cancer 1869_595_8517_3551_5925_1956_2308_1870_1871_1147_5595_5594_1385_1387_367_5970_7157_468_2033_4790_4792_3320_3326 23 7.22E-21 5.63E-19 1.13E-19 19120 hsa-mir-4308 hsa05221 Acute myeloid leukemia 595_8517_7704_3551_1050_5914_6774_861_1147_5595_5594_6776_5970_6688_4790_5371_4609 17 1.97E-16 1.54E-14 2.50E-15 19121 hsa-mir-4308 hsa05222 Small cell lung cancer 1869_595_8517_3551_5925_1870_1871_10401_1147_6258_6257_6256_5970_7157_4846_4790_4792_4609_8554 19 2.24E-16 1.75E-14 2.50E-15 19122 hsa-mir-4308 hsa04620 Toll-like receptor signaling pathway 8517_3551_3661_1147_29110_5595_5594_5599_6772_5970_3725_4790_4792_1326_5608_9641_841_6885_2353_6348 20 2.72E-16 2.12E-14 2.65E-15 19123 hsa-mir-4308 hsa04110 Cell cycle 1869_595_6500_4087_4089_3066_3065_4616_5925_1870_1871_5933_5591_1387_7157_10912_5111_4088_2033_8454_1111 21 3.15E-16 2.46E-14 2.73E-15 19124 hsa-mir-4308 hsa04920 Adipocytokine signaling pathway 10891_5465_8517_3551_8471_6774_1147_5599_6258_6257_6256_5970_4794_4790_4792_4793 16 1.88E-14 1.46E-12 1.46E-13 19125 hsa-mir-4308 hsa04310 Wnt signaling pathway 815_595_8607_6500_8945_4087_4089_23291_5599_1387_7157_3725_1457_4088_2033_5519_5515_5566_8454_6885_4609 21 2.46E-14 1.92E-12 1.74E-13 19126 hsa-mir-4308 hsa05016 Huntington's disease 10891_5468_292_293_3066_3065_3064_498_2902_6667_836_1385_1387_5437_7157_2033_6874_6908_841_5441_1213 21 1.05E-12 8.19E-11 6.82E-12 19127 hsa-mir-4308 hsa05214 Glioma 1869_815_595_5925_1956_1870_1871_5595_5594_7157_808_801_805_6464 14 2.77E-12 2.16E-10 1.66E-11 19128 hsa-mir-4308 hsa04720 Long-term potentiation 814_815_6195_2902_5595_5594_1387_468_6196_2033_808_801_805_5566 14 1.50E-11 1.17E-09 8.38E-11 19129 hsa-mir-4308 hsa05223 Non-small cell lung cancer 1869_595_5925_1956_1870_1871_5595_5594_6258_6257_6256_7157 12 7.43E-11 5.79E-09 3.71E-10 19130 hsa-mir-4308 hsa05216 Thyroid cancer 5468_595_5595_5594_6258_6257_6256_7157_8031_4609 10 7.62E-11 5.94E-09 3.71E-10 19131 hsa-mir-4308 hsa04350 TGF-beta signaling pathway 6500_4087_4089_6667_5933_5595_5594_1387_4088_2033_5519_5515_8454_4609 14 8.74E-11 6.82E-09 4.01E-10 19132 hsa-mir-4308 hsa05219 Bladder cancer 1869_595_9252_5925_1956_1870_1871_5595_5594_7157_4609 11 1.02E-10 7.96E-09 4.42E-10 19133 hsa-mir-4308 hsa04660 T cell receptor signaling pathway 8517_3551_9020_1147_5595_5594_5970_3725_4794_4790_4792_4793_1326_6885_2353 15 1.51E-10 1.18E-08 6.20E-10 19134 hsa-mir-4308 hsa04662 B cell receptor signaling pathway 8517_3551_1147_695_5595_5594_5970_3725_4794_4790_4792_4793_2353 13 1.83E-10 1.42E-08 7.12E-10 19135 hsa-mir-4308 hsa04910 Insulin signaling pathway 6720_10891_3551_2308_8471_8651_5590_5595_5594_5599_808_801_805_5566_6464_2002 16 3.26E-10 2.54E-08 1.21E-09 19136 hsa-mir-4308 hsa05210 Colorectal cancer 595_4087_4089_1956_836_5595_5594_5599_7157_3725_4088_4609_2353 13 6.36E-10 4.96E-08 2.25E-09 19137 hsa-mir-4308 hsa04912 GnRH signaling pathway 815_1956_5595_5594_5599_468_3725_808_801_805_5608_5566_2002 13 1.00E-08 7.81E-07 3.39E-08 19138 hsa-mir-4308 hsa04210 Apoptosis 8517_3551_9020_836_1147_5970_7157_9131_4790_4792_5566_841 12 1.18E-08 9.20E-07 3.83E-08 19139 hsa-mir-4308 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 8517_3551_9020_1956_836_1147_5599_5970_3725_4790_4792 11 1.32E-08 1.03E-06 4.13E-08 19140 hsa-mir-4308 hsa04062 Chemokine signaling pathway 8517_3551_653361_6774_1147_5590_5595_5594_6772_5970_4790_4792_4793_5566_6348_6464 16 2.75E-08 2.14E-06 8.24E-08 19141 hsa-mir-4308 hsa04520 Adherens junction 4087_4089_1956_71_5595_5594_1387_1457_4088_2033_6885 11 4.02E-08 3.13E-06 1.16E-07 19142 hsa-mir-4308 hsa03022 Basal transcription factors 6872_2969_6878_6874_6908_6882_2959_6880 8 1.37E-07 1.07E-05 3.82E-07 19143 hsa-mir-4308 hsa04012 ErbB signaling pathway 815_1956_5595_5594_5599_6776_3725_4609_6464_2002 10 7.55E-07 5.89E-05 2.03E-06 19144 hsa-mir-4308 hsa04120 Ubiquitin mediated proteolysis 55294_6500_8945_23291_10401_8651_51366_5371_672_8454_7428_8554 12 1.02E-06 7.92E-05 2.64E-06 19145 hsa-mir-4308 hsa05218 Melanoma 1869_595_5925_1956_1870_1871_5595_5594_7157 9 1.29E-06 0.000100739 3.25E-06 19146 hsa-mir-4308 hsa05211 Renal cell carcinoma 3091_2113_5595_5594_1387_3725_2034_2033_7428 9 1.44E-06 0.000112002 3.50E-06 19147 hsa-mir-4308 hsa04916 Melanogenesis 815_5595_5594_1385_1387_2033_808_801_805_5566 10 3.34E-06 0.000260249 7.89E-06 19148 hsa-mir-4308 hsa04930 Type II diabetes mellitus 3551_8471_8651_5590_5595_5594_5599 7 5.91E-06 0.000461291 1.36E-05 19149 hsa-mir-4308 hsa03020 RNA polymerase 25885_64425_51082_5437_84172_5441 6 6.57E-06 0.000512319 1.46E-05 19150 hsa-mir-4308 hsa04612 Antigen processing and presentation 3309_3305_3303_1385_3312_3320_3326_4800_4801 9 7.09E-06 0.000552918 1.54E-05 19151 hsa-mir-4308 hsa04330 Notch signaling pathway 9612_3066_3065_1387_2033_8850_4851 7 7.65E-06 0.000596736 1.61E-05 19152 hsa-mir-4308 hsa04540 Gap junction 7846_10382_1956_5595_5594_347733_5566_7278_203068 9 9.84E-06 0.000767735 2.02E-05 19153 hsa-mir-4308 hsa05213 Endometrial cancer 595_1956_5595_5594_7157_4609_2002 7 1.39E-05 0.001085189 2.78E-05 19154 hsa-mir-4308 hsa04630 Jak-STAT signaling pathway 595_10401_6774_8651_1387_6778_6776_6772_2033_4609_8554 11 1.63E-05 0.001271679 3.18E-05 19155 hsa-mir-4308 hsa05131 Shigellosis 7846_10382_71_347733_7278_4691_203068 7 2.15E-05 0.00168079 4.00E-05 19156 hsa-mir-4308 hsa05130 Pathogenic Escherichia coli infection 7846_10382_71_347733_7278_4691_203068 7 2.15E-05 0.00168079 4.00E-05 19157 hsa-mir-4308 hsa05010 Alzheimer's disease 498_2902_836_22926_5595_5594_4846_808_801_805_841 11 5.14E-05 0.004005774 9.32E-05 19158 hsa-mir-4308 hsa04020 Calcium signaling pathway 814_815_292_293_1956_2902_4846_808_801_805_5566 11 7.14E-05 0.005570689 0.000126607 19159 hsa-mir-4308 hsa04115 p53 signaling pathway 595_4616_836_7157_10912_841_1111 7 7.33E-05 0.005720226 0.000127116 19160 hsa-mir-4308 hsa03320 PPAR signaling pathway 5465_5468_2168_10062_6258_6257_6256 7 7.97E-05 0.00622048 0.000135228 19161 hsa-mir-4308 hsa03010 Ribosome 6155_6156_6207_6141_6217_9349_6128_6188 8 0.000122044 0.009519417 0.000202541 19162 hsa-mir-4308 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_834_7157_4846_5608 6 0.000183389 0.014304346 0.000298007 19163 hsa-mir-4308 hsa04150 mTOR signaling pathway 6195_3091_5595_5594_6196 5 0.001001947 0.078151844 0.001594936 19164 hsa-mir-4308 hsa04510 Focal adhesion 595_1956_71_5595_5594_5599_3725_6464_2002 9 0.002619577 0.204326983 0.00408654 19165 hsa-mir-4308 hsa04730 Long-term depression 5595_5594_4846_5519_5515 5 0.003594398 0.280363063 0.005497315 19166 hsa-mir-4308 hsa04664 Fc epsilon RI signaling pathway 695_5595_5594_5599_5608 5 0.005507373 0.429575123 0.00826106 19167 hsa-mir-4308 hsa04270 Vascular smooth muscle contraction 5595_5594_808_801_805_5566 6 0.006666879 0.520016526 0.009811633 19168 hsa-mir-4308 hsa04530 Tight junction 4628_71_5590_1457_5519_5515 6 0.012927169 1 0.018672578 19169 hsa-mir-4308 hsa03410 Base excision repair 3146_142_5111 3 0.015332606 1 0.021744423 19170 hsa-mir-4308 hsa05012 Parkinson's disease 292_293_498_7314_836 5 0.041889399 1 0.058345948 19171 hsa-mir-4308 hsa03430 Mismatch repair 5981_5111 2 0.043974084 1 0.060175062 19172 hsa-mir-4308 hsa04340 Hedgehog signaling pathway 8945_23291_5566 3 0.046807778 1 0.062948392 19173 hsa-mir-431 hsa05220 Chronic myeloid leukemia 3066_1870_1871_7157_4193_4609_1029 7 1.21E-10 4.95E-09 4.95E-09 19174 hsa-mir-431 hsa05219 Bladder cancer 1870_1871_7157_4193_4609_1029 6 2.60E-10 1.07E-08 5.34E-09 19175 hsa-mir-431 hsa04110 Cell cycle 3066_1870_1871_7157_2033_4193_1029 7 2.53E-09 1.04E-07 3.45E-08 19176 hsa-mir-431 hsa05218 Melanoma 1870_1871_4286_7157_4193_1029 6 4.84E-09 1.98E-07 4.96E-08 19177 hsa-mir-431 hsa05200 Pathways in cancer 3066_1870_1871_4286_7157_2033_4193_4609_1029 9 8.02E-09 3.29E-07 6.57E-08 19178 hsa-mir-431 hsa05215 Prostate cancer 1870_1871_7157_2033_4193_1385 6 1.62E-08 6.66E-07 1.01E-07 19179 hsa-mir-431 hsa05212 Pancreatic cancer 1870_1871_7157_2033_4193_1385 6 1.73E-08 7.10E-07 1.01E-07 19180 hsa-mir-431 hsa05016 Huntington's disease 3066_6908_7157_6667_2033_4716_1385 7 5.21E-08 2.13E-06 2.67E-07 19181 hsa-mir-431 hsa05214 Glioma 1870_1871_7157_4193_1029 5 1.56E-07 6.39E-06 7.10E-07 19182 hsa-mir-431 hsa05223 Non-small cell lung cancer 1870_1871_7157_1029 4 3.41E-06 0.000139698 1.40E-05 19183 hsa-mir-431 hsa05222 Small cell lung cancer 1870_1871_7157_4609 4 1.97E-05 0.000806981 7.34E-05 19184 hsa-mir-431 hsa04330 Notch signaling pathway 3066_2033_4851 3 9.57E-05 0.003924772 0.000327064 19185 hsa-mir-431 hsa04310 Wnt signaling pathway 7157_2033_1460_4609 4 0.000167811 0.006880254 0.00052925 19186 hsa-mir-431 hsa04115 p53 signaling pathway 7157_4193_1029 3 0.000283414 0.011619967 0.000829998 19187 hsa-mir-431 hsa04350 TGF-beta signaling pathway 6667_2033_4609 3 0.000545921 0.022382759 0.001492184 19188 hsa-mir-431 hsa04916 Melanogenesis 4286_2033_1385 3 0.000903078 0.03702621 0.002314138 19189 hsa-mir-431 hsa05216 Thyroid cancer 7157_4609 2 0.001373209 0.056301574 0.003311857 19190 hsa-mir-431 hsa04120 Ubiquitin mediated proteolysis 11059_4193_672 3 0.002035336 0.083448791 0.004636044 19191 hsa-mir-431 hsa03022 Basal transcription factors 2969_6908 2 0.002168622 0.088913491 0.004679657 19192 hsa-mir-431 hsa05213 Endometrial cancer 7157_4609 2 0.004117834 0.168831175 0.008441559 19193 hsa-mir-431 hsa04520 Adherens junction 2033_1460 2 0.00926059 0.379684187 0.018080199 19194 hsa-mir-431 hsa05210 Colorectal cancer 7157_4609 2 0.010146344 0.416000119 0.018909096 19195 hsa-mir-431 hsa04010 MAPK signaling pathway 7157_4609_1386 3 0.012800413 0.524816943 0.022818128 19196 hsa-mir-431 hsa04530 Tight junction 1460_10207 2 0.025094069 1 0.042869034 19197 hsa-mir-431 hsa04630 Jak-STAT signaling pathway 2033_4609 2 0.03140556 1 0.051505119 19198 hsa-mir-431 hsa05010 Alzheimer's disease 22926_4716 2 0.03987081 1 0.062873201 19199 hsa-mir-4310 hsa05200 Pathways in cancer 1147_3320_3326_405_3480_1956_5595_5594_6654_5914_2064_6256_595_2308_208_367_2932_4193_3265_7704_1387_6776_5970_8503_2885_7157_10401_4087_3725_4088_4089_5295_3065_5925_2033_207_8554_4790 38 3.05E-35 2.20E-33 2.20E-33 19200 hsa-mir-4310 hsa05215 Prostate cancer 1147_3320_3326_3480_1956_5595_5594_6654_2064_595_2308_208_367_2932_4193_3265_1387_5970_8503_2885_7157_5295_5925_2033_207_4790 26 1.03E-33 7.41E-32 3.18E-32 19201 hsa-mir-4310 hsa05212 Pancreatic cancer 1147_3320_3326_3480_1956_5595_5594_6654_2064_595_2308_208_367_2932_4193_3265_1387_5970_8503_2885_7157_5295_5925_2033_207_4790 26 1.32E-33 9.53E-32 3.18E-32 19202 hsa-mir-4310 hsa05220 Chronic myeloid leukemia 1147_5595_5594_6654_595_208_4193_3265_6776_5970_8503_2885_7157_4088_4089_5295_3065_5925_207_4790_6464 21 5.62E-27 4.04E-25 1.01E-25 19203 hsa-mir-4310 hsa05214 Glioma 3480_1956_5595_5594_6654_595_208_4193_3265_8503_2885_7157_5295_5925_207_801_6464_808_805 19 8.28E-25 5.96E-23 1.19E-23 19204 hsa-mir-4310 hsa04010 MAPK signaling pathway 1147_994_1956_5595_5594_6654_5566_208_4214_3265_1432_5970_627_2885_7157_10912_22800_3725_3727_6195_6197_5058_4616_2872_207_4790 26 2.22E-22 1.60E-20 2.66E-21 19205 hsa-mir-4310 hsa04910 Insulin signaling pathway 6720_10891_5595_5594_6654_2308_5566_7249_208_2932_3265_5770_8503_2885_5295_2872_207_801_6464_808_805 21 4.31E-22 3.10E-20 4.43E-21 19206 hsa-mir-4310 hsa04012 ErbB signaling pathway 1956_6714_5595_5594_6654_56924_2064_208_2932_3265_6776_8503_2885_3725_5295_5058_207_6464 18 3.23E-21 2.32E-19 2.91E-20 19207 hsa-mir-4310 hsa05223 Non-small cell lung cancer 1956_5595_5594_6654_2064_6256_595_2309_208_3265_8503_2885_7157_5295_5925_207 16 3.80E-21 2.74E-19 3.04E-20 19208 hsa-mir-4310 hsa04660 T cell receptor signaling pathway 1147_3932_5595_5594_6654_56924_208_2932_3265_5777_1432_5970_8503_2885_3725_5295_5058_207_4790 19 5.10E-21 3.67E-19 3.67E-20 19209 hsa-mir-4310 hsa05221 Acute myeloid leukemia 1147_5595_5594_6654_5914_595_208_3265_7704_6776_5970_8503_2885_5295_207_4790 16 1.28E-20 9.20E-19 8.36E-20 19210 hsa-mir-4310 hsa05210 Colorectal cancer 3480_1956_5595_5594_6654_595_208_2932_8503_2885_7157_4087_3725_4088_4089_5295_207 17 5.87E-20 4.23E-18 3.52E-19 19211 hsa-mir-4310 hsa05213 Endometrial cancer 1956_5595_5594_6654_2064_595_2309_208_2932_3265_8503_2885_7157_5295_207 15 9.51E-20 6.85E-18 5.27E-19 19212 hsa-mir-4310 hsa04510 Focal adhesion 9564_3480_1956_6714_5595_5594_6654_56924_2064_595_208_2932_3265_8503_857_2885_3725_5295_5058_207_6464 21 8.18E-19 5.89E-17 4.21E-18 19213 hsa-mir-4310 hsa05211 Renal cell carcinoma 405_5595_5594_6654_56924_208_3265_1387_8503_2885_3725_5295_5058_2033_207 15 6.51E-18 4.69E-16 3.13E-17 19214 hsa-mir-4310 hsa04662 B cell receptor signaling pathway 1147_5595_5594_6654_208_2932_3265_5777_5970_8503_2885_3725_5295_207_4790 15 1.11E-17 8.03E-16 4.77E-17 19215 hsa-mir-4310 hsa04110 Cell cycle 994_595_7533_2932_4193_902_1387_7157_10912_4087_1022_4088_4089_3065_4616_5925_2033 17 1.13E-17 8.11E-16 4.77E-17 19216 hsa-mir-4310 hsa04062 Chemokine signaling pathway 1147_9564_5595_5594_6654_2309_5566_208_2932_3265_5970_8503_2885_2770_5295_5058_207_4790_6464 19 7.27E-17 5.23E-15 2.91E-16 19217 hsa-mir-4310 hsa04520 Adherens junction 1460_3480_1956_6714_5595_5594_2064_5770_5777_1387_4087_4088_4089_2033 14 7.29E-16 5.25E-14 2.76E-15 19218 hsa-mir-4310 hsa05218 Melanoma 3480_1956_5595_5594_595_208_4193_3265_8503_7157_5295_5925_207 13 4.81E-15 3.47E-13 1.73E-14 19219 hsa-mir-4310 hsa04720 Long-term potentiation 5595_5594_2902_2906_5566_3265_1387_6195_6197_2033_801_808_805 13 9.04E-15 6.51E-13 3.10E-14 19220 hsa-mir-4310 hsa04912 GnRH signaling pathway 1956_6714_5595_5594_6654_5566_4214_3265_1432_2885_3725_801_808_805 14 3.08E-14 2.22E-12 1.01E-13 19221 hsa-mir-4310 hsa05222 Small cell lung cancer 1147_6256_595_208_5970_8503_7157_10401_5295_5925_207_8554_4790 13 4.39E-14 3.16E-12 1.38E-13 19222 hsa-mir-4310 hsa05219 Bladder cancer 1956_5595_5594_2064_595_4193_3265_7157_5925 9 2.45E-11 1.76E-09 7.34E-11 19223 hsa-mir-4310 hsa04630 Jak-STAT signaling pathway 6654_595_208_5777_1387_6776_8503_2885_10401_5295_2033_207_8554 13 4.17E-11 3.00E-09 1.20E-10 19224 hsa-mir-4310 hsa04620 Toll-like receptor signaling pathway 1147_5595_5594_208_1432_5970_8503_3725_5295_207_4790 11 1.15E-10 8.27E-09 3.18E-10 19225 hsa-mir-4310 hsa04150 mTOR signaling pathway 5595_5594_7249_208_8503_6195_6197_5295_207 9 1.32E-10 9.52E-09 3.53E-10 19226 hsa-mir-4310 hsa04916 Melanogenesis 5595_5594_5566_2932_3265_1387_2770_2033_801_808_805 11 1.39E-10 1.00E-08 3.58E-10 19227 hsa-mir-4310 hsa04664 Fc epsilon RI signaling pathway 5595_5594_6654_208_3265_1432_8503_2885_5295_207 10 1.96E-10 1.41E-08 4.86E-10 19228 hsa-mir-4310 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6654_3265_5777_8503_2885_5295_5058_6464 11 2.25E-09 1.62E-07 5.40E-09 19229 hsa-mir-4310 hsa04370 VEGF signaling pathway 6714_5595_5594_208_3265_1432_8503_5295_207 9 3.08E-09 2.21E-07 7.14E-09 19230 hsa-mir-4310 hsa04310 Wnt signaling pathway 1460_595_5566_2932_1387_7157_4087_3725_4088_4089_2033 11 5.81E-09 4.18E-07 1.31E-08 19231 hsa-mir-4310 hsa04210 Apoptosis 1147_5566_208_5970_8503_7157_5295_207_4790 9 9.88E-09 7.11E-07 2.16E-08 19232 hsa-mir-4310 hsa04540 Gap junction 1956_6714_5595_5594_6654_5566_3265_2885_2770 9 1.41E-08 1.01E-06 2.98E-08 19233 hsa-mir-4310 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_1956_6714_1432_5970_3725_5058_4790 8 3.08E-08 2.22E-06 6.33E-08 19234 hsa-mir-4310 hsa05216 Thyroid cancer 5595_5594_6256_595_3265_7157 6 6.84E-08 4.93E-06 1.37E-07 19235 hsa-mir-4310 hsa04350 TGF-beta signaling pathway 5595_5594_6667_1387_4087_4088_4089_2033 8 1.32E-07 9.50E-06 2.57E-07 19236 hsa-mir-4310 hsa04810 Regulation of actin cytoskeleton 9564_1956_5595_5594_6654_56924_3265_8503_22800_5295_5058 11 1.99E-07 1.43E-05 3.77E-07 19237 hsa-mir-4310 hsa04920 Adipocytokine signaling pathway 1147_10891_6256_208_5970_207_4790 7 3.69E-07 2.66E-05 6.81E-07 19238 hsa-mir-4310 hsa05016 Huntington's disease 10891_2902_6908_6667_1387_627_7157_3065_2033_9519 10 4.39E-07 3.16E-05 7.90E-07 19239 hsa-mir-4310 hsa05010 Alzheimer's disease 5595_5594_2902_2906_2932_801_808_351_805 9 2.39E-06 0.000171905 4.17E-06 19240 hsa-mir-4310 hsa04360 Axon guidance 5998_5595_5594_56924_2932_3265_2770_5058 8 2.43E-06 0.000174981 4.17E-06 19241 hsa-mir-4310 hsa04530 Tight junction 1460_6714_208_3265_2770_22800_8573_207 8 3.33E-06 0.000239895 5.58E-06 19242 hsa-mir-4310 hsa03022 Basal transcription factors 2965_6881_6908_2959_9519 5 5.80E-06 0.000417421 9.49E-06 19243 hsa-mir-4310 hsa04115 p53 signaling pathway 595_7249_4193_7157_10912_4616 6 6.93E-06 0.00049879 1.11E-05 19244 hsa-mir-4310 hsa04020 Calcium signaling pathway 1956_2064_2902_2906_5566_801_808_805 8 2.59E-05 0.001864931 4.05E-05 19245 hsa-mir-4310 hsa04120 Ubiquitin mediated proteolysis 672_4214_4193_10401_10273_7329_8554 7 3.43E-05 0.002471176 5.26E-05 19246 hsa-mir-4310 hsa04730 Long-term depression 3480_5595_5594_3265_2770 5 0.000106404 0.007661105 0.000159606 19247 hsa-mir-4310 hsa04270 Vascular smooth muscle contraction 5595_5594_5566_801_808_805 6 0.00011991 0.008633543 0.000176195 19248 hsa-mir-4310 hsa04070 Phosphatidylinositol signaling system 8503_5295_801_808_805 5 0.000143966 0.010365558 0.000207311 19249 hsa-mir-4310 hsa03420 Nucleotide excision repair 2965_902_1022_4331 4 0.000215269 0.015499369 0.000303909 19250 hsa-mir-4310 hsa04930 Type II diabetes mellitus 5595_5594_8503_5295 4 0.000233288 0.016796755 0.000323015 19251 hsa-mir-4310 hsa04330 Notch signaling pathway 1387_9612_3065_2033 4 0.000272542 0.019623055 0.000370246 19252 hsa-mir-4310 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906_1432_7157 4 0.000509492 0.036683413 0.000679322 19253 hsa-mir-4310 hsa04670 Leukocyte transendothelial migration 9564_1432_8503_2770_5295 5 0.001139068 0.082012925 0.001491144 19254 hsa-mir-4310 hsa04612 Antigen processing and presentation 3320_3326_6890 3 0.019100299 1 0.024557528 19255 hsa-mir-4310 hsa05340 Primary immunodeficiency 3932_6890 2 0.021619361 1 0.027308667 19256 hsa-mir-4310 hsa03410 Base excision repair 6996_4350 2 0.022729779 1 0.028216278 19257 hsa-mir-4310 hsa03050 Proteasome 5698_5705 2 0.037765911 1 0.046087214 19258 hsa-mir-4310 hsa05217 Basal cell carcinoma 2932_7157 2 0.047862428 1 0.057434914 19259 hsa-mir-4311 hsa04350 TGF-beta signaling pathway 6667_1387_5595_5594_3399 5 1.46E-09 6.55E-08 6.55E-08 19260 hsa-mir-4311 hsa05215 Prostate cancer 1387_5595_5594_2932 4 1.91E-07 8.58E-06 2.99E-06 19261 hsa-mir-4311 hsa05212 Pancreatic cancer 1387_5595_5594_2932 4 1.99E-07 8.97E-06 2.99E-06 19262 hsa-mir-4311 hsa04916 Melanogenesis 1387_5595_5594_2932 4 3.64E-07 1.64E-05 4.09E-06 19263 hsa-mir-4311 hsa04910 Insulin signaling pathway 5595_5594_2932_23265 4 1.09E-06 4.90E-05 9.80E-06 19264 hsa-mir-4311 hsa05213 Endometrial cancer 5595_5594_2932 3 3.89E-06 0.000174901 2.92E-05 19265 hsa-mir-4311 hsa05211 Renal cell carcinoma 1387_5595_5594 3 9.93E-06 0.00044703 5.59E-05 19266 hsa-mir-4311 hsa04720 Long-term potentiation 1387_5595_5594 3 1.12E-05 0.000503111 5.59E-05 19267 hsa-mir-4311 hsa04662 B cell receptor signaling pathway 5595_5594_2932 3 1.12E-05 0.000503111 5.59E-05 19268 hsa-mir-4311 hsa04520 Adherens junction 1387_5595_5594 3 1.35E-05 0.000606571 6.07E-05 19269 hsa-mir-4311 hsa05210 Colorectal cancer 5595_5594_2932 3 1.55E-05 0.000698769 6.35E-05 19270 hsa-mir-4311 hsa04012 ErbB signaling pathway 5595_5594_2932 3 1.72E-05 0.00077367 6.45E-05 19271 hsa-mir-4311 hsa05200 Pathways in cancer 1387_5595_5594_2932 4 3.27E-05 0.00147198 0.000109254 19272 hsa-mir-4311 hsa04660 T cell receptor signaling pathway 5595_5594_2932 3 3.40E-05 0.001529551 0.000109254 19273 hsa-mir-4311 hsa04360 Axon guidance 5595_5594_2932 3 5.65E-05 0.002542627 0.000169508 19274 hsa-mir-4311 hsa05010 Alzheimer's disease 5595_5594_2932 3 0.000135548 0.006099643 0.000368018 19275 hsa-mir-4311 hsa05216 Thyroid cancer 5595_5594 2 0.000139029 0.006256313 0.000368018 19276 hsa-mir-4311 hsa04062 Chemokine signaling pathway 5595_5594_2932 3 0.000174263 0.007841852 0.000435658 19277 hsa-mir-4311 hsa04510 Focal adhesion 5595_5594_2932 3 0.000210531 0.009473916 0.000498627 19278 hsa-mir-4311 hsa05219 Bladder cancer 5595_5594 2 0.00028162 0.012672913 0.000633646 19279 hsa-mir-4311 hsa04930 Type II diabetes mellitus 5595_5594 2 0.000321488 0.014466956 0.000688903 19280 hsa-mir-4311 hsa04150 mTOR signaling pathway 5595_5594 2 0.000424587 0.019106402 0.000868473 19281 hsa-mir-4311 hsa05223 Non-small cell lung cancer 5595_5594 2 0.000456624 0.02054806 0.000893394 19282 hsa-mir-4311 hsa05221 Acute myeloid leukemia 5595_5594 2 0.000541709 0.024376889 0.001015704 19283 hsa-mir-4311 hsa05214 Glioma 5595_5594 2 0.000653185 0.029393313 0.001175733 19284 hsa-mir-4311 hsa05218 Melanoma 5595_5594 2 0.000774828 0.034867262 0.00129138 19285 hsa-mir-4311 hsa04730 Long-term depression 5595_5594 2 0.000774828 0.034867262 0.00129138 19286 hsa-mir-4311 hsa05220 Chronic myeloid leukemia 5595_5594 2 0.000861541 0.038769362 0.00138462 19287 hsa-mir-4311 hsa04370 VEGF signaling pathway 5595_5594 2 0.000906576 0.040795942 0.001406757 19288 hsa-mir-4311 hsa04664 Fc epsilon RI signaling pathway 5595_5594 2 0.000952728 0.042872739 0.001429091 19289 hsa-mir-4311 hsa04540 Gap junction 5595_5594 2 0.001306839 0.058807753 0.001897024 19290 hsa-mir-4311 hsa04620 Toll-like receptor signaling pathway 5595_5594 2 0.001562935 0.070332068 0.002197877 19291 hsa-mir-4311 hsa04912 GnRH signaling pathway 5595_5594 2 0.001745914 0.07856611 0.002380791 19292 hsa-mir-4311 hsa04270 Vascular smooth muscle contraction 5595_5594 2 0.002072466 0.09326096 0.002708481 19293 hsa-mir-4311 hsa04110 Cell cycle 1387_2932 2 0.002106596 0.094796841 0.002708481 19294 hsa-mir-4311 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594 2 0.002805524 0.126248575 0.003460069 19295 hsa-mir-4311 hsa04120 Ubiquitin mediated proteolysis 55294_7329 2 0.002844945 0.128022535 0.003460069 19296 hsa-mir-4311 hsa04310 Wnt signaling pathway 1387_2932 2 0.003381133 0.152150991 0.004003973 19297 hsa-mir-4311 hsa05016 Huntington's disease 6667_1387 2 0.005091795 0.229130791 0.005875148 19298 hsa-mir-4311 hsa04810 Regulation of actin cytoskeleton 5595_5594 2 0.006823388 0.307052456 0.007676311 19299 hsa-mir-4311 hsa04010 MAPK signaling pathway 5595_5594 2 0.01038693 0.467411838 0.011400289 19300 hsa-mir-4311 hsa04330 Notch signaling pathway 1387 1 0.026846659 1 0.028764278 19301 hsa-mir-4311 hsa05217 Basal cell carcinoma 2932 1 0.031254607 1 0.03270831 19302 hsa-mir-4311 hsa04340 Hedgehog signaling pathway 2932 1 0.032353654 1 0.033088964 19303 hsa-mir-4312 hsa03022 Basal transcription factors 2967_2961_2960_2963_54457_2968_6877_6874_6872_2957_6879_6878_6873_2958_6884_2959_6880_6882_6881_138474_9519_6883 22 4.61E-35 3.23E-33 3.23E-33 19304 hsa-mir-4312 hsa05200 Pathways in cancer 3326_5925_5594_6256_10401_1487_1488_2932_4193_3265_5970_7157_6688_3725_4609_2353_4087_4088_3065_7184_2033_8554 22 7.11E-17 4.97E-15 2.49E-15 19305 hsa-mir-4312 hsa05220 Chronic myeloid leukemia 5925_5594_1487_1488_4193_3265_5970_7157_4609_4088_3065 11 1.96E-12 1.37E-10 4.57E-11 19306 hsa-mir-4312 hsa05215 Prostate cancer 3326_5925_5594_2932_4193_3265_5970_7157_7184_2033 10 2.01E-10 1.41E-08 3.12E-09 19307 hsa-mir-4312 hsa05212 Pancreatic cancer 3326_5925_5594_2932_4193_3265_5970_7157_7184_2033 10 2.23E-10 1.56E-08 3.12E-09 19308 hsa-mir-4312 hsa04310 Wnt signaling pathway 1460_8607_1487_1488_2932_7157_3725_4609_4087_4088_2033 11 2.12E-09 1.48E-07 2.47E-08 19309 hsa-mir-4312 hsa04110 Cell cycle 5925_2932_4193_4085_7157_4171_4087_4088_3065_2033 10 3.05E-09 2.13E-07 3.05E-08 19310 hsa-mir-4312 hsa05210 Colorectal cancer 5594_2932_7157_3725_4609_2353_4087_4088 8 4.89E-08 3.43E-06 4.28E-07 19311 hsa-mir-4312 hsa05016 Huntington's disease 6874_2902_6667_9001_5430_7157_3064_3065_2033_9519 10 1.81E-07 1.26E-05 1.41E-06 19312 hsa-mir-4312 hsa05219 Bladder cancer 5925_5594_4193_3265_7157_4609 6 2.76E-07 1.93E-05 1.93E-06 19313 hsa-mir-4312 hsa05222 Small cell lung cancer 5925_6256_10401_5970_7157_4609_8554 7 9.28E-07 6.50E-05 5.82E-06 19314 hsa-mir-4312 hsa04350 TGF-beta signaling pathway 5594_6667_659_4609_4087_4088_2033 7 9.98E-07 6.99E-05 5.82E-06 19315 hsa-mir-4312 hsa05216 Thyroid cancer 5594_6256_3265_7157_4609 5 1.23E-06 8.62E-05 6.63E-06 19316 hsa-mir-4312 hsa04010 MAPK signaling pathway 3727_5594_3265_3312_5970_7157_3725_4609_2353_22800 10 4.60E-06 0.000322088 2.30E-05 19317 hsa-mir-4312 hsa04662 B cell receptor signaling pathway 5594_2932_3265_5970_3725_2353 6 6.27E-06 0.000438574 2.92E-05 19318 hsa-mir-4312 hsa04330 Notch signaling pathway 1487_1488_3065_2033_8850 5 1.06E-05 0.000742781 4.64E-05 19319 hsa-mir-4312 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 1.17E-05 0.000816479 4.80E-05 19320 hsa-mir-4312 hsa05213 Endometrial cancer 5594_2932_3265_7157_4609 5 1.67E-05 0.001170104 6.50E-05 19321 hsa-mir-4312 hsa05223 Non-small cell lung cancer 5925_5594_6256_3265_7157 5 1.98E-05 0.001386551 7.30E-05 19322 hsa-mir-4312 hsa05221 Acute myeloid leukemia 5594_3265_5970_6688_4609 5 2.95E-05 0.002064811 0.000103241 19323 hsa-mir-4312 hsa05214 Glioma 5925_5594_4193_3265_7157 5 4.56E-05 0.003190632 0.000151935 19324 hsa-mir-4312 hsa04660 T cell receptor signaling pathway 5594_2932_3265_5970_3725_2353 6 4.88E-05 0.003415446 0.000155248 19325 hsa-mir-4312 hsa05218 Melanoma 5925_5594_4193_3265_7157 5 6.77E-05 0.004741183 0.000206138 19326 hsa-mir-4312 hsa04720 Long-term potentiation 5594_2902_2906_3265_2033 5 8.66E-05 0.006059828 0.000252493 19327 hsa-mir-4312 hsa04520 Adherens junction 1460_5594_4087_4088_2033 5 0.000115505 0.00808535 0.000323414 19328 hsa-mir-4312 hsa04012 ErbB signaling pathway 5594_2932_3265_3725_4609 5 0.00016783 0.01174812 0.000451851 19329 hsa-mir-4312 hsa05211 Renal cell carcinoma 5594_3265_3725_2033 4 0.000871372 0.060996043 0.002259113 19330 hsa-mir-4312 hsa03420 Nucleotide excision repair 2967_2968_5887 3 0.002297876 0.160851334 0.00574469 19331 hsa-mir-4312 hsa04620 Toll-like receptor signaling pathway 5594_5970_3725_2353 4 0.00296585 0.207609473 0.007158947 19332 hsa-mir-4312 hsa04916 Melanogenesis 5594_2932_3265_2033 4 0.003172224 0.222055691 0.007401856 19333 hsa-mir-4312 hsa05010 Alzheimer's disease 5594_2902_2906_2932_351 5 0.003600569 0.25203985 0.008130318 19334 hsa-mir-4312 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906_7157 3 0.004387938 0.307155626 0.009598613 19335 hsa-mir-4312 hsa04530 Tight junction 8573_1460_3265_22800 4 0.008111099 0.567776958 0.01702714 19336 hsa-mir-4312 hsa04910 Insulin signaling pathway 5594_2932_3265_5211 4 0.008310737 0.581751611 0.01702714 19337 hsa-mir-4312 hsa04120 Ubiquitin mediated proteolysis 10401_4193_7329_8554 4 0.00851357 0.5959499 0.01702714 19338 hsa-mir-4312 hsa04630 Jak-STAT signaling pathway 10401_4609_2033_8554 4 0.012209017 0.854631213 0.023739756 19339 hsa-mir-4312 hsa04612 Antigen processing and presentation 3326_4801_3312 3 0.014837484 1 0.028070915 19340 hsa-mir-4312 hsa04540 Gap junction 5594_3265_10382 3 0.01661265 1 0.030602251 19341 hsa-mir-4312 hsa04912 GnRH signaling pathway 5594_3265_3725 3 0.024287487 1 0.04319279 19342 hsa-mir-4312 hsa04062 Chemokine signaling pathway 5594_2932_3265_5970 4 0.024681595 1 0.04319279 19343 hsa-mir-4312 hsa04510 Focal adhesion 5594_2932_3265_3725 4 0.030231523 1 0.051614796 19344 hsa-mir-4312 hsa04360 Axon guidance 5594_2932_3265 3 0.039174782 1 0.065291303 19345 hsa-mir-4312 hsa05217 Basal cell carcinoma 2932_7157 2 0.040294001 1 0.065594886 19346 hsa-mir-4312 hsa05322 Systemic lupus erythematosus 3014_3015_8340 3 0.049221875 1 0.078307528 19347 hsa-mir-4314 hsa05200 Pathways in cancer 5371_5595_5594_5599_5914_1387_6257_6256_595_836_6258_367_7704_3091_5970_7428_1870_1871_8031_7157_4087_2113_4609_1869_3725_4088_4089_3066_3065_5925_2034_2033_4846_8554_4286 35 1.26E-35 7.80E-34 7.80E-34 19348 hsa-mir-4314 hsa04110 Cell cycle 5591_7533_1387_595_1870_1871_7157_4087_10912_1869_4088_4089_3066_3065_5925_2033_5933_4616 18 3.76E-21 2.33E-19 1.17E-19 19349 hsa-mir-4314 hsa05220 Chronic myeloid leukemia 5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464 15 1.98E-19 1.23E-17 4.10E-18 19350 hsa-mir-4314 hsa05222 Small cell lung cancer 6257_6256_595_6258_5970_1870_1871_7157_4609_1869_5925_4846_8554 13 1.41E-15 8.72E-14 2.18E-14 19351 hsa-mir-4314 hsa05223 Non-small cell lung cancer 5595_5594_6257_6256_595_6258_1870_1871_7157_1869_5925 11 1.23E-14 7.64E-13 1.53E-13 19352 hsa-mir-4314 hsa05215 Prostate cancer 5595_5594_1387_595_367_5970_1870_1871_7157_1869_5925_2033 12 5.49E-14 3.40E-12 5.50E-13 19353 hsa-mir-4314 hsa05212 Pancreatic cancer 5595_5594_1387_595_367_5970_1870_1871_7157_1869_5925_2033 12 6.21E-14 3.85E-12 5.50E-13 19354 hsa-mir-4314 hsa05216 Thyroid cancer 5595_5594_6257_6256_595_6258_8031_7157_4609 9 1.28E-13 7.96E-12 9.94E-13 19355 hsa-mir-4314 hsa05210 Colorectal cancer 5595_5594_5599_595_836_7157_4087_4609_3725_4088_4089 11 9.54E-13 5.91E-11 6.57E-12 19356 hsa-mir-4314 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5925 9 2.27E-12 1.41E-10 1.41E-11 19357 hsa-mir-4314 hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_6464 9 7.54E-11 4.67E-09 4.25E-10 19358 hsa-mir-4314 hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5925_4286 9 1.54E-10 9.58E-09 7.98E-10 19359 hsa-mir-4314 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2113_3725_2034_2033 9 1.73E-10 1.07E-08 8.25E-10 19360 hsa-mir-4314 hsa04310 Wnt signaling pathway 5599_1387_595_7157_4087_4609_3725_1457_4088_4089_2033 11 3.56E-10 2.21E-08 1.58E-09 19361 hsa-mir-4314 hsa04350 TGF-beta signaling pathway 5595_5594_1387_4087_4609_4088_4089_2033_5933 9 8.10E-10 5.02E-08 3.35E-09 19362 hsa-mir-4314 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_5970_4609 8 1.03E-09 6.36E-08 3.98E-09 19363 hsa-mir-4314 hsa04010 MAPK signaling pathway 5595_5594_5599_4208_836_3312_5970_7157_10912_4609_3725_4763_4616 13 1.12E-09 6.97E-08 4.10E-09 19364 hsa-mir-4314 hsa04520 Adherens junction 5595_5594_1387_4087_1457_4088_4089_2033 8 9.30E-09 5.77E-07 3.21E-08 19365 hsa-mir-4314 hsa05016 Huntington's disease 6874_10891_1387_2902_836_7157_3066_3065_3064_2033 10 3.73E-08 2.31E-06 1.22E-07 19366 hsa-mir-4314 hsa04920 Adipocytokine signaling pathway 10891_5599_6257_6256_6258_5970 6 1.29E-06 8.00E-05 4.00E-06 19367 hsa-mir-4314 hsa04330 Notch signaling pathway 1387_9612_3066_3065_2033 5 4.70E-06 0.000291527 1.39E-05 19368 hsa-mir-4314 hsa04012 ErbB signaling pathway 5595_5594_5599_4609_3725_6464 6 5.35E-06 0.000331759 1.51E-05 19369 hsa-mir-4314 hsa05213 Endometrial cancer 5595_5594_595_7157_4609 5 7.43E-06 0.000460876 2.00E-05 19370 hsa-mir-4314 hsa04115 p53 signaling pathway 595_836_7157_10912_4616 5 2.68E-05 0.001662841 6.93E-05 19371 hsa-mir-4314 hsa04720 Long-term potentiation 5595_5594_1387_2902_2033 5 3.91E-05 0.00242601 9.70E-05 19372 hsa-mir-4314 hsa04910 Insulin signaling pathway 6720_10891_5595_5594_5599_6464 6 6.43E-05 0.003985111 0.000153274 19373 hsa-mir-4314 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5970_3725 5 0.000156301 0.009690645 0.000358913 19374 hsa-mir-4314 hsa04916 Melanogenesis 5595_5594_1387_2033_4286 5 0.00017048 0.010569746 0.000377491 19375 hsa-mir-4314 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_7157_4846 4 0.000187588 0.011630461 0.00040105 19376 hsa-mir-4314 hsa03320 PPAR signaling pathway 6257_6256_6258_2168 4 0.000420642 0.026079816 0.000869327 19377 hsa-mir-4314 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_836_5970_3725 4 0.000442728 0.027449107 0.000885455 19378 hsa-mir-4314 hsa04510 Focal adhesion 5595_5594_5599_595_3725_6464 6 0.00052168 0.032344166 0.001010755 19379 hsa-mir-4314 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725 4 0.000539386 0.033441918 0.001013391 19380 hsa-mir-4314 hsa04630 Jak-STAT signaling pathway 1387_595_4609_2033_8554 5 0.000988597 0.061292985 0.001802735 19381 hsa-mir-4314 hsa04930 Type II diabetes mellitus 5595_5594_5599 3 0.001516008 0.093992526 0.002685501 19382 hsa-mir-4314 hsa05010 Alzheimer's disease 5595_5594_2902_836_4846 5 0.001747371 0.108337018 0.003009362 19383 hsa-mir-4314 hsa04912 GnRH signaling pathway 5595_5594_5599_3725 4 0.001978206 0.122648743 0.003314831 19384 hsa-mir-4314 hsa04660 T cell receptor signaling pathway 5595_5594_5970_3725 4 0.002110057 0.130823507 0.003442724 19385 hsa-mir-4314 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.002244965 0.139187825 0.003568919 19386 hsa-mir-4314 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_6464 4 0.004640191 0.287691827 0.007192296 19387 hsa-mir-4314 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428_8554 4 0.004756562 0.294906814 0.007192849 19388 hsa-mir-4314 hsa04730 Long-term depression 5595_5594_4846 3 0.005198066 0.322280064 0.007673335 19389 hsa-mir-4314 hsa04370 VEGF signaling pathway 5595_5594_4846 3 0.006454739 0.400193814 0.009306833 19390 hsa-mir-4314 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599 3 0.006910285 0.428437671 0.00973722 19391 hsa-mir-4314 hsa04612 Antigen processing and presentation 4800_4801_3312 3 0.009471077 0.587206804 0.012765365 19392 hsa-mir-4314 hsa04210 Apoptosis 836_5970_7157 3 0.009471077 0.587206804 0.012765365 19393 hsa-mir-4314 hsa04062 Chemokine signaling pathway 5595_5594_5970_6464 4 0.014281663 0.885463132 0.018839641 19394 hsa-mir-4317 hsa05200 Pathways in cancer 3320_3326_1147_3551_7046_1499_1387_367_8517_2932_6772_6256_5970_7157_4791_6688_4792_2113_4087_1869_861_6774_2353_7175_3065_5925 26 2.82E-20 1.92E-18 1.92E-18 19395 hsa-mir-4317 hsa05215 Prostate cancer 3320_3326_1147_3551_1499_1387_367_8517_2932_5970_7157_4792_1869_5925 14 2.77E-15 1.88E-13 7.22E-14 19396 hsa-mir-4317 hsa05212 Pancreatic cancer 3320_3326_1147_3551_1499_1387_367_8517_2932_5970_7157_4792_1869_5925 14 3.19E-15 2.17E-13 7.22E-14 19397 hsa-mir-4317 hsa05220 Chronic myeloid leukemia 1147_3551_7046_8517_5970_7157_4792_1869_861_3065_5925 11 6.26E-12 4.26E-10 1.06E-10 19398 hsa-mir-4317 hsa04010 MAPK signaling pathway 1147_3551_7046_1326_3305_3303_5566_8517_3310_3312_5970_7157_4791_2353_1616_5971 16 4.19E-11 2.85E-09 5.70E-10 19399 hsa-mir-4317 hsa04920 Adipocytokine signaling pathway 1147_3551_8517_6256_5970_4794_4792_6774_4793 9 1.10E-09 7.50E-08 1.25E-08 19400 hsa-mir-4317 hsa04662 B cell receptor signaling pathway 1147_3551_8517_2932_5970_4794_4792_2353_4793 9 2.73E-09 1.86E-07 2.65E-08 19401 hsa-mir-4317 hsa04660 T cell receptor signaling pathway 1147_3551_1326_8517_2932_5970_4794_4792_2353_4793 10 4.21E-09 2.86E-07 3.58E-08 19402 hsa-mir-4317 hsa04310 Wnt signaling pathway 23291_1499_1387_8607_5566_2932_8454_6500_7157_4087_8945 11 6.49E-09 4.41E-07 4.90E-08 19403 hsa-mir-4317 hsa05222 Small cell lung cancer 1147_3551_8517_6256_5970_7157_4792_1869_5925 9 8.23E-09 5.59E-07 5.25E-08 19404 hsa-mir-4317 hsa04110 Cell cycle 5591_1387_2932_8454_6500_7157_4087_1869_3065_5925 10 8.50E-09 5.78E-07 5.25E-08 19405 hsa-mir-4317 hsa04062 Chemokine signaling pathway 1147_3551_5566_8517_2932_6772_5970_4792_653361_6774_4793 11 6.60E-08 4.49E-06 3.74E-07 19406 hsa-mir-4317 hsa03020 RNA polymerase 25885_64425_5437_51082_84172_5441 6 7.29E-08 4.96E-06 3.81E-07 19407 hsa-mir-4317 hsa05131 Shigellosis 347733_1499_7278_10382_84617_203068_71 7 1.29E-07 8.78E-06 5.85E-07 19408 hsa-mir-4317 hsa05130 Pathogenic Escherichia coli infection 347733_1499_7278_10382_84617_203068_71 7 1.29E-07 8.78E-06 5.85E-07 19409 hsa-mir-4317 hsa04210 Apoptosis 1147_3551_5566_8517_5970_7157_4792_8837 8 1.69E-07 1.15E-05 7.16E-07 19410 hsa-mir-4317 hsa05221 Acute myeloid leukemia 1147_3551_8517_5970_6688_861_6774 7 1.79E-07 1.22E-05 7.16E-07 19411 hsa-mir-4317 hsa04120 Ubiquitin mediated proteolysis 23291_672_8454_6500_3093_8945_10273_7323_7329 9 3.87E-07 2.63E-05 1.46E-06 19412 hsa-mir-4317 hsa04620 Toll-like receptor signaling pathway 1147_3551_1326_8517_6772_5970_4792_2353 8 4.46E-07 3.03E-05 1.60E-06 19413 hsa-mir-4317 hsa04350 TGF-beta signaling pathway 7046_1387_8454_3399_3398_6500_4087 7 2.03E-06 0.000138205 6.91E-06 19414 hsa-mir-4317 hsa04612 Antigen processing and presentation 3320_3326_3309_3305_3303_3310_3312 7 2.34E-06 0.000159267 7.58E-06 19415 hsa-mir-4317 hsa05016 Huntington's disease 1387_292_293_6908_5437_7157_1213_3065_5441 9 4.17E-06 0.000283624 1.29E-05 19416 hsa-mir-4317 hsa05214 Glioma 7157_1869_5925_808_801_805 6 5.35E-06 0.000363553 1.58E-05 19417 hsa-mir-4317 hsa04916 Melanogenesis 1499_1387_5566_2932_808_801_805 7 6.17E-06 0.000419756 1.75E-05 19418 hsa-mir-4317 hsa04520 Adherens junction 4301_7046_1499_1387_4087_71 6 1.63E-05 0.001105187 4.42E-05 19419 hsa-mir-4317 hsa05210 Colorectal cancer 7046_1499_2932_7157_4087_2353 6 2.11E-05 0.001433912 5.52E-05 19420 hsa-mir-4317 hsa04540 Gap junction 347733_5566_7278_10382_84617_203068 6 3.62E-05 0.002464516 9.13E-05 19421 hsa-mir-4317 hsa05216 Thyroid cancer 1499_6256_7157_7175 4 5.07E-05 0.003447549 0.000123127 19422 hsa-mir-4317 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_3551_8517_5970_4792 5 0.000111875 0.00760753 0.000262329 19423 hsa-mir-4317 hsa04720 Long-term potentiation 1387_5566_808_801_805 5 0.000142697 0.009703398 0.000323447 19424 hsa-mir-4317 hsa04530 Tight junction 4301_1499_4627_4628_10627_71 6 0.000275944 0.018764163 0.00059032 19425 hsa-mir-4317 hsa04330 Notch signaling pathway 1387_4851_9612_3065 4 0.000283844 0.019301405 0.00059032 19426 hsa-mir-4317 hsa04910 Insulin signaling pathway 3551_5566_2932_808_801_805 6 0.000286479 0.019480548 0.00059032 19427 hsa-mir-4317 hsa05223 Non-small cell lung cancer 6256_7157_1869_5925 4 0.000465918 0.031682394 0.000931835 19428 hsa-mir-4317 hsa04340 Hedgehog signaling pathway 23291_5566_2932_8945 4 0.000564866 0.038410875 0.001097454 19429 hsa-mir-4317 hsa04270 Vascular smooth muscle contraction 5566_4637_808_801_805 5 0.001035437 0.070409722 0.001955826 19430 hsa-mir-4317 hsa04670 Leukocyte transendothelial migration 4301_1499_653361_10627_71 5 0.001194365 0.081216815 0.002195049 19431 hsa-mir-4317 hsa04020 Calcium signaling pathway 292_293_5566_808_801_805 6 0.001227877 0.083495604 0.002197253 19432 hsa-mir-4317 hsa05219 Bladder cancer 7157_1869_5925 3 0.002741543 0.186424902 0.004780126 19433 hsa-mir-4317 hsa04630 Jak-STAT signaling pathway 3559_1387_6778_6772_6774 5 0.003273421 0.222592603 0.005564815 19434 hsa-mir-4317 hsa03010 Ribosome 6156_6128_6207_6202 4 0.004334317 0.294733586 0.007188624 19435 hsa-mir-4317 hsa05213 Endometrial cancer 1499_2932_7157 3 0.004844615 0.329433848 0.007843663 19436 hsa-mir-4317 hsa04912 GnRH signaling pathway 5566_808_801_805 4 0.005266173 0.358099792 0.008327902 19437 hsa-mir-4317 hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.00562133 0.382250455 0.00868751 19438 hsa-mir-4317 hsa05218 Melanoma 7157_1869_5925 3 0.010989374 0.747277401 0.016606164 19439 hsa-mir-4317 hsa04810 Regulation of actin cytoskeleton 4627_4628_10788_10627_71 5 0.013090817 0.890175541 0.018965819 19440 hsa-mir-4317 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.013108728 0.891393471 0.018965819 19441 hsa-mir-4317 hsa03410 Base excision repair 3146_142 2 0.023185992 1 0.032846822 19442 hsa-mir-4317 hsa03022 Basal transcription factors 2969_6908 2 0.024341216 1 0.033779647 19443 hsa-mir-4317 hsa05010 Alzheimer's disease 2932_808_801_805 4 0.026464617 1 0.035991879 19444 hsa-mir-4317 hsa04510 Focal adhesion 1499_2932_10627_71 4 0.042066854 1 0.056089139 19445 hsa-mir-4319 hsa05210 Colorectal cancer 4088_4089_5601_3725_5595_5594_5599_2353 8 2.57E-13 1.18E-11 1.18E-11 19446 hsa-mir-4319 hsa04010 MAPK signaling pathway 5601_3725_5595_5594_5599_1649_2353_1386 8 2.04E-09 9.37E-08 4.68E-08 19447 hsa-mir-4319 hsa04620 Toll-like receptor signaling pathway 5601_3725_5595_5594_5599_2353 6 4.72E-09 2.17E-07 7.24E-08 19448 hsa-mir-4319 hsa05200 Pathways in cancer 4088_4089_5601_3725_5595_5594_5599_2353 8 9.03E-09 4.15E-07 1.04E-07 19449 hsa-mir-4319 hsa04310 Wnt signaling pathway 4088_4089_5601_8061_3725_5599 6 4.62E-08 2.13E-06 4.25E-07 19450 hsa-mir-4319 hsa04012 ErbB signaling pathway 5601_3725_5595_5594_5599 5 1.12E-07 5.15E-06 8.58E-07 19451 hsa-mir-4319 hsa04912 GnRH signaling pathway 5601_3725_5595_5594_5599 5 3.13E-07 1.44E-05 1.97E-06 19452 hsa-mir-4319 hsa04660 T cell receptor signaling pathway 5601_3725_5595_5594_2353 5 3.42E-07 1.57E-05 1.97E-06 19453 hsa-mir-4319 hsa04930 Type II diabetes mellitus 5601_5595_5594_5599 4 4.43E-07 2.04E-05 2.26E-06 19454 hsa-mir-4319 hsa05220 Chronic myeloid leukemia 4088_4089_5595_5594 4 3.06E-06 0.00014055 1.28E-05 19455 hsa-mir-4319 hsa04662 B cell receptor signaling pathway 3725_5595_5594_2353 4 3.06E-06 0.00014055 1.28E-05 19456 hsa-mir-4319 hsa04664 Fc epsilon RI signaling pathway 5601_5595_5594_5599 4 3.72E-06 0.000171277 1.38E-05 19457 hsa-mir-4319 hsa04520 Adherens junction 4088_4089_5595_5594 4 3.91E-06 0.000179678 1.38E-05 19458 hsa-mir-4319 hsa04350 TGF-beta signaling pathway 4088_4089_5595_5594 4 5.38E-06 0.000247311 1.77E-05 19459 hsa-mir-4319 hsa04510 Focal adhesion 5601_3725_5595_5594_5599 5 6.78E-06 0.000311825 2.08E-05 19460 hsa-mir-4319 hsa04910 Insulin signaling pathway 5601_5595_5594_5599 4 3.12E-05 0.001434474 8.97E-05 19461 hsa-mir-4319 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5601_3725_5599 3 0.000113795 0.005234573 0.000302663 19462 hsa-mir-4319 hsa05211 Renal cell carcinoma 3725_5595_5594 3 0.000118433 0.005447925 0.000302663 19463 hsa-mir-4319 hsa05216 Thyroid cancer 5595_5594 2 0.000708033 0.032569536 0.001714186 19464 hsa-mir-4319 hsa05219 Bladder cancer 5595_5594 2 0.001425577 0.065576559 0.003278828 19465 hsa-mir-4319 hsa05213 Endometrial cancer 5595_5594 2 0.002139341 0.098409665 0.004473167 19466 hsa-mir-4319 hsa04150 mTOR signaling pathway 5595_5594 2 0.002139341 0.098409665 0.004473167 19467 hsa-mir-4319 hsa05223 Non-small cell lung cancer 5595_5594 2 0.002298632 0.105737073 0.004597264 19468 hsa-mir-4319 hsa05221 Acute myeloid leukemia 5595_5594 2 0.002720642 0.125149531 0.005214564 19469 hsa-mir-4319 hsa05214 Glioma 5595_5594 2 0.003271416 0.15048515 0.006019406 19470 hsa-mir-4319 hsa04920 Adipocytokine signaling pathway 5601_5599 2 0.003465646 0.159419722 0.006131528 19471 hsa-mir-4319 hsa05218 Melanoma 5595_5594 2 0.003869904 0.178015571 0.006357699 19472 hsa-mir-4319 hsa04730 Long-term depression 5595_5594 2 0.003869904 0.178015571 0.006357699 19473 hsa-mir-4319 hsa04720 Long-term potentiation 5595_5594 2 0.004295049 0.197572261 0.006812837 19474 hsa-mir-4319 hsa04370 VEGF signaling pathway 5595_5594 2 0.004515389 0.2077079 0.006923597 19475 hsa-mir-4319 hsa05215 Prostate cancer 5595_5594 2 0.005818501 0.267651039 0.008545265 19476 hsa-mir-4319 hsa05212 Pancreatic cancer 5595_5594 2 0.005944532 0.273448464 0.008545265 19477 hsa-mir-4319 hsa04540 Gap junction 5595_5594 2 0.006461096 0.297210394 0.009006376 19478 hsa-mir-4319 hsa04916 Melanogenesis 5595_5594 2 0.007982882 0.367212557 0.010800369 19479 hsa-mir-4319 hsa04270 Vascular smooth muscle contraction 5595_5594 2 0.010129164 0.465941543 0.013149926 19480 hsa-mir-4319 hsa04110 Cell cycle 4088_4089 2 0.010291247 0.47339735 0.013149926 19481 hsa-mir-4319 hsa04360 Axon guidance 5595_5594 2 0.012325394 0.566968133 0.015323463 19482 hsa-mir-4319 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594 2 0.013586669 0.624986758 0.01624303 19483 hsa-mir-4319 hsa04120 Ubiquitin mediated proteolysis 64326_672 2 0.013771265 0.633478168 0.01624303 19484 hsa-mir-4319 hsa05010 Alzheimer's disease 5595_5594 2 0.021570884 0.992260651 0.024806516 19485 hsa-mir-4319 hsa04062 Chemokine signaling pathway 5595_5594 2 0.025290424 1 0.028374622 19486 hsa-mir-4319 hsa04810 Regulation of actin cytoskeleton 5595_5594 2 0.031845849 1 0.034878787 19487 hsa-mir-4319 hsa03022 Basal transcription factors 6908 1 0.046992537 1 0.050271086 19488 hsa-mir-432 hsa05200 Pathways in cancer 4149_7046_596_598_1017_4193_7704_5578_6502_3091_2736_3066_3065_1050_5925_613_5743_5747_25_6789_4436_1870_1871_2113_5894_861_207_1147_998_5595_5594_5599_1387_2932_6774_6772_5970_7157_6688_1869_3725_4087_4088_4089_5888_5728_2033_3910_4792_3320_3326_5371_675_5604_5601_5602_1856_4292_51588_4609_1026_1029_2353_8554 64 4.44E-42 3.82E-40 3.82E-40 19489 hsa-mir-432 hsa04110 Cell cycle 1017_4193_902_6502_6500_3066_3065_990_5925_25_1870_1871_9232_5933_545_995_5347_5591_1387_11200_7534_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_891_1031_983_8454_1026_1022_1029_1111_8556_8555_472 42 6.11E-37 5.25E-35 2.63E-35 19490 hsa-mir-432 hsa05220 Chronic myeloid leukemia 7046_598_4193_3066_3065_5925_613_25_1870_1871_5894_861_207_1147_5595_5594_5970_7157_1869_4088_4089_4792_5604_4609_1026_1029 26 3.77E-23 3.24E-21 1.08E-21 19491 hsa-mir-432 hsa04010 MAPK signaling pathway 6722_4149_7046_6195_6197_9252_5578_5923_3304_3305_3303_6789_1432_5894_1616_207_1147_998_5595_5594_5599_5598_8986_1386_3315_1649_5970_3164_7157_3725_6196_9261_5604_5601_5602_4609_2353 37 5.15E-20 4.43E-18 1.11E-18 19492 hsa-mir-432 hsa05215 Prostate cancer 596_1017_4193_5925_1870_1871_5894_207_1147_5595_5594_1385_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_5604_1026 24 1.96E-19 1.68E-17 3.37E-18 19493 hsa-mir-432 hsa05212 Pancreatic cancer 596_1017_4193_5925_1870_1871_5894_207_1147_5595_5594_1385_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_5604_1026 24 2.45E-19 2.10E-17 3.50E-18 19494 hsa-mir-432 hsa04115 p53 signaling pathway 1017_4194_4193_50484_6241_51246_545_7161_11200_7157_900_64326_5728_891_27113_25898_983_1026_1029_1111_472 21 5.47E-18 4.70E-16 6.72E-17 19495 hsa-mir-432 hsa05210 Colorectal cancer 7046_596_4436_5894_207_5595_5594_5599_2932_7157_3725_4087_4088_4089_5604_5601_5602_1856_4292_4609_2353 21 1.61E-16 1.38E-14 1.73E-15 19496 hsa-mir-432 hsa05222 Small cell lung cancer 4149_596_598_1017_6502_5925_5743_5747_1870_1871_207_1147_5970_7157_1869_5728_3910_4792_51588_4609_8554 21 2.42E-16 2.08E-14 2.31E-15 19497 hsa-mir-432 hsa04310 Wnt signaling pathway 5578_6500_1460_5599_1387_2932_7157_3725_1457_1452_1459_4087_4088_4089_8061_2033_5518_5515_5601_5602_1856_8454_4609_5527 24 9.77E-15 8.40E-13 8.40E-14 19498 hsa-mir-432 hsa04350 TGF-beta signaling pathway 7046_6500_3398_6667_3399_5933_5595_5594_1387_7027_4087_4088_4089_2033_5518_5515_8454_4609 18 3.92E-13 3.37E-11 3.07E-12 19499 hsa-mir-432 hsa05219 Bladder cancer 9252_4193_5925_1870_1871_5894_5595_5594_7157_1869_5604_4609_1026_1029 14 6.92E-13 5.95E-11 4.96E-12 19500 hsa-mir-432 hsa05214 Glioma 4193_5578_5925_1870_1871_5894_207_5595_5594_7157_1869_5728_5604_1026_1029 15 9.34E-12 8.03E-10 6.18E-11 19501 hsa-mir-432 hsa05221 Acute myeloid leukemia 7704_1050_5894_861_207_1147_5595_5594_6774_5970_6688_5371_5604_4609 14 3.35E-11 2.88E-09 2.06E-10 19502 hsa-mir-432 hsa04120 Ubiquitin mediated proteolysis 55294_4193_6502_6500_3093_7319_84447_7325_7329_10055_64326_7337_5371_672_25898_8454_51588_10075_8554 19 5.67E-11 4.87E-09 3.25E-10 19503 hsa-mir-432 hsa05223 Non-small cell lung cancer 5578_5925_6789_1870_1871_5894_207_5595_5594_7157_1869_5604_1029 13 1.45E-10 1.25E-08 7.81E-10 19504 hsa-mir-432 hsa05218 Melanoma 4193_5925_1870_1871_5894_207_5595_5594_7157_1869_5728_5604_1026_1029 14 2.84E-10 2.44E-08 1.44E-09 19505 hsa-mir-432 hsa04012 ErbB signaling pathway 5578_5747_25_5894_207_5595_5594_5599_2932_3725_5604_5601_5602_4609_1026 15 3.44E-10 2.96E-08 1.64E-09 19506 hsa-mir-432 hsa04520 Adherens junction 7046_4301_1460_998_5595_5594_1387_1457_1459_4087_4088_4089_2033_71 14 1.13E-09 9.68E-08 5.10E-09 19507 hsa-mir-432 hsa04660 T cell receptor signaling pathway 1432_5894_207_1147_998_5595_5594_2932_5970_3725_959_4792_5604_5601_2353 15 6.17E-09 5.31E-07 2.61E-08 19508 hsa-mir-432 hsa04540 Gap junction 5578_51807_5894_5592_5595_5594_5598_7846_1453_983_5604_7277_7278_10376 14 6.37E-09 5.48E-07 2.61E-08 19509 hsa-mir-432 hsa04620 Toll-like receptor signaling pathway 1432_207_1147_5595_5594_5599_6772_5970_3725_4792_5604_5601_5602_2353 14 1.84E-08 1.58E-06 7.18E-08 19510 hsa-mir-432 hsa04510 Focal adhesion 596_5578_5923_5747_5499_5894_207_998_5595_5594_5599_2932_3725_5728_3910_5604_5601_5602_71 19 2.23E-08 1.91E-06 8.32E-08 19511 hsa-mir-432 hsa05131 Shigellosis 5578_51807_25_998_7534_7846_7277_7278_71_4691_10376 11 2.42E-08 2.08E-06 8.32E-08 19512 hsa-mir-432 hsa05130 Pathogenic Escherichia coli infection 5578_51807_25_998_7534_7846_7277_7278_71_4691_10376 11 2.42E-08 2.08E-06 8.32E-08 19513 hsa-mir-432 hsa04662 B cell receptor signaling pathway 5894_207_1147_5595_5594_1380_2932_5970_3725_4792_5604_2353 12 4.23E-08 3.64E-06 1.40E-07 19514 hsa-mir-432 hsa04370 VEGF signaling pathway 5578_5743_5747_1432_5894_207_998_5595_5594_3315_9261_5604 12 5.49E-08 4.72E-06 1.75E-07 19515 hsa-mir-432 hsa03022 Basal transcription factors 51616_2965_2963_2962_2969_6908_2958_6880_2957 9 9.44E-08 8.12E-06 2.90E-07 19516 hsa-mir-432 hsa05213 Endometrial cancer 5894_207_5595_5594_2932_7157_5728_5604_4292_4609 10 1.25E-07 1.08E-05 3.72E-07 19517 hsa-mir-432 hsa05211 Renal cell carcinoma 3091_2113_5894_207_998_5595_5594_1387_3725_2033_5604 11 2.36E-07 2.03E-05 6.75E-07 19518 hsa-mir-432 hsa04720 Long-term potentiation 6195_6197_5578_5499_5894_5595_5594_1387_6196_2033_5604 11 3.41E-07 2.93E-05 9.45E-07 19519 hsa-mir-432 hsa04920 Adipocytokine signaling pathway 6794_207_1147_5599_6774_5970_4792_5601_5602_5563 10 1.01E-06 8.68E-05 2.71E-06 19520 hsa-mir-432 hsa04150 mTOR signaling pathway 6794_6195_6197_3091_207_5595_5594_6196_5563 9 1.18E-06 0.000101077 3.06E-06 19521 hsa-mir-432 hsa04912 GnRH signaling pathway 5578_1432_5894_998_5595_5594_5599_5598_3725_5604_5601_5602 12 1.49E-06 0.000127933 3.76E-06 19522 hsa-mir-432 hsa04664 Fc epsilon RI signaling pathway 5578_1432_5894_207_5595_5594_5599_5604_5601_5602 10 3.88E-06 0.00033339 9.53E-06 19523 hsa-mir-432 hsa04062 Chemokine signaling pathway 7074_5747_6362_5894_207_1147_998_5595_5594_2932_6774_6772_5970_4792_5604 15 4.82E-06 0.000414589 1.15E-05 19524 hsa-mir-432 hsa04330 Notch signaling pathway 3066_3065_1387_2033_8850_1856_2648_4851 8 5.18E-06 0.000445724 1.20E-05 19525 hsa-mir-432 hsa04612 Antigen processing and presentation 3308_3309_3304_3305_3303_1385_3320_3326_4801_4802 10 1.02E-05 0.000873089 2.30E-05 19526 hsa-mir-432 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_1147_998_5599_5970_3725_4792_5601_5602 9 1.17E-05 0.001005321 2.58E-05 19527 hsa-mir-432 hsa04530 Tight junction 5578_207_4301_1460_998_1457_1459_5728_5518_5515_71_5520 12 1.41E-05 0.001214629 3.04E-05 19528 hsa-mir-432 hsa04910 Insulin signaling pathway 6720_5499_5894_207_5595_5594_5599_2932_5604_5601_5602_5563 12 1.51E-05 0.001299484 3.17E-05 19529 hsa-mir-432 hsa03420 Nucleotide excision repair 902_2965_4331_2071_2074_1022_6117 7 3.00E-05 0.002578581 6.14E-05 19530 hsa-mir-432 hsa04916 Melanogenesis 5578_5894_5595_5594_1385_1387_2932_2033_5604_1856 10 3.51E-05 0.003015411 7.01E-05 19531 hsa-mir-432 hsa04210 Apoptosis 596_598_823_207_1147_5970_7157_4792_472 9 6.00E-05 0.005158152 0.000117231 19532 hsa-mir-432 hsa04730 Long-term depression 5578_5894_5592_5595_5594_5518_5515_5604 8 7.68E-05 0.006602029 0.000146712 19533 hsa-mir-432 hsa05016 Huntington's disease 3066_3065_3064_25942_6667_1385_1387_7157_1537_2033_27113_6908 12 0.0002428 0.020880805 0.000453931 19534 hsa-mir-432 hsa04930 Type II diabetes mellitus 3651_5595_5594_5599_5601_5602 6 0.000267358 0.022992792 0.000489208 19535 hsa-mir-432 hsa05216 Thyroid cancer 5595_5594_7157_5604_4609 5 0.000303876 0.026133332 0.000544444 19536 hsa-mir-432 hsa03440 Homologous recombination 641_5888_675_6117 4 0.002316514 0.199220162 0.004065718 19537 hsa-mir-432 hsa04630 Jak-STAT signaling pathway 598_207_1387_6774_6772_2033_51588_4609_8554 9 0.002606671 0.22417368 0.004483474 19538 hsa-mir-432 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_1432_1616_7157 5 0.004404996 0.378829629 0.007428032 19539 hsa-mir-432 hsa03410 Base excision repair 3146_142_4913_328 4 0.005270868 0.453294655 0.008717205 19540 hsa-mir-432 hsa04270 Vascular smooth muscle contraction 5578_5499_5894_5592_5595_5594_5604 7 0.006792428 0.584148791 0.011021675 19541 hsa-mir-432 hsa03430 Mismatch repair 4436_4292_6117 3 0.010461041 0.899649555 0.016660177 19542 hsa-mir-432 hsa04360 Axon guidance 5747_25_998_5595_5594_2932_1020 7 0.011381251 0.978787605 0.017796138 19543 hsa-mir-432 hsa04740 Olfactory transduction 5592 1 0.017232469 1 0.026464149 19544 hsa-mir-432 hsa05217 Basal cell carcinoma 2736_2932_7157_1856 4 0.02023249 1 0.030204156 19545 hsa-mir-432 hsa04810 Regulation of actin cytoskeleton 7074_5747_5499_5894_998_5595_5594_5604_71 9 0.020370245 1 0.030204156 19546 hsa-mir-432 hsa04340 Hedgehog signaling pathway 2736_2932_1452_1453 4 0.022576209 1 0.032907695 19547 hsa-mir-432 hsa04670 Leukocyte transendothelial migration 5578_5747_1432_4301_998_71 6 0.026099617 1 0.037409452 19548 hsa-mir-432 hsa03030 DNA replication 5557_6117_5422 3 0.031101503 1 0.043802213 19549 hsa-mir-432 hsa03450 Non-homologous end-joining 2547_5591 2 0.03157834 1 0.043802213 19550 hsa-mir-432 hsa05010 Alzheimer's disease 823_22926_5595_5594_2932_1537_1020 7 0.045136256 1 0.061614571 19551 hsa-mir-4321 hsa05200 Pathways in cancer 1147_3320_1869_5743_3326_5747_25_5925_675_998_1026_5594_5595_5599_596_5601_6789_1856_4088_613_1017_2932_4193_1387_5578_51588_8554_5371_4436_7157_598_3725_2353_4087_4089_5888_5728_3065_3091_2033_3910_1050_4792_5602 44 7.84E-32 6.58E-30 3.37E-30 19552 hsa-mir-4321 hsa04110 Cell cycle 1869_25_5925_545_995_1026_5591_983_4088_7534_1017_2932_4193_7027_902_1387_7157_1031_9232_5347_1022_4087_4089_7532_3065_1111_2033_890_11200_8556_8555_472 32 8.02E-32 6.74E-30 3.37E-30 19553 hsa-mir-4321 hsa04115 p53 signaling pathway 50484_545_6241_1026_25898_983_1017_27113_4194_4193_900_7157_7161_64326_5728_51246_1111_11200_472 19 1.58E-19 1.33E-17 4.42E-18 19554 hsa-mir-4321 hsa05215 Prostate cancer 1147_3320_1869_3326_5925_1026_5594_5595_596_1017_2932_4193_1387_7157_10488_468_5728_2033_4792 19 7.99E-18 6.71E-16 1.61E-16 19555 hsa-mir-4321 hsa05212 Pancreatic cancer 1147_3320_1869_3326_5925_1026_5594_5595_596_1017_2932_4193_1387_7157_10488_468_5728_2033_4792 19 9.60E-18 8.06E-16 1.61E-16 19556 hsa-mir-4321 hsa04310 Wnt signaling pathway 1460_5518_5515_5599_5601_1856_1457_4088_2932_1387_5578_7157_8061_3725_1452_4087_4089_5527_2033_5602 20 5.41E-15 4.54E-13 7.57E-14 19557 hsa-mir-4321 hsa05220 Chronic myeloid leukemia 1147_1869_25_5925_1026_5594_5595_4088_613_4193_7157_598_4089_3065_4792 15 6.45E-14 5.42E-12 7.74E-13 19558 hsa-mir-4321 hsa05210 Colorectal cancer 5594_5595_5599_596_5601_1856_4088_2932_4436_7157_3725_2353_4087_4089_5602 15 2.77E-13 2.33E-11 2.78E-12 19559 hsa-mir-4321 hsa04010 MAPK signaling pathway 1147_3727_998_5594_5595_5599_5601_3304_3305_3303_6789_3315_5578_3164_7157_3725_2353_1386_468_1616_5923_1432_5602 23 2.98E-13 2.50E-11 2.78E-12 19560 hsa-mir-4321 hsa05222 Small cell lung cancer 1147_1869_5743_5747_5925_596_1017_51588_8554_7157_598_5728_3910_4792 14 5.31E-12 4.46E-10 4.46E-11 19561 hsa-mir-4321 hsa04350 TGF-beta signaling pathway 4093_5518_5515_5594_5595_6667_4088_7027_1387_4086_4087_4089_2033 13 8.04E-11 6.75E-09 6.14E-10 19562 hsa-mir-4321 hsa04120 Ubiquitin mediated proteolysis 10055_672_7319_25898_84447_4193_3093_51588_8554_5371_64326_7329_10075_7337 14 1.71E-09 1.43E-07 1.20E-08 19563 hsa-mir-4321 hsa04012 ErbB signaling pathway 5747_25_1026_5594_5595_5599_5601_2932_5578_3725_5602 11 1.13E-08 9.52E-07 7.33E-08 19564 hsa-mir-4321 hsa04510 Focal adhesion 5747_998_5594_5595_5599_596_5601_5499_2932_5578_3725_5728_5923_3910_5602 15 2.67E-08 2.24E-06 1.60E-07 19565 hsa-mir-4321 hsa04520 Adherens junction 1460_998_5594_5595_1457_4088_1387_4087_4089_2033 10 5.84E-08 4.91E-06 3.27E-07 19566 hsa-mir-4321 hsa04660 T cell receptor signaling pathway 1147_998_5594_5595_5601_2932_3725_2353_959_4792_1432 11 1.03E-07 8.67E-06 5.42E-07 19567 hsa-mir-4321 hsa05214 Glioma 1869_5925_1026_5594_5595_4193_5578_7157_5728 9 1.23E-07 1.03E-05 6.07E-07 19568 hsa-mir-4321 hsa04620 Toll-like receptor signaling pathway 1147_5594_5595_5599_5601_3725_2353_4792_1432_5602 10 4.67E-07 3.93E-05 2.18E-06 19569 hsa-mir-4321 hsa04912 GnRH signaling pathway 998_5594_5595_5599_5601_5578_3725_468_1432_5602 10 7.59E-07 6.38E-05 3.36E-06 19570 hsa-mir-4321 hsa05219 Bladder cancer 1869_5925_1026_5594_5595_4193_7157 7 1.04E-06 8.77E-05 4.38E-06 19571 hsa-mir-4321 hsa03420 Nucleotide excision repair 2965_4331_2074_6117_2071_902_1022 7 1.38E-06 0.000115938 5.52E-06 19572 hsa-mir-4321 hsa05218 Melanoma 1869_5925_1026_5594_5595_4193_7157_5728 8 2.57E-06 0.000215976 9.39E-06 19573 hsa-mir-4321 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_998_5599_5601_3725_4792_1432_5602 8 2.57E-06 0.000215976 9.39E-06 19574 hsa-mir-4321 hsa04662 B cell receptor signaling pathway 1147_5594_5595_1380_2932_3725_2353_4792 8 3.74E-06 0.000314351 1.31E-05 19575 hsa-mir-4321 hsa04370 VEGF signaling pathway 5743_5747_998_5594_5595_3315_5578_1432 8 4.48E-06 0.000376319 1.51E-05 19576 hsa-mir-4321 hsa05223 Non-small cell lung cancer 1869_5925_5594_5595_6789_5578_7157 7 4.73E-06 0.000397722 1.53E-05 19577 hsa-mir-4321 hsa03022 Basal transcription factors 2965_2957_6908_51616_2958_6880 6 7.25E-06 0.000608598 2.25E-05 19578 hsa-mir-4321 hsa04920 Adipocytokine signaling pathway 1147_5563_6794_5599_5601_4792_5602 7 1.73E-05 0.001452295 5.19E-05 19579 hsa-mir-4321 hsa05211 Renal cell carcinoma 998_5594_5595_1387_3725_3091_2033 7 2.66E-05 0.002232336 7.70E-05 19580 hsa-mir-4321 hsa04720 Long-term potentiation 5594_5595_5499_1387_5578_468_2033 7 3.39E-05 0.002846677 9.28E-05 19581 hsa-mir-4321 hsa04916 Melanogenesis 5594_5595_1856_2932_1387_5578_10488_2033 8 3.43E-05 0.002878107 9.28E-05 19582 hsa-mir-4321 hsa04664 Fc epsilon RI signaling pathway 5594_5595_5599_5601_5578_1432_5602 7 4.61E-05 0.003875575 0.000121112 19583 hsa-mir-4321 hsa05016 Huntington's disease 25942_3064_6908_6667_27113_1387_7157_10488_3065_2033 10 7.30E-05 0.00613018 0.000185763 19584 hsa-mir-4321 hsa04210 Apoptosis 1147_823_596_7157_598_4792_472 7 9.32E-05 0.007830048 0.000230296 19585 hsa-mir-4321 hsa04530 Tight junction 1460_998_5518_5515_1457_5578_5728_5520 8 0.000210034 0.017642843 0.00049974 19586 hsa-mir-4321 hsa04930 Type II diabetes mellitus 5594_5595_5599_5601_5602 5 0.00021866 0.018367445 0.00049974 19587 hsa-mir-4321 hsa04910 Insulin signaling pathway 5563_5594_5595_5599_5601_5499_2932_5602 8 0.000220123 0.018490369 0.00049974 19588 hsa-mir-4321 hsa04330 Notch signaling pathway 1856_1387_3065_2033_8850 5 0.000263458 0.022130452 0.00058238 19589 hsa-mir-4321 hsa03440 Homologous recombination 675_6117_641_5888 4 0.000402414 0.033802785 0.000831568 19590 hsa-mir-4321 hsa05213 Endometrial cancer 5594_5595_2932_7157_5728 5 0.000405884 0.034094288 0.000831568 19591 hsa-mir-4321 hsa04150 mTOR signaling pathway 5563_5594_6794_5595_3091 5 0.000405884 0.034094288 0.000831568 19592 hsa-mir-4321 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_7157_598_1616_1432 5 0.000556446 0.046741466 0.001062306 19593 hsa-mir-4321 hsa05131 Shigellosis 25_998_7534_5578_4691 5 0.000556446 0.046741466 0.001062306 19594 hsa-mir-4321 hsa05130 Pathogenic Escherichia coli infection 25_998_7534_5578_4691 5 0.000556446 0.046741466 0.001062306 19595 hsa-mir-4321 hsa04612 Antigen processing and presentation 3320_3326_3309_3304_3305_3303 6 0.000640768 0.053824497 0.0011961 19596 hsa-mir-4321 hsa05221 Acute myeloid leukemia 1147_5594_5595_5371_1050 5 0.000694306 0.058321738 0.001267864 19597 hsa-mir-4321 hsa04360 Axon guidance 5747_25_998_5594_5595_2932_1020 7 0.000857094 0.071995887 0.001531827 19598 hsa-mir-4321 hsa03410 Base excision repair 142_3146_328_4913 4 0.000954561 0.080183117 0.001670482 19599 hsa-mir-4321 hsa04730 Long-term depression 5518_5515_5594_5595_5578 5 0.001511809 0.126991926 0.002591672 19600 hsa-mir-4321 hsa04062 Chemokine signaling pathway 1147_5747_998_5594_5595_2932_6362_4792 8 0.001788104 0.150200746 0.003004015 19601 hsa-mir-4321 hsa04540 Gap junction 5594_5595_983_1453_5578 5 0.00457243 0.384084139 0.007531062 19602 hsa-mir-4321 hsa05216 Thyroid cancer 5594_5595_7157 3 0.005137647 0.431562349 0.008299276 19603 hsa-mir-4321 hsa03030 DNA replication 6117_5557_5422 3 0.008947529 0.751592475 0.01418099 19604 hsa-mir-4321 hsa03450 Non-homologous end-joining 5591_2547 2 0.013025988 1 0.020262648 19605 hsa-mir-4321 hsa05217 Basal cell carcinoma 1856_2932_7157 3 0.025953813 1 0.039638551 19606 hsa-mir-4321 hsa04340 Hedgehog signaling pathway 1453_2932_1452 3 0.028329784 1 0.042494676 19607 hsa-mir-4321 hsa03430 Mismatch repair 6117_4436 2 0.030526438 1 0.04498633 19608 hsa-mir-4321 hsa04630 Jak-STAT signaling pathway 1387_51588_8554_598_2033 5 0.032098297 1 0.046487189 19609 hsa-mir-4321 hsa04950 Maturity onset diabetes of the young 4760_3172 2 0.032834731 1 0.046747753 19610 hsa-mir-4321 hsa04270 Vascular smooth muscle contraction 5594_5595_5499_5578 4 0.045810228 1 0.064134319 19611 hsa-mir-4323 hsa05200 Pathways in cancer 3320_3326_25_3551_5371_1499_5594_5599_1387_6257_6256_595_9915_6258_367_1017_1147_8517_4149_7704_3091_5970_1870_1871_8031_7157_4791_6688_4792_2113_5595_1869_3725_861_6774_2353_2735_2736_2737_4088_4089_7175_3065_207_1050_5925_2034_2033_2932_8554_7186 51 3.16E-40 2.34E-38 2.34E-38 19612 hsa-mir-4323 hsa05215 Prostate cancer 3320_3326_3551_1499_5594_1387_595_367_1017_1147_8517_5970_1870_1871_7157_4792_5595_1869_207_5925_2033_2932 22 7.31E-22 5.41E-20 1.67E-20 19613 hsa-mir-4323 hsa04110 Cell cycle 25_5591_1387_890_595_1017_8454_6500_1870_1871_7157_10912_1869_4088_4089_3065_5925_2033_4616_894_896_2932_5934_5933 24 7.93E-22 5.87E-20 1.67E-20 19614 hsa-mir-4323 hsa05212 Pancreatic cancer 3320_3326_3551_1499_5594_1387_595_367_1017_1147_8517_5970_1870_1871_7157_4792_5595_1869_207_5925_2033_2932 22 9.03E-22 6.68E-20 1.67E-20 19615 hsa-mir-4323 hsa05220 Chronic myeloid leukemia 25_3551_5594_595_1147_8517_5970_1870_1871_7157_4792_5595_1869_861_4088_4089_3065_207_5925 19 3.83E-19 2.84E-17 5.67E-18 19616 hsa-mir-4323 hsa05222 Small cell lung cancer 3551_6257_6256_595_6258_1017_1147_8517_4149_5970_1870_1871_7157_4792_1869_207_5925_8554_7186 19 3.51E-18 2.60E-16 4.33E-17 19617 hsa-mir-4323 hsa04920 Adipocytokine signaling pathway 3551_10891_5599_6257_6256_6258_1147_8517_5970_4794_4792_6774_207_4793_7186 15 1.07E-14 7.90E-13 1.13E-13 19618 hsa-mir-4323 hsa04350 TGF-beta signaling pathway 5594_1387_8454_3399_3398_6500_1874_1875_5595_4086_4088_4089_2033_4093_5934_5933 16 2.03E-14 1.50E-12 1.83E-13 19619 hsa-mir-4323 hsa04010 MAPK signaling pathway 3551_1326_5594_5599_3305_5566_1147_8517_4149_3312_5970_7157_4791_10912_5595_3725_2353_3310_207_1616_3303_4616_5971_7186 24 2.23E-14 1.65E-12 1.83E-13 19620 hsa-mir-4323 hsa04310 Wnt signaling pathway 23291_1499_5599_1387_595_5566_8454_6500_7157_8945_8607_3725_1457_4088_4089_2033_894_896_2932 19 3.94E-14 2.92E-12 2.81E-13 19621 hsa-mir-4323 hsa05221 Acute myeloid leukemia 3551_5371_5594_595_1147_8517_7704_5970_6688_5595_861_6774_207_1050 14 4.17E-14 3.09E-12 2.81E-13 19622 hsa-mir-4323 hsa05223 Non-small cell lung cancer 5594_6257_6256_595_6258_1870_1871_7157_5595_1869_207_5925 12 5.50E-12 4.07E-10 3.39E-11 19623 hsa-mir-4323 hsa05216 Thyroid cancer 1499_5594_6257_6256_595_6258_8031_7157_5595_7175 10 8.41E-12 6.22E-10 4.78E-11 19624 hsa-mir-4323 hsa04662 B cell receptor signaling pathway 3551_5594_1147_8517_5970_4794_4792_5595_3725_2353_207_2932_4793 13 1.13E-11 8.37E-10 5.98E-11 19625 hsa-mir-4323 hsa05214 Glioma 5594_595_808_1870_1871_7157_5595_1869_207_5925_805_801 12 3.70E-11 2.74E-09 1.82E-10 19626 hsa-mir-4323 hsa04660 T cell receptor signaling pathway 3551_1326_5594_1147_8517_5970_4794_4792_5595_3725_2353_207_2932_4793 14 7.52E-11 5.57E-09 3.48E-10 19627 hsa-mir-4323 hsa05210 Colorectal cancer 1499_5594_5599_595_7157_5595_3725_2353_4088_4089_207_2932 12 5.24E-10 3.88E-08 2.28E-09 19628 hsa-mir-4323 hsa04620 Toll-like receptor signaling pathway 3551_1326_5594_5599_1147_8517_5970_4792_5595_3725_2353_207 12 3.90E-09 2.89E-07 1.60E-08 19629 hsa-mir-4323 hsa05211 Renal cell carcinoma 5594_1387_9915_3091_2113_5595_3725_207_2034_2033 10 1.88E-08 1.39E-06 7.33E-08 19630 hsa-mir-4323 hsa05219 Bladder cancer 5594_595_1870_1871_7157_5595_1869_5925 8 5.80E-08 4.29E-06 2.14E-07 19631 hsa-mir-4323 hsa04210 Apoptosis 3551_5566_1147_8517_8837_5970_7157_4792_207_7186 10 1.17E-07 8.64E-06 4.11E-07 19632 hsa-mir-4323 hsa05218 Melanoma 5594_595_1870_1871_7157_5595_1869_207_5925 9 1.99E-07 1.47E-05 6.68E-07 19633 hsa-mir-4323 hsa04062 Chemokine signaling pathway 3551_5594_5566_1147_8517_5970_4792_653361_5595_6774_207_2932_4793 13 4.00E-07 2.96E-05 1.24E-06 19634 hsa-mir-4323 hsa05131 Shigellosis 25_203068_1499_347733_7278_71_10382_84617 8 4.20E-07 3.11E-05 1.24E-06 19635 hsa-mir-4323 hsa05130 Pathogenic Escherichia coli infection 25_203068_1499_347733_7278_71_10382_84617 8 4.20E-07 3.11E-05 1.24E-06 19636 hsa-mir-4323 hsa04916 Melanogenesis 1499_5594_1387_5566_808_5595_2033_2932_805_801 10 4.43E-07 3.28E-05 1.26E-06 19637 hsa-mir-4323 hsa04520 Adherens junction 1499_5594_1387_71_5595_1457_4088_4089_2033 9 5.00E-07 3.70E-05 1.37E-06 19638 hsa-mir-4323 hsa04910 Insulin signaling pathway 3551_10891_5594_5599_5566_808_5595_207_2932_805_801 11 6.71E-07 4.97E-05 1.77E-06 19639 hsa-mir-4323 hsa04120 Ubiquitin mediated proteolysis 5371_23291_672_8454_6500_10273_8945_7323_3093_7329_8554 11 7.18E-07 5.31E-05 1.83E-06 19640 hsa-mir-4323 hsa03020 RNA polymerase 25885_64425_5437_51082_84172_5441 6 1.81E-06 0.000133755 4.46E-06 19641 hsa-mir-4323 hsa05016 Huntington's disease 10891_25942_1387_6908_5437_293_7157_292_1213_3065_2033_5441 12 1.90E-06 0.000140663 4.54E-06 19642 hsa-mir-4323 hsa04720 Long-term potentiation 5594_1387_5566_808_5595_2033_805_801 8 3.13E-06 0.00023198 7.22E-06 19643 hsa-mir-4323 hsa05213 Endometrial cancer 1499_5594_595_7157_5595_207_2932 7 3.22E-06 0.000238361 7.22E-06 19644 hsa-mir-4323 hsa04510 Focal adhesion 1499_5594_5599_595_71_10627_5595_3725_207_894_896_2932 12 4.63E-06 0.000342953 1.01E-05 19645 hsa-mir-4323 hsa04340 Hedgehog signaling pathway 23291_5566_8945_2735_2736_2737_2932 7 5.60E-06 0.000414617 1.18E-05 19646 hsa-mir-4323 hsa04630 Jak-STAT signaling pathway 3559_1387_595_6778_6774_207_2033_894_896_8554 10 1.26E-05 0.000929202 2.58E-05 19647 hsa-mir-4323 hsa04540 Gap junction 203068_5594_5566_347733_7278_10382_84617_5595 8 1.36E-05 0.001006064 2.72E-05 19648 hsa-mir-4323 hsa04115 p53 signaling pathway 595_1017_7157_10912_4616_894_896 7 1.77E-05 0.001307439 3.44E-05 19649 hsa-mir-4323 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3551_5599_1147_8517_5970_4792_3725 7 2.10E-05 0.001551361 3.98E-05 19650 hsa-mir-4323 hsa04912 GnRH signaling pathway 5594_5599_5566_808_5595_3725_805_801 8 3.72E-05 0.002753052 6.88E-05 19651 hsa-mir-4323 hsa05217 Basal cell carcinoma 1499_7157_2735_2736_2737_2932 6 4.89E-05 0.003621288 8.83E-05 19652 hsa-mir-4323 hsa04012 ErbB signaling pathway 25_5594_5599_5595_3725_207_2932 7 7.02E-05 0.00519398 0.000123666 19653 hsa-mir-4323 hsa04612 Antigen processing and presentation 3320_3326_3305_3312_3310_3309_3303 7 8.03E-05 0.005938887 0.000138114 19654 hsa-mir-4323 hsa04330 Notch signaling pathway 1387_4851_9612_3065_2033 5 0.000235821 0.017450739 0.000396608 19655 hsa-mir-4323 hsa04270 Vascular smooth muscle contraction 5594_5566_808_4637_5595_805_801 7 0.000412444 0.030520877 0.000678242 19656 hsa-mir-4323 hsa04530 Tight junction 1499_4627_4628_71_10627_1457_207 7 0.000956563 0.070785688 0.001538819 19657 hsa-mir-4323 hsa04930 Type II diabetes mellitus 3551_5594_5599_5595 4 0.001877028 0.138900046 0.00295532 19658 hsa-mir-4323 hsa04150 mTOR signaling pathway 5594_3091_5595_207 4 0.003068818 0.227092568 0.004731095 19659 hsa-mir-4323 hsa03320 PPAR signaling pathway 6257_6256_6258_2168 4 0.008275992 0.61242342 0.012498437 19660 hsa-mir-4323 hsa03022 Basal transcription factors 2963_2969_6908 3 0.008989685 0.665236678 0.013304734 19661 hsa-mir-4323 hsa04810 Regulation of actin cytoskeleton 5594_4627_4628_71_10788_10627_5595 7 0.011338043 0.839015176 0.016451278 19662 hsa-mir-4323 hsa04664 Fc epsilon RI signaling pathway 5594_5599_5595_207 4 0.01226798 0.907830554 0.01745828 19663 hsa-mir-4323 hsa05010 Alzheimer's disease 5594_808_5595_2932_805_801 6 0.014348771 1 0.020034133 19664 hsa-mir-4323 hsa04020 Calcium signaling pathway 5566_293_808_292_805_801 6 0.016958926 1 0.02324001 19665 hsa-mir-4323 hsa03010 Ribosome 6156_6128_6207_6202 4 0.027446253 1 0.036927686 19666 hsa-mir-4323 hsa04670 Leukocyte transendothelial migration 1499_71_653361_10627 4 0.046978311 1 0.062078483 19667 hsa-mir-4329 hsa05200 Pathways in cancer 1147_3320_4149_3551_5371_367_1499_5595_5599_1387_5604_836_2932_6774_6502_5970_5894_4609_3725_1029_2353_2735_2736_2737_4087_4088_4089_5881_4292_5925_2033_1050_207_208 34 7.93E-32 5.08E-30 5.08E-30 19668 hsa-mir-4329 hsa05210 Colorectal cancer 1499_5595_5599_5604_836_2932_5894_4609_3725_2353_4087_4088_4089_5881_4292_207_208 17 8.13E-21 5.21E-19 2.60E-19 19669 hsa-mir-4329 hsa05215 Prostate cancer 1147_3320_3551_367_1499_5595_1387_5604_2932_5970_468_5894_5925_2033_207_208 16 5.36E-19 3.43E-17 1.01E-17 19670 hsa-mir-4329 hsa05212 Pancreatic cancer 1147_3320_3551_367_1499_5595_1387_5604_2932_5970_468_5894_5925_2033_207_208 16 6.29E-19 4.02E-17 1.01E-17 19671 hsa-mir-4329 hsa04010 MAPK signaling pathway 1147_6722_4149_3551_3727_5595_5599_5598_5604_836_1386_1432_5970_468_5894_4609_3725_2353_5881_207_208 21 1.55E-17 9.89E-16 1.98E-16 19672 hsa-mir-4329 hsa04110 Cell cycle 990_1387_983_7534_7532_2932_8454_6502_6500_1029_4087_4088_4089_5925_2033_5933 16 4.03E-17 2.58E-15 4.30E-16 19673 hsa-mir-4329 hsa05220 Chronic myeloid leukemia 1147_3551_5595_5604_5970_5894_4609_1029_4088_4089_5925_207_208 13 2.05E-15 1.31E-13 1.87E-14 19674 hsa-mir-4329 hsa05221 Acute myeloid leukemia 1147_3551_5371_5595_5604_6774_5970_5894_4609_1050_207_208 12 4.63E-15 2.96E-13 3.71E-14 19675 hsa-mir-4329 hsa04310 Wnt signaling pathway 1499_5599_1387_2932_8454_6500_4609_3725_1457_1459_4087_4088_4089_5881_2033 15 2.63E-14 1.68E-12 1.87E-13 19676 hsa-mir-4329 hsa04662 B cell receptor signaling pathway 1147_3551_5595_5604_2932_5970_5894_3725_2353_5881_207_208 12 5.95E-14 3.81E-12 3.81E-13 19677 hsa-mir-4329 hsa04520 Adherens junction 1499_6714_5595_1387_1457_1459_4087_4088_4089_5881_2033 11 3.04E-12 1.94E-10 1.77E-11 19678 hsa-mir-4329 hsa04660 T cell receptor signaling pathway 1147_3551_5595_5604_2932_1432_5970_5894_3725_2353_207_208 12 3.70E-12 2.37E-10 1.97E-11 19679 hsa-mir-4329 hsa04350 TGF-beta signaling pathway 5595_1387_6667_8454_6500_4609_4087_4088_4089_2033_5933 11 6.96E-12 4.46E-10 3.43E-11 19680 hsa-mir-4329 hsa04540 Gap junction 7277_6714_5595_5598_983_5604_7278_10376_5894_7846_51807 11 1.35E-11 8.62E-10 6.16E-11 19681 hsa-mir-4329 hsa04620 Toll-like receptor signaling pathway 1147_3551_5595_5599_5604_1432_5970_3725_2353_207_208 11 3.37E-11 2.15E-09 1.44E-10 19682 hsa-mir-4329 hsa05213 Endometrial cancer 1499_5595_5604_2932_5894_4609_4292_207_208 9 4.78E-11 3.06E-09 1.91E-10 19683 hsa-mir-4329 hsa04012 ErbB signaling pathway 6714_5595_5599_5604_2932_5894_4609_3725_207_208 10 1.52E-10 9.74E-09 5.73E-10 19684 hsa-mir-4329 hsa05131 Shigellosis 7277_1499_7534_7278_10376_7846_51807_4691 8 2.31E-09 1.48E-07 7.77E-09 19685 hsa-mir-4329 hsa05130 Pathogenic Escherichia coli infection 7277_1499_7534_7278_10376_7846_51807_4691 8 2.31E-09 1.48E-07 7.77E-09 19686 hsa-mir-4329 hsa05222 Small cell lung cancer 1147_4149_3551_6502_5970_4609_5925_207_208 9 2.77E-09 1.77E-07 8.85E-09 19687 hsa-mir-4329 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_3551_6714_5599_836_1432_5970_3725 8 1.27E-08 8.11E-07 3.86E-08 19688 hsa-mir-4329 hsa05211 Renal cell carcinoma 5595_1387_5604_5894_3725_2033_207_208 8 1.40E-08 8.97E-07 4.08E-08 19689 hsa-mir-4329 hsa04912 GnRH signaling pathway 6714_5595_5599_5598_5604_1432_468_5894_3725 9 1.75E-08 1.12E-06 4.88E-08 19690 hsa-mir-4329 hsa04062 Chemokine signaling pathway 1147_3551_5595_5604_2932_6774_5970_5894_7074_207_208 11 1.83E-08 1.17E-06 4.89E-08 19691 hsa-mir-4329 hsa04370 VEGF signaling pathway 6714_5595_5604_1432_5894_5881_207_208 8 2.27E-08 1.46E-06 5.82E-08 19692 hsa-mir-4329 hsa04664 Fc epsilon RI signaling pathway 5595_5599_5604_1432_5894_5881_207_208 8 2.74E-08 1.75E-06 6.73E-08 19693 hsa-mir-4329 hsa04510 Focal adhesion 1499_6714_5595_5599_5604_2932_5894_3725_5881_207_208 11 3.46E-08 2.21E-06 8.20E-08 19694 hsa-mir-4329 hsa05223 Non-small cell lung cancer 5595_5604_5894_1029_5925_207_208 7 4.39E-08 2.81E-06 1.00E-07 19695 hsa-mir-4329 hsa04210 Apoptosis 1147_3551_823_836_840_5970_207_208 8 6.46E-08 4.13E-06 1.43E-07 19696 hsa-mir-4329 hsa05214 Glioma 5595_5604_5894_1029_5925_207_208 7 1.41E-07 9.02E-06 3.01E-07 19697 hsa-mir-4329 hsa04920 Adipocytokine signaling pathway 1147_3551_5599_6774_5970_207_208 7 1.71E-07 1.09E-05 3.52E-07 19698 hsa-mir-4329 hsa05218 Melanoma 5595_5604_5894_1029_5925_207_208 7 2.46E-07 1.57E-05 4.81E-07 19699 hsa-mir-4329 hsa05219 Bladder cancer 5595_5604_5894_4609_1029_5925 6 2.48E-07 1.59E-05 4.81E-07 19700 hsa-mir-4329 hsa04910 Insulin signaling pathway 3551_5595_5599_5604_2932_5894_207_208 8 1.50E-06 9.61E-05 2.83E-06 19701 hsa-mir-4329 hsa04916 Melanogenesis 1499_5595_1387_5604_2932_5894_2033 7 2.72E-06 0.000173905 4.97E-06 19702 hsa-mir-4329 hsa04720 Long-term potentiation 5595_1387_5604_468_5894_2033 6 5.65E-06 0.0003618 1.00E-05 19703 hsa-mir-4329 hsa05010 Alzheimer's disease 22926_5595_823_836_2932_840_1020_9451 8 8.69E-06 0.000556207 1.50E-05 19704 hsa-mir-4329 hsa05217 Basal cell carcinoma 1499_2932_2735_2736_2737 5 1.97E-05 0.001263087 3.32E-05 19705 hsa-mir-4329 hsa05216 Thyroid cancer 1499_5595_5604_4609 4 3.12E-05 0.001997264 5.12E-05 19706 hsa-mir-4329 hsa04530 Tight junction 1499_6714_1457_1459_207_208 6 0.00014077 0.009009312 0.000225233 19707 hsa-mir-4329 hsa04120 Ubiquitin mediated proteolysis 5371_672_8454_55294_6502_6500 6 0.000151864 0.009719264 0.000237055 19708 hsa-mir-4329 hsa04330 Notch signaling pathway 1387_2033_2648_8850 4 0.000176533 0.011298114 0.000269003 19709 hsa-mir-4329 hsa04630 Jak-STAT signaling pathway 1387_6774_4609_2033_207_208 6 0.000267695 0.017132452 0.000398429 19710 hsa-mir-4329 hsa04340 Hedgehog signaling pathway 2932_2735_2736_2737 4 0.000353324 0.022612741 0.000513926 19711 hsa-mir-4329 hsa04115 p53 signaling pathway 983_836_7161_1029 4 0.00070039 0.044824976 0.000996111 19712 hsa-mir-4329 hsa04650 Natural killer cell mediated cytotoxicity 5595_5604_836_5894_5881 5 0.001165877 0.074616149 0.00162209 19713 hsa-mir-4329 hsa03022 Basal transcription factors 2969_2962_6908 3 0.001368465 0.087581731 0.001863441 19714 hsa-mir-4329 hsa04612 Antigen processing and presentation 3320_4800_4801_4802 4 0.001726533 0.110498107 0.002302044 19715 hsa-mir-4329 hsa04930 Type II diabetes mellitus 3551_5595_5599 3 0.002320278 0.148497768 0.003030567 19716 hsa-mir-4329 hsa04150 mTOR signaling pathway 5595_207_208 3 0.003422566 0.21904423 0.004380885 19717 hsa-mir-4329 hsa05016 Huntington's disease 1387_6908_836_6667_2033 5 0.004278384 0.273816554 0.005368952 19718 hsa-mir-4329 hsa04360 Axon guidance 5595_2932_1020_5881 4 0.006558559 0.419747786 0.008072073 19719 hsa-mir-4329 hsa04730 Long-term depression 5595_5604_5894 3 0.007841733 0.501870942 0.009405738 19720 hsa-mir-4329 hsa04810 Regulation of actin cytoskeleton 5595_5604_5894_5881_7074 5 0.007936091 0.507909855 0.009405738 19721 hsa-mir-4329 hsa04950 Maturity onset diabetes of the young 3172_6928 2 0.008867205 0.567501131 0.010318202 19722 hsa-mir-4329 hsa04270 Vascular smooth muscle contraction 5595_5604_5894 3 0.028949283 1 0.033084895 19723 hsa-mir-4329 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432 2 0.04026068 1 0.045204974 19724 hsa-mir-433 hsa05200 Pathways in cancer 1147_4609_3320_3326_405_2249_3480_1956_5595_5594_6654_5599_5914_2064_6256_595_2308_208_367_4193_7704_1387_6776_6777_2885_5970_8503_1870_1871_7157_4087_4089_10401_3725_1029_2353_3066_2736_4088_5295_5925_2033_207_2932_8554_4286_4790 47 4.42E-35 3.31E-33 3.31E-33 19725 hsa-mir-433 hsa05215 Prostate cancer 1147_3320_3326_3480_1956_5595_5594_6654_2064_595_2308_208_367_4193_1387_2885_5970_8503_1870_1871_7157_1385_468_5295_5925_2033_207_2932_4790 29 4.84E-31 3.63E-29 1.59E-29 19726 hsa-mir-433 hsa05212 Pancreatic cancer 1147_3320_3326_3480_1956_5595_5594_6654_2064_595_2308_208_367_4193_1387_2885_5970_8503_1870_1871_7157_1385_468_5295_5925_2033_207_2932_4790 29 6.35E-31 4.77E-29 1.59E-29 19727 hsa-mir-433 hsa05220 Chronic myeloid leukemia 1147_4609_5595_5594_6654_595_208_4193_6776_6777_2885_5970_8503_1870_1871_7157_4089_1029_3066_4088_5295_5925_207_4790_6464 25 5.17E-27 3.88E-25 9.69E-26 19728 hsa-mir-433 hsa04010 MAPK signaling pathway 9479_1147_4609_6722_2249_994_1956_5595_5594_6654_5599_9261_8986_5566_208_4214_9252_1386_1432_2885_5970_627_7157_10912_468_3725_3727_6195_6196_6197_2353_5058_4616_2872_207_4790 36 4.65E-26 3.49E-24 6.97E-25 19729 hsa-mir-433 hsa05214 Glioma 3480_1956_5595_5594_6654_595_208_4193_2885_8503_1870_1871_7157_1029_5295_5925_207_801_6464_808_805 21 1.21E-22 9.06E-21 1.51E-21 19730 hsa-mir-433 hsa05223 Non-small cell lung cancer 1956_5595_5594_6654_2064_6256_595_2309_208_2885_8503_1870_1871_7157_1029_5295_5925_207 18 8.65E-20 6.49E-18 9.27E-19 19731 hsa-mir-433 hsa05210 Colorectal cancer 4609_3480_1956_5595_5594_6654_5599_595_208_2885_8503_7157_4087_4089_3725_2353_4088_5295_207_2932 20 2.15E-19 1.61E-17 2.01E-18 19732 hsa-mir-433 hsa04110 Cell cycle 994_993_595_983_7533_4193_902_1387_1870_1871_7157_4087_10912_4089_1022_1029_3066_4088_5925_2033_4616_2932 22 3.85E-19 2.89E-17 2.92E-18 19733 hsa-mir-433 hsa04012 ErbB signaling pathway 4609_1956_6714_5595_5594_6654_56924_5599_2064_208_6776_6777_2885_8503_3725_5295_5058_207_2932_6464 20 3.90E-19 2.92E-17 2.92E-18 19734 hsa-mir-433 hsa05221 Acute myeloid leukemia 1147_4609_5595_5594_6654_5914_595_208_7704_6776_6777_2885_5970_8503_5295_207_4790 17 7.26E-18 5.45E-16 4.95E-17 19735 hsa-mir-433 hsa04660 T cell receptor signaling pathway 1147_3932_5595_5594_6654_56924_208_5777_1432_2885_5970_8503_1739_3725_2353_5295_5058_207_2932_4790 20 2.17E-17 1.63E-15 1.36E-16 19736 hsa-mir-433 hsa04910 Insulin signaling pathway 6720_10891_5595_5594_6654_5599_2308_5566_7249_208_5770_2885_8503_5295_2872_207_2932_801_6464_808_805 21 8.50E-17 6.37E-15 4.90E-16 19737 hsa-mir-433 hsa05218 Melanoma 2249_3480_1956_5595_5594_595_208_4193_8503_1870_1871_7157_1029_5295_5925_207_4286 17 1.03E-16 7.76E-15 5.54E-16 19738 hsa-mir-433 hsa05213 Endometrial cancer 4609_1956_5595_5594_6654_2064_595_2309_208_2885_8503_7157_5295_207_2932 15 6.39E-16 4.79E-14 3.19E-15 19739 hsa-mir-433 hsa04510 Focal adhesion 9564_3480_1956_6714_5595_5594_6654_56924_5599_2064_595_208_1729_2885_8503_857_3725_5295_5058_207_2932_6464 22 1.26E-14 9.43E-13 5.89E-14 19740 hsa-mir-433 hsa05222 Small cell lung cancer 1147_4609_6256_595_208_5970_8503_1870_1871_7157_10401_5295_5925_207_8554_4790 16 2.63E-14 1.97E-12 1.11E-13 19741 hsa-mir-433 hsa05219 Bladder cancer 4609_1956_5595_5594_2064_595_9252_4193_1870_1871_7157_1029_5925 13 2.65E-14 1.99E-12 1.11E-13 19742 hsa-mir-433 hsa04662 B cell receptor signaling pathway 1147_5595_5594_6654_208_5777_2885_5970_8503_3725_2353_5295_207_2932_4790 15 6.73E-14 5.05E-12 2.66E-13 19743 hsa-mir-433 hsa05211 Renal cell carcinoma 405_5595_5594_6654_56924_208_1387_2885_8503_3725_5295_5058_2033_207 14 6.52E-13 4.89E-11 2.45E-12 19744 hsa-mir-433 hsa04520 Adherens junction 1460_3480_1956_6714_5595_5594_2064_5770_5777_1387_4087_4089_4088_2033 14 2.31E-12 1.74E-10 8.26E-12 19745 hsa-mir-433 hsa04062 Chemokine signaling pathway 1147_9564_5595_5594_6654_2770_2309_5566_208_6777_2885_5970_8503_5295_5058_207_2932_4790_6464 19 3.11E-12 2.33E-10 1.06E-11 19746 hsa-mir-433 hsa04912 GnRH signaling pathway 1956_6714_5595_5594_6654_5599_5566_4214_1432_2885_468_3725_801_808_805 15 7.44E-12 5.58E-10 2.42E-11 19747 hsa-mir-433 hsa04630 Jak-STAT signaling pathway 4609_6654_595_208_5777_1387_6776_6777_2885_8503_10401_5295_2033_3977_207_8554 16 8.66E-11 6.50E-09 2.71E-10 19748 hsa-mir-433 hsa04720 Long-term potentiation 5595_5594_5566_1387_468_6195_6196_6197_2033_801_808_805 12 2.21E-10 1.66E-08 6.63E-10 19749 hsa-mir-433 hsa04620 Toll-like receptor signaling pathway 1147_5595_5594_5599_208_1432_5970_8503_3725_2353_5295_207_4790 13 4.94E-10 3.71E-08 1.43E-09 19750 hsa-mir-433 hsa04150 mTOR signaling pathway 5595_5594_7249_208_8503_6195_6196_6197_5295_207 10 1.48E-09 1.11E-07 4.12E-09 19751 hsa-mir-433 hsa04310 Wnt signaling pathway 4609_1460_5599_595_5566_6423_1387_7157_4087_4089_3725_4088_2033_2932 14 5.13E-09 3.85E-07 1.38E-08 19752 hsa-mir-433 hsa04916 Melanogenesis 5595_5594_2770_5566_1387_1385_2033_2932_4286_801_808_805 12 6.44E-09 4.83E-07 1.67E-08 19753 hsa-mir-433 hsa04664 Fc epsilon RI signaling pathway 5595_5594_6654_5599_208_1432_2885_8503_5295_207 10 5.39E-08 4.05E-06 1.35E-07 19754 hsa-mir-433 hsa04350 TGF-beta signaling pathway 4609_6667_5595_5594_1387_3398_4087_4089_4088_2033 10 1.23E-07 9.26E-06 2.99E-07 19755 hsa-mir-433 hsa04210 Apoptosis 1147_5566_208_5970_8503_823_7157_5295_207_4790 10 1.50E-07 1.12E-05 3.51E-07 19756 hsa-mir-433 hsa04540 Gap junction 1956_6714_5592_5595_5594_6654_2770_983_5566_2885 10 2.18E-07 1.64E-05 4.96E-07 19757 hsa-mir-433 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_1956_6714_5599_1432_5970_3725_5058_4790 9 2.49E-07 1.87E-05 5.50E-07 19758 hsa-mir-433 hsa04370 VEGF signaling pathway 6714_5595_5594_9261_208_1432_8503_5295_207 9 4.67E-07 3.50E-05 1.00E-06 19759 hsa-mir-433 hsa04920 Adipocytokine signaling pathway 1147_10891_5599_6256_208_5970_207_4790 8 1.77E-06 0.000132422 3.68E-06 19760 hsa-mir-433 hsa05216 Thyroid cancer 4609_5595_5594_6256_595_7157 6 2.11E-06 0.000158456 4.26E-06 19761 hsa-mir-433 hsa04115 p53 signaling pathway 595_983_7249_4193_7157_10912_1029_4616 8 2.16E-06 0.000162041 4.26E-06 19762 hsa-mir-433 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6654_5777_2885_8503_5295_5058_6464 10 6.09E-06 0.000457098 1.17E-05 19763 hsa-mir-433 hsa03022 Basal transcription factors 2965_2963_2969_6908_2959_6881 6 7.37E-06 0.000552648 1.38E-05 19764 hsa-mir-433 hsa05016 Huntington's disease 6667_10891_6908_1387_627_7157_1385_3066_3064_2033_4716 11 1.43E-05 0.001071111 2.61E-05 19765 hsa-mir-433 hsa04930 Type II diabetes mellitus 5595_5594_5599_3651_8503_5295 6 2.02E-05 0.001516152 3.61E-05 19766 hsa-mir-433 hsa04330 Notch signaling pathway 1387_3066_9612_2033_4851_8850 6 2.53E-05 0.001897323 4.41E-05 19767 hsa-mir-433 hsa05010 Alzheimer's disease 22926_5595_5594_823_9451_2932_801_4716_808_805 10 4.63E-05 0.003473349 7.89E-05 19768 hsa-mir-433 hsa04810 Regulation of actin cytoskeleton 9564_2249_1956_5595_5594_6654_56924_1729_8503_5295_5058 11 5.40E-05 0.00404969 9.00E-05 19769 hsa-mir-433 hsa04120 Ubiquitin mediated proteolysis 672_11059_4214_4193_10273_10401_7329_8554 8 0.000235261 0.017644546 0.000383577 19770 hsa-mir-433 hsa04270 Vascular smooth muscle contraction 5592_5595_5594_5566_801_808_805 7 0.000484413 0.036330988 0.000773 19771 hsa-mir-433 hsa04612 Antigen processing and presentation 3320_3326_1514_1385_6890_4800 6 0.000650752 0.048806426 0.001016801 19772 hsa-mir-433 hsa04360 Axon guidance 5998_5595_5594_56924_2770_5058_2932 7 0.000872009 0.065400663 0.001334707 19773 hsa-mir-433 hsa03410 Base excision repair 6996_3146_4350_142 4 0.000965101 0.072382564 0.001447651 19774 hsa-mir-433 hsa04730 Long-term depression 3480_5592_5595_5594_2770 5 0.001531602 0.114870136 0.002252356 19775 hsa-mir-433 hsa03420 Nucleotide excision repair 2965_902_1022_4331 4 0.001917889 0.143841651 0.002766186 19776 hsa-mir-433 hsa04070 Phosphatidylinositol signaling system 8503_5295_801_808_805 5 0.002031497 0.152362308 0.002874761 19777 hsa-mir-433 hsa04950 Maturity onset diabetes of the young 3172_3651_6927 3 0.003181075 0.238580594 0.004418159 19778 hsa-mir-433 hsa04530 Tight junction 1460_10207_6714_2770_208_207 6 0.005162492 0.387186915 0.007039762 19779 hsa-mir-433 hsa04670 Leukocyte transendothelial migration 9564_2770_1432_8503_5295 5 0.013417732 1 0.017970177 19780 hsa-mir-433 hsa04020 Calcium signaling pathway 1956_2064_5566_801_808_805 6 0.019091957 1 0.025120997 19781 hsa-mir-433 hsa05217 Basal cell carcinoma 7157_2736_2932 3 0.026152051 1 0.033817308 19782 hsa-mir-433 hsa04340 Hedgehog signaling pathway 5566_2736_2932 3 0.028544853 1 0.03628583 19783 hsa-mir-4330 hsa05210 Colorectal cancer 1499_207_4088_208_4089 5 9.32E-11 3.73E-09 3.73E-09 19784 hsa-mir-4330 hsa05200 Pathways in cancer 1499_207_4088_208_4089_1387 6 8.60E-10 3.44E-08 1.72E-08 19785 hsa-mir-4330 hsa05220 Chronic myeloid leukemia 207_4088_208_4089 4 1.45E-08 5.79E-07 1.86E-07 19786 hsa-mir-4330 hsa04520 Adherens junction 1499_4088_4089_1387 4 1.86E-08 7.43E-07 1.86E-07 19787 hsa-mir-4330 hsa05215 Prostate cancer 1499_207_208_1387 4 2.68E-08 1.07E-06 1.87E-07 19788 hsa-mir-4330 hsa05212 Pancreatic cancer 1499_207_208_1387 4 2.80E-08 1.12E-06 1.87E-07 19789 hsa-mir-4330 hsa04110 Cell cycle 4088_4089_7534_1387 4 8.67E-08 3.47E-06 4.95E-07 19790 hsa-mir-4330 hsa04310 Wnt signaling pathway 1499_4088_4089_1387 4 2.25E-07 9.01E-06 1.13E-06 19791 hsa-mir-4330 hsa05213 Endometrial cancer 1499_207_208 3 9.51E-07 3.80E-05 4.23E-06 19792 hsa-mir-4330 hsa05211 Renal cell carcinoma 207_208_1387 3 2.44E-06 9.75E-05 9.75E-06 19793 hsa-mir-4330 hsa04350 TGF-beta signaling pathway 4088_4089_1387 3 4.23E-06 0.000169161 1.54E-05 19794 hsa-mir-4330 hsa04530 Tight junction 1499_207_208 3 1.60E-05 0.000638057 5.32E-05 19795 hsa-mir-4330 hsa04630 Jak-STAT signaling pathway 207_208_1387 3 2.29E-05 0.000916121 7.05E-05 19796 hsa-mir-4330 hsa04510 Focal adhesion 1499_207_208 3 5.27E-05 0.002108685 0.00015062 19797 hsa-mir-4330 hsa04010 MAPK signaling pathway 207_208_6722 3 0.000120206 0.00480825 0.00032055 19798 hsa-mir-4330 hsa04150 mTOR signaling pathway 207_208 2 0.00017297 0.006918789 0.000420303 19799 hsa-mir-4330 hsa05223 Non-small cell lung cancer 207_208 2 0.00018607 0.00744282 0.000420303 19800 hsa-mir-4330 hsa05131 Shigellosis 1499_7534 2 0.000199644 0.007985754 0.000420303 19801 hsa-mir-4330 hsa05130 Pathogenic Escherichia coli infection 1499_7534 2 0.000199644 0.007985754 0.000420303 19802 hsa-mir-4330 hsa05221 Acute myeloid leukemia 207_208 2 0.000220889 0.008835551 0.000441778 19803 hsa-mir-4330 hsa05214 Glioma 207_208 2 0.000266557 0.010662285 0.000507728 19804 hsa-mir-4330 hsa04920 Adipocytokine signaling pathway 207_208 2 0.00028272 0.011308783 0.000514036 19805 hsa-mir-4330 hsa05218 Melanoma 207_208 2 0.000316451 0.012658022 0.000550349 19806 hsa-mir-4330 hsa04662 B cell receptor signaling pathway 207_208 2 0.000352053 0.0140821 0.000586754 19807 hsa-mir-4330 hsa04370 VEGF signaling pathway 207_208 2 0.000370554 0.014822148 0.000592886 19808 hsa-mir-4330 hsa04664 Fc epsilon RI signaling pathway 207_208 2 0.000389521 0.015580836 0.000599263 19809 hsa-mir-4330 hsa05222 Small cell lung cancer 207_208 2 0.000459568 0.018382721 0.000671484 19810 hsa-mir-4330 hsa04012 ErbB signaling pathway 207_208 2 0.000470039 0.018801552 0.000671484 19811 hsa-mir-4330 hsa04210 Apoptosis 207_208 2 0.000491328 0.019653109 0.000677693 19812 hsa-mir-4330 hsa04620 Toll-like receptor signaling pathway 207_208 2 0.000640957 0.025638286 0.00085461 19813 hsa-mir-4330 hsa04916 Melanogenesis 1499_1387 2 0.000665702 0.026628083 0.00085897 19814 hsa-mir-4330 hsa04660 T cell receptor signaling pathway 207_208 2 0.000742685 0.029707404 0.000928356 19815 hsa-mir-4330 hsa04910 Insulin signaling pathway 207_208 2 0.001156046 0.046241832 0.001401268 19816 hsa-mir-4330 hsa04062 Chemokine signaling pathway 207_208 2 0.002222759 0.088910373 0.002615011 19817 hsa-mir-4330 hsa05216 Thyroid cancer 1499 1 0.010942987 0.437719485 0.012506271 19818 hsa-mir-4330 hsa04330 Notch signaling pathway 1387 1 0.01745641 0.698256419 0.019396012 19819 hsa-mir-4330 hsa05217 Basal cell carcinoma 1499 1 0.020338728 0.813549139 0.021987815 19820 hsa-mir-4330 hsa04720 Long-term potentiation 1387 1 0.027510926 1 0.028958869 19821 hsa-mir-4330 hsa04670 Leukocyte transendothelial migration 1499 1 0.044178074 1 0.045310846 19822 hsa-mir-449a hsa05200 Pathways in cancer 3326_4149_2249_5914_1387_6256_1871_367_1017_2932_3265_6776_6777_5970_1870_7157_1869_3725_2353_2736_4088_4089_3065_1050_5925_207 26 4.75E-26 3.13E-24 3.13E-24 19823 hsa-mir-449a hsa05220 Chronic myeloid leukemia 1871_3265_6776_6777_5970_1870_7157_1869_4088_4089_3065_5925_207 13 1.53E-17 1.01E-15 5.06E-16 19824 hsa-mir-449a hsa05215 Prostate cancer 3326_1387_1871_367_1017_2932_3265_5970_1870_7157_1869_5925_207 13 1.00E-16 6.61E-15 1.51E-15 19825 hsa-mir-449a hsa05212 Pancreatic cancer 3326_1387_1871_367_1017_2932_3265_5970_1870_7157_1869_5925_207 13 1.14E-16 7.55E-15 1.51E-15 19826 hsa-mir-449a hsa04110 Cell cycle 1387_1871_1017_2932_1870_7157_1869_4088_4089_3065_5925_890_5934_5933 14 1.15E-16 7.56E-15 1.51E-15 19827 hsa-mir-449a hsa04010 MAPK signaling pathway 6722_8986_4149_2249_9261_6195_9252_3265_1432_5970_7157_22800_3725_6196_6197_2353_207 17 1.06E-15 6.99E-14 1.16E-14 19828 hsa-mir-449a hsa05222 Small cell lung cancer 4149_6256_1871_1017_5970_1870_7157_1869_5925_207 10 3.47E-12 2.29E-10 3.27E-11 19829 hsa-mir-449a hsa05223 Non-small cell lung cancer 6256_1871_3265_1870_7157_1869_5925_207 8 9.38E-11 6.19E-09 7.73E-10 19830 hsa-mir-449a hsa05218 Melanoma 2249_1871_3265_1870_7157_1869_5925_207 8 6.86E-10 4.53E-08 4.60E-09 19831 hsa-mir-449a hsa05219 Bladder cancer 1871_9252_3265_1870_7157_1869_5925 7 6.96E-10 4.60E-08 4.60E-09 19832 hsa-mir-449a hsa04350 TGF-beta signaling pathway 6667_1387_1874_1875_4088_4089_5934_5933 8 3.04E-09 2.01E-07 1.82E-08 19833 hsa-mir-449a hsa05221 Acute myeloid leukemia 5914_3265_6776_6777_5970_1050_207 7 5.99E-09 3.95E-07 3.29E-08 19834 hsa-mir-449a hsa05214 Glioma 1871_3265_1870_7157_1869_5925_207 7 1.11E-08 7.34E-07 5.64E-08 19835 hsa-mir-449a hsa04720 Long-term potentiation 1387_2902_2906_6195_3265_6196_6197 7 2.78E-08 1.84E-06 1.31E-07 19836 hsa-mir-449a hsa05210 Colorectal cancer 2932_7157_3725_2353_4088_4089_207 7 5.76E-08 3.80E-06 2.53E-07 19837 hsa-mir-449a hsa04660 T cell receptor signaling pathway 2932_3265_1432_5970_3725_2353_207 7 3.25E-07 2.15E-05 1.34E-06 19838 hsa-mir-449a hsa04662 B cell receptor signaling pathway 2932_3265_5970_3725_2353_207 6 6.64E-07 4.38E-05 2.58E-06 19839 hsa-mir-449a hsa05016 Huntington's disease 6667_1387_2902_6908_7157_3065_3064_9519 8 8.52E-07 5.62E-05 3.12E-06 19840 hsa-mir-449a hsa04012 ErbB signaling pathway 2932_3265_6776_6777_3725_207 6 1.50E-06 9.92E-05 5.22E-06 19841 hsa-mir-449a hsa04310 Wnt signaling pathway 1387_2932_7157_3725_4088_4089 6 3.17E-05 0.002092589 0.000104629 19842 hsa-mir-449a hsa04620 Toll-like receptor signaling pathway 1432_5970_3725_2353_207 5 5.56E-05 0.003671955 0.000174855 19843 hsa-mir-449a hsa05213 Endometrial cancer 2932_3265_7157_207 4 6.15E-05 0.004056516 0.00017637 19844 hsa-mir-449a hsa04150 mTOR signaling pathway 6195_6196_6197_207 4 6.15E-05 0.004056516 0.00017637 19845 hsa-mir-449a hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906_1432_7157 4 8.07E-05 0.005323298 0.000221804 19846 hsa-mir-449a hsa05211 Renal cell carcinoma 1387_3265_3725_207 4 0.000202557 0.013368785 0.000534751 19847 hsa-mir-449a hsa05216 Thyroid cancer 6256_3265_7157 3 0.000241897 0.015965172 0.000614045 19848 hsa-mir-449a hsa04370 VEGF signaling pathway 9261_3265_1432_207 4 0.000258884 0.017086364 0.000632828 19849 hsa-mir-449a hsa04630 Jak-STAT signaling pathway 1387_6776_6777_3977_207 5 0.000366279 0.024174421 0.000863372 19850 hsa-mir-449a hsa03022 Basal transcription factors 2963_6908_9519 3 0.000471342 0.031108567 0.001072709 19851 hsa-mir-449a hsa04330 Notch signaling pathway 1387_9612_3065 3 0.000909687 0.060039317 0.002001311 19852 hsa-mir-449a hsa04062 Chemokine signaling pathway 2932_3265_6777_5970_207 5 0.000960566 0.063397364 0.002045076 19853 hsa-mir-449a hsa05217 Basal cell carcinoma 2932_7157_2736 3 0.00140099 0.092465313 0.002889541 19854 hsa-mir-449a hsa04530 Tight junction 3265_22800_8573_207 4 0.002063441 0.136187084 0.004126881 19855 hsa-mir-449a hsa04920 Adipocytokine signaling pathway 6256_5970_207 3 0.002404991 0.158729377 0.004668511 19856 hsa-mir-449a hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_5970_3725 3 0.002817011 0.185922754 0.005312079 19857 hsa-mir-449a hsa04664 Fc epsilon RI signaling pathway 3265_1432_207 3 0.003765204 0.248503462 0.006902874 19858 hsa-mir-449a hsa04520 Adherens junction 1387_4088_4089 3 0.003895738 0.257118738 0.006949155 19859 hsa-mir-449a hsa04950 Maturity onset diabetes of the young 3651_6927 2 0.004350632 0.287141683 0.00755636 19860 hsa-mir-449a hsa05010 Alzheimer's disease 2902_2906_2932_351 4 0.00504129 0.332725168 0.008531415 19861 hsa-mir-449a hsa04210 Apoptosis 5970_7157_207 3 0.005195321 0.342891161 0.008572279 19862 hsa-mir-449a hsa04916 Melanogenesis 1387_2932_3265 3 0.007882601 0.520251683 0.012689065 19863 hsa-mir-449a hsa04510 Focal adhesion 2932_3265_3725_207 4 0.0084447 0.55735019 0.013270243 19864 hsa-mir-449a hsa04912 GnRH signaling pathway 3265_1432_3725 3 0.008713794 0.575110436 0.013374661 19865 hsa-mir-449a hsa04910 Insulin signaling pathway 2932_3265_207 3 0.016561251 1 0.024841876 19866 hsa-mir-449a hsa04080 Neuroactive ligand-receptor interaction 2902_2906_2908_7067 4 0.017298271 1 0.025370798 19867 hsa-mir-449a hsa04340 Hedgehog signaling pathway 2932_2736 2 0.021122743 1 0.030306544 19868 hsa-mir-449a hsa04115 p53 signaling pathway 1017_7157 2 0.029793675 1 0.041837926 19869 hsa-mir-449a hsa04730 Long-term depression 5592_3265 2 0.031355262 1 0.043113486 19870 hsa-mir-449a hsa04512 ECM-receptor interaction 6383_9672 2 0.042254413 1 0.056914108 19871 hsa-mir-449a hsa04612 Antigen processing and presentation 3326_4800 2 0.046771772 1 0.061738739 19872 hsa-mir-449b hsa05200 Pathways in cancer 3326_4149_2249_5914_1387_6256_1871_367_1017_2932_3265_6776_6777_5970_1870_7157_1869_3725_2353_2736_4088_4089_3065_1050_5925_207 26 4.75E-26 3.13E-24 3.13E-24 19873 hsa-mir-449b hsa05220 Chronic myeloid leukemia 1871_3265_6776_6777_5970_1870_7157_1869_4088_4089_3065_5925_207 13 1.53E-17 1.01E-15 5.06E-16 19874 hsa-mir-449b hsa05215 Prostate cancer 3326_1387_1871_367_1017_2932_3265_5970_1870_7157_1869_5925_207 13 1.00E-16 6.61E-15 1.51E-15 19875 hsa-mir-449b hsa05212 Pancreatic cancer 3326_1387_1871_367_1017_2932_3265_5970_1870_7157_1869_5925_207 13 1.14E-16 7.55E-15 1.51E-15 19876 hsa-mir-449b hsa04110 Cell cycle 1387_1871_1017_2932_1870_7157_1869_4088_4089_3065_5925_890_5934_5933 14 1.15E-16 7.56E-15 1.51E-15 19877 hsa-mir-449b hsa04010 MAPK signaling pathway 6722_8986_4149_2249_9261_6195_9252_3265_1432_5970_7157_22800_3725_6196_6197_2353_207 17 1.06E-15 6.99E-14 1.16E-14 19878 hsa-mir-449b hsa05222 Small cell lung cancer 4149_6256_1871_1017_5970_1870_7157_1869_5925_207 10 3.47E-12 2.29E-10 3.27E-11 19879 hsa-mir-449b hsa05223 Non-small cell lung cancer 6256_1871_3265_1870_7157_1869_5925_207 8 9.38E-11 6.19E-09 7.73E-10 19880 hsa-mir-449b hsa05218 Melanoma 2249_1871_3265_1870_7157_1869_5925_207 8 6.86E-10 4.53E-08 4.60E-09 19881 hsa-mir-449b hsa05219 Bladder cancer 1871_9252_3265_1870_7157_1869_5925 7 6.96E-10 4.60E-08 4.60E-09 19882 hsa-mir-449b hsa04350 TGF-beta signaling pathway 6667_1387_1874_1875_4088_4089_5934_5933 8 3.04E-09 2.01E-07 1.82E-08 19883 hsa-mir-449b hsa05221 Acute myeloid leukemia 5914_3265_6776_6777_5970_1050_207 7 5.99E-09 3.95E-07 3.29E-08 19884 hsa-mir-449b hsa05214 Glioma 1871_3265_1870_7157_1869_5925_207 7 1.11E-08 7.34E-07 5.64E-08 19885 hsa-mir-449b hsa04720 Long-term potentiation 1387_2902_2906_6195_3265_6196_6197 7 2.78E-08 1.84E-06 1.31E-07 19886 hsa-mir-449b hsa05210 Colorectal cancer 2932_7157_3725_2353_4088_4089_207 7 5.76E-08 3.80E-06 2.53E-07 19887 hsa-mir-449b hsa04660 T cell receptor signaling pathway 2932_3265_1432_5970_3725_2353_207 7 3.25E-07 2.15E-05 1.34E-06 19888 hsa-mir-449b hsa04662 B cell receptor signaling pathway 2932_3265_5970_3725_2353_207 6 6.64E-07 4.38E-05 2.58E-06 19889 hsa-mir-449b hsa05016 Huntington's disease 6667_1387_2902_6908_7157_3065_3064_9519 8 8.52E-07 5.62E-05 3.12E-06 19890 hsa-mir-449b hsa04012 ErbB signaling pathway 2932_3265_6776_6777_3725_207 6 1.50E-06 9.92E-05 5.22E-06 19891 hsa-mir-449b hsa04310 Wnt signaling pathway 1387_2932_7157_3725_4088_4089 6 3.17E-05 0.002092589 0.000104629 19892 hsa-mir-449b hsa04620 Toll-like receptor signaling pathway 1432_5970_3725_2353_207 5 5.56E-05 0.003671955 0.000174855 19893 hsa-mir-449b hsa05213 Endometrial cancer 2932_3265_7157_207 4 6.15E-05 0.004056516 0.00017637 19894 hsa-mir-449b hsa04150 mTOR signaling pathway 6195_6196_6197_207 4 6.15E-05 0.004056516 0.00017637 19895 hsa-mir-449b hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906_1432_7157 4 8.07E-05 0.005323298 0.000221804 19896 hsa-mir-449b hsa05211 Renal cell carcinoma 1387_3265_3725_207 4 0.000202557 0.013368785 0.000534751 19897 hsa-mir-449b hsa05216 Thyroid cancer 6256_3265_7157 3 0.000241897 0.015965172 0.000614045 19898 hsa-mir-449b hsa04370 VEGF signaling pathway 9261_3265_1432_207 4 0.000258884 0.017086364 0.000632828 19899 hsa-mir-449b hsa04630 Jak-STAT signaling pathway 1387_6776_6777_3977_207 5 0.000366279 0.024174421 0.000863372 19900 hsa-mir-449b hsa03022 Basal transcription factors 2963_6908_9519 3 0.000471342 0.031108567 0.001072709 19901 hsa-mir-449b hsa04330 Notch signaling pathway 1387_9612_3065 3 0.000909687 0.060039317 0.002001311 19902 hsa-mir-449b hsa04062 Chemokine signaling pathway 2932_3265_6777_5970_207 5 0.000960566 0.063397364 0.002045076 19903 hsa-mir-449b hsa05217 Basal cell carcinoma 2932_7157_2736 3 0.00140099 0.092465313 0.002889541 19904 hsa-mir-449b hsa04530 Tight junction 3265_22800_8573_207 4 0.002063441 0.136187084 0.004126881 19905 hsa-mir-449b hsa04920 Adipocytokine signaling pathway 6256_5970_207 3 0.002404991 0.158729377 0.004668511 19906 hsa-mir-449b hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_5970_3725 3 0.002817011 0.185922754 0.005312079 19907 hsa-mir-449b hsa04664 Fc epsilon RI signaling pathway 3265_1432_207 3 0.003765204 0.248503462 0.006902874 19908 hsa-mir-449b hsa04520 Adherens junction 1387_4088_4089 3 0.003895738 0.257118738 0.006949155 19909 hsa-mir-449b hsa04950 Maturity onset diabetes of the young 3651_6927 2 0.004350632 0.287141683 0.00755636 19910 hsa-mir-449b hsa05010 Alzheimer's disease 2902_2906_2932_351 4 0.00504129 0.332725168 0.008531415 19911 hsa-mir-449b hsa04210 Apoptosis 5970_7157_207 3 0.005195321 0.342891161 0.008572279 19912 hsa-mir-449b hsa04916 Melanogenesis 1387_2932_3265 3 0.007882601 0.520251683 0.012689065 19913 hsa-mir-449b hsa04510 Focal adhesion 2932_3265_3725_207 4 0.0084447 0.55735019 0.013270243 19914 hsa-mir-449b hsa04912 GnRH signaling pathway 3265_1432_3725 3 0.008713794 0.575110436 0.013374661 19915 hsa-mir-449b hsa04910 Insulin signaling pathway 2932_3265_207 3 0.016561251 1 0.024841876 19916 hsa-mir-449b hsa04080 Neuroactive ligand-receptor interaction 2902_2906_2908_7067 4 0.017298271 1 0.025370798 19917 hsa-mir-449b hsa04340 Hedgehog signaling pathway 2932_2736 2 0.021122743 1 0.030306544 19918 hsa-mir-449b hsa04115 p53 signaling pathway 1017_7157 2 0.029793675 1 0.041837926 19919 hsa-mir-449b hsa04730 Long-term depression 5592_3265 2 0.031355262 1 0.043113486 19920 hsa-mir-449b hsa04512 ECM-receptor interaction 6383_9672 2 0.042254413 1 0.056914108 19921 hsa-mir-449b hsa04612 Antigen processing and presentation 3326_4800 2 0.046771772 1 0.061738739 19922 hsa-mir-449c hsa05200 Pathways in cancer 3326_4149_2249_5914_1387_6256_1871_367_1017_2932_3265_6776_6777_5970_1870_7157_1869_3725_2353_2736_4088_4089_3065_1050_5925_207 26 4.75E-26 3.13E-24 3.13E-24 19923 hsa-mir-449c hsa05220 Chronic myeloid leukemia 1871_3265_6776_6777_5970_1870_7157_1869_4088_4089_3065_5925_207 13 1.53E-17 1.01E-15 5.06E-16 19924 hsa-mir-449c hsa05215 Prostate cancer 3326_1387_1871_367_1017_2932_3265_5970_1870_7157_1869_5925_207 13 1.00E-16 6.61E-15 1.51E-15 19925 hsa-mir-449c hsa05212 Pancreatic cancer 3326_1387_1871_367_1017_2932_3265_5970_1870_7157_1869_5925_207 13 1.14E-16 7.55E-15 1.51E-15 19926 hsa-mir-449c hsa04110 Cell cycle 1387_1871_1017_2932_1870_7157_1869_4088_4089_3065_5925_890_5934_5933 14 1.15E-16 7.56E-15 1.51E-15 19927 hsa-mir-449c hsa04010 MAPK signaling pathway 6722_8986_4149_2249_9261_6195_9252_3265_1432_5970_7157_22800_3725_6196_6197_2353_207 17 1.06E-15 6.99E-14 1.16E-14 19928 hsa-mir-449c hsa05222 Small cell lung cancer 4149_6256_1871_1017_5970_1870_7157_1869_5925_207 10 3.47E-12 2.29E-10 3.27E-11 19929 hsa-mir-449c hsa05223 Non-small cell lung cancer 6256_1871_3265_1870_7157_1869_5925_207 8 9.38E-11 6.19E-09 7.73E-10 19930 hsa-mir-449c hsa05218 Melanoma 2249_1871_3265_1870_7157_1869_5925_207 8 6.86E-10 4.53E-08 4.60E-09 19931 hsa-mir-449c hsa05219 Bladder cancer 1871_9252_3265_1870_7157_1869_5925 7 6.96E-10 4.60E-08 4.60E-09 19932 hsa-mir-449c hsa04350 TGF-beta signaling pathway 6667_1387_1874_1875_4088_4089_5934_5933 8 3.04E-09 2.01E-07 1.82E-08 19933 hsa-mir-449c hsa05221 Acute myeloid leukemia 5914_3265_6776_6777_5970_1050_207 7 5.99E-09 3.95E-07 3.29E-08 19934 hsa-mir-449c hsa05214 Glioma 1871_3265_1870_7157_1869_5925_207 7 1.11E-08 7.34E-07 5.64E-08 19935 hsa-mir-449c hsa04720 Long-term potentiation 1387_2902_2906_6195_3265_6196_6197 7 2.78E-08 1.84E-06 1.31E-07 19936 hsa-mir-449c hsa05210 Colorectal cancer 2932_7157_3725_2353_4088_4089_207 7 5.76E-08 3.80E-06 2.53E-07 19937 hsa-mir-449c hsa04660 T cell receptor signaling pathway 2932_3265_1432_5970_3725_2353_207 7 3.25E-07 2.15E-05 1.34E-06 19938 hsa-mir-449c hsa04662 B cell receptor signaling pathway 2932_3265_5970_3725_2353_207 6 6.64E-07 4.38E-05 2.58E-06 19939 hsa-mir-449c hsa05016 Huntington's disease 6667_1387_2902_6908_7157_3065_3064_9519 8 8.52E-07 5.62E-05 3.12E-06 19940 hsa-mir-449c hsa04012 ErbB signaling pathway 2932_3265_6776_6777_3725_207 6 1.50E-06 9.92E-05 5.22E-06 19941 hsa-mir-449c hsa04310 Wnt signaling pathway 1387_2932_7157_3725_4088_4089 6 3.17E-05 0.002092589 0.000104629 19942 hsa-mir-449c hsa04620 Toll-like receptor signaling pathway 1432_5970_3725_2353_207 5 5.56E-05 0.003671955 0.000174855 19943 hsa-mir-449c hsa05213 Endometrial cancer 2932_3265_7157_207 4 6.15E-05 0.004056516 0.00017637 19944 hsa-mir-449c hsa04150 mTOR signaling pathway 6195_6196_6197_207 4 6.15E-05 0.004056516 0.00017637 19945 hsa-mir-449c hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906_1432_7157 4 8.07E-05 0.005323298 0.000221804 19946 hsa-mir-449c hsa05211 Renal cell carcinoma 1387_3265_3725_207 4 0.000202557 0.013368785 0.000534751 19947 hsa-mir-449c hsa05216 Thyroid cancer 6256_3265_7157 3 0.000241897 0.015965172 0.000614045 19948 hsa-mir-449c hsa04370 VEGF signaling pathway 9261_3265_1432_207 4 0.000258884 0.017086364 0.000632828 19949 hsa-mir-449c hsa04630 Jak-STAT signaling pathway 1387_6776_6777_3977_207 5 0.000366279 0.024174421 0.000863372 19950 hsa-mir-449c hsa03022 Basal transcription factors 2963_6908_9519 3 0.000471342 0.031108567 0.001072709 19951 hsa-mir-449c hsa04330 Notch signaling pathway 1387_9612_3065 3 0.000909687 0.060039317 0.002001311 19952 hsa-mir-449c hsa04062 Chemokine signaling pathway 2932_3265_6777_5970_207 5 0.000960566 0.063397364 0.002045076 19953 hsa-mir-449c hsa05217 Basal cell carcinoma 2932_7157_2736 3 0.00140099 0.092465313 0.002889541 19954 hsa-mir-449c hsa04530 Tight junction 3265_22800_8573_207 4 0.002063441 0.136187084 0.004126881 19955 hsa-mir-449c hsa04920 Adipocytokine signaling pathway 6256_5970_207 3 0.002404991 0.158729377 0.004668511 19956 hsa-mir-449c hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_5970_3725 3 0.002817011 0.185922754 0.005312079 19957 hsa-mir-449c hsa04664 Fc epsilon RI signaling pathway 3265_1432_207 3 0.003765204 0.248503462 0.006902874 19958 hsa-mir-449c hsa04520 Adherens junction 1387_4088_4089 3 0.003895738 0.257118738 0.006949155 19959 hsa-mir-449c hsa04950 Maturity onset diabetes of the young 3651_6927 2 0.004350632 0.287141683 0.00755636 19960 hsa-mir-449c hsa05010 Alzheimer's disease 2902_2906_2932_351 4 0.00504129 0.332725168 0.008531415 19961 hsa-mir-449c hsa04210 Apoptosis 5970_7157_207 3 0.005195321 0.342891161 0.008572279 19962 hsa-mir-449c hsa04916 Melanogenesis 1387_2932_3265 3 0.007882601 0.520251683 0.012689065 19963 hsa-mir-449c hsa04510 Focal adhesion 2932_3265_3725_207 4 0.0084447 0.55735019 0.013270243 19964 hsa-mir-449c hsa04912 GnRH signaling pathway 3265_1432_3725 3 0.008713794 0.575110436 0.013374661 19965 hsa-mir-449c hsa04910 Insulin signaling pathway 2932_3265_207 3 0.016561251 1 0.024841876 19966 hsa-mir-449c hsa04080 Neuroactive ligand-receptor interaction 2902_2906_2908_7067 4 0.017298271 1 0.025370798 19967 hsa-mir-449c hsa04340 Hedgehog signaling pathway 2932_2736 2 0.021122743 1 0.030306544 19968 hsa-mir-449c hsa04115 p53 signaling pathway 1017_7157 2 0.029793675 1 0.041837926 19969 hsa-mir-449c hsa04730 Long-term depression 5592_3265 2 0.031355262 1 0.043113486 19970 hsa-mir-449c hsa04512 ECM-receptor interaction 6383_9672 2 0.042254413 1 0.056914108 19971 hsa-mir-449c hsa04612 Antigen processing and presentation 3326_4800 2 0.046771772 1 0.061738739 19972 hsa-mir-450a-1 hsa05215 Prostate cancer 5970_2033_4790 3 0.000150419 0.003760472 0.001913416 19973 hsa-mir-450a-1 hsa05212 Pancreatic cancer 5970_2033_4790 3 0.000155369 0.003884227 0.001913416 19974 hsa-mir-450a-1 hsa04620 Toll-like receptor signaling pathway 6772_5970_4790 3 0.00022961 0.005740248 0.001913416 19975 hsa-mir-450a-1 hsa05200 Pathways in cancer 6772_5970_2033_4790 4 0.000547455 0.013686371 0.003421593 19976 hsa-mir-450a-1 hsa04062 Chemokine signaling pathway 6772_5970_4790 3 0.001411016 0.035275396 0.005895134 19977 hsa-mir-450a-1 hsa04330 Notch signaling pathway 2033_8850 2 0.001414832 0.035370806 0.005895134 19978 hsa-mir-450a-1 hsa05221 Acute myeloid leukemia 5970_4790 2 0.002183021 0.054575524 0.007796503 19979 hsa-mir-450a-1 hsa04920 Adipocytokine signaling pathway 5970_4790 2 0.002782761 0.069569022 0.007843536 19980 hsa-mir-450a-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_4790 2 0.003108453 0.077711318 0.007843536 19981 hsa-mir-450a-1 hsa05220 Chronic myeloid leukemia 5970_4790 2 0.003451156 0.086278895 0.007843536 19982 hsa-mir-450a-1 hsa04662 B cell receptor signaling pathway 5970_4790 2 0.003451156 0.086278895 0.007843536 19983 hsa-mir-450a-1 hsa05222 Small cell lung cancer 5970_4790 2 0.004480072 0.11200181 0.00854001 19984 hsa-mir-450a-1 hsa04350 TGF-beta signaling pathway 2033_659 2 0.004579825 0.114495628 0.00854001 19985 hsa-mir-450a-1 hsa04210 Apoptosis 5970_4790 2 0.004782406 0.119560138 0.00854001 19986 hsa-mir-450a-1 hsa04660 T cell receptor signaling pathway 5970_4790 2 0.007152607 0.178815166 0.011921011 19987 hsa-mir-450a-1 hsa04630 Jak-STAT signaling pathway 6772_2033 2 0.013651484 0.341287103 0.021330444 19988 hsa-mir-450a-1 hsa04010 MAPK signaling pathway 5970_4790 2 0.038666791 0.966669773 0.056862928 19989 hsa-mir-450a-2 hsa05215 Prostate cancer 5970_2033_4790 3 0.000150419 0.003760472 0.001913416 19990 hsa-mir-450a-2 hsa05212 Pancreatic cancer 5970_2033_4790 3 0.000155369 0.003884227 0.001913416 19991 hsa-mir-450a-2 hsa04620 Toll-like receptor signaling pathway 6772_5970_4790 3 0.00022961 0.005740248 0.001913416 19992 hsa-mir-450a-2 hsa05200 Pathways in cancer 6772_5970_2033_4790 4 0.000547455 0.013686371 0.003421593 19993 hsa-mir-450a-2 hsa04062 Chemokine signaling pathway 6772_5970_4790 3 0.001411016 0.035275396 0.005895134 19994 hsa-mir-450a-2 hsa04330 Notch signaling pathway 2033_8850 2 0.001414832 0.035370806 0.005895134 19995 hsa-mir-450a-2 hsa05221 Acute myeloid leukemia 5970_4790 2 0.002183021 0.054575524 0.007796503 19996 hsa-mir-450a-2 hsa04920 Adipocytokine signaling pathway 5970_4790 2 0.002782761 0.069569022 0.007843536 19997 hsa-mir-450a-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_4790 2 0.003108453 0.077711318 0.007843536 19998 hsa-mir-450a-2 hsa05220 Chronic myeloid leukemia 5970_4790 2 0.003451156 0.086278895 0.007843536 19999 hsa-mir-450a-2 hsa04662 B cell receptor signaling pathway 5970_4790 2 0.003451156 0.086278895 0.007843536 20000 hsa-mir-450a-2 hsa05222 Small cell lung cancer 5970_4790 2 0.004480072 0.11200181 0.00854001 20001 hsa-mir-450a-2 hsa04350 TGF-beta signaling pathway 2033_659 2 0.004579825 0.114495628 0.00854001 20002 hsa-mir-450a-2 hsa04210 Apoptosis 5970_4790 2 0.004782406 0.119560138 0.00854001 20003 hsa-mir-450a-2 hsa04660 T cell receptor signaling pathway 5970_4790 2 0.007152607 0.178815166 0.011921011 20004 hsa-mir-450a-2 hsa04630 Jak-STAT signaling pathway 6772_2033 2 0.013651484 0.341287103 0.021330444 20005 hsa-mir-450a-2 hsa04010 MAPK signaling pathway 5970_4790 2 0.038666791 0.966669773 0.056862928 20006 hsa-mir-450b hsa05200 Pathways in cancer 4089_6772_5970_836_2033_4087_4790 7 2.78E-06 0.000105788 0.000105788 20007 hsa-mir-450b hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_836_1432_4790 4 1.11E-05 0.000420849 0.000152031 20008 hsa-mir-450b hsa04010 MAPK signaling pathway 5970_836_1432_4790_6722_5598 6 1.20E-05 0.000456094 0.000152031 20009 hsa-mir-450b hsa04350 TGF-beta signaling pathway 4089_2033_659_4087 4 2.38E-05 0.000905558 0.000197318 20010 hsa-mir-450b hsa04210 Apoptosis 5970_836_4790_840 4 2.60E-05 0.000986592 0.000197318 20011 hsa-mir-450b hsa04620 Toll-like receptor signaling pathway 6772_5970_1432_4790 4 4.34E-05 0.001649301 0.000274883 20012 hsa-mir-450b hsa05220 Chronic myeloid leukemia 4089_5970_4790 3 0.000400286 0.015210874 0.002172982 20013 hsa-mir-450b hsa04520 Adherens junction 4089_2033_4087 3 0.000480333 0.01825264 0.002241704 20014 hsa-mir-450b hsa05210 Colorectal cancer 4089_836_4087 3 0.000551261 0.020947914 0.002241704 20015 hsa-mir-450b hsa05215 Prostate cancer 5970_2033_4790 3 0.000628565 0.023885483 0.002241704 20016 hsa-mir-450b hsa05212 Pancreatic cancer 5970_2033_4790 3 0.000648914 0.024658743 0.002241704 20017 hsa-mir-450b hsa04660 T cell receptor signaling pathway 5970_1432_4790 3 0.001177509 0.044745329 0.003728777 20018 hsa-mir-450b hsa04110 Cell cycle 4089_2033_4087 3 0.00146768 0.055771826 0.00429014 20019 hsa-mir-450b hsa04310 Wnt signaling pathway 4089_2033_4087 3 0.002899977 0.110199108 0.007871365 20020 hsa-mir-450b hsa04330 Notch signaling pathway 8850_2033 2 0.00365932 0.139054153 0.009270277 20021 hsa-mir-450b hsa05010 Alzheimer's disease 836_1020_840 3 0.004410039 0.167581486 0.010473843 20022 hsa-mir-450b hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432 2 0.005089754 0.19341064 0.011230086 20023 hsa-mir-450b hsa04062 Chemokine signaling pathway 6772_5970_4790 3 0.005585617 0.212253459 0.011230086 20024 hsa-mir-450b hsa05221 Acute myeloid leukemia 5970_4790 2 0.005615043 0.213371643 0.011230086 20025 hsa-mir-450b hsa04920 Adipocytokine signaling pathway 5970_4790 2 0.007131394 0.270992983 0.013549649 20026 hsa-mir-450b hsa04662 B cell receptor signaling pathway 5970_4790 2 0.008811895 0.334851996 0.015945333 20027 hsa-mir-450b hsa05222 Small cell lung cancer 5970_4790 2 0.011381588 0.432500349 0.019659107 20028 hsa-mir-450b hsa04912 GnRH signaling pathway 1432_5598 2 0.01737463 0.660235926 0.02870591 20029 hsa-mir-450b hsa04630 Jak-STAT signaling pathway 6772_2033 2 0.033612694 1 0.0532201 20030 hsa-mir-450b hsa05016 Huntington's disease 836_2033 2 0.047446003 1 0.072117925 20031 hsa-mir-451 hsa05200 Pathways in cancer 5371_5595_5594_5914_6256_595_4286_367_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_4088_4089_3066_3065_5925_2034_2033_4846_836 29 9.48E-32 5.88E-30 5.88E-30 20032 hsa-mir-451 hsa05220 Chronic myeloid leukemia 5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464 15 1.32E-21 8.19E-20 4.10E-20 20033 hsa-mir-451 hsa04110 Cell cycle 5591_595_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933 14 2.64E-17 1.64E-15 5.46E-16 20034 hsa-mir-451 hsa05215 Prostate cancer 5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033 11 4.27E-14 2.65E-12 5.93E-13 20035 hsa-mir-451 hsa05212 Pancreatic cancer 5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033 11 4.78E-14 2.97E-12 5.93E-13 20036 hsa-mir-451 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5925 9 1.21E-13 7.53E-12 1.25E-12 20037 hsa-mir-451 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925 9 9.13E-13 5.66E-11 7.76E-12 20038 hsa-mir-451 hsa05210 Colorectal cancer 5595_5594_595_7157_4087_4609_3725_4088_4089_836 10 1.00E-12 6.21E-11 7.76E-12 20039 hsa-mir-451 hsa05222 Small cell lung cancer 6256_595_5970_1870_1871_7157_4609_1869_5925_4846 10 1.24E-12 7.70E-11 8.56E-12 20040 hsa-mir-451 hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_6464 9 4.13E-12 2.56E-10 2.56E-11 20041 hsa-mir-451 hsa05218 Melanoma 5595_5594_595_4286_1870_1871_7157_1869_5925 9 8.53E-12 5.29E-10 4.81E-11 20042 hsa-mir-451 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_5970_4609 8 7.86E-11 4.88E-09 4.06E-10 20043 hsa-mir-451 hsa05211 Renal cell carcinoma 5595_5594_3091_7428_2113_3725_2034_2033 8 3.37E-10 2.09E-08 1.61E-09 20044 hsa-mir-451 hsa04350 TGF-beta signaling pathway 5595_5594_4087_4609_4088_4089_2033_5933 8 1.35E-09 8.40E-08 6.00E-09 20045 hsa-mir-451 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 2.07E-09 1.29E-07 8.57E-09 20046 hsa-mir-451 hsa04010 MAPK signaling pathway 5595_5594_4208_3312_1386_5970_7157_4609_3725_4763_836 11 4.02E-09 2.49E-07 1.56E-08 20047 hsa-mir-451 hsa04310 Wnt signaling pathway 595_7157_4087_4609_3725_1457_4088_4089_2033 9 4.67E-09 2.90E-07 1.70E-08 20048 hsa-mir-451 hsa04520 Adherens junction 5595_5594_4087_1457_4088_4089_2033 7 2.08E-08 1.29E-06 7.18E-08 20049 hsa-mir-451 hsa05016 Huntington's disease 6874_2902_7157_3066_3065_3064_2033_836 8 3.92E-07 2.43E-05 1.28E-06 20050 hsa-mir-451 hsa05213 Endometrial cancer 5595_5594_595_7157_4609 5 1.55E-06 9.58E-05 4.79E-06 20051 hsa-mir-451 hsa04012 ErbB signaling pathway 5595_5594_4609_3725_6464 5 1.65E-05 0.001023785 4.88E-05 20052 hsa-mir-451 hsa04330 Notch signaling pathway 9612_3066_3065_2033 4 2.85E-05 0.001769647 8.04E-05 20053 hsa-mir-451 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_7157_4846_836 4 5.44E-05 0.003372571 0.000146634 20054 hsa-mir-451 hsa04720 Long-term potentiation 5595_5594_2902_2033 4 0.000159466 0.009886891 0.000395476 20055 hsa-mir-451 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725 4 0.000159466 0.009886891 0.000395476 20056 hsa-mir-451 hsa05010 Alzheimer's disease 5595_5594_2902_4846_836 5 0.000414675 0.025709879 0.000988841 20057 hsa-mir-451 hsa04620 Toll-like receptor signaling pathway 5595_5594_5970_3725 4 0.000491299 0.030460516 0.001128167 20058 hsa-mir-451 hsa04916 Melanogenesis 5595_5594_4286_2033 4 0.000527247 0.032689323 0.001167476 20059 hsa-mir-451 hsa04660 T cell receptor signaling pathway 5595_5594_5970_3725 4 0.000646299 0.040070533 0.001381743 20060 hsa-mir-451 hsa04510 Focal adhesion 5595_5594_595_3725_6464 5 0.000809526 0.050190623 0.001673021 20061 hsa-mir-451 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.000896844 0.055604329 0.001793688 20062 hsa-mir-451 hsa04910 Insulin signaling pathway 6720_5595_5594_6464 4 0.001461722 0.090626737 0.002746265 20063 hsa-mir-451 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_6464 4 0.001461722 0.090626737 0.002746265 20064 hsa-mir-451 hsa04115 p53 signaling pathway 595_7157_836 3 0.001954848 0.12120056 0.003564722 20065 hsa-mir-451 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_3725_836 3 0.002114296 0.131086374 0.003641288 20066 hsa-mir-451 hsa04730 Long-term depression 5595_5594_4846 3 0.002114296 0.131086374 0.003641288 20067 hsa-mir-451 hsa04370 VEGF signaling pathway 5595_5594_4846 3 0.002640332 0.163700578 0.00442434 20068 hsa-mir-451 hsa04612 Antigen processing and presentation 4800_4801_3312 3 0.003918069 0.242920304 0.006228726 20069 hsa-mir-451 hsa04210 Apoptosis 5970_7157_836 3 0.003918069 0.242920304 0.006228726 20070 hsa-mir-451 hsa04062 Chemokine signaling pathway 5595_5594_5970_6464 4 0.004750734 0.294545482 0.007363637 20071 hsa-mir-451 hsa04912 GnRH signaling pathway 5595_5594_3725 3 0.006604658 0.409488823 0.009987532 20072 hsa-mir-451 hsa04930 Type II diabetes mellitus 5595_5594 2 0.011338112 0.702962923 0.016737212 20073 hsa-mir-451 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428 3 0.012893289 0.799383912 0.018590324 20074 hsa-mir-451 hsa04630 Jak-STAT signaling pathway 595_4609_2033 3 0.017117918 1 0.024120702 20075 hsa-mir-451 hsa04920 Adipocytokine signaling pathway 6256_5970 2 0.023439873 1 0.032294935 20076 hsa-mir-451 hsa04664 Fc epsilon RI signaling pathway 5595_5594 2 0.03152989 1 0.042496808 20077 hsa-mir-451 hsa04540 Gap junction 5595_5594 2 0.042139387 1 0.055588127 20078 hsa-mir-451 hsa04710 Circadian rhythm - mammal 8863 1 0.046861183 1 0.060529028 20079 hsa-mir-452 hsa05200 Pathways in cancer 3725_5467_1499_5914_595_1017_4193_6934_7704_6502_3091_4089_3066_3065_1050_5925_5468_25_405_9063_1487_1488_1870_1871_2113_861_862_10401_207_4286_5595_5594_1387_6256_836_367_6774_6776_6777_6772_5970_7157_7849_1869_4088_2034_2033_4846_51176_5371_5604_7428_4087_4609_2956 55 1.20E-39 9.08E-38 9.08E-38 20080 hsa-mir-452 hsa05220 Chronic myeloid leukemia 595_4193_4089_3066_3065_5925_25_1487_1488_1870_1871_861_207_5595_5594_6776_6777_5970_7157_1869_4088_5604_4609_6464 24 1.27E-23 9.64E-22 4.82E-22 20081 hsa-mir-452 hsa05221 Acute myeloid leukemia 5467_5914_595_6934_7704_1050_861_862_207_5595_5594_6774_6776_6777_5970_51176_5371_5604_4609 19 5.22E-19 3.97E-17 1.32E-17 20082 hsa-mir-452 hsa04110 Cell cycle 595_1017_4193_6502_5111_4089_3066_3065_5925_25_1870_1871_5934_5933_5591_1387_7157_1869_4088_2033_4087 21 2.86E-16 2.18E-14 4.51E-15 20083 hsa-mir-452 hsa05215 Prostate cancer 1499_595_1017_4193_6934_5925_1870_1871_207_5595_5594_1387_367_5970_7157_1869_2033_51176_5604 19 2.97E-16 2.26E-14 4.51E-15 20084 hsa-mir-452 hsa05212 Pancreatic cancer 1499_595_1017_4193_6934_5925_1870_1871_207_5595_5594_1387_367_5970_7157_1869_2033_51176_5604 19 3.56E-16 2.70E-14 4.51E-15 20085 hsa-mir-452 hsa04350 TGF-beta signaling pathway 4086_4089_6667_3397_3399_3398_1875_5934_5933_5595_5594_1387_4088_2033_4087_4609_4092 17 4.65E-14 3.54E-12 5.05E-13 20086 hsa-mir-452 hsa04330 Notch signaling pathway 1840_3066_3065_9794_22938_1487_1488_388585_1387_2033_8850_9612_2648_4851 14 5.84E-14 4.44E-12 5.54E-13 20087 hsa-mir-452 hsa05216 Thyroid cancer 1499_595_6934_5468_5595_5594_6256_7157_7849_51176_5604_4609 12 1.52E-13 1.16E-11 1.29E-12 20088 hsa-mir-452 hsa05214 Glioma 595_4193_5925_1870_1871_207_5595_5594_7157_1869_808_801_805_5604_6464 15 1.78E-13 1.35E-11 1.35E-12 20089 hsa-mir-452 hsa05210 Colorectal cancer 3725_1499_595_6934_4089_207_5595_5594_836_7157_4088_51176_5604_4087_4609_2956 16 3.69E-13 2.80E-11 2.55E-12 20090 hsa-mir-452 hsa04310 Wnt signaling pathway 3725_5467_1499_595_6934_4089_4772_4773_1487_1488_1387_7157_1457_4088_2033_51176_4087_4609_5527 19 1.95E-12 1.48E-10 1.23E-11 20091 hsa-mir-452 hsa05219 Bladder cancer 595_9252_4193_5925_1870_1871_5595_5594_7157_1869_5604_4609 12 5.65E-12 4.30E-10 3.31E-11 20092 hsa-mir-452 hsa05222 Small cell lung cancer 595_1017_6502_5925_9063_1870_1871_10401_207_6256_5970_7157_1869_4846_4609 15 6.19E-12 4.71E-10 3.36E-11 20093 hsa-mir-452 hsa05213 Endometrial cancer 1499_595_6934_2309_207_5595_5594_7157_51176_5604_4609_2002 12 4.80E-11 3.65E-09 2.43E-10 20094 hsa-mir-452 hsa05223 Non-small cell lung cancer 595_5925_2309_1870_1871_207_5595_5594_6256_7157_1869_5604 12 7.03E-11 5.34E-09 3.34E-10 20095 hsa-mir-452 hsa04010 MAPK signaling pathway 6722_3725_9252_7867_4773_1432_4763_207_5595_5594_1386_836_3312_5970_3164_7157_9261_5604_4208_5608_4609_2002 22 1.02E-10 7.74E-09 4.55E-10 20096 hsa-mir-452 hsa05218 Melanoma 595_4193_5925_1870_1871_207_4286_5595_5594_7157_1869_5604 12 1.13E-09 8.57E-08 4.76E-09 20097 hsa-mir-452 hsa05211 Renal cell carcinoma 3725_3091_405_2113_207_5595_5594_1387_2034_2033_5604_7428 12 1.30E-09 9.87E-08 5.20E-09 20098 hsa-mir-452 hsa05322 Systemic lupus erythematosus 3021_3020_8294_8370_121504_8361_8360_8363_8362_8365_8364_8367_8366_8368_8359 15 4.19E-09 3.18E-07 1.59E-08 20099 hsa-mir-452 hsa04520 Adherens junction 1499_6934_4089_5595_5594_1387_1457_4088_2033_51176_4087 11 3.82E-08 2.91E-06 1.38E-07 20100 hsa-mir-452 hsa04916 Melanogenesis 1499_6934_4286_5595_5594_1387_2033_808_801_805_51176_5604 12 5.39E-08 4.10E-06 1.86E-07 20101 hsa-mir-452 hsa04630 Jak-STAT signaling pathway 595_9063_3595_3594_10401_207_1387_6778_6774_6776_6777_6772_2033_4609 14 7.19E-08 5.47E-06 2.38E-07 20102 hsa-mir-452 hsa04012 ErbB signaling pathway 3725_25_207_5595_5594_6776_6777_5604_4609_6464_2002 11 8.33E-08 6.33E-06 2.64E-07 20103 hsa-mir-452 hsa04370 VEGF signaling pathway 7867_4772_4773_1432_207_5595_5594_4846_9261_5604 10 2.59E-07 1.97E-05 7.86E-07 20104 hsa-mir-452 hsa04620 Toll-like receptor signaling pathway 3725_3665_3661_1432_207_5595_5594_6772_5970_5604_5608 11 3.61E-07 2.75E-05 1.06E-06 20105 hsa-mir-452 hsa04912 GnRH signaling pathway 3725_5580_1432_5595_5594_808_801_805_5604_5608_2002 11 6.10E-07 4.64E-05 1.72E-06 20106 hsa-mir-452 hsa04720 Long-term potentiation 2902_5595_5594_1387_2033_808_801_805_5604 9 1.88E-06 0.000142856 5.10E-06 20107 hsa-mir-452 hsa05016 Huntington's disease 10891_3066_3065_3064_5468_2902_6667_1387_836_7157_2033_6874_6908 13 3.48E-06 0.000264478 9.12E-06 20108 hsa-mir-452 hsa04910 Insulin signaling pathway 6720_10891_207_5595_5594_808_801_805_5604_6464_2002 11 5.59E-06 0.000424566 1.42E-05 20109 hsa-mir-452 hsa04662 B cell receptor signaling pathway 3725_4772_4773_207_5595_5594_5970_5604 8 1.55E-05 0.001180471 3.81E-05 20110 hsa-mir-452 hsa03410 Base excision repair 4350_5111_252969_328_2237_6996 6 1.91E-05 0.001450307 4.53E-05 20111 hsa-mir-452 hsa04660 T cell receptor signaling pathway 3725_4772_4773_1432_207_5595_5594_5970_5604 9 3.28E-05 0.002491049 7.55E-05 20112 hsa-mir-452 hsa04950 Maturity onset diabetes of the young 6927_4760_3651_168620_5080 5 3.78E-05 0.00287008 8.44E-05 20113 hsa-mir-452 hsa04115 p53 signaling pathway 595_1017_4194_4193_836_7157_7161 7 7.11E-05 0.005407323 0.000154495 20114 hsa-mir-452 hsa03450 Non-homologous end-joining 10111_2237_5591_4361 4 8.26E-05 0.006280148 0.000174449 20115 hsa-mir-452 hsa04062 Chemokine signaling pathway 5580_2309_207_5595_5594_6774_6777_6772_5970_5604_6464 11 0.000102335 0.00777747 0.000210202 20116 hsa-mir-452 hsa04664 Fc epsilon RI signaling pathway 5580_1432_207_5595_5594_5604_5608 7 0.00015602 0.011857494 0.000312039 20117 hsa-mir-452 hsa04120 Ubiquitin mediated proteolysis 4193_6502_9063_10401_8925_7329_5371_672_7428 9 0.000176992 0.013451406 0.000339441 20118 hsa-mir-452 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_1432_836_7157_4846_5608 6 0.000178653 0.013577658 0.000339441 20119 hsa-mir-452 hsa04270 Vascular smooth muscle contraction 5580_5595_5594_808_801_805_59_5604 8 0.000300902 0.022868518 0.000557769 20120 hsa-mir-452 hsa04920 Adipocytokine signaling pathway 10891_5465_207_6256_6774_5970 6 0.00043744 0.033245472 0.000791559 20121 hsa-mir-452 hsa04510 Focal adhesion 3725_1499_595_207_5595_5594_5604_6464_2002 9 0.002536501 0.192774046 0.004483117 20122 hsa-mir-452 hsa04650 Natural killer cell mediated cytotoxicity 4772_4773_5595_5594_836_5604_6464 7 0.00343555 0.26110181 0.005934132 20123 hsa-mir-452 hsa05010 Alzheimer's disease 2902_5595_5594_836_4846_808_801_805 8 0.003556545 0.270297448 0.00600661 20124 hsa-mir-452 hsa04930 Type II diabetes mellitus 5580_3651_5595_5594 4 0.00413197 0.314029745 0.006826734 20125 hsa-mir-452 hsa04150 mTOR signaling pathway 3091_207_5595_5594 4 0.006659589 0.506128782 0.010768697 20126 hsa-mir-452 hsa05217 Basal cell carcinoma 1499_6934_7157_51176 4 0.007999157 0.60793591 0.012487107 20127 hsa-mir-452 hsa03440 Homologous recombination 10111_4683_4361 3 0.008050898 0.611868266 0.012487107 20128 hsa-mir-452 hsa03022 Basal transcription factors 6874_2959_6908 3 0.016205338 1 0.024632113 20129 hsa-mir-452 hsa04710 Circadian rhythm - mammal 8863_4862 2 0.01664803 1 0.02480883 20130 hsa-mir-452 hsa03320 PPAR signaling pathway 5465_5467_5468_6256 4 0.017318913 1 0.025312257 20131 hsa-mir-452 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1432_836_5970 4 0.018107285 1 0.025484327 20132 hsa-mir-452 hsa04730 Long-term depression 5595_5594_4846_5604 4 0.018107285 1 0.025484327 20133 hsa-mir-452 hsa04360 Axon guidance 4772_4773_25_5595_5594 5 0.036135824 1 0.049093231 20134 hsa-mir-452 hsa04210 Apoptosis 207_836_5970_7157 4 0.036173959 1 0.049093231 20135 hsa-mir-452 hsa03430 Mismatch repair 5111_2956 2 0.043591876 1 0.058122501 20136 hsa-mir-454 hsa05210 Colorectal cancer 4087_4088_4609 3 1.95E-06 3.32E-05 1.84E-05 20137 hsa-mir-454 hsa04350 TGF-beta signaling pathway 4087_4088_4609 3 2.16E-06 3.68E-05 1.84E-05 20138 hsa-mir-454 hsa04310 Wnt signaling pathway 4087_4088_4609 3 1.11E-05 0.000188646 6.29E-05 20139 hsa-mir-454 hsa05200 Pathways in cancer 4087_4088_4609 3 0.000110184 0.00187313 0.000468282 20140 hsa-mir-454 hsa05220 Chronic myeloid leukemia 4088_4609 2 0.000231234 0.003930974 0.000743029 20141 hsa-mir-454 hsa04520 Adherens junction 4087_4088 2 0.000262245 0.004458172 0.000743029 20142 hsa-mir-454 hsa04612 Antigen processing and presentation 4800_4801 2 0.000322912 0.005489511 0.000784216 20143 hsa-mir-454 hsa04110 Cell cycle 4087_4088 2 0.000569823 0.00968699 0.001210874 20144 hsa-mir-454 hsa05216 Thyroid cancer 4609 1 0.008962596 0.152364134 0.016929348 20145 hsa-mir-454 hsa05219 Bladder cancer 4609 1 0.012824162 0.218010751 0.021801075 20146 hsa-mir-454 hsa05213 Endometrial cancer 4609 1 0.01578549 0.268353325 0.024395757 20147 hsa-mir-454 hsa05221 Acute myeloid leukemia 4609 1 0.017853718 0.303513211 0.025292768 20148 hsa-mir-454 hsa05222 Small cell lung cancer 4609 1 0.025795031 0.43851552 0.031678351 20149 hsa-mir-454 hsa04012 ErbB signaling pathway 4609 1 0.026088054 0.443496917 0.031678351 20150 hsa-mir-454 hsa04630 Jak-STAT signaling pathway 4609 1 0.0458308 0.779123593 0.051941573 20151 hsa-mir-455 hsa05200 Pathways in cancer 3725_1147_3551_1499_595_2261_8517_4193_7704_6502_3091_3066_3065_1050_5925_4087_7187_10342_1956_1487_2113_5894_861_862_10401_207_836_3716_4233_5595_5594_5599_1387_2064_9915_367_2932_6774_6776_6777_6772_5979_5879_7157_2736_4088_4089_2034_2033_4790_4791_4792_5970_3320_3326_5371_3480_5159_5156_3265_1026_2353_1488_1441 64 2.53E-40 2.07E-38 2.07E-38 20152 hsa-mir-455 hsa04010 MAPK signaling pathway 3925_6722_3725_1147_3551_2261_2264_8517_9252_7867_9020_5536_8986_1956_3305_3303_1432_22800_5894_1616_207_836_5595_5594_5599_5598_3310_3312_5971_5879_7157_6195_6196_6197_4790_4791_51701_5970_5159_9261_1326_5156_4208_5566_3265_6885_2353 47 6.64E-28 5.44E-26 2.72E-26 20153 hsa-mir-455 hsa05215 Prostate cancer 1147_3551_1499_595_8517_4193_5925_1956_5894_207_5595_5594_1385_1387_2064_367_2932_7157_2033_4790_4792_5970_3320_3326_3480_5159_5156_3265_1026 29 2.32E-24 1.91E-22 6.21E-23 20154 hsa-mir-455 hsa05212 Pancreatic cancer 1147_3551_1499_595_8517_4193_5925_1956_5894_207_5595_5594_1385_1387_2064_367_2932_7157_2033_4790_4792_5970_3320_3326_3480_5159_5156_3265_1026 29 3.03E-24 2.48E-22 6.21E-23 20155 hsa-mir-455 hsa05220 Chronic myeloid leukemia 1147_3551_595_8517_4193_3066_3065_5925_1487_5894_861_207_5595_5594_6776_6777_7157_4088_4089_4790_4792_5970_3265_5781_1026_1488 26 1.96E-22 1.61E-20 3.22E-21 20156 hsa-mir-455 hsa04630 Jak-STAT signaling pathway 3559_595_3454_3455_3560_1439_2690_10401_207_3717_3716_3718_85480_1387_3575_3570_3572_6774_6776_6777_6772_2033_149233_3953_3460_5781_1441 27 1.17E-16 9.63E-15 1.61E-15 20157 hsa-mir-455 hsa05221 Acute myeloid leukemia 1147_3551_595_8517_7704_1050_5894_861_862_207_5595_5594_6774_6776_6777_4790_5970_5371_3265 19 2.91E-16 2.39E-14 3.41E-15 20158 hsa-mir-455 hsa05210 Colorectal cancer 3725_1499_595_4087_1956_5894_207_836_4233_5595_5594_5599_2932_5879_7157_4088_4089_3480_5159_5156_2353 21 5.91E-16 4.84E-14 6.05E-15 20159 hsa-mir-455 hsa04660 T cell receptor signaling pathway 3725_1147_3551_8517_9020_3932_1432_4794_5894_207_5595_5594_920_2932_4790_4792_4793_5970_1326_915_3265_6885_2353 23 6.97E-16 5.72E-14 6.35E-15 20160 hsa-mir-455 hsa03010 Ribosome 6156_6204_6205_6207_6202_6141_6217_6210_6130_6137_6135_6191_6193_6222_6223_6229_6129_6128_6181_6189_6188_6232 22 1.71E-15 1.40E-13 1.27E-14 20161 hsa-mir-455 hsa04620 Toll-like receptor signaling pathway 3725_1147_3551_8517_3454_3455_7187_1432_207_3654_5595_5594_5599_6772_5879_4790_4792_5970_1326_9641_6885_2353 22 1.71E-15 1.40E-13 1.27E-14 20162 hsa-mir-455 hsa04520 Adherens junction 1499_1457_4087_1956_6714_71_2241_4233_5595_5594_1387_2064_5879_4088_4089_2033_51701_3480_8826_6885 20 2.93E-15 2.40E-13 2.00E-14 20163 hsa-mir-455 hsa04310 Wnt signaling pathway 3725_1499_595_8607_1457_6500_4087_23291_1487_5599_1387_2932_5879_7157_4088_4089_2033_51701_5519_5518_5566_8454_8945_6885_1488 25 5.19E-15 4.25E-13 3.27E-14 20164 hsa-mir-455 hsa04062 Chemokine signaling pathway 1147_3551_1234_8517_5580_7852_5894_207_3055_3717_3718_5590_5595_5594_1230_2932_6774_6777_6772_5879_4790_4792_4793_5970_5566_3265_2185 27 1.46E-14 1.20E-12 8.55E-14 20165 hsa-mir-455 hsa04662 B cell receptor signaling pathway 3725_1147_3551_8517_6850_4794_5894_207_5595_5594_2932_5879_4790_4792_4793_5970_3265_2353 18 1.31E-13 1.08E-11 7.18E-13 20166 hsa-mir-455 hsa05214 Glioma 595_4193_5925_1956_5894_207_5595_5594_7157_808_801_805_3480_5159_5156_3265_1026 17 1.91E-13 1.56E-11 9.77E-13 20167 hsa-mir-455 hsa04110 Cell cycle 993_595_4193_6502_6500_3066_3065_5925_4087_5591_1387_7533_2932_7157_4088_4089_2033_8454_983_2810_1026 21 2.37E-13 1.95E-11 1.14E-12 20168 hsa-mir-455 hsa04540 Gap junction 10382_203068_1956_6714_84617_5894_5592_5595_5594_5598_7846_347733_5159_5156_5566_3265_7278_983 18 3.14E-12 2.57E-10 1.43E-11 20169 hsa-mir-455 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1147_3551_8517_9020_1956_6714_1432_836_4233_5599_5879_4790_4792_5970_5781 16 6.88E-12 5.64E-10 2.97E-11 20170 hsa-mir-455 hsa04350 TGF-beta signaling pathway 6667_6500_4087_3397_3399_3398_5595_5594_1387_4086_4088_4089_2033_5519_5518_8454_4093 17 1.10E-11 9.05E-10 4.52E-11 20171 hsa-mir-455 hsa05219 Bladder cancer 595_2261_9252_4193_5925_1956_5894_5595_5594_2064_7157_3265_1026 13 2.27E-11 1.86E-09 8.86E-11 20172 hsa-mir-455 hsa04920 Adipocytokine signaling pathway 1147_3551_10891_8517_4794_207_3717_5599_6774_4790_4792_4793_5970_3953_5781 15 3.40E-11 2.79E-09 1.27E-10 20173 hsa-mir-455 hsa05218 Melanoma 595_4193_5925_1956_5894_207_4233_5595_5594_7157_3480_5159_5156_3265_1026 15 6.93E-11 5.68E-09 2.47E-10 20174 hsa-mir-455 hsa05211 Renal cell carcinoma 3725_3091_2113_5894_207_4233_5595_5594_1387_9915_5879_2034_2033_3265_5781 15 8.23E-11 6.75E-09 2.81E-10 20175 hsa-mir-455 hsa03050 Proteasome 5708_5709_5705_5706_5700_5693_5719_5713_5710_5684_5717_5687_5707 13 9.26E-11 7.59E-09 3.04E-10 20176 hsa-mir-455 hsa04210 Apoptosis 1147_3556_3551_8517_9020_840_1439_207_836_3654_7157_9131_4790_4792_5970_5566 16 1.33E-10 1.09E-08 4.13E-10 20177 hsa-mir-455 hsa04720 Long-term potentiation 2902_5894_5595_5594_1387_6195_6196_6197_2033_808_801_805_5566_3265_2906 15 1.36E-10 1.11E-08 4.13E-10 20178 hsa-mir-455 hsa04912 GnRH signaling pathway 3725_5580_1956_6714_1432_5894_5595_5594_5599_5598_808_801_805_5566_3265_2185 16 1.66E-09 1.36E-07 4.87E-09 20179 hsa-mir-455 hsa04510 Focal adhesion 3725_1499_595_1956_6714_5894_207_71_4233_5595_5594_5599_2064_2932_5879_2321_3480_5159_5156_3265_85366 21 2.49E-09 2.04E-07 7.04E-09 20180 hsa-mir-455 hsa04060 Cytokine-cytokine receptor interaction 3556_3559_1234_3454_3455_1956_3560_1439_7852_2690_85480_4233_1230_3575_3570_3572_2321_149233_5159_5156_3953_3460_1441 23 6.10E-09 5.00E-07 1.67E-08 20181 hsa-mir-455 hsa04012 ErbB signaling pathway 3725_1956_6714_5894_207_5595_5594_5599_2064_2932_6776_6777_3265_1026 14 6.77E-09 5.55E-07 1.79E-08 20182 hsa-mir-455 hsa05213 Endometrial cancer 1499_595_1956_5894_207_5595_5594_2064_2932_7157_3265 11 2.41E-08 1.97E-06 6.17E-08 20183 hsa-mir-455 hsa04910 Insulin signaling pathway 3551_10891_5894_5211_207_5590_5595_5594_5599_2932_2194_808_801_805_5566_3265 16 3.89E-08 3.19E-06 9.67E-08 20184 hsa-mir-455 hsa05222 Small cell lung cancer 1147_3551_595_8517_6502_5925_7187_10401_207_7157_4790_4792_5970 13 4.55E-08 3.73E-06 1.10E-07 20185 hsa-mir-455 hsa04612 Antigen processing and presentation 811_3309_3305_3303_920_1385_3310_3312_1514_3320_3326_4802_2923 13 6.53E-08 5.35E-06 1.53E-07 20186 hsa-mir-455 hsa05016 Huntington's disease 6667_10891_291_3066_3065_3064_2902_836_1213_1385_1387_5481_5437_7157_2033_6908_5441_9519 18 8.22E-08 6.74E-06 1.87E-07 20187 hsa-mir-455 hsa04330 Notch signaling pathway 3066_3065_1487_3280_1387_9612_2033_8850_388585_1488 10 1.00E-07 8.20E-06 2.22E-07 20188 hsa-mir-455 hsa05223 Non-small cell lung cancer 595_5925_1956_5894_207_5595_5594_2064_7157_3265 10 3.12E-07 2.56E-05 6.72E-07 20189 hsa-mir-455 hsa04916 Melanogenesis 1499_5894_5595_5594_1385_1387_2932_2033_808_801_805_5566_3265 13 3.34E-07 2.74E-05 7.03E-07 20190 hsa-mir-455 hsa05216 Thyroid cancer 1499_595_10342_5595_5594_5979_7157_3265 8 3.56E-07 2.92E-05 7.30E-07 20191 hsa-mir-455 hsa05131 Shigellosis 1499_10382_203068_84617_71_7846_347733_7278_4691 9 3.46E-06 0.000284041 6.76E-06 20192 hsa-mir-455 hsa05130 Pathogenic Escherichia coli infection 1499_10382_203068_84617_71_7846_347733_7278_4691 9 3.46E-06 0.000284041 6.76E-06 20193 hsa-mir-455 hsa04370 VEGF signaling pathway 7867_6714_1432_5894_207_5595_5594_5879_9261_3265 10 5.59E-06 0.000458505 1.05E-05 20194 hsa-mir-455 hsa04530 Tight junction 1499_1457_5580_6714_4627_22800_8573_207_71_5590_5519_5518_3265 13 5.63E-06 0.000461396 1.05E-05 20195 hsa-mir-455 hsa04650 Natural killer cell mediated cytotoxicity 3454_3455_3932_6850_5894_836_5595_5594_5879_3265_3460_5781_2185 13 6.05E-06 0.000496327 1.10E-05 20196 hsa-mir-455 hsa04664 Fc epsilon RI signaling pathway 5580_6850_1432_5894_207_5595_5594_5599_5879_3265 10 6.87E-06 0.000563535 1.23E-05 20197 hsa-mir-455 hsa04810 Regulation of actin cytoskeleton 2261_2264_1956_4627_22800_5894_71_5595_5594_5879_5159_5156_3265_10788_8826_85366 16 1.11E-05 0.000907752 1.93E-05 20198 hsa-mir-455 hsa05340 Primary immunodeficiency 8517_100_3932_3718_920_3575_915 7 1.22E-05 0.001002719 2.09E-05 20199 hsa-mir-455 hsa04020 Calcium signaling pathway 291_1956_2902_2064_5481_808_801_805_5159_5156_5566_2906_2185_85366 14 2.55E-05 0.002094616 4.27E-05 20200 hsa-mir-455 hsa03020 RNA polymerase 25885_51082_64425_5437_84172_5441 6 4.40E-05 0.003607301 7.21E-05 20201 hsa-mir-455 hsa04930 Type II diabetes mellitus 3551_5580_3651_5590_5595_5594_5599 7 5.16E-05 0.004227511 8.29E-05 20202 hsa-mir-455 hsa05010 Alzheimer's disease 840_3416_2902_836_5595_5594_2932_808_351_801_805_2906_1020 13 6.91E-05 0.005664061 0.000108924 20203 hsa-mir-455 hsa04150 mTOR signaling pathway 3091_207_5595_5594_6195_6196_6197 7 0.000117377 0.009624951 0.000181603 20204 hsa-mir-455 hsa04730 Long-term depression 5894_5592_5595_5594_3480_5519_5518_3265 8 0.000120472 0.009878673 0.000182938 20205 hsa-mir-455 hsa04120 Ubiquitin mediated proteolysis 4193_55294_6502_6500_23291_10401_5371_672_8454_8945_7329 11 0.000133874 0.010977635 0.000199593 20206 hsa-mir-455 hsa04270 Vascular smooth muscle contraction 5580_5894_5592_5595_5594_808_801_805_5566_85366 10 0.000159676 0.013093454 0.000233812 20207 hsa-mir-455 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_1432_1616_836_5879_7157_2906 7 0.00017844 0.014632093 0.000256703 20208 hsa-mir-455 hsa04950 Maturity onset diabetes of the young 6927_3280_3651_3175_168620 5 0.00018894 0.015493048 0.000267122 20209 hsa-mir-455 hsa04115 p53 signaling pathway 595_4193_836_7157_983_2810_1026 7 0.00057173 0.046881828 0.000794607 20210 hsa-mir-455 hsa04360 Axon guidance 7852_2242_4233_5595_5594_2932_5879_3265_1020 9 0.001372038 0.112507117 0.001875119 20211 hsa-mir-455 hsa04340 Hedgehog signaling pathway 23291_2932_2736_5566_8945 5 0.006198989 0.50831707 0.008333067 20212 hsa-mir-455 hsa03022 Basal transcription factors 2963_2969_6908_9519 4 0.007228986 0.59277687 0.009560917 20213 hsa-mir-455 hsa04640 Hematopoietic cell lineage 3559_920_3575_3570_915_1441 6 0.008280501 0.679001086 0.010777795 20214 hsa-mir-455 hsa04670 Leukocyte transendothelial migration 1499_1432_7852_71_5879_5781_2185 7 0.011217702 0.919851579 0.014372681 20215 hsa-mir-455 hsa05217 Basal cell carcinoma 1499_2932_7157_2736 4 0.02497859 1 0.031511452 20216 hsa-mir-455 hsa03450 Non-homologous end-joining 7520_5591 2 0.035594361 1 0.044223297 20217 hsa-mir-466 hsa05200 Pathways in cancer 2249_367_3725_6776_6777_2353_5914_5970_6256 9 2.03E-10 7.70E-09 7.70E-09 20218 hsa-mir-466 hsa05221 Acute myeloid leukemia 6776_6777_5914_5970 4 9.84E-07 3.74E-05 1.87E-05 20219 hsa-mir-466 hsa05220 Chronic myeloid leukemia 6776_6777_5970 3 0.000113081 0.004297074 0.001074269 20220 hsa-mir-466 hsa04662 B cell receptor signaling pathway 3725_2353_5970 3 0.000113081 0.004297074 0.001074269 20221 hsa-mir-466 hsa04012 ErbB signaling pathway 3725_6776_6777 3 0.00017291 0.006570564 0.001314113 20222 hsa-mir-466 hsa04620 Toll-like receptor signaling pathway 3725_2353_5970 3 0.000272526 0.010355982 0.001606221 20223 hsa-mir-466 hsa04010 MAPK signaling pathway 2249_3725_2353_5970 4 0.000330487 0.012558499 0.001606221 20224 hsa-mir-466 hsa04660 T cell receptor signaling pathway 3725_2353_5970 3 0.000338152 0.012849769 0.001606221 20225 hsa-mir-466 hsa04630 Jak-STAT signaling pathway 3977_6776_6777 3 0.000897685 0.03411204 0.003790227 20226 hsa-mir-466 hsa04920 Adipocytokine signaling pathway 5970_6256 2 0.003115381 0.11838449 0.011838449 20227 hsa-mir-466 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5970 2 0.003479392 0.132216888 0.012019717 20228 hsa-mir-466 hsa05210 Colorectal cancer 3725_2353 2 0.004792101 0.18209983 0.0135505 20229 hsa-mir-466 hsa05222 Small cell lung cancer 5970_6256 2 0.005011395 0.190433006 0.0135505 20230 hsa-mir-466 hsa05215 Prostate cancer 367_5970 2 0.00523525 0.198939509 0.0135505 20231 hsa-mir-466 hsa05212 Pancreatic cancer 367_5970 2 0.005348882 0.203257498 0.0135505 20232 hsa-mir-466 hsa03450 Non-homologous end-joining 2547 1 0.01783249 0.677634628 0.042352164 20233 hsa-mir-466 hsa05016 Huntington's disease 6908_6667 2 0.021779742 0.827630199 0.048257818 20234 hsa-mir-466 hsa04062 Chemokine signaling pathway 6777_5970 2 0.022858967 0.868640727 0.048257818 20235 hsa-mir-466 hsa04950 Maturity onset diabetes of the young 6927 1 0.02954865 1 0.0590973 20236 hsa-mir-466 hsa05216 Thyroid cancer 6256 1 0.035355663 1 0.067175759 20237 hsa-mir-466 hsa04080 Neuroactive ligand-receptor interaction 2908_7067 2 0.038234048 1 0.06918542 20238 hsa-mir-466 hsa03410 Base excision repair 142 1 0.043428758 1 0.073648431 20239 hsa-mir-466 hsa03022 Basal transcription factors 6908 1 0.044576682 1 0.073648431 20240 hsa-mir-483 hsa03022 Basal transcription factors 2967_2961_2960_2963_6881_54457_2968_6879_6878_6877_6874_6872_2957_6873_2958_6884_2959_6880_6882_138474_6883 21 1.94E-35 1.26E-33 1.26E-33 20241 hsa-mir-483 hsa05200 Pathways in cancer 5925_5594_6256_3326_4193_5970_7157_6688_3725_10401_4609_2353_2033_8554_7184 15 4.37E-11 2.84E-09 1.42E-09 20242 hsa-mir-483 hsa05215 Prostate cancer 5925_5594_3326_4193_5970_7157_2033_7184 8 1.11E-08 7.24E-07 1.97E-07 20243 hsa-mir-483 hsa05212 Pancreatic cancer 5925_5594_3326_4193_5970_7157_2033_7184 8 1.21E-08 7.87E-07 1.97E-07 20244 hsa-mir-483 hsa05222 Small cell lung cancer 5925_6256_5970_7157_10401_4609_8554 7 1.92E-07 1.25E-05 2.50E-06 20245 hsa-mir-483 hsa05220 Chronic myeloid leukemia 5925_5594_4193_5970_7157_4609 6 1.63E-06 0.000106142 1.77E-05 20246 hsa-mir-483 hsa05219 Bladder cancer 5925_5594_4193_7157_4609 5 2.05E-06 0.000133441 1.91E-05 20247 hsa-mir-483 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 3.76E-06 0.000244401 3.06E-05 20248 hsa-mir-483 hsa05216 Thyroid cancer 5594_6256_7157_4609 4 1.34E-05 0.0008735 9.71E-05 20249 hsa-mir-483 hsa04110 Cell cycle 5925_4193_7157_4171_4085_2033 6 2.01E-05 0.001309216 0.000130922 20250 hsa-mir-483 hsa04010 MAPK signaling pathway 3727_5594_5970_3312_7157_3725_4609_2353 8 3.71E-05 0.002410564 0.000219142 20251 hsa-mir-483 hsa05210 Colorectal cancer 5594_7157_3725_4609_2353 5 4.79E-05 0.003113308 0.000259442 20252 hsa-mir-483 hsa04310 Wnt signaling pathway 1460_8607_7157_3725_4609_2033 6 7.49E-05 0.004865764 0.00037429 20253 hsa-mir-483 hsa05223 Non-small cell lung cancer 5925_5594_6256_7157 4 0.000127933 0.008315673 0.000593977 20254 hsa-mir-483 hsa05221 Acute myeloid leukemia 5594_5970_6688_4609 4 0.000176581 0.011477736 0.000765182 20255 hsa-mir-483 hsa05016 Huntington's disease 6874_9001_5430_7157_3064_2033 6 0.000229523 0.014918981 0.000932436 20256 hsa-mir-483 hsa05214 Glioma 5925_5594_4193_7157 4 0.000251091 0.01632092 0.000960054 20257 hsa-mir-483 hsa05218 Melanoma 5925_5594_4193_7157 4 0.000345887 0.022482668 0.001249037 20258 hsa-mir-483 hsa04662 B cell receptor signaling pathway 5594_5970_3725_2353 4 0.000421797 0.027416813 0.00144299 20259 hsa-mir-483 hsa03420 Nucleotide excision repair 2967_2968_5887 3 0.001182634 0.07687119 0.00384356 20260 hsa-mir-483 hsa04620 Toll-like receptor signaling pathway 5594_5970_3725_2353 4 0.001272446 0.08270899 0.003938523 20261 hsa-mir-483 hsa04660 T cell receptor signaling pathway 5594_5970_3725_2353 4 0.001663531 0.1081295 0.004914977 20262 hsa-mir-483 hsa05213 Endometrial cancer 5594_7157_4609 3 0.001864907 0.121218972 0.00527039 20263 hsa-mir-483 hsa05211 Renal cell carcinoma 5594_3725_2033 3 0.004502222 0.292644441 0.012193518 20264 hsa-mir-483 hsa04630 Jak-STAT signaling pathway 10401_4609_2033_8554 4 0.005490711 0.356896225 0.014275849 20265 hsa-mir-483 hsa04520 Adherens junction 1460_5594_2033 3 0.005971651 0.388157339 0.014929128 20266 hsa-mir-483 hsa04350 TGF-beta signaling pathway 5594_4609_2033 3 0.00746691 0.485349136 0.017333898 20267 hsa-mir-483 hsa04012 ErbB signaling pathway 5594_3725_4609 3 0.00746691 0.485349136 0.017333898 20268 hsa-mir-483 hsa04612 Antigen processing and presentation 3326_4801_3312 3 0.007931055 0.515518593 0.017776503 20269 hsa-mir-483 hsa04330 Notch signaling pathway 2033_8850 2 0.019860078 1 0.043030168 20270 hsa-mir-483 hsa04120 Ubiquitin mediated proteolysis 4193_10401_8554 3 0.025183516 1 0.052804147 20271 hsa-mir-483 hsa05322 Systemic lupus erythematosus 8340_3014_3015 3 0.027522157 1 0.055904381 20272 hsa-mir-483 hsa04920 Adipocytokine signaling pathway 6256_5970 2 0.037426761 1 0.073719378 20273 hsa-mir-483 hsa04115 p53 signaling pathway 4193_7157 2 0.039420171 1 0.075362092 20274 hsa-mir-483 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_3725 2 0.041453112 1 0.076984351 20275 hsa-mir-483 hsa04720 Long-term potentiation 5594_2033 2 0.04563424 1 0.082395156 20276 hsa-mir-484 hsa05215 Prostate cancer 5970_7157_2033_4790 4 5.79E-08 2.08E-06 1.09E-06 20277 hsa-mir-484 hsa05212 Pancreatic cancer 5970_7157_2033_4790 4 6.05E-08 2.18E-06 1.09E-06 20278 hsa-mir-484 hsa05200 Pathways in cancer 5970_7157_6772_2033_4790 5 2.07E-07 7.46E-06 2.49E-06 20279 hsa-mir-484 hsa05220 Chronic myeloid leukemia 5970_7157_4790 3 4.74E-06 0.000170623 4.27E-05 20280 hsa-mir-484 hsa05222 Small cell lung cancer 5970_7157_4790 3 7.06E-06 0.000254002 4.68E-05 20281 hsa-mir-484 hsa04210 Apoptosis 5970_7157_4790 3 7.80E-06 0.000280666 4.68E-05 20282 hsa-mir-484 hsa04620 Toll-like receptor signaling pathway 5970_6772_4790 3 1.16E-05 0.000417605 5.97E-05 20283 hsa-mir-484 hsa04062 Chemokine signaling pathway 5970_6772_4790 3 7.47E-05 0.002690952 0.000336369 20284 hsa-mir-484 hsa04330 Notch signaling pathway 2033_8850 2 0.000201345 0.007248404 0.000739779 20285 hsa-mir-484 hsa04010 MAPK signaling pathway 5970_7157_4790 3 0.000205494 0.00739779 0.000739779 20286 hsa-mir-484 hsa05221 Acute myeloid leukemia 5970_4790 2 0.0003124 0.011246384 0.001022399 20287 hsa-mir-484 hsa04920 Adipocytokine signaling pathway 5970_4790 2 0.000399704 0.014389346 0.001199112 20288 hsa-mir-484 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_4790 2 0.000447313 0.016103268 0.001238713 20289 hsa-mir-484 hsa04662 B cell receptor signaling pathway 5970_4790 2 0.000497549 0.017911775 0.001279412 20290 hsa-mir-484 hsa04660 T cell receptor signaling pathway 5970_4790 2 0.001047997 0.037727892 0.002515193 20291 hsa-mir-484 hsa04110 Cell cycle 7157_2033 2 0.001221325 0.043967682 0.00274798 20292 hsa-mir-484 hsa04310 Wnt signaling pathway 7157_2033 2 0.00196597 0.070774924 0.004084142 20293 hsa-mir-484 hsa04630 Jak-STAT signaling pathway 6772_2033 2 0.002042071 0.073514565 0.004084142 20294 hsa-mir-484 hsa05016 Huntington's disease 7157_2033 2 0.002970046 0.106921642 0.005627455 20295 hsa-mir-484 hsa04950 Maturity onset diabetes of the young 4760 1 0.01077683 0.387965879 0.019398294 20296 hsa-mir-484 hsa05216 Thyroid cancer 7157 1 0.012919289 0.465094406 0.022147353 20297 hsa-mir-484 hsa05219 Bladder cancer 7157 1 0.018469654 0.664907527 0.030223069 20298 hsa-mir-484 hsa05213 Endometrial cancer 7157 1 0.022719545 0.817903628 0.033805026 20299 hsa-mir-484 hsa05223 Non-small cell lung cancer 7157 1 0.023567483 0.848429373 0.033805026 20300 hsa-mir-484 hsa05217 Basal cell carcinoma 7157 1 0.023991197 0.863683075 0.033805026 20301 hsa-mir-484 hsa05014 Amyotrophic lateral sclerosis (ALS) 7157 1 0.024414741 0.878930668 0.033805026 20302 hsa-mir-484 hsa05214 Glioma 7157 1 0.028219011 1 0.037402099 20303 hsa-mir-484 hsa04115 p53 signaling pathway 7157 1 0.029905399 1 0.037402099 20304 hsa-mir-484 hsa05218 Melanoma 7157 1 0.030747579 1 0.037402099 20305 hsa-mir-484 hsa05211 Renal cell carcinoma 2033 1 0.031168416 1 0.037402099 20306 hsa-mir-484 hsa04720 Long-term potentiation 2033 1 0.032429915 1 0.037660547 20307 hsa-mir-484 hsa04520 Adherens junction 2033 1 0.034529045 1 0.038845176 20308 hsa-mir-484 hsa05210 Colorectal cancer 7157 1 0.036205322 1 0.039496715 20309 hsa-mir-484 hsa04350 TGF-beta signaling pathway 2033 1 0.037460766 1 0.03966434 20310 hsa-mir-484 hsa04916 Melanogenesis 2033 1 0.044546479 1 0.045819236 20311 hsa-mir-485 hsa05200 Pathways in cancer 3551_5467_5468_5914_595_1017_4193_6934_7704_3091_4089_3065_1050_5925_1499_25_405_1956_4436_1487_1488_2113_10401_861_867_207_3716_1147_5595_5594_5599_6258_1387_6257_6256_4286_367_6774_6777_6772_5970_7157_7849_3725_6776_4088_2034_2033_3320_51176_5371_675_5159_8031_5156_5604_5601_1399_1398_3815_841_4087_4609_2956_2353_8554 66 7.75E-41 6.12E-39 6.12E-39 20312 hsa-mir-485 hsa05220 Chronic myeloid leukemia 3551_595_4193_4089_3065_5925_25_1487_1488_861_867_207_1147_5595_5594_6777_5970_7157_6776_4088_5604_1399_1398_5781_4609_6464 26 7.46E-22 5.90E-20 2.95E-20 20313 hsa-mir-485 hsa05221 Acute myeloid leukemia 3551_5467_5914_595_6934_7704_1050_861_207_1147_5595_5594_6774_6777_5970_6776_51176_5371_5604_3815_4609 21 4.24E-18 3.35E-16 1.12E-16 20314 hsa-mir-485 hsa05215 Prostate cancer 3551_595_1017_4193_6934_5925_1499_1956_207_9586_1147_5595_5594_1387_367_5970_7157_2033_3320_51176_5159_5156_5604 23 3.31E-17 2.61E-15 6.46E-16 20315 hsa-mir-485 hsa05212 Pancreatic cancer 3551_595_1017_4193_6934_5925_1499_1956_207_9586_1147_5595_5594_1387_367_5970_7157_2033_3320_51176_5159_5156_5604 23 4.09E-17 3.23E-15 6.46E-16 20316 hsa-mir-485 hsa05210 Colorectal cancer 595_6934_4089_1499_1956_4436_207_5595_5594_5599_7157_3725_4088_51176_5159_5156_5604_5601_4087_4609_2956_2353 22 1.56E-16 1.23E-14 2.05E-15 20317 hsa-mir-485 hsa04630 Jak-STAT signaling pathway 3559_595_5777_3560_3561_2057_10401_867_2690_207_3575_3717_3716_3718_85480_1387_6778_6774_6777_6772_6776_2033_894_896_5781_4609_8554 27 4.36E-16 3.44E-14 4.92E-15 20318 hsa-mir-485 hsa04110 Cell cycle 595_1017_4193_4089_3065_4616_993_5925_25_8379_5934_7534_1387_7532_7027_7157_10912_5111_4088_2033_894_896_983_4087 24 1.08E-15 8.53E-14 1.07E-14 20319 hsa-mir-485 hsa04310 Wnt signaling pathway 5467_595_6934_4089_4772_4773_1499_1487_1488_1459_5599_1387_7157_8061_3725_1457_4088_2033_894_896_51176_5515_5601_4087_4609_5527 26 2.25E-15 1.78E-13 1.98E-14 20320 hsa-mir-485 hsa05216 Thyroid cancer 5468_595_6934_1499_5595_5594_6258_6257_6256_7157_7849_51176_8031_5604_4609 15 3.29E-15 2.60E-13 2.60E-14 20321 hsa-mir-485 hsa04010 MAPK signaling pathway 3727_3551_9252_4773_4616_1956_1432_207_1147_5595_5594_5599_1386_1649_5970_3164_7157_10912_3725_5159_5156_5604_4208_5601_5600_1399_1398_4609_2353_5603_8550_2002 32 2.10E-14 1.66E-12 1.50E-13 20322 hsa-mir-485 hsa04012 ErbB signaling pathway 25_1956_6714_867_207_5595_5594_5599_2066_6777_3725_6776_5604_5601_1399_1398_4609_6464_2002 19 3.04E-13 2.40E-11 2.00E-12 20323 hsa-mir-485 hsa04520 Adherens junction 6934_5770_5777_4089_1499_1956_6714_1459_71_5595_5594_1387_1457_4088_2033_51176_3643_4087 18 8.29E-13 6.55E-11 5.04E-12 20324 hsa-mir-485 hsa04660 T cell receptor signaling pathway 3551_1493_5777_4772_4773_3932_1432_867_207_1147_5595_5594_5970_3725_5604_5601_5600_919_2353_5603 20 1.43E-12 1.13E-10 8.08E-12 20325 hsa-mir-485 hsa04620 Toll-like receptor signaling pathway 3551_3665_3661_1432_207_1147_5595_5594_5599_6772_5970_3725_5604_5601_5600_841_2353_5603 18 2.92E-11 2.31E-09 1.54E-10 20326 hsa-mir-485 hsa05213 Endometrial cancer 595_6934_1499_1956_2309_207_5595_5594_7157_51176_5604_4609_2002 13 4.13E-10 3.26E-08 2.04E-09 20327 hsa-mir-485 hsa04920 Adipocytokine signaling pathway 3551_10891_5465_207_3717_1147_5599_6258_6257_6256_6774_5970_5601_5781 14 6.75E-10 5.33E-08 3.14E-09 20328 hsa-mir-485 hsa05211 Renal cell carcinoma 3091_405_2113_207_5595_5594_1387_3725_2034_2033_5604_1399_1398_5781 14 1.53E-09 1.21E-07 6.62E-09 20329 hsa-mir-485 hsa04330 Notch signaling pathway 1840_3065_22938_1487_1488_1387_2033_8850_2648_4851_9612_9794 12 1.59E-09 1.26E-07 6.62E-09 20330 hsa-mir-485 hsa04350 TGF-beta signaling pathway 6667_4086_4089_1875_5934_5595_5594_1387_7027_4088_2033_5515_4087_4609_4092 15 1.73E-09 1.37E-07 6.84E-09 20331 hsa-mir-485 hsa04662 B cell receptor signaling pathway 3551_5777_4772_4773_6850_207_1147_695_5595_5594_5970_3725_5604_2353 14 2.44E-09 1.93E-07 9.19E-09 20332 hsa-mir-485 hsa05223 Non-small cell lung cancer 595_5925_1956_2309_207_5595_5594_6258_6257_6256_7157_5604 12 6.17E-09 4.87E-07 2.21E-08 20333 hsa-mir-485 hsa04115 p53 signaling pathway 595_1017_4194_4193_4616_7157_10912_64326_894_896_841_983_7161 13 8.25E-09 6.51E-07 2.83E-08 20334 hsa-mir-485 hsa05222 Small cell lung cancer 3551_595_1017_5925_10401_207_1147_6258_6257_6256_5970_7157_4609_8554 14 1.16E-08 9.15E-07 3.81E-08 20335 hsa-mir-485 hsa05322 Systemic lupus erythematosus 3021_3020_9555_8349_8365_8294_8370_121504_8361_8360_8363_8362_8364_8367_8366_8368_8359 17 2.49E-08 1.97E-06 7.88E-08 20336 hsa-mir-485 hsa04510 Focal adhesion 595_1499_1956_6714_207_71_5595_5594_5599_3725_894_896_5159_5156_5604_5601_1399_1398_6464_2002 20 3.06E-08 2.41E-06 9.28E-08 20337 hsa-mir-485 hsa05214 Glioma 595_4193_5925_1956_207_5595_5594_7157_5159_5156_5604_6464 12 3.78E-08 2.98E-06 1.11E-07 20338 hsa-mir-485 hsa04062 Chemokine signaling pathway 3551_1234_7852_2309_207_3717_1147_3718_5595_5594_5580_6774_6777_6772_5970_5604_1399_1398_6464 19 5.51E-08 4.36E-06 1.56E-07 20339 hsa-mir-485 hsa05219 Bladder cancer 595_9252_4193_5925_1956_5595_5594_7157_5604_4609 10 6.54E-08 5.17E-06 1.78E-07 20340 hsa-mir-485 hsa05218 Melanoma 595_4193_5925_1956_207_5595_5594_4286_7157_5159_5156_5604 12 8.93E-08 7.06E-06 2.28E-07 20341 hsa-mir-485 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3551_1956_6714_1432_1147_5599_5970_3725_5601_5600_5781_5603 12 8.93E-08 7.06E-06 2.28E-07 20342 hsa-mir-485 hsa04664 Fc epsilon RI signaling pathway 6850_1432_207_695_5595_5594_5599_5580_5604_5601_5600_5603 12 2.52E-07 1.99E-05 6.22E-07 20343 hsa-mir-485 hsa04910 Insulin signaling pathway 3551_10891_5770_867_207_5595_5594_5599_3643_5604_5601_1399_1398_6464_2002 15 4.35E-07 3.44E-05 1.04E-06 20344 hsa-mir-485 hsa04912 GnRH signaling pathway 1956_6714_1432_5595_5594_5599_5580_3725_5604_5601_5600_5603_2002 13 8.96E-07 7.08E-05 2.08E-06 20345 hsa-mir-485 hsa04370 VEGF signaling pathway 4772_4773_6714_1432_207_5595_5594_5604_5600_5603 10 8.88E-06 0.00070184 2.01E-05 20346 hsa-mir-485 hsa03410 Base excision repair 3146_4350_252969_328_2237_5111_6996 7 2.02E-05 0.001596862 4.44E-05 20347 hsa-mir-485 hsa04930 Type II diabetes mellitus 3551_5595_5594_5599_5580_3643_5601 7 7.19E-05 0.005682976 0.000153594 20348 hsa-mir-485 hsa04916 Melanogenesis 6934_1499_5595_5594_1387_4286_2033_51176_5604_3815 10 9.38E-05 0.007409541 0.000194988 20349 hsa-mir-485 hsa03320 PPAR signaling pathway 5465_5467_5468_10062_6258_6257_6256_2168 8 0.000158314 0.01250678 0.000320687 20350 hsa-mir-485 hsa04650 Natural killer cell mediated cytotoxicity 5777_4772_4773_3932_6850_5595_5594_5604_919_5781_6464 11 0.000199765 0.015781421 0.000394536 20351 hsa-mir-485 hsa05016 Huntington's disease 6667_10891_5468_3065_25942_4724_9586_1387_7157_2033_841_6908 12 0.000695385 0.054935405 0.001339888 20352 hsa-mir-485 hsa04540 Gap junction 1956_6714_5595_5594_5159_5156_5604_983 8 0.000917935 0.072516884 0.001726592 20353 hsa-mir-485 hsa05340 Primary immunodeficiency 3932_3561_3575_3718_695 5 0.00111893 0.088395445 0.002055708 20354 hsa-mir-485 hsa04120 Ubiquitin mediated proteolysis 4193_10401_867_7329_8925_64326_5371_672_8554 9 0.002869133 0.22666149 0.005151398 20355 hsa-mir-485 hsa04210 Apoptosis 3551_207_1147_5970_7157_841_840 7 0.00303601 0.239844757 0.005329883 20356 hsa-mir-485 hsa03440 Homologous recombination 10111_4683_675_4361 4 0.003544887 0.280046056 0.006047099 20357 hsa-mir-485 hsa04060 Cytokine-cytokine receptor interaction 3559_1234_1956_7852_3560_3561_2057_2690_3575_85480_5159_5156_3815 13 0.003597641 0.284213636 0.006047099 20358 hsa-mir-485 hsa03450 Non-homologous end-joining 10111_2237_4361 3 0.004289658 0.338883015 0.007060063 20359 hsa-mir-485 hsa04530 Tight junction 1499_6714_1459_207_71_5580_1457_5515 8 0.008530788 0.673932278 0.013714341 20360 hsa-mir-485 hsa03022 Basal transcription factors 2963_2969_2959_6908 4 0.008679962 0.685717032 0.013714341 20361 hsa-mir-485 hsa03430 Mismatch repair 4436_5111_2956 3 0.014376782 1 0.022248178 20362 hsa-mir-485 hsa04670 Leukocyte transendothelial migration 1499_7852_1432_71_5600_5781_5603 7 0.01464437 1 0.022248178 20363 hsa-mir-485 hsa04950 Maturity onset diabetes of the young 6927_4760_5080 3 0.015940056 1 0.023759705 20364 hsa-mir-485 hsa04720 Long-term potentiation 5595_5594_1387_2033_5604 5 0.021488438 1 0.031436788 20365 hsa-mir-485 hsa04150 mTOR signaling pathway 3091_207_5595_5594 4 0.02498742 1 0.035891022 20366 hsa-mir-485 hsa05217 Basal cell carcinoma 6934_1499_7157_51176 4 0.029574745 1 0.041721515 20367 hsa-mir-485 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_7157_5600_5603 4 0.031207141 1 0.041785833 20368 hsa-mir-485 hsa05131 Shigellosis 1499_25_71_7534 4 0.031207141 1 0.041785833 20369 hsa-mir-485 hsa05130 Pathogenic Escherichia coli infection 1499_25_71_7534 4 0.031207141 1 0.041785833 20370 hsa-mir-485 hsa04612 Antigen processing and presentation 3308_1514_3320_4800_4801 5 0.039315454 1 0.051765348 20371 hsa-mir-485 hsa04810 Regulation of actin cytoskeleton 1956_71_5595_5594_5159_5156_5604_1399_1398 9 0.049250286 1 0.063783157 20372 hsa-mir-486 hsa04630 Jak-STAT signaling pathway 3717_3716_3718_85480_3560_3561_1387_3575_6777_6772_2057_5781_867_6774_2690_2033 16 2.36E-17 1.56E-15 1.20E-15 20373 hsa-mir-486 hsa05200 Pathways in cancer 3716_675_1499_5595_5594_1387_5159_5156_1399_1398_3815_6777_6772_862_867_6774_6502_5925_2033_1956 20 3.63E-17 2.39E-15 1.20E-15 20374 hsa-mir-486 hsa05214 Glioma 5595_5594_5159_5156_5925_808_6464_1956_801_805 10 7.50E-13 4.95E-11 1.65E-11 20375 hsa-mir-486 hsa04012 ErbB signaling pathway 6714_5595_5594_2066_1399_1398_6777_867_6464_1956 10 1.05E-11 6.96E-10 1.74E-10 20376 hsa-mir-486 hsa04910 Insulin signaling pathway 3643_5595_5594_1399_1398_5770_867_808_6464_801_805 11 3.72E-11 2.46E-09 4.91E-10 20377 hsa-mir-486 hsa05220 Chronic myeloid leukemia 5595_5594_1399_1398_6777_5781_867_5925_6464 9 8.29E-11 5.47E-09 9.11E-10 20378 hsa-mir-486 hsa04520 Adherens junction 1499_6714_3643_5595_5594_1387_5770_2033_1956 9 1.41E-10 9.28E-09 1.33E-09 20379 hsa-mir-486 hsa04350 TGF-beta signaling pathway 5515_3400_5595_5594_1387_3397_3399_3398_2033 9 2.80E-10 1.85E-08 2.23E-09 20380 hsa-mir-486 hsa05215 Prostate cancer 1499_5595_5594_1387_5159_5156_5925_2033_1956 9 3.07E-10 2.03E-08 2.23E-09 20381 hsa-mir-486 hsa05212 Pancreatic cancer 1499_5595_5594_1387_5159_5156_5925_2033_1956 9 3.37E-10 2.23E-08 2.23E-09 20382 hsa-mir-486 hsa04062 Chemokine signaling pathway 3717_3718_5595_5594_1399_1398_1234_6777_6772_6774_6464 11 1.08E-09 7.12E-08 6.47E-09 20383 hsa-mir-486 hsa04916 Melanogenesis 1499_5595_5594_1387_3815_808_2033_801_805 9 1.21E-09 8.01E-08 6.68E-09 20384 hsa-mir-486 hsa04010 MAPK signaling pathway 5595_5594_6722_5159_9261_5156_4208_1399_1398_7867_1432_1956 12 3.05E-09 2.01E-07 1.55E-08 20385 hsa-mir-486 hsa04060 Cytokine-cytokine receptor interaction 85480_3560_3561_5159_5156_3575_1234_3815_2057_2690_1956 11 2.24E-08 1.48E-06 1.06E-07 20386 hsa-mir-486 hsa04510 Focal adhesion 1499_6714_5595_5594_5159_5156_1399_1398_6464_1956 10 2.72E-08 1.80E-06 1.20E-07 20387 hsa-mir-486 hsa04912 GnRH signaling pathway 6714_5595_5594_1432_808_1956_801_805 8 3.26E-08 2.15E-06 1.34E-07 20388 hsa-mir-486 hsa05211 Renal cell carcinoma 5595_5594_1387_1399_1398_5781_2033 7 4.27E-08 2.82E-06 1.66E-07 20389 hsa-mir-486 hsa04720 Long-term potentiation 5595_5594_1387_808_2033_801_805 7 5.55E-08 3.66E-06 2.03E-07 20390 hsa-mir-486 hsa05221 Acute myeloid leukemia 5595_5594_3815_6777_862_6774 6 3.20E-07 2.11E-05 1.11E-06 20391 hsa-mir-486 hsa04660 T cell receptor signaling pathway 3932_1493_5595_5594_919_1432_867 7 6.41E-07 4.23E-05 2.12E-06 20392 hsa-mir-486 hsa05340 Primary immunodeficiency 3718_695_3932_3561_3575 5 6.91E-07 4.56E-05 2.17E-06 20393 hsa-mir-486 hsa05218 Melanoma 5595_5594_5159_5156_5925_1956 6 8.83E-07 5.83E-05 2.65E-06 20394 hsa-mir-486 hsa04370 VEGF signaling pathway 6714_5595_5594_9261_7867_1432 6 1.38E-06 9.09E-05 3.95E-06 20395 hsa-mir-486 hsa05210 Colorectal cancer 1499_5595_5594_5159_5156_1956 6 2.22E-06 0.000146393 6.10E-06 20396 hsa-mir-486 hsa04330 Notch signaling pathway 388585_1387_9612_2033_8850 5 2.62E-06 0.000173145 6.88E-06 20397 hsa-mir-486 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6850_919_5781_6464 7 2.71E-06 0.000178778 6.88E-06 20398 hsa-mir-486 hsa04540 Gap junction 6714_5595_5594_5159_5156_1956 6 3.87E-06 0.000255508 9.46E-06 20399 hsa-mir-486 hsa04020 Calcium signaling pathway 2066_5159_5156_808_1956_801_805 7 1.65E-05 0.001088095 3.89E-05 20400 hsa-mir-486 hsa04664 Fc epsilon RI signaling pathway 695_5595_5594_6850_1432 5 2.80E-05 0.001848327 6.37E-05 20401 hsa-mir-486 hsa05219 Bladder cancer 5595_5594_5925_1956 4 4.15E-05 0.002742126 9.14E-05 20402 hsa-mir-486 hsa04810 Regulation of actin cytoskeleton 5595_5594_5159_5156_1399_1398_1956 7 4.83E-05 0.003187284 0.000102816 20403 hsa-mir-486 hsa04930 Type II diabetes mellitus 3651_3643_5595_5594 4 5.34E-05 0.003525986 0.000110187 20404 hsa-mir-486 hsa05213 Endometrial cancer 1499_5595_5594_1956 4 9.05E-05 0.005975772 0.000181084 20405 hsa-mir-486 hsa05223 Non-small cell lung cancer 5595_5594_5925_1956 4 0.000103916 0.006858431 0.000201719 20406 hsa-mir-486 hsa05010 Alzheimer's disease 5595_5594_4724_808_801_805 6 0.000124692 0.008229665 0.000235133 20407 hsa-mir-486 hsa04270 Vascular smooth muscle contraction 5595_5594_808_801_805 5 0.000172135 0.011360932 0.000315581 20408 hsa-mir-486 hsa04950 Maturity onset diabetes of the young 3651_168620_4760 3 0.000194153 0.012814095 0.000346327 20409 hsa-mir-486 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_1432_5781_1956 4 0.000281825 0.018600481 0.000489486 20410 hsa-mir-486 hsa05216 Thyroid cancer 1499_5595_5594 3 0.000324243 0.02140005 0.000548719 20411 hsa-mir-486 hsa04662 B cell receptor signaling pathway 695_5595_5594_6850 4 0.000343927 0.022699159 0.000567479 20412 hsa-mir-486 hsa04620 Toll-like receptor signaling pathway 5595_5594_1432_6772 4 0.001042625 0.068813273 0.001678373 20413 hsa-mir-486 hsa04110 Cell cycle 1387_6502_5925_2033 4 0.001804406 0.11909079 0.002835495 20414 hsa-mir-486 hsa04120 Ubiquitin mediated proteolysis 672_7329_867_6502 4 0.003113885 0.205516411 0.004779451 20415 hsa-mir-486 hsa04920 Adipocytokine signaling pathway 3717_5781_6774 3 0.003187978 0.210406578 0.004781968 20416 hsa-mir-486 hsa04730 Long-term depression 5515_5595_5594 3 0.003729799 0.246166745 0.005470372 20417 hsa-mir-486 hsa04310 Wnt signaling pathway 5515_1499_1387_2033 4 0.004246052 0.280239453 0.006092162 20418 hsa-mir-486 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.004481674 0.295790502 0.006293415 20419 hsa-mir-486 hsa04640 Hematopoietic cell lineage 3575_3815_2057 3 0.006440364 0.425064 0.0088555 20420 hsa-mir-486 hsa03010 Ribosome 6124_6129_6143 3 0.009822551 0.648288398 0.013230375 20421 hsa-mir-486 hsa04670 Leukocyte transendothelial migration 1499_1432_5781 3 0.015678993 1 0.020696271 20422 hsa-mir-486 hsa04530 Tight junction 5515_1499_6714 3 0.021115937 1 0.027326507 20423 hsa-mir-486 hsa04150 mTOR signaling pathway 5595_5594 2 0.02155285 1 0.02735554 20424 hsa-mir-486 hsa05016 Huntington's disease 1387_4724_2033 3 0.046346524 1 0.057714539 20425 hsa-mir-487b hsa05200 Pathways in cancer 7046_1499_5914_595_596_598_1017_4193_5578_6502_3091_2064_3066_3065_5925_613_5743_5747_25_1956_6789_4436_5970_2113_862_867_207_3716_1147_998_367_4233_2261_5595_5594_5599_1387_10401_2932_6777_6772_5979_5879_1869_3725_6774_6776_4087_4088_4089_5888_5728_2033_3480_3910_4790_4792_3320_3326_5371_675_5159_5156_5601_5602_1856_1399_1398_3815_51588_8772_1026_2353_1441_8554 75 5.84E-50 5.02E-48 5.02E-48 20426 hsa-mir-487b hsa04110 Cell cycle 595_1017_4193_902_6502_4174_4172_3066_3065_5925_25_9232_545_995_5347_5591_1387_11200_7534_7532_2932_7027_1869_4087_4088_4089_2033_890_891_1031_983_1026_1022_1111_8556_8555_472 37 3.09E-29 2.66E-27 1.33E-27 20427 hsa-mir-487b hsa04630 Jak-STAT signaling pathway 3559_595_598_5777_58985_3454_3455_3459_1439_3560_3561_2057_867_2690_207_3717_3716_3718_6773_85480_1387_3575_3570_3572_10401_6777_6772_7297_6774_6776_2033_149233_3953_51588_10379_5781_1441_8554 38 8.38E-27 7.20E-25 2.40E-25 20428 hsa-mir-487b hsa05220 Chronic myeloid leukemia 7046_595_598_4193_3066_3065_5925_613_25_5970_867_207_1147_5595_5594_6777_1869_6776_4088_4089_4790_4792_1399_1398_5781_1026_6464 27 4.72E-23 4.06E-21 1.01E-21 20429 hsa-mir-487b hsa04010 MAPK signaling pathway 3925_6722_7046_2264_9252_7867_5578_1845_7132_5923_1956_3304_3305_3303_6789_1432_5970_1616_207_1147_998_2261_5595_5594_5599_3315_5879_3164_3725_4790_51701_5159_9261_5156_4208_5601_5602_1399_1398_6885_2353 41 1.05E-21 9.00E-20 1.80E-20 20430 hsa-mir-487b hsa05215 Prostate cancer 1499_595_596_1017_4193_2064_5925_1956_5970_207_1147_367_5595_5594_1387_2932_1869_5728_2033_3480_4790_4792_3320_3326_5159_5156_1026 27 1.51E-21 1.30E-19 2.17E-20 20431 hsa-mir-487b hsa05212 Pancreatic cancer 1499_595_596_1017_4193_2064_5925_1956_5970_207_1147_367_5595_5594_1387_2932_1869_5728_2033_3480_4790_4792_3320_3326_5159_5156_1026 27 1.94E-21 1.66E-19 2.38E-20 20432 hsa-mir-487b hsa04520 Adherens junction 4301_7046_1499_5770_5777_2241_2064_2534_1956_6714_1460_998_4233_5595_5594_1387_5879_1457_4087_4088_4089_2033_3480_51701_3643_6885 26 2.54E-21 2.18E-19 2.73E-20 20433 hsa-mir-487b hsa05210 Colorectal cancer 7046_1499_595_596_1956_4436_207_4233_5595_5594_5599_2932_5879_3725_4087_4088_4089_3480_5159_5156_5601_5602_1856_2353 24 1.07E-18 9.17E-17 1.02E-17 20434 hsa-mir-487b hsa04012 ErbB signaling pathway 818_817_5578_2064_5747_25_1956_6714_867_207_5595_5594_5599_2066_2932_6777_3725_6776_5601_5602_1399_1398_1026_6464 24 2.11E-18 1.82E-16 1.82E-17 20435 hsa-mir-487b hsa04510 Focal adhesion 1499_595_596_5578_2064_5923_2534_5747_3791_1956_6714_5499_207_998_4233_5595_5594_5599_2932_5879_3725_5728_3480_3910_2321_5159_5156_5601_5602_1399_1398_6464 32 1.36E-17 1.17E-15 1.07E-16 20436 hsa-mir-487b hsa04060 Cytokine-cytokine receptor interaction 3556_3559_7046_1234_1230_7132_58985_3454_3455_3459_90_1439_3791_1956_3560_3561_7852_2057_6362_2690_85480_4233_3575_3570_3572_959_2321_149233_5159_5156_3815_3953_7133_1441 34 1.78E-16 1.53E-14 1.27E-15 20437 hsa-mir-487b hsa05214 Glioma 818_817_595_4193_5578_5925_1956_207_5595_5594_1869_5728_3480_808_801_805_5159_5156_1026_6464 20 2.51E-16 2.16E-14 1.66E-15 20438 hsa-mir-487b hsa04115 p53 signaling pathway 595_1017_4194_4193_900_50484_6241_51246_545_7161_11200_64326_5728_891_27113_25898_983_1026_1111_472 20 6.58E-16 5.66E-14 4.04E-15 20439 hsa-mir-487b hsa04062 Chemokine signaling pathway 2185_1234_1230_5747_5580_5590_7852_5970_6362_207_3055_3717_1147_3718_6773_998_5595_5594_2932_6777_6772_5879_6774_4790_4792_1399_1398_6464 28 6.92E-15 5.95E-13 3.97E-14 20440 hsa-mir-487b hsa04310 Wnt signaling pathway 818_817_1499_595_5578_1460_5599_1387_2932_5879_3725_1457_1452_4087_4088_4089_2033_51701_5515_5518_5601_5602_1856_6885_5527 25 1.55E-14 1.33E-12 8.32E-14 20441 hsa-mir-487b hsa04660 T cell receptor signaling pathway 5777_1493_2534_3932_1432_5970_867_207_1147_998_5595_5594_2932_3725_959_4790_4792_5601_919_6885_2353 21 1.56E-13 1.34E-11 7.88E-13 20442 hsa-mir-487b hsa05222 Small cell lung cancer 595_596_598_1017_6502_5925_5743_5747_5970_207_1147_10401_1869_5728_3910_4790_4792_51588_8554 19 2.34E-13 2.01E-11 1.12E-12 20443 hsa-mir-487b hsa04620 Toll-like receptor signaling pathway 3454_3455_1432_5970_207_1147_3654_5595_5594_5599_6772_5879_3725_4790_4792_5601_5602_8772_6885_2353 20 3.83E-13 3.29E-11 1.73E-12 20444 hsa-mir-487b hsa04920 Adipocytokine signaling pathway 6794_7132_8717_5970_207_3717_1147_5599_6774_4790_4792_5601_5602_5563_3953_5781_7133 17 6.28E-13 5.40E-11 2.70E-12 20445 hsa-mir-487b hsa04350 TGF-beta signaling pathway 7046_90_3398_57154_6667_3397_3399_5595_5594_1387_7027_4086_4087_4088_4089_2033_5515_5518 18 2.62E-12 2.25E-10 1.07E-11 20446 hsa-mir-487b hsa04912 GnRH signaling pathway 818_817_2185_5578_5580_1956_6714_1432_998_5595_5594_5599_3725_808_801_805_5601_5602 18 6.23E-11 5.36E-09 2.43E-10 20447 hsa-mir-487b hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_1432_5970_1147_998_4233_5599_5879_3725_4790_4792_5601_5602_5781 15 1.35E-10 1.16E-08 5.06E-10 20448 hsa-mir-487b hsa05221 Acute myeloid leukemia 5914_595_5970_862_207_1147_5595_5594_6777_6774_6776_4790_5371_3815 14 1.49E-10 1.28E-08 5.33E-10 20449 hsa-mir-487b hsa04910 Insulin signaling pathway 5770_5590_5499_867_207_5595_5594_5599_2932_808_801_805_3643_5601_5602_5563_1399_1398_6464 19 3.43E-10 2.95E-08 1.18E-09 20450 hsa-mir-487b hsa04120 Ubiquitin mediated proteolysis 4193_6502_3093_57154_7319_84447_867_7325_7329_10055_10401_64326_7337_5371_672_25898_51588_10075_8554 19 3.82E-10 3.29E-08 1.26E-09 20451 hsa-mir-487b hsa05218 Melanoma 595_4193_5925_1956_207_4233_5595_5594_1869_5728_3480_5159_5156_1026 14 1.23E-09 1.06E-07 3.92E-09 20452 hsa-mir-487b hsa05211 Renal cell carcinoma 3091_2113_207_998_4233_5595_5594_1387_5879_3725_2033_1399_1398_5781 14 1.44E-09 1.24E-07 4.43E-09 20453 hsa-mir-487b hsa04210 Apoptosis 3556_596_598_7132_8717_1439_823_5970_207_1147_3654_4790_4792_8772_472 15 2.14E-09 1.84E-07 6.34E-09 20454 hsa-mir-487b hsa04662 B cell receptor signaling pathway 5777_6850_5970_207_1147_5595_5594_1380_2932_5879_3725_4790_4792_2353 14 2.30E-09 1.98E-07 6.59E-09 20455 hsa-mir-487b hsa04370 VEGF signaling pathway 7867_5578_5743_5747_3791_6714_1432_207_998_5595_5594_3315_5879_9261 14 3.10E-09 2.67E-07 8.60E-09 20456 hsa-mir-487b hsa05219 Bladder cancer 595_9252_4193_2064_5925_1956_2261_5595_5594_1869_1026 11 5.82E-09 5.00E-07 1.56E-08 20457 hsa-mir-487b hsa04916 Melanogenesis 818_817_1499_5578_5595_5594_1387_2932_2033_808_801_805_1856_3815 14 9.30E-08 8.00E-06 2.42E-07 20458 hsa-mir-487b hsa04664 Fc epsilon RI signaling pathway 5578_2534_5580_6850_1432_207_5595_5594_5599_5879_5601_5602 12 2.39E-07 2.06E-05 6.05E-07 20459 hsa-mir-487b hsa04650 Natural killer cell mediated cytotoxicity 2185_5777_5578_3454_3455_3459_2534_3932_6850_5595_5594_5879_919_5781_6464 15 4.09E-07 3.52E-05 1.01E-06 20460 hsa-mir-487b hsa05223 Non-small cell lung cancer 595_5578_2064_5925_1956_6789_207_5595_5594_1869 10 4.84E-07 4.16E-05 1.16E-06 20461 hsa-mir-487b hsa04930 Type II diabetes mellitus 5580_5590_3651_5595_5594_5599_3643_5601_5602 9 1.03E-06 8.88E-05 2.35E-06 20462 hsa-mir-487b hsa04720 Long-term potentiation 818_817_5578_5499_5595_5594_1387_2033_808_801_805 11 1.04E-06 8.92E-05 2.35E-06 20463 hsa-mir-487b hsa04330 Notch signaling pathway 3066_3065_3280_1387_9612_2033_8850_388585_1856 9 1.42E-06 0.000122085 3.13E-06 20464 hsa-mir-487b hsa04530 Tight junction 4301_1499_5578_5580_5590_6714_207_1460_998_1457_5728_5515_5518_5520 14 1.94E-06 0.000166912 4.17E-06 20465 hsa-mir-487b hsa05213 Endometrial cancer 1499_595_2064_1956_207_5595_5594_2932_5728 9 2.98E-06 0.000256025 6.24E-06 20466 hsa-mir-487b hsa03420 Nucleotide excision repair 902_2965_4331_2071_2074_6118_1022_6117 8 7.70E-06 0.000662145 1.58E-05 20467 hsa-mir-487b hsa03022 Basal transcription factors 51616_2965_2969_6908_2958_6880_2957 7 2.29E-05 0.001970007 4.58E-05 20468 hsa-mir-487b hsa04360 Axon guidance 2534_5747_25_7852_2242_998_4233_5595_5594_2932_5879_1020 12 2.85E-05 0.002449292 5.57E-05 20469 hsa-mir-487b hsa04020 Calcium signaling pathway 818_817_2185_5578_2064_147_1956_2066_808_801_805_5159_5156 13 0.00016029 0.013784904 0.000306331 20470 hsa-mir-487b hsa03030 DNA replication 4174_4172_5557_6118_6117_5422 6 0.000165278 0.014213949 0.000308999 20471 hsa-mir-487b hsa04540 Gap junction 5578_1956_6714_5595_5594_1453_5159_983_5156 9 0.000192341 0.016541348 0.000351944 20472 hsa-mir-487b hsa04950 Maturity onset diabetes of the young 6927_3280_3651_3172_168620 5 0.000236241 0.020316684 0.000403712 20473 hsa-mir-487b hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_7132_1432_1616_5879_7133 7 0.000239411 0.020589316 0.000403712 20474 hsa-mir-487b hsa05131 Shigellosis 1499_5578_2534_25_998_7534_4691 7 0.000239411 0.020589316 0.000403712 20475 hsa-mir-487b hsa05130 Pathogenic Escherichia coli infection 1499_5578_2534_25_998_7534_4691 7 0.000239411 0.020589316 0.000403712 20476 hsa-mir-487b hsa04670 Leukocyte transendothelial migration 4301_2185_1499_5578_5747_1432_7852_998_5879_5781 10 0.000301502 0.025929169 0.000498638 20477 hsa-mir-487b hsa03440 Homologous recombination 641_5888_675_6118_6117 5 0.000442421 0.038048238 0.000717891 20478 hsa-mir-487b hsa05216 Thyroid cancer 1499_595_5595_5594_5979 5 0.00051035 0.043890123 0.00081278 20479 hsa-mir-487b hsa04612 Antigen processing and presentation 3309_3304_3305_3303_3320_3326_4802_2923 8 0.000681349 0.058596048 0.001065383 20480 hsa-mir-487b hsa04810 Regulation of actin cytoskeleton 2264_5747_1956_5499_998_2261_5595_5594_5879_5159_5156_1399_1398 13 0.000767361 0.065993016 0.001178447 20481 hsa-mir-487b hsa04270 Vascular smooth muscle contraction 5578_147_5580_5499_5595_5594_808_801_805 9 0.000965182 0.083005688 0.001449084 20482 hsa-mir-487b hsa04150 mTOR signaling pathway 6794_3091_207_5595_5594_5563 6 0.000977289 0.084046862 0.001449084 20483 hsa-mir-487b hsa05340 Primary immunodeficiency 3932_3561_3718_3575_959 5 0.00109506 0.094175174 0.001596189 20484 hsa-mir-487b hsa05010 Alzheimer's disease 7132_823_5595_5594_2932_1537_808_801_805_8772_1020 11 0.001349565 0.116062626 0.001934377 20485 hsa-mir-487b hsa04640 Hematopoietic cell lineage 3559_2057_1380_3575_3570_3815_1441 7 0.002625049 0.225754184 0.003700888 20486 hsa-mir-487b hsa04730 Long-term depression 5578_5595_5594_3480_5515_5518 6 0.004182866 0.359726461 0.00580204 20487 hsa-mir-487b hsa05016 Huntington's disease 3066_3065_3064_25942_6667_1387_1537_2033_27113_6908 10 0.006217379 0.534694572 0.008487215 20488 hsa-mir-487b hsa03410 Base excision repair 3146_142_4913_328 4 0.00782345 0.67281666 0.01051276 20489 hsa-mir-487b hsa03430 Mismatch repair 4436_6118_6117 3 0.014191802 1 0.018776845 20490 hsa-mir-487b hsa04070 Phosphatidylinositol signaling system 5578_5728_808_801_805 5 0.022129664 1 0.028835622 20491 hsa-mir-487b hsa04710 Circadian rhythm - mammal 1453_8553 2 0.034451873 1 0.044221807 20492 hsa-mir-487b hsa03450 Non-homologous end-joining 2547_5591 2 0.038868366 1 0.049157052 20493 hsa-mir-488 hsa05200 Pathways in cancer 5371_7046_6258_1387_6256_836_2932_842_841_6772_5970_4824_2736_4087_5925_2033_207 17 4.64E-14 2.87E-12 2.87E-12 20494 hsa-mir-488 hsa04010 MAPK signaling pathway 6722_8986_7046_9261_836_6197_9252_1432_5970_6195_6196_207_2002_2005 14 8.96E-12 5.56E-10 2.78E-10 20495 hsa-mir-488 hsa05215 Prostate cancer 1385_1387_2932_842_5970_4824_5925_2033_207 9 1.84E-10 1.14E-08 3.13E-09 20496 hsa-mir-488 hsa05212 Pancreatic cancer 1385_1387_2932_842_5970_4824_5925_2033_207 9 2.02E-10 1.25E-08 3.13E-09 20497 hsa-mir-488 hsa04520 Adherens junction 4301_7046_6714_1387_1457_4087_2033 7 5.66E-08 3.51E-06 7.02E-07 20498 hsa-mir-488 hsa04210 Apoptosis 836_839_842_841_840_5970_207 7 1.12E-07 6.95E-06 1.16E-06 20499 hsa-mir-488 hsa04720 Long-term potentiation 815_1387_6197_6195_6196_2033 6 8.54E-07 5.29E-05 7.56E-06 20500 hsa-mir-488 hsa05210 Colorectal cancer 7046_836_2932_842_4087_207 6 1.59E-06 9.87E-05 1.23E-05 20501 hsa-mir-488 hsa05222 Small cell lung cancer 6258_6256_842_5970_5925_207 6 1.81E-06 0.000112266 1.25E-05 20502 hsa-mir-488 hsa05223 Non-small cell lung cancer 6258_6256_842_5925_207 5 3.73E-06 0.000231554 2.32E-05 20503 hsa-mir-488 hsa04110 Cell cycle 5591_1387_2932_4087_5925_2033 6 1.07E-05 0.000664306 6.04E-05 20504 hsa-mir-488 hsa05016 Huntington's disease 1385_1387_836_842_841_3064_2033 7 1.30E-05 0.000806371 6.72E-05 20505 hsa-mir-488 hsa04370 VEGF signaling pathway 6714_9261_1432_842_207 5 1.89E-05 0.001173892 9.03E-05 20506 hsa-mir-488 hsa04012 ErbB signaling pathway 815_6714_2932_207_2002 5 3.31E-05 0.002050275 0.000146448 20507 hsa-mir-488 hsa04310 Wnt signaling pathway 815_1387_2932_1457_4087_2033 6 4.03E-05 0.002501025 0.000166735 20508 hsa-mir-488 hsa04620 Toll-like receptor signaling pathway 1432_841_6772_5970_207 5 6.82E-05 0.004228248 0.00024303 20509 hsa-mir-488 hsa05213 Endometrial cancer 2932_842_207_2002 4 7.26E-05 0.004500708 0.00024303 20510 hsa-mir-488 hsa04150 mTOR signaling pathway 6197_6195_6196_207 4 7.26E-05 0.004500708 0.00024303 20511 hsa-mir-488 hsa04916 Melanogenesis 815_1385_1387_2932_2033 5 7.45E-05 0.004617577 0.00024303 20512 hsa-mir-488 hsa05010 Alzheimer's disease 22926_836_2932_842_841_840 6 9.11E-05 0.005648123 0.000282406 20513 hsa-mir-488 hsa04920 Adipocytokine signaling pathway 6258_6256_5970_207 4 0.000183473 0.011375341 0.000541683 20514 hsa-mir-488 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_836_1432_5970 4 0.000226741 0.014057917 0.000638996 20515 hsa-mir-488 hsa05220 Chronic myeloid leukemia 7046_5970_5925_207 4 0.000276906 0.017168151 0.000746441 20516 hsa-mir-488 hsa04350 TGF-beta signaling pathway 7046_1387_4087_2033 4 0.000474953 0.029447099 0.001226962 20517 hsa-mir-488 hsa03022 Basal transcription factors 2963_2962_2969 3 0.000534007 0.033108436 0.001324337 20518 hsa-mir-488 hsa04330 Notch signaling pathway 1387_9612_2033 3 0.001029368 0.063820791 0.002378277 20519 hsa-mir-488 hsa04912 GnRH signaling pathway 815_6714_1432_2002 4 0.001035701 0.064213483 0.002378277 20520 hsa-mir-488 hsa04660 T cell receptor signaling pathway 2932_1432_5970_207 4 0.001106042 0.068574595 0.002449093 20521 hsa-mir-488 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432_842 3 0.001663829 0.103157386 0.003557151 20522 hsa-mir-488 hsa05221 Acute myeloid leukemia 5371_5970_207 3 0.001919084 0.118983223 0.003966107 20523 hsa-mir-488 hsa04530 Tight junction 4301_6714_1457_207 4 0.002410355 0.149442028 0.004820711 20524 hsa-mir-488 hsa05214 Glioma 815_5925_207 3 0.002499711 0.154982101 0.004843191 20525 hsa-mir-488 hsa04115 p53 signaling pathway 836_842_841 3 0.002940917 0.182336872 0.00552536 20526 hsa-mir-488 hsa05211 Renal cell carcinoma 1387_2033_207 3 0.003301307 0.204681025 0.00602003 20527 hsa-mir-488 hsa04662 B cell receptor signaling pathway 2932_5970_207 3 0.003687628 0.228632936 0.006389461 20528 hsa-mir-488 hsa04630 Jak-STAT signaling pathway 1387_6772_2033_207 4 0.00371001 0.230020593 0.006389461 20529 hsa-mir-488 hsa05216 Thyroid cancer 6258_6256 2 0.006678707 0.414079844 0.011191347 20530 hsa-mir-488 hsa04062 Chemokine signaling pathway 2932_6772_5970_207 4 0.007858104 0.487202477 0.012821118 20531 hsa-mir-488 hsa04510 Focal adhesion 6714_2932_207_2002 4 0.009778316 0.606255592 0.015545015 20532 hsa-mir-488 hsa05219 Bladder cancer 9252_5925 2 0.013141504 0.814773243 0.020369331 20533 hsa-mir-488 hsa04910 Insulin signaling pathway 2932_207_2002 3 0.018536322 1 0.028030536 20534 hsa-mir-488 hsa05217 Basal cell carcinoma 2932_2736 2 0.021446677 1 0.03165938 20535 hsa-mir-488 hsa04340 Hedgehog signaling pathway 2932_2736 2 0.022875092 1 0.032982691 20536 hsa-mir-488 hsa03320 PPAR signaling pathway 6258_6256 2 0.033060942 1 0.046585872 20537 hsa-mir-488 hsa05218 Melanoma 5925_207 2 0.033906089 1 0.046715056 20538 hsa-mir-488 hsa04664 Fc epsilon RI signaling pathway 1432_207 2 0.040963199 1 0.055211268 20539 hsa-mir-490 hsa05200 Pathways in cancer 3065_4087_4088_4089_3725_1488_207_208_2932_367_1499_5594_1387_5595_1487 15 9.31E-14 5.31E-12 5.31E-12 20540 hsa-mir-490 hsa05210 Colorectal cancer 4087_4088_4089_3725_207_208_2932_1499_5594_5595 10 2.00E-13 1.14E-11 5.70E-12 20541 hsa-mir-490 hsa05220 Chronic myeloid leukemia 3065_4088_4089_1488_207_208_5594_5595_1487 9 3.17E-12 1.80E-10 6.02E-11 20542 hsa-mir-490 hsa05215 Prostate cancer 468_207_208_2932_367_1499_5594_1387_5595 9 1.19E-11 6.79E-10 1.49E-10 20543 hsa-mir-490 hsa05212 Pancreatic cancer 468_207_208_2932_367_1499_5594_1387_5595 9 1.31E-11 7.46E-10 1.49E-10 20544 hsa-mir-490 hsa04520 Adherens junction 4087_4088_4089_1499_6714_5594_1387_5595 8 2.05E-10 1.17E-08 1.95E-09 20545 hsa-mir-490 hsa04012 ErbB signaling pathway 5058_3725_207_208_2932_6714_5594_5595 8 3.82E-10 2.18E-08 3.11E-09 20546 hsa-mir-490 hsa04310 Wnt signaling pathway 4087_4088_4089_3725_1488_2932_1499_1387_1487 9 1.14E-09 6.52E-08 8.15E-09 20547 hsa-mir-490 hsa05211 Renal cell carcinoma 5058_3725_207_208_5594_1387_5595 7 3.51E-09 2.00E-07 2.22E-08 20548 hsa-mir-490 hsa04110 Cell cycle 3065_4087_4088_4089_7534_7532_2932_1387 8 3.91E-09 2.23E-07 2.23E-08 20549 hsa-mir-490 hsa04350 TGF-beta signaling pathway 4087_4088_4089_659_5594_1387_5595 7 1.20E-08 6.82E-07 6.20E-08 20550 hsa-mir-490 hsa04510 Focal adhesion 5058_3725_207_208_2932_1499_6714_5594_5595 9 1.44E-08 8.21E-07 6.84E-08 20551 hsa-mir-490 hsa05213 Endometrial cancer 207_208_2932_1499_5594_5595 6 1.89E-08 1.07E-06 8.27E-08 20552 hsa-mir-490 hsa04660 T cell receptor signaling pathway 5058_3725_207_208_2932_5594_5595 7 5.49E-08 3.13E-06 2.23E-07 20553 hsa-mir-490 hsa04662 B cell receptor signaling pathway 3725_207_208_2932_5594_5595 6 1.43E-07 8.17E-06 5.24E-07 20554 hsa-mir-490 hsa04010 MAPK signaling pathway 6722_5058_3725_3727_468_207_208_5594_5595 9 1.47E-07 8.38E-06 5.24E-07 20555 hsa-mir-490 hsa04530 Tight junction 207_208_60412_4628_1499_6714 6 4.08E-06 0.000232574 1.31E-05 20556 hsa-mir-490 hsa04910 Insulin signaling pathway 207_208_2932_5594_5595_2538 6 4.25E-06 0.00024212 1.31E-05 20557 hsa-mir-490 hsa04370 VEGF signaling pathway 207_208_6714_5594_5595 5 4.36E-06 0.000248495 1.31E-05 20558 hsa-mir-490 hsa04330 Notch signaling pathway 3065_1488_1387_1487 4 1.54E-05 0.000875987 4.33E-05 20559 hsa-mir-490 hsa04620 Toll-like receptor signaling pathway 3725_207_208_5594_5595 5 1.60E-05 0.000914222 4.33E-05 20560 hsa-mir-490 hsa05010 Alzheimer's disease 9451_10476_2932_5594_5595_823 6 1.67E-05 0.000952676 4.33E-05 20561 hsa-mir-490 hsa04916 Melanogenesis 2932_1499_5594_1387_5595 5 1.75E-05 0.001000092 4.35E-05 20562 hsa-mir-490 hsa04912 GnRH signaling pathway 3725_468_6714_5594_5595 5 2.09E-05 0.001190604 4.96E-05 20563 hsa-mir-490 hsa04150 mTOR signaling pathway 207_208_5594_5595 4 2.23E-05 0.001273212 5.09E-05 20564 hsa-mir-490 hsa05223 Non-small cell lung cancer 207_208_5594_5595 4 2.57E-05 0.001464193 5.63E-05 20565 hsa-mir-490 hsa04062 Chemokine signaling pathway 5058_207_208_2932_5594_5595 6 2.68E-05 0.001527875 5.66E-05 20566 hsa-mir-490 hsa05221 Acute myeloid leukemia 207_208_5594_5595 4 3.57E-05 0.00203292 7.26E-05 20567 hsa-mir-490 hsa05214 Glioma 207_208_5594_5595 4 5.11E-05 0.002911259 0.000100388 20568 hsa-mir-490 hsa04950 Maturity onset diabetes of the young 3651_3172_5080 3 6.72E-05 0.003830752 0.000127692 20569 hsa-mir-490 hsa05218 Melanoma 207_208_5594_5595 4 7.09E-05 0.004038795 0.000130284 20570 hsa-mir-490 hsa04720 Long-term potentiation 468_5594_1387_5595 4 8.68E-05 0.004948389 0.000154637 20571 hsa-mir-490 hsa04664 Fc epsilon RI signaling pathway 207_208_5594_5595 4 0.000105236 0.005998466 0.000181772 20572 hsa-mir-490 hsa05216 Thyroid cancer 1499_5594_5595 3 0.000112765 0.00642758 0.000189046 20573 hsa-mir-490 hsa04930 Type II diabetes mellitus 3651_5594_5595 3 0.000380154 0.021668773 0.000619108 20574 hsa-mir-490 hsa04360 Axon guidance 5058_2932_5594_5595 4 0.000675186 0.038485589 0.001069044 20575 hsa-mir-490 hsa04920 Adipocytokine signaling pathway 207_208_2538 3 0.001148638 0.065472386 0.001769524 20576 hsa-mir-490 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5058_3725_6714 3 0.001348836 0.076883652 0.002023254 20577 hsa-mir-490 hsa05016 Huntington's disease 3065_25942_10476_1387 4 0.002468142 0.14068407 0.003585357 20578 hsa-mir-490 hsa04210 Apoptosis 207_208_823 3 0.00251604 0.143414283 0.003585357 20579 hsa-mir-490 hsa04540 Gap junction 6714_5594_5595 3 0.002838724 0.161807275 0.003946519 20580 hsa-mir-490 hsa04810 Regulation of actin cytoskeleton 5058_4628_5594_5595 4 0.004213309 0.240158637 0.005718063 20581 hsa-mir-490 hsa05219 Bladder cancer 5594_5595 2 0.007387231 0.42107218 0.009792376 20582 hsa-mir-490 hsa04650 Natural killer cell mediated cytotoxicity 5058_5594_5595 3 0.008269487 0.471360782 0.010712745 20583 hsa-mir-490 hsa04630 Jak-STAT signaling pathway 207_208_1387 3 0.011256779 0.641636402 0.014258587 20584 hsa-mir-490 hsa05217 Basal cell carcinoma 2932_1499 2 0.012160915 0.693172154 0.014928677 20585 hsa-mir-490 hsa05131 Shigellosis 7534_1499 2 0.012571518 0.716576506 0.014928677 20586 hsa-mir-490 hsa05130 Pathogenic Escherichia coli infection 7534_1499 2 0.012571518 0.716576506 0.014928677 20587 hsa-mir-490 hsa04340 Hedgehog signaling pathway 2932_53944 2 0.012988127 0.74032326 0.015108638 20588 hsa-mir-490 hsa04730 Long-term depression 5594_5595 2 0.019430525 1 0.022150799 20589 hsa-mir-490 hsa05222 Small cell lung cancer 207_208 2 0.027517997 1 0.030755409 20590 hsa-mir-490 hsa04270 Vascular smooth muscle contraction 5594_5595 2 0.048353264 1 0.053002616 20591 hsa-mir-492 hsa04110 Cell cycle 1869_25_5925_545_995_1026_5591_983_4088_7534_1017_2932_4193_7027_902_1387_1031_9232_5347_1022_4087_7532_3065_1111_2033_890_11200_8556_8555_472 30 2.37E-31 1.99E-29 1.99E-29 20592 hsa-mir-492 hsa05200 Pathways in cancer 1147_3320_1869_5743_3326_5747_25_5925_675_998_1026_5594_5595_5599_596_5601_6789_1856_4088_613_1017_2932_4193_1387_5578_51588_8554_5371_4436_598_4087_5888_5728_3065_3091_2033_3910_4792_5602 39 2.92E-29 2.45E-27 1.23E-27 20593 hsa-mir-492 hsa04115 p53 signaling pathway 50484_545_6241_1026_25898_983_1017_27113_4194_4193_900_7161_64326_5728_51246_1111_11200_472 18 1.74E-19 1.46E-17 4.87E-18 20594 hsa-mir-492 hsa05215 Prostate cancer 1147_3320_1869_3326_5925_1026_5594_5595_596_1017_2932_4193_1387_5728_2033_4792 16 2.66E-15 2.23E-13 5.23E-14 20595 hsa-mir-492 hsa05212 Pancreatic cancer 1147_3320_1869_3326_5925_1026_5594_5595_596_1017_2932_4193_1387_5728_2033_4792 16 3.11E-15 2.61E-13 5.23E-14 20596 hsa-mir-492 hsa05220 Chronic myeloid leukemia 1147_1869_25_5925_1026_5594_5595_4088_613_4193_598_3065_4792 13 1.93E-12 1.63E-10 2.71E-11 20597 hsa-mir-492 hsa04310 Wnt signaling pathway 1460_5518_5515_5599_5601_1856_1457_4088_2932_1387_5578_1452_4087_5527_2033_5602 16 5.42E-12 4.56E-10 6.51E-11 20598 hsa-mir-492 hsa05222 Small cell lung cancer 1147_1869_5743_5747_5925_596_1017_51588_8554_598_5728_3910_4792 13 9.10E-12 7.65E-10 9.56E-11 20599 hsa-mir-492 hsa04120 Ubiquitin mediated proteolysis 10055_672_7319_25898_84447_4193_3093_51588_8554_5371_64326_7329_10075_7337 14 2.01E-10 1.69E-08 1.88E-09 20600 hsa-mir-492 hsa05210 Colorectal cancer 5594_5595_5599_596_5601_1856_4088_2932_4436_4087_5602 11 1.47E-09 1.23E-07 1.23E-08 20601 hsa-mir-492 hsa04010 MAPK signaling pathway 1147_998_5594_5595_5599_5601_3304_3305_3303_6789_3315_5578_3164_1616_5923_5602 16 1.60E-08 1.34E-06 1.22E-07 20602 hsa-mir-492 hsa04510 Focal adhesion 5747_998_5594_5595_5599_596_5601_5499_2932_5578_5728_5923_3910_5602 14 2.26E-08 1.90E-06 1.55E-07 20603 hsa-mir-492 hsa04350 TGF-beta signaling pathway 5518_5515_5594_5595_6667_4088_7027_1387_4087_2033 10 2.58E-08 2.17E-06 1.55E-07 20604 hsa-mir-492 hsa04012 ErbB signaling pathway 5747_25_1026_5594_5595_5599_5601_2932_5578_5602 10 2.58E-08 2.17E-06 1.55E-07 20605 hsa-mir-492 hsa04520 Adherens junction 1460_998_5594_5595_1457_4088_1387_4087_2033 9 1.54E-07 1.29E-05 8.61E-07 20606 hsa-mir-492 hsa05214 Glioma 1869_5925_1026_5594_5595_4193_5578_5728 8 4.08E-07 3.43E-05 2.14E-06 20607 hsa-mir-492 hsa03420 Nucleotide excision repair 2965_4331_2074_6117_2071_902_1022 7 4.60E-07 3.86E-05 2.27E-06 20608 hsa-mir-492 hsa03022 Basal transcription factors 2965_2957_6908_51616_2958_6880 6 2.82E-06 0.00023712 1.32E-05 20609 hsa-mir-492 hsa05219 Bladder cancer 1869_5925_1026_5594_5595_4193 6 5.46E-06 0.000459039 2.42E-05 20610 hsa-mir-492 hsa04920 Adipocytokine signaling pathway 1147_5563_6794_5599_5601_4792_5602 7 5.96E-06 0.00050027 2.50E-05 20611 hsa-mir-492 hsa05218 Melanoma 1869_5925_1026_5594_5595_4193_5728 7 8.47E-06 0.000711521 3.39E-05 20612 hsa-mir-492 hsa04370 VEGF signaling pathway 5743_5747_998_5594_5595_3315_5578 7 1.38E-05 0.001163259 5.29E-05 20613 hsa-mir-492 hsa04660 T cell receptor signaling pathway 1147_998_5594_5595_5601_2932_959_4792 8 1.55E-05 0.001299151 5.65E-05 20614 hsa-mir-492 hsa05223 Non-small cell lung cancer 1869_5925_5594_5595_6789_5578 6 2.03E-05 0.001705569 7.11E-05 20615 hsa-mir-492 hsa04530 Tight junction 1460_998_5518_5515_1457_5578_5728_5520 8 6.78E-05 0.005698228 0.000227929 20616 hsa-mir-492 hsa04910 Insulin signaling pathway 5563_5594_5595_5599_5601_5499_2932_5602 8 7.12E-05 0.005980607 0.000230023 20617 hsa-mir-492 hsa04620 Toll-like receptor signaling pathway 1147_5594_5595_5599_5601_4792_5602 7 7.48E-05 0.006280528 0.000232612 20618 hsa-mir-492 hsa04916 Melanogenesis 5594_5595_1856_2932_1387_5578_2033 7 8.39E-05 0.007046724 0.000244044 20619 hsa-mir-492 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_998_5599_5601_4792_5602 6 8.43E-05 0.00707728 0.000244044 20620 hsa-mir-492 hsa05211 Renal cell carcinoma 998_5594_5595_1387_3091_2033 6 9.06E-05 0.00760776 0.000253592 20621 hsa-mir-492 hsa04930 Type II diabetes mellitus 5594_5595_5599_5601_5602 5 0.000101659 0.008539332 0.000275252 20622 hsa-mir-492 hsa04912 GnRH signaling pathway 998_5594_5595_5599_5601_5578_5602 7 0.000104858 0.008808071 0.000275252 20623 hsa-mir-492 hsa04720 Long-term potentiation 5594_5595_5499_1387_5578_2033 6 0.000111803 0.009391419 0.000276218 20624 hsa-mir-492 hsa04662 B cell receptor signaling pathway 1147_5594_5595_1380_2932_4792 6 0.000111803 0.009391419 0.000276218 20625 hsa-mir-492 hsa04330 Notch signaling pathway 1856_1387_3065_2033_8850 5 0.000122822 0.010317032 0.000294772 20626 hsa-mir-492 hsa04664 Fc epsilon RI signaling pathway 5594_5595_5599_5601_5578_5602 6 0.000146063 0.012269315 0.000340814 20627 hsa-mir-492 hsa04150 mTOR signaling pathway 5563_5594_6794_5595_3091 5 0.000190517 0.016003464 0.000432526 20628 hsa-mir-492 hsa03440 Homologous recombination 675_6117_641_5888 4 0.000215567 0.018107618 0.000476516 20629 hsa-mir-492 hsa05131 Shigellosis 25_998_7534_5578_4691 5 0.000262618 0.022059887 0.000537232 20630 hsa-mir-492 hsa05130 Pathogenic Escherichia coli infection 25_998_7534_5578_4691 5 0.000262618 0.022059887 0.000537232 20631 hsa-mir-492 hsa04612 Antigen processing and presentation 3320_3326_3309_3304_3305_3303 6 0.000268616 0.022563757 0.000537232 20632 hsa-mir-492 hsa04210 Apoptosis 1147_823_596_598_4792_472 6 0.000268616 0.022563757 0.000537232 20633 hsa-mir-492 hsa04360 Axon guidance 5747_25_998_5594_5595_2932_1020 7 0.000323521 0.027175774 0.000631995 20634 hsa-mir-492 hsa03410 Base excision repair 142_3146_328_4913 4 0.00051675 0.043407036 0.000986524 20635 hsa-mir-492 hsa05016 Huntington's disease 25942_3064_6908_6667_27113_1387_3065_2033 8 0.000530413 0.044554698 0.000990104 20636 hsa-mir-492 hsa04062 Chemokine signaling pathway 1147_5747_998_5594_5595_2932_6362_4792 8 0.000625847 0.052571111 0.00114285 20637 hsa-mir-492 hsa04730 Long-term depression 5518_5515_5594_5595_5578 5 0.000728171 0.061166388 0.001301413 20638 hsa-mir-492 hsa05213 Endometrial cancer 5594_5595_2932_5728 4 0.001848488 0.155273032 0.003234855 20639 hsa-mir-492 hsa04540 Gap junction 5594_5595_983_1453_5578 5 0.002268327 0.190539465 0.003888561 20640 hsa-mir-492 hsa05221 Acute myeloid leukemia 1147_5594_5595_5371 4 0.002849461 0.239354748 0.004787095 20641 hsa-mir-492 hsa03030 DNA replication 6117_5557_5422 3 0.00570072 0.478860514 0.009389422 20642 hsa-mir-492 hsa03450 Non-homologous end-joining 5591_2547 2 0.009514126 0.799186573 0.015368973 20643 hsa-mir-492 hsa04630 Jak-STAT signaling pathway 1387_51588_8554_598_2033 5 0.017267025 1 0.027366606 20644 hsa-mir-492 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_1616 3 0.017703213 1 0.027538331 20645 hsa-mir-492 hsa04340 Hedgehog signaling pathway 1453_2932_1452 3 0.01850949 1 0.028269039 20646 hsa-mir-492 hsa03430 Mismatch repair 6117_4436 2 0.022514911 1 0.033772366 20647 hsa-mir-492 hsa04270 Vascular smooth muscle contraction 5594_5595_5499_5578 4 0.027517877 1 0.040552661 20648 hsa-mir-492 hsa05010 Alzheimer's disease 5594_5595_823_2932_1020 5 0.028178022 1 0.040809549 20649 hsa-mir-492 hsa05216 Thyroid cancer 5594_5595 2 0.033651395 1 0.047910461 20650 hsa-mir-493 hsa04950 Maturity onset diabetes of the young 3651_5080 2 0.000330014 0.002640114 0.002640114 20651 hsa-mir-493 hsa04530 Tight junction 60412_4628 2 0.00905837 0.072466958 0.036233479 20652 hsa-mir-493 hsa04930 Type II diabetes mellitus 3651 1 0.046431905 0.371455239 0.123818413 20653 hsa-mir-495 hsa04520 Adherens junction 1499_4089_4088_2033_1460_6714_1387 7 5.44E-09 3.26E-07 2.33E-07 20654 hsa-mir-495 hsa04010 MAPK signaling pathway 9261_6722_8986_6195_207_9252_1432_6196_6197_5058 10 7.78E-09 4.67E-07 2.33E-07 20655 hsa-mir-495 hsa05200 Pathways in cancer 2736_1499_4089_4286_4088_2033_207_2932_367_1387 10 4.65E-08 2.79E-06 9.30E-07 20656 hsa-mir-495 hsa04110 Cell cycle 4089_4088_2033_2932_7534_1387_7532 7 7.19E-08 4.31E-06 1.08E-06 20657 hsa-mir-495 hsa05215 Prostate cancer 1499_2033_207_2932_367_1387 6 2.84E-07 1.70E-05 3.02E-06 20658 hsa-mir-495 hsa05212 Pancreatic cancer 1499_2033_207_2932_367_1387 6 3.02E-07 1.81E-05 3.02E-06 20659 hsa-mir-495 hsa04310 Wnt signaling pathway 1499_4089_4088_2033_1460_2932_1387 7 3.52E-07 2.11E-05 3.02E-06 20660 hsa-mir-495 hsa04720 Long-term potentiation 6195_2033_6196_6197_1387 5 3.25E-06 0.000195156 2.44E-05 20661 hsa-mir-495 hsa05210 Colorectal cancer 1499_4089_4088_207_2932 5 5.51E-06 0.000330314 3.67E-05 20662 hsa-mir-495 hsa04916 Melanogenesis 1499_4286_2033_2932_1387 5 1.48E-05 0.000889491 8.89E-05 20663 hsa-mir-495 hsa04660 T cell receptor signaling pathway 1739_207_2932_1432_5058 5 1.92E-05 0.001153123 9.74E-05 20664 hsa-mir-495 hsa04150 mTOR signaling pathway 6195_207_6196_6197 4 1.95E-05 0.001169 9.74E-05 20665 hsa-mir-495 hsa04510 Focal adhesion 1499_207_2932_6714_1729_5058 6 3.14E-05 0.00188319 0.000144861 20666 hsa-mir-495 hsa04530 Tight junction 1499_1460_207_10207_6714 5 5.29E-05 0.003171647 0.000226546 20667 hsa-mir-495 hsa05211 Renal cell carcinoma 2033_207_5058_1387 4 6.52E-05 0.003911705 0.00026078 20668 hsa-mir-495 hsa04370 VEGF signaling pathway 9261_207_6714_1432 4 8.36E-05 0.005018487 0.000313655 20669 hsa-mir-495 hsa04350 TGF-beta signaling pathway 4089_4088_2033_1387 4 0.000131512 0.007890714 0.000438373 20670 hsa-mir-495 hsa04012 ErbB signaling pathway 207_2932_6714_5058 4 0.000131512 0.007890714 0.000438373 20671 hsa-mir-495 hsa05016 Huntington's disease 3064_6908_2033_4716_1387 5 0.000223291 0.013397442 0.000705129 20672 hsa-mir-495 hsa05213 Endometrial cancer 1499_207_2932 3 0.000513529 0.030811749 0.001540587 20673 hsa-mir-495 hsa05217 Basal cell carcinoma 2736_1499_2932 3 0.000600307 0.036018399 0.001715162 20674 hsa-mir-495 hsa04340 Hedgehog signaling pathway 2736_53944_2932 3 0.000663051 0.039783069 0.001808321 20675 hsa-mir-495 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_1432_5058 3 0.001220812 0.073248725 0.003184727 20676 hsa-mir-495 hsa05220 Chronic myeloid leukemia 4089_4088_207 3 0.001421133 0.085267962 0.003552832 20677 hsa-mir-495 hsa04950 Maturity onset diabetes of the young 3651_3172 2 0.002453308 0.147198506 0.00588794 20678 hsa-mir-495 hsa03022 Basal transcription factors 2963_6908 2 0.005462071 0.327724288 0.01260478 20679 hsa-mir-495 hsa04360 Axon guidance 2932_5998_5058 3 0.006539987 0.392399247 0.014533305 20680 hsa-mir-495 hsa04910 Insulin signaling pathway 2538_207_2932 3 0.007521132 0.451267912 0.016116711 20681 hsa-mir-495 hsa04330 Notch signaling pathway 2033_1387 2 0.00851177 0.510706213 0.017610559 20682 hsa-mir-495 hsa04630 Jak-STAT signaling pathway 2033_207_1387 3 0.010250591 0.615035436 0.020501181 20683 hsa-mir-495 hsa05131 Shigellosis 1499_7534 2 0.011769713 0.706182795 0.022068212 20684 hsa-mir-495 hsa05130 Pathogenic Escherichia coli infection 1499_7534 2 0.011769713 0.706182795 0.022068212 20685 hsa-mir-495 hsa04920 Adipocytokine signaling pathway 2538_207 2 0.016373367 0.982402023 0.029769758 20686 hsa-mir-495 hsa04062 Chemokine signaling pathway 207_2932_5058 3 0.018200018 1 0.031215205 20687 hsa-mir-495 hsa05218 Melanoma 4286_207 2 0.018208869 1 0.031215205 20688 hsa-mir-495 hsa04662 B cell receptor signaling pathway 207_2932 2 0.020127151 1 0.033545251 20689 hsa-mir-495 hsa04664 Fc epsilon RI signaling pathway 207_1432 2 0.022126162 1 0.035880262 20690 hsa-mir-495 hsa04540 Gap junction 6714_5592 2 0.029729662 1 0.046941572 20691 hsa-mir-495 hsa04620 Toll-like receptor signaling pathway 207_1432 2 0.035088133 1 0.053981743 20692 hsa-mir-495 hsa04912 GnRH signaling pathway 6714_1432 2 0.038852364 1 0.058278547 20693 hsa-mir-495 hsa04670 Leukocyte transendothelial migration 1499_1432 2 0.048195086 1 0.070529394 20694 hsa-mir-496 hsa05200 Pathways in cancer 7046_5468_595_2261_8517_3551_4089_3066_3065_5925_7187_5747_10342_1956_207_3716_1147_4233_5595_5594_5599_1387_2064_6256_4286_367_10401_2932_6774_6776_6777_6772_5979_5879_3725_2033_898_4790_4791_4792_5970_3320_3326_5371_3480_5159_5156_3815_3265_8772_4609_1026_2353_1441_8554 55 2.37E-28 1.99E-26 1.99E-26 20695 hsa-mir-496 hsa04630 Jak-STAT signaling pathway 3559_595_58985_3454_3455_3560_3561_1439_2690_207_3717_3716_3718_8651_85480_1387_3575_3570_3572_10401_6778_6774_6776_6777_6772_6773_7297_2033_149233_3953_3459_5781_4609_1441_8554_10379 36 3.30E-23 2.78E-21 1.39E-21 20696 hsa-mir-496 hsa04010 MAPK signaling pathway 3925_6722_7046_2261_2264_8517_3551_1845_9020_1956_7132_3303_1432_22800_207_1147_5595_5594_5599_9252_3310_3312_5971_5879_3725_4790_4791_51701_5970_5159_1326_5156_5608_5566_3265_6885_4609_2353_3305 39 1.97E-18 1.66E-16 5.52E-17 20697 hsa-mir-496 hsa05215 Prostate cancer 595_8517_3551_5925_1956_207_1147_5595_5594_1387_2064_367_2932_2033_898_4790_4792_5970_3320_3326_3480_5159_5156_3265_1026 25 2.78E-18 2.34E-16 5.84E-17 20698 hsa-mir-496 hsa05212 Pancreatic cancer 595_8517_3551_5925_1956_207_1147_5595_5594_1387_2064_367_2932_2033_898_4790_4792_5970_3320_3326_3480_5159_5156_3265_1026 25 3.49E-18 2.93E-16 5.87E-17 20699 hsa-mir-496 hsa04620 Toll-like receptor signaling pathway 8517_3551_3454_3455_7187_3661_1432_207_1147_3654_29110_5595_5594_5599_6772_5879_3725_4790_4792_5970_1326_5608_9641_8772_6885_2353 26 5.66E-18 4.75E-16 7.92E-17 20700 hsa-mir-496 hsa03010 Ribosome 6155_6156_6128_6193_6204_6205_6207_6202_6141_6217_6130_6137_6135_6210_6191_9349_6222_6223_6229_6129_6181_6189_6188_6232 24 5.06E-16 4.25E-14 6.07E-15 20701 hsa-mir-496 hsa05220 Chronic myeloid leukemia 7046_595_8517_3551_4089_3066_3065_5925_207_1147_5595_5594_6776_6777_4790_4792_5970_3265_5781_4609_1026 21 1.81E-15 1.52E-13 1.90E-14 20702 hsa-mir-496 hsa04920 Adipocytokine signaling pathway 5465_8517_3551_7133_7132_4794_8471_207_3717_1147_8717_5599_6256_6774_4790_4792_4793_5970_3953_5781 20 3.05E-15 2.56E-13 2.84E-14 20703 hsa-mir-496 hsa04062 Chemokine signaling pathway 8517_1230_3551_653361_5747_5580_7852_207_3055_3717_1147_3718_5590_5595_5594_1234_2932_6774_6777_6772_6773_5879_4790_4792_4793_5970_5566_3265_2185 29 1.52E-14 1.28E-12 1.28E-13 20704 hsa-mir-496 hsa04520 Adherens junction 7046_4089_1460_2534_1956_6714_71_2241_4233_5595_5594_1387_2064_5879_1457_2033_51701_3480_8826_6885 20 5.27E-14 4.42E-12 4.02E-13 20705 hsa-mir-496 hsa04660 T cell receptor signaling pathway 8517_3551_9020_2534_3932_1432_4794_207_1147_5595_5594_2932_3725_4790_4792_4793_5970_1326_3265_1739_6885_2353 22 1.50E-13 1.26E-11 1.05E-12 20706 hsa-mir-496 hsa04060 Cytokine-cytokine receptor interaction 3556_3559_7046_1230_58985_3454_3455_90_3791_1956_3560_3561_7133_7132_1439_7852_2690_85480_4233_1234_3575_3570_3572_2321_149233_5159_5156_3815_3953_3459_1441 31 6.14E-13 5.16E-11 3.97E-12 20707 hsa-mir-496 hsa04310 Wnt signaling pathway 818_817_595_8607_6500_4089_1460_23291_8945_5599_1387_2932_5879_3725_1457_2033_51701_5519_5518_5515_5566_8454_6885_4609 24 1.11E-12 9.31E-11 6.65E-12 20708 hsa-mir-496 hsa04662 B cell receptor signaling pathway 8517_3551_6850_4794_207_1147_695_5595_5594_2932_5879_3725_4790_4792_4793_5970_3265_2353 18 1.75E-12 1.47E-10 9.78E-12 20709 hsa-mir-496 hsa05221 Acute myeloid leukemia 595_8517_3551_207_1147_5595_5594_6774_6776_6777_4790_5970_5371_3815_3265_4609 16 6.23E-12 5.23E-10 3.27E-11 20710 hsa-mir-496 hsa05214 Glioma 818_817_595_5925_1956_207_5595_5594_808_801_805_3480_5159_5156_3265_1026 16 2.17E-11 1.82E-09 1.07E-10 20711 hsa-mir-496 hsa05210 Colorectal cancer 7046_595_4089_1956_207_4233_5595_5594_5599_2932_5879_3725_3480_5159_5156_4609_2353 17 7.48E-11 6.29E-09 3.49E-10 20712 hsa-mir-496 hsa04012 ErbB signaling pathway 818_817_5747_1956_6714_207_5595_5594_5599_2064_2932_6776_6777_3725_3265_4609_1026 17 1.21E-10 1.02E-08 5.35E-10 20713 hsa-mir-496 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 8517_3551_9020_1956_6714_1432_1147_4233_5599_5879_3725_4790_4792_5970_5781 15 5.82E-10 4.89E-08 2.44E-09 20714 hsa-mir-496 hsa05222 Small cell lung cancer 595_8517_3551_5925_7187_5747_207_1147_6256_10401_898_4790_4792_5970_4609_8554 16 7.98E-10 6.71E-08 3.19E-09 20715 hsa-mir-496 hsa04350 TGF-beta signaling pathway 7046_6500_4089_90_57154_6667_5595_5594_1387_4086_2033_5519_5518_5515_8454_4609 16 9.26E-10 7.78E-08 3.54E-09 20716 hsa-mir-496 hsa04210 Apoptosis 3556_8517_3551_9020_7132_1439_207_1147_3654_8717_9131_4790_4792_5970_5566_8772 16 1.24E-09 1.04E-07 4.53E-09 20717 hsa-mir-496 hsa04510 Focal adhesion 595_2534_5747_3791_1956_6714_207_71_4233_5595_5594_5599_2064_2932_1729_5879_3725_2321_3480_5159_5156_3265_85366 23 1.66E-09 1.39E-07 5.80E-09 20718 hsa-mir-496 hsa04912 GnRH signaling pathway 818_817_5580_1956_6714_1432_5595_5594_5599_3725_808_801_805_5608_5566_3265_2185 17 2.30E-09 1.93E-07 7.71E-09 20719 hsa-mir-496 hsa03050 Proteasome 5709_5705_5706_5700_5693_5719_5717_5713_5684_5707_5687_5708 12 6.04E-09 5.07E-07 1.95E-08 20720 hsa-mir-496 hsa04110 Cell cycle 595_6500_4089_4174_4172_3066_3065_5925_5591_1387_2932_5111_2033_898_8454_1026_1111 17 8.48E-09 7.12E-07 2.64E-08 20721 hsa-mir-496 hsa04720 Long-term potentiation 818_814_817_2902_5595_5594_1387_2033_808_801_805_5566_3265_2906 14 8.79E-09 7.38E-07 2.64E-08 20722 hsa-mir-496 hsa05219 Bladder cancer 595_2261_5925_1956_5595_5594_2064_9252_3265_4609_1026 11 1.73E-08 1.45E-06 5.00E-08 20723 hsa-mir-496 hsa05218 Melanoma 595_5925_1956_207_4233_5595_5594_4286_3480_5159_5156_3265_1026 13 3.65E-08 3.07E-06 1.02E-07 20724 hsa-mir-496 hsa04540 Gap junction 10382_1956_6714_5595_5594_7846_203068_347733_5159_5156_5566_3265_7278_84617 14 9.75E-08 8.19E-06 2.64E-07 20725 hsa-mir-496 hsa05216 Thyroid cancer 5468_595_10342_5595_5594_6256_5979_3265_4609 9 1.03E-07 8.66E-06 2.71E-07 20726 hsa-mir-496 hsa04530 Tight junction 10207_1460_5580_6714_4627_4628_22800_8573_207_71_5590_1457_5519_5518_5515_3265 16 2.87E-07 2.41E-05 7.29E-07 20727 hsa-mir-496 hsa04910 Insulin signaling pathway 3551_8471_5211_207_8651_5590_5595_5594_5599_2932_2194_808_801_805_5566_3265 16 3.13E-07 2.63E-05 7.74E-07 20728 hsa-mir-496 hsa04916 Melanogenesis 818_817_5595_5594_1387_4286_2932_2033_808_801_805_5566_3815_3265 14 3.35E-07 2.82E-05 8.04E-07 20729 hsa-mir-496 hsa04020 Calcium signaling pathway 818_814_817_292_293_147_1956_2902_2064_808_801_805_5159_5156_5566_2906_2185_85366 18 5.85E-07 4.92E-05 1.37E-06 20730 hsa-mir-496 hsa04664 Fc epsilon RI signaling pathway 2534_5580_6850_1432_207_695_5595_5594_5599_5879_5608_3265 12 7.33E-07 6.16E-05 1.66E-06 20731 hsa-mir-496 hsa04330 Notch signaling pathway 9612_3066_3065_3280_1387_2033_8850_388585_4851 9 3.37E-06 0.000283262 7.45E-06 20732 hsa-mir-496 hsa04810 Regulation of actin cytoskeleton 2261_2264_5747_1956_4627_4628_22800_71_5595_5594_1729_5879_5159_5156_3265_10788_8826_85366 18 5.75E-06 0.000482867 1.24E-05 20733 hsa-mir-496 hsa05213 Endometrial cancer 595_1956_207_5595_5594_2064_2932_3265_4609 9 7.00E-06 0.000588168 1.47E-05 20734 hsa-mir-496 hsa04120 Ubiquitin mediated proteolysis 55294_6500_57154_23291_8945_7329_51366_11059_8651_10401_5371_672_8454_8554 14 7.61E-06 0.00063952 1.56E-05 20735 hsa-mir-496 hsa05223 Non-small cell lung cancer 595_5925_1956_207_5595_5594_2064_6256_3265 9 9.19E-06 0.00077204 1.84E-05 20736 hsa-mir-496 hsa05131 Shigellosis 10382_2534_71_7846_203068_347733_7278_84617_4691 9 1.19E-05 0.001002918 2.28E-05 20737 hsa-mir-496 hsa05130 Pathogenic Escherichia coli infection 10382_2534_71_7846_203068_347733_7278_84617_4691 9 1.19E-05 0.001002918 2.28E-05 20738 hsa-mir-496 hsa05211 Renal cell carcinoma 207_4233_5595_5594_1387_5879_3725_2033_3265_5781 10 1.25E-05 0.001049919 2.30E-05 20739 hsa-mir-496 hsa05016 Huntington's disease 5468_292_293_3066_3065_498_2902_6667_4716_1387_5437_2033_6908_5441_1213_9519 16 1.26E-05 0.00105638 2.30E-05 20740 hsa-mir-496 hsa04930 Type II diabetes mellitus 3551_5580_8471_8651_5590_5595_5594_5599 8 1.91E-05 0.001605942 3.42E-05 20741 hsa-mir-496 hsa03022 Basal transcription factors 2969_6878_6872_6908_6882_2959_9519 7 4.49E-05 0.003771893 7.86E-05 20742 hsa-mir-496 hsa03020 RNA polymerase 64425_25885_51082_5437_84172_5441 6 0.000102964 0.008648937 0.000176509 20743 hsa-mir-496 hsa04370 VEGF signaling pathway 5747_3791_6714_1432_207_5595_5594_5879_3265 9 0.000114216 0.009594124 0.000191882 20744 hsa-mir-496 hsa04650 Natural killer cell mediated cytotoxicity 3454_3455_2534_3932_6850_5595_5594_5879_3265_3459_5781_2185 12 0.000124167 0.010430059 0.000204511 20745 hsa-mir-496 hsa05340 Primary immunodeficiency 8517_3932_3561_3718_695_3575 6 0.000255128 0.021430715 0.000412129 20746 hsa-mir-496 hsa04360 Axon guidance 2534_5747_5998_7852_2242_4233_5595_5594_2932_5879_3265 11 0.000311093 0.026131834 0.000485791 20747 hsa-mir-496 hsa05010 Alzheimer's disease 498_2902_7132_4716_5595_5594_2932_808_351_801_805_2906_8772 13 0.000312294 0.026232705 0.000485791 20748 hsa-mir-496 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_7133_7132_1432_5879_5608_2906 7 0.000452592 0.038017759 0.000691232 20749 hsa-mir-496 hsa04612 Antigen processing and presentation 3309_3303_3310_3312_3320_3326_2923_3305 8 0.001342717 0.112788225 0.002014075 20750 hsa-mir-496 hsa04730 Long-term depression 5595_5594_3480_5519_5518_5515_3265 7 0.001630042 0.136923488 0.002402166 20751 hsa-mir-496 hsa03030 DNA replication 5981_4174_4172_5111_6118 5 0.001954039 0.164139238 0.002829987 20752 hsa-mir-496 hsa04270 Vascular smooth muscle contraction 147_5580_5595_5594_808_801_805_5566_85366 9 0.001996302 0.167689335 0.002842192 20753 hsa-mir-496 hsa04670 Leukocyte transendothelial migration 653361_5747_1432_7852_71_5879_5781_2185 8 0.00808243 0.678924153 0.011315403 20754 hsa-mir-496 hsa03430 Mismatch repair 5981_5111_6118 3 0.018787983 1 0.025871976 20755 hsa-mir-496 hsa04340 Hedgehog signaling pathway 23291_8945_2932_5566 4 0.044919438 1 0.060858593 20756 hsa-mir-496 hsa03450 Non-homologous end-joining 5591_7520 2 0.047077889 1 0.062770518 20757 hsa-mir-497 hsa05200 Pathways in cancer 4149_5467_1499_6654_5914_595_1019_1017_4193_6934_7704_3551_5578_3091_2735_842_7175_3066_3065_5925_1050_5468_25_405_1956_1487_1488_2308_4824_8503_4436_1870_2885_2113_10401_861_836_207_208_9915_5894_1147_4609_2249_367_5595_5594_5599_6258_1387_2064_6256_8517_4286_2932_6774_6776_6777_6772_5970_7157_6688_7849_1869_3725_6502_4087_4088_4089_5295_2034_2033_4790_4791_4792_3320_3326_51176_5371_3480_8031_5604_5601_1871_3265_841_4292_6257_2956_1029_2736_2353_2737_8554 94 1.04E-38 8.98E-37 8.98E-37 20758 hsa-mir-497 hsa05215 Prostate cancer 1499_6654_595_1017_4193_6934_3551_842_5925_1956_2308_4824_8503_1870_2885_9586_207_208_5894_1147_367_5595_5594_1385_1387_2064_8517_2932_5970_7157_1869_5295_2033_4790_4792_3320_3326_51176_3480_5604_1871_3265_468 43 8.52E-26 7.32E-24 3.47E-24 20759 hsa-mir-497 hsa05212 Pancreatic cancer 1499_6654_595_1017_4193_6934_3551_842_5925_1956_2308_4824_8503_1870_2885_9586_207_208_5894_1147_367_5595_5594_1385_1387_2064_8517_2932_5970_7157_1869_5295_2033_4790_4792_3320_3326_51176_3480_5604_1871_3265_468 43 1.21E-25 1.04E-23 3.47E-24 20760 hsa-mir-497 hsa04010 MAPK signaling pathway 6722_4149_6654_4214_9252_3551_5578_4773_9020_4616_8986_1956_3303_1432_627_4342_2885_22800_836_2872_207_208_3305_5894_1147_4609_2249_994_5595_5594_5599_5598_1386_8517_1649_3310_3312_5971_5970_3164_7157_10912_3725_3727_6195_6196_6197_5058_4790_4791_1616_9261_5604_4208_5601_5600_5603_5608_5566_3265_1326_6885_2353_468_2005_8550_2002 67 6.91E-25 5.94E-23 1.49E-23 20761 hsa-mir-497 hsa05220 Chronic myeloid leukemia 6654_595_1019_4193_3551_3066_3065_5925_25_1487_1488_8503_1870_2885_861_207_208_5894_1147_4609_5595_5594_8517_6776_6777_5970_7157_1869_4088_4089_5295_4790_4792_5604_1871_3265_1029_6464 38 2.18E-23 1.87E-21 3.75E-22 20762 hsa-mir-497 hsa04110 Cell cycle 595_1019_1017_4193_902_3066_3065_4616_5925_25_6500_1870_8379_5934_5933_994_5591_1387_7534_7531_7533_7532_2932_7027_990_7157_5111_10912_1869_6502_4087_4088_4089_2033_891_983_1871_8454_1022_1029_1028_1111 42 6.54E-21 5.62E-19 9.37E-20 20763 hsa-mir-497 hsa05221 Acute myeloid leukemia 5467_6654_5914_595_6934_7704_3551_1050_8503_2885_861_207_208_5894_1147_4609_5595_5594_8517_6774_6776_6777_5970_6688_5295_4790_51176_5371_5604_3265 30 8.57E-19 7.37E-17 1.05E-17 20764 hsa-mir-497 hsa04660 T cell receptor signaling pathway 6654_1019_5777_3551_4772_4773_9020_3932_1432_8503_4794_2885_207_208_5894_1147_5595_5594_56924_8517_2932_5970_3725_5295_5058_4790_4792_4793_5604_5601_5600_5603_3265_1326_6885_2353 36 2.90E-17 2.50E-15 3.12E-16 20765 hsa-mir-497 hsa05223 Non-small cell lung cancer 6654_595_1019_5578_842_5925_1956_2309_8503_1870_2885_207_208_5894_5595_5594_6258_2064_6256_7157_1869_5295_5604_1871_3265_6257_1029 27 6.50E-17 5.59E-15 6.21E-16 20766 hsa-mir-497 hsa05210 Colorectal cancer 1499_6654_595_6934_842_1956_8503_4436_2885_836_207_208_5894_4609_5595_5594_5599_2932_7157_3725_4087_4088_4089_5295_51176_3480_5604_5601_4292_2956_2353 31 3.04E-16 2.61E-14 2.61E-15 20767 hsa-mir-497 hsa05214 Glioma 815_6654_595_1019_4193_5578_5925_1956_8503_1870_2885_207_208_5894_5595_5594_7157_1869_5295_808_801_805_3480_5604_1871_3265_1029_6464 28 3.53E-16 3.04E-14 2.76E-15 20768 hsa-mir-497 hsa05213 Endometrial cancer 1499_6654_595_6934_842_1956_2309_8503_2885_207_208_5894_4609_5595_5594_2064_2932_7157_5295_51176_5604_3265_4292_2002 24 1.37E-14 1.18E-12 9.82E-14 20769 hsa-mir-497 hsa04310 Wnt signaling pathway 815_5467_1499_595_1457_6934_5578_8945_4772_4773_23291_1487_1488_6500_1459_4609_1460_5599_1387_2932_7157_8061_3725_4087_4088_4089_2033_8607_51176_5519_5515_5601_5566_8454_6885_5527 36 1.31E-13 1.12E-11 8.30E-13 20770 hsa-mir-497 hsa04012 ErbB signaling pathway 815_6654_5578_25_1956_6714_8503_2885_207_208_5894_4609_5595_5594_5599_56924_2064_2932_6776_6777_3725_5295_5058_5604_5601_3265_6464_2002 28 1.35E-13 1.16E-11 8.30E-13 20771 hsa-mir-497 hsa04662 B cell receptor signaling pathway 6654_5777_3551_4772_4773_8503_4794_2885_207_208_5894_1147_695_5595_5594_8517_2932_5970_3725_5295_4790_4792_4793_5604_3265_2353 26 2.45E-13 2.10E-11 1.40E-12 20772 hsa-mir-497 hsa05222 Small cell lung cancer 4149_595_1019_1017_3551_842_5925_8503_1870_10401_207_208_1147_4609_6258_6256_8517_5970_7157_1869_6502_5295_4790_4792_1871_6257_8554 27 5.99E-13 5.15E-11 3.22E-12 20773 hsa-mir-497 hsa04620 Toll-like receptor signaling pathway 3665_3551_9641_3661_1432_8503_207_208_1147_29110_5595_5594_5599_8517_6772_5970_3725_5295_4790_4792_5604_5601_5600_5603_5608_841_1326_6885_2353 29 6.77E-13 5.83E-11 3.43E-12 20774 hsa-mir-497 hsa04910 Insulin signaling pathway 6720_10891_6654_5770_3551_2538_5590_2308_8503_2885_8471_2872_207_208_5894_8651_5595_5594_5599_7249_2932_5295_808_801_805_5604_5601_5566_5563_3265_6464_2002 32 4.77E-12 4.10E-10 2.28E-11 20775 hsa-mir-497 hsa05216 Thyroid cancer 1499_595_6934_7175_5468_4609_5595_5594_6258_6256_7157_7849_51176_8031_5604_3265_6257 17 5.34E-12 4.59E-10 2.42E-11 20776 hsa-mir-497 hsa04912 GnRH signaling pathway 815_6654_4214_5578_1956_6714_1432_2885_5894_5595_5594_5599_5598_5580_3725_808_801_805_5604_5601_5600_5603_5608_5566_3265_468_2002 27 5.11E-11 4.40E-09 2.20E-10 20777 hsa-mir-497 hsa05219 Bladder cancer 595_1019_9252_4193_5925_1956_1870_5894_4609_5595_5594_2064_7157_1869_5604_1871_3265_1029 18 7.15E-11 6.15E-09 2.93E-10 20778 hsa-mir-497 hsa05218 Melanoma 595_1019_4193_5925_1956_8503_1870_207_208_5894_2249_5595_5594_4286_7157_1869_5295_3480_5604_1871_3265_1029 22 1.01E-10 8.68E-09 3.95E-10 20779 hsa-mir-497 hsa04350 TGF-beta signaling pathway 4086_1875_6667_6500_3397_3399_3398_5934_5933_4609_3400_5595_5594_1387_7027_4087_4088_4089_2033_5519_5515_8454_4093_4092 24 1.09E-10 9.35E-09 4.07E-10 20780 hsa-mir-497 hsa04920 Adipocytokine signaling pathway 10891_3551_2538_4794_8471_207_208_1147_5599_6258_6256_8517_6774_5970_5465_4790_4792_4793_5601_5563_6257 21 2.25E-10 1.93E-08 8.05E-10 20781 hsa-mir-497 hsa04540 Gap junction 6654_5578_51807_1956_6714_2885_5894_5592_5595_5594_5598_7846_347733_10382_2770_983_5604_5566_3265_7277_7278_84617_203068_10376 24 3.45E-10 2.97E-08 1.19E-09 20782 hsa-mir-497 hsa05211 Renal cell carcinoma 6654_3091_405_8503_2885_2113_207_208_9915_5894_5595_5594_56924_1387_3725_5295_5058_2034_2033_5604_3265 21 6.74E-10 5.79E-08 2.23E-09 20783 hsa-mir-497 hsa04062 Chemokine signaling pathway 6654_3551_653361_9564_5590_2309_8503_2885_207_208_7074_5894_1147_5595_5594_8517_2932_2931_5580_6774_6777_6772_5970_5295_5058_4790_4792_4793_2770_5604_5566_3265_6464 33 2.32E-09 1.99E-07 7.38E-09 20784 hsa-mir-497 hsa04520 Adherens junction 1499_1457_6934_5770_5777_1956_6714_1459_71_1460_5595_5594_1387_2064_4087_4088_4089_2033_51176_3480_6885 21 3.34E-09 2.87E-07 1.02E-08 20785 hsa-mir-497 hsa04720 Long-term potentiation 814_815_5578_2902_2906_5894_5595_5594_1387_6195_6196_6197_2033_808_801_805_5604_5566_3265_468 20 6.25E-09 5.38E-07 1.85E-08 20786 hsa-mir-497 hsa04664 Fc epsilon RI signaling pathway 6654_5578_1432_8503_2885_207_208_5894_695_5595_5594_5599_5580_5295_5604_5601_5600_5603_5608_3265 20 1.32E-08 1.14E-06 3.79E-08 20787 hsa-mir-497 hsa04210 Apoptosis 3551_842_9020_8837_823_8503_836_207_208_1147_8517_839_5970_7157_9131_5295_4790_4792_5566_841_840 21 1.66E-08 1.43E-06 4.60E-08 20788 hsa-mir-497 hsa03022 Basal transcription factors 6882_6879_2965_2963_2962_2969_6878_6872_6908_2958_2959_6880_6881_9519 14 3.29E-08 2.83E-06 8.85E-08 20789 hsa-mir-497 hsa04370 VEGF signaling pathway 5578_842_4772_4773_6714_1432_8503_207_208_5894_5595_5594_5295_9261_5604_5600_5603_3265 18 1.94E-07 1.67E-05 5.06E-07 20790 hsa-mir-497 hsa04115 p53 signaling pathway 595_1019_1017_4194_4193_842_4616_836_7249_7157_10912_891_983_841_7161_1029_1111 17 2.23E-07 1.92E-05 5.64E-07 20791 hsa-mir-497 hsa04510 Focal adhesion 1499_6654_595_5578_857_9564_1956_6714_8503_2885_10627_207_208_71_5894_5595_5594_5599_56924_2064_2932_3725_5295_5058_3480_5604_5601_3265_6464_2002 30 2.83E-07 2.43E-05 6.96E-07 20792 hsa-mir-497 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3551_9020_1956_6714_1432_836_1147_5599_8517_5970_3725_5058_4790_4792_5601_5600_5603 17 3.15E-07 2.71E-05 7.54E-07 20793 hsa-mir-497 hsa05131 Shigellosis 1499_5578_51807_25_71_7534_7846_347733_10382_7277_7278_84617_4691_203068_10376 15 4.61E-07 3.96E-05 1.04E-06 20794 hsa-mir-497 hsa05130 Pathogenic Escherichia coli infection 1499_5578_51807_25_71_7534_7846_347733_10382_7277_7278_84617_4691_203068_10376 15 4.61E-07 3.96E-05 1.04E-06 20795 hsa-mir-497 hsa04916 Melanogenesis 815_1499_6934_5578_5894_5595_5594_1385_1387_4286_2932_2033_808_801_805_51176_2770_5604_5566_3265 20 6.39E-07 5.49E-05 1.41E-06 20796 hsa-mir-497 hsa04330 Notch signaling pathway 1840_9612_3066_3065_22938_1487_1488_2648_1387_2033_8850_9794_4851 13 1.97E-06 0.000169583 4.24E-06 20797 hsa-mir-497 hsa04530 Tight junction 1499_1457_1019_5578_4627_5590_6714_4628_1459_22800_8573_8189_10627_207_208_71_1460_5580_5519_5515_2770_3265 22 2.60E-06 0.000223413 5.45E-06 20798 hsa-mir-497 hsa04930 Type II diabetes mellitus 3551_5590_8503_8471_8651_5595_5594_5599_5580_5295_3651_5601 12 6.69E-06 0.000575242 1.37E-05 20799 hsa-mir-497 hsa04120 Ubiquitin mediated proteolysis 55294_4214_4193_3093_8945_23291_6500_10401_10273_7325_7323_7329_8925_51366_8651_997_6502_5371_672_8454_8554 21 1.01E-05 0.000864526 2.01E-05 20800 hsa-mir-497 hsa05016 Huntington's disease 10891_293_1537_1213_292_842_3066_3065_3064_498_5468_2902_6667_627_9586_836_5441_1385_1387_5437_7157_2033_6908_841_9519 25 1.12E-05 0.000963977 2.19E-05 20801 hsa-mir-497 hsa04150 mTOR signaling pathway 3091_8503_207_208_5595_5594_7249_6195_6196_6197_5295_5563 12 2.33E-05 0.002000634 4.45E-05 20802 hsa-mir-497 hsa04630 Jak-STAT signaling pathway 6654_595_5777_3559_8503_2885_10401_3977_207_208_4609_8651_1387_6778_6774_6776_6777_6772_5295_2033_8554 21 4.30E-05 0.003696275 8.04E-05 20803 hsa-mir-497 hsa03450 Non-homologous end-joining 2547_10111_7520_2237_5591_4361 6 0.000178877 0.015383425 0.000327307 20804 hsa-mir-497 hsa05322 Systemic lupus erythematosus 8363_8365_3021_3020_9555_8349_8368_8364_8366_3015_8294_8370_121504_8361_8360_8362_8367_8359 18 0.000358814 0.030857969 0.000642874 20805 hsa-mir-497 hsa04650 Natural killer cell mediated cytotoxicity 6654_5777_5578_4772_4773_3932_8503_2885_836_5894_5595_5594_5295_5058_5604_3265_6464 17 0.000599881 0.051589724 0.001052852 20806 hsa-mir-497 hsa04612 Antigen processing and presentation 6890_3308_3309_3303_3305_1385_3310_3312_3320_3326_4800_4802_4801 13 0.000628218 0.054026761 0.001080535 20807 hsa-mir-497 hsa03410 Base excision repair 4350_142_252969_3146_328_2237_5111_6996 8 0.00066176 0.056911393 0.001105629 20808 hsa-mir-497 hsa05014 Amyotrophic lateral sclerosis (ALS) 842_2902_2906_1432_836_7157_1616_5600_5603_5608 10 0.00066852 0.057492695 0.001105629 20809 hsa-mir-497 hsa04730 Long-term depression 5578_5894_5592_5595_5594_3480_5519_5515_2770_5604_3265 11 0.001047789 0.090109825 0.001700185 20810 hsa-mir-497 hsa04950 Maturity onset diabetes of the young 5080_6927_168620_4760_3651_3172 6 0.001868171 0.160662742 0.002975236 20811 hsa-mir-497 hsa04740 Olfactory transduction 815_5592_808_801_805_5566 6 0.001984419 0.170660023 0.00310291 20812 hsa-mir-497 hsa04810 Regulation of actin cytoskeleton 6654_4627_9564_1956_4628_8503_4342_22800_10627_71_7074_5894_2249_5595_5594_56924_5295_5058_5604_3265_10788 21 0.00398324 0.342558647 0.006117119 20813 hsa-mir-497 hsa03020 RNA polymerase 64425_25885_51082_5441_5437_84172 6 0.004222561 0.363140234 0.006370881 20814 hsa-mir-497 hsa05010 Alzheimer's disease 1537_842_498_823_2902_2906_836_5595_5594_2932_9451_808_351_801_805_22926_841_840 18 0.004339235 0.373174169 0.006434037 20815 hsa-mir-497 hsa05217 Basal cell carcinoma 1499_6934_2735_2932_7157_51176_2736_2737 8 0.006853974 0.589441777 0.009990539 20816 hsa-mir-497 hsa03420 Nucleotide excision repair 5981_902_5111_5886_2965_4331_1022 7 0.007314175 0.62901902 0.010439579 20817 hsa-mir-497 hsa03430 Mismatch repair 5981_4436_5111_4292_2956 5 0.007404817 0.636814295 0.010439579 20818 hsa-mir-497 hsa04340 Hedgehog signaling pathway 2735_8945_23291_53944_2932_5566_2736_2737 8 0.008262238 0.710552457 0.011460523 20819 hsa-mir-497 hsa04270 Vascular smooth muscle contraction 5578_5894_5592_5595_5594_5580_4637_808_801_805_59_5604_5566 13 0.008417926 0.72394162 0.011491137 20820 hsa-mir-497 hsa03010 Ribosome 6155_6207_6202_6156_6141_9349_6217_6128_6222_6188_6231 11 0.018108886 1 0.024333816 20821 hsa-mir-497 hsa04670 Leukocyte transendothelial migration 1499_5578_653361_9564_1432_8503_10627_71_5295_2770_5600_5603 12 0.019408879 1 0.02567944 20822 hsa-mir-497 hsa03320 PPAR signaling pathway 5467_2168_10062_5468_6258_6256_5465_6257 8 0.023185417 1 0.030211302 20823 hsa-mir-497 hsa04060 Cytokine-cytokine receptor interaction 8600_3559_8764_1956_3977 5 0.036212241 1 0.046481383 20824 hsa-mir-497 hsa04080 Neuroactive ligand-receptor interaction 2902_2906_2908_7068_7067 5 0.048429523 1 0.061249102 20825 hsa-mir-499 hsa05200 Pathways in cancer 1147_2034_4609_3320_3326_5371_405_3480_1956_5595_5594_6654_5914_1387_2064_6256_595_2308_836_208_367_4193_7704_6776_3091_5970_7428_8503_1870_1871_2885_7157_4087_2113_10401_1869_3725_4088_4089_5295_3066_3065_5925_2033_4846_207_8554_4790 48 9.58E-42 7.18E-40 7.18E-40 20826 hsa-mir-499 hsa05215 Prostate cancer 1147_3320_3326_3480_1956_5595_5594_6654_1387_2064_595_2308_208_367_4193_5970_8503_1870_1871_2885_7157_1869_5295_5925_2033_207_4790 27 2.27E-31 1.70E-29 7.33E-30 20827 hsa-mir-499 hsa05212 Pancreatic cancer 1147_3320_3326_3480_1956_5595_5594_6654_1387_2064_595_2308_208_367_4193_5970_8503_1870_1871_2885_7157_1869_5295_5925_2033_207_4790 27 2.93E-31 2.20E-29 7.33E-30 20828 hsa-mir-499 hsa05220 Chronic myeloid leukemia 1147_4609_5595_5594_6654_595_208_4193_6776_5970_8503_1870_1871_2885_7157_1869_4088_4089_5295_3066_3065_5925_207_4790_6464 25 7.10E-30 5.33E-28 1.33E-28 20829 hsa-mir-499 hsa05214 Glioma 3480_1956_5595_5594_6654_595_208_4193_8503_1870_1871_2885_7157_1869_5295_5925_207_801_6464_808_805 21 4.99E-25 3.74E-23 7.48E-24 20830 hsa-mir-499 hsa04010 MAPK signaling pathway 1147_4609_994_1956_5595_5594_6654_4208_836_5566_208_4214_1432_5970_627_2885_7157_10912_3312_3725_3727_4763_6195_6197_5058_4616_2872_207_4790 29 5.46E-22 4.09E-20 6.82E-21 20831 hsa-mir-499 hsa05223 Non-small cell lung cancer 1956_5595_5594_6654_2064_6256_595_2309_208_8503_1870_1871_2885_7157_1869_5295_5925_207 18 7.99E-22 5.99E-20 8.56E-21 20832 hsa-mir-499 hsa04110 Cell cycle 994_5591_1387_595_7533_4193_902_1870_1871_7157_4087_10912_1869_1022_4088_4089_3066_3065_4616_5925_2033_5933 22 1.37E-21 1.03E-19 1.29E-20 20833 hsa-mir-499 hsa05211 Renal cell carcinoma 2034_405_5595_5594_6654_56924_1387_208_3091_7428_8503_2885_2113_3725_5295_5058_2033_207 18 6.38E-20 4.79E-18 5.32E-19 20834 hsa-mir-499 hsa05221 Acute myeloid leukemia 1147_4609_5371_5595_5594_6654_5914_595_208_7704_6776_5970_8503_2885_5295_207_4790 17 8.94E-20 6.71E-18 6.71E-19 20835 hsa-mir-499 hsa05210 Colorectal cancer 4609_3480_1956_5595_5594_6654_595_836_208_8503_2885_7157_4087_3725_4088_4089_5295_207 18 6.97E-19 5.23E-17 4.75E-18 20836 hsa-mir-499 hsa05222 Small cell lung cancer 1147_4609_6256_595_208_5970_8503_1870_1871_7157_10401_1869_5295_5925_4846_207_8554_4790 18 1.01E-18 7.55E-17 6.29E-18 20837 hsa-mir-499 hsa04012 ErbB signaling pathway 4609_1956_6714_5595_5594_6654_56924_2064_208_6776_8503_2885_3725_5295_5058_207_6464 17 2.60E-17 1.95E-15 1.50E-16 20838 hsa-mir-499 hsa04910 Insulin signaling pathway 6720_10891_5595_5594_6654_2308_5566_7249_208_5770_8503_2885_5295_2872_207_801_6464_808_805 19 1.13E-16 8.48E-15 6.06E-16 20839 hsa-mir-499 hsa05213 Endometrial cancer 4609_1956_5595_5594_6654_2064_595_2309_208_8503_2885_7157_5295_207 14 3.72E-16 2.79E-14 1.86E-15 20840 hsa-mir-499 hsa05218 Melanoma 3480_1956_5595_5594_595_208_4193_8503_1870_1871_7157_1869_5295_5925_207 15 7.30E-16 5.47E-14 3.42E-15 20841 hsa-mir-499 hsa04660 T cell receptor signaling pathway 1147_3932_5595_5594_6654_56924_208_5777_1432_5970_8503_2885_3725_5295_5058_207_4790 17 8.50E-16 6.37E-14 3.75E-15 20842 hsa-mir-499 hsa04520 Adherens junction 1460_3480_1956_6714_5595_5594_1387_2064_5770_5777_4087_4088_4089_2033_1457 15 3.46E-15 2.59E-13 1.44E-14 20843 hsa-mir-499 hsa05219 Bladder cancer 4609_1956_5595_5594_2064_595_4193_1870_1871_7157_1869_5925 12 2.73E-14 2.04E-12 1.08E-13 20844 hsa-mir-499 hsa04510 Focal adhesion 9564_3480_1956_6714_5595_5594_6654_56924_2064_595_208_8503_857_2885_3725_5295_5058_207_6464 19 8.99E-14 6.75E-12 3.37E-13 20845 hsa-mir-499 hsa04662 B cell receptor signaling pathway 1147_5595_5594_6654_208_5777_5970_8503_2885_3725_5295_207_4790 13 6.03E-13 4.52E-11 2.15E-12 20846 hsa-mir-499 hsa04062 Chemokine signaling pathway 1147_9564_5595_5594_6654_2770_2309_5566_208_5970_8503_2885_5295_5058_207_4790_6464 17 3.70E-12 2.78E-10 1.26E-11 20847 hsa-mir-499 hsa04912 GnRH signaling pathway 1956_6714_5595_5594_6654_5566_4214_1432_2885_3725_801_808_805 13 3.84E-11 2.88E-09 1.25E-10 20848 hsa-mir-499 hsa04150 mTOR signaling pathway 5595_5594_7249_208_3091_8503_6195_6197_5295_207 10 1.20E-10 8.98E-09 3.74E-10 20849 hsa-mir-499 hsa04720 Long-term potentiation 5595_5594_1387_2902_5566_6195_6197_2033_801_808_805 11 1.87E-10 1.40E-08 5.61E-10 20850 hsa-mir-499 hsa04630 Jak-STAT signaling pathway 4609_6654_1387_595_208_5777_6776_8503_2885_10401_5295_2033_207_8554 14 2.27E-10 1.70E-08 6.54E-10 20851 hsa-mir-499 hsa04620 Toll-like receptor signaling pathway 1147_5595_5594_208_1432_5970_8503_3725_5295_207_4790 11 3.63E-09 2.72E-07 1.01E-08 20852 hsa-mir-499 hsa04350 TGF-beta signaling pathway 4609_5595_5594_1387_6667_4087_4088_4089_2033_5933 10 1.08E-08 8.09E-07 2.89E-08 20853 hsa-mir-499 hsa04210 Apoptosis 1147_836_5566_208_5970_8503_7157_5295_207_4790 10 1.32E-08 9.88E-07 3.41E-08 20854 hsa-mir-499 hsa04310 Wnt signaling pathway 4609_1460_1387_595_5566_7157_4087_3725_4088_4089_2033_1457 12 1.82E-08 1.37E-06 4.56E-08 20855 hsa-mir-499 hsa05016 Huntington's disease 6874_10891_1387_2902_6908_836_6667_627_7157_3066_3065_3064_2033 13 2.03E-08 1.52E-06 4.91E-08 20856 hsa-mir-499 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_1956_6714_836_1432_5970_3725_5058_4790 9 2.74E-08 2.06E-06 6.43E-08 20857 hsa-mir-499 hsa04370 VEGF signaling pathway 6714_5595_5594_208_1432_8503_5295_4846_207 9 5.20E-08 3.90E-06 1.18E-07 20858 hsa-mir-499 hsa04664 Fc epsilon RI signaling pathway 5595_5594_6654_208_1432_8503_2885_5295_207 9 6.37E-08 4.78E-06 1.41E-07 20859 hsa-mir-499 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6654_836_5777_8503_2885_5295_5058_6464 11 6.59E-08 4.94E-06 1.41E-07 20860 hsa-mir-499 hsa05216 Thyroid cancer 4609_5595_5594_6256_595_7157 6 4.68E-07 3.51E-05 9.74E-07 20861 hsa-mir-499 hsa04916 Melanogenesis 5595_5594_1387_2770_5566_2033_801_808_805 9 5.54E-07 4.15E-05 1.12E-06 20862 hsa-mir-499 hsa04540 Gap junction 1956_6714_5595_5594_6654_2770_5566_2885 8 2.48E-06 0.000186373 4.90E-06 20863 hsa-mir-499 hsa04920 Adipocytokine signaling pathway 1147_10891_6256_208_5970_207_4790 7 3.26E-06 0.00024431 6.26E-06 20864 hsa-mir-499 hsa04115 p53 signaling pathway 595_836_7249_4193_7157_10912_4616 7 3.90E-06 0.000292545 7.31E-06 20865 hsa-mir-499 hsa04120 Ubiquitin mediated proteolysis 5371_672_4214_4193_7428_10401_10273_7329_8554 9 5.25E-06 0.000393851 9.61E-06 20866 hsa-mir-499 hsa03022 Basal transcription factors 2965_6874_6908_2959_6881 5 2.80E-05 0.002098567 5.00E-05 20867 hsa-mir-499 hsa04330 Notch signaling pathway 1387_9612_3066_3065_2033 5 7.98E-05 0.005983203 0.000139144 20868 hsa-mir-499 hsa04810 Regulation of actin cytoskeleton 9564_1956_5595_5594_6654_56924_8503_5295_5058 9 0.000155879 0.011690903 0.000265702 20869 hsa-mir-499 hsa04612 Antigen processing and presentation 3320_3326_3312_6890_4800_4801 6 0.000163709 0.012278207 0.000272849 20870 hsa-mir-499 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_1432_7157_4846 5 0.000171613 0.012870973 0.000279804 20871 hsa-mir-499 hsa05010 Alzheimer's disease 5595_5594_2902_836_4846_801_808_805 8 0.000194827 0.014612044 0.000310895 20872 hsa-mir-499 hsa04020 Calcium signaling pathway 1956_2064_2902_5566_4846_801_808_805 8 0.000250681 0.01880106 0.000391689 20873 hsa-mir-499 hsa04730 Long-term depression 3480_5595_5594_2770_4846 5 0.000480637 0.036047783 0.000735669 20874 hsa-mir-499 hsa04070 Phosphatidylinositol signaling system 8503_5295_801_808_805 5 0.000644049 0.048303697 0.000966074 20875 hsa-mir-499 hsa04270 Vascular smooth muscle contraction 5595_5594_5566_801_808_805 6 0.00068581 0.051435778 0.001008545 20876 hsa-mir-499 hsa03420 Nucleotide excision repair 2965_902_1022_4331 4 0.000737688 0.055326563 0.001063972 20877 hsa-mir-499 hsa04930 Type II diabetes mellitus 5595_5594_8503_5295 4 0.000797948 0.05984609 0.001129172 20878 hsa-mir-499 hsa04360 Axon guidance 5998_5595_5594_56924_2770_5058 6 0.001152143 0.086410709 0.001600198 20879 hsa-mir-499 hsa04530 Tight junction 1460_6714_2770_208_207_1457 6 0.00143545 0.107658776 0.001957432 20880 hsa-mir-499 hsa04670 Leukocyte transendothelial migration 9564_2770_1432_8503_5295 5 0.00466614 0.349960527 0.006249295 20881 hsa-mir-499 hsa05340 Primary immunodeficiency 3932_6890 2 0.039388465 1 0.051826927 20882 hsa-mir-499 hsa03410 Base excision repair 6996_4350 2 0.041348789 1 0.053468262 20883 hsa-mir-503 hsa05200 Pathways in cancer 5914_595_596_598_1017_4193_5578_3091_3066_3065_1050_5925_613_5743_5747_25_6789_4436_1870_1871_2113_4286_1147_998_367_5595_5594_5599_1387_6256_836_2932_5970_7157_7704_1869_3725_4087_4088_4089_5888_5728_2034_2033_4846_3910_4792_3320_3326_5371_675_5601_5602_1856_51588_7428_4609_1026_1029_2353_8554 61 1.24E-39 1.06E-37 1.06E-37 20884 hsa-mir-503 hsa04110 Cell cycle 595_1017_4193_902_3066_3065_5925_25_1870_1871_9232_5933_545_995_993_5347_5591_1387_11200_7534_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_1031_983_1026_1022_1029_1111_8556_8555_472 39 9.99E-34 8.49E-32 4.24E-32 20885 hsa-mir-503 hsa05215 Prostate cancer 595_596_1017_4193_5925_1870_1871_9586_1147_367_5595_5594_1385_1387_2932_5970_7157_1869_5728_10488_2033_4792_3320_3326_1026_468 26 6.30E-22 5.35E-20 1.70E-20 20886 hsa-mir-503 hsa05212 Pancreatic cancer 595_596_1017_4193_5925_1870_1871_9586_1147_367_5595_5594_1385_1387_2932_5970_7157_1869_5728_10488_2033_4792_3320_3326_1026_468 26 8.01E-22 6.81E-20 1.70E-20 20887 hsa-mir-503 hsa05220 Chronic myeloid leukemia 595_598_4193_3066_3065_5925_613_25_1870_1871_1147_5595_5594_5970_7157_1869_4088_4089_4792_4609_1026_1029_6464 23 7.50E-20 6.38E-18 1.28E-18 20888 hsa-mir-503 hsa04115 p53 signaling pathway 595_1017_4194_4193_900_50484_6241_51246_545_7161_11200_836_7157_64326_5728_27113_25898_983_1026_1029_1111_472 22 2.39E-19 2.03E-17 3.39E-18 20889 hsa-mir-503 hsa04010 MAPK signaling pathway 9252_5578_5923_3304_3305_3303_6789_1432_4763_1616_1147_998_5595_5594_5599_1386_836_3312_3315_1649_5970_3164_7157_3725_3727_4208_5601_5600_5603_5602_4609_2353_468_8550 34 9.12E-18 7.75E-16 1.11E-16 20890 hsa-mir-503 hsa05222 Small cell lung cancer 595_596_598_1017_5925_5743_5747_1870_1871_1147_6256_5970_7157_1869_5728_4846_3910_4792_51588_4609_8554 21 1.55E-16 1.32E-14 1.65E-15 20891 hsa-mir-503 hsa04310 Wnt signaling pathway 595_5578_1460_5599_1387_2932_7157_8061_3725_1457_1452_1459_4087_4088_4089_2033_5518_5515_5601_5602_1856_4609_5527 23 4.97E-14 4.22E-12 4.69E-13 20892 hsa-mir-503 hsa05210 Colorectal cancer 595_596_4436_5595_5594_5599_836_2932_7157_3725_4087_4088_4089_5601_5602_1856_4609_2353 18 1.60E-13 1.36E-11 1.36E-12 20893 hsa-mir-503 hsa05219 Bladder cancer 595_9252_4193_5925_1870_1871_5595_5594_7157_1869_4609_1026_1029 13 7.64E-12 6.50E-10 5.91E-11 20894 hsa-mir-503 hsa05214 Glioma 595_4193_5578_5925_1870_1871_5595_5594_7157_1869_5728_1026_1029_6464 14 7.65E-11 6.51E-09 5.42E-10 20895 hsa-mir-503 hsa05223 Non-small cell lung cancer 595_5578_5925_6789_1870_1871_5595_5594_6256_7157_1869_1029 12 1.28E-09 1.09E-07 8.37E-09 20896 hsa-mir-503 hsa05218 Melanoma 595_4193_5925_1870_1871_4286_5595_5594_7157_1869_5728_1026_1029 13 2.09E-09 1.78E-07 1.27E-08 20897 hsa-mir-503 hsa04350 TGF-beta signaling pathway 6667_5933_5595_5594_1387_7027_4087_4088_4089_2033_5518_5515_4609 13 1.85E-08 1.57E-06 9.66E-08 20898 hsa-mir-503 hsa04012 ErbB signaling pathway 5578_5747_25_5595_5594_5599_2932_3725_5601_5602_4609_1026_6464 13 1.85E-08 1.57E-06 9.66E-08 20899 hsa-mir-503 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_1147_998_5599_836_5970_3725_4792_5601_5600_5603_5602 12 1.93E-08 1.64E-06 9.66E-08 20900 hsa-mir-503 hsa04660 T cell receptor signaling pathway 1432_1147_998_5595_5594_2932_5970_3725_959_4792_5601_5600_5603_2353 14 3.30E-08 2.80E-06 1.56E-07 20901 hsa-mir-503 hsa03022 Basal transcription factors 51616_2965_2963_2969_6874_6908_2958_6880_2957 9 7.82E-08 6.65E-06 3.35E-07 20902 hsa-mir-503 hsa04120 Ubiquitin mediated proteolysis 4193_3093_7319_84447_7329_10055_64326_7337_5371_672_25898_10075_51588_7428_8554 15 7.88E-08 6.69E-06 3.35E-07 20903 hsa-mir-503 hsa04620 Toll-like receptor signaling pathway 1432_1147_5595_5594_5599_5970_3725_4792_5601_5600_5603_5602_2353 13 1.01E-07 8.54E-06 4.07E-07 20904 hsa-mir-503 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_2902_1432_1616_836_7157_4846_5600_5603 10 1.88E-07 1.60E-05 7.28E-07 20905 hsa-mir-503 hsa05221 Acute myeloid leukemia 5914_595_1050_1147_5595_5594_5970_7704_5371_4609 10 2.90E-07 2.46E-05 1.07E-06 20906 hsa-mir-503 hsa04370 VEGF signaling pathway 5578_5743_5747_1432_998_5595_5594_3315_4846_5600_5603 11 3.47E-07 2.95E-05 1.23E-06 20907 hsa-mir-503 hsa04510 Focal adhesion 595_596_5578_5923_5747_5499_998_5595_5594_5599_2932_3725_5728_3910_5601_5602_6464 17 3.86E-07 3.28E-05 1.31E-06 20908 hsa-mir-503 hsa04520 Adherens junction 1460_998_5595_5594_1387_1457_1459_4087_4088_4089_2033 11 4.90E-07 4.16E-05 1.60E-06 20909 hsa-mir-503 hsa05016 Huntington's disease 3066_3065_3064_25942_2902_6667_9586_1385_1387_836_7157_10488_2033_27113_6874_6908 16 5.79E-07 4.93E-05 1.82E-06 20910 hsa-mir-503 hsa04912 GnRH signaling pathway 5578_1432_998_5595_5594_5599_3725_5601_5600_5603_5602_468 12 1.18E-06 0.000100459 3.59E-06 20911 hsa-mir-503 hsa04612 Antigen processing and presentation 3309_3304_3305_3303_1385_3312_1514_3320_3326_4800_4801 11 1.27E-06 0.000108342 3.74E-06 20912 hsa-mir-503 hsa05211 Renal cell carcinoma 3091_2113_998_5595_5594_1387_3725_2034_2033_7428 10 1.49E-06 0.00012693 4.23E-06 20913 hsa-mir-503 hsa04330 Notch signaling pathway 3066_3065_1387_9612_2033_8850_1856_4851 8 4.41E-06 0.000374554 1.21E-05 20914 hsa-mir-503 hsa04920 Adipocytokine signaling pathway 6794_1147_5599_6256_5970_4792_5601_5602_5563 9 6.40E-06 0.000543922 1.70E-05 20915 hsa-mir-503 hsa04662 B cell receptor signaling pathway 1147_5595_5594_1380_2932_5970_3725_4792_2353 9 1.46E-05 0.00124447 3.77E-05 20916 hsa-mir-503 hsa04664 Fc epsilon RI signaling pathway 5578_1432_5595_5594_5599_5601_5600_5603_5602 9 2.14E-05 0.001817519 5.35E-05 20917 hsa-mir-503 hsa03420 Nucleotide excision repair 902_2965_4331_2071_2074_1022_6117 7 2.60E-05 0.002213196 6.32E-05 20918 hsa-mir-503 hsa05216 Thyroid cancer 595_5595_5594_6256_7157_4609 6 2.70E-05 0.002295762 6.38E-05 20919 hsa-mir-503 hsa04916 Melanogenesis 5578_4286_5595_5594_1385_1387_2932_10488_2033_1856 10 2.91E-05 0.002472079 6.68E-05 20920 hsa-mir-503 hsa04210 Apoptosis 596_598_823_1147_836_5970_7157_4792_472 9 5.06E-05 0.00430098 0.000113184 20921 hsa-mir-503 hsa05213 Endometrial cancer 595_5595_5594_2932_7157_5728_4609 7 6.81E-05 0.00579198 0.000148512 20922 hsa-mir-503 hsa04720 Long-term potentiation 5578_2902_5499_5595_5594_1387_2033_468 8 9.37E-05 0.00796402 0.0001991 20923 hsa-mir-503 hsa03440 Homologous recombination 641_4683_5888_675_6117 5 0.00023742 0.020180705 0.000492212 20924 hsa-mir-503 hsa04910 Insulin signaling pathway 6720_5499_5595_5594_5599_2932_5601_5602_5563_6464 10 0.000258966 0.022012113 0.000524098 20925 hsa-mir-503 hsa04530 Tight junction 5578_1460_998_1457_1459_5728_5518_5515_5520 9 0.001006007 0.085510605 0.001988619 20926 hsa-mir-503 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601_5602 5 0.001667317 0.141721975 0.003220954 20927 hsa-mir-503 hsa04730 Long-term depression 5578_5595_5594_4846_5518_5515 6 0.002146795 0.182477546 0.004055057 20928 hsa-mir-503 hsa04062 Chemokine signaling pathway 5747_6362_1147_998_5595_5594_2932_5970_4792_6464 10 0.00288843 0.245516517 0.005337316 20929 hsa-mir-503 hsa04150 mTOR signaling pathway 6794_3091_5595_5594_5563 5 0.002986536 0.253855533 0.005401182 20930 hsa-mir-503 hsa05131 Shigellosis 5578_25_998_7534_4691 5 0.00401218 0.341035278 0.006959904 20931 hsa-mir-503 hsa05130 Pathogenic Escherichia coli infection 5578_25_998_7534_4691 5 0.00401218 0.341035278 0.006959904 20932 hsa-mir-503 hsa03410 Base excision repair 3146_142_4913_328 4 0.004875985 0.414458751 0.008289175 20933 hsa-mir-503 hsa05010 Alzheimer's disease 823_2902_22926_1020_5595_5594_836_2932_4846 9 0.005161527 0.438729764 0.008602544 20934 hsa-mir-503 hsa04360 Axon guidance 5747_25_998_1020_5595_5594_2932 7 0.010167989 0.864279046 0.016620751 20935 hsa-mir-503 hsa04630 Jak-STAT signaling pathway 595_598_1387_2033_51588_4609_8554 7 0.022616537 1 0.036271805 20936 hsa-mir-503 hsa04670 Leukocyte transendothelial migration 5578_5747_1432_998_5600_5603 6 0.023747982 1 0.037381083 20937 hsa-mir-503 hsa04710 Circadian rhythm - mammal 8863_1453 2 0.026827802 1 0.041461148 20938 hsa-mir-503 hsa04540 Gap junction 5578_5595_5594_1453_983 5 0.027420696 1 0.041620699 20939 hsa-mir-503 hsa03030 DNA replication 5557_6117_5422 3 0.029396076 1 0.043836253 20940 hsa-mir-503 hsa03450 Non-homologous end-joining 2547_5591 2 0.030316035 1 0.044428671 20941 hsa-mir-504 hsa05200 Pathways in cancer 4087_4088_4089_1869_1870_1871_4149_7157_5371_6688_2034_1017_1050_207_3091_2033_4609_7704_9915_5595_5594_6774_1387 23 4.23E-26 2.24E-24 2.24E-24 20942 hsa-mir-504 hsa04350 TGF-beta signaling pathway 4093_4087_4088_4089_1874_1875_5933_2033_4609_5595_5594_5934_1387 13 4.98E-19 2.64E-17 1.32E-17 20943 hsa-mir-504 hsa04110 Cell cycle 4087_4088_4089_1869_1870_1871_7157_5933_1017_890_2033_5934_1387 13 2.12E-17 1.12E-15 3.74E-16 20944 hsa-mir-504 hsa05220 Chronic myeloid leukemia 4088_4089_1869_1870_1871_7157_207_4609_5595_5594 10 2.02E-14 1.07E-12 2.68E-13 20945 hsa-mir-504 hsa05215 Prostate cancer 1869_1870_1871_7157_1017_207_2033_5595_5594_1387 10 8.82E-14 4.67E-12 8.65E-13 20946 hsa-mir-504 hsa05212 Pancreatic cancer 1869_1870_1871_7157_1017_207_2033_5595_5594_1387 10 9.79E-14 5.19E-12 8.65E-13 20947 hsa-mir-504 hsa05221 Acute myeloid leukemia 5371_6688_1050_207_4609_7704_5595_5594_6774 9 1.43E-13 7.60E-12 1.09E-12 20948 hsa-mir-504 hsa05211 Renal cell carcinoma 2034_207_3091_2033_9915_5595_5594_1387 8 3.53E-11 1.87E-09 2.34E-10 20949 hsa-mir-504 hsa05219 Bladder cancer 1869_1870_1871_7157_4609_5595_5594 7 4.71E-11 2.50E-09 2.77E-10 20950 hsa-mir-504 hsa04520 Adherens junction 4087_4088_4089_2033_5595_5594_1457_1387 8 7.69E-11 4.08E-09 4.08E-10 20951 hsa-mir-504 hsa05210 Colorectal cancer 4087_4088_4089_7157_207_4609_5595_5594 8 1.10E-10 5.86E-09 5.32E-10 20952 hsa-mir-504 hsa05222 Small cell lung cancer 1869_1870_1871_4149_7157_1017_207_4609 8 1.32E-10 6.97E-09 5.81E-10 20953 hsa-mir-504 hsa05223 Non-small cell lung cancer 1869_1870_1871_7157_207_5595_5594 7 2.33E-10 1.24E-08 9.52E-10 20954 hsa-mir-504 hsa05214 Glioma 1869_1870_1871_7157_207_5595_5594 7 7.70E-10 4.08E-08 2.92E-09 20955 hsa-mir-504 hsa05218 Melanoma 1869_1870_1871_7157_207_5595_5594 7 1.36E-09 7.23E-08 4.82E-09 20956 hsa-mir-504 hsa04310 Wnt signaling pathway 4087_4088_4089_7157_2033_4609_1457_1387 8 9.19E-09 4.87E-07 3.05E-08 20957 hsa-mir-504 hsa05213 Endometrial cancer 7157_207_4609_5595_5594 5 3.88E-07 2.06E-05 1.21E-06 20958 hsa-mir-504 hsa05216 Thyroid cancer 7157_4609_5595_5594 4 1.62E-06 8.57E-05 4.76E-06 20959 hsa-mir-504 hsa04150 mTOR signaling pathway 207_3091_5595_5594 4 1.39E-05 0.000735191 3.87E-05 20960 hsa-mir-504 hsa04720 Long-term potentiation 2033_5595_5594_1387 4 5.42E-05 0.002874704 0.000143735 20961 hsa-mir-504 hsa04630 Jak-STAT signaling pathway 207_2033_4609_6774_1387 5 6.17E-05 0.003272673 0.000155842 20962 hsa-mir-504 hsa04010 MAPK signaling pathway 4149_7157_207_4609_5595_5594 6 8.86E-05 0.004696327 0.000213469 20963 hsa-mir-504 hsa04012 ErbB signaling pathway 207_4609_5595_5594 4 9.42E-05 0.004994608 0.000217157 20964 hsa-mir-504 hsa04916 Melanogenesis 2033_5595_5594_1387 4 0.000182769 0.009686753 0.000403615 20965 hsa-mir-504 hsa04330 Notch signaling pathway 9612_2033_1387 3 0.00030118 0.015962548 0.000638502 20966 hsa-mir-504 hsa04662 B cell receptor signaling pathway 207_5595_5594 3 0.001109664 0.058812181 0.002262007 20967 hsa-mir-504 hsa04370 VEGF signaling pathway 207_5595_5594 3 0.001193962 0.063279986 0.002343703 20968 hsa-mir-504 hsa04664 Fc epsilon RI signaling pathway 207_5595_5594 3 0.001282196 0.067956377 0.002427013 20969 hsa-mir-504 hsa04062 Chemokine signaling pathway 207_5595_5594_6774 4 0.001744421 0.092454293 0.003188079 20970 hsa-mir-504 hsa04620 Toll-like receptor signaling pathway 207_5595_5594 3 0.002600737 0.137839037 0.004594635 20971 hsa-mir-504 hsa04660 T cell receptor signaling pathway 207_5595_5594 3 0.003200528 0.169627994 0.005471871 20972 hsa-mir-504 hsa04910 Insulin signaling pathway 207_5595_5594 3 0.005935916 0.314603523 0.00983136 20973 hsa-mir-504 hsa04930 Type II diabetes mellitus 5595_5594 2 0.006654459 0.352686329 0.010687465 20974 hsa-mir-504 hsa05010 Alzheimer's disease 22926_5595_5594 3 0.011547276 0.612005639 0.018000166 20975 hsa-mir-504 hsa05016 Huntington's disease 7157_2033_1387 3 0.013533486 0.71727474 0.020493564 20976 hsa-mir-504 hsa04920 Adipocytokine signaling pathway 207_6774 2 0.013921134 0.73782008 0.020495002 20977 hsa-mir-504 hsa04115 p53 signaling pathway 7157_1017 2 0.01469695 0.778938361 0.021052388 20978 hsa-mir-504 hsa04730 Long-term depression 5595_5594 2 0.015491055 0.821025905 0.021605945 20979 hsa-mir-504 hsa04510 Focal adhesion 207_5595_5594 3 0.017179419 0.910509222 0.02334639 20980 hsa-mir-504 hsa04612 Antigen processing and presentation 4800_4801 2 0.023427622 1 0.030284487 20981 hsa-mir-504 hsa04210 Apoptosis 7157_207 2 0.023427622 1 0.030284487 20982 hsa-mir-504 hsa04540 Gap junction 5595_5594 2 0.025375656 1 0.032021661 20983 hsa-mir-504 hsa04912 GnRH signaling pathway 5595_5594 2 0.033236173 1 0.040965516 20984 hsa-mir-504 hsa04270 Vascular smooth muscle contraction 5595_5594 2 0.038936358 1 0.046900613 20985 hsa-mir-504 hsa04360 Axon guidance 5595_5594 2 0.046855452 1 0.055185311 20986 hsa-mir-505 hsa05200 Pathways in cancer 2353_3326_3065_5925_2033_2249_367_2932_3265_3725_6776_6777_5914_5970_6256 15 5.45E-14 3.27E-12 3.27E-12 20987 hsa-mir-505 hsa05215 Prostate cancer 3326_5925_2033_367_2932_3265_5970 7 1.01E-08 6.06E-07 2.17E-07 20988 hsa-mir-505 hsa05212 Pancreatic cancer 3326_5925_2033_367_2932_3265_5970 7 1.09E-08 6.52E-07 2.17E-07 20989 hsa-mir-505 hsa05220 Chronic myeloid leukemia 3065_5925_3265_6776_6777_5970 6 1.16E-07 6.99E-06 1.75E-06 20990 hsa-mir-505 hsa05221 Acute myeloid leukemia 3265_6776_6777_5914_5970 5 1.07E-06 6.41E-05 1.28E-05 20991 hsa-mir-505 hsa04662 B cell receptor signaling pathway 2353_2932_3265_3725_5970 5 3.25E-06 0.000195156 3.25E-05 20992 hsa-mir-505 hsa04012 ErbB signaling pathway 2932_3265_3725_6776_6777 5 6.48E-06 0.000388759 5.55E-05 20993 hsa-mir-505 hsa04010 MAPK signaling pathway 2353_2249_22800_3265_3725_1386_5970 7 1.49E-05 0.000894566 0.000111821 20994 hsa-mir-505 hsa05016 Huntington's disease 2902_3065_6667_2033_6908_9519 6 1.91E-05 0.001143755 0.000115312 20995 hsa-mir-505 hsa04660 T cell receptor signaling pathway 2353_2932_3265_3725_5970 5 1.92E-05 0.001153123 0.000115312 20996 hsa-mir-505 hsa04720 Long-term potentiation 2902_2906_2033_3265 4 7.59E-05 0.004551622 0.000413784 20997 hsa-mir-505 hsa03022 Basal transcription factors 2959_6908_9519 3 0.000199392 0.011963504 0.000996959 20998 hsa-mir-505 hsa04330 Notch signaling pathway 9612_3065_2033 3 0.000387578 0.023254708 0.001787694 20999 hsa-mir-505 hsa04110 Cell cycle 3065_5925_2033_2932 4 0.000417129 0.025027722 0.001787694 21000 hsa-mir-505 hsa05223 Non-small cell lung cancer 5925_3265_6256 3 0.000570415 0.034224924 0.002281662 21001 hsa-mir-505 hsa04630 Jak-STAT signaling pathway 2033_3977_6776_6777 4 0.001090698 0.065441895 0.004090118 21002 hsa-mir-505 hsa05218 Melanoma 5925_2249_3265 3 0.001220812 0.073248725 0.004230334 21003 hsa-mir-505 hsa05211 Renal cell carcinoma 2033_3265_3725 3 0.0012691 0.076146014 0.004230334 21004 hsa-mir-505 hsa05010 Alzheimer's disease 2902_2906_2932_351 4 0.001755795 0.105347678 0.005544615 21005 hsa-mir-505 hsa05210 Colorectal cancer 2353_2932_3725 3 0.001944217 0.11665304 0.005832652 21006 hsa-mir-505 hsa05222 Small cell lung cancer 5925_5970_6256 3 0.002074625 0.124477491 0.0059275 21007 hsa-mir-505 hsa04062 Chemokine signaling pathway 2932_3265_6777_5970 4 0.002387863 0.143271778 0.006512354 21008 hsa-mir-505 hsa04620 Toll-like receptor signaling pathway 2353_3725_5970 3 0.003315418 0.198925055 0.008390963 21009 hsa-mir-505 hsa05216 Thyroid cancer 3265_6256 2 0.003478127 0.208687638 0.008390963 21010 hsa-mir-505 hsa04916 Melanogenesis 2033_2932_3265 3 0.003496234 0.209774063 0.008390963 21011 hsa-mir-505 hsa03410 Base excision repair 142_3146 2 0.005191443 0.311486572 0.011980253 21012 hsa-mir-505 hsa04080 Neuroactive ligand-receptor interaction 2902_2908_2906_7067 4 0.006385255 0.383115325 0.014189456 21013 hsa-mir-505 hsa05219 Bladder cancer 5925_3265 2 0.006909791 0.414587455 0.014806695 21014 hsa-mir-505 hsa04530 Tight junction 22800_3265_8573 3 0.007375949 0.442556931 0.015260584 21015 hsa-mir-505 hsa04310 Wnt signaling pathway 2033_2932_3725 3 0.009732633 0.583958007 0.019465267 21016 hsa-mir-505 hsa05213 Endometrial cancer 2932_3265 2 0.010263494 0.615809614 0.019864826 21017 hsa-mir-505 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906 2 0.011769713 0.706182795 0.022068212 21018 hsa-mir-505 hsa05214 Glioma 5925_3265 2 0.015487308 0.929238487 0.028158742 21019 hsa-mir-505 hsa04920 Adipocytokine signaling pathway 5970_6256 2 0.016373367 0.982402023 0.028894177 21020 hsa-mir-505 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5970 2 0.018208869 1 0.031215205 21021 hsa-mir-505 hsa04510 Focal adhesion 2932_3265_3725 3 0.021521697 1 0.035869496 21022 hsa-mir-505 hsa04512 ECM-receptor interaction 6383_9672 2 0.024735385 1 0.039716256 21023 hsa-mir-505 hsa04810 Regulation of actin cytoskeleton 2249_22800_3265 3 0.025153629 1 0.039716256 21024 hsa-mir-505 hsa04350 TGF-beta signaling pathway 6667_2033 2 0.026358347 1 0.040551303 21025 hsa-mir-505 hsa04612 Antigen processing and presentation 3326_4800 2 0.027463742 1 0.041195613 21026 hsa-mir-505 hsa04912 GnRH signaling pathway 3265_3725 2 0.038852364 1 0.056857119 21027 hsa-mir-505 hsa03450 Non-homologous end-joining 2547 1 0.041561419 1 0.059373456 21028 hsa-mir-506 hsa04110 Cell cycle 5925_2033_1019_1017_7027_1026_5933_1387 8 3.59E-12 1.47E-10 1.47E-10 21029 hsa-mir-506 hsa05200 Pathways in cancer 6688_5925_2033_1019_1017_8554_4609_1499_1026_1387 10 1.14E-11 4.69E-10 2.34E-10 21030 hsa-mir-506 hsa05215 Prostate cancer 5925_2033_1017_468_1499_1026_1387 7 2.94E-11 1.21E-09 3.25E-10 21031 hsa-mir-506 hsa05212 Pancreatic cancer 5925_2033_1017_468_1499_1026_1387 7 3.17E-11 1.30E-09 3.25E-10 21032 hsa-mir-506 hsa04350 TGF-beta signaling pathway 1874_2033_7027_4609_5933_1387 6 1.91E-09 7.81E-08 1.56E-08 21033 hsa-mir-506 hsa05222 Small cell lung cancer 5925_1019_1017_8554_4609 5 1.06E-07 4.34E-06 7.24E-07 21034 hsa-mir-506 hsa05219 Bladder cancer 5925_1019_4609_1026 4 3.42E-07 1.40E-05 2.00E-06 21035 hsa-mir-506 hsa05220 Chronic myeloid leukemia 5925_1019_4609_1026 4 3.06E-06 0.000125273 1.57E-05 21036 hsa-mir-506 hsa04310 Wnt signaling pathway 2033_4609_1499_1387 4 4.50E-05 0.001846021 0.000198824 21037 hsa-mir-506 hsa04630 Jak-STAT signaling pathway 2033_8554_4609_1387 4 4.85E-05 0.001988237 0.000198824 21038 hsa-mir-506 hsa05214 Glioma 5925_1019_1026 3 8.84E-05 0.003625945 0.000329631 21039 hsa-mir-506 hsa04115 p53 signaling pathway 1019_1017_1026 3 0.000104878 0.004299984 0.000358332 21040 hsa-mir-506 hsa05218 Melanoma 5925_1019_1026 3 0.000113795 0.004665597 0.000358892 21041 hsa-mir-506 hsa04720 Long-term potentiation 2033_468_1387 3 0.000133082 0.005456369 0.000389741 21042 hsa-mir-506 hsa04520 Adherens junction 2033_1499_1387 3 0.000160031 0.006561269 0.000437418 21043 hsa-mir-506 hsa04916 Melanogenesis 2033_1499_1387 3 0.000338547 0.013880445 0.000867528 21044 hsa-mir-506 hsa04010 MAPK signaling pathway 468_4609_1649_1386 4 0.000408091 0.016731749 0.000984221 21045 hsa-mir-506 hsa05216 Thyroid cancer 4609_1499 2 0.000708033 0.029029369 0.001612743 21046 hsa-mir-506 hsa04330 Notch signaling pathway 2033_1387 2 0.001765131 0.072370374 0.003808967 21047 hsa-mir-506 hsa05213 Endometrial cancer 4609_1499 2 0.002139341 0.087712962 0.004385648 21048 hsa-mir-506 hsa05223 Non-small cell lung cancer 5925_1019 2 0.002298632 0.094243913 0.004487805 21049 hsa-mir-506 hsa05221 Acute myeloid leukemia 6688_4609 2 0.002720642 0.111546321 0.005070287 21050 hsa-mir-506 hsa05211 Renal cell carcinoma 2033_1387 2 0.00397424 0.162943843 0.007084515 21051 hsa-mir-506 hsa05210 Colorectal cancer 4609_1499 2 0.005326912 0.218403407 0.009100142 21052 hsa-mir-506 hsa04012 ErbB signaling pathway 4609_1026 2 0.00569372 0.233442528 0.009337701 21053 hsa-mir-506 hsa04530 Tight junction 1019_1499 2 0.01340317 0.549529986 0.021135769 21054 hsa-mir-506 hsa05016 Huntington's disease 2033_1387 2 0.024101573 0.988164496 0.036598685 21055 hsa-mir-506 hsa03430 Mismatch repair 5981 1 0.029935202 1 0.043833689 21056 hsa-mir-506 hsa04950 Maturity onset diabetes of the young 6927 1 0.031163378 1 0.044058568 21057 hsa-mir-506 hsa03030 DNA replication 5981 1 0.045783903 1 0.062571334 21058 hsa-mir-509-2 hsa05200 Pathways in cancer 5970_595_2033_2249_367_5914_3725_1387_6777_6256_2353_6776 12 4.08E-11 1.88E-09 1.88E-09 21059 hsa-mir-509-2 hsa04630 Jak-STAT signaling pathway 595_2033_3977_894_896_1387_6777_6776 8 6.25E-09 2.87E-07 1.44E-07 21060 hsa-mir-509-2 hsa05221 Acute myeloid leukemia 5970_595_5914_6777_6776 5 5.00E-07 2.30E-05 7.67E-06 21061 hsa-mir-509-2 hsa04310 Wnt signaling pathway 595_2033_894_896_3725_1387 6 2.43E-06 0.000111965 2.61E-05 21062 hsa-mir-509-2 hsa05215 Prostate cancer 5970_595_2033_367_1387 5 3.23E-06 0.000148467 2.61E-05 21063 hsa-mir-509-2 hsa05212 Pancreatic cancer 5970_595_2033_367_1387 5 3.40E-06 0.000156513 2.61E-05 21064 hsa-mir-509-2 hsa04110 Cell cycle 595_2033_894_896_1387 5 1.32E-05 0.000606755 8.67E-05 21065 hsa-mir-509-2 hsa05220 Chronic myeloid leukemia 5970_595_6777_6776 4 4.18E-05 0.001924086 0.000240511 21066 hsa-mir-509-2 hsa05016 Huntington's disease 6667_2033_25942_6908_1387 5 0.000108998 0.005013921 0.000557102 21067 hsa-mir-509-2 hsa04330 Notch signaling pathway 9612_2033_1387 3 0.000247793 0.011398471 0.001139847 21068 hsa-mir-509-2 hsa04115 p53 signaling pathway 595_894_896 3 0.000725709 0.03338261 0.003034783 21069 hsa-mir-509-2 hsa05211 Renal cell carcinoma 2033_3725_1387 3 0.000817386 0.037599771 0.003133314 21070 hsa-mir-509-2 hsa04662 B cell receptor signaling pathway 5970_3725_2353 3 0.000916113 0.042141199 0.003241631 21071 hsa-mir-509-2 hsa05210 Colorectal cancer 595_3725_2353 3 0.001256627 0.057804851 0.00374917 21072 hsa-mir-509-2 hsa05222 Small cell lung cancer 5970_595_6256 3 0.001341701 0.061718255 0.00374917 21073 hsa-mir-509-2 hsa04350 TGF-beta signaling pathway 6667_2033_1387 3 0.001385563 0.063735887 0.00374917 21074 hsa-mir-509-2 hsa04012 ErbB signaling pathway 3725_6777_6776 3 0.001385563 0.063735887 0.00374917 21075 hsa-mir-509-2 hsa04510 Focal adhesion 595_894_896_3725 4 0.001726087 0.079400004 0.004411111 21076 hsa-mir-509-2 hsa04620 Toll-like receptor signaling pathway 5970_3725_2353 3 0.002154203 0.099093337 0.005215439 21077 hsa-mir-509-2 hsa05216 Thyroid cancer 595_6256 2 0.002582125 0.118777738 0.005812637 21078 hsa-mir-509-2 hsa04660 T cell receptor signaling pathway 5970_3725_2353 3 0.002653595 0.12206537 0.005812637 21079 hsa-mir-509-2 hsa03022 Basal transcription factors 6908_2959 2 0.0040635 0.186920985 0.008496408 21080 hsa-mir-509-2 hsa04010 MAPK signaling pathway 5970_2249_3725_2353 4 0.004659698 0.214346117 0.009319396 21081 hsa-mir-509-2 hsa05223 Non-small cell lung cancer 595_6256 2 0.008223629 0.378286917 0.015761955 21082 hsa-mir-509-2 hsa04920 Adipocytokine signaling pathway 5970_6256 2 0.012276377 0.564713325 0.022588533 21083 hsa-mir-509-2 hsa05218 Melanoma 595_2249 2 0.013666705 0.628668427 0.023284016 21084 hsa-mir-509-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_3725 2 0.013666705 0.628668427 0.023284016 21085 hsa-mir-509-2 hsa04720 Long-term potentiation 2033_1387 2 0.015122061 0.695614812 0.024843386 21086 hsa-mir-509-2 hsa04520 Adherens junction 2033_1387 2 0.017030643 0.783409594 0.027014124 21087 hsa-mir-509-2 hsa04916 Melanogenesis 2033_1387 2 0.027496189 1 0.042160823 21088 hsa-mir-509-2 hsa03450 Non-homologous end-joining 2547 1 0.035807352 1 0.05313349 21089 hsa-mir-509-3 hsa05200 Pathways in cancer 5970_595_2033_2249_367_5914_3725_1387_6777_6256_2353_6776 12 4.08E-11 1.88E-09 1.88E-09 21090 hsa-mir-509-3 hsa04630 Jak-STAT signaling pathway 595_2033_3977_894_896_1387_6777_6776 8 6.25E-09 2.87E-07 1.44E-07 21091 hsa-mir-509-3 hsa05221 Acute myeloid leukemia 5970_595_5914_6777_6776 5 5.00E-07 2.30E-05 7.67E-06 21092 hsa-mir-509-3 hsa04310 Wnt signaling pathway 595_2033_894_896_3725_1387 6 2.43E-06 0.000111965 2.61E-05 21093 hsa-mir-509-3 hsa05215 Prostate cancer 5970_595_2033_367_1387 5 3.23E-06 0.000148467 2.61E-05 21094 hsa-mir-509-3 hsa05212 Pancreatic cancer 5970_595_2033_367_1387 5 3.40E-06 0.000156513 2.61E-05 21095 hsa-mir-509-3 hsa04110 Cell cycle 595_2033_894_896_1387 5 1.32E-05 0.000606755 8.67E-05 21096 hsa-mir-509-3 hsa05220 Chronic myeloid leukemia 5970_595_6777_6776 4 4.18E-05 0.001924086 0.000240511 21097 hsa-mir-509-3 hsa05016 Huntington's disease 6667_2033_25942_6908_1387 5 0.000108998 0.005013921 0.000557102 21098 hsa-mir-509-3 hsa04330 Notch signaling pathway 9612_2033_1387 3 0.000247793 0.011398471 0.001139847 21099 hsa-mir-509-3 hsa04115 p53 signaling pathway 595_894_896 3 0.000725709 0.03338261 0.003034783 21100 hsa-mir-509-3 hsa05211 Renal cell carcinoma 2033_3725_1387 3 0.000817386 0.037599771 0.003133314 21101 hsa-mir-509-3 hsa04662 B cell receptor signaling pathway 5970_3725_2353 3 0.000916113 0.042141199 0.003241631 21102 hsa-mir-509-3 hsa05210 Colorectal cancer 595_3725_2353 3 0.001256627 0.057804851 0.00374917 21103 hsa-mir-509-3 hsa05222 Small cell lung cancer 5970_595_6256 3 0.001341701 0.061718255 0.00374917 21104 hsa-mir-509-3 hsa04350 TGF-beta signaling pathway 6667_2033_1387 3 0.001385563 0.063735887 0.00374917 21105 hsa-mir-509-3 hsa04012 ErbB signaling pathway 3725_6777_6776 3 0.001385563 0.063735887 0.00374917 21106 hsa-mir-509-3 hsa04510 Focal adhesion 595_894_896_3725 4 0.001726087 0.079400004 0.004411111 21107 hsa-mir-509-3 hsa04620 Toll-like receptor signaling pathway 5970_3725_2353 3 0.002154203 0.099093337 0.005215439 21108 hsa-mir-509-3 hsa05216 Thyroid cancer 595_6256 2 0.002582125 0.118777738 0.005812637 21109 hsa-mir-509-3 hsa04660 T cell receptor signaling pathway 5970_3725_2353 3 0.002653595 0.12206537 0.005812637 21110 hsa-mir-509-3 hsa03022 Basal transcription factors 6908_2959 2 0.0040635 0.186920985 0.008496408 21111 hsa-mir-509-3 hsa04010 MAPK signaling pathway 5970_2249_3725_2353 4 0.004659698 0.214346117 0.009319396 21112 hsa-mir-509-3 hsa05223 Non-small cell lung cancer 595_6256 2 0.008223629 0.378286917 0.015761955 21113 hsa-mir-509-3 hsa04920 Adipocytokine signaling pathway 5970_6256 2 0.012276377 0.564713325 0.022588533 21114 hsa-mir-509-3 hsa05218 Melanoma 595_2249 2 0.013666705 0.628668427 0.023284016 21115 hsa-mir-509-3 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_3725 2 0.013666705 0.628668427 0.023284016 21116 hsa-mir-509-3 hsa04720 Long-term potentiation 2033_1387 2 0.015122061 0.695614812 0.024843386 21117 hsa-mir-509-3 hsa04520 Adherens junction 2033_1387 2 0.017030643 0.783409594 0.027014124 21118 hsa-mir-509-3 hsa04916 Melanogenesis 2033_1387 2 0.027496189 1 0.042160823 21119 hsa-mir-509-3 hsa03450 Non-homologous end-joining 2547 1 0.035807352 1 0.05313349 21120 hsa-mir-511-1 hsa03022 Basal transcription factors 2967_2961_2960_2963_6881_54457_2968_6879_6878_6877_6874_6872_2957_6873_2958_6884_2959_6880_6882_138474_6883 21 1.42E-32 9.38E-31 9.38E-31 21121 hsa-mir-511-1 hsa05200 Pathways in cancer 5925_5595_5594_6256_3326_4193_1387_6774_5970_7157_6688_3725_7704_4609_2353_10401_2033_207_8554_7184 20 3.67E-14 2.42E-12 1.21E-12 21122 hsa-mir-511-1 hsa05215 Prostate cancer 5925_5595_5594_3326_4193_1387_5970_7157_2033_207_7184 11 1.88E-11 1.24E-09 3.47E-10 21123 hsa-mir-511-1 hsa05212 Pancreatic cancer 5925_5595_5594_3326_4193_1387_5970_7157_2033_207_7184 11 2.10E-11 1.39E-09 3.47E-10 21124 hsa-mir-511-1 hsa05221 Acute myeloid leukemia 5595_5594_6774_5970_6688_7704_4609_207 8 6.34E-09 4.18E-07 8.36E-08 21125 hsa-mir-511-1 hsa05220 Chronic myeloid leukemia 5925_5595_5594_4193_5970_7157_4609_207 8 3.53E-08 2.33E-06 3.89E-07 21126 hsa-mir-511-1 hsa05222 Small cell lung cancer 5925_6256_5970_7157_4609_10401_207_8554 8 9.44E-08 6.23E-06 8.90E-07 21127 hsa-mir-511-1 hsa05219 Bladder cancer 5925_5595_5594_4193_7157_4609 6 3.99E-07 2.64E-05 3.30E-06 21128 hsa-mir-511-1 hsa05210 Colorectal cancer 5595_5594_7157_3725_4609_2353_207 7 1.22E-06 8.06E-05 8.96E-06 21129 hsa-mir-511-1 hsa05223 Non-small cell lung cancer 5925_5595_5594_6256_7157_207 6 1.54E-06 0.000101413 1.01E-05 21130 hsa-mir-511-1 hsa05216 Thyroid cancer 5595_5594_6256_7157_4609 5 1.68E-06 0.000110874 1.01E-05 21131 hsa-mir-511-1 hsa05214 Glioma 5925_5595_5594_4193_7157_207 6 4.16E-06 0.00027488 2.29E-05 21132 hsa-mir-511-1 hsa05218 Melanoma 5925_5595_5594_4193_7157_207 6 6.69E-06 0.000441868 3.40E-05 21133 hsa-mir-511-1 hsa05211 Renal cell carcinoma 5595_5594_1387_3725_2033_207 6 7.22E-06 0.000476351 3.40E-05 21134 hsa-mir-511-1 hsa04010 MAPK signaling pathway 5595_5594_3312_5970_7157_3725_4609_3727_2353_207 10 8.04E-06 0.000530568 3.54E-05 21135 hsa-mir-511-1 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725_2353_207 6 8.99E-06 0.000593104 3.71E-05 21136 hsa-mir-511-1 hsa04110 Cell cycle 5925_4171_4193_1387_7157_4085_2033 7 1.07E-05 0.000706625 4.16E-05 21137 hsa-mir-511-1 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 1.58E-05 0.001043862 5.80E-05 21138 hsa-mir-511-1 hsa05213 Endometrial cancer 5595_5594_7157_4609_207 5 2.26E-05 0.001494175 7.86E-05 21139 hsa-mir-511-1 hsa04620 Toll-like receptor signaling pathway 5595_5594_5970_3725_2353_207 6 4.64E-05 0.003064327 0.000150846 21140 hsa-mir-511-1 hsa04310 Wnt signaling pathway 1460_8607_1387_7157_3725_4609_2033 7 4.80E-05 0.003167757 0.000150846 21141 hsa-mir-511-1 hsa04630 Jak-STAT signaling pathway 1387_6774_4609_10401_2033_207_8554 7 5.40E-05 0.003566236 0.000162102 21142 hsa-mir-511-1 hsa04660 T cell receptor signaling pathway 5595_5594_5970_3725_2353_207 6 6.92E-05 0.004569509 0.000198674 21143 hsa-mir-511-1 hsa04520 Adherens junction 1460_5595_5594_1387_2033 5 0.000155132 0.010238731 0.000426614 21144 hsa-mir-511-1 hsa05016 Huntington's disease 6874_9001_1387_5430_7157_3064_2033 7 0.000171834 0.011341018 0.000453641 21145 hsa-mir-511-1 hsa04350 TGF-beta signaling pathway 5595_5594_1387_4609_2033 5 0.000224941 0.014846106 0.000549856 21146 hsa-mir-511-1 hsa04012 ErbB signaling pathway 5595_5594_3725_4609_207 5 0.000224941 0.014846106 0.000549856 21147 hsa-mir-511-1 hsa04920 Adipocytokine signaling pathway 6256_6774_5970_207 4 0.000853062 0.056302068 0.002010788 21148 hsa-mir-511-1 hsa04720 Long-term potentiation 5595_5594_1387_2033 4 0.001271552 0.08392241 0.002893876 21149 hsa-mir-511-1 hsa03420 Nucleotide excision repair 2967_2968_5887 3 0.002746683 0.181281104 0.006042703 21150 hsa-mir-511-1 hsa04330 Notch signaling pathway 1387_2033_8850 3 0.003277226 0.216296936 0.006977321 21151 hsa-mir-511-1 hsa04916 Melanogenesis 5595_5594_1387_2033 4 0.003971584 0.262124541 0.008191392 21152 hsa-mir-511-1 hsa04150 mTOR signaling pathway 5595_5594_207 3 0.004292794 0.283324389 0.008585588 21153 hsa-mir-511-1 hsa04062 Chemokine signaling pathway 5595_5594_6774_5970_207 5 0.006673458 0.440448245 0.01295436 21154 hsa-mir-511-1 hsa04910 Insulin signaling pathway 5595_5594_5211_207 4 0.010307142 0.680271386 0.019436325 21155 hsa-mir-511-1 hsa04370 VEGF signaling pathway 5595_5594_207 3 0.012071644 0.796728474 0.022131347 21156 hsa-mir-511-1 hsa04664 Fc epsilon RI signaling pathway 5595_5594_207 3 0.012900847 0.851455875 0.023012321 21157 hsa-mir-511-1 hsa04612 Antigen processing and presentation 3326_4801_3312 3 0.017527006 1 0.029661087 21158 hsa-mir-511-1 hsa04210 Apoptosis 5970_7157_207 3 0.017527006 1 0.029661087 21159 hsa-mir-511-1 hsa04540 Gap junction 5595_5594_10382 3 0.019603657 1 0.032346034 21160 hsa-mir-511-1 hsa04912 GnRH signaling pathway 5595_5594_3725 3 0.02855002 1 0.045958569 21161 hsa-mir-511-1 hsa04930 Type II diabetes mellitus 5595_5594 2 0.031763711 1 0.049914402 21162 hsa-mir-511-1 hsa04510 Focal adhesion 5595_5594_3725_207 4 0.036808795 1 0.056497221 21163 hsa-mir-511-2 hsa03022 Basal transcription factors 2967_2961_2960_2963_6881_54457_2968_6879_6878_6877_6874_6872_2957_6873_2958_6884_2959_6880_6882_138474_6883 21 1.42E-32 9.38E-31 9.38E-31 21164 hsa-mir-511-2 hsa05200 Pathways in cancer 5925_5595_5594_6256_3326_4193_1387_6774_5970_7157_6688_3725_7704_4609_2353_10401_2033_207_8554_7184 20 3.67E-14 2.42E-12 1.21E-12 21165 hsa-mir-511-2 hsa05215 Prostate cancer 5925_5595_5594_3326_4193_1387_5970_7157_2033_207_7184 11 1.88E-11 1.24E-09 3.47E-10 21166 hsa-mir-511-2 hsa05212 Pancreatic cancer 5925_5595_5594_3326_4193_1387_5970_7157_2033_207_7184 11 2.10E-11 1.39E-09 3.47E-10 21167 hsa-mir-511-2 hsa05221 Acute myeloid leukemia 5595_5594_6774_5970_6688_7704_4609_207 8 6.34E-09 4.18E-07 8.36E-08 21168 hsa-mir-511-2 hsa05220 Chronic myeloid leukemia 5925_5595_5594_4193_5970_7157_4609_207 8 3.53E-08 2.33E-06 3.89E-07 21169 hsa-mir-511-2 hsa05222 Small cell lung cancer 5925_6256_5970_7157_4609_10401_207_8554 8 9.44E-08 6.23E-06 8.90E-07 21170 hsa-mir-511-2 hsa05219 Bladder cancer 5925_5595_5594_4193_7157_4609 6 3.99E-07 2.64E-05 3.30E-06 21171 hsa-mir-511-2 hsa05210 Colorectal cancer 5595_5594_7157_3725_4609_2353_207 7 1.22E-06 8.06E-05 8.96E-06 21172 hsa-mir-511-2 hsa05223 Non-small cell lung cancer 5925_5595_5594_6256_7157_207 6 1.54E-06 0.000101413 1.01E-05 21173 hsa-mir-511-2 hsa05216 Thyroid cancer 5595_5594_6256_7157_4609 5 1.68E-06 0.000110874 1.01E-05 21174 hsa-mir-511-2 hsa05214 Glioma 5925_5595_5594_4193_7157_207 6 4.16E-06 0.00027488 2.29E-05 21175 hsa-mir-511-2 hsa05218 Melanoma 5925_5595_5594_4193_7157_207 6 6.69E-06 0.000441868 3.40E-05 21176 hsa-mir-511-2 hsa05211 Renal cell carcinoma 5595_5594_1387_3725_2033_207 6 7.22E-06 0.000476351 3.40E-05 21177 hsa-mir-511-2 hsa04010 MAPK signaling pathway 5595_5594_3312_5970_7157_3725_4609_3727_2353_207 10 8.04E-06 0.000530568 3.54E-05 21178 hsa-mir-511-2 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725_2353_207 6 8.99E-06 0.000593104 3.71E-05 21179 hsa-mir-511-2 hsa04110 Cell cycle 5925_4171_4193_1387_7157_4085_2033 7 1.07E-05 0.000706625 4.16E-05 21180 hsa-mir-511-2 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 1.58E-05 0.001043862 5.80E-05 21181 hsa-mir-511-2 hsa05213 Endometrial cancer 5595_5594_7157_4609_207 5 2.26E-05 0.001494175 7.86E-05 21182 hsa-mir-511-2 hsa04620 Toll-like receptor signaling pathway 5595_5594_5970_3725_2353_207 6 4.64E-05 0.003064327 0.000150846 21183 hsa-mir-511-2 hsa04310 Wnt signaling pathway 1460_8607_1387_7157_3725_4609_2033 7 4.80E-05 0.003167757 0.000150846 21184 hsa-mir-511-2 hsa04630 Jak-STAT signaling pathway 1387_6774_4609_10401_2033_207_8554 7 5.40E-05 0.003566236 0.000162102 21185 hsa-mir-511-2 hsa04660 T cell receptor signaling pathway 5595_5594_5970_3725_2353_207 6 6.92E-05 0.004569509 0.000198674 21186 hsa-mir-511-2 hsa04520 Adherens junction 1460_5595_5594_1387_2033 5 0.000155132 0.010238731 0.000426614 21187 hsa-mir-511-2 hsa05016 Huntington's disease 6874_9001_1387_5430_7157_3064_2033 7 0.000171834 0.011341018 0.000453641 21188 hsa-mir-511-2 hsa04350 TGF-beta signaling pathway 5595_5594_1387_4609_2033 5 0.000224941 0.014846106 0.000549856 21189 hsa-mir-511-2 hsa04012 ErbB signaling pathway 5595_5594_3725_4609_207 5 0.000224941 0.014846106 0.000549856 21190 hsa-mir-511-2 hsa04920 Adipocytokine signaling pathway 6256_6774_5970_207 4 0.000853062 0.056302068 0.002010788 21191 hsa-mir-511-2 hsa04720 Long-term potentiation 5595_5594_1387_2033 4 0.001271552 0.08392241 0.002893876 21192 hsa-mir-511-2 hsa03420 Nucleotide excision repair 2967_2968_5887 3 0.002746683 0.181281104 0.006042703 21193 hsa-mir-511-2 hsa04330 Notch signaling pathway 1387_2033_8850 3 0.003277226 0.216296936 0.006977321 21194 hsa-mir-511-2 hsa04916 Melanogenesis 5595_5594_1387_2033 4 0.003971584 0.262124541 0.008191392 21195 hsa-mir-511-2 hsa04150 mTOR signaling pathway 5595_5594_207 3 0.004292794 0.283324389 0.008585588 21196 hsa-mir-511-2 hsa04062 Chemokine signaling pathway 5595_5594_6774_5970_207 5 0.006673458 0.440448245 0.01295436 21197 hsa-mir-511-2 hsa04910 Insulin signaling pathway 5595_5594_5211_207 4 0.010307142 0.680271386 0.019436325 21198 hsa-mir-511-2 hsa04370 VEGF signaling pathway 5595_5594_207 3 0.012071644 0.796728474 0.022131347 21199 hsa-mir-511-2 hsa04664 Fc epsilon RI signaling pathway 5595_5594_207 3 0.012900847 0.851455875 0.023012321 21200 hsa-mir-511-2 hsa04612 Antigen processing and presentation 3326_4801_3312 3 0.017527006 1 0.029661087 21201 hsa-mir-511-2 hsa04210 Apoptosis 5970_7157_207 3 0.017527006 1 0.029661087 21202 hsa-mir-511-2 hsa04540 Gap junction 5595_5594_10382 3 0.019603657 1 0.032346034 21203 hsa-mir-511-2 hsa04912 GnRH signaling pathway 5595_5594_3725 3 0.02855002 1 0.045958569 21204 hsa-mir-511-2 hsa04930 Type II diabetes mellitus 5595_5594 2 0.031763711 1 0.049914402 21205 hsa-mir-511-2 hsa04510 Focal adhesion 5595_5594_3725_207 4 0.036808795 1 0.056497221 21206 hsa-mir-539 hsa05200 Pathways in cancer 7046_1499_596_598_1017_4193_5578_6502_3091_3065_5925_613_5743_5747_25_6789_4436_862_1147_998_5595_5594_5599_6258_1387_6256_2932_6772_5970_1869_4087_4088_5888_5728_2033_3910_4792_3320_3326_5371_675_8031_5601_5602_1856_6257_51588_1026_2353_8554 50 2.35E-33 2.04E-31 2.04E-31 21207 hsa-mir-539 hsa04110 Cell cycle 1017_4193_902_6502_3065_4616_5925_25_9232_545_995_5347_5591_1387_11200_7534_7533_7532_2932_7027_10912_1869_4087_4088_2033_890_891_1031_983_1026_1022_1111_8556_8555_472 35 3.50E-32 3.04E-30 1.52E-30 21208 hsa-mir-539 hsa04115 p53 signaling pathway 1017_4194_4193_900_4616_50484_6241_51246_545_7161_11200_10912_64326_5728_891_27113_25898_983_1026_1111_472 21 4.80E-20 4.17E-18 1.39E-18 21209 hsa-mir-539 hsa05222 Small cell lung cancer 596_598_1017_6502_5925_5743_5747_1147_6258_6256_5970_1869_5728_3910_4792_6257_51588_8554 18 6.34E-15 5.52E-13 1.38E-13 21210 hsa-mir-539 hsa05215 Prostate cancer 1499_596_1017_4193_5925_1147_5595_5594_1387_2932_5970_1869_5728_2033_4792_3320_3326_1026 18 8.99E-15 7.82E-13 1.55E-13 21211 hsa-mir-539 hsa05212 Pancreatic cancer 1499_596_1017_4193_5925_1147_5595_5594_1387_2932_5970_1869_5728_2033_4792_3320_3326_1026 18 1.07E-14 9.28E-13 1.55E-13 21212 hsa-mir-539 hsa04010 MAPK signaling pathway 6722_7046_7867_5578_4616_5923_3304_3305_3303_6789_1432_1616_1147_998_5595_5594_5599_3315_5970_3164_10912_9261_4208_5601_5602_2353 26 1.60E-13 1.39E-11 1.99E-12 21213 hsa-mir-539 hsa05220 Chronic myeloid leukemia 7046_598_4193_3065_5925_613_25_1147_5595_5594_5970_1869_4088_4792_1026 15 2.08E-12 1.81E-10 2.26E-11 21214 hsa-mir-539 hsa05210 Colorectal cancer 7046_1499_596_4436_5595_5594_5599_2932_4087_4088_5601_5602_1856_2353 14 9.79E-11 8.51E-09 9.46E-10 21215 hsa-mir-539 hsa04350 TGF-beta signaling pathway 7046_3398_6667_3397_3399_5595_5594_1387_7027_4087_4088_2033_5518_5515 14 1.48E-10 1.29E-08 1.29E-09 21216 hsa-mir-539 hsa04310 Wnt signaling pathway 1499_5578_1460_5599_1387_2932_1457_1452_4087_4088_2033_5518_5515_5601_5602_1856_5527 17 2.81E-10 2.45E-08 2.23E-09 21217 hsa-mir-539 hsa04120 Ubiquitin mediated proteolysis 4193_6502_3093_7319_84447_7325_7329_10055_64326_7337_5371_672_25898_51588_10075_8554 16 6.44E-10 5.60E-08 4.67E-09 21218 hsa-mir-539 hsa04920 Adipocytokine signaling pathway 10891_6794_1147_5599_6258_6256_5970_4792_5601_5602_5563_6257 12 1.04E-09 9.06E-08 6.97E-09 21219 hsa-mir-539 hsa04520 Adherens junction 7046_1499_4301_1460_998_5595_5594_1387_1457_4087_4088_2033 12 6.27E-09 5.45E-07 3.89E-08 21220 hsa-mir-539 hsa05214 Glioma 4193_5578_5925_5595_5594_1869_5728_808_801_805_1026 11 8.81E-09 7.67E-07 5.11E-08 21221 hsa-mir-539 hsa05223 Non-small cell lung cancer 5578_5925_6789_5595_5594_6258_6256_1869_6257 9 2.26E-07 1.97E-05 1.23E-06 21222 hsa-mir-539 hsa04370 VEGF signaling pathway 7867_5578_5743_5747_1432_998_5595_5594_3315_9261 10 3.91E-07 3.40E-05 2.00E-06 21223 hsa-mir-539 hsa04620 Toll-like receptor signaling pathway 1432_1147_5595_5594_5599_6772_5970_4792_5601_5602_2353 11 5.63E-07 4.90E-05 2.58E-06 21224 hsa-mir-539 hsa05216 Thyroid cancer 1499_5595_5594_6258_6256_8031_6257 7 5.81E-07 5.06E-05 2.58E-06 21225 hsa-mir-539 hsa04510 Focal adhesion 1499_596_5578_5923_5747_5499_998_5595_5594_5599_2932_5728_3910_5601_5602 15 5.94E-07 5.17E-05 2.58E-06 21226 hsa-mir-539 hsa04916 Melanogenesis 1499_5578_5595_5594_1387_2932_2033_808_801_805_1856 11 6.73E-07 5.85E-05 2.79E-06 21227 hsa-mir-539 hsa04912 GnRH signaling pathway 5578_1432_998_5595_5594_5599_808_801_805_5601_5602 11 9.48E-07 8.25E-05 3.75E-06 21228 hsa-mir-539 hsa04012 ErbB signaling pathway 5578_5747_25_5595_5594_5599_2932_5601_5602_1026 10 1.09E-06 9.44E-05 4.06E-06 21229 hsa-mir-539 hsa04660 T cell receptor signaling pathway 1432_1147_998_5595_5594_2932_5970_959_4792_5601_2353 11 1.12E-06 9.74E-05 4.06E-06 21230 hsa-mir-539 hsa04910 Insulin signaling pathway 10891_5499_5595_5594_5599_2932_808_801_805_5601_5602_5563 12 1.44E-06 0.000125185 5.01E-06 21231 hsa-mir-539 hsa03022 Basal transcription factors 51616_2965_2969_6908_2958_6880_2957 7 2.42E-06 0.000210863 8.11E-06 21232 hsa-mir-539 hsa04720 Long-term potentiation 5578_5499_5595_5594_1387_2033_808_801_805 9 2.72E-06 0.000236343 8.75E-06 21233 hsa-mir-539 hsa03420 Nucleotide excision repair 902_2965_4331_2071_2074_1022_6117 7 6.73E-06 0.000585683 2.09E-05 21234 hsa-mir-539 hsa04330 Notch signaling pathway 3065_1387_9612_2033_8850_1856_388585 7 9.93E-06 0.000864233 2.98E-05 21235 hsa-mir-539 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_1147_998_5599_5970_4792_5601_5602 8 1.49E-05 0.001295845 4.32E-05 21236 hsa-mir-539 hsa04662 B cell receptor signaling pathway 1147_5595_5594_1380_2932_5970_4792_2353 8 2.15E-05 0.001866315 6.02E-05 21237 hsa-mir-539 hsa04530 Tight junction 1499_5578_4301_1460_998_1457_5728_5518_5515_5520 10 4.42E-05 0.003841942 0.000120061 21238 hsa-mir-539 hsa05219 Bladder cancer 4193_5925_5595_5594_1869_1026 6 5.36E-05 0.00466197 0.000141272 21239 hsa-mir-539 hsa04930 Type II diabetes mellitus 3651_5595_5594_5599_5601_5602 6 7.59E-05 0.006604712 0.000194256 21240 hsa-mir-539 hsa05218 Melanoma 4193_5925_5595_5594_1869_5728_1026 7 0.000111182 0.009672845 0.000276367 21241 hsa-mir-539 hsa04664 Fc epsilon RI signaling pathway 5578_1432_5595_5594_5599_5601_5602 7 0.000205538 0.017881781 0.000496716 21242 hsa-mir-539 hsa05131 Shigellosis 1499_5578_25_998_7534_4691 6 0.000227752 0.01981441 0.000521432 21243 hsa-mir-539 hsa05130 Pathogenic Escherichia coli infection 1499_5578_25_998_7534_4691 6 0.000227752 0.01981441 0.000521432 21244 hsa-mir-539 hsa05221 Acute myeloid leukemia 862_1147_5595_5594_5970_5371 6 0.000295446 0.02570376 0.000659071 21245 hsa-mir-539 hsa04612 Antigen processing and presentation 3309_3304_3305_3303_3320_3326_4802 7 0.00040474 0.035212382 0.000858839 21246 hsa-mir-539 hsa04210 Apoptosis 596_598_823_1147_5970_4792_472 7 0.00040474 0.035212382 0.000858839 21247 hsa-mir-539 hsa05016 Huntington's disease 10891_3065_3064_25942_6667_1387_1537_2033_27113_6908 10 0.000503287 0.043785977 0.001042523 21248 hsa-mir-539 hsa04062 Chemokine signaling pathway 5747_6362_1147_998_5595_5594_2932_6772_5970_4792 10 0.000610983 0.053155531 0.001236175 21249 hsa-mir-539 hsa05211 Renal cell carcinoma 3091_998_5595_5594_1387_2033 6 0.000789193 0.068659777 0.001560449 21250 hsa-mir-539 hsa03440 Homologous recombination 641_5888_675_6117 4 0.000990458 0.086169848 0.001914886 21251 hsa-mir-539 hsa05213 Endometrial cancer 1499_5595_5594_2932_5728 5 0.001197808 0.104209303 0.002217219 21252 hsa-mir-539 hsa04150 mTOR signaling pathway 6794_3091_5595_5594_5563 5 0.001197808 0.104209303 0.002217219 21253 hsa-mir-539 hsa05010 Alzheimer's disease 823_5595_5594_2932_1537_808_801_805_1020 9 0.001281627 0.111501588 0.00232295 21254 hsa-mir-539 hsa04270 Vascular smooth muscle contraction 5578_5499_5595_5594_808_801_805 7 0.001919642 0.167008822 0.003408343 21255 hsa-mir-539 hsa03410 Base excision repair 3146_142_4913_328 4 0.002305661 0.200592494 0.00401185 21256 hsa-mir-539 hsa04360 Axon guidance 5747_25_998_5595_5594_2932_1020 7 0.003345498 0.291058321 0.005707026 21257 hsa-mir-539 hsa04730 Long-term depression 5578_5595_5594_5518_5515 5 0.004260875 0.370696104 0.007128771 21258 hsa-mir-539 hsa04070 Phosphatidylinositol signaling system 5578_5728_808_801_805 5 0.005584883 0.485884842 0.009167639 21259 hsa-mir-539 hsa04950 Maturity onset diabetes of the young 3651_3172_168620 3 0.006172088 0.536971643 0.009943919 21260 hsa-mir-539 hsa04670 Leukocyte transendothelial migration 1499_5578_5747_1432_4301_998 6 0.009336226 0.812251652 0.014768212 21261 hsa-mir-539 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_1432_1616 4 0.009893606 0.860743764 0.015370424 21262 hsa-mir-539 hsa04540 Gap junction 5578_5595_5594_1453_983 5 0.012228308 1 0.018664259 21263 hsa-mir-539 hsa03030 DNA replication 5557_6117_5422 3 0.017054243 1 0.025581365 21264 hsa-mir-539 hsa03320 PPAR signaling pathway 2168_6258_6256_6257 4 0.02006925 1 0.02959364 21265 hsa-mir-539 hsa03450 Non-homologous end-joining 2547_5591 2 0.020525536 1 0.029762028 21266 hsa-mir-539 hsa04630 Jak-STAT signaling pathway 598_1387_6772_2033_51588_8554 6 0.025978613 1 0.037051464 21267 hsa-mir-539 hsa03050 Proteasome 5705_5717_5710 3 0.034405623 1 0.048278858 21268 hsa-mir-539 hsa03430 Mismatch repair 4436_6117 2 0.047271741 1 0.064580241 21269 hsa-mir-539 hsa05217 Basal cell carcinoma 1499_2932_1856 3 0.047507304 1 0.064580241 21270 hsa-mir-541 hsa05200 Pathways in cancer 3320_2249_1956_5594_5595_1387_6256_2308_367_5914_841_6776_6777_5970_6688_4609_3725_4088_861_2353_4089_1050_5925_2033_8554_4790 26 3.75E-21 2.63E-19 2.63E-19 21271 hsa-mir-541 hsa04010 MAPK signaling pathway 6722_2249_1956_3727_5594_5595_1386_1649_5566_9252_5970_468_4609_3725_6195_6196_2353_4790_2002 19 7.70E-15 5.39E-13 2.69E-13 21272 hsa-mir-541 hsa05215 Prostate cancer 3320_1956_5594_5595_1385_1387_2308_367_5970_468_5925_2033_4790 13 2.42E-14 1.69E-12 4.82E-13 21273 hsa-mir-541 hsa05212 Pancreatic cancer 3320_1956_5594_5595_1385_1387_2308_367_5970_468_5925_2033_4790 13 2.75E-14 1.93E-12 4.82E-13 21274 hsa-mir-541 hsa05221 Acute myeloid leukemia 5594_5595_5914_6776_6777_5970_6688_4609_861_1050_4790 11 2.58E-13 1.80E-11 3.61E-12 21275 hsa-mir-541 hsa05220 Chronic myeloid leukemia 5594_5595_6776_6777_5970_4609_4088_861_4089_5925_4790 11 2.69E-12 1.89E-10 3.14E-11 21276 hsa-mir-541 hsa04720 Long-term potentiation 815_5594_5595_1387_5566_468_6195_6196_2033 9 1.38E-09 9.68E-08 1.38E-08 21277 hsa-mir-541 hsa04350 TGF-beta signaling pathway 5518_5594_5595_1387_4609_4088_4089_2033_6667 9 4.59E-09 3.22E-07 3.57E-08 21278 hsa-mir-541 hsa04012 ErbB signaling pathway 815_1956_5594_5595_6776_6777_4609_3725_2002 9 4.59E-09 3.22E-07 3.57E-08 21279 hsa-mir-541 hsa04520 Adherens junction 1956_5594_5595_1387_71_4088_4089_2033 8 4.32E-08 3.02E-06 3.02E-07 21280 hsa-mir-541 hsa05210 Colorectal cancer 1956_5594_5595_4609_3725_4088_2353_4089 8 6.13E-08 4.29E-06 3.90E-07 21281 hsa-mir-541 hsa04620 Toll-like receptor signaling pathway 5594_5595_841_5970_3725_2353_6348_4790 8 2.47E-07 1.73E-05 1.44E-06 21282 hsa-mir-541 hsa05219 Bladder cancer 1956_5594_5595_9252_4609_5925 6 3.27E-07 2.29E-05 1.76E-06 21283 hsa-mir-541 hsa04912 GnRH signaling pathway 815_1956_5594_5595_5566_468_3725_2002 8 3.73E-07 2.61E-05 1.86E-06 21284 hsa-mir-541 hsa04310 Wnt signaling pathway 815_5518_1387_5566_4609_3725_4088_4089_2033 9 4.11E-07 2.88E-05 1.92E-06 21285 hsa-mir-541 hsa04916 Melanogenesis 815_5594_5595_1385_1387_5566_2033 7 3.71E-06 0.000259762 1.62E-05 21286 hsa-mir-541 hsa04630 Jak-STAT signaling pathway 1387_6778_6776_6777_4609_2033_3977_8554 8 4.85E-06 0.000339288 2.00E-05 21287 hsa-mir-541 hsa04662 B cell receptor signaling pathway 5594_5595_5970_3725_2353_4790 6 7.40E-06 0.000518302 2.88E-05 21288 hsa-mir-541 hsa04110 Cell cycle 993_1387_983_4088_4089_5925_2033 7 8.58E-06 0.0006009 3.16E-05 21289 hsa-mir-541 hsa05222 Small cell lung cancer 6256_5970_4609_5925_8554_4790 6 1.54E-05 0.001081083 5.41E-05 21290 hsa-mir-541 hsa04612 Antigen processing and presentation 3320_1514_1385_4800_4802_3308 6 1.86E-05 0.001299108 6.12E-05 21291 hsa-mir-541 hsa05213 Endometrial cancer 1956_5594_5595_4609_2002 5 1.92E-05 0.001346517 6.12E-05 21292 hsa-mir-541 hsa05223 Non-small cell lung cancer 1956_5594_5595_6256_5925 5 2.28E-05 0.001595163 6.94E-05 21293 hsa-mir-541 hsa05216 Thyroid cancer 5594_5595_6256_4609 4 3.75E-05 0.002625583 0.000109399 21294 hsa-mir-541 hsa05214 Glioma 815_1956_5594_5595_5925 5 5.24E-05 0.003665188 0.000146608 21295 hsa-mir-541 hsa04660 T cell receptor signaling pathway 5594_5595_5970_3725_2353_4790 6 5.74E-05 0.004016665 0.000154487 21296 hsa-mir-541 hsa05218 Melanoma 2249_1956_5594_5595_5925 5 7.77E-05 0.005441927 0.000201553 21297 hsa-mir-541 hsa05211 Renal cell carcinoma 5594_5595_1387_3725_2033 5 8.28E-05 0.005793041 0.000206894 21298 hsa-mir-541 hsa03022 Basal transcription factors 2969_6908_2959_6880 4 8.96E-05 0.006269731 0.000216198 21299 hsa-mir-541 hsa04062 Chemokine signaling pathway 5594_5595_5566_6777_5970_6348_4790 7 0.00016295 0.011406471 0.000380216 21300 hsa-mir-541 hsa04330 Notch signaling pathway 1387_9612_2033_8850 4 0.00021138 0.014796578 0.000465031 21301 hsa-mir-541 hsa04210 Apoptosis 823_5566_841_5970_4790 5 0.000212585 0.014880983 0.000465031 21302 hsa-mir-541 hsa04540 Gap junction 1956_5594_5595_5566_983 5 0.00025821 0.018074687 0.000547718 21303 hsa-mir-541 hsa04150 mTOR signaling pathway 5594_5595_6195_6196 4 0.000303831 0.021268164 0.000625534 21304 hsa-mir-541 hsa05016 Huntington's disease 1385_1387_6908_841_2033_6667 6 0.000917818 0.06424727 0.001796678 21305 hsa-mir-541 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_5970_3725_4790 4 0.000924006 0.064680415 0.001796678 21306 hsa-mir-541 hsa04910 Insulin signaling pathway 5594_5595_2308_5566_2002 5 0.00143589 0.100512275 0.002664346 21307 hsa-mir-541 hsa04510 Focal adhesion 1956_5594_5595_71_3725_2002 6 0.001446359 0.101245161 0.002664346 21308 hsa-mir-541 hsa05010 Alzheimer's disease 5594_5595_823_841_9451 5 0.004074651 0.285225589 0.007313477 21309 hsa-mir-541 hsa04920 Adipocytokine signaling pathway 6256_5970_4790 3 0.007654308 0.535801541 0.013395039 21310 hsa-mir-541 hsa04730 Long-term depression 5518_5594_5595 3 0.008914863 0.624040419 0.015220498 21311 hsa-mir-541 hsa04810 Regulation of actin cytoskeleton 2249_1956_5594_5595_71 5 0.009609076 0.672635308 0.015798388 21312 hsa-mir-541 hsa04950 Maturity onset diabetes of the young 3172_6927 2 0.009704724 0.679330664 0.015798388 21313 hsa-mir-541 hsa03410 Base excision repair 3146_142 2 0.020072048 1 0.031932803 21314 hsa-mir-541 hsa04930 Type II diabetes mellitus 5594_5595 2 0.029849463 1 0.046432498 21315 hsa-mir-541 hsa04270 Vascular smooth muscle contraction 5594_5595_5566 3 0.032621409 1 0.049641275 21316 hsa-mir-541 hsa05110 Vibrio cholerae infection 5566_71 2 0.047983362 1 0.070831088 21317 hsa-mir-541 hsa04120 Ubiquitin mediated proteolysis 672_7329_8554 3 0.048569889 1 0.070831088 21318 hsa-mir-542 hsa04310 Wnt signaling pathway 595_2033_894_896_3725_1387 6 5.21E-09 1.67E-07 1.67E-07 21319 hsa-mir-542 hsa04110 Cell cycle 595_2033_894_896_1387 5 8.31E-08 2.66E-06 1.33E-06 21320 hsa-mir-542 hsa04630 Jak-STAT signaling pathway 595_2033_894_896_1387 5 2.96E-07 9.48E-06 3.16E-06 21321 hsa-mir-542 hsa05200 Pathways in cancer 595_2033_367_3725_1387_2353 6 4.72E-07 1.51E-05 3.78E-06 21322 hsa-mir-542 hsa05215 Prostate cancer 595_2033_367_1387 4 1.37E-06 4.39E-05 7.64E-06 21323 hsa-mir-542 hsa05212 Pancreatic cancer 595_2033_367_1387 4 1.43E-06 4.58E-05 7.64E-06 21324 hsa-mir-542 hsa04330 Notch signaling pathway 9612_2033_1387 3 1.24E-05 0.000395324 5.65E-05 21325 hsa-mir-542 hsa04510 Focal adhesion 595_894_896_3725 4 3.60E-05 0.001150823 0.000131907 21326 hsa-mir-542 hsa04115 p53 signaling pathway 595_894_896 3 3.71E-05 0.001187161 0.000131907 21327 hsa-mir-542 hsa05211 Renal cell carcinoma 2033_3725_1387 3 4.19E-05 0.001341702 0.00013417 21328 hsa-mir-542 hsa05210 Colorectal cancer 595_3725_2353 3 6.53E-05 0.002091004 0.000190091 21329 hsa-mir-542 hsa05016 Huntington's disease 2033_25942_1387 3 0.000662189 0.021190052 0.001765838 21330 hsa-mir-542 hsa04720 Long-term potentiation 2033_1387 2 0.002185478 0.069935297 0.004995378 21331 hsa-mir-542 hsa04662 B cell receptor signaling pathway 3725_2353 2 0.002185478 0.069935297 0.004995378 21332 hsa-mir-542 hsa04520 Adherens junction 2033_1387 2 0.002473657 0.079157024 0.005277135 21333 hsa-mir-542 hsa04350 TGF-beta signaling pathway 2033_1387 2 0.002905572 0.092978298 0.005811144 21334 hsa-mir-542 hsa04620 Toll-like receptor signaling pathway 3725_2353 2 0.003941193 0.126118187 0.007271931 21335 hsa-mir-542 hsa04916 Melanogenesis 2033_1387 2 0.004090461 0.130894763 0.007271931 21336 hsa-mir-542 hsa04660 T cell receptor signaling pathway 3725_2353 2 0.004553845 0.145723044 0.007669634 21337 hsa-mir-542 hsa04010 MAPK signaling pathway 3725_2353 2 0.025232456 0.807438607 0.04037193 21338 hsa-mir-542 hsa05216 Thyroid cancer 595 1 0.026639638 0.852468432 0.040593735 21339 hsa-mir-542 hsa05219 Bladder cancer 595 1 0.037970041 1 0.055229151 21340 hsa-mir-542 hsa05213 Endometrial cancer 595 1 0.046599202 1 0.064421422 21341 hsa-mir-542 hsa05223 Non-small cell lung cancer 595 1 0.048316067 1 0.064421422 21342 hsa-mir-543 hsa05200 Pathways in cancer 2735_2736_2737_4088_4089_6776_1050_2308_6688_2033_1956_4609_5595_4790_5925_1387_5594_841_861_5970 20 1.09E-21 6.52E-20 6.52E-20 21343 hsa-mir-543 hsa04010 MAPK signaling pathway 2002_468_9252_1956_4609_5595_4790_6195_5594_6722_1649_6196_1386_5970_5566 15 7.50E-16 4.50E-14 2.25E-14 21344 hsa-mir-543 hsa05215 Prostate cancer 468_2308_2033_1956_5595_4790_5925_1387_5594_1385_5970 11 1.55E-15 9.29E-14 2.60E-14 21345 hsa-mir-543 hsa05212 Pancreatic cancer 468_2308_2033_1956_5595_4790_5925_1387_5594_1385_5970 11 1.74E-15 1.04E-13 2.60E-14 21346 hsa-mir-543 hsa05220 Chronic myeloid leukemia 4088_4089_6776_4609_5595_4790_5925_5594_861_5970 10 1.77E-14 1.06E-12 2.12E-13 21347 hsa-mir-543 hsa05221 Acute myeloid leukemia 6776_1050_6688_4609_5595_4790_5594_861_5970 9 1.27E-13 7.63E-12 1.27E-12 21348 hsa-mir-543 hsa04720 Long-term potentiation 468_2033_815_5595_6195_1387_5594_6196_5566 9 9.19E-13 5.52E-11 7.88E-12 21349 hsa-mir-543 hsa04350 TGF-beta signaling pathway 4088_4089_6667_2033_4609_5595_1387_5594 8 1.29E-10 7.74E-09 9.68E-10 21350 hsa-mir-543 hsa05219 Bladder cancer 9252_1956_4609_5595_5925_5594 6 2.60E-09 1.56E-07 1.62E-08 21351 hsa-mir-543 hsa04520 Adherens junction 4088_4089_2033_1956_5595_1387_5594 7 2.70E-09 1.62E-07 1.62E-08 21352 hsa-mir-543 hsa04012 ErbB signaling pathway 2002_6776_815_1956_4609_5595_5594 7 4.67E-09 2.80E-07 2.55E-08 21353 hsa-mir-543 hsa04916 Melanogenesis 2033_815_5595_1387_5594_1385_5566 7 1.50E-08 8.98E-07 7.48E-08 21354 hsa-mir-543 hsa04912 GnRH signaling pathway 2002_468_815_1956_5595_5594_5566 7 1.91E-08 1.15E-06 8.84E-08 21355 hsa-mir-543 hsa05210 Colorectal cancer 4088_4089_1956_4609_5595_5594 6 1.21E-07 7.27E-06 5.19E-07 21356 hsa-mir-543 hsa04310 Wnt signaling pathway 4088_4089_2033_815_4609_1387_5566 7 1.78E-07 1.07E-05 7.13E-07 21357 hsa-mir-543 hsa04620 Toll-like receptor signaling pathway 5595_4790_5594_841_6348_5970 6 3.59E-07 2.15E-05 1.28E-06 21358 hsa-mir-543 hsa05213 Endometrial cancer 2002_1956_4609_5595_5594 5 3.64E-07 2.18E-05 1.28E-06 21359 hsa-mir-543 hsa05214 Glioma 815_1956_5595_5925_5594 5 1.02E-06 6.15E-05 3.41E-06 21360 hsa-mir-543 hsa04062 Chemokine signaling pathway 5595_4790_5594_6348_5970_5566 6 1.25E-05 0.000748845 3.94E-05 21361 hsa-mir-543 hsa04150 mTOR signaling pathway 5595_6195_5594_6196 4 1.32E-05 0.000790804 3.95E-05 21362 hsa-mir-543 hsa05223 Non-small cell lung cancer 1956_5595_5925_5594 4 1.52E-05 0.000909952 4.33E-05 21363 hsa-mir-543 hsa04110 Cell cycle 4088_4089_2033_5925_1387 5 1.71E-05 0.001026784 4.67E-05 21364 hsa-mir-543 hsa04340 Hedgehog signaling pathway 2735_2736_2737_5566 4 1.85E-05 0.001112759 4.84E-05 21365 hsa-mir-543 hsa04910 Insulin signaling pathway 2002_2308_5595_5594_5566 5 3.40E-05 0.002038904 8.50E-05 21366 hsa-mir-543 hsa05218 Melanoma 1956_5595_5925_5594 4 4.20E-05 0.002522381 0.000100895 21367 hsa-mir-543 hsa05211 Renal cell carcinoma 2033_5595_1387_5594 4 4.43E-05 0.002657363 0.000102206 21368 hsa-mir-543 hsa04662 B cell receptor signaling pathway 5595_4790_5594_5970 4 5.16E-05 0.003094033 0.000114594 21369 hsa-mir-543 hsa04630 Jak-STAT signaling pathway 6776_2033_4609_1387_6778 5 5.80E-05 0.003482812 0.000124386 21370 hsa-mir-543 hsa05216 Thyroid cancer 4609_5595_5594 3 7.58E-05 0.004550991 0.000156931 21371 hsa-mir-543 hsa05222 Small cell lung cancer 4609_4790_5925_5970 4 8.58E-05 0.005150961 0.000171699 21372 hsa-mir-543 hsa04210 Apoptosis 4790_841_5970_5566 4 9.75E-05 0.005851782 0.000188767 21373 hsa-mir-543 hsa04540 Gap junction 1956_5595_5594_5566 4 0.000114846 0.006890774 0.000215337 21374 hsa-mir-543 hsa05016 Huntington's disease 6667_2033_1387_841_1385 5 0.000140352 0.008421094 0.000255185 21375 hsa-mir-543 hsa04660 T cell receptor signaling pathway 5595_4790_5594_5970 4 0.000214031 0.01284184 0.000377701 21376 hsa-mir-543 hsa05217 Basal cell carcinoma 2735_2736_2737 3 0.000449821 0.026989288 0.000771123 21377 hsa-mir-543 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_4790_5970 3 0.000917657 0.05505941 0.001529428 21378 hsa-mir-543 hsa04510 Focal adhesion 2002_1956_5595_5594 4 0.002099116 0.125946948 0.003403972 21379 hsa-mir-543 hsa04270 Vascular smooth muscle contraction 5595_5594_5566 3 0.003740736 0.22444416 0.005906425 21380 hsa-mir-543 hsa04930 Type II diabetes mellitus 5595_5594 2 0.006490672 0.389440326 0.009985649 21381 hsa-mir-543 hsa04330 Notch signaling pathway 2033_1387 2 0.007037822 0.422269295 0.010556732 21382 hsa-mir-543 hsa05010 Alzheimer's disease 5595_5594_841 3 0.011152341 0.669140479 0.016320499 21383 hsa-mir-543 hsa04020 Calcium signaling pathway 815_1956_5566 3 0.012354784 0.741287018 0.017649691 21384 hsa-mir-543 hsa04920 Adipocytokine signaling pathway 4790_5970 2 0.013584961 0.815097677 0.01895576 21385 hsa-mir-543 hsa04730 Long-term depression 5595_5594 2 0.015118274 0.907096426 0.020615828 21386 hsa-mir-543 hsa04370 VEGF signaling pathway 5595_5594 2 0.017550615 1 0.02340082 21387 hsa-mir-543 hsa04664 Fc epsilon RI signaling pathway 5595_5594 2 0.018395913 1 0.023994669 21388 hsa-mir-543 hsa04810 Regulation of actin cytoskeleton 1956_5595_5594 3 0.019452847 1 0.024833422 21389 hsa-mir-543 hsa04360 Axon guidance 5595_5594 2 0.045786222 1 0.057232778 21390 hsa-mir-544 hsa04010 MAPK signaling pathway 6722_8986_3725_5595_5599_9261_5601_5600_5603_6197_9252_2353_1432_1649_4609_3727_6195_6196_207_8550 20 3.10E-19 1.83E-17 1.83E-17 21391 hsa-mir-544 hsa05200 Pathways in cancer 3725_5371_5595_5599_1387_5601_1488_367_2932_2353_4609_1487_2736_4087_4088_4089_1050_5925_2033_207 20 1.13E-17 6.68E-16 3.34E-16 21392 hsa-mir-544 hsa04310 Wnt signaling pathway 3725_5599_1387_5601_1488_2932_8061_4609_1457_1487_1459_4087_4088_4089_2033 15 1.91E-16 1.13E-14 3.75E-15 21393 hsa-mir-544 hsa05210 Colorectal cancer 3725_5595_5599_5601_2932_2353_4609_4087_4088_4089_207 11 1.35E-13 7.96E-12 1.99E-12 21394 hsa-mir-544 hsa04620 Toll-like receptor signaling pathway 3725_5595_5599_5601_5600_5603_2353_1432_207 9 6.22E-10 3.67E-08 7.34E-09 21395 hsa-mir-544 hsa04660 T cell receptor signaling pathway 3725_5595_5601_5600_5603_2932_2353_1432_207 9 1.16E-09 6.84E-08 1.14E-08 21396 hsa-mir-544 hsa05220 Chronic myeloid leukemia 5595_1488_4609_1487_4088_4089_5925_207 8 1.44E-09 8.50E-08 1.21E-08 21397 hsa-mir-544 hsa04520 Adherens junction 5595_1387_1457_1459_4087_4088_4089_2033 8 2.31E-09 1.36E-07 1.70E-08 21398 hsa-mir-544 hsa05215 Prostate cancer 5595_1387_367_2932_9586_5925_2033_207 8 4.64E-09 2.74E-07 2.98E-08 21399 hsa-mir-544 hsa05212 Pancreatic cancer 5595_1387_367_2932_9586_5925_2033_207 8 5.04E-09 2.98E-07 2.98E-08 21400 hsa-mir-544 hsa04664 Fc epsilon RI signaling pathway 5595_5599_5601_5600_5603_1432_207 7 5.22E-08 3.08E-06 2.80E-07 21401 hsa-mir-544 hsa04350 TGF-beta signaling pathway 5595_1387_4609_4087_4088_4089_2033 7 9.69E-08 5.72E-06 4.40E-07 21402 hsa-mir-544 hsa04012 ErbB signaling pathway 3725_5595_5599_5601_2932_4609_207 7 9.69E-08 5.72E-06 4.40E-07 21403 hsa-mir-544 hsa04912 GnRH signaling pathway 3725_5595_5599_5601_5600_5603_1432 7 3.87E-07 2.29E-05 1.63E-06 21404 hsa-mir-544 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5599_5601_5600_5603_1432 6 6.32E-07 3.73E-05 2.49E-06 21405 hsa-mir-544 hsa04110 Cell cycle 1387_2932_4087_4088_4089_5925_2033 7 7.20E-07 4.25E-05 2.66E-06 21406 hsa-mir-544 hsa04720 Long-term potentiation 5595_1387_6197_6195_6196_2033 6 8.54E-07 5.04E-05 2.96E-06 21407 hsa-mir-544 hsa04370 VEGF signaling pathway 5595_9261_5600_5603_1432_207 6 9.87E-07 5.82E-05 3.23E-06 21408 hsa-mir-544 hsa04150 mTOR signaling pathway 5595_6197_6195_6196_207 5 3.14E-06 0.000185455 9.76E-06 21409 hsa-mir-544 hsa05221 Acute myeloid leukemia 5371_5595_4609_1050_207 5 5.60E-06 0.000330342 1.65E-05 21410 hsa-mir-544 hsa05211 Renal cell carcinoma 3725_5595_1387_2033_207 5 1.39E-05 0.000821725 3.91E-05 21411 hsa-mir-544 hsa04662 B cell receptor signaling pathway 3725_5595_2932_2353_207 5 1.68E-05 0.000990432 4.50E-05 21412 hsa-mir-544 hsa05219 Bladder cancer 5595_9252_4609_5925 4 3.32E-05 0.001961719 8.53E-05 21413 hsa-mir-544 hsa04930 Type II diabetes mellitus 3651_5595_5599_5601 4 4.28E-05 0.002523884 0.000105162 21414 hsa-mir-544 hsa04330 Notch signaling pathway 1387_1488_1487_2033 4 5.01E-05 0.002958753 0.00011835 21415 hsa-mir-544 hsa05213 Endometrial cancer 5595_2932_4609_207 4 7.26E-05 0.004282931 0.000164728 21416 hsa-mir-544 hsa04510 Focal adhesion 3725_5595_5599_5601_2932_207 6 0.000203022 0.011978284 0.00044364 21417 hsa-mir-544 hsa04530 Tight junction 4628_60412_1457_1459_207 5 0.000257573 0.015196781 0.000541316 21418 hsa-mir-544 hsa04910 Insulin signaling pathway 5595_5599_5601_2932_207 5 0.000266071 0.015698166 0.000541316 21419 hsa-mir-544 hsa04916 Melanogenesis 5595_1387_2932_2033 4 0.000904551 0.053368501 0.00177895 21420 hsa-mir-544 hsa05016 Huntington's disease 1387_9586_10476_3064_2033 5 0.001038159 0.061251366 0.001975851 21421 hsa-mir-544 hsa05223 Non-small cell lung cancer 5595_5925_207 3 0.001506152 0.088862965 0.002776968 21422 hsa-mir-544 hsa05014 Amyotrophic lateral sclerosis (ALS) 5600_5603_1432 3 0.001663829 0.098165899 0.002974724 21423 hsa-mir-544 hsa05214 Glioma 5595_5925_207 3 0.002499711 0.147482967 0.004337734 21424 hsa-mir-544 hsa04920 Adipocytokine signaling pathway 5599_5601_207 3 0.002714774 0.160171659 0.004576333 21425 hsa-mir-544 hsa05218 Melanoma 5595_5925_207 3 0.003178324 0.187521128 0.00520892 21426 hsa-mir-544 hsa04630 Jak-STAT signaling pathway 1387_4609_2033_207 4 0.00371001 0.218890564 0.005915961 21427 hsa-mir-544 hsa04950 Maturity onset diabetes of the young 3651_5080 2 0.004728351 0.278972696 0.007341387 21428 hsa-mir-544 hsa05222 Small cell lung cancer 4609_5925_207 3 0.005334706 0.314747677 0.008070453 21429 hsa-mir-544 hsa05216 Thyroid cancer 5595_4609 2 0.006678707 0.394043723 0.009851093 21430 hsa-mir-544 hsa04670 Leukocyte transendothelial migration 5600_5603_1432 3 0.013475401 0.795048633 0.01939143 21431 hsa-mir-544 hsa04120 Ubiquitin mediated proteolysis 5371_672_7329 3 0.018883018 1 0.026526145 21432 hsa-mir-544 hsa05217 Basal cell carcinoma 2932_2736 2 0.021446677 1 0.029426835 21433 hsa-mir-544 hsa04340 Hedgehog signaling pathway 2932_2736 2 0.022875092 1 0.030673419 21434 hsa-mir-544 hsa04730 Long-term depression 5592_5595 2 0.033906089 1 0.04445465 21435 hsa-mir-544 hsa05010 Alzheimer's disease 5595_2932_10476 3 0.034720096 1 0.044532297 21436 hsa-mir-544 hsa04062 Chemokine signaling pathway 5595_2932_207 3 0.042923494 1 0.053882684 21437 hsa-mir-548aa-1 hsa04010 MAPK signaling pathway 6722_5601_468_9252_5603_8550_4609_3725_3727_5595_5600_1432_1649_5599_2353_1386 16 1.36E-15 7.48E-14 7.48E-14 21438 hsa-mir-548aa-1 hsa04310 Wnt signaling pathway 4089_5601_4088_2033_8061_4609_3725_1387_5599_1457_1459 11 5.57E-12 3.06E-10 1.18E-10 21439 hsa-mir-548aa-1 hsa05200 Pathways in cancer 4089_5601_1050_5925_5371_4088_2033_367_4609_3725_5595_1387_5599_2353 14 6.41E-12 3.53E-10 1.18E-10 21440 hsa-mir-548aa-1 hsa05210 Colorectal cancer 4089_5601_4088_4609_3725_5595_5599_2353 8 6.46E-10 3.56E-08 8.89E-09 21441 hsa-mir-548aa-1 hsa05215 Prostate cancer 5925_10488_2033_367_468_5595_1387_9586 8 9.11E-10 5.01E-08 9.08E-09 21442 hsa-mir-548aa-1 hsa05212 Pancreatic cancer 5925_10488_2033_367_468_5595_1387_9586 8 9.90E-10 5.45E-08 9.08E-09 21443 hsa-mir-548aa-1 hsa04620 Toll-like receptor signaling pathway 5601_5603_3725_5595_5600_1432_5599_2353 8 2.71E-09 1.49E-07 2.13E-08 21444 hsa-mir-548aa-1 hsa04912 GnRH signaling pathway 5601_468_5603_3725_5595_5600_1432_5599 8 4.14E-09 2.28E-07 2.85E-08 21445 hsa-mir-548aa-1 hsa04520 Adherens junction 4089_4088_2033_5595_1387_1457_1459 7 1.37E-08 7.55E-07 8.39E-08 21446 hsa-mir-548aa-1 hsa04660 T cell receptor signaling pathway 5601_5603_3725_5595_5600_1432_2353 7 1.08E-07 5.92E-06 5.92E-07 21447 hsa-mir-548aa-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5601_5603_3725_5600_1432_5599 6 1.89E-07 1.04E-05 9.44E-07 21448 hsa-mir-548aa-1 hsa04664 Fc epsilon RI signaling pathway 5601_5603_5595_5600_1432_5599 6 3.41E-07 1.88E-05 1.56E-06 21449 hsa-mir-548aa-1 hsa04350 TGF-beta signaling pathway 4089_4088_2033_4609_5595_1387 6 5.83E-07 3.20E-05 2.46E-06 21450 hsa-mir-548aa-1 hsa05220 Chronic myeloid leukemia 4089_5925_4088_4609_5595 5 6.22E-06 0.000342178 2.44E-05 21451 hsa-mir-548aa-1 hsa04012 ErbB signaling pathway 5601_4609_3725_5595_5599 5 1.23E-05 0.000678947 4.53E-05 21452 hsa-mir-548aa-1 hsa05219 Bladder cancer 5925_9252_4609_5595 4 1.49E-05 0.000820068 5.13E-05 21453 hsa-mir-548aa-1 hsa05016 Huntington's disease 23186_3064_10488_2033_1387_9586 6 4.03E-05 0.002217199 0.000130423 21454 hsa-mir-548aa-1 hsa04110 Cell cycle 4089_5925_4088_2033_1387 5 5.21E-05 0.002865915 0.000151082 21455 hsa-mir-548aa-1 hsa05221 Acute myeloid leukemia 1050_5371_4609_5595 4 5.22E-05 0.002870559 0.000151082 21456 hsa-mir-548aa-1 hsa05211 Renal cell carcinoma 2033_3725_5595_1387 4 0.000108872 0.005987944 0.000299397 21457 hsa-mir-548aa-1 hsa04720 Long-term potentiation 2033_468_5595_1387 4 0.000126562 0.006960935 0.000331473 21458 hsa-mir-548aa-1 hsa04370 VEGF signaling pathway 5603_5595_5600_1432 4 0.000139456 0.007670097 0.000348641 21459 hsa-mir-548aa-1 hsa04916 Melanogenesis 10488_2033_5595_1387 4 0.000420362 0.023119917 0.001005214 21460 hsa-mir-548aa-1 hsa04930 Type II diabetes mellitus 5601_5595_5599 3 0.000505221 0.027787175 0.001157799 21461 hsa-mir-548aa-1 hsa05014 Amyotrophic lateral sclerosis (ALS) 5603_5600_1432 3 0.00092557 0.050906362 0.002036254 21462 hsa-mir-548aa-1 hsa04662 B cell receptor signaling pathway 3725_5595_2353 3 0.002072373 0.113980506 0.004383866 21463 hsa-mir-548aa-1 hsa05216 Thyroid cancer 4609_5595 2 0.004498013 0.247390711 0.009162619 21464 hsa-mir-548aa-1 hsa04510 Focal adhesion 5601_3725_5595_5599 4 0.004813281 0.26473047 0.00945466 21465 hsa-mir-548aa-1 hsa04670 Leukocyte transendothelial migration 5603_5600_1432 3 0.007763648 0.427000631 0.01472416 21466 hsa-mir-548aa-1 hsa04910 Insulin signaling pathway 5601_5595_5599 3 0.010769162 0.592303886 0.019438235 21467 hsa-mir-548aa-1 hsa04330 Notch signaling pathway 2033_1387 2 0.010956096 0.602585279 0.019438235 21468 hsa-mir-548aa-1 hsa05213 Endometrial cancer 4609_5595 2 0.013193739 0.725655657 0.022676739 21469 hsa-mir-548aa-1 hsa05223 Non-small cell lung cancer 5925_5595 2 0.014139774 0.777687555 0.02356629 21470 hsa-mir-548aa-1 hsa04630 Jak-STAT signaling pathway 2033_4609_1387 3 0.014606052 0.803332856 0.023627437 21471 hsa-mir-548aa-1 hsa05214 Glioma 5925_5595 2 0.019842242 1 0.031180666 21472 hsa-mir-548aa-1 hsa04920 Adipocytokine signaling pathway 5601_5599 2 0.020966666 1 0.032032406 21473 hsa-mir-548aa-1 hsa05218 Melanoma 5925_5595 2 0.023293146 1 0.034624947 21474 hsa-mir-548aa-1 hsa05222 Small cell lung cancer 5925_4609 2 0.03289369 1 0.047609288 21475 hsa-mir-548aa-2 hsa05200 Pathways in cancer 3725_4149_3551_7046_1499_595_1019_2261_8517_7175_3066_3065_1050_5925_5747_1956_4824_1870_1871_2113_10401_867_207_208_3716_1147_1017_5595_5594_5599_6258_1387_2064_6256_836_367_2932_6774_6777_6772_5970_7157_6688_1869_6776_4088_4089_2033_5468_4790_4791_4792_5879_3320_5371_675_5159_5156_5601_1399_1398_3815_842_841_4087_8772_4609_1026_2353_3326_8554 71 4.69E-39 3.80E-37 3.80E-37 21476 hsa-mir-548aa-2 hsa04010 MAPK signaling pathway 6722_3725_4149_3551_7046_2261_2264_8517_1845_4773_9020_1956_7132_3303_1432_207_208_1147_5595_5594_5599_5598_1386_836_9252_3310_3312_1649_5971_5970_7157_468_6195_5058_4790_4791_5879_5159_9261_1326_5156_5601_5608_5566_1399_1398_6885_4609_2353_3305_2005_2002 52 9.31E-27 7.54E-25 3.77E-25 21477 hsa-mir-548aa-2 hsa05215 Prostate cancer 3551_1499_595_8517_5925_1956_4824_1870_1871_207_208_1147_1017_5595_5594_1385_1387_2064_367_2932_5970_7157_468_1869_2033_4790_4792_3320_5159_5156_842_1026_3326 33 3.98E-25 3.23E-23 1.08E-23 21478 hsa-mir-548aa-2 hsa05212 Pancreatic cancer 3551_1499_595_8517_5925_1956_4824_1870_1871_207_208_1147_1017_5595_5594_1385_1387_2064_367_2932_5970_7157_468_1869_2033_4790_4792_3320_5159_5156_842_1026_3326 33 5.33E-25 4.32E-23 1.08E-23 21479 hsa-mir-548aa-2 hsa05220 Chronic myeloid leukemia 3551_7046_595_1019_8517_3066_3065_5925_1870_1871_867_207_208_1147_5595_5594_6777_5970_7157_1869_6776_4088_4089_4790_4792_1399_1398_5781_4609_1026_6464 31 1.05E-24 8.53E-23 1.71E-23 21480 hsa-mir-548aa-2 hsa04110 Cell cycle 595_1019_6500_5111_4174_4172_3066_3065_5925_1870_1871_5934_5933_7534_5591_1017_1387_7531_7532_2932_7027_7157_1869_4088_4089_2033_890_894_896_8454_4087_1026_1111 33 1.04E-21 8.40E-20 1.40E-20 21481 hsa-mir-548aa-2 hsa04630 Jak-STAT signaling pathway 3559_595_58985_3455_3459_3560_3561_1439_2057_10401_867_2690_207_208_3717_3716_3718_8651_85480_1387_3575_6778_6774_6777_6772_6773_7297_6776_2033_894_896_5781_4609_8554_10379 35 1.84E-20 1.49E-18 2.12E-19 21482 hsa-mir-548aa-2 hsa04012 ErbB signaling pathway 3725_818_815_817_5747_1956_6714_867_207_208_5595_5594_5599_2064_2066_2932_6777_6776_5058_5601_1399_1398_4609_1026_6464_2002 26 4.62E-18 3.74E-16 4.68E-17 21483 hsa-mir-548aa-2 hsa04660 T cell receptor signaling pathway 3725_3551_919_1019_8517_4773_9020_1493_2534_3932_1432_4794_867_207_208_1147_5595_5594_2932_5970_5058_4790_4792_4793_1326_5601_6885_2353 28 8.50E-18 6.89E-16 7.65E-17 21484 hsa-mir-548aa-2 hsa04920 Adipocytokine signaling pathway 3551_8517_2538_5465_7133_7132_4794_8471_207_208_3717_1147_8717_5599_6258_6256_6774_5970_4790_4792_4793_5601_5781 23 3.15E-17 2.55E-15 2.55E-16 21485 hsa-mir-548aa-2 hsa04620 Toll-like receptor signaling pathway 3725_3551_8517_3455_3661_1432_207_208_1147_29110_5595_5594_5599_6772_5970_4790_4792_5879_1326_5601_5608_9641_841_8772_6885_2353 26 1.23E-16 9.97E-15 9.07E-16 21486 hsa-mir-548aa-2 hsa05214 Glioma 818_815_817_595_1019_5925_1956_1870_1871_207_208_5595_5594_7157_1869_808_801_805_5159_5156_1026_6464 22 1.97E-16 1.59E-14 1.33E-15 21487 hsa-mir-548aa-2 hsa04310 Wnt signaling pathway 3725_818_815_817_1499_595_8607_6500_4773_23291_8945_5599_1387_2932_7157_1457_4088_4089_2033_894_896_5879_5519_5515_5601_5566_8454_4087_6885_4609 30 2.44E-16 1.97E-14 1.52E-15 21488 hsa-mir-548aa-2 hsa05222 Small cell lung cancer 4149_3551_595_1019_8517_5925_5747_1870_1871_10401_207_208_1147_1017_6258_6256_5970_7157_1869_4790_4792_842_4609_8554 24 3.27E-16 2.65E-14 1.89E-15 21489 hsa-mir-548aa-2 hsa05210 Colorectal cancer 3725_7046_1499_595_1956_207_208_5595_5594_5599_836_2932_7157_4088_4089_5879_5159_5156_5601_842_4087_4609_2353 23 1.92E-15 1.56E-13 9.94E-15 21490 hsa-mir-548aa-2 hsa04062 Chemokine signaling pathway 3551_1234_8517_1230_653361_5747_5580_7852_207_208_3717_1147_3718_5590_5595_5594_2932_2931_6774_6777_6772_6773_5970_5058_4790_4792_4793_5879_5566_1399_1398_6464 32 1.96E-15 1.59E-13 9.94E-15 21491 hsa-mir-548aa-2 hsa04210 Apoptosis 3551_8517_9020_8837_7132_1439_207_208_1147_8717_836_839_5970_7157_9131_4790_4792_5566_842_841_840_8772 22 4.69E-14 3.80E-12 2.23E-13 21492 hsa-mir-548aa-2 hsa04350 TGF-beta signaling pathway 7046_6500_90_57154_6667_1874_1875_5934_5933_5595_5594_1387_7027_4088_4089_2033_5519_5515_8454_4087_4609 21 2.63E-13 2.13E-11 1.18E-12 21493 hsa-mir-548aa-2 hsa05221 Acute myeloid leukemia 3551_595_8517_1050_207_208_1147_5595_5594_6774_6777_5970_6688_6776_4790_5371_3815_4609 18 4.69E-13 3.80E-11 2.00E-12 21494 hsa-mir-548aa-2 hsa04510 Focal adhesion 3725_1499_595_2534_5747_3791_1956_6714_10627_207_208_71_5595_5594_5599_2064_2932_5058_894_896_5879_2321_5159_5156_5601_1399_1398_6464_2002 29 1.61E-12 1.31E-10 6.54E-12 21495 hsa-mir-548aa-2 hsa04662 B cell receptor signaling pathway 3725_3551_8517_4773_6850_4794_207_208_1147_695_5595_5594_2932_5970_4790_4792_4793_5879_2353 19 1.73E-12 1.40E-10 6.68E-12 21496 hsa-mir-548aa-2 hsa04520 Adherens junction 7046_1499_5770_2534_1956_6714_71_5595_5594_1387_2064_1457_4088_4089_2033_5879_3643_4087_6885 19 4.58E-12 3.71E-10 1.69E-11 21497 hsa-mir-548aa-2 hsa05219 Bladder cancer 595_1019_2261_5925_1956_1870_1871_5595_5594_2064_9252_7157_1869_4609_1026 15 6.51E-12 5.27E-10 2.29E-11 21498 hsa-mir-548aa-2 hsa05223 Non-small cell lung cancer 595_1019_5925_1956_1870_1871_207_208_5595_5594_6258_2064_6256_7157_1869_842 16 1.35E-11 1.09E-09 4.56E-11 21499 hsa-mir-548aa-2 hsa04910 Insulin signaling pathway 3551_5770_2538_8471_867_207_208_8651_5590_5595_5594_5599_2932_808_801_805_3643_5601_5566_1399_1398_6464_2002 23 1.61E-11 1.30E-09 5.21E-11 21500 hsa-mir-548aa-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_3551_8517_9020_1956_6714_1432_1147_5599_836_5970_5058_4790_4792_5879_5601_5781 17 5.48E-11 4.44E-09 1.71E-10 21501 hsa-mir-548aa-2 hsa04912 GnRH signaling pathway 3725_818_815_817_5580_1956_6714_1432_5595_5594_5599_5598_468_808_801_805_5601_5608_5566_2002 20 6.46E-11 5.23E-09 1.94E-10 21502 hsa-mir-548aa-2 hsa05218 Melanoma 595_1019_5925_1956_1870_1871_207_208_5595_5594_7157_1869_5159_5156_1026 15 3.29E-09 2.66E-07 9.51E-09 21503 hsa-mir-548aa-2 hsa05213 Endometrial cancer 1499_595_1956_207_208_5595_5594_2064_2932_7157_842_4609_2002 13 6.46E-09 5.24E-07 1.81E-08 21504 hsa-mir-548aa-2 hsa05216 Thyroid cancer 1499_595_7175_5595_5594_6258_6256_7157_5468_4609 10 2.89E-08 2.34E-06 7.81E-08 21505 hsa-mir-548aa-2 hsa04720 Long-term potentiation 818_814_815_817_5595_5594_1387_468_6195_2033_808_801_805_5566 14 4.32E-08 3.50E-06 1.13E-07 21506 hsa-mir-548aa-2 hsa04060 Cytokine-cytokine receptor interaction 3559_7046_1234_1230_58985_3455_3459_90_3791_1956_7852_3560_3561_7133_7132_1439_2057_8600_2690_85480_3575_2321_5159_5156_3815 25 7.43E-08 6.02E-06 1.88E-07 21507 hsa-mir-548aa-2 hsa05211 Renal cell carcinoma 3725_2113_207_208_5595_5594_1387_5058_2033_5879_1399_1398_5781 13 1.84E-07 1.49E-05 4.52E-07 21508 hsa-mir-548aa-2 hsa03022 Basal transcription factors 6882_2962_2969_6879_6878_6872_6908_2958_2959_6880 10 1.97E-07 1.59E-05 4.69E-07 21509 hsa-mir-548aa-2 hsa04916 Melanogenesis 818_815_817_1499_5595_5594_1385_1387_2932_2033_808_801_805_5566_3815 15 2.92E-07 2.37E-05 6.76E-07 21510 hsa-mir-548aa-2 hsa05016 Huntington's disease 292_293_3066_3065_498_25942_4724_6667_5441_1385_1387_836_5437_7157_1213_2033_5468_6908_842_841 20 3.08E-07 2.49E-05 6.92E-07 21511 hsa-mir-548aa-2 hsa04120 Ubiquitin mediated proteolysis 55294_6500_3093_7329_57154_23291_10401_8945_867_10273_7323_51366_8651_5371_672_8454_8554 17 4.04E-07 3.27E-05 8.84E-07 21512 hsa-mir-548aa-2 hsa04540 Gap junction 10382_1956_6714_5595_5594_5598_7846_203068_347733_5159_5156_5566_7278_84617 14 4.55E-07 3.69E-05 9.71E-07 21513 hsa-mir-548aa-2 hsa04664 Fc epsilon RI signaling pathway 2534_5580_6850_1432_207_208_695_5595_5594_5599_5879_5601_5608 13 4.74E-07 3.84E-05 9.84E-07 21514 hsa-mir-548aa-2 hsa05131 Shigellosis 1499_10382_2534_71_7534_7846_203068_347733_7278_84617_4691 11 7.76E-07 6.29E-05 1.53E-06 21515 hsa-mir-548aa-2 hsa05130 Pathogenic Escherichia coli infection 1499_10382_2534_71_7534_7846_203068_347733_7278_84617_4691 11 7.76E-07 6.29E-05 1.53E-06 21516 hsa-mir-548aa-2 hsa04930 Type II diabetes mellitus 3551_5580_8471_8651_5590_5595_5594_5599_3643_5601 10 9.28E-07 7.52E-05 1.79E-06 21517 hsa-mir-548aa-2 hsa04370 VEGF signaling pathway 4773_5747_3791_6714_1432_207_208_5595_5594_5879_9261_842 12 2.17E-06 0.000175721 4.09E-06 21518 hsa-mir-548aa-2 hsa04115 p53 signaling pathway 595_1019_1017_836_7157_894_896_842_841_1026_1111 11 4.72E-06 0.000382375 8.69E-06 21519 hsa-mir-548aa-2 hsa04530 Tight junction 1499_1019_5580_6714_4627_4628_10627_8189_207_208_71_5590_1457_5519_5515 15 6.61E-06 0.000535784 1.19E-05 21520 hsa-mir-548aa-2 hsa03010 Ribosome 6155_6156_6207_6202_9349_6143_6141_6217_6128_6124_6129_6188 12 2.86E-05 0.002320459 5.01E-05 21521 hsa-mir-548aa-2 hsa04650 Natural killer cell mediated cytotoxicity 919_3455_3459_4773_2534_3932_6850_5595_5594_836_5058_5879_5781_6464 14 2.91E-05 0.002355982 5.01E-05 21522 hsa-mir-548aa-2 hsa05010 Alzheimer's disease 498_7132_4724_22926_1020_5595_5594_836_2932_808_801_805_842_841_840_8772 16 2.98E-05 0.002413492 5.03E-05 21523 hsa-mir-548aa-2 hsa04020 Calcium signaling pathway 818_814_815_817_292_293_147_1956_2064_2066_808_801_805_5159_5156_5566 16 4.59E-05 0.003719093 7.59E-05 21524 hsa-mir-548aa-2 hsa04810 Regulation of actin cytoskeleton 2261_2264_5747_1956_4627_4628_10627_71_5595_5594_5058_5879_5159_5156_1399_1398_10788 17 9.95E-05 0.008062797 0.000161256 21525 hsa-mir-548aa-2 hsa05014 Amyotrophic lateral sclerosis (ALS) 7133_7132_1432_836_7157_5879_5608_842 8 0.000185729 0.015044039 0.000294981 21526 hsa-mir-548aa-2 hsa03020 RNA polymerase 25885_51082_5441_64425_5437_84172 6 0.000206093 0.016693535 0.00032103 21527 hsa-mir-548aa-2 hsa04330 Notch signaling pathway 3066_3065_1387_9612_2033_8850_4851 7 0.000372395 0.030163978 0.000569132 21528 hsa-mir-548aa-2 hsa05340 Primary immunodeficiency 8517_3932_3561_3718_695_3575 6 0.000502946 0.040738617 0.000754419 21529 hsa-mir-548aa-2 hsa04612 Antigen processing and presentation 3309_3303_1385_3310_3312_3320_4800_3305_3326 9 0.000774628 0.062744878 0.001140816 21530 hsa-mir-548aa-2 hsa04360 Axon guidance 4773_2534_5747_7852_1020_5595_5594_2932_5058_5879 10 0.002894528 0.234456784 0.004186728 21531 hsa-mir-548aa-2 hsa04270 Vascular smooth muscle contraction 147_5580_5595_5594_4637_808_801_805_5566 9 0.004628966 0.374946251 0.006578004 21532 hsa-mir-548aa-2 hsa04670 Leukocyte transendothelial migration 1499_653361_5747_7852_1432_10627_71_5879_5781 9 0.005660621 0.458510291 0.00790535 21533 hsa-mir-548aa-2 hsa03450 Non-homologous end-joining 2547_7520_5591 3 0.008083753 0.654783962 0.011098033 21534 hsa-mir-548aa-2 hsa04150 mTOR signaling pathway 207_208_5595_5594_6195 5 0.013690011 1 0.018481514 21535 hsa-mir-548aa-2 hsa03030 DNA replication 5981_5111_4174_4172 4 0.017212439 1 0.022855862 21536 hsa-mir-548aa-2 hsa04340 Hedgehog signaling pathway 23291_8945_53944_2932_5566 5 0.019132369 1 0.024995515 21537 hsa-mir-548aa-2 hsa03320 PPAR signaling pathway 5465_10062_6258_6256_5468 5 0.039356527 1 0.050601249 21538 hsa-mir-548b hsa04350 TGF-beta signaling pathway 4093_4086_4088_4089 4 2.34E-07 3.28E-06 3.28E-06 21539 hsa-mir-548b hsa05220 Chronic myeloid leukemia 25_4088_4089 3 1.34E-05 0.000187458 9.37E-05 21540 hsa-mir-548b hsa05200 Pathways in cancer 25_4088_4089_367 4 4.17E-05 0.00058353 0.000178899 21541 hsa-mir-548b hsa04110 Cell cycle 25_4088_4089 3 5.11E-05 0.000715594 0.000178899 21542 hsa-mir-548b hsa04520 Adherens junction 4088_4089 2 0.001096231 0.01534723 0.002811129 21543 hsa-mir-548b hsa05210 Colorectal cancer 4088_4089 2 0.00120477 0.016866775 0.002811129 21544 hsa-mir-548b hsa04310 Wnt signaling pathway 4088_4089 2 0.003790764 0.053070701 0.007581529 21545 hsa-mir-548b hsa03410 Base excision repair 3146 1 0.021961913 0.307466776 0.038433347 21546 hsa-mir-548b hsa05131 Shigellosis 25 1 0.033642746 0.470998445 0.047099845 21547 hsa-mir-548b hsa05130 Pathogenic Escherichia coli infection 25 1 0.033642746 0.470998445 0.047099845 21548 hsa-mir-548c hsa05200 Pathways in cancer 3716_3320_3326_4087_5371_5747_3480_1956_367_1499_4233_5595_5594_5599_5914_1387_2064_6256_5159_595_5156_836_3815_2261_2932_7704_6774_6776_6777_6772_5979_3091_5879_7428_1870_1871_7157_2113_8772_4609_1869_3725_1026_2353_3065_10401_4088_4089_3066_5925_2034_2033_1441_4846_207_208_8554_4286_4790_5970_7046 61 5.37E-53 4.08E-51 4.08E-51 21549 hsa-mir-548c hsa04630 Jak-STAT signaling pathway 3717_3716_3718_3559_85480_3560_3561_149233_1387_595_3575_3570_3572_3953_6774_6776_6777_6772_1439_3459_58985_3454_3455_5781_4609_2690_10401_6773_7297_2033_1441_207_208_8554_10379 35 3.30E-33 2.51E-31 1.25E-31 21550 hsa-mir-548c hsa05215 Prostate cancer 3320_3326_3480_1956_367_1499_5595_5594_1387_2064_5159_595_5156_2932_1870_1871_7157_1869_1026_5925_2033_207_208_4790_5970 25 3.98E-26 3.03E-24 9.60E-25 21551 hsa-mir-548c hsa05212 Pancreatic cancer 3320_3326_3480_1956_367_1499_5595_5594_1387_2064_5159_595_5156_2932_1870_1871_7157_1869_1026_5925_2033_207_208_4790_5970 25 5.05E-26 3.84E-24 9.60E-25 21552 hsa-mir-548c hsa05220 Chronic myeloid leukemia 5595_5594_595_6776_6777_1870_1871_7157_5781_4609_1869_1026_3065_4088_4089_3066_5925_207_208_4790_5970_6464_7046 23 9.05E-25 6.88E-23 1.38E-23 21553 hsa-mir-548c hsa05210 Colorectal cancer 4087_3480_1956_1499_4233_5595_5594_5599_5159_595_5156_836_2932_5879_7157_4609_3725_2353_4088_4089_207_208_7046 23 8.11E-24 6.16E-22 1.03E-22 21554 hsa-mir-548c hsa04060 Cytokine-cytokine receptor interaction 3556_2321_3559_85480_1956_4233_3560_3561_149233_90_5159_5156_7133_7132_3575_3815_3570_3572_1234_1230_3953_1439_3459_3791_7852_58985_3454_3455_2690_1441_7046 31 5.54E-22 4.21E-20 6.01E-21 21555 hsa-mir-548c hsa04010 MAPK signaling pathway 3925_6722_1956_5595_5594_5599_5159_5156_4208_7132_836_2261_2264_9252_1432_5879_3312_7157_6885_4609_3725_1845_2353_4763_5058_207_208_4790_51701_5970_7046 31 1.67E-21 1.27E-19 1.58E-20 21556 hsa-mir-548c hsa04520 Adherens junction 4087_2241_3480_1956_1499_6714_4233_5595_5594_1387_2064_5879_6885_1457_4088_4089_2033_51701_7046_2534 20 3.37E-20 2.56E-18 2.84E-19 21557 hsa-mir-548c hsa05214 Glioma 818_817_3480_1956_5595_5594_5159_595_5156_1870_1871_7157_1869_1026_5925_207_208_6464 18 5.57E-19 4.23E-17 4.23E-18 21558 hsa-mir-548c hsa04110 Cell cycle 4087_5591_1387_595_7534_7532_2932_1870_1871_7157_4172_1869_4174_1026_3065_4088_4089_3066_5925_2033_5933 21 2.02E-18 1.54E-16 1.40E-17 21559 hsa-mir-548c hsa04012 ErbB signaling pathway 818_817_5747_1956_6714_5595_5594_5599_2064_2932_6776_6777_4609_3725_1026_5058_207_208_6464 19 2.67E-18 2.03E-16 1.69E-17 21560 hsa-mir-548c hsa04062 Chemokine signaling pathway 3717_3718_5580_5747_5590_5595_5594_1234_1230_2932_6774_6777_6772_5879_7852_2185_5058_6773_207_208_3055_4790_5970_6464 24 1.02E-17 7.72E-16 5.94E-17 21561 hsa-mir-548c hsa05218 Melanoma 3480_1956_4233_5595_5594_5159_595_5156_1870_1871_7157_1869_1026_5925_207_208_4286 17 4.36E-17 3.31E-15 2.37E-16 21562 hsa-mir-548c hsa04510 Focal adhesion 2321_5747_3480_1956_1499_6714_4233_5595_5594_5599_2064_5159_595_5156_2932_5879_3791_3725_5058_207_208_6464_2534 23 4.21E-16 3.20E-14 2.13E-15 21563 hsa-mir-548c hsa05219 Bladder cancer 1956_5595_5594_2064_595_2261_9252_1870_1871_7157_4609_1869_1026_5925 14 5.48E-16 4.17E-14 2.60E-15 21564 hsa-mir-548c hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_3815_7704_6774_6776_6777_4609_207_208_4790_5970 15 1.47E-15 1.12E-13 6.56E-15 21565 hsa-mir-548c hsa04620 Toll-like receptor signaling pathway 3654_5595_5594_5599_1432_6772_5879_3454_3455_8772_6885_3725_2353_207_208_4790_5970 17 8.66E-15 6.58E-13 3.66E-14 21566 hsa-mir-548c hsa05222 Small cell lung cancer 5747_6256_595_1870_1871_7157_4609_1869_10401_5925_4846_207_208_8554_4790_5970 16 1.18E-14 8.97E-13 4.72E-14 21567 hsa-mir-548c hsa05211 Renal cell carcinoma 4233_5595_5594_1387_3091_5879_7428_5781_2113_3725_5058_2034_2033_207_208 15 1.87E-14 1.42E-12 7.12E-14 21568 hsa-mir-548c hsa04310 Wnt signaling pathway 4087_818_817_1499_5599_1387_595_5518_2932_5879_7157_6885_4609_3725_1457_4088_4089_2033_51701 19 2.53E-14 1.92E-12 9.14E-14 21569 hsa-mir-548c hsa04920 Adipocytokine signaling pathway 3717_8717_5599_6256_7133_7132_3953_6774_5781_207_208_4790_5970_2538 14 1.36E-13 1.04E-11 4.71E-13 21570 hsa-mir-548c hsa05223 Non-small cell lung cancer 1956_5595_5594_2064_6256_595_1870_1871_7157_1869_5925_207_208 13 2.14E-13 1.62E-11 7.06E-13 21571 hsa-mir-548c hsa04350 TGF-beta signaling pathway 4087_5595_5594_1387_90_5518_57154_4609_4086_4088_4089_2033_7046_5933 14 3.18E-12 2.41E-10 1.01E-11 21572 hsa-mir-548c hsa05213 Endometrial cancer 1956_1499_5595_5594_2064_595_2932_7157_4609_207_208 11 5.22E-11 3.96E-09 1.59E-10 21573 hsa-mir-548c hsa04660 T cell receptor signaling pathway 3932_5595_5594_2932_1432_6885_3725_2353_5058_207_208_4790_5970_2534 14 5.43E-11 4.13E-09 1.59E-10 21574 hsa-mir-548c hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_4233_5599_836_1432_5879_5781_3725_5058_4790_5970 12 6.93E-11 5.26E-09 1.95E-10 21575 hsa-mir-548c hsa04210 Apoptosis 3654_3556_8717_7132_836_1439_7157_8772_207_208_4790_5970 12 7.21E-10 5.48E-08 1.96E-09 21576 hsa-mir-548c hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6850_836_5879_3459_3454_3455_5781_2185_5058_6464_2534 14 8.36E-10 6.35E-08 2.19E-09 21577 hsa-mir-548c hsa04662 B cell receptor signaling pathway 5595_5594_6850_2932_5879_3725_2353_207_208_4790_5970 11 1.67E-09 1.27E-07 4.24E-09 21578 hsa-mir-548c hsa05216 Thyroid cancer 1499_5595_5594_6256_595_5979_7157_4609 8 3.88E-09 2.95E-07 9.51E-09 21579 hsa-mir-548c hsa04370 VEGF signaling pathway 5747_6714_5595_5594_1432_5879_3791_4846_207_208 10 2.66E-08 2.02E-06 6.33E-08 21580 hsa-mir-548c hsa04664 Fc epsilon RI signaling pathway 5580_5595_5594_5599_6850_1432_5879_207_208_2534 10 3.32E-08 2.53E-06 7.65E-08 21581 hsa-mir-548c hsa04912 GnRH signaling pathway 5580_818_817_1956_6714_5595_5594_5599_1432_2185_3725 11 5.31E-08 4.04E-06 1.19E-07 21582 hsa-mir-548c hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_7133_7132_836_1432_5879_7157_4846 8 3.48E-07 2.65E-05 7.46E-07 21583 hsa-mir-548c hsa04916 Melanogenesis 818_817_1499_5595_5594_1387_3815_2932_2033_4286 10 3.53E-07 2.69E-05 7.46E-07 21584 hsa-mir-548c hsa04330 Notch signaling pathway 388585_1387_3280_9612_3065_3066_2033 7 1.49E-06 0.000112975 3.05E-06 21585 hsa-mir-548c hsa04360 Axon guidance 2242_5747_4233_5595_5594_2932_5879_7852_5058_2534 10 2.50E-06 0.000190095 5.00E-06 21586 hsa-mir-548c hsa04910 Insulin signaling pathway 6720_5590_5595_5594_5599_2932_207_208_6464_2538 10 3.87E-06 0.000293995 7.54E-06 21587 hsa-mir-548c hsa04720 Long-term potentiation 818_817_5595_5594_1387_2902_2033 7 2.49E-05 0.001889046 4.72E-05 21588 hsa-mir-548c hsa04020 Calcium signaling pathway 818_817_1956_2064_5159_2902_5156_2185_4846_147 10 4.10E-05 0.003112869 7.59E-05 21589 hsa-mir-548c hsa04530 Tight junction 5580_1499_6714_5590_5518_1457_207_208 8 0.000150871 0.011466171 0.000273004 21590 hsa-mir-548c hsa04810 Regulation of actin cytoskeleton 5747_1956_5595_5594_5159_5156_2261_2264_5879_5058 10 0.000162044 0.012315323 0.000286403 21591 hsa-mir-548c hsa04930 Type II diabetes mellitus 5580_5590_5595_5594_5599 5 0.000174506 0.013262437 0.000301419 21592 hsa-mir-548c hsa05016 Huntington's disease 6874_1387_2902_836_7157_3065_3066_3064_2033 9 0.00024544 0.018653402 0.00041452 21593 hsa-mir-548c hsa04150 mTOR signaling pathway 5595_5594_3091_207_208 5 0.000324896 0.024692072 0.000536784 21594 hsa-mir-548c hsa04670 Leukocyte transendothelial migration 5747_1499_1432_5879_7852_5781_2185 7 0.000430549 0.032721731 0.000696207 21595 hsa-mir-548c hsa04640 Hematopoietic cell lineage 3559_914_3575_3815_3570_1441 6 0.000443105 0.033676015 0.000701584 21596 hsa-mir-548c hsa04612 Antigen processing and presentation 3320_3326_4800_2923_3312_4801 6 0.000496511 0.037734808 0.000770098 21597 hsa-mir-548c hsa04540 Gap junction 1956_6714_5595_5594_5159_5156 6 0.000618261 0.046987867 0.000939757 21598 hsa-mir-548c hsa05340 Primary immunodeficiency 3718_3932_3561_3575 4 0.000722918 0.054941796 0.00107729 21599 hsa-mir-548c hsa05010 Alzheimer's disease 5595_5594_2902_7132_836_2932_8772_4846 8 0.00077285 0.058736592 0.00112955 21600 hsa-mir-548c hsa04120 Ubiquitin mediated proteolysis 5371_672_7428_57154_7329_10401_8554 7 0.000898736 0.068303956 0.001288754 21601 hsa-mir-548c hsa04730 Long-term depression 3480_5595_5594_5518_4846 5 0.001219955 0.092716596 0.001716974 21602 hsa-mir-548c hsa04950 Maturity onset diabetes of the young 6927_3172_3280 3 0.002750104 0.209007938 0.003800144 21603 hsa-mir-548c hsa04115 p53 signaling pathway 595_836_7157_1026 4 0.007251111 0.551084459 0.009840794 21604 hsa-mir-548c hsa03030 DNA replication 4172_4174_6118 3 0.007835932 0.595530833 0.010447909 21605 hsa-mir-548c hsa04710 Circadian rhythm - mammal 8863_8553 2 0.010460023 0.794961719 0.013706237 21606 hsa-mir-548c hsa04080 Neuroactive ligand-receptor interaction 7253_2902_2908_3953_2690_147_7068 7 0.021248461 1 0.027370899 21607 hsa-mir-548c hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.022891876 1 0.028996376 21608 hsa-mir-548c hsa05131 Shigellosis 1499_7534_2534 3 0.023936239 1 0.029341196 21609 hsa-mir-548c hsa05130 Pathogenic Escherichia coli infection 1499_7534_2534 3 0.023936239 1 0.029341196 21610 hsa-mir-548c hsa04270 Vascular smooth muscle contraction 5580_5595_5594_147 4 0.039495915 1 0.047645865 21611 hsa-mir-548d-1 hsa04010 MAPK signaling pathway 9344_6722_5606_5601_5600_2885_5595_1432_5594_5604_5599_2005_2353 13 1.33E-19 6.52E-18 6.52E-18 21612 hsa-mir-548d-1 hsa04664 Fc epsilon RI signaling pathway 5606_5601_5600_2885_5595_1432_5594_5604_5599 9 6.90E-17 3.38E-15 1.69E-15 21613 hsa-mir-548d-1 hsa04620 Toll-like receptor signaling pathway 5606_5601_5600_5595_1432_5594_5604_5599_2353 9 6.03E-16 2.95E-14 9.84E-15 21614 hsa-mir-548d-1 hsa04912 GnRH signaling pathway 5606_5601_5600_2885_5595_1432_5594_5604_5599 9 9.82E-16 4.81E-14 1.20E-14 21615 hsa-mir-548d-1 hsa04660 T cell receptor signaling pathway 5601_5600_2885_5595_1432_5594_5604_2353 8 1.30E-13 6.37E-12 1.27E-12 21616 hsa-mir-548d-1 hsa05200 Pathways in cancer 5601_2885_2033_9063_5595_5594_5604_5599_2353_1387 10 3.52E-13 1.73E-11 2.88E-12 21617 hsa-mir-548d-1 hsa05210 Colorectal cancer 5601_2885_5595_5594_5604_5599_2353 7 2.09E-12 1.02E-10 1.46E-11 21618 hsa-mir-548d-1 hsa04350 TGF-beta signaling pathway 2033_5595_5594_3397_3399_3398_1387 7 2.63E-12 1.29E-10 1.61E-11 21619 hsa-mir-548d-1 hsa05211 Renal cell carcinoma 2885_2033_5595_5594_5604_1387 6 9.09E-11 4.45E-09 4.95E-10 21620 hsa-mir-548d-1 hsa04012 ErbB signaling pathway 5601_2885_5595_5594_5604_5599 6 2.67E-10 1.31E-08 1.24E-09 21621 hsa-mir-548d-1 hsa05215 Prostate cancer 2885_2033_5595_5594_5604_1387 6 2.85E-10 1.40E-08 1.24E-09 21622 hsa-mir-548d-1 hsa05212 Pancreatic cancer 2885_2033_5595_5594_5604_1387 6 3.04E-10 1.49E-08 1.24E-09 21623 hsa-mir-548d-1 hsa04910 Insulin signaling pathway 5601_2885_5595_5594_5604_5599 6 3.78E-09 1.85E-07 1.43E-08 21624 hsa-mir-548d-1 hsa04720 Long-term potentiation 2033_5595_5594_5604_1387 5 1.11E-08 5.43E-07 3.62E-08 21625 hsa-mir-548d-1 hsa04662 B cell receptor signaling pathway 2885_5595_5594_5604_2353 5 1.11E-08 5.43E-07 3.62E-08 21626 hsa-mir-548d-1 hsa04370 VEGF signaling pathway 5600_5595_1432_5594_5604 5 1.26E-08 6.15E-07 3.84E-08 21627 hsa-mir-548d-1 hsa04510 Focal adhesion 5601_2885_5595_5594_5604_5599 6 3.82E-08 1.87E-06 1.10E-07 21628 hsa-mir-548d-1 hsa04916 Melanogenesis 2033_5595_5594_5604_1387 5 5.28E-08 2.59E-06 1.44E-07 21629 hsa-mir-548d-1 hsa04930 Type II diabetes mellitus 5601_5595_5594_5599 4 1.24E-07 6.10E-06 3.21E-07 21630 hsa-mir-548d-1 hsa05213 Endometrial cancer 2885_5595_5594_5604 4 2.15E-07 1.05E-05 5.26E-07 21631 hsa-mir-548d-1 hsa05223 Non-small cell lung cancer 2885_5595_5594_5604 4 2.48E-07 1.21E-05 5.78E-07 21632 hsa-mir-548d-1 hsa05221 Acute myeloid leukemia 2885_5595_5594_5604 4 3.47E-07 1.70E-05 7.72E-07 21633 hsa-mir-548d-1 hsa05214 Glioma 2885_5595_5594_5604 4 5.01E-07 2.46E-05 1.07E-06 21634 hsa-mir-548d-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5601_5600_1432_5599 4 7.02E-07 3.44E-05 1.43E-06 21635 hsa-mir-548d-1 hsa05220 Chronic myeloid leukemia 2885_5595_5594_5604 4 8.66E-07 4.24E-05 1.70E-06 21636 hsa-mir-548d-1 hsa04520 Adherens junction 2033_5595_5594_1387 4 1.11E-06 5.43E-05 2.09E-06 21637 hsa-mir-548d-1 hsa04540 Gap junction 2885_5595_5594_5604 4 1.97E-06 9.67E-05 3.58E-06 21638 hsa-mir-548d-1 hsa05216 Thyroid cancer 5595_5594_5604 3 3.54E-06 0.000173289 6.19E-06 21639 hsa-mir-548d-1 hsa04650 Natural killer cell mediated cytotoxicity 2885_5595_5594_5604 4 8.98E-06 0.000440262 1.52E-05 21640 hsa-mir-548d-1 hsa05219 Bladder cancer 5595_5594_5604 3 1.00E-05 0.000491753 1.64E-05 21641 hsa-mir-548d-1 hsa04310 Wnt signaling pathway 5601_2033_5599_1387 4 1.30E-05 0.000638027 2.06E-05 21642 hsa-mir-548d-1 hsa04630 Jak-STAT signaling pathway 2885_2033_9063_1387 4 1.40E-05 0.000687726 2.15E-05 21643 hsa-mir-548d-1 hsa05014 Amyotrophic lateral sclerosis (ALS) 5606_5600_1432 3 2.28E-05 0.001116794 3.38E-05 21644 hsa-mir-548d-1 hsa04062 Chemokine signaling pathway 2885_5595_5594_5604 4 3.25E-05 0.001593448 4.69E-05 21645 hsa-mir-548d-1 hsa05218 Melanoma 5595_5594_5604 3 4.50E-05 0.002206174 6.13E-05 21646 hsa-mir-548d-1 hsa04730 Long-term depression 5595_5594_5604 3 4.50E-05 0.002206174 6.13E-05 21647 hsa-mir-548d-1 hsa04270 Vascular smooth muscle contraction 5595_5594_5604 3 0.00019424 0.009517744 0.000257236 21648 hsa-mir-548d-1 hsa04120 Ubiquitin mediated proteolysis 7329_9063_672 3 0.00031101 0.015239482 0.000401039 21649 hsa-mir-548d-1 hsa05010 Alzheimer's disease 6622_5595_5594 3 0.000621442 0.030450666 0.000780786 21650 hsa-mir-548d-1 hsa04330 Notch signaling pathway 2033_1387 2 0.000959659 0.047023291 0.001175582 21651 hsa-mir-548d-1 hsa04810 Regulation of actin cytoskeleton 5595_5594_5604 3 0.00113937 0.055829137 0.001358454 21652 hsa-mir-548d-1 hsa04150 mTOR signaling pathway 5595_5594 2 0.001164389 0.057055084 0.001358454 21653 hsa-mir-548d-1 hsa04920 Adipocytokine signaling pathway 5601_5599 2 0.001892498 0.092732422 0.002156568 21654 hsa-mir-548d-1 hsa04110 Cell cycle 2033_1387 2 0.005684096 0.278520706 0.006330016 21655 hsa-mir-548d-1 hsa04670 Leukocyte transendothelial migration 5600_1432 2 0.005960375 0.292058382 0.006490186 21656 hsa-mir-548d-1 hsa04360 Axon guidance 5595_5594 2 0.006825415 0.334445331 0.007270551 21657 hsa-mir-548d-1 hsa05016 Huntington's disease 2033_1387 2 0.013512466 0.662110821 0.014087464 21658 hsa-mir-548e hsa05200 Pathways in cancer 5371_9063_5595_5594_5599_861_5914_1387_6256_595_5601_836_1487_6258_367_1017_4149_7704_842_3091_5970_7428_1870_1871_2885_7157_4824_2113_4609_1869_3725_5604_841_2353_4087_4088_4089_3066_3065_1050_5925_2034_2033_4846 44 6.86E-39 4.39E-37 4.39E-37 21659 hsa-mir-548e hsa05220 Chronic myeloid leukemia 5595_5594_861_595_1487_5970_1870_1871_2885_7157_4609_1869_5604_4088_4089_3066_3065_5925_6464 19 6.18E-22 3.95E-20 1.98E-20 21660 hsa-mir-548e hsa04010 MAPK signaling pathway 6722_5595_5594_5599_9261_4208_5601_5600_836_6195_4149_3312_1432_5970_9344_2885_7157_4773_4609_3725_5604_5606_2353_4763_1616_2002_2005 27 5.11E-21 3.27E-19 1.09E-19 21661 hsa-mir-548e hsa05215 Prostate cancer 5595_5594_1387_595_367_1017_1385_842_5970_1870_1871_2885_7157_4824_1869_5604_5925_2033 18 2.15E-19 1.38E-17 3.29E-18 21662 hsa-mir-548e hsa05212 Pancreatic cancer 5595_5594_1387_595_367_1017_1385_842_5970_1870_1871_2885_7157_4824_1869_5604_5925_2033 18 2.57E-19 1.64E-17 3.29E-18 21663 hsa-mir-548e hsa04110 Cell cycle 5591_1387_595_1017_1870_1871_7157_1869_4087_4088_4089_3066_3065_5925_2033_5933_890_5934 18 2.54E-17 1.63E-15 2.71E-16 21664 hsa-mir-548e hsa05210 Colorectal cancer 5595_5594_5599_595_5601_836_842_2885_7157_4609_3725_5604_2353_4087_4088_4089 16 6.10E-17 3.90E-15 5.58E-16 21665 hsa-mir-548e hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_3397_3399_3398_1874_1875_4609_4087_4088_4089_2033_5933_5934 16 9.97E-17 6.38E-15 7.98E-16 21666 hsa-mir-548e hsa05222 Small cell lung cancer 9063_6256_595_6258_1017_4149_842_5970_1870_1871_7157_4609_1869_5925_4846 15 1.86E-15 1.19E-13 1.32E-14 21667 hsa-mir-548e hsa05223 Non-small cell lung cancer 5595_5594_6256_595_6258_842_1870_1871_2885_7157_1869_5604_5925 13 3.80E-15 2.43E-13 2.43E-14 21668 hsa-mir-548e hsa05221 Acute myeloid leukemia 5371_5595_5594_861_5914_595_7704_5970_2885_4609_5604_1050 12 2.56E-13 1.64E-11 1.49E-12 21669 hsa-mir-548e hsa05214 Glioma 815_5595_5594_595_1870_1871_2885_7157_1869_5604_5925_6464 12 7.06E-13 4.52E-11 3.76E-12 21670 hsa-mir-548e hsa04310 Wnt signaling pathway 815_5599_1387_595_5601_1487_7157_4773_4609_3725_1457_4087_4088_4089_2033 15 3.52E-12 2.25E-10 1.73E-11 21671 hsa-mir-548e hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5604_5925 10 6.67E-12 4.27E-10 3.05E-11 21672 hsa-mir-548e hsa04912 GnRH signaling pathway 815_6714_5595_5594_5599_5601_5600_1432_2885_3725_5604_5606_2002 13 1.02E-11 6.54E-10 4.36E-11 21673 hsa-mir-548e hsa04012 ErbB signaling pathway 815_6714_5595_5594_5599_5601_2885_4609_3725_5604_6464_2002 12 1.53E-11 9.80E-10 6.12E-11 21674 hsa-mir-548e hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2885_2113_3725_5604_2034_2033 11 4.07E-11 2.60E-09 1.53E-10 21675 hsa-mir-548e hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5601_5600_1432_5970_3725_5604_841_5606_2353 12 8.27E-11 5.29E-09 2.94E-10 21676 hsa-mir-548e hsa05216 Thyroid cancer 5595_5594_6256_595_6258_7157_4609_5604 8 3.28E-10 2.10E-08 1.11E-09 21677 hsa-mir-548e hsa05016 Huntington's disease 6874_1387_2902_6908_836_6667_1385_842_7157_841_3066_3065_3064_2033 14 5.97E-10 3.82E-08 1.91E-09 21678 hsa-mir-548e hsa05213 Endometrial cancer 5595_5594_595_842_2885_7157_4609_5604_2002 9 9.33E-10 5.97E-08 2.84E-09 21679 hsa-mir-548e hsa04370 VEGF signaling pathway 6714_5595_5594_9261_5600_1432_842_4773_5604_4846 10 1.34E-09 8.55E-08 3.89E-09 21680 hsa-mir-548e hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_5600_836_1432_842_7157_5606_1616_4846 9 1.67E-09 1.07E-07 4.66E-09 21681 hsa-mir-548e hsa04660 T cell receptor signaling pathway 5595_5594_5601_5600_1432_5970_2885_4773_3725_5604_2353 11 2.50E-09 1.60E-07 6.65E-09 21682 hsa-mir-548e hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5604_5925 9 1.10E-08 7.04E-07 2.82E-08 21683 hsa-mir-548e hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5601_5600_1432_2885_5604_5606 9 2.57E-08 1.65E-06 6.33E-08 21684 hsa-mir-548e hsa04520 Adherens junction 6714_5595_5594_1387_1457_4087_4088_4089_2033 9 2.84E-08 1.82E-06 6.74E-08 21685 hsa-mir-548e hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5599_5601_5600_836_1432_5970_3725 8 1.68E-07 1.08E-05 3.85E-07 21686 hsa-mir-548e hsa04720 Long-term potentiation 815_5595_5594_1387_2902_6195_5604_2033 8 2.48E-07 1.59E-05 5.29E-07 21687 hsa-mir-548e hsa04662 B cell receptor signaling pathway 5595_5594_5970_2885_4773_3725_5604_2353 8 2.48E-07 1.59E-05 5.29E-07 21688 hsa-mir-548e hsa04510 Focal adhesion 6714_5595_5594_5599_595_5601_2885_3725_5604_6464_2002 11 1.00E-06 6.41E-05 2.07E-06 21689 hsa-mir-548e hsa05010 Alzheimer's disease 22926_5595_5594_2902_836_842_840_841_6622_4846 10 1.94E-06 0.000124034 3.88E-06 21690 hsa-mir-548e hsa04910 Insulin signaling pathway 6720_5595_5594_5599_5601_2885_5604_6464_2002 9 2.10E-06 0.000134217 4.07E-06 21691 hsa-mir-548e hsa04330 Notch signaling pathway 1387_1487_9612_3066_3065_2033 6 3.17E-06 0.000203008 5.97E-06 21692 hsa-mir-548e hsa04210 Apoptosis 836_839_842_840_5970_7157_841 7 9.29E-06 0.000594816 1.70E-05 21693 hsa-mir-548e hsa04916 Melanogenesis 815_5595_5594_1387_1385_5604_2033 7 2.40E-05 0.001538496 4.18E-05 21694 hsa-mir-548e hsa04115 p53 signaling pathway 595_836_1017_842_7157_841 6 2.42E-05 0.00154807 4.18E-05 21695 hsa-mir-548e hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_2885_4773_5604_6464 7 0.000131244 0.008399598 0.000221042 21696 hsa-mir-548e hsa04920 Adipocytokine signaling pathway 5599_6256_5601_6258_5970 5 0.000230119 0.014727648 0.000377632 21697 hsa-mir-548e hsa03022 Basal transcription factors 2962_6874_2969_6908 4 0.000269424 0.017243108 0.000431078 21698 hsa-mir-548e hsa04930 Type II diabetes mellitus 5595_5594_5599_5601 4 0.000537399 0.034393546 0.000838867 21699 hsa-mir-548e hsa04150 mTOR signaling pathway 5595_5594_6195_3091 4 0.000893532 0.057186079 0.001361573 21700 hsa-mir-548e hsa04540 Gap junction 6714_5595_5594_2885_5604 5 0.000951386 0.060888681 0.001416016 21701 hsa-mir-548e hsa04630 Jak-STAT signaling pathway 9063_1387_595_2885_4609_2033 6 0.00153584 0.098293769 0.002233949 21702 hsa-mir-548e hsa04730 Long-term depression 5595_5594_5604_4846 4 0.002641377 0.169048125 0.003756625 21703 hsa-mir-548e hsa04062 Chemokine signaling pathway 5595_5594_5970_2885_5604_6464 6 0.004395335 0.281301456 0.006115249 21704 hsa-mir-548e hsa04120 Ubiquitin mediated proteolysis 5371_9063_672_7428_7329 5 0.005082818 0.325300358 0.006921284 21705 hsa-mir-548e hsa04612 Antigen processing and presentation 4800_4801_1385_3312 4 0.005704621 0.365095729 0.007606161 21706 hsa-mir-548f-1 hsa04350 TGF-beta signaling pathway 4092_4088_4089_6667_2033_3400_1387_3397_3399_3398 10 9.95E-15 5.67E-13 5.67E-13 21707 hsa-mir-548f-1 hsa05200 Pathways in cancer 4088_4089_3320_3065_5925_2033_1019_1017_3725_1387_5578_6774_6256 13 3.71E-13 2.11E-11 1.06E-11 21708 hsa-mir-548f-1 hsa04110 Cell cycle 4088_4089_3065_5925_2033_1019_1017_1387_1028 9 7.81E-12 4.45E-10 1.48E-10 21709 hsa-mir-548f-1 hsa05214 Glioma 5925_1019_5578_808_801_805 6 9.41E-09 5.36E-07 1.34E-07 21710 hsa-mir-548f-1 hsa04720 Long-term potentiation 2033_1387_5578_808_801_805 6 2.10E-08 1.20E-06 2.39E-07 21711 hsa-mir-548f-1 hsa04330 Notch signaling pathway 9612_3065_2033_1387_8850 5 8.97E-08 5.11E-06 8.52E-07 21712 hsa-mir-548f-1 hsa04916 Melanogenesis 2033_1387_5578_808_801_805 6 1.32E-07 7.52E-06 1.07E-06 21713 hsa-mir-548f-1 hsa04912 GnRH signaling pathway 3725_1432_5578_808_801_805 6 1.63E-07 9.30E-06 1.16E-06 21714 hsa-mir-548f-1 hsa05220 Chronic myeloid leukemia 4088_4089_3065_5925_1019 5 7.92E-07 4.52E-05 5.02E-06 21715 hsa-mir-548f-1 hsa04310 Wnt signaling pathway 4088_4089_2033_3725_1387_5578 6 1.12E-06 6.36E-05 6.36E-06 21716 hsa-mir-548f-1 hsa05215 Prostate cancer 3320_5925_2033_1017_1387 5 1.68E-06 9.56E-05 8.40E-06 21717 hsa-mir-548f-1 hsa05212 Pancreatic cancer 3320_5925_2033_1017_1387 5 1.77E-06 0.0001008 8.40E-06 21718 hsa-mir-548f-1 hsa05223 Non-small cell lung cancer 5925_1019_5578_6256 4 7.27E-06 0.000414209 3.19E-05 21719 hsa-mir-548f-1 hsa04070 Phosphatidylinositol signaling system 5578_808_801_805 4 2.62E-05 0.001490869 0.000106491 21720 hsa-mir-548f-1 hsa04010 MAPK signaling pathway 6722_4342_3725_1386_1432_5578 6 2.89E-05 0.001647278 0.000109819 21721 hsa-mir-548f-1 hsa04520 Adherens junction 4088_4089_2033_1387 4 3.17E-05 0.001807281 0.000112955 21722 hsa-mir-548f-1 hsa05222 Small cell lung cancer 5925_1019_1017_6256 4 4.16E-05 0.002370574 0.000139446 21723 hsa-mir-548f-1 hsa04270 Vascular smooth muscle contraction 5578_808_801_805 4 0.000135863 0.007744165 0.000430231 21724 hsa-mir-548f-1 hsa05211 Renal cell carcinoma 2033_3725_1387 3 0.000556908 0.031743766 0.001670725 21725 hsa-mir-548f-1 hsa04020 Calcium signaling pathway 5578_808_801_805 4 0.000702084 0.040018772 0.002000939 21726 hsa-mir-548f-1 hsa05016 Huntington's disease 3065_6667_2033_1387 4 0.000759452 0.043288748 0.002061369 21727 hsa-mir-548f-1 hsa05210 Colorectal cancer 4088_4089_3725 3 0.000858448 0.048931555 0.002224162 21728 hsa-mir-548f-1 hsa04660 T cell receptor signaling pathway 1019_3725_1432 3 0.001823171 0.103920741 0.004518293 21729 hsa-mir-548f-1 hsa04910 Insulin signaling pathway 808_801_805 3 0.003413716 0.194581795 0.008107575 21730 hsa-mir-548f-1 hsa05219 Bladder cancer 5925_1019 2 0.003983935 0.227084274 0.009083371 21731 hsa-mir-548f-1 hsa04630 Jak-STAT signaling pathway 2033_1387_6774 3 0.004692786 0.267488823 0.010288032 21732 hsa-mir-548f-1 hsa05010 Alzheimer's disease 808_801_805 3 0.006728729 0.383537538 0.014205094 21733 hsa-mir-548f-1 hsa04920 Adipocytokine signaling pathway 6774_6256 2 0.009548406 0.544259132 0.019437826 21734 hsa-mir-548f-1 hsa04115 p53 signaling pathway 1019_1017 2 0.010086633 0.574938103 0.019560309 21735 hsa-mir-548f-1 hsa05218 Melanoma 5925_1019 2 0.010638063 0.606369577 0.019560309 21736 hsa-mir-548f-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1432 2 0.010638063 0.606369577 0.019560309 21737 hsa-mir-548f-1 hsa04370 VEGF signaling pathway 1432_5578 2 0.012370382 0.705111754 0.022034742 21738 hsa-mir-548f-1 hsa04664 Fc epsilon RI signaling pathway 1432_5578 2 0.012973442 0.739486184 0.022408672 21739 hsa-mir-548f-1 hsa04012 ErbB signaling pathway 3725_5578 2 0.015510712 0.88411056 0.026003252 21740 hsa-mir-548f-1 hsa04620 Toll-like receptor signaling pathway 3725_1432 2 0.020787067 1 0.033853223 21741 hsa-mir-548f-1 hsa04670 Leukocyte transendothelial migration 1432_5578 2 0.028807117 1 0.045292597 21742 hsa-mir-548f-1 hsa04710 Circadian rhythm - mammal 79365 1 0.029400458 1 0.045292597 21743 hsa-mir-548f-1 hsa04530 Tight junction 1019_5578 2 0.035504139 1 0.053256208 21744 hsa-mir-548f-1 hsa04120 Ubiquitin mediated proteolysis 997_672 2 0.036438636 1 0.053256467 21745 hsa-mir-548f-2 hsa05200 Pathways in cancer 5467_1499_5914_595_1019_1017_4193_6934_7704_5578_6502_3091_3066_3065_1050_5925_5468_25_405_1956_1487_1488_2308_1870_1871_2113_10401_861_862_207_836_5595_5594_5599_1387_6256_4286_367_2932_6774_6776_6777_6772_5970_7157_6688_7849_1869_3725_4088_4089_2034_2033_4846_4790_9915_3320_51176_5371_5604_841_7428_4087_4609_2956_2736 66 3.51E-40 2.77E-38 2.77E-38 21746 hsa-mir-548f-2 hsa05220 Chronic myeloid leukemia 595_1019_4193_3066_3065_5925_25_1487_1488_1870_1871_861_207_5595_5594_6776_6777_5970_7157_1869_4088_4089_4790_5604_4609_6464 26 1.36E-21 1.07E-19 5.37E-20 21747 hsa-mir-548f-2 hsa05215 Prostate cancer 1499_595_1017_4193_6934_5925_1956_2308_1870_1871_207_5595_5594_1385_1387_367_2932_5970_7157_468_1869_2033_4790_3320_51176_5604 26 3.84E-20 3.03E-18 9.61E-19 21748 hsa-mir-548f-2 hsa05212 Pancreatic cancer 1499_595_1017_4193_6934_5925_1956_2308_1870_1871_207_5595_5594_1385_1387_367_2932_5970_7157_468_1869_2033_4790_3320_51176_5604 26 4.86E-20 3.84E-18 9.61E-19 21749 hsa-mir-548f-2 hsa05221 Acute myeloid leukemia 5467_5914_595_6934_7704_1050_861_862_207_5595_5594_6774_6776_6777_5970_6688_4790_51176_5371_5604_4609 21 6.87E-18 5.43E-16 1.09E-16 21750 hsa-mir-548f-2 hsa04010 MAPK signaling pathway 6722_6197_9252_7867_5578_4773_8986_1956_1432_4342_4763_207_836_9479_5595_5594_5599_1386_3312_1649_5970_3164_7157_468_3725_6195_6196_4790_9261_5604_4208_5566_4609_2002 34 1.26E-15 9.98E-14 1.66E-14 21751 hsa-mir-548f-2 hsa04110 Cell cycle 595_1019_1017_4193_6502_3066_3065_5925_25_1870_1871_5934_5933_5591_1387_2932_7157_1869_5111_4088_4089_2033_4087_1028 24 1.83E-15 1.45E-13 2.07E-14 21752 hsa-mir-548f-2 hsa05214 Glioma 815_595_1019_4193_5578_5925_1956_1870_1871_207_5595_5594_7157_1869_808_801_805_5604_6464 19 5.19E-15 4.10E-13 5.12E-14 21753 hsa-mir-548f-2 hsa04310 Wnt signaling pathway 815_5467_1499_595_6934_5578_4772_4773_1487_1488_5599_1387_2932_7157_3725_1457_4088_4089_2033_51176_5566_6423_4087_4609_5527 25 2.96E-14 2.34E-12 2.60E-13 21754 hsa-mir-548f-2 hsa05210 Colorectal cancer 1499_595_6934_1956_207_836_5595_5594_5599_2932_7157_3725_4088_4089_51176_5604_4087_4609_2956 19 2.70E-13 2.13E-11 2.13E-12 21755 hsa-mir-548f-2 hsa04350 TGF-beta signaling pathway 4086_6667_3397_3399_3398_1875_5934_5933_3400_5595_5594_1387_4088_4089_2033_4093_4087_4609_4092 19 4.64E-13 3.66E-11 3.33E-12 21756 hsa-mir-548f-2 hsa05219 Bladder cancer 595_1019_9252_4193_5925_1956_1870_1871_5595_5594_7157_1869_5604_4609 14 4.66E-12 3.68E-10 3.07E-11 21757 hsa-mir-548f-2 hsa05223 Non-small cell lung cancer 595_1019_5578_5925_1956_2309_1870_1871_207_5595_5594_6256_7157_1869_5604 15 7.21E-12 5.69E-10 4.38E-11 21758 hsa-mir-548f-2 hsa04330 Notch signaling pathway 1840_3066_3065_9794_22938_1487_1488_9612_2648_388585_1387_2033_8850_4851 14 1.65E-11 1.30E-09 9.30E-11 21759 hsa-mir-548f-2 hsa05216 Thyroid cancer 1499_595_6934_5468_5595_5594_6256_7157_7849_51176_5604_4609 12 2.05E-11 1.62E-09 1.08E-10 21760 hsa-mir-548f-2 hsa04720 Long-term potentiation 815_6197_5578_2902_5595_5594_1387_468_6195_6196_2033_808_801_805_5604_5566 16 4.42E-11 3.49E-09 2.18E-10 21761 hsa-mir-548f-2 hsa05213 Endometrial cancer 1499_595_6934_1956_2309_207_5595_5594_2932_7157_51176_5604_4609_2002 14 5.16E-11 4.08E-09 2.40E-10 21762 hsa-mir-548f-2 hsa05222 Small cell lung cancer 595_1019_1017_6502_5925_1870_1871_10401_207_6256_5970_7157_1869_4846_4790_4609 16 2.62E-10 2.07E-08 1.15E-09 21763 hsa-mir-548f-2 hsa04012 ErbB signaling pathway 815_5578_25_1956_207_5595_5594_5599_2932_6776_6777_3725_5604_4609_6464_2002 16 3.04E-10 2.40E-08 1.26E-09 21764 hsa-mir-548f-2 hsa04916 Melanogenesis 815_1499_6934_5578_5595_5594_1385_1387_4286_2932_2033_808_801_805_51176_5604_5566 17 4.29E-10 3.39E-08 1.69E-09 21765 hsa-mir-548f-2 hsa05218 Melanoma 595_1019_4193_5925_1956_1870_1871_207_5595_5594_4286_7157_1869_5604 14 1.78E-09 1.40E-07 6.69E-09 21766 hsa-mir-548f-2 hsa04912 GnRH signaling pathway 815_5578_5580_1956_1432_5595_5594_5599_468_3725_808_801_805_5604_5566_2002 16 4.97E-09 3.92E-07 1.78E-08 21767 hsa-mir-548f-2 hsa05211 Renal cell carcinoma 3091_405_2113_207_5595_5594_1387_3725_2034_2033_9915_5604_7428 13 1.71E-08 1.35E-06 5.89E-08 21768 hsa-mir-548f-2 hsa04620 Toll-like receptor signaling pathway 3665_3661_1432_207_5595_5594_5599_6772_5970_3725_4790_5604_841_6348 14 1.06E-07 8.40E-06 3.50E-07 21769 hsa-mir-548f-2 hsa04520 Adherens junction 1499_6934_1956_5595_5594_1387_1457_4088_4089_2033_51176_4087 12 3.67E-07 2.90E-05 1.16E-06 21770 hsa-mir-548f-2 hsa04910 Insulin signaling pathway 6720_10891_2308_207_5595_5594_5599_2932_808_801_805_5604_5566_6464_2002 15 5.88E-07 4.64E-05 1.79E-06 21771 hsa-mir-548f-2 hsa05322 Systemic lupus erythematosus 3021_3020_8365_8368_8294_8370_121504_8361_8360_8363_8362_8364_8367_8366_8359 15 9.62E-07 7.60E-05 2.81E-06 21772 hsa-mir-548f-2 hsa04370 VEGF signaling pathway 7867_5578_4772_4773_1432_207_5595_5594_4846_9261_5604 11 1.73E-06 0.000136585 4.88E-06 21773 hsa-mir-548f-2 hsa04660 T cell receptor signaling pathway 1019_4772_4773_1432_207_5595_5594_2932_5970_3725_4790_5604 12 7.56E-06 0.000597143 2.06E-05 21774 hsa-mir-548f-2 hsa04662 B cell receptor signaling pathway 4772_4773_207_5595_5594_2932_5970_3725_4790_5604 10 8.86E-06 0.000700265 2.33E-05 21775 hsa-mir-548f-2 hsa05016 Huntington's disease 10891_3066_3065_3064_5468_2902_6667_836_1385_1387_7157_2033_6874_841_6908 15 1.93E-05 0.001523775 4.92E-05 21776 hsa-mir-548f-2 hsa03410 Base excision repair 3146_4350_328_2237_5111_252969_6996 7 2.36E-05 0.001860948 5.82E-05 21777 hsa-mir-548f-2 hsa04062 Chemokine signaling pathway 5580_2309_207_5595_5594_2932_6774_6777_6772_5970_4790_5604_5566_6348_6464 15 2.57E-05 0.002026863 6.14E-05 21778 hsa-mir-548f-2 hsa04115 p53 signaling pathway 595_1019_1017_4194_4193_836_7157_841_7161 9 2.91E-05 0.002300455 6.77E-05 21779 hsa-mir-548f-2 hsa04270 Vascular smooth muscle contraction 5578_5580_5592_5595_5594_808_801_805_59_5604_5566 11 6.80E-05 0.005371533 0.000153472 21780 hsa-mir-548f-2 hsa04920 Adipocytokine signaling pathway 10891_5465_207_5599_6256_6774_5970_4790 8 0.000141337 0.011165631 0.000310156 21781 hsa-mir-548f-2 hsa04150 mTOR signaling pathway 6197_3091_207_5595_5594_6195_6196 7 0.000188424 0.014885493 0.000402311 21782 hsa-mir-548f-2 hsa04950 Maturity onset diabetes of the young 6927_3651_168620_4760_5080 5 0.000269787 0.021313164 0.000560873 21783 hsa-mir-548f-2 hsa04664 Fc epsilon RI signaling pathway 5578_5580_1432_207_5595_5594_5599_5604 8 0.000395882 0.031274713 0.000801916 21784 hsa-mir-548f-2 hsa03450 Non-homologous end-joining 10111_2237_5591_4361 4 0.000411235 0.032487547 0.000812189 21785 hsa-mir-548f-2 hsa04510 Focal adhesion 1499_595_5578_1956_207_5595_5594_5599_2932_3725_5604_6464_2002 13 0.000584868 0.046204558 0.00112694 21786 hsa-mir-548f-2 hsa04630 Jak-STAT signaling pathway 595_10401_207_1387_6778_6774_6776_6777_6772_2033_4609 11 0.000615135 0.048595681 0.00115704 21787 hsa-mir-548f-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_1432_836_5599_5970_3725_4790 7 0.00104795 0.082788039 0.001925303 21788 hsa-mir-548f-2 hsa05217 Basal cell carcinoma 1499_6934_2932_7157_51176_2736 6 0.001476664 0.116656433 0.002651283 21789 hsa-mir-548f-2 hsa03022 Basal transcription factors 2963_6874_2959_6880_6908 5 0.00155567 0.122897908 0.002731065 21790 hsa-mir-548f-2 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_1432_836_834_7157_4846 6 0.00160726 0.12697357 0.002760295 21791 hsa-mir-548f-2 hsa05010 Alzheimer's disease 2902_836_22926_5595_5594_2932_4846_808_801_805_841 11 0.00169256 0.133712217 0.002844941 21792 hsa-mir-548f-2 hsa04120 Ubiquitin mediated proteolysis 4193_6502_10401_7329_8925_997_5371_672_7428 9 0.003358025 0.265284009 0.00546979 21793 hsa-mir-548f-2 hsa04930 Type II diabetes mellitus 5580_3651_5595_5594_5599 5 0.003393033 0.268049631 0.00546979 21794 hsa-mir-548f-2 hsa04210 Apoptosis 207_836_5970_7157_4790_5566_841 7 0.003461892 0.273489493 0.00546979 21795 hsa-mir-548f-2 hsa04710 Circadian rhythm - mammal 8863_4862_79365 3 0.00383419 0.302901045 0.005939236 21796 hsa-mir-548f-2 hsa04540 Gap junction 5578_1956_5592_5595_5594_5604_5566 7 0.004339397 0.342812396 0.006592546 21797 hsa-mir-548f-2 hsa04730 Long-term depression 5578_5592_5595_5594_4846_5604 6 0.004805164 0.379607921 0.007162414 21798 hsa-mir-548f-2 hsa04650 Natural killer cell mediated cytotoxicity 5578_4772_4773_836_5595_5594_5604_6464 8 0.010153009 0.802087742 0.014853477 21799 hsa-mir-548f-2 hsa04020 Calcium signaling pathway 815_5578_1956_2902_4846_808_801_805_5566 9 0.017610584 1 0.025295202 21800 hsa-mir-548f-2 hsa03440 Homologous recombination 10111_4683_4361 3 0.024590361 1 0.034689974 21801 hsa-mir-548f-2 hsa04612 Antigen processing and presentation 1385_3312_3320_4800_4801 5 0.042827133 1 0.059356904 21802 hsa-mir-548f-4 hsa05200 Pathways in cancer 2033_2249_367_3725_6776_6777_2353_5914_5970_6256 10 9.08E-11 3.90E-09 3.90E-09 21803 hsa-mir-548f-4 hsa05221 Acute myeloid leukemia 6776_6777_5914_5970 4 2.68E-06 0.000115251 5.76E-05 21804 hsa-mir-548f-4 hsa04630 Jak-STAT signaling pathway 2033_3977_6776_6777 4 0.000103629 0.004456067 0.001485356 21805 hsa-mir-548f-4 hsa05220 Chronic myeloid leukemia 6776_6777_5970 3 0.000235738 0.010136732 0.002027346 21806 hsa-mir-548f-4 hsa04662 B cell receptor signaling pathway 3725_2353_5970 3 0.000235738 0.010136732 0.002027346 21807 hsa-mir-548f-4 hsa04012 ErbB signaling pathway 3725_6776_6777 3 0.000359393 0.015453882 0.002060511 21808 hsa-mir-548f-4 hsa05215 Prostate cancer 2033_367_5970 3 0.000371247 0.015963633 0.002060511 21809 hsa-mir-548f-4 hsa05212 Pancreatic cancer 2033_367_5970 3 0.000383351 0.016484091 0.002060511 21810 hsa-mir-548f-4 hsa04620 Toll-like receptor signaling pathway 3725_2353_5970 3 0.000564349 0.024266992 0.002696332 21811 hsa-mir-548f-4 hsa04660 T cell receptor signaling pathway 3725_2353_5970 3 0.000698866 0.030051226 0.003005123 21812 hsa-mir-548f-4 hsa04010 MAPK signaling pathway 2249_3725_2353_5970 4 0.000850712 0.036580627 0.003325512 21813 hsa-mir-548f-4 hsa04330 Notch signaling pathway 9612_2033 2 0.002575876 0.110762655 0.009230221 21814 hsa-mir-548f-4 hsa05016 Huntington's disease 6908_6667_2033 3 0.003139741 0.135008858 0.010385297 21815 hsa-mir-548f-4 hsa04920 Adipocytokine signaling pathway 5970_6256 2 0.00503974 0.216708822 0.015479202 21816 hsa-mir-548f-4 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5970 2 0.005623673 0.24181792 0.015518383 21817 hsa-mir-548f-4 hsa05211 Renal cell carcinoma 2033_3725 2 0.005774282 0.248294125 0.015518383 21818 hsa-mir-548f-4 hsa05210 Colorectal cancer 3725_2353 2 0.007723408 0.332106541 0.018673131 21819 hsa-mir-548f-4 hsa05222 Small cell lung cancer 5970_6256 2 0.00807332 0.347152744 0.018673131 21820 hsa-mir-548f-4 hsa04350 TGF-beta signaling pathway 6667_2033 2 0.008250918 0.35478948 0.018673131 21821 hsa-mir-548f-4 hsa03450 Non-homologous end-joining 2547 1 0.02272554 0.977198205 0.047735616 21822 hsa-mir-548f-4 hsa04310 Wnt signaling pathway 2033_3725 2 0.023312743 1 0.047735616 21823 hsa-mir-548f-4 hsa04062 Chemokine signaling pathway 6777_5970 2 0.03598526 1 0.070285177 21824 hsa-mir-548f-4 hsa04950 Maturity onset diabetes of the young 6927 1 0.037594397 1 0.070285177 21825 hsa-mir-548f-4 hsa05216 Thyroid cancer 6256 1 0.044945606 1 0.080527544 21826 hsa-mir-548f-5 hsa05200 Pathways in cancer 4087_4088_4089_2308_7157_2033_2249_367_3725_5594_5970_6776_6777_2353_5914_1387_6256 17 1.32E-16 8.19E-15 8.19E-15 21827 hsa-mir-548f-5 hsa05220 Chronic myeloid leukemia 4088_4089_7157_5594_5970_6776_6777 7 3.58E-09 2.22E-07 1.11E-07 21828 hsa-mir-548f-5 hsa05210 Colorectal cancer 4087_4088_4089_7157_3725_5594_2353 7 7.46E-09 4.63E-07 1.12E-07 21829 hsa-mir-548f-5 hsa04350 TGF-beta signaling pathway 4087_4088_4089_6667_2033_5594_1387 7 9.37E-09 5.81E-07 1.12E-07 21830 hsa-mir-548f-5 hsa05215 Prostate cancer 2308_7157_2033_367_5594_5970_1387 7 1.01E-08 6.26E-07 1.12E-07 21831 hsa-mir-548f-5 hsa05212 Pancreatic cancer 2308_7157_2033_367_5594_5970_1387 7 1.09E-08 6.74E-07 1.12E-07 21832 hsa-mir-548f-5 hsa04520 Adherens junction 4087_4088_4089_2033_5594_1387 6 1.67E-07 1.03E-05 1.48E-06 21833 hsa-mir-548f-5 hsa04310 Wnt signaling pathway 4087_4088_4089_7157_2033_3725_1387 7 3.52E-07 2.18E-05 2.73E-06 21834 hsa-mir-548f-5 hsa05221 Acute myeloid leukemia 5594_5970_6776_6777_5914 5 1.07E-06 6.63E-05 7.36E-06 21835 hsa-mir-548f-5 hsa04110 Cell cycle 4087_4088_4089_7157_2033_1387 6 1.52E-06 9.45E-05 9.45E-06 21836 hsa-mir-548f-5 hsa04620 Toll-like receptor signaling pathway 3725_5594_5970_1432_2353 5 1.35E-05 0.000840083 7.64E-05 21837 hsa-mir-548f-5 hsa04010 MAPK signaling pathway 7157_2249_3725_5594_5970_1432_2353 7 1.49E-05 0.000924384 7.70E-05 21838 hsa-mir-548f-5 hsa05016 Huntington's disease 6667_7157_10891_2033_6908_1387 6 1.91E-05 0.00118188 8.51E-05 21839 hsa-mir-548f-5 hsa04660 T cell receptor signaling pathway 3725_5594_5970_1432_2353 5 1.92E-05 0.00119156 8.51E-05 21840 hsa-mir-548f-5 hsa04920 Adipocytokine signaling pathway 10891_5563_5970_6256 4 4.99E-05 0.003094237 0.000206282 21841 hsa-mir-548f-5 hsa05211 Renal cell carcinoma 2033_3725_5594_1387 4 6.52E-05 0.004042095 0.000252631 21842 hsa-mir-548f-5 hsa04662 B cell receptor signaling pathway 3725_5594_5970_2353 4 7.59E-05 0.004703342 0.000276667 21843 hsa-mir-548f-5 hsa04630 Jak-STAT signaling pathway 2033_3977_6776_6777_1387 5 9.30E-05 0.005766929 0.000320385 21844 hsa-mir-548f-5 hsa05216 Thyroid cancer 7157_5594_6256 3 0.000101746 0.006308239 0.000332013 21845 hsa-mir-548f-5 hsa04012 ErbB signaling pathway 3725_5594_6776_6777 4 0.000131512 0.008153738 0.000407687 21846 hsa-mir-548f-5 hsa04330 Notch signaling pathway 9612_2033_1387 3 0.000387578 0.024029865 0.001144279 21847 hsa-mir-548f-5 hsa05223 Non-small cell lung cancer 7157_5594_6256 3 0.000570415 0.035365755 0.001607534 21848 hsa-mir-548f-5 hsa04910 Insulin signaling pathway 2308_10891_5563_5594 4 0.000716216 0.044405385 0.001930669 21849 hsa-mir-548f-5 hsa05218 Melanoma 7157_2249_5594 3 0.001220812 0.07569035 0.003027614 21850 hsa-mir-548f-5 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5970_1432 3 0.001220812 0.07569035 0.003027614 21851 hsa-mir-548f-5 hsa04720 Long-term potentiation 2033_5594_1387 3 0.001421133 0.088110228 0.003388855 21852 hsa-mir-548f-5 hsa05222 Small cell lung cancer 7157_5970_6256 3 0.002074625 0.128626741 0.004763953 21853 hsa-mir-548f-5 hsa04916 Melanogenesis 2033_5594_1387 3 0.003496234 0.216766532 0.007741662 21854 hsa-mir-548f-5 hsa04912 GnRH signaling pathway 3725_5594_1432 3 0.003875712 0.240294131 0.008286005 21855 hsa-mir-548f-5 hsa03410 Base excision repair 3146_142 2 0.005191443 0.321869457 0.010728982 21856 hsa-mir-548f-5 hsa03022 Basal transcription factors 6908_2959 2 0.005462071 0.338648431 0.010924143 21857 hsa-mir-548f-5 hsa05219 Bladder cancer 7157_5594 2 0.006909791 0.428407036 0.01338772 21858 hsa-mir-548f-5 hsa05213 Endometrial cancer 7157_5594 2 0.010263494 0.636336601 0.018715782 21859 hsa-mir-548f-5 hsa04150 mTOR signaling pathway 5563_5594 2 0.010263494 0.636336601 0.018715782 21860 hsa-mir-548f-5 hsa05014 Amyotrophic lateral sclerosis (ALS) 7157_1432 2 0.011769713 0.729722222 0.020849206 21861 hsa-mir-548f-5 hsa05214 Glioma 7157_5594 2 0.015487308 0.960213103 0.026672586 21862 hsa-mir-548f-5 hsa04062 Chemokine signaling pathway 5594_5970_6777 3 0.018200018 1 0.030497327 21863 hsa-mir-548f-5 hsa04370 VEGF signaling pathway 5594_1432 2 0.021116692 1 0.03445355 21864 hsa-mir-548f-5 hsa04664 Fc epsilon RI signaling pathway 5594_1432 2 0.022126162 1 0.035174924 21865 hsa-mir-548f-5 hsa04210 Apoptosis 7157_5970 2 0.027463742 1 0.0425688 21866 hsa-mir-548f-5 hsa03450 Non-homologous end-joining 2547 1 0.041561419 1 0.062848975 21867 hsa-mir-548h-3 hsa05200 Pathways in cancer 5371_2249_367_1499_5595_5594_5914_1387_6256_595_836_7704_6774_6776_6777_3091_5970_7428_1870_1871_7157_4087_4089_2113_4609_1869_3725_5881_2353_4088_3066_3065_1050_5925_2034_2033_4846_8554_9915 39 2.57E-34 1.82E-32 1.82E-32 21868 hsa-mir-548h-3 hsa05220 Chronic myeloid leukemia 5595_5594_595_6776_6777_5970_1870_1871_7157_4089_4609_1869_4088_3066_3065_5925_6464 17 9.55E-20 6.78E-18 3.39E-18 21869 hsa-mir-548h-3 hsa04110 Cell cycle 993_5591_1387_595_983_7534_1870_1871_7157_4087_4089_1869_4088_3066_3065_5925_2033_10971_5933 19 2.16E-19 1.53E-17 5.11E-18 21870 hsa-mir-548h-3 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_6774_6776_6777_5970_4609_1050 12 8.29E-14 5.89E-12 1.47E-12 21871 hsa-mir-548h-3 hsa05210 Colorectal cancer 1499_5595_5594_595_836_7157_4087_4089_4609_3725_5881_2353_4088 13 1.70E-13 1.21E-11 2.41E-12 21872 hsa-mir-548h-3 hsa05215 Prostate cancer 367_1499_5595_5594_1387_595_5970_1870_1871_7157_1869_5925_2033 13 2.90E-13 2.06E-11 3.35E-12 21873 hsa-mir-548h-3 hsa05212 Pancreatic cancer 367_1499_5595_5594_1387_595_5970_1870_1871_7157_1869_5925_2033 13 3.31E-13 2.35E-11 3.35E-12 21874 hsa-mir-548h-3 hsa04310 Wnt signaling pathway 1499_1387_595_7157_4087_4089_8061_4609_3725_5881_1457_1452_4088_2033 14 1.24E-11 8.80E-10 1.10E-10 21875 hsa-mir-548h-3 hsa04520 Adherens junction 1499_5595_5594_1387_6714_4087_4089_5881_1457_4088_2033 11 4.10E-11 2.91E-09 3.23E-10 21876 hsa-mir-548h-3 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5925 9 7.54E-11 5.35E-09 5.35E-10 21877 hsa-mir-548h-3 hsa05222 Small cell lung cancer 6256_595_5970_1870_1871_7157_4609_1869_5925_4846_8554 11 8.31E-11 5.90E-09 5.36E-10 21878 hsa-mir-548h-3 hsa04350 TGF-beta signaling pathway 6667_5595_5594_1387_4087_4089_4609_4088_2033_4093_5933 11 9.30E-11 6.60E-09 5.50E-10 21879 hsa-mir-548h-3 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2113_3725_2034_2033_9915 10 2.94E-10 2.09E-08 1.61E-09 21880 hsa-mir-548h-3 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925 9 5.46E-10 3.88E-08 2.77E-09 21881 hsa-mir-548h-3 hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_6464 9 2.39E-09 1.69E-07 1.13E-08 21882 hsa-mir-548h-3 hsa05218 Melanoma 2249_5595_5594_595_1870_1871_7157_1869_5925 9 4.83E-09 3.43E-07 2.08E-08 21883 hsa-mir-548h-3 hsa05216 Thyroid cancer 1499_5595_5594_6256_595_7157_4609 7 4.99E-09 3.54E-07 2.08E-08 21884 hsa-mir-548h-3 hsa04010 MAPK signaling pathway 2249_5595_5594_4208_836_1432_5970_3312_7157_4609_3725_5881_2353_4763 14 1.61E-08 1.14E-06 6.36E-08 21885 hsa-mir-548h-3 hsa05016 Huntington's disease 6667_6874_1387_2902_6908_836_7157_3066_3065_3064_2033 11 1.65E-07 1.17E-05 6.17E-07 21886 hsa-mir-548h-3 hsa04012 ErbB signaling pathway 5595_5594_6776_6777_6714_4609_3725_6464 8 3.45E-07 2.45E-05 1.23E-06 21887 hsa-mir-548h-3 hsa04330 Notch signaling pathway 1387_8850_9612_3066_3065_2033 6 1.84E-06 0.000130395 6.21E-06 21888 hsa-mir-548h-3 hsa04630 Jak-STAT signaling pathway 1387_595_6774_6776_6777_4609_2033_3977_8554 9 2.38E-06 0.000169187 7.69E-06 21889 hsa-mir-548h-3 hsa05213 Endometrial cancer 1499_5595_5594_595_7157_4609 6 3.15E-06 0.000223347 9.71E-06 21890 hsa-mir-548h-3 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725_5881_2353 6 2.21E-05 0.00156826 6.53E-05 21891 hsa-mir-548h-3 hsa04370 VEGF signaling pathway 5595_5594_1432_6714_5881_4846 6 2.54E-05 0.001803018 7.21E-05 21892 hsa-mir-548h-3 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_1432_7157_4846 5 6.71E-05 0.004763786 0.000183223 21893 hsa-mir-548h-3 hsa04620 Toll-like receptor signaling pathway 5595_5594_1432_5970_3725_2353 6 0.000111493 0.007915975 0.000293184 21894 hsa-mir-548h-3 hsa04510 Focal adhesion 1499_5595_5594_595_6714_3725_5881_6464 8 0.000134263 0.00953265 0.000340452 21895 hsa-mir-548h-3 hsa04660 T cell receptor signaling pathway 5595_5594_1432_5970_3725_2353 6 0.000165118 0.011723394 0.000404255 21896 hsa-mir-548h-3 hsa03022 Basal transcription factors 2963_2969_6874_6908 4 0.000187836 0.013336335 0.000438628 21897 hsa-mir-548h-3 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_1432_5970_6714_3725 5 0.000191514 0.013597468 0.000438628 21898 hsa-mir-548h-3 hsa04720 Long-term potentiation 5595_5594_1387_2902_2033 5 0.00024367 0.017300579 0.000540643 21899 hsa-mir-548h-3 hsa04950 Maturity onset diabetes of the young 6928_6927_3172 3 0.000856321 0.060798812 0.001842388 21900 hsa-mir-548h-3 hsa04916 Melanogenesis 1499_5595_5594_1387_2033 5 0.001006693 0.071475208 0.002102212 21901 hsa-mir-548h-3 hsa04912 GnRH signaling pathway 5595_5594_1432_6714_3725 5 0.001182783 0.083977592 0.00239936 21902 hsa-mir-548h-3 hsa04115 p53 signaling pathway 595_983_836_7157 4 0.001697871 0.120548806 0.003348578 21903 hsa-mir-548h-3 hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432_5881 4 0.002716263 0.192854645 0.005172378 21904 hsa-mir-548h-3 hsa04062 Chemokine signaling pathway 5595_5594_6774_6777_5970_6464 6 0.002768315 0.196550361 0.005172378 21905 hsa-mir-548h-3 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_5881_6464 5 0.003310496 0.235045215 0.0060268 21906 hsa-mir-548h-3 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428_7329_8554 5 0.003410581 0.242151223 0.006053781 21907 hsa-mir-548h-3 hsa04612 Antigen processing and presentation 4800_4801_1514_3312 4 0.004090017 0.290391192 0.007082712 21908 hsa-mir-548h-3 hsa04540 Gap junction 5595_5594_983_6714 4 0.004750576 0.337290894 0.008030736 21909 hsa-mir-548h-3 hsa03450 Non-homologous end-joining 5591_2547 2 0.005412355 0.384277231 0.00893668 21910 hsa-mir-548h-3 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.00666042 0.472889808 0.010747496 21911 hsa-mir-548h-3 hsa05131 Shigellosis 1499_7534_10971 3 0.008087812 0.574234649 0.012483362 21912 hsa-mir-548h-3 hsa05130 Pathogenic Escherichia coli infection 1499_7534_10971 3 0.008087812 0.574234649 0.012483362 21913 hsa-mir-548h-3 hsa05010 Alzheimer's disease 5595_5594_2902_836_4846 5 0.009045327 0.642218245 0.013664218 21914 hsa-mir-548h-3 hsa04920 Adipocytokine signaling pathway 6256_6774_5970 3 0.012882932 0.914688198 0.019056004 21915 hsa-mir-548h-3 hsa04730 Long-term depression 5595_5594_4846 3 0.014951992 1 0.021665131 21916 hsa-mir-548h-3 hsa04910 Insulin signaling pathway 6720_5595_5594_6464 4 0.017509862 1 0.024864004 21917 hsa-mir-548h-3 hsa04210 Apoptosis 836_5970_7157 3 0.026465456 1 0.036844066 21918 hsa-mir-548h-3 hsa03410 Base excision repair 3146_142 2 0.028694857 1 0.039179517 21919 hsa-mir-548h-3 hsa04930 Type II diabetes mellitus 5595_5594 2 0.042373747 1 0.056764831 21920 hsa-mir-548h-4 hsa05200 Pathways in cancer 4088_4089_5601_2033_367_3725_4790_5970_5595_5594_5599_6772_2353 13 1.82E-15 9.08E-14 9.08E-14 21921 hsa-mir-548h-4 hsa04620 Toll-like receptor signaling pathway 5601_3725_4790_5970_5595_5594_5599_6772_2353 9 5.86E-14 2.93E-12 1.47E-12 21922 hsa-mir-548h-4 hsa05210 Colorectal cancer 4088_4089_5601_3725_5595_5594_5599_2353 8 9.17E-13 4.58E-11 1.53E-11 21923 hsa-mir-548h-4 hsa04010 MAPK signaling pathway 5601_3725_4790_5970_5595_5594_5599_1649_2353_1386 10 8.78E-12 4.39E-10 1.10E-10 21924 hsa-mir-548h-4 hsa04660 T cell receptor signaling pathway 5601_3725_4790_5970_5595_5594_2353 7 3.85E-10 1.93E-08 3.85E-09 21925 hsa-mir-548h-4 hsa05220 Chronic myeloid leukemia 4088_4089_4790_5970_5595_5594 6 2.07E-09 1.03E-07 1.48E-08 21926 hsa-mir-548h-4 hsa04662 B cell receptor signaling pathway 3725_4790_5970_5595_5594_2353 6 2.07E-09 1.03E-07 1.48E-08 21927 hsa-mir-548h-4 hsa04310 Wnt signaling pathway 4088_4089_5601_2033_8061_3725_5599 7 3.31E-09 1.65E-07 2.07E-08 21928 hsa-mir-548h-4 hsa05215 Prostate cancer 2033_367_4790_5970_5595_5594 6 5.12E-09 2.56E-07 2.73E-08 21929 hsa-mir-548h-4 hsa05212 Pancreatic cancer 2033_367_4790_5970_5595_5594 6 5.46E-09 2.73E-07 2.73E-08 21930 hsa-mir-548h-4 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5601_3725_4790_5970_5599 5 9.11E-08 4.56E-06 4.14E-07 21931 hsa-mir-548h-4 hsa04520 Adherens junction 4088_4089_2033_5595_5594 5 1.60E-07 8.01E-06 6.67E-07 21932 hsa-mir-548h-4 hsa04350 TGF-beta signaling pathway 4088_4089_2033_5595_5594 5 2.38E-07 1.19E-05 8.51E-07 21933 hsa-mir-548h-4 hsa04012 ErbB signaling pathway 5601_3725_5595_5594_5599 5 2.38E-07 1.19E-05 8.51E-07 21934 hsa-mir-548h-4 hsa04912 GnRH signaling pathway 5601_3725_5595_5594_5599 5 6.65E-07 3.33E-05 2.22E-06 21935 hsa-mir-548h-4 hsa04930 Type II diabetes mellitus 5601_5595_5594_5599 4 8.08E-07 4.04E-05 2.52E-06 21936 hsa-mir-548h-4 hsa05221 Acute myeloid leukemia 4790_5970_5595_5594 4 2.24E-06 0.000111863 6.58E-06 21937 hsa-mir-548h-4 hsa04920 Adipocytokine signaling pathway 5601_4790_5970_5599 4 3.62E-06 0.000180921 1.01E-05 21938 hsa-mir-548h-4 hsa05211 Renal cell carcinoma 2033_3725_5595_5594 4 4.75E-06 0.000237625 1.25E-05 21939 hsa-mir-548h-4 hsa04664 Fc epsilon RI signaling pathway 5601_5595_5594_5599 4 6.76E-06 0.000337826 1.69E-05 21940 hsa-mir-548h-4 hsa04062 Chemokine signaling pathway 4790_5970_5595_5594_6772 5 1.04E-05 0.000520804 2.48E-05 21941 hsa-mir-548h-4 hsa04510 Focal adhesion 5601_3725_5595_5594_5599 5 1.42E-05 0.000707986 3.22E-05 21942 hsa-mir-548h-4 hsa04910 Insulin signaling pathway 5601_5595_5594_5599 4 5.61E-05 0.002802968 0.000121868 21943 hsa-mir-548h-4 hsa04720 Long-term potentiation 2033_5595_5594 3 0.000206482 0.010324107 0.000430171 21944 hsa-mir-548h-4 hsa04916 Melanogenesis 2033_5595_5594 3 0.000523014 0.026150692 0.001046028 21945 hsa-mir-548h-4 hsa04110 Cell cycle 4088_4089_2033 3 0.000766163 0.03830813 0.00147339 21946 hsa-mir-548h-4 hsa05216 Thyroid cancer 5595_5594 2 0.000948733 0.047436673 0.001756914 21947 hsa-mir-548h-4 hsa05219 Bladder cancer 5595_5594 2 0.001906931 0.095346528 0.003405233 21948 hsa-mir-548h-4 hsa04330 Notch signaling pathway 2033_8850 2 0.002359579 0.117978939 0.004068239 21949 hsa-mir-548h-4 hsa05213 Endometrial cancer 5595_5594 2 0.002857927 0.142896359 0.00460956 21950 hsa-mir-548h-4 hsa04150 mTOR signaling pathway 5595_5594 2 0.002857927 0.142896359 0.00460956 21951 hsa-mir-548h-4 hsa05223 Non-small cell lung cancer 5595_5594 2 0.003069914 0.153495716 0.004796741 21952 hsa-mir-548h-4 hsa05214 Glioma 5595_5594 2 0.004362787 0.218139365 0.006610284 21953 hsa-mir-548h-4 hsa05218 Melanoma 5595_5594 2 0.005156869 0.257843453 0.007366956 21954 hsa-mir-548h-4 hsa04730 Long-term depression 5595_5594 2 0.005156869 0.257843453 0.007366956 21955 hsa-mir-548h-4 hsa04370 VEGF signaling pathway 5595_5594 2 0.006012281 0.300614042 0.00835039 21956 hsa-mir-548h-4 hsa05222 Small cell lung cancer 4790_5970 2 0.007408023 0.370401127 0.010010841 21957 hsa-mir-548h-4 hsa04210 Apoptosis 4790_5970 2 0.007902768 0.395138397 0.010398379 21958 hsa-mir-548h-4 hsa04540 Gap junction 5595_5594 2 0.008585006 0.429250298 0.011006418 21959 hsa-mir-548h-4 hsa04270 Vascular smooth muscle contraction 5595_5594 2 0.013415061 0.670753039 0.016768826 21960 hsa-mir-548h-4 hsa04360 Axon guidance 5595_5594 2 0.016296214 0.814810705 0.019873432 21961 hsa-mir-548h-4 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594 2 0.01794754 0.897377019 0.021150035 21962 hsa-mir-548h-4 hsa04120 Ubiquitin mediated proteolysis 64326_672 2 0.01818903 0.90945151 0.021150035 21963 hsa-mir-548h-4 hsa04630 Jak-STAT signaling pathway 2033_6772 2 0.022238047 1 0.025270508 21964 hsa-mir-548h-4 hsa05010 Alzheimer's disease 5595_5594 2 0.028351471 1 0.031501634 21965 hsa-mir-548h-4 hsa05016 Huntington's disease 6908_2033 2 0.031632988 1 0.034383683 21966 hsa-mir-548h-4 hsa04810 Regulation of actin cytoskeleton 5595_5594 2 0.041632108 1 0.044289476 21967 hsa-mir-548i-4 hsa05200 Pathways in cancer 2249_367_3725_6776_6777_2353_5914_5970_6256 9 2.03E-10 7.70E-09 7.70E-09 21968 hsa-mir-548i-4 hsa05221 Acute myeloid leukemia 6776_6777_5914_5970 4 9.84E-07 3.74E-05 1.87E-05 21969 hsa-mir-548i-4 hsa05220 Chronic myeloid leukemia 6776_6777_5970 3 0.000113081 0.004297074 0.001074269 21970 hsa-mir-548i-4 hsa04662 B cell receptor signaling pathway 3725_2353_5970 3 0.000113081 0.004297074 0.001074269 21971 hsa-mir-548i-4 hsa04012 ErbB signaling pathway 3725_6776_6777 3 0.00017291 0.006570564 0.001314113 21972 hsa-mir-548i-4 hsa04620 Toll-like receptor signaling pathway 3725_2353_5970 3 0.000272526 0.010355982 0.001606221 21973 hsa-mir-548i-4 hsa04010 MAPK signaling pathway 2249_3725_2353_5970 4 0.000330487 0.012558499 0.001606221 21974 hsa-mir-548i-4 hsa04660 T cell receptor signaling pathway 3725_2353_5970 3 0.000338152 0.012849769 0.001606221 21975 hsa-mir-548i-4 hsa04630 Jak-STAT signaling pathway 3977_6776_6777 3 0.000897685 0.03411204 0.003790227 21976 hsa-mir-548i-4 hsa04920 Adipocytokine signaling pathway 5970_6256 2 0.003115381 0.11838449 0.011838449 21977 hsa-mir-548i-4 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5970 2 0.003479392 0.132216888 0.012019717 21978 hsa-mir-548i-4 hsa05210 Colorectal cancer 3725_2353 2 0.004792101 0.18209983 0.0135505 21979 hsa-mir-548i-4 hsa05222 Small cell lung cancer 5970_6256 2 0.005011395 0.190433006 0.0135505 21980 hsa-mir-548i-4 hsa05215 Prostate cancer 367_5970 2 0.00523525 0.198939509 0.0135505 21981 hsa-mir-548i-4 hsa05212 Pancreatic cancer 367_5970 2 0.005348882 0.203257498 0.0135505 21982 hsa-mir-548i-4 hsa03450 Non-homologous end-joining 2547 1 0.01783249 0.677634628 0.042352164 21983 hsa-mir-548i-4 hsa05016 Huntington's disease 6908_6667 2 0.021779742 0.827630199 0.048257818 21984 hsa-mir-548i-4 hsa04062 Chemokine signaling pathway 6777_5970 2 0.022858967 0.868640727 0.048257818 21985 hsa-mir-548i-4 hsa04950 Maturity onset diabetes of the young 6927 1 0.02954865 1 0.0590973 21986 hsa-mir-548i-4 hsa05216 Thyroid cancer 6256 1 0.035355663 1 0.067175759 21987 hsa-mir-548i-4 hsa04080 Neuroactive ligand-receptor interaction 2908_7067 2 0.038234048 1 0.06918542 21988 hsa-mir-548i-4 hsa03410 Base excision repair 142 1 0.043428758 1 0.073648431 21989 hsa-mir-548i-4 hsa03022 Basal transcription factors 6908 1 0.044576682 1 0.073648431 21990 hsa-mir-548k hsa05200 Pathways in cancer 3320_4149_5371_5595_5599_1387_5604_2932_6502_5970_5894_1029_2736_4087_4088_4292_1050_5925_2033_207 20 1.53E-18 9.49E-17 9.49E-17 21991 hsa-mir-548k hsa04010 MAPK signaling pathway 6722_8986_4149_5595_5599_5598_9261_5604_9252_1386_1432_5970_5894_6195_6196_6197_207 17 4.14E-16 2.57E-14 1.28E-14 21992 hsa-mir-548k hsa04110 Cell cycle 990_1387_983_2932_8454_6502_6500_1029_4087_4088_5925_2033_5933 13 1.75E-15 1.08E-13 3.61E-14 21993 hsa-mir-548k hsa04540 Gap junction 5592_5595_5598_983_5604_7277_7278_10376_5894_7846_51807 11 1.27E-13 7.86E-12 1.97E-12 21994 hsa-mir-548k hsa05215 Prostate cancer 3320_5595_1387_5604_2932_5970_5894_5925_2033_207 10 2.48E-12 1.54E-10 2.84E-11 21995 hsa-mir-548k hsa05212 Pancreatic cancer 3320_5595_1387_5604_2932_5970_5894_5925_2033_207 10 2.75E-12 1.71E-10 2.84E-11 21996 hsa-mir-548k hsa05210 Colorectal cancer 5595_5599_5604_2932_5894_4087_4088_4292_207 9 5.24E-11 3.25E-09 4.64E-10 21997 hsa-mir-548k hsa04350 TGF-beta signaling pathway 5595_1387_6667_8454_6500_4087_4088_2033_5933 9 7.00E-11 4.34E-09 5.43E-10 21998 hsa-mir-548k hsa04310 Wnt signaling pathway 5599_1387_1457_2932_8454_6500_1459_4087_4088_2033 10 3.79E-10 2.35E-08 2.61E-09 21999 hsa-mir-548k hsa04720 Long-term potentiation 5595_1387_5604_5894_6195_6196_6197_2033 8 6.65E-10 4.12E-08 3.75E-09 22000 hsa-mir-548k hsa05220 Chronic myeloid leukemia 5595_5604_5970_5894_1029_4088_5925_207 8 6.65E-10 4.12E-08 3.75E-09 22001 hsa-mir-548k hsa05221 Acute myeloid leukemia 5371_5595_5604_5970_5894_1050_207 7 4.11E-09 2.55E-07 2.12E-08 22002 hsa-mir-548k hsa05219 Bladder cancer 5595_5604_9252_5894_1029_5925 6 2.01E-08 1.25E-06 9.59E-08 22003 hsa-mir-548k hsa04520 Adherens junction 5595_1387_1457_1459_4087_4088_2033 7 2.90E-08 1.80E-06 1.28E-07 22004 hsa-mir-548k hsa05213 Endometrial cancer 5595_5604_2932_5894_4292_207 6 6.44E-08 3.99E-06 2.66E-07 22005 hsa-mir-548k hsa05223 Non-small cell lung cancer 5595_5604_5894_1029_5925_207 6 7.92E-08 4.91E-06 3.07E-07 22006 hsa-mir-548k hsa05131 Shigellosis 7277_7278_10376_7846_51807_4691 6 9.67E-08 5.99E-06 3.33E-07 22007 hsa-mir-548k hsa05130 Pathogenic Escherichia coli infection 7277_7278_10376_7846_51807_4691 6 9.67E-08 5.99E-06 3.33E-07 22008 hsa-mir-548k hsa05214 Glioma 5595_5604_5894_1029_5925_207 6 2.19E-07 1.36E-05 6.98E-07 22009 hsa-mir-548k hsa04660 T cell receptor signaling pathway 5595_5604_2932_1432_5970_5894_207 7 2.25E-07 1.40E-05 6.98E-07 22010 hsa-mir-548k hsa05218 Melanoma 5595_5604_5894_1029_5925_207 6 3.57E-07 2.21E-05 1.05E-06 22011 hsa-mir-548k hsa05211 Renal cell carcinoma 5595_1387_5604_5894_2033_207 6 3.86E-07 2.39E-05 1.09E-06 22012 hsa-mir-548k hsa04662 B cell receptor signaling pathway 5595_5604_2932_5970_5894_207 6 4.83E-07 2.99E-05 1.30E-06 22013 hsa-mir-548k hsa04370 VEGF signaling pathway 5595_9261_5604_1432_5894_207 6 5.58E-07 3.46E-05 1.44E-06 22014 hsa-mir-548k hsa04664 Fc epsilon RI signaling pathway 5595_5599_5604_1432_5894_207 6 6.43E-07 3.99E-05 1.60E-06 22015 hsa-mir-548k hsa04012 ErbB signaling pathway 5595_5599_5604_2932_5894_207 6 1.10E-06 6.79E-05 2.61E-06 22016 hsa-mir-548k hsa04150 mTOR signaling pathway 5595_6195_6196_6197_207 5 1.95E-06 0.000121055 4.48E-06 22017 hsa-mir-548k hsa04620 Toll-like receptor signaling pathway 5595_5599_5604_1432_5970_207 6 2.63E-06 0.000163267 5.83E-06 22018 hsa-mir-548k hsa04916 Melanogenesis 5595_1387_5604_2932_5894_2033 6 2.93E-06 0.000181689 6.27E-06 22019 hsa-mir-548k hsa04912 GnRH signaling pathway 5595_5599_5598_5604_1432_5894 6 3.61E-06 0.000223623 7.45E-06 22020 hsa-mir-548k hsa04062 Chemokine signaling pathway 5595_5604_2932_5970_5894_7074_207 7 8.13E-06 0.000503936 1.63E-05 22021 hsa-mir-548k hsa04910 Insulin signaling pathway 5595_5599_5604_2932_5894_207 6 1.38E-05 0.000856613 2.62E-05 22022 hsa-mir-548k hsa03022 Basal transcription factors 2963_2962_2969_6908 4 1.43E-05 0.000887428 2.62E-05 22023 hsa-mir-548k hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_8454_6502_6500 6 1.44E-05 0.000891006 2.62E-05 22024 hsa-mir-548k hsa05222 Small cell lung cancer 4149_6502_5970_5925_207 5 1.97E-05 0.00122056 3.49E-05 22025 hsa-mir-548k hsa04510 Focal adhesion 5595_5599_5604_2932_5894_207 6 0.000119587 0.007414394 0.000205955 22026 hsa-mir-548k hsa04730 Long-term depression 5592_5595_5604_5894 4 0.000156433 0.009698863 0.000262131 22027 hsa-mir-548k hsa05016 Huntington's disease 1387_6908_6667_3064_2033 5 0.000671589 0.041638501 0.00109575 22028 hsa-mir-548k hsa04930 Type II diabetes mellitus 3651_5595_5599 3 0.000690298 0.042798491 0.001097397 22029 hsa-mir-548k hsa04330 Notch signaling pathway 1387_2033_2648 3 0.000778194 0.048248013 0.0012062 22030 hsa-mir-548k hsa04270 Vascular smooth muscle contraction 5592_5595_5604_5894 4 0.000993691 0.061608813 0.001502654 22031 hsa-mir-548k hsa04920 Adipocytokine signaling pathway 5599_5970_207 3 0.002063389 0.127930117 0.003045955 22032 hsa-mir-548k hsa04115 p53 signaling pathway 983_7161_1029 3 0.002236466 0.138660897 0.003224672 22033 hsa-mir-548k hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_1432_5970 3 0.002418297 0.149934397 0.0034076 22034 hsa-mir-548k hsa04612 Antigen processing and presentation 3320_4802_4801 3 0.004471655 0.277242618 0.006160947 22035 hsa-mir-548k hsa05216 Thyroid cancer 5595_5604 2 0.005538931 0.343413746 0.007465516 22036 hsa-mir-548k hsa04810 Regulation of actin cytoskeleton 5595_5604_5894_7074 4 0.00861784 0.534306058 0.011368214 22037 hsa-mir-548k hsa04530 Tight junction 1457_1459_207 3 0.0140855 0.873301009 0.018163303 22038 hsa-mir-548k hsa04650 Natural killer cell mediated cytotoxicity 5595_5604_5894 3 0.014354869 0.890001865 0.018163303 22039 hsa-mir-548k hsa05217 Basal cell carcinoma 2932_2736 2 0.017896621 1 0.02219181 22040 hsa-mir-548k hsa04340 Hedgehog signaling pathway 2932_2736 2 0.019097566 1 0.023110732 22041 hsa-mir-548k hsa04630 Jak-STAT signaling pathway 1387_2033_207 3 0.019383194 1 0.023110732 22042 hsa-mir-548k hsa04210 Apoptosis 5970_207 2 0.042459554 1 0.049669667 22043 hsa-mir-548l hsa05210 Colorectal cancer 4087_4088_4609 3 1.95E-06 3.32E-05 1.84E-05 22044 hsa-mir-548l hsa04350 TGF-beta signaling pathway 4087_4088_4609 3 2.16E-06 3.68E-05 1.84E-05 22045 hsa-mir-548l hsa04310 Wnt signaling pathway 4087_4088_4609 3 1.11E-05 0.000188646 6.29E-05 22046 hsa-mir-548l hsa05200 Pathways in cancer 4087_4088_4609 3 0.000110184 0.00187313 0.000468282 22047 hsa-mir-548l hsa05220 Chronic myeloid leukemia 4088_4609 2 0.000231234 0.003930974 0.000743029 22048 hsa-mir-548l hsa04520 Adherens junction 4087_4088 2 0.000262245 0.004458172 0.000743029 22049 hsa-mir-548l hsa04612 Antigen processing and presentation 4800_4801 2 0.000322912 0.005489511 0.000784216 22050 hsa-mir-548l hsa04110 Cell cycle 4087_4088 2 0.000569823 0.00968699 0.001210874 22051 hsa-mir-548l hsa05216 Thyroid cancer 4609 1 0.008962596 0.152364134 0.016929348 22052 hsa-mir-548l hsa05219 Bladder cancer 4609 1 0.012824162 0.218010751 0.021801075 22053 hsa-mir-548l hsa05213 Endometrial cancer 4609 1 0.01578549 0.268353325 0.024395757 22054 hsa-mir-548l hsa05221 Acute myeloid leukemia 4609 1 0.017853718 0.303513211 0.025292768 22055 hsa-mir-548l hsa05222 Small cell lung cancer 4609 1 0.025795031 0.43851552 0.031678351 22056 hsa-mir-548l hsa04012 ErbB signaling pathway 4609 1 0.026088054 0.443496917 0.031678351 22057 hsa-mir-548l hsa04630 Jak-STAT signaling pathway 4609 1 0.0458308 0.779123593 0.051941573 22058 hsa-mir-548p hsa04620 Toll-like receptor signaling pathway 3654_4615_353376_3661_148022_7189 6 1.56E-08 4.53E-07 4.53E-07 22059 hsa-mir-548p hsa04330 Notch signaling pathway 2033_2648_8850_1387 4 1.14E-06 3.30E-05 1.65E-05 22060 hsa-mir-548p hsa04350 TGF-beta signaling pathway 2033_658_7046_1387 4 1.17E-05 0.000338009 0.00011267 22061 hsa-mir-548p hsa05200 Pathways in cancer 2033_7046_7189_51588_1387 5 0.000161971 0.004697148 0.001174287 22062 hsa-mir-548p hsa04520 Adherens junction 2033_7046_1387 3 0.000283194 0.008212617 0.001642523 22063 hsa-mir-548p hsa04950 Maturity onset diabetes of the young 3651_5080 2 0.000727989 0.021111678 0.003518613 22064 hsa-mir-548p hsa04630 Jak-STAT signaling pathway 2033_51588_1387 3 0.001834826 0.053209956 0.007601422 22065 hsa-mir-548p hsa05016 Huntington's disease 2033_10476_1387 3 0.003139741 0.091052486 0.011381561 22066 hsa-mir-548p hsa05211 Renal cell carcinoma 2033_1387 2 0.005774282 0.167454178 0.017837843 22067 hsa-mir-548p hsa04720 Long-term potentiation 2033_1387 2 0.006237121 0.180876522 0.017837843 22068 hsa-mir-548p hsa05222 Small cell lung cancer 7189_51588 2 0.00807332 0.23412627 0.017837843 22069 hsa-mir-548p hsa05215 Prostate cancer 2033_1387 2 0.008430271 0.244477859 0.017837843 22070 hsa-mir-548p hsa04210 Apoptosis 3654_4615 2 0.008611373 0.249729807 0.017837843 22071 hsa-mir-548p hsa05212 Pancreatic cancer 2033_1387 2 0.008611373 0.249729807 0.017837843 22072 hsa-mir-548p hsa04916 Melanogenesis 2033_1387 2 0.01153402 0.334486585 0.022299106 22073 hsa-mir-548p hsa04110 Cell cycle 2033_1387 2 0.014830605 0.430087543 0.026880471 22074 hsa-mir-548p hsa04530 Tight junction 60412_4628 2 0.019255154 0.558399461 0.031863166 22075 hsa-mir-548p hsa04120 Ubiquitin mediated proteolysis 7189_51588 2 0.019777138 0.573536994 0.031863166 22076 hsa-mir-548p hsa04310 Wnt signaling pathway 2033_1387 2 0.023312743 0.676069542 0.035582607 22077 hsa-mir-548t hsa03022 Basal transcription factors 2967_2961_2963_2962_6881_2969_2968_6879_6878_6877_2960_2957_54457_6908_6874_6872_2958_6873_6884_2959_6880_6882_138474_6883 24 1.12E-34 7.75E-33 7.75E-33 22078 hsa-mir-548t hsa05200 Pathways in cancer 3320_25_4149_5371_1499_5595_5594_5599_1387_6256_3326_10401_5604_1488_2932_4193_2353_6774_6502_4292_5970_7157_6688_3725_5894_4609_1029_1487_4087_4088_4089_5881_1050_5925_2033_8554_7184 37 3.69E-29 2.55E-27 1.27E-27 22079 hsa-mir-548t hsa04110 Cell cycle 25_990_1387_983_2932_4193_8454_6502_6500_7157_4171_1029_4085_4087_4088_4089_5925_2033_5933 19 4.56E-18 3.15E-16 1.05E-16 22080 hsa-mir-548t hsa04310 Wnt signaling pathway 1460_1499_5599_1387_8607_1488_2932_8454_6500_7157_3725_4609_1457_1487_1459_4087_4088_4089_5881_2033 20 1.78E-17 1.23E-15 3.07E-16 22081 hsa-mir-548t hsa05210 Colorectal cancer 1499_5595_5594_5599_5604_2932_2353_4292_7157_3725_5894_4609_4087_4088_4089_5881 16 1.75E-16 1.21E-14 2.42E-15 22082 hsa-mir-548t hsa05220 Chronic myeloid leukemia 25_5595_5594_5604_1488_4193_5970_7157_5894_4609_1029_1487_4088_4089_5925 15 8.30E-16 5.73E-14 9.54E-15 22083 hsa-mir-548t hsa05215 Prostate cancer 3320_1499_5595_5594_1387_3326_5604_2932_4193_5970_7157_5894_5925_2033_7184 15 6.74E-15 4.65E-13 6.64E-14 22084 hsa-mir-548t hsa05212 Pancreatic cancer 3320_1499_5595_5594_1387_3326_5604_2932_4193_5970_7157_5894_5925_2033_7184 15 7.81E-15 5.39E-13 6.74E-14 22085 hsa-mir-548t hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_8454_6500_4609_4086_4087_4088_4089_2033_4093_5933 14 1.11E-13 7.63E-12 8.48E-13 22086 hsa-mir-548t hsa04520 Adherens junction 1460_1499_6714_5595_5594_1387_1457_1459_4087_4088_4089_5881_2033 13 7.61E-13 5.25E-11 5.25E-12 22087 hsa-mir-548t hsa04540 Gap junction 6714_5595_5594_5598_10382_983_5604_7277_7278_10376_5894_7846_51807 13 4.25E-12 2.93E-10 2.67E-11 22088 hsa-mir-548t hsa05221 Acute myeloid leukemia 5371_5595_5594_5604_6774_5970_6688_5894_4609_1050 10 2.45E-10 1.69E-08 1.41E-09 22089 hsa-mir-548t hsa05219 Bladder cancer 5595_5594_5604_4193_7157_5894_4609_1029_5925 9 3.15E-10 2.17E-08 1.67E-09 22090 hsa-mir-548t hsa05213 Endometrial cancer 1499_5595_5594_5604_2932_4292_7157_5894_4609 9 1.67E-09 1.15E-07 8.24E-09 22091 hsa-mir-548t hsa04010 MAPK signaling pathway 4149_3727_5595_5594_5599_5598_5604_2353_3312_1386_5970_7157_3725_5894_4609_5881 16 2.47E-09 1.70E-07 1.14E-08 22092 hsa-mir-548t hsa05131 Shigellosis 25_1499_10382_7277_7278_10376_7846_51807_4691 9 3.00E-09 2.07E-07 1.22E-08 22093 hsa-mir-548t hsa05130 Pathogenic Escherichia coli infection 25_1499_10382_7277_7278_10376_7846_51807_4691 9 3.00E-09 2.07E-07 1.22E-08 22094 hsa-mir-548t hsa04012 ErbB signaling pathway 25_6714_5595_5594_5599_5604_2932_3725_5894_4609 10 7.42E-09 5.12E-07 2.84E-08 22095 hsa-mir-548t hsa05216 Thyroid cancer 1499_5595_5594_6256_5604_7157_4609 7 1.52E-08 1.05E-06 5.51E-08 22096 hsa-mir-548t hsa04662 B cell receptor signaling pathway 5595_5594_5604_2932_2353_5970_3725_5894_5881 9 3.02E-08 2.08E-06 1.04E-07 22097 hsa-mir-548t hsa05223 Non-small cell lung cancer 5595_5594_6256_5604_7157_5894_1029_5925 8 4.08E-08 2.82E-06 1.34E-07 22098 hsa-mir-548t hsa05222 Small cell lung cancer 4149_6256_10401_6502_5970_7157_4609_5925_8554 9 8.91E-08 6.14E-06 2.79E-07 22099 hsa-mir-548t hsa05214 Glioma 5595_5594_5604_4193_7157_5894_1029_5925 8 1.50E-07 1.04E-05 4.51E-07 22100 hsa-mir-548t hsa05218 Melanoma 5595_5594_5604_4193_7157_5894_1029_5925 8 2.79E-07 1.93E-05 8.03E-07 22101 hsa-mir-548t hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_10401_4193_8454_6502_6500_8554 9 3.82E-06 0.000263363 1.03E-05 22102 hsa-mir-548t hsa05211 Renal cell carcinoma 5595_5594_1387_5604_3725_5894_2033 7 3.91E-06 0.000269755 1.03E-05 22103 hsa-mir-548t hsa04916 Melanogenesis 1499_5595_5594_1387_5604_2932_5894_2033 8 4.04E-06 0.000278847 1.03E-05 22104 hsa-mir-548t hsa04330 Notch signaling pathway 1387_2648_1488_1487_2033_8850 6 4.65E-06 0.000320609 1.15E-05 22105 hsa-mir-548t hsa04912 GnRH signaling pathway 6714_5595_5594_5599_5598_5604_3725_5894 8 5.25E-06 0.000362275 1.25E-05 22106 hsa-mir-548t hsa04660 T cell receptor signaling pathway 5595_5594_5604_2932_2353_5970_3725_5894 8 5.96E-06 0.000411345 1.37E-05 22107 hsa-mir-548t hsa04510 Focal adhesion 1499_6714_5595_5594_5599_5604_2932_3725_5894_5881 10 1.25E-05 0.000860848 2.78E-05 22108 hsa-mir-548t hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5604_2353_5970_3725 7 3.27E-05 0.002253354 7.04E-05 22109 hsa-mir-548t hsa05016 Huntington's disease 1387_6908_6874_6667_9001_5430_7157_3064_2033 9 3.77E-05 0.002603342 7.89E-05 22110 hsa-mir-548t hsa04720 Long-term potentiation 5595_5594_1387_5604_5894_2033 6 5.43E-05 0.003746112 0.00011018 22111 hsa-mir-548t hsa04370 VEGF signaling pathway 6714_5595_5594_5604_5894_5881 6 6.23E-05 0.004298035 0.000122801 22112 hsa-mir-548t hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5604_5894_5881 6 7.12E-05 0.004913031 0.000135545 22113 hsa-mir-548t hsa03050 Proteasome 5705_5701_5702_5719_5710 5 7.27E-05 0.005015166 0.000135545 22114 hsa-mir-548t hsa04910 Insulin signaling pathway 5595_5594_5599_5604_2932_5894_5211 7 0.000197394 0.013620198 0.000358426 22115 hsa-mir-548t hsa04062 Chemokine signaling pathway 5595_5594_5604_2932_6774_5970_5894_7074 8 0.000262055 0.018081771 0.000463635 22116 hsa-mir-548t hsa04115 p53 signaling pathway 983_4193_7157_7161_1029 5 0.000355021 0.024496421 0.000612411 22117 hsa-mir-548t hsa04612 Antigen processing and presentation 3320_3326_4801_4802_3312 5 0.001060176 0.073152157 0.001784199 22118 hsa-mir-548t hsa04950 Maturity onset diabetes of the young 3172_6928_5080 3 0.001361259 0.093926904 0.002236355 22119 hsa-mir-548t hsa04630 Jak-STAT signaling pathway 1387_10401_6774_4609_2033_8554 6 0.002145304 0.14802596 0.003442464 22120 hsa-mir-548t hsa04920 Adipocytokine signaling pathway 5599_6256_6774_5970 4 0.002747677 0.189589701 0.004308857 22121 hsa-mir-548t hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5599_5970_3725 4 0.003351153 0.231229578 0.00502673 22122 hsa-mir-548t hsa04730 Long-term depression 5595_5594_5604_5894 4 0.003351153 0.231229578 0.00502673 22123 hsa-mir-548t hsa04360 Axon guidance 25_5595_5594_2932_5881 5 0.005277978 0.364180479 0.007748521 22124 hsa-mir-548t hsa04530 Tight junction 1460_1499_6714_1457_1459 5 0.006318115 0.435949914 0.00908229 22125 hsa-mir-548t hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_5604_5894_5881 5 0.006504473 0.44880867 0.009159361 22126 hsa-mir-548t hsa03420 Nucleotide excision repair 2967_2968_5887 3 0.00669431 0.461907392 0.009238148 22127 hsa-mir-548t hsa04930 Type II diabetes mellitus 5595_5594_5599 3 0.007098137 0.489771458 0.009603362 22128 hsa-mir-548t hsa04810 Regulation of actin cytoskeleton 5595_5594_5604_5894_5881_7074 6 0.010707025 0.738784759 0.014207399 22129 hsa-mir-548t hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.011931526 0.823275274 0.015533496 22130 hsa-mir-548t hsa04270 Vascular smooth muscle contraction 5595_5594_5604_5894 4 0.018019507 1 0.023024926 22131 hsa-mir-548v hsa05200 Pathways in cancer 5601_2885_6688_5925_2033_1019_1017_9063_8554_4609_1499_1026_5595_5594_5604_5599_2353_1387 18 1.76E-19 1.06E-17 6.56E-18 22132 hsa-mir-548v hsa04010 MAPK signaling pathway 1432_9344_6722_5606_5601_5600_2885_468_4609_5595_5594_5604_1649_5599_2005_2353_1386 17 2.19E-19 1.31E-17 6.56E-18 22133 hsa-mir-548v hsa04350 TGF-beta signaling pathway 1874_2033_7027_4609_5595_5594_3397_3399_3398_5933_1387 11 5.38E-16 3.23E-14 8.13E-15 22134 hsa-mir-548v hsa05215 Prostate cancer 2885_5925_2033_1017_468_1499_1026_5595_5594_5604_1387 11 6.04E-16 3.62E-14 8.13E-15 22135 hsa-mir-548v hsa05212 Pancreatic cancer 2885_5925_2033_1017_468_1499_1026_5595_5594_5604_1387 11 6.78E-16 4.07E-14 8.13E-15 22136 hsa-mir-548v hsa04912 GnRH signaling pathway 1432_5606_5601_5600_2885_468_5595_5594_5604_5599 10 2.22E-13 1.33E-11 2.22E-12 22137 hsa-mir-548v hsa04664 Fc epsilon RI signaling pathway 1432_5606_5601_5600_2885_5595_5594_5604_5599 9 6.64E-13 3.98E-11 5.69E-12 22138 hsa-mir-548v hsa05210 Colorectal cancer 5601_2885_4609_1499_5595_5594_5604_5599_2353 9 1.11E-12 6.64E-11 8.30E-12 22139 hsa-mir-548v hsa04620 Toll-like receptor signaling pathway 1432_5606_5601_5600_5595_5594_5604_5599_2353 9 5.63E-12 3.38E-10 3.75E-11 22140 hsa-mir-548v hsa04660 T cell receptor signaling pathway 1432_5601_5600_2885_1019_5595_5594_5604_2353 9 1.06E-11 6.37E-10 6.37E-11 22141 hsa-mir-548v hsa05220 Chronic myeloid leukemia 2885_5925_1019_4609_1026_5595_5594_5604 8 2.20E-11 1.32E-09 1.20E-10 22142 hsa-mir-548v hsa05219 Bladder cancer 5925_1019_4609_1026_5595_5594_5604 7 2.40E-11 1.44E-09 1.20E-10 22143 hsa-mir-548v hsa04012 ErbB signaling pathway 5601_2885_4609_1026_5595_5594_5604_5599 8 6.64E-11 3.98E-09 3.06E-10 22144 hsa-mir-548v hsa05214 Glioma 2885_5925_1019_1026_5595_5594_5604 7 3.94E-10 2.36E-08 1.69E-09 22145 hsa-mir-548v hsa04110 Cell cycle 5925_2033_1019_1017_7027_1026_5933_1387 8 6.89E-10 4.14E-08 2.76E-09 22146 hsa-mir-548v hsa05213 Endometrial cancer 2885_4609_1499_5595_5594_5604 6 5.13E-09 3.08E-07 1.92E-08 22147 hsa-mir-548v hsa05223 Non-small cell lung cancer 2885_5925_1019_5595_5594_5604 6 6.32E-09 3.79E-07 2.23E-08 22148 hsa-mir-548v hsa05221 Acute myeloid leukemia 2885_6688_4609_5595_5594_5604 6 1.03E-08 6.20E-07 3.44E-08 22149 hsa-mir-548v hsa05216 Thyroid cancer 4609_1499_5595_5594_5604 5 1.68E-08 1.01E-06 5.30E-08 22150 hsa-mir-548v hsa05218 Melanoma 5925_1019_1026_5595_5594_5604 6 2.90E-08 1.74E-06 8.70E-08 22151 hsa-mir-548v hsa05211 Renal cell carcinoma 2885_2033_5595_5594_5604_1387 6 3.14E-08 1.88E-06 8.96E-08 22152 hsa-mir-548v hsa04720 Long-term potentiation 2033_468_5595_5594_5604_1387 6 3.94E-08 2.36E-06 1.07E-07 22153 hsa-mir-548v hsa05222 Small cell lung cancer 5925_1019_1017_9063_8554_4609 6 8.48E-08 5.09E-06 2.21E-07 22154 hsa-mir-548v hsa04916 Melanogenesis 2033_1499_5595_5594_5604_1387 6 2.46E-07 1.48E-05 6.16E-07 22155 hsa-mir-548v hsa04510 Focal adhesion 5601_2885_1499_5595_5594_5604_5599 7 7.34E-07 4.40E-05 1.76E-06 22156 hsa-mir-548v hsa04910 Insulin signaling pathway 5601_2885_5595_5594_5604_5599 6 1.20E-06 7.22E-05 2.78E-06 22157 hsa-mir-548v hsa04662 B cell receptor signaling pathway 2885_5595_5594_5604_2353 5 1.33E-06 7.99E-05 2.96E-06 22158 hsa-mir-548v hsa04370 VEGF signaling pathway 1432_5600_5595_5594_5604 5 1.51E-06 9.04E-05 3.23E-06 22159 hsa-mir-548v hsa04520 Adherens junction 2033_1499_5595_5594_1387 5 1.80E-06 0.000108065 3.73E-06 22160 hsa-mir-548v hsa04310 Wnt signaling pathway 5601_2033_4609_1499_5599_1387 6 2.07E-06 0.000123982 4.13E-06 22161 hsa-mir-548v hsa04630 Jak-STAT signaling pathway 2885_2033_9063_8554_4609_1387 6 2.30E-06 0.000138276 4.46E-06 22162 hsa-mir-548v hsa04930 Type II diabetes mellitus 5601_5595_5594_5599 4 5.58E-06 0.000334663 1.05E-05 22163 hsa-mir-548v hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_5601_5600_5599 4 3.06E-05 0.001833039 5.55E-05 22164 hsa-mir-548v hsa04540 Gap junction 2885_5595_5594_5604 4 8.38E-05 0.00502501 0.000147794 22165 hsa-mir-548v hsa04650 Natural killer cell mediated cytotoxicity 2885_5595_5594_5604 4 0.000362299 0.021737948 0.000604744 22166 hsa-mir-548v hsa04120 Ubiquitin mediated proteolysis 7329_9063_672_8554 4 0.000372065 0.022323905 0.000604744 22167 hsa-mir-548v hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_5606_5600 3 0.000372926 0.022375531 0.000604744 22168 hsa-mir-548v hsa04115 p53 signaling pathway 1019_1017_1026 3 0.000669305 0.040158328 0.001056798 22169 hsa-mir-548v hsa04730 Long-term depression 5595_5594_5604 3 0.000725032 0.043501916 0.001115434 22170 hsa-mir-548v hsa04062 Chemokine signaling pathway 2885_5595_5594_5604 4 0.001232274 0.073936416 0.00184841 22171 hsa-mir-548v hsa04270 Vascular smooth muscle contraction 5595_5594_5604 3 0.002975938 0.178556302 0.004355032 22172 hsa-mir-548v hsa04670 Leukocyte transendothelial migration 1432_5600_1499 3 0.003261594 0.195695639 0.00465942 22173 hsa-mir-548v hsa04330 Notch signaling pathway 2033_1387 2 0.006016624 0.360997432 0.008395289 22174 hsa-mir-548v hsa04150 mTOR signaling pathway 5595_5594 2 0.007265879 0.43595273 0.009908017 22175 hsa-mir-548v hsa05010 Alzheimer's disease 6622_5595_5594 3 0.008948277 0.536896613 0.011931036 22176 hsa-mir-548v hsa04920 Adipocytokine signaling pathway 5601_5599 2 0.011644009 0.698640516 0.015187837 22177 hsa-mir-548v hsa04810 Regulation of actin cytoskeleton 5595_5594_5604 3 0.015702255 0.942135275 0.020045431 22178 hsa-mir-548v hsa04360 Axon guidance 5595_5594 2 0.039566914 1 0.049458642 22179 hsa-mir-548v hsa04530 Tight junction 1019_1499 2 0.04284525 1 0.052463572 22180 hsa-mir-548w hsa05200 Pathways in cancer 1488_4087_4088_4089_5881_1487_1050_5925_2033_207_208_1499_6774_5599_2353_1387 16 1.46E-18 7.45E-17 7.45E-17 22181 hsa-mir-548w hsa04310 Wnt signaling pathway 1488_4087_4088_4089_5881_1487_2033_1499_5518_6423_5599_1387 12 1.66E-16 8.46E-15 4.23E-15 22182 hsa-mir-548w hsa05210 Colorectal cancer 4087_4088_4089_5881_207_208_1499_5599_2353 9 9.89E-14 5.04E-12 1.68E-12 22183 hsa-mir-548w hsa04520 Adherens junction 4087_4088_4089_5881_6714_2033_1499_1387 8 4.24E-12 2.16E-10 5.41E-11 22184 hsa-mir-548w hsa05220 Chronic myeloid leukemia 1488_4088_4089_1487_5925_207_208 7 1.58E-10 8.07E-09 1.61E-09 22185 hsa-mir-548w hsa04350 TGF-beta signaling pathway 4087_4088_4089_3398_2033_5518_1387 7 4.19E-10 2.14E-08 3.56E-09 22186 hsa-mir-548w hsa04110 Cell cycle 4087_4088_4089_5925_2033_7534_1387 7 3.30E-09 1.68E-07 2.41E-08 22187 hsa-mir-548w hsa05215 Prostate cancer 5925_2033_207_208_1499_1387 6 2.04E-08 1.04E-06 1.23E-07 22188 hsa-mir-548w hsa05212 Pancreatic cancer 5925_2033_207_208_1499_1387 6 2.17E-08 1.11E-06 1.23E-07 22189 hsa-mir-548w hsa04330 Notch signaling pathway 1488_1487_2033_8850_1387 5 4.15E-08 2.11E-06 2.11E-07 22190 hsa-mir-548w hsa04010 MAPK signaling pathway 9479_6722_5881_207_208_5599_2353 7 7.83E-07 3.99E-05 3.63E-06 22191 hsa-mir-548w hsa04510 Focal adhesion 5881_6714_207_208_1499_5599 6 2.49E-06 0.000127181 1.06E-05 22192 hsa-mir-548w hsa05221 Acute myeloid leukemia 1050_207_208_6774 4 5.52E-06 0.000281349 2.16E-05 22193 hsa-mir-548w hsa04530 Tight junction 6714_207_208_1499_5518 5 6.31E-06 0.000321807 2.30E-05 22194 hsa-mir-548w hsa04920 Adipocytokine signaling pathway 207_208_6774_5599 4 8.90E-06 0.000453978 3.03E-05 22195 hsa-mir-548w hsa04630 Jak-STAT signaling pathway 2033_207_208_6774_1387 5 1.13E-05 0.000574694 3.50E-05 22196 hsa-mir-548w hsa05211 Renal cell carcinoma 2033_207_208_1387 4 1.17E-05 0.000595395 3.50E-05 22197 hsa-mir-548w hsa04662 B cell receptor signaling pathway 5881_207_208_2353 4 1.36E-05 0.000694442 3.86E-05 22198 hsa-mir-548w hsa04370 VEGF signaling pathway 5881_6714_207_208 4 1.50E-05 0.000766883 4.04E-05 22199 hsa-mir-548w hsa04664 Fc epsilon RI signaling pathway 5881_207_208_5599 4 1.66E-05 0.000844738 4.22E-05 22200 hsa-mir-548w hsa04012 ErbB signaling pathway 6714_207_208_5599 4 2.38E-05 0.001215354 5.79E-05 22201 hsa-mir-548w hsa04620 Toll-like receptor signaling pathway 207_208_5599_2353 4 4.34E-05 0.002213535 0.000100615 22202 hsa-mir-548w hsa05213 Endometrial cancer 207_208_1499 3 0.000142208 0.00725263 0.000315332 22203 hsa-mir-548w hsa05223 Non-small cell lung cancer 5925_207_208 3 0.000158196 0.008067973 0.000336166 22204 hsa-mir-548w hsa05214 Glioma 5925_207_208 3 0.000267125 0.01362339 0.000544936 22205 hsa-mir-548w hsa05218 Melanoma 5925_207_208 3 0.00034285 0.017485368 0.000672514 22206 hsa-mir-548w hsa05222 Small cell lung cancer 5925_207_208 3 0.000589102 0.030044195 0.001112748 22207 hsa-mir-548w hsa04916 Melanogenesis 2033_1499_1387 3 0.00100597 0.051304481 0.001827043 22208 hsa-mir-548w hsa04950 Maturity onset diabetes of the young 6928_3172 2 0.001038907 0.052984233 0.001827043 22209 hsa-mir-548w hsa04660 T cell receptor signaling pathway 207_208_2353 3 0.001177509 0.060052941 0.002001765 22210 hsa-mir-548w hsa04910 Insulin signaling pathway 207_208_5599 3 0.002218384 0.113137595 0.0036496 22211 hsa-mir-548w hsa04150 mTOR signaling pathway 207_208 2 0.004426838 0.22576874 0.007055273 22212 hsa-mir-548w hsa05131 Shigellosis 7534_1499 2 0.005089754 0.259577437 0.007634631 22213 hsa-mir-548w hsa05130 Pathogenic Escherichia coli infection 7534_1499 2 0.005089754 0.259577437 0.007634631 22214 hsa-mir-548w hsa04062 Chemokine signaling pathway 207_208_6774 3 0.005585617 0.284866485 0.008139042 22215 hsa-mir-548w hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5599 2 0.007951436 0.405523223 0.011264534 22216 hsa-mir-548w hsa04720 Long-term potentiation 2033_1387 2 0.008811895 0.449406626 0.012146125 22217 hsa-mir-548w hsa04210 Apoptosis 207_208 2 0.012133015 0.618783765 0.016283783 22218 hsa-mir-548w hsa04912 GnRH signaling pathway 6714_5599 2 0.01737463 0.886106112 0.02272067 22219 hsa-mir-548w hsa05016 Huntington's disease 2033_1387 2 0.047446003 1 0.060493654 22220 hsa-mir-548x hsa05200 Pathways in cancer 1050_1387_6774_5881_2033_1499_2353 7 3.89E-10 1.52E-08 1.52E-08 22221 hsa-mir-548x hsa04520 Adherens junction 1387_5881_2033_1499_6714 5 9.74E-10 3.80E-08 1.90E-08 22222 hsa-mir-548x hsa04310 Wnt signaling pathway 1387_5881_2033_1499 4 1.58E-06 6.18E-05 2.06E-05 22223 hsa-mir-548x hsa04330 Notch signaling pathway 1387_8850_2033 3 2.91E-06 0.000113444 2.84E-05 22224 hsa-mir-548x hsa05210 Colorectal cancer 5881_1499_2353 3 1.55E-05 0.000605599 0.00010232 22225 hsa-mir-548x hsa05215 Prostate cancer 1387_2033_1499 3 1.78E-05 0.00069313 0.00010232 22226 hsa-mir-548x hsa05212 Pancreatic cancer 1387_2033_1499 3 1.84E-05 0.000716243 0.00010232 22227 hsa-mir-548x hsa04916 Melanogenesis 1387_2033_1499 3 2.89E-05 0.001126128 0.000140766 22228 hsa-mir-548x hsa04630 Jak-STAT signaling pathway 1387_6774_2033 3 9.22E-05 0.003594488 0.000379598 22229 hsa-mir-548x hsa04950 Maturity onset diabetes of the young 3172_6928 2 9.73E-05 0.003795983 0.000379598 22230 hsa-mir-548x hsa04510 Focal adhesion 5881_1499_6714 3 0.000210531 0.008210727 0.00074643 22231 hsa-mir-548x hsa05221 Acute myeloid leukemia 1050_6774 2 0.000541709 0.021126637 0.001760553 22232 hsa-mir-548x hsa05211 Renal cell carcinoma 1387_2033 2 0.000796086 0.031047356 0.00220978 22233 hsa-mir-548x hsa04720 Long-term potentiation 1387_2033 2 0.000861541 0.033600114 0.00220978 22234 hsa-mir-548x hsa04662 B cell receptor signaling pathway 5881_2353 2 0.000861541 0.033600114 0.00220978 22235 hsa-mir-548x hsa04370 VEGF signaling pathway 5881_6714 2 0.000906576 0.035356483 0.00220978 22236 hsa-mir-548x hsa04350 TGF-beta signaling pathway 1387_2033 2 0.001148445 0.044789362 0.002634668 22237 hsa-mir-548x hsa04110 Cell cycle 1387_2033 2 0.002106596 0.082157262 0.004564292 22238 hsa-mir-548x hsa04530 Tight junction 1499_6714 2 0.002766364 0.107888214 0.005678327 22239 hsa-mir-548x hsa05016 Huntington's disease 1387_2033 2 0.005091795 0.198580019 0.009929001 22240 hsa-mir-548x hsa04010 MAPK signaling pathway 5881_2353 2 0.01038693 0.40509026 0.019290012 22241 hsa-mir-548x hsa05216 Thyroid cancer 1499 1 0.016859661 0.657526762 0.02988758 22242 hsa-mir-548x hsa05213 Endometrial cancer 1499 1 0.029603833 1 0.047706416 22243 hsa-mir-548x hsa05217 Basal cell carcinoma 1499 1 0.031254607 1 0.047706416 22244 hsa-mir-548x hsa05131 Shigellosis 1499 1 0.031804277 1 0.047706416 22245 hsa-mir-548x hsa05130 Pathogenic Escherichia coli infection 1499 1 0.031804277 1 0.047706416 22246 hsa-mir-548x hsa04920 Adipocytokine signaling pathway 6774 1 0.037831309 1 0.054645224 22247 hsa-mir-548x hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714 1 0.040014188 1 0.055734048 22248 hsa-mir-548x hsa04664 Fc epsilon RI signaling pathway 5881 1 0.044365971 1 0.059664582 22249 hsa-mir-548x hsa04012 ErbB signaling pathway 6714 1 0.048699183 1 0.063308937 22250 hsa-mir-548y hsa04520 Adherens junction 4087_4089_2033 3 0.000160031 0.005441052 0.002304883 22251 hsa-mir-548y hsa05210 Colorectal cancer 4087_4089_836 3 0.000183971 0.006255005 0.002304883 22252 hsa-mir-548y hsa04350 TGF-beta signaling pathway 4087_4089_2033 3 0.000203372 0.00691465 0.002304883 22253 hsa-mir-548y hsa04110 Cell cycle 4087_4089_2033 3 0.00049704 0.016899376 0.004224844 22254 hsa-mir-548y hsa05200 Pathways in cancer 4087_4089_836_2033 4 0.000840866 0.02858943 0.005445395 22255 hsa-mir-548y hsa04310 Wnt signaling pathway 4087_4089_2033 3 0.000995712 0.033854204 0.005445395 22256 hsa-mir-548y hsa03022 Basal transcription factors 6908_2959 2 0.001121111 0.038117767 0.005445395 22257 hsa-mir-548y hsa05010 Alzheimer's disease 836_1020_840 3 0.001530008 0.052020276 0.006502534 22258 hsa-mir-548y hsa05016 Huntington's disease 6908_836_2033 3 0.001812363 0.061620352 0.006846706 22259 hsa-mir-548y hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432 2 0.002463373 0.083754674 0.008375467 22260 hsa-mir-548y hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_1432 2 0.003869904 0.131576726 0.011961521 22261 hsa-mir-548y hsa04010 MAPK signaling pathway 836_5598_1432 3 0.005104608 0.173556688 0.014463057 22262 hsa-mir-548y hsa04210 Apoptosis 836_840 2 0.005944532 0.202114082 0.015547237 22263 hsa-mir-548y hsa04912 GnRH signaling pathway 5598_1432 2 0.008572476 0.291464182 0.02081887 22264 hsa-mir-548z hsa05210 Colorectal cancer 1499_207_4088_208_4089 5 1.59E-10 6.54E-09 6.54E-09 22265 hsa-mir-548z hsa05200 Pathways in cancer 1499_207_4088_208_4089_1387 6 1.70E-09 6.99E-08 3.49E-08 22266 hsa-mir-548z hsa05220 Chronic myeloid leukemia 207_4088_208_4089 4 2.17E-08 8.88E-07 2.85E-07 22267 hsa-mir-548z hsa04520 Adherens junction 1499_4088_4089_1387 4 2.78E-08 1.14E-06 2.85E-07 22268 hsa-mir-548z hsa05215 Prostate cancer 1499_207_208_1387 4 4.02E-08 1.65E-06 2.87E-07 22269 hsa-mir-548z hsa05212 Pancreatic cancer 1499_207_208_1387 4 4.20E-08 1.72E-06 2.87E-07 22270 hsa-mir-548z hsa04110 Cell cycle 4088_4089_7534_1387 4 1.30E-07 5.31E-06 7.59E-07 22271 hsa-mir-548z hsa04310 Wnt signaling pathway 1499_4088_4089_1387 4 3.37E-07 1.38E-05 1.72E-06 22272 hsa-mir-548z hsa05213 Endometrial cancer 1499_207_208 3 1.27E-06 5.19E-05 5.77E-06 22273 hsa-mir-548z hsa05211 Renal cell carcinoma 207_208_1387 3 3.24E-06 0.000133028 1.33E-05 22274 hsa-mir-548z hsa04350 TGF-beta signaling pathway 4088_4089_1387 3 5.63E-06 0.000230662 2.10E-05 22275 hsa-mir-548z hsa04530 Tight junction 1499_207_208 3 2.12E-05 0.000868944 7.24E-05 22276 hsa-mir-548z hsa04630 Jak-STAT signaling pathway 207_208_1387 3 3.04E-05 0.001247067 9.59E-05 22277 hsa-mir-548z hsa04510 Focal adhesion 1499_207_208 3 6.99E-05 0.002866787 0.000204771 22278 hsa-mir-548z hsa04010 MAPK signaling pathway 207_208_6722 3 0.00015917 0.006525955 0.000435064 22279 hsa-mir-548z hsa04150 mTOR signaling pathway 207_208 2 0.00020731 0.008499727 0.000516296 22280 hsa-mir-548z hsa05223 Non-small cell lung cancer 207_208 2 0.000223002 0.009143093 0.000516296 22281 hsa-mir-548z hsa05131 Shigellosis 1499_7534 2 0.000239259 0.009809623 0.000516296 22282 hsa-mir-548z hsa05130 Pathogenic Escherichia coli infection 1499_7534 2 0.000239259 0.009809623 0.000516296 22283 hsa-mir-548z hsa05221 Acute myeloid leukemia 207_208 2 0.000264702 0.010852783 0.000542639 22284 hsa-mir-548z hsa05214 Glioma 207_208 2 0.000319386 0.013094833 0.000623563 22285 hsa-mir-548z hsa04920 Adipocytokine signaling pathway 207_208 2 0.000338737 0.01388821 0.000631282 22286 hsa-mir-548z hsa05218 Melanoma 207_208 2 0.000379118 0.01554382 0.000675818 22287 hsa-mir-548z hsa04662 B cell receptor signaling pathway 207_208 2 0.000421732 0.017291029 0.00072046 22288 hsa-mir-548z hsa04370 VEGF signaling pathway 207_208 2 0.000443876 0.018198906 0.000727956 22289 hsa-mir-548z hsa04664 Fc epsilon RI signaling pathway 207_208 2 0.000466575 0.01912959 0.000735753 22290 hsa-mir-548z hsa05222 Small cell lung cancer 207_208 2 0.000550394 0.022566142 0.000824278 22291 hsa-mir-548z hsa04012 ErbB signaling pathway 207_208 2 0.000562921 0.023079777 0.000824278 22292 hsa-mir-548z hsa04210 Apoptosis 207_208 2 0.000588391 0.024124033 0.000831863 22293 hsa-mir-548z hsa04620 Toll-like receptor signaling pathway 207_208 2 0.000767359 0.031461728 0.001048724 22294 hsa-mir-548z hsa04916 Melanogenesis 1499_1387 2 0.000796949 0.032674899 0.001054029 22295 hsa-mir-548z hsa04660 T cell receptor signaling pathway 207_208 2 0.000888991 0.036448641 0.00113902 22296 hsa-mir-548z hsa04910 Insulin signaling pathway 207_208 2 0.001382925 0.056699926 0.00171818 22297 hsa-mir-548z hsa04062 Chemokine signaling pathway 207_208 2 0.002655755 0.108885941 0.003202528 22298 hsa-mir-548z hsa05216 Thyroid cancer 1499 1 0.011931649 0.489197596 0.013977074 22299 hsa-mir-548z hsa03410 Base excision repair 3146 1 0.014696856 0.602571084 0.016738086 22300 hsa-mir-548z hsa04330 Notch signaling pathway 1387 1 0.019027852 0.780141917 0.021084917 22301 hsa-mir-548z hsa05217 Basal cell carcinoma 1499 1 0.022166698 0.908834631 0.023916701 22302 hsa-mir-548z hsa04720 Long-term potentiation 1387 1 0.02997358 1 0.031510686 22303 hsa-mir-548z hsa04670 Leukocyte transendothelial migration 1499 1 0.048095377 1 0.049297762 22304 hsa-mir-550b-1 hsa04350 TGF-beta signaling pathway 4093_4086_4089 3 9.27E-06 0.000111193 0.000111193 22305 hsa-mir-550b-1 hsa05220 Chronic myeloid leukemia 25_4089 2 0.000579471 0.00695365 0.003476825 22306 hsa-mir-550b-1 hsa04110 Cell cycle 25_4089 2 0.001421032 0.017052378 0.005684126 22307 hsa-mir-550b-1 hsa05200 Pathways in cancer 25_4089 2 0.010285271 0.123423249 0.030855812 22308 hsa-mir-550b-1 hsa03410 Base excision repair 3146 1 0.01712468 0.205496154 0.041099231 22309 hsa-mir-550b-1 hsa05131 Shigellosis 25 1 0.026267488 0.315209858 0.04502998 22310 hsa-mir-550b-1 hsa05130 Pathogenic Escherichia coli infection 25 1 0.026267488 0.315209858 0.04502998 22311 hsa-mir-550b-1 hsa04520 Adherens junction 4089 1 0.037134601 0.445615212 0.048339476 22312 hsa-mir-550b-1 hsa05210 Colorectal cancer 4089 1 0.0389348 0.467217595 0.048339476 22313 hsa-mir-550b-1 hsa04012 ErbB signaling pathway 25 1 0.040282897 0.483394763 0.048339476 22314 hsa-mir-551b hsa04010 MAPK signaling pathway 6722_1956_5595_5594_1386_9261_4208_5566_9252_7867_1649_5970_468_4609_6195_6196_1432_4790_2002 19 3.52E-17 2.36E-15 2.29E-15 22315 hsa-mir-551b hsa05200 Pathways in cancer 1956_1499_5595_5594_1387_862_6502_2308_6776_5970_6688_4609_841_861_4088_4089_1050_5925_2033_4790 20 6.82E-17 4.57E-15 2.29E-15 22316 hsa-mir-551b hsa04720 Long-term potentiation 815_5595_5594_1387_5566_468_6195_6196_2033_808_801_805 12 3.34E-15 2.24E-13 7.46E-14 22317 hsa-mir-551b hsa04350 TGF-beta signaling pathway 3400_5595_5594_1387_3397_3399_3398_4609_4088_4089_2033_6667 12 1.67E-14 1.12E-12 2.38E-13 22318 hsa-mir-551b hsa05215 Prostate cancer 1956_1499_5595_5594_1385_1387_2308_5970_468_5925_2033_4790 12 1.89E-14 1.26E-12 2.38E-13 22319 hsa-mir-551b hsa05212 Pancreatic cancer 1956_1499_5595_5594_1385_1387_2308_5970_468_5925_2033_4790 12 2.13E-14 1.43E-12 2.38E-13 22320 hsa-mir-551b hsa05221 Acute myeloid leukemia 5595_5594_862_6776_5970_6688_4609_861_1050_4790 10 4.31E-13 2.89E-11 4.13E-12 22321 hsa-mir-551b hsa04916 Melanogenesis 815_1499_5595_5594_1385_1387_5566_2033_808_801_805 11 3.05E-12 2.04E-10 2.56E-11 22322 hsa-mir-551b hsa05220 Chronic myeloid leukemia 5595_5594_6776_5970_4609_861_4088_4089_5925_4790 10 3.74E-12 2.51E-10 2.79E-11 22323 hsa-mir-551b hsa04912 GnRH signaling pathway 815_1956_5595_5594_5566_468_1432_2002_808_801_805 11 4.46E-12 2.99E-10 2.99E-11 22324 hsa-mir-551b hsa05214 Glioma 815_1956_5595_5594_5925_808_801_805 8 1.03E-09 6.88E-08 6.25E-09 22325 hsa-mir-551b hsa04520 Adherens junction 1956_1499_5595_5594_1387_4088_4089_2033 8 4.65E-09 3.12E-07 2.60E-08 22326 hsa-mir-551b hsa05219 Bladder cancer 1956_5595_5594_9252_4609_5925 6 6.07E-08 4.07E-06 3.13E-07 22327 hsa-mir-551b hsa05210 Colorectal cancer 1956_1499_5595_5594_4609_4088_4089 7 1.42E-07 9.49E-06 6.78E-07 22328 hsa-mir-551b hsa04012 ErbB signaling pathway 815_1956_5595_5594_6776_4609_2002 7 1.77E-07 1.19E-05 7.92E-07 22329 hsa-mir-551b hsa05213 Endometrial cancer 1956_1499_5595_5594_4609_2002 6 1.93E-07 1.30E-05 8.10E-07 22330 hsa-mir-551b hsa04910 Insulin signaling pathway 5595_5594_2308_5566_2002_808_801_805 8 2.47E-07 1.66E-05 9.75E-07 22331 hsa-mir-551b hsa04620 Toll-like receptor signaling pathway 5595_5594_5970_841_1432_6348_4790 7 4.89E-07 3.28E-05 1.76E-06 22332 hsa-mir-551b hsa04310 Wnt signaling pathway 815_1499_1387_5566_4609_4088_4089_2033 8 4.98E-07 3.33E-05 1.76E-06 22333 hsa-mir-551b hsa05216 Thyroid cancer 1499_5595_5594_4609 4 1.23E-05 0.000823195 4.12E-05 22334 hsa-mir-551b hsa04270 Vascular smooth muscle contraction 5595_5594_5566_808_801_805 6 1.69E-05 0.001133335 5.39E-05 22335 hsa-mir-551b hsa04110 Cell cycle 1387_6502_4088_4089_5925_2033 6 1.77E-05 0.001186301 5.39E-05 22336 hsa-mir-551b hsa04370 VEGF signaling pathway 5595_5594_9261_7867_1432 5 2.89E-05 0.001938915 8.43E-05 22337 hsa-mir-551b hsa05222 Small cell lung cancer 6502_5970_4609_5925_4790 5 4.78E-05 0.003203809 0.000133492 22338 hsa-mir-551b hsa04330 Notch signaling pathway 388585_1387_2033_8850 4 7.07E-05 0.004734194 0.000189368 22339 hsa-mir-551b hsa04150 mTOR signaling pathway 5595_5594_6195_6196 4 0.000102136 0.006843089 0.000263196 22340 hsa-mir-551b hsa05223 Non-small cell lung cancer 1956_5595_5594_5925 4 0.000117197 0.007852211 0.000290823 22341 hsa-mir-551b hsa04660 T cell receptor signaling pathway 5595_5594_5970_1432_4790 5 0.000145311 0.009735831 0.000341662 22342 hsa-mir-551b hsa05010 Alzheimer's disease 5595_5594_841_808_801_805 6 0.000147884 0.009908198 0.000341662 22343 hsa-mir-551b hsa04020 Calcium signaling pathway 815_1956_5566_808_801_805 6 0.000181311 0.012147858 0.000404929 22344 hsa-mir-551b hsa04950 Maturity onset diabetes of the young 3651_168620_4760 3 0.000212804 0.014257862 0.000459931 22345 hsa-mir-551b hsa04062 Chemokine signaling pathway 5595_5594_5566_5970_6348_4790 6 0.000232765 0.015595278 0.000487352 22346 hsa-mir-551b hsa05218 Melanoma 1956_5595_5594_5925 4 0.000317282 0.021257899 0.000625232 22347 hsa-mir-551b hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_5970_1432_4790 4 0.000317282 0.021257899 0.000625232 22348 hsa-mir-551b hsa05211 Renal cell carcinoma 5595_5594_1387_2033 4 0.000333798 0.022364434 0.000638984 22349 hsa-mir-551b hsa04662 B cell receptor signaling pathway 5595_5594_5970_4790 4 0.000387035 0.025931344 0.000720315 22350 hsa-mir-551b hsa04630 Jak-STAT signaling pathway 1387_6778_6776_4609_2033 5 0.000665677 0.044600348 0.001205415 22351 hsa-mir-551b hsa04210 Apoptosis 5566_5970_841_4790 4 0.000717953 0.048102832 0.001265864 22352 hsa-mir-551b hsa04540 Gap junction 1956_5595_5594_5566 4 0.000840767 0.056331361 0.001444394 22353 hsa-mir-551b hsa04930 Type II diabetes mellitus 3651_5595_5594 3 0.001177888 0.0789185 0.001972962 22354 hsa-mir-551b hsa05016 Huntington's disease 1385_1387_841_2033_6667 5 0.001535299 0.102865065 0.002508904 22355 hsa-mir-551b hsa04510 Focal adhesion 1956_1499_5595_5594_2002 5 0.002265226 0.151770122 0.003613574 22356 hsa-mir-551b hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.004887359 0.327453028 0.007615187 22357 hsa-mir-551b hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432 3 0.005422329 0.363296051 0.008256728 22358 hsa-mir-551b hsa05014 Amyotrophic lateral sclerosis (ALS) 834_1432 2 0.026090079 1 0.038845229 22359 hsa-mir-551b hsa04740 Olfactory transduction 815_5566_808_801_805 5 0.027550323 1 0.040127645 22360 hsa-mir-551b hsa04920 Adipocytokine signaling pathway 5970_4790 2 0.035913665 1 0.051196075 22361 hsa-mir-551b hsa04730 Long-term depression 5595_5594 2 0.039787266 1 0.055536392 22362 hsa-mir-553 hsa05216 Thyroid cancer 7157 1 0.004989512 0.104779753 0.020872303 22363 hsa-mir-553 hsa05219 Bladder cancer 7157 1 0.007145439 0.150054223 0.020872303 22364 hsa-mir-553 hsa05213 Endometrial cancer 7157 1 0.0088013 0.184827307 0.020872303 22365 hsa-mir-553 hsa05223 Non-small cell lung cancer 7157 1 0.009132207 0.191776353 0.020872303 22366 hsa-mir-553 hsa05217 Basal cell carcinoma 7157 1 0.009297628 0.19525018 0.020872303 22367 hsa-mir-553 hsa05014 Amyotrophic lateral sclerosis (ALS) 7157 1 0.009463026 0.198723543 0.020872303 22368 hsa-mir-553 hsa05214 Glioma 7157 1 0.010950616 0.229962939 0.020872303 22369 hsa-mir-553 hsa04115 p53 signaling pathway 7157 1 0.011611193 0.243835062 0.020872303 22370 hsa-mir-553 hsa05218 Melanoma 7157 1 0.01194135 0.250768344 0.020872303 22371 hsa-mir-553 hsa05220 Chronic myeloid leukemia 7157 1 0.012601398 0.264629348 0.020872303 22372 hsa-mir-553 hsa05210 Colorectal cancer 7157 1 0.014085216 0.295789526 0.020872303 22373 hsa-mir-553 hsa05222 Small cell lung cancer 7157 1 0.01441471 0.30270892 0.020872303 22374 hsa-mir-553 hsa05215 Prostate cancer 7157 1 0.014744117 0.309626463 0.020872303 22375 hsa-mir-553 hsa04210 Apoptosis 7157 1 0.014908788 0.313084542 0.020872303 22376 hsa-mir-553 hsa05212 Pancreatic cancer 7157 1 0.014908788 0.313084542 0.020872303 22377 hsa-mir-553 hsa04110 Cell cycle 7157 1 0.019838671 0.416612086 0.026038255 22378 hsa-mir-553 hsa04120 Ubiquitin mediated proteolysis 7329 1 0.02311428 0.485399873 0.028552934 22379 hsa-mir-553 hsa04310 Wnt signaling pathway 7157 1 0.025238725 0.530013226 0.029445179 22380 hsa-mir-553 hsa05016 Huntington's disease 7157 1 0.031102522 0.653152954 0.034376471 22381 hsa-mir-553 hsa04010 MAPK signaling pathway 7157 1 0.044835671 0.9415491 0.047077455 22382 hsa-mir-554 hsa04110 Cell cycle 4088_983_3065_5925_2033_1019_4089_1017_7533_993_1028_1387 12 9.26E-17 5.56E-15 5.56E-15 22383 hsa-mir-554 hsa04350 TGF-beta signaling pathway 4092_4088_6667_2033_4089_3400_3397_3399_3398_1387 10 1.17E-14 7.04E-13 3.52E-13 22384 hsa-mir-554 hsa05200 Pathways in cancer 4088_3320_3065_5925_2033_1019_4089_1017_3725_5578_6774_1387_6256 13 4.58E-13 2.75E-11 9.17E-12 22385 hsa-mir-554 hsa05214 Glioma 5925_1019_5578_808_801_805 6 1.03E-08 6.21E-07 1.55E-07 22386 hsa-mir-554 hsa04720 Long-term potentiation 2033_5578_808_801_1387_805 6 2.30E-08 1.38E-06 2.77E-07 22387 hsa-mir-554 hsa04330 Notch signaling pathway 9612_3065_2033_8850_1387 5 9.70E-08 5.82E-06 9.70E-07 22388 hsa-mir-554 hsa04916 Melanogenesis 2033_5578_808_801_1387_805 6 1.45E-07 8.69E-06 1.24E-06 22389 hsa-mir-554 hsa04912 GnRH signaling pathway 3725_1432_5578_808_801_805 6 1.79E-07 1.07E-05 1.34E-06 22390 hsa-mir-554 hsa05220 Chronic myeloid leukemia 4088_3065_5925_1019_4089 5 8.57E-07 5.14E-05 5.71E-06 22391 hsa-mir-554 hsa04310 Wnt signaling pathway 4088_2033_4089_3725_5578_1387 6 1.22E-06 7.35E-05 7.35E-06 22392 hsa-mir-554 hsa05215 Prostate cancer 3320_5925_2033_1017_1387 5 1.81E-06 0.000108728 9.55E-06 22393 hsa-mir-554 hsa05212 Pancreatic cancer 3320_5925_2033_1017_1387 5 1.91E-06 0.000114645 9.55E-06 22394 hsa-mir-554 hsa05223 Non-small cell lung cancer 5925_1019_5578_6256 4 7.73E-06 0.000463874 3.57E-05 22395 hsa-mir-554 hsa04070 Phosphatidylinositol signaling system 5578_808_801_805 4 2.78E-05 0.001668657 0.00011919 22396 hsa-mir-554 hsa04520 Adherens junction 4088_2033_4089_1387 4 3.37E-05 0.002022588 0.000134839 22397 hsa-mir-554 hsa05222 Small cell lung cancer 5925_1019_1017_6256 4 4.42E-05 0.002652569 0.000165786 22398 hsa-mir-554 hsa04270 Vascular smooth muscle contraction 5578_808_801_805 4 0.000144302 0.008658093 0.0005093 22399 hsa-mir-554 hsa04010 MAPK signaling pathway 6722_4342_3725_1432_5578 5 0.000342391 0.020543449 0.001141303 22400 hsa-mir-554 hsa04115 p53 signaling pathway 983_1019_1017 3 0.00051709 0.031025395 0.001632916 22401 hsa-mir-554 hsa05211 Renal cell carcinoma 2033_3725_1387 3 0.000582757 0.034965398 0.00174827 22402 hsa-mir-554 hsa04020 Calcium signaling pathway 5578_808_801_805 4 0.000744407 0.044664445 0.002126878 22403 hsa-mir-554 hsa05016 Huntington's disease 3065_6667_2033_1387 4 0.00080515 0.048308994 0.002195863 22404 hsa-mir-554 hsa05210 Colorectal cancer 4088_4089_3725 3 0.000898028 0.053881656 0.002342681 22405 hsa-mir-554 hsa04660 T cell receptor signaling pathway 1019_3725_1432 3 0.001906015 0.114360911 0.004765038 22406 hsa-mir-554 hsa04910 Insulin signaling pathway 808_801_805 3 0.0035664 0.213984021 0.008559361 22407 hsa-mir-554 hsa05219 Bladder cancer 5925_1019 2 0.004106337 0.246380224 0.009476162 22408 hsa-mir-554 hsa04630 Jak-STAT signaling pathway 2033_6774_1387 3 0.004900659 0.29403954 0.010890353 22409 hsa-mir-554 hsa05010 Alzheimer's disease 808_801_805 3 0.007023053 0.421383177 0.015049399 22410 hsa-mir-554 hsa04920 Adipocytokine signaling pathway 6774_6256 2 0.009836416 0.590184989 0.020351207 22411 hsa-mir-554 hsa05218 Melanoma 5925_1019 2 0.010957991 0.657479488 0.021209016 22412 hsa-mir-554 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1432 2 0.010957991 0.657479488 0.021209016 22413 hsa-mir-554 hsa04370 VEGF signaling pathway 1432_5578 2 0.012740755 0.764445293 0.023888915 22414 hsa-mir-554 hsa04664 Fc epsilon RI signaling pathway 1432_5578 2 0.013361294 0.801677628 0.024293261 22415 hsa-mir-554 hsa04012 ErbB signaling pathway 3725_5578 2 0.015971663 0.958299761 0.028185287 22416 hsa-mir-554 hsa04612 Antigen processing and presentation 3320_1514 2 0.016655715 0.999342906 0.028552654 22417 hsa-mir-554 hsa04540 Gap junction 983_5578 2 0.018060752 1 0.030101254 22418 hsa-mir-554 hsa04620 Toll-like receptor signaling pathway 3725_1432 2 0.021397929 1 0.034699345 22419 hsa-mir-554 hsa04670 Leukocyte transendothelial migration 1432_5578 2 0.029641009 1 0.045926807 22420 hsa-mir-554 hsa04710 Circadian rhythm - mammal 79365 1 0.029852425 1 0.045926807 22421 hsa-mir-554 hsa04530 Tight junction 1019_5578 2 0.036520274 1 0.054780411 22422 hsa-mir-555 hsa05200 Pathways in cancer 5371_5595_5594_5914_1387_6256_595_836_367_2932_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_2736_4088_4089_3066_3065_5925_2034_2033_4846_207_9915 33 2.28E-29 1.51E-27 1.51E-27 22423 hsa-mir-555 hsa05220 Chronic myeloid leukemia 5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_207_6464 16 1.92E-19 1.26E-17 6.32E-18 22424 hsa-mir-555 hsa04110 Cell cycle 5591_1387_595_2932_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933 16 1.36E-16 8.96E-15 2.99E-15 22425 hsa-mir-555 hsa05215 Prostate cancer 5595_5594_1387_595_367_2932_5970_1870_1871_7157_1869_5925_2033_207 14 1.39E-15 9.18E-14 2.11E-14 22426 hsa-mir-555 hsa05212 Pancreatic cancer 5595_5594_1387_595_367_2932_5970_1870_1871_7157_1869_5925_2033_207 14 1.60E-15 1.06E-13 2.11E-14 22427 hsa-mir-555 hsa04010 MAPK signaling pathway 6722_5595_5594_4208_836_6195_6197_9252_3312_1432_5970_9261_7157_4609_3725_6196_8986_4763_207 19 1.30E-14 8.59E-13 1.43E-13 22428 hsa-mir-555 hsa05210 Colorectal cancer 5595_5594_595_836_2932_7157_4087_4609_3725_4088_4089_207 12 4.95E-13 3.27E-11 4.16E-12 22429 hsa-mir-555 hsa05219 Bladder cancer 5595_5594_595_9252_1870_1871_7157_4609_1869_5925 10 5.04E-13 3.33E-11 4.16E-12 22430 hsa-mir-555 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2113_3725_2034_2033_207_9915 11 2.46E-12 1.62E-10 1.80E-11 22431 hsa-mir-555 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925_207 10 4.54E-12 3.00E-10 3.00E-11 22432 hsa-mir-555 hsa05222 Small cell lung cancer 6256_595_5970_1870_1871_7157_4609_1869_5925_4846_207 11 1.41E-11 9.31E-10 8.47E-11 22433 hsa-mir-555 hsa04350 TGF-beta signaling pathway 5518_5595_5594_1387_4087_4609_4088_4089_2033_5933_4093 11 1.58E-11 1.04E-09 8.70E-11 22434 hsa-mir-555 hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_207_6464 10 2.35E-11 1.55E-09 1.19E-10 22435 hsa-mir-555 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_5970_4609_207 9 2.58E-10 1.70E-08 1.21E-09 22436 hsa-mir-555 hsa04310 Wnt signaling pathway 5518_1387_595_2932_7157_4087_4609_3725_1457_4088_4089_2033 12 2.94E-10 1.94E-08 1.29E-09 22437 hsa-mir-555 hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5925_207 9 1.14E-09 7.53E-08 4.71E-09 22438 hsa-mir-555 hsa04720 Long-term potentiation 5595_5594_1387_2902_6195_6197_6196_2033 8 3.39E-08 2.23E-06 1.31E-07 22439 hsa-mir-555 hsa04520 Adherens junction 5595_5594_1387_4087_1457_4088_4089_2033 8 5.38E-08 3.55E-06 1.83E-07 22440 hsa-mir-555 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 5.45E-08 3.60E-06 1.83E-07 22441 hsa-mir-555 hsa05213 Endometrial cancer 5595_5594_595_2932_7157_4609_207 7 5.81E-08 3.84E-06 1.83E-07 22442 hsa-mir-555 hsa04150 mTOR signaling pathway 5595_5594_6195_6197_3091_6196_207 7 5.81E-08 3.84E-06 1.83E-07 22443 hsa-mir-555 hsa05016 Huntington's disease 6874_1387_2902_6908_836_7157_3066_3065_3064_2033 10 3.08E-07 2.03E-05 9.25E-07 22444 hsa-mir-555 hsa04012 ErbB signaling pathway 5595_5594_2932_4609_3725_207_6464 7 1.47E-06 9.68E-05 4.21E-06 22445 hsa-mir-555 hsa04660 T cell receptor signaling pathway 5595_5594_2932_1432_5970_3725_207 7 6.34E-06 0.000418499 1.74E-05 22446 hsa-mir-555 hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_3725_207 6 8.71E-06 0.000574551 2.30E-05 22447 hsa-mir-555 hsa04370 VEGF signaling pathway 5595_5594_1432_9261_4846_207 6 1.00E-05 0.000661738 2.55E-05 22448 hsa-mir-555 hsa04330 Notch signaling pathway 1387_9612_3066_3065_2033 5 1.40E-05 0.000924735 3.42E-05 22449 hsa-mir-555 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_1432_7157_4846 5 3.07E-05 0.002027962 7.24E-05 22450 hsa-mir-555 hsa04620 Toll-like receptor signaling pathway 5595_5594_1432_5970_3725_207 6 4.50E-05 0.002970708 0.000102438 22451 hsa-mir-555 hsa04730 Long-term depression 5518_5592_5595_5594_4846 5 8.89E-05 0.005864203 0.000195473 22452 hsa-mir-555 hsa03022 Basal transcription factors 2963_6874_6908_2959 4 9.99E-05 0.006595038 0.000212743 22453 hsa-mir-555 hsa04910 Insulin signaling pathway 6720_5595_5594_2932_207_6464 6 0.000220112 0.014527374 0.00045398 22454 hsa-mir-555 hsa04510 Focal adhesion 5595_5594_595_2932_3725_207_6464 7 0.00028461 0.018784283 0.000569221 22455 hsa-mir-555 hsa04916 Melanogenesis 5595_5594_1387_2932_2033 5 0.000480488 0.03171222 0.000932712 22456 hsa-mir-555 hsa05010 Alzheimer's disease 5595_5594_2902_836_2932_4846 6 0.000785507 0.051843444 0.001481241 22457 hsa-mir-555 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_1432_5970_3725 4 0.001026315 0.067736806 0.001881578 22458 hsa-mir-555 hsa04062 Chemokine signaling pathway 5595_5594_2932_5970_207_6464 6 0.001210518 0.079894161 0.002159302 22459 hsa-mir-555 hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432_207 4 0.001496038 0.098738498 0.002598382 22460 hsa-mir-555 hsa04210 Apoptosis 836_5970_7157_207 4 0.002271132 0.149894744 0.003843455 22461 hsa-mir-555 hsa04630 Jak-STAT signaling pathway 1387_595_4609_2033_207 5 0.002652784 0.175083715 0.004377093 22462 hsa-mir-555 hsa04930 Type II diabetes mellitus 5595_5594_3651 3 0.002871693 0.189531768 0.004622726 22463 hsa-mir-555 hsa04912 GnRH signaling pathway 5595_5594_1432_3725 4 0.004431535 0.292481313 0.006963841 22464 hsa-mir-555 hsa05217 Basal cell carcinoma 2932_7157_2736 3 0.004907458 0.323892241 0.007532378 22465 hsa-mir-555 hsa04920 Adipocytokine signaling pathway 6256_5970_207 3 0.008269552 0.545790423 0.012404328 22466 hsa-mir-555 hsa04115 p53 signaling pathway 595_836_7157 3 0.008933036 0.589580376 0.013101786 22467 hsa-mir-555 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_6464 4 0.010114058 0.667527824 0.014511474 22468 hsa-mir-555 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428_7329 4 0.010358307 0.683648262 0.014545708 22469 hsa-mir-555 hsa04612 Antigen processing and presentation 4800_4801_3312 3 0.017272096 1 0.023749132 22470 hsa-mir-555 hsa04540 Gap junction 5592_5595_5594 3 0.019320357 1 0.026023338 22471 hsa-mir-555 hsa04270 Vascular smooth muscle contraction 5592_5595_5594 3 0.035033196 1 0.046243818 22472 hsa-mir-555 hsa04360 Axon guidance 5595_5594_2932 3 0.045160214 1 0.05844263 22473 hsa-mir-555 hsa04340 Hedgehog signaling pathway 2932_2736 2 0.047545498 1 0.060346208 22474 hsa-mir-556 hsa05200 Pathways in cancer 5914_595_596_598_1017_4193_5578_3091_3066_3065_5925_613_5743_5747_25_1487_2308_6789_4436_1870_1871_2113_9915_4286_1147_998_367_5595_5594_5599_1387_6256_836_2932_5970_7157_7704_1869_3725_4087_4088_4089_5888_5728_2034_2033_4846_3910_4792_3320_3326_5371_675_5601_5602_1856_51588_7428_4609_1026_1488_8554 62 1.28E-43 1.09E-41 1.09E-41 22475 hsa-mir-556 hsa04110 Cell cycle 595_1017_4193_902_3066_3065_5925_25_1870_1871_9232_5933_545_995_5347_5591_1387_11200_7534_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_1031_983_1026_1022_1111_8556_8555_472 37 3.76E-33 3.19E-31 1.60E-31 22476 hsa-mir-556 hsa05220 Chronic myeloid leukemia 595_598_4193_3066_3065_5925_613_25_1487_1870_1871_1147_5595_5594_5970_7157_1869_4088_4089_4792_4609_1026_1488_6464 24 3.65E-22 3.10E-20 1.03E-20 22477 hsa-mir-556 hsa05215 Prostate cancer 595_596_1017_4193_5925_2308_1870_1871_1147_367_5595_5594_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_1026 23 1.26E-19 1.07E-17 2.65E-18 22478 hsa-mir-556 hsa05212 Pancreatic cancer 595_596_1017_4193_5925_2308_1870_1871_1147_367_5595_5594_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_1026 23 1.56E-19 1.32E-17 2.65E-18 22479 hsa-mir-556 hsa04115 p53 signaling pathway 595_1017_4194_4193_900_50484_6241_51246_545_7161_11200_836_7157_64326_5728_27113_25898_983_1026_1111_472 21 3.51E-19 2.99E-17 4.98E-18 22480 hsa-mir-556 hsa05222 Small cell lung cancer 595_596_598_1017_5925_5743_5747_1870_1871_1147_6256_5970_7157_1869_5728_4846_3910_4792_51588_4609_8554 21 1.61E-17 1.37E-15 1.96E-16 22481 hsa-mir-556 hsa04310 Wnt signaling pathway 595_5578_1487_1460_5599_1387_2932_7157_3725_1457_1452_4087_4088_4089_2033_5518_5515_5601_5602_1856_4609_1488_5527 23 4.58E-15 3.89E-13 4.87E-14 22482 hsa-mir-556 hsa05210 Colorectal cancer 595_596_4436_5595_5594_5599_836_2932_7157_3725_4087_4088_4089_5601_5602_1856_4609 17 2.80E-13 2.38E-11 2.64E-12 22483 hsa-mir-556 hsa04010 MAPK signaling pathway 5578_5923_3304_3305_3303_6789_1432_4763_1616_1147_998_5595_5594_5599_836_3312_3315_5970_3164_7157_3725_4208_5601_5602_4609 25 8.77E-12 7.46E-10 7.46E-11 22484 hsa-mir-556 hsa05214 Glioma 595_4193_5578_5925_1870_1871_5595_5594_7157_1869_5728_1026_6464 13 2.05E-10 1.74E-08 1.59E-09 22485 hsa-mir-556 hsa05219 Bladder cancer 595_4193_5925_1870_1871_5595_5594_7157_1869_4609_1026 11 4.36E-10 3.70E-08 3.09E-09 22486 hsa-mir-556 hsa04350 TGF-beta signaling pathway 6667_5933_5595_5594_1387_7027_4087_4088_4089_2033_5518_5515_4609_4093 14 5.24E-10 4.45E-08 3.42E-09 22487 hsa-mir-556 hsa05223 Non-small cell lung cancer 595_5578_5925_6789_1870_1871_5595_5594_6256_7157_1869 11 4.33E-09 3.68E-07 2.63E-08 22488 hsa-mir-556 hsa04012 ErbB signaling pathway 5578_5747_25_5595_5594_5599_2932_3725_5601_5602_4609_1026_6464 13 4.87E-09 4.14E-07 2.76E-08 22489 hsa-mir-556 hsa05218 Melanoma 595_4193_5925_1870_1871_4286_5595_5594_7157_1869_5728_1026 12 5.55E-09 4.71E-07 2.95E-08 22490 hsa-mir-556 hsa04120 Ubiquitin mediated proteolysis 4193_3093_7319_84447_7329_10055_64326_7337_5371_672_25898_51588_7428_10075_8554 15 1.80E-08 1.53E-06 9.00E-08 22491 hsa-mir-556 hsa05211 Renal cell carcinoma 3091_2113_9915_998_5595_5594_1387_3725_2034_2033_7428 11 6.10E-08 5.18E-06 2.88E-07 22492 hsa-mir-556 hsa04510 Focal adhesion 595_596_5578_5923_5747_5499_998_5595_5594_5599_2932_3725_5728_3910_5601_5602_6464 17 7.88E-08 6.70E-06 3.53E-07 22493 hsa-mir-556 hsa04330 Notch signaling pathway 3066_3065_1487_1387_9612_2033_8850_1856_1488 9 1.79E-07 1.52E-05 7.62E-07 22494 hsa-mir-556 hsa04920 Adipocytokine signaling pathway 10891_6794_1147_5599_6256_5970_4792_5601_5602_5563 10 2.96E-07 2.52E-05 1.20E-06 22495 hsa-mir-556 hsa03022 Basal transcription factors 51616_2965_2963_6874_6908_2958_6880_2957 8 3.88E-07 3.30E-05 1.50E-06 22496 hsa-mir-556 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_1147_998_5599_836_5970_3725_4792_5601_5602 10 4.80E-07 4.08E-05 1.78E-06 22497 hsa-mir-556 hsa05221 Acute myeloid leukemia 5914_595_1147_5595_5594_5970_7704_5371_4609 9 9.91E-07 8.42E-05 3.51E-06 22498 hsa-mir-556 hsa04520 Adherens junction 1460_998_5595_5594_1387_1457_4087_4088_4089_2033 10 1.29E-06 0.00010995 4.40E-06 22499 hsa-mir-556 hsa04660 T cell receptor signaling pathway 1432_1147_998_5595_5594_2932_5970_3725_959_4792_5601 11 2.86E-06 0.000242719 9.34E-06 22500 hsa-mir-556 hsa05016 Huntington's disease 6667_10891_3066_3065_3064_25942_2902_1387_836_7157_2033_27113_6874_6908 14 3.39E-06 0.000288513 1.07E-05 22501 hsa-mir-556 hsa04910 Insulin signaling pathway 10891_6720_5499_2308_5595_5594_5599_2932_5601_5602_5563_6464 12 3.90E-06 0.00033167 1.18E-05 22502 hsa-mir-556 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_2902_1432_1616_836_7157_4846 8 6.18E-06 0.000525116 1.81E-05 22503 hsa-mir-556 hsa04370 VEGF signaling pathway 5578_5743_5747_1432_998_5595_5594_3315_4846 9 7.24E-06 0.000615563 2.05E-05 22504 hsa-mir-556 hsa04620 Toll-like receptor signaling pathway 1432_1147_5595_5594_5599_5970_3725_4792_5601_5602 10 9.47E-06 0.000805182 2.60E-05 22505 hsa-mir-556 hsa03420 Nucleotide excision repair 902_2965_4331_2071_2074_1022_6117 7 1.26E-05 0.001073431 3.35E-05 22506 hsa-mir-556 hsa05216 Thyroid cancer 595_5595_5594_6256_7157_4609 6 1.43E-05 0.001217228 3.69E-05 22507 hsa-mir-556 hsa04612 Antigen processing and presentation 3309_3304_3305_3303_3312_3320_3326_4800_4801 9 2.11E-05 0.001790484 5.12E-05 22508 hsa-mir-556 hsa04210 Apoptosis 596_598_823_1147_836_5970_7157_4792_472 9 2.11E-05 0.001790484 5.12E-05 22509 hsa-mir-556 hsa05213 Endometrial cancer 595_5595_5594_2932_7157_5728_4609 7 3.35E-05 0.002845281 7.90E-05 22510 hsa-mir-556 hsa04662 B cell receptor signaling pathway 1147_5595_5594_1380_2932_5970_3725_4792 8 4.27E-05 0.003627193 9.80E-05 22511 hsa-mir-556 hsa04912 GnRH signaling pathway 5578_1432_998_5595_5594_5599_3725_5601_5602 9 8.55E-05 0.007268704 0.000191282 22512 hsa-mir-556 hsa04720 Long-term potentiation 5578_2902_5499_5595_5594_1387_2033 7 0.000275428 0.023411359 0.000600291 22513 hsa-mir-556 hsa04916 Melanogenesis 5578_4286_5595_5594_1387_2932_2033_1856 8 0.00034929 0.029689673 0.000742242 22514 hsa-mir-556 hsa04664 Fc epsilon RI signaling pathway 5578_1432_5595_5594_5599_5601_5602 7 0.000369331 0.031393134 0.000765686 22515 hsa-mir-556 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601_5602 5 0.001013495 0.086147046 0.00205112 22516 hsa-mir-556 hsa04730 Long-term depression 5578_5595_5594_4846_5518_5515 6 0.001214751 0.103253799 0.002401251 22517 hsa-mir-556 hsa04062 Chemokine signaling pathway 5747_6362_1147_998_5595_5594_2932_5970_4792_6464 10 0.001272059 0.108124997 0.002457386 22518 hsa-mir-556 hsa03440 Homologous recombination 641_5888_675_6117 4 0.001416477 0.120400574 0.002675568 22519 hsa-mir-556 hsa04150 mTOR signaling pathway 6794_3091_5595_5594_5563 5 0.001834435 0.155926939 0.003389716 22520 hsa-mir-556 hsa04530 Tight junction 5578_1460_998_1457_5728_5518_5515_5520 8 0.001887697 0.160454254 0.00341392 22521 hsa-mir-556 hsa05131 Shigellosis 5578_25_998_7534_4691 5 0.002479078 0.210721662 0.004300442 22522 hsa-mir-556 hsa05130 Pathogenic Escherichia coli infection 5578_25_998_7534_4691 5 0.002479078 0.210721662 0.004300442 22523 hsa-mir-556 hsa03030 DNA replication 79621_5557_6117_5422 4 0.003268083 0.277787047 0.005446805 22524 hsa-mir-556 hsa03410 Base excision repair 3146_142_4913_328 4 0.003268083 0.277787047 0.005446805 22525 hsa-mir-556 hsa04360 Axon guidance 5747_25_998_5595_5594_2932_1020 7 0.005647606 0.480046489 0.009231663 22526 hsa-mir-556 hsa04950 Maturity onset diabetes of the young 6927_3172_5080 3 0.00805616 0.684773583 0.012863216 22527 hsa-mir-556 hsa05010 Alzheimer's disease 823_2902_5595_5594_836_2932_4846_1020 8 0.008171925 0.694613664 0.012863216 22528 hsa-mir-556 hsa04630 Jak-STAT signaling pathway 595_598_1387_2033_51588_4609_8554 7 0.013021799 1 0.020124599 22529 hsa-mir-556 hsa04540 Gap junction 5578_5595_5594_1453_983 5 0.017877081 1 0.027134855 22530 hsa-mir-556 hsa04710 Circadian rhythm - mammal 8863_1453 2 0.021745143 1 0.032426968 22531 hsa-mir-556 hsa03450 Non-homologous end-joining 2547_5591 2 0.024601875 1 0.036054472 22532 hsa-mir-557 hsa04110 Cell cycle 10971_7534_1387 3 6.05E-05 0.001573305 0.001573305 22533 hsa-mir-557 hsa05131 Shigellosis 10971_7534 2 0.000614246 0.015970397 0.005323466 22534 hsa-mir-557 hsa05130 Pathogenic Escherichia coli infection 10971_7534 2 0.000614246 0.015970397 0.005323466 22535 hsa-mir-557 hsa05215 Prostate cancer 1387_90993 2 0.001470389 0.038230121 0.007814899 22536 hsa-mir-557 hsa05212 Pancreatic cancer 1387_90993 2 0.001502865 0.039074496 0.007814899 22537 hsa-mir-557 hsa04916 Melanogenesis 1387_90993 2 0.002030844 0.052801944 0.008800324 22538 hsa-mir-557 hsa04120 Ubiquitin mediated proteolysis 4734_11059 2 0.00355471 0.092422456 0.013203208 22539 hsa-mir-557 hsa04310 Wnt signaling pathway 1452_1387 2 0.004222252 0.109778551 0.013722319 22540 hsa-mir-557 hsa05016 Huntington's disease 1387_90993 2 0.006348427 0.165059109 0.018339901 22541 hsa-mir-557 hsa04330 Notch signaling pathway 1387 1 0.029956343 0.778864906 0.072303108 22542 hsa-mir-557 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432 1 0.035477663 0.922419231 0.072303108 22543 hsa-mir-557 hsa04340 Hedgehog signaling pathway 1452 1 0.036089302 0.938321842 0.072303108 22544 hsa-mir-557 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432 1 0.044613757 1 0.072303108 22545 hsa-mir-557 hsa05211 Renal cell carcinoma 1387 1 0.045219906 1 0.072303108 22546 hsa-mir-557 hsa04720 Long-term potentiation 1387 1 0.047036167 1 0.072303108 22547 hsa-mir-557 hsa04370 VEGF signaling pathway 1432 1 0.048245189 1 0.072303108 22548 hsa-mir-557 hsa04664 Fc epsilon RI signaling pathway 1432 1 0.049452758 1 0.072303108 22549 hsa-mir-558 hsa04010 MAPK signaling pathway 9344_6722_5606_5601_5600_2885_5595_1432_5594_5604_5599_2005_2353 13 1.76E-17 8.80E-16 8.80E-16 22550 hsa-mir-558 hsa04664 Fc epsilon RI signaling pathway 5606_5601_5600_2885_5595_1432_5594_5604_5599 9 1.59E-15 7.93E-14 3.97E-14 22551 hsa-mir-558 hsa04620 Toll-like receptor signaling pathway 5606_5601_5600_5595_1432_5594_5604_5599_2353 9 1.38E-14 6.88E-13 2.29E-13 22552 hsa-mir-558 hsa04912 GnRH signaling pathway 5606_5601_5600_2885_5595_1432_5594_5604_5599 9 2.24E-14 1.12E-12 2.80E-13 22553 hsa-mir-558 hsa04660 T cell receptor signaling pathway 5601_5600_2885_5595_1432_5594_5604_2353 8 1.98E-12 9.88E-11 1.98E-11 22554 hsa-mir-558 hsa05200 Pathways in cancer 5601_2885_2033_9063_5595_5594_5604_5599_2353_1387 10 1.14E-11 5.72E-10 9.53E-11 22555 hsa-mir-558 hsa05210 Colorectal cancer 5601_2885_5595_5594_5604_5599_2353 7 2.16E-11 1.08E-09 1.55E-10 22556 hsa-mir-558 hsa04350 TGF-beta signaling pathway 2033_5595_5594_3397_3399_3398_1387 7 2.73E-11 1.36E-09 1.71E-10 22557 hsa-mir-558 hsa05211 Renal cell carcinoma 2885_2033_5595_5594_5604_1387 6 6.51E-10 3.26E-08 3.62E-09 22558 hsa-mir-558 hsa04012 ErbB signaling pathway 5601_2885_5595_5594_5604_5599 6 1.91E-09 9.53E-08 9.04E-09 22559 hsa-mir-558 hsa05215 Prostate cancer 2885_2033_5595_5594_5604_1387 6 2.03E-09 1.02E-07 9.04E-09 22560 hsa-mir-558 hsa05212 Pancreatic cancer 2885_2033_5595_5594_5604_1387 6 2.17E-09 1.08E-07 9.04E-09 22561 hsa-mir-558 hsa04910 Insulin signaling pathway 5601_2885_5595_5594_5604_5599 6 2.66E-08 1.33E-06 1.02E-07 22562 hsa-mir-558 hsa04720 Long-term potentiation 2033_5595_5594_5604_1387 5 5.53E-08 2.76E-06 1.84E-07 22563 hsa-mir-558 hsa04662 B cell receptor signaling pathway 2885_5595_5594_5604_2353 5 5.53E-08 2.76E-06 1.84E-07 22564 hsa-mir-558 hsa04370 VEGF signaling pathway 5600_5595_1432_5594_5604 5 6.26E-08 3.13E-06 1.96E-07 22565 hsa-mir-558 hsa04916 Melanogenesis 2033_5595_5594_5604_1387 5 2.62E-07 1.31E-05 7.31E-07 22566 hsa-mir-558 hsa04510 Focal adhesion 5601_2885_5595_5594_5604_5599 6 2.63E-07 1.32E-05 7.31E-07 22567 hsa-mir-558 hsa04930 Type II diabetes mellitus 5601_5595_5594_5599 4 4.43E-07 2.21E-05 1.17E-06 22568 hsa-mir-558 hsa05213 Endometrial cancer 2885_5595_5594_5604 4 7.63E-07 3.81E-05 1.91E-06 22569 hsa-mir-558 hsa05223 Non-small cell lung cancer 2885_5595_5594_5604 4 8.79E-07 4.40E-05 2.09E-06 22570 hsa-mir-558 hsa05221 Acute myeloid leukemia 2885_5595_5594_5604 4 1.23E-06 6.14E-05 2.79E-06 22571 hsa-mir-558 hsa05214 Glioma 2885_5595_5594_5604 4 1.77E-06 8.87E-05 3.86E-06 22572 hsa-mir-558 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5601_5600_1432_5599 4 2.48E-06 0.000124033 5.17E-06 22573 hsa-mir-558 hsa05220 Chronic myeloid leukemia 2885_5595_5594_5604 4 3.06E-06 0.000152772 6.11E-06 22574 hsa-mir-558 hsa04520 Adherens junction 2033_5595_5594_1387 4 3.91E-06 0.000195302 7.51E-06 22575 hsa-mir-558 hsa04540 Gap junction 2885_5595_5594_5604 4 6.93E-06 0.000346605 1.28E-05 22576 hsa-mir-558 hsa05216 Thyroid cancer 5595_5594_5604 3 9.03E-06 0.000451609 1.61E-05 22577 hsa-mir-558 hsa05219 Bladder cancer 5595_5594_5604 3 2.55E-05 0.001277416 4.40E-05 22578 hsa-mir-558 hsa04650 Natural killer cell mediated cytotoxicity 2885_5595_5594_5604 4 3.12E-05 0.001559211 5.20E-05 22579 hsa-mir-558 hsa04310 Wnt signaling pathway 5601_2033_5599_1387 4 4.50E-05 0.002251245 7.26E-05 22580 hsa-mir-558 hsa04630 Jak-STAT signaling pathway 2885_2033_9063_1387 4 4.85E-05 0.002424679 7.58E-05 22581 hsa-mir-558 hsa05014 Amyotrophic lateral sclerosis (ALS) 5606_5600_1432 3 5.78E-05 0.002890983 8.76E-05 22582 hsa-mir-558 hsa04062 Chemokine signaling pathway 2885_5595_5594_5604 4 0.000111235 0.005561735 0.000158049 22583 hsa-mir-558 hsa05218 Melanoma 5595_5594_5604 3 0.000113795 0.005689753 0.000158049 22584 hsa-mir-558 hsa04730 Long-term depression 5595_5594_5604 3 0.000113795 0.005689753 0.000158049 22585 hsa-mir-558 hsa04270 Vascular smooth muscle contraction 5595_5594_5604 3 0.000485241 0.024262031 0.000655731 22586 hsa-mir-558 hsa04120 Ubiquitin mediated proteolysis 7329_9063_672 3 0.000772927 0.038646328 0.001017009 22587 hsa-mir-558 hsa03022 Basal transcription factors 6908_2959 2 0.001121111 0.05605554 0.001437322 22588 hsa-mir-558 hsa05010 Alzheimer's disease 6622_5595_5594 3 0.001530008 0.076500406 0.00191251 22589 hsa-mir-558 hsa04330 Notch signaling pathway 2033_1387 2 0.001765131 0.088256554 0.002152599 22590 hsa-mir-558 hsa05016 Huntington's disease 6908_2033_1387 3 0.001812363 0.090618164 0.002157575 22591 hsa-mir-558 hsa04150 mTOR signaling pathway 5595_5594 2 0.002139341 0.106967027 0.002487605 22592 hsa-mir-558 hsa04810 Regulation of actin cytoskeleton 5595_5594_5604 3 0.002776341 0.138817058 0.003154933 22593 hsa-mir-558 hsa04920 Adipocytokine signaling pathway 5601_5599 2 0.003465646 0.173282306 0.003850718 22594 hsa-mir-558 hsa04110 Cell cycle 2033_1387 2 0.010291247 0.514562337 0.011186138 22595 hsa-mir-558 hsa04670 Leukocyte transendothelial migration 5600_1432 2 0.010784407 0.539220353 0.011472773 22596 hsa-mir-558 hsa04360 Axon guidance 5595_5594 2 0.012325394 0.61626971 0.012838952 22597 hsa-mir-562 hsa05211 Renal cell carcinoma 9915_2034_2033_3091 4 6.36E-07 1.15E-05 1.15E-05 22598 hsa-mir-562 hsa05200 Pathways in cancer 9915_5371_2034_2033_3091 5 1.14E-05 0.000205052 0.000102526 22599 hsa-mir-562 hsa04330 Notch signaling pathway 9612_2033 2 0.000892099 0.016057782 0.005352594 22600 hsa-mir-562 hsa04520 Adherens junction 2033_1457 2 0.002473657 0.044525826 0.010460059 22601 hsa-mir-562 hsa04350 TGF-beta signaling pathway 2033_4093 2 0.002905572 0.052300293 0.010460059 22602 hsa-mir-562 hsa04120 Ubiquitin mediated proteolysis 5371_7329 2 0.007115914 0.128086445 0.021347741 22603 hsa-mir-562 hsa04310 Wnt signaling pathway 2033_1457 2 0.008432989 0.151793802 0.021684829 22604 hsa-mir-562 hsa03022 Basal transcription factors 2963 1 0.033627306 0.605291512 0.075661439 22605 hsa-mir-562 hsa04150 mTOR signaling pathway 3091 1 0.046599202 0.838785631 0.093198403 22606 hsa-mir-566 hsa05200 Pathways in cancer 5914_595_596_598_3815_1017_4193_7704_5578_3091_3066_3065_5925_613_5743_5747_25_1956_6789_4436_1870_1871_2113_867_207_9915_4286_3716_1147_998_367_5595_5594_5599_861_1387_6256_836_2932_6774_6777_6772_5970_7157_6688_1869_3725_2735_2736_2737_4087_4088_4089_5888_5728_2034_2033_4846_3910_4792_3320_3326_5371_675_5159_5156_5601_5602_1856_1399_1398_51588_7428_4609_1026_2353_8554 77 8.31E-52 7.06E-50 7.06E-50 22607 hsa-mir-566 hsa04110 Cell cycle 595_1017_4193_902_3066_3065_5925_25_1870_1871_9232_5933_545_995_5347_5591_1387_11200_7534_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_1031_983_1026_1022_1111_8556_8555_472 37 3.90E-29 3.32E-27 1.66E-27 22608 hsa-mir-566 hsa05220 Chronic myeloid leukemia 595_598_4193_3066_3065_5925_613_25_1870_1871_867_207_1147_5595_5594_861_6777_5970_7157_1869_4088_4089_4792_1399_1398_5781_4609_1026_6464 29 2.66E-25 2.26E-23 7.54E-24 22609 hsa-mir-566 hsa05215 Prostate cancer 595_596_1017_4193_5925_1956_1870_1871_207_1147_367_5595_5594_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_5159_5156_1026 26 2.21E-20 1.87E-18 4.69E-19 22610 hsa-mir-566 hsa05212 Pancreatic cancer 595_596_1017_4193_5925_1956_1870_1871_207_1147_367_5595_5594_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_5159_5156_1026 26 2.80E-20 2.38E-18 4.75E-19 22611 hsa-mir-566 hsa04115 p53 signaling pathway 595_1017_4194_4193_50484_6241_51246_545_7161_11200_836_7157_900_64326_5728_27113_25898_983_1026_1111_472 21 6.13E-17 5.21E-15 8.68E-16 22612 hsa-mir-566 hsa05210 Colorectal cancer 595_596_1956_4436_207_5595_5594_5599_836_2932_7157_3725_4087_4088_4089_5159_5156_5601_5602_1856_4609_2353 22 1.61E-16 1.37E-14 1.96E-15 22613 hsa-mir-566 hsa05222 Small cell lung cancer 595_596_598_1017_5925_5743_5747_1870_1871_207_1147_6256_5970_7157_1869_5728_4846_3910_4792_51588_4609_8554 22 2.46E-16 2.09E-14 2.61E-15 22614 hsa-mir-566 hsa04010 MAPK signaling pathway 5578_4773_5923_1956_3304_3305_3303_6789_4763_1616_207_1147_998_5595_5594_5599_1386_836_3312_3315_1649_5970_3164_7157_3725_5159_5156_4208_5601_5602_1399_1398_4609_2353 34 6.54E-16 5.56E-14 6.18E-15 22615 hsa-mir-566 hsa04012 ErbB signaling pathway 5578_5747_25_1956_867_207_5595_5594_5599_2066_2932_6777_3725_6714_5601_5602_1399_1398_4609_1026_6464 21 3.18E-15 2.70E-13 2.70E-14 22616 hsa-mir-566 hsa05214 Glioma 595_4193_5578_5925_1956_1870_1871_207_5595_5594_7157_1869_5728_5159_5156_1026_6464 17 4.59E-13 3.90E-11 3.54E-12 22617 hsa-mir-566 hsa04310 Wnt signaling pathway 595_5578_4773_1460_5599_1387_2932_7157_8061_3725_1457_1452_4087_4088_4089_2033_5518_5515_5601_5602_1856_4609_5527 23 9.46E-13 8.04E-11 6.70E-12 22618 hsa-mir-566 hsa04630 Jak-STAT signaling pathway 595_598_3560_3561_2057_867_2690_207_3717_3716_3718_85480_1387_3575_6774_6777_6772_2033_51588_5781_4609_8554 22 9.18E-12 7.80E-10 6.00E-11 22619 hsa-mir-566 hsa05221 Acute myeloid leukemia 5914_595_3815_7704_207_1147_5595_5594_861_6774_6777_5970_6688_5371_4609 15 1.54E-11 1.31E-09 8.81E-11 22620 hsa-mir-566 hsa05218 Melanoma 595_4193_5925_1956_1870_1871_207_4286_5595_5594_7157_1869_5728_5159_5156_1026 16 1.56E-11 1.32E-09 8.81E-11 22621 hsa-mir-566 hsa04350 TGF-beta signaling pathway 3398_6667_3399_5933_5595_5594_1387_7027_4086_4087_4088_4089_2033_5518_5515_4609_4093 17 2.59E-11 2.21E-09 1.38E-10 22622 hsa-mir-566 hsa04510 Focal adhesion 595_596_5578_5923_5747_1956_5499_207_998_5595_5594_5599_2932_3725_5728_3910_6714_5159_5156_5601_5602_1399_1398_6464 24 4.49E-11 3.81E-09 2.24E-10 22623 hsa-mir-566 hsa05211 Renal cell carcinoma 3091_2113_207_9915_998_5595_5594_1387_3725_2034_2033_1399_1398_7428_5781 15 1.76E-10 1.49E-08 8.30E-10 22624 hsa-mir-566 hsa05219 Bladder cancer 595_4193_5925_1956_1870_1871_5595_5594_7157_1869_4609_1026 12 5.44E-10 4.62E-08 2.43E-09 22625 hsa-mir-566 hsa05223 Non-small cell lung cancer 595_5578_5925_1956_6789_1870_1871_207_5595_5594_6256_7157_1869 13 6.28E-10 5.33E-08 2.67E-09 22626 hsa-mir-566 hsa04660 T cell receptor signaling pathway 1493_4773_3932_867_207_1147_998_5595_5594_2932_5970_3725_4792_5601_919_2353_959 17 6.60E-10 5.61E-08 2.67E-09 22627 hsa-mir-566 hsa04520 Adherens junction 5770_1956_1460_998_5595_5594_1387_1457_4087_4088_4089_2033_6714_3643 14 5.20E-09 4.42E-07 2.01E-08 22628 hsa-mir-566 hsa04920 Adipocytokine signaling pathway 6794_207_3717_1147_5599_6256_6774_5970_4792_5601_5602_5781_5563 13 6.16E-09 5.23E-07 2.28E-08 22629 hsa-mir-566 hsa04662 B cell receptor signaling pathway 4773_6850_207_1147_695_5595_5594_1380_2932_5970_3725_4792_2353 13 2.03E-08 1.72E-06 7.19E-08 22630 hsa-mir-566 hsa04062 Chemokine signaling pathway 1234_5747_6362_207_3717_1147_3718_998_5595_5594_2932_6774_6777_6772_5970_4792_1399_1398_6464 19 5.65E-08 4.81E-06 1.92E-07 22631 hsa-mir-566 hsa04910 Insulin signaling pathway 6720_5770_5499_867_207_5595_5594_5599_2932_3643_5601_5602_1399_1398_5563_6464 16 8.22E-08 6.99E-06 2.69E-07 22632 hsa-mir-566 hsa04120 Ubiquitin mediated proteolysis 4193_3093_7319_84447_867_7329_10055_64326_7337_5371_672_25898_10075_51588_7428_8554 16 9.00E-08 7.65E-06 2.76E-07 22633 hsa-mir-566 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_1147_998_5599_836_5970_3725_4792_6714_5601_5602_5781 12 9.09E-08 7.73E-06 2.76E-07 22634 hsa-mir-566 hsa03022 Basal transcription factors 51616_2965_2963_6874_6908_2958_2959_6880_2957 9 2.60E-07 2.21E-05 7.61E-07 22635 hsa-mir-566 hsa04370 VEGF signaling pathway 5578_4773_5743_5747_207_998_5595_5594_3315_4846_6714 11 1.39E-06 0.000118466 3.95E-06 22636 hsa-mir-566 hsa04620 Toll-like receptor signaling pathway 207_1147_5595_5594_5599_6772_5970_3725_4792_5601_5602_2353 12 2.97E-06 0.000252196 8.14E-06 22637 hsa-mir-566 hsa05213 Endometrial cancer 595_1956_207_5595_5594_2932_7157_5728_4609 9 3.14E-06 0.000266708 8.33E-06 22638 hsa-mir-566 hsa04210 Apoptosis 596_598_823_207_1147_836_5970_7157_4792_472 10 2.84E-05 0.002410839 7.31E-05 22639 hsa-mir-566 hsa05016 Huntington's disease 3066_3065_3064_25942_2902_6667_1387_836_7157_2033_27113_6874_6908_4724 14 5.74E-05 0.004880824 0.000143554 22640 hsa-mir-566 hsa05216 Thyroid cancer 595_5595_5594_6256_7157_4609 6 5.96E-05 0.005064186 0.000144691 22641 hsa-mir-566 hsa03420 Nucleotide excision repair 902_2965_4331_2071_2074_1022_6117 7 6.40E-05 0.005437444 0.000147749 22642 hsa-mir-566 hsa04664 Fc epsilon RI signaling pathway 5578_6850_207_695_5595_5594_5599_5601_5602 9 6.43E-05 0.005466713 0.000147749 22643 hsa-mir-566 hsa04330 Notch signaling pathway 3066_3065_1387_9612_2033_8850_1856 7 9.30E-05 0.007901152 0.000207925 22644 hsa-mir-566 hsa04912 GnRH signaling pathway 5578_1956_998_5595_5594_5599_3725_6714_5601_5602 10 0.000126813 0.010779118 0.000276388 22645 hsa-mir-566 hsa04612 Antigen processing and presentation 3309_3304_3305_3303_3312_3320_3326_4800_4801 9 0.000148681 0.012637851 0.000309318 22646 hsa-mir-566 hsa05340 Primary immunodeficiency 3932_3561_3718_695_3575_959 6 0.0001492 0.012682038 0.000309318 22647 hsa-mir-566 hsa04540 Gap junction 5578_1956_5595_5594_1453_6714_5159_983_5156 9 0.000201779 0.017151187 0.000408362 22648 hsa-mir-566 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_2902_1616_836_7157_4846 7 0.00024899 0.021164168 0.00049219 22649 hsa-mir-566 hsa04916 Melanogenesis 3815_5578_4286_5595_5594_1387_2932_2033_1856 9 0.000434035 0.03689295 0.000838476 22650 hsa-mir-566 hsa04930 Type II diabetes mellitus 5595_5594_5599_3643_5601_5602 6 0.000505348 0.042954611 0.000954547 22651 hsa-mir-566 hsa04530 Tight junction 5578_207_1460_998_1457_5728_6714_5518_5515_5520 10 0.00074167 0.063041962 0.001370477 22652 hsa-mir-566 hsa04650 Natural killer cell mediated cytotoxicity 5578_4773_3932_6850_5595_5594_836_919_5781_6464 10 0.000781577 0.066434045 0.00141349 22653 hsa-mir-566 hsa04150 mTOR signaling pathway 6794_3091_207_5595_5594_5563 6 0.001010367 0.085881229 0.001789192 22654 hsa-mir-566 hsa04720 Long-term potentiation 5578_2902_5499_5595_5594_1387_2033 7 0.001238246 0.105250879 0.002147977 22655 hsa-mir-566 hsa05217 Basal cell carcinoma 2932_7157_2735_2736_2737_1856 6 0.001318414 0.112065195 0.002241304 22656 hsa-mir-566 hsa04340 Hedgehog signaling pathway 2932_1452_1453_2735_2736_2737 6 0.001560452 0.132638438 0.002600754 22657 hsa-mir-566 hsa03440 Homologous recombination 641_5888_675_6117 4 0.003565345 0.303054352 0.005827968 22658 hsa-mir-566 hsa04060 Cytokine-cytokine receptor interaction 3815_1234_1956_3560_3561_2057_6362_2690_85480_3575_5159_5156_959 13 0.003646501 0.30995259 0.005848162 22659 hsa-mir-566 hsa04730 Long-term depression 5578_5595_5594_4846_5518_5515 6 0.004315727 0.366836775 0.006793274 22660 hsa-mir-566 hsa04360 Axon guidance 4773_5747_25_998_5595_5594_2932_1020 8 0.006740713 0.572960577 0.010417465 22661 hsa-mir-566 hsa05131 Shigellosis 5578_25_998_7534_4691 5 0.007252384 0.616452666 0.010814959 22662 hsa-mir-566 hsa05130 Pathogenic Escherichia coli infection 5578_25_998_7534_4691 5 0.007252384 0.616452666 0.010814959 22663 hsa-mir-566 hsa03410 Base excision repair 3146_142_4913_328 4 0.007999781 0.67998136 0.011723817 22664 hsa-mir-566 hsa05010 Alzheimer's disease 823_2902_5595_5594_836_2932_4846_1020_4724 9 0.012414134 1 0.017884769 22665 hsa-mir-566 hsa04810 Regulation of actin cytoskeleton 5747_1956_5499_998_5595_5594_5159_5156_1399_1398 10 0.026725488 1 0.037861108 22666 hsa-mir-566 hsa04710 Circadian rhythm - mammal 8863_1453 2 0.034862509 1 0.048578906 22667 hsa-mir-566 hsa04640 Hematopoietic cell lineage 3815_2057_1380_3575_914 5 0.036564122 1 0.050128232 22668 hsa-mir-566 hsa03450 Non-homologous end-joining 2547_5591 2 0.039328391 1 0.053062115 22669 hsa-mir-566 hsa03030 DNA replication 5557_6117_5422 3 0.042038935 1 0.055832961 22670 hsa-mir-567 hsa03022 Basal transcription factors 6908_2959 2 4.94E-06 1.97E-05 1.97E-05 22671 hsa-mir-567 hsa04350 TGF-beta signaling pathway 659 1 0.008773629 0.035094515 0.017547257 22672 hsa-mir-567 hsa05016 Huntington's disease 6908 1 0.018779936 0.075119744 0.025039915 22673 hsa-mir-567 hsa04060 Cytokine-cytokine receptor interaction 659 1 0.026068388 0.104273551 0.026068388 22674 hsa-mir-568 hsa05200 Pathways in cancer 4149_5914_1017_8517_4193_3551_3091_4089_1050_5925_7184_7187_10342_1956_2308_1870_1871_10401_861_1147_2249_5595_5594_5599_1387_6256_9915_367_2932_6776_6777_6772_5970_7157_6688_1869_3725_4088_2033_898_4790_4792_3320_3326_5371_841_4609_1026_1029_2353_2034_8554 52 1.13E-30 8.80E-29 8.80E-29 22675 hsa-mir-568 hsa04110 Cell cycle 1017_5001_4193_6500_4089_4174_4171_4172_4173_5925_1870_1871_5934_5933_993_5591_1387_7532_2932_7157_1869_4085_4088_2033_890_898_983_8454_1026_1029_4998_4999 32 1.68E-25 1.31E-23 6.57E-24 22676 hsa-mir-568 hsa03022 Basal transcription factors 54457_6879_2958_6872_138474_6883_6881_6873_2967_2961_2960_2963_2969_2968_6878_6877_6874_6908_6884_6882_2959_6880_2957 23 2.71E-25 2.11E-23 7.03E-24 22677 hsa-mir-568 hsa05215 Prostate cancer 1017_8517_4193_3551_5925_7184_1956_2308_1870_1871_1147_5595_5594_1385_1387_367_2932_5970_7157_468_1869_2033_898_4790_4792_3320_3326_1026 28 3.85E-24 3.00E-22 7.50E-23 22678 hsa-mir-568 hsa05212 Pancreatic cancer 1017_8517_4193_3551_5925_7184_1956_2308_1870_1871_1147_5595_5594_1385_1387_367_2932_5970_7157_468_1869_2033_898_4790_4792_3320_3326_1026 28 4.98E-24 3.88E-22 7.76E-23 22679 hsa-mir-568 hsa05220 Chronic myeloid leukemia 8517_4193_3551_4089_5925_1870_1871_861_1147_5595_5594_6776_6777_5970_7157_1869_4088_4790_4792_4609_1026_1029 22 1.30E-18 1.01E-16 1.69E-17 22680 hsa-mir-568 hsa03010 Ribosome 6156_6193_6204_6205_6207_6202_6141_9349_6217_6210_6130_6137_6135_6191_6222_6223_6229_6129_6128_6189_6181_6188_6232 23 3.08E-17 2.40E-15 3.43E-16 22681 hsa-mir-568 hsa04010 MAPK signaling pathway 6722_3727_4149_8517_9252_3551_9020_1956_3305_3303_9479_1147_2249_5595_5594_5599_1386_3310_3312_5971_5970_7157_468_3725_6195_6196_1649_4790_1326_5566_4609_2353_2002 33 8.18E-17 6.38E-15 7.97E-16 22682 hsa-mir-568 hsa05222 Small cell lung cancer 4149_1017_8517_3551_5925_7187_1870_1871_10401_1147_6256_5970_7157_1869_898_4790_4792_4609_8554 19 2.47E-14 1.92E-12 2.14E-13 22683 hsa-mir-568 hsa04350 TGF-beta signaling pathway 6667_6500_4089_3399_3398_1874_1875_5934_5933_5595_5594_1387_4088_2033_5519_5518_8454_4609_4093 19 2.96E-14 2.31E-12 2.31E-13 22684 hsa-mir-568 hsa03050 Proteasome 5708_5709_5705_5706_5707_5700_5701_5702_5693_5719_5713_5710_5684_5717_5687 15 1.88E-13 1.47E-11 1.33E-12 22685 hsa-mir-568 hsa05221 Acute myeloid leukemia 5914_8517_3551_1050_861_1147_5595_5594_6776_6777_5970_6688_4790_5371_4609 15 2.36E-12 1.84E-10 1.53E-11 22686 hsa-mir-568 hsa04310 Wnt signaling pathway 815_6500_4089_23291_8607_1460_5599_1387_2932_7157_3725_1457_4088_2033_5519_5518_5566_8454_8945_6423_4609 21 3.60E-12 2.81E-10 2.16E-11 22687 hsa-mir-568 hsa05214 Glioma 815_4193_5925_1956_1870_1871_5595_5594_7157_1869_808_801_805_1026_1029 15 7.79E-12 6.07E-10 4.34E-11 22688 hsa-mir-568 hsa05219 Bladder cancer 9252_4193_5925_1956_1870_1871_5595_5594_7157_1869_4609_1026_1029 13 8.58E-12 6.70E-10 4.46E-11 22689 hsa-mir-568 hsa04620 Toll-like receptor signaling pathway 8517_3551_7187_1147_5595_5594_5599_6772_5970_3725_4790_4792_1326_9641_841_2353_6348 17 3.01E-11 2.35E-09 1.47E-10 22690 hsa-mir-568 hsa04720 Long-term potentiation 815_5499_5595_5594_1387_468_6195_6196_2033_808_801_805_5566 13 4.21E-09 3.28E-07 1.82E-08 22691 hsa-mir-568 hsa04662 B cell receptor signaling pathway 8517_3551_4794_1147_5595_5594_2932_5970_3725_4790_4792_4793_2353 13 4.21E-09 3.28E-07 1.82E-08 22692 hsa-mir-568 hsa04660 T cell receptor signaling pathway 8517_3551_9020_4794_1147_5595_5594_2932_5970_3725_4790_4792_4793_1326_2353 15 5.20E-09 4.05E-07 2.13E-08 22693 hsa-mir-568 hsa05218 Melanoma 4193_5925_1956_1870_1871_2249_5595_5594_7157_1869_1026_1029 12 2.14E-08 1.67E-06 8.34E-08 22694 hsa-mir-568 hsa04910 Insulin signaling pathway 3551_5499_2308_23265_5211_5595_5594_5599_2932_2194_808_801_805_5566_2002 15 8.15E-08 6.35E-06 3.03E-07 22695 hsa-mir-568 hsa05223 Non-small cell lung cancer 5925_1956_1870_1871_5595_5594_6256_7157_1869_1029 10 1.52E-07 1.19E-05 5.38E-07 22696 hsa-mir-568 hsa04012 ErbB signaling pathway 815_1956_5595_5594_5599_2932_6776_6777_3725_4609_1026_2002 12 1.59E-07 1.24E-05 5.38E-07 22697 hsa-mir-568 hsa04520 Adherens junction 4089_1956_71_1460_5595_5594_1387_1457_4088_2033_8826 11 5.36E-07 4.18E-05 1.74E-06 22698 hsa-mir-568 hsa05210 Colorectal cancer 4089_1956_5595_5594_5599_2932_7157_3725_4088_4609_2353 11 8.31E-07 6.48E-05 2.59E-06 22699 hsa-mir-568 hsa04920 Adipocytokine signaling pathway 8517_3551_4794_1147_5599_6256_5970_4790_4792_4793 10 8.99E-07 7.01E-05 2.70E-06 22700 hsa-mir-568 hsa04912 GnRH signaling pathway 815_1956_5595_5594_5599_468_3725_808_801_805_5566_2002 12 1.30E-06 0.000101537 3.75E-06 22701 hsa-mir-568 hsa04612 Antigen processing and presentation 3309_3305_3303_1385_3310_3312_1514_3320_3326_4800_4801 11 1.39E-06 0.000108787 3.75E-06 22702 hsa-mir-568 hsa04210 Apoptosis 8517_3551_9020_1147_5970_7157_9131_4790_4792_5566_841 11 1.39E-06 0.000108787 3.75E-06 22703 hsa-mir-568 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 8517_3551_9020_1956_1147_5599_5970_3725_4790_4792 10 1.45E-06 0.000112881 3.76E-06 22704 hsa-mir-568 hsa04540 Gap junction 10382_203068_1956_5595_5594_7846_347733_983_5566_7278_84617 11 2.06E-06 0.000160954 5.19E-06 22705 hsa-mir-568 hsa03020 RNA polymerase 25885_64425_51082_5430_5437_84172_5441 7 2.49E-06 0.000194607 6.08E-06 22706 hsa-mir-568 hsa05016 Huntington's disease 6667_3064_1385_1387_9001_5430_5437_7157_1213_2033_6874_6908_841_5441_4697 15 3.06E-06 0.000238927 7.24E-06 22707 hsa-mir-568 hsa04916 Melanogenesis 815_5595_5594_1385_1387_2932_2033_808_801_805_5566 11 5.54E-06 0.000432507 1.27E-05 22708 hsa-mir-568 hsa05131 Shigellosis 10382_203068_71_7846_347733_7278_84617_4691 8 1.50E-05 0.00116644 3.24E-05 22709 hsa-mir-568 hsa05130 Pathogenic Escherichia coli infection 10382_203068_71_7846_347733_7278_84617_4691 8 1.50E-05 0.00116644 3.24E-05 22710 hsa-mir-568 hsa04062 Chemokine signaling pathway 8517_3551_1147_5595_5594_2932_6777_6772_5970_4790_4792_4793_5566_6348 14 1.78E-05 0.001386359 3.75E-05 22711 hsa-mir-568 hsa05216 Thyroid cancer 10342_5595_5594_6256_7157_4609 6 2.85E-05 0.002219204 5.84E-05 22712 hsa-mir-568 hsa04115 p53 signaling pathway 1017_4193_7157_898_983_841_1026_1029 8 5.84E-05 0.004552471 0.00011673 22713 hsa-mir-568 hsa04120 Ubiquitin mediated proteolysis 55294_4193_6500_23291_10401_7329_5371_672_8454_8945_8554 11 6.73E-05 0.005249587 0.00013124 22714 hsa-mir-568 hsa05213 Endometrial cancer 1956_5595_5594_2932_7157_4609_2002 7 7.22E-05 0.005633023 0.000137391 22715 hsa-mir-568 hsa05211 Renal cell carcinoma 3091_5595_5594_1387_9915_3725_2033_2034 8 7.68E-05 0.005992813 0.000142686 22716 hsa-mir-568 hsa04630 Jak-STAT signaling pathway 10401_3977_1387_6778_6776_6777_6772_2033_4609_8554 10 0.000658148 0.051335519 0.001193849 22717 hsa-mir-568 hsa04270 Vascular smooth muscle contraction 5499_5595_5594_808_801_805_5566_85366 8 0.001664277 0.12981362 0.00295031 22718 hsa-mir-568 hsa03450 Non-homologous end-joining 2547_7520_5591 3 0.002966307 0.231371919 0.005141598 22719 hsa-mir-568 hsa04150 mTOR signaling pathway 3091_5595_5594_6195_6196 5 0.003107628 0.242395011 0.005269457 22720 hsa-mir-568 hsa04510 Focal adhesion 1956_5499_71_5595_5594_5599_2932_3725_85366_2002 10 0.004775139 0.372460811 0.007924698 22721 hsa-mir-568 hsa03030 DNA replication 4174_4171_4172_4173 4 0.005038039 0.392967018 0.008186813 22722 hsa-mir-568 hsa04810 Regulation of actin cytoskeleton 1956_5499_4627_71_2249_5595_5594_10788_8826_85366 10 0.007119441 0.555316428 0.011332988 22723 hsa-mir-568 hsa03420 Nucleotide excision repair 5887_2967_2968_4331 4 0.009622356 0.750543763 0.015010875 22724 hsa-mir-568 hsa04930 Type II diabetes mellitus 3551_5595_5594_5599 4 0.01033677 0.806268061 0.015809178 22725 hsa-mir-568 hsa04330 Notch signaling pathway 1387_9612_2033_8850 4 0.011866449 0.925582985 0.017799673 22726 hsa-mir-568 hsa05010 Alzheimer's disease 5595_5594_2932_808_801_805_841_4697 8 0.016079341 1 0.023663937 22727 hsa-mir-568 hsa04340 Hedgehog signaling pathway 23291_2932_5566_8945 4 0.021656988 1 0.031282316 22728 hsa-mir-568 hsa04530 Tight junction 4627_71_1460_1457_5519_5518 6 0.039331806 1 0.055779652 22729 hsa-mir-568 hsa04730 Long-term depression 5595_5594_5519_5518 4 0.041836604 1 0.058272412 22730 hsa-mir-569 hsa05200 Pathways in cancer 3320_1147_4087_405_9063_3480_1956_5595_5594_5599_6654_2064_6256_595_10401_5604_5601_208_367_2932_4193_7704_1387_6774_6776_6777_5970_8503_8554_2885_7157_2113_5894_3725_2353_5295_2736_4088_4089_5925_2033_5914_1050_207_2308_3326_4790_4791 48 2.10E-33 1.61E-31 1.61E-31 22731 hsa-mir-569 hsa04010 MAPK signaling pathway 9479_8986_1147_994_1956_5595_5594_6722_5599_6654_9261_5604_5606_5601_5600_3303_5566_208_4214_9252_1432_5970_627_9344_2885_7157_10912_5894_3725_3727_6195_6196_6197_2353_5058_4616_2872_207_5536_4790_4791_2005_4773 43 2.33E-31 1.80E-29 8.98E-30 22732 hsa-mir-569 hsa05215 Prostate cancer 3320_1147_3480_1956_5595_5594_6654_1385_2064_595_5604_208_367_2932_4193_1387_5970_8503_2885_7157_5894_5295_5925_2033_207_2308_3326_4790 28 5.32E-28 4.10E-26 1.33E-26 22733 hsa-mir-569 hsa05212 Pancreatic cancer 3320_1147_3480_1956_5595_5594_6654_1385_2064_595_5604_208_367_2932_4193_1387_5970_8503_2885_7157_5894_5295_5925_2033_207_2308_3326_4790 28 6.91E-28 5.32E-26 1.33E-26 22734 hsa-mir-569 hsa04660 T cell receptor signaling pathway 1147_3932_5595_5594_6654_56924_920_5604_5601_5600_208_915_2932_1432_5970_8503_2885_5777_5894_3725_2353_5295_5058_207_4790_4773 26 2.85E-23 2.19E-21 4.39E-22 22735 hsa-mir-569 hsa05220 Chronic myeloid leukemia 1147_6464_5595_5594_6654_595_5604_208_4193_6776_6777_5970_8503_2885_7157_5894_5295_4088_4089_5925_207_4790 22 1.30E-21 1.00E-19 1.67E-20 22736 hsa-mir-569 hsa05221 Acute myeloid leukemia 1147_5595_5594_6654_595_5604_208_7704_6774_6776_6777_5970_8503_2885_5894_5295_5914_1050_207_4790 20 8.41E-21 6.48E-19 9.25E-20 22737 hsa-mir-569 hsa05210 Colorectal cancer 4087_3480_1956_5595_5594_5599_6654_595_5604_5601_208_2932_8503_2885_7157_5894_3725_2353_5295_4088_4089_207 22 1.05E-20 8.05E-19 1.01E-19 22738 hsa-mir-569 hsa04012 ErbB signaling pathway 6464_1956_5595_6714_5594_5599_6654_56924_2064_5604_5601_208_2932_6776_6777_8503_2885_5894_3725_5295_5058_207 22 2.00E-20 1.54E-18 1.71E-19 22739 hsa-mir-569 hsa05214 Glioma 6464_3480_1956_5595_5594_6654_595_5604_208_4193_8503_2885_7157_5894_5295_5925_207_808_801_805 20 4.16E-20 3.20E-18 3.20E-19 22740 hsa-mir-569 hsa04910 Insulin signaling pathway 10891_6464_5595_7249_5594_5599_6654_6720_5604_5601_5566_208_2932_5770_8503_2885_5894_5295_2872_207_2308_808_801_805 24 7.42E-19 5.71E-17 5.19E-18 22741 hsa-mir-569 hsa05223 Non-small cell lung cancer 1956_5595_5594_6654_2064_6256_595_5604_2309_208_8503_2885_7157_5894_5295_5925_207 17 2.00E-17 1.54E-15 1.29E-16 22742 hsa-mir-569 hsa04662 B cell receptor signaling pathway 1147_5595_5594_6654_5604_208_2932_5970_8503_2885_5777_5894_3725_2353_5295_207_4790_4773 18 1.34E-16 1.03E-14 7.91E-16 22743 hsa-mir-569 hsa05213 Endometrial cancer 1956_5595_5594_6654_2064_595_5604_2309_208_2932_8503_2885_7157_5894_5295_207 16 2.41E-16 1.85E-14 1.32E-15 22744 hsa-mir-569 hsa04110 Cell cycle 4087_994_993_5591_595_7533_2932_4193_1387_7157_10912_983_902_2810_1022_4088_4089_5925_2033_4616 20 1.13E-15 8.71E-14 5.74E-15 22745 hsa-mir-569 hsa05211 Renal cell carcinoma 405_5595_5594_6654_56924_5604_208_1387_8503_2885_2113_5894_3725_5295_5058_2033_207 17 1.19E-15 9.19E-14 5.74E-15 22746 hsa-mir-569 hsa04510 Focal adhesion 6464_9564_3480_1956_5595_6714_5594_5599_6654_56924_2064_595_5604_5601_208_2932_8503_857_2885_5894_3725_5295_5058_207 24 2.66E-15 2.05E-13 1.20E-14 22747 hsa-mir-569 hsa04912 GnRH signaling pathway 1956_5595_6714_5594_5599_6654_5604_5606_5601_5600_5566_4214_1432_2885_5894_3725_808_801_805 19 2.82E-15 2.17E-13 1.21E-14 22748 hsa-mir-569 hsa04062 Chemokine signaling pathway 1147_6464_9564_5595_5594_6654_5604_2309_5566_208_2932_6774_6777_5970_8503_2885_2770_5894_5295_5058_207_4790 22 5.88E-14 4.53E-12 2.38E-13 22749 hsa-mir-569 hsa04620 Toll-like receptor signaling pathway 1147_5595_5594_5599_5604_5606_5601_5600_208_1432_5970_8503_3725_2353_5295_207_4790 17 1.82E-13 1.40E-11 7.01E-13 22750 hsa-mir-569 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_6654_5604_5606_5601_5600_208_1432_8503_2885_5894_5295_207 15 9.24E-13 7.12E-11 3.39E-12 22751 hsa-mir-569 hsa04520 Adherens junction 4087_1460_3480_1956_5595_6714_5594_2064_5770_1387_5777_4088_4089_2033_1457 15 1.09E-12 8.36E-11 3.80E-12 22752 hsa-mir-569 hsa05218 Melanoma 3480_1956_5595_5594_595_5604_208_4193_8503_7157_5894_5295_5925_207 14 3.41E-12 2.63E-10 1.14E-11 22753 hsa-mir-569 hsa05222 Small cell lung cancer 1147_9063_6256_595_10401_208_5970_8503_8554_7157_5295_5925_207_4790 14 3.35E-11 2.58E-09 1.07E-10 22754 hsa-mir-569 hsa05219 Bladder cancer 1956_5595_5594_2064_595_5604_9252_4193_7157_5894_5925 11 5.25E-11 4.05E-09 1.62E-10 22755 hsa-mir-569 hsa04630 Jak-STAT signaling pathway 9063_6654_595_10401_208_1387_6774_6776_6777_8503_8554_2885_5777_3460_5295_2033_207 17 7.64E-11 5.88E-09 2.26E-10 22756 hsa-mir-569 hsa04720 Long-term potentiation 5595_5594_5604_5566_1387_5894_6195_6196_6197_2033_808_801_805 13 8.48E-11 6.53E-09 2.42E-10 22757 hsa-mir-569 hsa04370 VEGF signaling pathway 5595_6714_5594_9261_5604_5600_208_1432_8503_5894_5295_207_4773 13 1.13E-10 8.74E-09 3.12E-10 22758 hsa-mir-569 hsa04310 Wnt signaling pathway 4087_1460_5599_595_5601_5566_2932_1387_6423_7157_3725_4088_4089_2033_1457_4773 16 4.81E-10 3.71E-08 1.28E-09 22759 hsa-mir-569 hsa04916 Melanogenesis 5595_5594_1385_5604_5566_2932_1387_2770_5894_2033_808_801_805 13 3.15E-09 2.42E-07 8.07E-09 22760 hsa-mir-569 hsa04150 mTOR signaling pathway 5595_7249_5594_208_8503_6195_6196_6197_5295_207 10 5.41E-09 4.17E-07 1.34E-08 22761 hsa-mir-569 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_1956_6714_5599_5601_5600_1432_5970_3725_5058_4790 11 6.96E-09 5.36E-07 1.68E-08 22762 hsa-mir-569 hsa04650 Natural killer cell mediated cytotoxicity 6464_3932_5595_5594_6654_5604_8503_2885_5777_5894_3460_5295_5058_4773 14 9.11E-09 7.02E-07 2.09E-08 22763 hsa-mir-569 hsa04540 Gap junction 1956_5595_6714_5594_5592_6654_5604_5566_2885_2770_983_5894 12 9.23E-09 7.11E-07 2.09E-08 22764 hsa-mir-569 hsa04350 TGF-beta signaling pathway 4087_5595_5594_6667_1387_3397_3398_3399_4088_4089_2033 11 4.65E-08 3.58E-06 9.98E-08 22765 hsa-mir-569 hsa04920 Adipocytokine signaling pathway 1147_10891_5599_6256_5601_208_6774_5970_207_4790 10 4.67E-08 3.59E-06 9.98E-08 22766 hsa-mir-569 hsa04930 Type II diabetes mellitus 3651_5595_5594_5599_5601_8503_5295 7 3.93E-06 0.000302764 8.18E-06 22767 hsa-mir-569 hsa04210 Apoptosis 1147_5566_208_5970_8503_7157_5295_207_4790 9 4.29E-06 0.000330279 8.69E-06 22768 hsa-mir-569 hsa05216 Thyroid cancer 5595_5594_6256_595_5604_7157 6 4.60E-06 0.000354052 9.08E-06 22769 hsa-mir-569 hsa04115 p53 signaling pathway 7249_595_4193_7157_10912_983_2810_4616 8 5.84E-06 0.000449989 1.12E-05 22770 hsa-mir-569 hsa04612 Antigen processing and presentation 3320_811_920_1385_3303_1514_6890_3326 8 3.23E-05 0.002483731 6.06E-05 22771 hsa-mir-569 hsa04270 Vascular smooth muscle contraction 5595_5594_5592_5604_5566_5894_808_801_805 9 3.51E-05 0.00270094 6.43E-05 22772 hsa-mir-569 hsa05016 Huntington's disease 10891_1385_291_6908_6667_5481_1387_627_7157_3064_2033 11 4.91E-05 0.003782198 8.80E-05 22773 hsa-mir-569 hsa04730 Long-term depression 3480_5595_5594_5592_5604_2770_5894 7 5.86E-05 0.004515974 0.000102636 22774 hsa-mir-569 hsa05340 Primary immunodeficiency 3932_920_915_100_6890 5 0.000141953 0.010930396 0.000242898 22775 hsa-mir-569 hsa04810 Regulation of actin cytoskeleton 9564_1956_5595_5594_6654_56924_5604_8503_5894_5295_5058 11 0.000177655 0.013679454 0.000294513 22776 hsa-mir-569 hsa03022 Basal transcription factors 2965_2963_6908_2959_6881 5 0.000179768 0.013842117 0.000294513 22777 hsa-mir-569 hsa04360 Axon guidance 5595_5998_5594_56924_2932_2770_5058_4773 8 0.000397808 0.030631239 0.000629484 22778 hsa-mir-569 hsa04950 Maturity onset diabetes of the young 3651_3172_3175_4760 4 0.000400581 0.030844713 0.000629484 22779 hsa-mir-569 hsa04120 Ubiquitin mediated proteolysis 7329_9063_672_10401_4214_4193_8554_10273 8 0.000577241 0.044447534 0.000888951 22780 hsa-mir-569 hsa05010 Alzheimer's disease 5595_5594_3416_2932_6622_808_801_805 8 0.002508611 0.193163009 0.00378751 22781 hsa-mir-569 hsa03420 Nucleotide excision repair 2965_902_1022_4331 4 0.003123478 0.240507779 0.004575368 22782 hsa-mir-569 hsa04020 Calcium signaling pathway 1956_2064_291_5566_5481_808_801_805 8 0.00314928 0.242494527 0.004575368 22783 hsa-mir-569 hsa04070 Phosphatidylinositol signaling system 8503_5295_808_801_805 5 0.003629967 0.279507434 0.005176064 22784 hsa-mir-569 hsa04330 Notch signaling pathway 1387_9612_2033_8850 4 0.003894776 0.299897724 0.005452686 22785 hsa-mir-569 hsa04670 Leukocyte transendothelial migration 9564_5600_1432_8503_2770_5295 6 0.005775647 0.444724796 0.007941514 22786 hsa-mir-569 hsa05014 Amyotrophic lateral sclerosis (ALS) 5606_5600_1432_7157 4 0.006957338 0.535715024 0.009398509 22787 hsa-mir-569 hsa04530 Tight junction 1460_6714_208_2770_207_1457 6 0.009732856 0.749429883 0.012921205 22788 hsa-mir-569 hsa03410 Base excision repair 6996_3146_4350 3 0.012986213 0.999938384 0.016948108 22789 hsa-mir-569 hsa03050 Proteasome 5684_5698_5705 3 0.026506093 1 0.034016153 22790 hsa-mir-569 hsa05217 Basal cell carcinoma 2932_7157_2736 3 0.036845665 1 0.046510102 22791 hsa-mir-569 hsa04340 Hedgehog signaling pathway 5566_2932_2736 3 0.040126717 1 0.049834793 22792 hsa-mir-572 hsa03022 Basal transcription factors 2959_6908 2 1.65E-06 3.29E-06 3.29E-06 22793 hsa-mir-572 hsa05016 Huntington's disease 6908 1 0.012559684 0.025119368 0.012559684 22794 hsa-mir-574 hsa05200 Pathways in cancer 5371_5595_5594_5914_6256_595_836_367_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_4088_4089_3066_3065_5925_2034_2033_4846 28 1.32E-29 8.33E-28 8.33E-28 22795 hsa-mir-574 hsa05220 Chronic myeloid leukemia 5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464 15 2.80E-21 1.76E-19 8.80E-20 22796 hsa-mir-574 hsa04110 Cell cycle 5591_595_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933 14 5.25E-17 3.31E-15 1.10E-15 22797 hsa-mir-574 hsa05215 Prostate cancer 5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033 11 7.27E-14 4.58E-12 1.03E-12 22798 hsa-mir-574 hsa05212 Pancreatic cancer 5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033 11 8.15E-14 5.13E-12 1.03E-12 22799 hsa-mir-574 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5925 9 1.88E-13 1.18E-11 1.97E-12 22800 hsa-mir-574 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925 9 1.41E-12 8.88E-11 1.27E-11 22801 hsa-mir-574 hsa05210 Colorectal cancer 5595_5594_595_836_7157_4087_4609_3725_4088_4089 10 1.62E-12 1.02E-10 1.28E-11 22802 hsa-mir-574 hsa05222 Small cell lung cancer 6256_595_5970_1870_1871_7157_4609_1869_5925_4846 10 2.01E-12 1.27E-10 1.41E-11 22803 hsa-mir-574 hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_6464 9 6.37E-12 4.01E-10 4.01E-11 22804 hsa-mir-574 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_5970_4609 8 1.15E-10 7.26E-09 6.60E-10 22805 hsa-mir-574 hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5925 8 4.45E-10 2.80E-08 2.30E-09 22806 hsa-mir-574 hsa05211 Renal cell carcinoma 5595_5594_3091_7428_2113_3725_2034_2033 8 4.93E-10 3.11E-08 2.30E-09 22807 hsa-mir-574 hsa04010 MAPK signaling pathway 5595_5594_5598_4208_836_3312_1432_5970_7157_4609_3725_4763 12 5.11E-10 3.22E-08 2.30E-09 22808 hsa-mir-574 hsa04350 TGF-beta signaling pathway 5595_5594_4087_4609_4088_4089_2033_5933 8 1.98E-09 1.25E-07 8.31E-09 22809 hsa-mir-574 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 2.76E-09 1.74E-07 1.09E-08 22810 hsa-mir-574 hsa04310 Wnt signaling pathway 595_7157_4087_4609_3725_1457_4088_4089_2033 9 7.11E-09 4.48E-07 2.63E-08 22811 hsa-mir-574 hsa04520 Adherens junction 5595_5594_4087_1457_4088_4089_2033 7 2.90E-08 1.82E-06 1.01E-07 22812 hsa-mir-574 hsa05016 Huntington's disease 6874_2902_836_7157_3066_3065_3064_2033 8 5.64E-07 3.55E-05 1.87E-06 22813 hsa-mir-574 hsa05213 Endometrial cancer 5595_5594_595_7157_4609 5 1.95E-06 0.000123007 6.15E-06 22814 hsa-mir-574 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_1432_7157_4846 5 2.74E-06 0.000172793 8.23E-06 22815 hsa-mir-574 hsa05010 Alzheimer's disease 5595_5594_2902_836_840_1020_4846 7 4.71E-06 0.000296577 1.35E-05 22816 hsa-mir-574 hsa04012 ErbB signaling pathway 5595_5594_4609_3725_6464 5 2.08E-05 0.001307803 5.69E-05 22817 hsa-mir-574 hsa04330 Notch signaling pathway 9612_3066_3065_2033 4 3.44E-05 0.002164676 9.02E-05 22818 hsa-mir-574 hsa04620 Toll-like receptor signaling pathway 5595_5594_1432_5970_3725 5 4.30E-05 0.002709219 0.000108369 22819 hsa-mir-574 hsa04912 GnRH signaling pathway 5595_5594_5598_1432_3725 5 5.58E-05 0.00351671 0.000135258 22820 hsa-mir-574 hsa04660 T cell receptor signaling pathway 5595_5594_1432_5970_3725 5 6.07E-05 0.003823448 0.000141609 22821 hsa-mir-574 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_1432_5970_3725 4 0.000156433 0.009855296 0.000351975 22822 hsa-mir-574 hsa04720 Long-term potentiation 5595_5594_2902_2033 4 0.000191263 0.012049562 0.000401652 22823 hsa-mir-574 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725 4 0.000191263 0.012049562 0.000401652 22824 hsa-mir-574 hsa04370 VEGF signaling pathway 5595_5594_1432_4846 4 0.000210627 0.013269501 0.000428048 22825 hsa-mir-574 hsa04210 Apoptosis 836_840_5970_7157 4 0.000357649 0.022531909 0.000704122 22826 hsa-mir-574 hsa04510 Focal adhesion 5595_5594_595_3725_6464 5 0.001001419 0.063089394 0.001905149 22827 hsa-mir-574 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.001028176 0.064775061 0.001905149 22828 hsa-mir-574 hsa04910 Insulin signaling pathway 6720_5595_5594_6464 4 0.001738903 0.109550859 0.003043079 22829 hsa-mir-574 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_6464 4 0.001738903 0.109550859 0.003043079 22830 hsa-mir-574 hsa04115 p53 signaling pathway 595_836_7157 3 0.002236466 0.140897363 0.003808037 22831 hsa-mir-574 hsa04730 Long-term depression 5595_5594_4846 3 0.002418297 0.152352694 0.004009281 22832 hsa-mir-574 hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432 3 0.003236047 0.20387098 0.005227461 22833 hsa-mir-574 hsa04612 Antigen processing and presentation 4800_4801_3312 3 0.004471655 0.281714273 0.007042857 22834 hsa-mir-574 hsa04540 Gap junction 5595_5594_5598 3 0.005035384 0.317229169 0.007737297 22835 hsa-mir-574 hsa04062 Chemokine signaling pathway 5595_5594_5970_6464 4 0.005611944 0.353552454 0.008417916 22836 hsa-mir-574 hsa04916 Melanogenesis 5595_5594_2033 3 0.006799319 0.428357107 0.009961793 22837 hsa-mir-574 hsa04930 Type II diabetes mellitus 5595_5594 2 0.012405995 0.781577666 0.017542486 22838 hsa-mir-574 hsa04360 Axon guidance 5595_5594_1020 3 0.012530347 0.789411863 0.017542486 22839 hsa-mir-574 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428 3 0.014627156 0.921510817 0.020032844 22840 hsa-mir-574 hsa04630 Jak-STAT signaling pathway 595_4609_2033 3 0.019383194 1 0.025981728 22841 hsa-mir-574 hsa04920 Adipocytokine signaling pathway 6256_5970 2 0.025587179 1 0.033583172 22842 hsa-mir-574 hsa04710 Circadian rhythm - mammal 8863 1 0.049075283 1 0.063096792 22843 hsa-mir-576 hsa03022 Basal transcription factors 2969 1 0.006316679 0.018950037 0.018950037 22844 hsa-mir-576 hsa04612 Antigen processing and presentation 4802 1 0.014908788 0.044726363 0.022363182 22845 hsa-mir-576 hsa04010 MAPK signaling pathway 6722 1 0.044835671 0.134507014 0.044835671 22846 hsa-mir-578 hsa05200 Pathways in cancer 1499_5595_5594_1387_1487_1488_1019_367_1017_2353_6688_4609_3725_1026_5601_4087_4088_3065_1050_5925_2033_8554 22 7.43E-22 4.83E-20 4.83E-20 22847 hsa-mir-578 hsa04110 Cell cycle 1387_1019_1017_7027_1026_4087_4088_3065_5925_2033_891_5933 12 2.37E-14 1.54E-12 7.70E-13 22848 hsa-mir-578 hsa05220 Chronic myeloid leukemia 5595_5594_1487_1488_1019_4609_1026_4088_3065_5925 10 2.91E-13 1.89E-11 6.31E-12 22849 hsa-mir-578 hsa04350 TGF-beta signaling pathway 5595_5594_1387_7027_1874_4609_4087_4088_2033_5933 10 1.13E-12 7.36E-11 1.51E-11 22850 hsa-mir-578 hsa05215 Prostate cancer 1499_5595_5594_1387_367_1017_468_1026_5925_2033 10 1.26E-12 8.17E-11 1.51E-11 22851 hsa-mir-578 hsa05212 Pancreatic cancer 1499_5595_5594_1387_367_1017_468_1026_5925_2033 10 1.39E-12 9.06E-11 1.51E-11 22852 hsa-mir-578 hsa04310 Wnt signaling pathway 1499_1387_1487_1488_8061_4609_3725_5601_4087_4088_2033 11 8.72E-12 5.67E-10 8.10E-11 22853 hsa-mir-578 hsa05210 Colorectal cancer 1499_5595_5594_2353_4609_3725_5601_4087_4088 9 2.85E-11 1.85E-09 2.32E-10 22854 hsa-mir-578 hsa04010 MAPK signaling pathway 6722_5595_5594_2353_1386_1649_468_4609_3725_3727_5601 11 3.26E-09 2.12E-07 2.35E-08 22855 hsa-mir-578 hsa05219 Bladder cancer 5595_5594_1019_4609_1026_5925 6 1.34E-08 8.74E-07 8.74E-08 22856 hsa-mir-578 hsa04520 Adherens junction 1499_5595_5594_1387_4087_4088_2033 7 1.82E-08 1.18E-06 1.07E-07 22857 hsa-mir-578 hsa04012 ErbB signaling pathway 5595_5594_4609_3725_1026_5601 6 7.39E-07 4.81E-05 4.00E-06 22858 hsa-mir-578 hsa04330 Notch signaling pathway 1387_1487_1488_3065_2033 5 8.83E-07 5.74E-05 4.41E-06 22859 hsa-mir-578 hsa05221 Acute myeloid leukemia 5595_5594_6688_4609_1050 5 2.51E-06 0.00016301 1.16E-05 22860 hsa-mir-578 hsa04660 T cell receptor signaling pathway 5595_5594_1019_2353_3725_5601 6 2.70E-06 0.000175787 1.17E-05 22861 hsa-mir-578 hsa05214 Glioma 5595_5594_1019_1026_5925 5 3.92E-06 0.000254672 1.59E-05 22862 hsa-mir-578 hsa05216 Thyroid cancer 1499_5595_5594_4609 4 4.53E-06 0.000294657 1.73E-05 22863 hsa-mir-578 hsa05218 Melanoma 5595_5594_1019_1026_5925 5 5.89E-06 0.000382609 2.13E-05 22864 hsa-mir-578 hsa05211 Renal cell carcinoma 5595_5594_1387_3725_2033 5 6.28E-06 0.000408095 2.15E-05 22865 hsa-mir-578 hsa04720 Long-term potentiation 5595_5594_1387_468_2033 5 7.58E-06 0.000492609 2.46E-05 22866 hsa-mir-578 hsa05222 Small cell lung cancer 1019_1017_4609_5925_8554 5 1.42E-05 0.000925544 4.41E-05 22867 hsa-mir-578 hsa04620 Toll-like receptor signaling pathway 5595_5594_2353_3725_5601 5 3.12E-05 0.002027972 9.22E-05 22868 hsa-mir-578 hsa04916 Melanogenesis 1499_5595_5594_1387_2033 5 3.41E-05 0.002216878 9.64E-05 22869 hsa-mir-578 hsa05213 Endometrial cancer 1499_5595_5594_4609 4 3.84E-05 0.002492795 0.000103866 22870 hsa-mir-578 hsa04912 GnRH signaling pathway 5595_5594_468_3725_5601 5 4.05E-05 0.002635433 0.000105417 22871 hsa-mir-578 hsa05223 Non-small cell lung cancer 5595_5594_1019_5925 4 4.41E-05 0.002864752 0.000110183 22872 hsa-mir-578 hsa05016 Huntington's disease 6874_25942_1387_1537_3065_2033 6 5.06E-05 0.003287365 0.000121754 22873 hsa-mir-578 hsa04115 p53 signaling pathway 1019_1017_1026_891 4 0.000108792 0.007071502 0.000252554 22874 hsa-mir-578 hsa04662 B cell receptor signaling pathway 5595_5594_2353_3725 4 0.000147885 0.009612549 0.000331467 22875 hsa-mir-578 hsa03022 Basal transcription factors 2969_6874_6883 3 0.000330996 0.021514756 0.000717159 22876 hsa-mir-578 hsa04930 Type II diabetes mellitus 5595_5594_5601 3 0.000568283 0.036938406 0.001191561 22877 hsa-mir-578 hsa04510 Focal adhesion 1499_5595_5594_3725_5601 5 0.000741 0.048164983 0.001505156 22878 hsa-mir-578 hsa04630 Jak-STAT signaling pathway 1387_4609_2033_8554 4 0.002056601 0.133679092 0.004050882 22879 hsa-mir-578 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5601 3 0.002679569 0.174172003 0.005122706 22880 hsa-mir-578 hsa04910 Insulin signaling pathway 5595_5594_5601 3 0.012004805 0.780312343 0.022294638 22881 hsa-mir-578 hsa04150 mTOR signaling pathway 5595_5594 2 0.014241596 0.925703741 0.025713993 22882 hsa-mir-578 hsa05010 Alzheimer's disease 5595_5594_1537 3 0.02285978 1 0.040159073 22883 hsa-mir-578 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5601 2 0.025102216 1 0.041837027 22884 hsa-mir-578 hsa04730 Long-term depression 5595_5594 2 0.025102216 1 0.041837027 22885 hsa-mir-578 hsa04370 VEGF signaling pathway 5595_5594 2 0.029051311 1 0.04720838 22886 hsa-mir-578 hsa04612 Antigen processing and presentation 4800_4802 2 0.037629593 1 0.059656672 22887 hsa-mir-578 hsa04540 Gap junction 5595_5594 2 0.04067919 1 0.062955889 22888 hsa-mir-578 hsa03010 Ribosome 6222_6231 2 0.047865802 1 0.072355282 22889 hsa-mir-579 hsa05200 Pathways in cancer 1147_3320_1869_5743_3326_5747_25_5925_675_998_1026_5594_5595_5599_6257_8031_596_5601_6789_1856_4088_613_1017_2932_4193_1387_5578_6256_51588_5970_8554_5371_4436_6688_2113_598_3725_4087_5888_5728_3065_3091_2033_3910_4792_5602_6258 47 1.32E-34 1.13E-32 1.13E-32 22890 hsa-mir-579 hsa04110 Cell cycle 1869_25_5925_545_995_1026_5591_983_4088_7534_1017_2932_4193_7027_902_1387_10912_1031_9232_5347_1022_4087_7532_4616_3065_1111_2033_890_11200_8556_8555_472 32 1.88E-31 1.60E-29 7.99E-30 22891 hsa-mir-579 hsa04115 p53 signaling pathway 50484_545_6241_1026_25898_983_1017_27113_4194_4193_900_10912_7161_64326_4616_5728_51246_1111_11200_472 20 1.23E-20 1.05E-18 3.49E-19 22892 hsa-mir-579 hsa05215 Prostate cancer 1147_3320_1869_3326_5925_1026_5594_5595_596_1017_2932_4193_1387_5970_468_5728_2033_4792 18 2.17E-16 1.84E-14 4.39E-15 22893 hsa-mir-579 hsa05212 Pancreatic cancer 1147_3320_1869_3326_5925_1026_5594_5595_596_1017_2932_4193_1387_5970_468_5728_2033_4792 18 2.58E-16 2.19E-14 4.39E-15 22894 hsa-mir-579 hsa05222 Small cell lung cancer 1147_1869_5743_5747_5925_6257_596_1017_6256_51588_5970_8554_598_5728_3910_4792_6258 17 2.46E-15 2.09E-13 3.48E-14 22895 hsa-mir-579 hsa04010 MAPK signaling pathway 9479_1147_998_3727_5594_5595_5599_5601_3304_3305_3303_6789_3315_5578_5970_468_3164_10912_3725_4616_1616_5923_5602 23 5.17E-13 4.39E-11 6.27E-12 22896 hsa-mir-579 hsa04310 Wnt signaling pathway 1460_5518_5515_5599_5601_1856_1457_4088_2932_1387_5578_3725_1452_6423_4087_5527_2033_5602 18 1.01E-12 8.60E-11 1.08E-11 22897 hsa-mir-579 hsa05220 Chronic myeloid leukemia 1147_1869_25_5925_1026_5594_5595_4088_613_4193_5970_598_3065_4792 14 1.46E-12 1.24E-10 1.38E-11 22898 hsa-mir-579 hsa04920 Adipocytokine signaling pathway 1147_5563_10891_6794_5599_6257_5601_6256_5970_4792_5602_6258 12 9.03E-11 7.68E-09 7.68E-10 22899 hsa-mir-579 hsa05210 Colorectal cancer 5594_5595_5599_596_5601_1856_4088_2932_4436_3725_4087_5602 12 9.29E-10 7.89E-08 7.18E-09 22900 hsa-mir-579 hsa04120 Ubiquitin mediated proteolysis 10055_672_7319_25898_84447_4193_3093_51588_8554_5371_64326_7329_10075_7337 14 2.39E-09 2.04E-07 1.70E-08 22901 hsa-mir-579 hsa04350 TGF-beta signaling pathway 3398_5518_5515_5594_5595_6667_4088_7027_1387_4087_2033 11 1.49E-08 1.26E-06 9.03E-08 22902 hsa-mir-579 hsa04012 ErbB signaling pathway 5747_25_1026_5594_5595_5599_5601_2932_5578_3725_5602 11 1.49E-08 1.26E-06 9.03E-08 22903 hsa-mir-579 hsa05223 Non-small cell lung cancer 1869_5925_5594_5595_6257_6789_5578_6256_6258 9 3.66E-08 3.11E-06 2.00E-07 22904 hsa-mir-579 hsa04510 Focal adhesion 5747_998_5594_5595_5599_596_5601_5499_2932_5578_3725_5728_5923_3910_5602 15 3.77E-08 3.21E-06 2.00E-07 22905 hsa-mir-579 hsa04520 Adherens junction 1460_998_5594_5595_1457_4088_1387_4087_2033 9 7.61E-07 6.47E-05 3.81E-06 22906 hsa-mir-579 hsa04660 T cell receptor signaling pathway 1147_998_5594_5595_5601_2932_5970_3725_959_4792 10 1.13E-06 9.57E-05 5.31E-06 22907 hsa-mir-579 hsa03420 Nucleotide excision repair 2965_4331_2074_6117_2071_902_1022 7 1.64E-06 0.000139747 7.25E-06 22908 hsa-mir-579 hsa05214 Glioma 1869_5925_1026_5594_5595_4193_5578_5728 8 1.71E-06 0.000145062 7.25E-06 22909 hsa-mir-579 hsa05216 Thyroid cancer 5594_5595_6257_8031_6256_6258 6 2.42E-06 0.000205537 9.79E-06 22910 hsa-mir-579 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_998_5599_5601_5970_3725_4792_5602 8 3.12E-06 0.000265514 1.21E-05 22911 hsa-mir-579 hsa05211 Renal cell carcinoma 998_5594_5595_1387_2113_3725_3091_2033 8 3.44E-06 0.000292149 1.27E-05 22912 hsa-mir-579 hsa04662 B cell receptor signaling pathway 1147_5594_5595_1380_2932_5970_3725_4792 8 4.54E-06 0.000386053 1.61E-05 22913 hsa-mir-579 hsa04620 Toll-like receptor signaling pathway 1147_5594_5595_5599_5601_5970_3725_4792_5602 9 4.87E-06 0.000414075 1.66E-05 22914 hsa-mir-579 hsa04912 GnRH signaling pathway 998_5594_5595_5599_5601_5578_468_3725_5602 9 7.51E-06 0.000637957 2.45E-05 22915 hsa-mir-579 hsa03022 Basal transcription factors 2965_2957_6908_51616_2958_6880 6 8.42E-06 0.000715577 2.65E-05 22916 hsa-mir-579 hsa05219 Bladder cancer 1869_5925_1026_5594_5595_4193 6 1.62E-05 0.001373751 4.91E-05 22917 hsa-mir-579 hsa04330 Notch signaling pathway 1856_1387_9612_3065_2033_8850 6 2.88E-05 0.002451233 8.19E-05 22918 hsa-mir-579 hsa05218 Melanoma 1869_5925_1026_5594_5595_4193_5728 7 2.89E-05 0.002458445 8.19E-05 22919 hsa-mir-579 hsa04720 Long-term potentiation 5594_5595_5499_1387_5578_468_2033 7 4.01E-05 0.003404297 0.000109816 22920 hsa-mir-579 hsa04910 Insulin signaling pathway 5563_10891_5594_5595_5599_5601_5499_2932_5602 9 4.66E-05 0.003957533 0.000120565 22921 hsa-mir-579 hsa04370 VEGF signaling pathway 5743_5747_998_5594_5595_3315_5578 7 4.68E-05 0.003978634 0.000120565 22922 hsa-mir-579 hsa05221 Acute myeloid leukemia 1147_5594_5595_5970_5371_6688 6 9.26E-05 0.00787402 0.000231589 22923 hsa-mir-579 hsa04210 Apoptosis 1147_823_596_5970_598_4792_472 7 0.000109774 0.009330772 0.000266593 22924 hsa-mir-579 hsa04930 Type II diabetes mellitus 5594_5595_5599_5601_5602 5 0.000246952 0.020990959 0.00057636 22925 hsa-mir-579 hsa04530 Tight junction 1460_998_5518_5515_1457_5578_5728_5520 8 0.000250886 0.021325327 0.00057636 22926 hsa-mir-579 hsa04916 Melanogenesis 5594_5595_1856_2932_1387_5578_2033 7 0.000270935 0.023029464 0.000606039 22927 hsa-mir-579 hsa04664 Fc epsilon RI signaling pathway 5594_5595_5599_5601_5578_5602 6 0.000406287 0.034534398 0.000885497 22928 hsa-mir-579 hsa05016 Huntington's disease 10891_25942_3064_6908_6667_27113_1387_3065_2033 9 0.000424311 0.036066401 0.00090166 22929 hsa-mir-579 hsa03440 Homologous recombination 675_6117_641_5888 4 0.000444469 0.037779858 0.00092146 22930 hsa-mir-579 hsa04150 mTOR signaling pathway 5563_5594_6794_5595_3091 5 0.000457631 0.038898634 0.000926158 22931 hsa-mir-579 hsa04062 Chemokine signaling pathway 1147_5747_998_5594_5595_2932_5970_6362_4792 9 0.000508715 0.043240735 0.001005598 22932 hsa-mir-579 hsa05131 Shigellosis 25_998_7534_5578_4691 5 0.000626787 0.053276885 0.001183931 22933 hsa-mir-579 hsa05130 Pathogenic Escherichia coli infection 25_998_7534_5578_4691 5 0.000626787 0.053276885 0.001183931 22934 hsa-mir-579 hsa04612 Antigen processing and presentation 3320_3326_3309_3304_3305_3303 6 0.000735018 0.062476558 0.001358186 22935 hsa-mir-579 hsa04360 Axon guidance 5747_25_998_5594_5595_2932_1020 7 0.000998809 0.084898743 0.001806356 22936 hsa-mir-579 hsa03410 Base excision repair 142_3146_328_4913 4 0.00105237 0.089451463 0.001863572 22937 hsa-mir-579 hsa04730 Long-term depression 5518_5515_5594_5595_5578 5 0.001696844 0.144231762 0.002943505 22938 hsa-mir-579 hsa05213 Endometrial cancer 5594_5595_2932_5728 4 0.003673313 0.31223159 0.006244632 22939 hsa-mir-579 hsa04540 Gap junction 5594_5595_983_1453_5578 5 0.005105563 0.433972846 0.008509271 22940 hsa-mir-579 hsa03030 DNA replication 6117_5557_5422 3 0.009610923 0.816928434 0.015710162 22941 hsa-mir-579 hsa03320 PPAR signaling pathway 6257_6256_2168_6258 4 0.009830452 0.835588389 0.015765819 22942 hsa-mir-579 hsa03450 Non-homologous end-joining 5591_2547 2 0.013695174 1 0.021557218 22943 hsa-mir-579 hsa05010 Alzheimer's disease 5594_5595_823_2932_9451_1020 6 0.017936952 1 0.027720744 22944 hsa-mir-579 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_1616 3 0.029016965 1 0.044043607 22945 hsa-mir-579 hsa04340 Hedgehog signaling pathway 1453_2932_1452 3 0.030296348 1 0.045178765 22946 hsa-mir-579 hsa03430 Mismatch repair 6117_4436 2 0.032039735 1 0.046954784 22947 hsa-mir-579 hsa04630 Jak-STAT signaling pathway 1387_51588_8554_598_2033 5 0.035337225 1 0.050909561 22948 hsa-mir-579 hsa04270 Vascular smooth muscle contraction 5594_5595_5499_5578 4 0.049592805 1 0.070256473 22949 hsa-mir-580 hsa05200 Pathways in cancer 3716_3320_1499_4149_5371_675_5595_5594_5599_1387_5159_5156_5601_9915_1399_1398_1017_3815_6774_6777_6772_3091_5970_1870_1871_7157_1869_867_2353_4088_4089_5881_1050_2034_2033_4790_1956 37 9.59E-31 6.62E-29 6.62E-29 22950 hsa-mir-580 hsa05220 Chronic myeloid leukemia 5595_5594_1399_1398_6777_5970_1870_1871_7157_5781_1869_867_4088_4089_4790_6464 16 7.69E-18 5.30E-16 2.65E-16 22951 hsa-mir-580 hsa05215 Prostate cancer 3320_1499_5595_5594_1387_5159_5156_1017_5970_1870_1871_7157_1869_2033_4790_1956 16 7.20E-17 4.97E-15 1.46E-15 22952 hsa-mir-580 hsa05212 Pancreatic cancer 3320_1499_5595_5594_1387_5159_5156_1017_5970_1870_1871_7157_1869_2033_4790_1956 16 8.44E-17 5.82E-15 1.46E-15 22953 hsa-mir-580 hsa04110 Cell cycle 5591_1387_890_7534_1017_7531_1870_1871_7157_1869_4088_4089_2033_5934_5933 15 8.75E-14 6.04E-12 1.21E-12 22954 hsa-mir-580 hsa04630 Jak-STAT signaling pathway 3717_3716_3718_85480_3560_3561_1387_3575_6774_6777_6772_2057_5781_867_2690_2033 16 2.17E-13 1.50E-11 2.18E-12 22955 hsa-mir-580 hsa04520 Adherens junction 1499_6714_3643_5595_5594_1387_1457_5770_4088_4089_5881_2033_1956 13 2.21E-13 1.52E-11 2.18E-12 22956 hsa-mir-580 hsa05210 Colorectal cancer 1499_5595_5594_5599_5159_5156_5601_7157_2353_4088_4089_5881_1956 13 3.86E-13 2.66E-11 3.33E-12 22957 hsa-mir-580 hsa04350 TGF-beta signaling pathway 5515_5595_5594_1874_1387_1875_4088_4089_2033_4093_5934_5518_5933 13 5.78E-13 3.99E-11 3.99E-12 22958 hsa-mir-580 hsa04012 ErbB signaling pathway 815_6714_5595_5594_5599_2066_5601_1399_1398_6777_867_6464_1956 13 5.78E-13 3.99E-11 3.99E-12 22959 hsa-mir-580 hsa05214 Glioma 815_5595_5594_5159_5156_1870_1871_7157_1869_6464_1956 11 1.09E-11 7.50E-10 6.82E-11 22960 hsa-mir-580 hsa04310 Wnt signaling pathway 1499_5515_815_5599_1387_5601_1457_7157_8061_4088_4089_5881_2033_5518 14 2.93E-11 2.02E-09 1.68E-10 22961 hsa-mir-580 hsa04010 MAPK signaling pathway 4149_5595_5594_5599_5159_5156_5601_3303_1399_1398_3312_5970_7157_2353_5881_4790_1956 17 7.10E-11 4.90E-09 3.77E-10 22962 hsa-mir-580 hsa05211 Renal cell carcinoma 5595_5594_1387_9915_1399_1398_3091_5781_2034_2033 10 5.49E-10 3.79E-08 2.54E-09 22963 hsa-mir-580 hsa04062 Chemokine signaling pathway 3717_3718_5595_5594_1399_1398_1234_2931_6774_6777_6772_5970_4790_6464 14 5.52E-10 3.81E-08 2.54E-09 22964 hsa-mir-580 hsa03022 Basal transcription factors 2963_2969_6879_6908_6872_2959_6880_2958 8 1.37E-09 9.43E-08 5.90E-09 22965 hsa-mir-580 hsa05221 Acute myeloid leukemia 5371_5595_5594_3815_6774_6777_5970_1050_4790 9 1.94E-09 1.34E-07 7.86E-09 22966 hsa-mir-580 hsa05218 Melanoma 5595_5594_5159_5156_1870_1871_7157_1869_1956 9 8.44E-09 5.82E-07 3.24E-08 22967 hsa-mir-580 hsa04510 Focal adhesion 1499_6714_5595_5594_5599_5159_5156_5601_1399_1398_5881_6464_1956 13 1.12E-08 7.70E-07 4.05E-08 22968 hsa-mir-580 hsa04660 T cell receptor signaling pathway 3932_1493_5595_5594_5601_919_5970_867_2353_4790 10 2.33E-08 1.61E-06 8.04E-08 22969 hsa-mir-580 hsa05219 Bladder cancer 5595_5594_1870_1871_7157_1869_1956 7 7.37E-08 5.09E-06 2.42E-07 22970 hsa-mir-580 hsa04910 Insulin signaling pathway 3643_5595_5594_5599_5601_1399_1398_5770_867_6464 10 1.71E-07 1.18E-05 5.36E-07 22971 hsa-mir-580 hsa04662 B cell receptor signaling pathway 695_5595_5594_6850_5970_2353_5881_4790 8 1.97E-07 1.36E-05 5.90E-07 22972 hsa-mir-580 hsa05223 Non-small cell lung cancer 5595_5594_1870_1871_7157_1869_1956 7 3.47E-07 2.40E-05 9.98E-07 22973 hsa-mir-580 hsa05222 Small cell lung cancer 4149_1017_5970_1870_1871_7157_1869_4790 8 5.17E-07 3.57E-05 1.43E-06 22974 hsa-mir-580 hsa04920 Adipocytokine signaling pathway 3717_5599_5601_6774_5970_5781_4790 7 1.32E-06 9.11E-05 3.50E-06 22975 hsa-mir-580 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5601_6772_5970_2353_4790 8 1.72E-06 0.000118679 4.40E-06 22976 hsa-mir-580 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5599_5601_5970_5781_4790_1956 7 1.89E-06 0.000130425 4.66E-06 22977 hsa-mir-580 hsa04930 Type II diabetes mellitus 3651_3643_5595_5594_5599_5601 6 2.11E-06 0.000145771 5.03E-06 22978 hsa-mir-580 hsa04950 Maturity onset diabetes of the young 3651_6928_3172_5080_4760 5 2.20E-06 0.000151556 5.05E-06 22979 hsa-mir-580 hsa04664 Fc epsilon RI signaling pathway 695_5595_5594_5599_6850_5601_5881 7 3.66E-06 0.00025229 8.14E-06 22980 hsa-mir-580 hsa04060 Cytokine-cytokine receptor interaction 85480_3560_3561_5159_5156_3575_1234_3815_2057_2690_1956 11 6.81E-06 0.000470195 1.47E-05 22981 hsa-mir-580 hsa05340 Primary immunodeficiency 3718_695_3932_3561_3575 5 1.14E-05 0.000785852 2.38E-05 22982 hsa-mir-580 hsa04530 Tight junction 1499_5515_6714_1457_4628_60412_8189_5518 8 1.34E-05 0.000924122 2.72E-05 22983 hsa-mir-580 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6850_919_5781_5881_6464 8 1.41E-05 0.00097153 2.78E-05 22984 hsa-mir-580 hsa04916 Melanogenesis 1499_815_5595_5594_1387_3815_2033 7 1.98E-05 0.001363707 3.79E-05 22985 hsa-mir-580 hsa04912 GnRH signaling pathway 815_6714_5595_5594_5599_5601_1956 7 2.49E-05 0.001715762 4.64E-05 22986 hsa-mir-580 hsa04810 Regulation of actin cytoskeleton 5595_5594_5159_5156_1399_1398_4628_5881_1956 9 5.53E-05 0.003815897 0.000100418 22987 hsa-mir-580 hsa05213 Endometrial cancer 1499_5595_5594_7157_1956 5 6.54E-05 0.004514299 0.000115751 22988 hsa-mir-580 hsa04540 Gap junction 6714_5595_5594_5159_5156_1956 6 9.78E-05 0.006748961 0.000168724 22989 hsa-mir-580 hsa05216 Thyroid cancer 1499_5595_5594_7157 4 0.000101525 0.00700525 0.00017086 22990 hsa-mir-580 hsa03450 Non-homologous end-joining 5591_7520_2547 3 0.000252952 0.017453685 0.000415564 22991 hsa-mir-580 hsa04720 Long-term potentiation 815_5595_5594_1387_2033 5 0.000327219 0.022578122 0.000525073 22992 hsa-mir-580 hsa04330 Notch signaling pathway 1387_9612_2033_8850 4 0.000558634 0.03854574 0.00087604 22993 hsa-mir-580 hsa04730 Long-term depression 5515_5595_5594_5518 4 0.002366064 0.163258444 0.003627965 22994 hsa-mir-580 hsa04370 VEGF signaling pathway 6714_5595_5594_5881 4 0.003129044 0.215904058 0.004693566 22995 hsa-mir-580 hsa05016 Huntington's disease 1387_6908_7157_10476_2033_4724 6 0.003347388 0.23096978 0.004914251 22996 hsa-mir-580 hsa04120 Ubiquitin mediated proteolysis 5371_672_10273_7329_867 5 0.004472393 0.308595109 0.006429065 22997 hsa-mir-580 hsa04612 Antigen processing and presentation 3320_3303_4800_3312 4 0.005126374 0.353719799 0.007218771 22998 hsa-mir-580 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.007937486 0.547686527 0.010953731 22999 hsa-mir-580 hsa04020 Calcium signaling pathway 815_2066_5159_5156_1956 5 0.013587152 0.937513475 0.018382617 23000 hsa-mir-580 hsa04640 Hematopoietic cell lineage 3575_3815_2057 3 0.029460673 1 0.039092047 23001 hsa-mir-580 hsa04210 Apoptosis 5970_7157_4790 3 0.031158338 1 0.040564629 23002 hsa-mir-580 hsa03010 Ribosome 6124_6143_6129 3 0.043410107 1 0.055468471 23003 hsa-mir-580 hsa05010 Alzheimer's disease 5595_5594_10476_4724 4 0.04617269 1 0.057925738 23004 hsa-mir-581 hsa04110 Cell cycle 1017_7532_4174_5001_898_1026_4172_4173_1029_4998_4999 11 2.10E-19 4.42E-18 4.42E-18 23005 hsa-mir-581 hsa04115 p53 signaling pathway 1017_898_1026_1029 4 7.29E-07 1.53E-05 7.65E-06 23006 hsa-mir-581 hsa03030 DNA replication 4174_4172_4173 3 7.23E-06 0.000151811 5.06E-05 23007 hsa-mir-581 hsa05215 Prostate cancer 1017_898_1026 3 9.29E-05 0.001951069 0.000403106 23008 hsa-mir-581 hsa05212 Pancreatic cancer 1017_898_1026 3 9.60E-05 0.002015528 0.000403106 23009 hsa-mir-581 hsa05200 Pathways in cancer 1017_898_1026_1029 4 0.000293168 0.006156518 0.001026086 23010 hsa-mir-581 hsa05219 Bladder cancer 1026_1029 2 0.000830718 0.017445073 0.002492153 23011 hsa-mir-581 hsa05214 Glioma 1026_1029 2 0.001915038 0.040215803 0.005026975 23012 hsa-mir-581 hsa05218 Melanoma 1026_1029 2 0.002268072 0.047629517 0.005290385 23013 hsa-mir-581 hsa05220 Chronic myeloid leukemia 1026_1029 2 0.002519231 0.05290385 0.005290385 23014 hsa-mir-581 hsa05222 Small cell lung cancer 1017_898 2 0.003274256 0.068759368 0.006250852 23015 hsa-mir-582 hsa05221 Acute myeloid leukemia 6688_207_7704_5595_5594_6774 6 1.04E-10 5.10E-09 5.10E-09 23016 hsa-mir-582 hsa05200 Pathways in cancer 6688_2033_207_7704_5595_5594_6774_1387 8 3.49E-09 1.71E-07 8.55E-08 23017 hsa-mir-582 hsa05211 Renal cell carcinoma 2033_207_5595_5594_1387 5 2.55E-08 1.25E-06 4.16E-07 23018 hsa-mir-582 hsa05215 Prostate cancer 2033_207_5595_5594_1387 5 6.62E-08 3.24E-06 6.84E-07 23019 hsa-mir-582 hsa05212 Pancreatic cancer 2033_207_5595_5594_1387 5 6.98E-08 3.42E-06 6.84E-07 23020 hsa-mir-582 hsa04720 Long-term potentiation 2033_5595_5594_1387 4 1.94E-06 9.49E-05 1.58E-05 23021 hsa-mir-582 hsa04520 Adherens junction 2033_5595_5594_1387 4 2.48E-06 0.000121341 1.73E-05 23022 hsa-mir-582 hsa04350 TGF-beta signaling pathway 2033_5595_5594_1387 4 3.41E-06 0.000167139 2.09E-05 23023 hsa-mir-582 hsa04916 Melanogenesis 2033_5595_5594_1387 4 6.75E-06 0.000330617 3.67E-05 23024 hsa-mir-582 hsa04630 Jak-STAT signaling pathway 2033_207_6774_1387 4 3.10E-05 0.001518472 0.000136384 23025 hsa-mir-582 hsa05213 Endometrial cancer 207_5595_5594 3 3.34E-05 0.001636607 0.000136384 23026 hsa-mir-582 hsa04150 mTOR signaling pathway 207_5595_5594 3 3.34E-05 0.001636607 0.000136384 23027 hsa-mir-582 hsa05223 Non-small cell lung cancer 207_5595_5594 3 3.72E-05 0.001822493 0.000140192 23028 hsa-mir-582 hsa05214 Glioma 207_5595_5594 3 6.32E-05 0.003095091 0.000221078 23029 hsa-mir-582 hsa04062 Chemokine signaling pathway 207_5595_5594_6774 4 7.14E-05 0.00349709 0.000233139 23030 hsa-mir-582 hsa05218 Melanoma 207_5595_5594 3 8.13E-05 0.003984907 0.000249057 23031 hsa-mir-582 hsa05220 Chronic myeloid leukemia 207_5595_5594 3 9.51E-05 0.004662159 0.000259009 23032 hsa-mir-582 hsa04662 B cell receptor signaling pathway 207_5595_5594 3 9.51E-05 0.004662159 0.000259009 23033 hsa-mir-582 hsa04370 VEGF signaling pathway 207_5595_5594 3 0.000102596 0.005027226 0.000264591 23034 hsa-mir-582 hsa04664 Fc epsilon RI signaling pathway 207_5595_5594 3 0.000110418 0.00541046 0.000270523 23035 hsa-mir-582 hsa05210 Colorectal cancer 207_5595_5594 3 0.000131646 0.006450652 0.000307174 23036 hsa-mir-582 hsa04012 ErbB signaling pathway 207_5595_5594 3 0.000145572 0.007133051 0.00032423 23037 hsa-mir-582 hsa04620 Toll-like receptor signaling pathway 207_5595_5594 3 0.00022961 0.011250887 0.000489169 23038 hsa-mir-582 hsa04010 MAPK signaling pathway 6722_207_5595_5594 4 0.000264052 0.012938533 0.000539106 23039 hsa-mir-582 hsa04660 T cell receptor signaling pathway 207_5595_5594 3 0.000285014 0.013965702 0.000558628 23040 hsa-mir-582 hsa04910 Insulin signaling pathway 207_5595_5594 3 0.00054478 0.026694224 0.001026701 23041 hsa-mir-582 hsa05216 Thyroid cancer 5595_5594 2 0.00056662 0.027764399 0.001028311 23042 hsa-mir-582 hsa05219 Bladder cancer 5595_5594 2 0.001142161 0.055965905 0.001998782 23043 hsa-mir-582 hsa04930 Type II diabetes mellitus 5595_5594 2 0.001302383 0.063816769 0.002200578 23044 hsa-mir-582 hsa04330 Notch signaling pathway 2033_1387 2 0.001414832 0.069326779 0.002310893 23045 hsa-mir-582 hsa04510 Focal adhesion 207_5595_5594 3 0.001695391 0.083074141 0.002679811 23046 hsa-mir-582 hsa04920 Adipocytokine signaling pathway 207_6774 2 0.002782761 0.136355284 0.004261103 23047 hsa-mir-582 hsa04730 Long-term depression 5595_5594 2 0.003108453 0.152314182 0.004615581 23048 hsa-mir-582 hsa04540 Gap junction 5595_5594 2 0.005199801 0.254790268 0.007493831 23049 hsa-mir-582 hsa04912 GnRH signaling pathway 5595_5594 2 0.006908049 0.338494385 0.009671268 23050 hsa-mir-582 hsa04270 Vascular smooth muscle contraction 5595_5594 2 0.008169602 0.400310504 0.010993284 23051 hsa-mir-582 hsa04110 Cell cycle 2033_1387 2 0.008301051 0.406751494 0.010993284 23052 hsa-mir-582 hsa04360 Axon guidance 5595_5594 2 0.009952193 0.487657447 0.012833091 23053 hsa-mir-582 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594 2 0.010977279 0.537886648 0.013791965 23054 hsa-mir-582 hsa04310 Wnt signaling pathway 2033_1387 2 0.013160861 0.644882208 0.016122055 23055 hsa-mir-582 hsa05010 Alzheimer's disease 5595_5594 2 0.017486908 0.856858501 0.020898988 23056 hsa-mir-582 hsa05016 Huntington's disease 2033_1387 2 0.019556962 0.958291119 0.022816455 23057 hsa-mir-582 hsa04810 Regulation of actin cytoskeleton 5595_5594 2 0.0259097 1 0.029525007 23058 hsa-mir-582 hsa03410 Base excision repair 3146 1 0.041067642 1 0.04573442 23059 hsa-mir-583 hsa05200 Pathways in cancer 5371_6258_1387_6256_595_836_367_842_841_5970_4824_3725_2353_2033 14 4.69E-11 2.58E-09 2.58E-09 23060 hsa-mir-583 hsa05215 Prostate cancer 1385_1387_595_367_842_5970_4824_2033 8 2.87E-09 1.58E-07 5.72E-08 23061 hsa-mir-583 hsa05212 Pancreatic cancer 1385_1387_595_367_842_5970_4824_2033 8 3.12E-09 1.72E-07 5.72E-08 23062 hsa-mir-583 hsa04310 Wnt signaling pathway 815_1387_595_3725_1457_2033_894_896 8 1.59E-07 8.73E-06 2.18E-06 23063 hsa-mir-583 hsa04115 p53 signaling pathway 595_836_842_841_894_896 6 3.78E-07 2.08E-05 4.16E-06 23064 hsa-mir-583 hsa05016 Huntington's disease 25942_1385_1387_836_842_841_10476_2033 8 7.45E-07 4.10E-05 6.83E-06 23065 hsa-mir-583 hsa04210 Apoptosis 836_839_842_841_840_5970 6 1.54E-06 8.45E-05 1.21E-05 23066 hsa-mir-583 hsa04110 Cell cycle 5591_1387_595_2033_894_896 6 7.57E-06 0.000416548 5.21E-05 23067 hsa-mir-583 hsa04010 MAPK signaling pathway 9261_836_5970_3725_6195_2353_2002_2005 8 1.07E-05 0.000588667 6.54E-05 23068 hsa-mir-583 hsa05210 Colorectal cancer 595_836_842_3725_2353 5 2.11E-05 0.001158186 0.000115819 23069 hsa-mir-583 hsa05222 Small cell lung cancer 6258_6256_595_842_5970 5 2.35E-05 0.001289976 0.000117271 23070 hsa-mir-583 hsa05010 Alzheimer's disease 22926_836_842_841_840_10476 6 6.51E-05 0.003582081 0.000278819 23071 hsa-mir-583 hsa05223 Non-small cell lung cancer 6258_6256_595_842 4 6.59E-05 0.003624642 0.000278819 23072 hsa-mir-583 hsa04510 Focal adhesion 6714_595_3725_894_896_2002 6 0.000145968 0.008028213 0.000573444 23073 hsa-mir-583 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_836_5970_3725 4 0.000179848 0.009891631 0.000659442 23074 hsa-mir-583 hsa04720 Long-term potentiation 815_1387_6195_2033 4 0.000219799 0.01208893 0.000742995 23075 hsa-mir-583 hsa05216 Thyroid cancer 6258_6256_595 3 0.000229653 0.012630923 0.000742995 23076 hsa-mir-583 hsa04520 Adherens junction 6714_1387_1457_2033 4 0.000278267 0.015304664 0.000850259 23077 hsa-mir-583 hsa04630 Jak-STAT signaling pathway 1387_595_2033_894_896 5 0.000337679 0.018572327 0.000977491 23078 hsa-mir-583 hsa04012 ErbB signaling pathway 815_6714_3725_2002 4 0.000377828 0.020780563 0.001039028 23079 hsa-mir-583 hsa04620 Toll-like receptor signaling pathway 841_5970_3725_2353 4 0.000672903 0.037009686 0.001762366 23080 hsa-mir-583 hsa04916 Melanogenesis 815_1385_1387_2033 4 0.000721802 0.039699135 0.001804506 23081 hsa-mir-583 hsa04912 GnRH signaling pathway 815_6714_3725_2002 4 0.000827056 0.04548806 0.001977742 23082 hsa-mir-583 hsa04330 Notch signaling pathway 1387_9612_2033 3 0.000864408 0.047542414 0.001980934 23083 hsa-mir-583 hsa05213 Endometrial cancer 595_842_2002 3 0.001141525 0.062783884 0.002511355 23084 hsa-mir-583 hsa05221 Acute myeloid leukemia 5371_595_5970 3 0.001614852 0.088816858 0.003416033 23085 hsa-mir-583 hsa04530 Tight junction 6714_4628_60412_1457 4 0.00193488 0.106418376 0.003941421 23086 hsa-mir-583 hsa04920 Adipocytokine signaling pathway 6258_6256_5970 3 0.002287514 0.125813292 0.004493332 23087 hsa-mir-583 hsa05211 Renal cell carcinoma 1387_3725_2033 3 0.0027841 0.1531255 0.00528019 23088 hsa-mir-583 hsa04662 B cell receptor signaling pathway 5970_3725_2353 3 0.00311148 0.171131377 0.005704379 23089 hsa-mir-583 hsa04370 VEGF signaling pathway 6714_9261_842 3 0.00334231 0.183827048 0.005929905 23090 hsa-mir-583 hsa04950 Maturity onset diabetes of the young 3651_5080 2 0.00420364 0.231200197 0.007225006 23091 hsa-mir-583 hsa04660 T cell receptor signaling pathway 5970_3725_2353 3 0.008719142 0.479552828 0.014531904 23092 hsa-mir-583 hsa03022 Basal transcription factors 2962_2969 2 0.009287741 0.510825777 0.015024288 23093 hsa-mir-583 hsa05012 Parkinson's disease 836_842_10476 3 0.015218887 0.837038762 0.023915393 23094 hsa-mir-583 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_842 2 0.019792788 1 0.030238982 23095 hsa-mir-583 hsa05214 Glioma 815_595 2 0.025909274 1 0.038513785 23096 hsa-mir-583 hsa03320 PPAR signaling pathway 6258_6256 2 0.029596062 1 0.042836406 23097 hsa-mir-583 hsa05220 Chronic myeloid leukemia 595_5970 2 0.033478173 1 0.047212808 23098 hsa-mir-583 hsa04350 TGF-beta signaling pathway 1387_2033 2 0.043542797 1 0.059871346 23099 hsa-mir-583 hsa04612 Antigen processing and presentation 1385_4800 2 0.045317189 1 0.060791351 23100 hsa-mir-584 hsa05200 Pathways in cancer 6772_6688_4087_207_7046_5925_7704_5595_5594_6774_1387 11 4.31E-10 2.11E-08 2.11E-08 23101 hsa-mir-584 hsa05221 Acute myeloid leukemia 6688_207_7704_5595_5594_6774 6 9.48E-09 4.64E-07 2.32E-07 23102 hsa-mir-584 hsa04520 Adherens junction 4301_4087_7046_5595_5594_1387 6 5.19E-08 2.54E-06 8.48E-07 23103 hsa-mir-584 hsa05220 Chronic myeloid leukemia 207_7046_5925_5595_5594 5 1.24E-06 6.08E-05 1.52E-05 23104 hsa-mir-584 hsa05210 Colorectal cancer 4087_207_7046_5595_5594 5 2.11E-06 0.000103313 1.69E-05 23105 hsa-mir-584 hsa04350 TGF-beta signaling pathway 4087_7046_5595_5594_1387 5 2.48E-06 0.000121744 1.69E-05 23106 hsa-mir-584 hsa05215 Prostate cancer 207_5925_5595_5594_1387 5 2.62E-06 0.00012843 1.69E-05 23107 hsa-mir-584 hsa05212 Pancreatic cancer 207_5925_5595_5594_1387 5 2.76E-06 0.000135401 1.69E-05 23108 hsa-mir-584 hsa05223 Non-small cell lung cancer 207_5925_5595_5594 4 1.04E-05 0.00050904 5.66E-05 23109 hsa-mir-584 hsa05214 Glioma 207_5925_5595_5594 4 2.08E-05 0.001017422 0.000101742 23110 hsa-mir-584 hsa05218 Melanoma 207_5925_5595_5594 4 2.89E-05 0.001415491 0.000124293 23111 hsa-mir-584 hsa05211 Renal cell carcinoma 207_5595_5594_1387 4 3.04E-05 0.001491515 0.000124293 23112 hsa-mir-584 hsa04062 Chemokine signaling pathway 6772_207_5595_5594_6774 5 0.000100648 0.004931744 0.000379365 23113 hsa-mir-584 hsa04620 Toll-like receptor signaling pathway 6772_207_5595_5594 4 0.000111831 0.005479701 0.000391407 23114 hsa-mir-584 hsa05219 Bladder cancer 5925_5595_5594 3 0.000159818 0.007831072 0.000522071 23115 hsa-mir-584 hsa05213 Endometrial cancer 207_5595_5594 3 0.000290595 0.014239172 0.000837598 23116 hsa-mir-584 hsa04150 mTOR signaling pathway 207_5595_5594 3 0.000290595 0.014239172 0.000837598 23117 hsa-mir-584 hsa04630 Jak-STAT signaling pathway 6772_207_6774_1387 4 0.000526096 0.025778682 0.001432149 23118 hsa-mir-584 hsa04720 Long-term potentiation 5595_5594_1387 3 0.000811033 0.039740639 0.001987032 23119 hsa-mir-584 hsa04662 B cell receptor signaling pathway 207_5595_5594 3 0.000811033 0.039740639 0.001987032 23120 hsa-mir-584 hsa04370 VEGF signaling pathway 207_5595_5594 3 0.000872988 0.042776407 0.002036972 23121 hsa-mir-584 hsa04664 Fc epsilon RI signaling pathway 207_5595_5594 3 0.000937869 0.0459556 0.002088891 23122 hsa-mir-584 hsa04012 ErbB signaling pathway 207_5595_5594 3 0.001227719 0.060158252 0.002615576 23123 hsa-mir-584 hsa04916 Melanogenesis 5595_5594_1387 3 0.002016585 0.098812647 0.004117194 23124 hsa-mir-584 hsa04660 T cell receptor signaling pathway 207_5595_5594 3 0.002355262 0.115407839 0.004481374 23125 hsa-mir-584 hsa05216 Thyroid cancer 5595_5594 2 0.002377872 0.116515718 0.004481374 23126 hsa-mir-584 hsa04110 Cell cycle 4087_5925_1387 3 0.002925999 0.14337393 0.005310146 23127 hsa-mir-584 hsa04010 MAPK signaling pathway 207_7046_5595_5594 4 0.0040118 0.196578184 0.007020649 23128 hsa-mir-584 hsa04910 Insulin signaling pathway 207_5595_5594 3 0.004392017 0.215208822 0.007420994 23129 hsa-mir-584 hsa04930 Type II diabetes mellitus 5595_5594 2 0.005396846 0.26444545 0.008814848 23130 hsa-mir-584 hsa04920 Adipocytokine signaling pathway 207_6774 2 0.011333372 0.555335205 0.017914039 23131 hsa-mir-584 hsa04730 Long-term depression 5595_5594 2 0.012620172 0.618388432 0.019121783 23132 hsa-mir-584 hsa04510 Focal adhesion 207_5595_5594 3 0.012877935 0.631018829 0.019121783 23133 hsa-mir-584 hsa05222 Small cell lung cancer 207_5925 2 0.017976729 0.880859734 0.025907639 23134 hsa-mir-584 hsa04540 Gap junction 5595_5594 2 0.020751122 1 0.029051571 23135 hsa-mir-584 hsa04912 GnRH signaling pathway 5595_5594 2 0.027248656 1 0.037088448 23136 hsa-mir-584 hsa04270 Vascular smooth muscle contraction 5595_5594 2 0.031976091 1 0.042346715 23137 hsa-mir-584 hsa04360 Axon guidance 5595_5594 2 0.038564023 1 0.049727292 23138 hsa-mir-584 hsa04530 Tight junction 4301_207 2 0.041764541 1 0.051826593 23139 hsa-mir-584 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594 2 0.042307423 1 0.051826593 23140 hsa-mir-585 hsa05200 Pathways in cancer 3725_2249_367_1499_5595_5594_5599_5914_1387_6257_6256_8031_6258_2353_7704_6774_6776_6777_5970_6688_862_6502_2736_4088_5925_2033_207_2932_8554 29 6.77E-22 4.80E-20 4.80E-20 23141 hsa-mir-585 hsa04010 MAPK signaling pathway 6722_3725_2249_5595_5594_5599_4208_6195_9252_7867_2353_1432_5970_9261_10912_6196_6197_8986_4616_207 20 4.54E-14 3.22E-12 1.61E-12 23142 hsa-mir-585 hsa05221 Acute myeloid leukemia 5595_5594_5914_7704_6774_6776_6777_5970_6688_862_207 11 3.03E-12 2.15E-10 7.18E-11 23143 hsa-mir-585 hsa04720 Long-term potentiation 5595_5594_1387_6195_6196_6197_2033_808_801_805 10 5.80E-10 4.12E-08 1.03E-08 23144 hsa-mir-585 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_3397_3398_3399_659_4088_2033 10 2.16E-09 1.54E-07 2.68E-08 23145 hsa-mir-585 hsa05215 Prostate cancer 367_1499_5595_5594_1387_5970_5925_2033_207_2932 10 2.39E-09 1.70E-07 2.68E-08 23146 hsa-mir-585 hsa05212 Pancreatic cancer 367_1499_5595_5594_1387_5970_5925_2033_207_2932 10 2.65E-09 1.88E-07 2.68E-08 23147 hsa-mir-585 hsa05216 Thyroid cancer 1499_5595_5594_6257_6256_8031_6258 7 6.25E-09 4.44E-07 5.55E-08 23148 hsa-mir-585 hsa05210 Colorectal cancer 3725_1499_5595_5594_5599_2353_4088_207_2932 9 2.45E-08 1.74E-06 1.94E-07 23149 hsa-mir-585 hsa04110 Cell cycle 993_1387_983_10912_6502_4088_5925_2033_4616_2932 10 3.46E-08 2.46E-06 2.46E-07 23150 hsa-mir-585 hsa04920 Adipocytokine signaling pathway 10891_5599_6257_6256_6258_6774_5970_207 8 6.94E-08 4.93E-06 4.48E-07 23151 hsa-mir-585 hsa04916 Melanogenesis 1499_5595_5594_1387_2033_2932_808_801_805 9 1.35E-07 9.56E-06 7.96E-07 23152 hsa-mir-585 hsa05220 Chronic myeloid leukemia 5595_5594_6776_6777_5970_4088_5925_207 8 1.54E-07 1.10E-05 8.44E-07 23153 hsa-mir-585 hsa05223 Non-small cell lung cancer 5595_5594_6257_6256_6258_5925_207 7 2.81E-07 1.99E-05 1.42E-06 23154 hsa-mir-585 hsa05222 Small cell lung cancer 6257_6256_6258_5970_6502_5925_207_8554 8 4.07E-07 2.89E-05 1.93E-06 23155 hsa-mir-585 hsa04012 ErbB signaling pathway 3725_5595_5594_5599_6776_6777_207_2932 8 4.42E-07 3.14E-05 1.96E-06 23156 hsa-mir-585 hsa05214 Glioma 5595_5594_5925_207_808_801_805 7 8.87E-07 6.29E-05 3.70E-06 23157 hsa-mir-585 hsa04910 Insulin signaling pathway 10891_5595_5594_5599_207_2932_808_801_805 9 1.26E-06 8.93E-05 4.96E-06 23158 hsa-mir-585 hsa04620 Toll-like receptor signaling pathway 3725_5595_5594_5599_2353_1432_5970_207 8 1.36E-06 9.65E-05 5.08E-06 23159 hsa-mir-585 hsa04912 GnRH signaling pathway 3725_5595_5594_5599_1432_808_801_805 8 2.03E-06 0.000144232 7.21E-06 23160 hsa-mir-585 hsa04662 B cell receptor signaling pathway 3725_5595_5594_2353_5970_207_2932 7 2.15E-06 0.000152879 7.28E-06 23161 hsa-mir-585 hsa04660 T cell receptor signaling pathway 3725_5595_5594_2353_1432_5970_207_2932 8 2.31E-06 0.000164053 7.46E-06 23162 hsa-mir-585 hsa04150 mTOR signaling pathway 5595_5594_6195_6196_6197_207 6 3.79E-06 0.00026939 1.17E-05 23163 hsa-mir-585 hsa05211 Renal cell carcinoma 3725_5595_5594_1387_2033_207 6 2.14E-05 0.001517208 6.32E-05 23164 hsa-mir-585 hsa04630 Jak-STAT signaling pathway 1387_6774_6776_6777_2033_3977_207_8554 8 2.49E-05 0.001767103 7.07E-05 23165 hsa-mir-585 hsa04370 VEGF signaling pathway 5595_5594_7867_1432_9261_207 6 3.05E-05 0.002164112 8.32E-05 23166 hsa-mir-585 hsa04330 Notch signaling pathway 388585_1387_9612_2033_8850 5 3.60E-05 0.002557263 9.46E-05 23167 hsa-mir-585 hsa04520 Adherens junction 1499_5595_5594_1387_4088_2033 6 3.73E-05 0.002647918 9.46E-05 23168 hsa-mir-585 hsa05213 Endometrial cancer 1499_5595_5594_207_2932 5 5.64E-05 0.004001709 0.00013799 23169 hsa-mir-585 hsa04310 Wnt signaling pathway 3725_1499_5599_1387_4088_2033_2932 7 0.000158491 0.011252867 0.000375096 23170 hsa-mir-585 hsa05218 Melanoma 2249_5595_5594_5925_207 5 0.000222687 0.015810759 0.000510024 23171 hsa-mir-585 hsa04270 Vascular smooth muscle contraction 5592_5595_5594_808_801_805 6 0.000282621 0.020066084 0.000627065 23172 hsa-mir-585 hsa05219 Bladder cancer 5595_5594_9252_5925 4 0.000333283 0.023663064 0.000717063 23173 hsa-mir-585 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_1432_207 5 0.000355245 0.025222393 0.000741835 23174 hsa-mir-585 hsa04930 Type II diabetes mellitus 5595_5594_5599_3651 4 0.000425514 0.03021148 0.000863185 23175 hsa-mir-585 hsa04062 Chemokine signaling pathway 5595_5594_6774_6777_5970_207_2932 7 0.000634343 0.045038338 0.001251065 23176 hsa-mir-585 hsa04510 Focal adhesion 3725_1499_5595_5594_5599_207_2932 7 0.000917741 0.065159627 0.001757676 23177 hsa-mir-585 hsa04950 Maturity onset diabetes of the young 3651_168620_6927 3 0.000940728 0.066791685 0.001757676 23178 hsa-mir-585 hsa03320 PPAR signaling pathway 6257_6256_6258_2168 4 0.002009661 0.142685965 0.003658614 23179 hsa-mir-585 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5599_1432_5970 4 0.002111093 0.149887622 0.003713994 23180 hsa-mir-585 hsa05010 Alzheimer's disease 5595_5594_2932_808_801_805 6 0.002144701 0.152273749 0.003713994 23181 hsa-mir-585 hsa05016 Huntington's disease 10891_1387_6908_6667_3064_2033 6 0.002867016 0.203558147 0.004846623 23182 hsa-mir-585 hsa04540 Gap junction 5592_5595_5594_983 4 0.005325919 0.378140247 0.008793959 23183 hsa-mir-585 hsa05217 Basal cell carcinoma 1499_2736_2932 3 0.008431796 0.598657529 0.013605853 23184 hsa-mir-585 hsa04115 p53 signaling pathway 983_10912_4616 3 0.01515027 1 0.02390376 23185 hsa-mir-585 hsa04730 Long-term depression 5592_5595_5594 3 0.01629685 1 0.025153834 23186 hsa-mir-585 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.019371199 1 0.029262874 23187 hsa-mir-585 hsa04120 Ubiquitin mediated proteolysis 672_7329_6502_8554 4 0.01992794 1 0.029476745 23188 hsa-mir-585 hsa03410 Base excision repair 3146_142 2 0.030464273 1 0.04414211 23189 hsa-mir-585 hsa03022 Basal transcription factors 2963_6908 2 0.031961855 1 0.045385833 23190 hsa-mir-586 hsa05220 Chronic myeloid leukemia 3066_1870_1871_7157_4193_4609_1029 7 4.03E-13 1.37E-11 1.37E-11 23191 hsa-mir-586 hsa05219 Bladder cancer 1870_1871_7157_4193_4609_1029 6 2.09E-12 7.10E-11 3.55E-11 23192 hsa-mir-586 hsa04110 Cell cycle 3066_1870_1871_7157_2033_4193_1029 7 8.74E-12 2.97E-10 9.91E-11 23193 hsa-mir-586 hsa05215 Prostate cancer 1870_1871_7157_2033_4193_1385 6 1.35E-10 4.60E-09 9.81E-10 23194 hsa-mir-586 hsa05212 Pancreatic cancer 1870_1871_7157_2033_4193_1385 6 1.44E-10 4.90E-09 9.81E-10 23195 hsa-mir-586 hsa05200 Pathways in cancer 3066_1870_1871_7157_2033_4193_4609_1029 8 2.28E-10 7.74E-09 1.29E-09 23196 hsa-mir-586 hsa05214 Glioma 1870_1871_7157_4193_1029 5 3.05E-09 1.04E-07 1.48E-08 23197 hsa-mir-586 hsa05218 Melanoma 1870_1871_7157_4193_1029 5 4.64E-09 1.58E-07 1.97E-08 23198 hsa-mir-586 hsa05223 Non-small cell lung cancer 1870_1871_7157_1029 4 1.54E-07 5.23E-06 5.81E-07 23199 hsa-mir-586 hsa05016 Huntington's disease 3066_7157_6667_2033_1385 5 4.99E-07 1.70E-05 1.70E-06 23200 hsa-mir-586 hsa05222 Small cell lung cancer 1870_1871_7157_4609 4 9.10E-07 3.09E-05 2.81E-06 23201 hsa-mir-586 hsa04330 Notch signaling pathway 3066_2033_4851 3 9.74E-06 0.000331123 2.76E-05 23202 hsa-mir-586 hsa04115 p53 signaling pathway 7157_4193_1029 3 2.93E-05 0.000995455 7.66E-05 23203 hsa-mir-586 hsa04350 TGF-beta signaling pathway 6667_2033_4609 3 5.71E-05 0.001941574 0.000138684 23204 hsa-mir-586 hsa04310 Wnt signaling pathway 7157_2033_4609 3 0.000285499 0.009706957 0.00064713 23205 hsa-mir-586 hsa05216 Thyroid cancer 7157_4609 2 0.000304946 0.010368147 0.000648009 23206 hsa-mir-586 hsa05213 Endometrial cancer 7157_4609 2 0.0009275 0.031535016 0.001855001 23207 hsa-mir-586 hsa04010 MAPK signaling pathway 7157_4609_1386 3 0.001521354 0.051726038 0.002873669 23208 hsa-mir-586 hsa05210 Colorectal cancer 7157_4609 2 0.002330672 0.079242863 0.004170677 23209 hsa-mir-586 hsa04916 Melanogenesis 2033_1385 2 0.003512677 0.119431022 0.005971551 23210 hsa-mir-586 hsa04120 Ubiquitin mediated proteolysis 4193_672 2 0.006120155 0.208085273 0.009908823 23211 hsa-mir-586 hsa04630 Jak-STAT signaling pathway 2033_4609 2 0.007532003 0.256088112 0.011640369 23212 hsa-mir-586 hsa03022 Basal transcription factors 2969 1 0.031176672 1 0.046087254 23213 hsa-mir-586 hsa05217 Basal cell carcinoma 7157 1 0.045616816 1 0.063121623 23214 hsa-mir-586 hsa05014 Amyotrophic lateral sclerosis (ALS) 7157 1 0.046412958 1 0.063121623 23215 hsa-mir-586 hsa05221 Acute myeloid leukemia 4609 1 0.048797561 1 0.063812195 23216 hsa-mir-587 hsa05200 Pathways in cancer 5970_595_2033_367_3725_4790_1387_6772_2353 9 1.15E-10 4.04E-09 4.04E-09 23217 hsa-mir-587 hsa05215 Prostate cancer 5970_595_2033_367_4790_1387 6 1.00E-09 3.51E-08 1.25E-08 23218 hsa-mir-587 hsa05212 Pancreatic cancer 5970_595_2033_367_4790_1387 6 1.07E-09 3.74E-08 1.25E-08 23219 hsa-mir-587 hsa04310 Wnt signaling pathway 595_2033_894_896_3725_1387 6 2.29E-08 8.03E-07 1.80E-07 23220 hsa-mir-587 hsa04630 Jak-STAT signaling pathway 595_2033_894_896_1387_6772 6 2.57E-08 8.98E-07 1.80E-07 23221 hsa-mir-587 hsa04620 Toll-like receptor signaling pathway 5970_3725_4790_6772_2353 5 1.34E-07 4.68E-06 7.81E-07 23222 hsa-mir-587 hsa04110 Cell cycle 595_2033_894_896_1387 5 2.80E-07 9.79E-06 1.40E-06 23223 hsa-mir-587 hsa04330 Notch signaling pathway 8850_9612_2033_1387 4 3.29E-07 1.15E-05 1.44E-06 23224 hsa-mir-587 hsa04662 B cell receptor signaling pathway 5970_3725_4790_2353 4 1.94E-06 6.78E-05 7.53E-06 23225 hsa-mir-587 hsa04660 T cell receptor signaling pathway 5970_3725_4790_2353 4 8.36E-06 0.000292642 2.93E-05 23226 hsa-mir-587 hsa05221 Acute myeloid leukemia 5970_595_4790 3 4.79E-05 0.001676122 0.000152375 23227 hsa-mir-587 hsa04115 p53 signaling pathway 595_894_896 3 7.49E-05 0.00262279 0.000208132 23228 hsa-mir-587 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_3725_4790 3 8.13E-05 0.002846362 0.000208132 23229 hsa-mir-587 hsa05211 Renal cell carcinoma 2033_3725_1387 3 8.46E-05 0.002962669 0.000208132 23230 hsa-mir-587 hsa04510 Focal adhesion 595_894_896_3725 4 9.14E-05 0.003198242 0.000208132 23231 hsa-mir-587 hsa05220 Chronic myeloid leukemia 5970_595_4790 3 9.51E-05 0.003330113 0.000208132 23232 hsa-mir-587 hsa05210 Colorectal cancer 595_3725_2353 3 0.000131646 0.004607609 0.000271036 23233 hsa-mir-587 hsa05222 Small cell lung cancer 5970_595_4790 3 0.000140829 0.004929009 0.000273834 23234 hsa-mir-587 hsa04010 MAPK signaling pathway 5970_3725_4790_2353 4 0.000264052 0.009241809 0.000486411 23235 hsa-mir-587 hsa05016 Huntington's disease 2033_25942_1387 3 0.001310272 0.045859537 0.002292977 23236 hsa-mir-587 hsa04062 Chemokine signaling pathway 5970_4790_6772 3 0.001411016 0.049385555 0.002351693 23237 hsa-mir-587 hsa04920 Adipocytokine signaling pathway 5970_4790 2 0.002782761 0.097396631 0.00442712 23238 hsa-mir-587 hsa04720 Long-term potentiation 2033_1387 2 0.003451156 0.120790453 0.005251759 23239 hsa-mir-587 hsa04520 Adherens junction 2033_1387 2 0.003903226 0.136612927 0.005692205 23240 hsa-mir-587 hsa04350 TGF-beta signaling pathway 2033_1387 2 0.004579825 0.16029388 0.006411755 23241 hsa-mir-587 hsa04210 Apoptosis 5970_4790 2 0.004782406 0.167384193 0.006437854 23242 hsa-mir-587 hsa04916 Melanogenesis 2033_1387 2 0.006430687 0.225074031 0.008336075 23243 hsa-mir-587 hsa05216 Thyroid cancer 595 1 0.033425763 1 0.041782204 23244 hsa-mir-587 hsa05219 Bladder cancer 595 1 0.047571124 1 0.057413425 23245 hsa-mir-589 hsa04010 MAPK signaling pathway 6722_2249_5595_5594_5599_1386_5604_5606_5601_5600_1432_2885_5970_468_3725_3727_2353_9344_2005 19 1.36E-19 8.29E-18 8.29E-18 23246 hsa-mir-589 hsa05200 Pathways in cancer 2249_9063_5595_5594_5599_5914_1387_6256_5604_5601_367_6776_2885_5970_3725_2353_6777_1050_2033 19 4.28E-18 2.61E-16 1.31E-16 23247 hsa-mir-589 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5604_5606_5601_5600_1432_5970_3725_2353 11 1.08E-13 6.60E-12 2.20E-12 23248 hsa-mir-589 hsa04912 GnRH signaling pathway 5595_5594_5599_5604_5606_5601_5600_1432_2885_468_3725 11 1.93E-13 1.18E-11 2.95E-12 23249 hsa-mir-589 hsa05215 Prostate cancer 5595_5594_1387_5604_367_2885_5970_468_10488_2033 10 9.24E-13 5.64E-11 1.04E-11 23250 hsa-mir-589 hsa05212 Pancreatic cancer 5595_5594_1387_5604_367_2885_5970_468_10488_2033 10 1.03E-12 6.26E-11 1.04E-11 23251 hsa-mir-589 hsa05221 Acute myeloid leukemia 5595_5594_5914_5604_6776_2885_5970_6777_1050 9 1.19E-12 7.25E-11 1.04E-11 23252 hsa-mir-589 hsa04660 T cell receptor signaling pathway 5595_5594_5604_5601_5600_1432_2885_5970_3725_2353 10 7.22E-12 4.41E-10 5.51E-11 23253 hsa-mir-589 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5604_5606_5601_5600_1432_2885 9 1.31E-11 7.96E-10 8.85E-11 23254 hsa-mir-589 hsa04012 ErbB signaling pathway 5595_5594_5599_5604_5601_6776_2885_3725_6777 9 2.90E-11 1.77E-09 1.77E-10 23255 hsa-mir-589 hsa05210 Colorectal cancer 5595_5594_5599_5604_5601_2885_3725_2353 8 7.02E-10 4.28E-08 3.89E-09 23256 hsa-mir-589 hsa04350 TGF-beta signaling pathway 6667_5595_5594_1387_3397_3399_3398_2033 8 9.09E-10 5.55E-08 4.62E-09 23257 hsa-mir-589 hsa05211 Renal cell carcinoma 5595_5594_1387_5604_2885_3725_2033 7 7.47E-09 4.56E-07 3.51E-08 23258 hsa-mir-589 hsa05220 Chronic myeloid leukemia 5595_5594_5604_6776_2885_5970_6777 7 9.72E-09 5.93E-07 3.95E-08 23259 hsa-mir-589 hsa04662 B cell receptor signaling pathway 5595_5594_5604_2885_5970_3725_2353 7 9.72E-09 5.93E-07 3.95E-08 23260 hsa-mir-589 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5601_5600_1432_5970_3725 6 2.01E-07 1.22E-05 7.65E-07 23261 hsa-mir-589 hsa04720 Long-term potentiation 5595_5594_1387_5604_468_2033 6 2.72E-07 1.66E-05 9.76E-07 23262 hsa-mir-589 hsa04310 Wnt signaling pathway 5599_1387_5601_8061_3725_1457_2033 7 9.30E-07 5.67E-05 3.15E-06 23263 hsa-mir-589 hsa04630 Jak-STAT signaling pathway 9063_1387_6776_2885_6777_2033_3977 7 1.05E-06 6.43E-05 3.38E-06 23264 hsa-mir-589 hsa05223 Non-small cell lung cancer 5595_5594_6256_5604_2885 5 1.44E-06 8.77E-05 4.39E-06 23265 hsa-mir-589 hsa04916 Melanogenesis 5595_5594_1387_5604_10488_2033 6 1.66E-06 0.000101475 4.83E-06 23266 hsa-mir-589 hsa05216 Thyroid cancer 5595_5594_6256_5604 4 4.02E-06 0.000245311 1.12E-05 23267 hsa-mir-589 hsa04510 Focal adhesion 5595_5594_5599_5604_5601_2885_3725 7 6.46E-06 0.000394026 1.71E-05 23268 hsa-mir-589 hsa04370 VEGF signaling pathway 5595_5594_5604_5600_1432 5 7.39E-06 0.000450563 1.88E-05 23269 hsa-mir-589 hsa04910 Insulin signaling pathway 5595_5594_5599_5604_5601_2885 6 7.92E-06 0.000483028 1.93E-05 23270 hsa-mir-589 hsa04520 Adherens junction 5595_5594_1387_1457_2033 5 8.81E-06 0.000537493 2.07E-05 23271 hsa-mir-589 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601 4 2.00E-05 0.001220471 4.52E-05 23272 hsa-mir-589 hsa05213 Endometrial cancer 5595_5594_5604_2885 4 3.41E-05 0.002079109 7.43E-05 23273 hsa-mir-589 hsa04062 Chemokine signaling pathway 5595_5594_5604_2885_5970_6777 6 4.92E-05 0.003001366 0.000103495 23274 hsa-mir-589 hsa05214 Glioma 5595_5594_5604_2885 4 7.77E-05 0.004737755 0.000157925 23275 hsa-mir-589 hsa04920 Adipocytokine signaling pathway 5599_6256_5601_5970 4 8.69E-05 0.005298444 0.000170918 23276 hsa-mir-589 hsa05218 Melanoma 2249_5595_5594_5604 4 0.00010758 0.006562351 0.000205073 23277 hsa-mir-589 hsa04540 Gap junction 5595_5594_5604_2885 4 0.000290353 0.017711518 0.000536713 23278 hsa-mir-589 hsa05219 Bladder cancer 5595_5594_5604 3 0.000430095 0.026235803 0.000751926 23279 hsa-mir-589 hsa05016 Huntington's disease 6667_1387_6908_10488_2033 5 0.000431433 0.02631742 0.000751926 23280 hsa-mir-589 hsa04330 Notch signaling pathway 1387_9612_2033 3 0.000587113 0.035813876 0.00099483 23281 hsa-mir-589 hsa05014 Amyotrophic lateral sclerosis (ALS) 5606_5600_1432 3 0.000953384 0.058156419 0.001571795 23282 hsa-mir-589 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_5604_2885 4 0.001216859 0.07422837 0.001953378 23283 hsa-mir-589 hsa04730 Long-term depression 5595_5594_5604 3 0.001835229 0.111948953 0.002870486 23284 hsa-mir-589 hsa05222 Small cell lung cancer 9063_6256_5970 3 0.003103969 0.189342133 0.004733553 23285 hsa-mir-589 hsa04810 Regulation of actin cytoskeleton 2249_5595_5594_5604 4 0.006156767 0.375562789 0.009160068 23286 hsa-mir-589 hsa04270 Vascular smooth muscle contraction 5595_5594_5604 3 0.007303922 0.445539252 0.010608077 23287 hsa-mir-589 hsa04120 Ubiquitin mediated proteolysis 9063_672_7329 3 0.011283489 0.6882928 0.016006809 23288 hsa-mir-589 hsa04150 mTOR signaling pathway 5595_5594 2 0.013452428 0.820598125 0.018649957 23289 hsa-mir-589 hsa05010 Alzheimer's disease 5595_5594_6622 3 0.021139671 1 0.028655999 23290 hsa-mir-589 hsa03450 Non-homologous end-joining 2547 1 0.047753682 1 0.063325535 23291 hsa-mir-590 hsa05200 Pathways in cancer 3320_3326_1147_4149_5371_3551_1499_5595_5599_861_1387_5604_367_8517_2932_6502_5970_6256_6688_2113_5894_1869_6774_1029_2353_2736_4087_4088_7175_3065_4292_1050_5925_2033_207_4791_4792 37 8.51E-28 6.38E-26 6.38E-26 23292 hsa-mir-590 hsa04010 MAPK signaling pathway 6722_8986_1147_4149_3551_5595_5599_5598_9261_1326_5604_3305_3303_8517_9252_3310_3312_1386_1432_5971_5970_5894_6195_6196_6197_2353_207_4791_1616_5566 30 1.59E-22 1.19E-20 5.96E-21 23293 hsa-mir-590 hsa05215 Prostate cancer 3320_3326_1147_3551_1499_5595_1387_5604_367_8517_2932_5970_5894_1869_5925_2033_207_4792 18 3.24E-18 2.43E-16 7.24E-17 23294 hsa-mir-590 hsa05212 Pancreatic cancer 3320_3326_1147_3551_1499_5595_1387_5604_367_8517_2932_5970_5894_1869_5925_2033_207_4792 18 3.86E-18 2.90E-16 7.24E-17 23295 hsa-mir-590 hsa04540 Gap junction 347733_5592_5595_5598_983_5604_7277_7278_10376_10382_84617_5894_7846_51807_203068_5566 16 2.76E-15 2.07E-13 3.64E-14 23296 hsa-mir-590 hsa05220 Chronic myeloid leukemia 1147_3551_5595_861_5604_8517_5970_5894_1869_1029_4088_3065_5925_207_4792 15 2.91E-15 2.18E-13 3.64E-14 23297 hsa-mir-590 hsa05221 Acute myeloid leukemia 1147_5371_3551_5595_861_5604_8517_5970_6688_5894_6774_1050_207 13 7.17E-14 5.38E-12 7.68E-13 23298 hsa-mir-590 hsa04110 Cell cycle 990_5591_1387_983_2932_8454_6502_6500_1869_1029_4087_4088_3065_5925_2033_5933 16 8.68E-14 6.51E-12 8.14E-13 23299 hsa-mir-590 hsa04660 T cell receptor signaling pathway 1147_3551_5595_1326_5604_4794_8517_2932_1432_5970_5894_2353_207_4792_4793 15 4.37E-13 3.27E-11 3.64E-12 23300 hsa-mir-590 hsa05131 Shigellosis 347733_1499_7277_7278_10376_10382_84617_7846_51807_203068_4691_71 12 8.89E-13 6.67E-11 6.06E-12 23301 hsa-mir-590 hsa05130 Pathogenic Escherichia coli infection 347733_1499_7277_7278_10376_10382_84617_7846_51807_203068_4691_71 12 8.89E-13 6.67E-11 6.06E-12 23302 hsa-mir-590 hsa04662 B cell receptor signaling pathway 1147_3551_5595_5604_4794_8517_2932_5970_5894_2353_207_4792_4793 13 1.07E-12 8.03E-11 6.69E-12 23303 hsa-mir-590 hsa04720 Long-term potentiation 5595_1387_5604_5894_6195_6196_6197_2033_808_801_5566_805 12 1.86E-11 1.40E-09 1.08E-10 23304 hsa-mir-590 hsa04310 Wnt signaling pathway 23291_1499_5599_1387_8607_1457_2932_8454_6500_8945_1459_4087_4088_2033_5566 15 3.03E-11 2.27E-09 1.62E-10 23305 hsa-mir-590 hsa04920 Adipocytokine signaling pathway 1147_3551_5599_4794_8517_5970_6256_6774_207_4792_4793 11 1.02E-10 7.67E-09 5.12E-10 23306 hsa-mir-590 hsa04620 Toll-like receptor signaling pathway 1147_3551_5595_5599_1326_5604_8517_1432_5970_2353_207_4792 12 4.70E-10 3.52E-08 2.20E-09 23307 hsa-mir-590 hsa04062 Chemokine signaling pathway 1147_3551_5595_5604_8517_2932_5970_653361_5894_6774_7074_207_4792_4793_5566 15 6.73E-10 5.05E-08 2.97E-09 23308 hsa-mir-590 hsa05210 Colorectal cancer 1499_5595_5599_5604_2932_5894_2353_4087_4088_4292_207 11 8.99E-10 6.74E-08 3.75E-09 23309 hsa-mir-590 hsa05222 Small cell lung cancer 1147_4149_3551_8517_6502_5970_6256_1869_5925_207_4792 11 1.13E-09 8.46E-08 4.45E-09 23310 hsa-mir-590 hsa04350 TGF-beta signaling pathway 5595_1387_6667_8454_3399_6500_3398_4087_4088_2033_5933 11 1.26E-09 9.45E-08 4.63E-09 23311 hsa-mir-590 hsa05214 Glioma 5595_5604_5894_1869_1029_5925_207_808_801_805 10 1.30E-09 9.73E-08 4.63E-09 23312 hsa-mir-590 hsa04916 Melanogenesis 1499_5595_1387_5604_2932_5894_2033_808_801_5566_805 11 7.00E-09 5.25E-07 2.39E-08 23313 hsa-mir-590 hsa05223 Non-small cell lung cancer 5595_5604_6256_5894_1869_1029_5925_207 8 7.83E-08 5.87E-06 2.55E-07 23314 hsa-mir-590 hsa04520 Adherens junction 1499_5595_1387_1457_1459_4087_4088_2033_71 9 1.03E-07 7.76E-06 3.10E-07 23315 hsa-mir-590 hsa04910 Insulin signaling pathway 3551_5595_5599_5604_2932_5894_207_808_801_5566_805 11 1.04E-07 7.81E-06 3.10E-07 23316 hsa-mir-590 hsa04912 GnRH signaling pathway 5595_5599_5598_5604_1432_5894_808_801_5566_805 10 1.09E-07 8.18E-06 3.10E-07 23317 hsa-mir-590 hsa04120 Ubiquitin mediated proteolysis 55294_5371_23291_672_8454_6502_6500_3093_10273_8945_7323 11 1.11E-07 8.36E-06 3.10E-07 23318 hsa-mir-590 hsa04612 Antigen processing and presentation 3320_3326_3309_3305_3303_4802_3310_3312_4801 9 2.39E-07 1.79E-05 6.40E-07 23319 hsa-mir-590 hsa05219 Bladder cancer 5595_5604_9252_5894_1869_1029_5925 7 2.53E-07 1.90E-05 6.54E-07 23320 hsa-mir-590 hsa05016 Huntington's disease 1387_292_293_6908_6667_5437_1213_23186_3065_3064_2033_5441 12 2.64E-07 1.98E-05 6.61E-07 23321 hsa-mir-590 hsa03020 RNA polymerase 64425_5437_25885_51082_84172_5441 6 6.09E-07 4.57E-05 1.47E-06 23322 hsa-mir-590 hsa05213 Endometrial cancer 1499_5595_5604_2932_5894_4292_207 7 9.31E-07 6.98E-05 2.18E-06 23323 hsa-mir-590 hsa04270 Vascular smooth muscle contraction 5592_5595_4637_5604_5894_808_801_5566_805 9 2.15E-06 0.000161268 4.89E-06 23324 hsa-mir-590 hsa04210 Apoptosis 1147_3551_8517_5970_8837_207_4792_5566 8 2.56E-06 0.000191978 5.65E-06 23325 hsa-mir-590 hsa05218 Melanoma 5595_5604_5894_1869_1029_5925_207 7 6.25E-06 0.000468478 1.30E-05 23326 hsa-mir-590 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_3551_5599_8517_1432_5970_4792 7 6.25E-06 0.000468478 1.30E-05 23327 hsa-mir-590 hsa05211 Renal cell carcinoma 5595_1387_5604_2113_5894_2033_207 7 6.80E-06 0.000510158 1.38E-05 23328 hsa-mir-590 hsa04330 Notch signaling pathway 1387_9612_3065_2033_2648_4851 6 7.54E-06 0.000565181 1.49E-05 23329 hsa-mir-590 hsa05216 Thyroid cancer 1499_5595_5604_6256_7175 5 1.20E-05 0.00090268 2.31E-05 23330 hsa-mir-590 hsa04530 Tight junction 1499_1457_4628_4627_10627_1459_207_71 8 4.89E-05 0.003667052 9.17E-05 23331 hsa-mir-590 hsa04370 VEGF signaling pathway 5595_9261_5604_1432_5894_207 6 9.92E-05 0.00743904 0.00018144 23332 hsa-mir-590 hsa04664 Fc epsilon RI signaling pathway 5595_5599_5604_1432_5894_207 6 0.000113242 0.00849314 0.000202218 23333 hsa-mir-590 hsa04510 Focal adhesion 1499_5595_5599_5604_2932_10627_5894_207_71 9 0.000140782 0.010558625 0.000245549 23334 hsa-mir-590 hsa04150 mTOR signaling pathway 5595_6195_6196_6197_207 5 0.000153325 0.011499401 0.00026135 23335 hsa-mir-590 hsa04012 ErbB signaling pathway 5595_5599_5604_2932_5894_207 6 0.000186032 0.013952411 0.000310054 23336 hsa-mir-590 hsa04810 Regulation of actin cytoskeleton 5595_5604_4628_4627_10788_10627_5894_7074_71 9 0.000218276 0.016370714 0.000355885 23337 hsa-mir-590 hsa04340 Hedgehog signaling pathway 23291_2932_8945_2736_5566 5 0.000228556 0.017141669 0.000364716 23338 hsa-mir-590 hsa03022 Basal transcription factors 2963_2962_2969_6908 4 0.00047693 0.035769736 0.000745203 23339 hsa-mir-590 hsa04930 Type II diabetes mellitus 3651_3551_5595_5599 4 0.000943858 0.070789363 0.001444681 23340 hsa-mir-590 hsa04630 Jak-STAT signaling pathway 3559_1387_6778_6774_2033_207 6 0.003259862 0.244489681 0.004889794 23341 hsa-mir-590 hsa04730 Long-term depression 5592_5595_5604_5894 4 0.004523485 0.339261394 0.006652184 23342 hsa-mir-590 hsa04670 Leukocyte transendothelial migration 1499_1432_653361_10627_71 5 0.005635301 0.422647562 0.008127838 23343 hsa-mir-590 hsa04020 Calcium signaling pathway 292_293_808_801_5566_805 6 0.007232565 0.5424424 0.010234762 23344 hsa-mir-590 hsa03010 Ribosome 6207_6156_6128_6202 4 0.014948678 1 0.020386872 23345 hsa-mir-590 hsa05217 Basal cell carcinoma 1499_2932_2736 3 0.014950373 1 0.020386872 23346 hsa-mir-590 hsa05010 Alzheimer's disease 5595_2932_808_801_805 5 0.023656098 1 0.031682274 23347 hsa-mir-590 hsa04115 p53 signaling pathway 983_7161_1029 3 0.026407386 1 0.034746561 23348 hsa-mir-590 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.033479935 1 0.04329302 23349 hsa-mir-590 hsa03410 Base excision repair 3146_142 2 0.044855559 1 0.057019779 23350 hsa-mir-591 hsa05200 Pathways in cancer 2113_861_5925_5599_1387 5 2.34E-06 7.71E-05 7.71E-05 23351 hsa-mir-591 hsa04350 TGF-beta signaling pathway 3398_3399_1387 3 2.86E-05 0.000944701 0.00047235 23352 hsa-mir-591 hsa04310 Wnt signaling pathway 6423_5599_1387 3 0.000144284 0.004761377 0.001587126 23353 hsa-mir-591 hsa04010 MAPK signaling pathway 1616_9479_5599 3 0.000780462 0.025755259 0.006438815 23354 hsa-mir-591 hsa05211 Renal cell carcinoma 2113_1387 2 0.001106649 0.036519408 0.006585704 23355 hsa-mir-591 hsa05220 Chronic myeloid leukemia 861_5925 2 0.001197401 0.039514226 0.006585704 23356 hsa-mir-591 hsa05215 Prostate cancer 5925_1387 2 0.001630478 0.053805775 0.006874119 23357 hsa-mir-591 hsa05212 Pancreatic cancer 5925_1387 2 0.001666453 0.054992949 0.006874119 23358 hsa-mir-591 hsa04110 Cell cycle 5925_1387 2 0.002919309 0.096337197 0.010704133 23359 hsa-mir-591 hsa05016 Huntington's disease 1387_6908 2 0.007024157 0.23179718 0.023179718 23360 hsa-mir-591 hsa03022 Basal transcription factors 6908 1 0.025022141 0.825730669 0.06971657 23361 hsa-mir-591 hsa05219 Bladder cancer 5925 1 0.0282699 0.932906688 0.06971657 23362 hsa-mir-591 hsa04930 Type II diabetes mellitus 5599 1 0.030213618 0.997049408 0.06971657 23363 hsa-mir-591 hsa04330 Notch signaling pathway 1387 1 0.031507378 1 0.06971657 23364 hsa-mir-591 hsa05223 Non-small cell lung cancer 5925 1 0.036022638 1 0.06971657 23365 hsa-mir-591 hsa05014 Amyotrophic lateral sclerosis (ALS) 1616 1 0.037309034 1 0.06971657 23366 hsa-mir-591 hsa05221 Acute myeloid leukemia 861 1 0.039235572 1 0.06971657 23367 hsa-mir-591 hsa05214 Glioma 5925 1 0.043077664 1 0.06971657 23368 hsa-mir-591 hsa04920 Adipocytokine signaling pathway 5599 1 0.044355114 1 0.06971657 23369 hsa-mir-591 hsa05218 Melanoma 5925 1 0.046905157 1 0.06971657 23370 hsa-mir-591 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599 1 0.046905157 1 0.06971657 23371 hsa-mir-591 hsa04720 Long-term potentiation 1387 1 0.049448734 1 0.06971657 23372 hsa-mir-592 hsa05200 Pathways in cancer 3716_3320_4149_5371_2249_1499_5595_5594_5599_5914_1387_6256_862_5604_1488_1487_367_2932_6502_6776_6777_6772_5970_5894_3725_1029_2353_4087_4088_3065_4292_5925_2033_1050 34 3.86E-30 2.70E-28 2.70E-28 23373 hsa-mir-592 hsa05220 Chronic myeloid leukemia 5595_5594_5604_1488_1487_6776_6777_5970_5894_1029_4088_3065_5925 13 8.43E-15 5.90E-13 2.95E-13 23374 hsa-mir-592 hsa04350 TGF-beta signaling pathway 6667_5595_5594_1387_8454_3399_3397_3398_6500_4087_4088_2033_5933 13 4.69E-14 3.28E-12 1.09E-12 23375 hsa-mir-592 hsa04110 Cell cycle 990_1387_983_2932_8454_6502_1029_6500_4087_4088_3065_5925_2033_5933 14 9.66E-14 6.76E-12 1.69E-12 23376 hsa-mir-592 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_862_5604_6776_6777_5970_5894_1050 11 5.06E-13 3.54E-11 7.08E-12 23377 hsa-mir-592 hsa05210 Colorectal cancer 1499_5595_5594_5599_5604_2932_5894_3725_2353_4087_4088_4292 12 7.34E-13 5.14E-11 8.56E-12 23378 hsa-mir-592 hsa05215 Prostate cancer 3320_1499_5595_5594_1387_5604_367_2932_5970_5894_5925_2033 12 1.21E-12 8.46E-11 1.19E-11 23379 hsa-mir-592 hsa05212 Pancreatic cancer 3320_1499_5595_5594_1387_5604_367_2932_5970_5894_5925_2033 12 1.36E-12 9.55E-11 1.19E-11 23380 hsa-mir-592 hsa04310 Wnt signaling pathway 1499_5599_1387_1488_1487_2932_8454_1459_3725_1457_6500_4087_4088_2033 14 2.09E-12 1.46E-10 1.62E-11 23381 hsa-mir-592 hsa04010 MAPK signaling pathway 6722_4149_2249_5595_5594_5599_5598_9261_5604_4208_7867_1386_1432_5970_5894_3725_2353 17 3.13E-12 2.19E-10 2.19E-11 23382 hsa-mir-592 hsa04630 Jak-STAT signaling pathway 3717_3716_1387_6776_6777_6772_3455_3454_7297_6778_2033_3977_10379 13 3.90E-11 2.73E-09 2.48E-10 23383 hsa-mir-592 hsa04540 Gap junction 5595_5594_5598_983_5604_7277_10376_5894_7846_7278_51807 11 4.36E-11 3.05E-09 2.54E-10 23384 hsa-mir-592 hsa04330 Notch signaling pathway 388585_1387_1488_1487_9612_3065_2033_2648_8850 9 5.65E-11 3.96E-09 3.04E-10 23385 hsa-mir-592 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5604_1432_6772_5970_3455_3454_3725_2353 11 1.08E-10 7.59E-09 5.42E-10 23386 hsa-mir-592 hsa04916 Melanogenesis 1499_5595_5594_1387_5604_2932_5894_2033_808_801_805 11 1.31E-10 9.19E-09 6.13E-10 23387 hsa-mir-592 hsa04912 GnRH signaling pathway 5595_5594_5599_5598_5604_1432_5894_3725_808_801_805 11 1.90E-10 1.33E-08 8.33E-10 23388 hsa-mir-592 hsa05214 Glioma 5595_5594_5604_5894_1029_5925_808_801_805 9 7.51E-10 5.25E-08 3.09E-09 23389 hsa-mir-592 hsa04720 Long-term potentiation 5595_5594_1387_5604_5894_2033_808_801_805 9 2.37E-09 1.66E-07 9.23E-09 23390 hsa-mir-592 hsa04520 Adherens junction 1499_5595_5594_1387_1459_1457_4087_4088_2033 9 3.99E-09 2.79E-07 1.47E-08 23391 hsa-mir-592 hsa04012 ErbB signaling pathway 5595_5594_5599_5604_2932_6776_6777_5894_3725 9 7.85E-09 5.49E-07 2.75E-08 23392 hsa-mir-592 hsa04662 B cell receptor signaling pathway 5595_5594_5604_2932_5970_5894_3725_2353 8 4.37E-08 3.06E-06 1.46E-07 23393 hsa-mir-592 hsa04660 T cell receptor signaling pathway 5595_5594_5604_2932_1432_5970_5894_3725_2353 9 5.19E-08 3.64E-06 1.65E-07 23394 hsa-mir-592 hsa04062 Chemokine signaling pathway 3717_5595_5594_5604_2932_6777_6772_5970_7852_5894_7074 11 5.60E-08 3.92E-06 1.70E-07 23395 hsa-mir-592 hsa05213 Endometrial cancer 1499_5595_5594_5604_2932_5894_4292 7 7.28E-08 5.10E-06 2.12E-07 23396 hsa-mir-592 hsa05223 Non-small cell lung cancer 5595_5594_6256_5604_5894_1029_5925 7 9.22E-08 6.45E-06 2.58E-07 23397 hsa-mir-592 hsa05131 Shigellosis 1499_7277_10376_7846_7278_51807_4691 7 1.16E-07 8.10E-06 3.00E-07 23398 hsa-mir-592 hsa05130 Pathogenic Escherichia coli infection 1499_7277_10376_7846_7278_51807_4691 7 1.16E-07 8.10E-06 3.00E-07 23399 hsa-mir-592 hsa04910 Insulin signaling pathway 5595_5594_5599_5604_2932_5894_808_801_805 9 3.19E-07 2.23E-05 7.98E-07 23400 hsa-mir-592 hsa05219 Bladder cancer 5595_5594_5604_5894_1029_5925 6 4.69E-07 3.28E-05 1.13E-06 23401 hsa-mir-592 hsa05218 Melanoma 2249_5595_5594_5604_5894_1029_5925 7 5.12E-07 3.58E-05 1.19E-06 23402 hsa-mir-592 hsa05211 Renal cell carcinoma 5595_5594_1387_5604_5894_3725_2033 7 5.59E-07 3.91E-05 1.26E-06 23403 hsa-mir-592 hsa04370 VEGF signaling pathway 5595_5594_9261_5604_7867_1432_5894 7 8.51E-07 5.95E-05 1.86E-06 23404 hsa-mir-592 hsa05216 Thyroid cancer 1499_5595_5594_6256_5604 5 1.92E-06 0.000134521 4.08E-06 23405 hsa-mir-592 hsa04270 Vascular smooth muscle contraction 5595_5594_5604_5894_808_801_805 7 1.21E-05 0.000849929 2.50E-05 23406 hsa-mir-592 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5604_1432_5894 6 1.39E-05 0.000971126 2.77E-05 23407 hsa-mir-592 hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_8454_6502_7329_6500 7 3.32E-05 0.002321397 6.45E-05 23408 hsa-mir-592 hsa04510 Focal adhesion 1499_5595_5594_5599_5604_2932_5894_3725 8 5.38E-05 0.003766969 0.00010181 23409 hsa-mir-592 hsa04930 Type II diabetes mellitus 5595_5594_5599_3651 4 0.000228544 0.015998099 0.000421003 23410 hsa-mir-592 hsa05222 Small cell lung cancer 4149_6256_6502_5970_5925 5 0.000242612 0.016982826 0.000435457 23411 hsa-mir-592 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_5604_3455_3454_5894 6 0.000262821 0.0183975 0.000459938 23412 hsa-mir-592 hsa04950 Maturity onset diabetes of the young 3651_168620_6927 3 0.000585251 0.040967538 0.000999208 23413 hsa-mir-592 hsa05010 Alzheimer's disease 5595_5594_2932_808_801_805 6 0.000931917 0.065234156 0.00153737 23414 hsa-mir-592 hsa04920 Adipocytokine signaling pathway 3717_5599_6256_5970 4 0.000944384 0.066106915 0.00153737 23415 hsa-mir-592 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_1432_5970_3725 4 0.00115925 0.081147481 0.001803277 23416 hsa-mir-592 hsa04730 Long-term depression 5595_5594_5604_5894 4 0.00115925 0.081147481 0.001803277 23417 hsa-mir-592 hsa03022 Basal transcription factors 2962_2969_6908 3 0.001865244 0.13056705 0.002838414 23418 hsa-mir-592 hsa04612 Antigen processing and presentation 3320_4800_4801_4802 4 0.002558206 0.179074446 0.003810095 23419 hsa-mir-592 hsa04810 Regulation of actin cytoskeleton 2249_5595_5594_5604_5894_7074 6 0.002652834 0.185698379 0.003868716 23420 hsa-mir-592 hsa05016 Huntington's disease 6667_1387_6908_3065_2033 5 0.006723812 0.470666811 0.009605445 23421 hsa-mir-592 hsa04360 Axon guidance 5595_5594_2932_7852 4 0.009523115 0.666618082 0.013332362 23422 hsa-mir-592 hsa04115 p53 signaling pathway 983_7161_1029 3 0.009767921 0.683754453 0.01340695 23423 hsa-mir-592 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.012557545 0.879028173 0.016904388 23424 hsa-mir-592 hsa04670 Leukocyte transendothelial migration 1499_1432_7852 3 0.041253793 1 0.054486142 23425 hsa-mir-592 hsa04150 mTOR signaling pathway 5595_5594 2 0.043006386 1 0.055749019 23426 hsa-mir-592 hsa05217 Basal cell carcinoma 1499_2932 2 0.047403998 1 0.060332361 23427 hsa-mir-593 hsa05200 Pathways in cancer 3716_3725_5371_9063_675_1956_1499_5595_5594_5599_6258_2736_1387_6257_6256_5159_8031_5156_5604_5601_9915_1399_1398_367_3815_6774_6777_6772_3091_5970_2885_4609_862_867_6502_2353_4088_4089_1050_5925_2034_2033_207_2932_8554 45 2.65E-32 1.99E-30 1.99E-30 23428 hsa-mir-593 hsa04010 MAPK signaling pathway 8986_3725_1956_3727_5595_5594_6722_5599_5159_5156_5604_4208_5601_5600_5603_1399_1398_6195_7867_1432_8550_5970_9261_9344_2885_10912_468_4609_6196_5606_1386_2353_6197_4616_207_1649_9252_2005 38 9.23E-28 6.92E-26 3.46E-26 23429 hsa-mir-593 hsa04012 ErbB signaling pathway 3725_1956_6714_5595_5594_5599_2066_5604_5601_1399_1398_6777_2885_4609_867_207_2932_6464 18 2.01E-16 1.51E-14 5.03E-15 23430 hsa-mir-593 hsa04630 Jak-STAT signaling pathway 3717_3716_3718_9063_85480_3560_3561_1387_3575_6774_6777_6772_2057_2885_5781_4609_867_2690_2033_207_8554 21 1.25E-15 9.36E-14 2.34E-14 23431 hsa-mir-593 hsa05210 Colorectal cancer 3725_1956_1499_5595_5594_5599_5159_5156_5604_5601_2885_4609_2353_4088_4089_207_2932 17 1.92E-15 1.44E-13 2.88E-14 23432 hsa-mir-593 hsa05215 Prostate cancer 1956_1499_5595_5594_1387_5159_5156_5604_367_5970_2885_468_9586_5925_2033_207_2932 17 3.78E-15 2.83E-13 4.72E-14 23433 hsa-mir-593 hsa05212 Pancreatic cancer 1956_1499_5595_5594_1387_5159_5156_5604_367_5970_2885_468_9586_5925_2033_207_2932 17 4.45E-15 3.34E-13 4.77E-14 23434 hsa-mir-593 hsa05220 Chronic myeloid leukemia 5595_5594_5604_1399_1398_6777_5970_2885_5781_4609_867_4088_4089_5925_207_6464 16 6.34E-15 4.76E-13 5.95E-14 23435 hsa-mir-593 hsa04912 GnRH signaling pathway 3725_1956_6714_5595_5594_5599_5604_5601_5600_5603_808_1432_2885_468_5606_801_805 17 7.50E-14 5.63E-12 6.25E-13 23436 hsa-mir-593 hsa04660 T cell receptor signaling pathway 3725_3932_5595_5594_5604_5601_5600_5603_919_1432_5970_2885_867_2353_207_2932_1493 17 9.81E-14 7.36E-12 7.36E-13 23437 hsa-mir-593 hsa04910 Insulin signaling pathway 10891_3643_5595_5594_5599_5604_5601_808_1399_1398_5770_2885_867_207_2932_6464_801_805 18 2.51E-13 1.88E-11 1.71E-12 23438 hsa-mir-593 hsa05211 Renal cell carcinoma 3725_5595_5594_1387_5604_9915_1399_1398_3091_2885_5781_2034_2033_207 14 9.67E-13 7.26E-11 6.05E-12 23439 hsa-mir-593 hsa05221 Acute myeloid leukemia 5371_5595_5594_5604_3815_6774_6777_5970_2885_4609_862_1050_207 13 1.58E-12 1.19E-10 9.14E-12 23440 hsa-mir-593 hsa05214 Glioma 1956_5595_5594_5159_5156_5604_808_2885_5925_207_6464_801_805 13 4.63E-12 3.47E-10 2.48E-11 23441 hsa-mir-593 hsa04664 Fc epsilon RI signaling pathway 695_5595_5594_5599_6850_5604_5601_5600_5603_1432_2885_5606_207 13 4.07E-11 3.05E-09 2.03E-10 23442 hsa-mir-593 hsa04520 Adherens junction 1956_1499_6714_3643_5595_5594_1387_1457_5770_1459_4088_4089_2033 13 4.68E-11 3.51E-09 2.19E-10 23443 hsa-mir-593 hsa04620 Toll-like receptor signaling pathway 3725_5595_5594_5599_5604_5601_5600_5603_1432_6772_5970_5606_2353_207 14 6.36E-11 4.77E-09 2.80E-10 23444 hsa-mir-593 hsa04350 TGF-beta signaling pathway 5515_3400_5595_5594_1387_3397_3398_4609_3399_4088_4089_2033_4093 13 1.19E-10 8.96E-09 4.98E-10 23445 hsa-mir-593 hsa04720 Long-term potentiation 5595_5594_1387_5604_808_6195_468_6196_6197_2033_801_805 12 3.08E-10 2.31E-08 1.22E-09 23446 hsa-mir-593 hsa05216 Thyroid cancer 1499_5595_5594_6258_6257_6256_8031_5604_4609 9 3.40E-10 2.55E-08 1.28E-09 23447 hsa-mir-593 hsa04510 Focal adhesion 3725_1956_1499_6714_5595_5594_5599_5159_5156_5604_5601_1399_1398_2885_207_2932_6464 17 8.64E-10 6.48E-08 3.09E-09 23448 hsa-mir-593 hsa04920 Adipocytokine signaling pathway 3717_10891_5599_6258_6257_6256_5601_6774_5970_5781_207 11 1.34E-09 1.00E-07 4.57E-09 23449 hsa-mir-593 hsa04062 Chemokine signaling pathway 3717_3718_5595_5594_5604_1399_1398_1234_6774_6777_6772_5970_2885_207_2932_6464 16 2.56E-09 1.92E-07 8.36E-09 23450 hsa-mir-593 hsa05223 Non-small cell lung cancer 1956_5595_5594_6258_6257_6256_5604_2885_5925_207 10 2.71E-09 2.03E-07 8.47E-09 23451 hsa-mir-593 hsa04662 B cell receptor signaling pathway 3725_695_5595_5594_6850_5604_5970_2885_2353_207_2932 11 3.89E-09 2.92E-07 1.17E-08 23452 hsa-mir-593 hsa04310 Wnt signaling pathway 3725_5515_1499_5599_1387_5601_1457_8061_4609_1459_4088_4089_2033_2932 14 7.43E-09 5.57E-07 2.14E-08 23453 hsa-mir-593 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1956_6714_5599_5601_5600_5603_1432_5970_5781 10 2.83E-08 2.13E-06 7.71E-08 23454 hsa-mir-593 hsa05213 Endometrial cancer 1956_1499_5595_5594_5604_2885_4609_207_2932 9 2.88E-08 2.16E-06 7.71E-08 23455 hsa-mir-593 hsa04370 VEGF signaling pathway 6714_5595_5594_5604_5600_5603_7867_1432_9261_207 10 5.68E-08 4.26E-06 1.47E-07 23456 hsa-mir-593 hsa04916 Melanogenesis 1499_5595_5594_1387_5604_808_3815_2033_2932_801_805 11 8.44E-08 6.33E-06 2.11E-07 23457 hsa-mir-593 hsa05222 Small cell lung cancer 9063_6258_6257_6256_5970_4609_6502_5925_207_8554 10 1.46E-07 1.10E-05 3.54E-07 23458 hsa-mir-593 hsa04110 Cell cycle 1387_7533_10912_6502_4088_4089_5925_2033_4616_891_2932 11 2.96E-07 2.22E-05 6.95E-07 23459 hsa-mir-593 hsa05219 Bladder cancer 1956_5595_5594_5604_4609_5925_9252 7 1.29E-06 9.69E-05 2.94E-06 23460 hsa-mir-593 hsa04540 Gap junction 1956_6714_5595_5594_5159_5156_5604_2885_5592 9 2.53E-06 0.000189681 5.58E-06 23461 hsa-mir-593 hsa05218 Melanoma 1956_5595_5594_5159_5156_5604_5925_207 8 3.26E-06 0.000244444 6.98E-06 23462 hsa-mir-593 hsa04150 mTOR signaling pathway 5595_5594_6195_3091_6196_6197_207 7 4.66E-06 0.000349289 9.70E-06 23463 hsa-mir-593 hsa04930 Type II diabetes mellitus 3651_3643_5595_5594_5599_5601 6 2.38E-05 0.00178592 4.83E-05 23464 hsa-mir-593 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6850_5604_919_2885_5781_6464 9 4.87E-05 0.003650618 9.61E-05 23465 hsa-mir-593 hsa05340 Primary immunodeficiency 3718_695_3932_3561_3575 5 8.64E-05 0.006480102 0.000166156 23466 hsa-mir-593 hsa04120 Ubiquitin mediated proteolysis 5371_9063_672_867_6502_7325_7329_8554 8 0.000286159 0.021461906 0.000531558 23467 hsa-mir-593 hsa05010 Alzheimer's disease 5595_5594_4724_808_1537_6622_2932_801_805 9 0.000290585 0.02179389 0.000531558 23468 hsa-mir-593 hsa04330 Notch signaling pathway 388585_1387_9612_2033_8850 5 0.000305375 0.022903119 0.00054498 23469 hsa-mir-593 hsa04060 Cytokine-cytokine receptor interaction 85480_1956_3560_3561_5159_5156_3575_1234_3815_2057_2690 11 0.000312455 0.02343413 0.00054498 23470 hsa-mir-593 hsa05016 Huntington's disease 6874_10891_1387_4724_1537_9586_23186_3064_2033 9 0.000442326 0.033174426 0.000753964 23471 hsa-mir-593 hsa04270 Vascular smooth muscle contraction 5595_5594_5604_808_5592_801_805 7 0.000575719 0.043178919 0.000959532 23472 hsa-mir-593 hsa03022 Basal transcription factors 2963_2969_6874_6883 4 0.001180698 0.088552321 0.00192505 23473 hsa-mir-593 hsa04730 Long-term depression 5515_5595_5594_5604_5592 5 0.00174011 0.130508277 0.002776772 23474 hsa-mir-593 hsa04950 Maturity onset diabetes of the young 3651_168620_4760 3 0.003452692 0.258951869 0.005394831 23475 hsa-mir-593 hsa04810 Regulation of actin cytoskeleton 1956_5595_5594_5159_5156_5604_1399_1398 8 0.004567691 0.342576805 0.006991363 23476 hsa-mir-593 hsa05014 Amyotrophic lateral sclerosis (ALS) 5600_5603_1432_5606 4 0.004805133 0.360384998 0.0072077 23477 hsa-mir-593 hsa04530 Tight junction 5515_1499_6714_1457_1459_207 6 0.005931223 0.44484172 0.008722387 23478 hsa-mir-593 hsa04020 Calcium signaling pathway 1956_2066_5159_5156_808_801_805 7 0.006330368 0.474777592 0.009130338 23479 hsa-mir-593 hsa03010 Ribosome 6124_6129_6143_6222_6231 5 0.007542177 0.565663265 0.010672892 23480 hsa-mir-593 hsa03320 PPAR signaling pathway 6258_6257_6256_2168 4 0.01002482 0.751861469 0.013923361 23481 hsa-mir-593 hsa04670 Leukocyte transendothelial migration 1499_5600_5603_1432_5781 5 0.015044534 1 0.020515274 23482 hsa-mir-593 hsa05217 Basal cell carcinoma 1499_2736_2932 3 0.028178727 1 0.037739366 23483 hsa-mir-593 hsa03440 Homologous recombination 675_4683 2 0.045253386 1 0.059543929 23484 hsa-mir-593 hsa04115 p53 signaling pathway 10912_4616_891 3 0.04858247 1 0.06282216 23485 hsa-mir-595 hsa05218 Melanoma 4286 1 0.009564701 0.028694103 0.020888276 23486 hsa-mir-595 hsa04916 Melanogenesis 4286 1 0.013925517 0.041776551 0.020888276 23487 hsa-mir-595 hsa05200 Pathways in cancer 4286 1 0.043662618 0.130987853 0.043662618 23488 hsa-mir-597 hsa05200 Pathways in cancer 2034_5468_25_405_5467_367_1499_861_1387_595_1487_1488_4286_1017_51176_4193_6934_6774_6776_6772_5970_5371_7157_4087_4089_2113_10401_7704_7849_4609_3725_2956_5604_4088_3065_1050_5925_3091_6777_207 40 1.17E-31 7.71E-30 7.71E-30 23489 hsa-mir-597 hsa05220 Chronic myeloid leukemia 25_861_595_1487_1488_4193_6776_5970_7157_4089_4609_5604_4088_3065_5925_6777_207 17 4.04E-18 2.67E-16 1.33E-16 23490 hsa-mir-597 hsa05221 Acute myeloid leukemia 5467_861_595_51176_6934_6774_6776_5970_5371_7704_4609_5604_1050_6777_207 15 8.90E-17 5.87E-15 1.96E-15 23491 hsa-mir-597 hsa04310 Wnt signaling pathway 4772_5467_1499_1387_595_1487_1488_51176_6934_7157_4087_4089_4609_3725_4088_5527_4773 17 1.45E-13 9.58E-12 2.40E-12 23492 hsa-mir-597 hsa05210 Colorectal cancer 1499_595_51176_6934_7157_4087_4089_4609_3725_2956_5604_4088_207 13 2.78E-12 1.84E-10 3.67E-11 23493 hsa-mir-597 hsa05215 Prostate cancer 367_1499_1387_595_1017_51176_4193_6934_5970_7157_5604_5925_207 13 4.73E-12 3.12E-10 5.07E-11 23494 hsa-mir-597 hsa05212 Pancreatic cancer 367_1499_1387_595_1017_51176_4193_6934_5970_7157_5604_5925_207 13 5.38E-12 3.55E-10 5.07E-11 23495 hsa-mir-597 hsa05322 Systemic lupus erythematosus 3021_3020_8359_8294_8370_8361_8360_8363_8362_8365_8364_8367_8366_8368_121504 15 1.03E-11 6.80E-10 8.50E-11 23496 hsa-mir-597 hsa05216 Thyroid cancer 5468_1499_595_51176_6934_7157_7849_4609_5604 9 3.12E-11 2.06E-09 2.29E-10 23497 hsa-mir-597 hsa04330 Notch signaling pathway 22938_1387_2648_4851_1487_1488_1840_9794_3065_8850 10 6.02E-11 3.97E-09 3.97E-10 23498 hsa-mir-597 hsa05213 Endometrial cancer 1499_595_2309_51176_6934_7157_4609_5604_207_2002 10 1.44E-10 9.52E-09 8.09E-10 23499 hsa-mir-597 hsa04110 Cell cycle 25_1387_595_1017_4193_5934_5111_7157_4087_4089_4088_3065_5925 13 1.47E-10 9.71E-09 8.09E-10 23500 hsa-mir-597 hsa04350 TGF-beta signaling pathway 6667_1387_5934_1875_4087_4089_4609_4088_4086_4092 10 1.29E-08 8.54E-07 6.57E-08 23501 hsa-mir-597 hsa05219 Bladder cancer 595_9252_4193_7157_4609_5604_5925 7 2.12E-07 1.40E-05 9.99E-07 23502 hsa-mir-597 hsa05211 Renal cell carcinoma 2034_405_1387_2113_3725_5604_3091_207 8 4.80E-07 3.17E-05 2.11E-06 23503 hsa-mir-597 hsa03410 Base excision repair 6996_252969_4350_5111_328_2237 6 1.61E-06 0.000106023 6.45E-06 23504 hsa-mir-597 hsa05222 Small cell lung cancer 595_1017_5970_7157_10401_4609_5925_207 8 1.66E-06 0.000109623 6.45E-06 23505 hsa-mir-597 hsa04012 ErbB signaling pathway 25_6776_4609_3725_5604_6777_207_2002 8 1.80E-06 0.000118816 6.60E-06 23506 hsa-mir-597 hsa04630 Jak-STAT signaling pathway 1387_595_6778_6774_6776_6772_10401_4609_6777_207 10 1.92E-06 0.000126702 6.67E-06 23507 hsa-mir-597 hsa05218 Melanoma 595_4286_4193_7157_5604_5925_207 7 5.27E-06 0.000347523 1.74E-05 23508 hsa-mir-597 hsa04010 MAPK signaling pathway 1386_4208_3164_9252_5970_7157_4609_3725_5604_207_2002_4773 12 8.11E-06 0.000535384 2.55E-05 23509 hsa-mir-597 hsa04520 Adherens junction 1499_1387_51176_6934_4087_4089_4088 7 1.09E-05 0.000719456 3.27E-05 23510 hsa-mir-597 hsa05223 Non-small cell lung cancer 595_2309_7157_5604_5925_207 6 1.35E-05 0.000888262 3.86E-05 23511 hsa-mir-597 hsa05214 Glioma 595_4193_7157_5604_5925_207 6 3.56E-05 0.002346998 9.78E-05 23512 hsa-mir-597 hsa04620 Toll-like receptor signaling pathway 3665_3661_6772_5970_3725_5604_207 7 4.73E-05 0.003121812 0.000123304 23513 hsa-mir-597 hsa04115 p53 signaling pathway 595_1017_4194_4193_7157_7161 6 4.86E-05 0.003205903 0.000123304 23514 hsa-mir-597 hsa04662 B cell receptor signaling pathway 4772_5970_3725_5604_207_4773 6 7.50E-05 0.004948332 0.000183272 23515 hsa-mir-597 hsa04062 Chemokine signaling pathway 5580_2309_6774_6772_5970_5604_6777_207 8 0.000387343 0.025564622 0.000869147 23516 hsa-mir-597 hsa03450 Non-homologous end-joining 10111_4361_2237 3 0.000398768 0.026318702 0.000869147 23517 hsa-mir-597 hsa04916 Melanogenesis 1499_1387_4286_51176_6934_5604 6 0.00040166 0.026509542 0.000869147 23518 hsa-mir-597 hsa04920 Adipocytokine signaling pathway 10891_5465_6774_5970_207 5 0.000408236 0.026943557 0.000869147 23519 hsa-mir-597 hsa04660 T cell receptor signaling pathway 4772_5970_3725_5604_207_4773 6 0.000532998 0.035177835 0.001099307 23520 hsa-mir-597 hsa04950 Maturity onset diabetes of the young 5080_4760_6927 3 0.001609092 0.106200047 0.003139725 23521 hsa-mir-597 hsa05016 Huntington's disease 6667_5468_10891_1387_7157_3065_6908 7 0.001617434 0.106750642 0.003139725 23522 hsa-mir-597 hsa04120 Ubiquitin mediated proteolysis 672_4193_5371_10401_7329_8925 6 0.001696877 0.111993897 0.003153347 23523 hsa-mir-597 hsa05217 Basal cell carcinoma 1499_51176_6934_7157 4 0.001720007 0.113520487 0.003153347 23524 hsa-mir-597 hsa03440 Homologous recombination 10111_4361_4683 3 0.002410543 0.159095805 0.004299887 23525 hsa-mir-597 hsa04370 VEGF signaling pathway 4772_5604_207_4773 4 0.005423304 0.357938074 0.009419423 23526 hsa-mir-597 hsa04510 Focal adhesion 1499_595_3725_5604_207_2002 6 0.01065268 0.703076873 0.018027612 23527 hsa-mir-597 hsa04912 GnRH signaling pathway 5580_3725_5604_2002 4 0.016464991 1 0.027167235 23528 hsa-mir-597 hsa03430 Mismatch repair 5111_2956 2 0.019649197 1 0.031630415 23529 hsa-mir-597 hsa03320 PPAR signaling pathway 5468_5465_5467 3 0.025590754 1 0.040214042 23530 hsa-mir-597 hsa04664 Fc epsilon RI signaling pathway 5580_5604_207 3 0.034449834 1 0.052876489 23531 hsa-mir-597 hsa04910 Insulin signaling pathway 10891_5604_207_2002 4 0.035304298 1 0.052956447 23532 hsa-mir-597 hsa03030 DNA replication 5111_2237 2 0.042797041 1 0.062768994 23533 hsa-mir-597 hsa03022 Basal transcription factors 2959_6908 2 0.04485861 1 0.064362353 23534 hsa-mir-597 hsa04210 Apoptosis 5970_7157_207 3 0.045910589 1 0.064470189 23535 hsa-mir-598 hsa05200 Pathways in cancer 3725_7046_1499_5914_595_596_598_1017_8517_4193_3551_5578_6502_3091_4089_2064_7175_3066_3065_1050_5925_613_5743_5747_25_1956_6789_4436_1870_1871_2885_2113_6774_861_862_5879_207_3716_1147_2249_998_367_4233_2261_5595_5594_5599_6258_1387_6256_10401_2932_6777_6772_5979_5970_7157_6688_1869_6776_2736_4087_4088_9063_5888_5728_2033_5468_3480_3910_4790_4791_4792_3320_3326_5371_675_5159_8031_5156_5604_5601_5602_1856_3815_3265_6257_51588_8772_4609_1026_1029_2353_7704_1441_8554 96 1.79E-43 1.58E-41 1.58E-41 23536 hsa-mir-598 hsa04010 MAPK signaling pathway 3925_6722_3725_7046_6195_6197_2264_8517_9252_7867_3551_5578_1845_7132_9344_9020_4616_5923_1956_3304_3305_3303_6789_1432_2885_22800_5879_1616_207_1147_2249_998_2261_5595_5594_5599_1386_3310_3312_3315_5971_5970_3164_7157_10912_3727_6196_1649_4790_4791_51701_5159_9261_5156_5604_4208_5606_5601_5600_5603_5602_8986_5608_5566_3265_1326_6885_4609_2353_468_8550_2005 72 1.07E-30 9.45E-29 4.72E-29 23537 hsa-mir-598 hsa04110 Cell cycle 4172_595_1017_4193_902_6502_6500_4089_4174_3066_3065_4616_5925_25_1870_1871_5111_9232_545_995_993_5347_5591_1387_11200_7534_7532_2932_7027_7157_10912_1869_4087_4088_2033_890_1031_983_8454_1026_1022_1029_1111_8556_8555_472 46 1.01E-25 8.86E-24 2.95E-24 23538 hsa-mir-598 hsa05215 Prostate cancer 1499_595_596_1017_8517_4193_3551_2064_5925_1956_1870_1871_2885_9586_207_1147_367_5595_5594_1385_1387_2932_5970_7157_1869_5728_10488_2033_3480_4790_4792_3320_3326_5159_5156_5604_3265_1026_468 39 1.00E-23 8.83E-22 2.21E-22 23539 hsa-mir-598 hsa05212 Pancreatic cancer 1499_595_596_1017_8517_4193_3551_2064_5925_1956_1870_1871_2885_9586_207_1147_367_5595_5594_1385_1387_2932_5970_7157_1869_5728_10488_2033_3480_4790_4792_3320_3326_5159_5156_5604_3265_1026_468 39 1.39E-23 1.22E-21 2.44E-22 23540 hsa-mir-598 hsa05220 Chronic myeloid leukemia 7046_595_598_8517_4193_3551_4089_3066_3065_5925_613_25_1870_1871_2885_861_207_1147_5595_5594_6777_5970_7157_1869_6776_4088_4790_4792_5604_3265_5781_4609_1026_1029 34 4.17E-21 3.67E-19 6.11E-20 23541 hsa-mir-598 hsa04630 Jak-STAT signaling pathway 3559_595_598_5777_3454_3455_3566_3560_3561_1439_2885_6774_2690_3977_207_3717_3716_3718_8651_1387_3575_3570_3572_10401_6778_6777_6772_6773_7297_6776_9063_2033_149233_3953_51588_3459_10379_5781_58985_4609_85480_1441_8554 43 1.52E-19 1.34E-17 1.91E-18 23542 hsa-mir-598 hsa04920 Adipocytokine signaling pathway 10891_6794_8517_3551_7132_8717_4794_8471_6774_207_3717_1147_5599_6258_6256_5970_5465_4790_4792_4793_5601_5602_5563_3953_6257_5781_7133 27 4.90E-16 4.32E-14 5.39E-15 23543 hsa-mir-598 hsa05222 Small cell lung cancer 595_596_598_1017_8517_3551_6502_5925_5743_5747_1870_1871_207_1147_6258_6256_10401_5970_7157_1869_9063_5728_3910_4790_4792_6257_51588_4609_8554 29 1.85E-15 1.63E-13 1.73E-14 23544 hsa-mir-598 hsa05214 Glioma 818_817_595_4193_5578_5925_1956_1870_1871_2885_207_5595_5594_7157_1869_5728_3480_808_801_805_5159_5156_5604_3265_1026_1029 26 1.97E-15 1.73E-13 1.73E-14 23545 hsa-mir-598 hsa04620 Toll-like receptor signaling pathway 3725_8517_3551_3454_3455_3661_1432_5879_207_1147_3654_29110_5595_5594_5599_6772_5970_4790_4792_5604_5606_5601_5600_5603_5602_5608_9641_1326_8772_6885_2353 31 2.16E-15 1.90E-13 1.73E-14 23546 hsa-mir-598 hsa05210 Colorectal cancer 3725_7046_1499_595_596_4089_1956_4436_2885_5879_207_4233_5595_5594_5599_2932_7157_4087_4088_3480_5159_5156_5604_5601_5602_1856_4609_2353 28 7.17E-15 6.31E-13 5.26E-14 23547 hsa-mir-598 hsa04310 Wnt signaling pathway 3725_818_817_1499_595_5578_6500_1459_8945_4089_23291_8607_5879_1460_5599_1387_2932_7157_8061_1457_1452_4087_4088_2033_51701_5519_5518_5515_5601_5602_5566_1856_8454_6885_4609_5527 36 8.87E-15 7.80E-13 6.00E-14 23548 hsa-mir-598 hsa05221 Acute myeloid leukemia 5914_595_8517_3551_1050_2885_6774_861_862_207_1147_5595_5594_6777_5970_6688_6776_4790_5371_5604_3815_3265_4609_7704 24 1.75E-14 1.54E-12 1.10E-13 23549 hsa-mir-598 hsa04660 T cell receptor signaling pathway 3725_8517_5777_3551_9020_2534_3932_4794_1432_2885_207_1147_998_5595_5594_2932_5970_959_4790_4792_4793_5604_5601_5600_5603_3265_1326_6885_2353 29 3.61E-13 3.17E-11 2.12E-12 23550 hsa-mir-598 hsa04520 Adherens junction 7046_1499_5777_1459_4089_2241_2064_2534_1956_6714_5879_1460_998_4233_5595_5594_1387_1457_4087_4088_2033_3480_51701_71_6885 25 6.54E-13 5.76E-11 3.60E-12 23551 hsa-mir-598 hsa04115 p53 signaling pathway 595_1017_4194_4193_900_4616_50484_6241_51246_545_11200_7157_10912_64326_5728_27113_25898_983_1026_7161_1029_1111_472 23 1.81E-12 1.59E-10 9.38E-12 23552 hsa-mir-598 hsa04912 GnRH signaling pathway 3725_818_817_2185_5578_5580_1956_6714_1432_2885_998_5595_5594_5599_808_801_805_5604_5606_5601_5600_5603_5602_5608_5566_3265_468 27 6.67E-12 5.87E-10 3.26E-11 23553 hsa-mir-598 hsa05223 Non-small cell lung cancer 595_5578_2064_5925_1956_6789_1870_1871_2885_207_5595_5594_6258_6256_7157_1869_5604_3265_6257_1029 20 1.06E-11 9.31E-10 4.90E-11 23554 hsa-mir-598 hsa05219 Bladder cancer 595_9252_4193_2064_5925_1956_1870_1871_2261_5595_5594_7157_1869_5604_3265_4609_1026_1029 18 1.64E-11 1.45E-09 7.23E-11 23555 hsa-mir-598 hsa04662 B cell receptor signaling pathway 3725_8517_5777_3551_4794_1380_2885_6850_5879_207_1147_695_5595_5594_2932_5970_4790_4792_4793_5604_3265_2353 22 4.39E-11 3.86E-09 1.84E-10 23556 hsa-mir-598 hsa04012 ErbB signaling pathway 3725_818_817_5578_2064_5747_25_1956_6714_2885_207_5595_5594_5599_2932_6777_6776_5604_5601_5602_3265_4609_1026 23 9.29E-11 8.18E-09 3.72E-10 23557 hsa-mir-598 hsa05216 Thyroid cancer 1499_595_7175_5595_5594_6258_6256_5979_7157_5468_8031_5604_3265_6257_4609 15 1.04E-10 9.12E-09 3.90E-10 23558 hsa-mir-598 hsa05218 Melanoma 595_4193_5925_1956_1870_1871_207_2249_4233_5595_5594_7157_1869_5728_3480_5159_5156_5604_3265_1026_1029 21 1.06E-10 9.36E-09 3.90E-10 23559 hsa-mir-598 hsa04062 Chemokine signaling pathway 2185_8517_3551_653361_5747_5580_5590_7852_2885_6362_6774_5879_207_3055_3717_1147_3718_998_5595_5594_1234_1230_2932_6777_6772_6773_5970_4790_4792_4793_5604_5566_3265 33 2.42E-10 2.13E-08 8.41E-10 23560 hsa-mir-598 hsa04720 Long-term potentiation 818_814_817_6195_6197_5578_2902_2906_5499_5595_5594_1387_6196_2033_808_801_805_5604_5566_3265_468 21 2.49E-10 2.19E-08 8.41E-10 23561 hsa-mir-598 hsa04510 Focal adhesion 3725_1499_595_596_5578_2064_5923_2534_5747_3791_1956_6714_5499_2885_10627_5879_207_998_4233_5595_5594_5599_2932_5728_3480_3910_2321_5159_5156_5604_5601_5602_3265_71 34 2.97E-10 2.61E-08 9.68E-10 23562 hsa-mir-598 hsa04350 TGF-beta signaling pathway 7046_6500_4089_90_3398_57154_6667_3397_3399_5595_5594_1387_7027_4086_4087_4088_2033_5519_5518_5515_8454_4609 22 4.85E-10 4.27E-08 1.53E-09 23563 hsa-mir-598 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_8517_3551_9020_1956_6714_1432_5879_1147_998_4233_5599_5970_4790_4792_5601_5600_5603_5602_5781 20 6.06E-10 5.33E-08 1.84E-09 23564 hsa-mir-598 hsa04210 Apoptosis 3556_596_598_8517_3551_7132_8717_9020_8837_823_1439_207_1147_3654_5970_7157_9131_4790_4792_5566_8772_472 22 7.00E-10 6.16E-08 2.05E-09 23565 hsa-mir-598 hsa04120 Ubiquitin mediated proteolysis 55294_4193_6502_6500_3093_8945_57154_23291_7319_84447_10273_7329_8651_10055_51366_10401_9063_64326_7337_5371_672_25898_7323_8454_51588_10075_8554 27 9.11E-10 8.01E-08 2.59E-09 23566 hsa-mir-598 hsa03022 Basal transcription factors 51616_6872_6882_2959_2965_2963_2969_6878_6874_6908_2958_6883_6880_2957_9519 15 1.49E-09 1.31E-07 4.09E-09 23567 hsa-mir-598 hsa04664 Fc epsilon RI signaling pathway 5578_2534_5580_1432_2885_6850_5879_207_695_5595_5594_5599_5604_5606_5601_5600_5603_5602_5608_3265 20 2.91E-09 2.56E-07 7.76E-09 23568 hsa-mir-598 hsa04060 Cytokine-cytokine receptor interaction 3556_3559_7046_8600_7132_3454_3455_90_3566_3791_1956_7852_3560_3561_1439_6362_2690_3977_4233_1234_1230_3575_3570_3572_959_2321_149233_5159_5156_3815_3953_3459_58985_85480_7133_1441 36 7.35E-09 6.47E-07 1.90E-08 23569 hsa-mir-598 hsa04540 Gap junction 5592_5578_10382_1956_6714_2885_5595_5594_1453_203068_7846_347733_5159_983_5156_5604_5566_3265_7278_84617 20 3.12E-08 2.75E-06 7.86E-08 23570 hsa-mir-598 hsa04370 VEGF signaling pathway 7867_5578_5743_5747_3791_6714_1432_5879_207_998_5595_5594_3315_9261_5604_5600_5603_3265 18 5.09E-08 4.48E-06 1.24E-07 23571 hsa-mir-598 hsa04910 Insulin signaling pathway 10891_6720_3551_5590_5499_2885_8471_207_8651_5595_5594_5599_23265_2932_808_801_805_5604_5601_5602_5566_5563_3265 23 1.85E-07 1.63E-05 4.40E-07 23572 hsa-mir-598 hsa05213 Endometrial cancer 1499_595_2064_1956_2885_207_5595_5594_2932_7157_5728_5604_3265_4609 14 3.60E-07 3.17E-05 8.33E-07 23573 hsa-mir-598 hsa04530 Tight junction 1499_5578_1459_5580_5590_6714_4627_4628_10627_22800_8573_207_1460_998_1457_5728_5519_5518_5515_3265_71_5520 22 5.94E-07 5.23E-05 1.34E-06 23574 hsa-mir-598 hsa04916 Melanogenesis 818_817_1499_5578_5595_5594_1385_1387_2932_10488_2033_808_801_805_5604_5566_1856_3815_3265 19 6.24E-07 5.50E-05 1.37E-06 23575 hsa-mir-598 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_7132_2902_2906_1432_5879_1616_7157_5606_5600_5603_5608_7133 14 7.71E-07 6.78E-05 1.58E-06 23576 hsa-mir-598 hsa05131 Shigellosis 1499_5578_10382_2534_25_998_7534_203068_7846_347733_7278_71_84617_4691 14 7.71E-07 6.78E-05 1.58E-06 23577 hsa-mir-598 hsa05130 Pathogenic Escherichia coli infection 1499_5578_10382_2534_25_998_7534_203068_7846_347733_7278_71_84617_4691 14 7.71E-07 6.78E-05 1.58E-06 23578 hsa-mir-598 hsa05211 Renal cell carcinoma 3725_3091_2885_2113_5879_207_998_4233_5595_5594_1387_2033_5604_3265_5781 15 2.28E-06 0.00020076 4.56E-06 23579 hsa-mir-598 hsa05016 Huntington's disease 10891_292_293_3066_3065_3064_498_25942_2902_6667_9586_5441_1385_1387_5437_7157_23186_10488_2033_5468_27113_6874_6908_1213_9519 25 2.37E-06 0.000208596 4.64E-06 23580 hsa-mir-598 hsa04930 Type II diabetes mellitus 3551_5580_5590_8471_3651_8651_5595_5594_5599_5601_5602 11 1.40E-05 0.001233753 2.68E-05 23581 hsa-mir-598 hsa03420 Nucleotide excision repair 902_5981_5111_6117_2965_4331_2071_2074_6118_1022 10 5.85E-05 0.00514702 0.000109511 23582 hsa-mir-598 hsa04330 Notch signaling pathway 3066_3065_3280_1387_9612_2033_8850_388585_1856_4851 10 9.44E-05 0.008311531 0.000173157 23583 hsa-mir-598 hsa03030 DNA replication 4172_5981_4174_5111_6117_5557_6118_5422 8 0.000364666 0.032090623 0.000654911 23584 hsa-mir-598 hsa04650 Natural killer cell mediated cytotoxicity 2185_5777_5578_3454_3455_2534_3932_2885_6850_5879_5595_5594_5604_3265_3459_5781 16 0.00059571 0.05242246 0.001048449 23585 hsa-mir-598 hsa04150 mTOR signaling pathway 6794_6195_6197_3091_207_5595_5594_6196_5563 9 0.000793536 0.069831134 0.001369238 23586 hsa-mir-598 hsa04612 Antigen processing and presentation 3309_3304_3305_3303_1385_3310_3312_1514_3320_3326_4800_2923 12 0.000863849 0.07601868 0.001461898 23587 hsa-mir-598 hsa04670 Leukocyte transendothelial migration 2185_1499_5578_653361_5747_7852_1432_10627_5879_998_5600_5603_71_5781 14 0.001395285 0.122785089 0.0023167 23588 hsa-mir-598 hsa05340 Primary immunodeficiency 8517_3932_3561_3718_695_3575_959 7 0.001446654 0.127305584 0.002357511 23589 hsa-mir-598 hsa04730 Long-term depression 5592_5578_5595_5594_3480_5519_5518_5515_5604_3265 10 0.001698107 0.149433455 0.002716972 23590 hsa-mir-598 hsa04020 Calcium signaling pathway 818_814_817_2185_292_293_5578_2064_1956_2902_2906_147_808_801_805_5159_5156_5566 18 0.001905906 0.167719762 0.002994996 23591 hsa-mir-598 hsa03440 Homologous recombination 641_6117_4683_5888_675_6118 6 0.002323925 0.204505428 0.003587815 23592 hsa-mir-598 hsa04810 Regulation of actin cytoskeleton 10788_2264_5747_1956_5499_4627_4628_10627_22800_5879_2249_998_2261_5595_5594_5159_5156_5604_3265_71 20 0.002563712 0.225606649 0.00388977 23593 hsa-mir-598 hsa03020 RNA polymerase 64425_25885_51082_5441_5437_84172 6 0.002709065 0.238397733 0.00404064 23594 hsa-mir-598 hsa04270 Vascular smooth muscle contraction 5592_5578_5580_147_5499_5595_5594_4637_808_801_805_5604_5566 13 0.002815685 0.247780297 0.004129672 23595 hsa-mir-598 hsa05010 Alzheimer's disease 7132_498_823_2902_2906_6622_22926_5595_5594_2932_808_351_801_805_8772_1020_9451 17 0.002970863 0.261435957 0.004285835 23596 hsa-mir-598 hsa03430 Mismatch repair 5981_4436_5111_6117_6118 5 0.005084881 0.447469495 0.00721725 23597 hsa-mir-598 hsa04950 Maturity onset diabetes of the young 6927_3651_3172_3280_168620 5 0.005940728 0.522784098 0.00829816 23598 hsa-mir-598 hsa04360 Axon guidance 2534_5747_25_7852_5879_2242_998_4233_5595_5594_2932_3265_1020 13 0.008709408 0.76642788 0.011975436 23599 hsa-mir-598 hsa04740 Olfactory transduction 818_817_5592_808_801_805_5566 7 0.014621145 1 0.019794781 23600 hsa-mir-598 hsa04340 Hedgehog signaling pathway 8945_23291_2932_1452_1453_2736_5566 7 0.01537433 1 0.020499107 23601 hsa-mir-598 hsa03410 Base excision repair 142_4913_5111_3146_328 5 0.025105602 1 0.032974522 23602 hsa-mir-598 hsa03010 Ribosome 6207_6202_6141_9349_6155_6217_6156_6128_6125_6188 10 0.025822227 1 0.033417 23603 hsa-mir-598 hsa03320 PPAR signaling pathway 2168_10062_6258_6256_5465_5468_6257 7 0.037940434 1 0.0483878 23604 hsa-mir-599 hsa04950 Maturity onset diabetes of the young 3651_5080 2 0.00049684 0.01043364 0.01043364 23605 hsa-mir-599 hsa04330 Notch signaling pathway 2033_1387 2 0.001765131 0.037067753 0.012686543 23606 hsa-mir-599 hsa05016 Huntington's disease 2033_10476_1387 3 0.001812363 0.038059629 0.012686543 23607 hsa-mir-599 hsa05211 Renal cell carcinoma 2033_1387 2 0.00397424 0.083459041 0.013870574 23608 hsa-mir-599 hsa04720 Long-term potentiation 2033_1387 2 0.004295049 0.090196032 0.013870574 23609 hsa-mir-599 hsa04520 Adherens junction 2033_1387 2 0.004855535 0.10196623 0.013870574 23610 hsa-mir-599 hsa04350 TGF-beta signaling pathway 2033_1387 2 0.00569372 0.119568124 0.013870574 23611 hsa-mir-599 hsa05215 Prostate cancer 2033_1387 2 0.005818501 0.122188518 0.013870574 23612 hsa-mir-599 hsa05212 Pancreatic cancer 2033_1387 2 0.005944532 0.124835169 0.013870574 23613 hsa-mir-599 hsa04916 Melanogenesis 2033_1387 2 0.007982882 0.167640515 0.016764052 23614 hsa-mir-599 hsa04110 Cell cycle 2033_1387 2 0.010291247 0.216116181 0.019646926 23615 hsa-mir-599 hsa04530 Tight junction 60412_4628 2 0.01340317 0.281466578 0.023455548 23616 hsa-mir-599 hsa04310 Wnt signaling pathway 2033_1387 2 0.016269572 0.341661008 0.025307561 23617 hsa-mir-599 hsa04630 Jak-STAT signaling pathway 2033_1387 2 0.016871707 0.354305848 0.025307561 23618 hsa-mir-600 hsa04110 Cell cycle 1029_595_898_2033_1017_7532_4174_5001_894_896_1026_1387_4172_4173_4998_4999 16 3.92E-25 1.49E-23 1.49E-23 23619 hsa-mir-600 hsa04115 p53 signaling pathway 1029_595_898_1017_894_896_1026 7 1.05E-10 3.97E-09 1.99E-09 23620 hsa-mir-600 hsa05215 Prostate cancer 595_898_2033_1017_367_1026_1387 7 5.14E-10 1.95E-08 5.26E-09 23621 hsa-mir-600 hsa05212 Pancreatic cancer 595_898_2033_1017_367_1026_1387 7 5.54E-10 2.11E-08 5.26E-09 23622 hsa-mir-600 hsa05200 Pathways in cancer 1029_595_898_2033_1017_367_1026_3725_1387_2353 10 7.15E-10 2.72E-08 5.43E-09 23623 hsa-mir-600 hsa04310 Wnt signaling pathway 595_2033_894_896_3725_1387 6 5.01E-07 1.90E-05 3.17E-06 23624 hsa-mir-600 hsa04630 Jak-STAT signaling pathway 595_2033_894_896_1387 5 1.23E-05 0.000468099 6.69E-05 23625 hsa-mir-600 hsa04510 Focal adhesion 5499_595_894_896_3725 5 4.64E-05 0.001764208 0.000220526 23626 hsa-mir-600 hsa03030 DNA replication 4174_4172_4173 3 5.34E-05 0.002028645 0.000225405 23627 hsa-mir-600 hsa05219 Bladder cancer 1029_595_1026 3 8.22E-05 0.003124994 0.000312499 23628 hsa-mir-600 hsa04330 Notch signaling pathway 9612_2033_1387 3 0.000112843 0.00428802 0.00038982 23629 hsa-mir-600 hsa05214 Glioma 1029_595_1026 3 0.000281762 0.010706971 0.000892248 23630 hsa-mir-600 hsa05218 Melanoma 1029_595_1026 3 0.000361583 0.013740163 0.001002525 23631 hsa-mir-600 hsa05211 Renal cell carcinoma 2033_3725_1387 3 0.000376153 0.014293823 0.001002525 23632 hsa-mir-600 hsa04720 Long-term potentiation 5499_2033_1387 3 0.000422116 0.016040393 0.001002525 23633 hsa-mir-600 hsa05220 Chronic myeloid leukemia 1029_595_1026 3 0.000422116 0.016040393 0.001002525 23634 hsa-mir-600 hsa05016 Huntington's disease 4697_2033_25942_1387 4 0.000457251 0.017375541 0.001022091 23635 hsa-mir-600 hsa05210 Colorectal cancer 595_3725_2353 3 0.000581195 0.0220854 0.001226967 23636 hsa-mir-600 hsa05222 Small cell lung cancer 595_898_1017 3 0.00062106 0.023600277 0.00124212 23637 hsa-mir-600 hsa05223 Non-small cell lung cancer 1029_595 2 0.004922761 0.187064933 0.009353247 23638 hsa-mir-600 hsa04662 B cell receptor signaling pathway 3725_2353 2 0.009122627 0.346659833 0.016507611 23639 hsa-mir-600 hsa04520 Adherens junction 2033_1387 2 0.010292889 0.391129787 0.017778627 23640 hsa-mir-600 hsa04350 TGF-beta signaling pathway 2033_1387 2 0.012036656 0.457392946 0.019058039 23641 hsa-mir-600 hsa04012 ErbB signaling pathway 1026_3725 2 0.012036656 0.457392946 0.019058039 23642 hsa-mir-600 hsa04620 Toll-like receptor signaling pathway 3725_2353 2 0.016172955 0.614572295 0.024501733 23643 hsa-mir-600 hsa04916 Melanogenesis 2033_1387 2 0.016764343 0.637045053 0.024501733 23644 hsa-mir-600 hsa04660 T cell receptor signaling pathway 3725_2353 2 0.018593097 0.706537667 0.026168062 23645 hsa-mir-601 hsa04620 Toll-like receptor signaling pathway 3661_7189_353376_148022_3654_4615 6 5.53E-12 1.16E-10 1.16E-10 23646 hsa-mir-601 hsa04330 Notch signaling pathway 2648_1387_2033_8850 4 7.31E-09 1.53E-07 7.67E-08 23647 hsa-mir-601 hsa04350 TGF-beta signaling pathway 1387_7046_2033_658 4 7.73E-08 1.62E-06 5.41E-07 23648 hsa-mir-601 hsa05200 Pathways in cancer 1387_7189_51588_7046_2033 5 3.19E-07 6.70E-06 1.68E-06 23649 hsa-mir-601 hsa04520 Adherens junction 1387_7046_2033 3 7.26E-06 0.00015248 3.05E-05 23650 hsa-mir-601 hsa04630 Jak-STAT signaling pathway 1387_51588_2033 3 4.99E-05 0.001048466 0.000174744 23651 hsa-mir-601 hsa05211 Renal cell carcinoma 1387_2033 2 0.000535339 0.011242121 0.001413935 23652 hsa-mir-601 hsa04720 Long-term potentiation 1387_2033 2 0.000579471 0.012168887 0.001413935 23653 hsa-mir-601 hsa05222 Small cell lung cancer 7189_51588 2 0.000755886 0.015873611 0.001413935 23654 hsa-mir-601 hsa05215 Prostate cancer 1387_2033 2 0.000790416 0.016598733 0.001413935 23655 hsa-mir-601 hsa04210 Apoptosis 3654_4615 2 0.000807963 0.016967218 0.001413935 23656 hsa-mir-601 hsa05212 Pancreatic cancer 1387_2033 2 0.000807963 0.016967218 0.001413935 23657 hsa-mir-601 hsa04916 Melanogenesis 1387_2033 2 0.001093622 0.022966066 0.00176662 23658 hsa-mir-601 hsa04110 Cell cycle 1387_2033 2 0.001421032 0.029841662 0.002131547 23659 hsa-mir-601 hsa04120 Ubiquitin mediated proteolysis 7189_51588 2 0.001921636 0.040354362 0.002690291 23660 hsa-mir-601 hsa04310 Wnt signaling pathway 1387_2033 2 0.002285772 0.048001214 0.003000076 23661 hsa-mir-601 hsa05016 Huntington's disease 1387_2033 2 0.003450438 0.072459198 0.004262306 23662 hsa-mir-601 hsa04060 Cytokine-cytokine receptor interaction 7046_658 2 0.006541355 0.137368456 0.007631581 23663 hsa-mir-601 hsa04010 MAPK signaling pathway 7189_7046 2 0.007078166 0.148641489 0.007823236 23664 hsa-mir-601 hsa05220 Chronic myeloid leukemia 7046 1 0.03487995 0.732478941 0.036623947 23665 hsa-mir-601 hsa05210 Colorectal cancer 7046 1 0.0389348 0.81763079 0.0389348 23666 hsa-mir-602 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725 1 0.014312216 0.171746595 0.032989677 23667 hsa-mir-602 hsa05211 Renal cell carcinoma 3725 1 0.014509789 0.174117462 0.032989677 23668 hsa-mir-602 hsa04662 B cell receptor signaling pathway 3725 1 0.015102307 0.181227686 0.032989677 23669 hsa-mir-602 hsa05210 Colorectal cancer 3725 1 0.016878082 0.202536986 0.032989677 23670 hsa-mir-602 hsa04012 ErbB signaling pathway 3725 1 0.017469414 0.209632967 0.032989677 23671 hsa-mir-602 hsa04620 Toll-like receptor signaling pathway 3725 1 0.020421629 0.245059544 0.032989677 23672 hsa-mir-602 hsa04912 GnRH signaling pathway 3725 1 0.021600443 0.259205315 0.032989677 23673 hsa-mir-602 hsa04660 T cell receptor signaling pathway 3725 1 0.021993118 0.263917418 0.032989677 23674 hsa-mir-602 hsa04310 Wnt signaling pathway 3725 1 0.030209014 0.362508162 0.040278685 23675 hsa-mir-602 hsa04510 Focal adhesion 3725 1 0.040687721 0.488252655 0.048825266 23676 hsa-mir-603 hsa05200 Pathways in cancer 3551_1499_596_598_1017_4193_6934_5578_3091_3065_5925_613_5743_5747_25_6789_4436_2113_6774_207_208_1147_998_367_5595_5594_5599_861_1387_9915_2932_6772_5970_6688_1869_3725_2736_4087_4088_4089_5888_5728_2034_2033_3910_4792_3326_5371_675_5601_5602_1856_51588_3320_1026_2353_8554 57 3.85E-35 3.35E-33 3.35E-33 23677 hsa-mir-603 hsa04110 Cell cycle 1017_4193_902_3065_5925_25_9232_545_995_5347_5591_1387_11200_7534_7533_7532_2932_7027_1869_4087_4088_4089_2033_890_1031_983_1026_1022_1111_8556_8555_472 32 2.51E-25 2.18E-23 1.09E-23 23678 hsa-mir-603 hsa05215 Prostate cancer 3551_1499_596_1017_4193_6934_5925_9586_207_208_1147_367_5595_5594_1387_2932_5970_468_1869_5728_10488_2033_4792_3326_3320_1026 26 1.10E-21 9.57E-20 3.04E-20 23679 hsa-mir-603 hsa05212 Pancreatic cancer 3551_1499_596_1017_4193_6934_5925_9586_207_208_1147_367_5595_5594_1387_2932_5970_468_1869_5728_10488_2033_4792_3326_3320_1026 26 1.40E-21 1.22E-19 3.04E-20 23680 hsa-mir-603 hsa04010 MAPK signaling pathway 6722_3551_6195_6197_9252_5578_4773_5923_3304_3305_3303_6789_1432_1616_207_208_1147_998_5595_5594_5599_8986_1386_3315_1649_5970_3164_468_3725_3727_6196_9261_5601_5600_5602_2353_8550 37 5.15E-20 4.48E-18 8.97E-19 23681 hsa-mir-603 hsa05220 Chronic myeloid leukemia 3551_598_4193_3065_5925_613_25_207_208_1147_5595_5594_861_5970_1869_4088_4089_4792_1026 19 3.65E-15 3.17E-13 5.29E-14 23682 hsa-mir-603 hsa04115 p53 signaling pathway 1017_4194_4193_900_50484_6241_51246_545_7161_11200_64326_5728_27113_25898_983_1026_1111_472 18 1.26E-14 1.10E-12 1.57E-13 23683 hsa-mir-603 hsa05210 Colorectal cancer 1499_596_6934_4436_207_208_5595_5594_5599_2932_3725_4087_4088_4089_5601_5602_1856_2353 18 2.33E-13 2.03E-11 2.53E-12 23684 hsa-mir-603 hsa04310 Wnt signaling pathway 1499_6934_5578_4773_1460_5599_1387_2932_8061_3725_1457_1452_4087_4088_4089_2033_5518_5515_5601_5602_1856_5527 22 6.14E-13 5.34E-11 5.94E-12 23685 hsa-mir-603 hsa05222 Small cell lung cancer 3551_596_598_1017_5925_5743_5747_207_208_1147_5970_1869_5728_3910_4792_51588_8554 17 3.36E-12 2.92E-10 2.92E-11 23686 hsa-mir-603 hsa04660 T cell receptor signaling pathway 3551_4773_1432_207_208_1147_998_5595_5594_2932_5970_3725_959_4792_5601_5600_2353 17 1.06E-10 9.18E-09 8.35E-10 23687 hsa-mir-603 hsa04620 Toll-like receptor signaling pathway 3551_1432_207_208_1147_5595_5594_5599_6772_5970_3725_4792_5601_5600_5602_2353 16 3.08E-10 2.68E-08 2.23E-09 23688 hsa-mir-603 hsa05221 Acute myeloid leukemia 3551_6934_6774_207_208_1147_5595_5594_861_5970_6688_5371 12 3.94E-09 3.43E-07 2.64E-08 23689 hsa-mir-603 hsa04662 B cell receptor signaling pathway 3551_4773_207_208_1147_5595_5594_1380_2932_5970_3725_4792_2353 13 4.91E-09 4.27E-07 3.05E-08 23690 hsa-mir-603 hsa04370 VEGF signaling pathway 5578_4773_5743_5747_1432_207_208_998_5595_5594_3315_9261_5600 13 6.51E-09 5.66E-07 3.77E-08 23691 hsa-mir-603 hsa04920 Adipocytokine signaling pathway 3551_6794_6774_207_208_1147_5599_5970_4792_5601_5602_5563 12 1.39E-08 1.21E-06 7.55E-08 23692 hsa-mir-603 hsa04120 Ubiquitin mediated proteolysis 4193_55294_3093_7319_84447_7329_83737_10055_64326_7337_5371_672_25898_51588_10075_8554 16 1.73E-08 1.51E-06 8.86E-08 23693 hsa-mir-603 hsa04350 TGF-beta signaling pathway 6667_3399_5595_5594_1387_7027_4087_4088_4089_2033_5518_5515_4093 13 2.40E-08 2.09E-06 1.10E-07 23694 hsa-mir-603 hsa04012 ErbB signaling pathway 5578_5747_25_207_208_5595_5594_5599_2932_3725_5601_5602_1026 13 2.40E-08 2.09E-06 1.10E-07 23695 hsa-mir-603 hsa05211 Renal cell carcinoma 3091_2113_207_208_998_5595_5594_1387_9915_3725_2034_2033 12 2.83E-08 2.46E-06 1.23E-07 23696 hsa-mir-603 hsa04520 Adherens junction 1499_6934_1460_998_5595_5594_1387_1457_4087_4088_4089_2033 12 7.99E-08 6.96E-06 3.31E-07 23697 hsa-mir-603 hsa03022 Basal transcription factors 51616_2965_2963_6872_6908_2958_2959_6880_2957 9 9.44E-08 8.21E-06 3.73E-07 23698 hsa-mir-603 hsa04510 Focal adhesion 1499_596_5578_5923_5747_5499_207_208_998_5595_5594_5599_2932_3725_5728_3910_5601_5602 18 1.11E-07 9.65E-06 4.19E-07 23699 hsa-mir-603 hsa04150 mTOR signaling pathway 6794_6195_6197_3091_207_208_5595_5594_6196_5563 10 1.25E-07 1.09E-05 4.54E-07 23700 hsa-mir-603 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3551_1432_1147_998_5599_5970_3725_4792_5601_5600_5602 11 2.08E-07 1.81E-05 7.23E-07 23701 hsa-mir-603 hsa05214 Glioma 4193_5578_5925_207_208_5595_5594_1869_5728_1026 10 7.87E-07 6.85E-05 2.64E-06 23702 hsa-mir-603 hsa04720 Long-term potentiation 6195_6197_5578_5499_5595_5594_1387_468_6196_2033 10 2.54E-06 0.000221001 8.19E-06 23703 hsa-mir-603 hsa04664 Fc epsilon RI signaling pathway 5578_1432_207_208_5595_5594_5599_5601_5600_5602 10 3.88E-06 0.000337267 1.20E-05 23704 hsa-mir-603 hsa04912 GnRH signaling pathway 5578_1432_998_5595_5594_5599_468_3725_5601_5600_5602 11 8.71E-06 0.000757625 2.61E-05 23705 hsa-mir-603 hsa05213 Endometrial cancer 1499_6934_207_208_5595_5594_2932_5728 8 1.01E-05 0.000877263 2.85E-05 23706 hsa-mir-603 hsa04210 Apoptosis 3551_596_598_823_207_208_1147_5970_4792_472 10 1.02E-05 0.000883242 2.85E-05 23707 hsa-mir-603 hsa05218 Melanoma 4193_5925_207_208_5595_5594_1869_5728_1026 9 1.17E-05 0.001017011 3.18E-05 23708 hsa-mir-603 hsa05223 Non-small cell lung cancer 5578_5925_6789_207_208_5595_5594_1869 8 1.29E-05 0.001124095 3.41E-05 23709 hsa-mir-603 hsa04910 Insulin signaling pathway 3551_5499_207_208_5595_5594_5599_23265_2932_5601_5602_5563 12 1.51E-05 0.001314594 3.87E-05 23710 hsa-mir-603 hsa04062 Chemokine signaling pathway 3551_5747_6362_6774_207_208_1147_998_5595_5594_2932_6772_5970_4792 14 2.05E-05 0.001781766 5.09E-05 23711 hsa-mir-603 hsa05219 Bladder cancer 9252_4193_5925_5595_5594_1869_1026 7 2.29E-05 0.001995127 5.54E-05 23712 hsa-mir-603 hsa03420 Nucleotide excision repair 902_2965_4331_2071_2074_1022_6117 7 3.00E-05 0.002608564 7.05E-05 23713 hsa-mir-603 hsa04930 Type II diabetes mellitus 3551_3651_5595_5594_5599_5601_5602 7 3.41E-05 0.002968936 7.81E-05 23714 hsa-mir-603 hsa04916 Melanogenesis 1499_6934_5578_5595_5594_1387_2932_10488_2033_1856 10 3.51E-05 0.003050474 7.82E-05 23715 hsa-mir-603 hsa04530 Tight junction 1499_5578_207_208_1460_998_1457_5728_5518_5515_5520 11 6.68E-05 0.005813299 0.000145332 23716 hsa-mir-603 hsa04330 Notch signaling pathway 3065_1387_9612_2033_8850_1856 6 0.00033085 0.028783973 0.000702048 23717 hsa-mir-603 hsa04630 Jak-STAT signaling pathway 598_6774_207_208_1387_6775_6772_2033_51588_8554 10 0.000726097 0.063170439 0.001496447 23718 hsa-mir-603 hsa03410 Base excision repair 3146_142_4913_328_6996 5 0.000739623 0.064347242 0.001496447 23719 hsa-mir-603 hsa05131 Shigellosis 1499_5578_25_998_7534_4691 6 0.000775404 0.067460112 0.001499114 23720 hsa-mir-603 hsa05130 Pathogenic Escherichia coli infection 1499_5578_25_998_7534_4691 6 0.000775404 0.067460112 0.001499114 23721 hsa-mir-603 hsa05016 Huntington's disease 3064_3065_25942_6667_9586_1387_23186_10488_2033_27113_6908 11 0.000861725 0.074970101 0.001629785 23722 hsa-mir-603 hsa04612 Antigen processing and presentation 3309_3304_3305_3303_3326_4800_3320 7 0.001565376 0.136187707 0.002897611 23723 hsa-mir-603 hsa03440 Homologous recombination 641_5888_675_6117 4 0.002316514 0.201536675 0.004198681 23724 hsa-mir-603 hsa04730 Long-term depression 5578_5592_5595_5594_5518_5515 6 0.002397196 0.208556061 0.004256246 23725 hsa-mir-603 hsa05216 Thyroid cancer 1499_6934_5595_5594 4 0.002599761 0.226179202 0.004523584 23726 hsa-mir-603 hsa04360 Axon guidance 4773_5747_25_998_5595_5594_2932_1020 8 0.003319145 0.288765636 0.005662071 23727 hsa-mir-603 hsa05217 Basal cell carcinoma 1499_6934_2932_2736_1856 5 0.004102193 0.356890751 0.006863284 23728 hsa-mir-603 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_1432_1616_5600 5 0.004404996 0.383234625 0.007230842 23729 hsa-mir-603 hsa04540 Gap junction 5578_5592_5595_5594_1453_983 6 0.008209244 0.71420422 0.013226004 23730 hsa-mir-603 hsa04950 Maturity onset diabetes of the young 3087_3651_3172 3 0.011617195 1 0.01837629 23731 hsa-mir-603 hsa04740 Olfactory transduction 5592 1 0.017232469 1 0.026771872 23732 hsa-mir-603 hsa04340 Hedgehog signaling pathway 2932_1452_1453_2736 4 0.022576209 1 0.034458424 23733 hsa-mir-603 hsa04670 Leukocyte transendothelial migration 1499_5578_5747_1432_998_5600 6 0.026099617 1 0.039149426 23734 hsa-mir-603 hsa04710 Circadian rhythm - mammal 406_1453 2 0.02795186 1 0.04121715 23735 hsa-mir-603 hsa03030 DNA replication 5557_6117_5422 3 0.031101503 1 0.04503796 23736 hsa-mir-603 hsa03450 Non-homologous end-joining 2547_5591 2 0.03157834 1 0.04503796 23737 hsa-mir-604 hsa03022 Basal transcription factors 2967_2961_2960_2963_2962_6881_2969_2968_6879_6878_6877_6874_6872_2957_54457_2958_6873_6884_2959_6880_6882_138474_6883 23 2.03E-33 1.44E-31 1.44E-31 23738 hsa-mir-604 hsa05200 Pathways in cancer 5371_1499_5594_6258_1387_6256_10401_1487_1488_836_1019_1017_4193_842_841_5970_4824_7157_6688_3725_4609_1026_2353_4087_4088_5925_2033_3326_8554_7184 30 6.08E-22 4.32E-20 2.16E-20 23739 hsa-mir-604 hsa05215 Prostate cancer 1499_5594_1385_1387_1017_4193_842_5970_4824_7157_468_1026_5925_2033_3326_7184 16 1.64E-16 1.17E-14 3.41E-15 23740 hsa-mir-604 hsa05212 Pancreatic cancer 1499_5594_1385_1387_1017_4193_842_5970_4824_7157_468_1026_5925_2033_3326_7184 16 1.92E-16 1.37E-14 3.41E-15 23741 hsa-mir-604 hsa04110 Cell cycle 5591_1387_1019_1017_4193_7027_4171_7157_1026_4085_4087_4088_5925_2033_5933 15 1.87E-13 1.33E-11 2.65E-12 23742 hsa-mir-604 hsa04310 Wnt signaling pathway 815_1499_1387_8607_1487_1488_7157_3725_4609_1460_1457_4087_4088_2033 14 5.84E-11 4.14E-09 6.91E-10 23743 hsa-mir-604 hsa05220 Chronic myeloid leukemia 5594_1487_1488_1019_4193_5970_7157_4609_1026_4088_5925 11 7.59E-11 5.39E-09 7.69E-10 23744 hsa-mir-604 hsa04010 MAPK signaling pathway 6722_5594_1386_9261_836_3312_1649_5970_7157_3725_468_4609_3727_6195_2353_2002_2005 17 1.60E-10 1.13E-08 1.42E-09 23745 hsa-mir-604 hsa05222 Small cell lung cancer 6258_6256_10401_1019_1017_842_5970_7157_4609_5925_8554 11 2.86E-10 2.03E-08 2.26E-09 23746 hsa-mir-604 hsa05210 Colorectal cancer 1499_5594_836_842_7157_3725_4609_2353_4087_4088 10 3.53E-09 2.51E-07 2.51E-08 23747 hsa-mir-604 hsa04520 Adherens junction 1499_6714_5594_1387_1460_1457_4087_4088_2033 9 3.41E-08 2.42E-06 2.20E-07 23748 hsa-mir-604 hsa04350 TGF-beta signaling pathway 5594_1387_7027_1874_4609_4087_4088_2033_5933 9 6.64E-08 4.71E-06 3.93E-07 23749 hsa-mir-604 hsa05219 Bladder cancer 5594_1019_4193_7157_4609_1026_5925 7 1.05E-07 7.45E-06 5.73E-07 23750 hsa-mir-604 hsa04115 p53 signaling pathway 836_1019_1017_4193_842_841_7157_1026 8 1.62E-07 1.15E-05 8.21E-07 23751 hsa-mir-604 hsa05216 Thyroid cancer 1499_5594_6258_6256_7157_4609 6 2.85E-07 2.02E-05 1.35E-06 23752 hsa-mir-604 hsa05223 Non-small cell lung cancer 5594_6258_6256_1019_842_7157_5925 7 4.92E-07 3.49E-05 2.18E-06 23753 hsa-mir-604 hsa05016 Huntington's disease 6874_3064_1385_1387_836_9001_842_841_5430_7157_2033 11 5.25E-07 3.73E-05 2.19E-06 23754 hsa-mir-604 hsa05214 Glioma 815_5594_1019_4193_7157_1026_5925 7 1.55E-06 0.000109709 6.09E-06 23755 hsa-mir-604 hsa04330 Notch signaling pathway 1387_1487_1488_9612_2033_8850 6 3.58E-06 0.000254504 1.34E-05 23756 hsa-mir-604 hsa05213 Endometrial cancer 1499_5594_842_7157_4609_2002 6 6.12E-06 0.000434342 2.17E-05 23757 hsa-mir-604 hsa04012 ErbB signaling pathway 815_6714_5594_3725_4609_1026_2002 7 9.28E-06 0.000659146 3.14E-05 23758 hsa-mir-604 hsa04210 Apoptosis 836_839_842_841_840_5970_7157 7 1.07E-05 0.000757476 3.44E-05 23759 hsa-mir-604 hsa05218 Melanoma 5594_1019_4193_7157_1026_5925 6 3.17E-05 0.002248786 9.78E-05 23760 hsa-mir-604 hsa04720 Long-term potentiation 815_5594_1387_468_6195_2033 6 4.22E-05 0.002999337 0.000124972 23761 hsa-mir-604 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 5.87E-05 0.004168576 0.000166743 23762 hsa-mir-604 hsa05221 Acute myeloid leukemia 5371_5594_5970_6688_4609 5 0.000145497 0.010330253 0.000397317 23763 hsa-mir-604 hsa04916 Melanogenesis 815_1499_5594_1385_1387_2033 6 0.000231069 0.016405869 0.000607625 23764 hsa-mir-604 hsa04912 GnRH signaling pathway 815_6714_5594_3725_468_2002 6 0.000280374 0.019906586 0.000710949 23765 hsa-mir-604 hsa03420 Nucleotide excision repair 2967_2968_5981_5887 4 0.000537725 0.038178485 0.001316499 23766 hsa-mir-604 hsa04612 Antigen processing and presentation 1385_4800_4801_3312_3326 5 0.00086681 0.061543511 0.00205145 23767 hsa-mir-604 hsa04620 Toll-like receptor signaling pathway 5594_841_5970_3725_2353 5 0.001547038 0.109839705 0.003543216 23768 hsa-mir-604 hsa04660 T cell receptor signaling pathway 5594_1019_5970_3725_2353 5 0.002124106 0.150811561 0.004712861 23769 hsa-mir-604 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_836_5970_3725 4 0.002850909 0.202414573 0.006133775 23770 hsa-mir-604 hsa05211 Renal cell carcinoma 5594_1387_3725_2033 4 0.002991138 0.212370784 0.0062462 23771 hsa-mir-604 hsa05010 Alzheimer's disease 22926_5594_836_842_841_840 6 0.003239569 0.230009378 0.006571697 23772 hsa-mir-604 hsa04662 B cell receptor signaling pathway 5594_5970_3725_2353 4 0.003439956 0.244236846 0.006784357 23773 hsa-mir-604 hsa04370 VEGF signaling pathway 6714_5594_9261_842 4 0.003763341 0.267197195 0.007221546 23774 hsa-mir-604 hsa04530 Tight junction 1499_6714_1019_1460_1457 5 0.005237972 0.371895984 0.009786736 23775 hsa-mir-604 hsa04630 Jak-STAT signaling pathway 1387_10401_4609_2033_8554 5 0.008573703 0.608732947 0.015608537 23776 hsa-mir-604 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_842_7157 3 0.011069534 0.785936924 0.019648423 23777 hsa-mir-604 hsa04950 Maturity onset diabetes of the young 5080_6927 2 0.017430115 1 0.029606459 23778 hsa-mir-604 hsa04920 Adipocytokine signaling pathway 6258_6256_5970 3 0.01751368 1 0.029606459 23779 hsa-mir-604 hsa04510 Focal adhesion 1499_6714_5594_3725_2002 5 0.025337257 1 0.041835936 23780 hsa-mir-604 hsa04120 Ubiquitin mediated proteolysis 5371_10401_4193_8554 4 0.026056863 1 0.042046302 23781 hsa-mir-604 hsa03030 DNA replication 5981_4171 2 0.03547464 1 0.055971098 23782 hsa-mir-604 hsa04540 Gap junction 6714_5594_10382 3 0.039499037 1 0.060965905 23783 hsa-mir-605 hsa05200 Pathways in cancer 3320_4149_5371_2249_4292_5595_5594_5914_1387_6257_6256_8031_5604_4286_367_2932_5599_6502_6776_6777_5970_2736_4088_5894_3725_1029_2353_4087_1050_5925_2033_207_8554_6258 34 2.48E-25 1.76E-23 1.76E-23 23784 hsa-mir-605 hsa04010 MAPK signaling pathway 6722_4149_2249_5595_5594_9252_5598_1386_9261_5604_5599_1432_5970_10912_5894_3725_6195_6196_2353_8986_6197_4616_207 23 9.63E-16 6.84E-14 3.42E-14 23785 hsa-mir-605 hsa04110 Cell cycle 990_1387_983_7533_2932_8454_6500_6502_4088_10912_1029_4087_5925_2033_4616_891_5933 17 2.26E-15 1.61E-13 5.36E-14 23786 hsa-mir-605 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_5604_6776_6777_5970_5894_1050_207 11 1.64E-11 1.17E-09 2.92E-10 23787 hsa-mir-605 hsa05210 Colorectal cancer 4292_5595_5594_5604_2932_5599_4088_5894_3725_2353_4087_207 12 3.16E-11 2.25E-09 4.49E-10 23788 hsa-mir-605 hsa05215 Prostate cancer 3320_5595_5594_1387_5604_367_2932_5970_5894_5925_2033_207 12 5.17E-11 3.67E-09 5.90E-10 23789 hsa-mir-605 hsa05212 Pancreatic cancer 3320_5595_5594_1387_5604_367_2932_5970_5894_5925_2033_207 12 5.82E-11 4.13E-09 5.90E-10 23790 hsa-mir-605 hsa04540 Gap junction 5592_5595_5594_5598_983_5604_7277_5894_7846_7278_51807_10376 12 9.25E-11 6.57E-09 8.21E-10 23791 hsa-mir-605 hsa05223 Non-small cell lung cancer 5595_5594_6257_6256_5604_5894_1029_5925_207_6258 10 1.48E-10 1.05E-08 1.17E-09 23792 hsa-mir-605 hsa05220 Chronic myeloid leukemia 5595_5594_5604_6776_6777_5970_4088_5894_1029_5925_207 11 1.65E-10 1.17E-08 1.17E-09 23793 hsa-mir-605 hsa04350 TGF-beta signaling pathway 6667_5595_5594_1387_8454_6500_3399_4088_4087_2033_5933 11 6.92E-10 4.92E-08 4.47E-09 23794 hsa-mir-605 hsa04660 T cell receptor signaling pathway 5595_5594_5604_2932_1432_5970_1739_5894_3725_2353_207 11 6.66E-09 4.73E-07 3.94E-08 23795 hsa-mir-605 hsa04012 ErbB signaling pathway 5595_5594_5604_2932_5599_6776_6777_5894_3725_207 10 9.66E-09 6.86E-07 5.28E-08 23796 hsa-mir-605 hsa04310 Wnt signaling pathway 1460_1387_1459_2932_8454_6500_5599_4088_3725_1457_4087_2033 12 1.60E-08 1.14E-06 8.13E-08 23797 hsa-mir-605 hsa05216 Thyroid cancer 5595_5594_6257_6256_8031_5604_6258 7 1.84E-08 1.30E-06 8.69E-08 23798 hsa-mir-605 hsa05218 Melanoma 2249_5595_5594_5604_4286_5894_1029_5925_207 9 2.48E-08 1.76E-06 1.10E-07 23799 hsa-mir-605 hsa04720 Long-term potentiation 5595_5594_1387_5604_5894_6195_6196_6197_2033 9 3.83E-08 2.72E-06 1.51E-07 23800 hsa-mir-605 hsa04662 B cell receptor signaling pathway 5595_5594_5604_2932_5970_5894_3725_2353_207 9 3.83E-08 2.72E-06 1.51E-07 23801 hsa-mir-605 hsa04520 Adherens junction 1460_5595_5594_1387_1459_4088_1457_4087_2033 9 6.37E-08 4.52E-06 2.38E-07 23802 hsa-mir-605 hsa05222 Small cell lung cancer 4149_6257_6256_6502_5970_5925_207_8554_6258 9 1.13E-07 8.00E-06 4.00E-07 23803 hsa-mir-605 hsa05219 Bladder cancer 5595_5594_9252_5604_5894_1029_5925 7 1.72E-07 1.22E-05 5.82E-07 23804 hsa-mir-605 hsa05211 Renal cell carcinoma 5595_5594_1387_5604_5894_3725_2033_207 8 3.80E-07 2.70E-05 1.23E-06 23805 hsa-mir-605 hsa04620 Toll-like receptor signaling pathway 5595_5594_5604_5599_1432_5970_3725_2353_207 9 4.31E-07 3.06E-05 1.33E-06 23806 hsa-mir-605 hsa04120 Ubiquitin mediated proteolysis 11059_55294_5371_672_8454_6500_6502_7325_7329_8554 10 5.73E-07 4.07E-05 1.69E-06 23807 hsa-mir-605 hsa05213 Endometrial cancer 4292_5595_5594_5604_2932_5894_207 7 6.37E-07 4.52E-05 1.81E-06 23808 hsa-mir-605 hsa05214 Glioma 5595_5594_5604_5894_1029_5925_207 7 2.51E-06 0.00017786 6.84E-06 23809 hsa-mir-605 hsa04920 Adipocytokine signaling pathway 10891_6257_6256_5599_5970_207_6258 7 3.02E-06 0.000214201 7.93E-06 23810 hsa-mir-605 hsa04910 Insulin signaling pathway 10891_5595_5594_5604_23265_2932_5599_5894_207 9 4.52E-06 0.000321019 1.15E-05 23811 hsa-mir-605 hsa04916 Melanogenesis 5595_5594_1387_5604_4286_2932_5894_2033 8 4.95E-06 0.000351757 1.21E-05 23812 hsa-mir-605 hsa04912 GnRH signaling pathway 5595_5594_5598_5604_5599_1432_5894_3725 8 6.43E-06 0.000456631 1.52E-05 23813 hsa-mir-605 hsa04370 VEGF signaling pathway 5595_5594_9261_5604_1432_5894_207 7 7.07E-06 0.000502051 1.62E-05 23814 hsa-mir-605 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5604_5599_1432_5894_207 7 8.27E-06 0.000587163 1.83E-05 23815 hsa-mir-605 hsa04150 mTOR signaling pathway 5595_5594_6195_6196_6197_207 6 9.27E-06 0.000658213 1.99E-05 23816 hsa-mir-605 hsa05131 Shigellosis 4691_7277_7846_7278_51807_10376 6 1.37E-05 0.000972078 2.78E-05 23817 hsa-mir-605 hsa05130 Pathogenic Escherichia coli infection 4691_7277_7846_7278_51807_10376 6 1.37E-05 0.000972078 2.78E-05 23818 hsa-mir-605 hsa04115 p53 signaling pathway 983_10912_7161_1029_4616_891 6 4.09E-05 0.002907179 8.08E-05 23819 hsa-mir-605 hsa04062 Chemokine signaling pathway 5595_5594_5604_7074_2932_6777_5970_5894_207 9 5.68E-05 0.00403211 0.000108976 23820 hsa-mir-605 hsa04510 Focal adhesion 5595_5594_5604_2932_5599_1729_5894_3725_207 9 9.16E-05 0.006505221 0.00017119 23821 hsa-mir-605 hsa05016 Huntington's disease 6667_10891_1387_6908_1537_3064_2033_4716 8 0.000266414 0.018915391 0.00048501 23822 hsa-mir-605 hsa03022 Basal transcription factors 2963_2962_2969_6908 4 0.000384912 0.027328757 0.000683219 23823 hsa-mir-605 hsa04730 Long-term depression 5592_5595_5594_5604_5894 5 0.000455873 0.032366949 0.000773253 23824 hsa-mir-605 hsa04630 Jak-STAT signaling pathway 1387_6776_6777_2033_3977_207_8554 7 0.000457417 0.032476629 0.000773253 23825 hsa-mir-605 hsa04930 Type II diabetes mellitus 5595_5594_5599_3651 4 0.000764113 0.054251991 0.001261674 23826 hsa-mir-605 hsa04330 Notch signaling pathway 1387_9612_2033_2648 4 0.000889505 0.06315484 0.001435337 23827 hsa-mir-605 hsa04810 Regulation of actin cytoskeleton 2249_5595_5594_5604_7074_1729_5894 7 0.003113408 0.221051979 0.004912266 23828 hsa-mir-605 hsa03320 PPAR signaling pathway 6257_6256_2168_6258 4 0.003524258 0.250222332 0.005439616 23829 hsa-mir-605 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_1432_5970_3725 4 0.003698651 0.262604224 0.005587324 23830 hsa-mir-605 hsa04270 Vascular smooth muscle contraction 5592_5595_5594_5604_5894 5 0.003879668 0.275456426 0.005738676 23831 hsa-mir-605 hsa04530 Tight junction 1460_10207_1459_1457_207 5 0.007081326 0.502774163 0.010260697 23832 hsa-mir-605 hsa04612 Antigen processing and presentation 3320_4800_4801_4802 4 0.007904947 0.561251231 0.011225025 23833 hsa-mir-605 hsa05010 Alzheimer's disease 5595_5594_2932_1537_4716 5 0.019052332 1 0.026523835 23834 hsa-mir-605 hsa04950 Maturity onset diabetes of the young 6927_3651 2 0.019984667 1 0.027286757 23835 hsa-mir-605 hsa04360 Axon guidance 5998_5595_5594_2932 4 0.027343723 1 0.036630271 23836 hsa-mir-605 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_5604_5894 4 0.032080112 1 0.042179406 23837 hsa-mir-608 hsa05200 Pathways in cancer 3716_3326_5747_3725_1956_1499_1387_2064_5159_5156_367_2261_3815_2932_6774_6776_6777_3265_5879_7157_8772_2353_4088_4089_5881_3065_5925_2033_207_1050_8554_5970_7046_7186 34 6.52E-31 4.50E-29 4.50E-29 23838 hsa-mir-608 hsa04010 MAPK signaling pathway 3725_1956_5159_5156_7132_3303_2261_2264_9252_1432_1845_3265_5879_7157_22800_2353_5881_5058_207_5970_7046_7186_4773 23 2.37E-19 1.64E-17 8.19E-18 23839 hsa-mir-608 hsa04630 Jak-STAT signaling pathway 3717_3716_3560_3561_1387_6774_6776_6777_6773_58985_3455_3459_5781_7297_1439_2033_207_8554_10379 19 5.99E-19 4.13E-17 1.38E-17 23840 hsa-mir-608 hsa05215 Prostate cancer 3326_1956_1499_1387_2064_5159_5156_367_2932_3265_7157_5925_2033_207_5970 15 4.02E-17 2.78E-15 6.46E-16 23841 hsa-mir-608 hsa05212 Pancreatic cancer 3326_1956_1499_1387_2064_5159_5156_367_2932_3265_7157_5925_2033_207_5970 15 4.68E-17 3.23E-15 6.46E-16 23842 hsa-mir-608 hsa05210 Colorectal cancer 3725_1956_1499_5159_5156_2932_5879_7157_2353_4088_4089_5881_207_7046 14 6.14E-16 4.24E-14 7.06E-15 23843 hsa-mir-608 hsa04060 Cytokine-cytokine receptor interaction 2321_3791_1956_3560_3561_90_5159_5156_7133_7132_1234_1230_3815_7852_58985_3455_3459_1439_7046 19 4.73E-15 3.26E-13 4.66E-14 23844 hsa-mir-608 hsa04520 Adherens junction 1956_1499_6714_1387_2064_5879_1457_4088_4089_5881_2033_7046_2534 13 9.28E-15 6.40E-13 8.00E-14 23845 hsa-mir-608 hsa04510 Focal adhesion 5747_3725_2321_3791_1956_1499_6714_2064_5159_5156_2932_3265_5879_5881_5058_207_2534 17 1.93E-14 1.33E-12 1.48E-13 23846 hsa-mir-608 hsa04012 ErbB signaling pathway 5747_3725_818_817_1956_6714_2064_2932_6776_6777_3265_5058_207 13 2.45E-14 1.69E-12 1.69E-13 23847 hsa-mir-608 hsa05220 Chronic myeloid leukemia 6776_6777_3265_7157_5781_4088_4089_3065_5925_207_5970_7046 12 1.20E-13 8.30E-12 7.54E-13 23848 hsa-mir-608 hsa04310 Wnt signaling pathway 3725_818_817_1499_1387_2932_5879_7157_1457_4088_4089_5881_2033_4773 14 1.06E-12 7.28E-11 6.07E-12 23849 hsa-mir-608 hsa04062 Chemokine signaling pathway 3717_5747_5580_1234_1230_2932_6774_6777_6773_3265_5879_7852_5058_207_5970 15 1.57E-12 1.08E-10 8.33E-12 23850 hsa-mir-608 hsa04110 Cell cycle 7534_1387_7532_2932_7157_4174_4172_4088_4089_3065_5925_2033 12 1.73E-11 1.19E-09 8.51E-11 23851 hsa-mir-608 hsa04920 Adipocytokine signaling pathway 3717_8717_7133_7132_6774_5781_207_5970_2538_7186 10 2.61E-11 1.80E-09 1.20E-10 23852 hsa-mir-608 hsa04662 B cell receptor signaling pathway 3725_6850_2932_3265_5879_2353_5881_207_5970_4773 10 7.14E-11 4.93E-09 3.08E-10 23853 hsa-mir-608 hsa04660 T cell receptor signaling pathway 3725_3932_2932_1432_3265_2353_5058_207_5970_2534_4773 11 1.34E-10 9.23E-09 5.43E-10 23854 hsa-mir-608 hsa05214 Glioma 818_817_1956_5159_5156_3265_7157_5925_207 9 4.83E-10 3.33E-08 1.85E-09 23855 hsa-mir-608 hsa04650 Natural killer cell mediated cytotoxicity 3932_6850_3265_5879_3455_3459_5781_5881_5058_2534_4773 11 1.26E-09 8.67E-08 4.56E-09 23856 hsa-mir-608 hsa04370 VEGF signaling pathway 5747_3791_6714_1432_3265_5879_5881_207_4773 9 1.89E-09 1.31E-07 6.53E-09 23857 hsa-mir-608 hsa05221 Acute myeloid leukemia 3815_6774_6776_6777_3265_207_1050_5970 8 5.31E-09 3.66E-07 1.74E-08 23858 hsa-mir-608 hsa05219 Bladder cancer 1956_2064_2261_9252_3265_7157_5925 7 1.37E-08 9.44E-07 4.29E-08 23859 hsa-mir-608 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1956_6714_1432_5879_5781_5058_5970 8 2.00E-08 1.38E-06 6.01E-08 23860 hsa-mir-608 hsa05211 Renal cell carcinoma 3725_1387_3265_5879_5781_5058_2033_207 8 2.21E-08 1.53E-06 6.37E-08 23861 hsa-mir-608 hsa04664 Fc epsilon RI signaling pathway 5580_6850_1432_3265_5879_5881_207_2534 8 4.31E-08 2.98E-06 1.19E-07 23862 hsa-mir-608 hsa05213 Endometrial cancer 1956_1499_2064_2932_3265_7157_207 7 5.18E-08 3.57E-06 1.37E-07 23863 hsa-mir-608 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_7133_7132_1432_5879_2906_7157 7 8.23E-08 5.68E-06 2.10E-07 23864 hsa-mir-608 hsa04350 TGF-beta signaling pathway 1387_90_6667_4088_4089_2033_7046_57154 8 8.62E-08 5.95E-06 2.13E-07 23865 hsa-mir-608 hsa04210 Apoptosis 8717_7132_7157_8772_1439_207_5970_7186 8 1.02E-07 7.01E-06 2.42E-07 23866 hsa-mir-608 hsa04810 Regulation of actin cytoskeleton 5747_1956_5159_5156_2261_2264_3265_5879_22800_5881_5058 11 1.14E-07 7.85E-06 2.62E-07 23867 hsa-mir-608 hsa04360 Axon guidance 5747_2932_3265_5879_7852_5881_5058_2534_4773 9 1.38E-07 9.51E-06 3.07E-07 23868 hsa-mir-608 hsa04620 Toll-like receptor signaling pathway 3725_1432_5879_3455_8772_2353_207_5970 8 2.70E-07 1.86E-05 5.82E-07 23869 hsa-mir-608 hsa04916 Melanogenesis 818_817_1499_1387_3815_2932_3265_2033 8 3.10E-07 2.14E-05 6.49E-07 23870 hsa-mir-608 hsa05218 Melanoma 1956_5159_5156_3265_7157_5925_207 7 3.65E-07 2.52E-05 7.42E-07 23871 hsa-mir-608 hsa04912 GnRH signaling pathway 3725_5580_818_817_1956_6714_1432_3265 8 4.06E-07 2.80E-05 8.01E-07 23872 hsa-mir-608 hsa04720 Long-term potentiation 818_817_1387_2902_3265_2906_2033 7 5.16E-07 3.56E-05 9.89E-07 23873 hsa-mir-608 hsa05222 Small cell lung cancer 5747_7157_5925_207_8554_5970_7186 7 1.22E-06 8.41E-05 2.27E-06 23874 hsa-mir-608 hsa05223 Non-small cell lung cancer 1956_2064_3265_7157_5925_207 6 1.35E-06 9.30E-05 2.45E-06 23875 hsa-mir-608 hsa04020 Calcium signaling pathway 818_817_1956_2064_5159_2902_5156_2906_147 9 2.05E-06 0.000141637 3.63E-06 23876 hsa-mir-608 hsa04530 Tight junction 5580_1499_6714_3265_22800_8573_1457_207 8 2.21E-06 0.000152456 3.81E-06 23877 hsa-mir-608 hsa05016 Huntington's disease 1387_2902_6908_6667_7157_3065_2033_9519 8 2.02E-05 0.001393622 3.40E-05 23878 hsa-mir-608 hsa03022 Basal transcription factors 2969_6908_2959_9519 4 9.36E-05 0.006459239 0.000153791 23879 hsa-mir-608 hsa04670 Leukocyte transendothelial migration 5747_1499_1432_5879_7852_5781 6 0.000105532 0.007281701 0.000169342 23880 hsa-mir-608 hsa04330 Notch signaling pathway 1387_3065_8850_2033 4 0.00022081 0.015235866 0.00034627 23881 hsa-mir-608 hsa04540 Gap junction 1956_6714_5159_5156_3265 5 0.000272193 0.018781333 0.000417363 23882 hsa-mir-608 hsa05010 Alzheimer's disease 2902_7132_2932_2906_8772_351 6 0.000719302 0.049631838 0.001078953 23883 hsa-mir-608 hsa05216 Thyroid cancer 1499_3265_7157 3 0.000840334 0.057983051 0.001233682 23884 hsa-mir-608 hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.00468236 0.323082867 0.006730893 23885 hsa-mir-608 hsa05131 Shigellosis 7534_1499_2534 3 0.00491242 0.338957005 0.00677914 23886 hsa-mir-608 hsa05130 Pathogenic Escherichia coli infection 7534_1499_2534 3 0.00491242 0.338957005 0.00677914 23887 hsa-mir-608 hsa04910 Insulin signaling pathway 2932_3265_207_2538 4 0.009548866 0.658871767 0.012913882 23888 hsa-mir-608 hsa04120 Ubiquitin mediated proteolysis 672_7329_8554_57154 4 0.0097802 0.674833811 0.012913882 23889 hsa-mir-608 hsa04950 Maturity onset diabetes of the young 6928_3172 2 0.009919359 0.684435759 0.012913882 23890 hsa-mir-608 hsa05340 Primary immunodeficiency 3932_3561 2 0.019499518 1 0.02491605 23891 hsa-mir-608 hsa03030 DNA replication 4174_4172 2 0.02050542 1 0.025724982 23892 hsa-mir-608 hsa04340 Hedgehog signaling pathway 53944_2932 2 0.046129948 1 0.056838686 23893 hsa-mir-610 hsa04110 Cell cycle 1387_993_983_5925 4 6.13E-07 1.53E-05 1.53E-05 23894 hsa-mir-610 hsa04330 Notch signaling pathway 1387_8850 2 0.000349508 0.008737699 0.004368849 23895 hsa-mir-610 hsa05215 Prostate cancer 1387_5925 2 0.001174155 0.029353887 0.007500885 23896 hsa-mir-610 hsa05212 Pancreatic cancer 1387_5925 2 0.001200142 0.03000354 0.007500885 23897 hsa-mir-610 hsa05200 Pathways in cancer 1387_5925 2 0.015034947 0.37587367 0.064921185 23898 hsa-mir-610 hsa03410 Base excision repair 3146 1 0.020754901 0.518872528 0.064921185 23899 hsa-mir-610 hsa05219 Bladder cancer 5925 1 0.024082113 0.60205283 0.064921185 23900 hsa-mir-610 hsa05223 Non-small cell lung cancer 5925 1 0.030704643 0.767616075 0.064921185 23901 hsa-mir-610 hsa05214 Glioma 5925 1 0.036738118 0.918452946 0.064921185 23902 hsa-mir-610 hsa04115 p53 signaling pathway 983 1 0.038923332 0.97308329 0.064921185 23903 hsa-mir-610 hsa05218 Melanoma 5925 1 0.040014188 1 0.064921185 23904 hsa-mir-610 hsa05211 Renal cell carcinoma 1387 1 0.040559179 1 0.064921185 23905 hsa-mir-610 hsa04720 Long-term potentiation 1387 1 0.042192406 1 0.064921185 23906 hsa-mir-610 hsa05220 Chronic myeloid leukemia 5925 1 0.042192406 1 0.064921185 23907 hsa-mir-610 hsa04520 Adherens junction 1387 1 0.044908637 1 0.064921185 23908 hsa-mir-610 hsa04512 ECM-receptor interaction 9672 1 0.0470764 1 0.064921185 23909 hsa-mir-610 hsa05222 Small cell lung cancer 5925 1 0.048158544 1 0.064921185 23910 hsa-mir-610 hsa04350 TGF-beta signaling pathway 1387 1 0.048699183 1 0.064921185 23911 hsa-mir-610 hsa04612 Antigen processing and presentation 1514 1 0.049779592 1 0.064921185 23912 hsa-mir-611 hsa05200 Pathways in cancer 4088_4089_4436_9915_5371_2034_2033_3091_4609 9 1.13E-08 4.17E-07 3.54E-07 23913 hsa-mir-611 hsa04350 TGF-beta signaling pathway 4088_4089_2033_4093_7027_4609 6 1.91E-08 7.08E-07 3.54E-07 23914 hsa-mir-611 hsa04110 Cell cycle 4088_4089_2033_8379_7027 5 3.25E-06 0.000120276 4.01E-05 23915 hsa-mir-611 hsa04310 Wnt signaling pathway 4088_4089_2033_4609_1457 5 1.03E-05 0.000380402 8.64E-05 23916 hsa-mir-611 hsa05211 Renal cell carcinoma 9915_2034_2033_3091 4 1.17E-05 0.000431954 8.64E-05 23917 hsa-mir-611 hsa04520 Adherens junction 4088_4089_2033_1457 4 1.74E-05 0.00064262 0.000107103 23918 hsa-mir-611 hsa05210 Colorectal cancer 4088_4089_4436_4609 4 2.09E-05 0.000772437 0.000110348 23919 hsa-mir-611 hsa05220 Chronic myeloid leukemia 4088_4089_4609 3 0.000400286 0.014810588 0.001851324 23920 hsa-mir-611 hsa04330 Notch signaling pathway 9612_2033 2 0.00365932 0.135394834 0.01504387 23921 hsa-mir-611 hsa05221 Acute myeloid leukemia 5371_4609 2 0.005615043 0.207756599 0.02077566 23922 hsa-mir-611 hsa04120 Ubiquitin mediated proteolysis 5371_7329 2 0.027596234 1 0.092823696 23923 hsa-mir-611 hsa04630 Jak-STAT signaling pathway 2033_4609 2 0.033612694 1 0.103639141 23924 hsa-mir-611 hsa03430 Mismatch repair 4436 1 0.043023612 1 0.122451818 23925 hsa-mir-612 hsa05200 Pathways in cancer 841_836_4824_5371_1387_842_6258_5970_6256 9 9.52E-09 4.67E-07 4.67E-07 23926 hsa-mir-612 hsa04210 Apoptosis 841_836_839_842_840_5970 6 1.94E-08 9.52E-07 4.76E-07 23927 hsa-mir-612 hsa05215 Prostate cancer 4824_1387_842_1385_5970 5 7.14E-07 3.50E-05 9.22E-06 23928 hsa-mir-612 hsa05212 Pancreatic cancer 4824_1387_842_1385_5970 5 7.53E-07 3.69E-05 9.22E-06 23929 hsa-mir-612 hsa04010 MAPK signaling pathway 9261_836_6195_2002_2005_5970 6 1.08E-05 0.000528146 0.000105629 23930 hsa-mir-612 hsa05010 Alzheimer's disease 841_836_22926_842_840 5 1.92E-05 0.000939141 0.000148441 23931 hsa-mir-612 hsa05222 Small cell lung cancer 842_6258_5970_6256 4 2.12E-05 0.001039084 0.000148441 23932 hsa-mir-612 hsa05016 Huntington's disease 841_836_1387_842_1385 5 2.54E-05 0.001244687 0.000155586 23933 hsa-mir-612 hsa05223 Non-small cell lung cancer 842_6258_6256 3 0.000149782 0.007339342 0.000815482 23934 hsa-mir-612 hsa04920 Adipocytokine signaling pathway 6258_5970_6256 3 0.00027563 0.013505866 0.001326077 23935 hsa-mir-612 hsa04115 p53 signaling pathway 841_836_842 3 0.000299542 0.014677546 0.001326077 23936 hsa-mir-612 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_836_5970 3 0.000324754 0.015912922 0.001326077 23937 hsa-mir-612 hsa04720 Long-term potentiation 6195_815_1387 3 0.000379195 0.01858056 0.001429274 23938 hsa-mir-612 hsa04370 VEGF signaling pathway 9261_6714_842 3 0.000408483 0.020015676 0.001429691 23939 hsa-mir-612 hsa04520 Adherens junction 6714_1457_1387 3 0.00045508 0.022298921 0.001486595 23940 hsa-mir-612 hsa04012 ErbB signaling pathway 6714_815_2002 3 0.000576731 0.028259816 0.001766238 23941 hsa-mir-612 hsa04916 Melanogenesis 815_1387_1385 3 0.000953646 0.046728661 0.002748745 23942 hsa-mir-612 hsa04912 GnRH signaling pathway 6714_815_2002 3 0.001060357 0.051957477 0.002886526 23943 hsa-mir-612 hsa05216 Thyroid cancer 6258_6256 2 0.001425017 0.069825823 0.003675043 23944 hsa-mir-612 hsa03022 Basal transcription factors 2962_2969 2 0.002250043 0.110252086 0.005512604 23945 hsa-mir-612 hsa04310 Wnt signaling pathway 1457_815_1387 3 0.002752369 0.13486607 0.006422194 23946 hsa-mir-612 hsa04330 Notch signaling pathway 9612_1387 2 0.003530142 0.172976964 0.007862589 23947 hsa-mir-612 hsa05213 Endometrial cancer 842_2002 2 0.004271033 0.209280633 0.009099158 23948 hsa-mir-612 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_842 2 0.004911047 0.24064128 0.01002672 23949 hsa-mir-612 hsa05221 Acute myeloid leukemia 5371_5970 2 0.005418247 0.26549412 0.010619765 23950 hsa-mir-612 hsa03320 PPAR signaling pathway 6258_6256 2 0.00747304 0.36617896 0.014083806 23951 hsa-mir-612 hsa05210 Colorectal cancer 836_842 2 0.010516499 0.515308437 0.019085498 23952 hsa-mir-612 hsa04612 Antigen processing and presentation 4800_1385 2 0.011715411 0.574055156 0.02050197 23953 hsa-mir-612 hsa04620 Toll-like receptor signaling pathway 841_5970 2 0.015097431 0.739774138 0.025509453 23954 hsa-mir-612 hsa04110 Cell cycle 5591_1387 2 0.020072063 0.983531065 0.032784369 23955 hsa-mir-612 hsa05012 Parkinson's disease 836_842 2 0.025635162 1 0.039528533 23956 hsa-mir-612 hsa04530 Tight junction 6714_1457 2 0.025979895 1 0.039528533 23957 hsa-mir-612 hsa03450 Non-homologous end-joining 5591 1 0.026621257 1 0.039528533 23958 hsa-mir-613 hsa04110 Cell cycle 5925_993_1387_983_7534_1017_7532_5001_1871_2932_4193_7157_1870_4174_1026_4172_4173_1029_4087_4088_4089_3066_2033_898_4998_4999 26 6.71E-32 4.30E-30 4.30E-30 23959 hsa-mir-613 hsa05200 Pathways in cancer 1147_3551_5925_5371_367_1499_5595_5594_1387_1487_1488_9915_1017_1871_2932_4193_7157_3091_1870_4609_1026_1029_4087_4088_4089_3066_2034_2033_207_898_4286 31 1.18E-27 7.58E-26 3.79E-26 23960 hsa-mir-613 hsa05215 Prostate cancer 1147_3551_5925_367_1499_5595_5594_1385_1387_1017_1871_2932_4193_7157_1870_1026_2033_207_898 19 1.85E-23 1.19E-21 3.58E-22 23961 hsa-mir-613 hsa05212 Pancreatic cancer 1147_3551_5925_367_1499_5595_5594_1385_1387_1017_1871_2932_4193_7157_1870_1026_2033_207_898 19 2.24E-23 1.43E-21 3.58E-22 23962 hsa-mir-613 hsa05220 Chronic myeloid leukemia 1147_3551_5925_5595_5594_1487_1488_1871_4193_7157_1870_4609_1026_1029_4088_4089_3066_207 18 5.30E-23 3.39E-21 6.78E-22 23963 hsa-mir-613 hsa05219 Bladder cancer 5925_5595_5594_1871_4193_7157_1870_4609_1026_1029 10 2.83E-13 1.81E-11 3.02E-12 23964 hsa-mir-613 hsa05218 Melanoma 5925_5595_5594_1871_4193_7157_1870_1026_1029_207_4286 11 1.14E-12 7.31E-11 1.04E-11 23965 hsa-mir-613 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_3399_4609_4087_4088_4089_2033_4093 11 8.46E-12 5.42E-10 6.77E-11 23966 hsa-mir-613 hsa05214 Glioma 5925_5595_5594_1871_4193_7157_1870_1026_1029_207 10 1.33E-11 8.50E-10 9.45E-11 23967 hsa-mir-613 hsa04520 Adherens junction 1499_6714_5595_5594_1387_1457_4087_4088_4089_2033 10 8.54E-11 5.46E-09 5.46E-10 23968 hsa-mir-613 hsa05210 Colorectal cancer 1499_5595_5594_2932_7157_4609_4087_4088_4089_207 10 1.32E-10 8.47E-09 7.70E-10 23969 hsa-mir-613 hsa04310 Wnt signaling pathway 1499_1387_1487_1488_2932_7157_4609_1457_4087_4088_4089_2033 12 1.51E-10 9.65E-09 8.04E-10 23970 hsa-mir-613 hsa05222 Small cell lung cancer 1147_3551_5925_1017_1871_7157_1870_4609_207_898 10 1.64E-10 1.05E-08 8.05E-10 23971 hsa-mir-613 hsa04330 Notch signaling pathway 1387_1487_1488_9612_3066_2033_4851_8850 8 7.62E-10 4.88E-08 3.28E-09 23972 hsa-mir-613 hsa05211 Renal cell carcinoma 5595_5594_1387_9915_3091_5058_2034_2033_207 9 7.68E-10 4.92E-08 3.28E-09 23973 hsa-mir-613 hsa05223 Non-small cell lung cancer 5925_5595_5594_1871_7157_1870_1029_207 8 2.05E-09 1.31E-07 8.19E-09 23974 hsa-mir-613 hsa05213 Endometrial cancer 1499_5595_5594_2932_7157_4609_207 7 3.92E-08 2.51E-06 1.47E-07 23975 hsa-mir-613 hsa04012 ErbB signaling pathway 6714_5595_5594_2932_4609_1026_5058_207 8 6.30E-08 4.03E-06 2.24E-07 23976 hsa-mir-613 hsa05221 Acute myeloid leukemia 1147_3551_5371_5595_5594_4609_207 7 8.65E-08 5.54E-06 2.92E-07 23977 hsa-mir-613 hsa04910 Insulin signaling pathway 6720_3551_5595_5594_23265_5499_2932_207_2538 9 1.48E-07 9.48E-06 4.74E-07 23978 hsa-mir-613 hsa04916 Melanogenesis 1499_5595_5594_1385_1387_2932_2033_4286 8 2.28E-07 1.46E-05 6.75E-07 23979 hsa-mir-613 hsa04115 p53 signaling pathway 983_1017_4193_7157_1026_1029_898 7 2.32E-07 1.48E-05 6.75E-07 23980 hsa-mir-613 hsa05216 Thyroid cancer 1499_5595_5594_7157_4609 5 1.23E-06 7.88E-05 3.43E-06 23981 hsa-mir-613 hsa04660 T cell receptor signaling pathway 1147_3551_5595_5594_2932_5058_207 7 4.35E-06 0.000278088 1.16E-05 23982 hsa-mir-613 hsa04662 B cell receptor signaling pathway 1147_3551_5595_5594_2932_207 6 6.27E-06 0.000400982 1.60E-05 23983 hsa-mir-613 hsa04510 Focal adhesion 1499_6714_5595_5594_5499_2932_5058_207 8 2.83E-05 0.001811571 6.97E-05 23984 hsa-mir-613 hsa04010 MAPK signaling pathway 1147_3551_5595_5594_1386_7157_4609_5058_207 9 3.10E-05 0.001986761 7.36E-05 23985 hsa-mir-613 hsa04720 Long-term potentiation 5595_5594_1387_5499_2033 5 8.66E-05 0.005540414 0.000197872 23986 hsa-mir-613 hsa05016 Huntington's disease 1385_1387_6667_7157_3066_4697_2033 7 0.000116327 0.007444937 0.000256722 23987 hsa-mir-613 hsa04062 Chemokine signaling pathway 1147_3551_5595_5594_2932_5058_207 7 0.000136075 0.008708812 0.000290294 23988 hsa-mir-613 hsa04150 mTOR signaling pathway 5595_5594_3091_207 4 0.000271946 0.017404528 0.000561436 23989 hsa-mir-613 hsa04620 Toll-like receptor signaling pathway 1147_3551_5595_5594_207 5 0.000339289 0.021714504 0.000678578 23990 hsa-mir-613 hsa04920 Adipocytokine signaling pathway 1147_3551_207_2538 4 0.000674293 0.043154751 0.00130772 23991 hsa-mir-613 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_3551_6714_5058 4 0.000829075 0.05306081 0.001560612 23992 hsa-mir-613 hsa04370 VEGF signaling pathway 6714_5595_5594_207 4 0.001105908 0.070778082 0.002022231 23993 hsa-mir-613 hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_4193_7329 5 0.001301908 0.083322141 0.002314333 23994 hsa-mir-613 hsa03030 DNA replication 4174_4172_4173 3 0.001337974 0.085630319 0.002314333 23995 hsa-mir-613 hsa04210 Apoptosis 1147_3551_7157_207 4 0.001843167 0.117962702 0.003104282 23996 hsa-mir-613 hsa04540 Gap junction 6714_5595_5594_983 4 0.002150028 0.137601823 0.003528252 23997 hsa-mir-613 hsa04930 Type II diabetes mellitus 3551_5595_5594 3 0.002441125 0.156232007 0.0039058 23998 hsa-mir-613 hsa05010 Alzheimer's disease 22926_5595_5594_2932_4697 5 0.003600569 0.230436435 0.005620401 23999 hsa-mir-613 hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.004181736 0.267631098 0.006372169 24000 hsa-mir-613 hsa04360 Axon guidance 5595_5594_2932_5058 4 0.006979216 0.446669812 0.01038767 24001 hsa-mir-613 hsa04530 Tight junction 1499_6714_1457_207 4 0.008111099 0.519110362 0.011797963 24002 hsa-mir-613 hsa04664 Fc epsilon RI signaling pathway 5595_5594_207 3 0.010892869 0.69714363 0.015492081 24003 hsa-mir-613 hsa04630 Jak-STAT signaling pathway 1387_4609_2033_207 4 0.012209017 0.781377109 0.016986459 24004 hsa-mir-613 hsa03022 Basal transcription factors 2963_2969 2 0.019960678 1 0.027180498 24005 hsa-mir-613 hsa04912 GnRH signaling pathway 6714_5595_5594 3 0.024287487 1 0.032383316 24006 hsa-mir-613 hsa04270 Vascular smooth muscle contraction 5595_5594_5499 3 0.030299287 1 0.039574579 24007 hsa-mir-613 hsa04810 Regulation of actin cytoskeleton 5595_5594_5499_5058 4 0.036462201 1 0.046671617 24008 hsa-mir-613 hsa05131 Shigellosis 1499_7534 2 0.041583725 1 0.051179969 24009 hsa-mir-613 hsa05130 Pathogenic Escherichia coli infection 1499_7534 2 0.041583725 1 0.051179969 24010 hsa-mir-613 hsa04340 Hedgehog signaling pathway 53944_2932 2 0.042888841 1 0.051790298 24011 hsa-mir-613 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_5058 3 0.044441568 1 0.052671488 24012 hsa-mir-615 hsa05200 Pathways in cancer 4149_3551_7046_5467_5468_5914_595_1017_4193_6934_7704_3091_4087_4089_3066_3065_1050_5925_1499_25_405_1956_1487_1488_2064_1870_1871_2113_10401_861_207_208_3716_1147_2249_4233_3320_2261_5595_5594_5599_6258_1387_6257_6256_5747_4286_367_6774_6776_6777_6772_5979_5970_7157_6688_7849_1869_3725_4088_2034_2033_4790_5879_3326_51176_5371_3480_5159_8031_5156_5604_3815_8772_4609_2956_1026_2353_1441_8554 80 3.39E-51 2.61E-49 2.61E-49 24013 hsa-mir-615 hsa05220 Chronic myeloid leukemia 3551_7046_595_4193_4089_3066_3065_5925_25_1487_1488_1870_1871_861_207_208_1147_5595_5594_6776_6777_5970_7157_1869_4088_4790_5604_5781_4609_1026 30 4.30E-25 3.31E-23 1.66E-23 24014 hsa-mir-615 hsa05215 Prostate cancer 3551_595_1017_4193_6934_5925_1499_1956_2064_1870_1871_207_208_1147_3320_5595_5594_1387_367_5970_7157_1869_2033_4790_3326_51176_3480_5159_5156_5604_1026 31 1.55E-24 1.19E-22 3.94E-23 24015 hsa-mir-615 hsa05212 Pancreatic cancer 3551_595_1017_4193_6934_5925_1499_1956_2064_1870_1871_207_208_1147_3320_5595_5594_1387_367_5970_7157_1869_2033_4790_3326_51176_3480_5159_5156_5604_1026 31 2.05E-24 1.58E-22 3.94E-23 24016 hsa-mir-615 hsa04630 Jak-STAT signaling pathway 3717_3559_595_58985_3454_3455_3560_3561_1439_10401_2690_3977_207_208_3716_3718_85480_1387_3575_3570_3572_6778_6774_6776_6777_6772_7297_6773_2033_149233_3953_3459_5781_4609_1441_8554_10379 37 5.07E-24 3.91E-22 7.81E-23 24017 hsa-mir-615 hsa05221 Acute myeloid leukemia 3551_5467_5914_595_6934_7704_1050_861_207_208_1147_5595_5594_6774_6776_6777_5970_6688_4790_51176_5371_5604_3815_4609 24 1.78E-20 1.37E-18 2.29E-19 24018 hsa-mir-615 hsa05210 Colorectal cancer 7046_595_6934_4087_4089_1499_1956_207_208_4233_5595_5594_5599_7157_3725_4088_5879_51176_3480_5159_5156_5604_4609_2956_2353 25 1.39E-18 1.07E-16 1.53E-17 24019 hsa-mir-615 hsa04010 MAPK signaling pathway 3925_6722_4149_3551_7046_2264_9252_1845_7132_4773_4616_1956_1432_207_208_1147_2249_2261_5595_5594_5599_1386_5970_3164_7157_10912_3725_4790_5879_51701_5159_5156_5604_4208_6885_4609_2353_2002 38 1.66E-17 1.27E-15 1.59E-16 24020 hsa-mir-615 hsa04110 Cell cycle 595_1017_4193_5111_4087_4089_4174_4172_3066_3065_4616_5925_25_1870_1871_5934_5933_7534_1387_7532_7157_10912_1869_4088_2033_890_1026 27 2.11E-17 1.63E-15 1.81E-16 24021 hsa-mir-615 hsa04520 Adherens junction 7046_6934_4087_4089_2534_1499_1956_6714_2064_4301_2241_4233_5595_5594_1387_1457_4088_2033_5879_51176_3480_51701_6885 23 6.28E-17 4.84E-15 4.84E-16 24022 hsa-mir-615 hsa05216 Thyroid cancer 5468_595_6934_1499_5595_5594_6258_6257_6256_5979_7157_7849_51176_8031_5604_4609 16 1.01E-15 7.81E-14 7.10E-15 24023 hsa-mir-615 hsa05218 Melanoma 595_4193_5925_1956_1870_1871_207_208_2249_4233_5595_5594_4286_7157_1869_3480_5159_5156_5604_1026 20 9.34E-15 7.19E-13 5.99E-14 24024 hsa-mir-615 hsa05222 Small cell lung cancer 4149_3551_595_1017_5925_1870_1871_10401_207_208_1147_6258_6257_6256_5747_5970_7157_1869_4790_4609_8554 21 2.23E-14 1.72E-12 1.32E-13 24025 hsa-mir-615 hsa05214 Glioma 818_817_595_4193_5925_1956_1870_1871_207_208_5595_5594_7157_1869_3480_5159_5156_5604_1026 19 2.48E-14 1.91E-12 1.37E-13 24026 hsa-mir-615 hsa04920 Adipocytokine signaling pathway 3717_3551_10891_7132_5465_7133_207_208_1147_8717_5599_6258_6257_6256_6774_5970_4790_3953_5781 19 3.94E-14 3.03E-12 2.02E-13 24027 hsa-mir-615 hsa04620 Toll-like receptor signaling pathway 3551_3454_3455_3665_3661_1432_207_208_1147_3654_5595_5594_5599_6772_5970_3725_4790_5879_5604_8772_6885_2353 22 4.83E-14 3.72E-12 2.33E-13 24028 hsa-mir-615 hsa05219 Bladder cancer 595_9252_4193_5925_1956_2064_1870_1871_2261_5595_5594_7157_1869_5604_4609_1026 16 9.61E-14 7.40E-12 4.35E-13 24029 hsa-mir-615 hsa04060 Cytokine-cytokine receptor interaction 3556_3559_7046_1230_7132_58985_3454_3455_90_3791_1956_3560_3561_7133_1439_2690_3977_85480_4233_1234_3575_3570_3572_2321_149233_5159_5156_3815_3953_7852_3459_1441 32 1.56E-13 1.20E-11 6.66E-13 24030 hsa-mir-615 hsa04310 Wnt signaling pathway 818_817_5467_595_6934_4087_4089_4772_4773_1499_1487_1488_5599_1387_7157_3725_1457_4088_2033_5879_51176_51701_6885_4609_5527 25 2.08E-13 1.60E-11 8.09E-13 24031 hsa-mir-615 hsa05223 Non-small cell lung cancer 595_5925_1956_2309_2064_1870_1871_207_208_5595_5594_6258_6257_6256_7157_1869_5604 17 2.10E-13 1.62E-11 8.09E-13 24032 hsa-mir-615 hsa04350 TGF-beta signaling pathway 6667_7046_4086_4087_4089_90_57154_1874_1875_5934_5933_4093_5595_5594_1387_4088_2033_4609_4092 19 2.13E-12 1.64E-10 7.47E-12 24033 hsa-mir-615 hsa04012 ErbB signaling pathway 818_817_25_1956_6714_2064_207_208_5595_5594_5599_5747_6776_6777_3725_5604_4609_1026_2002 19 2.13E-12 1.64E-10 7.47E-12 24034 hsa-mir-615 hsa04330 Notch signaling pathway 1840_3066_3065_22938_1487_1488_3280_388585_1387_2033_8850_9612_9794_2648_4851 15 4.66E-12 3.59E-10 1.56E-11 24035 hsa-mir-615 hsa05213 Endometrial cancer 595_6934_1499_1956_2309_2064_207_208_5595_5594_7157_51176_5604_4609_2002 15 1.56E-11 1.20E-09 5.02E-11 24036 hsa-mir-615 hsa04062 Chemokine signaling pathway 3717_3551_1230_5580_5590_2309_207_208_3055_1147_3718_5595_5594_1234_5747_6774_6777_6772_5970_6773_4790_5879_5604_7852_2185 25 2.30E-11 1.77E-09 7.08E-11 24037 hsa-mir-615 hsa05211 Renal cell carcinoma 3091_405_2113_207_208_4233_5595_5594_1387_3725_2034_2033_5879_5604_5781 15 7.91E-10 6.09E-08 2.34E-09 24038 hsa-mir-615 hsa04662 B cell receptor signaling pathway 3551_4772_4773_6850_207_208_1147_5595_5594_5970_3725_4790_5879_5604_2353 15 1.29E-09 9.96E-08 3.69E-09 24039 hsa-mir-615 hsa04660 T cell receptor signaling pathway 3551_4772_4773_2534_3932_1432_207_208_1147_5595_5594_5970_3725_4790_5604_6885_2353 17 3.42E-09 2.63E-07 9.40E-09 24040 hsa-mir-615 hsa04510 Focal adhesion 595_2534_1499_3791_1956_6714_2064_207_208_4233_5595_5594_5599_5747_3725_5879_2321_3480_5159_5156_5604_2002 22 9.43E-09 7.26E-07 2.50E-08 24041 hsa-mir-615 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3551_1956_6714_1432_1147_4233_5599_5970_3725_4790_5879_5781 12 2.94E-07 2.26E-05 7.55E-07 24042 hsa-mir-615 hsa04210 Apoptosis 3556_3551_7132_1439_207_208_1147_3654_8717_5970_7157_4790_8772 13 4.26E-07 3.28E-05 1.06E-06 24043 hsa-mir-615 hsa04370 VEGF signaling pathway 4772_4773_3791_6714_1432_207_208_5595_5594_5747_5879_5604 12 6.39E-07 4.92E-05 1.54E-06 24044 hsa-mir-615 hsa05322 Systemic lupus erythematosus 3021_3020_8294_8370_121504_8361_8360_8363_8362_8365_8364_8367_8366_8368_8359 15 2.81E-06 0.000216191 6.55E-06 24045 hsa-mir-615 hsa04912 GnRH signaling pathway 818_817_5580_1956_6714_1432_5595_5594_5599_3725_5604_2185_2002 13 3.05E-06 0.000234541 6.90E-06 24046 hsa-mir-615 hsa03410 Base excision repair 3146_4350_5111_142_328_2237_252969_6996 8 4.90E-06 0.000377109 1.07E-05 24047 hsa-mir-615 hsa04664 Fc epsilon RI signaling pathway 2534_5580_6850_1432_207_208_5595_5594_5599_5879_5604 11 4.98E-06 0.00038342 1.07E-05 24048 hsa-mir-615 hsa04650 Natural killer cell mediated cytotoxicity 3454_3455_4772_4773_2534_3932_6850_5595_5594_5879_5604_3459_5781_2185 14 7.91E-06 0.000609045 1.65E-05 24049 hsa-mir-615 hsa04916 Melanogenesis 818_817_6934_1499_5595_5594_1387_4286_2033_51176_5604_3815 12 1.08E-05 0.00082779 2.18E-05 24050 hsa-mir-615 hsa04115 p53 signaling pathway 595_1017_4194_4193_4616_7157_10912_1026_7161 9 5.72E-05 0.004402273 0.000112879 24051 hsa-mir-615 hsa04930 Type II diabetes mellitus 3551_5580_5590_5595_5594_5599_3651 7 0.000143378 0.011040084 0.000276002 24052 hsa-mir-615 hsa03320 PPAR signaling pathway 5467_5468_5465_10062_6258_6257_6256_2168 8 0.000334846 0.025783166 0.000621165 24053 hsa-mir-615 hsa04360 Axon guidance 4772_4773_2534_25_2242_4233_5595_5594_5747_5879_7852 11 0.000338817 0.026088925 0.000621165 24054 hsa-mir-615 hsa04950 Maturity onset diabetes of the young 5080_6927_4760_3280_3651 5 0.000402644 0.031003589 0.000721014 24055 hsa-mir-615 hsa03450 Non-homologous end-joining 2547_10111_2237_4361 4 0.000571421 0.043999442 0.000999987 24056 hsa-mir-615 hsa04530 Tight junction 1499_5580_5590_6714_4628_207_208_4301_60412_1457 10 0.001681793 0.129498088 0.002877735 24057 hsa-mir-615 hsa04910 Insulin signaling pathway 3551_10891_5590_207_208_5595_5594_5599_5604_2002 10 0.00176872 0.136191477 0.002960684 24058 hsa-mir-615 hsa03030 DNA replication 5111_4174_4172_2237_6118 5 0.002042065 0.157238972 0.00334551 24059 hsa-mir-615 hsa04720 Long-term potentiation 818_817_5595_5594_1387_2033_5604 7 0.002303026 0.177333031 0.003694438 24060 hsa-mir-615 hsa03440 Homologous recombination 10111_4683_6118_4361 4 0.005255205 0.404650749 0.008258179 24061 hsa-mir-615 hsa04810 Regulation of actin cytoskeleton 2264_1956_4628_2249_2261_5595_5594_5747_5879_5159_5156_5604 12 0.005714375 0.44000684 0.008800137 24062 hsa-mir-615 hsa04540 Gap junction 1956_6714_5595_5594_5159_5156_5604 7 0.006907713 0.531893894 0.010429292 24063 hsa-mir-615 hsa04150 mTOR signaling pathway 3091_207_208_5595_5594 5 0.008546412 0.658073695 0.012438267 24064 hsa-mir-615 hsa04670 Leukocyte transendothelial migration 1499_1432_4301_5747_5879_7852_5781_2185 8 0.008561405 0.659228154 0.012438267 24065 hsa-mir-615 hsa05340 Primary immunodeficiency 3932_3561_3718_3575 4 0.01064472 0.819643471 0.015178583 24066 hsa-mir-615 hsa05014 Amyotrophic lateral sclerosis (ALS) 7132_7133_1432_7157_5879 5 0.011301877 0.870244495 0.015822627 24067 hsa-mir-615 hsa05016 Huntington's disease 6667_10891_5468_3066_3065_10476_1387_7157_2033_6908 10 0.013311433 1 0.01830322 24068 hsa-mir-615 hsa04740 Olfactory transduction 818_817 2 0.014204267 1 0.01918822 24069 hsa-mir-615 hsa04120 Ubiquitin mediated proteolysis 4193_57154_10401_8925_7329_5371_672_8554 8 0.017018279 1 0.022593233 24070 hsa-mir-615 hsa03430 Mismatch repair 5111_2956_6118 3 0.01929425 1 0.025180631 24071 hsa-mir-615 hsa03420 Nucleotide excision repair 5111_5886_4331_6118 4 0.021562505 1 0.027671881 24072 hsa-mir-615 hsa05217 Basal cell carcinoma 6934_1499_7157_51176 4 0.041792444 1 0.052754397 24073 hsa-mir-615 hsa04710 Circadian rhythm - mammal 4862_8553 2 0.042561177 1 0.052858236 24074 hsa-mir-615 hsa05131 Shigellosis 2534_1499_25_7534 4 0.044023106 1 0.0529653 24075 hsa-mir-615 hsa05130 Pathogenic Escherichia coli infection 2534_1499_25_7534 4 0.044023106 1 0.0529653 24076 hsa-mir-616 hsa05200 Pathways in cancer 3725_1147_7046_1499_9915_5914_595_3815_1019_1017_4193_7704_5578_6502_3091_3716_2064_3066_3065_1050_5925_4149_5743_5747_25_405_1956_6654_1487_2308_6789_613_1387_8503_4436_1870_1871_2885_596_598_2113_5894_862_5879_207_208_836_998_1026_367_2261_5595_5594_5599_6256_10401_4286_2932_6774_6777_5970_7157_6688_1869_6776_2736_4087_4088_4089_5295_5888_5728_2033_3480_4846_3910_4790_4791_4792_3320_3326_5371_675_5159_5156_5604_5601_5602_1856_4292_51588_7428_8772_4609_1029_2353_1488_2034_8554 99 1.25E-52 1.11E-50 1.11E-50 24077 hsa-mir-616 hsa04110 Cell cycle 4172_595_1019_1017_4193_902_6502_6500_4174_994_3066_3065_4616_5925_25_1387_1870_1871_9232_5934_5933_545_995_1026_5591_11200_7534_7533_7532_2932_7027_7157_10912_1869_4087_4088_4089_2033_890_1031_8454_983_2810_5347_1022_1029_1111_8556_8555_472_990 51 1.18E-33 1.05E-31 5.26E-32 24078 hsa-mir-616 hsa04010 MAPK signaling pathway 6722_3725_1147_7046_6197_6195_2264_4214_9252_7867_5578_1845_7132_994_4616_5923_4149_5536_1956_6654_3304_3305_3303_6789_1432_627_2885_5894_4763_5879_2872_207_208_836_9479_998_2261_5595_5594_5599_5598_8986_1386_3312_3315_1649_5970_3164_7157_10912_468_3727_6196_5058_4790_4791_1616_5159_9261_5156_5604_4208_5601_5602_5566_4609_2353 67 1.64E-31 1.46E-29 4.86E-30 24079 hsa-mir-616 hsa05220 Chronic myeloid leukemia 1147_7046_595_1019_4193_3066_3065_5925_25_6654_1487_613_8503_1870_1871_2885_598_5894_207_208_1026_5595_5594_6777_5970_7157_1869_6776_4088_4089_5295_4790_4792_5604_5781_4609_1029_1488_6464 39 1.78E-28 1.58E-26 3.62E-27 24080 hsa-mir-616 hsa05215 Prostate cancer 1147_1499_595_1017_4193_2064_5925_1956_6654_2308_1387_8503_1870_1871_2885_596_5894_207_208_1026_367_5595_5594_1385_2932_5970_7157_468_1869_5295_5728_10488_2033_3480_4790_4792_3320_3326_5159_5156_5604 41 2.03E-28 1.81E-26 3.62E-27 24081 hsa-mir-616 hsa05212 Pancreatic cancer 1147_1499_595_1017_4193_2064_5925_1956_6654_2308_1387_8503_1870_1871_2885_596_5894_207_208_1026_367_5595_5594_1385_2932_5970_7157_468_1869_5295_5728_10488_2033_3480_4790_4792_3320_3326_5159_5156_5604 41 2.88E-28 2.56E-26 4.26E-27 24082 hsa-mir-616 hsa05214 Glioma 818_817_595_1019_4193_5578_5925_1956_6654_8503_1870_1871_2885_5894_207_208_1026_5595_5594_7157_1869_5295_5728_3480_808_801_805_5159_5156_5604_1029_6464 32 4.80E-23 4.27E-21 6.10E-22 24083 hsa-mir-616 hsa05210 Colorectal cancer 3725_7046_1499_595_1956_6654_8503_4436_2885_596_5894_5879_207_208_836_5595_5594_5599_2932_7157_4087_4088_4089_5295_3480_5159_5156_5604_5601_5602_1856_4292_4609_2353 34 3.09E-22 2.75E-20 3.44E-21 24084 hsa-mir-616 hsa05222 Small cell lung cancer 1147_595_1019_1017_6502_5925_4149_5743_5747_8503_1870_1871_596_598_207_208_6256_10401_5970_7157_1869_5295_5728_4846_3910_4790_4792_51588_4609_8554 30 2.57E-18 2.28E-16 2.54E-17 24085 hsa-mir-616 hsa04012 ErbB signaling pathway 3725_818_817_5578_2064_5747_25_1956_6714_6654_56924_8503_2885_5894_207_208_1026_5595_5594_5599_2932_6777_6776_5295_5058_5604_5601_5602_4609_6464 30 3.34E-18 2.97E-16 2.97E-17 24086 hsa-mir-616 hsa04115 p53 signaling pathway 595_1019_1017_4194_4193_4616_50484_6241_51246_836_545_1026_11200_7249_7157_10912_900_64326_5728_27113_25898_983_2810_7161_1029_1111_472 27 1.21E-17 1.07E-15 9.76E-17 24087 hsa-mir-616 hsa05221 Acute myeloid leukemia 1147_5914_595_3815_7704_1050_6654_8503_2885_5894_862_207_208_5595_5594_6774_6777_5970_6688_6776_5295_4790_5371_5604_4609 25 4.31E-17 3.84E-15 3.20E-16 24088 hsa-mir-616 hsa05223 Non-small cell lung cancer 595_1019_5578_2064_5925_1956_6654_2309_6789_8503_1870_1871_2885_5894_207_208_5595_5594_6256_7157_1869_5295_5604_1029 24 7.76E-17 6.91E-15 5.31E-16 24089 hsa-mir-616 hsa04510 Focal adhesion 3725_1499_595_5578_2064_5923_2534_5747_3791_1956_6714_6654_56924_5499_8503_2885_596_5894_5879_207_208_998_5595_5594_5599_2932_5295_5058_5728_3480_3910_2321_9564_5159_5156_5604_5601_5602_857_6464 40 2.93E-16 2.60E-14 1.86E-15 24090 hsa-mir-616 hsa04660 T cell receptor signaling pathway 3725_1147_1019_5777_2534_3932_6654_56924_1432_8503_2885_5894_207_208_998_5595_5594_920_2932_5970_5295_5058_959_4790_4792_5604_5601_915_2353 29 4.52E-15 4.03E-13 2.68E-14 24091 hsa-mir-616 hsa04310 Wnt signaling pathway 3725_818_817_1499_595_5578_6500_1487_1387_5879_1460_5599_1459_2932_7157_6423_1457_1452_4087_4088_4089_2033_5518_5515_8454_5601_5602_5566_1856_4609_1488_5527_8061 33 7.48E-15 6.66E-13 4.16E-14 24092 hsa-mir-616 hsa04350 TGF-beta signaling pathway 6667_7046_6500_90_1875_1387_3397_3399_3398_1874_57154_5934_5933_3400_5595_5594_7027_4087_4088_4089_2033_5518_5515_8454_4609_4093 26 9.83E-15 8.75E-13 5.15E-14 24093 hsa-mir-616 hsa05218 Melanoma 595_1019_4193_5925_1956_8503_1870_1871_5894_207_208_1026_5595_5594_4286_7157_1869_5295_5728_3480_5159_5156_5604_1029 24 1.10E-14 9.80E-13 5.44E-14 24094 hsa-mir-616 hsa05211 Renal cell carcinoma 3725_9915_3091_405_6654_56924_1387_8503_2885_2113_5894_5879_207_208_998_5595_5594_5295_5058_2033_5604_7428_5781_2034 24 1.42E-14 1.26E-12 6.65E-14 24095 hsa-mir-616 hsa05219 Bladder cancer 595_1019_9252_4193_2064_5925_1956_1870_1871_5894_1026_2261_5595_5594_7157_1869_5604_4609_1029 19 9.99E-14 8.89E-12 4.45E-13 24096 hsa-mir-616 hsa05213 Endometrial cancer 1499_595_2064_1956_6654_2309_8503_2885_5894_207_208_5595_5594_2932_7157_5295_5728_5604_4292_4609 20 2.55E-13 2.27E-11 1.08E-12 24097 hsa-mir-616 hsa04630 Jak-STAT signaling pathway 595_5777_58985_3455_3716_3560_3561_6654_1387_1439_8503_2885_598_207_208_3717_10401_6774_6777_6773_7297_6776_5295_2033_3460_51588_3459_10379_5781_4609_8554 31 3.27E-13 2.91E-11 1.32E-12 24098 hsa-mir-616 hsa04062 Chemokine signaling pathway 1147_1234_7074_5747_5580_6654_2309_8503_2885_6362_5894_5879_207_208_3717_998_5595_5594_2932_6774_6777_6773_5970_5295_5058_4790_4792_1230_9564_2770_5604_5566_7852_6464 34 5.71E-13 5.08E-11 2.21E-12 24099 hsa-mir-616 hsa04910 Insulin signaling pathway 10891_6720_5770_6654_5499_2308_8503_2885_5894_2872_207_208_5595_5594_5599_23265_7249_2932_5295_808_801_805_5604_5601_5602_5566_5563_6464 28 3.36E-12 2.99E-10 1.25E-11 24100 hsa-mir-616 hsa04912 GnRH signaling pathway 3725_818_817_4214_5578_5580_1956_6714_6654_1432_2885_5894_998_5595_5594_5599_5598_468_808_801_805_5604_5601_5602_5566 25 4.06E-12 3.62E-10 1.45E-11 24101 hsa-mir-616 hsa04662 B cell receptor signaling pathway 3725_1147_5777_6654_6850_8503_2885_5894_5879_207_208_5595_5594_1380_2932_5970_5295_4790_4792_5604_2353 21 1.02E-11 9.06E-10 3.49E-11 24102 hsa-mir-616 hsa04520 Adherens junction 7046_1499_5770_5777_2064_2534_1956_6714_1387_5879_1460_998_5595_5594_1459_1457_4087_4088_4089_2033_3480 21 2.85E-11 2.54E-09 9.39E-11 24103 hsa-mir-616 hsa04540 Gap junction 5592_5578_51807_1956_6714_6654_2885_5894_5595_5594_5598_1453_7846_5159_2770_983_5156_5604_5566_7277_7278_10376 22 5.47E-11 4.87E-09 1.74E-10 24104 hsa-mir-616 hsa04920 Adipocytokine signaling pathway 1147_10891_6794_7132_8717_207_208_3717_5599_6256_6774_5970_4790_4792_5601_5602_5563_5781_7133 19 8.15E-11 7.25E-09 2.50E-10 24105 hsa-mir-616 hsa04370 VEGF signaling pathway 7867_5578_5743_5747_3791_6714_1432_8503_5894_5879_207_208_998_5595_5594_3315_5295_4846_9261_5604 20 9.88E-11 8.79E-09 2.93E-10 24106 hsa-mir-616 hsa04720 Long-term potentiation 818_817_6197_6195_5578_2902_5499_1387_5894_5595_5594_468_6196_2033_808_801_805_5604_5566 19 4.15E-10 3.69E-08 1.19E-09 24107 hsa-mir-616 hsa04664 Fc epsilon RI signaling pathway 5578_2534_5580_6654_6850_1432_8503_2885_5894_5879_207_208_5595_5594_5599_5295_5604_5601_5602 19 8.76E-10 7.79E-08 2.38E-09 24108 hsa-mir-616 hsa04210 Apoptosis 1147_7132_8717_840_823_1439_8503_596_598_207_208_836_5970_7157_5295_4790_4792_5566_8772_472 20 8.83E-10 7.85E-08 2.38E-09 24109 hsa-mir-616 hsa04916 Melanogenesis 818_817_1499_3815_5578_1387_5894_5595_5594_1385_4286_2932_10488_2033_808_801_805_2770_5604_5566_1856 21 1.81E-09 1.61E-07 4.74E-09 24110 hsa-mir-616 hsa04620 Toll-like receptor signaling pathway 3725_1147_3455_1432_8503_5879_207_208_5595_5594_5599_5970_5295_4790_4792_5604_5601_5602_8772_2353 20 6.79E-09 6.05E-07 1.73E-08 24111 hsa-mir-616 hsa04120 Ubiquitin mediated proteolysis 55294_4214_4193_6502_6500_3093_7319_84447_10273_57154_10055_10401_64326_7337_5371_672_25898_8454_51588_7428_7329_10075_8554 23 8.99E-09 8.00E-07 2.22E-08 24112 hsa-mir-616 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1147_1956_6714_1432_5879_836_998_5599_5970_5058_4790_4792_5601_5602_5781 16 4.08E-08 3.63E-06 9.81E-08 24113 hsa-mir-616 hsa03022 Basal transcription factors 51616_6881_2957_2965_2963_2962_2969_6874_6908_2958_2959_6880 12 7.30E-08 6.50E-06 1.71E-07 24114 hsa-mir-616 hsa04650 Natural killer cell mediated cytotoxicity 5777_5578_3455_2534_3932_6654_6850_8503_2885_5894_5879_836_5595_5594_5295_5058_5604_3460_3459_5781_6464 21 1.40E-07 1.24E-05 3.19E-07 24115 hsa-mir-616 hsa04150 mTOR signaling pathway 6794_6197_6195_3091_8503_207_208_5595_5594_7249_6196_5295_5563 13 2.72E-07 2.42E-05 6.06E-07 24116 hsa-mir-616 hsa05131 Shigellosis 1499_5578_51807_2534_25_998_7534_7846_7277_7278_4691_10376 12 3.16E-06 0.000281187 6.69E-06 24117 hsa-mir-616 hsa05130 Pathogenic Escherichia coli infection 1499_5578_51807_2534_25_998_7534_7846_7277_7278_4691_10376 12 3.16E-06 0.000281187 6.69E-06 24118 hsa-mir-616 hsa04330 Notch signaling pathway 3066_3065_1487_1387_9612_2033_8850_2648_1856_388585_1488 11 3.90E-06 0.00034685 8.07E-06 24119 hsa-mir-616 hsa04612 Antigen processing and presentation 811_6890_3309_3304_3305_3303_920_1385_3312_3320_3326_4800_4801_4802 14 1.18E-05 0.001051848 2.39E-05 24120 hsa-mir-616 hsa05014 Amyotrophic lateral sclerosis (ALS) 7132_2902_1432_596_598_5879_836_7157_4846_1616_7133 11 1.66E-05 0.00147659 3.28E-05 24121 hsa-mir-616 hsa05216 Thyroid cancer 1499_595_5595_5594_6256_7157_5604_4609 8 3.02E-05 0.002686787 5.84E-05 24122 hsa-mir-616 hsa04530 Tight junction 1499_1019_5578_5580_6714_207_208_1460_998_1459_1457_5728_5518_5515_2770_5520 16 7.95E-05 0.007074902 0.00015053 24123 hsa-mir-616 hsa04930 Type II diabetes mellitus 5580_8503_3651_5595_5594_5599_5295_5601_5602 9 8.57E-05 0.007628532 0.000158928 24124 hsa-mir-616 hsa05016 Huntington's disease 6667_10891_291_3066_3065_3064_25942_2902_1387_627_836_1385_7157_5481_10488_2033_27113_6874_6908 19 0.000105748 0.009411531 0.000192072 24125 hsa-mir-616 hsa04730 Long-term depression 5592_5578_5894_5595_5594_3480_4846_5518_5515_2770_5604 11 0.000113164 0.010071636 0.000201433 24126 hsa-mir-616 hsa04060 Cytokine-cytokine receptor interaction 7046_3815_1234_7132_58985_3455_90_8764_3791_1956_3560_3561_1439_6362_959_2321_1230_5159_5156_3460_7852_3459_7133 23 0.000195122 0.017365898 0.000340508 24127 hsa-mir-616 hsa04810 Regulation of actin cytoskeleton 2264_7074_5747_1956_6654_56924_5499_8503_5894_5879_998_2261_5595_5594_5295_5058_9564_5159_5156_5604 20 0.000246258 0.021916934 0.00042148 24128 hsa-mir-616 hsa03420 Nucleotide excision repair 5981_902_6117_2965_4331_2071_2074_1022 8 0.000373208 0.033215525 0.000626708 24129 hsa-mir-616 hsa04950 Maturity onset diabetes of the young 6927_4760_3651_168620_3172_3175 6 0.000475909 0.042355879 0.000784368 24130 hsa-mir-616 hsa04360 Axon guidance 2534_5747_25_56924_5879_998_5595_5594_2932_5058_5998_2770_7852_1020 14 0.000495402 0.044090785 0.000801651 24131 hsa-mir-616 hsa05340 Primary immunodeficiency 100_6890_3932_3561_920_959_915 7 0.000523865 0.046623964 0.000832571 24132 hsa-mir-616 hsa04270 Vascular smooth muscle contraction 5592_5578_5580_147_5499_5894_5595_5594_808_801_805_5604_5566 13 0.0005987 0.053284299 0.000934812 24133 hsa-mir-616 hsa05010 Alzheimer's disease 7132_840_3416_823_2902_836_22926_5595_5594_2932_4846_808_801_805_8772_1020 16 0.001090029 0.097012586 0.001672631 24134 hsa-mir-616 hsa04670 Leukocyte transendothelial migration 1499_5578_5747_1432_8503_5879_998_5295_9564_2770_7852_5781 12 0.002316323 0.206152717 0.003494114 24135 hsa-mir-616 hsa04020 Calcium signaling pathway 818_817_291_5578_2064_1956_2902_147_5481_4846_808_801_805_5159_5156_5566 16 0.002475203 0.220293101 0.003671552 24136 hsa-mir-616 hsa03030 DNA replication 5981_4172_4174_6117_5422_5557 6 0.002963091 0.263715068 0.004253469 24137 hsa-mir-616 hsa03410 Base excision repair 3146_4350_142_4913_328_6996 6 0.002963091 0.263715068 0.004253469 24138 hsa-mir-616 hsa03430 Mismatch repair 5981_4436_6117_4292 4 0.012975726 1 0.018330788 24139 hsa-mir-616 hsa04710 Circadian rhythm - mammal 8863_406_1453 3 0.016229349 1 0.022568938 24140 hsa-mir-616 hsa03440 Homologous recombination 641_6117_5888_675 4 0.023239756 1 0.031820589 24141 hsa-mir-616 hsa04070 Phosphatidylinositol signaling system 5578_8503_5295_5728_808_801_805 7 0.024128754 1 0.032537259 24142 hsa-mir-617 hsa05200 Pathways in cancer 3725_2249_1499_5914_1387_6256_1019_367_1017_6776_5970_6688_4609_1026_2353_6777_5925_2033_8554 19 1.68E-17 9.39E-16 9.39E-16 24143 hsa-mir-617 hsa05215 Prostate cancer 1499_1387_367_1017_5970_468_1026_5925_2033 9 5.96E-11 3.34E-09 1.22E-09 24144 hsa-mir-617 hsa05212 Pancreatic cancer 1499_1387_367_1017_5970_468_1026_5925_2033 9 6.55E-11 3.67E-09 1.22E-09 24145 hsa-mir-617 hsa05220 Chronic myeloid leukemia 1019_6776_5970_4609_1026_6777_5925 7 1.57E-08 8.81E-07 1.78E-07 24146 hsa-mir-617 hsa04110 Cell cycle 1387_1019_1017_7027_1026_5925_2033_5933 8 1.59E-08 8.90E-07 1.78E-07 24147 hsa-mir-617 hsa05222 Small cell lung cancer 6256_1019_1017_5970_4609_5925_8554 7 3.80E-08 2.13E-06 3.27E-07 24148 hsa-mir-617 hsa04350 TGF-beta signaling pathway 1387_7027_1874_4609_2033_6667_5933 7 4.09E-08 2.29E-06 3.27E-07 24149 hsa-mir-617 hsa05221 Acute myeloid leukemia 5914_6776_5970_6688_4609_6777 6 1.09E-07 6.10E-06 7.62E-07 24150 hsa-mir-617 hsa04630 Jak-STAT signaling pathway 1387_6776_4609_6777_2033_3977_8554 7 1.68E-06 9.40E-05 1.04E-05 24151 hsa-mir-617 hsa04010 MAPK signaling pathway 3725_2249_1386_5970_468_4609_2353_1649 8 6.65E-06 0.000372403 3.72E-05 24152 hsa-mir-617 hsa04012 ErbB signaling pathway 3725_6776_4609_1026_6777 5 1.81E-05 0.001014774 9.23E-05 24153 hsa-mir-617 hsa05219 Bladder cancer 1019_4609_1026_5925 4 2.04E-05 0.00114056 9.50E-05 24154 hsa-mir-617 hsa04950 Maturity onset diabetes of the young 3651_5080_6927 3 0.000113458 0.006353641 0.000488742 24155 hsa-mir-617 hsa05218 Melanoma 2249_1019_1026_5925 4 0.000140378 0.007861159 0.000561511 24156 hsa-mir-617 hsa05216 Thyroid cancer 1499_6256_4609 3 0.00018997 0.010638339 0.000709223 24157 hsa-mir-617 hsa04310 Wnt signaling pathway 3725_1499_1387_4609_2033 5 0.00022964 0.012859867 0.000803742 24158 hsa-mir-617 hsa05210 Colorectal cancer 3725_1499_4609_2353 4 0.000260134 0.014567483 0.000856911 24159 hsa-mir-617 hsa05016 Huntington's disease 1387_6908_10476_2033_6667 5 0.000591087 0.033100884 0.001838938 24160 hsa-mir-617 hsa04660 T cell receptor signaling pathway 3725_1019_5970_2353 4 0.00069456 0.03889535 0.00200833 24161 hsa-mir-617 hsa04330 Notch signaling pathway 1387_9612_2033 3 0.000717261 0.040166594 0.00200833 24162 hsa-mir-617 hsa05223 Non-small cell lung cancer 6256_1019_5925 3 0.001052001 0.058912052 0.002805336 24163 hsa-mir-617 hsa04530 Tight junction 1499_1019_4628_60412 4 0.001528464 0.085593995 0.003890636 24164 hsa-mir-617 hsa05214 Glioma 1019_1026_5925 3 0.001752538 0.098142126 0.004267049 24165 hsa-mir-617 hsa04115 p53 signaling pathway 1019_1017_1026 3 0.002064674 0.115621765 0.004817574 24166 hsa-mir-617 hsa05211 Renal cell carcinoma 3725_1387_2033 3 0.002320051 0.129922835 0.005196913 24167 hsa-mir-617 hsa04720 Long-term potentiation 1387_468_2033 3 0.002594185 0.145274372 0.005380532 24168 hsa-mir-617 hsa04662 B cell receptor signaling pathway 3725_5970_2353 3 0.002594185 0.145274372 0.005380532 24169 hsa-mir-617 hsa04520 Adherens junction 1499_1387_2033 3 0.003093973 0.173262465 0.006187945 24170 hsa-mir-617 hsa04620 Toll-like receptor signaling pathway 3725_5970_2353 3 0.005973302 0.334504912 0.011534652 24171 hsa-mir-617 hsa04916 Melanogenesis 1499_1387_2033 3 0.006292992 0.352407575 0.011746919 24172 hsa-mir-617 hsa03420 Nucleotide excision repair 5981_4331 2 0.011285191 0.631970716 0.020386152 24173 hsa-mir-617 hsa05213 Endometrial cancer 1499_4609 2 0.015324059 0.858147301 0.026817103 24174 hsa-mir-617 hsa04920 Adipocytokine signaling pathway 6256_5970 2 0.024289515 1 0.041218571 24175 hsa-mir-617 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5970 2 0.02696631 1 0.044415099 24176 hsa-mir-618 hsa05200 Pathways in cancer 3725_2249_1499_5914_1387_6256_1019_367_1017_6776_5970_6688_4609_1026_2353_6777_5925_2033_8554 19 1.68E-17 9.39E-16 9.39E-16 24177 hsa-mir-618 hsa05215 Prostate cancer 1499_1387_367_1017_5970_468_1026_5925_2033 9 5.96E-11 3.34E-09 1.22E-09 24178 hsa-mir-618 hsa05212 Pancreatic cancer 1499_1387_367_1017_5970_468_1026_5925_2033 9 6.55E-11 3.67E-09 1.22E-09 24179 hsa-mir-618 hsa05220 Chronic myeloid leukemia 1019_6776_5970_4609_1026_6777_5925 7 1.57E-08 8.81E-07 1.78E-07 24180 hsa-mir-618 hsa04110 Cell cycle 1387_1019_1017_7027_1026_5925_2033_5933 8 1.59E-08 8.90E-07 1.78E-07 24181 hsa-mir-618 hsa05222 Small cell lung cancer 6256_1019_1017_5970_4609_5925_8554 7 3.80E-08 2.13E-06 3.27E-07 24182 hsa-mir-618 hsa04350 TGF-beta signaling pathway 1387_7027_1874_4609_2033_6667_5933 7 4.09E-08 2.29E-06 3.27E-07 24183 hsa-mir-618 hsa05221 Acute myeloid leukemia 5914_6776_5970_6688_4609_6777 6 1.09E-07 6.10E-06 7.62E-07 24184 hsa-mir-618 hsa04630 Jak-STAT signaling pathway 1387_6776_4609_6777_2033_3977_8554 7 1.68E-06 9.40E-05 1.04E-05 24185 hsa-mir-618 hsa04010 MAPK signaling pathway 3725_2249_1386_5970_468_4609_2353_1649 8 6.65E-06 0.000372403 3.72E-05 24186 hsa-mir-618 hsa04012 ErbB signaling pathway 3725_6776_4609_1026_6777 5 1.81E-05 0.001014774 9.23E-05 24187 hsa-mir-618 hsa05219 Bladder cancer 1019_4609_1026_5925 4 2.04E-05 0.00114056 9.50E-05 24188 hsa-mir-618 hsa04950 Maturity onset diabetes of the young 3651_5080_6927 3 0.000113458 0.006353641 0.000488742 24189 hsa-mir-618 hsa05218 Melanoma 2249_1019_1026_5925 4 0.000140378 0.007861159 0.000561511 24190 hsa-mir-618 hsa05216 Thyroid cancer 1499_6256_4609 3 0.00018997 0.010638339 0.000709223 24191 hsa-mir-618 hsa04310 Wnt signaling pathway 3725_1499_1387_4609_2033 5 0.00022964 0.012859867 0.000803742 24192 hsa-mir-618 hsa05210 Colorectal cancer 3725_1499_4609_2353 4 0.000260134 0.014567483 0.000856911 24193 hsa-mir-618 hsa05016 Huntington's disease 1387_6908_10476_2033_6667 5 0.000591087 0.033100884 0.001838938 24194 hsa-mir-618 hsa04660 T cell receptor signaling pathway 3725_1019_5970_2353 4 0.00069456 0.03889535 0.00200833 24195 hsa-mir-618 hsa04330 Notch signaling pathway 1387_9612_2033 3 0.000717261 0.040166594 0.00200833 24196 hsa-mir-618 hsa05223 Non-small cell lung cancer 6256_1019_5925 3 0.001052001 0.058912052 0.002805336 24197 hsa-mir-618 hsa04530 Tight junction 1499_1019_4628_60412 4 0.001528464 0.085593995 0.003890636 24198 hsa-mir-618 hsa05214 Glioma 1019_1026_5925 3 0.001752538 0.098142126 0.004267049 24199 hsa-mir-618 hsa04115 p53 signaling pathway 1019_1017_1026 3 0.002064674 0.115621765 0.004817574 24200 hsa-mir-618 hsa05211 Renal cell carcinoma 3725_1387_2033 3 0.002320051 0.129922835 0.005196913 24201 hsa-mir-618 hsa04720 Long-term potentiation 1387_468_2033 3 0.002594185 0.145274372 0.005380532 24202 hsa-mir-618 hsa04662 B cell receptor signaling pathway 3725_5970_2353 3 0.002594185 0.145274372 0.005380532 24203 hsa-mir-618 hsa04520 Adherens junction 1499_1387_2033 3 0.003093973 0.173262465 0.006187945 24204 hsa-mir-618 hsa04620 Toll-like receptor signaling pathway 3725_5970_2353 3 0.005973302 0.334504912 0.011534652 24205 hsa-mir-618 hsa04916 Melanogenesis 1499_1387_2033 3 0.006292992 0.352407575 0.011746919 24206 hsa-mir-618 hsa03420 Nucleotide excision repair 5981_4331 2 0.011285191 0.631970716 0.020386152 24207 hsa-mir-618 hsa05213 Endometrial cancer 1499_4609 2 0.015324059 0.858147301 0.026817103 24208 hsa-mir-618 hsa04920 Adipocytokine signaling pathway 6256_5970 2 0.024289515 1 0.041218571 24209 hsa-mir-618 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5970 2 0.02696631 1 0.044415099 24210 hsa-mir-624 hsa05200 Pathways in cancer 5371_5595_5594_5914_1387_6256_595_836_367_2932_3091_5970_7428_1870_1871_7157_4087_2113_7704_4609_1869_3725_3066_2736_4088_4089_3065_5925_2034_2033_4846_207 32 2.65E-30 1.75E-28 1.75E-28 24211 hsa-mir-624 hsa05220 Chronic myeloid leukemia 5595_5594_595_5970_1870_1871_7157_4609_1869_3066_4088_4089_3065_5925_207_6464 16 1.62E-20 1.07E-18 5.36E-19 24212 hsa-mir-624 hsa04110 Cell cycle 5591_1387_595_2932_1870_1871_7157_4087_1869_3066_4088_4089_3065_5925_2033_5933 16 1.19E-17 7.86E-16 2.62E-16 24213 hsa-mir-624 hsa05215 Prostate cancer 5595_5594_1387_595_367_2932_5970_1870_1871_7157_1869_5925_2033_207 14 1.66E-16 1.09E-14 2.52E-15 24214 hsa-mir-624 hsa05212 Pancreatic cancer 5595_5594_1387_595_367_2932_5970_1870_1871_7157_1869_5925_2033_207 14 1.91E-16 1.26E-14 2.52E-15 24215 hsa-mir-624 hsa04010 MAPK signaling pathway 6722_8986_5595_5594_9261_4208_836_9252_1432_5970_3312_7157_4609_3725_6195_6196_6197_4763_207 19 7.80E-16 5.15E-14 8.58E-15 24216 hsa-mir-624 hsa05210 Colorectal cancer 5595_5594_595_836_2932_7157_4087_4609_3725_4088_4089_207 12 8.14E-14 5.37E-12 7.68E-13 24217 hsa-mir-624 hsa05219 Bladder cancer 5595_5594_595_9252_1870_1871_7157_4609_1869_5925 10 1.11E-13 7.31E-12 9.13E-13 24218 hsa-mir-624 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925_207 10 1.01E-12 6.64E-11 7.38E-12 24219 hsa-mir-624 hsa05222 Small cell lung cancer 6256_595_5970_1870_1871_7157_4609_1869_5925_4846_207 11 2.73E-12 1.80E-10 1.80E-11 24220 hsa-mir-624 hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_207_6464 10 5.25E-12 3.47E-10 3.15E-11 24221 hsa-mir-624 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2113_3725_2034_2033_207 10 1.32E-11 8.68E-10 7.23E-11 24222 hsa-mir-624 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_5970_7704_4609_207 9 6.71E-11 4.43E-09 3.41E-10 24223 hsa-mir-624 hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5925_207 9 3.00E-10 1.98E-08 1.41E-09 24224 hsa-mir-624 hsa04310 Wnt signaling pathway 1387_595_1457_2932_7157_4087_4609_3725_4088_4089_2033 11 7.90E-10 5.21E-08 3.47E-09 24225 hsa-mir-624 hsa04350 TGF-beta signaling pathway 5595_5594_1387_4087_4609_4088_4089_2033_5933 9 1.57E-09 1.03E-07 6.46E-09 24226 hsa-mir-624 hsa04720 Long-term potentiation 5595_5594_1387_2902_6195_6196_6197_2033 8 1.04E-08 6.90E-07 4.06E-08 24227 hsa-mir-624 hsa04520 Adherens junction 5595_5594_1387_1457_4087_4088_4089_2033 8 1.67E-08 1.10E-06 6.11E-08 24228 hsa-mir-624 hsa05213 Endometrial cancer 5595_5594_595_2932_7157_4609_207 7 2.06E-08 1.36E-06 6.81E-08 24229 hsa-mir-624 hsa04150 mTOR signaling pathway 5595_5594_3091_6195_6196_6197_207 7 2.06E-08 1.36E-06 6.81E-08 24230 hsa-mir-624 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 2.22E-08 1.47E-06 6.99E-08 24231 hsa-mir-624 hsa04012 ErbB signaling pathway 5595_5594_2932_4609_3725_207_6464 7 5.34E-07 3.52E-05 1.60E-06 24232 hsa-mir-624 hsa05016 Huntington's disease 6874_1387_2902_836_7157_3066_3065_3064_2033 9 8.00E-07 5.28E-05 2.30E-06 24233 hsa-mir-624 hsa04660 T cell receptor signaling pathway 5595_5594_2932_1432_5970_3725_207 7 2.35E-06 0.000154848 6.45E-06 24234 hsa-mir-624 hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_3725_207 6 3.67E-06 0.000242092 9.68E-06 24235 hsa-mir-624 hsa04370 VEGF signaling pathway 5595_5594_9261_1432_4846_207 6 4.23E-06 0.000279221 1.07E-05 24236 hsa-mir-624 hsa04330 Notch signaling pathway 1387_3066_9612_3065_2033 5 6.75E-06 0.000445784 1.65E-05 24237 hsa-mir-624 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_1432_7157_4846 5 1.49E-05 0.000983631 3.51E-05 24238 hsa-mir-624 hsa04620 Toll-like receptor signaling pathway 5595_5594_1432_5970_3725_207 6 1.93E-05 0.001275588 4.40E-05 24239 hsa-mir-624 hsa04910 Insulin signaling pathway 5595_5594_6720_2932_207_6464 6 9.69E-05 0.006395887 0.000213196 24240 hsa-mir-624 hsa04510 Focal adhesion 5595_5594_595_2932_3725_207_6464 7 0.00011273 0.007440212 0.000240007 24241 hsa-mir-624 hsa04916 Melanogenesis 5595_5594_1387_2932_2033 5 0.000240748 0.0158894 0.000496544 24242 hsa-mir-624 hsa05010 Alzheimer's disease 5595_5594_2902_836_2932_4846 6 0.000355256 0.023446875 0.000710511 24243 hsa-mir-624 hsa04062 Chemokine signaling pathway 5595_5594_2932_5970_207_6464 6 0.000553508 0.036531556 0.001073492 24244 hsa-mir-624 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_1432_5970_3725 4 0.000585541 0.038645725 0.001073492 24245 hsa-mir-624 hsa04730 Long-term depression 5592_5595_5594_4846 4 0.000585541 0.038645725 0.001073492 24246 hsa-mir-624 hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432_207 4 0.000857946 0.056624462 0.001530391 24247 hsa-mir-624 hsa04210 Apoptosis 836_5970_7157_207 4 0.001310845 0.086515763 0.002276731 24248 hsa-mir-624 hsa04630 Jak-STAT signaling pathway 1387_595_4609_2033_207 5 0.001375211 0.090763948 0.002327281 24249 hsa-mir-624 hsa04930 Type II diabetes mellitus 3651_5595_5594 3 0.001874197 0.123696999 0.003092425 24250 hsa-mir-624 hsa04912 GnRH signaling pathway 5595_5594_1432_3725 4 0.002589024 0.170875551 0.004167696 24251 hsa-mir-624 hsa05217 Basal cell carcinoma 2932_7157_2736 3 0.003222243 0.212668017 0.005063524 24252 hsa-mir-624 hsa04920 Adipocytokine signaling pathway 6256_5970_207 3 0.005469064 0.360958253 0.008394378 24253 hsa-mir-624 hsa04115 p53 signaling pathway 595_836_7157 3 0.00591493 0.390385353 0.00883244 24254 hsa-mir-624 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_6464 4 0.006022118 0.397459803 0.00883244 24255 hsa-mir-624 hsa04612 Antigen processing and presentation 4800_3312_4801 3 0.011573258 0.763835025 0.016605109 24256 hsa-mir-624 hsa04540 Gap junction 5592_5595_5594 3 0.01297628 0.856434501 0.018222011 24257 hsa-mir-624 hsa03022 Basal transcription factors 2963_6874 2 0.016763015 1 0.023049145 24258 hsa-mir-624 hsa04270 Vascular smooth muscle contraction 5592_5595_5594 3 0.023875882 1 0.032159351 24259 hsa-mir-624 hsa04360 Axon guidance 5595_5594_2932 3 0.031009471 1 0.040932502 24260 hsa-mir-624 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428 3 0.035894672 1 0.046006482 24261 hsa-mir-624 hsa04340 Hedgehog signaling pathway 2932_2736 2 0.036247531 1 0.046006482 24262 hsa-mir-624 hsa04080 Neuroactive ligand-receptor interaction 2902_2908_7068_7067 4 0.043862996 1 0.054621844 24263 hsa-mir-625 hsa05200 Pathways in cancer 5159_4088_4089_867_5156_5881_1050_3815_2033_1399_1398_367_2113_207_2932_1499_5594_5914_6774_6772_1956_2353_1387_6776 24 1.65E-27 1.00E-25 1.00E-25 24264 hsa-mir-625 hsa04630 Jak-STAT signaling pathway 3717_867_2057_3575_3559_2033_5781_207_5777_3560_6774_6772_1387_6776_2690 15 4.03E-19 2.46E-17 1.23E-17 24265 hsa-mir-625 hsa04520 Adherens junction 4088_4089_5881_5770_2033_1499_6714_3643_5777_5594_1956_1387 12 1.38E-17 8.41E-16 2.80E-16 24266 hsa-mir-625 hsa04012 ErbB signaling pathway 867_5058_1399_1398_207_2932_6714_5594_6464_1956_6776_2066 12 3.46E-17 2.11E-15 5.28E-16 24267 hsa-mir-625 hsa05210 Colorectal cancer 5159_4088_4089_5156_5881_207_2932_1499_5594_1956_2353 11 1.30E-15 7.93E-14 1.59E-14 24268 hsa-mir-625 hsa04510 Focal adhesion 5159_5156_5881_5058_1399_1398_207_2932_1499_6714_5594_6464_1956 13 1.95E-14 1.19E-12 1.98E-13 24269 hsa-mir-625 hsa05220 Chronic myeloid leukemia 4088_4089_867_5781_1399_1398_207_5594_6464_6776 10 2.31E-14 1.41E-12 2.01E-13 24270 hsa-mir-625 hsa05215 Prostate cancer 5159_5156_2033_367_207_2932_1499_5594_1956_1387 10 1.01E-13 6.14E-12 7.57E-13 24271 hsa-mir-625 hsa05212 Pancreatic cancer 5159_5156_2033_367_207_2932_1499_5594_1956_1387 10 1.12E-13 6.81E-12 7.57E-13 24272 hsa-mir-625 hsa05211 Renal cell carcinoma 5058_2033_5781_1399_1398_2113_207_5594_1387 9 8.32E-13 5.08E-11 5.08E-12 24273 hsa-mir-625 hsa04062 Chemokine signaling pathway 3717_7852_5058_1399_1398_207_2932_5594_6774_6464_6772 11 6.43E-12 3.92E-10 3.35E-11 24274 hsa-mir-625 hsa04910 Insulin signaling pathway 867_5770_1399_1398_207_2932_3643_5594_6464_2538 10 6.59E-12 4.02E-10 3.35E-11 24275 hsa-mir-625 hsa04660 T cell receptor signaling pathway 919_867_5058_207_2932_1493_5777_5594_2353 9 2.85E-11 1.74E-09 1.34E-10 24276 hsa-mir-625 hsa05221 Acute myeloid leukemia 1050_3815_207_5594_5914_6774_6776 7 4.52E-10 2.75E-08 1.97E-09 24277 hsa-mir-625 hsa04060 Cytokine-cytokine receptor interaction 5159_5156_7852_2057_3575_3815_3559_3560_1956_2690 10 2.58E-09 1.57E-07 1.05E-08 24278 hsa-mir-625 hsa04010 MAPK signaling pathway 5159_5156_5881_5058_1399_1398_207_5594_1956_2353 10 3.77E-09 2.30E-07 1.44E-08 24279 hsa-mir-625 hsa04310 Wnt signaling pathway 4088_4089_5881_2033_2932_1499_5515_1387 8 1.02E-08 6.21E-07 3.65E-08 24280 hsa-mir-625 hsa05214 Glioma 5159_5156_207_5594_6464_1956 6 3.38E-08 2.06E-06 1.15E-07 24281 hsa-mir-625 hsa04110 Cell cycle 4088_4089_2033_7532_2932_7534_1387 7 4.32E-08 2.63E-06 1.39E-07 24282 hsa-mir-625 hsa04662 B cell receptor signaling pathway 5881_207_2932_5777_5594_2353 6 7.51E-08 4.58E-06 2.29E-07 24283 hsa-mir-625 hsa04650 Natural killer cell mediated cytotoxicity 919_5881_5058_5781_5777_5594_6464 7 1.13E-07 6.92E-06 3.29E-07 24284 hsa-mir-625 hsa04810 Regulation of actin cytoskeleton 5159_5156_5881_5058_1399_1398_5594_1956 8 1.53E-07 9.34E-06 4.24E-07 24285 hsa-mir-625 hsa04350 TGF-beta signaling pathway 4088_4089_2033_5594_5515_1387 6 1.72E-07 1.05E-05 4.56E-07 24286 hsa-mir-625 hsa05213 Endometrial cancer 207_2932_1499_5594_1956 5 4.14E-07 2.52E-05 1.05E-06 24287 hsa-mir-625 hsa04916 Melanogenesis 3815_2033_2932_1499_5594_1387 6 4.66E-07 2.84E-05 1.14E-06 24288 hsa-mir-625 hsa04920 Adipocytokine signaling pathway 3717_5781_207_6774_2538 5 1.34E-06 8.17E-05 3.14E-06 24289 hsa-mir-625 hsa05218 Melanoma 5159_5156_207_5594_1956 5 1.75E-06 0.000107054 3.96E-06 24290 hsa-mir-625 hsa04540 Gap junction 5159_5156_6714_5594_1956 5 6.17E-06 0.000376183 1.34E-05 24291 hsa-mir-625 hsa04330 Notch signaling pathway 9612_2033_8850_1387 4 1.00E-05 0.000611569 2.11E-05 24292 hsa-mir-625 hsa04360 Axon guidance 7852_5881_5058_2932_5594 5 3.02E-05 0.001844711 6.15E-05 24293 hsa-mir-625 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5058_5781_6714_1956 4 4.65E-05 0.002835768 9.15E-05 24294 hsa-mir-625 hsa04370 VEGF signaling pathway 5881_207_6714_5594 4 6.29E-05 0.003835636 0.000119864 24295 hsa-mir-625 hsa04640 Hematopoietic cell lineage 2057_3575_3815_3559 4 9.90E-05 0.00604039 0.000183042 24296 hsa-mir-625 hsa04620 Toll-like receptor signaling pathway 207_5594_6772_2353 4 0.000178651 0.010897717 0.000320521 24297 hsa-mir-625 hsa05223 Non-small cell lung cancer 207_5594_1956 3 0.00046065 0.028099652 0.000802847 24298 hsa-mir-625 hsa04530 Tight junction 207_1499_6714_5515 4 0.000529343 0.032289908 0.000896942 24299 hsa-mir-625 hsa04720 Long-term potentiation 2033_5594_1387 3 0.001151216 0.070224167 0.00189795 24300 hsa-mir-625 hsa04664 Fc epsilon RI signaling pathway 5881_207_5594 3 0.001330078 0.081134769 0.002135126 24301 hsa-mir-625 hsa04020 Calcium signaling pathway 5159_5156_1956_2066 4 0.001541009 0.094001519 0.002410295 24302 hsa-mir-625 hsa04950 Maturity onset diabetes of the young 6928_3172 2 0.002124844 0.129615461 0.003240387 24303 hsa-mir-625 hsa05216 Thyroid cancer 1499_5594 2 0.003014433 0.183880407 0.004484888 24304 hsa-mir-625 hsa04912 GnRH signaling pathway 6714_5594_1956 3 0.003154774 0.192441198 0.004581933 24305 hsa-mir-625 hsa04670 Leukocyte transendothelial migration 7852_5781_1499 3 0.004402165 0.268532046 0.006244931 24306 hsa-mir-625 hsa05219 Bladder cancer 5594_1956 2 0.005998795 0.365926484 0.008316511 24307 hsa-mir-625 hsa04930 Type II diabetes mellitus 3643_5594 2 0.006820108 0.416026607 0.009245036 24308 hsa-mir-625 hsa04150 mTOR signaling pathway 207_5594 2 0.008921952 0.544239069 0.011831284 24309 hsa-mir-625 hsa05217 Basal cell carcinoma 2932_1499 2 0.009900341 0.603920791 0.012743532 24310 hsa-mir-625 hsa05131 Shigellosis 7534_1499 2 0.010236608 0.624433087 0.012743532 24311 hsa-mir-625 hsa05130 Pathogenic Escherichia coli infection 7534_1499 2 0.010236608 0.624433087 0.012743532 24312 hsa-mir-625 hsa04340 Hedgehog signaling pathway 2932_53944 2 0.010577897 0.645251713 0.012905034 24313 hsa-mir-625 hsa04730 Long-term depression 5594_5515 2 0.015867748 0.967932637 0.018979071 24314 hsa-mir-626 hsa05200 Pathways in cancer 5371_5595_5594_5914_1387_6256_595_5601_836_367_7704_3091_5970_7428_2736_1870_1871_7157_4087_2113_4609_1869_3725_2353_4088_4089_3066_3065_1050_5925_2034_2033_4846_207_2932_4286 36 1.92E-33 1.35E-31 1.35E-31 24315 hsa-mir-626 hsa04010 MAPK signaling pathway 6722_5595_5594_9261_4208_5601_836_6195_6197_9252_1386_1432_1649_5970_3312_7157_468_4609_3725_3727_6196_2353_8986_4763_207 25 1.03E-21 7.23E-20 3.62E-20 24316 hsa-mir-626 hsa05220 Chronic myeloid leukemia 5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_207_6464 16 1.60E-19 1.12E-17 3.72E-18 24317 hsa-mir-626 hsa04110 Cell cycle 5591_1387_595_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_891_2932_5933 17 4.82E-18 3.37E-16 8.43E-17 24318 hsa-mir-626 hsa05215 Prostate cancer 5595_5594_1387_595_367_5970_1870_1871_7157_468_1869_5925_2033_207_2932 15 4.38E-17 3.07E-15 5.95E-16 24319 hsa-mir-626 hsa05212 Pancreatic cancer 5595_5594_1387_595_367_5970_1870_1871_7157_468_1869_5925_2033_207_2932 15 5.10E-17 3.57E-15 5.95E-16 24320 hsa-mir-626 hsa05210 Colorectal cancer 5595_5594_595_5601_836_7157_4087_4609_3725_2353_4088_4089_207_2932 14 6.65E-16 4.66E-14 6.65E-15 24321 hsa-mir-626 hsa05219 Bladder cancer 5595_5594_595_9252_1870_1871_7157_4609_1869_5925 10 4.51E-13 3.15E-11 3.94E-12 24322 hsa-mir-626 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925_207 10 4.06E-12 2.84E-10 3.16E-11 24323 hsa-mir-626 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_5970_4609_1050_207 10 8.89E-12 6.23E-10 6.23E-11 24324 hsa-mir-626 hsa05222 Small cell lung cancer 6256_595_5970_1870_1871_7157_4609_1869_5925_4846_207 11 1.25E-11 8.74E-10 7.95E-11 24325 hsa-mir-626 hsa04310 Wnt signaling pathway 1387_595_5601_7157_4087_8061_4609_3725_1457_4088_4089_2033_2932 13 1.78E-11 1.25E-09 1.04E-10 24326 hsa-mir-626 hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_207_6464 10 2.10E-11 1.47E-09 1.13E-10 24327 hsa-mir-626 hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5925_207_4286 10 4.63E-11 3.24E-09 2.31E-10 24328 hsa-mir-626 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2113_3725_2034_2033_207 10 5.24E-11 3.67E-09 2.45E-10 24329 hsa-mir-626 hsa04720 Long-term potentiation 5595_5594_1387_2902_6195_6197_468_6196_2033 9 1.61E-09 1.13E-07 7.04E-09 24330 hsa-mir-626 hsa04350 TGF-beta signaling pathway 5595_5594_1387_4087_4609_4088_4089_2033_5933 9 5.33E-09 3.73E-07 2.20E-08 24331 hsa-mir-626 hsa04660 T cell receptor signaling pathway 5595_5594_5601_1432_5970_3725_2353_207_2932 9 3.55E-08 2.48E-06 1.38E-07 24332 hsa-mir-626 hsa04520 Adherens junction 5595_5594_1387_4087_1457_4088_4089_2033 8 4.93E-08 3.45E-06 1.71E-07 24333 hsa-mir-626 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 5.10E-08 3.57E-06 1.71E-07 24334 hsa-mir-626 hsa05213 Endometrial cancer 5595_5594_595_7157_4609_207_2932 7 5.38E-08 3.77E-06 1.71E-07 24335 hsa-mir-626 hsa04150 mTOR signaling pathway 5595_5594_6195_6197_3091_6196_207 7 5.38E-08 3.77E-06 1.71E-07 24336 hsa-mir-626 hsa04012 ErbB signaling pathway 5595_5594_5601_4609_3725_207_2932_6464 8 9.01E-08 6.31E-06 2.74E-07 24337 hsa-mir-626 hsa05016 Huntington's disease 6874_1387_2902_836_1537_7157_3066_3065_3064_2033 10 2.78E-07 1.94E-05 7.89E-07 24338 hsa-mir-626 hsa04620 Toll-like receptor signaling pathway 5595_5594_5601_1432_5970_3725_2353_207 8 2.82E-07 1.97E-05 7.89E-07 24339 hsa-mir-626 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725_2353_207_2932 7 5.36E-07 3.75E-05 1.44E-06 24340 hsa-mir-626 hsa04370 VEGF signaling pathway 5595_5594_9261_1432_4846_207 6 9.40E-06 0.000658309 2.44E-05 24341 hsa-mir-626 hsa04330 Notch signaling pathway 1387_9612_3066_3065_2033 5 1.33E-05 0.000929001 3.32E-05 24342 hsa-mir-626 hsa04910 Insulin signaling pathway 6720_5595_5594_5601_207_2932_6464 7 2.39E-05 0.001673969 5.77E-05 24343 hsa-mir-626 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_1432_7157_4846 5 2.91E-05 0.002038318 6.79E-05 24344 hsa-mir-626 hsa04510 Focal adhesion 5595_5594_595_5601_3725_207_2932_6464 8 3.94E-05 0.002755588 8.89E-05 24345 hsa-mir-626 hsa04916 Melanogenesis 5595_5594_1387_2033_2932_4286 6 4.69E-05 0.00328085 0.000102527 24346 hsa-mir-626 hsa04912 GnRH signaling pathway 5595_5594_5601_1432_468_3725 6 5.72E-05 0.004007436 0.000121437 24347 hsa-mir-626 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5601_836_1432_5970_3725 5 8.43E-05 0.00589895 0.000173499 24348 hsa-mir-626 hsa03022 Basal transcription factors 2963_6874_2969_6883 4 9.57E-05 0.006697831 0.000191367 24349 hsa-mir-626 hsa05010 Alzheimer's disease 5595_5594_2902_836_1537_4846_2932 7 0.000108142 0.007569941 0.000210276 24350 hsa-mir-626 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5601_1432_207 5 0.000135628 0.009493995 0.000256594 24351 hsa-mir-626 hsa04930 Type II diabetes mellitus 3651_5595_5594_5601 4 0.000193047 0.013513319 0.000355614 24352 hsa-mir-626 hsa04920 Adipocytokine signaling pathway 6256_5601_5970_207 4 0.000801352 0.056094664 0.001438325 24353 hsa-mir-626 hsa04115 p53 signaling pathway 595_836_7157_891 4 0.000889603 0.06227223 0.001556806 24354 hsa-mir-626 hsa04730 Long-term depression 5592_5595_5594_4846 4 0.000984487 0.068914077 0.001680831 24355 hsa-mir-626 hsa04062 Chemokine signaling pathway 5595_5594_5970_207_2932_6464 6 0.001142731 0.079991184 0.001904552 24356 hsa-mir-626 hsa04612 Antigen processing and presentation 4800_4801_4802_3312 4 0.002180585 0.152640953 0.003469113 24357 hsa-mir-626 hsa04210 Apoptosis 836_5970_7157_207 4 0.002180585 0.152640953 0.003469113 24358 hsa-mir-626 hsa04630 Jak-STAT signaling pathway 1387_595_4609_2033_207 5 0.002527348 0.176914361 0.00393143 24359 hsa-mir-626 hsa05217 Basal cell carcinoma 2736_7157_2932 3 0.004756685 0.332967955 0.007238434 24360 hsa-mir-626 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_6464 4 0.00973493 0.681445127 0.014498832 24361 hsa-mir-626 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428_7325 4 0.009970522 0.697936572 0.014540345 24362 hsa-mir-626 hsa04540 Gap junction 5592_5595_5594 3 0.018760598 1 0.026800854 24363 hsa-mir-626 hsa04270 Vascular smooth muscle contraction 5592_5595_5594 3 0.034057761 1 0.047680865 24364 hsa-mir-626 hsa04360 Axon guidance 5595_5594_2932 3 0.043929 1 0.060294706 24365 hsa-mir-626 hsa04340 Hedgehog signaling pathway 2736_2932 2 0.046600054 1 0.062730842 24366 hsa-mir-627 hsa05200 Pathways in cancer 5371_5595_5594_5914_1387_6256_595_836_367_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_861_4088_4089_3066_3065_5925_2034_2033_4846 30 2.84E-33 1.76E-31 1.76E-31 24367 hsa-mir-627 hsa05220 Chronic myeloid leukemia 5595_5594_595_5970_1870_1871_7157_4609_1869_861_4088_4089_3066_3065_5925_6464 16 2.20E-23 1.37E-21 6.83E-22 24368 hsa-mir-627 hsa04110 Cell cycle 5591_1387_595_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933 15 6.99E-19 4.33E-17 1.44E-17 24369 hsa-mir-627 hsa05215 Prostate cancer 5595_5594_1387_595_367_5970_1870_1871_7157_1869_5925_2033 12 1.09E-15 6.75E-14 1.53E-14 24370 hsa-mir-627 hsa05212 Pancreatic cancer 5595_5594_1387_595_367_5970_1870_1871_7157_1869_5925_2033 12 1.23E-15 7.64E-14 1.53E-14 24371 hsa-mir-627 hsa04350 TGF-beta signaling pathway 5595_5594_1387_3399_3398_4087_4609_4088_4089_2033_5933 11 3.81E-14 2.36E-12 3.93E-13 24372 hsa-mir-627 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5925 9 1.21E-13 7.53E-12 1.08E-12 24373 hsa-mir-627 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925 9 9.13E-13 5.66E-11 6.90E-12 24374 hsa-mir-627 hsa05210 Colorectal cancer 5595_5594_595_836_7157_4087_4609_3725_4088_4089 10 1.00E-12 6.21E-11 6.90E-12 24375 hsa-mir-627 hsa05222 Small cell lung cancer 6256_595_5970_1870_1871_7157_4609_1869_5925_4846 10 1.24E-12 7.70E-11 7.70E-12 24376 hsa-mir-627 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_5970_4609_861 9 1.87E-12 1.16E-10 1.06E-11 24377 hsa-mir-627 hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_6464 9 4.13E-12 2.56E-10 2.14E-11 24378 hsa-mir-627 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2113_3725_2034_2033 9 9.57E-12 5.93E-10 4.56E-11 24379 hsa-mir-627 hsa04310 Wnt signaling pathway 1387_595_7157_4087_4609_3725_1457_4088_4089_2033 10 2.36E-10 1.47E-08 1.05E-09 24380 hsa-mir-627 hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5925 8 3.04E-10 1.89E-08 1.26E-09 24381 hsa-mir-627 hsa04520 Adherens junction 5595_5594_1387_4087_1457_4088_4089_2033 8 7.31E-10 4.53E-08 2.83E-09 24382 hsa-mir-627 hsa05016 Huntington's disease 6874_1387_2902_6908_836_7157_3066_3065_3064_2033 10 1.67E-09 1.04E-07 6.11E-09 24383 hsa-mir-627 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 2.07E-09 1.29E-07 7.14E-09 24384 hsa-mir-627 hsa04010 MAPK signaling pathway 5595_5594_4208_836_3312_5970_7157_4609_3725_4763_1616 11 4.02E-09 2.49E-07 1.31E-08 24385 hsa-mir-627 hsa04330 Notch signaling pathway 1387_9612_3066_3065_2033 5 9.73E-07 6.03E-05 3.01E-06 24386 hsa-mir-627 hsa05213 Endometrial cancer 5595_5594_595_7157_4609 5 1.55E-06 9.58E-05 4.56E-06 24387 hsa-mir-627 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_7157_1616_4846 5 2.17E-06 0.000134694 6.12E-06 24388 hsa-mir-627 hsa04720 Long-term potentiation 5595_5594_1387_2902_2033 5 8.34E-06 0.000516989 2.25E-05 24389 hsa-mir-627 hsa04012 ErbB signaling pathway 5595_5594_4609_3725_6464 5 1.65E-05 0.001023785 4.27E-05 24390 hsa-mir-627 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725 4 0.000159466 0.009886891 0.000395476 24391 hsa-mir-627 hsa05010 Alzheimer's disease 5595_5594_2902_836_4846 5 0.000414675 0.025709879 0.000988841 24392 hsa-mir-627 hsa04620 Toll-like receptor signaling pathway 5595_5594_5970_3725 4 0.000491299 0.030460516 0.001128167 24393 hsa-mir-627 hsa04916 Melanogenesis 5595_5594_1387_2033 4 0.000527247 0.032689323 0.001167476 24394 hsa-mir-627 hsa04660 T cell receptor signaling pathway 5595_5594_5970_3725 4 0.000646299 0.040070533 0.001381743 24395 hsa-mir-627 hsa04510 Focal adhesion 5595_5594_595_3725_6464 5 0.000809526 0.050190623 0.001673021 24396 hsa-mir-627 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.000896844 0.055604329 0.001793688 24397 hsa-mir-627 hsa04910 Insulin signaling pathway 6720_5595_5594_6464 4 0.001461722 0.090626737 0.002746265 24398 hsa-mir-627 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_6464 4 0.001461722 0.090626737 0.002746265 24399 hsa-mir-627 hsa04115 p53 signaling pathway 595_836_7157 3 0.001954848 0.12120056 0.003564722 24400 hsa-mir-627 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_5970_3725 3 0.002114296 0.131086374 0.003641288 24401 hsa-mir-627 hsa04730 Long-term depression 5595_5594_4846 3 0.002114296 0.131086374 0.003641288 24402 hsa-mir-627 hsa04630 Jak-STAT signaling pathway 1387_595_4609_2033 4 0.002208463 0.136924734 0.003700668 24403 hsa-mir-627 hsa04370 VEGF signaling pathway 5595_5594_4846 3 0.002640332 0.163700578 0.00430791 24404 hsa-mir-627 hsa04612 Antigen processing and presentation 4800_4801_3312 3 0.003918069 0.242920304 0.006073008 24405 hsa-mir-627 hsa04210 Apoptosis 836_5970_7157 3 0.003918069 0.242920304 0.006073008 24406 hsa-mir-627 hsa04062 Chemokine signaling pathway 5595_5594_5970_6464 4 0.004750734 0.294545482 0.007184036 24407 hsa-mir-627 hsa04912 GnRH signaling pathway 5595_5594_3725 3 0.006604658 0.409488823 0.009749734 24408 hsa-mir-627 hsa03022 Basal transcription factors 6874_6908 2 0.007911016 0.490482979 0.011406581 24409 hsa-mir-627 hsa04930 Type II diabetes mellitus 5595_5594 2 0.011338112 0.702962923 0.01597643 24410 hsa-mir-627 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428 3 0.012893289 0.799383912 0.017764087 24411 hsa-mir-627 hsa04920 Adipocytokine signaling pathway 6256_5970 2 0.023439873 1 0.031592872 24412 hsa-mir-627 hsa04664 Fc epsilon RI signaling pathway 5595_5594 2 0.03152989 1 0.041592621 24413 hsa-mir-627 hsa04540 Gap junction 5595_5594 2 0.042139387 1 0.054430041 24414 hsa-mir-627 hsa04710 Circadian rhythm - mammal 8863 1 0.046861183 1 0.059293741 24415 hsa-mir-629 hsa05200 Pathways in cancer 3725_4149_7046_1499_6654_5914_595_1017_4193_7704_6502_4089_3066_1050_5925_7189_405_1956_2308_1387_8503_1870_1871_2885_10401_862_207_208_5894_1147_4609_2249_5595_5594_5599_2064_6256_4286_367_2932_6774_6776_6777_6772_5970_7157_6688_1869_2736_4087_4088_5295_2033_4790_3320_3326_5371_3480_5604_5601_4292_51588_1029_2353_8554 65 1.34E-36 1.07E-34 1.07E-34 24416 hsa-mir-629 hsa05215 Prostate cancer 1499_6654_595_1017_4193_5925_1956_2308_1387_8503_1870_1871_2885_9586_207_208_5894_1147_5595_5594_1385_2064_367_2932_5970_7157_468_1869_5295_10488_2033_4790_3320_3326_3480_5604 36 5.83E-30 4.66E-28 2.14E-28 24417 hsa-mir-629 hsa05212 Pancreatic cancer 1499_6654_595_1017_4193_5925_1956_2308_1387_8503_1870_1871_2885_9586_207_208_5894_1147_5595_5594_1385_2064_367_2932_5970_7157_468_1869_5295_10488_2033_4790_3320_3326_3480_5604 36 8.02E-30 6.42E-28 2.14E-28 24418 hsa-mir-629 hsa04010 MAPK signaling pathway 6722_3725_4149_7046_6654_4214_9252_7867_4616_7189_8986_1956_1432_627_2885_2872_207_208_5894_1147_4609_2249_994_5595_5594_5599_5598_1386_1649_5970_7157_10912_468_3727_6195_6196_6197_5058_4790_9261_5604_4208_5601_5600_5603_5566_2353_8550 48 1.86E-25 1.49E-23 3.71E-24 24419 hsa-mir-629 hsa05220 Chronic myeloid leukemia 7046_6654_595_4193_4089_3066_5925_8503_1870_1871_2885_207_208_5894_1147_4609_5595_5594_6776_6777_5970_7157_1869_4088_5295_4790_5604_1029_6464 29 7.97E-24 6.37E-22 1.27E-22 24420 hsa-mir-629 hsa04110 Cell cycle 595_1017_4193_902_6502_6500_4089_3066_4616_5925_1387_1870_1871_5934_5933_994_993_7533_2932_990_7157_10912_1869_4087_4088_2033_890_983_8454_1022_1029 31 3.88E-21 3.10E-19 5.17E-20 24421 hsa-mir-629 hsa05221 Acute myeloid leukemia 6654_5914_595_7704_1050_8503_2885_862_207_208_5894_1147_4609_5595_5594_6774_6776_6777_5970_6688_5295_4790_5371_5604 24 2.32E-20 1.86E-18 2.65E-19 24422 hsa-mir-629 hsa05214 Glioma 6654_595_4193_5925_1956_8503_1870_1871_2885_207_208_5894_5595_5594_7157_1869_5295_808_801_805_3480_5604_1029_6464 24 1.44E-19 1.15E-17 1.44E-18 24423 hsa-mir-629 hsa05210 Colorectal cancer 3725_7046_1499_6654_595_4089_1956_8503_2885_207_208_5894_4609_5595_5594_5599_2932_7157_4087_4088_5295_3480_5604_5601_4292_2353 26 1.66E-19 1.33E-17 1.48E-18 24424 hsa-mir-629 hsa05223 Non-small cell lung cancer 6654_595_5925_1956_2309_8503_1870_1871_2885_207_208_5894_5595_5594_2064_6256_7157_1869_5295_5604_1029 21 1.16E-17 9.25E-16 9.25E-17 24425 hsa-mir-629 hsa04012 ErbB signaling pathway 3725_6654_1956_6714_8503_2885_207_208_5894_4609_5595_5594_5599_56924_2064_2932_6776_6777_5295_5058_5604_5601_6464 23 3.78E-16 3.03E-14 2.73E-15 24426 hsa-mir-629 hsa04660 T cell receptor signaling pathway 3725_6654_5777_3932_1739_1432_8503_2885_207_208_5894_1147_5595_5594_56924_2932_5970_5295_5058_4790_5604_5601_5600_5603_2353 25 4.10E-16 3.28E-14 2.73E-15 24427 hsa-mir-629 hsa04620 Toll-like receptor signaling pathway 3725_4615_7189_3661_1432_8503_207_208_1147_3654_5595_5594_5599_6772_5970_5295_4790_5604_5601_5600_5603_353376_148022_2353 24 8.16E-16 6.53E-14 5.02E-15 24428 hsa-mir-629 hsa05213 Endometrial cancer 1499_6654_595_1956_2309_8503_2885_207_208_5894_4609_5595_5594_2064_2932_7157_5295_5604_4292 19 1.05E-15 8.39E-14 5.99E-15 24429 hsa-mir-629 hsa05222 Small cell lung cancer 4149_595_1017_6502_5925_7189_8503_1870_1871_10401_207_208_1147_4609_6256_5970_7157_1869_5295_4790_51588_8554 22 2.97E-15 2.38E-13 1.58E-14 24430 hsa-mir-629 hsa04350 TGF-beta signaling pathway 6667_7046_6500_4089_1387_3397_3399_3398_1874_1875_658_5934_5933_4609_3400_5595_5594_4087_4088_2033_5518_8454 22 3.64E-15 2.92E-13 1.82E-14 24431 hsa-mir-629 hsa05218 Melanoma 595_4193_5925_1956_8503_1870_1871_207_208_5894_2249_5595_5594_4286_7157_1869_5295_3480_5604_1029 20 1.16E-14 9.25E-13 5.44E-14 24432 hsa-mir-629 hsa05219 Bladder cancer 595_9252_4193_5925_1956_1870_1871_5894_4609_5595_5594_2064_7157_1869_5604_1029 16 1.14E-13 9.15E-12 5.08E-13 24433 hsa-mir-629 hsa04910 Insulin signaling pathway 6720_10891_6654_5770_2308_8503_2885_2872_207_208_5894_5595_5594_5599_7249_2932_5295_808_801_805_5604_5601_5566_6464 24 2.76E-13 2.21E-11 1.16E-12 24434 hsa-mir-629 hsa04912 GnRH signaling pathway 3725_6654_4214_1956_6714_1432_2885_5894_5595_5594_5599_5598_468_808_801_805_5604_5601_5600_5603_5566 21 1.30E-12 1.04E-10 5.22E-12 24435 hsa-mir-629 hsa04520 Adherens junction 7046_1499_1457_5770_5777_4089_1956_6714_1387_1460_5595_5594_2064_1459_4087_4088_2033_3480 18 6.36E-12 5.09E-10 2.42E-11 24436 hsa-mir-629 hsa04510 Focal adhesion 3725_1499_6654_595_857_9564_1956_6714_8503_2885_207_208_5894_5595_5594_5599_56924_2064_2932_1729_5295_5058_3480_5604_5601_6464 26 1.99E-11 1.59E-09 7.23E-11 24437 hsa-mir-629 hsa04662 B cell receptor signaling pathway 3725_6654_5777_8503_2885_207_208_5894_1147_5595_5594_2932_5970_5295_4790_5604_2353 17 2.22E-11 1.77E-09 7.71E-11 24438 hsa-mir-629 hsa04540 Gap junction 6654_51807_1956_6714_2885_5894_5592_5595_5594_5598_7846_2770_983_5604_5566_7277_7278_10376 18 5.61E-11 4.49E-09 1.87E-10 24439 hsa-mir-629 hsa05211 Renal cell carcinoma 3725_6654_405_1387_8503_2885_207_208_5894_5595_5594_56924_5295_5058_2033_5604 16 1.11E-10 8.88E-09 3.55E-10 24440 hsa-mir-629 hsa04062 Chemokine signaling pathway 6654_9564_2309_8503_2885_207_208_5894_1147_5595_5594_7074_2932_6774_6777_6772_5970_5295_5058_4790_2770_5604_5566_6464 24 1.56E-10 1.24E-08 4.78E-10 24441 hsa-mir-629 hsa04310 Wnt signaling pathway 3725_1499_595_1457_6500_4089_1387_4609_1460_5599_1459_2932_7157_8061_4087_4088_2033_5518_5601_5566_8454 21 3.89E-10 3.11E-08 1.15E-09 24442 hsa-mir-629 hsa04664 Fc epsilon RI signaling pathway 6654_1432_8503_2885_207_208_5894_5595_5594_5599_5295_5604_5601_5600_5603 15 2.82E-09 2.26E-07 8.07E-09 24443 hsa-mir-629 hsa04720 Long-term potentiation 1387_5894_5595_5594_468_6195_6196_6197_2033_808_801_805_5604_5566 14 1.15E-08 9.22E-07 3.18E-08 24444 hsa-mir-629 hsa04916 Melanogenesis 1499_1387_5894_5595_5594_1385_4286_2932_10488_2033_808_801_805_2770_5604_5566 16 1.23E-08 9.81E-07 3.27E-08 24445 hsa-mir-629 hsa04370 VEGF signaling pathway 7867_6714_1432_8503_207_208_5894_5595_5594_5295_9261_5604_5600_5603 14 1.55E-08 1.24E-06 3.88E-08 24446 hsa-mir-629 hsa04630 Jak-STAT signaling pathway 6654_595_5777_1387_8503_2885_10401_3977_207_208_4609_6774_6776_6777_6772_5295_2033_51588_8554 19 1.55E-08 1.24E-06 3.88E-08 24447 hsa-mir-629 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1956_6714_1432_1147_5599_5970_5058_4790_5601_5600_5603 12 3.32E-07 2.66E-05 8.05E-07 24448 hsa-mir-629 hsa04120 Ubiquitin mediated proteolysis 55294_4214_4193_6502_6500_7189_10401_10273_11059_64326_5371_672_8454_51588_7329_8554 16 4.56E-07 3.64E-05 1.07E-06 24449 hsa-mir-629 hsa03022 Basal transcription factors 2959_2965_2963_2962_2969_6874_6908_6883_6881 9 7.13E-07 5.70E-05 1.63E-06 24450 hsa-mir-629 hsa04150 mTOR signaling pathway 8503_207_208_5595_5594_7249_6195_6196_6197_5295 10 1.13E-06 9.04E-05 2.51E-06 24451 hsa-mir-629 hsa05216 Thyroid cancer 1499_595_4609_5595_5594_6256_7157_5604 8 1.33E-06 0.000106558 2.88E-06 24452 hsa-mir-629 hsa04115 p53 signaling pathway 595_1017_4193_4616_7249_7157_10912_64326_983_7161_1029 11 1.71E-06 0.000136849 3.60E-06 24453 hsa-mir-629 hsa04920 Adipocytokine signaling pathway 10891_207_208_1147_5599_6256_6774_5970_4790_5601 10 8.53E-06 0.00068239 1.75E-05 24454 hsa-mir-629 hsa04210 Apoptosis 4615_8503_207_208_1147_3654_5970_7157_5295_4790_5566 11 1.54E-05 0.00123445 3.09E-05 24455 hsa-mir-629 hsa04330 Notch signaling pathway 3066_1387_388585_9612_2033_8850_2648_4851 8 2.95E-05 0.00235644 5.75E-05 24456 hsa-mir-629 hsa04650 Natural killer cell mediated cytotoxicity 6654_5777_3932_8503_2885_5894_5595_5594_5295_5058_5604_6464 12 0.000151624 0.012129919 0.000286182 24457 hsa-mir-629 hsa04930 Type II diabetes mellitus 3651_8503_5595_5594_5599_5295_5601 7 0.000153823 0.012305807 0.000286182 24458 hsa-mir-629 hsa05016 Huntington's disease 6667_10891_3066_3064_1387_627_9586_4716_1385_7157_10488_2033_6874_6908 14 0.000202926 0.016234072 0.000368956 24459 hsa-mir-629 hsa04730 Long-term depression 5894_5592_5595_5594_3480_5518_2770_5604 8 0.000394247 0.031539792 0.000700884 24460 hsa-mir-629 hsa04950 Maturity onset diabetes of the young 3651_6927_4760_168620_3172 5 0.000424228 0.033938269 0.000737788 24461 hsa-mir-629 hsa05131 Shigellosis 1499_51807_7846_7277_7278_4691_10376 7 0.000514452 0.041156165 0.00085742 24462 hsa-mir-629 hsa05130 Pathogenic Escherichia coli infection 1499_51807_7846_7277_7278_4691_10376 7 0.000514452 0.041156165 0.00085742 24463 hsa-mir-629 hsa04810 Regulation of actin cytoskeleton 6654_9564_1956_8503_5894_2249_5595_5594_56924_7074_1729_5295_5058_5604 14 0.000848867 0.067909346 0.001385905 24464 hsa-mir-629 hsa04612 Antigen processing and presentation 6890_1385_1514_3320_3326_4800_4801_4802 8 0.001537871 0.1230297 0.002460594 24465 hsa-mir-629 hsa04530 Tight junction 10207_1499_1457_6714_207_208_1460_1459_5518_2770 10 0.001828414 0.146273144 0.002868101 24466 hsa-mir-629 hsa04270 Vascular smooth muscle contraction 5894_5592_5595_5594_808_801_805_5604_5566 9 0.00230727 0.184581562 0.003549645 24467 hsa-mir-629 hsa04670 Leukocyte transendothelial migration 1499_9564_1432_8503_5295_2770_5600_5603 8 0.009134284 0.730742756 0.013787599 24468 hsa-mir-629 hsa03410 Base excision repair 3146_4350_142_6996 4 0.012081817 0.966545351 0.017898988 24469 hsa-mir-629 hsa03420 Nucleotide excision repair 902_2965_4331_1022 4 0.022375886 1 0.032546743 24470 hsa-mir-629 hsa04070 Phosphatidylinositol signaling system 8503_5295_808_801_805 5 0.035544414 1 0.050777734 24471 hsa-mir-629 hsa04360 Axon guidance 5998_5595_5594_56924_2932_5058_2770 7 0.036302062 1 0.050950262 24472 hsa-mir-629 hsa05217 Basal cell carcinoma 1499_2932_7157_2736 4 0.043278366 1 0.059694297 24473 hsa-mir-629 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_7157_5600_5603 4 0.045579787 1 0.061803101 24474 hsa-mir-630 hsa03022 Basal transcription factors 2967_2961_2960_2963_6881_54457_2968_6878_6877_6874_6879_6908_2958_2957_6873_6872_6884_2959_6880_6882_138474_6883 22 1.21E-29 8.45E-28 8.45E-28 24475 hsa-mir-630 hsa05200 Pathways in cancer 5371_5594_5599_6258_5914_1387_6257_6256_8031_10401_836_1017_4193_7704_6774_7157_3091_5970_6688_4089_2113_4087_4609_3725_1026_1029_1050_5925_2033_207_898_3326_8554_2353_7184 35 1.99E-24 1.39E-22 6.97E-23 24476 hsa-mir-630 hsa04110 Cell cycle 993_1387_983_1017_5001_4193_7157_10912_4089_4087_4174_1026_4171_4172_4173_1029_4085_7532_4616_5925_2033_898_4998_4999 24 5.88E-23 4.12E-21 1.37E-21 24477 hsa-mir-630 hsa05215 Prostate cancer 5594_1387_1017_4193_7157_5970_1026_5925_2033_207_898_3326_7184 13 1.74E-11 1.22E-09 2.77E-10 24478 hsa-mir-630 hsa05212 Pancreatic cancer 5594_1387_1017_4193_7157_5970_1026_5925_2033_207_898_3326_7184 13 1.98E-11 1.39E-09 2.77E-10 24479 hsa-mir-630 hsa05222 Small cell lung cancer 6258_6257_6256_10401_1017_7157_5970_4609_5925_207_898_8554 12 1.92E-10 1.34E-08 2.24E-09 24480 hsa-mir-630 hsa05221 Acute myeloid leukemia 5371_5594_5914_7704_6774_5970_6688_4609_1050_207 10 1.18E-09 8.29E-08 1.18E-08 24481 hsa-mir-630 hsa04010 MAPK signaling pathway 6722_3727_5594_5599_5598_836_3312_1432_7157_5970_10912_4609_3725_4616_207_51701_2353 17 3.83E-09 2.68E-07 3.35E-08 24482 hsa-mir-630 hsa04115 p53 signaling pathway 983_836_1017_4193_7157_10912_1026_1029_4616_898 10 4.61E-09 3.23E-07 3.58E-08 24483 hsa-mir-630 hsa05220 Chronic myeloid leukemia 5594_4193_7157_5970_4089_4609_1026_1029_5925_207 10 9.52E-09 6.66E-07 6.66E-08 24484 hsa-mir-630 hsa05210 Colorectal cancer 5594_5599_836_7157_4089_4087_4609_3725_207_2353 10 2.55E-08 1.78E-06 1.62E-07 24485 hsa-mir-630 hsa05216 Thyroid cancer 5594_6258_6257_6256_8031_7157_4609 7 4.62E-08 3.23E-06 2.70E-07 24486 hsa-mir-630 hsa04310 Wnt signaling pathway 1460_5599_1387_7157_4089_4087_4609_3725_2033_8607_51701_1457 12 7.05E-08 4.93E-06 3.79E-07 24487 hsa-mir-630 hsa05223 Non-small cell lung cancer 5594_6258_6257_6256_7157_1029_5925_207 8 1.42E-07 9.95E-06 7.11E-07 24488 hsa-mir-630 hsa05219 Bladder cancer 5594_4193_7157_4609_1026_1029_5925 7 4.27E-07 2.99E-05 1.99E-06 24489 hsa-mir-630 hsa04920 Adipocytokine signaling pathway 10891_5599_6258_6257_6256_6774_5970_207 8 6.37E-07 4.46E-05 2.79E-06 24490 hsa-mir-630 hsa04520 Adherens junction 1460_5594_1387_4089_4087_2033_51701_1457 8 2.18E-06 0.000152452 8.97E-06 24491 hsa-mir-630 hsa05016 Huntington's disease 6874_10891_3064_1387_6908_836_9001_7157_5430_4697_2033 11 3.96E-06 0.000276955 1.54E-05 24492 hsa-mir-630 hsa05214 Glioma 5594_4193_7157_1026_1029_5925_207 7 6.07E-06 0.000424927 2.24E-05 24493 hsa-mir-630 hsa05218 Melanoma 5594_4193_7157_1026_1029_5925_207 7 1.04E-05 0.000725579 3.63E-05 24494 hsa-mir-630 hsa05211 Renal cell carcinoma 5594_1387_3091_2113_3725_2033_207 7 1.13E-05 0.000789639 3.76E-05 24495 hsa-mir-630 hsa04350 TGF-beta signaling pathway 5594_1387_4089_4087_4609_659_2033 7 3.52E-05 0.002466814 0.000112128 24496 hsa-mir-630 hsa04620 Toll-like receptor signaling pathway 5594_5599_1432_5970_3725_207_2353 7 9.08E-05 0.006354378 0.000276277 24497 hsa-mir-630 hsa03050 Proteasome 5719_5705_5701_5702_5710 5 0.000155586 0.010891039 0.000453793 24498 hsa-mir-630 hsa04012 ErbB signaling pathway 5594_5599_4609_3725_1026_207 6 0.000282628 0.019783971 0.000791359 24499 hsa-mir-630 hsa03030 DNA replication 4174_4171_4172_4173 4 0.000580709 0.040649611 0.001563447 24500 hsa-mir-630 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_836_1432_5970_3725 5 0.000837112 0.058597814 0.002170289 24501 hsa-mir-630 hsa04660 T cell receptor signaling pathway 5594_1432_5970_3725_207_2353 6 0.000915804 0.064106281 0.00228951 24502 hsa-mir-630 hsa04630 Jak-STAT signaling pathway 1387_10401_6774_4609_2033_207_8554 7 0.001009469 0.070662836 0.00243665 24503 hsa-mir-630 hsa04662 B cell receptor signaling pathway 5594_5970_3725_207_2353 5 0.001055906 0.07391344 0.002463781 24504 hsa-mir-630 hsa04330 Notch signaling pathway 1387_9612_2033_8850 4 0.001461924 0.102334708 0.00330112 24505 hsa-mir-630 hsa05213 Endometrial cancer 5594_7157_4609_207 4 0.002069622 0.144873552 0.004527299 24506 hsa-mir-630 hsa04210 Apoptosis 836_840_7157_5970_207 5 0.002162717 0.151390166 0.004587581 24507 hsa-mir-630 hsa04910 Insulin signaling pathway 10891_5594_5599_5499_5211_207 6 0.002753761 0.192763293 0.005669509 24508 hsa-mir-630 hsa04912 GnRH signaling pathway 5594_5599_5598_1432_3725 5 0.004774892 0.334242431 0.009549784 24509 hsa-mir-630 hsa03320 PPAR signaling pathway 6258_6257_6256_2168 4 0.005668156 0.396770904 0.011021414 24510 hsa-mir-630 hsa04720 Long-term potentiation 5594_1387_5499_2033 4 0.00713132 0.499192384 0.013491686 24511 hsa-mir-630 hsa04664 Fc epsilon RI signaling pathway 5594_5599_1432_207 4 0.008466596 0.592661701 0.015596361 24512 hsa-mir-630 hsa03420 Nucleotide excision repair 2967_2968_5887 3 0.010418683 0.729307813 0.0187002 24513 hsa-mir-630 hsa04612 Antigen processing and presentation 4801_3312_1514_3326 4 0.012491653 0.87441569 0.021860392 24514 hsa-mir-630 hsa04120 Ubiquitin mediated proteolysis 5371_10401_4193_7329_8554 5 0.012895302 0.90267115 0.02201637 24515 hsa-mir-630 hsa04540 Gap junction 5594_5598_983_10382 4 0.014391985 1 0.023986642 24516 hsa-mir-630 hsa04150 mTOR signaling pathway 5594_3091_207 3 0.015939322 1 0.025947733 24517 hsa-mir-630 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432_7157 3 0.019207718 1 0.030557733 24518 hsa-mir-630 hsa05010 Alzheimer's disease 1020_5594_836_840_4697 5 0.031606698 1 0.049165974 24519 hsa-mir-630 hsa04370 VEGF signaling pathway 5594_1432_207 3 0.04196932 1 0.063866356 24520 hsa-mir-631 hsa05200 Pathways in cancer 3716_3320_3326_3725_5371_3480_1956_1499_4233_5595_5594_5599_6258_1387_2064_6256_5159_595_5156_367_2261_6776_6777_6772_6257_5979_5879_1026_862_6502_10401_3066_3065_5925_8031_2033_1441_8554_4790_5970 40 8.41E-34 6.06E-32 6.06E-32 24521 hsa-mir-631 hsa04630 Jak-STAT signaling pathway 3717_3716_3718_3559_85480_3560_149233_1387_595_3575_3570_3572_3953_6776_6777_6772_1439_3454_3455_5781_2690_10401_2033_1441_8554 25 3.42E-24 2.46E-22 1.23E-22 24522 hsa-mir-631 hsa05215 Prostate cancer 3320_3326_3480_1956_1499_5595_5594_1387_2064_5159_595_5156_367_1026_5925_2033_4790_5970 18 2.32E-19 1.67E-17 4.99E-18 24523 hsa-mir-631 hsa05212 Pancreatic cancer 3320_3326_3480_1956_1499_5595_5594_1387_2064_5159_595_5156_367_1026_5925_2033_4790_5970 18 2.77E-19 2.00E-17 4.99E-18 24524 hsa-mir-631 hsa04010 MAPK signaling pathway 3925_6722_3725_1956_5595_5594_5599_5159_9261_5156_4208_2261_2264_9252_7867_1432_5879_10912_6885_4616_4790_51701_5970 23 1.33E-16 9.60E-15 1.92E-15 24525 hsa-mir-631 hsa04060 Cytokine-cytokine receptor interaction 3556_2321_3559_85480_1956_4233_3560_149233_5159_5156_3575_3570_3572_1234_1230_3953_1439_7852_3454_3455_2690_1441 22 6.70E-16 4.82E-14 8.04E-15 24526 hsa-mir-631 hsa04520 Adherens junction 2241_3480_1956_1499_6714_4233_5595_5594_1387_2064_5879_6885_2033_51701 14 1.68E-14 1.21E-12 1.72E-13 24527 hsa-mir-631 hsa05214 Glioma 3480_1956_5595_5594_5159_595_5156_1026_5925_808_801_805 12 7.42E-13 5.34E-11 6.68E-12 24528 hsa-mir-631 hsa05220 Chronic myeloid leukemia 5595_5594_595_6776_6777_5781_1026_3066_3065_5925_4790_5970 12 3.35E-12 2.41E-10 2.68E-11 24529 hsa-mir-631 hsa04620 Toll-like receptor signaling pathway 3725_3654_5595_5594_5599_1432_6772_5879_3454_3455_6885_4790_5970 13 5.59E-12 4.03E-10 4.03E-11 24530 hsa-mir-631 hsa04062 Chemokine signaling pathway 3717_3718_5580_5590_5595_5594_1234_1230_6777_6772_5879_7852_2185_3055_4790_5970 16 8.17E-12 5.88E-10 5.35E-11 24531 hsa-mir-631 hsa05216 Thyroid cancer 1499_5595_5594_6258_6256_595_6257_5979_8031 9 1.06E-11 7.64E-10 6.15E-11 24532 hsa-mir-631 hsa05210 Colorectal cancer 3725_3480_1956_1499_4233_5595_5594_5599_5159_595_5156_5879 12 1.11E-11 7.99E-10 6.15E-11 24533 hsa-mir-631 hsa04912 GnRH signaling pathway 3725_5580_1956_6714_5595_5594_5599_1432_2185_808_801_805 12 1.59E-10 1.15E-08 8.20E-10 24534 hsa-mir-631 hsa05219 Bladder cancer 1956_5595_5594_2064_595_2261_9252_1026_5925 9 1.82E-10 1.31E-08 8.72E-10 24535 hsa-mir-631 hsa04510 Focal adhesion 3725_2321_3480_1956_1499_6714_4233_5595_5594_5599_2064_5159_595_5156_5879 15 2.04E-10 1.47E-08 9.19E-10 24536 hsa-mir-631 hsa04920 Adipocytokine signaling pathway 3717_10891_5599_6258_6256_3953_6257_5781_4790_5970 10 4.08E-10 2.94E-08 1.73E-09 24537 hsa-mir-631 hsa05218 Melanoma 3480_1956_4233_5595_5594_5159_595_5156_1026_5925 10 6.80E-10 4.90E-08 2.58E-09 24538 hsa-mir-631 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1956_6714_4233_5599_1432_5879_5781_4790_5970 10 6.80E-10 4.90E-08 2.58E-09 24539 hsa-mir-631 hsa05223 Non-small cell lung cancer 1956_5595_5594_6258_2064_6256_595_6257_5925 9 1.30E-09 9.39E-08 4.70E-09 24540 hsa-mir-631 hsa05221 Acute myeloid leukemia 5371_5595_5594_595_6776_6777_862_4790_5970 9 2.63E-09 1.89E-07 9.01E-09 24541 hsa-mir-631 hsa05222 Small cell lung cancer 6258_6256_595_6257_6502_10401_5925_8554_4790_5970 10 3.70E-09 2.66E-07 1.21E-08 24542 hsa-mir-631 hsa04350 TGF-beta signaling pathway 3400_5595_5594_1387_3397_3399_3398_4086_2033_6667 10 4.09E-09 2.95E-07 1.23E-08 24543 hsa-mir-631 hsa04012 ErbB signaling pathway 3725_1956_6714_5595_5594_5599_2064_6776_6777_1026 10 4.09E-09 2.95E-07 1.23E-08 24544 hsa-mir-631 hsa04330 Notch signaling pathway 388585_1387_3280_9612_3066_3065_2033_8850 8 9.51E-09 6.85E-07 2.74E-08 24545 hsa-mir-631 hsa04110 Cell cycle 1387_595_10912_1026_6502_3066_3065_4616_5925_2033 10 6.46E-08 4.65E-06 1.79E-07 24546 hsa-mir-631 hsa04950 Maturity onset diabetes of the young 3651_3172_168620_6927_3280_4760 6 9.74E-08 7.02E-06 2.60E-07 24547 hsa-mir-631 hsa05211 Renal cell carcinoma 3725_4233_5595_5594_1387_5879_5781_2033 8 1.92E-07 1.38E-05 4.94E-07 24548 hsa-mir-631 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6850_5879_3454_3455_5781_2185 9 2.17E-06 0.000156403 5.39E-06 24549 hsa-mir-631 hsa04916 Melanogenesis 1499_5595_5594_1387_2033_808_801_805 8 2.55E-06 0.000183821 6.00E-06 24550 hsa-mir-631 hsa04930 Type II diabetes mellitus 3651_5580_5590_5595_5594_5599 6 2.58E-06 0.000186002 6.00E-06 24551 hsa-mir-631 hsa04720 Long-term potentiation 5595_5594_1387_2033_808_801_805 7 3.34E-06 0.000240349 7.28E-06 24552 hsa-mir-631 hsa04662 B cell receptor signaling pathway 3725_5595_5594_6850_5879_4790_5970 7 3.34E-06 0.000240349 7.28E-06 24553 hsa-mir-631 hsa04660 T cell receptor signaling pathway 3725_3932_5595_5594_1432_6885_4790_5970 8 3.78E-06 0.000271872 8.00E-06 24554 hsa-mir-631 hsa04370 VEGF signaling pathway 6714_5595_5594_9261_7867_1432_5879 7 3.93E-06 0.000282653 8.08E-06 24555 hsa-mir-631 hsa04310 Wnt signaling pathway 3725_1499_5599_1387_595_5879_6885_2033_51701 9 4.59E-06 0.000330498 8.95E-06 24556 hsa-mir-631 hsa04664 Fc epsilon RI signaling pathway 5580_5595_5594_5599_6850_1432_5879 7 4.60E-06 0.000330985 8.95E-06 24557 hsa-mir-631 hsa05213 Endometrial cancer 1956_1499_5595_5594_2064_595 6 5.55E-06 0.000399729 1.05E-05 24558 hsa-mir-631 hsa04910 Insulin signaling pathway 10891_5590_5595_5594_5599_808_801_805 8 1.81E-05 0.001302882 3.34E-05 24559 hsa-mir-631 hsa04540 Gap junction 1956_6714_5595_5594_5159_5156 6 0.000118334 0.008520043 0.000213001 24560 hsa-mir-631 hsa04020 Calcium signaling pathway 1956_2064_5159_5156_2185_808_801_805 8 0.000125604 0.009043504 0.000220573 24561 hsa-mir-631 hsa04810 Regulation of actin cytoskeleton 1956_5595_5594_5159_5156_2261_2264_5879 8 0.000390513 0.028116958 0.000669451 24562 hsa-mir-631 hsa04270 Vascular smooth muscle contraction 5580_5595_5594_808_801_805 6 0.000402341 0.028968538 0.000673687 24563 hsa-mir-631 hsa04670 Leukocyte transendothelial migration 1499_1432_5879_7852_5781_2185 6 0.000476433 0.034303184 0.000779618 24564 hsa-mir-631 hsa04360 Axon guidance 2242_4233_5595_5594_5879_7852 6 0.00068194 0.049099715 0.001091105 24565 hsa-mir-631 hsa04210 Apoptosis 3654_3556_1439_4790_5970 5 0.000803451 0.057848438 0.001257575 24566 hsa-mir-631 hsa04120 Ubiquitin mediated proteolysis 5371_672_7329_6502_10401_8554 6 0.000916944 0.066019942 0.00140468 24567 hsa-mir-631 hsa04115 p53 signaling pathway 595_10912_1026_4616 4 0.002430854 0.175021474 0.003646281 24568 hsa-mir-631 hsa03320 PPAR signaling pathway 6258_6256_6257_2168 4 0.002554508 0.183924583 0.003753563 24569 hsa-mir-631 hsa05340 Primary immunodeficiency 3718_3932_3575 3 0.003086954 0.222260681 0.004445214 24570 hsa-mir-631 hsa05016 Huntington's disease 10891_1387_3066_3065_2033_6667 6 0.00396678 0.285608177 0.00560016 24571 hsa-mir-631 hsa04640 Hematopoietic cell lineage 3559_3575_3570_1441 4 0.005363788 0.386192709 0.007426783 24572 hsa-mir-631 hsa05010 Alzheimer's disease 5595_5594_808_801_805 5 0.013429407 0.966917298 0.018243723 24573 hsa-mir-631 hsa04730 Long-term depression 3480_5595_5594 3 0.01939884 1 0.025865121 24574 hsa-mir-631 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.023017966 1 0.03013261 24575 hsa-mir-631 hsa04530 Tight junction 5580_1499_6714_5590 4 0.023591308 1 0.030331682 24576 hsa-mir-631 hsa04612 Antigen processing and presentation 3320_3326_2923 3 0.034021415 1 0.042974419 24577 hsa-mir-631 hsa03022 Basal transcription factors 2969_2959 2 0.036074615 1 0.044782281 24578 hsa-mir-632 hsa03022 Basal transcription factors 2969 1 0.006316679 0.018950037 0.018950037 24579 hsa-mir-632 hsa04612 Antigen processing and presentation 4800 1 0.014908788 0.044726363 0.022363182 24580 hsa-mir-632 hsa04310 Wnt signaling pathway 8061 1 0.025238725 0.075716175 0.025238725 24581 hsa-mir-635 hsa03022 Basal transcription factors 2967_2961_2960_2963_6881_2968_6879_6878_6877_6874_6872_2957_2969_2958_6873_54457_6884_2959_6880_6882_138474_6883 22 1.21E-31 8.57E-30 8.57E-30 24582 hsa-mir-635 hsa05200 Pathways in cancer 5371_5595_5594_5914_6256_595_3326_10401_836_367_4193_7704_3091_5970_7428_1870_1871_7157_6688_2113_4609_1869_3725_2353_4087_4088_4089_3066_3065_5925_2034_2033_4846_8554_7184 35 1.72E-27 1.22E-25 6.10E-26 24583 hsa-mir-635 hsa05220 Chronic myeloid leukemia 5595_5594_595_4193_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464 16 1.88E-17 1.34E-15 4.46E-16 24584 hsa-mir-635 hsa04110 Cell cycle 5591_595_4193_1870_1871_7157_1869_4171_4085_4087_4088_4089_3066_3065_5925_2033_5933 17 7.21E-16 5.12E-14 1.28E-14 24585 hsa-mir-635 hsa05215 Prostate cancer 5595_5594_595_3326_367_4193_5970_1870_1871_7157_1869_5925_2033_7184 14 7.25E-14 5.15E-12 9.86E-13 24586 hsa-mir-635 hsa05212 Pancreatic cancer 5595_5594_595_3326_367_4193_5970_1870_1871_7157_1869_5925_2033_7184 14 8.33E-14 5.92E-12 9.86E-13 24587 hsa-mir-635 hsa05219 Bladder cancer 5595_5594_595_4193_1870_1871_7157_4609_1869_5925 10 8.58E-12 6.09E-10 8.70E-11 24588 hsa-mir-635 hsa05222 Small cell lung cancer 6256_595_10401_5970_1870_1871_7157_4609_1869_5925_4846_8554 12 1.82E-11 1.29E-09 1.62E-10 24589 hsa-mir-635 hsa05210 Colorectal cancer 5595_5594_595_836_7157_4609_3725_2353_4087_4088_4089 11 2.38E-10 1.69E-08 1.88E-09 24590 hsa-mir-635 hsa05214 Glioma 5595_5594_595_4193_1870_1871_7157_1869_5925_6464 10 3.84E-10 2.73E-08 2.73E-09 24591 hsa-mir-635 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925 9 1.57E-09 1.12E-07 1.01E-08 24592 hsa-mir-635 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_5970_6688_4609 9 3.16E-09 2.25E-07 1.87E-08 24593 hsa-mir-635 hsa04310 Wnt signaling pathway 1460_595_8607_7157_8061_4609_3725_1457_4087_4088_4089_2033 12 7.46E-09 5.29E-07 4.07E-08 24594 hsa-mir-635 hsa05218 Melanoma 5595_5594_595_4193_1870_1871_7157_1869_5925 9 1.37E-08 9.74E-07 6.96E-08 24595 hsa-mir-635 hsa05211 Renal cell carcinoma 5595_5594_3091_7428_2113_3725_2034_2033 8 2.26E-07 1.60E-05 1.07E-06 24596 hsa-mir-635 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 2.92E-07 2.07E-05 1.30E-06 24597 hsa-mir-635 hsa04520 Adherens junction 1460_5595_5594_1457_4087_4088_4089_2033 8 4.74E-07 3.37E-05 1.98E-06 24598 hsa-mir-635 hsa04350 TGF-beta signaling pathway 5595_5594_4609_4087_4088_4089_2033_5933 8 8.56E-07 6.08E-05 3.38E-06 24599 hsa-mir-635 hsa04010 MAPK signaling pathway 5595_5594_4208_836_3312_5970_7157_4609_3725_3727_2353_4763 12 2.94E-06 0.000208791 1.10E-05 24600 hsa-mir-635 hsa05016 Huntington's disease 6874_2902_836_9001_5430_7157_3066_3065_3064_2033 10 4.06E-06 0.00028793 1.44E-05 24601 hsa-mir-635 hsa04330 Notch signaling pathway 9612_3066_3065_2033_8850 5 5.46E-05 0.003875587 0.000184552 24602 hsa-mir-635 hsa03050 Proteasome 5719_5705_5701_5702_5710 5 5.99E-05 0.004252136 0.000193279 24603 hsa-mir-635 hsa05213 Endometrial cancer 5595_5594_595_7157_4609 5 8.52E-05 0.006048277 0.000262969 24604 hsa-mir-635 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725_2353 5 0.000422644 0.030007751 0.001250323 24605 hsa-mir-635 hsa04012 ErbB signaling pathway 5595_5594_4609_3725_6464 5 0.000801342 0.056895284 0.002275811 24606 hsa-mir-635 hsa04120 Ubiquitin mediated proteolysis 5371_672_10401_4193_7428_8554 6 0.001022553 0.072601273 0.002792357 24607 hsa-mir-635 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_7157_4846 4 0.001272173 0.090324309 0.003345345 24608 hsa-mir-635 hsa04620 Toll-like receptor signaling pathway 5595_5594_5970_3725_2353 5 0.001575769 0.11187963 0.003995701 24609 hsa-mir-635 hsa04660 T cell receptor signaling pathway 5595_5594_5970_3725_2353 5 0.002163098 0.153579949 0.00529586 24610 hsa-mir-635 hsa04115 p53 signaling pathway 595_836_4193_7157 4 0.002623386 0.186260431 0.006208681 24611 hsa-mir-635 hsa05010 Alzheimer's disease 22926_5595_5594_2902_836_4846 6 0.003306847 0.234786135 0.007573746 24612 hsa-mir-635 hsa04720 Long-term potentiation 5595_5594_2902_2033 4 0.003491755 0.247914599 0.007747331 24613 hsa-mir-635 hsa04910 Insulin signaling pathway 6720_5595_5594_5211_6464 5 0.005489 0.38971899 0.011809666 24614 hsa-mir-635 hsa03420 Nucleotide excision repair 2967_2968_5887 3 0.0059802 0.424594206 0.012488065 24615 hsa-mir-635 hsa04612 Antigen processing and presentation 3326_4800_4801_3312 4 0.006233439 0.442574167 0.012644976 24616 hsa-mir-635 hsa04630 Jak-STAT signaling pathway 595_10401_4609_2033_8554 5 0.008720841 0.619179721 0.017199437 24617 hsa-mir-635 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.009243053 0.656256792 0.01773667 24618 hsa-mir-635 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_5970_3725 3 0.020499728 1 0.037320017 24619 hsa-mir-635 hsa04730 Long-term depression 5595_5594_4846 3 0.020499728 1 0.037320017 24620 hsa-mir-635 hsa04370 VEGF signaling pathway 5595_5594_4846 3 0.025114881 1 0.04365157 24621 hsa-mir-635 hsa04510 Focal adhesion 5595_5594_595_3725_6464 5 0.025738631 1 0.04365157 24622 hsa-mir-635 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_6464 4 0.025822055 1 0.04365157 24623 hsa-mir-635 hsa04210 Apoptosis 836_5970_7157 3 0.035877261 1 0.059239198 24624 hsa-mir-635 hsa04540 Gap junction 5595_5594_10382 3 0.039912865 1 0.06440485 24625 hsa-mir-636 hsa05200 Pathways in cancer 5371_5595_5594_5599_5914_1387_6256_595_5601_836_367_1017_2932_4149_7704_6774_3091_5970_7428_1870_1871_7157_4087_6688_2113_4609_1869_3725_2353_4088_4089_3066_3065_1050_5925_2034_2033_4846_207_4286 40 2.18E-36 1.42E-34 1.42E-34 24626 hsa-mir-636 hsa04110 Cell cycle 5591_1387_595_1017_2932_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_890_5934_5933 19 9.39E-20 6.11E-18 3.05E-18 24627 hsa-mir-636 hsa05220 Chronic myeloid leukemia 5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_207_6464 16 1.36E-18 8.84E-17 2.95E-17 24628 hsa-mir-636 hsa05215 Prostate cancer 5595_5594_1387_595_367_1017_2932_5970_1870_1871_7157_1869_10488_5925_2033_207 16 1.29E-17 8.35E-16 1.96E-16 24629 hsa-mir-636 hsa05212 Pancreatic cancer 5595_5594_1387_595_367_1017_2932_5970_1870_1871_7157_1869_10488_5925_2033_207 16 1.51E-17 9.80E-16 1.96E-16 24630 hsa-mir-636 hsa05210 Colorectal cancer 5595_5594_5599_595_5601_836_2932_7157_4087_4609_3725_2353_4088_4089_207 15 1.73E-16 1.13E-14 1.88E-15 24631 hsa-mir-636 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_1874_1875_4087_659_4609_3399_4088_4089_2033_5934_5933 15 2.76E-16 1.79E-14 2.56E-15 24632 hsa-mir-636 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_6774_5970_6688_4609_1050_207 12 4.93E-14 3.20E-12 4.00E-13 24633 hsa-mir-636 hsa05222 Small cell lung cancer 6256_595_1017_4149_5970_1870_1871_7157_4609_1869_5925_4846_207 13 1.27E-13 8.28E-12 9.20E-13 24634 hsa-mir-636 hsa04310 Wnt signaling pathway 5599_1387_595_5601_2932_7157_4087_4609_3725_1457_4088_4089_2033_8061 14 6.89E-12 4.48E-10 4.48E-11 24635 hsa-mir-636 hsa04010 MAPK signaling pathway 5595_5594_5599_4208_5601_836_4149_3312_1386_1649_5970_7157_4609_3725_2353_4763_207 17 1.29E-11 8.37E-10 7.61E-11 24636 hsa-mir-636 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925_207 10 1.51E-11 9.81E-10 8.17E-11 24637 hsa-mir-636 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5925 9 5.11E-11 3.32E-09 2.56E-10 24638 hsa-mir-636 hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_207_6464 10 7.75E-11 5.04E-09 3.60E-10 24639 hsa-mir-636 hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5925_207_4286 10 1.70E-10 1.10E-08 7.35E-10 24640 hsa-mir-636 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2113_3725_2034_2033_207 10 1.92E-10 1.25E-08 7.81E-10 24641 hsa-mir-636 hsa05016 Huntington's disease 6874_1387_2902_6908_836_6667_7157_3066_3065_3064_10488_2033 12 1.11E-08 7.24E-07 4.26E-08 24642 hsa-mir-636 hsa04012 ErbB signaling pathway 5595_5594_5599_5601_2932_4609_3725_207_6464 9 1.68E-08 1.09E-06 6.08E-08 24643 hsa-mir-636 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 1.11E-07 7.24E-06 3.81E-07 24644 hsa-mir-636 hsa05213 Endometrial cancer 5595_5594_595_2932_7157_4609_207 7 1.33E-07 8.62E-06 4.22E-07 24645 hsa-mir-636 hsa04520 Adherens junction 5595_5594_1387_4087_1457_4088_4089_2033 8 1.36E-07 8.87E-06 4.22E-07 24646 hsa-mir-636 hsa04910 Insulin signaling pathway 6720_5595_5594_5599_5601_2932_23265_207_6464 9 6.68E-07 4.34E-05 1.97E-06 24647 hsa-mir-636 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5601_5970_3725_2353_207 8 7.68E-07 4.99E-05 2.17E-06 24648 hsa-mir-636 hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_3725_2353_207 7 1.30E-06 8.44E-05 3.41E-06 24649 hsa-mir-636 hsa04660 T cell receptor signaling pathway 5595_5594_5601_2932_5970_3725_2353_207 8 1.31E-06 8.51E-05 3.41E-06 24650 hsa-mir-636 hsa04920 Adipocytokine signaling pathway 5599_6256_5601_6774_5970_207 6 9.47E-06 0.000615842 2.37E-05 24651 hsa-mir-636 hsa04916 Melanogenesis 5595_5594_1387_2932_10488_2033_4286 7 9.86E-06 0.000640883 2.37E-05 24652 hsa-mir-636 hsa04510 Focal adhesion 5595_5594_5599_595_5601_2932_3725_207_6464 9 1.50E-05 0.000976731 3.49E-05 24653 hsa-mir-636 hsa04330 Notch signaling pathway 1387_9612_3066_3065_2033 5 2.50E-05 0.001627732 5.61E-05 24654 hsa-mir-636 hsa04115 p53 signaling pathway 595_836_1017_7157_64326 5 0.000137882 0.008962315 0.000298744 24655 hsa-mir-636 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5601_836_5970_3725 5 0.000156444 0.010168843 0.000328027 24656 hsa-mir-636 hsa04720 Long-term potentiation 5595_5594_1387_2902_2033 5 0.000199242 0.012950762 0.000404711 24657 hsa-mir-636 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5601_207 5 0.000250431 0.016277983 0.000493272 24658 hsa-mir-636 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601 4 0.000319156 0.020745113 0.00061015 24659 hsa-mir-636 hsa04062 Chemokine signaling pathway 5595_5594_2932_6774_5970_207_6464 7 0.00040348 0.026226202 0.00074932 24660 hsa-mir-636 hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_7428_7329_64326 6 0.000435516 0.028308549 0.000786349 24661 hsa-mir-636 hsa04150 mTOR signaling pathway 5595_5594_3091_207 4 0.000533548 0.034680599 0.000937313 24662 hsa-mir-636 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_7157_4846 4 0.00069385 0.045100244 0.001186849 24663 hsa-mir-636 hsa04630 Jak-STAT signaling pathway 1387_595_6774_4609_2033_207 6 0.000755627 0.049115773 0.001259379 24664 hsa-mir-636 hsa04912 GnRH signaling pathway 5595_5594_5599_5601_3725 5 0.000974848 0.0633651 0.001584128 24665 hsa-mir-636 hsa05010 Alzheimer's disease 5595_5594_2902_836_2932_4846 6 0.001461723 0.095012002 0.002317366 24666 hsa-mir-636 hsa04370 VEGF signaling pathway 5595_5594_4846_207 4 0.002124051 0.138063307 0.003287222 24667 hsa-mir-636 hsa03022 Basal transcription factors 6874_6908_2959 3 0.00239354 0.155580086 0.003618142 24668 hsa-mir-636 hsa04210 Apoptosis 836_5970_7157_207 4 0.003504363 0.227783618 0.0051769 24669 hsa-mir-636 hsa04730 Long-term depression 5595_5594_4846 3 0.01331845 0.865699236 0.019237761 24670 hsa-mir-636 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_6464 4 0.015169222 0.985999418 0.02143477 24671 hsa-mir-636 hsa04612 Antigen processing and presentation 4800_4801_3312 3 0.023663621 1 0.032726284 24672 hsa-mir-638 hsa05210 Colorectal cancer 4087_4088_4609 3 0.000143673 0.002442437 0.001350308 24673 hsa-mir-638 hsa04350 TGF-beta signaling pathway 4087_4088_4609 3 0.00015886 0.002700615 0.001350308 24674 hsa-mir-638 hsa04310 Wnt signaling pathway 4087_4088_4609 3 0.000781535 0.013286093 0.004428698 24675 hsa-mir-638 hsa05220 Chronic myeloid leukemia 4088_4609 2 0.003654022 0.062118376 0.014049526 24676 hsa-mir-638 hsa04520 Adherens junction 4087_4088 2 0.004132214 0.070247631 0.014049526 24677 hsa-mir-638 hsa04612 Antigen processing and presentation 4800_4801 2 0.005061973 0.086053541 0.014342257 24678 hsa-mir-638 hsa05200 Pathways in cancer 4087_4088_4609 3 0.006911549 0.117496333 0.01678519 24679 hsa-mir-638 hsa04110 Cell cycle 4087_4088 2 0.008780558 0.149269494 0.018658687 24680 hsa-mir-638 hsa05216 Thyroid cancer 4609 1 0.034391211 0.584650589 0.064961177 24681 hsa-mir-638 hsa05219 Bladder cancer 4609 1 0.048934681 0.831889579 0.083188958 24682 hsa-mir-639 hsa05200 Pathways in cancer 5371_5595_5594_5914_6256_595_836_367_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_4088_4089_3066_3065_5925_2034_2033_4846 28 4.16E-32 2.58E-30 2.58E-30 24683 hsa-mir-639 hsa05220 Chronic myeloid leukemia 5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464 15 1.54E-22 9.54E-21 4.77E-21 24684 hsa-mir-639 hsa04110 Cell cycle 5591_595_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933 14 3.66E-18 2.27E-16 7.56E-17 24685 hsa-mir-639 hsa05215 Prostate cancer 5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033 11 9.26E-15 5.74E-13 1.29E-13 24686 hsa-mir-639 hsa05212 Pancreatic cancer 5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033 11 1.04E-14 6.44E-13 1.29E-13 24687 hsa-mir-639 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5925 9 3.49E-14 2.16E-12 3.60E-13 24688 hsa-mir-639 hsa05210 Colorectal cancer 5595_5594_595_836_7157_4087_4609_3725_4088_4089 10 2.52E-13 1.56E-11 2.04E-12 24689 hsa-mir-639 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_5925 9 2.63E-13 1.63E-11 2.04E-12 24690 hsa-mir-639 hsa05222 Small cell lung cancer 6256_595_5970_1870_1871_7157_4609_1869_5925_4846 10 3.13E-13 1.94E-11 2.16E-12 24691 hsa-mir-639 hsa05214 Glioma 5595_5594_595_1870_1871_7157_1869_5925_6464 9 1.20E-12 7.43E-11 7.43E-12 24692 hsa-mir-639 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_5970_4609 8 2.63E-11 1.63E-09 1.48E-10 24693 hsa-mir-639 hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5925 8 1.02E-10 6.34E-09 5.28E-10 24694 hsa-mir-639 hsa05211 Renal cell carcinoma 5595_5594_3091_7428_2113_3725_2034_2033 8 1.13E-10 7.03E-09 5.40E-10 24695 hsa-mir-639 hsa04350 TGF-beta signaling pathway 5595_5594_4087_4609_4088_4089_2033_5933 8 4.58E-10 2.84E-08 2.03E-09 24696 hsa-mir-639 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 9.15E-10 5.67E-08 3.78E-09 24697 hsa-mir-639 hsa04310 Wnt signaling pathway 595_7157_4087_4609_3725_1457_4088_4089_2033 9 1.40E-09 8.68E-08 5.42E-09 24698 hsa-mir-639 hsa04520 Adherens junction 5595_5594_4087_1457_4088_4089_2033 7 8.13E-09 5.04E-07 2.96E-08 24699 hsa-mir-639 hsa04010 MAPK signaling pathway 5595_5594_4208_836_3312_5970_7157_4609_3725_4763 10 1.36E-08 8.45E-07 4.69E-08 24700 hsa-mir-639 hsa05016 Huntington's disease 6874_2902_836_7157_3066_3065_3064_2033 8 1.38E-07 8.55E-06 4.50E-07 24701 hsa-mir-639 hsa05213 Endometrial cancer 5595_5594_595_7157_4609 5 7.92E-07 4.91E-05 2.46E-06 24702 hsa-mir-639 hsa04012 ErbB signaling pathway 5595_5594_4609_3725_6464 5 8.57E-06 0.000531387 2.53E-05 24703 hsa-mir-639 hsa04330 Notch signaling pathway 9612_3066_3065_2033 4 1.68E-05 0.001041198 4.73E-05 24704 hsa-mir-639 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_7157_4846 4 3.21E-05 0.001990422 8.65E-05 24705 hsa-mir-639 hsa04720 Long-term potentiation 5595_5594_2902_2033 4 9.47E-05 0.005872995 0.00023492 24706 hsa-mir-639 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725 4 9.47E-05 0.005872995 0.00023492 24707 hsa-mir-639 hsa05010 Alzheimer's disease 5595_5594_2902_836_4846 5 0.000222199 0.013776311 0.000529858 24708 hsa-mir-639 hsa04620 Toll-like receptor signaling pathway 5595_5594_5970_3725 4 0.00029453 0.018260834 0.000676327 24709 hsa-mir-639 hsa04660 T cell receptor signaling pathway 5595_5594_5970_3725 4 0.000388502 0.024087104 0.000860254 24710 hsa-mir-639 hsa04510 Focal adhesion 5595_5594_595_3725_6464 5 0.000438211 0.027169068 0.000936864 24711 hsa-mir-639 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.000606587 0.037608391 0.001253613 24712 hsa-mir-639 hsa04910 Insulin signaling pathway 6720_5595_5594_6464 4 0.000887004 0.054994227 0.00171857 24713 hsa-mir-639 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_6464 4 0.000887004 0.054994227 0.00171857 24714 hsa-mir-639 hsa04115 p53 signaling pathway 595_836_7157 3 0.001329343 0.082419271 0.002497554 24715 hsa-mir-639 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_5970_3725 3 0.001438684 0.089198411 0.002548526 24716 hsa-mir-639 hsa04730 Long-term depression 5595_5594_4846 3 0.001438684 0.089198411 0.002548526 24717 hsa-mir-639 hsa04370 VEGF signaling pathway 5595_5594_4846 3 0.001800045 0.11160278 0.003100077 24718 hsa-mir-639 hsa04612 Antigen processing and presentation 4800_4801_3312 3 0.002681283 0.166239573 0.004374726 24719 hsa-mir-639 hsa04210 Apoptosis 836_5970_7157 3 0.002681283 0.166239573 0.004374726 24720 hsa-mir-639 hsa04062 Chemokine signaling pathway 5595_5594_5970_6464 4 0.002936341 0.182053166 0.00466803 24721 hsa-mir-639 hsa04916 Melanogenesis 5595_5594_2033 3 0.004103678 0.25442802 0.0063607 24722 hsa-mir-639 hsa04912 GnRH signaling pathway 5595_5594_3725 3 0.004546884 0.281906832 0.006875776 24723 hsa-mir-639 hsa04930 Type II diabetes mellitus 5595_5594 2 0.008763359 0.543328272 0.012922499 24724 hsa-mir-639 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428 3 0.008962379 0.555667472 0.012922499 24725 hsa-mir-639 hsa04630 Jak-STAT signaling pathway 595_4609_2033 3 0.011958015 0.741396911 0.01684993 24726 hsa-mir-639 hsa04920 Adipocytokine signaling pathway 6256_5970 2 0.018228702 1 0.025115101 24727 hsa-mir-639 hsa04664 Fc epsilon RI signaling pathway 5595_5594 2 0.024601767 1 0.033158903 24728 hsa-mir-639 hsa04540 Gap junction 5595_5594 2 0.033006835 1 0.043540931 24729 hsa-mir-639 hsa04710 Circadian rhythm - mammal 8863 1 0.041078632 1 0.0530599 24730 hsa-mir-639 hsa03450 Non-homologous end-joining 5591 1 0.043948127 1 0.055607834 24731 hsa-mir-640 hsa05200 Pathways in cancer 3551_5467_5468_595_1017_8517_4193_6934_7704_3091_7175_3065_1050_5925_1499_25_405_9063_1487_1488_2885_2113_10401_861_207_1147_3320_5595_5594_5599_1387_6256_4286_367_2932_6774_6776_6777_6772_5970_7157_6688_7849_1869_3725_4087_4088_4089_2034_2033_4791_4792_3326_51176_5371_5604_5601_4609_2956_2353 60 2.61E-44 2.11E-42 2.11E-42 24732 hsa-mir-640 hsa05220 Chronic myeloid leukemia 3551_595_8517_4193_3065_5925_25_1487_1488_2885_861_207_1147_5595_5594_6776_6777_5970_7157_1869_4088_4089_4792_5604_4609 25 1.46E-24 1.18E-22 5.85E-23 24733 hsa-mir-640 hsa05215 Prostate cancer 3551_595_1017_8517_4193_6934_5925_1499_2885_207_1147_3320_5595_5594_1387_367_2932_5970_7157_468_1869_2033_4792_3326_51176_5604 26 2.26E-24 1.83E-22 5.85E-23 24734 hsa-mir-640 hsa05212 Pancreatic cancer 3551_595_1017_8517_4193_6934_5925_1499_2885_207_1147_3320_5595_5594_1387_367_2932_5970_7157_468_1869_2033_4792_3326_51176_5604 26 2.89E-24 2.34E-22 5.85E-23 24735 hsa-mir-640 hsa04010 MAPK signaling pathway 6722_3551_8517_9252_4773_3303_9344_1432_2885_207_1147_5595_5594_5599_1386_3310_3312_5971_5970_3164_7157_468_3725_3727_4791_1326_5604_4208_5606_5601_5600_5566_3305_4609_2353_2002_2005 37 1.21E-23 9.83E-22 1.97E-22 24736 hsa-mir-640 hsa05221 Acute myeloid leukemia 3551_5467_595_8517_6934_7704_1050_2885_861_207_1147_5595_5594_6774_6776_6777_5970_6688_51176_5371_5604_4609 22 1.23E-22 9.96E-21 1.66E-21 24737 hsa-mir-640 hsa04310 Wnt signaling pathway 5467_595_8607_6934_6500_8945_4772_4773_1499_23291_1487_1488_5599_1387_2932_7157_3725_4087_4088_4089_2033_51176_5601_5566_8454_4609_5527 27 3.02E-20 2.45E-18 3.50E-19 24738 hsa-mir-640 hsa05210 Colorectal cancer 595_6934_1499_2885_207_5595_5594_5599_2932_7157_3725_4087_4088_4089_51176_5604_5601_4609_2956_2353 20 1.78E-17 1.44E-15 1.81E-16 24739 hsa-mir-640 hsa04660 T cell receptor signaling pathway 3551_8517_4772_4773_1432_2885_4794_207_1147_5595_5594_2932_5970_3725_4792_4793_1326_5604_5601_5600_2353 21 1.38E-16 1.12E-14 1.24E-15 24740 hsa-mir-640 hsa04620 Toll-like receptor signaling pathway 3551_8517_3665_3661_1432_207_1147_5595_5594_5599_6772_5970_3725_4792_1326_5604_5606_5601_5600_2353 20 4.70E-16 3.80E-14 3.80E-15 24741 hsa-mir-640 hsa04350 TGF-beta signaling pathway 6500_4086_6667_3397_3399_3398_1875_5934_5595_5594_1387_4087_4088_4089_2033_8454_4609_4092 18 6.18E-15 5.01E-13 4.55E-14 24742 hsa-mir-640 hsa04662 B cell receptor signaling pathway 3551_8517_4772_4773_2885_4794_207_1147_5595_5594_2932_5970_3725_4792_4793_5604_2353 17 9.55E-15 7.73E-13 6.09E-14 24743 hsa-mir-640 hsa05216 Thyroid cancer 5468_595_6934_7175_1499_5595_5594_6256_7157_7849_51176_5604_4609 13 9.78E-15 7.92E-13 6.09E-14 24744 hsa-mir-640 hsa04110 Cell cycle 595_1017_4193_6500_5111_3065_5925_25_5934_5591_1387_2932_7157_1869_4087_4088_4089_2033_8454 19 6.95E-14 5.63E-12 4.02E-13 24745 hsa-mir-640 hsa05213 Endometrial cancer 595_6934_1499_2309_2885_207_5595_5594_2932_7157_51176_5604_4609_2002 14 2.97E-13 2.41E-11 1.61E-12 24746 hsa-mir-640 hsa04912 GnRH signaling pathway 5580_1432_2885_5595_5594_5599_468_3725_808_801_805_5604_5606_5601_5600_5566_2002 17 1.79E-12 1.45E-10 9.04E-12 24747 hsa-mir-640 hsa04920 Adipocytokine signaling pathway 3551_10891_5465_8517_4794_207_1147_5599_6256_6774_5970_4792_4793_5601 14 5.80E-12 4.70E-10 2.77E-11 24748 hsa-mir-640 hsa05222 Small cell lung cancer 3551_595_1017_8517_5925_9063_10401_207_1147_6256_5970_7157_1869_4792_4609 15 9.94E-12 8.06E-10 4.48E-11 24749 hsa-mir-640 hsa04330 Notch signaling pathway 3065_22938_1487_1488_9612_1387_2033_8850_9794_1840_2648_4851 12 2.56E-11 2.07E-09 1.09E-10 24750 hsa-mir-640 hsa05214 Glioma 595_4193_5925_2885_207_5595_5594_7157_1869_808_801_805_5604 13 5.39E-11 4.37E-09 2.18E-10 24751 hsa-mir-640 hsa04012 ErbB signaling pathway 25_2885_207_5595_5594_5599_2932_6776_6777_3725_5604_5601_4609_2002 14 1.27E-10 1.03E-08 4.90E-10 24752 hsa-mir-640 hsa04062 Chemokine signaling pathway 3551_8517_653361_5580_2309_2885_207_1147_5595_5594_2932_6774_6777_6772_5970_4792_4793_5604_5566 19 1.52E-10 1.23E-08 5.60E-10 24753 hsa-mir-640 hsa04916 Melanogenesis 6934_1499_5595_5594_1387_4286_2932_2033_808_801_805_51176_5604_5566 14 1.05E-09 8.47E-08 3.68E-09 24754 hsa-mir-640 hsa05223 Non-small cell lung cancer 595_5925_2309_2885_207_5595_5594_6256_7157_1869_5604 11 1.40E-09 1.13E-07 4.72E-09 24755 hsa-mir-640 hsa05211 Renal cell carcinoma 3091_405_2885_2113_207_5595_5594_1387_3725_2034_2033_5604 12 1.89E-09 1.53E-07 6.13E-09 24756 hsa-mir-640 hsa05219 Bladder cancer 595_9252_4193_5925_5595_5594_7157_1869_5604_4609 10 2.13E-09 1.73E-07 6.65E-09 24757 hsa-mir-640 hsa04910 Insulin signaling pathway 3551_10891_2885_207_5595_5594_5599_2932_808_801_805_5604_5601_5566_2002 15 3.86E-09 3.13E-07 1.16E-08 24758 hsa-mir-640 hsa05322 Systemic lupus erythematosus 3021_3020_8366_8368_8294_8370_121504_8361_8360_8363_8362_8365_8364_8367_8359 15 6.56E-09 5.31E-07 1.90E-08 24759 hsa-mir-640 hsa04120 Ubiquitin mediated proteolysis 4193_6500_3093_8945_23291_9063_10401_10273_7323_7329_8925_5371_672_8454 14 3.10E-08 2.51E-06 8.65E-08 24760 hsa-mir-640 hsa04664 Fc epsilon RI signaling pathway 5580_1432_2885_207_5595_5594_5599_5604_5606_5601_5600 11 4.77E-08 3.87E-06 1.29E-07 24761 hsa-mir-640 hsa04520 Adherens junction 6934_1499_71_5595_5594_1387_4087_4088_4089_2033_51176 11 5.36E-08 4.35E-06 1.40E-07 24762 hsa-mir-640 hsa04630 Jak-STAT signaling pathway 3559_595_9063_2885_10401_207_1387_6778_6774_6776_6777_6772_2033_4609 14 1.08E-07 8.78E-06 2.74E-07 24763 hsa-mir-640 hsa03410 Base excision repair 3146_4350_5111_142_252969_328_2237_6996 8 1.42E-07 1.15E-05 3.48E-07 24764 hsa-mir-640 hsa05218 Melanoma 595_4193_5925_207_5595_5594_4286_7157_1869_5604 10 1.78E-07 1.44E-05 4.11E-07 24765 hsa-mir-640 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3551_8517_1432_1147_5599_5970_3725_4792_5601_5600 10 1.78E-07 1.44E-05 4.11E-07 24766 hsa-mir-640 hsa04720 Long-term potentiation 5595_5594_1387_468_2033_808_801_805_5604_5566 10 2.82E-07 2.28E-05 6.33E-07 24767 hsa-mir-640 hsa04210 Apoptosis 3551_8517_8837_823_207_1147_5970_7157_4792_5566 10 1.18E-06 9.56E-05 2.59E-06 24768 hsa-mir-640 hsa04540 Gap junction 10382_203068_2885_5595_5594_347733_5604_5566_7278_84617 10 1.70E-06 0.000137919 3.63E-06 24769 hsa-mir-640 hsa04510 Focal adhesion 595_1499_2885_10627_207_71_5595_5594_5599_2932_3725_5604_5601_2002 14 2.63E-06 0.00021269 5.45E-06 24770 hsa-mir-640 hsa05131 Shigellosis 10382_1499_25_203068_71_347733_7278_84617 8 2.78E-06 0.000225377 5.50E-06 24771 hsa-mir-640 hsa05130 Pathogenic Escherichia coli infection 10382_1499_25_203068_71_347733_7278_84617 8 2.78E-06 0.000225377 5.50E-06 24772 hsa-mir-640 hsa05016 Huntington's disease 10891_5468_293_3065_6667_292_5441_1387_5437_7157_2033_1213_6908 13 5.00E-06 0.000404769 9.64E-06 24773 hsa-mir-640 hsa03020 RNA polymerase 64425_25885_51082_5441_5437_84172 6 7.73E-06 0.000626143 1.46E-05 24774 hsa-mir-640 hsa04270 Vascular smooth muscle contraction 5580_5595_5594_4637_808_801_805_59_5604_5566 10 1.21E-05 0.000977006 2.22E-05 24775 hsa-mir-640 hsa04370 VEGF signaling pathway 4772_4773_1432_207_5595_5594_5604_5600 8 2.35E-05 0.00190431 4.23E-05 24776 hsa-mir-640 hsa04612 Antigen processing and presentation 3309_3303_3320_3310_3312_3326_4801_3305 8 6.11E-05 0.004953104 0.000107676 24777 hsa-mir-640 hsa04930 Type II diabetes mellitus 3551_5580_5595_5594_5599_5601 6 7.12E-05 0.005766923 0.0001227 24778 hsa-mir-640 hsa03450 Non-homologous end-joining 10111_2237_5591_4361 4 9.40E-05 0.007616046 0.000158668 24779 hsa-mir-640 hsa04115 p53 signaling pathway 595_1017_4194_4193_7157_7161 6 0.00060288 0.048833289 0.000996598 24780 hsa-mir-640 hsa05010 Alzheimer's disease 823_6622_5595_5594_2932_808_801_805_9451 9 0.001182468 0.095779884 0.001915598 24781 hsa-mir-640 hsa05217 Basal cell carcinoma 6934_1499_2932_7157_51176 5 0.001434536 0.116197425 0.002278381 24782 hsa-mir-640 hsa04530 Tight junction 1499_5580_4627_4628_10627_207_71 7 0.003967841 0.321395107 0.006180675 24783 hsa-mir-640 hsa04950 Maturity onset diabetes of the young 6927_4760_5080 3 0.005976545 0.48410018 0.009133966 24784 hsa-mir-640 hsa04150 mTOR signaling pathway 3091_207_5595_5594 4 0.007475854 0.605544175 0.011213781 24785 hsa-mir-640 hsa03440 Homologous recombination 10111_4683_4361 3 0.008818931 0.714333404 0.012796136 24786 hsa-mir-640 hsa04670 Leukocyte transendothelial migration 653361_1499_1432_10627_71_5600 6 0.008846711 0.716583599 0.012796136 24787 hsa-mir-640 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_7157_5606_5600 4 0.009508499 0.770188419 0.013512078 24788 hsa-mir-640 hsa04340 Hedgehog signaling pathway 8945_23291_2932_5566 4 0.010067329 0.815453671 0.014059546 24789 hsa-mir-640 hsa04360 Axon guidance 4772_4773_25_5595_5594_2932 6 0.012103262 0.980364243 0.016616343 24790 hsa-mir-640 hsa04810 Regulation of actin cytoskeleton 4627_4628_10627_71_5595_5594_5604_10788 8 0.014029602 1 0.018939962 24791 hsa-mir-640 hsa04650 Natural killer cell mediated cytotoxicity 4772_4773_2885_5595_5594_5604 6 0.015159856 1 0.0201303 24792 hsa-mir-640 hsa03022 Basal transcription factors 2969_2959_6908 3 0.01769889 1 0.023122743 24793 hsa-mir-640 hsa03320 PPAR signaling pathway 5465_5467_5468_6256 4 0.019321235 1 0.024841588 24794 hsa-mir-640 hsa03430 Mismatch repair 5111_2956 2 0.046292851 1 0.05858939 24795 hsa-mir-640 hsa04020 Calcium signaling pathway 293_292_808_801_805_5566 6 0.048973337 1 0.061028312 24796 hsa-mir-641 hsa05200 Pathways in cancer 3716_1147_3320_3326_3725_5371_3480_1956_4233_5595_5594_5599_1387_2064_5159_595_5156_1487_1488_898_367_2261_8517_3551_6776_6777_6772_5979_5879_4087_1026_10401_4088_3066_3065_2033_1441_4790_4791_4792_5970 41 5.20E-41 3.69E-39 3.69E-39 24797 hsa-mir-641 hsa05215 Prostate cancer 1147_3320_3326_3480_1956_5595_5594_1387_2064_5159_595_5156_898_367_8517_3551_1026_2033_4790_4792_5970 21 1.44E-26 1.02E-24 4.19E-25 24798 hsa-mir-641 hsa05212 Pancreatic cancer 1147_3320_3326_3480_1956_5595_5594_1387_2064_5159_595_5156_898_367_8517_3551_1026_2033_4790_4792_5970 21 1.77E-26 1.26E-24 4.19E-25 24799 hsa-mir-641 hsa04630 Jak-STAT signaling pathway 3717_3716_3718_3559_85480_3560_149233_1387_595_3575_3570_3572_3953_6776_6777_6772_1439_3454_3455_5781_2690_10401_2033_1441 24 3.03E-26 2.15E-24 5.38E-25 24800 hsa-mir-641 hsa05220 Chronic myeloid leukemia 1147_5595_5594_595_1487_1488_8517_3551_6776_6777_5781_1026_4088_3066_3065_4790_4792_5970 18 5.91E-23 4.20E-21 8.40E-22 24801 hsa-mir-641 hsa04010 MAPK signaling pathway 1147_3925_3725_1956_5595_5594_5599_5159_5156_2261_2264_8517_9252_3551_5971_5879_1326_3312_6885_9020_4790_4791_51701_5970 24 6.42E-21 4.56E-19 7.59E-20 24802 hsa-mir-641 hsa04620 Toll-like receptor signaling pathway 1147_3725_3654_5595_5594_5599_8517_9641_3551_6772_5879_1326_3454_3455_6885_4790_4792_5970 18 7.76E-21 5.51E-19 7.87E-20 24803 hsa-mir-641 hsa04062 Chemokine signaling pathway 3717_1147_3718_5580_5590_5595_5594_1234_8517_1230_3551_6777_6772_5879_7852_2185_3055_4790_4792_4793_5970 21 3.55E-20 2.52E-18 3.15E-19 24804 hsa-mir-641 hsa04060 Cytokine-cytokine receptor interaction 3556_2321_3559_85480_1956_4233_3560_149233_5159_5156_3575_3570_3572_1234_1230_3953_1439_7852_3454_3455_2690_1441 22 7.45E-19 5.29E-17 5.88E-18 24805 hsa-mir-641 hsa04520 Adherens junction 2241_3480_1956_6714_4233_5595_5594_1387_2064_5879_4087_6885_4088_2033_51701 15 6.68E-18 4.74E-16 4.74E-17 24806 hsa-mir-641 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_3725_1956_6714_4233_5599_8517_3551_5879_5781_9020_4790_4792_5970 14 4.67E-17 3.31E-15 3.01E-16 24807 hsa-mir-641 hsa04660 T cell receptor signaling pathway 1147_3725_3932_5595_5594_8517_3551_4794_1326_6885_9020_4790_4792_4793_5970 15 4.75E-16 3.37E-14 2.81E-15 24808 hsa-mir-641 hsa04662 B cell receptor signaling pathway 1147_3725_5595_5594_6850_8517_3551_5879_4794_4790_4792_4793_5970 13 2.79E-15 1.98E-13 1.53E-14 24809 hsa-mir-641 hsa05210 Colorectal cancer 3725_3480_1956_4233_5595_5594_5599_5159_595_5156_5879_4087_4088 13 1.04E-14 7.38E-13 5.27E-14 24810 hsa-mir-641 hsa04920 Adipocytokine signaling pathway 3717_1147_5599_8517_3953_3551_4794_5781_4790_4792_4793_5970 12 2.38E-14 1.69E-12 1.13E-13 24811 hsa-mir-641 hsa04310 Wnt signaling pathway 3725_5599_1387_595_1487_1488_8454_5879_4087_6885_23291_6500_4088_2033_51701 15 3.75E-14 2.66E-12 1.67E-13 24812 hsa-mir-641 hsa05221 Acute myeloid leukemia 1147_5371_5595_5594_595_8517_3551_6776_6777_4790_5970 11 1.99E-13 1.42E-11 8.33E-13 24813 hsa-mir-641 hsa05214 Glioma 3480_1956_5595_5594_5159_595_5156_1026_808_805_801 11 5.13E-13 3.64E-11 2.02E-12 24814 hsa-mir-641 hsa04330 Notch signaling pathway 388585_1387_1487_1488_3280_3066_3065_2033_4851 9 2.65E-11 1.88E-09 9.90E-11 24815 hsa-mir-641 hsa04510 Focal adhesion 3725_2321_3480_1956_6714_4233_5595_5594_5599_2064_5159_595_5156_5879 14 3.00E-11 2.13E-09 1.06E-10 24816 hsa-mir-641 hsa04912 GnRH signaling pathway 3725_5580_1956_6714_5595_5594_5599_2185_808_805_801 11 7.68E-11 5.45E-09 2.60E-10 24817 hsa-mir-641 hsa04350 TGF-beta signaling pathway 5595_5594_1387_8454_4087_6500_4086_4088_2033_6667 10 1.92E-10 1.37E-08 5.94E-10 24818 hsa-mir-641 hsa04012 ErbB signaling pathway 3725_1956_6714_5595_5594_5599_2064_6776_6777_1026 10 1.92E-10 1.37E-08 5.94E-10 24819 hsa-mir-641 hsa04110 Cell cycle 1387_595_898_8454_4087_1026_6500_4088_3066_3065_2033 11 2.01E-10 1.43E-08 5.94E-10 24820 hsa-mir-641 hsa04210 Apoptosis 1147_3654_3556_8517_3551_1439_9020_4790_4792_5970 10 2.36E-10 1.68E-08 6.70E-10 24821 hsa-mir-641 hsa05219 Bladder cancer 1956_5595_5594_2064_595_2261_9252_1026 8 3.61E-10 2.56E-08 9.85E-10 24822 hsa-mir-641 hsa05218 Melanoma 3480_1956_4233_5595_5594_5159_595_5156_1026 9 7.23E-10 5.13E-08 1.90E-09 24823 hsa-mir-641 hsa05222 Small cell lung cancer 1147_595_898_8517_3551_10401_4790_4792_5970 9 3.41E-09 2.42E-07 8.65E-09 24824 hsa-mir-641 hsa05211 Renal cell carcinoma 3725_4233_5595_5594_1387_5879_5781_2033 8 1.69E-08 1.20E-06 4.14E-08 24825 hsa-mir-641 hsa03020 RNA polymerase 64425_5437_25885_51082_84172_5441 6 4.01E-08 2.85E-06 9.49E-08 24826 hsa-mir-641 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6850_5879_3454_3455_5781_2185 9 1.56E-07 1.11E-05 3.57E-07 24827 hsa-mir-641 hsa04720 Long-term potentiation 5595_5594_1387_2033_808_805_801 7 4.08E-07 2.90E-05 8.89E-07 24828 hsa-mir-641 hsa04930 Type II diabetes mellitus 5580_5590_5595_5594_5599_3551 6 4.13E-07 2.93E-05 8.89E-07 24829 hsa-mir-641 hsa04910 Insulin signaling pathway 5590_5595_5594_5599_3551_808_805_801 8 1.80E-06 0.000127454 3.75E-06 24830 hsa-mir-641 hsa04916 Melanogenesis 5595_5594_1387_2033_808_805_801 7 3.18E-06 0.000225915 6.45E-06 24831 hsa-mir-641 hsa04810 Regulation of actin cytoskeleton 1956_5595_5594_5159_5156_2261_2264_10788_5879 9 6.02E-06 0.000427253 1.19E-05 24832 hsa-mir-641 hsa04664 Fc epsilon RI signaling pathway 5580_5595_5594_5599_6850_5879 6 8.57E-06 0.000608751 1.65E-05 24833 hsa-mir-641 hsa04020 Calcium signaling pathway 1956_2064_5159_5156_2185_808_805_801 8 1.35E-05 0.000961668 2.53E-05 24834 hsa-mir-641 hsa05016 Huntington's disease 1387_6908_5437_3066_3065_2033_6667_5441 8 1.57E-05 0.001116303 2.86E-05 24835 hsa-mir-641 hsa05213 Endometrial cancer 1956_5595_5594_2064_595 5 1.72E-05 0.001221057 3.05E-05 24836 hsa-mir-641 hsa04120 Ubiquitin mediated proteolysis 55294_5371_672_8454_23291_6500_10401 7 1.93E-05 0.001368941 3.34E-05 24837 hsa-mir-641 hsa05223 Non-small cell lung cancer 1956_5595_5594_2064_595 5 2.04E-05 0.001446851 3.40E-05 24838 hsa-mir-641 hsa04540 Gap junction 1956_6714_5595_5594_5159_5156 6 2.06E-05 0.001462098 3.40E-05 24839 hsa-mir-641 hsa05216 Thyroid cancer 5595_5594_595_5979 4 3.43E-05 0.002431898 5.53E-05 24840 hsa-mir-641 hsa05340 Primary immunodeficiency 3718_3932_3575_8517 4 6.71E-05 0.004761902 0.00010582 24841 hsa-mir-641 hsa04270 Vascular smooth muscle contraction 5580_5595_5594_808_805_801 6 7.31E-05 0.005192799 0.000112887 24842 hsa-mir-641 hsa04360 Axon guidance 2242_4233_5595_5594_5879_7852 6 0.000126793 0.00900232 0.000191539 24843 hsa-mir-641 hsa04370 VEGF signaling pathway 6714_5595_5594_5879 4 0.00113029 0.080250607 0.001671888 24844 hsa-mir-641 hsa03022 Basal transcription factors 2969_6908_2959 3 0.001465133 0.104024464 0.002122948 24845 hsa-mir-641 hsa04640 Hematopoietic cell lineage 3559_3575_3570_1441 4 0.001738834 0.123457249 0.002469145 24846 hsa-mir-641 hsa04612 Antigen processing and presentation 3320_3326_2923_3312 4 0.001883224 0.1337089 0.002621743 24847 hsa-mir-641 hsa05010 Alzheimer's disease 5595_5594_808_805_801 5 0.003692054 0.262135857 0.005041074 24848 hsa-mir-641 hsa04670 Leukocyte transendothelial migration 5879_7852_5781_2185 4 0.005600167 0.397611846 0.00750211 24849 hsa-mir-641 hsa04115 p53 signaling pathway 595_898_1026 3 0.007761771 0.551085751 0.010205292 24850 hsa-mir-641 hsa04730 Long-term depression 3480_5595_5594 3 0.008368195 0.594141829 0.010802579 24851 hsa-mir-641 hsa04950 Maturity onset diabetes of the young 6927_3280 2 0.009281744 0.659003807 0.011767925 24852 hsa-mir-641 hsa04070 Phosphatidylinositol signaling system 808_805_801 3 0.010003398 0.710241231 0.012460372 24853 hsa-mir-641 hsa03010 Ribosome 6128_6156_6207 3 0.021349298 1 0.026134486 24854 hsa-mir-641 hsa04150 mTOR signaling pathway 5595_5594 2 0.036912835 1 0.044420531 24855 hsa-mir-641 hsa04530 Tight junction 5580_6714_5590 3 0.044308181 1 0.052431348 24856 hsa-mir-642a hsa04310 Wnt signaling pathway 4087_4088_1487_2033_1488 5 7.66E-11 1.15E-09 1.15E-09 24857 hsa-mir-642a hsa05200 Pathways in cancer 4087_4088_1487_2033_1488 5 3.58E-09 5.36E-08 2.68E-08 24858 hsa-mir-642a hsa04330 Notch signaling pathway 1487_2033_1488 3 1.52E-07 2.27E-06 7.58E-07 24859 hsa-mir-642a hsa05220 Chronic myeloid leukemia 4088_1487_1488 3 5.87E-07 8.80E-06 2.13E-06 24860 hsa-mir-642a hsa04520 Adherens junction 4087_4088_2033 3 7.09E-07 1.06E-05 2.13E-06 24861 hsa-mir-642a hsa04350 TGF-beta signaling pathway 4087_4088_2033 3 9.05E-07 1.36E-05 2.26E-06 24862 hsa-mir-642a hsa04110 Cell cycle 4087_4088_2033 3 2.27E-06 3.40E-05 4.86E-06 24863 hsa-mir-642a hsa05210 Colorectal cancer 4087_4088 2 0.000168908 0.002533625 0.000316703 24864 hsa-mir-642a hsa05211 Renal cell carcinoma 2033 1 0.016907255 0.253608829 0.026011491 24865 hsa-mir-642a hsa04720 Long-term potentiation 2033 1 0.017596799 0.263951989 0.026011491 24866 hsa-mir-642a hsa05215 Prostate cancer 2033 1 0.020580035 0.308700524 0.026011491 24867 hsa-mir-642a hsa05212 Pancreatic cancer 2033 1 0.020809193 0.31213789 0.026011491 24868 hsa-mir-642a hsa04916 Melanogenesis 2033 1 0.024241047 0.363615709 0.027970439 24869 hsa-mir-642a hsa04630 Jak-STAT signaling pathway 2033 1 0.035832353 0.53748529 0.038391806 24870 hsa-mir-642a hsa05016 Huntington's disease 2033 1 0.043269546 0.649043197 0.043269546 24871 hsa-mir-642b hsa04330 Notch signaling pathway 2033 1 0.015882399 0.222353592 0.051787524 24872 hsa-mir-642b hsa03050 Proteasome 5705 1 0.016210855 0.226951966 0.051787524 24873 hsa-mir-642b hsa05211 Renal cell carcinoma 2033 1 0.024064242 0.336899383 0.051787524 24874 hsa-mir-642b hsa04720 Long-term potentiation 2033 1 0.025041937 0.35058712 0.051787524 24875 hsa-mir-642b hsa04520 Adherens junction 2033 1 0.026669471 0.373372593 0.051787524 24876 hsa-mir-642b hsa04350 TGF-beta signaling pathway 2033 1 0.02894391 0.405214745 0.051787524 24877 hsa-mir-642b hsa05215 Prostate cancer 2033 1 0.029268439 0.409758153 0.051787524 24878 hsa-mir-642b hsa05212 Pancreatic cancer 2033 1 0.029592871 0.414300194 0.051787524 24879 hsa-mir-642b hsa04916 Melanogenesis 2033 1 0.034447648 0.482267068 0.05358523 24880 hsa-mir-642b hsa04110 Cell cycle 2033 1 0.039280555 0.549927764 0.054992776 24881 hsa-mir-642b hsa04310 Wnt signaling pathway 2033 1 0.049836399 0.697709593 0.059255964 24882 hsa-mir-644 hsa04110 Cell cycle 1869_25_5925_545_995_1026_5591_983_4088_7534_1017_2932_4193_7027_902_1387_1031_9232_5347_1022_4087_7532_3065_1111_2033_890_11200_8556_8555_472 30 2.37E-31 1.99E-29 1.99E-29 24883 hsa-mir-644 hsa05200 Pathways in cancer 1147_3320_1869_5743_3326_5747_25_5925_675_998_1026_5594_5595_5599_596_5601_6789_1856_4088_613_1017_2932_4193_1387_5578_51588_8554_5371_4436_598_4087_5888_5728_3065_3091_2033_3910_4792_5602 39 2.92E-29 2.45E-27 1.23E-27 24884 hsa-mir-644 hsa04115 p53 signaling pathway 50484_545_6241_1026_25898_983_1017_27113_4194_4193_900_7161_64326_5728_51246_1111_11200_472 18 1.74E-19 1.46E-17 4.87E-18 24885 hsa-mir-644 hsa05215 Prostate cancer 1147_3320_1869_3326_5925_1026_5594_5595_596_1017_2932_4193_1387_5728_2033_4792 16 2.66E-15 2.23E-13 5.23E-14 24886 hsa-mir-644 hsa05212 Pancreatic cancer 1147_3320_1869_3326_5925_1026_5594_5595_596_1017_2932_4193_1387_5728_2033_4792 16 3.11E-15 2.61E-13 5.23E-14 24887 hsa-mir-644 hsa05220 Chronic myeloid leukemia 1147_1869_25_5925_1026_5594_5595_4088_613_4193_598_3065_4792 13 1.93E-12 1.63E-10 2.71E-11 24888 hsa-mir-644 hsa04310 Wnt signaling pathway 1460_5518_5515_5599_5601_1856_1457_4088_2932_1387_5578_1452_4087_5527_2033_5602 16 5.42E-12 4.56E-10 6.51E-11 24889 hsa-mir-644 hsa05222 Small cell lung cancer 1147_1869_5743_5747_5925_596_1017_51588_8554_598_5728_3910_4792 13 9.10E-12 7.65E-10 9.56E-11 24890 hsa-mir-644 hsa04120 Ubiquitin mediated proteolysis 10055_672_7319_25898_84447_4193_3093_51588_8554_5371_64326_7329_10075_7337 14 2.01E-10 1.69E-08 1.88E-09 24891 hsa-mir-644 hsa05210 Colorectal cancer 5594_5595_5599_596_5601_1856_4088_2932_4436_4087_5602 11 1.47E-09 1.23E-07 1.23E-08 24892 hsa-mir-644 hsa04010 MAPK signaling pathway 1147_998_5594_5595_5599_5601_3304_3305_3303_6789_3315_5578_3164_1616_5923_5602 16 1.60E-08 1.34E-06 1.22E-07 24893 hsa-mir-644 hsa04510 Focal adhesion 5747_998_5594_5595_5599_596_5601_5499_2932_5578_5728_5923_3910_5602 14 2.26E-08 1.90E-06 1.55E-07 24894 hsa-mir-644 hsa04350 TGF-beta signaling pathway 5518_5515_5594_5595_6667_4088_7027_1387_4087_2033 10 2.58E-08 2.17E-06 1.55E-07 24895 hsa-mir-644 hsa04012 ErbB signaling pathway 5747_25_1026_5594_5595_5599_5601_2932_5578_5602 10 2.58E-08 2.17E-06 1.55E-07 24896 hsa-mir-644 hsa04520 Adherens junction 1460_998_5594_5595_1457_4088_1387_4087_2033 9 1.54E-07 1.29E-05 8.61E-07 24897 hsa-mir-644 hsa05214 Glioma 1869_5925_1026_5594_5595_4193_5578_5728 8 4.08E-07 3.43E-05 2.14E-06 24898 hsa-mir-644 hsa03420 Nucleotide excision repair 2965_4331_2074_6117_2071_902_1022 7 4.60E-07 3.86E-05 2.27E-06 24899 hsa-mir-644 hsa03022 Basal transcription factors 2965_2957_6908_51616_2958_6880 6 2.82E-06 0.00023712 1.32E-05 24900 hsa-mir-644 hsa05219 Bladder cancer 1869_5925_1026_5594_5595_4193 6 5.46E-06 0.000459039 2.42E-05 24901 hsa-mir-644 hsa04920 Adipocytokine signaling pathway 1147_5563_6794_5599_5601_4792_5602 7 5.96E-06 0.00050027 2.50E-05 24902 hsa-mir-644 hsa05218 Melanoma 1869_5925_1026_5594_5595_4193_5728 7 8.47E-06 0.000711521 3.39E-05 24903 hsa-mir-644 hsa04370 VEGF signaling pathway 5743_5747_998_5594_5595_3315_5578 7 1.38E-05 0.001163259 5.29E-05 24904 hsa-mir-644 hsa04660 T cell receptor signaling pathway 1147_998_5594_5595_5601_2932_959_4792 8 1.55E-05 0.001299151 5.65E-05 24905 hsa-mir-644 hsa05223 Non-small cell lung cancer 1869_5925_5594_5595_6789_5578 6 2.03E-05 0.001705569 7.11E-05 24906 hsa-mir-644 hsa04530 Tight junction 1460_998_5518_5515_1457_5578_5728_5520 8 6.78E-05 0.005698228 0.000227929 24907 hsa-mir-644 hsa04910 Insulin signaling pathway 5563_5594_5595_5599_5601_5499_2932_5602 8 7.12E-05 0.005980607 0.000230023 24908 hsa-mir-644 hsa04620 Toll-like receptor signaling pathway 1147_5594_5595_5599_5601_4792_5602 7 7.48E-05 0.006280528 0.000232612 24909 hsa-mir-644 hsa04916 Melanogenesis 5594_5595_1856_2932_1387_5578_2033 7 8.39E-05 0.007046724 0.000244044 24910 hsa-mir-644 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_998_5599_5601_4792_5602 6 8.43E-05 0.00707728 0.000244044 24911 hsa-mir-644 hsa05211 Renal cell carcinoma 998_5594_5595_1387_3091_2033 6 9.06E-05 0.00760776 0.000253592 24912 hsa-mir-644 hsa04930 Type II diabetes mellitus 5594_5595_5599_5601_5602 5 0.000101659 0.008539332 0.000275252 24913 hsa-mir-644 hsa04912 GnRH signaling pathway 998_5594_5595_5599_5601_5578_5602 7 0.000104858 0.008808071 0.000275252 24914 hsa-mir-644 hsa04720 Long-term potentiation 5594_5595_5499_1387_5578_2033 6 0.000111803 0.009391419 0.000276218 24915 hsa-mir-644 hsa04662 B cell receptor signaling pathway 1147_5594_5595_1380_2932_4792 6 0.000111803 0.009391419 0.000276218 24916 hsa-mir-644 hsa04330 Notch signaling pathway 1856_1387_3065_2033_8850 5 0.000122822 0.010317032 0.000294772 24917 hsa-mir-644 hsa04664 Fc epsilon RI signaling pathway 5594_5595_5599_5601_5578_5602 6 0.000146063 0.012269315 0.000340814 24918 hsa-mir-644 hsa04150 mTOR signaling pathway 5563_5594_6794_5595_3091 5 0.000190517 0.016003464 0.000432526 24919 hsa-mir-644 hsa03440 Homologous recombination 675_6117_641_5888 4 0.000215567 0.018107618 0.000476516 24920 hsa-mir-644 hsa05131 Shigellosis 25_998_7534_5578_4691 5 0.000262618 0.022059887 0.000537232 24921 hsa-mir-644 hsa05130 Pathogenic Escherichia coli infection 25_998_7534_5578_4691 5 0.000262618 0.022059887 0.000537232 24922 hsa-mir-644 hsa04612 Antigen processing and presentation 3320_3326_3309_3304_3305_3303 6 0.000268616 0.022563757 0.000537232 24923 hsa-mir-644 hsa04210 Apoptosis 1147_823_596_598_4792_472 6 0.000268616 0.022563757 0.000537232 24924 hsa-mir-644 hsa04360 Axon guidance 5747_25_998_5594_5595_2932_1020 7 0.000323521 0.027175774 0.000631995 24925 hsa-mir-644 hsa03410 Base excision repair 142_3146_328_4913 4 0.00051675 0.043407036 0.000986524 24926 hsa-mir-644 hsa05016 Huntington's disease 25942_3064_6908_6667_27113_1387_3065_2033 8 0.000530413 0.044554698 0.000990104 24927 hsa-mir-644 hsa04062 Chemokine signaling pathway 1147_5747_998_5594_5595_2932_6362_4792 8 0.000625847 0.052571111 0.00114285 24928 hsa-mir-644 hsa04730 Long-term depression 5518_5515_5594_5595_5578 5 0.000728171 0.061166388 0.001301413 24929 hsa-mir-644 hsa05213 Endometrial cancer 5594_5595_2932_5728 4 0.001848488 0.155273032 0.003234855 24930 hsa-mir-644 hsa04540 Gap junction 5594_5595_983_1453_5578 5 0.002268327 0.190539465 0.003888561 24931 hsa-mir-644 hsa05221 Acute myeloid leukemia 1147_5594_5595_5371 4 0.002849461 0.239354748 0.004787095 24932 hsa-mir-644 hsa03030 DNA replication 6117_5557_5422 3 0.00570072 0.478860514 0.009389422 24933 hsa-mir-644 hsa03450 Non-homologous end-joining 5591_2547 2 0.009514126 0.799186573 0.015368973 24934 hsa-mir-644 hsa04630 Jak-STAT signaling pathway 1387_51588_8554_598_2033 5 0.017267025 1 0.027366606 24935 hsa-mir-644 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_1616 3 0.017703213 1 0.027538331 24936 hsa-mir-644 hsa04340 Hedgehog signaling pathway 1453_2932_1452 3 0.01850949 1 0.028269039 24937 hsa-mir-644 hsa03430 Mismatch repair 6117_4436 2 0.022514911 1 0.033772366 24938 hsa-mir-644 hsa04270 Vascular smooth muscle contraction 5594_5595_5499_5578 4 0.027517877 1 0.040552661 24939 hsa-mir-644 hsa05010 Alzheimer's disease 5594_5595_823_2932_1020 5 0.028178022 1 0.040809549 24940 hsa-mir-644 hsa05216 Thyroid cancer 5594_5595 2 0.033651395 1 0.047910461 24941 hsa-mir-645 hsa05200 Pathways in cancer 25_5371_5595_5599_861_1387_5601_5602_367_6934_6774_6772_3091_5970_6688_2113_3725_2736_2353_4087_4088_4089_5925_2033_207_2932_8554 27 8.38E-22 5.45E-20 5.45E-20 24942 hsa-mir-645 hsa04010 MAPK signaling pathway 6722_8986_5595_5599_1386_9261_5601_5600_5602_6195_9252_1432_1649_5970_468_4773_3725_3727_6196_2353_6197_207_8550 23 5.13E-19 3.33E-17 1.67E-17 24943 hsa-mir-645 hsa05210 Colorectal cancer 5595_5599_5601_5602_6934_3725_2353_4087_4088_4089_207_2932 12 6.04E-13 3.93E-11 1.31E-11 24944 hsa-mir-645 hsa04310 Wnt signaling pathway 5599_1387_5601_5602_6934_8061_4773_3725_1457_4087_4088_4089_2033_2932 14 1.67E-12 1.09E-10 2.71E-11 24945 hsa-mir-645 hsa05215 Prostate cancer 5595_1387_367_6934_5970_468_9586_5925_2033_207_2932 11 2.12E-11 1.38E-09 2.57E-10 24946 hsa-mir-645 hsa05212 Pancreatic cancer 5595_1387_367_6934_5970_468_9586_5925_2033_207_2932 11 2.37E-11 1.54E-09 2.57E-10 24947 hsa-mir-645 hsa04620 Toll-like receptor signaling pathway 5595_5599_5601_5600_5602_1432_6772_5970_3725_2353_207 11 9.09E-11 5.91E-09 8.44E-10 24948 hsa-mir-645 hsa04660 T cell receptor signaling pathway 5595_5601_5600_1432_5970_4773_3725_2353_207_2932 10 3.08E-09 2.00E-07 2.50E-08 24949 hsa-mir-645 hsa04110 Cell cycle 25_5591_1387_7533_4087_4088_4089_5925_2033_2932 10 6.23E-09 4.05E-07 4.49E-08 24950 hsa-mir-645 hsa05221 Acute myeloid leukemia 5371_5595_861_6934_6774_5970_6688_207 8 6.91E-09 4.49E-07 4.49E-08 24951 hsa-mir-645 hsa05220 Chronic myeloid leukemia 25_5595_861_5970_4088_4089_5925_207 8 3.85E-08 2.50E-06 2.28E-07 24952 hsa-mir-645 hsa04520 Adherens junction 5595_1387_6934_1457_4087_4088_4089_2033 8 6.12E-08 3.98E-06 3.31E-07 24953 hsa-mir-645 hsa04012 ErbB signaling pathway 25_5595_5599_5601_5602_3725_207_2932 8 1.12E-07 7.26E-06 5.58E-07 24954 hsa-mir-645 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5601_5600_5602_1432_5970_3725 7 4.58E-07 2.98E-05 2.13E-06 24955 hsa-mir-645 hsa05211 Renal cell carcinoma 5595_1387_3091_2113_3725_2033_207 7 5.00E-07 3.25E-05 2.13E-06 24956 hsa-mir-645 hsa04912 GnRH signaling pathway 5595_5599_5601_5600_5602_1432_468_3725 8 5.24E-07 3.41E-05 2.13E-06 24957 hsa-mir-645 hsa04720 Long-term potentiation 5595_1387_6195_468_6196_6197_2033 7 6.46E-07 4.20E-05 2.33E-06 24958 hsa-mir-645 hsa04662 B cell receptor signaling pathway 5595_5970_4773_3725_2353_207_2932 7 6.46E-07 4.20E-05 2.33E-06 24959 hsa-mir-645 hsa04664 Fc epsilon RI signaling pathway 5595_5599_5601_5600_5602_1432_207 7 8.95E-07 5.82E-05 3.06E-06 24960 hsa-mir-645 hsa04150 mTOR signaling pathway 5595_6195_3091_6196_6197_207 6 1.34E-06 8.70E-05 4.35E-06 24961 hsa-mir-645 hsa04350 TGF-beta signaling pathway 5595_1387_6667_4087_4088_4089_2033 7 1.64E-06 0.000106479 5.07E-06 24962 hsa-mir-645 hsa04920 Adipocytokine signaling pathway 5599_5601_5602_6774_5970_207 6 5.22E-06 0.000339501 1.54E-05 24963 hsa-mir-645 hsa04370 VEGF signaling pathway 5595_9261_5600_1432_4773_207 6 1.10E-05 0.000716375 3.11E-05 24964 hsa-mir-645 hsa04930 Type II diabetes mellitus 5595_5599_5601_5602_3651 5 1.25E-05 0.000812246 3.38E-05 24965 hsa-mir-645 hsa04120 Ubiquitin mediated proteolysis 5371_83737_672_55294_7329_64326_8554 7 2.99E-05 0.001941984 7.77E-05 24966 hsa-mir-645 hsa04630 Jak-STAT signaling pathway 1387_6774_6775_6772_2033_207_8554 7 5.79E-05 0.003765959 0.000144845 24967 hsa-mir-645 hsa03022 Basal transcription factors 2963_6872_6908_2959 4 0.00010654 0.006925102 0.000256485 24968 hsa-mir-645 hsa04910 Insulin signaling pathway 5595_5599_5601_5602_207_2932 6 0.000240724 0.015647051 0.000558823 24969 hsa-mir-645 hsa04510 Focal adhesion 5595_5599_5601_5602_3725_207_2932 7 0.000314752 0.020458895 0.000705479 24970 hsa-mir-645 hsa05213 Endometrial cancer 5595_6934_207_2932 4 0.000360277 0.023417992 0.0007806 24971 hsa-mir-645 hsa04916 Melanogenesis 5595_1387_6934_2033_2932 5 0.000518183 0.033681927 0.001086514 24972 hsa-mir-645 hsa05016 Huntington's disease 1387_6908_6667_9586_3064_2033 6 0.001157066 0.075209283 0.00235029 24973 hsa-mir-645 hsa04062 Chemokine signaling pathway 5595_6774_6772_5970_207_2932 6 0.0013179 0.085663495 0.002595863 24974 hsa-mir-645 hsa05222 Small cell lung cancer 5970_5925_207_8554 4 0.002140145 0.13910943 0.004091454 24975 hsa-mir-645 hsa05219 Bladder cancer 5595_9252_5925 3 0.00250158 0.162602716 0.004645792 24976 hsa-mir-645 hsa04330 Notch signaling pathway 1387_9612_2033 3 0.003380479 0.21973116 0.006103643 24977 hsa-mir-645 hsa05223 Non-small cell lung cancer 5595_5925_207 3 0.004894473 0.318140721 0.008598398 24978 hsa-mir-645 hsa05217 Basal cell carcinoma 6934_2736_2932 3 0.005138954 0.334032032 0.008790317 24979 hsa-mir-645 hsa05214 Glioma 5595_5925_207 3 0.007990568 0.519386945 0.013317614 24980 hsa-mir-645 hsa04360 Axon guidance 25_5595_4773_2932 4 0.009006553 0.585425958 0.014635649 24981 hsa-mir-645 hsa05218 Melanoma 5595_5925_207 3 0.010069402 0.654511149 0.015963687 24982 hsa-mir-645 hsa04950 Maturity onset diabetes of the young 3651_3087 2 0.010575747 0.687423528 0.016367227 24983 hsa-mir-645 hsa05216 Thyroid cancer 5595_6934 2 0.014838299 0.964489433 0.022429987 24984 hsa-mir-645 hsa04210 Apoptosis 823_5970_207 3 0.018043085 1 0.026654558 24985 hsa-mir-645 hsa05010 Alzheimer's disease 5595_823_9451_2932 4 0.023859237 1 0.034463343 24986 hsa-mir-645 hsa05014 Amyotrophic lateral sclerosis (ALS) 5600_1432 2 0.047499117 1 0.067118318 24987 hsa-mir-645 hsa04340 Hedgehog signaling pathway 2736_2932 2 0.048976606 1 0.067733605 24988 hsa-mir-646 hsa05200 Pathways in cancer 2249_367_3725_6776_6777_2353_5914_5970_6256 9 2.65E-10 1.01E-08 1.01E-08 24989 hsa-mir-646 hsa05221 Acute myeloid leukemia 6776_6777_5914_5970 4 1.10E-06 4.19E-05 2.09E-05 24990 hsa-mir-646 hsa05220 Chronic myeloid leukemia 6776_6777_5970 3 0.000122817 0.004667042 0.001166761 24991 hsa-mir-646 hsa04662 B cell receptor signaling pathway 3725_2353_5970 3 0.000122817 0.004667042 0.001166761 24992 hsa-mir-646 hsa04012 ErbB signaling pathway 3725_6776_6777 3 0.000187741 0.007134151 0.00142683 24993 hsa-mir-646 hsa04620 Toll-like receptor signaling pathway 3725_2353_5970 3 0.000295792 0.011240086 0.001747191 24994 hsa-mir-646 hsa04660 T cell receptor signaling pathway 3725_2353_5970 3 0.000366948 0.013944012 0.001747191 24995 hsa-mir-646 hsa04010 MAPK signaling pathway 2249_3725_2353_5970 4 0.00036783 0.013977528 0.001747191 24996 hsa-mir-646 hsa04950 Maturity onset diabetes of the young 5080_6927 2 0.000470972 0.017896939 0.001988549 24997 hsa-mir-646 hsa04630 Jak-STAT signaling pathway 3977_6776_6777 3 0.000973048 0.036975826 0.003697583 24998 hsa-mir-646 hsa04920 Adipocytokine signaling pathway 5970_6256 2 0.003288319 0.124956119 0.011359647 24999 hsa-mir-646 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5970 2 0.003672214 0.139544124 0.011628677 25000 hsa-mir-646 hsa05210 Colorectal cancer 3725_2353 2 0.005056231 0.192136787 0.013402324 25001 hsa-mir-646 hsa05222 Small cell lung cancer 5970_6256 2 0.005287381 0.200920481 0.013402324 25002 hsa-mir-646 hsa05215 Prostate cancer 367_5970 2 0.005523323 0.209886274 0.013402324 25003 hsa-mir-646 hsa05212 Pancreatic cancer 367_5970 2 0.005643084 0.214437177 0.013402324 25004 hsa-mir-646 hsa03450 Non-homologous end-joining 2547 1 0.018322969 0.696272824 0.040957225 25005 hsa-mir-646 hsa05016 Huntington's disease 6908_6667 2 0.022928457 0.871281358 0.04812404 25006 hsa-mir-646 hsa04062 Chemokine signaling pathway 6777_5970 2 0.02406202 0.914356765 0.04812404 25007 hsa-mir-646 hsa05216 Thyroid cancer 6256 1 0.036319119 1 0.069006325 25008 hsa-mir-646 hsa04080 Neuroactive ligand-receptor interaction 2908_7067 2 0.040192254 1 0.072728841 25009 hsa-mir-646 hsa03410 Base excision repair 142 1 0.044607076 1 0.075645433 25010 hsa-mir-646 hsa03022 Basal transcription factors 6908 1 0.045785394 1 0.075645433 25011 hsa-mir-652 hsa05200 Pathways in cancer 8031_3065_5925_6257_2033_3326_2932_3265_8554_5970_5594_5599_6258_1387_6256 15 6.08E-16 3.65E-14 3.65E-14 25012 hsa-mir-652 hsa05215 Prostate cancer 5925_2033_3326_2932_3265_5970_5594_1387 8 3.07E-11 1.84E-09 6.67E-10 25013 hsa-mir-652 hsa05212 Pancreatic cancer 5925_2033_3326_2932_3265_5970_5594_1387 8 3.34E-11 2.00E-09 6.67E-10 25014 hsa-mir-652 hsa05216 Thyroid cancer 8031_6257_3265_5594_6258_6256 6 1.13E-10 6.79E-09 1.70E-09 25015 hsa-mir-652 hsa05223 Non-small cell lung cancer 5925_6257_3265_5594_6258_6256 6 3.35E-09 2.01E-07 4.02E-08 25016 hsa-mir-652 hsa04110 Cell cycle 3065_5925_2033_4616_10912_2932_1387 7 9.78E-09 5.87E-07 9.55E-08 25017 hsa-mir-652 hsa04920 Adipocytokine signaling pathway 10891_6257_5970_5599_6258_6256 6 1.11E-08 6.69E-07 9.55E-08 25018 hsa-mir-652 hsa04720 Long-term potentiation 2902_2906_2033_3265_5594_1387 6 2.10E-08 1.26E-06 1.57E-07 25019 hsa-mir-652 hsa05222 Small cell lung cancer 5925_6257_8554_5970_6258_6256 6 4.52E-08 2.71E-06 3.02E-07 25020 hsa-mir-652 hsa05016 Huntington's disease 2902_3065_10891_6667_2033_1387_9519 7 1.97E-07 1.18E-05 1.18E-06 25021 hsa-mir-652 hsa05220 Chronic myeloid leukemia 3065_5925_3265_5970_5594 5 7.92E-07 4.75E-05 4.32E-06 25022 hsa-mir-652 hsa04010 MAPK signaling pathway 4616_10912_22800_3265_5970_5594_5599 7 2.23E-06 0.000133564 1.11E-05 25023 hsa-mir-652 hsa04916 Melanogenesis 2033_2932_3265_5594_1387 5 3.67E-06 0.000220362 1.70E-05 25024 hsa-mir-652 hsa04330 Notch signaling pathway 3065_9612_2033_1387 4 4.33E-06 0.000259698 1.85E-05 25025 hsa-mir-652 hsa04910 Insulin signaling pathway 10891_2932_3265_5594_5599 5 1.38E-05 0.000828475 5.52E-05 25026 hsa-mir-652 hsa03320 PPAR signaling pathway 6257_6258_2168_6256 4 1.92E-05 0.001152686 7.20E-05 25027 hsa-mir-652 hsa05211 Renal cell carcinoma 2033_3265_5594_1387 4 2.14E-05 0.001281182 7.54E-05 25028 hsa-mir-652 hsa04662 B cell receptor signaling pathway 2932_3265_5970_5594 4 2.49E-05 0.001493246 8.30E-05 25029 hsa-mir-652 hsa04350 TGF-beta signaling pathway 6667_2033_5594_1387 4 4.34E-05 0.002605916 0.000125525 25030 hsa-mir-652 hsa04012 ErbB signaling pathway 2932_3265_5594_5599 4 4.34E-05 0.002605916 0.000125525 25031 hsa-mir-652 hsa05010 Alzheimer's disease 2902_2906_2932_5594_351 5 4.39E-05 0.00263602 0.000125525 25032 hsa-mir-652 hsa04660 T cell receptor signaling pathway 2932_3265_5970_5594 4 0.000104539 0.006272324 0.000285106 25033 hsa-mir-652 hsa05219 Bladder cancer 5925_3265_5594 3 0.000122478 0.007348704 0.000319509 25034 hsa-mir-652 hsa05213 Endometrial cancer 2932_3265_5594 3 0.000223032 0.013381915 0.00055758 25035 hsa-mir-652 hsa05221 Acute myeloid leukemia 3265_5970_5594 3 0.000318124 0.019087451 0.000763498 25036 hsa-mir-652 hsa04310 Wnt signaling pathway 2033_2932_5599_1387 4 0.000347879 0.020872718 0.000802797 25037 hsa-mir-652 hsa05214 Glioma 5925_3265_5594 3 0.000417736 0.025064136 0.000928301 25038 hsa-mir-652 hsa05218 Melanoma 5925_3265_5594 3 0.000535442 0.032126539 0.001147376 25039 hsa-mir-652 hsa04664 Fc epsilon RI signaling pathway 3265_5594_5599 3 0.000722692 0.043361503 0.001495224 25040 hsa-mir-652 hsa04520 Adherens junction 2033_5594_1387 3 0.000748658 0.044919508 0.001497317 25041 hsa-mir-652 hsa04062 Chemokine signaling pathway 2932_3265_5970_5594 4 0.000835731 0.050143832 0.001609591 25042 hsa-mir-652 hsa05210 Colorectal cancer 2932_5594_5599 3 0.000858448 0.0515069 0.001609591 25043 hsa-mir-652 hsa04510 Focal adhesion 2932_3265_5594_5599 4 0.001059156 0.063549363 0.001925738 25044 hsa-mir-652 hsa04620 Toll-like receptor signaling pathway 5970_5594_5599 3 0.001477462 0.088647693 0.002607285 25045 hsa-mir-652 hsa04912 GnRH signaling pathway 3265_5594_5599 3 0.001732455 0.103947279 0.002969922 25046 hsa-mir-652 hsa04360 Axon guidance 2932_3265_5594 3 0.002957859 0.17747154 0.004929765 25047 hsa-mir-652 hsa04530 Tight junction 22800_3265_8573 3 0.003346121 0.200767282 0.005426143 25048 hsa-mir-652 hsa04930 Type II diabetes mellitus 5594_5599 2 0.004533834 0.272030035 0.007158685 25049 hsa-mir-652 hsa04630 Jak-STAT signaling pathway 2033_8554_1387 3 0.004692786 0.281567182 0.007219671 25050 hsa-mir-652 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906 2 0.006829498 0.409769883 0.010244247 25051 hsa-mir-652 hsa04115 p53 signaling pathway 4616_10912 2 0.010086633 0.605198003 0.014760927 25052 hsa-mir-652 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5970_5599 2 0.010638063 0.638283766 0.014843809 25053 hsa-mir-652 hsa04730 Long-term depression 3265_5594 2 0.010638063 0.638283766 0.014843809 25054 hsa-mir-652 hsa04810 Regulation of actin cytoskeleton 22800_3265_5594 3 0.011890813 0.713448763 0.016214745 25055 hsa-mir-652 hsa04370 VEGF signaling pathway 3265_5594 2 0.012370382 0.742222899 0.016493842 25056 hsa-mir-652 hsa04512 ECM-receptor interaction 6383_9672 2 0.014536042 0.872162524 0.018960055 25057 hsa-mir-652 hsa04540 Gap junction 3265_5594 2 0.017541772 1 0.022393752 25058 hsa-mir-652 hsa04514 Cell adhesion molecules (CAMs) 6383_9672 2 0.034120366 1 0.042650457 25059 hsa-mir-652 hsa04650 Natural killer cell mediated cytotoxicity 3265_5594 2 0.035970197 1 0.044045139 25060 hsa-mir-654 hsa04110 Cell cycle 4174_5591_1387_10971_7534_1017_7533_7532_5001_1026_4172_4173_1029_898_4998_4999 16 1.75E-21 1.03E-19 1.03E-19 25061 hsa-mir-654 hsa05200 Pathways in cancer 5371_6258_1387_6256_836_1017_842_841_5970_4824_1026_1029_898 13 3.51E-11 2.07E-09 1.04E-09 25062 hsa-mir-654 hsa05215 Prostate cancer 1385_1387_1017_842_5970_4824_1026_898 8 4.99E-10 2.94E-08 8.00E-09 25063 hsa-mir-654 hsa05212 Pancreatic cancer 1385_1387_1017_842_5970_4824_1026_898 8 5.42E-10 3.20E-08 8.00E-09 25064 hsa-mir-654 hsa04115 p53 signaling pathway 836_1017_842_841_1026_1029_898 7 3.12E-09 1.84E-07 3.68E-08 25065 hsa-mir-654 hsa05222 Small cell lung cancer 6258_6256_1017_842_5970_898 6 3.51E-07 2.07E-05 3.45E-06 25066 hsa-mir-654 hsa04210 Apoptosis 836_839_842_841_840_5970 6 4.24E-07 2.50E-05 3.58E-06 25067 hsa-mir-654 hsa05010 Alzheimer's disease 22926_836_842_841_840_4697 6 1.90E-05 0.001121177 0.000140147 25068 hsa-mir-654 hsa04010 MAPK signaling pathway 9261_836_1432_5970_6195_2002_2005 7 2.17E-05 0.001278576 0.000142064 25069 hsa-mir-654 hsa05016 Huntington's disease 1385_1387_836_842_841_4697 6 2.64E-05 0.001557539 0.000150502 25070 hsa-mir-654 hsa05223 Non-small cell lung cancer 6258_6256_842_1029 4 2.81E-05 0.001655518 0.000150502 25071 hsa-mir-654 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_836_1432_5970 4 7.73E-05 0.004562461 0.000380205 25072 hsa-mir-654 hsa04720 Long-term potentiation 815_1387_5499_6195 4 9.47E-05 0.005588818 0.000429909 25073 hsa-mir-654 hsa04370 VEGF signaling pathway 6714_9261_1432_842 4 0.000104414 0.006160453 0.000440032 25074 hsa-mir-654 hsa04012 ErbB signaling pathway 815_6714_1026_2002 4 0.000163959 0.00967357 0.000644905 25075 hsa-mir-654 hsa03030 DNA replication 4174_4172_4173 3 0.000218735 0.012905351 0.000806584 25076 hsa-mir-654 hsa04912 GnRH signaling pathway 815_6714_1432_2002 4 0.000363247 0.021431571 0.001260681 25077 hsa-mir-654 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432_842 3 0.000745192 0.043966355 0.002442575 25078 hsa-mir-654 hsa05214 Glioma 815_1026_1029 3 0.001126722 0.066476623 0.00349877 25079 hsa-mir-654 hsa04920 Adipocytokine signaling pathway 6258_6256_5970 3 0.001225391 0.072298046 0.00353022 25080 hsa-mir-654 hsa04310 Wnt signaling pathway 815_1387_1457_1452 4 0.001256519 0.074134615 0.00353022 25081 hsa-mir-654 hsa05220 Chronic myeloid leukemia 5970_1026_1029 3 0.001673937 0.098762257 0.004489193 25082 hsa-mir-654 hsa04520 Adherens junction 6714_1387_1457 3 0.002000078 0.118004578 0.005130634 25083 hsa-mir-654 hsa05216 Thyroid cancer 6258_6256 2 0.003888214 0.229404642 0.009186037 25084 hsa-mir-654 hsa04620 Toll-like receptor signaling pathway 1432_841_5970 3 0.003892388 0.229650916 0.009186037 25085 hsa-mir-654 hsa04916 Melanogenesis 815_1385_1387 3 0.004103678 0.242116987 0.009312192 25086 hsa-mir-654 hsa03022 Basal transcription factors 2962_2969 2 0.00610075 0.359944238 0.013331268 25087 hsa-mir-654 hsa05219 Bladder cancer 1026_1029 2 0.007713556 0.455099831 0.016253565 25088 hsa-mir-654 hsa05012 Parkinson's disease 836_842_4697 3 0.008456344 0.49892431 0.017204287 25089 hsa-mir-654 hsa04330 Notch signaling pathway 1387_9612 2 0.009496731 0.560307115 0.018676904 25090 hsa-mir-654 hsa05213 Endometrial cancer 842_2002 2 0.011444965 0.675252961 0.021782354 25091 hsa-mir-654 hsa05131 Shigellosis 10971_7534 2 0.013118905 0.774015396 0.023455012 25092 hsa-mir-654 hsa05130 Pathogenic Escherichia coli infection 10971_7534 2 0.013118905 0.774015396 0.023455012 25093 hsa-mir-654 hsa05221 Acute myeloid leukemia 5371_5970 2 0.014439935 0.851956184 0.025057535 25094 hsa-mir-654 hsa03320 PPAR signaling pathway 6258_6256 2 0.019746238 1 0.03320963 25095 hsa-mir-654 hsa05218 Melanoma 1026_1029 2 0.020263503 1 0.03320963 25096 hsa-mir-654 hsa04510 Focal adhesion 6714_5499_2002 3 0.024955444 1 0.039793816 25097 hsa-mir-654 hsa05210 Colorectal cancer 836_842 2 0.027488279 1 0.04267917 25098 hsa-mir-654 hsa04612 Antigen processing and presentation 1385_4800 2 0.030504072 1 0.046147186 25099 hsa-mir-654 hsa03450 Non-homologous end-joining 5591 1 0.043948127 1 0.064014771 25100 hsa-mir-654 hsa04660 T cell receptor signaling pathway 1432_5970 2 0.044484841 1 0.064014771 25101 hsa-mir-655 hsa05200 Pathways in cancer 3716_3320_3326_3725_5371_3480_1956_4233_5595_5594_5599_1387_2064_5159_595_5156_5601_367_2261_2932_6776_6777_6772_5979_5879_4088_4609_1026_2353_2736_10401_4089_3066_3065_5925_2033_1441_1050_207_4790_5970 41 5.82E-39 4.02E-37 4.02E-37 25102 hsa-mir-655 hsa04010 MAPK signaling pathway 3925_6722_8986_3725_1956_5595_5594_5599_5159_9261_5156_5601_5600_5603_6195_2261_2264_9252_1432_1649_5879_6885_4609_3727_6196_6197_2353_207_8550_4790_51701_5970 32 9.05E-30 6.25E-28 3.12E-28 25103 hsa-mir-655 hsa04630 Jak-STAT signaling pathway 3717_3716_3718_3559_85480_3560_149233_1387_595_3575_3570_3572_3953_6776_6777_6772_1439_3454_3455_5781_4609_2690_10401_2033_1441_207 26 6.24E-28 4.30E-26 1.43E-26 25104 hsa-mir-655 hsa05215 Prostate cancer 3320_3326_3480_1956_5595_5594_1387_2064_5159_595_5156_367_2932_9586_1026_5925_2033_207_4790_5970 20 5.00E-24 3.45E-22 8.40E-23 25105 hsa-mir-655 hsa05212 Pancreatic cancer 3320_3326_3480_1956_5595_5594_1387_2064_5159_595_5156_367_2932_9586_1026_5925_2033_207_4790_5970 20 6.09E-24 4.20E-22 8.40E-23 25106 hsa-mir-655 hsa05210 Colorectal cancer 3725_3480_1956_4233_5595_5594_5599_5159_595_5156_5601_2932_5879_4088_4609_2353_4089_207 18 2.49E-21 1.72E-19 2.86E-20 25107 hsa-mir-655 hsa04520 Adherens junction 2241_3480_1956_6714_4233_5595_5594_1387_2064_1457_5879_4088_6885_1459_4089_2033_51701 17 3.74E-20 2.58E-18 3.68E-19 25108 hsa-mir-655 hsa04620 Toll-like receptor signaling pathway 3725_3654_5595_5594_5599_5601_5600_5603_1432_6772_5879_3454_3455_6885_2353_207_4790_5970 18 5.42E-20 3.74E-18 4.67E-19 25109 hsa-mir-655 hsa05220 Chronic myeloid leukemia 5595_5594_595_6776_6777_4088_5781_4609_1026_4089_3066_3065_5925_207_4790_5970 16 4.64E-19 3.20E-17 3.55E-18 25110 hsa-mir-655 hsa04060 Cytokine-cytokine receptor interaction 3556_2321_3559_85480_1956_4233_3560_149233_5159_5156_3575_3570_3572_1234_1230_3953_1439_7852_3454_3455_2690_1441 22 7.60E-18 5.24E-16 5.24E-17 25111 hsa-mir-655 hsa04310 Wnt signaling pathway 3725_5518_5599_1387_595_5601_1457_2932_5879_4088_8061_6885_4609_1459_4089_2033_51701 17 6.15E-16 4.24E-14 3.85E-15 25112 hsa-mir-655 hsa04062 Chemokine signaling pathway 3717_3718_5580_5590_5595_5594_1234_1230_2932_6777_6772_5879_7852_2185_207_3055_4790_5970 18 1.56E-15 1.07E-13 8.96E-15 25113 hsa-mir-655 hsa04012 ErbB signaling pathway 3725_1956_6714_5595_5594_5599_2064_5601_2932_6776_6777_4609_1026_207 14 2.59E-15 1.78E-13 1.37E-14 25114 hsa-mir-655 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1956_6714_4233_5599_5601_5600_5603_1432_5879_5781_4790_5970 13 5.93E-15 4.09E-13 2.92E-14 25115 hsa-mir-655 hsa04660 T cell receptor signaling pathway 3725_3932_5595_5594_5601_5600_5603_2932_1432_6885_2353_207_4790_5970 14 4.84E-14 3.34E-12 2.23E-13 25116 hsa-mir-655 hsa04510 Focal adhesion 3725_2321_3480_1956_6714_4233_5595_5594_5599_2064_5159_595_5156_5601_2932_5879_207 17 6.30E-14 4.35E-12 2.72E-13 25117 hsa-mir-655 hsa05221 Acute myeloid leukemia 5371_5595_5594_595_6776_6777_4609_1050_207_4790_5970 11 6.40E-13 4.41E-11 2.60E-12 25118 hsa-mir-655 hsa05219 Bladder cancer 1956_5595_5594_2064_595_2261_9252_4609_1026_5925 10 8.70E-13 6.00E-11 3.33E-12 25119 hsa-mir-655 hsa05218 Melanoma 3480_1956_4233_5595_5594_5159_595_5156_1026_5925_207 11 3.88E-12 2.68E-10 1.41E-11 25120 hsa-mir-655 hsa04664 Fc epsilon RI signaling pathway 5580_5595_5594_5599_6850_5601_5600_5603_1432_5879_207 11 1.10E-11 7.62E-10 3.81E-11 25121 hsa-mir-655 hsa04912 GnRH signaling pathway 3725_5580_1956_6714_5595_5594_5599_5601_5600_5603_1432_2185 12 1.40E-11 9.68E-10 4.61E-11 25122 hsa-mir-655 hsa05214 Glioma 3480_1956_5595_5594_5159_595_5156_1026_5925_207 10 4.03E-11 2.78E-09 1.26E-10 25123 hsa-mir-655 hsa04662 B cell receptor signaling pathway 3725_5595_5594_6850_2932_5879_2353_207_4790_5970 10 1.44E-10 9.94E-09 4.32E-10 25124 hsa-mir-655 hsa05211 Renal cell carcinoma 3725_4233_5595_5594_1387_5879_5781_2033_207 9 2.06E-09 1.42E-07 5.93E-09 25125 hsa-mir-655 hsa04370 VEGF signaling pathway 6714_5595_5594_9261_5600_5603_1432_5879_207 9 3.54E-09 2.44E-07 9.77E-09 25126 hsa-mir-655 hsa05213 Endometrial cancer 1956_5595_5594_2064_595_2932_4609_207 8 3.78E-09 2.61E-07 1.00E-08 25127 hsa-mir-655 hsa04110 Cell cycle 1387_595_2932_4088_1026_4089_3066_3065_5925_2033 10 8.94E-09 6.17E-07 2.28E-08 25128 hsa-mir-655 hsa04350 TGF-beta signaling pathway 5518_5595_5594_1387_4088_4609_4086_4089_2033 9 9.46E-09 6.53E-07 2.33E-08 25129 hsa-mir-655 hsa04920 Adipocytokine signaling pathway 3717_5599_5601_3953_5781_207_4790_5970 8 2.30E-08 1.59E-06 5.48E-08 25130 hsa-mir-655 hsa04930 Type II diabetes mellitus 3651_5580_5590_5595_5594_5599_5601 7 3.43E-08 2.37E-06 7.89E-08 25131 hsa-mir-655 hsa05223 Non-small cell lung cancer 1956_5595_5594_2064_595_5925_207 7 1.07E-07 7.36E-06 2.37E-07 25132 hsa-mir-655 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6850_5879_3454_3455_5781_2185 9 3.82E-07 2.64E-05 8.24E-07 25133 hsa-mir-655 hsa04720 Long-term potentiation 5595_5594_1387_6195_6196_6197_2033 7 8.33E-07 5.75E-05 1.74E-06 25134 hsa-mir-655 hsa04330 Notch signaling pathway 388585_1387_3280_3066_3065_2033 6 9.69E-07 6.69E-05 1.97E-06 25135 hsa-mir-655 hsa04150 mTOR signaling pathway 5595_5594_6195_6196_6197_207 6 1.67E-06 0.000114926 3.28E-06 25136 hsa-mir-655 hsa05222 Small cell lung cancer 595_4609_10401_5925_207_4790_5970 7 1.96E-06 0.000135151 3.75E-06 25137 hsa-mir-655 hsa05216 Thyroid cancer 5595_5594_595_5979_4609 5 2.13E-06 0.000147258 3.98E-06 25138 hsa-mir-655 hsa04540 Gap junction 1956_6714_5592_5595_5594_5159_5156 7 3.19E-06 0.000220149 5.79E-06 25139 hsa-mir-655 hsa04670 Leukocyte transendothelial migration 5600_5603_1432_5879_7852_5781_2185 7 1.71E-05 0.001181216 3.03E-05 25140 hsa-mir-655 hsa04360 Axon guidance 2242_4233_5595_5594_2932_5879_7852 7 2.65E-05 0.00182689 4.57E-05 25141 hsa-mir-655 hsa04210 Apoptosis 3654_3556_1439_207_4790_5970 6 2.96E-05 0.002039481 4.97E-05 25142 hsa-mir-655 hsa04530 Tight junction 5580_5518_6714_5590_1457_1459_207 7 3.48E-05 0.002400704 5.72E-05 25143 hsa-mir-655 hsa04910 Insulin signaling pathway 5590_5595_5594_5599_5601_2932_207 7 3.64E-05 0.002509351 5.84E-05 25144 hsa-mir-655 hsa04810 Regulation of actin cytoskeleton 1956_5595_5594_5159_5156_2261_2264_5879 8 9.43E-05 0.006509354 0.00014794 25145 hsa-mir-655 hsa04730 Long-term depression 3480_5518_5592_5595_5594 5 0.00011469 0.007913641 0.000175859 25146 hsa-mir-655 hsa05014 Amyotrophic lateral sclerosis (ALS) 5600_5603_1432_5879 4 0.000541036 0.037331469 0.000811554 25147 hsa-mir-655 hsa04916 Melanogenesis 5595_5594_1387_2932_2033 5 0.000614733 0.042416544 0.000895203 25148 hsa-mir-655 hsa04950 Maturity onset diabetes of the young 3651_6927_3280 3 0.00062275 0.042969768 0.000895203 25149 hsa-mir-655 hsa05016 Huntington's disease 1387_9586_3066_3065_3064_2033 6 0.001403107 0.096814368 0.001975803 25150 hsa-mir-655 hsa05340 Primary immunodeficiency 3718_3932_3575 3 0.00170804 0.117854728 0.002357095 25151 hsa-mir-655 hsa04640 Hematopoietic cell lineage 3559_3575_3570_1441 4 0.002553452 0.176188213 0.003454671 25152 hsa-mir-655 hsa04020 Calcium signaling pathway 1956_2064_5159_5156_2185 5 0.006735897 0.464776919 0.008938018 25153 hsa-mir-655 hsa04270 Vascular smooth muscle contraction 5580_5592_5595_5594 4 0.007232709 0.499056924 0.009416168 25154 hsa-mir-655 hsa04120 Ubiquitin mediated proteolysis 5371_672_10401_7329 4 0.012442697 0.858546066 0.015899001 25155 hsa-mir-655 hsa03440 Homologous recombination 6118_4683 2 0.014966286 1 0.018775886 25156 hsa-mir-655 hsa04612 Antigen processing and presentation 3320_3326_2923 3 0.019915151 1 0.024538311 25157 hsa-mir-655 hsa04080 Neuroactive ligand-receptor interaction 7253_2908_3953_2690_7067 5 0.024103749 1 0.029178222 25158 hsa-mir-655 hsa03022 Basal transcription factors 2963_2969 2 0.024581635 1 0.02924367 25159 hsa-mir-655 hsa05217 Basal cell carcinoma 2932_2736 2 0.049247322 1 0.057594326 25160 hsa-mir-656 hsa05200 Pathways in cancer 4088_4089_4087_1488_5925_2033_367_6502_207_2932_1499_5594_5595_862_1487_1387 16 2.28E-15 1.35E-13 1.35E-13 25161 hsa-mir-656 hsa04350 TGF-beta signaling pathway 4088_4089_4087_3398_2033_5594_5595_3397_3399_1387 10 1.71E-13 1.01E-11 5.04E-12 25162 hsa-mir-656 hsa04110 Cell cycle 4088_4089_4087_5925_2033_7532_6502_2932_7534_1387 10 3.11E-12 1.84E-10 5.19E-11 25163 hsa-mir-656 hsa04520 Adherens junction 4088_4089_4087_2033_1499_6714_5594_5595_1387 9 3.52E-12 2.08E-10 5.19E-11 25164 hsa-mir-656 hsa05215 Prostate cancer 5925_2033_367_207_2932_1499_5594_5595_1387 9 7.77E-12 4.58E-10 8.39E-11 25165 hsa-mir-656 hsa05212 Pancreatic cancer 5925_2033_367_207_2932_1499_5594_5595_1387 9 8.54E-12 5.04E-10 8.39E-11 25166 hsa-mir-656 hsa04916 Melanogenesis 2033_2932_1499_5594_5595_808_801_1387_805 9 3.13E-11 1.85E-09 2.64E-10 25167 hsa-mir-656 hsa05220 Chronic myeloid leukemia 4088_4089_1488_5925_207_5594_5595_1487 8 8.74E-11 5.16E-09 6.44E-10 25168 hsa-mir-656 hsa05210 Colorectal cancer 4088_4089_4087_207_2932_1499_5594_5595 8 2.02E-10 1.19E-08 1.32E-09 25169 hsa-mir-656 hsa04310 Wnt signaling pathway 4088_4089_4087_1488_2033_2932_1499_1487_1387 9 7.51E-10 4.43E-08 4.43E-09 25170 hsa-mir-656 hsa05214 Glioma 5925_207_5594_5595_808_801_805 7 1.30E-09 7.70E-08 7.00E-09 25171 hsa-mir-656 hsa04720 Long-term potentiation 2033_5594_5595_808_801_1387_805 7 3.29E-09 1.94E-07 1.62E-08 25172 hsa-mir-656 hsa04370 VEGF signaling pathway 9261_1432_207_6714_5594_5595_7867 7 3.90E-09 2.30E-07 1.77E-08 25173 hsa-mir-656 hsa04910 Insulin signaling pathway 207_2932_5594_5595_2538_808_801_805 8 8.10E-09 4.78E-07 3.21E-08 25174 hsa-mir-656 hsa04330 Notch signaling pathway 1488_2033_388585_8850_1487_1387 6 8.17E-09 4.82E-07 3.21E-08 25175 hsa-mir-656 hsa04912 GnRH signaling pathway 1432_6714_5594_5595_808_801_805 7 3.52E-08 2.08E-06 1.30E-07 25176 hsa-mir-656 hsa05211 Renal cell carcinoma 5058_2033_207_5594_5595_1387 6 8.64E-08 5.10E-06 3.00E-07 25177 hsa-mir-656 hsa04010 MAPK signaling pathway 9261_4208_5058_1432_207_5594_5595_6722_7867 9 9.80E-08 5.78E-06 3.21E-07 25178 hsa-mir-656 hsa04012 ErbB signaling pathway 5058_207_2932_6714_5594_5595 6 2.48E-07 1.46E-05 7.70E-07 25179 hsa-mir-656 hsa05213 Endometrial cancer 207_2932_1499_5594_5595 5 5.62E-07 3.32E-05 1.66E-06 25180 hsa-mir-656 hsa04660 T cell receptor signaling pathway 5058_1432_207_2932_5594_5595 6 9.18E-07 5.41E-05 2.58E-06 25181 hsa-mir-656 hsa04510 Focal adhesion 5058_207_2932_1499_6714_5594_5595 7 2.31E-06 0.000136069 6.18E-06 25182 hsa-mir-656 hsa05010 Alzheimer's disease 2932_5594_5595_808_801_805 6 1.28E-05 0.000755213 3.28E-05 25183 hsa-mir-656 hsa05223 Non-small cell lung cancer 5925_207_5594_5595 4 2.14E-05 0.001261904 5.26E-05 25184 hsa-mir-656 hsa04270 Vascular smooth muscle contraction 5594_5595_808_801_805 5 2.51E-05 0.001481188 5.92E-05 25185 hsa-mir-656 hsa05221 Acute myeloid leukemia 207_5594_5595_862 4 2.97E-05 0.001752981 6.74E-05 25186 hsa-mir-656 hsa04950 Maturity onset diabetes of the young 3651_3172_168620 3 5.85E-05 0.003452558 0.000124537 25187 hsa-mir-656 hsa05218 Melanoma 5925_207_5594_5595 4 5.91E-05 0.003487041 0.000124537 25188 hsa-mir-656 hsa04662 B cell receptor signaling pathway 207_2932_5594_5595 4 7.24E-05 0.004274168 0.000147385 25189 hsa-mir-656 hsa04664 Fc epsilon RI signaling pathway 1432_207_5594_5595 4 8.79E-05 0.005183348 0.000172778 25190 hsa-mir-656 hsa05216 Thyroid cancer 1499_5594_5595 3 9.82E-05 0.00579588 0.000186964 25191 hsa-mir-656 hsa04620 Toll-like receptor signaling pathway 1432_207_5594_5595 4 0.000226206 0.013346134 0.000417067 25192 hsa-mir-656 hsa04062 Chemokine signaling pathway 5058_207_2932_5594_5595 5 0.000237818 0.014031287 0.000425191 25193 hsa-mir-656 hsa05219 Bladder cancer 5925_5594_5595 3 0.000273778 0.016152897 0.000475085 25194 hsa-mir-656 hsa04930 Type II diabetes mellitus 3651_5594_5595 3 0.000331696 0.019570065 0.000559145 25195 hsa-mir-656 hsa04150 mTOR signaling pathway 207_5594_5595 3 0.000496092 0.029269442 0.00081304 25196 hsa-mir-656 hsa04360 Axon guidance 5058_2932_5594_5595 4 0.00056673 0.033437084 0.000903705 25197 hsa-mir-656 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5058_1432_6714 3 0.001179909 0.069614642 0.001831964 25198 hsa-mir-656 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.001425016 0.084075945 0.002155793 25199 hsa-mir-656 hsa05222 Small cell lung cancer 5925_6502_207 3 0.00200585 0.118345144 0.002958629 25200 hsa-mir-656 hsa04540 Gap junction 6714_5594_5595 3 0.00248854 0.146823858 0.00358107 25201 hsa-mir-656 hsa04530 Tight junction 207_1499_6714 3 0.00714024 0.421274156 0.009990152 25202 hsa-mir-656 hsa04650 Natural killer cell mediated cytotoxicity 5058_5594_5595 3 0.007280958 0.429576543 0.009990152 25203 hsa-mir-656 hsa04630 Jak-STAT signaling pathway 2033_207_1387 3 0.0099273 0.585710716 0.013311607 25204 hsa-mir-656 hsa05217 Basal cell carcinoma 2932_1499 2 0.011130814 0.656718034 0.014445748 25205 hsa-mir-656 hsa05131 Shigellosis 7534_1499 2 0.01150763 0.678950178 0.014445748 25206 hsa-mir-656 hsa05130 Pathogenic Escherichia coli infection 7534_1499 2 0.01150763 0.678950178 0.014445748 25207 hsa-mir-656 hsa04340 Hedgehog signaling pathway 2932_53944 2 0.01189001 0.70151058 0.014614804 25208 hsa-mir-656 hsa04020 Calcium signaling pathway 808_801_805 3 0.015585114 0.91952175 0.01876575 25209 hsa-mir-656 hsa04920 Adipocytokine signaling pathway 207_2538 2 0.016012566 0.944741378 0.018894828 25210 hsa-mir-656 hsa04730 Long-term depression 5594_5595 2 0.01780915 1 0.020602743 25211 hsa-mir-656 hsa04810 Regulation of actin cytoskeleton 5058_5594_5595 3 0.02439726 1 0.027681506 25212 hsa-mir-656 hsa04670 Leukocyte transendothelial migration 1432_1499 2 0.047188076 1 0.052530122 25213 hsa-mir-657 hsa04110 Cell cycle 4088_4089_1870_1871_7157_4087_2033_1017_890_1869_5934_5933 12 1.43E-20 4.15E-19 4.15E-19 25214 hsa-mir-657 hsa05200 Pathways in cancer 4088_4089_1487_1870_1871_1488_1050_4149_7157_4087_2033_1017_1869 13 3.61E-17 1.05E-15 5.24E-16 25215 hsa-mir-657 hsa05220 Chronic myeloid leukemia 4088_4089_1487_1870_1871_1488_7157_1869 8 4.12E-14 1.19E-12 3.98E-13 25216 hsa-mir-657 hsa04350 TGF-beta signaling pathway 4088_4089_1874_1875_4087_2033_5934_5933 8 1.26E-13 3.65E-12 9.12E-13 25217 hsa-mir-657 hsa04310 Wnt signaling pathway 4088_4089_1487_1488_7157_4087_2033 7 4.87E-10 1.41E-08 2.82E-09 25218 hsa-mir-657 hsa05222 Small cell lung cancer 1870_1871_4149_7157_1017_1869 6 8.79E-10 2.55E-08 3.87E-09 25219 hsa-mir-657 hsa05215 Prostate cancer 1870_1871_7157_2033_1017_1869 6 1.00E-09 2.90E-08 3.87E-09 25220 hsa-mir-657 hsa05212 Pancreatic cancer 1870_1871_7157_2033_1017_1869 6 1.07E-09 3.10E-08 3.87E-09 25221 hsa-mir-657 hsa05219 Bladder cancer 1870_1871_7157_1869 4 2.16E-07 6.26E-06 6.96E-07 25222 hsa-mir-657 hsa05223 Non-small cell lung cancer 1870_1871_7157_1869 4 5.56E-07 1.61E-05 1.61E-06 25223 hsa-mir-657 hsa05214 Glioma 1870_1871_7157_1869 4 1.12E-06 3.26E-05 2.96E-06 25224 hsa-mir-657 hsa05218 Melanoma 1870_1871_7157_1869 4 1.57E-06 4.56E-05 3.80E-06 25225 hsa-mir-657 hsa04520 Adherens junction 4088_4089_4087_2033 4 2.48E-06 7.18E-05 5.52E-06 25226 hsa-mir-657 hsa05210 Colorectal cancer 4088_4089_7157_4087 4 2.98E-06 8.65E-05 6.18E-06 25227 hsa-mir-657 hsa04330 Notch signaling pathway 1487_1488_2033 3 2.50E-05 0.000726442 4.84E-05 25228 hsa-mir-657 hsa04115 p53 signaling pathway 7157_1017 2 0.002943471 0.085360656 0.005335041 25229 hsa-mir-657 hsa05016 Huntington's disease 7157_2033 2 0.019556962 0.567151887 0.033361876 25230 hsa-mir-657 hsa05216 Thyroid cancer 7157 1 0.033425763 0.969347133 0.053852619 25231 hsa-mir-657 hsa04010 MAPK signaling pathway 4149_7157 2 0.038666791 1 0.059017734 25232 hsa-mir-658 hsa05210 Colorectal cancer 4087_4088_4609 3 1.95E-06 3.32E-05 1.84E-05 25233 hsa-mir-658 hsa04350 TGF-beta signaling pathway 4087_4088_4609 3 2.16E-06 3.68E-05 1.84E-05 25234 hsa-mir-658 hsa04310 Wnt signaling pathway 4087_4088_4609 3 1.11E-05 0.000188646 6.29E-05 25235 hsa-mir-658 hsa05200 Pathways in cancer 4087_4088_4609 3 0.000110184 0.00187313 0.000468282 25236 hsa-mir-658 hsa05220 Chronic myeloid leukemia 4088_4609 2 0.000231234 0.003930974 0.000743029 25237 hsa-mir-658 hsa04520 Adherens junction 4087_4088 2 0.000262245 0.004458172 0.000743029 25238 hsa-mir-658 hsa04612 Antigen processing and presentation 4800_4801 2 0.000322912 0.005489511 0.000784216 25239 hsa-mir-658 hsa04110 Cell cycle 4087_4088 2 0.000569823 0.00968699 0.001210874 25240 hsa-mir-658 hsa05216 Thyroid cancer 4609 1 0.008962596 0.152364134 0.016929348 25241 hsa-mir-658 hsa05219 Bladder cancer 4609 1 0.012824162 0.218010751 0.021801075 25242 hsa-mir-658 hsa05213 Endometrial cancer 4609 1 0.01578549 0.268353325 0.024395757 25243 hsa-mir-658 hsa05221 Acute myeloid leukemia 4609 1 0.017853718 0.303513211 0.025292768 25244 hsa-mir-658 hsa05222 Small cell lung cancer 4609 1 0.025795031 0.43851552 0.031678351 25245 hsa-mir-658 hsa04012 ErbB signaling pathway 4609 1 0.026088054 0.443496917 0.031678351 25246 hsa-mir-658 hsa04630 Jak-STAT signaling pathway 4609 1 0.0458308 0.779123593 0.051941573 25247 hsa-mir-661 hsa05200 Pathways in cancer 1147_3320_3326_5371_405_3480_1956_3265_5595_5594_6654_5914_1387_2064_6256_595_836_208_367_2932_4193_7704_6776_3091_2308_5970_7428_8503_1870_1871_8554_2885_7157_4087_2113_10401_4609_1869_3725_4088_4089_5295_3066_3065_5925_2034_2033_4846_207_9915_4790 51 1.52E-37 1.15E-35 1.15E-35 25248 hsa-mir-661 hsa05215 Prostate cancer 1147_3320_3326_3480_1956_3265_5595_5594_6654_1387_2064_595_208_367_2932_4193_2308_5970_8503_1870_1871_2885_7157_1869_5295_5925_2033_207_4790_90993 30 3.24E-31 2.46E-29 1.08E-29 25249 hsa-mir-661 hsa05212 Pancreatic cancer 1147_3320_3326_3480_1956_3265_5595_5594_6654_1387_2064_595_208_367_2932_4193_2308_5970_8503_1870_1871_2885_7157_1869_5295_5925_2033_207_4790_90993 30 4.28E-31 3.25E-29 1.08E-29 25250 hsa-mir-661 hsa05220 Chronic myeloid leukemia 1147_3265_5595_5594_6654_595_208_4193_6776_5970_8503_1870_1871_2885_7157_4609_1869_4088_4089_5295_3066_3065_5925_207_4790_6464 26 2.34E-27 1.78E-25 4.45E-26 25251 hsa-mir-661 hsa05214 Glioma 3480_1956_3265_5595_5594_6654_595_208_4193_8503_1870_1871_2885_7157_1869_5295_5925_207_801_6464_808_805 22 3.82E-23 2.90E-21 5.81E-22 25252 hsa-mir-661 hsa04010 MAPK signaling pathway 1147_1956_3265_5595_5594_6654_2872_5598_4208_994_836_5566_208_4214_3312_1386_1432_5970_2885_7157_10912_22800_4609_3725_3727_6195_4763_5058_6197_4616_207_627_4790_4773 34 1.30E-22 9.86E-21 1.64E-21 25253 hsa-mir-661 hsa05223 Non-small cell lung cancer 1956_3265_5595_5594_6654_2064_6256_595_208_8503_1870_1871_2885_7157_1869_5295_5925_2309_207 19 2.02E-20 1.53E-18 2.19E-19 25254 hsa-mir-661 hsa05211 Renal cell carcinoma 405_3265_5595_5594_6654_56924_1387_208_3091_7428_8503_2885_2113_3725_5295_5058_2034_2033_207_9915 20 9.96E-20 7.57E-18 9.46E-19 25255 hsa-mir-661 hsa04110 Cell cycle 5591_1387_595_994_2932_4193_902_1870_1871_7157_4087_10912_1869_1022_7533_4088_4089_3066_3065_5925_2033_5933_4616 23 1.98E-19 1.51E-17 1.67E-18 25256 hsa-mir-661 hsa05221 Acute myeloid leukemia 1147_5371_3265_5595_5594_6654_5914_595_208_7704_6776_5970_8503_2885_4609_5295_207_4790 18 1.71E-18 1.30E-16 1.30E-17 25257 hsa-mir-661 hsa05210 Colorectal cancer 3480_1956_5595_5594_6654_595_836_208_2932_8503_2885_7157_4087_4609_3725_4088_4089_5295_207 19 2.24E-17 1.70E-15 1.55E-16 25258 hsa-mir-661 hsa04012 ErbB signaling pathway 1956_3265_6714_5595_5594_6654_56924_2064_208_2932_6776_8503_2885_4609_3725_5295_5058_207_6464 19 3.95E-17 3.00E-15 2.50E-16 25259 hsa-mir-661 hsa05213 Endometrial cancer 1956_3265_5595_5594_6654_2064_595_208_2932_8503_2885_7157_4609_5295_2309_207 16 1.24E-16 9.44E-15 7.15E-16 25260 hsa-mir-661 hsa04660 T cell receptor signaling pathway 1147_3932_3265_5595_5594_6654_56924_208_2932_5777_1432_5970_8503_2885_3725_5295_5058_207_4790_4773 20 1.32E-16 1.00E-14 7.15E-16 25261 hsa-mir-661 hsa05222 Small cell lung cancer 1147_6256_595_208_5970_8503_1870_1871_8554_7157_10401_4609_1869_5295_5925_4846_207_4790 18 5.15E-16 3.92E-14 2.61E-15 25262 hsa-mir-661 hsa04910 Insulin signaling pathway 6720_10891_3265_5595_5594_6654_2872_5566_7249_208_2932_5770_2308_8503_2885_5295_207_801_6464_808_805 21 5.52E-16 4.20E-14 2.62E-15 25263 hsa-mir-661 hsa05218 Melanoma 3480_1956_3265_5595_5594_595_208_4193_8503_1870_1871_7157_1869_5295_5925_207 16 8.13E-15 6.18E-13 3.63E-14 25264 hsa-mir-661 hsa04662 B cell receptor signaling pathway 1147_3265_5595_5594_6654_208_2932_5777_5970_8503_2885_3725_5295_207_4790_4773 16 1.71E-14 1.30E-12 7.22E-14 25265 hsa-mir-661 hsa05219 Bladder cancer 1956_3265_5595_5594_2064_595_4193_1870_1871_7157_4609_1869_5925 13 8.72E-14 6.63E-12 3.49E-13 25266 hsa-mir-661 hsa04520 Adherens junction 1460_3480_1956_6714_5595_5594_1387_2064_5770_5777_4087_1457_4088_4089_2033 15 5.93E-13 4.50E-11 2.25E-12 25267 hsa-mir-661 hsa04510 Focal adhesion 9564_3480_1956_3265_6714_5595_5594_6654_56924_2064_595_208_2932_857_8503_2885_3725_5295_5058_207_6464 21 7.10E-13 5.40E-11 2.57E-12 25268 hsa-mir-661 hsa04062 Chemokine signaling pathway 1147_9564_3265_5595_5594_6654_2770_5566_208_2932_5970_8503_2885_5295_5058_2309_207_4790_6464 19 1.57E-11 1.19E-09 5.42E-11 25269 hsa-mir-661 hsa04912 GnRH signaling pathway 1956_3265_6714_5595_5594_6654_5598_5566_4214_1432_2885_3725_801_808_805 15 2.77E-11 2.11E-09 9.16E-11 25270 hsa-mir-661 hsa04720 Long-term potentiation 3265_5595_5594_1387_2902_5566_2906_6195_6197_2033_801_808_805 13 5.04E-11 3.83E-09 1.60E-10 25271 hsa-mir-661 hsa04150 mTOR signaling pathway 5595_5594_7249_208_3091_8503_6195_5295_6197_207 10 3.62E-09 2.75E-07 1.10E-08 25272 hsa-mir-661 hsa04370 VEGF signaling pathway 3265_6714_5595_5594_208_1432_8503_5295_4846_207_4773 11 9.65E-09 7.33E-07 2.82E-08 25273 hsa-mir-661 hsa04310 Wnt signaling pathway 1460_1387_595_5566_2932_7157_4087_4609_3725_1457_4088_4089_2033_4773 14 1.66E-08 1.26E-06 4.68E-08 25274 hsa-mir-661 hsa04916 Melanogenesis 3265_5595_5594_1387_2770_5566_2932_2033_801_808_90993_805 12 1.81E-08 1.37E-06 4.91E-08 25275 hsa-mir-661 hsa04630 Jak-STAT signaling pathway 6654_1387_595_208_5777_6776_8503_8554_2885_10401_4609_5295_2033_207 14 2.09E-08 1.59E-06 5.48E-08 25276 hsa-mir-661 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_4087_4609_4088_4089_2033_5933_4093 11 3.03E-08 2.30E-06 7.47E-08 25277 hsa-mir-661 hsa05016 Huntington's disease 6874_10891_1387_2902_6908_836_6667_7157_3066_3065_3064_2033_627_90993_9519 15 3.05E-08 2.32E-06 7.47E-08 25278 hsa-mir-661 hsa04210 Apoptosis 1147_836_5566_208_840_5970_8503_7157_5295_207_4790 11 3.75E-08 2.85E-06 8.91E-08 25279 hsa-mir-661 hsa04650 Natural killer cell mediated cytotoxicity 3932_3265_5595_5594_6654_836_5777_8503_2885_5295_5058_6464_4773 13 4.24E-08 3.22E-06 9.77E-08 25280 hsa-mir-661 hsa04664 Fc epsilon RI signaling pathway 3265_5595_5594_6654_208_1432_8503_2885_5295_207 10 1.28E-07 9.75E-06 2.87E-07 25281 hsa-mir-661 hsa04620 Toll-like receptor signaling pathway 1147_5595_5594_208_1432_5970_8503_3725_5295_207_4790 11 1.34E-07 1.02E-05 2.91E-07 25282 hsa-mir-661 hsa05216 Thyroid cancer 3265_5595_5594_6256_595_7157_4609 7 2.20E-07 1.67E-05 4.64E-07 25283 hsa-mir-661 hsa04540 Gap junction 1956_3265_6714_5595_5594_6654_5598_2770_5566_2885 10 5.12E-07 3.89E-05 1.05E-06 25284 hsa-mir-661 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_1956_6714_836_1432_5970_3725_5058_4790 9 5.44E-07 4.13E-05 1.09E-06 25285 hsa-mir-661 hsa05010 Alzheimer's disease 5595_5594_2902_836_2932_840_1020_2906_351_4846_801_808_805 13 6.16E-07 4.68E-05 1.20E-06 25286 hsa-mir-661 hsa03022 Basal transcription factors 2965_2963_6874_6908_2959_6881_9519 7 9.28E-07 7.05E-05 1.76E-06 25287 hsa-mir-661 hsa04120 Ubiquitin mediated proteolysis 11059_5371_672_4734_4214_4193_7428_8554_10273_10401_7329 11 2.30E-06 0.000175147 4.27E-06 25288 hsa-mir-661 hsa04360 Axon guidance 5998_3265_5595_5594_56924_2770_2932_1020_5058_4773 10 8.94E-06 0.000679417 1.62E-05 25289 hsa-mir-661 hsa04920 Adipocytokine signaling pathway 1147_10891_6256_208_5970_207_4790 7 3.19E-05 0.002427218 5.64E-05 25290 hsa-mir-661 hsa04115 p53 signaling pathway 595_836_7249_4193_7157_10912_4616 7 3.80E-05 0.002888403 6.56E-05 25291 hsa-mir-661 hsa04530 Tight junction 1460_3265_6714_2770_208_8573_22800_1457_207 9 7.54E-05 0.005726693 0.00012726 25292 hsa-mir-661 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_1432_7157_2906_4846 6 0.000103957 0.007900707 0.000171754 25293 hsa-mir-661 hsa04810 Regulation of actin cytoskeleton 9564_1956_3265_5595_5594_6654_56924_8503_22800_5295_5058 11 0.000123189 0.009362383 0.0001992 25294 hsa-mir-661 hsa04730 Long-term depression 3480_3265_5595_5594_2770_4846 6 0.0003445 0.026181998 0.000545458 25295 hsa-mir-661 hsa04330 Notch signaling pathway 1387_9612_3066_3065_2033 5 0.000409095 0.031091218 0.000634515 25296 hsa-mir-661 hsa04020 Calcium signaling pathway 1956_2064_2902_5566_2906_4846_801_808_805 9 0.000603216 0.045844427 0.000916889 25297 hsa-mir-661 hsa04612 Antigen processing and presentation 3320_3326_4800_4801_3312_6890 6 0.001053338 0.080053717 0.001569681 25298 hsa-mir-661 hsa03420 Nucleotide excision repair 2965_902_1022_4331 4 0.002685421 0.20409201 0.003924846 25299 hsa-mir-661 hsa04930 Type II diabetes mellitus 5595_5594_8503_5295 4 0.002896643 0.220144902 0.004153677 25300 hsa-mir-661 hsa04070 Phosphatidylinositol signaling system 8503_5295_801_808_805 5 0.003033984 0.230582796 0.004270052 25301 hsa-mir-661 hsa04270 Vascular smooth muscle contraction 5595_5594_5566_801_808_805 6 0.00404713 0.30758189 0.005592398 25302 hsa-mir-661 hsa04670 Leukocyte transendothelial migration 9564_2770_1432_8503_5295 5 0.019270714 1 0.026153111 25303 hsa-mir-661 hsa03050 Proteasome 5684_5705_5698 3 0.023781997 1 0.031709329 25304 hsa-mir-662 hsa05200 Pathways in cancer 3320_5594_5599_1387_367_2932_4193_7704_6776_6777_5970_7157_2113_5894_3725_6774_861_2353_2736_4088_5925_1050_207_4790_4791 25 2.94E-21 2.09E-19 2.09E-19 25305 hsa-mir-662 hsa04010 MAPK signaling pathway 6722_8986_5594_5599_9261_3303_9252_1432_5970_7157_5894_3725_6195_6196_6197_2353_1616_207_5536_4790_4791_5566 22 2.17E-19 1.54E-17 7.70E-18 25306 hsa-mir-662 hsa05215 Prostate cancer 3320_5594_1385_1387_367_2932_4193_5970_7157_5894_5925_207_4790 13 5.33E-15 3.78E-13 1.08E-13 25307 hsa-mir-662 hsa05212 Pancreatic cancer 3320_5594_1385_1387_367_2932_4193_5970_7157_5894_5925_207_4790 13 6.08E-15 4.32E-13 1.08E-13 25308 hsa-mir-662 hsa05220 Chronic myeloid leukemia 5594_4193_6776_6777_5970_7157_5894_861_4088_5925_207_4790 12 2.60E-14 1.85E-12 3.69E-13 25309 hsa-mir-662 hsa05221 Acute myeloid leukemia 5594_7704_6776_6777_5970_5894_6774_861_1050_207_4790 11 7.17E-14 5.09E-12 8.48E-13 25310 hsa-mir-662 hsa04660 T cell receptor signaling pathway 3932_5594_920_915_2932_1432_5970_5894_3725_2353_207_4790 12 1.63E-12 1.16E-10 1.66E-11 25311 hsa-mir-662 hsa04720 Long-term potentiation 5594_1387_5894_6195_6196_6197_808_801_5566_805 10 2.03E-11 1.44E-09 1.80E-10 25312 hsa-mir-662 hsa05214 Glioma 5594_4193_7157_5894_5925_207_808_801_805 9 1.55E-10 1.10E-08 1.23E-09 25313 hsa-mir-662 hsa05210 Colorectal cancer 5594_5599_2932_7157_5894_3725_2353_4088_207 9 1.25E-09 8.85E-08 8.85E-09 25314 hsa-mir-662 hsa04910 Insulin signaling pathway 10891_5594_5599_2932_5894_207_808_801_5566_805 10 5.01E-09 3.56E-07 3.23E-08 25315 hsa-mir-662 hsa04916 Melanogenesis 5594_1385_1387_2932_5894_808_801_5566_805 9 7.09E-09 5.04E-07 4.20E-08 25316 hsa-mir-662 hsa04912 GnRH signaling pathway 5594_5599_1432_5894_3725_808_801_5566_805 9 9.64E-09 6.85E-07 5.27E-08 25317 hsa-mir-662 hsa04662 B cell receptor signaling pathway 5594_2932_5970_5894_3725_2353_207_4790 8 1.10E-08 7.80E-07 5.57E-08 25318 hsa-mir-662 hsa04110 Cell cycle 5591_1387_7533_2932_4193_7157_2810_4088_5925 9 2.12E-08 1.51E-06 1.00E-07 25319 hsa-mir-662 hsa04012 ErbB signaling pathway 5594_5599_2932_6776_6777_5894_3725_207 8 3.22E-08 2.28E-06 1.43E-07 25320 hsa-mir-662 hsa04620 Toll-like receptor signaling pathway 5594_5599_1432_5970_3725_2353_207_4790 8 1.02E-07 7.22E-06 4.25E-07 25321 hsa-mir-662 hsa05219 Bladder cancer 5594_9252_4193_7157_5894_5925 6 1.65E-07 1.17E-05 6.52E-07 25322 hsa-mir-662 hsa04062 Chemokine signaling pathway 5594_2932_6777_5970_5894_6774_207_4790_5566 9 1.04E-06 7.39E-05 3.89E-06 25323 hsa-mir-662 hsa04310 Wnt signaling pathway 5518_5599_1387_2932_7157_3725_4088_5566 8 1.78E-06 0.000126703 6.34E-06 25324 hsa-mir-662 hsa04920 Adipocytokine signaling pathway 10891_5599_5970_6774_207_4790 6 2.07E-06 0.000146657 6.98E-06 25325 hsa-mir-662 hsa05218 Melanoma 5594_4193_7157_5894_5925_207 6 2.83E-06 0.000200859 9.13E-06 25326 hsa-mir-662 hsa05211 Renal cell carcinoma 5594_1387_2113_5894_3725_207 6 3.05E-06 0.000216686 9.42E-06 25327 hsa-mir-662 hsa04270 Vascular smooth muscle contraction 5594_5592_5894_808_801_5566_805 7 3.81E-06 0.000270275 1.13E-05 25328 hsa-mir-662 hsa05016 Huntington's disease 10891_1385_1387_291_6908_5481_7157_3064 8 8.01E-06 0.000569004 2.28E-05 25329 hsa-mir-662 hsa04350 TGF-beta signaling pathway 5518_5594_1387_3399_3398_4088 6 8.50E-06 0.000603823 2.32E-05 25330 hsa-mir-662 hsa05213 Endometrial cancer 5594_2932_7157_5894_207 5 1.10E-05 0.000781149 2.79E-05 25331 hsa-mir-662 hsa04150 mTOR signaling pathway 5594_6195_6196_6197_207 5 1.10E-05 0.000781149 2.79E-05 25332 hsa-mir-662 hsa05223 Non-small cell lung cancer 5594_7157_5894_5925_207 5 1.30E-05 0.000926355 3.19E-05 25333 hsa-mir-662 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_1432_5970_3725_4790 5 4.49E-05 0.003188166 0.000106272 25334 hsa-mir-662 hsa05340 Primary immunodeficiency 3932_920_915_100 4 4.68E-05 0.003324029 0.000107227 25335 hsa-mir-662 hsa04370 VEGF signaling pathway 5594_9261_1432_5894_207 5 6.47E-05 0.004594203 0.000143569 25336 hsa-mir-662 hsa04664 Fc epsilon RI signaling pathway 5594_5599_1432_5894_207 5 7.26E-05 0.005155698 0.000156233 25337 hsa-mir-662 hsa05222 Small cell lung cancer 5970_7157_5925_207_4790 5 0.000106294 0.007546895 0.000221967 25338 hsa-mir-662 hsa04612 Antigen processing and presentation 3320_811_920_1385_3303 5 0.000123932 0.008799186 0.000244422 25339 hsa-mir-662 hsa04210 Apoptosis 5970_7157_207_4790_5566 5 0.000123932 0.008799186 0.000244422 25340 hsa-mir-662 hsa04630 Jak-STAT signaling pathway 1387_3460_6776_6777_6774_207 6 0.000184793 0.013120303 0.000354603 25341 hsa-mir-662 hsa05010 Alzheimer's disease 5594_3416_2932_808_801_805 6 0.000367757 0.026110728 0.000687124 25342 hsa-mir-662 hsa04020 Calcium signaling pathway 291_5481_808_801_5566_805 6 0.000448796 0.031864496 0.000817038 25343 hsa-mir-662 hsa04730 Long-term depression 5518_5594_5592_5894 4 0.000599958 0.042597038 0.001064926 25344 hsa-mir-662 hsa04510 Focal adhesion 5594_5599_2932_5894_3725_207 6 0.000796906 0.056580326 0.001380008 25345 hsa-mir-662 hsa04540 Gap junction 5594_5592_5894_5566 4 0.001568255 0.111346122 0.002651098 25346 hsa-mir-662 hsa04930 Type II diabetes mellitus 3651_5594_5599 3 0.00190913 0.135548215 0.003152284 25347 hsa-mir-662 hsa05217 Basal cell carcinoma 2932_7157_2736 3 0.003281506 0.232986931 0.005295158 25348 hsa-mir-662 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_7157_1616 3 0.00344448 0.244558106 0.005434625 25349 hsa-mir-662 hsa04340 Hedgehog signaling pathway 2932_2736_5566 3 0.003612327 0.256475193 0.005575548 25350 hsa-mir-662 hsa04115 p53 signaling pathway 4193_7157_2810 3 0.006021686 0.427539713 0.00909659 25351 hsa-mir-662 hsa04650 Natural killer cell mediated cytotoxicity 3932_5594_3460_5894 4 0.006159821 0.437347281 0.009111402 25352 hsa-mir-662 hsa04950 Maturity onset diabetes of the young 3651_3175 2 0.007771289 0.551761505 0.011047968 25353 hsa-mir-662 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.007780259 0.552398418 0.011047968 25354 hsa-mir-662 hsa04520 Adherens junction 5594_1387_4088 3 0.008907179 0.632409723 0.012400191 25355 hsa-mir-662 hsa05216 Thyroid cancer 5594_7157 2 0.010935254 0.776403042 0.014930828 25356 hsa-mir-662 hsa03022 Basal transcription factors 2963_6908 2 0.016968797 1 0.022731784 25357 hsa-mir-662 hsa04330 Notch signaling pathway 1387_9612 2 0.026053445 1 0.034255456 25358 hsa-mir-662 hsa05012 Parkinson's disease 7314_291_5481 3 0.034578237 1 0.044637361 25359 hsa-mir-662 hsa04120 Ubiquitin mediated proteolysis 672_4193_7329 3 0.0364824 1 0.046254471 25360 hsa-mir-664 hsa05200 Pathways in cancer 3716_3320_3326_3725_5371_5747_3480_1956_4233_5595_5594_5599_1387_2064_5159_595_5156_367_2261_3815_6774_6776_6777_6772_5979_5879_8772_1026_2353_10401_4089_3066_3065_2033_1441_207_8554_4790_5970_7046_7186 41 1.46E-38 1.01E-36 1.01E-36 25361 hsa-mir-664 hsa04630 Jak-STAT signaling pathway 3717_3716_3718_3559_85480_3560_3561_149233_1387_595_3575_3570_3572_3953_6774_6776_6777_6772_1439_58985_3454_3455_3459_5781_7297_2690_10401_6773_2033_1441_207_8554_10379 33 5.22E-38 3.60E-36 1.80E-36 25362 hsa-mir-664 hsa04060 Cytokine-cytokine receptor interaction 3556_2321_3559_85480_1956_4233_3560_3561_149233_90_5159_5156_7133_7132_3575_3570_3572_1234_1230_3815_3953_1439_3791_7852_58985_3454_3455_3459_2690_1441_7046 31 1.13E-28 7.77E-27 2.59E-27 25363 hsa-mir-664 hsa04010 MAPK signaling pathway 3925_3725_1956_5595_5594_5599_5159_5156_7132_3303_2261_2264_9252_1432_5879_6885_1845_2353_207_4790_51701_5970_7046_7186 24 1.37E-19 9.43E-18 2.36E-18 25364 hsa-mir-664 hsa05215 Prostate cancer 3320_3326_3480_1956_5595_5594_1387_2064_5159_595_5156_367_1026_2033_207_4790_5970 17 2.23E-19 1.54E-17 3.03E-18 25365 hsa-mir-664 hsa05212 Pancreatic cancer 3320_3326_3480_1956_5595_5594_1387_2064_5159_595_5156_367_1026_2033_207_4790_5970 17 2.64E-19 1.82E-17 3.03E-18 25366 hsa-mir-664 hsa04520 Adherens junction 2241_3480_1956_6714_4233_5595_5594_1387_2064_5879_6885_4089_2033_51701_7046_2534 16 1.61E-18 1.11E-16 1.59E-17 25367 hsa-mir-664 hsa04062 Chemokine signaling pathway 3717_3718_5580_5747_5590_5595_5594_1234_1230_6774_6777_6772_5879_7852_2185_6773_207_3055_4790_5970 20 8.92E-18 6.15E-16 7.69E-17 25368 hsa-mir-664 hsa04620 Toll-like receptor signaling pathway 3725_3654_5595_5594_5599_1432_6772_5879_3454_3455_8772_6885_2353_207_4790_5970 16 5.02E-17 3.46E-15 3.85E-16 25369 hsa-mir-664 hsa05210 Colorectal cancer 3725_3480_1956_4233_5595_5594_5599_5159_595_5156_5879_2353_4089_207_7046 15 8.73E-17 6.02E-15 6.02E-16 25370 hsa-mir-664 hsa05220 Chronic myeloid leukemia 5595_5594_595_6776_6777_5781_1026_4089_3066_3065_207_4790_5970_7046 14 5.51E-16 3.80E-14 3.46E-15 25371 hsa-mir-664 hsa04012 ErbB signaling pathway 3725_818_817_5747_1956_6714_5595_5594_5599_2064_6776_6777_1026_207 14 3.46E-15 2.39E-13 1.99E-14 25372 hsa-mir-664 hsa04510 Focal adhesion 3725_2321_5747_3480_1956_6714_4233_5595_5594_5599_2064_5159_595_5156_5879_3791_207_2534 18 6.44E-15 4.45E-13 3.42E-14 25373 hsa-mir-664 hsa04920 Adipocytokine signaling pathway 3717_8717_5599_7133_7132_3953_6774_5781_207_4790_5970_7186 12 1.09E-13 7.53E-12 5.38E-13 25374 hsa-mir-664 hsa05221 Acute myeloid leukemia 5371_5595_5594_595_3815_6774_6776_6777_207_4790_5970 11 8.05E-13 5.55E-11 3.70E-12 25375 hsa-mir-664 hsa05214 Glioma 818_817_3480_1956_5595_5594_5159_595_5156_1026_207 11 2.06E-12 1.42E-10 8.88E-12 25376 hsa-mir-664 hsa05218 Melanoma 3480_1956_4233_5595_5594_5159_595_5156_1026_207 10 1.09E-10 7.49E-09 4.16E-10 25377 hsa-mir-664 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1956_6714_4233_5599_1432_5879_5781_4790_5970 10 1.09E-10 7.49E-09 4.16E-10 25378 hsa-mir-664 hsa04912 GnRH signaling pathway 3725_5580_818_817_1956_6714_5595_5594_5599_1432_2185 11 2.99E-10 2.07E-08 1.09E-09 25379 hsa-mir-664 hsa04660 T cell receptor signaling pathway 3725_3932_5595_5594_1432_6885_2353_207_4790_5970_2534 11 3.58E-10 2.47E-08 1.24E-09 25380 hsa-mir-664 hsa04210 Apoptosis 3654_3556_8717_7132_1439_8772_207_4790_5970_7186 10 8.16E-10 5.63E-08 2.68E-09 25381 hsa-mir-664 hsa05219 Bladder cancer 1956_5595_5594_2064_595_2261_9252_1026 8 9.87E-10 6.81E-08 3.10E-09 25382 hsa-mir-664 hsa05211 Renal cell carcinoma 3725_4233_5595_5594_1387_5879_5781_2033_207 9 2.48E-09 1.71E-07 7.43E-09 25383 hsa-mir-664 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6850_5879_3454_3455_3459_5781_2185_2534 11 3.32E-09 2.29E-07 9.49E-09 25384 hsa-mir-664 hsa04662 B cell receptor signaling pathway 3725_5595_5594_6850_5879_2353_207_4790_5970 9 3.44E-09 2.37E-07 9.49E-09 25385 hsa-mir-664 hsa04664 Fc epsilon RI signaling pathway 5580_5595_5594_5599_6850_1432_5879_207_2534 9 5.22E-09 3.60E-07 1.39E-08 25386 hsa-mir-664 hsa04310 Wnt signaling pathway 3725_818_817_5599_1387_595_5879_6885_4089_2033_51701 11 8.53E-09 5.89E-07 2.18E-08 25387 hsa-mir-664 hsa04350 TGF-beta signaling pathway 5595_5594_1387_90_4086_4089_2033_7046_57154 9 1.13E-08 7.83E-07 2.80E-08 25388 hsa-mir-664 hsa04370 VEGF signaling pathway 5747_6714_5595_5594_1432_5879_3791_207 8 7.32E-08 5.05E-06 1.74E-07 25389 hsa-mir-664 hsa04110 Cell cycle 1387_595_4174_1026_4172_4089_3066_3065_2033 9 1.40E-07 9.67E-06 3.22E-07 25390 hsa-mir-664 hsa05222 Small cell lung cancer 5747_595_10401_207_8554_4790_5970_7186 8 1.61E-07 1.11E-05 3.59E-07 25391 hsa-mir-664 hsa04330 Notch signaling pathway 388585_1387_3280_3066_3065_2033 6 1.10E-06 7.56E-05 2.36E-06 25392 hsa-mir-664 hsa05213 Endometrial cancer 1956_5595_5594_2064_595_207 6 1.88E-06 0.000129753 3.93E-06 25393 hsa-mir-664 hsa05223 Non-small cell lung cancer 1956_5595_5594_2064_595_207 6 2.30E-06 0.000158808 4.67E-06 25394 hsa-mir-664 hsa04360 Axon guidance 2242_5747_4233_5595_5594_5879_7852_2534 8 3.20E-06 0.000220579 6.30E-06 25395 hsa-mir-664 hsa04916 Melanogenesis 818_817_5595_5594_1387_3815_2033 7 7.33E-06 0.000505661 1.40E-05 25396 hsa-mir-664 hsa04720 Long-term potentiation 818_817_5595_5594_1387_2033 6 1.34E-05 0.000921695 2.49E-05 25397 hsa-mir-664 hsa04930 Type II diabetes mellitus 5580_5590_5595_5594_5599 5 1.66E-05 0.001144057 2.95E-05 25398 hsa-mir-664 hsa04810 Regulation of actin cytoskeleton 5747_1956_5595_5594_5159_5156_2261_2264_5879 9 1.67E-05 0.001150426 2.95E-05 25399 hsa-mir-664 hsa04020 Calcium signaling pathway 818_817_1956_2064_5159_5156_2185_147 8 3.37E-05 0.002325862 5.81E-05 25400 hsa-mir-664 hsa04540 Gap junction 1956_6714_5595_5594_5159_5156 6 4.20E-05 0.002894985 7.06E-05 25401 hsa-mir-664 hsa05216 Thyroid cancer 5595_5594_595_5979 4 5.61E-05 0.003873567 9.22E-05 25402 hsa-mir-664 hsa05340 Primary immunodeficiency 3718_3932_3561_3575 4 0.000109529 0.007557497 0.000175756 25403 hsa-mir-664 hsa04670 Leukocyte transendothelial migration 5747_1432_5879_7852_5781_2185 6 0.000174422 0.012035115 0.000273525 25404 hsa-mir-664 hsa04640 Hematopoietic cell lineage 3559_3575_3570_3815_1441 5 0.000310209 0.021404421 0.000475654 25405 hsa-mir-664 hsa04120 Ubiquitin mediated proteolysis 5371_672_7329_10401_8554_57154 6 0.000342014 0.023598976 0.000513021 25406 hsa-mir-664 hsa05014 Amyotrophic lateral sclerosis (ALS) 7133_7132_1432_5879 4 0.000585214 0.040379796 0.000859145 25407 hsa-mir-664 hsa03030 DNA replication 4174_6118_4172 3 0.001955004 0.134895288 0.002810319 25408 hsa-mir-664 hsa04910 Insulin signaling pathway 5590_5595_5594_5599_207 5 0.002258062 0.155806248 0.003179719 25409 hsa-mir-664 hsa04612 Antigen processing and presentation 3320_3326_3303_2923 4 0.002978285 0.205501637 0.004110033 25410 hsa-mir-664 hsa04150 mTOR signaling pathway 5595_5594_207 3 0.005210126 0.359498687 0.007048994 25411 hsa-mir-664 hsa04270 Vascular smooth muscle contraction 5580_5595_5594_147 4 0.007773968 0.536403811 0.010315458 25412 hsa-mir-664 hsa04730 Long-term depression 3480_5595_5594 3 0.011791733 0.813629557 0.015112478 25413 hsa-mir-664 hsa04950 Maturity onset diabetes of the young 6927_3280 2 0.011827157 0.816073801 0.015112478 25414 hsa-mir-664 hsa04530 Tight junction 5580_6714_5590_207 4 0.012730141 0.878379758 0.015970541 25415 hsa-mir-664 hsa04080 Neuroactive ligand-receptor interaction 7253_2908_3953_2690_147 5 0.02607507 1 0.032128212 25416 hsa-mir-664 hsa05010 Alzheimer's disease 5595_5594_7132_8772 4 0.028760371 1 0.034815186 25417 hsa-mir-664 hsa05016 Huntington's disease 1387_3066_3065_2033 4 0.034606034 1 0.041169248 25418 hsa-mir-665 hsa05200 Pathways in cancer 1147_3320_3326_3725_3551_6774_5468_861_1387_367_8517_6772_6256_5371_4791_6688_10401_4609_2113_2353_3065_3066_5925_2033_8554_4790_4792 27 2.48E-18 1.71E-16 1.71E-16 25419 hsa-mir-665 hsa04010 MAPK signaling pathway 1147_6722_3725_3551_1326_3305_3303_5566_8517_9252_3312_5971_4791_6885_4609_9020_2353_1616_5608_4790 20 4.41E-13 3.05E-11 1.52E-11 25420 hsa-mir-665 hsa04620 Toll-like receptor signaling pathway 1147_3725_3551_29110_1326_8517_3661_9641_6772_6885_2353_5608_4790_4792 14 7.02E-13 4.84E-11 1.61E-11 25421 hsa-mir-665 hsa04920 Adipocytokine signaling pathway 1147_3551_6774_5465_8517_6256_4794_4793_8471_4790_4792 11 3.80E-11 2.62E-09 6.55E-10 25422 hsa-mir-665 hsa04310 Wnt signaling pathway 3725_23291_5519_5515_1387_8607_5566_8454_6500_8945_6885_4609_1457_2033 14 9.55E-11 6.59E-09 1.32E-09 25423 hsa-mir-665 hsa04660 T cell receptor signaling pathway 1147_3725_3551_1326_8517_4794_4793_6885_9020_2353_4790_4792 12 3.60E-10 2.49E-08 4.14E-09 25424 hsa-mir-665 hsa05215 Prostate cancer 1147_3320_3326_3551_1387_367_8517_5925_2033_4790_4792 11 5.30E-10 3.66E-08 5.10E-09 25425 hsa-mir-665 hsa05212 Pancreatic cancer 1147_3320_3326_3551_1387_367_8517_5925_2033_4790_4792 11 5.91E-10 4.08E-08 5.10E-09 25426 hsa-mir-665 hsa05220 Chronic myeloid leukemia 1147_3551_861_8517_4609_3065_3066_5925_4790_4792 10 1.86E-09 1.28E-07 1.28E-08 25427 hsa-mir-665 hsa04662 B cell receptor signaling pathway 1147_3725_3551_695_8517_4794_4793_2353_4790_4792 10 1.86E-09 1.28E-07 1.28E-08 25428 hsa-mir-665 hsa05221 Acute myeloid leukemia 1147_3551_6774_861_8517_5371_6688_4609_4790 9 4.22E-09 2.91E-07 2.64E-08 25429 hsa-mir-665 hsa05222 Small cell lung cancer 1147_3551_8517_6256_10401_4609_5925_8554_4790_4792 10 6.21E-09 4.28E-07 3.57E-08 25430 hsa-mir-665 hsa04350 TGF-beta signaling pathway 3399_5519_5515_1387_6667_8454_3398_6500_4609_2033 10 6.87E-09 4.74E-07 3.65E-08 25431 hsa-mir-665 hsa05016 Huntington's disease 498_5468_1387_292_293_6667_1213_5437_3065_3066_2033_6908_5441 13 1.16E-08 7.97E-07 5.70E-08 25432 hsa-mir-665 hsa04120 Ubiquitin mediated proteolysis 8651_23291_672_51366_8454_55294_6500_5371_8945_10401_8554 11 4.36E-08 3.01E-06 2.00E-07 25433 hsa-mir-665 hsa04110 Cell cycle 5591_1387_8454_6500_5111_3065_3066_1111_5925_2033 10 1.07E-07 7.39E-06 4.62E-07 25434 hsa-mir-665 hsa04330 Notch signaling pathway 1387_4851_9612_3065_3066_2033_8850 7 2.69E-07 1.86E-05 1.09E-06 25435 hsa-mir-665 hsa03020 RNA polymerase 25885_64425_5437_51082_84172_5441 6 3.54E-07 2.44E-05 1.36E-06 25436 hsa-mir-665 hsa05131 Shigellosis 7278_71_10382_347733_7846_4691_203068 7 7.90E-07 5.45E-05 2.73E-06 25437 hsa-mir-665 hsa05130 Pathogenic Escherichia coli infection 7278_71_10382_347733_7846_4691_203068 7 7.90E-07 5.45E-05 2.73E-06 25438 hsa-mir-665 hsa04062 Chemokine signaling pathway 1147_3551_6774_5590_5566_8517_6772_653361_4793_4790_4792 11 9.68E-07 6.68E-05 3.18E-06 25439 hsa-mir-665 hsa03022 Basal transcription factors 2969_6878_6872_6882_2959_6908 6 1.26E-06 8.70E-05 3.85E-06 25440 hsa-mir-665 hsa04210 Apoptosis 1147_3551_5566_8517_9131_9020_4790_4792 8 1.28E-06 8.86E-05 3.85E-06 25441 hsa-mir-665 hsa03010 Ribosome 6128_6155_6156_6141_6207_6217_9349_6188 8 3.33E-06 0.000229579 9.39E-06 25442 hsa-mir-665 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_3725_3551_8517_9020_4790_4792 7 3.40E-06 0.000234763 9.39E-06 25443 hsa-mir-665 hsa04720 Long-term potentiation 814_1387_5566_2033_808_801_805 7 4.76E-06 0.000328676 1.26E-05 25444 hsa-mir-665 hsa04630 Jak-STAT signaling pathway 8651_6774_1387_6778_6772_10401_4609_2033_8554 9 8.25E-06 0.000569329 2.11E-05 25445 hsa-mir-665 hsa04910 Insulin signaling pathway 3551_8651_5590_5566_8471_808_801_805 8 2.67E-05 0.001838865 6.57E-05 25446 hsa-mir-665 hsa04612 Antigen processing and presentation 3320_3326_3309_3305_3303_3312 6 0.000126535 0.008730927 0.000301066 25447 hsa-mir-665 hsa04540 Gap junction 5566_7278_10382_347733_7846_203068 6 0.000158812 0.010958031 0.000365268 25448 hsa-mir-665 hsa04916 Melanogenesis 1387_5566_2033_808_801_805 6 0.000281948 0.019454427 0.000627562 25449 hsa-mir-665 hsa04912 GnRH signaling pathway 3725_5566_5608_808_801_805 6 0.000341773 0.023582317 0.000736947 25450 hsa-mir-665 hsa04520 Adherens junction 1387_71_6885_1457_2033 5 0.00064828 0.044731348 0.001355495 25451 hsa-mir-665 hsa04930 Type II diabetes mellitus 3551_8651_5590_8471 4 0.000668672 0.046138346 0.00135701 25452 hsa-mir-665 hsa04020 Calcium signaling pathway 814_292_293_5566_808_801_805 7 0.000979845 0.067609275 0.001931694 25453 hsa-mir-665 hsa04530 Tight junction 5519_5515_5590_4628_71_1457 6 0.001127111 0.077770636 0.002160295 25454 hsa-mir-665 hsa05216 Thyroid cancer 5468_6256_4609 3 0.002189361 0.151065878 0.004082862 25455 hsa-mir-665 hsa05214 Glioma 5925_808_801_805 4 0.002404945 0.165941176 0.004366873 25456 hsa-mir-665 hsa03320 PPAR signaling pathway 10062_5465_5468_6256 4 0.003101858 0.214028186 0.005487902 25457 hsa-mir-665 hsa05211 Renal cell carcinoma 3725_1387_2113_2033 4 0.003415469 0.235667372 0.005891684 25458 hsa-mir-665 hsa03410 Base excision repair 3146_5111_142 3 0.00386955 0.266998941 0.006512169 25459 hsa-mir-665 hsa05219 Bladder cancer 9252_4609_5925 3 0.005798196 0.4000755 0.009525607 25460 hsa-mir-665 hsa04340 Hedgehog signaling pathway 23291_5566_8945 3 0.012797594 0.883033968 0.020535674 25461 hsa-mir-665 hsa03430 Mismatch repair 5981_5111 2 0.017342893 1 0.026909282 25462 hsa-mir-665 hsa04270 Vascular smooth muscle contraction 5566_808_801_805 4 0.017549532 1 0.026909282 25463 hsa-mir-665 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.026456847 1 0.039685271 25464 hsa-mir-665 hsa05012 Parkinson's disease 498_7314_292_293 4 0.027404681 1 0.040232403 25465 hsa-mir-665 hsa05210 Colorectal cancer 3725_4609_2353 3 0.033846509 1 0.048654357 25466 hsa-mir-665 hsa05340 Primary immunodeficiency 695_8517 2 0.036141881 1 0.050893669 25467 hsa-mir-665 hsa03030 DNA replication 5981_5111 2 0.037950143 1 0.052371197 25468 hsa-mir-668 hsa05200 Pathways in cancer 3551_5467_5468_5914_595_1017_4193_6934_7704_3091_4089_3065_1050_5925_1499_25_405_1956_4436_1487_1488_2113_10401_861_867_207_3716_1147_5595_5594_5599_6258_1387_6257_6256_4286_367_6774_6777_6772_5970_7157_7849_3725_6776_4088_2034_2033_3320_51176_5371_675_5159_8031_5156_5604_5601_1399_1398_3815_841_4087_4609_2956_2353_8554 66 7.75E-41 6.12E-39 6.12E-39 25469 hsa-mir-668 hsa05220 Chronic myeloid leukemia 3551_595_4193_4089_3065_5925_25_1487_1488_861_867_207_1147_5595_5594_6777_5970_7157_6776_4088_5604_1399_1398_5781_4609_6464 26 7.46E-22 5.90E-20 2.95E-20 25470 hsa-mir-668 hsa05221 Acute myeloid leukemia 3551_5467_5914_595_6934_7704_1050_861_207_1147_5595_5594_6774_6777_5970_6776_51176_5371_5604_3815_4609 21 4.24E-18 3.35E-16 1.12E-16 25471 hsa-mir-668 hsa05215 Prostate cancer 3551_595_1017_4193_6934_5925_1499_1956_207_9586_1147_5595_5594_1387_367_5970_7157_2033_3320_51176_5159_5156_5604 23 3.31E-17 2.61E-15 6.46E-16 25472 hsa-mir-668 hsa05212 Pancreatic cancer 3551_595_1017_4193_6934_5925_1499_1956_207_9586_1147_5595_5594_1387_367_5970_7157_2033_3320_51176_5159_5156_5604 23 4.09E-17 3.23E-15 6.46E-16 25473 hsa-mir-668 hsa05210 Colorectal cancer 595_6934_4089_1499_1956_4436_207_5595_5594_5599_7157_3725_4088_51176_5159_5156_5604_5601_4087_4609_2956_2353 22 1.56E-16 1.23E-14 2.05E-15 25474 hsa-mir-668 hsa04630 Jak-STAT signaling pathway 3559_595_5777_3560_3561_2057_10401_867_2690_207_3575_3717_3716_3718_85480_1387_6778_6774_6777_6772_6776_2033_894_896_5781_4609_8554 27 4.36E-16 3.44E-14 4.92E-15 25475 hsa-mir-668 hsa04110 Cell cycle 595_1017_4193_4089_3065_4616_993_5925_25_8379_5934_7534_1387_7532_7027_7157_10912_5111_4088_2033_894_896_983_4087 24 1.08E-15 8.53E-14 1.07E-14 25476 hsa-mir-668 hsa04310 Wnt signaling pathway 5467_595_6934_4089_4772_4773_1499_1487_1488_1459_5599_1387_7157_8061_3725_1457_4088_2033_894_896_51176_5515_5601_4087_4609_5527 26 2.25E-15 1.78E-13 1.98E-14 25477 hsa-mir-668 hsa05216 Thyroid cancer 5468_595_6934_1499_5595_5594_6258_6257_6256_7157_7849_51176_8031_5604_4609 15 3.29E-15 2.60E-13 2.60E-14 25478 hsa-mir-668 hsa04010 MAPK signaling pathway 3727_3551_9252_4773_4616_1956_1432_207_1147_5595_5594_5599_1386_1649_5970_3164_7157_10912_3725_5159_5156_5604_4208_5601_5600_1399_1398_4609_2353_5603_8550_2002 32 2.10E-14 1.66E-12 1.50E-13 25479 hsa-mir-668 hsa04012 ErbB signaling pathway 25_1956_6714_867_207_5595_5594_5599_2066_6777_3725_6776_5604_5601_1399_1398_4609_6464_2002 19 3.04E-13 2.40E-11 2.00E-12 25480 hsa-mir-668 hsa04520 Adherens junction 6934_5770_5777_4089_1499_1956_6714_1459_71_5595_5594_1387_1457_4088_2033_51176_3643_4087 18 8.29E-13 6.55E-11 5.04E-12 25481 hsa-mir-668 hsa04660 T cell receptor signaling pathway 3551_1493_5777_4772_4773_3932_1432_867_207_1147_5595_5594_5970_3725_5604_5601_5600_919_2353_5603 20 1.43E-12 1.13E-10 8.08E-12 25482 hsa-mir-668 hsa04620 Toll-like receptor signaling pathway 3551_3665_3661_1432_207_1147_5595_5594_5599_6772_5970_3725_5604_5601_5600_841_2353_5603 18 2.92E-11 2.31E-09 1.54E-10 25483 hsa-mir-668 hsa05213 Endometrial cancer 595_6934_1499_1956_2309_207_5595_5594_7157_51176_5604_4609_2002 13 4.13E-10 3.26E-08 2.04E-09 25484 hsa-mir-668 hsa04920 Adipocytokine signaling pathway 3551_10891_5465_207_3717_1147_5599_6258_6257_6256_6774_5970_5601_5781 14 6.75E-10 5.33E-08 3.14E-09 25485 hsa-mir-668 hsa05211 Renal cell carcinoma 3091_405_2113_207_5595_5594_1387_3725_2034_2033_5604_1399_1398_5781 14 1.53E-09 1.21E-07 6.62E-09 25486 hsa-mir-668 hsa04330 Notch signaling pathway 1840_3065_22938_1487_1488_1387_2033_8850_2648_4851_9612_9794 12 1.59E-09 1.26E-07 6.62E-09 25487 hsa-mir-668 hsa04350 TGF-beta signaling pathway 6667_4086_4089_1875_5934_5595_5594_1387_7027_4088_2033_5515_4087_4609_4092 15 1.73E-09 1.37E-07 6.84E-09 25488 hsa-mir-668 hsa04662 B cell receptor signaling pathway 3551_5777_4772_4773_6850_207_1147_695_5595_5594_5970_3725_5604_2353 14 2.44E-09 1.93E-07 9.19E-09 25489 hsa-mir-668 hsa05223 Non-small cell lung cancer 595_5925_1956_2309_207_5595_5594_6258_6257_6256_7157_5604 12 6.17E-09 4.87E-07 2.21E-08 25490 hsa-mir-668 hsa04115 p53 signaling pathway 595_1017_4194_4193_4616_7157_10912_64326_894_896_841_983_7161 13 8.25E-09 6.51E-07 2.83E-08 25491 hsa-mir-668 hsa05222 Small cell lung cancer 3551_595_1017_5925_10401_207_1147_6258_6257_6256_5970_7157_4609_8554 14 1.16E-08 9.15E-07 3.81E-08 25492 hsa-mir-668 hsa05322 Systemic lupus erythematosus 3021_3020_9555_8349_8365_8294_8370_121504_8361_8360_8363_8362_8364_8367_8366_8368_8359 17 2.49E-08 1.97E-06 7.88E-08 25493 hsa-mir-668 hsa04510 Focal adhesion 595_1499_1956_6714_207_71_5595_5594_5599_3725_894_896_5159_5156_5604_5601_1399_1398_6464_2002 20 3.06E-08 2.41E-06 9.28E-08 25494 hsa-mir-668 hsa05214 Glioma 595_4193_5925_1956_207_5595_5594_7157_5159_5156_5604_6464 12 3.78E-08 2.98E-06 1.11E-07 25495 hsa-mir-668 hsa04062 Chemokine signaling pathway 3551_1234_7852_2309_207_3717_1147_3718_5595_5594_5580_6774_6777_6772_5970_5604_1399_1398_6464 19 5.51E-08 4.36E-06 1.56E-07 25496 hsa-mir-668 hsa05219 Bladder cancer 595_9252_4193_5925_1956_5595_5594_7157_5604_4609 10 6.54E-08 5.17E-06 1.78E-07 25497 hsa-mir-668 hsa05218 Melanoma 595_4193_5925_1956_207_5595_5594_4286_7157_5159_5156_5604 12 8.93E-08 7.06E-06 2.28E-07 25498 hsa-mir-668 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3551_1956_6714_1432_1147_5599_5970_3725_5601_5600_5781_5603 12 8.93E-08 7.06E-06 2.28E-07 25499 hsa-mir-668 hsa04664 Fc epsilon RI signaling pathway 6850_1432_207_695_5595_5594_5599_5580_5604_5601_5600_5603 12 2.52E-07 1.99E-05 6.22E-07 25500 hsa-mir-668 hsa04910 Insulin signaling pathway 3551_10891_5770_867_207_5595_5594_5599_3643_5604_5601_1399_1398_6464_2002 15 4.35E-07 3.44E-05 1.04E-06 25501 hsa-mir-668 hsa04912 GnRH signaling pathway 1956_6714_1432_5595_5594_5599_5580_3725_5604_5601_5600_5603_2002 13 8.96E-07 7.08E-05 2.08E-06 25502 hsa-mir-668 hsa04370 VEGF signaling pathway 4772_4773_6714_1432_207_5595_5594_5604_5600_5603 10 8.88E-06 0.00070184 2.01E-05 25503 hsa-mir-668 hsa03410 Base excision repair 3146_4350_252969_328_2237_5111_6996 7 2.02E-05 0.001596862 4.44E-05 25504 hsa-mir-668 hsa04930 Type II diabetes mellitus 3551_5595_5594_5599_5580_3643_5601 7 7.19E-05 0.005682976 0.000153594 25505 hsa-mir-668 hsa04916 Melanogenesis 6934_1499_5595_5594_1387_4286_2033_51176_5604_3815 10 9.38E-05 0.007409541 0.000194988 25506 hsa-mir-668 hsa03320 PPAR signaling pathway 5465_5467_5468_10062_6258_6257_6256_2168 8 0.000158314 0.01250678 0.000320687 25507 hsa-mir-668 hsa04650 Natural killer cell mediated cytotoxicity 5777_4772_4773_3932_6850_5595_5594_5604_919_5781_6464 11 0.000199765 0.015781421 0.000394536 25508 hsa-mir-668 hsa05016 Huntington's disease 6667_10891_5468_3065_25942_4724_9586_1387_7157_2033_841_6908 12 0.000695385 0.054935405 0.001339888 25509 hsa-mir-668 hsa04540 Gap junction 1956_6714_5595_5594_5159_5156_5604_983 8 0.000917935 0.072516884 0.001726592 25510 hsa-mir-668 hsa05340 Primary immunodeficiency 3932_3561_3575_3718_695 5 0.00111893 0.088395445 0.002055708 25511 hsa-mir-668 hsa04120 Ubiquitin mediated proteolysis 4193_10401_867_7329_8925_64326_5371_672_8554 9 0.002869133 0.22666149 0.005151398 25512 hsa-mir-668 hsa04210 Apoptosis 3551_207_1147_5970_7157_841_840 7 0.00303601 0.239844757 0.005329883 25513 hsa-mir-668 hsa03440 Homologous recombination 10111_4683_675_4361 4 0.003544887 0.280046056 0.006047099 25514 hsa-mir-668 hsa04060 Cytokine-cytokine receptor interaction 3559_1234_1956_7852_3560_3561_2057_2690_3575_85480_5159_5156_3815 13 0.003597641 0.284213636 0.006047099 25515 hsa-mir-668 hsa03450 Non-homologous end-joining 10111_2237_4361 3 0.004289658 0.338883015 0.007060063 25516 hsa-mir-668 hsa04530 Tight junction 1499_6714_1459_207_71_5580_1457_5515 8 0.008530788 0.673932278 0.013714341 25517 hsa-mir-668 hsa03022 Basal transcription factors 2963_2969_2959_6908 4 0.008679962 0.685717032 0.013714341 25518 hsa-mir-668 hsa03430 Mismatch repair 4436_5111_2956 3 0.014376782 1 0.022248178 25519 hsa-mir-668 hsa04670 Leukocyte transendothelial migration 1499_7852_1432_71_5600_5781_5603 7 0.01464437 1 0.022248178 25520 hsa-mir-668 hsa04950 Maturity onset diabetes of the young 6927_4760_5080 3 0.015940056 1 0.023759705 25521 hsa-mir-668 hsa04720 Long-term potentiation 5595_5594_1387_2033_5604 5 0.021488438 1 0.031436788 25522 hsa-mir-668 hsa04150 mTOR signaling pathway 3091_207_5595_5594 4 0.02498742 1 0.035891022 25523 hsa-mir-668 hsa05217 Basal cell carcinoma 6934_1499_7157_51176 4 0.029574745 1 0.041721515 25524 hsa-mir-668 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_7157_5600_5603 4 0.031207141 1 0.041785833 25525 hsa-mir-668 hsa05131 Shigellosis 1499_25_71_7534 4 0.031207141 1 0.041785833 25526 hsa-mir-668 hsa05130 Pathogenic Escherichia coli infection 1499_25_71_7534 4 0.031207141 1 0.041785833 25527 hsa-mir-668 hsa04612 Antigen processing and presentation 3308_1514_3320_4800_4801 5 0.039315454 1 0.051765348 25528 hsa-mir-668 hsa04810 Regulation of actin cytoskeleton 1956_71_5595_5594_5159_5156_5604_1399_1398 9 0.049250286 1 0.063783157 25529 hsa-mir-670 hsa05200 Pathways in cancer 3716_675_5595_5594_1387_5159_5156_1399_1398_3815_6774_6777_6772_5970_7157_3725_867_5925_2033_1956_7186 21 2.14E-20 1.48E-18 1.48E-18 25530 hsa-mir-670 hsa04630 Jak-STAT signaling pathway 3717_3716_3718_3560_3561_1387_3575_6774_6777_6772_2057_5781_867_2690_85480_2033 16 7.15E-19 4.93E-17 2.47E-17 25531 hsa-mir-670 hsa05220 Chronic myeloid leukemia 5595_5594_1399_1398_6777_5970_7157_5781_867_5925_6464 11 7.70E-15 5.31E-13 1.77E-13 25532 hsa-mir-670 hsa04012 ErbB signaling pathway 6714_5595_5594_2066_1399_1398_6777_3725_867_6464_1956 11 3.41E-14 2.35E-12 5.88E-13 25533 hsa-mir-670 hsa04010 MAPK signaling pathway 5595_5594_5159_5156_3303_1399_1398_1432_5970_7157_4773_3725_1956_7186 14 1.05E-12 7.24E-11 1.45E-11 25534 hsa-mir-670 hsa05215 Prostate cancer 5595_5594_1387_5159_5156_5970_7157_5925_2033_1956 10 1.39E-12 9.59E-11 1.52E-11 25535 hsa-mir-670 hsa05212 Pancreatic cancer 5595_5594_1387_5159_5156_5970_7157_5925_2033_1956 10 1.54E-12 1.06E-10 1.52E-11 25536 hsa-mir-670 hsa04062 Chemokine signaling pathway 3717_3718_5595_5594_1399_1398_1234_6774_6777_6772_5970_6464 12 5.69E-12 3.92E-10 4.91E-11 25537 hsa-mir-670 hsa04660 T cell receptor signaling pathway 3932_1493_5595_5594_919_1432_5970_4773_3725_867 10 1.08E-11 7.47E-10 8.30E-11 25538 hsa-mir-670 hsa04520 Adherens junction 6714_3643_5595_5594_1387_5770_1457_2033_1956 9 2.09E-11 1.44E-09 1.44E-10 25539 hsa-mir-670 hsa05214 Glioma 5595_5594_5159_5156_7157_5925_6464_1956 8 1.47E-10 1.02E-08 9.24E-10 25540 hsa-mir-670 hsa05211 Renal cell carcinoma 5595_5594_1387_1399_1398_5781_3725_2033 8 3.12E-10 2.15E-08 1.79E-09 25541 hsa-mir-670 hsa04060 Cytokine-cytokine receptor interaction 3560_3561_5159_5156_3575_1234_3815_2057_2690_85480_1956 11 2.40E-09 1.65E-07 1.27E-08 25542 hsa-mir-670 hsa04510 Focal adhesion 6714_5595_5594_5159_5156_1399_1398_3725_6464_1956 10 3.52E-09 2.43E-07 1.74E-08 25543 hsa-mir-670 hsa05218 Melanoma 5595_5594_5159_5156_7157_5925_1956 7 9.03E-09 6.23E-07 4.15E-08 25544 hsa-mir-670 hsa04110 Cell cycle 993_1387_983_10971_7534_7157_5925_2033 8 1.26E-08 8.72E-07 5.22E-08 25545 hsa-mir-670 hsa04662 B cell receptor signaling pathway 695_5595_5594_6850_5970_4773_3725 7 1.29E-08 8.87E-07 5.22E-08 25546 hsa-mir-670 hsa05210 Colorectal cancer 5595_5594_5159_5156_7157_3725_1956 7 2.67E-08 1.84E-06 1.02E-07 25547 hsa-mir-670 hsa04910 Insulin signaling pathway 3643_5595_5594_1399_1398_5770_867_6464 8 3.77E-08 2.60E-06 1.30E-07 25548 hsa-mir-670 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6850_919_5781_4773_6464 8 3.77E-08 2.60E-06 1.30E-07 25549 hsa-mir-670 hsa04540 Gap junction 6714_5595_5594_5159_983_5156_1956 7 5.15E-08 3.55E-06 1.69E-07 25550 hsa-mir-670 hsa04310 Wnt signaling pathway 5515_1387_7157_4773_3725_1457_1452_2033 8 7.67E-08 5.29E-06 2.41E-07 25551 hsa-mir-670 hsa05221 Acute myeloid leukemia 5595_5594_3815_6774_6777_5970 6 9.16E-08 6.32E-06 2.75E-07 25552 hsa-mir-670 hsa05340 Primary immunodeficiency 3718_695_3932_3561_3575 5 2.42E-07 1.67E-05 6.97E-07 25553 hsa-mir-670 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_1432_5970_5781_3725_1956 6 2.55E-07 1.76E-05 7.03E-07 25554 hsa-mir-670 hsa05219 Bladder cancer 5595_5594_7157_5925_1956 5 5.54E-07 3.82E-05 1.47E-06 25555 hsa-mir-670 hsa04350 TGF-beta signaling pathway 5515_5595_5594_1387_6667_2033 6 7.83E-07 5.41E-05 2.00E-06 25556 hsa-mir-670 hsa05223 Non-small cell lung cancer 5595_5594_7157_5925_1956 5 1.75E-06 0.000120875 4.32E-06 25557 hsa-mir-670 hsa04620 Toll-like receptor signaling pathway 5595_5594_1432_6772_5970_3725 6 1.89E-06 0.000130253 4.49E-06 25558 hsa-mir-670 hsa04912 GnRH signaling pathway 6714_5595_5594_1432_3725_1956 6 2.59E-06 0.000178585 5.95E-06 25559 hsa-mir-670 hsa04920 Adipocytokine signaling pathway 3717_6774_5970_5781_7186 5 4.73E-06 0.000326241 1.05E-05 25560 hsa-mir-670 hsa04370 VEGF signaling pathway 6714_5595_5594_1432_4773 5 8.98E-06 0.000619391 1.94E-05 25561 hsa-mir-670 hsa04664 Fc epsilon RI signaling pathway 695_5595_5594_6850_1432 5 1.01E-05 0.000697065 2.11E-05 25562 hsa-mir-670 hsa04810 Regulation of actin cytoskeleton 5595_5594_5159_5156_1399_1398_1956 7 1.24E-05 0.000852699 2.51E-05 25563 hsa-mir-670 hsa04330 Notch signaling pathway 1387_9612_2033_8850 4 2.75E-05 0.001895569 5.42E-05 25564 hsa-mir-670 hsa04916 Melanogenesis 5595_5594_1387_3815_2033 5 3.58E-05 0.002467131 6.85E-05 25565 hsa-mir-670 hsa05213 Endometrial cancer 5595_5594_7157_1956 4 3.99E-05 0.002750057 7.43E-05 25566 hsa-mir-670 hsa04720 Long-term potentiation 5595_5594_1387_2033 4 0.000153597 0.01059819 0.0002789 25567 hsa-mir-670 hsa05216 Thyroid cancer 5595_5594_7157 3 0.000174427 0.012035467 0.000308602 25568 hsa-mir-670 hsa05222 Small cell lung cancer 5970_7157_5925_7186 4 0.000253872 0.017517172 0.000437929 25569 hsa-mir-670 hsa05016 Huntington's disease 1387_4724_6667_7157_2033 5 0.000518036 0.035744486 0.000871817 25570 hsa-mir-670 hsa04930 Type II diabetes mellitus 3643_5595_5594 3 0.000584794 0.040350812 0.000960734 25571 hsa-mir-670 hsa04730 Long-term depression 5515_5595_5594 3 0.002056512 0.141899312 0.003299984 25572 hsa-mir-670 hsa04640 Hematopoietic cell lineage 3575_3815_2057 3 0.003584174 0.247307988 0.005620636 25573 hsa-mir-670 hsa04210 Apoptosis 5970_7157_7186 3 0.003812652 0.263072985 0.005834997 25574 hsa-mir-670 hsa04020 Calcium signaling pathway 2066_5159_5156_1956 4 0.003889998 0.268409841 0.005834997 25575 hsa-mir-670 hsa03010 Ribosome 6124_6129_6143 3 0.005513927 0.38046099 0.008094915 25576 hsa-mir-670 hsa04360 Axon guidance 5595_5594_4773 3 0.010748485 0.741645447 0.015450947 25577 hsa-mir-670 hsa04530 Tight junction 5515_6714_1457 3 0.012092836 0.834405667 0.017028687 25578 hsa-mir-670 hsa04150 mTOR signaling pathway 5595_5594 2 0.014508989 1 0.020022405 25579 hsa-mir-670 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_7157 2 0.016613896 1 0.021629412 25580 hsa-mir-670 hsa05131 Shigellosis 10971_7534 2 0.016613896 1 0.021629412 25581 hsa-mir-670 hsa05130 Pathogenic Escherichia coli infection 10971_7534 2 0.016613896 1 0.021629412 25582 hsa-mir-670 hsa05010 Alzheimer's disease 5595_5594_4724 3 0.023449514 1 0.029963268 25583 hsa-mir-670 hsa04115 p53 signaling pathway 983_7157 2 0.024277639 1 0.030457401 25584 hsa-mir-670 hsa04612 Antigen processing and presentation 3303_1514 2 0.038305932 1 0.047198381 25585 hsa-mir-671 hsa05200 Pathways in cancer 4089_25_5371_6688_5925_3091_2033_1050_207_7704_3725_5599_6774_5914_5594 15 1.28E-15 6.50E-14 6.50E-14 25586 hsa-mir-671 hsa05221 Acute myeloid leukemia 5371_6688_1050_207_7704_6774_5914_5594 8 2.32E-12 1.18E-10 5.91E-11 25587 hsa-mir-671 hsa04350 TGF-beta signaling pathway 4086_4089_2033_4093_3398_5594 6 6.37E-08 3.25E-06 1.08E-06 25588 hsa-mir-671 hsa05211 Renal cell carcinoma 3091_2033_207_3725_5594 5 8.24E-07 4.20E-05 1.02E-05 25589 hsa-mir-671 hsa05220 Chronic myeloid leukemia 4089_25_5925_207_5594 5 9.97E-07 5.08E-05 1.02E-05 25590 hsa-mir-671 hsa05210 Colorectal cancer 4089_207_3725_5599_5594 5 1.70E-06 8.64E-05 1.44E-05 25591 hsa-mir-671 hsa04012 ErbB signaling pathway 25_207_3725_5599_5594 5 2.00E-06 0.000101893 1.46E-05 25592 hsa-mir-671 hsa04310 Wnt signaling pathway 4089_2033_3725_6423_5599 5 2.71E-05 0.001381463 0.000172683 25593 hsa-mir-671 hsa05215 Prostate cancer 5925_2033_207_5594 4 5.43E-05 0.002768563 0.000288816 25594 hsa-mir-671 hsa05212 Pancreatic cancer 5925_2033_207_5594 4 5.66E-05 0.002888161 0.000288816 25595 hsa-mir-671 hsa04620 Toll-like receptor signaling pathway 207_3725_5599_5594 4 9.43E-05 0.004808382 0.000437126 25596 hsa-mir-671 hsa04110 Cell cycle 4089_25_5925_2033 4 0.000167482 0.008541558 0.000711797 25597 hsa-mir-671 hsa04150 mTOR signaling pathway 3091_207_5594 3 0.000255373 0.013024038 0.001001849 25598 hsa-mir-671 hsa05223 Non-small cell lung cancer 5925_207_5594 3 0.000283914 0.014479613 0.001034258 25599 hsa-mir-671 hsa04010 MAPK signaling pathway 9479_207_3725_5599_5594 5 0.000394248 0.020106673 0.001340445 25600 hsa-mir-671 hsa05214 Glioma 5925_207_5594 3 0.000477851 0.024370382 0.001523149 25601 hsa-mir-671 hsa04920 Adipocytokine signaling pathway 207_5599_6774 3 0.000520284 0.026534461 0.001560851 25602 hsa-mir-671 hsa05218 Melanoma 5925_207_5594 3 0.000612225 0.031223463 0.001734637 25603 hsa-mir-671 hsa04662 B cell receptor signaling pathway 207_3725_5594 3 0.000713943 0.036411084 0.001916373 25604 hsa-mir-671 hsa04664 Fc epsilon RI signaling pathway 207_5599_5594 3 0.000825838 0.042117752 0.002077517 25605 hsa-mir-671 hsa04520 Adherens junction 4089_2033_5594 3 0.000855448 0.043627853 0.002077517 25606 hsa-mir-671 hsa04510 Focal adhesion 207_3725_5599_5594 4 0.001256613 0.064087252 0.002913057 25607 hsa-mir-671 hsa04912 GnRH signaling pathway 3725_5599_5594 3 0.001975505 0.100750762 0.004380468 25608 hsa-mir-671 hsa04660 T cell receptor signaling pathway 207_3725_5594 3 0.002078644 0.106010822 0.004417118 25609 hsa-mir-671 hsa04910 Insulin signaling pathway 207_5599_5594 3 0.003884112 0.198089706 0.007923588 25610 hsa-mir-671 hsa05219 Bladder cancer 5925_5594 2 0.004356316 0.222172112 0.008545081 25611 hsa-mir-671 hsa04930 Type II diabetes mellitus 5599_5594 2 0.00495664 0.252788649 0.009362543 25612 hsa-mir-671 hsa04630 Jak-STAT signaling pathway 2033_207_6774 3 0.005332837 0.271974712 0.009713383 25613 hsa-mir-671 hsa05213 Endometrial cancer 207_5594 2 0.006496053 0.331298714 0.011424094 25614 hsa-mir-671 hsa04062 Chemokine signaling pathway 207_6774_5594 3 0.009624676 0.490858486 0.01636195 25615 hsa-mir-671 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5599 2 0.011610424 0.592131614 0.01910102 25616 hsa-mir-671 hsa04720 Long-term potentiation 2033_5594 2 0.012853462 0.655526579 0.020485206 25617 hsa-mir-671 hsa04370 VEGF signaling pathway 207_5594 2 0.013495832 0.688287424 0.020857195 25618 hsa-mir-671 hsa05222 Small cell lung cancer 5925_207 2 0.016554443 0.844276598 0.024831665 25619 hsa-mir-671 hsa04916 Melanogenesis 2033_5594 2 0.023458586 1 0.034182511 25620 hsa-mir-671 hsa04360 Axon guidance 25_5594 2 0.035615197 1 0.050454862 25621 hsa-mir-675 hsa05200 Pathways in cancer 1499_596_598_1017_4193_5578_6502_3091_3065_5925_613_5743_5747_25_6789_4436_862_1147_998_5595_5594_5599_1387_9915_2932_1869_4087_4088_5888_5728_2034_2033_3910_4792_3320_3326_5371_675_5601_5602_1856_51588_1026_8554 44 3.94E-30 3.35E-28 3.35E-28 25622 hsa-mir-675 hsa04110 Cell cycle 1017_4193_902_6502_3065_5925_25_9232_545_995_5347_5591_1387_11200_7534_7532_2932_7027_1869_4087_4088_2033_890_1031_983_1026_1022_1111_8556_8555_472 31 2.85E-29 2.43E-27 1.21E-27 25623 hsa-mir-675 hsa04115 p53 signaling pathway 1017_4194_4193_900_50484_6241_51246_545_7161_11200_64326_5728_27113_25898_983_1026_1111_472 18 1.63E-17 1.39E-15 4.63E-16 25624 hsa-mir-675 hsa05215 Prostate cancer 1499_596_1017_4193_5925_1147_5595_5594_1387_2932_1869_5728_2033_4792_3320_3326_1026 17 9.88E-15 8.40E-13 1.98E-13 25625 hsa-mir-675 hsa05212 Pancreatic cancer 1499_596_1017_4193_5925_1147_5595_5594_1387_2932_1869_5728_2033_4792_3320_3326_1026 17 1.16E-14 9.89E-13 1.98E-13 25626 hsa-mir-675 hsa05222 Small cell lung cancer 596_598_1017_6502_5925_5743_5747_1147_1869_5728_3910_4792_51588_8554 14 1.78E-11 1.51E-09 2.48E-10 25627 hsa-mir-675 hsa04350 TGF-beta signaling pathway 6667_3397_3399_3398_5595_5594_1387_7027_4087_4088_2033_5518_5515_4093 14 2.05E-11 1.74E-09 2.48E-10 25628 hsa-mir-675 hsa04310 Wnt signaling pathway 1499_5578_1460_5599_1387_2932_1457_1452_4087_4088_2033_5518_5515_5601_5602_1856_5527 17 2.75E-11 2.34E-09 2.92E-10 25629 hsa-mir-675 hsa05220 Chronic myeloid leukemia 598_4193_3065_5925_613_25_1147_5595_5594_1869_4088_4792_1026 13 4.71E-11 4.01E-09 4.45E-10 25630 hsa-mir-675 hsa04010 MAPK signaling pathway 6722_7867_5578_5923_3304_3305_3303_6789_1432_1616_1147_998_5595_5594_5599_3315_3164_9261_4208_5601_5602 21 8.80E-11 7.48E-09 7.48E-10 25631 hsa-mir-675 hsa04120 Ubiquitin mediated proteolysis 4193_6502_3093_7319_84447_10055_64326_7337_7329_5371_672_25898_51588_10075_8554 15 6.44E-10 5.47E-08 4.97E-09 25632 hsa-mir-675 hsa05214 Glioma 4193_5578_5925_5595_5594_1869_5728_808_801_805_1026 11 1.86E-09 1.58E-07 1.25E-08 25633 hsa-mir-675 hsa05210 Colorectal cancer 1499_596_4436_5595_5594_5599_2932_4087_4088_5601_5602_1856 12 1.92E-09 1.63E-07 1.25E-08 25634 hsa-mir-675 hsa04510 Focal adhesion 1499_596_5578_5923_5747_5499_998_5595_5594_5599_2932_5728_3910_5601_5602 15 8.73E-08 7.42E-06 5.30E-07 25635 hsa-mir-675 hsa04370 VEGF signaling pathway 7867_5578_5743_5747_1432_998_5595_5594_3315_9261 10 9.80E-08 8.33E-06 5.56E-07 25636 hsa-mir-675 hsa04520 Adherens junction 1499_1460_998_5595_5594_1387_1457_4087_4088_2033 10 1.36E-07 1.15E-05 7.21E-07 25637 hsa-mir-675 hsa04916 Melanogenesis 1499_5578_5595_5594_1387_2932_2033_808_801_805_1856 11 1.52E-07 1.29E-05 7.60E-07 25638 hsa-mir-675 hsa04912 GnRH signaling pathway 5578_1432_998_5595_5594_5599_808_801_805_5601_5602 11 2.16E-07 1.83E-05 1.02E-06 25639 hsa-mir-675 hsa04012 ErbB signaling pathway 5578_5747_25_5595_5594_5599_2932_5601_5602_1026 10 2.77E-07 2.36E-05 1.24E-06 25640 hsa-mir-675 hsa04720 Long-term potentiation 5578_5499_5595_5594_1387_2033_808_801_805 9 7.91E-07 6.72E-05 3.36E-06 25641 hsa-mir-675 hsa03022 Basal transcription factors 51616_2965_2963_6908_2958_6880_2957 7 8.95E-07 7.61E-05 3.62E-06 25642 hsa-mir-675 hsa04910 Insulin signaling pathway 5499_5595_5594_5599_2932_808_801_805_5601_5602_5563 11 2.05E-06 0.000174187 7.92E-06 25643 hsa-mir-675 hsa03420 Nucleotide excision repair 902_2965_4331_2071_2074_1022_6117 7 2.52E-06 0.000213815 9.30E-06 25644 hsa-mir-675 hsa04330 Notch signaling pathway 3065_1387_9612_2033_8850_1856_388585 7 3.73E-06 0.000317115 1.32E-05 25645 hsa-mir-675 hsa05211 Renal cell carcinoma 3091_998_5595_5594_1387_9915_2034_2033 8 5.51E-06 0.000468297 1.87E-05 25646 hsa-mir-675 hsa04660 T cell receptor signaling pathway 1432_1147_998_5595_5594_2932_959_4792_5601 9 1.44E-05 0.001221866 4.70E-05 25647 hsa-mir-675 hsa05219 Bladder cancer 4193_5925_5595_5594_1869_1026 6 2.32E-05 0.001972492 7.31E-05 25648 hsa-mir-675 hsa04920 Adipocytokine signaling pathway 6794_1147_5599_4792_5601_5602_5563 7 3.09E-05 0.002623137 9.37E-05 25649 hsa-mir-675 hsa04930 Type II diabetes mellitus 3651_5595_5594_5599_5601_5602 6 3.30E-05 0.00280838 9.68E-05 25650 hsa-mir-675 hsa05218 Melanoma 4193_5925_5595_5594_1869_5728_1026 7 4.35E-05 0.003695996 0.000119226 25651 hsa-mir-675 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_1147_998_5599_4792_5601_5602 7 4.35E-05 0.003695996 0.000119226 25652 hsa-mir-675 hsa04620 Toll-like receptor signaling pathway 1432_1147_5595_5594_5599_4792_5601_5602 8 5.70E-05 0.004844184 0.000151381 25653 hsa-mir-675 hsa04530 Tight junction 1499_5578_1460_998_1457_5728_5518_5515_5520 9 7.23E-05 0.006146711 0.000186264 25654 hsa-mir-675 hsa04664 Fc epsilon RI signaling pathway 5578_1432_5595_5594_5599_5601_5602 7 8.15E-05 0.006924882 0.000203673 25655 hsa-mir-675 hsa05223 Non-small cell lung cancer 5578_5925_6789_5595_5594_1869 6 8.39E-05 0.007129236 0.000203692 25656 hsa-mir-675 hsa05131 Shigellosis 1499_5578_25_998_7534_4691 6 0.000100935 0.008579466 0.000231877 25657 hsa-mir-675 hsa05130 Pathogenic Escherichia coli infection 1499_5578_25_998_7534_4691 6 0.000100935 0.008579466 0.000231877 25658 hsa-mir-675 hsa04662 B cell receptor signaling pathway 1147_5595_5594_1380_2932_4792 6 0.000440195 0.037416549 0.000984646 25659 hsa-mir-675 hsa03440 Homologous recombination 641_5888_675_6117 4 0.000565975 0.048107865 0.001233535 25660 hsa-mir-675 hsa05213 Endometrial cancer 1499_5595_5594_2932_5728 5 0.00061232 0.052047198 0.001269444 25661 hsa-mir-675 hsa04150 mTOR signaling pathway 6794_3091_5595_5594_5563 5 0.00061232 0.052047198 0.001269444 25662 hsa-mir-675 hsa04270 Vascular smooth muscle contraction 5578_5499_5595_5594_808_801_805 7 0.000811728 0.068996907 0.001642783 25663 hsa-mir-675 hsa04612 Antigen processing and presentation 3309_3304_3305_3303_3320_3326 6 0.001024562 0.087087799 0.001966756 25664 hsa-mir-675 hsa04210 Apoptosis 596_598_823_1147_4792_472 6 0.001024562 0.087087799 0.001966756 25665 hsa-mir-675 hsa05221 Acute myeloid leukemia 862_1147_5595_5594_5371 5 0.001041224 0.088504022 0.001966756 25666 hsa-mir-675 hsa03410 Base excision repair 3146_142_4913_328 4 0.001333753 0.113368964 0.002464543 25667 hsa-mir-675 hsa04360 Axon guidance 5747_25_998_5595_5594_2932_1020 7 0.001445088 0.122832487 0.002613457 25668 hsa-mir-675 hsa05010 Alzheimer's disease 823_5595_5594_2932_808_801_805_1020 8 0.001870952 0.159030918 0.003313144 25669 hsa-mir-675 hsa04730 Long-term depression 5578_5595_5594_5518_5515 5 0.00224434 0.190768897 0.003893243 25670 hsa-mir-675 hsa05016 Huntington's disease 3065_3064_25942_6667_1387_2033_27113_6908 8 0.002676039 0.227463299 0.004549266 25671 hsa-mir-675 hsa04070 Phosphatidylinositol signaling system 5578_5728_808_801_805 5 0.002964782 0.25200649 0.004941304 25672 hsa-mir-675 hsa04062 Chemokine signaling pathway 5747_6362_1147_998_5595_5594_2932_4792 8 0.003121305 0.265310915 0.005102133 25673 hsa-mir-675 hsa04950 Maturity onset diabetes of the young 3651_3172_168620 3 0.004067792 0.345762324 0.006523817 25674 hsa-mir-675 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_1432_1616 4 0.005898551 0.501376873 0.009284757 25675 hsa-mir-675 hsa05216 Thyroid cancer 1499_5595_5594 3 0.006599498 0.560957313 0.010115658 25676 hsa-mir-675 hsa04540 Gap junction 5578_5595_5594_1453_983 5 0.006664433 0.566476832 0.010115658 25677 hsa-mir-675 hsa03030 DNA replication 5557_6117_5422 3 0.01143256 0.971767561 0.017048554 25678 hsa-mir-675 hsa03450 Non-homologous end-joining 2547_5591 2 0.015470428 1 0.022672179 25679 hsa-mir-675 hsa04670 Leukocyte transendothelial migration 1499_5578_5747_1432_998 5 0.018875658 1 0.027193744 25680 hsa-mir-675 hsa05217 Basal cell carcinoma 1499_2932_1856 3 0.03269557 1 0.046318724 25681 hsa-mir-675 hsa04340 Hedgehog signaling pathway 2932_1452_1453 3 0.035636308 1 0.049403072 25682 hsa-mir-675 hsa03430 Mismatch repair 4436_6117 2 0.036035182 1 0.049403072 25683 hsa-mir-675 hsa04630 Jak-STAT signaling pathway 598_1387_2033_51588_8554 5 0.044497034 1 0.06003568 25684 hsa-mir-676 hsa05200 Pathways in cancer 5467_1499_5914_595_3815_1019_1017_4193_6934_7704_6502_3091_4089_3066_3065_1050_5925_5468_25_405_1956_1487_1488_1870_1871_2113_10401_861_862_867_207_836_2249_5595_5594_5599_6258_1387_6257_6256_4286_367_6774_6776_6777_6772_5970_7157_6688_7849_1869_3725_4088_5881_2034_2033_4846_51176_5371_5159_8031_5156_5604_1399_1398_7428_4087_4609_2956_1026_2353_8554 72 8.79E-45 6.94E-43 6.94E-43 25685 hsa-mir-676 hsa05220 Chronic myeloid leukemia 595_1019_4193_4089_3066_3065_5925_25_1487_1488_1870_1871_861_867_207_5595_5594_6776_6777_5970_7157_1869_4088_5604_1399_1398_5781_4609_1026_6464 30 1.14E-25 9.01E-24 4.51E-24 25686 hsa-mir-676 hsa04110 Cell cycle 595_1019_1017_4193_6502_4089_3066_3065_4616_5925_25_1870_1871_5934_5933_993_5591_1387_7027_7157_10912_1869_5111_4088_2033_983_4087_1026 28 7.19E-19 5.68E-17 1.89E-17 25687 hsa-mir-676 hsa05215 Prostate cancer 1499_595_1017_4193_6934_5925_1956_1870_1871_207_5595_5594_1387_367_5970_7157_468_1869_2033_51176_5159_5156_5604_1026 24 1.30E-17 1.03E-15 2.14E-16 25688 hsa-mir-676 hsa05221 Acute myeloid leukemia 5467_5914_595_3815_6934_7704_1050_861_862_207_5595_5594_6774_6776_6777_5970_6688_51176_5371_5604_4609 21 1.59E-17 1.26E-15 2.14E-16 25689 hsa-mir-676 hsa05212 Pancreatic cancer 1499_595_1017_4193_6934_5925_1956_1870_1871_207_5595_5594_1387_367_5970_7157_468_1869_2033_51176_5159_5156_5604_1026 24 1.62E-17 1.28E-15 2.14E-16 25690 hsa-mir-676 hsa04010 MAPK signaling pathway 6722_9252_7867_4773_4616_1956_1432_4763_1616_207_836_9479_2249_5595_5594_5599_1386_1649_3312_5970_3164_7157_10912_468_3725_5881_5159_9261_5156_5604_4208_1399_1398_4609_2353_2002 36 1.31E-16 1.04E-14 1.48E-15 25691 hsa-mir-676 hsa05210 Colorectal cancer 1499_595_6934_4089_1956_207_836_5595_5594_5599_7157_3725_4088_5881_51176_5159_5156_5604_4087_4609_2956_2353 22 6.06E-16 4.78E-14 5.98E-15 25692 hsa-mir-676 hsa05214 Glioma 595_1019_4193_5925_1956_1870_1871_207_5595_5594_7157_1869_808_801_805_5159_5156_5604_1026_6464 20 9.57E-16 7.56E-14 8.40E-15 25693 hsa-mir-676 hsa05216 Thyroid cancer 1499_595_6934_5468_5595_5594_6258_6257_6256_7157_7849_51176_8031_5604_4609 15 8.57E-15 6.77E-13 6.77E-14 25694 hsa-mir-676 hsa04350 TGF-beta signaling pathway 6667_4086_4089_3397_3399_3398_1874_1875_5934_5933_5595_5594_1387_7027_4088_2033_5515_4087_4609_4092 20 1.06E-13 8.34E-12 7.59E-13 25695 hsa-mir-676 hsa05218 Melanoma 595_1019_4193_5925_1956_1870_1871_207_2249_5595_5594_4286_7157_1869_5159_5156_5604_1026 18 4.35E-13 3.44E-11 2.86E-12 25696 hsa-mir-676 hsa05219 Bladder cancer 595_1019_9252_4193_5925_1956_1870_1871_5595_5594_7157_1869_5604_4609_1026 15 6.38E-13 5.04E-11 3.88E-12 25697 hsa-mir-676 hsa04012 ErbB signaling pathway 25_1956_6714_867_207_5595_5594_5599_2066_6776_6777_3725_5604_1399_1398_4609_1026_6464_2002 19 9.62E-13 7.60E-11 5.43E-12 25698 hsa-mir-676 hsa05223 Non-small cell lung cancer 595_1019_5925_1956_2309_1870_1871_207_5595_5594_6258_6257_6256_7157_1869_5604 16 1.17E-12 9.25E-11 6.16E-12 25699 hsa-mir-676 hsa04310 Wnt signaling pathway 5467_1499_595_6934_4089_4772_4773_1487_1488_5599_1387_7157_3725_1457_4088_5881_2033_51176_5515_6423_4087_4609_5527 23 3.48E-12 2.75E-10 1.72E-11 25700 hsa-mir-676 hsa05222 Small cell lung cancer 595_1019_1017_6502_5925_1870_1871_10401_207_6258_6257_6256_5970_7157_1869_4846_4609_8554 18 7.09E-12 5.60E-10 3.29E-11 25701 hsa-mir-676 hsa04520 Adherens junction 1499_6934_5770_5777_4089_1956_6714_5595_5594_1387_1457_4088_5881_2033_51176_3643_4087 17 2.21E-11 1.74E-09 9.69E-11 25702 hsa-mir-676 hsa04330 Notch signaling pathway 1840_3066_3065_9794_22938_1487_1488_388585_1387_2033_8850_2648_9612_4851 14 2.86E-11 2.26E-09 1.19E-10 25703 hsa-mir-676 hsa04630 Jak-STAT signaling pathway 3559_595_5777_3560_2057_10401_867_2690_3977_207_3575_3717_1387_6778_6774_6776_6777_6772_2033_5781_4609_8554 22 3.15E-11 2.49E-09 1.24E-10 25704 hsa-mir-676 hsa05211 Renal cell carcinoma 3091_405_2113_207_5595_5594_1387_3725_2034_2033_5604_1399_1398_7428_5781 15 4.24E-10 3.35E-08 1.59E-09 25705 hsa-mir-676 hsa05213 Endometrial cancer 1499_595_6934_1956_2309_207_5595_5594_7157_51176_5604_4609_2002 13 9.14E-10 7.22E-08 3.28E-09 25706 hsa-mir-676 hsa04910 Insulin signaling pathway 10891_6720_5770_867_207_5595_5594_5599_808_801_805_3643_5604_1399_1398_6464_2002 17 3.65E-08 2.88E-06 1.25E-07 25707 hsa-mir-676 hsa04660 T cell receptor signaling pathway 1493_1019_5777_4772_4773_1432_867_207_5595_5594_5970_3725_5604_919_2353 15 6.95E-08 5.49E-06 2.29E-07 25708 hsa-mir-676 hsa04115 p53 signaling pathway 595_1019_1017_4194_4193_4616_836_7157_10912_983_1026_7161 12 1.37E-07 1.08E-05 4.33E-07 25709 hsa-mir-676 hsa04912 GnRH signaling pathway 5580_1956_6714_1432_5595_5594_5599_468_3725_808_801_805_5604_2002 14 3.32E-07 2.62E-05 1.01E-06 25710 hsa-mir-676 hsa04370 VEGF signaling pathway 7867_4772_4773_6714_1432_207_5595_5594_5881_4846_9261_5604 12 3.95E-07 3.12E-05 1.15E-06 25711 hsa-mir-676 hsa04920 Adipocytokine signaling pathway 10891_5465_207_3717_5599_6258_6257_6256_6774_5970_5781 11 7.59E-07 5.99E-05 2.14E-06 25712 hsa-mir-676 hsa04916 Melanogenesis 1499_3815_6934_5595_5594_1387_4286_2033_808_801_805_51176_5604 13 1.26E-06 9.96E-05 3.43E-06 25713 hsa-mir-676 hsa05322 Systemic lupus erythematosus 3021_3020_8365_8294_8366_8370_121504_8361_8360_8363_8362_8364_8367_8368_8359 15 1.61E-06 0.000127024 4.23E-06 25714 hsa-mir-676 hsa04662 B cell receptor signaling pathway 5777_4772_4773_207_5595_5594_5970_3725_5881_5604_2353 11 2.05E-06 0.000161805 5.22E-06 25715 hsa-mir-676 hsa04950 Maturity onset diabetes of the young 5080_6928_6927_3651_3172_168620_4760 7 3.12E-06 0.000246756 7.71E-06 25716 hsa-mir-676 hsa03410 Base excision repair 3146_4350_142_252969_328_2237_5111_6996 8 3.50E-06 0.000276719 8.39E-06 25717 hsa-mir-676 hsa04620 Toll-like receptor signaling pathway 3665_3661_1432_207_5595_5594_5599_6772_5970_3725_5604_2353 12 5.68E-06 0.000448789 1.32E-05 25718 hsa-mir-676 hsa04510 Focal adhesion 1499_595_1956_6714_207_5595_5594_5599_3725_5881_5159_5156_5604_1399_1398_6464_2002 17 6.23E-06 0.00049223 1.41E-05 25719 hsa-mir-676 hsa04720 Long-term potentiation 2902_5595_5594_1387_468_2033_808_801_805_5604 10 1.27E-05 0.001003589 2.79E-05 25720 hsa-mir-676 hsa03450 Non-homologous end-joining 2547_10111_2237_5591_4361 5 3.81E-05 0.003010431 8.14E-05 25721 hsa-mir-676 hsa04062 Chemokine signaling pathway 5580_7852_2309_207_3717_5595_5594_6774_6777_6772_5970_5604_1399_1398_6464 15 4.12E-05 0.003257378 8.57E-05 25722 hsa-mir-676 hsa05016 Huntington's disease 6667_10891_23186_3066_3065_3064_5468_2902_836_1387_7157_2033_6874_6908 14 0.000112649 0.008899289 0.000228187 25723 hsa-mir-676 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_1432_836_5599_5970_3725_5781 8 0.000269466 0.021287799 0.000532195 25724 hsa-mir-676 hsa04650 Natural killer cell mediated cytotoxicity 5777_4772_4773_836_5595_5594_5881_5604_919_5781_6464 11 0.00034868 0.027545743 0.000671847 25725 hsa-mir-676 hsa04664 Fc epsilon RI signaling pathway 5580_1432_207_5595_5594_5599_5881_5604 8 0.000520789 0.041142351 0.00097958 25726 hsa-mir-676 hsa04930 Type II diabetes mellitus 5580_3651_5595_5594_5599_3643 6 0.000706077 0.05578009 0.001297211 25727 hsa-mir-676 hsa03320 PPAR signaling pathway 5465_5467_2168_5468_6258_6257_6256 7 0.001233916 0.097479325 0.002215439 25728 hsa-mir-676 hsa04120 Ubiquitin mediated proteolysis 4193_6502_10401_867_7329_8925_5371_672_7428_8554 10 0.001329299 0.105014625 0.002333658 25729 hsa-mir-676 hsa04540 Gap junction 1956_6714_5595_5594_5159_983_5156_5604 8 0.001392574 0.110013369 0.002391595 25730 hsa-mir-676 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_1432_1616_836_7157_4846 6 0.001981704 0.156554601 0.003330949 25731 hsa-mir-676 hsa04270 Vascular smooth muscle contraction 5580_5595_5594_808_801_805_59_5604 8 0.005481017 0.43300034 0.00902084 25732 hsa-mir-676 hsa03430 Mismatch repair 5981_5111_2956 3 0.017108178 1 0.027582572 25733 hsa-mir-676 hsa03420 Nucleotide excision repair 5981_5111_5886_4331 4 0.018581473 1 0.029358727 25734 hsa-mir-676 hsa04020 Calcium signaling pathway 1956_2902_2066_4846_808_801_805_5159_5156 9 0.022334769 1 0.034365282 25735 hsa-mir-676 hsa04730 Long-term depression 5595_5594_4846_5515_5604 5 0.022620186 1 0.034365282 25736 hsa-mir-676 hsa03440 Homologous recombination 10111_4683_4361 3 0.027372098 1 0.04079992 25737 hsa-mir-676 hsa04360 Axon guidance 4772_4773_25_7852_5595_5594_5881 7 0.027903042 1 0.040821116 25738 hsa-mir-676 hsa04150 mTOR signaling pathway 3091_207_5595_5594 4 0.030769123 1 0.044195649 25739 hsa-mir-676 hsa04810 Regulation of actin cytoskeleton 1956_2249_5595_5594_5881_5159_5156_5604_1399_1398 10 0.032094897 1 0.04527673 25740 hsa-mir-676 hsa04530 Tight junction 1499_1019_5580_6714_207_1457_5515 7 0.034032601 1 0.047167991 25741 hsa-mir-676 hsa05217 Basal cell carcinoma 1499_6934_7157_51176 4 0.036308685 1 0.049454932 25742 hsa-mir-676 hsa04710 Circadian rhythm - mammal 8863_4862 2 0.039176485 1 0.05245665 25743 hsa-mir-676 hsa04640 Hematopoietic cell lineage 3559_3815_2057_3575_914 5 0.045957026 1 0.060510084 25744 hsa-mir-676 hsa03030 DNA replication 5981_2237_5111 3 0.049209913 1 0.06373087 25745 hsa-mir-708 hsa05200 Pathways in cancer 4149_5467_5468_595_1017_4193_6934_7704_3091_4089_3065_1050_5925_1499_25_405_1487_1488_1870_1871_2113_10401_5894_861_836_207_4286_5595_5594_5599_1387_9915_367_2932_6774_6776_6777_6772_5970_7157_7849_1869_3725_6502_4088_2034_2033_3320_3326_51176_5371_5604_3265_4292_4087_4609_2956_1029_2736 59 5.74E-39 4.25E-37 4.25E-37 25746 hsa-mir-708 hsa05220 Chronic myeloid leukemia 595_4193_4089_3065_5925_25_1487_1488_1870_1871_5894_861_207_5595_5594_6776_6777_5970_7157_1869_4088_5604_3265_4609_1029 25 9.06E-23 6.70E-21 3.35E-21 25747 hsa-mir-708 hsa05215 Prostate cancer 595_1017_4193_6934_5925_1499_1870_1871_5894_207_5595_5594_1387_367_2932_5970_7157_468_1869_2033_3320_3326_51176_5604_3265 25 2.38E-21 1.76E-19 5.56E-20 25748 hsa-mir-708 hsa05212 Pancreatic cancer 595_1017_4193_6934_5925_1499_1870_1871_5894_207_5595_5594_1387_367_2932_5970_7157_468_1869_2033_3320_3326_51176_5604_3265 25 3.01E-21 2.22E-19 5.56E-20 25749 hsa-mir-708 hsa04110 Cell cycle 595_1017_4193_6500_4089_3065_5925_25_1870_1871_5934_5933_990_1387_2932_7157_5111_1869_6502_4088_2033_890_983_8454_4087_1029 26 1.07E-19 7.93E-18 1.59E-18 25750 hsa-mir-708 hsa05221 Acute myeloid leukemia 5467_595_6934_7704_1050_5894_861_207_5595_5594_6774_6776_6777_5970_51176_5371_5604_3265_4609 19 2.18E-17 1.62E-15 2.69E-16 25751 hsa-mir-708 hsa04010 MAPK signaling pathway 6722_4149_6195_6197_9252_4773_8986_1432_22800_5894_836_207_9479_3727_5595_5594_5599_5598_1386_5970_3164_7157_468_3725_6196_1616_9261_5604_4208_3265_4609_2002 32 8.90E-17 6.59E-15 9.41E-16 25752 hsa-mir-708 hsa04310 Wnt signaling pathway 5467_595_6934_6500_4089_4772_4773_1499_1487_1488_5599_1387_2932_7157_6423_3725_1457_1459_4088_2033_51176_8454_4087_4609_5527 25 2.02E-16 1.49E-14 1.87E-15 25753 hsa-mir-708 hsa05210 Colorectal cancer 595_6934_4089_1499_5894_836_207_5595_5594_5599_2932_7157_3725_4088_51176_5604_4292_4087_4609_2956 20 4.48E-16 3.32E-14 3.68E-15 25754 hsa-mir-708 hsa04350 TGF-beta signaling pathway 6500_4086_4089_6667_3399_3398_1874_1875_5934_5933_5595_5594_1387_4088_2033_8454_4087_4609_4093_4092 20 8.02E-16 5.94E-14 5.94E-15 25755 hsa-mir-708 hsa05213 Endometrial cancer 595_6934_1499_2309_5894_207_5595_5594_2932_7157_51176_5604_3265_4292_4609_2002 16 1.36E-14 1.00E-12 9.12E-14 25756 hsa-mir-708 hsa05219 Bladder cancer 595_9252_4193_5925_1870_1871_5894_5595_5594_7157_1869_5604_3265_4609_1029 15 1.49E-14 1.11E-12 9.21E-14 25757 hsa-mir-708 hsa05216 Thyroid cancer 5468_595_6934_1499_5595_5594_7157_7849_51176_5604_3265_4609 12 1.62E-12 1.20E-10 9.22E-12 25758 hsa-mir-708 hsa05223 Non-small cell lung cancer 595_5925_2309_1870_1871_5894_207_5595_5594_7157_1869_5604_3265_1029 14 4.40E-12 3.26E-10 2.33E-11 25759 hsa-mir-708 hsa05218 Melanoma 595_4193_5925_1870_1871_5894_207_4286_5595_5594_7157_1869_5604_3265_1029 15 9.56E-12 7.08E-10 4.72E-11 25760 hsa-mir-708 hsa05214 Glioma 595_4193_5925_1870_1871_5894_207_5595_5594_7157_1869_5604_3265_1029 14 3.77E-11 2.79E-09 1.74E-10 25761 hsa-mir-708 hsa05211 Renal cell carcinoma 3091_405_2113_5894_207_5595_5594_1387_9915_3725_2034_2033_5604_3265 14 1.24E-10 9.17E-09 5.40E-10 25762 hsa-mir-708 hsa04330 Notch signaling pathway 9612_3065_22938_1487_1488_2648_1387_2033_8850_9794_1840_4851 12 1.76E-10 1.30E-08 7.23E-10 25763 hsa-mir-708 hsa04012 ErbB signaling pathway 25_5894_207_5595_5594_5599_2932_6776_6777_3725_5604_3265_4609_2002 14 1.12E-09 8.30E-08 4.37E-09 25764 hsa-mir-708 hsa04720 Long-term potentiation 6195_6197_2902_2906_5894_5595_5594_1387_468_6196_2033_5604_3265 13 1.98E-09 1.46E-07 7.32E-09 25765 hsa-mir-708 hsa05222 Small cell lung cancer 4149_595_1017_5925_1870_1871_10401_207_5970_7157_1869_6502_4609 13 8.66E-09 6.41E-07 3.05E-08 25766 hsa-mir-708 hsa04540 Gap junction 7846_51807_5894_5592_5595_5594_5598_983_5604_3265_7277_7278_10376 13 2.01E-08 1.49E-06 6.76E-08 25767 hsa-mir-708 hsa04520 Adherens junction 6934_4089_1499_5595_5594_1387_1457_1459_4088_2033_51176_4087 12 3.50E-08 2.59E-06 1.13E-07 25768 hsa-mir-708 hsa05322 Systemic lupus erythematosus 3021_3020_8294_8370_121504_8361_8360_8363_8362_8365_8364_8367_8366_8368_8359 15 6.00E-08 4.44E-06 1.85E-07 25769 hsa-mir-708 hsa04662 B cell receptor signaling pathway 4772_4773_5894_207_5595_5594_2932_5970_3725_5604_3265 11 1.60E-07 1.19E-05 4.74E-07 25770 hsa-mir-708 hsa04916 Melanogenesis 6934_1499_5894_4286_5595_5594_1387_2932_2033_51176_5604_3265 12 4.66E-07 3.45E-05 1.33E-06 25771 hsa-mir-708 hsa04912 GnRH signaling pathway 1432_5894_5595_5594_5599_5598_5580_468_3725_5604_3265_2002 12 6.74E-07 4.99E-05 1.85E-06 25772 hsa-mir-708 hsa04660 T cell receptor signaling pathway 4772_4773_1432_5894_207_5595_5594_2932_5970_3725_5604_3265 12 8.05E-07 5.96E-05 2.13E-06 25773 hsa-mir-708 hsa04370 VEGF signaling pathway 4772_4773_1432_5894_207_5595_5594_9261_5604_3265 10 1.60E-06 0.000118522 4.09E-06 25774 hsa-mir-708 hsa04620 Toll-like receptor signaling pathway 3665_3661_1432_207_5595_5594_5599_6772_5970_3725_5604 11 2.56E-06 0.000189654 6.32E-06 25775 hsa-mir-708 hsa04115 p53 signaling pathway 595_1017_4194_4193_836_7157_983_7161_1029 9 5.16E-06 0.000381863 1.23E-05 25776 hsa-mir-708 hsa04062 Chemokine signaling pathway 7074_2309_5894_207_5595_5594_2932_5580_6774_6777_6772_5970_5604_3265 14 8.80E-06 0.000651447 2.04E-05 25777 hsa-mir-708 hsa05131 Shigellosis 7846_51807_1499_25_7277_7278_4691_10376 8 9.49E-06 0.000702106 2.07E-05 25778 hsa-mir-708 hsa05130 Pathogenic Escherichia coli infection 7846_51807_1499_25_7277_7278_4691_10376 8 9.49E-06 0.000702106 2.07E-05 25779 hsa-mir-708 hsa04664 Fc epsilon RI signaling pathway 1432_5894_207_5595_5594_5599_5580_5604_3265 9 1.40E-05 0.001035947 2.96E-05 25780 hsa-mir-708 hsa04910 Insulin signaling pathway 10891_5894_207_5595_5594_5599_23265_2932_5604_3265_2002 11 3.60E-05 0.002660727 7.39E-05 25781 hsa-mir-708 hsa04150 mTOR signaling pathway 6195_6197_3091_207_5595_5594_6196 7 4.86E-05 0.003597754 9.72E-05 25782 hsa-mir-708 hsa03410 Base excision repair 4350_252969_328_2237_5111_6996 6 5.86E-05 0.004336907 0.000114129 25783 hsa-mir-708 hsa03022 Basal transcription factors 2963_2962_2969_6908_2959_9519 6 6.72E-05 0.00497118 0.000127466 25784 hsa-mir-708 hsa04630 Jak-STAT signaling pathway 595_10401_207_1387_6778_6774_6776_6777_6772_2033_4609 11 9.59E-05 0.007093899 0.000177347 25785 hsa-mir-708 hsa05016 Huntington's disease 10891_5468_3065_3064_2902_6667_836_1387_7157_2033_6908_9519 12 0.000120771 0.008937036 0.000217976 25786 hsa-mir-708 hsa04120 Ubiquitin mediated proteolysis 55294_4193_6500_10401_7329_8925_6502_5371_672_8454 10 0.00017802 0.0131735 0.000313655 25787 hsa-mir-708 hsa04510 Focal adhesion 595_1499_5894_207_5595_5594_5599_2932_3725_5604_3265_2002 12 0.000268709 0.019884472 0.00046243 25788 hsa-mir-708 hsa05010 Alzheimer's disease 823_2902_2906_836_5595_5594_2932_351_840_1020_9451 11 0.00028511 0.021098149 0.000479503 25789 hsa-mir-708 hsa05217 Basal cell carcinoma 6934_1499_2932_7157_51176_2736 6 0.000477727 0.035351776 0.000785595 25790 hsa-mir-708 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906_1432_836_7157_1616 6 0.000521712 0.038606675 0.000839276 25791 hsa-mir-708 hsa04950 Maturity onset diabetes of the young 6927_4760_3651_5080 4 0.001053824 0.077982998 0.001659213 25792 hsa-mir-708 hsa04920 Adipocytokine signaling pathway 10891_5465_207_5599_6774_5970 6 0.001242857 0.091971452 0.001916072 25793 hsa-mir-708 hsa04930 Type II diabetes mellitus 3651_5595_5594_5599_5580 5 0.001316416 0.097414752 0.001988056 25794 hsa-mir-708 hsa04730 Long-term depression 5894_5592_5595_5594_5604_3265 6 0.001639073 0.121291402 0.002425828 25795 hsa-mir-708 hsa04360 Axon guidance 4772_4773_25_5595_5594_2932_3265_1020 8 0.002087764 0.154494532 0.003029305 25796 hsa-mir-708 hsa03450 Non-homologous end-joining 10111_2237_4361 3 0.002481547 0.183634483 0.003531432 25797 hsa-mir-708 hsa04530 Tight junction 1499_22800_8573_207_5580_1457_1459_3265 8 0.002714559 0.200877368 0.003790139 25798 hsa-mir-708 hsa04650 Natural killer cell mediated cytotoxicity 4772_4773_5894_836_5595_5594_5604_3265 8 0.002831943 0.209563804 0.003880811 25799 hsa-mir-708 hsa04270 Vascular smooth muscle contraction 5894_5592_5595_5594_5580_59_5604 7 0.00453527 0.335609951 0.006101999 25800 hsa-mir-708 hsa04210 Apoptosis 823_836_207_5970_7157_840 6 0.00470405 0.348099705 0.006216066 25801 hsa-mir-708 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_836_5599_5970_3725 5 0.008132679 0.601818252 0.010558215 25802 hsa-mir-708 hsa03430 Mismatch repair 5111_4292_2956 3 0.00851173 0.629868052 0.010859794 25803 hsa-mir-708 hsa03440 Homologous recombination 10111_4683_4361 3 0.013858851 1 0.017382288 25804 hsa-mir-708 hsa04740 Olfactory transduction 5592 1 0.024131745 1 0.029762486 25805 hsa-mir-7-1 hsa05210 Colorectal cancer 4087_4088_4609 3 8.37E-06 0.000150608 5.94E-05 25806 hsa-mir-7-1 hsa04350 TGF-beta signaling pathway 4087_4088_4609 3 9.27E-06 0.00016679 5.94E-05 25807 hsa-mir-7-1 hsa04612 Antigen processing and presentation 4800_4801_4802 3 9.90E-06 0.000178191 5.94E-05 25808 hsa-mir-7-1 hsa04310 Wnt signaling pathway 4087_4088_4609 3 4.72E-05 0.000848846 0.000212211 25809 hsa-mir-7-1 hsa05200 Pathways in cancer 4087_4088_4609 3 0.00045784 0.008241117 0.001648223 25810 hsa-mir-7-1 hsa05220 Chronic myeloid leukemia 4088_4609 2 0.000579471 0.010430475 0.00168897 25811 hsa-mir-7-1 hsa04520 Adherens junction 4087_4088 2 0.000656822 0.011822793 0.00168897 25812 hsa-mir-7-1 hsa04110 Cell cycle 4087_4088 2 0.001421032 0.025578567 0.003197321 25813 hsa-mir-7-1 hsa04010 MAPK signaling pathway 6722_4609 2 0.007078166 0.127406991 0.014156332 25814 hsa-mir-7-1 hsa05216 Thyroid cancer 4609 1 0.013905909 0.250306368 0.025030637 25815 hsa-mir-7-1 hsa03022 Basal transcription factors 2969 1 0.017583707 0.316506719 0.028773338 25816 hsa-mir-7-1 hsa05219 Bladder cancer 4609 1 0.019875857 0.357765434 0.029813786 25817 hsa-mir-7-1 hsa05213 Endometrial cancer 4609 1 0.024445269 0.440014837 0.033847295 25818 hsa-mir-7-1 hsa05221 Acute myeloid leukemia 4609 1 0.027632078 0.497377405 0.035526957 25819 hsa-mir-7-1 hsa05222 Small cell lung cancer 4609 1 0.039833726 0.717007075 0.045318259 25820 hsa-mir-7-1 hsa04012 ErbB signaling pathway 4609 1 0.040282897 0.725092145 0.045318259 25821 hsa-mir-711 hsa05200 Pathways in cancer 7046_596_598_1017_4193_5578_3091_3065_5925_613_5743_5747_25_9063_1487_1488_6789_4436_2885_1147_998_367_5595_5594_5599_1387_2932_6772_1869_3725_4087_4088_4089_5888_5728_2033_3910_4792_3320_3326_5371_675_5604_5601_5602_1856_51588_1026_2353_8554 50 3.72E-34 3.13E-32 3.13E-32 25822 hsa-mir-711 hsa04110 Cell cycle 1017_4193_902_3065_5925_25_9232_545_995_5347_5591_1387_11200_7534_7532_2932_7027_1869_4087_4088_4089_2033_890_1031_983_1026_1022_1111_8556_8555_472 31 9.09E-28 7.64E-26 3.82E-26 25823 hsa-mir-711 hsa05220 Chronic myeloid leukemia 7046_598_4193_3065_5925_613_25_1487_1488_2885_1147_5595_5594_1869_4088_4089_4792_5604_1026 19 2.64E-17 2.21E-15 7.38E-16 25824 hsa-mir-711 hsa04115 p53 signaling pathway 1017_4194_4193_900_50484_6241_51246_545_7161_11200_64326_5728_27113_25898_983_1026_1111_472 18 1.18E-16 9.89E-15 2.47E-15 25825 hsa-mir-711 hsa04010 MAPK signaling pathway 6722_7046_5578_5923_3304_3303_6789_1432_2885_1616_1147_998_5595_5594_5599_1386_3315_1649_3164_3725_9344_5604_5606_5601_5600_5602_2353_3305_2005 29 1.67E-16 1.40E-14 2.80E-15 25826 hsa-mir-711 hsa05215 Prostate cancer 596_1017_4193_5925_2885_1147_367_5595_5594_1387_2932_1869_5728_2033_4792_3320_3326_5604_1026 19 3.39E-16 2.85E-14 4.75E-15 25827 hsa-mir-711 hsa05212 Pancreatic cancer 596_1017_4193_5925_2885_1147_367_5595_5594_1387_2932_1869_5728_2033_4792_3320_3326_5604_1026 19 4.06E-16 3.41E-14 4.88E-15 25828 hsa-mir-711 hsa04310 Wnt signaling pathway 5578_1487_1488_1460_5599_1387_2932_8061_3725_1457_1452_4087_4088_4089_2033_5518_5515_5601_5602_1856_5527 21 2.58E-14 2.16E-12 2.70E-13 25829 hsa-mir-711 hsa05210 Colorectal cancer 7046_596_4436_2885_5595_5594_5599_2932_3725_4087_4088_4089_5604_5601_5602_1856_2353 17 3.16E-14 2.65E-12 2.95E-13 25830 hsa-mir-711 hsa04350 TGF-beta signaling pathway 7046_6667_3397_3399_3398_5595_5594_1387_7027_4086_4087_4088_4089_2033_5518_5515_4093 17 5.23E-14 4.40E-12 4.40E-13 25831 hsa-mir-711 hsa05222 Small cell lung cancer 596_598_1017_5925_5743_5747_9063_1147_1869_5728_3910_4792_51588_8554 14 7.87E-11 6.61E-09 6.01E-10 25832 hsa-mir-711 hsa04620 Toll-like receptor signaling pathway 1432_1147_5595_5594_5599_6772_3725_4792_5604_5606_5601_5600_5602_2353 14 5.93E-10 4.98E-08 4.15E-09 25833 hsa-mir-711 hsa04012 ErbB signaling pathway 5578_5747_25_2885_5595_5594_5599_2932_3725_5604_5601_5602_1026 13 9.63E-10 8.09E-08 6.22E-09 25834 hsa-mir-711 hsa04660 T cell receptor signaling pathway 1432_2885_1147_998_5595_5594_2932_3725_4792_5604_5601_5600_2353_959 14 1.45E-09 1.21E-07 8.67E-09 25835 hsa-mir-711 hsa04120 Ubiquitin mediated proteolysis 4193_3093_9063_7319_84447_7329_10055_64326_7337_5371_672_25898_10075_51588_8554 15 2.97E-09 2.50E-07 1.66E-08 25836 hsa-mir-711 hsa04520 Adherens junction 7046_4301_1460_998_5595_5594_1387_1457_4087_4088_4089_2033 12 4.11E-09 3.45E-07 2.16E-08 25837 hsa-mir-711 hsa04912 GnRH signaling pathway 5578_1432_2885_998_5595_5594_5599_3725_5604_5606_5601_5600_5602 13 1.03E-08 8.65E-07 5.09E-08 25838 hsa-mir-711 hsa04510 Focal adhesion 596_5578_5923_5747_5499_2885_998_5595_5594_5599_2932_3725_5728_3910_5604_5601_5602 17 1.11E-08 9.36E-07 5.20E-08 25839 hsa-mir-711 hsa04664 Fc epsilon RI signaling pathway 5578_1432_2885_5595_5594_5599_5604_5606_5601_5600_5602 11 3.66E-08 3.08E-06 1.62E-07 25840 hsa-mir-711 hsa05214 Glioma 4193_5578_5925_2885_5595_5594_1869_5728_5604_1026 10 6.61E-08 5.55E-06 2.78E-07 25841 hsa-mir-711 hsa04662 B cell receptor signaling pathway 2885_1147_5595_5594_1380_2932_3725_4792_5604_2353 10 2.21E-07 1.86E-05 8.86E-07 25842 hsa-mir-711 hsa04370 VEGF signaling pathway 5578_5743_5747_1432_998_5595_5594_3315_5604_5600 10 2.76E-07 2.32E-05 1.06E-06 25843 hsa-mir-711 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_1147_998_5599_3725_4792_5601_5600_5602 9 1.32E-06 0.000110666 4.81E-06 25844 hsa-mir-711 hsa05211 Renal cell carcinoma 3091_2885_998_5595_5594_1387_3725_2033_5604 9 1.46E-06 0.000123035 5.13E-06 25845 hsa-mir-711 hsa05223 Non-small cell lung cancer 5578_5925_6789_2885_5595_5594_1869_5604 8 1.79E-06 0.000150631 6.03E-06 25846 hsa-mir-711 hsa05219 Bladder cancer 4193_5925_5595_5594_1869_5604_1026 7 3.99E-06 0.000335463 1.29E-05 25847 hsa-mir-711 hsa03420 Nucleotide excision repair 902_2965_4331_2071_2074_1022_6117 7 5.26E-06 0.000441801 1.64E-05 25848 hsa-mir-711 hsa04330 Notch signaling pathway 3065_1487_1488_1387_2033_8850_1856 7 7.77E-06 0.000652804 2.33E-05 25849 hsa-mir-711 hsa05218 Melanoma 4193_5925_5595_5594_1869_5728_5604_1026 8 1.13E-05 0.000952647 3.28E-05 25850 hsa-mir-711 hsa03022 Basal transcription factors 51616_2965_6908_2958_6880_2957 6 2.28E-05 0.001918694 6.40E-05 25851 hsa-mir-711 hsa04910 Insulin signaling pathway 5499_2885_5595_5594_5599_2932_5604_5601_5602_5563 10 3.40E-05 0.002860036 9.23E-05 25852 hsa-mir-711 hsa04920 Adipocytokine signaling pathway 6794_1147_5599_4792_5601_5602_5563 7 6.27E-05 0.005267679 0.000164615 25853 hsa-mir-711 hsa04062 Chemokine signaling pathway 5747_2885_6362_1147_998_5595_5594_2932_6772_4792_5604 11 0.000109072 0.009162041 0.000277638 25854 hsa-mir-711 hsa04720 Long-term potentiation 5578_5499_5595_5594_1387_2033_5604 7 0.00012084 0.010150587 0.000298547 25855 hsa-mir-711 hsa05213 Endometrial cancer 2885_5595_5594_2932_5728_5604 6 0.000127978 0.01075016 0.000307147 25856 hsa-mir-711 hsa04916 Melanogenesis 5578_5595_5594_1387_2932_2033_5604_1856 8 0.000140694 0.011818306 0.000328286 25857 hsa-mir-711 hsa04530 Tight junction 5578_4301_1460_998_1457_5728_5518_5515_5520 9 0.000168606 0.014162938 0.000382782 25858 hsa-mir-711 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_1432_1616_5606_5600 6 0.000185794 0.015606662 0.000410702 25859 hsa-mir-711 hsa05221 Acute myeloid leukemia 2885_1147_5595_5594_5371_5604 6 0.000241332 0.020271912 0.000519793 25860 hsa-mir-711 hsa04540 Gap junction 5578_2885_5595_5594_1453_983_5604 7 0.000413914 0.034768812 0.00086922 25861 hsa-mir-711 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601_5602 5 0.000553375 0.046483499 0.001133744 25862 hsa-mir-711 hsa04730 Long-term depression 5578_5595_5594_5518_5515_5604 6 0.000605194 0.050836299 0.001210388 25863 hsa-mir-711 hsa03440 Homologous recombination 641_5888_675_6117 4 0.000860768 0.072304521 0.0016815 25864 hsa-mir-711 hsa04150 mTOR signaling pathway 6794_3091_5595_5594_5563 5 0.001012763 0.085072105 0.001933457 25865 hsa-mir-711 hsa05131 Shigellosis 5578_25_998_7534_4691 5 0.001377306 0.11569372 0.002515081 25866 hsa-mir-711 hsa05130 Pathogenic Escherichia coli infection 5578_25_998_7534_4691 5 0.001377306 0.11569372 0.002515081 25867 hsa-mir-711 hsa04630 Jak-STAT signaling pathway 598_9063_2885_1387_6772_2033_51588_8554 8 0.001701648 0.142938397 0.003041242 25868 hsa-mir-711 hsa04612 Antigen processing and presentation 3309_3304_3303_3320_3326_3305 6 0.001812962 0.152288827 0.003107935 25869 hsa-mir-711 hsa04210 Apoptosis 596_598_823_1147_4792_472 6 0.001812962 0.152288827 0.003107935 25870 hsa-mir-711 hsa03410 Base excision repair 3146_142_4913_328 4 0.002010296 0.168864894 0.003377298 25871 hsa-mir-711 hsa04360 Axon guidance 5747_25_998_5595_5594_2932_1020 7 0.002716428 0.228179955 0.004474117 25872 hsa-mir-711 hsa05016 Huntington's disease 3065_3064_25942_6667_1387_2033_27113_6908 8 0.005243429 0.440448053 0.008470155 25873 hsa-mir-711 hsa04670 Leukocyte transendothelial migration 5578_5747_1432_4301_998_5600 6 0.007834547 0.658101967 0.012417018 25874 hsa-mir-711 hsa05216 Thyroid cancer 5595_5594_5604 3 0.008972515 0.753691276 0.013957246 25875 hsa-mir-711 hsa03030 DNA replication 5557_6117_5422 3 0.015431047 1 0.023567417 25876 hsa-mir-711 hsa03450 Non-homologous end-joining 2547_5591 2 0.019119242 1 0.028678863 25877 hsa-mir-711 hsa04270 Vascular smooth muscle contraction 5578_5499_5595_5594_5604 5 0.025579874 1 0.037696657 25878 hsa-mir-711 hsa05010 Alzheimer's disease 823_6622_5595_5594_2932_1020 6 0.037902228 1 0.054892882 25879 hsa-mir-711 hsa03430 Mismatch repair 4436_6117 2 0.044165647 1 0.062198702 25880 hsa-mir-711 hsa04650 Natural killer cell mediated cytotoxicity 5578_2885_5595_5594_5604 5 0.044427644 1 0.062198702 25881 hsa-mir-711 hsa04340 Hedgehog signaling pathway 2932_1452_1453 3 0.0470856 1 0.064839187 25882 hsa-mir-718 hsa05200 Pathways in cancer 1499_5914_596_598_1017_4193_5578_3091_3065_1050_5925_613_7184_5743_5747_25_1487_1488_6789_4436_4824_10401_207_208_1147_2249_998_5595_5594_5599_6258_1387_6256_836_367_2932_6777_5970_7157_6688_1869_3725_6776_4087_4088_4089_5888_5728_2033_3910_4792_3320_3326_5371_675_5601_5602_1856_842_841_51588_4609_1026_2353_8554 65 1.61E-38 1.40E-36 1.40E-36 25883 hsa-mir-718 hsa03022 Basal transcription factors 54457_6879_51616_138474_6883_6881_6872_2965_2967_2961_2960_2963_2962_2969_2968_6878_6877_6874_6873_6908_6884_2958_2959_6880_2957_6882 26 2.09E-27 1.82E-25 9.10E-26 25884 hsa-mir-718 hsa04110 Cell cycle 4171_1017_4193_902_3065_5925_25_9232_545_995_5347_7534_5591_1387_11200_7532_2932_7027_7157_1869_4085_4087_4088_4089_2033_890_1031_983_1026_1022_1111_8556_8555_472 34 3.60E-25 3.13E-23 1.04E-23 25885 hsa-mir-718 hsa05215 Prostate cancer 1499_596_1017_4193_5925_7184_4824_9586_207_208_1147_5595_5594_1385_1387_367_2932_5970_7157_1869_5728_2033_4792_3320_3326_842_1026 27 6.29E-21 5.48E-19 1.37E-19 25886 hsa-mir-718 hsa05212 Pancreatic cancer 1499_596_1017_4193_5925_7184_4824_9586_207_208_1147_5595_5594_1385_1387_367_2932_5970_7157_1869_5728_2033_4792_3320_3326_842_1026 27 8.04E-21 7.00E-19 1.40E-19 25887 hsa-mir-718 hsa04010 MAPK signaling pathway 6722_6195_9252_5578_5923_3304_3303_6789_1432_1616_207_208_1147_2249_998_5595_5594_5599_1386_1649_836_3312_3315_5970_3164_7157_3725_3727_5058_9261_5601_5600_5603_5602_4609_2353_2002_3305_8550_2005 40 5.32E-20 4.63E-18 7.71E-19 25888 hsa-mir-718 hsa05220 Chronic myeloid leukemia 598_4193_3065_5925_613_25_1487_1488_207_208_1147_5595_5594_6777_5970_7157_1869_6776_4088_4089_4792_4609_1026 23 5.07E-18 4.41E-16 6.30E-17 25889 hsa-mir-718 hsa04115 p53 signaling pathway 1017_4194_4193_900_50484_51246_545_7161_11200_836_7157_6241_64326_5728_27113_25898_983_842_841_1026_1111_472 22 1.35E-17 1.18E-15 1.47E-16 25890 hsa-mir-718 hsa05222 Small cell lung cancer 596_598_1017_5925_5743_5747_10401_207_208_1147_6258_6256_5970_7157_1869_5728_3910_4792_842_51588_4609_8554 22 6.73E-16 5.85E-14 6.50E-15 25891 hsa-mir-718 hsa04310 Wnt signaling pathway 815_1499_8607_5578_1459_1487_1488_1460_5599_1387_2932_7157_8061_3725_1457_1452_4087_4088_4089_2033_5518_5515_5601_5602_1856_4609_5527 27 9.77E-16 8.50E-14 8.50E-15 25892 hsa-mir-718 hsa05210 Colorectal cancer 1499_596_4436_207_208_5595_5594_5599_836_2932_7157_3725_4087_4088_4089_5601_5602_1856_842_4609_2353 21 4.55E-15 3.96E-13 3.60E-14 25893 hsa-mir-718 hsa04012 ErbB signaling pathway 815_5578_5747_25_6714_207_208_5595_5594_5599_2932_6777_3725_6776_5058_5601_5602_4609_1026_2002 20 7.97E-14 6.93E-12 5.78E-13 25894 hsa-mir-718 hsa04370 VEGF signaling pathway 5578_5743_5747_6714_1432_207_208_998_5595_5594_3315_9261_5600_5603_842 15 7.77E-10 6.76E-08 5.20E-09 25895 hsa-mir-718 hsa04660 T cell receptor signaling pathway 1432_207_208_1147_998_5595_5594_2932_5970_3725_5058_959_4792_5601_5600_5603_2353 17 1.38E-09 1.20E-07 8.56E-09 25896 hsa-mir-718 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_1432_1147_998_5599_836_5970_3725_5058_4792_5601_5600_5603_5602 14 2.49E-09 2.17E-07 1.44E-08 25897 hsa-mir-718 hsa05221 Acute myeloid leukemia 5914_1050_207_208_1147_5595_5594_6777_5970_6688_6776_5371_4609 13 2.87E-09 2.50E-07 1.56E-08 25898 hsa-mir-718 hsa04620 Toll-like receptor signaling pathway 1432_207_208_1147_5595_5594_5599_5970_3725_4792_5601_5600_5603_5602_841_2353 16 3.46E-09 3.01E-07 1.77E-08 25899 hsa-mir-718 hsa04210 Apoptosis 596_598_823_207_208_1147_836_839_5970_7157_4792_842_841_840_472 15 4.50E-09 3.91E-07 2.17E-08 25900 hsa-mir-718 hsa05223 Non-small cell lung cancer 5578_5925_6789_207_208_5595_5594_6258_6256_7157_1869_842 12 1.08E-08 9.37E-07 4.77E-08 25901 hsa-mir-718 hsa04920 Adipocytokine signaling pathway 6794_2538_207_208_1147_5599_6258_6256_5970_4792_5601_5602_5563 13 1.10E-08 9.54E-07 4.77E-08 25902 hsa-mir-718 hsa04510 Focal adhesion 1499_596_5578_5923_5747_6714_5499_207_208_998_5595_5594_5599_2932_3725_5058_5728_3910_5601_5602_2002 21 1.51E-08 1.31E-06 6.25E-08 25903 hsa-mir-718 hsa05214 Glioma 815_4193_5578_5925_207_208_5595_5594_7157_1869_5728_1026 12 6.53E-08 5.68E-06 2.56E-07 25904 hsa-mir-718 hsa05213 Endometrial cancer 1499_207_208_5595_5594_2932_7157_5728_842_4609_2002 11 6.87E-08 5.98E-06 2.56E-07 25905 hsa-mir-718 hsa04520 Adherens junction 1499_1459_6714_1460_998_5595_5594_1387_1457_4087_4088_4089_2033 13 7.05E-08 6.13E-06 2.56E-07 25906 hsa-mir-718 hsa03420 Nucleotide excision repair 902_5887_2965_2967_2968_4331_2071_2074_1022_6117 10 1.52E-07 1.32E-05 5.29E-07 25907 hsa-mir-718 hsa04350 TGF-beta signaling pathway 6667_659_5595_5594_1387_7027_4087_4088_4089_2033_5518_5515_4609 13 1.69E-07 1.47E-05 5.66E-07 25908 hsa-mir-718 hsa04912 GnRH signaling pathway 815_5578_6714_1432_998_5595_5594_5599_3725_5601_5600_5603_5602_2002 14 2.76E-07 2.40E-05 8.90E-07 25909 hsa-mir-718 hsa04120 Ubiquitin mediated proteolysis 4193_3093_7319_84447_10401_7329_10055_64326_7337_5371_672_25898_51588_10075_8554 15 8.88E-07 7.73E-05 2.76E-06 25910 hsa-mir-718 hsa05219 Bladder cancer 9252_4193_5925_5595_5594_7157_1869_4609_1026 9 9.83E-07 8.55E-05 2.95E-06 25911 hsa-mir-718 hsa05218 Melanoma 4193_5925_207_208_2249_5595_5594_7157_1869_5728_1026 11 1.09E-06 9.50E-05 3.17E-06 25912 hsa-mir-718 hsa05016 Huntington's disease 3065_3064_25942_6667_9586_1385_1387_836_9001_5430_7157_2033_27113_6874_6908_842_841 17 1.63E-06 0.00014184 4.58E-06 25913 hsa-mir-718 hsa04662 B cell receptor signaling pathway 207_208_1147_5595_5594_1380_2932_5970_3725_4792_2353 11 1.77E-06 0.000153925 4.81E-06 25914 hsa-mir-718 hsa04664 Fc epsilon RI signaling pathway 5578_1432_207_208_5595_5594_5599_5601_5600_5603_5602 11 2.79E-06 0.000242805 7.36E-06 25915 hsa-mir-718 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_1432_1616_836_7157_5600_5603_842 9 7.97E-06 0.000693312 1.98E-05 25916 hsa-mir-718 hsa05211 Renal cell carcinoma 3091_207_208_998_5595_5594_1387_3725_5058_2033 10 8.06E-06 0.000700825 1.98E-05 25917 hsa-mir-718 hsa05216 Thyroid cancer 1499_5595_5594_6258_6256_7157_4609 7 8.20E-06 0.000712983 1.98E-05 25918 hsa-mir-718 hsa04530 Tight junction 1499_5578_1459_6714_207_208_1460_998_1457_5728_5518_5515_5520 13 1.68E-05 0.001465196 3.96E-05 25919 hsa-mir-718 hsa04330 Notch signaling pathway 3065_1487_1488_1387_9612_2033_8850_1856 8 1.76E-05 0.001530274 4.03E-05 25920 hsa-mir-718 hsa04910 Insulin signaling pathway 2538_5499_5211_207_208_5595_5594_5599_2932_5601_5602_5563_2002 13 1.81E-05 0.001573156 4.03E-05 25921 hsa-mir-718 hsa04150 mTOR signaling pathway 6794_6195_3091_207_208_5595_5594_5563 8 3.37E-05 0.002934897 7.34E-05 25922 hsa-mir-718 hsa04612 Antigen processing and presentation 3309_3304_3303_1385_3312_3320_3326_4800_3305_4801 10 4.27E-05 0.00371888 9.07E-05 25923 hsa-mir-718 hsa04916 Melanogenesis 815_1499_5578_5595_5594_1385_1387_2932_2033_1856 10 0.000141341 0.012296679 0.000292778 25924 hsa-mir-718 hsa04630 Jak-STAT signaling pathway 598_10401_3977_207_208_1387_6777_6776_2033_51588_4609_8554 12 0.000213245 0.018552304 0.000431449 25925 hsa-mir-718 hsa05131 Shigellosis 1499_5578_10382_25_998_7534_4691 7 0.000334105 0.029067137 0.000645936 25926 hsa-mir-718 hsa05130 Pathogenic Escherichia coli infection 1499_5578_10382_25_998_7534_4691 7 0.000334105 0.029067137 0.000645936 25927 hsa-mir-718 hsa04720 Long-term potentiation 815_6195_5578_5499_5595_5594_1387_2033 8 0.000342073 0.029760313 0.000646963 25928 hsa-mir-718 hsa04062 Chemokine signaling pathway 5747_6362_207_208_1147_998_5595_5594_2932_6777_5970_5058_4792 13 0.000419804 0.036522991 0.000777085 25929 hsa-mir-718 hsa03440 Homologous recombination 641_4683_5888_675_6117 5 0.000568436 0.049453968 0.001030291 25930 hsa-mir-718 hsa03050 Proteasome 5705_5701_5702_5719_5717_5710 6 0.000887436 0.07720697 0.001575652 25931 hsa-mir-718 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601_5602 5 0.003795969 0.330249313 0.006604986 25932 hsa-mir-718 hsa04540 Gap junction 5578_10382_6714_5595_5594_1453_983 7 0.005001805 0.435157065 0.008532491 25933 hsa-mir-718 hsa04740 Olfactory transduction 815 1 0.005984522 0.520653412 0.010012566 25934 hsa-mir-718 hsa05010 Alzheimer's disease 823_22926_5595_5594_836_2932_842_841_840_1020 10 0.006112497 0.531787263 0.010033722 25935 hsa-mir-718 hsa04360 Axon guidance 5747_25_998_5595_5594_2932_5058_1020 8 0.008905069 0.774741028 0.014347056 25936 hsa-mir-718 hsa03030 DNA replication 4171_5557_6117_5422 4 0.009454248 0.822519535 0.014687849 25937 hsa-mir-718 hsa03410 Base excision repair 3146_142_4913_328 4 0.009454248 0.822519535 0.014687849 25938 hsa-mir-718 hsa04950 Maturity onset diabetes of the young 5080_6927_3172 3 0.018207282 1 0.027790062 25939 hsa-mir-718 hsa04670 Leukocyte transendothelial migration 1499_5578_5747_1432_998_5600_5603 7 0.018753314 1 0.028129971 25940 hsa-mir-718 hsa04730 Long-term depression 5578_5595_5594_5518_5515 5 0.02135034 1 0.031482704 25941 hsa-mir-718 hsa05217 Basal cell carcinoma 1499_2932_7157_1856 4 0.034632811 1 0.050217576 25942 hsa-mir-718 hsa04340 Hedgehog signaling pathway 53944_2932_1452_1453 4 0.038458378 1 0.054850473 25943 hsa-mir-718 hsa05322 Systemic lupus erythematosus 9555_8349_8340_3014_3015_6628_959 7 0.039462273 1 0.05537448 25944 hsa-mir-718 hsa03450 Non-homologous end-joining 2547_5591 2 0.042960934 1 0.059327004 25945 hsa-mir-7-2 hsa04010 MAPK signaling pathway 9344_6722_5606_5601_5600_2885_5595_1432_5594_5604_5599_2005_2353 13 1.33E-19 6.52E-18 6.52E-18 25946 hsa-mir-7-2 hsa04664 Fc epsilon RI signaling pathway 5606_5601_5600_2885_5595_1432_5594_5604_5599 9 6.90E-17 3.38E-15 1.69E-15 25947 hsa-mir-7-2 hsa04620 Toll-like receptor signaling pathway 5606_5601_5600_5595_1432_5594_5604_5599_2353 9 6.03E-16 2.95E-14 9.84E-15 25948 hsa-mir-7-2 hsa04912 GnRH signaling pathway 5606_5601_5600_2885_5595_1432_5594_5604_5599 9 9.82E-16 4.81E-14 1.20E-14 25949 hsa-mir-7-2 hsa04660 T cell receptor signaling pathway 5601_5600_2885_5595_1432_5594_5604_2353 8 1.30E-13 6.37E-12 1.27E-12 25950 hsa-mir-7-2 hsa05200 Pathways in cancer 5601_2885_2033_9063_5595_5594_5604_5599_2353_1387 10 3.52E-13 1.73E-11 2.88E-12 25951 hsa-mir-7-2 hsa05210 Colorectal cancer 5601_2885_5595_5594_5604_5599_2353 7 2.09E-12 1.02E-10 1.46E-11 25952 hsa-mir-7-2 hsa04350 TGF-beta signaling pathway 2033_5595_5594_3397_3399_3398_1387 7 2.63E-12 1.29E-10 1.61E-11 25953 hsa-mir-7-2 hsa05211 Renal cell carcinoma 2885_2033_5595_5594_5604_1387 6 9.09E-11 4.45E-09 4.95E-10 25954 hsa-mir-7-2 hsa04012 ErbB signaling pathway 5601_2885_5595_5594_5604_5599 6 2.67E-10 1.31E-08 1.24E-09 25955 hsa-mir-7-2 hsa05215 Prostate cancer 2885_2033_5595_5594_5604_1387 6 2.85E-10 1.40E-08 1.24E-09 25956 hsa-mir-7-2 hsa05212 Pancreatic cancer 2885_2033_5595_5594_5604_1387 6 3.04E-10 1.49E-08 1.24E-09 25957 hsa-mir-7-2 hsa04910 Insulin signaling pathway 5601_2885_5595_5594_5604_5599 6 3.78E-09 1.85E-07 1.43E-08 25958 hsa-mir-7-2 hsa04720 Long-term potentiation 2033_5595_5594_5604_1387 5 1.11E-08 5.43E-07 3.62E-08 25959 hsa-mir-7-2 hsa04662 B cell receptor signaling pathway 2885_5595_5594_5604_2353 5 1.11E-08 5.43E-07 3.62E-08 25960 hsa-mir-7-2 hsa04370 VEGF signaling pathway 5600_5595_1432_5594_5604 5 1.26E-08 6.15E-07 3.84E-08 25961 hsa-mir-7-2 hsa04510 Focal adhesion 5601_2885_5595_5594_5604_5599 6 3.82E-08 1.87E-06 1.10E-07 25962 hsa-mir-7-2 hsa04916 Melanogenesis 2033_5595_5594_5604_1387 5 5.28E-08 2.59E-06 1.44E-07 25963 hsa-mir-7-2 hsa04930 Type II diabetes mellitus 5601_5595_5594_5599 4 1.24E-07 6.10E-06 3.21E-07 25964 hsa-mir-7-2 hsa05213 Endometrial cancer 2885_5595_5594_5604 4 2.15E-07 1.05E-05 5.26E-07 25965 hsa-mir-7-2 hsa05223 Non-small cell lung cancer 2885_5595_5594_5604 4 2.48E-07 1.21E-05 5.78E-07 25966 hsa-mir-7-2 hsa05221 Acute myeloid leukemia 2885_5595_5594_5604 4 3.47E-07 1.70E-05 7.72E-07 25967 hsa-mir-7-2 hsa05214 Glioma 2885_5595_5594_5604 4 5.01E-07 2.46E-05 1.07E-06 25968 hsa-mir-7-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5601_5600_1432_5599 4 7.02E-07 3.44E-05 1.43E-06 25969 hsa-mir-7-2 hsa05220 Chronic myeloid leukemia 2885_5595_5594_5604 4 8.66E-07 4.24E-05 1.70E-06 25970 hsa-mir-7-2 hsa04520 Adherens junction 2033_5595_5594_1387 4 1.11E-06 5.43E-05 2.09E-06 25971 hsa-mir-7-2 hsa04540 Gap junction 2885_5595_5594_5604 4 1.97E-06 9.67E-05 3.58E-06 25972 hsa-mir-7-2 hsa05216 Thyroid cancer 5595_5594_5604 3 3.54E-06 0.000173289 6.19E-06 25973 hsa-mir-7-2 hsa04650 Natural killer cell mediated cytotoxicity 2885_5595_5594_5604 4 8.98E-06 0.000440262 1.52E-05 25974 hsa-mir-7-2 hsa05219 Bladder cancer 5595_5594_5604 3 1.00E-05 0.000491753 1.64E-05 25975 hsa-mir-7-2 hsa04310 Wnt signaling pathway 5601_2033_5599_1387 4 1.30E-05 0.000638027 2.06E-05 25976 hsa-mir-7-2 hsa04630 Jak-STAT signaling pathway 2885_2033_9063_1387 4 1.40E-05 0.000687726 2.15E-05 25977 hsa-mir-7-2 hsa05014 Amyotrophic lateral sclerosis (ALS) 5606_5600_1432 3 2.28E-05 0.001116794 3.38E-05 25978 hsa-mir-7-2 hsa04062 Chemokine signaling pathway 2885_5595_5594_5604 4 3.25E-05 0.001593448 4.69E-05 25979 hsa-mir-7-2 hsa05218 Melanoma 5595_5594_5604 3 4.50E-05 0.002206174 6.13E-05 25980 hsa-mir-7-2 hsa04730 Long-term depression 5595_5594_5604 3 4.50E-05 0.002206174 6.13E-05 25981 hsa-mir-7-2 hsa04270 Vascular smooth muscle contraction 5595_5594_5604 3 0.00019424 0.009517744 0.000257236 25982 hsa-mir-7-2 hsa04120 Ubiquitin mediated proteolysis 7329_9063_672 3 0.00031101 0.015239482 0.000401039 25983 hsa-mir-7-2 hsa05010 Alzheimer's disease 6622_5595_5594 3 0.000621442 0.030450666 0.000780786 25984 hsa-mir-7-2 hsa04330 Notch signaling pathway 2033_1387 2 0.000959659 0.047023291 0.001175582 25985 hsa-mir-7-2 hsa04810 Regulation of actin cytoskeleton 5595_5594_5604 3 0.00113937 0.055829137 0.001358454 25986 hsa-mir-7-2 hsa04150 mTOR signaling pathway 5595_5594 2 0.001164389 0.057055084 0.001358454 25987 hsa-mir-7-2 hsa04920 Adipocytokine signaling pathway 5601_5599 2 0.001892498 0.092732422 0.002156568 25988 hsa-mir-7-2 hsa04110 Cell cycle 2033_1387 2 0.005684096 0.278520706 0.006330016 25989 hsa-mir-7-2 hsa04670 Leukocyte transendothelial migration 5600_1432 2 0.005960375 0.292058382 0.006490186 25990 hsa-mir-7-2 hsa04360 Axon guidance 5595_5594 2 0.006825415 0.334445331 0.007270551 25991 hsa-mir-7-2 hsa05016 Huntington's disease 2033_1387 2 0.013512466 0.662110821 0.014087464 25992 hsa-mir-744 hsa05200 Pathways in cancer 1869_5371_367_1499_5595_5594_861_5914_1387_6256_595_836_1019_1017_7704_841_3091_5970_7428_1870_1871_7157_4087_6688_2113_4609_3725_1026_4088_4089_3066_3065_5925_2034_2033_4846_8554_9915 38 8.89E-35 6.13E-33 6.13E-33 25993 hsa-mir-744 hsa05220 Chronic myeloid leukemia 1869_5595_5594_861_595_1019_5970_1870_1871_7157_4609_1026_4088_4089_3066_3065_5925_6464 18 5.09E-22 3.51E-20 1.76E-20 25994 hsa-mir-744 hsa04110 Cell cycle 1869_5591_1387_595_1019_1017_7027_1870_1871_7157_4087_1026_4088_4089_3066_3065_5925_2033_5933 19 3.21E-20 2.21E-18 7.38E-19 25995 hsa-mir-744 hsa05215 Prostate cancer 1869_367_1499_5595_5594_1387_595_1017_5970_1870_1871_7157_468_1026_5925_2033 16 5.22E-18 3.60E-16 8.45E-17 25996 hsa-mir-744 hsa05212 Pancreatic cancer 1869_367_1499_5595_5594_1387_595_1017_5970_1870_1871_7157_468_1026_5925_2033 16 6.13E-18 4.23E-16 8.45E-17 25997 hsa-mir-744 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_3399_3398_7027_1874_4087_4609_4088_4089_2033_4093_5933 15 1.19E-16 8.20E-15 1.37E-15 25998 hsa-mir-744 hsa05219 Bladder cancer 1869_5595_5594_595_1019_1870_1871_7157_4609_1026_5925 11 2.77E-14 1.91E-12 2.73E-13 25999 hsa-mir-744 hsa05222 Small cell lung cancer 1869_6256_595_1019_1017_5970_1870_1871_7157_4609_5925_4846_8554 13 6.19E-14 4.27E-12 5.34E-13 26000 hsa-mir-744 hsa05214 Glioma 1869_5595_5594_595_1019_1870_1871_7157_1026_5925_6464 11 1.84E-12 1.27E-10 1.41E-11 26001 hsa-mir-744 hsa05223 Non-small cell lung cancer 1869_5595_5594_6256_595_1019_1870_1871_7157_5925 10 8.67E-12 5.98E-10 5.98E-11 26002 hsa-mir-744 hsa05221 Acute myeloid leukemia 5371_5595_5594_861_5914_595_7704_5970_6688_4609 10 1.89E-11 1.31E-09 1.19E-10 26003 hsa-mir-744 hsa05210 Colorectal cancer 1499_5595_5594_595_836_7157_4087_4609_3725_4088_4089 11 2.26E-11 1.56E-09 1.30E-10 26004 hsa-mir-744 hsa05218 Melanoma 1869_5595_5594_595_1019_1870_1871_7157_1026_5925 10 9.80E-11 6.76E-09 5.20E-10 26005 hsa-mir-744 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2113_3725_2034_2033_9915 10 1.11E-10 7.66E-09 5.47E-10 26006 hsa-mir-744 hsa04010 MAPK signaling pathway 5595_5594_4208_836_1386_1649_5970_3312_7157_468_4773_4609_3725_4763_1616 15 5.07E-10 3.50E-08 2.33E-09 26007 hsa-mir-744 hsa04310 Wnt signaling pathway 1499_1387_595_7157_4087_4773_4609_3725_1457_4088_4089_2033 12 6.20E-10 4.28E-08 2.67E-09 26008 hsa-mir-744 hsa05216 Thyroid cancer 1499_5595_5594_6256_595_7157_4609 7 2.50E-09 1.73E-07 1.02E-08 26009 hsa-mir-744 hsa04520 Adherens junction 1499_5595_5594_1387_4087_1457_4088_4089_2033 9 5.28E-09 3.64E-07 2.02E-08 26010 hsa-mir-744 hsa05016 Huntington's disease 6874_1387_2902_6908_836_6667_841_7157_3066_3065_3064_2033 12 5.94E-09 4.10E-07 2.16E-08 26011 hsa-mir-744 hsa04115 p53 signaling pathway 595_836_1019_1017_841_7157_1026 7 5.30E-07 3.66E-05 1.83E-06 26012 hsa-mir-744 hsa05213 Endometrial cancer 1499_5595_5594_595_7157_4609 6 1.77E-06 0.000122157 5.82E-06 26013 hsa-mir-744 hsa04720 Long-term potentiation 5595_5594_1387_2902_468_2033 6 1.26E-05 0.000868849 3.95E-05 26014 hsa-mir-744 hsa04330 Notch signaling pathway 1387_9612_3066_3065_2033 5 1.91E-05 0.001321228 5.74E-05 26015 hsa-mir-744 hsa04012 ErbB signaling pathway 5595_5594_4609_3725_1026_6464 6 2.78E-05 0.001917153 7.99E-05 26016 hsa-mir-744 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_7157_1616_4846 5 4.19E-05 0.002888978 0.000115559 26017 hsa-mir-744 hsa04660 T cell receptor signaling pathway 5595_5594_1019_5970_4773_3725 6 9.60E-05 0.006622556 0.000254714 26018 hsa-mir-744 hsa04662 B cell receptor signaling pathway 5595_5594_5970_4773_3725 5 0.000153626 0.010600182 0.000392599 26019 hsa-mir-744 hsa04620 Toll-like receptor signaling pathway 5595_5594_841_5970_3725 5 0.000592547 0.040885734 0.001460205 26020 hsa-mir-744 hsa04916 Melanogenesis 1499_5595_5594_1387_2033 5 0.000644634 0.044479721 0.001533783 26021 hsa-mir-744 hsa05010 Alzheimer's disease 5595_5594_2902_836_841_4846 6 0.001098416 0.075790737 0.002526358 26022 hsa-mir-744 hsa04370 VEGF signaling pathway 5595_5594_4773_4846 4 0.001733197 0.119590603 0.003857761 26023 hsa-mir-744 hsa03022 Basal transcription factors 2963_6874_6908 3 0.002042412 0.140926451 0.004403952 26024 hsa-mir-744 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_4773_6464 5 0.002158436 0.148932082 0.004513093 26025 hsa-mir-744 hsa04120 Ubiquitin mediated proteolysis 5371_672_7428_7329_8554 5 0.002224863 0.15351553 0.004515163 26026 hsa-mir-744 hsa04510 Focal adhesion 1499_5595_5594_595_3725_6464 6 0.002313295 0.159617343 0.004560496 26027 hsa-mir-744 hsa04210 Apoptosis 836_841_5970_7157 4 0.002869163 0.197972267 0.00549923 26028 hsa-mir-744 hsa04630 Jak-STAT signaling pathway 1387_595_4609_2033_8554 5 0.003501654 0.24161413 0.006530112 26029 hsa-mir-744 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.005062001 0.349278091 0.009191529 26030 hsa-mir-744 hsa04912 GnRH signaling pathway 5595_5594_468_3725 4 0.005566088 0.384060096 0.009847695 26031 hsa-mir-744 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_5970_3725 3 0.011466878 0.791214574 0.019297916 26032 hsa-mir-744 hsa04730 Long-term depression 5595_5594_4846 3 0.011466878 0.791214574 0.019297916 26033 hsa-mir-744 hsa04910 Insulin signaling pathway 6720_5595_5594_6464 4 0.012589056 0.868644836 0.02068202 26034 hsa-mir-744 hsa04612 Antigen processing and presentation 4800_4801_3312 3 0.020468839 1 0.032845347 26035 hsa-mir-744 hsa04930 Type II diabetes mellitus 5595_5594 2 0.035393509 1 0.055503457 26036 hsa-mir-744 hsa04062 Chemokine signaling pathway 5595_5594_5970_6464 4 0.036288659 1 0.05564261 26037 hsa-mir-744 hsa03050 Proteasome 5705_5684 2 0.03962235 1 0.059433524 26038 hsa-mir-758 hsa05200 Pathways in cancer 3725_4149_1499_5914_1017_6934_7704_6502_3091_842_3065_1050_5925_7046_5747_25_1956_1870_1871_4824_2113_5894_861_862_867_207_4286_3716_367_2261_5595_5594_5599_6258_1387_2064_6256_836_2932_6774_6776_6777_6772_5970_7157_6688_1869_2735_2736_2737_4087_4088_4089_2033_898_4790_4792_5879_3320_3326_5371_675_5159_5156_5604_5601_5602_1399_1398_3815_3265_841_4292_8772_1026_1029_2353_8554 78 2.08E-45 1.66E-43 1.66E-43 26039 hsa-mir-758 hsa05215 Prostate cancer 1499_1017_6934_842_5925_1956_1870_1871_4824_5894_9586_207_367_5595_5594_1385_1387_2064_2932_5970_7157_468_1869_2033_898_4790_4792_3320_3326_5159_5156_5604_3265_1026 34 3.42E-26 2.73E-24 1.23E-24 26040 hsa-mir-758 hsa05212 Pancreatic cancer 1499_1017_6934_842_5925_1956_1870_1871_4824_5894_9586_207_367_5595_5594_1385_1387_2064_2932_5970_7157_468_1869_2033_898_4790_4792_3320_3326_5159_5156_5604_3265_1026 34 4.61E-26 3.69E-24 1.23E-24 26041 hsa-mir-758 hsa04010 MAPK signaling pathway 6722_3725_3727_4149_6197_2264_9252_7867_1845_4773_7046_8986_1956_7132_3303_1432_5894_207_22800_2261_5595_5594_5599_5598_1386_836_3312_1649_5970_7157_468_6195_6196_4790_5879_5159_9261_5156_5604_4208_5601_5600_5602_1399_1398_3265_2353_2005_8550_2002 50 4.26E-25 3.41E-23 8.52E-24 26042 hsa-mir-758 hsa04110 Cell cycle 1017_5001_6502_6500_4174_4172_4173_3065_990_5925_25_1870_1871_5934_5933_5591_1387_7534_7531_7533_7532_2932_7157_1869_4087_4088_4089_2033_890_898_983_8454_1026_1029_4999_4998 36 1.20E-24 9.63E-23 1.93E-23 26043 hsa-mir-758 hsa05220 Chronic myeloid leukemia 3065_5925_7046_25_1870_1871_5894_861_867_207_5595_5594_6776_6777_5970_7157_1869_4088_4089_4790_4792_5604_1399_1398_3265_5781_1026_1029_6464 29 1.53E-22 1.22E-20 2.04E-21 26044 hsa-mir-758 hsa04012 ErbB signaling pathway 3725_818_815_817_5747_25_1956_6714_5894_867_207_5595_5594_5599_2064_2066_2932_6776_6777_5604_5601_5602_1399_1398_3265_1026_6464_2002 28 4.65E-20 3.72E-18 5.31E-19 26045 hsa-mir-758 hsa05214 Glioma 818_815_817_5925_1956_1870_1871_5894_207_5595_5594_7157_1869_808_801_805_5159_5156_5604_3265_1026_1029_6464 23 1.82E-17 1.46E-15 1.82E-16 26046 hsa-mir-758 hsa05210 Colorectal cancer 3725_1499_6934_842_7046_1956_5894_207_5595_5594_5599_836_2932_7157_4087_4088_4089_5879_5159_5156_5604_5601_5602_4292_2353 25 2.20E-17 1.76E-15 1.96E-16 26047 hsa-mir-758 hsa04630 Jak-STAT signaling pathway 3559_5777_58985_3455_3560_3561_3566_1439_2057_867_2690_207_3717_3716_3718_85480_1387_3575_6774_6775_6776_6777_6772_7297_6773_2033_3459_5781_8554_10379 30 3.87E-16 3.10E-14 3.10E-15 26048 hsa-mir-758 hsa04350 TGF-beta signaling pathway 6667_6500_90_3397_7046_57154_3399_3398_1874_1875_5934_5933_5595_5594_1387_4086_4087_4088_4089_2033_5515_4093_8454 23 3.65E-15 2.92E-13 2.65E-14 26049 hsa-mir-758 hsa05221 Acute myeloid leukemia 5914_6934_7704_1050_5894_861_862_207_5595_5594_6774_6776_6777_5970_6688_4790_5371_5604_3815_3265 20 4.49E-15 3.59E-13 2.99E-14 26050 hsa-mir-758 hsa04520 Adherens junction 4301_1499_6934_5770_5777_7046_2534_1956_6714_1460_5595_5594_1387_2064_1457_1459_4087_4088_4089_2033_5879_3643 22 7.28E-15 5.82E-13 4.48E-14 26051 hsa-mir-758 hsa04912 GnRH signaling pathway 3725_818_815_817_5580_1956_6714_1432_5894_5595_5594_5599_5598_468_808_801_805_5604_5601_5600_5602_3265_2002 23 1.89E-13 1.51E-11 1.06E-12 26052 hsa-mir-758 hsa04720 Long-term potentiation 818_815_817_6197_2902_2906_5499_5894_5595_5594_1387_468_6195_6196_2033_808_801_805_5604_3265 20 2.00E-13 1.60E-11 1.06E-12 26053 hsa-mir-758 hsa04660 T cell receptor signaling pathway 3725_1493_5777_4773_2534_3932_1432_5894_867_207_5595_5594_2932_5970_4790_4792_5604_5601_5600_919_3265_1739_2353 23 2.64E-13 2.11E-11 1.32E-12 26054 hsa-mir-758 hsa05219 Bladder cancer 9252_5925_1956_1870_1871_5894_2261_5595_5594_2064_7157_1869_5604_3265_1026_1029 16 5.75E-13 4.60E-11 2.71E-12 26055 hsa-mir-758 hsa05223 Non-small cell lung cancer 842_5925_1956_1870_1871_5894_207_5595_5594_6258_2064_6256_7157_1869_5604_3265_1029 17 1.37E-12 1.10E-10 6.10E-12 26056 hsa-mir-758 hsa04062 Chemokine signaling pathway 1234_7074_5747_5580_7852_5894_207_3717_3718_5590_5595_5594_1230_2932_2931_6774_6777_6772_5970_6773_4790_4792_5879_5604_1399_1398_3265_6464 28 2.05E-12 1.64E-10 8.62E-12 26057 hsa-mir-758 hsa04310 Wnt signaling pathway 3725_818_815_817_1499_6934_6500_4773_1460_5599_1387_2932_7157_8061_1457_1459_4087_4088_4089_2033_5879_5515_5601_5602_8454 25 2.74E-12 2.19E-10 1.09E-11 26058 hsa-mir-758 hsa04510 Focal adhesion 3725_1499_2534_5747_3791_1956_6714_5499_5894_207_5595_5594_5599_2064_2932_1729_5879_2321_5159_5156_5604_5601_5602_1399_1398_3265_6464_2002 28 8.29E-12 6.63E-10 3.16E-11 26059 hsa-mir-758 hsa05218 Melanoma 5925_1956_1870_1871_5894_207_4286_5595_5594_7157_1869_5159_5156_5604_3265_1026_1029 17 5.48E-11 4.38E-09 1.99E-10 26060 hsa-mir-758 hsa05213 Endometrial cancer 1499_6934_842_1956_5894_207_5595_5594_2064_2932_7157_5604_3265_4292_2002 15 8.10E-11 6.48E-09 2.82E-10 26061 hsa-mir-758 hsa04910 Insulin signaling pathway 5770_5499_5894_867_207_5590_5595_5594_5599_2932_808_801_805_3643_5604_5601_5602_1399_1398_3265_6464_2002 22 9.50E-11 7.60E-09 3.17E-10 26062 hsa-mir-758 hsa05222 Small cell lung cancer 4149_1017_6502_842_5925_5747_1870_1871_207_6258_6256_5970_7157_1869_898_4790_4792_8554 18 1.02E-10 8.14E-09 3.25E-10 26063 hsa-mir-758 hsa04662 B cell receptor signaling pathway 3725_5777_4773_5894_207_695_5595_5594_2932_5970_4790_4792_5879_5604_3265_6850_2353 17 1.15E-10 9.18E-09 3.53E-10 26064 hsa-mir-758 hsa04620 Toll-like receptor signaling pathway 3725_3455_1432_207_5595_5594_5599_6772_5970_4790_4792_5879_5604_5601_5600_5602_841_8772_2353 19 1.77E-10 1.42E-08 5.25E-10 26065 hsa-mir-758 hsa04916 Melanogenesis 818_815_817_1499_6934_5894_4286_5595_5594_1385_1387_2932_2033_808_801_805_5604_3815_3265 19 2.37E-10 1.90E-08 6.77E-10 26066 hsa-mir-758 hsa04370 VEGF signaling pathway 7867_4773_842_5747_3791_6714_1432_5894_207_5595_5594_5879_9261_5604_5600_3265 16 1.22E-09 9.74E-08 3.36E-09 26067 hsa-mir-758 hsa04920 Adipocytokine signaling pathway 7133_7132_207_3717_8717_5599_6258_6256_6774_5970_4790_4792_5601_5602_5781 15 1.65E-09 1.32E-07 4.35E-09 26068 hsa-mir-758 hsa04664 Fc epsilon RI signaling pathway 2534_5580_1432_5894_207_695_5595_5594_5599_5879_5604_5601_5600_5602_3265_6850 16 1.68E-09 1.35E-07 4.35E-09 26069 hsa-mir-758 hsa04540 Gap junction 5592_51807_1956_6714_5894_5595_5594_5598_7846_5159_983_5156_5604_3265_7277_7278_10376 17 2.07E-09 1.66E-07 5.17E-09 26070 hsa-mir-758 hsa05211 Renal cell carcinoma 3725_3091_2113_5894_207_5595_5594_1387_2033_5879_5604_1399_1398_3265_5781 15 3.88E-09 3.11E-07 9.41E-09 26071 hsa-mir-758 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1956_6714_1432_5599_836_5970_4790_4792_5879_5601_5600_5602_5781 14 2.36E-08 1.89E-06 5.55E-08 26072 hsa-mir-758 hsa04060 Cytokine-cytokine receptor interaction 3559_1234_58985_3455_90_7046_3791_1956_7852_3560_3561_3566_7133_7132_1439_2057_2690_85480_1230_3575_2321_5159_5156_3815_3459 25 7.43E-08 5.94E-06 1.70E-07 26073 hsa-mir-758 hsa03022 Basal transcription factors 6879_2963_2962_2969_6872_6908_2958_2959_6880_9519 10 1.97E-07 1.57E-05 4.37E-07 26074 hsa-mir-758 hsa04210 Apoptosis 842_7132_1439_207_8717_836_839_5970_7157_4790_4792_841_840_8772 14 2.82E-07 2.26E-05 6.10E-07 26075 hsa-mir-758 hsa05216 Thyroid cancer 1499_6934_5595_5594_6258_6256_7157_5604_3265 9 3.03E-07 2.42E-05 6.37E-07 26076 hsa-mir-758 hsa04650 Natural killer cell mediated cytotoxicity 5777_3455_4773_2534_3932_5894_5595_5594_836_5879_5604_919_3265_3459_6850_5781_6464 17 3.68E-07 2.94E-05 7.55E-07 26077 hsa-mir-758 hsa05010 Alzheimer's disease 842_2902_2906_7132_22926_5595_5594_836_2932_808_351_801_805_841_840_8772_4716_4697_4724 19 5.34E-07 4.27E-05 1.07E-06 26078 hsa-mir-758 hsa04115 p53 signaling pathway 1017_842_836_7157_64326_898_983_841_1026_7161_1029 11 4.72E-06 0.000377654 9.21E-06 26079 hsa-mir-758 hsa05014 Amyotrophic lateral sclerosis (ALS) 842_2902_2906_7133_7132_1432_836_7157_5879_5600 10 5.23E-06 0.000418587 9.51E-06 26080 hsa-mir-758 hsa05131 Shigellosis 1499_51807_2534_25_7534_7846_7277_7278_4691_10376 10 5.23E-06 0.000418587 9.51E-06 26081 hsa-mir-758 hsa05130 Pathogenic Escherichia coli infection 1499_51807_2534_25_7534_7846_7277_7278_4691_10376 10 5.23E-06 0.000418587 9.51E-06 26082 hsa-mir-758 hsa04530 Tight junction 4301_10207_1499_5580_6714_8573_8189_207_22800_1460_5590_1457_1459_5515_3265 15 6.61E-06 0.00052917 1.18E-05 26083 hsa-mir-758 hsa04930 Type II diabetes mellitus 5580_3651_5590_5595_5594_5599_3643_5601_5602 9 6.92E-06 0.000553346 1.20E-05 26084 hsa-mir-758 hsa05016 Huntington's disease 6667_842_3065_3064_2902_9586_1385_1387_836_7157_2033_6908_841_4716_4697_4724_9519 17 1.69E-05 0.001352602 2.88E-05 26085 hsa-mir-758 hsa04120 Ubiquitin mediated proteolysis 55294_6502_6500_57154_867_10273_7329_11059_83737_64326_5371_672_8454_8554 14 3.13E-05 0.002503509 5.14E-05 26086 hsa-mir-758 hsa04810 Regulation of actin cytoskeleton 2264_7074_5747_1956_5499_5894_22800_2261_5595_5594_1729_5879_5159_5156_5604_1399_1398_3265 18 3.15E-05 0.002520231 5.14E-05 26087 hsa-mir-758 hsa04330 Notch signaling pathway 9612_3065_388585_1387_2033_8850_2648 7 0.000372395 0.029791584 0.000595832 26088 hsa-mir-758 hsa04270 Vascular smooth muscle contraction 5592_147_5580_5499_5894_5595_5594_808_801_805_5604 11 0.000398939 0.03191516 0.000625787 26089 hsa-mir-758 hsa04020 Calcium signaling pathway 818_815_817_147_1956_2902_2906_2064_2066_808_801_805_5159_5156 14 0.000479425 0.038354033 0.000737578 26090 hsa-mir-758 hsa04150 mTOR signaling pathway 6197_3091_207_5595_5594_6195_6196 7 0.00064433 0.051546369 0.000972573 26091 hsa-mir-758 hsa05217 Basal cell carcinoma 1499_6934_2932_7157_2735_2736_2737 7 0.000871008 0.06968066 0.001290383 26092 hsa-mir-758 hsa04360 Axon guidance 4773_2534_5747_25_7852_5595_5594_2932_5879_5998_3265 11 0.000894368 0.071549438 0.001300899 26093 hsa-mir-758 hsa04612 Antigen processing and presentation 3303_1385_3312_3320_3326_4800_4801_4802 8 0.002962791 0.237023296 0.004232559 26094 hsa-mir-758 hsa05340 Primary immunodeficiency 3932_3561_3718_695_3575 5 0.003037285 0.242982779 0.004262856 26095 hsa-mir-758 hsa04730 Long-term depression 5592_5894_5595_5594_5515_5604_3265 7 0.003325176 0.266014101 0.00458645 26096 hsa-mir-758 hsa03450 Non-homologous end-joining 2547_7520_5591 3 0.008083753 0.646700209 0.01096102 26097 hsa-mir-758 hsa04670 Leukocyte transendothelial migration 4301_1499_5747_7852_1432_5879_5600_5781 8 0.016411628 1 0.02188217 26098 hsa-mir-758 hsa04950 Maturity onset diabetes of the young 3087_3651_168620 3 0.028942829 1 0.037957809 26099 hsa-mir-759 hsa05200 Pathways in cancer 1147_3320_3326_25_405_3480_1956_5595_5594_6654_5914_2064_6256_595_2308_208_367_4193_7704_1387_6776_5970_8503_2885_7157_4087_10401_3725_2735_2736_2737_4088_4089_5295_2033_207_8554_4790 38 1.66E-34 1.20E-32 1.20E-32 26100 hsa-mir-759 hsa05215 Prostate cancer 1147_3320_3326_3480_1956_5595_5594_6654_2064_595_2308_208_367_4193_1387_5970_8503_2885_7157_468_5295_2033_207_4790 24 5.25E-30 3.78E-28 1.59E-28 26101 hsa-mir-759 hsa05212 Pancreatic cancer 1147_3320_3326_3480_1956_5595_5594_6654_2064_595_2308_208_367_4193_1387_5970_8503_2885_7157_468_5295_2033_207_4790 24 6.62E-30 4.77E-28 1.59E-28 26102 hsa-mir-759 hsa05220 Chronic myeloid leukemia 1147_25_5595_5594_6654_595_208_4193_6776_5970_8503_2885_7157_4088_4089_5295_207_4790_6464 19 1.95E-23 1.40E-21 3.51E-22 26103 hsa-mir-759 hsa05214 Glioma 3480_1956_5595_5594_6654_595_208_4193_8503_2885_7157_5295_207_801_6464_808_805 17 2.73E-21 1.97E-19 3.93E-20 26104 hsa-mir-759 hsa04010 MAPK signaling pathway 1147_994_1956_5595_5594_6654_5566_208_4214_1432_5970_627_2885_7157_10912_468_3725_3727_6195_6197_5058_4616_2872_207_4790 25 1.04E-20 7.48E-19 1.25E-19 26105 hsa-mir-759 hsa04012 ErbB signaling pathway 25_1956_6714_5595_5594_6654_56924_2064_208_6776_8503_2885_3725_5295_5058_207_6464 17 2.05E-19 1.48E-17 2.11E-18 26106 hsa-mir-759 hsa04910 Insulin signaling pathway 6720_10891_5595_5594_6654_2308_5566_7249_208_5770_8503_2885_5295_2872_207_801_6464_808_805 19 5.33E-19 3.84E-17 4.80E-18 26107 hsa-mir-759 hsa05221 Acute myeloid leukemia 1147_5595_5594_6654_5914_595_208_7704_6776_5970_8503_2885_5295_207_4790 15 9.18E-19 6.61E-17 7.34E-18 26108 hsa-mir-759 hsa05210 Colorectal cancer 3480_1956_5595_5594_6654_595_208_8503_2885_7157_4087_3725_4088_4089_5295_207 16 3.48E-18 2.51E-16 2.51E-17 26109 hsa-mir-759 hsa04660 T cell receptor signaling pathway 1147_3932_5595_5594_6654_56924_208_5777_1432_5970_8503_2885_3725_5295_5058_207_4790 17 7.01E-18 5.05E-16 4.59E-17 26110 hsa-mir-759 hsa05223 Non-small cell lung cancer 1956_5595_5594_6654_2064_6256_595_2309_208_8503_2885_7157_5295_207 14 1.07E-17 7.74E-16 6.45E-17 26111 hsa-mir-759 hsa05213 Endometrial cancer 1956_5595_5594_6654_2064_595_2309_208_8503_2885_7157_5295_207 13 2.43E-16 1.75E-14 1.34E-15 26112 hsa-mir-759 hsa05211 Renal cell carcinoma 405_5595_5594_6654_56924_208_1387_8503_2885_3725_5295_5058_2033_207 14 3.58E-16 2.58E-14 1.84E-15 26113 hsa-mir-759 hsa04510 Focal adhesion 9564_3480_1956_6714_5595_5594_6654_56924_2064_595_208_8503_857_2885_3725_5295_5058_207_6464 19 4.86E-16 3.50E-14 2.33E-15 26114 hsa-mir-759 hsa04520 Adherens junction 1460_3480_1956_6714_5595_5594_2064_5770_5777_1387_4087_4088_4089_2033 14 1.32E-15 9.47E-14 5.92E-15 26115 hsa-mir-759 hsa04110 Cell cycle 25_994_595_7533_4193_902_1387_7157_4087_10912_1022_4088_4089_4616_2033 15 9.86E-15 7.10E-13 4.18E-14 26116 hsa-mir-759 hsa04662 B cell receptor signaling pathway 1147_5595_5594_6654_208_5777_5970_8503_2885_3725_5295_207_4790 13 1.56E-14 1.12E-12 6.25E-14 26117 hsa-mir-759 hsa04062 Chemokine signaling pathway 1147_9564_5595_5594_6654_2770_2309_5566_208_5970_8503_2885_5295_5058_207_4790_6464 17 3.61E-14 2.60E-12 1.37E-13 26118 hsa-mir-759 hsa04912 GnRH signaling pathway 1956_6714_5595_5594_6654_5566_4214_1432_2885_468_3725_801_808_805 14 5.52E-14 3.98E-12 1.99E-13 26119 hsa-mir-759 hsa05222 Small cell lung cancer 1147_6256_595_208_5970_8503_7157_10401_5295_207_8554_4790 12 1.66E-12 1.19E-10 5.69E-12 26120 hsa-mir-759 hsa05218 Melanoma 3480_1956_5595_5594_595_208_4193_8503_7157_5295_207 11 5.16E-12 3.71E-10 1.69E-11 26121 hsa-mir-759 hsa04720 Long-term potentiation 5595_5594_5566_1387_468_6195_6197_2033_801_808_805 11 8.81E-12 6.34E-10 2.76E-11 26122 hsa-mir-759 hsa04630 Jak-STAT signaling pathway 6654_595_208_5777_1387_6776_8503_2885_10401_5295_2033_207_8554 13 7.07E-11 5.09E-09 2.12E-10 26123 hsa-mir-759 hsa04620 Toll-like receptor signaling pathway 1147_5595_5594_208_1432_5970_8503_3725_5295_207_4790 11 1.80E-10 1.30E-08 5.19E-10 26124 hsa-mir-759 hsa04150 mTOR signaling pathway 5595_5594_7249_208_8503_6195_6197_5295_207 9 1.92E-10 1.38E-08 5.33E-10 26125 hsa-mir-759 hsa04350 TGF-beta signaling pathway 5595_5594_6667_1387_4087_4086_4088_4089_2033_4093 10 7.00E-10 5.04E-08 1.87E-09 26126 hsa-mir-759 hsa04210 Apoptosis 1147_5566_208_5970_8503_823_7157_5295_207_4790 10 8.58E-10 6.17E-08 2.21E-09 26127 hsa-mir-759 hsa04664 Fc epsilon RI signaling pathway 5595_5594_6654_208_1432_8503_2885_5295_207 9 5.46E-09 3.93E-07 1.36E-08 26128 hsa-mir-759 hsa05219 Bladder cancer 1956_5595_5594_2064_595_4193_7157 7 2.68E-08 1.93E-06 6.42E-08 26129 hsa-mir-759 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_1956_6714_1432_5970_3725_5058_4790 8 4.27E-08 3.07E-06 9.63E-08 26130 hsa-mir-759 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6654_5777_8503_2885_5295_5058_6464 10 4.28E-08 3.08E-06 9.63E-08 26131 hsa-mir-759 hsa04916 Melanogenesis 5595_5594_2770_5566_1387_2033_801_808_805 9 4.98E-08 3.58E-06 1.09E-07 26132 hsa-mir-759 hsa04370 VEGF signaling pathway 6714_5595_5594_208_1432_8503_5295_207 8 7.62E-08 5.48E-06 1.61E-07 26133 hsa-mir-759 hsa04310 Wnt signaling pathway 1460_595_5566_1387_7157_4087_3725_4088_4089_2033 10 1.00E-07 7.24E-06 2.07E-07 26134 hsa-mir-759 hsa04540 Gap junction 1956_6714_5595_5594_6654_2770_5566_2885 8 2.93E-07 2.11E-05 5.86E-07 26135 hsa-mir-759 hsa04920 Adipocytokine signaling pathway 1147_10891_6256_208_5970_207_4790 7 4.90E-07 3.53E-05 9.54E-07 26136 hsa-mir-759 hsa05216 Thyroid cancer 5595_5594_6256_595_7157 5 2.43E-06 0.000174613 4.60E-06 26137 hsa-mir-759 hsa04115 p53 signaling pathway 595_7249_4193_7157_10912_4616 6 8.81E-06 0.000634268 1.63E-05 26138 hsa-mir-759 hsa04810 Regulation of actin cytoskeleton 9564_1956_5595_5594_6654_56924_8503_5295_5058 9 1.74E-05 0.001250682 3.13E-05 26139 hsa-mir-759 hsa04360 Axon guidance 25_5998_5595_5594_56924_2770_5058 7 3.13E-05 0.002252249 5.49E-05 26140 hsa-mir-759 hsa04120 Ubiquitin mediated proteolysis 672_4214_4193_10401_10273_7329_8554 7 4.48E-05 0.003228832 7.69E-05 26141 hsa-mir-759 hsa03022 Basal transcription factors 2965_6908_2959_6881 4 0.000136199 0.009806345 0.000228055 26142 hsa-mir-759 hsa04270 Vascular smooth muscle contraction 5595_5594_5566_801_808_805 6 0.000150825 0.010859428 0.000246805 26143 hsa-mir-759 hsa04070 Phosphatidylinositol signaling system 8503_5295_801_808_805 5 0.000175144 0.012610348 0.00028023 26144 hsa-mir-759 hsa05010 Alzheimer's disease 5595_5594_823_9451_801_808_805 7 0.000190506 0.013716452 0.000298184 26145 hsa-mir-759 hsa03420 Nucleotide excision repair 2965_902_1022_4331 4 0.000252722 0.018195957 0.000387148 26146 hsa-mir-759 hsa05016 Huntington's disease 10891_6908_6667_1387_627_7157_2033 7 0.000271501 0.019548043 0.000402346 26147 hsa-mir-759 hsa04930 Type II diabetes mellitus 5595_5594_8503_5295 4 0.000273819 0.019714961 0.000402346 26148 hsa-mir-759 hsa05217 Basal cell carcinoma 7157_2735_2736_2737 4 0.000559643 0.040294302 0.000805886 26149 hsa-mir-759 hsa04340 Hedgehog signaling pathway 5566_2735_2736_2737 4 0.000635351 0.045745306 0.000896967 26150 hsa-mir-759 hsa04670 Leukocyte transendothelial migration 9564_2770_1432_8503_5295 5 0.001372152 0.098794973 0.001875423 26151 hsa-mir-759 hsa04730 Long-term depression 3480_5595_5594_2770 4 0.00138052 0.09939741 0.001875423 26152 hsa-mir-759 hsa04020 Calcium signaling pathway 1956_2064_5566_801_808_805 6 0.001441113 0.103760158 0.001921484 26153 hsa-mir-759 hsa03410 Base excision repair 6996_3146_4350 3 0.001983922 0.142842402 0.002597135 26154 hsa-mir-759 hsa04530 Tight junction 1460_6714_2770_208_207 5 0.00223978 0.161264162 0.002879717 26155 hsa-mir-759 hsa04330 Notch signaling pathway 1387_9612_2033 3 0.004041622 0.290996773 0.005105207 26156 hsa-mir-759 hsa04612 Antigen processing and presentation 3320_3326_6890 3 0.021315055 1 0.026460069 26157 hsa-mir-759 hsa05340 Primary immunodeficiency 3932_6890 2 0.023380225 1 0.0285318 26158 hsa-mir-759 hsa03050 Proteasome 5698_5705 2 0.040752382 1 0.048902858 26159 hsa-mir-760 hsa04110 Cell cycle 1869_25_5925_545_995_1026_5591_983_4088_7534_1017_2932_4193_7027_902_1387_1031_9232_5347_1022_4087_4089_7532_3065_1111_2033_890_11200_8556_8555_472 31 9.09E-32 7.63E-30 7.63E-30 26160 hsa-mir-760 hsa05200 Pathways in cancer 1147_3320_1869_5743_3326_5747_25_5925_675_998_1026_5594_5595_5599_596_5601_6789_1856_4088_613_1017_2932_4193_1387_5578_51588_8554_5371_4436_598_4087_4089_5888_5728_3065_3091_2033_3910_4792_5602 40 3.73E-29 3.13E-27 1.57E-27 26161 hsa-mir-760 hsa04115 p53 signaling pathway 50484_545_6241_1026_25898_983_1017_27113_4194_4193_900_7161_64326_5728_51246_1111_11200_472 18 6.22E-19 5.22E-17 1.74E-17 26162 hsa-mir-760 hsa05215 Prostate cancer 1147_3320_1869_3326_5925_1026_5594_5595_596_1017_2932_4193_1387_5728_2033_4792 16 8.08E-15 6.79E-13 1.59E-13 26163 hsa-mir-760 hsa05212 Pancreatic cancer 1147_3320_1869_3326_5925_1026_5594_5595_596_1017_2932_4193_1387_5728_2033_4792 16 9.45E-15 7.94E-13 1.59E-13 26164 hsa-mir-760 hsa04310 Wnt signaling pathway 1460_5518_5515_5599_5601_1856_1457_4088_2932_1387_5578_6423_1452_4087_4089_5527_2033_5602 18 1.33E-13 1.12E-11 1.86E-12 26165 hsa-mir-760 hsa05220 Chronic myeloid leukemia 1147_1869_25_5925_1026_5594_5595_4088_613_4193_598_4089_3065_4792 14 2.88E-13 2.42E-11 3.46E-12 26166 hsa-mir-760 hsa04350 TGF-beta signaling pathway 4093_3398_5518_5515_5594_5595_6667_4088_7027_1387_4086_4087_4089_2033 14 1.74E-12 1.46E-10 1.83E-11 26167 hsa-mir-760 hsa05222 Small cell lung cancer 1147_1869_5743_5747_5925_596_1017_51588_8554_598_5728_3910_4792 13 2.21E-11 1.86E-09 2.07E-10 26168 hsa-mir-760 hsa05210 Colorectal cancer 5594_5595_5599_596_5601_1856_4088_2932_4436_4087_4089_5602 12 2.37E-10 1.99E-08 1.99E-09 26169 hsa-mir-760 hsa04120 Ubiquitin mediated proteolysis 10055_672_7319_25898_84447_4193_3093_51588_8554_5371_64326_7329_10075_7337 14 5.10E-10 4.29E-08 3.90E-09 26170 hsa-mir-760 hsa04010 MAPK signaling pathway 9479_1147_998_5594_5595_5599_5601_3304_3305_3303_6789_3315_5578_3164_1616_5923_5602 17 6.96E-09 5.84E-07 4.87E-08 26171 hsa-mir-760 hsa04520 Adherens junction 1460_998_5594_5595_1457_4088_1387_4087_4089_2033 10 2.43E-08 2.04E-06 1.57E-07 26172 hsa-mir-760 hsa04012 ErbB signaling pathway 5747_25_1026_5594_5595_5599_5601_2932_5578_5602 10 5.03E-08 4.23E-06 3.02E-07 26173 hsa-mir-760 hsa04510 Focal adhesion 5747_998_5594_5595_5599_596_5601_5499_2932_5578_5728_5923_3910_5602 14 5.48E-08 4.61E-06 3.07E-07 26174 hsa-mir-760 hsa05214 Glioma 1869_5925_1026_5594_5595_4193_5578_5728 8 6.97E-07 5.86E-05 3.66E-06 26175 hsa-mir-760 hsa03420 Nucleotide excision repair 2965_4331_2074_6117_2071_902_1022 7 7.41E-07 6.22E-05 3.66E-06 26176 hsa-mir-760 hsa03022 Basal transcription factors 2965_2957_6908_51616_2958_6880 6 4.25E-06 0.000356832 1.98E-05 26177 hsa-mir-760 hsa05219 Bladder cancer 1869_5925_1026_5594_5595_4193 6 8.20E-06 0.000688766 3.63E-05 26178 hsa-mir-760 hsa04920 Adipocytokine signaling pathway 1147_5563_6794_5599_5601_4792_5602 7 9.46E-06 0.000794766 3.97E-05 26179 hsa-mir-760 hsa05218 Melanoma 1869_5925_1026_5594_5595_4193_5728 7 1.34E-05 0.001127686 5.37E-05 26180 hsa-mir-760 hsa04370 VEGF signaling pathway 5743_5747_998_5594_5595_3315_5578 7 2.19E-05 0.00183708 8.35E-05 26181 hsa-mir-760 hsa04660 T cell receptor signaling pathway 1147_998_5594_5595_5601_2932_959_4792 8 2.57E-05 0.002161453 9.40E-05 26182 hsa-mir-760 hsa05223 Non-small cell lung cancer 1869_5925_5594_5595_6789_5578 6 3.03E-05 0.002541252 0.000105885 26183 hsa-mir-760 hsa04530 Tight junction 1460_998_5518_5515_1457_5578_5728_5520 8 0.000111049 0.009328148 0.000362391 26184 hsa-mir-760 hsa04620 Toll-like receptor signaling pathway 1147_5594_5595_5599_5601_4792_5602 7 0.000116344 0.009772908 0.000362391 26185 hsa-mir-760 hsa04910 Insulin signaling pathway 5563_5594_5595_5599_5601_5499_2932_5602 8 0.000116483 0.009784562 0.000362391 26186 hsa-mir-760 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_998_5599_5601_4792_5602 6 0.000124301 0.010441324 0.000372904 26187 hsa-mir-760 hsa04916 Melanogenesis 5594_5595_1856_2932_1387_5578_2033 7 0.000130384 0.010952245 0.000373915 26188 hsa-mir-760 hsa05211 Renal cell carcinoma 998_5594_5595_1387_3091_2033 6 0.000133541 0.011217461 0.000373915 26189 hsa-mir-760 hsa04930 Type II diabetes mellitus 5594_5595_5599_5601_5602 5 0.00014175 0.01190698 0.000384096 26190 hsa-mir-760 hsa04912 GnRH signaling pathway 998_5594_5595_5599_5601_5578_5602 7 0.00016259 0.01365759 0.000406571 26191 hsa-mir-760 hsa04720 Long-term potentiation 5594_5595_5499_1387_5578_2033 6 0.000164564 0.01382341 0.000406571 26192 hsa-mir-760 hsa04662 B cell receptor signaling pathway 1147_5594_5595_1380_2932_4792 6 0.000164564 0.01382341 0.000406571 26193 hsa-mir-760 hsa04330 Notch signaling pathway 1856_1387_3065_2033_8850 5 0.000171066 0.014369507 0.000410557 26194 hsa-mir-760 hsa04664 Fc epsilon RI signaling pathway 5594_5595_5599_5601_5578_5602 6 0.000214497 0.018017755 0.000500493 26195 hsa-mir-760 hsa04150 mTOR signaling pathway 5563_5594_6794_5595_3091 5 0.000264605 0.022226785 0.000600724 26196 hsa-mir-760 hsa03440 Homologous recombination 675_6117_641_5888 4 0.000282568 0.023735706 0.000624624 26197 hsa-mir-760 hsa05131 Shigellosis 25_998_7534_5578_4691 5 0.000363923 0.030569518 0.000764238 26198 hsa-mir-760 hsa05130 Pathogenic Escherichia coli infection 25_998_7534_5578_4691 5 0.000363923 0.030569518 0.000764238 26199 hsa-mir-760 hsa04612 Antigen processing and presentation 3320_3326_3309_3304_3305_3303 6 0.000392203 0.032945013 0.000784405 26200 hsa-mir-760 hsa04210 Apoptosis 1147_823_596_598_4792_472 6 0.000392203 0.032945013 0.000784405 26201 hsa-mir-760 hsa04360 Axon guidance 5747_25_998_5594_5595_2932_1020 7 0.000494928 0.04157391 0.000966835 26202 hsa-mir-760 hsa03410 Base excision repair 142_3146_328_4913 4 0.000674431 0.056652169 0.001287549 26203 hsa-mir-760 hsa05016 Huntington's disease 25942_3064_6908_6667_27113_1387_3065_2033 8 0.000842419 0.070763177 0.001572515 26204 hsa-mir-760 hsa04062 Chemokine signaling pathway 1147_5747_998_5594_5595_2932_6362_4792 8 0.000991068 0.083249749 0.001788353 26205 hsa-mir-760 hsa04730 Long-term depression 5518_5515_5594_5595_5578 5 0.001000626 0.084052591 0.001788353 26206 hsa-mir-760 hsa05213 Endometrial cancer 5594_5595_2932_5728 4 0.00239186 0.20091626 0.004185755 26207 hsa-mir-760 hsa04540 Gap junction 5594_5595_983_1453_5578 5 0.003079272 0.258658841 0.005278752 26208 hsa-mir-760 hsa05221 Acute myeloid leukemia 1147_5594_5595_5371 4 0.003673333 0.308559954 0.006171199 26209 hsa-mir-760 hsa03030 DNA replication 6117_5557_5422 3 0.006933568 0.582419726 0.011419995 26210 hsa-mir-760 hsa03450 Non-homologous end-joining 5591_2547 2 0.010901569 0.915731811 0.017610227 26211 hsa-mir-760 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_1616 3 0.021319561 1 0.033789493 26212 hsa-mir-760 hsa04340 Hedgehog signaling pathway 1453_2932_1452 3 0.022279635 1 0.034619494 26213 hsa-mir-760 hsa04630 Jak-STAT signaling pathway 1387_51588_8554_598_2033 5 0.022667526 1 0.034619494 26214 hsa-mir-760 hsa03430 Mismatch repair 6117_4436 2 0.02569462 1 0.038541931 26215 hsa-mir-760 hsa04270 Vascular smooth muscle contraction 5594_5595_5499_5578 4 0.034402989 1 0.050699142 26216 hsa-mir-760 hsa05010 Alzheimer's disease 5594_5595_823_2932_1020 5 0.03656576 1 0.052957308 26217 hsa-mir-760 hsa05216 Thyroid cancer 5594_5595 2 0.038302275 1 0.054532053 26218 hsa-mir-761 hsa04110 Cell cycle 1387_993_983_5925 4 6.13E-07 1.53E-05 1.53E-05 26219 hsa-mir-761 hsa04330 Notch signaling pathway 1387_8850 2 0.000349508 0.008737699 0.004368849 26220 hsa-mir-761 hsa05215 Prostate cancer 1387_5925 2 0.001174155 0.029353887 0.007500885 26221 hsa-mir-761 hsa05212 Pancreatic cancer 1387_5925 2 0.001200142 0.03000354 0.007500885 26222 hsa-mir-761 hsa05200 Pathways in cancer 1387_5925 2 0.015034947 0.37587367 0.064921185 26223 hsa-mir-761 hsa03410 Base excision repair 3146 1 0.020754901 0.518872528 0.064921185 26224 hsa-mir-761 hsa05219 Bladder cancer 5925 1 0.024082113 0.60205283 0.064921185 26225 hsa-mir-761 hsa05223 Non-small cell lung cancer 5925 1 0.030704643 0.767616075 0.064921185 26226 hsa-mir-761 hsa05214 Glioma 5925 1 0.036738118 0.918452946 0.064921185 26227 hsa-mir-761 hsa04115 p53 signaling pathway 983 1 0.038923332 0.97308329 0.064921185 26228 hsa-mir-761 hsa05218 Melanoma 5925 1 0.040014188 1 0.064921185 26229 hsa-mir-761 hsa05211 Renal cell carcinoma 1387 1 0.040559179 1 0.064921185 26230 hsa-mir-761 hsa04720 Long-term potentiation 1387 1 0.042192406 1 0.064921185 26231 hsa-mir-761 hsa05220 Chronic myeloid leukemia 5925 1 0.042192406 1 0.064921185 26232 hsa-mir-761 hsa04520 Adherens junction 1387 1 0.044908637 1 0.064921185 26233 hsa-mir-761 hsa04512 ECM-receptor interaction 9672 1 0.0470764 1 0.064921185 26234 hsa-mir-761 hsa05222 Small cell lung cancer 5925 1 0.048158544 1 0.064921185 26235 hsa-mir-761 hsa04350 TGF-beta signaling pathway 1387 1 0.048699183 1 0.064921185 26236 hsa-mir-761 hsa04612 Antigen processing and presentation 1514 1 0.049779592 1 0.064921185 26237 hsa-mir-762 hsa05200 Pathways in cancer 5371_7046_5595_5594_861_5914_1387_6256_595_1488_836_1487_4193_367_7704_51588_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_1029_4088_4089_3066_3065_5925_2034_2033_4846_4286_7189 38 5.82E-35 3.78E-33 3.78E-33 26238 hsa-mir-762 hsa05220 Chronic myeloid leukemia 6464_7046_5595_5594_861_595_1488_1487_4193_5970_1870_1871_7157_4609_1869_1029_4088_4089_3066_3065_5925 21 7.96E-27 5.17E-25 2.59E-25 26239 hsa-mir-762 hsa04110 Cell cycle 993_5591_1387_595_983_4193_1870_1871_7157_4087_1869_1029_4088_4089_3066_3065_5925_2033_5933 19 2.62E-20 1.70E-18 5.68E-19 26240 hsa-mir-762 hsa05215 Prostate cancer 5595_5594_1387_595_4193_1385_367_5970_1870_1871_7157_468_1869_5925_2033 15 1.18E-16 7.68E-15 1.78E-15 26241 hsa-mir-762 hsa05212 Pancreatic cancer 5595_5594_1387_595_4193_1385_367_5970_1870_1871_7157_468_1869_5925_2033 15 1.37E-16 8.92E-15 1.78E-15 26242 hsa-mir-762 hsa04350 TGF-beta signaling pathway 7046_5595_5594_1387_6667_3399_3398_4087_658_4609_4088_4089_2033_5933 14 2.59E-15 1.68E-13 2.80E-14 26243 hsa-mir-762 hsa05219 Bladder cancer 5595_5594_595_4193_1870_1871_7157_4609_1869_1029_5925 11 2.47E-14 1.61E-12 2.29E-13 26244 hsa-mir-762 hsa05222 Small cell lung cancer 6256_595_51588_5970_1870_1871_7157_4609_1869_5925_4846_7189 12 1.22E-12 7.91E-11 9.89E-12 26245 hsa-mir-762 hsa05214 Glioma 6464_5595_5594_595_4193_1870_1871_7157_1869_1029_5925 11 1.64E-12 1.07E-10 1.18E-11 26246 hsa-mir-762 hsa04330 Notch signaling pathway 1387_1488_1487_9612_3066_3065_2033_2648_8850_4851 10 2.31E-12 1.50E-10 1.50E-11 26247 hsa-mir-762 hsa05218 Melanoma 5595_5594_595_4193_1870_1871_7157_1869_1029_5925_4286 11 3.88E-12 2.52E-10 2.29E-11 26248 hsa-mir-762 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_7157_1869_1029_5925 10 7.81E-12 5.07E-10 4.23E-11 26249 hsa-mir-762 hsa05210 Colorectal cancer 7046_5595_5594_595_836_7157_4087_4609_3725_4088_4089 11 2.02E-11 1.31E-09 1.01E-10 26250 hsa-mir-762 hsa04310 Wnt signaling pathway 1387_595_1488_1487_7157_4087_8061_4609_3725_1457_4088_4089_2033 13 4.06E-11 2.64E-09 1.89E-10 26251 hsa-mir-762 hsa04010 MAPK signaling pathway 7046_5595_5594_4208_836_3312_1386_5970_7157_468_4609_3725_3727_4763_1616_7189 16 4.54E-11 2.95E-09 1.97E-10 26252 hsa-mir-762 hsa05221 Acute myeloid leukemia 5371_5595_5594_861_5914_595_7704_5970_4609 9 4.17E-10 2.71E-08 1.70E-09 26253 hsa-mir-762 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2113_3725_2034_2033 9 2.06E-09 1.34E-07 7.88E-09 26254 hsa-mir-762 hsa04620 Toll-like receptor signaling pathway 3654_5595_5594_353376_3661_148022_5970_3725_4615_7189 10 2.25E-09 1.46E-07 8.14E-09 26255 hsa-mir-762 hsa04520 Adherens junction 7046_5595_5594_1387_4087_1457_4088_4089_2033 9 4.81E-09 3.13E-07 1.65E-08 26256 hsa-mir-762 hsa05016 Huntington's disease 6874_1387_2902_6908_836_6667_1385_7157_3066_3065_3064_2033 12 5.28E-09 3.43E-07 1.72E-08 26257 hsa-mir-762 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609 6 7.52E-08 4.89E-06 2.33E-07 26258 hsa-mir-762 hsa04115 p53 signaling pathway 595_983_836_4193_7157_1029 6 7.59E-06 0.000493396 2.24E-05 26259 hsa-mir-762 hsa04720 Long-term potentiation 5595_5594_1387_2902_468_2033 6 1.19E-05 0.000771027 3.35E-05 26260 hsa-mir-762 hsa05010 Alzheimer's disease 22926_5595_5594_823_2902_836_9451_4846 8 2.23E-05 0.001446836 6.03E-05 26261 hsa-mir-762 hsa05213 Endometrial cancer 5595_5594_595_7157_4609 5 2.86E-05 0.001858914 7.39E-05 26262 hsa-mir-762 hsa04210 Apoptosis 3654_823_836_5970_7157_4615 6 2.96E-05 0.00192125 7.39E-05 26263 hsa-mir-762 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_836_7157_1616_4846 5 3.98E-05 0.002588558 9.59E-05 26264 hsa-mir-762 hsa04916 Melanogenesis 5595_5594_1387_1385_2033_4286 6 6.74E-05 0.004383472 0.000156553 26265 hsa-mir-762 hsa04012 ErbB signaling pathway 6464_5595_5594_4609_3725 5 0.000281744 0.018313333 0.000631494 26266 hsa-mir-762 hsa04120 Ubiquitin mediated proteolysis 5371_672_4193_51588_7428_7189 6 0.000305876 0.01988195 0.000652818 26267 hsa-mir-762 hsa04612 Antigen processing and presentation 4800_4801_1385_3312_1514 5 0.000311344 0.020237355 0.000652818 26268 hsa-mir-762 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725 4 0.001520868 0.098856405 0.003089263 26269 hsa-mir-762 hsa03022 Basal transcription factors 2969_6874_6908 3 0.001982245 0.128845954 0.003904423 26270 hsa-mir-762 hsa04630 Jak-STAT signaling pathway 1387_595_51588_4609_2033 5 0.003348275 0.2176379 0.006401115 26271 hsa-mir-762 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.004916439 0.319568551 0.00913053 26272 hsa-mir-762 hsa04912 GnRH signaling pathway 5595_5594_468_3725 4 0.005364917 0.34871962 0.009686656 26273 hsa-mir-762 hsa04660 T cell receptor signaling pathway 5595_5594_5970_3725 4 0.005709113 0.371092315 0.010029522 26274 hsa-mir-762 hsa04510 Focal adhesion 6464_5595_5594_595_3725 5 0.010538984 0.685033948 0.018027209 26275 hsa-mir-762 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_5970_3725 3 0.01114724 0.724570603 0.018114265 26276 hsa-mir-762 hsa04730 Long-term depression 5595_5594_4846 3 0.01114724 0.724570603 0.018114265 26277 hsa-mir-762 hsa04910 Insulin signaling pathway 6720_6464_5595_5594 4 0.012152329 0.789901365 0.018807175 26278 hsa-mir-762 hsa04650 Natural killer cell mediated cytotoxicity 6464_5595_5594_836 4 0.012152329 0.789901365 0.018807175 26279 hsa-mir-762 hsa04370 VEGF signaling pathway 5595_5594_4846 3 0.013751397 0.893840831 0.020786996 26280 hsa-mir-762 hsa04540 Gap junction 5595_5594_983 3 0.022255985 1 0.03287816 26281 hsa-mir-762 hsa04930 Type II diabetes mellitus 5595_5594 2 0.034722181 1 0.049632273 26282 hsa-mir-762 hsa04062 Chemokine signaling pathway 6464_5595_5594_5970 4 0.035124378 1 0.049632273 26283 hsa-mir-765 hsa04920 Adipocytokine signaling pathway 1147_3551_4790_8517_4794_4792_4793_5599_5970 9 5.48E-14 2.41E-12 1.65E-12 26284 hsa-mir-765 hsa04660 T cell receptor signaling pathway 1326_1147_3551_4790_8517_4794_9020_4792_4793_5970 10 7.49E-14 3.30E-12 1.65E-12 26285 hsa-mir-765 hsa04620 Toll-like receptor signaling pathway 1326_1147_3551_4790_8517_9641_4792_5599_5970 9 1.84E-12 8.08E-11 2.69E-11 26286 hsa-mir-765 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_3551_4790_8517_9020_4792_5599_5970 8 5.44E-12 2.40E-10 5.99E-11 26287 hsa-mir-765 hsa04662 B cell receptor signaling pathway 1147_3551_4790_8517_4794_4792_4793_5970 8 8.18E-12 3.60E-10 7.20E-11 26288 hsa-mir-765 hsa04010 MAPK signaling pathway 1326_1147_3312_3551_4790_4791_8517_9020_5599_5971_5970 11 1.76E-11 7.73E-10 1.29E-10 26289 hsa-mir-765 hsa03020 RNA polymerase 25885_5437_51082_84172_64425_5441 6 1.03E-10 4.52E-09 6.45E-10 26290 hsa-mir-765 hsa05222 Small cell lung cancer 1147_3551_4790_8517_898_4792_5970 7 1.04E-09 4.55E-08 5.18E-09 26291 hsa-mir-765 hsa05215 Prostate cancer 1147_3551_4790_8517_898_4792_5970 7 1.20E-09 5.30E-08 5.18E-09 26292 hsa-mir-765 hsa04210 Apoptosis 1147_3551_4790_8517_9020_4792_5970 7 1.30E-09 5.70E-08 5.18E-09 26293 hsa-mir-765 hsa05212 Pancreatic cancer 1147_3551_4790_8517_898_4792_5970 7 1.30E-09 5.70E-08 5.18E-09 26294 hsa-mir-765 hsa05220 Chronic myeloid leukemia 1147_3551_4790_8517_4792_5970 6 1.90E-08 8.38E-07 6.98E-08 26295 hsa-mir-765 hsa05200 Pathways in cancer 1147_3551_4790_4791_8517_898_4792_5599_5970 9 3.86E-08 1.70E-06 1.31E-07 26296 hsa-mir-765 hsa04062 Chemokine signaling pathway 1147_3551_4790_8517_4792_4793_5970 7 2.10E-07 9.22E-06 6.59E-07 26297 hsa-mir-765 hsa05221 Acute myeloid leukemia 1147_3551_4790_8517_5970 5 2.38E-07 1.05E-05 6.99E-07 26298 hsa-mir-765 hsa04910 Insulin signaling pathway 801_3551_5599_808_805 5 1.28E-05 0.000562313 3.51E-05 26299 hsa-mir-765 hsa03022 Basal transcription factors 2969_6908_2959 3 8.20E-05 0.003607255 0.000212191 26300 hsa-mir-765 hsa04912 GnRH signaling pathway 801_5599_808_805 4 9.18E-05 0.004038475 0.00022436 26301 hsa-mir-765 hsa04120 Ubiquitin mediated proteolysis 8454_55294_6500_23291 4 0.000235138 0.010346062 0.00054453 26302 hsa-mir-765 hsa04310 Wnt signaling pathway 8454_5599_6500_23291 4 0.00032749 0.014409576 0.000720479 26303 hsa-mir-765 hsa05214 Glioma 801_808_805 3 0.000398836 0.017548795 0.000835657 26304 hsa-mir-765 hsa04720 Long-term potentiation 801_808_805 3 0.000596477 0.026244977 0.001184363 26305 hsa-mir-765 hsa04070 Phosphatidylinositol signaling system 801_808_805 3 0.000619099 0.027240352 0.001184363 26306 hsa-mir-765 hsa05016 Huntington's disease 6908_5437_6667_5441 4 0.000715614 0.031487027 0.001311959 26307 hsa-mir-765 hsa04350 TGF-beta signaling pathway 6667_8454_6500 3 0.000904794 0.039810917 0.001592437 26308 hsa-mir-765 hsa03010 Ribosome 6128_6207_6156 3 0.0014119 0.062123614 0.00238937 26309 hsa-mir-765 hsa04916 Melanogenesis 801_808_805 3 0.0014905 0.065581996 0.002428963 26310 hsa-mir-765 hsa04270 Vascular smooth muscle contraction 801_808_805 3 0.00211804 0.093193766 0.003289705 26311 hsa-mir-765 hsa04110 Cell cycle 898_8454_6500 3 0.002168215 0.095401443 0.003289705 26312 hsa-mir-765 hsa04930 Type II diabetes mellitus 3551_5599 2 0.004396796 0.193459008 0.006448634 26313 hsa-mir-765 hsa05010 Alzheimer's disease 801_808_805 3 0.006441875 0.28344251 0.009143307 26314 hsa-mir-765 hsa04020 Calcium signaling pathway 801_808_805 3 0.00715323 0.314742111 0.009835691 26315 hsa-mir-765 hsa04740 Olfactory transduction 801_808_805 3 0.048310333 1 0.064413777 26316 hsa-mir-767 hsa05200 Pathways in cancer 4087_4088_4089_5881_1050_836_2033_367_1499_6774_2353_1387 12 1.25E-14 5.73E-13 5.73E-13 26317 hsa-mir-767 hsa04520 Adherens junction 4087_4088_4089_5881_2033_1499_6714_1387 8 2.24E-13 1.03E-11 5.14E-12 26318 hsa-mir-767 hsa05210 Colorectal cancer 4087_4088_4089_5881_836_1499_2353 7 2.63E-11 1.21E-09 4.03E-10 26319 hsa-mir-767 hsa04310 Wnt signaling pathway 4087_4088_4089_5881_2033_1499_1387 7 1.36E-09 6.25E-08 1.56E-08 26320 hsa-mir-767 hsa04350 TGF-beta signaling pathway 4087_4088_4089_2033_1387 5 1.28E-07 5.89E-06 1.18E-06 26321 hsa-mir-767 hsa04110 Cell cycle 4087_4088_4089_2033_1387 5 5.69E-07 2.62E-05 4.36E-06 26322 hsa-mir-767 hsa05215 Prostate cancer 2033_367_1499_1387 4 6.24E-06 0.00028713 3.75E-05 26323 hsa-mir-767 hsa05212 Pancreatic cancer 2033_367_1499_1387 4 6.52E-06 0.000299755 3.75E-05 26324 hsa-mir-767 hsa04010 MAPK signaling pathway 5881_836_1432_5598_2353 5 2.91E-05 0.001340653 0.000148961 26325 hsa-mir-767 hsa04330 Notch signaling pathway 2033_8850_1387 3 3.80E-05 0.001748671 0.000174867 26326 hsa-mir-767 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_6714_1432 3 0.000123048 0.005660212 0.000514565 26327 hsa-mir-767 hsa04370 VEGF signaling pathway 5881_6714_1432 3 0.000155118 0.007135424 0.000594619 26328 hsa-mir-767 hsa04916 Melanogenesis 2033_1499_1387 3 0.000365777 0.016825735 0.001294287 26329 hsa-mir-767 hsa04912 GnRH signaling pathway 6714_1432_5598 3 0.000407308 0.018736162 0.001338297 26330 hsa-mir-767 hsa04950 Maturity onset diabetes of the young 6928_3172 2 0.000523383 0.024075624 0.001605042 26331 hsa-mir-767 hsa04630 Jak-STAT signaling pathway 2033_6774_1387 3 0.001135503 0.052233137 0.003264571 26332 hsa-mir-767 hsa05010 Alzheimer's disease 836_1020_840 3 0.001650097 0.075904473 0.004464969 26333 hsa-mir-767 hsa05016 Huntington's disease 836_2033_1387 3 0.001954087 0.089888003 0.004993778 26334 hsa-mir-767 hsa04510 Focal adhesion 5881_1499_6714 3 0.002522862 0.116051634 0.005964239 26335 hsa-mir-767 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432 2 0.002593147 0.119284774 0.005964239 26336 hsa-mir-767 hsa05221 Acute myeloid leukemia 1050_6774 2 0.002863781 0.131733935 0.006273045 26337 hsa-mir-767 hsa05211 Renal cell carcinoma 2033_1387 2 0.004182142 0.192378517 0.008315763 26338 hsa-mir-767 hsa04720 Long-term potentiation 2033_1387 2 0.004519436 0.207894064 0.008315763 26339 hsa-mir-767 hsa05220 Chronic myeloid leukemia 4088_4089 2 0.004519436 0.207894064 0.008315763 26340 hsa-mir-767 hsa04662 B cell receptor signaling pathway 5881_2353 2 0.004519436 0.207894064 0.008315763 26341 hsa-mir-767 hsa04664 Fc epsilon RI signaling pathway 5881_1432 2 0.004988114 0.229453251 0.008825125 26342 hsa-mir-767 hsa04210 Apoptosis 836_840 2 0.006253179 0.28764624 0.010653564 26343 hsa-mir-767 hsa04540 Gap junction 6714_5598 2 0.00679597 0.312614628 0.011164808 26344 hsa-mir-767 hsa04620 Toll-like receptor signaling pathway 1432_2353 2 0.008092526 0.372256178 0.01283642 26345 hsa-mir-767 hsa04660 T cell receptor signaling pathway 1432_2353 2 0.009330911 0.429221901 0.014307397 26346 hsa-mir-767 hsa04670 Leukocyte transendothelial migration 1499_1432 2 0.011336202 0.521465301 0.016821461 26347 hsa-mir-767 hsa04360 Axon guidance 5881_1020 2 0.012953508 0.595861377 0.018620668 26348 hsa-mir-767 hsa04530 Tight junction 1499_6714 2 0.01408438 0.647881463 0.0193158 26349 hsa-mir-767 hsa04650 Natural killer cell mediated cytotoxicity 5881_836 2 0.014276895 0.656737184 0.0193158 26350 hsa-mir-767 hsa05216 Thyroid cancer 1499 1 0.038243049 1 0.050262293 26351 hsa-mir-769 hsa04010 MAPK signaling pathway 9261_6722_6195_6196_6197_207_9252_1432_8986 9 5.11E-08 3.01E-06 3.01E-06 26352 hsa-mir-769 hsa04720 Long-term potentiation 1387_6195_6196_6197_2033 5 2.13E-06 0.000125458 6.27E-05 26353 hsa-mir-769 hsa04150 mTOR signaling pathway 6195_6196_6197_207 4 1.39E-05 0.00081842 0.000272807 26354 hsa-mir-769 hsa05200 Pathways in cancer 2736_1387_1487_4286_2033_207_2932 7 2.89E-05 0.001704952 0.000426238 26355 hsa-mir-769 hsa04310 Wnt signaling pathway 1387_1487_2033_1460_2932 5 5.64E-05 0.003330227 0.000666045 26356 hsa-mir-769 hsa05215 Prostate cancer 1387_2033_207_2932 4 9.83E-05 0.005801378 0.00086432 26357 hsa-mir-769 hsa05212 Pancreatic cancer 1387_2033_207_2932 4 0.000102546 0.00605024 0.00086432 26358 hsa-mir-769 hsa05016 Huntington's disease 1387_3064_6908_2033_4716 5 0.000149168 0.008800892 0.001100112 26359 hsa-mir-769 hsa04916 Melanogenesis 1387_4286_2033_2932 4 0.000182769 0.010783367 0.001198152 26360 hsa-mir-769 hsa04660 T cell receptor signaling pathway 1739_207_2932_1432 4 0.000224916 0.013270053 0.001327005 26361 hsa-mir-769 hsa04330 Notch signaling pathway 1387_1487_2033 3 0.00030118 0.017769628 0.001615421 26362 hsa-mir-769 hsa05211 Renal cell carcinoma 1387_2033_207 3 0.000990443 0.058436136 0.004869678 26363 hsa-mir-769 hsa04370 VEGF signaling pathway 9261_207_1432 3 0.001193962 0.070443758 0.005418751 26364 hsa-mir-769 hsa04520 Adherens junction 1387_2033_1460 3 0.00132781 0.078340786 0.00559577 26365 hsa-mir-769 hsa04350 TGF-beta signaling pathway 1387_2033_659 3 0.001675833 0.098874142 0.006591609 26366 hsa-mir-769 hsa04110 Cell cycle 1387_2033_2932 3 0.003969142 0.234179396 0.014636212 26367 hsa-mir-769 hsa03022 Basal transcription factors 2963_6908 2 0.004622943 0.272753654 0.016044333 26368 hsa-mir-769 hsa04530 Tight junction 1460_207_10207 3 0.005820352 0.34340076 0.01907782 26369 hsa-mir-769 hsa04630 Jak-STAT signaling pathway 1387_2033_207 3 0.008113236 0.478680935 0.025193733 26370 hsa-mir-769 hsa05213 Endometrial cancer 207_2932 2 0.008706576 0.513687963 0.025684398 26371 hsa-mir-769 hsa05217 Basal cell carcinoma 2736_2932 2 0.009661974 0.570056481 0.027145547 26372 hsa-mir-769 hsa04340 Hedgehog signaling pathway 2736_2932 2 0.010323664 0.609096178 0.02768619 26373 hsa-mir-769 hsa05218 Melanoma 4286_207 2 0.015491055 0.913972234 0.038984067 26374 hsa-mir-769 hsa05220 Chronic myeloid leukemia 1487_207 2 0.017133309 1 0.038984067 26375 hsa-mir-769 hsa04662 B cell receptor signaling pathway 207_2932 2 0.017133309 1 0.038984067 26376 hsa-mir-769 hsa04510 Focal adhesion 207_2932_1729 3 0.017179419 1 0.038984067 26377 hsa-mir-769 hsa04664 Fc epsilon RI signaling pathway 207_1432 2 0.018846274 1 0.041182598 26378 hsa-mir-769 hsa05210 Colorectal cancer 207_2932 2 0.021084485 1 0.044428022 26379 hsa-mir-769 hsa04012 ErbB signaling pathway 207_2932 2 0.02247797 1 0.045731042 26380 hsa-mir-769 hsa04620 Toll-like receptor signaling pathway 207_1432 2 0.029989424 1 0.0589792 26381 hsa-mir-769 hsa04360 Axon guidance 2932_5998 2 0.046855452 1 0.089176506 26382 hsa-mir-770 hsa05200 Pathways in cancer 4149_3551_1499_1019_1017_4193_6934_5578_6502_3091_4087_3066_3065_1050_5925_7184_1487_1488_1870_1871_2113_10401_5894_861_207_5602_1147_5595_5594_5599_6258_1387_6257_6256_367_25_2932_6774_6772_5970_7157_6688_3725_2736_4088_4089_5881_2033_3320_5371_8031_5604_5601_4292_4609_1029_2353_3326_8554 59 2.08E-33 1.61E-31 1.61E-31 26383 hsa-mir-770 hsa03022 Basal transcription factors 54457_2958_6883_6881_2960_2957_6879_2967_2961_2963_2962_2969_2968_6878_6877_6874_6873_6872_138474_6908_6884_6882_2959_6880 24 5.77E-25 4.45E-23 2.22E-23 26384 hsa-mir-770 hsa04110 Cell cycle 4171_1019_1017_4193_6502_6500_4087_3066_3065_4616_5925_1870_1871_5933_990_7534_5591_1387_7533_7532_25_2932_7157_10912_4085_4088_4089_2033_983_8454_1029_1028 32 2.63E-23 2.03E-21 6.75E-22 26385 hsa-mir-770 hsa04010 MAPK signaling pathway 6722_3727_4149_3551_6195_6197_9252_5578_4773_4616_8986_1432_4342_5894_207_5602_1147_5595_5594_5599_5598_1386_3312_1649_5970_7157_10912_468_3725_6196_5881_5058_9261_5604_5601_5600_5603_4609_2353_8550 40 2.90E-20 2.23E-18 5.58E-19 26386 hsa-mir-770 hsa05215 Prostate cancer 3551_1499_1017_4193_6934_5925_7184_1870_1871_5894_207_9586_1147_5595_5594_1385_1387_367_2932_5970_7157_468_2033_3320_5604_3326 26 4.84E-20 3.73E-18 7.46E-19 26387 hsa-mir-770 hsa05212 Pancreatic cancer 3551_1499_1017_4193_6934_5925_7184_1870_1871_5894_207_9586_1147_5595_5594_1385_1387_367_2932_5970_7157_468_2033_3320_5604_3326 26 6.14E-20 4.73E-18 7.88E-19 26388 hsa-mir-770 hsa05220 Chronic myeloid leukemia 3551_1019_4193_3066_3065_5925_1487_1488_1870_1871_5894_861_207_1147_5595_5594_25_5970_7157_4088_4089_5604_4609_1029 24 2.85E-19 2.19E-17 3.13E-18 26389 hsa-mir-770 hsa04310 Wnt signaling pathway 1499_6934_5578_6500_4087_4773_1487_1488_8607_5602_1460_5599_1387_2932_7157_8061_3725_1457_1459_4088_4089_5881_2033_5601_8454_4609 26 4.94E-15 3.80E-13 4.75E-14 26390 hsa-mir-770 hsa05210 Colorectal cancer 1499_6934_4087_5894_207_5602_5595_5594_5599_2932_7157_3725_4088_4089_5881_5604_5601_4292_4609_2353 20 3.29E-14 2.53E-12 2.81E-13 26391 hsa-mir-770 hsa05222 Small cell lung cancer 4149_3551_1019_1017_6502_5925_1870_1871_10401_207_1147_6258_6257_6256_5970_7157_4609_8554 18 4.16E-12 3.21E-10 3.21E-11 26392 hsa-mir-770 hsa05214 Glioma 1019_4193_5578_5925_1870_1871_5894_207_5595_5594_7157_808_801_805_5604_1029 16 7.91E-12 6.09E-10 5.28E-11 26393 hsa-mir-770 hsa05223 Non-small cell lung cancer 1019_5578_5925_1870_1871_5894_207_5595_5594_6258_6257_6256_7157_5604_1029 15 8.23E-12 6.34E-10 5.28E-11 26394 hsa-mir-770 hsa05221 Acute myeloid leukemia 3551_6934_1050_5894_861_207_1147_5595_5594_6774_5970_6688_5371_5604_4609 15 2.41E-11 1.86E-09 1.43E-10 26395 hsa-mir-770 hsa04350 TGF-beta signaling pathway 6667_6500_4087_3397_3399_3398_5933_3400_5595_5594_1387_4088_4089_2033_8454_4609_4092 17 4.25E-11 3.27E-09 2.34E-10 26396 hsa-mir-770 hsa05219 Bladder cancer 1019_9252_4193_5925_1870_1871_5894_5595_5594_7157_5604_4609_1029 13 6.60E-11 5.08E-09 3.39E-10 26397 hsa-mir-770 hsa04912 GnRH signaling pathway 5578_6714_1432_5894_5602_5595_5594_5599_5598_468_3725_808_801_805_5604_5601_5600_5603 18 1.15E-10 8.89E-09 5.56E-10 26398 hsa-mir-770 hsa04660 T cell receptor signaling pathway 3551_1019_4773_1432_5894_207_1147_5595_5594_2932_5970_3725_5058_5604_5601_5600_5603_2353 18 1.51E-10 1.16E-08 6.83E-10 26399 hsa-mir-770 hsa05216 Thyroid cancer 1499_6934_5595_5594_6258_6257_6256_7157_8031_5604_4609 11 3.33E-10 2.56E-08 1.42E-09 26400 hsa-mir-770 hsa04012 ErbB signaling pathway 5578_6714_5894_207_5602_5595_5594_5599_25_2932_3725_5058_5604_5601_4609 15 2.72E-09 2.09E-07 1.05E-08 26401 hsa-mir-770 hsa04620 Toll-like receptor signaling pathway 3551_1432_207_5602_1147_5595_5594_5599_6772_5970_3725_5604_5601_5600_5603_2353 16 2.72E-09 2.10E-07 1.05E-08 26402 hsa-mir-770 hsa04720 Long-term potentiation 6195_6197_5578_5894_5595_5594_1387_468_6196_2033_808_801_805_5604 14 3.73E-09 2.88E-07 1.37E-08 26403 hsa-mir-770 hsa04540 Gap junction 5578_10382_51807_6714_5894_5592_5595_5594_5598_7846_983_5604_7277_7278_10376 15 6.09E-09 4.69E-07 2.13E-08 26404 hsa-mir-770 hsa04520 Adherens junction 1499_6934_4087_6714_1460_5595_5594_1387_1457_1459_4088_4089_5881_2033 14 7.76E-09 5.98E-07 2.60E-08 26405 hsa-mir-770 hsa04920 Adipocytokine signaling pathway 3551_10891_2538_207_5602_1147_5599_6258_6257_6256_6774_5970_5601 13 8.97E-09 6.90E-07 2.88E-08 26406 hsa-mir-770 hsa04910 Insulin signaling pathway 6720_3551_10891_2538_5894_5211_207_5602_5595_5594_5599_2932_808_801_805_5604_5601 17 2.29E-08 1.76E-06 7.05E-08 26407 hsa-mir-770 hsa04662 B cell receptor signaling pathway 3551_4773_5894_207_1147_5595_5594_2932_5970_3725_5881_5604_2353 13 2.94E-08 2.26E-06 8.71E-08 26408 hsa-mir-770 hsa04370 VEGF signaling pathway 5578_4773_6714_1432_5894_207_5595_5594_5881_9261_5604_5600_5603 13 3.88E-08 2.99E-06 1.11E-07 26409 hsa-mir-770 hsa04664 Fc epsilon RI signaling pathway 5578_1432_5894_207_5602_5595_5594_5599_5881_5604_5601_5600_5603 13 5.07E-08 3.91E-06 1.40E-07 26410 hsa-mir-770 hsa05213 Endometrial cancer 1499_6934_5894_207_5595_5594_2932_7157_5604_4292_4609 11 5.78E-08 4.45E-06 1.54E-07 26411 hsa-mir-770 hsa05131 Shigellosis 1499_5578_10382_51807_7534_25_7846_7277_7278_4691_10376 11 1.12E-07 8.63E-06 2.78E-07 26412 hsa-mir-770 hsa05130 Pathogenic Escherichia coli infection 1499_5578_10382_51807_7534_25_7846_7277_7278_4691_10376 11 1.12E-07 8.63E-06 2.78E-07 26413 hsa-mir-770 hsa05218 Melanoma 1019_4193_5925_1870_1871_5894_207_5595_5594_7157_5604_1029 12 1.28E-07 9.85E-06 2.98E-07 26414 hsa-mir-770 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3551_6714_1432_5602_1147_5599_5970_3725_5058_5601_5600_5603 12 1.28E-07 9.85E-06 2.98E-07 26415 hsa-mir-770 hsa04916 Melanogenesis 1499_6934_5578_5894_5595_5594_1385_1387_2932_2033_808_801_805_5604 14 1.48E-07 1.14E-05 3.35E-07 26416 hsa-mir-770 hsa04330 Notch signaling pathway 3066_3065_1487_1488_1387_9612_2033_8850_2648_4851 10 2.22E-07 1.71E-05 4.88E-07 26417 hsa-mir-770 hsa05211 Renal cell carcinoma 3091_2113_5894_207_5595_5594_1387_3725_5058_2033_5604 11 1.05E-06 8.06E-05 2.24E-06 26418 hsa-mir-770 hsa04950 Maturity onset diabetes of the young 3651_6928_3087_4760_168620_5080_3172 7 2.53E-06 0.00019451 5.26E-06 26419 hsa-mir-770 hsa04115 p53 signaling pathway 1019_1017_4193_4616_7157_10912_64326_983_7161_1029 10 4.94E-06 0.000380583 1.00E-05 26420 hsa-mir-770 hsa04120 Ubiquitin mediated proteolysis 4193_55294_6502_6500_10401_7329_83737_997_64326_5371_672_8454_8554 13 1.62E-05 0.001250901 3.21E-05 26421 hsa-mir-770 hsa04510 Focal adhesion 1499_5578_6714_5894_207_5602_5595_5594_5599_2932_3725_5881_5058_5604_5601 15 5.74E-05 0.004418999 0.000110475 26422 hsa-mir-770 hsa05016 Huntington's disease 6667_10891_3066_3065_3064_9586_1385_1387_9001_5430_7157_2033_6874_6908 14 8.04E-05 0.006188518 0.000150939 26423 hsa-mir-770 hsa04930 Type II diabetes mellitus 3551_3651_5602_5595_5594_5599_5601 7 8.86E-05 0.006818766 0.000162352 26424 hsa-mir-770 hsa04150 mTOR signaling pathway 6195_6197_3091_207_5595_5594_6196 7 0.000199555 0.015365754 0.000357343 26425 hsa-mir-770 hsa04062 Chemokine signaling pathway 3551_7074_5894_207_1147_5595_5594_2932_6774_6772_5970_5058_5604 13 0.000357616 0.027536409 0.000625827 26426 hsa-mir-770 hsa04270 Vascular smooth muscle contraction 5578_5894_5592_5595_5594_808_801_805_5604 9 0.001257843 0.096853916 0.002152309 26427 hsa-mir-770 hsa04612 Antigen processing and presentation 4801_1385_3312_3320_4800_4802_3326 7 0.003644344 0.280614504 0.006100315 26428 hsa-mir-770 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 0.004549533 0.350314036 0.00745349 26429 hsa-mir-770 hsa04730 Long-term depression 5578_5894_5592_5595_5594_5604 6 0.005026859 0.387068116 0.008063919 26430 hsa-mir-770 hsa04630 Jak-STAT signaling pathway 10401_207_1387_6774_6775_6772_2033_4609_8554 9 0.006933751 0.533898796 0.010895894 26431 hsa-mir-770 hsa05217 Basal cell carcinoma 1499_6934_2932_7157_2736 5 0.007706023 0.593363757 0.011867275 26432 hsa-mir-770 hsa04530 Tight junction 1499_1019_5578_6714_207_1460_1457_1459 8 0.010293537 0.792602367 0.015541223 26433 hsa-mir-770 hsa04650 Natural killer cell mediated cytotoxicity 5578_4773_5894_5595_5594_5881_5058_5604 8 0.010701113 0.823985714 0.015845879 26434 hsa-mir-770 hsa03320 PPAR signaling pathway 2168_10062_6258_6257_6256 5 0.019001561 1 0.027606042 26435 hsa-mir-770 hsa04360 Axon guidance 4773_5595_5594_25_2932_5881_5058 7 0.023973954 1 0.034185082 26436 hsa-mir-770 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_7157_5600_5603 4 0.034637184 1 0.048492057 26437 hsa-mir-770 hsa04210 Apoptosis 3551_207_1147_5970_7157 5 0.044282354 1 0.060888237 26438 hsa-mir-802 hsa05200 Pathways in cancer 2249_1956_1499_5595_5594_5599_1387_6257_6256_8031_5601_2308_6258_367_5914_7704_841_6774_6777_6772_5970_6688_4609_3725_861_2353_6776_4088_4089_5881_1050_5925_2033_207_8554_4790 36 9.62E-27 6.64E-25 6.64E-25 26439 hsa-mir-802 hsa04010 MAPK signaling pathway 6722_2249_1956_5595_5594_5599_1386_5601_5566_9252_1649_5970_10912_468_4609_3725_6195_6196_2353_5881_4616_207_4790_2002 24 3.08E-16 2.13E-14 1.06E-14 26440 hsa-mir-802 hsa05221 Acute myeloid leukemia 5595_5594_5914_7704_6774_6777_5970_6688_4609_861_6776_1050_207_4790 14 3.00E-15 2.07E-13 6.91E-14 26441 hsa-mir-802 hsa05215 Prostate cancer 1956_1499_5595_5594_1385_1387_2308_367_5970_468_5925_2033_207_4790 14 3.85E-13 2.65E-11 6.09E-12 26442 hsa-mir-802 hsa05212 Pancreatic cancer 1956_1499_5595_5594_1385_1387_2308_367_5970_468_5925_2033_207_4790 14 4.42E-13 3.05E-11 6.09E-12 26443 hsa-mir-802 hsa05210 Colorectal cancer 1956_1499_5595_5594_5599_5601_4609_3725_2353_4088_4089_5881_207 13 3.70E-12 2.55E-10 4.25E-11 26444 hsa-mir-802 hsa04012 ErbB signaling pathway 815_1956_6714_5595_5594_5599_5601_6777_4609_3725_6776_207_2002 13 5.51E-12 3.80E-10 5.43E-11 26445 hsa-mir-802 hsa05220 Chronic myeloid leukemia 5595_5594_6777_5970_4609_861_6776_4088_4089_5925_207_4790 12 1.79E-11 1.23E-09 1.54E-10 26446 hsa-mir-802 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5601_841_6772_5970_3725_2353_6348_207_4790 12 4.50E-10 3.11E-08 3.45E-09 26447 hsa-mir-802 hsa05216 Thyroid cancer 1499_5595_5594_6257_6256_8031_6258_4609 8 1.05E-09 7.26E-08 7.26E-09 26448 hsa-mir-802 hsa04920 Adipocytokine signaling pathway 5599_6257_6256_5601_6258_6774_5970_10891_207_4790 10 1.63E-09 1.13E-07 1.02E-08 26449 hsa-mir-802 hsa04310 Wnt signaling pathway 815_1499_5599_1387_5601_5566_8061_4609_3725_4088_4089_5881_2033 13 3.09E-09 2.13E-07 1.78E-08 26450 hsa-mir-802 hsa04520 Adherens junction 1956_1499_6714_5595_5594_1387_4088_4089_5881_2033 10 7.69E-09 5.30E-07 4.08E-08 26451 hsa-mir-802 hsa04912 GnRH signaling pathway 815_1956_6714_5595_5594_5599_5601_5566_468_3725_2002 11 9.68E-09 6.68E-07 4.77E-08 26452 hsa-mir-802 hsa04720 Long-term potentiation 815_5595_5594_1387_5566_468_6195_6196_2033 9 6.03E-08 4.16E-06 2.78E-07 26453 hsa-mir-802 hsa05223 Non-small cell lung cancer 1956_5595_5594_6257_6256_6258_5925_207 8 7.61E-08 5.25E-06 3.28E-07 26454 hsa-mir-802 hsa05222 Small cell lung cancer 6257_6256_6258_5970_4609_5925_207_8554_4790 9 1.77E-07 1.22E-05 7.18E-07 26455 hsa-mir-802 hsa04630 Jak-STAT signaling pathway 1387_6778_6774_6777_6772_4609_6776_2033_3977_207_8554 11 3.00E-07 2.07E-05 1.15E-06 26456 hsa-mir-802 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725_2353_5881_207_4790 8 7.56E-07 5.22E-05 2.75E-06 26457 hsa-mir-802 hsa05213 Endometrial cancer 1956_1499_5595_5594_4609_207_2002 7 9.09E-07 6.27E-05 3.13E-06 26458 hsa-mir-802 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_4609_4088_4089_2033 8 2.13E-06 0.000146762 6.99E-06 26459 hsa-mir-802 hsa05219 Bladder cancer 1956_5595_5594_9252_4609_5925 6 4.09E-06 0.000282418 1.25E-05 26460 hsa-mir-802 hsa04510 Focal adhesion 1956_1499_6714_5595_5594_5599_5601_3725_5881_207_2002 11 4.17E-06 0.000287592 1.25E-05 26461 hsa-mir-802 hsa04950 Maturity onset diabetes of the young 3172_3651_6928_6927_5080 5 5.23E-06 0.000360997 1.50E-05 26462 hsa-mir-802 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_5599_5601_5970_3725_4790 7 6.10E-06 0.000420737 1.68E-05 26463 hsa-mir-802 hsa04910 Insulin signaling pathway 5595_5594_5599_5601_2308_5566_10891_207_2002 9 6.95E-06 0.000479295 1.84E-05 26464 hsa-mir-802 hsa04916 Melanogenesis 815_1499_5595_5594_1385_1387_5566_2033 8 7.31E-06 0.000504414 1.87E-05 26465 hsa-mir-802 hsa04660 T cell receptor signaling pathway 5595_5594_5601_5970_3725_2353_207_4790 8 1.07E-05 0.000741399 2.65E-05 26466 hsa-mir-802 hsa04062 Chemokine signaling pathway 5595_5594_5566_6774_6777_6772_5970_6348_207_4790 10 1.47E-05 0.001011274 3.49E-05 26467 hsa-mir-802 hsa05214 Glioma 815_1956_5595_5594_5925_207 6 4.03E-05 0.002780483 9.27E-05 26468 hsa-mir-802 hsa05218 Melanoma 2249_1956_5595_5594_5925_207 6 6.38E-05 0.004403603 0.000142052 26469 hsa-mir-802 hsa05211 Renal cell carcinoma 5595_5594_1387_3725_2033_207 6 6.86E-05 0.004735508 0.000147985 26470 hsa-mir-802 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601_3651 5 8.02E-05 0.005534328 0.000167707 26471 hsa-mir-802 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5601_5881_207 6 0.000110983 0.007657812 0.00022523 26472 hsa-mir-802 hsa04110 Cell cycle 1387_10912_4088_4089_5925_2033_4616 7 0.000135934 0.009379453 0.000267984 26473 hsa-mir-802 hsa04150 mTOR signaling pathway 5595_5594_6195_6196_207 5 0.000150713 0.010399223 0.000288867 26474 hsa-mir-802 hsa05016 Huntington's disease 1385_1387_6908_6667_841_10891_10476_2033 8 0.000380129 0.026228875 0.000708889 26475 hsa-mir-802 hsa04370 VEGF signaling pathway 6714_5595_5594_5881_207 5 0.000820767 0.056632916 0.00149034 26476 hsa-mir-802 hsa04330 Notch signaling pathway 1387_9612_2033_8850 4 0.001083042 0.074729883 0.001916151 26477 hsa-mir-802 hsa04210 Apoptosis 5566_841_5970_207_4790 5 0.001515379 0.104561178 0.002614029 26478 hsa-mir-802 hsa04540 Gap junction 1956_6714_5595_5594_5566 5 0.001822037 0.125720548 0.003066355 26479 hsa-mir-802 hsa04115 p53 signaling pathway 841_10912_64326_4616 4 0.00405366 0.279702534 0.006659584 26480 hsa-mir-802 hsa03320 PPAR signaling pathway 6257_6256_6258_2168 4 0.004255974 0.293662222 0.006829354 26481 hsa-mir-802 hsa03022 Basal transcription factors 6908_2959_6880 3 0.005324907 0.367418584 0.008350422 26482 hsa-mir-802 hsa04530 Tight junction 1499_6714_4628_60412_207 5 0.0087957 0.60690328 0.01348674 26483 hsa-mir-802 hsa04810 Regulation of actin cytoskeleton 2249_1956_5595_5594_4628_5881 6 0.015418931 1 0.023128396 26484 hsa-mir-802 hsa03410 Base excision repair 3146_142 2 0.044559299 1 0.065416844 26485 hsa-mir-874 hsa04110 Cell cycle 595_4087_10971_894_5925_2033_896_7534_1387 9 2.06E-11 9.05E-10 6.38E-10 26486 hsa-mir-874 hsa05200 Pathways in cancer 595_2113_4087_5925_2033_367_7046_3725_6772_861_2353_1387 12 2.90E-11 1.28E-09 6.38E-10 26487 hsa-mir-874 hsa04310 Wnt signaling pathway 595_4087_894_2033_896_3725_1452_1387 8 4.31E-09 1.90E-07 6.33E-08 26488 hsa-mir-874 hsa04350 TGF-beta signaling pathway 3399_4087_3398_2033_7046_1387 6 9.05E-08 3.98E-06 9.96E-07 26489 hsa-mir-874 hsa04520 Adherens junction 4301_4087_2033_7046_1387 5 1.80E-06 7.92E-05 1.45E-05 26490 hsa-mir-874 hsa05210 Colorectal cancer 595_4087_7046_3725_2353 5 2.26E-06 9.96E-05 1.45E-05 26491 hsa-mir-874 hsa04630 Jak-STAT signaling pathway 595_894_2033_896_6772_1387 6 2.30E-06 0.000101402 1.45E-05 26492 hsa-mir-874 hsa05215 Prostate cancer 595_5925_2033_367_1387 5 2.81E-06 0.00012374 1.45E-05 26493 hsa-mir-874 hsa05212 Pancreatic cancer 595_5925_2033_367_1387 5 2.96E-06 0.000130453 1.45E-05 26494 hsa-mir-874 hsa05211 Renal cell carcinoma 2113_2033_3725_1387 4 3.22E-05 0.001416387 0.000141639 26495 hsa-mir-874 hsa05220 Chronic myeloid leukemia 595_5925_7046_861 4 3.75E-05 0.001649916 0.000149992 26496 hsa-mir-874 hsa04620 Toll-like receptor signaling pathway 3725_1432_6772_2353 4 0.000118172 0.005199582 0.000433299 26497 hsa-mir-874 hsa04330 Notch signaling pathway 9612_2033_1387 3 0.000228286 0.010044601 0.000772662 26498 hsa-mir-874 hsa04010 MAPK signaling pathway 1616_7046_3725_1432_2353 5 0.000515489 0.022681502 0.001620107 26499 hsa-mir-874 hsa04115 p53 signaling pathway 595_894_896 3 0.000669305 0.02944944 0.001963296 26500 hsa-mir-874 hsa05016 Huntington's disease 6908_2033_25942_1387 4 0.00112082 0.049316086 0.003082255 26501 hsa-mir-874 hsa04510 Focal adhesion 595_894_896_3725 4 0.001558029 0.068553255 0.004032544 26502 hsa-mir-874 hsa04660 T cell receptor signaling pathway 3725_1432_2353 3 0.002452266 0.107899719 0.005994429 26503 hsa-mir-874 hsa05219 Bladder cancer 595_5925 2 0.004876818 0.214579984 0.011293683 26504 hsa-mir-874 hsa05223 Non-small cell lung cancer 595_5925 2 0.00779563 0.343007725 0.015959182 26505 hsa-mir-874 hsa05014 Amyotrophic lateral sclerosis (ALS) 1616_1432 2 0.0083423 0.367061195 0.015959182 26506 hsa-mir-874 hsa05131 Shigellosis 10971_7534 2 0.0083423 0.367061195 0.015959182 26507 hsa-mir-874 hsa05130 Pathogenic Escherichia coli infection 10971_7534 2 0.0083423 0.367061195 0.015959182 26508 hsa-mir-874 hsa05221 Acute myeloid leukemia 595_861 2 0.009193662 0.404521141 0.016855048 26509 hsa-mir-874 hsa05214 Glioma 595_5925 2 0.011007237 0.484318413 0.019372737 26510 hsa-mir-874 hsa05218 Melanoma 595_5925 2 0.012964959 0.570458185 0.021128081 26511 hsa-mir-874 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1432 2 0.012964959 0.570458185 0.021128081 26512 hsa-mir-874 hsa04720 Long-term potentiation 2033_1387 2 0.014348061 0.631314666 0.021769471 26513 hsa-mir-874 hsa04662 B cell receptor signaling pathway 3725_2353 2 0.014348061 0.631314666 0.021769471 26514 hsa-mir-874 hsa05222 Small cell lung cancer 595_5925 2 0.018461897 0.812323453 0.027077448 26515 hsa-mir-874 hsa04916 Melanogenesis 2033_1387 2 0.026121262 1 0.037075339 26516 hsa-mir-874 hsa04912 GnRH signaling pathway 3725_1432 2 0.027970905 1 0.038459995 26517 hsa-mir-874 hsa04670 Leukocyte transendothelial migration 4301_1432 2 0.034840795 1 0.046454393 26518 hsa-mir-875 hsa04950 Maturity onset diabetes of the young 3651_5080 2 0.00049684 0.01043364 0.01043364 26519 hsa-mir-875 hsa04330 Notch signaling pathway 2033_1387 2 0.001765131 0.037067753 0.012686543 26520 hsa-mir-875 hsa05016 Huntington's disease 2033_10476_1387 3 0.001812363 0.038059629 0.012686543 26521 hsa-mir-875 hsa05211 Renal cell carcinoma 2033_1387 2 0.00397424 0.083459041 0.013870574 26522 hsa-mir-875 hsa04720 Long-term potentiation 2033_1387 2 0.004295049 0.090196032 0.013870574 26523 hsa-mir-875 hsa04520 Adherens junction 2033_1387 2 0.004855535 0.10196623 0.013870574 26524 hsa-mir-875 hsa04350 TGF-beta signaling pathway 2033_1387 2 0.00569372 0.119568124 0.013870574 26525 hsa-mir-875 hsa05215 Prostate cancer 2033_1387 2 0.005818501 0.122188518 0.013870574 26526 hsa-mir-875 hsa05212 Pancreatic cancer 2033_1387 2 0.005944532 0.124835169 0.013870574 26527 hsa-mir-875 hsa04916 Melanogenesis 2033_1387 2 0.007982882 0.167640515 0.016764052 26528 hsa-mir-875 hsa04110 Cell cycle 2033_1387 2 0.010291247 0.216116181 0.019646926 26529 hsa-mir-875 hsa04530 Tight junction 60412_4628 2 0.01340317 0.281466578 0.023455548 26530 hsa-mir-875 hsa04310 Wnt signaling pathway 2033_1387 2 0.016269572 0.341661008 0.025307561 26531 hsa-mir-875 hsa04630 Jak-STAT signaling pathway 2033_1387 2 0.016871707 0.354305848 0.025307561 26532 hsa-mir-885 hsa04916 Melanogenesis 1499_5595_5594_1387_2033_808_801_805 8 2.44E-09 1.36E-07 1.36E-07 26533 hsa-mir-885 hsa04720 Long-term potentiation 5595_5594_1387_2033_808_801_805 7 7.26E-09 4.07E-07 2.03E-07 26534 hsa-mir-885 hsa04330 Notch signaling pathway 388585_1387_9612_3065_2033_8850 6 1.61E-08 9.02E-07 2.66E-07 26535 hsa-mir-885 hsa04350 TGF-beta signaling pathway 5595_5594_1387_3397_3399_3398_2033 7 1.90E-08 1.06E-06 2.66E-07 26536 hsa-mir-885 hsa05214 Glioma 5595_5594_5925_808_801_805 6 9.61E-08 5.38E-06 1.08E-06 26537 hsa-mir-885 hsa05200 Pathways in cancer 1499_5595_5594_1387_862_6502_3065_5925_2033_8554 10 1.22E-07 6.85E-06 1.14E-06 26538 hsa-mir-885 hsa05215 Prostate cancer 1499_5595_5594_1387_5925_2033 6 5.16E-07 2.89E-05 3.84E-06 26539 hsa-mir-885 hsa05212 Pancreatic cancer 1499_5595_5594_1387_5925_2033 6 5.49E-07 3.07E-05 3.84E-06 26540 hsa-mir-885 hsa04912 GnRH signaling pathway 5595_5594_1432_808_801_805 6 1.61E-06 9.00E-05 1.00E-05 26541 hsa-mir-885 hsa04370 VEGF signaling pathway 5595_5594_9261_7867_1432 5 6.03E-06 0.000337404 3.37E-05 26542 hsa-mir-885 hsa04520 Adherens junction 1499_5595_5594_1387_2033 5 7.19E-06 0.000402634 3.66E-05 26543 hsa-mir-885 hsa04010 MAPK signaling pathway 6722_5595_5594_9261_4208_7867_1432 7 2.87E-05 0.001609524 0.000134127 26544 hsa-mir-885 hsa04270 Vascular smooth muscle contraction 5595_5594_808_801_805 5 4.31E-05 0.00241581 0.000179367 26545 hsa-mir-885 hsa04110 Cell cycle 1387_6502_3065_5925_2033 5 4.48E-05 0.002511143 0.000179367 26546 hsa-mir-885 hsa04910 Insulin signaling pathway 5595_5594_808_801_805 5 8.83E-05 0.004942621 0.000329508 26547 hsa-mir-885 hsa05211 Renal cell carcinoma 5595_5594_1387_2033 4 9.64E-05 0.005398813 0.000337426 26548 hsa-mir-885 hsa05220 Chronic myeloid leukemia 5595_5594_3065_5925 4 0.000112099 0.006277556 0.000369268 26549 hsa-mir-885 hsa05216 Thyroid cancer 1499_5595_5594 3 0.000137068 0.007675805 0.000426434 26550 hsa-mir-885 hsa05010 Alzheimer's disease 5595_5594_808_801_805 5 0.000272005 0.015232306 0.0008017 26551 hsa-mir-885 hsa05219 Bladder cancer 5595_5594_5925 3 0.00038078 0.021323652 0.001066183 26552 hsa-mir-885 hsa04930 Type II diabetes mellitus 3651_5595_5594 3 0.000460993 0.025815622 0.001229315 26553 hsa-mir-885 hsa05213 Endometrial cancer 1499_5595_5594 3 0.000688286 0.038544031 0.001752001 26554 hsa-mir-885 hsa05223 Non-small cell lung cancer 5595_5594_5925 3 0.000764193 0.042794829 0.001860645 26555 hsa-mir-885 hsa05221 Acute myeloid leukemia 5595_5594_862 3 0.000976686 0.05469442 0.002278934 26556 hsa-mir-885 hsa05218 Melanoma 5595_5594_5925 3 0.001629421 0.091247578 0.003649903 26557 hsa-mir-885 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.001965505 0.110068288 0.004233396 26558 hsa-mir-885 hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432 3 0.002186359 0.122436113 0.004534671 26559 hsa-mir-885 hsa05210 Colorectal cancer 1499_5595_5594 3 0.002587558 0.144903226 0.005175115 26560 hsa-mir-885 hsa05222 Small cell lung cancer 6502_5925_8554 3 0.002759908 0.154554828 0.005329477 26561 hsa-mir-885 hsa04950 Maturity onset diabetes of the young 3651_168620 2 0.002987717 0.167312164 0.005577072 26562 hsa-mir-885 hsa04620 Toll-like receptor signaling pathway 5595_5594_1432 3 0.004395165 0.246129262 0.007939654 26563 hsa-mir-885 hsa04660 T cell receptor signaling pathway 5595_5594_1432 3 0.00539205 0.301954805 0.009436088 26564 hsa-mir-885 hsa04120 Ubiquitin mediated proteolysis 7329_6502_8554 3 0.010084082 0.564708588 0.017112381 26565 hsa-mir-885 hsa04150 mTOR signaling pathway 5595_5594 2 0.012430897 0.696130222 0.020421622 26566 hsa-mir-885 hsa04310 Wnt signaling pathway 1499_1387_2033 3 0.012763513 0.714756756 0.020421622 26567 hsa-mir-885 hsa04630 Jak-STAT signaling pathway 1387_2033_8554 3 0.01343412 0.752310724 0.02089752 26568 hsa-mir-885 hsa04020 Calcium signaling pathway 808_801_805 3 0.020945935 1 0.031701955 26569 hsa-mir-885 hsa04730 Long-term depression 5595_5594 2 0.021973216 1 0.031775992 26570 hsa-mir-885 hsa05016 Huntington's disease 1387_3065_2033 3 0.022129709 1 0.031775992 26571 hsa-mir-885 hsa04662 B cell receptor signaling pathway 5595_5594 2 0.024269383 1 0.033977137 26572 hsa-mir-885 hsa04510 Focal adhesion 1499_5595_5594 3 0.027901371 1 0.038109189 26573 hsa-mir-885 hsa04012 ErbB signaling pathway 5595_5594 2 0.031709985 1 0.04227998 26574 hsa-mir-885 hsa04540 Gap junction 5595_5594 2 0.035724885 1 0.046525432 26575 hsa-mir-887 hsa05200 Pathways in cancer 1499_596_598_1017_4193_5578_6502_3091_3066_3065_5925_613_7184_5743_5747_25_6789_4436_1870_1871_2113_861_862_1147_3725_998_5595_5594_5599_1387_6256_10401_2932_5970_7157_6688_1869_4087_4088_5888_5728_2033_3910_4792_3320_3326_5371_675_5601_5602_1856_51588_4609_1026_1029_2353_8554 57 3.33E-36 2.90E-34 2.90E-34 26576 hsa-mir-887 hsa04110 Cell cycle 1017_4193_902_6502_4171_3066_3065_5925_25_1870_1871_9232_545_995_5347_5591_1387_11200_7534_7532_2932_7027_7157_1869_4085_4087_4088_2033_890_1031_983_1026_1022_1029_1111_8556_8555_472 38 6.57E-33 5.72E-31 2.86E-31 26577 hsa-mir-887 hsa03022 Basal transcription factors 54457_51616_138474_6883_6881_6879_2965_2967_2961_2960_2963_2969_2968_6878_6877_6874_6873_6872_6908_6884_2958_2959_6880_2957_6882 25 2.12E-28 1.85E-26 6.16E-27 26578 hsa-mir-887 hsa05215 Prostate cancer 1499_596_1017_4193_5925_7184_1870_1871_1147_5595_5594_1385_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_1026 23 9.25E-19 8.05E-17 1.99E-17 26579 hsa-mir-887 hsa05212 Pancreatic cancer 1499_596_1017_4193_5925_7184_1870_1871_1147_5595_5594_1385_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_1026 23 1.15E-18 9.97E-17 1.99E-17 26580 hsa-mir-887 hsa05220 Chronic myeloid leukemia 598_4193_3066_3065_5925_613_25_1870_1871_861_1147_5595_5594_5970_7157_1869_4088_4792_4609_1026_1029 21 9.24E-18 8.04E-16 1.34E-16 26581 hsa-mir-887 hsa04115 p53 signaling pathway 1017_4194_4193_900_50484_6241_51246_545_7161_11200_7157_64326_5728_27113_25898_983_1026_1029_1111_472 20 3.18E-17 2.76E-15 3.95E-16 26582 hsa-mir-887 hsa05222 Small cell lung cancer 596_598_1017_6502_5925_5743_5747_1870_1871_1147_6256_10401_5970_7157_1869_5728_3910_4792_51588_4609_8554 21 9.86E-17 8.58E-15 1.07E-15 26583 hsa-mir-887 hsa04010 MAPK signaling pathway 6722_7867_5578_5923_3304_3305_3303_6789_1432_1616_1147_3725_998_5595_5594_5599_1386_3312_3315_5970_3164_7157_3727_9261_4208_5601_5602_4609_2353 29 5.67E-14 4.93E-12 5.48E-13 26584 hsa-mir-887 hsa04310 Wnt signaling pathway 1499_8607_5578_3725_1460_5599_1387_2932_7157_1457_1452_4087_4088_2033_5518_5515_5601_5602_1856_4609_5527 21 1.97E-12 1.71E-10 1.71E-11 26585 hsa-mir-887 hsa05214 Glioma 4193_5578_5925_1870_1871_5595_5594_7157_1869_5728_808_801_805_1026_1029 15 4.95E-12 4.31E-10 3.92E-11 26586 hsa-mir-887 hsa05210 Colorectal cancer 1499_596_4436_3725_5595_5594_5599_2932_7157_4087_4088_5601_5602_1856_4609_2353 16 1.22E-11 1.06E-09 8.86E-11 26587 hsa-mir-887 hsa05219 Bladder cancer 4193_5925_1870_1871_5595_5594_7157_1869_4609_1026_1029 11 1.12E-09 9.76E-08 7.51E-09 26588 hsa-mir-887 hsa04350 TGF-beta signaling pathway 6667_3397_3399_3398_5595_5594_1387_7027_4087_4088_2033_5518_5515_4609 14 1.67E-09 1.45E-07 1.04E-08 26589 hsa-mir-887 hsa04120 Ubiquitin mediated proteolysis 4193_6502_3093_7319_84447_10055_10401_64326_7337_5371_672_25898_51588_7329_10075_8554 16 9.25E-09 8.05E-07 5.37E-08 26590 hsa-mir-887 hsa05223 Non-small cell lung cancer 5578_5925_6789_1870_1871_5595_5594_6256_7157_1869_1029 11 1.10E-08 9.55E-07 5.97E-08 26591 hsa-mir-887 hsa03420 Nucleotide excision repair 902_5887_2965_2967_2968_4331_2071_2074_1022_6117 10 2.08E-08 1.81E-06 1.06E-07 26592 hsa-mir-887 hsa04012 ErbB signaling pathway 5578_5747_25_3725_5595_5594_5599_2932_5601_5602_4609_1026 12 1.13E-07 9.79E-06 5.44E-07 26593 hsa-mir-887 hsa05218 Melanoma 4193_5925_1870_1871_5595_5594_7157_1869_5728_1026_1029 11 1.33E-07 1.15E-05 6.08E-07 26594 hsa-mir-887 hsa04916 Melanogenesis 1499_5578_5595_5594_1385_1387_2932_2033_808_801_805_1856 12 6.47E-07 5.63E-05 2.81E-06 26595 hsa-mir-887 hsa04912 GnRH signaling pathway 5578_1432_3725_998_5595_5594_5599_808_801_805_5601_5602 12 9.33E-07 8.12E-05 3.87E-06 26596 hsa-mir-887 hsa04660 T cell receptor signaling pathway 1432_1147_3725_998_5595_5594_2932_5970_959_4792_5601_2353 12 1.11E-06 9.70E-05 4.41E-06 26597 hsa-mir-887 hsa04510 Focal adhesion 1499_596_5578_5923_5747_5499_3725_998_5595_5594_5599_2932_5728_3910_5601_5602 16 1.32E-06 0.000115227 5.01E-06 26598 hsa-mir-887 hsa04910 Insulin signaling pathway 6720_5499_5211_5595_5594_5599_2932_808_801_805_5601_5602_5563 13 1.83E-06 0.000159318 6.64E-06 26599 hsa-mir-887 hsa05221 Acute myeloid leukemia 861_862_1147_5595_5594_5970_6688_5371_4609 9 2.08E-06 0.000180765 7.07E-06 26600 hsa-mir-887 hsa04370 VEGF signaling pathway 7867_5578_5743_5747_1432_998_5595_5594_3315_9261 10 2.11E-06 0.000183911 7.07E-06 26601 hsa-mir-887 hsa04520 Adherens junction 1499_1460_998_5595_5594_1387_1457_4087_4088_2033 10 2.89E-06 0.000251398 9.31E-06 26602 hsa-mir-887 hsa04620 Toll-like receptor signaling pathway 1432_1147_3725_5595_5594_5599_5970_4792_5601_5602_2353 11 3.45E-06 0.000300108 1.07E-05 26603 hsa-mir-887 hsa04330 Notch signaling pathway 3066_3065_1387_2033_8850_388585_1856_4851 8 3.73E-06 0.000324576 1.12E-05 26604 hsa-mir-887 hsa04920 Adipocytokine signaling pathway 6794_1147_5599_6256_5970_4792_5601_5602_5563 9 5.33E-06 0.000463923 1.55E-05 26605 hsa-mir-887 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_1147_3725_998_5599_5970_4792_5601_5602 9 8.18E-06 0.000711544 2.30E-05 26606 hsa-mir-887 hsa05016 Huntington's disease 3066_3065_3064_25942_6667_1385_1387_9001_5430_7157_2033_27113_6874_6908 14 9.45E-06 0.000821912 2.57E-05 26607 hsa-mir-887 hsa04720 Long-term potentiation 5578_5499_5595_5594_1387_2033_808_801_805 9 1.22E-05 0.001064371 3.13E-05 26608 hsa-mir-887 hsa04662 B cell receptor signaling pathway 1147_3725_5595_5594_1380_2932_5970_4792_2353 9 1.22E-05 0.001064371 3.13E-05 26609 hsa-mir-887 hsa05216 Thyroid cancer 1499_5595_5594_6256_7157_4609 6 2.38E-05 0.0020693 5.91E-05 26610 hsa-mir-887 hsa04612 Antigen processing and presentation 3309_3304_3305_3303_1385_3312_3320_3326_4801 9 4.25E-05 0.003696291 0.000102675 26611 hsa-mir-887 hsa05213 Endometrial cancer 1499_5595_5594_2932_7157_5728_4609 7 5.91E-05 0.005142981 0.000138999 26612 hsa-mir-887 hsa05211 Renal cell carcinoma 3091_2113_3725_998_5595_5594_1387_2033 8 6.15E-05 0.005350747 0.000140809 26613 hsa-mir-887 hsa05131 Shigellosis 1499_5578_10382_25_998_7534_4691 7 9.05E-05 0.007871651 0.000196791 26614 hsa-mir-887 hsa05130 Pathogenic Escherichia coli infection 1499_5578_10382_25_998_7534_4691 7 9.05E-05 0.007871651 0.000196791 26615 hsa-mir-887 hsa04930 Type II diabetes mellitus 3651_5595_5594_5599_5601_5602 6 0.000210191 0.018286598 0.000446015 26616 hsa-mir-887 hsa04210 Apoptosis 596_598_823_1147_5970_7157_4792_472 8 0.000239067 0.020798792 0.000495209 26617 hsa-mir-887 hsa03050 Proteasome 5705_5701_5702_5719_5710_5717 6 0.000288878 0.025132383 0.000584474 26618 hsa-mir-887 hsa04664 Fc epsilon RI signaling pathway 5578_1432_5595_5594_5599_5601_5602 7 0.000630618 0.054863771 0.001246904 26619 hsa-mir-887 hsa04530 Tight junction 1499_5578_1460_998_1457_5728_5518_5515_5520 9 0.000858559 0.074694644 0.001659881 26620 hsa-mir-887 hsa04950 Maturity onset diabetes of the young 5080_3651_3172_168620 4 0.001182098 0.102842493 0.002235706 26621 hsa-mir-887 hsa03440 Homologous recombination 641_5888_675_6117 4 0.00196878 0.171283857 0.003644337 26622 hsa-mir-887 hsa04150 mTOR signaling pathway 6794_3091_5595_5594_5563 5 0.002709767 0.235749746 0.004911453 26623 hsa-mir-887 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_1432_1616_7157 5 0.003644895 0.317105847 0.006471548 26624 hsa-mir-887 hsa05010 Alzheimer's disease 823_22926_5595_5594_2932_808_801_805_1020 9 0.00446387 0.388356673 0.007531025 26625 hsa-mir-887 hsa03030 DNA replication 4171_5557_6117_5422 4 0.004501302 0.391613295 0.007531025 26626 hsa-mir-887 hsa03410 Base excision repair 3146_142_4913_328 4 0.004501302 0.391613295 0.007531025 26627 hsa-mir-887 hsa04270 Vascular smooth muscle contraction 5578_5499_5595_5594_808_801_805 7 0.0053574 0.46609381 0.008794223 26628 hsa-mir-887 hsa04540 Gap junction 5578_10382_5595_5594_1453_983 6 0.006655302 0.579011262 0.010722431 26629 hsa-mir-887 hsa04062 Chemokine signaling pathway 5747_6362_1147_998_5595_5594_2932_5970_4792 9 0.007550269 0.656873437 0.011943153 26630 hsa-mir-887 hsa04360 Axon guidance 5747_25_998_5595_5594_2932_1020 7 0.009051243 0.787458168 0.014061753 26631 hsa-mir-887 hsa04730 Long-term depression 5578_5595_5594_5518_5515 5 0.009225695 0.802635469 0.014081324 26632 hsa-mir-887 hsa04070 Phosphatidylinositol signaling system 5578_5728_808_801_805 5 0.011955329 1 0.017932994 26633 hsa-mir-887 hsa05217 Basal cell carcinoma 1499_2932_7157_1856 4 0.01747362 1 0.025766186 26634 hsa-mir-887 hsa04630 Jak-STAT signaling pathway 598_1387_10401_2033_51588_4609_8554 7 0.020284571 1 0.029412628 26635 hsa-mir-887 hsa03450 Non-homologous end-joining 2547_5591 2 0.029073955 1 0.041466132 26636 hsa-mir-889 hsa04110 Cell cycle 1017_4193_902_4087_3065_4616_5925_25_9232_545_995_5347_5591_1387_11200_7534_7533_7532_2932_7027_10912_1869_4088_2033_890_891_1031_983_1026_1022_1111_8556_8555_472 34 1.89E-32 1.63E-30 1.02E-30 26637 hsa-mir-889 hsa05200 Pathways in cancer 596_598_1017_4193_5578_3091_4087_3065_5925_613_5743_5747_25_1487_6789_4436_5602_1147_998_5595_5594_5599_6258_1387_6256_2932_5970_1869_4088_5888_5728_2033_3910_4792_3320_3326_5371_675_8031_5601_1856_6257_51588_1026_2353_1488_8554 47 2.37E-32 2.04E-30 1.02E-30 26638 hsa-mir-889 hsa04115 p53 signaling pathway 1017_4194_4193_900_4616_50484_6241_51246_545_7161_11200_10912_64326_5728_891_27113_25898_983_1026_1111_472 21 5.75E-21 4.94E-19 1.65E-19 26639 hsa-mir-889 hsa05222 Small cell lung cancer 596_598_1017_5925_5743_5747_1147_6258_6256_5970_1869_5728_3910_4792_6257_51588_8554 17 1.54E-14 1.33E-12 3.31E-13 26640 hsa-mir-889 hsa05215 Prostate cancer 596_1017_4193_5925_1147_5595_5594_1387_2932_5970_1869_5728_2033_4792_3320_3326_1026 17 2.15E-14 1.85E-12 3.63E-13 26641 hsa-mir-889 hsa05212 Pancreatic cancer 596_1017_4193_5925_1147_5595_5594_1387_2932_5970_1869_5728_2033_4792_3320_3326_1026 17 2.53E-14 2.18E-12 3.63E-13 26642 hsa-mir-889 hsa05220 Chronic myeloid leukemia 598_4193_3065_5925_613_25_1487_1147_5595_5594_5970_1869_4088_4792_1026_1488 16 3.28E-14 2.82E-12 4.03E-13 26643 hsa-mir-889 hsa04310 Wnt signaling pathway 5578_4087_1487_5602_1460_5599_1387_2932_1457_1452_4088_2033_5518_5515_5601_1856_1488_5527 18 6.56E-12 5.64E-10 7.05E-11 26644 hsa-mir-889 hsa04010 MAPK signaling pathway 6722_5578_4616_5923_3304_3305_3303_6789_1616_5602_1147_998_5595_5594_5599_3315_5970_3164_10912_5601_2353 21 2.11E-10 1.81E-08 2.01E-09 26645 hsa-mir-889 hsa04920 Adipocytokine signaling pathway 10891_6794_5602_1147_5599_6258_6256_5970_4792_5601_5563_6257 12 3.25E-10 2.80E-08 2.80E-09 26646 hsa-mir-889 hsa04120 Ubiquitin mediated proteolysis 4193_3093_7319_84447_7325_7329_10055_64326_7337_5371_672_25898_51588_10075_8554 15 1.23E-09 1.06E-07 9.64E-09 26647 hsa-mir-889 hsa05210 Colorectal cancer 596_4087_4436_5602_5595_5594_5599_2932_4088_5601_1856_2353 12 3.27E-09 2.81E-07 2.34E-08 26648 hsa-mir-889 hsa05223 Non-small cell lung cancer 5578_5925_6789_5595_5594_6258_6256_1869_6257 9 9.50E-08 8.17E-06 6.29E-07 26649 hsa-mir-889 hsa04350 TGF-beta signaling pathway 4087_6667_5595_5594_1387_7027_4088_2033_5518_5515 10 4.28E-07 3.68E-05 2.31E-06 26650 hsa-mir-889 hsa04012 ErbB signaling pathway 5578_5747_25_5602_5595_5594_5599_2932_5601_1026 10 4.28E-07 3.68E-05 2.31E-06 26651 hsa-mir-889 hsa04330 Notch signaling pathway 3065_1487_1387_9612_2033_8850_1856_1488 8 4.30E-07 3.70E-05 2.31E-06 26652 hsa-mir-889 hsa04510 Focal adhesion 596_5578_5923_5747_5499_5602_998_5595_5594_5599_2932_5728_3910_5601 14 9.06E-07 7.79E-05 4.58E-06 26653 hsa-mir-889 hsa03022 Basal transcription factors 51616_2965_2969_6908_2958_6880_2957 7 1.23E-06 0.000105618 5.87E-06 26654 hsa-mir-889 hsa04520 Adherens junction 4087_1460_998_5595_5594_1387_1457_4088_2033 9 1.91E-06 0.000164587 8.66E-06 26655 hsa-mir-889 hsa04660 T cell receptor signaling pathway 1147_998_5595_5594_2932_5970_959_4792_5601_2353 10 3.06E-06 0.000262906 1.31E-05 26656 hsa-mir-889 hsa03420 Nucleotide excision repair 902_2965_4331_2071_2074_1022_6117 7 3.44E-06 0.000295814 1.41E-05 26657 hsa-mir-889 hsa05214 Glioma 4193_5578_5925_5595_5594_1869_5728_1026 8 3.90E-06 0.000335434 1.52E-05 26658 hsa-mir-889 hsa05216 Thyroid cancer 5595_5594_6258_6256_8031_6257 6 4.60E-06 0.000395435 1.72E-05 26659 hsa-mir-889 hsa04662 B cell receptor signaling pathway 1147_5595_5594_1380_2932_5970_4792_2353 8 1.03E-05 0.000882238 3.68E-05 26660 hsa-mir-889 hsa04620 Toll-like receptor signaling pathway 5602_1147_5595_5594_5599_5970_4792_5601_2353 9 1.19E-05 0.001026067 4.10E-05 26661 hsa-mir-889 hsa04530 Tight junction 5578_4628_1460_998_1457_5728_5518_5515_5520_60412 10 1.85E-05 0.001592789 6.13E-05 26662 hsa-mir-889 hsa05219 Bladder cancer 4193_5925_5595_5594_1869_1026 6 3.03E-05 0.002604138 9.64E-05 26663 hsa-mir-889 hsa04930 Type II diabetes mellitus 5602_3651_5595_5594_5599_5601 6 4.30E-05 0.003702171 0.00013222 26664 hsa-mir-889 hsa05016 Huntington's disease 10891_3065_3064_25942_6667_10476_1387_1537_2033_27113_6908 11 4.91E-05 0.004224273 0.000145665 26665 hsa-mir-889 hsa05218 Melanoma 4193_5925_5595_5594_1869_5728_1026 7 5.86E-05 0.005043816 0.000162704 26666 hsa-mir-889 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5602_1147_998_5599_5970_4792_5601 7 5.86E-05 0.005043816 0.000162704 26667 hsa-mir-889 hsa04370 VEGF signaling pathway 5578_5743_5747_998_5595_5594_3315 7 9.43E-05 0.008106518 0.000253329 26668 hsa-mir-889 hsa04910 Insulin signaling pathway 10891_5499_5602_5595_5594_5599_2932_5601_5563 9 0.000109281 0.009398131 0.000284792 26669 hsa-mir-889 hsa04612 Antigen processing and presentation 3309_3304_3305_3303_3320_3326_4802 7 0.000218044 0.018751773 0.000535765 26670 hsa-mir-889 hsa04210 Apoptosis 596_598_823_1147_5970_4792_472 7 0.000218044 0.018751773 0.000535765 26671 hsa-mir-889 hsa05211 Renal cell carcinoma 3091_998_5595_5594_1387_2033 6 0.000461601 0.039697697 0.001102714 26672 hsa-mir-889 hsa04916 Melanogenesis 5578_5595_5594_1387_2932_2033_1856 7 0.000529032 0.045496734 0.001229641 26673 hsa-mir-889 hsa04720 Long-term potentiation 5578_5499_5595_5594_1387_2033 6 0.000565116 0.048599936 0.001278946 26674 hsa-mir-889 hsa04912 GnRH signaling pathway 5578_5602_998_5595_5594_5599_5601 7 0.000653868 0.056232652 0.001441863 26675 hsa-mir-889 hsa03440 Homologous recombination 641_5888_675_6117 4 0.000676147 0.058148668 0.001453717 26676 hsa-mir-889 hsa04664 Fc epsilon RI signaling pathway 5578_5602_5595_5594_5599_5601 6 0.000730178 0.06279532 0.001531593 26677 hsa-mir-889 hsa04150 mTOR signaling pathway 6794_3091_5595_5594_5563 5 0.000758267 0.065210937 0.001552641 26678 hsa-mir-889 hsa05131 Shigellosis 5578_25_998_7534_4691 5 0.001034039 0.088927377 0.002021077 26679 hsa-mir-889 hsa05130 Pathogenic Escherichia coli infection 5578_25_998_7534_4691 5 0.001034039 0.088927377 0.002021077 26680 hsa-mir-889 hsa04062 Chemokine signaling pathway 5747_6362_1147_998_5595_5594_2932_5970_4792 9 0.00111982 0.096304533 0.002140101 26681 hsa-mir-889 hsa05221 Acute myeloid leukemia 1147_5595_5594_5970_5371 5 0.001285109 0.110519356 0.002402595 26682 hsa-mir-889 hsa03410 Base excision repair 3146_142_4913_328 4 0.001587522 0.136526895 0.002904828 26683 hsa-mir-889 hsa04360 Axon guidance 5747_25_998_5595_5594_2932_1020 7 0.001891688 0.162685147 0.003389274 26684 hsa-mir-889 hsa04730 Long-term depression 5578_5595_5594_5518_5515 5 0.002754351 0.236874178 0.004834167 26685 hsa-mir-889 hsa04950 Maturity onset diabetes of the young 5080_3651_3172 3 0.0046443 0.399409827 0.007988197 26686 hsa-mir-889 hsa05213 Endometrial cancer 5595_5594_2932_5728 4 0.005449923 0.468693378 0.009190066 26687 hsa-mir-889 hsa04540 Gap junction 5578_5595_5594_1453_983 5 0.008095271 0.696193342 0.013388334 26688 hsa-mir-889 hsa05010 Alzheimer's disease 823_10476_5595_5594_2932_1537_1020 7 0.009051476 0.778426939 0.014687301 26689 hsa-mir-889 hsa03030 DNA replication 5557_6117_5422 3 0.012986213 1 0.020681746 26690 hsa-mir-889 hsa03320 PPAR signaling pathway 2168_6258_6256_6257 4 0.014319093 1 0.022389855 26691 hsa-mir-889 hsa03450 Non-homologous end-joining 2547_5591 2 0.0169237 1 0.025989968 26692 hsa-mir-889 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_1616 3 0.038468248 1 0.058039813 26693 hsa-mir-889 hsa03430 Mismatch repair 4436_6117 2 0.039286176 1 0.058251916 26694 hsa-mir-889 hsa04340 Hedgehog signaling pathway 2932_1452_1453 3 0.040126717 1 0.058489791 26695 hsa-mir-892a hsa04010 MAPK signaling pathway 468_3725_3727_1432_2353_1386 6 3.69E-07 9.23E-06 9.23E-06 26696 hsa-mir-892a hsa04620 Toll-like receptor signaling pathway 3725_1432_2353 3 0.000173846 0.004346153 0.00134952 26697 hsa-mir-892a hsa04912 GnRH signaling pathway 468_3725_1432 3 0.000204846 0.005121159 0.00134952 26698 hsa-mir-892a hsa04660 T cell receptor signaling pathway 3725_1432_2353 3 0.000215923 0.005398079 0.00134952 26699 hsa-mir-892a hsa04310 Wnt signaling pathway 8061_3725_1457 3 0.000545127 0.013628169 0.002725634 26700 hsa-mir-892a hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1432 2 0.002589188 0.064729691 0.009970571 26701 hsa-mir-892a hsa04662 B cell receptor signaling pathway 3725_2353 2 0.0028754 0.071884998 0.009970571 26702 hsa-mir-892a hsa05210 Colorectal cancer 3725_2353 2 0.003571126 0.089278161 0.009970571 26703 hsa-mir-892a hsa05215 Prostate cancer 10488_468 2 0.003903076 0.09757689 0.009970571 26704 hsa-mir-892a hsa05212 Pancreatic cancer 10488_468 2 0.003988229 0.099705714 0.009970571 26705 hsa-mir-892a hsa05200 Pathways in cancer 1050_3725_2353 3 0.004906646 0.122666147 0.011151468 26706 hsa-mir-9-1 hsa05200 Pathways in cancer 3716_5747_25_2249_7046_5595_5594_5914_1387_2064_6256_5159_595_5156_1487_367_2261_3815_7704_6774_6776_6777_6772_5970_6688_2113_8772_3725_861_2353_4087_4089_5925_2033_207_2932_8554_4286_5879_1956_7186 41 2.00E-32 1.42E-30 1.42E-30 26707 hsa-mir-9-1 hsa04630 Jak-STAT signaling pathway 3716_3717_3560_3561_1439_1387_595_894_58985_6774_6776_6777_6772_3455_3459_5781_896_6773_7297_2033_3977_207_8554_10379 24 2.11E-21 1.50E-19 7.51E-20 26708 hsa-mir-9-1 hsa05220 Chronic myeloid leukemia 25_7046_5595_5594_595_1487_6776_6777_5970_5781_861_4089_5925_207 14 5.47E-14 3.88E-12 1.21E-12 26709 hsa-mir-9-1 hsa05221 Acute myeloid leukemia 5595_5594_5914_595_3815_7704_6774_6776_6777_5970_6688_861_207 13 6.84E-14 4.86E-12 1.21E-12 26710 hsa-mir-9-1 hsa05210 Colorectal cancer 7046_5595_5594_5159_595_5156_3725_2353_4087_4089_207_2932_5879_1956 14 2.18E-13 1.55E-11 2.97E-12 26711 hsa-mir-9-1 hsa04010 MAPK signaling pathway 2249_7046_5595_5594_5159_5156_7132_3303_2261_2264_9252_1432_5970_3725_2353_1845_207_5879_1616_1956_7186 21 2.65E-13 1.88E-11 2.97E-12 26712 hsa-mir-9-1 hsa04350 TGF-beta signaling pathway 6667_7046_5595_5594_1387_90_3398_3399_4086_4087_4089_2033_4093_57154 14 3.34E-13 2.37E-11 2.97E-12 26713 hsa-mir-9-1 hsa04012 ErbB signaling pathway 5747_25_818_817_6714_5595_5594_2064_6776_6777_3725_207_2932_1956 14 3.34E-13 2.37E-11 2.97E-12 26714 hsa-mir-9-1 hsa05215 Prostate cancer 5595_5594_1387_2064_5159_595_5156_367_5970_5925_2033_207_2932_1956 14 3.85E-13 2.73E-11 3.03E-12 26715 hsa-mir-9-1 hsa05212 Pancreatic cancer 5595_5594_1387_2064_5159_595_5156_367_5970_5925_2033_207_2932_1956 14 4.42E-13 3.14E-11 3.14E-12 26716 hsa-mir-9-1 hsa04060 Cytokine-cytokine receptor interaction 2321_3791_7046_3560_3561_1439_90_5159_5156_7132_1234_1230_3815_58985_7852_3455_3459_7133_3977_1956 20 1.14E-12 8.08E-11 7.34E-12 26717 hsa-mir-9-1 hsa04510 Focal adhesion 5747_2534_2321_3791_6714_5595_5594_2064_5159_595_5156_894_896_3725_207_2932_5879_1956 18 1.94E-12 1.37E-10 1.15E-11 26718 hsa-mir-9-1 hsa04520 Adherens junction 4301_2534_7046_6714_5595_5594_1387_2064_4087_4089_2033_5879_1956 13 2.12E-12 1.51E-10 1.16E-11 26719 hsa-mir-9-1 hsa04062 Chemokine signaling pathway 3717_5747_5580_5595_5594_1234_1230_6774_6777_6772_5970_7852_6773_207_2932_5879 16 6.98E-11 4.96E-09 3.54E-10 26720 hsa-mir-9-1 hsa05214 Glioma 818_817_5595_5594_5159_595_5156_5925_207_1956 10 1.25E-09 8.89E-08 5.92E-09 26721 hsa-mir-9-1 hsa04920 Adipocytokine signaling pathway 3717_8717_6256_7132_6774_5970_5781_7133_207_7186 10 1.63E-09 1.16E-07 7.24E-09 26722 hsa-mir-9-1 hsa04110 Cell cycle 25_1387_595_894_896_4174_4172_4087_4089_5925_2033_2932 12 2.26E-09 1.61E-07 9.46E-09 26723 hsa-mir-9-1 hsa05218 Melanoma 2249_5595_5594_5159_595_5156_5925_207_4286_1956 10 2.71E-09 1.92E-07 1.07E-08 26724 hsa-mir-9-1 hsa04310 Wnt signaling pathway 818_817_1387_595_1487_894_896_3725_4087_4089_2033_2932_5879 13 3.09E-09 2.19E-07 1.15E-08 26725 hsa-mir-9-1 hsa04620 Toll-like receptor signaling pathway 5595_5594_1432_6772_5970_3455_8772_3725_2353_207_5879 11 5.60E-09 3.97E-07 1.99E-08 26726 hsa-mir-9-1 hsa05219 Bladder cancer 5595_5594_2064_595_2261_9252_5925_1956 8 1.32E-08 9.40E-07 4.48E-08 26727 hsa-mir-9-1 hsa05211 Renal cell carcinoma 5595_5594_1387_5781_2113_3725_2033_207_5879 9 4.38E-08 3.11E-06 1.41E-07 26728 hsa-mir-9-1 hsa04662 B cell receptor signaling pathway 5595_5594_6850_5970_3725_2353_207_2932_5879 9 6.03E-08 4.28E-06 1.86E-07 26729 hsa-mir-9-1 hsa05223 Non-small cell lung cancer 5595_5594_2064_6256_595_5925_207_1956 8 7.61E-08 5.40E-06 2.25E-07 26730 hsa-mir-9-1 hsa04660 T cell receptor signaling pathway 2534_5595_5594_1432_5970_3725_2353_207_2932_3932 10 1.24E-07 8.78E-06 3.51E-07 26731 hsa-mir-9-1 hsa04916 Melanogenesis 818_817_5595_5594_1387_3815_2033_2932_4286 9 7.83E-07 5.56E-05 2.14E-06 26732 hsa-mir-9-1 hsa05213 Endometrial cancer 5595_5594_2064_595_207_2932_1956 7 9.09E-07 6.45E-05 2.30E-06 26733 hsa-mir-9-1 hsa04370 VEGF signaling pathway 5747_3791_6714_5595_5594_1432_207_5879 8 9.09E-07 6.45E-05 2.30E-06 26734 hsa-mir-9-1 hsa04912 GnRH signaling pathway 5580_818_817_6714_5595_5594_1432_3725_1956 9 1.05E-06 7.45E-05 2.57E-06 26735 hsa-mir-9-1 hsa04664 Fc epsilon RI signaling pathway 2534_5580_5595_5594_6850_1432_207_5879 8 1.09E-06 7.72E-05 2.57E-06 26736 hsa-mir-9-1 hsa05222 Small cell lung cancer 5747_6256_595_5970_5925_207_8554_7186 8 1.96E-06 0.000139356 4.50E-06 26737 hsa-mir-9-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_1432_5970_5781_3725_5879_1956 7 6.10E-06 0.000432932 1.35E-05 26738 hsa-mir-9-1 hsa04650 Natural killer cell mediated cytotoxicity 2534_5595_5594_6850_3455_3459_5781_3932_5879 9 6.95E-06 0.000493187 1.49E-05 26739 hsa-mir-9-1 hsa04210 Apoptosis 8717_1439_7132_5970_8772_207_7186 7 2.40E-05 0.001706065 5.02E-05 26740 hsa-mir-9-1 hsa04360 Axon guidance 5747_2534_25_5595_5594_7852_2932_5879 8 3.53E-05 0.002502869 7.15E-05 26741 hsa-mir-9-1 hsa04810 Regulation of actin cytoskeleton 5747_2249_5595_5594_5159_5156_2261_2264_5879_1956 10 4.11E-05 0.002916499 8.10E-05 26742 hsa-mir-9-1 hsa04720 Long-term potentiation 818_817_5595_5594_1387_2033 6 8.48E-05 0.006022184 0.000162762 26743 hsa-mir-9-1 hsa05216 Thyroid cancer 5595_5594_6256_595 4 0.000200907 0.014264372 0.000375378 26744 hsa-mir-9-1 hsa05014 Amyotrophic lateral sclerosis (ALS) 7132_1432_7133_5879_1616 5 0.000208063 0.014772451 0.000378781 26745 hsa-mir-9-1 hsa04540 Gap junction 6714_5595_5594_5159_5156_1956 6 0.000256503 0.018211685 0.000455292 26746 hsa-mir-9-1 hsa04670 Leukocyte transendothelial migration 4301_5747_1432_7852_5781_5879 6 0.001003595 0.071255254 0.001737933 26747 hsa-mir-9-1 hsa04330 Notch signaling pathway 1387_1487_9612_2033 4 0.001083042 0.076895967 0.001830856 26748 hsa-mir-9-1 hsa04020 Calcium signaling pathway 818_817_2064_5159_5156_147_1956 7 0.001632697 0.115921516 0.002695849 26749 hsa-mir-9-1 hsa04930 Type II diabetes mellitus 5580_5595_5594 3 0.008851315 0.628443351 0.014279242 26750 hsa-mir-9-1 hsa04910 Insulin signaling pathway 5595_5594_23265_207_2932 5 0.009050224 0.642565883 0.014279242 26751 hsa-mir-9-1 hsa04120 Ubiquitin mediated proteolysis 672_55294_7329_8554_57154 5 0.009309786 0.660994814 0.014369452 26752 hsa-mir-9-1 hsa04150 mTOR signaling pathway 5595_5594_207 3 0.012833021 0.911144494 0.019386053 26753 hsa-mir-9-1 hsa05010 Alzheimer's disease 5595_5594_7132_8772_2932 5 0.023328975 1 0.033943554 26754 hsa-mir-9-1 hsa04270 Vascular smooth muscle contraction 5580_5595_5594_147 4 0.023425833 1 0.033943554 26755 hsa-mir-9-1 hsa04115 p53 signaling pathway 595_894_896 3 0.026158682 1 0.037145329 26756 hsa-mir-9-1 hsa05016 Huntington's disease 6667_25942_1387_6908_2033 5 0.029062526 1 0.040459595 26757 hsa-mir-9-1 hsa04530 Tight junction 4301_5580_6714_207 4 0.037022199 1 0.05054954 26758 hsa-mir-9-1 hsa05340 Primary immunodeficiency 3561_3932 2 0.042456496 1 0.056875684 26759 hsa-mir-9-1 hsa03030 DNA replication 4174_4172 2 0.044559299 1 0.057522005 26760 hsa-mir-9-1 hsa03410 Base excision repair 3146_142 2 0.044559299 1 0.057522005 26761 hsa-mir-9-1 hsa03022 Basal transcription factors 2969_6908 2 0.046699932 1 0.059208842 26762 hsa-mir-9-2 hsa05200 Pathways in cancer 3725_25_5371_1499_5595_5594_5599_1387_5601_367_2932_4193_6502_1870_1871_7157_2113_4609_861_862_1029_2353_3066_2736_4088_4089_1050_5925_2033_207 30 1.45E-23 9.58E-22 9.58E-22 26763 hsa-mir-9-2 hsa04010 MAPK signaling pathway 6722_3725_5595_5594_5599_8986_9261_4208_5601_5600_6195_9252_7867_1386_1432_8550_7157_4609_3727_6196_6197_2353_5603_1616_207_1649 26 4.64E-21 3.06E-19 1.53E-19 26764 hsa-mir-9-2 hsa05215 Prostate cancer 1499_5595_5594_1385_1387_367_2932_4193_1870_1871_7157_9586_90993_5925_2033_207 16 2.22E-17 1.46E-15 4.29E-16 26765 hsa-mir-9-2 hsa05212 Pancreatic cancer 1499_5595_5594_1385_1387_367_2932_4193_1870_1871_7157_9586_90993_5925_2033_207 16 2.60E-17 1.72E-15 4.29E-16 26766 hsa-mir-9-2 hsa05220 Chronic myeloid leukemia 25_5595_5594_4193_1870_1871_7157_4609_861_1029_3066_4088_4089_5925_207 15 6.47E-17 4.27E-15 8.54E-16 26767 hsa-mir-9-2 hsa05210 Colorectal cancer 3725_1499_5595_5594_5599_5601_2932_7157_4609_2353_4088_4089_207 13 1.50E-13 9.93E-12 1.65E-12 26768 hsa-mir-9-2 hsa05214 Glioma 5595_5594_4193_1870_1871_7157_1029_5925_207_808_801_805 12 2.05E-13 1.35E-11 1.86E-12 26769 hsa-mir-9-2 hsa04350 TGF-beta signaling pathway 5595_5594_1387_3397_3399_4609_3398_4086_4088_4089_2033_4093_6667 13 2.25E-13 1.49E-11 1.86E-12 26770 hsa-mir-9-2 hsa04110 Cell cycle 25_1387_2932_4193_6502_1870_1871_7157_1029_3066_4088_4089_5925_2033 14 5.17E-13 3.41E-11 3.79E-12 26771 hsa-mir-9-2 hsa05219 Bladder cancer 5595_5594_9252_4193_1870_1871_7157_4609_1029_5925 10 2.37E-12 1.56E-10 1.56E-11 26772 hsa-mir-9-2 hsa04310 Wnt signaling pathway 3725_1499_5599_1387_5601_1457_2932_7157_8061_4609_1459_4088_4089_2033 14 1.09E-11 7.19E-10 6.54E-11 26773 hsa-mir-9-2 hsa04720 Long-term potentiation 5595_5594_1387_6195_6196_6197_2033_808_801_805 10 3.85E-10 2.54E-08 2.12E-09 26774 hsa-mir-9-2 hsa04916 Melanogenesis 1499_5595_5594_1385_1387_2932_90993_2033_808_801_805 11 4.82E-10 3.18E-08 2.45E-09 26775 hsa-mir-9-2 hsa04912 GnRH signaling pathway 3725_5595_5594_5599_5601_5600_1432_5603_808_801_805 11 6.97E-10 4.60E-08 3.29E-09 26776 hsa-mir-9-2 hsa05218 Melanoma 5595_5594_4193_1870_1871_7157_1029_5925_207 9 4.44E-09 2.93E-07 1.96E-08 26777 hsa-mir-9-2 hsa04620 Toll-like receptor signaling pathway 3725_5595_5594_5599_5601_5600_1432_2353_5603_207 10 5.93E-09 3.91E-07 2.45E-08 26778 hsa-mir-9-2 hsa05223 Non-small cell lung cancer 5595_5594_1870_1871_7157_1029_5925_207 8 1.09E-08 7.16E-07 4.03E-08 26779 hsa-mir-9-2 hsa04520 Adherens junction 1499_5595_5594_1387_1457_1459_4088_4089_2033 9 1.15E-08 7.62E-07 4.03E-08 26780 hsa-mir-9-2 hsa04660 T cell receptor signaling pathway 3725_5595_5594_5601_5600_2932_1432_2353_5603_207 10 1.16E-08 7.65E-07 4.03E-08 26781 hsa-mir-9-2 hsa05221 Acute myeloid leukemia 5371_5595_5594_4609_861_862_1050_207 8 2.03E-08 1.34E-06 6.71E-08 26782 hsa-mir-9-2 hsa04012 ErbB signaling pathway 3725_25_5595_5594_5599_5601_2932_4609_207 9 2.26E-08 1.49E-06 7.10E-08 26783 hsa-mir-9-2 hsa04910 Insulin signaling pathway 5595_5594_5599_5601_6720_2932_207_808_801_805 10 8.61E-08 5.68E-06 2.58E-07 26784 hsa-mir-9-2 hsa04370 VEGF signaling pathway 5595_5594_9261_5600_7867_1432_5603_207 8 1.35E-07 8.90E-06 3.87E-07 26785 hsa-mir-9-2 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5601_5600_1432_5603_207 8 1.62E-07 1.07E-05 4.41E-07 26786 hsa-mir-9-2 hsa05213 Endometrial cancer 1499_5595_5594_2932_7157_4609_207 7 1.67E-07 1.10E-05 4.41E-07 26787 hsa-mir-9-2 hsa05211 Renal cell carcinoma 3725_5595_5594_1387_2113_2033_207 7 1.26E-06 8.34E-05 3.11E-06 26788 hsa-mir-9-2 hsa05016 Huntington's disease 1385_1387_6908_7157_9586_90993_3066_3064_2033_6667 10 1.27E-06 8.39E-05 3.11E-06 26789 hsa-mir-9-2 hsa04330 Notch signaling pathway 388585_1387_3066_2033_4851_8850 6 1.74E-06 0.000114718 4.10E-06 26790 hsa-mir-9-2 hsa04150 mTOR signaling pathway 5595_5594_6195_6196_6197_207 6 2.98E-06 0.000196549 6.78E-06 26791 hsa-mir-9-2 hsa05216 Thyroid cancer 1499_5595_5594_7157_4609 5 3.49E-06 0.000230251 7.68E-06 26792 hsa-mir-9-2 hsa05222 Small cell lung cancer 6502_1870_1871_7157_4609_5925_207 7 3.81E-06 0.000251259 8.11E-06 26793 hsa-mir-9-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5599_5601_5600_1432_5603 6 1.56E-05 0.001032851 3.23E-05 26794 hsa-mir-9-2 hsa04662 B cell receptor signaling pathway 3725_5595_5594_2932_2353_207 6 2.09E-05 0.001381874 4.19E-05 26795 hsa-mir-9-2 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601_3651 5 2.43E-05 0.001603258 4.72E-05 26796 hsa-mir-9-2 hsa05014 Amyotrophic lateral sclerosis (ALS) 5600_1432_7157_5603_1616 5 6.41E-05 0.004233789 0.000120965 26797 hsa-mir-9-2 hsa04120 Ubiquitin mediated proteolysis 7329_11059_5371_672_4734_4193_6502 7 7.17E-05 0.004729876 0.000131385 26798 hsa-mir-9-2 hsa04510 Focal adhesion 3725_1499_5595_5594_5599_5601_2932_207 8 0.000125764 0.00830041 0.000224335 26799 hsa-mir-9-2 hsa04270 Vascular smooth muscle contraction 5592_5595_5594_808_801_805 6 0.000225515 0.014883964 0.000391683 26800 hsa-mir-9-2 hsa05010 Alzheimer's disease 5595_5594_2932_808_22926_801_805 7 0.000299593 0.019773147 0.000507004 26801 hsa-mir-9-2 hsa05217 Basal cell carcinoma 1499_2932_7157_2736 4 0.000739072 0.04877872 0.001219468 26802 hsa-mir-9-2 hsa03022 Basal transcription factors 2963_2969_6908 3 0.002635148 0.17391979 0.004241946 26803 hsa-mir-9-2 hsa04670 Leukocyte transendothelial migration 1499_5600_1432_5603 4 0.011383051 0.751281353 0.017887651 26804 hsa-mir-9-2 hsa04920 Adipocytokine signaling pathway 5599_5601_207 3 0.012559797 0.828946579 0.019277827 26805 hsa-mir-9-2 hsa04115 p53 signaling pathway 4193_7157_1029 3 0.013548198 0.894181087 0.020175443 26806 hsa-mir-9-2 hsa04950 Maturity onset diabetes of the young 3651_168620 2 0.013755984 0.907894927 0.020175443 26807 hsa-mir-9-2 hsa04360 Axon guidance 25_5595_5594_2932 4 0.014352296 0.947251547 0.020473635 26808 hsa-mir-9-2 hsa04730 Long-term depression 5592_5595_5594 3 0.01457971 0.962260865 0.020473635 26809 hsa-mir-9-2 hsa04530 Tight junction 1499_1457_1459_207 4 0.01658037 1 0.022798009 26810 hsa-mir-9-2 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.017348445 1 0.023367293 26811 hsa-mir-9-2 hsa04630 Jak-STAT signaling pathway 1387_4609_2033_207 4 0.02451562 1 0.032360618 26812 hsa-mir-9-2 hsa04540 Gap junction 5592_5595_5594 3 0.028810395 1 0.037284041 26813 hsa-mir-9-2 hsa04062 Chemokine signaling pathway 5595_5594_2932_207 4 0.047754664 1 0.060611689 26814 hsa-mir-921 hsa04950 Maturity onset diabetes of the young 3651_5080 2 0.000607052 0.014569243 0.014569243 26815 hsa-mir-921 hsa05010 Alzheimer's disease 9451_10476_823 3 0.002045116 0.049082775 0.024541388 26816 hsa-mir-921 hsa04010 MAPK signaling pathway 3725_468_3727 3 0.006759583 0.162230003 0.054076668 26817 hsa-mir-921 hsa04912 GnRH signaling pathway 3725_468 2 0.010397246 0.249533909 0.062383477 26818 hsa-mir-921 hsa04530 Tight junction 60412_4628 2 0.016215412 0.3891699 0.07783398 26819 hsa-mir-922 hsa05200 Pathways in cancer 2034_5468_3725_25_405_9063_5467_367_1499_5595_5599_861_1387_5594_595_5601_1488_4286_1017_51176_4193_6934_2353_7704_6776_6772_5970_5371_2885_7157_4087_4089_2113_10401_7849_4609_2956_5604_6774_1487_4088_3065_1050_5925_3091_2033_6777_207 48 4.39E-41 2.99E-39 2.99E-39 26820 hsa-mir-922 hsa05220 Chronic myeloid leukemia 25_5595_861_5594_595_1488_4193_6776_5970_2885_7157_4089_4609_5604_1487_4088_3065_5925_6777_207 20 3.24E-22 2.20E-20 1.10E-20 26821 hsa-mir-922 hsa05221 Acute myeloid leukemia 5467_5595_861_5594_595_51176_6934_7704_6776_5970_5371_2885_4609_5604_6774_1050_6777_207 18 5.27E-21 3.58E-19 1.19E-19 26822 hsa-mir-922 hsa05210 Colorectal cancer 3725_1499_5595_5599_5594_595_5601_51176_6934_2353_2885_7157_4087_4089_4609_2956_5604_4088_207 19 5.33E-20 3.62E-18 9.05E-19 26823 hsa-mir-922 hsa05215 Prostate cancer 367_1499_5595_1387_5594_595_1017_51176_4193_6934_5970_2885_7157_5604_5925_2033_207 17 5.14E-17 3.49E-15 6.77E-16 26824 hsa-mir-922 hsa05212 Pancreatic cancer 367_1499_5595_1387_5594_595_1017_51176_4193_6934_5970_2885_7157_5604_5925_2033_207 17 6.07E-17 4.13E-15 6.77E-16 26825 hsa-mir-922 hsa04310 Wnt signaling pathway 3725_4772_5467_1499_5599_1387_595_5601_1488_51176_6934_7157_4087_4089_4609_1487_4088_5527_2033_4773 20 6.97E-17 4.74E-15 6.77E-16 26826 hsa-mir-922 hsa04010 MAPK signaling pathway 6722_3725_5595_5599_1386_5594_4208_5606_5601_5600_3164_9252_2353_1432_5970_2885_7157_4609_5604_9344_207_2002_2005_4773 24 2.39E-16 1.63E-14 2.03E-15 26827 hsa-mir-922 hsa04350 TGF-beta signaling pathway 5595_1387_5594_6667_3397_3399_3398_5934_1875_4087_4089_4609_4088_4086_2033_4092 16 8.62E-16 5.86E-14 6.51E-15 26828 hsa-mir-922 hsa05213 Endometrial cancer 1499_5595_5594_595_2309_51176_6934_2885_7157_4609_5604_207_2002 13 1.45E-14 9.86E-13 9.86E-14 26829 hsa-mir-922 hsa05216 Thyroid cancer 5468_1499_5595_5594_595_51176_6934_7157_7849_4609_5604 11 3.48E-14 2.37E-12 2.15E-13 26830 hsa-mir-922 hsa04620 Toll-like receptor signaling pathway 3725_5595_5599_5594_5606_5601_5600_3665_3661_2353_1432_6772_5970_5604_207 15 1.30E-13 8.87E-12 7.39E-13 26831 hsa-mir-922 hsa04110 Cell cycle 25_1387_595_1017_7533_4193_5934_7157_5111_4087_4089_4088_3065_5925_2033 15 9.90E-13 6.73E-11 5.18E-12 26832 hsa-mir-922 hsa04330 Notch signaling pathway 22938_1387_2648_1488_9794_1487_3065_2033_1840_8850_4851 11 2.98E-12 2.03E-10 1.45E-11 26833 hsa-mir-922 hsa04012 ErbB signaling pathway 3725_25_5595_5599_5594_5601_6776_2885_4609_5604_6777_207_2002 13 4.78E-12 3.25E-10 2.17E-11 26834 hsa-mir-922 hsa05211 Renal cell carcinoma 2034_3725_405_5595_1387_5594_2885_2113_5604_3091_2033_207 12 1.02E-11 6.95E-10 4.35E-11 26835 hsa-mir-922 hsa05322 Systemic lupus erythematosus 3021_3020_8359_8294_8365_8370_121504_8361_8360_8363_8362_8364_8367_8366_8368 15 1.21E-11 8.23E-10 4.84E-11 26836 hsa-mir-922 hsa04660 T cell receptor signaling pathway 3725_4772_5595_5594_5601_5600_2353_1432_5970_2885_5604_207_4773 13 6.91E-11 4.70E-09 2.61E-10 26837 hsa-mir-922 hsa04664 Fc epsilon RI signaling pathway 5580_5595_5599_5594_5606_5601_5600_1432_2885_5604_207 11 4.26E-10 2.89E-08 1.52E-09 26838 hsa-mir-922 hsa05219 Bladder cancer 5595_5594_595_9252_4193_7157_4609_5604_5925 9 5.83E-10 3.96E-08 1.98E-09 26839 hsa-mir-922 hsa04912 GnRH signaling pathway 3725_5580_5595_5599_5594_5606_5601_5600_1432_2885_5604_2002 12 7.22E-10 4.91E-08 2.34E-09 26840 hsa-mir-922 hsa04630 Jak-STAT signaling pathway 9063_1387_595_6776_6772_2885_10401_4609_6778_6774_2033_6777_207 13 3.36E-09 2.29E-07 1.04E-08 26841 hsa-mir-922 hsa04662 B cell receptor signaling pathway 3725_4772_5595_5594_2353_5970_2885_5604_207_4773 10 3.93E-09 2.67E-07 1.16E-08 26842 hsa-mir-922 hsa05223 Non-small cell lung cancer 5595_5594_595_2309_2885_7157_5604_5925_207 9 4.14E-09 2.81E-07 1.17E-08 26843 hsa-mir-922 hsa04520 Adherens junction 1499_5595_1387_5594_51176_6934_4087_4089_4088_2033 10 6.91E-09 4.70E-07 1.88E-08 26844 hsa-mir-922 hsa05214 Glioma 5595_5594_595_4193_2885_7157_5604_5925_207 9 1.78E-08 1.21E-06 4.65E-08 26845 hsa-mir-922 hsa05218 Melanoma 5595_5594_595_4286_4193_7157_5604_5925_207 9 3.56E-08 2.42E-06 8.97E-08 26846 hsa-mir-922 hsa05222 Small cell lung cancer 9063_595_1017_5970_7157_10401_4609_5925_207 9 1.61E-07 1.09E-05 3.91E-07 26847 hsa-mir-922 hsa04916 Melanogenesis 1499_5595_1387_5594_4286_51176_6934_5604_2033 9 7.13E-07 4.85E-05 1.67E-06 26848 hsa-mir-922 hsa04370 VEGF signaling pathway 4772_5595_5594_5600_1432_5604_207_4773 8 8.36E-07 5.68E-05 1.89E-06 26849 hsa-mir-922 hsa03410 Base excision repair 6996_252969_4350_5111_328_2237 6 1.71E-06 0.000116611 3.76E-06 26850 hsa-mir-922 hsa04062 Chemokine signaling pathway 5580_5595_5594_2309_6772_5970_2885_5604_6774_6777_207 11 2.06E-06 0.000140318 4.38E-06 26851 hsa-mir-922 hsa04510 Focal adhesion 3725_1499_5595_5599_5594_595_5601_2885_5604_207_2002 11 3.75E-06 0.000254767 7.72E-06 26852 hsa-mir-922 hsa04920 Adipocytokine signaling pathway 10891_5465_5599_5601_5970_6774_207 7 3.98E-06 0.000270512 7.96E-06 26853 hsa-mir-922 hsa04910 Insulin signaling pathway 10891_5595_5599_5594_5601_2885_5604_207_2002 9 6.35E-06 0.000431784 1.23E-05 26854 hsa-mir-922 hsa04115 p53 signaling pathway 595_1017_4194_4193_7157_7161 6 5.17E-05 0.003516348 9.77E-05 26855 hsa-mir-922 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5599_5601_5600_1432_5970 6 6.00E-05 0.004080405 0.000110281 26856 hsa-mir-922 hsa04930 Type II diabetes mellitus 5580_5595_5599_5594_5601 5 7.61E-05 0.005174968 0.000136183 26857 hsa-mir-922 hsa04120 Ubiquitin mediated proteolysis 9063_672_4193_5371_10401_7329_8925 7 0.000314311 0.021373119 0.000548029 26858 hsa-mir-922 hsa05016 Huntington's disease 5468_10891_1387_6667_7157_3065_2033_6908 8 0.000352941 0.023999968 0.000599999 26859 hsa-mir-922 hsa03450 Non-homologous end-joining 10111_4361_2237 3 0.000412129 0.028024772 0.000683531 26860 hsa-mir-922 hsa04720 Long-term potentiation 5595_1387_5594_5604_2033 5 0.000697714 0.047444528 0.001129632 26861 hsa-mir-922 hsa04150 mTOR signaling pathway 5595_5594_3091_207 4 0.001476233 0.100383877 0.002334509 26862 hsa-mir-922 hsa04950 Maturity onset diabetes of the young 5080_6927_4760 3 0.001661791 0.113001774 0.002568222 26863 hsa-mir-922 hsa04650 Natural killer cell mediated cytotoxicity 4772_5595_5594_2885_5604_4773 6 0.001734257 0.117929456 0.002620655 26864 hsa-mir-922 hsa05217 Basal cell carcinoma 1499_51176_6934_7157 4 0.001792207 0.121870095 0.00264935 26865 hsa-mir-922 hsa05014 Amyotrophic lateral sclerosis (ALS) 5606_5600_1432_7157 4 0.001907173 0.12968776 0.002759314 26866 hsa-mir-922 hsa03440 Homologous recombination 10111_4361_4683 3 0.002488768 0.169236196 0.003525754 26867 hsa-mir-922 hsa04270 Vascular smooth muscle contraction 5580_5595_59_5594_5604 5 0.004630794 0.314894011 0.006426408 26868 hsa-mir-922 hsa04360 Axon guidance 25_4772_5595_5594_4773 5 0.007042287 0.478875502 0.00957751 26869 hsa-mir-922 hsa04540 Gap junction 5595_5594_2885_5604 4 0.010544643 0.717035706 0.014059524 26870 hsa-mir-922 hsa03430 Mismatch repair 5111_2956 2 0.020068687 1 0.026243668 26871 hsa-mir-922 hsa03320 PPAR signaling pathway 5468_5465_5467 3 0.02634257 1 0.033798014 26872 hsa-mir-922 hsa04730 Long-term depression 5595_5594_5604 3 0.027282764 1 0.034356073 26873 hsa-mir-922 hsa03030 DNA replication 5111_2237 2 0.043674878 1 0.05399803 26874 hsa-mir-922 hsa03022 Basal transcription factors 2959_6908 2 0.045775876 1 0.055584993 26875 hsa-mir-922 hsa04210 Apoptosis 5970_7157_207 3 0.047197652 1 0.056305971 26876 hsa-mir-924 hsa05200 Pathways in cancer 1147_3320_1869_5743_3326_5747_25_5925_2249_675_998_1026_5594_5595_5599_5914_596_5601_6789_1856_4088_613_1017_2932_4193_367_1387_5578_6256_51588_5970_8554_5371_4436_598_3725_6776_6777_4087_5888_5728_3065_3091_2033_3910_4792_5602_2353 48 3.20E-37 2.72E-35 2.72E-35 26877 hsa-mir-924 hsa04110 Cell cycle 1869_25_5925_545_995_1026_5591_983_4088_7534_1017_2932_4193_7027_902_1387_1031_9232_5347_1022_4087_7532_3065_1111_2033_890_11200_8556_8555_472 30 8.86E-30 7.53E-28 3.76E-28 26878 hsa-mir-924 hsa04115 p53 signaling pathway 50484_545_6241_1026_25898_983_1017_27113_4194_4193_900_7161_64326_5728_51246_1111_11200_472 18 1.46E-18 1.24E-16 4.13E-17 26879 hsa-mir-924 hsa05215 Prostate cancer 1147_3320_1869_3326_5925_1026_5594_5595_596_1017_2932_4193_367_1387_5970_5728_2033_4792 18 6.12E-17 5.20E-15 1.24E-15 26880 hsa-mir-924 hsa05212 Pancreatic cancer 1147_3320_1869_3326_5925_1026_5594_5595_596_1017_2932_4193_367_1387_5970_5728_2033_4792 18 7.29E-17 6.20E-15 1.24E-15 26881 hsa-mir-924 hsa05220 Chronic myeloid leukemia 1147_1869_25_5925_1026_5594_5595_4088_613_4193_5970_598_6776_6777_3065_4792 16 1.89E-15 1.60E-13 2.67E-14 26882 hsa-mir-924 hsa05222 Small cell lung cancer 1147_1869_5743_5747_5925_596_1017_6256_51588_5970_8554_598_5728_3910_4792 15 1.94E-13 1.65E-11 2.36E-12 26883 hsa-mir-924 hsa04310 Wnt signaling pathway 1460_5518_5515_5599_5601_1856_1457_4088_2932_1387_5578_3725_1452_4087_5527_2033_5602 17 3.20E-12 2.72E-10 3.40E-11 26884 hsa-mir-924 hsa05210 Colorectal cancer 5594_5595_5599_596_5601_1856_4088_2932_4436_3725_4087_5602_2353 13 3.08E-11 2.62E-09 2.91E-10 26885 hsa-mir-924 hsa04012 ErbB signaling pathway 5747_25_1026_5594_5595_5599_5601_2932_5578_3725_6776_6777_5602 13 4.57E-11 3.89E-09 3.86E-10 26886 hsa-mir-924 hsa04010 MAPK signaling pathway 1147_2249_998_5594_5595_5599_5601_3304_3305_3303_6789_3315_5578_5970_3164_3725_1616_5923_5602_2353 20 4.99E-11 4.24E-09 3.86E-10 26887 hsa-mir-924 hsa04120 Ubiquitin mediated proteolysis 10055_672_7319_25898_84447_4193_3093_51588_8554_5371_64326_7329_10075_7337 14 9.49E-10 8.06E-08 6.72E-09 26888 hsa-mir-924 hsa04510 Focal adhesion 5747_998_5594_5595_5599_596_5601_5499_2932_5578_3725_5728_5923_3910_5602 15 1.46E-08 1.24E-06 9.52E-08 26889 hsa-mir-924 hsa04660 T cell receptor signaling pathway 1147_998_5594_5595_5601_2932_5970_3725_959_4792_2353 11 6.52E-08 5.54E-06 3.96E-07 26890 hsa-mir-924 hsa04350 TGF-beta signaling pathway 5518_5515_5594_5595_6667_4088_7027_1387_4087_2033 10 7.86E-08 6.68E-06 4.45E-07 26891 hsa-mir-924 hsa04920 Adipocytokine signaling pathway 1147_5563_6794_5599_5601_6256_5970_4792_5602 9 1.06E-07 8.97E-06 5.61E-07 26892 hsa-mir-924 hsa04662 B cell receptor signaling pathway 1147_5594_5595_1380_2932_5970_3725_4792_2353 9 2.53E-07 2.15E-05 1.27E-06 26893 hsa-mir-924 hsa04620 Toll-like receptor signaling pathway 1147_5594_5595_5599_5601_5970_3725_4792_5602_2353 10 3.08E-07 2.62E-05 1.45E-06 26894 hsa-mir-924 hsa04520 Adherens junction 1460_998_5594_5595_1457_4088_1387_4087_2033 9 4.18E-07 3.55E-05 1.87E-06 26895 hsa-mir-924 hsa05221 Acute myeloid leukemia 1147_5594_5595_5914_5970_5371_6776_6777 8 5.11E-07 4.35E-05 2.17E-06 26896 hsa-mir-924 hsa05214 Glioma 1869_5925_1026_5594_5595_4193_5578_5728 8 9.98E-07 8.48E-05 3.94E-06 26897 hsa-mir-924 hsa03420 Nucleotide excision repair 2965_4331_2074_6117_2071_902_1022 7 1.02E-06 8.66E-05 3.94E-06 26898 hsa-mir-924 hsa05218 Melanoma 1869_5925_2249_1026_5594_5595_4193_5728 8 1.83E-06 0.00015589 6.50E-06 26899 hsa-mir-924 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_998_5599_5601_5970_3725_4792_5602 8 1.83E-06 0.00015589 6.50E-06 26900 hsa-mir-924 hsa05223 Non-small cell lung cancer 1869_5925_5594_5595_6789_5578_6256 7 3.51E-06 0.00029844 1.19E-05 26901 hsa-mir-924 hsa03022 Basal transcription factors 2965_2957_6908_51616_2958_6880 6 5.59E-06 0.000474768 1.83E-05 26902 hsa-mir-924 hsa05219 Bladder cancer 1869_5925_1026_5594_5595_4193 6 1.08E-05 0.000914498 3.39E-05 26903 hsa-mir-924 hsa04330 Notch signaling pathway 1856_1387_9612_3065_2033_8850 6 1.93E-05 0.001637213 5.82E-05 26904 hsa-mir-924 hsa05211 Renal cell carcinoma 998_5594_5595_1387_3725_3091_2033 7 1.99E-05 0.001687933 5.82E-05 26905 hsa-mir-924 hsa04370 VEGF signaling pathway 5743_5747_998_5594_5595_3315_5578 7 2.97E-05 0.002522193 8.41E-05 26906 hsa-mir-924 hsa04912 GnRH signaling pathway 998_5594_5595_5599_5601_5578_3725_5602 8 3.19E-05 0.002715299 8.76E-05 26907 hsa-mir-924 hsa04062 Chemokine signaling pathway 1147_5747_998_5594_5595_2932_5970_6362_6777_4792 10 6.16E-05 0.005233852 0.000163558 26908 hsa-mir-924 hsa04612 Antigen processing and presentation 3320_3326_3309_3304_3305_3303_4800 7 7.02E-05 0.005963144 0.000175387 26909 hsa-mir-924 hsa04210 Apoptosis 1147_823_596_5970_598_4792_472 7 7.02E-05 0.005963144 0.000175387 26910 hsa-mir-924 hsa04530 Tight junction 1460_998_5518_5515_1457_5578_5728_5520 8 0.000154113 0.013099618 0.000374275 26911 hsa-mir-924 hsa04910 Insulin signaling pathway 5563_5594_5595_5599_5601_5499_2932_5602 8 0.000161585 0.013734723 0.00038152 26912 hsa-mir-924 hsa04916 Melanogenesis 5594_5595_1856_2932_1387_5578_2033 7 0.000174901 0.014866615 0.000396028 26913 hsa-mir-924 hsa04930 Type II diabetes mellitus 5594_5595_5599_5601_5602 5 0.000177048 0.015049057 0.000396028 26914 hsa-mir-924 hsa04720 Long-term potentiation 5594_5595_5499_1387_5578_2033 6 0.000212992 0.018104354 0.000464214 26915 hsa-mir-924 hsa04664 Fc epsilon RI signaling pathway 5594_5595_5599_5601_5578_5602 6 0.000277163 0.023558823 0.000588971 26916 hsa-mir-924 hsa04150 mTOR signaling pathway 5563_5594_6794_5595_3091 5 0.000329567 0.028013158 0.000675407 26917 hsa-mir-924 hsa03440 Homologous recombination 675_6117_641_5888 4 0.000338726 0.028791707 0.000675407 26918 hsa-mir-924 hsa04630 Jak-STAT signaling pathway 1387_51588_8554_598_6776_6777_2033_3977 8 0.000341677 0.029042514 0.000675407 26919 hsa-mir-924 hsa05131 Shigellosis 25_998_7534_5578_4691 5 0.000452542 0.038466056 0.000854801 26920 hsa-mir-924 hsa05130 Pathogenic Escherichia coli infection 25_998_7534_5578_4691 5 0.000452542 0.038466056 0.000854801 26921 hsa-mir-924 hsa04360 Axon guidance 5747_25_998_5594_5595_2932_1020 7 0.00065647 0.055799982 0.001213043 26922 hsa-mir-924 hsa03410 Base excision repair 142_3146_328_4913 4 0.000805972 0.068507583 0.001457608 26923 hsa-mir-924 hsa05016 Huntington's disease 25942_3064_6908_6667_27113_1387_3065_2033 8 0.001144198 0.097256793 0.002026183 26924 hsa-mir-924 hsa04730 Long-term depression 5518_5515_5594_5595_5578 5 0.001236869 0.105133873 0.002145589 26925 hsa-mir-924 hsa05213 Endometrial cancer 5594_5595_2932_5728 4 0.0028409 0.241476537 0.004829531 26926 hsa-mir-924 hsa04540 Gap junction 5594_5595_983_1453_5578 5 0.003773385 0.320737728 0.006288975 26927 hsa-mir-924 hsa05216 Thyroid cancer 5594_5595_6256 3 0.004526489 0.384751601 0.007399069 26928 hsa-mir-924 hsa03030 DNA replication 6117_5557_5422 3 0.007902884 0.671745141 0.012674437 26929 hsa-mir-924 hsa03450 Non-homologous end-joining 5591_2547 2 0.011943152 1 0.018799406 26930 hsa-mir-924 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_1616 3 0.024129437 1 0.037290947 26931 hsa-mir-924 hsa04340 Hedgehog signaling pathway 1453_2932_1452 3 0.025207277 1 0.038261045 26932 hsa-mir-924 hsa03430 Mismatch repair 6117_4436 2 0.028068996 1 0.041857275 26933 hsa-mir-924 hsa04950 Maturity onset diabetes of the young 3172_6927 2 0.030200973 1 0.044260047 26934 hsa-mir-924 hsa04810 Regulation of actin cytoskeleton 5747_2249_998_5594_5595_5499 6 0.031958041 1 0.046041245 26935 hsa-mir-924 hsa04270 Vascular smooth muscle contraction 5594_5595_5499_5578 4 0.039875134 1 0.056489773 26936 hsa-mir-924 hsa05010 Alzheimer's disease 5594_5595_823_2932_1020 5 0.043397452 1 0.060471859 26937 hsa-mir-92a-1 hsa05200 Pathways in cancer 4149_3551_1398_1499_5914_595_596_598_3815_1017_8517_4193_6934_5578_3091_2735_2064_3066_3065_5925_1050_613_5743_5747_10342_25_405_9063_1956_1487_6789_7046_4436_1870_1871_2113_6774_867_10401_207_208_9915_7187_4286_3716_1147_5879_2249_998_1488_2261_5595_5594_5599_861_1387_6256_836_367_2932_6777_6772_5970_7157_7849_1869_3725_5467_6776_4087_4088_4089_5888_5728_2034_2033_5468_4846_3910_898_4790_4791_4792_3320_3326_51176_5371_675_5159_5156_5604_5601_5602_1856_1399_3265_51588_7428_8772_4609_2956_1026_2736_2353_7704_2737_8554 107 1.09E-45 9.69E-44 9.69E-44 26938 hsa-mir-92a-1 hsa04010 MAPK signaling pathway 6722_4149_3551_1398_6195_6197_2264_8517_9252_5578_1845_7132_4773_9020_5923_1956_3304_3305_3303_6789_1432_7046_22800_4763_1616_207_208_1147_5879_2249_998_3727_2261_5595_5594_5599_5598_8986_1386_1649_836_3310_3312_3315_5971_5970_3164_7157_3725_6196_5058_4790_4791_5159_9261_1326_5156_5604_4208_5601_5600_5603_5602_5608_1399_3265_6885_4609_2353_2002_8550_5566 72 1.47E-26 1.31E-24 6.54E-25 26939 hsa-mir-92a-1 hsa05220 Chronic myeloid leukemia 3551_1398_595_598_8517_4193_3066_3065_5925_613_25_1487_7046_1870_1871_867_207_208_1147_1488_5595_5594_861_6777_5970_7157_1869_6776_4088_4089_4790_4792_5604_1399_3265_5781_4609_1026_6464 39 2.88E-23 2.56E-21 8.53E-22 26940 hsa-mir-92a-1 hsa04110 Cell cycle 4174_4172_595_1017_4193_902_6500_3066_3065_5925_25_1870_1871_5111_9232_5934_5933_545_995_5347_7534_5591_1387_11200_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_898_1031_983_8454_1026_1022_1111_8556_8555_472 44 2.18E-21 1.94E-19 4.85E-20 26941 hsa-mir-92a-1 hsa05215 Prostate cancer 3551_1499_595_596_1017_8517_4193_6934_2064_5925_1956_1870_1871_207_208_9586_1147_5595_5594_1387_367_2932_5970_7157_1869_5728_2033_898_4790_4792_3320_3326_51176_5159_5156_5604_3265_1026 38 1.64E-20 1.46E-18 2.92E-19 26942 hsa-mir-92a-1 hsa05212 Pancreatic cancer 3551_1499_595_596_1017_8517_4193_6934_2064_5925_1956_1870_1871_207_208_9586_1147_5595_5594_1387_367_2932_5970_7157_1869_5728_2033_898_4790_4792_3320_3326_51176_5159_5156_5604_3265_1026 38 2.24E-20 1.99E-18 3.32E-19 26943 hsa-mir-92a-1 hsa04310 Wnt signaling pathway 818_817_1499_595_8607_6934_5578_6500_4772_4773_23291_1487_5879_1460_1488_5599_1387_1459_2932_7157_8061_3725_5467_1457_1452_4087_4088_4089_2033_51176_5519_5518_5515_5601_5602_1856_8454_8945_6885_4609_5527_5566 42 1.16E-16 1.03E-14 1.48E-15 26944 hsa-mir-92a-1 hsa04660 T cell receptor signaling pathway 3551_1493_8517_5777_4772_4773_9020_2534_3932_4794_1432_867_207_208_1147_998_5595_5594_2932_5970_3725_5058_959_4790_4792_4793_1326_5604_5601_5600_5603_919_3265_6885_2353 35 1.17E-15 1.04E-13 1.30E-14 26945 hsa-mir-92a-1 hsa05222 Small cell lung cancer 4149_3551_595_596_598_1017_8517_5925_5743_5747_9063_1870_1871_10401_207_208_7187_1147_6256_5970_7157_1869_5728_4846_3910_898_4790_4792_51588_4609_8554 31 3.05E-15 2.72E-13 3.02E-14 26946 hsa-mir-92a-1 hsa05210 Colorectal cancer 1499_595_596_6934_1956_7046_4436_207_208_5879_5595_5594_5599_836_2932_7157_3725_4087_4088_4089_51176_5159_5156_5604_5601_5602_1856_4609_2956_2353 30 1.04E-14 9.26E-13 9.26E-14 26947 hsa-mir-92a-1 hsa04012 ErbB signaling pathway 818_817_1398_5578_2064_5747_25_1956_6714_867_207_208_5595_5594_5599_2066_2932_6777_3725_6776_5058_5604_5601_5602_1399_3265_4609_1026_2002_6464 30 2.22E-14 1.98E-12 1.80E-13 26948 hsa-mir-92a-1 hsa05221 Acute myeloid leukemia 3551_5914_595_3815_8517_6934_1050_6774_207_208_1147_5595_5594_861_6777_5970_5467_6776_4790_51176_5371_5604_3265_4609_7704 25 7.83E-14 6.97E-12 5.61E-13 26949 hsa-mir-92a-1 hsa04630 Jak-STAT signaling pathway 3559_595_598_5777_3455_3594_9063_3560_3561_6773_1439_3595_2057_6774_867_2690_10401_3459_3977_207_208_3717_3716_8651_1387_6778_6777_6772_7297_6776_2033_51588_10379_5781_58985_4609_3575_8554 38 8.19E-14 7.29E-12 5.61E-13 26950 hsa-mir-92a-1 hsa04920 Adipocytokine signaling pathway 3551_10891_5465_6794_8517_7132_8717_2538_4794_8471_6774_207_208_3717_1147_5599_6256_5970_4790_4792_4793_5601_5602_5563_5781_7133 26 1.29E-13 1.15E-11 8.15E-13 26951 hsa-mir-92a-1 hsa04620 Toll-like receptor signaling pathway 3551_8517_3455_3665_3661_1432_207_208_7187_1147_5879_29110_5595_5594_5599_6772_5970_3725_4790_4792_1326_5604_5601_5600_5603_5602_5608_9641_8772_6885_2353 31 1.37E-13 1.22E-11 8.15E-13 26952 hsa-mir-92a-1 hsa05214 Glioma 818_817_595_4193_5578_5925_1956_1870_1871_207_208_5595_5594_7157_1869_5728_808_801_805_5159_5156_5604_3265_1026_6464 25 4.48E-13 3.98E-11 2.49E-12 26953 hsa-mir-92a-1 hsa04520 Adherens junction 1499_6934_5770_5777_2064_2534_1956_6714_7046_5879_1460_998_5595_5594_1387_1459_1457_4087_4088_4089_2033_51176_3643_71_8826_6885 26 3.59E-12 3.20E-10 1.88E-11 26954 hsa-mir-92a-1 hsa04910 Insulin signaling pathway 3551_10891_1398_6720_5770_2538_5590_5499_8471_867_5211_207_208_8651_5595_5594_5599_2932_2194_808_801_805_3643_5604_5601_5602_5563_1399_3265_2002_6464_5566 32 2.57E-11 2.28E-09 1.27E-10 26955 hsa-mir-92a-1 hsa04662 B cell receptor signaling pathway 3551_8517_5777_4772_4773_4794_207_208_1147_5879_695_5595_5594_1380_2932_6850_5970_3725_4790_4792_4793_5604_3265_2353 24 3.15E-11 2.80E-09 1.48E-10 26956 hsa-mir-92a-1 hsa04350 TGF-beta signaling pathway 6500_90_4086_1875_6667_7046_1874_57154_5934_5933_5595_5594_1387_7027_4087_4088_4089_2033_5519_5518_5515_8454_4609_4093_4092 25 8.45E-11 7.52E-09 3.76E-10 26957 hsa-mir-92a-1 hsa04115 p53 signaling pathway 595_1017_4194_4193_900_50484_51246_545_7161_11200_836_7157_6241_64326_5728_898_27113_25898_983_1026_1111_472 22 2.19E-10 1.95E-08 9.29E-10 26958 hsa-mir-92a-1 hsa04510 Focal adhesion 1398_1499_595_596_5578_2064_5923_2534_5747_3791_1956_6714_5499_207_208_5879_998_5595_5594_5599_2932_3725_5058_5728_3910_2321_5159_5156_5604_5601_5602_1399_3265_71_2002_85366_6464 37 4.52E-10 4.03E-08 1.83E-09 26959 hsa-mir-92a-1 hsa04062 Chemokine signaling pathway 3551_1398_8517_653361_5747_5580_5590_6773_2309_6362_6774_207_208_3717_1147_5879_998_5595_5594_1234_2932_6777_6772_5970_5058_4790_4792_4793_1230_5604_1399_3265_7852_6464_5566 35 1.06E-09 9.45E-08 4.11E-09 26960 hsa-mir-92a-1 hsa05219 Bladder cancer 595_9252_4193_2064_5925_1956_1870_1871_2261_5595_5594_7157_1869_5604_3265_4609_1026 17 1.31E-09 1.16E-07 4.85E-09 26961 hsa-mir-92a-1 hsa03010 Ribosome 6193_6204_6205_6207_6202_6141_9349_6217_6137_6135_6210_6155_6156_6191_6222_6223_6229_6129_6128_6125_6130_6181_6189_6188_6232 25 1.42E-09 1.26E-07 5.05E-09 26962 hsa-mir-92a-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3551_8517_9020_1956_6714_1432_1147_5879_998_5599_836_5970_3725_5058_4790_4792_5601_5600_5603_5602_5781 21 1.74E-09 1.55E-07 5.96E-09 26963 hsa-mir-92a-1 hsa05211 Renal cell carcinoma 1398_3091_405_2113_207_208_9915_5879_998_5595_5594_1387_3725_5058_2034_2033_5604_1399_3265_7428_5781 21 2.15E-09 1.91E-07 7.08E-09 26964 hsa-mir-92a-1 hsa05213 Endometrial cancer 1499_595_6934_2064_1956_2309_207_208_5595_5594_2932_7157_5728_51176_5604_3265_4609_2002 18 3.26E-09 2.90E-07 1.04E-08 26965 hsa-mir-92a-1 hsa04912 GnRH signaling pathway 818_817_5578_5580_1956_6714_1432_998_5595_5594_5599_5598_3725_808_801_805_5604_5601_5600_5603_5602_5608_3265_2002_5566 25 3.86E-09 3.43E-07 1.18E-08 26966 hsa-mir-92a-1 hsa05223 Non-small cell lung cancer 595_5578_2064_5925_1956_2309_6789_1870_1871_207_208_5595_5594_6256_7157_1869_5604_3265 18 5.31E-09 4.73E-07 1.58E-08 26967 hsa-mir-92a-1 hsa04370 VEGF signaling pathway 5578_4772_4773_5743_5747_3791_6714_1432_207_208_5879_998_5595_5594_3315_4846_9261_5604_5600_5603_3265 21 5.87E-09 5.23E-07 1.69E-08 26968 hsa-mir-92a-1 hsa05216 Thyroid cancer 1499_595_6934_10342_5595_5594_6256_7157_7849_5468_51176_5604_3265_4609 14 6.40E-09 5.70E-07 1.78E-08 26969 hsa-mir-92a-1 hsa05218 Melanoma 595_4193_5925_1956_1870_1871_207_208_4286_2249_5595_5594_7157_1869_5728_5159_5156_5604_3265_1026 20 8.48E-09 7.55E-07 2.29E-08 26970 hsa-mir-92a-1 hsa04210 Apoptosis 3551_596_598_8517_7132_8717_9020_823_1439_207_208_1147_836_5970_7157_9131_4790_4792_840_8772_472_5566 22 1.19E-08 1.06E-06 3.10E-08 26971 hsa-mir-92a-1 hsa04720 Long-term potentiation 818_814_817_6195_6197_5578_2902_2906_5499_5595_5594_1387_6196_2033_808_801_805_5604_3265_5566 20 1.85E-08 1.65E-06 4.71E-08 26972 hsa-mir-92a-1 hsa04120 Ubiquitin mediated proteolysis 4193_55294_6500_3093_23291_9063_7319_84447_867_10401_7329_8925_57154_8651_10055_51366_64326_7337_5371_672_25898_8454_8945_51588_7428_10075_8554 27 2.40E-08 2.13E-06 5.93E-08 26973 hsa-mir-92a-1 hsa03022 Basal transcription factors 51616_6872_2965_2963_2969_6878_6874_6908_2958_2959_6880_2957_6882_9519 14 7.37E-08 6.56E-06 1.77E-07 26974 hsa-mir-92a-1 hsa04664 Fc epsilon RI signaling pathway 5578_2534_5580_1432_207_208_5879_695_5595_5594_5599_6850_5604_5601_5600_5603_5602_5608_3265 19 1.67E-07 1.49E-05 3.91E-07 26975 hsa-mir-92a-1 hsa04540 Gap junction 5592_5578_10382_1956_6714_5595_5594_5598_7846_1453_347733_5159_983_5156_5604_3265_7278_84617_203068_5566 20 3.78E-07 3.36E-05 8.62E-07 26976 hsa-mir-92a-1 hsa04330 Notch signaling pathway 3066_3065_1840_9794_1487_2648_1488_1387_22938_9612_2033_8850_1856_4851 14 8.20E-07 7.30E-05 1.83E-06 26977 hsa-mir-92a-1 hsa05014 Amyotrophic lateral sclerosis (ALS) 596_598_7132_2902_2906_1432_1616_5879_836_7157_4846_5600_5603_5608_7133 15 1.04E-06 9.28E-05 2.26E-06 26978 hsa-mir-92a-1 hsa04916 Melanogenesis 818_817_1499_3815_6934_5578_4286_5595_5594_1387_2932_2033_808_801_805_51176_5604_1856_3265_5566 20 1.74E-06 0.000154611 3.68E-06 26979 hsa-mir-92a-1 hsa05131 Shigellosis 1499_5578_10382_2534_25_998_7534_7846_347733_7278_71_84617_4691_203068 14 4.71E-06 0.00041917 9.53E-06 26980 hsa-mir-92a-1 hsa05130 Pathogenic Escherichia coli infection 1499_5578_10382_2534_25_998_7534_7846_347733_7278_71_84617_4691_203068 14 4.71E-06 0.00041917 9.53E-06 26981 hsa-mir-92a-1 hsa04530 Tight junction 1499_5578_5580_5590_6714_4627_4628_22800_8573_207_208_1460_998_1459_1457_5728_5519_5518_5515_3265_71_5520 22 7.30E-06 0.000649919 1.44E-05 26982 hsa-mir-92a-1 hsa04930 Type II diabetes mellitus 3551_5580_5590_8471_3651_8651_5595_5594_5599_3643_5601_5602 12 1.29E-05 0.001144695 2.49E-05 26983 hsa-mir-92a-1 hsa03050 Proteasome 5708_5709_5705_5706_5700_5684_5719_5717_5713_5687_5693_5707 12 2.23E-05 0.001983967 4.22E-05 26984 hsa-mir-92a-1 hsa05322 Systemic lupus erythematosus 3021_3020_8366_9555_8349_8362_8365_8368_3018_8294_8370_6628_121504_8360_8363_8364_8367_959_8359_8361 20 0.000114962 0.010231574 0.000213158 26985 hsa-mir-92a-1 hsa04650 Natural killer cell mediated cytotoxicity 5777_5578_3455_4772_4773_2534_3932_3459_5879_5595_5594_836_6850_5058_5604_919_3265_5781_6464 19 0.00018639 0.016588666 0.000338544 26986 hsa-mir-92a-1 hsa03420 Nucleotide excision repair 5981_902_5111_5886_2965_4331_2071_2074_1022_6117 10 0.000208973 0.018598561 0.000371971 26987 hsa-mir-92a-1 hsa03410 Base excision repair 4350_142_4913_252969_5111_3146_328_2237_6996 9 0.000234704 0.020888642 0.000404365 26988 hsa-mir-92a-1 hsa05016 Huntington's disease 10891_293_292_3066_3065_3064_498_25942_2902_6667_9586_1387_836_5437_7157_1213_2033_5468_27113_6874_6908_5441_9519 23 0.000236258 0.021026969 0.000404365 26989 hsa-mir-92a-1 hsa03450 Non-homologous end-joining 2547_10111_7520_2237_5591_4361 6 0.000254676 0.022666203 0.000427664 26990 hsa-mir-92a-1 hsa04060 Cytokine-cytokine receptor interaction 3559_3815_7132_3455_90_3594_3791_1956_3560_3561_1439_7046_3595_2057_6362_2690_3459_3977_1234_959_2321_1230_5159_5156_7852_58985_3575_7133 28 0.000428557 0.038141597 0.000706326 26991 hsa-mir-92a-1 hsa04150 mTOR signaling pathway 6794_6195_6197_3091_207_208_5595_5594_6196_5563 10 0.000664511 0.059141519 0.0010753 26992 hsa-mir-92a-1 hsa04810 Regulation of actin cytoskeleton 10788_1398_2264_5747_1956_5499_4627_4628_22800_5879_2249_998_2261_5595_5594_5058_5159_5156_5604_1399_3265_71_8826_85366 24 0.000734187 0.065342612 0.001166832 26993 hsa-mir-92a-1 hsa03030 DNA replication 5981_4174_4172_5111_2237_5557_6117_5422 8 0.001009998 0.089889789 0.001577014 26994 hsa-mir-92a-1 hsa03440 Homologous recombination 641_10111_4361_4683_5888_675_6117 7 0.001154958 0.102791261 0.001772263 26995 hsa-mir-92a-1 hsa04340 Hedgehog signaling pathway 2735_23291_53944_2932_1452_1453_8945_2736_2737_5566 10 0.001235803 0.10998646 0.001864177 26996 hsa-mir-92a-1 hsa04020 Calcium signaling pathway 818_814_817_293_5578_292_2064_1956_2902_2906_147_2066_4846_808_801_805_5159_5156_85366_5566 20 0.002418527 0.215248871 0.003587481 26997 hsa-mir-92a-1 hsa04740 Olfactory transduction 818_817_5592_808_801_805_5566 7 0.002690948 0.239494361 0.003926137 26998 hsa-mir-92a-1 hsa05217 Basal cell carcinoma 1499_6934_2735_2932_7157_51176_1856_2736_2737 9 0.003243108 0.288636595 0.004655429 26999 hsa-mir-92a-1 hsa04730 Long-term depression 5592_5578_5595_5594_4846_5519_5518_5515_5604_3265 10 0.005138341 0.457312374 0.007258927 27000 hsa-mir-92a-1 hsa03020 RNA polymerase 64425_25885_51082_5437_84172_5441 6 0.005784676 0.514836197 0.008007755 27001 hsa-mir-92a-1 hsa04270 Vascular smooth muscle contraction 5592_5578_5580_147_5499_59_5595_5594_808_801_805_5604_85366_5566 14 0.005848361 0.520504088 0.008007755 27002 hsa-mir-92a-1 hsa03430 Mismatch repair 5981_4436_5111_2956_6117 5 0.00967112 0.860729705 0.013041359 27003 hsa-mir-92a-1 hsa04360 Axon guidance 4772_4773_2534_5747_25_5879_998_5595_5594_2932_5058_3265_7852_1020 14 0.010520257 0.936302834 0.013974669 27004 hsa-mir-92a-1 hsa04950 Maturity onset diabetes of the young 5080_6927_4760_3651_3172 5 0.011235995 1 0.014705934 27005 hsa-mir-92a-1 hsa05340 Primary immunodeficiency 8517_3932_3561_695_959_3575 6 0.012581327 1 0.016228089 27006 hsa-mir-92a-1 hsa05010 Alzheimer's disease 7132_498_823_2902_2906_5595_5594_836_2932_4846_808_351_801_805_840_8772_1020 17 0.016210182 1 0.020610088 27007 hsa-mir-92a-1 hsa04612 Antigen processing and presentation 3309_3304_3305_3303_3310_3312_3320_3326_4800_4801 10 0.027680759 1 0.034698417 27008 hsa-mir-92a-1 hsa04670 Leukocyte transendothelial migration 1499_5578_653361_5747_1432_5879_998_5600_5603_7852_71_5781 12 0.037827534 1 0.046535049 27009 hsa-mir-92a-1 hsa04710 Circadian rhythm - mammal 8863_4862_1453 3 0.038169197 1 0.046535049 27010 hsa-mir-92a-2 hsa05200 Pathways in cancer 5371_2249_367_5595_5594_5914_1387_6256_595_6258_4193_7704_842_6774_6776_6777_3091_5970_7428_1870_1871_7157_4824_4087_6688_4089_2113_4609_1869_3725_841_1029_2353_4088_3066_3065_5925_2034_2033_4846_207_836 42 1.31E-36 8.79E-35 8.79E-35 27011 hsa-mir-92a-2 hsa05220 Chronic myeloid leukemia 5595_5594_595_4193_6776_6777_5970_1870_1871_7157_4089_4609_1869_1029_4088_3066_3065_5925_207_6464 20 1.58E-23 1.06E-21 5.30E-22 27012 hsa-mir-92a-2 hsa05215 Prostate cancer 367_5595_5594_1387_595_4193_1385_842_5970_1870_1871_7157_4824_1869_5925_2033_207 17 4.13E-18 2.77E-16 8.18E-17 27013 hsa-mir-92a-2 hsa05212 Pancreatic cancer 367_5595_5594_1387_595_4193_1385_842_5970_1870_1871_7157_4824_1869_5925_2033_207 17 4.89E-18 3.27E-16 8.18E-17 27014 hsa-mir-92a-2 hsa04110 Cell cycle 5591_1387_595_4193_1870_1871_7157_4087_4089_1869_1029_4088_3066_3065_5925_2033_5933 17 3.79E-16 2.54E-14 5.07E-15 27015 hsa-mir-92a-2 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_6258_842_1870_1871_7157_1869_1029_5925_207 13 3.21E-15 2.15E-13 3.58E-14 27016 hsa-mir-92a-2 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_6774_6776_6777_5970_6688_4609_207 13 8.68E-15 5.81E-13 8.31E-14 27017 hsa-mir-92a-2 hsa05214 Glioma 815_5595_5594_595_4193_1870_1871_7157_1869_1029_5925_207_6464 13 2.59E-14 1.74E-12 2.17E-13 27018 hsa-mir-92a-2 hsa05219 Bladder cancer 5595_5594_595_4193_1870_1871_7157_4609_1869_1029_5925 11 2.04E-13 1.36E-11 1.52E-12 27019 hsa-mir-92a-2 hsa05210 Colorectal cancer 5595_5594_595_842_7157_4087_4089_4609_3725_2353_4088_207_836 13 4.83E-13 3.24E-11 3.24E-12 27020 hsa-mir-92a-2 hsa05222 Small cell lung cancer 6256_595_6258_842_5970_1870_1871_7157_4609_1869_5925_4846_207 13 6.33E-13 4.24E-11 3.86E-12 27021 hsa-mir-92a-2 hsa05218 Melanoma 2249_5595_5594_595_4193_1870_1871_7157_1869_1029_5925_207 12 1.53E-12 1.03E-10 8.56E-12 27022 hsa-mir-92a-2 hsa04010 MAPK signaling pathway 2249_5595_5594_4208_1386_5970_9261_3312_7157_4609_3725_6195_2353_4763_207_836_2002_2005 18 1.06E-11 7.09E-10 5.45E-11 27023 hsa-mir-92a-2 hsa04012 ErbB signaling pathway 815_6714_5595_5594_6776_6777_4609_3725_207_6464_2002 11 2.22E-10 1.49E-08 1.06E-09 27024 hsa-mir-92a-2 hsa05016 Huntington's disease 6874_1387_2902_6908_6667_1385_842_7157_841_3066_3065_3064_2033_836 14 5.04E-10 3.38E-08 2.25E-09 27025 hsa-mir-92a-2 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2113_3725_2034_2033_207 10 6.51E-10 4.36E-08 2.73E-09 27026 hsa-mir-92a-2 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_4087_4089_4609_4088_2033_5933 10 3.47E-09 2.32E-07 1.37E-08 27027 hsa-mir-92a-2 hsa05216 Thyroid cancer 5595_5594_6256_595_6258_7157_4609 7 8.78E-09 5.88E-07 3.27E-08 27028 hsa-mir-92a-2 hsa05213 Endometrial cancer 5595_5594_595_842_7157_4609_207_2002 8 1.69E-08 1.13E-06 5.96E-08 27029 hsa-mir-92a-2 hsa04520 Adherens junction 6714_5595_5594_1387_4087_4089_1457_4088_2033 9 2.54E-08 1.70E-06 8.51E-08 27030 hsa-mir-92a-2 hsa04310 Wnt signaling pathway 815_1387_595_7157_4087_4089_4609_3725_1457_4088_2033 11 4.95E-08 3.32E-06 1.58E-07 27031 hsa-mir-92a-2 hsa04210 Apoptosis 839_842_840_5970_7157_841_207_836 8 7.52E-07 5.04E-05 2.29E-06 27032 hsa-mir-92a-2 hsa04115 p53 signaling pathway 595_4193_842_7157_841_1029_836 7 1.78E-06 0.000119259 5.19E-06 27033 hsa-mir-92a-2 hsa04330 Notch signaling pathway 1387_9612_3066_3065_2033_4851 6 2.94E-06 0.000197221 7.98E-06 27034 hsa-mir-92a-2 hsa04720 Long-term potentiation 815_5595_5594_1387_2902_6195_2033 7 2.98E-06 0.000199597 7.98E-06 27035 hsa-mir-92a-2 hsa04370 VEGF signaling pathway 6714_5595_5594_842_9261_4846_207 7 3.50E-06 0.000234782 9.03E-06 27036 hsa-mir-92a-2 hsa04630 Jak-STAT signaling pathway 1387_595_6774_6776_6777_4609_2033_3977_207 9 4.64E-06 0.000310856 1.15E-05 27037 hsa-mir-92a-2 hsa05010 Alzheimer's disease 22926_5595_5594_2902_842_840_841_4846_836 9 1.28E-05 0.000859328 3.07E-05 27038 hsa-mir-92a-2 hsa04620 Toll-like receptor signaling pathway 5595_5594_5970_3725_841_2353_207 7 1.97E-05 0.001317011 4.54E-05 27039 hsa-mir-92a-2 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725_2353_207 6 3.49E-05 0.002338817 7.80E-05 27040 hsa-mir-92a-2 hsa04150 mTOR signaling pathway 5595_5594_3091_6195_207 5 7.11E-05 0.004762566 0.000153631 27041 hsa-mir-92a-2 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_842_7157_4846_836 5 9.86E-05 0.00660323 0.000206351 27042 hsa-mir-92a-2 hsa04916 Melanogenesis 815_5595_5594_1387_1385_2033 6 0.000192168 0.012875279 0.00039016 27043 hsa-mir-92a-2 hsa04920 Adipocytokine signaling pathway 6256_6258_6774_5970_207 5 0.000216725 0.014520574 0.000427076 27044 hsa-mir-92a-2 hsa04912 GnRH signaling pathway 815_6714_5595_5594_3725_2002 6 0.000233379 0.015636395 0.000435941 27045 hsa-mir-92a-2 hsa04510 Focal adhesion 6714_5595_5594_595_3725_207_6464_2002 8 0.000234237 0.015693878 0.000435941 27046 hsa-mir-92a-2 hsa04660 T cell receptor signaling pathway 5595_5594_5970_3725_2353_207 6 0.000256436 0.01718124 0.000452172 27047 hsa-mir-92a-2 hsa03022 Basal transcription factors 2962_6874_2969_6908 4 0.000256456 0.01718253 0.000452172 27048 hsa-mir-92a-2 hsa04910 Insulin signaling pathway 6720_5595_5594_207_6464_2002 6 0.000808965 0.054200684 0.001389761 27049 hsa-mir-92a-2 hsa04062 Chemokine signaling pathway 5595_5594_6774_6777_5970_207_6464 7 0.000846128 0.056690589 0.001417265 27050 hsa-mir-92a-2 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5970_3725_836 4 0.002520845 0.168896645 0.00411943 27051 hsa-mir-92a-2 hsa04612 Antigen processing and presentation 4800_4801_1385_3312 4 0.005451762 0.365268043 0.008696858 27052 hsa-mir-92a-2 hsa03450 Non-homologous end-joining 5591_2547 2 0.006339776 0.424764996 0.009878256 27053 hsa-mir-92a-2 hsa04730 Long-term depression 5595_5594_4846 3 0.018542228 1 0.028234757 27054 hsa-mir-92a-2 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_6464 4 0.022832258 1 0.033994696 27055 hsa-mir-92a-2 hsa04120 Ubiquitin mediated proteolysis 5371_672_4193_7428 4 0.023354759 1 0.034016714 27056 hsa-mir-92a-2 hsa04664 Fc epsilon RI signaling pathway 5595_5594_207 3 0.02425184 1 0.034571773 27057 hsa-mir-92a-2 hsa04540 Gap junction 6714_5595_5594 3 0.036267399 1 0.050623245 27058 hsa-mir-92a-2 hsa04930 Type II diabetes mellitus 5595_5594 2 0.049049909 1 0.067068242 27059 hsa-mir-92b hsa03022 Basal transcription factors 2967_2961_2960_2963_6881_54457_2968_6878_6877_138474_6879_6908_6874_2958_2957_6873_6872_6884_6880_6882_6883_2959 22 7.46E-32 5.00E-30 5.00E-30 27060 hsa-mir-92b hsa05200 Pathways in cancer 3716_25_5594_5599_6258_1387_6257_6256_8031_10401_4193_5970_7157_6688_2113_4609_3725_861_2353_4089_5925_2033_3326_8554_4790_4792_7184 27 6.05E-19 4.05E-17 2.03E-17 27061 hsa-mir-92b hsa05220 Chronic myeloid leukemia 25_5594_4193_5970_7157_4609_861_4089_5925_4790_4792 11 6.33E-11 4.24E-09 1.41E-09 27062 hsa-mir-92b hsa05222 Small cell lung cancer 6258_6257_6256_10401_5970_7157_4609_5925_8554_4790_4792 11 2.39E-10 1.60E-08 3.72E-09 27063 hsa-mir-92b hsa05215 Prostate cancer 5594_1387_4193_5970_7157_5925_2033_3326_4790_4792_7184 11 2.99E-10 2.00E-08 3.72E-09 27064 hsa-mir-92b hsa05212 Pancreatic cancer 5594_1387_4193_5970_7157_5925_2033_3326_4790_4792_7184 11 3.33E-10 2.23E-08 3.72E-09 27065 hsa-mir-92b hsa04350 TGF-beta signaling pathway 5594_1387_6667_3399_3398_4609_4086_4089_2033_4093 10 4.09E-09 2.74E-07 3.92E-08 27066 hsa-mir-92b hsa04110 Cell cycle 25_1387_4193_7157_10912_4171_4085_4089_5925_2033_4616 11 5.59E-09 3.75E-07 4.68E-08 27067 hsa-mir-92b hsa05216 Thyroid cancer 5594_6258_6257_6256_8031_7157_4609 7 9.89E-09 6.63E-07 7.36E-08 27068 hsa-mir-92b hsa04010 MAPK signaling pathway 3727_5594_5599_3312_5970_7157_10912_4773_4609_3725_2353_1616_4616_4790 14 5.59E-08 3.74E-06 3.60E-07 27069 hsa-mir-92b hsa04310 Wnt signaling pathway 1460_5599_1387_7157_8607_4773_4609_3725_1457_4089_2033 11 5.91E-08 3.96E-06 3.60E-07 27070 hsa-mir-92b hsa04920 Adipocytokine signaling pathway 10891_5599_6258_6257_6256_5970_4790_4792 8 1.16E-07 7.74E-06 6.45E-07 27071 hsa-mir-92b hsa04662 B cell receptor signaling pathway 5594_5777_5970_4773_3725_2353_4790_4792 8 2.56E-07 1.72E-05 1.32E-06 27072 hsa-mir-92b hsa04520 Adherens junction 1460_6714_5594_1387_5777_1457_4089_2033 8 4.04E-07 2.71E-05 1.93E-06 27073 hsa-mir-92b hsa05016 Huntington's disease 10891_3064_1387_6908_6874_6667_9001_5430_7157_2033 10 3.36E-06 0.000225191 1.49E-05 27074 hsa-mir-92b hsa03050 Proteasome 5684_5705_5701_5702_5719_5710 6 3.63E-06 0.000243502 1.49E-05 27075 hsa-mir-92b hsa04660 T cell receptor signaling pathway 5594_5777_5970_4773_3725_2353_4790_4792 8 3.78E-06 0.000252992 1.49E-05 27076 hsa-mir-92b hsa04630 Jak-STAT signaling pathway 3716_3566_1387_10401_5777_6773_4609_2033_8554 9 5.34E-06 0.000357512 1.99E-05 27077 hsa-mir-92b hsa05210 Colorectal cancer 5594_5599_7157_4609_3725_2353_4089 7 6.70E-06 0.00044914 2.27E-05 27078 hsa-mir-92b hsa05223 Non-small cell lung cancer 5594_6258_6257_6256_7157_5925 6 6.78E-06 0.000454244 2.27E-05 27079 hsa-mir-92b hsa05221 Acute myeloid leukemia 5594_5970_6688_4609_861_4790 6 1.08E-05 0.000725879 3.46E-05 27080 hsa-mir-92b hsa04620 Toll-like receptor signaling pathway 5594_5599_5970_3725_2353_4790_4792 7 2.20E-05 0.001471249 6.69E-05 27081 hsa-mir-92b hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5599_5970_3725_4790_4792 6 2.88E-05 0.001929941 8.39E-05 27082 hsa-mir-92b hsa05219 Bladder cancer 5594_4193_7157_4609_5925 5 3.01E-05 0.002014395 8.39E-05 27083 hsa-mir-92b hsa04012 ErbB signaling pathway 25_6714_5594_5599_4609_3725 6 8.36E-05 0.00560323 0.000224129 27084 hsa-mir-92b hsa05211 Renal cell carcinoma 5594_1387_2113_3725_2033 5 0.000321325 0.021528756 0.000828029 27085 hsa-mir-92b hsa04330 Notch signaling pathway 1387_9612_2033_8850 4 0.000636451 0.04264225 0.001579343 27086 hsa-mir-92b hsa05214 Glioma 5594_4193_7157_5925 4 0.001977295 0.13247874 0.004731384 27087 hsa-mir-92b hsa04115 p53 signaling pathway 4193_7157_10912_4616 4 0.002430854 0.162867205 0.005616111 27088 hsa-mir-92b hsa03320 PPAR signaling pathway 6258_6257_6256_2168 4 0.002554508 0.171152043 0.005705068 27089 hsa-mir-92b hsa05218 Melanoma 5594_4193_7157_5925 4 0.002682413 0.179721662 0.005797473 27090 hsa-mir-92b hsa04062 Chemokine signaling pathway 5590_5594_6773_5970_4790_4792 6 0.004487186 0.300641461 0.009395046 27091 hsa-mir-92b hsa04910 Insulin signaling pathway 10891_5590_5594_5599_5211 5 0.005025619 0.33671648 0.01020353 27092 hsa-mir-92b hsa03420 Nucleotide excision repair 2967_2968_5887 3 0.005641016 0.377948085 0.010834892 27093 hsa-mir-92b hsa04210 Apoptosis 5970_7157_4790_4792 4 0.005790606 0.387970616 0.010834892 27094 hsa-mir-92b hsa05322 Systemic lupus erythematosus 333932_3014_8340_3015_126961 5 0.005966546 0.399758552 0.010834892 27095 hsa-mir-92b hsa04930 Type II diabetes mellitus 5590_5594_5599 3 0.005983448 0.40089099 0.010834892 27096 hsa-mir-92b hsa05213 Endometrial cancer 5594_7157_4609 3 0.008727125 0.584717363 0.015387299 27097 hsa-mir-92b hsa04912 GnRH signaling pathway 6714_5594_5599_3725 4 0.011009893 0.737662857 0.018914432 27098 hsa-mir-92b hsa04950 Maturity onset diabetes of the young 5080_4760 2 0.016882577 1 0.028278317 27099 hsa-mir-92b hsa04720 Long-term potentiation 5594_1387_2033 3 0.022266826 1 0.036387253 27100 hsa-mir-92b hsa04530 Tight junction 1460_6714_5590_1457 4 0.023591308 1 0.037056863 27101 hsa-mir-92b hsa04370 VEGF signaling pathway 6714_5594_4773 3 0.023782763 1 0.037056863 27102 hsa-mir-92b hsa04612 Antigen processing and presentation 4801_3312_3326 3 0.034021415 1 0.051805337 27103 hsa-mir-92b hsa04540 Gap junction 6714_5594_10382 3 0.037865624 1 0.056377707 27104 hsa-mir-92b hsa04916 Melanogenesis 5594_1387_2033 3 0.04952211 1 0.07213003 27105 hsa-mir-93 hsa05200 Pathways in cancer 3320_5371_9063_5595_5594_5599_5914_1387_6256_595_1487_1488_836_367_1017_2932_2353_4149_7704_3091_5970_7428_1870_1871_2885_7157_2113_4609_1869_3725_5604_1029_5601_4087_4088_4089_3066_3065_4292_1050_5925_2034_2033_4846_6502_5894_7186 47 1.41E-42 9.43E-41 9.43E-41 27106 hsa-mir-93 hsa04110 Cell cycle 990_5591_1387_595_983_1017_2932_8454_6500_1870_1871_7157_1869_1029_4087_4088_4089_3066_3065_5925_2033_5933_890_6502_5934 25 1.15E-26 7.69E-25 3.85E-25 27107 hsa-mir-93 hsa05220 Chronic myeloid leukemia 5595_5594_595_1487_1488_5970_1870_1871_2885_7157_4609_1869_5604_1029_4088_4089_3066_3065_5925_6464_5894 21 7.91E-25 5.30E-23 1.77E-23 27108 hsa-mir-93 hsa04010 MAPK signaling pathway 6722_5595_5594_5599_5598_4208_5600_3303_836_2353_4149_3312_1386_1432_5970_9344_2885_7157_4609_3725_5604_5606_5601_4763_2005_5894_7186 27 6.41E-21 4.29E-19 1.07E-19 27109 hsa-mir-93 hsa05210 Colorectal cancer 5595_5594_5599_595_836_2932_2353_2885_7157_4609_3725_5604_5601_4087_4088_4089_4292_5894 18 1.21E-19 8.10E-18 1.62E-18 27110 hsa-mir-93 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_8454_3397_3399_3398_6500_1874_1875_4609_4087_4088_4089_2033_5933_5934 18 2.10E-19 1.40E-17 2.34E-18 27111 hsa-mir-93 hsa05215 Prostate cancer 3320_5595_5594_1387_595_367_1017_2932_5970_1870_1871_2885_7157_1869_5604_5925_2033_5894 18 2.51E-19 1.68E-17 2.40E-18 27112 hsa-mir-93 hsa05212 Pancreatic cancer 3320_5595_5594_1387_595_367_1017_2932_5970_1870_1871_2885_7157_1869_5604_5925_2033_5894 18 3.00E-19 2.01E-17 2.51E-18 27113 hsa-mir-93 hsa04310 Wnt signaling pathway 5599_1387_595_1487_1488_1459_2932_8454_6500_7157_8061_4609_3725_1457_5601_4087_4088_4089_2033 19 9.34E-17 6.26E-15 6.95E-16 27114 hsa-mir-93 hsa05222 Small cell lung cancer 9063_6256_595_1017_4149_5970_1870_1871_7157_4609_1869_5925_4846_6502_7186 15 2.11E-15 1.42E-13 1.42E-14 27115 hsa-mir-93 hsa05223 Non-small cell lung cancer 5595_5594_6256_595_1870_1871_2885_7157_1869_5604_1029_5925_5894 13 4.24E-15 2.84E-13 2.58E-14 27116 hsa-mir-93 hsa05219 Bladder cancer 5595_5594_595_1870_1871_7157_4609_1869_5604_1029_5925_5894 12 8.51E-15 5.70E-13 4.75E-14 27117 hsa-mir-93 hsa05214 Glioma 5595_5594_595_1870_1871_2885_7157_1869_5604_1029_5925_6464_5894 13 3.42E-14 2.29E-12 1.76E-13 27118 hsa-mir-93 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_5970_2885_4609_5604_1050_5894 12 2.83E-13 1.90E-11 1.36E-12 27119 hsa-mir-93 hsa05211 Renal cell carcinoma 5595_5594_1387_3091_7428_2885_2113_3725_5604_2034_2033_5894 12 2.29E-12 1.53E-10 1.02E-11 27120 hsa-mir-93 hsa04540 Gap junction 5595_5594_5598_983_7277_2885_7846_5604_7278_51807_10376_5894 12 3.43E-11 2.30E-09 1.44E-10 27121 hsa-mir-93 hsa05218 Melanoma 5595_5594_595_1870_1871_7157_1869_5604_1029_5925_5894 11 3.89E-11 2.61E-09 1.53E-10 27122 hsa-mir-93 hsa05213 Endometrial cancer 5595_5594_595_2932_2885_7157_4609_5604_4292_5894 10 4.61E-11 3.09E-09 1.72E-10 27123 hsa-mir-93 hsa04912 GnRH signaling pathway 5595_5594_5599_5598_5600_1432_2885_3725_5604_5606_5601_5894 12 1.67E-10 1.12E-08 5.90E-10 27124 hsa-mir-93 hsa04660 T cell receptor signaling pathway 5595_5594_5600_2932_2353_1432_5970_2885_3725_5604_5601_5894 12 2.03E-10 1.36E-08 6.81E-10 27125 hsa-mir-93 hsa04012 ErbB signaling pathway 5595_5594_5599_2932_2885_4609_3725_5604_5601_6464_5894 11 2.80E-10 1.87E-08 8.92E-10 27126 hsa-mir-93 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_5600_2353_1432_5970_3725_5604_5606_5601 11 1.31E-09 8.79E-08 3.99E-09 27127 hsa-mir-93 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599_5600_1432_2885_5604_5606_5601_5894 10 1.82E-09 1.22E-07 5.30E-09 27128 hsa-mir-93 hsa04330 Notch signaling pathway 2648_1387_1487_1488_9612_3066_3065_2033 8 9.84E-09 6.59E-07 2.73E-08 27129 hsa-mir-93 hsa05216 Thyroid cancer 5595_5594_6256_595_7157_4609_5604 7 1.02E-08 6.82E-07 2.73E-08 27130 hsa-mir-93 hsa04662 B cell receptor signaling pathway 5595_5594_2932_2353_5970_2885_3725_5604_5894 9 1.83E-08 1.23E-06 4.72E-08 27131 hsa-mir-93 hsa04520 Adherens junction 5595_5594_1387_1459_1457_4087_4088_4089_2033 9 3.06E-08 2.05E-06 7.59E-08 27132 hsa-mir-93 hsa04910 Insulin signaling pathway 6720_5595_5594_5599_2932_2885_5604_5601_6464_5894 10 2.45E-07 1.64E-05 5.87E-07 27133 hsa-mir-93 hsa05016 Huntington's disease 6874_1387_2902_6908_836_6667_7157_3066_3065_3064_2033 11 4.63E-07 3.10E-05 1.07E-06 27134 hsa-mir-93 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_5600_836_1432_7157_5606_4846 7 5.66E-07 3.79E-05 1.26E-06 27135 hsa-mir-93 hsa04510 Focal adhesion 5595_5594_5599_595_2932_2885_3725_5604_5601_6464_5894 11 1.09E-06 7.30E-05 2.35E-06 27136 hsa-mir-93 hsa04115 p53 signaling pathway 595_983_836_1017_7157_7161_1029 7 2.05E-06 0.000137564 4.30E-06 27137 hsa-mir-93 hsa04120 Ubiquitin mediated proteolysis 55294_5371_9063_672_8454_6500_7428_7329_6502 9 2.38E-06 0.000159424 4.83E-06 27138 hsa-mir-93 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_5600_836_1432_5970_3725_5601 7 2.45E-06 0.000164083 4.83E-06 27139 hsa-mir-93 hsa04720 Long-term potentiation 5595_5594_1387_2902_5604_2033_5894 7 3.43E-06 0.000230036 6.57E-06 27140 hsa-mir-93 hsa04370 VEGF signaling pathway 5595_5594_5600_1432_5604_4846_5894 7 4.04E-06 0.000270509 7.51E-06 27141 hsa-mir-93 hsa05131 Shigellosis 7277_7846_7278_51807_4691_10376 6 8.42E-06 0.000564246 1.48E-05 27142 hsa-mir-93 hsa05130 Pathogenic Escherichia coli infection 7277_7846_7278_51807_4691_10376 6 8.42E-06 0.000564246 1.48E-05 27143 hsa-mir-93 hsa04916 Melanogenesis 5595_5594_1387_2932_5604_2033_5894 7 2.54E-05 0.001701205 4.36E-05 27144 hsa-mir-93 hsa04062 Chemokine signaling pathway 5595_5594_2932_5970_2885_5604_7074_6464_5894 9 2.92E-05 0.001957872 4.89E-05 27145 hsa-mir-93 hsa04612 Antigen processing and presentation 3320_3303_4800_4801_4802_3312 6 9.64E-05 0.006457281 0.000157495 27146 hsa-mir-93 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_836_2885_5604_6464_5894 7 0.00013836 0.009270124 0.000220717 27147 hsa-mir-93 hsa04920 Adipocytokine signaling pathway 5599_6256_5970_5601_7186 5 0.000239392 0.016039244 0.000373006 27148 hsa-mir-93 hsa03022 Basal transcription factors 2962_2969_6874_6908 4 0.000278325 0.018647788 0.000423813 27149 hsa-mir-93 hsa04730 Long-term depression 5595_5594_5604_4846_5894 5 0.000308313 0.020656972 0.000459044 27150 hsa-mir-93 hsa04930 Type II diabetes mellitus 5595_5594_5599_5601 4 0.000554925 0.037179954 0.00080826 27151 hsa-mir-93 hsa05010 Alzheimer's disease 5595_5594_2902_836_2932_6622_4846 7 0.000587752 0.039379394 0.000837859 27152 hsa-mir-93 hsa04630 Jak-STAT signaling pathway 9063_1387_595_2885_4609_2033 6 0.001603795 0.10745425 0.00223863 27153 hsa-mir-93 hsa04210 Apoptosis 836_5970_7157_7186 4 0.005877447 0.393788966 0.00803651 27154 hsa-mir-93 hsa04150 mTOR signaling pathway 5595_5594_3091 3 0.008828926 0.591538067 0.011830761 27155 hsa-mir-93 hsa04270 Vascular smooth muscle contraction 5595_5594_5604_5894 4 0.014889906 0.997623676 0.019561249 27156 hsa-mir-93 hsa04810 Regulation of actin cytoskeleton 5595_5594_5604_7074_5894 5 0.030189739 1 0.038898317 27157 hsa-mir-9-3 hsa05200 Pathways in cancer 4149_5467_5468_5914_595_1017_4193_6934_7704_3091_2735_2737_4089_3065_1050_5925_1499_25_405_1956_4436_1487_1488_1870_1871_4824_2113_10401_861_867_207_4286_3716_5595_5594_5599_6258_1387_6256_836_367_6774_6776_6777_6772_5970_7157_6688_7849_1869_3725_4087_4088_2034_2033_9915_51176_5371_675_5159_5156_5604_5601_5602_1399_1398_3815_842_841_4609_2956_2736_2353_8554 74 9.91E-46 7.83E-44 7.83E-44 27158 hsa-mir-9-3 hsa05220 Chronic myeloid leukemia 595_4193_4089_3065_5925_25_1487_1488_1870_1871_861_867_207_5595_5594_6776_6777_5970_7157_1869_4088_5604_1399_1398_5781_4609_6464 27 6.90E-22 5.45E-20 2.73E-20 27159 hsa-mir-9-3 hsa05215 Prostate cancer 595_1017_4193_6934_5925_1499_1956_1870_1871_4824_207_9586_5595_5594_1385_1387_367_5970_7157_468_1869_2033_51176_5159_5156_5604_842 27 2.15E-20 1.70E-18 5.43E-19 27160 hsa-mir-9-3 hsa05212 Pancreatic cancer 595_1017_4193_6934_5925_1499_1956_1870_1871_4824_207_9586_5595_5594_1385_1387_367_5970_7157_468_1869_2033_51176_5159_5156_5604_842 27 2.75E-20 2.17E-18 5.43E-19 27161 hsa-mir-9-3 hsa05210 Colorectal cancer 595_6934_4089_1499_1956_4436_207_5595_5594_5599_836_7157_3725_4087_4088_51176_5159_5156_5604_5601_5602_842_4609_2956_2353 25 1.02E-18 8.07E-17 1.61E-17 27162 hsa-mir-9-3 hsa04010 MAPK signaling pathway 3727_4149_9252_4773_1956_1432_1616_207_5595_5594_5599_1386_836_1649_5970_3164_7157_468_3725_6195_5159_9261_5156_5604_4208_5601_5600_5603_5602_1399_1398_4609_2353_8550_2002_2005 36 3.63E-16 2.87E-14 4.28E-15 27163 hsa-mir-9-3 hsa05221 Acute myeloid leukemia 5467_5914_595_6934_7704_1050_861_207_5595_5594_6774_6776_6777_5970_6688_51176_5371_5604_3815_4609 20 3.79E-16 2.99E-14 4.28E-15 27164 hsa-mir-9-3 hsa04012 ErbB signaling pathway 815_25_1956_6714_867_207_5595_5594_5599_2066_6776_6777_3725_5604_5601_5602_1399_1398_4609_6464_2002 21 2.10E-14 1.66E-12 1.97E-13 27165 hsa-mir-9-3 hsa04310 Wnt signaling pathway 815_5467_595_6934_4089_4772_4773_1499_1487_1488_5599_1387_1459_7157_8061_3725_1457_4087_4088_2033_51176_5515_5601_5602_4609_5527 26 2.24E-14 1.77E-12 1.97E-13 27166 hsa-mir-9-3 hsa04630 Jak-STAT signaling pathway 3559_595_5777_3560_3561_2057_10401_867_2690_207_3717_3716_3718_85480_1387_3575_6778_6774_6775_6776_6777_6772_2033_5781_4609_8554 26 3.37E-14 2.66E-12 2.66E-13 27167 hsa-mir-9-3 hsa04110 Cell cycle 595_1017_4193_4089_3065_5925_25_1870_1871_8379_5934_5933_5591_1387_7533_7027_7157_1869_5111_4087_4088_2033_890 23 7.45E-14 5.89E-12 5.35E-13 27168 hsa-mir-9-3 hsa04350 TGF-beta signaling pathway 4086_4089_6667_3399_3398_1874_1875_5934_5933_5595_5594_1387_7027_4087_4088_2033_5515_4093_4609_4092 20 1.93E-13 1.52E-11 1.27E-12 27169 hsa-mir-9-3 hsa05216 Thyroid cancer 5468_595_6934_1499_5595_5594_6258_6256_7157_7849_51176_5604_4609 13 3.34E-12 2.64E-10 2.03E-11 27170 hsa-mir-9-3 hsa05223 Non-small cell lung cancer 595_5925_1956_2309_1870_1871_207_5595_5594_6258_6256_7157_1869_5604_842 15 2.05E-11 1.62E-09 1.09E-10 27171 hsa-mir-9-3 hsa05214 Glioma 815_595_4193_5925_1956_1870_1871_207_5595_5594_7157_1869_5159_5156_5604_6464 16 2.07E-11 1.64E-09 1.09E-10 27172 hsa-mir-9-3 hsa04520 Adherens junction 6934_5770_5777_4089_1499_1956_6714_5595_5594_1387_1459_1457_4087_4088_2033_51176_3643 17 3.67E-11 2.90E-09 1.81E-10 27173 hsa-mir-9-3 hsa05213 Endometrial cancer 595_6934_1499_1956_2309_207_5595_5594_7157_51176_5604_842_4609_2002 14 1.37E-10 1.08E-08 6.34E-10 27174 hsa-mir-9-3 hsa05219 Bladder cancer 595_9252_4193_5925_1956_1870_1871_5595_5594_7157_1869_5604_4609 13 1.46E-10 1.16E-08 6.42E-10 27175 hsa-mir-9-3 hsa04660 T cell receptor signaling pathway 1493_5777_4772_4773_3932_1432_867_207_5595_5594_5970_3725_5604_5601_5600_5603_919_2353 18 4.25E-10 3.36E-08 1.77E-09 27176 hsa-mir-9-3 hsa05218 Melanoma 595_4193_5925_1956_1870_1871_207_4286_5595_5594_7157_1869_5159_5156_5604 15 5.59E-10 4.42E-08 2.21E-09 27177 hsa-mir-9-3 hsa05211 Renal cell carcinoma 3091_405_2113_207_5595_5594_1387_3725_2034_2033_9915_5604_1399_1398_5781 15 6.62E-10 5.23E-08 2.49E-09 27178 hsa-mir-9-3 hsa05222 Small cell lung cancer 4149_595_1017_5925_1870_1871_10401_207_6258_6256_5970_7157_1869_842_4609_8554 16 7.66E-10 6.05E-08 2.75E-09 27179 hsa-mir-9-3 hsa04620 Toll-like receptor signaling pathway 3665_3661_1432_207_5595_5594_5599_6772_5970_3725_5604_5601_5600_5603_5602_841_2353 17 1.01E-09 8.00E-08 3.48E-09 27180 hsa-mir-9-3 hsa04330 Notch signaling pathway 1840_3065_22938_1487_1488_2648_1387_2033_8850_9612_9794_4851 12 4.77E-09 3.77E-07 1.57E-08 27181 hsa-mir-9-3 hsa04912 GnRH signaling pathway 815_5580_1956_6714_1432_5595_5594_5599_468_3725_5604_5601_5600_5603_5602_2002 16 1.41E-08 1.11E-06 4.44E-08 27182 hsa-mir-9-3 hsa05322 Systemic lupus erythematosus 3020_9555_8349_8365_8366_8294_8370_121504_8361_8360_8363_8362_8364_8367_8368_8359_3021 17 1.02E-07 8.06E-06 3.10E-07 27183 hsa-mir-9-3 hsa04664 Fc epsilon RI signaling pathway 5580_6850_1432_207_695_5595_5594_5599_5604_5601_5600_5603_5602 13 1.07E-07 8.48E-06 3.14E-07 27184 hsa-mir-9-3 hsa04920 Adipocytokine signaling pathway 10891_5465_207_3717_5599_6258_6256_6774_5970_5601_5602_5781 12 1.47E-07 1.16E-05 4.14E-07 27185 hsa-mir-9-3 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_1432_5599_836_5970_3725_5601_5600_5603_5602_5781 12 2.56E-07 2.02E-05 6.97E-07 27186 hsa-mir-9-3 hsa04662 B cell receptor signaling pathway 5777_4772_4773_6850_207_695_5595_5594_5970_3725_5604_2353 12 4.33E-07 3.42E-05 1.14E-06 27187 hsa-mir-9-3 hsa04370 VEGF signaling pathway 4772_4773_6714_1432_207_5595_5594_9261_5604_5600_5603_842 12 5.57E-07 4.40E-05 1.42E-06 27188 hsa-mir-9-3 hsa04910 Insulin signaling pathway 10891_5770_867_207_5595_5594_5599_3643_5604_5601_5602_1399_1398_6464_2002 15 1.48E-06 0.000116655 3.65E-06 27189 hsa-mir-9-3 hsa04510 Focal adhesion 595_1499_1956_6714_207_5595_5594_5599_3725_5159_5156_5604_5601_5602_1399_1398_6464_2002 18 2.50E-06 0.000197636 5.99E-06 27190 hsa-mir-9-3 hsa04062 Chemokine signaling pathway 1234_5580_2309_207_3717_3718_5595_5594_6774_6777_6772_5970_5604_1399_1398_7852_6464 17 4.28E-06 0.000338297 9.95E-06 27191 hsa-mir-9-3 hsa04115 p53 signaling pathway 595_1017_4194_4193_836_7157_64326_842_841_7161 10 8.71E-06 0.000687713 1.96E-05 27192 hsa-mir-9-3 hsa04916 Melanogenesis 815_6934_1499_4286_5595_5594_1385_1387_2033_51176_5604_3815 12 9.44E-06 0.00074582 2.07E-05 27193 hsa-mir-9-3 hsa04650 Natural killer cell mediated cytotoxicity 5777_4772_4773_3932_6850_5595_5594_836_5604_919_5781_6464 12 0.00012085 0.009547123 0.00025803 27194 hsa-mir-9-3 hsa04930 Type II diabetes mellitus 5580_5595_5594_5599_3643_5601_5602 7 0.000132319 0.010453166 0.000275083 27195 hsa-mir-9-3 hsa05016 Huntington's disease 10891_5468_3065_4724_6667_9586_1385_1387_836_7157_2033_6908_842_841 14 0.000157932 0.012476645 0.000319914 27196 hsa-mir-9-3 hsa03410 Base excision repair 4350_252969_328_2237_5111_6996 6 0.000287666 0.02272564 0.000568141 27197 hsa-mir-9-3 hsa03022 Basal transcription factors 2963_2962_2969_6872_6908_2959 6 0.000328188 0.025926887 0.000632363 27198 hsa-mir-9-3 hsa05217 Basal cell carcinoma 6934_2735_2737_1499_7157_51176_2736 7 0.000402892 0.0318285 0.000757821 27199 hsa-mir-9-3 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_1616_836_7157_5600_5603_842 7 0.000444812 0.035140112 0.000817212 27200 hsa-mir-9-3 hsa04720 Long-term potentiation 815_5595_5594_1387_468_6195_2033_5604 8 0.00046946 0.037087351 0.000842894 27201 hsa-mir-9-3 hsa04120 Ubiquitin mediated proteolysis 55294_4193_10401_867_7329_8925_83737_64326_5371_672_8554 11 0.000484779 0.038297571 0.000851057 27202 hsa-mir-9-3 hsa03450 Non-homologous end-joining 10111_2237_5591_4361 4 0.000544096 0.042983618 0.000934426 27203 hsa-mir-9-3 hsa04210 Apoptosis 207_836_839_5970_7157_842_841_840 8 0.00131825 0.104141777 0.002215782 27204 hsa-mir-9-3 hsa05340 Primary immunodeficiency 3932_3561_3718_695_3575 5 0.00172474 0.136254474 0.002838635 27205 hsa-mir-9-3 hsa04950 Maturity onset diabetes of the young 6927_3087_4760_5080 4 0.00306193 0.241892445 0.004936581 27206 hsa-mir-9-3 hsa04740 Olfactory transduction 815 1 0.004169671 0.329404032 0.006588081 27207 hsa-mir-9-3 hsa03440 Homologous recombination 10111_4683_675_4361 4 0.005019773 0.396562064 0.007775727 27208 hsa-mir-9-3 hsa04540 Gap junction 1956_6714_5595_5594_5159_5156_5604 7 0.006449787 0.509533194 0.009798715 27209 hsa-mir-9-3 hsa04150 mTOR signaling pathway 3091_207_5595_5594_6195 5 0.008104798 0.640279047 0.012080737 27210 hsa-mir-9-3 hsa04060 Cytokine-cytokine receptor interaction 3559_1234_1956_3560_3561_2057_2690_85480_3575_5159_5156_3815_7852 13 0.010205487 0.80623345 0.014930249 27211 hsa-mir-9-3 hsa03430 Mismatch repair 4436_5111_2956 3 0.018644689 1 0.026780554 27212 hsa-mir-9-3 hsa03320 PPAR signaling pathway 5465_5467_5468_6258_6256 5 0.024321017 1 0.034310007 27213 hsa-mir-9-3 hsa04530 Tight junction 1499_5580_6714_207_1459_1457_5515 7 0.03945948 1 0.054689455 27214 hsa-mir-933 hsa05200 Pathways in cancer 5467_5468_5914_595_1019_1017_4193_6934_7704_3091_4087_4089_3066_3065_1050_5925_1499_25_405_1487_1488_4436_1870_1871_2113_10401_861_207_836_5595_5594_1387_6256_4286_367_2932_6774_6776_6777_6772_5970_7157_6688_7849_1869_3725_4088_2034_2033_4846_9915_51176_5371_5604_7428_4609_2956_1026_8554 59 6.32E-41 4.67E-39 4.67E-39 27215 hsa-mir-933 hsa05220 Chronic myeloid leukemia 595_1019_4193_4089_3066_3065_5925_25_1487_1488_1870_1871_861_207_5595_5594_6776_6777_5970_7157_1869_4088_5604_4609_1026_6464 26 7.42E-25 5.49E-23 2.74E-23 27216 hsa-mir-933 hsa04110 Cell cycle 595_1019_1017_4193_5111_4087_4089_3066_3065_5925_25_1870_1871_8379_5934_5933_5591_1387_2932_7027_7157_1869_4088_2033_1026 25 1.92E-19 1.42E-17 4.74E-18 27217 hsa-mir-933 hsa05215 Prostate cancer 595_1017_4193_6934_5925_1499_1870_1871_207_5595_5594_1387_367_2932_5970_7157_468_1869_2033_51176_5604_1026 22 1.18E-18 8.74E-17 2.15E-17 27218 hsa-mir-933 hsa05212 Pancreatic cancer 595_1017_4193_6934_5925_1499_1870_1871_207_5595_5594_1387_367_2932_5970_7157_468_1869_2033_51176_5604_1026 22 1.45E-18 1.08E-16 2.15E-17 27219 hsa-mir-933 hsa05221 Acute myeloid leukemia 5467_5914_595_6934_7704_1050_861_207_5595_5594_6774_6776_6777_5970_6688_51176_5371_5604_4609 19 5.15E-18 3.81E-16 6.36E-17 27220 hsa-mir-933 hsa05210 Colorectal cancer 595_6934_4087_4089_1499_4436_207_836_5595_5594_2932_7157_3725_4088_51176_5604_4609_2956 18 1.70E-14 1.26E-12 1.79E-13 27221 hsa-mir-933 hsa04350 TGF-beta signaling pathway 4086_4087_4089_1875_6667_3399_1874_5934_5933_5595_5594_1387_7027_4088_2033_4093_4609_4092 18 2.88E-14 2.13E-12 2.66E-13 27222 hsa-mir-933 hsa05219 Bladder cancer 595_1019_9252_4193_5925_1870_1871_5595_5594_7157_1869_5604_4609_1026 14 8.59E-14 6.35E-12 7.06E-13 27223 hsa-mir-933 hsa05216 Thyroid cancer 5468_595_6934_1499_5595_5594_6256_7157_7849_51176_5604_4609 12 6.48E-13 4.80E-11 4.80E-12 27224 hsa-mir-933 hsa04310 Wnt signaling pathway 5467_595_6934_4087_4089_4772_4773_1499_1487_1488_1387_2932_7157_3725_1457_4088_2033_51176_4609_5527 20 2.05E-12 1.52E-10 1.38E-11 27225 hsa-mir-933 hsa04330 Notch signaling pathway 1840_3066_3065_9794_22938_1487_1488_2648_1387_2033_8850_9612_4851 13 4.87E-12 3.60E-10 3.00E-11 27226 hsa-mir-933 hsa05214 Glioma 595_1019_4193_5925_1870_1871_207_5595_5594_7157_1869_5604_1026_6464 14 1.34E-11 9.93E-10 7.64E-11 27227 hsa-mir-933 hsa05213 Endometrial cancer 595_6934_1499_2309_207_5595_5594_2932_7157_51176_5604_4609_2002 13 1.45E-11 1.07E-09 7.64E-11 27228 hsa-mir-933 hsa05223 Non-small cell lung cancer 595_1019_5925_2309_1870_1871_207_5595_5594_6256_7157_1869_5604 13 2.17E-11 1.61E-09 1.07E-10 27229 hsa-mir-933 hsa05222 Small cell lung cancer 595_1019_1017_5925_1870_1871_10401_207_6256_5970_7157_1869_4846_4609_8554 15 3.51E-11 2.60E-09 1.62E-10 27230 hsa-mir-933 hsa05218 Melanoma 595_1019_4193_5925_1870_1871_207_5595_5594_4286_7157_1869_5604_1026 14 3.77E-11 2.79E-09 1.64E-10 27231 hsa-mir-933 hsa05211 Renal cell carcinoma 3091_405_2113_207_5595_5594_1387_3725_2034_2033_9915_5604_7428 13 4.94E-10 3.66E-08 2.03E-09 27232 hsa-mir-933 hsa04012 ErbB signaling pathway 25_207_5595_5594_2932_6776_6777_3725_5604_4609_1026_6464_2002 13 3.88E-09 2.87E-07 1.51E-08 27233 hsa-mir-933 hsa05322 Systemic lupus erythematosus 3021_3020_8294_8370_121504_8361_8360_8363_8362_8365_8364_8367_8366_8368_8359 15 2.16E-08 1.60E-06 7.99E-08 27234 hsa-mir-933 hsa04010 MAPK signaling pathway 9252_4773_1432_4763_207_836_5595_5594_1386_3312_1649_5970_3164_7157_468_3725_5604_4208_4609_2002 20 2.64E-08 1.96E-06 9.31E-08 27235 hsa-mir-933 hsa04520 Adherens junction 6934_4087_4089_1499_5595_5594_1387_1457_4088_2033_51176 11 1.32E-07 9.79E-06 4.45E-07 27236 hsa-mir-933 hsa04660 T cell receptor signaling pathway 1019_4772_4773_1432_207_5595_5594_2932_5970_3725_5604 11 2.38E-06 0.000176013 7.65E-06 27237 hsa-mir-933 hsa04115 p53 signaling pathway 595_1019_1017_4194_4193_836_7157_1026_7161 9 2.74E-06 0.000202849 8.45E-06 27238 hsa-mir-933 hsa04662 B cell receptor signaling pathway 4772_4773_207_5595_5594_2932_5970_3725_5604 9 5.11E-06 0.000378069 1.51E-05 27239 hsa-mir-933 hsa04620 Toll-like receptor signaling pathway 3665_3661_1432_207_5595_5594_6772_5970_3725_5604 10 8.03E-06 0.000593966 2.28E-05 27240 hsa-mir-933 hsa04916 Melanogenesis 6934_1499_5595_5594_1387_4286_2932_2033_51176_5604 10 9.40E-06 0.000695412 2.56E-05 27241 hsa-mir-933 hsa04630 Jak-STAT signaling pathway 595_10401_207_1387_6778_6774_6776_6777_6772_2033_4609_8554 12 9.70E-06 0.000717713 2.56E-05 27242 hsa-mir-933 hsa05016 Huntington's disease 10891_5468_3066_3065_3064_2902_6667_836_1387_7157_2033_6874_6908 13 1.30E-05 0.00096148 3.32E-05 27243 hsa-mir-933 hsa03410 Base excision repair 4350_5111_252969_328_2237_6996 6 3.80E-05 0.002812027 9.37E-05 27244 hsa-mir-933 hsa04370 VEGF signaling pathway 4772_4773_1432_207_5595_5594_4846_5604 8 4.43E-05 0.003280965 0.000105838 27245 hsa-mir-933 hsa04062 Chemokine signaling pathway 5580_2309_207_5595_5594_2932_6774_6777_6772_5970_5604_6464 12 7.33E-05 0.005426782 0.000169587 27246 hsa-mir-933 hsa04910 Insulin signaling pathway 6720_10891_207_5595_5594_23265_2932_5604_6464_2002 10 8.93E-05 0.006605613 0.00020017 27247 hsa-mir-933 hsa03450 Non-homologous end-joining 10111_2237_5591_4361 4 0.000132802 0.009827338 0.000289039 27248 hsa-mir-933 hsa04720 Long-term potentiation 2902_5595_5594_1387_468_2033_5604 7 0.000245406 0.018160078 0.000518859 27249 hsa-mir-933 hsa04912 GnRH signaling pathway 5580_1432_5595_5594_468_3725_5604_2002 8 0.000390087 0.028866434 0.000801845 27250 hsa-mir-933 hsa04120 Ubiquitin mediated proteolysis 55294_4193_10401_7329_8925_5371_672_7428_8554 9 0.000435691 0.03224117 0.000871383 27251 hsa-mir-933 hsa03430 Mismatch repair 5981_5111_4436_2956 4 0.000684034 0.050618494 0.001332066 27252 hsa-mir-933 hsa04920 Adipocytokine signaling pathway 10891_5465_207_6256_6774_5970 6 0.000832105 0.061575802 0.001578867 27253 hsa-mir-933 hsa04510 Focal adhesion 595_1499_207_5595_5594_2932_3725_5604_6464_2002 10 0.001752376 0.129675834 0.003241896 27254 hsa-mir-933 hsa04664 Fc epsilon RI signaling pathway 5580_1432_207_5595_5594_5604 6 0.001837624 0.135984206 0.003316688 27255 hsa-mir-933 hsa05217 Basal cell carcinoma 6934_1499_2932_7157_51176 5 0.002121843 0.15701638 0.003738485 27256 hsa-mir-933 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_1432_836_7157_4846 5 0.002283086 0.168948338 0.003929031 27257 hsa-mir-933 hsa03022 Basal transcription factors 2963_6874_2959_6908 4 0.003342699 0.247359753 0.005621813 27258 hsa-mir-933 hsa04650 Natural killer cell mediated cytotoxicity 4772_4773_836_5595_5594_5604_6464 7 0.00664903 0.492028229 0.010933961 27259 hsa-mir-933 hsa04950 Maturity onset diabetes of the young 6927_4760_5080 3 0.007646676 0.56585406 0.012301175 27260 hsa-mir-933 hsa04150 mTOR signaling pathway 3091_207_5595_5594 4 0.010159954 0.751836612 0.015996524 27261 hsa-mir-933 hsa03440 Homologous recombination 10111_4683_4361 3 0.011240821 0.831820729 0.017329599 27262 hsa-mir-933 hsa04210 Apoptosis 207_836_5970_7157_840 5 0.014086773 1 0.021273902 27263 hsa-mir-933 hsa04360 Axon guidance 4772_4773_25_5595_5594_2932 6 0.01804458 1 0.026705979 27264 hsa-mir-933 hsa03030 DNA replication 5981_5111_2237 3 0.020921713 1 0.029859892 27265 hsa-mir-933 hsa04710 Circadian rhythm - mammal 8863_4862 2 0.020982627 1 0.029859892 27266 hsa-mir-933 hsa05010 Alzheimer's disease 2902_836_5595_5594_2932_4846_840 7 0.022212355 1 0.031013476 27267 hsa-mir-933 hsa03320 PPAR signaling pathway 5465_5467_5468_6256 4 0.025798801 1 0.035353912 27268 hsa-mir-933 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_836_5970_3725 4 0.026937871 1 0.035596472 27269 hsa-mir-933 hsa04730 Long-term depression 5595_5594_4846_5604 4 0.026937871 1 0.035596472 27270 hsa-mir-933 hsa03420 Nucleotide excision repair 5981_5111_5886 3 0.034001627 1 0.044142463 27271 hsa-mir-933 hsa04930 Type II diabetes mellitus 5580_5595_5594 3 0.035874186 1 0.045770513 27272 hsa-mir-933 hsa04270 Vascular smooth muscle contraction 5580_5595_5594_59_5604 5 0.039121321 1 0.04906742 27273 hsa-mir-934 hsa04520 Adherens junction 4301_4087_2033_7046_4088 5 7.51E-08 2.03E-06 2.03E-06 27274 hsa-mir-934 hsa05200 Pathways in cancer 4087_5925_2033_367_7046_4088_6772 7 2.05E-07 5.53E-06 2.77E-06 27275 hsa-mir-934 hsa04350 TGF-beta signaling pathway 4087_2033_7046_4088 4 5.38E-06 0.000145161 4.84E-05 27276 hsa-mir-934 hsa04110 Cell cycle 4087_5925_2033_4088 4 1.77E-05 0.000479011 0.000119753 27277 hsa-mir-934 hsa05220 Chronic myeloid leukemia 5925_7046_4088 3 0.000133082 0.003593219 0.000718644 27278 hsa-mir-934 hsa05210 Colorectal cancer 4087_7046_4088 3 0.000183971 0.00496721 0.000732427 27279 hsa-mir-934 hsa05215 Prostate cancer 5925_2033_367 3 0.000210122 0.005673291 0.000732427 27280 hsa-mir-934 hsa05212 Pancreatic cancer 5925_2033_367 3 0.000217015 0.005859415 0.000732427 27281 hsa-mir-934 hsa04310 Wnt signaling pathway 4087_2033_4088 3 0.000995712 0.026884221 0.002987136 27282 hsa-mir-934 hsa03022 Basal transcription factors 6908_2959 2 0.001121111 0.030269992 0.003026999 27283 hsa-mir-934 hsa04630 Jak-STAT signaling pathway 2033_6772 2 0.016871707 0.45553609 0.041412372 27284 hsa-mir-934 hsa05016 Huntington's disease 6908_2033 2 0.024101573 0.650742473 0.054228539 27285 hsa-mir-935 hsa05200 Pathways in cancer 1147_3320_3326_405_3480_1956_5595_5594_6654_5914_1387_2064_6256_595_2308_208_367_4193_7704_6776_5970_8503_2885_7157_4087_10401_3725_4088_4089_5295_2033_207_8554_4790 34 1.19E-30 8.59E-29 8.59E-29 27286 hsa-mir-935 hsa05215 Prostate cancer 1147_3320_3326_3480_1956_5595_5594_6654_1387_2064_595_2308_208_367_4193_5970_8503_2885_7157_5295_2033_207_4790 23 2.90E-29 2.09E-27 8.70E-28 27287 hsa-mir-935 hsa05212 Pancreatic cancer 1147_3320_3326_3480_1956_5595_5594_6654_1387_2064_595_2308_208_367_4193_5970_8503_2885_7157_5295_2033_207_4790 23 3.63E-29 2.61E-27 8.70E-28 27288 hsa-mir-935 hsa05220 Chronic myeloid leukemia 1147_5595_5594_6654_595_208_4193_6776_5970_8503_2885_7157_4088_4089_5295_207_4790_6464 18 1.54E-22 1.11E-20 2.77E-21 27289 hsa-mir-935 hsa05214 Glioma 3480_1956_5595_5594_6654_595_208_4193_8503_2885_7157_5295_207_801_6464_808_805 17 6.74E-22 4.85E-20 9.71E-21 27290 hsa-mir-935 hsa04010 MAPK signaling pathway 1147_994_1956_5595_5594_6654_5566_208_4214_1432_5970_627_2885_7157_10912_3725_3727_6195_6197_5058_4616_2872_207_4790 24 2.24E-20 1.61E-18 2.69E-19 27291 hsa-mir-935 hsa04910 Insulin signaling pathway 6720_10891_5595_5594_6654_2308_5566_7249_208_5770_8503_2885_5295_2872_207_801_6464_808_805 19 1.14E-19 8.21E-18 1.17E-18 27292 hsa-mir-935 hsa05221 Acute myeloid leukemia 1147_5595_5594_6654_5914_595_208_7704_6776_5970_8503_2885_5295_207_4790 15 2.69E-19 1.94E-17 2.42E-18 27293 hsa-mir-935 hsa05210 Colorectal cancer 3480_1956_5595_5594_6654_595_208_8503_2885_7157_4087_3725_4088_4089_5295_207 16 9.46E-19 6.81E-17 7.57E-18 27294 hsa-mir-935 hsa04012 ErbB signaling pathway 1956_6714_5595_5594_6654_56924_2064_208_6776_8503_2885_3725_5295_5058_207_6464 16 1.55E-18 1.12E-16 1.12E-17 27295 hsa-mir-935 hsa04660 T cell receptor signaling pathway 1147_3932_5595_5594_6654_56924_208_5777_1432_5970_8503_2885_3725_5295_5058_207_4790 17 1.77E-18 1.27E-16 1.16E-17 27296 hsa-mir-935 hsa05223 Non-small cell lung cancer 1956_5595_5594_6654_2064_6256_595_2309_208_8503_2885_7157_5295_207 14 3.43E-18 2.47E-16 2.06E-17 27297 hsa-mir-935 hsa04510 Focal adhesion 9564_3480_1956_6714_5595_5594_6654_56924_2064_595_208_71_8503_857_2885_3725_5295_5058_207_6464 20 6.42E-18 4.62E-16 3.55E-17 27298 hsa-mir-935 hsa04520 Adherens junction 1460_3480_1956_6714_5595_5594_1387_2064_71_5770_5777_4087_4088_4089_2033 15 1.46E-17 1.05E-15 7.53E-17 27299 hsa-mir-935 hsa05213 Endometrial cancer 1956_5595_5594_6654_2064_595_2309_208_8503_2885_7157_5295_207 13 8.43E-17 6.07E-15 4.05E-16 27300 hsa-mir-935 hsa05211 Renal cell carcinoma 405_5595_5594_6654_56924_1387_208_8503_2885_3725_5295_5058_2033_207 14 1.15E-16 8.29E-15 5.18E-16 27301 hsa-mir-935 hsa04662 B cell receptor signaling pathway 1147_5595_5594_6654_208_5777_5970_8503_2885_3725_5295_207_4790 13 5.49E-15 3.95E-13 2.32E-14 27302 hsa-mir-935 hsa04062 Chemokine signaling pathway 1147_9564_5595_5594_6654_2770_2309_5566_208_5970_8503_2885_5295_5058_207_4790_6464 17 9.45E-15 6.80E-13 3.78E-14 27303 hsa-mir-935 hsa04110 Cell cycle 994_1387_595_7533_4193_902_7157_4087_10912_1022_4088_4089_4616_2033 14 6.11E-14 4.40E-12 2.32E-13 27304 hsa-mir-935 hsa04912 GnRH signaling pathway 1956_6714_5595_5594_6654_5566_4214_1432_2885_3725_801_808_805 13 3.79E-13 2.73E-11 1.36E-12 27305 hsa-mir-935 hsa05222 Small cell lung cancer 1147_6256_595_208_5970_8503_7157_10401_5295_207_8554_4790 12 6.38E-13 4.59E-11 2.19E-12 27306 hsa-mir-935 hsa05218 Melanoma 3480_1956_5595_5594_595_208_4193_8503_7157_5295_207 11 2.14E-12 1.54E-10 7.02E-12 27307 hsa-mir-935 hsa04630 Jak-STAT signaling pathway 6654_1387_595_208_5777_6776_8503_2885_10401_5295_2033_207_8554 13 2.57E-11 1.85E-09 8.06E-11 27308 hsa-mir-935 hsa04620 Toll-like receptor signaling pathway 1147_5595_5594_208_1432_5970_8503_3725_5295_207_4790 11 7.60E-11 5.48E-09 2.28E-10 27309 hsa-mir-935 hsa04720 Long-term potentiation 5595_5594_1387_5566_6195_6197_2033_801_808_805 10 8.44E-11 6.08E-09 2.43E-10 27310 hsa-mir-935 hsa04150 mTOR signaling pathway 5595_5594_7249_208_8503_6195_6197_5295_207 9 9.39E-11 6.76E-09 2.60E-10 27311 hsa-mir-935 hsa04664 Fc epsilon RI signaling pathway 5595_5594_6654_208_1432_8503_2885_5295_207 9 2.70E-09 1.94E-07 7.20E-09 27312 hsa-mir-935 hsa04210 Apoptosis 1147_5566_208_5970_8503_7157_5295_207_4790 9 7.07E-09 5.09E-07 1.82E-08 27313 hsa-mir-935 hsa05219 Bladder cancer 1956_5595_5594_2064_595_4193_7157 7 1.54E-08 1.11E-06 3.82E-08 27314 hsa-mir-935 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6654_5777_8503_2885_5295_5058_6464 10 2.00E-08 1.44E-06 4.79E-08 27315 hsa-mir-935 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1147_1956_6714_1432_5970_3725_5058_4790 8 2.28E-08 1.64E-06 5.31E-08 27316 hsa-mir-935 hsa04916 Melanogenesis 5595_5594_1387_2770_5566_2033_801_808_805 9 2.49E-08 1.79E-06 5.60E-08 27317 hsa-mir-935 hsa04370 VEGF signaling pathway 6714_5595_5594_208_1432_8503_5295_207 8 4.09E-08 2.94E-06 8.92E-08 27318 hsa-mir-935 hsa04310 Wnt signaling pathway 1460_1387_595_5566_7157_4087_3725_4088_4089_2033 10 4.72E-08 3.40E-06 9.99E-08 27319 hsa-mir-935 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_4087_4088_4089_2033 8 9.82E-08 7.07E-06 2.02E-07 27320 hsa-mir-935 hsa04540 Gap junction 1956_6714_5595_5594_6654_2770_5566_2885 8 1.58E-07 1.14E-05 3.17E-07 27321 hsa-mir-935 hsa04920 Adipocytokine signaling pathway 1147_10891_6256_208_5970_207_4790 7 2.85E-07 2.05E-05 5.54E-07 27322 hsa-mir-935 hsa04810 Regulation of actin cytoskeleton 9564_1956_5595_5594_6654_56924_71_8503_5295_5058 10 1.16E-06 8.39E-05 2.21E-06 27323 hsa-mir-935 hsa05216 Thyroid cancer 5595_5594_6256_595_7157 5 1.63E-06 0.000117689 3.02E-06 27324 hsa-mir-935 hsa04115 p53 signaling pathway 595_7249_4193_7157_10912_4616 6 5.56E-06 0.000400418 1.00E-05 27325 hsa-mir-935 hsa04120 Ubiquitin mediated proteolysis 672_4214_4193_10401_10273_7329_8554 7 2.69E-05 0.00193412 4.72E-05 27326 hsa-mir-935 hsa04270 Vascular smooth muscle contraction 5595_5594_5566_801_808_805 6 9.72E-05 0.00699738 0.000166604 27327 hsa-mir-935 hsa03022 Basal transcription factors 2965_6908_2959_6881 4 9.99E-05 0.007194587 0.000167316 27328 hsa-mir-935 hsa04670 Leukocyte transendothelial migration 9564_2770_71_1432_8503_5295 6 0.00011577 0.008335443 0.000189442 27329 hsa-mir-935 hsa04070 Phosphatidylinositol signaling system 8503_5295_801_808_805 5 0.000120331 0.00866383 0.00019253 27330 hsa-mir-935 hsa05016 Huntington's disease 10891_1387_6908_6667_627_7157_2033 7 0.000166042 0.011955033 0.000257266 27331 hsa-mir-935 hsa04360 Axon guidance 5998_5595_5594_56924_2770_5058 6 0.000167937 0.012091492 0.000257266 27332 hsa-mir-935 hsa03420 Nucleotide excision repair 2965_902_1022_4331 4 0.000185921 0.013386344 0.000278882 27333 hsa-mir-935 hsa04930 Type II diabetes mellitus 5595_5594_8503_5295 4 0.000201521 0.014509501 0.000296112 27334 hsa-mir-935 hsa04530 Tight junction 1460_6714_2770_208_71_207 6 0.000211965 0.015261454 0.000305229 27335 hsa-mir-935 hsa04020 Calcium signaling pathway 1956_2064_5566_801_808_805 6 0.000954193 0.068701898 0.001347096 27336 hsa-mir-935 hsa04730 Long-term depression 3480_5595_5594_2770 4 0.001026315 0.073894698 0.001421052 27337 hsa-mir-935 hsa04612 Antigen processing and presentation 3320_3326_3308_6890 4 0.002271132 0.163521539 0.003085312 27338 hsa-mir-935 hsa04330 Notch signaling pathway 1387_9612_2033 3 0.003226333 0.232295948 0.004301777 27339 hsa-mir-935 hsa05010 Alzheimer's disease 5595_5594_801_808_805 5 0.004591588 0.330594339 0.006010806 27340 hsa-mir-935 hsa05340 Primary immunodeficiency 3932_6890 2 0.020125856 1 0.0258761 27341 hsa-mir-935 hsa03410 Base excision repair 6996_4350 2 0.021162716 1 0.026731852 27342 hsa-mir-935 hsa03050 Proteasome 5698_5705 2 0.035224677 1 0.043727186 27343 hsa-mir-935 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_7157 2 0.046108301 1 0.056267757 27344 hsa-mir-936 hsa03022 Basal transcription factors 2967_2961_2960_2963_6881_54457_2968_6879_6878_6877_6874_6872_2957_6873_2958_6884_2959_6880_6882_138474_6883 21 1.29E-31 8.89E-30 8.89E-30 27345 hsa-mir-936 hsa05200 Pathways in cancer 5925_5595_5594_1387_6256_3326_2932_4193_7704_6774_5970_4436_7157_6688_3725_4609_2353_10401_4088_4089_2033_207_8554_7184 24 1.85E-17 1.28E-15 6.39E-16 27346 hsa-mir-936 hsa05215 Prostate cancer 5925_5595_5594_1387_3326_2932_4193_5970_7157_2033_207_7184 12 2.86E-12 1.98E-10 5.57E-11 27347 hsa-mir-936 hsa05212 Pancreatic cancer 5925_5595_5594_1387_3326_2932_4193_5970_7157_2033_207_7184 12 3.23E-12 2.23E-10 5.57E-11 27348 hsa-mir-936 hsa05210 Colorectal cancer 5595_5594_2932_4436_7157_3725_4609_2353_4088_4089_207 11 3.52E-11 2.43E-09 4.86E-10 27349 hsa-mir-936 hsa04110 Cell cycle 5925_1387_2932_4193_7027_4085_7157_8379_4171_4088_4089_2033 12 7.25E-11 5.00E-09 8.34E-10 27350 hsa-mir-936 hsa05220 Chronic myeloid leukemia 5925_5595_5594_4193_5970_7157_4609_4088_4089_207 10 2.39E-10 1.65E-08 2.35E-09 27351 hsa-mir-936 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_7027_4609_3399_4088_4089_2033 10 8.96E-10 6.18E-08 7.73E-09 27352 hsa-mir-936 hsa04310 Wnt signaling pathway 1460_1387_2932_7157_3725_4609_1457_4088_4089_2033_8607 11 1.17E-08 8.09E-07 8.99E-08 27353 hsa-mir-936 hsa05221 Acute myeloid leukemia 5595_5594_7704_6774_5970_6688_4609_207 8 1.39E-08 9.58E-07 9.58E-08 27354 hsa-mir-936 hsa04520 Adherens junction 1460_5595_5594_1387_1457_4088_4089_2033 8 1.22E-07 8.39E-06 7.63E-07 27355 hsa-mir-936 hsa05222 Small cell lung cancer 5925_6256_5970_7157_4609_10401_207_8554 8 2.04E-07 1.41E-05 1.17E-06 27356 hsa-mir-936 hsa05219 Bladder cancer 5925_5595_5594_4193_7157_4609 6 7.19E-07 4.96E-05 3.81E-06 27357 hsa-mir-936 hsa04660 T cell receptor signaling pathway 5595_5594_2932_1432_5970_3725_2353_207 8 1.17E-06 8.08E-05 5.41E-06 27358 hsa-mir-936 hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_3725_2353_207 7 1.18E-06 8.11E-05 5.41E-06 27359 hsa-mir-936 hsa05213 Endometrial cancer 5595_5594_2932_7157_4609_207 6 2.24E-06 0.000154885 9.68E-06 27360 hsa-mir-936 hsa05223 Non-small cell lung cancer 5925_5595_5594_6256_7157_207 6 2.75E-06 0.000189504 1.05E-05 27361 hsa-mir-936 hsa05216 Thyroid cancer 5595_5594_6256_7157_4609 5 2.75E-06 0.000189505 1.05E-05 27362 hsa-mir-936 hsa04010 MAPK signaling pathway 5595_5594_3312_1432_5970_7157_3725_4609_3727_2353_207 11 3.07E-06 0.000212105 1.12E-05 27363 hsa-mir-936 hsa05214 Glioma 5925_5595_5594_4193_7157_207 6 7.40E-06 0.000510646 2.55E-05 27364 hsa-mir-936 hsa04620 Toll-like receptor signaling pathway 5595_5594_1432_5970_3725_2353_207 7 7.94E-06 0.000547562 2.61E-05 27365 hsa-mir-936 hsa05218 Melanoma 5925_5595_5594_4193_7157_207 6 1.19E-05 0.000818246 3.72E-05 27366 hsa-mir-936 hsa05211 Renal cell carcinoma 5595_5594_1387_3725_2033_207 6 1.28E-05 0.000881632 3.83E-05 27367 hsa-mir-936 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 2.56E-05 0.001766663 7.36E-05 27368 hsa-mir-936 hsa04012 ErbB signaling pathway 5595_5594_2932_3725_4609_207 6 3.50E-05 0.002411844 9.65E-05 27369 hsa-mir-936 hsa05016 Huntington's disease 6874_1387_6667_9001_5430_7157_3064_2033 8 4.84E-05 0.003342964 0.000128576 27370 hsa-mir-936 hsa04630 Jak-STAT signaling pathway 1387_6774_4609_10401_2033_207_8554 7 0.000101351 0.006993216 0.000259008 27371 hsa-mir-936 hsa04910 Insulin signaling pathway 5595_5594_23265_2932_5211_207 6 0.000387815 0.026759267 0.000955688 27372 hsa-mir-936 hsa04916 Melanogenesis 5595_5594_1387_2932_2033 5 0.00077521 0.053489476 0.001844465 27373 hsa-mir-936 hsa04920 Adipocytokine signaling pathway 6256_6774_5970_207 4 0.001236256 0.085301653 0.002843388 27374 hsa-mir-936 hsa04720 Long-term potentiation 5595_5594_1387_2033 4 0.001835545 0.126652572 0.004085567 27375 hsa-mir-936 hsa04370 VEGF signaling pathway 5595_5594_1432_207 4 0.002011993 0.138827529 0.00432737 27376 hsa-mir-936 hsa04062 Chemokine signaling pathway 5595_5594_2932_6774_5970_207 6 0.002069612 0.142803221 0.00432737 27377 hsa-mir-936 hsa04664 Fc epsilon RI signaling pathway 5595_5594_1432_207 4 0.002199832 0.151788409 0.004464365 27378 hsa-mir-936 hsa04120 Ubiquitin mediated proteolysis 55294_4193_10401_7329_8554 5 0.002655708 0.183243885 0.00523554 27379 hsa-mir-936 hsa04210 Apoptosis 840_5970_7157_207 4 0.003322533 0.229254789 0.006368189 27380 hsa-mir-936 hsa03420 Nucleotide excision repair 2967_2968_5887 3 0.003641166 0.251240475 0.006790283 27381 hsa-mir-936 hsa04330 Notch signaling pathway 1387_2033_8850 3 0.004338517 0.29935765 0.007877833 27382 hsa-mir-936 hsa04150 mTOR signaling pathway 5595_5594_207 3 0.005669991 0.391229379 0.010031523 27383 hsa-mir-936 hsa04912 GnRH signaling pathway 5595_5594_1432_3725 4 0.006420833 0.443037472 0.011075937 27384 hsa-mir-936 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_5970_3725 3 0.012797717 0.88304247 0.021257405 27385 hsa-mir-936 hsa04510 Focal adhesion 5595_5594_2932_3725_207 5 0.01293929 0.892811002 0.021257405 27386 hsa-mir-936 hsa04612 Antigen processing and presentation 3326_4801_3312 3 0.022767234 1 0.036533469 27387 hsa-mir-936 hsa04540 Gap junction 5595_5594_10382 3 0.025419573 1 0.039862513 27388 hsa-mir-936 hsa05010 Alzheimer's disease 5595_5594_2932_840 4 0.031665966 1 0.048554481 27389 hsa-mir-936 hsa04930 Type II diabetes mellitus 5595_5594 2 0.038128111 1 0.057192167 27390 hsa-mir-937 hsa05200 Pathways in cancer 3716_3320_3326_4149_5371_2249_4292_3480_1956_4233_5595_5594_5599_5914_1387_2064_6256_5159_595_5156_1488_1487_367_2261_2932_7704_6774_6502_6776_6777_6772_5979_3091_5879_1026_7157_4087_6688_4089_5894_3725_5604_1029_2353_10401_4088_5601_3066_3065_1050_5925_2034_2033_1441_207_8554_9915_4790_5970 59 3.76E-47 2.75E-45 2.75E-45 27391 hsa-mir-937 hsa04630 Jak-STAT signaling pathway 3717_3716_3718_3559_3570_3977_85480_3560_149233_1387_595_3572_3953_6774_6776_6777_6772_1439_3454_3455_5781_2690_10401_2033_1441_207_8554_3575 28 6.48E-23 4.73E-21 2.37E-21 27392 hsa-mir-937 hsa05215 Prostate cancer 3320_3326_3480_1956_5595_5594_1387_2064_5159_595_5156_367_2932_1026_7157_468_5894_5604_5925_2033_207_4790_5970 23 3.55E-22 2.59E-20 8.06E-21 27393 hsa-mir-937 hsa05212 Pancreatic cancer 3320_3326_3480_1956_5595_5594_1387_2064_5159_595_5156_367_2932_1026_7157_468_5894_5604_5925_2033_207_4790_5970 23 4.42E-22 3.23E-20 8.06E-21 27394 hsa-mir-937 hsa05210 Colorectal cancer 4292_3480_1956_4233_5595_5594_5599_5159_595_5156_2932_5879_7157_4087_4089_5894_3725_5604_2353_4088_5601_207 22 2.78E-21 2.03E-19 4.06E-20 27395 hsa-mir-937 hsa05220 Chronic myeloid leukemia 5595_5594_595_1488_1487_6776_6777_1026_7157_5781_4089_5894_5604_1029_4088_3066_3065_5925_207_4790_5970 21 6.96E-21 5.08E-19 8.47E-20 27396 hsa-mir-937 hsa04010 MAPK signaling pathway 3925_3727_4149_2249_1956_5595_5594_5599_5159_5156_1649_2261_2264_9252_1386_5598_5879_7157_468_6885_5894_3725_5604_2353_5601_207_4790_51701_5970 29 5.73E-18 4.19E-16 5.98E-17 27397 hsa-mir-937 hsa04520 Adherens junction 2241_3480_1956_6714_4233_5595_5594_1387_2064_5879_1459_4087_4089_6885_1457_4088_2033_51701 18 1.22E-16 8.92E-15 1.11E-15 27398 hsa-mir-937 hsa05221 Acute myeloid leukemia 5371_5595_5594_5914_595_7704_6774_6776_6777_6688_5894_5604_1050_207_4790_5970 16 4.97E-16 3.63E-14 4.03E-15 27399 hsa-mir-937 hsa04310 Wnt signaling pathway 5599_1387_595_1488_1487_2932_8454_5879_1459_7157_4087_4089_8061_6885_3725_1457_6500_4088_5601_2033_51701 21 2.15E-15 1.57E-13 1.57E-14 27400 hsa-mir-937 hsa04110 Cell cycle 1387_595_983_2932_8454_6502_990_1026_7157_4087_4089_1029_6500_4088_3066_3065_5925_2033_5933 19 4.49E-15 3.28E-13 2.98E-14 27401 hsa-mir-937 hsa05218 Melanoma 2249_3480_1956_4233_5595_5594_5159_595_5156_1026_7157_5894_5604_1029_5925_207 16 6.05E-15 4.42E-13 3.68E-14 27402 hsa-mir-937 hsa04062 Chemokine signaling pathway 3717_3718_5580_5590_5595_5594_1234_7074_1230_2932_6774_6777_6772_5879_7852_5894_2185_5604_207_3055_4790_5970 22 1.69E-14 1.23E-12 9.49E-14 27403 hsa-mir-937 hsa05219 Bladder cancer 1956_5595_5594_2064_595_2261_9252_1026_7157_5894_5604_1029_5925 13 6.84E-14 4.99E-12 3.57E-13 27404 hsa-mir-937 hsa05214 Glioma 3480_1956_5595_5594_5159_595_5156_1026_7157_5894_5604_1029_5925_207 14 5.24E-13 3.82E-11 2.55E-12 27405 hsa-mir-937 hsa04060 Cytokine-cytokine receptor interaction 3556_2321_3559_3570_3977_85480_1956_4233_3560_149233_5159_5156_3572_1234_1230_3953_1439_7852_3454_3455_2690_1441_3575 23 6.72E-13 4.90E-11 3.06E-12 27406 hsa-mir-937 hsa04620 Toll-like receptor signaling pathway 3654_5595_5594_5599_6772_5879_3454_3455_6885_3725_5604_2353_5601_207_4790_5970 16 8.53E-13 6.23E-11 3.66E-12 27407 hsa-mir-937 hsa04012 ErbB signaling pathway 1956_6714_5595_5594_5599_2064_2932_6776_6777_1026_5894_3725_5604_5601_207 15 1.32E-12 9.65E-11 5.36E-12 27408 hsa-mir-937 hsa05211 Renal cell carcinoma 4233_5595_5594_1387_3091_5879_5781_5894_3725_5604_2034_2033_207_9915 14 1.77E-12 1.29E-10 6.81E-12 27409 hsa-mir-937 hsa04540 Gap junction 1956_6714_5595_5594_5159_983_5156_7277_5598_5894_7846_5604_7278_51807_10376 15 3.11E-12 2.27E-10 1.14E-11 27410 hsa-mir-937 hsa05223 Non-small cell lung cancer 1956_5595_5594_2064_6256_595_7157_5894_5604_1029_5925_207 12 1.78E-11 1.30E-09 6.20E-11 27411 hsa-mir-937 hsa04510 Focal adhesion 2321_3480_1956_6714_4233_5595_5594_5599_2064_5159_595_5156_2932_5879_5894_3725_5604_5601_207 19 3.20E-11 2.33E-09 1.06E-10 27412 hsa-mir-937 hsa05213 Endometrial cancer 4292_1956_5595_5594_2064_595_2932_7157_5894_5604_207 11 1.99E-10 1.45E-08 6.31E-10 27413 hsa-mir-937 hsa04350 TGF-beta signaling pathway 5595_5594_1387_4093_8454_4087_4089_6500_4086_4088_2033_6667_5933 13 2.07E-10 1.51E-08 6.31E-10 27414 hsa-mir-937 hsa04662 B cell receptor signaling pathway 5595_5594_6850_2932_5879_5894_3725_5604_2353_207_4790_5970 12 5.14E-10 3.75E-08 1.50E-09 27415 hsa-mir-937 hsa04330 Notch signaling pathway 3280_388585_1387_1488_1487_9612_3066_3065_2033_2648 10 1.28E-09 9.33E-08 3.59E-09 27416 hsa-mir-937 hsa04912 GnRH signaling pathway 5580_1956_6714_5595_5594_5599_5598_468_5894_2185_3725_5604_5601 13 2.29E-09 1.67E-07 6.19E-09 27417 hsa-mir-937 hsa04660 T cell receptor signaling pathway 3932_5595_5594_2932_6885_5894_3725_5604_2353_5601_207_4790_5970 13 2.81E-09 2.05E-07 7.31E-09 27418 hsa-mir-937 hsa05222 Small cell lung cancer 4149_6256_595_6502_7157_10401_5925_207_8554_4790_5970 11 2.24E-08 1.64E-06 5.64E-08 27419 hsa-mir-937 hsa04920 Adipocytokine signaling pathway 3717_5599_6256_3953_6774_5781_5601_207_4790_5970 10 2.63E-08 1.92E-06 6.40E-08 27420 hsa-mir-937 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_6714_4233_5599_5879_5781_3725_5601_4790_5970 10 4.32E-08 3.15E-06 1.02E-07 27421 hsa-mir-937 hsa04664 Fc epsilon RI signaling pathway 5580_5595_5594_5599_6850_5879_5894_5604_5601_207 10 1.08E-07 7.85E-06 2.45E-07 27422 hsa-mir-937 hsa05216 Thyroid cancer 5595_5594_6256_595_5979_7157_5604 7 1.93E-07 1.41E-05 4.27E-07 27423 hsa-mir-937 hsa04650 Natural killer cell mediated cytotoxicity 3932_5595_5594_6850_5879_3454_3455_5781_5894_2185_5604 11 1.80E-06 0.000131173 3.86E-06 27424 hsa-mir-937 hsa04120 Ubiquitin mediated proteolysis 5371_672_8454_55294_6502_7329_6500_10401_64326_8554 10 1.23E-05 0.00089933 2.57E-05 27425 hsa-mir-937 hsa04210 Apoptosis 3654_3556_1439_823_7157_207_4790_5970 8 2.09E-05 0.001524155 4.23E-05 27426 hsa-mir-937 hsa04810 Regulation of actin cytoskeleton 2249_1956_5595_5594_5159_5156_2261_2264_7074_5879_5894_5604 12 2.28E-05 0.001663383 4.50E-05 27427 hsa-mir-937 hsa04930 Type II diabetes mellitus 5580_5590_5595_5594_5599_5601 6 3.06E-05 0.002235247 5.88E-05 27428 hsa-mir-937 hsa04115 p53 signaling pathway 595_983_1026_7157_7161_1029_64326 7 3.37E-05 0.00245926 6.31E-05 27429 hsa-mir-937 hsa04720 Long-term potentiation 5595_5594_1387_468_5894_5604_2033 7 5.51E-05 0.004024642 0.000100616 27430 hsa-mir-937 hsa04370 VEGF signaling pathway 6714_5595_5594_5879_5894_5604_207 7 6.44E-05 0.004698883 0.000114607 27431 hsa-mir-937 hsa04910 Insulin signaling pathway 5590_5595_5594_5599_2932_5894_5604_5601_207 9 6.87E-05 0.005015407 0.000119414 27432 hsa-mir-937 hsa05131 Shigellosis 4691_7277_7846_7278_51807_10376 6 9.37E-05 0.006838937 0.00015543 27433 hsa-mir-937 hsa05130 Pathogenic Escherichia coli infection 4691_7277_7846_7278_51807_10376 6 9.37E-05 0.006838937 0.00015543 27434 hsa-mir-937 hsa04916 Melanogenesis 5595_5594_1387_2932_5894_5604_2033 7 0.000367559 0.026831795 0.000596262 27435 hsa-mir-937 hsa05016 Huntington's disease 23186_1387_6908_7157_3064_3066_3065_2033_6667 9 0.00061025 0.044548239 0.00096844 27436 hsa-mir-937 hsa04612 Antigen processing and presentation 3320_3326_4800_4801_4802_2923 6 0.000955251 0.069733332 0.001483688 27437 hsa-mir-937 hsa04360 Axon guidance 2242_4233_5595_5594_2932_5879_7852 7 0.001336947 0.097597163 0.002033274 27438 hsa-mir-937 hsa03022 Basal transcription factors 2963_2969_2962_6908 4 0.001392744 0.101670291 0.002074904 27439 hsa-mir-937 hsa04730 Long-term depression 3480_5595_5594_5894_5604 5 0.002115753 0.154449956 0.003088999 27440 hsa-mir-937 hsa04150 mTOR signaling pathway 5595_5594_3091_207 4 0.004395829 0.320895487 0.006292068 27441 hsa-mir-937 hsa04530 Tight junction 5580_6714_5590_1459_1457_207 6 0.007329137 0.535027024 0.010288981 27442 hsa-mir-937 hsa05340 Primary immunodeficiency 3718_3932_3575 3 0.010261887 0.749117743 0.014134297 27443 hsa-mir-937 hsa04270 Vascular smooth muscle contraction 5580_5595_5594_5894_5604 5 0.015809356 1 0.021371907 27444 hsa-mir-937 hsa04640 Hematopoietic cell lineage 3559_3570_1441_3575 4 0.023208375 1 0.030803843 27445 hsa-mir-937 hsa03430 Mismatch repair 4292_6118 2 0.035151227 1 0.045822136 27446 hsa-mir-937 hsa04950 Maturity onset diabetes of the young 3280_6927 2 0.037787892 1 0.04839502 27447 hsa-mir-938 hsa03022 Basal transcription factors 2967_2961_2960_2963_2962_6881_2969_2968_6879_6878_6877_6874_6872_2957_54457_2958_6873_6884_2959_6880_6882_138474_6883 23 2.03E-33 1.44E-31 1.44E-31 27448 hsa-mir-938 hsa05200 Pathways in cancer 5371_1499_5594_6258_1387_6256_10401_1487_1488_836_1019_1017_4193_842_841_5970_4824_7157_6688_3725_4609_1026_2353_4087_4088_5925_2033_3326_8554_7184 30 6.08E-22 4.32E-20 2.16E-20 27449 hsa-mir-938 hsa05215 Prostate cancer 1499_5594_1385_1387_1017_4193_842_5970_4824_7157_468_1026_5925_2033_3326_7184 16 1.64E-16 1.17E-14 3.41E-15 27450 hsa-mir-938 hsa05212 Pancreatic cancer 1499_5594_1385_1387_1017_4193_842_5970_4824_7157_468_1026_5925_2033_3326_7184 16 1.92E-16 1.37E-14 3.41E-15 27451 hsa-mir-938 hsa04110 Cell cycle 5591_1387_1019_1017_4193_7027_4171_7157_1026_4085_4087_4088_5925_2033_5933 15 1.87E-13 1.33E-11 2.65E-12 27452 hsa-mir-938 hsa04310 Wnt signaling pathway 815_1499_1387_8607_1487_1488_7157_3725_4609_1460_1457_4087_4088_2033 14 5.84E-11 4.14E-09 6.91E-10 27453 hsa-mir-938 hsa05220 Chronic myeloid leukemia 5594_1487_1488_1019_4193_5970_7157_4609_1026_4088_5925 11 7.59E-11 5.39E-09 7.69E-10 27454 hsa-mir-938 hsa04010 MAPK signaling pathway 6722_5594_1386_9261_836_3312_1649_5970_7157_3725_468_4609_3727_6195_2353_2002_2005 17 1.60E-10 1.13E-08 1.42E-09 27455 hsa-mir-938 hsa05222 Small cell lung cancer 6258_6256_10401_1019_1017_842_5970_7157_4609_5925_8554 11 2.86E-10 2.03E-08 2.26E-09 27456 hsa-mir-938 hsa05210 Colorectal cancer 1499_5594_836_842_7157_3725_4609_2353_4087_4088 10 3.53E-09 2.51E-07 2.51E-08 27457 hsa-mir-938 hsa04520 Adherens junction 1499_6714_5594_1387_1460_1457_4087_4088_2033 9 3.41E-08 2.42E-06 2.20E-07 27458 hsa-mir-938 hsa04350 TGF-beta signaling pathway 5594_1387_7027_1874_4609_4087_4088_2033_5933 9 6.64E-08 4.71E-06 3.93E-07 27459 hsa-mir-938 hsa05219 Bladder cancer 5594_1019_4193_7157_4609_1026_5925 7 1.05E-07 7.45E-06 5.73E-07 27460 hsa-mir-938 hsa04115 p53 signaling pathway 836_1019_1017_4193_842_841_7157_1026 8 1.62E-07 1.15E-05 8.21E-07 27461 hsa-mir-938 hsa05216 Thyroid cancer 1499_5594_6258_6256_7157_4609 6 2.85E-07 2.02E-05 1.35E-06 27462 hsa-mir-938 hsa05223 Non-small cell lung cancer 5594_6258_6256_1019_842_7157_5925 7 4.92E-07 3.49E-05 2.18E-06 27463 hsa-mir-938 hsa05016 Huntington's disease 6874_3064_1385_1387_836_9001_842_841_5430_7157_2033 11 5.25E-07 3.73E-05 2.19E-06 27464 hsa-mir-938 hsa05214 Glioma 815_5594_1019_4193_7157_1026_5925 7 1.55E-06 0.000109709 6.09E-06 27465 hsa-mir-938 hsa04330 Notch signaling pathway 1387_1487_1488_9612_2033_8850 6 3.58E-06 0.000254504 1.34E-05 27466 hsa-mir-938 hsa05213 Endometrial cancer 1499_5594_842_7157_4609_2002 6 6.12E-06 0.000434342 2.17E-05 27467 hsa-mir-938 hsa04012 ErbB signaling pathway 815_6714_5594_3725_4609_1026_2002 7 9.28E-06 0.000659146 3.14E-05 27468 hsa-mir-938 hsa04210 Apoptosis 836_839_842_841_840_5970_7157 7 1.07E-05 0.000757476 3.44E-05 27469 hsa-mir-938 hsa05218 Melanoma 5594_1019_4193_7157_1026_5925 6 3.17E-05 0.002248786 9.78E-05 27470 hsa-mir-938 hsa04720 Long-term potentiation 815_5594_1387_468_6195_2033 6 4.22E-05 0.002999337 0.000124972 27471 hsa-mir-938 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 5.87E-05 0.004168576 0.000166743 27472 hsa-mir-938 hsa05221 Acute myeloid leukemia 5371_5594_5970_6688_4609 5 0.000145497 0.010330253 0.000397317 27473 hsa-mir-938 hsa04916 Melanogenesis 815_1499_5594_1385_1387_2033 6 0.000231069 0.016405869 0.000607625 27474 hsa-mir-938 hsa04912 GnRH signaling pathway 815_6714_5594_3725_468_2002 6 0.000280374 0.019906586 0.000710949 27475 hsa-mir-938 hsa03420 Nucleotide excision repair 2967_2968_5981_5887 4 0.000537725 0.038178485 0.001316499 27476 hsa-mir-938 hsa04612 Antigen processing and presentation 1385_4800_4801_3312_3326 5 0.00086681 0.061543511 0.00205145 27477 hsa-mir-938 hsa04620 Toll-like receptor signaling pathway 5594_841_5970_3725_2353 5 0.001547038 0.109839705 0.003543216 27478 hsa-mir-938 hsa04660 T cell receptor signaling pathway 5594_1019_5970_3725_2353 5 0.002124106 0.150811561 0.004712861 27479 hsa-mir-938 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_836_5970_3725 4 0.002850909 0.202414573 0.006133775 27480 hsa-mir-938 hsa05211 Renal cell carcinoma 5594_1387_3725_2033 4 0.002991138 0.212370784 0.0062462 27481 hsa-mir-938 hsa05010 Alzheimer's disease 22926_5594_836_842_841_840 6 0.003239569 0.230009378 0.006571697 27482 hsa-mir-938 hsa04662 B cell receptor signaling pathway 5594_5970_3725_2353 4 0.003439956 0.244236846 0.006784357 27483 hsa-mir-938 hsa04370 VEGF signaling pathway 6714_5594_9261_842 4 0.003763341 0.267197195 0.007221546 27484 hsa-mir-938 hsa04530 Tight junction 1499_6714_1019_1460_1457 5 0.005237972 0.371895984 0.009786736 27485 hsa-mir-938 hsa04630 Jak-STAT signaling pathway 1387_10401_4609_2033_8554 5 0.008573703 0.608732947 0.015608537 27486 hsa-mir-938 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_842_7157 3 0.011069534 0.785936924 0.019648423 27487 hsa-mir-938 hsa04950 Maturity onset diabetes of the young 5080_6927 2 0.017430115 1 0.029606459 27488 hsa-mir-938 hsa04920 Adipocytokine signaling pathway 6258_6256_5970 3 0.01751368 1 0.029606459 27489 hsa-mir-938 hsa04510 Focal adhesion 1499_6714_5594_3725_2002 5 0.025337257 1 0.041835936 27490 hsa-mir-938 hsa04120 Ubiquitin mediated proteolysis 5371_10401_4193_8554 4 0.026056863 1 0.042046302 27491 hsa-mir-938 hsa03030 DNA replication 5981_4171 2 0.03547464 1 0.055971098 27492 hsa-mir-938 hsa04540 Gap junction 6714_5594_10382 3 0.039499037 1 0.060965905 27493 hsa-mir-940 hsa04350 TGF-beta signaling pathway 6667_1387_5595_5594_3399 5 1.46E-09 6.55E-08 6.55E-08 27494 hsa-mir-940 hsa05215 Prostate cancer 1387_5595_5594_2932 4 1.91E-07 8.58E-06 2.99E-06 27495 hsa-mir-940 hsa05212 Pancreatic cancer 1387_5595_5594_2932 4 1.99E-07 8.97E-06 2.99E-06 27496 hsa-mir-940 hsa04916 Melanogenesis 1387_5595_5594_2932 4 3.64E-07 1.64E-05 4.09E-06 27497 hsa-mir-940 hsa04910 Insulin signaling pathway 5595_5594_2932_23265 4 1.09E-06 4.90E-05 9.80E-06 27498 hsa-mir-940 hsa05213 Endometrial cancer 5595_5594_2932 3 3.89E-06 0.000174901 2.92E-05 27499 hsa-mir-940 hsa05211 Renal cell carcinoma 1387_5595_5594 3 9.93E-06 0.00044703 5.59E-05 27500 hsa-mir-940 hsa04720 Long-term potentiation 1387_5595_5594 3 1.12E-05 0.000503111 5.59E-05 27501 hsa-mir-940 hsa04662 B cell receptor signaling pathway 5595_5594_2932 3 1.12E-05 0.000503111 5.59E-05 27502 hsa-mir-940 hsa04520 Adherens junction 1387_5595_5594 3 1.35E-05 0.000606571 6.07E-05 27503 hsa-mir-940 hsa05210 Colorectal cancer 5595_5594_2932 3 1.55E-05 0.000698769 6.35E-05 27504 hsa-mir-940 hsa04012 ErbB signaling pathway 5595_5594_2932 3 1.72E-05 0.00077367 6.45E-05 27505 hsa-mir-940 hsa05200 Pathways in cancer 1387_5595_5594_2932 4 3.27E-05 0.00147198 0.000109254 27506 hsa-mir-940 hsa04660 T cell receptor signaling pathway 5595_5594_2932 3 3.40E-05 0.001529551 0.000109254 27507 hsa-mir-940 hsa04360 Axon guidance 5595_5594_2932 3 5.65E-05 0.002542627 0.000169508 27508 hsa-mir-940 hsa05010 Alzheimer's disease 5595_5594_2932 3 0.000135548 0.006099643 0.000368018 27509 hsa-mir-940 hsa05216 Thyroid cancer 5595_5594 2 0.000139029 0.006256313 0.000368018 27510 hsa-mir-940 hsa04062 Chemokine signaling pathway 5595_5594_2932 3 0.000174263 0.007841852 0.000435658 27511 hsa-mir-940 hsa04510 Focal adhesion 5595_5594_2932 3 0.000210531 0.009473916 0.000498627 27512 hsa-mir-940 hsa05219 Bladder cancer 5595_5594 2 0.00028162 0.012672913 0.000633646 27513 hsa-mir-940 hsa04930 Type II diabetes mellitus 5595_5594 2 0.000321488 0.014466956 0.000688903 27514 hsa-mir-940 hsa04150 mTOR signaling pathway 5595_5594 2 0.000424587 0.019106402 0.000868473 27515 hsa-mir-940 hsa05223 Non-small cell lung cancer 5595_5594 2 0.000456624 0.02054806 0.000893394 27516 hsa-mir-940 hsa05221 Acute myeloid leukemia 5595_5594 2 0.000541709 0.024376889 0.001015704 27517 hsa-mir-940 hsa05214 Glioma 5595_5594 2 0.000653185 0.029393313 0.001175733 27518 hsa-mir-940 hsa05218 Melanoma 5595_5594 2 0.000774828 0.034867262 0.00129138 27519 hsa-mir-940 hsa04730 Long-term depression 5595_5594 2 0.000774828 0.034867262 0.00129138 27520 hsa-mir-940 hsa05220 Chronic myeloid leukemia 5595_5594 2 0.000861541 0.038769362 0.00138462 27521 hsa-mir-940 hsa04370 VEGF signaling pathway 5595_5594 2 0.000906576 0.040795942 0.001406757 27522 hsa-mir-940 hsa04664 Fc epsilon RI signaling pathway 5595_5594 2 0.000952728 0.042872739 0.001429091 27523 hsa-mir-940 hsa04540 Gap junction 5595_5594 2 0.001306839 0.058807753 0.001897024 27524 hsa-mir-940 hsa04620 Toll-like receptor signaling pathway 5595_5594 2 0.001562935 0.070332068 0.002197877 27525 hsa-mir-940 hsa04912 GnRH signaling pathway 5595_5594 2 0.001745914 0.07856611 0.002380791 27526 hsa-mir-940 hsa04270 Vascular smooth muscle contraction 5595_5594 2 0.002072466 0.09326096 0.002708481 27527 hsa-mir-940 hsa04110 Cell cycle 1387_2932 2 0.002106596 0.094796841 0.002708481 27528 hsa-mir-940 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594 2 0.002805524 0.126248575 0.003460069 27529 hsa-mir-940 hsa04120 Ubiquitin mediated proteolysis 55294_7329 2 0.002844945 0.128022535 0.003460069 27530 hsa-mir-940 hsa04310 Wnt signaling pathway 1387_2932 2 0.003381133 0.152150991 0.004003973 27531 hsa-mir-940 hsa05016 Huntington's disease 6667_1387 2 0.005091795 0.229130791 0.005875148 27532 hsa-mir-940 hsa04810 Regulation of actin cytoskeleton 5595_5594 2 0.006823388 0.307052456 0.007676311 27533 hsa-mir-940 hsa04010 MAPK signaling pathway 5595_5594 2 0.01038693 0.467411838 0.011400289 27534 hsa-mir-940 hsa04330 Notch signaling pathway 1387 1 0.026846659 1 0.028764278 27535 hsa-mir-940 hsa05217 Basal cell carcinoma 2932 1 0.031254607 1 0.03270831 27536 hsa-mir-940 hsa04340 Hedgehog signaling pathway 2932 1 0.032353654 1 0.033088964 27537 hsa-mir-941-1 hsa05200 Pathways in cancer 1956_1499_5595_5594_5599_6258_1387_6257_6256_8031_2308_1019_1017_841_6776_5970_6688_4609_3725_1026_861_4088_4089_1050_5925_2033_8554_4790 28 7.69E-26 5.39E-24 5.39E-24 27538 hsa-mir-941-1 hsa04010 MAPK signaling pathway 6722_3727_1956_5595_5594_5599_1386_5566_9252_1649_5970_10912_468_4609_3725_6195_6196_4616_4790_2002 20 1.52E-17 1.06E-15 5.31E-16 27539 hsa-mir-941-1 hsa05215 Prostate cancer 1956_1499_5595_5594_1385_1387_2308_1017_5970_468_1026_5925_2033_4790 14 7.02E-17 4.91E-15 1.42E-15 27540 hsa-mir-941-1 hsa05212 Pancreatic cancer 1956_1499_5595_5594_1385_1387_2308_1017_5970_468_1026_5925_2033_4790 14 8.09E-17 5.66E-15 1.42E-15 27541 hsa-mir-941-1 hsa05220 Chronic myeloid leukemia 5595_5594_1019_6776_5970_4609_1026_861_4088_4089_5925_4790 12 1.16E-14 8.10E-13 1.62E-13 27542 hsa-mir-941-1 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_7027_1874_4609_4088_4089_2033_5933 11 1.58E-12 1.10E-10 1.73E-11 27543 hsa-mir-941-1 hsa04110 Cell cycle 1387_1019_1017_7027_10912_1026_4088_4089_4616_5925_2033_5933 12 1.73E-12 1.21E-10 1.73E-11 27544 hsa-mir-941-1 hsa05216 Thyroid cancer 1499_5595_5594_6258_6257_6256_8031_4609 8 7.65E-12 5.36E-10 6.70E-11 27545 hsa-mir-941-1 hsa05222 Small cell lung cancer 6258_6257_6256_1019_1017_5970_4609_5925_8554_4790 10 3.59E-11 2.51E-09 2.53E-10 27546 hsa-mir-941-1 hsa05221 Acute myeloid leukemia 5595_5594_6776_5970_6688_4609_861_1050_4790 9 3.90E-11 2.73E-09 2.53E-10 27547 hsa-mir-941-1 hsa04012 ErbB signaling pathway 815_1956_5595_5594_5599_6776_4609_3725_1026_2002 10 3.98E-11 2.79E-09 2.53E-10 27548 hsa-mir-941-1 hsa05219 Bladder cancer 1956_5595_5594_1019_9252_4609_1026_5925 8 1.01E-10 7.07E-09 5.89E-10 27549 hsa-mir-941-1 hsa04720 Long-term potentiation 815_5595_5594_1387_5566_468_6195_6196_2033 9 2.73E-10 1.91E-08 1.47E-09 27550 hsa-mir-941-1 hsa05223 Non-small cell lung cancer 1956_5595_5594_6258_6257_6256_1019_5925 8 6.06E-10 4.24E-08 3.03E-09 27551 hsa-mir-941-1 hsa05210 Colorectal cancer 1956_1499_5595_5594_5599_4609_3725_4088_4089 9 6.89E-10 4.82E-08 3.21E-09 27552 hsa-mir-941-1 hsa04912 GnRH signaling pathway 815_1956_5595_5594_5599_5566_468_3725_2002 9 5.37E-09 3.76E-07 2.35E-08 27553 hsa-mir-941-1 hsa04310 Wnt signaling pathway 815_1499_5599_1387_5566_4609_3725_4088_4089_2033 10 6.29E-09 4.40E-07 2.59E-08 27554 hsa-mir-941-1 hsa04520 Adherens junction 1956_1499_5595_5594_1387_4088_4089_2033 8 1.04E-08 7.27E-07 4.04E-08 27555 hsa-mir-941-1 hsa05214 Glioma 815_1956_5595_5594_1019_1026_5925 7 5.57E-08 3.90E-06 2.05E-07 27556 hsa-mir-941-1 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_841_5970_3725_6348_4790 8 6.06E-08 4.24E-06 2.12E-07 27557 hsa-mir-941-1 hsa04920 Adipocytokine signaling pathway 5599_6258_6257_6256_5970_10891_4790 7 6.75E-08 4.73E-06 2.22E-07 27558 hsa-mir-941-1 hsa04916 Melanogenesis 815_1499_5595_5594_1385_1387_5566_2033 8 6.97E-08 4.88E-06 2.22E-07 27559 hsa-mir-941-1 hsa05213 Endometrial cancer 1956_1499_5595_5594_4609_2002 6 3.53E-07 2.47E-05 1.07E-06 27560 hsa-mir-941-1 hsa04115 p53 signaling pathway 1019_1017_841_10912_1026_4616 6 1.64E-06 0.000115029 4.79E-06 27561 hsa-mir-941-1 hsa05218 Melanoma 1956_5595_5594_1019_1026_5925 6 1.92E-06 0.000134385 5.38E-06 27562 hsa-mir-941-1 hsa04910 Insulin signaling pathway 5595_5594_5599_2308_5566_10891_2002 7 6.53E-06 0.000457337 1.76E-05 27563 hsa-mir-941-1 hsa04660 T cell receptor signaling pathway 5595_5594_1019_5970_3725_4790 6 2.06E-05 0.001443811 5.35E-05 27564 hsa-mir-941-1 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_5599_5970_3725_4790 5 3.26E-05 0.00228437 8.16E-05 27565 hsa-mir-941-1 hsa05211 Renal cell carcinoma 5595_5594_1387_3725_2033 5 3.48E-05 0.002433675 8.39E-05 27566 hsa-mir-941-1 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725_4790 5 4.18E-05 0.002927337 9.76E-05 27567 hsa-mir-941-1 hsa04510 Focal adhesion 1956_1499_5595_5594_5599_3725_2002 7 7.72E-05 0.005407483 0.000174435 27568 hsa-mir-941-1 hsa04630 Jak-STAT signaling pathway 1387_6778_6776_4609_2033_8554 6 0.000128378 0.008986473 0.000280827 27569 hsa-mir-941-1 hsa04150 mTOR signaling pathway 5595_5594_6195_6196 4 0.000151252 0.010587661 0.000320838 27570 hsa-mir-941-1 hsa05016 Huntington's disease 1385_1387_6667_841_10891_2033 6 0.000351229 0.024586001 0.000723118 27571 hsa-mir-941-1 hsa04062 Chemokine signaling pathway 5595_5594_5566_5970_6348_4790 6 0.000402083 0.028145837 0.000804167 27572 hsa-mir-941-1 hsa03320 PPAR signaling pathway 6258_6257_6256_2168 4 0.000443361 0.031035241 0.00086209 27573 hsa-mir-941-1 hsa04210 Apoptosis 5566_841_5970_4790 4 0.001048989 0.073429252 0.001984574 27574 hsa-mir-941-1 hsa04540 Gap junction 1956_5595_5594_5566 4 0.001226654 0.085865813 0.002259627 27575 hsa-mir-941-1 hsa04930 Type II diabetes mellitus 5595_5594_5599 3 0.001577628 0.110433982 0.002831641 27576 hsa-mir-941-1 hsa04330 Notch signaling pathway 1387_9612_2033 3 0.001775382 0.124276768 0.003106919 27577 hsa-mir-941-1 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599 3 0.007179361 0.50255525 0.012257445 27578 hsa-mir-941-1 hsa04270 Vascular smooth muscle contraction 5595_5594_5566 3 0.020415455 1 0.034025759 27579 hsa-mir-941-1 hsa04730 Long-term depression 5595_5594 2 0.047776944 1 0.077776421 27580 hsa-mir-941-3 hsa05200 Pathways in cancer 1956_1499_5595_5594_5599_6258_1387_6257_6256_8031_2308_1019_1017_841_6776_5970_6688_4609_3725_1026_861_4088_4089_1050_5925_2033_8554_4790 28 7.69E-26 5.39E-24 5.39E-24 27581 hsa-mir-941-3 hsa04010 MAPK signaling pathway 6722_3727_1956_5595_5594_5599_1386_5566_9252_1649_5970_10912_468_4609_3725_6195_6196_4616_4790_2002 20 1.52E-17 1.06E-15 5.31E-16 27582 hsa-mir-941-3 hsa05215 Prostate cancer 1956_1499_5595_5594_1385_1387_2308_1017_5970_468_1026_5925_2033_4790 14 7.02E-17 4.91E-15 1.42E-15 27583 hsa-mir-941-3 hsa05212 Pancreatic cancer 1956_1499_5595_5594_1385_1387_2308_1017_5970_468_1026_5925_2033_4790 14 8.09E-17 5.66E-15 1.42E-15 27584 hsa-mir-941-3 hsa05220 Chronic myeloid leukemia 5595_5594_1019_6776_5970_4609_1026_861_4088_4089_5925_4790 12 1.16E-14 8.10E-13 1.62E-13 27585 hsa-mir-941-3 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_7027_1874_4609_4088_4089_2033_5933 11 1.58E-12 1.10E-10 1.73E-11 27586 hsa-mir-941-3 hsa04110 Cell cycle 1387_1019_1017_7027_10912_1026_4088_4089_4616_5925_2033_5933 12 1.73E-12 1.21E-10 1.73E-11 27587 hsa-mir-941-3 hsa05216 Thyroid cancer 1499_5595_5594_6258_6257_6256_8031_4609 8 7.65E-12 5.36E-10 6.70E-11 27588 hsa-mir-941-3 hsa05222 Small cell lung cancer 6258_6257_6256_1019_1017_5970_4609_5925_8554_4790 10 3.59E-11 2.51E-09 2.53E-10 27589 hsa-mir-941-3 hsa05221 Acute myeloid leukemia 5595_5594_6776_5970_6688_4609_861_1050_4790 9 3.90E-11 2.73E-09 2.53E-10 27590 hsa-mir-941-3 hsa04012 ErbB signaling pathway 815_1956_5595_5594_5599_6776_4609_3725_1026_2002 10 3.98E-11 2.79E-09 2.53E-10 27591 hsa-mir-941-3 hsa05219 Bladder cancer 1956_5595_5594_1019_9252_4609_1026_5925 8 1.01E-10 7.07E-09 5.89E-10 27592 hsa-mir-941-3 hsa04720 Long-term potentiation 815_5595_5594_1387_5566_468_6195_6196_2033 9 2.73E-10 1.91E-08 1.47E-09 27593 hsa-mir-941-3 hsa05223 Non-small cell lung cancer 1956_5595_5594_6258_6257_6256_1019_5925 8 6.06E-10 4.24E-08 3.03E-09 27594 hsa-mir-941-3 hsa05210 Colorectal cancer 1956_1499_5595_5594_5599_4609_3725_4088_4089 9 6.89E-10 4.82E-08 3.21E-09 27595 hsa-mir-941-3 hsa04912 GnRH signaling pathway 815_1956_5595_5594_5599_5566_468_3725_2002 9 5.37E-09 3.76E-07 2.35E-08 27596 hsa-mir-941-3 hsa04310 Wnt signaling pathway 815_1499_5599_1387_5566_4609_3725_4088_4089_2033 10 6.29E-09 4.40E-07 2.59E-08 27597 hsa-mir-941-3 hsa04520 Adherens junction 1956_1499_5595_5594_1387_4088_4089_2033 8 1.04E-08 7.27E-07 4.04E-08 27598 hsa-mir-941-3 hsa05214 Glioma 815_1956_5595_5594_1019_1026_5925 7 5.57E-08 3.90E-06 2.05E-07 27599 hsa-mir-941-3 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_841_5970_3725_6348_4790 8 6.06E-08 4.24E-06 2.12E-07 27600 hsa-mir-941-3 hsa04920 Adipocytokine signaling pathway 5599_6258_6257_6256_5970_10891_4790 7 6.75E-08 4.73E-06 2.22E-07 27601 hsa-mir-941-3 hsa04916 Melanogenesis 815_1499_5595_5594_1385_1387_5566_2033 8 6.97E-08 4.88E-06 2.22E-07 27602 hsa-mir-941-3 hsa05213 Endometrial cancer 1956_1499_5595_5594_4609_2002 6 3.53E-07 2.47E-05 1.07E-06 27603 hsa-mir-941-3 hsa04115 p53 signaling pathway 1019_1017_841_10912_1026_4616 6 1.64E-06 0.000115029 4.79E-06 27604 hsa-mir-941-3 hsa05218 Melanoma 1956_5595_5594_1019_1026_5925 6 1.92E-06 0.000134385 5.38E-06 27605 hsa-mir-941-3 hsa04910 Insulin signaling pathway 5595_5594_5599_2308_5566_10891_2002 7 6.53E-06 0.000457337 1.76E-05 27606 hsa-mir-941-3 hsa04660 T cell receptor signaling pathway 5595_5594_1019_5970_3725_4790 6 2.06E-05 0.001443811 5.35E-05 27607 hsa-mir-941-3 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_5599_5970_3725_4790 5 3.26E-05 0.00228437 8.16E-05 27608 hsa-mir-941-3 hsa05211 Renal cell carcinoma 5595_5594_1387_3725_2033 5 3.48E-05 0.002433675 8.39E-05 27609 hsa-mir-941-3 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725_4790 5 4.18E-05 0.002927337 9.76E-05 27610 hsa-mir-941-3 hsa04510 Focal adhesion 1956_1499_5595_5594_5599_3725_2002 7 7.72E-05 0.005407483 0.000174435 27611 hsa-mir-941-3 hsa04630 Jak-STAT signaling pathway 1387_6778_6776_4609_2033_8554 6 0.000128378 0.008986473 0.000280827 27612 hsa-mir-941-3 hsa04150 mTOR signaling pathway 5595_5594_6195_6196 4 0.000151252 0.010587661 0.000320838 27613 hsa-mir-941-3 hsa05016 Huntington's disease 1385_1387_6667_841_10891_2033 6 0.000351229 0.024586001 0.000723118 27614 hsa-mir-941-3 hsa04062 Chemokine signaling pathway 5595_5594_5566_5970_6348_4790 6 0.000402083 0.028145837 0.000804167 27615 hsa-mir-941-3 hsa03320 PPAR signaling pathway 6258_6257_6256_2168 4 0.000443361 0.031035241 0.00086209 27616 hsa-mir-941-3 hsa04210 Apoptosis 5566_841_5970_4790 4 0.001048989 0.073429252 0.001984574 27617 hsa-mir-941-3 hsa04540 Gap junction 1956_5595_5594_5566 4 0.001226654 0.085865813 0.002259627 27618 hsa-mir-941-3 hsa04930 Type II diabetes mellitus 5595_5594_5599 3 0.001577628 0.110433982 0.002831641 27619 hsa-mir-941-3 hsa04330 Notch signaling pathway 1387_9612_2033 3 0.001775382 0.124276768 0.003106919 27620 hsa-mir-941-3 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599 3 0.007179361 0.50255525 0.012257445 27621 hsa-mir-941-3 hsa04270 Vascular smooth muscle contraction 5595_5594_5566 3 0.020415455 1 0.034025759 27622 hsa-mir-941-3 hsa04730 Long-term depression 5595_5594 2 0.047776944 1 0.077776421 27623 hsa-mir-941-4 hsa05200 Pathways in cancer 1956_1499_5595_5594_5599_6258_1387_6257_6256_8031_2308_1019_1017_841_6776_5970_6688_4609_3725_1026_861_4088_4089_1050_5925_2033_8554_4790 28 7.69E-26 5.39E-24 5.39E-24 27624 hsa-mir-941-4 hsa04010 MAPK signaling pathway 6722_3727_1956_5595_5594_5599_1386_5566_9252_1649_5970_10912_468_4609_3725_6195_6196_4616_4790_2002 20 1.52E-17 1.06E-15 5.31E-16 27625 hsa-mir-941-4 hsa05215 Prostate cancer 1956_1499_5595_5594_1385_1387_2308_1017_5970_468_1026_5925_2033_4790 14 7.02E-17 4.91E-15 1.42E-15 27626 hsa-mir-941-4 hsa05212 Pancreatic cancer 1956_1499_5595_5594_1385_1387_2308_1017_5970_468_1026_5925_2033_4790 14 8.09E-17 5.66E-15 1.42E-15 27627 hsa-mir-941-4 hsa05220 Chronic myeloid leukemia 5595_5594_1019_6776_5970_4609_1026_861_4088_4089_5925_4790 12 1.16E-14 8.10E-13 1.62E-13 27628 hsa-mir-941-4 hsa04350 TGF-beta signaling pathway 5595_5594_1387_6667_7027_1874_4609_4088_4089_2033_5933 11 1.58E-12 1.10E-10 1.73E-11 27629 hsa-mir-941-4 hsa04110 Cell cycle 1387_1019_1017_7027_10912_1026_4088_4089_4616_5925_2033_5933 12 1.73E-12 1.21E-10 1.73E-11 27630 hsa-mir-941-4 hsa05216 Thyroid cancer 1499_5595_5594_6258_6257_6256_8031_4609 8 7.65E-12 5.36E-10 6.70E-11 27631 hsa-mir-941-4 hsa05222 Small cell lung cancer 6258_6257_6256_1019_1017_5970_4609_5925_8554_4790 10 3.59E-11 2.51E-09 2.53E-10 27632 hsa-mir-941-4 hsa05221 Acute myeloid leukemia 5595_5594_6776_5970_6688_4609_861_1050_4790 9 3.90E-11 2.73E-09 2.53E-10 27633 hsa-mir-941-4 hsa04012 ErbB signaling pathway 815_1956_5595_5594_5599_6776_4609_3725_1026_2002 10 3.98E-11 2.79E-09 2.53E-10 27634 hsa-mir-941-4 hsa05219 Bladder cancer 1956_5595_5594_1019_9252_4609_1026_5925 8 1.01E-10 7.07E-09 5.89E-10 27635 hsa-mir-941-4 hsa04720 Long-term potentiation 815_5595_5594_1387_5566_468_6195_6196_2033 9 2.73E-10 1.91E-08 1.47E-09 27636 hsa-mir-941-4 hsa05223 Non-small cell lung cancer 1956_5595_5594_6258_6257_6256_1019_5925 8 6.06E-10 4.24E-08 3.03E-09 27637 hsa-mir-941-4 hsa05210 Colorectal cancer 1956_1499_5595_5594_5599_4609_3725_4088_4089 9 6.89E-10 4.82E-08 3.21E-09 27638 hsa-mir-941-4 hsa04912 GnRH signaling pathway 815_1956_5595_5594_5599_5566_468_3725_2002 9 5.37E-09 3.76E-07 2.35E-08 27639 hsa-mir-941-4 hsa04310 Wnt signaling pathway 815_1499_5599_1387_5566_4609_3725_4088_4089_2033 10 6.29E-09 4.40E-07 2.59E-08 27640 hsa-mir-941-4 hsa04520 Adherens junction 1956_1499_5595_5594_1387_4088_4089_2033 8 1.04E-08 7.27E-07 4.04E-08 27641 hsa-mir-941-4 hsa05214 Glioma 815_1956_5595_5594_1019_1026_5925 7 5.57E-08 3.90E-06 2.05E-07 27642 hsa-mir-941-4 hsa04620 Toll-like receptor signaling pathway 5595_5594_5599_841_5970_3725_6348_4790 8 6.06E-08 4.24E-06 2.12E-07 27643 hsa-mir-941-4 hsa04920 Adipocytokine signaling pathway 5599_6258_6257_6256_5970_10891_4790 7 6.75E-08 4.73E-06 2.22E-07 27644 hsa-mir-941-4 hsa04916 Melanogenesis 815_1499_5595_5594_1385_1387_5566_2033 8 6.97E-08 4.88E-06 2.22E-07 27645 hsa-mir-941-4 hsa05213 Endometrial cancer 1956_1499_5595_5594_4609_2002 6 3.53E-07 2.47E-05 1.07E-06 27646 hsa-mir-941-4 hsa04115 p53 signaling pathway 1019_1017_841_10912_1026_4616 6 1.64E-06 0.000115029 4.79E-06 27647 hsa-mir-941-4 hsa05218 Melanoma 1956_5595_5594_1019_1026_5925 6 1.92E-06 0.000134385 5.38E-06 27648 hsa-mir-941-4 hsa04910 Insulin signaling pathway 5595_5594_5599_2308_5566_10891_2002 7 6.53E-06 0.000457337 1.76E-05 27649 hsa-mir-941-4 hsa04660 T cell receptor signaling pathway 5595_5594_1019_5970_3725_4790 6 2.06E-05 0.001443811 5.35E-05 27650 hsa-mir-941-4 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_5599_5970_3725_4790 5 3.26E-05 0.00228437 8.16E-05 27651 hsa-mir-941-4 hsa05211 Renal cell carcinoma 5595_5594_1387_3725_2033 5 3.48E-05 0.002433675 8.39E-05 27652 hsa-mir-941-4 hsa04662 B cell receptor signaling pathway 5595_5594_5970_3725_4790 5 4.18E-05 0.002927337 9.76E-05 27653 hsa-mir-941-4 hsa04510 Focal adhesion 1956_1499_5595_5594_5599_3725_2002 7 7.72E-05 0.005407483 0.000174435 27654 hsa-mir-941-4 hsa04630 Jak-STAT signaling pathway 1387_6778_6776_4609_2033_8554 6 0.000128378 0.008986473 0.000280827 27655 hsa-mir-941-4 hsa04150 mTOR signaling pathway 5595_5594_6195_6196 4 0.000151252 0.010587661 0.000320838 27656 hsa-mir-941-4 hsa05016 Huntington's disease 1385_1387_6667_841_10891_2033 6 0.000351229 0.024586001 0.000723118 27657 hsa-mir-941-4 hsa04062 Chemokine signaling pathway 5595_5594_5566_5970_6348_4790 6 0.000402083 0.028145837 0.000804167 27658 hsa-mir-941-4 hsa03320 PPAR signaling pathway 6258_6257_6256_2168 4 0.000443361 0.031035241 0.00086209 27659 hsa-mir-941-4 hsa04210 Apoptosis 5566_841_5970_4790 4 0.001048989 0.073429252 0.001984574 27660 hsa-mir-941-4 hsa04540 Gap junction 1956_5595_5594_5566 4 0.001226654 0.085865813 0.002259627 27661 hsa-mir-941-4 hsa04930 Type II diabetes mellitus 5595_5594_5599 3 0.001577628 0.110433982 0.002831641 27662 hsa-mir-941-4 hsa04330 Notch signaling pathway 1387_9612_2033 3 0.001775382 0.124276768 0.003106919 27663 hsa-mir-941-4 hsa04664 Fc epsilon RI signaling pathway 5595_5594_5599 3 0.007179361 0.50255525 0.012257445 27664 hsa-mir-941-4 hsa04270 Vascular smooth muscle contraction 5595_5594_5566 3 0.020415455 1 0.034025759 27665 hsa-mir-941-4 hsa04730 Long-term depression 5595_5594 2 0.047776944 1 0.077776421 27666 hsa-mir-942 hsa05200 Pathways in cancer 2249_367_3725_6776_6777_2353_5914_5970_6256 9 2.03E-10 7.70E-09 7.70E-09 27667 hsa-mir-942 hsa05221 Acute myeloid leukemia 6776_6777_5914_5970 4 9.84E-07 3.74E-05 1.87E-05 27668 hsa-mir-942 hsa05220 Chronic myeloid leukemia 6776_6777_5970 3 0.000113081 0.004297074 0.001074269 27669 hsa-mir-942 hsa04662 B cell receptor signaling pathway 3725_2353_5970 3 0.000113081 0.004297074 0.001074269 27670 hsa-mir-942 hsa04012 ErbB signaling pathway 3725_6776_6777 3 0.00017291 0.006570564 0.001314113 27671 hsa-mir-942 hsa04620 Toll-like receptor signaling pathway 3725_2353_5970 3 0.000272526 0.010355982 0.001606221 27672 hsa-mir-942 hsa04010 MAPK signaling pathway 2249_3725_2353_5970 4 0.000330487 0.012558499 0.001606221 27673 hsa-mir-942 hsa04660 T cell receptor signaling pathway 3725_2353_5970 3 0.000338152 0.012849769 0.001606221 27674 hsa-mir-942 hsa04630 Jak-STAT signaling pathway 3977_6776_6777 3 0.000897685 0.03411204 0.003790227 27675 hsa-mir-942 hsa04920 Adipocytokine signaling pathway 5970_6256 2 0.003115381 0.11838449 0.011838449 27676 hsa-mir-942 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5970 2 0.003479392 0.132216888 0.012019717 27677 hsa-mir-942 hsa05210 Colorectal cancer 3725_2353 2 0.004792101 0.18209983 0.0135505 27678 hsa-mir-942 hsa05222 Small cell lung cancer 5970_6256 2 0.005011395 0.190433006 0.0135505 27679 hsa-mir-942 hsa05215 Prostate cancer 367_5970 2 0.00523525 0.198939509 0.0135505 27680 hsa-mir-942 hsa05212 Pancreatic cancer 367_5970 2 0.005348882 0.203257498 0.0135505 27681 hsa-mir-942 hsa03450 Non-homologous end-joining 2547 1 0.01783249 0.677634628 0.042352164 27682 hsa-mir-942 hsa05016 Huntington's disease 6908_6667 2 0.021779742 0.827630199 0.048257818 27683 hsa-mir-942 hsa04062 Chemokine signaling pathway 6777_5970 2 0.022858967 0.868640727 0.048257818 27684 hsa-mir-942 hsa04950 Maturity onset diabetes of the young 6927 1 0.02954865 1 0.0590973 27685 hsa-mir-942 hsa05216 Thyroid cancer 6256 1 0.035355663 1 0.067175759 27686 hsa-mir-942 hsa04080 Neuroactive ligand-receptor interaction 2908_7067 2 0.038234048 1 0.06918542 27687 hsa-mir-942 hsa03410 Base excision repair 142 1 0.043428758 1 0.073648431 27688 hsa-mir-942 hsa03022 Basal transcription factors 6908 1 0.044576682 1 0.073648431 27689 hsa-mir-944 hsa03022 Basal transcription factors 2967_2961_2963_54457_2968_6877_6874_2960_6878_2957_6879_6908_2958_6873_6872_6884_2959_6880_6882_6883_6881_138474_9519 23 9.75E-31 7.32E-29 7.32E-29 27690 hsa-mir-944 hsa05200 Pathways in cancer 4609_3326_3725_2249_1499_5595_5594_5914_1387_6256_367_2932_4193_3265_10401_6776_6777_5970_7157_6688_4089_2113_4087_862_6774_6502_2353_5881_3065_7184_1050_5925_2033_8554_836 35 1.20E-23 9.03E-22 4.52E-22 27691 hsa-mir-944 hsa05215 Prostate cancer 3326_1499_5595_5594_1387_367_2932_4193_3265_5970_7157_7184_5925_2033 14 2.38E-12 1.79E-10 5.12E-11 27692 hsa-mir-944 hsa05212 Pancreatic cancer 3326_1499_5595_5594_1387_367_2932_4193_3265_5970_7157_7184_5925_2033 14 2.73E-12 2.05E-10 5.12E-11 27693 hsa-mir-944 hsa05221 Acute myeloid leukemia 4609_5595_5594_5914_3265_6776_6777_5970_6688_862_6774_1050 12 7.07E-12 5.31E-10 1.06E-10 27694 hsa-mir-944 hsa04010 MAPK signaling pathway 4609_6722_3725_3727_2249_5595_5594_5598_9261_4208_7867_3265_3312_1432_5970_7157_22800_2353_5881_836 20 2.67E-11 2.00E-09 3.34E-10 27695 hsa-mir-944 hsa05220 Chronic myeloid leukemia 4609_5595_5594_4193_3265_6776_6777_5970_7157_4089_3065_5925 12 8.48E-11 6.36E-09 9.09E-10 27696 hsa-mir-944 hsa05210 Colorectal cancer 4609_3725_1499_5595_5594_2932_7157_4089_4087_2353_5881_836 12 2.76E-10 2.07E-08 2.58E-09 27697 hsa-mir-944 hsa04350 TGF-beta signaling pathway 4609_5595_5594_1387_6667_3397_3399_3398_4089_659_4087_2033 12 3.97E-10 2.98E-08 3.31E-09 27698 hsa-mir-944 hsa04110 Cell cycle 4171_1387_2932_4193_4085_7157_4089_4087_6502_3065_5925_2033 12 1.02E-08 7.66E-07 7.66E-08 27699 hsa-mir-944 hsa04720 Long-term potentiation 5595_5594_1387_2902_2906_3265_2033_808_801_805 10 1.57E-08 1.18E-06 1.07E-07 27700 hsa-mir-944 hsa04520 Adherens junction 1460_1499_6714_5595_5594_1387_4089_4087_5881_2033 10 2.75E-08 2.06E-06 1.72E-07 27701 hsa-mir-944 hsa05214 Glioma 5595_5594_4193_3265_7157_5925_808_801_805 9 6.20E-08 4.65E-06 3.55E-07 27702 hsa-mir-944 hsa05216 Thyroid cancer 4609_1499_5595_5594_6256_3265_7157 7 6.63E-08 4.97E-06 3.55E-07 27703 hsa-mir-944 hsa04310 Wnt signaling pathway 4609_3725_1460_1499_1387_8607_2932_7157_4089_4087_5881_2033 12 1.25E-07 9.39E-06 6.26E-07 27704 hsa-mir-944 hsa05016 Huntington's disease 6874_1387_2902_6908_6667_9001_5430_7157_3064_3065_2033_836_9519 13 1.58E-07 1.19E-05 7.42E-07 27705 hsa-mir-944 hsa04916 Melanogenesis 1499_5595_5594_1387_2932_3265_2033_808_801_805 10 2.64E-07 1.98E-05 1.17E-06 27706 hsa-mir-944 hsa04912 GnRH signaling pathway 3725_6714_5595_5594_5598_3265_1432_808_801_805 10 3.65E-07 2.74E-05 1.52E-06 27707 hsa-mir-944 hsa04950 Maturity onset diabetes of the young 5080_3651_168620_6928_6927_3172 6 4.98E-07 3.73E-05 1.97E-06 27708 hsa-mir-944 hsa05010 Alzheimer's disease 5595_5594_2902_2906_2932_840_1020_836_808_351_801_805 12 5.80E-07 4.35E-05 2.08E-06 27709 hsa-mir-944 hsa04012 ErbB signaling pathway 4609_3725_6714_5595_5594_2932_3265_6776_6777 9 5.99E-07 4.49E-05 2.08E-06 27710 hsa-mir-944 hsa05219 Bladder cancer 4609_5595_5594_4193_3265_7157_5925 7 6.10E-07 4.57E-05 2.08E-06 27711 hsa-mir-944 hsa04662 B cell receptor signaling pathway 3725_5595_5594_2932_3265_5970_2353_5881 8 2.07E-06 0.000154951 6.74E-06 27712 hsa-mir-944 hsa05213 Endometrial cancer 4609_1499_5595_5594_2932_3265_7157 7 2.22E-06 0.000166581 6.94E-06 27713 hsa-mir-944 hsa04370 VEGF signaling pathway 6714_5595_5594_9261_7867_3265_1432_5881 8 2.48E-06 0.000185774 7.43E-06 27714 hsa-mir-944 hsa05222 Small cell lung cancer 4609_6256_10401_5970_7157_6502_5925_8554 8 5.30E-06 0.000397176 1.53E-05 27715 hsa-mir-944 hsa05218 Melanoma 2249_5595_5594_4193_3265_7157_5925 7 1.46E-05 0.001094744 4.05E-05 27716 hsa-mir-944 hsa04330 Notch signaling pathway 388585_1387_9612_3065_2033_8850 6 1.58E-05 0.001187155 4.11E-05 27717 hsa-mir-944 hsa05211 Renal cell carcinoma 3725_5595_5594_1387_3265_2113_2033 7 1.59E-05 0.001190858 4.11E-05 27718 hsa-mir-944 hsa04660 T cell receptor signaling pathway 3725_5595_5594_2932_3265_1432_5970_2353 8 2.82E-05 0.002116562 7.06E-05 27719 hsa-mir-944 hsa05223 Non-small cell lung cancer 5595_5594_6256_3265_7157_5925 6 3.25E-05 0.002439597 7.87E-05 27720 hsa-mir-944 hsa04630 Jak-STAT signaling pathway 4609_1387_10401_6776_6777_6774_2033_3977_8554 9 4.80E-05 0.003596882 0.000112403 27721 hsa-mir-944 hsa04910 Insulin signaling pathway 5595_5594_2932_3265_5211_808_801_805 8 0.000127344 0.009550822 0.000289419 27722 hsa-mir-944 hsa03050 Proteasome 5705_5701_5702_5719_5710 5 0.000198965 0.014922359 0.000438893 27723 hsa-mir-944 hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_2906_1432_7157_836 5 0.000386148 0.0289611 0.00082746 27724 hsa-mir-944 hsa04540 Gap junction 6714_5595_5594_5598_10382_3265 6 0.000523652 0.039273891 0.001090941 27725 hsa-mir-944 hsa04620 Toll-like receptor signaling pathway 3725_5595_5594_1432_5970_2353 6 0.000829043 0.062178211 0.001680492 27726 hsa-mir-944 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_6714_1432_5970_836 5 0.001060042 0.079503142 0.002092188 27727 hsa-mir-944 hsa03420 Nucleotide excision repair 2967_2968_4331_5887 4 0.001414575 0.106093109 0.002720336 27728 hsa-mir-944 hsa04510 Focal adhesion 3725_1499_6714_5595_5594_2932_3265_5881 8 0.001602842 0.120213128 0.003005328 27729 hsa-mir-944 hsa04664 Fc epsilon RI signaling pathway 5595_5594_3265_1432_5881 5 0.001658917 0.124418779 0.003034604 27730 hsa-mir-944 hsa04360 Axon guidance 5595_5594_2932_3265_1020_5881 6 0.002792244 0.209418289 0.00498615 27731 hsa-mir-944 hsa04530 Tight junction 1460_1499_6714_3265_22800_8573 6 0.003450861 0.258814546 0.006018943 27732 hsa-mir-944 hsa04120 Ubiquitin mediated proteolysis 672_4193_10401_7329_6502_8554 6 0.003694145 0.277060902 0.006296839 27733 hsa-mir-944 hsa04062 Chemokine signaling pathway 5595_5594_2932_3265_6777_5970_6774 7 0.004443337 0.333250264 0.007405561 27734 hsa-mir-944 hsa04270 Vascular smooth muscle contraction 5595_5594_808_801_805 5 0.008449747 0.633731031 0.013776762 27735 hsa-mir-944 hsa04930 Type II diabetes mellitus 5595_5594_3651 3 0.012721224 0.954091826 0.020299826 27736 hsa-mir-944 hsa04612 Antigen processing and presentation 3326_4800_4801_3312 4 0.014905486 1 0.02281452 27737 hsa-mir-944 hsa04210 Apoptosis 840_5970_7157_836 4 0.014905486 1 0.02281452 27738 hsa-mir-944 hsa04650 Natural killer cell mediated cytotoxicity 5595_5594_3265_5881_836 5 0.01544685 1 0.023170275 27739 hsa-mir-944 hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.021083418 1 0.031005027 27740 hsa-mir-944 hsa04810 Regulation of actin cytoskeleton 2249_5595_5594_3265_22800_5881 6 0.02762224 1 0.039839769 27741 hsa-mir-944 hsa04920 Adipocytokine signaling pathway 6256_5970_6774 3 0.034257677 1 0.048477845 27742 hsa-mir-944 hsa04115 p53 signaling pathway 4193_7157_836 3 0.036783871 1 0.05108871 27743 hsa-mir-944 hsa04730 Long-term depression 5595_5594_3265 3 0.039403013 1 0.053731381 27744 hsa-mir-944 hsa04020 Calcium signaling pathway 2902_2906_808_801_805 5 0.043859571 1 0.058740497 27745 hsa-mir-944 hsa04070 Phosphatidylinositol signaling system 808_801_805 3 0.046352229 1 0.060989775 27746 hsa-mir-95 hsa05200 Pathways in cancer 4088_4089_5601_1050_5371_5925_2033_367_4609_3725_5595_5599_2353_1387 14 6.71E-17 3.49E-15 3.49E-15 27747 hsa-mir-95 hsa04010 MAPK signaling pathway 1432_5601_5600_5603_9252_8550_4609_3725_3727_5595_5599_1649_2353 13 2.23E-16 1.16E-14 5.80E-15 27748 hsa-mir-95 hsa04310 Wnt signaling pathway 4088_4089_5601_2033_8061_4609_3725_5599_1457_1387_1459 11 7.37E-16 3.83E-14 1.28E-14 27749 hsa-mir-95 hsa05210 Colorectal cancer 4088_4089_5601_4609_3725_5595_5599_2353 8 1.11E-12 5.78E-11 1.45E-11 27750 hsa-mir-95 hsa04620 Toll-like receptor signaling pathway 1432_5601_5600_5603_3725_5595_5599_2353 8 4.80E-12 2.50E-10 4.99E-11 27751 hsa-mir-95 hsa04520 Adherens junction 4088_4089_2033_5595_1457_1387_1459 7 5.54E-11 2.88E-09 4.80E-10 27752 hsa-mir-95 hsa04912 GnRH signaling pathway 1432_5601_5600_5603_3725_5595_5599 7 4.03E-10 2.09E-08 2.96E-09 27753 hsa-mir-95 hsa04660 T cell receptor signaling pathway 1432_5601_5600_5603_3725_5595_2353 7 4.55E-10 2.36E-08 2.96E-09 27754 hsa-mir-95 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_5601_5600_5603_3725_5599 6 1.75E-09 9.09E-08 1.01E-08 27755 hsa-mir-95 hsa04664 Fc epsilon RI signaling pathway 1432_5601_5600_5603_5595_5599 6 3.19E-09 1.66E-07 1.66E-08 27756 hsa-mir-95 hsa04350 TGF-beta signaling pathway 4088_4089_2033_4609_5595_1387 6 5.52E-09 2.87E-07 2.51E-08 27757 hsa-mir-95 hsa05215 Prostate cancer 5925_2033_367_9586_5595_1387 6 5.89E-09 3.06E-07 2.51E-08 27758 hsa-mir-95 hsa05212 Pancreatic cancer 5925_2033_367_9586_5595_1387 6 6.28E-09 3.26E-07 2.51E-08 27759 hsa-mir-95 hsa05220 Chronic myeloid leukemia 4088_4089_5925_4609_5595 5 1.33E-07 6.89E-06 4.92E-07 27760 hsa-mir-95 hsa04012 ErbB signaling pathway 5601_4609_3725_5595_5599 5 2.67E-07 1.39E-05 9.27E-07 27761 hsa-mir-95 hsa05219 Bladder cancer 5925_9252_4609_5595 4 6.84E-07 3.56E-05 2.22E-06 27762 hsa-mir-95 hsa04110 Cell cycle 4088_4089_5925_2033_1387 5 1.18E-06 6.15E-05 3.62E-06 27763 hsa-mir-95 hsa05221 Acute myeloid leukemia 1050_5371_4609_5595 4 2.45E-06 0.00012747 7.08E-06 27764 hsa-mir-95 hsa05211 Renal cell carcinoma 2033_3725_5595_1387 4 5.21E-06 0.000270685 1.42E-05 27765 hsa-mir-95 hsa04370 VEGF signaling pathway 1432_5600_5603_5595 4 6.71E-06 0.000349111 1.75E-05 27766 hsa-mir-95 hsa04930 Type II diabetes mellitus 5601_5595_5599 3 5.18E-05 0.00269356 0.000128265 27767 hsa-mir-95 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_5600_5603 3 9.62E-05 0.005004767 0.000227489 27768 hsa-mir-95 hsa04720 Long-term potentiation 2033_5595_1387 3 0.000220797 0.011481436 0.000478393 27769 hsa-mir-95 hsa04662 B cell receptor signaling pathway 3725_5595_2353 3 0.000220797 0.011481436 0.000478393 27770 hsa-mir-95 hsa04510 Focal adhesion 5601_3725_5595_5599 4 0.000276073 0.014355785 0.000574231 27771 hsa-mir-95 hsa04916 Melanogenesis 2033_5595_1387 3 0.000558872 0.02906135 0.001117744 27772 hsa-mir-95 hsa04670 Leukocyte transendothelial migration 1432_5600_5603 3 0.000878033 0.045657691 0.001691026 27773 hsa-mir-95 hsa05216 Thyroid cancer 4609_5595 2 0.000992158 0.051592217 0.001842579 27774 hsa-mir-95 hsa04910 Insulin signaling pathway 5601_5595_5599 3 0.001242763 0.064623688 0.002228403 27775 hsa-mir-95 hsa04630 Jak-STAT signaling pathway 2033_4609_1387 3 0.001721922 0.089539941 0.002984665 27776 hsa-mir-95 hsa04330 Notch signaling pathway 2033_1387 2 0.002466602 0.128263312 0.004137526 27777 hsa-mir-95 hsa05016 Huntington's disease 2033_9586_1387 3 0.002948918 0.153343712 0.004707144 27778 hsa-mir-95 hsa05213 Endometrial cancer 4609_5595 2 0.002987226 0.155335766 0.004707144 27779 hsa-mir-95 hsa05223 Non-small cell lung cancer 5925_5595 2 0.003208663 0.166850499 0.004907368 27780 hsa-mir-95 hsa05214 Glioma 5925_5595 2 0.004558871 0.237061306 0.00677318 27781 hsa-mir-95 hsa04920 Adipocytokine signaling pathway 5601_5599 2 0.004828059 0.251059084 0.006973863 27782 hsa-mir-95 hsa05218 Melanoma 5925_5595 2 0.005387936 0.280172675 0.007572234 27783 hsa-mir-95 hsa05222 Small cell lung cancer 5925_4609 2 0.007737427 0.402346194 0.010588058 27784 hsa-mir-95 hsa04530 Tight junction 1457_1459 2 0.018474408 0.960669214 0.024632544 27785 hsa-mir-95 hsa04120 Ubiquitin mediated proteolysis 5371_7329 2 0.018976043 0.986754217 0.024668855 27786 hsa-mir-95 hsa05322 Systemic lupus erythematosus 8349_9555 2 0.020255115 1 0.025689415 27787 hsa-mir-95 hsa03440 Homologous recombination 4683 1 0.04255566 1 0.05268796 27788 hsa-mir-96 hsa05200 Pathways in cancer 25_1499_1387_836_1019_367_1017_2932_6688_4609_3725_1026_2353_4087_4088_4089_1050_5925_2033_207_8554 21 4.22E-18 2.66E-16 2.66E-16 27789 hsa-mir-96 hsa04110 Cell cycle 25_7534_1387_1019_1017_7532_2932_7027_1026_4087_4088_4089_5925_2033_5933 15 2.58E-17 1.63E-15 8.14E-16 27790 hsa-mir-96 hsa04350 TGF-beta signaling pathway 1387_7027_1874_659_4609_4086_4087_4088_4089_2033_4093_5933 12 1.67E-14 1.05E-12 3.50E-13 27791 hsa-mir-96 hsa05215 Prostate cancer 1499_1387_367_1017_2932_468_1026_10488_5925_2033_207 11 5.73E-13 3.61E-11 8.08E-12 27792 hsa-mir-96 hsa05212 Pancreatic cancer 1499_1387_367_1017_2932_468_1026_10488_5925_2033_207 11 6.41E-13 4.04E-11 8.08E-12 27793 hsa-mir-96 hsa05210 Colorectal cancer 1499_836_2932_4609_3725_2353_4087_4088_4089_207 10 1.05E-11 6.59E-10 1.10E-10 27794 hsa-mir-96 hsa04310 Wnt signaling pathway 1499_1387_2932_8061_4609_3725_1457_4087_4088_4089_2033 11 1.38E-10 8.69E-09 1.24E-09 27795 hsa-mir-96 hsa05220 Chronic myeloid leukemia 25_1019_4609_1026_4088_4089_5925_207 8 2.90E-09 1.83E-07 2.29E-08 27796 hsa-mir-96 hsa04010 MAPK signaling pathway 3727_5598_1386_836_1432_1649_468_4609_3725_2353_5058_207 12 4.35E-09 2.74E-07 2.93E-08 27797 hsa-mir-96 hsa04520 Adherens junction 1499_6714_1387_1457_4087_4088_4089_2033 8 4.65E-09 2.93E-07 2.93E-08 27798 hsa-mir-96 hsa04012 ErbB signaling pathway 25_6714_2932_4609_3725_1026_5058_207 8 8.57E-09 5.40E-07 4.91E-08 27799 hsa-mir-96 hsa04660 T cell receptor signaling pathway 1019_2932_1432_3725_2353_5058_207 7 7.91E-07 4.98E-05 4.15E-06 27800 hsa-mir-96 hsa05222 Small cell lung cancer 1019_1017_4609_5925_207_8554 6 3.02E-06 0.000190445 1.46E-05 27801 hsa-mir-96 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_836_1432_3725_5058 5 2.00E-05 0.001260239 8.95E-05 27802 hsa-mir-96 hsa05211 Renal cell carcinoma 1387_3725_5058_2033_207 5 2.13E-05 0.001343119 8.95E-05 27803 hsa-mir-96 hsa05219 Bladder cancer 1019_4609_1026_5925 4 4.69E-05 0.002955744 0.000184734 27804 hsa-mir-96 hsa05213 Endometrial cancer 1499_2932_4609_207 4 0.000102136 0.006434547 0.000378503 27805 hsa-mir-96 hsa04916 Melanogenesis 1499_1387_2932_10488_2033 5 0.000112917 0.007113763 0.000395209 27806 hsa-mir-96 hsa04912 GnRH signaling pathway 6714_5598_1432_468_3725 5 0.000133813 0.008430228 0.000443696 27807 hsa-mir-96 hsa05221 Acute myeloid leukemia 6688_4609_1050_207 4 0.000161825 0.010194991 0.00050975 27808 hsa-mir-96 hsa05214 Glioma 1019_1026_5925_207 4 0.000230218 0.014503714 0.000690653 27809 hsa-mir-96 hsa04115 p53 signaling pathway 836_1019_1017_1026 4 0.00028602 0.018019263 0.000819057 27810 hsa-mir-96 hsa05218 Melanoma 1019_1026_5925_207 4 0.000317282 0.01998877 0.000857502 27811 hsa-mir-96 hsa04510 Focal adhesion 1499_6714_2932_3725_5058_207 6 0.000326667 0.020580046 0.000857502 27812 hsa-mir-96 hsa04530 Tight junction 1499_6714_1019_1457_207 5 0.000386695 0.024361795 0.000937816 27813 hsa-mir-96 hsa04662 B cell receptor signaling pathway 2932_3725_2353_207 4 0.000387035 0.024383204 0.000937816 27814 hsa-mir-96 hsa04630 Jak-STAT signaling pathway 1387_4609_2033_207_8554 5 0.000665677 0.04193764 0.001552443 27815 hsa-mir-96 hsa03022 Basal transcription factors 2969_6908_2959 3 0.000689975 0.043468408 0.001552443 27816 hsa-mir-96 hsa04620 Toll-like receptor signaling pathway 1432_3725_2353_207 4 0.00117003 0.073711881 0.002541789 27817 hsa-mir-96 hsa05016 Huntington's disease 1387_6908_836_10488_2033 5 0.001535299 0.096723867 0.003224129 27818 hsa-mir-96 hsa05223 Non-small cell lung cancer 1019_5925_207 3 0.001937182 0.122042441 0.003936853 27819 hsa-mir-96 hsa05131 Shigellosis 25_7534_1499 3 0.002138837 0.134746703 0.004083233 27820 hsa-mir-96 hsa05130 Pathogenic Escherichia coli infection 25_7534_1499 3 0.002138837 0.134746703 0.004083233 27821 hsa-mir-96 hsa04360 Axon guidance 25_1020_2932_5058 4 0.002831842 0.178406038 0.005247236 27822 hsa-mir-96 hsa04720 Long-term potentiation 1387_468_2033 3 0.00471646 0.297136997 0.008489628 27823 hsa-mir-96 hsa04370 VEGF signaling pathway 6714_1432_207 3 0.005061955 0.31890316 0.008858421 27824 hsa-mir-96 hsa04950 Maturity onset diabetes of the young 6927_3172 2 0.005610245 0.353445438 0.009552579 27825 hsa-mir-96 hsa04210 Apoptosis 836_840_207 3 0.007453107 0.469545713 0.012356466 27826 hsa-mir-96 hsa05216 Thyroid cancer 1499_4609 2 0.007914906 0.498639052 0.012531583 27827 hsa-mir-96 hsa05010 Alzheimer's disease 1020_836_2932_840 4 0.007956561 0.501263334 0.012531583 27828 hsa-mir-96 hsa04330 Notch signaling pathway 1387_2033 2 0.019032942 1 0.029245741 27829 hsa-mir-96 hsa04910 Insulin signaling pathway 2932_207_2538 3 0.023319939 1 0.034979909 27830 hsa-mir-96 hsa05217 Basal cell carcinoma 1499_2932 2 0.025260644 1 0.03700978 27831 hsa-mir-96 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_1432 2 0.026090079 1 0.03735625 27832 hsa-mir-96 hsa04340 Hedgehog signaling pathway 53944_2932 2 0.026930474 1 0.037702663 27833 hsa-mir-96 hsa04920 Adipocytokine signaling pathway 207_2538 2 0.035913665 1 0.049186106 27834 hsa-mir-96 hsa04664 Fc epsilon RI signaling pathway 1432_207 2 0.047979788 1 0.064313333 27835 hsa-mir-99a hsa03022 Basal transcription factors 2967_2961_2960_2963_6881_54457_2968_6877_6874_6878_2957_6879_6908_6872_2958_6873_2959_6880_6882_138474_6884_6883 22 3.42E-30 2.49E-28 2.49E-28 27836 hsa-mir-99a hsa05200 Pathways in cancer 2249_367_1499_5595_5594_5914_1387_6256_10401_1487_1488_2932_4193_6776_6777_5970_7157_6688_4609_3725_2353_3065_4087_4088_4089_5925_2033_207_208_3326_8554_7184 32 4.46E-22 3.25E-20 1.63E-20 27837 hsa-mir-99a hsa05220 Chronic myeloid leukemia 5595_5594_1487_1488_4193_6776_6777_5970_7157_4609_3065_4088_4089_5925_207_208 16 1.96E-16 1.43E-14 4.78E-15 27838 hsa-mir-99a hsa05215 Prostate cancer 367_1499_5595_5594_1387_2932_4193_5970_7157_468_5925_2033_207_208_3326_7184 16 1.80E-15 1.31E-13 3.08E-14 27839 hsa-mir-99a hsa05212 Pancreatic cancer 367_1499_5595_5594_1387_2932_4193_5970_7157_468_5925_2033_207_208_3326_7184 16 2.11E-15 1.54E-13 3.08E-14 27840 hsa-mir-99a hsa04110 Cell cycle 993_1387_4171_983_7534_7533_7532_2932_4193_4085_7157_3065_4087_4088_4089_5925_2033 17 8.34E-15 6.09E-13 1.01E-13 27841 hsa-mir-99a hsa05210 Colorectal cancer 1499_5595_5594_2932_7157_4609_3725_2353_4087_4088_4089_207_208 13 5.10E-12 3.72E-10 5.32E-11 27842 hsa-mir-99a hsa04310 Wnt signaling pathway 1460_1499_1387_8607_1487_1488_2932_7157_4609_3725_4087_4088_4089_2033 14 4.30E-10 3.14E-08 3.93E-09 27843 hsa-mir-99a hsa05221 Acute myeloid leukemia 5595_5594_5914_6776_6777_5970_6688_4609_207_208 10 6.89E-10 5.03E-08 5.59E-09 27844 hsa-mir-99a hsa04012 ErbB signaling pathway 6714_5595_5594_2932_6776_6777_4609_3725_5058_207_208 11 1.58E-09 1.16E-07 1.16E-08 27845 hsa-mir-99a hsa04520 Adherens junction 1460_1499_6714_5595_5594_1387_4087_4088_4089_2033 10 9.80E-09 7.16E-07 6.51E-08 27846 hsa-mir-99a hsa04010 MAPK signaling pathway 6722_3727_2249_5595_5594_1649_3312_5970_7157_468_4609_3725_2353_5058_207_208 16 1.13E-08 8.22E-07 6.85E-08 27847 hsa-mir-99a hsa05213 Endometrial cancer 1499_5595_5594_2932_7157_4609_207_208 8 7.12E-08 5.20E-06 4.00E-07 27848 hsa-mir-99a hsa05222 Small cell lung cancer 6256_10401_5970_7157_4609_5925_207_208_8554 9 2.19E-07 1.60E-05 1.14E-06 27849 hsa-mir-99a hsa04350 TGF-beta signaling pathway 6667_5595_5594_1387_4609_4087_4088_4089_2033 9 2.40E-07 1.75E-05 1.17E-06 27850 hsa-mir-99a hsa05016 Huntington's disease 6667_6874_25942_1387_6908_9001_5430_7157_3065_3064_10476_2033 12 3.34E-07 2.44E-05 1.52E-06 27851 hsa-mir-99a hsa04330 Notch signaling pathway 1387_1487_1488_9612_3065_2033_8850 7 5.81E-07 4.24E-05 2.50E-06 27852 hsa-mir-99a hsa05218 Melanoma 2249_5595_5594_4193_7157_5925_207_208 8 6.25E-07 4.56E-05 2.53E-06 27853 hsa-mir-99a hsa05211 Renal cell carcinoma 5595_5594_1387_3725_5058_2033_207_208 8 6.89E-07 5.03E-05 2.53E-06 27854 hsa-mir-99a hsa05216 Thyroid cancer 1499_5595_5594_6256_7157_4609 6 6.92E-07 5.05E-05 2.53E-06 27855 hsa-mir-99a hsa04662 B cell receptor signaling pathway 5595_5594_2932_5970_3725_2353_207_208 8 9.16E-07 6.69E-05 3.19E-06 27856 hsa-mir-99a hsa05223 Non-small cell lung cancer 5595_5594_6256_7157_5925_207_208 7 1.36E-06 9.90E-05 4.50E-06 27857 hsa-mir-99a hsa04660 T cell receptor signaling pathway 5595_5594_2932_5970_3725_2353_5058_207_208 9 1.49E-06 0.000109123 4.74E-06 27858 hsa-mir-99a hsa04630 Jak-STAT signaling pathway 1387_10401_6776_6777_4609_2033_3977_207_208_8554 10 2.95E-06 0.00021507 8.96E-06 27859 hsa-mir-99a hsa05214 Glioma 5595_5594_4193_7157_5925_207_208 7 4.21E-06 0.000307121 1.23E-05 27860 hsa-mir-99a hsa05219 Bladder cancer 5595_5594_4193_7157_4609_5925 6 4.74E-06 0.00034593 1.33E-05 27861 hsa-mir-99a hsa04620 Toll-like receptor signaling pathway 5595_5594_5970_3725_2353_207_208 7 6.40E-05 0.004670189 0.00017297 27862 hsa-mir-99a hsa04950 Maturity onset diabetes of the young 3651_6927_3172_5080 4 0.000114844 0.00838363 0.000299415 27863 hsa-mir-99a hsa03050 Proteasome 5705_5701_5702_5719_5710 5 0.000119815 0.008746512 0.000301604 27864 hsa-mir-99a hsa04510 Focal adhesion 1499_6714_5595_5594_2932_3725_5058_207_208 9 0.000165803 0.012103594 0.000403453 27865 hsa-mir-99a hsa04530 Tight junction 1460_1499_6714_4628_60412_207_208 7 0.00036051 0.026317233 0.000848943 27866 hsa-mir-99a hsa04910 Insulin signaling pathway 5595_5594_2932_5211_207_208_2538 7 0.000375905 0.027441101 0.000857534 27867 hsa-mir-99a hsa04920 Adipocytokine signaling pathway 6256_5970_207_208_2538 5 0.000507773 0.037067394 0.001109063 27868 hsa-mir-99a hsa04916 Melanogenesis 1499_5595_5594_1387_2932_2033 6 0.000517339 0.037765725 0.001109063 27869 hsa-mir-99a hsa04062 Chemokine signaling pathway 5595_5594_2932_6777_5970_5058_207_208 8 0.000531743 0.038817215 0.001109063 27870 hsa-mir-99a hsa04720 Long-term potentiation 5595_5594_1387_468_2033 5 0.000822584 0.060048631 0.001668018 27871 hsa-mir-99a hsa04370 VEGF signaling pathway 6714_5595_5594_207_208 5 0.000920009 0.067160675 0.001815153 27872 hsa-mir-99a hsa03420 Nucleotide excision repair 2967_2968_4331_5887 4 0.000946548 0.069098018 0.001818369 27873 hsa-mir-99a hsa04150 mTOR signaling pathway 5595_5594_207_208 4 0.001688186 0.123237547 0.003093072 27874 hsa-mir-99a hsa04612 Antigen processing and presentation 4801_4800_1514_3312_3326 5 0.001694834 0.123722894 0.003093072 27875 hsa-mir-99a hsa04540 Gap junction 6714_5595_5594_983_10382 5 0.002036302 0.148650031 0.003625611 27876 hsa-mir-99a hsa04912 GnRH signaling pathway 6714_5595_5594_468_3725 5 0.003771824 0.275343176 0.00655579 27877 hsa-mir-99a hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5970_3725_5058 4 0.00488524 0.356622545 0.008293548 27878 hsa-mir-99a hsa04664 Fc epsilon RI signaling pathway 5595_5594_207_208 4 0.006981957 0.509682856 0.011583701 27879 hsa-mir-99a hsa04930 Type II diabetes mellitus 3651_5595_5594 3 0.009486581 0.692520444 0.015389343 27880 hsa-mir-99a hsa04210 Apoptosis 5970_7157_207_208 4 0.010342351 0.754991642 0.016412862 27881 hsa-mir-99a hsa05217 Basal cell carcinoma 1499_2932_7157 3 0.015841104 1 0.024604268 27882 hsa-mir-99a hsa05131 Shigellosis 1499_7534_10382 3 0.016580022 1 0.02470085 27883 hsa-mir-99a hsa05130 Pathogenic Escherichia coli infection 1499_7534_10382 3 0.016580022 1 0.02470085 27884 hsa-mir-99a hsa04115 p53 signaling pathway 983_4193_7157 3 0.027926018 1 0.040771987 27885 hsa-mir-99a hsa04360 Axon guidance 5595_5594_2932_5058 4 0.035008199 1 0.050109775 27886 hsa-mir-99a hsa04120 Ubiquitin mediated proteolysis 672_10401_4193_8554 4 0.041816075 1 0.058703337 27887 hsa-mir-99a hsa03410 Base excision repair 3146_142 2 0.046648205 1 0.064251301 27888 hsa-mir-99b hsa05200 Pathways in cancer 3065_4089_25_836_7157_5925_2033_324_2113_8554_1499_841_861_1387 14 5.93E-14 2.67E-12 2.67E-12 27889 hsa-mir-99b hsa05016 Huntington's disease 3065_6908_836_7157_2033_1213_841_3092_1387 9 8.53E-10 3.84E-08 1.92E-08 27890 hsa-mir-99b hsa04350 TGF-beta signaling pathway 4086_4089_2033_4093_3399_3398_1387 7 2.37E-09 1.07E-07 3.56E-08 27891 hsa-mir-99b hsa04110 Cell cycle 3065_4089_25_7157_5925_2033_1387 7 1.85E-08 8.31E-07 2.08E-07 27892 hsa-mir-99b hsa05220 Chronic myeloid leukemia 3065_4089_25_7157_5925_861 6 3.62E-08 1.63E-06 3.25E-07 27893 hsa-mir-99b hsa04310 Wnt signaling pathway 4089_7157_2033_324_1499_1387 6 1.90E-06 8.55E-05 1.36E-05 27894 hsa-mir-99b hsa05210 Colorectal cancer 4089_836_7157_324_1499 5 2.11E-06 9.49E-05 1.36E-05 27895 hsa-mir-99b hsa05215 Prostate cancer 7157_5925_2033_1499_1387 5 2.62E-06 0.000117946 1.38E-05 27896 hsa-mir-99b hsa05212 Pancreatic cancer 7157_5925_2033_1499_1387 5 2.76E-06 0.000124348 1.38E-05 27897 hsa-mir-99b hsa04330 Notch signaling pathway 9612_3065_2033_1387 4 6.19E-06 0.000278755 2.79E-05 27898 hsa-mir-99b hsa05014 Amyotrophic lateral sclerosis (ALS) 836_834_7157_1616 4 1.19E-05 0.000535424 4.87E-05 27899 hsa-mir-99b hsa04520 Adherens junction 4089_2033_1499_1387 4 4.51E-05 0.002031354 0.00016928 27900 hsa-mir-99b hsa04210 Apoptosis 836_7157_839_841 4 6.72E-05 0.003025806 0.000232754 27901 hsa-mir-99b hsa05213 Endometrial cancer 7157_324_1499 3 0.000290595 0.013076791 0.000934056 27902 hsa-mir-99b hsa05217 Basal cell carcinoma 7157_324_1499 3 0.000340078 0.015303488 0.000991237 27903 hsa-mir-99b hsa04120 Ubiquitin mediated proteolysis 7329_11059_8554_11060 4 0.00035244 0.015859786 0.000991237 27904 hsa-mir-99b hsa04115 p53 signaling pathway 836_7157_841 3 0.000642185 0.028898327 0.001699902 27905 hsa-mir-99b hsa05211 Renal cell carcinoma 2033_2113_1387 3 0.000723471 0.032556195 0.001808677 27906 hsa-mir-99b hsa05222 Small cell lung cancer 7157_5925_8554 3 0.001188767 0.053494527 0.002815501 27907 hsa-mir-99b hsa04916 Melanogenesis 2033_1499_1387 3 0.002016585 0.090746308 0.004537315 27908 hsa-mir-99b hsa05216 Thyroid cancer 7157_1499 2 0.002377872 0.107004231 0.00509544 27909 hsa-mir-99b hsa05219 Bladder cancer 7157_5925 2 0.004744138 0.213486202 0.009703918 27910 hsa-mir-99b hsa04630 Jak-STAT signaling pathway 2033_8554_1387 3 0.006022749 0.271023688 0.011783639 27911 hsa-mir-99b hsa05223 Non-small cell lung cancer 7157_5925 2 0.007585522 0.341348488 0.014050057 27912 hsa-mir-99b hsa05131 Shigellosis 25_1499 2 0.00811781 0.365301471 0.014050057 27913 hsa-mir-99b hsa05130 Pathogenic Escherichia coli infection 25_1499 2 0.00811781 0.365301471 0.014050057 27914 hsa-mir-99b hsa05214 Glioma 7157_5925 2 0.010713124 0.482090574 0.017855206 27915 hsa-mir-99b hsa05218 Melanoma 7157_5925 2 0.012620172 0.567907744 0.020282419 27916 hsa-mir-99b hsa04720 Long-term potentiation 2033_1387 2 0.013967697 0.628546374 0.021674013 27917 hsa-mir-99b hsa04010 MAPK signaling pathway 836_7157_1616 3 0.026671979 1 0.040007969 27918 hsa-mir-99b hsa04530 Tight junction 9223_1499 2 0.041764541 1 0.060625947